data_2lqn_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lqn _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.525 ' HB2' HD13 ' A' ' 99' ' ' ILE . 13.0 p . . . . . 0 N--CA 1.443 -0.782 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.51 ' HB3' ' HG2' ' A' ' 89' ' ' LYS . . . -93.87 127.91 39.88 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.766 178.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 26.0 mtt180 -142.14 -66.61 0.4 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.443 -176.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.422 ' HB2' ' H ' ' A' ' 7' ' ' ASP . 6.8 p90 11.15 -147.18 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 113.653 -1.612 . . . . 0.0 115.253 -161.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.422 ' H ' ' HB2' ' A' ' 6' ' ' PHE . 6.2 p-10 -101.98 -49.54 3.92 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.986 -174.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.407 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 50.4 m 65.16 35.87 7.58 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.586 -175.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.7 m -161.23 -25.92 0.05 Allowed 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 176.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -85.31 108.71 17.93 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.238 0.542 . . . . 0.0 111.064 -169.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.545 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 9.7 mmt180 -62.06 -25.72 67.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.758 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.9 m -90.11 3.51 53.13 Favored 'General case' 0 C--N 1.32 -0.714 0 O-C-N 122.149 -0.344 . . . . 0.0 110.941 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -99.21 -47.62 5.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.448 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.427 ' HB3' ' HB3' ' A' ' 101' ' ' PRO . 36.2 p-90 -114.2 -24.76 8.79 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -174.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.545 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 21.6 t80 -76.97 116.42 17.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.303 0.573 . . . . 0.0 110.107 -177.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.58 ' SD ' ' HA ' ' A' ' 104' ' ' ARG . 9.1 tpp -97.26 -9.16 28.19 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.085 -171.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.5 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 49.81 -115.21 2.85 Favored Glycine 0 CA--C 1.523 0.564 0 CA-C-N 115.398 -0.819 . . . . 0.0 114.292 177.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.5 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 4.6 Cg_exo -74.99 101.19 1.44 Allowed 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 123.056 2.504 . . . . 0.0 112.239 -177.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.576 HG23 ' HG3' ' A' ' 16' ' ' MET . 5.3 t -138.55 -76.46 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 CA-C-O 118.909 -0.567 . . . . 0.0 111.523 -175.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.74 ' H ' ' HD2' ' A' ' 39' ' ' ARG . 51.4 m 94.8 171.66 0.02 OUTLIER 'General case' 0 C--N 1.35 0.63 0 C-N-CA 124.187 0.995 . . . . 0.0 109.353 170.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.504 ' HD2' ' NH2' ' A' ' 39' ' ' ARG . 19.4 mmm180 -51.65 -53.46 38.52 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 123.388 0.43 . . . . 0.0 112.129 -169.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -62.95 -42.53 99.85 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.506 -175.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.418 ' HB3' HG11 ' A' ' 19' ' ' VAL . 12.7 tp10 -72.63 -46.03 56.08 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.296 0.569 . . . . 0.0 109.521 -174.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.24 -47.62 80.89 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.305 -0.862 . . . . 0.0 111.455 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -64.05 -41.57 97.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.081 -175.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.5 t -79.55 -20.92 45.89 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -175.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -80.69 -13.72 58.76 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 120.944 0.402 . . . . 0.0 110.708 178.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.585 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 80.2 mt -128.96 17.07 6.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.244 -177.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.5 82.0 0.1 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.99 -63.94 4.22 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.715 -177.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 45.41 -105.16 0.1 Allowed 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.191 0.596 . . . . 0.0 111.858 -176.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 54.5 mtm180 -126.72 3.0 6.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.579 0.228 . . . . 0.0 110.409 176.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 28.0 m170 66.85 150.62 0.06 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.033 -174.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.33 19.22 79.68 Favored Glycine 0 C--O 1.227 -0.314 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.011 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 76.3 mtp -112.3 141.78 45.6 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.459 ' CD2' HD21 ' A' ' 98' ' ' LEU . 38.4 p90 -137.98 161.62 36.22 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.136 -174.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.481 HD13 ' O ' ' A' ' 37' ' ' LEU . 4.6 pp -150.25 133.83 16.6 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.247 0.546 . . . . 0.0 110.569 172.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.42 HG22 HD11 ' A' ' 50' ' ' LEU . 42.3 t -101.92 107.21 21.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 175.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.74 ' HD2' ' H ' ' A' ' 20' ' ' SER . 28.3 ptt-85 -103.32 177.45 4.84 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 -178.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -75.2 137.43 41.27 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 174.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.516 ' HB3' ' O ' ' A' ' 44' ' ' CYS . 21.1 t -64.56 109.9 2.14 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.378 0.609 . . . . 0.0 111.229 -173.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 57.2 p -77.45 -4.83 47.43 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.602 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.69 -51.34 4.76 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.313 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.516 ' O ' ' HB3' ' A' ' 41' ' ' SER . 34.3 m -135.03 118.95 13.29 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.602 -177.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -59.03 123.86 14.41 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.601 2.201 . . . . 0.0 112.104 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.05 -34.73 4.94 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.947 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.58 ' OD1' ' HA ' ' A' ' 64' ' ' ASN . 44.5 m-20 -86.4 -176.86 6.04 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.491 ' HE2' ' CE1' ' A' ' 71' ' ' PHE . 35.1 m-85 -134.15 172.58 12.65 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 176.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.466 HG23 ' HA ' ' A' ' 41' ' ' SER . 43.1 t -140.7 106.12 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.938 0.399 . . . . 0.0 111.065 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.449 HD13 ' HB2' ' A' ' 36' ' ' PHE . 43.0 tp -78.9 106.26 10.79 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.308 176.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 24.1 m -96.66 132.38 42.37 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 174.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.577 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 72.0 t -125.13 133.3 69.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.712 0.291 . . . . 0.0 111.297 -177.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.585 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 30.7 t -87.52 116.49 25.67 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.288 -0.415 . . . . 0.0 112.063 -176.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.513 ' CG ' HG22 ' A' ' 95' ' ' THR . 7.6 tp10 -151.65 147.7 27.05 Favored 'General case' 0 C--O 1.21 -1.009 0 C-N-CA 119.682 -0.807 . . . . 0.0 109.225 164.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.481 ' ND2' ' HG3' ' A' ' 54' ' ' GLU . 67.4 m-80 56.84 24.05 8.79 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.4 m 57.47 52.82 8.07 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 122.522 1.153 . . . . 0.0 108.411 -174.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.485 ' HG3' ' O ' ' A' ' 54' ' ' GLU 0.25 0.0 OUTLIER -167.44 66.49 0.08 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 113.504 -1.68 . . . . 0.0 109.814 -152.188 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.577 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 20.2 t -73.32 101.01 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 120.861 -1.15 . . . . 0.0 111.252 -167.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.8 m -69.87 122.15 18.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.807 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -96.26 115.92 28.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.891 -175.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.616 ' OH ' ' HB3' ' A' ' 93' ' ' LEU . 37.0 m-85 -108.84 113.95 27.31 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.63 178.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.643 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 57.3 mt -81.35 133.83 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 O-C-N 122.078 -0.388 . . . . 0.0 111.986 -177.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.518 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 5.3 mp -114.27 119.43 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 122.968 0.507 . . . . 0.0 110.853 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.58 ' HA ' ' OD1' ' A' ' 47' ' ' ASP . 11.0 m120 -86.97 148.23 25.41 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.356 -174.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.7 t -89.53 94.96 10.06 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 170.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.45 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 81.6 mt -71.6 135.58 83.66 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 66' ' ' LEU . 33.7 Cg_exo -60.66 -22.43 72.83 Favored 'Trans proline' 0 N--CA 1.473 0.312 0 C-N-CA 123.014 2.476 . . . . 0.0 113.072 -174.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -84.28 17.48 2.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.259 0.552 . . . . 0.0 110.37 176.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.613 ' NE ' ' HA ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER 65.33 52.1 1.48 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.142 175.846 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 63.8 mtt180 -135.54 -175.16 3.85 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.462 175.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.518 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 67.8 m-85 -137.27 136.58 38.18 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.633 0.254 . . . . 0.0 111.25 -173.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 64' ' ' ASN . 61.7 tttp -125.76 108.49 11.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.763 -174.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.643 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 7.3 tt -99.52 102.26 13.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.238 0.542 . . . . 0.0 111.494 -175.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.4 ' C ' ' H ' ' A' ' 76' ' ' GLN . . . 53.3 70.34 0.95 Allowed Glycine 0 CA--C 1.52 0.392 0 CA-C-N 115.437 -0.801 . . . . 0.0 113.728 175.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 34.6 t70 74.89 -30.41 0.2 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.325 0.65 . . . . 0.0 111.568 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.4 ' H ' ' C ' ' A' ' 74' ' ' GLY . 12.1 mm100 -89.55 112.82 24.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.642 0.258 . . . . 0.0 110.809 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 1.3 pm0 -97.41 139.79 32.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.663 0.744 . . . . 0.0 111.484 176.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.502 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 89.9 m-85 -122.34 -172.04 2.38 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.611 175.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -86.11 -29.21 23.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.745 0.307 . . . . 0.0 111.514 -179.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.715 ' HD1' ' HD2' ' A' ' 82' ' ' PRO . 9.1 p80 -163.78 168.11 20.05 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.515 0.198 . . . . 0.0 111.417 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.646 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 6.7 mt -54.51 -58.61 13.3 Favored Pre-proline 0 N--CA 1.468 0.462 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.211 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.715 ' HD2' ' HD1' ' A' ' 80' ' ' HIS . 36.9 Cg_exo -63.9 -3.05 5.19 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.132 1.888 . . . . 0.0 113.263 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.82 -33.79 17.28 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.646 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.1 pp -76.39 -34.09 58.87 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 177.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.503 HD13 ' HA ' ' A' ' 82' ' ' PRO . 60.1 mt -64.66 -29.51 70.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.13 177.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.491 ' CD ' ' HZ2' ' A' ' 89' ' ' LYS . 21.2 tp10 -79.1 -33.9 43.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.378 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -72.21 -33.44 67.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.402 0.62 . . . . 0.0 110.388 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.679 ' CD1' HD22 ' A' ' 93' ' ' LEU . 38.3 m-85 -82.44 1.86 35.47 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.619 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.51 ' HG2' ' HB3' ' A' ' 4' ' ' ALA . 93.8 mttt -73.76 -16.53 61.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.774 173.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 36.8 pt -129.96 -0.65 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 CA-C-O 121.15 0.5 . . . . 0.0 110.725 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -82.67 -40.83 20.17 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.889 -175.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 64.82 101.05 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.382 0 O-C-N 124.548 1.155 . . . . 0.0 109.209 -164.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.679 HD22 ' CD1' ' A' ' 88' ' ' TYR . 26.6 mt -63.66 -99.25 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.763 174.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.659 ' HA ' ' HB3' ' A' ' 154' ' ' GLU . 40.7 t0 -68.35 -59.97 2.79 Favored 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -175.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.651 ' CB ' ' HA ' ' A' ' 156' ' ' PRO . 12.6 t -154.37 14.85 0.45 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.661 0.743 . . . . 0.0 109.594 169.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 12.3 t -145.57 167.07 23.93 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.542 -177.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 38.9 p -97.86 176.01 5.95 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.459 HD21 ' CD2' ' A' ' 36' ' ' PHE . 96.2 mt -77.99 89.4 4.15 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.188 0.518 . . . . 0.0 110.088 177.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.525 HD13 ' HB2' ' A' ' 3' ' ' SER . 38.9 mm -61.95 -64.1 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.327 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.457 ' HB2' ' HD2' ' A' ' 101' ' ' PRO . 13.3 pt-20 -159.44 159.53 28.32 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.569 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' A' ' 100' ' ' GLU . 59.8 Cg_endo -72.63 155.62 54.29 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.268 1.979 . . . . 0.0 112.074 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.03 135.3 70.46 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 176.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.76 138.07 67.9 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.285 1.99 . . . . 0.0 111.262 176.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.58 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 36.6 mtm180 . . . . . 0 C--N 1.327 -0.403 0 CA-C-O 121.082 0.468 . . . . 0.0 110.737 -177.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.625 HD11 ' CZ3' ' A' ' 161' ' ' TRP . 3.0 mm? . . . . . 0 CA--C 1.516 -0.363 0 CA-C-O 121.862 0.839 . . . . 0.0 112.993 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 173.29 -51.84 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 113.34 -1.755 . . . . 0.0 107.08 177.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -119.73 110.83 17.26 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.196 0.522 . . . . 0.0 110.681 173.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 1.016 HG22 ' HG3' ' A' ' 180' ' ' LYS . 61.1 t -128.72 139.39 52.02 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.018 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.557 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 7.5 ptp180 -112.48 155.52 24.12 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 116.834 -1.946 . . . . 0.0 108.952 170.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.687 ' HG1' ' CD ' ' A' ' 148' ' ' GLU . 1.0 OUTLIER -110.32 140.6 44.34 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.477 0.656 . . . . 0.0 110.896 178.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.562 HD22 ' HG2' ' A' ' 179' ' ' GLU . 8.1 mt -113.38 -15.14 12.7 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -177.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -94.73 -14.72 24.5 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -171.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.55 ' HB3' ' C ' ' A' ' 145' ' ' LYS . 3.8 p-10 54.99 102.08 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 122.559 1.171 . . . . 0.0 112.637 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -119.39 86.64 34.08 Favored Pre-proline 0 C--N 1.317 -0.84 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 171.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.64 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 65.9 Cg_endo -85.56 72.97 4.09 Favored 'Trans proline' 0 N--CA 1.445 -1.376 0 C-N-CA 121.897 1.731 . . . . 0.0 112.638 -176.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.67 -34.19 66.92 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 174.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.884 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 0.4 OUTLIER 70.98 40.5 0.9 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.471 -0.864 . . . . 0.0 111.589 174.784 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -126.09 175.03 8.04 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.881 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -92.66 -7.66 46.23 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.8 0.81 . . . . 0.0 109.052 171.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.601 ' O ' ' HB2' ' A' ' 172' ' ' MET . 8.8 mm-40 -93.32 -29.87 15.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.752 176.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -136.18 108.88 7.5 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.851 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.731 ' CD1' ' HB2' ' A' ' 165' ' ' ASN . 58.1 tp -67.26 123.87 87.56 Favored Pre-proline 0 CA--C 1.509 -0.611 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.824 -176.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.884 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 56.3 Cg_endo -71.87 93.6 0.71 Allowed 'Trans proline' 0 N--CA 1.443 -1.472 0 C-N-CA 120.987 1.125 . . . . 0.0 111.348 167.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.614 ' HB2' ' OG1' ' A' ' 130' ' ' THR . 16.7 p90 -103.32 159.61 15.41 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.942 ' H ' ' HG3' ' A' ' 148' ' ' GLU . 47.6 mtpt -110.16 -151.81 0.48 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.144 0.497 . . . . 0.0 111.929 -170.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.787 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -104.47 27.94 7.41 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.323 -176.843 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 159.14 36.96 0.02 OUTLIER Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.242 178.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.942 ' HG3' ' H ' ' A' ' 145' ' ' LYS . 0.0 OUTLIER -86.11 170.25 12.37 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.895 0.878 . . . . 0.0 109.399 171.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.5 mp -114.0 133.04 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 172.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.662 ' CD2' ' HA ' ' A' ' 165' ' ' ASN . 72.2 mt -118.47 155.79 30.18 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -174.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.567 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 92.2 t -122.22 121.73 64.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 174.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.432 ' CD1' ' HB3' ' A' ' 163' ' ' ALA . 46.9 mm -78.04 79.09 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 122.125 0.964 . . . . 0.0 108.411 -177.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.738 HG23 ' HG2' ' A' ' 154' ' ' GLU . 16.9 tt -69.38 -27.96 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 CA-C-N 113.91 -1.495 . . . . 0.0 109.288 -177.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.738 ' HG2' HG23 ' A' ' 153' ' ' ILE . 0.0 OUTLIER -133.01 141.49 48.31 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 171.778 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.539 ' HD2' ' HG ' ' A' ' 125' ' ' LEU . 82.9 tttt -135.1 82.61 41.74 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 168.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.651 ' HA ' ' CB ' ' A' ' 95' ' ' THR . 8.3 Cg_exo -73.03 -47.72 0.31 Allowed 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.538 2.159 . . . . 0.0 111.87 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -107.57 171.13 7.56 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.032 -173.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.626 ' HG3' ' HG2' ' A' ' 159' ' ' GLN . 8.1 pt-20 -89.7 -26.92 20.43 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.752 178.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.626 ' HG2' ' HG3' ' A' ' 158' ' ' GLU . 82.9 mm-40 -101.8 -18.74 15.63 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.483 -175.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.508 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 63.7 m95 -126.66 135.28 50.96 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 175.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . 0.767 ' O ' HG13 ' A' ' 173' ' ' ILE . 49.4 m0 -125.33 137.93 54.06 Favored 'General case' 0 C--O 1.214 -0.771 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.531 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 14.7 m -96.87 102.79 14.64 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -174.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.517 ' HB2' ' HB3' ' A' ' 150' ' ' LEU . . . -118.93 151.74 37.6 Favored 'General case' 0 N--CA 1.426 -1.667 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.069 -174.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.777 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 15.3 ptt-85 -88.69 129.39 35.54 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 175.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.731 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . 65.2 t30 -60.72 178.64 0.21 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.234 -1.348 . . . . 0.0 111.514 -171.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.525 ' HB2' ' HB2' ' A' ' 148' ' ' GLU . 44.0 tptt -50.71 -33.2 21.91 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.103 166.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -64.7 -38.68 91.82 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.709 173.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.484 ' C ' ' HB2' ' A' ' 164' ' ' ARG . . . 107.09 3.81 35.92 Favored Glycine 0 CA--C 1.522 0.471 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.217 -171.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.777 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.4 OUTLIER -77.4 134.61 38.39 Favored 'General case' 0 C--O 1.216 -0.671 0 C-N-CA 123.141 0.576 . . . . 0.0 111.21 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.468 HG23 HG22 ' A' ' 153' ' ' ILE . 60.4 t -85.12 125.55 40.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 117.684 0.22 . . . . 0.0 111.526 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -157.1 157.71 28.27 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.172 172.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.601 ' HB2' ' O ' ' A' ' 140' ' ' GLU . 0.0 OUTLIER -76.94 141.09 40.62 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 117.242 0.521 . . . . 0.0 111.228 179.367 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.767 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.4 pp -142.25 142.9 25.44 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.424 -176.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.501 ' HB2' ' CD1' ' A' ' 177' ' ' TYR . 15.7 Cg_exo -70.36 138.57 36.21 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 123.275 2.65 . . . . 0.0 113.351 -178.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.566 ' O ' HG22 ' A' ' 178' ' ' VAL . 58.9 t -65.1 -45.09 72.57 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 28.0 Cg_endo -63.81 3.09 0.77 Allowed 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.044 1.829 . . . . 0.0 113.2 177.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.501 ' CD1' ' HB2' ' A' ' 174' ' ' PRO . 3.3 m-85 -103.41 -11.85 17.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.237 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.603 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 4.6 m -104.84 -170.8 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 115.691 1.737 . . . . 0.0 115.691 -166.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.562 ' HG2' HD22 ' A' ' 131' ' ' LEU . 4.0 tp10 -159.73 48.21 0.29 Allowed 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 113.164 -1.835 . . . . 0.0 113.226 -153.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 1.016 ' HG3' HG22 ' A' ' 128' ' ' VAL . 2.9 mppt? -70.73 138.1 50.24 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 119.746 -1.846 . . . . 0.0 110.248 -162.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.434 HD13 ' NH2' ' A' ' 129' ' ' ARG . 39.9 tp . . . . . 0 C--N 1.332 -0.188 0 CA-C-N 113.557 -1.656 . . . . 0.0 112.473 -162.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo . . . . . 0 C--O 1.236 0.378 0 CA-C-O 120.782 0.242 . . . . 0.0 111.802 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.523 ' HB ' HG12 ' A' ' 266' ' ' VAL . 11.7 t -101.91 130.85 50.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.025 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -115.56 134.92 54.6 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.35 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . 0.498 ' HB3' HD13 ' A' ' 293' ' ' ILE . . . -131.72 145.1 51.45 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.359 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -98.5 127.94 44.64 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.156 177.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . 0.556 ' O ' ' HA ' ' A' ' 260' ' ' VAL . . . -76.82 102.09 6.15 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 176.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 25.3 pt -94.65 -5.02 10.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.585 -173.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.12 147.62 46.13 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -63.57 133.04 53.06 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.112 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.78 95.37 3.12 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.793 0.33 . . . . 0.0 110.582 -177.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 27.2 m -90.26 162.37 34.83 Favored Pre-proline 0 C--N 1.318 -0.773 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 172.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.502 ' HG3' ' HB2' ' A' ' 257' ' ' ALA . 5.1 Cg_exo -75.67 -151.45 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.152 1.901 . . . . 0.0 111.399 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' CYS . . . . . 0.493 ' O ' ' HB3' ' A' ' 252' ' ' ASP . 42.6 t -147.45 171.74 15.04 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 122.123 -0.361 . . . . 0.0 111.342 -173.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -68.08 -31.16 70.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.958 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -102.41 22.59 13.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.285 0.564 . . . . 0.0 110.539 176.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . 0.493 ' HB3' ' O ' ' A' ' 249' ' ' CYS . 0.1 OUTLIER -83.2 129.03 34.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.416 178.205 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -138.68 -0.57 1.92 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.416 167.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 2.1 p -151.45 21.38 0.73 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.924 -177.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -102.93 109.44 21.0 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.034 0.445 . . . . 0.0 110.594 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.508 ' HA ' ' NH1' ' A' ' 282' ' ' ARG . 0.5 OUTLIER -65.93 139.07 58.23 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.874 -176.821 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.502 ' HB2' ' HG3' ' A' ' 248' ' ' PRO . . . -103.03 123.76 47.23 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.032 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.684 HD11 HG22 ' A' ' 289' ' ' THR . 57.1 mt -135.93 176.36 8.76 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.233 -175.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.448 ' O ' ' HB3' ' A' ' 242' ' ' ALA . 9.7 pt-20 -160.38 177.29 10.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.65 0.262 . . . . 0.0 111.095 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . 0.556 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 57.4 t -66.42 126.55 26.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.954 -171.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 96.14 8.65 57.66 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.888 175.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -103.61 147.27 27.41 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 31.4 mm -107.24 116.08 50.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.124 0.488 . . . . 0.0 110.336 -176.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 10.2 t -85.77 120.77 36.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.572 -177.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . 0.692 ' HD3' ' HG3' ' A' ' 278' ' ' GLU . 35.8 tttp -86.48 100.41 12.35 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.784 175.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.523 HG12 ' HB ' ' A' ' 238' ' ' VAL . 3.9 p -117.0 117.19 54.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.7 0.762 . . . . 0.0 111.095 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 12.7 p -98.2 -38.51 9.27 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.308 177.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . 0.506 ' HB2' ' HB2' ' A' ' 276' ' ' GLU . 42.7 mtt180 -106.81 108.75 20.41 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.141 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 6.2 ptp -114.18 114.51 26.13 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.717 0.77 . . . . 0.0 110.972 173.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -83.89 150.93 25.39 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.514 -176.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 34.4 pt -82.72 11.37 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.042 -177.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -98.58 -6.62 29.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.722 0.296 . . . . 0.0 110.544 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 113.25 -39.13 2.95 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.725 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.514 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 2.4 mp0 -88.3 111.16 21.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.862 0.363 . . . . 0.0 110.366 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.5 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 10.1 m0 -93.86 157.03 16.33 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . 0.506 ' HB2' ' HB2' ' A' ' 268' ' ' ARG . 38.8 mt-10 -100.62 114.05 27.42 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 176.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -138.32 146.53 18.32 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.615 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.692 ' HG3' ' HD3' ' A' ' 265' ' ' LYS . 6.1 pt-20 -114.02 109.95 19.26 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.027 0.441 . . . . 0.0 110.024 177.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . 0.509 HG22 HD22 ' A' ' 258' ' ' LEU . 14.5 t -109.27 -109.68 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.013 -175.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -85.98 82.56 8.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.788 0.327 . . . . 0.0 111.615 -174.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 66.02 6.68 32.99 Favored Glycine 0 C--N 1.332 0.337 0 CA-C-N 115.928 -0.578 . . . . 0.0 113.421 174.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . 0.508 ' NH1' ' HA ' ' A' ' 256' ' ' LEU . 1.7 tmt_? -146.92 127.98 14.61 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -176.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.425 ' HB3' ' HB3' ' A' ' 278' ' ' GLU . 15.0 ptpt -120.71 142.43 49.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.684 -178.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -173.69 -169.7 36.29 Favored Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 111.564 -0.614 . . . . 0.0 111.564 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.514 ' HB3' ' HB3' ' A' ' 274' ' ' GLN . 94.4 mt -86.78 146.95 26.04 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.167 0.508 . . . . 0.0 110.247 177.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.971 ' HB2' ' HG1' ' A' ' 289' ' ' THR . 26.3 p90 -143.18 123.39 7.88 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.582 176.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . 0.657 ' C ' ' H ' ' A' ' 289' ' ' THR . 51.5 Cg_exo -62.98 62.26 0.16 Allowed 'Trans proline' 0 N--CA 1.486 1.061 0 C-N-CA 124.597 3.531 . . . . 0.0 112.565 175.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.675 ' O ' HG22 ' A' ' 291' ' ' VAL . 4.3 m-85 62.54 -14.77 0.06 Allowed 'General case' 0 C--O 1.213 -0.849 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.736 -168.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' THR . . . . . 0.971 ' HG1' ' HB2' ' A' ' 286' ' ' PHE . 1.4 m 69.68 -12.31 0.46 Allowed 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 123.573 0.749 . . . . 0.0 112.824 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . 0.518 ' HB2' ' O ' ' A' ' 289' ' ' THR . 32.2 m170 89.37 25.0 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 O-C-N 124.313 1.008 . . . . 0.0 109.829 -164.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.675 HG22 ' O ' ' A' ' 288' ' ' PHE . 13.1 m -86.99 179.57 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.358 0.599 . . . . 0.0 111.206 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . 0.494 ' HZ2' ' HB2' ' A' ' 292' ' ' LYS . 0.9 OUTLIER -135.25 129.99 34.49 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.306 173.842 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.498 HD13 ' HB3' ' A' ' 240' ' ' ALA . 19.0 mm -77.35 126.02 37.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.064 0.459 . . . . 0.0 111.16 -178.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -151.44 -171.56 3.97 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -133.07 105.88 12.45 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-O 120.889 0.376 . . . . 0.0 110.221 175.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo . . . . . 0 C--O 1.234 0.294 0 C-N-CA 122.919 2.413 . . . . 0.0 112.678 -179.176 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.491 ' O ' HG22 ' A' ' 99' ' ' ILE . 19.5 m . . . . . 0 N--CA 1.449 -0.477 0 CA-C-O 120.762 0.315 . . . . 0.0 110.42 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -86.7 56.11 3.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.168 0.509 . . . . 0.0 110.707 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 20.7 tpp180 -93.55 96.75 10.06 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.383 -174.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.599 ' CE1' ' HE2' ' A' ' 89' ' ' LYS . 41.3 p90 -167.62 147.93 5.21 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.105 174.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -79.04 102.79 8.57 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.867 -178.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.4 m -69.36 76.88 0.39 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.079 175.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.4 t 178.48 -37.33 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.831 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -69.13 106.95 3.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.428 -173.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 -61.58 -31.03 71.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.397 -177.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 61.1 m -80.37 3.41 21.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.352 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -91.71 -47.81 7.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.941 0.4 . . . . 0.0 110.513 175.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 25.9 p-90 -122.62 -24.21 4.96 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -168.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -74.65 118.6 17.79 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.173 0.511 . . . . 0.0 110.913 -174.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.754 ' HG3' ' HB2' ' A' ' 37' ' ' LEU . 25.9 mmt -101.16 -11.71 19.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.062 -174.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.402 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 50.55 -114.21 2.51 Favored Glycine 0 CA--C 1.524 0.602 0 O-C-N 123.653 0.595 . . . . 0.0 113.25 -176.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.402 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 9.0 Cg_exo -72.31 91.33 0.76 Allowed 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 122.994 2.463 . . . . 0.0 113.273 -175.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.673 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 71.1 t -143.88 161.74 15.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 176.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.606 ' HA ' ' OG ' ' A' ' 42' ' ' SER . 16.0 m -128.68 174.06 9.76 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -172.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 63.3 mtp85 -57.32 -54.27 48.71 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.484 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -60.99 -40.95 95.43 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.726 0.298 . . . . 0.0 111.684 -177.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.533 ' O ' ' HG3' ' A' ' 27' ' ' ARG . 0.3 OUTLIER -70.98 -47.04 61.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.138 0.494 . . . . 0.0 110.17 -177.262 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.5 ' HB2' HD11 ' A' ' 37' ' ' LEU . . . -57.44 -42.83 83.19 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.157 0.503 . . . . 0.0 110.998 175.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.653 ' HG3' HG23 ' A' ' 58' ' ' VAL . 64.6 tt0 -65.29 -40.84 94.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.232 -177.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.6 t -76.19 -4.58 42.54 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.929 0.395 . . . . 0.0 111.167 -177.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.533 ' HG3' ' O ' ' A' ' 23' ' ' GLU . 90.7 mtt180 -90.03 -25.91 20.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.206 0.527 . . . . 0.0 109.746 172.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.512 HD23 ' HB2' ' A' ' 53' ' ' SER . 25.5 mt -116.7 16.9 15.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.953 -171.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.4 90.57 4.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.036 0.446 . . . . 0.0 110.686 -176.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.97 -4.68 74.34 Favored Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.576 176.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -65.55 167.99 8.1 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.792 0.329 . . . . 0.0 111.527 -178.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.491 ' HB2' ' HE2' ' A' ' 35' ' ' MET . 46.7 mtm180 -43.19 125.53 3.72 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.476 -178.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.517 ' HB3' HG23 ' A' ' 96' ' ' THR . 29.8 m170 -69.39 142.22 53.96 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.335 -178.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.537 ' HA3' ' HB ' ' A' ' 99' ' ' ILE . . . 110.64 -20.16 25.24 Favored Glycine 0 N--CA 1.437 -1.241 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 -175.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.65 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 63.3 mtt -61.75 142.41 57.29 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 173.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.531 ' HB2' HD13 ' A' ' 50' ' ' LEU . 51.6 p90 -153.19 162.74 40.97 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.754 ' HB2' ' HG3' ' A' ' 16' ' ' MET . 4.4 pp -155.66 132.66 10.68 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.132 0.491 . . . . 0.0 111.432 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.4 t -103.79 109.8 28.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 174.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.673 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 29.5 ptt-85 -113.22 177.82 4.5 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.82 -177.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -73.78 134.35 43.41 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 172.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.498 ' HA ' HG23 ' A' ' 49' ' ' VAL . 39.2 t -57.09 119.13 5.81 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.61 0.719 . . . . 0.0 111.965 -173.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.606 ' OG ' ' HA ' ' A' ' 20' ' ' SER . 1.5 m -77.44 -11.75 59.88 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.426 173.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.0 m -83.58 -41.4 17.92 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.372 177.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.461 ' O ' ' HB3' ' A' ' 41' ' ' SER . 6.5 p -157.36 94.63 2.15 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.107 178.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -47.91 127.05 13.96 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.11 2.54 . . . . 0.0 112.087 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.48 -45.58 1.15 Allowed Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -172.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -83.67 -166.06 1.29 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 172.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.574 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 25.4 m-85 -134.8 171.27 14.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 117.902 0.319 . . . . 0.0 110.563 177.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.498 HG23 ' HA ' ' A' ' 41' ' ' SER . 59.9 t -145.37 109.4 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 175.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.531 HD13 ' HB2' ' A' ' 36' ' ' PHE . 56.2 tp -80.33 100.95 8.66 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.636 175.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.3 m -96.69 121.78 38.91 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 174.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.638 HG13 ' HG3' ' A' ' 54' ' ' GLU . 87.0 t -111.82 138.59 39.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.712 -174.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.678 ' HA ' ' O ' ' A' ' 57' ' ' ARG . 48.1 t -82.63 98.48 9.03 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 175.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.638 ' HG3' HG13 ' A' ' 52' ' ' VAL . 24.2 mt-10 -151.36 160.81 43.58 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.97 -175.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.55 ' ND2' ' H ' ' A' ' 155' ' ' LYS . 0.5 OUTLIER 70.43 -65.85 0.31 Allowed 'General case' 0 CA--C 1.49 -1.333 0 CA-C-O 122.742 1.258 . . . . 0.0 110.456 -168.417 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.411 ' HB2' ' HD3' ' A' ' 57' ' ' ARG . 74.8 m -157.9 -22.16 0.08 Allowed 'General case' 0 N--CA 1.419 -1.992 0 CA-C-N 112.56 -2.109 . . . . 0.0 107.626 -175.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.692 ' HG2' ' N ' ' A' ' 58' ' ' VAL 0.359 0.0 OUTLIER -166.61 -50.23 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.124 1 N-CA-C 121.877 4.029 . . . . 0.0 121.877 -179.836 . . . . . . . . 5 4 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.692 ' N ' ' HG2' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -149.78 99.42 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 CA-C-N 121.729 2.058 . . . . 0.0 112.939 -170.148 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.7 m -94.83 111.06 22.87 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 172.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -97.39 112.67 24.4 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -168.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.716 ' OH ' ' HB3' ' A' ' 93' ' ' LEU . 54.3 m-85 -120.14 105.78 11.32 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.415 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.601 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 63.6 mt -80.52 127.0 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -174.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.574 ' HB ' ' HB2' ' A' ' 48' ' ' TYR . 4.3 mp -101.05 119.72 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 121.17 0.51 . . . . 0.0 111.17 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.533 ' HB2' ' HB3' ' A' ' 72' ' ' LYS . 16.7 m120 -86.04 136.11 33.37 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.798 -178.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.1 t -85.58 93.75 8.88 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 171.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.547 HD12 ' HB2' ' A' ' 72' ' ' LYS . 83.6 mt -84.99 145.84 44.36 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.834 -177.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 66' ' ' LEU . 18.5 Cg_exo -67.57 -3.85 10.95 Favored 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 122.92 2.414 . . . . 0.0 111.547 174.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 42.2 m-20 -80.66 2.21 26.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.71 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? 63.59 31.89 14.37 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.469 0.652 . . . . 0.0 109.51 -170.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.738 ' HG2' ' HA ' ' A' ' 79' ' ' ASP . 35.5 mtp180 -132.44 162.03 32.19 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.708 -175.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.436 ' HB3' HG22 ' A' ' 63' ' ' ILE . 47.3 m-85 -122.85 117.84 26.55 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.965 0.412 . . . . 0.0 111.142 -174.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.547 ' HB2' HD12 ' A' ' 66' ' ' LEU . 29.5 ttpp -104.09 98.99 8.73 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.462 -173.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.601 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 6.7 tt -88.45 119.64 36.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.293 0.568 . . . . 0.0 111.286 -177.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.37 32.16 83.19 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.828 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.461 ' HA ' ' NZ ' ' A' ' 72' ' ' LYS . 35.1 t70 74.62 -11.61 1.01 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.035 0.534 . . . . 0.0 111.835 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -86.66 126.66 34.68 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 171.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.531 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 0.7 OUTLIER -100.57 140.79 34.34 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.909 0.861 . . . . 0.0 113.169 -169.134 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.546 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 91.0 m-85 -129.02 172.16 11.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.218 -1.356 . . . . 0.0 108.376 173.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.738 ' HA ' ' HG2' ' A' ' 70' ' ' ARG . 5.9 m-20 -74.88 -30.33 61.28 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.66 0.266 . . . . 0.0 111.693 -175.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.837 ' HD1' ' HG2' ' A' ' 82' ' ' PRO . 4.9 p80 -165.07 168.35 17.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.563 -176.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.662 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 14.3 mt -57.97 -54.63 53.5 Favored Pre-proline 0 N--CA 1.469 0.482 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -177.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.837 ' HG2' ' HD1' ' A' ' 80' ' ' HIS . 20.9 Cg_endo -62.95 -3.02 4.15 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 121.976 1.784 . . . . 0.0 113.637 178.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.42 ' HB3' ' CE1' ' A' ' 80' ' ' HIS . . . -89.01 -36.51 15.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.94 0.4 . . . . 0.0 110.263 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.662 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.0 pp -76.81 -29.86 56.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.064 0.459 . . . . 0.0 109.891 178.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.493 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 79.7 mt -68.46 -21.04 64.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.336 177.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -91.97 -17.45 25.12 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.37 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -91.23 -30.88 16.39 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 121.784 0.802 . . . . 0.0 109.272 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.676 ' CD1' HD22 ' A' ' 93' ' ' LEU . 28.4 m-85 -84.21 1.88 42.48 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.125 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.599 ' HE2' ' CE1' ' A' ' 6' ' ' PHE . 85.8 mttt -77.61 -11.91 59.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.687 169.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 35.7 pt -134.84 8.82 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.204 0 CA-C-O 121.05 0.453 . . . . 0.0 110.302 -176.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.461 ' HB2' ' HA ' ' A' ' 88' ' ' TYR . 16.8 t60 -88.14 -38.87 15.0 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.199 -177.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.498 ' HA ' ' O ' ' A' ' 96' ' ' THR . 92.5 m-85 58.46 86.07 0.09 Allowed 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.344 -1.298 . . . . 0.0 107.797 -161.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.716 ' HB3' ' OH ' ' A' ' 61' ' ' TYR . 76.2 mt -44.23 -65.32 0.53 Allowed 'General case' 0 CA--C 1.517 -0.297 0 O-C-N 124.151 0.907 . . . . 0.0 108.805 178.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.686 ' HB3' ' HB3' ' A' ' 154' ' ' GLU . 1.6 p30 -111.99 -86.53 0.56 Allowed 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.771 163.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 1.051 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 11.5 t -118.97 14.4 13.22 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.296 0.57 . . . . 0.0 110.994 -174.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.517 HG23 ' HB3' ' A' ' 33' ' ' HIS . 5.8 t -153.72 -179.89 8.23 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 172.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 20.2 p -116.56 171.13 8.05 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 122.4 -0.188 . . . . 0.0 110.733 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 92.5 mt -61.62 104.12 0.4 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.018 0.437 . . . . 0.0 110.113 175.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.537 ' HB ' ' HA3' ' A' ' 34' ' ' GLY . 45.8 mm -89.21 -56.91 4.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.807 -176.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.65 ' O ' ' HA ' ' A' ' 35' ' ' MET . 10.6 pt-20 -162.98 142.3 6.8 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.956 -177.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.21 149.51 90.14 Favored 'Trans proline' 0 C--O 1.235 0.375 0 C-N-CA 122.411 2.074 . . . . 0.0 112.57 -177.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.638 ' HB1' ' HB3' ' A' ' 35' ' ' MET . . . -73.07 146.24 87.05 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.99 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.67 115.68 3.69 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.234 1.956 . . . . 0.0 111.625 176.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.616 ' HB3' ' SD ' ' A' ' 16' ' ' MET . 37.6 ptt180 . . . . . 0 C--N 1.328 -0.368 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 178.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.633 HD22 ' CH2' ' A' ' 161' ' ' TRP . 3.9 mm? . . . . . 0 N--CA 1.47 0.555 0 CA-C-O 121.521 0.677 . . . . 0.0 111.913 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 32.9 tt0 177.73 -60.16 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.302 -177.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -112.69 112.97 24.86 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.286 176.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 1.008 HG21 ' HG3' ' A' ' 180' ' ' LYS . 10.4 t -115.71 146.34 20.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 177.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.612 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 0.0 OUTLIER -118.71 147.69 43.56 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 117.244 -1.783 . . . . 0.0 109.024 158.903 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.468 HG21 HD12 ' A' ' 150' ' ' LEU . 0.8 OUTLIER -102.69 130.32 49.58 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.839 -1.073 . . . . 0.0 111.3 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.551 HD22 ' HG2' ' A' ' 179' ' ' GLU . 24.6 mt -104.97 -7.47 19.25 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -175.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.5 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 63.6 t80 -95.42 -42.53 8.43 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.233 -0.587 . . . . 0.0 112.543 -174.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.604 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 15.7 t70 77.75 89.71 0.07 Allowed 'General case' 0 N--CA 1.474 0.761 0 O-C-N 123.746 0.654 . . . . 0.0 110.431 -175.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.431 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 63.3 t80 -119.09 85.79 30.46 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 176.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.586 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 87.5 Cg_endo -81.94 83.76 2.02 Favored 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 121.608 1.539 . . . . 0.0 112.556 178.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -76.31 -20.58 76.97 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 175.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.817 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 12.3 m120 58.41 68.23 0.85 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.643 -0.778 . . . . 0.0 111.679 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.43 ' HB3' ' H ' ' A' ' 140' ' ' GLU . 0.4 OUTLIER -152.3 170.73 19.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.85 179.066 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -94.97 -5.42 44.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.937 0.875 . . . . 0.0 108.975 170.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.43 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 42.7 mm-40 -96.34 -36.91 10.7 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.809 174.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -123.01 112.73 18.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.273 178.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.712 ' CD1' ' HB2' ' A' ' 165' ' ' ASN . 30.4 tp -68.61 129.95 92.25 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-O 120.776 0.322 . . . . 0.0 110.534 -177.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.817 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 11.6 Cg_endo -85.64 91.26 0.69 Allowed 'Trans proline' 0 N--CA 1.442 -1.55 0 C-N-CA 122.092 1.861 . . . . 0.0 111.012 172.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.555 ' CE2' ' HB ' ' A' ' 173' ' ' ILE . 14.3 p90 -101.54 164.85 11.55 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.817 -174.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.604 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 1.4 mptp? -100.29 -172.71 2.26 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.203 0.525 . . . . 0.0 111.75 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.671 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -91.62 9.03 33.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.972 -175.986 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -167.13 32.95 0.21 Allowed Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.48 175.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.494 ' OE1' ' HA ' ' A' ' 144' ' ' PHE . 0.1 OUTLIER -100.13 157.45 16.56 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.214 -174.92 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.559 HD12 ' HB3' ' A' ' 129' ' ' ARG . 0.6 OUTLIER -97.49 129.38 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-O 121.692 0.758 . . . . 0.0 109.978 -176.682 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.704 HD23 ' CD2' ' A' ' 142' ' ' LEU . 31.9 mt -123.94 158.77 31.24 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 114.522 -1.217 . . . . 0.0 108.01 -177.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.567 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 97.4 t -122.04 120.43 61.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 175.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.523 HG21 ' CD1' ' A' ' 125' ' ' LEU . 42.1 mm -78.21 79.14 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -178.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.667 HG22 ' HG2' ' A' ' 154' ' ' GLU . 7.6 tt -74.57 -34.18 34.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 114.535 -1.212 . . . . 0.0 109.318 -178.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.686 ' HB3' ' HB3' ' A' ' 94' ' ' ASP . 0.0 OUTLIER -123.46 142.92 50.51 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.502 175.577 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.55 ' H ' ' ND2' ' A' ' 55' ' ' ASN . 83.1 tttt -140.47 81.75 17.13 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-O 120.982 0.42 . . . . 0.0 109.993 172.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 1.051 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 38.4 Cg_endo -73.25 -40.28 1.74 Allowed 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.03 1.82 . . . . 0.0 111.972 175.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -111.05 162.65 14.66 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.407 -171.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -100.17 -11.54 20.36 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 172.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -89.81 -34.1 16.27 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.916 177.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 49.4 m95 -129.45 139.44 51.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.942 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . 0.748 ' O ' HG13 ' A' ' 173' ' ' ILE . 47.8 m0 -113.63 137.02 52.18 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 176.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.519 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 16.2 m -96.96 97.59 9.39 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -175.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.497 ' HB2' ' HB3' ' A' ' 150' ' ' LEU . . . -110.84 149.54 30.43 Favored 'General case' 0 N--CA 1.425 -1.72 0 C-N-CA 119.859 -0.736 . . . . 0.0 109.956 -174.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.713 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 11.7 ptt180 -87.25 122.16 30.67 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 173.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.712 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . 12.9 t30 -58.42 -178.07 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 113.755 -1.566 . . . . 0.0 111.381 -173.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.527 ' HD3' ' HB ' ' A' ' 149' ' ' ILE . 10.0 mmmm -66.38 -11.67 52.68 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.414 0.626 . . . . 0.0 109.906 166.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.415 ' H ' ' HB3' ' A' ' 165' ' ' ASN . 22.3 m-20 -82.29 -15.99 50.99 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 170.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 80.28 10.82 84.98 Favored Glycine 0 CA--C 1.52 0.36 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.923 -174.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.713 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.3 OUTLIER -81.94 133.91 35.34 Favored 'General case' 0 C--O 1.217 -0.615 0 C-N-CA 123.106 0.562 . . . . 0.0 110.803 -178.846 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 80.4 t -82.38 123.62 38.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.862 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -157.02 158.11 28.58 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.75 171.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.494 ' HE2' ' HG2' ' A' ' 156' ' ' PRO . 10.5 mtp -82.84 144.79 29.87 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 117.482 0.641 . . . . 0.0 111.039 -178.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.748 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.7 pp -142.87 147.96 43.85 Favored Pre-proline 0 C--O 1.223 -0.317 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.43 -175.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.479 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 8.0 Cg_exo -73.55 129.8 14.13 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.547 2.165 . . . . 0.0 112.71 -175.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.567 ' O ' HG23 ' A' ' 178' ' ' VAL . 61.5 t -59.19 -44.51 98.57 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.463 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 36.4 Cg_exo -61.93 -2.54 2.96 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 122.206 1.937 . . . . 0.0 113.136 176.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.479 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.1 m-30 -100.85 -9.23 21.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.641 -178.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 175' ' ' VAL . 6.1 m -107.87 -173.29 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 -166.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.612 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 5.2 tp10 -159.74 49.18 0.3 Allowed 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 113.221 -1.809 . . . . 0.0 112.559 -151.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 1.008 ' HG3' HG21 ' A' ' 128' ' ' VAL . 1.2 mppt? -71.47 138.52 49.05 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 120.042 -1.661 . . . . 0.0 111.803 -158.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.568 ' HB2' ' NH1' ' A' ' 129' ' ' ARG . 11.8 tp . . . . . 0 N--CA 1.455 -0.191 0 CA-C-N 112.84 -1.982 . . . . 0.0 111.387 -170.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo . . . . . 0 N--CA 1.461 -0.384 0 CA-C-O 120.673 0.197 . . . . 0.0 111.751 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.482 ' HB ' HG12 ' A' ' 266' ' ' VAL . 18.3 t -89.03 128.95 40.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.503 ' HB2' ' HG3' ' A' ' 296' ' ' PRO . 93.9 m-85 -102.87 117.68 35.16 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.092 0.472 . . . . 0.0 110.959 -177.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . 0.463 ' HB3' HD11 ' A' ' 293' ' ' ILE . . . -119.95 134.35 55.27 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.104 178.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -84.59 126.39 33.29 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . 0.465 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -72.65 100.71 2.87 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.03 0.443 . . . . 0.0 109.829 177.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 2.4 pp -96.05 -9.0 9.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.557 -176.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.28 138.25 36.59 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 176.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -58.23 149.62 23.72 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 120.968 0.414 . . . . 0.0 110.71 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.459 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 24.7 tpt180 -143.78 91.52 2.24 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 174.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 29.2 m -100.23 142.6 24.93 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.098 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.489 ' HB3' ' HB3' ' A' ' 255' ' ' ALA . 72.8 Cg_endo -79.11 148.58 21.71 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.404 2.07 . . . . 0.0 112.101 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 48.7 t -79.66 176.58 9.59 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 173.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -59.62 -30.36 68.64 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.659 0.266 . . . . 0.0 111.548 -177.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -96.02 -5.42 41.11 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . 0.415 ' HB3' ' HB3' ' A' ' 255' ' ' ALA . 4.1 m-20 -82.82 107.6 15.56 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.263 0.554 . . . . 0.0 111.467 -176.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 47.2 mttp -104.01 -34.41 8.46 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.308 176.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 3.0 p -86.81 9.4 19.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.589 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . 0.489 ' HB3' ' HB3' ' A' ' 248' ' ' PRO . . . -95.8 131.84 41.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.051 0.453 . . . . 0.0 110.857 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.538 HD21 ' HB ' ' A' ' 279' ' ' VAL . 0.9 OUTLIER -88.24 133.32 34.07 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.188 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -89.3 109.75 20.61 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.861 0.363 . . . . 0.0 110.169 -179.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 94.2 mt -115.11 143.69 44.82 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.012 -175.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -120.4 149.95 41.55 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.503 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 59.8 t -64.17 117.15 4.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.784 0.326 . . . . 0.0 110.874 -178.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 108.93 10.19 24.95 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.587 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -103.19 167.59 9.72 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . 0.425 HD12 ' HA ' ' A' ' 263' ' ' ILE . 37.3 mm -114.35 118.09 57.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.038 0.447 . . . . 0.0 110.814 -176.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 20.0 t -93.69 109.37 21.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.514 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -87.2 87.47 7.45 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.746 177.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.482 HG12 ' HB ' ' A' ' 238' ' ' VAL . 7.2 p -91.19 136.52 24.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.88 -175.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 18.1 p -114.06 -50.61 2.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.19 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 14.2 tpp180 -100.79 101.27 12.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.12 0.486 . . . . 0.0 110.657 -175.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 41.4 mtt -91.54 118.9 31.01 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.007 0.432 . . . . 0.0 110.304 177.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 274' ' ' GLN . 90.6 m-20 -83.11 0.61 44.3 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.472 -176.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 50.6 mm 72.94 -47.85 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 171.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -61.84 -24.75 67.09 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -173.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 155.38 -48.48 0.49 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.252 -0.975 . . . . 0.0 112.694 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.51 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 1.8 mp0 -86.46 116.52 24.66 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.387 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.455 ' HB3' HG23 ' A' ' 266' ' ' VAL . 43.8 m0 -97.17 153.42 18.0 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.613 178.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -106.26 109.47 21.41 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.184 0.516 . . . . 0.0 110.026 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -123.21 164.18 16.33 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.786 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -114.61 115.28 26.91 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -178.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . 0.538 ' HB ' HD21 ' A' ' 256' ' ' LEU . 88.1 t -136.15 125.2 38.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.258 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 56.95 38.78 29.58 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.893 176.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 89.34 -15.63 57.99 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.437 175.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 282' ' ' ARG . 40.6 mtp-105 -107.96 132.7 53.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 117.164 0.482 . . . . 0.0 110.645 -177.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 0.0 OUTLIER -114.61 130.06 56.74 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 174.507 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -157.96 -175.73 29.22 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.279 -177.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.51 ' HB3' ' HB3' ' A' ' 274' ' ' GLN . 78.6 mt -93.8 129.75 40.06 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.126 0.489 . . . . 0.0 110.804 -178.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.461 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 47.8 p90 -132.72 141.18 40.18 Favored Pre-proline 0 C--N 1.317 -0.804 0 CA-C-N 115.696 -0.683 . . . . 0.0 109.837 176.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 4.6 Cg_exo -74.89 140.38 25.71 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.735 2.29 . . . . 0.0 111.58 177.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -72.58 7.12 2.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.045 0.45 . . . . 0.0 111.821 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 4.1 p -90.83 -10.68 41.84 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.157 0.503 . . . . 0.0 110.968 177.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -104.89 -10.45 17.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.874 -178.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.465 HG12 ' HA ' ' A' ' 242' ' ' ALA . 35.6 m -128.36 162.74 34.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.455 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -140.69 136.72 32.91 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.32 175.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.463 HD11 ' HB3' ' A' ' 240' ' ' ALA . 1.2 mp -72.56 135.96 26.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 174.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -144.63 -165.81 2.24 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.941 -175.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -103.43 95.35 6.98 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.228 175.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . 0.503 ' HG3' ' HB2' ' A' ' 239' ' ' PHE . 74.5 Cg_endo . . . . . 0 N--CA 1.461 -0.396 0 C-N-CA 122.193 1.929 . . . . 0.0 111.665 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.453 -0.277 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.544 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . -75.38 87.19 2.56 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.83 175.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -115.55 88.56 2.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.648 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -161.09 161.29 31.18 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.385 177.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -88.25 91.47 8.8 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.875 0.845 . . . . 0.0 110.11 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.6 p -73.86 77.81 1.62 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.894 -176.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.4 t -176.59 -39.78 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.586 176.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -64.51 113.81 3.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.018 0.437 . . . . 0.0 110.828 -174.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -58.46 -35.81 72.71 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.742 -176.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.2 t -73.51 -6.49 46.8 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.176 -176.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.01 -47.49 7.25 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 121.046 -0.262 . . . . 0.0 111.556 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 30.1 p-90 -116.67 -22.74 8.49 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -171.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -73.27 112.84 9.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.361 0.6 . . . . 0.0 109.747 -177.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.552 ' SD ' ' HA ' ' A' ' 104' ' ' ARG . 15.7 tpp -95.3 5.86 50.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.31 -171.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.477 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 49.65 -113.65 1.92 Allowed Glycine 0 CA--C 1.522 0.493 0 CA-C-N 115.516 -0.765 . . . . 0.0 114.357 176.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.477 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 5.0 Cg_exo -77.13 88.49 1.4 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.454 2.77 . . . . 0.0 113.159 -175.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.54 HG13 ' HD2' ' A' ' 39' ' ' ARG . 71.3 t -145.34 160.44 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.494 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -143.27 -168.81 2.9 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -171.354 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 35.6 mtp85 -59.06 -57.82 11.4 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 118.652 0.66 . . . . 0.0 112.182 -176.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -64.68 -44.97 88.64 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 123.29 0.369 . . . . 0.0 110.847 -175.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.64 ' O ' ' HG3' ' A' ' 27' ' ' ARG . 12.5 mp0 -60.68 -49.84 75.9 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.534 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.494 ' HB1' ' O ' ' A' ' 20' ' ' SER . . . -56.92 -44.69 82.7 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.427 0.632 . . . . 0.0 110.344 177.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.516 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 6.9 tp60 -60.72 -58.25 9.24 Favored 'General case' 0 C--O 1.214 -0.786 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.563 -178.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.2 t -61.83 -27.53 68.84 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -172.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.64 ' HG3' ' O ' ' A' ' 23' ' ' GLU . 62.5 mtp180 -83.48 -10.44 58.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.717 0.294 . . . . 0.0 111.258 -178.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.593 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 87.7 mt -125.58 -13.39 6.53 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.516 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -70.24 107.09 3.57 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 122.765 0.426 . . . . 0.0 110.434 -174.855 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 70.61 20.24 77.08 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.05 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.482 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 12.2 mm100 -92.89 -161.17 0.81 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 47.0 mtm180 -52.64 130.76 33.23 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 175.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 63.5 m170 -86.35 126.31 34.25 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.25 11.2 42.92 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -171.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.528 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 50.6 ttp -104.07 134.61 47.04 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -178.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.453 ' HB2' HG21 ' A' ' 52' ' ' VAL . 39.9 p90 -139.29 167.78 21.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.768 0.318 . . . . 0.0 111.777 -174.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.529 ' HG ' HD11 ' A' ' 28' ' ' LEU . 4.6 pp -153.83 140.0 18.45 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.146 0.498 . . . . 0.0 110.825 173.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.6 t -105.71 114.21 44.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 174.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.54 ' HD2' HG13 ' A' ' 19' ' ' VAL . 22.3 ptt-85 -112.33 167.72 10.2 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.953 -173.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -76.44 125.36 29.06 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 170.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.0 t -75.77 152.51 37.36 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.395 0.617 . . . . 0.0 111.531 -172.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.8 t -111.69 14.54 21.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.226 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 46.7 p -92.16 -57.25 2.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.957 176.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.402 ' HB2' ' OD2' ' A' ' 47' ' ' ASP . 56.8 m -134.56 137.9 28.74 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.754 178.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.6 127.18 17.47 Favored 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 122.8 2.333 . . . . 0.0 112.754 -178.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.65 -16.68 43.8 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.339 176.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.402 ' OD2' ' HB2' ' A' ' 44' ' ' CYS . 65.8 m-20 -96.89 166.34 11.67 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 -177.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -128.33 175.22 8.65 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -178.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.7 t -144.66 117.35 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 120.902 0.382 . . . . 0.0 110.93 174.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 33.5 tp -84.83 102.1 12.8 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.442 176.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 55.9 m -96.52 133.65 40.72 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 175.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.678 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 99.2 t -129.53 134.3 63.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.841 0.353 . . . . 0.0 111.825 -173.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.593 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 9.2 t -94.5 117.18 29.73 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -177.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.669 ' O ' ' HB3' ' A' ' 57' ' ' ARG . 9.9 tp10 -158.26 147.94 19.71 Favored 'General case' 0 C--O 1.211 -0.967 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.276 163.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.508 ' ND2' ' HG3' ' A' ' 54' ' ' GLU . 50.7 m-80 62.89 16.59 9.27 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 123.35 0.407 . . . . 0.0 111.59 -176.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 67.2 m 56.22 59.46 3.68 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 122.724 1.25 . . . . 0.0 108.164 -168.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.669 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 19.4 ttp85 -155.59 65.12 0.6 Allowed 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 112.768 -2.015 . . . . 0.0 109.398 -160.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.678 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 21.4 t -71.61 96.79 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 122.346 1.07 . . . . 0.0 109.187 -171.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.484 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 1.4 p -75.07 121.37 21.92 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 113.237 -1.801 . . . . 0.0 111.166 -176.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 62.4 m-70 -93.59 108.08 19.84 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.211 -176.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.549 ' CE2' HD21 ' A' ' 93' ' ' LEU . 66.6 m-85 -105.63 103.24 12.71 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.071 177.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.679 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 55.8 mt -78.33 133.47 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -174.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.554 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 4.2 mp -118.03 118.67 58.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 122.831 0.452 . . . . 0.0 111.275 -179.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -87.78 151.06 23.17 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.0 t -92.46 100.84 13.32 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 171.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.599 HD23 ' HD2' ' A' ' 72' ' ' LYS . 80.2 mt -78.61 137.16 58.99 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.663 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -63.3 -7.03 11.14 Favored 'Trans proline' 0 CA--C 1.529 0.237 0 C-N-CA 122.889 2.392 . . . . 0.0 112.238 177.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 -78.24 6.74 7.53 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.723 173.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.743 ' HA ' ' HE ' ' A' ' 69' ' ' ARG . 2.6 tpm_? 63.57 32.87 13.8 Favored 'General case' 0 N--CA 1.46 0.065 0 CA-C-O 122.009 0.909 . . . . 0.0 109.106 -173.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.793 ' HG2' ' HA ' ' A' ' 79' ' ' ASP . 69.6 mtt180 -120.78 179.39 4.37 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.692 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.554 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 54.0 m-85 -135.82 119.35 16.98 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.096 0.474 . . . . 0.0 111.379 -176.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.599 ' HD2' HD23 ' A' ' 66' ' ' LEU . 46.3 tttm -101.82 101.28 11.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.567 -172.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.679 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 7.0 tt -100.77 110.17 27.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.38 0.609 . . . . 0.0 111.444 -176.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.96 -55.39 3.51 Favored Glycine 0 CA--C 1.519 0.326 0 CA-C-N 115.396 -0.82 . . . . 0.0 113.263 177.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -165.4 -40.86 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -176.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.466 HE21 ' HB2' ' A' ' 76' ' ' GLN . 6.4 mt-30 -69.27 141.18 54.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.24 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.562 ' HG2' ' HG3' ' A' ' 72' ' ' LYS . 43.5 mt-10 -108.99 104.86 14.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.434 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.526 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 77.6 m-85 -100.26 160.41 14.35 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 176.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.793 ' HA ' ' HG2' ' A' ' 70' ' ' ARG . 6.0 m-20 -74.82 -32.79 62.07 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -174.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.765 ' HD1' ' HG2' ' A' ' 82' ' ' PRO . 1.2 p80 -153.22 166.44 32.54 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.473 0.178 . . . . 0.0 110.875 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.569 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 9.0 mt -57.23 -51.22 83.33 Favored Pre-proline 0 N--CA 1.466 0.328 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.865 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.765 ' HG2' ' HD1' ' A' ' 80' ' ' HIS . 23.4 Cg_endo -61.11 -10.69 15.93 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.118 1.879 . . . . 0.0 113.034 177.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.58 -36.3 16.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.672 0.272 . . . . 0.0 110.466 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.569 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.1 pp -76.49 -35.38 58.41 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 177.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.565 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 77.3 mt -62.07 -38.5 89.04 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.554 175.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.545 ' HA ' ' HD3' ' A' ' 89' ' ' LYS . 11.0 tp10 -67.55 -38.73 84.6 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.596 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -65.66 -37.99 88.06 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.216 0.531 . . . . 0.0 110.747 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.629 ' CD1' HD22 ' A' ' 93' ' ' LEU . 35.0 m-85 -81.25 -15.59 55.13 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.777 -177.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.565 ' HG3' ' O ' ' A' ' 85' ' ' LEU . 40.8 mtpt -64.72 -26.33 68.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.092 174.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.8 pp -114.48 8.48 7.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.421 -0.512 . . . . 0.0 112.349 174.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.404 ' CB ' ' HA ' ' A' ' 88' ' ' TYR . 6.2 t-160 -93.81 -37.95 11.5 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.747 0.308 . . . . 0.0 110.868 -176.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.48 ' N ' HG23 ' A' ' 97' ' ' THR . 58.8 m-85 67.41 84.55 0.15 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.275 -168.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.725 ' HA ' ' OE2' ' A' ' 154' ' ' GLU . 14.2 mt -53.98 -25.05 18.93 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 122.208 1.004 . . . . 0.0 110.888 175.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.522 ' CG ' ' HB3' ' A' ' 54' ' ' GLU . 0.4 OUTLIER -132.05 -91.6 0.4 Allowed 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 114.339 -1.3 . . . . 0.0 107.607 175.6 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.488 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 13.8 t -145.67 21.63 1.47 Allowed 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 172.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.431 ' O ' HD11 ' A' ' 99' ' ' ILE . 11.8 t -135.41 -21.85 1.54 Allowed 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 119.605 -0.838 . . . . 0.0 112.852 -174.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.48 HG23 ' N ' ' A' ' 92' ' ' TYR . 7.1 p 72.96 -162.2 0.1 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.02 0.928 . . . . 0.0 110.214 -173.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.443 HD21 ' CD2' ' A' ' 36' ' ' PHE . 81.5 mt -95.96 94.45 7.61 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.068 178.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.544 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 43.9 mm -76.52 -61.26 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.958 -176.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.528 ' O ' ' HA ' ' A' ' 35' ' ' MET . 11.3 pt-20 -161.66 151.8 14.32 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.569 178.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.37 159.04 55.25 Favored 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 122.892 2.395 . . . . 0.0 113.512 -177.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.454 ' HA ' ' SD ' ' A' ' 35' ' ' MET . . . -72.31 145.7 88.43 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.91 176.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -50.24 120.91 6.82 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.696 2.264 . . . . 0.0 111.503 175.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.552 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 39.1 ttt180 . . . . . 0 C--N 1.328 -0.356 0 N-CA-C 109.776 -0.454 . . . . 0.0 109.776 -175.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.583 ' CD1' HG23 ' A' ' 152' ' ' ILE . 1.9 mm? . . . . . 0 N--CA 1.474 0.746 0 CA-C-O 121.229 0.538 . . . . 0.0 111.547 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 40.2 tt0 179.86 -39.73 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.341 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -124.38 119.82 30.32 Favored 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 119.839 -0.745 . . . . 0.0 110.302 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.713 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 56.0 t -134.63 144.07 35.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.976 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.758 ' NH2' ' HG ' ' A' ' 181' ' ' LEU . 0.0 OUTLIER -118.9 143.54 46.93 Favored 'General case' 0 CA--C 1.501 -0.928 0 C-N-CA 116.755 -1.978 . . . . 0.0 108.741 168.059 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.669 ' HG1' ' CD ' ' A' ' 148' ' ' GLU . 1.4 p -103.89 141.08 36.77 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.749 0.785 . . . . 0.0 111.005 -177.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.589 HD11 ' HG2' ' A' ' 179' ' ' GLU . 0.5 OUTLIER -116.43 -20.34 9.73 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.921 -173.652 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.424 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 37.3 t80 -83.85 -26.23 29.66 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.764 -171.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.454 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 12.6 t70 67.94 90.65 0.09 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.748 0.785 . . . . 0.0 110.204 -178.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.545 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 74.4 t80 -120.56 91.1 46.59 Favored Pre-proline 0 C--N 1.314 -0.976 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 176.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.683 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 92.7 Cg_endo -84.14 79.9 2.5 Favored 'Trans proline' 0 N--CA 1.444 -1.421 0 C-N-CA 121.832 1.688 . . . . 0.0 112.71 -176.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.15 -23.25 74.67 Favored Glycine 0 C--N 1.334 0.417 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.687 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 18.9 m120 62.77 31.92 16.26 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 122.669 0.387 . . . . 0.0 111.686 176.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.405 ' HB3' ' H ' ' A' ' 140' ' ' GLU . 0.2 OUTLIER -127.17 178.32 6.1 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.054 0.454 . . . . 0.0 111.586 -176.097 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -97.15 -10.49 25.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.634 172.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.657 ' O ' ' HB2' ' A' ' 172' ' ' MET . 46.4 mt-10 -113.14 -7.97 13.59 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.48 176.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -135.65 104.63 5.86 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 173.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.755 ' CD1' ' HB2' ' A' ' 165' ' ' ASN . 52.5 tp -70.83 129.24 89.95 Favored Pre-proline 0 CA--C 1.509 -0.621 0 CA-C-O 120.837 0.351 . . . . 0.0 110.83 -172.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.683 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 47.6 Cg_endo -80.21 96.46 1.02 Allowed 'Trans proline' 0 N--CA 1.436 -1.899 0 C-N-CA 121.01 1.14 . . . . 0.0 111.544 168.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.626 ' HB2' ' OG1' ' A' ' 130' ' ' THR . 9.0 p90 -107.18 159.87 16.01 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.857 ' H ' ' HG3' ' A' ' 148' ' ' GLU . 4.1 mppt? -111.09 -140.34 0.38 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.368 0.604 . . . . 0.0 111.818 -175.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.723 ' N ' ' HD3' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -116.58 55.72 0.81 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.276 -177.019 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 135.6 23.86 0.56 Allowed Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.244 -0.889 . . . . 0.0 113.055 174.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.857 ' HG3' ' H ' ' A' ' 145' ' ' LYS . 0.0 OUTLIER -74.73 164.83 26.14 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 169.694 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.501 HD12 ' HB3' ' A' ' 129' ' ' ARG . 0.4 OUTLIER -107.86 132.12 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 173.392 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.693 HD23 ' CD2' ' A' ' 142' ' ' LEU . 37.9 mt -118.54 154.69 32.15 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -176.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.525 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 98.0 t -121.98 122.83 67.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.583 HG23 ' CD1' ' A' ' 125' ' ' LEU . 44.4 mm -75.0 83.27 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -175.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.584 HD13 ' HD3' ' A' ' 164' ' ' ARG . 16.4 tt -75.3 -27.94 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 CA-C-N 113.398 -1.728 . . . . 0.0 110.134 -171.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.725 ' OE2' ' HA ' ' A' ' 93' ' ' LEU . 1.8 mt-10 -135.66 141.05 44.95 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 170.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.558 ' HD2' ' HG ' ' A' ' 125' ' ' LEU . 58.6 tttp -130.1 91.53 38.97 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 122.047 -0.408 . . . . 0.0 111.202 173.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.548 ' HG2' ' HE1' ' A' ' 172' ' ' MET . 8.4 Cg_exo -77.59 -45.14 0.16 Allowed 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.656 2.237 . . . . 0.0 112.285 171.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -117.83 -178.61 3.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.152 0.501 . . . . 0.0 111.832 -170.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.488 ' O ' HG22 ' A' ' 175' ' ' VAL . 2.6 mm-40 -106.39 -19.1 13.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.485 174.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -95.5 -28.68 14.77 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.735 0.302 . . . . 0.0 111.547 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.506 ' O ' ' HD1' ' A' ' 161' ' ' TRP . 42.6 m95 -124.22 137.91 54.46 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 174.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . 0.717 ' O ' HG13 ' A' ' 173' ' ' ILE . 45.8 m0 -124.37 140.0 53.37 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-O 121.025 0.441 . . . . 0.0 111.007 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.541 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 19.4 m -97.94 97.02 8.58 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -174.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.522 ' HB2' ' HB3' ' A' ' 150' ' ' LEU . . . -110.93 148.68 31.95 Favored 'General case' 0 N--CA 1.425 -1.695 0 C-N-CA 119.846 -0.742 . . . . 0.0 109.903 -174.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.834 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 17.2 ptt-85 -86.86 122.29 30.53 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 173.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.755 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . 63.8 t30 -56.38 177.44 0.07 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.005 -1.452 . . . . 0.0 110.443 -174.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 46.8 tttt -63.66 -12.76 36.56 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.759 169.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -74.16 -30.38 62.23 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.186 0.517 . . . . 0.0 109.745 168.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 97.26 15.85 36.96 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.462 -171.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.834 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 2.5 ttm-85 -95.43 139.0 32.34 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 122.785 0.434 . . . . 0.0 111.457 -177.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.501 HG22 HD12 ' A' ' 153' ' ' ILE . 39.2 t -78.71 130.98 35.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.202 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -162.93 155.27 26.55 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.501 166.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.657 ' HB2' ' O ' ' A' ' 140' ' ' GLU . 0.2 OUTLIER -76.9 140.56 40.58 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 117.057 0.428 . . . . 0.0 111.042 178.854 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.717 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.4 pp -142.0 146.7 41.51 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.343 -176.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.592 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 5.3 Cg_exo -77.02 130.34 11.21 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.85 2.367 . . . . 0.0 112.746 -176.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.541 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 87.0 t -62.02 -42.2 80.48 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 24.6 Cg_endo -63.36 -0.12 2.13 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 121.948 1.766 . . . . 0.0 112.969 175.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.592 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.3 m-85 -97.07 -16.4 20.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.399 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.638 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 2.4 m -112.11 -173.52 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 117.712 2.486 . . . . 0.0 117.712 -160.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.63 ' HB2' ' O ' ' A' ' 129' ' ' ARG . 2.1 mm-40 -139.96 49.35 1.77 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 111.558 -2.565 . . . . 0.0 115.654 -161.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.713 ' HA ' ' HA ' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -69.51 134.35 48.77 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 124.366 3.257 . . . . 0.0 111.879 -158.69 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.758 ' HG ' ' NH2' ' A' ' 129' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.446 -0.641 0 CA-C-N 110.755 -2.93 . . . . 0.0 111.997 -170.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo . . . . . 0 N--CA 1.463 -0.286 0 N-CA-C 110.156 -0.748 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.1 t -66.81 135.6 28.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.24 -170.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -104.05 123.42 47.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.688 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -119.32 124.22 46.1 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 175.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.645 ' HB2' ' CE1' ' A' ' 294' ' ' PHE . 44.8 tttp -88.19 119.92 29.05 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -176.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -67.74 110.82 3.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.013 0.435 . . . . 0.0 110.254 -178.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 21.1 pt -85.16 1.42 4.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.122 0.486 . . . . 0.0 111.207 -174.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -158.13 152.12 24.01 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.866 178.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.892 ' HG3' HG22 ' A' ' 260' ' ' VAL . 54.6 mtmt -78.67 120.72 23.75 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.135 0.493 . . . . 0.0 110.625 177.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.62 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 22.6 ttt85 -113.01 109.67 19.23 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.843 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 29.5 m -102.69 143.05 25.82 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 177.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.514 ' HD3' ' HB2' ' A' ' 257' ' ' ALA . 55.2 Cg_endo -70.46 151.59 65.18 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 122.461 2.107 . . . . 0.0 112.764 -177.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 46.0 t -89.09 168.26 12.47 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 174.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -55.84 -41.03 73.69 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.657 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -95.44 8.23 43.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.91 0.386 . . . . 0.0 111.452 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . 0.43 ' HB3' ' HB1' ' A' ' 255' ' ' ALA . 8.5 m-20 -110.82 73.47 0.82 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.851 0.358 . . . . 0.0 111.017 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -72.95 -24.73 60.84 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-O 121.269 0.557 . . . . 0.0 110.146 175.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 1.1 p -86.48 11.0 13.53 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.709 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . 0.43 ' HB1' ' HB3' ' A' ' 252' ' ' ASP . . . -99.92 116.6 32.36 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.847 0.356 . . . . 0.0 110.515 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.55 137.46 40.85 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.085 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.62 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -91.75 128.66 37.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.169 177.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 69.4 mt -132.04 149.3 52.45 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.146 -173.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.775 ' HA ' ' HG2' ' A' ' 245' ' ' LYS . 64.5 mm-40 -101.54 167.77 9.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.604 178.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . 0.892 HG22 ' HG3' ' A' ' 245' ' ' LYS . 60.0 t -74.89 115.94 16.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 176.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . 0.533 ' HA2' ' HE3' ' A' ' 241' ' ' LYS . . . 99.71 -2.76 57.27 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.635 -177.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -71.75 151.93 43.15 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -174.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 43.0 mm -103.75 109.05 25.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.107 0.48 . . . . 0.0 110.907 -175.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.453 ' HA ' HG21 ' A' ' 279' ' ' VAL . 39.1 t -82.77 105.27 12.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.103 178.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -91.07 98.95 12.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.583 178.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 4.8 p -92.13 123.12 44.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.414 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 6.6 p -96.54 -33.01 11.98 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.654 -177.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 32.6 mtm180 -131.9 126.03 33.15 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.412 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' MET . . . . . 0.532 ' HE3' ' CE3' ' A' ' 275' ' ' TRP . 38.3 mtt -105.04 121.28 43.45 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.183 0.516 . . . . 0.0 111.127 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 274' ' ' GLN . 79.4 m-20 -88.72 120.68 30.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.536 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 32.1 mm -76.35 80.84 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.333 0.587 . . . . 0.0 110.389 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . 0.783 HD22 ' HG2' ' A' ' 274' ' ' GLN . 3.3 p-10 -163.14 -37.55 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.622 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 131.4 28.73 0.62 Allowed Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.179 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.783 ' HG2' HD22 ' A' ' 272' ' ' ASN . 2.4 pt20 -159.79 113.51 2.24 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 168.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.532 ' CE3' ' HE3' ' A' ' 269' ' ' MET . 3.6 m0 -93.68 158.21 15.79 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 122.16 -0.337 . . . . 0.0 110.454 -175.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -101.06 108.45 20.15 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -132.44 136.45 8.75 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 177.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -114.69 114.62 25.89 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.987 0.423 . . . . 0.0 110.022 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . 0.453 HG21 ' HA ' ' A' ' 264' ' ' VAL . 28.4 t -118.94 -78.69 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.195 0.522 . . . . 0.0 111.147 -175.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -86.58 60.7 6.38 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.22 -173.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 71.66 2.05 48.58 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.489 -0.778 . . . . 0.0 113.111 177.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 44.5 mtp180 -139.91 137.91 35.21 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.389 -0.226 . . . . 0.0 110.389 -175.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.454 ' HB3' ' NZ ' ' A' ' 283' ' ' LYS . 0.1 OUTLIER -91.92 125.15 36.51 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 168.391 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -142.52 162.0 27.34 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.241 -0.981 . . . . 0.0 112.07 -176.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 67.3 mt -95.23 131.76 40.93 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.125 0.488 . . . . 0.0 109.917 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -123.47 149.95 59.67 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.34 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . 0.539 ' HD3' ' CZ ' ' A' ' 246' ' ' ARG . 76.8 Cg_endo -83.59 16.12 1.97 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.729 2.286 . . . . 0.0 113.496 -171.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.534 ' CZ ' ' HA ' ' A' ' 274' ' ' GLN . 2.8 m-85 66.46 -40.98 0.37 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.041 0.936 . . . . 0.0 113.11 177.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 1.7 m -66.63 -16.57 64.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.974 0.416 . . . . 0.0 111.973 -177.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -89.94 -3.82 57.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.861 0.362 . . . . 0.0 110.787 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 33.6 m -127.12 165.68 25.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -130.7 115.95 17.38 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -84.55 138.65 18.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -177.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' PHE . . . . . 0.645 ' CE1' ' HB2' ' A' ' 241' ' ' LYS . 0.8 OUTLIER -159.57 174.2 14.98 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.729 -171.537 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -92.08 105.06 12.34 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 172.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo . . . . . 0 N--CA 1.463 -0.283 0 C-N-CA 122.085 1.856 . . . . 0.0 111.819 -179.971 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.439 ' O ' HG21 ' A' ' 99' ' ' ILE . 3.1 t . . . . . 0 N--CA 1.451 -0.404 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.51 106.65 11.69 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.631 175.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 5' ' ' ARG . 1.6 tpp180 -140.45 91.55 2.45 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.409 0.623 . . . . 0.0 110.904 -177.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.613 ' CE1' ' HE2' ' A' ' 89' ' ' LYS . 29.1 p90 -161.74 154.59 20.44 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.08 -0.963 . . . . 0.0 108.91 178.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -79.87 111.82 16.56 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.1 m -65.13 -13.18 57.47 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.222 -173.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.1 m -103.9 -20.55 13.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.788 0.328 . . . . 0.0 111.729 -178.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -73.91 92.93 2.13 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.323 0.582 . . . . 0.0 111.041 -175.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.8 mtm-85 -64.27 -23.32 67.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.121 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.5 m -70.1 -9.14 54.54 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.778 0.323 . . . . 0.0 110.802 177.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -100.48 -47.95 4.72 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.673 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 43.7 p-90 -113.24 -20.9 11.23 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -171.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -75.32 107.39 7.4 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.089 -0.644 . . . . 0.0 109.763 -178.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.766 ' SD ' ' HA ' ' A' ' 104' ' ' ARG . 10.8 tpp -86.71 -10.83 52.81 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.796 -172.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 51.3 -112.79 1.91 Allowed Glycine 0 CA--C 1.522 0.51 0 CA-C-N 115.476 -0.784 . . . . 0.0 114.721 175.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.17 70.06 1.29 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.562 2.841 . . . . 0.0 114.037 -173.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.648 HG22 ' HG3' ' A' ' 16' ' ' MET . 60.0 t -130.76 172.26 16.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 176.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.583 ' H ' HG11 ' A' ' 19' ' ' VAL . 89.6 p -145.08 -176.68 5.19 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 -169.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 26.7 ttt85 -68.08 -41.57 81.71 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.902 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -65.79 -48.92 70.17 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.4 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -65.65 -48.11 73.28 Favored 'General case' 0 C--O 1.221 -0.399 0 O-C-N 122.423 -0.173 . . . . 0.0 111.357 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.573 ' HB1' ' O ' ' A' ' 20' ' ' SER . . . -57.77 -46.94 83.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.7 0.286 . . . . 0.0 111.507 -177.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.536 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 51.5 tp60 -59.2 -42.57 91.24 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.814 178.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.7 m -62.3 -43.24 99.27 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.774 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.534 ' O ' ' HG3' ' A' ' 31' ' ' GLN . 46.2 mtt180 -74.01 -13.83 60.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.796 -174.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.574 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 37.8 mt -124.99 2.23 8.01 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.121 0.486 . . . . 0.0 111.275 -176.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.536 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 29.8 tp60 -71.14 96.11 1.32 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.649 -176.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.1 20.83 75.02 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.391 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.534 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 4.6 mm100 -87.98 -176.14 5.35 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.562 0.22 . . . . 0.0 110.431 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.802 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 50.4 ttp180 -55.79 133.41 51.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.074 177.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -83.66 140.73 31.99 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.904 0.383 . . . . 0.0 110.367 -174.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.58 -10.91 53.65 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.169 -173.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.802 ' SD ' ' HB3' ' A' ' 32' ' ' ARG . 24.8 mtp -79.81 140.07 36.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.475 -0.363 . . . . 0.0 110.436 177.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.454 ' HB2' HD13 ' A' ' 50' ' ' LEU . 45.1 p90 -146.58 163.66 35.1 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.124 -176.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.672 ' HB2' ' HB2' ' A' ' 16' ' ' MET . 4.2 pp -152.04 133.63 14.67 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.17 0.51 . . . . 0.0 110.966 175.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 56.1 t -101.84 106.9 20.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 174.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.6 ptt-85 -108.87 179.41 4.19 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.216 -175.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -79.66 138.54 37.41 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 172.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.447 ' HB3' ' O ' ' A' ' 44' ' ' CYS . 46.1 t -60.38 137.05 58.2 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.343 0.592 . . . . 0.0 111.92 -173.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.9 m -87.82 -4.47 58.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.756 -178.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.0 p -112.53 -45.91 3.2 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.901 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.447 ' O ' ' HB3' ' A' ' 41' ' ' SER . 39.2 m -131.17 90.45 38.7 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.493 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.77 133.68 51.49 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.887 2.391 . . . . 0.0 111.804 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 111.46 -41.66 2.17 Favored Glycine 0 CA--C 1.505 -0.566 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -172.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -79.48 177.16 9.07 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 167.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.542 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 39.2 m-85 -134.66 174.5 10.49 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 118.477 0.581 . . . . 0.0 110.916 -176.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.5 t -144.67 108.09 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.922 0.392 . . . . 0.0 110.706 175.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.454 HD13 ' HB2' ' A' ' 36' ' ' PHE . 48.4 tp -77.54 103.21 7.34 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.881 173.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.5 m -96.42 127.4 42.38 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 175.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 89.2 t -118.85 138.58 49.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.937 0.399 . . . . 0.0 111.085 -175.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.574 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 32.3 t -87.67 113.66 23.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.578 -176.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.631 ' HG3' HG21 ' A' ' 95' ' ' THR . 0.0 OUTLIER -149.47 137.29 20.35 Favored 'General case' 0 C--O 1.205 -1.249 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.241 172.921 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.427 HD21 ' CD ' ' A' ' 54' ' ' GLU . 75.8 m-20 56.53 27.13 11.85 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 173.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 49.0 m 57.74 53.06 7.45 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 122.516 1.15 . . . . 0.0 108.189 -175.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.648 HH22 ' HA ' ' A' ' 154' ' ' GLU . 6.0 ttp180 -167.98 64.81 0.07 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 113.133 -1.849 . . . . 0.0 109.246 -153.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 37.3 t -70.25 107.07 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 122.333 1.063 . . . . 0.0 110.142 -167.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 45.5 m -75.71 121.74 22.97 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 113.304 -1.771 . . . . 0.0 110.533 -176.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -99.01 115.32 28.68 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -173.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.468 ' CE2' HD12 ' A' ' 93' ' ' LEU . 44.0 m-85 -112.14 107.88 16.95 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.586 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.525 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 65.4 mt -80.77 127.9 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -173.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.542 ' HB ' ' HB2' ' A' ' 48' ' ' TYR . 3.8 mp -102.43 119.32 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 122.947 0.499 . . . . 0.0 111.209 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.536 ' HB2' ' HB3' ' A' ' 72' ' ' LYS . 0.8 OUTLIER -87.77 134.81 33.6 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.999 -178.818 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.0 t -83.7 86.1 7.18 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 172.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.491 HD11 ' HB2' ' A' ' 70' ' ' ARG . 83.0 mt -70.21 137.96 86.89 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.778 -176.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -61.85 -16.2 47.7 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.914 2.409 . . . . 0.0 111.394 176.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.8 m-20 -81.47 7.98 10.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.222 178.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.775 ' HA ' ' HE ' ' A' ' 69' ' ' ARG . 2.9 mmp_? 64.51 36.59 8.58 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.812 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.491 ' HB2' HD11 ' A' ' 66' ' ' LEU . 82.1 mtm-85 -126.38 179.17 5.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.271 177.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.488 ' HB3' HG21 ' A' ' 63' ' ' ILE . 57.0 m-85 -136.35 116.7 13.63 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.019 0.438 . . . . 0.0 111.156 -176.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 77' ' ' GLU . 24.2 ttmm -99.73 116.06 30.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.217 -176.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.525 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 18.5 tt -93.52 92.37 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 121.995 0.902 . . . . 0.0 111.345 -176.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 75' ' ' ASP . . . 77.76 -15.7 7.61 Favored Glycine 0 CA--C 1.517 0.203 0 CA-C-N 115.191 -0.913 . . . . 0.0 113.959 174.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 74' ' ' GLY . 22.3 t70 161.35 -55.24 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.607 0.717 . . . . 0.0 109.167 -171.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -71.27 118.78 14.49 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.63 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.573 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 14.3 pt-20 -105.89 134.44 49.01 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.751 0.786 . . . . 0.0 111.785 -175.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.45 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 88.9 m-85 -112.45 -177.47 3.16 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.848 176.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -78.54 -28.67 46.09 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 121.136 -0.226 . . . . 0.0 111.208 -176.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -171.02 174.31 4.76 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 173.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.533 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 13.1 mt -53.9 -56.47 25.25 Favored Pre-proline 0 N--CA 1.471 0.582 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -176.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.533 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 38.9 Cg_exo -61.23 -10.14 14.7 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 122.175 1.917 . . . . 0.0 112.81 -177.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.5 -36.02 15.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.798 -178.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.0 pp -75.44 -34.58 60.97 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.561 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 92.0 mt -64.85 -25.93 68.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.377 177.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -87.27 -34.21 18.99 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.463 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -70.35 -36.87 74.47 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.299 0.571 . . . . 0.0 110.56 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.81 ' CG ' HD22 ' A' ' 93' ' ' LEU . 27.1 m-85 -77.32 -9.41 58.81 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.197 -177.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.613 ' HE2' ' CE1' ' A' ' 6' ' ' PHE . 99.0 mttt -68.1 -12.5 60.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.919 0.39 . . . . 0.0 111.221 177.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 24.2 pt -134.55 18.86 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 121.368 0.604 . . . . 0.0 109.492 -178.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.427 ' O ' ' HB2' ' A' ' 92' ' ' TYR . 4.0 t60 -116.55 -40.66 3.18 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.969 -175.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.427 ' HB2' ' O ' ' A' ' 91' ' ' HIS . 52.6 m-85 68.85 114.21 0.04 OUTLIER 'General case' 0 N--CA 1.461 0.104 0 O-C-N 124.291 0.995 . . . . 0.0 109.115 -169.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.81 HD22 ' CG ' ' A' ' 88' ' ' TYR . 0.8 OUTLIER -109.18 -7.39 15.3 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.055 -0.658 . . . . 0.0 111.099 176.347 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 1.058 ' HA ' ' HB3' ' A' ' 154' ' ' GLU . 0.5 OUTLIER -159.52 81.42 0.74 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.143 0.497 . . . . 0.0 111.166 170.372 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.693 ' CB ' ' HA ' ' A' ' 156' ' ' PRO . 2.3 t 47.67 3.79 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 125.208 1.403 . . . . 0.0 113.858 -176.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.509 ' H ' ' C ' ' A' ' 94' ' ' ASP . 14.6 t -153.76 168.16 27.22 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 32.5 p -101.85 178.46 4.61 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 177.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.1 mt -75.11 96.19 3.21 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 176.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.439 HG21 ' O ' ' A' ' 3' ' ' SER . 37.5 mm -82.15 -63.68 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.707 -173.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.62 ' O ' ' HA ' ' A' ' 35' ' ' MET . 33.3 tt0 -153.33 137.13 10.41 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.16 -178.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -57.33 162.57 9.62 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 123.087 2.524 . . . . 0.0 113.248 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.437 ' HB1' HD21 ' A' ' 28' ' ' LEU . . . -78.16 157.98 77.67 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.198 178.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.93 107.52 0.23 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.452 2.101 . . . . 0.0 112.089 177.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.766 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 65.0 ttt180 . . . . . 0 C--N 1.326 -0.42 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.705 178.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.451 ' HA ' HD12 ' A' ' 125' ' ' LEU . 2.6 mm? . . . . . 0 N--CA 1.467 0.408 0 CA-C-O 121.657 0.741 . . . . 0.0 111.351 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.562 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 46.5 tt0 -169.37 -77.12 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.561 -176.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -104.74 107.67 18.75 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 121.611 0.719 . . . . 0.0 110.773 -177.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.764 HG21 ' CG ' ' A' ' 180' ' ' LYS . 65.7 t -123.48 130.67 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 CA-C-N 114.448 -1.251 . . . . 0.0 108.882 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.675 ' HG3' ' HB3' ' A' ' 179' ' ' GLU . 5.2 ptp180 -108.6 149.65 28.6 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 116.831 -1.947 . . . . 0.0 108.196 171.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.481 ' HB ' ' CD1' ' A' ' 144' ' ' PHE . 0.8 OUTLIER -106.12 129.56 54.18 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.102 -178.734 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 1.016 HD12 ' HG2' ' A' ' 179' ' ' GLU . 16.8 mt -104.08 -21.17 13.63 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -174.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.419 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 59.2 t80 -77.31 -35.18 55.14 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -172.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.567 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 23.0 t70 70.77 94.72 0.07 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.633 0.73 . . . . 0.0 109.784 -174.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.517 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 37.1 t80 -126.69 86.39 58.66 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.562 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 90.8 Cg_endo -88.89 79.36 1.01 Allowed 'Trans proline' 0 N--CA 1.441 -1.563 0 C-N-CA 121.896 1.731 . . . . 0.0 112.66 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.51 -22.5 75.02 Favored Glycine 0 CA--C 1.51 -0.248 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 175.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.816 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 1.0 OUTLIER 57.43 73.12 0.48 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.09 -1.055 . . . . 0.0 110.997 -175.704 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.511 ' HB3' ' H ' ' A' ' 141' ' ' ASP . 0.6 OUTLIER -141.26 -173.65 3.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.394 0.616 . . . . 0.0 111.545 -178.588 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -114.99 1.9 14.1 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.674 167.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.549 ' O ' ' HB2' ' A' ' 172' ' ' MET . 40.3 mt-10 -116.35 -41.18 3.15 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.994 175.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.511 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 9.2 m-20 -101.86 114.25 28.17 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 167.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.673 ' CD2' HD23 ' A' ' 150' ' ' LEU . 35.2 tp -69.92 127.64 92.31 Favored Pre-proline 0 N--CA 1.465 0.324 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.816 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 6.5 Cg_endo -82.02 90.23 1.14 Allowed 'Trans proline' 0 N--CA 1.443 -1.497 0 C-N-CA 121.956 1.771 . . . . 0.0 110.752 173.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.529 ' CE2' ' HB ' ' A' ' 173' ' ' ILE . 9.1 p90 -102.39 155.04 18.51 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.317 -175.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.567 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 99.0 mttt -99.92 -166.65 1.36 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.235 0.54 . . . . 0.0 112.427 -174.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.777 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -83.71 5.29 25.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.288 -169.42 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -179.07 37.59 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.996 176.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.504 ' OE1' ' HA ' ' A' ' 144' ' ' PHE . 1.2 pt-20 -96.59 148.92 22.35 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.751 -174.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.493 HD13 ' N ' ' A' ' 149' ' ' ILE . 1.7 mp -87.58 128.58 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.673 HD23 ' CD2' ' A' ' 142' ' ' LEU . 16.6 mt -121.7 156.63 32.67 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 -178.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.562 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 49.2 t -119.51 123.43 71.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 174.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.46 ' HA ' ' HA ' ' A' ' 163' ' ' ALA . 50.4 mm -73.92 94.53 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 -176.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.581 HD13 ' HD3' ' A' ' 164' ' ' ARG . 18.7 tt -79.33 -26.34 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.547 -173.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 1.058 ' HB3' ' HA ' ' A' ' 94' ' ' ASP . 0.0 OUTLIER -141.0 145.56 36.11 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.454 169.123 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -121.86 84.93 44.63 Favored Pre-proline 0 C--N 1.318 -0.784 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 167.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.693 ' HA ' ' CB ' ' A' ' 95' ' ' THR . 13.0 Cg_exo -70.42 -47.73 0.69 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.603 2.202 . . . . 0.0 111.824 177.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -118.15 177.29 4.85 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.589 -174.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.424 ' O ' HG23 ' A' ' 175' ' ' VAL . 13.3 pt-20 -92.98 -34.76 13.62 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.556 -176.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -98.74 -10.42 23.15 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.865 0.364 . . . . 0.0 111.66 -176.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.527 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 59.1 m95 -124.36 134.83 53.03 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 172.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . 0.773 ' O ' HG13 ' A' ' 173' ' ' ILE . 50.7 m0 -123.99 133.81 53.6 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.144 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.749 ' HB2' ' HG3' ' A' ' 154' ' ' GLU . 50.5 m -93.82 98.47 11.1 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -173.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.555 ' HB2' ' HB3' ' A' ' 150' ' ' LEU . . . -112.33 146.09 38.88 Favored 'General case' 0 N--CA 1.419 -1.998 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.701 -172.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.722 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 15.1 ptt180 -87.0 120.62 28.46 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 175.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.636 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . 20.7 t30 -52.52 176.85 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 113.455 -1.702 . . . . 0.0 111.753 -173.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 45.5 tptt -58.46 -21.02 49.96 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 169.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -77.38 -28.89 52.97 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.614 175.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 100.17 7.56 52.06 Favored Glycine 0 CA--C 1.519 0.333 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.119 -174.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.722 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.4 OUTLIER -79.9 135.72 36.49 Favored 'General case' 0 C--O 1.22 -0.498 0 C-N-CA 122.819 0.448 . . . . 0.0 111.217 -179.621 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.495 HG23 HG22 ' A' ' 153' ' ' ILE . 47.9 t -81.08 123.34 37.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 C-N-CA 121.119 -0.232 . . . . 0.0 111.252 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -158.06 146.29 13.13 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.865 171.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.549 ' HB2' ' O ' ' A' ' 140' ' ' GLU . 0.0 OUTLIER -68.97 141.06 55.03 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 122.922 0.489 . . . . 0.0 111.219 178.265 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.773 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.7 pp -142.91 143.17 24.23 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.246 -176.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.513 ' HB2' ' CD1' ' A' ' 177' ' ' TYR . 20.5 Cg_exo -68.24 132.26 25.48 Favored 'Trans proline' 0 CA--C 1.528 0.219 0 C-N-CA 122.96 2.44 . . . . 0.0 113.282 -178.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.553 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 67.0 t -60.79 -44.34 94.7 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 178.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 20.0 Cg_endo -61.52 -2.05 2.35 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 122.211 1.94 . . . . 0.0 113.217 178.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.513 ' CD1' ' HB2' ' A' ' 174' ' ' PRO . 2.8 m-85 -99.83 -12.17 20.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.555 -177.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.633 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 3.7 m -106.36 -172.83 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 -164.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 1.016 ' HG2' HD12 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -157.29 46.44 0.39 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 112.897 -1.956 . . . . 0.0 111.545 -151.755 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.764 ' CG ' HG21 ' A' ' 128' ' ' VAL . 0.8 OUTLIER -71.45 136.55 47.7 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 120.193 -1.567 . . . . 0.0 110.009 -163.369 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.458 HD21 ' NH2' ' A' ' 129' ' ' ARG . 38.8 tp . . . . . 0 CA--C 1.523 -0.067 0 CA-C-N 113.524 -1.671 . . . . 0.0 111.796 -165.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo . . . . . 0 N--CA 1.46 -0.447 0 N-CA-C 110.54 -0.6 . . . . 0.0 110.54 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.488 ' HB ' HG12 ' A' ' 266' ' ' VAL . 6.2 t -74.49 127.74 36.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -176.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -98.69 118.2 34.87 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.193 0.52 . . . . 0.0 111.198 -175.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . 0.541 ' HB3' HD11 ' A' ' 293' ' ' ILE . . . -121.78 134.95 54.92 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.067 175.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -94.45 133.62 37.85 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 177.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . 0.579 ' O ' ' HA ' ' A' ' 260' ' ' VAL . . . -82.29 105.2 13.17 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.178 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.466 ' H ' HD12 ' A' ' 243' ' ' ILE . 0.2 OUTLIER -88.84 -23.08 6.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.999 0.428 . . . . 0.0 110.727 -178.483 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -130.25 122.61 28.37 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 178.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -60.34 138.42 57.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.799 0.809 . . . . 0.0 112.374 -171.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.494 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 20.4 tpt180 -116.83 113.99 23.29 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.946 -1.025 . . . . 0.0 108.998 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.41 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 19.9 m -111.65 147.68 37.28 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.774 -178.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.458 ' HA ' ' HB3' ' A' ' 255' ' ' ALA . 11.9 Cg_exo -69.24 105.63 1.43 Allowed 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.68 2.253 . . . . 0.0 111.399 178.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' CYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 252' ' ' ASP . 34.0 t -76.92 172.34 13.31 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.965 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -55.62 -42.58 75.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.823 0.344 . . . . 0.0 111.131 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -94.23 8.83 40.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.122 0.487 . . . . 0.0 111.172 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . 0.425 ' HB2' ' HB3' ' A' ' 249' ' ' CYS . 1.6 m-20 -131.94 51.28 2.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.538 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -67.65 -17.49 64.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.128 0.489 . . . . 0.0 110.106 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 3.7 p -88.23 4.37 46.02 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.55 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . 0.458 ' HB3' ' HA ' ' A' ' 248' ' ' PRO . . . -88.39 142.82 27.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.223 0.535 . . . . 0.0 111.299 -178.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.2 tt -81.68 141.22 33.83 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.11 177.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -88.63 109.53 20.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.139 0.495 . . . . 0.0 110.297 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 72.2 mt -118.42 157.38 27.3 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.96 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -146.01 167.9 22.22 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 177.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . 0.579 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 26.0 t -55.82 120.39 2.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 O-C-N 123.673 0.608 . . . . 0.0 112.55 -171.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 109.76 -21.13 26.07 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.713 -0.676 . . . . 0.0 113.574 172.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -78.79 154.44 29.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 117.033 0.416 . . . . 0.0 110.797 -170.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 43.9 mm -98.12 120.55 47.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.877 -177.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.432 HG22 HG11 ' A' ' 291' ' ' VAL . 21.7 t -95.81 116.67 38.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.532 179.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 43.1 tttm -89.86 99.02 12.11 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.461 177.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.488 HG12 ' HB ' ' A' ' 238' ' ' VAL . 3.6 p -99.52 117.53 44.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.36 0.6 . . . . 0.0 110.174 174.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.42 -13.66 15.04 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.816 -177.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . 0.536 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 5.6 ttp180 -130.46 107.3 9.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.174 0.512 . . . . 0.0 110.86 175.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' MET . . . . . 0.576 ' HE1' ' CH2' ' A' ' 275' ' ' TRP . 44.7 mtt -97.92 123.8 42.07 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.684 173.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.425 ' O ' ' HB ' ' A' ' 271' ' ' ILE . 90.8 m-20 -80.74 -93.55 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.976 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.425 ' HB ' ' O ' ' A' ' 270' ' ' ASN . 10.5 tp 177.1 -29.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.153 0.502 . . . . 0.0 109.778 176.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -68.29 -37.5 80.73 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.734 177.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 141.42 -34.36 1.91 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.422 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.446 ' NE2' HD11 ' A' ' 285' ' ' LEU . 26.8 mt-30 -76.38 107.72 8.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.875 0.369 . . . . 0.0 110.198 178.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.576 ' CH2' ' HE1' ' A' ' 269' ' ' MET . 40.6 m0 -98.24 158.1 15.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.176 -178.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . 0.536 ' HB2' ' HB3' ' A' ' 268' ' ' ARG . 53.6 mt-10 -95.84 104.27 16.2 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.216 173.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -121.63 141.05 14.26 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 174.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -116.3 112.05 21.0 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.999 0.428 . . . . 0.0 110.43 -177.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 66.3 t -129.4 127.9 65.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.2 -177.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 63.66 21.8 12.86 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.451 177.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 102.44 -14.89 56.52 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.731 177.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 53.4 mtp180 -104.43 132.02 51.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.694 0.247 . . . . 0.0 111.128 -179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 4.8 ptpp? -111.57 114.83 28.16 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 171.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -133.4 166.38 23.83 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.757 -177.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.446 HD11 ' NE2' ' A' ' 274' ' ' GLN . 74.8 mt -86.98 112.56 21.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.265 0.555 . . . . 0.0 110.443 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -115.56 149.34 42.8 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.859 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -86.11 143.61 7.97 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.471 2.114 . . . . 0.0 111.618 177.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -68.93 4.01 1.72 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -175.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 23.9 p -89.54 -33.67 16.65 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.855 0.359 . . . . 0.0 111.511 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -77.5 -12.32 59.95 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.984 0.421 . . . . 0.0 110.96 -177.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.503 ' HB ' ' HB1' ' A' ' 240' ' ' ALA . 27.8 m -128.38 160.57 38.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.279 179.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -133.55 134.92 43.96 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.9 0.381 . . . . 0.0 110.753 174.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.541 HD11 ' HB3' ' A' ' 240' ' ' ALA . 1.2 mp -68.34 138.89 21.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.482 177.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -156.73 158.8 37.57 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 177.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -84.85 114.5 55.97 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 174.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.463 -0.313 0 C-N-CA 122.987 2.458 . . . . 0.0 111.123 178.482 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.517 ' O ' HG22 ' A' ' 99' ' ' ILE . 3.0 p . . . . . 0 N--CA 1.451 -0.391 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -87.86 66.46 8.75 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.772 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -97.91 84.46 3.33 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.816 -173.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -154.37 164.67 38.25 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.506 176.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -89.68 107.29 19.01 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 175.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.575 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 37.8 t -79.09 69.9 5.35 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.306 -178.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.4 t -176.29 -40.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.167 176.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -58.14 108.23 0.58 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.108 0.48 . . . . 0.0 111.469 -174.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 17.8 mmt180 -61.92 -32.22 72.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.853 -174.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 72.4 m -74.47 -5.7 44.11 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.974 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.53 -48.41 6.64 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.429 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.414 ' HB3' ' HB3' ' A' ' 101' ' ' PRO . 22.9 p-90 -114.54 -29.94 6.68 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -170.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -72.27 122.2 20.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.908 0.385 . . . . 0.0 110.618 -175.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.534 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 26.1 mmt -103.06 -5.5 23.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.401 -176.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.472 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 50.97 -114.43 2.79 Favored Glycine 0 CA--C 1.522 0.492 0 CA-C-N 115.614 -0.721 . . . . 0.0 113.498 -177.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.472 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 5.3 Cg_exo -77.33 89.18 1.34 Allowed 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 123.091 2.527 . . . . 0.0 113.274 -175.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.569 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 97.1 t -139.15 155.51 26.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 177.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.5 m -119.46 174.06 6.61 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -174.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 70.0 mtp85 -55.77 -47.32 77.25 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -62.7 -56.2 19.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.853 0.358 . . . . 0.0 111.113 -178.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.503 ' HB3' HG12 ' A' ' 19' ' ' VAL . 0.5 OUTLIER -57.08 -47.12 81.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.789 -179.156 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.467 ' HB2' HD11 ' A' ' 37' ' ' LEU . . . -57.52 -47.4 82.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.204 0.526 . . . . 0.0 111.079 176.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -63.91 -43.19 96.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.495 -178.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.9 t -70.66 -9.16 56.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.651 0.262 . . . . 0.0 111.437 -177.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.492 ' HG3' ' O ' ' A' ' 23' ' ' GLU . 77.5 mtt180 -87.65 -25.84 23.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.987 0.422 . . . . 0.0 110.661 174.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.517 HD23 ' HB2' ' A' ' 53' ' ' SER . 27.3 mt -108.71 -12.49 14.94 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.76 -175.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.0 tp60 -79.7 105.51 11.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.161 0.505 . . . . 0.0 111.297 -177.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.97 -17.84 47.75 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.86 175.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -86.16 175.54 8.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.678 0.275 . . . . 0.0 110.785 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 18.3 ttp180 -62.0 132.09 51.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.732 -177.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.416 ' CD2' ' HA ' ' A' ' 54' ' ' GLU . 33.3 m80 -76.35 158.18 31.71 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.376 -176.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.69 -11.86 46.24 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -174.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.554 ' HB3' ' HB1' ' A' ' 102' ' ' ALA . 66.1 mtt -73.96 150.7 40.62 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 175.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.419 ' CB ' HG22 ' A' ' 52' ' ' VAL . 37.9 p90 -147.8 156.26 42.54 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 175.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.534 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.5 pp -150.45 134.72 17.08 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.058 0.456 . . . . 0.0 110.592 178.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.4 t -105.84 107.57 22.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.508 176.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.569 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 24.6 ptt-85 -106.34 -178.85 3.77 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.46 138.82 33.28 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 172.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.591 ' HB3' ' O ' ' A' ' 44' ' ' CYS . 20.8 t -68.05 104.26 1.72 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.39 0.614 . . . . 0.0 110.736 -174.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.4 p -69.02 -11.01 60.4 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.839 177.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.0 p -104.97 -22.15 13.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.719 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.591 ' O ' ' HB3' ' A' ' 41' ' ' SER . 57.9 m -136.51 112.68 10.03 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.763 0.316 . . . . 0.0 110.561 -177.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -62.01 114.95 2.53 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.958 2.439 . . . . 0.0 113.098 -175.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.94 -26.53 23.71 Favored Glycine 0 CA--C 1.51 -0.236 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.735 174.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.597 ' OD1' ' HA ' ' A' ' 64' ' ' ASN . 32.0 m-20 -79.95 179.66 7.47 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.523 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 38.3 m-85 -127.48 174.36 9.08 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 176.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.403 HG22 HD11 ' A' ' 62' ' ' ILE . 27.9 t -141.37 111.01 2.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.662 0.267 . . . . 0.0 111.049 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.3 tp -78.33 98.76 6.06 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 171.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.8 m -95.62 119.66 34.51 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.266 0.555 . . . . 0.0 109.543 175.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 48.7 t -112.12 143.32 22.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.903 -173.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.578 ' HA ' ' O ' ' A' ' 57' ' ' ARG . 36.6 t -87.34 111.87 21.52 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.612 -0.144 . . . . 0.0 110.612 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.416 ' HA ' ' CD2' ' A' ' 33' ' ' HIS . 6.8 tp10 -175.92 157.3 1.89 Allowed 'General case' 0 N--CA 1.469 0.523 0 O-C-N 123.486 0.491 . . . . 0.0 111.022 176.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.66 ' HB2' ' NH2' ' A' ' 57' ' ' ARG . 27.0 m-80 61.81 58.26 2.0 Allowed 'General case' 0 CA--C 1.479 -1.752 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -171.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.9 t 70.54 -37.54 0.39 Allowed 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 113.777 -1.556 . . . . 0.0 110.21 -169.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.861 ' NE ' ' H ' ' A' ' 58' ' ' VAL 0.399 0.0 OUTLIER -157.76 -48.06 0.06 Allowed 'General case' 0 C--N 1.364 1.237 1 N-CA-C 125.571 5.397 . . . . 0.0 125.571 -170.116 . . . . . . . . 5 4 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.861 ' H ' ' NE ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -149.43 112.09 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 122.088 2.222 . . . . 0.0 114.573 -168.292 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.531 ' HB2' ' HB ' ' A' ' 52' ' ' VAL . 1.4 m -98.34 114.13 26.34 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 166.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.565 ' O ' HD11 ' A' ' 153' ' ' ILE . 92.0 m-70 -100.68 110.81 22.96 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -170.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.603 ' CZ ' ' HB2' ' A' ' 93' ' ' LEU . 98.7 m-85 -119.03 117.25 28.28 Favored 'General case' 0 C--O 1.218 -0.579 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -178.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.509 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 44.8 mm -78.09 127.64 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -177.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.54 HG13 ' HB ' ' A' ' 73' ' ' ILE . 3.8 mp -104.34 114.54 44.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 175.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.597 ' HA ' ' OD1' ' A' ' 47' ' ' ASP . 7.9 m120 -85.89 137.06 33.02 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.577 -173.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.8 t -87.72 95.73 10.18 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 174.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.512 HD12 ' HB2' ' A' ' 72' ' ' LYS . 99.0 mt -82.15 136.19 47.02 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.444 -178.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 66' ' ' LEU . 27.0 Cg_exo -64.82 -2.0 4.87 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.942 2.428 . . . . 0.0 111.311 172.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -79.58 5.22 13.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.614 175.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.505 ' HA ' ' HE ' ' A' ' 69' ' ' ARG . 0.1 OUTLIER 67.91 29.9 6.38 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.227 -176.835 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.413 ' HB3' ' O ' ' A' ' 78' ' ' PHE . 30.7 mtm-85 -140.52 175.23 9.78 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.933 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.45 ' HB3' HG23 ' A' ' 63' ' ' ILE . 68.1 m-85 -125.99 132.22 52.07 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.505 0.193 . . . . 0.0 111.06 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.642 ' HE2' ' HB3' ' A' ' 77' ' ' GLU . 37.1 ttmt -114.32 112.19 22.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.978 -177.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.54 ' HB ' HG13 ' A' ' 63' ' ' ILE . 14.0 tt -105.04 110.72 31.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.344 0.592 . . . . 0.0 111.127 -177.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' A' ' 76' ' ' GLN . . . 67.58 50.12 45.47 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.63 177.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.9 t0 75.58 -29.24 0.19 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.607 0.763 . . . . 0.0 110.985 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.431 ' H ' ' C ' ' A' ' 74' ' ' GLY . 14.9 mm100 -81.18 121.43 26.13 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.185 0.517 . . . . 0.0 110.716 178.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.642 ' HB3' ' HE2' ' A' ' 72' ' ' LYS . 7.8 pt-20 -99.6 141.86 31.84 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.437 -176.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.413 ' O ' ' HB3' ' A' ' 70' ' ' ARG . 95.5 m-85 -131.95 -175.56 3.77 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.201 -177.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -64.01 -50.88 66.76 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.186 0.517 . . . . 0.0 110.335 175.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.554 ' HD1' ' HD2' ' A' ' 82' ' ' PRO . 4.2 p80 -173.0 -173.8 0.99 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.246 -176.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.637 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 19.6 mt -54.3 -58.16 15.1 Favored Pre-proline 0 N--CA 1.467 0.421 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.637 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 52.4 Cg_exo -59.52 -7.7 5.93 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 122.562 2.175 . . . . 0.0 113.765 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -95.46 -36.68 11.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.915 0.388 . . . . 0.0 110.925 -178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.9 pp -76.59 -30.52 57.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.311 -178.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.437 ' HB2' ' OG ' ' A' ' 8' ' ' SER . 60.0 mt -66.12 -21.91 66.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.322 0.582 . . . . 0.0 110.002 177.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -81.66 -39.84 23.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.086 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.685 ' O ' HD11 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -71.64 -21.38 61.83 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.073 0.463 . . . . 0.0 111.079 -179.873 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.628 ' CE1' ' HE1' ' A' ' 87' ' ' PHE . 32.7 m-85 -89.34 1.91 55.12 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 121.665 -0.647 . . . . 0.0 111.641 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -76.38 -21.47 56.02 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.953 175.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.685 HD11 ' O ' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -125.4 -1.78 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-O 121.558 0.694 . . . . 0.0 110.301 -175.477 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -101.86 -30.71 11.11 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.345 -174.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 67.81 153.56 0.09 Allowed 'General case' 0 C--N 1.332 -0.168 0 O-C-N 124.501 1.125 . . . . 0.0 109.346 -168.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.603 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 0.7 OUTLIER -138.24 39.97 2.28 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 164.648 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 1.029 ' HA ' ' HB3' ' A' ' 154' ' ' GLU . 13.8 t0 168.08 -158.47 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 112.058 -2.337 . . . . 0.0 106.01 172.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.719 ' CB ' ' HA ' ' A' ' 156' ' ' PRO . 14.2 t -76.76 11.36 1.73 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.21 0.529 . . . . 0.0 110.564 176.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.2 t -146.43 161.58 40.1 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.752 176.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.8 p -97.7 -176.18 3.4 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 176.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 81.5 mt -77.33 92.91 3.96 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 176.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.517 HG22 ' O ' ' A' ' 3' ' ' SER . 48.1 mm -74.9 -59.08 3.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.985 -176.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.548 ' O ' ' HA ' ' A' ' 35' ' ' MET . 8.8 pt-20 -159.98 154.42 20.36 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.257 178.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.414 ' HB3' ' HB3' ' A' ' 14' ' ' TRP . 38.1 Cg_endo -67.18 142.64 61.75 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.323 2.015 . . . . 0.0 112.003 177.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.554 ' HB1' ' HB3' ' A' ' 35' ' ' MET . . . -69.01 148.0 97.8 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.945 177.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -63.26 129.13 24.57 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.704 1.603 . . . . 0.0 111.102 174.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 . . . . . 0 C--N 1.33 -0.279 0 CA-C-O 121.056 0.455 . . . . 0.0 111.194 178.336 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.627 ' HG ' ' CD ' ' A' ' 155' ' ' LYS . 4.6 mm? . . . . . 0 N--CA 1.468 0.465 0 CA-C-O 121.696 0.76 . . . . 0.0 110.516 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 40.1 tt0 -172.88 -68.72 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.825 -1.08 . . . . 0.0 108.942 -172.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -115.63 108.02 15.86 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 121.061 0.457 . . . . 0.0 110.163 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.72 HG21 ' CG ' ' A' ' 180' ' ' LYS . 69.4 t -118.1 132.47 67.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.961 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.68 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 5.6 ptp180 -110.38 144.37 39.25 Favored 'General case' 0 N--CA 1.436 -1.167 0 C-N-CA 117.162 -1.815 . . . . 0.0 107.92 169.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.658 ' HG1' ' CB ' ' A' ' 144' ' ' PHE . 6.0 p -98.19 138.5 35.38 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.064 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.55 HD22 ' HG2' ' A' ' 179' ' ' GLU . 15.6 mt -110.96 -8.14 14.5 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.434 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 22.0 t80 -91.03 -42.46 10.51 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.432 -0.507 . . . . 0.0 112.01 -173.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.537 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 10.0 t70 77.3 98.39 0.07 Allowed 'General case' 0 N--CA 1.475 0.808 0 O-C-N 123.581 0.55 . . . . 0.0 110.459 -176.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.512 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 76.0 t80 -134.12 93.86 19.11 Favored Pre-proline 0 N--CA 1.45 -0.47 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 176.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.656 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 91.9 Cg_endo -84.02 89.53 0.97 Allowed 'Trans proline' 0 N--CA 1.443 -1.476 0 C-N-CA 121.767 1.645 . . . . 0.0 112.64 -178.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -79.74 -36.48 25.66 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.65 176.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.538 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 16.7 m120 67.62 34.21 4.64 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 122.958 0.503 . . . . 0.0 111.648 175.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.465 ' HB3' ' H ' ' A' ' 140' ' ' GLU . 0.1 OUTLIER -117.3 178.22 4.45 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.135 -178.071 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -92.71 -7.31 47.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.926 0.87 . . . . 0.0 108.749 171.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.66 ' O ' ' HB2' ' A' ' 172' ' ' MET . 32.4 mt-10 -118.06 -5.02 10.98 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.712 177.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.446 ' HB2' ' HB2' ' A' ' 138' ' ' ASP . 7.9 m-20 -139.53 102.44 4.46 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 174.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.721 ' CD2' HD23 ' A' ' 150' ' ' LEU . 31.0 tp -71.74 135.21 83.45 Favored Pre-proline 0 CA--C 1.512 -0.517 0 C-N-CA 120.535 -0.466 . . . . 0.0 109.966 -177.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.656 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 94.4 Cg_endo -88.54 96.85 0.38 Allowed 'Trans proline' 0 N--CA 1.438 -1.767 0 C-N-CA 121.54 1.493 . . . . 0.0 112.193 173.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.658 ' CB ' ' HG1' ' A' ' 130' ' ' THR . 1.8 p90 -94.54 -177.7 4.32 Favored 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.85 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.537 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 29.1 mtmm -125.96 -172.25 2.57 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.676 174.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.985 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -78.13 22.74 0.29 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.749 -173.1 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 145' ' ' LYS . . . 165.5 35.13 0.02 OUTLIER Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.446 179.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.561 ' OE1' ' HA ' ' A' ' 144' ' ' PHE . 0.8 OUTLIER -96.79 150.51 20.63 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 119.286 -0.966 . . . . 0.0 110.688 -178.876 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.451 HD11 ' HB3' ' A' ' 129' ' ' ARG . 1.2 mp -93.5 123.76 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -173.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.721 HD23 ' CD2' ' A' ' 142' ' ' LEU . 13.2 mt -119.91 156.89 29.88 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -175.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.543 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 99.5 t -117.74 121.42 67.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 176.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.511 HG13 HD12 ' A' ' 125' ' ' LEU . 47.2 mm -77.21 105.21 5.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.548 0.69 . . . . 0.0 109.181 -175.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.565 HD11 ' O ' ' A' ' 60' ' ' HIS . 19.5 tt -96.33 -29.01 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.954 -174.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 1.029 ' HB3' ' HA ' ' A' ' 94' ' ' ASP . 2.6 mt-10 -123.25 143.15 50.24 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 168.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.627 ' CD ' ' HG ' ' A' ' 125' ' ' LEU . 70.2 tttt -134.86 78.44 54.58 Favored Pre-proline 0 C--N 1.314 -0.952 0 CA-C-O 121.323 0.583 . . . . 0.0 109.512 166.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.719 ' HA ' ' CB ' ' A' ' 95' ' ' THR . 26.1 Cg_exo -64.47 -52.41 1.47 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.178 1.919 . . . . 0.0 111.908 172.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.423 ' HG2' ' HB2' ' A' ' 156' ' ' PRO . 17.7 mm-40 -114.73 168.08 10.2 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.194 -169.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -96.19 1.56 52.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.395 0.617 . . . . 0.0 109.466 173.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.907 HE21 ' HA ' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -104.73 -34.34 8.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.72 179.651 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.467 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 35.1 m95 -129.55 142.28 50.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.985 176.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . 0.741 ' O ' HG13 ' A' ' 173' ' ' ILE . 52.4 m0 -125.68 137.96 53.87 Favored 'General case' 0 C--O 1.216 -0.695 0 C-N-CA 123.155 0.582 . . . . 0.0 110.143 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.54 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 18.2 m -98.12 107.11 19.51 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -175.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.5 ' HB2' ' HB3' ' A' ' 150' ' ' LEU . . . -117.3 152.22 35.32 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 119.899 -0.72 . . . . 0.0 110.742 -176.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.816 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 11.8 ptt180 -87.37 121.91 30.42 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 171.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.682 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . 14.9 t30 -55.92 -179.83 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 113.748 -1.569 . . . . 0.0 111.668 -174.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -66.51 -22.15 66.17 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 167.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -68.85 -20.36 64.28 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.709 168.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 82.73 19.51 63.46 Favored Glycine 0 CA--C 1.527 0.844 0 CA-C-N 115.148 -0.933 . . . . 0.0 113.246 -175.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.816 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 1.5 ttm-85 -94.12 142.53 27.3 Favored 'General case' 0 C--O 1.214 -0.788 0 C-N-CA 122.482 0.313 . . . . 0.0 111.03 -178.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 59.4 t -83.96 123.41 38.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 O-C-N 122.191 -0.318 . . . . 0.0 111.29 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -158.53 151.97 23.05 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.723 171.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.66 ' HB2' ' O ' ' A' ' 140' ' ' GLU . 0.2 OUTLIER -73.17 142.91 47.4 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.735 0.302 . . . . 0.0 111.187 178.202 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.741 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.7 pp -143.88 147.96 40.52 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.115 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.505 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 11.2 Cg_exo -72.67 132.37 18.67 Favored 'Trans proline' 0 CA--C 1.528 0.214 0 C-N-CA 122.654 2.236 . . . . 0.0 112.826 -175.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.49 ' O ' HG21 ' A' ' 178' ' ' VAL . 70.1 t -60.41 -44.32 95.5 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.459 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 39.2 Cg_exo -62.59 -5.7 7.56 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 122.213 1.942 . . . . 0.0 112.95 176.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.505 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.2 m-85 -94.67 -12.17 27.82 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.216 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.629 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 2.8 m -107.41 -175.18 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 -166.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.707 ' O ' ' HG3' ' A' ' 179' ' ' GLU . 3.6 tp10 -160.9 46.32 0.2 Allowed 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 112.725 -2.034 . . . . 0.0 111.541 -152.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.72 ' CG ' HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -73.17 137.86 45.34 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 119.125 -2.235 . . . . 0.0 111.874 -161.328 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 15.3 tp . . . . . 0 N--CA 1.445 -0.69 0 CA-C-N 112.217 -2.265 . . . . 0.0 110.15 -173.401 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo . . . . . 0 N--CA 1.459 -0.516 0 N-CA-C 110.732 -0.526 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.485 ' CG1' HD11 ' A' ' 293' ' ' ILE . 2.8 t -90.18 145.0 7.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.557 -176.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.447 ' HB2' ' HA ' ' A' ' 295' ' ' ASP . 77.1 m-85 -116.28 124.77 51.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.291 0.567 . . . . 0.0 112.302 -172.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . 0.543 ' HB3' HD13 ' A' ' 293' ' ' ILE . . . -119.48 149.85 41.21 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.919 175.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -106.65 123.72 48.54 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 173.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . 0.51 ' O ' ' HA ' ' A' ' 260' ' ' VAL . . . -68.34 97.24 0.72 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.92 0.391 . . . . 0.0 110.304 -178.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.47 HD12 ' HB2' ' A' ' 292' ' ' LYS . 27.1 pt -86.29 -24.39 6.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.077 -177.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.39 123.85 38.88 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 176.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -53.98 138.63 36.56 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.38 0.609 . . . . 0.0 111.598 -173.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 28.4 tpt180 -123.32 111.63 16.63 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.161 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.442 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 23.6 m -115.95 144.22 32.34 Favored Pre-proline 0 C--N 1.318 -0.802 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.264 177.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 247' ' ' VAL . 4.4 Cg_exo -75.09 121.87 6.81 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.478 2.119 . . . . 0.0 110.953 177.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 18.2 t -75.42 -178.41 4.02 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.105 -177.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -59.23 -23.62 62.48 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.289 0.478 . . . . 0.0 112.289 -176.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -107.0 4.9 27.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.621 -177.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -96.3 112.88 24.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.773 0.32 . . . . 0.0 110.808 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -106.75 -37.82 6.29 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.014 176.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 24.8 p -99.41 19.97 14.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.708 -176.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -93.36 145.09 24.72 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.057 0.456 . . . . 0.0 111.164 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -93.78 135.79 34.73 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.921 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -91.91 122.09 34.11 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.162 177.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 81.4 mt -129.43 135.74 49.05 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -175.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -99.38 161.86 13.37 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 175.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 36.4 t -73.21 109.06 5.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.642 -178.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 120.35 -0.77 12.78 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.716 178.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -89.73 160.34 16.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.943 0.372 . . . . 0.0 110.131 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 30.1 mm -103.65 116.75 47.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.184 0.516 . . . . 0.0 110.733 -176.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 13.7 t -97.8 109.66 23.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.476 -178.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 9.4 ptmt -93.35 102.47 14.73 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.274 175.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.424 HG13 ' HB ' ' A' ' 238' ' ' VAL . 2.3 p -93.22 128.54 44.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.333 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.23 -39.33 7.69 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.149 -176.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . 0.491 ' HB2' ' CG ' ' A' ' 276' ' ' GLU . 63.2 mtt85 -128.11 127.27 42.75 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.979 0.418 . . . . 0.0 110.498 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' MET . . . . . 0.472 ' HE2' HG23 ' A' ' 238' ' ' VAL . 43.4 mtt -105.36 140.11 38.97 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.342 -176.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -106.94 169.08 8.76 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.477 177.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 18.4 pt -98.24 9.36 7.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.156 0.503 . . . . 0.0 111.162 -176.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -87.69 -20.87 25.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.995 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 114.83 -12.39 20.43 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.386 -178.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -116.98 122.5 44.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.085 0.469 . . . . 0.0 110.373 177.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.426 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 6.6 m0 -99.02 169.22 9.58 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.807 -176.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . 0.491 ' CG ' ' HB2' ' A' ' 268' ' ' ARG . 0.0 OUTLIER -101.36 115.76 31.24 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 121.536 0.684 . . . . 0.0 110.324 174.882 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -119.57 146.85 18.17 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.167 177.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -109.88 106.58 16.21 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 60.9 t -131.85 125.37 55.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.829 0.347 . . . . 0.0 111.025 -171.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 58.74 27.77 16.41 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.336 175.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 91.02 -4.25 81.28 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.721 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 19.3 mtp-105 -113.55 120.2 40.13 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.454 ' HB2' ' HE3' ' A' ' 283' ' ' LYS . 15.1 ptmt -111.39 138.71 47.53 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.24 0.543 . . . . 0.0 110.611 175.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -173.45 -169.73 36.17 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.426 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 87.4 mt -90.41 134.14 34.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.981 0.419 . . . . 0.0 110.734 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -133.7 137.74 29.41 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.983 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -78.06 130.91 10.6 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 122.647 2.231 . . . . 0.0 112.042 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.486 ' HA ' HG21 ' A' ' 291' ' ' VAL . 35.6 p90 -62.33 -17.91 60.04 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.911 0.386 . . . . 0.0 110.731 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.39 -20.18 65.32 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.888 -0.597 . . . . 0.0 112.099 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -105.66 -5.69 19.82 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.713 0.292 . . . . 0.0 111.601 -176.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.486 HG21 ' HA ' ' A' ' 288' ' ' PHE . 33.7 m -123.43 166.26 18.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 120.987 0.422 . . . . 0.0 110.676 -177.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . 0.47 ' HB2' HD12 ' A' ' 243' ' ' ILE . 39.9 tptt -122.4 107.25 11.85 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.543 HD13 ' HB3' ' A' ' 240' ' ' ALA . 4.2 tp -74.54 135.36 27.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -157.14 -29.33 0.09 Allowed 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.321 -0.552 . . . . 0.0 112.042 -175.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . 0.447 ' HA ' ' HB2' ' A' ' 239' ' ' PHE . 32.5 m-20 60.79 97.22 0.04 OUTLIER Pre-proline 0 N--CA 1.464 0.227 0 CA-C-O 121.056 0.455 . . . . 0.0 110.613 -176.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo . . . . . 0 C--N 1.345 0.371 0 C-N-CA 122.841 2.361 . . . . 0.0 112.486 -177.399 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 121.54 0.686 . . . . 0.0 109.767 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.79 93.44 5.6 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.122 175.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -115.27 90.34 3.31 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.597 0.713 . . . . 0.0 111.014 -178.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.459 ' CE1' ' HE2' ' A' ' 89' ' ' LYS . 32.1 p90 -160.66 151.67 18.83 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.446 -1.252 . . . . 0.0 108.482 177.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -80.46 115.46 20.0 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 177.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.3 m -67.29 -9.01 36.55 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -173.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.7 t -106.86 -24.43 12.05 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.308 -176.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -63.39 98.83 0.17 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.028 0.442 . . . . 0.0 110.874 -174.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.44 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 2.9 tpp180 -57.11 -43.41 82.25 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.402 -176.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.0 m -75.74 7.0 4.21 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -177.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -95.75 -46.28 6.65 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.613 0.244 . . . . 0.0 110.749 173.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.43 ' HB3' ' HB3' ' A' ' 101' ' ' PRO . 34.7 p-90 -121.68 -26.66 4.85 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -173.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.44 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 60.8 t80 -75.32 107.98 7.79 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.335 0.588 . . . . 0.0 110.03 -176.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.461 ' SD ' ' HG2' ' A' ' 104' ' ' ARG . 5.4 tpp -91.4 -9.53 44.41 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.993 -174.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 39' ' ' ARG . . . 50.5 -112.66 1.66 Allowed Glycine 0 C--N 1.333 0.399 0 O-C-N 123.839 0.712 . . . . 0.0 114.293 175.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -74.16 93.66 0.89 Allowed 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.473 2.115 . . . . 0.0 112.461 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.473 ' O ' ' CB ' ' A' ' 20' ' ' SER . 7.3 t -125.7 -77.02 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.954 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.473 ' CB ' ' O ' ' A' ' 19' ' ' VAL . 32.3 t 125.86 156.39 0.0 OUTLIER 'General case' 0 C--N 1.355 0.84 0 C-N-CA 124.973 1.309 . . . . 0.0 108.311 168.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.525 ' HA ' ' NH2' ' A' ' 39' ' ' ARG . 21.1 tpt180 -52.91 -52.33 58.1 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.746 0.308 . . . . 0.0 111.003 178.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -64.77 -33.89 77.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.111 -176.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.615 ' HG2' ' HE ' ' A' ' 27' ' ' ARG . 24.8 tt0 -82.57 -45.99 13.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.929 0.395 . . . . 0.0 110.898 -177.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.49 -38.29 68.96 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.132 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 55.0 tp60 -60.9 -47.52 86.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.342 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.6 t -78.27 -22.66 47.95 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 121.056 -0.258 . . . . 0.0 111.166 -175.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.615 ' HE ' ' HG2' ' A' ' 23' ' ' GLU . 63.9 mtt180 -68.59 -21.19 64.53 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.662 0.268 . . . . 0.0 110.565 177.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.562 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 95.3 mt -125.93 6.96 7.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.154 -0.475 . . . . 0.0 112.276 -176.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -82.89 110.91 18.29 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 122.129 -0.357 . . . . 0.0 110.933 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.77 18.66 74.33 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.841 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.556 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 12.2 mm100 -83.34 -168.33 2.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.604 0.24 . . . . 0.0 110.607 -178.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.564 ' HB2' ' SD ' ' A' ' 35' ' ' MET . 46.3 mtm180 -58.31 141.98 49.4 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 173.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 63.6 m170 -88.33 122.22 31.6 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 120.847 0.356 . . . . 0.0 110.495 -177.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.75 -5.73 14.1 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.91 -175.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.659 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 34.1 mtp -80.3 146.81 31.43 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 122.451 0.3 . . . . 0.0 110.74 177.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -151.81 161.31 42.87 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 121.118 -0.233 . . . . 0.0 110.931 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.525 ' HG ' HD11 ' A' ' 28' ' ' LEU . 4.5 pp -154.75 140.99 18.57 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.057 0.456 . . . . 0.0 111.229 176.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 51.8 t -110.99 112.29 39.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.547 176.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.53 ' HD3' ' O ' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -113.99 -179.3 3.6 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 178.345 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.53 ' O ' ' HD3' ' A' ' 39' ' ' ARG . 4.1 m-20 -66.97 137.83 56.81 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 175.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.495 ' HA ' HG23 ' A' ' 49' ' ' VAL . 46.7 t -54.4 141.74 29.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.179 0.514 . . . . 0.0 111.281 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.2 m -85.53 -13.07 50.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.087 -176.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.4 p -125.1 -44.68 1.89 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -174.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.411 ' HA ' ' HD2' ' A' ' 45' ' ' PRO . 3.0 p -114.66 102.36 54.8 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-O 120.858 0.361 . . . . 0.0 111.559 -176.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 44' ' ' CYS . 10.8 Cg_endo -54.59 139.03 76.06 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.881 2.387 . . . . 0.0 111.908 177.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.1 -32.38 7.37 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.251 -177.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -87.42 175.18 8.1 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.856 0.36 . . . . 0.0 110.201 177.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.44 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 38.2 m-85 -131.39 174.28 10.23 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.861 178.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.495 HG23 ' HA ' ' A' ' 41' ' ' SER . 65.0 t -142.47 106.67 1.39 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-O 120.969 0.414 . . . . 0.0 110.952 177.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.6 tp -78.42 104.75 9.22 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.148 175.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.7 m -96.33 132.8 41.46 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 176.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.621 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 86.9 t -124.49 136.27 61.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.882 0.372 . . . . 0.0 111.158 -175.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.562 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 32.2 t -96.38 104.86 16.86 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.207 -172.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.787 ' O ' ' HB3' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -152.8 151.74 30.8 Favored 'General case' 0 C--O 1.204 -1.332 0 C-N-CA 120.287 -0.565 . . . . 0.0 109.704 169.245 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.561 ' HB2' ' HD3' ' A' ' 57' ' ' ARG . 54.9 m-80 56.76 22.76 7.23 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 178.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.8 m 54.06 54.8 9.12 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 122.801 1.286 . . . . 0.0 107.964 -172.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.787 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 0.2 OUTLIER -161.96 65.94 0.25 Allowed 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 112.873 -1.967 . . . . 0.0 109.353 -151.168 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.621 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 18.6 t -72.54 97.11 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 121.865 0.841 . . . . 0.0 109.789 -170.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.7 m -68.32 121.12 15.61 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 113.88 -1.509 . . . . 0.0 110.96 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -100.15 107.12 18.91 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.811 0.339 . . . . 0.0 111.491 -176.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.676 ' HE1' HD11 ' A' ' 153' ' ' ILE . 72.8 m-85 -102.34 107.04 17.92 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.128 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.52 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 63.8 mt -80.4 129.37 37.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -174.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.48 HG23 ' HB3' ' A' ' 71' ' ' PHE . 5.0 mp -104.28 114.97 45.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.392 178.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -87.76 139.41 30.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.744 -173.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 31.3 t -81.86 95.05 7.2 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 169.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.53 HD12 ' HB2' ' A' ' 72' ' ' LYS . 91.9 mt -74.63 148.45 85.37 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.996 -176.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.67 -14.85 45.23 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.682 2.255 . . . . 0.0 110.617 171.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.35 -3.01 24.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.847 176.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.472 ' NE ' ' HA ' ' A' ' 69' ' ' ARG . 3.7 mmp_? 66.38 26.27 10.21 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.291 0.567 . . . . 0.0 110.049 -173.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 47.7 mtp180 -123.76 -179.64 4.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.599 -177.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.48 ' HB3' HG23 ' A' ' 63' ' ' ILE . 29.2 m-85 -127.87 115.9 19.31 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -173.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.563 ' HA ' ' HA ' ' A' ' 77' ' ' GLU . 38.6 ttmt -102.09 116.47 32.76 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.188 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.52 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 11.7 tt -94.7 93.04 3.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.707 0.765 . . . . 0.0 110.773 -178.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.62 69.92 1.16 Allowed Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.438 -0.801 . . . . 0.0 113.075 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.507 ' HA ' ' HD3' ' A' ' 72' ' ' LYS . 31.4 t70 75.47 -38.76 0.37 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.139 0.576 . . . . 0.0 112.354 176.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -80.83 114.22 19.57 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 9.5 pt-20 -95.07 134.33 37.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.681 0.753 . . . . 0.0 112.177 -174.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -119.27 179.03 4.31 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.528 171.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.24 -32.4 22.61 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 -175.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.491 ' HD1' ' HD2' ' A' ' 82' ' ' PRO . 5.5 p80 -161.68 167.66 24.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.673 0.273 . . . . 0.0 111.074 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.606 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 14.5 mt -53.94 -56.47 25.3 Favored Pre-proline 0 N--CA 1.467 0.398 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.403 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.606 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 29.7 Cg_exo -65.94 2.17 1.89 Allowed 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.409 2.072 . . . . 0.0 113.204 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -98.7 -34.91 10.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.839 0.352 . . . . 0.0 110.567 176.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.2 pp -76.56 -33.9 58.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.134 0.492 . . . . 0.0 109.78 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.445 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 72.8 mt -67.89 -14.76 63.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.185 176.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -88.94 -40.2 13.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.247 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -71.77 -28.97 63.99 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.784 -178.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.472 ' CG ' HD22 ' A' ' 93' ' ' LEU . 20.7 m-85 -84.58 -2.5 57.49 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -177.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.459 ' HE2' ' CE1' ' A' ' 6' ' ' PHE . 98.8 mttt -73.3 -6.89 48.96 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.099 174.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.6 pt -132.91 -6.45 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.232 0 CA-C-O 120.938 0.399 . . . . 0.0 110.573 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -93.16 -34.19 13.72 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.516 -171.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 70.87 128.36 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.159 0 O-C-N 124.411 1.07 . . . . 0.0 109.956 -169.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.541 ' HB3' ' CZ ' ' A' ' 61' ' ' TYR . 0.9 OUTLIER -103.75 -14.96 15.88 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.767 0.794 . . . . 0.0 109.783 173.084 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.848 ' HA ' ' HB3' ' A' ' 154' ' ' GLU . 1.5 m-20 -133.22 -100.01 0.27 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.613 -177.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.763 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 14.0 t -134.13 14.76 3.87 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 165.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.512 HG22 ' HG3' ' A' ' 54' ' ' GLU . 3.8 t -140.84 169.88 16.8 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 113.962 -1.472 . . . . 0.0 107.403 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.6 p -104.11 -179.38 3.93 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 176.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 74.2 mt -68.39 88.59 0.33 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 175.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 48.9 mm -78.25 -54.98 11.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.137 -173.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.659 ' O ' ' HA ' ' A' ' 35' ' ' MET . 39.7 tt0 -160.09 136.71 6.53 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.925 -177.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.43 ' HB3' ' HB3' ' A' ' 14' ' ' TRP . 18.2 Cg_endo -59.9 158.95 27.04 Favored 'Trans proline' 0 CA--C 1.531 0.325 0 C-N-CA 122.793 2.329 . . . . 0.0 112.743 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.469 ' HB1' HD21 ' A' ' 28' ' ' LEU . . . -75.17 145.4 80.35 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.844 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -55.66 130.93 43.08 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.634 2.223 . . . . 0.0 111.514 174.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.461 ' HG2' ' SD ' ' A' ' 16' ' ' MET . 78.3 mtp180 . . . . . 0 C--N 1.322 -0.598 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.248 -174.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.592 HD11 ' CZ3' ' A' ' 161' ' ' TRP . 4.0 mm? . . . . . 0 N--CA 1.455 -0.194 0 CA-C-O 122.128 0.966 . . . . 0.0 112.686 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -169.6 -60.37 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 113.866 -1.516 . . . . 0.0 107.614 -176.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -123.0 133.48 54.36 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.95 176.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.555 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 23.7 t -133.18 160.86 42.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.756 ' HG2' ' O ' ' A' ' 180' ' ' LYS . 2.0 ptp180 -138.39 138.03 37.86 Favored 'General case' 0 CA--C 1.494 -1.2 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.924 171.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.6 HG23 ' OE2' ' A' ' 148' ' ' GLU . 30.4 p -92.75 140.44 29.52 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.566 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.5 mt -114.06 -5.08 13.11 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.82 -172.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.48 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 59.7 t80 -107.21 -42.68 4.79 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -171.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.691 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 16.1 t70 79.79 93.5 0.05 Allowed 'General case' 0 N--CA 1.474 0.73 0 O-C-N 123.778 0.673 . . . . 0.0 110.63 -173.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.563 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 68.4 t80 -124.07 88.06 52.89 Favored Pre-proline 0 N--CA 1.45 -0.436 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 172.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.589 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 95.4 Cg_endo -84.55 84.82 1.42 Allowed 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 121.488 1.459 . . . . 0.0 112.239 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.54 -25.0 75.26 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 173.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.68 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 19.8 m120 53.68 72.09 0.46 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.214 -0.993 . . . . 0.0 111.17 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -141.88 173.11 11.81 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.483 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -100.33 12.03 38.07 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -127.57 -36.64 2.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.048 -1.433 . . . . 0.0 109.261 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -113.77 128.04 56.26 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 173.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.753 ' CD1' ' HB2' ' A' ' 165' ' ' ASN . 32.4 tp -83.29 124.72 75.73 Favored Pre-proline 0 C--N 1.325 -0.489 0 C-N-CA 120.178 -0.609 . . . . 0.0 111.457 -176.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.68 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 57.4 Cg_endo -76.31 102.41 1.61 Allowed 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 121.71 1.607 . . . . 0.0 111.673 167.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.563 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 0.5 OUTLIER -92.03 -163.84 1.1 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.938 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.691 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 55.4 mttp -134.8 -176.02 4.09 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.114 175.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.733 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -77.61 39.61 0.28 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.481 0.657 . . . . 0.0 111.382 -174.641 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.454 ' HA2' ' O ' ' A' ' 130' ' ' THR . . . 136.05 49.16 0.07 OUTLIER Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 -176.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.702 ' OE2' ' HG ' ' A' ' 150' ' ' LEU . 1.2 pp20? -92.28 179.26 5.6 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.3 mp -118.48 124.48 73.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 175.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.729 ' CD2' ' HA ' ' A' ' 165' ' ' ASN . 72.5 mt -118.91 156.44 29.52 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.405 0.621 . . . . 0.0 109.691 -172.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.531 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 52.4 t -118.49 122.95 70.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 173.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.484 HD12 ' HB3' ' A' ' 161' ' ' TRP . 46.5 mm -77.54 79.61 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.468 0 CA-C-O 122.519 1.152 . . . . 0.0 108.964 -175.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.676 HD11 ' HE1' ' A' ' 61' ' ' TYR . 21.0 tt -65.87 -27.31 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 CA-C-N 113.107 -1.86 . . . . 0.0 109.852 -176.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.848 ' HB3' ' HA ' ' A' ' 94' ' ' ASP . 0.2 OUTLIER -145.83 146.45 31.15 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 121.143 0.497 . . . . 0.0 110.957 171.248 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.559 ' HD2' ' HG ' ' A' ' 125' ' ' LEU . 86.3 tttt -126.14 87.69 55.68 Favored Pre-proline 0 C--N 1.319 -0.758 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 168.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.763 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 5.4 Cg_exo -81.58 -51.55 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.993 2.462 . . . . 0.0 111.721 175.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.677 ' HG2' ' CE ' ' A' ' 172' ' ' MET . 6.1 mm-40 -97.39 160.75 14.14 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.094 0.474 . . . . 0.0 111.049 -175.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -85.25 -33.14 22.25 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.914 175.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -92.82 -17.15 24.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.399 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.415 ' HB2' ' HB2' ' A' ' 157' ' ' GLU . 62.7 m95 -127.41 124.17 37.86 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.116 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . 0.592 ' CZ3' HD11 ' A' ' 125' ' ' LEU . 45.9 m0 -110.67 136.27 50.02 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.702 ' OG ' ' HG2' ' A' ' 172' ' ' MET . 38.0 m -97.35 109.09 21.92 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -173.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.541 ' HB2' ' HB3' ' A' ' 150' ' ' LEU . . . -122.85 152.1 41.07 Favored 'General case' 0 N--CA 1.426 -1.657 0 C-N-CA 119.888 -0.725 . . . . 0.0 110.405 -174.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.824 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 9.8 ptt180 -87.69 126.88 35.23 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 171.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.753 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . 64.2 t30 -60.31 178.09 0.22 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.306 -1.315 . . . . 0.0 111.406 -172.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 19.5 tttp -58.15 -11.99 3.1 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.866 167.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -89.84 -27.65 19.79 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.393 174.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 105.07 -0.81 41.04 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.729 -175.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.824 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 3.3 ttm-85 -76.11 140.02 41.61 Favored 'General case' 0 C--O 1.217 -0.61 0 C-N-CA 123.324 0.65 . . . . 0.0 112.008 -177.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.469 HG23 HD12 ' A' ' 153' ' ' ILE . 48.1 t -87.21 123.52 40.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 111.353 0.131 . . . . 0.0 111.353 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -158.12 151.9 23.05 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.258 172.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.702 ' HG2' ' OG ' ' A' ' 162' ' ' SER . 36.8 mtp -81.37 142.73 32.75 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.885 0.342 . . . . 0.0 110.583 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.678 ' CD1' HG12 ' A' ' 178' ' ' VAL . 2.8 pp -143.24 150.63 52.72 Favored Pre-proline 0 C--O 1.222 -0.349 0 O-C-N 123.442 0.464 . . . . 0.0 111.119 -178.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.5 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 6.7 Cg_exo -72.82 132.1 18.05 Favored 'Trans proline' 0 CA--C 1.529 0.241 0 C-N-CA 122.387 2.058 . . . . 0.0 112.615 -176.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.545 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 18.3 t -57.9 -43.1 98.31 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 32.8 Cg_endo -64.84 -2.36 5.33 Favored 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 122.049 1.833 . . . . 0.0 113.116 176.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.5 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 4.5 m-85 -98.2 -18.45 18.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.71 177.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.678 HG12 ' CD1' ' A' ' 173' ' ' ILE . 2.2 m -130.68 -172.32 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.102 -168.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.896 ' HG3' ' H ' ' A' ' 180' ' ' LYS . 8.7 pt-20 -156.34 -65.67 0.11 Allowed 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 117.404 2.372 . . . . 0.0 117.404 152.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.896 ' H ' ' HG3' ' A' ' 179' ' ' GLU . 4.2 mptt -157.59 -177.54 6.66 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.153 0.888 . . . . 0.0 109.891 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.412 ' HG ' ' NH2' ' A' ' 129' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.319 -0.719 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 153.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 N--CA 1.459 -0.558 0 N-CA-C 111.02 -0.415 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.476 ' HB ' HG12 ' A' ' 266' ' ' VAL . 66.8 t -77.06 123.83 34.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.92 0.391 . . . . 0.0 110.562 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -99.04 115.25 28.55 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.999 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . 0.513 ' HB3' HD12 ' A' ' 293' ' ' ILE . . . -119.37 121.16 38.9 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.091 178.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.528 ' HB2' ' CE1' ' A' ' 294' ' ' PHE . 48.2 tttp -86.68 118.85 26.36 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -178.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -72.8 102.59 3.42 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 9.6 pt -89.47 4.6 5.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.955 0.407 . . . . 0.0 111.142 -176.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -149.89 149.11 29.96 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 173.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 10.3 ptpp? -75.59 175.88 8.15 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.02 0.438 . . . . 0.0 111.169 -176.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.462 ' CB ' HG22 ' A' ' 289' ' ' THR . 21.4 tpt180 -157.08 127.41 6.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.979 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 28.0 m -121.37 143.57 37.91 Favored Pre-proline 0 C--N 1.32 -0.706 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 171.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.58 104.51 0.79 Allowed 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.179 1.919 . . . . 0.0 111.694 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 1.7 t -72.61 169.7 16.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.862 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.74 -32.43 69.23 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.806 0.336 . . . . 0.0 111.609 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -95.08 -15.42 23.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.948 0.404 . . . . 0.0 110.886 177.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . 0.458 ' HB3' ' HB1' ' A' ' 255' ' ' ALA . 60.3 m-20 -100.69 67.93 1.3 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.061 0.458 . . . . 0.0 110.071 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . 0.653 ' H ' ' HD2' ' A' ' 253' ' ' LYS . 0.0 OUTLIER -75.24 -33.99 61.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.291 -174.95 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.66 -1.04 57.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.554 -178.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . 0.458 ' HB1' ' HB3' ' A' ' 252' ' ' ASP . . . -70.12 126.06 28.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.165 0.507 . . . . 0.0 111.81 -175.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.3 tt -71.77 134.16 46.02 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.315 176.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -84.92 128.95 34.85 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 89.4 mt -135.43 165.53 25.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.59 -172.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -129.49 -177.25 4.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.08 177.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 39.8 t -80.83 129.88 36.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.865 -178.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 80.37 11.81 83.8 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.654 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -87.14 140.28 29.71 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -176.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 38.5 mm -88.11 110.28 20.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.992 0.425 . . . . 0.0 110.561 -178.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 20.9 t -88.1 102.99 13.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.287 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 5.6 tppp? -79.44 95.1 5.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.232 177.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.476 HG12 ' HB ' ' A' ' 238' ' ' VAL . 4.5 p -99.88 117.42 45.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.384 0.612 . . . . 0.0 110.4 177.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' THR . . . . . 0.509 ' OG1' ' HD2' ' A' ' 268' ' ' ARG . 20.2 p -104.19 -18.9 14.32 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.155 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . 0.509 ' HD2' ' OG1' ' A' ' 267' ' ' THR . 0.1 OUTLIER -130.48 91.79 3.15 Favored 'General case' 0 C--O 1.224 -0.281 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 176.847 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' MET . . . . . 0.407 ' HB3' ' HE3' ' A' ' 269' ' ' MET . 6.5 ptp -98.56 130.51 45.12 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 119.531 -0.868 . . . . 0.0 111.028 177.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -103.28 150.1 24.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.153 -174.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.401 ' H ' HG13 ' A' ' 271' ' ' ILE . 1.8 pp -71.87 -5.8 6.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.419 0.628 . . . . 0.0 110.941 175.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -70.75 -21.03 62.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.087 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 110.93 -47.67 1.02 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.683 -178.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.464 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 59.1 mt-30 -80.18 121.13 25.2 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 174.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 34.2 m0 -103.36 149.98 24.24 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . 0.434 ' HB3' ' HB2' ' A' ' 268' ' ' ARG . 34.3 tt0 -99.53 116.81 32.51 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.074 0.464 . . . . 0.0 109.929 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -139.94 164.44 26.12 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.934 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.53 ' HG2' ' HB2' ' A' ' 283' ' ' LYS . 37.2 mt-10 -123.42 109.85 14.38 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 25.6 t -123.62 -81.06 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 120.354 -0.539 . . . . 0.0 111.793 -175.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -91.96 77.2 5.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.793 0.33 . . . . 0.0 111.284 -173.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 50.5 34.73 27.75 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.372 -0.831 . . . . 0.0 113.335 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 282' ' ' ARG . 34.0 ttt-85 -170.71 138.75 1.45 Allowed 'General case' 0 C--O 1.237 0.423 0 CA-C-O 120.895 0.379 . . . . 0.0 111.0 -173.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.53 ' HB2' ' HG2' ' A' ' 278' ' ' GLU . 38.2 ttpt -99.72 137.85 37.63 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.087 173.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -158.13 169.98 34.85 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.167 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.464 ' HB3' ' HB3' ' A' ' 274' ' ' GLN . 62.8 mt -97.59 113.3 25.0 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 176.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.759 ' HD2' ' H ' ' A' ' 289' ' ' THR . 49.4 p90 -113.72 125.31 29.68 Favored Pre-proline 0 C--N 1.315 -0.931 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.468 -177.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 35.0 Cg_exo -64.06 70.93 0.19 Allowed 'Trans proline' 0 N--CA 1.479 0.665 0 C-N-CA 123.709 2.939 . . . . 0.0 112.689 176.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.539 ' O ' ' N ' ' A' ' 290' ' ' HIS . 34.5 p90 37.96 40.55 0.3 Allowed 'General case' 0 CA--C 1.49 -1.355 0 O-C-N 124.447 1.092 . . . . 0.0 108.689 -171.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' THR . . . . . 0.759 ' H ' ' HD2' ' A' ' 286' ' ' PHE . 41.9 m -40.81 73.41 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.043 0 O-C-N 126.499 2.374 . . . . 0.0 112.995 -156.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . 0.539 ' N ' ' O ' ' A' ' 288' ' ' PHE . 16.4 m80 63.87 25.21 13.95 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 112.192 -2.276 . . . . 0.0 109.363 169.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.493 ' HB ' ' HB1' ' A' ' 240' ' ' ALA . 33.5 m -88.58 169.71 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 121.41 0.624 . . . . 0.0 111.621 -173.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -129.69 114.36 15.91 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.115 178.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.513 HD12 ' HB3' ' A' ' 240' ' ' ALA . 50.2 mm -72.0 124.55 28.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.331 -178.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' PHE . . . . . 0.528 ' CE1' ' HB2' ' A' ' 241' ' ' LYS . 1.8 p90 -154.27 -176.01 5.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.984 -178.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -130.37 116.96 17.64 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 172.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo . . . . . 0 C--O 1.232 0.183 0 C-N-CA 122.789 2.326 . . . . 0.0 112.508 -177.549 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.559 ' O ' HG23 ' A' ' 99' ' ' ILE . 16.1 m . . . . . 0 N--CA 1.451 -0.384 0 CA-C-O 121.128 0.489 . . . . 0.0 109.714 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.5 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . -78.79 105.81 10.36 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.996 176.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 32.6 ttm180 -138.84 97.12 3.25 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.331 0.586 . . . . 0.0 111.113 -176.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -168.45 163.04 12.57 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.726 178.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.452 ' HB2' ' HB2' ' A' ' 10' ' ' ASP . 22.8 m-20 -89.19 117.08 27.91 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 174.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.8 m -66.57 -13.53 61.15 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.092 -0.503 . . . . 0.0 112.086 -172.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.7 t -115.54 -0.16 13.14 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.26 0.552 . . . . 0.0 111.107 -176.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.452 ' HB2' ' HB2' ' A' ' 7' ' ' ASP . 8.1 t0 -79.47 91.68 5.16 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 121.916 -0.49 . . . . 0.0 110.232 -177.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.493 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 5.0 mtm-85 -69.44 -14.25 62.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.513 -178.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.7 t -84.9 0.04 52.48 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 175.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -109.95 -48.79 3.15 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 40.2 p-90 -108.86 -20.45 13.05 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -173.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.493 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 19.3 t80 -73.38 108.89 6.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.094 0.473 . . . . 0.0 109.808 -177.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.708 ' HG3' HG23 ' A' ' 19' ' ' VAL . 12.0 tpp -89.01 -8.45 54.02 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.901 -171.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.495 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 50.23 -114.97 2.83 Favored Glycine 0 CA--C 1.522 0.475 0 CA-C-N 115.269 -0.878 . . . . 0.0 114.438 177.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.495 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 8.5 Cg_exo -72.52 82.14 1.45 Allowed 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 123.202 2.601 . . . . 0.0 113.158 -173.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.708 HG23 ' HG3' ' A' ' 16' ' ' MET . 44.0 t -142.02 166.4 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.515 ' H ' HG13 ' A' ' 19' ' ' VAL . 15.6 m -137.79 172.12 13.42 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -170.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 54.8 mtp85 -54.53 -53.79 49.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 118.154 0.434 . . . . 0.0 111.925 -177.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -57.89 -63.13 1.36 Allowed 'General case' 0 C--N 1.327 -0.374 0 O-C-N 123.477 0.486 . . . . 0.0 111.087 -177.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.441 ' O ' ' HB ' ' A' ' 26' ' ' THR . 36.6 tt0 -57.95 -45.45 86.62 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.67 -176.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.433 ' HB1' HG13 ' A' ' 19' ' ' VAL . . . -57.09 -50.8 71.65 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 120.933 0.397 . . . . 0.0 111.375 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.64 ' HG3' ' HB ' ' A' ' 58' ' ' VAL . 18.5 tt0 -64.4 -32.91 74.72 Favored 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.441 ' HB ' ' O ' ' A' ' 23' ' ' GLU . 7.8 m -59.81 -41.93 92.34 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.607 174.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.489 ' O ' ' HG3' ' A' ' 31' ' ' GLN . 95.4 mtt180 -68.8 -14.44 63.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.893 0.377 . . . . 0.0 110.896 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.586 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 72.3 mt -120.62 -12.6 8.87 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -174.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.757 HE21 ' HA ' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -70.03 105.77 2.99 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.833 0.349 . . . . 0.0 111.024 -174.328 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 72.64 5.35 63.77 Favored Glycine 0 C--O 1.226 -0.398 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.241 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.489 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 12.9 mm100 -80.67 -162.16 0.45 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.845 0.355 . . . . 0.0 111.194 -176.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.428 ' HB2' ' HG3' ' A' ' 35' ' ' MET . 34.7 mtm180 -59.31 119.29 7.15 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.984 0.421 . . . . 0.0 110.098 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 27.4 m170 -76.6 125.93 30.1 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.952 -177.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.42 -6.25 22.96 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 -175.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.573 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 51.3 mtm -82.93 146.64 28.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.762 0.315 . . . . 0.0 110.216 177.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -145.94 163.6 34.64 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 176.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.443 HD13 ' O ' ' A' ' 37' ' ' LEU . 4.4 pp -152.61 137.21 16.87 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.058 0.456 . . . . 0.0 111.067 177.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.9 t -107.1 105.38 18.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 173.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.402 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 25.8 ptt-85 -104.13 166.69 10.24 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.731 -175.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -76.79 124.23 27.38 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 174.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.514 ' HB2' HG22 ' A' ' 49' ' ' VAL . 25.6 t -99.39 166.19 11.3 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.24 0.543 . . . . 0.0 111.225 -173.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.8 m -118.28 18.16 13.76 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.999 -175.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.2 m -75.02 -43.91 51.02 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 177.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 49.5 t -168.09 112.93 0.59 Allowed Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.696 177.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -34.67 102.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 124.155 3.237 . . . . 0.0 113.433 -175.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 134.1 -25.43 3.5 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.638 -175.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -83.17 151.59 25.63 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 177.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -128.43 174.08 9.65 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -178.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.514 HG22 ' HB2' ' A' ' 41' ' ' SER . 58.5 t -137.74 112.81 9.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.425 0.631 . . . . 0.0 111.541 176.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.513 HD21 HD12 ' A' ' 73' ' ' ILE . 51.5 tp -81.01 98.34 7.91 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.225 -1.352 . . . . 0.0 109.698 174.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.3 m -96.0 128.93 43.33 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 175.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.614 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 94.6 t -122.06 142.4 38.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.117 -174.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.586 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 45.0 t -105.89 114.91 29.35 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -175.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.53 155.65 33.77 Favored 'General case' 0 C--O 1.207 -1.18 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 160.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 59.13 20.42 8.38 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 174.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.3 m 56.43 54.34 7.67 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 122.797 1.284 . . . . 0.0 108.082 -172.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.412 HH22 ' C ' ' A' ' 153' ' ' ILE . 0.2 OUTLIER -162.33 64.03 0.22 Allowed 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 112.751 -2.022 . . . . 0.0 109.493 -151.166 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.64 ' HB ' ' HG3' ' A' ' 25' ' ' GLN . 26.1 t -74.65 99.94 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 122.032 0.92 . . . . 0.0 111.03 -168.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.3 m -67.84 120.9 14.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 113.985 -1.461 . . . . 0.0 111.255 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -96.68 109.32 21.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.882 0.372 . . . . 0.0 111.513 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.572 ' HB3' HD13 ' A' ' 73' ' ' ILE . 89.4 m-85 -106.0 117.59 34.43 Favored 'General case' 0 C--O 1.216 -0.709 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.537 177.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.693 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 53.4 mt -80.36 145.99 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 O-C-N 121.872 -0.517 . . . . 0.0 111.076 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.646 HG13 HG12 ' A' ' 73' ' ' ILE . 4.8 mp -129.53 104.11 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.122 0.487 . . . . 0.0 110.455 177.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.537 ' HB2' ' HB3' ' A' ' 72' ' ' LYS . 31.0 m-80 -90.56 142.75 27.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.485 -172.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 31.6 t -81.82 97.17 7.87 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 172.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.0 mt -73.99 143.44 80.85 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.543 -177.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.5 -23.29 70.16 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 123.078 2.518 . . . . 0.0 112.555 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 36.8 p30 -83.64 12.34 5.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.8 177.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 69' ' ' ARG . 5.2 tpp85 69.79 25.82 4.97 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.465 0.65 . . . . 0.0 111.317 175.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.7 ' HG2' ' HA ' ' A' ' 79' ' ' ASP . 68.1 mtt180 -113.71 -174.81 2.54 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.815 174.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.487 ' HB3' HG23 ' A' ' 63' ' ' ILE . 39.1 m-85 -131.09 131.78 44.41 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.019 0.438 . . . . 0.0 111.471 -177.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.537 ' HB3' ' HB2' ' A' ' 64' ' ' ASN . 14.6 tppt? -97.58 100.92 12.33 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.679 177.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.693 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 0.0 OUTLIER -99.1 86.4 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 122.92 1.343 . . . . 0.0 109.017 -177.262 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.16 -110.76 3.74 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.502 -174.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.423 ' HB2' ' O ' ' A' ' 168' ' ' GLY . 26.4 t0 -108.24 -18.99 13.63 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.575 0.702 . . . . 0.0 109.536 176.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -90.74 136.35 33.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.747 -176.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.468 ' HB3' ' HE2' ' A' ' 72' ' ' LYS . 0.9 OUTLIER -110.41 128.13 55.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.364 0.602 . . . . 0.0 111.025 175.306 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.422 ' O ' ' HB3' ' A' ' 70' ' ' ARG . 8.8 m-85 -122.88 172.24 8.62 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 176.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.7 ' HA ' ' HG2' ' A' ' 70' ' ' ARG . 5.7 m-20 -75.09 -34.84 61.81 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -172.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.882 ' HD1' ' HG2' ' A' ' 82' ' ' PRO . 3.3 p80 -156.58 166.66 32.76 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 121.33 -0.148 . . . . 0.0 110.819 -178.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.538 HD21 HD22 ' A' ' 84' ' ' LEU . 18.0 mt -54.94 -54.68 47.17 Favored Pre-proline 0 N--CA 1.469 0.487 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -177.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.882 ' HG2' ' HD1' ' A' ' 80' ' ' HIS . 18.0 Cg_endo -61.67 -10.51 17.01 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.172 1.914 . . . . 0.0 113.418 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.421 ' HB3' ' CE1' ' A' ' 80' ' ' HIS . . . -90.62 -36.79 14.2 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.873 0.368 . . . . 0.0 110.554 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.648 HD11 HG13 ' A' ' 73' ' ' ILE . 3.2 pp -76.92 -35.78 57.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.92 0.39 . . . . 0.0 110.022 -178.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.488 ' O ' ' HG2' ' A' ' 89' ' ' LYS . 89.1 mt -64.91 -24.1 67.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.999 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.498 ' HA ' ' CG ' ' A' ' 89' ' ' LYS . 26.9 tt0 -83.09 -22.34 33.45 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.79 -176.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -72.2 -35.67 69.0 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.731 0.777 . . . . 0.0 109.547 175.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.755 ' CG ' HD22 ' A' ' 93' ' ' LEU . 74.5 m-85 -86.63 1.43 51.87 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.43 -176.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.498 ' CG ' ' HA ' ' A' ' 86' ' ' GLU . 9.6 mmmm -71.75 -23.39 61.59 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 171.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 30.6 pt -121.2 7.96 6.07 Favored 'Isoleucine or valine' 0 C--N 1.339 0.151 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.112 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -98.28 -40.37 8.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.08 -176.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.586 ' CD2' HG23 ' A' ' 97' ' ' THR . 60.7 m-85 64.75 77.64 0.31 Allowed 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -170.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.755 HD22 ' CG ' ' A' ' 88' ' ' TYR . 1.4 pp -79.29 18.15 0.72 Allowed 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -172.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.52 ' O ' HG23 ' A' ' 95' ' ' THR . 27.3 t70 -175.22 65.19 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.258 162.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.676 ' HB ' ' O ' ' A' ' 155' ' ' LYS . 0.6 OUTLIER 62.16 -28.5 0.07 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.048 1.339 . . . . 0.0 112.528 -174.013 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.51 ' H ' ' C ' ' A' ' 94' ' ' ASP . 2.0 t -109.3 157.4 18.89 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 172.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.586 HG23 ' CD2' ' A' ' 92' ' ' TYR . 7.4 p -90.33 -179.99 5.75 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 177.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 89.4 mt -73.16 91.49 1.65 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 171.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.559 HG23 ' O ' ' A' ' 3' ' ' SER . 37.4 mm -74.84 -61.87 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.856 -174.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.573 ' O ' ' HA ' ' A' ' 35' ' ' MET . 10.4 pt-20 -157.19 157.46 30.46 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.183 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.449 ' HD2' ' HB2' ' A' ' 100' ' ' GLU . 55.9 Cg_endo -69.58 152.83 70.31 Favored 'Trans proline' 0 C--O 1.237 0.458 0 C-N-CA 122.502 2.135 . . . . 0.0 112.91 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -77.29 156.78 81.34 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.526 177.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.497 ' HD3' ' SD ' ' A' ' 35' ' ' MET . 23.6 Cg_exo -64.21 132.16 32.98 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.342 2.028 . . . . 0.0 112.186 177.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.426 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 34.2 ptt180 . . . . . 0 C--N 1.326 -0.451 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.855 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.64 ' HG ' ' HD2' ' A' ' 155' ' ' LYS . 3.3 mm? . . . . . 0 CA--C 1.517 -0.297 0 CA-C-O 121.703 0.763 . . . . 0.0 111.66 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -174.5 -38.79 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.566 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . 0.439 ' HB3' ' HB3' ' A' ' 181' ' ' LEU . 79.9 m-85 -127.64 116.02 19.65 Favored 'General case' 0 CA--C 1.504 -0.804 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.487 176.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.622 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 2.1 t -115.47 153.72 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.748 -177.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.669 ' HG2' ' O ' ' A' ' 180' ' ' LYS . 1.7 ptp180 -137.59 124.59 21.43 Favored 'General case' 0 CA--C 1.496 -1.11 0 C-N-CA 117.281 -1.767 . . . . 0.0 112.891 173.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.651 HG23 ' CG ' ' A' ' 144' ' ' PHE . 81.7 p -79.49 131.88 36.18 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 114.268 -1.333 . . . . 0.0 111.13 -177.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.5 mt -116.59 8.5 13.91 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.624 -175.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -122.82 -36.07 2.94 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -171.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.501 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 11.0 t70 78.52 110.7 0.07 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.23 0.612 . . . . 0.0 110.873 -178.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.597 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 79.2 t80 -144.55 91.66 6.17 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 177.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.557 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 72.8 Cg_endo -79.53 85.98 1.75 Allowed 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 121.846 1.697 . . . . 0.0 112.404 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.38 -35.38 60.0 Favored Glycine 0 C--N 1.333 0.384 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.445 179.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.769 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 0.9 OUTLIER 68.27 37.66 2.75 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 122.652 0.381 . . . . 0.0 111.548 178.05 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -137.71 170.41 16.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.662 0.267 . . . . 0.0 110.554 -177.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -89.86 -6.19 56.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.74 0.781 . . . . 0.0 109.108 174.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -103.14 -34.14 8.96 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.57 177.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -120.08 109.55 15.6 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.385 176.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.73 ' CD1' ' HB2' ' A' ' 165' ' ' ASN . 36.5 tp -68.15 132.11 91.92 Favored Pre-proline 0 CA--C 1.515 -0.378 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.394 -177.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.769 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 7.6 Cg_endo -83.05 104.1 1.22 Allowed 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 121.785 1.657 . . . . 0.0 110.108 169.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.651 ' CG ' HG23 ' A' ' 130' ' ' THR . 9.4 p90 -121.39 163.6 18.44 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.254 -176.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.508 ' HB2' ' HB3' ' A' ' 148' ' ' GLU . 12.8 mptt -96.51 -169.82 1.97 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.376 0.607 . . . . 0.0 112.494 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.83 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -89.29 5.49 44.69 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.238 -176.456 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -168.7 37.35 0.21 Allowed Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 176.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.555 ' OE1' ' HA ' ' A' ' 144' ' ' PHE . 0.4 OUTLIER -92.95 157.69 16.21 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 120.87 0.367 . . . . 0.0 110.272 -177.713 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -98.38 131.89 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-O 121.774 0.797 . . . . 0.0 109.727 178.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.633 HD23 ' CD2' ' A' ' 142' ' ' LEU . 14.9 mt -120.31 156.27 31.62 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.086 -1.415 . . . . 0.0 107.646 -174.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.549 ' HB ' ' CG ' ' A' ' 164' ' ' ARG . 60.8 t -124.16 122.93 65.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 176.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.512 HD13 HG22 ' A' ' 128' ' ' VAL . 26.1 mm -76.16 102.99 3.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.578 0.704 . . . . 0.0 109.458 -174.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.484 HG22 HG22 ' A' ' 170' ' ' VAL . 20.3 tt -97.91 -30.0 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-N 114.801 -1.091 . . . . 0.0 109.802 -173.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.609 ' OE2' ' HA ' ' A' ' 93' ' ' LEU . 1.8 mt-10 -131.77 140.84 49.33 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 165.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.676 ' O ' ' HB ' ' A' ' 95' ' ' THR . 39.9 tttp -123.02 89.55 50.68 Favored Pre-proline 0 C--N 1.321 -0.657 0 O-C-N 121.231 -0.918 . . . . 0.0 109.868 167.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.674 ' HA ' ' CB ' ' A' ' 95' ' ' THR . 3.0 Cg_exo -77.81 -51.54 0.08 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.592 2.195 . . . . 0.0 112.023 175.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.567 ' HG2' ' CE ' ' A' ' 172' ' ' MET . 22.5 mm-40 -102.67 179.44 4.29 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -171.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -107.13 -20.03 13.43 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.56 176.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -109.41 -8.69 15.01 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.803 0.335 . . . . 0.0 110.871 177.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.555 ' HA ' ' O ' ' A' ' 173' ' ' ILE . 83.4 m95 -132.03 131.39 42.44 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 169.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . 0.565 ' CZ3' HD11 ' A' ' 125' ' ' LEU . 48.1 m0 -122.88 143.47 49.85 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.37 177.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.578 ' HA ' ' HA ' ' A' ' 172' ' ' MET . 21.6 m -89.14 99.67 12.61 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -176.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.48 ' HB1' HD11 ' A' ' 152' ' ' ILE . . . -110.09 151.6 27.02 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.027 -175.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.826 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 12.8 ptt180 -87.97 121.18 30.08 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-O 122.109 0.957 . . . . 0.0 108.944 172.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.73 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . 11.7 t30 -45.21 167.3 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 112.131 -2.304 . . . . 0.0 112.006 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.402 ' HA ' ' HD2' ' A' ' 166' ' ' LYS . 15.5 tptm -58.32 -14.29 7.1 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.015 173.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.524 ' HB2' ' ND2' ' A' ' 165' ' ' ASN . 21.7 m-20 -95.62 -9.19 32.81 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.001 0.429 . . . . 0.0 109.987 174.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 75' ' ' ASP . . . 90.2 39.06 6.15 Favored Glycine 0 CA--C 1.522 0.489 0 CA-C-N 115.85 -0.614 . . . . 0.0 113.406 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.826 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 7.8 ttm-85 -111.76 138.71 47.98 Favored 'General case' 0 C--O 1.214 -0.777 0 CA-C-N 116.933 0.367 . . . . 0.0 111.472 -177.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.484 HG22 HG22 ' A' ' 153' ' ' ILE . 21.9 t -78.96 125.61 38.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 C-N-CA 120.839 -0.345 . . . . 0.0 111.552 -179.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -164.02 149.72 17.24 Favored Glycine 0 C--N 1.332 0.321 0 N-CA-C 111.59 -0.604 . . . . 0.0 111.59 168.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.578 ' HA ' ' HA ' ' A' ' 162' ' ' SER . 59.5 mtp -77.0 143.32 39.48 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 117.565 0.682 . . . . 0.0 110.751 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.721 ' O ' HD11 ' A' ' 173' ' ' ILE . 1.6 pp -134.88 151.84 76.33 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.444 -177.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.747 ' O ' HG11 ' A' ' 178' ' ' VAL . 1.0 OUTLIER -85.24 123.79 2.72 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.821 2.347 . . . . 0.0 113.241 -174.819 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.53 ' HA ' HG22 ' A' ' 178' ' ' VAL . 94.8 t -53.73 -45.42 98.77 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 178.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.465 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 65.2 Cg_exo -54.91 -23.93 36.69 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 122.112 1.875 . . . . 0.0 112.817 174.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.547 ' CD2' ' HG2' ' A' ' 174' ' ' PRO . 3.4 m-30 -84.82 -39.58 18.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.018 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.747 HG11 ' O ' ' A' ' 174' ' ' PRO . 1.1 m -111.65 -177.77 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.637 -164.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.897 ' HG3' ' H ' ' A' ' 180' ' ' LYS . 11.2 pt-20 -158.13 -71.03 0.09 Allowed 'General case' 0 C--O 1.207 -1.142 0 N-CA-C 118.011 2.597 . . . . 0.0 118.011 144.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.897 ' H ' ' HG3' ' A' ' 179' ' ' GLU . 3.6 mppt? -156.25 179.64 9.05 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 118.855 -2.403 . . . . 0.0 114.593 -169.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.666 HD12 ' NH2' ' A' ' 129' ' ' ARG . 12.0 tp . . . . . 0 C--N 1.327 -0.408 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.929 164.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo . . . . . 0 N--CA 1.459 -0.507 0 N-CA-C 110.87 -0.473 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.418 ' CG1' HD11 ' A' ' 293' ' ' ILE . 3.5 t -89.82 141.59 14.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.846 -173.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.434 ' HB2' ' HG3' ' A' ' 296' ' ' PRO . 94.0 m-85 -113.26 122.98 49.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.28 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . 0.477 ' HB3' HD13 ' A' ' 293' ' ' ILE . . . -119.72 144.26 47.33 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.421 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -90.87 119.83 31.39 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -66.95 102.46 0.98 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.928 0.394 . . . . 0.0 110.024 177.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 24.8 pt -83.31 -35.29 11.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.421 -174.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -132.89 130.89 40.29 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -54.36 140.38 33.75 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.883 -171.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.57 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 27.5 tpt180 -124.03 107.12 10.96 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.896 -178.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 16.5 m -115.87 126.67 27.46 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-O 120.954 0.407 . . . . 0.0 110.477 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.497 ' HB3' ' HB3' ' A' ' 255' ' ' ALA . 39.5 Cg_endo -67.68 127.66 16.68 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.629 2.219 . . . . 0.0 112.596 -178.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 39.2 t -78.58 171.94 14.41 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -53.1 -37.78 62.02 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.734 0.302 . . . . 0.0 111.72 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -97.71 14.25 27.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.898 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -90.89 -75.19 0.47 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 173.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 66.0 mttm 69.87 -58.41 0.53 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.944 178.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 11.2 p -73.32 -13.54 61.13 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.368 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . 0.497 ' HB3' ' HB3' ' A' ' 248' ' ' PRO . . . -71.86 123.99 23.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.047 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.2 tt -73.5 133.94 43.75 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.636 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.57 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -81.62 104.93 12.37 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.093 0.473 . . . . 0.0 109.934 176.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 96.0 mt -109.0 134.94 50.98 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.481 -177.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -99.41 155.14 17.7 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.216 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 62.2 t -66.94 122.04 17.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.006 0.431 . . . . 0.0 111.083 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 95.21 11.42 56.15 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.675 -0.693 . . . . 0.0 113.202 175.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -95.14 166.93 11.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.985 0.392 . . . . 0.0 109.971 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 34.3 mm -102.55 118.24 49.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.114 0.483 . . . . 0.0 110.728 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 19.3 t -93.48 104.9 16.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.165 0.507 . . . . 0.0 110.284 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -85.7 87.7 7.44 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.814 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.432 HG21 ' HB3' ' A' ' 275' ' ' TRP . 6.2 p -91.73 126.02 44.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.489 0.661 . . . . 0.0 111.607 -175.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 44.7 p -104.69 -39.23 6.42 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.725 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 -105.6 117.44 34.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.124 -177.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 41.5 mtt -114.4 134.86 54.68 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.798 174.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -97.45 160.06 14.55 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.714 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 10.5 tp -75.21 -11.98 14.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.502 0.667 . . . . 0.0 109.972 176.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -75.2 -65.49 0.88 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.938 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 156.47 -23.55 0.5 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.383 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -87.06 119.75 27.61 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 176.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.473 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 31.4 m0 -101.43 156.23 17.59 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.789 -176.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 284' ' ' GLY . 47.9 mt-10 -112.28 114.57 27.41 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.061 175.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . 0.689 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -120.71 155.01 16.32 Favored Glycine 0 C--O 1.225 -0.434 0 C-N-CA 120.894 -0.669 . . . . 0.0 111.595 177.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.755 ' HG2' ' HB3' ' A' ' 283' ' ' LYS . 38.0 mt-10 -100.7 109.9 21.97 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.092 0.473 . . . . 0.0 110.849 179.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 48.7 t -118.95 130.82 73.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 176.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 10.1 p30 44.54 34.77 1.18 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.958 0.903 . . . . 0.0 112.482 -174.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 94.49 -9.1 71.77 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.483 175.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -108.35 124.72 50.79 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 117.014 0.407 . . . . 0.0 111.259 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.755 ' HB3' ' HG2' ' A' ' 278' ' ' GLU . 9.4 ptpp? -96.33 142.17 28.78 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 172.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 276' ' ' GLU . . . -164.05 172.03 39.78 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.987 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.473 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 17.2 mt -82.44 130.74 35.17 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.158 0.504 . . . . 0.0 111.341 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -136.23 135.49 21.15 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.651 173.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . 0.899 ' HB2' HG22 ' A' ' 289' ' ' THR . 59.0 Cg_endo -75.61 138.31 21.45 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.237 1.958 . . . . 0.0 111.444 175.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.438 ' HA ' HG23 ' A' ' 291' ' ' VAL . 49.4 p90 -63.27 -8.47 8.52 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.932 0.396 . . . . 0.0 111.282 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' THR . . . . . 0.899 HG22 ' HB2' ' A' ' 287' ' ' PRO . 15.3 t -79.62 -13.81 59.24 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.012 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . 0.503 ' HD2' HG21 ' A' ' 289' ' ' THR . 6.8 m-70 -101.19 -6.19 24.59 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.695 0.283 . . . . 0.0 110.846 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.438 HG23 ' HA ' ' A' ' 288' ' ' PHE . 35.9 m -127.78 178.99 4.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.94 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -140.76 116.01 9.95 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.039 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.477 HD13 ' HB3' ' A' ' 240' ' ' ALA . 34.2 mm -70.41 112.96 5.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 174.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -135.24 -169.87 2.47 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.865 -176.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -115.68 94.67 41.31 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . 0.434 ' HG3' ' HB2' ' A' ' 239' ' ' PHE . 36.2 Cg_endo . . . . . 0 C--N 1.345 0.39 0 C-N-CA 122.31 2.006 . . . . 0.0 111.334 178.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.48 ' O ' HG23 ' A' ' 99' ' ' ILE . 9.4 p . . . . . 0 N--CA 1.446 -0.634 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.439 ' HB3' ' HE3' ' A' ' 89' ' ' LYS . . . -83.27 104.56 13.53 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.745 175.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 63.8 mtt180 -109.47 -10.49 14.88 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -167.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -84.31 156.02 22.11 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.594 -170.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.429 ' C ' ' H ' ' A' ' 9' ' ' SER . 18.4 m-20 -66.7 -27.77 67.9 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.587 -177.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.3 t 75.09 -22.73 0.25 Allowed 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.412 0.685 . . . . 0.0 111.137 -178.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.429 ' H ' ' C ' ' A' ' 7' ' ' ASP . 25.6 t -105.17 -17.39 14.49 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 122.262 -0.273 . . . . 0.0 111.707 -177.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -81.08 107.74 14.15 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 121.718 -0.614 . . . . 0.0 110.625 -177.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.49 -41.59 94.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.948 -176.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.436 ' C ' HH22 ' A' ' 104' ' ' ARG . 24.2 t -68.77 -4.01 14.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.156 -176.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -91.84 -47.27 7.42 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.419 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 43.4 p-90 -117.33 -21.21 8.82 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -171.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -75.05 127.16 32.58 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -177.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.756 ' HG3' ' HB2' ' A' ' 37' ' ' LEU . 26.3 mmt -109.67 -8.35 14.96 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -173.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 50.55 -112.84 1.74 Allowed Glycine 0 CA--C 1.525 0.665 0 C-N-CA 121.376 -0.44 . . . . 0.0 113.2 -176.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -76.01 102.16 1.57 Allowed 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.52 2.147 . . . . 0.0 112.766 -178.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.71 ' HB ' ' HG3' ' A' ' 39' ' ' ARG . 22.2 t -142.07 -76.39 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.397 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.705 ' H ' ' HG3' ' A' ' 39' ' ' ARG . 51.1 m 93.41 171.01 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 168.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.0 mtp85 -62.1 -32.58 73.16 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.861 -172.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -59.65 -54.12 50.08 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 123.842 0.713 . . . . 0.0 110.751 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.484 ' O ' ' HG3' ' A' ' 27' ' ' ARG . 17.4 mt-10 -74.71 -47.22 32.64 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.784 -177.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.502 ' HB2' HD11 ' A' ' 37' ' ' LEU . . . -57.35 -51.17 70.46 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -172.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.522 ' HA ' HG11 ' A' ' 58' ' ' VAL . 3.9 tt0 -66.27 -33.79 76.53 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -177.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.3 m -63.41 -35.45 80.45 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.344 -0.843 . . . . 0.0 112.113 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.484 ' HG3' ' O ' ' A' ' 23' ' ' GLU . 98.0 mtt180 -81.19 -13.3 58.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.599 0.238 . . . . 0.0 111.256 -177.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.563 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 41.0 mt -121.27 -13.33 8.5 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -172.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.504 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 26.6 tp60 -66.61 104.8 1.36 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.926 0.393 . . . . 0.0 110.32 -176.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 64.59 34.17 89.19 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.444 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 12.0 mm100 -106.5 -160.85 0.76 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 178.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.551 ' HB2' ' HG3' ' A' ' 35' ' ' MET . 43.6 mtm180 -56.17 111.17 0.89 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.896 0.379 . . . . 0.0 110.624 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -67.38 111.06 3.84 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.008 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.427 ' HA2' HG23 ' A' ' 96' ' ' THR . . . 130.86 -14.26 5.5 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.499 -176.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.552 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 55.3 mtm -77.3 143.6 38.71 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 120.871 0.367 . . . . 0.0 110.426 177.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.459 ' HB2' HG23 ' A' ' 52' ' ' VAL . 34.0 p90 -141.39 166.01 25.94 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.236 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.756 ' HB2' ' HG3' ' A' ' 16' ' ' MET . 4.3 pp -157.13 139.14 14.4 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.234 0.54 . . . . 0.0 110.674 176.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.3 t -113.27 108.27 25.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.181 177.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.71 ' HG3' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -120.77 173.85 6.96 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.26 -178.533 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -61.69 130.32 45.29 Favored 'General case' 0 C--O 1.238 0.459 0 O-C-N 123.854 0.721 . . . . 0.0 110.147 178.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.4 t -80.13 154.98 27.69 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.517 -173.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.9 m -92.83 -5.32 51.3 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.744 177.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.2 m -73.34 -49.54 26.85 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.973 177.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 49.1 t -167.36 136.61 2.2 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.618 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -59.96 105.68 0.29 Allowed 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.503 2.135 . . . . 0.0 111.796 176.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 133.27 -29.41 3.18 Favored Glycine 0 N--CA 1.452 -0.278 0 N-CA-C 110.526 -1.029 . . . . 0.0 110.526 -174.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -80.58 151.41 29.1 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 173.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -127.25 157.93 38.51 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.503 ' HB ' ' CZ ' ' A' ' 39' ' ' ARG . 39.2 t -128.52 110.38 21.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.761 0.791 . . . . 0.0 111.316 176.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.438 ' HB3' ' HB2' ' A' ' 61' ' ' TYR . 47.5 tp -76.29 95.78 3.83 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 113.731 -1.577 . . . . 0.0 110.121 175.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 59' ' ' SER . 65.7 m -96.96 133.79 41.16 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 175.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.69 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 60.1 t -130.92 138.5 53.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.302 -171.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.563 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 40.0 t -89.68 108.22 19.55 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.803 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.666 ' O ' ' HB3' ' A' ' 57' ' ' ARG . 26.8 mt-10 -146.67 131.93 18.46 Favored 'General case' 0 C--O 1.206 -1.206 0 C-N-CA 119.685 -0.806 . . . . 0.0 110.253 176.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.401 HD22 ' HB ' ' A' ' 95' ' ' THR . 43.0 m-80 52.47 28.8 6.27 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 177.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.2 m 59.83 58.68 2.72 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 122.778 1.275 . . . . 0.0 108.67 -175.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.779 HH21 ' HB2' ' A' ' 94' ' ' ASP . 17.0 ttp85 -162.2 66.88 0.24 Allowed 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 112.869 -1.969 . . . . 0.0 109.395 -159.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.69 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 41.1 t -69.08 92.11 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-O 122.58 1.181 . . . . 0.0 109.143 -170.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' A' ' 51' ' ' SER . 1.8 m -61.17 119.64 8.79 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 112.579 -2.1 . . . . 0.0 110.722 -177.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -99.53 96.49 7.7 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.913 0.387 . . . . 0.0 110.969 -178.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.623 ' HB3' HD13 ' A' ' 73' ' ' ILE . 88.6 m-85 -95.5 116.44 28.82 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.074 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 55.4 mt -81.53 146.48 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 O-C-N 122.24 -0.287 . . . . 0.0 111.35 -178.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.645 HG13 ' CG1' ' A' ' 73' ' ' ILE . 4.8 mp -134.14 102.04 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 122.571 0.349 . . . . 0.0 110.243 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -81.14 130.95 35.25 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.237 -177.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.2 t -78.54 100.39 6.9 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 172.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.524 HD12 ' HB2' ' A' ' 72' ' ' LYS . 85.8 mt -80.64 142.78 53.69 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.28 -174.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -63.07 -8.63 14.56 Favored 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 122.766 2.31 . . . . 0.0 111.344 170.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -75.82 2.85 11.21 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.883 172.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? 68.01 24.9 7.74 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.489 -178.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.41 ' HB3' ' O ' ' A' ' 78' ' ' PHE . 67.2 mtt180 -121.4 176.41 5.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.952 -178.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.417 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 57.2 m-85 -124.46 117.92 25.49 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.112 0.482 . . . . 0.0 110.277 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.651 ' HG3' ' HB3' ' A' ' 77' ' ' GLU . 74.1 tttt -98.12 99.93 11.21 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.826 -173.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.645 ' CG1' HG13 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -90.14 76.45 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 123.0 1.381 . . . . 0.0 110.228 -173.69 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.43 74.71 0.88 Allowed Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 114.578 -1.192 . . . . 0.0 113.262 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.436 ' HA ' ' HE2' ' A' ' 72' ' ' LYS . 38.6 t70 73.94 -40.96 0.47 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 174.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -91.82 119.73 31.88 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.651 ' HB3' ' HG3' ' A' ' 72' ' ' LYS . 13.5 pt-20 -100.14 139.85 35.21 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.328 0.585 . . . . 0.0 111.488 -176.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.431 ' CE1' HG22 ' A' ' 73' ' ' ILE . 26.9 m-85 -117.66 168.13 10.71 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 174.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -69.91 -20.72 63.35 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -171.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.51 ' CE1' ' HB3' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -170.81 172.92 5.46 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 122.553 -0.092 . . . . 0.0 111.183 174.741 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.599 HD21 HD22 ' A' ' 84' ' ' LEU . 13.0 mt -51.8 -54.89 35.23 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 81' ' ' LEU . 38.3 Cg_endo -64.68 -4.53 8.63 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 122.369 2.046 . . . . 0.0 113.448 -177.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.51 ' HB3' ' CE1' ' A' ' 80' ' ' HIS . . . -94.43 -34.17 12.85 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.921 0.391 . . . . 0.0 110.524 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.641 HD21 ' HB ' ' A' ' 73' ' ' ILE . 2.3 pp -75.34 -36.67 60.99 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.534 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 81.4 mt -65.35 -31.24 72.26 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.236 177.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.615 ' HA ' ' HD3' ' A' ' 89' ' ' LYS . 3.3 tp10 -70.77 -27.84 64.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.935 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.401 ' CD2' ' HZ ' ' A' ' 78' ' ' PHE . 18.5 t80 -75.66 -32.17 60.08 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.734 0.778 . . . . 0.0 109.593 -177.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.62 ' CG ' HD22 ' A' ' 93' ' ' LEU . 64.7 m-85 -89.62 2.05 55.22 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.471 -175.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.615 ' HD3' ' HA ' ' A' ' 86' ' ' GLU . 56.9 mtpt -84.4 -15.29 46.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.884 173.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 34.0 pt -121.03 0.49 7.25 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 CA-C-O 121.291 0.567 . . . . 0.0 110.285 174.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.486 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 3.3 t-160 -88.97 -44.29 10.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.859 -176.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.457 ' HB2' ' O ' ' A' ' 91' ' ' HIS . 90.4 m-85 67.33 88.64 0.11 Allowed 'General case' 0 CA--C 1.519 -0.237 0 O-C-N 124.135 0.897 . . . . 0.0 108.946 -165.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.639 ' O ' ' HB3' ' A' ' 154' ' ' GLU . 11.9 mt -44.02 -61.59 1.41 Allowed 'General case' 0 C--O 1.218 -0.576 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 175.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.779 ' HB2' HH21 ' A' ' 57' ' ' ARG . 21.0 t0 -141.62 89.68 2.23 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.688 170.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.493 ' HB ' ' O ' ' A' ' 94' ' ' ASP . 1.3 m 69.91 -6.84 1.0 Allowed 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.981 0.896 . . . . 0.0 110.558 175.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.471 ' H ' ' C ' ' A' ' 94' ' ' ASP . 76.2 m -135.59 142.91 45.36 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.782 -178.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.1 p -95.4 171.37 8.74 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 174.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.43 HD12 ' O ' ' A' ' 85' ' ' LEU . 96.8 mt -66.77 91.84 0.2 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 173.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.48 HG23 ' O ' ' A' ' 3' ' ' SER . 47.0 mm -75.41 -66.86 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.298 -174.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.552 ' O ' ' HA ' ' A' ' 35' ' ' MET . 9.7 pt-20 -156.75 154.76 27.39 Favored Pre-proline 0 N--CA 1.447 -0.588 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.743 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.33 155.3 67.74 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.409 2.072 . . . . 0.0 112.982 -177.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.57 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . . . -77.21 166.41 44.67 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.925 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.57 ' HD2' ' HB2' ' A' ' 102' ' ' ALA . 43.3 Cg_endo -68.63 132.94 26.38 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.317 2.011 . . . . 0.0 112.566 176.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.436 HH22 ' C ' ' A' ' 12' ' ' SER . 46.3 ttm180 . . . . . 0 C--N 1.324 -0.509 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.859 177.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.548 HD11 HG22 ' A' ' 152' ' ' ILE . 3.9 mm? . . . . . 0 N--CA 1.474 0.739 0 CA-C-O 121.639 0.733 . . . . 0.0 112.881 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.549 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 41.5 tt0 -179.7 -75.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.35 -1.295 . . . . 0.0 109.157 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -98.88 108.13 20.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.188 0.518 . . . . 0.0 110.96 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.989 HG21 ' HG3' ' A' ' 180' ' ' LYS . 56.2 t -124.07 135.48 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.667 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.677 ' NH1' ' HB2' ' A' ' 181' ' ' LEU . 0.0 OUTLIER -111.29 148.05 33.75 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 117.51 -1.676 . . . . 0.0 108.538 169.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.426 ' HG1' ' HB2' ' A' ' 144' ' ' PHE . 0.9 OUTLIER -101.78 131.82 47.87 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.269 -179.903 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.53 HD22 ' HG2' ' A' ' 179' ' ' GLU . 21.8 mt -106.58 -17.5 14.23 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -176.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -87.09 -34.16 19.23 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.507 -174.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.488 ' HB2' ' HA ' ' A' ' 145' ' ' LYS . 0.0 OUTLIER 65.06 121.1 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 122.229 1.014 . . . . 0.0 111.317 -173.838 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -146.36 87.42 6.54 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 114.636 -1.166 . . . . 0.0 108.194 177.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.609 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 72.6 Cg_endo -83.0 85.99 1.51 Allowed 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 121.778 1.652 . . . . 0.0 112.578 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -77.18 -13.74 83.31 Favored Glycine 0 C--N 1.332 0.358 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 173.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.63 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 17.4 m120 52.59 64.74 1.74 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 114.235 -0.982 . . . . 0.0 111.216 178.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.486 ' HB3' ' H ' ' A' ' 141' ' ' ASP . 0.4 OUTLIER -130.84 -177.29 4.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.239 0.543 . . . . 0.0 111.335 -175.931 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -110.95 0.8 17.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.675 167.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -116.72 -43.54 2.89 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.1 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.486 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 14.5 m-20 -101.07 123.62 45.52 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 169.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.693 ' CD2' HD23 ' A' ' 150' ' ' LEU . 32.2 tp -77.98 120.44 81.26 Favored Pre-proline 0 N--CA 1.468 0.459 0 CA-C-O 120.743 0.306 . . . . 0.0 111.058 -175.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.63 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 36.2 Cg_endo -72.44 95.46 0.78 Allowed 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.444 1.429 . . . . 0.0 111.272 168.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.582 ' CE2' ' HB ' ' A' ' 173' ' ' ILE . 10.4 p90 -106.7 160.55 15.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.391 -177.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.488 ' HA ' ' HB2' ' A' ' 133' ' ' ASP . 0.1 OUTLIER -103.56 -171.77 2.0 Allowed 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.929 -0.308 . . . . 0.0 111.25 -177.344 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.762 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -88.57 5.31 43.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.36 -171.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -165.11 36.68 0.28 Allowed Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 175.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.434 ' HB3' ' HB2' ' A' ' 145' ' ' LYS . 0.0 OUTLIER -101.08 150.53 22.82 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.043 0.449 . . . . 0.0 111.368 -175.365 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.553 HD11 ' HB3' ' A' ' 129' ' ' ARG . 0.7 OUTLIER -90.14 132.14 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.567 -177.541 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.693 HD23 ' CD2' ' A' ' 142' ' ' LEU . 44.7 mt -127.9 157.15 41.31 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -177.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 58.0 t -122.93 123.8 68.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 174.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.548 HG22 HD11 ' A' ' 125' ' ' LEU . 36.8 mm -76.21 79.04 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.704 HG21 ' HG3' ' A' ' 154' ' ' GLU . 11.1 tt -75.62 -28.25 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-N 113.165 -1.834 . . . . 0.0 109.559 -174.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.704 ' HG3' HG21 ' A' ' 153' ' ' ILE . 29.8 mt-10 -134.39 142.15 47.08 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 175.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.428 ' HZ3' ' HG ' ' A' ' 125' ' ' LEU . 81.8 tttt -143.62 78.23 14.6 Favored Pre-proline 0 C--N 1.324 -0.505 0 O-C-N 121.547 -0.721 . . . . 0.0 111.264 177.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.437 ' HG2' ' HG2' ' A' ' 157' ' ' GLU . 59.2 Cg_endo -73.93 -31.56 8.02 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.113 1.875 . . . . 0.0 111.552 176.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.437 ' HG2' ' HG2' ' A' ' 156' ' ' PRO . 14.2 mm-40 -119.89 164.37 16.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.519 -172.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.559 ' O ' HG22 ' A' ' 175' ' ' VAL . 9.3 tp10 -102.86 -22.24 13.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.587 0.232 . . . . 0.0 110.878 178.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.913 HE21 ' HA ' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -91.19 -21.14 21.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.094 0.474 . . . . 0.0 110.059 177.463 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 56.7 m95 -124.75 133.51 53.14 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.119 174.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . 0.708 ' O ' HG13 ' A' ' 173' ' ' ILE . 46.1 m0 -110.94 133.6 53.24 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.258 0.551 . . . . 0.0 110.664 176.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.54 ' OG ' ' HG2' ' A' ' 172' ' ' MET . 67.4 m -93.02 89.05 6.35 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -176.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.555 ' HB2' ' HB3' ' A' ' 150' ' ' LEU . . . -106.27 145.63 31.37 Favored 'General case' 0 N--CA 1.418 -2.033 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 -169.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.682 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 13.3 ptt180 -87.07 123.85 32.59 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 175.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.611 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . 24.3 t30 -53.0 171.11 0.07 Allowed 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 113.277 -1.783 . . . . 0.0 110.736 -174.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 61.9 tttt -57.35 -19.99 26.31 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 173.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -70.64 -54.94 10.0 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.273 169.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 164' ' ' ARG . . . 134.3 -8.86 4.72 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.947 -171.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.682 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -65.57 130.26 42.67 Favored 'General case' 0 C--O 1.217 -0.624 0 C-N-CA 123.343 0.657 . . . . 0.0 111.734 178.767 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.493 HG12 ' OE1' ' A' ' 154' ' ' GLU . 27.0 t -83.69 126.99 40.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.128 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -158.07 149.45 19.82 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.428 -0.892 . . . . 0.0 112.243 171.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.54 ' HG2' ' OG ' ' A' ' 162' ' ' SER . 9.3 mtp -74.63 141.14 44.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.843 0.354 . . . . 0.0 110.773 -178.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.708 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.6 pp -142.12 141.72 22.38 Favored Pre-proline 0 N--CA 1.45 -0.474 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.795 -174.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.499 ' HB2' ' CD1' ' A' ' 177' ' ' TYR . 24.5 Cg_exo -64.88 127.47 18.68 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.804 2.336 . . . . 0.0 112.879 -178.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 158' ' ' GLU . 72.9 t -61.33 -40.73 74.86 Favored Pre-proline 0 CA--C 1.545 0.75 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 177.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -61.44 -5.4 5.39 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 121.92 1.747 . . . . 0.0 112.906 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.499 ' CD1' ' HB2' ' A' ' 174' ' ' PRO . 2.8 m-30 -97.53 -10.96 24.31 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.632 -177.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.622 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 4.0 m -105.67 -172.98 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -164.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.64 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 3.8 tp10 -159.98 50.76 0.31 Allowed 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 113.143 -1.844 . . . . 0.0 112.949 -151.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.989 ' HG3' HG21 ' A' ' 128' ' ' VAL . 2.2 mppt? -69.83 137.56 51.87 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 119.451 -2.031 . . . . 0.0 111.061 -161.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.677 ' HB2' ' NH1' ' A' ' 129' ' ' ARG . 12.3 tp . . . . . 0 C--N 1.332 -0.182 0 CA-C-N 112.999 -1.91 . . . . 0.0 111.694 -169.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo . . . . . 0 C--O 1.234 0.284 0 CA-C-O 120.872 0.28 . . . . 0.0 111.937 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.503 ' HB ' HG12 ' A' ' 266' ' ' VAL . 58.6 t -83.91 116.5 27.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.315 0.578 . . . . 0.0 110.908 -176.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -103.91 114.45 28.71 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.566 175.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . 0.533 ' HB3' HD12 ' A' ' 293' ' ' ILE . . . -119.54 131.17 55.49 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.06 -178.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.627 ' HE3' ' HA2' ' A' ' 261' ' ' GLY . 48.5 tttp -90.13 126.12 35.68 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 260' ' ' VAL . . . -74.83 97.08 3.21 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.23 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 48.2 pt -77.35 -21.91 14.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.127 0.489 . . . . 0.0 110.444 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.17 141.11 50.69 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -67.91 161.4 26.51 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-O 121.175 0.512 . . . . 0.0 111.073 -174.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.441 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 24.7 tpt180 -151.67 101.36 2.78 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.623 179.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 29.6 m -97.46 154.24 38.07 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.528 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.469 ' HA ' ' HB3' ' A' ' 255' ' ' ALA . 10.1 Cg_exo -69.63 99.98 0.77 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.202 1.934 . . . . 0.0 111.176 177.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' CYS . . . . . 0.504 ' HB3' ' HB2' ' A' ' 252' ' ' ASP . 42.3 t -70.24 167.96 16.82 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.325 -178.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -53.83 -38.28 64.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.917 0.389 . . . . 0.0 110.977 176.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -103.53 17.27 24.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.006 0.431 . . . . 0.0 111.142 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . 0.504 ' HB2' ' HB3' ' A' ' 249' ' ' CYS . 4.0 m-20 -140.18 54.4 1.64 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.539 175.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -75.04 -14.85 60.64 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.37 -177.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 4.4 p -93.57 6.76 47.18 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.733 176.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . 0.487 ' HB1' ' HB3' ' A' ' 252' ' ' ASP . . . -80.8 150.92 29.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.14 0.495 . . . . 0.0 110.984 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.9 tt -90.63 124.43 35.05 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -67.87 100.13 0.91 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.335 0.588 . . . . 0.0 110.427 177.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.457 HD21 HG21 ' A' ' 264' ' ' VAL . 93.4 mt -108.29 147.82 30.9 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.138 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -129.03 163.49 25.28 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.854 178.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 61.6 t -62.13 122.48 12.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.164 0.506 . . . . 0.0 111.4 -176.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . 0.627 ' HA2' ' HE3' ' A' ' 241' ' ' LYS . . . 102.71 -9.39 55.41 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.694 177.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -79.52 140.28 37.3 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 -173.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 44.3 mm -88.57 109.22 19.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.394 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.457 HG21 HD21 ' A' ' 258' ' ' LEU . 15.0 t -83.58 100.69 7.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.129 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -83.14 87.33 6.92 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.853 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.503 HG12 ' HB ' ' A' ' 238' ' ' VAL . 4.8 p -97.53 133.4 39.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.071 0.462 . . . . 0.0 110.688 -177.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 20.7 p -103.57 -35.46 8.29 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.849 -175.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 3.1 ptp180 -118.21 121.53 40.71 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.095 0.474 . . . . 0.0 110.68 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' MET . . . . . 0.488 ' HE2' HG11 ' A' ' 266' ' ' VAL . 45.7 mmm -95.36 99.38 11.31 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.577 -177.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.501 ' HB2' ' O ' ' A' ' 274' ' ' GLN . 84.3 m-20 -75.34 129.94 38.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.542 -178.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 11.1 tp -69.25 -15.19 19.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -171.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -71.39 -18.34 62.36 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.756 0.313 . . . . 0.0 111.033 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 115.24 -34.1 4.98 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.993 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.512 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 17.2 mt-30 -83.6 105.04 14.21 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 175.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.406 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 40.2 m0 -92.71 156.7 16.87 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -176.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -108.01 106.52 16.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.99 0.424 . . . . 0.0 110.379 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -121.06 153.82 16.55 Favored Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 177.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -116.23 111.92 20.87 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . 0.566 HG11 ' ND2' ' A' ' 280' ' ' ASN . 16.7 t -122.93 125.76 72.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.515 -177.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . 0.566 ' ND2' HG11 ' A' ' 279' ' ' VAL . 9.6 p30 44.0 41.58 4.11 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.144 0.978 . . . . 0.0 112.981 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 102.6 -20.48 44.08 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.782 -0.723 . . . . 0.0 113.675 173.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 17.2 mtp-105 -109.1 125.18 51.88 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 117.232 0.516 . . . . 0.0 110.908 -177.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 42.1 pttt -114.88 134.73 54.91 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 120.289 -0.564 . . . . 0.0 109.999 172.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -155.96 176.41 33.45 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.675 -177.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.512 ' HB3' ' HB3' ' A' ' 274' ' ' GLN . 57.6 mt -91.08 118.29 30.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.983 0.42 . . . . 0.0 110.678 178.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.418 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 45.9 p90 -120.94 138.86 28.29 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.256 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 6.3 Cg_exo -76.06 139.41 21.6 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.043 2.495 . . . . 0.0 111.469 175.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -69.8 1.38 4.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.997 -177.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 19.8 p -82.7 -15.03 53.5 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.682 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -103.57 -17.27 15.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.794 0.331 . . . . 0.0 111.343 -177.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.5 ' O ' ' HD2' ' A' ' 292' ' ' LYS . 32.7 m -115.29 159.31 15.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.269 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . 0.5 ' HD2' ' O ' ' A' ' 291' ' ' VAL . 11.1 mptt -126.9 129.02 47.4 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.923 0.392 . . . . 0.0 110.682 177.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.533 HD12 ' HB3' ' A' ' 240' ' ' ALA . 39.7 mm -73.41 130.84 35.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.42 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' PHE . . . . . 0.434 ' CE1' ' HB2' ' A' ' 241' ' ' LYS . 0.6 OUTLIER -152.56 165.34 35.46 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.451 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -104.8 102.01 32.51 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 175.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo . . . . . 0 C--N 1.341 0.182 0 C-N-CA 122.702 2.268 . . . . 0.0 112.567 -173.854 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.4 t . . . . . 0 N--CA 1.453 -0.32 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.403 ' HA ' HG22 ' A' ' 99' ' ' ILE . . . -85.39 119.82 26.18 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.617 177.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.496 ' HD3' ' HA ' ' A' ' 5' ' ' ARG . 22.1 mmt180 -131.35 87.7 2.5 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.38 0.609 . . . . 0.0 111.412 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -158.81 168.17 27.53 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 177.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -100.58 131.59 46.41 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.061 175.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.5 m -69.65 -19.76 63.61 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.19 -174.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.8 t -106.24 -24.37 12.32 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -172.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -60.82 95.13 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.961 0.41 . . . . 0.0 111.143 -175.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.8 tpp180 -52.74 -51.23 61.41 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 123.205 0.602 . . . . 0.0 112.15 -174.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.6 m -72.93 4.88 3.71 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -176.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -91.65 -48.7 6.69 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.55 175.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 37.4 p-90 -113.92 -30.39 6.74 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -172.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -70.99 113.52 8.11 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.391 -0.524 . . . . 0.0 109.634 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.904 ' HB3' HG13 ' A' ' 19' ' ' VAL . 27.9 tpp -94.22 1.63 56.0 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 120.911 0.386 . . . . 0.0 110.293 -170.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 50.65 -111.96 1.43 Allowed Glycine 0 C--N 1.334 0.451 0 CA-C-N 115.041 -0.981 . . . . 0.0 113.653 177.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -64.97 90.87 0.2 Allowed 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.846 2.364 . . . . 0.0 112.297 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.994 HG22 ' HD2' ' A' ' 39' ' ' ARG . 2.7 p -162.5 159.43 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.7 m -156.64 -166.63 2.17 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 -160.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 25' ' ' GLN . 44.1 mtp85 -69.25 -41.56 76.76 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.663 -175.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 15.5 tp60 -64.24 -54.02 39.89 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 123.458 0.473 . . . . 0.0 111.024 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.41 ' O ' ' HG3' ' A' ' 27' ' ' ARG . 47.9 mm-40 -61.12 -56.43 20.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.835 -176.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.91 -33.66 67.15 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.738 0.304 . . . . 0.0 111.614 -178.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.536 ' NE2' HG21 ' A' ' 58' ' ' VAL . 26.9 tp60 -61.8 -47.69 83.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.867 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.0 t -79.97 -25.27 40.45 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 120.88 0.372 . . . . 0.0 111.553 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.418 ' NH1' ' HB ' ' A' ' 19' ' ' VAL . 97.5 mtt180 -74.72 -38.16 62.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.987 0.422 . . . . 0.0 110.962 -177.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.908 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 28.7 mt -99.72 6.66 45.5 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.935 -176.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.473 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 17.0 tp60 -72.05 95.31 1.6 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.083 0.468 . . . . 0.0 111.725 -172.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 66.37 29.04 74.16 Favored Glycine 0 N--CA 1.453 -0.202 0 CA-C-N 115.608 -0.724 . . . . 0.0 113.815 173.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.44 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 0.0 OUTLIER -85.39 -91.91 0.09 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 117.027 0.414 . . . . 0.0 110.082 178.483 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.564 ' HB2' ' SD ' ' A' ' 35' ' ' MET . 86.7 mtm-85 -127.54 135.54 50.48 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 170.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 58.5 m170 -71.06 124.61 24.79 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.06 -13.75 14.03 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.649 -176.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.653 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 93.4 mtp -73.62 126.37 30.13 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 175.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.507 ' CB ' HG22 ' A' ' 52' ' ' VAL . 47.1 p90 -133.6 166.0 23.61 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.901 0.381 . . . . 0.0 111.013 -177.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.503 ' HB2' ' HB2' ' A' ' 16' ' ' MET . 4.0 pp -158.07 138.79 12.96 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.499 176.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.496 ' CG2' HD11 ' A' ' 50' ' ' LEU . 87.7 t -102.1 123.58 55.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.994 ' HD2' HG22 ' A' ' 19' ' ' VAL . 5.0 mtm-85 -106.77 175.01 5.64 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.163 -171.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -86.62 90.96 8.43 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 167.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.582 ' HA ' HG22 ' A' ' 49' ' ' VAL . 7.5 t 24.76 -141.41 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.347 1.459 . . . . 0.0 114.487 -176.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.591 ' HB3' HH21 ' A' ' 39' ' ' ARG . 56.0 p 172.26 -29.13 0.0 OUTLIER 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 114.106 -1.406 . . . . 0.0 108.778 174.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 40.3 p -122.88 -13.0 7.95 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.982 -177.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.433 ' HA ' ' HD2' ' A' ' 45' ' ' PRO . 64.0 m -133.47 100.17 13.96 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 110.527 -0.175 . . . . 0.0 110.527 -175.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 44' ' ' CYS . 17.9 Cg_endo -57.42 109.18 0.43 Allowed 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.97 2.447 . . . . 0.0 113.069 -174.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.81 -19.73 18.26 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.695 177.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 41' ' ' SER . 74.8 m-20 -90.25 -174.65 4.25 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.34 -0.245 . . . . 0.0 110.34 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.55 ' HA ' ' H ' ' A' ' 41' ' ' SER . 26.9 m-85 -129.55 167.77 17.41 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.629 ' O ' ' HG3' ' A' ' 39' ' ' ARG . 96.6 t -142.22 98.07 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 121.046 0.451 . . . . 0.0 111.298 177.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.496 HD11 ' CG2' ' A' ' 38' ' ' VAL . 40.8 tp -70.1 103.02 2.19 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.963 175.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.497 ' HB3' ' CG1' ' A' ' 58' ' ' VAL . 21.5 m -96.56 134.4 39.82 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.807 175.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.533 HG23 HD12 ' A' ' 93' ' ' LEU . 96.4 t -123.0 142.8 38.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.329 -178.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.908 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 36.0 t -88.05 116.92 26.57 Favored 'General case' 0 C--N 1.334 -0.081 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.649 176.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.836 ' HB2' ' HB3' ' A' ' 94' ' ' ASP . 4.8 pt-20 -165.64 141.88 5.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.775 -0.193 . . . . 0.0 110.997 -177.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.569 HD22 ' HE2' ' A' ' 155' ' ' LYS . 0.5 OUTLIER 53.16 32.12 12.65 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 122.933 0.493 . . . . 0.0 111.881 -174.385 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.1 m 67.34 11.12 8.21 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.62 177.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.581 ' HG3' ' O ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -125.39 165.31 18.63 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.187 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.536 HG21 ' NE2' ' A' ' 25' ' ' GLN . 84.1 t -106.32 105.47 18.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.035 0.445 . . . . 0.0 110.651 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.7 t -76.51 120.36 21.61 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.765 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -99.76 102.4 13.84 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.61 -174.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.915 ' HH ' ' HB3' ' A' ' 93' ' ' LEU . 66.9 m-85 -100.53 101.5 12.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.621 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.465 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 25.6 mt -81.05 138.41 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 121.152 0.501 . . . . 0.0 112.311 -174.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.623 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 3.7 mp -116.85 122.24 69.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.603 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -104.01 140.42 37.77 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -175.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.4 t -79.85 104.83 10.7 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.103 0.478 . . . . 0.0 110.444 -177.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.497 HD12 ' HB2' ' A' ' 72' ' ' LYS . 90.6 mt -75.24 132.73 75.87 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.617 178.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -57.18 -19.85 35.81 Favored 'Trans proline' 0 N--CA 1.473 0.302 0 C-N-CA 123.425 2.75 . . . . 0.0 113.409 -174.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -90.28 26.85 1.81 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.238 178.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.696 ' HA ' ' HE ' ' A' ' 69' ' ' ARG . 2.2 mmp_? 69.3 26.07 5.44 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.356 173.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.635 ' HG2' ' HA ' ' A' ' 79' ' ' ASP . 69.8 mtt180 -114.47 179.0 4.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.604 176.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.623 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 36.6 m-85 -139.1 120.39 14.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.774 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.497 ' HB2' HD12 ' A' ' 66' ' ' LEU . 19.6 ttmm -106.65 110.21 22.34 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.615 -178.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.585 ' HB ' HG13 ' A' ' 63' ' ' ILE . 3.9 tt -94.06 103.62 14.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.084 0.468 . . . . 0.0 110.869 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 52.69 63.11 5.24 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.658 -0.701 . . . . 0.0 113.111 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.1 t0 78.59 -38.88 0.24 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.002 0.521 . . . . 0.0 111.081 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -69.09 119.12 12.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.002 0.429 . . . . 0.0 110.259 177.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.433 ' HB3' ' NZ ' ' A' ' 72' ' ' LYS . 7.7 pt-20 -99.23 133.67 43.18 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.274 0.559 . . . . 0.0 111.846 -174.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.448 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 79.7 m-85 -136.83 164.1 29.09 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.818 177.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.635 ' HA ' ' HG2' ' A' ' 70' ' ' ARG . 6.9 m-20 -73.75 -26.56 60.73 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -176.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.421 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 5.7 p80 -163.11 172.96 14.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.848 -0.16 . . . . 0.0 110.937 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.538 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 19.6 mt -58.34 -52.25 75.93 Favored Pre-proline 0 CA--C 1.535 0.367 0 O-C-N 123.251 0.344 . . . . 0.0 111.656 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.538 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 52.0 Cg_exo -58.11 -9.03 5.56 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 122.419 2.079 . . . . 0.0 113.467 177.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.28 -36.35 15.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.953 0.406 . . . . 0.0 110.799 -178.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.567 HD11 HD13 ' A' ' 73' ' ' ILE . 3.7 pp -79.97 -33.89 39.12 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.3 mt -68.08 -14.2 62.79 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.635 0.731 . . . . 0.0 110.115 175.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -85.98 -44.9 11.96 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.667 177.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.435 ' O ' HG12 ' A' ' 90' ' ' ILE . 84.9 t80 -70.15 -37.13 75.17 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.534 -177.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -72.77 5.2 3.33 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -176.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -83.76 -14.98 50.21 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 119.915 -0.714 . . . . 0.0 111.144 171.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.435 HG12 ' O ' ' A' ' 87' ' ' PHE . 5.6 pt -87.89 -28.93 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.227 166.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.431 ' N ' HG13 ' A' ' 90' ' ' ILE . 3.0 m170 -91.14 124.53 35.43 Favored 'General case' 0 CA--C 1.502 -0.865 0 CA-C-O 121.135 0.493 . . . . 0.0 111.181 -177.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -86.81 90.04 8.17 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 175.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.915 ' HB3' ' HH ' ' A' ' 61' ' ' TYR . 5.3 mt -46.63 -36.36 6.91 Favored 'General case' 0 C--O 1.218 -0.567 0 O-C-N 124.346 1.029 . . . . 0.0 110.204 -177.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.836 ' HB3' ' HB2' ' A' ' 54' ' ' GLU . 21.6 t70 -158.82 99.35 1.54 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.841 165.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.659 ' HA ' ' HA ' ' A' ' 156' ' ' PRO . 5.7 t 44.3 18.16 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.663 1.185 . . . . 0.0 112.498 -177.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.7 t -162.77 154.58 18.15 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.478 ' O ' HG12 ' A' ' 99' ' ' ILE . 52.2 p -104.11 -179.01 3.82 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.422 ' HG ' HD11 ' A' ' 93' ' ' LEU . 85.7 mt -64.4 104.97 0.84 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 173.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.478 HG12 ' O ' ' A' ' 97' ' ' THR . 45.1 mm -99.86 -54.93 6.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.737 -173.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.653 ' O ' ' HA ' ' A' ' 35' ' ' MET . 10.6 pt-20 -151.59 153.02 31.55 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.062 -173.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 100' ' ' GLU . 1.9 Cg_endo -83.84 158.61 13.89 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.948 2.432 . . . . 0.0 112.746 178.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.462 ' O ' ' HE2' ' A' ' 16' ' ' MET . . . -88.18 164.62 32.56 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.054 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -78.28 164.92 26.23 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.99 2.46 . . . . 0.0 112.453 175.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.777 ' HG2' ' SD ' ' A' ' 16' ' ' MET . 19.8 mtm180 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.492 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.529 HD12 HG21 ' A' ' 152' ' ' ILE . 2.6 mm? . . . . . 0 N--CA 1.468 0.473 0 CA-C-O 121.305 0.574 . . . . 0.0 112.328 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.664 ' O ' HG12 ' A' ' 151' ' ' VAL . 10.0 tp10 179.84 -48.57 0.01 OUTLIER 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.106 174.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -122.76 131.03 53.59 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.373 177.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.5 ' CG1' ' HB ' ' A' ' 178' ' ' VAL . 5.8 t -134.93 156.8 40.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.087 -174.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.579 ' NH2' HD11 ' A' ' 181' ' ' LEU . 1.2 ptp180 -134.17 133.54 41.1 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 172.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.71 HG23 ' CG1' ' A' ' 178' ' ' VAL . 23.8 p -88.77 140.57 29.31 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.273 0.559 . . . . 0.0 112.213 -174.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.573 HD11 ' HG2' ' A' ' 179' ' ' GLU . 13.6 mt -106.99 -42.23 4.96 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.397 -176.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -83.31 -36.45 24.45 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -168.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.783 ' HB2' ' HA ' ' A' ' 145' ' ' LYS . 0.0 OUTLIER 79.25 133.67 0.06 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.434 0.693 . . . . 0.0 111.021 -174.59 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.568 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 59.1 t80 -156.05 110.38 2.11 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.072 -178.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -89.42 90.91 0.36 Allowed 'Trans proline' 0 N--CA 1.445 -1.348 0 C-N-CA 122.591 2.194 . . . . 0.0 112.586 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . 0.474 ' HA3' ' HB3' ' A' ' 141' ' ' ASP . . . -84.4 -21.14 57.31 Favored Glycine 0 N--CA 1.454 -0.166 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.048 173.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 28.4 m120 46.29 48.67 13.27 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 114.443 -0.878 . . . . 0.0 112.532 178.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.405 ' OD1' ' HG2' ' A' ' 140' ' ' GLU . 5.0 t70 -149.53 179.23 8.14 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.39 -178.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -95.17 -7.5 39.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.336 0.588 . . . . 0.0 110.197 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.568 ' O ' ' HB2' ' A' ' 172' ' ' MET . 10.0 pt-20 -113.28 -3.32 13.86 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.987 173.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.474 ' HB3' ' HA3' ' A' ' 136' ' ' GLY . 4.1 m-20 -140.14 102.03 4.29 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.687 ' HB3' ' CG2' ' A' ' 173' ' ' ILE . 57.8 tp -74.03 126.13 89.56 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.417 0.627 . . . . 0.0 111.639 -172.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.663 ' HD2' ' CD1' ' A' ' 142' ' ' LEU . 68.8 Cg_endo -76.73 65.58 7.54 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 124.263 3.308 . . . . 0.0 113.132 177.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.568 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 36.3 p90 -84.43 162.08 20.09 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.504 -0.479 . . . . 0.0 111.736 -176.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.783 ' HA ' ' HB2' ' A' ' 133' ' ' ASP . 10.9 mtmt -121.98 179.92 4.36 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.178 -176.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.659 ' H ' ' HD3' ' A' ' 146' ' ' LYS . 0.3 OUTLIER -79.47 27.62 0.27 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -167.753 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 175.72 32.91 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 119.721 -1.228 . . . . 0.0 113.594 176.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.565 ' OE2' ' HA ' ' A' ' 144' ' ' PHE . 8.7 pt-20 -106.63 167.15 10.06 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 117.826 0.813 . . . . 0.0 110.916 177.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.423 ' HA ' HD11 ' A' ' 149' ' ' ILE . 19.8 mm -101.55 138.38 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -175.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.714 HD22 ' HA ' ' A' ' 165' ' ' ASN . 11.5 mt -122.9 179.64 4.57 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.86 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 47.8 t -145.29 123.46 5.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 178.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.848 HD13 ' HB3' ' A' ' 163' ' ' ALA . 20.4 mm -77.85 77.77 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-O 122.659 1.219 . . . . 0.0 108.55 -178.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.604 HD11 ' HE1' ' A' ' 61' ' ' TYR . 13.5 tt -71.4 -41.45 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-N 112.847 -1.979 . . . . 0.0 109.905 -177.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 1.153 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 73.4 mt-10 -116.79 138.92 51.15 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 172.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.596 ' O ' ' HB ' ' A' ' 95' ' ' THR . 22.1 ttpt -132.94 79.54 62.94 Favored Pre-proline 0 C--N 1.322 -0.593 0 O-C-N 122.043 -0.411 . . . . 0.0 110.015 167.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.659 ' HA ' ' HA ' ' A' ' 95' ' ' THR . 14.6 Cg_exo -66.35 -49.17 1.97 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 121.95 1.767 . . . . 0.0 110.945 177.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -119.93 176.44 5.41 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.205 -174.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -95.6 -30.34 13.85 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.619 -176.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.405 ' O ' HG21 ' A' ' 175' ' ' VAL . 24.2 mt-30 -84.25 -22.71 30.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.021 0.438 . . . . 0.0 110.793 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.751 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 60.5 m95 -129.2 126.89 40.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.425 -178.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . 0.711 ' HB3' HG22 ' A' ' 152' ' ' ILE . 49.5 m0 -119.75 134.26 55.3 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.752 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 1.153 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 6.5 m -84.47 98.09 9.9 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 177.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.848 ' HB3' HD13 ' A' ' 152' ' ' ILE . . . -103.98 157.78 16.87 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.136 -176.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.86 ' HG2' ' HB ' ' A' ' 151' ' ' VAL . 14.2 ptt180 -104.66 129.64 52.8 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 176.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.714 ' HA ' HD22 ' A' ' 150' ' ' LEU . 0.2 OUTLIER -73.03 -166.99 0.35 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.453 0.168 . . . . 0.0 110.971 -178.225 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.503 ' HE3' ' HB2' ' A' ' 148' ' ' GLU . 93.8 mttt -55.96 -38.06 69.86 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -176.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.43 ' CG ' HD22 ' A' ' 165' ' ' ASN . 3.3 p30 -86.46 0.96 53.07 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.308 -178.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 92.42 3.06 67.34 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 120.447 -0.882 . . . . 0.0 113.973 174.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.707 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 12.5 ttm-85 -68.1 130.25 42.36 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 122.511 0.324 . . . . 0.0 110.777 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 39.8 t -95.19 143.02 12.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-O 120.855 0.36 . . . . 0.0 111.008 -177.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -170.92 155.53 24.87 Favored Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 175.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.751 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.4 OUTLIER -70.26 131.66 44.53 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.967 0.384 . . . . 0.0 110.864 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.687 ' CG2' ' HB3' ' A' ' 142' ' ' LEU . 2.6 pp -133.52 145.4 56.2 Favored Pre-proline 0 N--CA 1.451 -0.394 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.199 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.474 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 8.2 Cg_exo -71.69 125.43 11.11 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.957 2.438 . . . . 0.0 111.859 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.613 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 24.1 t -68.76 -35.29 6.34 Favored Pre-proline 0 C--N 1.32 -0.682 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -178.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 19.0 Cg_endo -61.43 -11.22 18.77 Favored 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 121.656 1.571 . . . . 0.0 112.537 172.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.474 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.4 m-85 -92.01 -14.35 29.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.243 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.71 ' CG1' HG23 ' A' ' 130' ' ' THR . 10.3 m -122.01 173.64 7.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -169.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.573 ' HG2' HD11 ' A' ' 131' ' ' LEU . 9.3 mm-40 -136.34 169.71 17.23 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.933 177.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.525 ' N ' ' HD3' ' A' ' 180' ' ' LYS . 2.3 mppt? -101.22 136.92 40.27 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.802 0.334 . . . . 0.0 110.563 -175.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.579 HD11 ' NH2' ' A' ' 129' ' ' ARG . 7.8 tp . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.371 -178.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo . . . . . 0 C--O 1.234 0.283 0 CA-C-O 120.973 0.322 . . . . 0.0 111.83 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.591 ' HB ' HG13 ' A' ' 266' ' ' VAL . 39.6 t -100.68 135.88 34.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.967 -173.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -88.27 121.85 31.14 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.459 173.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -126.5 123.69 38.36 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.391 176.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.422 ' O ' HG22 ' A' ' 243' ' ' ILE . 63.8 tttm -86.07 119.41 26.34 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.131 -177.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . 0.439 ' HA ' HG11 ' A' ' 291' ' ' VAL . . . -70.81 99.9 1.81 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.31 0.576 . . . . 0.0 110.418 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.422 HG22 ' O ' ' A' ' 241' ' ' LYS . 34.2 pt -88.75 -27.87 5.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.421 -173.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -129.89 147.81 51.69 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.368 -0.378 . . . . 0.0 109.996 -178.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -55.53 122.21 10.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.432 0.634 . . . . 0.0 111.296 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.729 ' HB3' ' HB2' ' A' ' 258' ' ' LEU . 20.9 tpt180 -122.73 77.04 1.4 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.382 -0.826 . . . . 0.0 108.856 173.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.423 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 7.4 m -111.62 137.46 21.2 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.67 -178.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 247' ' ' VAL . 31.8 Cg_exo -57.76 111.4 0.83 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 123.048 2.499 . . . . 0.0 112.044 -178.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' CYS . . . . . 0.427 ' N ' ' HB2' ' A' ' 252' ' ' ASP . 19.3 t -88.6 -169.86 2.71 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.2 -39.15 78.25 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -177.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -91.1 -9.91 43.92 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.381 -176.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . 0.463 ' HB3' ' HB3' ' A' ' 255' ' ' ALA . 19.4 m-20 -80.89 116.67 20.99 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.364 0.602 . . . . 0.0 111.571 -174.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -120.47 145.97 46.73 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 172.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 25.2 p 61.92 17.73 9.19 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.581 0.752 . . . . 0.0 111.017 -174.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . 0.463 ' HB3' ' HB3' ' A' ' 252' ' ' ASP . . . -81.17 130.99 35.27 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.999 0.428 . . . . 0.0 111.426 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.827 HD21 ' HB ' ' A' ' 279' ' ' VAL . 2.0 tt -86.07 131.29 34.29 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 175.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -79.86 95.95 6.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.211 0.529 . . . . 0.0 111.182 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.897 HD22 HG22 ' A' ' 279' ' ' VAL . 68.8 mt -105.39 105.48 15.54 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.377 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -87.82 150.3 23.62 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.066 -177.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 47.0 t -61.8 121.21 9.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.038 -176.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 101.87 39.73 2.85 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.964 175.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -141.58 174.82 10.2 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.938 0.369 . . . . 0.0 110.138 177.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 49.8 mm -107.38 133.82 50.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.944 0.402 . . . . 0.0 111.203 -175.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.467 HG21 HD21 ' A' ' 258' ' ' LEU . 5.2 t -113.75 115.76 50.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.885 175.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -95.94 103.17 15.04 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 173.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.591 HG13 ' HB ' ' A' ' 238' ' ' VAL . 2.1 p -94.65 141.4 15.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.562 -178.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 19.5 p -126.34 -23.74 3.77 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.913 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . 0.455 ' HB2' ' HB3' ' A' ' 276' ' ' GLU . 83.4 mtt180 -116.51 119.42 35.53 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.43 177.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 58.6 mtt -117.25 110.36 18.01 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 175.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.401 ' C ' ' H ' ' A' ' 272' ' ' ASN . 53.6 m-80 -84.21 12.12 7.09 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.237 -170.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.451 HG23 HD11 ' A' ' 271' ' ' ILE . 48.0 mm 72.05 -39.0 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 175.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . 0.401 ' H ' ' C ' ' A' ' 270' ' ' ASN . 5.8 t30 -78.8 27.05 0.23 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.444 0.64 . . . . 0.0 111.067 -178.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 81.99 -29.14 3.12 Favored Glycine 0 C--N 1.32 -0.308 0 C-N-CA 121.096 -0.573 . . . . 0.0 113.077 176.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -78.7 105.54 10.08 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.506 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 49.4 m0 -99.82 153.96 18.72 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.274 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . 0.455 ' HB3' ' HB2' ' A' ' 268' ' ' ARG . 38.9 tt0 -120.59 115.6 23.72 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.887 178.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . 0.549 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -138.06 164.3 25.56 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 176.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -106.17 112.33 25.32 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 117.784 0.792 . . . . 0.0 109.669 -177.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . 0.897 HG22 HD22 ' A' ' 258' ' ' LEU . 70.8 t -121.15 99.67 7.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.171 -177.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 42.18 63.13 1.44 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.353 -1.294 . . . . 0.0 113.173 173.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 144.68 -51.08 0.63 Allowed Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.025 -1.083 . . . . 0.0 112.585 173.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.46 162.15 16.71 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.222 0.534 . . . . 0.0 111.755 -178.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 0.0 OUTLIER -88.84 143.06 27.15 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.673 175.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -150.56 172.18 30.33 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.539 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.506 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 72.0 mt -90.1 123.65 34.13 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.16 0.505 . . . . 0.0 110.958 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.422 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 36.6 p90 -133.68 136.71 27.22 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.173 177.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 10.4 Cg_exo -71.78 140.08 34.81 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.501 2.134 . . . . 0.0 111.614 176.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -60.07 -20.56 58.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.837 -178.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 1.4 p -73.89 -3.52 29.37 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -177.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -101.19 -7.54 23.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.666 0.27 . . . . 0.0 110.678 177.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.439 HG11 ' HA ' ' A' ' 242' ' ' ALA . 15.4 m -128.74 178.0 5.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.145 0.498 . . . . 0.0 111.302 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 57.8 tttm -140.81 123.28 15.97 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.515 175.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.562 HD12 HG13 ' A' ' 238' ' ' VAL . 35.3 mm -65.07 144.31 14.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.152 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -173.39 -179.07 1.81 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.637 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -151.58 144.48 16.97 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 172.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo . . . . . 0 C--N 1.348 0.504 0 C-N-CA 123.563 2.842 . . . . 0.0 114.178 178.435 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.5 p . . . . . 0 N--CA 1.449 -0.523 0 CA-C-O 121.091 0.472 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.511 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . -67.07 133.64 50.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.771 178.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 5' ' ' ARG . 47.0 ttm180 -150.92 100.09 2.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.773 0.32 . . . . 0.0 110.821 -176.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -166.07 -177.23 4.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.885 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.498 ' HB3' ' CB ' ' A' ' 13' ' ' ALA . 12.9 t70 -103.17 141.46 35.83 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.465 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 31.7 m -79.36 -0.19 31.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.808 0.337 . . . . 0.0 111.429 -176.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.737 ' CA ' ' HE1' ' A' ' 14' ' ' TRP . 8.7 t -149.17 -95.22 0.07 Allowed 'General case' 0 C--O 1.245 0.816 0 CA-C-O 122.2 1.0 . . . . 0.0 111.302 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.476 ' O ' ' N ' ' A' ' 12' ' ' SER . 37.5 t70 -8.16 74.89 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.099 -1.409 . . . . 0.0 112.01 -155.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.447 ' HA ' ' HD3' ' A' ' 11' ' ' ARG . 7.6 mmt180 -2.24 -58.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 126.189 2.18 . . . . 0.0 115.331 -163.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.476 ' N ' ' O ' ' A' ' 10' ' ' ASP . 58.2 m -70.1 18.08 0.05 Allowed 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -177.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.498 ' CB ' ' HB3' ' A' ' 7' ' ' ASP . . . -91.46 -19.1 23.2 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 120.332 -0.547 . . . . 0.0 109.725 170.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.737 ' HE1' ' CA ' ' A' ' 9' ' ' SER . 7.4 p-90 -151.71 -39.84 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.477 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.536 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 34.0 t80 -67.36 119.84 12.88 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 121.126 0.489 . . . . 0.0 110.179 -177.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.8 ' SD ' ' HB3' ' A' ' 104' ' ' ARG . 15.0 tpp -110.03 9.22 24.25 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.296 -172.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.566 ' O ' ' HB2' ' A' ' 39' ' ' ARG . . . 50.85 -112.07 1.51 Allowed Glycine 0 C--O 1.222 -0.639 0 CA-C-N 115.805 -0.634 . . . . 0.0 113.713 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.408 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 2.8 Cg_exo -77.03 109.15 2.78 Favored 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 122.462 2.108 . . . . 0.0 112.606 178.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 1.051 ' HB ' ' HG3' ' A' ' 39' ' ' ARG . 27.5 t -136.29 -71.4 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 119.212 -0.423 . . . . 0.0 111.701 178.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.479 ' HB3' ' O ' ' A' ' 19' ' ' VAL . 37.7 t 79.72 -172.6 0.05 Allowed 'General case' 0 C--N 1.345 0.412 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 171.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 -65.6 -42.95 91.06 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.716 0.293 . . . . 0.0 110.977 -173.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.533 ' HG3' ' H ' ' A' ' 23' ' ' GLU . 2.2 pt20 -61.01 -59.96 4.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.58 -0.737 . . . . 0.0 112.002 -176.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.609 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 64.8 mm-40 -66.61 -45.28 79.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.818 -175.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.485 ' O ' ' HB2' ' A' ' 28' ' ' LEU . . . -54.72 -36.75 65.07 Favored 'General case' 0 C--O 1.222 -0.371 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.187 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.577 ' HA ' HG21 ' A' ' 58' ' ' VAL . 6.1 tp-100 -73.4 -51.96 15.45 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.994 178.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 6.2 t -63.24 -26.68 68.9 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -171.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.609 ' HG2' ' O ' ' A' ' 23' ' ' GLU . 18.1 ptp180 -101.58 -9.46 20.96 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.565 -178.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.687 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 87.6 mt -119.61 17.2 12.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.75 -0.205 . . . . 0.0 111.542 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -71.56 74.15 0.78 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.377 0.608 . . . . 0.0 110.314 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.23 -69.43 1.34 Allowed Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.122 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 34.12 -93.24 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.947 1.299 . . . . 0.0 113.561 -175.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 33.2 ttp-105 -115.46 -11.78 11.78 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -172.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 33.6 m170 67.65 157.65 0.13 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.296 0.638 . . . . 0.0 111.948 -178.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.48 3.21 82.38 Favored Glycine 0 C--N 1.334 0.451 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 177.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.508 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 44.2 mtp -90.13 136.6 32.95 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.959 -0.62 . . . . 0.0 109.918 -176.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.468 ' CB ' HG22 ' A' ' 52' ' ' VAL . 34.2 p90 -138.78 165.06 27.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.55 0.214 . . . . 0.0 110.657 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.583 ' O ' ' HA ' ' A' ' 50' ' ' LEU . 4.6 pp -158.3 140.61 14.25 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.835 174.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.562 HG21 HD11 ' A' ' 50' ' ' LEU . 80.2 t -110.17 120.66 61.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 174.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 1.051 ' HG3' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -138.01 175.93 9.15 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.683 -176.61 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.455 ' O ' ' HG2' ' A' ' 39' ' ' ARG . 2.1 m-20 -66.82 137.71 56.81 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.997 0.427 . . . . 0.0 110.337 176.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.491 ' HB3' ' O ' ' A' ' 44' ' ' CYS . 22.8 t -76.92 147.95 36.67 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.495 -179.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.8 p -87.03 -29.43 21.96 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.034 -178.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.5 p -82.54 -42.27 18.57 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.035 0.445 . . . . 0.0 110.955 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.491 ' O ' ' HB3' ' A' ' 41' ' ' SER . 56.1 m -127.15 112.25 21.6 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.209 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.93 14.86 0.63 Allowed 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.792 2.328 . . . . 0.0 112.918 -178.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -117.06 -5.72 14.75 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.627 -0.589 . . . . 0.0 111.627 175.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -119.61 175.26 5.94 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -177.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -127.49 179.67 5.37 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 122.176 0.19 . . . . 0.0 110.491 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 62' ' ' ILE . 54.2 t -148.91 96.82 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-O 120.743 0.306 . . . . 0.0 111.319 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.583 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 50.6 tp -70.8 101.01 2.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.481 171.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.4 m -97.21 130.01 44.49 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.439 177.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.607 HG23 HD12 ' A' ' 93' ' ' LEU . 69.9 t -119.86 140.97 42.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.205 -177.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.687 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 42.1 t -102.82 107.8 18.78 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.687 -177.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.578 ' HG3' ' CG2' ' A' ' 96' ' ' THR . 0.0 OUTLIER -158.39 157.28 32.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.769 -0.196 . . . . 0.0 110.756 171.31 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 59.41 18.6 6.97 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 123.557 0.536 . . . . 0.0 110.424 -173.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.0 m 68.47 21.85 8.02 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.949 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -125.65 151.67 46.22 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 174.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.577 HG21 ' HA ' ' A' ' 25' ' ' GLN . 44.9 t -97.33 91.55 2.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.931 0.396 . . . . 0.0 110.521 178.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.9 t -68.46 118.12 11.11 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -98.62 106.75 19.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.312 -174.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.673 ' HH ' ' HB3' ' A' ' 93' ' ' LEU . 53.9 m-85 -101.97 92.05 4.62 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.581 178.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.572 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 38.5 mt -72.15 130.52 35.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -177.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.636 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 4.9 mp -106.98 119.46 56.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.204 178.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -97.96 134.6 40.86 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -177.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.5 t -84.3 110.85 18.89 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.156 0.503 . . . . 0.0 110.066 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.69 HD11 ' HG3' ' A' ' 70' ' ' ARG . 67.9 mt -83.32 144.65 46.98 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.422 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.34 -19.01 20.48 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.106 2.538 . . . . 0.0 113.095 -178.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 56.0 m-20 -84.83 14.76 4.45 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.632 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.632 ' HA ' ' HE ' ' A' ' 69' ' ' ARG . 3.3 tpm_? 66.29 26.71 10.3 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.299 0.64 . . . . 0.0 111.154 176.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.69 ' HG3' HD11 ' A' ' 66' ' ' LEU . 6.7 ptm180 -119.47 164.49 15.69 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 176.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.636 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 74.1 m-85 -123.05 120.11 32.35 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.821 0.343 . . . . 0.0 111.853 -171.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.462 ' HZ2' ' HB3' ' A' ' 77' ' ' GLU . 20.7 ttmm -102.21 110.29 22.2 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 175.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.607 HD13 HD11 ' A' ' 84' ' ' LEU . 2.4 tt -87.05 83.58 2.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.614 0.721 . . . . 0.0 111.406 -175.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.25 -53.25 2.25 Favored Glycine 0 C--N 1.336 0.567 0 CA-C-N 114.66 -1.155 . . . . 0.0 113.342 174.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.705 ' OD2' ' HA2' ' A' ' 168' ' ' GLY . 11.6 t70 -135.57 -55.26 0.79 Allowed 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.081 0.467 . . . . 0.0 109.931 -174.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.5 124.74 28.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.896 -177.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.462 ' HB3' ' HZ2' ' A' ' 72' ' ' LYS . 10.0 pt-20 -99.08 129.94 45.38 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.185 0.517 . . . . 0.0 110.984 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.515 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 93.9 m-85 -124.92 -169.1 1.92 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.893 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -112.11 -19.93 12.11 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -177.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.801 ' HD1' ' HG2' ' A' ' 82' ' ' PRO . 6.7 p80 -149.11 165.41 31.83 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 122.376 -0.203 . . . . 0.0 110.533 172.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.494 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 4.4 mt -61.34 -52.19 72.41 Favored Pre-proline 0 N--CA 1.467 0.383 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.466 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.801 ' HG2' ' HD1' ' A' ' 80' ' ' HIS . 12.9 Cg_endo -60.31 -5.87 4.63 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 121.982 1.788 . . . . 0.0 113.18 176.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.484 ' HB1' ' CE1' ' A' ' 80' ' ' HIS . . . -85.77 -30.47 23.02 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.118 0.485 . . . . 0.0 110.172 -175.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.607 HD11 HD13 ' A' ' 73' ' ' ILE . 3.4 pp -82.58 -32.93 28.24 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 174.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.0 mt -66.37 -37.15 84.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.676 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.401 ' HG2' ' HA ' ' A' ' 83' ' ' ALA . 13.8 pt-20 -78.65 -19.77 51.83 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.947 178.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.519 ' O ' HG12 ' A' ' 90' ' ' ILE . 73.7 t80 -81.76 -33.97 30.66 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.253 0.549 . . . . 0.0 110.06 -178.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.484 ' CG ' HD22 ' A' ' 93' ' ' LEU . 33.9 m-85 -79.18 5.07 13.02 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.713 -178.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.74 ' HE3' HG23 ' A' ' 90' ' ' ILE . 0.1 OUTLIER -68.01 -34.03 75.72 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 168.873 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.74 HG23 ' HE3' ' A' ' 89' ' ' LYS . 11.0 pt -85.77 -30.91 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 174.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 8.1 m170 -93.35 125.58 38.03 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.074 0.464 . . . . 0.0 111.168 -176.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.486 ' CD2' HG22 ' A' ' 97' ' ' THR . 59.0 m-85 -86.71 82.1 7.98 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.615 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.673 ' HB3' ' HH ' ' A' ' 61' ' ' TYR . 24.0 mt -31.79 -52.24 0.24 Allowed 'General case' 0 N--CA 1.473 0.694 0 O-C-N 125.199 1.562 . . . . 0.0 113.962 -172.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.463 ' OD1' ' HB3' ' A' ' 54' ' ' GLU . 7.3 t70 -118.53 -34.05 4.13 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.49 0.662 . . . . 0.0 109.769 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.404 ' HB ' ' O ' ' A' ' 94' ' ' ASP . 5.8 t 176.99 -20.41 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.245 176.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.578 ' CG2' ' HG3' ' A' ' 54' ' ' GLU . 3.6 t -113.97 171.76 7.4 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.407 170.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.486 HG22 ' CD2' ' A' ' 92' ' ' TYR . 69.9 p -99.58 -177.26 3.52 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.546 ' HG ' HD11 ' A' ' 93' ' ' LEU . 89.5 mt -70.52 105.37 3.07 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.511 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 45.8 mm -99.7 -53.71 7.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.701 -174.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.508 ' O ' ' HA ' ' A' ' 35' ' ' MET . 7.4 pt-20 -149.37 157.25 39.42 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 120.819 0.342 . . . . 0.0 111.46 -174.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.52 163.33 29.69 Favored 'Trans proline' 0 C--O 1.233 0.275 0 C-N-CA 122.495 2.13 . . . . 0.0 112.504 176.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.528 ' HB1' HD21 ' A' ' 28' ' ' LEU . . . -90.01 161.36 38.33 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.776 177.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -68.46 159.71 52.28 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.444 2.096 . . . . 0.0 111.912 174.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.8 ' HB3' ' SD ' ' A' ' 16' ' ' MET . 13.8 ptm180 . . . . . 0 C--N 1.325 -0.467 0 CA-C-O 121.081 0.467 . . . . 0.0 111.715 -177.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.576 HD12 HG21 ' A' ' 152' ' ' ILE . 4.1 mm? . . . . . 0 N--CA 1.473 0.678 0 CA-C-O 121.045 0.45 . . . . 0.0 112.205 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.472 ' HG3' ' CD1' ' A' ' 127' ' ' TYR . 9.9 tp10 -170.72 -72.97 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.546 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . 0.473 ' CE2' HG23 ' A' ' 151' ' ' VAL . 38.4 m-85 -112.97 131.99 55.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.231 0.539 . . . . 0.0 111.123 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.56 ' CG1' ' HB ' ' A' ' 178' ' ' VAL . 8.3 t -131.59 158.26 43.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.361 -176.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -138.77 133.43 32.13 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 170.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.52 HG23 HG12 ' A' ' 178' ' ' VAL . 35.8 p -86.97 141.46 28.68 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.231 -173.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.681 HD11 ' CG ' ' A' ' 179' ' ' GLU . 10.9 mt -111.27 -30.93 7.24 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -174.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.507 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 55.5 t80 -90.09 -27.38 19.7 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -168.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.507 ' HB3' ' O ' ' A' ' 132' ' ' TYR . 19.5 t70 73.83 130.88 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 O-C-N 123.564 0.54 . . . . 0.0 111.06 -172.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 76.4 t80 -161.86 99.48 1.19 Allowed Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.97 -177.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -82.36 81.46 2.49 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.916 2.411 . . . . 0.0 112.731 178.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.56 -17.12 74.44 Favored Glycine 0 C--O 1.227 -0.319 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 172.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 40.53 35.54 0.31 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.944 1.298 . . . . 0.0 113.945 178.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.486 ' HB2' ' HB2' ' A' ' 141' ' ' ASP . 1.6 m-20 -121.12 -173.42 2.61 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 121.981 -0.449 . . . . 0.0 111.5 -178.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -105.13 -6.64 19.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.245 0.545 . . . . 0.0 110.637 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -122.17 -1.26 9.27 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.692 174.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.486 ' HB2' ' HB2' ' A' ' 138' ' ' ASP . 5.4 m-20 -132.32 108.4 9.18 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 174.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.637 ' HB3' ' CG2' ' A' ' 173' ' ' ILE . 60.5 tp -74.59 119.79 78.35 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 121.215 0.531 . . . . 0.0 111.868 -170.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.534 ' HD2' ' HD2' ' A' ' 169' ' ' ARG . 55.8 Cg_endo -72.8 102.66 1.46 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.579 2.186 . . . . 0.0 111.57 171.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.433 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 12.6 p90 -117.49 163.94 15.64 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.786 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.472 ' HB3' ' H ' ' A' ' 146' ' ' LYS . 12.4 mmtm -108.65 -159.48 0.69 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.001 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.472 ' H ' ' HB3' ' A' ' 145' ' ' LYS . 0.0 OUTLIER -101.46 6.53 42.47 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.986 -0.285 . . . . 0.0 111.768 -173.885 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -155.34 24.28 0.59 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.055 -1.069 . . . . 0.0 112.704 178.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.13 159.47 14.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.636 0.255 . . . . 0.0 110.562 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.403 ' HA ' HD11 ' A' ' 149' ' ' ILE . 15.5 mm -101.56 135.88 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -174.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.683 ' HB3' ' HB1' ' A' ' 163' ' ' ALA . 10.4 mt -122.11 175.9 6.11 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 46.6 t -145.5 123.0 4.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.822 HD13 ' HB3' ' A' ' 163' ' ' ALA . 23.9 mm -79.16 78.75 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-O 122.483 1.135 . . . . 0.0 108.657 -176.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.649 HG22 ' HG3' ' A' ' 154' ' ' GLU . 11.5 tt -69.2 -46.21 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 CA-C-N 113.176 -1.829 . . . . 0.0 109.359 -178.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 1.002 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 40.5 mt-10 -115.27 140.05 49.44 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -127.66 82.12 68.91 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 167.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.56 ' HG2' ' HE1' ' A' ' 172' ' ' MET . 3.3 Cg_exo -77.32 -50.76 0.09 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.327 2.685 . . . . 0.0 111.242 176.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -108.4 170.33 8.09 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.402 -176.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -88.3 -41.39 12.92 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.742 -176.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -83.18 -24.37 32.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.909 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 57.2 m95 -123.72 119.65 30.4 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.244 -176.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . 0.772 ' HB3' HG22 ' A' ' 152' ' ' ILE . 44.8 m0 -106.24 138.29 42.69 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.732 176.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 1.002 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 13.8 m -85.83 101.01 12.46 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 177.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.822 ' HB3' HD13 ' A' ' 152' ' ' ILE . . . -106.23 157.01 17.89 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.909 -179.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.7 ' HB3' HG22 ' A' ' 170' ' ' VAL . 25.0 ptt-85 -107.67 128.98 55.04 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 175.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.485 ' HA ' HD22 ' A' ' 150' ' ' LEU . 58.5 t30 -69.15 151.91 45.78 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 175.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 29.0 ttpp -65.06 -12.0 45.74 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.683 -176.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.433 ' HB3' ' NH2' ' A' ' 169' ' ' ARG . 19.4 t70 -86.41 -26.43 24.75 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -177.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.705 ' HA2' ' OD2' ' A' ' 75' ' ' ASP . . . 123.54 67.42 0.21 Allowed Glycine 0 CA--C 1.528 0.845 0 C-N-CA 118.587 -1.768 . . . . 0.0 115.684 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.534 ' HD2' ' HD2' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -178.66 148.64 0.44 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.656 0.383 . . . . 0.0 110.178 161.568 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.7 HG22 ' HB3' ' A' ' 164' ' ' ARG . 61.2 t -101.06 142.87 15.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.316 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -167.05 157.01 29.26 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.56 ' HE1' ' HG2' ' A' ' 156' ' ' PRO . 31.7 mtp -74.21 136.49 42.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.973 0.386 . . . . 0.0 110.135 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.637 ' CG2' ' HB3' ' A' ' 142' ' ' LEU . 2.7 pp -134.17 150.19 73.47 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.631 -177.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -76.97 127.86 9.61 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 123.0 2.467 . . . . 0.0 112.33 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.62 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 26.2 t -64.11 -42.16 66.79 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.62 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 9.6 Cg_endo -53.27 -13.6 3.44 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.968 2.445 . . . . 0.0 113.962 171.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -96.58 -14.69 22.04 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 111.607 0.225 . . . . 0.0 111.607 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.56 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 5.9 m -125.6 161.55 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 121.992 0.901 . . . . 0.0 113.112 -169.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.681 ' CG ' HD11 ' A' ' 131' ' ' LEU . 3.5 mm-40 -124.45 160.36 28.42 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.156 177.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -98.34 137.18 37.43 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -176.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 10.2 tp . . . . . 0 C--N 1.324 -0.501 0 CA-C-O 121.094 0.473 . . . . 0.0 109.921 -179.451 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo . . . . . 0 N--CA 1.466 -0.144 0 CA-C-O 121.224 0.427 . . . . 0.0 111.691 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.495 ' HB ' HG13 ' A' ' 266' ' ' VAL . 41.4 t -115.49 136.88 50.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.992 -176.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -104.68 117.04 33.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.96 178.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -120.2 125.12 47.38 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.739 -178.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -85.26 124.15 31.57 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . 0.464 ' HA ' HG11 ' A' ' 291' ' ' VAL . . . -69.53 112.38 6.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.841 0.353 . . . . 0.0 110.385 -178.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.4 HD11 HG21 ' A' ' 243' ' ' ILE . 33.7 pt -84.46 -16.94 10.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.507 -177.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.528 ' HA ' HG21 ' A' ' 260' ' ' VAL . 16.4 pt20 -150.35 153.68 36.48 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.099 173.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.454 ' C ' ' HD2' ' A' ' 245' ' ' LYS . 0.1 OUTLIER -75.75 169.79 17.45 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.449 0.642 . . . . 0.0 112.112 -171.708 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 38.6 ttt85 -170.28 115.94 0.51 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.409 172.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.527 HG21 ' HD2' ' A' ' 248' ' ' PRO . 8.7 p -122.11 141.02 33.4 Favored Pre-proline 0 C--N 1.316 -0.875 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.527 ' HD2' HG21 ' A' ' 247' ' ' VAL . 81.0 Cg_exo -45.49 111.36 0.31 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.846 2.364 . . . . 0.0 112.873 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' CYS . . . . . 0.427 ' H ' ' HB2' ' A' ' 252' ' ' ASP . 31.7 t -90.16 -173.03 3.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.717 178.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -62.69 -27.92 69.58 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.982 0.42 . . . . 0.0 111.938 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -101.02 1.14 39.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.327 -177.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . 0.511 ' HB3' ' HB3' ' A' ' 255' ' ' ALA . 27.2 m-20 -97.7 97.19 8.81 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -173.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . 0.469 ' HE2' ' HB1' ' A' ' 4' ' ' ALA . 45.6 tptt -91.25 139.44 30.74 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 171.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 26.2 p 65.96 14.92 9.85 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.035 0.934 . . . . 0.0 112.27 178.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . 0.511 ' HB3' ' HB3' ' A' ' 252' ' ' ASP . . . -79.11 151.88 31.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.655 0.264 . . . . 0.0 110.974 -178.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.584 HD21 ' HB ' ' A' ' 279' ' ' VAL . 2.5 tt -102.91 142.99 33.09 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -87.43 101.75 13.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.147 0.499 . . . . 0.0 110.451 178.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.914 HD22 HG22 ' A' ' 279' ' ' VAL . 84.0 mt -116.38 142.75 46.44 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.557 -177.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -124.13 162.57 23.3 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.109 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . 0.528 HG21 ' HA ' ' A' ' 244' ' ' GLN . 43.6 t -66.59 125.46 23.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.38 -174.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 105.53 -11.92 46.88 Favored Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.074 176.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -84.8 175.44 9.15 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.932 0.366 . . . . 0.0 110.204 -174.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 48.4 mm -115.57 117.46 55.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.352 0.596 . . . . 0.0 110.982 -176.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.509 HG13 ' CZ ' ' A' ' 286' ' ' PHE . 2.9 t -97.05 103.06 14.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.713 178.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -85.94 90.4 8.07 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.259 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.552 ' HA ' ' HA2' ' A' ' 277' ' ' GLY . 1.8 p -86.82 137.51 20.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.158 0.504 . . . . 0.0 110.582 -175.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 20.5 p -109.67 -35.73 6.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.527 -173.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 268' ' ' ARG . 1.0 OUTLIER -131.73 126.24 34.0 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.139 0.495 . . . . 0.0 109.683 179.407 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 57.9 mtt -106.3 116.64 32.28 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.935 0.398 . . . . 0.0 111.162 -178.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.529 ' HB2' ' O ' ' A' ' 274' ' ' GLN . 85.6 m-20 -78.68 121.46 24.72 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 175.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 47.2 mm -57.79 -24.96 24.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.173 -174.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -61.77 -32.28 72.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.411 -178.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 146.41 -44.45 0.84 Allowed Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.172 -1.013 . . . . 0.0 113.342 177.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.529 ' O ' ' HB2' ' A' ' 270' ' ' ASN . 0.1 OUTLIER -86.29 120.05 27.23 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.067 0.46 . . . . 0.0 110.608 -178.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.416 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 41.7 m0 -94.48 160.83 14.47 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.597 -177.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . 0.481 ' HB3' ' HD2' ' A' ' 283' ' ' LYS . 39.3 mt-10 -106.59 105.84 16.07 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 173.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -108.5 146.7 16.52 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.608 -178.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -102.03 108.54 20.01 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . 0.914 HG22 HD22 ' A' ' 258' ' ' LEU . 97.1 t -119.4 117.58 54.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.694 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . 0.452 ' N ' HD21 ' A' ' 280' ' ' ASN . 0.9 OUTLIER 62.86 30.82 16.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.549 -179.387 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 83.38 6.27 87.86 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.772 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -117.52 126.28 52.32 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.667 0.27 . . . . 0.0 110.759 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 27.2 ttpp -102.97 133.62 47.78 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.124 0.488 . . . . 0.0 111.035 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -153.98 171.02 32.63 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.625 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.416 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 64.0 mt -83.88 131.33 34.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.977 0.417 . . . . 0.0 111.027 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.509 ' CZ ' HG13 ' A' ' 264' ' ' VAL . 23.9 p90 -142.34 144.37 30.79 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.777 175.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -83.7 138.77 8.46 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.911 2.407 . . . . 0.0 111.661 176.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -65.54 -8.39 19.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.592 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 17.2 p -75.85 -9.34 58.52 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.52 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -104.97 -6.25 20.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.799 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.464 HG11 ' HA ' ' A' ' 242' ' ' ALA . 22.4 m -128.34 172.25 15.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.125 0.488 . . . . 0.0 111.173 -177.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -137.47 131.42 31.86 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.032 171.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.402 HD11 ' CG1' ' A' ' 238' ' ' VAL . 47.5 mm -73.39 134.47 29.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.731 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -138.03 151.68 48.11 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 174.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . 0.777 ' HB3' ' HD3' ' A' ' 296' ' ' PRO . 12.2 t70 -93.1 -58.48 0.22 Allowed Pre-proline 0 C--N 1.323 -0.586 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.026 -178.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . 0.777 ' HD3' ' HB3' ' A' ' 295' ' ' ASP . 9.6 Cg_endo . . . . . 0 C--N 1.357 0.983 0 C-N-CA 122.615 2.21 . . . . 0.0 112.779 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.412 ' O ' HG23 ' A' ' 99' ' ' ILE . 20.4 m . . . . . 0 CA--C 1.529 0.158 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.15 102.66 3.09 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 177.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 25.6 mtm105 -122.35 3.35 9.73 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -175.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.425 ' HB3' ' HA ' ' A' ' 100' ' ' GLU . 17.0 p90 -83.13 150.42 26.27 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.917 -178.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -52.61 -43.85 65.65 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.479 -176.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.6 t 58.33 47.59 13.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.048 -172.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.7 t -171.97 -36.36 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.617 178.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -70.73 107.19 3.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.472 -175.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -60.43 -37.35 80.63 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.506 -175.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.5 t -72.87 -6.52 45.59 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.463 -177.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.86 -37.39 12.31 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -178.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 38.2 p-90 -122.58 -24.85 4.84 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -174.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -79.41 118.05 20.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.166 0.508 . . . . 0.0 110.687 -176.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.561 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 22.0 mmt -99.42 -10.08 22.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.894 -176.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.476 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.22 -113.47 2.27 Favored Glycine 0 CA--C 1.519 0.327 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.282 -178.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.476 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 19.4 Cg_exo -66.62 87.13 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.271 2.648 . . . . 0.0 113.161 -176.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.975 HG13 ' H ' ' A' ' 20' ' ' SER . 93.3 t -136.84 -166.58 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 178.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.975 ' H ' HG13 ' A' ' 19' ' ' VAL . 42.1 p -162.25 169.73 20.2 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 119.768 1.167 . . . . 0.0 108.122 -168.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 34.8 ttt85 -67.16 -39.37 86.5 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.739 -175.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -65.0 -53.83 39.96 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.88 0.372 . . . . 0.0 110.995 178.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -62.57 -47.22 84.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.356 -177.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.535 ' HB1' ' O ' ' A' ' 20' ' ' SER . . . -56.14 -38.58 71.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.117 0.484 . . . . 0.0 110.706 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -62.24 -57.74 10.33 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.655 178.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.8 t -65.73 -15.23 62.62 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -173.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.6 mtp180 -87.33 -13.52 43.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.589 0.233 . . . . 0.0 110.951 179.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.548 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 32.6 mt -130.43 -1.88 4.4 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 30.6 tp60 -73.91 96.0 2.55 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.216 0.531 . . . . 0.0 111.109 -174.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.13 14.09 69.97 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.146 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -81.58 -169.03 2.11 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 122.281 0.233 . . . . 0.0 110.752 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.607 ' HB2' ' SD ' ' A' ' 35' ' ' MET . 51.3 mtm180 -60.99 127.03 29.54 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 177.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.506 ' CE1' ' HA ' ' A' ' 55' ' ' ASN . 41.0 m170 -77.49 116.97 18.5 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.862 -176.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 129.33 -17.92 5.55 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -172.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.748 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 50.0 mtp -72.88 160.15 32.59 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 115.432 -0.384 . . . . 0.0 110.335 176.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -163.98 169.23 18.29 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 178.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.561 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.6 pp -157.0 140.89 16.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.163 0.506 . . . . 0.0 111.183 175.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 50.8 t -108.92 123.0 64.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.261 175.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.424 ' HB2' ' HB ' ' A' ' 19' ' ' VAL . 33.3 ptt-85 -123.04 -177.83 3.79 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.013 -177.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -80.34 138.99 36.78 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 175.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.1 m -77.4 99.06 5.46 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 172.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.9 m -73.93 -9.62 58.83 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.247 178.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.3 p -83.53 -56.69 3.6 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.101 175.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 57.7 m -114.84 96.33 44.17 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.88 176.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.82 132.72 51.0 Favored 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 123.006 2.471 . . . . 0.0 112.618 -178.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.64 -27.14 17.55 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.389 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.58 ' OD1' ' HA ' ' A' ' 64' ' ' ASN . 33.1 m-20 -93.45 178.24 5.77 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -131.42 171.41 13.41 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 178.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.6 t -139.41 112.24 5.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.97 0.414 . . . . 0.0 110.999 175.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.0 tp -82.05 103.44 11.69 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.741 174.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 37.5 m -96.18 127.66 42.39 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 174.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 98.3 t -111.18 139.89 33.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.02 0.438 . . . . 0.0 111.038 -174.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.548 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 28.3 t -87.95 116.12 25.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.282 179.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.498 ' O ' ' N ' ' A' ' 56' ' ' SER . 75.8 mt-10 -144.46 178.4 7.97 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-O 118.379 -0.819 . . . . 0.0 108.832 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.615 ' C ' ' HB2' ' A' ' 57' ' ' ARG . 11.2 m-80 -24.11 65.46 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 126.934 2.094 . . . . 0.0 115.833 -176.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 54' ' ' GLU . 21.0 m 48.59 57.35 6.39 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -171.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.731 HH22 ' HA ' ' A' ' 154' ' ' GLU . 0.3 OUTLIER -162.05 58.24 0.25 Allowed 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.322 -1.308 . . . . 0.0 112.18 -145.641 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 11.2 t -74.5 97.91 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 122.058 0.933 . . . . 0.0 109.394 -172.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.561 ' HB2' ' CE2' ' A' ' 61' ' ' TYR . 0.1 OUTLIER -79.07 121.02 24.45 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 113.907 -1.497 . . . . 0.0 111.287 -175.456 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -98.05 108.34 21.02 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -173.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.561 ' CE2' ' HB2' ' A' ' 59' ' ' SER . 79.3 m-85 -110.18 107.42 17.22 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.04 178.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.587 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 53.3 mt -80.49 137.35 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -175.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.577 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 5.4 mp -116.47 117.69 56.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.728 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.58 ' HA ' ' OD1' ' A' ' 47' ' ' ASP . 13.7 m120 -87.3 139.73 30.26 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.863 -177.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.8 t -86.76 98.51 11.2 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 173.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.983 HD12 ' HG3' ' A' ' 72' ' ' LYS . 91.6 mt -80.78 146.66 60.55 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.346 -175.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 66' ' ' LEU . 11.9 Cg_exo -71.05 -2.19 10.69 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.743 2.295 . . . . 0.0 110.235 170.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -81.92 5.07 20.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.151 177.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.675 ' HA ' ' HE ' ' A' ' 69' ' ' ARG . 3.2 tpm_? 62.98 29.0 16.47 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.306 -173.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.448 ' HG2' ' HA ' ' A' ' 79' ' ' ASP . 88.7 mtt180 -128.63 179.17 5.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.402 -177.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.577 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 31.4 m-85 -134.92 119.76 18.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.19 -178.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.983 ' HG3' HD12 ' A' ' 66' ' ' LEU . 38.8 mttm -96.31 101.11 12.7 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -175.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.587 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 10.0 tt -83.37 99.11 5.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.405 0.622 . . . . 0.0 109.476 173.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.8 44.31 97.65 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.428 -174.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.442 ' HA ' ' HD3' ' A' ' 72' ' ' LYS . 25.4 t70 75.61 -25.07 0.21 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.172 0.589 . . . . 0.0 111.915 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.69 107.79 4.1 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 174.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.484 ' HB3' ' CG ' ' A' ' 72' ' ' LYS . 12.7 pt-20 -96.23 137.87 34.66 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.887 0.851 . . . . 0.0 112.404 -171.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.585 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 96.6 m-85 -122.33 162.65 21.14 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 114.159 -1.382 . . . . 0.0 107.97 174.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.448 ' HA ' ' HG2' ' A' ' 70' ' ' ARG . 3.2 p-10 -69.55 -15.36 63.21 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -172.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.441 ' CE1' ' HB3' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -172.29 171.57 4.75 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.459 174.036 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.522 HD21 HD22 ' A' ' 84' ' ' LEU . 9.7 mt -53.32 -54.22 47.52 Favored Pre-proline 0 N--CA 1.469 0.511 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 81' ' ' LEU . 27.6 Cg_endo -63.21 3.56 0.56 Allowed 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.436 2.09 . . . . 0.0 114.176 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.441 ' HB3' ' CE1' ' A' ' 80' ' ' HIS . . . -98.46 -31.49 11.97 Favored 'General case' 0 C--N 1.331 -0.211 0 O-C-N 122.292 -0.255 . . . . 0.0 110.53 178.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.585 ' HB3' ' CD2' ' A' ' 78' ' ' PHE . 4.0 pp -76.42 -35.7 58.4 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 51.0 mt -68.54 -20.03 64.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.893 176.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.445 ' CD ' ' HZ2' ' A' ' 89' ' ' LYS . 13.2 tp10 -86.53 -28.41 23.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.619 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.755 ' O ' HD11 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -88.41 -19.52 26.46 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.238 0.542 . . . . 0.0 111.167 -177.341 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.757 ' CD1' HD22 ' A' ' 93' ' ' LEU . 45.1 m-85 -87.33 2.33 50.6 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 121.19 -0.944 . . . . 0.0 110.659 177.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.445 ' HZ2' ' CD ' ' A' ' 86' ' ' GLU . 99.1 mttt -74.97 -18.32 60.4 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.021 174.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.755 HD11 ' O ' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -127.02 -3.83 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 CA-C-O 121.174 0.512 . . . . 0.0 110.194 -179.306 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -88.92 -32.76 17.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.848 -173.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.51 ' CD2' HG22 ' A' ' 97' ' ' THR . 95.5 m-85 61.86 106.25 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 O-C-N 124.119 0.887 . . . . 0.0 110.108 -171.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.757 HD22 ' CD1' ' A' ' 88' ' ' TYR . 13.0 mt -66.49 -85.51 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 174.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.418 ' OD1' ' ND2' ' A' ' 55' ' ' ASN . 14.5 t70 -79.9 -130.76 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 172.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.1 t -87.27 12.25 12.29 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.211 0.529 . . . . 0.0 110.164 177.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.9 t -143.03 160.34 40.55 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.585 -178.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.51 HG22 ' CD2' ' A' ' 92' ' ' TYR . 6.6 p -100.27 -179.7 4.2 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.119 175.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.7 mt -75.41 106.89 7.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.187 0.517 . . . . 0.0 109.779 175.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.412 HG23 ' O ' ' A' ' 3' ' ' SER . 46.4 mm -90.23 -65.21 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.503 -175.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.748 ' O ' ' HA ' ' A' ' 35' ' ' MET . 10.9 pt-20 -159.18 140.81 9.7 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.206 178.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.49 170.2 11.4 Favored 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.831 2.354 . . . . 0.0 112.984 -175.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.454 ' C ' ' H ' ' A' ' 104' ' ' ARG . . . -68.71 126.5 92.81 Favored Pre-proline 0 N--CA 1.447 -0.597 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 170.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -69.15 28.86 0.16 Allowed 'Trans proline' 0 N--CA 1.478 0.571 0 C-N-CA 123.461 2.774 . . . . 0.0 114.135 -169.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.454 ' H ' ' C ' ' A' ' 102' ' ' ALA . 41.0 ttm180 . . . . . 0 N--CA 1.464 0.255 0 C-N-CA 123.644 0.777 . . . . 0.0 111.056 -177.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.629 ' CD1' HG22 ' A' ' 152' ' ' ILE . 3.1 mm? . . . . . 0 CA--C 1.516 -0.347 0 CA-C-O 121.665 0.745 . . . . 0.0 109.493 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.522 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 39.9 tt0 -173.69 -60.07 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.303 -172.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -118.76 106.79 12.9 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 121.691 0.758 . . . . 0.0 110.524 177.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.565 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 20.9 t -115.68 134.97 57.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 114.375 -1.284 . . . . 0.0 108.771 -178.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.662 ' HG3' ' CG ' ' A' ' 179' ' ' GLU . 5.7 ptp180 -110.48 136.12 50.12 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 116.463 -2.095 . . . . 0.0 109.773 167.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.526 ' C ' HD21 ' A' ' 131' ' ' LEU . 0.7 OUTLIER -93.57 142.21 27.6 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.711 -175.655 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.662 HD21 ' N ' ' A' ' 131' ' ' LEU . 2.0 mm? -115.04 -26.99 7.5 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.342 -165.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.504 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 37.1 t80 -89.36 -30.79 18.14 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.86 -172.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.589 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 8.8 t70 71.63 98.69 0.07 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.391 0.615 . . . . 0.0 109.545 -174.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.423 ' O ' ' HA ' ' A' ' 143' ' ' PRO . 53.7 t80 -123.9 84.07 54.67 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 177.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.6 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 66.7 Cg_endo -82.29 61.29 7.67 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.281 1.988 . . . . 0.0 112.894 -177.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -62.38 -29.8 74.35 Favored Glycine 0 C--N 1.331 0.301 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.589 178.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.469 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 10.0 m-80 64.03 65.39 0.69 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 114.861 -0.669 . . . . 0.0 112.143 176.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -145.72 169.49 18.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.908 177.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -89.41 -6.64 56.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.765 0.793 . . . . 0.0 109.253 172.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 172' ' ' MET . 11.6 mp0 -104.23 -19.76 14.01 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.575 175.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -135.38 107.69 7.28 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.732 ' CD2' HD23 ' A' ' 150' ' ' LEU . 33.1 tp -70.96 127.32 91.83 Favored Pre-proline 0 C--N 1.325 -0.465 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.745 -176.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.6 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 95.9 Cg_endo -81.7 93.71 0.95 Allowed 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 122.014 1.809 . . . . 0.0 111.367 172.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.505 ' CD1' ' HB ' ' A' ' 130' ' ' THR . 10.0 p90 -105.76 159.74 15.76 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.385 -174.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.589 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 56.5 mtpt -102.68 -169.0 1.6 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -175.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.576 ' HD2' ' N ' ' A' ' 146' ' ' LYS . 9.2 mptt -74.54 -13.49 60.68 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.154 -167.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -164.67 25.77 0.18 Allowed Glycine 0 CA--C 1.503 -0.692 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.32 -178.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.518 ' HB3' ' HB2' ' A' ' 145' ' ' LYS . 0.1 OUTLIER -79.54 148.28 31.84 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.001 0.429 . . . . 0.0 111.024 -177.458 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.557 HD13 ' N ' ' A' ' 149' ' ' ILE . 1.8 mp -94.13 129.77 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.399 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.732 HD23 ' CD2' ' A' ' 142' ' ' LEU . 9.3 mt -121.47 156.95 31.67 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 -175.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.568 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 57.3 t -111.12 122.82 66.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 174.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.629 HG22 ' CD1' ' A' ' 125' ' ' LEU . 49.8 mm -76.78 79.91 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 122.344 1.069 . . . . 0.0 108.49 -177.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.487 HG22 ' HG3' ' A' ' 154' ' ' GLU . 18.1 tt -72.6 -25.89 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 113.551 -1.658 . . . . 0.0 110.113 -174.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.731 ' HA ' HH22 ' A' ' 57' ' ' ARG . 0.5 OUTLIER -140.88 153.36 45.68 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 173.85 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.559 ' HD2' HD11 ' A' ' 125' ' ' LEU . 79.3 tttt -140.85 91.98 8.94 Favored Pre-proline 0 C--N 1.32 -0.68 0 O-C-N 122.047 -0.408 . . . . 0.0 110.591 177.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.745 ' HG2' ' SD ' ' A' ' 172' ' ' MET . 2.8 Cg_endo -81.62 -39.85 0.17 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.573 2.182 . . . . 0.0 111.999 -174.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.414 ' HB2' ' HB2' ' A' ' 160' ' ' TRP . 46.2 mm-40 -114.66 161.86 17.55 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.38 -179.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -85.68 -7.87 58.54 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 173.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.993 ' HG3' ' HD1' ' A' ' 160' ' ' TRP . 21.0 pt20 -111.16 -17.69 13.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.728 178.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.993 ' HD1' ' HG3' ' A' ' 159' ' ' GLN . 47.5 m95 -131.78 131.55 43.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.397 178.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . 0.639 ' O ' HG13 ' A' ' 173' ' ' ILE . 48.5 m0 -119.53 140.56 50.32 Favored 'General case' 0 C--O 1.212 -0.911 0 C-N-CA 122.877 0.471 . . . . 0.0 110.643 -176.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.576 ' OG ' ' HG2' ' A' ' 172' ' ' MET . 30.4 m -100.2 97.59 8.38 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -176.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.521 ' HB2' ' HB3' ' A' ' 150' ' ' LEU . . . -108.66 146.44 33.42 Favored 'General case' 0 N--CA 1.416 -2.129 0 C-N-CA 119.951 -0.7 . . . . 0.0 109.154 -173.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.682 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 19.9 ptt-85 -87.48 122.67 31.5 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 175.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.72 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . 7.6 t30 -56.74 175.5 0.12 Allowed 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 113.572 -1.649 . . . . 0.0 110.282 -175.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -60.3 -13.48 13.06 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.322 0.582 . . . . 0.0 109.78 171.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -81.92 -26.43 34.07 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.005 174.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 100.69 -4.97 56.6 Favored Glycine 0 CA--C 1.521 0.421 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.112 -173.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.682 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.7 OUTLIER -69.05 134.31 49.24 Favored 'General case' 0 C--O 1.216 -0.71 0 C-N-CA 123.108 0.563 . . . . 0.0 110.903 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.471 HG22 HG21 ' A' ' 153' ' ' ILE . 39.3 t -86.75 128.07 39.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 O-C-N 122.049 -0.407 . . . . 0.0 110.969 178.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -154.08 154.72 25.7 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.122 170.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.745 ' SD ' ' HG2' ' A' ' 156' ' ' PRO . 29.5 mtp -81.11 141.05 34.66 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 117.284 0.542 . . . . 0.0 110.889 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.639 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.6 pp -141.4 143.14 29.01 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.558 -174.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.464 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 15.3 Cg_exo -67.7 135.91 37.31 Favored 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 122.739 2.293 . . . . 0.0 113.164 -178.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.533 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 98.1 t -64.54 -45.65 76.86 Favored Pre-proline 0 CA--C 1.539 0.519 0 N-CA-C 112.816 0.672 . . . . 0.0 112.816 178.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 36.1 Cg_endo -66.41 7.9 0.35 Allowed 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 122.022 1.815 . . . . 0.0 112.938 178.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.464 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.7 m-85 -101.05 -13.87 18.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.258 177.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.528 ' HA ' HD23 ' A' ' 131' ' ' LEU . 1.5 m -116.07 175.49 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 N-CA-C 115.956 1.836 . . . . 0.0 115.956 -166.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.727 ' O ' ' HG3' ' A' ' 179' ' ' GLU 0.273 2.0 pt-20 -149.09 57.69 1.02 Allowed 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 112.294 -2.23 . . . . 0.0 111.044 -165.699 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.596 ' HD3' ' H ' ' A' ' 180' ' ' LYS . 0.0 OUTLIER -69.36 141.7 54.13 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 118.748 -2.47 . . . . 0.0 111.768 -165.498 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 32.7 tp . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 112.161 -2.291 . . . . 0.0 112.362 -162.119 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo . . . . . 0 N--CA 1.454 -0.809 0 N-CA-C 109.604 -0.96 . . . . 0.0 109.604 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.436 ' HB ' ' CG1' ' A' ' 266' ' ' VAL . 2.8 t -65.66 139.67 20.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.729 -169.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -106.16 121.56 44.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.994 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . 0.505 ' HB3' HD13 ' A' ' 293' ' ' ILE . . . -119.26 136.57 54.16 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.36 179.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.408 ' HB2' ' CE1' ' A' ' 294' ' ' PHE . 2.8 tppp? -86.97 122.34 30.69 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 178.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . 0.513 ' HA ' HG11 ' A' ' 291' ' ' VAL . . . -72.43 97.02 1.99 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.154 0.502 . . . . 0.0 110.278 177.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 19.1 pt -85.59 -25.68 6.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.712 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.79 138.92 50.14 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.401 ' HE3' ' HB2' ' A' ' 245' ' ' LYS . 34.5 ttmt -67.61 155.81 38.28 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.2 -173.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 15.5 mmm180 -134.91 128.44 32.58 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.473 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.477 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 8.2 m -134.56 130.14 19.78 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.18 176.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.645 ' HD3' ' HB3' ' A' ' 257' ' ' ALA . 3.5 Cg_exo -75.5 145.51 29.87 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 123.059 2.506 . . . . 0.0 112.128 -176.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 51.1 t -75.12 169.98 16.95 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -61.68 -19.56 62.48 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -176.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -110.61 4.52 20.32 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -178.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . 0.429 ' HB3' ' HB3' ' A' ' 255' ' ' ALA . 61.7 m-20 -91.06 112.96 25.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.51 0.195 . . . . 0.0 111.054 -178.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . 0.435 ' N ' ' HD2' ' A' ' 253' ' ' LYS . 10.9 mptt -95.4 -41.3 9.06 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.272 0.558 . . . . 0.0 109.986 175.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 6.8 p -98.93 21.25 11.86 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.188 -174.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . 0.429 ' HB3' ' HB3' ' A' ' 252' ' ' ASP . . . -102.61 113.31 26.57 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 121.06 -0.256 . . . . 0.0 110.434 177.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.454 HD22 ' H ' ' A' ' 257' ' ' ALA . 0.5 OUTLIER -70.87 144.03 50.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.048 0.452 . . . . 0.0 110.965 -175.705 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.645 ' HB3' ' HD3' ' A' ' 248' ' ' PRO . . . -105.43 136.21 45.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.58 177.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 94.9 mt -135.88 152.16 50.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.799 -173.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -118.64 155.57 30.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.267 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 36.6 t -68.19 129.9 33.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.607 -174.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 83.32 33.92 21.64 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.316 178.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -119.28 162.67 18.34 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 39.2 mm -102.18 109.81 27.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.01 0.434 . . . . 0.0 110.78 -177.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 16.8 t -89.61 104.82 15.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.381 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . 0.413 ' HE2' ' HB3' ' A' ' 278' ' ' GLU . 4.4 ptmt -87.06 102.02 14.02 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.631 177.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.439 HG21 ' HB3' ' A' ' 275' ' ' TRP . 3.0 p -92.93 123.99 45.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.182 0.515 . . . . 0.0 110.723 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 16.1 p -94.98 -27.01 15.86 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.383 -177.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . 0.552 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 42.2 ttm180 -131.92 103.16 6.16 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.997 0.427 . . . . 0.0 110.394 178.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' MET . . . . . 0.467 ' HG3' ' CD1' ' A' ' 275' ' ' TRP . 29.6 ttm -93.97 109.87 21.58 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.992 0.425 . . . . 0.0 110.734 -179.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -87.78 173.93 8.68 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.502 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 31.3 pt -107.6 5.7 9.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.874 0.369 . . . . 0.0 111.523 -176.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -83.3 -26.28 30.78 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.124 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 119.18 -10.29 11.83 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.139 -177.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.531 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 27.1 mt-30 -118.06 111.97 19.6 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 177.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.58 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 19.2 m0 -96.74 159.55 14.86 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.117 -175.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . 0.552 ' HB2' ' HB3' ' A' ' 268' ' ' ARG . 48.0 mt-10 -100.81 111.68 23.95 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.255 175.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -129.15 158.58 22.08 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.533 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.413 ' HB3' ' HE2' ' A' ' 265' ' ' LYS . 39.6 tt0 -110.25 109.99 20.66 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.902 0.382 . . . . 0.0 110.155 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . 0.668 HG11 HD21 ' A' ' 280' ' ' ASN . 57.3 t -127.18 128.49 70.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.869 179.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . 0.668 HD21 HG11 ' A' ' 279' ' ' VAL . 46.2 m-80 63.03 25.59 15.07 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 123.442 0.464 . . . . 0.0 111.238 -177.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 75.52 19.49 79.25 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.059 -177.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -129.73 117.36 20.16 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 25.1 pttm -103.68 142.4 34.39 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.803 -178.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -173.18 178.37 45.18 Favored Glycine 0 N--CA 1.439 -1.12 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.707 178.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.58 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 94.8 mt -81.09 130.55 35.07 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.766 0.317 . . . . 0.0 110.314 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -129.2 125.24 22.61 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.424 175.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -58.36 126.42 21.38 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 123.183 2.589 . . . . 0.0 111.787 174.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -64.75 -12.66 49.73 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.305 -174.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.19 -3.77 11.75 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -176.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -114.91 -2.65 12.83 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.023 -0.423 . . . . 0.0 111.212 -178.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.513 HG11 ' HA ' ' A' ' 242' ' ' ALA . 35.8 m -128.7 166.51 25.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.737 -0.21 . . . . 0.0 110.606 179.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? -131.34 132.49 44.5 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.716 0.293 . . . . 0.0 110.26 172.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.505 HD13 ' HB3' ' A' ' 240' ' ' ALA . 40.8 mm -76.61 125.29 36.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.116 177.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' PHE . . . . . 0.408 ' CE1' ' HB2' ' A' ' 241' ' ' LYS . 5.3 p90 -149.67 166.64 28.72 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -103.7 104.81 44.49 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 178.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo . . . . . 0 N--CA 1.459 -0.501 0 C-N-CA 122.883 2.388 . . . . 0.0 112.368 -179.261 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.8 m . . . . . 0 C--O 1.233 0.219 0 CA-C-O 120.865 0.364 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.556 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . 69.39 100.86 0.06 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.161 -176.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 5' ' ' ARG . 3.4 ptp180 -125.87 81.33 1.98 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.433 0.635 . . . . 0.0 111.32 -177.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -147.98 157.56 43.59 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.74 177.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.419 ' C ' ' H ' ' A' ' 9' ' ' SER . 9.6 m-20 -85.88 9.51 16.55 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -171.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.0 m 65.54 -15.61 0.11 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 173.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.814 ' CA ' ' HE1' ' A' ' 14' ' ' TRP . 8.2 t -142.4 -71.02 0.33 Allowed 'General case' 0 C--O 1.246 0.919 0 CA-C-O 122.224 1.011 . . . . 0.0 110.82 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' A' ' 12' ' ' SER . 25.0 t0 -25.16 72.29 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 113.908 -1.497 . . . . 0.0 111.484 -148.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.6 ' H ' ' HD2' ' A' ' 11' ' ' ARG . 11.4 mmm180 -6.03 -53.37 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 126.437 2.335 . . . . 0.0 115.099 -159.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.5 ' N ' ' O ' ' A' ' 10' ' ' ASP . 6.0 t -65.49 12.84 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 121.548 -0.061 . . . . 0.0 110.912 176.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.502 ' H ' ' C ' ' A' ' 11' ' ' ARG . . . -91.0 -29.71 17.22 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.187 177.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.814 ' HE1' ' CA ' ' A' ' 9' ' ' SER . 24.5 p-90 -151.49 -28.03 0.19 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -173.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -59.4 123.79 17.91 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -178.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.481 ' SD ' ' HA ' ' A' ' 104' ' ' ARG . 33.1 tpp -110.1 2.66 19.62 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.485 -171.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.536 ' O ' ' HB2' ' A' ' 39' ' ' ARG . . . 51.53 -104.85 0.17 Allowed Glycine 0 CA--C 1.524 0.619 0 O-C-N 123.592 0.557 . . . . 0.0 114.476 177.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.424 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 3.5 Cg_exo -78.25 110.13 2.81 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.783 2.322 . . . . 0.0 112.756 179.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.94 ' HB ' ' HG3' ' A' ' 39' ' ' ARG . 23.5 t -138.23 -73.1 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 119.421 -0.323 . . . . 0.0 111.636 177.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.488 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 69.9 m 79.93 -177.35 0.08 Allowed 'General case' 0 C--N 1.342 0.26 0 CA-C-N 117.781 0.264 . . . . 0.0 110.929 174.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -63.81 -49.61 72.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.549 0.214 . . . . 0.0 111.154 -171.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -59.89 -53.62 55.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.622 -173.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 57.9 mm-40 -64.07 -48.93 74.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.42 -178.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.02 -39.66 75.18 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.811 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.575 ' HA ' HG21 ' A' ' 58' ' ' VAL . 12.4 mm100 -70.06 -53.7 16.31 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -178.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.0 t -68.28 -27.14 66.06 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.007 0.432 . . . . 0.0 111.611 -173.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -87.46 -33.75 18.93 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.094 0.473 . . . . 0.0 110.87 -175.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.673 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 30.7 mt -106.33 28.17 8.01 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.616 -176.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.11 65.77 2.16 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.073 0.463 . . . . 0.0 111.941 -173.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 59.53 23.53 58.4 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.979 176.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -64.46 -81.67 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.681 0.277 . . . . 0.0 110.367 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.43 HH11 ' HD3' ' A' ' 32' ' ' ARG . 39.9 ttp-105 -107.34 132.57 52.99 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 173.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 67.2 m170 -81.74 110.64 17.25 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.026 0.441 . . . . 0.0 110.527 -179.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 137.25 -19.92 3.39 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.382 -175.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.703 ' HB2' ' HB3' ' A' ' 53' ' ' SER . 34.3 mtt -59.82 137.04 58.16 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 122.404 0.282 . . . . 0.0 111.169 176.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.566 ' HB2' HG22 ' A' ' 52' ' ' VAL . 22.0 p90 -146.78 158.27 43.87 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.941 173.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.481 HD13 ' O ' ' A' ' 37' ' ' LEU . 4.5 pp -151.66 143.0 23.42 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.574 173.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.432 HG21 HD11 ' A' ' 50' ' ' LEU . 84.2 t -114.65 120.58 64.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 176.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.94 ' HG3' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -134.51 169.22 17.6 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.714 -176.728 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -57.99 127.96 34.73 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 175.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.3 t -64.62 157.57 26.71 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.401 0.62 . . . . 0.0 111.895 -173.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.2 p -86.47 -11.01 52.98 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.4 177.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 32.7 p -88.62 -63.6 1.27 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.645 178.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 57.4 m -136.91 145.4 50.59 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.835 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 44' ' ' CYS . 21.8 Cg_exo -65.51 -28.09 53.74 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.765 2.31 . . . . 0.0 112.51 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -76.73 -6.17 84.63 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.121 -0.561 . . . . 0.0 112.317 178.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.472 ' OD1' ' HA ' ' A' ' 64' ' ' ASN . 46.1 m-20 -111.28 159.48 17.9 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 176.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -129.54 169.45 14.97 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 177.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 45.2 t -140.14 98.84 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.184 0.516 . . . . 0.0 111.144 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.432 HD11 HG21 ' A' ' 38' ' ' VAL . 35.8 tp -69.05 99.84 1.15 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.872 172.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.1 m -96.74 126.2 41.73 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 177.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.616 HG23 HD12 ' A' ' 93' ' ' LEU . 80.9 t -117.46 146.92 21.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.704 -176.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.703 ' HB3' ' HB2' ' A' ' 35' ' ' MET . 26.6 t -100.27 98.88 9.5 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 175.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.461 ' HB2' ' OD1' ' A' ' 94' ' ' ASP . 0.0 OUTLIER -144.35 156.39 44.22 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.727 -176.352 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.544 ' OD1' ' HE2' ' A' ' 155' ' ' LYS . 0.7 OUTLIER 66.56 -56.04 0.4 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.243 0.617 . . . . 0.0 112.652 -179.235 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.8 p 169.77 -6.95 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.721 0.809 . . . . 0.0 110.774 -175.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -134.68 -169.11 2.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.512 -175.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.575 HG21 ' HA ' ' A' ' 25' ' ' GLN . 26.2 t -114.55 104.92 17.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.504 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 75.1 m -84.0 119.34 24.82 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.551 0.691 . . . . 0.0 110.133 176.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -94.88 104.22 16.11 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.033 -175.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.823 ' HH ' ' HB3' ' A' ' 93' ' ' LEU . 57.6 m-85 -98.95 98.43 9.48 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.431 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 30.3 mt -80.75 130.93 35.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -174.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.582 HG13 ' HB ' ' A' ' 73' ' ' ILE . 4.0 mp -103.81 123.46 57.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.858 178.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.472 ' HA ' ' OD1' ' A' ' 47' ' ' ASP . 17.0 m120 -104.13 131.07 51.79 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -175.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.9 t -77.55 111.18 13.01 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 175.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 93.2 mt -77.15 143.69 70.24 Favored Pre-proline 0 C--N 1.318 -0.78 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.36 -22.33 41.11 Favored 'Trans proline' 0 CA--C 1.528 0.214 0 C-N-CA 122.888 2.392 . . . . 0.0 112.383 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.9 p30 -86.03 16.42 4.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.916 178.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.781 ' HA ' ' HE ' ' A' ' 69' ' ' ARG . 0.2 OUTLIER 66.73 35.38 5.15 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.008 174.172 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -114.4 171.03 7.87 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.096 173.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.494 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 36.6 m-85 -119.69 120.3 36.2 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.014 0.435 . . . . 0.0 110.753 179.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.869 ' HE2' ' HA ' ' A' ' 75' ' ' ASP . 88.0 tttt -114.48 103.74 11.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.867 -176.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.582 ' HB ' HG13 ' A' ' 63' ' ' ILE . 5.6 tt -92.71 111.69 24.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.279 0.561 . . . . 0.0 111.531 -175.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.408 ' C ' ' H ' ' A' ' 76' ' ' GLN . . . 57.25 51.15 59.29 Favored Glycine 0 C--N 1.329 0.183 0 CA-C-N 115.446 -0.797 . . . . 0.0 113.164 177.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.869 ' HA ' ' HE2' ' A' ' 72' ' ' LYS . 29.7 t70 72.04 -15.43 0.46 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.997 0.519 . . . . 0.0 111.872 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.408 ' H ' ' C ' ' A' ' 74' ' ' GLY . 46.3 tp60 -82.85 110.64 18.04 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -87.82 127.82 35.33 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.026 -171.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -129.61 -179.86 5.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.066 177.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -76.71 -56.48 4.57 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.172 0.51 . . . . 0.0 110.843 177.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.784 ' HD1' ' HG2' ' A' ' 82' ' ' PRO . 2.4 p80 -147.08 177.8 8.88 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.519 -176.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.56 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 12.5 mt -59.49 -52.36 74.72 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -176.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.784 ' HG2' ' HD1' ' A' ' 80' ' ' HIS . 14.6 Cg_endo -60.65 -8.78 9.82 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 121.953 1.769 . . . . 0.0 113.197 177.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.92 -26.35 21.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.787 0.327 . . . . 0.0 110.485 -178.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.1 pp -91.1 -30.72 16.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.925 0.393 . . . . 0.0 110.082 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.403 HD22 HD11 ' A' ' 98' ' ' LEU . 95.0 mt -68.58 -33.9 74.86 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.253 178.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -71.83 -27.78 63.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.519 0.676 . . . . 0.0 110.376 175.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.503 ' O ' HG12 ' A' ' 90' ' ' ILE . 82.8 t80 -79.82 -37.02 36.01 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.806 -174.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.451 ' HD1' ' HB2' ' A' ' 91' ' ' HIS . 27.7 m-85 -74.16 0.59 13.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.795 0.331 . . . . 0.0 111.787 -178.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.432 ' O ' HG23 ' A' ' 97' ' ' THR . 62.4 tttm -66.18 -25.35 66.9 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.34 168.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.503 HG12 ' O ' ' A' ' 87' ' ' PHE . 6.6 pt -88.21 -28.96 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 174.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.458 ' O ' ' HB2' ' A' ' 92' ' ' TYR . 2.5 m170 -84.58 -24.44 29.21 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -172.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.584 ' HA ' ' CA ' ' A' ' 97' ' ' THR . 29.8 m-85 73.07 -7.61 1.46 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -179.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.823 ' HB3' ' HH ' ' A' ' 61' ' ' TYR . 14.3 mt 53.8 -25.67 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.586 1.554 . . . . 0.0 113.656 -169.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.581 ' H ' ' C ' ' A' ' 92' ' ' TYR . 2.9 p-10 -151.46 -51.92 0.12 Allowed 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 169.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.675 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 14.1 t -177.0 14.53 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.77 0.319 . . . . 0.0 110.745 -178.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 13.2 t -128.58 -29.38 2.41 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -173.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.584 ' CA ' ' HA ' ' A' ' 92' ' ' TYR . 16.4 p 70.18 166.0 0.28 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.995 1.318 . . . . 0.0 110.56 -171.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.495 ' CD2' HD11 ' A' ' 93' ' ' LEU . 21.3 mt -70.1 103.16 2.23 Favored 'General case' 0 C--O 1.221 -0.401 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 178.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.556 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 43.4 mm -87.81 -61.09 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.482 -175.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -148.43 154.82 42.13 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-O 120.994 0.426 . . . . 0.0 110.549 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.474 ' HG2' ' O ' ' A' ' 13' ' ' ALA . 16.9 Cg_exo -69.36 149.04 68.94 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.792 2.328 . . . . 0.0 112.092 177.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.48 153.42 93.77 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.577 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.87 136.4 69.74 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.561 2.174 . . . . 0.0 111.787 175.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.481 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 36.0 mtt180 . . . . . 0 C--N 1.327 -0.408 0 CA-C-O 121.235 0.54 . . . . 0.0 110.474 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.628 HD13 HG21 ' A' ' 152' ' ' ILE . 4.4 mm? . . . . . 0 CA--C 1.519 -0.238 0 CA-C-O 121.85 0.833 . . . . 0.0 112.861 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.608 ' O ' HG12 ' A' ' 151' ' ' VAL . 16.9 tp10 -173.27 -73.04 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.073 -1.421 . . . . 0.0 107.364 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . 0.419 ' HB3' ' HB3' ' A' ' 181' ' ' LEU . 47.2 m-85 -109.64 139.21 44.94 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.081 -0.647 . . . . 0.0 110.643 177.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.48 ' CG1' ' HB ' ' A' ' 178' ' ' VAL . 5.3 t -135.29 161.5 39.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -178.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.484 ' CZ ' HD11 ' A' ' 181' ' ' LEU . 2.1 ptp180 -140.56 136.56 32.95 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 169.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.579 ' HG1' ' HB2' ' A' ' 144' ' ' PHE . 20.7 p -87.08 140.03 29.96 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.027 -174.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.459 HD23 ' HG2' ' A' ' 179' ' ' GLU . 13.1 mt -112.05 -31.66 6.82 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.245 -175.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -81.7 -31.78 31.98 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.432 -169.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.459 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 9.8 t70 69.02 110.4 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 O-C-N 123.627 0.58 . . . . 0.0 110.373 -173.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -141.85 101.5 5.9 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.877 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -94.42 90.69 0.12 Allowed 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 123.153 2.569 . . . . 0.0 112.44 176.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -89.86 -28.82 17.3 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.211 176.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 18.2 m120 63.11 83.97 0.15 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 114.695 -0.753 . . . . 0.0 112.232 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.737 ' HB3' ' HB3' ' A' ' 141' ' ' ASP . 31.9 t70 -160.66 178.06 9.86 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 177.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -92.83 -12.19 31.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.082 0.468 . . . . 0.0 110.929 178.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.54 ' O ' ' HB2' ' A' ' 172' ' ' MET . 5.0 mp0 -120.54 6.78 10.56 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 176.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.737 ' HB3' ' HB3' ' A' ' 138' ' ' ASP . 10.7 t70 -132.91 107.21 8.16 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 175.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.62 ' HB3' ' CG2' ' A' ' 173' ' ' ILE . 57.3 tp -82.25 112.92 40.02 Favored Pre-proline 0 C--N 1.323 -0.575 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.681 -173.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.511 ' HD2' ' HD2' ' A' ' 169' ' ' ARG . 28.6 Cg_endo -69.71 100.96 0.85 Allowed 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 121.998 1.799 . . . . 0.0 111.489 175.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.579 ' HB2' ' HG1' ' A' ' 130' ' ' THR . 13.0 p90 -115.61 168.7 9.78 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.047 0.451 . . . . 0.0 111.669 -176.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.517 ' HB2' ' HG2' ' A' ' 148' ' ' GLU . 1.4 mptp? -112.66 -169.93 1.57 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.32 -177.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.848 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -87.56 3.96 45.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.226 0.536 . . . . 0.0 110.355 179.093 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.11 31.61 1.43 Allowed Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.157 -178.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.517 ' HG2' ' HB2' ' A' ' 145' ' ' LYS . 13.0 mm-40 -98.16 143.95 28.15 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.421 -0.215 . . . . 0.0 110.421 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.6 mp -102.6 132.69 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 175.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.758 ' HB3' ' HB1' ' A' ' 163' ' ' ALA . 11.1 mt -119.02 175.78 5.6 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -177.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.608 HG12 ' O ' ' A' ' 126' ' ' GLU . 15.3 t -142.25 123.56 12.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.819 HD13 ' HB3' ' A' ' 163' ' ' ALA . 25.2 mm -78.91 79.79 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-O 122.404 1.097 . . . . 0.0 110.285 -174.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.421 HG22 ' HG3' ' A' ' 154' ' ' GLU . 19.4 tt -74.67 -35.76 38.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 113.452 -1.704 . . . . 0.0 110.418 -175.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 1.049 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 53.0 mt-10 -120.18 139.44 52.63 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 171.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.544 ' HE2' ' OD1' ' A' ' 55' ' ' ASN . 35.9 ttpt -132.25 81.89 59.8 Favored Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 122.037 -0.414 . . . . 0.0 110.058 170.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.675 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 11.7 Cg_exo -72.1 -46.36 0.54 Allowed 'Trans proline' 0 CA--C 1.515 -0.465 0 C-N-CA 122.43 2.086 . . . . 0.0 111.34 177.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -122.15 -178.94 4.0 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.265 -174.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -101.73 -22.25 14.45 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.302 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -89.14 -27.6 20.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.21 0.528 . . . . 0.0 110.5 -179.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.704 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 42.0 m95 -129.21 130.4 46.26 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.906 -179.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . 0.667 ' HB3' HG22 ' A' ' 152' ' ' ILE . 54.2 m0 -123.12 137.58 54.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.704 178.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 1.049 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 16.2 m -84.46 106.37 15.99 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 176.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.819 ' HB3' HD13 ' A' ' 152' ' ' ILE . . . -116.9 162.27 18.01 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.279 -174.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.737 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 21.8 ptt-85 -109.93 127.78 54.96 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 175.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.702 ' HA ' HD22 ' A' ' 150' ' ' LEU . 19.7 p-10 -77.3 -174.06 3.11 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.999 -0.28 . . . . 0.0 111.205 -176.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -66.46 -25.8 66.9 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.237 0.541 . . . . 0.0 110.29 -177.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -70.72 -28.62 64.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.46 175.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 107.33 15.39 15.88 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.854 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.737 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 13.3 ttm-85 -92.86 134.3 35.22 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 122.779 0.431 . . . . 0.0 111.051 -176.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.555 HG22 ' HB3' ' A' ' 164' ' ' ARG . 60.0 t -99.18 136.89 28.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 120.848 0.356 . . . . 0.0 110.825 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -168.97 161.28 34.96 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 175.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.704 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.0 OUTLIER -69.26 132.56 46.66 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.897 0.348 . . . . 0.0 110.124 179.234 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.669 HD12 HG12 ' A' ' 178' ' ' VAL . 2.6 pp -134.12 144.0 49.58 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.645 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.481 ' HG3' ' CH2' ' A' ' 160' ' ' TRP . 5.2 Cg_exo -73.87 127.82 11.85 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.853 2.369 . . . . 0.0 111.688 -178.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.641 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 19.2 t -69.93 -35.33 5.16 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.641 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 11.3 Cg_endo -57.76 -16.83 26.82 Favored 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 121.832 1.688 . . . . 0.0 112.672 170.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.474 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.8 m-30 -87.33 -20.34 26.91 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.392 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.669 HG12 HD12 ' A' ' 173' ' ' ILE . 4.8 m -118.83 174.66 4.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -168.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.459 ' HG2' HD23 ' A' ' 131' ' ' LEU . 13.2 pt-20 -140.62 166.83 23.67 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 173.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -94.76 138.68 32.27 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.119 0.485 . . . . 0.0 111.451 -176.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.484 HD11 ' CZ ' ' A' ' 129' ' ' ARG . 57.7 tp . . . . . 0 C--N 1.324 -0.521 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.34 175.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo . . . . . 0 N--CA 1.461 -0.423 0 CA-C-O 120.707 0.211 . . . . 0.0 111.594 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.577 HG13 HD12 ' A' ' 293' ' ' ILE . 41.1 t -91.23 129.39 42.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 120.908 0.385 . . . . 0.0 110.247 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -93.85 114.55 26.81 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.911 177.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -120.37 126.48 50.59 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.029 178.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -92.05 125.19 36.64 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . 0.523 ' HA ' HG11 ' A' ' 291' ' ' VAL . . . -71.52 114.77 9.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.038 0.447 . . . . 0.0 110.955 -176.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 23.1 pt -96.46 -20.28 5.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.672 -177.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -140.16 138.09 34.91 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -55.8 152.89 9.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.491 0.662 . . . . 0.0 112.596 -172.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.684 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -142.4 99.95 3.6 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 177.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 17.9 m -123.51 156.1 64.75 Favored Pre-proline 0 C--N 1.321 -0.672 0 C-N-CA 120.804 -0.359 . . . . 0.0 111.9 -174.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -66.0 132.83 31.33 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.116 2.544 . . . . 0.0 112.949 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 25.7 p -151.19 152.2 32.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.991 177.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 60.03 -78.43 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 O-C-N 124.197 0.936 . . . . 0.0 112.963 176.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . 0.579 ' HD1' ' H ' ' A' ' 253' ' ' LYS . 6.4 p90 -79.74 -32.63 41.15 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.175 -178.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 55.57 25.42 7.96 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.898 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . 0.579 ' H ' ' HD1' ' A' ' 251' ' ' TYR . 63.1 tttm -130.88 144.6 51.58 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -178.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 27.0 p 60.77 15.4 5.86 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.716 0.806 . . . . 0.0 111.1 -175.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -102.12 102.43 12.89 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.154 -176.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.707 HD21 ' HB ' ' A' ' 279' ' ' VAL . 1.6 tt -83.95 123.38 29.91 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 176.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.684 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -79.43 93.18 5.33 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.185 0.517 . . . . 0.0 110.903 -178.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.779 HD22 HG22 ' A' ' 279' ' ' VAL . 65.7 mt -95.34 128.18 41.99 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.878 -178.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -101.94 148.13 25.71 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.22 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 57.5 t -63.94 127.56 24.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.009 0.433 . . . . 0.0 110.634 -177.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 103.21 -9.18 53.99 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.679 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -88.63 165.72 14.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.885 0.342 . . . . 0.0 110.339 -175.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 43.9 mm -107.5 132.11 55.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.826 -177.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.65 ' HA ' HG21 ' A' ' 279' ' ' VAL . 20.3 t -107.13 111.21 34.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.816 178.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -77.69 87.27 3.97 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.987 174.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.601 HG22 ' HB3' ' A' ' 275' ' ' TRP . 14.9 p -95.04 120.78 44.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.608 179.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 9.8 p -113.46 -16.72 12.38 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.891 -178.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . 0.543 ' HB2' ' HB3' ' A' ' 276' ' ' GLU . 16.1 mmm180 -121.98 100.28 6.89 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.566 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 55.6 mtt -95.49 116.35 28.7 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.967 0.413 . . . . 0.0 110.347 176.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.416 ' O ' ' HB ' ' A' ' 271' ' ' ILE . 78.8 m-20 -80.38 -6.73 58.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.915 -176.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.416 ' HB ' ' O ' ' A' ' 270' ' ' ASN . 48.1 mm 77.91 -39.52 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 123.537 0.735 . . . . 0.0 112.649 174.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . 0.694 HD22 ' HG2' ' A' ' 274' ' ' GLN . 22.7 p-10 -55.92 -37.92 69.56 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -177.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 150.82 -34.64 0.94 Allowed Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.622 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.694 ' HG2' HD22 ' A' ' 272' ' ' ASN . 2.4 pt20 -94.2 124.86 38.48 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 176.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.601 ' HB3' HG22 ' A' ' 266' ' ' VAL . 34.0 m0 -108.61 171.15 7.59 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 120.764 0.316 . . . . 0.0 111.243 -175.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . 0.543 ' HB3' ' HB2' ' A' ' 268' ' ' ARG . 6.3 tp10 -112.93 100.24 8.49 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -178.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -119.54 145.69 17.97 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.872 -177.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.613 ' HB3' ' HG2' ' A' ' 283' ' ' LYS . 3.5 pt-20 -103.12 109.27 20.78 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.322 0.582 . . . . 0.0 109.765 176.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . 0.779 HG22 HD22 ' A' ' 258' ' ' LEU . 95.4 t -122.73 112.61 34.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.456 -173.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 59.14 20.25 8.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.412 172.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 127.63 -30.35 4.02 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.258 -0.972 . . . . 0.0 114.201 176.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 9.1 ttm105 -110.17 139.46 45.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 117.889 0.845 . . . . 0.0 111.578 -177.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.613 ' HG2' ' HB3' ' A' ' 278' ' ' GLU . 51.5 mttm -97.98 130.25 44.83 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 170.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . 0.533 ' HA3' ' HB2' ' A' ' 256' ' ' LEU . . . -152.94 162.47 30.07 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.263 -0.97 . . . . 0.0 112.65 -177.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.54 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 76.5 mt -85.35 115.71 23.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.13 0.49 . . . . 0.0 110.595 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -122.82 129.37 25.03 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.132 178.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -67.47 138.3 45.64 Favored 'Trans proline' 0 C--O 1.236 0.394 0 C-N-CA 122.435 2.09 . . . . 0.0 111.018 173.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -58.38 -22.17 52.82 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.065 -176.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 2.7 p -71.35 -1.49 13.11 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -178.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -100.03 -13.46 19.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.899 0.38 . . . . 0.0 110.396 177.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.523 HG11 ' HA ' ' A' ' 242' ' ' ALA . 30.7 m -128.31 177.78 5.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.634 -177.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -132.88 128.87 37.54 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.854 172.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.577 HD12 HG13 ' A' ' 238' ' ' VAL . 37.3 mm -78.63 128.02 38.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.691 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -141.31 151.42 43.6 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.787 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -99.14 129.43 29.47 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 175.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo . . . . . 0 CA--C 1.529 0.268 0 C-N-CA 122.975 2.45 . . . . 0.0 112.994 -178.19 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.535 ' HB2' HD12 ' A' ' 99' ' ' ILE . 8.7 p . . . . . 0 N--CA 1.452 -0.355 0 CA-C-O 120.651 0.262 . . . . 0.0 110.766 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . -69.74 98.82 1.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.775 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 5' ' ' ARG . 10.4 mmt85 -140.41 93.77 2.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.418 0.627 . . . . 0.0 111.566 -178.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -156.65 150.86 25.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.823 175.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.5 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 35.1 t0 -81.72 115.39 20.94 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 177.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.4 m -70.11 -12.73 61.81 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.743 -175.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.2 t -102.85 -12.32 17.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.239 0.542 . . . . 0.0 110.741 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.5 ' HB2' ' HB3' ' A' ' 7' ' ' ASP . 6.9 t70 -75.42 91.41 2.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.921 0.391 . . . . 0.0 110.05 -178.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -57.82 -39.13 76.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.545 -176.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.474 ' HA ' ' NH2' ' A' ' 104' ' ' ARG . 4.8 t -73.43 -1.55 18.76 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.159 -176.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.61 -44.47 8.58 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.356 176.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 29.9 p-90 -120.24 -21.2 7.05 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -171.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -77.58 122.83 25.81 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.102 0.477 . . . . 0.0 110.782 -176.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.53 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 25.0 mmt -104.53 -8.24 19.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.436 -175.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.444 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 50.89 -114.74 2.94 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-N 115.8 -0.636 . . . . 0.0 113.556 -176.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.444 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 11.3 Cg_exo -71.64 92.18 0.69 Allowed 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.948 2.432 . . . . 0.0 113.081 -176.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.433 HG23 ' HB3' ' A' ' 16' ' ' MET . 69.9 t -142.17 157.69 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 177.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.6 m -120.91 166.48 13.75 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -170.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 41.4 ttt85 -58.68 -48.98 79.26 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 123.04 0.213 . . . . 0.0 111.493 -177.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -60.59 -52.28 65.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.332 0.587 . . . . 0.0 110.767 -178.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -65.43 -47.62 75.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.261 -175.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.408 ' HB2' HD11 ' A' ' 37' ' ' LEU . . . -56.34 -38.65 71.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.488 0.661 . . . . 0.0 111.076 178.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.53 ' HA ' HG13 ' A' ' 58' ' ' VAL . 38.3 tt0 -72.66 -37.71 67.87 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.982 -174.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 10.2 t -75.08 -22.53 58.24 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 120.481 -0.487 . . . . 0.0 110.819 -178.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -81.26 -13.44 58.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.233 0.539 . . . . 0.0 110.583 177.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.573 ' O ' HG23 ' A' ' 58' ' ' VAL . 83.1 mt -126.11 16.25 7.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.486 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.35 77.67 3.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.087 0.47 . . . . 0.0 111.099 -174.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.63 16.75 72.25 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.678 -0.692 . . . . 0.0 113.067 177.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -64.41 -77.26 0.06 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.992 0.425 . . . . 0.0 110.39 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.6 mtm180 -124.63 125.69 44.55 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 175.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 53.0 m170 -71.38 119.08 15.01 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.957 0.408 . . . . 0.0 110.478 -178.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 109.36 -8.77 32.92 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.749 -176.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.602 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 37.4 ttp -84.28 129.5 34.88 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -138.11 171.43 14.41 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.711 -172.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.544 ' HG ' HD11 ' A' ' 28' ' ' LEU . 4.6 pp -157.72 139.58 14.08 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.181 173.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.451 HG22 HD11 ' A' ' 50' ' ' LEU . 42.4 t -105.83 123.69 60.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 176.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.401 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 24.3 ptt-85 -124.67 -179.47 4.52 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.341 -176.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -78.5 135.55 37.37 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 175.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.7 t -78.41 118.37 20.52 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.123 -178.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.8 t -78.46 -15.56 58.49 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.314 172.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 25.5 m -73.69 -45.32 53.09 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.734 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 50.6 t -138.83 124.47 12.2 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.323 -178.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 44' ' ' CYS . 23.4 Cg_exo -64.63 114.56 2.78 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 123.067 2.511 . . . . 0.0 112.548 -178.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.62 -16.05 29.04 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.835 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.569 ' OD2' ' HA ' ' A' ' 64' ' ' ASN . 1.2 m-20 -93.35 177.89 5.89 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.54 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 38.6 m-85 -130.59 174.18 10.16 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 179.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.9 t -142.59 110.04 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.611 0.243 . . . . 0.0 110.418 175.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.451 HD11 HG22 ' A' ' 38' ' ' VAL . 36.7 tp -82.23 106.31 14.02 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.951 174.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 53.1 m -96.15 134.04 39.71 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 173.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.673 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 67.2 t -121.96 146.46 27.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.097 -177.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.565 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 12.9 t -94.74 106.53 18.52 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 174.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.655 ' O ' ' HB3' ' A' ' 57' ' ' ARG . 1.0 OUTLIER -147.06 138.75 24.24 Favored 'General case' 0 C--O 1.207 -1.166 0 C-N-CA 118.564 -1.254 . . . . 0.0 110.989 176.075 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.5 p30 37.66 47.48 0.82 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -175.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.5 m 58.47 44.33 18.2 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 122.279 1.038 . . . . 0.0 109.907 176.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.655 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 8.7 ttp180 -157.84 67.41 0.49 Allowed 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.705 -1.589 . . . . 0.0 110.71 -154.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.673 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 5.0 t -69.98 99.53 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.893 0.854 . . . . 0.0 108.901 -170.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.437 ' HB2' ' CE2' ' A' ' 61' ' ' TYR . 7.9 m -84.19 122.58 29.06 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 113.799 -1.546 . . . . 0.0 111.157 -172.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 60.0 m-70 -93.39 101.95 14.18 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.968 0.413 . . . . 0.0 111.982 -174.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.486 ' HB3' ' CD1' ' A' ' 73' ' ' ILE . 65.1 m-85 -99.91 105.42 17.14 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.805 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.818 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 61.6 mt -80.7 129.53 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -173.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.565 HG13 ' HB ' ' A' ' 73' ' ' ILE . 3.8 mp -98.8 119.09 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.129 0.572 . . . . 0.0 110.424 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.606 ' O ' ' HA ' ' A' ' 71' ' ' PHE . 4.3 m120 -89.25 139.44 30.49 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.405 -169.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.1 t -88.34 92.06 9.03 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 171.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.634 HD11 ' HG3' ' A' ' 70' ' ' ARG . 84.8 mt -79.83 138.96 53.77 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.576 -178.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.99 -7.98 16.85 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.949 2.433 . . . . 0.0 112.118 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -90.21 20.22 4.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.758 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.588 ' HA ' ' HE ' ' A' ' 69' ' ' ARG . 0.3 OUTLIER 65.78 30.52 10.09 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.247 0.546 . . . . 0.0 111.089 177.362 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.634 ' HG3' HD11 ' A' ' 66' ' ' LEU . 3.8 ptp180 -138.66 -177.03 4.69 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.444 -178.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.606 ' HA ' ' O ' ' A' ' 64' ' ' ASN . 47.8 m-85 -124.06 157.87 33.51 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.264 -178.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.55 ' HB2' HD12 ' A' ' 66' ' ' LEU . 35.1 ttpt -138.69 100.49 4.09 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 175.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.818 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 3.9 tt -89.28 108.25 18.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.442 0.639 . . . . 0.0 110.666 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.09 37.88 94.69 Favored Glycine 0 C--N 1.321 -0.265 0 CA-C-N 115.175 -0.921 . . . . 0.0 112.366 176.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.423 ' HA ' ' HE3' ' A' ' 72' ' ' LYS . 17.5 t70 77.75 6.2 2.84 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.607 0.763 . . . . 0.0 111.501 178.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -102.73 123.39 46.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.867 0.365 . . . . 0.0 110.308 171.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -94.04 134.38 36.52 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.697 0.761 . . . . 0.0 112.102 -175.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.558 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 51.0 m-85 -136.43 170.28 16.3 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 172.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -70.68 -54.66 11.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.136 0.493 . . . . 0.0 111.182 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.547 ' ND1' ' HG2' ' A' ' 82' ' ' PRO . 3.0 p80 -144.31 172.65 12.64 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.624 -174.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.541 HD21 HD22 ' A' ' 84' ' ' LEU . 16.2 mt -55.18 -52.75 68.71 Favored Pre-proline 0 N--CA 1.469 0.514 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.547 ' HG2' ' ND1' ' A' ' 80' ' ' HIS . 19.5 Cg_endo -60.52 -3.41 2.56 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.316 2.011 . . . . 0.0 113.597 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.37 -36.45 10.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.723 0.297 . . . . 0.0 110.896 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.558 ' HB3' ' CD2' ' A' ' 78' ' ' PHE . 4.4 pp -76.51 -34.84 58.59 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.048 0.451 . . . . 0.0 110.154 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 78.0 mt -62.22 -33.31 74.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.122 176.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.612 ' HA ' ' HD3' ' A' ' 89' ' ' LYS . 20.0 tp10 -73.9 -37.4 64.67 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.506 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.436 ' CD2' ' HZ ' ' A' ' 78' ' ' PHE . 23.1 t80 -64.28 -37.61 88.09 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.124 0.487 . . . . 0.0 110.67 177.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.688 ' CD1' HD22 ' A' ' 93' ' ' LEU . 36.1 m-85 -79.16 -6.52 56.74 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.92 0.39 . . . . 0.0 111.759 -178.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.612 ' HD3' ' HA ' ' A' ' 86' ' ' GLU . 53.7 mtpt -83.81 -8.56 59.19 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.384 172.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 21.8 pt -128.23 9.42 3.01 Favored 'Isoleucine or valine' 0 C--N 1.342 0.26 0 CA-C-O 121.549 0.69 . . . . 0.0 109.604 174.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.402 ' O ' ' HB2' ' A' ' 92' ' ' TYR . 3.3 t-160 -95.02 -47.2 6.5 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.244 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.432 ' CD2' HG21 ' A' ' 97' ' ' THR . 95.3 m-85 62.77 88.33 0.1 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.028 -161.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.688 HD22 ' CD1' ' A' ' 88' ' ' TYR . 13.7 mt -46.37 -65.14 0.6 Allowed 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 177.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.588 ' CG ' ' H ' ' A' ' 95' ' ' THR . 13.7 p-10 -98.86 -120.36 0.14 Allowed 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.249 172.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.588 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 4.6 t -94.11 6.15 49.49 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-O 120.963 0.411 . . . . 0.0 109.989 176.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.4 HG23 ' OD1' ' A' ' 94' ' ' ASP . 8.3 t -141.26 164.58 29.86 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.085 0.469 . . . . 0.0 110.706 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.432 HG21 ' CD2' ' A' ' 92' ' ' TYR . 9.1 p -99.61 174.53 6.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.62 178.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 82.3 mt -68.42 107.06 2.73 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 173.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.542 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 49.2 mm -91.55 -58.73 3.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.792 -174.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.602 ' O ' ' HA ' ' A' ' 35' ' ' MET . 11.9 pt-20 -159.02 153.23 19.97 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.176 -178.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.34 163.31 39.03 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 122.668 2.245 . . . . 0.0 113.364 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.406 ' HB1' ' HG2' ' A' ' 35' ' ' MET . . . -83.11 158.39 64.41 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.803 178.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -66.91 136.39 41.32 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.315 2.01 . . . . 0.0 111.151 173.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.514 ' HG2' ' SD ' ' A' ' 16' ' ' MET . 87.6 mtt180 . . . . . 0 C--N 1.328 -0.353 0 CA-C-O 120.815 0.34 . . . . 0.0 110.787 178.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.55 HD11 HG21 ' A' ' 152' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.278 0 N-CA-C 102.41 -3.182 . . . . 0.0 102.41 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.716 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 4.9 tp10 74.19 -73.23 0.1 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 118.501 0.591 . . . . 0.0 110.759 175.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -101.33 107.44 18.8 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 118.848 -1.141 . . . . 0.0 111.494 -176.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 1.056 HG21 ' HG3' ' A' ' 180' ' ' LYS . 97.3 t -124.87 136.37 61.02 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.078 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.298 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.592 ' NH1' ' HB2' ' A' ' 181' ' ' LEU . 0.0 OUTLIER -111.18 151.37 28.29 Favored 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 117.376 -1.73 . . . . 0.0 108.33 167.925 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.693 ' HG1' ' CD ' ' A' ' 148' ' ' GLU . 0.9 OUTLIER -107.77 134.26 50.98 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.882 0.849 . . . . 0.0 111.234 179.379 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.556 HD22 ' HG2' ' A' ' 179' ' ' GLU . 10.5 mt -110.21 2.39 19.28 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.61 -176.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.513 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 24.2 t80 -105.2 -39.62 6.13 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.103 -0.639 . . . . 0.0 112.614 -174.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.575 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 8.6 t70 79.05 98.47 0.06 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.444 0.64 . . . . 0.0 109.973 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.422 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 69.4 t80 -126.32 91.65 47.26 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 173.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.683 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 70.8 Cg_endo -86.24 83.61 1.22 Allowed 'Trans proline' 0 N--CA 1.442 -1.549 0 C-N-CA 121.675 1.583 . . . . 0.0 112.808 -178.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -76.58 -31.19 54.97 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.092 175.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.433 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 20.9 m120 63.46 49.85 3.02 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.247 0.546 . . . . 0.0 111.34 176.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -135.24 177.44 7.81 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.779 176.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 170' ' ' VAL . . . -91.57 -10.96 38.65 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.674 0.75 . . . . 0.0 109.583 172.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.681 ' O ' ' HB2' ' A' ' 172' ' ' MET . 45.3 mt-10 -109.23 -2.83 17.68 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.066 176.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -143.5 100.96 3.7 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 174.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.779 ' CD1' ' HB2' ' A' ' 165' ' ' ASN . 52.9 tp -70.6 132.1 87.57 Favored Pre-proline 0 CA--C 1.51 -0.581 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.351 -175.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.683 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 73.2 Cg_endo -83.07 93.53 0.85 Allowed 'Trans proline' 0 N--CA 1.436 -1.885 0 C-N-CA 120.931 1.088 . . . . 0.0 111.761 170.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.612 ' HB2' ' OG1' ' A' ' 130' ' ' THR . 17.2 p90 -102.78 164.18 11.78 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.919 ' H ' ' HG3' ' A' ' 148' ' ' GLU . 2.9 mptp? -114.57 -148.51 0.43 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.119 0.485 . . . . 0.0 111.769 -171.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.751 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -109.44 41.29 1.69 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.256 -179.648 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 147.89 28.88 0.07 OUTLIER Glycine 0 CA--C 1.525 0.716 0 C-N-CA 120.723 -0.751 . . . . 0.0 113.435 177.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.919 ' HG3' ' H ' ' A' ' 145' ' ' LYS . 0.0 OUTLIER -80.83 172.78 13.31 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 123.871 0.868 . . . . 0.0 109.732 171.319 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.523 HD12 ' HB3' ' A' ' 129' ' ' ARG . 0.6 OUTLIER -115.92 129.28 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.584 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.715 HD23 ' CD2' ' A' ' 142' ' ' LEU . 27.0 mt -120.76 157.27 30.07 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -173.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.716 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 70.7 t -130.78 123.15 53.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.577 177.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.55 HG21 HD11 ' A' ' 125' ' ' LEU . 40.8 mm -75.91 84.36 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 122.109 0.957 . . . . 0.0 109.706 -172.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.539 ' C ' HH12 ' A' ' 57' ' ' ARG . 14.0 tt -87.42 -31.89 6.08 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 CA-C-N 114.043 -1.435 . . . . 0.0 111.605 -169.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.654 ' HA ' HH22 ' A' ' 57' ' ' ARG . 10.8 mt-10 -122.49 142.27 50.76 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 164.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -137.43 87.6 17.73 Favored Pre-proline 0 C--N 1.316 -0.86 0 CA-C-O 121.314 0.578 . . . . 0.0 110.627 176.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.549 ' HG2' ' HE1' ' A' ' 172' ' ' MET . 17.5 Cg_exo -71.24 -54.52 0.16 Allowed 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.683 2.255 . . . . 0.0 111.826 170.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.422 ' HG2' ' HB2' ' A' ' 156' ' ' PRO . 6.5 mm-40 -112.53 -176.58 2.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.815 -169.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -109.87 -8.9 14.82 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.231 173.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -96.13 -32.28 12.58 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.513 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.41 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 28.7 m95 -127.19 144.02 51.13 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.082 174.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . 0.752 ' O ' HG13 ' A' ' 173' ' ' ILE . 20.7 m0 -126.71 139.92 52.79 Favored 'General case' 0 C--O 1.213 -0.835 0 CA-C-O 121.032 0.444 . . . . 0.0 111.126 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.533 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 19.6 m -97.51 94.55 7.08 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -175.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.533 ' HB2' ' HB3' ' A' ' 150' ' ' LEU . . . -109.18 152.25 25.4 Favored 'General case' 0 N--CA 1.428 -1.574 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.135 -173.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.84 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 27.5 ptt-85 -87.42 123.82 32.76 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 172.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.779 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . 66.1 t30 -59.01 -178.2 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.259 -1.337 . . . . 0.0 110.957 -172.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.605 ' HB2' ' HB2' ' A' ' 148' ' ' GLU . 37.8 tttp -66.77 -12.15 57.64 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.222 168.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -73.59 -21.25 60.39 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.412 167.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 77.47 35.13 37.92 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.005 -168.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.84 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 2.9 ttm-85 -113.47 137.65 51.24 Favored 'General case' 0 C--O 1.213 -0.845 0 C-N-CA 122.779 0.431 . . . . 0.0 110.937 -176.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.496 HG21 HG23 ' A' ' 153' ' ' ILE . 38.9 t -78.17 128.98 38.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 118.146 0.43 . . . . 0.0 111.777 -177.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -164.49 155.95 27.61 Favored Glycine 0 C--N 1.339 0.708 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.612 167.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.681 ' HB2' ' O ' ' A' ' 140' ' ' GLU . 0.6 OUTLIER -74.95 142.83 43.9 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 117.144 0.472 . . . . 0.0 111.291 178.817 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.752 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.4 pp -143.67 141.04 18.08 Favored Pre-proline 0 N--CA 1.452 -0.336 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.715 -176.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.436 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 18.5 Cg_exo -66.38 127.09 16.7 Favored 'Trans proline' 0 C--N 1.34 0.125 0 C-N-CA 122.468 2.112 . . . . 0.0 112.546 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.619 ' O ' HG22 ' A' ' 178' ' ' VAL . 96.2 t -61.94 -40.99 73.84 Favored Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 11.5 Cg_endo -56.88 -15.81 18.13 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 121.974 1.783 . . . . 0.0 113.221 175.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.436 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.2 m-30 -88.71 -8.04 55.23 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -177.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.649 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 3.3 m -105.59 -170.89 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 115.896 1.813 . . . . 0.0 115.896 -164.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.562 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 7.7 tp10 -159.89 49.98 0.3 Allowed 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 112.956 -1.929 . . . . 0.0 112.705 -152.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 1.056 ' HG3' HG21 ' A' ' 128' ' ' VAL . 3.5 mppt? -69.89 135.77 49.91 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 119.583 -1.948 . . . . 0.0 111.246 -161.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.592 ' HB2' ' NH1' ' A' ' 129' ' ' ARG . 16.5 tp . . . . . 0 N--CA 1.463 0.22 0 CA-C-N 112.956 -1.929 . . . . 0.0 113.582 -163.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo . . . . . 0 N--CA 1.459 -0.533 0 N-CA-C 111.031 -0.411 . . . . 0.0 111.031 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.452 ' HB ' ' CG1' ' A' ' 266' ' ' VAL . 2.5 t -75.9 138.13 21.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.415 -175.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -112.57 121.29 44.36 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.784 0.326 . . . . 0.0 110.927 -178.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . 0.521 ' HB3' HD11 ' A' ' 293' ' ' ILE . . . -120.15 137.8 53.96 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.636 177.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.486 ' HB2' ' CE1' ' A' ' 294' ' ' PHE . 11.6 tppt? -80.94 123.53 28.39 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.656 177.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -75.45 102.9 5.36 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 174.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 290' ' ' HIS . 18.6 pt -88.15 -7.17 10.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.245 0.545 . . . . 0.0 110.783 -176.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.524 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 2.3 tt0 -138.66 142.89 39.03 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.231 175.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.467 ' HE3' ' OE2' ' A' ' 259' ' ' GLU . 1.5 ptpp? -68.65 174.16 4.5 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 174.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.859 ' HG3' ' HE1' ' A' ' 290' ' ' HIS . 0.0 OUTLIER -166.57 136.43 3.15 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.187 -179.77 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 24.6 m -127.8 150.29 72.9 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.304 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.526 ' HD3' ' HB3' ' A' ' 257' ' ' ALA . 58.0 Cg_endo -72.41 149.08 49.83 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.477 2.118 . . . . 0.0 112.631 -179.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' CYS . . . . . 0.533 ' HB3' ' HB2' ' A' ' 252' ' ' ASP . 25.0 t -95.95 165.97 12.01 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 177.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -55.3 -39.77 70.3 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.114 0.483 . . . . 0.0 111.446 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -102.43 15.74 28.34 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.167 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . 0.533 ' HB2' ' HB3' ' A' ' 249' ' ' CYS . 1.7 m-20 -124.6 85.59 2.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.039 0.447 . . . . 0.0 110.334 177.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -86.56 -22.85 26.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.876 -179.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 4.0 p -89.87 5.01 48.13 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.259 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . 0.461 ' HB1' ' HB3' ' A' ' 252' ' ' ASP . . . -82.57 109.43 16.76 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.565 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.418 ' HA ' ' NH1' ' A' ' 282' ' ' ARG . 0.6 OUTLIER -66.0 137.34 57.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.456 -177.524 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.526 ' HB3' ' HD3' ' A' ' 248' ' ' PRO . . . -98.18 129.13 44.96 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.673 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 84.2 mt -136.71 162.51 32.98 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.512 -174.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.467 ' OE2' ' HE3' ' A' ' 245' ' ' LYS . 65.7 mm-40 -127.26 165.79 18.99 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 172.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 62.1 t -70.71 123.04 23.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.145 0.498 . . . . 0.0 110.956 -178.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 107.81 0.48 34.23 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.201 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -84.73 142.98 29.46 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.003 0.43 . . . . 0.0 110.713 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 48.6 mm -100.02 110.12 26.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.084 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 33.3 t -86.4 109.45 18.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.689 -177.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 27.8 tttm -84.46 94.67 8.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.923 175.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.452 ' CG1' ' HB ' ' A' ' 238' ' ' VAL . 3.6 p -93.32 117.56 37.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.33 0.586 . . . . 0.0 110.454 -178.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 1.2 p -95.9 -35.21 11.54 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.615 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 13.0 ttp180 -115.89 122.12 44.4 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 177.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' MET . . . . . 0.449 ' HE3' ' CE3' ' A' ' 275' ' ' TRP . 32.4 mtt -106.49 125.08 50.55 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.189 0.519 . . . . 0.0 110.981 178.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 274' ' ' GLN . 87.6 m-20 -89.69 134.04 34.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.767 -179.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.443 ' H ' HG13 ' A' ' 271' ' ' ILE . 2.3 pp -74.45 9.5 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -173.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . 0.928 HD22 ' HG2' ' A' ' 274' ' ' GLN . 1.7 p-10 -97.95 -24.55 15.33 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 122.299 -0.25 . . . . 0.0 111.172 -178.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 135.4 -37.25 1.94 Allowed Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.151 -1.023 . . . . 0.0 113.222 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.928 ' HG2' HD22 ' A' ' 272' ' ' ASN . 18.9 pt20 -95.6 118.27 31.99 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 177.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.449 ' CE3' ' HE3' ' A' ' 269' ' ' MET . 20.3 m0 -95.2 166.95 11.66 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.293 -173.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -99.64 99.09 9.89 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.106 -178.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -108.74 153.26 16.87 Favored Glycine 0 C--O 1.224 -0.528 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.382 -175.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.656 ' HG2' ' HE2' ' A' ' 283' ' ' LYS . 21.2 mt-10 -119.83 108.46 14.41 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -178.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 50.9 t -138.05 132.64 43.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.613 -176.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 64.14 24.07 13.35 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.975 0.417 . . . . 0.0 110.965 176.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 86.47 -2.88 87.44 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.272 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . 0.418 ' NH1' ' HA ' ' A' ' 256' ' ' LEU . 0.6 OUTLIER -117.57 131.48 56.68 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.956 0.408 . . . . 0.0 109.937 -176.503 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.656 ' HE2' ' HG2' ' A' ' 278' ' ' GLU . 15.7 ptpt -113.08 142.32 45.88 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.977 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -168.04 -174.24 36.74 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.481 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.442 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 86.0 mt -88.05 136.04 33.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.245 0.545 . . . . 0.0 111.92 -177.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -138.94 127.86 14.06 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.979 174.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . 0.845 ' HD2' ' HE2' ' A' ' 290' ' ' HIS . 11.6 Cg_exo -73.48 151.35 47.53 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.925 2.417 . . . . 0.0 111.78 175.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -73.08 -1.6 18.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.135 0.493 . . . . 0.0 111.765 -178.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 3.4 m -64.63 -42.21 95.63 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.731 -176.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . 0.859 ' HE1' ' HG3' ' A' ' 246' ' ' ARG . 0.3 OUTLIER -110.63 12.31 22.7 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -174.852 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 22.3 m -129.33 149.94 34.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 172.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -139.36 136.12 34.43 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.738 0.304 . . . . 0.0 110.559 177.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.521 HD11 ' HB3' ' A' ' 240' ' ' ALA . 1.1 mp -76.85 141.39 15.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.89 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 294' ' ' PHE . . . . . 0.564 ' CE2' ' HA ' ' A' ' 296' ' ' PRO . 7.9 p90 -154.87 176.53 12.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.2 -179.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -91.47 104.28 9.63 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 173.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . 0.564 ' HA ' ' CE2' ' A' ' 294' ' ' PHE . 26.3 Cg_endo . . . . . 0 C--N 1.344 0.323 0 C-N-CA 122.326 2.017 . . . . 0.0 112.776 -173.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.7 m . . . . . 0 N--CA 1.461 0.112 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -78.98 78.92 5.4 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.258 0.551 . . . . 0.0 110.28 177.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 18.7 tpp180 -99.61 86.79 3.41 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.357 0.598 . . . . 0.0 110.503 -176.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -167.52 143.39 4.08 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.991 -1.004 . . . . 0.0 108.798 175.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.4 ' C ' ' H ' ' A' ' 9' ' ' SER . 17.4 m-20 -72.48 -9.37 58.46 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -173.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.4 t 73.19 -29.52 0.2 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.267 0.627 . . . . 0.0 112.086 175.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.4 ' H ' ' C ' ' A' ' 7' ' ' ASP . 6.0 t -102.6 -19.21 14.92 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 122.067 -0.395 . . . . 0.0 111.016 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -67.09 104.05 1.33 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.979 0.419 . . . . 0.0 111.003 -176.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -60.75 -37.67 82.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.872 -175.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.5 m -69.17 -5.47 22.73 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.802 -177.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.33 -47.52 6.57 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.895 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.471 ' HB3' ' HB3' ' A' ' 101' ' ' PRO . 41.9 p-90 -119.72 -20.46 7.64 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -169.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -72.16 108.43 5.33 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.131 0.491 . . . . 0.0 110.455 -175.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.647 ' SD ' ' HA ' ' A' ' 104' ' ' ARG . 9.2 tpp -90.84 -4.79 56.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.868 -174.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 50.02 -114.57 2.53 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-N 115.243 -0.89 . . . . 0.0 114.344 176.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -74.4 83.19 1.73 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.04 2.493 . . . . 0.0 113.368 -174.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.702 HG13 ' H ' ' A' ' 20' ' ' SER . 98.4 t -135.92 177.08 6.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.702 ' H ' HG13 ' A' ' 19' ' ' VAL . 57.3 p -149.36 177.53 9.59 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -168.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.5 ttt85 -63.69 -39.6 94.71 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.784 178.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 35.5 mm-40 -61.87 -64.02 1.07 Allowed 'General case' 0 C--O 1.235 0.318 0 O-C-N 123.38 0.425 . . . . 0.0 110.754 176.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.455 ' O ' ' HB ' ' A' ' 26' ' ' THR . 8.1 tp10 -56.77 -47.78 79.36 Favored 'General case' 0 C--O 1.217 -0.658 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.467 -176.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.69 -42.01 82.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.96 0.41 . . . . 0.0 111.79 -177.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.436 ' NE2' ' HG2' ' A' ' 29' ' ' GLN . 23.1 tm0? -68.11 -32.52 72.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.55 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.455 ' HB ' ' O ' ' A' ' 23' ' ' GLU . 4.2 m -65.23 -43.4 91.55 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.661 176.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.423 ' HG2' ' O ' ' A' ' 23' ' ' GLU . 42.0 mmm-85 -72.85 -20.75 61.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.518 -173.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.595 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 88.6 mt -126.83 17.4 7.37 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.059 -171.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.436 ' HG2' ' NE2' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -69.49 76.53 0.4 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.476 0.655 . . . . 0.0 109.475 178.916 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.7 -66.72 3.86 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.4 -176.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.508 ' CD ' ' HE2' ' A' ' 35' ' ' MET . 30.2 tt0 27.55 -99.12 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.208 1.003 . . . . 0.0 112.536 -166.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.58 ' HB2' ' SD ' ' A' ' 35' ' ' MET . 47.6 mtm105 -112.76 -6.77 13.84 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -176.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 49.7 m170 67.49 155.12 0.1 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.229 0.538 . . . . 0.0 111.132 -175.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.14 10.87 84.28 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 121.085 -0.578 . . . . 0.0 111.824 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.594 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 41.4 mtp -103.97 145.82 29.59 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -177.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.447 ' CG ' HD21 ' A' ' 98' ' ' LEU . 33.5 p90 -146.26 164.32 32.68 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.694 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.516 ' HG ' HD11 ' A' ' 28' ' ' LEU . 4.3 pp -152.72 137.16 16.72 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.847 174.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.4 t -101.95 114.37 41.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 173.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.572 ' HG3' ' O ' ' A' ' 40' ' ' ASP . 24.2 ptt-85 -116.09 176.5 5.07 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.7 -172.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.572 ' O ' ' HG3' ' A' ' 39' ' ' ARG . 10.6 t70 -58.66 132.28 53.37 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 166.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.513 ' HA ' HG21 ' A' ' 49' ' ' VAL . 44.5 t -44.37 -48.66 9.77 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 123.674 0.609 . . . . 0.0 112.223 -174.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.1 t 72.73 -1.66 2.93 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.979 0.799 . . . . 0.0 109.81 -175.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.411 ' H ' ' C ' ' A' ' 41' ' ' SER . 23.4 m -111.51 -37.09 5.33 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.712 175.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 45.3 t -147.2 122.84 5.37 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.306 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -61.95 122.12 10.49 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.94 2.426 . . . . 0.0 112.857 -178.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.94 -31.81 7.0 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.742 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.4 ' C ' ' HB2' ' A' ' 41' ' ' SER . 4.7 m-20 -87.81 174.96 8.06 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -133.28 169.66 16.59 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 122.284 -0.26 . . . . 0.0 111.049 -177.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.513 HG21 ' HA ' ' A' ' 41' ' ' SER . 90.3 t -143.01 117.28 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 121.29 0.566 . . . . 0.0 110.632 174.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.441 ' CB ' HD13 ' A' ' 63' ' ' ILE . 28.3 tp -85.04 108.48 17.65 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.885 178.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.7 m -96.39 137.26 35.72 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 174.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.691 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 91.3 t -130.76 134.24 62.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.632 0.253 . . . . 0.0 111.444 -175.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.595 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 40.8 t -94.93 114.66 26.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.208 -175.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.659 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 8.6 tp10 -159.45 153.56 23.51 Favored 'General case' 0 C--O 1.21 -0.991 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 164.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.618 ' HB2' ' CG ' ' A' ' 57' ' ' ARG . 63.2 m-80 61.4 17.36 8.3 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 179.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.2 m 55.22 55.54 7.43 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 122.59 1.186 . . . . 0.0 108.19 -170.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.737 HH21 ' HA ' ' A' ' 154' ' ' GLU 0.282 0.0 OUTLIER -163.24 67.73 0.2 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 113.227 -1.806 . . . . 0.0 109.883 -153.69 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.691 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 5.2 t -73.64 102.57 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.316 -1.311 . . . . 0.0 110.26 -173.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.632 ' HG ' ' CZ ' ' A' ' 57' ' ' ARG . 71.6 m -78.38 122.46 25.8 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.174 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 45.3 m-70 -93.14 102.97 15.28 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.971 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.553 ' HB3' ' CD1' ' A' ' 73' ' ' ILE . 70.0 m-85 -97.99 105.07 17.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.591 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 54.8 mt -80.47 127.77 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -174.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.577 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 3.5 mp -115.44 112.01 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 120.82 0.343 . . . . 0.0 110.22 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -87.4 148.29 25.07 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.415 -176.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.8 t -87.83 109.19 19.56 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 175.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.3 mt -81.52 143.25 50.99 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -62.14 -11.54 22.46 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.44 2.094 . . . . 0.0 110.915 175.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -76.24 0.51 18.93 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.421 176.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.34 21.78 9.7 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.559 -174.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -115.96 175.0 5.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.82 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.577 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 64.8 m-85 -130.76 132.19 45.16 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.962 0.411 . . . . 0.0 111.21 -176.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -121.88 122.41 39.36 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.996 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.59 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 7.5 tt -108.42 109.25 27.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.502 0.668 . . . . 0.0 111.218 -174.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.03 -94.37 0.37 Allowed Glycine 0 CA--C 1.519 0.329 0 CA-C-N 115.431 -0.804 . . . . 0.0 113.136 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -121.2 -11.04 8.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.332 0.587 . . . . 0.0 110.323 -176.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -108.86 126.07 52.66 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.382 0.61 . . . . 0.0 110.784 -176.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.35 135.1 37.39 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.64 178.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.464 ' HE2' ' CG2' ' A' ' 73' ' ' ILE . 93.4 m-85 -126.38 178.43 5.85 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -71.18 -43.06 68.21 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.284 -178.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.43 ' ND1' ' HG2' ' A' ' 82' ' ' PRO . 16.4 p80 -165.97 -179.43 5.21 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.742 -178.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.611 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 10.0 mt -57.33 -62.18 5.76 Favored Pre-proline 0 N--CA 1.471 0.585 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -175.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.43 ' HG2' ' ND1' ' A' ' 80' ' ' HIS . 19.8 Cg_endo -63.99 1.24 1.6 Allowed 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 121.702 1.602 . . . . 0.0 113.483 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.97 -36.38 14.13 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.844 0.354 . . . . 0.0 110.323 177.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.611 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.1 pp -76.68 -32.69 58.07 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.465 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 80.0 mt -63.45 -28.7 70.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.857 176.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.9 tp10 -77.8 -38.72 45.94 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.758 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -64.88 -37.4 87.51 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.421 0.629 . . . . 0.0 110.884 178.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.635 ' CG ' HD22 ' A' ' 93' ' ' LEU . 30.3 m-85 -80.55 -2.75 47.52 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.958 -176.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 85' ' ' LEU . 97.5 mttt -69.9 -27.02 64.45 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.889 174.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.4 pp -120.1 9.0 6.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.889 179.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 -90.6 -39.89 12.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.627 -178.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.467 ' HD2' ' C ' ' A' ' 95' ' ' THR . 82.0 m-85 67.51 84.86 0.15 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.173 -169.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.687 ' HA ' ' OE2' ' A' ' 154' ' ' GLU . 5.8 mt -56.39 -20.79 21.1 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 122.241 1.02 . . . . 0.0 111.007 178.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.546 ' OD1' HG21 ' A' ' 96' ' ' THR . 0.1 OUTLIER -134.78 -68.41 0.54 Allowed 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.003 -1.453 . . . . 0.0 109.063 -179.666 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.754 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 8.8 t -177.64 15.93 0.0 OUTLIER 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 114.198 -1.364 . . . . 0.0 108.548 174.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.546 HG21 ' OD1' ' A' ' 94' ' ' ASP . 4.9 t -129.58 -28.48 2.27 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.492 ' O ' HG23 ' A' ' 96' ' ' THR . 12.8 p 78.82 -179.52 0.11 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.964 1.306 . . . . 0.0 110.805 -175.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.447 HD21 ' CG ' ' A' ' 36' ' ' PHE . 89.9 mt -78.77 89.62 4.63 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.804 177.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 50.2 mm -75.6 -54.44 13.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.723 -177.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.594 ' O ' ' HA ' ' A' ' 35' ' ' MET . 15.5 pt-20 -157.22 152.72 22.18 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.561 -177.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.471 ' HB3' ' HB3' ' A' ' 14' ' ' TRP . 72.8 Cg_endo -76.06 148.58 31.47 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.262 1.975 . . . . 0.0 112.135 176.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.495 ' HB1' HD21 ' A' ' 28' ' ' LEU . . . -73.04 146.05 86.9 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.206 178.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.49 124.18 15.25 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.465 2.11 . . . . 0.0 111.232 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.647 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 34.8 ptt180 . . . . . 0 C--N 1.328 -0.329 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -172.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.566 ' HG ' ' HD2' ' A' ' 155' ' ' LYS . 4.6 mm? . . . . . 0 N--CA 1.464 0.257 0 CA-C-O 121.779 0.8 . . . . 0.0 112.779 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.759 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 0.6 OUTLIER -178.35 -72.44 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.033 -1.44 . . . . 0.0 107.858 179.59 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . 0.419 ' O ' ' HB3' ' A' ' 180' ' ' LYS . 70.8 m-85 -96.95 107.45 19.98 Favored 'General case' 0 CA--C 1.495 -1.148 0 C-N-CA 119.199 -1.0 . . . . 0.0 110.569 -179.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.997 HG23 ' HG3' ' A' ' 180' ' ' LYS . 89.4 t -124.16 126.67 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 CA-C-N 114.55 -1.205 . . . . 0.0 109.301 175.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.671 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 6.5 ptp180 -107.52 142.79 36.85 Favored 'General case' 0 N--CA 1.435 -1.175 0 C-N-CA 117.528 -1.669 . . . . 0.0 108.093 171.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.49 ' HB ' ' CD1' ' A' ' 144' ' ' PHE . 0.8 OUTLIER -102.58 127.4 49.68 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.873 -176.941 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.542 ' CD1' ' HB2' ' A' ' 179' ' ' GLU . 6.3 mt -100.21 -21.73 15.4 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.629 -174.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.421 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 30.1 t80 -81.17 -35.88 30.88 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.93 -171.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.578 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 13.6 t70 71.06 101.14 0.06 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.688 0.756 . . . . 0.0 110.562 -175.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 51.5 t80 -129.87 85.6 57.4 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 177.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.604 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 94.8 Cg_endo -82.17 80.43 2.81 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 121.896 1.731 . . . . 0.0 112.773 -178.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -75.97 -30.59 57.27 Favored Glycine 0 C--N 1.329 0.173 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.765 178.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 66.04 50.95 1.37 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.096 -0.552 . . . . 0.0 111.234 179.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -142.14 177.75 8.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.414 177.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.494 ' O ' ' HA2' ' A' ' 171' ' ' GLY . . . -92.71 -11.0 35.12 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.73 0.776 . . . . 0.0 109.136 172.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.429 ' O ' ' HB2' ' A' ' 172' ' ' MET . 44.9 mt-10 -91.95 -31.95 15.44 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.001 -0.999 . . . . 0.0 109.537 175.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -127.57 104.82 8.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.317 176.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.87 ' CD1' ' HD2' ' A' ' 169' ' ' ARG . 32.1 tp -65.42 129.52 94.42 Favored Pre-proline 0 C--N 1.327 -0.394 0 C-N-CA 120.562 -0.455 . . . . 0.0 109.977 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.604 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 72.6 Cg_endo -78.78 88.57 1.44 Allowed 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 121.541 1.494 . . . . 0.0 111.511 175.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.512 ' CE2' ' HB ' ' A' ' 173' ' ' ILE . 10.4 p90 -103.49 156.14 17.99 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.96 -174.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.578 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -96.85 -171.63 2.28 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.189 0.441 . . . . 0.0 112.189 -174.858 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.812 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -92.81 33.05 1.17 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.942 -174.029 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 159.51 31.33 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.555 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.521 ' HB3' ' HB2' ' A' ' 145' ' ' LYS . 0.1 OUTLIER -101.01 152.71 20.25 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.663 -176.554 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.576 HD13 ' N ' ' A' ' 149' ' ' ILE . 1.7 mp -97.55 127.14 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-O 121.496 0.665 . . . . 0.0 109.802 -176.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.722 HD23 ' CD2' ' A' ' 142' ' ' LEU . 9.7 mt -121.63 157.71 30.21 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 -176.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.759 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 92.7 t -118.09 124.19 72.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 174.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.518 HG21 HD13 ' A' ' 125' ' ' LEU . 43.6 mm -75.93 79.66 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 122.024 0.916 . . . . 0.0 108.717 -177.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.482 HD11 ' CE1' ' A' ' 61' ' ' TYR . 18.4 tt -70.37 -29.7 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-N 114.005 -1.452 . . . . 0.0 109.76 -176.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.737 ' HA ' HH21 ' A' ' 57' ' ' ARG . 0.4 OUTLIER -131.44 141.72 49.87 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 172.152 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.566 ' HD2' ' HG ' ' A' ' 125' ' ' LEU . 81.4 tttt -134.77 87.83 29.64 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 172.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.754 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 2.3 Cg_endo -82.5 -37.78 0.2 Allowed 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.695 2.264 . . . . 0.0 111.8 176.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.598 ' HG2' ' CE ' ' A' ' 172' ' ' MET . 25.2 mm-40 -109.91 168.13 9.65 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.755 -174.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.499 ' O ' HG23 ' A' ' 175' ' ' VAL . 6.1 pt-20 -101.67 -16.86 16.55 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.462 178.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.403 ' C ' HG21 ' A' ' 175' ' ' VAL . 5.2 tp-100 -107.32 -11.72 15.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.163 0.506 . . . . 0.0 109.873 176.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -129.07 121.6 28.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.212 176.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . 0.684 ' O ' HG13 ' A' ' 173' ' ' ILE . 49.2 m0 -115.32 134.87 54.72 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.501 -178.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.563 ' HA ' ' HA ' ' A' ' 172' ' ' MET . 13.4 m -93.79 94.22 8.41 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -173.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.527 ' HB2' ' HB3' ' A' ' 150' ' ' LEU . . . -108.54 147.05 32.33 Favored 'General case' 0 N--CA 1.419 -1.998 0 C-N-CA 119.501 -0.88 . . . . 0.0 109.703 -171.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.829 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 15.8 ptt-85 -86.79 119.66 27.25 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 175.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.648 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . 18.1 t30 -53.34 177.69 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 113.724 -1.58 . . . . 0.0 110.865 -176.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -63.56 -15.31 57.68 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 168.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -69.28 -30.38 68.47 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.74 169.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 90.28 25.79 25.29 Favored Glycine 0 C--O 1.228 -0.259 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.16 -170.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.87 ' HD2' ' CD1' ' A' ' 142' ' ' LEU . 0.3 OUTLIER -105.06 138.14 41.72 Favored 'General case' 0 C--O 1.217 -0.608 0 C-N-CA 123.437 0.695 . . . . 0.0 111.331 -174.003 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.476 HG22 HG23 ' A' ' 153' ' ' ILE . 24.1 t -86.45 119.75 35.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -175.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 139' ' ' ALA . . . -152.49 148.94 20.44 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.696 170.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.598 ' CE ' ' HG2' ' A' ' 157' ' ' GLU . 59.6 mtp -78.43 142.48 37.51 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 117.663 0.731 . . . . 0.0 110.703 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.684 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.7 pp -140.54 145.47 40.78 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.9 -173.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.529 ' HB2' ' CD1' ' A' ' 177' ' ' TYR . 17.6 Cg_exo -68.41 129.87 19.93 Favored 'Trans proline' 0 N--CA 1.465 -0.149 0 C-N-CA 122.959 2.439 . . . . 0.0 113.104 -177.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.554 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 58.0 t -62.62 -42.22 77.68 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 29.0 Cg_endo -63.62 -5.16 8.14 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 121.951 1.767 . . . . 0.0 112.682 177.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.529 ' CD1' ' HB2' ' A' ' 174' ' ' PRO . 3.0 m-85 -91.95 -15.8 27.5 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.442 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.595 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 3.2 m -105.95 -174.04 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -163.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.671 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 3.5 tp10 -159.95 49.22 0.29 Allowed 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 113.071 -1.877 . . . . 0.0 112.454 -150.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.997 ' HG3' HG23 ' A' ' 128' ' ' VAL . 0.5 OUTLIER -69.27 170.73 9.68 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 118.937 -2.352 . . . . 0.0 111.308 -160.511 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 15.9 tp . . . . . 0 C--O 1.236 0.355 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.767 -168.131 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo . . . . . 0 N--CA 1.445 -1.336 0 N-CA-C 110.291 -0.696 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.413 ' CG1' HD11 ' A' ' 293' ' ' ILE . 15.2 t -95.3 138.93 19.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.158 0.504 . . . . 0.0 111.393 -171.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -109.9 121.68 45.8 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.833 177.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . 0.495 ' HB3' HD13 ' A' ' 293' ' ' ILE . . . -118.68 155.02 31.78 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.887 -175.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -99.84 120.47 39.81 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.779 179.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . 0.528 ' HA ' HG11 ' A' ' 291' ' ' VAL . . . -72.31 106.78 4.6 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 175.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 41.2 pt -94.85 -5.83 10.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.159 0.504 . . . . 0.0 110.995 -176.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -137.37 140.76 41.61 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.98 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -63.62 126.29 27.05 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 176.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.536 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 24.5 tpt180 -125.62 101.89 7.1 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.968 0.413 . . . . 0.0 110.562 -178.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 25.7 m -111.94 150.13 41.9 Favored Pre-proline 0 C--N 1.316 -0.88 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 174.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -62.89 102.73 0.31 Allowed 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.245 1.963 . . . . 0.0 111.865 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 250' ' ' ALA . 45.8 t -73.33 178.17 4.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.58 -177.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . 0.405 ' N ' ' SG ' ' A' ' 249' ' ' CYS . . . -63.74 -25.2 68.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.853 -177.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -99.11 1.11 44.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.876 0.37 . . . . 0.0 111.314 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . 0.403 ' HB3' ' HB1' ' A' ' 255' ' ' ALA . 46.7 m-20 -101.32 161.13 13.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.233 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -138.74 -66.12 0.48 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.393 178.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 2.3 m -82.49 10.34 7.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.006 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 285' ' ' LEU . . . -65.57 119.07 10.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.044 0.449 . . . . 0.0 111.434 -175.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.2 tt -72.27 140.51 48.65 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.696 178.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.536 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -86.88 117.53 25.68 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.333 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 84.5 mt -126.86 142.69 51.48 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.557 -177.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -106.56 158.34 17.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.085 177.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 45.0 t -70.23 109.99 3.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.975 0.417 . . . . 0.0 110.088 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 108.54 11.69 22.79 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.852 -0.69 . . . . 0.0 111.948 -177.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -95.3 146.64 24.22 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 39.8 mm -90.28 117.63 33.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.914 0.388 . . . . 0.0 110.651 -179.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.405 HG22 HG12 ' A' ' 291' ' ' VAL . 22.0 t -92.94 109.4 21.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.432 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -91.11 88.18 6.86 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.065 178.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 7.6 p -88.67 125.47 41.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.341 0.591 . . . . 0.0 110.536 -177.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 37.2 p -97.27 -31.1 12.59 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.527 -175.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . 0.475 ' HD3' ' OE1' ' A' ' 276' ' ' GLU . 55.8 mtp180 -131.2 113.87 14.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.723 -177.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' MET . . . . . 0.655 ' HE1' ' CH2' ' A' ' 275' ' ' TRP . 31.6 mtt -93.86 113.42 25.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.124 178.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -83.57 169.98 14.84 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.576 176.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 32.4 mm -94.75 -20.32 6.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.476 -176.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -81.68 3.89 23.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.758 -176.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 99.31 -35.17 4.87 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.55 -0.833 . . . . 0.0 113.129 174.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -84.2 111.32 19.26 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.655 ' CH2' ' HE1' ' A' ' 269' ' ' MET . 41.1 m0 -93.53 158.45 15.7 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.297 -177.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . 0.475 ' OE1' ' HD3' ' A' ' 268' ' ' ARG . 58.7 mt-10 -91.66 106.75 18.71 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 172.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -108.52 146.33 16.49 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.012 -176.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -114.81 106.26 13.98 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 176.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . 0.578 HG11 ' ND2' ' A' ' 280' ' ' ASN . 15.1 t -141.48 134.11 29.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -175.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . 0.578 ' ND2' HG11 ' A' ' 279' ' ' VAL . 52.1 m-80 62.21 23.59 13.96 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.251 -177.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 84.5 -4.19 84.78 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.511 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 -104.62 134.07 48.4 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.865 0.364 . . . . 0.0 111.021 -176.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 42.8 tttp -104.78 117.33 33.79 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.176 177.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -146.79 175.51 26.16 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' A' ' 255' ' ' ALA . 89.5 mt -94.61 143.8 26.13 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 177.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.407 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 43.2 p90 -144.7 139.83 15.81 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.301 176.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 15.4 Cg_exo -69.59 125.11 11.84 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.651 2.234 . . . . 0.0 111.19 173.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -58.71 -19.96 44.53 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.269 -0.423 . . . . 0.0 112.04 -175.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 15.8 p -67.66 -9.26 41.75 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -177.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -99.55 -7.86 25.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.903 0.383 . . . . 0.0 111.053 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.528 HG11 ' HA ' ' A' ' 242' ' ' ALA . 34.0 m -127.56 170.12 17.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.891 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -138.77 134.83 33.98 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.07 0.462 . . . . 0.0 110.83 174.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.495 HD13 ' HB3' ' A' ' 240' ' ' ALA . 46.9 mm -76.78 128.81 37.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.329 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -138.61 -36.04 0.57 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.401 178.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 62.36 103.47 0.03 OUTLIER Pre-proline 0 C--N 1.341 0.197 0 CA-C-O 121.418 0.628 . . . . 0.0 111.354 -178.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo . . . . . 0 C--O 1.235 0.351 0 C-N-CA 123.209 2.606 . . . . 0.0 111.677 -178.824 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.451 -0.402 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.527 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . -75.51 89.92 2.72 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.429 171.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -119.09 95.72 4.93 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.607 0.718 . . . . 0.0 111.741 -175.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.415 ' HE1' ' O ' ' A' ' 98' ' ' LEU . 12.2 p90 -159.66 169.84 22.87 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.532 174.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.404 ' C ' ' H ' ' A' ' 9' ' ' SER . 13.4 m-20 -75.83 -26.83 57.54 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -173.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.0 t 72.61 -39.16 0.44 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.622 0.769 . . . . 0.0 111.382 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.404 ' H ' ' C ' ' A' ' 7' ' ' ASP . 13.1 m -91.03 -26.11 19.35 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.49 0.186 . . . . 0.0 111.1 178.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -63.36 105.76 0.8 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.987 0.422 . . . . 0.0 111.291 -172.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -60.62 -39.75 89.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.63 -176.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.1 m -72.99 -3.18 24.43 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.614 -176.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.52 -41.74 10.09 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.654 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 33.1 p-90 -125.09 -21.68 4.6 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -172.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -71.6 109.25 5.41 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.044 -176.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.815 ' SD ' ' HA ' ' A' ' 104' ' ' ARG . 8.3 tpp -91.03 -9.25 46.56 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.649 -174.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.443 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 50.6 -112.07 1.46 Allowed Glycine 0 CA--C 1.52 0.358 0 CA-C-N 115.55 -0.75 . . . . 0.0 113.986 177.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.443 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 19.3 Cg_exo -66.15 82.18 0.28 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.424 2.749 . . . . 0.0 113.324 -177.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.8 HG11 ' H ' ' A' ' 20' ' ' SER . 59.5 t -139.68 -178.31 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.8 ' H ' HG11 ' A' ' 19' ' ' VAL . 47.4 t -168.62 178.88 4.52 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 -166.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.476 ' O ' ' HG2' ' A' ' 25' ' ' GLN . 0.1 OUTLIER -58.73 -45.16 90.24 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 118.59 0.632 . . . . 0.0 109.391 176.222 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -60.07 -60.2 4.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.799 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.542 ' O ' ' HG3' ' A' ' 27' ' ' ARG . 29.5 mm-40 -56.94 -49.31 76.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.007 -178.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.507 ' HB1' ' O ' ' A' ' 20' ' ' SER . . . -56.83 -38.0 72.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.582 -175.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.552 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 16.4 mm100 -61.9 -52.69 63.07 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.889 178.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.2 t -70.45 -10.54 59.41 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -172.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.542 ' HG3' ' O ' ' A' ' 23' ' ' GLU . 55.5 mtp180 -100.44 -11.2 20.4 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 121.081 -0.248 . . . . 0.0 111.338 -179.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.564 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 62.9 mt -132.2 -13.0 3.15 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -176.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.552 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -68.69 109.0 3.6 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.919 -0.488 . . . . 0.0 109.944 -178.316 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.52 26.1 66.3 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.393 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.418 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 13.3 mm100 -94.07 -170.61 2.34 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 178.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.519 ' HB2' ' SD ' ' A' ' 35' ' ' MET . 56.0 mtm180 -61.81 150.83 35.99 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 177.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.43 ' CE1' ' HA ' ' A' ' 55' ' ' ASN . 55.9 m170 -92.31 113.92 26.33 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -178.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.476 ' CA ' HG22 ' A' ' 96' ' ' THR . . . 127.75 -4.62 7.02 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.746 -175.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.608 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 62.8 mtp -84.7 143.14 29.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.464 -0.368 . . . . 0.0 110.387 178.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.529 ' CD1' HD21 ' A' ' 98' ' ' LEU . 46.9 p90 -149.6 159.19 44.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.742 -0.208 . . . . 0.0 110.604 -178.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.605 ' HB2' ' HB2' ' A' ' 16' ' ' MET . 4.6 pp -150.69 138.52 19.92 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.141 0.496 . . . . 0.0 111.01 177.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 85.5 t -105.19 119.89 54.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 174.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.511 ' CB ' ' HB ' ' A' ' 19' ' ' VAL . 28.2 ptt-85 -117.08 161.58 19.18 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.89 -174.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -73.87 124.51 26.26 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 173.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.473 ' HB2' HG22 ' A' ' 49' ' ' VAL . 47.2 t -87.56 143.98 26.93 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.0 0.429 . . . . 0.0 110.902 -176.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.4 p -91.9 4.25 53.38 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.234 176.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 26.4 m -76.28 -43.12 43.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.173 175.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.463 ' HB2' ' HB2' ' A' ' 47' ' ' ASP . 11.7 m -143.66 135.27 12.84 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -70.38 72.84 1.72 Allowed 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.453 2.102 . . . . 0.0 111.677 176.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.444 ' O ' ' HB2' ' A' ' 65' ' ' SER . . . 155.55 -23.51 0.56 Allowed Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -176.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.463 ' HB2' ' HB2' ' A' ' 44' ' ' CYS . 16.0 m-20 -81.79 155.83 25.23 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 176.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -131.79 177.21 7.7 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.543 HG11 HD11 ' A' ' 62' ' ' ILE . 38.7 t -145.4 115.3 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.714 0.292 . . . . 0.0 111.288 177.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.435 HD13 ' HB2' ' A' ' 36' ' ' PHE . 57.5 tp -81.61 103.94 11.67 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.267 175.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.5 m -96.92 127.84 43.28 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 176.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.545 HG21 HD12 ' A' ' 93' ' ' LEU . 59.7 t -121.69 133.27 68.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.025 0.44 . . . . 0.0 111.063 -175.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.564 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 26.6 t -91.0 110.31 21.57 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.531 -178.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.635 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 40.8 mt-10 -146.78 136.88 23.47 Favored 'General case' 0 C--O 1.21 -0.984 0 C-N-CA 119.673 -0.811 . . . . 0.0 109.678 175.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.43 ' HA ' ' CE1' ' A' ' 33' ' ' HIS . 80.2 m-20 52.95 31.09 10.3 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 174.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 44.8 m 58.33 53.31 6.49 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 122.134 0.968 . . . . 0.0 109.367 -178.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.88 HH21 ' HB2' ' A' ' 94' ' ' ASP 0.256 0.2 OUTLIER -168.39 67.94 0.07 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 113.577 -1.647 . . . . 0.0 108.668 -156.915 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 21.7 t -72.49 102.8 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 O-C-N 120.588 -1.32 . . . . 0.0 110.299 -167.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.6 m -73.61 118.88 17.08 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 113.133 -1.849 . . . . 0.0 110.737 -176.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -97.93 113.53 25.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.854 0.359 . . . . 0.0 111.43 -178.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.508 ' HB3' ' CD1' ' A' ' 73' ' ' ILE . 70.2 m-85 -107.24 110.2 22.18 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.964 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.796 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 34.2 mm -77.46 132.75 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -173.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.511 HG22 ' HB3' ' A' ' 71' ' ' PHE . 3.7 mp -115.84 115.91 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 120.947 0.403 . . . . 0.0 111.125 177.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -88.57 142.71 27.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.371 -177.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' A' ' 46' ' ' GLY . 35.9 t -83.38 100.15 10.5 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 169.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 90.3 mt -78.11 140.42 61.69 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -59.05 -15.45 27.95 Favored 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 122.982 2.455 . . . . 0.0 112.446 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -83.45 10.79 8.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.419 176.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? 63.59 27.81 15.02 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.667 -178.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.445 ' NH2' ' HB3' ' A' ' 77' ' ' GLU . 37.0 mtp180 -115.44 -175.21 2.66 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.988 -1.006 . . . . 0.0 109.52 178.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.511 ' HB3' HG22 ' A' ' 63' ' ' ILE . 62.0 m-85 -135.57 143.44 45.67 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.063 0.459 . . . . 0.0 111.735 -175.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -123.47 116.46 23.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.992 177.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.796 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 7.9 tt -102.87 94.74 3.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.493 0.663 . . . . 0.0 110.807 -179.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 58.78 68.75 1.53 Allowed Glycine 0 C--N 1.331 0.284 0 CA-C-N 115.098 -0.955 . . . . 0.0 112.651 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.4 t0 76.55 -45.01 0.49 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 122.628 0.371 . . . . 0.0 111.333 178.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -75.78 129.18 36.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.146 0.498 . . . . 0.0 110.861 -178.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.445 ' HB3' ' NH2' ' A' ' 70' ' ' ARG . 64.6 mt-10 -101.32 153.3 19.77 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.428 -177.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.457 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 96.8 m-85 -141.01 -173.91 3.85 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.041 173.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -77.68 -48.76 15.97 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.019 0.438 . . . . 0.0 110.729 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.728 ' HD1' ' HD2' ' A' ' 82' ' ' PRO . 4.7 p80 -156.89 -179.38 8.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.397 -178.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.604 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 14.2 mt -57.77 -57.1 27.93 Favored Pre-proline 0 N--CA 1.469 0.493 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -178.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.728 ' HD2' ' HD1' ' A' ' 80' ' ' HIS . 24.4 Cg_exo -64.37 -2.33 4.86 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.13 1.887 . . . . 0.0 112.948 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.9 -36.8 14.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.793 0.33 . . . . 0.0 110.348 179.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.604 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.7 pp -76.78 -31.11 56.8 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.459 ' HA ' ' CD1' ' A' ' 98' ' ' LEU . 57.2 mt -67.62 -26.72 66.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.653 174.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -79.12 -33.44 44.29 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.788 177.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -76.07 -38.11 57.47 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.028 0.442 . . . . 0.0 111.049 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.757 ' CD1' HD22 ' A' ' 93' ' ' LEU . 33.5 m-85 -76.26 1.55 15.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.962 0.41 . . . . 0.0 111.779 -177.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -70.27 -25.99 63.61 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.45 171.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 29.8 pt -117.14 26.57 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 120.585 -0.446 . . . . 0.0 112.067 178.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.427 ' O ' ' HB2' ' A' ' 92' ' ' TYR . 2.8 t-160 -114.46 -42.64 3.27 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -175.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.466 ' CD1' HG21 ' A' ' 97' ' ' THR . 97.8 m-85 70.46 86.62 0.12 Allowed 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.751 0.657 . . . . 0.0 110.278 -171.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.757 HD22 ' CD1' ' A' ' 88' ' ' TYR . 14.8 mt -59.94 -30.75 69.28 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.51 -178.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.88 ' HB2' HH21 ' A' ' 57' ' ' ARG . 31.6 t0 -160.94 68.55 0.33 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.317 0.58 . . . . 0.0 109.863 170.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.531 HG22 ' O ' ' A' ' 94' ' ' ASP . 0.5 OUTLIER 70.2 -4.49 1.54 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.956 -175.629 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.635 ' HB ' ' OE2' ' A' ' 54' ' ' GLU . 16.2 m -127.73 138.84 52.9 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 121.237 0.542 . . . . 0.0 109.933 178.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.47 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.5 p -89.5 168.39 12.22 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 173.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.529 HD21 ' CD1' ' A' ' 36' ' ' PHE . 97.3 mt -63.58 96.36 0.12 Allowed 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.635 -0.426 . . . . 0.0 109.871 178.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.527 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 49.0 mm -86.06 -56.72 5.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.645 -174.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.608 ' O ' ' HA ' ' A' ' 35' ' ' MET . 42.5 tt0 -158.85 133.39 5.37 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.912 -176.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 100' ' ' GLU . 17.8 Cg_exo -64.91 157.75 55.03 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 122.88 2.386 . . . . 0.0 112.829 -177.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.09 141.13 86.15 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.9 112.44 1.21 Allowed 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.384 2.056 . . . . 0.0 112.116 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.815 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 41.7 ttp180 . . . . . 0 C--O 1.234 0.241 0 CA-C-O 121.374 0.607 . . . . 0.0 109.474 178.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.515 HD22 ' N ' ' A' ' 125' ' ' LEU . 3.3 mm? . . . . . 0 CA--C 1.515 -0.399 0 CA-C-O 121.771 0.796 . . . . 0.0 111.803 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.513 ' HG2' ' CD2' ' A' ' 127' ' ' TYR . 28.4 tt0 -171.72 -78.23 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.531 -1.213 . . . . 0.0 109.674 -174.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . 0.513 ' CD2' ' HG2' ' A' ' 126' ' ' GLU . 54.7 m-85 -117.57 107.85 14.76 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.377 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.703 HG22 ' CG ' ' A' ' 180' ' ' LYS . 56.6 t -114.87 131.11 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -178.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.648 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 0.2 OUTLIER -109.79 144.66 37.91 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 116.892 -1.923 . . . . 0.0 108.989 170.988 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.417 ' HG1' ' HB2' ' A' ' 144' ' ' PHE . 1.2 p -100.68 128.91 46.56 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.316 -179.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.534 HD22 ' HG2' ' A' ' 179' ' ' GLU . 14.8 mt -105.27 -23.16 12.92 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.934 -176.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.45 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 32.6 t80 -79.9 -33.41 39.89 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.727 -173.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.598 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 15.7 t70 71.77 120.14 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.365 0.602 . . . . 0.0 110.842 -174.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.544 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 64.4 t80 -153.85 91.96 3.16 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.573 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 74.2 Cg_endo -90.0 86.77 0.39 Allowed 'Trans proline' 0 N--CA 1.441 -1.605 0 C-N-CA 122.014 1.809 . . . . 0.0 112.573 177.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -76.79 -16.11 81.04 Favored Glycine 0 C--N 1.331 0.298 0 N-CA-C 111.056 -0.817 . . . . 0.0 111.056 174.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.675 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 18.1 m120 52.97 68.31 0.86 Allowed 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.21 -0.995 . . . . 0.0 111.8 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.478 ' HB3' ' H ' ' A' ' 141' ' ' ASP . 1.0 OUTLIER -136.27 -174.87 3.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.229 0.538 . . . . 0.0 110.932 -178.962 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -115.32 3.69 14.27 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 166.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.415 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 32.9 tt0 -112.34 -49.74 2.94 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 113.9 -1.5 . . . . 0.0 108.65 177.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.478 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 4.9 m-20 -96.64 133.28 41.36 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.852 167.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.705 ' CD2' HD23 ' A' ' 150' ' ' LEU . 34.2 tp -83.62 131.65 51.68 Favored Pre-proline 0 N--CA 1.468 0.44 0 O-C-N 122.075 -0.39 . . . . 0.0 110.135 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.675 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 11.6 Cg_endo -85.63 91.06 0.69 Allowed 'Trans proline' 0 N--CA 1.444 -1.425 0 C-N-CA 122.115 1.877 . . . . 0.0 111.266 172.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.582 ' CE2' ' HB ' ' A' ' 173' ' ' ILE . 12.8 p90 -103.71 159.48 15.59 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.234 -176.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.598 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 5.0 mppt? -104.91 -168.28 1.45 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.262 0.554 . . . . 0.0 112.195 -178.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.682 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -86.84 9.11 20.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.0 -169.688 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -172.63 36.93 0.14 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.857 175.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.528 ' OE1' ' HA ' ' A' ' 144' ' ' PHE . 0.3 OUTLIER -101.06 149.05 24.35 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.351 -175.648 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.631 HD12 ' HB3' ' A' ' 129' ' ' ARG . 0.3 OUTLIER -89.06 124.57 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.677 -178.116 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.705 HD23 ' CD2' ' A' ' 142' ' ' LEU . 19.3 mt -119.45 155.35 32.21 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.551 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 67.6 t -117.56 125.53 74.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 174.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.472 HG13 HD12 ' A' ' 125' ' ' LEU . 49.5 mm -76.54 87.18 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 122.423 1.106 . . . . 0.0 108.118 -176.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.466 HG22 HG21 ' A' ' 170' ' ' VAL . 17.9 tt -75.66 -25.1 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 CA-C-N 113.292 -1.776 . . . . 0.0 109.875 -174.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.685 ' OE2' ' HA ' ' A' ' 93' ' ' LEU . 0.2 OUTLIER -141.0 141.21 34.39 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 170.458 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 61.0 tttt -128.83 92.75 39.16 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.44 0.638 . . . . 0.0 110.356 170.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.538 ' HG2' ' HE1' ' A' ' 172' ' ' MET . 10.3 Cg_exo -74.3 -44.04 0.46 Allowed 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.338 2.025 . . . . 0.0 112.002 172.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -120.2 178.74 4.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.099 -172.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.401 ' HA ' ' HE1' ' A' ' 161' ' ' TRP . 6.7 pt-20 -116.12 4.68 13.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.094 0.473 . . . . 0.0 110.672 174.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -102.34 -31.26 10.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.696 172.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.422 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 34.5 m95 -129.11 146.16 51.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.613 173.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . 0.73 ' O ' HG13 ' A' ' 173' ' ' ILE . 47.8 m0 -126.79 138.33 53.34 Favored 'General case' 0 C--O 1.215 -0.757 0 C-N-CA 122.788 0.435 . . . . 0.0 110.657 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.545 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 25.6 m -95.4 96.33 9.05 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -175.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.564 ' HB2' ' HB3' ' A' ' 150' ' ' LEU . . . -108.7 150.29 27.77 Favored 'General case' 0 N--CA 1.422 -1.833 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.505 -172.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.772 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 12.7 ptt180 -87.46 122.17 30.85 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 173.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.653 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . 17.5 t30 -54.61 176.79 0.04 OUTLIER 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 113.293 -1.776 . . . . 0.0 110.91 -177.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.527 ' HD2' ' H ' ' A' ' 149' ' ' ILE . 30.9 mtpt -62.95 -17.98 62.61 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.828 169.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -68.94 -36.24 77.72 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.468 0.652 . . . . 0.0 109.46 168.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.419 ' C ' ' HB2' ' A' ' 164' ' ' ARG . . . 105.06 3.96 41.75 Favored Glycine 0 CA--C 1.524 0.598 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.343 -172.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.772 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -79.33 137.59 37.39 Favored 'General case' 0 C--O 1.218 -0.574 0 C-N-CA 123.16 0.584 . . . . 0.0 111.77 -178.77 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.466 HG21 HG22 ' A' ' 153' ' ' ILE . 22.1 t -79.87 125.87 39.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 120.417 0.151 . . . . 0.0 111.291 177.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -157.88 148.37 17.67 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 120.209 -0.996 . . . . 0.0 112.665 169.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.538 ' HE1' ' HG2' ' A' ' 156' ' ' PRO . 0.4 OUTLIER -69.88 140.65 53.19 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 122.756 0.422 . . . . 0.0 111.378 179.408 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.73 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.6 pp -144.45 144.39 25.1 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.105 -176.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.516 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 8.1 Cg_exo -73.38 132.13 17.3 Favored 'Trans proline' 0 C--O 1.23 0.115 0 C-N-CA 122.498 2.132 . . . . 0.0 112.644 -174.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.593 ' O ' HG23 ' A' ' 178' ' ' VAL . 82.9 t -60.98 -44.03 93.2 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 19.0 Cg_endo -61.08 -11.2 17.56 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 121.981 1.787 . . . . 0.0 112.873 177.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.516 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.1 m-85 -88.22 -15.18 36.63 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.525 -178.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.602 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 4.1 m -106.58 -172.44 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 115.558 1.688 . . . . 0.0 115.558 -164.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.667 ' O ' ' HG3' ' A' ' 179' ' ' GLU . 3.9 tp10 -159.9 44.32 0.22 Allowed 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 112.941 -1.936 . . . . 0.0 111.638 -154.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.748 ' HD2' ' H ' ' A' ' 180' ' ' LYS . 0.0 OUTLIER -74.13 144.23 44.99 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 119.275 -2.141 . . . . 0.0 111.554 -166.07 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.448 ' HB2' HH12 ' A' ' 129' ' ' ARG . 23.8 tp . . . . . 0 N--CA 1.448 -0.533 0 CA-C-N 111.416 -2.629 . . . . 0.0 114.282 -157.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo . . . . . 0 N--CA 1.46 -0.473 0 N-CA-C 111.283 -0.314 . . . . 0.0 111.283 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.438 ' CG1' HD11 ' A' ' 293' ' ' ILE . 21.7 t -84.71 134.55 26.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.945 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.518 ' HB2' ' CG ' ' A' ' 296' ' ' PRO . 93.8 m-85 -104.46 124.24 48.9 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.141 0.496 . . . . 0.0 110.468 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . 0.511 ' HB3' HD13 ' A' ' 293' ' ' ILE . . . -119.24 140.65 49.89 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.26 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -88.2 124.36 33.76 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . 0.51 ' HA ' HG11 ' A' ' 291' ' ' VAL . . . -75.29 99.52 4.09 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.253 178.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 39.4 pt -80.59 -23.26 11.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.276 0.56 . . . . 0.0 110.74 -177.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -135.26 148.52 49.59 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 177.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -67.79 169.56 9.47 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.239 0.542 . . . . 0.0 110.607 -178.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.55 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 27.3 tpt180 -154.1 109.78 3.2 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.166 178.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.4 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 24.0 m -108.77 150.15 40.43 Favored Pre-proline 0 C--N 1.315 -0.923 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 178.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.528 ' HA ' ' HB3' ' A' ' 255' ' ' ALA . 12.4 Cg_exo -68.44 110.5 2.29 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.416 2.077 . . . . 0.0 111.518 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' CYS . . . . . 0.51 ' HB3' ' HB2' ' A' ' 252' ' ' ASP . 51.9 t -70.52 164.65 24.32 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.907 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -53.34 -40.05 64.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.6 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -99.86 7.17 45.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.793 0.33 . . . . 0.0 111.493 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . 0.51 ' HB2' ' HB3' ' A' ' 249' ' ' CYS . 7.4 m-20 -127.6 69.19 1.31 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.132 0.491 . . . . 0.0 110.131 176.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -78.2 -21.58 49.86 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.178 0.513 . . . . 0.0 110.189 -179.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 19.8 p -83.04 -0.35 48.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.847 177.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . 0.528 ' HB3' ' HA ' ' A' ' 248' ' ' PRO . . . -77.19 132.59 38.84 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.572 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.62 137.28 40.64 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.026 -178.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -87.26 107.59 18.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.141 0.496 . . . . 0.0 110.095 179.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 94.4 mt -116.3 151.11 36.5 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.782 -176.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -119.13 157.0 28.77 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.22 176.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 47.4 t -65.03 122.64 16.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.565 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 96.28 18.45 31.09 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.801 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -99.38 170.5 8.59 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 177.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . 0.407 ' HA ' HD12 ' A' ' 263' ' ' ILE . 25.9 mm -117.76 112.83 40.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.042 0.449 . . . . 0.0 110.307 -178.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 239' ' ' PHE . 30.8 t -88.41 113.0 24.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.65 -178.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -92.26 87.59 6.13 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.829 177.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.445 HG21 ' HB3' ' A' ' 275' ' ' TRP . 3.0 p -92.69 120.05 41.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.384 0.611 . . . . 0.0 110.809 -177.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 1.4 p -94.03 -26.95 16.57 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.754 -178.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . 0.553 ' HB2' ' HB3' ' A' ' 276' ' ' GLU . 28.6 mmm180 -116.24 104.51 11.58 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.864 0.364 . . . . 0.0 110.938 -178.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 36.9 mmm -94.51 131.87 39.78 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 177.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 31.7 p30 -125.44 -179.16 4.49 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.638 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 19.6 pt -103.31 8.21 9.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.172 0.51 . . . . 0.0 110.738 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -81.35 -31.51 33.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.717 -176.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 117.91 -40.2 2.39 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.665 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.527 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 1.9 mp0 -94.76 114.98 26.96 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 174.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.445 ' HB3' HG21 ' A' ' 266' ' ' VAL . 21.9 m0 -91.68 157.53 16.9 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -177.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . 0.553 ' HB3' ' HB2' ' A' ' 268' ' ' ARG . 8.0 tp10 -90.39 103.08 15.8 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -115.91 137.96 14.17 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.266 -0.968 . . . . 0.0 113.559 -172.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -105.99 108.95 20.72 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 175.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . 0.418 HG22 ' HA ' ' A' ' 264' ' ' VAL . 37.9 t -119.47 -87.64 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.056 -0.658 . . . . 0.0 112.108 -173.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -105.08 76.25 1.23 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.936 0.398 . . . . 0.0 111.072 -174.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 66.15 20.73 69.38 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.825 176.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 282' ' ' ARG . 38.1 ttt-85 -158.87 137.41 10.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.838 0.319 . . . . 0.0 110.64 -175.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 38.1 ttpt -110.08 128.45 55.44 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.599 177.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -156.67 173.72 34.4 Favored Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 -178.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.527 ' HB3' ' HB3' ' A' ' 274' ' ' GLN . 72.5 mt -89.1 138.01 31.8 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.039 0.447 . . . . 0.0 110.417 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.445 ' O ' ' HA ' ' A' ' 274' ' ' GLN . 35.7 p90 -137.83 133.08 17.53 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.21 178.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.67 131.93 23.97 Favored 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 122.547 2.164 . . . . 0.0 111.656 176.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -65.62 -2.39 3.47 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.69 -177.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.89 -0.46 55.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.96 0.41 . . . . 0.0 111.296 -179.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -111.65 -12.5 13.89 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.801 0.334 . . . . 0.0 110.892 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.51 HG11 ' HA ' ' A' ' 242' ' ' ALA . 27.9 m -128.29 162.47 34.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.999 -179.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -136.43 132.35 35.33 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.944 0.402 . . . . 0.0 111.027 175.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.511 HD13 ' HB3' ' A' ' 240' ' ' ALA . 42.0 mm -72.29 129.81 35.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.454 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 294' ' ' PHE . . . . . 0.637 ' O ' ' HD3' ' A' ' 296' ' ' PRO . 10.2 p90 -135.08 -170.93 2.68 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.595 -179.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -98.07 97.08 3.99 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-O 121.357 0.599 . . . . 0.0 110.87 176.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . 0.637 ' HD3' ' O ' ' A' ' 294' ' ' PHE . 1.1 Cg_endo . . . . . 0 N--CA 1.458 -0.579 0 C-N-CA 122.921 2.414 . . . . 0.0 112.098 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.53 ' HB3' HD11 ' A' ' 99' ' ' ILE . 64.2 m . . . . . 0 N--CA 1.467 0.403 0 CA-C-O 120.508 0.194 . . . . 0.0 111.485 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.544 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . -72.36 107.22 4.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.689 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.442 ' HD3' ' HA ' ' A' ' 5' ' ' ARG . 19.1 mmt180 -137.55 100.05 4.11 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.112 0.482 . . . . 0.0 111.418 -178.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -167.65 159.69 12.16 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.33 -0.85 . . . . 0.0 108.88 177.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -83.11 108.42 16.37 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 177.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.633 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 15.4 m -74.89 55.86 0.71 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.319 179.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.1 m -161.85 -39.67 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.948 0.404 . . . . 0.0 110.781 -179.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -71.81 110.37 6.29 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.19 0.519 . . . . 0.0 111.386 -171.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -60.78 -35.65 77.0 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.712 -178.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.513 ' HA ' ' NH1' ' A' ' 104' ' ' ARG . 67.0 m -71.18 -3.57 20.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.504 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.73 -46.87 7.36 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.139 177.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 17.3 p-90 -118.57 -21.25 8.04 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -170.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -80.4 121.72 26.07 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 121.86 -0.525 . . . . 0.0 111.18 -173.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.563 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 23.1 mmt -99.81 -5.21 28.95 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.653 -176.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.438 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.15 -113.82 2.47 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 116.034 -0.53 . . . . 0.0 113.359 -176.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.438 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 9.2 Cg_exo -72.56 91.09 0.79 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.19 2.593 . . . . 0.0 113.511 -176.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.451 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 73.7 t -144.99 153.76 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 176.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.433 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 22.2 p -121.19 -179.83 4.17 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 118.233 0.469 . . . . 0.0 109.78 -174.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.596 ' HD2' HH22 ' A' ' 39' ' ' ARG . 21.2 mmm180 -55.25 -54.59 41.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.649 0.261 . . . . 0.0 110.879 177.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -64.47 -39.59 94.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.868 -175.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.492 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 50.4 mt-10 -69.68 -48.08 60.98 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.404 179.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.433 ' HB1' ' O ' ' A' ' 20' ' ' SER . . . -56.19 -38.8 71.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.017 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -53.2 -58.56 6.62 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.451 175.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.54 ' HA ' ' HB3' ' A' ' 29' ' ' GLN . 10.4 t -75.99 -2.63 31.48 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -171.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.492 ' HG2' ' O ' ' A' ' 23' ' ' GLU . 52.2 mmm-85 -85.29 -20.93 29.29 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.162 0.506 . . . . 0.0 109.682 175.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.552 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 29.7 mt -123.14 -12.71 7.87 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.737 -177.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.709 ' NE2' ' HB3' ' A' ' 57' ' ' ARG . 3.9 tp-100 -67.33 115.64 7.2 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.172 0.589 . . . . 0.0 111.743 -178.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 66.62 10.98 56.1 Favored Glycine 0 C--N 1.331 0.292 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.855 176.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.472 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 15.2 mm100 -70.1 -87.02 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -177.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -158.07 -4.36 0.09 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.45 ' HA ' ' OG ' ' A' ' 53' ' ' SER . 29.0 m170 71.17 161.37 0.23 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.359 0.599 . . . . 0.0 111.559 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.11 -22.55 8.15 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.07 177.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.736 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 57.9 mtm -82.25 147.44 28.94 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 178.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -140.25 164.37 30.26 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.261 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.563 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.3 pp -152.69 134.88 14.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.037 0.446 . . . . 0.0 111.463 178.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.6 t -105.81 127.29 60.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 173.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.596 HH22 ' HD2' ' A' ' 21' ' ' ARG . 31.9 ptt-85 -131.15 -178.45 4.84 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.684 -0.235 . . . . 0.0 110.652 -174.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -69.93 132.21 45.61 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 171.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.489 ' HA ' HG23 ' A' ' 49' ' ' VAL . 22.6 t -72.87 155.91 39.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.65 0.738 . . . . 0.0 112.246 -175.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.4 p -102.14 10.29 39.55 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.383 177.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 36.0 p -95.27 -51.54 4.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.855 178.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.7 p -165.91 144.11 4.81 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.127 179.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -57.54 125.37 18.57 Favored 'Trans proline' 0 C--O 1.237 0.471 0 C-N-CA 123.006 2.471 . . . . 0.0 112.268 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.65 -31.42 5.56 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -176.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -89.3 167.78 12.78 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 177.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -135.98 176.01 9.08 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.76 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.489 HG23 ' HA ' ' A' ' 41' ' ' SER . 48.4 t -142.93 110.87 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.945 0.402 . . . . 0.0 111.319 177.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.3 tp -80.84 105.61 12.2 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.184 174.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.0 m -98.27 131.57 44.48 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 174.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.612 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 46.2 t -118.64 143.13 30.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.493 -177.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.552 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 40.2 t -88.75 110.32 20.9 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 122.218 -0.301 . . . . 0.0 111.267 -177.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.495 ' HG2' ' O ' ' A' ' 94' ' ' ASP . 6.2 tp10 -177.85 165.93 2.05 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 174.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.538 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 2.6 m-80 60.3 50.48 6.17 Favored 'General case' 0 CA--C 1.48 -1.742 0 C-N-CA 123.905 0.882 . . . . 0.0 108.657 -168.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.445 ' HB2' ' O ' ' A' ' 55' ' ' ASN . 66.4 m 71.61 -28.7 0.19 Allowed 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 113.516 -1.675 . . . . 0.0 110.95 -171.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.709 ' HB3' ' NE2' ' A' ' 29' ' ' GLN 0.399 0.0 OUTLIER -153.21 -54.01 0.11 Allowed 'General case' 0 C--N 1.364 1.23 1 N-CA-C 124.965 5.172 . . . . 0.0 124.965 -174.619 . . . . . . . . 5 4 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.701 ' H ' ' NE ' ' A' ' 57' ' ' ARG . 1.7 t -152.29 120.8 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 CA-C-N 122.49 2.405 . . . . 0.0 114.046 -173.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.521 ' HB2' ' HB ' ' A' ' 52' ' ' VAL . 0.9 OUTLIER -97.98 110.83 23.33 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 163.513 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.571 ' CE1' HG11 ' A' ' 58' ' ' VAL . 92.4 m-70 -98.13 118.17 34.16 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 121.546 -0.721 . . . . 0.0 112.555 -173.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.672 ' OH ' ' HB3' ' A' ' 93' ' ' LEU . 37.2 m-85 -122.36 109.21 14.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.674 179.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.564 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 67.9 mt -81.03 135.12 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 O-C-N 121.859 -0.526 . . . . 0.0 111.636 -178.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.469 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 5.3 mp -112.96 111.69 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 120.881 0.372 . . . . 0.0 110.905 179.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.691 ' HB2' ' CG ' ' A' ' 72' ' ' LYS . 23.4 m120 -88.98 148.13 23.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.495 -174.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.6 t -83.82 105.84 15.04 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.136 175.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.47 HD12 ' OE1' ' A' ' 77' ' ' GLU . 91.0 mt -82.74 140.68 43.98 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 177.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.52 -9.05 16.68 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.077 2.518 . . . . 0.0 112.978 -177.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -91.82 19.26 6.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.326 177.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.464 ' HA ' ' NE ' ' A' ' 69' ' ' ARG . 5.2 mmp_? 58.7 32.32 22.06 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.405 0.621 . . . . 0.0 110.627 -174.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 70' ' ' ARG . 34.1 mtp180 -114.42 -178.84 3.47 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.272 179.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.469 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 55.6 m-85 -138.87 142.41 38.59 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.486 0.184 . . . . 0.0 111.148 -178.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.691 ' CG ' ' HB2' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -123.26 120.57 33.49 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-O 120.813 0.339 . . . . 0.0 110.874 178.914 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.576 HD13 HD11 ' A' ' 84' ' ' LEU . 17.6 tt -93.51 89.53 2.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.917 0.865 . . . . 0.0 110.817 -177.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.513 ' O ' ' HB3' ' A' ' 75' ' ' ASP . . . 59.51 77.08 0.19 Allowed Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.305 -178.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.513 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 16.6 t70 78.54 -52.24 0.48 Allowed 'General case' 0 N--CA 1.48 1.051 0 O-C-N 123.749 0.323 . . . . 0.0 111.409 178.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -70.47 134.8 48.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.0 0.429 . . . . 0.0 111.795 -173.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.47 ' OE1' HD12 ' A' ' 66' ' ' LEU . 6.0 mm-40 -89.49 143.9 26.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.185 -177.33 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.481 ' HZ ' ' CD2' ' A' ' 87' ' ' PHE . 47.0 m-85 -140.52 -175.42 4.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.293 172.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -75.38 -56.81 4.35 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.17 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.481 ' ND1' ' HD2' ' A' ' 82' ' ' PRO . 2.5 p80 -166.81 -174.0 2.59 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.762 175.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.645 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 16.4 mt -53.51 -59.74 8.73 Favored Pre-proline 0 N--CA 1.47 0.547 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -177.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.645 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 38.5 Cg_exo -65.11 3.2 1.05 Allowed 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 122.752 2.301 . . . . 0.0 113.56 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -106.07 -35.06 7.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.911 0.386 . . . . 0.0 110.669 179.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.576 HD11 HD13 ' A' ' 73' ' ' ILE . 4.6 pp -76.14 -30.74 58.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.938 0.399 . . . . 0.0 110.127 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.47 ' N ' HD12 ' A' ' 84' ' ' LEU . 79.2 mt -63.66 -27.88 69.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.042 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.555 ' HA ' ' HD3' ' A' ' 89' ' ' LYS . 19.9 tp10 -80.9 -21.96 40.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.98 -176.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.481 ' CD2' ' HZ ' ' A' ' 78' ' ' PHE . 62.4 t80 -83.02 -20.61 34.72 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.898 0.856 . . . . 0.0 109.243 -177.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.725 ' CG ' HD22 ' A' ' 93' ' ' LEU . 35.5 m-85 -97.27 1.98 50.24 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.444 -177.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.555 ' HD3' ' HA ' ' A' ' 86' ' ' GLU . 53.8 mtpt -86.23 -2.24 58.19 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.967 173.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 33.2 pt -131.85 -8.52 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 CA-C-O 121.432 0.634 . . . . 0.0 109.365 177.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.441 ' HB2' ' O ' ' A' ' 87' ' ' PHE . 8.2 t60 -82.82 -32.54 27.56 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.602 -174.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.404 ' CD2' HG21 ' A' ' 97' ' ' THR . 95.4 m-85 56.93 78.84 0.2 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.92 -166.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.725 HD22 ' CG ' ' A' ' 88' ' ' TYR . 12.9 mt -45.77 -83.03 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.21 0 O-C-N 124.091 0.87 . . . . 0.0 110.34 178.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.578 ' HB2' ' HG3' ' A' ' 154' ' ' GLU . 45.5 t0 -109.13 84.17 1.88 Allowed 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.908 -179.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 1.09 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 4.8 t 49.93 17.68 0.31 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.643 0.777 . . . . 0.0 112.152 -178.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.8 t -163.12 157.58 20.82 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 -178.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.404 HG21 ' CD2' ' A' ' 92' ' ' TYR . 7.9 p -98.4 176.33 5.73 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.644 0.259 . . . . 0.0 110.463 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.4 mt -72.02 90.65 1.18 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 174.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.544 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 50.1 mm -73.74 -54.39 15.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.247 -175.031 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.736 ' O ' ' HA ' ' A' ' 35' ' ' MET . 11.1 pt-20 -158.44 153.74 22.06 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.032 -177.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.73 145.95 33.23 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 121.924 1.749 . . . . 0.0 111.531 176.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.512 ' O ' ' HE2' ' A' ' 16' ' ' MET . . . -72.08 150.7 92.5 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.34 134.35 63.17 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.409 2.073 . . . . 0.0 111.673 175.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.513 ' NH1' ' HA ' ' A' ' 12' ' ' SER . 56.2 mtm180 . . . . . 0 C--N 1.33 -0.263 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -174.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.574 ' HG ' ' HD2' ' A' ' 155' ' ' LYS . 3.9 mm? . . . . . 0 N--CA 1.469 0.488 0 CA-C-O 121.695 0.76 . . . . 0.0 111.386 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.453 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 44.7 tt0 -169.39 -72.25 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.161 -178.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -117.66 114.64 23.67 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.634 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.938 HG23 ' HG3' ' A' ' 180' ' ' LYS . 57.4 t -126.38 150.15 31.82 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.096 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.721 ' CZ ' HD13 ' A' ' 181' ' ' LEU . 0.0 OUTLIER -124.73 155.01 39.98 Favored 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 118.014 -1.474 . . . . 0.0 109.031 165.158 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.565 ' OG1' ' HB2' ' A' ' 144' ' ' PHE . 72.9 p -106.02 140.05 39.61 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.216 0.531 . . . . 0.0 111.072 178.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.574 HD22 ' HG2' ' A' ' 179' ' ' GLU . 8.8 mt -113.73 -5.9 13.31 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.039 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.433 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 28.6 t80 -93.91 -41.11 9.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.694 -173.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.624 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 10.7 t70 74.28 95.53 0.07 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.486 0.66 . . . . 0.0 110.69 -178.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.619 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 75.4 t80 -126.01 90.46 50.21 Favored Pre-proline 0 C--N 1.318 -0.765 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 173.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.578 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 95.0 Cg_endo -85.92 81.19 1.7 Allowed 'Trans proline' 0 N--CA 1.44 -1.636 0 C-N-CA 121.712 1.608 . . . . 0.0 112.144 178.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -69.69 -11.96 66.55 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.302 175.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.52 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 19.5 m120 50.3 65.86 1.32 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 114.297 -0.951 . . . . 0.0 111.629 177.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.463 ' HB3' ' H ' ' A' ' 141' ' ' ASP . 1.0 OUTLIER -130.88 -176.61 4.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.364 0.602 . . . . 0.0 110.898 -178.612 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -111.41 0.63 16.64 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 167.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -117.09 -45.99 2.73 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.691 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.463 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 8.4 m-20 -97.67 128.1 44.12 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 168.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.667 ' CD1' ' HB2' ' A' ' 165' ' ' ASN . 28.9 tp -84.61 124.48 73.17 Favored Pre-proline 0 CA--C 1.517 -0.321 0 O-C-N 122.095 -0.378 . . . . 0.0 110.98 -176.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.578 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 49.7 Cg_endo -76.11 105.79 2.14 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 121.502 1.468 . . . . 0.0 111.707 166.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.619 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -93.42 -161.68 0.87 Allowed 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 175.364 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.624 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 68.6 mttm -138.07 -170.94 2.9 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.801 176.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.944 ' H ' ' HD2' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -84.7 25.26 0.93 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.384 0.612 . . . . 0.0 109.913 -179.533 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.404 ' H ' ' C ' ' A' ' 145' ' ' LYS . . . 158.78 41.6 0.02 OUTLIER Glycine 0 N--CA 1.436 -1.353 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.898 -177.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.723 ' CD ' ' HG ' ' A' ' 150' ' ' LEU . 1.8 pp20? -84.7 170.04 13.68 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 173.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.569 HD11 ' HB3' ' A' ' 129' ' ' ARG . 1.1 mp -111.78 128.54 68.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 118.453 0.569 . . . . 0.0 109.62 170.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.756 ' CD2' ' HA ' ' A' ' 165' ' ' ASN . 82.1 mt -119.42 155.95 31.05 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -172.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.554 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 62.0 t -123.51 120.22 59.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 172.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.525 HG22 HD13 ' A' ' 125' ' ' LEU . 25.8 mm -79.79 82.34 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.675 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.699 HG12 ' OE2' ' A' ' 154' ' ' GLU . 14.3 tt -72.21 -33.72 47.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-N 114.203 -1.362 . . . . 0.0 108.904 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.699 ' OE2' HG12 ' A' ' 153' ' ' ILE . 3.4 mp0 -125.86 143.61 51.0 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.046 176.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.574 ' HD2' ' HG ' ' A' ' 125' ' ' LEU . 83.1 tttt -136.08 87.82 23.12 Favored Pre-proline 0 C--N 1.316 -0.858 0 CA-C-O 121.108 0.48 . . . . 0.0 109.76 171.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 1.09 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 8.0 Cg_exo -76.35 -50.52 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.787 2.324 . . . . 0.0 112.112 174.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.647 ' HG2' ' CE ' ' A' ' 172' ' ' MET . 5.4 mm-40 -102.21 173.31 6.43 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.113 -173.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.495 ' O ' HG22 ' A' ' 175' ' ' VAL . 8.7 tp10 -104.83 -17.93 14.41 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 175.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -99.99 -17.0 17.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.314 174.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.417 ' HA ' ' O ' ' A' ' 173' ' ' ILE . 73.1 m95 -130.26 125.35 34.61 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.735 178.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . 0.674 ' O ' HG13 ' A' ' 173' ' ' ILE . 50.0 m0 -112.81 135.81 53.14 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.021 0.438 . . . . 0.0 110.437 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.606 ' OG ' ' HG2' ' A' ' 172' ' ' MET . 70.5 m -93.31 92.93 7.92 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -174.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.526 ' HB2' ' HB3' ' A' ' 150' ' ' LEU . . . -109.45 146.78 33.96 Favored 'General case' 0 N--CA 1.415 -2.194 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -172.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.77 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 12.3 ptt180 -88.16 127.21 35.43 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 174.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.756 ' HA ' ' CD2' ' A' ' 150' ' ' LEU . 63.5 t30 -59.41 179.94 0.1 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.103 -1.408 . . . . 0.0 111.793 -170.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 48.9 tptt -56.74 -20.88 24.37 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.52 167.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -79.88 -30.71 40.23 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.843 172.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.509 ' C ' ' HB2' ' A' ' 164' ' ' ARG . . . 101.53 7.95 47.43 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.064 -174.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.77 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -77.97 132.11 37.7 Favored 'General case' 0 C--O 1.217 -0.625 0 C-N-CA 122.646 0.378 . . . . 0.0 111.222 177.243 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.479 HG23 HG22 ' A' ' 153' ' ' ILE . 47.9 t -82.43 125.47 39.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.634 -179.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -159.17 152.39 23.4 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 121.042 -0.599 . . . . 0.0 111.965 173.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.647 ' CE ' ' HG2' ' A' ' 157' ' ' GLU . 35.9 mtp -77.5 142.96 38.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.893 0.346 . . . . 0.0 110.704 -178.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.674 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.7 pp -142.45 144.93 32.67 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.019 -175.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.453 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 22.8 Cg_exo -65.05 129.94 24.41 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 122.834 2.356 . . . . 0.0 113.004 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.632 ' O ' HG23 ' A' ' 178' ' ' VAL . 58.0 t -64.87 -41.6 56.75 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 18.6 Cg_endo -61.29 -6.8 7.23 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 121.858 1.705 . . . . 0.0 112.748 176.204 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.453 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.2 m-30 -95.53 -9.23 32.96 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.814 -178.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 175' ' ' VAL . 4.3 m -105.04 -171.98 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 -166.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.633 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 6.7 tp10 -159.15 49.6 0.34 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 112.678 -2.056 . . . . 0.0 111.812 -153.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.938 ' HG3' HG23 ' A' ' 128' ' ' VAL . 3.2 mppt? -69.66 136.13 50.74 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 119.603 -1.935 . . . . 0.0 111.081 -160.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.721 HD13 ' CZ ' ' A' ' 129' ' ' ARG . 14.6 tp . . . . . 0 CA--C 1.523 -0.096 0 CA-C-N 113.207 -1.815 . . . . 0.0 110.655 -168.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo . . . . . 0 N--CA 1.451 -1.02 0 CA-C-O 120.808 0.253 . . . . 0.0 112.029 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 22.9 t -89.63 145.32 7.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.482 ' HB2' ' HG3' ' A' ' 296' ' ' PRO . 84.7 m-85 -108.78 119.72 40.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.077 0.465 . . . . 0.0 111.105 -177.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -119.66 140.93 49.86 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.691 178.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.507 ' HB2' ' CE1' ' A' ' 294' ' ' PHE . 47.5 tttp -95.07 123.44 38.56 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . 0.486 ' HA ' HG13 ' A' ' 291' ' ' VAL . . . -71.44 102.77 2.74 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.29 -0.414 . . . . 0.0 109.961 -179.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 2.3 pp -82.27 -5.56 9.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.923 0.392 . . . . 0.0 111.972 -174.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . 0.45 ' HG2' ' H ' ' A' ' 245' ' ' LYS . 2.2 tt0 -146.95 164.32 33.33 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 176.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.45 ' H ' ' HG2' ' A' ' 244' ' ' GLN . 45.1 mttp -61.37 149.66 37.58 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 176.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.575 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 24.3 tpt180 -137.62 94.81 2.96 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 169.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 34.4 m -101.2 152.94 38.03 Favored Pre-proline 0 C--N 1.315 -0.919 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.709 -176.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.53 -161.2 0.11 Allowed 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.424 2.083 . . . . 0.0 111.816 177.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 34.9 t -151.05 -179.22 7.13 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -175.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -64.37 -34.01 77.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.671 0.272 . . . . 0.0 111.254 -178.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -95.55 11.19 33.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.399 -179.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.33 131.96 47.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.505 0.669 . . . . 0.0 112.638 -175.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . 0.428 ' HE3' ' HB3' ' A' ' 253' ' ' LYS . 6.3 ptpp? -150.53 0.46 0.43 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.663 167.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 1.2 p -144.88 14.85 1.54 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.304 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -101.59 117.86 35.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.137 0.494 . . . . 0.0 110.494 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.496 HD21 ' HB ' ' A' ' 279' ' ' VAL . 0.7 OUTLIER -78.59 134.68 37.18 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.178 -178.228 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.575 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -93.9 121.22 35.14 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.201 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.519 ' HB2' ' HB3' ' A' ' 246' ' ' ARG . 79.9 mt -123.73 152.68 41.86 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.041 -175.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -102.47 177.74 4.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.038 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 59.2 t -90.18 111.83 23.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.195 0.521 . . . . 0.0 110.551 -179.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 98.39 9.18 53.85 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.188 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -82.84 166.4 19.0 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -175.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 33.5 mm -104.67 110.82 31.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.255 0.55 . . . . 0.0 110.281 -177.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 14.0 t -96.44 108.75 21.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.806 -177.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 38.4 tttt -83.3 105.31 14.15 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.728 175.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.49 HG11 ' HE3' ' A' ' 269' ' ' MET . 4.3 p -99.22 117.17 43.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.496 0.665 . . . . 0.0 110.605 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 12.1 m -94.94 -25.23 16.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.844 -176.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 268' ' ' ARG . 36.6 ttm180 -132.2 108.22 9.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.007 0.432 . . . . 0.0 110.954 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' MET . . . . . 0.53 ' HE1' ' CZ2' ' A' ' 275' ' ' TRP . 32.1 mtt -94.75 126.95 40.4 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.657 178.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' ' 274' ' ' GLN . 56.5 m-80 -99.9 153.56 19.06 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 177.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.555 ' H ' HD11 ' A' ' 271' ' ' ILE . 4.3 mp -72.73 -34.48 47.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.147 -172.005 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -62.67 -26.4 68.63 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.742 -176.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 127.92 -26.93 4.7 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.35 -0.929 . . . . 0.0 112.637 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.482 ' O ' ' HB2' ' A' ' 270' ' ' ASN . 45.3 mt-30 -78.92 115.5 18.65 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 177.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.53 ' CZ2' ' HE1' ' A' ' 269' ' ' MET . 49.9 m0 -96.24 150.9 20.03 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.816 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 284' ' ' GLY . 43.6 tt0 -108.93 109.58 20.69 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 175.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . 0.546 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -122.16 155.36 16.83 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.841 -178.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.547 ' HG2' ' HB3' ' A' ' 283' ' ' LYS . 23.2 mt-10 -104.58 109.0 20.73 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . 0.521 HG11 ' ND2' ' A' ' 280' ' ' ASN . 46.9 t -121.92 114.5 43.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -178.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . 0.521 ' ND2' HG11 ' A' ' 279' ' ' VAL . 67.2 m-80 64.77 27.6 13.0 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.896 -178.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 90.01 -10.78 72.83 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.417 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 44.5 ttt-85 -102.35 118.55 37.12 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.547 ' HB3' ' HG2' ' A' ' 278' ' ' GLU . 57.3 pttt -109.82 141.95 41.78 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.094 0.473 . . . . 0.0 111.188 179.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 276' ' ' GLU . . . -167.21 -174.79 36.68 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 -179.077 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.51 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 68.8 mt -90.2 138.66 31.34 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.162 0.506 . . . . 0.0 111.252 -177.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.417 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 46.1 p90 -142.74 131.58 11.69 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.711 173.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 17.6 Cg_exo -69.06 139.2 42.03 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 122.902 2.401 . . . . 0.0 111.822 177.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -65.57 -4.64 6.36 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.663 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 2.4 m -74.42 -22.82 58.96 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.933 0.397 . . . . 0.0 111.088 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 41.0 m-70 -94.12 -11.58 30.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.848 0.356 . . . . 0.0 111.149 -176.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.486 HG13 ' HA ' ' A' ' 242' ' ' ALA . 34.8 m -128.02 167.5 22.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.057 -178.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -140.9 128.47 21.4 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.848 0.356 . . . . 0.0 110.727 175.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 41.0 mm -67.83 126.54 27.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.241 177.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 294' ' ' PHE . . . . . 0.507 ' CE1' ' HB2' ' A' ' 241' ' ' LYS . 1.4 p90 -141.14 -179.59 6.19 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.504 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -101.6 96.09 5.96 Favored Pre-proline 0 C--N 1.322 -0.628 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . 0.482 ' HG3' ' HB2' ' A' ' 239' ' ' PHE . 43.0 Cg_endo . . . . . 0 C--N 1.345 0.363 0 C-N-CA 122.604 2.203 . . . . 0.0 113.112 -173.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.539 ' HB2' HD13 ' A' ' 99' ' ' ILE . 13.7 p . . . . . 0 CA--C 1.529 0.171 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.98 110.76 4.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.378 177.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.548 ' CZ ' ' HA ' ' A' ' 5' ' ' ARG . 3.6 mmp_? -115.25 -5.72 12.38 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -172.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -79.25 155.41 28.58 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.476 -174.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -66.24 -36.29 82.63 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.574 -176.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.1 t 65.39 37.88 6.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.335 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.8 m -152.34 -33.05 0.13 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.278 177.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -77.56 113.93 15.88 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.98 0.419 . . . . 0.0 111.285 -173.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -57.72 -45.35 85.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.201 -175.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 51.1 m -71.74 1.67 6.5 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -91.06 -42.07 10.71 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.601 176.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 22.4 p-90 -122.73 -29.07 4.07 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -174.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -77.71 103.2 7.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.808 0.337 . . . . 0.0 111.554 -173.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.45 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 23.6 mmt -87.28 -6.53 58.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.288 -176.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 49.93 -115.54 3.17 Favored Glycine 0 CA--C 1.52 0.359 0 CA-C-N 115.629 -0.714 . . . . 0.0 113.306 -178.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.58 99.78 1.26 Allowed 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 122.475 2.116 . . . . 0.0 112.535 -176.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.434 ' O ' ' CB ' ' A' ' 20' ' ' SER . 3.5 t -130.11 -70.49 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-O 118.243 -0.884 . . . . 0.0 111.73 -176.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 19' ' ' VAL . 22.9 t 108.46 161.32 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.126 1.371 . . . . 0.0 109.219 173.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 34.0 ttt85 -64.89 -38.81 92.23 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.801 0.334 . . . . 0.0 110.241 -177.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.415 ' H ' ' HG2' ' A' ' 22' ' ' GLN . 3.8 mm-40 -64.9 -34.26 77.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.429 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.509 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 0.4 OUTLIER -84.21 -53.13 5.72 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.801 -174.565 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.515 ' HB2' HD11 ' A' ' 37' ' ' LEU . . . -56.05 -40.95 74.3 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.782 -178.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.57 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 55.0 tp60 -62.42 -44.53 96.22 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.569 -178.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.476 HG21 ' O ' ' A' ' 23' ' ' GLU . 9.1 t -75.69 -15.49 60.3 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 120.818 0.342 . . . . 0.0 111.055 -177.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' A' ' 23' ' ' GLU . 52.2 mmm-85 -76.96 -19.59 57.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.922 0.392 . . . . 0.0 110.357 176.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.613 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 78.1 mt -128.84 -13.1 4.7 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -173.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.57 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -66.21 107.61 2.01 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.844 0.354 . . . . 0.0 110.757 -173.789 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.3 -2.24 67.2 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.822 -0.704 . . . . 0.0 113.331 175.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.403 HE21 ' HB3' ' A' ' 31' ' ' GLN . 9.6 mt-30 -78.31 -175.05 4.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.728 0.264 . . . . 0.0 110.587 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.598 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 12.4 ttp180 -52.68 131.02 34.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.334 0.588 . . . . 0.0 110.827 -179.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.572 ' HB3' ' OE1' ' A' ' 54' ' ' GLU . 43.6 m170 -82.03 145.1 30.4 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.407 -175.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.35 -12.91 48.02 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 111.606 -0.597 . . . . 0.0 111.606 -176.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.598 ' SD ' ' HB3' ' A' ' 32' ' ' ARG . 11.6 mtp -81.55 141.47 33.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.687 0.28 . . . . 0.0 110.737 178.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.437 ' CD2' HD21 ' A' ' 98' ' ' LEU . 33.1 p90 -143.24 167.43 22.15 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.691 -178.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.515 HD11 ' HB2' ' A' ' 24' ' ' ALA . 4.4 pp -158.08 138.52 12.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.155 0.503 . . . . 0.0 111.453 175.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.413 HG21 HD11 ' A' ' 50' ' ' LEU . 48.3 t -102.94 120.8 53.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 174.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.423 ' HD2' ' H ' ' A' ' 20' ' ' SER . 23.8 ptt-85 -125.94 -169.45 2.01 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.639 0.257 . . . . 0.0 110.71 -175.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -68.9 140.49 55.14 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.829 177.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.4 t -86.23 104.66 15.98 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 167.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.9 m -71.65 -11.4 60.82 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.378 -177.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 16.9 p -84.59 -29.74 25.57 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.996 0.427 . . . . 0.0 110.261 176.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 52.4 t -151.34 95.37 3.34 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.017 178.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -58.06 113.9 1.73 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.922 2.415 . . . . 0.0 112.066 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 130.37 -33.04 2.97 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -174.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.591 ' OD2' ' HA ' ' A' ' 64' ' ' ASN . 2.6 m-20 -88.42 175.86 7.43 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 170.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.523 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 44.1 m-85 -136.17 175.58 9.47 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.407 -175.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.2 t -142.46 106.71 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.926 0.393 . . . . 0.0 110.67 176.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.413 HD11 HG21 ' A' ' 38' ' ' VAL . 46.7 tp -80.97 103.76 11.01 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.389 176.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.1 m -96.45 126.66 41.79 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 176.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.566 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 95.4 t -121.76 135.89 60.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.754 -175.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.613 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 23.4 t -95.88 114.75 26.51 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -175.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.572 ' OE1' ' HB3' ' A' ' 33' ' ' HIS . 9.4 tp10 -151.48 154.7 37.08 Favored 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 119.53 -0.868 . . . . 0.0 108.999 164.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.564 ' ND2' ' HG3' ' A' ' 54' ' ' GLU . 0.5 OUTLIER 45.4 37.52 3.01 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.537 0.735 . . . . 0.0 112.701 -177.666 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 34.5 m 49.38 56.09 8.35 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 122.403 1.097 . . . . 0.0 109.459 -178.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.513 ' HB2' ' O ' ' A' ' 55' ' ' ASN . 1.5 tmm_? -165.67 64.32 0.11 Allowed 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 113.312 -1.767 . . . . 0.0 109.33 -152.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.566 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 14.1 t -72.3 106.33 2.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.961 0.886 . . . . 0.0 110.353 -169.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.4 m -76.64 122.49 24.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 113.899 -1.5 . . . . 0.0 111.31 -177.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -95.55 102.37 14.17 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.107 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.669 ' OH ' ' HB3' ' A' ' 93' ' ' LEU . 70.8 m-85 -97.35 109.26 22.05 Favored 'General case' 0 C--O 1.221 -0.396 0 C-N-CA 123.079 0.552 . . . . 0.0 110.667 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.546 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 59.2 mt -80.03 128.88 38.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -173.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.523 ' HB ' ' HB2' ' A' ' 48' ' ' TYR . 3.1 mp -99.7 111.08 28.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.707 177.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.591 ' HA ' ' OD2' ' A' ' 47' ' ' ASP . 15.9 m120 -83.94 133.81 34.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.944 178.137 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.2 t -89.16 95.79 10.45 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.517 HD12 ' HB2' ' A' ' 72' ' ' LYS . 83.6 mt -81.07 147.79 62.25 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.247 -176.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.414 ' C ' ' H ' ' A' ' 69' ' ' ARG . 64.6 Cg_endo -76.77 -9.38 18.3 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.932 2.421 . . . . 0.0 112.877 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 35.2 p30 -81.19 7.85 10.25 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.575 0.702 . . . . 0.0 109.322 171.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.716 ' NE ' ' HA ' ' A' ' 69' ' ' ARG . 3.4 tpm_? 61.64 58.27 2.06 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.125 -1.398 . . . . 0.0 110.981 -176.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.853 ' HG2' ' HA ' ' A' ' 79' ' ' ASP . 79.4 mtt180 -135.41 176.73 8.41 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.24 172.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.529 ' HA ' ' O ' ' A' ' 64' ' ' ASN . 52.2 m-85 -130.48 113.51 14.38 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.021 0.438 . . . . 0.0 109.83 176.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.586 ' HE2' ' HA ' ' A' ' 75' ' ' ASP . 36.0 tttm -98.19 105.02 17.1 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.981 -173.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.64 HD12 ' CE2' ' A' ' 88' ' ' TYR . 16.3 tt -81.0 79.35 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 122.18 0.99 . . . . 0.0 111.0 -176.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.78 -10.36 18.97 Favored Glycine 0 CA--C 1.52 0.378 0 CA-C-N 115.004 -0.998 . . . . 0.0 113.87 176.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.586 ' HA ' ' HE2' ' A' ' 72' ' ' LYS . 8.7 t70 177.28 -68.71 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 116.944 0.372 . . . . 0.0 110.321 -170.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -66.35 123.64 20.52 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.921 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' A' ' 77' ' ' GLU . 13.7 pt-20 -93.62 105.25 17.31 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.734 0.778 . . . . 0.0 110.728 177.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.478 ' CZ ' ' CD1' ' A' ' 87' ' ' PHE . 84.1 m-85 -95.03 152.25 18.48 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 174.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.853 ' HA ' ' HG2' ' A' ' 70' ' ' ARG . 8.3 m-20 -67.99 -23.24 65.0 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -171.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.977 ' HD1' ' HG2' ' A' ' 82' ' ' PRO . 6.0 p80 -162.36 165.47 26.44 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.736 -0.211 . . . . 0.0 110.438 -178.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.539 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 10.0 mt -55.99 -54.89 47.32 Favored Pre-proline 0 CA--C 1.535 0.377 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -178.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.977 ' HG2' ' HD1' ' A' ' 80' ' ' HIS . 15.4 Cg_endo -61.12 -4.17 3.65 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.183 1.922 . . . . 0.0 113.796 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.414 ' HB3' ' CE1' ' A' ' 80' ' ' HIS . . . -89.87 -34.94 15.91 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.762 0.315 . . . . 0.0 110.769 178.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.1 pp -76.94 -30.96 56.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.135 0.493 . . . . 0.0 109.838 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 70.1 mt -68.43 -21.56 64.65 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.491 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.533 ' OE2' ' HD2' ' A' ' 89' ' ' LYS . 18.8 tp10 -85.81 -35.43 20.68 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.183 176.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.539 ' HE1' ' CZ ' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -71.56 -19.54 62.14 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.333 0.587 . . . . 0.0 111.436 -179.815 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.747 ' CD1' HD22 ' A' ' 93' ' ' LEU . 38.7 m-85 -94.96 5.47 51.83 Favored 'General case' 0 C--N 1.313 -0.98 0 O-C-N 121.685 -0.634 . . . . 0.0 111.769 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.533 ' HD2' ' OE2' ' A' ' 86' ' ' GLU . 96.2 mttt -77.52 -25.91 50.64 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.685 171.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.545 ' H ' HD12 ' A' ' 90' ' ' ILE . 0.3 OUTLIER -106.32 -17.67 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 CA-C-O 121.41 0.624 . . . . 0.0 109.756 174.148 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.478 ' HB2' ' O ' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -93.97 106.41 18.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.78 178.771 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -72.46 104.23 3.74 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.756 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.747 HD22 ' CD1' ' A' ' 88' ' ' TYR . 16.5 mt -59.43 -31.02 68.9 Favored 'General case' 0 C--O 1.215 -0.757 0 O-C-N 124.356 1.035 . . . . 0.0 111.431 -176.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.465 ' HB3' ' HA ' ' A' ' 154' ' ' GLU . 24.5 p-10 -176.18 85.47 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.883 0.849 . . . . 0.0 110.532 164.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 71.78 -19.18 0.27 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.592 -175.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.453 ' H ' ' C ' ' A' ' 94' ' ' ASP . 18.0 m -132.49 146.03 51.62 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 120.968 0.413 . . . . 0.0 110.625 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.415 ' O ' HG21 ' A' ' 96' ' ' THR . 37.4 p -96.16 -178.17 4.24 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.533 178.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.493 ' HG ' HD11 ' A' ' 93' ' ' LEU . 96.1 mt -70.84 106.3 3.55 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 174.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.539 HD13 ' HB2' ' A' ' 3' ' ' SER . 46.4 mm -89.86 -63.07 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.189 0.519 . . . . 0.0 110.422 -177.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.572 ' O ' ' HA ' ' A' ' 35' ' ' MET . 11.2 pt-20 -157.69 151.5 19.51 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.426 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.6 155.55 68.55 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.274 1.983 . . . . 0.0 112.362 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.42 ' HB1' HD21 ' A' ' 28' ' ' LEU . . . -69.07 146.56 97.25 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.476 179.095 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -57.61 130.92 41.25 Favored 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 122.618 2.212 . . . . 0.0 112.951 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 . . . . . 0 C--N 1.325 -0.485 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 172.823 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.53 HD13 HG22 ' A' ' 152' ' ' ILE . 4.3 mm? . . . . . 0 N--CA 1.468 0.428 0 CA-C-O 121.652 0.739 . . . . 0.0 110.814 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.711 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 4.9 tp10 -165.61 -74.28 0.03 OUTLIER 'General case' 0 C--O 1.218 -0.554 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.028 -169.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -108.17 110.95 22.71 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.036 0.446 . . . . 0.0 110.296 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.829 HG23 ' HG3' ' A' ' 180' ' ' LYS . 86.4 t -125.87 136.65 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.647 176.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.671 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 5.6 ptp180 -112.13 147.16 36.71 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 117.41 -1.716 . . . . 0.0 108.474 169.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.663 ' HG1' ' CB ' ' A' ' 144' ' ' PHE . 7.6 p -99.72 135.56 40.96 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.628 177.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.552 HD22 ' HG2' ' A' ' 179' ' ' GLU . 14.3 mt -108.41 3.0 22.8 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -177.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.439 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 27.0 t80 -99.94 -43.34 6.42 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.494 -0.483 . . . . 0.0 112.112 -174.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.639 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 14.5 t70 73.04 96.85 0.07 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.513 0.673 . . . . 0.0 109.888 -171.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.514 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 44.2 t80 -129.14 90.06 46.37 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 174.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.603 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 92.7 Cg_endo -90.52 84.35 0.4 Allowed 'Trans proline' 0 N--CA 1.436 -1.862 0 C-N-CA 121.914 1.743 . . . . 0.0 112.358 -178.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -78.67 -2.37 85.31 Favored Glycine 0 C--N 1.329 0.191 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.217 176.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 19.0 m120 36.16 71.04 0.14 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 113.872 -1.164 . . . . 0.0 112.461 -175.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.479 ' HB3' ' H ' ' A' ' 141' ' ' ASP . 0.4 OUTLIER -132.7 -176.59 4.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.22 0.533 . . . . 0.0 111.317 -177.394 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -112.17 1.75 16.37 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 167.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -115.41 -44.4 2.98 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.296 175.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.479 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 9.7 m-20 -98.36 127.61 44.37 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 166.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.734 ' CD2' HD23 ' A' ' 150' ' ' LEU . 24.6 tp -81.88 130.7 59.68 Favored Pre-proline 0 CA--C 1.518 -0.254 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.283 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.603 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 72.0 Cg_endo -84.0 92.04 0.82 Allowed 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.121 1.881 . . . . 0.0 112.292 174.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.663 ' CB ' ' HG1' ' A' ' 130' ' ' THR . 1.5 p90 -90.89 179.73 5.69 Favored 'General case' 0 CA--C 1.504 -0.799 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.817 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.639 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 16.3 mtpp -122.05 -176.6 3.38 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.294 172.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.716 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -78.65 36.78 0.27 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.798 0.809 . . . . 0.0 110.852 -174.635 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 145' ' ' LYS . . . 151.66 42.75 0.02 OUTLIER Glycine 0 N--CA 1.433 -1.554 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.32 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.402 ' OE1' ' HA ' ' A' ' 144' ' ' PHE . 0.1 OUTLIER -103.84 147.11 27.68 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 119.352 -0.939 . . . . 0.0 109.993 179.647 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.527 HD13 ' N ' ' A' ' 149' ' ' ILE . 1.6 mp -87.26 125.76 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.868 -177.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.734 HD23 ' CD2' ' A' ' 142' ' ' LEU . 33.8 mt -122.18 158.11 30.1 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -176.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.711 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 61.8 t -120.08 121.49 65.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 175.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.53 HG22 HD13 ' A' ' 125' ' ' LEU . 38.0 mm -77.18 79.31 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 CA-C-O 122.183 0.992 . . . . 0.0 108.682 -177.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.643 HD12 ' HD3' ' A' ' 164' ' ' ARG . 16.7 tt -71.43 -32.87 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 CA-C-N 113.856 -1.52 . . . . 0.0 109.09 -177.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.719 ' HB3' ' O ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -123.35 140.27 53.18 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.604 171.909 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -127.73 88.46 53.37 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 167.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.583 ' HG2' ' CE ' ' A' ' 172' ' ' MET . 0.9 OUTLIER -81.74 -46.75 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.224 2.616 . . . . 0.0 111.71 177.678 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.607 ' HG2' ' HE3' ' A' ' 172' ' ' MET . 33.8 mm-40 -102.94 161.67 13.57 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.928 -176.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -88.96 -27.41 20.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.452 0.644 . . . . 0.0 109.338 172.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -94.12 -18.76 21.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.249 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.6 ' HB3' ' HE2' ' A' ' 172' ' ' MET . 48.5 m95 -130.24 131.45 45.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.132 -178.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . 0.705 ' O ' HG13 ' A' ' 173' ' ' ILE . 50.5 m0 -119.4 135.15 54.87 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -178.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.582 ' OG ' ' HG2' ' A' ' 172' ' ' MET . 21.6 m -99.6 95.0 6.68 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -174.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.53 ' HB2' ' HB3' ' A' ' 150' ' ' LEU . . . -104.03 147.21 27.65 Favored 'General case' 0 N--CA 1.418 -2.037 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.075 -174.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.745 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 24.5 ptt-85 -86.44 123.24 31.44 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 175.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.72 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . 6.1 t30 -55.09 172.04 0.13 Allowed 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 113.151 -1.841 . . . . 0.0 110.416 -172.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 36.5 tttp -58.21 -12.68 3.82 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.227 0.537 . . . . 0.0 110.039 174.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -83.5 -45.76 13.22 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.71 172.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 130.24 -9.62 5.93 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.959 -173.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.745 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.1 OUTLIER -62.56 132.47 52.53 Favored 'General case' 0 C--O 1.216 -0.703 0 C-N-CA 123.712 0.805 . . . . 0.0 112.373 179.489 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.434 HG23 HG21 ' A' ' 153' ' ' ILE . 78.8 t -85.81 122.25 38.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 O-C-N 122.462 -0.149 . . . . 0.0 110.906 177.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 162' ' ' SER . . . -153.59 149.37 20.85 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.55 172.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.607 ' HE3' ' HG2' ' A' ' 157' ' ' GLU . 7.0 mtp -77.51 142.42 39.1 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.705 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.8 pp -143.77 144.94 28.94 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.42 -178.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.479 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 21.7 Cg_exo -65.01 133.47 35.9 Favored 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 122.854 2.369 . . . . 0.0 113.181 -178.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.477 ' O ' HG21 ' A' ' 178' ' ' VAL . 60.2 t -63.24 -42.02 72.66 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 177.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -62.3 1.32 0.98 Allowed 'Trans proline' 0 C--N 1.359 1.097 0 C-N-CA 122.164 1.91 . . . . 0.0 113.172 176.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.479 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.1 m-85 -103.16 -12.78 17.11 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.506 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.656 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 3.8 m -105.83 -172.82 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 -166.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.671 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 7.5 tp10 -160.23 50.97 0.3 Allowed 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 113.004 -1.907 . . . . 0.0 112.271 -152.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.829 ' HG3' HG23 ' A' ' 128' ' ' VAL . 2.2 mppt? -69.2 137.45 53.25 Favored 'General case' 0 N--CA 1.462 0.161 0 O-C-N 119.706 -1.871 . . . . 0.0 111.319 -159.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 13.0 tp . . . . . 0 N--CA 1.45 -0.464 0 CA-C-N 112.634 -2.076 . . . . 0.0 111.016 -170.184 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo . . . . . 0 N--CA 1.451 -1.023 0 N-CA-C 110.322 -0.684 . . . . 0.0 110.322 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.522 ' HB ' HG11 ' A' ' 266' ' ' VAL . 19.6 t -89.09 126.35 42.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-O 121.056 0.455 . . . . 0.0 110.425 -175.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -115.89 120.38 39.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.72 -177.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . 0.525 ' HB3' HG13 ' A' ' 293' ' ' ILE . . . -120.34 145.05 47.5 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.262 178.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -95.1 120.69 35.75 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 175.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . 0.522 ' HA ' HG13 ' A' ' 291' ' ' VAL . . . -68.62 107.6 3.03 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.381 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.483 HD11 ' HD3' ' A' ' 292' ' ' LYS . 39.1 pt -85.17 -21.28 7.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.049 0.452 . . . . 0.0 110.611 -177.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -134.85 147.12 49.81 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.487 -178.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . 0.689 ' HB2' ' HZ2' ' A' ' 245' ' ' LYS . 10.7 mtmp? -63.32 156.9 24.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.519 0.676 . . . . 0.0 111.32 -176.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.512 ' HG3' ' O ' ' A' ' 256' ' ' LEU . 27.6 tpt180 -140.35 122.21 15.48 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.764 -179.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . 0.403 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 16.9 m -127.58 153.68 77.58 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-O 120.834 0.35 . . . . 0.0 111.613 -175.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.496 ' HB3' ' CG ' ' A' ' 252' ' ' ASP . 7.4 Cg_exo -72.92 159.35 48.29 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.966 2.444 . . . . 0.0 112.078 178.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' CYS . . . . . 0.477 ' SG ' ' N ' ' A' ' 250' ' ' ALA . 42.3 t -104.59 -175.63 2.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.875 -178.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . 0.477 ' N ' ' SG ' ' A' ' 249' ' ' CYS . . . -58.85 -44.6 91.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.154 0.502 . . . . 0.0 110.506 176.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -91.43 31.94 1.11 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.809 178.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . 0.496 ' CG ' ' HB3' ' A' ' 248' ' ' PRO . 2.9 t70 -60.92 112.75 2.18 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.492 178.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -139.13 -6.77 1.39 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.385 169.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -151.77 34.81 0.55 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.376 176.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . 0.413 ' CB ' ' HA ' ' A' ' 248' ' ' PRO . . . -112.54 100.62 8.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.201 0.524 . . . . 0.0 110.759 -179.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.512 ' O ' ' HG3' ' A' ' 246' ' ' ARG . 0.5 OUTLIER -67.13 146.76 53.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.977 -175.764 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -107.87 120.22 41.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.055 178.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.521 HD22 HG22 ' A' ' 279' ' ' VAL . 51.3 mt -136.39 152.75 50.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.536 -175.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . 0.439 ' HA ' ' HG2' ' A' ' 245' ' ' LYS . 0.9 OUTLIER -115.07 -176.39 2.9 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 172.657 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 51.1 t -81.29 120.91 33.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.569 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 111.08 2.78 28.17 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.001 -0.619 . . . . 0.0 113.054 177.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -90.88 146.74 23.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.814 0.34 . . . . 0.0 110.79 -178.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 24.3 mm -92.67 109.86 22.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.538 177.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 20.8 t -83.28 108.46 15.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.217 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -80.42 86.48 5.75 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.881 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.522 HG11 ' HB ' ' A' ' 238' ' ' VAL . 2.6 p -98.41 117.69 43.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.671 0.748 . . . . 0.0 110.656 -178.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 18.4 p -94.46 -49.66 5.58 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.303 -177.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -100.61 114.31 27.88 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 120.955 0.407 . . . . 0.0 111.06 -177.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' MET . . . . . 0.532 ' HE3' ' CE3' ' A' ' 275' ' ' TRP . 40.7 mtt -106.61 140.19 39.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.145 0.497 . . . . 0.0 110.735 174.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -119.78 -170.05 1.88 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.575 -175.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.419 HD11 ' N ' ' A' ' 271' ' ' ILE . 4.5 mp -95.81 -30.81 4.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.135 -174.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -66.81 -23.39 66.05 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -173.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 115.21 -32.37 5.79 Favored Glycine 0 C--O 1.23 -0.128 0 C-N-CA 120.194 -1.003 . . . . 0.0 113.084 173.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.458 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 48.7 mt-30 -86.23 107.53 17.96 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 176.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.532 ' CE3' ' HE3' ' A' ' 269' ' ' MET . 12.7 m0 -92.22 157.61 16.6 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.106 -173.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -100.29 108.35 20.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.256 0.551 . . . . 0.0 109.857 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -110.0 145.38 17.02 Favored Glycine 0 N--CA 1.44 -1.042 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.573 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -107.66 108.68 20.04 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.33 0.586 . . . . 0.0 110.042 177.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . 0.567 HG13 HD21 ' A' ' 280' ' ' ASN . 60.3 t -120.54 127.62 75.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.777 -178.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . 0.567 HD21 HG13 ' A' ' 279' ' ' VAL . 10.7 p30 47.91 33.02 3.05 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.18 0.992 . . . . 0.0 112.203 -178.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 81.37 25.85 53.3 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.773 177.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . 0.468 ' NH1' ' HA ' ' A' ' 256' ' ' LEU . 1.0 OUTLIER -137.85 125.72 22.59 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 178.643 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -101.36 142.82 32.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.978 -175.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -163.53 152.16 22.01 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.208 177.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.503 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 90.9 mt -78.39 120.68 23.48 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.116 0.484 . . . . 0.0 110.372 176.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -118.24 146.24 38.95 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.857 178.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . 0.409 ' HG2' ' CD2' ' A' ' 290' ' ' HIS . 20.9 Cg_endo -87.69 137.08 3.95 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.752 2.302 . . . . 0.0 111.948 -179.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -60.17 -14.95 19.97 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -175.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.08 -12.28 61.42 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.005 0.431 . . . . 0.0 111.358 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . 0.409 ' CD2' ' HG2' ' A' ' 287' ' ' PRO . 10.9 m170 -101.07 -15.91 17.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.362 -176.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.522 HG13 ' HA ' ' A' ' 242' ' ' ALA . 35.4 m -128.39 152.7 36.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.897 0.38 . . . . 0.0 111.33 -175.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . 0.483 ' HD3' HD11 ' A' ' 243' ' ' ILE . 3.2 mptp? -130.88 134.83 47.14 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 170.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.525 HG13 ' HB3' ' A' ' 240' ' ' ALA . 1.0 OUTLIER -88.43 122.58 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 CA-C-O 122.068 0.937 . . . . 0.0 112.029 -177.291 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 294' ' ' PHE . . . . . 0.577 ' O ' ' HD3' ' A' ' 296' ' ' PRO . 5.1 p90 -117.3 140.15 49.92 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 168.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -79.95 107.61 7.21 Favored Pre-proline 0 C--N 1.317 -0.833 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.297 178.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . 0.577 ' HD3' ' O ' ' A' ' 294' ' ' PHE . 91.0 Cg_endo . . . . . 0 N--CA 1.459 -0.542 0 C-N-CA 122.666 2.244 . . . . 0.0 110.912 -177.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.4 p . . . . . 0 N--CA 1.452 -0.342 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -81.45 102.48 10.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.18 175.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -115.2 77.35 1.07 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.549 0.69 . . . . 0.0 111.572 -177.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -157.61 151.61 24.39 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.171 176.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -85.41 126.91 34.16 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.772 176.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.447 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 5.3 t -68.67 -20.12 64.43 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.044 -174.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 t -97.8 -13.62 21.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.766 0.317 . . . . 0.0 110.909 -177.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -79.09 78.41 5.54 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.514 0.674 . . . . 0.0 109.412 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.431 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 3.8 ptp180 -69.8 -14.69 62.89 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.179 -175.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.5 t -82.91 14.86 3.01 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.61 0.719 . . . . 0.0 109.333 173.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.25 -42.51 3.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.122 170.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.425 ' CE2' ' HA ' ' A' ' 11' ' ' ARG . 44.9 p-90 -108.45 -22.05 12.47 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -172.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.431 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 25.1 t80 -86.34 120.63 27.9 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.205 0.526 . . . . 0.0 110.108 -177.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.56 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 25.1 mmt -100.38 1.36 41.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.796 -172.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.444 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.0 -112.46 1.69 Allowed Glycine 0 CA--C 1.525 0.719 0 N-CA-C 114.368 0.507 . . . . 0.0 114.368 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.444 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 11.3 Cg_exo -72.4 55.22 2.5 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 124.191 3.26 . . . . 0.0 114.299 -172.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.796 HG13 ' H ' ' A' ' 20' ' ' SER . 59.5 t -104.18 -178.42 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 172.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.796 ' H ' HG13 ' A' ' 19' ' ' VAL . 23.4 t -165.38 176.49 8.24 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -165.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 21.3 tpt180 -55.09 -55.7 28.12 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.684 0.278 . . . . 0.0 111.393 -174.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -59.11 -60.06 4.47 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.46 -177.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.432 ' O ' ' HG3' ' A' ' 27' ' ' ARG . 25.6 tt0 -61.5 -46.03 91.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.679 -175.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.418 ' HB1' HG13 ' A' ' 19' ' ' VAL . . . -53.57 -49.23 68.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.962 0.41 . . . . 0.0 111.67 -175.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.59 ' HG3' ' HB ' ' A' ' 58' ' ' VAL . 12.5 tt0 -74.25 -37.25 63.81 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 120.117 -0.633 . . . . 0.0 111.183 -174.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.412 HG22 ' O ' ' A' ' 23' ' ' GLU . 7.4 t -70.42 -21.5 62.82 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 120.784 -0.367 . . . . 0.0 111.177 -177.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.432 ' HG3' ' O ' ' A' ' 23' ' ' GLU . 56.4 mtp180 -82.79 -20.56 35.57 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.996 0.427 . . . . 0.0 110.736 178.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.53 HD11 ' HG ' ' A' ' 37' ' ' LEU . 13.0 mt -108.14 -15.74 14.43 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.95 179.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -84.71 130.24 34.72 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.243 0.544 . . . . 0.0 110.832 -173.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.504 ' C ' ' HG2' ' A' ' 32' ' ' ARG . . . 76.81 -3.38 56.45 Favored Glycine 0 C--N 1.314 -0.668 0 C-N-CA 119.914 -1.136 . . . . 0.0 112.747 178.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.483 ' HB2' ' CE ' ' A' ' 35' ' ' MET . 10.8 mt-30 -91.86 -52.17 4.86 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 172.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.748 ' NH1' ' H ' ' A' ' 57' ' ' ARG . 3.6 mmp_? 85.08 128.82 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 116.378 1.992 . . . . 0.0 116.378 152.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.722 ' CD2' ' HB3' ' A' ' 32' ' ' ARG . 9.0 m170 77.24 109.13 0.08 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 112.657 -2.065 . . . . 0.0 113.021 157.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.84 -37.83 3.46 Favored Glycine 0 N--CA 1.453 -0.222 0 CA-C-N 114.981 -1.009 . . . . 0.0 112.842 173.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.502 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 33.4 mtm -70.5 141.48 51.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.794 0.331 . . . . 0.0 111.293 -177.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.413 ' CG ' HD21 ' A' ' 98' ' ' LEU . 37.7 p90 -143.93 160.8 40.19 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 172.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.56 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.4 pp -153.91 139.57 17.93 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.172 0.511 . . . . 0.0 111.447 174.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 49.9 t -104.67 130.82 55.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.415 -0.811 . . . . 0.0 108.949 173.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 24.9 ptt-85 -127.9 175.97 7.95 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -177.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -80.89 137.6 36.16 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 170.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.3 t -78.95 97.3 5.98 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.196 0.522 . . . . 0.0 110.64 -176.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.22 -8.82 26.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.426 0.631 . . . . 0.0 110.483 174.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.5 p -97.95 -8.26 28.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.764 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.455 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 28.4 t -164.4 122.88 1.21 Allowed Pre-proline 0 C--N 1.333 -0.136 0 CA-C-O 120.589 0.233 . . . . 0.0 110.763 -177.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 44' ' ' CYS . 10.1 Cg_exo -71.53 119.41 6.23 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 123.048 2.499 . . . . 0.0 112.618 -179.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.07 25.34 17.25 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.019 178.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -134.35 163.17 30.26 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.546 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 25.3 m-85 -124.61 166.07 16.75 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 175.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.485 HG13 HD11 ' A' ' 62' ' ' ILE . 21.5 t -137.13 108.16 5.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.239 178.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.4 tp -84.18 102.02 12.29 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.864 175.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 51.0 m -95.61 124.39 39.61 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 177.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.618 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 58.0 t -114.67 139.89 38.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.271 0.558 . . . . 0.0 111.421 -173.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.469 ' HB2' HD23 ' A' ' 28' ' ' LEU . 47.0 t -98.46 103.33 15.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.74 -174.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.772 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 6.3 tp10 -157.68 163.04 38.6 Favored 'General case' 0 C--O 1.213 -0.831 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.33 171.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.75 ' ND2' ' HG3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER 44.62 42.23 5.55 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.724 1.209 . . . . 0.0 112.813 -175.653 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.744 ' HA ' ' CD ' ' A' ' 32' ' ' ARG . 68.2 m 44.23 54.72 5.95 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 121.809 0.814 . . . . 0.0 111.028 -175.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.772 ' HG3' ' O ' ' A' ' 54' ' ' GLU 0.341 0.0 OUTLIER -169.24 75.59 0.09 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.642 -1.163 . . . . 0.0 113.543 -154.384 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.618 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 14.9 t -69.14 108.12 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 O-C-N 119.475 -2.016 . . . . 0.0 110.355 -173.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.562 ' HG ' ' CZ ' ' A' ' 57' ' ' ARG . 5.2 m -84.9 123.9 31.02 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.475 -178.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 36.1 m-70 -96.59 108.97 21.66 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.682 -174.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.568 ' CE1' HD11 ' A' ' 153' ' ' ILE . 79.1 m-85 -98.7 110.57 23.14 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.268 0.627 . . . . 0.0 111.118 178.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.664 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 40.3 mm -80.55 123.95 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -174.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.546 ' HB ' ' HB2' ' A' ' 48' ' ' TYR . 5.3 mp -102.68 112.54 36.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 120.797 0.332 . . . . 0.0 110.76 177.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.5 ' HB2' ' HB3' ' A' ' 72' ' ' LYS . 15.0 m120 -86.13 140.38 30.26 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.686 -176.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.3 t -86.52 101.15 12.92 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 169.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.851 HD11 ' HG3' ' A' ' 70' ' ' ARG . 91.9 mt -83.56 140.22 41.32 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.515 -178.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.65 -11.44 26.38 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.408 2.072 . . . . 0.0 110.678 172.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.491 ' HB2' ' HG2' ' A' ' 70' ' ' ARG . 2.9 m-20 -72.15 -2.48 18.8 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.114 174.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.815 ' HA ' ' HE ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER 67.09 35.02 4.76 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.858 -178.459 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.851 ' HG3' HD11 ' A' ' 66' ' ' LEU . 4.3 ptp180 -133.64 168.22 19.07 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.829 176.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.419 ' HB3' HG22 ' A' ' 63' ' ' ILE . 37.5 m-85 -114.0 124.23 51.65 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.977 0.418 . . . . 0.0 110.553 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.562 ' HB2' HD12 ' A' ' 66' ' ' LEU . 28.9 ttpp -108.73 95.88 5.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.287 -173.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.664 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 3.8 tt -87.83 118.31 33.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.073 0.463 . . . . 0.0 110.747 -178.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.95 31.54 78.87 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.729 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.518 ' HA ' ' HG2' ' A' ' 72' ' ' LYS . 31.2 t70 74.34 4.65 4.53 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.139 0.576 . . . . 0.0 111.47 -178.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -90.93 119.73 31.36 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 173.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -81.72 121.77 26.81 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.968 0.413 . . . . 0.0 111.487 -176.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.413 ' O ' ' HB2' ' A' ' 70' ' ' ARG . 87.3 m-85 -125.28 165.75 17.77 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 172.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -58.28 -49.25 77.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.132 0.491 . . . . 0.0 111.316 -179.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.494 ' ND1' ' HG2' ' A' ' 82' ' ' PRO . 4.7 p80 -164.0 -178.5 5.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.063 -177.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.516 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 14.2 mt -56.76 -57.05 26.56 Favored Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -176.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.494 ' HG2' ' ND1' ' A' ' 80' ' ' HIS . 24.0 Cg_endo -64.46 3.03 0.94 Allowed 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.237 1.958 . . . . 0.0 113.605 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.35 -36.27 10.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.868 0.366 . . . . 0.0 110.297 178.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.1 pp -76.48 -33.89 58.67 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.496 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 68.0 mt -66.74 -19.76 65.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.735 178.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -89.08 -37.9 14.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.444 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -71.32 -30.68 66.49 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.405 0.622 . . . . 0.0 110.382 -178.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.512 ' CG ' HD22 ' A' ' 93' ' ' LEU . 19.8 m-85 -82.57 -3.2 55.67 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.978 -0.556 . . . . 0.0 112.025 -178.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.496 ' HG3' ' O ' ' A' ' 85' ' ' LEU . 99.4 mttt -72.33 -13.06 61.39 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.523 174.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 16.7 pt -132.68 10.53 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 CA-C-O 121.37 0.605 . . . . 0.0 110.054 -177.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -107.0 -37.48 6.31 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.954 -175.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.486 ' CD2' HG22 ' A' ' 97' ' ' THR . 75.1 m-85 69.06 115.89 0.04 OUTLIER 'General case' 0 C--O 1.224 -0.279 0 O-C-N 124.227 0.954 . . . . 0.0 109.702 -173.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.619 ' O ' ' HG2' ' A' ' 154' ' ' GLU . 1.2 mt -91.14 -7.64 50.99 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.516 0.674 . . . . 0.0 110.433 177.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.672 ' HA ' ' HB3' ' A' ' 154' ' ' GLU . 0.2 OUTLIER -144.61 -45.52 0.24 Allowed 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 122.107 0.956 . . . . 0.0 111.032 -172.381 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.589 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 5.6 t 152.45 -15.72 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 104.457 -2.423 . . . . 0.0 104.457 -167.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.425 ' HB ' ' HG2' ' A' ' 54' ' ' GLU . 1.1 m -117.81 145.83 44.27 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 112.878 -1.965 . . . . 0.0 108.162 177.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.486 HG22 ' CD2' ' A' ' 92' ' ' TYR . 27.4 p -94.94 171.49 8.73 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 174.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.413 HD21 ' CG ' ' A' ' 36' ' ' PHE . 92.7 mt -66.24 93.33 0.21 Allowed 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 177.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 39.9 mm -79.66 -61.05 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.969 -175.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.502 ' O ' ' HA ' ' A' ' 35' ' ' MET . 0.6 OUTLIER -160.58 150.1 14.19 Favored Pre-proline 0 N--CA 1.453 -0.312 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.121 178.452 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.86 163.41 30.93 Favored 'Trans proline' 0 CA--C 1.532 0.384 0 C-N-CA 122.91 2.407 . . . . 0.0 114.414 -172.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.518 ' HB1' HD21 ' A' ' 28' ' ' LEU . . . -63.83 155.47 77.17 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.475 176.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -51.38 95.83 0.03 OUTLIER 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 123.116 2.544 . . . . 0.0 112.755 174.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.45 ' HG3' ' SD ' ' A' ' 16' ' ' MET . 49.5 ttt180 . . . . . 0 C--N 1.331 -0.218 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 177.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.575 ' HG ' ' HD2' ' A' ' 155' ' ' LYS . 4.2 mm? . . . . . 0 N--CA 1.467 0.414 0 CA-C-O 121.527 0.68 . . . . 0.0 112.53 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 48.4 tt0 -172.65 -56.46 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.65 178.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -117.99 108.64 15.51 Favored 'General case' 0 CA--C 1.51 -0.582 0 C-N-CA 120.071 -0.651 . . . . 0.0 111.134 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.648 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 3.1 t -115.8 142.32 29.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.658 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 0.1 OUTLIER -115.38 145.01 42.94 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 116.623 -2.031 . . . . 0.0 108.688 160.493 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.528 ' HB ' ' CD1' ' A' ' 144' ' ' PHE . 0.8 OUTLIER -103.48 128.04 50.75 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.086 -177.601 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.524 HD22 ' HG2' ' A' ' 179' ' ' GLU . 20.3 mt -102.0 -24.0 14.04 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -174.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.488 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 46.8 t80 -82.03 -35.3 28.94 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.271 -0.571 . . . . 0.0 112.378 -172.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.645 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 9.7 t70 75.18 104.64 0.07 Allowed 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.423 0.63 . . . . 0.0 110.726 -175.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 63.9 t80 -129.77 88.85 48.1 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 175.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.589 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 60.4 Cg_endo -85.3 71.18 4.95 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.039 1.826 . . . . 0.0 113.099 -176.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.72 -30.53 76.41 Favored Glycine 0 C--N 1.331 0.287 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.778 178.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.541 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 13.7 m-80 56.0 71.01 0.58 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 114.862 -0.669 . . . . 0.0 110.718 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . 0.466 ' HB3' ' H ' ' A' ' 141' ' ' ASP . 0.7 OUTLIER -145.6 -169.47 3.23 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.149 -174.442 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -110.73 -5.53 14.97 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 166.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -101.31 -56.88 2.2 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 113.698 -1.592 . . . . 0.0 108.529 177.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . 0.466 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 3.4 m-20 -96.81 120.86 37.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.489 174.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.704 ' CD1' ' HB2' ' A' ' 165' ' ' ASN . 32.9 tp -76.68 130.13 77.34 Favored Pre-proline 0 N--CA 1.467 0.404 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 175.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.589 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 74.1 Cg_endo -82.28 94.04 0.9 Allowed 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 121.67 1.58 . . . . 0.0 111.966 172.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.592 ' CE2' ' HB ' ' A' ' 173' ' ' ILE . 12.2 p90 -106.58 153.7 21.97 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -176.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.645 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 88.9 mttt -103.16 -162.03 0.88 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -173.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.573 ' HD2' ' N ' ' A' ' 146' ' ' LYS . 9.0 mptt -81.98 -7.94 59.64 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.858 -166.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -167.83 27.5 0.15 Allowed Glycine 0 C--N 1.311 -0.825 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.352 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.554 ' OE1' ' HA ' ' A' ' 144' ' ' PHE . 0.1 OUTLIER -78.99 154.39 29.55 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.071 0.462 . . . . 0.0 111.684 -177.157 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.577 HD12 ' HB3' ' A' ' 129' ' ' ARG . 0.5 OUTLIER -95.19 128.72 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.702 -177.961 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.663 HD23 ' CD2' ' A' ' 142' ' ' LEU . 61.8 mt -122.98 156.19 35.27 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -175.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.563 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 85.2 t -119.2 121.07 65.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 174.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.481 HG22 HD13 ' A' ' 125' ' ' LEU . 48.5 mm -76.88 91.75 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 CA-C-O 121.889 0.852 . . . . 0.0 108.711 -176.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.568 HD11 ' CE1' ' A' ' 61' ' ' TYR . 17.6 tt -79.95 -26.66 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 CA-C-N 114.237 -1.347 . . . . 0.0 109.696 -174.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.734 ' HA ' HH21 ' A' ' 57' ' ' ARG . 0.9 OUTLIER -134.7 144.9 48.04 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 172.461 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.575 ' HD2' ' HG ' ' A' ' 125' ' ' LEU . 77.0 tttt -127.84 85.06 61.61 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-O 121.148 0.499 . . . . 0.0 109.914 164.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.589 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 13.2 Cg_exo -73.45 -41.33 1.22 Allowed 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.62 2.213 . . . . 0.0 112.28 175.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -121.7 176.84 5.52 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.931 -173.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -106.65 -0.98 23.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.777 0.798 . . . . 0.0 109.283 174.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -102.82 -36.68 8.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.801 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.52 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 31.1 m95 -127.03 144.71 50.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.932 176.072 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . 0.755 ' O ' HG13 ' A' ' 173' ' ' ILE . 49.3 m0 -125.75 138.98 53.89 Favored 'General case' 0 C--O 1.215 -0.756 0 C-N-CA 123.346 0.658 . . . . 0.0 109.776 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.514 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 23.9 m -97.98 104.87 16.94 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -173.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.525 ' HB2' ' HB3' ' A' ' 150' ' ' LEU . . . -114.94 149.4 37.34 Favored 'General case' 0 N--CA 1.425 -1.687 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.235 -176.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.693 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 13.0 ptt180 -87.48 122.33 31.07 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 171.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.704 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . 14.4 t30 -52.8 172.19 0.05 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.577 -1.647 . . . . 0.0 110.648 -175.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -63.75 -10.22 18.53 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.282 0.563 . . . . 0.0 109.554 173.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -85.21 -27.02 26.38 Favored 'General case' 0 N--CA 1.46 0.073 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.332 171.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 108.73 -2.28 32.11 Favored Glycine 0 CA--C 1.522 0.49 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.677 -176.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.693 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 3.3 ttm-85 -74.3 132.79 42.39 Favored 'General case' 0 C--O 1.214 -0.815 0 C-N-CA 123.054 0.542 . . . . 0.0 111.798 -177.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 64.7 t -84.81 121.88 37.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 O-C-N 122.032 -0.418 . . . . 0.0 111.391 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -158.36 156.35 27.33 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.578 173.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.537 ' HE1' ' HG2' ' A' ' 156' ' ' PRO . 0.0 OUTLIER -75.75 145.22 40.97 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 122.604 0.361 . . . . 0.0 111.479 -179.735 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.755 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.6 pp -144.69 145.62 28.86 Favored Pre-proline 0 C--O 1.221 -0.411 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.444 -177.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.49 ' HB2' ' CD1' ' A' ' 177' ' ' TYR . 10.3 Cg_exo -73.69 132.98 18.0 Favored 'Trans proline' 0 CA--C 1.527 0.126 0 C-N-CA 122.688 2.259 . . . . 0.0 112.889 -175.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.535 ' O ' HG21 ' A' ' 178' ' ' VAL . 47.8 t -61.43 -45.71 94.45 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.531 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 50.8 Cg_exo -57.55 -8.01 3.62 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.383 2.056 . . . . 0.0 113.643 175.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.49 ' CD1' ' HB2' ' A' ' 174' ' ' PRO . 3.0 m-85 -95.57 -11.49 27.24 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.622 -178.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.535 HG21 ' O ' ' A' ' 175' ' ' VAL . 3.4 m -106.49 -174.08 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 -165.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.691 ' O ' ' HG3' ' A' ' 179' ' ' GLU . 8.2 tp10 -161.02 44.29 0.17 Allowed 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 112.477 -2.147 . . . . 0.0 111.152 -155.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.765 ' HD2' ' H ' ' A' ' 180' ' ' LYS . 0.0 OUTLIER -73.71 141.85 46.38 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 119.411 -2.056 . . . . 0.0 111.663 -163.49 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.457 ' HB2' HH12 ' A' ' 129' ' ' ARG . 18.0 tp . . . . . 0 C--O 1.231 0.094 0 CA-C-N 112.608 -2.087 . . . . 0.0 112.259 -161.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo . . . . . 0 N--CA 1.462 -0.346 0 N-CA-C 111.347 -0.29 . . . . 0.0 111.347 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.406 ' CG1' HD12 ' A' ' 293' ' ' ILE . 13.2 t -66.85 136.48 26.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.18 -174.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.515 ' HB2' ' HG3' ' A' ' 296' ' ' PRO . 82.8 m-85 -98.63 125.51 43.93 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.971 178.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -118.21 148.53 42.29 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.417 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -92.31 125.29 36.91 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 177.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . 0.522 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -71.01 104.95 3.14 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 176.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.582 HD11 ' HG2' ' A' ' 292' ' ' LYS . 41.2 pt -88.0 0.82 6.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.936 0.398 . . . . 0.0 111.311 -174.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -155.79 146.47 22.05 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 15.7 pttm -66.41 109.16 2.62 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.57 0.7 . . . . 0.0 110.542 176.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.55 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 24.9 tpt180 -84.46 93.56 8.33 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.711 178.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 27.1 m -105.87 138.17 19.56 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.007 176.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.498 ' HB3' ' HB3' ' A' ' 255' ' ' ALA . 90.4 Cg_endo -80.62 148.72 18.19 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.471 2.114 . . . . 0.0 112.282 -179.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' CYS . . . . . 0.417 ' SG ' ' N ' ' A' ' 250' ' ' ALA . 41.8 t -92.74 -176.55 4.28 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 175.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . 0.417 ' N ' ' SG ' ' A' ' 249' ' ' CYS . . . -61.34 -24.0 66.14 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -175.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -102.75 -9.63 19.84 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -177.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -84.35 88.1 7.24 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.109 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -87.21 -16.92 33.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.039 -178.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 10.2 p -110.3 7.12 22.94 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.622 -176.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . 0.498 ' HB3' ' HB3' ' A' ' 248' ' ' PRO . . . -86.85 132.92 33.69 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.258 0.551 . . . . 0.0 111.328 -176.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . 0.457 ' O ' ' HG3' ' A' ' 246' ' ' ARG . 1.0 OUTLIER -81.89 143.39 31.72 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 176.633 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -97.53 110.36 22.93 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.928 0.394 . . . . 0.0 110.329 178.054 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.543 ' HB2' ' HB3' ' A' ' 246' ' ' ARG . 65.5 mt -113.34 139.13 49.12 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.451 -175.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -91.67 137.61 32.22 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.726 173.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 2.5 p -67.37 119.21 12.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.163 0.506 . . . . 0.0 110.284 178.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 115.55 -3.26 21.72 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.266 -177.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -99.08 159.58 14.87 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -177.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 20.8 mm -87.38 122.76 39.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.062 0.458 . . . . 0.0 110.45 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.469 HG13 HG23 ' A' ' 279' ' ' VAL . 21.5 t -102.07 99.2 7.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.906 176.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -78.94 101.75 7.91 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.925 176.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.505 HG11 ' HE3' ' A' ' 269' ' ' MET . 5.5 p -88.27 123.73 40.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.293 0.568 . . . . 0.0 109.983 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 2.4 m -93.83 -35.11 12.88 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.47 -175.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . 0.487 ' NE ' ' HA ' ' A' ' 268' ' ' ARG . 3.2 mmp_? -132.6 112.74 12.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.923 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' MET . . . . . 0.585 ' HE1' ' CH2' ' A' ' 275' ' ' TRP . 41.3 mtt -87.83 121.52 30.35 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.455 175.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -95.78 155.55 16.7 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . 0.73 ' H ' HD11 ' A' ' 271' ' ' ILE . 0.2 OUTLIER -82.53 -8.61 11.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -172.522 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -80.63 -24.0 39.34 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.717 0.294 . . . . 0.0 111.077 -178.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 123.85 -21.86 6.96 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.569 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -94.97 123.2 38.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.056 0.455 . . . . 0.0 109.805 177.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.585 ' CH2' ' HE1' ' A' ' 269' ' ' MET . 47.4 m0 -98.3 153.29 18.63 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.929 -176.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -105.45 105.69 15.84 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.492 176.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -127.41 153.07 19.0 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.207 -178.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -107.46 108.62 20.03 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . 0.469 HG23 HG13 ' A' ' 264' ' ' VAL . 89.2 t -133.04 128.67 56.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.544 -175.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 59.83 27.5 16.83 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.262 176.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 92.19 -5.92 78.42 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.337 177.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -115.74 134.48 54.98 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 122.714 -0.286 . . . . 0.0 110.768 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 15.7 ptpt -112.87 131.01 55.9 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.038 0.447 . . . . 0.0 110.018 171.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -156.04 -175.79 27.43 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.51 -177.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 79.5 mt -98.63 124.31 43.36 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.422 0.629 . . . . 0.0 111.128 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -129.59 135.05 26.93 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.68 177.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.88 140.08 28.33 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.381 2.054 . . . . 0.0 111.461 178.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -64.22 -8.5 12.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.775 -176.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -71.03 -16.6 62.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.045 0.45 . . . . 0.0 111.209 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -101.89 -8.31 21.7 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.827 -176.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.522 HG12 ' HA ' ' A' ' 242' ' ' ALA . 30.2 m -129.61 166.89 26.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.639 0.257 . . . . 0.0 110.783 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . 0.582 ' HG2' HD11 ' A' ' 243' ' ' ILE . 28.8 mmtp -137.48 136.26 37.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.966 0.412 . . . . 0.0 110.903 175.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.406 HD12 ' CG1' ' A' ' 238' ' ' VAL . 38.9 mm -82.17 101.85 7.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 174.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -105.81 -7.72 18.15 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.005 -174.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 59.48 93.03 0.06 OUTLIER Pre-proline 0 N--CA 1.464 0.249 0 O-C-N 123.72 0.637 . . . . 0.0 111.465 -176.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . 0.515 ' HG3' ' HB2' ' A' ' 239' ' ' PHE . 60.4 Cg_endo . . . . . 0 C--O 1.233 0.272 0 C-N-CA 122.766 2.311 . . . . 0.0 111.4 175.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.6 t . . . . . 0 N--CA 1.45 -0.433 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -74.0 105.59 5.31 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.551 173.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -121.32 35.92 4.75 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.357 -172.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -117.51 157.45 26.27 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.107 -179.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -84.63 111.18 19.31 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 174.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.6 m -61.33 -15.49 36.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.183 -174.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.4 p -101.11 -20.88 15.15 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -177.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -77.11 93.99 3.98 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.943 -172.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.415 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 13.4 mtm-85 -61.11 -28.68 69.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.464 -178.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.438 ' HA ' ' NH1' ' A' ' 104' ' ' ARG . 67.7 m -73.83 4.45 5.22 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.799 0.333 . . . . 0.0 111.504 178.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -106.29 -43.8 4.7 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.521 174.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . 0.439 ' HB3' ' HB3' ' A' ' 101' ' ' PRO . 19.9 p-90 -114.91 -20.22 10.64 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -172.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.415 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 70.8 t80 -80.69 125.21 29.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.04 0.447 . . . . 0.0 110.92 -175.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.478 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 25.5 mmt -104.63 -6.18 20.72 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.182 -173.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 51.62 -113.36 2.34 Favored Glycine 0 CA--C 1.524 0.606 0 O-C-N 123.419 0.449 . . . . 0.0 113.738 -176.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -69.56 85.51 0.58 Allowed 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 122.924 2.416 . . . . 0.0 113.604 -176.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.435 ' HB ' ' HB2' ' A' ' 39' ' ' ARG . 85.9 t -140.3 156.85 24.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 175.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.579 ' HB3' ' OE1' ' A' ' 23' ' ' GLU . 34.4 t -127.39 -179.32 4.84 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -171.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 45.6 ttt85 -62.05 -53.24 58.28 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -173.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.86 -43.13 93.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.729 0.3 . . . . 0.0 110.786 -177.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.579 ' OE1' ' HB3' ' A' ' 20' ' ' SER . 13.6 mp0 -60.22 -51.16 70.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.682 179.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.519 ' HB2' HD11 ' A' ' 37' ' ' LEU . . . -57.25 -40.87 78.54 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.649 0.737 . . . . 0.0 110.795 176.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.444 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 33.4 tp60 -64.28 -44.28 92.18 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.441 -177.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 10.6 t -75.67 -31.25 59.69 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 111.655 0.242 . . . . 0.0 111.655 -176.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.474 ' O ' ' HG3' ' A' ' 31' ' ' GLN . 74.9 mtp180 -74.12 -13.21 60.79 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.711 0.291 . . . . 0.0 111.232 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.569 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 79.8 mt -121.48 -6.0 9.27 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.503 -178.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . 0.444 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 19.2 tp60 -65.24 103.34 0.77 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.783 0.325 . . . . 0.0 111.127 -175.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.74 9.04 84.96 Favored Glycine 0 C--N 1.329 0.154 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.494 175.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.474 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 13.4 mm100 -73.96 -164.91 0.26 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.998 0.427 . . . . 0.0 111.213 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.546 ' HB3' ' HE2' ' A' ' 35' ' ' MET . 55.2 ttp180 -58.08 125.88 25.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.989 176.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.424 ' HB3' ' CD ' ' A' ' 54' ' ' GLU . 65.0 m170 -72.5 122.14 20.81 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.906 -178.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 108.89 -4.73 32.18 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 -173.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.771 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 43.6 ttm -77.27 129.44 35.89 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 176.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.438 ' HB2' HG23 ' A' ' 52' ' ' VAL . 37.9 p90 -138.99 162.18 35.54 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.34 -177.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.524 ' HG ' HD11 ' A' ' 28' ' ' LEU . 4.6 pp -151.48 141.36 21.98 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.108 0.48 . . . . 0.0 110.777 174.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.5 t -107.59 118.79 56.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.59 176.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.435 ' HB2' ' HB ' ' A' ' 19' ' ' VAL . 23.4 ptt-85 -116.25 175.91 5.34 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.318 -176.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -77.7 127.56 32.64 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 173.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.8 t -71.61 121.55 18.97 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.693 -174.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.9 t -83.54 -18.71 37.45 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 170.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 27.2 m -62.59 -44.61 95.88 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.712 174.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.409 ' HA ' ' HD2' ' A' ' 45' ' ' PRO . 51.1 t -150.84 99.59 3.11 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.056 176.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 44' ' ' CYS . 10.3 Cg_endo -52.68 132.27 45.22 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.998 2.465 . . . . 0.0 112.213 -179.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.24 -34.68 5.52 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -175.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.615 ' OD2' ' HA ' ' A' ' 64' ' ' ASN . 2.7 m-20 -85.25 -177.49 6.51 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 175.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -130.87 168.47 17.23 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.568 0.223 . . . . 0.0 110.971 -177.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.2 t -138.87 109.52 4.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.065 0.46 . . . . 0.0 110.82 174.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.419 ' CB ' HD13 ' A' ' 63' ' ' ILE . 40.5 tp -84.74 102.04 12.7 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.051 176.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 53.8 m -96.14 126.18 41.18 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 175.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.524 HG21 HD12 ' A' ' 93' ' ' LEU . 58.8 t -121.7 133.53 67.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.257 -175.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.569 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 41.6 t -87.43 121.45 29.88 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -176.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.644 ' HG3' ' HB3' ' A' ' 94' ' ' ASP . 0.6 OUTLIER -150.48 148.59 28.91 Favored 'General case' 0 C--O 1.209 -1.076 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.424 165.863 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 40.05 40.56 0.78 Allowed 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -176.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.2 m 57.25 49.86 12.62 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 122.139 0.971 . . . . 0.0 109.267 178.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.473 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 2.6 tmm_? -167.13 64.44 0.09 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 113.906 -1.497 . . . . 0.0 109.711 -151.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 46.6 t -71.6 113.89 9.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 122.004 0.906 . . . . 0.0 110.612 -166.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.0 m -76.86 120.73 22.41 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 113.915 -1.493 . . . . 0.0 110.807 -177.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -96.35 106.05 18.21 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -176.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.551 ' HB3' HD11 ' A' ' 73' ' ' ILE . 88.7 m-85 -105.7 109.26 21.15 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 122.853 0.461 . . . . 0.0 111.691 179.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.567 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 66.3 mt -81.31 132.68 30.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -177.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.454 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 5.4 mp -110.07 117.8 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 122.779 0.432 . . . . 0.0 110.481 178.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.615 ' HA ' ' OD2' ' A' ' 47' ' ' ASP . 6.6 m120 -87.75 133.59 33.83 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.194 -175.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.7 t -86.8 96.63 10.25 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 170.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.4 mt -70.54 140.22 87.0 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.634 178.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.61 -21.39 31.14 Favored 'Trans proline' 0 CA--C 1.529 0.25 0 C-N-CA 122.86 2.373 . . . . 0.0 112.413 177.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -78.69 7.55 6.74 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.214 176.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.626 ' HA ' ' HE ' ' A' ' 69' ' ' ARG . 7.7 mmp_? 65.39 51.35 1.57 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.738 0.78 . . . . 0.0 110.764 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.427 ' NH2' ' HB3' ' A' ' 77' ' ' GLU . 30.2 mtp180 -137.49 174.01 11.05 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.096 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.546 ' HA ' ' O ' ' A' ' 64' ' ' ASN . 47.2 m-85 -132.09 121.15 23.35 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.15 0.5 . . . . 0.0 111.694 -176.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 1.045 ' HD3' ' HG2' ' A' ' 77' ' ' GLU . 24.5 ttpt -111.91 119.33 38.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.513 176.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.567 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 2.9 tt -109.3 102.89 14.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.397 0.618 . . . . 0.0 111.068 -176.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.411 ' C ' ' H ' ' A' ' 76' ' ' GLN . . . 64.49 61.94 5.52 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.4 177.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 30.6 t70 75.04 -28.63 0.19 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.976 0.51 . . . . 0.0 111.788 175.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.411 ' H ' ' C ' ' A' ' 74' ' ' GLY . 12.9 mm-40 -78.23 122.86 26.24 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.698 0.285 . . . . 0.0 110.579 175.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 1.045 ' HG2' ' HD3' ' A' ' 72' ' ' LYS . 30.6 mt-10 -95.53 126.26 40.7 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.792 0.329 . . . . 0.0 110.605 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -121.78 -169.81 1.94 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.388 177.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -82.67 -56.78 3.65 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.07 0.462 . . . . 0.0 110.365 177.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -157.87 179.95 8.72 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.485 -176.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.641 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 19.6 mt -49.96 -59.17 7.42 Favored Pre-proline 0 N--CA 1.469 0.495 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.641 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 15.4 Cg_exo -68.85 -2.49 9.6 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 121.975 1.783 . . . . 0.0 112.743 -175.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.32 -36.71 12.4 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.063 176.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.604 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.4 pp -76.69 -34.68 58.19 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.12 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.569 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 76.2 mt -62.59 -38.01 88.46 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.834 177.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.561 ' HA ' ' HD3' ' A' ' 89' ' ' LYS . 14.4 tp10 -70.63 -34.13 71.75 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 -177.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -70.56 -37.8 74.05 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.321 0.582 . . . . 0.0 110.594 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.556 ' CG ' HD22 ' A' ' 93' ' ' LEU . 21.3 m-85 -78.32 -19.77 52.85 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.743 -177.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.569 ' HG3' ' O ' ' A' ' 85' ' ' LEU . 50.0 mtpt -62.34 -20.18 64.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.685 172.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 23.9 pt -121.04 18.58 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 120.58 -0.448 . . . . 0.0 112.105 175.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 6.6 t-160 -106.14 -33.23 7.92 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.887 0.375 . . . . 0.0 110.559 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.532 ' N ' HG23 ' A' ' 97' ' ' THR . 52.9 m-85 66.61 91.63 0.08 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.284 -168.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.562 ' HA ' ' OE2' ' A' ' 154' ' ' GLU . 12.7 mt -60.81 -8.45 3.05 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.989 0.9 . . . . 0.0 110.506 173.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.644 ' HB3' ' HG3' ' A' ' 54' ' ' GLU . 16.1 t70 -161.68 -108.59 0.02 OUTLIER 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 174.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.8 t -117.6 15.56 14.58 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.638 -0.825 . . . . 0.0 111.198 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.464 HG23 ' O ' ' A' ' 97' ' ' THR . 13.3 t -139.71 -19.39 0.93 Allowed 'General case' 0 C--N 1.349 0.544 0 C-N-CA 118.192 -1.403 . . . . 0.0 114.326 -177.075 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.532 HG23 ' N ' ' A' ' 92' ' ' TYR . 6.6 p 74.95 -164.1 0.08 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.845 0.858 . . . . 0.0 109.989 -171.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.537 ' HG ' HD11 ' A' ' 93' ' ' LEU . 42.7 mt -89.6 111.29 22.19 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 175.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.459 HD11 ' O ' ' A' ' 96' ' ' THR . 51.3 mm -105.19 -58.07 4.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -173.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.771 ' O ' ' HA ' ' A' ' 35' ' ' MET . 4.7 tp10 -153.72 131.27 6.13 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 -174.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.439 ' HB3' ' HB3' ' A' ' 14' ' ' TRP . 28.3 Cg_endo -62.8 166.43 13.95 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 122.764 2.309 . . . . 0.0 112.896 -179.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -75.62 148.17 82.42 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.648 176.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.33 106.62 0.31 Allowed 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 122.562 2.175 . . . . 0.0 112.628 -177.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . 0.438 ' NH1' ' HA ' ' A' ' 12' ' ' SER . 24.1 ttp180 . . . . . 0 C--N 1.329 -0.298 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 174.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.58 HD12 ' CE2' ' A' ' 161' ' ' TRP . 1.0 OUTLIER . . . . . 0 N--CA 1.47 0.553 0 CA-C-O 121.648 0.737 . . . . 0.0 111.36 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.683 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 28.0 tt0 174.92 -52.33 0.01 OUTLIER 'General case' 0 C--O 1.22 -0.488 0 CA-C-N 114.005 -1.452 . . . . 0.0 109.26 179.19 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -110.97 105.93 14.87 Favored 'General case' 0 CA--C 1.511 -0.55 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.416 178.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.68 HG22 ' CG ' ' A' ' 180' ' ' LYS . 41.5 t -120.93 127.71 75.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.982 -178.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.591 ' O ' ' HG2' ' A' ' 179' ' ' GLU . 9.3 ptp180 -109.11 140.05 43.19 Favored 'General case' 0 C--O 1.22 -0.452 0 C-N-CA 117.336 -1.745 . . . . 0.0 110.267 173.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.451 ' HB ' ' CD1' ' A' ' 144' ' ' PHE . 1.4 p -98.54 139.91 33.57 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.285 -179.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.861 ' CD1' ' HG3' ' A' ' 179' ' ' GLU . 62.9 mt -126.39 1.94 6.99 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -178.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.51 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 36.7 t80 -93.46 -33.98 13.6 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.677 178.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.572 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 11.7 t70 74.51 101.3 0.07 Allowed 'General case' 0 N--CA 1.467 0.411 0 O-C-N 123.916 0.76 . . . . 0.0 109.868 -177.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.6 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 70.3 t80 -131.61 87.99 44.35 Favored Pre-proline 0 N--CA 1.446 -0.667 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.641 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 97.1 Cg_endo -79.08 88.3 1.47 Allowed 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 121.729 1.62 . . . . 0.0 112.49 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.72 -31.76 32.0 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.89 177.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.801 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 21.8 m120 66.89 35.68 4.74 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.027 0.531 . . . . 0.0 111.563 177.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -136.39 172.81 12.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.734 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.625 ' O ' ' HA2' ' A' ' 171' ' ' GLY . . . -86.88 -13.79 43.86 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.642 0.734 . . . . 0.0 109.498 171.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.663 ' O ' ' HB2' ' A' ' 172' ' ' MET . 3.4 mp0 -94.83 -18.59 21.06 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.635 176.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -139.77 102.29 4.4 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 176.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.724 ' CD2' HD23 ' A' ' 150' ' ' LEU . 49.9 tp -64.46 129.54 94.23 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -178.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.801 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 27.8 Cg_endo -81.92 88.62 1.3 Allowed 'Trans proline' 0 N--CA 1.439 -1.69 0 C-N-CA 121.239 1.292 . . . . 0.0 111.535 174.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.6 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 20.5 p90 -108.06 165.5 11.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.389 -173.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.572 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 37.0 mttp -109.49 -173.76 2.34 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.253 0.549 . . . . 0.0 111.853 -175.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.694 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -89.09 21.29 3.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.322 -174.846 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -179.96 35.03 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.121 177.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -107.68 150.25 27.16 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.073 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.502 HG13 ' HB3' ' A' ' 129' ' ' ARG . 1.9 mp -98.32 131.22 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -177.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.724 HD23 ' CD2' ' A' ' 142' ' ' LEU . 7.7 mt -122.3 169.51 10.86 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -175.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.683 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 74.1 t -128.98 122.4 56.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 110.422 -0.214 . . . . 0.0 110.422 178.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.513 HG23 HD11 ' A' ' 125' ' ' LEU . 45.8 mm -75.84 98.59 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -174.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.466 HG21 HG22 ' A' ' 170' ' ' VAL . 19.9 tt -96.07 -32.74 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.581 -173.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.562 ' OE2' ' HA ' ' A' ' 93' ' ' LEU . 7.7 mt-10 -115.93 140.05 49.63 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 167.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.676 ' HE3' ' HE1' ' A' ' 161' ' ' TRP . 83.7 tttt -127.84 73.66 78.77 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 121.901 -0.499 . . . . 0.0 110.944 170.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.547 ' HG2' ' HE1' ' A' ' 172' ' ' MET . 39.9 Cg_exo -61.19 -42.1 38.03 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.439 2.092 . . . . 0.0 112.183 175.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -124.91 -177.91 4.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.4 -175.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.455 ' O ' HG23 ' A' ' 175' ' ' VAL . 0.2 OUTLIER -108.5 -10.92 15.21 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 173.537 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -93.62 -30.95 14.69 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.555 177.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.566 ' CH2' ' HG3' ' A' ' 174' ' ' PRO . 65.0 m95 -124.06 141.71 51.82 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.409 174.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . 0.676 ' HE1' ' HE3' ' A' ' 155' ' ' LYS . 43.9 m0 -132.52 137.97 47.35 Favored 'General case' 0 C--O 1.21 -1.021 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.238 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.558 ' HA ' ' HA ' ' A' ' 172' ' ' MET . 19.0 m -93.34 99.34 11.89 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -174.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.524 ' HA ' ' O ' ' A' ' 151' ' ' VAL . . . -109.09 143.17 38.79 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -171.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.791 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 11.1 ptt180 -86.35 119.46 26.64 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 176.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.682 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . 16.4 t30 -50.75 170.12 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 113.117 -1.856 . . . . 0.0 111.543 -174.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -66.7 -9.14 33.24 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.49 0.662 . . . . 0.0 109.392 174.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -85.91 -18.7 31.99 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.259 171.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.29 56.87 2.2 Favored Glycine 0 CA--C 1.52 0.397 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.422 -174.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.791 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 4.2 ttm-85 -136.61 135.0 37.97 Favored 'General case' 0 C--O 1.216 -0.669 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 139' ' ' ALA . 43.0 t -79.66 124.95 38.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.375 -178.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . 0.625 ' HA2' ' O ' ' A' ' 139' ' ' ALA . . . -160.86 150.78 20.93 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.856 169.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.663 ' HB2' ' O ' ' A' ' 140' ' ' GLU . 1.5 mmt -67.18 138.2 56.82 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 117.515 0.657 . . . . 0.0 111.187 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.674 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.8 pp -134.1 140.06 35.01 Favored Pre-proline 0 N--CA 1.443 -0.799 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.271 179.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.742 ' O ' HG11 ' A' ' 178' ' ' VAL . 26.3 Cg_exo -67.77 128.81 18.56 Favored 'Trans proline' 0 C--O 1.212 -0.779 0 C-N-CA 123.243 2.629 . . . . 0.0 112.871 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.561 ' C ' ' H ' ' A' ' 177' ' ' TYR . 88.0 t -64.72 -45.09 75.4 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 178.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 39.5 Cg_endo -67.63 8.96 0.37 Allowed 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 121.996 1.798 . . . . 0.0 111.933 175.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.726 ' HB2' ' HB2' ' A' ' 174' ' ' PRO . 1.5 m-85 -111.79 -5.34 14.42 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.256 -1.338 . . . . 0.0 109.649 -175.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.742 HG11 ' O ' ' A' ' 174' ' ' PRO . 2.7 m -133.28 171.24 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-O 123.596 1.665 . . . . 0.0 114.717 -167.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.861 ' HG3' ' CD1' ' A' ' 131' ' ' LEU . 2.7 mm-40 -140.64 51.88 1.64 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 110.612 -2.995 . . . . 0.0 110.635 -155.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 0.68 ' CG ' HG22 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -69.69 136.78 51.47 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 120.209 -1.557 . . . . 0.0 109.894 -166.733 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.413 HD13 ' NH2' ' A' ' 129' ' ' ARG . 20.7 tp . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 112.329 -2.214 . . . . 0.0 113.244 -156.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo . . . . . 0 N--CA 1.459 -0.51 0 N-CA-C 111.187 -0.351 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 3.4 t -83.07 146.06 7.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -178.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.403 ' CB ' ' HG3' ' A' ' 296' ' ' PRO . 57.0 m-85 -115.0 131.88 56.78 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.45 0.643 . . . . 0.0 112.02 -172.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . 0.529 ' HB3' HD11 ' A' ' 293' ' ' ILE . . . -133.37 146.03 50.9 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.092 176.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.418 ' HB3' HD11 ' A' ' 263' ' ' ILE . 18.5 ptmt -111.38 132.34 54.5 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.693 -0.403 . . . . 0.0 109.952 176.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -63.36 117.86 7.25 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.945 -175.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 19.2 pt -98.43 -14.02 7.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.082 -177.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -146.17 138.91 25.53 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 47.7 mttp -52.95 140.0 25.99 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.843 0.83 . . . . 0.0 113.159 -172.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.509 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 21.0 tpt180 -130.42 86.15 2.36 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.969 172.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 19.4 m -95.99 140.89 22.48 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.189 -179.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.439 ' HA ' ' HB3' ' A' ' 255' ' ' ALA . 13.4 Cg_exo -66.96 136.87 42.8 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.405 2.07 . . . . 0.0 111.604 -179.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 33.0 t -104.03 175.5 5.46 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.652 -178.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -56.3 -42.88 78.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.994 0.425 . . . . 0.0 111.43 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -85.81 -14.79 44.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.06 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -129.58 70.58 1.42 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.946 0.403 . . . . 0.0 110.185 -176.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -83.73 -14.13 52.35 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 174.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 5.2 p -76.82 -5.81 49.8 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.409 174.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . 0.439 ' HB3' ' HA ' ' A' ' 248' ' ' PRO . . . -72.88 139.55 46.95 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.745 178.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.07 119.75 23.95 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.509 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -70.03 103.65 2.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.653 178.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . 0.476 ' HB2' ' HB3' ' A' ' 246' ' ' ARG . 96.1 mt -112.07 128.03 56.08 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.075 -178.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.75 157.17 17.04 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 176.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 47.4 t -67.57 124.18 22.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.985 0.422 . . . . 0.0 110.253 -178.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 98.74 5.65 56.55 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.255 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -93.38 135.42 34.63 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . 0.418 HD11 ' HB3' ' A' ' 241' ' ' LYS . 24.8 mm -81.52 121.79 35.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.964 0.411 . . . . 0.0 110.184 177.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.49 HG11 ' CZ ' ' A' ' 286' ' ' PHE . 22.0 t -95.15 109.66 22.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.91 -178.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 43.4 tttp -85.76 87.46 7.41 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.59 176.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 4.0 p -89.92 125.8 42.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.156 0.503 . . . . 0.0 110.59 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 16.1 p -95.8 -32.87 12.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.256 -177.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . 0.553 ' HD2' ' OE2' ' A' ' 276' ' ' GLU . 41.3 ttm180 -132.39 118.46 19.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.992 0.425 . . . . 0.0 111.786 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' MET . . . . . 0.653 ' HE1' ' CH2' ' A' ' 275' ' ' TRP . 46.8 mtt -90.78 107.25 19.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.137 172.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.678 HD22 ' HG3' ' A' ' 276' ' ' GLU . 44.1 m-80 -78.68 137.82 37.99 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 178.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 10.7 tt -79.9 71.46 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 122.153 0.978 . . . . 0.0 110.969 -178.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . 0.609 HD22 ' HG2' ' A' ' 274' ' ' GLN . 2.8 p-10 -168.27 -4.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.852 176.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 119.42 -31.24 5.49 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.159 171.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.609 ' HG2' HD22 ' A' ' 272' ' ' ASN . 12.1 pt20 -95.46 129.48 42.61 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.04 0.447 . . . . 0.0 110.519 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . 0.653 ' CH2' ' HE1' ' A' ' 269' ' ' MET . 50.7 m0 -105.72 154.01 21.06 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.317 -179.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . 0.678 ' HG3' HD22 ' A' ' 270' ' ' ASN . 43.0 mt-10 -96.0 111.45 23.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.335 172.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . 0.551 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -134.26 156.56 22.45 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.493 -0.861 . . . . 0.0 111.625 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.547 ' HG2' ' HB2' ' A' ' 283' ' ' LYS . 41.1 mt-10 -117.32 108.08 15.17 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.091 0.472 . . . . 0.0 109.808 178.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . 0.563 HG13 ' ND2' ' A' ' 280' ' ' ASN . 15.4 t -138.39 137.68 43.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.574 -177.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . 0.563 ' ND2' HG13 ' A' ' 279' ' ' VAL . 52.9 m-80 61.64 21.51 12.19 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.604 0.362 . . . . 0.0 111.051 -178.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 90.97 -5.87 81.86 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.979 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 32.7 mtp-105 -110.08 132.45 54.15 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 122.663 -0.316 . . . . 0.0 111.258 -178.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.551 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 2.0 ttmp? -97.11 122.28 39.94 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 168.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -150.85 168.5 30.59 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.308 -0.949 . . . . 0.0 111.949 -178.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 84.6 mt -91.28 138.72 31.36 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.07 0.462 . . . . 0.0 110.313 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.49 ' CZ ' HG11 ' A' ' 264' ' ' VAL . 34.3 p90 -148.14 144.42 18.82 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.663 178.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . 0.486 ' HG2' ' CD2' ' A' ' 290' ' ' HIS . 84.5 Cg_endo -82.11 144.31 13.25 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.49 2.127 . . . . 0.0 111.542 176.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -65.93 -10.52 39.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.869 0.366 . . . . 0.0 111.89 -176.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 3.0 p -71.94 -4.87 30.85 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -178.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . 0.486 ' CD2' ' HG2' ' A' ' 287' ' ' PRO . 14.2 m-70 -111.29 -2.71 15.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.705 0.288 . . . . 0.0 111.155 -177.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.466 ' HB ' ' HB1' ' A' ' 240' ' ' ALA . 31.2 m -127.58 156.3 39.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.082 0.468 . . . . 0.0 111.371 -176.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 44.9 tptt -112.71 111.27 21.94 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.406 177.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.529 HD11 ' HB3' ' A' ' 240' ' ' ALA . 4.0 tp -72.11 141.2 16.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -162.54 -174.66 4.1 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.809 0.338 . . . . 0.0 110.694 -178.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -108.82 106.94 59.63 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.707 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . 0.403 ' HG3' ' CB ' ' A' ' 239' ' ' PHE . 87.3 Cg_endo . . . . . 0 N--CA 1.462 -0.336 0 C-N-CA 122.786 2.324 . . . . 0.0 112.471 -178.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.3 t . . . . . 0 N--CA 1.451 -0.378 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.552 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . -77.19 101.28 6.11 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 114.535 -1.212 . . . . 0.0 109.775 174.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -131.53 106.81 8.44 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.503 0.668 . . . . 0.0 111.269 -177.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.557 ' CE1' ' HE2' ' A' ' 89' ' ' LYS . 34.3 p90 -168.01 139.44 2.88 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.647 -1.161 . . . . 0.0 108.402 175.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -74.1 102.34 4.19 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.208 0.528 . . . . 0.0 110.284 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.1 m -57.73 -32.13 67.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.586 -175.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.4 t -81.47 -2.12 48.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.888 -174.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -103.66 105.83 16.17 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 121.585 -0.697 . . . . 0.0 110.901 -177.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.11 -29.09 70.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.899 178.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.8 m -74.79 4.04 7.06 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.974 0.416 . . . . 0.0 110.731 178.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -99.05 -30.48 12.3 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.558 175.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 36.6 p-90 -138.2 -20.83 1.08 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -171.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -77.14 115.41 16.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.041 0.448 . . . . 0.0 110.15 -174.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' MET . . . . . 0.558 ' HG3' ' HB2' ' A' ' 37' ' ' LEU . 25.1 mmt -97.94 -7.68 29.62 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.991 -175.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.488 ' O ' ' HB2' ' A' ' 39' ' ' ARG . . . 50.78 -111.69 1.34 Allowed Glycine 0 CA--C 1.523 0.577 0 O-C-N 123.694 0.622 . . . . 0.0 113.427 -178.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.412 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 4.4 Cg_exo -76.87 103.18 1.71 Allowed 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.845 2.363 . . . . 0.0 112.417 -179.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.69 ' HB ' ' HG3' ' A' ' 39' ' ' ARG . 2.9 t -138.13 -69.87 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.758 -178.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.482 ' H ' ' HG3' ' A' ' 39' ' ' ARG . 21.4 t 95.85 162.89 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 124.662 1.185 . . . . 0.0 109.083 172.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . 0.433 ' O ' ' HG2' ' A' ' 25' ' ' GLN . 69.8 mtp85 -55.78 -44.56 77.83 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 123.04 0.212 . . . . 0.0 110.804 -175.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.87 -46.95 74.79 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 123.993 0.808 . . . . 0.0 110.718 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.445 ' HB3' HG12 ' A' ' 19' ' ' VAL . 14.1 tp10 -76.24 -46.91 25.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.298 0.57 . . . . 0.0 110.469 -175.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.498 ' HB2' HD11 ' A' ' 37' ' ' LEU . . . -57.11 -39.6 75.38 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.99 -176.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' ' 21' ' ' ARG . 2.1 pt20 -75.34 -33.15 61.09 Favored 'General case' 0 C--O 1.219 -0.513 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -173.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.1 t -75.48 -32.14 60.46 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.149 -176.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -84.22 -7.07 59.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.947 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.562 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 97.0 mt -125.97 13.3 7.87 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.639 175.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.3 tp60 -72.36 84.72 1.08 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.624 ' HA2' ' HA ' ' A' ' 56' ' ' SER . . . 85.12 -64.81 4.15 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.518 -178.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.494 ' HB3' ' HE2' ' A' ' 35' ' ' MET . 15.4 mm100 39.87 -125.8 0.4 Allowed 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 123.257 0.623 . . . . 0.0 112.222 -176.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 20.1 ptp180 -106.73 -7.24 17.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.242 -0.436 . . . . 0.0 109.876 178.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 37.7 m80 67.91 153.15 0.09 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.254 -173.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.98 -0.79 76.69 Favored Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.881 -177.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.662 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 37.1 mtm -104.7 147.51 27.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.749 0.309 . . . . 0.0 110.566 -178.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.4 ' CB ' HG22 ' A' ' 52' ' ' VAL . 43.2 p90 -143.27 169.42 17.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.49 -178.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.558 ' HB2' ' HG3' ' A' ' 16' ' ' MET . 4.5 pp -158.21 143.76 16.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.012 0.434 . . . . 0.0 110.769 173.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.5 t -115.44 112.66 40.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 175.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.69 ' HG3' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -121.66 167.75 12.57 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.407 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -62.28 137.93 58.34 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 28.4 t -66.63 126.11 27.9 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.282 0.563 . . . . 0.0 111.298 -173.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.409 ' HG ' ' HG3' ' A' ' 21' ' ' ARG . 19.4 p -86.13 6.44 29.2 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.591 174.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.8 -39.73 8.47 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.046 179.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.456 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 71.1 m -149.66 137.4 11.61 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.956 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 44' ' ' CYS . 38.2 Cg_exo -61.15 -32.5 91.15 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.283 2.655 . . . . 0.0 113.799 -175.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -101.84 33.06 6.81 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.849 -176.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.629 ' OD1' ' HA ' ' A' ' 64' ' ' ASN . 15.6 m-20 -138.71 167.56 21.71 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 110.375 -0.232 . . . . 0.0 110.375 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -126.42 170.62 11.77 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 174.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.422 ' HB ' ' NH1' ' A' ' 39' ' ' ARG . 44.8 t -144.16 115.96 2.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-O 121.002 0.43 . . . . 0.0 111.653 176.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.5 tp -82.7 106.05 14.23 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.025 174.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.8 m -96.82 129.04 44.31 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 176.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.691 HG11 ' HG2' ' A' ' 54' ' ' GLU . 70.8 t -121.9 134.56 64.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.843 -176.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.562 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 41.0 t -88.04 99.18 11.97 Favored 'General case' 0 CA--C 1.513 -0.442 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.965 -177.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.691 ' HG2' HG11 ' A' ' 52' ' ' VAL . 65.5 mm-40 -144.94 142.08 29.55 Favored 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 119.51 -0.876 . . . . 0.0 109.403 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 61.04 15.81 6.51 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.594 0.558 . . . . 0.0 111.927 -178.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.624 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 27.4 m 58.89 54.55 5.05 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 122.935 1.35 . . . . 0.0 107.374 -173.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.593 HH22 ' CG ' ' A' ' 94' ' ' ASP . 0.1 OUTLIER -167.01 67.88 0.09 Allowed 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 112.26 -2.245 . . . . 0.0 108.831 -151.638 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.57 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 9.9 t -69.63 100.52 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.815 0.816 . . . . 0.0 109.777 -167.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 50.9 m -74.76 120.72 20.69 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 114.213 -1.358 . . . . 0.0 110.474 -178.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 -93.29 103.28 15.53 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.003 -177.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.534 ' HB3' HD11 ' A' ' 73' ' ' ILE . 58.5 m-85 -91.35 104.29 16.83 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.159 177.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 59.9 mt -79.46 125.76 38.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.848 0.356 . . . . 0.0 111.758 -175.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.457 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 4.6 mp -103.51 109.93 28.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.471 178.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.629 ' HA ' ' OD1' ' A' ' 47' ' ' ASP . 15.4 m120 -83.13 160.41 21.87 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.735 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.6 t -99.87 109.7 22.08 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 172.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.537 HD12 ' HB2' ' A' ' 72' ' ' LYS . 85.3 mt -78.68 153.25 78.31 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.327 -176.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -62.9 -14.58 41.95 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.668 2.245 . . . . 0.0 111.655 173.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -81.65 8.63 9.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.618 177.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? 62.9 29.0 16.56 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.587 0.708 . . . . 0.0 110.014 -177.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 27.8 mtp180 -124.34 -174.9 3.12 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.581 -177.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . 0.457 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 72.9 m-85 -122.12 151.37 41.01 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.551 0.215 . . . . 0.0 111.027 -177.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.562 ' HE3' ' O ' ' A' ' 75' ' ' ASP . 86.5 tttt -138.89 113.81 9.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.767 -175.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.534 HD11 ' HB3' ' A' ' 61' ' ' TYR . 20.3 tt -89.87 100.48 10.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.858 0.837 . . . . 0.0 110.916 -174.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.45 -65.04 2.45 Favored Glycine 0 CA--C 1.519 0.29 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.95 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.562 ' O ' ' HE3' ' A' ' 72' ' ' LYS . 20.0 t70 -154.15 -29.56 0.12 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.024 0.44 . . . . 0.0 110.221 -176.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -85.48 121.7 28.56 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -93.49 145.87 24.19 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.226 0.536 . . . . 0.0 111.288 -175.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.43 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 86.3 m-85 -131.94 -173.73 3.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.815 178.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -74.94 -61.7 1.8 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.555 178.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . 0.698 ' HD1' ' HD2' ' A' ' 82' ' ' PRO . 5.6 p80 -146.27 -179.1 6.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.272 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.552 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 7.5 mt -56.27 -56.9 26.48 Favored Pre-proline 0 N--CA 1.467 0.405 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -178.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.698 ' HD2' ' HD1' ' A' ' 80' ' ' HIS . 50.9 Cg_exo -57.79 -10.52 7.58 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.399 2.066 . . . . 0.0 113.607 178.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.04 -32.93 17.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.554 0.216 . . . . 0.0 111.034 -175.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.1 pp -76.6 -33.89 58.4 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 77.6 mt -65.25 -31.21 72.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.603 178.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -72.85 -39.82 66.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.267 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.43 ' CE2' ' ND1' ' A' ' 91' ' ' HIS . 68.6 t80 -68.03 -30.94 70.29 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.405 -178.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.634 ' CD1' HD22 ' A' ' 93' ' ' LEU . 27.8 m-85 -84.08 2.3 40.0 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -176.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.557 ' HE2' ' CE1' ' A' ' 6' ' ' PHE . 96.4 mttt -80.47 -15.82 55.82 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.335 172.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.7 pp -126.74 9.39 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.14 0 CA-C-O 121.385 0.612 . . . . 0.0 110.556 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.44 ' O ' ' HB2' ' A' ' 92' ' ' TYR . 9.1 t60 -94.32 -42.43 8.91 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.713 -177.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.44 ' HB2' ' O ' ' A' ' 91' ' ' HIS . 75.8 m-85 65.53 95.72 0.05 Allowed 'General case' 0 C--N 1.329 -0.318 0 O-C-N 124.402 1.063 . . . . 0.0 109.054 -163.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.634 HD22 ' CD1' ' A' ' 88' ' ' TYR . 30.8 mt -61.07 -92.8 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 173.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.593 ' CG ' HH22 ' A' ' 57' ' ' ARG . 20.6 t0 -99.83 86.3 3.26 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.104 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.783 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 2.2 t 48.6 15.18 0.08 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.815 -1.084 . . . . 0.0 112.665 -176.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -156.75 153.17 27.96 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 120.966 0.412 . . . . 0.0 110.383 -177.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.5 p -98.15 168.28 10.35 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.133 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 97.3 mt -70.08 92.67 0.75 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 177.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.552 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 37.4 mm -78.18 -59.29 3.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.34 -174.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.662 ' O ' ' HA ' ' A' ' 35' ' ' MET . 38.4 tt0 -155.8 135.4 8.11 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.14 -176.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -62.12 157.1 46.23 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.791 2.327 . . . . 0.0 113.023 -178.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.455 ' HB1' HD21 ' A' ' 28' ' ' LEU . . . -68.91 142.87 93.97 Favored Pre-proline 0 N--CA 1.452 -0.366 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.131 177.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -60.91 124.78 15.63 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.604 2.203 . . . . 0.0 112.362 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.746 176.054 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . 0.693 ' CD1' HG23 ' A' ' 152' ' ' ILE . 1.4 mm? . . . . . 0 N--CA 1.468 0.454 0 CA-C-O 120.965 0.412 . . . . 0.0 111.811 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.753 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 0.0 OUTLIER -171.83 -61.59 0.02 OUTLIER 'General case' 0 C--O 1.215 -0.729 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.566 -179.926 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . 0.571 ' N ' ' HG2' ' A' ' 126' ' ' GLU . 50.1 m-85 -115.21 108.44 16.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.394 0.616 . . . . 0.0 111.843 179.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 1.021 HG21 ' HG3' ' A' ' 180' ' ' LYS . 38.8 t -126.88 136.13 61.67 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.287 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.629 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 5.7 ptp180 -113.39 153.75 28.06 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 117.789 -1.564 . . . . 0.0 108.915 172.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.51 HG23 HG13 ' A' ' 178' ' ' VAL . 68.2 p -102.74 140.17 37.36 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.512 0.672 . . . . 0.0 111.757 178.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.554 HD22 ' HG2' ' A' ' 179' ' ' GLU . 9.8 mt -113.4 -16.26 12.49 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.89 178.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.436 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 21.7 t80 -82.72 -39.66 21.65 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.313 -174.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ASP . . . . . 0.673 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 13.6 t70 72.82 104.81 0.07 Allowed 'General case' 0 N--CA 1.468 0.443 0 O-C-N 123.695 0.622 . . . . 0.0 110.873 -177.219 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.519 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 67.0 t80 -132.12 94.14 24.7 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 174.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.644 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 69.8 Cg_endo -87.05 92.25 0.53 Allowed 'Trans proline' 0 N--CA 1.442 -1.507 0 C-N-CA 121.667 1.578 . . . . 0.0 112.893 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -88.54 -25.51 30.21 Favored Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.672 174.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ASN . . . . . 0.527 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 0.8 OUTLIER 60.13 52.28 5.16 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.385 0.674 . . . . 0.0 111.933 178.685 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -138.57 172.89 12.21 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.794 177.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -89.32 -13.15 38.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.924 0.869 . . . . 0.0 109.084 172.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.661 ' O ' ' HB2' ' A' ' 172' ' ' MET . 5.9 mm-40 -93.02 -35.25 13.36 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.994 176.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -125.72 109.69 12.87 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.817 177.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.761 ' CD1' ' HB2' ' A' ' 165' ' ' ASN . 34.2 tp -69.35 130.76 90.65 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.002 -176.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . 0.644 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 73.7 Cg_endo -82.26 88.69 1.26 Allowed 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 121.867 1.711 . . . . 0.0 112.071 171.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . 0.519 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 22.3 p90 -100.25 172.92 6.87 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -176.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' LYS . . . . . 0.673 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 14.1 mptt -122.92 -164.59 1.21 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -168.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.565 ' HD2' ' N ' ' A' ' 146' ' ' LYS . 7.6 mptt -85.39 1.29 49.23 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.59 -174.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -177.39 30.86 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.612 -178.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.681 ' OE2' ' HG ' ' A' ' 150' ' ' LEU . 1.6 pp20? -73.06 169.92 15.98 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 175.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.6 mp -117.89 128.46 75.02 Favored 'Isoleucine or valine' 0 C--N 1.35 0.619 0 CA-C-N 118.498 0.59 . . . . 0.0 110.083 173.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.839 ' CD2' ' HA ' ' A' ' 165' ' ' ASN . 86.0 mt -118.38 158.67 24.83 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-O 121.51 0.671 . . . . 0.0 110.493 -173.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.753 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 97.2 t -128.08 121.07 55.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.187 174.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.693 HG23 ' CD1' ' A' ' 125' ' ' LEU . 26.6 mm -78.83 84.0 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 CA-C-O 121.826 0.822 . . . . 0.0 109.134 -176.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.772 HG23 ' HG2' ' A' ' 154' ' ' GLU . 20.9 tt -73.94 -32.83 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.535 -176.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' GLU . . . . . 0.772 ' HG2' HG23 ' A' ' 153' ' ' ILE . 0.0 OUTLIER -125.46 144.84 50.35 Favored 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 175.753 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -131.94 76.59 73.51 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-O 121.453 0.644 . . . . 0.0 109.638 168.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.783 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 15.6 Cg_exo -66.88 -47.67 2.43 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.512 2.142 . . . . 0.0 111.581 176.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -112.19 -170.97 1.76 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.629 -177.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -124.85 -14.45 6.69 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.24 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -89.96 -21.35 22.47 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 168.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.647 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 80.9 m95 -125.97 139.15 53.67 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.171 177.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' TRP . . . . . 0.749 ' O ' HG13 ' A' ' 173' ' ' ILE . 45.7 m0 -128.37 137.39 51.87 Favored 'General case' 0 C--O 1.206 -1.187 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.25 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.534 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 6.3 m -97.67 102.68 14.5 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -172.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.585 ' HB2' ' HB3' ' A' ' 150' ' ' LEU . . . -115.53 147.09 41.09 Favored 'General case' 0 N--CA 1.415 -2.2 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.489 -171.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.737 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 13.5 ptt-85 -86.64 127.26 34.92 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 175.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ASN . . . . . 0.839 ' HA ' ' CD2' ' A' ' 150' ' ' LEU . 61.5 t30 -62.41 177.03 0.55 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.875 -169.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.506 ' HB2' ' HB2' ' A' ' 148' ' ' GLU . 40.5 tptt -50.86 -26.42 5.78 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.331 164.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -69.51 -43.04 73.9 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.832 173.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 113.12 -5.02 25.4 Favored Glycine 0 CA--C 1.516 0.146 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.276 -170.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ARG . . . . . 0.737 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.6 OUTLIER -71.29 135.82 47.6 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 123.389 0.675 . . . . 0.0 111.692 -178.819 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 59.6 t -83.48 123.44 38.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 C-N-CA 121.202 -0.199 . . . . 0.0 110.491 177.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -160.76 158.25 29.77 Favored Glycine 0 C--O 1.227 -0.299 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.68 173.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' MET . . . . . 0.661 ' HB2' ' O ' ' A' ' 140' ' ' GLU . 0.6 OUTLIER -74.89 140.67 43.97 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 117.234 0.517 . . . . 0.0 112.001 -178.19 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.749 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.8 pp -137.09 140.49 31.47 Favored Pre-proline 0 N--CA 1.451 -0.418 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.368 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' PRO . . . . . 0.599 ' O ' HG12 ' A' ' 178' ' ' VAL . 6.3 Cg_exo -76.56 127.04 9.38 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.969 2.446 . . . . 0.0 113.115 -175.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.585 ' O ' HG22 ' A' ' 178' ' ' VAL . 59.4 t -53.23 -45.3 98.41 Favored Pre-proline 0 CA--C 1.542 0.635 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 177.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 27.7 Cg_endo -63.44 -1.0 2.72 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.044 1.83 . . . . 0.0 113.318 176.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.475 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.1 m-30 -104.26 -10.01 18.17 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.588 0.232 . . . . 0.0 111.351 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.618 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 5.0 m -108.16 -171.96 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 115.786 1.773 . . . . 0.0 115.786 -162.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' GLU . . . . . 0.629 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 5.1 tp10 -155.75 50.95 0.55 Allowed 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 113.009 -1.905 . . . . 0.0 113.503 -153.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' LYS . . . . . 1.021 ' HG3' HG21 ' A' ' 128' ' ' VAL . 3.6 mppt? -67.28 136.44 54.91 Favored 'General case' 0 CA--C 1.518 -0.259 0 O-C-N 119.498 -2.001 . . . . 0.0 109.012 -165.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 61.5 tp . . . . . 0 C--N 1.33 -0.283 0 CA-C-N 112.583 -2.099 . . . . 0.0 112.369 -165.461 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo . . . . . 0 C--O 1.232 0.221 0 CA-C-O 120.741 0.226 . . . . 0.0 111.759 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.411 ' CG1' HD11 ' A' ' 293' ' ' ILE . 20.1 t -94.19 143.84 10.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.079 -178.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' PHE . . . . . 0.526 ' HB2' ' HG3' ' A' ' 296' ' ' PRO . 95.3 m-85 -111.8 124.21 51.87 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.503 -178.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' ALA . . . . . 0.47 ' HB3' HD13 ' A' ' 293' ' ' ILE . . . -119.7 127.62 53.04 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.076 179.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . 0.415 ' HB2' ' CE1' ' A' ' 294' ' ' PHE . 50.5 tttp -85.92 119.38 26.17 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -178.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' ALA . . . . . 0.475 ' HA ' HG11 ' A' ' 291' ' ' VAL . . . -71.03 106.84 3.84 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.542 -178.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.734 HG12 ' HG3' ' A' ' 292' ' ' LYS . 2.6 pp -104.56 -14.74 8.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.168 -177.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.76 137.95 49.72 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 175.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -62.3 163.6 8.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.409 0.623 . . . . 0.0 111.944 -173.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' ARG . . . . . 0.6 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -145.78 121.43 10.47 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 177.898 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 16.5 m -122.36 139.18 30.27 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-O 120.795 0.331 . . . . 0.0 110.753 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.46 ' HD3' ' HB3' ' A' ' 257' ' ' ALA . 42.5 Cg_endo -68.98 125.75 12.95 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.645 2.23 . . . . 0.0 112.249 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' CYS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 252' ' ' ASP . 16.5 t -90.64 172.45 8.67 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -55.71 -47.59 76.59 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.945 0.402 . . . . 0.0 111.283 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -87.68 -6.31 58.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.767 179.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . 0.515 ' HB2' ' HB3' ' A' ' 249' ' ' CYS . 2.9 m-20 -114.48 52.11 0.86 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.342 178.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -71.02 -13.51 62.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.32 0.581 . . . . 0.0 109.865 177.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 2.7 p -89.25 -8.22 53.91 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.969 176.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' ALA . . . . . 0.448 ' HB1' ' HB3' ' A' ' 252' ' ' ASP . . . -76.71 123.18 25.79 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.687 -178.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.33 139.34 51.99 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.629 -178.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' ALA . . . . . 0.6 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -89.15 117.55 28.22 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.094 0.473 . . . . 0.0 109.921 176.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 35.4 mt -129.14 157.76 40.88 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.928 -176.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -136.86 160.29 39.31 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 21.7 t -66.29 105.32 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.087 -172.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 130.6 10.7 2.56 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.689 175.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -118.41 157.57 26.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 117.879 0.839 . . . . 0.0 111.375 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 37.2 mm -94.04 124.07 46.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.753 -178.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 32.0 t -95.5 111.02 25.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.957 175.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -95.28 97.26 9.73 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.563 -178.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' VAL . . . . . 0.465 ' HA ' ' HA2' ' A' ' 277' ' ' GLY . 6.6 p -88.41 134.89 26.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.704 -0.399 . . . . 0.0 110.394 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 22.1 p -92.93 -44.1 8.61 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.512 -176.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 29.3 ptt180 -131.21 126.46 35.62 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 121.365 0.602 . . . . 0.0 110.951 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 40.1 mmm -83.08 110.44 18.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.527 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 274' ' ' GLN . 86.9 m-20 -85.4 126.97 34.2 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.283 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 22.8 mt -70.73 -18.62 21.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.295 -175.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -61.88 -23.89 66.59 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.702 0.287 . . . . 0.0 111.162 -178.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 109.19 21.79 7.17 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.746 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.521 ' HA ' ' CZ ' ' A' ' 288' ' ' PHE . 37.9 mt-30 -151.56 111.35 4.03 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 167.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 1.3 m0 -92.08 164.81 13.46 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -176.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 276' ' ' GLU . . . . . 0.64 ' HB3' ' HE2' ' A' ' 283' ' ' LYS . 43.3 mt-10 -104.78 117.98 35.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.128 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -122.01 142.33 14.97 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.725 -178.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -99.38 111.52 23.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.817 0.818 . . . . 0.0 109.922 175.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 95.7 t -124.39 158.03 31.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.74 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -61.8 82.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.732 0.777 . . . . 0.0 110.79 175.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 160.85 -35.77 0.42 Allowed Glycine 0 N--CA 1.441 -0.996 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.17 -177.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 282' ' ' ARG . 42.8 ttm105 177.92 159.71 0.49 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 117.054 0.427 . . . . 0.0 110.197 -178.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.64 ' HE2' ' HB3' ' A' ' 276' ' ' GLU . 2.5 tmtp? -110.1 101.17 9.99 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 171.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -151.96 -168.92 16.84 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.926 -172.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 73.2 mt -90.73 149.15 22.15 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.859 0.361 . . . . 0.0 110.455 -177.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 286' ' ' PHE . . . . . 0.405 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 42.0 p90 -143.91 152.54 55.58 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.402 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 287' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 2.3 Cg_endo -81.37 145.3 14.92 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 123.346 2.697 . . . . 0.0 111.752 177.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 288' ' ' PHE . . . . . 0.521 ' CZ ' ' HA ' ' A' ' 274' ' ' GLN . 3.6 m-85 -91.73 -5.47 53.59 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.116 0.414 . . . . 0.0 112.116 -167.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 4.5 m -94.4 -19.73 20.35 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.325 0.583 . . . . 0.0 109.887 175.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -77.23 -22.43 52.24 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.574 177.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 291' ' ' VAL . . . . . 0.475 HG11 ' HA ' ' A' ' 242' ' ' ALA . 28.5 m -117.19 164.49 13.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.235 178.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . 0.734 ' HG3' HG12 ' A' ' 243' ' ' ILE . 98.1 mttt -119.39 119.92 35.35 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.609 177.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 293' ' ' ILE . . . . . 0.47 HD13 ' HB3' ' A' ' 240' ' ' ALA . 18.9 mm -74.63 110.69 9.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 172.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 294' ' ' PHE . . . . . 0.415 ' CE1' ' HB2' ' A' ' 241' ' ' LYS . 2.3 p90 -132.24 -178.62 4.99 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.894 -175.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -104.49 101.88 30.37 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . 0.526 ' HG3' ' HB2' ' A' ' 239' ' ' PHE . 60.7 Cg_endo . . . . . 0 CA--C 1.529 0.256 0 C-N-CA 122.311 2.007 . . . . 0.0 111.878 177.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptm . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.0 p -91.51 131.77 36.73 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.154 0.502 . . . . 0.0 110.97 178.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.525 ' HB2' HD13 ' A' ' 99' ' ' ILE . 13.0 p -88.39 -38.14 15.32 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 174.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.51 ' HB3' ' HG2' ' A' ' 89' ' ' LYS . . . -93.87 127.91 39.88 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.766 178.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 26.0 mtt180 -142.14 -66.61 0.4 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.443 -176.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.422 ' HB2' ' H ' ' A' ' 7' ' ' ASP . 6.8 p90 11.15 -147.18 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 113.653 -1.612 . . . . 0.0 115.253 -161.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.422 ' H ' ' HB2' ' A' ' 6' ' ' PHE . 6.2 p-10 -101.98 -49.54 3.92 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.986 -174.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.407 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 50.4 m 65.16 35.87 7.58 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.586 -175.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.7 m -161.23 -25.92 0.05 Allowed 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 176.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -85.31 108.71 17.93 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.238 0.542 . . . . 0.0 111.064 -169.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.545 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 9.7 mmt180 -62.06 -25.72 67.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.758 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.9 m -90.11 3.51 53.13 Favored 'General case' 0 C--N 1.32 -0.714 0 O-C-N 122.149 -0.344 . . . . 0.0 110.941 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -99.21 -47.62 5.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.448 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.427 ' HB3' ' HB3' ' A' ' 101' ' ' PRO . 36.2 p-90 -114.2 -24.76 8.79 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -174.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.545 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 21.6 t80 -76.97 116.42 17.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.303 0.573 . . . . 0.0 110.107 -177.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.58 ' SD ' ' HA ' ' A' ' 104' ' ' ARG . 9.1 tpp -97.26 -9.16 28.19 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.085 -171.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.5 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 49.81 -115.21 2.85 Favored Glycine 0 CA--C 1.523 0.564 0 CA-C-N 115.398 -0.819 . . . . 0.0 114.292 177.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.5 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 4.6 Cg_exo -74.99 101.19 1.44 Allowed 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 123.056 2.504 . . . . 0.0 112.239 -177.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.576 HG23 ' HG3' ' A' ' 16' ' ' MET . 5.3 t -138.55 -76.46 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 CA-C-O 118.909 -0.567 . . . . 0.0 111.523 -175.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.74 ' H ' ' HD2' ' A' ' 39' ' ' ARG . 51.4 m 94.8 171.66 0.02 OUTLIER 'General case' 0 C--N 1.35 0.63 0 C-N-CA 124.187 0.995 . . . . 0.0 109.353 170.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.504 ' HD2' ' NH2' ' A' ' 39' ' ' ARG . 19.4 mmm180 -51.65 -53.46 38.52 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 123.388 0.43 . . . . 0.0 112.129 -169.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -62.95 -42.53 99.85 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.506 -175.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.418 ' HB3' HG11 ' A' ' 19' ' ' VAL . 12.7 tp10 -72.63 -46.03 56.08 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.296 0.569 . . . . 0.0 109.521 -174.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.24 -47.62 80.89 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.305 -0.862 . . . . 0.0 111.455 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.485 ' NE2' ' H ' ' A' ' 117' ' ' ASN . 50.6 tp60 -64.05 -41.57 97.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.081 -175.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.5 t -79.55 -20.92 45.89 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -175.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -80.69 -13.72 58.76 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 120.944 0.402 . . . . 0.0 110.708 178.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.585 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 80.2 mt -128.96 17.07 6.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.244 -177.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.501 ' HG2' ' O ' ' A' ' 114' ' ' SER . 0.0 OUTLIER -66.5 82.0 0.1 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.047 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.99 -63.94 4.22 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.715 -177.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 45.41 -105.16 0.1 Allowed 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.191 0.596 . . . . 0.0 111.858 -176.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 54.5 mtm180 -126.72 3.0 6.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.579 0.228 . . . . 0.0 110.409 176.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 28.0 m170 66.85 150.62 0.06 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.033 -174.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.33 19.22 79.68 Favored Glycine 0 C--O 1.227 -0.314 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.011 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 76.3 mtp -112.3 141.78 45.6 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.459 ' CD2' HD21 ' A' ' 98' ' ' LEU . 38.4 p90 -137.98 161.62 36.22 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.136 -174.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.481 HD13 ' O ' ' A' ' 37' ' ' LEU . 4.6 pp -150.25 133.83 16.6 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.247 0.546 . . . . 0.0 110.569 172.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.42 HG22 HD11 ' A' ' 50' ' ' LEU . 42.3 t -101.92 107.21 21.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 175.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.74 ' HD2' ' H ' ' A' ' 20' ' ' SER . 28.3 ptt-85 -103.32 177.45 4.84 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 -178.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -75.2 137.43 41.27 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 174.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.516 ' HB3' ' O ' ' A' ' 44' ' ' CYS . 21.1 t -64.56 109.9 2.14 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.378 0.609 . . . . 0.0 111.229 -173.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 57.2 p -77.45 -4.83 47.43 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.602 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.69 -51.34 4.76 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.313 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.516 ' O ' ' HB3' ' A' ' 41' ' ' SER . 34.3 m -135.03 118.95 13.29 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.602 -177.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -59.03 123.86 14.41 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.601 2.201 . . . . 0.0 112.104 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.05 -34.73 4.94 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.947 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.58 ' OD1' ' HA ' ' A' ' 64' ' ' ASN . 44.5 m-20 -86.4 -176.86 6.04 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.491 ' HE2' ' CE1' ' A' ' 71' ' ' PHE . 35.1 m-85 -134.15 172.58 12.65 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 176.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.466 HG23 ' HA ' ' A' ' 41' ' ' SER . 43.1 t -140.7 106.12 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.938 0.399 . . . . 0.0 111.065 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.449 HD13 ' HB2' ' A' ' 36' ' ' PHE . 43.0 tp -78.9 106.26 10.79 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.308 176.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 24.1 m -96.66 132.38 42.37 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 174.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.577 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 72.0 t -125.13 133.3 69.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.712 0.291 . . . . 0.0 111.297 -177.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.585 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 30.7 t -87.52 116.49 25.67 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.288 -0.415 . . . . 0.0 112.063 -176.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.513 ' CG ' HG22 ' A' ' 95' ' ' THR . 7.6 tp10 -151.65 147.7 27.05 Favored 'General case' 0 C--O 1.21 -1.009 0 C-N-CA 119.682 -0.807 . . . . 0.0 109.225 164.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.481 ' ND2' ' HG3' ' A' ' 54' ' ' GLU . 67.4 m-80 56.84 24.05 8.79 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.4 m 57.47 52.82 8.07 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 122.522 1.153 . . . . 0.0 108.411 -174.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.587 ' HA ' ' HA ' ' A' ' 117' ' ' ASN 0.25 0.0 OUTLIER -167.44 66.49 0.08 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 113.504 -1.68 . . . . 0.0 109.814 -152.188 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.577 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 20.2 t -73.32 101.01 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 120.861 -1.15 . . . . 0.0 111.252 -167.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.8 m -69.87 122.15 18.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.807 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -96.26 115.92 28.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.891 -175.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.616 ' OH ' ' HB3' ' A' ' 93' ' ' LEU . 37.0 m-85 -108.84 113.95 27.31 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.63 178.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.643 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 57.3 mt -81.35 133.83 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 O-C-N 122.078 -0.388 . . . . 0.0 111.986 -177.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.518 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 5.3 mp -114.27 119.43 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 122.968 0.507 . . . . 0.0 110.853 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.58 ' HA ' ' OD1' ' A' ' 47' ' ' ASP . 11.0 m120 -86.97 148.23 25.41 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.356 -174.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.7 t -89.53 94.96 10.06 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 170.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.45 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 81.6 mt -71.6 135.58 83.66 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 66' ' ' LEU . 33.7 Cg_exo -60.66 -22.43 72.83 Favored 'Trans proline' 0 N--CA 1.473 0.312 0 C-N-CA 123.014 2.476 . . . . 0.0 113.072 -174.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -84.28 17.48 2.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.259 0.552 . . . . 0.0 110.37 176.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.613 ' NE ' ' HA ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER 65.33 52.1 1.48 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.142 175.846 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 63.8 mtt180 -135.54 -175.16 3.85 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.462 175.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.518 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 67.8 m-85 -137.27 136.58 38.18 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.633 0.254 . . . . 0.0 111.25 -173.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 64' ' ' ASN . 61.7 tttp -125.76 108.49 11.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.763 -174.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.643 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 7.3 tt -99.52 102.26 13.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.238 0.542 . . . . 0.0 111.494 -175.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.4 ' C ' ' H ' ' A' ' 76' ' ' GLN . . . 53.3 70.34 0.95 Allowed Glycine 0 CA--C 1.52 0.392 0 CA-C-N 115.437 -0.801 . . . . 0.0 113.728 175.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 34.6 t70 74.89 -30.41 0.2 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.325 0.65 . . . . 0.0 111.568 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.4 ' H ' ' C ' ' A' ' 74' ' ' GLY . 12.1 mm100 -89.55 112.82 24.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.642 0.258 . . . . 0.0 110.809 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 1.3 pm0 -97.41 139.79 32.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.663 0.744 . . . . 0.0 111.484 176.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.502 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 89.9 m-85 -122.34 -172.04 2.38 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.611 175.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -86.11 -29.21 23.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.745 0.307 . . . . 0.0 111.514 -179.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.715 ' HD1' ' HD2' ' A' ' 82' ' ' PRO . 9.1 p80 -163.78 168.11 20.05 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.515 0.198 . . . . 0.0 111.417 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.646 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 6.7 mt -54.51 -58.61 13.3 Favored Pre-proline 0 N--CA 1.468 0.462 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.211 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.715 ' HD2' ' HD1' ' A' ' 80' ' ' HIS . 36.9 Cg_exo -63.9 -3.05 5.19 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.132 1.888 . . . . 0.0 113.263 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.82 -33.79 17.28 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.646 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.1 pp -76.39 -34.09 58.87 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 177.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.503 HD13 ' HA ' ' A' ' 82' ' ' PRO . 60.1 mt -64.66 -29.51 70.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.13 177.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.491 ' CD ' ' HZ2' ' A' ' 89' ' ' LYS . 21.2 tp10 -79.1 -33.9 43.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.378 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -72.21 -33.44 67.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.402 0.62 . . . . 0.0 110.388 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.679 ' CD1' HD22 ' A' ' 93' ' ' LEU . 38.3 m-85 -82.44 1.86 35.47 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.619 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.51 ' HG2' ' HB3' ' A' ' 4' ' ' ALA . 93.8 mttt -73.76 -16.53 61.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.774 173.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 36.8 pt -129.96 -0.65 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 CA-C-O 121.15 0.5 . . . . 0.0 110.725 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -82.67 -40.83 20.17 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.889 -175.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 64.82 101.05 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.382 0 O-C-N 124.548 1.155 . . . . 0.0 109.209 -164.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.679 HD22 ' CD1' ' A' ' 88' ' ' TYR . 26.6 mt -63.66 -99.25 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.763 174.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.659 ' HA ' ' HB3' ' A' ' 154' ' ' GLU . 40.7 t0 -68.35 -59.97 2.79 Favored 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -175.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.651 ' CB ' ' HA ' ' A' ' 156' ' ' PRO . 12.6 t -154.37 14.85 0.45 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.661 0.743 . . . . 0.0 109.594 169.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 12.3 t -145.57 167.07 23.93 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.542 -177.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 38.9 p -97.86 176.01 5.95 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 178.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.459 HD21 ' CD2' ' A' ' 36' ' ' PHE . 96.2 mt -77.99 89.4 4.15 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.188 0.518 . . . . 0.0 110.088 177.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.525 HD13 ' HB2' ' A' ' 3' ' ' SER . 38.9 mm -61.95 -64.1 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.327 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.457 ' HB2' ' HD2' ' A' ' 101' ' ' PRO . 13.3 pt-20 -159.44 159.53 28.32 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.569 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' A' ' 100' ' ' GLU . 59.8 Cg_endo -72.63 155.62 54.29 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.268 1.979 . . . . 0.0 112.074 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.03 135.3 70.46 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 176.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.76 138.07 67.9 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.285 1.99 . . . . 0.0 111.262 176.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.58 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 36.6 mtm180 -68.44 -16.41 63.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.082 0.468 . . . . 0.0 110.737 -177.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -120.67 76.47 27.59 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-O 121.617 0.723 . . . . 0.0 109.438 170.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -95.76 40.78 0.14 Allowed 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.431 2.754 . . . . 0.0 112.507 -173.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 9.7 p -51.39 108.67 1.11 Allowed Pre-proline 0 C--N 1.329 -0.321 0 O-C-N 123.82 0.7 . . . . 0.0 111.823 -177.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -94.2 153.89 2.11 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 123.339 2.693 . . . . 0.0 112.22 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -62.49 -68.8 0.04 OUTLIER 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.353 2.035 . . . . 0.0 112.075 176.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 18.7 ptp 179.81 -168.7 0.11 Allowed 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 89.76 -78.27 1.59 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.948 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.43 ' HB3' ' HB3' ' A' ' 29' ' ' GLN . 46.5 m -79.03 93.66 5.16 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.113 0.482 . . . . 0.0 110.727 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.1 m -123.65 126.28 72.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.752 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.501 ' O ' ' HG2' ' A' ' 29' ' ' GLN . 29.6 t 56.86 -97.91 0.08 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.226 -178.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . 51.5 85.06 0.2 Allowed Pre-proline 0 C--O 1.235 0.333 0 C-N-CA 123.148 0.579 . . . . 0.0 111.638 -178.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.02 91.89 0.54 Allowed 'Trans proline' 0 N--CA 1.465 -0.205 0 C-N-CA 122.678 2.252 . . . . 0.0 112.362 -178.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.587 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 9.0 m-20 56.01 83.45 0.09 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.378 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 37.5 tp -124.98 81.95 61.96 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.805 -176.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.444 ' C ' ' HG1' ' A' ' 120' ' ' THR . 87.3 Cg_endo -90.73 -10.22 3.09 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.547 2.165 . . . . 0.0 112.187 177.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.444 ' HG1' ' C ' ' A' ' 119' ' ' PRO . 19.5 m -157.04 -66.88 0.1 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.437 0.637 . . . . 0.0 110.393 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -158.48 -166.96 2.03 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.447 -178.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.93 30.02 1.48 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.673 0.273 . . . . 0.0 110.872 -178.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.813 ' HB2' ' HA ' ' A' ' 183' ' ' ARG . 21.1 p-10 -123.77 -75.86 0.59 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -175.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.413 ' H ' ' CG ' ' A' ' 123' ' ' ASP . 0.1 OUTLIER -86.93 149.93 24.44 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -165.899 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.625 HD11 ' CZ3' ' A' ' 161' ' ' TRP . 3.0 mm? 67.73 88.38 0.11 Allowed 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 114.138 -1.392 . . . . 0.0 112.993 177.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 173.29 -51.84 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 113.34 -1.755 . . . . 0.0 107.08 177.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -119.73 110.83 17.26 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.196 0.522 . . . . 0.0 110.681 173.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 1.016 HG22 ' HG3' ' A' ' 180' ' ' LYS . 61.1 t -128.72 139.39 52.02 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.018 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.557 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 7.5 ptp180 -112.48 155.52 24.12 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 116.834 -1.946 . . . . 0.0 108.952 170.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.687 ' HG1' ' CD ' ' A' ' 148' ' ' GLU . 1.0 OUTLIER -110.32 140.6 44.34 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.477 0.656 . . . . 0.0 110.896 178.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.562 HD22 ' HG2' ' A' ' 179' ' ' GLU . 8.1 mt -113.38 -15.14 12.7 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -177.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -94.73 -14.72 24.5 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -171.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.55 ' HB3' ' C ' ' A' ' 145' ' ' LYS . 3.8 p-10 54.99 102.08 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 122.559 1.171 . . . . 0.0 112.637 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -119.39 86.64 34.08 Favored Pre-proline 0 C--N 1.317 -0.84 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 171.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.64 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 65.9 Cg_endo -85.56 72.97 4.09 Favored 'Trans proline' 0 N--CA 1.445 -1.376 0 C-N-CA 121.897 1.731 . . . . 0.0 112.638 -176.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.67 -34.19 66.92 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 174.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.884 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 0.4 OUTLIER 70.98 40.5 0.9 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.471 -0.864 . . . . 0.0 111.589 174.784 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -126.09 175.03 8.04 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.881 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -92.66 -7.66 46.23 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.8 0.81 . . . . 0.0 109.052 171.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.601 ' O ' ' HB2' ' A' ' 172' ' ' MET . 8.8 mm-40 -93.32 -29.87 15.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.752 176.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -136.18 108.88 7.5 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.851 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.731 ' CD1' ' HB2' ' A' ' 165' ' ' ASN . 58.1 tp -67.26 123.87 87.56 Favored Pre-proline 0 CA--C 1.509 -0.611 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.824 -176.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.884 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 56.3 Cg_endo -71.87 93.6 0.71 Allowed 'Trans proline' 0 N--CA 1.443 -1.472 0 C-N-CA 120.987 1.125 . . . . 0.0 111.348 167.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.614 ' HB2' ' OG1' ' A' ' 130' ' ' THR . 16.7 p90 -103.32 159.61 15.41 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.942 ' H ' ' HG3' ' A' ' 148' ' ' GLU . 47.6 mtpt -110.16 -151.81 0.48 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.144 0.497 . . . . 0.0 111.929 -170.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.787 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -104.47 27.94 7.41 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.323 -176.843 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 159.14 36.96 0.02 OUTLIER Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.242 178.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.942 ' HG3' ' H ' ' A' ' 145' ' ' LYS . 0.0 OUTLIER -86.11 170.25 12.37 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.895 0.878 . . . . 0.0 109.399 171.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.5 mp -114.0 133.04 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 172.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.662 ' CD2' ' HA ' ' A' ' 165' ' ' ASN . 72.2 mt -118.47 155.79 30.18 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -174.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.567 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 92.2 t -122.22 121.73 64.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 174.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.432 ' CD1' ' HB3' ' A' ' 163' ' ' ALA . 46.9 mm -78.04 79.09 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 122.125 0.964 . . . . 0.0 108.411 -177.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.738 HG23 ' HG2' ' A' ' 154' ' ' GLU . 16.9 tt -69.38 -27.96 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 CA-C-N 113.91 -1.495 . . . . 0.0 109.288 -177.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.738 ' HG2' HG23 ' A' ' 153' ' ' ILE . 0.0 OUTLIER -133.01 141.49 48.31 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 171.778 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.539 ' HD2' ' HG ' ' A' ' 125' ' ' LEU . 82.9 tttt -135.1 82.61 41.74 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 168.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.651 ' HA ' ' CB ' ' A' ' 95' ' ' THR . 8.3 Cg_exo -73.03 -47.72 0.31 Allowed 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.538 2.159 . . . . 0.0 111.87 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -107.57 171.13 7.56 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.032 -173.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.626 ' HG3' ' HG2' ' A' ' 159' ' ' GLN . 8.1 pt-20 -89.7 -26.92 20.43 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.752 178.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.626 ' HG2' ' HG3' ' A' ' 158' ' ' GLU . 82.9 mm-40 -101.8 -18.74 15.63 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.483 -175.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.508 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 63.7 m95 -126.66 135.28 50.96 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 175.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . 0.767 ' O ' HG13 ' A' ' 173' ' ' ILE . 49.4 m0 -125.33 137.93 54.06 Favored 'General case' 0 C--O 1.214 -0.771 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.531 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 14.7 m -96.87 102.79 14.64 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -174.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.517 ' HB2' ' HB3' ' A' ' 150' ' ' LEU . . . -118.93 151.74 37.6 Favored 'General case' 0 N--CA 1.426 -1.667 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.069 -174.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.777 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 15.3 ptt-85 -88.69 129.39 35.54 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 175.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.731 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . 65.2 t30 -60.72 178.64 0.21 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.234 -1.348 . . . . 0.0 111.514 -171.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.525 ' HB2' ' HB2' ' A' ' 148' ' ' GLU . 44.0 tptt -50.71 -33.2 21.91 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.103 166.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -64.7 -38.68 91.82 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.709 173.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.484 ' C ' ' HB2' ' A' ' 164' ' ' ARG . . . 107.09 3.81 35.92 Favored Glycine 0 CA--C 1.522 0.471 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.217 -171.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.777 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.4 OUTLIER -77.4 134.61 38.39 Favored 'General case' 0 C--O 1.216 -0.671 0 C-N-CA 123.141 0.576 . . . . 0.0 111.21 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.468 HG23 HG22 ' A' ' 153' ' ' ILE . 60.4 t -85.12 125.55 40.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 117.684 0.22 . . . . 0.0 111.526 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -157.1 157.71 28.27 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.172 172.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.601 ' HB2' ' O ' ' A' ' 140' ' ' GLU . 0.0 OUTLIER -76.94 141.09 40.62 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 117.242 0.521 . . . . 0.0 111.228 179.367 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.767 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.4 pp -142.25 142.9 25.44 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.424 -176.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.501 ' HB2' ' CD1' ' A' ' 177' ' ' TYR . 15.7 Cg_exo -70.36 138.57 36.21 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 123.275 2.65 . . . . 0.0 113.351 -178.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.566 ' O ' HG22 ' A' ' 178' ' ' VAL . 58.9 t -65.1 -45.09 72.57 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 28.0 Cg_endo -63.81 3.09 0.77 Allowed 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.044 1.829 . . . . 0.0 113.2 177.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.501 ' CD1' ' HB2' ' A' ' 174' ' ' PRO . 3.3 m-85 -103.41 -11.85 17.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.237 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.603 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 4.6 m -104.84 -170.8 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 115.691 1.737 . . . . 0.0 115.691 -166.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.562 ' HG2' HD22 ' A' ' 131' ' ' LEU . 4.0 tp10 -159.73 48.21 0.29 Allowed 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 113.164 -1.835 . . . . 0.0 113.226 -153.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 1.016 ' HG3' HG22 ' A' ' 128' ' ' VAL . 2.9 mppt? -70.73 138.1 50.24 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 119.746 -1.846 . . . . 0.0 110.248 -162.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.434 HD13 ' NH2' ' A' ' 129' ' ' ARG . 39.9 tp -73.22 -91.41 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 113.557 -1.656 . . . . 0.0 112.473 -162.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 3.0 p -87.01 89.77 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-O 121.713 0.768 . . . . 0.0 109.743 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.813 ' HA ' ' HB2' ' A' ' 123' ' ' ASP . 0.0 OUTLIER -145.84 154.18 41.7 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.265 -178.211 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 11.7 m -76.65 -83.44 0.07 Allowed 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.358 178.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 9.8 p 175.26 168.88 0.35 Allowed Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -178.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -64.06 96.54 0.22 Allowed 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.289 1.993 . . . . 0.0 111.78 177.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 1.005 ' HB2' ' HB2' ' A' ' 190' ' ' HIS . 35.0 m80 -105.02 14.39 29.4 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.545 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 81.22 -79.14 1.84 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.699 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.734 ' H ' ' HD3' ' A' ' 189' ' ' LYS . 0.4 OUTLIER -73.56 -23.62 59.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.206 0.527 . . . . 0.0 110.024 177.112 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . 1.005 ' HB2' ' HB2' ' A' ' 187' ' ' HIS . 0.5 OUTLIER -88.24 84.13 6.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.942 172.9 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 175.47 17.86 0.02 OUTLIER Glycine 0 C--O 1.239 0.411 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.171 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 56.6 t30 70.7 -64.47 0.37 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.322 1.049 . . . . 0.0 111.069 -175.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 53.6 ttt-85 59.13 80.06 0.2 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.603 -177.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -54.14 -53.52 52.19 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 173.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 45.8 p -174.01 163.77 4.05 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 113.453 -1.703 . . . . 0.0 106.812 174.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -82.42 70.82 9.45 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 176.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 23.6 t 70.49 124.01 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.986 -177.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -76.45 177.19 7.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.151 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 175.61 124.87 0.84 Allowed Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.841 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 4.0 mp -104.12 102.78 34.39 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -88.59 86.65 0.53 Allowed 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.985 2.457 . . . . 0.0 113.144 -175.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -134.69 101.17 11.91 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 171.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -62.5 -11.45 23.22 Favored 'Trans proline' 0 N--CA 1.473 0.273 0 C-N-CA 123.434 2.756 . . . . 0.0 113.073 -175.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -65.99 -19.18 65.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.144 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . 0.526 ' HB3' ' HB1' ' A' ' 208' ' ' ALA . 95.9 m-70 -118.31 48.36 1.44 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.613 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -70.65 -40.48 73.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.272 0.558 . . . . 0.0 110.096 177.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -124.22 70.51 1.1 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 173.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . 0.526 ' HB1' ' HB3' ' A' ' 205' ' ' HIS . . . -72.37 152.91 41.75 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.988 -1.005 . . . . 0.0 112.301 -171.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -71.64 127.47 90.93 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.708 174.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.1 155.95 17.61 Favored 'Trans proline' 0 C--O 1.237 0.435 0 C-N-CA 122.938 2.425 . . . . 0.0 112.427 178.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -58.58 -40.55 83.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.737 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 20.0 m 72.88 132.88 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.304 172.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 23.6 m -74.54 106.21 6.02 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.639 175.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 33.4 m -149.26 91.3 4.51 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 120.968 0.413 . . . . 0.0 110.558 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -78.75 105.35 1.94 Allowed 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.992 2.462 . . . . 0.0 111.276 177.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.456 ' O ' HD12 ' A' ' 216' ' ' LEU . 3.4 pp -91.57 136.75 26.32 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-O 120.952 0.406 . . . . 0.0 110.936 -177.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -76.8 89.2 1.32 Allowed 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.349 2.033 . . . . 0.0 111.914 178.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -82.25 128.17 33.91 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.974 177.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 7.6 p -59.33 116.59 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.569 0.7 . . . . 0.0 111.188 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 24.6 p -113.9 -165.8 1.04 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.225 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 148.14 -107.28 0.37 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.444 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 8.2 t -131.55 150.93 77.73 Favored Pre-proline 0 C--N 1.32 -0.7 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -177.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -48.98 110.54 0.36 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.119 2.546 . . . . 0.0 112.47 177.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -86.44 80.51 1.76 Allowed Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.112 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -128.65 92.07 3.35 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.885 0.374 . . . . 0.0 110.382 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -80.17 104.7 10.91 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.777 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 33.7 mm -86.79 -8.34 11.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.609 0.719 . . . . 0.0 109.723 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 4.0 p -60.74 146.2 86.72 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.559 177.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.8 10.75 0.77 Allowed 'Trans proline' 0 CA--C 1.533 0.446 0 C-N-CA 122.837 2.358 . . . . 0.0 113.399 -175.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 33.9 tp 64.15 95.85 0.05 OUTLIER Pre-proline 0 C--O 1.235 0.294 0 C-N-CA 123.249 0.62 . . . . 0.0 111.206 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -73.5 -159.07 0.08 OUTLIER 'Trans proline' 0 C--O 1.237 0.454 0 C-N-CA 122.98 2.453 . . . . 0.0 112.538 -178.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 37.2 m -57.63 99.22 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.43 0.633 . . . . 0.0 111.051 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 7.1 p -129.94 -30.66 1.99 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.512 -178.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 64.89 25.11 12.8 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.223 178.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -77.04 156.89 31.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.592 176.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -118.98 -133.3 4.66 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.027 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -72.24 165.31 33.02 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 122.86 2.374 . . . . 0.0 111.802 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.523 ' HB ' HG12 ' A' ' 266' ' ' VAL . 11.7 t -101.91 130.85 50.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.025 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -115.56 134.92 54.6 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.35 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.498 ' HB3' HD13 ' A' ' 293' ' ' ILE . . . -131.72 145.1 51.45 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.359 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -98.5 127.94 44.64 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.156 177.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . 0.556 ' O ' ' HA ' ' A' ' 260' ' ' VAL . . . -76.82 102.09 6.15 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 176.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 25.3 pt -94.65 -5.02 10.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.585 -173.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.12 147.62 46.13 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -63.57 133.04 53.06 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.112 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.78 95.37 3.12 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.793 0.33 . . . . 0.0 110.582 -177.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 27.2 m -90.26 162.37 34.83 Favored Pre-proline 0 C--N 1.318 -0.773 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 172.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.502 ' HG3' ' HB2' ' A' ' 257' ' ' ALA . 5.1 Cg_exo -75.67 -151.45 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.152 1.901 . . . . 0.0 111.399 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' CYS . . . . . 0.493 ' O ' ' HB3' ' A' ' 252' ' ' ASP . 42.6 t -147.45 171.74 15.04 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 122.123 -0.361 . . . . 0.0 111.342 -173.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -68.08 -31.16 70.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.958 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -102.41 22.59 13.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.285 0.564 . . . . 0.0 110.539 176.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.493 ' HB3' ' O ' ' A' ' 249' ' ' CYS . 0.1 OUTLIER -83.2 129.03 34.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.416 178.205 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -138.68 -0.57 1.92 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.416 167.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 2.1 p -151.45 21.38 0.73 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.924 -177.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -102.93 109.44 21.0 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.034 0.445 . . . . 0.0 110.594 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.508 ' HA ' ' NH1' ' A' ' 282' ' ' ARG . 0.5 OUTLIER -65.93 139.07 58.23 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.874 -176.821 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.502 ' HB2' ' HG3' ' A' ' 248' ' ' PRO . . . -103.03 123.76 47.23 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.032 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.684 HD11 HG22 ' A' ' 289' ' ' THR . 57.1 mt -135.93 176.36 8.76 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.233 -175.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.448 ' O ' ' HB3' ' A' ' 242' ' ' ALA . 9.7 pt-20 -160.38 177.29 10.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.65 0.262 . . . . 0.0 111.095 179.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . 0.556 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 57.4 t -66.42 126.55 26.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.954 -171.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 96.14 8.65 57.66 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.888 175.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -103.61 147.27 27.41 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 31.4 mm -107.24 116.08 50.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.124 0.488 . . . . 0.0 110.336 -176.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 10.2 t -85.77 120.77 36.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.572 -177.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . 0.692 ' HD3' ' HG3' ' A' ' 278' ' ' GLU . 35.8 tttp -86.48 100.41 12.35 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.784 175.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.523 HG12 ' HB ' ' A' ' 238' ' ' VAL . 3.9 p -117.0 117.19 54.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.7 0.762 . . . . 0.0 111.095 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 12.7 p -98.2 -38.51 9.27 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.308 177.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . 0.506 ' HB2' ' HB2' ' A' ' 276' ' ' GLU . 42.7 mtt180 -106.81 108.75 20.41 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.141 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 6.2 ptp -114.18 114.51 26.13 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.717 0.77 . . . . 0.0 110.972 173.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -83.89 150.93 25.39 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.514 -176.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 34.4 pt -82.72 11.37 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.042 -177.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -98.58 -6.62 29.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.722 0.296 . . . . 0.0 110.544 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 113.25 -39.13 2.95 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.725 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.514 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 2.4 mp0 -88.3 111.16 21.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.862 0.363 . . . . 0.0 110.366 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.5 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 10.1 m0 -93.86 157.03 16.33 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . 0.506 ' HB2' ' HB2' ' A' ' 268' ' ' ARG . 38.8 mt-10 -100.62 114.05 27.42 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 176.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -138.32 146.53 18.32 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.615 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.692 ' HG3' ' HD3' ' A' ' 265' ' ' LYS . 6.1 pt-20 -114.02 109.95 19.26 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.027 0.441 . . . . 0.0 110.024 177.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . 0.509 HG22 HD22 ' A' ' 258' ' ' LEU . 14.5 t -109.27 -109.68 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.013 -175.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -85.98 82.56 8.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.788 0.327 . . . . 0.0 111.615 -174.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 66.02 6.68 32.99 Favored Glycine 0 C--N 1.332 0.337 0 CA-C-N 115.928 -0.578 . . . . 0.0 113.421 174.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . 0.508 ' NH1' ' HA ' ' A' ' 256' ' ' LEU . 1.7 tmt_? -146.92 127.98 14.61 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -176.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.425 ' HB3' ' HB3' ' A' ' 278' ' ' GLU . 15.0 ptpt -120.71 142.43 49.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.684 -178.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -173.69 -169.7 36.29 Favored Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 111.564 -0.614 . . . . 0.0 111.564 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.514 ' HB3' ' HB3' ' A' ' 274' ' ' GLN . 94.4 mt -86.78 146.95 26.04 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.167 0.508 . . . . 0.0 110.247 177.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.971 ' HB2' ' HG1' ' A' ' 289' ' ' THR . 26.3 p90 -143.18 123.39 7.88 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.582 176.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . 0.657 ' C ' ' H ' ' A' ' 289' ' ' THR . 51.5 Cg_exo -62.98 62.26 0.16 Allowed 'Trans proline' 0 N--CA 1.486 1.061 0 C-N-CA 124.597 3.531 . . . . 0.0 112.565 175.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.675 ' O ' HG22 ' A' ' 291' ' ' VAL . 4.3 m-85 62.54 -14.77 0.06 Allowed 'General case' 0 C--O 1.213 -0.849 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.736 -168.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' THR . . . . . 0.971 ' HG1' ' HB2' ' A' ' 286' ' ' PHE . 1.4 m 69.68 -12.31 0.46 Allowed 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 123.573 0.749 . . . . 0.0 112.824 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . 0.518 ' HB2' ' O ' ' A' ' 289' ' ' THR . 32.2 m170 89.37 25.0 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 O-C-N 124.313 1.008 . . . . 0.0 109.829 -164.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.675 HG22 ' O ' ' A' ' 288' ' ' PHE . 13.1 m -86.99 179.57 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.358 0.599 . . . . 0.0 111.206 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . 0.494 ' HZ2' ' HB2' ' A' ' 292' ' ' LYS . 0.9 OUTLIER -135.25 129.99 34.49 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.306 173.842 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.498 HD13 ' HB3' ' A' ' 240' ' ' ALA . 19.0 mm -77.35 126.02 37.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.064 0.459 . . . . 0.0 111.16 -178.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -151.44 -171.56 3.97 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.465 ' HB3' ' ND2' ' A' ' 298' ' ' ASN . 14.7 t70 -133.07 105.88 12.45 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-O 120.889 0.376 . . . . 0.0 110.221 175.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -85.32 11.87 3.23 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.919 2.413 . . . . 0.0 112.678 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -99.37 -32.49 11.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.297 -176.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . 0.465 ' ND2' ' HB3' ' A' ' 295' ' ' ASP . 7.8 p30 -91.28 150.43 41.46 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.471 -178.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' PRO . . . . . 0.509 ' HA ' ' HB3' ' A' ' 302' ' ' ASN . 6.1 Cg_exo -80.81 -15.67 10.59 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.994 2.463 . . . . 0.0 112.464 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -62.67 -47.14 84.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.138 -175.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -117.13 42.34 2.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.319 0.581 . . . . 0.0 110.092 175.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . 0.509 ' HB3' ' HA ' ' A' ' 299' ' ' PRO . 8.1 p30 -62.97 -25.1 68.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.229 -177.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 . . . . . 0 C--O 1.252 1.206 0 CA-C-O 118.26 -0.876 . . . . 0.0 109.724 -179.489 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ptp . . . . . 0 N--CA 1.483 1.192 0 CA-C-O 120.454 0.169 . . . . 0.0 110.549 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.6 m 70.13 142.0 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.468 0.707 . . . . 0.0 110.916 -175.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.491 ' O ' HG22 ' A' ' 99' ' ' ILE . 19.5 m -72.45 -46.28 55.71 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.42 -178.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -86.7 56.11 3.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.168 0.509 . . . . 0.0 110.707 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 20.7 tpp180 -93.55 96.75 10.06 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.383 -174.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.599 ' CE1' ' HE2' ' A' ' 89' ' ' LYS . 41.3 p90 -167.62 147.93 5.21 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.105 174.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -79.04 102.79 8.57 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.867 -178.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 30.4 m -69.36 76.88 0.39 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.079 175.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.4 t 178.48 -37.33 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.831 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -69.13 106.95 3.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.428 -173.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 -61.58 -31.03 71.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.397 -177.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 61.1 m -80.37 3.41 21.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.352 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -91.71 -47.81 7.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.941 0.4 . . . . 0.0 110.513 175.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 25.9 p-90 -122.62 -24.21 4.96 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -168.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -74.65 118.6 17.79 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.173 0.511 . . . . 0.0 110.913 -174.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.754 ' HG3' ' HB2' ' A' ' 37' ' ' LEU . 25.9 mmt -101.16 -11.71 19.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.062 -174.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.402 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 50.55 -114.21 2.51 Favored Glycine 0 CA--C 1.524 0.602 0 O-C-N 123.653 0.595 . . . . 0.0 113.25 -176.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.402 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 9.0 Cg_exo -72.31 91.33 0.76 Allowed 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 122.994 2.463 . . . . 0.0 113.273 -175.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.673 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 71.1 t -143.88 161.74 15.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 176.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.606 ' HA ' ' OG ' ' A' ' 42' ' ' SER . 16.0 m -128.68 174.06 9.76 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -172.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 63.3 mtp85 -57.32 -54.27 48.71 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.484 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -60.99 -40.95 95.43 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.726 0.298 . . . . 0.0 111.684 -177.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.533 ' O ' ' HG3' ' A' ' 27' ' ' ARG . 0.3 OUTLIER -70.98 -47.04 61.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.138 0.494 . . . . 0.0 110.17 -177.262 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.5 ' HB2' HD11 ' A' ' 37' ' ' LEU . . . -57.44 -42.83 83.19 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.157 0.503 . . . . 0.0 110.998 175.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.653 ' HG3' HG23 ' A' ' 58' ' ' VAL . 64.6 tt0 -65.29 -40.84 94.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.232 -177.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.6 t -76.19 -4.58 42.54 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.929 0.395 . . . . 0.0 111.167 -177.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.533 ' HG3' ' O ' ' A' ' 23' ' ' GLU . 90.7 mtt180 -90.03 -25.91 20.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.206 0.527 . . . . 0.0 109.746 172.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.512 HD23 ' HB2' ' A' ' 53' ' ' SER . 25.5 mt -116.7 16.9 15.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.953 -171.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.416 HE22 ' ND2' ' A' ' 117' ' ' ASN . 0.0 OUTLIER -78.4 90.57 4.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.036 0.446 . . . . 0.0 110.686 -176.125 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.421 ' HA2' ' HB2' ' A' ' 117' ' ' ASN . . . 81.97 -4.68 74.34 Favored Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.576 176.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.424 ' HA ' HG12 ' A' ' 113' ' ' VAL . 12.9 mm100 -65.55 167.99 8.1 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.792 0.329 . . . . 0.0 111.527 -178.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.491 ' HB2' ' HE2' ' A' ' 35' ' ' MET . 46.7 mtm180 -43.19 125.53 3.72 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.476 -178.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.517 ' HB3' HG23 ' A' ' 96' ' ' THR . 29.8 m170 -69.39 142.22 53.96 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.335 -178.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.537 ' HA3' ' HB ' ' A' ' 99' ' ' ILE . . . 110.64 -20.16 25.24 Favored Glycine 0 N--CA 1.437 -1.241 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 -175.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.65 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 63.3 mtt -61.75 142.41 57.29 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 173.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.531 ' HB2' HD13 ' A' ' 50' ' ' LEU . 51.6 p90 -153.19 162.74 40.97 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.754 ' HB2' ' HG3' ' A' ' 16' ' ' MET . 4.4 pp -155.66 132.66 10.68 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.132 0.491 . . . . 0.0 111.432 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.4 t -103.79 109.8 28.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 174.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.673 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 29.5 ptt-85 -113.22 177.82 4.5 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.82 -177.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -73.78 134.35 43.41 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 172.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.498 ' HA ' HG23 ' A' ' 49' ' ' VAL . 39.2 t -57.09 119.13 5.81 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.61 0.719 . . . . 0.0 111.965 -173.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.606 ' OG ' ' HA ' ' A' ' 20' ' ' SER . 1.5 m -77.44 -11.75 59.88 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.426 173.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.0 m -83.58 -41.4 17.92 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.372 177.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.461 ' O ' ' HB3' ' A' ' 41' ' ' SER . 6.5 p -157.36 94.63 2.15 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.107 178.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -47.91 127.05 13.96 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.11 2.54 . . . . 0.0 112.087 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.48 -45.58 1.15 Allowed Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -172.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -83.67 -166.06 1.29 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 172.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.574 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 25.4 m-85 -134.8 171.27 14.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 117.902 0.319 . . . . 0.0 110.563 177.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.498 HG23 ' HA ' ' A' ' 41' ' ' SER . 59.9 t -145.37 109.4 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 175.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.531 HD13 ' HB2' ' A' ' 36' ' ' PHE . 56.2 tp -80.33 100.95 8.66 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.636 175.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.3 m -96.69 121.78 38.91 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 174.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.638 HG13 ' HG3' ' A' ' 54' ' ' GLU . 87.0 t -111.82 138.59 39.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.712 -174.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.678 ' HA ' ' O ' ' A' ' 57' ' ' ARG . 48.1 t -82.63 98.48 9.03 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 175.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.638 ' HG3' HG13 ' A' ' 52' ' ' VAL . 24.2 mt-10 -151.36 160.81 43.58 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.97 -175.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.55 ' ND2' ' H ' ' A' ' 155' ' ' LYS . 0.5 OUTLIER 70.43 -65.85 0.31 Allowed 'General case' 0 CA--C 1.49 -1.333 0 CA-C-O 122.742 1.258 . . . . 0.0 110.456 -168.417 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.672 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 74.8 m -157.9 -22.16 0.08 Allowed 'General case' 0 N--CA 1.419 -1.992 0 CA-C-N 112.56 -2.109 . . . . 0.0 107.626 -175.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.692 ' HG2' ' N ' ' A' ' 58' ' ' VAL 0.359 0.0 OUTLIER -166.61 -50.23 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.124 1 N-CA-C 121.877 4.029 . . . . 0.0 121.877 -179.836 . . . . . . . . 5 4 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.692 ' N ' ' HG2' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -149.78 99.42 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 CA-C-N 121.729 2.058 . . . . 0.0 112.939 -170.148 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.7 m -94.83 111.06 22.87 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 172.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -97.39 112.67 24.4 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -168.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.716 ' OH ' ' HB3' ' A' ' 93' ' ' LEU . 54.3 m-85 -120.14 105.78 11.32 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.415 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.601 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 63.6 mt -80.52 127.0 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -174.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.574 ' HB ' ' HB2' ' A' ' 48' ' ' TYR . 4.3 mp -101.05 119.72 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 121.17 0.51 . . . . 0.0 111.17 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.533 ' HB2' ' HB3' ' A' ' 72' ' ' LYS . 16.7 m120 -86.04 136.11 33.37 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.798 -178.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.1 t -85.58 93.75 8.88 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 171.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.547 HD12 ' HB2' ' A' ' 72' ' ' LYS . 83.6 mt -84.99 145.84 44.36 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.834 -177.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 66' ' ' LEU . 18.5 Cg_exo -67.57 -3.85 10.95 Favored 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 122.92 2.414 . . . . 0.0 111.547 174.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 42.2 m-20 -80.66 2.21 26.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.71 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? 63.59 31.89 14.37 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.469 0.652 . . . . 0.0 109.51 -170.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.738 ' HG2' ' HA ' ' A' ' 79' ' ' ASP . 35.5 mtp180 -132.44 162.03 32.19 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.708 -175.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.436 ' HB3' HG22 ' A' ' 63' ' ' ILE . 47.3 m-85 -122.85 117.84 26.55 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.965 0.412 . . . . 0.0 111.142 -174.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.547 ' HB2' HD12 ' A' ' 66' ' ' LEU . 29.5 ttpp -104.09 98.99 8.73 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.462 -173.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.601 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 6.7 tt -88.45 119.64 36.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.293 0.568 . . . . 0.0 111.286 -177.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.37 32.16 83.19 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.828 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.461 ' HA ' ' NZ ' ' A' ' 72' ' ' LYS . 35.1 t70 74.62 -11.61 1.01 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.035 0.534 . . . . 0.0 111.835 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -86.66 126.66 34.68 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 171.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.531 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 0.7 OUTLIER -100.57 140.79 34.34 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.909 0.861 . . . . 0.0 113.169 -169.134 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.546 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 91.0 m-85 -129.02 172.16 11.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.218 -1.356 . . . . 0.0 108.376 173.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.738 ' HA ' ' HG2' ' A' ' 70' ' ' ARG . 5.9 m-20 -74.88 -30.33 61.28 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.66 0.266 . . . . 0.0 111.693 -175.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.837 ' HD1' ' HG2' ' A' ' 82' ' ' PRO . 4.9 p80 -165.07 168.35 17.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.563 -176.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.662 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 14.3 mt -57.97 -54.63 53.5 Favored Pre-proline 0 N--CA 1.469 0.482 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -177.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.837 ' HG2' ' HD1' ' A' ' 80' ' ' HIS . 20.9 Cg_endo -62.95 -3.02 4.15 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 121.976 1.784 . . . . 0.0 113.637 178.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.42 ' HB3' ' CE1' ' A' ' 80' ' ' HIS . . . -89.01 -36.51 15.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.94 0.4 . . . . 0.0 110.263 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.662 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.0 pp -76.81 -29.86 56.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.064 0.459 . . . . 0.0 109.891 178.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.493 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 79.7 mt -68.46 -21.04 64.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.336 177.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -91.97 -17.45 25.12 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.37 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -91.23 -30.88 16.39 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 121.784 0.802 . . . . 0.0 109.272 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.676 ' CD1' HD22 ' A' ' 93' ' ' LEU . 28.4 m-85 -84.21 1.88 42.48 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.125 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.599 ' HE2' ' CE1' ' A' ' 6' ' ' PHE . 85.8 mttt -77.61 -11.91 59.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.687 169.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 35.7 pt -134.84 8.82 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.204 0 CA-C-O 121.05 0.453 . . . . 0.0 110.302 -176.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.461 ' HB2' ' HA ' ' A' ' 88' ' ' TYR . 16.8 t60 -88.14 -38.87 15.0 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.199 -177.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.498 ' HA ' ' O ' ' A' ' 96' ' ' THR . 92.5 m-85 58.46 86.07 0.09 Allowed 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.344 -1.298 . . . . 0.0 107.797 -161.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.716 ' HB3' ' OH ' ' A' ' 61' ' ' TYR . 76.2 mt -44.23 -65.32 0.53 Allowed 'General case' 0 CA--C 1.517 -0.297 0 O-C-N 124.151 0.907 . . . . 0.0 108.805 178.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.686 ' HB3' ' HB3' ' A' ' 154' ' ' GLU . 1.6 p30 -111.99 -86.53 0.56 Allowed 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.771 163.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 1.051 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 11.5 t -118.97 14.4 13.22 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.296 0.57 . . . . 0.0 110.994 -174.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.517 HG23 ' HB3' ' A' ' 33' ' ' HIS . 5.8 t -153.72 -179.89 8.23 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 172.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 20.2 p -116.56 171.13 8.05 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 122.4 -0.188 . . . . 0.0 110.733 179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 92.5 mt -61.62 104.12 0.4 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.018 0.437 . . . . 0.0 110.113 175.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.537 ' HB ' ' HA3' ' A' ' 34' ' ' GLY . 45.8 mm -89.21 -56.91 4.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.807 -176.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.65 ' O ' ' HA ' ' A' ' 35' ' ' MET . 10.6 pt-20 -162.98 142.3 6.8 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.956 -177.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.21 149.51 90.14 Favored 'Trans proline' 0 C--O 1.235 0.375 0 C-N-CA 122.411 2.074 . . . . 0.0 112.57 -177.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.638 ' HB1' ' HB3' ' A' ' 35' ' ' MET . . . -73.07 146.24 87.05 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.99 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.67 115.68 3.69 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.234 1.956 . . . . 0.0 111.625 176.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.616 ' HB3' ' SD ' ' A' ' 16' ' ' MET . 37.6 ptt180 -66.22 135.16 54.09 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 178.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 59.64 68.03 1.64 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.859 -172.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -94.53 165.21 1.87 Allowed 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 123.168 2.579 . . . . 0.0 112.237 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 37.2 p -148.69 93.5 4.26 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.669 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -86.2 109.56 0.97 Allowed 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.448 2.099 . . . . 0.0 111.464 176.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -62.98 106.06 0.5 Allowed 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.678 2.252 . . . . 0.0 112.397 -176.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 51.8 ttm 72.87 -52.03 0.71 Allowed 'General case' 0 N--CA 1.47 0.542 0 O-C-N 123.922 0.764 . . . . 0.0 111.826 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 124.52 108.3 1.76 Allowed Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 -178.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 21.6 m -104.84 -3.76 23.07 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.109 0.481 . . . . 0.0 110.838 -177.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.424 HG12 ' HA ' ' A' ' 31' ' ' GLN . 8.7 m -80.96 81.48 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.627 0.727 . . . . 0.0 111.221 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 20.2 m -115.79 1.73 13.49 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.762 177.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.473 ' HB3' ' HD3' ' A' ' 116' ' ' PRO . . . -96.59 -48.74 0.24 Allowed Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.551 177.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.473 ' HD3' ' HB3' ' A' ' 115' ' ' ALA . 71.9 Cg_endo -81.47 171.59 13.4 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 121.848 1.699 . . . . 0.0 110.669 168.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.672 ' HA ' ' HB3' ' A' ' 56' ' ' SER . 60.3 t30 63.21 88.04 0.1 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.485 0.659 . . . . 0.0 110.316 -176.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.58 ' N ' ' HD2' ' A' ' 119' ' ' PRO . 4.1 mm? -86.81 -44.03 0.55 Allowed Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -174.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 118' ' ' LEU . 18.8 Cg_endo -59.23 99.53 0.11 Allowed 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.035 1.824 . . . . 0.0 112.589 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.584 HG22 ' H ' ' A' ' 121' ' ' ALA . 0.6 OUTLIER -89.54 -64.12 1.19 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.934 -179.459 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.584 ' H ' HG22 ' A' ' 120' ' ' THR . . . -151.35 88.59 1.44 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.098 0.475 . . . . 0.0 111.041 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -130.89 -30.95 1.76 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.362 173.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.79 ' O ' ' HA ' ' A' ' 183' ' ' ARG . 24.6 t70 62.5 99.66 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.197 0 O-C-N 124.159 0.912 . . . . 0.0 108.607 -169.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 178.82 168.3 0.91 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.73 -175.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.633 HD22 ' CH2' ' A' ' 161' ' ' TRP . 3.9 mm? 62.47 91.6 0.06 Allowed 'General case' 0 N--CA 1.47 0.555 0 O-C-N 123.913 0.758 . . . . 0.0 111.913 173.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 32.9 tt0 177.73 -60.16 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.302 -177.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -112.69 112.97 24.86 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.286 176.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 1.008 HG21 ' HG3' ' A' ' 180' ' ' LYS . 10.4 t -115.71 146.34 20.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 177.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.612 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 0.0 OUTLIER -118.71 147.69 43.56 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 117.244 -1.783 . . . . 0.0 109.024 158.903 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.468 HG21 HD12 ' A' ' 150' ' ' LEU . 0.8 OUTLIER -102.69 130.32 49.58 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.839 -1.073 . . . . 0.0 111.3 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.551 HD22 ' HG2' ' A' ' 179' ' ' GLU . 24.6 mt -104.97 -7.47 19.25 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -175.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.5 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 63.6 t80 -95.42 -42.53 8.43 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.233 -0.587 . . . . 0.0 112.543 -174.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.604 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 15.7 t70 77.75 89.71 0.07 Allowed 'General case' 0 N--CA 1.474 0.761 0 O-C-N 123.746 0.654 . . . . 0.0 110.431 -175.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.431 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 63.3 t80 -119.09 85.79 30.46 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 176.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.586 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 87.5 Cg_endo -81.94 83.76 2.02 Favored 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 121.608 1.539 . . . . 0.0 112.556 178.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -76.31 -20.58 76.97 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 175.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.817 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 12.3 m120 58.41 68.23 0.85 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.643 -0.778 . . . . 0.0 111.679 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.43 ' HB3' ' H ' ' A' ' 140' ' ' GLU . 0.4 OUTLIER -152.3 170.73 19.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.85 179.066 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -94.97 -5.42 44.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.937 0.875 . . . . 0.0 108.975 170.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.43 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 42.7 mm-40 -96.34 -36.91 10.7 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.809 174.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -123.01 112.73 18.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.273 178.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.712 ' CD1' ' HB2' ' A' ' 165' ' ' ASN . 30.4 tp -68.61 129.95 92.25 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-O 120.776 0.322 . . . . 0.0 110.534 -177.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.817 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 11.6 Cg_endo -85.64 91.26 0.69 Allowed 'Trans proline' 0 N--CA 1.442 -1.55 0 C-N-CA 122.092 1.861 . . . . 0.0 111.012 172.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.555 ' CE2' ' HB ' ' A' ' 173' ' ' ILE . 14.3 p90 -101.54 164.85 11.55 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.817 -174.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.604 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 1.4 mptp? -100.29 -172.71 2.26 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.203 0.525 . . . . 0.0 111.75 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.671 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -91.62 9.03 33.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.972 -175.986 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -167.13 32.95 0.21 Allowed Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.48 175.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.494 ' OE1' ' HA ' ' A' ' 144' ' ' PHE . 0.1 OUTLIER -100.13 157.45 16.56 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.214 -174.92 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.559 HD12 ' HB3' ' A' ' 129' ' ' ARG . 0.6 OUTLIER -97.49 129.38 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-O 121.692 0.758 . . . . 0.0 109.978 -176.682 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.704 HD23 ' CD2' ' A' ' 142' ' ' LEU . 31.9 mt -123.94 158.77 31.24 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 114.522 -1.217 . . . . 0.0 108.01 -177.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.567 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 97.4 t -122.04 120.43 61.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 175.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.523 HG21 ' CD1' ' A' ' 125' ' ' LEU . 42.1 mm -78.21 79.14 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -178.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.667 HG22 ' HG2' ' A' ' 154' ' ' GLU . 7.6 tt -74.57 -34.18 34.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 114.535 -1.212 . . . . 0.0 109.318 -178.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.686 ' HB3' ' HB3' ' A' ' 94' ' ' ASP . 0.0 OUTLIER -123.46 142.92 50.51 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.502 175.577 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.55 ' H ' ' ND2' ' A' ' 55' ' ' ASN . 83.1 tttt -140.47 81.75 17.13 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-O 120.982 0.42 . . . . 0.0 109.993 172.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 1.051 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 38.4 Cg_endo -73.25 -40.28 1.74 Allowed 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.03 1.82 . . . . 0.0 111.972 175.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -111.05 162.65 14.66 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.407 -171.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -100.17 -11.54 20.36 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 172.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -89.81 -34.1 16.27 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.916 177.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 49.4 m95 -129.45 139.44 51.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.942 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . 0.748 ' O ' HG13 ' A' ' 173' ' ' ILE . 47.8 m0 -113.63 137.02 52.18 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 176.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.519 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 16.2 m -96.96 97.59 9.39 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -175.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.497 ' HB2' ' HB3' ' A' ' 150' ' ' LEU . . . -110.84 149.54 30.43 Favored 'General case' 0 N--CA 1.425 -1.72 0 C-N-CA 119.859 -0.736 . . . . 0.0 109.956 -174.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.713 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 11.7 ptt180 -87.25 122.16 30.67 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 173.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.712 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . 12.9 t30 -58.42 -178.07 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 113.755 -1.566 . . . . 0.0 111.381 -173.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.527 ' HD3' ' HB ' ' A' ' 149' ' ' ILE . 10.0 mmmm -66.38 -11.67 52.68 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.414 0.626 . . . . 0.0 109.906 166.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.415 ' H ' ' HB3' ' A' ' 165' ' ' ASN . 22.3 m-20 -82.29 -15.99 50.99 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 170.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 80.28 10.82 84.98 Favored Glycine 0 CA--C 1.52 0.36 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.923 -174.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.713 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.3 OUTLIER -81.94 133.91 35.34 Favored 'General case' 0 C--O 1.217 -0.615 0 C-N-CA 123.106 0.562 . . . . 0.0 110.803 -178.846 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 80.4 t -82.38 123.62 38.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.862 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -157.02 158.11 28.58 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.75 171.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.494 ' HE2' ' HG2' ' A' ' 156' ' ' PRO . 10.5 mtp -82.84 144.79 29.87 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 117.482 0.641 . . . . 0.0 111.039 -178.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.748 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.7 pp -142.87 147.96 43.85 Favored Pre-proline 0 C--O 1.223 -0.317 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.43 -175.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.479 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 8.0 Cg_exo -73.55 129.8 14.13 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.547 2.165 . . . . 0.0 112.71 -175.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.567 ' O ' HG23 ' A' ' 178' ' ' VAL . 61.5 t -59.19 -44.51 98.57 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.463 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 36.4 Cg_exo -61.93 -2.54 2.96 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 122.206 1.937 . . . . 0.0 113.136 176.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.479 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.1 m-30 -100.85 -9.23 21.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.641 -178.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 175' ' ' VAL . 6.1 m -107.87 -173.29 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 -166.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.612 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 5.2 tp10 -159.74 49.18 0.3 Allowed 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 113.221 -1.809 . . . . 0.0 112.559 -151.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 1.008 ' HG3' HG21 ' A' ' 128' ' ' VAL . 1.2 mppt? -71.47 138.52 49.05 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 120.042 -1.661 . . . . 0.0 111.803 -158.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.568 ' HB2' ' NH1' ' A' ' 129' ' ' ARG . 11.8 tp -75.69 -80.08 0.09 Allowed 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 112.84 -1.982 . . . . 0.0 111.387 -170.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.441 ' H ' ' HB3' ' A' ' 181' ' ' LEU . 8.3 m -77.63 103.51 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.88 178.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.917 ' HD2' ' HB2' ' A' ' 180' ' ' LYS . 3.6 ptm180 -170.04 154.21 5.0 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.248 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 185' ' ' SER . 35.9 t -68.63 -94.37 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 169.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' SER . . . . . 0.766 ' HB3' ' CE1' ' A' ' 187' ' ' HIS . 37.1 t 173.12 154.95 0.26 Allowed Pre-proline 0 C--O 1.236 0.369 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.546 ' HG3' HH22 ' A' ' 183' ' ' ARG . 9.3 Cg_exo -69.45 80.69 0.78 Allowed 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.352 2.035 . . . . 0.0 111.655 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.766 ' CE1' ' HB3' ' A' ' 185' ' ' SER . 52.8 m80 -94.31 -12.86 27.17 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.279 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 67.8 -89.56 0.19 Allowed Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -173.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.947 ' HE2' ' HA ' ' A' ' 195' ' ' SER . 20.6 ttpp -66.33 111.56 3.57 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 168.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 64.9 m80 -91.02 90.82 8.03 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -136.18 159.86 24.49 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -105.9 6.13 31.19 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.912 0.356 . . . . 0.0 111.894 -175.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 25.9 ttp180 -117.9 -79.75 0.6 Allowed 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.325 -0.55 . . . . 0.0 111.774 -177.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -158.25 -163.23 1.25 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 -173.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.947 ' HA ' ' HE2' ' A' ' 189' ' ' LYS . 13.4 p -57.98 -69.81 0.16 Allowed 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 173.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 71.11 -40.98 0.49 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.66 0.784 . . . . 0.0 112.913 171.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 22.7 t 72.75 86.6 0.11 Allowed 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.391 0.676 . . . . 0.0 109.357 -174.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -83.36 75.49 9.98 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.181 -178.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -93.39 -33.78 7.01 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.364 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 12.2 pt -107.48 104.28 52.07 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-O 121.22 0.533 . . . . 0.0 111.835 -177.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -88.22 0.37 6.78 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.704 2.27 . . . . 0.0 111.587 174.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 203' ' ' PRO . 9.8 pt-20 -140.75 142.77 29.6 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.189 -177.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 202' ' ' GLU . 5.1 Cg_exo -75.3 96.82 1.05 Allowed 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.823 2.349 . . . . 0.0 111.107 174.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -88.91 89.8 8.14 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.854 -176.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -140.61 90.17 2.33 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.178 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . 58.08 25.42 12.36 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.512 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -103.43 -45.44 4.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.503 -175.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -101.24 -34.53 9.62 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.249 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -115.12 105.62 52.52 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.792 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -64.86 -58.13 0.24 Allowed 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.662 2.242 . . . . 0.0 111.732 175.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 63.11 172.55 0.15 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.627 0.727 . . . . 0.0 112.069 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 5.2 m -115.36 40.1 2.78 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 172.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 10.4 m -58.76 -45.85 88.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.712 -177.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 27.8 m -153.43 131.6 6.42 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.275 -176.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.481 ' HB2' ' O ' ' A' ' 218' ' ' ALA . 72.9 Cg_endo -80.17 120.41 4.11 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.424 2.083 . . . . 0.0 111.851 174.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.584 ' HB2' ' HD3' ' A' ' 217' ' ' PRO . 7.2 mp -99.77 -58.53 0.13 Allowed Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -178.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.584 ' HD3' ' HB2' ' A' ' 216' ' ' LEU . 87.9 Cg_endo -85.07 -10.82 7.87 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 121.754 1.636 . . . . 0.0 112.662 -178.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 215' ' ' PRO . . . -125.02 91.36 3.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.966 0.413 . . . . 0.0 110.893 -178.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 27.5 m -88.26 165.85 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.359 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 14.4 m -91.91 10.27 29.48 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.008 0.432 . . . . 0.0 110.766 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 80.78 -56.83 4.79 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.19 -0.529 . . . . 0.0 112.006 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.442 ' HA ' ' HD3' ' A' ' 223' ' ' PRO . 28.5 t -131.0 133.43 24.74 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 177.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 222' ' ' SER . 16.1 Cg_exo -67.49 161.14 44.69 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.579 2.186 . . . . 0.0 111.677 177.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -84.14 -25.4 44.55 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.589 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -138.45 157.7 45.69 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.721 -0.239 . . . . 0.0 110.373 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . 68.6 35.31 3.22 Favored 'General case' 0 C--O 1.233 0.23 0 O-C-N 123.971 0.795 . . . . 0.0 111.655 176.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.535 HD11 ' H ' ' A' ' 227' ' ' ILE . 4.3 mp -78.11 90.11 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 175.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 20.8 m 60.78 79.11 0.29 Allowed Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.324 -173.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.456 ' HB2' HD21 ' A' ' 230' ' ' LEU . 23.4 Cg_exo -64.79 -69.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.602 2.201 . . . . 0.0 111.774 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.456 HD21 ' HB2' ' A' ' 229' ' ' PRO . 2.6 pt? -162.31 123.25 1.55 Allowed Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.916 177.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 230' ' ' LEU . 7.7 Cg_exo -72.43 -68.09 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.296 1.997 . . . . 0.0 111.374 177.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 3.0 p -161.71 26.83 0.12 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.618 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 2.9 p -82.44 -16.79 47.64 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.207 -173.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 58.36 83.58 0.12 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 121.433 0.635 . . . . 0.0 110.881 -175.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -110.64 99.2 8.2 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.531 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -90.97 163.84 29.57 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.222 174.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -68.81 161.57 44.96 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.533 2.155 . . . . 0.0 111.751 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.482 ' HB ' HG12 ' A' ' 266' ' ' VAL . 18.3 t -89.03 128.95 40.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.503 ' HB2' ' HG3' ' A' ' 296' ' ' PRO . 93.9 m-85 -102.87 117.68 35.16 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.092 0.472 . . . . 0.0 110.959 -177.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.463 ' HB3' HD11 ' A' ' 293' ' ' ILE . . . -119.95 134.35 55.27 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.104 178.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -84.59 126.39 33.29 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . 0.465 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -72.65 100.71 2.87 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.03 0.443 . . . . 0.0 109.829 177.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 2.4 pp -96.05 -9.0 9.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.557 -176.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.28 138.25 36.59 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 176.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -58.23 149.62 23.72 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 120.968 0.414 . . . . 0.0 110.71 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.459 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 24.7 tpt180 -143.78 91.52 2.24 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 174.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 29.2 m -100.23 142.6 24.93 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.098 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.489 ' HB3' ' HB3' ' A' ' 255' ' ' ALA . 72.8 Cg_endo -79.11 148.58 21.71 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.404 2.07 . . . . 0.0 112.101 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 48.7 t -79.66 176.58 9.59 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 173.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -59.62 -30.36 68.64 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.659 0.266 . . . . 0.0 111.548 -177.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -96.02 -5.42 41.11 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.415 ' HB3' ' HB3' ' A' ' 255' ' ' ALA . 4.1 m-20 -82.82 107.6 15.56 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.263 0.554 . . . . 0.0 111.467 -176.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 47.2 mttp -104.01 -34.41 8.46 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.308 176.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 3.0 p -86.81 9.4 19.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.589 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.489 ' HB3' ' HB3' ' A' ' 248' ' ' PRO . . . -95.8 131.84 41.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.051 0.453 . . . . 0.0 110.857 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.538 HD21 ' HB ' ' A' ' 279' ' ' VAL . 0.9 OUTLIER -88.24 133.32 34.07 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.188 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -89.3 109.75 20.61 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.861 0.363 . . . . 0.0 110.169 -179.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 94.2 mt -115.11 143.69 44.82 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.012 -175.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -120.4 149.95 41.55 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.503 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 59.8 t -64.17 117.15 4.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.784 0.326 . . . . 0.0 110.874 -178.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 108.93 10.19 24.95 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.587 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -103.19 167.59 9.72 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . 0.425 HD12 ' HA ' ' A' ' 263' ' ' ILE . 37.3 mm -114.35 118.09 57.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.038 0.447 . . . . 0.0 110.814 -176.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 20.0 t -93.69 109.37 21.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.514 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -87.2 87.47 7.45 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.746 177.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.482 HG12 ' HB ' ' A' ' 238' ' ' VAL . 7.2 p -91.19 136.52 24.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.88 -175.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 18.1 p -114.06 -50.61 2.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.19 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 14.2 tpp180 -100.79 101.27 12.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.12 0.486 . . . . 0.0 110.657 -175.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 41.4 mtt -91.54 118.9 31.01 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.007 0.432 . . . . 0.0 110.304 177.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.44 ' HB2' ' O ' ' A' ' 274' ' ' GLN . 90.6 m-20 -83.11 0.61 44.3 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.472 -176.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 50.6 mm 72.94 -47.85 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 171.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -61.84 -24.75 67.09 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -173.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 155.38 -48.48 0.49 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.252 -0.975 . . . . 0.0 112.694 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.51 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 1.8 mp0 -86.46 116.52 24.66 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.387 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.455 ' HB3' HG23 ' A' ' 266' ' ' VAL . 43.8 m0 -97.17 153.42 18.0 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.613 178.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -106.26 109.47 21.41 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.184 0.516 . . . . 0.0 110.026 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . 0.485 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -123.21 164.18 16.33 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.786 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -114.61 115.28 26.91 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -178.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . 0.538 ' HB ' HD21 ' A' ' 256' ' ' LEU . 88.1 t -136.15 125.2 38.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.258 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 56.95 38.78 29.58 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.893 176.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 89.34 -15.63 57.99 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.437 175.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 282' ' ' ARG . 40.6 mtp-105 -107.96 132.7 53.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 117.164 0.482 . . . . 0.0 110.645 -177.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.485 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 0.0 OUTLIER -114.61 130.06 56.74 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 174.507 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -157.96 -175.73 29.22 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.279 -177.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.51 ' HB3' ' HB3' ' A' ' 274' ' ' GLN . 78.6 mt -93.8 129.75 40.06 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.126 0.489 . . . . 0.0 110.804 -178.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.461 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 47.8 p90 -132.72 141.18 40.18 Favored Pre-proline 0 C--N 1.317 -0.804 0 CA-C-N 115.696 -0.683 . . . . 0.0 109.837 176.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 4.6 Cg_exo -74.89 140.38 25.71 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.735 2.29 . . . . 0.0 111.58 177.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -72.58 7.12 2.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.045 0.45 . . . . 0.0 111.821 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 4.1 p -90.83 -10.68 41.84 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.157 0.503 . . . . 0.0 110.968 177.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -104.89 -10.45 17.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.874 -178.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.465 HG12 ' HA ' ' A' ' 242' ' ' ALA . 35.6 m -128.36 162.74 34.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.455 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -140.69 136.72 32.91 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.32 175.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.463 HD11 ' HB3' ' A' ' 240' ' ' ALA . 1.2 mp -72.56 135.96 26.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 174.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -144.63 -165.81 2.24 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.941 -175.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.936 ' HB3' ' HA ' ' A' ' 298' ' ' ASN . 23.8 m-20 -103.43 95.35 6.98 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.228 175.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . 0.503 ' HG3' ' HB2' ' A' ' 239' ' ' PHE . 74.5 Cg_endo -77.13 -30.8 4.08 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.193 1.929 . . . . 0.0 111.665 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -99.32 -20.73 16.39 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.444 175.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . 0.936 ' HA ' ' HB3' ' A' ' 295' ' ' ASP . 18.3 m120 72.53 157.63 0.16 Allowed Pre-proline 0 N--CA 1.467 0.391 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.881 175.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -90.29 7.59 3.75 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.897 2.398 . . . . 0.0 111.275 172.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -135.27 136.44 41.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.582 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 65.95 7.24 4.53 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.839 0.712 . . . . 0.0 111.31 -176.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -87.55 92.27 9.03 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 176.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 . . . . . 0 C--O 1.249 1.039 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.562 -172.749 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 ptp . . . . . 0 N--CA 1.484 1.245 0 CA-C-O 121.085 0.469 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.8 t -74.07 131.89 41.78 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.838 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 22.7 t -66.84 -18.32 65.32 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 177.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.544 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . -75.38 87.19 2.56 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.83 175.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -115.55 88.56 2.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.648 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -161.09 161.29 31.18 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.385 177.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -88.25 91.47 8.8 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.875 0.845 . . . . 0.0 110.11 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.6 p -73.86 77.81 1.62 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.894 -176.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.4 t -176.59 -39.78 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.586 176.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -64.51 113.81 3.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.018 0.437 . . . . 0.0 110.828 -174.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -58.46 -35.81 72.71 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.742 -176.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.2 t -73.51 -6.49 46.8 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.176 -176.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.01 -47.49 7.25 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 121.046 -0.262 . . . . 0.0 111.556 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 30.1 p-90 -116.67 -22.74 8.49 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -171.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -73.27 112.84 9.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.361 0.6 . . . . 0.0 109.747 -177.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.552 ' SD ' ' HA ' ' A' ' 104' ' ' ARG . 15.7 tpp -95.3 5.86 50.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.31 -171.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.477 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 49.65 -113.65 1.92 Allowed Glycine 0 CA--C 1.522 0.493 0 CA-C-N 115.516 -0.765 . . . . 0.0 114.357 176.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.477 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 5.0 Cg_exo -77.13 88.49 1.4 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.454 2.77 . . . . 0.0 113.159 -175.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.54 HG13 ' HD2' ' A' ' 39' ' ' ARG . 71.3 t -145.34 160.44 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.494 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -143.27 -168.81 2.9 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -171.354 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 35.6 mtp85 -59.06 -57.82 11.4 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 118.652 0.66 . . . . 0.0 112.182 -176.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -64.68 -44.97 88.64 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 123.29 0.369 . . . . 0.0 110.847 -175.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.64 ' O ' ' HG3' ' A' ' 27' ' ' ARG . 12.5 mp0 -60.68 -49.84 75.9 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.534 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.494 ' HB1' ' O ' ' A' ' 20' ' ' SER . . . -56.92 -44.69 82.7 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.427 0.632 . . . . 0.0 110.344 177.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.516 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 6.9 tp60 -60.72 -58.25 9.24 Favored 'General case' 0 C--O 1.214 -0.786 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.563 -178.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.2 t -61.83 -27.53 68.84 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -172.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.64 ' HG3' ' O ' ' A' ' 23' ' ' GLU . 62.5 mtp180 -83.48 -10.44 58.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.717 0.294 . . . . 0.0 111.258 -178.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.593 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 87.7 mt -125.58 -13.39 6.53 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.516 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -70.24 107.09 3.57 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 122.765 0.426 . . . . 0.0 110.434 -174.855 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.516 ' O ' ' HB3' ' A' ' 116' ' ' PRO . . . 70.61 20.24 77.08 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.05 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.482 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 12.2 mm100 -92.89 -161.17 0.81 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.479 ' HG2' ' HB1' ' A' ' 115' ' ' ALA . 47.0 mtm180 -52.64 130.76 33.23 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 175.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 63.5 m170 -86.35 126.31 34.25 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.25 11.2 42.92 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -171.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.528 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 50.6 ttp -104.07 134.61 47.04 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -178.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.453 ' HB2' HG21 ' A' ' 52' ' ' VAL . 39.9 p90 -139.29 167.78 21.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.768 0.318 . . . . 0.0 111.777 -174.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.529 ' HG ' HD11 ' A' ' 28' ' ' LEU . 4.6 pp -153.83 140.0 18.45 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.146 0.498 . . . . 0.0 110.825 173.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.6 t -105.71 114.21 44.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 174.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.54 ' HD2' HG13 ' A' ' 19' ' ' VAL . 22.3 ptt-85 -112.33 167.72 10.2 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.953 -173.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -76.44 125.36 29.06 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 170.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.0 t -75.77 152.51 37.36 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.395 0.617 . . . . 0.0 111.531 -172.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.8 t -111.69 14.54 21.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.226 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 46.7 p -92.16 -57.25 2.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.957 176.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.402 ' HB2' ' OD2' ' A' ' 47' ' ' ASP . 56.8 m -134.56 137.9 28.74 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.754 178.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.6 127.18 17.47 Favored 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 122.8 2.333 . . . . 0.0 112.754 -178.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.65 -16.68 43.8 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.339 176.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.402 ' OD2' ' HB2' ' A' ' 44' ' ' CYS . 65.8 m-20 -96.89 166.34 11.67 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 -177.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -128.33 175.22 8.65 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -178.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.7 t -144.66 117.35 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 120.902 0.382 . . . . 0.0 110.93 174.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 33.5 tp -84.83 102.1 12.8 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.442 176.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 55.9 m -96.52 133.65 40.72 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 175.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.678 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 99.2 t -129.53 134.3 63.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.841 0.353 . . . . 0.0 111.825 -173.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.593 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 9.2 t -94.5 117.18 29.73 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -177.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.669 ' O ' ' HB3' ' A' ' 57' ' ' ARG . 9.9 tp10 -158.26 147.94 19.71 Favored 'General case' 0 C--O 1.211 -0.967 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.276 163.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.508 ' ND2' ' HG3' ' A' ' 54' ' ' GLU . 50.7 m-80 62.89 16.59 9.27 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 123.35 0.407 . . . . 0.0 111.59 -176.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 67.2 m 56.22 59.46 3.68 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 122.724 1.25 . . . . 0.0 108.164 -168.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.669 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 19.4 ttp85 -155.59 65.12 0.6 Allowed 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 112.768 -2.015 . . . . 0.0 109.398 -160.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.678 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 21.4 t -71.61 96.79 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 122.346 1.07 . . . . 0.0 109.187 -171.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.484 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 1.4 p -75.07 121.37 21.92 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 113.237 -1.801 . . . . 0.0 111.166 -176.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 62.4 m-70 -93.59 108.08 19.84 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.211 -176.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.549 ' CE2' HD21 ' A' ' 93' ' ' LEU . 66.6 m-85 -105.63 103.24 12.71 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.071 177.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.679 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 55.8 mt -78.33 133.47 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -174.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.554 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 4.2 mp -118.03 118.67 58.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 122.831 0.452 . . . . 0.0 111.275 -179.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -87.78 151.06 23.17 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.0 t -92.46 100.84 13.32 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 171.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.599 HD23 ' HD2' ' A' ' 72' ' ' LYS . 80.2 mt -78.61 137.16 58.99 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.663 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -63.3 -7.03 11.14 Favored 'Trans proline' 0 CA--C 1.529 0.237 0 C-N-CA 122.889 2.392 . . . . 0.0 112.238 177.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 -78.24 6.74 7.53 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.723 173.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.743 ' HA ' ' HE ' ' A' ' 69' ' ' ARG . 2.6 tpm_? 63.57 32.87 13.8 Favored 'General case' 0 N--CA 1.46 0.065 0 CA-C-O 122.009 0.909 . . . . 0.0 109.106 -173.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.793 ' HG2' ' HA ' ' A' ' 79' ' ' ASP . 69.6 mtt180 -120.78 179.39 4.37 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.692 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.554 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 54.0 m-85 -135.82 119.35 16.98 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.096 0.474 . . . . 0.0 111.379 -176.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.599 ' HD2' HD23 ' A' ' 66' ' ' LEU . 46.3 tttm -101.82 101.28 11.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.567 -172.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.679 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 7.0 tt -100.77 110.17 27.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.38 0.609 . . . . 0.0 111.444 -176.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.96 -55.39 3.51 Favored Glycine 0 CA--C 1.519 0.326 0 CA-C-N 115.396 -0.82 . . . . 0.0 113.263 177.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -165.4 -40.86 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -176.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.466 HE21 ' HB2' ' A' ' 76' ' ' GLN . 6.4 mt-30 -69.27 141.18 54.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.24 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.562 ' HG2' ' HG3' ' A' ' 72' ' ' LYS . 43.5 mt-10 -108.99 104.86 14.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.434 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.526 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 77.6 m-85 -100.26 160.41 14.35 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 176.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.793 ' HA ' ' HG2' ' A' ' 70' ' ' ARG . 6.0 m-20 -74.82 -32.79 62.07 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -174.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.765 ' HD1' ' HG2' ' A' ' 82' ' ' PRO . 1.2 p80 -153.22 166.44 32.54 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.473 0.178 . . . . 0.0 110.875 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.569 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 9.0 mt -57.23 -51.22 83.33 Favored Pre-proline 0 N--CA 1.466 0.328 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.865 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.765 ' HG2' ' HD1' ' A' ' 80' ' ' HIS . 23.4 Cg_endo -61.11 -10.69 15.93 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.118 1.879 . . . . 0.0 113.034 177.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.58 -36.3 16.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.672 0.272 . . . . 0.0 110.466 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.569 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.1 pp -76.49 -35.38 58.41 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 177.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.565 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 77.3 mt -62.07 -38.5 89.04 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.554 175.248 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.545 ' HA ' ' HD3' ' A' ' 89' ' ' LYS . 11.0 tp10 -67.55 -38.73 84.6 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.596 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -65.66 -37.99 88.06 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.216 0.531 . . . . 0.0 110.747 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.629 ' CD1' HD22 ' A' ' 93' ' ' LEU . 35.0 m-85 -81.25 -15.59 55.13 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.777 -177.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.565 ' HG3' ' O ' ' A' ' 85' ' ' LEU . 40.8 mtpt -64.72 -26.33 68.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.092 174.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.8 pp -114.48 8.48 7.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.421 -0.512 . . . . 0.0 112.349 174.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.404 ' CB ' ' HA ' ' A' ' 88' ' ' TYR . 6.2 t-160 -93.81 -37.95 11.5 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.747 0.308 . . . . 0.0 110.868 -176.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.48 ' N ' HG23 ' A' ' 97' ' ' THR . 58.8 m-85 67.41 84.55 0.15 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.275 -168.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.725 ' HA ' ' OE2' ' A' ' 154' ' ' GLU . 14.2 mt -53.98 -25.05 18.93 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 122.208 1.004 . . . . 0.0 110.888 175.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.522 ' CG ' ' HB3' ' A' ' 54' ' ' GLU . 0.4 OUTLIER -132.05 -91.6 0.4 Allowed 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 114.339 -1.3 . . . . 0.0 107.607 175.6 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.488 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 13.8 t -145.67 21.63 1.47 Allowed 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 172.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.431 ' O ' HD11 ' A' ' 99' ' ' ILE . 11.8 t -135.41 -21.85 1.54 Allowed 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 119.605 -0.838 . . . . 0.0 112.852 -174.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.48 HG23 ' N ' ' A' ' 92' ' ' TYR . 7.1 p 72.96 -162.2 0.1 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.02 0.928 . . . . 0.0 110.214 -173.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.443 HD21 ' CD2' ' A' ' 36' ' ' PHE . 81.5 mt -95.96 94.45 7.61 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.068 178.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.544 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 43.9 mm -76.52 -61.26 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.958 -176.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.528 ' O ' ' HA ' ' A' ' 35' ' ' MET . 11.3 pt-20 -161.66 151.8 14.32 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.569 178.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.37 159.04 55.25 Favored 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 122.892 2.395 . . . . 0.0 113.512 -177.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.454 ' HA ' ' SD ' ' A' ' 35' ' ' MET . . . -72.31 145.7 88.43 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.91 176.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.417 ' HB3' ' HG3' ' A' ' 106' ' ' PRO . 82.1 Cg_exo -50.24 120.91 6.82 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.696 2.264 . . . . 0.0 111.503 175.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.552 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 39.1 ttt180 -58.22 -66.89 0.41 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.776 -0.454 . . . . 0.0 109.776 -175.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -163.34 81.49 1.53 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.769 0.795 . . . . 0.0 110.272 171.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.417 ' HG3' ' HB3' ' A' ' 103' ' ' PRO . 71.0 Cg_endo -83.0 -50.98 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.153 1.902 . . . . 0.0 112.315 179.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 47.3 t -169.81 151.45 4.18 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -177.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -51.02 143.98 29.53 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.409 2.073 . . . . 0.0 111.544 173.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -52.37 105.36 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.127 2.552 . . . . 0.0 112.848 -176.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 52.0 ttm -119.02 -28.94 5.4 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.469 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -150.11 -118.91 0.91 Allowed Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.03 177.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 30.7 m 59.72 27.67 16.98 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.912 0.387 . . . . 0.0 111.378 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.3 m -103.85 1.32 10.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.223 0.535 . . . . 0.0 110.731 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.4 p -88.32 41.77 1.03 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.673 176.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.558 ' H ' ' HD2' ' A' ' 116' ' ' PRO . . . -157.94 -44.65 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.375 -177.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.558 ' HD2' ' H ' ' A' ' 115' ' ' ALA . 90.3 Cg_exo -48.32 121.31 6.03 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 122.195 1.93 . . . . 0.0 112.274 170.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.14 -178.77 4.3 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.473 178.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 119' ' ' PRO . 3.6 pp -70.76 153.13 95.02 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-O 121.07 0.462 . . . . 0.0 112.092 -172.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 118' ' ' LEU . 2.7 Cg_exo -76.71 163.81 31.08 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.156 2.571 . . . . 0.0 112.308 179.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 51.2 m -148.27 -50.21 0.17 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.312 175.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.458 ' HB2' ' HB2' ' A' ' 57' ' ' ARG . . . -95.09 71.12 3.32 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.103 0.478 . . . . 0.0 110.686 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -118.3 117.03 28.01 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.752 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 30.3 t70 72.21 3.91 4.83 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 123.88 0.737 . . . . 0.0 110.386 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.526 ' HB2' ' CD ' ' A' ' 183' ' ' ARG . 6.4 p30 -148.28 169.73 19.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.636 -178.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.583 ' CD1' HG23 ' A' ' 152' ' ' ILE . 1.9 mm? 61.24 90.34 0.07 Allowed 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.229 0.538 . . . . 0.0 111.547 -177.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 40.2 tt0 179.86 -39.73 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.341 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -124.38 119.82 30.32 Favored 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 119.839 -0.745 . . . . 0.0 110.302 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.713 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 56.0 t -134.63 144.07 35.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.976 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.758 ' NH2' ' HG ' ' A' ' 181' ' ' LEU . 0.0 OUTLIER -118.9 143.54 46.93 Favored 'General case' 0 CA--C 1.501 -0.928 0 C-N-CA 116.755 -1.978 . . . . 0.0 108.741 168.059 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.669 ' HG1' ' CD ' ' A' ' 148' ' ' GLU . 1.4 p -103.89 141.08 36.77 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.749 0.785 . . . . 0.0 111.005 -177.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.589 HD11 ' HG2' ' A' ' 179' ' ' GLU . 0.5 OUTLIER -116.43 -20.34 9.73 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.921 -173.652 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.424 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 37.3 t80 -83.85 -26.23 29.66 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.764 -171.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.454 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 12.6 t70 67.94 90.65 0.09 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.748 0.785 . . . . 0.0 110.204 -178.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.545 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 74.4 t80 -120.56 91.1 46.59 Favored Pre-proline 0 C--N 1.314 -0.976 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 176.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.683 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 92.7 Cg_endo -84.14 79.9 2.5 Favored 'Trans proline' 0 N--CA 1.444 -1.421 0 C-N-CA 121.832 1.688 . . . . 0.0 112.71 -176.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.15 -23.25 74.67 Favored Glycine 0 C--N 1.334 0.417 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.687 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 18.9 m120 62.77 31.92 16.26 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 122.669 0.387 . . . . 0.0 111.686 176.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.405 ' HB3' ' H ' ' A' ' 140' ' ' GLU . 0.2 OUTLIER -127.17 178.32 6.1 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.054 0.454 . . . . 0.0 111.586 -176.097 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -97.15 -10.49 25.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.634 172.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.657 ' O ' ' HB2' ' A' ' 172' ' ' MET . 46.4 mt-10 -113.14 -7.97 13.59 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.48 176.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -135.65 104.63 5.86 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 173.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.755 ' CD1' ' HB2' ' A' ' 165' ' ' ASN . 52.5 tp -70.83 129.24 89.95 Favored Pre-proline 0 CA--C 1.509 -0.621 0 CA-C-O 120.837 0.351 . . . . 0.0 110.83 -172.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.683 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 47.6 Cg_endo -80.21 96.46 1.02 Allowed 'Trans proline' 0 N--CA 1.436 -1.899 0 C-N-CA 121.01 1.14 . . . . 0.0 111.544 168.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.626 ' HB2' ' OG1' ' A' ' 130' ' ' THR . 9.0 p90 -107.18 159.87 16.01 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.857 ' H ' ' HG3' ' A' ' 148' ' ' GLU . 4.1 mppt? -111.09 -140.34 0.38 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.368 0.604 . . . . 0.0 111.818 -175.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.723 ' N ' ' HD3' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -116.58 55.72 0.81 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.276 -177.019 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 135.6 23.86 0.56 Allowed Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.244 -0.889 . . . . 0.0 113.055 174.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.857 ' HG3' ' H ' ' A' ' 145' ' ' LYS . 0.0 OUTLIER -74.73 164.83 26.14 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 169.694 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.501 HD12 ' HB3' ' A' ' 129' ' ' ARG . 0.4 OUTLIER -107.86 132.12 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 173.392 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.693 HD23 ' CD2' ' A' ' 142' ' ' LEU . 37.9 mt -118.54 154.69 32.15 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -176.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.525 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 98.0 t -121.98 122.83 67.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.583 HG23 ' CD1' ' A' ' 125' ' ' LEU . 44.4 mm -75.0 83.27 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -175.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.584 HD13 ' HD3' ' A' ' 164' ' ' ARG . 16.4 tt -75.3 -27.94 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 CA-C-N 113.398 -1.728 . . . . 0.0 110.134 -171.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.725 ' OE2' ' HA ' ' A' ' 93' ' ' LEU . 1.8 mt-10 -135.66 141.05 44.95 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 170.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.558 ' HD2' ' HG ' ' A' ' 125' ' ' LEU . 58.6 tttp -130.1 91.53 38.97 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 122.047 -0.408 . . . . 0.0 111.202 173.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.548 ' HG2' ' HE1' ' A' ' 172' ' ' MET . 8.4 Cg_exo -77.59 -45.14 0.16 Allowed 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.656 2.237 . . . . 0.0 112.285 171.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -117.83 -178.61 3.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.152 0.501 . . . . 0.0 111.832 -170.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.488 ' O ' HG22 ' A' ' 175' ' ' VAL . 2.6 mm-40 -106.39 -19.1 13.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.485 174.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -95.5 -28.68 14.77 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.735 0.302 . . . . 0.0 111.547 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.506 ' O ' ' HD1' ' A' ' 161' ' ' TRP . 42.6 m95 -124.22 137.91 54.46 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 174.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . 0.717 ' O ' HG13 ' A' ' 173' ' ' ILE . 45.8 m0 -124.37 140.0 53.37 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-O 121.025 0.441 . . . . 0.0 111.007 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.541 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 19.4 m -97.94 97.02 8.58 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -174.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.522 ' HB2' ' HB3' ' A' ' 150' ' ' LEU . . . -110.93 148.68 31.95 Favored 'General case' 0 N--CA 1.425 -1.695 0 C-N-CA 119.846 -0.742 . . . . 0.0 109.903 -174.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.834 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 17.2 ptt-85 -86.86 122.29 30.53 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 173.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.755 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . 63.8 t30 -56.38 177.44 0.07 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.005 -1.452 . . . . 0.0 110.443 -174.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 46.8 tttt -63.66 -12.76 36.56 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.759 169.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -74.16 -30.38 62.23 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.186 0.517 . . . . 0.0 109.745 168.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 97.26 15.85 36.96 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.462 -171.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.834 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 2.5 ttm-85 -95.43 139.0 32.34 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 122.785 0.434 . . . . 0.0 111.457 -177.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.501 HG22 HD12 ' A' ' 153' ' ' ILE . 39.2 t -78.71 130.98 35.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.202 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -162.93 155.27 26.55 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.501 166.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.657 ' HB2' ' O ' ' A' ' 140' ' ' GLU . 0.2 OUTLIER -76.9 140.56 40.58 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 117.057 0.428 . . . . 0.0 111.042 178.854 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.717 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.4 pp -142.0 146.7 41.51 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.343 -176.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.592 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 5.3 Cg_exo -77.02 130.34 11.21 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.85 2.367 . . . . 0.0 112.746 -176.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.541 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 87.0 t -62.02 -42.2 80.48 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 24.6 Cg_endo -63.36 -0.12 2.13 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 121.948 1.766 . . . . 0.0 112.969 175.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.592 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.3 m-85 -97.07 -16.4 20.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.399 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.638 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 2.4 m -112.11 -173.52 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 117.712 2.486 . . . . 0.0 117.712 -160.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.63 ' HB2' ' O ' ' A' ' 129' ' ' ARG . 2.1 mm-40 -139.96 49.35 1.77 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 111.558 -2.565 . . . . 0.0 115.654 -161.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.713 ' HA ' ' HA ' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -69.51 134.35 48.77 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 124.366 3.257 . . . . 0.0 111.879 -158.69 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.758 ' HG ' ' NH2' ' A' ' 129' ' ' ARG . 0.3 OUTLIER -69.65 -65.41 0.72 Allowed 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 110.755 -2.93 . . . . 0.0 111.997 -170.483 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 29.5 m -93.46 17.44 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.485 0.66 . . . . 0.0 110.839 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.571 ' O ' ' HB2' ' A' ' 180' ' ' LYS . 4.6 tpt180 -142.39 108.93 5.33 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.212 -173.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 20.7 p -81.74 -164.04 0.73 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.778 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' SER . . . . . 0.522 ' HB2' ' HD2' ' A' ' 186' ' ' PRO . 2.9 p -65.18 166.3 13.69 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 173.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.522 ' HD2' ' HB2' ' A' ' 185' ' ' SER . 10.0 Cg_endo -51.21 107.48 0.18 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.984 2.456 . . . . 0.0 112.996 -179.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -131.27 -7.34 3.8 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.158 176.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 82.6 -79.4 1.89 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.138 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.427 ' O ' ' HB3' ' A' ' 190' ' ' HIS . 18.3 ptpt -85.08 -5.7 59.34 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.545 0.202 . . . . 0.0 111.545 -176.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . 0.427 ' HB3' ' O ' ' A' ' 189' ' ' LYS . 9.1 t-160 71.05 -52.51 0.68 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.975 0.51 . . . . 0.0 110.985 -175.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.62 ' HA3' HD22 ' A' ' 194' ' ' ASN . . . 145.79 159.97 8.43 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.228 176.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . 0.408 ' O ' ' HD3' ' A' ' 193' ' ' ARG . 33.0 t30 -72.39 -75.08 0.14 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.887 0.375 . . . . 0.0 110.793 177.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 193' ' ' ARG . 35.3 mmt180 -130.0 81.05 1.99 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.082 0.467 . . . . 0.0 110.311 -178.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.62 HD22 ' HA3' ' A' ' 191' ' ' GLY . 5.2 p30 -150.71 103.45 3.1 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.456 0.646 . . . . 0.0 110.131 177.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 6.7 m -82.22 -44.48 16.3 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.844 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -92.67 127.31 38.13 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.118 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 23.6 t -85.02 24.5 1.07 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.048 0.451 . . . . 0.0 110.507 -178.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -111.64 12.3 21.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.122 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -85.67 44.96 3.42 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.134 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 50.1 mm -111.14 121.79 39.62 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-O 120.571 0.224 . . . . 0.0 110.454 -177.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -74.41 87.13 1.26 Allowed 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.526 2.15 . . . . 0.0 112.311 177.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.517 ' N ' ' HD2' ' A' ' 203' ' ' PRO . 41.3 mm-40 -82.44 -50.48 0.79 Allowed Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.758 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 202' ' ' GLU . 13.3 Cg_endo -57.1 129.64 35.42 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 122.11 1.873 . . . . 0.0 112.133 177.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -120.71 140.49 51.56 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.029 -176.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 13.3 p-80 -140.88 153.91 45.92 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.484 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -99.59 -45.51 5.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.017 0.437 . . . . 0.0 110.155 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -142.68 110.77 5.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.519 177.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -78.04 129.11 34.85 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 174.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 68.31 93.19 0.06 OUTLIER Pre-proline 0 C--O 1.233 0.235 0 O-C-N 123.847 0.717 . . . . 0.0 110.43 -175.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.63 -43.92 35.48 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.797 2.331 . . . . 0.0 112.734 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -100.66 81.77 2.35 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.06 0.457 . . . . 0.0 110.528 -178.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 12.2 t -99.27 -34.66 10.24 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.837 173.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 75.1 m -159.29 101.96 1.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.676 174.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.408 ' HA ' ' HD3' ' A' ' 215' ' ' PRO . 9.2 t -177.4 140.93 0.45 Allowed Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.494 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 214' ' ' THR . 17.2 Cg_exo -68.03 143.52 60.34 Favored 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 122.435 2.09 . . . . 0.0 110.967 173.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.91 ' HB3' ' HD3' ' A' ' 217' ' ' PRO . 47.1 tp -141.42 -61.47 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.53 0 C-N-CA 121.024 -0.27 . . . . 0.0 111.413 -177.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.91 ' HD3' ' HB3' ' A' ' 216' ' ' LEU . 1.5 Cg_endo -83.92 -46.19 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 121.922 1.748 . . . . 0.0 112.607 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . 66.14 178.22 0.21 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.943 -173.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 43.8 t -115.87 -52.21 4.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.941 0.401 . . . . 0.0 111.098 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 2.6 p -91.85 116.27 28.76 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -171.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 84.35 -51.82 4.62 Favored Glycine 0 C--N 1.33 0.197 0 CA-C-N 116.07 -0.514 . . . . 0.0 114.053 168.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.65 ' HB3' ' HD3' ' A' ' 223' ' ' PRO . 20.9 t -53.58 -55.1 38.54 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -175.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.65 ' HD3' ' HB3' ' A' ' 222' ' ' SER . 4.4 Cg_endo -83.53 37.52 0.66 Allowed 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.117 1.878 . . . . 0.0 112.242 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -149.83 64.71 0.39 Allowed Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.871 -178.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -79.27 105.25 10.46 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.8 0.333 . . . . 0.0 110.176 178.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -70.66 146.63 49.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.613 -176.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 49.2 mm -103.27 121.88 55.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.998 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 5.9 t -81.81 133.55 51.83 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 120.686 0.279 . . . . 0.0 110.758 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -72.05 -176.68 2.23 Favored 'Trans proline' 0 C--O 1.237 0.459 0 C-N-CA 122.556 2.17 . . . . 0.0 111.994 174.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 9.6 mp 66.59 107.78 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.359 0 C-N-CA 123.192 0.597 . . . . 0.0 111.15 -176.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -55.18 -48.24 21.99 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.81 2.34 . . . . 0.0 111.411 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 7.0 t 179.17 152.46 0.38 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.01 175.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 7.6 p -144.15 -102.01 0.11 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.811 0.338 . . . . 0.0 110.761 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 175.25 -68.63 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . 0.41 ' HB3' ' H ' ' A' ' 236' ' ' GLY . 89.6 m-20 53.33 -155.01 0.22 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.478 175.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . 0.41 ' H ' ' HB3' ' A' ' 235' ' ' ASN . . . -139.3 81.15 0.27 Allowed Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.952 177.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -65.14 105.71 0.72 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.39 2.06 . . . . 0.0 110.156 175.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.1 t -66.81 135.6 28.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.24 -170.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -104.05 123.42 47.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.688 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -119.32 124.22 46.1 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 175.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.645 ' HB2' ' CE1' ' A' ' 294' ' ' PHE . 44.8 tttp -88.19 119.92 29.05 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -176.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -67.74 110.82 3.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.013 0.435 . . . . 0.0 110.254 -178.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 21.1 pt -85.16 1.42 4.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.122 0.486 . . . . 0.0 111.207 -174.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -158.13 152.12 24.01 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.866 178.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.892 ' HG3' HG22 ' A' ' 260' ' ' VAL . 54.6 mtmt -78.67 120.72 23.75 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.135 0.493 . . . . 0.0 110.625 177.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.62 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 22.6 ttt85 -113.01 109.67 19.23 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.843 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 29.5 m -102.69 143.05 25.82 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 177.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.514 ' HD3' ' HB2' ' A' ' 257' ' ' ALA . 55.2 Cg_endo -70.46 151.59 65.18 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 122.461 2.107 . . . . 0.0 112.764 -177.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 46.0 t -89.09 168.26 12.47 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 174.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -55.84 -41.03 73.69 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.657 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -95.44 8.23 43.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.91 0.386 . . . . 0.0 111.452 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.43 ' HB3' ' HB1' ' A' ' 255' ' ' ALA . 8.5 m-20 -110.82 73.47 0.82 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.851 0.358 . . . . 0.0 111.017 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -72.95 -24.73 60.84 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-O 121.269 0.557 . . . . 0.0 110.146 175.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 1.1 p -86.48 11.0 13.53 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.709 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.43 ' HB1' ' HB3' ' A' ' 252' ' ' ASP . . . -99.92 116.6 32.36 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.847 0.356 . . . . 0.0 110.515 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.55 137.46 40.85 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.085 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.62 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -91.75 128.66 37.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.169 177.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 69.4 mt -132.04 149.3 52.45 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.146 -173.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.775 ' HA ' ' HG2' ' A' ' 245' ' ' LYS . 64.5 mm-40 -101.54 167.77 9.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.604 178.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . 0.892 HG22 ' HG3' ' A' ' 245' ' ' LYS . 60.0 t -74.89 115.94 16.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 176.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . 0.533 ' HA2' ' HE3' ' A' ' 241' ' ' LYS . . . 99.71 -2.76 57.27 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.635 -177.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -71.75 151.93 43.15 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -174.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 43.0 mm -103.75 109.05 25.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.107 0.48 . . . . 0.0 110.907 -175.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.453 ' HA ' HG21 ' A' ' 279' ' ' VAL . 39.1 t -82.77 105.27 12.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.103 178.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -91.07 98.95 12.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.583 178.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 4.8 p -92.13 123.12 44.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.414 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 6.6 p -96.54 -33.01 11.98 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.654 -177.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 32.6 mtm180 -131.9 126.03 33.15 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.412 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' MET . . . . . 0.532 ' HE3' ' CE3' ' A' ' 275' ' ' TRP . 38.3 mtt -105.04 121.28 43.45 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.183 0.516 . . . . 0.0 111.127 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 274' ' ' GLN . 79.4 m-20 -88.72 120.68 30.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.536 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 32.1 mm -76.35 80.84 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.333 0.587 . . . . 0.0 110.389 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . 0.783 HD22 ' HG2' ' A' ' 274' ' ' GLN . 3.3 p-10 -163.14 -37.55 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.622 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 131.4 28.73 0.62 Allowed Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.179 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.783 ' HG2' HD22 ' A' ' 272' ' ' ASN . 2.4 pt20 -159.79 113.51 2.24 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 168.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.532 ' CE3' ' HE3' ' A' ' 269' ' ' MET . 3.6 m0 -93.68 158.21 15.79 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 122.16 -0.337 . . . . 0.0 110.454 -175.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -101.06 108.45 20.15 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -132.44 136.45 8.75 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 177.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -114.69 114.62 25.89 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.987 0.423 . . . . 0.0 110.022 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . 0.453 HG21 ' HA ' ' A' ' 264' ' ' VAL . 28.4 t -118.94 -78.69 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.195 0.522 . . . . 0.0 111.147 -175.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -86.58 60.7 6.38 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.22 -173.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 71.66 2.05 48.58 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.489 -0.778 . . . . 0.0 113.111 177.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 44.5 mtp180 -139.91 137.91 35.21 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.389 -0.226 . . . . 0.0 110.389 -175.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.454 ' HB3' ' NZ ' ' A' ' 283' ' ' LYS . 0.1 OUTLIER -91.92 125.15 36.51 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 168.391 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -142.52 162.0 27.34 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.241 -0.981 . . . . 0.0 112.07 -176.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 67.3 mt -95.23 131.76 40.93 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.125 0.488 . . . . 0.0 109.917 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -123.47 149.95 59.67 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.34 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . 0.539 ' HD3' ' CZ ' ' A' ' 246' ' ' ARG . 76.8 Cg_endo -83.59 16.12 1.97 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.729 2.286 . . . . 0.0 113.496 -171.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.534 ' CZ ' ' HA ' ' A' ' 274' ' ' GLN . 2.8 m-85 66.46 -40.98 0.37 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.041 0.936 . . . . 0.0 113.11 177.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 1.7 m -66.63 -16.57 64.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.974 0.416 . . . . 0.0 111.973 -177.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -89.94 -3.82 57.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.861 0.362 . . . . 0.0 110.787 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 33.6 m -127.12 165.68 25.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -130.7 115.95 17.38 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -84.55 138.65 18.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -177.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' PHE . . . . . 0.645 ' CE1' ' HB2' ' A' ' 241' ' ' LYS . 0.8 OUTLIER -159.57 174.2 14.98 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.729 -171.537 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -92.08 105.06 12.34 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 172.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -78.37 -15.64 14.02 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.085 1.856 . . . . 0.0 111.819 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -124.84 -28.01 3.55 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.902 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 19.2 m120 60.42 92.1 0.07 OUTLIER Pre-proline 0 N--CA 1.465 0.292 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.29 -173.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -76.48 21.3 0.56 Allowed 'Trans proline' 0 CA--C 1.528 0.198 0 C-N-CA 122.943 2.428 . . . . 0.0 113.202 -176.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -72.85 -56.17 5.59 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 176.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -93.45 34.5 1.16 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.55 176.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -53.16 -54.07 41.27 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.889 -174.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.306 -0.854 . . . . 0.0 109.66 -178.577 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 120.677 0.275 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.7 m -88.31 141.21 28.73 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 174.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.439 ' O ' HG21 ' A' ' 99' ' ' ILE . 3.1 t -73.52 -45.81 51.5 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 176.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.51 106.65 11.69 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.631 175.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 5' ' ' ARG . 1.6 tpp180 -140.45 91.55 2.45 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.409 0.623 . . . . 0.0 110.904 -177.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.613 ' CE1' ' HE2' ' A' ' 89' ' ' LYS . 29.1 p90 -161.74 154.59 20.44 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.08 -0.963 . . . . 0.0 108.91 178.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -79.87 111.82 16.56 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.1 m -65.13 -13.18 57.47 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.222 -173.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.1 m -103.9 -20.55 13.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.788 0.328 . . . . 0.0 111.729 -178.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -73.91 92.93 2.13 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.323 0.582 . . . . 0.0 111.041 -175.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.8 mtm-85 -64.27 -23.32 67.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.121 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.5 m -70.1 -9.14 54.54 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.778 0.323 . . . . 0.0 110.802 177.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -100.48 -47.95 4.72 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.673 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 43.7 p-90 -113.24 -20.9 11.23 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -171.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -75.32 107.39 7.4 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.089 -0.644 . . . . 0.0 109.763 -178.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.766 ' SD ' ' HA ' ' A' ' 104' ' ' ARG . 10.8 tpp -86.71 -10.83 52.81 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.796 -172.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 51.3 -112.79 1.91 Allowed Glycine 0 CA--C 1.522 0.51 0 CA-C-N 115.476 -0.784 . . . . 0.0 114.721 175.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.17 70.06 1.29 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.562 2.841 . . . . 0.0 114.037 -173.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.648 HG22 ' HG3' ' A' ' 16' ' ' MET . 60.0 t -130.76 172.26 16.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 176.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.583 ' H ' HG11 ' A' ' 19' ' ' VAL . 89.6 p -145.08 -176.68 5.19 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 -169.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 26.7 ttt85 -68.08 -41.57 81.71 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.902 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -65.79 -48.92 70.17 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.4 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -65.65 -48.11 73.28 Favored 'General case' 0 C--O 1.221 -0.399 0 O-C-N 122.423 -0.173 . . . . 0.0 111.357 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.573 ' HB1' ' O ' ' A' ' 20' ' ' SER . . . -57.77 -46.94 83.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.7 0.286 . . . . 0.0 111.507 -177.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.536 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 51.5 tp60 -59.2 -42.57 91.24 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.814 178.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.7 m -62.3 -43.24 99.27 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.774 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.534 ' O ' ' HG3' ' A' ' 31' ' ' GLN . 46.2 mtt180 -74.01 -13.83 60.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.796 -174.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.574 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 37.8 mt -124.99 2.23 8.01 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.121 0.486 . . . . 0.0 111.275 -176.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.536 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 29.8 tp60 -71.14 96.11 1.32 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.649 -176.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.1 20.83 75.02 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.391 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.534 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 4.6 mm100 -87.98 -176.14 5.35 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.562 0.22 . . . . 0.0 110.431 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.802 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 50.4 ttp180 -55.79 133.41 51.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.074 177.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -83.66 140.73 31.99 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.904 0.383 . . . . 0.0 110.367 -174.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.58 -10.91 53.65 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.169 -173.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.802 ' SD ' ' HB3' ' A' ' 32' ' ' ARG . 24.8 mtp -79.81 140.07 36.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.475 -0.363 . . . . 0.0 110.436 177.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.454 ' HB2' HD13 ' A' ' 50' ' ' LEU . 45.1 p90 -146.58 163.66 35.1 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.124 -176.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.672 ' HB2' ' HB2' ' A' ' 16' ' ' MET . 4.2 pp -152.04 133.63 14.67 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.17 0.51 . . . . 0.0 110.966 175.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 56.1 t -101.84 106.9 20.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 174.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.6 ptt-85 -108.87 179.41 4.19 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.216 -175.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -79.66 138.54 37.41 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 172.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.447 ' HB3' ' O ' ' A' ' 44' ' ' CYS . 46.1 t -60.38 137.05 58.2 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.343 0.592 . . . . 0.0 111.92 -173.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.9 m -87.82 -4.47 58.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.756 -178.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.0 p -112.53 -45.91 3.2 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.901 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.447 ' O ' ' HB3' ' A' ' 41' ' ' SER . 39.2 m -131.17 90.45 38.7 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.493 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -52.77 133.68 51.49 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.887 2.391 . . . . 0.0 111.804 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 111.46 -41.66 2.17 Favored Glycine 0 CA--C 1.505 -0.566 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -172.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -79.48 177.16 9.07 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 167.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.542 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 39.2 m-85 -134.66 174.5 10.49 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 118.477 0.581 . . . . 0.0 110.916 -176.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.5 t -144.67 108.09 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.922 0.392 . . . . 0.0 110.706 175.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.454 HD13 ' HB2' ' A' ' 36' ' ' PHE . 48.4 tp -77.54 103.21 7.34 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.881 173.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.5 m -96.42 127.4 42.38 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 175.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 89.2 t -118.85 138.58 49.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.937 0.399 . . . . 0.0 111.085 -175.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.574 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 32.3 t -87.67 113.66 23.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.578 -176.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.631 ' HG3' HG21 ' A' ' 95' ' ' THR . 0.0 OUTLIER -149.47 137.29 20.35 Favored 'General case' 0 C--O 1.205 -1.249 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.241 172.921 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.427 HD21 ' CD ' ' A' ' 54' ' ' GLU . 75.8 m-20 56.53 27.13 11.85 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 173.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.411 ' HB2' ' HB1' ' A' ' 121' ' ' ALA . 49.0 m 57.74 53.06 7.45 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 122.516 1.15 . . . . 0.0 108.189 -175.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.648 HH22 ' HA ' ' A' ' 154' ' ' GLU . 6.0 ttp180 -167.98 64.81 0.07 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 113.133 -1.849 . . . . 0.0 109.246 -153.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 37.3 t -70.25 107.07 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 122.333 1.063 . . . . 0.0 110.142 -167.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 45.5 m -75.71 121.74 22.97 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 113.304 -1.771 . . . . 0.0 110.533 -176.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -99.01 115.32 28.68 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -173.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.468 ' CE2' HD12 ' A' ' 93' ' ' LEU . 44.0 m-85 -112.14 107.88 16.95 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.586 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.525 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 65.4 mt -80.77 127.9 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -173.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.542 ' HB ' ' HB2' ' A' ' 48' ' ' TYR . 3.8 mp -102.43 119.32 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 122.947 0.499 . . . . 0.0 111.209 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.536 ' HB2' ' HB3' ' A' ' 72' ' ' LYS . 0.8 OUTLIER -87.77 134.81 33.6 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.999 -178.818 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.0 t -83.7 86.1 7.18 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 172.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.491 HD11 ' HB2' ' A' ' 70' ' ' ARG . 83.0 mt -70.21 137.96 86.89 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.778 -176.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -61.85 -16.2 47.7 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.914 2.409 . . . . 0.0 111.394 176.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.8 m-20 -81.47 7.98 10.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.222 178.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.775 ' HA ' ' HE ' ' A' ' 69' ' ' ARG . 2.9 mmp_? 64.51 36.59 8.58 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.812 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.491 ' HB2' HD11 ' A' ' 66' ' ' LEU . 82.1 mtm-85 -126.38 179.17 5.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.271 177.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.488 ' HB3' HG21 ' A' ' 63' ' ' ILE . 57.0 m-85 -136.35 116.7 13.63 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.019 0.438 . . . . 0.0 111.156 -176.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 77' ' ' GLU . 24.2 ttmm -99.73 116.06 30.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.217 -176.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.525 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 18.5 tt -93.52 92.37 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 121.995 0.902 . . . . 0.0 111.345 -176.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 75' ' ' ASP . . . 77.76 -15.7 7.61 Favored Glycine 0 CA--C 1.517 0.203 0 CA-C-N 115.191 -0.913 . . . . 0.0 113.959 174.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 74' ' ' GLY . 22.3 t70 161.35 -55.24 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.607 0.717 . . . . 0.0 109.167 -171.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -71.27 118.78 14.49 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.63 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.573 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 14.3 pt-20 -105.89 134.44 49.01 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.751 0.786 . . . . 0.0 111.785 -175.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.45 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 88.9 m-85 -112.45 -177.47 3.16 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.848 176.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -78.54 -28.67 46.09 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 121.136 -0.226 . . . . 0.0 111.208 -176.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -171.02 174.31 4.76 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 173.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.533 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 13.1 mt -53.9 -56.47 25.25 Favored Pre-proline 0 N--CA 1.471 0.582 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -176.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.533 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 38.9 Cg_exo -61.23 -10.14 14.7 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 122.175 1.917 . . . . 0.0 112.81 -177.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.5 -36.02 15.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.798 -178.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.0 pp -75.44 -34.58 60.97 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.561 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 92.0 mt -64.85 -25.93 68.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.377 177.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -87.27 -34.21 18.99 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.463 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -70.35 -36.87 74.47 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.299 0.571 . . . . 0.0 110.56 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.81 ' CG ' HD22 ' A' ' 93' ' ' LEU . 27.1 m-85 -77.32 -9.41 58.81 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.197 -177.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.613 ' HE2' ' CE1' ' A' ' 6' ' ' PHE . 99.0 mttt -68.1 -12.5 60.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.919 0.39 . . . . 0.0 111.221 177.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 24.2 pt -134.55 18.86 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 121.368 0.604 . . . . 0.0 109.492 -178.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.427 ' O ' ' HB2' ' A' ' 92' ' ' TYR . 4.0 t60 -116.55 -40.66 3.18 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.969 -175.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.427 ' HB2' ' O ' ' A' ' 91' ' ' HIS . 52.6 m-85 68.85 114.21 0.04 OUTLIER 'General case' 0 N--CA 1.461 0.104 0 O-C-N 124.291 0.995 . . . . 0.0 109.115 -169.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.81 HD22 ' CG ' ' A' ' 88' ' ' TYR . 0.8 OUTLIER -109.18 -7.39 15.3 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.055 -0.658 . . . . 0.0 111.099 176.347 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 1.058 ' HA ' ' HB3' ' A' ' 154' ' ' GLU . 0.5 OUTLIER -159.52 81.42 0.74 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.143 0.497 . . . . 0.0 111.166 170.372 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.693 ' CB ' ' HA ' ' A' ' 156' ' ' PRO . 2.3 t 47.67 3.79 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 125.208 1.403 . . . . 0.0 113.858 -176.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.509 ' H ' ' C ' ' A' ' 94' ' ' ASP . 14.6 t -153.76 168.16 27.22 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 32.5 p -101.85 178.46 4.61 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 177.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.1 mt -75.11 96.19 3.21 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 176.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.439 HG21 ' O ' ' A' ' 3' ' ' SER . 37.5 mm -82.15 -63.68 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.707 -173.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.62 ' O ' ' HA ' ' A' ' 35' ' ' MET . 33.3 tt0 -153.33 137.13 10.41 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.16 -178.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -57.33 162.57 9.62 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 123.087 2.524 . . . . 0.0 113.248 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.437 ' HB1' HD21 ' A' ' 28' ' ' LEU . . . -78.16 157.98 77.67 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.198 178.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.93 107.52 0.23 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.452 2.101 . . . . 0.0 112.089 177.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.766 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 65.0 ttt180 -60.34 -55.18 36.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.705 178.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -101.02 129.34 27.43 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.827 174.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.27 110.86 0.57 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.909 2.406 . . . . 0.0 112.548 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.1 p -96.57 149.2 35.53 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.113 177.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -56.4 128.36 29.79 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.598 2.199 . . . . 0.0 112.188 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.99 -9.98 27.39 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.926 2.417 . . . . 0.0 112.438 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 61.3 mtt -71.5 95.79 1.43 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.427 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 138.19 -66.64 0.53 Allowed Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.602 -178.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 51.0 m -81.51 53.45 2.1 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.294 0.569 . . . . 0.0 110.839 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 22.7 m -81.81 -23.23 9.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.904 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.539 ' HB3' ' HB3' ' A' ' 210' ' ' PRO . 41.2 m -98.03 12.24 34.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.967 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.578 ' HB1' ' HD3' ' A' ' 116' ' ' PRO . . . -79.99 -50.99 1.15 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.424 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.578 ' HD3' ' HB1' ' A' ' 115' ' ' ALA . 11.0 Cg_exo -71.21 86.79 0.77 Allowed 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 122.015 1.81 . . . . 0.0 112.317 178.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -89.97 119.4 30.3 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 174.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -148.03 149.57 33.08 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-O 120.708 0.29 . . . . 0.0 111.17 -176.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -89.79 9.08 3.47 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.408 2.739 . . . . 0.0 111.766 173.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.9 m 67.03 42.73 2.32 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.519 0.676 . . . . 0.0 111.071 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.411 ' HB1' ' HB2' ' A' ' 56' ' ' SER . . . 63.27 -171.51 0.17 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.579 174.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.438 ' HB3' ' H ' ' A' ' 123' ' ' ASP . 38.9 mt-10 -130.2 -160.33 1.03 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.664 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.438 ' H ' ' HB3' ' A' ' 122' ' ' GLU . 7.1 p-10 -86.11 -19.74 29.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.85 -175.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -174.28 -93.11 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 175.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.451 ' HA ' HD12 ' A' ' 125' ' ' LEU . 2.6 mm? 59.07 93.51 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.657 0.741 . . . . 0.0 111.351 -171.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.562 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 46.5 tt0 -169.37 -77.12 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.561 -176.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -104.74 107.67 18.75 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 121.611 0.719 . . . . 0.0 110.773 -177.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.764 HG21 ' CG ' ' A' ' 180' ' ' LYS . 65.7 t -123.48 130.67 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 CA-C-N 114.448 -1.251 . . . . 0.0 108.882 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.675 ' HG3' ' HB3' ' A' ' 179' ' ' GLU . 5.2 ptp180 -108.6 149.65 28.6 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 116.831 -1.947 . . . . 0.0 108.196 171.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.481 ' HB ' ' CD1' ' A' ' 144' ' ' PHE . 0.8 OUTLIER -106.12 129.56 54.18 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.102 -178.734 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 1.016 HD12 ' HG2' ' A' ' 179' ' ' GLU . 16.8 mt -104.08 -21.17 13.63 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -174.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.419 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 59.2 t80 -77.31 -35.18 55.14 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -172.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.567 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 23.0 t70 70.77 94.72 0.07 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.633 0.73 . . . . 0.0 109.784 -174.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.517 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 37.1 t80 -126.69 86.39 58.66 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.562 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 90.8 Cg_endo -88.89 79.36 1.01 Allowed 'Trans proline' 0 N--CA 1.441 -1.563 0 C-N-CA 121.896 1.731 . . . . 0.0 112.66 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.51 -22.5 75.02 Favored Glycine 0 CA--C 1.51 -0.248 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 175.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.816 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 1.0 OUTLIER 57.43 73.12 0.48 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.09 -1.055 . . . . 0.0 110.997 -175.704 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.511 ' HB3' ' H ' ' A' ' 141' ' ' ASP . 0.6 OUTLIER -141.26 -173.65 3.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.394 0.616 . . . . 0.0 111.545 -178.588 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -114.99 1.9 14.1 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.674 167.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.549 ' O ' ' HB2' ' A' ' 172' ' ' MET . 40.3 mt-10 -116.35 -41.18 3.15 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.994 175.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.511 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 9.2 m-20 -101.86 114.25 28.17 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 167.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.673 ' CD2' HD23 ' A' ' 150' ' ' LEU . 35.2 tp -69.92 127.64 92.31 Favored Pre-proline 0 N--CA 1.465 0.324 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.816 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 6.5 Cg_endo -82.02 90.23 1.14 Allowed 'Trans proline' 0 N--CA 1.443 -1.497 0 C-N-CA 121.956 1.771 . . . . 0.0 110.752 173.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.529 ' CE2' ' HB ' ' A' ' 173' ' ' ILE . 9.1 p90 -102.39 155.04 18.51 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.317 -175.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.567 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 99.0 mttt -99.92 -166.65 1.36 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.235 0.54 . . . . 0.0 112.427 -174.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.777 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -83.71 5.29 25.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.288 -169.42 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -179.07 37.59 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.996 176.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.504 ' OE1' ' HA ' ' A' ' 144' ' ' PHE . 1.2 pt-20 -96.59 148.92 22.35 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.751 -174.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.493 HD13 ' N ' ' A' ' 149' ' ' ILE . 1.7 mp -87.58 128.58 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.673 HD23 ' CD2' ' A' ' 142' ' ' LEU . 16.6 mt -121.7 156.63 32.67 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 -178.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.562 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 49.2 t -119.51 123.43 71.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 174.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.46 ' HA ' ' HA ' ' A' ' 163' ' ' ALA . 50.4 mm -73.92 94.53 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 -176.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.581 HD13 ' HD3' ' A' ' 164' ' ' ARG . 18.7 tt -79.33 -26.34 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.547 -173.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 1.058 ' HB3' ' HA ' ' A' ' 94' ' ' ASP . 0.0 OUTLIER -141.0 145.56 36.11 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.454 169.123 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -121.86 84.93 44.63 Favored Pre-proline 0 C--N 1.318 -0.784 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 167.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.693 ' HA ' ' CB ' ' A' ' 95' ' ' THR . 13.0 Cg_exo -70.42 -47.73 0.69 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.603 2.202 . . . . 0.0 111.824 177.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -118.15 177.29 4.85 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.589 -174.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.424 ' O ' HG23 ' A' ' 175' ' ' VAL . 13.3 pt-20 -92.98 -34.76 13.62 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.556 -176.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -98.74 -10.42 23.15 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.865 0.364 . . . . 0.0 111.66 -176.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.527 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 59.1 m95 -124.36 134.83 53.03 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 172.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . 0.773 ' O ' HG13 ' A' ' 173' ' ' ILE . 50.7 m0 -123.99 133.81 53.6 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.144 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.749 ' HB2' ' HG3' ' A' ' 154' ' ' GLU . 50.5 m -93.82 98.47 11.1 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -173.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.555 ' HB2' ' HB3' ' A' ' 150' ' ' LEU . . . -112.33 146.09 38.88 Favored 'General case' 0 N--CA 1.419 -1.998 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.701 -172.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.722 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 15.1 ptt180 -87.0 120.62 28.46 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 175.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.636 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . 20.7 t30 -52.52 176.85 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 113.455 -1.702 . . . . 0.0 111.753 -173.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 45.5 tptt -58.46 -21.02 49.96 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 169.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -77.38 -28.89 52.97 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.614 175.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 100.17 7.56 52.06 Favored Glycine 0 CA--C 1.519 0.333 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.119 -174.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.722 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.4 OUTLIER -79.9 135.72 36.49 Favored 'General case' 0 C--O 1.22 -0.498 0 C-N-CA 122.819 0.448 . . . . 0.0 111.217 -179.621 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.495 HG23 HG22 ' A' ' 153' ' ' ILE . 47.9 t -81.08 123.34 37.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 C-N-CA 121.119 -0.232 . . . . 0.0 111.252 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -158.06 146.29 13.13 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.865 171.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.549 ' HB2' ' O ' ' A' ' 140' ' ' GLU . 0.0 OUTLIER -68.97 141.06 55.03 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 122.922 0.489 . . . . 0.0 111.219 178.265 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.773 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.7 pp -142.91 143.17 24.23 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.246 -176.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.513 ' HB2' ' CD1' ' A' ' 177' ' ' TYR . 20.5 Cg_exo -68.24 132.26 25.48 Favored 'Trans proline' 0 CA--C 1.528 0.219 0 C-N-CA 122.96 2.44 . . . . 0.0 113.282 -178.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.553 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 67.0 t -60.79 -44.34 94.7 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 178.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 20.0 Cg_endo -61.52 -2.05 2.35 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 122.211 1.94 . . . . 0.0 113.217 178.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.513 ' CD1' ' HB2' ' A' ' 174' ' ' PRO . 2.8 m-85 -99.83 -12.17 20.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.555 -177.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.633 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 3.7 m -106.36 -172.83 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 -164.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 1.016 ' HG2' HD12 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -157.29 46.44 0.39 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 112.897 -1.956 . . . . 0.0 111.545 -151.755 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.764 ' CG ' HG21 ' A' ' 128' ' ' VAL . 0.8 OUTLIER -71.45 136.55 47.7 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 120.193 -1.567 . . . . 0.0 110.009 -163.369 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.458 HD21 ' NH2' ' A' ' 129' ' ' ARG . 38.8 tp -79.12 -80.88 0.11 Allowed 'General case' 0 CA--C 1.523 -0.067 0 CA-C-N 113.524 -1.671 . . . . 0.0 111.796 -165.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 4.1 m -70.32 81.58 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 175.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.582 ' HG2' ' HE2' ' A' ' 180' ' ' LYS . 5.5 tpt180 -153.91 135.65 14.46 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -166.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 30.1 p -132.79 62.47 1.65 Allowed 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 164.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' SER . . . . . 0.46 ' HB2' ' HD2' ' A' ' 186' ' ' PRO . 5.1 p -66.49 163.82 37.36 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 114.724 -1.126 . . . . 0.0 112.163 -170.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.46 ' HD2' ' HB2' ' A' ' 185' ' ' SER . 55.1 Cg_exo -37.97 110.16 0.08 OUTLIER 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 124.016 3.144 . . . . 0.0 114.086 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 31.5 m80 -128.73 42.77 3.26 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 175.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 93.24 -75.43 1.19 Allowed Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 -172.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.61 5.85 0.46 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 171.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 65.58 -67.45 0.13 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.378 -176.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 132.08 162.99 10.59 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -172.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -104.14 12.82 33.44 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 117.282 0.541 . . . . 0.0 110.49 -178.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -95.19 137.09 34.72 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.332 177.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 68.5 -66.2 0.24 Allowed 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.989 0.806 . . . . 0.0 111.41 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 13.1 m -116.2 116.07 27.15 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -97.43 148.41 23.22 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.018 0.437 . . . . 0.0 110.35 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 33.7 t -131.21 -61.98 0.9 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.224 -179.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 60.22 -90.38 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 O-C-N 123.867 0.729 . . . . 0.0 111.043 -178.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 76.21 -62.77 2.96 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.55 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.488 HG13 ' HD2' ' A' ' 201' ' ' PRO . 16.0 tt -150.51 136.06 10.34 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.488 ' HD2' HG13 ' A' ' 200' ' ' ILE . 9.5 Cg_endo -53.08 -43.2 59.03 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.777 2.318 . . . . 0.0 112.541 -178.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -142.1 121.37 7.91 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -56.3 105.42 0.17 Allowed 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 122.856 2.371 . . . . 0.0 112.275 177.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -98.61 152.21 19.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.678 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 34.0 m170 -116.29 148.28 40.68 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -133.57 157.18 46.36 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.995 0.426 . . . . 0.0 111.687 -175.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -102.76 -10.49 19.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.844 173.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . 57.92 -105.69 0.27 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.492 175.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 60.82 90.88 0.08 OUTLIER Pre-proline 0 C--O 1.233 0.23 0 O-C-N 123.767 0.667 . . . . 0.0 111.049 -174.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . 0.539 ' HB3' ' HB3' ' A' ' 114' ' ' SER . 11.9 Cg_exo -70.23 143.56 48.96 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.688 2.259 . . . . 0.0 111.828 178.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -82.91 89.87 6.9 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.203 0.525 . . . . 0.0 110.242 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 6.5 p -74.83 -36.98 62.4 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.137 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 56.9 m -69.98 96.4 1.03 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.494 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 13.5 p -125.19 155.74 70.73 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.29 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -79.6 29.8 0.49 Allowed 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 123.164 2.576 . . . . 0.0 112.308 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.544 ' N ' ' HD2' ' A' ' 217' ' ' PRO . 66.8 tp -71.83 -51.3 8.96 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.825 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 216' ' ' LEU . 19.0 Cg_endo -58.34 108.83 0.43 Allowed 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 122.343 2.028 . . . . 0.0 113.183 -178.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -145.52 102.79 3.74 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.912 176.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.445 HG11 ' H ' ' A' ' 220' ' ' SER . 3.5 p -158.0 -55.98 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.268 -176.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' SER . . . . . 0.445 ' H ' HG11 ' A' ' 219' ' ' VAL . 19.3 m -113.67 145.62 41.04 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.729 0.299 . . . . 0.0 110.379 -178.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -99.22 -139.62 10.96 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.027 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 8.7 t 61.36 84.42 0.19 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.131 0.491 . . . . 0.0 110.129 -178.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -56.65 101.33 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.986 2.457 . . . . 0.0 112.484 -178.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 161.89 57.39 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 71.53 -10.26 0.84 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.545 0.738 . . . . 0.0 112.372 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -84.64 4.38 32.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.662 0.268 . . . . 0.0 111.494 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 59.8 mt -62.65 -37.59 79.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-O 121.48 0.657 . . . . 0.0 110.575 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 34.2 m -150.92 100.97 3.04 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.482 177.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -63.69 113.34 2.1 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 122.738 2.292 . . . . 0.0 112.68 -178.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -81.28 127.31 74.25 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.102 177.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -71.99 73.05 2.58 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.934 2.423 . . . . 0.0 111.133 175.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 44.6 m 62.47 -83.03 0.02 OUTLIER 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.02 -176.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 7.0 m 64.2 -83.13 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 122.988 0.515 . . . . 0.0 111.08 -178.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -144.47 12.96 1.55 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 176.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -100.62 125.09 46.99 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.921 -177.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -173.07 88.78 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.403 -178.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -66.56 117.25 4.59 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.469 2.113 . . . . 0.0 110.54 173.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.488 ' HB ' HG12 ' A' ' 266' ' ' VAL . 6.2 t -74.49 127.74 36.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -176.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -98.69 118.2 34.87 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.193 0.52 . . . . 0.0 111.198 -175.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.541 ' HB3' HD11 ' A' ' 293' ' ' ILE . . . -121.78 134.95 54.92 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.067 175.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -94.45 133.62 37.85 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 177.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . 0.579 ' O ' ' HA ' ' A' ' 260' ' ' VAL . . . -82.29 105.2 13.17 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.178 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.466 ' H ' HD12 ' A' ' 243' ' ' ILE . 0.2 OUTLIER -88.84 -23.08 6.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.999 0.428 . . . . 0.0 110.727 -178.483 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -130.25 122.61 28.37 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 178.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -60.34 138.42 57.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.799 0.809 . . . . 0.0 112.374 -171.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.494 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 20.4 tpt180 -116.83 113.99 23.29 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.946 -1.025 . . . . 0.0 108.998 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.41 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 19.9 m -111.65 147.68 37.28 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.774 -178.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.458 ' HA ' ' HB3' ' A' ' 255' ' ' ALA . 11.9 Cg_exo -69.24 105.63 1.43 Allowed 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.68 2.253 . . . . 0.0 111.399 178.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' CYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 252' ' ' ASP . 34.0 t -76.92 172.34 13.31 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.965 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -55.62 -42.58 75.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.823 0.344 . . . . 0.0 111.131 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -94.23 8.83 40.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.122 0.487 . . . . 0.0 111.172 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.425 ' HB2' ' HB3' ' A' ' 249' ' ' CYS . 1.6 m-20 -131.94 51.28 2.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.538 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -67.65 -17.49 64.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.128 0.489 . . . . 0.0 110.106 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 3.7 p -88.23 4.37 46.02 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.55 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.458 ' HB3' ' HA ' ' A' ' 248' ' ' PRO . . . -88.39 142.82 27.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.223 0.535 . . . . 0.0 111.299 -178.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.2 tt -81.68 141.22 33.83 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.11 177.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -88.63 109.53 20.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.139 0.495 . . . . 0.0 110.297 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 72.2 mt -118.42 157.38 27.3 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.96 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -146.01 167.9 22.22 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 177.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . 0.579 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 26.0 t -55.82 120.39 2.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 O-C-N 123.673 0.608 . . . . 0.0 112.55 -171.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 109.76 -21.13 26.07 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.713 -0.676 . . . . 0.0 113.574 172.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -78.79 154.44 29.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 117.033 0.416 . . . . 0.0 110.797 -170.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 43.9 mm -98.12 120.55 47.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.877 -177.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.432 HG22 HG11 ' A' ' 291' ' ' VAL . 21.7 t -95.81 116.67 38.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.532 179.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 43.1 tttm -89.86 99.02 12.11 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.461 177.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.488 HG12 ' HB ' ' A' ' 238' ' ' VAL . 3.6 p -99.52 117.53 44.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.36 0.6 . . . . 0.0 110.174 174.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.42 -13.66 15.04 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.816 -177.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . 0.536 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 5.6 ttp180 -130.46 107.3 9.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.174 0.512 . . . . 0.0 110.86 175.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' MET . . . . . 0.576 ' HE1' ' CH2' ' A' ' 275' ' ' TRP . 44.7 mtt -97.92 123.8 42.07 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.684 173.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.425 ' O ' ' HB ' ' A' ' 271' ' ' ILE . 90.8 m-20 -80.74 -93.55 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.976 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.425 ' HB ' ' O ' ' A' ' 270' ' ' ASN . 10.5 tp 177.1 -29.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.153 0.502 . . . . 0.0 109.778 176.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -68.29 -37.5 80.73 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.734 177.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 141.42 -34.36 1.91 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.422 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.446 ' NE2' HD11 ' A' ' 285' ' ' LEU . 26.8 mt-30 -76.38 107.72 8.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.875 0.369 . . . . 0.0 110.198 178.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.576 ' CH2' ' HE1' ' A' ' 269' ' ' MET . 40.6 m0 -98.24 158.1 15.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.176 -178.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . 0.536 ' HB2' ' HB3' ' A' ' 268' ' ' ARG . 53.6 mt-10 -95.84 104.27 16.2 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.216 173.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -121.63 141.05 14.26 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 174.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -116.3 112.05 21.0 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.999 0.428 . . . . 0.0 110.43 -177.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 66.3 t -129.4 127.9 65.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.2 -177.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 63.66 21.8 12.86 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.451 177.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 102.44 -14.89 56.52 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.731 177.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 53.4 mtp180 -104.43 132.02 51.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.694 0.247 . . . . 0.0 111.128 -179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 4.8 ptpp? -111.57 114.83 28.16 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 171.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -133.4 166.38 23.83 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.757 -177.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.446 HD11 ' NE2' ' A' ' 274' ' ' GLN . 74.8 mt -86.98 112.56 21.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.265 0.555 . . . . 0.0 110.443 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -115.56 149.34 42.8 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.859 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -86.11 143.61 7.97 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.471 2.114 . . . . 0.0 111.618 177.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -68.93 4.01 1.72 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -175.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 23.9 p -89.54 -33.67 16.65 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.855 0.359 . . . . 0.0 111.511 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -77.5 -12.32 59.95 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.984 0.421 . . . . 0.0 110.96 -177.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.503 ' HB ' ' HB1' ' A' ' 240' ' ' ALA . 27.8 m -128.38 160.57 38.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.279 179.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -133.55 134.92 43.96 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.9 0.381 . . . . 0.0 110.753 174.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.541 HD11 ' HB3' ' A' ' 240' ' ' ALA . 1.2 mp -68.34 138.89 21.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.482 177.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -156.73 158.8 37.57 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 177.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.477 ' HB3' ' ND2' ' A' ' 298' ' ' ASN . 20.1 m-20 -84.85 114.5 55.97 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 174.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.9 46.97 1.83 Allowed 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.987 2.458 . . . . 0.0 111.123 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 65.91 14.04 9.36 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.794 -176.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . 0.477 ' ND2' ' HB3' ' A' ' 295' ' ' ASP . 1.0 OUTLIER 61.65 96.31 0.05 OUTLIER Pre-proline 0 N--CA 1.467 0.413 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.863 175.042 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.25 -9.02 15.24 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.631 2.221 . . . . 0.0 111.691 173.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -57.44 -61.95 2.12 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.717 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -89.57 46.79 1.4 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.669 -176.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -102.84 -59.01 1.77 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.204 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 . . . . . 0 C--O 1.247 0.946 0 CA-C-O 118.36 -0.828 . . . . 0.0 111.184 178.493 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.1 mtp . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.1 m -143.04 147.34 34.91 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.327 -178.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.517 ' O ' HG22 ' A' ' 99' ' ' ILE . 3.0 p -75.92 -50.89 13.72 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 175.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -87.86 66.46 8.75 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.772 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -97.91 84.46 3.33 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.816 -173.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -154.37 164.67 38.25 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.506 176.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -89.68 107.29 19.01 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 175.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.575 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 37.8 t -79.09 69.9 5.35 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.306 -178.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.4 t -176.29 -40.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.167 176.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -58.14 108.23 0.58 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.108 0.48 . . . . 0.0 111.469 -174.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 17.8 mmt180 -61.92 -32.22 72.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.853 -174.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 72.4 m -74.47 -5.7 44.11 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.974 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.53 -48.41 6.64 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.429 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.414 ' HB3' ' HB3' ' A' ' 101' ' ' PRO . 22.9 p-90 -114.54 -29.94 6.68 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -170.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -72.27 122.2 20.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.908 0.385 . . . . 0.0 110.618 -175.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.534 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 26.1 mmt -103.06 -5.5 23.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.401 -176.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.472 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 50.97 -114.43 2.79 Favored Glycine 0 CA--C 1.522 0.492 0 CA-C-N 115.614 -0.721 . . . . 0.0 113.498 -177.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.472 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 5.3 Cg_exo -77.33 89.18 1.34 Allowed 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 123.091 2.527 . . . . 0.0 113.274 -175.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.569 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 97.1 t -139.15 155.51 26.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 177.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.5 m -119.46 174.06 6.61 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -174.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 70.0 mtp85 -55.77 -47.32 77.25 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -62.7 -56.2 19.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.853 0.358 . . . . 0.0 111.113 -178.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.503 ' HB3' HG12 ' A' ' 19' ' ' VAL . 0.5 OUTLIER -57.08 -47.12 81.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.789 -179.156 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.467 ' HB2' HD11 ' A' ' 37' ' ' LEU . . . -57.52 -47.4 82.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.204 0.526 . . . . 0.0 111.079 176.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -63.91 -43.19 96.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.495 -178.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.9 t -70.66 -9.16 56.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.651 0.262 . . . . 0.0 111.437 -177.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.492 ' HG3' ' O ' ' A' ' 23' ' ' GLU . 77.5 mtt180 -87.65 -25.84 23.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.987 0.422 . . . . 0.0 110.661 174.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.517 HD23 ' HB2' ' A' ' 53' ' ' SER . 27.3 mt -108.71 -12.49 14.94 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.76 -175.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.0 tp60 -79.7 105.51 11.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.161 0.505 . . . . 0.0 111.297 -177.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.97 -17.84 47.75 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.86 175.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -86.16 175.54 8.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.678 0.275 . . . . 0.0 110.785 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 18.3 ttp180 -62.0 132.09 51.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.732 -177.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.416 ' CD2' ' HA ' ' A' ' 54' ' ' GLU . 33.3 m80 -76.35 158.18 31.71 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.376 -176.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.69 -11.86 46.24 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -174.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.554 ' HB3' ' HB1' ' A' ' 102' ' ' ALA . 66.1 mtt -73.96 150.7 40.62 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 175.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.419 ' CB ' HG22 ' A' ' 52' ' ' VAL . 37.9 p90 -147.8 156.26 42.54 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 175.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.534 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.5 pp -150.45 134.72 17.08 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.058 0.456 . . . . 0.0 110.592 178.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.4 t -105.84 107.57 22.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.508 176.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.569 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 24.6 ptt-85 -106.34 -178.85 3.77 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.46 138.82 33.28 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 172.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.591 ' HB3' ' O ' ' A' ' 44' ' ' CYS . 20.8 t -68.05 104.26 1.72 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.39 0.614 . . . . 0.0 110.736 -174.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.4 p -69.02 -11.01 60.4 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.839 177.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.0 p -104.97 -22.15 13.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.719 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.591 ' O ' ' HB3' ' A' ' 41' ' ' SER . 57.9 m -136.51 112.68 10.03 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.763 0.316 . . . . 0.0 110.561 -177.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -62.01 114.95 2.53 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.958 2.439 . . . . 0.0 113.098 -175.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.94 -26.53 23.71 Favored Glycine 0 CA--C 1.51 -0.236 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.735 174.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.597 ' OD1' ' HA ' ' A' ' 64' ' ' ASN . 32.0 m-20 -79.95 179.66 7.47 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.523 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 38.3 m-85 -127.48 174.36 9.08 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 176.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.403 HG22 HD11 ' A' ' 62' ' ' ILE . 27.9 t -141.37 111.01 2.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.662 0.267 . . . . 0.0 111.049 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 61.3 tp -78.33 98.76 6.06 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 171.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.8 m -95.62 119.66 34.51 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.266 0.555 . . . . 0.0 109.543 175.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 48.7 t -112.12 143.32 22.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.903 -173.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.578 ' HA ' ' O ' ' A' ' 57' ' ' ARG . 36.6 t -87.34 111.87 21.52 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.612 -0.144 . . . . 0.0 110.612 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.416 ' HA ' ' CD2' ' A' ' 33' ' ' HIS . 6.8 tp10 -175.92 157.3 1.89 Allowed 'General case' 0 N--CA 1.469 0.523 0 O-C-N 123.486 0.491 . . . . 0.0 111.022 176.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.66 ' HB2' ' NH2' ' A' ' 57' ' ' ARG . 27.0 m-80 61.81 58.26 2.0 Allowed 'General case' 0 CA--C 1.479 -1.752 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -171.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.9 t 70.54 -37.54 0.39 Allowed 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 113.777 -1.556 . . . . 0.0 110.21 -169.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.861 ' NE ' ' H ' ' A' ' 58' ' ' VAL 0.399 0.0 OUTLIER -157.76 -48.06 0.06 Allowed 'General case' 0 C--N 1.364 1.237 1 N-CA-C 125.571 5.397 . . . . 0.0 125.571 -170.116 . . . . . . . . 5 4 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.861 ' H ' ' NE ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -149.43 112.09 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 122.088 2.222 . . . . 0.0 114.573 -168.292 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.531 ' HB2' ' HB ' ' A' ' 52' ' ' VAL . 1.4 m -98.34 114.13 26.34 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 166.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.565 ' O ' HD11 ' A' ' 153' ' ' ILE . 92.0 m-70 -100.68 110.81 22.96 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -170.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.603 ' CZ ' ' HB2' ' A' ' 93' ' ' LEU . 98.7 m-85 -119.03 117.25 28.28 Favored 'General case' 0 C--O 1.218 -0.579 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -178.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.509 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 44.8 mm -78.09 127.64 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -177.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.54 HG13 ' HB ' ' A' ' 73' ' ' ILE . 3.8 mp -104.34 114.54 44.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 175.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.597 ' HA ' ' OD1' ' A' ' 47' ' ' ASP . 7.9 m120 -85.89 137.06 33.02 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.577 -173.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.8 t -87.72 95.73 10.18 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 174.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.512 HD12 ' HB2' ' A' ' 72' ' ' LYS . 99.0 mt -82.15 136.19 47.02 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.444 -178.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 66' ' ' LEU . 27.0 Cg_exo -64.82 -2.0 4.87 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.942 2.428 . . . . 0.0 111.311 172.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -79.58 5.22 13.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.614 175.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.505 ' HA ' ' HE ' ' A' ' 69' ' ' ARG . 0.1 OUTLIER 67.91 29.9 6.38 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.227 -176.835 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.413 ' HB3' ' O ' ' A' ' 78' ' ' PHE . 30.7 mtm-85 -140.52 175.23 9.78 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.933 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.45 ' HB3' HG23 ' A' ' 63' ' ' ILE . 68.1 m-85 -125.99 132.22 52.07 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.505 0.193 . . . . 0.0 111.06 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.642 ' HE2' ' HB3' ' A' ' 77' ' ' GLU . 37.1 ttmt -114.32 112.19 22.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.978 -177.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.54 ' HB ' HG13 ' A' ' 63' ' ' ILE . 14.0 tt -105.04 110.72 31.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.344 0.592 . . . . 0.0 111.127 -177.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' A' ' 76' ' ' GLN . . . 67.58 50.12 45.47 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.63 177.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.9 t0 75.58 -29.24 0.19 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.607 0.763 . . . . 0.0 110.985 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.431 ' H ' ' C ' ' A' ' 74' ' ' GLY . 14.9 mm100 -81.18 121.43 26.13 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.185 0.517 . . . . 0.0 110.716 178.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.642 ' HB3' ' HE2' ' A' ' 72' ' ' LYS . 7.8 pt-20 -99.6 141.86 31.84 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.437 -176.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.413 ' O ' ' HB3' ' A' ' 70' ' ' ARG . 95.5 m-85 -131.95 -175.56 3.77 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.201 -177.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -64.01 -50.88 66.76 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.186 0.517 . . . . 0.0 110.335 175.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.554 ' HD1' ' HD2' ' A' ' 82' ' ' PRO . 4.2 p80 -173.0 -173.8 0.99 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.246 -176.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.637 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 19.6 mt -54.3 -58.16 15.1 Favored Pre-proline 0 N--CA 1.467 0.421 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.637 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 52.4 Cg_exo -59.52 -7.7 5.93 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 122.562 2.175 . . . . 0.0 113.765 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -95.46 -36.68 11.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.915 0.388 . . . . 0.0 110.925 -178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.9 pp -76.59 -30.52 57.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.311 -178.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.437 ' HB2' ' OG ' ' A' ' 8' ' ' SER . 60.0 mt -66.12 -21.91 66.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.322 0.582 . . . . 0.0 110.002 177.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -81.66 -39.84 23.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.086 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.685 ' O ' HD11 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -71.64 -21.38 61.83 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.073 0.463 . . . . 0.0 111.079 -179.873 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.628 ' CE1' ' HE1' ' A' ' 87' ' ' PHE . 32.7 m-85 -89.34 1.91 55.12 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 121.665 -0.647 . . . . 0.0 111.641 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -76.38 -21.47 56.02 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.953 175.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.685 HD11 ' O ' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -125.4 -1.78 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-O 121.558 0.694 . . . . 0.0 110.301 -175.477 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -101.86 -30.71 11.11 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.345 -174.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 67.81 153.56 0.09 Allowed 'General case' 0 C--N 1.332 -0.168 0 O-C-N 124.501 1.125 . . . . 0.0 109.346 -168.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.603 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 0.7 OUTLIER -138.24 39.97 2.28 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 164.648 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 1.029 ' HA ' ' HB3' ' A' ' 154' ' ' GLU . 13.8 t0 168.08 -158.47 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 112.058 -2.337 . . . . 0.0 106.01 172.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.719 ' CB ' ' HA ' ' A' ' 156' ' ' PRO . 14.2 t -76.76 11.36 1.73 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.21 0.529 . . . . 0.0 110.564 176.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.2 t -146.43 161.58 40.1 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.752 176.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.8 p -97.7 -176.18 3.4 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 176.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 81.5 mt -77.33 92.91 3.96 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 176.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.517 HG22 ' O ' ' A' ' 3' ' ' SER . 48.1 mm -74.9 -59.08 3.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.985 -176.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.548 ' O ' ' HA ' ' A' ' 35' ' ' MET . 8.8 pt-20 -159.98 154.42 20.36 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.257 178.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.414 ' HB3' ' HB3' ' A' ' 14' ' ' TRP . 38.1 Cg_endo -67.18 142.64 61.75 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.323 2.015 . . . . 0.0 112.003 177.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.554 ' HB1' ' HB3' ' A' ' 35' ' ' MET . . . -69.01 148.0 97.8 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.945 177.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.401 ' C ' ' H ' ' A' ' 105' ' ' TYR . 20.9 Cg_endo -63.26 129.13 24.57 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.704 1.603 . . . . 0.0 111.102 174.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -71.75 7.3 1.56 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.056 0.455 . . . . 0.0 111.194 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.401 ' H ' ' C ' ' A' ' 103' ' ' PRO . 87.4 m-85 -121.97 103.37 39.84 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 175.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.413 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 27.2 Cg_exo -62.87 146.86 95.09 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.876 2.384 . . . . 0.0 112.303 -178.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 39.2 t -96.06 110.48 52.21 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.688 -178.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.61 ' HB2' ' HD3' ' A' ' 109' ' ' PRO . 47.5 Cg_exo -55.91 -51.54 9.4 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.709 2.273 . . . . 0.0 113.167 175.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.61 ' HD3' ' HB2' ' A' ' 108' ' ' PRO . 76.6 Cg_endo -91.52 176.23 2.11 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 121.965 1.777 . . . . 0.0 111.895 174.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 64.4 mtm -93.18 108.44 20.05 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.294 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -93.23 -106.05 1.75 Allowed Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.027 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 54.7 m -82.6 90.8 6.85 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.133 0.492 . . . . 0.0 111.037 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 48.8 t -82.03 116.3 26.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.847 177.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.2 t -135.74 141.76 44.89 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.778 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -137.5 158.56 71.8 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.338 -176.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.473 ' HG2' ' ND2' ' A' ' 194' ' ' ASN . 14.9 Cg_exo -69.38 163.27 38.62 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.539 2.159 . . . . 0.0 111.883 178.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -74.72 90.83 2.34 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.253 0.549 . . . . 0.0 110.884 -179.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.581 HD21 ' HB3' ' A' ' 121' ' ' ALA . 60.0 tp -159.69 114.1 1.5 Allowed Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.43 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.53 ' HD2' HD11 ' A' ' 118' ' ' LEU . 16.4 Cg_endo -58.34 -54.34 3.15 Favored 'Trans proline' 0 CA--C 1.529 0.246 0 C-N-CA 122.661 2.241 . . . . 0.0 113.066 -177.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 34.8 m -155.85 139.99 16.5 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.664 0.268 . . . . 0.0 111.025 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.581 ' HB3' HD21 ' A' ' 118' ' ' LEU . . . -140.88 129.06 22.19 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 174.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.746 ' HB2' ' HD3' ' A' ' 186' ' ' PRO . 10.8 pt-20 -97.94 -29.47 13.28 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -166.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.677 ' HB3' ' HE ' ' A' ' 183' ' ' ARG . 0.1 OUTLIER -72.18 -178.04 2.31 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -173.254 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.529 ' O ' ' HB2' ' A' ' 125' ' ' LEU . 56.5 t30 -110.74 -58.65 2.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.943 -176.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.627 ' HG ' ' CD ' ' A' ' 155' ' ' LYS . 4.6 mm? 72.89 105.96 0.07 Allowed 'General case' 0 N--CA 1.468 0.465 0 O-C-N 123.925 0.766 . . . . 0.0 110.516 -176.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 40.1 tt0 -172.88 -68.72 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.825 -1.08 . . . . 0.0 108.942 -172.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -115.63 108.02 15.86 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 121.061 0.457 . . . . 0.0 110.163 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.72 HG21 ' CG ' ' A' ' 180' ' ' LYS . 69.4 t -118.1 132.47 67.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.961 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.68 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 5.6 ptp180 -110.38 144.37 39.25 Favored 'General case' 0 N--CA 1.436 -1.167 0 C-N-CA 117.162 -1.815 . . . . 0.0 107.92 169.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.658 ' HG1' ' CB ' ' A' ' 144' ' ' PHE . 6.0 p -98.19 138.5 35.38 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.064 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.55 HD22 ' HG2' ' A' ' 179' ' ' GLU . 15.6 mt -110.96 -8.14 14.5 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.434 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 22.0 t80 -91.03 -42.46 10.51 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.432 -0.507 . . . . 0.0 112.01 -173.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.537 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 10.0 t70 77.3 98.39 0.07 Allowed 'General case' 0 N--CA 1.475 0.808 0 O-C-N 123.581 0.55 . . . . 0.0 110.459 -176.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.512 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 76.0 t80 -134.12 93.86 19.11 Favored Pre-proline 0 N--CA 1.45 -0.47 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 176.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.656 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 91.9 Cg_endo -84.02 89.53 0.97 Allowed 'Trans proline' 0 N--CA 1.443 -1.476 0 C-N-CA 121.767 1.645 . . . . 0.0 112.64 -178.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -79.74 -36.48 25.66 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.65 176.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.538 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 16.7 m120 67.62 34.21 4.64 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 122.958 0.503 . . . . 0.0 111.648 175.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.465 ' HB3' ' H ' ' A' ' 140' ' ' GLU . 0.1 OUTLIER -117.3 178.22 4.45 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.135 -178.071 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -92.71 -7.31 47.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.926 0.87 . . . . 0.0 108.749 171.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.66 ' O ' ' HB2' ' A' ' 172' ' ' MET . 32.4 mt-10 -118.06 -5.02 10.98 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.712 177.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.446 ' HB2' ' HB2' ' A' ' 138' ' ' ASP . 7.9 m-20 -139.53 102.44 4.46 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 174.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.721 ' CD2' HD23 ' A' ' 150' ' ' LEU . 31.0 tp -71.74 135.21 83.45 Favored Pre-proline 0 CA--C 1.512 -0.517 0 C-N-CA 120.535 -0.466 . . . . 0.0 109.966 -177.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.656 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 94.4 Cg_endo -88.54 96.85 0.38 Allowed 'Trans proline' 0 N--CA 1.438 -1.767 0 C-N-CA 121.54 1.493 . . . . 0.0 112.193 173.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.658 ' CB ' ' HG1' ' A' ' 130' ' ' THR . 1.8 p90 -94.54 -177.7 4.32 Favored 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.85 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.537 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 29.1 mtmm -125.96 -172.25 2.57 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.676 174.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.985 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -78.13 22.74 0.29 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.749 -173.1 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 145' ' ' LYS . . . 165.5 35.13 0.02 OUTLIER Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.446 179.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.561 ' OE1' ' HA ' ' A' ' 144' ' ' PHE . 0.8 OUTLIER -96.79 150.51 20.63 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 119.286 -0.966 . . . . 0.0 110.688 -178.876 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.451 HD11 ' HB3' ' A' ' 129' ' ' ARG . 1.2 mp -93.5 123.76 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -173.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.721 HD23 ' CD2' ' A' ' 142' ' ' LEU . 13.2 mt -119.91 156.89 29.88 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -175.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.543 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 99.5 t -117.74 121.42 67.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 176.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.511 HG13 HD12 ' A' ' 125' ' ' LEU . 47.2 mm -77.21 105.21 5.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.548 0.69 . . . . 0.0 109.181 -175.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.565 HD11 ' O ' ' A' ' 60' ' ' HIS . 19.5 tt -96.33 -29.01 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.954 -174.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 1.029 ' HB3' ' HA ' ' A' ' 94' ' ' ASP . 2.6 mt-10 -123.25 143.15 50.24 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 168.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.627 ' CD ' ' HG ' ' A' ' 125' ' ' LEU . 70.2 tttt -134.86 78.44 54.58 Favored Pre-proline 0 C--N 1.314 -0.952 0 CA-C-O 121.323 0.583 . . . . 0.0 109.512 166.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.719 ' HA ' ' CB ' ' A' ' 95' ' ' THR . 26.1 Cg_exo -64.47 -52.41 1.47 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.178 1.919 . . . . 0.0 111.908 172.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.423 ' HG2' ' HB2' ' A' ' 156' ' ' PRO . 17.7 mm-40 -114.73 168.08 10.2 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.194 -169.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -96.19 1.56 52.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.395 0.617 . . . . 0.0 109.466 173.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.907 HE21 ' HA ' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -104.73 -34.34 8.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.72 179.651 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.467 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 35.1 m95 -129.55 142.28 50.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.985 176.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . 0.741 ' O ' HG13 ' A' ' 173' ' ' ILE . 52.4 m0 -125.68 137.96 53.87 Favored 'General case' 0 C--O 1.216 -0.695 0 C-N-CA 123.155 0.582 . . . . 0.0 110.143 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.54 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 18.2 m -98.12 107.11 19.51 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -175.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.5 ' HB2' ' HB3' ' A' ' 150' ' ' LEU . . . -117.3 152.22 35.32 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 119.899 -0.72 . . . . 0.0 110.742 -176.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.816 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 11.8 ptt180 -87.37 121.91 30.42 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 171.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.682 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . 14.9 t30 -55.92 -179.83 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 113.748 -1.569 . . . . 0.0 111.668 -174.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -66.51 -22.15 66.17 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 167.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -68.85 -20.36 64.28 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.709 168.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 82.73 19.51 63.46 Favored Glycine 0 CA--C 1.527 0.844 0 CA-C-N 115.148 -0.933 . . . . 0.0 113.246 -175.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.816 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 1.5 ttm-85 -94.12 142.53 27.3 Favored 'General case' 0 C--O 1.214 -0.788 0 C-N-CA 122.482 0.313 . . . . 0.0 111.03 -178.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 59.4 t -83.96 123.41 38.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 O-C-N 122.191 -0.318 . . . . 0.0 111.29 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -158.53 151.97 23.05 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.723 171.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.66 ' HB2' ' O ' ' A' ' 140' ' ' GLU . 0.2 OUTLIER -73.17 142.91 47.4 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.735 0.302 . . . . 0.0 111.187 178.202 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.741 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.7 pp -143.88 147.96 40.52 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.115 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.505 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 11.2 Cg_exo -72.67 132.37 18.67 Favored 'Trans proline' 0 CA--C 1.528 0.214 0 C-N-CA 122.654 2.236 . . . . 0.0 112.826 -175.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.49 ' O ' HG21 ' A' ' 178' ' ' VAL . 70.1 t -60.41 -44.32 95.5 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.459 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 39.2 Cg_exo -62.59 -5.7 7.56 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 122.213 1.942 . . . . 0.0 112.95 176.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.505 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.2 m-85 -94.67 -12.17 27.82 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.216 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.629 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 2.8 m -107.41 -175.18 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 -166.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.707 ' O ' ' HG3' ' A' ' 179' ' ' GLU . 3.6 tp10 -160.9 46.32 0.2 Allowed 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 112.725 -2.034 . . . . 0.0 111.541 -152.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.72 ' CG ' HG21 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -73.17 137.86 45.34 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 119.125 -2.235 . . . . 0.0 111.874 -161.328 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 183' ' ' ARG . 15.3 tp -71.64 151.21 43.92 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 112.217 -2.265 . . . . 0.0 110.15 -173.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.659 HG12 ' H ' ' A' ' 183' ' ' ARG . 7.7 p 42.51 -72.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 125.385 1.474 . . . . 0.0 113.862 -174.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.677 ' HE ' ' HB3' ' A' ' 123' ' ' ASP . 66.8 ttt180 71.53 112.13 0.06 Allowed 'General case' 0 C--O 1.231 0.092 0 C-N-CA 123.798 0.839 . . . . 0.0 111.119 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.484 ' HB2' ' HB2' ' A' ' 124' ' ' ASN . 12.8 m -75.54 66.26 1.89 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.456 178.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' SER . . . . . 0.512 ' HB3' ' HD2' ' A' ' 186' ' ' PRO . 5.0 m -72.25 177.34 1.81 Allowed Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.107 179.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.746 ' HD3' ' HB2' ' A' ' 122' ' ' GLU . 71.1 Cg_exo -49.4 98.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.804 2.336 . . . . 0.0 113.198 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -130.79 22.73 5.0 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.735 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.97 -78.56 1.26 Allowed Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.818 -177.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 9.7 tmtm? -71.92 -23.92 61.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.402 0.62 . . . . 0.0 109.623 177.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . 0.48 ' CG ' ' HB3' ' A' ' 184' ' ' SER . 91.2 m-70 -107.17 144.5 33.82 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.774 175.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 138.34 19.8 0.52 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.052 -175.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -135.7 88.18 2.38 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.431 ' HG3' ' OD1' ' A' ' 123' ' ' ASP . 5.0 tmm_? -70.05 -35.29 74.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.399 -174.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.473 ' ND2' ' HG2' ' A' ' 116' ' ' PRO . 46.5 t30 -147.41 -51.43 0.19 Allowed 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.83 -177.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 15.6 m -89.91 160.77 16.27 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 175.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -123.29 131.08 53.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.474 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 7.5 t 65.78 -167.79 0.21 Allowed 'General case' 0 CA--C 1.533 0.315 0 O-C-N 123.852 0.72 . . . . 0.0 110.838 176.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -88.67 133.97 34.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.721 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -156.14 117.17 0.76 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.468 177.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.487 HG22 ' HG3' ' A' ' 202' ' ' GLU . 70.9 mt 72.21 107.43 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.332 0 CA-C-O 121.359 0.6 . . . . 0.0 112.366 173.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -85.86 119.34 1.86 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.231 2.621 . . . . 0.0 111.816 174.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.487 ' HG3' HG22 ' A' ' 200' ' ' ILE . 47.0 mt-10 -135.41 154.14 78.32 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.645 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -80.69 15.62 1.76 Allowed 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 123.244 2.629 . . . . 0.0 112.408 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.16 123.15 23.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.992 0.425 . . . . 0.0 110.817 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -119.58 126.88 52.26 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.491 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . 0.448 ' O ' ' HB2' ' A' ' 207' ' ' TYR . . . -69.79 155.79 40.0 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.361 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' TYR . . . . . 0.448 ' HB2' ' O ' ' A' ' 206' ' ' ALA . 45.0 m-85 73.42 -11.91 0.87 Allowed 'General case' 0 N--CA 1.471 0.597 0 O-C-N 123.847 0.717 . . . . 0.0 111.861 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -91.12 103.52 16.2 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.887 0.375 . . . . 0.0 110.294 178.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -109.38 147.25 35.65 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.61 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -85.97 11.17 3.41 Favored 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 123.032 2.488 . . . . 0.0 112.551 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -129.64 147.42 51.43 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.663 -178.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 14.0 t -99.58 159.63 14.89 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.659 0.266 . . . . 0.0 110.62 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 18.0 m -74.83 124.58 27.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.797 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 17.4 m -88.03 113.36 54.51 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.403 177.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -71.51 119.4 6.22 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.575 2.184 . . . . 0.0 111.393 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.799 ' HB2' ' HD3' ' A' ' 217' ' ' PRO . 6.5 mp -65.61 -56.81 16.57 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.823 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.799 ' HD3' ' HB2' ' A' ' 216' ' ' LEU . 6.3 Cg_exo -78.69 135.35 12.81 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 121.981 1.787 . . . . 0.0 111.352 175.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -67.09 127.38 32.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.337 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 43.2 t -74.02 86.98 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.227 0.537 . . . . 0.0 111.536 -175.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 16.7 t -95.39 -24.93 16.48 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 170.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -170.73 -171.25 35.87 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.229 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 14.4 p -100.97 130.9 24.12 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 117.519 0.66 . . . . 0.0 110.312 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -64.01 146.59 91.32 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.912 2.408 . . . . 0.0 112.304 -178.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 92.35 -87.44 1.26 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.835 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 68.23 -60.05 0.43 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.698 0.799 . . . . 0.0 112.021 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . 68.02 108.01 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.436 0.694 . . . . 0.0 111.161 -177.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 48.5 mm -79.02 115.56 21.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.866 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' THR . . . . . 0.489 ' HA ' ' HD3' ' A' ' 229' ' ' PRO . 8.7 t -57.65 130.23 81.6 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.433 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 228' ' ' THR . 16.4 Cg_exo -67.25 96.96 0.41 Allowed 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.906 2.404 . . . . 0.0 112.407 -177.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 98.4 mt -86.02 118.77 71.06 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.157 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.89 -54.7 4.37 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 123.136 2.558 . . . . 0.0 112.297 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 14.2 p -138.57 -72.25 0.41 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.398 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 73.4 p 47.68 43.28 16.46 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.806 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -77.83 96.44 4.96 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.185 -177.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -96.6 20.11 11.28 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.958 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 83.81 139.78 4.09 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.326 -176.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -66.43 113.6 2.75 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.135 1.89 . . . . 0.0 110.732 177.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.485 ' CG1' HD11 ' A' ' 293' ' ' ILE . 2.8 t -90.18 145.0 7.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.557 -176.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.46 ' HD1' HD21 ' A' ' 298' ' ' ASN . 77.1 m-85 -116.28 124.77 51.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.291 0.567 . . . . 0.0 112.302 -172.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.543 ' HB3' HD13 ' A' ' 293' ' ' ILE . . . -119.48 149.85 41.21 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.919 175.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -106.65 123.72 48.54 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 173.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . 0.51 ' O ' ' HA ' ' A' ' 260' ' ' VAL . . . -68.34 97.24 0.72 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.92 0.391 . . . . 0.0 110.304 -178.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.47 HD12 ' HB2' ' A' ' 292' ' ' LYS . 27.1 pt -86.29 -24.39 6.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.077 -177.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.39 123.85 38.88 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 176.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -53.98 138.63 36.56 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.38 0.609 . . . . 0.0 111.598 -173.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 28.4 tpt180 -123.32 111.63 16.63 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.161 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.442 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 23.6 m -115.95 144.22 32.34 Favored Pre-proline 0 C--N 1.318 -0.802 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.264 177.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 247' ' ' VAL . 4.4 Cg_exo -75.09 121.87 6.81 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.478 2.119 . . . . 0.0 110.953 177.263 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 18.2 t -75.42 -178.41 4.02 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.105 -177.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -59.23 -23.62 62.48 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.289 0.478 . . . . 0.0 112.289 -176.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -107.0 4.9 27.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.621 -177.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -96.3 112.88 24.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.773 0.32 . . . . 0.0 110.808 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -106.75 -37.82 6.29 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.014 176.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 24.8 p -99.41 19.97 14.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.708 -176.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -93.36 145.09 24.72 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.057 0.456 . . . . 0.0 111.164 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -93.78 135.79 34.73 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.921 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -91.91 122.09 34.11 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.162 177.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 81.4 mt -129.43 135.74 49.05 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -175.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -99.38 161.86 13.37 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 175.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 36.4 t -73.21 109.06 5.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.642 -178.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 120.35 -0.77 12.78 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.716 178.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -89.73 160.34 16.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.943 0.372 . . . . 0.0 110.131 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 30.1 mm -103.65 116.75 47.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.184 0.516 . . . . 0.0 110.733 -176.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 13.7 t -97.8 109.66 23.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.476 -178.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 9.4 ptmt -93.35 102.47 14.73 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.274 175.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.424 HG13 ' HB ' ' A' ' 238' ' ' VAL . 2.3 p -93.22 128.54 44.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.333 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.23 -39.33 7.69 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.149 -176.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . 0.491 ' HB2' ' CG ' ' A' ' 276' ' ' GLU . 63.2 mtt85 -128.11 127.27 42.75 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.979 0.418 . . . . 0.0 110.498 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' MET . . . . . 0.472 ' HE2' HG23 ' A' ' 238' ' ' VAL . 43.4 mtt -105.36 140.11 38.97 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.342 -176.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -106.94 169.08 8.76 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.477 177.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 18.4 pt -98.24 9.36 7.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.156 0.503 . . . . 0.0 111.162 -176.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 30.1 p-10 -87.69 -20.87 25.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.995 178.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 114.83 -12.39 20.43 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.386 -178.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -116.98 122.5 44.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.085 0.469 . . . . 0.0 110.373 177.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.426 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 6.6 m0 -99.02 169.22 9.58 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.807 -176.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . 0.491 ' CG ' ' HB2' ' A' ' 268' ' ' ARG . 0.0 OUTLIER -101.36 115.76 31.24 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 121.536 0.684 . . . . 0.0 110.324 174.882 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -119.57 146.85 18.17 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.167 177.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -109.88 106.58 16.21 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 60.9 t -131.85 125.37 55.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.829 0.347 . . . . 0.0 111.025 -171.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 58.74 27.77 16.41 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.336 175.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 91.02 -4.25 81.28 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.721 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 19.3 mtp-105 -113.55 120.2 40.13 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.454 ' HB2' ' HE3' ' A' ' 283' ' ' LYS . 15.1 ptmt -111.39 138.71 47.53 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.24 0.543 . . . . 0.0 110.611 175.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -173.45 -169.73 36.17 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.426 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 87.4 mt -90.41 134.14 34.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.981 0.419 . . . . 0.0 110.734 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -133.7 137.74 29.41 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.983 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -78.06 130.91 10.6 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 122.647 2.231 . . . . 0.0 112.042 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.486 ' HA ' HG21 ' A' ' 291' ' ' VAL . 35.6 p90 -62.33 -17.91 60.04 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.911 0.386 . . . . 0.0 110.731 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.39 -20.18 65.32 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.888 -0.597 . . . . 0.0 112.099 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -105.66 -5.69 19.82 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.713 0.292 . . . . 0.0 111.601 -176.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.486 HG21 ' HA ' ' A' ' 288' ' ' PHE . 33.7 m -123.43 166.26 18.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 120.987 0.422 . . . . 0.0 110.676 -177.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . 0.47 ' HB2' HD12 ' A' ' 243' ' ' ILE . 39.9 tptt -122.4 107.25 11.85 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.543 HD13 ' HB3' ' A' ' 240' ' ' ALA . 4.2 tp -74.54 135.36 27.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -157.14 -29.33 0.09 Allowed 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.321 -0.552 . . . . 0.0 112.042 -175.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.447 ' HA ' ' HB2' ' A' ' 239' ' ' PHE . 32.5 m-20 60.79 97.22 0.04 OUTLIER Pre-proline 0 N--CA 1.464 0.227 0 CA-C-O 121.056 0.455 . . . . 0.0 110.613 -176.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.57 50.05 2.27 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.841 2.361 . . . . 0.0 112.486 -177.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 60.45 50.76 5.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.721 0.772 . . . . 0.0 109.292 -177.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . 0.46 HD21 ' HD1' ' A' ' 239' ' ' PHE . 17.5 p30 -53.28 138.38 48.21 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 114.21 -1.359 . . . . 0.0 111.713 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 298' ' ' ASN . 5.9 Cg_endo -88.39 6.65 4.74 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.335 2.69 . . . . 0.0 112.892 -176.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -68.02 119.25 12.34 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.52 178.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 40.23 48.65 2.33 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 124.487 1.117 . . . . 0.0 112.148 -176.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -79.73 3.07 20.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.773 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.327 -0.844 . . . . 0.0 110.468 -178.746 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.5 ttm . . . . . 0 N--CA 1.48 1.048 0 CA-C-O 120.636 0.255 . . . . 0.0 110.43 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.8 m -119.46 116.31 25.86 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.358 177.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.3 p -70.98 -25.94 62.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.54 0.686 . . . . 0.0 109.767 174.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.79 93.44 5.6 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.122 175.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -115.27 90.34 3.31 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.597 0.713 . . . . 0.0 111.014 -178.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.459 ' CE1' ' HE2' ' A' ' 89' ' ' LYS . 32.1 p90 -160.66 151.67 18.83 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.446 -1.252 . . . . 0.0 108.482 177.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -80.46 115.46 20.0 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 177.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.3 m -67.29 -9.01 36.55 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -173.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.7 t -106.86 -24.43 12.05 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.308 -176.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -63.39 98.83 0.17 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.028 0.442 . . . . 0.0 110.874 -174.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.44 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 2.9 tpp180 -57.11 -43.41 82.25 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.402 -176.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.0 m -75.74 7.0 4.21 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -177.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -95.75 -46.28 6.65 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.613 0.244 . . . . 0.0 110.749 173.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.43 ' HB3' ' HB3' ' A' ' 101' ' ' PRO . 34.7 p-90 -121.68 -26.66 4.85 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -173.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.44 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 60.8 t80 -75.32 107.98 7.79 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.335 0.588 . . . . 0.0 110.03 -176.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.461 ' SD ' ' HG2' ' A' ' 104' ' ' ARG . 5.4 tpp -91.4 -9.53 44.41 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.993 -174.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.416 ' O ' ' HB2' ' A' ' 39' ' ' ARG . . . 50.5 -112.66 1.66 Allowed Glycine 0 C--N 1.333 0.399 0 O-C-N 123.839 0.712 . . . . 0.0 114.293 175.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -74.16 93.66 0.89 Allowed 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.473 2.115 . . . . 0.0 112.461 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.473 ' O ' ' CB ' ' A' ' 20' ' ' SER . 7.3 t -125.7 -77.02 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.954 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.473 ' CB ' ' O ' ' A' ' 19' ' ' VAL . 32.3 t 125.86 156.39 0.0 OUTLIER 'General case' 0 C--N 1.355 0.84 0 C-N-CA 124.973 1.309 . . . . 0.0 108.311 168.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.525 ' HA ' ' NH2' ' A' ' 39' ' ' ARG . 21.1 tpt180 -52.91 -52.33 58.1 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.746 0.308 . . . . 0.0 111.003 178.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -64.77 -33.89 77.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.111 -176.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.615 ' HG2' ' HE ' ' A' ' 27' ' ' ARG . 24.8 tt0 -82.57 -45.99 13.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.929 0.395 . . . . 0.0 110.898 -177.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.49 -38.29 68.96 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.132 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 55.0 tp60 -60.9 -47.52 86.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.342 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.6 t -78.27 -22.66 47.95 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 121.056 -0.258 . . . . 0.0 111.166 -175.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.615 ' HE ' ' HG2' ' A' ' 23' ' ' GLU . 63.9 mtt180 -68.59 -21.19 64.53 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.662 0.268 . . . . 0.0 110.565 177.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.562 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 95.3 mt -125.93 6.96 7.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.154 -0.475 . . . . 0.0 112.276 -176.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -82.89 110.91 18.29 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 122.129 -0.357 . . . . 0.0 110.933 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.77 18.66 74.33 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.841 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.556 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 12.2 mm100 -83.34 -168.33 2.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.604 0.24 . . . . 0.0 110.607 -178.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.564 ' HB2' ' SD ' ' A' ' 35' ' ' MET . 46.3 mtm180 -58.31 141.98 49.4 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 173.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 63.6 m170 -88.33 122.22 31.6 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 120.847 0.356 . . . . 0.0 110.495 -177.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.75 -5.73 14.1 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.91 -175.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.659 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 34.1 mtp -80.3 146.81 31.43 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 122.451 0.3 . . . . 0.0 110.74 177.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -151.81 161.31 42.87 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 121.118 -0.233 . . . . 0.0 110.931 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.525 ' HG ' HD11 ' A' ' 28' ' ' LEU . 4.5 pp -154.75 140.99 18.57 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.057 0.456 . . . . 0.0 111.229 176.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 51.8 t -110.99 112.29 39.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.547 176.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.53 ' HD3' ' O ' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -113.99 -179.3 3.6 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 178.345 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.53 ' O ' ' HD3' ' A' ' 39' ' ' ARG . 4.1 m-20 -66.97 137.83 56.81 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 175.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.495 ' HA ' HG23 ' A' ' 49' ' ' VAL . 46.7 t -54.4 141.74 29.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.179 0.514 . . . . 0.0 111.281 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.2 m -85.53 -13.07 50.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.087 -176.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.43 HG21 ' HB2' ' A' ' 196' ' ' ASN . 22.4 p -125.1 -44.68 1.89 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -174.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.411 ' HA ' ' HD2' ' A' ' 45' ' ' PRO . 3.0 p -114.66 102.36 54.8 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-O 120.858 0.361 . . . . 0.0 111.559 -176.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 44' ' ' CYS . 10.8 Cg_endo -54.59 139.03 76.06 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.881 2.387 . . . . 0.0 111.908 177.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.1 -32.38 7.37 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.251 -177.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -87.42 175.18 8.1 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.856 0.36 . . . . 0.0 110.201 177.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.44 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 38.2 m-85 -131.39 174.28 10.23 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.861 178.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.495 HG23 ' HA ' ' A' ' 41' ' ' SER . 65.0 t -142.47 106.67 1.39 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-O 120.969 0.414 . . . . 0.0 110.952 177.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.6 tp -78.42 104.75 9.22 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.148 175.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.7 m -96.33 132.8 41.46 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 176.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.621 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 86.9 t -124.49 136.27 61.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.882 0.372 . . . . 0.0 111.158 -175.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.562 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 32.2 t -96.38 104.86 16.86 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.207 -172.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.787 ' O ' ' HB3' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -152.8 151.74 30.8 Favored 'General case' 0 C--O 1.204 -1.332 0 C-N-CA 120.287 -0.565 . . . . 0.0 109.704 169.245 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.561 ' HB2' ' HD3' ' A' ' 57' ' ' ARG . 54.9 m-80 56.76 22.76 7.23 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 178.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 46.8 m 54.06 54.8 9.12 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 122.801 1.286 . . . . 0.0 107.964 -172.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.787 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 0.2 OUTLIER -161.96 65.94 0.25 Allowed 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 112.873 -1.967 . . . . 0.0 109.353 -151.168 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.621 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 18.6 t -72.54 97.11 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 121.865 0.841 . . . . 0.0 109.789 -170.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.7 m -68.32 121.12 15.61 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 113.88 -1.509 . . . . 0.0 110.96 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -100.15 107.12 18.91 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.811 0.339 . . . . 0.0 111.491 -176.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.676 ' HE1' HD11 ' A' ' 153' ' ' ILE . 72.8 m-85 -102.34 107.04 17.92 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.128 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.52 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 63.8 mt -80.4 129.37 37.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -174.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.48 HG23 ' HB3' ' A' ' 71' ' ' PHE . 5.0 mp -104.28 114.97 45.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.392 178.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -87.76 139.41 30.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.744 -173.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 31.3 t -81.86 95.05 7.2 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 169.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.53 HD12 ' HB2' ' A' ' 72' ' ' LYS . 91.9 mt -74.63 148.45 85.37 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.996 -176.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.67 -14.85 45.23 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.682 2.255 . . . . 0.0 110.617 171.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.35 -3.01 24.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.847 176.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.472 ' NE ' ' HA ' ' A' ' 69' ' ' ARG . 3.7 mmp_? 66.38 26.27 10.21 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.291 0.567 . . . . 0.0 110.049 -173.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 47.7 mtp180 -123.76 -179.64 4.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.599 -177.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.48 ' HB3' HG23 ' A' ' 63' ' ' ILE . 29.2 m-85 -127.87 115.9 19.31 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -173.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.563 ' HA ' ' HA ' ' A' ' 77' ' ' GLU . 38.6 ttmt -102.09 116.47 32.76 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.188 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.52 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 11.7 tt -94.7 93.04 3.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.707 0.765 . . . . 0.0 110.773 -178.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.62 69.92 1.16 Allowed Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.438 -0.801 . . . . 0.0 113.075 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.507 ' HA ' ' HD3' ' A' ' 72' ' ' LYS . 31.4 t70 75.47 -38.76 0.37 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.139 0.576 . . . . 0.0 112.354 176.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -80.83 114.22 19.57 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 9.5 pt-20 -95.07 134.33 37.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.681 0.753 . . . . 0.0 112.177 -174.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -119.27 179.03 4.31 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.528 171.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.24 -32.4 22.61 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 -175.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.491 ' HD1' ' HD2' ' A' ' 82' ' ' PRO . 5.5 p80 -161.68 167.66 24.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.673 0.273 . . . . 0.0 111.074 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.606 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 14.5 mt -53.94 -56.47 25.3 Favored Pre-proline 0 N--CA 1.467 0.398 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.403 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.606 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 29.7 Cg_exo -65.94 2.17 1.89 Allowed 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.409 2.072 . . . . 0.0 113.204 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -98.7 -34.91 10.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.839 0.352 . . . . 0.0 110.567 176.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.2 pp -76.56 -33.9 58.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.134 0.492 . . . . 0.0 109.78 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.445 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 72.8 mt -67.89 -14.76 63.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.185 176.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -88.94 -40.2 13.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.247 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -71.77 -28.97 63.99 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.784 -178.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.472 ' CG ' HD22 ' A' ' 93' ' ' LEU . 20.7 m-85 -84.58 -2.5 57.49 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -177.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.459 ' HE2' ' CE1' ' A' ' 6' ' ' PHE . 98.8 mttt -73.3 -6.89 48.96 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.099 174.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.6 pt -132.91 -6.45 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.232 0 CA-C-O 120.938 0.399 . . . . 0.0 110.573 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -93.16 -34.19 13.72 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.516 -171.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 70.87 128.36 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.159 0 O-C-N 124.411 1.07 . . . . 0.0 109.956 -169.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.541 ' HB3' ' CZ ' ' A' ' 61' ' ' TYR . 0.9 OUTLIER -103.75 -14.96 15.88 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.767 0.794 . . . . 0.0 109.783 173.084 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.848 ' HA ' ' HB3' ' A' ' 154' ' ' GLU . 1.5 m-20 -133.22 -100.01 0.27 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.613 -177.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.763 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 14.0 t -134.13 14.76 3.87 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 165.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.512 HG22 ' HG3' ' A' ' 54' ' ' GLU . 3.8 t -140.84 169.88 16.8 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 113.962 -1.472 . . . . 0.0 107.403 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.6 p -104.11 -179.38 3.93 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 176.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 74.2 mt -68.39 88.59 0.33 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 175.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 48.9 mm -78.25 -54.98 11.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.137 -173.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.659 ' O ' ' HA ' ' A' ' 35' ' ' MET . 39.7 tt0 -160.09 136.71 6.53 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.925 -177.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.43 ' HB3' ' HB3' ' A' ' 14' ' ' TRP . 18.2 Cg_endo -59.9 158.95 27.04 Favored 'Trans proline' 0 CA--C 1.531 0.325 0 C-N-CA 122.793 2.329 . . . . 0.0 112.743 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.469 ' HB1' HD21 ' A' ' 28' ' ' LEU . . . -75.17 145.4 80.35 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.844 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -55.66 130.93 43.08 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.634 2.223 . . . . 0.0 111.514 174.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.461 ' HG2' ' SD ' ' A' ' 16' ' ' MET . 78.3 mtp180 -76.56 -40.58 49.31 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.248 -174.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -140.75 100.43 6.66 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -73.3 70.93 3.82 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 123.284 2.656 . . . . 0.0 113.004 -176.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.888 ' HB3' ' HD3' ' A' ' 108' ' ' PRO . 47.2 t -93.23 -61.48 0.19 Allowed Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 173.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.888 ' HD3' ' HB3' ' A' ' 107' ' ' SER . 24.2 Cg_exo -65.59 -55.78 0.4 Allowed 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 121.851 1.701 . . . . 0.0 112.951 171.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.591 ' HD3' ' HB2' ' A' ' 108' ' ' PRO . 8.4 Cg_exo -72.01 107.01 2.13 Favored 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 121.662 1.575 . . . . 0.0 111.389 177.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 25.9 ttt -145.44 158.6 43.81 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -178.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 100.58 -81.74 0.49 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.145 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 55.0 p -80.41 39.59 0.47 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.927 0.394 . . . . 0.0 111.047 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.454 HG12 ' H ' ' A' ' 114' ' ' SER . 3.3 p -65.47 -54.47 28.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.286 -176.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.454 ' H ' HG12 ' A' ' 113' ' ' VAL . 0.9 OUTLIER -97.63 36.66 1.47 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.183 0.516 . . . . 0.0 111.23 -178.773 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.447 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . . . -97.86 107.59 41.21 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.915 176.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 115' ' ' ALA . 7.1 Cg_endo -86.43 -177.47 2.39 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 123.195 2.596 . . . . 0.0 112.56 -175.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.408 ' O ' ' HB2' ' A' ' 118' ' ' LEU . 2.1 m-20 -104.79 102.99 12.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.816 179.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.408 ' HB2' ' O ' ' A' ' 117' ' ' ASN . 10.5 mp 70.57 165.05 0.14 Allowed Pre-proline 0 CA--C 1.535 0.389 0 O-C-N 123.597 0.56 . . . . 0.0 111.492 176.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -73.37 17.5 0.43 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.311 2.674 . . . . 0.0 113.217 178.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 6.8 m -76.18 83.29 3.0 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 178.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -172.98 175.57 3.23 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.49 -177.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 61.57 -149.48 0.4 Allowed 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.056 -0.975 . . . . 0.0 113.627 169.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.3 t70 78.18 -61.76 0.37 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.646 -173.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.624 ' CG ' ' H ' ' A' ' 125' ' ' LEU . 4.0 p30 -176.12 -101.53 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 172.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.624 ' H ' ' CG ' ' A' ' 124' ' ' ASN . 4.0 mm? 64.35 96.61 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 122.128 0.966 . . . . 0.0 112.686 168.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -169.6 -60.37 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 113.866 -1.516 . . . . 0.0 107.614 -176.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.434 ' HD2' ' CG1' ' A' ' 182' ' ' VAL . 43.1 m-85 -123.0 133.48 54.36 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.95 176.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.555 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 23.7 t -133.18 160.86 42.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.756 ' HG2' ' O ' ' A' ' 180' ' ' LYS . 2.0 ptp180 -138.39 138.03 37.86 Favored 'General case' 0 CA--C 1.494 -1.2 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.924 171.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.6 HG23 ' OE2' ' A' ' 148' ' ' GLU . 30.4 p -92.75 140.44 29.52 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.566 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.5 mt -114.06 -5.08 13.11 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.82 -172.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.48 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 59.7 t80 -107.21 -42.68 4.79 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -171.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.691 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 16.1 t70 79.79 93.5 0.05 Allowed 'General case' 0 N--CA 1.474 0.73 0 O-C-N 123.778 0.673 . . . . 0.0 110.63 -173.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.563 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 68.4 t80 -124.07 88.06 52.89 Favored Pre-proline 0 N--CA 1.45 -0.436 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 172.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.589 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 95.4 Cg_endo -84.55 84.82 1.42 Allowed 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 121.488 1.459 . . . . 0.0 112.239 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.54 -25.0 75.26 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 173.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.68 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 19.8 m120 53.68 72.09 0.46 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.214 -0.993 . . . . 0.0 111.17 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -141.88 173.11 11.81 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.483 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -100.33 12.03 38.07 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -127.57 -36.64 2.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.048 -1.433 . . . . 0.0 109.261 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -113.77 128.04 56.26 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 173.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.753 ' CD1' ' HB2' ' A' ' 165' ' ' ASN . 32.4 tp -83.29 124.72 75.73 Favored Pre-proline 0 C--N 1.325 -0.489 0 C-N-CA 120.178 -0.609 . . . . 0.0 111.457 -176.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.68 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 57.4 Cg_endo -76.31 102.41 1.61 Allowed 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 121.71 1.607 . . . . 0.0 111.673 167.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.563 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 0.5 OUTLIER -92.03 -163.84 1.1 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.938 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.691 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 55.4 mttp -134.8 -176.02 4.09 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.114 175.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.733 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -77.61 39.61 0.28 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.481 0.657 . . . . 0.0 111.382 -174.641 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.454 ' HA2' ' O ' ' A' ' 130' ' ' THR . . . 136.05 49.16 0.07 OUTLIER Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 -176.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.702 ' OE2' ' HG ' ' A' ' 150' ' ' LEU . 1.2 pp20? -92.28 179.26 5.6 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.3 mp -118.48 124.48 73.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 175.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.729 ' CD2' ' HA ' ' A' ' 165' ' ' ASN . 72.5 mt -118.91 156.44 29.52 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.405 0.621 . . . . 0.0 109.691 -172.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.531 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 52.4 t -118.49 122.95 70.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 173.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.484 HD12 ' HB3' ' A' ' 161' ' ' TRP . 46.5 mm -77.54 79.61 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.468 0 CA-C-O 122.519 1.152 . . . . 0.0 108.964 -175.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.676 HD11 ' HE1' ' A' ' 61' ' ' TYR . 21.0 tt -65.87 -27.31 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 CA-C-N 113.107 -1.86 . . . . 0.0 109.852 -176.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.848 ' HB3' ' HA ' ' A' ' 94' ' ' ASP . 0.2 OUTLIER -145.83 146.45 31.15 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 121.143 0.497 . . . . 0.0 110.957 171.248 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.559 ' HD2' ' HG ' ' A' ' 125' ' ' LEU . 86.3 tttt -126.14 87.69 55.68 Favored Pre-proline 0 C--N 1.319 -0.758 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 168.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.763 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 5.4 Cg_exo -81.58 -51.55 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.993 2.462 . . . . 0.0 111.721 175.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.677 ' HG2' ' CE ' ' A' ' 172' ' ' MET . 6.1 mm-40 -97.39 160.75 14.14 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.094 0.474 . . . . 0.0 111.049 -175.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -85.25 -33.14 22.25 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.914 175.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -92.82 -17.15 24.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.399 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.415 ' HB2' ' HB2' ' A' ' 157' ' ' GLU . 62.7 m95 -127.41 124.17 37.86 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.116 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . 0.592 ' CZ3' HD11 ' A' ' 125' ' ' LEU . 45.9 m0 -110.67 136.27 50.02 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.702 ' OG ' ' HG2' ' A' ' 172' ' ' MET . 38.0 m -97.35 109.09 21.92 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -173.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.541 ' HB2' ' HB3' ' A' ' 150' ' ' LEU . . . -122.85 152.1 41.07 Favored 'General case' 0 N--CA 1.426 -1.657 0 C-N-CA 119.888 -0.725 . . . . 0.0 110.405 -174.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.824 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 9.8 ptt180 -87.69 126.88 35.23 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 171.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.753 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . 64.2 t30 -60.31 178.09 0.22 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.306 -1.315 . . . . 0.0 111.406 -172.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 19.5 tttp -58.15 -11.99 3.1 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.866 167.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -89.84 -27.65 19.79 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.393 174.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 105.07 -0.81 41.04 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.729 -175.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.824 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 3.3 ttm-85 -76.11 140.02 41.61 Favored 'General case' 0 C--O 1.217 -0.61 0 C-N-CA 123.324 0.65 . . . . 0.0 112.008 -177.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.469 HG23 HD12 ' A' ' 153' ' ' ILE . 48.1 t -87.21 123.52 40.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 111.353 0.131 . . . . 0.0 111.353 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -158.12 151.9 23.05 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.258 172.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.702 ' HG2' ' OG ' ' A' ' 162' ' ' SER . 36.8 mtp -81.37 142.73 32.75 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.885 0.342 . . . . 0.0 110.583 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.678 ' CD1' HG12 ' A' ' 178' ' ' VAL . 2.8 pp -143.24 150.63 52.72 Favored Pre-proline 0 C--O 1.222 -0.349 0 O-C-N 123.442 0.464 . . . . 0.0 111.119 -178.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.5 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 6.7 Cg_exo -72.82 132.1 18.05 Favored 'Trans proline' 0 CA--C 1.529 0.241 0 C-N-CA 122.387 2.058 . . . . 0.0 112.615 -176.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.545 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 18.3 t -57.9 -43.1 98.31 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 32.8 Cg_endo -64.84 -2.36 5.33 Favored 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 122.049 1.833 . . . . 0.0 113.116 176.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.5 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 4.5 m-85 -98.2 -18.45 18.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.71 177.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.678 HG12 ' CD1' ' A' ' 173' ' ' ILE . 2.2 m -130.68 -172.32 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.102 -168.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.896 ' HG3' ' H ' ' A' ' 180' ' ' LYS . 8.7 pt-20 -156.34 -65.67 0.11 Allowed 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 117.404 2.372 . . . . 0.0 117.404 152.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.896 ' H ' ' HG3' ' A' ' 179' ' ' GLU . 4.2 mptt -157.59 -177.54 6.66 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.153 0.888 . . . . 0.0 109.891 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.412 ' HG ' ' NH2' ' A' ' 129' ' ' ARG . 0.1 OUTLIER -128.71 -68.67 0.74 Allowed 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 153.421 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.434 ' CG1' ' HD2' ' A' ' 127' ' ' TYR . 4.1 p -108.74 99.78 9.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.494 0.664 . . . . 0.0 109.296 171.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.669 ' HB2' ' HG2' ' A' ' 180' ' ' LYS . 68.5 ttt180 -86.94 99.81 12.14 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.458 -176.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 18.6 m -84.14 95.33 8.59 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.87 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 3.3 p -74.8 167.6 34.94 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.258 177.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -49.11 105.6 0.1 OUTLIER 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.971 2.448 . . . . 0.0 113.294 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -131.55 -27.69 1.92 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.758 175.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 124.04 -70.42 0.45 Allowed Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 110.191 -1.163 . . . . 0.0 110.191 -176.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 16.2 pttm -135.87 133.75 38.07 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 171.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -86.92 -49.45 7.37 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.078 0.466 . . . . 0.0 110.112 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 132.22 111.69 1.35 Allowed Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 -175.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -87.96 99.25 12.01 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -177.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 193' ' ' ARG . 12.4 ttt180 -66.39 -55.39 16.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.345 -177.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 65.59 123.69 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 O-C-N 123.732 0.645 . . . . 0.0 109.962 -172.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 46.6 m -138.11 24.42 2.77 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.127 0.489 . . . . 0.0 111.639 -175.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . 0.43 ' HB2' HG21 ' A' ' 43' ' ' THR . 15.5 m120 -86.51 157.13 19.84 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.567 175.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 11.6 t -168.94 -165.85 0.59 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -176.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 65.9 -171.12 0.19 Allowed 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.764 0.665 . . . . 0.0 110.688 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 84.32 80.33 1.07 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.42 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.444 ' N ' HD13 ' A' ' 200' ' ' ILE . 0.1 OUTLIER -123.72 96.8 42.62 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-O 121.226 0.536 . . . . 0.0 110.7 178.88 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -76.21 -15.5 18.12 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.506 2.138 . . . . 0.0 112.473 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 65.17 101.99 0.04 OUTLIER Pre-proline 0 N--CA 1.463 0.204 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.194 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.75 118.02 4.91 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 122.595 2.197 . . . . 0.0 111.321 176.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -138.53 -67.81 0.46 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.462 -176.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -79.31 87.61 4.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.188 0.518 . . . . 0.0 110.703 -177.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -118.24 -5.97 10.86 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.778 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -115.82 114.65 25.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.185 0.517 . . . . 0.0 111.337 -178.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -150.47 123.99 9.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.829 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 0.442 ' HA ' ' HD3' ' A' ' 210' ' ' PRO . 9.6 tt0 -94.98 115.83 65.76 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.348 -179.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 209' ' ' GLN . 7.7 Cg_exo -72.65 100.32 1.15 Allowed 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.749 2.3 . . . . 0.0 112.105 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -108.14 3.13 23.47 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.282 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.569 HG21 HD11 ' A' ' 216' ' ' LEU . 16.8 m -77.13 79.42 3.66 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.215 0.531 . . . . 0.0 110.922 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 10.4 p -91.27 -72.32 0.59 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.546 172.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.723 ' H ' ' HD3' ' A' ' 215' ' ' PRO . 12.1 t -161.77 27.37 0.03 OUTLIER Pre-proline 0 CA--C 1.552 1.03 0 N-CA-C 112.781 0.659 . . . . 0.0 112.781 173.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.723 ' HD3' ' H ' ' A' ' 214' ' ' THR . 94.6 Cg_endo -96.48 11.37 1.26 Allowed 'Trans proline' 0 C--N 1.362 1.28 0 C-N-CA 121.896 1.73 . . . . 0.0 112.293 -175.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.596 ' HB2' ' HD2' ' A' ' 217' ' ' PRO . 2.5 pp -157.17 165.98 17.63 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.758 -176.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.596 ' HD2' ' HB2' ' A' ' 216' ' ' LEU . 9.6 Cg_endo -51.87 -37.39 66.23 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.35 2.7 . . . . 0.0 113.377 -177.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . 67.84 13.27 9.15 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 122.875 0.47 . . . . 0.0 111.697 178.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 9.5 p -69.8 -26.86 31.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.342 0.591 . . . . 0.0 110.075 176.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 13.5 t -139.02 155.07 48.25 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -70.99 -42.18 59.98 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.365 -177.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 13.8 p -96.52 112.92 61.57 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-O 120.47 0.176 . . . . 0.0 110.958 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -66.44 113.08 2.55 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.684 2.256 . . . . 0.0 111.64 177.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -162.59 44.39 0.35 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 121.115 -0.564 . . . . 0.0 111.727 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -107.35 -23.59 12.16 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.103 0.477 . . . . 0.0 110.241 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -83.0 61.57 6.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.351 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 62.5 mt -66.25 -36.71 78.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 176.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 19.1 m 68.11 95.93 0.05 OUTLIER Pre-proline 0 C--O 1.235 0.296 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.762 176.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -56.47 133.42 57.93 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.719 2.279 . . . . 0.0 111.608 177.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.586 ' H ' HD22 ' A' ' 230' ' ' LEU . 2.4 pt? -67.85 148.45 98.46 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.92 -177.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 230' ' ' LEU . 21.7 Cg_exo -66.07 176.81 3.5 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.878 2.385 . . . . 0.0 111.998 175.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 25.1 m -95.61 51.01 1.25 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.012 0.434 . . . . 0.0 110.993 -176.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 2.8 p -74.89 104.06 5.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.019 0.438 . . . . 0.0 110.311 177.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -76.39 98.93 4.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.028 0.442 . . . . 0.0 111.48 -175.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -157.63 7.81 0.16 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.767 174.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 80.98 -175.92 54.73 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.108 -177.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.09 148.11 30.81 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.718 2.279 . . . . 0.0 111.02 174.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.476 ' HB ' HG12 ' A' ' 266' ' ' VAL . 66.8 t -77.06 123.83 34.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.92 0.391 . . . . 0.0 110.562 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -99.04 115.25 28.55 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.999 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.513 ' HB3' HD12 ' A' ' 293' ' ' ILE . . . -119.37 121.16 38.9 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.091 178.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.528 ' HB2' ' CE1' ' A' ' 294' ' ' PHE . 48.2 tttp -86.68 118.85 26.36 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -178.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -72.8 102.59 3.42 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 9.6 pt -89.47 4.6 5.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.955 0.407 . . . . 0.0 111.142 -176.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -149.89 149.11 29.96 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 173.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 10.3 ptpp? -75.59 175.88 8.15 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.02 0.438 . . . . 0.0 111.169 -176.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.462 ' CB ' HG22 ' A' ' 289' ' ' THR . 21.4 tpt180 -157.08 127.41 6.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.979 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 28.0 m -121.37 143.57 37.91 Favored Pre-proline 0 C--N 1.32 -0.706 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 171.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.58 104.51 0.79 Allowed 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.179 1.919 . . . . 0.0 111.694 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 1.7 t -72.61 169.7 16.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.862 -178.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.74 -32.43 69.23 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.806 0.336 . . . . 0.0 111.609 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -95.08 -15.42 23.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.948 0.404 . . . . 0.0 110.886 177.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.458 ' HB3' ' HB1' ' A' ' 255' ' ' ALA . 60.3 m-20 -100.69 67.93 1.3 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.061 0.458 . . . . 0.0 110.071 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . 0.653 ' H ' ' HD2' ' A' ' 253' ' ' LYS . 0.0 OUTLIER -75.24 -33.99 61.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.291 -174.95 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.66 -1.04 57.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.554 -178.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.458 ' HB1' ' HB3' ' A' ' 252' ' ' ASP . . . -70.12 126.06 28.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.165 0.507 . . . . 0.0 111.81 -175.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.3 tt -71.77 134.16 46.02 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.315 176.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -84.92 128.95 34.85 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 89.4 mt -135.43 165.53 25.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.59 -172.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -129.49 -177.25 4.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.08 177.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 39.8 t -80.83 129.88 36.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.865 -178.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 80.37 11.81 83.8 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.654 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -87.14 140.28 29.71 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -176.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 38.5 mm -88.11 110.28 20.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.992 0.425 . . . . 0.0 110.561 -178.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 20.9 t -88.1 102.99 13.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.287 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 5.6 tppp? -79.44 95.1 5.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.232 177.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.476 HG12 ' HB ' ' A' ' 238' ' ' VAL . 4.5 p -99.88 117.42 45.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.384 0.612 . . . . 0.0 110.4 177.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' THR . . . . . 0.509 ' OG1' ' HD2' ' A' ' 268' ' ' ARG . 20.2 p -104.19 -18.9 14.32 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.155 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . 0.509 ' HD2' ' OG1' ' A' ' 267' ' ' THR . 0.1 OUTLIER -130.48 91.79 3.15 Favored 'General case' 0 C--O 1.224 -0.281 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 176.847 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' MET . . . . . 0.407 ' HB3' ' HE3' ' A' ' 269' ' ' MET . 6.5 ptp -98.56 130.51 45.12 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 119.531 -0.868 . . . . 0.0 111.028 177.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -103.28 150.1 24.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.153 -174.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.401 ' H ' HG13 ' A' ' 271' ' ' ILE . 1.8 pp -71.87 -5.8 6.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.419 0.628 . . . . 0.0 110.941 175.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -70.75 -21.03 62.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.087 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 110.93 -47.67 1.02 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.683 -178.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.464 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 59.1 mt-30 -80.18 121.13 25.2 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 174.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 34.2 m0 -103.36 149.98 24.24 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . 0.434 ' HB3' ' HB2' ' A' ' 268' ' ' ARG . 34.3 tt0 -99.53 116.81 32.51 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.074 0.464 . . . . 0.0 109.929 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -139.94 164.44 26.12 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.934 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.53 ' HG2' ' HB2' ' A' ' 283' ' ' LYS . 37.2 mt-10 -123.42 109.85 14.38 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 25.6 t -123.62 -81.06 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 120.354 -0.539 . . . . 0.0 111.793 -175.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -91.96 77.2 5.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.793 0.33 . . . . 0.0 111.284 -173.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 50.5 34.73 27.75 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.372 -0.831 . . . . 0.0 113.335 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 282' ' ' ARG . 34.0 ttt-85 -170.71 138.75 1.45 Allowed 'General case' 0 C--O 1.237 0.423 0 CA-C-O 120.895 0.379 . . . . 0.0 111.0 -173.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.53 ' HB2' ' HG2' ' A' ' 278' ' ' GLU . 38.2 ttpt -99.72 137.85 37.63 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.087 173.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -158.13 169.98 34.85 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.167 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.464 ' HB3' ' HB3' ' A' ' 274' ' ' GLN . 62.8 mt -97.59 113.3 25.0 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 176.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.759 ' HD2' ' H ' ' A' ' 289' ' ' THR . 49.4 p90 -113.72 125.31 29.68 Favored Pre-proline 0 C--N 1.315 -0.931 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.468 -177.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 35.0 Cg_exo -64.06 70.93 0.19 Allowed 'Trans proline' 0 N--CA 1.479 0.665 0 C-N-CA 123.709 2.939 . . . . 0.0 112.689 176.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.539 ' O ' ' N ' ' A' ' 290' ' ' HIS . 34.5 p90 37.96 40.55 0.3 Allowed 'General case' 0 CA--C 1.49 -1.355 0 O-C-N 124.447 1.092 . . . . 0.0 108.689 -171.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' THR . . . . . 0.759 ' H ' ' HD2' ' A' ' 286' ' ' PHE . 41.9 m -40.81 73.41 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.043 0 O-C-N 126.499 2.374 . . . . 0.0 112.995 -156.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . 0.539 ' N ' ' O ' ' A' ' 288' ' ' PHE . 16.4 m80 63.87 25.21 13.95 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 112.192 -2.276 . . . . 0.0 109.363 169.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.493 ' HB ' ' HB1' ' A' ' 240' ' ' ALA . 33.5 m -88.58 169.71 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 121.41 0.624 . . . . 0.0 111.621 -173.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -129.69 114.36 15.91 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.115 178.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.513 HD12 ' HB3' ' A' ' 240' ' ' ALA . 50.2 mm -72.0 124.55 28.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.331 -178.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' PHE . . . . . 0.528 ' CE1' ' HB2' ' A' ' 241' ' ' LYS . 1.8 p90 -154.27 -176.01 5.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.984 -178.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.578 ' OD2' ' HB2' ' A' ' 297' ' ' GLN . 21.1 t70 -130.37 116.96 17.64 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 172.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.62 -13.31 34.84 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.789 2.326 . . . . 0.0 112.508 -177.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . 0.578 ' HB2' ' OD2' ' A' ' 295' ' ' ASP . 18.1 mt-30 -72.27 -46.86 54.09 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.67 178.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . 0.42 ' HA ' ' HD3' ' A' ' 299' ' ' PRO . 0.3 OUTLIER -110.47 96.44 27.32 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-O 121.712 0.768 . . . . 0.0 110.723 171.8 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 298' ' ' ASN . 2.9 Cg_exo -76.57 35.96 0.49 Allowed 'Trans proline' 0 CA--C 1.528 0.211 0 C-N-CA 123.306 2.671 . . . . 0.0 113.272 -173.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -79.51 -65.64 0.97 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.696 0.284 . . . . 0.0 110.349 177.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -90.45 85.54 6.19 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.973 0.416 . . . . 0.0 110.738 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -178.57 141.24 0.21 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.356 174.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 . . . . . 0 C--O 1.246 0.895 0 CA-C-O 118.295 -0.859 . . . . 0.0 110.55 177.625 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.4 tpp . . . . . 0 N--CA 1.481 1.119 0 CA-C-O 120.924 0.392 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m -83.71 118.5 23.92 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.16 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.559 ' O ' HG23 ' A' ' 99' ' ' ILE . 16.1 m -61.58 -56.13 23.22 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.128 0.489 . . . . 0.0 109.714 173.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.5 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . -78.79 105.81 10.36 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.996 176.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 32.6 ttm180 -138.84 97.12 3.25 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.331 0.586 . . . . 0.0 111.113 -176.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -168.45 163.04 12.57 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.726 178.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.452 ' HB2' ' HB2' ' A' ' 10' ' ' ASP . 22.8 m-20 -89.19 117.08 27.91 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 174.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.8 m -66.57 -13.53 61.15 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.092 -0.503 . . . . 0.0 112.086 -172.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.7 t -115.54 -0.16 13.14 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.26 0.552 . . . . 0.0 111.107 -176.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.452 ' HB2' ' HB2' ' A' ' 7' ' ' ASP . 8.1 t0 -79.47 91.68 5.16 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 121.916 -0.49 . . . . 0.0 110.232 -177.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.493 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 5.0 mtm-85 -69.44 -14.25 62.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.513 -178.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.7 t -84.9 0.04 52.48 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 175.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -109.95 -48.79 3.15 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 40.2 p-90 -108.86 -20.45 13.05 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -173.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.493 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 19.3 t80 -73.38 108.89 6.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.094 0.473 . . . . 0.0 109.808 -177.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.708 ' HG3' HG23 ' A' ' 19' ' ' VAL . 12.0 tpp -89.01 -8.45 54.02 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.901 -171.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.495 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 50.23 -114.97 2.83 Favored Glycine 0 CA--C 1.522 0.475 0 CA-C-N 115.269 -0.878 . . . . 0.0 114.438 177.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.495 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 8.5 Cg_exo -72.52 82.14 1.45 Allowed 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 123.202 2.601 . . . . 0.0 113.158 -173.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.708 HG23 ' HG3' ' A' ' 16' ' ' MET . 44.0 t -142.02 166.4 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.515 ' H ' HG13 ' A' ' 19' ' ' VAL . 15.6 m -137.79 172.12 13.42 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -170.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 54.8 mtp85 -54.53 -53.79 49.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 118.154 0.434 . . . . 0.0 111.925 -177.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -57.89 -63.13 1.36 Allowed 'General case' 0 C--N 1.327 -0.374 0 O-C-N 123.477 0.486 . . . . 0.0 111.087 -177.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.441 ' O ' ' HB ' ' A' ' 26' ' ' THR . 36.6 tt0 -57.95 -45.45 86.62 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.67 -176.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.433 ' HB1' HG13 ' A' ' 19' ' ' VAL . . . -57.09 -50.8 71.65 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 120.933 0.397 . . . . 0.0 111.375 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.64 ' HG3' ' HB ' ' A' ' 58' ' ' VAL . 18.5 tt0 -64.4 -32.91 74.72 Favored 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.441 ' HB ' ' O ' ' A' ' 23' ' ' GLU . 7.8 m -59.81 -41.93 92.34 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.607 174.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.489 ' O ' ' HG3' ' A' ' 31' ' ' GLN . 95.4 mtt180 -68.8 -14.44 63.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.893 0.377 . . . . 0.0 110.896 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.586 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 72.3 mt -120.62 -12.6 8.87 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -174.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.757 HE21 ' HA ' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -70.03 105.77 2.99 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.833 0.349 . . . . 0.0 111.024 -174.328 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 117' ' ' ASN . . . 72.64 5.35 63.77 Favored Glycine 0 C--O 1.226 -0.398 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.241 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.489 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 12.9 mm100 -80.67 -162.16 0.45 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.845 0.355 . . . . 0.0 111.194 -176.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.448 ' HA ' ' CB ' ' A' ' 116' ' ' PRO . 34.7 mtm180 -59.31 119.29 7.15 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.984 0.421 . . . . 0.0 110.098 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.585 ' H ' ' HB3' ' A' ' 116' ' ' PRO . 27.4 m170 -76.6 125.93 30.1 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.952 -177.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.42 -6.25 22.96 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 -175.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.573 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 51.3 mtm -82.93 146.64 28.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.762 0.315 . . . . 0.0 110.216 177.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -145.94 163.6 34.64 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 176.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.443 HD13 ' O ' ' A' ' 37' ' ' LEU . 4.4 pp -152.61 137.21 16.87 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.058 0.456 . . . . 0.0 111.067 177.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.9 t -107.1 105.38 18.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 173.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.402 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 25.8 ptt-85 -104.13 166.69 10.24 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.731 -175.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -76.79 124.23 27.38 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 174.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.514 ' HB2' HG22 ' A' ' 49' ' ' VAL . 25.6 t -99.39 166.19 11.3 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.24 0.543 . . . . 0.0 111.225 -173.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.8 m -118.28 18.16 13.76 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.999 -175.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.2 m -75.02 -43.91 51.02 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 177.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 49.5 t -168.09 112.93 0.59 Allowed Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.696 177.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -34.67 102.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 124.155 3.237 . . . . 0.0 113.433 -175.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 134.1 -25.43 3.5 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.638 -175.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -83.17 151.59 25.63 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 177.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -128.43 174.08 9.65 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -178.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.514 HG22 ' HB2' ' A' ' 41' ' ' SER . 58.5 t -137.74 112.81 9.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.425 0.631 . . . . 0.0 111.541 176.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.513 HD21 HD12 ' A' ' 73' ' ' ILE . 51.5 tp -81.01 98.34 7.91 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.225 -1.352 . . . . 0.0 109.698 174.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.3 m -96.0 128.93 43.33 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 175.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.614 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 94.6 t -122.06 142.4 38.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.117 -174.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.586 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 45.0 t -105.89 114.91 29.35 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -175.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.53 155.65 33.77 Favored 'General case' 0 C--O 1.207 -1.18 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 160.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 59.13 20.42 8.38 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 174.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.511 ' OG ' ' HA ' ' A' ' 119' ' ' PRO . 22.3 m 56.43 54.34 7.67 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 122.797 1.284 . . . . 0.0 108.082 -172.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.412 HH22 ' C ' ' A' ' 153' ' ' ILE . 0.2 OUTLIER -162.33 64.03 0.22 Allowed 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 112.751 -2.022 . . . . 0.0 109.493 -151.166 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.64 ' HB ' ' HG3' ' A' ' 25' ' ' GLN . 26.1 t -74.65 99.94 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 122.032 0.92 . . . . 0.0 111.03 -168.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.3 m -67.84 120.9 14.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 113.985 -1.461 . . . . 0.0 111.255 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -96.68 109.32 21.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.882 0.372 . . . . 0.0 111.513 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.572 ' HB3' HD13 ' A' ' 73' ' ' ILE . 89.4 m-85 -106.0 117.59 34.43 Favored 'General case' 0 C--O 1.216 -0.709 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.537 177.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.693 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 53.4 mt -80.36 145.99 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 O-C-N 121.872 -0.517 . . . . 0.0 111.076 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.646 HG13 HG12 ' A' ' 73' ' ' ILE . 4.8 mp -129.53 104.11 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.122 0.487 . . . . 0.0 110.455 177.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.537 ' HB2' ' HB3' ' A' ' 72' ' ' LYS . 31.0 m-80 -90.56 142.75 27.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.485 -172.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 31.6 t -81.82 97.17 7.87 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 172.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.0 mt -73.99 143.44 80.85 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.543 -177.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.5 -23.29 70.16 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 123.078 2.518 . . . . 0.0 112.555 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 36.8 p30 -83.64 12.34 5.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.8 177.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 69' ' ' ARG . 5.2 tpp85 69.79 25.82 4.97 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.465 0.65 . . . . 0.0 111.317 175.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.7 ' HG2' ' HA ' ' A' ' 79' ' ' ASP . 68.1 mtt180 -113.71 -174.81 2.54 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.815 174.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.487 ' HB3' HG23 ' A' ' 63' ' ' ILE . 39.1 m-85 -131.09 131.78 44.41 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.019 0.438 . . . . 0.0 111.471 -177.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.537 ' HB3' ' HB2' ' A' ' 64' ' ' ASN . 14.6 tppt? -97.58 100.92 12.33 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.679 177.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.693 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 0.0 OUTLIER -99.1 86.4 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 122.92 1.343 . . . . 0.0 109.017 -177.262 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.16 -110.76 3.74 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.502 -174.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.423 ' HB2' ' O ' ' A' ' 168' ' ' GLY . 26.4 t0 -108.24 -18.99 13.63 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.575 0.702 . . . . 0.0 109.536 176.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -90.74 136.35 33.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.747 -176.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.468 ' HB3' ' HE2' ' A' ' 72' ' ' LYS . 0.9 OUTLIER -110.41 128.13 55.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.364 0.602 . . . . 0.0 111.025 175.306 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.422 ' O ' ' HB3' ' A' ' 70' ' ' ARG . 8.8 m-85 -122.88 172.24 8.62 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 176.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.7 ' HA ' ' HG2' ' A' ' 70' ' ' ARG . 5.7 m-20 -75.09 -34.84 61.81 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -172.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.882 ' HD1' ' HG2' ' A' ' 82' ' ' PRO . 3.3 p80 -156.58 166.66 32.76 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 121.33 -0.148 . . . . 0.0 110.819 -178.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.538 HD21 HD22 ' A' ' 84' ' ' LEU . 18.0 mt -54.94 -54.68 47.17 Favored Pre-proline 0 N--CA 1.469 0.487 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -177.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.882 ' HG2' ' HD1' ' A' ' 80' ' ' HIS . 18.0 Cg_endo -61.67 -10.51 17.01 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.172 1.914 . . . . 0.0 113.418 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.421 ' HB3' ' CE1' ' A' ' 80' ' ' HIS . . . -90.62 -36.79 14.2 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.873 0.368 . . . . 0.0 110.554 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.648 HD11 HG13 ' A' ' 73' ' ' ILE . 3.2 pp -76.92 -35.78 57.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.92 0.39 . . . . 0.0 110.022 -178.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.488 ' O ' ' HG2' ' A' ' 89' ' ' LYS . 89.1 mt -64.91 -24.1 67.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.999 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.498 ' HA ' ' CG ' ' A' ' 89' ' ' LYS . 26.9 tt0 -83.09 -22.34 33.45 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.79 -176.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -72.2 -35.67 69.0 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.731 0.777 . . . . 0.0 109.547 175.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.755 ' CG ' HD22 ' A' ' 93' ' ' LEU . 74.5 m-85 -86.63 1.43 51.87 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.43 -176.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.498 ' CG ' ' HA ' ' A' ' 86' ' ' GLU . 9.6 mmmm -71.75 -23.39 61.59 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 171.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 30.6 pt -121.2 7.96 6.07 Favored 'Isoleucine or valine' 0 C--N 1.339 0.151 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.112 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -98.28 -40.37 8.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.08 -176.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.586 ' CD2' HG23 ' A' ' 97' ' ' THR . 60.7 m-85 64.75 77.64 0.31 Allowed 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -170.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.755 HD22 ' CG ' ' A' ' 88' ' ' TYR . 1.4 pp -79.29 18.15 0.72 Allowed 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -172.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.52 ' O ' HG23 ' A' ' 95' ' ' THR . 27.3 t70 -175.22 65.19 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.258 162.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.676 ' HB ' ' O ' ' A' ' 155' ' ' LYS . 0.6 OUTLIER 62.16 -28.5 0.07 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.048 1.339 . . . . 0.0 112.528 -174.013 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.51 ' H ' ' C ' ' A' ' 94' ' ' ASP . 2.0 t -109.3 157.4 18.89 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 172.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.586 HG23 ' CD2' ' A' ' 92' ' ' TYR . 7.4 p -90.33 -179.99 5.75 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 177.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 89.4 mt -73.16 91.49 1.65 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 171.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.559 HG23 ' O ' ' A' ' 3' ' ' SER . 37.4 mm -74.84 -61.87 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.856 -174.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.573 ' O ' ' HA ' ' A' ' 35' ' ' MET . 10.4 pt-20 -157.19 157.46 30.46 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.183 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.449 ' HD2' ' HB2' ' A' ' 100' ' ' GLU . 55.9 Cg_endo -69.58 152.83 70.31 Favored 'Trans proline' 0 C--O 1.237 0.458 0 C-N-CA 122.502 2.135 . . . . 0.0 112.91 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -77.29 156.78 81.34 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.526 177.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.497 ' HD3' ' SD ' ' A' ' 35' ' ' MET . 23.6 Cg_exo -64.21 132.16 32.98 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.342 2.028 . . . . 0.0 112.186 177.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.426 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 34.2 ptt180 -86.33 27.85 0.89 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.855 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -95.45 116.49 66.33 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.341 178.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -65.46 124.22 12.55 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.186 1.924 . . . . 0.0 110.673 174.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.9 m 65.77 96.98 0.04 OUTLIER Pre-proline 0 C--O 1.233 0.188 0 O-C-N 123.688 0.618 . . . . 0.0 109.659 -170.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.437 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 22.4 Cg_endo -60.91 146.33 97.78 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 123.088 2.525 . . . . 0.0 113.071 -173.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 108' ' ' PRO . 38.1 Cg_exo -61.55 150.76 83.97 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 123.123 2.548 . . . . 0.0 112.01 178.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 38.2 tpp -85.8 107.95 17.88 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.724 -174.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 134.56 -158.04 23.25 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.96 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.1 m 65.77 25.19 11.39 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.129 0.49 . . . . 0.0 111.21 177.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 39.3 t -77.1 98.88 2.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.121 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.513 ' HB3' ' HD2' ' A' ' 116' ' ' PRO . 20.0 t -105.22 -148.57 0.41 Allowed 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.414 ' HB1' ' HD3' ' A' ' 116' ' ' PRO . . . -58.84 -41.55 89.29 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 175.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.585 ' HB3' ' H ' ' A' ' 33' ' ' HIS . 22.1 Cg_exo -68.11 -167.36 0.17 Allowed 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 122.034 1.823 . . . . 0.0 112.192 171.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.414 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 4.9 m-20 67.19 19.9 10.27 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.947 0.403 . . . . 0.0 111.245 -177.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 73.5 mt -99.93 113.11 65.01 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.262 177.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.511 ' HA ' ' OG ' ' A' ' 56' ' ' SER . 32.5 Cg_exo -59.31 -64.24 0.11 Allowed 'Trans proline' 0 N--CA 1.464 -0.247 0 C-N-CA 122.872 2.382 . . . . 0.0 112.115 177.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 69.4 p 61.41 -36.96 0.11 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.049 1.34 . . . . 0.0 113.637 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.44 ' H ' ' C ' ' A' ' 119' ' ' PRO . . . -134.51 172.66 12.61 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 177.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -132.01 -106.74 0.26 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.299 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -88.12 93.32 9.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.136 0.494 . . . . 0.0 110.442 177.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -163.82 146.06 9.39 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.64 ' HG ' ' HD2' ' A' ' 155' ' ' LYS . 3.3 mm? 67.82 96.73 0.06 Allowed 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.703 0.763 . . . . 0.0 111.66 -177.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -174.5 -38.79 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.566 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.439 ' HB3' ' HB3' ' A' ' 181' ' ' LEU . 79.9 m-85 -127.64 116.02 19.65 Favored 'General case' 0 CA--C 1.504 -0.804 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.487 176.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.622 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 2.1 t -115.47 153.72 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.748 -177.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.669 ' HG2' ' O ' ' A' ' 180' ' ' LYS . 1.7 ptp180 -137.59 124.59 21.43 Favored 'General case' 0 CA--C 1.496 -1.11 0 C-N-CA 117.281 -1.767 . . . . 0.0 112.891 173.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.651 HG23 ' CG ' ' A' ' 144' ' ' PHE . 81.7 p -79.49 131.88 36.18 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 114.268 -1.333 . . . . 0.0 111.13 -177.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 2.5 mt -116.59 8.5 13.91 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.624 -175.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -122.82 -36.07 2.94 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -171.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.501 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 11.0 t70 78.52 110.7 0.07 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.23 0.612 . . . . 0.0 110.873 -178.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.597 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 79.2 t80 -144.55 91.66 6.17 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 177.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.557 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 72.8 Cg_endo -79.53 85.98 1.75 Allowed 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 121.846 1.697 . . . . 0.0 112.404 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.38 -35.38 60.0 Favored Glycine 0 C--N 1.333 0.384 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.445 179.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.769 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 0.9 OUTLIER 68.27 37.66 2.75 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 122.652 0.381 . . . . 0.0 111.548 178.05 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -137.71 170.41 16.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.662 0.267 . . . . 0.0 110.554 -177.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -89.86 -6.19 56.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.74 0.781 . . . . 0.0 109.108 174.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -103.14 -34.14 8.96 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.57 177.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -120.08 109.55 15.6 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.385 176.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.73 ' CD1' ' HB2' ' A' ' 165' ' ' ASN . 36.5 tp -68.15 132.11 91.92 Favored Pre-proline 0 CA--C 1.515 -0.378 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.394 -177.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.769 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 7.6 Cg_endo -83.05 104.1 1.22 Allowed 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 121.785 1.657 . . . . 0.0 110.108 169.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.651 ' CG ' HG23 ' A' ' 130' ' ' THR . 9.4 p90 -121.39 163.6 18.44 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.254 -176.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.508 ' HB2' ' HB3' ' A' ' 148' ' ' GLU . 12.8 mptt -96.51 -169.82 1.97 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.376 0.607 . . . . 0.0 112.494 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.83 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -89.29 5.49 44.69 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.238 -176.456 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -168.7 37.35 0.21 Allowed Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 176.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.555 ' OE1' ' HA ' ' A' ' 144' ' ' PHE . 0.4 OUTLIER -92.95 157.69 16.21 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 120.87 0.367 . . . . 0.0 110.272 -177.713 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -98.38 131.89 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-O 121.774 0.797 . . . . 0.0 109.727 178.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.633 HD23 ' CD2' ' A' ' 142' ' ' LEU . 14.9 mt -120.31 156.27 31.62 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.086 -1.415 . . . . 0.0 107.646 -174.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.549 ' HB ' ' CG ' ' A' ' 164' ' ' ARG . 60.8 t -124.16 122.93 65.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 176.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.512 HD13 HG22 ' A' ' 128' ' ' VAL . 26.1 mm -76.16 102.99 3.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.578 0.704 . . . . 0.0 109.458 -174.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.484 HG22 HG22 ' A' ' 170' ' ' VAL . 20.3 tt -97.91 -30.0 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-N 114.801 -1.091 . . . . 0.0 109.802 -173.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.609 ' OE2' ' HA ' ' A' ' 93' ' ' LEU . 1.8 mt-10 -131.77 140.84 49.33 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 165.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.676 ' O ' ' HB ' ' A' ' 95' ' ' THR . 39.9 tttp -123.02 89.55 50.68 Favored Pre-proline 0 C--N 1.321 -0.657 0 O-C-N 121.231 -0.918 . . . . 0.0 109.868 167.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.674 ' HA ' ' CB ' ' A' ' 95' ' ' THR . 3.0 Cg_exo -77.81 -51.54 0.08 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.592 2.195 . . . . 0.0 112.023 175.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.567 ' HG2' ' CE ' ' A' ' 172' ' ' MET . 22.5 mm-40 -102.67 179.44 4.29 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -171.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -107.13 -20.03 13.43 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.56 176.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -109.41 -8.69 15.01 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.803 0.335 . . . . 0.0 110.871 177.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.555 ' HA ' ' O ' ' A' ' 173' ' ' ILE . 83.4 m95 -132.03 131.39 42.44 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 169.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . 0.565 ' CZ3' HD11 ' A' ' 125' ' ' LEU . 48.1 m0 -122.88 143.47 49.85 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.37 177.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.578 ' HA ' ' HA ' ' A' ' 172' ' ' MET . 21.6 m -89.14 99.67 12.61 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -176.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.48 ' HB1' HD11 ' A' ' 152' ' ' ILE . . . -110.09 151.6 27.02 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.027 -175.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.826 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 12.8 ptt180 -87.97 121.18 30.08 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-O 122.109 0.957 . . . . 0.0 108.944 172.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.73 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . 11.7 t30 -45.21 167.3 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 112.131 -2.304 . . . . 0.0 112.006 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.402 ' HA ' ' HD2' ' A' ' 166' ' ' LYS . 15.5 tptm -58.32 -14.29 7.1 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.015 173.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.524 ' HB2' ' ND2' ' A' ' 165' ' ' ASN . 21.7 m-20 -95.62 -9.19 32.81 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.001 0.429 . . . . 0.0 109.987 174.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 75' ' ' ASP . . . 90.2 39.06 6.15 Favored Glycine 0 CA--C 1.522 0.489 0 CA-C-N 115.85 -0.614 . . . . 0.0 113.406 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.826 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 7.8 ttm-85 -111.76 138.71 47.98 Favored 'General case' 0 C--O 1.214 -0.777 0 CA-C-N 116.933 0.367 . . . . 0.0 111.472 -177.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.484 HG22 HG22 ' A' ' 153' ' ' ILE . 21.9 t -78.96 125.61 38.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 C-N-CA 120.839 -0.345 . . . . 0.0 111.552 -179.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -164.02 149.72 17.24 Favored Glycine 0 C--N 1.332 0.321 0 N-CA-C 111.59 -0.604 . . . . 0.0 111.59 168.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.578 ' HA ' ' HA ' ' A' ' 162' ' ' SER . 59.5 mtp -77.0 143.32 39.48 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 117.565 0.682 . . . . 0.0 110.751 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.721 ' O ' HD11 ' A' ' 173' ' ' ILE . 1.6 pp -134.88 151.84 76.33 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.444 -177.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.747 ' O ' HG11 ' A' ' 178' ' ' VAL . 1.0 OUTLIER -85.24 123.79 2.72 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.821 2.347 . . . . 0.0 113.241 -174.819 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.53 ' HA ' HG22 ' A' ' 178' ' ' VAL . 94.8 t -53.73 -45.42 98.77 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 178.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.465 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 65.2 Cg_exo -54.91 -23.93 36.69 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 122.112 1.875 . . . . 0.0 112.817 174.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.547 ' CD2' ' HG2' ' A' ' 174' ' ' PRO . 3.4 m-30 -84.82 -39.58 18.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.018 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.747 HG11 ' O ' ' A' ' 174' ' ' PRO . 1.1 m -111.65 -177.77 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.637 -164.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.897 ' HG3' ' H ' ' A' ' 180' ' ' LYS . 11.2 pt-20 -158.13 -71.03 0.09 Allowed 'General case' 0 C--O 1.207 -1.142 0 N-CA-C 118.011 2.597 . . . . 0.0 118.011 144.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.897 ' H ' ' HG3' ' A' ' 179' ' ' GLU . 3.6 mppt? -156.25 179.64 9.05 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 118.855 -2.403 . . . . 0.0 114.593 -169.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.666 HD12 ' NH2' ' A' ' 129' ' ' ARG . 12.0 tp -125.15 -60.49 1.34 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.929 164.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.83 HG12 ' H ' ' A' ' 183' ' ' ARG . 2.4 p -90.65 -89.81 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 119.447 -0.311 . . . . 0.0 110.717 177.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.83 ' H ' HG12 ' A' ' 182' ' ' VAL . 0.2 OUTLIER 68.82 141.84 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.612 0.765 . . . . 0.0 112.979 172.235 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.438 ' N ' ' HD3' ' A' ' 183' ' ' ARG . 10.5 p -85.47 -100.72 0.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.771 171.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' SER . . . . . 0.4 ' HB3' ' O ' ' A' ' 184' ' ' SER . 60.5 p 170.46 166.11 0.2 Allowed Pre-proline 0 C--O 1.237 0.4 0 C-N-CA 123.273 0.629 . . . . 0.0 109.814 178.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -61.32 123.67 13.26 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.46 2.107 . . . . 0.0 111.099 173.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.436 ' HB2' ' HB2' ' A' ' 190' ' ' HIS . 31.6 m80 -122.92 15.73 10.05 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.228 -175.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 77.25 -63.6 3.26 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.754 -177.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 64.0 mmtt -76.15 -11.3 59.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.587 0.708 . . . . 0.0 109.299 176.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . 0.436 ' HB2' ' HB2' ' A' ' 187' ' ' HIS . 18.4 m-70 -119.38 88.75 2.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.055 173.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 142.49 -148.66 20.43 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.014 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 66.59 142.62 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.773 0.797 . . . . 0.0 112.328 -178.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.447 ' NE ' ' HA ' ' A' ' 193' ' ' ARG . 4.6 mmp_? -125.49 113.57 17.65 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.053 176.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -102.8 140.28 37.28 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.957 0.408 . . . . 0.0 110.259 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 29.0 m -128.06 107.94 10.24 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -114.79 -43.75 3.11 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.29 -175.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 12.6 t 61.64 -176.48 0.13 Allowed 'General case' 0 CA--C 1.535 0.389 0 O-C-N 123.296 0.373 . . . . 0.0 110.685 178.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -132.69 -16.54 2.61 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.878 0.371 . . . . 0.0 110.026 175.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 78.82 -57.62 4.26 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.755 -178.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.437 HD13 ' HD2' ' A' ' 201' ' ' PRO . 6.6 tp -114.03 122.02 35.52 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-O 120.895 0.378 . . . . 0.0 110.467 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.493 ' O ' ' HD3' ' A' ' 203' ' ' PRO . 9.6 Cg_exo -72.65 163.8 37.44 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.715 2.276 . . . . 0.0 111.208 174.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -83.39 103.37 2.62 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.493 ' HD3' ' O ' ' A' ' 201' ' ' PRO . 93.0 Cg_endo -93.61 -5.75 2.68 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.878 2.385 . . . . 0.0 113.889 -171.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -113.1 -63.86 1.39 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.876 0.37 . . . . 0.0 111.3 -177.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -83.22 67.06 9.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.437 0.637 . . . . 0.0 111.576 -174.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -140.03 -3.18 1.43 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.033 174.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 55.18 72.76 0.46 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.478 -176.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -80.4 92.12 5.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.254 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -115.46 150.0 43.85 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.193 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.83 120.32 8.06 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.835 2.357 . . . . 0.0 112.666 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -139.16 -162.63 1.35 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.18 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 12.7 p -71.94 -61.72 1.69 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.985 0.421 . . . . 0.0 111.547 -177.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.69 95.99 9.91 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.724 178.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.557 HG23 ' HG ' ' A' ' 216' ' ' LEU . 8.8 m -82.04 115.05 55.14 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.043 -178.047 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 214' ' ' THR . 1.2 Cg_endo -82.94 82.54 2.15 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.912 2.408 . . . . 0.0 112.251 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.926 ' HB2' ' HD3' ' A' ' 217' ' ' PRO . 97.2 mt -111.01 -62.91 0.04 OUTLIER Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.421 174.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.926 ' HD3' ' HB2' ' A' ' 216' ' ' LEU . 4.4 Cg_exo -80.58 -57.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 121.704 1.602 . . . . 0.0 110.91 175.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -166.15 142.56 5.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.305 176.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 40.1 t -63.99 -34.94 71.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.049 0.452 . . . . 0.0 110.781 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 5.5 m -74.58 -13.36 60.65 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.157 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 94.06 103.15 1.72 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.51 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 14.1 m -74.29 125.05 90.29 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 110.435 -0.209 . . . . 0.0 110.435 178.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -56.07 121.52 10.14 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.878 2.386 . . . . 0.0 112.058 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.551 ' H ' HG21 ' A' ' 227' ' ' ILE . . . 102.7 -48.09 1.07 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.327 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -87.44 -37.12 17.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.832 0.348 . . . . 0.0 111.535 -177.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -115.12 27.28 9.5 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.599 -175.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.551 HG21 ' H ' ' A' ' 224' ' ' GLY . 2.7 pp -85.83 161.71 2.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.468 176.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 5.0 t -102.94 118.69 57.58 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-O 121.211 0.529 . . . . 0.0 111.148 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -84.63 -177.13 2.77 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.661 2.241 . . . . 0.0 111.705 174.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.763 HD21 ' H ' ' A' ' 230' ' ' LEU . 2.0 pt? -91.0 125.69 57.93 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.859 0.361 . . . . 0.0 110.679 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.517 ' HD3' ' HA ' ' A' ' 230' ' ' LEU . 1.2 Cg_endo -84.94 93.85 0.68 Allowed 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.265 2.644 . . . . 0.0 112.692 -178.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 22.1 t 67.05 -79.32 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.569 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 70.6 p 55.69 -84.0 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.324 1.05 . . . . 0.0 112.377 -177.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -175.14 -35.92 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 -178.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -103.23 17.04 25.01 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.418 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -64.29 -56.18 19.28 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.802 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -74.4 108.89 2.78 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.139 1.893 . . . . 0.0 110.87 172.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.418 ' CG1' HD11 ' A' ' 293' ' ' ILE . 3.5 t -89.82 141.59 14.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.846 -173.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.434 ' HB2' ' HG3' ' A' ' 296' ' ' PRO . 94.0 m-85 -113.26 122.98 49.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.28 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.477 ' HB3' HD13 ' A' ' 293' ' ' ILE . . . -119.72 144.26 47.33 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.421 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -90.87 119.83 31.39 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -66.95 102.46 0.98 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.928 0.394 . . . . 0.0 110.024 177.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 24.8 pt -83.31 -35.29 11.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.421 -174.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -132.89 130.89 40.29 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -54.36 140.38 33.75 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.883 -171.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.57 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 27.5 tpt180 -124.03 107.12 10.96 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.896 -178.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 16.5 m -115.87 126.67 27.46 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-O 120.954 0.407 . . . . 0.0 110.477 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.497 ' HB3' ' HB3' ' A' ' 255' ' ' ALA . 39.5 Cg_endo -67.68 127.66 16.68 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.629 2.219 . . . . 0.0 112.596 -178.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 39.2 t -78.58 171.94 14.41 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -53.1 -37.78 62.02 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.734 0.302 . . . . 0.0 111.72 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -97.71 14.25 27.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.898 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -90.89 -75.19 0.47 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 173.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 66.0 mttm 69.87 -58.41 0.53 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.944 178.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 11.2 p -73.32 -13.54 61.13 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.368 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.497 ' HB3' ' HB3' ' A' ' 248' ' ' PRO . . . -71.86 123.99 23.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.047 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.2 tt -73.5 133.94 43.75 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.636 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.57 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -81.62 104.93 12.37 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.093 0.473 . . . . 0.0 109.934 176.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 96.0 mt -109.0 134.94 50.98 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.481 -177.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -99.41 155.14 17.7 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.216 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 62.2 t -66.94 122.04 17.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.006 0.431 . . . . 0.0 111.083 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 95.21 11.42 56.15 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.675 -0.693 . . . . 0.0 113.202 175.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -95.14 166.93 11.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.985 0.392 . . . . 0.0 109.971 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 34.3 mm -102.55 118.24 49.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.114 0.483 . . . . 0.0 110.728 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 19.3 t -93.48 104.9 16.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.165 0.507 . . . . 0.0 110.284 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -85.7 87.7 7.44 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.814 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.432 HG21 ' HB3' ' A' ' 275' ' ' TRP . 6.2 p -91.73 126.02 44.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.489 0.661 . . . . 0.0 111.607 -175.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 44.7 p -104.69 -39.23 6.42 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.725 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 -105.6 117.44 34.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.124 -177.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 41.5 mtt -114.4 134.86 54.68 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.798 174.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -97.45 160.06 14.55 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.714 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 10.5 tp -75.21 -11.98 14.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.502 0.667 . . . . 0.0 109.972 176.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -75.2 -65.49 0.88 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.938 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 156.47 -23.55 0.5 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.383 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -87.06 119.75 27.61 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 176.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.473 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 31.4 m0 -101.43 156.23 17.59 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.789 -176.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 284' ' ' GLY . 47.9 mt-10 -112.28 114.57 27.41 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.061 175.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . 0.689 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -120.71 155.01 16.32 Favored Glycine 0 C--O 1.225 -0.434 0 C-N-CA 120.894 -0.669 . . . . 0.0 111.595 177.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.755 ' HG2' ' HB3' ' A' ' 283' ' ' LYS . 38.0 mt-10 -100.7 109.9 21.97 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.092 0.473 . . . . 0.0 110.849 179.203 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 48.7 t -118.95 130.82 73.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 176.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 10.1 p30 44.54 34.77 1.18 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.958 0.903 . . . . 0.0 112.482 -174.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 94.49 -9.1 71.77 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.483 175.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -108.35 124.72 50.79 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 117.014 0.407 . . . . 0.0 111.259 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.755 ' HB3' ' HG2' ' A' ' 278' ' ' GLU . 9.4 ptpp? -96.33 142.17 28.78 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 172.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 276' ' ' GLU . . . -164.05 172.03 39.78 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.987 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.473 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 17.2 mt -82.44 130.74 35.17 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.158 0.504 . . . . 0.0 111.341 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -136.23 135.49 21.15 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.651 173.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . 0.899 ' HB2' HG22 ' A' ' 289' ' ' THR . 59.0 Cg_endo -75.61 138.31 21.45 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.237 1.958 . . . . 0.0 111.444 175.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.438 ' HA ' HG23 ' A' ' 291' ' ' VAL . 49.4 p90 -63.27 -8.47 8.52 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.932 0.396 . . . . 0.0 111.282 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' THR . . . . . 0.899 HG22 ' HB2' ' A' ' 287' ' ' PRO . 15.3 t -79.62 -13.81 59.24 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.012 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . 0.503 ' HD2' HG21 ' A' ' 289' ' ' THR . 6.8 m-70 -101.19 -6.19 24.59 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.695 0.283 . . . . 0.0 110.846 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.438 HG23 ' HA ' ' A' ' 288' ' ' PHE . 35.9 m -127.78 178.99 4.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.94 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -140.76 116.01 9.95 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.039 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.477 HD13 ' HB3' ' A' ' 240' ' ' ALA . 34.2 mm -70.41 112.96 5.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 174.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -135.24 -169.87 2.47 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.865 -176.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -115.68 94.67 41.31 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . 0.434 ' HG3' ' HB2' ' A' ' 239' ' ' PHE . 36.2 Cg_endo -67.13 -48.06 2.01 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.31 2.006 . . . . 0.0 111.334 178.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -108.07 82.44 1.64 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.708 175.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . 0.407 ' HA ' ' HD2' ' A' ' 299' ' ' PRO . 14.0 m120 -58.51 118.32 27.28 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.604 176.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 298' ' ' ASN . 9.9 Cg_endo -52.97 -31.35 52.64 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.087 2.524 . . . . 0.0 112.784 -176.15 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -58.83 -40.54 84.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.051 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -119.49 37.49 4.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.364 0.602 . . . . 0.0 110.477 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -76.27 -3.54 37.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.787 175.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 . . . . . 0 C--O 1.252 1.191 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.662 177.386 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.0 mtt . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 120.879 0.371 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.2 m -84.74 141.34 30.61 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.139 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.48 ' O ' HG23 ' A' ' 99' ' ' ILE . 9.4 p -83.75 -47.73 10.86 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 174.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.439 ' HB3' ' HE3' ' A' ' 89' ' ' LYS . . . -83.27 104.56 13.53 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.745 175.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 63.8 mtt180 -109.47 -10.49 14.88 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -167.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -84.31 156.02 22.11 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.594 -170.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.429 ' C ' ' H ' ' A' ' 9' ' ' SER . 18.4 m-20 -66.7 -27.77 67.9 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.587 -177.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.3 t 75.09 -22.73 0.25 Allowed 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.412 0.685 . . . . 0.0 111.137 -178.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.429 ' H ' ' C ' ' A' ' 7' ' ' ASP . 25.6 t -105.17 -17.39 14.49 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 122.262 -0.273 . . . . 0.0 111.707 -177.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -81.08 107.74 14.15 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 121.718 -0.614 . . . . 0.0 110.625 -177.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.49 -41.59 94.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.948 -176.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.436 ' C ' HH22 ' A' ' 104' ' ' ARG . 24.2 t -68.77 -4.01 14.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.156 -176.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -91.84 -47.27 7.42 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.419 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 43.4 p-90 -117.33 -21.21 8.82 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -171.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -75.05 127.16 32.58 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -177.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.756 ' HG3' ' HB2' ' A' ' 37' ' ' LEU . 26.3 mmt -109.67 -8.35 14.96 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -173.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 50.55 -112.84 1.74 Allowed Glycine 0 CA--C 1.525 0.665 0 C-N-CA 121.376 -0.44 . . . . 0.0 113.2 -176.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -76.01 102.16 1.57 Allowed 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.52 2.147 . . . . 0.0 112.766 -178.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.71 ' HB ' ' HG3' ' A' ' 39' ' ' ARG . 22.2 t -142.07 -76.39 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.397 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.705 ' H ' ' HG3' ' A' ' 39' ' ' ARG . 51.1 m 93.41 171.01 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 168.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.43 ' HD3' ' HA ' ' A' ' 116' ' ' PRO . 74.0 mtp85 -62.1 -32.58 73.16 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.861 -172.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -59.65 -54.12 50.08 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 123.842 0.713 . . . . 0.0 110.751 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.484 ' O ' ' HG3' ' A' ' 27' ' ' ARG . 17.4 mt-10 -74.71 -47.22 32.64 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.784 -177.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.502 ' HB2' HD11 ' A' ' 37' ' ' LEU . . . -57.35 -51.17 70.46 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -172.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.522 ' HA ' HG11 ' A' ' 58' ' ' VAL . 3.9 tt0 -66.27 -33.79 76.53 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -177.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.43 ' HA ' ' HB2' ' A' ' 112' ' ' SER . 2.3 m -63.41 -35.45 80.45 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.344 -0.843 . . . . 0.0 112.113 178.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.484 ' HG3' ' O ' ' A' ' 23' ' ' GLU . 98.0 mtt180 -81.19 -13.3 58.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.599 0.238 . . . . 0.0 111.256 -177.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.563 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 41.0 mt -121.27 -13.33 8.5 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -172.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.504 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 26.6 tp60 -66.61 104.8 1.36 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.926 0.393 . . . . 0.0 110.32 -176.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 64.59 34.17 89.19 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.444 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 12.0 mm100 -106.5 -160.85 0.76 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 178.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.551 ' HB2' ' HG3' ' A' ' 35' ' ' MET . 43.6 mtm180 -56.17 111.17 0.89 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.896 0.379 . . . . 0.0 110.624 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -67.38 111.06 3.84 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.008 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.427 ' HA2' HG23 ' A' ' 96' ' ' THR . . . 130.86 -14.26 5.5 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.499 -176.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.552 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 55.3 mtm -77.3 143.6 38.71 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 120.871 0.367 . . . . 0.0 110.426 177.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.459 ' HB2' HG23 ' A' ' 52' ' ' VAL . 34.0 p90 -141.39 166.01 25.94 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.236 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.756 ' HB2' ' HG3' ' A' ' 16' ' ' MET . 4.3 pp -157.13 139.14 14.4 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.234 0.54 . . . . 0.0 110.674 176.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.3 t -113.27 108.27 25.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.181 177.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.71 ' HG3' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -120.77 173.85 6.96 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.26 -178.533 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -61.69 130.32 45.29 Favored 'General case' 0 C--O 1.238 0.459 0 O-C-N 123.854 0.721 . . . . 0.0 110.147 178.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.4 t -80.13 154.98 27.69 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.517 -173.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.9 m -92.83 -5.32 51.3 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.744 177.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.2 m -73.34 -49.54 26.85 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.973 177.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 49.1 t -167.36 136.61 2.2 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.618 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -59.96 105.68 0.29 Allowed 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.503 2.135 . . . . 0.0 111.796 176.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 133.27 -29.41 3.18 Favored Glycine 0 N--CA 1.452 -0.278 0 N-CA-C 110.526 -1.029 . . . . 0.0 110.526 -174.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -80.58 151.41 29.1 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 173.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -127.25 157.93 38.51 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.503 ' HB ' ' CZ ' ' A' ' 39' ' ' ARG . 39.2 t -128.52 110.38 21.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.761 0.791 . . . . 0.0 111.316 176.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.438 ' HB3' ' HB2' ' A' ' 61' ' ' TYR . 47.5 tp -76.29 95.78 3.83 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 113.731 -1.577 . . . . 0.0 110.121 175.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 59' ' ' SER . 65.7 m -96.96 133.79 41.16 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 175.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.69 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 60.1 t -130.92 138.5 53.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.302 -171.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.563 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 40.0 t -89.68 108.22 19.55 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.803 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.666 ' O ' ' HB3' ' A' ' 57' ' ' ARG . 26.8 mt-10 -146.67 131.93 18.46 Favored 'General case' 0 C--O 1.206 -1.206 0 C-N-CA 119.685 -0.806 . . . . 0.0 110.253 176.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.401 HD22 ' HB ' ' A' ' 95' ' ' THR . 43.0 m-80 52.47 28.8 6.27 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 177.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.2 m 59.83 58.68 2.72 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 122.778 1.275 . . . . 0.0 108.67 -175.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.779 HH21 ' HB2' ' A' ' 94' ' ' ASP . 17.0 ttp85 -162.2 66.88 0.24 Allowed 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 112.869 -1.969 . . . . 0.0 109.395 -159.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.69 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 41.1 t -69.08 92.11 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-O 122.58 1.181 . . . . 0.0 109.143 -170.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.434 ' O ' ' HA ' ' A' ' 51' ' ' SER . 1.8 m -61.17 119.64 8.79 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 112.579 -2.1 . . . . 0.0 110.722 -177.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -99.53 96.49 7.7 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.913 0.387 . . . . 0.0 110.969 -178.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.623 ' HB3' HD13 ' A' ' 73' ' ' ILE . 88.6 m-85 -95.5 116.44 28.82 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.074 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 55.4 mt -81.53 146.48 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 O-C-N 122.24 -0.287 . . . . 0.0 111.35 -178.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.645 HG13 ' CG1' ' A' ' 73' ' ' ILE . 4.8 mp -134.14 102.04 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 122.571 0.349 . . . . 0.0 110.243 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -81.14 130.95 35.25 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.237 -177.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.2 t -78.54 100.39 6.9 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 172.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.524 HD12 ' HB2' ' A' ' 72' ' ' LYS . 85.8 mt -80.64 142.78 53.69 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.28 -174.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -63.07 -8.63 14.56 Favored 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 122.766 2.31 . . . . 0.0 111.344 170.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -75.82 2.85 11.21 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.883 172.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? 68.01 24.9 7.74 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.489 -178.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.41 ' HB3' ' O ' ' A' ' 78' ' ' PHE . 67.2 mtt180 -121.4 176.41 5.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.952 -178.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.417 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 57.2 m-85 -124.46 117.92 25.49 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.112 0.482 . . . . 0.0 110.277 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.651 ' HG3' ' HB3' ' A' ' 77' ' ' GLU . 74.1 tttt -98.12 99.93 11.21 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.826 -173.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.645 ' CG1' HG13 ' A' ' 63' ' ' ILE . 0.0 OUTLIER -90.14 76.45 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 123.0 1.381 . . . . 0.0 110.228 -173.69 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.43 74.71 0.88 Allowed Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 114.578 -1.192 . . . . 0.0 113.262 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.436 ' HA ' ' HE2' ' A' ' 72' ' ' LYS . 38.6 t70 73.94 -40.96 0.47 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 174.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -91.82 119.73 31.88 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.651 ' HB3' ' HG3' ' A' ' 72' ' ' LYS . 13.5 pt-20 -100.14 139.85 35.21 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.328 0.585 . . . . 0.0 111.488 -176.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.431 ' CE1' HG22 ' A' ' 73' ' ' ILE . 26.9 m-85 -117.66 168.13 10.71 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 174.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -69.91 -20.72 63.35 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -171.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.51 ' CE1' ' HB3' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -170.81 172.92 5.46 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 122.553 -0.092 . . . . 0.0 111.183 174.741 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.599 HD21 HD22 ' A' ' 84' ' ' LEU . 13.0 mt -51.8 -54.89 35.23 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 81' ' ' LEU . 38.3 Cg_endo -64.68 -4.53 8.63 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 122.369 2.046 . . . . 0.0 113.448 -177.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.51 ' HB3' ' CE1' ' A' ' 80' ' ' HIS . . . -94.43 -34.17 12.85 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.921 0.391 . . . . 0.0 110.524 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.641 HD21 ' HB ' ' A' ' 73' ' ' ILE . 2.3 pp -75.34 -36.67 60.99 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.534 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 81.4 mt -65.35 -31.24 72.26 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.236 177.174 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.615 ' HA ' ' HD3' ' A' ' 89' ' ' LYS . 3.3 tp10 -70.77 -27.84 64.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.935 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.401 ' CD2' ' HZ ' ' A' ' 78' ' ' PHE . 18.5 t80 -75.66 -32.17 60.08 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.734 0.778 . . . . 0.0 109.593 -177.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.62 ' CG ' HD22 ' A' ' 93' ' ' LEU . 64.7 m-85 -89.62 2.05 55.22 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.471 -175.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.615 ' HD3' ' HA ' ' A' ' 86' ' ' GLU . 56.9 mtpt -84.4 -15.29 46.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.884 173.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 34.0 pt -121.03 0.49 7.25 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 CA-C-O 121.291 0.567 . . . . 0.0 110.285 174.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.486 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 3.3 t-160 -88.97 -44.29 10.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.859 -176.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.457 ' HB2' ' O ' ' A' ' 91' ' ' HIS . 90.4 m-85 67.33 88.64 0.11 Allowed 'General case' 0 CA--C 1.519 -0.237 0 O-C-N 124.135 0.897 . . . . 0.0 108.946 -165.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.639 ' O ' ' HB3' ' A' ' 154' ' ' GLU . 11.9 mt -44.02 -61.59 1.41 Allowed 'General case' 0 C--O 1.218 -0.576 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 175.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.779 ' HB2' HH21 ' A' ' 57' ' ' ARG . 21.0 t0 -141.62 89.68 2.23 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.688 170.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.493 ' HB ' ' O ' ' A' ' 94' ' ' ASP . 1.3 m 69.91 -6.84 1.0 Allowed 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.981 0.896 . . . . 0.0 110.558 175.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.471 ' H ' ' C ' ' A' ' 94' ' ' ASP . 76.2 m -135.59 142.91 45.36 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.782 -178.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.1 p -95.4 171.37 8.74 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 174.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.43 HD12 ' O ' ' A' ' 85' ' ' LEU . 96.8 mt -66.77 91.84 0.2 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 173.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.48 HG23 ' O ' ' A' ' 3' ' ' SER . 47.0 mm -75.41 -66.86 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.298 -174.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.552 ' O ' ' HA ' ' A' ' 35' ' ' MET . 9.7 pt-20 -156.75 154.76 27.39 Favored Pre-proline 0 N--CA 1.447 -0.588 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.743 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.33 155.3 67.74 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.409 2.072 . . . . 0.0 112.982 -177.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.57 ' HB2' ' HD2' ' A' ' 103' ' ' PRO . . . -77.21 166.41 44.67 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.925 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.57 ' HD2' ' HB2' ' A' ' 102' ' ' ALA . 43.3 Cg_endo -68.63 132.94 26.38 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.317 2.011 . . . . 0.0 112.566 176.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.436 HH22 ' C ' ' A' ' 12' ' ' SER . 46.3 ttm180 -86.84 90.58 8.36 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.859 177.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.427 ' HA ' ' HD2' ' A' ' 106' ' ' PRO . 32.1 t80 -145.18 117.33 5.26 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.46 -177.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.521 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 10.4 Cg_endo -53.38 117.6 3.97 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.954 2.436 . . . . 0.0 111.452 178.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 18.7 m -90.73 109.73 36.57 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.511 -172.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.521 ' HD3' ' O ' ' A' ' 106' ' ' PRO . 39.2 Cg_exo -60.12 -55.27 1.67 Allowed 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 123.082 2.521 . . . . 0.0 113.894 178.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.438 ' HD3' ' HB2' ' A' ' 108' ' ' PRO . 60.7 Cg_endo -72.98 118.18 5.45 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 121.455 1.437 . . . . 0.0 112.84 -177.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 25.7 ttt -83.11 103.83 12.84 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.531 175.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -120.68 -64.73 0.26 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.151 -1.023 . . . . 0.0 113.076 -176.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.43 ' HB2' ' HA ' ' A' ' 26' ' ' THR . 13.4 m -94.56 125.54 39.28 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.873 0.368 . . . . 0.0 111.222 -173.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.5 p -175.64 144.0 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.817 -178.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 21.8 t -159.68 109.8 1.9 Allowed 'General case' 0 C--O 1.239 0.545 0 CA-C-O 120.484 0.183 . . . . 0.0 110.662 -178.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.582 ' HB1' ' O ' ' A' ' 118' ' ' LEU . . . 63.11 168.95 0.09 OUTLIER Pre-proline 0 N--CA 1.469 0.516 0 O-C-N 124.133 0.896 . . . . 0.0 112.36 174.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.43 ' HA ' ' HD3' ' A' ' 21' ' ' ARG . 9.9 Cg_endo -92.34 -10.15 2.28 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 123.422 2.748 . . . . 0.0 113.028 175.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 26.4 t30 -154.53 105.71 2.66 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -175.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.648 ' HG ' ' HD2' ' A' ' 119' ' ' PRO . 15.8 tp 71.55 151.76 0.14 Allowed Pre-proline 0 N--CA 1.466 0.359 0 O-C-N 124.32 1.012 . . . . 0.0 108.503 -174.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.648 ' HD2' ' HG ' ' A' ' 118' ' ' LEU . 42.2 Cg_endo -69.2 -147.07 0.02 OUTLIER 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 121.544 1.496 . . . . 0.0 111.808 174.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 41.1 m -145.4 119.2 9.24 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 174.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.74 ' HB2' ' HB3' ' A' ' 126' ' ' GLU . . . -67.56 73.91 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.449 0.642 . . . . 0.0 111.502 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -84.05 -21.89 31.42 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.355 177.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -108.59 -69.1 0.87 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.537 171.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.402 HD21 ' N ' ' A' ' 124' ' ' ASN . 0.1 OUTLIER -172.47 161.92 5.18 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 118.66 0.663 . . . . 0.0 112.76 177.789 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.548 HD11 HG22 ' A' ' 152' ' ' ILE . 3.9 mm? 72.25 98.59 0.07 Allowed 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.881 174.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.74 ' HB3' ' HB2' ' A' ' 121' ' ' ALA . 41.5 tt0 -179.7 -75.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.35 -1.295 . . . . 0.0 109.157 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -98.88 108.13 20.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.188 0.518 . . . . 0.0 110.96 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.989 HG21 ' HG3' ' A' ' 180' ' ' LYS . 56.2 t -124.07 135.48 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.667 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.677 ' NH1' ' HB2' ' A' ' 181' ' ' LEU . 0.0 OUTLIER -111.29 148.05 33.75 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 117.51 -1.676 . . . . 0.0 108.538 169.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.426 ' HG1' ' HB2' ' A' ' 144' ' ' PHE . 0.9 OUTLIER -101.78 131.82 47.87 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.269 -179.903 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.53 HD22 ' HG2' ' A' ' 179' ' ' GLU . 21.8 mt -106.58 -17.5 14.23 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -176.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -87.09 -34.16 19.23 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.507 -174.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.488 ' HB2' ' HA ' ' A' ' 145' ' ' LYS . 0.0 OUTLIER 65.06 121.1 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 122.229 1.014 . . . . 0.0 111.317 -173.838 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -146.36 87.42 6.54 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 114.636 -1.166 . . . . 0.0 108.194 177.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.609 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 72.6 Cg_endo -83.0 85.99 1.51 Allowed 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 121.778 1.652 . . . . 0.0 112.578 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -77.18 -13.74 83.31 Favored Glycine 0 C--N 1.332 0.358 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 173.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.63 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 17.4 m120 52.59 64.74 1.74 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 114.235 -0.982 . . . . 0.0 111.216 178.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.486 ' HB3' ' H ' ' A' ' 141' ' ' ASP . 0.4 OUTLIER -130.84 -177.29 4.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.239 0.543 . . . . 0.0 111.335 -175.931 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -110.95 0.8 17.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.675 167.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -116.72 -43.54 2.89 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.1 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.486 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 14.5 m-20 -101.07 123.62 45.52 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 169.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.693 ' CD2' HD23 ' A' ' 150' ' ' LEU . 32.2 tp -77.98 120.44 81.26 Favored Pre-proline 0 N--CA 1.468 0.459 0 CA-C-O 120.743 0.306 . . . . 0.0 111.058 -175.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.63 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 36.2 Cg_endo -72.44 95.46 0.78 Allowed 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.444 1.429 . . . . 0.0 111.272 168.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.582 ' CE2' ' HB ' ' A' ' 173' ' ' ILE . 10.4 p90 -106.7 160.55 15.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.391 -177.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.488 ' HA ' ' HB2' ' A' ' 133' ' ' ASP . 0.1 OUTLIER -103.56 -171.77 2.0 Allowed 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.929 -0.308 . . . . 0.0 111.25 -177.344 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.762 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -88.57 5.31 43.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.36 -171.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -165.11 36.68 0.28 Allowed Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 175.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.434 ' HB3' ' HB2' ' A' ' 145' ' ' LYS . 0.0 OUTLIER -101.08 150.53 22.82 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.043 0.449 . . . . 0.0 111.368 -175.365 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.553 HD11 ' HB3' ' A' ' 129' ' ' ARG . 0.7 OUTLIER -90.14 132.14 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.567 -177.541 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.693 HD23 ' CD2' ' A' ' 142' ' ' LEU . 44.7 mt -127.9 157.15 41.31 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -177.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 58.0 t -122.93 123.8 68.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 174.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.548 HG22 HD11 ' A' ' 125' ' ' LEU . 36.8 mm -76.21 79.04 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.704 HG21 ' HG3' ' A' ' 154' ' ' GLU . 11.1 tt -75.62 -28.25 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-N 113.165 -1.834 . . . . 0.0 109.559 -174.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.704 ' HG3' HG21 ' A' ' 153' ' ' ILE . 29.8 mt-10 -134.39 142.15 47.08 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 175.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.428 ' HZ3' ' HG ' ' A' ' 125' ' ' LEU . 81.8 tttt -143.62 78.23 14.6 Favored Pre-proline 0 C--N 1.324 -0.505 0 O-C-N 121.547 -0.721 . . . . 0.0 111.264 177.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.437 ' HG2' ' HG2' ' A' ' 157' ' ' GLU . 59.2 Cg_endo -73.93 -31.56 8.02 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.113 1.875 . . . . 0.0 111.552 176.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.437 ' HG2' ' HG2' ' A' ' 156' ' ' PRO . 14.2 mm-40 -119.89 164.37 16.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.519 -172.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.559 ' O ' HG22 ' A' ' 175' ' ' VAL . 9.3 tp10 -102.86 -22.24 13.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.587 0.232 . . . . 0.0 110.878 178.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.913 HE21 ' HA ' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -91.19 -21.14 21.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.094 0.474 . . . . 0.0 110.059 177.463 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 56.7 m95 -124.75 133.51 53.14 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.119 174.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . 0.708 ' O ' HG13 ' A' ' 173' ' ' ILE . 46.1 m0 -110.94 133.6 53.24 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.258 0.551 . . . . 0.0 110.664 176.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.54 ' OG ' ' HG2' ' A' ' 172' ' ' MET . 67.4 m -93.02 89.05 6.35 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -176.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.555 ' HB2' ' HB3' ' A' ' 150' ' ' LEU . . . -106.27 145.63 31.37 Favored 'General case' 0 N--CA 1.418 -2.033 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 -169.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.682 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 13.3 ptt180 -87.07 123.85 32.59 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 175.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.611 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . 24.3 t30 -53.0 171.11 0.07 Allowed 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 113.277 -1.783 . . . . 0.0 110.736 -174.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 61.9 tttt -57.35 -19.99 26.31 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 173.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -70.64 -54.94 10.0 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.273 169.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.419 ' O ' ' HB2' ' A' ' 164' ' ' ARG . . . 134.3 -8.86 4.72 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.947 -171.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.682 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -65.57 130.26 42.67 Favored 'General case' 0 C--O 1.217 -0.624 0 C-N-CA 123.343 0.657 . . . . 0.0 111.734 178.767 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.493 HG12 ' OE1' ' A' ' 154' ' ' GLU . 27.0 t -83.69 126.99 40.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.128 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -158.07 149.45 19.82 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.428 -0.892 . . . . 0.0 112.243 171.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.54 ' HG2' ' OG ' ' A' ' 162' ' ' SER . 9.3 mtp -74.63 141.14 44.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.843 0.354 . . . . 0.0 110.773 -178.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.708 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.6 pp -142.12 141.72 22.38 Favored Pre-proline 0 N--CA 1.45 -0.474 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.795 -174.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.499 ' HB2' ' CD1' ' A' ' 177' ' ' TYR . 24.5 Cg_exo -64.88 127.47 18.68 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.804 2.336 . . . . 0.0 112.879 -178.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 158' ' ' GLU . 72.9 t -61.33 -40.73 74.86 Favored Pre-proline 0 CA--C 1.545 0.75 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 177.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -61.44 -5.4 5.39 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 121.92 1.747 . . . . 0.0 112.906 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.499 ' CD1' ' HB2' ' A' ' 174' ' ' PRO . 2.8 m-30 -97.53 -10.96 24.31 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.632 -177.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.622 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 4.0 m -105.67 -172.98 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -164.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.64 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 3.8 tp10 -159.98 50.76 0.31 Allowed 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 113.143 -1.844 . . . . 0.0 112.949 -151.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.989 ' HG3' HG21 ' A' ' 128' ' ' VAL . 2.2 mppt? -69.83 137.56 51.87 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 119.451 -2.031 . . . . 0.0 111.061 -161.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.677 ' HB2' ' NH1' ' A' ' 129' ' ' ARG . 12.3 tp -71.98 -92.31 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 112.999 -1.91 . . . . 0.0 111.694 -169.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.439 ' H ' ' HB3' ' A' ' 181' ' ' LEU . 6.9 p -86.27 122.34 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 176.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.43 ' NH1' ' HE3' ' A' ' 180' ' ' LYS . 24.3 ttt180 -173.63 141.3 0.84 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.149 -173.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 27.7 t -82.43 143.53 31.11 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 172.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' SER . . . . . 0.67 ' HB2' ' HD2' ' A' ' 186' ' ' PRO . 5.0 p -65.88 168.46 8.86 Favored Pre-proline 0 C--N 1.324 -0.534 0 N-CA-C 110.49 -0.189 . . . . 0.0 110.49 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.67 ' HD2' ' HB2' ' A' ' 185' ' ' SER . 18.3 Cg_endo -58.96 82.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.005 2.47 . . . . 0.0 113.266 -175.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -102.09 -43.96 5.6 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.34 174.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 81.95 -53.86 4.78 Favored Glycine 0 N--CA 1.451 -0.315 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -176.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.411 ' HE2' ' HB3' ' A' ' 189' ' ' LYS . 35.1 ttpt -79.32 76.28 5.89 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.258 0.551 . . . . 0.0 110.323 175.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -114.91 90.36 3.32 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 174.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 84.24 -151.09 26.66 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 -171.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -117.77 108.78 15.79 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 117.476 0.638 . . . . 0.0 109.739 176.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -136.01 24.16 3.3 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -128.44 86.42 2.45 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.593 -176.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 14.1 t -176.6 178.17 1.31 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 13.1 m120 64.89 100.82 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.74 0.65 . . . . 0.0 112.493 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 20.4 m -93.94 103.9 15.98 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 174.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -92.59 111.52 23.14 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -174.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -79.12 152.26 36.17 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 165.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.451 ' HA ' ' HD3' ' A' ' 201' ' ' PRO . 45.9 mm -48.1 110.54 1.44 Allowed Pre-proline 0 C--O 1.236 0.37 0 CA-C-N 117.44 0.62 . . . . 0.0 111.467 -175.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 200' ' ' ILE . 16.8 Cg_exo -67.44 144.59 67.98 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 123.208 2.605 . . . . 0.0 112.446 -175.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -83.01 130.03 59.05 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.652 -176.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -77.79 106.49 2.19 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.367 2.045 . . . . 0.0 110.948 172.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.65 141.54 56.68 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.328 -176.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -107.08 -22.22 12.72 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 177.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -112.98 121.01 43.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.486 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' TYR . . . . . 0.452 ' O ' ' HD2' ' A' ' 210' ' ' PRO . 76.7 m-85 -115.16 159.54 20.79 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.995 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -78.65 -20.22 50.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.786 -177.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 0.664 ' HB2' ' HD3' ' A' ' 210' ' ' PRO . 15.7 mm100 -60.12 -53.79 61.62 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -178.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . 0.664 ' HD3' ' HB2' ' A' ' 209' ' ' GLN . 38.4 Cg_exo -62.17 -16.66 52.11 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.252 1.968 . . . . 0.0 113.563 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -109.18 -7.87 15.22 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.615 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.43 HG21 ' HA ' ' A' ' 209' ' ' GLN . 6.9 t -95.07 -11.44 28.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.16 0.505 . . . . 0.0 109.843 177.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' THR . . . . . 0.408 ' O ' ' HD3' ' A' ' 215' ' ' PRO . 50.9 m -126.42 109.52 12.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.973 176.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 33.4 p -109.66 94.31 16.39 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.302 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 213' ' ' THR . 74.1 Cg_endo -89.64 133.18 2.15 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.799 2.332 . . . . 0.0 113.27 -175.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.411 ' HA ' ' HD3' ' A' ' 217' ' ' PRO . 3.5 mm? -97.74 105.13 24.73 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 173.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 216' ' ' LEU . 17.0 Cg_exo -66.55 -75.84 0.01 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.194 0 C-N-CA 122.845 2.363 . . . . 0.0 112.55 -175.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -138.32 103.14 4.83 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.914 0.387 . . . . 0.0 110.603 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 27.6 m -106.23 -16.4 8.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.325 177.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 3.5 p -79.4 161.34 26.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.868 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 157.08 -6.51 0.2 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.412 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 16.7 t -98.87 105.9 34.17 Favored Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -68.31 -44.64 3.31 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.772 2.315 . . . . 0.0 113.009 -176.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 62.05 91.24 0.02 OUTLIER Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.874 -175.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -87.68 86.09 7.15 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 122.533 -0.392 . . . . 0.0 110.788 -177.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . 70.16 -64.7 0.35 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.654 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 45.1 mm -121.57 123.41 69.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 44.7 m -70.42 126.13 92.2 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.932 176.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.16 -177.89 2.92 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.497 2.131 . . . . 0.0 112.444 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.482 HD23 HD21 ' A' ' 235' ' ' ASN . 60.3 mt 68.73 92.19 0.06 OUTLIER Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.465 177.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -67.15 -66.91 0.04 OUTLIER 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.716 2.277 . . . . 0.0 112.147 177.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 14.0 m -141.57 13.38 2.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.006 0.431 . . . . 0.0 110.78 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 2.2 p -113.11 122.8 48.63 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.951 0.405 . . . . 0.0 111.872 -177.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.478 ' O ' ' HG2' ' A' ' 234' ' ' GLN . 5.1 pm0 -77.14 98.09 4.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.636 0.731 . . . . 0.0 109.386 173.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . 0.482 HD21 HD23 ' A' ' 230' ' ' LEU . 36.6 m-80 -95.53 104.89 16.82 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.101 -175.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . 0.424 ' HA2' ' HD3' ' A' ' 237' ' ' PRO . . . 174.14 145.76 5.35 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.648 177.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.424 ' HD3' ' HA2' ' A' ' 236' ' ' GLY . 39.6 Cg_exo -63.11 169.71 8.77 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.964 2.443 . . . . 0.0 111.937 174.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.503 ' HB ' HG12 ' A' ' 266' ' ' VAL . 58.6 t -83.91 116.5 27.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.315 0.578 . . . . 0.0 110.908 -176.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -103.91 114.45 28.71 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.566 175.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.533 ' HB3' HD12 ' A' ' 293' ' ' ILE . . . -119.54 131.17 55.49 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.06 -178.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.627 ' HE3' ' HA2' ' A' ' 261' ' ' GLY . 48.5 tttp -90.13 126.12 35.68 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 260' ' ' VAL . . . -74.83 97.08 3.21 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.23 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 48.2 pt -77.35 -21.91 14.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.127 0.489 . . . . 0.0 110.444 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.17 141.11 50.69 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -67.91 161.4 26.51 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-O 121.175 0.512 . . . . 0.0 111.073 -174.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.441 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 24.7 tpt180 -151.67 101.36 2.78 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.623 179.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 29.6 m -97.46 154.24 38.07 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.528 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.469 ' HA ' ' HB3' ' A' ' 255' ' ' ALA . 10.1 Cg_exo -69.63 99.98 0.77 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.202 1.934 . . . . 0.0 111.176 177.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' CYS . . . . . 0.504 ' HB3' ' HB2' ' A' ' 252' ' ' ASP . 42.3 t -70.24 167.96 16.82 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.325 -178.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -53.83 -38.28 64.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.917 0.389 . . . . 0.0 110.977 176.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -103.53 17.27 24.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.006 0.431 . . . . 0.0 111.142 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.504 ' HB2' ' HB3' ' A' ' 249' ' ' CYS . 4.0 m-20 -140.18 54.4 1.64 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.539 175.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -75.04 -14.85 60.64 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.37 -177.029 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 4.4 p -93.57 6.76 47.18 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.733 176.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.487 ' HB1' ' HB3' ' A' ' 252' ' ' ASP . . . -80.8 150.92 29.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.14 0.495 . . . . 0.0 110.984 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.9 tt -90.63 124.43 35.05 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -67.87 100.13 0.91 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.335 0.588 . . . . 0.0 110.427 177.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.457 HD21 HG21 ' A' ' 264' ' ' VAL . 93.4 mt -108.29 147.82 30.9 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.138 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -129.03 163.49 25.28 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.854 178.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 61.6 t -62.13 122.48 12.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.164 0.506 . . . . 0.0 111.4 -176.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . 0.627 ' HA2' ' HE3' ' A' ' 241' ' ' LYS . . . 102.71 -9.39 55.41 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.694 177.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -79.52 140.28 37.3 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 -173.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 44.3 mm -88.57 109.22 19.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.394 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.457 HG21 HD21 ' A' ' 258' ' ' LEU . 15.0 t -83.58 100.69 7.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.129 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -83.14 87.33 6.92 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.853 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.503 HG12 ' HB ' ' A' ' 238' ' ' VAL . 4.8 p -97.53 133.4 39.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.071 0.462 . . . . 0.0 110.688 -177.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 20.7 p -103.57 -35.46 8.29 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.849 -175.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 3.1 ptp180 -118.21 121.53 40.71 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.095 0.474 . . . . 0.0 110.68 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' MET . . . . . 0.488 ' HE2' HG11 ' A' ' 266' ' ' VAL . 45.7 mmm -95.36 99.38 11.31 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.577 -177.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.501 ' HB2' ' O ' ' A' ' 274' ' ' GLN . 84.3 m-20 -75.34 129.94 38.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.542 -178.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 11.1 tp -69.25 -15.19 19.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -171.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -71.39 -18.34 62.36 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.756 0.313 . . . . 0.0 111.033 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 115.24 -34.1 4.98 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.993 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.512 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 17.2 mt-30 -83.6 105.04 14.21 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 175.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.406 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 40.2 m0 -92.71 156.7 16.87 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -176.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -108.01 106.52 16.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.99 0.424 . . . . 0.0 110.379 -179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . 0.45 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -121.06 153.82 16.55 Favored Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 177.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -116.23 111.92 20.87 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . 0.566 HG11 ' ND2' ' A' ' 280' ' ' ASN . 16.7 t -122.93 125.76 72.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.515 -177.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . 0.566 ' ND2' HG11 ' A' ' 279' ' ' VAL . 9.6 p30 44.0 41.58 4.11 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.144 0.978 . . . . 0.0 112.981 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 102.6 -20.48 44.08 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.782 -0.723 . . . . 0.0 113.675 173.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 17.2 mtp-105 -109.1 125.18 51.88 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 117.232 0.516 . . . . 0.0 110.908 -177.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 42.1 pttt -114.88 134.73 54.91 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 120.289 -0.564 . . . . 0.0 109.999 172.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -155.96 176.41 33.45 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.675 -177.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.512 ' HB3' ' HB3' ' A' ' 274' ' ' GLN . 57.6 mt -91.08 118.29 30.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.983 0.42 . . . . 0.0 110.678 178.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.418 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 45.9 p90 -120.94 138.86 28.29 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.256 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 6.3 Cg_exo -76.06 139.41 21.6 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.043 2.495 . . . . 0.0 111.469 175.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -69.8 1.38 4.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.997 -177.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 19.8 p -82.7 -15.03 53.5 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.682 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -103.57 -17.27 15.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.794 0.331 . . . . 0.0 111.343 -177.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.5 ' O ' ' HD2' ' A' ' 292' ' ' LYS . 32.7 m -115.29 159.31 15.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.269 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . 0.5 ' HD2' ' O ' ' A' ' 291' ' ' VAL . 11.1 mptt -126.9 129.02 47.4 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.923 0.392 . . . . 0.0 110.682 177.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.533 HD12 ' HB3' ' A' ' 240' ' ' ALA . 39.7 mm -73.41 130.84 35.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.42 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' PHE . . . . . 0.434 ' CE1' ' HB2' ' A' ' 241' ' ' LYS . 0.6 OUTLIER -152.56 165.34 35.46 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.451 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.454 ' HB3' ' HA ' ' A' ' 298' ' ' ASN . 17.2 m-20 -104.8 102.01 32.51 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 175.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -66.41 -33.03 39.22 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.702 2.268 . . . . 0.0 112.567 -173.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -120.83 -6.92 9.59 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.82 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . 0.454 ' HA ' ' HB3' ' A' ' 295' ' ' ASP . 16.8 m120 59.61 100.12 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.474 0 O-C-N 123.63 0.581 . . . . 0.0 111.09 -173.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -73.76 36.87 0.4 Allowed 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 123.236 2.624 . . . . 0.0 112.334 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.425 ' H ' ' C ' ' A' ' 298' ' ' ASN . 29.0 t70 -73.69 -48.09 34.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.221 0.534 . . . . 0.0 109.755 178.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -130.64 6.68 4.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.324 173.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -100.64 119.84 39.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.52 -174.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 . . . . . 0 C--O 1.252 1.215 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.146 176.336 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 pmm? . . . . . 0 N--CA 1.483 1.22 0 CA-C-O 120.267 0.079 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.4 t 72.06 137.82 0.05 OUTLIER 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 121.388 0.613 . . . . 0.0 110.974 -178.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.4 t -152.35 -60.39 0.15 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.403 ' HA ' HG22 ' A' ' 99' ' ' ILE . . . -85.39 119.82 26.18 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.617 177.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.496 ' HD3' ' HA ' ' A' ' 5' ' ' ARG . 22.1 mmt180 -131.35 87.7 2.5 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.38 0.609 . . . . 0.0 111.412 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -158.81 168.17 27.53 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 177.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -100.58 131.59 46.41 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.061 175.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.5 m -69.65 -19.76 63.61 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.19 -174.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.8 t -106.24 -24.37 12.32 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -172.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -60.82 95.13 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.961 0.41 . . . . 0.0 111.143 -175.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.8 tpp180 -52.74 -51.23 61.41 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 123.205 0.602 . . . . 0.0 112.15 -174.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.6 m -72.93 4.88 3.71 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -176.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -91.65 -48.7 6.69 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.55 175.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 37.4 p-90 -113.92 -30.39 6.74 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -172.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -70.99 113.52 8.11 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.391 -0.524 . . . . 0.0 109.634 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.904 ' HB3' HG13 ' A' ' 19' ' ' VAL . 27.9 tpp -94.22 1.63 56.0 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 120.911 0.386 . . . . 0.0 110.293 -170.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 50.65 -111.96 1.43 Allowed Glycine 0 C--N 1.334 0.451 0 CA-C-N 115.041 -0.981 . . . . 0.0 113.653 177.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -64.97 90.87 0.2 Allowed 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.846 2.364 . . . . 0.0 112.297 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.994 HG22 ' HD2' ' A' ' 39' ' ' ARG . 2.7 p -162.5 159.43 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.7 m -156.64 -166.63 2.17 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 -160.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 25' ' ' GLN . 44.1 mtp85 -69.25 -41.56 76.76 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.663 -175.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 15.5 tp60 -64.24 -54.02 39.89 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 123.458 0.473 . . . . 0.0 111.024 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.672 ' OE1' ' HA ' ' A' ' 106' ' ' PRO . 47.9 mm-40 -61.12 -56.43 20.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.835 -176.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.91 -33.66 67.15 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.738 0.304 . . . . 0.0 111.614 -178.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.536 ' NE2' HG21 ' A' ' 58' ' ' VAL . 26.9 tp60 -61.8 -47.69 83.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.867 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.0 t -79.97 -25.27 40.45 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 120.88 0.372 . . . . 0.0 111.553 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.418 ' NH1' ' HB ' ' A' ' 19' ' ' VAL . 97.5 mtt180 -74.72 -38.16 62.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.987 0.422 . . . . 0.0 110.962 -177.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.908 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 28.7 mt -99.72 6.66 45.5 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.935 -176.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.473 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 17.0 tp60 -72.05 95.31 1.6 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.083 0.468 . . . . 0.0 111.725 -172.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 66.37 29.04 74.16 Favored Glycine 0 N--CA 1.453 -0.202 0 CA-C-N 115.608 -0.724 . . . . 0.0 113.815 173.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.44 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 0.0 OUTLIER -85.39 -91.91 0.09 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 117.027 0.414 . . . . 0.0 110.082 178.483 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.564 ' HB2' ' SD ' ' A' ' 35' ' ' MET . 86.7 mtm-85 -127.54 135.54 50.48 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 170.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 58.5 m170 -71.06 124.61 24.79 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.06 -13.75 14.03 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.649 -176.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.653 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 93.4 mtp -73.62 126.37 30.13 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 175.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.507 ' CB ' HG22 ' A' ' 52' ' ' VAL . 47.1 p90 -133.6 166.0 23.61 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.901 0.381 . . . . 0.0 111.013 -177.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.503 ' HB2' ' HB2' ' A' ' 16' ' ' MET . 4.0 pp -158.07 138.79 12.96 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.499 176.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.496 ' CG2' HD11 ' A' ' 50' ' ' LEU . 87.7 t -102.1 123.58 55.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.994 ' HD2' HG22 ' A' ' 19' ' ' VAL . 5.0 mtm-85 -106.77 175.01 5.64 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.163 -171.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -86.62 90.96 8.43 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 167.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.582 ' HA ' HG22 ' A' ' 49' ' ' VAL . 7.5 t 24.76 -141.41 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.347 1.459 . . . . 0.0 114.487 -176.096 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.591 ' HB3' HH21 ' A' ' 39' ' ' ARG . 56.0 p 172.26 -29.13 0.0 OUTLIER 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 114.106 -1.406 . . . . 0.0 108.778 174.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 40.3 p -122.88 -13.0 7.95 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.982 -177.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.433 ' HA ' ' HD2' ' A' ' 45' ' ' PRO . 64.0 m -133.47 100.17 13.96 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 110.527 -0.175 . . . . 0.0 110.527 -175.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 44' ' ' CYS . 17.9 Cg_endo -57.42 109.18 0.43 Allowed 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.97 2.447 . . . . 0.0 113.069 -174.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.81 -19.73 18.26 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.695 177.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.458 ' O ' ' HB2' ' A' ' 41' ' ' SER . 74.8 m-20 -90.25 -174.65 4.25 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.34 -0.245 . . . . 0.0 110.34 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.55 ' HA ' ' H ' ' A' ' 41' ' ' SER . 26.9 m-85 -129.55 167.77 17.41 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.629 ' O ' ' HG3' ' A' ' 39' ' ' ARG . 96.6 t -142.22 98.07 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 121.046 0.451 . . . . 0.0 111.298 177.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.496 HD11 ' CG2' ' A' ' 38' ' ' VAL . 40.8 tp -70.1 103.02 2.19 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.963 175.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.497 ' HB3' ' CG1' ' A' ' 58' ' ' VAL . 21.5 m -96.56 134.4 39.82 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.807 175.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.533 HG23 HD12 ' A' ' 93' ' ' LEU . 96.4 t -123.0 142.8 38.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.329 -178.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.908 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 36.0 t -88.05 116.92 26.57 Favored 'General case' 0 C--N 1.334 -0.081 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.649 176.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.836 ' HB2' ' HB3' ' A' ' 94' ' ' ASP . 4.8 pt-20 -165.64 141.88 5.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.775 -0.193 . . . . 0.0 110.997 -177.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.569 HD22 ' HE2' ' A' ' 155' ' ' LYS . 0.5 OUTLIER 53.16 32.12 12.65 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 122.933 0.493 . . . . 0.0 111.881 -174.385 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.1 m 67.34 11.12 8.21 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.62 177.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.581 ' HG3' ' O ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -125.39 165.31 18.63 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.187 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.536 HG21 ' NE2' ' A' ' 25' ' ' GLN . 84.1 t -106.32 105.47 18.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.035 0.445 . . . . 0.0 110.651 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.7 t -76.51 120.36 21.61 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.765 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -99.76 102.4 13.84 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.61 -174.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.915 ' HH ' ' HB3' ' A' ' 93' ' ' LEU . 66.9 m-85 -100.53 101.5 12.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.621 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.465 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 25.6 mt -81.05 138.41 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 121.152 0.501 . . . . 0.0 112.311 -174.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.623 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 3.7 mp -116.85 122.24 69.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.603 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -104.01 140.42 37.77 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -175.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.4 t -79.85 104.83 10.7 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.103 0.478 . . . . 0.0 110.444 -177.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.497 HD12 ' HB2' ' A' ' 72' ' ' LYS . 90.6 mt -75.24 132.73 75.87 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.617 178.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -57.18 -19.85 35.81 Favored 'Trans proline' 0 N--CA 1.473 0.302 0 C-N-CA 123.425 2.75 . . . . 0.0 113.409 -174.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -90.28 26.85 1.81 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.238 178.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.696 ' HA ' ' HE ' ' A' ' 69' ' ' ARG . 2.2 mmp_? 69.3 26.07 5.44 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.356 173.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.635 ' HG2' ' HA ' ' A' ' 79' ' ' ASP . 69.8 mtt180 -114.47 179.0 4.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.604 176.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.623 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 36.6 m-85 -139.1 120.39 14.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.774 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.497 ' HB2' HD12 ' A' ' 66' ' ' LEU . 19.6 ttmm -106.65 110.21 22.34 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.615 -178.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.585 ' HB ' HG13 ' A' ' 63' ' ' ILE . 3.9 tt -94.06 103.62 14.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.084 0.468 . . . . 0.0 110.869 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 52.69 63.11 5.24 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.658 -0.701 . . . . 0.0 113.111 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.1 t0 78.59 -38.88 0.24 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.002 0.521 . . . . 0.0 111.081 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -69.09 119.12 12.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.002 0.429 . . . . 0.0 110.259 177.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.433 ' HB3' ' NZ ' ' A' ' 72' ' ' LYS . 7.7 pt-20 -99.23 133.67 43.18 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.274 0.559 . . . . 0.0 111.846 -174.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.448 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 79.7 m-85 -136.83 164.1 29.09 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.818 177.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.635 ' HA ' ' HG2' ' A' ' 70' ' ' ARG . 6.9 m-20 -73.75 -26.56 60.73 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -176.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.421 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 5.7 p80 -163.11 172.96 14.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.848 -0.16 . . . . 0.0 110.937 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.538 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 19.6 mt -58.34 -52.25 75.93 Favored Pre-proline 0 CA--C 1.535 0.367 0 O-C-N 123.251 0.344 . . . . 0.0 111.656 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.538 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 52.0 Cg_exo -58.11 -9.03 5.56 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 122.419 2.079 . . . . 0.0 113.467 177.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.28 -36.35 15.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.953 0.406 . . . . 0.0 110.799 -178.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.567 HD11 HD13 ' A' ' 73' ' ' ILE . 3.7 pp -79.97 -33.89 39.12 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.3 mt -68.08 -14.2 62.79 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.635 0.731 . . . . 0.0 110.115 175.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -85.98 -44.9 11.96 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.667 177.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.435 ' O ' HG12 ' A' ' 90' ' ' ILE . 84.9 t80 -70.15 -37.13 75.17 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.534 -177.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -72.77 5.2 3.33 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -176.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -83.76 -14.98 50.21 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 119.915 -0.714 . . . . 0.0 111.144 171.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.435 HG12 ' O ' ' A' ' 87' ' ' PHE . 5.6 pt -87.89 -28.93 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.227 166.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.431 ' N ' HG13 ' A' ' 90' ' ' ILE . 3.0 m170 -91.14 124.53 35.43 Favored 'General case' 0 CA--C 1.502 -0.865 0 CA-C-O 121.135 0.493 . . . . 0.0 111.181 -177.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -86.81 90.04 8.17 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 175.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.915 ' HB3' ' HH ' ' A' ' 61' ' ' TYR . 5.3 mt -46.63 -36.36 6.91 Favored 'General case' 0 C--O 1.218 -0.567 0 O-C-N 124.346 1.029 . . . . 0.0 110.204 -177.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.836 ' HB3' ' HB2' ' A' ' 54' ' ' GLU . 21.6 t70 -158.82 99.35 1.54 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.841 165.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.659 ' HA ' ' HA ' ' A' ' 156' ' ' PRO . 5.7 t 44.3 18.16 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.663 1.185 . . . . 0.0 112.498 -177.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.7 t -162.77 154.58 18.15 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.478 ' O ' HG12 ' A' ' 99' ' ' ILE . 52.2 p -104.11 -179.01 3.82 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.422 ' HG ' HD11 ' A' ' 93' ' ' LEU . 85.7 mt -64.4 104.97 0.84 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 173.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.478 HG12 ' O ' ' A' ' 97' ' ' THR . 45.1 mm -99.86 -54.93 6.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.737 -173.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.653 ' O ' ' HA ' ' A' ' 35' ' ' MET . 10.6 pt-20 -151.59 153.02 31.55 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.062 -173.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 100' ' ' GLU . 1.9 Cg_endo -83.84 158.61 13.89 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.948 2.432 . . . . 0.0 112.746 178.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.462 ' O ' ' HE2' ' A' ' 16' ' ' MET . . . -88.18 164.62 32.56 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.054 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -78.28 164.92 26.23 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.99 2.46 . . . . 0.0 112.453 175.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.777 ' HG2' ' SD ' ' A' ' 16' ' ' MET . 19.8 mtm180 -99.78 111.99 24.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.492 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.413 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 1.6 t80 -170.48 117.71 0.49 Allowed Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 120.511 0.196 . . . . 0.0 111.099 178.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.672 ' HA ' ' OE1' ' A' ' 23' ' ' GLU . 2.6 Cg_endo -82.29 159.37 17.51 Favored 'Trans proline' 0 C--O 1.238 0.487 0 C-N-CA 123.449 2.766 . . . . 0.0 111.945 176.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.862 ' HB2' ' HD3' ' A' ' 108' ' ' PRO . 41.0 m -150.26 -68.39 0.02 OUTLIER Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.862 ' HD3' ' HB2' ' A' ' 107' ' ' SER . 3.0 Cg_endo -85.87 164.62 10.32 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.84 2.36 . . . . 0.0 113.048 -173.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.416 ' HB2' ' H ' ' A' ' 110' ' ' MET . 10.8 Cg_exo -71.75 -79.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.818 2.346 . . . . 0.0 112.186 177.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.416 ' H ' ' HB2' ' A' ' 109' ' ' PRO . 0.0 OUTLIER -168.61 140.85 2.78 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.121 0.486 . . . . 0.0 110.703 177.414 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 151.63 74.24 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.6 -178.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 12.1 p -74.87 172.22 12.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.757 0.313 . . . . 0.0 110.826 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.9 t -82.29 46.24 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 120.74 0.305 . . . . 0.0 111.236 -175.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 25.4 t 67.41 179.35 0.23 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.111 176.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.424 ' HA ' ' HD2' ' A' ' 116' ' ' PRO . . . 60.07 102.49 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.368 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 173.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 115' ' ' ALA . 26.2 Cg_endo -63.9 -26.61 66.97 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.761 2.307 . . . . 0.0 112.267 177.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.588 ' O ' ' HB2' ' A' ' 118' ' ' LEU . 24.0 t-20 -116.16 59.69 0.73 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.645 0.259 . . . . 0.0 110.363 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.588 ' HB2' ' O ' ' A' ' 117' ' ' ASN . 10.2 mp 90.35 118.18 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.899 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.247 172.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.415 ' HA ' ' HB2' ' A' ' 115' ' ' ALA . 43.5 Cg_endo -93.98 121.28 0.37 Allowed 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 123.63 2.887 . . . . 0.0 113.633 -175.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.574 HG23 ' HB3' ' A' ' 126' ' ' GLU . 7.0 m -75.08 -13.04 60.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.177 0.513 . . . . 0.0 110.352 174.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.457 ' O ' ' HG2' ' A' ' 122' ' ' GLU . . . 66.24 -79.39 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.058 -172.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.501 ' O ' ' HB2' ' A' ' 184' ' ' SER . 36.8 mm-40 -162.5 -35.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 O-C-N 123.438 0.461 . . . . 0.0 111.165 -178.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.447 ' O ' ' HD3' ' A' ' 183' ' ' ARG . 1.5 t70 -74.45 -92.36 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -164.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.422 ' OD1' HD21 ' A' ' 125' ' ' LEU . 8.4 p30 -161.85 172.99 15.18 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.775 -172.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.529 HD12 HG21 ' A' ' 152' ' ' ILE . 2.6 mm? 57.47 87.37 0.06 Allowed 'General case' 0 N--CA 1.468 0.473 0 O-C-N 124.014 0.821 . . . . 0.0 112.328 -178.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.664 ' O ' HG12 ' A' ' 151' ' ' VAL . 10.0 tp10 179.84 -48.57 0.01 OUTLIER 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.106 174.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.406 ' HD1' ' OG1' ' A' ' 120' ' ' THR . 35.5 m-85 -122.76 131.03 53.59 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.373 177.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.5 ' CG1' ' HB ' ' A' ' 178' ' ' VAL . 5.8 t -134.93 156.8 40.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.087 -174.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.579 ' NH2' HD11 ' A' ' 181' ' ' LEU . 1.2 ptp180 -134.17 133.54 41.1 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 172.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.71 HG23 ' CG1' ' A' ' 178' ' ' VAL . 23.8 p -88.77 140.57 29.31 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.273 0.559 . . . . 0.0 112.213 -174.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.573 HD11 ' HG2' ' A' ' 179' ' ' GLU . 13.6 mt -106.99 -42.23 4.96 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.397 -176.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -83.31 -36.45 24.45 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -168.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.783 ' HB2' ' HA ' ' A' ' 145' ' ' LYS . 0.0 OUTLIER 79.25 133.67 0.06 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.434 0.693 . . . . 0.0 111.021 -174.59 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.568 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 59.1 t80 -156.05 110.38 2.11 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.072 -178.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -89.42 90.91 0.36 Allowed 'Trans proline' 0 N--CA 1.445 -1.348 0 C-N-CA 122.591 2.194 . . . . 0.0 112.586 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.474 ' HA3' ' HB3' ' A' ' 141' ' ' ASP . . . -84.4 -21.14 57.31 Favored Glycine 0 N--CA 1.454 -0.166 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.048 173.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 28.4 m120 46.29 48.67 13.27 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 114.443 -0.878 . . . . 0.0 112.532 178.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.405 ' OD1' ' HG2' ' A' ' 140' ' ' GLU . 5.0 t70 -149.53 179.23 8.14 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.39 -178.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -95.17 -7.5 39.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.336 0.588 . . . . 0.0 110.197 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.568 ' O ' ' HB2' ' A' ' 172' ' ' MET . 10.0 pt-20 -113.28 -3.32 13.86 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.987 173.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.474 ' HB3' ' HA3' ' A' ' 136' ' ' GLY . 4.1 m-20 -140.14 102.03 4.29 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.687 ' HB3' ' CG2' ' A' ' 173' ' ' ILE . 57.8 tp -74.03 126.13 89.56 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.417 0.627 . . . . 0.0 111.639 -172.448 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.663 ' HD2' ' CD1' ' A' ' 142' ' ' LEU . 68.8 Cg_endo -76.73 65.58 7.54 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 124.263 3.308 . . . . 0.0 113.132 177.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.568 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 36.3 p90 -84.43 162.08 20.09 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.504 -0.479 . . . . 0.0 111.736 -176.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.783 ' HA ' ' HB2' ' A' ' 133' ' ' ASP . 10.9 mtmt -121.98 179.92 4.36 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.178 -176.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.659 ' H ' ' HD3' ' A' ' 146' ' ' LYS . 0.3 OUTLIER -79.47 27.62 0.27 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -167.753 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 175.72 32.91 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 119.721 -1.228 . . . . 0.0 113.594 176.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.565 ' OE2' ' HA ' ' A' ' 144' ' ' PHE . 8.7 pt-20 -106.63 167.15 10.06 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 117.826 0.813 . . . . 0.0 110.916 177.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.423 ' HA ' HD11 ' A' ' 149' ' ' ILE . 19.8 mm -101.55 138.38 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -175.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.714 HD22 ' HA ' ' A' ' 165' ' ' ASN . 11.5 mt -122.9 179.64 4.57 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.86 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 47.8 t -145.29 123.46 5.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 178.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.848 HD13 ' HB3' ' A' ' 163' ' ' ALA . 20.4 mm -77.85 77.77 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-O 122.659 1.219 . . . . 0.0 108.55 -178.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.604 HD11 ' HE1' ' A' ' 61' ' ' TYR . 13.5 tt -71.4 -41.45 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-N 112.847 -1.979 . . . . 0.0 109.905 -177.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 1.153 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 73.4 mt-10 -116.79 138.92 51.15 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 172.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.596 ' O ' ' HB ' ' A' ' 95' ' ' THR . 22.1 ttpt -132.94 79.54 62.94 Favored Pre-proline 0 C--N 1.322 -0.593 0 O-C-N 122.043 -0.411 . . . . 0.0 110.015 167.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.659 ' HA ' ' HA ' ' A' ' 95' ' ' THR . 14.6 Cg_exo -66.35 -49.17 1.97 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 121.95 1.767 . . . . 0.0 110.945 177.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -119.93 176.44 5.41 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.205 -174.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -95.6 -30.34 13.85 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.619 -176.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.405 ' O ' HG21 ' A' ' 175' ' ' VAL . 24.2 mt-30 -84.25 -22.71 30.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.021 0.438 . . . . 0.0 110.793 -179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.751 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 60.5 m95 -129.2 126.89 40.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.425 -178.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . 0.711 ' HB3' HG22 ' A' ' 152' ' ' ILE . 49.5 m0 -119.75 134.26 55.3 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.752 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 1.153 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 6.5 m -84.47 98.09 9.9 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 177.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.848 ' HB3' HD13 ' A' ' 152' ' ' ILE . . . -103.98 157.78 16.87 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.136 -176.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.86 ' HG2' ' HB ' ' A' ' 151' ' ' VAL . 14.2 ptt180 -104.66 129.64 52.8 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 176.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.714 ' HA ' HD22 ' A' ' 150' ' ' LEU . 0.2 OUTLIER -73.03 -166.99 0.35 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.453 0.168 . . . . 0.0 110.971 -178.225 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.503 ' HE3' ' HB2' ' A' ' 148' ' ' GLU . 93.8 mttt -55.96 -38.06 69.86 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -176.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.43 ' CG ' HD22 ' A' ' 165' ' ' ASN . 3.3 p30 -86.46 0.96 53.07 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.308 -178.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 92.42 3.06 67.34 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 120.447 -0.882 . . . . 0.0 113.973 174.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.707 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 12.5 ttm-85 -68.1 130.25 42.36 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 122.511 0.324 . . . . 0.0 110.777 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 39.8 t -95.19 143.02 12.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-O 120.855 0.36 . . . . 0.0 111.008 -177.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -170.92 155.53 24.87 Favored Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 175.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.751 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.4 OUTLIER -70.26 131.66 44.53 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.967 0.384 . . . . 0.0 110.864 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.687 ' CG2' ' HB3' ' A' ' 142' ' ' LEU . 2.6 pp -133.52 145.4 56.2 Favored Pre-proline 0 N--CA 1.451 -0.394 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.199 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.474 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 8.2 Cg_exo -71.69 125.43 11.11 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.957 2.438 . . . . 0.0 111.859 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.613 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 24.1 t -68.76 -35.29 6.34 Favored Pre-proline 0 C--N 1.32 -0.682 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -178.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 19.0 Cg_endo -61.43 -11.22 18.77 Favored 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 121.656 1.571 . . . . 0.0 112.537 172.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.474 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.4 m-85 -92.01 -14.35 29.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.243 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.71 ' CG1' HG23 ' A' ' 130' ' ' THR . 10.3 m -122.01 173.64 7.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -169.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.573 ' HG2' HD11 ' A' ' 131' ' ' LEU . 9.3 mm-40 -136.34 169.71 17.23 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.933 177.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.525 ' N ' ' HD3' ' A' ' 180' ' ' LYS . 2.3 mppt? -101.22 136.92 40.27 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.802 0.334 . . . . 0.0 110.563 -175.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.579 HD11 ' NH2' ' A' ' 129' ' ' ARG . 7.8 tp -84.18 -86.17 0.12 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.371 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.486 HG13 ' HG ' ' A' ' 181' ' ' LEU . 1.6 m -82.26 38.55 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.125 -174.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.447 ' HD3' ' O ' ' A' ' 123' ' ' ASP . 1.4 tpp180 -70.68 115.82 10.28 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 168.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.501 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 0.9 OUTLIER -72.97 76.28 1.18 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.523 0.678 . . . . 0.0 110.119 179.956 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' SER . . . . . 0.594 ' HB2' ' HD2' ' A' ' 186' ' ' PRO . 28.1 p -85.19 168.57 19.77 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.889 178.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.594 ' HD2' ' HB2' ' A' ' 185' ' ' SER . 6.0 Cg_endo -48.84 -55.77 3.81 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.115 2.543 . . . . 0.0 112.883 177.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.459 ' HB2' ' O ' ' A' ' 186' ' ' PRO . 48.7 m80 72.5 -43.08 0.55 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.396 0.678 . . . . 0.0 111.996 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.412 ' H ' ' C ' ' A' ' 186' ' ' PRO . . . 108.72 95.83 2.41 Favored Glycine 0 N--CA 1.439 -1.129 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -168.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm 68.93 11.28 8.29 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.109 0.564 . . . . 0.0 110.771 -173.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 1.3 t60 62.18 21.64 12.58 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.529 176.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -91.03 173.47 37.9 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.327 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -83.26 -75.49 0.32 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.851 0.357 . . . . 0.0 111.195 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 31.8 mmm180 -127.73 125.83 40.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.744 -175.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -73.65 137.94 44.47 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.686 174.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 17.4 m -65.36 97.07 0.26 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.064 0.459 . . . . 0.0 110.85 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -84.95 96.1 9.26 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.376 -178.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 15.7 m -95.24 117.93 31.12 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.598 176.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -72.88 130.32 40.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.193 0.521 . . . . 0.0 111.502 -175.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -107.02 54.32 0.57 Allowed Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 175.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 40.7 mm -129.58 131.56 23.66 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.878 -0.161 . . . . 0.0 110.604 -174.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -66.88 120.33 7.41 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.573 2.182 . . . . 0.0 111.322 174.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -74.59 127.21 87.73 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.9 -175.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -77.3 131.01 11.41 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.434 2.089 . . . . 0.0 111.404 174.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.03 -77.94 0.08 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.358 -177.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -119.98 -9.5 9.63 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.087 0.47 . . . . 0.0 110.644 -178.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -84.55 100.74 11.59 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.632 177.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -133.16 173.34 11.54 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.308 178.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -85.29 137.38 33.0 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.71 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -79.21 145.63 65.16 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.013 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -81.6 92.39 1.02 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.359 2.039 . . . . 0.0 113.431 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -143.99 13.25 1.65 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.289 0.566 . . . . 0.0 109.729 171.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 4.5 m -89.28 15.17 9.46 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.269 -176.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 27.9 m 77.45 135.95 0.06 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.418 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 56.5 p 54.66 93.66 0.05 OUTLIER Pre-proline 0 N--CA 1.468 0.439 0 C-N-CA 123.866 0.866 . . . . 0.0 112.041 -178.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -66.81 -14.28 43.18 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.857 2.371 . . . . 0.0 112.04 178.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.422 ' HA ' ' HD3' ' A' ' 217' ' ' PRO . 6.8 mp -92.95 132.7 30.35 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.737 177.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.43 ' HB2' HG11 ' A' ' 219' ' ' VAL . 42.1 Cg_exo -58.94 -28.87 88.85 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.879 2.386 . . . . 0.0 112.438 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . 58.87 24.99 13.07 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.191 176.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.43 HG11 ' HB2' ' A' ' 217' ' ' PRO . 3.7 p -96.8 110.23 24.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.438 0.637 . . . . 0.0 110.628 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 50.6 m -152.97 -3.12 0.22 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.755 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 125.22 178.85 15.48 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.937 -177.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 23.6 t 61.38 93.43 0.06 OUTLIER Pre-proline 0 CA--C 1.532 0.284 0 C-N-CA 123.061 0.544 . . . . 0.0 111.707 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -84.48 13.91 2.6 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 123.175 2.583 . . . . 0.0 112.311 177.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 140.93 107.7 0.69 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.092 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -85.06 -53.93 4.96 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.853 0.359 . . . . 0.0 111.102 -178.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -134.74 36.17 3.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.976 0.417 . . . . 0.0 110.7 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 6.0 tp -78.49 117.43 23.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.336 178.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 20.3 p 48.49 81.99 0.25 Allowed Pre-proline 0 N--CA 1.468 0.425 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.259 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -70.67 134.61 26.44 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.823 2.349 . . . . 0.0 112.289 -177.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.444 HD11 ' HA ' ' A' ' 230' ' ' LEU . 3.6 mm? -93.06 126.72 50.05 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 176.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 230' ' ' LEU . 6.4 Cg_exo -75.77 47.73 2.0 Favored 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 123.081 2.52 . . . . 0.0 112.454 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 50.4 m 61.05 26.72 16.63 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.279 0.562 . . . . 0.0 110.557 -176.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' THR . . . . . 0.51 ' HB ' ' ND2' ' A' ' 235' ' ' ASN . 12.3 p -81.49 124.92 29.87 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.743 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.633 ' NE2' ' H ' ' A' ' 234' ' ' GLN . 0.8 OUTLIER -83.99 77.09 9.98 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.658 0.742 . . . . 0.0 111.343 -179.326 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . 0.51 ' ND2' ' HB ' ' A' ' 233' ' ' THR . 11.1 p30 -164.43 -178.65 5.55 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.68 177.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . 0.431 ' HA2' ' HD3' ' A' ' 237' ' ' PRO . . . -154.11 139.32 6.72 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.198 -0.525 . . . . 0.0 111.994 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.431 ' HD3' ' HA2' ' A' ' 236' ' ' GLY . 12.2 Cg_exo -71.19 124.32 10.38 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 123.084 2.523 . . . . 0.0 111.83 178.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.591 ' HB ' HG13 ' A' ' 266' ' ' VAL . 39.6 t -100.68 135.88 34.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.967 -173.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -88.27 121.85 31.14 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.459 173.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -126.5 123.69 38.36 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.391 176.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.422 ' O ' HG22 ' A' ' 243' ' ' ILE . 63.8 tttm -86.07 119.41 26.34 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.131 -177.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . 0.439 ' HA ' HG11 ' A' ' 291' ' ' VAL . . . -70.81 99.9 1.81 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.31 0.576 . . . . 0.0 110.418 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.422 HG22 ' O ' ' A' ' 241' ' ' LYS . 34.2 pt -88.75 -27.87 5.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.421 -173.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -129.89 147.81 51.69 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.368 -0.378 . . . . 0.0 109.996 -178.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -55.53 122.21 10.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.432 0.634 . . . . 0.0 111.296 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.729 ' HB3' ' HB2' ' A' ' 258' ' ' LEU . 20.9 tpt180 -122.73 77.04 1.4 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.382 -0.826 . . . . 0.0 108.856 173.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.423 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 7.4 m -111.62 137.46 21.2 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.67 -178.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 247' ' ' VAL . 31.8 Cg_exo -57.76 111.4 0.83 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 123.048 2.499 . . . . 0.0 112.044 -178.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' CYS . . . . . 0.427 ' N ' ' HB2' ' A' ' 252' ' ' ASP . 19.3 t -88.6 -169.86 2.71 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.2 -39.15 78.25 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -177.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -91.1 -9.91 43.92 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.381 -176.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.463 ' HB3' ' HB3' ' A' ' 255' ' ' ALA . 19.4 m-20 -80.89 116.67 20.99 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.364 0.602 . . . . 0.0 111.571 -174.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -120.47 145.97 46.73 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 172.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 25.2 p 61.92 17.73 9.19 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.581 0.752 . . . . 0.0 111.017 -174.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.463 ' HB3' ' HB3' ' A' ' 252' ' ' ASP . . . -81.17 130.99 35.27 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.999 0.428 . . . . 0.0 111.426 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.827 HD21 ' HB ' ' A' ' 279' ' ' VAL . 2.0 tt -86.07 131.29 34.29 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 175.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -79.86 95.95 6.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.211 0.529 . . . . 0.0 111.182 179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.897 HD22 HG22 ' A' ' 279' ' ' VAL . 68.8 mt -105.39 105.48 15.54 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.377 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -87.82 150.3 23.62 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.066 -177.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 47.0 t -61.8 121.21 9.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.038 -176.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 101.87 39.73 2.85 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.964 175.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -141.58 174.82 10.2 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.938 0.369 . . . . 0.0 110.138 177.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 49.8 mm -107.38 133.82 50.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.944 0.402 . . . . 0.0 111.203 -175.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.467 HG21 HD21 ' A' ' 258' ' ' LEU . 5.2 t -113.75 115.76 50.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.885 175.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -95.94 103.17 15.04 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 173.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.591 HG13 ' HB ' ' A' ' 238' ' ' VAL . 2.1 p -94.65 141.4 15.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.562 -178.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 19.5 p -126.34 -23.74 3.77 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.913 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . 0.455 ' HB2' ' HB3' ' A' ' 276' ' ' GLU . 83.4 mtt180 -116.51 119.42 35.53 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.43 177.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 58.6 mtt -117.25 110.36 18.01 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 175.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.401 ' C ' ' H ' ' A' ' 272' ' ' ASN . 53.6 m-80 -84.21 12.12 7.09 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.237 -170.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.451 HG23 HD11 ' A' ' 271' ' ' ILE . 48.0 mm 72.05 -39.0 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 175.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . 0.401 ' H ' ' C ' ' A' ' 270' ' ' ASN . 5.8 t30 -78.8 27.05 0.23 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.444 0.64 . . . . 0.0 111.067 -178.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 81.99 -29.14 3.12 Favored Glycine 0 C--N 1.32 -0.308 0 C-N-CA 121.096 -0.573 . . . . 0.0 113.077 176.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -78.7 105.54 10.08 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.506 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 49.4 m0 -99.82 153.96 18.72 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.274 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . 0.455 ' HB3' ' HB2' ' A' ' 268' ' ' ARG . 38.9 tt0 -120.59 115.6 23.72 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.887 178.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . 0.549 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -138.06 164.3 25.56 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 176.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -106.17 112.33 25.32 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 117.784 0.792 . . . . 0.0 109.669 -177.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . 0.897 HG22 HD22 ' A' ' 258' ' ' LEU . 70.8 t -121.15 99.67 7.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.171 -177.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 42.18 63.13 1.44 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.353 -1.294 . . . . 0.0 113.173 173.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 144.68 -51.08 0.63 Allowed Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.025 -1.083 . . . . 0.0 112.585 173.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.46 162.15 16.71 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.222 0.534 . . . . 0.0 111.755 -178.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 0.0 OUTLIER -88.84 143.06 27.15 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.673 175.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -150.56 172.18 30.33 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.539 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.506 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 72.0 mt -90.1 123.65 34.13 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.16 0.505 . . . . 0.0 110.958 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.422 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 36.6 p90 -133.68 136.71 27.22 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.173 177.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 10.4 Cg_exo -71.78 140.08 34.81 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.501 2.134 . . . . 0.0 111.614 176.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -60.07 -20.56 58.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.837 -178.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 1.4 p -73.89 -3.52 29.37 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -177.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -101.19 -7.54 23.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.666 0.27 . . . . 0.0 110.678 177.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.439 HG11 ' HA ' ' A' ' 242' ' ' ALA . 15.4 m -128.74 178.0 5.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.145 0.498 . . . . 0.0 111.302 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 57.8 tttm -140.81 123.28 15.97 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.515 175.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.562 HD12 HG13 ' A' ' 238' ' ' VAL . 35.3 mm -65.07 144.31 14.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.152 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -173.39 -179.07 1.81 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.637 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -151.58 144.48 16.97 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 172.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -45.73 -28.47 4.65 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.563 2.842 . . . . 0.0 114.178 178.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -141.83 -51.03 0.41 Allowed 'General case' 0 C--O 1.234 0.268 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -143.24 104.24 5.12 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.699 0.285 . . . . 0.0 111.12 -173.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.17 73.49 5.75 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.483 2.122 . . . . 0.0 112.586 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -98.22 150.28 21.67 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 175.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -70.1 -29.51 66.49 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.421 -175.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -124.89 -24.32 4.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.235 -177.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 . . . . . 0 C--O 1.247 0.932 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.545 -178.782 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 N--CA 1.482 1.17 0 CA-C-O 120.807 0.336 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.614 ' HA ' ' HZ2' ' A' ' 253' ' ' LYS . 14.2 t -116.35 92.89 4.02 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.361 0.6 . . . . 0.0 111.084 -175.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.5 p -80.45 -71.55 0.46 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.221 173.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.511 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . -67.07 133.64 50.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.771 178.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.417 HH11 ' HD2' ' A' ' 5' ' ' ARG . 47.0 ttm180 -150.92 100.09 2.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.773 0.32 . . . . 0.0 110.821 -176.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -166.07 -177.23 4.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.885 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.498 ' HB3' ' CB ' ' A' ' 13' ' ' ALA . 12.9 t70 -103.17 141.46 35.83 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.465 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 31.7 m -79.36 -0.19 31.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.808 0.337 . . . . 0.0 111.429 -176.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.737 ' CA ' ' HE1' ' A' ' 14' ' ' TRP . 8.7 t -149.17 -95.22 0.07 Allowed 'General case' 0 C--O 1.245 0.816 0 CA-C-O 122.2 1.0 . . . . 0.0 111.302 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.476 ' O ' ' N ' ' A' ' 12' ' ' SER . 37.5 t70 -8.16 74.89 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.099 -1.409 . . . . 0.0 112.01 -155.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.447 ' HA ' ' HD3' ' A' ' 11' ' ' ARG . 7.6 mmt180 -2.24 -58.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 126.189 2.18 . . . . 0.0 115.331 -163.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.476 ' N ' ' O ' ' A' ' 10' ' ' ASP . 58.2 m -70.1 18.08 0.05 Allowed 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -177.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.498 ' CB ' ' HB3' ' A' ' 7' ' ' ASP . . . -91.46 -19.1 23.2 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 120.332 -0.547 . . . . 0.0 109.725 170.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.737 ' HE1' ' CA ' ' A' ' 9' ' ' SER . 7.4 p-90 -151.71 -39.84 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.477 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.536 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 34.0 t80 -67.36 119.84 12.88 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 121.126 0.489 . . . . 0.0 110.179 -177.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.8 ' SD ' ' HB3' ' A' ' 104' ' ' ARG . 15.0 tpp -110.03 9.22 24.25 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.296 -172.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.566 ' O ' ' HB2' ' A' ' 39' ' ' ARG . . . 50.85 -112.07 1.51 Allowed Glycine 0 C--O 1.222 -0.639 0 CA-C-N 115.805 -0.634 . . . . 0.0 113.713 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.408 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 2.8 Cg_exo -77.03 109.15 2.78 Favored 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 122.462 2.108 . . . . 0.0 112.606 178.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 1.051 ' HB ' ' HG3' ' A' ' 39' ' ' ARG . 27.5 t -136.29 -71.4 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 119.212 -0.423 . . . . 0.0 111.701 178.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.479 ' HB3' ' O ' ' A' ' 19' ' ' VAL . 37.7 t 79.72 -172.6 0.05 Allowed 'General case' 0 C--N 1.345 0.412 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 171.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 -65.6 -42.95 91.06 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.716 0.293 . . . . 0.0 110.977 -173.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.533 ' HG3' ' H ' ' A' ' 23' ' ' GLU . 2.2 pt20 -61.01 -59.96 4.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.58 -0.737 . . . . 0.0 112.002 -176.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.609 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 64.8 mm-40 -66.61 -45.28 79.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.818 -175.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.485 ' O ' ' HB2' ' A' ' 28' ' ' LEU . . . -54.72 -36.75 65.07 Favored 'General case' 0 C--O 1.222 -0.371 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.187 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.577 ' HA ' HG21 ' A' ' 58' ' ' VAL . 6.1 tp-100 -73.4 -51.96 15.45 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.994 178.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.611 ' HA ' ' SD ' ' A' ' 110' ' ' MET . 6.2 t -63.24 -26.68 68.9 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -171.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.609 ' HG2' ' O ' ' A' ' 23' ' ' GLU . 18.1 ptp180 -101.58 -9.46 20.96 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.565 -178.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.687 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 87.6 mt -119.61 17.2 12.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.75 -0.205 . . . . 0.0 111.542 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -71.56 74.15 0.78 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.377 0.608 . . . . 0.0 110.314 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.23 -69.43 1.34 Allowed Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.122 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 34.12 -93.24 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.947 1.299 . . . . 0.0 113.561 -175.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 33.2 ttp-105 -115.46 -11.78 11.78 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -172.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 33.6 m170 67.65 157.65 0.13 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.296 0.638 . . . . 0.0 111.948 -178.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.48 3.21 82.38 Favored Glycine 0 C--N 1.334 0.451 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 177.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.508 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 44.2 mtp -90.13 136.6 32.95 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.959 -0.62 . . . . 0.0 109.918 -176.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.468 ' CB ' HG22 ' A' ' 52' ' ' VAL . 34.2 p90 -138.78 165.06 27.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.55 0.214 . . . . 0.0 110.657 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.583 ' O ' ' HA ' ' A' ' 50' ' ' LEU . 4.6 pp -158.3 140.61 14.25 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.835 174.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.562 HG21 HD11 ' A' ' 50' ' ' LEU . 80.2 t -110.17 120.66 61.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 174.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 1.051 ' HG3' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -138.01 175.93 9.15 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.683 -176.61 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.455 ' O ' ' HG2' ' A' ' 39' ' ' ARG . 2.1 m-20 -66.82 137.71 56.81 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.997 0.427 . . . . 0.0 110.337 176.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.491 ' HB3' ' O ' ' A' ' 44' ' ' CYS . 22.8 t -76.92 147.95 36.67 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.495 -179.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.8 p -87.03 -29.43 21.96 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.034 -178.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.464 HG21 ' HB3' ' A' ' 116' ' ' PRO . 20.5 p -82.54 -42.27 18.57 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.035 0.445 . . . . 0.0 110.955 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.491 ' O ' ' HB3' ' A' ' 41' ' ' SER . 56.1 m -127.15 112.25 21.6 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.209 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.93 14.86 0.63 Allowed 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.792 2.328 . . . . 0.0 112.918 -178.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -117.06 -5.72 14.75 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.627 -0.589 . . . . 0.0 111.627 175.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -119.61 175.26 5.94 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -177.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -127.49 179.67 5.37 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 122.176 0.19 . . . . 0.0 110.491 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 62' ' ' ILE . 54.2 t -148.91 96.82 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-O 120.743 0.306 . . . . 0.0 111.319 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.583 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 50.6 tp -70.8 101.01 2.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.481 171.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.4 m -97.21 130.01 44.49 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.439 177.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.607 HG23 HD12 ' A' ' 93' ' ' LEU . 69.9 t -119.86 140.97 42.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.205 -177.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.687 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 42.1 t -102.82 107.8 18.78 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.687 -177.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.578 ' HG3' ' CG2' ' A' ' 96' ' ' THR . 0.0 OUTLIER -158.39 157.28 32.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.769 -0.196 . . . . 0.0 110.756 171.31 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 59.41 18.6 6.97 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 123.557 0.536 . . . . 0.0 110.424 -173.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.0 m 68.47 21.85 8.02 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.949 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -125.65 151.67 46.22 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 174.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.577 HG21 ' HA ' ' A' ' 25' ' ' GLN . 44.9 t -97.33 91.55 2.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.931 0.396 . . . . 0.0 110.521 178.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.583 ' HA ' ' HB3' ' A' ' 119' ' ' PRO . 5.9 t -68.46 118.12 11.11 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.447 ' HE2' HG22 ' A' ' 113' ' ' VAL . 98.7 m-70 -98.62 106.75 19.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.312 -174.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.673 ' HH ' ' HB3' ' A' ' 93' ' ' LEU . 53.9 m-85 -101.97 92.05 4.62 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.581 178.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.572 ' HA ' ' HA ' ' A' ' 49' ' ' VAL . 38.5 mt -72.15 130.52 35.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -177.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.636 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 4.9 mp -106.98 119.46 56.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.204 178.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -97.96 134.6 40.86 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -177.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.5 t -84.3 110.85 18.89 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.156 0.503 . . . . 0.0 110.066 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.69 HD11 ' HG3' ' A' ' 70' ' ' ARG . 67.9 mt -83.32 144.65 46.98 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.422 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.34 -19.01 20.48 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.106 2.538 . . . . 0.0 113.095 -178.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 56.0 m-20 -84.83 14.76 4.45 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.632 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.632 ' HA ' ' HE ' ' A' ' 69' ' ' ARG . 3.3 tpm_? 66.29 26.71 10.3 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.299 0.64 . . . . 0.0 111.154 176.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.69 ' HG3' HD11 ' A' ' 66' ' ' LEU . 6.7 ptm180 -119.47 164.49 15.69 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 176.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.636 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 74.1 m-85 -123.05 120.11 32.35 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.821 0.343 . . . . 0.0 111.853 -171.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.462 ' HZ2' ' HB3' ' A' ' 77' ' ' GLU . 20.7 ttmm -102.21 110.29 22.2 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 175.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.607 HD13 HD11 ' A' ' 84' ' ' LEU . 2.4 tt -87.05 83.58 2.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.614 0.721 . . . . 0.0 111.406 -175.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.25 -53.25 2.25 Favored Glycine 0 C--N 1.336 0.567 0 CA-C-N 114.66 -1.155 . . . . 0.0 113.342 174.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.705 ' OD2' ' HA2' ' A' ' 168' ' ' GLY . 11.6 t70 -135.57 -55.26 0.79 Allowed 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.081 0.467 . . . . 0.0 109.931 -174.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.5 124.74 28.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.896 -177.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.462 ' HB3' ' HZ2' ' A' ' 72' ' ' LYS . 10.0 pt-20 -99.08 129.94 45.38 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.185 0.517 . . . . 0.0 110.984 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.515 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 93.9 m-85 -124.92 -169.1 1.92 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.893 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -112.11 -19.93 12.11 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -177.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.801 ' HD1' ' HG2' ' A' ' 82' ' ' PRO . 6.7 p80 -149.11 165.41 31.83 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 122.376 -0.203 . . . . 0.0 110.533 172.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.494 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 4.4 mt -61.34 -52.19 72.41 Favored Pre-proline 0 N--CA 1.467 0.383 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.466 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.801 ' HG2' ' HD1' ' A' ' 80' ' ' HIS . 12.9 Cg_endo -60.31 -5.87 4.63 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 121.982 1.788 . . . . 0.0 113.18 176.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.484 ' HB1' ' CE1' ' A' ' 80' ' ' HIS . . . -85.77 -30.47 23.02 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.118 0.485 . . . . 0.0 110.172 -175.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.607 HD11 HD13 ' A' ' 73' ' ' ILE . 3.4 pp -82.58 -32.93 28.24 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 174.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.0 mt -66.37 -37.15 84.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.676 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.401 ' HG2' ' HA ' ' A' ' 83' ' ' ALA . 13.8 pt-20 -78.65 -19.77 51.83 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.947 178.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.519 ' O ' HG12 ' A' ' 90' ' ' ILE . 73.7 t80 -81.76 -33.97 30.66 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.253 0.549 . . . . 0.0 110.06 -178.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.484 ' CG ' HD22 ' A' ' 93' ' ' LEU . 33.9 m-85 -79.18 5.07 13.02 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.713 -178.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.74 ' HE3' HG23 ' A' ' 90' ' ' ILE . 0.1 OUTLIER -68.01 -34.03 75.72 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 168.873 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.74 HG23 ' HE3' ' A' ' 89' ' ' LYS . 11.0 pt -85.77 -30.91 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 174.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 8.1 m170 -93.35 125.58 38.03 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.074 0.464 . . . . 0.0 111.168 -176.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.486 ' CD2' HG22 ' A' ' 97' ' ' THR . 59.0 m-85 -86.71 82.1 7.98 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.615 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.673 ' HB3' ' HH ' ' A' ' 61' ' ' TYR . 24.0 mt -31.79 -52.24 0.24 Allowed 'General case' 0 N--CA 1.473 0.694 0 O-C-N 125.199 1.562 . . . . 0.0 113.962 -172.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.463 ' OD1' ' HB3' ' A' ' 54' ' ' GLU . 7.3 t70 -118.53 -34.05 4.13 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.49 0.662 . . . . 0.0 109.769 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.404 ' HB ' ' O ' ' A' ' 94' ' ' ASP . 5.8 t 176.99 -20.41 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.245 176.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.578 ' CG2' ' HG3' ' A' ' 54' ' ' GLU . 3.6 t -113.97 171.76 7.4 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.407 170.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.486 HG22 ' CD2' ' A' ' 92' ' ' TYR . 69.9 p -99.58 -177.26 3.52 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.546 ' HG ' HD11 ' A' ' 93' ' ' LEU . 89.5 mt -70.52 105.37 3.07 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.511 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 45.8 mm -99.7 -53.71 7.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.701 -174.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.508 ' O ' ' HA ' ' A' ' 35' ' ' MET . 7.4 pt-20 -149.37 157.25 39.42 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 120.819 0.342 . . . . 0.0 111.46 -174.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.52 163.33 29.69 Favored 'Trans proline' 0 C--O 1.233 0.275 0 C-N-CA 122.495 2.13 . . . . 0.0 112.504 176.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.528 ' HB1' HD21 ' A' ' 28' ' ' LEU . . . -90.01 161.36 38.33 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.776 177.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -68.46 159.71 52.28 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.444 2.096 . . . . 0.0 111.912 174.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.8 ' HB3' ' SD ' ' A' ' 16' ' ' MET . 13.8 ptm180 -126.25 88.18 2.8 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.081 0.467 . . . . 0.0 111.715 -177.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.427 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 45.4 t80 -169.63 116.22 0.53 Allowed Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.009 177.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 105' ' ' TYR . 8.8 Cg_exo -72.29 142.4 37.38 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.74 2.294 . . . . 0.0 111.222 176.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.752 ' HB3' ' HD3' ' A' ' 108' ' ' PRO . 41.7 t -171.76 -57.87 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.09 -177.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.752 ' HD3' ' HB3' ' A' ' 107' ' ' SER . 5.5 Cg_exo -77.61 124.31 6.9 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.136 1.891 . . . . 0.0 112.187 -178.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 108' ' ' PRO . 4.9 Cg_endo -87.53 113.73 0.93 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.297 2.665 . . . . 0.0 112.208 178.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.611 ' SD ' ' HA ' ' A' ' 26' ' ' THR . 62.8 mtt -119.76 168.25 11.26 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.887 178.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.471 ' O ' ' HB3' ' A' ' 112' ' ' SER . . . -69.67 -25.21 75.78 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.411 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.471 ' HB3' ' O ' ' A' ' 111' ' ' GLY . 30.6 t 73.96 154.55 0.15 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.29 0.567 . . . . 0.0 111.737 177.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.447 HG22 ' HE2' ' A' ' 60' ' ' HIS . 39.7 t -62.79 113.35 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.721 173.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 13.5 m -83.35 30.9 0.46 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.944 0.402 . . . . 0.0 111.716 -174.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.404 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . . . -143.0 143.91 26.9 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.015 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.464 ' HB3' HG21 ' A' ' 43' ' ' THR . 20.7 Cg_exo -66.97 -36.36 22.83 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.131 2.554 . . . . 0.0 111.819 177.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -107.45 -163.36 0.89 Allowed 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 173.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 9.1 mp 66.99 135.45 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.311 0 CA-C-O 121.52 0.676 . . . . 0.0 111.622 -178.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.583 ' HB3' ' HA ' ' A' ' 59' ' ' SER . 44.6 Cg_exo -61.02 -58.39 0.46 Allowed 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.979 2.453 . . . . 0.0 112.949 176.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 85.1 m -154.36 -66.24 0.14 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.846 0.355 . . . . 0.0 111.01 -178.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -154.75 175.17 14.05 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.418 ' OE1' ' HA ' ' A' ' 186' ' ' PRO . 0.0 OUTLIER -94.07 -90.92 0.2 Allowed 'General case' 0 C--N 1.321 -0.659 0 O-C-N 123.18 0.3 . . . . 0.0 111.209 -178.941 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.55 ' OD2' ' HD3' ' A' ' 186' ' ' PRO . 13.1 t70 64.39 -73.04 0.06 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.057 0.543 . . . . 0.0 110.879 -175.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.435 ' O ' ' HB2' ' A' ' 125' ' ' LEU . 74.1 m-20 -146.9 125.55 12.54 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.416 0.686 . . . . 0.0 109.961 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.576 HD12 HG21 ' A' ' 152' ' ' ILE . 4.1 mm? 71.81 96.27 0.07 Allowed 'General case' 0 N--CA 1.473 0.678 0 O-C-N 123.522 0.513 . . . . 0.0 112.205 174.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.472 ' HG3' ' CD1' ' A' ' 127' ' ' TYR . 9.9 tp10 -170.72 -72.97 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.546 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.473 ' CE2' HG23 ' A' ' 151' ' ' VAL . 38.4 m-85 -112.97 131.99 55.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.231 0.539 . . . . 0.0 111.123 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.56 ' CG1' ' HB ' ' A' ' 178' ' ' VAL . 8.3 t -131.59 158.26 43.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.361 -176.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -138.77 133.43 32.13 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 170.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.52 HG23 HG12 ' A' ' 178' ' ' VAL . 35.8 p -86.97 141.46 28.68 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.231 -173.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.681 HD11 ' CG ' ' A' ' 179' ' ' GLU . 10.9 mt -111.27 -30.93 7.24 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -174.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.507 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 55.5 t80 -90.09 -27.38 19.7 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -168.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.507 ' HB3' ' O ' ' A' ' 132' ' ' TYR . 19.5 t70 73.83 130.88 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 O-C-N 123.564 0.54 . . . . 0.0 111.06 -172.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 76.4 t80 -161.86 99.48 1.19 Allowed Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.97 -177.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -82.36 81.46 2.49 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.916 2.411 . . . . 0.0 112.731 178.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.56 -17.12 74.44 Favored Glycine 0 C--O 1.227 -0.319 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 172.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 40.53 35.54 0.31 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.944 1.298 . . . . 0.0 113.945 178.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.486 ' HB2' ' HB2' ' A' ' 141' ' ' ASP . 1.6 m-20 -121.12 -173.42 2.61 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 121.981 -0.449 . . . . 0.0 111.5 -178.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -105.13 -6.64 19.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.245 0.545 . . . . 0.0 110.637 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -122.17 -1.26 9.27 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.692 174.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.486 ' HB2' ' HB2' ' A' ' 138' ' ' ASP . 5.4 m-20 -132.32 108.4 9.18 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 174.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.637 ' HB3' ' CG2' ' A' ' 173' ' ' ILE . 60.5 tp -74.59 119.79 78.35 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 121.215 0.531 . . . . 0.0 111.868 -170.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.534 ' HD2' ' HD2' ' A' ' 169' ' ' ARG . 55.8 Cg_endo -72.8 102.66 1.46 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.579 2.186 . . . . 0.0 111.57 171.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.433 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 12.6 p90 -117.49 163.94 15.64 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.786 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.472 ' HB3' ' H ' ' A' ' 146' ' ' LYS . 12.4 mmtm -108.65 -159.48 0.69 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.001 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.472 ' H ' ' HB3' ' A' ' 145' ' ' LYS . 0.0 OUTLIER -101.46 6.53 42.47 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.986 -0.285 . . . . 0.0 111.768 -173.885 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -155.34 24.28 0.59 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.055 -1.069 . . . . 0.0 112.704 178.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.13 159.47 14.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.636 0.255 . . . . 0.0 110.562 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.403 ' HA ' HD11 ' A' ' 149' ' ' ILE . 15.5 mm -101.56 135.88 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -174.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.683 ' HB3' ' HB1' ' A' ' 163' ' ' ALA . 10.4 mt -122.11 175.9 6.11 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 46.6 t -145.5 123.0 4.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.822 HD13 ' HB3' ' A' ' 163' ' ' ALA . 23.9 mm -79.16 78.75 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-O 122.483 1.135 . . . . 0.0 108.657 -176.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.649 HG22 ' HG3' ' A' ' 154' ' ' GLU . 11.5 tt -69.2 -46.21 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 CA-C-N 113.176 -1.829 . . . . 0.0 109.359 -178.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 1.002 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 40.5 mt-10 -115.27 140.05 49.44 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -127.66 82.12 68.91 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 167.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.56 ' HG2' ' HE1' ' A' ' 172' ' ' MET . 3.3 Cg_exo -77.32 -50.76 0.09 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.327 2.685 . . . . 0.0 111.242 176.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -108.4 170.33 8.09 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.402 -176.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -88.3 -41.39 12.92 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.742 -176.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -83.18 -24.37 32.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.909 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 57.2 m95 -123.72 119.65 30.4 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.244 -176.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . 0.772 ' HB3' HG22 ' A' ' 152' ' ' ILE . 44.8 m0 -106.24 138.29 42.69 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.732 176.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 1.002 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 13.8 m -85.83 101.01 12.46 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 177.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.822 ' HB3' HD13 ' A' ' 152' ' ' ILE . . . -106.23 157.01 17.89 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.909 -179.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.7 ' HB3' HG22 ' A' ' 170' ' ' VAL . 25.0 ptt-85 -107.67 128.98 55.04 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 175.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.485 ' HA ' HD22 ' A' ' 150' ' ' LEU . 58.5 t30 -69.15 151.91 45.78 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 175.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 29.0 ttpp -65.06 -12.0 45.74 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.683 -176.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.433 ' HB3' ' NH2' ' A' ' 169' ' ' ARG . 19.4 t70 -86.41 -26.43 24.75 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -177.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.705 ' HA2' ' OD2' ' A' ' 75' ' ' ASP . . . 123.54 67.42 0.21 Allowed Glycine 0 CA--C 1.528 0.845 0 C-N-CA 118.587 -1.768 . . . . 0.0 115.684 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.534 ' HD2' ' HD2' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -178.66 148.64 0.44 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.656 0.383 . . . . 0.0 110.178 161.568 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.7 HG22 ' HB3' ' A' ' 164' ' ' ARG . 61.2 t -101.06 142.87 15.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.316 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -167.05 157.01 29.26 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.56 ' HE1' ' HG2' ' A' ' 156' ' ' PRO . 31.7 mtp -74.21 136.49 42.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.973 0.386 . . . . 0.0 110.135 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.637 ' CG2' ' HB3' ' A' ' 142' ' ' LEU . 2.7 pp -134.17 150.19 73.47 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.631 -177.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -76.97 127.86 9.61 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 123.0 2.467 . . . . 0.0 112.33 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.62 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 26.2 t -64.11 -42.16 66.79 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.62 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 9.6 Cg_endo -53.27 -13.6 3.44 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.968 2.445 . . . . 0.0 113.962 171.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -96.58 -14.69 22.04 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 111.607 0.225 . . . . 0.0 111.607 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.56 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 5.9 m -125.6 161.55 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 121.992 0.901 . . . . 0.0 113.112 -169.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.681 ' CG ' HD11 ' A' ' 131' ' ' LEU . 3.5 mm-40 -124.45 160.36 28.42 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.156 177.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.684 ' HG2' ' HD2' ' A' ' 183' ' ' ARG . 1.4 mppt? -98.34 137.18 37.43 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -176.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 10.2 tp -66.72 -83.23 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.094 0.473 . . . . 0.0 109.921 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.465 HG11 ' HA3' ' A' ' 191' ' ' GLY . 10.9 m -102.04 113.75 39.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-O 121.296 0.569 . . . . 0.0 109.734 172.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.684 ' HD2' ' HG2' ' A' ' 180' ' ' LYS . 31.6 ttt180 -153.29 122.38 6.55 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.956 -178.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.423 ' C ' ' HG ' ' A' ' 185' ' ' SER . 16.3 p 179.58 -64.87 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 177.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' SER . . . . . 0.487 ' HB2' ' CE1' ' A' ' 187' ' ' HIS . 7.8 m -160.97 168.28 11.97 Favored Pre-proline 0 C--N 1.316 -0.859 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 167.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.55 ' HD3' ' OD2' ' A' ' 123' ' ' ASP . 23.3 Cg_exo -63.85 102.5 0.36 Allowed 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 121.33 1.353 . . . . 0.0 111.049 177.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.487 ' CE1' ' HB2' ' A' ' 185' ' ' SER . 38.4 m80 -125.9 155.5 41.17 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.207 -174.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -68.42 97.8 0.48 Allowed Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.806 -0.633 . . . . 0.0 112.203 174.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 64.4 pttt 45.56 32.0 1.05 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.515 1.126 . . . . 0.0 113.415 177.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -98.69 91.34 5.07 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 177.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.465 ' HA3' HG11 ' A' ' 182' ' ' VAL . . . -128.36 -88.7 0.59 Allowed Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.92 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -135.99 95.96 3.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.087 0.47 . . . . 0.0 110.44 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.646 ' HA ' ' HE ' ' A' ' 193' ' ' ARG . 1.2 tpm_? -157.58 -88.98 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.185 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -150.08 130.98 14.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.896 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 69.4 m -152.8 85.92 1.25 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.104 0.478 . . . . 0.0 111.134 177.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -107.42 -45.39 4.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.696 174.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 69.6 m -86.88 63.64 8.06 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 171.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -96.42 164.52 12.6 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.844 -176.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 149.0 49.24 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 11.7 pt -121.82 86.11 45.44 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-O 121.171 0.51 . . . . 0.0 111.758 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -87.97 116.11 1.0 Allowed 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 123.174 2.583 . . . . 0.0 110.956 171.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.486 ' CD ' ' HA ' ' A' ' 187' ' ' HIS . 6.9 pt-20 -122.21 120.32 28.27 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-O 121.015 0.436 . . . . 0.0 110.287 -178.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 202' ' ' GLU . 22.9 Cg_exo -64.12 125.95 16.21 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 123.269 2.646 . . . . 0.0 113.03 -175.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -95.76 8.09 44.48 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.956 177.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -123.83 109.0 13.08 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.748 178.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -124.55 173.71 8.3 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.618 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 18.9 m-30 63.15 -163.36 0.27 Allowed 'General case' 0 N--CA 1.465 0.31 0 O-C-N 123.796 0.685 . . . . 0.0 110.552 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -143.72 -71.63 0.29 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.737 0.304 . . . . 0.0 111.107 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -166.68 157.72 10.91 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.983 -176.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -66.73 104.08 0.77 Allowed 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.072 1.848 . . . . 0.0 110.21 170.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -70.9 -40.42 72.18 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.146 -172.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 13.9 m -123.98 97.15 5.22 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.95 0.405 . . . . 0.0 110.277 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 47.6 m -78.41 -39.36 39.18 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.457 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 21.7 m 69.57 94.59 0.05 OUTLIER Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.316 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -71.57 141.15 37.56 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.714 2.276 . . . . 0.0 111.737 178.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.447 ' HA ' ' HD3' ' A' ' 217' ' ' PRO . 3.4 mm? -88.92 131.96 39.69 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.053 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 216' ' ' LEU . 31.3 Cg_exo -62.46 -46.49 11.83 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.64 2.226 . . . . 0.0 112.041 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -150.11 115.76 5.54 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.02 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 61.9 t -88.03 105.36 15.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 171.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 4.8 p -85.42 162.76 18.86 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.371 -175.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -88.7 161.42 30.86 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.915 177.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 5.7 p -80.74 117.73 69.23 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-O 120.566 0.222 . . . . 0.0 110.555 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -57.36 129.46 34.15 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.906 2.404 . . . . 0.0 112.522 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -125.45 119.79 3.66 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.065 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -95.63 -5.05 43.31 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.092 0.472 . . . . 0.0 110.684 177.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -100.39 88.17 3.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.255 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 20.3 pt -93.71 120.2 42.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.992 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 6.2 t -172.87 126.27 0.49 Allowed Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.548 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -82.06 -170.67 1.0 Allowed 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.582 2.188 . . . . 0.0 111.423 174.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 231' ' ' PRO . 4.0 mm? -95.65 112.55 59.46 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 177.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 230' ' ' LEU . 5.8 Cg_exo -79.49 -168.74 0.67 Allowed 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.18 2.586 . . . . 0.0 112.026 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 50.3 m -73.89 102.84 4.21 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.052 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 13.6 p -73.53 -31.63 63.78 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 173.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.664 ' HA ' HE21 ' A' ' 234' ' ' GLN . 0.1 OUTLIER 60.3 76.23 0.37 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.023 174.535 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . 0.477 ' HB2' ' O ' ' A' ' 267' ' ' THR . 0.9 OUTLIER -85.53 -36.05 20.74 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.745 176.876 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 157.14 94.31 0.1 Allowed Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.605 178.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -65.45 100.98 0.41 Allowed 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.606 2.204 . . . . 0.0 111.691 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.495 ' HB ' HG13 ' A' ' 266' ' ' VAL . 41.4 t -115.49 136.88 50.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.992 -176.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -104.68 117.04 33.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.96 178.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -120.2 125.12 47.38 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.739 -178.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -85.26 124.15 31.57 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . 0.464 ' HA ' HG11 ' A' ' 291' ' ' VAL . . . -69.53 112.38 6.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.841 0.353 . . . . 0.0 110.385 -178.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.4 HD11 HG21 ' A' ' 243' ' ' ILE . 33.7 pt -84.46 -16.94 10.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.507 -177.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.528 ' HA ' HG21 ' A' ' 260' ' ' VAL . 16.4 pt20 -150.35 153.68 36.48 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.099 173.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.454 ' C ' ' HD2' ' A' ' 245' ' ' LYS . 0.1 OUTLIER -75.75 169.79 17.45 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.449 0.642 . . . . 0.0 112.112 -171.708 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 38.6 ttt85 -170.28 115.94 0.51 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.409 172.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.527 HG21 ' HD2' ' A' ' 248' ' ' PRO . 8.7 p -122.11 141.02 33.4 Favored Pre-proline 0 C--N 1.316 -0.875 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.527 ' HD2' HG21 ' A' ' 247' ' ' VAL . 81.0 Cg_exo -45.49 111.36 0.31 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.846 2.364 . . . . 0.0 112.873 179.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' CYS . . . . . 0.427 ' H ' ' HB2' ' A' ' 252' ' ' ASP . 31.7 t -90.16 -173.03 3.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.717 178.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -62.69 -27.92 69.58 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.982 0.42 . . . . 0.0 111.938 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -101.02 1.14 39.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.327 -177.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.511 ' HB3' ' HB3' ' A' ' 255' ' ' ALA . 27.2 m-20 -97.7 97.19 8.81 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -173.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . 0.614 ' HZ2' ' HA ' ' A' ' 2' ' ' SER . 45.6 tptt -91.25 139.44 30.74 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 171.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 26.2 p 65.96 14.92 9.85 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.035 0.934 . . . . 0.0 112.27 178.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.511 ' HB3' ' HB3' ' A' ' 252' ' ' ASP . . . -79.11 151.88 31.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.655 0.264 . . . . 0.0 110.974 -178.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.584 HD21 ' HB ' ' A' ' 279' ' ' VAL . 2.5 tt -102.91 142.99 33.09 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -87.43 101.75 13.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.147 0.499 . . . . 0.0 110.451 178.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.914 HD22 HG22 ' A' ' 279' ' ' VAL . 84.0 mt -116.38 142.75 46.44 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.557 -177.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -124.13 162.57 23.3 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.109 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . 0.528 HG21 ' HA ' ' A' ' 244' ' ' GLN . 43.6 t -66.59 125.46 23.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.38 -174.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 105.53 -11.92 46.88 Favored Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.074 176.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -84.8 175.44 9.15 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.932 0.366 . . . . 0.0 110.204 -174.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 48.4 mm -115.57 117.46 55.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.352 0.596 . . . . 0.0 110.982 -176.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.509 HG13 ' CZ ' ' A' ' 286' ' ' PHE . 2.9 t -97.05 103.06 14.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.713 178.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -85.94 90.4 8.07 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.259 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.552 ' HA ' ' HA2' ' A' ' 277' ' ' GLY . 1.8 p -86.82 137.51 20.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.158 0.504 . . . . 0.0 110.582 -175.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' THR . . . . . 0.477 ' O ' ' HB2' ' A' ' 235' ' ' ASN . 20.5 p -109.67 -35.73 6.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.527 -173.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 268' ' ' ARG . 1.0 OUTLIER -131.73 126.24 34.0 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.139 0.495 . . . . 0.0 109.683 179.407 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 57.9 mtt -106.3 116.64 32.28 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.935 0.398 . . . . 0.0 111.162 -178.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.529 ' HB2' ' O ' ' A' ' 274' ' ' GLN . 85.6 m-20 -78.68 121.46 24.72 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 175.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 47.2 mm -57.79 -24.96 24.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.173 -174.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -61.77 -32.28 72.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.411 -178.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 146.41 -44.45 0.84 Allowed Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.172 -1.013 . . . . 0.0 113.342 177.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.529 ' O ' ' HB2' ' A' ' 270' ' ' ASN . 0.1 OUTLIER -86.29 120.05 27.23 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.067 0.46 . . . . 0.0 110.608 -178.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.416 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 41.7 m0 -94.48 160.83 14.47 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.597 -177.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . 0.481 ' HB3' ' HD2' ' A' ' 283' ' ' LYS . 39.3 mt-10 -106.59 105.84 16.07 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 173.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -108.5 146.7 16.52 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.608 -178.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -102.03 108.54 20.01 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . 0.914 HG22 HD22 ' A' ' 258' ' ' LEU . 97.1 t -119.4 117.58 54.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.694 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . 0.452 ' N ' HD21 ' A' ' 280' ' ' ASN . 0.9 OUTLIER 62.86 30.82 16.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.549 -179.387 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 83.38 6.27 87.86 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.772 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 51.1 ttt180 -117.52 126.28 52.32 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.667 0.27 . . . . 0.0 110.759 -179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 27.2 ttpp -102.97 133.62 47.78 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.124 0.488 . . . . 0.0 111.035 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -153.98 171.02 32.63 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.625 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.416 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 64.0 mt -83.88 131.33 34.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.977 0.417 . . . . 0.0 111.027 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.509 ' CZ ' HG13 ' A' ' 264' ' ' VAL . 23.9 p90 -142.34 144.37 30.79 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.777 175.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -83.7 138.77 8.46 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.911 2.407 . . . . 0.0 111.661 176.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -65.54 -8.39 19.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.592 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 17.2 p -75.85 -9.34 58.52 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.52 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -104.97 -6.25 20.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.799 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.464 HG11 ' HA ' ' A' ' 242' ' ' ALA . 22.4 m -128.34 172.25 15.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.125 0.488 . . . . 0.0 111.173 -177.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -137.47 131.42 31.86 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.032 171.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.402 HD11 ' CG1' ' A' ' 238' ' ' VAL . 47.5 mm -73.39 134.47 29.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.731 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -138.03 151.68 48.11 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 174.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.777 ' HB3' ' HD3' ' A' ' 296' ' ' PRO . 12.2 t70 -93.1 -58.48 0.22 Allowed Pre-proline 0 C--N 1.323 -0.586 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.026 -178.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . 0.777 ' HD3' ' HB3' ' A' ' 295' ' ' ASP . 9.6 Cg_endo -91.16 -78.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 122.615 2.21 . . . . 0.0 112.779 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . 0.427 ' HB3' ' H ' ' A' ' 298' ' ' ASN . 79.5 mm-40 -142.76 -160.12 1.06 Allowed 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.883 -177.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . 0.478 ' H ' ' CD ' ' A' ' 299' ' ' PRO . 9.5 t30 -149.48 -48.41 0.02 OUTLIER Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.844 -178.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' PRO . . . . . 0.478 ' CD ' ' H ' ' A' ' 298' ' ' ASN . 12.1 Cg_exo -71.21 18.01 0.26 Allowed 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 122.522 2.148 . . . . 0.0 113.815 -176.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -69.19 -36.33 77.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.063 0.459 . . . . 0.0 110.156 175.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -78.75 -71.69 0.42 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.175 177.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . 0.457 ' O ' ' HA ' ' A' ' 299' ' ' PRO . 21.8 m120 -141.89 174.44 10.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.746 176.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.372 -0.823 . . . . 0.0 109.462 178.893 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 N--CA 1.48 1.057 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.3 m -115.91 -18.18 10.79 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.796 -177.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.412 ' O ' HG23 ' A' ' 99' ' ' ILE . 20.4 m 68.51 -71.45 0.11 Allowed 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.307 -175.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.15 102.66 3.09 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 177.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 25.6 mtm105 -122.35 3.35 9.73 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -175.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.425 ' HB3' ' HA ' ' A' ' 100' ' ' GLU . 17.0 p90 -83.13 150.42 26.27 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.917 -178.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -52.61 -43.85 65.65 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.479 -176.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.6 t 58.33 47.59 13.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.048 -172.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.7 t -171.97 -36.36 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.617 178.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -70.73 107.19 3.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.472 -175.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -60.43 -37.35 80.63 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.506 -175.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.5 t -72.87 -6.52 45.59 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.463 -177.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.86 -37.39 12.31 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -178.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 38.2 p-90 -122.58 -24.85 4.84 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -174.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -79.41 118.05 20.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.166 0.508 . . . . 0.0 110.687 -176.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.561 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 22.0 mmt -99.42 -10.08 22.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.894 -176.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.476 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.22 -113.47 2.27 Favored Glycine 0 CA--C 1.519 0.327 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.282 -178.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.476 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 19.4 Cg_exo -66.62 87.13 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.271 2.648 . . . . 0.0 113.161 -176.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.975 HG13 ' H ' ' A' ' 20' ' ' SER . 93.3 t -136.84 -166.58 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 178.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.975 ' H ' HG13 ' A' ' 19' ' ' VAL . 42.1 p -162.25 169.73 20.2 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 119.768 1.167 . . . . 0.0 108.122 -168.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 34.8 ttt85 -67.16 -39.37 86.5 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.739 -175.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -65.0 -53.83 39.96 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.88 0.372 . . . . 0.0 110.995 178.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -62.57 -47.22 84.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.356 -177.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.535 ' HB1' ' O ' ' A' ' 20' ' ' SER . . . -56.14 -38.58 71.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.117 0.484 . . . . 0.0 110.706 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -62.24 -57.74 10.33 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.655 178.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.8 t -65.73 -15.23 62.62 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -173.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.6 mtp180 -87.33 -13.52 43.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.589 0.233 . . . . 0.0 110.951 179.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.548 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 32.6 mt -130.43 -1.88 4.4 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 30.6 tp60 -73.91 96.0 2.55 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.216 0.531 . . . . 0.0 111.109 -174.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.13 14.09 69.97 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.146 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -81.58 -169.03 2.11 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 122.281 0.233 . . . . 0.0 110.752 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.607 ' HB2' ' SD ' ' A' ' 35' ' ' MET . 51.3 mtm180 -60.99 127.03 29.54 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 177.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.506 ' CE1' ' HA ' ' A' ' 55' ' ' ASN . 41.0 m170 -77.49 116.97 18.5 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.862 -176.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 129.33 -17.92 5.55 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -172.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.748 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 50.0 mtp -72.88 160.15 32.59 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 115.432 -0.384 . . . . 0.0 110.335 176.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -163.98 169.23 18.29 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 178.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.561 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.6 pp -157.0 140.89 16.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.163 0.506 . . . . 0.0 111.183 175.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 50.8 t -108.92 123.0 64.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.261 175.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.424 ' HB2' ' HB ' ' A' ' 19' ' ' VAL . 33.3 ptt-85 -123.04 -177.83 3.79 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.013 -177.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -80.34 138.99 36.78 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 175.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.1 m -77.4 99.06 5.46 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 172.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.9 m -73.93 -9.62 58.83 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.247 178.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.3 p -83.53 -56.69 3.6 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.101 175.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 57.7 m -114.84 96.33 44.17 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.88 176.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.82 132.72 51.0 Favored 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 123.006 2.471 . . . . 0.0 112.618 -178.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.64 -27.14 17.55 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.389 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.58 ' OD1' ' HA ' ' A' ' 64' ' ' ASN . 33.1 m-20 -93.45 178.24 5.77 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -131.42 171.41 13.41 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 178.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.6 t -139.41 112.24 5.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.97 0.414 . . . . 0.0 110.999 175.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 51.0 tp -82.05 103.44 11.69 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.741 174.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 37.5 m -96.18 127.66 42.39 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 174.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.553 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 98.3 t -111.18 139.89 33.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.02 0.438 . . . . 0.0 111.038 -174.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.548 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 28.3 t -87.95 116.12 25.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.282 179.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.498 ' O ' ' N ' ' A' ' 56' ' ' SER . 75.8 mt-10 -144.46 178.4 7.97 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-O 118.379 -0.819 . . . . 0.0 108.832 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.615 ' C ' ' HB2' ' A' ' 57' ' ' ARG . 11.2 m-80 -24.11 65.46 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 126.934 2.094 . . . . 0.0 115.833 -176.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 54' ' ' GLU . 21.0 m 48.59 57.35 6.39 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -171.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.731 HH22 ' HA ' ' A' ' 154' ' ' GLU . 0.3 OUTLIER -162.05 58.24 0.25 Allowed 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.322 -1.308 . . . . 0.0 112.18 -145.641 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 11.2 t -74.5 97.91 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 122.058 0.933 . . . . 0.0 109.394 -172.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.561 ' HB2' ' CE2' ' A' ' 61' ' ' TYR . 0.1 OUTLIER -79.07 121.02 24.45 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 113.907 -1.497 . . . . 0.0 111.287 -175.456 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -98.05 108.34 21.02 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -173.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.561 ' CE2' ' HB2' ' A' ' 59' ' ' SER . 79.3 m-85 -110.18 107.42 17.22 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.04 178.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.587 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 53.3 mt -80.49 137.35 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -175.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.577 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 5.4 mp -116.47 117.69 56.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.728 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.58 ' HA ' ' OD1' ' A' ' 47' ' ' ASP . 13.7 m120 -87.3 139.73 30.26 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.863 -177.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.8 t -86.76 98.51 11.2 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 173.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.983 HD12 ' HG3' ' A' ' 72' ' ' LYS . 91.6 mt -80.78 146.66 60.55 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.346 -175.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 66' ' ' LEU . 11.9 Cg_exo -71.05 -2.19 10.69 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.743 2.295 . . . . 0.0 110.235 170.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -81.92 5.07 20.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.151 177.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.675 ' HA ' ' HE ' ' A' ' 69' ' ' ARG . 3.2 tpm_? 62.98 29.0 16.47 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.306 -173.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.448 ' HG2' ' HA ' ' A' ' 79' ' ' ASP . 88.7 mtt180 -128.63 179.17 5.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.402 -177.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.577 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 31.4 m-85 -134.92 119.76 18.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.19 -178.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.983 ' HG3' HD12 ' A' ' 66' ' ' LEU . 38.8 mttm -96.31 101.11 12.7 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -175.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.587 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 10.0 tt -83.37 99.11 5.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.405 0.622 . . . . 0.0 109.476 173.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 62.8 44.31 97.65 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.428 -174.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.442 ' HA ' ' HD3' ' A' ' 72' ' ' LYS . 25.4 t70 75.61 -25.07 0.21 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.172 0.589 . . . . 0.0 111.915 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.69 107.79 4.1 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 174.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.484 ' HB3' ' CG ' ' A' ' 72' ' ' LYS . 12.7 pt-20 -96.23 137.87 34.66 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.887 0.851 . . . . 0.0 112.404 -171.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.585 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 96.6 m-85 -122.33 162.65 21.14 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 114.159 -1.382 . . . . 0.0 107.97 174.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.448 ' HA ' ' HG2' ' A' ' 70' ' ' ARG . 3.2 p-10 -69.55 -15.36 63.21 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -172.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.441 ' CE1' ' HB3' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -172.29 171.57 4.75 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.459 174.036 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.522 HD21 HD22 ' A' ' 84' ' ' LEU . 9.7 mt -53.32 -54.22 47.52 Favored Pre-proline 0 N--CA 1.469 0.511 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 81' ' ' LEU . 27.6 Cg_endo -63.21 3.56 0.56 Allowed 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.436 2.09 . . . . 0.0 114.176 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.441 ' HB3' ' CE1' ' A' ' 80' ' ' HIS . . . -98.46 -31.49 11.97 Favored 'General case' 0 C--N 1.331 -0.211 0 O-C-N 122.292 -0.255 . . . . 0.0 110.53 178.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.585 ' HB3' ' CD2' ' A' ' 78' ' ' PHE . 4.0 pp -76.42 -35.7 58.4 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 51.0 mt -68.54 -20.03 64.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.893 176.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.445 ' CD ' ' HZ2' ' A' ' 89' ' ' LYS . 13.2 tp10 -86.53 -28.41 23.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.619 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.755 ' O ' HD11 ' A' ' 90' ' ' ILE . 0.0 OUTLIER -88.41 -19.52 26.46 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.238 0.542 . . . . 0.0 111.167 -177.341 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.757 ' CD1' HD22 ' A' ' 93' ' ' LEU . 45.1 m-85 -87.33 2.33 50.6 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 121.19 -0.944 . . . . 0.0 110.659 177.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.445 ' HZ2' ' CD ' ' A' ' 86' ' ' GLU . 99.1 mttt -74.97 -18.32 60.4 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.021 174.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.755 HD11 ' O ' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -127.02 -3.83 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 CA-C-O 121.174 0.512 . . . . 0.0 110.194 -179.306 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -88.92 -32.76 17.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.848 -173.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.51 ' CD2' HG22 ' A' ' 97' ' ' THR . 95.5 m-85 61.86 106.25 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 O-C-N 124.119 0.887 . . . . 0.0 110.108 -171.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.757 HD22 ' CD1' ' A' ' 88' ' ' TYR . 13.0 mt -66.49 -85.51 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 174.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.418 ' OD1' ' ND2' ' A' ' 55' ' ' ASN . 14.5 t70 -79.9 -130.76 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 172.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.1 t -87.27 12.25 12.29 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.211 0.529 . . . . 0.0 110.164 177.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.9 t -143.03 160.34 40.55 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.585 -178.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.51 HG22 ' CD2' ' A' ' 92' ' ' TYR . 6.6 p -100.27 -179.7 4.2 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.119 175.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.7 mt -75.41 106.89 7.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.187 0.517 . . . . 0.0 109.779 175.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.412 HG23 ' O ' ' A' ' 3' ' ' SER . 46.4 mm -90.23 -65.21 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.503 -175.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.748 ' O ' ' HA ' ' A' ' 35' ' ' MET . 10.9 pt-20 -159.18 140.81 9.7 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.206 178.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.49 170.2 11.4 Favored 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.831 2.354 . . . . 0.0 112.984 -175.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.454 ' C ' ' H ' ' A' ' 104' ' ' ARG . . . -68.71 126.5 92.81 Favored Pre-proline 0 N--CA 1.447 -0.597 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 170.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -69.15 28.86 0.16 Allowed 'Trans proline' 0 N--CA 1.478 0.571 0 C-N-CA 123.461 2.774 . . . . 0.0 114.135 -169.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.454 ' H ' ' C ' ' A' ' 102' ' ' ALA . 41.0 ttm180 66.46 -60.44 0.33 Allowed 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.644 0.777 . . . . 0.0 111.056 -177.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -89.34 134.82 32.08 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 178.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -61.47 -25.67 80.07 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.948 2.432 . . . . 0.0 112.51 178.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.3 t 72.03 142.75 0.09 OUTLIER Pre-proline 0 CA--C 1.533 0.298 0 O-C-N 123.799 0.687 . . . . 0.0 110.993 178.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.72 153.0 79.49 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.344 2.029 . . . . 0.0 111.433 175.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -65.47 98.26 0.33 Allowed 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.346 2.031 . . . . 0.0 112.041 178.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 86.2 mmm -105.74 -175.16 2.71 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.794 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -80.22 69.5 3.11 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.169 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 33.7 t -112.07 135.41 52.76 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.042 0.449 . . . . 0.0 110.609 -178.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.3 p -141.42 15.11 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.766 0.793 . . . . 0.0 109.555 177.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.7 p -77.91 8.13 5.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.928 -175.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -129.22 125.0 22.51 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.262 177.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -62.17 -52.46 2.71 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 122.716 2.277 . . . . 0.0 112.128 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.454 ' C ' HD12 ' A' ' 118' ' ' LEU . 6.4 m-20 67.14 152.64 0.08 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 121.589 0.709 . . . . 0.0 112.002 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.484 ' HA ' ' HD3' ' A' ' 119' ' ' PRO . 9.2 mp -131.05 115.58 16.57 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.036 -178.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' ' 118' ' ' LEU . 4.4 Cg_exo -81.14 19.31 1.18 Allowed 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 123.398 2.732 . . . . 0.0 112.207 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 27.1 m -68.6 117.11 9.92 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.596 -177.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -100.78 90.22 4.15 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 172.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -112.37 155.31 24.36 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.188 0.518 . . . . 0.0 110.913 -173.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -102.66 170.23 8.15 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.137 -178.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 7.2 p30 50.28 -147.77 0.35 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.385 1.074 . . . . 0.0 113.127 173.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.629 ' CD1' HG22 ' A' ' 152' ' ' ILE . 3.1 mm? 64.11 80.3 0.23 Allowed 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.665 0.745 . . . . 0.0 109.493 -166.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.522 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 39.9 tt0 -173.69 -60.07 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.303 -172.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -118.76 106.79 12.9 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 121.691 0.758 . . . . 0.0 110.524 177.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.565 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 20.9 t -115.68 134.97 57.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 114.375 -1.284 . . . . 0.0 108.771 -178.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.662 ' HG3' ' CG ' ' A' ' 179' ' ' GLU . 5.7 ptp180 -110.48 136.12 50.12 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 116.463 -2.095 . . . . 0.0 109.773 167.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.526 ' C ' HD21 ' A' ' 131' ' ' LEU . 0.7 OUTLIER -93.57 142.21 27.6 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.711 -175.655 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.662 HD21 ' N ' ' A' ' 131' ' ' LEU . 2.0 mm? -115.04 -26.99 7.5 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.342 -165.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.504 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 37.1 t80 -89.36 -30.79 18.14 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.86 -172.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.589 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 8.8 t70 71.63 98.69 0.07 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.391 0.615 . . . . 0.0 109.545 -174.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.423 ' O ' ' HA ' ' A' ' 143' ' ' PRO . 53.7 t80 -123.9 84.07 54.67 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 177.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.6 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 66.7 Cg_endo -82.29 61.29 7.67 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.281 1.988 . . . . 0.0 112.894 -177.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -62.38 -29.8 74.35 Favored Glycine 0 C--N 1.331 0.301 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.589 178.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.469 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 10.0 m-80 64.03 65.39 0.69 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 114.861 -0.669 . . . . 0.0 112.143 176.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -145.72 169.49 18.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.908 177.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -89.41 -6.64 56.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.765 0.793 . . . . 0.0 109.253 172.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 172' ' ' MET . 11.6 mp0 -104.23 -19.76 14.01 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.575 175.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -135.38 107.69 7.28 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.732 ' CD2' HD23 ' A' ' 150' ' ' LEU . 33.1 tp -70.96 127.32 91.83 Favored Pre-proline 0 C--N 1.325 -0.465 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.745 -176.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.6 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 95.9 Cg_endo -81.7 93.71 0.95 Allowed 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 122.014 1.809 . . . . 0.0 111.367 172.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.505 ' CD1' ' HB ' ' A' ' 130' ' ' THR . 10.0 p90 -105.76 159.74 15.76 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.385 -174.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.589 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 56.5 mtpt -102.68 -169.0 1.6 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -175.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.576 ' HD2' ' N ' ' A' ' 146' ' ' LYS . 9.2 mptt -74.54 -13.49 60.68 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.154 -167.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -164.67 25.77 0.18 Allowed Glycine 0 CA--C 1.503 -0.692 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.32 -178.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.518 ' HB3' ' HB2' ' A' ' 145' ' ' LYS . 0.1 OUTLIER -79.54 148.28 31.84 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.001 0.429 . . . . 0.0 111.024 -177.458 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.557 HD13 ' N ' ' A' ' 149' ' ' ILE . 1.8 mp -94.13 129.77 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.399 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.732 HD23 ' CD2' ' A' ' 142' ' ' LEU . 9.3 mt -121.47 156.95 31.67 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 -175.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.568 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 57.3 t -111.12 122.82 66.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 174.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.629 HG22 ' CD1' ' A' ' 125' ' ' LEU . 49.8 mm -76.78 79.91 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 122.344 1.069 . . . . 0.0 108.49 -177.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.487 HG22 ' HG3' ' A' ' 154' ' ' GLU . 18.1 tt -72.6 -25.89 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 113.551 -1.658 . . . . 0.0 110.113 -174.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.731 ' HA ' HH22 ' A' ' 57' ' ' ARG . 0.5 OUTLIER -140.88 153.36 45.68 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 173.85 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.559 ' HD2' HD11 ' A' ' 125' ' ' LEU . 79.3 tttt -140.85 91.98 8.94 Favored Pre-proline 0 C--N 1.32 -0.68 0 O-C-N 122.047 -0.408 . . . . 0.0 110.591 177.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.745 ' HG2' ' SD ' ' A' ' 172' ' ' MET . 2.8 Cg_endo -81.62 -39.85 0.17 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.573 2.182 . . . . 0.0 111.999 -174.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.414 ' HB2' ' HB2' ' A' ' 160' ' ' TRP . 46.2 mm-40 -114.66 161.86 17.55 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.38 -179.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -85.68 -7.87 58.54 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 173.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.993 ' HG3' ' HD1' ' A' ' 160' ' ' TRP . 21.0 pt20 -111.16 -17.69 13.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.728 178.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.993 ' HD1' ' HG3' ' A' ' 159' ' ' GLN . 47.5 m95 -131.78 131.55 43.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.397 178.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . 0.639 ' O ' HG13 ' A' ' 173' ' ' ILE . 48.5 m0 -119.53 140.56 50.32 Favored 'General case' 0 C--O 1.212 -0.911 0 C-N-CA 122.877 0.471 . . . . 0.0 110.643 -176.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.576 ' OG ' ' HG2' ' A' ' 172' ' ' MET . 30.4 m -100.2 97.59 8.38 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -176.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.521 ' HB2' ' HB3' ' A' ' 150' ' ' LEU . . . -108.66 146.44 33.42 Favored 'General case' 0 N--CA 1.416 -2.129 0 C-N-CA 119.951 -0.7 . . . . 0.0 109.154 -173.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.682 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 19.9 ptt-85 -87.48 122.67 31.5 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 175.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.72 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . 7.6 t30 -56.74 175.5 0.12 Allowed 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 113.572 -1.649 . . . . 0.0 110.282 -175.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -60.3 -13.48 13.06 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.322 0.582 . . . . 0.0 109.78 171.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -81.92 -26.43 34.07 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.005 174.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 100.69 -4.97 56.6 Favored Glycine 0 CA--C 1.521 0.421 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.112 -173.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.682 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.7 OUTLIER -69.05 134.31 49.24 Favored 'General case' 0 C--O 1.216 -0.71 0 C-N-CA 123.108 0.563 . . . . 0.0 110.903 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.471 HG22 HG21 ' A' ' 153' ' ' ILE . 39.3 t -86.75 128.07 39.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 O-C-N 122.049 -0.407 . . . . 0.0 110.969 178.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -154.08 154.72 25.7 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.122 170.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.745 ' SD ' ' HG2' ' A' ' 156' ' ' PRO . 29.5 mtp -81.11 141.05 34.66 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 117.284 0.542 . . . . 0.0 110.889 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.639 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.6 pp -141.4 143.14 29.01 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.558 -174.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.464 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 15.3 Cg_exo -67.7 135.91 37.31 Favored 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 122.739 2.293 . . . . 0.0 113.164 -178.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.533 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 98.1 t -64.54 -45.65 76.86 Favored Pre-proline 0 CA--C 1.539 0.519 0 N-CA-C 112.816 0.672 . . . . 0.0 112.816 178.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 36.1 Cg_endo -66.41 7.9 0.35 Allowed 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 122.022 1.815 . . . . 0.0 112.938 178.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.464 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.7 m-85 -101.05 -13.87 18.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.258 177.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.528 ' HA ' HD23 ' A' ' 131' ' ' LEU . 1.5 m -116.07 175.49 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 N-CA-C 115.956 1.836 . . . . 0.0 115.956 -166.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.727 ' O ' ' HG3' ' A' ' 179' ' ' GLU 0.273 2.0 pt-20 -149.09 57.69 1.02 Allowed 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 112.294 -2.23 . . . . 0.0 111.044 -165.699 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.596 ' HD3' ' H ' ' A' ' 180' ' ' LYS . 0.0 OUTLIER -69.36 141.7 54.13 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 118.748 -2.47 . . . . 0.0 111.768 -165.498 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 32.7 tp -78.39 -66.72 0.82 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 112.161 -2.291 . . . . 0.0 112.362 -162.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 11.3 p -77.64 55.76 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 122.242 1.02 . . . . 0.0 111.051 -173.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.621 ' CD ' ' HB2' ' A' ' 185' ' ' SER . 0.0 OUTLIER -142.74 -6.65 0.87 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.323 178.712 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 8.6 t 61.92 23.53 13.86 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.095 178.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' SER . . . . . 0.624 ' HB3' ' HD3' ' A' ' 186' ' ' PRO . 9.3 t -37.01 -49.73 2.1 Favored Pre-proline 0 N--CA 1.471 0.618 0 C-N-CA 124.805 1.242 . . . . 0.0 113.773 -176.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.624 ' HD3' ' HB3' ' A' ' 185' ' ' SER . 16.8 Cg_exo -68.52 92.18 0.41 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 121.11 1.207 . . . . 0.0 110.292 169.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 6.6 m-70 -88.0 80.98 7.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.959 0.409 . . . . 0.0 110.11 -174.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -107.74 -27.19 5.29 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 177.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -106.79 -29.24 9.66 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 175.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -82.75 91.87 7.11 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.218 0.532 . . . . 0.0 110.656 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 169.3 49.53 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -73.93 -29.62 62.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.993 0.425 . . . . 0.0 111.037 -172.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 70.7 mtp180 -84.79 -12.7 53.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.98 177.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 68.82 -62.39 0.39 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.627 0.771 . . . . 0.0 111.419 -176.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 13.6 p -160.96 155.06 22.8 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.254 -178.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -91.14 -167.22 1.75 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 175.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 47.0 m 72.29 -58.97 0.57 Allowed 'General case' 0 N--CA 1.466 0.371 0 O-C-N 123.679 0.612 . . . . 0.0 110.695 -177.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -85.9 145.22 27.26 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 173.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 82.16 -54.78 4.9 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.328 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 6.5 tp -159.48 108.6 1.5 Allowed Pre-proline 0 N--CA 1.448 -0.544 0 CA-C-O 121.08 0.467 . . . . 0.0 110.036 176.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -63.64 -30.4 70.17 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.544 2.163 . . . . 0.0 111.096 175.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.44 ' N ' ' HD3' ' A' ' 203' ' ' PRO . 37.8 tt0 58.88 66.37 2.44 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.501 177.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.44 ' HD3' ' N ' ' A' ' 202' ' ' GLU . 3.3 Cg_endo -86.4 124.46 2.38 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.068 2.512 . . . . 0.0 111.063 175.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -61.79 -41.04 97.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.931 0.396 . . . . 0.0 111.165 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -115.16 -85.15 0.61 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.168 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -144.99 -70.71 0.28 Allowed 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 121.121 -0.231 . . . . 0.0 111.331 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -102.88 -21.18 14.04 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.447 -175.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . 67.67 -169.0 0.19 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.849 178.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 0.775 ' H ' ' HD2' ' A' ' 210' ' ' PRO . 76.4 mm-40 -138.02 -50.58 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.95 -177.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . 0.775 ' HD2' ' H ' ' A' ' 209' ' ' GLN . 37.8 Cg_endo -66.23 85.91 0.26 Allowed 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 121.984 1.79 . . . . 0.0 112.88 -179.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -104.44 3.7 32.47 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.105 177.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 8.1 p -78.62 -30.73 46.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.593 -176.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -78.95 105.83 10.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.909 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.463 ' HA ' ' HD3' ' A' ' 215' ' ' PRO . 10.2 t -151.92 136.1 10.0 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.524 -178.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 214' ' ' THR . 4.4 Cg_endo -86.17 148.14 9.1 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 123.385 2.724 . . . . 0.0 112.118 177.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 48.0 tp -139.19 94.69 9.64 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 120.858 0.361 . . . . 0.0 110.745 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.21 73.98 4.26 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 123.125 2.55 . . . . 0.0 111.972 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -143.62 -70.42 0.31 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.941 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 26.1 m -93.64 -27.2 4.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.182 175.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 9.4 t -93.58 97.09 10.27 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.434 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -138.01 117.06 1.4 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.044 -178.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 3.1 t -123.61 143.42 41.62 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -179.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.26 119.5 6.78 Favored 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 122.789 2.326 . . . . 0.0 112.162 176.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -81.55 -28.37 43.7 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.918 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -154.77 143.75 20.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.655 0.264 . . . . 0.0 110.42 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -74.86 94.16 2.75 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.024 0.44 . . . . 0.0 110.656 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 8.0 tp -163.27 137.63 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.068 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' THR . . . . . 0.866 ' HB ' ' HD3' ' A' ' 229' ' ' PRO . 25.2 m -152.75 -59.8 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.727 177.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.866 ' HD3' ' HB ' ' A' ' 228' ' ' THR . 5.9 Cg_exo -79.9 112.93 2.94 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.151 1.901 . . . . 0.0 111.927 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 79.5 mt -73.23 154.23 90.34 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.458 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.38 124.43 15.14 Favored 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 122.288 1.992 . . . . 0.0 110.707 172.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 27.8 m -74.75 74.02 2.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.619 0.723 . . . . 0.0 110.811 -176.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 11.0 p -78.13 -37.66 45.57 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.052 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 55.62 84.49 0.08 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.448 0.642 . . . . 0.0 111.108 -177.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . 0.484 ' N ' HD21 ' A' ' 235' ' ' ASN . 0.1 OUTLIER -168.35 142.03 3.2 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.732 179.118 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . 0.486 ' N ' ' HD3' ' A' ' 237' ' ' PRO . . . 75.15 57.97 4.15 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 115.924 -0.58 . . . . 0.0 113.853 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.486 ' HD3' ' N ' ' A' ' 236' ' ' GLY . 1.1 Cg_endo -82.61 95.31 0.85 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.144 1.896 . . . . 0.0 109.604 170.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.436 ' HB ' ' CG1' ' A' ' 266' ' ' VAL . 2.8 t -65.66 139.67 20.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.729 -169.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -106.16 121.56 44.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.994 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.505 ' HB3' HD13 ' A' ' 293' ' ' ILE . . . -119.26 136.57 54.16 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.36 179.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.408 ' HB2' ' CE1' ' A' ' 294' ' ' PHE . 2.8 tppp? -86.97 122.34 30.69 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 178.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . 0.513 ' HA ' HG11 ' A' ' 291' ' ' VAL . . . -72.43 97.02 1.99 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.154 0.502 . . . . 0.0 110.278 177.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 19.1 pt -85.59 -25.68 6.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.712 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.79 138.92 50.14 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.401 ' HE3' ' HB2' ' A' ' 245' ' ' LYS . 34.5 ttmt -67.61 155.81 38.28 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.2 -173.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 15.5 mmm180 -134.91 128.44 32.58 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.473 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.477 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 8.2 m -134.56 130.14 19.78 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.18 176.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.645 ' HD3' ' HB3' ' A' ' 257' ' ' ALA . 3.5 Cg_exo -75.5 145.51 29.87 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 123.059 2.506 . . . . 0.0 112.128 -176.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 51.1 t -75.12 169.98 16.95 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -61.68 -19.56 62.48 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -176.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -110.61 4.52 20.32 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -178.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.429 ' HB3' ' HB3' ' A' ' 255' ' ' ALA . 61.7 m-20 -91.06 112.96 25.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.51 0.195 . . . . 0.0 111.054 -178.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . 0.435 ' N ' ' HD2' ' A' ' 253' ' ' LYS . 10.9 mptt -95.4 -41.3 9.06 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.272 0.558 . . . . 0.0 109.986 175.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 6.8 p -98.93 21.25 11.86 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.188 -174.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.429 ' HB3' ' HB3' ' A' ' 252' ' ' ASP . . . -102.61 113.31 26.57 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 121.06 -0.256 . . . . 0.0 110.434 177.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.454 HD22 ' H ' ' A' ' 257' ' ' ALA . 0.5 OUTLIER -70.87 144.03 50.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.048 0.452 . . . . 0.0 110.965 -175.705 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.645 ' HB3' ' HD3' ' A' ' 248' ' ' PRO . . . -105.43 136.21 45.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.58 177.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 94.9 mt -135.88 152.16 50.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.799 -173.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -118.64 155.57 30.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.267 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 36.6 t -68.19 129.9 33.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.607 -174.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 83.32 33.92 21.64 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.316 178.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -119.28 162.67 18.34 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 39.2 mm -102.18 109.81 27.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.01 0.434 . . . . 0.0 110.78 -177.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 16.8 t -89.61 104.82 15.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.381 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . 0.413 ' HE2' ' HB3' ' A' ' 278' ' ' GLU . 4.4 ptmt -87.06 102.02 14.02 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.631 177.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.439 HG21 ' HB3' ' A' ' 275' ' ' TRP . 3.0 p -92.93 123.99 45.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.182 0.515 . . . . 0.0 110.723 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 16.1 p -94.98 -27.01 15.86 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.383 -177.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . 0.552 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 42.2 ttm180 -131.92 103.16 6.16 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.997 0.427 . . . . 0.0 110.394 178.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' MET . . . . . 0.467 ' HG3' ' CD1' ' A' ' 275' ' ' TRP . 29.6 ttm -93.97 109.87 21.58 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.992 0.425 . . . . 0.0 110.734 -179.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -87.78 173.93 8.68 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.502 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 31.3 pt -107.6 5.7 9.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.874 0.369 . . . . 0.0 111.523 -176.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -83.3 -26.28 30.78 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.124 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 119.18 -10.29 11.83 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.139 -177.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.531 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 27.1 mt-30 -118.06 111.97 19.6 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 177.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.58 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 19.2 m0 -96.74 159.55 14.86 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.117 -175.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . 0.552 ' HB2' ' HB3' ' A' ' 268' ' ' ARG . 48.0 mt-10 -100.81 111.68 23.95 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.255 175.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -129.15 158.58 22.08 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.533 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.413 ' HB3' ' HE2' ' A' ' 265' ' ' LYS . 39.6 tt0 -110.25 109.99 20.66 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.902 0.382 . . . . 0.0 110.155 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . 0.668 HG11 HD21 ' A' ' 280' ' ' ASN . 57.3 t -127.18 128.49 70.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.869 179.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . 0.668 HD21 HG11 ' A' ' 279' ' ' VAL . 46.2 m-80 63.03 25.59 15.07 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 123.442 0.464 . . . . 0.0 111.238 -177.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 75.52 19.49 79.25 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.059 -177.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -129.73 117.36 20.16 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 25.1 pttm -103.68 142.4 34.39 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.803 -178.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -173.18 178.37 45.18 Favored Glycine 0 N--CA 1.439 -1.12 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.707 178.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.58 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 94.8 mt -81.09 130.55 35.07 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.766 0.317 . . . . 0.0 110.314 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -129.2 125.24 22.61 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.424 175.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -58.36 126.42 21.38 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 123.183 2.589 . . . . 0.0 111.787 174.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -64.75 -12.66 49.73 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.305 -174.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.19 -3.77 11.75 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -176.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -114.91 -2.65 12.83 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.023 -0.423 . . . . 0.0 111.212 -178.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.513 HG11 ' HA ' ' A' ' 242' ' ' ALA . 35.8 m -128.7 166.51 25.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.737 -0.21 . . . . 0.0 110.606 179.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? -131.34 132.49 44.5 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.716 0.293 . . . . 0.0 110.26 172.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.505 HD13 ' HB3' ' A' ' 240' ' ' ALA . 40.8 mm -76.61 125.29 36.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.116 177.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' PHE . . . . . 0.408 ' CE1' ' HB2' ' A' ' 241' ' ' LYS . 5.3 p90 -149.67 166.64 28.72 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -103.7 104.81 44.49 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 178.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -87.42 10.03 3.67 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.883 2.388 . . . . 0.0 112.368 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -90.51 -47.0 7.98 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.246 -177.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . 0.456 ' OD1' ' HB3' ' A' ' 300' ' ' ASP . 4.8 p30 -98.07 135.45 21.39 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.299 -179.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -87.53 5.62 5.48 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.717 2.278 . . . . 0.0 112.004 177.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.456 ' HB3' ' OD1' ' A' ' 298' ' ' ASN . 14.3 t70 -70.76 -45.86 63.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.993 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -120.86 10.69 10.94 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.53 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -79.4 110.61 14.86 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.154 178.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 . . . . . 0 C--O 1.246 0.89 0 CA-C-O 118.575 -0.726 . . . . 0.0 109.531 178.346 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.404 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.286 0 CA-C-O 120.724 0.297 . . . . 0.0 110.419 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.7 m -115.25 168.19 10.17 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.8 m 60.82 86.59 0.1 Allowed 'General case' 0 C--O 1.233 0.219 0 O-C-N 123.661 0.601 . . . . 0.0 110.279 -175.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.556 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . 69.39 100.86 0.06 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.161 -176.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 5' ' ' ARG . 3.4 ptp180 -125.87 81.33 1.98 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.433 0.635 . . . . 0.0 111.32 -177.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -147.98 157.56 43.59 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.74 177.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.419 ' C ' ' H ' ' A' ' 9' ' ' SER . 9.6 m-20 -85.88 9.51 16.55 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -171.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.0 m 65.54 -15.61 0.11 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 173.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.814 ' CA ' ' HE1' ' A' ' 14' ' ' TRP . 8.2 t -142.4 -71.02 0.33 Allowed 'General case' 0 C--O 1.246 0.919 0 CA-C-O 122.224 1.011 . . . . 0.0 110.82 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' A' ' 12' ' ' SER . 25.0 t0 -25.16 72.29 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 113.908 -1.497 . . . . 0.0 111.484 -148.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.6 ' H ' ' HD2' ' A' ' 11' ' ' ARG . 11.4 mmm180 -6.03 -53.37 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 126.437 2.335 . . . . 0.0 115.099 -159.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.5 ' N ' ' O ' ' A' ' 10' ' ' ASP . 6.0 t -65.49 12.84 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 121.548 -0.061 . . . . 0.0 110.912 176.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.502 ' H ' ' C ' ' A' ' 11' ' ' ARG . . . -91.0 -29.71 17.22 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.187 177.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.814 ' HE1' ' CA ' ' A' ' 9' ' ' SER . 24.5 p-90 -151.49 -28.03 0.19 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -173.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -59.4 123.79 17.91 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -178.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.481 ' SD ' ' HA ' ' A' ' 104' ' ' ARG . 33.1 tpp -110.1 2.66 19.62 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.485 -171.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.536 ' O ' ' HB2' ' A' ' 39' ' ' ARG . . . 51.53 -104.85 0.17 Allowed Glycine 0 CA--C 1.524 0.619 0 O-C-N 123.592 0.557 . . . . 0.0 114.476 177.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.424 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 3.5 Cg_exo -78.25 110.13 2.81 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.783 2.322 . . . . 0.0 112.756 179.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.94 ' HB ' ' HG3' ' A' ' 39' ' ' ARG . 23.5 t -138.23 -73.1 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 119.421 -0.323 . . . . 0.0 111.636 177.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.488 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 69.9 m 79.93 -177.35 0.08 Allowed 'General case' 0 C--N 1.342 0.26 0 CA-C-N 117.781 0.264 . . . . 0.0 110.929 174.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -63.81 -49.61 72.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.549 0.214 . . . . 0.0 111.154 -171.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -59.89 -53.62 55.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.622 -173.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 57.9 mm-40 -64.07 -48.93 74.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.42 -178.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.02 -39.66 75.18 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.811 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.575 ' HA ' HG21 ' A' ' 58' ' ' VAL . 12.4 mm100 -70.06 -53.7 16.31 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -178.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.0 t -68.28 -27.14 66.06 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.007 0.432 . . . . 0.0 111.611 -173.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -87.46 -33.75 18.93 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.094 0.473 . . . . 0.0 110.87 -175.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.673 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 30.7 mt -106.33 28.17 8.01 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.616 -176.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.11 65.77 2.16 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.073 0.463 . . . . 0.0 111.941 -173.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 59.53 23.53 58.4 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.979 176.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.462 ' O ' ' HB2' ' A' ' 117' ' ' ASN . 4.6 tt0 -64.46 -81.67 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.681 0.277 . . . . 0.0 110.367 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.43 HH11 ' HD3' ' A' ' 32' ' ' ARG . 39.9 ttp-105 -107.34 132.57 52.99 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 173.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 67.2 m170 -81.74 110.64 17.25 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.026 0.441 . . . . 0.0 110.527 -179.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 137.25 -19.92 3.39 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.382 -175.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.703 ' HB2' ' HB3' ' A' ' 53' ' ' SER . 34.3 mtt -59.82 137.04 58.16 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 122.404 0.282 . . . . 0.0 111.169 176.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.566 ' HB2' HG22 ' A' ' 52' ' ' VAL . 22.0 p90 -146.78 158.27 43.87 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.941 173.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.481 HD13 ' O ' ' A' ' 37' ' ' LEU . 4.5 pp -151.66 143.0 23.42 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.574 173.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.432 HG21 HD11 ' A' ' 50' ' ' LEU . 84.2 t -114.65 120.58 64.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 176.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.94 ' HG3' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -134.51 169.22 17.6 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.714 -176.728 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -57.99 127.96 34.73 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 175.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.3 t -64.62 157.57 26.71 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.401 0.62 . . . . 0.0 111.895 -173.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.2 p -86.47 -11.01 52.98 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.4 177.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 32.7 p -88.62 -63.6 1.27 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.645 178.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 57.4 m -136.91 145.4 50.59 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.835 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 44' ' ' CYS . 21.8 Cg_exo -65.51 -28.09 53.74 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.765 2.31 . . . . 0.0 112.51 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -76.73 -6.17 84.63 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.121 -0.561 . . . . 0.0 112.317 178.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.472 ' OD1' ' HA ' ' A' ' 64' ' ' ASN . 46.1 m-20 -111.28 159.48 17.9 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 176.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -129.54 169.45 14.97 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 177.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 45.2 t -140.14 98.84 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.184 0.516 . . . . 0.0 111.144 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.432 HD11 HG21 ' A' ' 38' ' ' VAL . 35.8 tp -69.05 99.84 1.15 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.872 172.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.1 m -96.74 126.2 41.73 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 177.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.616 HG23 HD12 ' A' ' 93' ' ' LEU . 80.9 t -117.46 146.92 21.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.704 -176.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.703 ' HB3' ' HB2' ' A' ' 35' ' ' MET . 26.6 t -100.27 98.88 9.5 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 175.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.461 ' HB2' ' OD1' ' A' ' 94' ' ' ASP . 0.0 OUTLIER -144.35 156.39 44.22 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.727 -176.352 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.544 ' OD1' ' HE2' ' A' ' 155' ' ' LYS . 0.7 OUTLIER 66.56 -56.04 0.4 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.243 0.617 . . . . 0.0 112.652 -179.235 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.8 p 169.77 -6.95 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.721 0.809 . . . . 0.0 110.774 -175.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -134.68 -169.11 2.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.512 -175.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.575 HG21 ' HA ' ' A' ' 25' ' ' GLN . 26.2 t -114.55 104.92 17.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.504 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 75.1 m -84.0 119.34 24.82 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.551 0.691 . . . . 0.0 110.133 176.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -94.88 104.22 16.11 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.033 -175.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.823 ' HH ' ' HB3' ' A' ' 93' ' ' LEU . 57.6 m-85 -98.95 98.43 9.48 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.431 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 30.3 mt -80.75 130.93 35.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -174.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.582 HG13 ' HB ' ' A' ' 73' ' ' ILE . 4.0 mp -103.81 123.46 57.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.858 178.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.472 ' HA ' ' OD1' ' A' ' 47' ' ' ASP . 17.0 m120 -104.13 131.07 51.79 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -175.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.9 t -77.55 111.18 13.01 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 175.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 93.2 mt -77.15 143.69 70.24 Favored Pre-proline 0 C--N 1.318 -0.78 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.36 -22.33 41.11 Favored 'Trans proline' 0 CA--C 1.528 0.214 0 C-N-CA 122.888 2.392 . . . . 0.0 112.383 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.9 p30 -86.03 16.42 4.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.916 178.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.781 ' HA ' ' HE ' ' A' ' 69' ' ' ARG . 0.2 OUTLIER 66.73 35.38 5.15 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.008 174.172 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -114.4 171.03 7.87 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.096 173.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.494 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 36.6 m-85 -119.69 120.3 36.2 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.014 0.435 . . . . 0.0 110.753 179.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.869 ' HE2' ' HA ' ' A' ' 75' ' ' ASP . 88.0 tttt -114.48 103.74 11.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.867 -176.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.582 ' HB ' HG13 ' A' ' 63' ' ' ILE . 5.6 tt -92.71 111.69 24.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.279 0.561 . . . . 0.0 111.531 -175.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.408 ' C ' ' H ' ' A' ' 76' ' ' GLN . . . 57.25 51.15 59.29 Favored Glycine 0 C--N 1.329 0.183 0 CA-C-N 115.446 -0.797 . . . . 0.0 113.164 177.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.869 ' HA ' ' HE2' ' A' ' 72' ' ' LYS . 29.7 t70 72.04 -15.43 0.46 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.997 0.519 . . . . 0.0 111.872 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.408 ' H ' ' C ' ' A' ' 74' ' ' GLY . 46.3 tp60 -82.85 110.64 18.04 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -87.82 127.82 35.33 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.026 -171.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -129.61 -179.86 5.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.066 177.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -76.71 -56.48 4.57 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.172 0.51 . . . . 0.0 110.843 177.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.784 ' HD1' ' HG2' ' A' ' 82' ' ' PRO . 2.4 p80 -147.08 177.8 8.88 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.519 -176.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.56 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 12.5 mt -59.49 -52.36 74.72 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -176.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.784 ' HG2' ' HD1' ' A' ' 80' ' ' HIS . 14.6 Cg_endo -60.65 -8.78 9.82 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 121.953 1.769 . . . . 0.0 113.197 177.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.92 -26.35 21.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.787 0.327 . . . . 0.0 110.485 -178.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.1 pp -91.1 -30.72 16.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.925 0.393 . . . . 0.0 110.082 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.403 HD22 HD11 ' A' ' 98' ' ' LEU . 95.0 mt -68.58 -33.9 74.86 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.253 178.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -71.83 -27.78 63.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.519 0.676 . . . . 0.0 110.376 175.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.503 ' O ' HG12 ' A' ' 90' ' ' ILE . 82.8 t80 -79.82 -37.02 36.01 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.806 -174.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.451 ' HD1' ' HB2' ' A' ' 91' ' ' HIS . 27.7 m-85 -74.16 0.59 13.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.795 0.331 . . . . 0.0 111.787 -178.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.432 ' O ' HG23 ' A' ' 97' ' ' THR . 62.4 tttm -66.18 -25.35 66.9 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.34 168.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.503 HG12 ' O ' ' A' ' 87' ' ' PHE . 6.6 pt -88.21 -28.96 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 174.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.458 ' O ' ' HB2' ' A' ' 92' ' ' TYR . 2.5 m170 -84.58 -24.44 29.21 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -172.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.584 ' HA ' ' CA ' ' A' ' 97' ' ' THR . 29.8 m-85 73.07 -7.61 1.46 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -179.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.823 ' HB3' ' HH ' ' A' ' 61' ' ' TYR . 14.3 mt 53.8 -25.67 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.586 1.554 . . . . 0.0 113.656 -169.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.581 ' H ' ' C ' ' A' ' 92' ' ' TYR . 2.9 p-10 -151.46 -51.92 0.12 Allowed 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 169.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.675 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 14.1 t -177.0 14.53 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.77 0.319 . . . . 0.0 110.745 -178.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 13.2 t -128.58 -29.38 2.41 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -173.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.584 ' CA ' ' HA ' ' A' ' 92' ' ' TYR . 16.4 p 70.18 166.0 0.28 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.995 1.318 . . . . 0.0 110.56 -171.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.495 ' CD2' HD11 ' A' ' 93' ' ' LEU . 21.3 mt -70.1 103.16 2.23 Favored 'General case' 0 C--O 1.221 -0.401 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 178.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.556 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 43.4 mm -87.81 -61.09 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.482 -175.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -148.43 154.82 42.13 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-O 120.994 0.426 . . . . 0.0 110.549 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.474 ' HG2' ' O ' ' A' ' 13' ' ' ALA . 16.9 Cg_exo -69.36 149.04 68.94 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.792 2.328 . . . . 0.0 112.092 177.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.48 153.42 93.77 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.577 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.87 136.4 69.74 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.561 2.174 . . . . 0.0 111.787 175.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.481 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 36.0 mtt180 -67.53 -30.76 70.49 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.235 0.54 . . . . 0.0 110.474 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -153.49 164.64 19.84 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.25 104.75 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.418 2.079 . . . . 0.0 111.752 175.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.5 m -106.8 141.57 23.13 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.165 -173.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.408 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 57.7 Cg_endo -70.83 156.97 59.57 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.944 2.429 . . . . 0.0 112.06 177.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 108' ' ' PRO . 15.7 Cg_exo -68.2 96.34 0.46 Allowed 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.675 2.25 . . . . 0.0 112.419 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -72.95 -22.0 60.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.427 0.632 . . . . 0.0 109.859 174.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -159.57 -163.72 13.75 Favored Glycine 0 N--CA 1.441 -0.971 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 178.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.2 t -103.92 138.85 39.89 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.3 m -119.97 94.59 3.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.527 0.68 . . . . 0.0 111.098 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 52.7 m -92.79 30.26 1.61 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.77 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.409 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . . . -81.42 137.4 48.49 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.216 177.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 115' ' ' ALA . 22.5 Cg_exo -64.53 94.63 0.21 Allowed 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.803 2.335 . . . . 0.0 112.591 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 31' ' ' GLN . 4.8 p30 -74.4 -64.3 1.05 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.604 175.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.624 ' HG ' ' HG1' ' A' ' 120' ' ' THR . 44.8 tp 60.27 83.66 0.21 Allowed Pre-proline 0 C--O 1.236 0.367 0 O-C-N 123.755 0.659 . . . . 0.0 111.587 178.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -73.11 73.76 3.11 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 123.054 2.502 . . . . 0.0 110.942 176.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.624 ' HG1' ' HG ' ' A' ' 118' ' ' LEU . 7.5 m -68.34 125.37 26.23 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.295 -176.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -93.77 90.11 6.43 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 172.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -95.87 150.93 19.88 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.766 -174.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -113.85 161.31 17.75 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.103 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 59.82 -148.09 0.46 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -177.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.628 HD13 HG21 ' A' ' 152' ' ' ILE . 4.4 mm? 57.03 89.86 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.85 0.833 . . . . 0.0 112.861 171.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.608 ' O ' HG12 ' A' ' 151' ' ' VAL . 16.9 tp10 -173.27 -73.04 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.073 -1.421 . . . . 0.0 107.364 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.419 ' HB3' ' HB3' ' A' ' 181' ' ' LEU . 47.2 m-85 -109.64 139.21 44.94 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.081 -0.647 . . . . 0.0 110.643 177.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.48 ' CG1' ' HB ' ' A' ' 178' ' ' VAL . 5.3 t -135.29 161.5 39.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -178.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.484 ' CZ ' HD11 ' A' ' 181' ' ' LEU . 2.1 ptp180 -140.56 136.56 32.95 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 169.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.579 ' HG1' ' HB2' ' A' ' 144' ' ' PHE . 20.7 p -87.08 140.03 29.96 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.027 -174.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.459 HD23 ' HG2' ' A' ' 179' ' ' GLU . 13.1 mt -112.05 -31.66 6.82 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.245 -175.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -81.7 -31.78 31.98 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.432 -169.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.459 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 9.8 t70 69.02 110.4 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 O-C-N 123.627 0.58 . . . . 0.0 110.373 -173.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -141.85 101.5 5.9 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.877 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -94.42 90.69 0.12 Allowed 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 123.153 2.569 . . . . 0.0 112.44 176.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -89.86 -28.82 17.3 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.211 176.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 18.2 m120 63.11 83.97 0.15 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 114.695 -0.753 . . . . 0.0 112.232 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.737 ' HB3' ' HB3' ' A' ' 141' ' ' ASP . 31.9 t70 -160.66 178.06 9.86 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 177.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -92.83 -12.19 31.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.082 0.468 . . . . 0.0 110.929 178.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.54 ' O ' ' HB2' ' A' ' 172' ' ' MET . 5.0 mp0 -120.54 6.78 10.56 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 176.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.737 ' HB3' ' HB3' ' A' ' 138' ' ' ASP . 10.7 t70 -132.91 107.21 8.16 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 175.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.62 ' HB3' ' CG2' ' A' ' 173' ' ' ILE . 57.3 tp -82.25 112.92 40.02 Favored Pre-proline 0 C--N 1.323 -0.575 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.681 -173.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.511 ' HD2' ' HD2' ' A' ' 169' ' ' ARG . 28.6 Cg_endo -69.71 100.96 0.85 Allowed 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 121.998 1.799 . . . . 0.0 111.489 175.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.579 ' HB2' ' HG1' ' A' ' 130' ' ' THR . 13.0 p90 -115.61 168.7 9.78 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.047 0.451 . . . . 0.0 111.669 -176.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.517 ' HB2' ' HG2' ' A' ' 148' ' ' GLU . 1.4 mptp? -112.66 -169.93 1.57 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.32 -177.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.848 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -87.56 3.96 45.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.226 0.536 . . . . 0.0 110.355 179.093 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.11 31.61 1.43 Allowed Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.157 -178.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.517 ' HG2' ' HB2' ' A' ' 145' ' ' LYS . 13.0 mm-40 -98.16 143.95 28.15 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.421 -0.215 . . . . 0.0 110.421 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.6 mp -102.6 132.69 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 175.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.758 ' HB3' ' HB1' ' A' ' 163' ' ' ALA . 11.1 mt -119.02 175.78 5.6 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -177.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.608 HG12 ' O ' ' A' ' 126' ' ' GLU . 15.3 t -142.25 123.56 12.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.819 HD13 ' HB3' ' A' ' 163' ' ' ALA . 25.2 mm -78.91 79.79 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-O 122.404 1.097 . . . . 0.0 110.285 -174.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.421 HG22 ' HG3' ' A' ' 154' ' ' GLU . 19.4 tt -74.67 -35.76 38.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 113.452 -1.704 . . . . 0.0 110.418 -175.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 1.049 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 53.0 mt-10 -120.18 139.44 52.63 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 171.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.544 ' HE2' ' OD1' ' A' ' 55' ' ' ASN . 35.9 ttpt -132.25 81.89 59.8 Favored Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 122.037 -0.414 . . . . 0.0 110.058 170.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.675 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 11.7 Cg_exo -72.1 -46.36 0.54 Allowed 'Trans proline' 0 CA--C 1.515 -0.465 0 C-N-CA 122.43 2.086 . . . . 0.0 111.34 177.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -122.15 -178.94 4.0 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.265 -174.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -101.73 -22.25 14.45 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.302 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -89.14 -27.6 20.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.21 0.528 . . . . 0.0 110.5 -179.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.704 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 42.0 m95 -129.21 130.4 46.26 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.906 -179.406 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . 0.667 ' HB3' HG22 ' A' ' 152' ' ' ILE . 54.2 m0 -123.12 137.58 54.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.704 178.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 1.049 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 16.2 m -84.46 106.37 15.99 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 176.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.819 ' HB3' HD13 ' A' ' 152' ' ' ILE . . . -116.9 162.27 18.01 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.279 -174.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.737 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 21.8 ptt-85 -109.93 127.78 54.96 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 175.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.702 ' HA ' HD22 ' A' ' 150' ' ' LEU . 19.7 p-10 -77.3 -174.06 3.11 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.999 -0.28 . . . . 0.0 111.205 -176.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -66.46 -25.8 66.9 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.237 0.541 . . . . 0.0 110.29 -177.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -70.72 -28.62 64.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.46 175.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 107.33 15.39 15.88 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.854 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.737 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 13.3 ttm-85 -92.86 134.3 35.22 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 122.779 0.431 . . . . 0.0 111.051 -176.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.555 HG22 ' HB3' ' A' ' 164' ' ' ARG . 60.0 t -99.18 136.89 28.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 120.848 0.356 . . . . 0.0 110.825 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -168.97 161.28 34.96 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 175.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.704 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.0 OUTLIER -69.26 132.56 46.66 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.897 0.348 . . . . 0.0 110.124 179.234 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.669 HD12 HG12 ' A' ' 178' ' ' VAL . 2.6 pp -134.12 144.0 49.58 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.645 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.481 ' HG3' ' CH2' ' A' ' 160' ' ' TRP . 5.2 Cg_exo -73.87 127.82 11.85 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.853 2.369 . . . . 0.0 111.688 -178.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.641 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 19.2 t -69.93 -35.33 5.16 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.641 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 11.3 Cg_endo -57.76 -16.83 26.82 Favored 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 121.832 1.688 . . . . 0.0 112.672 170.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.474 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.8 m-30 -87.33 -20.34 26.91 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.392 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.669 HG12 HD12 ' A' ' 173' ' ' ILE . 4.8 m -118.83 174.66 4.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -168.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.459 ' HG2' HD23 ' A' ' 131' ' ' LEU . 13.2 pt-20 -140.62 166.83 23.67 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 173.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.456 ' HB2' ' HD2' ' A' ' 183' ' ' ARG . 3.2 mppt? -94.76 138.68 32.27 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.119 0.485 . . . . 0.0 111.451 -176.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.484 HD11 ' CZ ' ' A' ' 129' ' ' ARG . 57.7 tp -93.68 157.74 16.02 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.34 175.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.412 ' C ' ' H ' ' A' ' 184' ' ' SER . 18.3 m 38.6 39.36 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.959 0.904 . . . . 0.0 111.71 -176.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.456 ' HD2' ' HB2' ' A' ' 180' ' ' LYS . 53.5 ttt180 -75.39 12.2 1.03 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.434 -174.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.412 ' H ' ' C ' ' A' ' 182' ' ' VAL . 32.5 t -74.32 73.68 1.84 Allowed 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.025 174.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' SER . . . . . 0.542 ' HA ' ' CE1' ' A' ' 187' ' ' HIS . 37.7 m -34.8 -45.31 0.72 Allowed Pre-proline 0 N--CA 1.472 0.655 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 -173.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 185' ' ' SER . 9.6 Cg_endo -57.63 92.91 0.06 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 121.28 1.32 . . . . 0.0 111.79 169.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.542 ' CE1' ' HA ' ' A' ' 185' ' ' SER . 2.0 p-80 -160.69 133.93 6.62 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.826 0.822 . . . . 0.0 112.998 -178.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -123.9 -33.08 0.82 Allowed Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 114.071 -1.422 . . . . 0.0 110.088 170.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -122.64 80.76 1.78 Allowed 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.175 0.512 . . . . 0.0 110.566 178.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -135.57 32.0 3.07 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.506 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -91.28 59.95 3.02 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.258 -175.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -94.05 153.26 18.25 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.3 177.52 5.53 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.336 178.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -136.8 116.99 13.46 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.264 0.554 . . . . 0.0 111.327 -171.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 24.4 p -87.44 -160.68 0.63 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.249 -177.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 45.5 95.51 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.434 1.093 . . . . 0.0 113.644 174.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 16.5 m -126.47 121.62 32.89 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.114 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 65.61 111.25 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.898 0.749 . . . . 0.0 112.108 175.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -142.53 108.37 0.52 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.04 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.722 HG23 ' HG3' ' A' ' 202' ' ' GLU . 4.3 mp -125.8 109.75 25.23 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -65.52 -58.46 0.19 Allowed 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.963 2.442 . . . . 0.0 113.073 -176.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.722 ' HG3' HG23 ' A' ' 200' ' ' ILE . 47.6 mt-10 62.54 90.08 0.1 OUTLIER Pre-proline 0 N--CA 1.467 0.423 0 C-N-CA 123.105 0.562 . . . . 0.0 111.503 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -78.4 128.67 8.97 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.609 2.206 . . . . 0.0 112.097 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.56 140.71 57.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.544 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 18.8 p-80 -147.65 93.2 2.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.374 0.606 . . . . 0.0 111.141 -177.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -86.61 112.21 21.38 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.753 175.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -113.13 107.72 16.32 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.975 0.417 . . . . 0.0 110.742 -175.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -111.17 140.49 45.68 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.124 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -107.72 115.08 59.62 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.415 178.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.41 170.96 19.18 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.842 2.361 . . . . 0.0 112.711 -177.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -93.79 165.29 12.76 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.418 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 4.3 m -93.55 -26.41 17.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.432 -173.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 11.7 p 53.86 -167.23 0.07 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.698 0.799 . . . . 0.0 111.997 -176.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 5.6 t -95.78 121.83 60.23 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 121.122 0.487 . . . . 0.0 111.234 -176.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -78.03 157.48 30.56 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.544 2.163 . . . . 0.0 110.807 173.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 7.8 mp 58.19 93.54 0.05 OUTLIER Pre-proline 0 N--CA 1.465 0.306 0 O-C-N 123.631 0.582 . . . . 0.0 110.951 -177.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -79.69 3.73 7.29 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.587 2.191 . . . . 0.0 112.852 -176.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . 68.25 111.74 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 O-C-N 123.91 0.756 . . . . 0.0 110.902 -177.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 27.8 m -79.39 157.43 4.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.956 -177.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 12.6 t -104.09 -28.98 11.17 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.763 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -95.72 48.69 1.83 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.417 -177.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 56.5 m -154.09 99.47 2.53 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 120.711 0.291 . . . . 0.0 110.586 177.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.4 -20.3 14.31 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.316 2.011 . . . . 0.0 110.989 173.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.72 -147.4 24.0 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.918 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -146.5 87.09 1.7 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.989 0.423 . . . . 0.0 110.131 178.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -153.45 173.91 15.07 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.309 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 7.4 tt -96.41 110.58 24.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.102 0.477 . . . . 0.0 110.072 177.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 23.5 m -61.34 121.26 62.11 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.343 -178.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -63.16 141.38 82.59 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 122.845 2.363 . . . . 0.0 112.071 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.423 ' HB3' HG22 ' A' ' 233' ' ' THR . 3.7 mm? -63.28 121.02 67.03 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.688 -178.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.66 62.14 7.7 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 122.704 2.269 . . . . 0.0 112.446 -178.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 48.8 m 66.45 93.48 0.07 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.163 -178.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' THR . . . . . 0.423 HG22 ' HB3' ' A' ' 230' ' ' LEU . 24.4 p -111.26 156.61 21.23 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.765 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.416 HE21 ' CB ' ' A' ' 267' ' ' THR . 43.8 mt-30 -96.26 91.33 5.83 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.491 -176.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -114.35 -39.08 3.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.034 0.445 . . . . 0.0 110.088 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -123.67 98.8 0.6 Allowed Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.131 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -72.1 135.57 25.37 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.392 2.061 . . . . 0.0 111.594 176.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.577 HG13 HD12 ' A' ' 293' ' ' ILE . 41.1 t -91.23 129.39 42.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 120.908 0.385 . . . . 0.0 110.247 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -93.85 114.55 26.81 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.911 177.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -120.37 126.48 50.59 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.029 178.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -92.05 125.19 36.64 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . 0.523 ' HA ' HG11 ' A' ' 291' ' ' VAL . . . -71.52 114.77 9.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.038 0.447 . . . . 0.0 110.955 -176.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 23.1 pt -96.46 -20.28 5.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.672 -177.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -140.16 138.09 34.91 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -55.8 152.89 9.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.491 0.662 . . . . 0.0 112.596 -172.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.684 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -142.4 99.95 3.6 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 177.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 17.9 m -123.51 156.1 64.75 Favored Pre-proline 0 C--N 1.321 -0.672 0 C-N-CA 120.804 -0.359 . . . . 0.0 111.9 -174.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -66.0 132.83 31.33 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.116 2.544 . . . . 0.0 112.949 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 25.7 p -151.19 152.2 32.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.991 177.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 60.03 -78.43 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 O-C-N 124.197 0.936 . . . . 0.0 112.963 176.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . 0.579 ' HD1' ' H ' ' A' ' 253' ' ' LYS . 6.4 p90 -79.74 -32.63 41.15 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.175 -178.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 55.57 25.42 7.96 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.898 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . 0.579 ' H ' ' HD1' ' A' ' 251' ' ' TYR . 63.1 tttm -130.88 144.6 51.58 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -178.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 27.0 p 60.77 15.4 5.86 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.716 0.806 . . . . 0.0 111.1 -175.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -102.12 102.43 12.89 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.154 -176.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.707 HD21 ' HB ' ' A' ' 279' ' ' VAL . 1.6 tt -83.95 123.38 29.91 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 176.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.684 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -79.43 93.18 5.33 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.185 0.517 . . . . 0.0 110.903 -178.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.779 HD22 HG22 ' A' ' 279' ' ' VAL . 65.7 mt -95.34 128.18 41.99 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.878 -178.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -101.94 148.13 25.71 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.22 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 57.5 t -63.94 127.56 24.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.009 0.433 . . . . 0.0 110.634 -177.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 103.21 -9.18 53.99 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.679 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -88.63 165.72 14.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.885 0.342 . . . . 0.0 110.339 -175.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 43.9 mm -107.5 132.11 55.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.826 -177.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.65 ' HA ' HG21 ' A' ' 279' ' ' VAL . 20.3 t -107.13 111.21 34.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.816 178.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -77.69 87.27 3.97 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.987 174.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.601 HG22 ' HB3' ' A' ' 275' ' ' TRP . 14.9 p -95.04 120.78 44.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.608 179.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' THR . . . . . 0.416 ' CB ' HE21 ' A' ' 234' ' ' GLN . 9.8 p -113.46 -16.72 12.38 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.891 -178.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . 0.543 ' HB2' ' HB3' ' A' ' 276' ' ' GLU . 16.1 mmm180 -121.98 100.28 6.89 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.566 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 55.6 mtt -95.49 116.35 28.7 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.967 0.413 . . . . 0.0 110.347 176.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.416 ' O ' ' HB ' ' A' ' 271' ' ' ILE . 78.8 m-20 -80.38 -6.73 58.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.915 -176.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.416 ' HB ' ' O ' ' A' ' 270' ' ' ASN . 48.1 mm 77.91 -39.52 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 123.537 0.735 . . . . 0.0 112.649 174.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . 0.694 HD22 ' HG2' ' A' ' 274' ' ' GLN . 22.7 p-10 -55.92 -37.92 69.56 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -177.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 150.82 -34.64 0.94 Allowed Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.622 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.694 ' HG2' HD22 ' A' ' 272' ' ' ASN . 2.4 pt20 -94.2 124.86 38.48 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 176.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.601 ' HB3' HG22 ' A' ' 266' ' ' VAL . 34.0 m0 -108.61 171.15 7.59 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 120.764 0.316 . . . . 0.0 111.243 -175.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . 0.543 ' HB3' ' HB2' ' A' ' 268' ' ' ARG . 6.3 tp10 -112.93 100.24 8.49 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -178.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -119.54 145.69 17.97 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.872 -177.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.613 ' HB3' ' HG2' ' A' ' 283' ' ' LYS . 3.5 pt-20 -103.12 109.27 20.78 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.322 0.582 . . . . 0.0 109.765 176.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . 0.779 HG22 HD22 ' A' ' 258' ' ' LEU . 95.4 t -122.73 112.61 34.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.456 -173.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 59.14 20.25 8.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.412 172.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 127.63 -30.35 4.02 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.258 -0.972 . . . . 0.0 114.201 176.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 9.1 ttm105 -110.17 139.46 45.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 117.889 0.845 . . . . 0.0 111.578 -177.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.613 ' HG2' ' HB3' ' A' ' 278' ' ' GLU . 51.5 mttm -97.98 130.25 44.83 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 170.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . 0.533 ' HA3' ' HB2' ' A' ' 256' ' ' LEU . . . -152.94 162.47 30.07 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.263 -0.97 . . . . 0.0 112.65 -177.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.54 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 76.5 mt -85.35 115.71 23.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.13 0.49 . . . . 0.0 110.595 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -122.82 129.37 25.03 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.132 178.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -67.47 138.3 45.64 Favored 'Trans proline' 0 C--O 1.236 0.394 0 C-N-CA 122.435 2.09 . . . . 0.0 111.018 173.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -58.38 -22.17 52.82 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.065 -176.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 2.7 p -71.35 -1.49 13.11 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -178.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -100.03 -13.46 19.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.899 0.38 . . . . 0.0 110.396 177.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.523 HG11 ' HA ' ' A' ' 242' ' ' ALA . 30.7 m -128.31 177.78 5.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.634 -177.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -132.88 128.87 37.54 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.854 172.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.577 HD12 HG13 ' A' ' 238' ' ' VAL . 37.3 mm -78.63 128.02 38.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.691 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -141.31 151.42 43.6 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.787 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -99.14 129.43 29.47 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 175.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -58.34 -24.15 66.68 Favored 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 122.975 2.45 . . . . 0.0 112.994 -178.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -134.31 -160.03 1.01 Allowed 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -177.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . 0.403 ' HA ' ' HD3' ' A' ' 299' ' ' PRO . 8.1 t30 -110.79 111.86 56.41 Favored Pre-proline 0 C--N 1.316 -0.859 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 298' ' ' ASN . 14.7 Cg_exo -68.83 -16.68 41.73 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.899 2.399 . . . . 0.0 112.406 -177.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 64.18 -167.68 0.21 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.271 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -125.49 -28.8 3.27 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.067 -178.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -131.96 170.02 15.49 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -177.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 . . . . . 0 C--O 1.252 1.221 0 CA-C-O 118.372 -0.823 . . . . 0.0 111.166 -178.481 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 pmm? . . . . . 0 N--CA 1.48 1.072 0 CA-C-O 120.516 0.198 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.8 m -105.59 136.14 45.72 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.535 ' HB2' HD12 ' A' ' 99' ' ' ILE . 8.7 p -70.39 -54.66 11.53 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.651 0.262 . . . . 0.0 110.766 178.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . -69.74 98.82 1.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.775 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 5' ' ' ARG . 10.4 mmt85 -140.41 93.77 2.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.418 0.627 . . . . 0.0 111.566 -178.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -156.65 150.86 25.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.823 175.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.5 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 35.1 t0 -81.72 115.39 20.94 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 177.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.4 m -70.11 -12.73 61.81 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.743 -175.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.2 t -102.85 -12.32 17.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.239 0.542 . . . . 0.0 110.741 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.5 ' HB2' ' HB3' ' A' ' 7' ' ' ASP . 6.9 t70 -75.42 91.41 2.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.921 0.391 . . . . 0.0 110.05 -178.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -57.82 -39.13 76.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.545 -176.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.474 ' HA ' ' NH2' ' A' ' 104' ' ' ARG . 4.8 t -73.43 -1.55 18.76 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.159 -176.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.61 -44.47 8.58 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.356 176.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 29.9 p-90 -120.24 -21.2 7.05 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -171.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -77.58 122.83 25.81 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.102 0.477 . . . . 0.0 110.782 -176.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.53 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 25.0 mmt -104.53 -8.24 19.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.436 -175.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.444 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 50.89 -114.74 2.94 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-N 115.8 -0.636 . . . . 0.0 113.556 -176.272 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.444 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 11.3 Cg_exo -71.64 92.18 0.69 Allowed 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.948 2.432 . . . . 0.0 113.081 -176.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.433 HG23 ' HB3' ' A' ' 16' ' ' MET . 69.9 t -142.17 157.69 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 177.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.6 m -120.91 166.48 13.75 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -170.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 41.4 ttt85 -58.68 -48.98 79.26 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 123.04 0.213 . . . . 0.0 111.493 -177.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -60.59 -52.28 65.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.332 0.587 . . . . 0.0 110.767 -178.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -65.43 -47.62 75.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.261 -175.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.408 ' HB2' HD11 ' A' ' 37' ' ' LEU . . . -56.34 -38.65 71.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.488 0.661 . . . . 0.0 111.076 178.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.53 ' HA ' HG13 ' A' ' 58' ' ' VAL . 38.3 tt0 -72.66 -37.71 67.87 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.982 -174.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 10.2 t -75.08 -22.53 58.24 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 120.481 -0.487 . . . . 0.0 110.819 -178.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -81.26 -13.44 58.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.233 0.539 . . . . 0.0 110.583 177.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.573 ' O ' HG23 ' A' ' 58' ' ' VAL . 83.1 mt -126.11 16.25 7.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.486 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.35 77.67 3.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.087 0.47 . . . . 0.0 111.099 -174.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.63 16.75 72.25 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.678 -0.692 . . . . 0.0 113.067 177.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.597 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 44.1 tt0 -64.41 -77.26 0.06 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.992 0.425 . . . . 0.0 110.39 -178.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.6 mtm180 -124.63 125.69 44.55 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 175.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.445 ' HB2' HD22 ' A' ' 117' ' ' ASN . 53.0 m170 -71.38 119.08 15.01 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.957 0.408 . . . . 0.0 110.478 -178.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 109.36 -8.77 32.92 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.749 -176.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.602 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 37.4 ttp -84.28 129.5 34.88 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -138.11 171.43 14.41 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.711 -172.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.544 ' HG ' HD11 ' A' ' 28' ' ' LEU . 4.6 pp -157.72 139.58 14.08 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.181 173.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.451 HG22 HD11 ' A' ' 50' ' ' LEU . 42.4 t -105.83 123.69 60.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 176.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.401 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 24.3 ptt-85 -124.67 -179.47 4.52 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.341 -176.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -78.5 135.55 37.37 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 175.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.7 t -78.41 118.37 20.52 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.123 -178.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.8 t -78.46 -15.56 58.49 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.314 172.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 25.5 m -73.69 -45.32 53.09 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.734 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 50.6 t -138.83 124.47 12.2 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.323 -178.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 44' ' ' CYS . 23.4 Cg_exo -64.63 114.56 2.78 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 123.067 2.511 . . . . 0.0 112.548 -178.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.62 -16.05 29.04 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.835 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.569 ' OD2' ' HA ' ' A' ' 64' ' ' ASN . 1.2 m-20 -93.35 177.89 5.89 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.54 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 38.6 m-85 -130.59 174.18 10.16 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 179.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.9 t -142.59 110.04 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.611 0.243 . . . . 0.0 110.418 175.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.451 HD11 HG22 ' A' ' 38' ' ' VAL . 36.7 tp -82.23 106.31 14.02 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.951 174.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 53.1 m -96.15 134.04 39.71 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 173.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.673 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 67.2 t -121.96 146.46 27.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.097 -177.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.565 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 12.9 t -94.74 106.53 18.52 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 174.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.655 ' O ' ' HB3' ' A' ' 57' ' ' ARG . 1.0 OUTLIER -147.06 138.75 24.24 Favored 'General case' 0 C--O 1.207 -1.166 0 C-N-CA 118.564 -1.254 . . . . 0.0 110.989 176.075 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.5 p30 37.66 47.48 0.82 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -175.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.5 m 58.47 44.33 18.2 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 122.279 1.038 . . . . 0.0 109.907 176.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.655 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 8.7 ttp180 -157.84 67.41 0.49 Allowed 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.705 -1.589 . . . . 0.0 110.71 -154.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.673 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 5.0 t -69.98 99.53 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.893 0.854 . . . . 0.0 108.901 -170.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.437 ' HB2' ' CE2' ' A' ' 61' ' ' TYR . 7.9 m -84.19 122.58 29.06 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 113.799 -1.546 . . . . 0.0 111.157 -172.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 60.0 m-70 -93.39 101.95 14.18 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.968 0.413 . . . . 0.0 111.982 -174.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.486 ' HB3' ' CD1' ' A' ' 73' ' ' ILE . 65.1 m-85 -99.91 105.42 17.14 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.805 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.818 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 61.6 mt -80.7 129.53 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -173.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.565 HG13 ' HB ' ' A' ' 73' ' ' ILE . 3.8 mp -98.8 119.09 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.129 0.572 . . . . 0.0 110.424 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.606 ' O ' ' HA ' ' A' ' 71' ' ' PHE . 4.3 m120 -89.25 139.44 30.49 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.405 -169.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.1 t -88.34 92.06 9.03 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 171.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.634 HD11 ' HG3' ' A' ' 70' ' ' ARG . 84.8 mt -79.83 138.96 53.77 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.576 -178.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.99 -7.98 16.85 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.949 2.433 . . . . 0.0 112.118 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -90.21 20.22 4.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.758 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.588 ' HE ' ' HA ' ' A' ' 69' ' ' ARG . 0.3 OUTLIER 65.78 30.52 10.09 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.247 0.546 . . . . 0.0 111.089 177.362 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.634 ' HG3' HD11 ' A' ' 66' ' ' LEU . 3.8 ptp180 -138.66 -177.03 4.69 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.444 -178.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.606 ' HA ' ' O ' ' A' ' 64' ' ' ASN . 47.8 m-85 -124.06 157.87 33.51 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.264 -178.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.55 ' HB2' HD12 ' A' ' 66' ' ' LEU . 35.1 ttpt -138.69 100.49 4.09 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 175.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.818 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 3.9 tt -89.28 108.25 18.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.442 0.639 . . . . 0.0 110.666 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.09 37.88 94.69 Favored Glycine 0 C--N 1.321 -0.265 0 CA-C-N 115.175 -0.921 . . . . 0.0 112.366 176.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.423 ' HA ' ' HE3' ' A' ' 72' ' ' LYS . 17.5 t70 77.75 6.2 2.84 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.607 0.763 . . . . 0.0 111.501 178.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -102.73 123.39 46.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.867 0.365 . . . . 0.0 110.308 171.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -94.04 134.38 36.52 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.697 0.761 . . . . 0.0 112.102 -175.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.558 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 51.0 m-85 -136.43 170.28 16.3 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 172.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -70.68 -54.66 11.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.136 0.493 . . . . 0.0 111.182 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.547 ' ND1' ' HG2' ' A' ' 82' ' ' PRO . 3.0 p80 -144.31 172.65 12.64 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.624 -174.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.541 HD21 HD22 ' A' ' 84' ' ' LEU . 16.2 mt -55.18 -52.75 68.71 Favored Pre-proline 0 N--CA 1.469 0.514 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.547 ' HG2' ' ND1' ' A' ' 80' ' ' HIS . 19.5 Cg_endo -60.52 -3.41 2.56 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.316 2.011 . . . . 0.0 113.597 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.37 -36.45 10.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.723 0.297 . . . . 0.0 110.896 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.558 ' HB3' ' CD2' ' A' ' 78' ' ' PHE . 4.4 pp -76.51 -34.84 58.59 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.048 0.451 . . . . 0.0 110.154 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 78.0 mt -62.22 -33.31 74.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.122 176.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.612 ' HA ' ' HD3' ' A' ' 89' ' ' LYS . 20.0 tp10 -73.9 -37.4 64.67 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.506 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.436 ' CD2' ' HZ ' ' A' ' 78' ' ' PHE . 23.1 t80 -64.28 -37.61 88.09 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.124 0.487 . . . . 0.0 110.67 177.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.688 ' CD1' HD22 ' A' ' 93' ' ' LEU . 36.1 m-85 -79.16 -6.52 56.74 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.92 0.39 . . . . 0.0 111.759 -178.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.612 ' HD3' ' HA ' ' A' ' 86' ' ' GLU . 53.7 mtpt -83.81 -8.56 59.19 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.384 172.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 21.8 pt -128.23 9.42 3.01 Favored 'Isoleucine or valine' 0 C--N 1.342 0.26 0 CA-C-O 121.549 0.69 . . . . 0.0 109.604 174.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.402 ' O ' ' HB2' ' A' ' 92' ' ' TYR . 3.3 t-160 -95.02 -47.2 6.5 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.244 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.432 ' CD2' HG21 ' A' ' 97' ' ' THR . 95.3 m-85 62.77 88.33 0.1 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.028 -161.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.688 HD22 ' CD1' ' A' ' 88' ' ' TYR . 13.7 mt -46.37 -65.14 0.6 Allowed 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 177.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.588 ' CG ' ' H ' ' A' ' 95' ' ' THR . 13.7 p-10 -98.86 -120.36 0.14 Allowed 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.249 172.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.588 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 4.6 t -94.11 6.15 49.49 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-O 120.963 0.411 . . . . 0.0 109.989 176.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.4 HG23 ' OD1' ' A' ' 94' ' ' ASP . 8.3 t -141.26 164.58 29.86 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.085 0.469 . . . . 0.0 110.706 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.432 HG21 ' CD2' ' A' ' 92' ' ' TYR . 9.1 p -99.61 174.53 6.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.62 178.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 82.3 mt -68.42 107.06 2.73 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 173.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.542 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 49.2 mm -91.55 -58.73 3.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.792 -174.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.602 ' O ' ' HA ' ' A' ' 35' ' ' MET . 11.9 pt-20 -159.02 153.23 19.97 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.176 -178.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.34 163.31 39.03 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 122.668 2.245 . . . . 0.0 113.364 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.406 ' HB1' ' HG2' ' A' ' 35' ' ' MET . . . -83.11 158.39 64.41 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.803 178.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -66.91 136.39 41.32 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.315 2.01 . . . . 0.0 111.151 173.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.514 ' HG2' ' SD ' ' A' ' 16' ' ' MET . 87.6 mtt180 -64.97 -38.69 91.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.815 0.34 . . . . 0.0 110.787 178.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.529 ' HB2' ' HD2' ' A' ' 106' ' ' PRO . 41.1 p90 -170.26 164.59 5.84 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.308 178.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.529 ' HD2' ' HB2' ' A' ' 105' ' ' TYR . 29.6 Cg_endo -64.88 79.37 0.19 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.414 2.076 . . . . 0.0 111.73 175.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.762 ' HB3' ' HD3' ' A' ' 108' ' ' PRO . 35.0 t -78.13 -57.47 0.93 Allowed Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.964 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.762 ' HD3' ' HB3' ' A' ' 107' ' ' SER . 10.3 Cg_exo -71.47 125.16 10.97 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 121.746 1.631 . . . . 0.0 111.916 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -66.63 -30.01 42.94 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.288 1.992 . . . . 0.0 111.056 175.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 25.3 ptm -141.5 145.89 35.75 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.754 177.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 97.0 11.8 51.79 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.079 178.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.3 m -82.85 101.19 10.82 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.026 0.441 . . . . 0.0 109.993 177.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 43.3 t -66.2 100.45 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.777 178.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 17.7 m -109.34 77.15 1.04 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.659 178.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -112.77 102.06 53.95 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.822 -178.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.597 ' HA ' ' O ' ' A' ' 31' ' ' GLN . 80.6 Cg_endo -85.2 126.06 3.14 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.74 2.293 . . . . 0.0 111.751 176.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.445 HD22 ' HB2' ' A' ' 33' ' ' HIS . 25.3 p-10 -89.35 72.7 8.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.974 0.892 . . . . 0.0 111.095 -177.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.402 ' HA ' HD23 ' A' ' 118' ' ' LEU . 0.4 OUTLIER 60.13 89.75 0.1 Allowed Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 113.672 -1.604 . . . . 0.0 112.017 176.04 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -89.58 134.57 2.37 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.327 2.685 . . . . 0.0 111.987 174.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 45.4 m -155.14 97.09 1.89 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 176.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' A' ' 122' ' ' GLU . . . -112.83 -162.9 0.82 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.1 -176.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 121' ' ' ALA . 42.1 mt-10 72.51 29.24 2.11 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.829 0.705 . . . . 0.0 110.677 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -91.54 -173.43 3.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.294 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.734 ' O ' HD23 ' A' ' 125' ' ' LEU . 10.5 m120 -123.32 140.5 52.95 Favored 'General case' 0 C--O 1.211 -0.948 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.87 178.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.734 HD23 ' O ' ' A' ' 124' ' ' ASN . 0.3 OUTLIER 158.19 -162.08 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 102.41 -3.182 . . . . 0.0 102.41 -151.511 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.716 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 4.9 tp10 74.19 -73.23 0.1 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 118.501 0.591 . . . . 0.0 110.759 175.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -101.33 107.44 18.8 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 118.848 -1.141 . . . . 0.0 111.494 -176.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 1.056 HG21 ' HG3' ' A' ' 180' ' ' LYS . 97.3 t -124.87 136.37 61.02 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.078 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.298 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.592 ' NH1' ' HB2' ' A' ' 181' ' ' LEU . 0.0 OUTLIER -111.18 151.37 28.29 Favored 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 117.376 -1.73 . . . . 0.0 108.33 167.925 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.693 ' HG1' ' CD ' ' A' ' 148' ' ' GLU . 0.9 OUTLIER -107.77 134.26 50.98 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.882 0.849 . . . . 0.0 111.234 179.379 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.556 HD22 ' HG2' ' A' ' 179' ' ' GLU . 10.5 mt -110.21 2.39 19.28 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.61 -176.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.513 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 24.2 t80 -105.2 -39.62 6.13 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.103 -0.639 . . . . 0.0 112.614 -174.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.575 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 8.6 t70 79.05 98.47 0.06 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.444 0.64 . . . . 0.0 109.973 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.422 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 69.4 t80 -126.32 91.65 47.26 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 173.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.683 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 70.8 Cg_endo -86.24 83.61 1.22 Allowed 'Trans proline' 0 N--CA 1.442 -1.549 0 C-N-CA 121.675 1.583 . . . . 0.0 112.808 -178.171 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -76.58 -31.19 54.97 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.092 175.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.433 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 20.9 m120 63.46 49.85 3.02 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.247 0.546 . . . . 0.0 111.34 176.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -135.24 177.44 7.81 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.779 176.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 170' ' ' VAL . . . -91.57 -10.96 38.65 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.674 0.75 . . . . 0.0 109.583 172.232 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.681 ' O ' ' HB2' ' A' ' 172' ' ' MET . 45.3 mt-10 -109.23 -2.83 17.68 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.066 176.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -143.5 100.96 3.7 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 174.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.779 ' CD1' ' HB2' ' A' ' 165' ' ' ASN . 52.9 tp -70.6 132.1 87.57 Favored Pre-proline 0 CA--C 1.51 -0.581 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.351 -175.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.683 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 73.2 Cg_endo -83.07 93.53 0.85 Allowed 'Trans proline' 0 N--CA 1.436 -1.885 0 C-N-CA 120.931 1.088 . . . . 0.0 111.761 170.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.612 ' HB2' ' OG1' ' A' ' 130' ' ' THR . 17.2 p90 -102.78 164.18 11.78 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.919 ' H ' ' HG3' ' A' ' 148' ' ' GLU . 2.9 mptp? -114.57 -148.51 0.43 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.119 0.485 . . . . 0.0 111.769 -171.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.751 ' H ' ' HD2' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -109.44 41.29 1.69 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.256 -179.648 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 147.89 28.88 0.07 OUTLIER Glycine 0 CA--C 1.525 0.716 0 C-N-CA 120.723 -0.751 . . . . 0.0 113.435 177.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.919 ' HG3' ' H ' ' A' ' 145' ' ' LYS . 0.0 OUTLIER -80.83 172.78 13.31 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 123.871 0.868 . . . . 0.0 109.732 171.319 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.523 HD12 ' HB3' ' A' ' 129' ' ' ARG . 0.6 OUTLIER -115.92 129.28 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.584 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.715 HD23 ' CD2' ' A' ' 142' ' ' LEU . 27.0 mt -120.76 157.27 30.07 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -173.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.716 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 70.7 t -130.78 123.15 53.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.577 177.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.55 HG21 HD11 ' A' ' 125' ' ' LEU . 40.8 mm -75.91 84.36 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 122.109 0.957 . . . . 0.0 109.706 -172.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.539 ' C ' HH12 ' A' ' 57' ' ' ARG . 14.0 tt -87.42 -31.89 6.08 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 CA-C-N 114.043 -1.435 . . . . 0.0 111.605 -169.075 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.654 ' HA ' HH22 ' A' ' 57' ' ' ARG . 10.8 mt-10 -122.49 142.27 50.76 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 164.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -137.43 87.6 17.73 Favored Pre-proline 0 C--N 1.316 -0.86 0 CA-C-O 121.314 0.578 . . . . 0.0 110.627 176.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.549 ' HG2' ' HE1' ' A' ' 172' ' ' MET . 17.5 Cg_exo -71.24 -54.52 0.16 Allowed 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.683 2.255 . . . . 0.0 111.826 170.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.422 ' HG2' ' HB2' ' A' ' 156' ' ' PRO . 6.5 mm-40 -112.53 -176.58 2.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.815 -169.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -109.87 -8.9 14.82 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.231 173.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -96.13 -32.28 12.58 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.513 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.41 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 28.7 m95 -127.19 144.02 51.13 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.082 174.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . 0.752 ' O ' HG13 ' A' ' 173' ' ' ILE . 20.7 m0 -126.71 139.92 52.79 Favored 'General case' 0 C--O 1.213 -0.835 0 CA-C-O 121.032 0.444 . . . . 0.0 111.126 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.533 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 19.6 m -97.51 94.55 7.08 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -175.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.533 ' HB2' ' HB3' ' A' ' 150' ' ' LEU . . . -109.18 152.25 25.4 Favored 'General case' 0 N--CA 1.428 -1.574 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.135 -173.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.84 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 27.5 ptt-85 -87.42 123.82 32.76 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 172.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.779 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . 66.1 t30 -59.01 -178.2 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.259 -1.337 . . . . 0.0 110.957 -172.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.605 ' HB2' ' HB2' ' A' ' 148' ' ' GLU . 37.8 tttp -66.77 -12.15 57.64 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.222 168.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -73.59 -21.25 60.39 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.412 167.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 77.47 35.13 37.92 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.005 -168.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.84 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 2.9 ttm-85 -113.47 137.65 51.24 Favored 'General case' 0 C--O 1.213 -0.845 0 C-N-CA 122.779 0.431 . . . . 0.0 110.937 -176.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.496 HG21 HG23 ' A' ' 153' ' ' ILE . 38.9 t -78.17 128.98 38.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 118.146 0.43 . . . . 0.0 111.777 -177.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -164.49 155.95 27.61 Favored Glycine 0 C--N 1.339 0.708 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.612 167.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.681 ' HB2' ' O ' ' A' ' 140' ' ' GLU . 0.6 OUTLIER -74.95 142.83 43.9 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 117.144 0.472 . . . . 0.0 111.291 178.817 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.752 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.4 pp -143.67 141.04 18.08 Favored Pre-proline 0 N--CA 1.452 -0.336 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.715 -176.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.436 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 18.5 Cg_exo -66.38 127.09 16.7 Favored 'Trans proline' 0 C--N 1.34 0.125 0 C-N-CA 122.468 2.112 . . . . 0.0 112.546 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.619 ' O ' HG22 ' A' ' 178' ' ' VAL . 96.2 t -61.94 -40.99 73.84 Favored Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 11.5 Cg_endo -56.88 -15.81 18.13 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 121.974 1.783 . . . . 0.0 113.221 175.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.436 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.2 m-30 -88.71 -8.04 55.23 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -177.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.649 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 3.3 m -105.59 -170.89 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 115.896 1.813 . . . . 0.0 115.896 -164.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.562 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 7.7 tp10 -159.89 49.98 0.3 Allowed 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 112.956 -1.929 . . . . 0.0 112.705 -152.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 1.056 ' HG3' HG21 ' A' ' 128' ' ' VAL . 3.5 mppt? -69.89 135.77 49.91 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 119.583 -1.948 . . . . 0.0 111.246 -161.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.592 ' HB2' ' NH1' ' A' ' 129' ' ' ARG . 16.5 tp -67.1 -97.74 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 112.956 -1.929 . . . . 0.0 113.582 -163.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.401 ' H ' ' HB3' ' A' ' 181' ' ' LEU . 22.2 m -79.67 37.29 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.54 0.686 . . . . 0.0 110.743 -175.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.717 HH12 ' HH2' ' A' ' 161' ' ' TRP . 50.0 ttt180 -93.76 135.01 35.5 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.724 -175.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 43.1 m -113.74 175.76 5.32 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.377 174.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 39.3 t -100.7 139.93 20.97 Favored Pre-proline 0 C--N 1.317 -0.823 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -63.97 88.14 0.15 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 123.003 2.469 . . . . 0.0 112.543 -178.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 51.2 m80 -91.7 -19.44 22.63 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.819 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 117.98 -74.68 0.29 Allowed Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -177.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -100.28 68.59 1.43 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.167 0.508 . . . . 0.0 110.669 177.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -130.28 75.99 1.69 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 173.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -162.81 70.66 0.21 Allowed Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.005 -177.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -92.29 -43.27 9.37 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 68.4 mtt85 63.99 179.54 0.17 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.009 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -130.94 -33.7 1.54 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.363 -178.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 17.5 m -117.82 136.11 53.63 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.789 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -64.39 133.17 52.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.053 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 36.4 m -75.35 84.33 2.48 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.178 0.513 . . . . 0.0 110.177 175.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -107.45 -19.18 13.65 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.204 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 148.46 -104.29 0.28 Allowed Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 -178.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.48 ' HA ' ' HD3' ' A' ' 201' ' ' PRO . 19.0 pt -105.98 112.82 64.18 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-O 121.13 0.49 . . . . 0.0 110.314 175.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 200' ' ' ILE . 12.2 Cg_exo -71.22 -50.04 0.34 Allowed 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.75 2.3 . . . . 0.0 112.976 -177.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 201' ' ' PRO . 18.0 mm-40 68.71 114.87 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.305 0 O-C-N 123.893 0.746 . . . . 0.0 110.62 -172.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -62.61 124.52 14.3 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.528 2.152 . . . . 0.0 111.472 179.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . 60.06 52.65 5.01 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.882 -177.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -75.42 -16.35 60.36 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.442 0.639 . . . . 0.0 109.466 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -141.48 112.71 7.45 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.153 174.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -90.0 14.88 11.13 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.376 -176.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . 71.56 121.45 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 O-C-N 124.039 0.837 . . . . 0.0 112.965 171.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 87.7 mm-40 -110.18 156.0 40.88 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.611 174.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.88 -61.73 0.47 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.887 2.392 . . . . 0.0 112.876 -177.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . 0.416 ' O ' ' HG3' ' A' ' 211' ' ' GLN . 9.0 tp-100 61.38 26.67 16.43 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.877 0.846 . . . . 0.0 109.548 -177.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 16.8 p -97.22 102.8 14.65 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.595 -176.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 28.0 m -115.76 91.84 3.72 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.743 177.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.801 ' HB ' ' HD3' ' A' ' 215' ' ' PRO . 85.1 m -79.1 -57.05 0.78 Allowed Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.701 -177.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.801 ' HD3' ' HB ' ' A' ' 214' ' ' THR . 6.5 Cg_exo -73.15 94.82 0.82 Allowed 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 121.843 1.695 . . . . 0.0 111.35 176.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 9.5 tt -105.93 107.41 59.53 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.148 -178.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -84.09 104.92 1.09 Allowed 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.089 2.526 . . . . 0.0 111.785 177.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -112.33 -31.02 6.97 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.157 0.503 . . . . 0.0 110.146 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 24.3 m -96.06 137.27 24.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.532 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 16.0 p -129.33 80.86 1.99 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.408 0.623 . . . . 0.0 110.827 177.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -112.2 179.59 19.52 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.504 178.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.599 ' HB2' ' HD3' ' A' ' 223' ' ' PRO . 68.3 m -157.06 -53.78 0.02 OUTLIER Pre-proline 0 C--N 1.323 -0.553 0 CA-C-O 119.483 -0.294 . . . . 0.0 111.523 -179.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.599 ' HD3' ' HB2' ' A' ' 222' ' ' SER . 76.8 Cg_exo -52.2 -53.08 7.54 Favored 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 122.411 2.074 . . . . 0.0 113.251 -177.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 76.01 -67.67 2.37 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.783 -177.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -97.08 140.71 31.18 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 176.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -93.35 154.83 17.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.51 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 11.6 pt -59.67 100.79 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.313 0.577 . . . . 0.0 110.543 177.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' THR . . . . . 0.648 ' HB ' ' HD3' ' A' ' 229' ' ' PRO . 5.3 m -91.41 -55.19 0.26 Allowed Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.448 -173.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.648 ' HD3' ' HB ' ' A' ' 228' ' ' THR . 13.2 Cg_exo -70.23 91.2 0.56 Allowed 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 122.399 2.066 . . . . 0.0 112.992 -176.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 95.4 mt -106.56 124.15 36.52 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 173.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -57.5 -67.75 0.06 OUTLIER 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.84 2.36 . . . . 0.0 112.578 -176.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 35.9 m -151.04 67.41 0.92 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.032 0.444 . . . . 0.0 110.726 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' THR . . . . . 0.424 ' HB ' ' ND2' ' A' ' 235' ' ' ASN . 39.7 p -143.5 116.6 8.91 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.47 177.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -90.15 31.56 0.98 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 177.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . 0.424 ' ND2' ' HB ' ' A' ' 233' ' ' THR . 30.5 p30 -114.88 164.06 14.66 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.275 -171.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 165.37 -170.33 40.24 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.227 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -70.69 105.32 1.61 Allowed 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.409 2.073 . . . . 0.0 111.031 177.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.452 ' HB ' ' CG1' ' A' ' 266' ' ' VAL . 2.5 t -75.9 138.13 21.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.415 -175.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -112.57 121.29 44.36 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.784 0.326 . . . . 0.0 110.927 -178.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.521 ' HB3' HD11 ' A' ' 293' ' ' ILE . . . -120.15 137.8 53.96 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.636 177.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.486 ' HB2' ' CE1' ' A' ' 294' ' ' PHE . 11.6 tppt? -80.94 123.53 28.39 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.656 177.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -75.45 102.9 5.36 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 174.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 290' ' ' HIS . 18.6 pt -88.15 -7.17 10.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.245 0.545 . . . . 0.0 110.783 -176.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.524 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 2.3 tt0 -138.66 142.89 39.03 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.231 175.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.467 ' HE3' ' OE2' ' A' ' 259' ' ' GLU . 1.5 ptpp? -68.65 174.16 4.5 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 174.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.859 ' HG3' ' HE1' ' A' ' 290' ' ' HIS . 0.0 OUTLIER -166.57 136.43 3.15 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.187 -179.77 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 24.6 m -127.8 150.29 72.9 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.304 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.526 ' HD3' ' HB3' ' A' ' 257' ' ' ALA . 58.0 Cg_endo -72.41 149.08 49.83 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.477 2.118 . . . . 0.0 112.631 -179.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' CYS . . . . . 0.533 ' HB3' ' HB2' ' A' ' 252' ' ' ASP . 25.0 t -95.95 165.97 12.01 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 177.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -55.3 -39.77 70.3 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.114 0.483 . . . . 0.0 111.446 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -102.43 15.74 28.34 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.167 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.533 ' HB2' ' HB3' ' A' ' 249' ' ' CYS . 1.7 m-20 -124.6 85.59 2.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.039 0.447 . . . . 0.0 110.334 177.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -86.56 -22.85 26.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.876 -179.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 4.0 p -89.87 5.01 48.13 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.259 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.461 ' HB1' ' HB3' ' A' ' 252' ' ' ASP . . . -82.57 109.43 16.76 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.565 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.418 ' HA ' ' NH1' ' A' ' 282' ' ' ARG . 0.6 OUTLIER -66.0 137.34 57.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.456 -177.524 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.526 ' HB3' ' HD3' ' A' ' 248' ' ' PRO . . . -98.18 129.13 44.96 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.673 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 84.2 mt -136.71 162.51 32.98 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.512 -174.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.467 ' OE2' ' HE3' ' A' ' 245' ' ' LYS . 65.7 mm-40 -127.26 165.79 18.99 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 172.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 62.1 t -70.71 123.04 23.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.145 0.498 . . . . 0.0 110.956 -178.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 107.81 0.48 34.23 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.201 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -84.73 142.98 29.46 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.003 0.43 . . . . 0.0 110.713 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 48.6 mm -100.02 110.12 26.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.084 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 33.3 t -86.4 109.45 18.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.689 -177.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 27.8 tttm -84.46 94.67 8.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.923 175.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.452 ' CG1' ' HB ' ' A' ' 238' ' ' VAL . 3.6 p -93.32 117.56 37.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.33 0.586 . . . . 0.0 110.454 -178.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 1.2 p -95.9 -35.21 11.54 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.615 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 13.0 ttp180 -115.89 122.12 44.4 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 177.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' MET . . . . . 0.449 ' HE3' ' CE3' ' A' ' 275' ' ' TRP . 32.4 mtt -106.49 125.08 50.55 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.189 0.519 . . . . 0.0 110.981 178.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 274' ' ' GLN . 87.6 m-20 -89.69 134.04 34.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.767 -179.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.443 ' H ' HG13 ' A' ' 271' ' ' ILE . 2.3 pp -74.45 9.5 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -173.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . 0.928 HD22 ' HG2' ' A' ' 274' ' ' GLN . 1.7 p-10 -97.95 -24.55 15.33 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 122.299 -0.25 . . . . 0.0 111.172 -178.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 135.4 -37.25 1.94 Allowed Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.151 -1.023 . . . . 0.0 113.222 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.928 ' HG2' HD22 ' A' ' 272' ' ' ASN . 18.9 pt20 -95.6 118.27 31.99 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 177.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.449 ' CE3' ' HE3' ' A' ' 269' ' ' MET . 20.3 m0 -95.2 166.95 11.66 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.293 -173.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -99.64 99.09 9.89 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.106 -178.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -108.74 153.26 16.87 Favored Glycine 0 C--O 1.224 -0.528 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.382 -175.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.656 ' HG2' ' HE2' ' A' ' 283' ' ' LYS . 21.2 mt-10 -119.83 108.46 14.41 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -178.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 50.9 t -138.05 132.64 43.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.613 -176.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 64.14 24.07 13.35 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.975 0.417 . . . . 0.0 110.965 176.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 86.47 -2.88 87.44 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.272 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . 0.418 ' NH1' ' HA ' ' A' ' 256' ' ' LEU . 0.6 OUTLIER -117.57 131.48 56.68 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.956 0.408 . . . . 0.0 109.937 -176.503 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.656 ' HE2' ' HG2' ' A' ' 278' ' ' GLU . 15.7 ptpt -113.08 142.32 45.88 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.977 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -168.04 -174.24 36.74 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.481 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.442 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 86.0 mt -88.05 136.04 33.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.245 0.545 . . . . 0.0 111.92 -177.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -138.94 127.86 14.06 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.979 174.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . 0.845 ' HD2' ' HE2' ' A' ' 290' ' ' HIS . 11.6 Cg_exo -73.48 151.35 47.53 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.925 2.417 . . . . 0.0 111.78 175.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -73.08 -1.6 18.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.135 0.493 . . . . 0.0 111.765 -178.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 3.4 m -64.63 -42.21 95.63 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.731 -176.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . 0.859 ' HE1' ' HG3' ' A' ' 246' ' ' ARG . 0.3 OUTLIER -110.63 12.31 22.7 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -174.852 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 22.3 m -129.33 149.94 34.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 172.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -139.36 136.12 34.43 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.738 0.304 . . . . 0.0 110.559 177.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.521 HD11 ' HB3' ' A' ' 240' ' ' ALA . 1.1 mp -76.85 141.39 15.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.89 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' PHE . . . . . 0.564 ' CE2' ' HA ' ' A' ' 296' ' ' PRO . 7.9 p90 -154.87 176.53 12.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.2 -179.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -91.47 104.28 9.63 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 173.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . 0.564 ' HA ' ' CE2' ' A' ' 294' ' ' PHE . 26.3 Cg_endo -63.29 -42.69 21.28 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.326 2.017 . . . . 0.0 112.776 -173.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . 0.456 ' HB3' HD22 ' A' ' 302' ' ' ASN . 27.6 mp0 -103.38 79.73 1.74 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.143 0.497 . . . . 0.0 110.162 176.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -63.97 136.47 96.75 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.538 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.03 -30.69 94.03 Favored 'Trans proline' 0 N--CA 1.466 -0.145 0 C-N-CA 122.378 2.052 . . . . 0.0 110.884 174.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -65.05 -26.49 68.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.549 177.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -99.01 -20.64 16.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.819 -175.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . 0.456 HD22 ' HB3' ' A' ' 297' ' ' GLN . 94.8 m-20 -86.14 -13.19 47.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.318 -177.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.492 -0.765 . . . . 0.0 110.185 177.8 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.8 mtm . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.4 m -107.68 -20.2 13.3 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.745 177.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.7 m 65.32 -71.3 0.08 Allowed 'General case' 0 N--CA 1.461 0.112 0 O-C-N 123.828 0.705 . . . . 0.0 109.807 -170.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -78.98 78.92 5.4 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.258 0.551 . . . . 0.0 110.28 177.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 18.7 tpp180 -99.61 86.79 3.41 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.357 0.598 . . . . 0.0 110.503 -176.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -167.52 143.39 4.08 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.991 -1.004 . . . . 0.0 108.798 175.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.4 ' C ' ' H ' ' A' ' 9' ' ' SER . 17.4 m-20 -72.48 -9.37 58.46 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -173.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.4 t 73.19 -29.52 0.2 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.267 0.627 . . . . 0.0 112.086 175.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.4 ' H ' ' C ' ' A' ' 7' ' ' ASP . 6.0 t -102.6 -19.21 14.92 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 122.067 -0.395 . . . . 0.0 111.016 179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -67.09 104.05 1.33 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.979 0.419 . . . . 0.0 111.003 -176.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -60.75 -37.67 82.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.872 -175.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.5 m -69.17 -5.47 22.73 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.802 -177.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.33 -47.52 6.57 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.895 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.471 ' HB3' ' HB3' ' A' ' 101' ' ' PRO . 41.9 p-90 -119.72 -20.46 7.64 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -169.538 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -72.16 108.43 5.33 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.131 0.491 . . . . 0.0 110.455 -175.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.647 ' SD ' ' HA ' ' A' ' 104' ' ' ARG . 9.2 tpp -90.84 -4.79 56.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.868 -174.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 50.02 -114.57 2.53 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-N 115.243 -0.89 . . . . 0.0 114.344 176.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -74.4 83.19 1.73 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.04 2.493 . . . . 0.0 113.368 -174.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.702 HG13 ' H ' ' A' ' 20' ' ' SER . 98.4 t -135.92 177.08 6.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.702 ' H ' HG13 ' A' ' 19' ' ' VAL . 57.3 p -149.36 177.53 9.59 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -168.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.5 ttt85 -63.69 -39.6 94.71 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.784 178.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 35.5 mm-40 -61.87 -64.02 1.07 Allowed 'General case' 0 C--O 1.235 0.318 0 O-C-N 123.38 0.425 . . . . 0.0 110.754 176.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.455 ' O ' ' HB ' ' A' ' 26' ' ' THR . 8.1 tp10 -56.77 -47.78 79.36 Favored 'General case' 0 C--O 1.217 -0.658 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.467 -176.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.69 -42.01 82.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.96 0.41 . . . . 0.0 111.79 -177.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.436 ' NE2' ' HG2' ' A' ' 29' ' ' GLN . 23.1 tm0? -68.11 -32.52 72.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.55 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.455 ' HB ' ' O ' ' A' ' 23' ' ' GLU . 4.2 m -65.23 -43.4 91.55 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.661 176.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.423 ' HG2' ' O ' ' A' ' 23' ' ' GLU . 42.0 mmm-85 -72.85 -20.75 61.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.518 -173.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.595 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 88.6 mt -126.83 17.4 7.37 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.059 -171.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.436 ' HG2' ' NE2' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -69.49 76.53 0.4 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.476 0.655 . . . . 0.0 109.475 178.916 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.7 -66.72 3.86 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.4 -176.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.508 ' CD ' ' HE2' ' A' ' 35' ' ' MET . 30.2 tt0 27.55 -99.12 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.208 1.003 . . . . 0.0 112.536 -166.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.58 ' HB2' ' SD ' ' A' ' 35' ' ' MET . 47.6 mtm105 -112.76 -6.77 13.84 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -176.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 49.7 m170 67.49 155.12 0.1 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.229 0.538 . . . . 0.0 111.132 -175.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.14 10.87 84.28 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 121.085 -0.578 . . . . 0.0 111.824 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.594 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 41.4 mtp -103.97 145.82 29.59 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -177.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.447 ' CG ' HD21 ' A' ' 98' ' ' LEU . 33.5 p90 -146.26 164.32 32.68 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.694 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.516 ' HG ' HD11 ' A' ' 28' ' ' LEU . 4.3 pp -152.72 137.16 16.72 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.847 174.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.4 t -101.95 114.37 41.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 173.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.572 ' HG3' ' O ' ' A' ' 40' ' ' ASP . 24.2 ptt-85 -116.09 176.5 5.07 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.7 -172.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.572 ' O ' ' HG3' ' A' ' 39' ' ' ARG . 10.6 t70 -58.66 132.28 53.37 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 166.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.513 ' HA ' HG21 ' A' ' 49' ' ' VAL . 44.5 t -44.37 -48.66 9.77 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 123.674 0.609 . . . . 0.0 112.223 -174.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.1 t 72.73 -1.66 2.93 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.979 0.799 . . . . 0.0 109.81 -175.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.411 ' H ' ' C ' ' A' ' 41' ' ' SER . 23.4 m -111.51 -37.09 5.33 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.712 175.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 45.3 t -147.2 122.84 5.37 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.306 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -61.95 122.12 10.49 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.94 2.426 . . . . 0.0 112.857 -178.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.94 -31.81 7.0 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.742 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.4 ' C ' ' HB2' ' A' ' 41' ' ' SER . 4.7 m-20 -87.81 174.96 8.06 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -133.28 169.66 16.59 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 122.284 -0.26 . . . . 0.0 111.049 -177.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.513 HG21 ' HA ' ' A' ' 41' ' ' SER . 90.3 t -143.01 117.28 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 121.29 0.566 . . . . 0.0 110.632 174.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.441 ' CB ' HD13 ' A' ' 63' ' ' ILE . 28.3 tp -85.04 108.48 17.65 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.885 178.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.7 m -96.39 137.26 35.72 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 174.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.691 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 91.3 t -130.76 134.24 62.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.632 0.253 . . . . 0.0 111.444 -175.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.595 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 40.8 t -94.93 114.66 26.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.208 -175.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.659 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 8.6 tp10 -159.45 153.56 23.51 Favored 'General case' 0 C--O 1.21 -0.991 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 164.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.618 ' HB2' ' CG ' ' A' ' 57' ' ' ARG . 63.2 m-80 61.4 17.36 8.3 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 179.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.2 m 55.22 55.54 7.43 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 122.59 1.186 . . . . 0.0 108.19 -170.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.737 HH21 ' HA ' ' A' ' 154' ' ' GLU 0.282 0.0 OUTLIER -163.24 67.73 0.2 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 113.227 -1.806 . . . . 0.0 109.883 -153.69 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.691 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 5.2 t -73.64 102.57 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.316 -1.311 . . . . 0.0 110.26 -173.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.632 ' HG ' ' CZ ' ' A' ' 57' ' ' ARG . 71.6 m -78.38 122.46 25.8 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.174 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 45.3 m-70 -93.14 102.97 15.28 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.971 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.553 ' HB3' ' CD1' ' A' ' 73' ' ' ILE . 70.0 m-85 -97.99 105.07 17.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.591 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 54.8 mt -80.47 127.77 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -174.003 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.577 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 3.5 mp -115.44 112.01 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 120.82 0.343 . . . . 0.0 110.22 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -87.4 148.29 25.07 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.415 -176.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.8 t -87.83 109.19 19.56 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 175.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.3 mt -81.52 143.25 50.99 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -62.14 -11.54 22.46 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.44 2.094 . . . . 0.0 110.915 175.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -76.24 0.51 18.93 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.421 176.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.34 21.78 9.7 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.559 -174.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -115.96 175.0 5.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.82 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.577 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 64.8 m-85 -130.76 132.19 45.16 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.962 0.411 . . . . 0.0 111.21 -176.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -121.88 122.41 39.36 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.996 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.59 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 7.5 tt -108.42 109.25 27.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.502 0.668 . . . . 0.0 111.218 -174.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.03 -94.37 0.37 Allowed Glycine 0 CA--C 1.519 0.329 0 CA-C-N 115.431 -0.804 . . . . 0.0 113.136 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -121.2 -11.04 8.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.332 0.587 . . . . 0.0 110.323 -176.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -108.86 126.07 52.66 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.382 0.61 . . . . 0.0 110.784 -176.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.35 135.1 37.39 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.64 178.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.464 ' HE2' ' CG2' ' A' ' 73' ' ' ILE . 93.4 m-85 -126.38 178.43 5.85 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -71.18 -43.06 68.21 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.284 -178.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.43 ' ND1' ' HG2' ' A' ' 82' ' ' PRO . 16.4 p80 -165.97 -179.43 5.21 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.742 -178.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.611 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 10.0 mt -57.33 -62.18 5.76 Favored Pre-proline 0 N--CA 1.471 0.585 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -175.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.43 ' HG2' ' ND1' ' A' ' 80' ' ' HIS . 19.8 Cg_endo -63.99 1.24 1.6 Allowed 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 121.702 1.602 . . . . 0.0 113.483 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.97 -36.38 14.13 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.844 0.354 . . . . 0.0 110.323 177.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.611 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.1 pp -76.68 -32.69 58.07 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.465 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 80.0 mt -63.45 -28.7 70.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.857 176.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.9 tp10 -77.8 -38.72 45.94 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.758 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -64.88 -37.4 87.51 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.421 0.629 . . . . 0.0 110.884 178.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.635 ' CG ' HD22 ' A' ' 93' ' ' LEU . 30.3 m-85 -80.55 -2.75 47.52 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.958 -176.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 85' ' ' LEU . 97.5 mttt -69.9 -27.02 64.45 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.889 174.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.4 pp -120.1 9.0 6.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.889 179.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 -90.6 -39.89 12.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.627 -178.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.467 ' HD2' ' C ' ' A' ' 95' ' ' THR . 82.0 m-85 67.51 84.86 0.15 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.173 -169.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.687 ' HA ' ' OE2' ' A' ' 154' ' ' GLU . 5.8 mt -56.39 -20.79 21.1 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 122.241 1.02 . . . . 0.0 111.007 178.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.546 ' OD1' HG21 ' A' ' 96' ' ' THR . 0.1 OUTLIER -134.78 -68.41 0.54 Allowed 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.003 -1.453 . . . . 0.0 109.063 -179.666 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.754 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 8.8 t -177.64 15.93 0.0 OUTLIER 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 114.198 -1.364 . . . . 0.0 108.548 174.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.546 HG21 ' OD1' ' A' ' 94' ' ' ASP . 4.9 t -129.58 -28.48 2.27 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.492 ' O ' HG23 ' A' ' 96' ' ' THR . 12.8 p 78.82 -179.52 0.11 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.964 1.306 . . . . 0.0 110.805 -175.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.447 HD21 ' CG ' ' A' ' 36' ' ' PHE . 89.9 mt -78.77 89.62 4.63 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.804 177.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 50.2 mm -75.6 -54.44 13.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.723 -177.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.594 ' O ' ' HA ' ' A' ' 35' ' ' MET . 15.5 pt-20 -157.22 152.72 22.18 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.561 -177.406 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.471 ' HB3' ' HB3' ' A' ' 14' ' ' TRP . 72.8 Cg_endo -76.06 148.58 31.47 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.262 1.975 . . . . 0.0 112.135 176.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.495 ' HB1' HD21 ' A' ' 28' ' ' LEU . . . -73.04 146.05 86.9 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.206 178.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.49 124.18 15.25 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.465 2.11 . . . . 0.0 111.232 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.647 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 34.8 ptt180 -79.36 22.34 0.44 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -172.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.447 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 85.6 t80 -105.52 108.62 61.87 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 171.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.458 ' C ' ' HD3' ' A' ' 108' ' ' PRO . 3.9 Cg_exo -80.23 119.99 3.99 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.934 2.422 . . . . 0.0 112.475 -178.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 40.0 p -126.66 64.74 58.71 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 172.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.458 ' HD3' ' C ' ' A' ' 106' ' ' PRO . 77.8 Cg_endo -98.49 146.26 0.6 Allowed 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 123.145 2.563 . . . . 0.0 113.769 -171.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -83.83 -9.46 9.85 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.422 2.081 . . . . 0.0 110.637 168.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 51.3 ttp 58.84 91.8 0.04 OUTLIER 'General case' 0 C--O 1.232 0.14 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.775 -175.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 166.83 133.59 1.55 Allowed Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.294 -177.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 21.6 t -92.53 122.87 35.38 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.674 0.274 . . . . 0.0 110.645 -177.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.4 t -75.42 -53.19 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.064 0.459 . . . . 0.0 109.858 175.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 17.4 t -142.74 153.05 42.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.303 174.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.453 ' O ' ' HB2' ' A' ' 121' ' ' ALA . . . -158.62 98.47 1.72 Allowed Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.161 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.423 ' HG2' ' HB2' ' A' ' 57' ' ' ARG . 31.6 Cg_exo -59.12 -39.37 80.01 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.547 2.165 . . . . 0.0 112.618 -178.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.701 ' HA ' ' HG3' ' A' ' 126' ' ' GLU . 0.1 OUTLIER -63.75 162.38 13.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.12 -175.447 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.616 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 91.1 mt 80.67 156.99 0.13 Allowed Pre-proline 0 N--CA 1.469 0.508 0 O-C-N 124.08 0.862 . . . . 0.0 111.458 176.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.616 ' HD2' ' HB3' ' A' ' 118' ' ' LEU . 37.7 Cg_exo -29.19 -64.11 0.08 OUTLIER 'Trans proline' 0 C--N 1.361 1.218 0 C-N-CA 125.23 3.953 . . . . 0.0 115.173 -172.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 22.5 m -154.1 97.44 2.05 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.874 0.369 . . . . 0.0 110.368 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.453 ' HB2' ' O ' ' A' ' 115' ' ' ALA . . . -128.61 19.1 6.23 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.818 176.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.537 ' HB3' ' O ' ' A' ' 188' ' ' GLY . 15.6 mm-40 75.28 -171.15 0.1 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.708 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.1 t0 68.79 171.15 0.29 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.535 -177.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -101.23 160.71 14.17 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -169.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.566 ' HG ' ' HD2' ' A' ' 155' ' ' LYS . 4.6 mm? 67.2 103.05 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.779 171.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.759 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 0.6 OUTLIER -178.35 -72.44 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.033 -1.44 . . . . 0.0 107.858 179.59 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.492 ' H ' ' HD3' ' A' ' 193' ' ' ARG . 70.8 m-85 -96.95 107.45 19.98 Favored 'General case' 0 CA--C 1.495 -1.148 0 C-N-CA 119.199 -1.0 . . . . 0.0 110.569 -179.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.997 HG23 ' HG3' ' A' ' 180' ' ' LYS . 89.4 t -124.16 126.67 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 CA-C-N 114.55 -1.205 . . . . 0.0 109.301 175.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.671 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 6.5 ptp180 -107.52 142.79 36.85 Favored 'General case' 0 N--CA 1.435 -1.175 0 C-N-CA 117.528 -1.669 . . . . 0.0 108.093 171.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.49 ' HB ' ' CD1' ' A' ' 144' ' ' PHE . 0.8 OUTLIER -102.58 127.4 49.68 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.873 -176.941 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.542 ' CD1' ' HB2' ' A' ' 179' ' ' GLU . 6.3 mt -100.21 -21.73 15.4 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.629 -174.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.421 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 30.1 t80 -81.17 -35.88 30.88 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.93 -171.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.578 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 13.6 t70 71.06 101.14 0.06 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.688 0.756 . . . . 0.0 110.562 -175.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 51.5 t80 -129.87 85.6 57.4 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 177.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.604 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 94.8 Cg_endo -82.17 80.43 2.81 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 121.896 1.731 . . . . 0.0 112.773 -178.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -75.97 -30.59 57.27 Favored Glycine 0 C--N 1.329 0.173 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.765 178.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 66.04 50.95 1.37 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.096 -0.552 . . . . 0.0 111.234 179.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -142.14 177.75 8.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.414 177.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.494 ' O ' ' HA2' ' A' ' 171' ' ' GLY . . . -92.71 -11.0 35.12 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.73 0.776 . . . . 0.0 109.136 172.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.429 ' O ' ' HB2' ' A' ' 172' ' ' MET . 44.9 mt-10 -91.95 -31.95 15.44 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.001 -0.999 . . . . 0.0 109.537 175.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -127.57 104.82 8.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.317 176.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.87 ' CD1' ' HD2' ' A' ' 169' ' ' ARG . 32.1 tp -65.42 129.52 94.42 Favored Pre-proline 0 C--N 1.327 -0.394 0 C-N-CA 120.562 -0.455 . . . . 0.0 109.977 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.604 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 72.6 Cg_endo -78.78 88.57 1.44 Allowed 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 121.541 1.494 . . . . 0.0 111.511 175.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.512 ' CE2' ' HB ' ' A' ' 173' ' ' ILE . 10.4 p90 -103.49 156.14 17.99 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.96 -174.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.578 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -96.85 -171.63 2.28 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.189 0.441 . . . . 0.0 112.189 -174.858 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.812 ' H ' ' HD2' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -92.81 33.05 1.17 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.942 -174.029 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 159.51 31.33 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.555 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.521 ' HB3' ' HB2' ' A' ' 145' ' ' LYS . 0.1 OUTLIER -101.01 152.71 20.25 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.663 -176.554 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.576 ' N ' HD13 ' A' ' 149' ' ' ILE . 1.7 mp -97.55 127.14 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-O 121.496 0.665 . . . . 0.0 109.802 -176.136 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.722 HD23 ' CD2' ' A' ' 142' ' ' LEU . 9.7 mt -121.63 157.71 30.21 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 -176.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.759 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 92.7 t -118.09 124.19 72.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 174.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.518 HG21 HD13 ' A' ' 125' ' ' LEU . 43.6 mm -75.93 79.66 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 122.024 0.916 . . . . 0.0 108.717 -177.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.482 HD11 ' CE1' ' A' ' 61' ' ' TYR . 18.4 tt -70.37 -29.7 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-N 114.005 -1.452 . . . . 0.0 109.76 -176.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.737 ' HA ' HH21 ' A' ' 57' ' ' ARG . 0.4 OUTLIER -131.44 141.72 49.87 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 172.152 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.566 ' HD2' ' HG ' ' A' ' 125' ' ' LEU . 81.4 tttt -134.77 87.83 29.64 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 172.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.754 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 2.3 Cg_endo -82.5 -37.78 0.2 Allowed 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.695 2.264 . . . . 0.0 111.8 176.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.598 ' HG2' ' CE ' ' A' ' 172' ' ' MET . 25.2 mm-40 -109.91 168.13 9.65 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.755 -174.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.499 ' O ' HG23 ' A' ' 175' ' ' VAL . 6.1 pt-20 -101.67 -16.86 16.55 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.462 178.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.403 ' C ' HG21 ' A' ' 175' ' ' VAL . 5.2 tp-100 -107.32 -11.72 15.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.163 0.506 . . . . 0.0 109.873 176.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -129.07 121.6 28.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.212 176.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . 0.684 ' O ' HG13 ' A' ' 173' ' ' ILE . 49.2 m0 -115.32 134.87 54.72 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.501 -178.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.563 ' HA ' ' HA ' ' A' ' 172' ' ' MET . 13.4 m -93.79 94.22 8.41 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -173.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.527 ' HB2' ' HB3' ' A' ' 150' ' ' LEU . . . -108.54 147.05 32.33 Favored 'General case' 0 N--CA 1.419 -1.998 0 C-N-CA 119.501 -0.88 . . . . 0.0 109.703 -171.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.829 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 15.8 ptt-85 -86.79 119.66 27.25 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 175.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.648 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . 18.1 t30 -53.34 177.69 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 113.724 -1.58 . . . . 0.0 110.865 -176.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -63.56 -15.31 57.68 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 168.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -69.28 -30.38 68.47 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.74 169.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 90.28 25.79 25.29 Favored Glycine 0 C--O 1.228 -0.259 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.16 -170.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.87 ' HD2' ' CD1' ' A' ' 142' ' ' LEU . 0.3 OUTLIER -105.06 138.14 41.72 Favored 'General case' 0 C--O 1.217 -0.608 0 C-N-CA 123.437 0.695 . . . . 0.0 111.331 -174.003 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.476 HG22 HG23 ' A' ' 153' ' ' ILE . 24.1 t -86.45 119.75 35.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -175.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 139' ' ' ALA . . . -152.49 148.94 20.44 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.696 170.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.598 ' CE ' ' HG2' ' A' ' 157' ' ' GLU . 59.6 mtp -78.43 142.48 37.51 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 117.663 0.731 . . . . 0.0 110.703 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.684 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.7 pp -140.54 145.47 40.78 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.9 -173.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.529 ' HB2' ' CD1' ' A' ' 177' ' ' TYR . 17.6 Cg_exo -68.41 129.87 19.93 Favored 'Trans proline' 0 N--CA 1.465 -0.149 0 C-N-CA 122.959 2.439 . . . . 0.0 113.104 -177.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.554 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 58.0 t -62.62 -42.22 77.68 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 29.0 Cg_endo -63.62 -5.16 8.14 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 121.951 1.767 . . . . 0.0 112.682 177.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.529 ' CD1' ' HB2' ' A' ' 174' ' ' PRO . 3.0 m-85 -91.95 -15.8 27.5 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.442 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.595 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 3.2 m -105.95 -174.04 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -163.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.671 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 3.5 tp10 -159.95 49.22 0.29 Allowed 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 113.071 -1.877 . . . . 0.0 112.454 -150.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.997 ' HG3' HG23 ' A' ' 128' ' ' VAL . 0.5 OUTLIER -69.27 170.73 9.68 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 118.937 -2.352 . . . . 0.0 111.308 -160.511 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 15.9 tp -100.28 114.71 28.39 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.767 -168.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 13.4 p 51.92 104.3 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 126.455 1.902 . . . . 0.0 114.158 -178.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.817 ' HB3' ' N ' ' A' ' 194' ' ' ASN . 0.2 OUTLIER -178.96 109.52 0.05 OUTLIER 'General case' 0 C--N 1.343 0.297 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.678 178.937 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.421 ' OG ' ' HE1' ' A' ' 187' ' ' HIS . 0.0 OUTLIER -69.26 -31.2 69.57 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.058 0.456 . . . . 0.0 111.469 176.349 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' SER . . . . . 0.802 ' HB2' ' HD2' ' A' ' 186' ' ' PRO . 21.2 p -176.03 -177.84 0.3 Allowed Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -174.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.802 ' HD2' ' HB2' ' A' ' 185' ' ' SER . 98.5 Cg_exo -43.73 -69.42 0.08 OUTLIER 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.377 2.052 . . . . 0.0 113.261 176.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.635 ' CD2' ' H ' ' A' ' 188' ' ' GLY . 1.0 OUTLIER 33.5 -89.3 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.303 1.041 . . . . 0.0 113.771 -175.487 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.635 ' H ' ' CD2' ' A' ' 187' ' ' HIS . . . 119.61 -54.16 0.65 Allowed Glycine 0 C--O 1.225 -0.464 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 -178.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 16.2 pttp -101.67 34.93 2.46 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.303 0.573 . . . . 0.0 110.731 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 60.0 t60 -162.94 38.15 0.1 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.132 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 135.95 160.67 8.93 Favored Glycine 0 CA--C 1.505 -0.564 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 -176.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . 0.646 ' HB3' ' CZ ' ' A' ' 193' ' ' ARG . 0.8 OUTLIER -101.97 -89.17 0.37 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.917 0.389 . . . . 0.0 111.532 -171.631 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.782 ' HG2' ' HB3' ' A' ' 180' ' ' LYS . 0.0 OUTLIER -149.28 134.73 18.46 Favored 'General case' 0 C--O 1.208 -1.098 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -177.633 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.891 ' HA ' ' HB2' ' A' ' 180' ' ' LYS . 34.6 t30 -171.74 156.71 4.37 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 118.315 0.507 . . . . 0.0 111.298 -175.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 16.4 m -103.28 -145.19 0.36 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 9.0 p30 41.13 40.03 1.02 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.693 0.797 . . . . 0.0 112.409 174.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 6.6 m -70.87 -13.75 62.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.56 -175.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -93.71 -9.87 36.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.163 0.506 . . . . 0.0 109.912 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 83.47 -124.31 6.52 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -171.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.633 HD12 ' HA ' ' A' ' 203' ' ' PRO . 10.2 tt -126.67 94.51 39.96 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-O 121.607 0.718 . . . . 0.0 110.017 172.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.66 -35.22 22.84 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.98 2.453 . . . . 0.0 112.456 -176.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -132.96 106.79 12.56 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.371 -177.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.633 ' HA ' HD12 ' A' ' 200' ' ' ILE . 34.1 Cg_exo -60.82 -60.49 0.24 Allowed 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 123.044 2.496 . . . . 0.0 112.648 -178.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -154.13 120.83 5.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.801 0.334 . . . . 0.0 110.562 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -97.78 105.25 17.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.045 -178.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . 71.27 -54.79 0.66 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.55 0.74 . . . . 0.0 111.943 179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -80.38 106.1 12.13 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.107 0.48 . . . . 0.0 110.579 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -129.37 -39.64 1.49 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.358 178.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -148.0 112.52 3.87 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.001 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -80.07 -172.63 1.58 Allowed 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.734 2.289 . . . . 0.0 112.006 178.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -91.74 88.43 6.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.058 0.456 . . . . 0.0 109.776 177.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.417 HG23 ' HB3' ' A' ' 216' ' ' LEU . 1.1 m -84.77 93.61 8.5 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.225 0.536 . . . . 0.0 110.875 -177.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' THR . . . . . 0.507 ' H ' ' HD2' ' A' ' 215' ' ' PRO . 13.7 p -113.3 -68.65 0.91 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.849 175.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.468 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 0.7 OUTLIER -87.55 -31.92 0.41 Allowed Pre-proline 0 CA--C 1.544 0.748 0 CA-C-N 115.442 -0.799 . . . . 0.0 113.006 173.374 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.507 ' HD2' ' H ' ' A' ' 213' ' ' THR . 83.7 Cg_exo -52.64 -16.87 6.1 Favored 'Trans proline' 0 C--N 1.368 1.583 0 C-N-CA 122.458 2.105 . . . . 0.0 114.219 174.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.487 ' O ' HD13 ' A' ' 216' ' ' LEU . 4.7 pp -99.39 135.49 20.67 Favored Pre-proline 0 C--N 1.329 -0.291 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.229 175.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 216' ' ' LEU . 6.3 Cg_exo -79.86 124.21 5.52 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.802 2.334 . . . . 0.0 111.048 173.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -77.9 -47.52 18.53 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.298 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 21.7 t 54.03 71.05 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.246 -178.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 49.2 m -95.04 104.53 16.41 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.664 -177.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . 0.562 ' O ' ' HD3' ' A' ' 223' ' ' PRO . . . -127.4 1.22 7.04 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.152 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 7.8 m -97.8 102.94 14.72 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 120.518 0.199 . . . . 0.0 110.528 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.562 ' HD3' ' O ' ' A' ' 221' ' ' GLY . 9.6 Cg_exo -72.31 130.29 16.09 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.568 2.179 . . . . 0.0 111.311 176.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -81.59 56.04 4.89 Favored Glycine 0 N--CA 1.454 -0.14 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.183 -178.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -162.39 166.87 24.55 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 122.446 0.298 . . . . 0.0 110.295 -177.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -93.85 104.63 16.7 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.854 177.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 10.9 tp -79.27 -15.47 13.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.381 -177.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 20.7 m 71.86 107.97 0.03 OUTLIER Pre-proline 0 C--O 1.232 0.176 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.157 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.453 ' C ' HD22 ' A' ' 230' ' ' LEU . 16.7 Cg_exo -66.99 -73.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.249 1.966 . . . . 0.0 110.767 174.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.453 HD22 ' C ' ' A' ' 229' ' ' PRO . 3.2 mm? -133.11 145.95 59.05 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 174.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.18 -56.93 1.94 Allowed 'Trans proline' 0 CA--C 1.53 0.278 0 C-N-CA 123.166 2.577 . . . . 0.0 113.334 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 21.9 t -140.01 79.31 1.7 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.046 0.45 . . . . 0.0 111.263 -176.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' THR . . . . . 0.523 ' HG1' ' ND2' ' A' ' 235' ' ' ASN . 26.0 p -132.97 4.14 3.78 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.493 174.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . 0.675 ' HB3' ' HG3' ' A' ' 237' ' ' PRO . 25.9 mt-30 70.19 -55.54 0.61 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.302 -177.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . 0.523 ' ND2' ' HG1' ' A' ' 233' ' ' THR . 6.3 m120 71.14 -56.63 0.62 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 173.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . 0.419 ' N ' ' HD3' ' A' ' 237' ' ' PRO . . . -134.17 61.77 0.64 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 119.867 -1.159 . . . . 0.0 113.926 -176.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.675 ' HG3' ' HB3' ' A' ' 234' ' ' GLN . 45.7 Cg_endo -93.95 95.37 0.13 Allowed 'Trans proline' 0 N--CA 1.445 -1.336 0 C-N-CA 122.728 2.285 . . . . 0.0 110.291 170.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.413 ' CG1' HD11 ' A' ' 293' ' ' ILE . 15.2 t -95.3 138.93 19.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.158 0.504 . . . . 0.0 111.393 -171.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -109.9 121.68 45.8 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.833 177.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.495 ' HB3' HD13 ' A' ' 293' ' ' ILE . . . -118.68 155.02 31.78 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.887 -175.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -99.84 120.47 39.81 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.779 179.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . 0.528 ' HA ' HG11 ' A' ' 291' ' ' VAL . . . -72.31 106.78 4.6 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 175.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 41.2 pt -94.85 -5.83 10.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.159 0.504 . . . . 0.0 110.995 -176.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -137.37 140.76 41.61 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.98 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -63.62 126.29 27.05 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 176.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.536 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 24.5 tpt180 -125.62 101.89 7.1 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.968 0.413 . . . . 0.0 110.562 -178.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 25.7 m -111.94 150.13 41.9 Favored Pre-proline 0 C--N 1.316 -0.88 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 174.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -62.89 102.73 0.31 Allowed 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.245 1.963 . . . . 0.0 111.865 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 250' ' ' ALA . 45.8 t -73.33 178.17 4.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.58 -177.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . 0.405 ' N ' ' SG ' ' A' ' 249' ' ' CYS . . . -63.74 -25.2 68.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.853 -177.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -99.11 1.11 44.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.876 0.37 . . . . 0.0 111.314 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.403 ' HB3' ' HB1' ' A' ' 255' ' ' ALA . 46.7 m-20 -101.32 161.13 13.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.233 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -138.74 -66.12 0.48 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.393 178.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 2.3 m -82.49 10.34 7.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.006 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 285' ' ' LEU . . . -65.57 119.07 10.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.044 0.449 . . . . 0.0 111.434 -175.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.2 tt -72.27 140.51 48.65 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.696 178.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.536 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -86.88 117.53 25.68 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.333 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 84.5 mt -126.86 142.69 51.48 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.557 -177.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -106.56 158.34 17.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.085 177.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 45.0 t -70.23 109.99 3.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.975 0.417 . . . . 0.0 110.088 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 108.54 11.69 22.79 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.852 -0.69 . . . . 0.0 111.948 -177.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -95.3 146.64 24.22 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 39.8 mm -90.28 117.63 33.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.914 0.388 . . . . 0.0 110.651 -179.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.405 HG22 HG12 ' A' ' 291' ' ' VAL . 22.0 t -92.94 109.4 21.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.432 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -91.11 88.18 6.86 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.065 178.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 7.6 p -88.67 125.47 41.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.341 0.591 . . . . 0.0 110.536 -177.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 37.2 p -97.27 -31.1 12.59 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.527 -175.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . 0.475 ' HD3' ' OE1' ' A' ' 276' ' ' GLU . 55.8 mtp180 -131.2 113.87 14.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.723 -177.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' MET . . . . . 0.655 ' HE1' ' CH2' ' A' ' 275' ' ' TRP . 31.6 mtt -93.86 113.42 25.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.124 178.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -83.57 169.98 14.84 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.576 176.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 32.4 mm -94.75 -20.32 6.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.476 -176.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -81.68 3.89 23.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.758 -176.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 99.31 -35.17 4.87 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.55 -0.833 . . . . 0.0 113.129 174.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -84.2 111.32 19.26 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.655 ' CH2' ' HE1' ' A' ' 269' ' ' MET . 41.1 m0 -93.53 158.45 15.7 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.297 -177.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . 0.475 ' OE1' ' HD3' ' A' ' 268' ' ' ARG . 58.7 mt-10 -91.66 106.75 18.71 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 172.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -108.52 146.33 16.49 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.012 -176.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -114.81 106.26 13.98 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 176.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . 0.578 HG11 ' ND2' ' A' ' 280' ' ' ASN . 15.1 t -141.48 134.11 29.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -175.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . 0.578 ' ND2' HG11 ' A' ' 279' ' ' VAL . 52.1 m-80 62.21 23.59 13.96 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.251 -177.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 84.5 -4.19 84.78 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.511 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 -104.62 134.07 48.4 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.865 0.364 . . . . 0.0 111.021 -176.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 42.8 tttp -104.78 117.33 33.79 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.176 177.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -146.79 175.51 26.16 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' A' ' 255' ' ' ALA . 89.5 mt -94.61 143.8 26.13 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 177.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.407 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 43.2 p90 -144.7 139.83 15.81 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.301 176.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 15.4 Cg_exo -69.59 125.11 11.84 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.651 2.234 . . . . 0.0 111.19 173.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -58.71 -19.96 44.53 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.269 -0.423 . . . . 0.0 112.04 -175.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 15.8 p -67.66 -9.26 41.75 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -177.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -99.55 -7.86 25.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.903 0.383 . . . . 0.0 111.053 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.528 HG11 ' HA ' ' A' ' 242' ' ' ALA . 34.0 m -127.56 170.12 17.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.891 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -138.77 134.83 33.98 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.07 0.462 . . . . 0.0 110.83 174.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.495 HD13 ' HB3' ' A' ' 240' ' ' ALA . 46.9 mm -76.78 128.81 37.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.329 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -138.61 -36.04 0.57 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.401 178.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 62.36 103.47 0.03 OUTLIER Pre-proline 0 C--N 1.341 0.197 0 CA-C-O 121.418 0.628 . . . . 0.0 111.354 -178.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . 0.491 ' O ' ' HB2' ' A' ' 297' ' ' GLN . 92.9 Cg_endo -79.43 50.45 3.51 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 123.209 2.606 . . . . 0.0 111.677 -178.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . 0.491 ' HB2' ' O ' ' A' ' 296' ' ' PRO . 2.0 mp0 77.84 -33.81 0.18 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.238 1.015 . . . . 0.0 111.309 -177.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . 0.467 ' HB2' ' O ' ' A' ' 297' ' ' GLN . 35.0 m-80 72.88 132.55 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.28 0 O-C-N 123.747 0.654 . . . . 0.0 111.383 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.93 -17.26 43.24 Favored 'Trans proline' 0 CA--C 1.527 0.162 0 C-N-CA 122.702 2.268 . . . . 0.0 111.675 176.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -64.52 -28.21 69.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.604 176.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -90.47 -6.65 54.59 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.066 178.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -104.82 13.96 30.39 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.173 0.511 . . . . 0.0 111.051 -173.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.556 -0.735 . . . . 0.0 110.17 178.048 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 mmt . . . . . 0 N--CA 1.48 1.029 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.0 m -84.43 99.09 10.45 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.513 177.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.9 p -65.75 -39.09 90.72 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 173.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.527 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . -75.51 89.92 2.72 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.429 171.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -119.09 95.72 4.93 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.607 0.718 . . . . 0.0 111.741 -175.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.415 ' HE1' ' O ' ' A' ' 98' ' ' LEU . 12.2 p90 -159.66 169.84 22.87 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.532 174.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.404 ' C ' ' H ' ' A' ' 9' ' ' SER . 13.4 m-20 -75.83 -26.83 57.54 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -173.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.0 t 72.61 -39.16 0.44 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.622 0.769 . . . . 0.0 111.382 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.404 ' H ' ' C ' ' A' ' 7' ' ' ASP . 13.1 m -91.03 -26.11 19.35 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.49 0.186 . . . . 0.0 111.1 178.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -63.36 105.76 0.8 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.987 0.422 . . . . 0.0 111.291 -172.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -60.62 -39.75 89.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.63 -176.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.1 m -72.99 -3.18 24.43 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.614 -176.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.52 -41.74 10.09 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.654 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 33.1 p-90 -125.09 -21.68 4.6 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -172.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -71.6 109.25 5.41 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.044 -176.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.815 ' SD ' ' HA ' ' A' ' 104' ' ' ARG . 8.3 tpp -91.03 -9.25 46.56 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.649 -174.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.443 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 50.6 -112.07 1.46 Allowed Glycine 0 CA--C 1.52 0.358 0 CA-C-N 115.55 -0.75 . . . . 0.0 113.986 177.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.443 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 19.3 Cg_exo -66.15 82.18 0.28 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.424 2.749 . . . . 0.0 113.324 -177.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.8 HG11 ' H ' ' A' ' 20' ' ' SER . 59.5 t -139.68 -178.31 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.8 ' H ' HG11 ' A' ' 19' ' ' VAL . 47.4 t -168.62 178.88 4.52 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 -166.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.476 ' O ' ' HG2' ' A' ' 25' ' ' GLN . 0.1 OUTLIER -58.73 -45.16 90.24 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 118.59 0.632 . . . . 0.0 109.391 176.222 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -60.07 -60.2 4.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.799 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.542 ' O ' ' HG3' ' A' ' 27' ' ' ARG . 29.5 mm-40 -56.94 -49.31 76.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.007 -178.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.507 ' HB1' ' O ' ' A' ' 20' ' ' SER . . . -56.83 -38.0 72.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.582 -175.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.552 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 16.4 mm100 -61.9 -52.69 63.07 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.889 178.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.2 t -70.45 -10.54 59.41 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -172.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.542 ' HG3' ' O ' ' A' ' 23' ' ' GLU . 55.5 mtp180 -100.44 -11.2 20.4 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 121.081 -0.248 . . . . 0.0 111.338 -179.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.564 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 62.9 mt -132.2 -13.0 3.15 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -176.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.552 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -68.69 109.0 3.6 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.919 -0.488 . . . . 0.0 109.944 -178.316 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.52 26.1 66.3 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.393 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.418 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 13.3 mm100 -94.07 -170.61 2.34 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 178.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.519 ' HB2' ' SD ' ' A' ' 35' ' ' MET . 56.0 mtm180 -61.81 150.83 35.99 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 177.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.43 ' CE1' ' HA ' ' A' ' 55' ' ' ASN . 55.9 m170 -92.31 113.92 26.33 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -178.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.476 ' CA ' HG22 ' A' ' 96' ' ' THR . . . 127.75 -4.62 7.02 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.746 -175.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.608 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 62.8 mtp -84.7 143.14 29.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.464 -0.368 . . . . 0.0 110.387 178.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.529 ' CD1' HD21 ' A' ' 98' ' ' LEU . 46.9 p90 -149.6 159.19 44.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.742 -0.208 . . . . 0.0 110.604 -178.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.605 ' HB2' ' HB2' ' A' ' 16' ' ' MET . 4.6 pp -150.69 138.52 19.92 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.141 0.496 . . . . 0.0 111.01 177.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 85.5 t -105.19 119.89 54.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 174.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.511 ' CB ' ' HB ' ' A' ' 19' ' ' VAL . 28.2 ptt-85 -117.08 161.58 19.18 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.89 -174.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -73.87 124.51 26.26 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 173.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.473 ' HB2' HG22 ' A' ' 49' ' ' VAL . 47.2 t -87.56 143.98 26.93 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.0 0.429 . . . . 0.0 110.902 -176.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.4 p -91.9 4.25 53.38 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.234 176.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 26.4 m -76.28 -43.12 43.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.173 175.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.463 ' HB2' ' HB2' ' A' ' 47' ' ' ASP . 11.7 m -143.66 135.27 12.84 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -70.38 72.84 1.72 Allowed 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.453 2.102 . . . . 0.0 111.677 176.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.444 ' O ' ' HB2' ' A' ' 65' ' ' SER . . . 155.55 -23.51 0.56 Allowed Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -176.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.463 ' HB2' ' HB2' ' A' ' 44' ' ' CYS . 16.0 m-20 -81.79 155.83 25.23 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 176.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -131.79 177.21 7.7 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.543 HG11 HD11 ' A' ' 62' ' ' ILE . 38.7 t -145.4 115.3 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.714 0.292 . . . . 0.0 111.288 177.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.435 HD13 ' HB2' ' A' ' 36' ' ' PHE . 57.5 tp -81.61 103.94 11.67 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.267 175.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.5 m -96.92 127.84 43.28 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 176.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.545 HG21 HD12 ' A' ' 93' ' ' LEU . 59.7 t -121.69 133.27 68.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.025 0.44 . . . . 0.0 111.063 -175.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.564 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 26.6 t -91.0 110.31 21.57 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.531 -178.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.635 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 40.8 mt-10 -146.78 136.88 23.47 Favored 'General case' 0 C--O 1.21 -0.984 0 C-N-CA 119.673 -0.811 . . . . 0.0 109.678 175.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.43 ' HA ' ' CE1' ' A' ' 33' ' ' HIS . 80.2 m-20 52.95 31.09 10.3 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 174.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 44.8 m 58.33 53.31 6.49 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 122.134 0.968 . . . . 0.0 109.367 -178.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.88 HH21 ' HB2' ' A' ' 94' ' ' ASP 0.256 0.2 OUTLIER -168.39 67.94 0.07 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 113.577 -1.647 . . . . 0.0 108.668 -156.915 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 21.7 t -72.49 102.8 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 O-C-N 120.588 -1.32 . . . . 0.0 110.299 -167.702 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.6 m -73.61 118.88 17.08 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 113.133 -1.849 . . . . 0.0 110.737 -176.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -97.93 113.53 25.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.854 0.359 . . . . 0.0 111.43 -178.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.508 ' HB3' ' CD1' ' A' ' 73' ' ' ILE . 70.2 m-85 -107.24 110.2 22.18 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.964 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.796 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 34.2 mm -77.46 132.75 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -173.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.511 HG22 ' HB3' ' A' ' 71' ' ' PHE . 3.7 mp -115.84 115.91 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 120.947 0.403 . . . . 0.0 111.125 177.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -88.57 142.71 27.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.371 -177.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' A' ' 46' ' ' GLY . 35.9 t -83.38 100.15 10.5 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 169.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 90.3 mt -78.11 140.42 61.69 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -59.05 -15.45 27.95 Favored 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 122.982 2.455 . . . . 0.0 112.446 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -83.45 10.79 8.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.419 176.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? 63.59 27.81 15.02 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.667 -178.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.445 ' NH2' ' HB3' ' A' ' 77' ' ' GLU . 37.0 mtp180 -115.44 -175.21 2.66 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.988 -1.006 . . . . 0.0 109.52 178.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.511 ' HB3' HG22 ' A' ' 63' ' ' ILE . 62.0 m-85 -135.57 143.44 45.67 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.063 0.459 . . . . 0.0 111.735 -175.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -123.47 116.46 23.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.992 177.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.796 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 7.9 tt -102.87 94.74 3.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.493 0.663 . . . . 0.0 110.807 -179.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 58.78 68.75 1.53 Allowed Glycine 0 C--N 1.331 0.284 0 CA-C-N 115.098 -0.955 . . . . 0.0 112.651 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.4 t0 76.55 -45.01 0.49 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 122.628 0.371 . . . . 0.0 111.333 178.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -75.78 129.18 36.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.146 0.498 . . . . 0.0 110.861 -178.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.445 ' HB3' ' NH2' ' A' ' 70' ' ' ARG . 64.6 mt-10 -101.32 153.3 19.77 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.428 -177.722 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.457 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 96.8 m-85 -141.01 -173.91 3.85 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.041 173.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -77.68 -48.76 15.97 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.019 0.438 . . . . 0.0 110.729 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.728 ' HD1' ' HD2' ' A' ' 82' ' ' PRO . 4.7 p80 -156.89 -179.38 8.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.397 -178.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.604 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 14.2 mt -57.77 -57.1 27.93 Favored Pre-proline 0 N--CA 1.469 0.493 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -178.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.728 ' HD2' ' HD1' ' A' ' 80' ' ' HIS . 24.4 Cg_exo -64.37 -2.33 4.86 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.13 1.887 . . . . 0.0 112.948 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.9 -36.8 14.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.793 0.33 . . . . 0.0 110.348 179.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.604 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.7 pp -76.78 -31.11 56.8 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.459 ' HA ' ' CD1' ' A' ' 98' ' ' LEU . 57.2 mt -67.62 -26.72 66.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.653 174.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -79.12 -33.44 44.29 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.788 177.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -76.07 -38.11 57.47 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.028 0.442 . . . . 0.0 111.049 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.757 ' CD1' HD22 ' A' ' 93' ' ' LEU . 33.5 m-85 -76.26 1.55 15.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.962 0.41 . . . . 0.0 111.779 -177.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -70.27 -25.99 63.61 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.45 171.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 29.8 pt -117.14 26.57 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 120.585 -0.446 . . . . 0.0 112.067 178.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.427 ' O ' ' HB2' ' A' ' 92' ' ' TYR . 2.8 t-160 -114.46 -42.64 3.27 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -175.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.466 ' CD1' HG21 ' A' ' 97' ' ' THR . 97.8 m-85 70.46 86.62 0.12 Allowed 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.751 0.657 . . . . 0.0 110.278 -171.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.757 HD22 ' CD1' ' A' ' 88' ' ' TYR . 14.8 mt -59.94 -30.75 69.28 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.51 -178.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.88 ' HB2' HH21 ' A' ' 57' ' ' ARG . 31.6 t0 -160.94 68.55 0.33 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.317 0.58 . . . . 0.0 109.863 170.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.531 HG22 ' O ' ' A' ' 94' ' ' ASP . 0.5 OUTLIER 70.2 -4.49 1.54 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.956 -175.629 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.635 ' HB ' ' OE2' ' A' ' 54' ' ' GLU . 16.2 m -127.73 138.84 52.9 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 121.237 0.542 . . . . 0.0 109.933 178.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.47 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.5 p -89.5 168.39 12.22 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 173.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.529 HD21 ' CD1' ' A' ' 36' ' ' PHE . 97.3 mt -63.58 96.36 0.12 Allowed 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.635 -0.426 . . . . 0.0 109.871 178.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.527 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 49.0 mm -86.06 -56.72 5.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.645 -174.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.608 ' O ' ' HA ' ' A' ' 35' ' ' MET . 42.5 tt0 -158.85 133.39 5.37 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.912 -176.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 100' ' ' GLU . 17.8 Cg_exo -64.91 157.75 55.03 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 122.88 2.386 . . . . 0.0 112.829 -177.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.09 141.13 86.15 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.9 112.44 1.21 Allowed 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.384 2.056 . . . . 0.0 112.116 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.815 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 41.7 ttp180 -59.09 -40.03 84.02 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.374 0.607 . . . . 0.0 109.474 178.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.45 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 59.7 m-85 -124.87 124.91 25.47 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.531 171.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 105' ' ' TYR . 16.3 Cg_exo -70.63 45.35 0.54 Allowed 'Trans proline' 0 N--CA 1.475 0.401 0 C-N-CA 123.544 2.83 . . . . 0.0 113.376 -177.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.65 ' HB3' ' HD3' ' A' ' 108' ' ' PRO . 22.8 t -80.11 -48.04 1.34 Allowed Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.43 175.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.65 ' HD3' ' HB3' ' A' ' 107' ' ' SER . 19.7 Cg_exo -67.66 129.2 19.44 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 121.957 1.771 . . . . 0.0 111.586 172.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 108' ' ' PRO . 15.6 Cg_exo -68.47 121.71 8.66 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.856 2.37 . . . . 0.0 112.028 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 79.2 mtp -80.46 -10.31 59.75 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.367 177.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 120.5 -11.41 10.43 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.585 177.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 26.7 m 60.42 30.56 19.89 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 121.325 0.583 . . . . 0.0 110.518 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.4 m -104.39 -43.0 7.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.494 -176.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 32.0 t 52.28 34.52 14.89 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.151 0.5 . . . . 0.0 110.648 -177.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -131.17 104.67 15.02 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.943 -174.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -91.61 -178.81 1.21 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.209 2.606 . . . . 0.0 111.459 172.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -87.82 31.83 0.76 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.261 0.553 . . . . 0.0 111.082 -177.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.4 tt -173.96 82.6 0.37 Allowed Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.52 -54.28 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.108 2.539 . . . . 0.0 111.99 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 6.3 m -87.76 105.25 17.26 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.539 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -122.93 14.67 9.95 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.463 -177.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.47 ' HG3' ' H ' ' A' ' 123' ' ' ASP . 6.1 pt-20 38.53 -115.78 0.16 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.462 0.705 . . . . 0.0 112.674 -179.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.47 ' H ' ' HG3' ' A' ' 122' ' ' GLU . 15.6 m-20 -131.23 29.2 4.66 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -178.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.852 ' HA ' ' HG3' ' A' ' 183' ' ' ARG . 0.1 OUTLIER -77.44 138.41 39.25 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -171.918 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.847 ' H ' ' HD2' ' A' ' 183' ' ' ARG . 3.3 mm? 72.53 108.06 0.07 Allowed 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.803 173.165 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.513 ' HG2' ' CD2' ' A' ' 127' ' ' TYR . 28.4 tt0 -171.72 -78.23 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.531 -1.213 . . . . 0.0 109.674 -174.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.513 ' CD2' ' HG2' ' A' ' 126' ' ' GLU . 54.7 m-85 -117.57 107.85 14.76 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.377 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.703 HG22 ' CG ' ' A' ' 180' ' ' LYS . 56.6 t -114.87 131.11 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -178.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.648 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 0.2 OUTLIER -109.79 144.66 37.91 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 116.892 -1.923 . . . . 0.0 108.989 170.988 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.417 ' HG1' ' HB2' ' A' ' 144' ' ' PHE . 1.2 p -100.68 128.91 46.56 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.316 -179.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.534 HD22 ' HG2' ' A' ' 179' ' ' GLU . 14.8 mt -105.27 -23.16 12.92 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.934 -176.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.45 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 32.6 t80 -79.9 -33.41 39.89 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.727 -173.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.598 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 15.7 t70 71.77 120.14 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.365 0.602 . . . . 0.0 110.842 -174.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.544 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 64.4 t80 -153.85 91.96 3.16 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.573 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 74.2 Cg_endo -90.0 86.77 0.39 Allowed 'Trans proline' 0 N--CA 1.441 -1.605 0 C-N-CA 122.014 1.809 . . . . 0.0 112.573 177.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -76.79 -16.11 81.04 Favored Glycine 0 C--N 1.331 0.298 0 N-CA-C 111.056 -0.817 . . . . 0.0 111.056 174.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.675 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 18.1 m120 52.97 68.31 0.86 Allowed 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.21 -0.995 . . . . 0.0 111.8 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.478 ' HB3' ' H ' ' A' ' 141' ' ' ASP . 1.0 OUTLIER -136.27 -174.87 3.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.229 0.538 . . . . 0.0 110.932 -178.962 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -115.32 3.69 14.27 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 166.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.415 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 32.9 tt0 -112.34 -49.74 2.94 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 113.9 -1.5 . . . . 0.0 108.65 177.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.478 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 4.9 m-20 -96.64 133.28 41.36 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.852 167.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.705 ' CD2' HD23 ' A' ' 150' ' ' LEU . 34.2 tp -83.62 131.65 51.68 Favored Pre-proline 0 N--CA 1.468 0.44 0 O-C-N 122.075 -0.39 . . . . 0.0 110.135 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.675 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 11.6 Cg_endo -85.63 91.06 0.69 Allowed 'Trans proline' 0 N--CA 1.444 -1.425 0 C-N-CA 122.115 1.877 . . . . 0.0 111.266 172.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.582 ' CE2' ' HB ' ' A' ' 173' ' ' ILE . 12.8 p90 -103.71 159.48 15.59 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.234 -176.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.598 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 5.0 mppt? -104.91 -168.28 1.45 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.262 0.554 . . . . 0.0 112.195 -178.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.682 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -86.84 9.11 20.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.0 -169.688 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -172.63 36.93 0.14 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.857 175.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.528 ' OE1' ' HA ' ' A' ' 144' ' ' PHE . 0.3 OUTLIER -101.06 149.05 24.35 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.351 -175.648 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.631 HD12 ' HB3' ' A' ' 129' ' ' ARG . 0.3 OUTLIER -89.06 124.57 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.677 -178.116 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.705 HD23 ' CD2' ' A' ' 142' ' ' LEU . 19.3 mt -119.45 155.35 32.21 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.551 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 67.6 t -117.56 125.53 74.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 174.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.472 HG13 HD12 ' A' ' 125' ' ' LEU . 49.5 mm -76.54 87.18 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 122.423 1.106 . . . . 0.0 108.118 -176.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.466 HG22 HG21 ' A' ' 170' ' ' VAL . 17.9 tt -75.66 -25.1 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 CA-C-N 113.292 -1.776 . . . . 0.0 109.875 -174.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.685 ' OE2' ' HA ' ' A' ' 93' ' ' LEU . 0.2 OUTLIER -141.0 141.21 34.39 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 170.458 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 61.0 tttt -128.83 92.75 39.16 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.44 0.638 . . . . 0.0 110.356 170.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.538 ' HG2' ' HE1' ' A' ' 172' ' ' MET . 10.3 Cg_exo -74.3 -44.04 0.46 Allowed 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.338 2.025 . . . . 0.0 112.002 172.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -120.2 178.74 4.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.099 -172.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.401 ' HA ' ' HE1' ' A' ' 161' ' ' TRP . 6.7 pt-20 -116.12 4.68 13.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.094 0.473 . . . . 0.0 110.672 174.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -102.34 -31.26 10.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.696 172.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.422 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 34.5 m95 -129.11 146.16 51.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.613 173.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . 0.73 ' O ' HG13 ' A' ' 173' ' ' ILE . 47.8 m0 -126.79 138.33 53.34 Favored 'General case' 0 C--O 1.215 -0.757 0 C-N-CA 122.788 0.435 . . . . 0.0 110.657 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.545 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 25.6 m -95.4 96.33 9.05 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -175.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.564 ' HB2' ' HB3' ' A' ' 150' ' ' LEU . . . -108.7 150.29 27.77 Favored 'General case' 0 N--CA 1.422 -1.833 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.505 -172.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.772 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 12.7 ptt180 -87.46 122.17 30.85 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 173.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.653 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . 17.5 t30 -54.61 176.79 0.04 OUTLIER 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 113.293 -1.776 . . . . 0.0 110.91 -177.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.527 ' HD2' ' H ' ' A' ' 149' ' ' ILE . 30.9 mtpt -62.95 -17.98 62.61 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.828 169.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -68.94 -36.24 77.72 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.468 0.652 . . . . 0.0 109.46 168.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.419 ' C ' ' HB2' ' A' ' 164' ' ' ARG . . . 105.06 3.96 41.75 Favored Glycine 0 CA--C 1.524 0.598 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.343 -172.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.772 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -79.33 137.59 37.39 Favored 'General case' 0 C--O 1.218 -0.574 0 C-N-CA 123.16 0.584 . . . . 0.0 111.77 -178.77 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.466 HG21 HG22 ' A' ' 153' ' ' ILE . 22.1 t -79.87 125.87 39.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 120.417 0.151 . . . . 0.0 111.291 177.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -157.88 148.37 17.67 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 120.209 -0.996 . . . . 0.0 112.665 169.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.538 ' HE1' ' HG2' ' A' ' 156' ' ' PRO . 0.4 OUTLIER -69.88 140.65 53.19 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 122.756 0.422 . . . . 0.0 111.378 179.408 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.73 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.6 pp -144.45 144.39 25.1 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.105 -176.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.516 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 8.1 Cg_exo -73.38 132.13 17.3 Favored 'Trans proline' 0 C--O 1.23 0.115 0 C-N-CA 122.498 2.132 . . . . 0.0 112.644 -174.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.593 ' O ' HG23 ' A' ' 178' ' ' VAL . 82.9 t -60.98 -44.03 93.2 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 19.0 Cg_endo -61.08 -11.2 17.56 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 121.981 1.787 . . . . 0.0 112.873 177.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.516 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.1 m-85 -88.22 -15.18 36.63 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.525 -178.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.602 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 4.1 m -106.58 -172.44 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 115.558 1.688 . . . . 0.0 115.558 -164.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.667 ' O ' ' HG3' ' A' ' 179' ' ' GLU . 3.9 tp10 -159.9 44.32 0.22 Allowed 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 112.941 -1.936 . . . . 0.0 111.638 -154.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.748 ' HD2' ' H ' ' A' ' 180' ' ' LYS . 0.0 OUTLIER -74.13 144.23 44.99 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 119.275 -2.141 . . . . 0.0 111.554 -166.07 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.448 ' HB2' HH12 ' A' ' 129' ' ' ARG . 23.8 tp -64.81 -85.07 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 111.416 -2.629 . . . . 0.0 114.282 -157.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 21.3 t -89.62 -14.69 9.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.666 0.746 . . . . 0.0 110.546 -173.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.852 ' HG3' ' HA ' ' A' ' 124' ' ' ASN . 28.2 ttt-85 -75.33 107.15 7.25 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.606 -177.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 50.6 m -65.16 152.85 42.57 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 170.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' SER . . . . . 0.553 ' HA ' HH12 ' A' ' 183' ' ' ARG . 41.3 t -113.76 148.43 39.82 Favored Pre-proline 0 C--N 1.315 -0.904 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.29 -173.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.458 ' HD2' HH22 ' A' ' 183' ' ' ARG . 19.2 Cg_endo -58.81 104.54 0.19 Allowed 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.031 2.487 . . . . 0.0 111.314 174.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.435 ' HB3' ' CD ' ' A' ' 193' ' ' ARG . 37.5 m80 -108.51 25.83 11.22 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.659 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 89.89 -65.55 2.93 Favored Glycine 0 CA--C 1.505 -0.538 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -173.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -132.84 136.38 46.2 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 168.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 64.3 m80 -79.03 115.1 18.5 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.483 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 109.16 -121.66 6.24 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 -176.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -68.07 115.29 7.39 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 176.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.435 ' CD ' ' HB3' ' A' ' 187' ' ' HIS . 16.7 ptt180 -145.61 150.69 36.82 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.182 0.515 . . . . 0.0 111.605 -173.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -117.61 87.12 2.65 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.443 172.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 1.5 p -76.37 138.38 40.39 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.356 -177.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -97.45 109.27 22.06 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.727 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 2.6 p -90.3 7.06 40.32 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.102 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -124.87 117.32 23.83 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.547 -178.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 107.7 172.41 22.03 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.341 176.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.463 ' H ' HD11 ' A' ' 200' ' ' ILE . 0.2 OUTLIER -133.98 144.39 51.41 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-O 120.632 0.253 . . . . 0.0 110.46 178.904 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 200' ' ' ILE . 3.0 Cg_exo -75.74 78.67 3.03 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.923 2.416 . . . . 0.0 111.566 176.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 66.19 123.33 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.382 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.062 -178.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -68.03 157.76 60.39 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.306 2.004 . . . . 0.0 111.531 176.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -95.51 142.23 28.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.731 0.301 . . . . 0.0 110.611 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 -86.33 -41.67 14.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.19 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -149.03 157.83 43.72 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.537 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -85.87 103.27 14.46 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.045 177.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . 64.67 -172.14 0.18 Allowed 'General case' 0 N--CA 1.465 0.314 0 O-C-N 123.848 0.718 . . . . 0.0 111.008 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -89.64 134.48 32.27 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-O 120.649 0.261 . . . . 0.0 110.714 176.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -62.05 140.23 83.1 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.776 2.317 . . . . 0.0 112.272 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -91.47 123.36 34.83 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.006 -176.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 7.7 m 61.67 49.17 5.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.723 0.773 . . . . 0.0 111.664 175.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.0 104.34 16.89 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.452 173.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.708 ' HB ' ' HD3' ' A' ' 215' ' ' PRO . 49.3 m -152.65 -56.47 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.668 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.708 ' HD3' ' HB ' ' A' ' 214' ' ' THR . 89.1 Cg_endo -85.03 171.62 9.13 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 121.873 1.715 . . . . 0.0 112.213 176.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 95.8 mt -111.93 117.68 47.79 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.018 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -69.45 -75.44 0.01 OUTLIER 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 122.976 2.451 . . . . 0.0 112.605 -178.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -145.34 149.11 34.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.374 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 61.1 t -84.12 100.49 7.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.964 -177.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 74.8 m 56.62 29.4 15.6 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.249 175.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 68.99 21.12 75.25 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.749 178.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.435 ' HA ' ' HD3' ' A' ' 223' ' ' PRO . 27.4 m -109.77 127.24 27.47 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-O 120.559 0.218 . . . . 0.0 110.522 178.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 222' ' ' SER . 17.4 Cg_exo -67.43 -17.63 49.14 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.852 2.368 . . . . 0.0 112.138 178.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 133.29 -79.28 0.34 Allowed Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -88.82 95.62 10.36 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 177.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . 61.67 -167.62 0.2 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.65 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 50.4 mm -109.2 -39.4 4.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.812 177.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' THR . . . . . 0.666 ' HB ' ' HD2' ' A' ' 229' ' ' PRO . 77.4 p -132.66 170.69 10.73 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.54 178.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.666 ' HD2' ' HB ' ' A' ' 228' ' ' THR . 53.6 Cg_endo -70.3 168.23 22.87 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 122.207 1.938 . . . . 0.0 111.616 172.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -100.75 115.16 65.67 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 120.672 0.272 . . . . 0.0 110.925 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.94 178.11 7.67 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 122.866 2.377 . . . . 0.0 111.938 177.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 61.3 m -81.44 56.22 2.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.976 0.417 . . . . 0.0 111.366 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 1.4 p -78.1 75.21 4.63 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.308 0.575 . . . . 0.0 110.116 175.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -85.27 98.29 10.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.505 -176.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -125.02 -35.98 2.6 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.41 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . 0.421 ' HA3' ' HD3' ' A' ' 237' ' ' PRO . . . 97.72 -100.61 2.41 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -174.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . 0.421 ' HD3' ' HA3' ' A' ' 236' ' ' GLY . 12.9 Cg_exo -69.9 114.82 3.85 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.563 2.175 . . . . 0.0 111.283 173.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.438 ' CG1' HD11 ' A' ' 293' ' ' ILE . 21.7 t -84.71 134.55 26.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.945 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.518 ' HB2' ' CG ' ' A' ' 296' ' ' PRO . 93.8 m-85 -104.46 124.24 48.9 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.141 0.496 . . . . 0.0 110.468 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.511 ' HB3' HD13 ' A' ' 293' ' ' ILE . . . -119.24 140.65 49.89 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.26 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -88.2 124.36 33.76 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . 0.51 ' HA ' HG11 ' A' ' 291' ' ' VAL . . . -75.29 99.52 4.09 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.253 178.388 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 39.4 pt -80.59 -23.26 11.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.276 0.56 . . . . 0.0 110.74 -177.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -135.26 148.52 49.59 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 177.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -67.79 169.56 9.47 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.239 0.542 . . . . 0.0 110.607 -178.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.55 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 27.3 tpt180 -154.1 109.78 3.2 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.166 178.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.4 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 24.0 m -108.77 150.15 40.43 Favored Pre-proline 0 C--N 1.315 -0.923 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 178.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.528 ' HA ' ' HB3' ' A' ' 255' ' ' ALA . 12.4 Cg_exo -68.44 110.5 2.29 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.416 2.077 . . . . 0.0 111.518 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' CYS . . . . . 0.51 ' HB3' ' HB2' ' A' ' 252' ' ' ASP . 51.9 t -70.52 164.65 24.32 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.907 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -53.34 -40.05 64.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.6 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -99.86 7.17 45.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.793 0.33 . . . . 0.0 111.493 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.51 ' HB2' ' HB3' ' A' ' 249' ' ' CYS . 7.4 m-20 -127.6 69.19 1.31 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.132 0.491 . . . . 0.0 110.131 176.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -78.2 -21.58 49.86 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.178 0.513 . . . . 0.0 110.189 -179.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 19.8 p -83.04 -0.35 48.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.847 177.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.528 ' HB3' ' HA ' ' A' ' 248' ' ' PRO . . . -77.19 132.59 38.84 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.572 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.62 137.28 40.64 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.026 -178.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -87.26 107.59 18.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.141 0.496 . . . . 0.0 110.095 179.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 94.4 mt -116.3 151.11 36.5 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.782 -176.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -119.13 157.0 28.77 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.22 176.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 47.4 t -65.03 122.64 16.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.565 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 96.28 18.45 31.09 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.801 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -99.38 170.5 8.59 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 177.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . 0.407 ' HA ' HD12 ' A' ' 263' ' ' ILE . 25.9 mm -117.76 112.83 40.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.042 0.449 . . . . 0.0 110.307 -178.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 239' ' ' PHE . 30.8 t -88.41 113.0 24.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.65 -178.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -92.26 87.59 6.13 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.829 177.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.445 HG21 ' HB3' ' A' ' 275' ' ' TRP . 3.0 p -92.69 120.05 41.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.384 0.611 . . . . 0.0 110.809 -177.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 1.4 p -94.03 -26.95 16.57 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.754 -178.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . 0.553 ' HB2' ' HB3' ' A' ' 276' ' ' GLU . 28.6 mmm180 -116.24 104.51 11.58 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.864 0.364 . . . . 0.0 110.938 -178.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 36.9 mmm -94.51 131.87 39.78 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 177.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 31.7 p30 -125.44 -179.16 4.49 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.638 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 19.6 pt -103.31 8.21 9.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.172 0.51 . . . . 0.0 110.738 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -81.35 -31.51 33.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.717 -176.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 117.91 -40.2 2.39 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.665 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.527 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 1.9 mp0 -94.76 114.98 26.96 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 174.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.445 ' HB3' HG21 ' A' ' 266' ' ' VAL . 21.9 m0 -91.68 157.53 16.9 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -177.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . 0.553 ' HB3' ' HB2' ' A' ' 268' ' ' ARG . 8.0 tp10 -90.39 103.08 15.8 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -115.91 137.96 14.17 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.266 -0.968 . . . . 0.0 113.559 -172.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -105.99 108.95 20.72 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 175.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . 0.418 HG22 ' HA ' ' A' ' 264' ' ' VAL . 37.9 t -119.47 -87.64 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.056 -0.658 . . . . 0.0 112.108 -173.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -105.08 76.25 1.23 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.936 0.398 . . . . 0.0 111.072 -174.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 66.15 20.73 69.38 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.825 176.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 282' ' ' ARG . 38.1 ttt-85 -158.87 137.41 10.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.838 0.319 . . . . 0.0 110.64 -175.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 38.1 ttpt -110.08 128.45 55.44 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.599 177.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -156.67 173.72 34.4 Favored Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 -178.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.527 ' HB3' ' HB3' ' A' ' 274' ' ' GLN . 72.5 mt -89.1 138.01 31.8 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.039 0.447 . . . . 0.0 110.417 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.445 ' O ' ' HA ' ' A' ' 274' ' ' GLN . 35.7 p90 -137.83 133.08 17.53 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.21 178.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.67 131.93 23.97 Favored 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 122.547 2.164 . . . . 0.0 111.656 176.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -65.62 -2.39 3.47 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.69 -177.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.89 -0.46 55.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.96 0.41 . . . . 0.0 111.296 -179.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -111.65 -12.5 13.89 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.801 0.334 . . . . 0.0 110.892 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.51 HG11 ' HA ' ' A' ' 242' ' ' ALA . 27.9 m -128.29 162.47 34.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.999 -179.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -136.43 132.35 35.33 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.944 0.402 . . . . 0.0 111.027 175.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.511 HD13 ' HB3' ' A' ' 240' ' ' ALA . 42.0 mm -72.29 129.81 35.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.454 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' PHE . . . . . 0.637 ' O ' ' HD3' ' A' ' 296' ' ' PRO . 10.2 p90 -135.08 -170.93 2.68 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.595 -179.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . 0.531 ' HB2' ' O ' ' A' ' 298' ' ' ASN . 6.1 p-10 -98.07 97.08 3.99 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-O 121.357 0.599 . . . . 0.0 110.87 176.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . 0.637 ' HD3' ' O ' ' A' ' 294' ' ' PHE . 1.1 Cg_endo -83.53 -53.27 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.921 2.414 . . . . 0.0 112.098 -178.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -124.49 -10.57 7.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.232 0.539 . . . . 0.0 110.554 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . 0.531 ' O ' ' HB2' ' A' ' 295' ' ' ASP . 2.7 p-10 -100.98 114.5 65.82 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.595 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -71.72 -11.21 27.62 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.755 2.303 . . . . 0.0 111.836 178.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.418 ' C ' ' H ' ' A' ' 302' ' ' ASN . 5.1 m-20 -65.14 153.47 40.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.131 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 73.12 -32.58 0.25 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.772 0.829 . . . . 0.0 111.999 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . 0.451 HD21 ' CG ' ' A' ' 295' ' ' ASP . 44.0 t-20 -80.84 116.85 21.03 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 175.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 . . . . . 0 C--O 1.246 0.87 0 CA-C-O 118.542 -0.742 . . . . 0.0 110.046 -177.932 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 N--CA 1.48 1.056 0 CA-C-O 120.596 0.236 . . . . 0.0 110.96 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.4 m -90.45 -10.86 42.18 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.732 -0.213 . . . . 0.0 110.866 -178.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.53 ' HB3' HD11 ' A' ' 99' ' ' ILE . 64.2 m 69.55 -55.9 0.57 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.331 0.652 . . . . 0.0 111.485 -176.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.544 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . -72.36 107.22 4.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.689 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.442 ' HD3' ' HA ' ' A' ' 5' ' ' ARG . 19.1 mmt180 -137.55 100.05 4.11 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.112 0.482 . . . . 0.0 111.418 -178.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -167.65 159.69 12.16 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.33 -0.85 . . . . 0.0 108.88 177.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -83.11 108.42 16.37 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 177.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.633 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 15.4 m -74.89 55.86 0.71 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.319 179.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.1 m -161.85 -39.67 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.948 0.404 . . . . 0.0 110.781 -179.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -71.81 110.37 6.29 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.19 0.519 . . . . 0.0 111.386 -171.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -60.78 -35.65 77.0 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.712 -178.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.513 ' HA ' ' NH1' ' A' ' 104' ' ' ARG . 67.0 m -71.18 -3.57 20.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.504 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.73 -46.87 7.36 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.139 177.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 17.3 p-90 -118.57 -21.25 8.04 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -170.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -80.4 121.72 26.07 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 121.86 -0.525 . . . . 0.0 111.18 -173.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.563 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 23.1 mmt -99.81 -5.21 28.95 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.653 -176.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.438 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.15 -113.82 2.47 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 116.034 -0.53 . . . . 0.0 113.359 -176.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.438 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 9.2 Cg_exo -72.56 91.09 0.79 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.19 2.593 . . . . 0.0 113.511 -176.091 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.451 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 73.7 t -144.99 153.76 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 176.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.433 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 22.2 p -121.19 -179.83 4.17 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 118.233 0.469 . . . . 0.0 109.78 -174.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.718 HH21 ' HA ' ' A' ' 117' ' ' ASN . 21.2 mmm180 -55.25 -54.59 41.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.649 0.261 . . . . 0.0 110.879 177.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.469 ' HB2' ' HB3' ' A' ' 114' ' ' SER . 11.3 pt20 -64.47 -39.59 94.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.868 -175.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.492 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 50.4 mt-10 -69.68 -48.08 60.98 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.404 179.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.433 ' HB1' ' O ' ' A' ' 20' ' ' SER . . . -56.19 -38.8 71.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.017 -179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.822 ' HG2' ' H ' ' A' ' 115' ' ' ALA . 3.6 tp-100 -53.2 -58.56 6.62 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.451 175.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.54 ' HA ' ' HB3' ' A' ' 29' ' ' GLN . 10.4 t -75.99 -2.63 31.48 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -171.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.492 ' HG2' ' O ' ' A' ' 23' ' ' GLU . 52.2 mmm-85 -85.29 -20.93 29.29 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.162 0.506 . . . . 0.0 109.682 175.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.552 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 29.7 mt -123.14 -12.71 7.87 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.737 -177.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.709 ' NE2' ' HB3' ' A' ' 57' ' ' ARG . 3.9 tp-100 -67.33 115.64 7.2 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.172 0.589 . . . . 0.0 111.743 -178.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 66.62 10.98 56.1 Favored Glycine 0 C--N 1.331 0.292 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.855 176.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.472 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 15.2 mm100 -70.1 -87.02 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -177.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -158.07 -4.36 0.09 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.45 ' HA ' ' OG ' ' A' ' 53' ' ' SER . 29.0 m170 71.17 161.37 0.23 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.359 0.599 . . . . 0.0 111.559 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.11 -22.55 8.15 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.07 177.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.736 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 57.9 mtm -82.25 147.44 28.94 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 178.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -140.25 164.37 30.26 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.261 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.563 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.3 pp -152.69 134.88 14.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.037 0.446 . . . . 0.0 111.463 178.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.6 t -105.81 127.29 60.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 173.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.596 HH22 ' HD2' ' A' ' 21' ' ' ARG . 31.9 ptt-85 -131.15 -178.45 4.84 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.684 -0.235 . . . . 0.0 110.652 -174.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -69.93 132.21 45.61 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 171.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.489 ' HA ' HG23 ' A' ' 49' ' ' VAL . 22.6 t -72.87 155.91 39.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.65 0.738 . . . . 0.0 112.246 -175.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.4 p -102.14 10.29 39.55 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.383 177.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 36.0 p -95.27 -51.54 4.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.855 178.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.7 p -165.91 144.11 4.81 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.127 179.158 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -57.54 125.37 18.57 Favored 'Trans proline' 0 C--O 1.237 0.471 0 C-N-CA 123.006 2.471 . . . . 0.0 112.268 178.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.65 -31.42 5.56 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -176.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -89.3 167.78 12.78 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 177.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -135.98 176.01 9.08 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.76 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.489 HG23 ' HA ' ' A' ' 41' ' ' SER . 48.4 t -142.93 110.87 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.945 0.402 . . . . 0.0 111.319 177.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.3 tp -80.84 105.61 12.2 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.184 174.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.0 m -98.27 131.57 44.48 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 174.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.612 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 46.2 t -118.64 143.13 30.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.493 -177.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.552 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 40.2 t -88.75 110.32 20.9 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 122.218 -0.301 . . . . 0.0 111.267 -177.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.495 ' HG2' ' O ' ' A' ' 94' ' ' ASP . 6.2 tp10 -177.85 165.93 2.05 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 174.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.538 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 2.6 m-80 60.3 50.48 6.17 Favored 'General case' 0 CA--C 1.48 -1.742 0 C-N-CA 123.905 0.882 . . . . 0.0 108.657 -168.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.445 ' HB2' ' O ' ' A' ' 55' ' ' ASN . 66.4 m 71.61 -28.7 0.19 Allowed 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 113.516 -1.675 . . . . 0.0 110.95 -171.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.709 ' HB3' ' NE2' ' A' ' 29' ' ' GLN 0.399 0.0 OUTLIER -153.21 -54.01 0.11 Allowed 'General case' 0 C--N 1.364 1.23 1 N-CA-C 124.965 5.172 . . . . 0.0 124.965 -174.619 . . . . . . . . 5 4 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.701 ' H ' ' NE ' ' A' ' 57' ' ' ARG . 1.7 t -152.29 120.8 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 CA-C-N 122.49 2.405 . . . . 0.0 114.046 -173.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.521 ' HB2' ' HB ' ' A' ' 52' ' ' VAL . 0.9 OUTLIER -97.98 110.83 23.33 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 163.513 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.648 ' HD2' HD21 ' A' ' 118' ' ' LEU . 92.4 m-70 -98.13 118.17 34.16 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 121.546 -0.721 . . . . 0.0 112.555 -173.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.672 ' OH ' ' HB3' ' A' ' 93' ' ' LEU . 37.2 m-85 -122.36 109.21 14.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.674 179.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.564 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 67.9 mt -81.03 135.12 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 O-C-N 121.859 -0.526 . . . . 0.0 111.636 -178.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.469 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 5.3 mp -112.96 111.69 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 120.881 0.372 . . . . 0.0 110.905 179.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.691 ' HB2' ' CG ' ' A' ' 72' ' ' LYS . 23.4 m120 -88.98 148.13 23.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.495 -174.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.6 t -83.82 105.84 15.04 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.136 175.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.47 HD12 ' OE1' ' A' ' 77' ' ' GLU . 91.0 mt -82.74 140.68 43.98 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 177.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.52 -9.05 16.68 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.077 2.518 . . . . 0.0 112.978 -177.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -91.82 19.26 6.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.326 177.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.464 ' HA ' ' NE ' ' A' ' 69' ' ' ARG . 5.2 mmp_? 58.7 32.32 22.06 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.405 0.621 . . . . 0.0 110.627 -174.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.434 HH11 ' HD3' ' A' ' 70' ' ' ARG . 34.1 mtp180 -114.42 -178.84 3.47 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.272 179.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.469 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 55.6 m-85 -138.87 142.41 38.59 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.486 0.184 . . . . 0.0 111.148 -178.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.691 ' CG ' ' HB2' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -123.26 120.57 33.49 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-O 120.813 0.339 . . . . 0.0 110.874 178.914 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.576 HD13 HD11 ' A' ' 84' ' ' LEU . 17.6 tt -93.51 89.53 2.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.917 0.865 . . . . 0.0 110.817 -177.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.513 ' O ' ' HB3' ' A' ' 75' ' ' ASP . . . 59.51 77.08 0.19 Allowed Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.305 -178.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.513 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 16.6 t70 78.54 -52.24 0.48 Allowed 'General case' 0 N--CA 1.48 1.051 0 O-C-N 123.749 0.323 . . . . 0.0 111.409 178.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -70.47 134.8 48.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.0 0.429 . . . . 0.0 111.795 -173.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.47 ' OE1' HD12 ' A' ' 66' ' ' LEU . 6.0 mm-40 -89.49 143.9 26.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.185 -177.33 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.481 ' HZ ' ' CD2' ' A' ' 87' ' ' PHE . 47.0 m-85 -140.52 -175.42 4.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.293 172.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -75.38 -56.81 4.35 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.17 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.481 ' ND1' ' HD2' ' A' ' 82' ' ' PRO . 2.5 p80 -166.81 -174.0 2.59 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.762 175.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.645 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 16.4 mt -53.51 -59.74 8.73 Favored Pre-proline 0 N--CA 1.47 0.547 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -177.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.645 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 38.5 Cg_exo -65.11 3.2 1.05 Allowed 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 122.752 2.301 . . . . 0.0 113.56 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -106.07 -35.06 7.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.911 0.386 . . . . 0.0 110.669 179.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.576 HD11 HD13 ' A' ' 73' ' ' ILE . 4.6 pp -76.14 -30.74 58.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.938 0.399 . . . . 0.0 110.127 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.47 ' N ' HD12 ' A' ' 84' ' ' LEU . 79.2 mt -63.66 -27.88 69.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.042 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.555 ' HA ' ' HD3' ' A' ' 89' ' ' LYS . 19.9 tp10 -80.9 -21.96 40.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.98 -176.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.481 ' CD2' ' HZ ' ' A' ' 78' ' ' PHE . 62.4 t80 -83.02 -20.61 34.72 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.898 0.856 . . . . 0.0 109.243 -177.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.725 ' CG ' HD22 ' A' ' 93' ' ' LEU . 35.5 m-85 -97.27 1.98 50.24 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.444 -177.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.555 ' HD3' ' HA ' ' A' ' 86' ' ' GLU . 53.8 mtpt -86.23 -2.24 58.19 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.967 173.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 33.2 pt -131.85 -8.52 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 CA-C-O 121.432 0.634 . . . . 0.0 109.365 177.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.441 ' HB2' ' O ' ' A' ' 87' ' ' PHE . 8.2 t60 -82.82 -32.54 27.56 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.602 -174.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.404 ' CD2' HG21 ' A' ' 97' ' ' THR . 95.4 m-85 56.93 78.84 0.2 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.92 -166.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.725 HD22 ' CG ' ' A' ' 88' ' ' TYR . 12.9 mt -45.77 -83.03 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.21 0 O-C-N 124.091 0.87 . . . . 0.0 110.34 178.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.578 ' HB2' ' HG3' ' A' ' 154' ' ' GLU . 45.5 t0 -109.13 84.17 1.88 Allowed 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.908 -179.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 1.09 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 4.8 t 49.93 17.68 0.31 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.643 0.777 . . . . 0.0 112.152 -178.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.8 t -163.12 157.58 20.82 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 -178.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.404 HG21 ' CD2' ' A' ' 92' ' ' TYR . 7.9 p -98.4 176.33 5.73 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.644 0.259 . . . . 0.0 110.463 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.4 mt -72.02 90.65 1.18 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 174.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.544 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 50.1 mm -73.74 -54.39 15.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.247 -175.031 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.736 ' O ' ' HA ' ' A' ' 35' ' ' MET . 11.1 pt-20 -158.44 153.74 22.06 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.032 -177.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.73 145.95 33.23 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 121.924 1.749 . . . . 0.0 111.531 176.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.512 ' O ' ' HE2' ' A' ' 16' ' ' MET . . . -72.08 150.7 92.5 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.34 134.35 63.17 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.409 2.073 . . . . 0.0 111.673 175.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.513 ' NH1' ' HA ' ' A' ' 12' ' ' SER . 56.2 mtm180 -80.83 -14.29 58.18 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -174.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -69.14 150.01 97.5 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -68.86 100.36 0.71 Allowed 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.229 1.952 . . . . 0.0 111.389 174.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.0 m -57.91 119.74 36.61 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.045 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.546 ' HB2' ' HD3' ' A' ' 109' ' ' PRO . 51.0 Cg_exo -53.27 -51.25 11.41 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.041 2.494 . . . . 0.0 113.672 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.546 ' HD3' ' HB2' ' A' ' 108' ' ' PRO . 78.0 Cg_endo -84.23 -1.88 9.91 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 121.648 1.565 . . . . 0.0 111.775 175.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' MET . . . . . 0.462 ' HB3' ' HG1' ' A' ' 26' ' ' THR . 64.1 mtt 64.37 -83.44 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.094 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.789 -175.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -173.54 -61.45 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -178.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' SER . . . . . 0.536 ' HB2' ' HG3' ' A' ' 29' ' ' GLN . 48.7 m -154.9 -81.62 0.08 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 172.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.3 m -140.82 162.84 22.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.742 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.469 ' HB3' ' HB2' ' A' ' 22' ' ' GLN . 14.9 m -90.24 91.75 8.64 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.87 0.367 . . . . 0.0 110.328 177.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.822 ' H ' ' HG2' ' A' ' 25' ' ' GLN . . . -92.63 147.19 33.74 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.433 178.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 115' ' ' ALA . 1.0 OUTLIER -84.32 136.49 6.66 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.908 2.405 . . . . 0.0 112.81 -178.597 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.718 ' HA ' HH21 ' A' ' 21' ' ' ARG . 63.7 t30 70.37 -140.08 0.06 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.632 173.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.818 ' HB2' ' HD3' ' A' ' 119' ' ' PRO . 83.4 mt -75.82 -66.62 0.38 Allowed Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -169.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.818 ' HD3' ' HB2' ' A' ' 118' ' ' LEU . 72.8 Cg_endo -87.58 -168.77 0.42 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.258 1.972 . . . . 0.0 113.323 -171.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.3 m -91.88 32.44 1.13 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.682 -177.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 73.16 -51.69 0.71 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.669 0.788 . . . . 0.0 112.272 178.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -137.44 85.34 2.11 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.387 0.613 . . . . 0.0 110.294 176.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -138.26 -74.45 0.4 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.539 176.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' A' ' 125' ' ' LEU . 0.4 OUTLIER 173.85 147.05 0.06 Allowed 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 123.199 0.6 . . . . 0.0 109.453 179.424 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.574 ' HG ' ' HD2' ' A' ' 155' ' ' LYS . 3.9 mm? 72.04 109.12 0.07 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.695 0.76 . . . . 0.0 111.386 177.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.453 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 44.7 tt0 -169.39 -72.25 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.161 -178.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -117.66 114.64 23.67 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.634 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.938 HG23 ' HG3' ' A' ' 180' ' ' LYS . 57.4 t -126.38 150.15 31.82 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.096 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.721 ' CZ ' HD13 ' A' ' 181' ' ' LEU . 0.0 OUTLIER -124.73 155.01 39.98 Favored 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 118.014 -1.474 . . . . 0.0 109.031 165.158 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.565 ' OG1' ' HB2' ' A' ' 144' ' ' PHE . 72.9 p -106.02 140.05 39.61 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.216 0.531 . . . . 0.0 111.072 178.129 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.574 HD22 ' HG2' ' A' ' 179' ' ' GLU . 8.8 mt -113.73 -5.9 13.31 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.039 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.433 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 28.6 t80 -93.91 -41.11 9.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.694 -173.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.624 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 10.7 t70 74.28 95.53 0.07 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.486 0.66 . . . . 0.0 110.69 -178.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.619 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 75.4 t80 -126.01 90.46 50.21 Favored Pre-proline 0 C--N 1.318 -0.765 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 173.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.578 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 95.0 Cg_endo -85.92 81.19 1.7 Allowed 'Trans proline' 0 N--CA 1.44 -1.636 0 C-N-CA 121.712 1.608 . . . . 0.0 112.144 178.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -69.69 -11.96 66.55 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.302 175.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.52 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 19.5 m120 50.3 65.86 1.32 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 114.297 -0.951 . . . . 0.0 111.629 177.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.463 ' HB3' ' H ' ' A' ' 141' ' ' ASP . 1.0 OUTLIER -130.88 -176.61 4.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.364 0.602 . . . . 0.0 110.898 -178.612 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -111.41 0.63 16.64 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 167.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -117.09 -45.99 2.73 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.691 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.463 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 8.4 m-20 -97.67 128.1 44.12 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 168.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.667 ' CD1' ' HB2' ' A' ' 165' ' ' ASN . 28.9 tp -84.61 124.48 73.17 Favored Pre-proline 0 CA--C 1.517 -0.321 0 O-C-N 122.095 -0.378 . . . . 0.0 110.98 -176.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.578 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 49.7 Cg_endo -76.11 105.79 2.14 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 121.502 1.468 . . . . 0.0 111.707 166.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.619 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -93.42 -161.68 0.87 Allowed 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 175.364 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.624 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 68.6 mttm -138.07 -170.94 2.9 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.801 176.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.944 ' H ' ' HD2' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -84.7 25.26 0.93 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.384 0.612 . . . . 0.0 109.913 -179.533 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.404 ' H ' ' C ' ' A' ' 145' ' ' LYS . . . 158.78 41.6 0.02 OUTLIER Glycine 0 N--CA 1.436 -1.353 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.898 -177.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.723 ' CD ' ' HG ' ' A' ' 150' ' ' LEU . 1.8 pp20? -84.7 170.04 13.68 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 173.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.569 HD11 ' HB3' ' A' ' 129' ' ' ARG . 1.1 mp -111.78 128.54 68.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 118.453 0.569 . . . . 0.0 109.62 170.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.756 ' CD2' ' HA ' ' A' ' 165' ' ' ASN . 82.1 mt -119.42 155.95 31.05 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -172.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.554 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 62.0 t -123.51 120.22 59.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 172.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.525 HG22 HD13 ' A' ' 125' ' ' LEU . 25.8 mm -79.79 82.34 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.675 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.789 ' HA ' HD11 ' A' ' 118' ' ' LEU . 14.3 tt -72.21 -33.72 47.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-N 114.203 -1.362 . . . . 0.0 108.904 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.699 ' OE2' HG12 ' A' ' 153' ' ' ILE . 3.4 mp0 -125.86 143.61 51.0 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.046 176.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.574 ' HD2' ' HG ' ' A' ' 125' ' ' LEU . 83.1 tttt -136.08 87.82 23.12 Favored Pre-proline 0 C--N 1.316 -0.858 0 CA-C-O 121.108 0.48 . . . . 0.0 109.76 171.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 1.09 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 8.0 Cg_exo -76.35 -50.52 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.787 2.324 . . . . 0.0 112.112 174.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.647 ' HG2' ' CE ' ' A' ' 172' ' ' MET . 5.4 mm-40 -102.21 173.31 6.43 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.113 -173.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.495 ' O ' HG22 ' A' ' 175' ' ' VAL . 8.7 tp10 -104.83 -17.93 14.41 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 175.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -99.99 -17.0 17.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.314 174.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.417 ' HA ' ' O ' ' A' ' 173' ' ' ILE . 73.1 m95 -130.26 125.35 34.61 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.735 178.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . 0.674 ' O ' HG13 ' A' ' 173' ' ' ILE . 50.0 m0 -112.81 135.81 53.14 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.021 0.438 . . . . 0.0 110.437 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.606 ' OG ' ' HG2' ' A' ' 172' ' ' MET . 70.5 m -93.31 92.93 7.92 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -174.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.526 ' HB2' ' HB3' ' A' ' 150' ' ' LEU . . . -109.45 146.78 33.96 Favored 'General case' 0 N--CA 1.415 -2.194 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -172.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.77 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 12.3 ptt180 -88.16 127.21 35.43 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 174.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.756 ' HA ' ' CD2' ' A' ' 150' ' ' LEU . 63.5 t30 -59.41 179.94 0.1 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.103 -1.408 . . . . 0.0 111.793 -170.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 48.9 tptt -56.74 -20.88 24.37 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.52 167.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -79.88 -30.71 40.23 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.843 172.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.509 ' C ' ' HB2' ' A' ' 164' ' ' ARG . . . 101.53 7.95 47.43 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.064 -174.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.77 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -77.97 132.11 37.7 Favored 'General case' 0 C--O 1.217 -0.625 0 C-N-CA 122.646 0.378 . . . . 0.0 111.222 177.243 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.479 HG23 HG22 ' A' ' 153' ' ' ILE . 47.9 t -82.43 125.47 39.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.634 -179.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -159.17 152.39 23.4 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 121.042 -0.599 . . . . 0.0 111.965 173.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.647 ' CE ' ' HG2' ' A' ' 157' ' ' GLU . 35.9 mtp -77.5 142.96 38.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.893 0.346 . . . . 0.0 110.704 -178.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.674 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.7 pp -142.45 144.93 32.67 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.019 -175.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.453 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 22.8 Cg_exo -65.05 129.94 24.41 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 122.834 2.356 . . . . 0.0 113.004 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.632 ' O ' HG23 ' A' ' 178' ' ' VAL . 58.0 t -64.87 -41.6 56.75 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 18.6 Cg_endo -61.29 -6.8 7.23 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 121.858 1.705 . . . . 0.0 112.748 176.204 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.453 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.2 m-30 -95.53 -9.23 32.96 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.814 -178.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 175' ' ' VAL . 4.3 m -105.04 -171.98 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 -166.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.633 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 6.7 tp10 -159.15 49.6 0.34 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 112.678 -2.056 . . . . 0.0 111.812 -153.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.938 ' HG3' HG23 ' A' ' 128' ' ' VAL . 3.2 mppt? -69.66 136.13 50.74 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 119.603 -1.935 . . . . 0.0 111.081 -160.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.721 HD13 ' CZ ' ' A' ' 129' ' ' ARG . 14.6 tp -72.21 -76.67 0.11 Allowed 'General case' 0 CA--C 1.523 -0.096 0 CA-C-N 113.207 -1.815 . . . . 0.0 110.655 -168.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.428 ' H ' ' HB3' ' A' ' 181' ' ' LEU . 5.7 m -101.08 105.24 17.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.179 -0.918 . . . . 0.0 109.263 175.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -164.36 -49.06 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.269 -175.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 41.7 m 59.56 91.18 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.567 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' SER . . . . . 0.705 ' HB3' ' HD2' ' A' ' 186' ' ' PRO . 1.0 OUTLIER -65.11 176.74 0.74 Allowed Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.749 -174.504 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.705 ' HD2' ' HB3' ' A' ' 185' ' ' SER . 2.3 Cg_endo -46.29 119.85 3.35 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.932 2.421 . . . . 0.0 112.409 173.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -137.71 -174.33 3.74 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -73.86 65.52 1.83 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.975 175.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 97.3 mttt 61.94 98.09 0.03 OUTLIER 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.57 0.7 . . . . 0.0 111.067 -176.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -103.29 162.43 13.0 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.757 -176.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -171.03 108.84 0.3 Allowed Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.267 178.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -64.29 -60.4 3.23 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 175.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 72.9 mtt180 -129.66 -7.58 4.58 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.333 -0.848 . . . . 0.0 108.8 168.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 66.9 t30 56.11 70.06 0.68 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.033 -166.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 13.0 m -72.86 -33.97 66.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.68 -172.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -161.32 -177.23 5.87 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -174.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' SER . . . . . 0.422 ' HA ' ' CG2' ' A' ' 200' ' ' ILE . 22.9 t 80.0 29.23 0.27 Allowed 'General case' 0 CA--C 1.531 0.233 0 O-C-N 123.91 0.756 . . . . 0.0 111.199 176.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -84.83 -40.66 16.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.323 177.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -137.6 36.15 1.98 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.909 -177.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.422 ' CG2' ' HA ' ' A' ' 197' ' ' SER . 6.2 tp -128.03 97.72 28.74 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 121.334 0.588 . . . . 0.0 111.007 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -73.62 -59.33 0.05 OUTLIER 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 123.344 2.696 . . . . 0.0 112.794 178.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -68.95 120.85 79.05 Favored Pre-proline 0 N--CA 1.463 0.215 0 CA-C-O 120.574 0.226 . . . . 0.0 110.98 -177.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -83.85 178.43 5.44 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.684 2.256 . . . . 0.0 112.129 177.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -77.95 84.26 4.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.102 0.477 . . . . 0.0 110.51 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 69.8 t60 -121.21 141.23 51.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.037 -177.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -72.12 106.66 4.43 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 177.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -74.5 159.89 31.64 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.094 -175.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -156.14 130.92 9.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.719 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -100.33 145.51 30.39 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.305 -0.407 . . . . 0.0 109.966 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.09 105.37 0.68 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.737 2.291 . . . . 0.0 111.395 174.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -83.62 -34.58 25.07 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.299 -173.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 2.7 m -134.25 112.8 11.36 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.26 -175.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 28.6 m -112.97 -80.17 0.59 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 175.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 7.6 p -144.8 94.37 5.46 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-O 120.976 0.417 . . . . 0.0 111.544 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -71.98 -39.37 3.26 Favored 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 122.279 1.986 . . . . 0.0 112.128 174.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 50.0 tp 58.95 90.06 0.1 OUTLIER Pre-proline 0 N--CA 1.464 0.238 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.798 -177.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.34 -67.95 0.05 OUTLIER 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 122.711 2.274 . . . . 0.0 112.434 -178.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -161.26 159.74 29.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.576 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 4.9 m -98.94 96.05 4.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.545 0.688 . . . . 0.0 110.684 178.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 16.0 m -94.82 99.96 11.93 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.642 -178.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 130.7 -167.46 22.14 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 -178.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.411 ' HA ' ' HD2' ' A' ' 223' ' ' PRO . 68.9 p 51.52 94.55 0.05 OUTLIER Pre-proline 0 N--CA 1.467 0.404 0 C-N-CA 123.753 0.821 . . . . 0.0 111.597 -178.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 222' ' ' SER . 11.1 Cg_endo -54.38 106.92 0.19 Allowed 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.182 2.588 . . . . 0.0 112.78 -176.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -106.84 49.59 0.86 Allowed Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 178.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -149.85 175.45 11.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.54 -0.33 . . . . 0.0 110.338 -176.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -78.72 89.98 4.61 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.16 0.505 . . . . 0.0 110.345 177.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.694 ' H ' HD13 ' A' ' 227' ' ' ILE . 0.2 OUTLIER -96.48 4.37 9.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.586 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' THR . . . . . 0.44 ' HA ' ' HD3' ' A' ' 229' ' ' PRO . 4.6 p -84.28 142.56 40.92 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.369 -178.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 228' ' ' THR . 13.1 Cg_exo -71.02 176.76 7.27 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.872 2.381 . . . . 0.0 112.025 177.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.517 HD13 ' HD2' ' A' ' 231' ' ' PRO . 24.4 tp -147.77 141.99 16.2 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.622 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.517 ' HD2' HD13 ' A' ' 230' ' ' LEU . 87.1 Cg_exo -47.98 144.31 12.21 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.529 2.153 . . . . 0.0 111.235 171.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.3 89.49 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.552 0.692 . . . . 0.0 112.786 -171.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' THR . . . . . 0.46 ' HB ' ' ND2' ' A' ' 235' ' ' ASN . 8.7 p -141.76 86.83 2.02 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.608 174.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -82.25 25.32 0.61 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.61 -169.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . 0.46 ' ND2' ' HB ' ' A' ' 233' ' ' THR . 9.3 p30 -83.4 -16.72 44.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.509 0.671 . . . . 0.0 109.266 171.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -97.64 -79.34 1.46 Allowed Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.556 176.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -92.1 116.41 0.4 Allowed 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 122.976 2.45 . . . . 0.0 112.029 175.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 22.9 t -89.63 145.32 7.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.482 ' HB2' ' HG3' ' A' ' 296' ' ' PRO . 84.7 m-85 -108.78 119.72 40.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.077 0.465 . . . . 0.0 111.105 -177.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -119.66 140.93 49.86 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.691 178.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.507 ' HB2' ' CE1' ' A' ' 294' ' ' PHE . 47.5 tttp -95.07 123.44 38.56 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . 0.486 ' HA ' HG13 ' A' ' 291' ' ' VAL . . . -71.44 102.77 2.74 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.29 -0.414 . . . . 0.0 109.961 -179.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 2.3 pp -82.27 -5.56 9.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.923 0.392 . . . . 0.0 111.972 -174.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . 0.45 ' HG2' ' H ' ' A' ' 245' ' ' LYS . 2.2 tt0 -146.95 164.32 33.33 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 176.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.45 ' H ' ' HG2' ' A' ' 244' ' ' GLN . 45.1 mttp -61.37 149.66 37.58 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 176.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.575 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 24.3 tpt180 -137.62 94.81 2.96 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 169.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 34.4 m -101.2 152.94 38.03 Favored Pre-proline 0 C--N 1.315 -0.919 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.709 -176.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.53 -161.2 0.11 Allowed 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.424 2.083 . . . . 0.0 111.816 177.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 34.9 t -151.05 -179.22 7.13 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -175.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -64.37 -34.01 77.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.671 0.272 . . . . 0.0 111.254 -178.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -95.55 11.19 33.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.399 -179.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.33 131.96 47.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.505 0.669 . . . . 0.0 112.638 -175.222 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . 0.428 ' HE3' ' HB3' ' A' ' 253' ' ' LYS . 6.3 ptpp? -150.53 0.46 0.43 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.663 167.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 1.2 p -144.88 14.85 1.54 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.304 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -101.59 117.86 35.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.137 0.494 . . . . 0.0 110.494 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.496 HD21 ' HB ' ' A' ' 279' ' ' VAL . 0.7 OUTLIER -78.59 134.68 37.18 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.178 -178.228 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.575 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -93.9 121.22 35.14 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.201 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.519 ' HB2' ' HB3' ' A' ' 246' ' ' ARG . 79.9 mt -123.73 152.68 41.86 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.041 -175.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -102.47 177.74 4.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.038 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 59.2 t -90.18 111.83 23.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.195 0.521 . . . . 0.0 110.551 -179.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 98.39 9.18 53.85 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.188 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -82.84 166.4 19.0 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -175.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 33.5 mm -104.67 110.82 31.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.255 0.55 . . . . 0.0 110.281 -177.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 14.0 t -96.44 108.75 21.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.806 -177.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 38.4 tttt -83.3 105.31 14.15 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.728 175.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.49 HG11 ' HE3' ' A' ' 269' ' ' MET . 4.3 p -99.22 117.17 43.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.496 0.665 . . . . 0.0 110.605 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 12.1 m -94.94 -25.23 16.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.844 -176.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 268' ' ' ARG . 36.6 ttm180 -132.2 108.22 9.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.007 0.432 . . . . 0.0 110.954 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' MET . . . . . 0.53 ' HE1' ' CZ2' ' A' ' 275' ' ' TRP . 32.1 mtt -94.75 126.95 40.4 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.657 178.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' ' 274' ' ' GLN . 56.5 m-80 -99.9 153.56 19.06 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 177.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.555 ' H ' HD11 ' A' ' 271' ' ' ILE . 4.3 mp -72.73 -34.48 47.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.147 -172.005 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -62.67 -26.4 68.63 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.742 -176.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 127.92 -26.93 4.7 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.35 -0.929 . . . . 0.0 112.637 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.482 ' O ' ' HB2' ' A' ' 270' ' ' ASN . 45.3 mt-30 -78.92 115.5 18.65 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 177.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.53 ' CZ2' ' HE1' ' A' ' 269' ' ' MET . 49.9 m0 -96.24 150.9 20.03 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.816 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 284' ' ' GLY . 43.6 tt0 -108.93 109.58 20.69 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 175.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . 0.546 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -122.16 155.36 16.83 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.841 -178.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.547 ' HG2' ' HB3' ' A' ' 283' ' ' LYS . 23.2 mt-10 -104.58 109.0 20.73 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . 0.521 HG11 ' ND2' ' A' ' 280' ' ' ASN . 46.9 t -121.92 114.5 43.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -178.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . 0.521 ' ND2' HG11 ' A' ' 279' ' ' VAL . 67.2 m-80 64.77 27.6 13.0 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.896 -178.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 90.01 -10.78 72.83 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.417 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 44.5 ttt-85 -102.35 118.55 37.12 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.547 ' HB3' ' HG2' ' A' ' 278' ' ' GLU . 57.3 pttt -109.82 141.95 41.78 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.094 0.473 . . . . 0.0 111.188 179.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 276' ' ' GLU . . . -167.21 -174.79 36.68 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 -179.077 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.51 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 68.8 mt -90.2 138.66 31.34 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.162 0.506 . . . . 0.0 111.252 -177.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.417 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 46.1 p90 -142.74 131.58 11.69 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.711 173.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 17.6 Cg_exo -69.06 139.2 42.03 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 122.902 2.401 . . . . 0.0 111.822 177.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -65.57 -4.64 6.36 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.663 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 2.4 m -74.42 -22.82 58.96 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.933 0.397 . . . . 0.0 111.088 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 41.0 m-70 -94.12 -11.58 30.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.848 0.356 . . . . 0.0 111.149 -176.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.486 HG13 ' HA ' ' A' ' 242' ' ' ALA . 34.8 m -128.02 167.5 22.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.057 -178.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -140.9 128.47 21.4 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.848 0.356 . . . . 0.0 110.727 175.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 41.0 mm -67.83 126.54 27.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.241 177.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' PHE . . . . . 0.507 ' CE1' ' HB2' ' A' ' 241' ' ' LYS . 1.4 p90 -141.14 -179.59 6.19 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.504 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -101.6 96.09 5.96 Favored Pre-proline 0 C--N 1.322 -0.628 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . 0.482 ' HG3' ' HB2' ' A' ' 239' ' ' PHE . 43.0 Cg_endo -69.24 -46.26 1.52 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.604 2.203 . . . . 0.0 113.112 -173.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . 0.452 ' OE1' ' HA ' ' A' ' 297' ' ' GLN . 6.3 tp60 -90.76 89.5 7.52 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.29 0.567 . . . . 0.0 109.924 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -121.43 113.84 32.0 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.406 176.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' PRO . . . . . 0.509 ' HA ' ' HB3' ' A' ' 302' ' ' ASN . 43.8 Cg_exo -57.56 -17.98 30.47 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 123.256 2.638 . . . . 0.0 112.104 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -54.81 -37.59 66.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.117 177.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -105.88 11.41 31.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.885 0.374 . . . . 0.0 110.832 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . 0.509 ' HB3' ' HA ' ' A' ' 299' ' ' PRO . 18.7 t-20 -113.27 -26.62 8.3 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.869 -176.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 . . . . . 0 C--O 1.245 0.836 0 CA-C-O 118.723 -0.656 . . . . 0.0 109.731 176.44 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.0 mtt . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.7 p -103.58 127.63 50.97 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 174.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.539 ' HB2' HD13 ' A' ' 99' ' ' ILE . 13.7 p -55.53 -44.63 76.87 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.985 -175.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.98 110.76 4.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.378 177.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.548 ' CZ ' ' HA ' ' A' ' 5' ' ' ARG . 3.6 mmp_? -115.25 -5.72 12.38 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -172.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -79.25 155.41 28.58 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.476 -174.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -66.24 -36.29 82.63 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.574 -176.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.1 t 65.39 37.88 6.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.335 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.8 m -152.34 -33.05 0.13 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.278 177.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -77.56 113.93 15.88 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.98 0.419 . . . . 0.0 111.285 -173.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -57.72 -45.35 85.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.201 -175.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 51.1 m -71.74 1.67 6.5 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -91.06 -42.07 10.71 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.601 176.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 22.4 p-90 -122.73 -29.07 4.07 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -174.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -77.71 103.2 7.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.808 0.337 . . . . 0.0 111.554 -173.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.45 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 23.6 mmt -87.28 -6.53 58.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.288 -176.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 49.93 -115.54 3.17 Favored Glycine 0 CA--C 1.52 0.359 0 CA-C-N 115.629 -0.714 . . . . 0.0 113.306 -178.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.58 99.78 1.26 Allowed 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 122.475 2.116 . . . . 0.0 112.535 -176.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.434 ' O ' ' CB ' ' A' ' 20' ' ' SER . 3.5 t -130.11 -70.49 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-O 118.243 -0.884 . . . . 0.0 111.73 -176.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 19' ' ' VAL . 22.9 t 108.46 161.32 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.126 1.371 . . . . 0.0 109.219 173.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 34.0 ttt85 -64.89 -38.81 92.23 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.801 0.334 . . . . 0.0 110.241 -177.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.415 ' H ' ' HG2' ' A' ' 22' ' ' GLN . 3.8 mm-40 -64.9 -34.26 77.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.429 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.509 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 0.4 OUTLIER -84.21 -53.13 5.72 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.801 -174.565 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.515 ' HB2' HD11 ' A' ' 37' ' ' LEU . . . -56.05 -40.95 74.3 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.782 -178.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.57 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 55.0 tp60 -62.42 -44.53 96.22 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.569 -178.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.476 HG21 ' O ' ' A' ' 23' ' ' GLU . 9.1 t -75.69 -15.49 60.3 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 120.818 0.342 . . . . 0.0 111.055 -177.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' A' ' 23' ' ' GLU . 52.2 mmm-85 -76.96 -19.59 57.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.922 0.392 . . . . 0.0 110.357 176.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.613 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 78.1 mt -128.84 -13.1 4.7 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -173.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.57 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -66.21 107.61 2.01 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.844 0.354 . . . . 0.0 110.757 -173.789 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.3 -2.24 67.2 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.822 -0.704 . . . . 0.0 113.331 175.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.403 HE21 ' HB3' ' A' ' 31' ' ' GLN . 9.6 mt-30 -78.31 -175.05 4.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.728 0.264 . . . . 0.0 110.587 179.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.598 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 12.4 ttp180 -52.68 131.02 34.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.334 0.588 . . . . 0.0 110.827 -179.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.572 ' HB3' ' OE1' ' A' ' 54' ' ' GLU . 43.6 m170 -82.03 145.1 30.4 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.407 -175.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.35 -12.91 48.02 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 111.606 -0.597 . . . . 0.0 111.606 -176.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.598 ' SD ' ' HB3' ' A' ' 32' ' ' ARG . 11.6 mtp -81.55 141.47 33.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.687 0.28 . . . . 0.0 110.737 178.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.437 ' CD2' HD21 ' A' ' 98' ' ' LEU . 33.1 p90 -143.24 167.43 22.15 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.691 -178.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.515 HD11 ' HB2' ' A' ' 24' ' ' ALA . 4.4 pp -158.08 138.52 12.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.155 0.503 . . . . 0.0 111.453 175.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.413 HG21 HD11 ' A' ' 50' ' ' LEU . 48.3 t -102.94 120.8 53.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 174.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.423 ' HD2' ' H ' ' A' ' 20' ' ' SER . 23.8 ptt-85 -125.94 -169.45 2.01 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.639 0.257 . . . . 0.0 110.71 -175.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -68.9 140.49 55.14 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.829 177.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.4 t -86.23 104.66 15.98 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 167.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.9 m -71.65 -11.4 60.82 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.378 -177.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 16.9 p -84.59 -29.74 25.57 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.996 0.427 . . . . 0.0 110.261 176.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 52.4 t -151.34 95.37 3.34 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.017 178.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -58.06 113.9 1.73 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.922 2.415 . . . . 0.0 112.066 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 130.37 -33.04 2.97 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -174.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.591 ' OD2' ' HA ' ' A' ' 64' ' ' ASN . 2.6 m-20 -88.42 175.86 7.43 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 170.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.523 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 44.1 m-85 -136.17 175.58 9.47 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.407 -175.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.2 t -142.46 106.71 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.926 0.393 . . . . 0.0 110.67 176.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.413 HD11 HG21 ' A' ' 38' ' ' VAL . 46.7 tp -80.97 103.76 11.01 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.389 176.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.1 m -96.45 126.66 41.79 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 176.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.566 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 95.4 t -121.76 135.89 60.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.754 -175.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.613 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 23.4 t -95.88 114.75 26.51 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -175.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.572 ' OE1' ' HB3' ' A' ' 33' ' ' HIS . 9.4 tp10 -151.48 154.7 37.08 Favored 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 119.53 -0.868 . . . . 0.0 108.999 164.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.564 ' ND2' ' HG3' ' A' ' 54' ' ' GLU . 0.5 OUTLIER 45.4 37.52 3.01 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.537 0.735 . . . . 0.0 112.701 -177.666 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 34.5 m 49.38 56.09 8.35 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 122.403 1.097 . . . . 0.0 109.459 -178.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.513 ' HB2' ' O ' ' A' ' 55' ' ' ASN . 1.5 tmm_? -165.67 64.32 0.11 Allowed 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 113.312 -1.767 . . . . 0.0 109.33 -152.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.566 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 14.1 t -72.3 106.33 2.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.961 0.886 . . . . 0.0 110.353 -169.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.4 m -76.64 122.49 24.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 113.899 -1.5 . . . . 0.0 111.31 -177.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -95.55 102.37 14.17 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.107 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.669 ' OH ' ' HB3' ' A' ' 93' ' ' LEU . 70.8 m-85 -97.35 109.26 22.05 Favored 'General case' 0 C--O 1.221 -0.396 0 C-N-CA 123.079 0.552 . . . . 0.0 110.667 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.546 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 59.2 mt -80.03 128.88 38.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -173.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.523 ' HB ' ' HB2' ' A' ' 48' ' ' TYR . 3.1 mp -99.7 111.08 28.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.707 177.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.591 ' HA ' ' OD2' ' A' ' 47' ' ' ASP . 15.9 m120 -83.94 133.81 34.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.944 178.137 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.2 t -89.16 95.79 10.45 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.517 HD12 ' HB2' ' A' ' 72' ' ' LYS . 83.6 mt -81.07 147.79 62.25 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.247 -176.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.414 ' C ' ' H ' ' A' ' 69' ' ' ARG . 64.6 Cg_endo -76.77 -9.38 18.3 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.932 2.421 . . . . 0.0 112.877 -179.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 35.2 p30 -81.19 7.85 10.25 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.575 0.702 . . . . 0.0 109.322 171.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.716 ' NE ' ' HA ' ' A' ' 69' ' ' ARG . 3.4 tpm_? 61.64 58.27 2.06 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.125 -1.398 . . . . 0.0 110.981 -176.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.853 ' HG2' ' HA ' ' A' ' 79' ' ' ASP . 79.4 mtt180 -135.41 176.73 8.41 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.24 172.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.529 ' HA ' ' O ' ' A' ' 64' ' ' ASN . 52.2 m-85 -130.48 113.51 14.38 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.021 0.438 . . . . 0.0 109.83 176.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.586 ' HE2' ' HA ' ' A' ' 75' ' ' ASP . 36.0 tttm -98.19 105.02 17.1 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.981 -173.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.64 HD12 ' CE2' ' A' ' 88' ' ' TYR . 16.3 tt -81.0 79.35 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 122.18 0.99 . . . . 0.0 111.0 -176.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.78 -10.36 18.97 Favored Glycine 0 CA--C 1.52 0.378 0 CA-C-N 115.004 -0.998 . . . . 0.0 113.87 176.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.586 ' HA ' ' HE2' ' A' ' 72' ' ' LYS . 8.7 t70 177.28 -68.71 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 116.944 0.372 . . . . 0.0 110.321 -170.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -66.35 123.64 20.52 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.921 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' A' ' 77' ' ' GLU . 13.7 pt-20 -93.62 105.25 17.31 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.734 0.778 . . . . 0.0 110.728 177.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.478 ' CZ ' ' CD1' ' A' ' 87' ' ' PHE . 84.1 m-85 -95.03 152.25 18.48 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 174.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.853 ' HA ' ' HG2' ' A' ' 70' ' ' ARG . 8.3 m-20 -67.99 -23.24 65.0 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -171.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.977 ' HD1' ' HG2' ' A' ' 82' ' ' PRO . 6.0 p80 -162.36 165.47 26.44 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.736 -0.211 . . . . 0.0 110.438 -178.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.539 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 10.0 mt -55.99 -54.89 47.32 Favored Pre-proline 0 CA--C 1.535 0.377 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -178.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.977 ' HG2' ' HD1' ' A' ' 80' ' ' HIS . 15.4 Cg_endo -61.12 -4.17 3.65 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.183 1.922 . . . . 0.0 113.796 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.414 ' HB3' ' CE1' ' A' ' 80' ' ' HIS . . . -89.87 -34.94 15.91 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.762 0.315 . . . . 0.0 110.769 178.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.1 pp -76.94 -30.96 56.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.135 0.493 . . . . 0.0 109.838 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 70.1 mt -68.43 -21.56 64.65 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.491 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.533 ' OE2' ' HD2' ' A' ' 89' ' ' LYS . 18.8 tp10 -85.81 -35.43 20.68 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.183 176.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.539 ' HE1' ' CZ ' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -71.56 -19.54 62.14 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.333 0.587 . . . . 0.0 111.436 -179.815 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.747 ' CD1' HD22 ' A' ' 93' ' ' LEU . 38.7 m-85 -94.96 5.47 51.83 Favored 'General case' 0 C--N 1.313 -0.98 0 O-C-N 121.685 -0.634 . . . . 0.0 111.769 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.533 ' HD2' ' OE2' ' A' ' 86' ' ' GLU . 96.2 mttt -77.52 -25.91 50.64 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.685 171.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.545 ' H ' HD12 ' A' ' 90' ' ' ILE . 0.3 OUTLIER -106.32 -17.67 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 CA-C-O 121.41 0.624 . . . . 0.0 109.756 174.148 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.478 ' HB2' ' O ' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -93.97 106.41 18.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.78 178.771 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -72.46 104.23 3.74 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.756 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.747 HD22 ' CD1' ' A' ' 88' ' ' TYR . 16.5 mt -59.43 -31.02 68.9 Favored 'General case' 0 C--O 1.215 -0.757 0 O-C-N 124.356 1.035 . . . . 0.0 111.431 -176.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.465 ' HB3' ' HA ' ' A' ' 154' ' ' GLU . 24.5 p-10 -176.18 85.47 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.883 0.849 . . . . 0.0 110.532 164.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 71.78 -19.18 0.27 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.592 -175.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.453 ' H ' ' C ' ' A' ' 94' ' ' ASP . 18.0 m -132.49 146.03 51.62 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 120.968 0.413 . . . . 0.0 110.625 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.415 ' O ' HG21 ' A' ' 96' ' ' THR . 37.4 p -96.16 -178.17 4.24 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.533 178.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.493 ' HG ' HD11 ' A' ' 93' ' ' LEU . 96.1 mt -70.84 106.3 3.55 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 174.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.539 HD13 ' HB2' ' A' ' 3' ' ' SER . 46.4 mm -89.86 -63.07 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.189 0.519 . . . . 0.0 110.422 -177.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.572 ' O ' ' HA ' ' A' ' 35' ' ' MET . 11.2 pt-20 -157.69 151.5 19.51 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.426 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.6 155.55 68.55 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.274 1.983 . . . . 0.0 112.362 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.42 ' HB1' HD21 ' A' ' 28' ' ' LEU . . . -69.07 146.56 97.25 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.476 179.095 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -57.61 130.92 41.25 Favored 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 122.618 2.212 . . . . 0.0 112.951 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -87.28 -31.76 20.07 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 172.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -115.35 147.41 38.59 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.04 175.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.55 -8.71 15.79 Favored 'Trans proline' 0 CA--C 1.529 0.256 0 C-N-CA 122.853 2.368 . . . . 0.0 112.88 -177.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 35.6 m 54.8 67.44 3.26 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.639 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.444 ' HB2' ' HD3' ' A' ' 109' ' ' PRO . 51.3 Cg_exo -53.3 -44.62 47.45 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 123.002 2.468 . . . . 0.0 114.147 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.444 ' HD3' ' HB2' ' A' ' 108' ' ' PRO . 32.1 Cg_exo -61.57 -22.55 74.74 Favored 'Trans proline' 0 C--N 1.362 1.263 0 C-N-CA 121.956 1.771 . . . . 0.0 112.56 176.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 54.2 ttm -89.91 68.2 7.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.43 0.633 . . . . 0.0 109.869 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -82.37 94.59 1.71 Allowed Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.502 178.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.1 p -149.25 168.7 22.57 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.584 0.23 . . . . 0.0 110.81 -176.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.3 p -113.62 107.51 23.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.493 0.663 . . . . 0.0 109.809 176.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.436 ' OG ' ' HD3' ' A' ' 32' ' ' ARG . 21.0 t -91.93 113.8 26.16 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.145 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -109.89 103.72 53.97 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.446 178.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -70.4 135.11 28.17 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.288 1.992 . . . . 0.0 111.852 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -70.22 143.45 52.18 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.225 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.7 mp 58.83 78.06 0.37 Allowed Pre-proline 0 N--CA 1.462 0.168 0 O-C-N 123.925 0.766 . . . . 0.0 110.82 -178.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -59.9 -74.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.119 1.879 . . . . 0.0 110.847 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.573 HG23 ' HB2' ' A' ' 122' ' ' GLU . 19.7 m 52.34 77.15 0.16 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 171.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -81.1 74.91 8.09 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 170.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.573 ' HB2' HG23 ' A' ' 120' ' ' THR . 7.4 tp10 -89.86 -32.56 16.83 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.293 -168.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.8 t70 61.02 -152.78 0.38 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -171.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 64.87 -170.62 0.19 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 118.278 0.49 . . . . 0.0 111.228 176.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.53 HD13 HG22 ' A' ' 152' ' ' ILE . 4.3 mm? 60.45 95.83 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.652 0.739 . . . . 0.0 110.814 178.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.711 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 4.9 tp10 -165.61 -74.28 0.03 OUTLIER 'General case' 0 C--O 1.218 -0.554 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.028 -169.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -108.17 110.95 22.71 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.036 0.446 . . . . 0.0 110.296 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.829 HG23 ' HG3' ' A' ' 180' ' ' LYS . 86.4 t -125.87 136.65 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.647 176.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.671 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 5.6 ptp180 -112.13 147.16 36.71 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 117.41 -1.716 . . . . 0.0 108.474 169.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.663 ' HG1' ' CB ' ' A' ' 144' ' ' PHE . 7.6 p -99.72 135.56 40.96 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.628 177.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.552 HD22 ' HG2' ' A' ' 179' ' ' GLU . 14.3 mt -108.41 3.0 22.8 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -177.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.439 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 27.0 t80 -99.94 -43.34 6.42 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.494 -0.483 . . . . 0.0 112.112 -174.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.639 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 14.5 t70 73.04 96.85 0.07 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.513 0.673 . . . . 0.0 109.888 -171.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.514 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 44.2 t80 -129.14 90.06 46.37 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 174.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.603 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 92.7 Cg_endo -90.52 84.35 0.4 Allowed 'Trans proline' 0 N--CA 1.436 -1.862 0 C-N-CA 121.914 1.743 . . . . 0.0 112.358 -178.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -78.67 -2.37 85.31 Favored Glycine 0 C--N 1.329 0.191 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.217 176.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 19.0 m120 36.16 71.04 0.14 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 113.872 -1.164 . . . . 0.0 112.461 -175.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.479 ' HB3' ' H ' ' A' ' 141' ' ' ASP . 0.4 OUTLIER -132.7 -176.59 4.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.22 0.533 . . . . 0.0 111.317 -177.394 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -112.17 1.75 16.37 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 167.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -115.41 -44.4 2.98 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.296 175.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.479 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 9.7 m-20 -98.36 127.61 44.37 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 166.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.734 ' CD2' HD23 ' A' ' 150' ' ' LEU . 24.6 tp -81.88 130.7 59.68 Favored Pre-proline 0 CA--C 1.518 -0.254 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.283 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.603 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 72.0 Cg_endo -84.0 92.04 0.82 Allowed 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.121 1.881 . . . . 0.0 112.292 174.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.663 ' CB ' ' HG1' ' A' ' 130' ' ' THR . 1.5 p90 -90.89 179.73 5.69 Favored 'General case' 0 CA--C 1.504 -0.799 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.817 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.639 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 16.3 mtpp -122.05 -176.6 3.38 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.294 172.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.716 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -78.65 36.78 0.27 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.798 0.809 . . . . 0.0 110.852 -174.635 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 145' ' ' LYS . . . 151.66 42.75 0.02 OUTLIER Glycine 0 N--CA 1.433 -1.554 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.32 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.402 ' OE1' ' HA ' ' A' ' 144' ' ' PHE . 0.1 OUTLIER -103.84 147.11 27.68 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 119.352 -0.939 . . . . 0.0 109.993 179.647 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.527 HD13 ' N ' ' A' ' 149' ' ' ILE . 1.6 mp -87.26 125.76 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.868 -177.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.734 HD23 ' CD2' ' A' ' 142' ' ' LEU . 33.8 mt -122.18 158.11 30.1 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -176.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.711 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 61.8 t -120.08 121.49 65.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 175.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.53 HG22 HD13 ' A' ' 125' ' ' LEU . 38.0 mm -77.18 79.31 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 CA-C-O 122.183 0.992 . . . . 0.0 108.682 -177.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.643 HD12 ' HD3' ' A' ' 164' ' ' ARG . 16.7 tt -71.43 -32.87 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 CA-C-N 113.856 -1.52 . . . . 0.0 109.09 -177.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.719 ' HB3' ' O ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -123.35 140.27 53.18 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.604 171.909 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -127.73 88.46 53.37 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 167.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.583 ' HG2' ' CE ' ' A' ' 172' ' ' MET . 0.9 OUTLIER -81.74 -46.75 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.224 2.616 . . . . 0.0 111.71 177.678 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.607 ' HG2' ' HE3' ' A' ' 172' ' ' MET . 33.8 mm-40 -102.94 161.67 13.57 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.928 -176.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -88.96 -27.41 20.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.452 0.644 . . . . 0.0 109.338 172.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -94.12 -18.76 21.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.249 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.6 ' HB3' ' HE2' ' A' ' 172' ' ' MET . 48.5 m95 -130.24 131.45 45.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.132 -178.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . 0.705 ' O ' HG13 ' A' ' 173' ' ' ILE . 50.5 m0 -119.4 135.15 54.87 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -178.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.582 ' OG ' ' HG2' ' A' ' 172' ' ' MET . 21.6 m -99.6 95.0 6.68 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -174.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.53 ' HB2' ' HB3' ' A' ' 150' ' ' LEU . . . -104.03 147.21 27.65 Favored 'General case' 0 N--CA 1.418 -2.037 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.075 -174.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.745 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 24.5 ptt-85 -86.44 123.24 31.44 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 175.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.72 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . 6.1 t30 -55.09 172.04 0.13 Allowed 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 113.151 -1.841 . . . . 0.0 110.416 -172.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 36.5 tttp -58.21 -12.68 3.82 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.227 0.537 . . . . 0.0 110.039 174.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -83.5 -45.76 13.22 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.71 172.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 130.24 -9.62 5.93 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.959 -173.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.745 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.1 OUTLIER -62.56 132.47 52.53 Favored 'General case' 0 C--O 1.216 -0.703 0 C-N-CA 123.712 0.805 . . . . 0.0 112.373 179.489 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.434 HG23 HG21 ' A' ' 153' ' ' ILE . 78.8 t -85.81 122.25 38.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 O-C-N 122.462 -0.149 . . . . 0.0 110.906 177.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 162' ' ' SER . . . -153.59 149.37 20.85 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.55 172.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.607 ' HE3' ' HG2' ' A' ' 157' ' ' GLU . 7.0 mtp -77.51 142.42 39.1 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.705 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.8 pp -143.77 144.94 28.94 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.42 -178.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.479 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 21.7 Cg_exo -65.01 133.47 35.9 Favored 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 122.854 2.369 . . . . 0.0 113.181 -178.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.477 ' O ' HG21 ' A' ' 178' ' ' VAL . 60.2 t -63.24 -42.02 72.66 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 177.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -62.3 1.32 0.98 Allowed 'Trans proline' 0 C--N 1.359 1.097 0 C-N-CA 122.164 1.91 . . . . 0.0 113.172 176.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.479 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.1 m-85 -103.16 -12.78 17.11 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.506 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.656 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 3.8 m -105.83 -172.82 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 -166.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.671 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 7.5 tp10 -160.23 50.97 0.3 Allowed 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 113.004 -1.907 . . . . 0.0 112.271 -152.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.829 ' HG3' HG23 ' A' ' 128' ' ' VAL . 2.2 mppt? -69.2 137.45 53.25 Favored 'General case' 0 N--CA 1.462 0.161 0 O-C-N 119.706 -1.871 . . . . 0.0 111.319 -159.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.691 ' HG ' HG21 ' A' ' 182' ' ' VAL . 13.0 tp -96.14 121.0 37.43 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 112.634 -2.076 . . . . 0.0 111.016 -170.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.691 HG21 ' HG ' ' A' ' 181' ' ' LEU . 4.7 t 44.36 64.94 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 O-C-N 124.009 0.818 . . . . 0.0 111.649 175.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 3.9 ttp180 -87.37 146.88 25.7 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.925 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.51 ' HB3' ' HB2' ' A' ' 190' ' ' HIS . 0.3 OUTLIER -80.16 48.1 0.97 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.968 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' SER . . . . . 1.053 ' HB2' ' HD3' ' A' ' 186' ' ' PRO . 2.8 m -46.45 -74.35 0.07 OUTLIER Pre-proline 0 CA--C 1.545 0.76 0 O-C-N 123.997 0.811 . . . . 0.0 112.35 -166.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 1.053 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 71.9 Cg_endo -103.82 26.88 0.1 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.133 1.889 . . . . 0.0 111.978 170.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.671 ' CD2' ' HD2' ' A' ' 186' ' ' PRO . 7.7 m170 -95.72 -44.32 7.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.822 0.344 . . . . 0.0 110.705 -173.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 80.87 116.99 0.37 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.6 -178.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 19.6 tptm 60.89 87.42 0.09 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.532 0.682 . . . . 0.0 111.099 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . 0.51 ' HB2' ' HB3' ' A' ' 184' ' ' SER . 53.8 t-80 -75.26 -43.51 51.04 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.473 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 80.98 -168.48 50.93 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 -172.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -166.69 166.03 16.15 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 62.1 mtp180 -100.05 -99.65 0.24 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 177.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 176.15 179.96 0.17 Allowed 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 42.5 t -157.91 -89.14 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . 0.42 HD21 ' N ' ' A' ' 196' ' ' ASN . 0.0 OUTLIER -171.75 142.16 1.51 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 176.132 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 8.7 t -115.33 92.24 3.86 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 176.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -115.29 -141.96 0.38 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.208 -176.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 78.35 47.66 8.01 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.406 -0.902 . . . . 0.0 110.857 -175.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 43.1 mm -98.48 127.93 34.56 Favored Pre-proline 0 C--N 1.323 -0.572 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -176.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -65.56 101.56 0.45 Allowed 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.597 2.198 . . . . 0.0 111.846 176.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -75.43 135.49 72.36 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.727 -179.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -70.62 165.22 32.67 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 122.64 2.227 . . . . 0.0 111.97 177.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -101.0 143.32 31.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.553 177.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . 0.42 ' HB3' ' O ' ' A' ' 208' ' ' ALA . 74.4 m80 -102.83 -45.97 4.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.393 178.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . 60.8 81.84 0.18 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.105 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 73.32 -32.95 0.25 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.375 177.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . 0.42 ' O ' ' HB3' ' A' ' 205' ' ' HIS . . . -81.53 74.63 8.52 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.109 0.48 . . . . 0.0 110.497 177.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 0.9 ' HB2' ' HD3' ' A' ' 210' ' ' PRO . 19.7 mm-40 -91.52 -58.93 0.23 Allowed Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.967 -178.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . 0.9 ' HD3' ' HB2' ' A' ' 209' ' ' GLN . 89.8 Cg_endo -98.49 178.23 0.37 Allowed 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.499 2.133 . . . . 0.0 112.371 178.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -147.06 -33.8 0.28 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.193 174.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 4.4 m 63.82 41.27 6.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.059 -178.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 8.9 m -56.45 -43.07 79.16 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.629 177.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 16.9 m -117.13 104.49 50.46 Favored Pre-proline 0 N--CA 1.447 -0.58 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.873 174.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.34 -43.87 31.71 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.541 2.16 . . . . 0.0 111.715 178.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -152.32 115.38 2.91 Favored Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -61.88 95.77 0.14 Allowed 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.834 2.356 . . . . 0.0 112.273 -177.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -172.44 158.4 4.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.858 -176.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.726 HG13 ' H ' ' A' ' 220' ' ' SER . 2.6 p -136.05 -72.01 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 121.069 -0.252 . . . . 0.0 111.406 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' SER . . . . . 0.726 ' H ' HG13 ' A' ' 219' ' ' VAL . 14.6 t -177.08 -176.22 0.64 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -178.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 175.2 173.32 40.88 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 121.104 -0.57 . . . . 0.0 111.866 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 20.7 t 64.69 92.45 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.213 0.53 . . . . 0.0 111.518 177.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.48 -178.27 4.34 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 123.068 2.512 . . . . 0.0 111.329 174.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 172.83 -165.64 38.05 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.17 -1.014 . . . . 0.0 112.493 178.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -83.59 84.9 7.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.89 0.376 . . . . 0.0 110.697 -179.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -85.36 -48.63 8.85 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.312 0.577 . . . . 0.0 109.545 175.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 64.4 mt -94.67 105.23 16.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.845 176.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 3.5 t -140.04 90.04 10.87 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-O 121.706 0.765 . . . . 0.0 110.866 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -81.33 -16.34 9.59 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.997 2.464 . . . . 0.0 112.388 178.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.668 ' H ' ' HD2' ' A' ' 231' ' ' PRO . 0.5 OUTLIER -154.45 -55.9 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.63 0 CA-C-O 119.162 -0.446 . . . . 0.0 111.792 -175.294 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.668 ' HD2' ' H ' ' A' ' 230' ' ' LEU . 0.9 OUTLIER -42.96 -66.48 0.15 Allowed 'Trans proline' 0 C--N 1.362 1.284 0 C-N-CA 123.357 2.705 . . . . 0.0 114.158 -174.228 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 20.4 t -91.16 90.33 7.75 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.068 0.461 . . . . 0.0 110.099 -177.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 17.2 p -142.87 157.21 44.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.645 177.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -100.87 -36.38 9.08 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 176.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 66.99 -168.2 0.2 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.78 174.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 108.35 -135.96 13.18 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -177.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -81.3 132.85 8.34 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.478 2.119 . . . . 0.0 110.322 172.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.522 ' HB ' HG11 ' A' ' 266' ' ' VAL . 19.6 t -89.09 126.35 42.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-O 121.056 0.455 . . . . 0.0 110.425 -175.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -115.89 120.38 39.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.72 -177.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.525 ' HB3' HG13 ' A' ' 293' ' ' ILE . . . -120.34 145.05 47.5 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.262 178.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -95.1 120.69 35.75 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 175.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . 0.522 ' HA ' HG13 ' A' ' 291' ' ' VAL . . . -68.62 107.6 3.03 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.381 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.483 HD11 ' HD3' ' A' ' 292' ' ' LYS . 39.1 pt -85.17 -21.28 7.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.049 0.452 . . . . 0.0 110.611 -177.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -134.85 147.12 49.81 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.487 -178.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . 0.689 ' HB2' ' HZ2' ' A' ' 245' ' ' LYS . 10.7 mtmp? -63.32 156.9 24.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.519 0.676 . . . . 0.0 111.32 -176.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.512 ' HG3' ' O ' ' A' ' 256' ' ' LEU . 27.6 tpt180 -140.35 122.21 15.48 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.764 -179.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . 0.403 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 16.9 m -127.58 153.68 77.58 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-O 120.834 0.35 . . . . 0.0 111.613 -175.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.496 ' HB3' ' CG ' ' A' ' 252' ' ' ASP . 7.4 Cg_exo -72.92 159.35 48.29 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.966 2.444 . . . . 0.0 112.078 178.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' CYS . . . . . 0.477 ' SG ' ' N ' ' A' ' 250' ' ' ALA . 42.3 t -104.59 -175.63 2.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.875 -178.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . 0.477 ' N ' ' SG ' ' A' ' 249' ' ' CYS . . . -58.85 -44.6 91.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.154 0.502 . . . . 0.0 110.506 176.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -91.43 31.94 1.11 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.809 178.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.496 ' CG ' ' HB3' ' A' ' 248' ' ' PRO . 2.9 t70 -60.92 112.75 2.18 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.492 178.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -139.13 -6.77 1.39 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.385 169.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -151.77 34.81 0.55 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.376 176.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.413 ' CB ' ' HA ' ' A' ' 248' ' ' PRO . . . -112.54 100.62 8.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.201 0.524 . . . . 0.0 110.759 -179.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.512 ' O ' ' HG3' ' A' ' 246' ' ' ARG . 0.5 OUTLIER -67.13 146.76 53.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.977 -175.764 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -107.87 120.22 41.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.055 178.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.521 HD22 HG22 ' A' ' 279' ' ' VAL . 51.3 mt -136.39 152.75 50.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.536 -175.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . 0.439 ' HA ' ' HG2' ' A' ' 245' ' ' LYS . 0.9 OUTLIER -115.07 -176.39 2.9 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 172.657 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 51.1 t -81.29 120.91 33.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.569 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 111.08 2.78 28.17 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.001 -0.619 . . . . 0.0 113.054 177.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -90.88 146.74 23.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.814 0.34 . . . . 0.0 110.79 -178.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 24.3 mm -92.67 109.86 22.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.538 177.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 20.8 t -83.28 108.46 15.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.217 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -80.42 86.48 5.75 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.881 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.522 HG11 ' HB ' ' A' ' 238' ' ' VAL . 2.6 p -98.41 117.69 43.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.671 0.748 . . . . 0.0 110.656 -178.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 18.4 p -94.46 -49.66 5.58 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.303 -177.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -100.61 114.31 27.88 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 120.955 0.407 . . . . 0.0 111.06 -177.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' MET . . . . . 0.532 ' HE3' ' CE3' ' A' ' 275' ' ' TRP . 40.7 mtt -106.61 140.19 39.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.145 0.497 . . . . 0.0 110.735 174.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -119.78 -170.05 1.88 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.575 -175.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.419 HD11 ' N ' ' A' ' 271' ' ' ILE . 4.5 mp -95.81 -30.81 4.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.135 -174.176 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -66.81 -23.39 66.05 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -173.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 115.21 -32.37 5.79 Favored Glycine 0 C--O 1.23 -0.128 0 C-N-CA 120.194 -1.003 . . . . 0.0 113.084 173.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.458 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 48.7 mt-30 -86.23 107.53 17.96 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 176.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.532 ' CE3' ' HE3' ' A' ' 269' ' ' MET . 12.7 m0 -92.22 157.61 16.6 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.106 -173.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -100.29 108.35 20.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.256 0.551 . . . . 0.0 109.857 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -110.0 145.38 17.02 Favored Glycine 0 N--CA 1.44 -1.042 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.573 179.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -107.66 108.68 20.04 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.33 0.586 . . . . 0.0 110.042 177.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . 0.567 HG13 HD21 ' A' ' 280' ' ' ASN . 60.3 t -120.54 127.62 75.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.777 -178.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . 0.567 HD21 HG13 ' A' ' 279' ' ' VAL . 10.7 p30 47.91 33.02 3.05 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.18 0.992 . . . . 0.0 112.203 -178.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 81.37 25.85 53.3 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.773 177.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . 0.468 ' NH1' ' HA ' ' A' ' 256' ' ' LEU . 1.0 OUTLIER -137.85 125.72 22.59 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 178.643 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 24.1 pttm -101.36 142.82 32.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.978 -175.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -163.53 152.16 22.01 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.208 177.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.503 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 90.9 mt -78.39 120.68 23.48 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.116 0.484 . . . . 0.0 110.372 176.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 43.8 p90 -118.24 146.24 38.95 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.857 178.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . 0.409 ' HG2' ' CD2' ' A' ' 290' ' ' HIS . 20.9 Cg_endo -87.69 137.08 3.95 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.752 2.302 . . . . 0.0 111.948 -179.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -60.17 -14.95 19.97 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -175.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.08 -12.28 61.42 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.005 0.431 . . . . 0.0 111.358 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . 0.409 ' CD2' ' HG2' ' A' ' 287' ' ' PRO . 10.9 m170 -101.07 -15.91 17.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.362 -176.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.522 HG13 ' HA ' ' A' ' 242' ' ' ALA . 35.4 m -128.39 152.7 36.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.897 0.38 . . . . 0.0 111.33 -175.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . 0.483 ' HD3' HD11 ' A' ' 243' ' ' ILE . 3.2 mptp? -130.88 134.83 47.14 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 170.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.525 HG13 ' HB3' ' A' ' 240' ' ' ALA . 1.0 OUTLIER -88.43 122.58 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 CA-C-O 122.068 0.937 . . . . 0.0 112.029 -177.291 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' PHE . . . . . 0.577 ' O ' ' HD3' ' A' ' 296' ' ' PRO . 5.1 p90 -117.3 140.15 49.92 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 168.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -79.95 107.61 7.21 Favored Pre-proline 0 C--N 1.317 -0.833 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.297 178.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . 0.577 ' HD3' ' O ' ' A' ' 294' ' ' PHE . 91.0 Cg_endo -81.36 -2.69 11.73 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.666 2.244 . . . . 0.0 110.912 -177.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -87.92 16.12 6.33 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.959 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -146.09 131.48 9.22 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.593 171.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -88.3 27.12 0.55 Allowed 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.831 2.354 . . . . 0.0 112.159 177.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -81.57 -9.99 59.55 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.636 0.732 . . . . 0.0 110.121 -178.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -110.69 14.79 22.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.191 176.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -155.38 126.74 7.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.941 0.401 . . . . 0.0 111.584 -175.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 . . . . . 0 C--O 1.246 0.912 0 CA-C-O 118.239 -0.886 . . . . 0.0 109.501 174.738 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.3 ptp . . . . . 0 N--CA 1.483 1.19 0 CA-C-O 120.822 0.344 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.5 p -141.61 94.83 2.73 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 120.994 0.426 . . . . 0.0 111.29 -178.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.4 p -70.85 -33.08 70.28 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 169.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -81.45 102.48 10.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.18 175.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -115.2 77.35 1.07 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.549 0.69 . . . . 0.0 111.572 -177.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -157.61 151.61 24.39 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.171 176.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -85.41 126.91 34.16 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.772 176.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.447 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 5.3 t -68.67 -20.12 64.43 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.044 -174.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 t -97.8 -13.62 21.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.766 0.317 . . . . 0.0 110.909 -177.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -79.09 78.41 5.54 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.514 0.674 . . . . 0.0 109.412 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.431 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 3.8 ptp180 -69.8 -14.69 62.89 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.179 -175.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.5 t -82.91 14.86 3.01 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.61 0.719 . . . . 0.0 109.333 173.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.25 -42.51 3.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.122 170.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.425 ' CE2' ' HA ' ' A' ' 11' ' ' ARG . 44.9 p-90 -108.45 -22.05 12.47 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -172.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.431 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 25.1 t80 -86.34 120.63 27.9 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.205 0.526 . . . . 0.0 110.108 -177.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.56 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 25.1 mmt -100.38 1.36 41.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.796 -172.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.444 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.0 -112.46 1.69 Allowed Glycine 0 CA--C 1.525 0.719 0 N-CA-C 114.368 0.507 . . . . 0.0 114.368 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.444 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 11.3 Cg_exo -72.4 55.22 2.5 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 124.191 3.26 . . . . 0.0 114.299 -172.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.796 HG13 ' H ' ' A' ' 20' ' ' SER . 59.5 t -104.18 -178.42 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 172.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.796 ' H ' HG13 ' A' ' 19' ' ' VAL . 23.4 t -165.38 176.49 8.24 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -165.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 21.3 tpt180 -55.09 -55.7 28.12 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.684 0.278 . . . . 0.0 111.393 -174.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -59.11 -60.06 4.47 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.46 -177.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.432 ' O ' ' HG3' ' A' ' 27' ' ' ARG . 25.6 tt0 -61.5 -46.03 91.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.679 -175.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.418 ' HB1' HG13 ' A' ' 19' ' ' VAL . . . -53.57 -49.23 68.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.962 0.41 . . . . 0.0 111.67 -175.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.59 ' HG3' ' HB ' ' A' ' 58' ' ' VAL . 12.5 tt0 -74.25 -37.25 63.81 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 120.117 -0.633 . . . . 0.0 111.183 -174.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.412 HG22 ' O ' ' A' ' 23' ' ' GLU . 7.4 t -70.42 -21.5 62.82 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 120.784 -0.367 . . . . 0.0 111.177 -177.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.432 ' HG3' ' O ' ' A' ' 23' ' ' GLU . 56.4 mtp180 -82.79 -20.56 35.57 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.996 0.427 . . . . 0.0 110.736 178.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.53 HD11 ' HG ' ' A' ' 37' ' ' LEU . 13.0 mt -108.14 -15.74 14.43 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.95 179.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -84.71 130.24 34.72 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.243 0.544 . . . . 0.0 110.832 -173.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.504 ' C ' ' HG2' ' A' ' 32' ' ' ARG . . . 76.81 -3.38 56.45 Favored Glycine 0 C--N 1.314 -0.668 0 C-N-CA 119.914 -1.136 . . . . 0.0 112.747 178.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.483 ' HB2' ' CE ' ' A' ' 35' ' ' MET . 10.8 mt-30 -91.86 -52.17 4.86 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 172.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.748 ' NH1' ' H ' ' A' ' 57' ' ' ARG . 3.6 mmp_? 85.08 128.82 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 116.378 1.992 . . . . 0.0 116.378 152.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.722 ' CD2' ' HB3' ' A' ' 32' ' ' ARG . 9.0 m170 77.24 109.13 0.08 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 112.657 -2.065 . . . . 0.0 113.021 157.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.84 -37.83 3.46 Favored Glycine 0 N--CA 1.453 -0.222 0 CA-C-N 114.981 -1.009 . . . . 0.0 112.842 173.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.502 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 33.4 mtm -70.5 141.48 51.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.794 0.331 . . . . 0.0 111.293 -177.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.413 ' CG ' HD21 ' A' ' 98' ' ' LEU . 37.7 p90 -143.93 160.8 40.19 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 172.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.56 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.4 pp -153.91 139.57 17.93 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.172 0.511 . . . . 0.0 111.447 174.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 49.9 t -104.67 130.82 55.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.415 -0.811 . . . . 0.0 108.949 173.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 24.9 ptt-85 -127.9 175.97 7.95 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -177.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -80.89 137.6 36.16 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 170.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.3 t -78.95 97.3 5.98 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.196 0.522 . . . . 0.0 110.64 -176.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.22 -8.82 26.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.426 0.631 . . . . 0.0 110.483 174.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.5 p -97.95 -8.26 28.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.764 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.455 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 28.4 t -164.4 122.88 1.21 Allowed Pre-proline 0 C--N 1.333 -0.136 0 CA-C-O 120.589 0.233 . . . . 0.0 110.763 -177.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 44' ' ' CYS . 10.1 Cg_exo -71.53 119.41 6.23 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 123.048 2.499 . . . . 0.0 112.618 -179.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.07 25.34 17.25 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.019 178.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -134.35 163.17 30.26 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.546 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 25.3 m-85 -124.61 166.07 16.75 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 175.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.485 HG13 HD11 ' A' ' 62' ' ' ILE . 21.5 t -137.13 108.16 5.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.239 178.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.4 tp -84.18 102.02 12.29 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.864 175.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 51.0 m -95.61 124.39 39.61 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 177.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.618 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 58.0 t -114.67 139.89 38.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.271 0.558 . . . . 0.0 111.421 -173.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.469 ' HB2' HD23 ' A' ' 28' ' ' LEU . 47.0 t -98.46 103.33 15.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.74 -174.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.772 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 6.3 tp10 -157.68 163.04 38.6 Favored 'General case' 0 C--O 1.213 -0.831 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.33 171.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.75 ' ND2' ' HG3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER 44.62 42.23 5.55 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.724 1.209 . . . . 0.0 112.813 -175.653 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.744 ' HA ' ' CD ' ' A' ' 32' ' ' ARG . 68.2 m 44.23 54.72 5.95 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 121.809 0.814 . . . . 0.0 111.028 -175.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.772 ' HG3' ' O ' ' A' ' 54' ' ' GLU 0.341 0.0 OUTLIER -169.24 75.59 0.09 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.642 -1.163 . . . . 0.0 113.543 -154.384 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.618 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 14.9 t -69.14 108.12 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 O-C-N 119.475 -2.016 . . . . 0.0 110.355 -173.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.562 ' HG ' ' CZ ' ' A' ' 57' ' ' ARG . 5.2 m -84.9 123.9 31.02 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.475 -178.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 36.1 m-70 -96.59 108.97 21.66 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.682 -174.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.568 ' CE1' HD11 ' A' ' 153' ' ' ILE . 79.1 m-85 -98.7 110.57 23.14 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.268 0.627 . . . . 0.0 111.118 178.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.664 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 40.3 mm -80.55 123.95 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -174.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.546 ' HB ' ' HB2' ' A' ' 48' ' ' TYR . 5.3 mp -102.68 112.54 36.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 120.797 0.332 . . . . 0.0 110.76 177.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.5 ' HB2' ' HB3' ' A' ' 72' ' ' LYS . 15.0 m120 -86.13 140.38 30.26 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.686 -176.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.3 t -86.52 101.15 12.92 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 169.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.851 HD11 ' HG3' ' A' ' 70' ' ' ARG . 91.9 mt -83.56 140.22 41.32 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.515 -178.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.65 -11.44 26.38 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.408 2.072 . . . . 0.0 110.678 172.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.491 ' HB2' ' HG2' ' A' ' 70' ' ' ARG . 2.9 m-20 -72.15 -2.48 18.8 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.114 174.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.815 ' HA ' ' HE ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER 67.09 35.02 4.76 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.858 -178.459 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.851 ' HG3' HD11 ' A' ' 66' ' ' LEU . 4.3 ptp180 -133.64 168.22 19.07 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.829 176.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.419 ' HB3' HG22 ' A' ' 63' ' ' ILE . 37.5 m-85 -114.0 124.23 51.65 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.977 0.418 . . . . 0.0 110.553 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.562 ' HB2' HD12 ' A' ' 66' ' ' LEU . 28.9 ttpp -108.73 95.88 5.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.287 -173.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.664 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 3.8 tt -87.83 118.31 33.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.073 0.463 . . . . 0.0 110.747 -178.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.95 31.54 78.87 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.729 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.518 ' HA ' ' HG2' ' A' ' 72' ' ' LYS . 31.2 t70 74.34 4.65 4.53 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.139 0.576 . . . . 0.0 111.47 -178.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -90.93 119.73 31.36 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 173.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -81.72 121.77 26.81 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.968 0.413 . . . . 0.0 111.487 -176.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.413 ' O ' ' HB2' ' A' ' 70' ' ' ARG . 87.3 m-85 -125.28 165.75 17.77 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 172.153 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -58.28 -49.25 77.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.132 0.491 . . . . 0.0 111.316 -179.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.494 ' ND1' ' HG2' ' A' ' 82' ' ' PRO . 4.7 p80 -164.0 -178.5 5.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.063 -177.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.516 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 14.2 mt -56.76 -57.05 26.56 Favored Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -176.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.494 ' HG2' ' ND1' ' A' ' 80' ' ' HIS . 24.0 Cg_endo -64.46 3.03 0.94 Allowed 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.237 1.958 . . . . 0.0 113.605 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.35 -36.27 10.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.868 0.366 . . . . 0.0 110.297 178.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.1 pp -76.48 -33.89 58.67 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.496 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 68.0 mt -66.74 -19.76 65.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.735 178.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -89.08 -37.9 14.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.444 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -71.32 -30.68 66.49 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.405 0.622 . . . . 0.0 110.382 -178.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.512 ' CG ' HD22 ' A' ' 93' ' ' LEU . 19.8 m-85 -82.57 -3.2 55.67 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.978 -0.556 . . . . 0.0 112.025 -178.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.496 ' HG3' ' O ' ' A' ' 85' ' ' LEU . 99.4 mttt -72.33 -13.06 61.39 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.523 174.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 16.7 pt -132.68 10.53 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 CA-C-O 121.37 0.605 . . . . 0.0 110.054 -177.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -107.0 -37.48 6.31 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.954 -175.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.486 ' CD2' HG22 ' A' ' 97' ' ' THR . 75.1 m-85 69.06 115.89 0.04 OUTLIER 'General case' 0 C--O 1.224 -0.279 0 O-C-N 124.227 0.954 . . . . 0.0 109.702 -173.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.619 ' O ' ' HG2' ' A' ' 154' ' ' GLU . 1.2 mt -91.14 -7.64 50.99 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.516 0.674 . . . . 0.0 110.433 177.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.672 ' HA ' ' HB3' ' A' ' 154' ' ' GLU . 0.2 OUTLIER -144.61 -45.52 0.24 Allowed 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 122.107 0.956 . . . . 0.0 111.032 -172.381 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.589 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 5.6 t 152.45 -15.72 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 104.457 -2.423 . . . . 0.0 104.457 -167.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.425 ' HB ' ' HG2' ' A' ' 54' ' ' GLU . 1.1 m -117.81 145.83 44.27 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 112.878 -1.965 . . . . 0.0 108.162 177.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.486 HG22 ' CD2' ' A' ' 92' ' ' TYR . 27.4 p -94.94 171.49 8.73 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 174.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.413 HD21 ' CG ' ' A' ' 36' ' ' PHE . 92.7 mt -66.24 93.33 0.21 Allowed 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 177.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 39.9 mm -79.66 -61.05 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.969 -175.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.502 ' O ' ' HA ' ' A' ' 35' ' ' MET . 0.6 OUTLIER -160.58 150.1 14.19 Favored Pre-proline 0 N--CA 1.453 -0.312 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.121 178.452 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.86 163.41 30.93 Favored 'Trans proline' 0 CA--C 1.532 0.384 0 C-N-CA 122.91 2.407 . . . . 0.0 114.414 -172.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.518 ' HB1' HD21 ' A' ' 28' ' ' LEU . . . -63.83 155.47 77.17 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.475 176.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -51.38 95.83 0.03 OUTLIER 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 123.116 2.544 . . . . 0.0 112.755 174.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.45 ' HG3' ' SD ' ' A' ' 16' ' ' MET . 49.5 ttt180 -71.08 -35.88 72.03 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 177.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -89.6 125.07 62.51 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.046 175.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.7 106.77 1.15 Allowed 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.47 2.113 . . . . 0.0 112.285 179.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.468 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 27.2 m -98.61 134.28 21.85 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.482 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 107' ' ' SER . 16.8 Cg_exo -67.93 122.38 9.49 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.961 2.441 . . . . 0.0 112.139 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 108' ' ' PRO . 2.8 Cg_exo -75.51 72.7 4.86 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.999 2.466 . . . . 0.0 111.629 178.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 52.3 ttp -73.44 -29.99 62.92 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.48 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -178.39 -168.32 37.57 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 9.3 p -67.3 110.32 3.49 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.978 0.418 . . . . 0.0 110.238 176.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 57.0 t -94.72 -61.45 2.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.007 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 31.7 p -131.9 -88.59 0.45 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.611 -177.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.554 ' HB2' ' HD3' ' A' ' 119' ' ' PRO . . . 49.12 64.24 9.0 Favored Pre-proline 0 N--CA 1.465 0.277 0 CA-C-O 121.141 0.496 . . . . 0.0 110.003 -171.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.96 -24.27 72.26 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.306 2.671 . . . . 0.0 114.123 -166.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -113.68 5.22 16.37 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.901 -174.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 50.4 tp 59.88 111.36 0.02 OUTLIER Pre-proline 0 N--CA 1.469 0.501 0 CA-C-O 121.059 0.457 . . . . 0.0 111.713 -175.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.554 ' HD3' ' HB2' ' A' ' 115' ' ' ALA . 38.5 Cg_exo -61.08 98.44 0.14 Allowed 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 122.724 2.282 . . . . 0.0 112.48 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.8 p -146.65 153.37 40.22 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.494 -177.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.572 ' HB1' ' HB2' ' A' ' 56' ' ' SER . . . 174.15 164.63 0.2 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.262 1.025 . . . . 0.0 108.811 174.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.407 ' O ' ' HB2' ' A' ' 123' ' ' ASP . 7.9 pt-20 -147.13 177.79 8.89 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -176.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 1.8 m-20 74.15 -104.62 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.093 -0.958 . . . . 0.0 112.801 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.461 ' HB3' ' HG3' ' A' ' 183' ' ' ARG . 28.0 t-20 -169.96 -87.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 110.52 -0.178 . . . . 0.0 110.52 -173.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.575 ' HG ' ' HD2' ' A' ' 155' ' ' LYS . 4.2 mm? 68.35 102.29 0.05 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.527 0.68 . . . . 0.0 112.53 177.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 48.4 tt0 -172.65 -56.46 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.65 178.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -117.99 108.64 15.51 Favored 'General case' 0 CA--C 1.51 -0.582 0 C-N-CA 120.071 -0.651 . . . . 0.0 111.134 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.648 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 3.1 t -115.8 142.32 29.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.658 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 0.1 OUTLIER -115.38 145.01 42.94 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 116.623 -2.031 . . . . 0.0 108.688 160.493 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.528 ' HB ' ' CD1' ' A' ' 144' ' ' PHE . 0.8 OUTLIER -103.48 128.04 50.75 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.086 -177.601 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.524 HD22 ' HG2' ' A' ' 179' ' ' GLU . 20.3 mt -102.0 -24.0 14.04 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -174.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.488 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 46.8 t80 -82.03 -35.3 28.94 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.271 -0.571 . . . . 0.0 112.378 -172.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.645 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 9.7 t70 75.18 104.64 0.07 Allowed 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.423 0.63 . . . . 0.0 110.726 -175.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 63.9 t80 -129.77 88.85 48.1 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 175.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.589 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 60.4 Cg_endo -85.3 71.18 4.95 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.039 1.826 . . . . 0.0 113.099 -176.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.72 -30.53 76.41 Favored Glycine 0 C--N 1.331 0.287 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.778 178.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.541 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 13.7 m-80 56.0 71.01 0.58 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 114.862 -0.669 . . . . 0.0 110.718 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . 0.466 ' HB3' ' H ' ' A' ' 141' ' ' ASP . 0.7 OUTLIER -145.6 -169.47 3.23 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.149 -174.442 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -110.73 -5.53 14.97 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 166.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -101.31 -56.88 2.2 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 113.698 -1.592 . . . . 0.0 108.529 177.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . 0.466 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 3.4 m-20 -96.81 120.86 37.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.489 174.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.704 ' CD1' ' HB2' ' A' ' 165' ' ' ASN . 32.9 tp -76.68 130.13 77.34 Favored Pre-proline 0 N--CA 1.467 0.404 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 175.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.589 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 74.1 Cg_endo -82.28 94.04 0.9 Allowed 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 121.67 1.58 . . . . 0.0 111.966 172.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.592 ' CE2' ' HB ' ' A' ' 173' ' ' ILE . 12.2 p90 -106.58 153.7 21.97 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -176.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.645 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 88.9 mttt -103.16 -162.03 0.88 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -173.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.573 ' HD2' ' N ' ' A' ' 146' ' ' LYS . 9.0 mptt -81.98 -7.94 59.64 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.858 -166.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -167.83 27.5 0.15 Allowed Glycine 0 C--N 1.311 -0.825 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.352 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.554 ' OE1' ' HA ' ' A' ' 144' ' ' PHE . 0.1 OUTLIER -78.99 154.39 29.55 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.071 0.462 . . . . 0.0 111.684 -177.157 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.577 HD12 ' HB3' ' A' ' 129' ' ' ARG . 0.5 OUTLIER -95.19 128.72 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.702 -177.961 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.663 HD23 ' CD2' ' A' ' 142' ' ' LEU . 61.8 mt -122.98 156.19 35.27 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -175.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.563 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 85.2 t -119.2 121.07 65.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 174.447 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.481 HG22 HD13 ' A' ' 125' ' ' LEU . 48.5 mm -76.88 91.75 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 CA-C-O 121.889 0.852 . . . . 0.0 108.711 -176.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.568 HD11 ' CE1' ' A' ' 61' ' ' TYR . 17.6 tt -79.95 -26.66 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 CA-C-N 114.237 -1.347 . . . . 0.0 109.696 -174.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.734 ' HA ' HH21 ' A' ' 57' ' ' ARG . 0.9 OUTLIER -134.7 144.9 48.04 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 172.461 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.575 ' HD2' ' HG ' ' A' ' 125' ' ' LEU . 77.0 tttt -127.84 85.06 61.61 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-O 121.148 0.499 . . . . 0.0 109.914 164.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.589 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 13.2 Cg_exo -73.45 -41.33 1.22 Allowed 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.62 2.213 . . . . 0.0 112.28 175.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -121.7 176.84 5.52 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.931 -173.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -106.65 -0.98 23.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.777 0.798 . . . . 0.0 109.283 174.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -102.82 -36.68 8.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.801 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.52 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 31.1 m95 -127.03 144.71 50.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.932 176.072 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . 0.755 ' O ' HG13 ' A' ' 173' ' ' ILE . 49.3 m0 -125.75 138.98 53.89 Favored 'General case' 0 C--O 1.215 -0.756 0 C-N-CA 123.346 0.658 . . . . 0.0 109.776 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.514 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 23.9 m -97.98 104.87 16.94 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -173.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.525 ' HB2' ' HB3' ' A' ' 150' ' ' LEU . . . -114.94 149.4 37.34 Favored 'General case' 0 N--CA 1.425 -1.687 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.235 -176.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.693 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 13.0 ptt180 -87.48 122.33 31.07 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 171.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.704 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . 14.4 t30 -52.8 172.19 0.05 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.577 -1.647 . . . . 0.0 110.648 -175.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -63.75 -10.22 18.53 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.282 0.563 . . . . 0.0 109.554 173.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -85.21 -27.02 26.38 Favored 'General case' 0 N--CA 1.46 0.073 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.332 171.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 108.73 -2.28 32.11 Favored Glycine 0 CA--C 1.522 0.49 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.677 -176.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.693 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 3.3 ttm-85 -74.3 132.79 42.39 Favored 'General case' 0 C--O 1.214 -0.815 0 C-N-CA 123.054 0.542 . . . . 0.0 111.798 -177.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 64.7 t -84.81 121.88 37.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 O-C-N 122.032 -0.418 . . . . 0.0 111.391 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -158.36 156.35 27.33 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.578 173.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.537 ' HE1' ' HG2' ' A' ' 156' ' ' PRO . 0.0 OUTLIER -75.75 145.22 40.97 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 122.604 0.361 . . . . 0.0 111.479 -179.735 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.755 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.6 pp -144.69 145.62 28.86 Favored Pre-proline 0 C--O 1.221 -0.411 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.444 -177.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.49 ' HB2' ' CD1' ' A' ' 177' ' ' TYR . 10.3 Cg_exo -73.69 132.98 18.0 Favored 'Trans proline' 0 CA--C 1.527 0.126 0 C-N-CA 122.688 2.259 . . . . 0.0 112.889 -175.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.535 ' O ' HG21 ' A' ' 178' ' ' VAL . 47.8 t -61.43 -45.71 94.45 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.531 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 50.8 Cg_exo -57.55 -8.01 3.62 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.383 2.056 . . . . 0.0 113.643 175.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.49 ' CD1' ' HB2' ' A' ' 174' ' ' PRO . 3.0 m-85 -95.57 -11.49 27.24 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.622 -178.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.535 HG21 ' O ' ' A' ' 175' ' ' VAL . 3.4 m -106.49 -174.08 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 -165.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.691 ' O ' ' HG3' ' A' ' 179' ' ' GLU . 8.2 tp10 -161.02 44.29 0.17 Allowed 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 112.477 -2.147 . . . . 0.0 111.152 -155.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.765 ' HD2' ' H ' ' A' ' 180' ' ' LYS . 0.0 OUTLIER -73.71 141.85 46.38 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 119.411 -2.056 . . . . 0.0 111.663 -163.49 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.457 ' HB2' HH12 ' A' ' 129' ' ' ARG . 18.0 tp -69.13 -84.72 0.03 OUTLIER 'General case' 0 C--O 1.231 0.094 0 CA-C-N 112.608 -2.087 . . . . 0.0 112.259 -161.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . 0.432 ' H ' ' HB3' ' A' ' 181' ' ' LEU . 26.5 m -89.02 137.86 20.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.401 178.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.525 ' NH1' ' HE3' ' A' ' 180' ' ' LYS . 37.2 ttt85 -167.73 162.07 13.71 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.222 0.534 . . . . 0.0 111.235 -176.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 47.0 p -141.67 115.07 8.89 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.366 173.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' SER . . . . . 0.402 ' HA ' ' HD3' ' A' ' 186' ' ' PRO . 5.6 p -68.18 150.32 97.78 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 178.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 185' ' ' SER . 24.7 Cg_exo -63.57 87.08 0.13 Allowed 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.695 2.263 . . . . 0.0 112.547 -178.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 46.9 m80 -87.18 -4.34 59.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.989 176.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 104.84 -56.76 0.53 Allowed Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 -177.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -121.46 116.42 24.69 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 177.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -104.41 128.58 52.3 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.553 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.4 ' O ' ' HG3' ' A' ' 193' ' ' ARG . . . -95.67 -122.88 4.06 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 174.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 17.7 m120 59.33 27.72 16.87 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 122.641 0.377 . . . . 0.0 111.294 177.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' A' ' 191' ' ' GLY . 66.1 mtp180 -121.73 -30.72 4.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.724 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 66.53 98.47 0.05 OUTLIER 'General case' 0 C--O 1.234 0.271 0 O-C-N 123.891 0.744 . . . . 0.0 110.35 -172.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 8.8 t -91.32 -176.87 4.69 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.186 -176.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 62.37 38.34 13.09 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.925 0.869 . . . . 0.0 109.397 -177.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 10.5 t -122.01 110.83 16.29 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.212 -0.903 . . . . 0.0 110.067 -177.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 60.74 -161.98 0.28 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.864 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 98.55 -42.13 2.11 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.51 177.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.557 HG23 ' HG3' ' A' ' 202' ' ' GLU . 47.9 mm -96.0 110.41 51.75 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 120.723 0.297 . . . . 0.0 110.236 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 200' ' ' ILE . 10.2 Cg_endo -90.11 97.24 0.28 Allowed 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.142 2.562 . . . . 0.0 112.37 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.557 ' HG3' HG23 ' A' ' 200' ' ' ILE . 43.0 mt-10 -124.94 99.99 34.16 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.471 176.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -74.81 -80.71 0.01 OUTLIER 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 122.403 2.069 . . . . 0.0 111.974 177.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -164.98 136.81 4.27 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 177.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 -134.24 96.67 3.66 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.931 0.396 . . . . 0.0 110.581 -178.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -100.77 -65.4 0.97 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.848 177.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -129.72 -61.17 1.01 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.843 176.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . 55.0 -96.6 0.06 Allowed 'General case' 0 C--O 1.231 0.101 0 O-C-N 123.748 0.655 . . . . 0.0 110.096 -171.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 0.438 ' HA ' ' HD2' ' A' ' 210' ' ' PRO . 89.7 mt-30 -143.77 104.69 4.92 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 172.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 209' ' ' GLN . 20.0 Cg_endo -61.69 -59.86 0.26 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.732 2.288 . . . . 0.0 112.357 -178.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -137.26 126.01 23.94 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 14.7 p -109.89 5.59 22.6 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -175.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 11.8 t -104.99 12.58 32.15 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 121.024 -0.27 . . . . 0.0 111.687 -175.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.53 ' OG1' ' HD3' ' A' ' 215' ' ' PRO . 2.4 p -132.19 -45.02 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -178.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.53 ' HD3' ' OG1' ' A' ' 214' ' ' THR . 18.2 Cg_exo -68.24 -43.37 4.6 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 121.863 1.709 . . . . 0.0 112.841 -177.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.836 ' HB2' ' HD3' ' A' ' 217' ' ' PRO . 5.8 mp -84.38 -58.8 0.36 Allowed Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.748 -179.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.836 ' HD3' ' HB2' ' A' ' 216' ' ' LEU . 57.8 Cg_endo -97.35 114.87 0.11 Allowed 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.581 2.187 . . . . 0.0 112.523 176.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -81.15 102.98 10.64 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 176.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 29.8 m -110.56 144.5 18.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.58 -176.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 15.5 p -148.21 127.43 12.96 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.746 176.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -155.56 61.37 0.36 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.468 -0.873 . . . . 0.0 112.68 -176.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 47.8 m -115.55 109.43 45.87 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-O 120.704 0.288 . . . . 0.0 110.296 178.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -73.58 -11.47 24.31 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 123.126 2.551 . . . . 0.0 112.206 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -76.87 61.66 3.32 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.356 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -123.61 13.18 9.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.961 0.41 . . . . 0.0 110.326 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -136.57 165.83 24.94 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.344 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 40.3 pt -70.01 -28.33 35.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.836 0.35 . . . . 0.0 110.747 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 31.7 m -135.91 88.69 22.27 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.84 177.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -83.0 164.0 15.49 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.549 2.166 . . . . 0.0 111.477 174.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -103.29 103.83 37.35 Favored Pre-proline 0 C--N 1.32 -0.682 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.434 ' HG2' HG22 ' A' ' 233' ' ' THR . 88.4 Cg_endo -79.23 -169.98 0.91 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.771 2.314 . . . . 0.0 111.759 -178.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 18.4 m -76.15 71.45 2.89 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.432 0.634 . . . . 0.0 110.57 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' THR . . . . . 0.457 ' C ' ' H ' ' A' ' 235' ' ' ASN . 15.1 p -84.46 -60.73 1.99 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.064 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 72.89 -33.77 0.28 Allowed 'General case' 0 N--CA 1.468 0.467 0 O-C-N 124.053 0.846 . . . . 0.0 111.544 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . 0.457 ' H ' ' C ' ' A' ' 233' ' ' THR . 45.9 m-80 71.18 102.39 0.06 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.505 0.722 . . . . 0.0 111.084 175.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 102.28 114.37 3.86 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.869 -178.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -62.36 113.98 2.15 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.582 2.188 . . . . 0.0 111.347 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.406 ' CG1' HD12 ' A' ' 293' ' ' ILE . 13.2 t -66.85 136.48 26.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.18 -174.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.515 ' HB2' ' HG3' ' A' ' 296' ' ' PRO . 82.8 m-85 -98.63 125.51 43.93 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.971 178.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -118.21 148.53 42.29 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.417 -179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -92.31 125.29 36.91 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 177.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . 0.522 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -71.01 104.95 3.14 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 176.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.582 HD11 ' HG2' ' A' ' 292' ' ' LYS . 41.2 pt -88.0 0.82 6.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.936 0.398 . . . . 0.0 111.311 -174.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -155.79 146.47 22.05 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 15.7 pttm -66.41 109.16 2.62 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.57 0.7 . . . . 0.0 110.542 176.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.55 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 24.9 tpt180 -84.46 93.56 8.33 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.711 178.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 27.1 m -105.87 138.17 19.56 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.007 176.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.498 ' HB3' ' HB3' ' A' ' 255' ' ' ALA . 90.4 Cg_endo -80.62 148.72 18.19 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.471 2.114 . . . . 0.0 112.282 -179.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' CYS . . . . . 0.417 ' SG ' ' N ' ' A' ' 250' ' ' ALA . 41.8 t -92.74 -176.55 4.28 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 175.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . 0.417 ' N ' ' SG ' ' A' ' 249' ' ' CYS . . . -61.34 -24.0 66.14 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -175.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -102.75 -9.63 19.84 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -177.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -84.35 88.1 7.24 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.109 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -87.21 -16.92 33.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.039 -178.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 10.2 p -110.3 7.12 22.94 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.622 -176.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.498 ' HB3' ' HB3' ' A' ' 248' ' ' PRO . . . -86.85 132.92 33.69 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.258 0.551 . . . . 0.0 111.328 -176.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . 0.457 ' O ' ' HG3' ' A' ' 246' ' ' ARG . 1.0 OUTLIER -81.89 143.39 31.72 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 176.633 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -97.53 110.36 22.93 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.928 0.394 . . . . 0.0 110.329 178.054 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.543 ' HB2' ' HB3' ' A' ' 246' ' ' ARG . 65.5 mt -113.34 139.13 49.12 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.451 -175.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -91.67 137.61 32.22 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.726 173.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 2.5 p -67.37 119.21 12.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.163 0.506 . . . . 0.0 110.284 178.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 115.55 -3.26 21.72 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.266 -177.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -99.08 159.58 14.87 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -177.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 20.8 mm -87.38 122.76 39.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.062 0.458 . . . . 0.0 110.45 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.469 HG13 HG23 ' A' ' 279' ' ' VAL . 21.5 t -102.07 99.2 7.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.906 176.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -78.94 101.75 7.91 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.925 176.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.505 HG11 ' HE3' ' A' ' 269' ' ' MET . 5.5 p -88.27 123.73 40.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.293 0.568 . . . . 0.0 109.983 179.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 2.4 m -93.83 -35.11 12.88 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.47 -175.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . 0.487 ' NE ' ' HA ' ' A' ' 268' ' ' ARG . 3.2 mmp_? -132.6 112.74 12.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.923 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' MET . . . . . 0.585 ' HE1' ' CH2' ' A' ' 275' ' ' TRP . 41.3 mtt -87.83 121.52 30.35 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.455 175.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -95.78 155.55 16.7 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . 0.73 ' H ' HD11 ' A' ' 271' ' ' ILE . 0.2 OUTLIER -82.53 -8.61 11.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -172.522 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -80.63 -24.0 39.34 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.717 0.294 . . . . 0.0 111.077 -178.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 123.85 -21.86 6.96 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.569 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -94.97 123.2 38.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.056 0.455 . . . . 0.0 109.805 177.204 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.585 ' CH2' ' HE1' ' A' ' 269' ' ' MET . 47.4 m0 -98.3 153.29 18.63 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.929 -176.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -105.45 105.69 15.84 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.492 176.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -127.41 153.07 19.0 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.207 -178.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -107.46 108.62 20.03 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . 0.469 HG23 HG13 ' A' ' 264' ' ' VAL . 89.2 t -133.04 128.67 56.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.544 -175.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 59.83 27.5 16.83 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.262 176.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 92.19 -5.92 78.42 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.337 177.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -115.74 134.48 54.98 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 122.714 -0.286 . . . . 0.0 110.768 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 15.7 ptpt -112.87 131.01 55.9 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.038 0.447 . . . . 0.0 110.018 171.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -156.04 -175.79 27.43 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.51 -177.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 79.5 mt -98.63 124.31 43.36 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.422 0.629 . . . . 0.0 111.128 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -129.59 135.05 26.93 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.68 177.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.88 140.08 28.33 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.381 2.054 . . . . 0.0 111.461 178.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -64.22 -8.5 12.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.775 -176.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -71.03 -16.6 62.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.045 0.45 . . . . 0.0 111.209 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -101.89 -8.31 21.7 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.827 -176.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.522 HG12 ' HA ' ' A' ' 242' ' ' ALA . 30.2 m -129.61 166.89 26.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.639 0.257 . . . . 0.0 110.783 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . 0.582 ' HG2' HD11 ' A' ' 243' ' ' ILE . 28.8 mmtp -137.48 136.26 37.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.966 0.412 . . . . 0.0 110.903 175.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.406 HD12 ' CG1' ' A' ' 238' ' ' VAL . 38.9 mm -82.17 101.85 7.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 174.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -105.81 -7.72 18.15 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.005 -174.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 59.48 93.03 0.06 OUTLIER Pre-proline 0 N--CA 1.464 0.249 0 O-C-N 123.72 0.637 . . . . 0.0 111.465 -176.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . 0.515 ' HG3' ' HB2' ' A' ' 239' ' ' PHE . 60.4 Cg_endo -73.95 59.9 4.45 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 122.766 2.311 . . . . 0.0 111.4 175.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . 0.415 ' HB3' ' O ' ' A' ' 296' ' ' PRO . 8.4 tt0 78.22 -64.66 0.27 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.05 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 62.36 95.76 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.254 0 O-C-N 123.845 0.716 . . . . 0.0 111.447 178.162 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -64.8 -21.92 64.14 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.618 2.212 . . . . 0.0 111.888 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' A' ' 301' ' ' GLU . 9.5 m-20 -70.62 89.35 0.72 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.923 -178.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 300' ' ' ASP . 33.4 tt0 165.3 -31.46 0.0 OUTLIER 'General case' 0 C--O 1.233 0.229 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.525 -177.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -78.34 73.19 4.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.166 -175.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 . . . . . 0 C--O 1.248 0.981 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 176.998 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 120.575 0.226 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 p -161.4 120.08 2.43 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 120.959 0.409 . . . . 0.0 111.197 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.6 t -76.13 -32.26 59.03 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 172.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -74.0 105.59 5.31 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.551 173.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -121.32 35.92 4.75 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.357 -172.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -117.51 157.45 26.27 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.107 -179.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -84.63 111.18 19.31 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 174.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.6 m -61.33 -15.49 36.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.183 -174.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.4 p -101.11 -20.88 15.15 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -177.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -77.11 93.99 3.98 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.943 -172.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.415 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 13.4 mtm-85 -61.11 -28.68 69.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.464 -178.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.438 ' HA ' ' NH1' ' A' ' 104' ' ' ARG . 67.7 m -73.83 4.45 5.22 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.799 0.333 . . . . 0.0 111.504 178.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -106.29 -43.8 4.7 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.521 174.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . 0.439 ' HB3' ' HB3' ' A' ' 101' ' ' PRO . 19.9 p-90 -114.91 -20.22 10.64 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -172.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.415 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 70.8 t80 -80.69 125.21 29.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.04 0.447 . . . . 0.0 110.92 -175.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.478 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 25.5 mmt -104.63 -6.18 20.72 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.182 -173.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 51.62 -113.36 2.34 Favored Glycine 0 CA--C 1.524 0.606 0 O-C-N 123.419 0.449 . . . . 0.0 113.738 -176.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -69.56 85.51 0.58 Allowed 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 122.924 2.416 . . . . 0.0 113.604 -176.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.435 ' HB ' ' HB2' ' A' ' 39' ' ' ARG . 85.9 t -140.3 156.85 24.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 175.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.579 ' HB3' ' OE1' ' A' ' 23' ' ' GLU . 34.4 t -127.39 -179.32 4.84 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -171.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 45.6 ttt85 -62.05 -53.24 58.28 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -173.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.86 -43.13 93.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.729 0.3 . . . . 0.0 110.786 -177.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.579 ' OE1' ' HB3' ' A' ' 20' ' ' SER . 13.6 mp0 -60.22 -51.16 70.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.682 179.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.519 ' HB2' HD11 ' A' ' 37' ' ' LEU . . . -57.25 -40.87 78.54 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.649 0.737 . . . . 0.0 110.795 176.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.444 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 33.4 tp60 -64.28 -44.28 92.18 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.441 -177.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 10.6 t -75.67 -31.25 59.69 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 111.655 0.242 . . . . 0.0 111.655 -176.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.474 ' O ' ' HG3' ' A' ' 31' ' ' GLN . 74.9 mtp180 -74.12 -13.21 60.79 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.711 0.291 . . . . 0.0 111.232 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.569 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 79.8 mt -121.48 -6.0 9.27 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.503 -178.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.444 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 19.2 tp60 -65.24 103.34 0.77 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.783 0.325 . . . . 0.0 111.127 -175.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.65 ' HA3' ' HB3' ' A' ' 119' ' ' PRO . . . 75.74 9.04 84.96 Favored Glycine 0 C--N 1.329 0.154 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.494 175.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.474 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 13.4 mm100 -73.96 -164.91 0.26 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.998 0.427 . . . . 0.0 111.213 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.546 ' HB3' ' HE2' ' A' ' 35' ' ' MET . 55.2 ttp180 -58.08 125.88 25.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.989 176.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.424 ' HB3' ' CD ' ' A' ' 54' ' ' GLU . 65.0 m170 -72.5 122.14 20.81 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.906 -178.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 108.89 -4.73 32.18 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 -173.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.771 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 43.6 ttm -77.27 129.44 35.89 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 176.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.438 ' HB2' HG23 ' A' ' 52' ' ' VAL . 37.9 p90 -138.99 162.18 35.54 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.34 -177.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.524 ' HG ' HD11 ' A' ' 28' ' ' LEU . 4.6 pp -151.48 141.36 21.98 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.108 0.48 . . . . 0.0 110.777 174.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.5 t -107.59 118.79 56.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.59 176.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.435 ' HB2' ' HB ' ' A' ' 19' ' ' VAL . 23.4 ptt-85 -116.25 175.91 5.34 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.318 -176.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -77.7 127.56 32.64 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 173.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.8 t -71.61 121.55 18.97 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.693 -174.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.9 t -83.54 -18.71 37.45 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 170.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 27.2 m -62.59 -44.61 95.88 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.712 174.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.409 ' HA ' ' HD2' ' A' ' 45' ' ' PRO . 51.1 t -150.84 99.59 3.11 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.056 176.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 44' ' ' CYS . 10.3 Cg_endo -52.68 132.27 45.22 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.998 2.465 . . . . 0.0 112.213 -179.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.24 -34.68 5.52 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -175.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.615 ' OD2' ' HA ' ' A' ' 64' ' ' ASN . 2.7 m-20 -85.25 -177.49 6.51 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 175.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -130.87 168.47 17.23 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.568 0.223 . . . . 0.0 110.971 -177.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.2 t -138.87 109.52 4.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.065 0.46 . . . . 0.0 110.82 174.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.419 ' CB ' HD13 ' A' ' 63' ' ' ILE . 40.5 tp -84.74 102.04 12.7 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.051 176.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 53.8 m -96.14 126.18 41.18 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 175.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.524 HG21 HD12 ' A' ' 93' ' ' LEU . 58.8 t -121.7 133.53 67.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.257 -175.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.569 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 41.6 t -87.43 121.45 29.88 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -176.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.644 ' HG3' ' HB3' ' A' ' 94' ' ' ASP . 0.6 OUTLIER -150.48 148.59 28.91 Favored 'General case' 0 C--O 1.209 -1.076 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.424 165.863 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 40.05 40.56 0.78 Allowed 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -176.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.652 ' OG ' ' HA ' ' A' ' 119' ' ' PRO . 7.2 m 57.25 49.86 12.62 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 122.139 0.971 . . . . 0.0 109.267 178.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.473 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 2.6 tmm_? -167.13 64.44 0.09 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 113.906 -1.497 . . . . 0.0 109.711 -151.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 46.6 t -71.6 113.89 9.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 122.004 0.906 . . . . 0.0 110.612 -166.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.0 m -76.86 120.73 22.41 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 113.915 -1.493 . . . . 0.0 110.807 -177.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -96.35 106.05 18.21 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -176.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.551 ' HB3' HD11 ' A' ' 73' ' ' ILE . 88.7 m-85 -105.7 109.26 21.15 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 122.853 0.461 . . . . 0.0 111.691 179.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.567 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 66.3 mt -81.31 132.68 30.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -177.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.454 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 5.4 mp -110.07 117.8 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 122.779 0.432 . . . . 0.0 110.481 178.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.615 ' HA ' ' OD2' ' A' ' 47' ' ' ASP . 6.6 m120 -87.75 133.59 33.83 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.194 -175.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.7 t -86.8 96.63 10.25 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 170.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.4 mt -70.54 140.22 87.0 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.634 178.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.61 -21.39 31.14 Favored 'Trans proline' 0 CA--C 1.529 0.25 0 C-N-CA 122.86 2.373 . . . . 0.0 112.413 177.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -78.69 7.55 6.74 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.214 176.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.626 ' HA ' ' HE ' ' A' ' 69' ' ' ARG . 7.7 mmp_? 65.39 51.35 1.57 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.738 0.78 . . . . 0.0 110.764 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.427 ' NH2' ' HB3' ' A' ' 77' ' ' GLU . 30.2 mtp180 -137.49 174.01 11.05 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.096 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.546 ' HA ' ' O ' ' A' ' 64' ' ' ASN . 47.2 m-85 -132.09 121.15 23.35 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.15 0.5 . . . . 0.0 111.694 -176.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 1.045 ' HD3' ' HG2' ' A' ' 77' ' ' GLU . 24.5 ttpt -111.91 119.33 38.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.513 176.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.567 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 2.9 tt -109.3 102.89 14.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.397 0.618 . . . . 0.0 111.068 -176.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.411 ' C ' ' H ' ' A' ' 76' ' ' GLN . . . 64.49 61.94 5.52 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.4 177.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 30.6 t70 75.04 -28.63 0.19 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.976 0.51 . . . . 0.0 111.788 175.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.411 ' H ' ' C ' ' A' ' 74' ' ' GLY . 12.9 mm-40 -78.23 122.86 26.24 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.698 0.285 . . . . 0.0 110.579 175.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 1.045 ' HG2' ' HD3' ' A' ' 72' ' ' LYS . 30.6 mt-10 -95.53 126.26 40.7 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.792 0.329 . . . . 0.0 110.605 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -121.78 -169.81 1.94 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.388 177.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -82.67 -56.78 3.65 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.07 0.462 . . . . 0.0 110.365 177.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -157.87 179.95 8.72 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.485 -176.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.641 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 19.6 mt -49.96 -59.17 7.42 Favored Pre-proline 0 N--CA 1.469 0.495 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.641 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 15.4 Cg_exo -68.85 -2.49 9.6 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 121.975 1.783 . . . . 0.0 112.743 -175.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.32 -36.71 12.4 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.063 176.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.604 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.4 pp -76.69 -34.68 58.19 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.12 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.569 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 76.2 mt -62.59 -38.01 88.46 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.834 177.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.561 ' HA ' ' HD3' ' A' ' 89' ' ' LYS . 14.4 tp10 -70.63 -34.13 71.75 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 -177.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -70.56 -37.8 74.05 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.321 0.582 . . . . 0.0 110.594 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.556 ' CG ' HD22 ' A' ' 93' ' ' LEU . 21.3 m-85 -78.32 -19.77 52.85 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.743 -177.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.569 ' HG3' ' O ' ' A' ' 85' ' ' LEU . 50.0 mtpt -62.34 -20.18 64.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.685 172.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 23.9 pt -121.04 18.58 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 120.58 -0.448 . . . . 0.0 112.105 175.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 6.6 t-160 -106.14 -33.23 7.92 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.887 0.375 . . . . 0.0 110.559 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.532 ' N ' HG23 ' A' ' 97' ' ' THR . 52.9 m-85 66.61 91.63 0.08 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.284 -168.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.562 ' HA ' ' OE2' ' A' ' 154' ' ' GLU . 12.7 mt -60.81 -8.45 3.05 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.989 0.9 . . . . 0.0 110.506 173.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.644 ' HB3' ' HG3' ' A' ' 54' ' ' GLU . 16.1 t70 -161.68 -108.59 0.02 OUTLIER 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 174.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.8 t -117.6 15.56 14.58 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.638 -0.825 . . . . 0.0 111.198 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.464 HG23 ' O ' ' A' ' 97' ' ' THR . 13.3 t -139.71 -19.39 0.93 Allowed 'General case' 0 C--N 1.349 0.544 0 C-N-CA 118.192 -1.403 . . . . 0.0 114.326 -177.075 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.532 HG23 ' N ' ' A' ' 92' ' ' TYR . 6.6 p 74.95 -164.1 0.08 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.845 0.858 . . . . 0.0 109.989 -171.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.537 ' HG ' HD11 ' A' ' 93' ' ' LEU . 42.7 mt -89.6 111.29 22.19 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 175.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.459 HD11 ' O ' ' A' ' 96' ' ' THR . 51.3 mm -105.19 -58.07 4.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -173.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.771 ' O ' ' HA ' ' A' ' 35' ' ' MET . 4.7 tp10 -153.72 131.27 6.13 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 -174.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.439 ' HB3' ' HB3' ' A' ' 14' ' ' TRP . 28.3 Cg_endo -62.8 166.43 13.95 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 122.764 2.309 . . . . 0.0 112.896 -179.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -75.62 148.17 82.42 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.648 176.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.33 106.62 0.31 Allowed 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 122.562 2.175 . . . . 0.0 112.628 -177.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . 0.438 ' NH1' ' HA ' ' A' ' 12' ' ' SER . 24.1 ttp180 -90.07 -9.97 46.49 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 174.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -117.27 114.85 38.39 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.643 177.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.8 129.31 20.65 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 122.693 2.262 . . . . 0.0 112.555 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.726 ' HB3' ' HD3' ' A' ' 108' ' ' PRO . 40.7 t -139.88 -56.86 0.02 OUTLIER Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.394 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.726 ' HD3' ' HB3' ' A' ' 107' ' ' SER . 91.7 Cg_endo -87.2 161.79 8.51 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 121.888 1.725 . . . . 0.0 112.012 177.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 108' ' ' PRO . 10.3 Cg_endo -91.06 -163.86 0.13 Allowed 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 123.015 2.477 . . . . 0.0 111.758 176.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -69.08 -23.0 63.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.679 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -78.44 58.86 4.09 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.545 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 57.8 m -114.39 105.15 12.79 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 176.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.8 p -118.24 -26.48 2.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.172 0.511 . . . . 0.0 110.854 -177.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 32.8 t -87.04 -21.32 26.17 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.797 -177.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.483 ' HB2' ' HD3' ' A' ' 116' ' ' PRO . . . -74.2 -53.3 3.83 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.111 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.483 ' HD3' ' HB2' ' A' ' 115' ' ' ALA . 81.1 Cg_endo -78.58 167.19 23.0 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 121.736 1.624 . . . . 0.0 112.294 178.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -92.23 1.39 57.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.458 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 88.8 mt 76.03 131.69 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.368 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.943 173.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.652 ' HA ' ' OG ' ' A' ' 56' ' ' SER . 74.5 Cg_endo -76.97 136.94 17.01 Favored 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 122.886 2.39 . . . . 0.0 113.236 -178.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.788 HG22 ' H ' ' A' ' 121' ' ' ALA . 2.1 t -158.42 -74.08 0.08 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.993 175.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.788 ' H ' HG22 ' A' ' 120' ' ' THR . . . 56.15 -157.54 0.25 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 175.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -132.28 -178.6 4.98 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 175.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -87.4 33.15 0.69 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.132 0.491 . . . . 0.0 111.902 -170.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.538 ' O ' ' HB2' ' A' ' 125' ' ' LEU . 4.7 p30 -167.57 -155.59 0.18 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 122.03 -0.419 . . . . 0.0 110.599 -177.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.58 HD12 ' CE2' ' A' ' 161' ' ' TRP . 1.0 OUTLIER 80.67 88.07 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.797 0.839 . . . . 0.0 111.36 -174.705 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.683 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 28.0 tt0 174.92 -52.33 0.01 OUTLIER 'General case' 0 C--O 1.22 -0.488 0 CA-C-N 114.005 -1.452 . . . . 0.0 109.26 179.19 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -110.97 105.93 14.87 Favored 'General case' 0 CA--C 1.511 -0.55 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.416 178.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.68 HG22 ' CG ' ' A' ' 180' ' ' LYS . 41.5 t -120.93 127.71 75.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.982 -178.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.591 ' O ' ' HG2' ' A' ' 179' ' ' GLU . 9.3 ptp180 -109.11 140.05 43.19 Favored 'General case' 0 C--O 1.22 -0.452 0 C-N-CA 117.336 -1.745 . . . . 0.0 110.267 173.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.451 ' HB ' ' CD1' ' A' ' 144' ' ' PHE . 1.4 p -98.54 139.91 33.57 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.285 -179.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.861 ' CD1' ' HG3' ' A' ' 179' ' ' GLU . 62.9 mt -126.39 1.94 6.99 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -178.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.51 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 36.7 t80 -93.46 -33.98 13.6 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.677 178.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.572 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 11.7 t70 74.51 101.3 0.07 Allowed 'General case' 0 N--CA 1.467 0.411 0 O-C-N 123.916 0.76 . . . . 0.0 109.868 -177.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.6 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 70.3 t80 -131.61 87.99 44.35 Favored Pre-proline 0 N--CA 1.446 -0.667 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.641 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 97.1 Cg_endo -79.08 88.3 1.47 Allowed 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 121.729 1.62 . . . . 0.0 112.49 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.72 -31.76 32.0 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.89 177.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.801 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 21.8 m120 66.89 35.68 4.74 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.027 0.531 . . . . 0.0 111.563 177.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -136.39 172.81 12.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.734 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.625 ' O ' ' HA2' ' A' ' 171' ' ' GLY . . . -86.88 -13.79 43.86 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.642 0.734 . . . . 0.0 109.498 171.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.663 ' O ' ' HB2' ' A' ' 172' ' ' MET . 3.4 mp0 -94.83 -18.59 21.06 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.635 176.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -139.77 102.29 4.4 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 176.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.724 ' CD2' HD23 ' A' ' 150' ' ' LEU . 49.9 tp -64.46 129.54 94.23 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -178.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.801 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 27.8 Cg_endo -81.92 88.62 1.3 Allowed 'Trans proline' 0 N--CA 1.439 -1.69 0 C-N-CA 121.239 1.292 . . . . 0.0 111.535 174.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.6 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 20.5 p90 -108.06 165.5 11.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.389 -173.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.572 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 37.0 mttp -109.49 -173.76 2.34 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.253 0.549 . . . . 0.0 111.853 -175.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.694 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -89.09 21.29 3.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.322 -174.846 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -179.96 35.03 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.121 177.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -107.68 150.25 27.16 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.073 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.502 HG13 ' HB3' ' A' ' 129' ' ' ARG . 1.9 mp -98.32 131.22 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -177.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.724 HD23 ' CD2' ' A' ' 142' ' ' LEU . 7.7 mt -122.3 169.51 10.86 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -175.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.683 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 74.1 t -128.98 122.4 56.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 110.422 -0.214 . . . . 0.0 110.422 178.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.513 HG23 HD11 ' A' ' 125' ' ' LEU . 45.8 mm -75.84 98.59 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -174.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.466 HG21 HG22 ' A' ' 170' ' ' VAL . 19.9 tt -96.07 -32.74 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.581 -173.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.562 ' OE2' ' HA ' ' A' ' 93' ' ' LEU . 7.7 mt-10 -115.93 140.05 49.63 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 167.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.676 ' HE3' ' HE1' ' A' ' 161' ' ' TRP . 83.7 tttt -127.84 73.66 78.77 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 121.901 -0.499 . . . . 0.0 110.944 170.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.547 ' HG2' ' HE1' ' A' ' 172' ' ' MET . 39.9 Cg_exo -61.19 -42.1 38.03 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.439 2.092 . . . . 0.0 112.183 175.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -124.91 -177.91 4.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.4 -175.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.455 ' O ' HG23 ' A' ' 175' ' ' VAL . 0.2 OUTLIER -108.5 -10.92 15.21 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 173.537 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -93.62 -30.95 14.69 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.555 177.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.566 ' CH2' ' HG3' ' A' ' 174' ' ' PRO . 65.0 m95 -124.06 141.71 51.82 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.409 174.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . 0.676 ' HE1' ' HE3' ' A' ' 155' ' ' LYS . 43.9 m0 -132.52 137.97 47.35 Favored 'General case' 0 C--O 1.21 -1.021 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.238 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.558 ' HA ' ' HA ' ' A' ' 172' ' ' MET . 19.0 m -93.34 99.34 11.89 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -174.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.524 ' HA ' ' O ' ' A' ' 151' ' ' VAL . . . -109.09 143.17 38.79 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -171.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.791 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 11.1 ptt180 -86.35 119.46 26.64 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 176.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.682 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . 16.4 t30 -50.75 170.12 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 113.117 -1.856 . . . . 0.0 111.543 -174.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -66.7 -9.14 33.24 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.49 0.662 . . . . 0.0 109.392 174.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -85.91 -18.7 31.99 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.259 171.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.29 56.87 2.2 Favored Glycine 0 CA--C 1.52 0.397 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.422 -174.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.791 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 4.2 ttm-85 -136.61 135.0 37.97 Favored 'General case' 0 C--O 1.216 -0.669 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 139' ' ' ALA . 43.0 t -79.66 124.95 38.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.375 -178.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.625 ' HA2' ' O ' ' A' ' 139' ' ' ALA . . . -160.86 150.78 20.93 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.856 169.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.663 ' HB2' ' O ' ' A' ' 140' ' ' GLU . 1.5 mmt -67.18 138.2 56.82 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 117.515 0.657 . . . . 0.0 111.187 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.674 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.8 pp -134.1 140.06 35.01 Favored Pre-proline 0 N--CA 1.443 -0.799 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.271 179.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.742 ' O ' HG11 ' A' ' 178' ' ' VAL . 26.3 Cg_exo -67.77 128.81 18.56 Favored 'Trans proline' 0 C--O 1.212 -0.779 0 C-N-CA 123.243 2.629 . . . . 0.0 112.871 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.561 ' C ' ' H ' ' A' ' 177' ' ' TYR . 88.0 t -64.72 -45.09 75.4 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 178.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 39.5 Cg_endo -67.63 8.96 0.37 Allowed 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 121.996 1.798 . . . . 0.0 111.933 175.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.726 ' HB2' ' HB2' ' A' ' 174' ' ' PRO . 1.5 m-85 -111.79 -5.34 14.42 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.256 -1.338 . . . . 0.0 109.649 -175.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.742 HG11 ' O ' ' A' ' 174' ' ' PRO . 2.7 m -133.28 171.24 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-O 123.596 1.665 . . . . 0.0 114.717 -167.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.861 ' HG3' ' CD1' ' A' ' 131' ' ' LEU . 2.7 mm-40 -140.64 51.88 1.64 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 110.612 -2.995 . . . . 0.0 110.635 -155.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 0.68 ' CG ' HG22 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -69.69 136.78 51.47 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 120.209 -1.557 . . . . 0.0 109.894 -166.733 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.413 HD13 ' NH2' ' A' ' 129' ' ' ARG . 20.7 tp -63.16 -79.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 112.329 -2.214 . . . . 0.0 113.244 -156.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 40.5 t -78.53 88.09 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.858 0.361 . . . . 0.0 110.349 -176.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . 0.487 ' HE ' ' ND2' ' A' ' 124' ' ' ASN . 24.3 ttt180 -146.51 -100.29 0.09 Allowed 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.491 177.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 33.9 t 55.91 93.88 0.02 OUTLIER 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -167.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 4.4 p -52.67 156.98 2.84 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.076 -177.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -48.79 99.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.877 2.385 . . . . 0.0 113.074 -177.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -119.31 -51.99 2.29 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.66 -0.866 . . . . 0.0 108.66 174.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 115.27 -71.31 0.25 Allowed Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.573 -178.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -109.97 104.44 13.35 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 174.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 74.8 t60 -136.97 -40.55 0.6 Allowed 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.056 -176.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 91.32 -129.87 10.01 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.787 -0.721 . . . . 0.0 113.122 178.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 12.3 m120 68.22 168.77 0.27 Allowed 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 123.566 0.747 . . . . 0.0 111.812 -176.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 20.9 ttm180 70.06 1.4 3.49 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.631 -177.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -100.47 84.63 2.81 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 176.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.81 ' HA ' ' CD1' ' A' ' 198' ' ' TYR . 23.3 t -159.87 118.0 2.69 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.01 0.434 . . . . 0.0 111.1 -178.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -135.6 -59.51 0.76 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.537 172.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 24.6 m -92.98 -4.37 52.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.685 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.81 ' CD1' ' HA ' ' A' ' 195' ' ' SER . 71.1 m-85 -69.33 -56.9 6.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.263 0.554 . . . . 0.0 109.515 176.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -73.56 135.83 21.24 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 115.351 -0.841 . . . . 0.0 112.13 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.435 ' HA ' ' HD3' ' A' ' 201' ' ' PRO . 10.6 pt -104.08 132.1 21.32 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-O 120.803 0.335 . . . . 0.0 110.436 178.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 200' ' ' ILE . 3.9 Cg_exo -75.69 77.59 3.31 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.957 2.438 . . . . 0.0 112.15 -178.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.19 80.13 3.47 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -93.91 -18.32 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.068 2.512 . . . . 0.0 113.5 -177.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -157.69 155.25 29.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.846 0.355 . . . . 0.0 110.295 -176.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 49.7 m80 -107.47 -177.44 3.35 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.546 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -146.66 147.37 30.95 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.999 177.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -88.63 145.31 25.75 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.432 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -133.82 177.07 8.01 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.824 -176.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -111.67 105.39 56.66 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 177.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -56.82 -64.29 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.871 2.381 . . . . 0.0 112.097 -178.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -109.62 109.33 20.06 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.418 178.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 10.8 t -115.63 8.22 14.99 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.632 0.73 . . . . 0.0 109.475 176.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 4.4 m -68.74 102.11 1.46 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.498 178.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.673 ' HB ' ' HD3' ' A' ' 215' ' ' PRO . 25.7 m -88.41 -55.6 0.32 Allowed Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.79 179.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.673 ' HD3' ' HB ' ' A' ' 214' ' ' THR . 72.6 Cg_endo -82.37 104.1 1.32 Allowed 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 121.804 1.669 . . . . 0.0 112.804 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 9.6 mp -97.92 116.18 65.7 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.618 177.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -87.75 31.71 0.43 Allowed 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.081 2.521 . . . . 0.0 112.172 178.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -86.68 27.43 0.98 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.7 -174.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 3.6 p -79.39 86.05 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.867 0.841 . . . . 0.0 110.815 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 35.2 t -86.39 109.5 19.06 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.864 177.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -86.99 80.76 1.72 Allowed Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.769 -176.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.45 ' HA ' ' HD3' ' A' ' 223' ' ' PRO . 14.6 p -82.0 111.85 30.41 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-O 120.701 0.286 . . . . 0.0 110.476 176.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . 0.648 ' HA ' ' HB2' ' A' ' 272' ' ' ASN . 5.4 Cg_exo -77.29 101.36 1.49 Allowed 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 123.316 2.677 . . . . 0.0 112.393 -177.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -128.15 75.88 0.41 Allowed Glycine 0 N--CA 1.443 -0.87 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 176.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 57.21 -155.61 0.32 Allowed 'General case' 0 C--O 1.235 0.317 0 O-C-N 123.939 0.435 . . . . 0.0 110.25 -175.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . 0.732 ' HB2' ' HE1' ' A' ' 288' ' ' PHE . . . 61.51 31.28 18.97 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.83 0.347 . . . . 0.0 111.85 174.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.477 ' O ' ' HD3' ' A' ' 229' ' ' PRO . 38.4 pt -65.67 146.96 12.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.248 179.012 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 8.6 m -110.28 95.84 23.73 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.088 -178.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 227' ' ' ILE . 37.7 Cg_endo -96.77 105.27 0.09 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 123.569 2.846 . . . . 0.0 112.231 177.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.461 ' HA ' ' HD3' ' A' ' 231' ' ' PRO . 3.4 pp -82.95 138.83 42.84 Favored Pre-proline 0 C--N 1.323 -0.554 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.271 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 230' ' ' LEU . 5.9 Cg_exo -74.76 71.85 4.68 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 123.173 2.582 . . . . 0.0 113.268 -175.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 67.6 p 51.13 27.65 3.53 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.782 0.833 . . . . 0.0 112.966 173.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 46.2 p -77.34 -56.16 4.79 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.973 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 39.22 42.98 0.83 Allowed 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 122.076 0.941 . . . . 0.0 111.207 -177.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -92.61 26.09 2.81 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.539 -1.209 . . . . 0.0 110.853 -175.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 94.27 -148.86 19.17 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.147 177.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -65.85 118.79 5.79 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.549 2.166 . . . . 0.0 111.187 176.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 3.4 t -83.07 146.06 7.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -178.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.403 ' CB ' ' HG3' ' A' ' 296' ' ' PRO . 57.0 m-85 -115.0 131.88 56.78 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.45 0.643 . . . . 0.0 112.02 -172.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.529 ' HB3' HD11 ' A' ' 293' ' ' ILE . . . -133.37 146.03 50.9 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.092 176.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.418 ' HB3' HD11 ' A' ' 263' ' ' ILE . 18.5 ptmt -111.38 132.34 54.5 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.693 -0.403 . . . . 0.0 109.952 176.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -63.36 117.86 7.25 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.945 -175.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 19.2 pt -98.43 -14.02 7.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.082 -177.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -146.17 138.91 25.53 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 47.7 mttp -52.95 140.0 25.99 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.843 0.83 . . . . 0.0 113.159 -172.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.509 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 21.0 tpt180 -130.42 86.15 2.36 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.969 172.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 19.4 m -95.99 140.89 22.48 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.189 -179.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.439 ' HA ' ' HB3' ' A' ' 255' ' ' ALA . 13.4 Cg_exo -66.96 136.87 42.8 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.405 2.07 . . . . 0.0 111.604 -179.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 33.0 t -104.03 175.5 5.46 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.652 -178.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -56.3 -42.88 78.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.994 0.425 . . . . 0.0 111.43 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -85.81 -14.79 44.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.06 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -129.58 70.58 1.42 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.946 0.403 . . . . 0.0 110.185 -176.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -83.73 -14.13 52.35 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 174.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 5.2 p -76.82 -5.81 49.8 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.409 174.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.439 ' HB3' ' HA ' ' A' ' 248' ' ' PRO . . . -72.88 139.55 46.95 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.745 178.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.07 119.75 23.95 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.509 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -70.03 103.65 2.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.653 178.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . 0.476 ' HB2' ' HB3' ' A' ' 246' ' ' ARG . 96.1 mt -112.07 128.03 56.08 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.075 -178.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.75 157.17 17.04 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 176.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 47.4 t -67.57 124.18 22.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.985 0.422 . . . . 0.0 110.253 -178.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 98.74 5.65 56.55 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.255 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -93.38 135.42 34.63 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . 0.418 HD11 ' HB3' ' A' ' 241' ' ' LYS . 24.8 mm -81.52 121.79 35.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.964 0.411 . . . . 0.0 110.184 177.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.49 HG11 ' CZ ' ' A' ' 286' ' ' PHE . 22.0 t -95.15 109.66 22.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.91 -178.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 43.4 tttp -85.76 87.46 7.41 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.59 176.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 4.0 p -89.92 125.8 42.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.156 0.503 . . . . 0.0 110.59 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 16.1 p -95.8 -32.87 12.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.256 -177.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . 0.553 ' HD2' ' OE2' ' A' ' 276' ' ' GLU . 41.3 ttm180 -132.39 118.46 19.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.992 0.425 . . . . 0.0 111.786 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' MET . . . . . 0.653 ' HE1' ' CH2' ' A' ' 275' ' ' TRP . 46.8 mtt -90.78 107.25 19.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.137 172.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.678 HD22 ' HG3' ' A' ' 276' ' ' GLU . 44.1 m-80 -78.68 137.82 37.99 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 178.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 10.7 tt -79.9 71.46 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 122.153 0.978 . . . . 0.0 110.969 -178.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . 0.648 ' HB2' ' HA ' ' A' ' 223' ' ' PRO . 2.8 p-10 -168.27 -4.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.852 176.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 119.42 -31.24 5.49 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.159 171.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.609 ' HG2' HD22 ' A' ' 272' ' ' ASN . 12.1 pt20 -95.46 129.48 42.61 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.04 0.447 . . . . 0.0 110.519 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.653 ' CH2' ' HE1' ' A' ' 269' ' ' MET . 50.7 m0 -105.72 154.01 21.06 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.317 -179.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . 0.678 ' HG3' HD22 ' A' ' 270' ' ' ASN . 43.0 mt-10 -96.0 111.45 23.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.335 172.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . 0.551 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -134.26 156.56 22.45 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.493 -0.861 . . . . 0.0 111.625 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.547 ' HG2' ' HB2' ' A' ' 283' ' ' LYS . 41.1 mt-10 -117.32 108.08 15.17 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.091 0.472 . . . . 0.0 109.808 178.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . 0.563 HG13 ' ND2' ' A' ' 280' ' ' ASN . 15.4 t -138.39 137.68 43.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.574 -177.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . 0.563 ' ND2' HG13 ' A' ' 279' ' ' VAL . 52.9 m-80 61.64 21.51 12.19 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.604 0.362 . . . . 0.0 111.051 -178.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 90.97 -5.87 81.86 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.979 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 32.7 mtp-105 -110.08 132.45 54.15 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 122.663 -0.316 . . . . 0.0 111.258 -178.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.551 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 2.0 ttmp? -97.11 122.28 39.94 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 168.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -150.85 168.5 30.59 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.308 -0.949 . . . . 0.0 111.949 -178.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 84.6 mt -91.28 138.72 31.36 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.07 0.462 . . . . 0.0 110.313 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.49 ' CZ ' HG11 ' A' ' 264' ' ' VAL . 34.3 p90 -148.14 144.42 18.82 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.663 178.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . 0.486 ' HG2' ' CD2' ' A' ' 290' ' ' HIS . 84.5 Cg_endo -82.11 144.31 13.25 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.49 2.127 . . . . 0.0 111.542 176.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.732 ' HE1' ' HB2' ' A' ' 226' ' ' ALA . 44.3 p90 -65.93 -10.52 39.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.869 0.366 . . . . 0.0 111.89 -176.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 3.0 p -71.94 -4.87 30.85 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -178.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . 0.486 ' CD2' ' HG2' ' A' ' 287' ' ' PRO . 14.2 m-70 -111.29 -2.71 15.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.705 0.288 . . . . 0.0 111.155 -177.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.466 ' HB ' ' HB1' ' A' ' 240' ' ' ALA . 31.2 m -127.58 156.3 39.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.082 0.468 . . . . 0.0 111.371 -176.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 44.9 tptt -112.71 111.27 21.94 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.406 177.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.529 HD11 ' HB3' ' A' ' 240' ' ' ALA . 4.0 tp -72.11 141.2 16.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -162.54 -174.66 4.1 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.809 0.338 . . . . 0.0 110.694 -178.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -108.82 106.94 59.63 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.707 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . 0.403 ' HG3' ' CB ' ' A' ' 239' ' ' PHE . 87.3 Cg_endo -83.55 2.62 8.23 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.786 2.324 . . . . 0.0 112.471 -178.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -95.02 -13.42 25.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.225 -178.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -63.6 120.96 67.4 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.995 173.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.46 31.33 0.47 Allowed 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 123.165 2.577 . . . . 0.0 112.497 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 32.0 p-10 -88.18 -63.7 1.26 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.901 0.381 . . . . 0.0 110.616 -179.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -82.21 -37.75 25.57 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 174.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 63.6 t30 53.75 -85.46 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 114.575 -1.193 . . . . 0.0 113.231 175.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.938 -0.554 . . . . 0.0 110.417 -173.973 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ttt . . . . . 0 N--CA 1.479 0.979 0 CA-C-O 120.545 0.212 . . . . 0.0 110.743 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.4 m -95.48 120.52 35.87 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.812 0.339 . . . . 0.0 111.113 -176.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.3 t -76.11 -44.98 36.05 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 169.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.552 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . -77.19 101.28 6.11 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 114.535 -1.212 . . . . 0.0 109.775 174.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -131.53 106.81 8.44 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.503 0.668 . . . . 0.0 111.269 -177.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.557 ' CE1' ' HE2' ' A' ' 89' ' ' LYS . 34.3 p90 -168.01 139.44 2.88 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.647 -1.161 . . . . 0.0 108.402 175.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -74.1 102.34 4.19 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.208 0.528 . . . . 0.0 110.284 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.1 m -57.73 -32.13 67.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.586 -175.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.4 t -81.47 -2.12 48.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.888 -174.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -103.66 105.83 16.17 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 121.585 -0.697 . . . . 0.0 110.901 -177.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.11 -29.09 70.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.899 178.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.8 m -74.79 4.04 7.06 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.974 0.416 . . . . 0.0 110.731 178.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -99.05 -30.48 12.3 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.558 175.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 36.6 p-90 -138.2 -20.83 1.08 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -171.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -77.14 115.41 16.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.041 0.448 . . . . 0.0 110.15 -174.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' MET . . . . . 0.558 ' HG3' ' HB2' ' A' ' 37' ' ' LEU . 25.1 mmt -97.94 -7.68 29.62 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.991 -175.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.488 ' O ' ' HB2' ' A' ' 39' ' ' ARG . . . 50.78 -111.69 1.34 Allowed Glycine 0 CA--C 1.523 0.577 0 O-C-N 123.694 0.622 . . . . 0.0 113.427 -178.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.412 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 4.4 Cg_exo -76.87 103.18 1.71 Allowed 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.845 2.363 . . . . 0.0 112.417 -179.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.69 ' HB ' ' HG3' ' A' ' 39' ' ' ARG . 2.9 t -138.13 -69.87 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.758 -178.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.482 ' H ' ' HG3' ' A' ' 39' ' ' ARG . 21.4 t 95.85 162.89 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 124.662 1.185 . . . . 0.0 109.083 172.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . 0.433 ' O ' ' HG2' ' A' ' 25' ' ' GLN . 69.8 mtp85 -55.78 -44.56 77.83 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 123.04 0.212 . . . . 0.0 110.804 -175.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.87 -46.95 74.79 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 123.993 0.808 . . . . 0.0 110.718 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.445 ' HB3' HG12 ' A' ' 19' ' ' VAL . 14.1 tp10 -76.24 -46.91 25.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.298 0.57 . . . . 0.0 110.469 -175.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.498 ' HB2' HD11 ' A' ' 37' ' ' LEU . . . -57.11 -39.6 75.38 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.99 -176.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' ' 21' ' ' ARG . 2.1 pt20 -75.34 -33.15 61.09 Favored 'General case' 0 C--O 1.219 -0.513 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -173.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.1 t -75.48 -32.14 60.46 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.149 -176.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -84.22 -7.07 59.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.947 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.562 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 97.0 mt -125.97 13.3 7.87 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.639 175.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 27.3 tp60 -72.36 84.72 1.08 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.624 ' HA2' ' HA ' ' A' ' 56' ' ' SER . . . 85.12 -64.81 4.15 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.518 -178.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.494 ' HB3' ' HE2' ' A' ' 35' ' ' MET . 15.4 mm100 39.87 -125.8 0.4 Allowed 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 123.257 0.623 . . . . 0.0 112.222 -176.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.425 ' HA ' ' HB3' ' A' ' 116' ' ' PRO . 20.1 ptp180 -106.73 -7.24 17.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.242 -0.436 . . . . 0.0 109.876 178.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 37.7 m80 67.91 153.15 0.09 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.254 -173.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.98 -0.79 76.69 Favored Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.881 -177.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.662 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 37.1 mtm -104.7 147.51 27.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.749 0.309 . . . . 0.0 110.566 -178.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.4 ' CB ' HG22 ' A' ' 52' ' ' VAL . 43.2 p90 -143.27 169.42 17.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.49 -178.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.558 ' HB2' ' HG3' ' A' ' 16' ' ' MET . 4.5 pp -158.21 143.76 16.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.012 0.434 . . . . 0.0 110.769 173.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.5 t -115.44 112.66 40.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 175.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.69 ' HG3' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -121.66 167.75 12.57 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.407 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -62.28 137.93 58.34 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 28.4 t -66.63 126.11 27.9 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.282 0.563 . . . . 0.0 111.298 -173.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.409 ' HG ' ' HG3' ' A' ' 21' ' ' ARG . 19.4 p -86.13 6.44 29.2 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.591 174.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.8 -39.73 8.47 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.046 179.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.456 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 71.1 m -149.66 137.4 11.61 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.956 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 44' ' ' CYS . 38.2 Cg_exo -61.15 -32.5 91.15 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.283 2.655 . . . . 0.0 113.799 -175.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -101.84 33.06 6.81 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.849 -176.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.629 ' OD1' ' HA ' ' A' ' 64' ' ' ASN . 15.6 m-20 -138.71 167.56 21.71 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 110.375 -0.232 . . . . 0.0 110.375 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -126.42 170.62 11.77 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 174.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.422 ' HB ' ' NH1' ' A' ' 39' ' ' ARG . 44.8 t -144.16 115.96 2.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-O 121.002 0.43 . . . . 0.0 111.653 176.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.5 tp -82.7 106.05 14.23 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.025 174.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.8 m -96.82 129.04 44.31 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 176.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.691 HG11 ' HG2' ' A' ' 54' ' ' GLU . 70.8 t -121.9 134.56 64.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.843 -176.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.562 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 41.0 t -88.04 99.18 11.97 Favored 'General case' 0 CA--C 1.513 -0.442 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.965 -177.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.691 ' HG2' HG11 ' A' ' 52' ' ' VAL . 65.5 mm-40 -144.94 142.08 29.55 Favored 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 119.51 -0.876 . . . . 0.0 109.403 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 61.04 15.81 6.51 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.594 0.558 . . . . 0.0 111.927 -178.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.624 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 27.4 m 58.89 54.55 5.05 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 122.935 1.35 . . . . 0.0 107.374 -173.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.593 HH22 ' CG ' ' A' ' 94' ' ' ASP . 0.1 OUTLIER -167.01 67.88 0.09 Allowed 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 112.26 -2.245 . . . . 0.0 108.831 -151.638 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.57 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 9.9 t -69.63 100.52 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.815 0.816 . . . . 0.0 109.777 -167.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 50.9 m -74.76 120.72 20.69 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 114.213 -1.358 . . . . 0.0 110.474 -178.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 -93.29 103.28 15.53 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.003 -177.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.534 ' HB3' HD11 ' A' ' 73' ' ' ILE . 58.5 m-85 -91.35 104.29 16.83 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.159 177.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 59.9 mt -79.46 125.76 38.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.848 0.356 . . . . 0.0 111.758 -175.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.457 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 4.6 mp -103.51 109.93 28.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.471 178.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.629 ' HA ' ' OD1' ' A' ' 47' ' ' ASP . 15.4 m120 -83.13 160.41 21.87 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.735 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.6 t -99.87 109.7 22.08 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 172.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.537 HD12 ' HB2' ' A' ' 72' ' ' LYS . 85.3 mt -78.68 153.25 78.31 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.327 -176.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -62.9 -14.58 41.95 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.668 2.245 . . . . 0.0 111.655 173.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -81.65 8.63 9.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.618 177.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? 62.9 29.0 16.56 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.587 0.708 . . . . 0.0 110.014 -177.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 27.8 mtp180 -124.34 -174.9 3.12 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.581 -177.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . 0.457 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 72.9 m-85 -122.12 151.37 41.01 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.551 0.215 . . . . 0.0 111.027 -177.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.562 ' HE3' ' O ' ' A' ' 75' ' ' ASP . 86.5 tttt -138.89 113.81 9.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.767 -175.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.534 HD11 ' HB3' ' A' ' 61' ' ' TYR . 20.3 tt -89.87 100.48 10.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.858 0.837 . . . . 0.0 110.916 -174.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.45 -65.04 2.45 Favored Glycine 0 CA--C 1.519 0.29 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.95 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.562 ' O ' ' HE3' ' A' ' 72' ' ' LYS . 20.0 t70 -154.15 -29.56 0.12 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.024 0.44 . . . . 0.0 110.221 -176.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -85.48 121.7 28.56 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -93.49 145.87 24.19 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.226 0.536 . . . . 0.0 111.288 -175.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.43 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 86.3 m-85 -131.94 -173.73 3.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.815 178.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -74.94 -61.7 1.8 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.555 178.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.698 ' HD1' ' HD2' ' A' ' 82' ' ' PRO . 5.6 p80 -146.27 -179.1 6.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.272 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.552 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 7.5 mt -56.27 -56.9 26.48 Favored Pre-proline 0 N--CA 1.467 0.405 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -178.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.698 ' HD2' ' HD1' ' A' ' 80' ' ' HIS . 50.9 Cg_exo -57.79 -10.52 7.58 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.399 2.066 . . . . 0.0 113.607 178.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.04 -32.93 17.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.554 0.216 . . . . 0.0 111.034 -175.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.1 pp -76.6 -33.89 58.4 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 77.6 mt -65.25 -31.21 72.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.603 178.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -72.85 -39.82 66.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.267 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.43 ' CE2' ' ND1' ' A' ' 91' ' ' HIS . 68.6 t80 -68.03 -30.94 70.29 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.405 -178.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.634 ' CD1' HD22 ' A' ' 93' ' ' LEU . 27.8 m-85 -84.08 2.3 40.0 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -176.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.557 ' HE2' ' CE1' ' A' ' 6' ' ' PHE . 96.4 mttt -80.47 -15.82 55.82 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.335 172.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.7 pp -126.74 9.39 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.14 0 CA-C-O 121.385 0.612 . . . . 0.0 110.556 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.44 ' O ' ' HB2' ' A' ' 92' ' ' TYR . 9.1 t60 -94.32 -42.43 8.91 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.713 -177.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.44 ' HB2' ' O ' ' A' ' 91' ' ' HIS . 75.8 m-85 65.53 95.72 0.05 Allowed 'General case' 0 C--N 1.329 -0.318 0 O-C-N 124.402 1.063 . . . . 0.0 109.054 -163.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.634 HD22 ' CD1' ' A' ' 88' ' ' TYR . 30.8 mt -61.07 -92.8 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 173.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.593 ' CG ' HH22 ' A' ' 57' ' ' ARG . 20.6 t0 -99.83 86.3 3.26 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.104 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.783 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 2.2 t 48.6 15.18 0.08 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.815 -1.084 . . . . 0.0 112.665 -176.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -156.75 153.17 27.96 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 120.966 0.412 . . . . 0.0 110.383 -177.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.5 p -98.15 168.28 10.35 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.133 -179.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 97.3 mt -70.08 92.67 0.75 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 177.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.552 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 37.4 mm -78.18 -59.29 3.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.34 -174.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.662 ' O ' ' HA ' ' A' ' 35' ' ' MET . 38.4 tt0 -155.8 135.4 8.11 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.14 -176.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -62.12 157.1 46.23 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.791 2.327 . . . . 0.0 113.023 -178.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.455 ' HB1' HD21 ' A' ' 28' ' ' LEU . . . -68.91 142.87 93.97 Favored Pre-proline 0 N--CA 1.452 -0.366 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.131 177.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -60.91 124.78 15.63 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.604 2.203 . . . . 0.0 112.362 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -100.82 3.55 42.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.746 176.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.555 ' HB3' ' HD3' ' A' ' 106' ' ' PRO . 80.1 t80 -153.6 -58.8 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.433 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.555 ' HD3' ' HB3' ' A' ' 105' ' ' TYR . 60.2 Cg_endo -73.55 109.85 2.94 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 121.912 1.741 . . . . 0.0 112.191 -178.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 50.5 m -152.66 107.4 2.72 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-O 120.8 0.333 . . . . 0.0 111.211 -178.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -88.93 119.47 1.01 Allowed 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.283 2.656 . . . . 0.0 111.606 176.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.76 -35.59 93.97 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.78 2.32 . . . . 0.0 112.792 -177.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 18.8 ptp -88.74 22.97 2.45 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.955 0.407 . . . . 0.0 110.957 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -77.2 83.05 1.1 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.827 -0.701 . . . . 0.0 111.549 176.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.9 p -75.39 101.53 4.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.071 0.462 . . . . 0.0 111.253 -178.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.7 p -80.67 110.71 16.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.348 0.594 . . . . 0.0 110.442 178.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 13.5 p -90.37 -35.46 15.19 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.936 -178.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -142.59 108.55 5.6 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.448 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.425 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 2.1 Cg_endo -81.08 -177.47 3.73 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.968 2.445 . . . . 0.0 111.753 178.073 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 14.1 t30 -67.51 -63.15 1.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.492 HD12 ' OE1' ' A' ' 54' ' ' GLU . 74.0 mt -96.57 156.88 36.2 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.708 169.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -88.09 -154.86 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.231 2.62 . . . . 0.0 110.376 165.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 26.5 m -122.25 105.47 10.25 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 174.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -72.97 -72.27 0.26 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.697 -174.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.458 ' OE1' HD21 ' A' ' 125' ' ' LEU . 43.3 tt0 -134.95 113.34 11.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.378 -175.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -75.11 73.3 2.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.386 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.685 ' HA ' ' HD3' ' A' ' 186' ' ' PRO . 22.1 m120 -160.44 -147.38 0.15 Allowed 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -176.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . 0.693 ' CD1' HG23 ' A' ' 152' ' ' ILE . 1.4 mm? 76.06 105.24 0.07 Allowed 'General case' 0 C--N 1.351 0.667 0 O-C-N 123.55 0.531 . . . . 0.0 111.811 166.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.753 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 0.0 OUTLIER -171.83 -61.59 0.02 OUTLIER 'General case' 0 C--O 1.215 -0.729 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.566 -179.926 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.571 ' N ' ' HG2' ' A' ' 126' ' ' GLU . 50.1 m-85 -115.21 108.44 16.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.394 0.616 . . . . 0.0 111.843 179.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 1.021 HG21 ' HG3' ' A' ' 180' ' ' LYS . 38.8 t -126.88 136.13 61.67 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.287 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.629 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 5.7 ptp180 -113.39 153.75 28.06 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 117.789 -1.564 . . . . 0.0 108.915 172.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.51 HG23 HG13 ' A' ' 178' ' ' VAL . 68.2 p -102.74 140.17 37.36 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.512 0.672 . . . . 0.0 111.757 178.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.554 HD22 ' HG2' ' A' ' 179' ' ' GLU . 9.8 mt -113.4 -16.26 12.49 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.89 178.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.436 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 21.7 t80 -82.72 -39.66 21.65 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.313 -174.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ASP . . . . . 0.673 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 13.6 t70 72.82 104.81 0.07 Allowed 'General case' 0 N--CA 1.468 0.443 0 O-C-N 123.695 0.622 . . . . 0.0 110.873 -177.219 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.519 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 67.0 t80 -132.12 94.14 24.7 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 174.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.644 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 69.8 Cg_endo -87.05 92.25 0.53 Allowed 'Trans proline' 0 N--CA 1.442 -1.507 0 C-N-CA 121.667 1.578 . . . . 0.0 112.893 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -88.54 -25.51 30.21 Favored Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.672 174.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ASN . . . . . 0.527 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 0.8 OUTLIER 60.13 52.28 5.16 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.385 0.674 . . . . 0.0 111.933 178.685 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -138.57 172.89 12.21 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.794 177.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -89.32 -13.15 38.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.924 0.869 . . . . 0.0 109.084 172.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.661 ' O ' ' HB2' ' A' ' 172' ' ' MET . 5.9 mm-40 -93.02 -35.25 13.36 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.994 176.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -125.72 109.69 12.87 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.817 177.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.761 ' CD1' ' HB2' ' A' ' 165' ' ' ASN . 34.2 tp -69.35 130.76 90.65 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.002 -176.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . 0.644 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 73.7 Cg_endo -82.26 88.69 1.26 Allowed 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 121.867 1.711 . . . . 0.0 112.071 171.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . 0.519 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 22.3 p90 -100.25 172.92 6.87 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -176.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.673 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 14.1 mptt -122.92 -164.59 1.21 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -168.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.565 ' HD2' ' N ' ' A' ' 146' ' ' LYS . 7.6 mptt -85.39 1.29 49.23 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.59 -174.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -177.39 30.86 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.612 -178.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.681 ' OE2' ' HG ' ' A' ' 150' ' ' LEU . 1.6 pp20? -73.06 169.92 15.98 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 175.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.6 mp -117.89 128.46 75.02 Favored 'Isoleucine or valine' 0 C--N 1.35 0.619 0 CA-C-N 118.498 0.59 . . . . 0.0 110.083 173.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.839 ' CD2' ' HA ' ' A' ' 165' ' ' ASN . 86.0 mt -118.38 158.67 24.83 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-O 121.51 0.671 . . . . 0.0 110.493 -173.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.753 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 97.2 t -128.08 121.07 55.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.187 174.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.693 HG23 ' CD1' ' A' ' 125' ' ' LEU . 26.6 mm -78.83 84.0 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 CA-C-O 121.826 0.822 . . . . 0.0 109.134 -176.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.772 HG23 ' HG2' ' A' ' 154' ' ' GLU . 20.9 tt -73.94 -32.83 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.535 -176.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLU . . . . . 0.772 ' HG2' HG23 ' A' ' 153' ' ' ILE . 0.0 OUTLIER -125.46 144.84 50.35 Favored 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 175.753 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -131.94 76.59 73.51 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-O 121.453 0.644 . . . . 0.0 109.638 168.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.783 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 15.6 Cg_exo -66.88 -47.67 2.43 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.512 2.142 . . . . 0.0 111.581 176.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -112.19 -170.97 1.76 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.629 -177.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -124.85 -14.45 6.69 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.24 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -89.96 -21.35 22.47 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 168.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.647 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 80.9 m95 -125.97 139.15 53.67 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.171 177.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' TRP . . . . . 0.749 ' O ' HG13 ' A' ' 173' ' ' ILE . 45.7 m0 -128.37 137.39 51.87 Favored 'General case' 0 C--O 1.206 -1.187 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.25 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.534 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 6.3 m -97.67 102.68 14.5 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -172.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.585 ' HB2' ' HB3' ' A' ' 150' ' ' LEU . . . -115.53 147.09 41.09 Favored 'General case' 0 N--CA 1.415 -2.2 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.489 -171.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.737 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 13.5 ptt-85 -86.64 127.26 34.92 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 175.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ASN . . . . . 0.839 ' HA ' ' CD2' ' A' ' 150' ' ' LEU . 61.5 t30 -62.41 177.03 0.55 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.875 -169.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.506 ' HB2' ' HB2' ' A' ' 148' ' ' GLU . 40.5 tptt -50.86 -26.42 5.78 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.331 164.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -69.51 -43.04 73.9 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.832 173.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 113.12 -5.02 25.4 Favored Glycine 0 CA--C 1.516 0.146 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.276 -170.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ARG . . . . . 0.737 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.6 OUTLIER -71.29 135.82 47.6 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 123.389 0.675 . . . . 0.0 111.692 -178.819 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 59.6 t -83.48 123.44 38.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 C-N-CA 121.202 -0.199 . . . . 0.0 110.491 177.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -160.76 158.25 29.77 Favored Glycine 0 C--O 1.227 -0.299 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.68 173.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' MET . . . . . 0.661 ' HB2' ' O ' ' A' ' 140' ' ' GLU . 0.6 OUTLIER -74.89 140.67 43.97 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 117.234 0.517 . . . . 0.0 112.001 -178.19 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.749 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.8 pp -137.09 140.49 31.47 Favored Pre-proline 0 N--CA 1.451 -0.418 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.368 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . 0.599 ' O ' HG12 ' A' ' 178' ' ' VAL . 6.3 Cg_exo -76.56 127.04 9.38 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.969 2.446 . . . . 0.0 113.115 -175.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.585 ' O ' HG22 ' A' ' 178' ' ' VAL . 59.4 t -53.23 -45.3 98.41 Favored Pre-proline 0 CA--C 1.542 0.635 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 177.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 27.7 Cg_endo -63.44 -1.0 2.72 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.044 1.83 . . . . 0.0 113.318 176.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.475 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.1 m-30 -104.26 -10.01 18.17 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.588 0.232 . . . . 0.0 111.351 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.618 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 5.0 m -108.16 -171.96 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 115.786 1.773 . . . . 0.0 115.786 -162.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . 0.629 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 5.1 tp10 -155.75 50.95 0.55 Allowed 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 113.009 -1.905 . . . . 0.0 113.503 -153.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' LYS . . . . . 1.021 ' HG3' HG21 ' A' ' 128' ' ' VAL . 3.6 mppt? -67.28 136.44 54.91 Favored 'General case' 0 CA--C 1.518 -0.259 0 O-C-N 119.498 -2.001 . . . . 0.0 109.012 -165.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 61.5 tp -54.2 -90.97 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 112.583 -2.099 . . . . 0.0 112.369 -165.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 17.1 m -118.86 -34.87 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 172.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 11.0 ttp180 60.09 -82.34 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 114.274 -1.33 . . . . 0.0 111.543 175.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 25.6 m 66.45 -67.9 0.15 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.222 0.609 . . . . 0.0 110.106 -173.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 17.8 p 170.09 160.61 0.2 Allowed Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 175.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' PRO . . . . . 0.685 ' HD3' ' HA ' ' A' ' 124' ' ' ASN . 96.4 Cg_exo -43.04 -61.37 0.57 Allowed 'Trans proline' 0 C--O 1.237 0.446 0 C-N-CA 122.85 2.366 . . . . 0.0 113.132 -176.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 28.2 m80 68.27 -47.6 0.54 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.483 0.713 . . . . 0.0 111.966 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 105.95 -22.61 31.24 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 111.629 -0.588 . . . . 0.0 111.629 -178.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -137.07 25.07 3.01 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -175.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -77.37 84.9 3.79 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 121.783 0.801 . . . . 0.0 110.669 179.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 100.72 133.53 8.17 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.597 -176.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -77.71 70.27 4.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.22 0.534 . . . . 0.0 109.664 178.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 68.69 -70.54 0.13 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.588 -176.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 19.5 m120 50.74 28.35 3.55 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.206 0.603 . . . . 0.0 111.953 178.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 20.2 m -108.46 114.57 28.51 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.461 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -126.64 141.53 51.83 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.941 -176.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 16.0 m -68.8 -28.15 66.51 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.155 0.502 . . . . 0.0 110.455 176.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -88.78 -171.25 3.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.345 -176.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 134.8 -31.33 2.74 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 -174.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 49.7 mm 71.86 103.97 0.03 OUTLIER Pre-proline 0 C--O 1.235 0.308 0 C-N-CA 123.483 0.713 . . . . 0.0 111.855 175.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -66.44 147.21 82.25 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.706 2.271 . . . . 0.0 111.441 174.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.639 ' HB2' ' HD3' ' A' ' 203' ' ' PRO . 2.2 mp0 -58.53 -55.83 41.83 Favored Pre-proline 0 CA--C 1.538 0.5 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.945 -177.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . 0.639 ' HD3' ' HB2' ' A' ' 202' ' ' GLU . 19.3 Cg_endo -92.05 30.36 0.32 Allowed 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.456 2.104 . . . . 0.0 112.746 -177.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -75.96 -40.15 54.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.864 0.364 . . . . 0.0 110.871 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -107.29 121.78 45.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.953 0.406 . . . . 0.0 110.963 178.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -111.27 113.92 26.75 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.718 177.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -65.53 125.43 25.15 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.293 -175.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -72.38 141.91 48.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.184 -178.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' GLN . . . . . 0.457 ' HA ' ' HD3' ' A' ' 210' ' ' PRO . 25.9 mt-30 -69.48 133.85 88.91 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.794 178.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 209' ' ' GLN . 8.0 Cg_exo -74.06 152.33 45.64 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.936 2.424 . . . . 0.0 111.162 173.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -127.46 145.99 50.64 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.123 0.487 . . . . 0.0 111.162 -178.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 87.3 m -155.31 117.0 4.05 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.516 177.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 26.4 m -79.62 91.07 5.18 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.295 0.569 . . . . 0.0 110.602 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.422 ' OG1' ' HD3' ' A' ' 215' ' ' PRO . 0.0 OUTLIER -83.71 -49.53 0.69 Allowed Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.385 178.185 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . 0.422 ' HD3' ' OG1' ' A' ' 214' ' ' THR . 11.3 Cg_exo -70.74 88.59 0.65 Allowed 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 122.122 1.881 . . . . 0.0 112.387 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.745 ' HB2' ' HD3' ' A' ' 217' ' ' PRO . 95.3 mt -93.6 -53.25 0.25 Allowed Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.466 176.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.745 ' HD3' ' HB2' ' A' ' 216' ' ' LEU . 22.0 Cg_exo -67.33 -28.18 39.8 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 121.944 1.763 . . . . 0.0 111.764 174.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . 64.79 -170.37 0.19 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.853 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 33.9 m -113.08 -4.21 11.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.038 0.446 . . . . 0.0 110.877 178.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 28.5 m -79.59 113.84 18.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.194 178.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -174.13 95.18 0.1 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.669 -178.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 8.2 t -115.18 97.23 47.64 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -179.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -80.07 131.64 8.99 Favored 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.79 2.327 . . . . 0.0 112.318 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -99.01 121.15 7.11 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.437 -178.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -87.65 87.42 7.38 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.103 0.478 . . . . 0.0 110.765 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' ALA . . . . . 0.811 ' HA ' HD12 ' A' ' 230' ' ' LEU . . . -81.12 74.65 8.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.538 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' ILE . . . . . 0.664 HG13 ' H ' ' A' ' 228' ' ' THR . 8.7 pt -132.91 -69.65 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -176.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' THR . . . . . 0.664 ' H ' HG13 ' A' ' 227' ' ' ILE . 2.5 m -106.67 -59.32 0.05 OUTLIER Pre-proline 0 CA--C 1.541 0.609 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -168.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.577 ' HD3' ' HB ' ' A' ' 228' ' ' THR . 84.7 Cg_endo -80.54 10.92 3.09 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.218 1.945 . . . . 0.0 114.335 -169.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.811 HD12 ' HA ' ' A' ' 226' ' ' ALA . 68.7 mt -104.34 111.75 65.26 Favored Pre-proline 0 C--N 1.321 -0.632 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.173 -178.251 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -80.83 112.6 2.67 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.31 2.673 . . . . 0.0 111.632 178.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' SER . . . . . 0.424 ' C ' ' HG1' ' A' ' 233' ' ' THR . 32.9 t 63.52 -81.5 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 123.148 0.579 . . . . 0.0 110.392 -174.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' THR . . . . . 0.424 ' HG1' ' C ' ' A' ' 232' ' ' SER . 29.6 p 48.84 -165.69 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.723 0.809 . . . . 0.0 112.86 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -97.71 83.62 3.23 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.505 178.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -101.76 5.65 41.36 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.006 0.431 . . . . 0.0 110.429 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 175.98 96.02 0.1 Allowed Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.794 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -66.28 124.71 12.89 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.596 2.198 . . . . 0.0 111.759 178.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.411 ' CG1' HD11 ' A' ' 293' ' ' ILE . 20.1 t -94.19 143.84 10.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.079 -178.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' PHE . . . . . 0.526 ' HB2' ' HG3' ' A' ' 296' ' ' PRO . 95.3 m-85 -111.8 124.21 51.87 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.503 -178.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . 0.47 ' HB3' HD13 ' A' ' 293' ' ' ILE . . . -119.7 127.62 53.04 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.076 179.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . 0.415 ' HB2' ' CE1' ' A' ' 294' ' ' PHE . 50.5 tttp -85.92 119.38 26.17 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -178.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' ALA . . . . . 0.475 ' HA ' HG11 ' A' ' 291' ' ' VAL . . . -71.03 106.84 3.84 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.542 -178.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.734 HG12 ' HG3' ' A' ' 292' ' ' LYS . 2.6 pp -104.56 -14.74 8.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.168 -177.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.76 137.95 49.72 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 175.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -62.3 163.6 8.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.409 0.623 . . . . 0.0 111.944 -173.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . 0.6 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -145.78 121.43 10.47 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 177.898 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 16.5 m -122.36 139.18 30.27 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-O 120.795 0.331 . . . . 0.0 110.753 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.46 ' HD3' ' HB3' ' A' ' 257' ' ' ALA . 42.5 Cg_endo -68.98 125.75 12.95 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.645 2.23 . . . . 0.0 112.249 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' CYS . . . . . 0.515 ' HB3' ' HB2' ' A' ' 252' ' ' ASP . 16.5 t -90.64 172.45 8.67 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -55.71 -47.59 76.59 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.945 0.402 . . . . 0.0 111.283 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -87.68 -6.31 58.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.767 179.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.515 ' HB2' ' HB3' ' A' ' 249' ' ' CYS . 2.9 m-20 -114.48 52.11 0.86 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.342 178.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -71.02 -13.51 62.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.32 0.581 . . . . 0.0 109.865 177.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 2.7 p -89.25 -8.22 53.91 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.969 176.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' ALA . . . . . 0.448 ' HB1' ' HB3' ' A' ' 252' ' ' ASP . . . -76.71 123.18 25.79 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.687 -178.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.33 139.34 51.99 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.629 -178.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' ALA . . . . . 0.6 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -89.15 117.55 28.22 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.094 0.473 . . . . 0.0 109.921 176.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 35.4 mt -129.14 157.76 40.88 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.928 -176.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -136.86 160.29 39.31 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 21.7 t -66.29 105.32 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.087 -172.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 130.6 10.7 2.56 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.689 175.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -118.41 157.57 26.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 117.879 0.839 . . . . 0.0 111.375 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 37.2 mm -94.04 124.07 46.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.753 -178.158 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 32.0 t -95.5 111.02 25.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.957 175.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -95.28 97.26 9.73 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.563 -178.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' VAL . . . . . 0.465 ' HA ' ' HA2' ' A' ' 277' ' ' GLY . 6.6 p -88.41 134.89 26.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.704 -0.399 . . . . 0.0 110.394 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 22.1 p -92.93 -44.1 8.61 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.512 -176.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 29.3 ptt180 -131.21 126.46 35.62 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 121.365 0.602 . . . . 0.0 110.951 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 40.1 mmm -83.08 110.44 18.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.527 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 274' ' ' GLN . 86.9 m-20 -85.4 126.97 34.2 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.283 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 22.8 mt -70.73 -18.62 21.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.295 -175.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -61.88 -23.89 66.59 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.702 0.287 . . . . 0.0 111.162 -178.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 109.19 21.79 7.17 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.746 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.521 ' HA ' ' CZ ' ' A' ' 288' ' ' PHE . 37.9 mt-30 -151.56 111.35 4.03 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 167.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 1.3 m0 -92.08 164.81 13.46 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -176.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' GLU . . . . . 0.64 ' HB3' ' HE2' ' A' ' 283' ' ' LYS . 43.3 mt-10 -104.78 117.98 35.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.128 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -122.01 142.33 14.97 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.725 -178.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -99.38 111.52 23.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.817 0.818 . . . . 0.0 109.922 175.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 95.7 t -124.39 158.03 31.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.74 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -61.8 82.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.732 0.777 . . . . 0.0 110.79 175.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 160.85 -35.77 0.42 Allowed Glycine 0 N--CA 1.441 -0.996 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.17 -177.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 282' ' ' ARG . 42.8 ttm105 177.92 159.71 0.49 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 117.054 0.427 . . . . 0.0 110.197 -178.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.64 ' HE2' ' HB3' ' A' ' 276' ' ' GLU . 2.5 tmtp? -110.1 101.17 9.99 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 171.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -151.96 -168.92 16.84 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.926 -172.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 73.2 mt -90.73 149.15 22.15 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.859 0.361 . . . . 0.0 110.455 -177.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' PHE . . . . . 0.405 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 42.0 p90 -143.91 152.54 55.58 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.402 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 2.3 Cg_endo -81.37 145.3 14.92 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 123.346 2.697 . . . . 0.0 111.752 177.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' PHE . . . . . 0.521 ' CZ ' ' HA ' ' A' ' 274' ' ' GLN . 3.6 m-85 -91.73 -5.47 53.59 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.116 0.414 . . . . 0.0 112.116 -167.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 4.5 m -94.4 -19.73 20.35 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.325 0.583 . . . . 0.0 109.887 175.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -77.23 -22.43 52.24 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.574 177.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' VAL . . . . . 0.475 HG11 ' HA ' ' A' ' 242' ' ' ALA . 28.5 m -117.19 164.49 13.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.235 178.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . 0.734 ' HG3' HG12 ' A' ' 243' ' ' ILE . 98.1 mttt -119.39 119.92 35.35 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.609 177.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' ILE . . . . . 0.47 HD13 ' HB3' ' A' ' 240' ' ' ALA . 18.9 mm -74.63 110.69 9.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 172.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' PHE . . . . . 0.415 ' CE1' ' HB2' ' A' ' 241' ' ' LYS . 2.3 p90 -132.24 -178.62 4.99 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.894 -175.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -104.49 101.88 30.37 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . 0.526 ' HG3' ' HB2' ' A' ' 239' ' ' PHE . 60.7 Cg_endo -75.43 -42.63 0.44 Allowed 'Trans proline' 0 CA--C 1.529 0.256 0 C-N-CA 122.311 2.007 . . . . 0.0 111.878 177.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -94.66 83.91 4.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.566 0.698 . . . . 0.0 109.907 176.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 298' ' ' ASN . . . . . 0.423 ' HA ' ' HD3' ' A' ' 299' ' ' PRO . 17.3 m120 -79.95 127.18 78.09 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.288 -175.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 299' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 298' ' ' ASN . 6.3 Cg_exo -74.81 7.18 2.9 Favored 'Trans proline' 0 CA--C 1.529 0.229 0 C-N-CA 123.126 2.55 . . . . 0.0 111.211 172.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' ASP . . . . . 0.402 ' H ' ' C ' ' A' ' 298' ' ' ASN . 22.6 t70 -53.39 -47.05 69.84 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.568 -179.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -111.42 -23.02 11.0 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.729 177.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 70.81 -58.1 0.57 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.443 178.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.414 -0.803 . . . . 0.0 110.047 177.86 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.54 ' HB2' HD12 ' A' ' 99' ' ' ILE . 13.0 p . . . . . 0 N--CA 1.443 -0.782 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.537 ' HB1' ' HG2' ' A' ' 89' ' ' LYS . . . -93.87 127.91 39.88 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.766 178.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 26.0 mtt180 -142.14 -66.61 0.4 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.443 -176.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.43 ' HB2' ' H ' ' A' ' 7' ' ' ASP . 6.8 p90 11.15 -147.18 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 113.653 -1.612 . . . . 0.0 115.253 -161.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.43 ' H ' ' HB2' ' A' ' 6' ' ' PHE . 6.2 p-10 -101.98 -49.54 3.92 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.986 -174.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.44 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 50.4 m 65.16 35.87 7.58 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.586 -175.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.7 m -161.23 -25.92 0.05 Allowed 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 176.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -85.31 108.71 17.93 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.238 0.542 . . . . 0.0 111.064 -169.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.568 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 9.7 mmt180 -62.06 -25.72 67.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.758 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.9 m -90.11 3.51 53.13 Favored 'General case' 0 C--N 1.32 -0.714 0 O-C-N 122.149 -0.344 . . . . 0.0 110.941 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -99.21 -47.62 5.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.448 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.475 ' HB3' ' HB3' ' A' ' 101' ' ' PRO . 36.2 p-90 -114.2 -24.76 8.79 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -174.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.568 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 21.6 t80 -76.97 116.42 17.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.303 0.573 . . . . 0.0 110.107 -177.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.607 ' HG3' HG21 ' A' ' 19' ' ' VAL . 9.1 tpp -97.26 -9.16 28.19 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.085 -171.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.509 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 49.81 -115.21 2.85 Favored Glycine 0 CA--C 1.523 0.564 0 CA-C-N 115.398 -0.819 . . . . 0.0 114.292 177.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.509 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 4.6 Cg_exo -74.99 101.19 1.44 Allowed 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 123.056 2.504 . . . . 0.0 112.239 -177.082 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.607 HG21 ' HG3' ' A' ' 16' ' ' MET . 5.3 t -138.55 -76.46 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 CA-C-O 118.909 -0.567 . . . . 0.0 111.523 -175.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.761 ' H ' ' HD2' ' A' ' 39' ' ' ARG . 51.4 m 94.8 171.66 0.02 OUTLIER 'General case' 0 C--N 1.35 0.63 0 C-N-CA 124.187 0.995 . . . . 0.0 109.353 170.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.524 ' HD2' ' NH2' ' A' ' 39' ' ' ARG . 19.4 mmm180 -51.65 -53.46 38.52 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 123.388 0.43 . . . . 0.0 112.129 -169.504 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -62.95 -42.53 99.85 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.506 -175.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.433 ' HB3' HG13 ' A' ' 19' ' ' VAL . 12.7 tp10 -72.63 -46.03 56.08 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.296 0.569 . . . . 0.0 109.521 -174.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.24 -47.62 80.89 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.305 -0.862 . . . . 0.0 111.455 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -64.05 -41.57 97.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.081 -175.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.5 t -79.55 -20.92 45.89 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -175.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -80.69 -13.72 58.76 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 120.944 0.402 . . . . 0.0 110.708 178.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.608 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 80.2 mt -128.96 17.07 6.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.244 -177.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.5 82.0 0.1 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.047 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.99 -63.94 4.22 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.715 -177.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 45.41 -105.16 0.1 Allowed 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.191 0.596 . . . . 0.0 111.858 -176.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 54.5 mtm180 -126.72 3.0 6.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.579 0.228 . . . . 0.0 110.409 176.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 28.0 m170 66.85 150.62 0.06 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.033 -174.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.33 19.22 79.68 Favored Glycine 0 C--O 1.227 -0.314 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.011 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 76.3 mtp -112.3 141.78 45.6 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.483 ' HB2' HD11 ' A' ' 50' ' ' LEU . 38.4 p90 -137.98 161.62 36.22 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.136 -174.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.489 ' O ' HD12 ' A' ' 37' ' ' LEU . 4.6 pp -150.25 133.83 16.6 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.247 0.546 . . . . 0.0 110.569 172.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.417 HG22 HD13 ' A' ' 50' ' ' LEU . 42.3 t -101.92 107.21 21.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 175.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.761 ' HD2' ' H ' ' A' ' 20' ' ' SER . 28.3 ptt-85 -103.32 177.45 4.84 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 -178.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -75.2 137.43 41.27 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 174.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.518 ' HB3' ' O ' ' A' ' 44' ' ' CYS . 21.1 t -64.56 109.9 2.14 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.378 0.609 . . . . 0.0 111.229 -173.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 57.2 p -77.45 -4.83 47.43 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.602 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.69 -51.34 4.76 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.313 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.518 ' O ' ' HB3' ' A' ' 41' ' ' SER . 34.3 m -135.03 118.95 13.29 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.602 -177.028 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -59.03 123.86 14.41 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.601 2.201 . . . . 0.0 112.104 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.05 -34.73 4.94 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.947 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.588 ' OD1' ' HA ' ' A' ' 64' ' ' ASN . 44.5 m-20 -86.4 -176.86 6.04 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.49 ' HE2' ' CE1' ' A' ' 71' ' ' PHE . 35.1 m-85 -134.15 172.58 12.65 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 176.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.471 HG23 ' HA ' ' A' ' 41' ' ' SER . 43.1 t -140.7 106.12 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.938 0.399 . . . . 0.0 111.065 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.483 HD11 ' HB2' ' A' ' 36' ' ' PHE . 43.0 tp -78.9 106.26 10.79 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.308 176.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 24.1 m -96.66 132.38 42.37 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 174.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 72.0 t -125.13 133.3 69.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.712 0.291 . . . . 0.0 111.297 -177.099 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.608 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 30.7 t -87.52 116.49 25.67 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.288 -0.415 . . . . 0.0 112.063 -176.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.54 ' HG2' HG22 ' A' ' 95' ' ' THR . 7.6 tp10 -151.65 147.7 27.05 Favored 'General case' 0 C--O 1.21 -1.009 0 C-N-CA 119.682 -0.807 . . . . 0.0 109.225 164.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.5 ' HB2' ' HG2' ' A' ' 57' ' ' ARG . 67.4 m-80 56.84 24.05 8.79 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.4 m 57.47 52.82 8.07 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 122.522 1.153 . . . . 0.0 108.411 -174.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.5 ' HG2' ' HB2' ' A' ' 55' ' ' ASN 0.25 0.0 OUTLIER -167.44 66.49 0.08 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 113.504 -1.68 . . . . 0.0 109.814 -152.188 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 20.2 t -73.32 101.01 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 120.861 -1.15 . . . . 0.0 111.252 -167.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.8 m -69.87 122.15 18.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.807 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -96.26 115.92 28.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.891 -175.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.626 ' OH ' ' HB3' ' A' ' 93' ' ' LEU . 37.0 m-85 -108.84 113.95 27.31 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.63 178.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.652 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 57.3 mt -81.35 133.83 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 O-C-N 122.078 -0.388 . . . . 0.0 111.986 -177.087 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.523 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 5.3 mp -114.27 119.43 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 122.968 0.507 . . . . 0.0 110.853 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.588 ' HA ' ' OD1' ' A' ' 47' ' ' ASP . 85.7 m-20 -86.97 148.23 25.41 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.356 -174.118 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.7 t -89.53 94.96 10.06 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 170.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.464 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 81.6 mt -71.6 135.58 83.66 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.007 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 66' ' ' LEU . 33.7 Cg_exo -60.66 -22.43 72.83 Favored 'Trans proline' 0 N--CA 1.473 0.312 0 C-N-CA 123.014 2.476 . . . . 0.0 113.072 -174.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -84.28 17.48 2.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.259 0.552 . . . . 0.0 110.37 176.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.627 ' NE ' ' HA ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER 65.33 52.1 1.48 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.142 175.846 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 63.8 mtt180 -135.54 -175.16 3.85 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.462 175.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.523 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 67.8 m-85 -137.27 136.58 38.18 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.633 0.254 . . . . 0.0 111.25 -173.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.533 ' HB3' ' HB2' ' A' ' 64' ' ' ASN . 61.7 tttp -125.76 108.49 11.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.763 -174.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.652 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 7.3 tt -99.52 102.26 13.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.238 0.542 . . . . 0.0 111.494 -175.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 53.3 70.34 0.95 Allowed Glycine 0 CA--C 1.52 0.392 0 CA-C-N 115.437 -0.801 . . . . 0.0 113.728 175.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 34.6 t70 74.89 -30.41 0.2 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.325 0.65 . . . . 0.0 111.568 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -89.55 112.82 24.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.642 0.258 . . . . 0.0 110.809 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 1.3 pm0 -97.41 139.79 32.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.663 0.744 . . . . 0.0 111.484 176.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.515 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 89.9 m-85 -122.34 -172.04 2.38 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.611 175.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -86.11 -29.21 23.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.745 0.307 . . . . 0.0 111.514 -179.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -163.78 168.11 20.05 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.515 0.198 . . . . 0.0 111.417 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.654 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 6.7 mt -54.51 -58.61 13.3 Favored Pre-proline 0 N--CA 1.468 0.462 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.211 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.576 ' HA ' HD12 ' A' ' 85' ' ' LEU . 36.9 Cg_exo -63.9 -3.05 5.19 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.132 1.888 . . . . 0.0 113.263 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.82 -33.79 17.28 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.654 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.1 pp -76.39 -34.09 58.87 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 177.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.576 HD12 ' HA ' ' A' ' 82' ' ' PRO . 60.1 mt -64.66 -29.51 70.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.13 177.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.2 tp10 -79.1 -33.9 43.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.378 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -72.21 -33.44 67.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.402 0.62 . . . . 0.0 110.388 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.413 ' HE2' HD13 ' A' ' 73' ' ' ILE . 38.3 m-85 -82.44 1.86 35.47 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.619 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.537 ' HG2' ' HB1' ' A' ' 4' ' ' ALA . 93.8 mttt -73.76 -16.53 61.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.774 173.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 36.8 pt -129.96 -0.65 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 CA-C-O 121.15 0.5 . . . . 0.0 110.725 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -82.67 -40.83 20.17 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.889 -175.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.413 ' H ' HG22 ' A' ' 97' ' ' THR . 96.1 m-85 64.82 101.05 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.382 0 O-C-N 124.548 1.155 . . . . 0.0 109.209 -164.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.626 ' HB3' ' OH ' ' A' ' 61' ' ' TYR . 26.6 mt -63.66 -99.25 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.763 174.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.648 ' HA ' ' HB3' ' A' ' 154' ' ' GLU . 40.7 t0 -68.35 -59.97 2.79 Favored 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -175.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.656 ' CB ' ' HA ' ' A' ' 156' ' ' PRO . 12.6 t -154.37 14.85 0.45 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.661 0.743 . . . . 0.0 109.594 169.063 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 12.3 t -145.57 167.07 23.93 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.542 -177.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.413 HG22 ' H ' ' A' ' 92' ' ' TYR . 38.9 p -97.86 176.01 5.95 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.458 HD22 ' CD2' ' A' ' 36' ' ' PHE . 96.2 mt -77.99 89.4 4.15 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.188 0.518 . . . . 0.0 110.088 177.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.54 HD12 ' HB2' ' A' ' 3' ' ' SER . 38.9 mm -61.95 -64.1 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.327 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.465 ' HB2' ' HD2' ' A' ' 101' ' ' PRO . 13.3 pt-20 -159.44 159.53 28.32 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.569 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.475 ' HB3' ' HB3' ' A' ' 14' ' ' TRP . 59.8 Cg_endo -72.63 155.62 54.29 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.268 1.979 . . . . 0.0 112.074 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.03 135.3 70.46 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 176.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.76 138.07 67.9 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.285 1.99 . . . . 0.0 111.262 176.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.592 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 36.6 mtm180 . . . . . 0 C--N 1.327 -0.403 0 CA-C-O 121.082 0.468 . . . . 0.0 110.737 -177.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.696 HD12 HG21 ' A' ' 152' ' ' ILE . 3.0 mm? . . . . . 0 CA--C 1.516 -0.363 0 CA-C-O 121.862 0.839 . . . . 0.0 112.993 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 173.29 -51.84 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 113.34 -1.755 . . . . 0.0 107.08 177.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -119.73 110.83 17.26 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.196 0.522 . . . . 0.0 110.681 173.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.96 HG22 ' HG3' ' A' ' 180' ' ' LYS . 61.1 t -128.72 139.39 52.02 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.018 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.572 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 7.5 ptp180 -112.48 155.52 24.12 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 116.834 -1.946 . . . . 0.0 108.952 170.206 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.603 ' OG1' ' HB2' ' A' ' 144' ' ' PHE . 1.0 OUTLIER -110.32 140.6 44.34 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.477 0.656 . . . . 0.0 110.896 178.981 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.567 HD21 ' HG2' ' A' ' 179' ' ' GLU . 8.1 mt -113.38 -15.14 12.7 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -177.273 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -94.73 -14.72 24.5 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -171.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.56 ' HB3' ' C ' ' A' ' 145' ' ' LYS . 3.8 p-10 54.99 102.08 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 122.559 1.171 . . . . 0.0 112.637 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -119.39 86.64 34.08 Favored Pre-proline 0 C--N 1.317 -0.84 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 171.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.666 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 65.9 Cg_endo -85.56 72.97 4.09 Favored 'Trans proline' 0 N--CA 1.445 -1.376 0 C-N-CA 121.897 1.731 . . . . 0.0 112.638 -176.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.67 -34.19 66.92 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 174.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.871 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 0.4 OUTLIER 70.98 40.5 0.9 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.471 -0.864 . . . . 0.0 111.589 174.784 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -126.09 175.03 8.04 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.881 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -92.66 -7.66 46.23 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.8 0.81 . . . . 0.0 109.052 171.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.615 ' O ' ' HB2' ' A' ' 172' ' ' MET . 8.8 mm-40 -93.32 -29.87 15.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.752 176.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -136.18 108.88 7.5 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.851 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.996 HD11 ' HB2' ' A' ' 165' ' ' ASN . 58.1 tp -67.26 123.87 87.56 Favored Pre-proline 0 CA--C 1.509 -0.611 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.824 -176.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.871 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 56.3 Cg_endo -71.87 93.6 0.71 Allowed 'Trans proline' 0 N--CA 1.443 -1.472 0 C-N-CA 120.987 1.125 . . . . 0.0 111.348 167.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.603 ' HB2' ' OG1' ' A' ' 130' ' ' THR . 16.7 p90 -103.32 159.61 15.41 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 1.002 ' H ' ' HG3' ' A' ' 148' ' ' GLU . 47.6 mtpt -110.16 -151.81 0.48 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.144 0.497 . . . . 0.0 111.929 -170.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.824 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -104.47 27.94 7.41 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.323 -176.843 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 159.14 36.96 0.02 OUTLIER Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.242 178.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 1.002 ' HG3' ' H ' ' A' ' 145' ' ' LYS . 0.0 OUTLIER -86.11 170.25 12.37 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.895 0.878 . . . . 0.0 109.399 171.966 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.5 mp -114.0 133.04 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 172.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.713 HD22 ' CD2' ' A' ' 142' ' ' LEU . 72.2 mt -118.47 155.79 30.18 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -174.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.603 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 92.2 t -122.22 121.73 64.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 174.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.984 HD13 ' HB2' ' A' ' 163' ' ' ALA . 46.9 mm -78.04 79.09 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 122.125 0.964 . . . . 0.0 108.411 -177.112 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.737 HG23 ' HG2' ' A' ' 154' ' ' GLU . 16.9 tt -69.38 -27.96 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 CA-C-N 113.91 -1.495 . . . . 0.0 109.288 -177.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.737 ' HG2' HG23 ' A' ' 153' ' ' ILE . 0.0 OUTLIER -133.01 141.49 48.31 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 171.778 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.56 ' HD2' ' HG ' ' A' ' 125' ' ' LEU . 82.9 tttt -135.1 82.61 41.74 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 168.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.656 ' HA ' ' CB ' ' A' ' 95' ' ' THR . 8.3 Cg_exo -73.03 -47.72 0.31 Allowed 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.538 2.159 . . . . 0.0 111.87 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -107.57 171.13 7.56 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.032 -173.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.642 ' HG3' ' HG2' ' A' ' 159' ' ' GLN . 8.1 pt-20 -89.7 -26.92 20.43 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.752 178.311 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.642 ' HG2' ' HG3' ' A' ' 158' ' ' GLU . 82.9 mm-40 -101.8 -18.74 15.63 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.483 -175.051 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.53 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 63.7 m95 -126.66 135.28 50.96 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 175.018 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' TRP . . . . . 0.779 ' O ' HG13 ' A' ' 173' ' ' ILE . 49.4 m0 -125.33 137.93 54.06 Favored 'General case' 0 C--O 1.214 -0.771 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.525 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 14.7 m -96.87 102.79 14.64 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -174.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.984 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -118.93 151.74 37.6 Favored 'General case' 0 N--CA 1.426 -1.667 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.069 -174.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.792 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 15.3 ptt-85 -88.69 129.39 35.54 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 175.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.996 ' HB2' HD11 ' A' ' 142' ' ' LEU . 65.2 t30 -60.72 178.64 0.21 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.234 -1.348 . . . . 0.0 111.514 -171.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.555 ' HB2' ' HB2' ' A' ' 148' ' ' GLU . 44.0 tptt -50.71 -33.2 21.91 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.103 166.225 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -64.7 -38.68 91.82 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.709 173.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.498 ' C ' ' HB2' ' A' ' 164' ' ' ARG . . . 107.09 3.81 35.92 Favored Glycine 0 CA--C 1.522 0.471 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.217 -171.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.792 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.4 OUTLIER -77.4 134.61 38.39 Favored 'General case' 0 C--O 1.216 -0.671 0 C-N-CA 123.141 0.576 . . . . 0.0 111.21 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.5 HG22 HG21 ' A' ' 153' ' ' ILE . 60.4 t -85.12 125.55 40.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 117.684 0.22 . . . . 0.0 111.526 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -157.1 157.71 28.27 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.172 172.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.615 ' HB2' ' O ' ' A' ' 140' ' ' GLU . 0.0 OUTLIER -76.94 141.09 40.62 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 117.242 0.521 . . . . 0.0 111.228 179.367 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.779 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.4 pp -142.25 142.9 25.44 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.424 -176.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.522 ' HB2' ' CD1' ' A' ' 177' ' ' TYR . 15.7 Cg_exo -70.36 138.57 36.21 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 123.275 2.65 . . . . 0.0 113.351 -178.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.574 ' O ' HG22 ' A' ' 178' ' ' VAL . 58.9 t -65.1 -45.09 72.57 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 28.0 Cg_endo -63.81 3.09 0.77 Allowed 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.044 1.829 . . . . 0.0 113.2 177.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.522 ' CD1' ' HB2' ' A' ' 174' ' ' PRO . 3.3 m-85 -103.41 -11.85 17.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.237 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.614 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 4.6 m -104.84 -170.8 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 115.691 1.737 . . . . 0.0 115.691 -166.12 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.572 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 4.0 tp10 -159.73 48.21 0.29 Allowed 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 113.164 -1.835 . . . . 0.0 113.226 -153.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.96 ' HG3' HG22 ' A' ' 128' ' ' VAL . 2.9 mppt? -70.73 138.1 50.24 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 119.746 -1.846 . . . . 0.0 110.248 -162.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.401 HD13 ' NH2' ' A' ' 129' ' ' ARG . 39.9 tp . . . . . 0 C--N 1.332 -0.188 0 CA-C-N 113.557 -1.656 . . . . 0.0 112.473 -162.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo . . . . . 0 C--O 1.236 0.378 0 CA-C-O 120.782 0.242 . . . . 0.0 111.802 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.541 ' HB ' HG13 ' A' ' 266' ' ' VAL . 11.7 t -101.91 130.85 50.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.025 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -115.56 134.92 54.6 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.35 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.628 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -131.72 145.1 51.45 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.359 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -98.5 127.94 44.64 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.156 177.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' ALA . . . . . 0.572 ' O ' ' HA ' ' A' ' 260' ' ' VAL . . . -76.82 102.09 6.15 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 176.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 25.3 pt -94.65 -5.02 10.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.585 -173.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.12 147.62 46.13 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.134 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -63.57 133.04 53.06 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.112 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.78 95.37 3.12 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.793 0.33 . . . . 0.0 110.582 -177.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 27.2 m -90.26 162.37 34.83 Favored Pre-proline 0 C--N 1.318 -0.773 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 172.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.504 ' HG3' ' HB2' ' A' ' 257' ' ' ALA . 5.1 Cg_exo -75.67 -151.45 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.152 1.901 . . . . 0.0 111.399 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 249' ' ' CYS . . . . . 0.504 ' O ' ' HB3' ' A' ' 252' ' ' ASP . 42.6 t -147.45 171.74 15.04 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 122.123 -0.361 . . . . 0.0 111.342 -173.222 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -68.08 -31.16 70.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.958 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -102.41 22.59 13.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.285 0.564 . . . . 0.0 110.539 176.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 252' ' ' ASP . . . . . 0.504 ' HB3' ' O ' ' A' ' 249' ' ' CYS . 0.1 OUTLIER -83.2 129.03 34.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.416 178.205 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -138.68 -0.57 1.92 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.416 167.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 2.1 p -151.45 21.38 0.73 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.924 -177.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -102.93 109.44 21.0 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.034 0.445 . . . . 0.0 110.594 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.519 ' HA ' ' NH1' ' A' ' 282' ' ' ARG . 0.5 OUTLIER -65.93 139.07 58.23 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.874 -176.821 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.504 ' HB2' ' HG3' ' A' ' 248' ' ' PRO . . . -103.03 123.76 47.23 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.032 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.693 HD12 HG21 ' A' ' 289' ' ' THR . 57.1 mt -135.93 176.36 8.76 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.233 -175.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -160.38 177.29 10.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.65 0.262 . . . . 0.0 111.095 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 57.4 t -66.42 126.55 26.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.954 -171.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 96.14 8.65 57.66 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.888 175.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -103.61 147.27 27.41 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 31.4 mm -107.24 116.08 50.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.124 0.488 . . . . 0.0 110.336 -176.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 10.2 t -85.77 120.77 36.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.572 -177.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 265' ' ' LYS . . . . . 0.706 ' HD3' ' HG3' ' A' ' 278' ' ' GLU . 35.8 tttp -86.48 100.41 12.35 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.784 175.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.541 HG13 ' HB ' ' A' ' 238' ' ' VAL . 3.9 p -117.0 117.19 54.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.7 0.762 . . . . 0.0 111.095 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 12.7 p -98.2 -38.51 9.27 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.308 177.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 268' ' ' ARG . . . . . 0.524 ' HB2' ' HB2' ' A' ' 276' ' ' GLU . 42.7 mtt180 -106.81 108.75 20.41 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.141 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 6.2 ptp -114.18 114.51 26.13 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.717 0.77 . . . . 0.0 110.972 173.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -83.89 150.93 25.39 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.514 -176.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 34.4 pt -82.72 11.37 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.042 -177.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -98.58 -6.62 29.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.722 0.296 . . . . 0.0 110.544 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 113.25 -39.13 2.95 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.725 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.518 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 2.4 mp0 -88.3 111.16 21.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.862 0.363 . . . . 0.0 110.366 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.504 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 10.1 m0 -93.86 157.03 16.33 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.524 ' HB2' ' HB2' ' A' ' 268' ' ' ARG . 38.8 mt-10 -100.62 114.05 27.42 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 176.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -138.32 146.53 18.32 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.615 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.706 ' HG3' ' HD3' ' A' ' 265' ' ' LYS . 6.1 pt-20 -114.02 109.95 19.26 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.027 0.441 . . . . 0.0 110.024 177.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 279' ' ' VAL . . . . . 0.441 HG21 HD21 ' A' ' 258' ' ' LEU . 14.5 t -109.27 -109.68 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.013 -175.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -85.98 82.56 8.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.788 0.327 . . . . 0.0 111.615 -174.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 66.02 6.68 32.99 Favored Glycine 0 C--N 1.332 0.337 0 CA-C-N 115.928 -0.578 . . . . 0.0 113.421 174.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 282' ' ' ARG . . . . . 0.519 ' NH1' ' HA ' ' A' ' 256' ' ' LEU . 1.7 tmt_? -146.92 127.98 14.61 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -176.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.454 ' HB3' ' HB3' ' A' ' 278' ' ' GLU . 15.0 ptpt -120.71 142.43 49.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.684 -178.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -173.69 -169.7 36.29 Favored Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 111.564 -0.614 . . . . 0.0 111.564 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.518 ' HB3' ' HB3' ' A' ' 274' ' ' GLN . 94.4 mt -86.78 146.95 26.04 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.167 0.508 . . . . 0.0 110.247 177.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.684 ' HB2' ' OG1' ' A' ' 289' ' ' THR . 26.3 p90 -143.18 123.39 7.88 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.582 176.233 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 287' ' ' PRO . . . . . 0.638 ' C ' ' H ' ' A' ' 289' ' ' THR . 51.5 Cg_exo -62.98 62.26 0.16 Allowed 'Trans proline' 0 N--CA 1.486 1.061 0 C-N-CA 124.597 3.531 . . . . 0.0 112.565 175.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.668 ' O ' HG22 ' A' ' 291' ' ' VAL . 4.3 m-85 62.54 -14.77 0.06 Allowed 'General case' 0 C--O 1.213 -0.849 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.736 -168.151 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 289' ' ' THR . . . . . 0.693 HG21 HD12 ' A' ' 258' ' ' LEU . 1.4 m 69.68 -12.31 0.46 Allowed 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 123.573 0.749 . . . . 0.0 112.824 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 290' ' ' HIS . . . . . 0.472 ' CB ' ' O ' ' A' ' 289' ' ' THR . 32.2 m170 89.37 25.0 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 O-C-N 124.313 1.008 . . . . 0.0 109.829 -164.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.668 HG22 ' O ' ' A' ' 288' ' ' PHE . 13.1 m -86.99 179.57 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.358 0.599 . . . . 0.0 111.206 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -135.25 129.99 34.49 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.306 173.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.628 HD13 ' HB2' ' A' ' 240' ' ' ALA . 19.0 mm -77.35 126.02 37.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.064 0.459 . . . . 0.0 111.16 -178.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -151.44 -171.56 3.97 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -133.07 105.88 12.45 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-O 120.889 0.376 . . . . 0.0 110.221 175.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo . . . . . 0 C--O 1.234 0.294 0 C-N-CA 122.919 2.413 . . . . 0.0 112.678 -179.176 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.485 ' O ' HG23 ' A' ' 99' ' ' ILE . 19.5 m . . . . . 0 N--CA 1.449 -0.477 0 CA-C-O 120.762 0.315 . . . . 0.0 110.42 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -86.7 56.11 3.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.168 0.509 . . . . 0.0 110.707 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 20.7 tpp180 -93.55 96.75 10.06 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.383 -174.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.617 ' CE1' ' HE2' ' A' ' 89' ' ' LYS . 41.3 p90 -167.62 147.93 5.21 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.105 174.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -79.04 102.79 8.57 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.867 -178.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.405 ' O ' ' HB2' ' A' ' 9' ' ' SER . 30.4 m -69.36 76.88 0.39 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.079 175.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 8' ' ' SER . 21.4 t 178.48 -37.33 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.831 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -69.13 106.95 3.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.428 -173.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 -61.58 -31.03 71.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.397 -177.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 61.1 m -80.37 3.41 21.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.352 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -91.71 -47.81 7.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.941 0.4 . . . . 0.0 110.513 175.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 25.9 p-90 -122.62 -24.21 4.96 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -168.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -74.65 118.6 17.79 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.173 0.511 . . . . 0.0 110.913 -174.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.787 ' HG3' ' HB2' ' A' ' 37' ' ' LEU . 25.9 mmt -101.16 -11.71 19.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.062 -174.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.406 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 50.55 -114.21 2.51 Favored Glycine 0 CA--C 1.524 0.602 0 O-C-N 123.653 0.595 . . . . 0.0 113.25 -176.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.406 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 9.0 Cg_exo -72.31 91.33 0.76 Allowed 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 122.994 2.463 . . . . 0.0 113.273 -175.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.722 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 71.1 t -143.88 161.74 15.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 176.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.614 ' HA ' ' OG ' ' A' ' 42' ' ' SER . 16.0 m -128.68 174.06 9.76 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -172.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 63.3 mtp85 -57.32 -54.27 48.71 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.484 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -60.99 -40.95 95.43 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.726 0.298 . . . . 0.0 111.684 -177.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.538 ' O ' ' HG3' ' A' ' 27' ' ' ARG . 0.3 OUTLIER -70.98 -47.04 61.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.138 0.494 . . . . 0.0 110.17 -177.262 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.44 -42.83 83.19 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.157 0.503 . . . . 0.0 110.998 175.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.663 ' HG3' HG21 ' A' ' 58' ' ' VAL . 64.6 tt0 -65.29 -40.84 94.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.232 -177.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.6 t -76.19 -4.58 42.54 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.929 0.395 . . . . 0.0 111.167 -177.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.538 ' HG3' ' O ' ' A' ' 23' ' ' GLU . 90.7 mtt180 -90.03 -25.91 20.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.206 0.527 . . . . 0.0 109.746 172.085 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.57 HD22 ' HB2' ' A' ' 53' ' ' SER . 25.5 mt -116.7 16.9 15.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.953 -171.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.4 90.57 4.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.036 0.446 . . . . 0.0 110.686 -176.125 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.97 -4.68 74.34 Favored Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.576 176.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 77.4 mm-40 -65.55 167.99 8.1 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.792 0.329 . . . . 0.0 111.527 -178.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -43.19 125.53 3.72 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.476 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.546 ' HB3' HG21 ' A' ' 96' ' ' THR . 29.8 m170 -69.39 142.22 53.96 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.335 -178.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.562 ' HA3' ' HB ' ' A' ' 99' ' ' ILE . . . 110.64 -20.16 25.24 Favored Glycine 0 N--CA 1.437 -1.241 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 -175.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.664 ' HB3' ' HB2' ' A' ' 102' ' ' ALA . 63.3 mtt -61.75 142.41 57.29 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 173.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.56 ' HB2' HD11 ' A' ' 50' ' ' LEU . 51.6 p90 -153.19 162.74 40.97 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.148 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.787 ' HB2' ' HG3' ' A' ' 16' ' ' MET . 4.4 pp -155.66 132.66 10.68 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.132 0.491 . . . . 0.0 111.432 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.4 t -103.79 109.8 28.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 174.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.722 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 29.5 ptt-85 -113.22 177.82 4.5 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.82 -177.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -73.78 134.35 43.41 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 172.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.524 ' HA ' HG23 ' A' ' 49' ' ' VAL . 39.2 t -57.09 119.13 5.81 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.61 0.719 . . . . 0.0 111.965 -173.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.614 ' OG ' ' HA ' ' A' ' 20' ' ' SER . 1.5 m -77.44 -11.75 59.88 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.426 173.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.0 m -83.58 -41.4 17.92 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.372 177.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.465 ' O ' ' HB3' ' A' ' 41' ' ' SER . 6.5 p -157.36 94.63 2.15 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.107 178.358 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -47.91 127.05 13.96 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.11 2.54 . . . . 0.0 112.087 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.48 -45.58 1.15 Allowed Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -172.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -83.67 -166.06 1.29 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 172.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.6 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 25.4 m-85 -134.8 171.27 14.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 117.902 0.319 . . . . 0.0 110.563 177.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.524 HG23 ' HA ' ' A' ' 41' ' ' SER . 59.9 t -145.37 109.4 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 175.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.56 HD11 ' HB2' ' A' ' 36' ' ' PHE . 56.2 tp -80.33 100.95 8.66 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.636 175.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.3 m -96.69 121.78 38.91 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 174.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.646 HG12 ' HG3' ' A' ' 54' ' ' GLU . 87.0 t -111.82 138.59 39.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.712 -174.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.679 ' HA ' ' O ' ' A' ' 57' ' ' ARG . 48.1 t -82.63 98.48 9.03 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 175.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.646 ' HG3' HG12 ' A' ' 52' ' ' VAL . 24.2 mt-10 -151.36 160.81 43.58 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.97 -175.129 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 70.43 -65.85 0.31 Allowed 'General case' 0 CA--C 1.49 -1.333 0 CA-C-O 122.742 1.258 . . . . 0.0 110.456 -168.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.438 ' HB2' ' HD3' ' A' ' 57' ' ' ARG . 74.8 m -157.9 -22.16 0.08 Allowed 'General case' 0 N--CA 1.419 -1.992 0 CA-C-N 112.56 -2.109 . . . . 0.0 107.626 -175.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.709 ' HG2' HG23 ' A' ' 58' ' ' VAL 0.359 0.0 OUTLIER -166.61 -50.23 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.124 1 N-CA-C 121.877 4.029 . . . . 0.0 121.877 -179.836 . . . . . . . . 5 4 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.709 HG23 ' HG2' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -149.78 99.42 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 CA-C-N 121.729 2.058 . . . . 0.0 112.939 -170.148 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.7 m -94.83 111.06 22.87 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 172.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -97.39 112.67 24.4 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -168.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.718 ' OH ' ' HB3' ' A' ' 93' ' ' LEU . 54.3 m-85 -120.14 105.78 11.32 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.415 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.606 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 63.6 mt -80.52 127.0 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -174.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.6 ' HB ' ' HB2' ' A' ' 48' ' ' TYR . 4.3 mp -101.05 119.72 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 121.17 0.51 . . . . 0.0 111.17 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.551 ' HB2' ' HB3' ' A' ' 72' ' ' LYS . 16.7 m120 -86.04 136.11 33.37 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.798 -178.148 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.1 t -85.58 93.75 8.88 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 171.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.663 HD11 ' HB2' ' A' ' 72' ' ' LYS . 83.6 mt -84.99 145.84 44.36 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.834 -177.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 66' ' ' LEU . 18.5 Cg_exo -67.57 -3.85 10.95 Favored 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 122.92 2.414 . . . . 0.0 111.547 174.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.426 ' HB3' ' HD3' ' A' ' 70' ' ' ARG . 42.2 m-20 -80.66 2.21 26.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.71 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? 63.59 31.89 14.37 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.469 0.652 . . . . 0.0 109.51 -170.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.754 ' HG2' ' HA ' ' A' ' 79' ' ' ASP . 35.5 mtp180 -132.44 162.03 32.19 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.708 -175.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.475 ' HB3' HG23 ' A' ' 63' ' ' ILE . 47.3 m-85 -122.85 117.84 26.55 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.965 0.412 . . . . 0.0 111.142 -174.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.663 ' HB2' HD11 ' A' ' 66' ' ' LEU . 29.5 ttpp -104.09 98.99 8.73 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.462 -173.236 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.706 HD11 ' CB ' ' A' ' 61' ' ' TYR . 6.7 tt -88.45 119.64 36.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.293 0.568 . . . . 0.0 111.286 -177.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.37 32.16 83.19 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.828 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.497 ' HA ' ' HZ3' ' A' ' 72' ' ' LYS . 35.1 t70 74.62 -11.61 1.01 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.035 0.534 . . . . 0.0 111.835 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -86.66 126.66 34.68 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 171.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 0.7 OUTLIER -100.57 140.79 34.34 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.909 0.861 . . . . 0.0 113.169 -169.134 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.559 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 91.0 m-85 -129.02 172.16 11.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.218 -1.356 . . . . 0.0 108.376 173.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.754 ' HA ' ' HG2' ' A' ' 70' ' ' ARG . 5.9 m-20 -74.88 -30.33 61.28 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.66 0.266 . . . . 0.0 111.693 -175.181 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.504 ' ND1' ' HG2' ' A' ' 82' ' ' PRO . 4.9 p80 -165.07 168.35 17.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.563 -176.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.668 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 14.3 mt -57.97 -54.63 53.5 Favored Pre-proline 0 N--CA 1.469 0.482 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -177.06 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.504 ' HG2' ' ND1' ' A' ' 80' ' ' HIS . 20.9 Cg_endo -62.95 -3.02 4.15 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 121.976 1.784 . . . . 0.0 113.637 178.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.421 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -89.01 -36.51 15.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.94 0.4 . . . . 0.0 110.263 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.668 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.0 pp -76.81 -29.86 56.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.064 0.459 . . . . 0.0 109.891 178.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.514 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 79.7 mt -68.46 -21.04 64.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.336 177.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -91.97 -17.45 25.12 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.37 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -91.23 -30.88 16.39 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 121.784 0.802 . . . . 0.0 109.272 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.694 ' HE2' HD13 ' A' ' 73' ' ' ILE . 28.4 m-85 -84.21 1.88 42.48 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.125 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.617 ' HE2' ' CE1' ' A' ' 6' ' ' PHE . 85.8 mttt -77.61 -11.91 59.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.687 169.129 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 35.7 pt -134.84 8.82 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.204 0 CA-C-O 121.05 0.453 . . . . 0.0 110.302 -176.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.487 ' HB2' ' HA ' ' A' ' 88' ' ' TYR . 16.8 t60 -88.14 -38.87 15.0 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.199 -177.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.499 ' HA ' ' O ' ' A' ' 96' ' ' THR . 92.5 m-85 58.46 86.07 0.09 Allowed 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.344 -1.298 . . . . 0.0 107.797 -161.07 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.718 ' HB3' ' OH ' ' A' ' 61' ' ' TYR . 76.2 mt -44.23 -65.32 0.53 Allowed 'General case' 0 CA--C 1.517 -0.297 0 O-C-N 124.151 0.907 . . . . 0.0 108.805 178.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.701 ' HB3' ' HB3' ' A' ' 154' ' ' GLU . 1.6 p30 -111.99 -86.53 0.56 Allowed 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.771 163.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' THR . . . . . 1.015 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 11.5 t -118.97 14.4 13.22 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.296 0.57 . . . . 0.0 110.994 -174.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.546 HG21 ' HB3' ' A' ' 33' ' ' HIS . 5.8 t -153.72 -179.89 8.23 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 172.236 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.474 HG22 ' H ' ' A' ' 92' ' ' TYR . 20.2 p -116.56 171.13 8.05 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 122.4 -0.188 . . . . 0.0 110.733 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 92.5 mt -61.62 104.12 0.4 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.018 0.437 . . . . 0.0 110.113 175.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.562 ' HB ' ' HA3' ' A' ' 34' ' ' GLY . 45.8 mm -89.21 -56.91 4.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.807 -176.122 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.658 ' O ' ' HA ' ' A' ' 35' ' ' MET . 10.6 pt-20 -162.98 142.3 6.8 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.956 -177.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.21 149.51 90.14 Favored 'Trans proline' 0 C--O 1.235 0.375 0 C-N-CA 122.411 2.074 . . . . 0.0 112.57 -177.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.664 ' HB2' ' HB3' ' A' ' 35' ' ' MET . . . -73.07 146.24 87.05 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.99 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.67 115.68 3.69 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.234 1.956 . . . . 0.0 111.625 176.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.631 ' HB3' ' SD ' ' A' ' 16' ' ' MET . 37.6 ptt180 . . . . . 0 C--N 1.328 -0.368 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 178.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.597 HD21 ' CH2' ' A' ' 161' ' ' TRP . 3.9 mm? . . . . . 0 N--CA 1.47 0.555 0 CA-C-O 121.521 0.677 . . . . 0.0 111.913 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 32.9 tt0 177.73 -60.16 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.302 -177.005 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -112.69 112.97 24.86 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.286 176.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.985 HG22 ' HG3' ' A' ' 180' ' ' LYS . 10.4 t -115.71 146.34 20.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 177.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.664 ' CZ ' HD13 ' A' ' 181' ' ' LEU . 0.0 OUTLIER -118.71 147.69 43.56 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 117.244 -1.783 . . . . 0.0 109.024 158.903 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.515 HG22 HG12 ' A' ' 178' ' ' VAL . 0.8 OUTLIER -102.69 130.32 49.58 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.839 -1.073 . . . . 0.0 111.3 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.559 HD21 ' HG2' ' A' ' 179' ' ' GLU . 24.6 mt -104.97 -7.47 19.25 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -175.215 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.51 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 63.6 t80 -95.42 -42.53 8.43 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.233 -0.587 . . . . 0.0 112.543 -174.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.61 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 15.7 t70 77.75 89.71 0.07 Allowed 'General case' 0 N--CA 1.474 0.761 0 O-C-N 123.746 0.654 . . . . 0.0 110.431 -175.185 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.455 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 63.3 t80 -119.09 85.79 30.46 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 176.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.596 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 87.5 Cg_endo -81.94 83.76 2.02 Favored 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 121.608 1.539 . . . . 0.0 112.556 178.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -76.31 -20.58 76.97 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 175.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.83 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 88.0 m-20 58.41 68.23 0.85 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.643 -0.778 . . . . 0.0 111.679 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.485 ' HB3' ' H ' ' A' ' 140' ' ' GLU . 0.4 OUTLIER -152.3 170.73 19.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.85 179.066 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -94.97 -5.42 44.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.937 0.875 . . . . 0.0 108.975 170.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.485 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 42.7 mm-40 -96.34 -36.91 10.7 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.809 174.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.458 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 13.6 m-20 -123.01 112.73 18.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.273 178.232 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.993 HD11 ' HB2' ' A' ' 165' ' ' ASN . 30.4 tp -68.61 129.95 92.25 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-O 120.776 0.322 . . . . 0.0 110.534 -177.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.83 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 11.6 Cg_endo -85.64 91.26 0.69 Allowed 'Trans proline' 0 N--CA 1.442 -1.55 0 C-N-CA 122.092 1.861 . . . . 0.0 111.012 172.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.522 ' CE2' ' HB ' ' A' ' 173' ' ' ILE . 14.3 p90 -101.54 164.85 11.55 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.817 -174.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.61 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 1.4 mptp? -100.29 -172.71 2.26 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.203 0.525 . . . . 0.0 111.75 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.742 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -91.62 9.03 33.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.972 -175.986 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -167.13 32.95 0.21 Allowed Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.48 175.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.511 ' OE1' ' HA ' ' A' ' 144' ' ' PHE . 0.1 OUTLIER -100.13 157.45 16.56 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.214 -174.92 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.638 HD12 ' HB3' ' A' ' 129' ' ' ARG . 0.6 OUTLIER -97.49 129.38 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-O 121.692 0.758 . . . . 0.0 109.978 -176.682 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.738 HD22 HD21 ' A' ' 142' ' ' LEU . 31.9 mt -123.94 158.77 31.24 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 114.522 -1.217 . . . . 0.0 108.01 -177.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.608 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 97.4 t -122.04 120.43 61.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 175.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 1.044 HD13 ' HB2' ' A' ' 163' ' ' ALA . 42.1 mm -78.21 79.14 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -178.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.665 HG23 ' HG2' ' A' ' 154' ' ' GLU . 7.6 tt -74.57 -34.18 34.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 114.535 -1.212 . . . . 0.0 109.318 -178.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.701 ' HB3' ' HB3' ' A' ' 94' ' ' ASP . 0.0 OUTLIER -123.46 142.92 50.51 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.502 175.577 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.486 ' HE3' ' NE1' ' A' ' 161' ' ' TRP . 83.1 tttt -140.47 81.75 17.13 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-O 120.982 0.42 . . . . 0.0 109.993 172.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 1.015 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 38.4 Cg_endo -73.25 -40.28 1.74 Allowed 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.03 1.82 . . . . 0.0 111.972 175.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -111.05 162.65 14.66 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.407 -171.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -100.17 -11.54 20.36 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 172.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -89.81 -34.1 16.27 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.916 177.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 49.4 m95 -129.45 139.44 51.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.942 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' TRP . . . . . 0.76 ' O ' HG13 ' A' ' 173' ' ' ILE . 47.8 m0 -113.63 137.02 52.18 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 176.095 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.53 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 16.2 m -96.96 97.59 9.39 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -175.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 1.044 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -110.84 149.54 30.43 Favored 'General case' 0 N--CA 1.425 -1.72 0 C-N-CA 119.859 -0.736 . . . . 0.0 109.956 -174.249 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.721 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 11.7 ptt180 -87.25 122.16 30.67 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 173.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.993 ' HB2' HD11 ' A' ' 142' ' ' LEU . 12.9 t30 -58.42 -178.07 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 113.755 -1.566 . . . . 0.0 111.381 -173.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.552 ' HD3' ' HB ' ' A' ' 149' ' ' ILE . 10.0 mmmm -66.38 -11.67 52.68 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.414 0.626 . . . . 0.0 109.906 166.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.499 ' H ' ' HB3' ' A' ' 165' ' ' ASN . 22.3 m-20 -82.29 -15.99 50.99 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 170.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 80.28 10.82 84.98 Favored Glycine 0 CA--C 1.52 0.36 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.923 -174.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.721 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.3 OUTLIER -81.94 133.91 35.34 Favored 'General case' 0 C--O 1.217 -0.615 0 C-N-CA 123.106 0.562 . . . . 0.0 110.803 -178.846 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 80.4 t -82.38 123.62 38.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.862 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -157.02 158.11 28.58 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.75 171.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.519 ' HA ' ' HA ' ' A' ' 162' ' ' SER . 10.5 mtp -82.84 144.79 29.87 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 117.482 0.641 . . . . 0.0 111.039 -178.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.76 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.7 pp -142.87 147.96 43.85 Favored Pre-proline 0 C--O 1.223 -0.317 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.43 -175.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.481 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 8.0 Cg_exo -73.55 129.8 14.13 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.547 2.165 . . . . 0.0 112.71 -175.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.579 ' O ' HG22 ' A' ' 178' ' ' VAL . 61.5 t -59.19 -44.51 98.57 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.467 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 36.4 Cg_exo -61.93 -2.54 2.96 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 122.206 1.937 . . . . 0.0 113.136 176.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.481 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.1 m-30 -100.85 -9.23 21.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.641 -178.361 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.635 ' HB ' HG13 ' A' ' 128' ' ' VAL . 6.1 m -107.87 -173.29 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 -166.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.63 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 5.2 tp10 -159.74 49.18 0.3 Allowed 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 113.221 -1.809 . . . . 0.0 112.559 -151.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.985 ' HG3' HG22 ' A' ' 128' ' ' VAL . 1.2 mppt? -71.47 138.52 49.05 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 120.042 -1.661 . . . . 0.0 111.803 -158.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.664 HD13 ' CZ ' ' A' ' 129' ' ' ARG . 11.8 tp . . . . . 0 N--CA 1.455 -0.191 0 CA-C-N 112.84 -1.982 . . . . 0.0 111.387 -170.125 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo . . . . . 0 N--CA 1.461 -0.384 0 CA-C-O 120.673 0.197 . . . . 0.0 111.751 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.505 ' HB ' HG13 ' A' ' 266' ' ' VAL . 18.3 t -89.03 128.95 40.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.516 ' HB2' ' HG3' ' A' ' 296' ' ' PRO . 93.9 m-85 -102.87 117.68 35.16 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.092 0.472 . . . . 0.0 110.959 -177.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -119.95 134.35 55.27 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.104 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -84.59 126.39 33.29 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' ALA . . . . . 0.476 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -72.65 100.71 2.87 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.03 0.443 . . . . 0.0 109.829 177.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.453 ' H ' HG13 ' A' ' 243' ' ' ILE . 2.4 pp -96.05 -9.0 9.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.557 -176.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.28 138.25 36.59 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 176.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -58.23 149.62 23.72 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 120.968 0.414 . . . . 0.0 110.71 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 24.7 tpt180 -143.78 91.52 2.24 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 174.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 29.2 m -100.23 142.6 24.93 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.098 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.486 ' HB3' ' HB3' ' A' ' 255' ' ' ALA . 72.8 Cg_endo -79.11 148.58 21.71 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.404 2.07 . . . . 0.0 112.101 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 48.7 t -79.66 176.58 9.59 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 173.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -59.62 -30.36 68.64 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.659 0.266 . . . . 0.0 111.548 -177.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -96.02 -5.42 41.11 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 252' ' ' ASP . . . . . 0.467 ' HB3' ' HB3' ' A' ' 255' ' ' ALA . 4.1 m-20 -82.82 107.6 15.56 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.263 0.554 . . . . 0.0 111.467 -176.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 47.2 mttp -104.01 -34.41 8.46 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.308 176.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 3.0 p -86.81 9.4 19.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.589 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 255' ' ' ALA . . . . . 0.486 ' HB3' ' HB3' ' A' ' 248' ' ' PRO . . . -95.8 131.84 41.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.051 0.453 . . . . 0.0 110.857 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.536 HD21 ' HB ' ' A' ' 279' ' ' VAL . 0.9 OUTLIER -88.24 133.32 34.07 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.188 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -89.3 109.75 20.61 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.861 0.363 . . . . 0.0 110.169 -179.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 94.2 mt -115.11 143.69 44.82 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.012 -175.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -120.4 149.95 41.55 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.503 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 59.8 t -64.17 117.15 4.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.784 0.326 . . . . 0.0 110.874 -178.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 108.93 10.19 24.95 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.587 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -103.19 167.59 9.72 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 37.3 mm -114.35 118.09 57.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.038 0.447 . . . . 0.0 110.814 -176.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 20.0 t -93.69 109.37 21.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.514 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -87.2 87.47 7.45 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.746 177.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.505 HG13 ' HB ' ' A' ' 238' ' ' VAL . 7.2 p -91.19 136.52 24.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.88 -175.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 18.1 p -114.06 -50.61 2.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.19 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 14.2 tpp180 -100.79 101.27 12.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.12 0.486 . . . . 0.0 110.657 -175.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 41.4 mtt -91.54 118.9 31.01 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.007 0.432 . . . . 0.0 110.304 177.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 274' ' ' GLN . 90.6 m-20 -83.11 0.61 44.3 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.472 -176.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 50.6 mm 72.94 -47.85 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 171.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -61.84 -24.75 67.09 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -173.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 155.38 -48.48 0.49 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.252 -0.975 . . . . 0.0 112.694 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.515 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 26.9 mp0 -86.46 116.52 24.66 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.387 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.475 ' HB3' HG21 ' A' ' 266' ' ' VAL . 43.8 m0 -97.17 153.42 18.0 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.613 178.174 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -106.26 109.47 21.41 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.184 0.516 . . . . 0.0 110.026 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 277' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -123.21 164.18 16.33 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.786 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -114.61 115.28 26.91 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -178.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 279' ' ' VAL . . . . . 0.536 ' HB ' HD21 ' A' ' 256' ' ' LEU . 88.1 t -136.15 125.2 38.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.258 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 56.95 38.78 29.58 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.893 176.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 89.34 -15.63 57.99 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.437 175.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 282' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' A' ' 282' ' ' ARG . 40.6 mtp-105 -107.96 132.7 53.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 117.164 0.482 . . . . 0.0 110.645 -177.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 0.0 OUTLIER -114.61 130.06 56.74 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 174.507 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -157.96 -175.73 29.22 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.279 -177.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.515 ' HB3' ' HB3' ' A' ' 274' ' ' GLN . 78.6 mt -93.8 129.75 40.06 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.126 0.489 . . . . 0.0 110.804 -178.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.474 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 47.8 p90 -132.72 141.18 40.18 Favored Pre-proline 0 C--N 1.317 -0.804 0 CA-C-N 115.696 -0.683 . . . . 0.0 109.837 176.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 287' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 4.6 Cg_exo -74.89 140.38 25.71 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.735 2.29 . . . . 0.0 111.58 177.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -72.58 7.12 2.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.045 0.45 . . . . 0.0 111.821 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 4.1 p -90.83 -10.68 41.84 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.157 0.503 . . . . 0.0 110.968 177.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -104.89 -10.45 17.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.874 -178.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.476 HG12 ' HA ' ' A' ' 242' ' ' ALA . 35.6 m -128.36 162.74 34.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.455 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -140.69 136.72 32.91 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.32 175.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 1.2 mp -72.56 135.96 26.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 174.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -144.63 -165.81 2.24 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.941 -175.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -103.43 95.35 6.98 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.228 175.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 296' ' ' PRO . . . . . 0.516 ' HG3' ' HB2' ' A' ' 239' ' ' PHE . 74.5 Cg_endo . . . . . 0 N--CA 1.461 -0.396 0 C-N-CA 122.193 1.929 . . . . 0.0 111.665 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.402 ' O ' HG23 ' A' ' 99' ' ' ILE . 22.7 t . . . . . 0 N--CA 1.453 -0.277 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . -75.38 87.19 2.56 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.83 175.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -115.55 88.56 2.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.648 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -161.09 161.29 31.18 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.385 177.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -88.25 91.47 8.8 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.875 0.845 . . . . 0.0 110.11 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.6 p -73.86 77.81 1.62 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.894 -176.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.4 t -176.59 -39.78 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.586 176.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -64.51 113.81 3.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.018 0.437 . . . . 0.0 110.828 -174.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -58.46 -35.81 72.71 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.742 -176.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.2 t -73.51 -6.49 46.8 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.176 -176.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.01 -47.49 7.25 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 121.046 -0.262 . . . . 0.0 111.556 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 30.1 p-90 -116.67 -22.74 8.49 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -171.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -73.27 112.84 9.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.361 0.6 . . . . 0.0 109.747 -177.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.565 ' SD ' ' HA ' ' A' ' 104' ' ' ARG . 15.7 tpp -95.3 5.86 50.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.31 -171.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.486 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 49.65 -113.65 1.92 Allowed Glycine 0 CA--C 1.522 0.493 0 CA-C-N 115.516 -0.765 . . . . 0.0 114.357 176.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.486 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 5.0 Cg_exo -77.13 88.49 1.4 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.454 2.77 . . . . 0.0 113.159 -175.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.582 HG12 ' HD2' ' A' ' 39' ' ' ARG . 71.3 t -145.34 160.44 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.452 ' H ' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -143.27 -168.81 2.9 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -171.354 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 35.6 mtp85 -59.06 -57.82 11.4 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 118.652 0.66 . . . . 0.0 112.182 -176.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -64.68 -44.97 88.64 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 123.29 0.369 . . . . 0.0 110.847 -175.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.638 ' O ' ' HG3' ' A' ' 27' ' ' ARG . 12.5 mp0 -60.68 -49.84 75.9 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.534 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.92 -44.69 82.7 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.427 0.632 . . . . 0.0 110.344 177.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.525 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 6.9 tp60 -60.72 -58.25 9.24 Favored 'General case' 0 C--O 1.214 -0.786 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.563 -178.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.2 t -61.83 -27.53 68.84 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -172.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.638 ' HG3' ' O ' ' A' ' 23' ' ' GLU . 62.5 mtp180 -83.48 -10.44 58.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.717 0.294 . . . . 0.0 111.258 -178.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.64 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 87.7 mt -125.58 -13.39 6.53 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.525 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -70.24 107.09 3.57 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 122.765 0.426 . . . . 0.0 110.434 -174.855 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 70.61 20.24 77.08 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.05 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.483 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 12.2 mm100 -92.89 -161.17 0.81 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 47.0 mtm180 -52.64 130.76 33.23 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 175.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 63.5 m170 -86.35 126.31 34.25 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.25 11.2 42.92 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -171.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.543 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 50.6 ttp -104.07 134.61 47.04 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -178.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.437 ' CB ' HG22 ' A' ' 52' ' ' VAL . 39.9 p90 -139.29 167.78 21.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.768 0.318 . . . . 0.0 111.777 -174.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.545 ' HG ' HD11 ' A' ' 28' ' ' LEU . 4.6 pp -153.83 140.0 18.45 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.146 0.498 . . . . 0.0 110.825 173.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.6 t -105.71 114.21 44.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 174.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.582 ' HD2' HG12 ' A' ' 19' ' ' VAL . 22.3 ptt-85 -112.33 167.72 10.2 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.953 -173.09 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -76.44 125.36 29.06 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 170.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.0 t -75.77 152.51 37.36 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.395 0.617 . . . . 0.0 111.531 -172.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.8 t -111.69 14.54 21.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.226 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 46.7 p -92.16 -57.25 2.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.957 176.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.418 ' HB2' ' OD2' ' A' ' 47' ' ' ASP . 56.8 m -134.56 137.9 28.74 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.754 178.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.6 127.18 17.47 Favored 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 122.8 2.333 . . . . 0.0 112.754 -178.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.65 -16.68 43.8 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.339 176.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.418 ' OD2' ' HB2' ' A' ' 44' ' ' CYS . 65.8 m-20 -96.89 166.34 11.67 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 -177.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -128.33 175.22 8.65 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -178.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.7 t -144.66 117.35 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 120.902 0.382 . . . . 0.0 110.93 174.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 33.5 tp -84.83 102.1 12.8 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.442 176.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 55.9 m -96.52 133.65 40.72 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 175.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.798 HG21 HD13 ' A' ' 93' ' ' LEU . 99.2 t -129.53 134.3 63.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.841 0.353 . . . . 0.0 111.825 -173.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.64 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 9.2 t -94.5 117.18 29.73 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -177.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.684 ' O ' ' HB3' ' A' ' 57' ' ' ARG . 9.9 tp10 -158.26 147.94 19.71 Favored 'General case' 0 C--O 1.211 -0.967 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.276 163.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.521 ' ND2' ' HG3' ' A' ' 54' ' ' GLU . 50.7 m-80 62.89 16.59 9.27 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 123.35 0.407 . . . . 0.0 111.59 -176.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 67.2 m 56.22 59.46 3.68 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 122.724 1.25 . . . . 0.0 108.164 -168.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.684 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 19.4 ttp85 -155.59 65.12 0.6 Allowed 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 112.768 -2.015 . . . . 0.0 109.398 -160.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.673 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 21.4 t -71.61 96.79 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 122.346 1.07 . . . . 0.0 109.187 -171.039 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.483 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 1.4 p -75.07 121.37 21.92 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 113.237 -1.801 . . . . 0.0 111.166 -176.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 62.4 m-70 -93.59 108.08 19.84 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.211 -176.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.935 ' HB3' HD11 ' A' ' 73' ' ' ILE . 66.6 m-85 -105.63 103.24 12.71 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.071 177.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.686 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 55.8 mt -78.33 133.47 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -174.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.587 HG13 ' HB ' ' A' ' 73' ' ' ILE . 4.2 mp -118.03 118.67 58.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 122.831 0.452 . . . . 0.0 111.275 -179.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -87.78 151.06 23.17 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.0 t -92.46 100.84 13.32 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 171.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.575 HD21 ' HD2' ' A' ' 72' ' ' LYS . 80.2 mt -78.61 137.16 58.99 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.663 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -63.3 -7.03 11.14 Favored 'Trans proline' 0 CA--C 1.529 0.237 0 C-N-CA 122.889 2.392 . . . . 0.0 112.238 177.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 -78.24 6.74 7.53 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.723 173.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.778 ' HA ' ' HE ' ' A' ' 69' ' ' ARG . 2.6 tpm_? 63.57 32.87 13.8 Favored 'General case' 0 N--CA 1.46 0.065 0 CA-C-O 122.009 0.909 . . . . 0.0 109.106 -173.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.788 ' HG2' ' HA ' ' A' ' 79' ' ' ASP . 69.6 mtt180 -120.78 179.39 4.37 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.692 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.559 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 54.0 m-85 -135.82 119.35 16.98 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.096 0.474 . . . . 0.0 111.379 -176.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.583 ' HG3' ' HG2' ' A' ' 77' ' ' GLU . 46.3 tttm -101.82 101.28 11.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.567 -172.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.935 HD11 ' HB3' ' A' ' 61' ' ' TYR . 7.0 tt -100.77 110.17 27.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.38 0.609 . . . . 0.0 111.444 -176.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.96 -55.39 3.51 Favored Glycine 0 CA--C 1.519 0.326 0 CA-C-N 115.396 -0.82 . . . . 0.0 113.263 177.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -165.4 -40.86 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -176.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -69.27 141.18 54.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.24 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.583 ' HG2' ' HG3' ' A' ' 72' ' ' LYS . 43.5 mt-10 -108.99 104.86 14.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.434 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.54 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 77.6 m-85 -100.26 160.41 14.35 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 176.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.788 ' HA ' ' HG2' ' A' ' 70' ' ' ARG . 6.0 m-20 -74.82 -32.79 62.07 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -174.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.54 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 1.2 p80 -153.22 166.44 32.54 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.473 0.178 . . . . 0.0 110.875 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.668 HD23 HD21 ' A' ' 84' ' ' LEU . 9.0 mt -57.23 -51.22 83.33 Favored Pre-proline 0 N--CA 1.466 0.328 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.865 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.54 ' HD2' ' HB2' ' A' ' 80' ' ' HIS . 23.4 Cg_endo -61.11 -10.69 15.93 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.118 1.879 . . . . 0.0 113.034 177.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.58 -36.3 16.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.672 0.272 . . . . 0.0 110.466 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.668 HD21 HD23 ' A' ' 81' ' ' LEU . 4.1 pp -76.49 -35.38 58.41 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 177.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.559 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 77.3 mt -62.07 -38.5 89.04 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.554 175.248 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.56 ' HA ' ' HD3' ' A' ' 89' ' ' LYS . 11.0 tp10 -67.55 -38.73 84.6 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.596 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -65.66 -37.99 88.06 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.216 0.531 . . . . 0.0 110.747 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.543 ' HE2' HD13 ' A' ' 73' ' ' ILE . 35.0 m-85 -81.25 -15.59 55.13 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.777 -177.197 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.56 ' HD3' ' HA ' ' A' ' 86' ' ' GLU . 40.8 mtpt -64.72 -26.33 68.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.092 174.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.8 pp -114.48 8.48 7.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.421 -0.512 . . . . 0.0 112.349 174.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.422 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 6.2 t-160 -93.81 -37.95 11.5 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.747 0.308 . . . . 0.0 110.868 -176.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.485 ' N ' HG22 ' A' ' 97' ' ' THR . 58.8 m-85 67.41 84.55 0.15 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.275 -168.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.798 HD13 HG21 ' A' ' 52' ' ' VAL . 14.2 mt -53.98 -25.05 18.93 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 122.208 1.004 . . . . 0.0 110.888 175.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.528 ' CG ' ' HB3' ' A' ' 54' ' ' GLU . 0.4 OUTLIER -132.05 -91.6 0.4 Allowed 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 114.339 -1.3 . . . . 0.0 107.607 175.6 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.541 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 13.8 t -145.67 21.63 1.47 Allowed 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 172.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.8 t -135.41 -21.85 1.54 Allowed 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 119.605 -0.838 . . . . 0.0 112.852 -174.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.485 HG22 ' N ' ' A' ' 92' ' ' TYR . 7.1 p 72.96 -162.2 0.1 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.02 0.928 . . . . 0.0 110.214 -173.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.421 HD22 ' CD2' ' A' ' 36' ' ' PHE . 81.5 mt -95.96 94.45 7.61 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.068 178.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.553 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 43.9 mm -76.52 -61.26 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.958 -176.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.543 ' O ' ' HA ' ' A' ' 35' ' ' MET . 11.3 pt-20 -161.66 151.8 14.32 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.569 178.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.37 159.04 55.25 Favored 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 122.892 2.395 . . . . 0.0 113.512 -177.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.459 ' HA ' ' SD ' ' A' ' 35' ' ' MET . . . -72.31 145.7 88.43 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.91 176.014 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -50.24 120.91 6.82 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.696 2.264 . . . . 0.0 111.503 175.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.565 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 39.1 ttt180 . . . . . 0 C--N 1.328 -0.356 0 N-CA-C 109.776 -0.454 . . . . 0.0 109.776 -175.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.702 HD12 HG21 ' A' ' 152' ' ' ILE . 1.9 mm? . . . . . 0 N--CA 1.474 0.746 0 CA-C-O 121.229 0.538 . . . . 0.0 111.547 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 40.2 tt0 179.86 -39.73 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.341 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -124.38 119.82 30.32 Favored 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 119.839 -0.745 . . . . 0.0 110.302 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.773 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 56.0 t -134.63 144.07 35.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.976 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.746 ' NH2' ' HG ' ' A' ' 181' ' ' LEU . 0.0 OUTLIER -118.9 143.54 46.93 Favored 'General case' 0 CA--C 1.501 -0.928 0 C-N-CA 116.755 -1.978 . . . . 0.0 108.741 168.059 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.813 HG22 HG12 ' A' ' 178' ' ' VAL . 1.4 p -103.89 141.08 36.77 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.749 0.785 . . . . 0.0 111.005 -177.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.771 HD11 ' HG2' ' A' ' 179' ' ' GLU . 0.5 OUTLIER -116.43 -20.34 9.73 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.921 -173.652 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.43 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 37.3 t80 -83.85 -26.23 29.66 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.764 -171.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.466 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 12.6 t70 67.94 90.65 0.09 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.748 0.785 . . . . 0.0 110.204 -178.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.565 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 74.4 t80 -120.56 91.1 46.59 Favored Pre-proline 0 C--N 1.314 -0.976 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 176.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.742 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 92.7 Cg_endo -84.14 79.9 2.5 Favored 'Trans proline' 0 N--CA 1.444 -1.421 0 C-N-CA 121.832 1.688 . . . . 0.0 112.71 -176.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.15 -23.25 74.67 Favored Glycine 0 C--N 1.334 0.417 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.687 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.424 ' H ' ' HB3' ' A' ' 143' ' ' PRO . 88.5 m-20 62.77 31.92 16.26 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 122.669 0.387 . . . . 0.0 111.686 176.196 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.469 ' HB3' ' H ' ' A' ' 141' ' ' ASP . 0.2 OUTLIER -127.17 178.32 6.1 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.054 0.454 . . . . 0.0 111.586 -176.097 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -97.15 -10.49 25.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.634 172.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.666 ' O ' ' HB2' ' A' ' 172' ' ' MET . 46.4 mt-10 -113.14 -7.97 13.59 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.48 176.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.469 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 9.8 m-20 -135.65 104.63 5.86 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 173.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 1.03 HD11 ' HB2' ' A' ' 165' ' ' ASN . 52.5 tp -70.83 129.24 89.95 Favored Pre-proline 0 CA--C 1.509 -0.621 0 CA-C-O 120.837 0.351 . . . . 0.0 110.83 -172.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.82 ' HD2' HD12 ' A' ' 142' ' ' LEU . 47.6 Cg_endo -80.21 96.46 1.02 Allowed 'Trans proline' 0 N--CA 1.436 -1.899 0 C-N-CA 121.01 1.14 . . . . 0.0 111.544 168.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.61 ' HB2' ' OG1' ' A' ' 130' ' ' THR . 9.0 p90 -107.18 159.87 16.01 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.926 ' H ' ' HG3' ' A' ' 148' ' ' GLU . 4.1 mppt? -111.09 -140.34 0.38 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.368 0.604 . . . . 0.0 111.818 -175.095 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.721 ' N ' ' HD3' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -116.58 55.72 0.81 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.276 -177.019 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 135.6 23.86 0.56 Allowed Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.244 -0.889 . . . . 0.0 113.055 174.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.926 ' HG3' ' H ' ' A' ' 145' ' ' LYS . 0.0 OUTLIER -74.73 164.83 26.14 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 169.694 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.682 HD12 ' HB3' ' A' ' 129' ' ' ARG . 0.4 OUTLIER -107.86 132.12 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 173.392 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.726 HD22 HD21 ' A' ' 142' ' ' LEU . 37.9 mt -118.54 154.69 32.15 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -176.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.565 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 98.0 t -121.98 122.83 67.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.992 HD13 ' HB2' ' A' ' 163' ' ' ALA . 44.4 mm -75.0 83.27 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -175.349 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.604 HD12 ' HD3' ' A' ' 164' ' ' ARG . 16.4 tt -75.3 -27.94 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 CA-C-N 113.398 -1.728 . . . . 0.0 110.134 -171.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.712 ' OE2' ' HA ' ' A' ' 93' ' ' LEU . 1.8 mt-10 -135.66 141.05 44.95 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 170.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.585 ' HD2' ' HG ' ' A' ' 125' ' ' LEU . 58.6 tttp -130.1 91.53 38.97 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 122.047 -0.408 . . . . 0.0 111.202 173.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.541 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 8.4 Cg_exo -77.59 -45.14 0.16 Allowed 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.656 2.237 . . . . 0.0 112.285 171.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -117.83 -178.61 3.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.152 0.501 . . . . 0.0 111.832 -170.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.506 ' O ' HG21 ' A' ' 175' ' ' VAL . 2.6 mm-40 -106.39 -19.1 13.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.485 174.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -95.5 -28.68 14.77 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.735 0.302 . . . . 0.0 111.547 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.493 ' O ' ' HD1' ' A' ' 161' ' ' TRP . 42.6 m95 -124.22 137.91 54.46 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 174.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' TRP . . . . . 0.733 ' HB3' HD12 ' A' ' 152' ' ' ILE . 45.8 m0 -124.37 140.0 53.37 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-O 121.025 0.441 . . . . 0.0 111.007 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.57 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 19.4 m -97.94 97.02 8.58 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -174.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.992 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -110.93 148.68 31.95 Favored 'General case' 0 N--CA 1.425 -1.695 0 C-N-CA 119.846 -0.742 . . . . 0.0 109.903 -174.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.84 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 17.2 ptt-85 -86.86 122.29 30.53 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 173.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 1.03 ' HB2' HD11 ' A' ' 142' ' ' LEU . 63.8 t30 -56.38 177.44 0.07 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.005 -1.452 . . . . 0.0 110.443 -174.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.402 ' HD2' ' H ' ' A' ' 149' ' ' ILE . 46.8 tttt -63.66 -12.76 36.56 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.759 169.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -74.16 -30.38 62.23 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.186 0.517 . . . . 0.0 109.745 168.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 97.26 15.85 36.96 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.462 -171.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.84 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 2.5 ttm-85 -95.43 139.0 32.34 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 122.785 0.434 . . . . 0.0 111.457 -177.143 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.549 HG22 HD13 ' A' ' 153' ' ' ILE . 39.2 t -78.71 130.98 35.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.202 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -162.93 155.27 26.55 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.501 166.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.666 ' HB2' ' O ' ' A' ' 140' ' ' GLU . 0.2 OUTLIER -76.9 140.56 40.58 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 117.057 0.428 . . . . 0.0 111.042 178.854 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.731 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.4 pp -142.0 146.7 41.51 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.343 -176.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.591 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 5.3 Cg_exo -77.02 130.34 11.21 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.85 2.367 . . . . 0.0 112.746 -176.069 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.553 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 87.0 t -62.02 -42.2 80.48 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 24.6 Cg_endo -63.36 -0.12 2.13 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 121.948 1.766 . . . . 0.0 112.969 175.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.591 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.3 m-85 -97.07 -16.4 20.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.399 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.813 HG12 HG22 ' A' ' 130' ' ' THR . 2.4 m -112.11 -173.52 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 117.712 2.486 . . . . 0.0 117.712 -160.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.771 ' HG2' HD11 ' A' ' 131' ' ' LEU . 2.1 mm-40 -139.96 49.35 1.77 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 111.558 -2.565 . . . . 0.0 115.654 -161.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.773 ' HA ' ' HA ' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -69.51 134.35 48.77 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 124.366 3.257 . . . . 0.0 111.879 -158.69 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.746 ' HG ' ' NH2' ' A' ' 129' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.446 -0.641 0 CA-C-N 110.755 -2.93 . . . . 0.0 111.997 -170.483 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo . . . . . 0 N--CA 1.463 -0.286 0 N-CA-C 110.156 -0.748 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.1 t -66.81 135.6 28.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.24 -170.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -104.05 123.42 47.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.688 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -119.32 124.22 46.1 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 175.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.659 ' HB2' ' CE1' ' A' ' 294' ' ' PHE . 44.8 tttp -88.19 119.92 29.05 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -176.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -67.74 110.82 3.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.013 0.435 . . . . 0.0 110.254 -178.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 21.1 pt -85.16 1.42 4.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.122 0.486 . . . . 0.0 111.207 -174.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -158.13 152.12 24.01 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.866 178.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.92 ' HG3' HG23 ' A' ' 260' ' ' VAL . 54.6 mtmt -78.67 120.72 23.75 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.135 0.493 . . . . 0.0 110.625 177.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.633 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 22.6 ttt85 -113.01 109.67 19.23 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.843 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 29.5 m -102.69 143.05 25.82 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 177.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.557 ' HD3' ' HB2' ' A' ' 257' ' ' ALA . 55.2 Cg_endo -70.46 151.59 65.18 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 122.461 2.107 . . . . 0.0 112.764 -177.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 249' ' ' CYS . . . . . 0.43 ' H ' ' HB2' ' A' ' 252' ' ' ASP . 46.0 t -89.09 168.26 12.47 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 174.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -55.84 -41.03 73.69 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.657 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -95.44 8.23 43.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.91 0.386 . . . . 0.0 111.452 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 252' ' ' ASP . . . . . 0.43 ' HB2' ' H ' ' A' ' 249' ' ' CYS . 8.5 m-20 -110.82 73.47 0.82 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.851 0.358 . . . . 0.0 111.017 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -72.95 -24.73 60.84 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-O 121.269 0.557 . . . . 0.0 110.146 175.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 1.1 p -86.48 11.0 13.53 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.709 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 255' ' ' ALA . . . . . 0.415 ' HB2' ' HB3' ' A' ' 252' ' ' ASP . . . -99.92 116.6 32.36 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.847 0.356 . . . . 0.0 110.515 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.404 HD23 ' H ' ' A' ' 257' ' ' ALA . 0.8 OUTLIER -75.55 137.46 40.85 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.085 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.633 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -91.75 128.66 37.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.169 177.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 245' ' ' LYS . 69.4 mt -132.04 149.3 52.45 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.146 -173.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.799 ' HA ' ' HG2' ' A' ' 245' ' ' LYS . 64.5 mm-40 -101.54 167.77 9.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.604 178.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.92 HG23 ' HG3' ' A' ' 245' ' ' LYS . 60.0 t -74.89 115.94 16.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 176.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 261' ' ' GLY . . . . . 0.543 ' HA2' ' HE3' ' A' ' 241' ' ' LYS . . . 99.71 -2.76 57.27 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.635 -177.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -71.75 151.93 43.15 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -174.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 43.0 mm -103.75 109.05 25.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.107 0.48 . . . . 0.0 110.907 -175.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.453 ' HA ' HG21 ' A' ' 279' ' ' VAL . 39.1 t -82.77 105.27 12.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.103 178.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -91.07 98.95 12.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.583 178.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 4.8 p -92.13 123.12 44.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.414 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 6.6 p -96.54 -33.01 11.98 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.654 -177.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 32.6 mtm180 -131.9 126.03 33.15 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.412 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 38.3 mtt -105.04 121.28 43.45 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.183 0.516 . . . . 0.0 111.127 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' A' ' 274' ' ' GLN . 79.4 m-20 -88.72 120.68 30.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.536 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 32.1 mm -76.35 80.84 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.333 0.587 . . . . 0.0 110.389 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -163.14 -37.55 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.622 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 131.4 28.73 0.62 Allowed Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.179 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.508 ' HA ' ' CZ ' ' A' ' 288' ' ' PHE . 12.8 pt20 -159.79 113.51 2.24 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 168.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 3.6 m0 -93.68 158.21 15.79 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 122.16 -0.337 . . . . 0.0 110.454 -175.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -101.06 108.45 20.15 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -132.44 136.45 8.75 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 177.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 283' ' ' LYS . 29.4 tt0 -114.69 114.62 25.89 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.987 0.423 . . . . 0.0 110.022 -178.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 279' ' ' VAL . . . . . 0.453 HG21 ' HA ' ' A' ' 264' ' ' VAL . 28.4 t -118.94 -78.69 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.195 0.522 . . . . 0.0 111.147 -175.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -86.58 60.7 6.38 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.22 -173.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 71.66 2.05 48.58 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.489 -0.778 . . . . 0.0 113.111 177.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 44.5 mtp180 -139.91 137.91 35.21 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.389 -0.226 . . . . 0.0 110.389 -175.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.459 ' HB3' ' NZ ' ' A' ' 283' ' ' LYS . 0.1 OUTLIER -91.92 125.15 36.51 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 168.391 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -142.52 162.0 27.34 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.241 -0.981 . . . . 0.0 112.07 -176.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 67.3 mt -95.23 131.76 40.93 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.125 0.488 . . . . 0.0 109.917 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -123.47 149.95 59.67 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.34 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 287' ' ' PRO . . . . . 0.558 ' HD3' ' CZ ' ' A' ' 246' ' ' ARG . 76.8 Cg_endo -83.59 16.12 1.97 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.729 2.286 . . . . 0.0 113.496 -171.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.508 ' CZ ' ' HA ' ' A' ' 274' ' ' GLN . 2.8 m-85 66.46 -40.98 0.37 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.041 0.936 . . . . 0.0 113.11 177.012 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 1.7 m -66.63 -16.57 64.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.974 0.416 . . . . 0.0 111.973 -177.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -89.94 -3.82 57.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.861 0.362 . . . . 0.0 110.787 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.421 HG11 HG21 ' A' ' 264' ' ' VAL . 33.6 m -127.12 165.68 25.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -130.7 115.95 17.38 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -84.55 138.65 18.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -177.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 294' ' ' PHE . . . . . 0.659 ' CE1' ' HB2' ' A' ' 241' ' ' LYS . 0.8 OUTLIER -159.57 174.2 14.98 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.729 -171.537 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -92.08 105.06 12.34 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 172.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo . . . . . 0 N--CA 1.463 -0.283 0 C-N-CA 122.085 1.856 . . . . 0.0 111.819 -179.971 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.47 ' O ' HG23 ' A' ' 99' ' ' ILE . 3.1 t . . . . . 0 N--CA 1.451 -0.404 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.402 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . -79.51 106.65 11.69 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.631 175.398 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.435 HH11 ' HD2' ' A' ' 5' ' ' ARG . 1.6 tpp180 -140.45 91.55 2.45 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.409 0.623 . . . . 0.0 110.904 -177.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.629 ' CE1' ' HE2' ' A' ' 89' ' ' LYS . 29.1 p90 -161.74 154.59 20.44 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.08 -0.963 . . . . 0.0 108.91 178.081 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -79.87 111.82 16.56 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.1 m -65.13 -13.18 57.47 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.222 -173.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.1 m -103.9 -20.55 13.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.788 0.328 . . . . 0.0 111.729 -178.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -73.91 92.93 2.13 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.323 0.582 . . . . 0.0 111.041 -175.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.402 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 10.8 mtm-85 -64.27 -23.32 67.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.121 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.5 m -70.1 -9.14 54.54 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.778 0.323 . . . . 0.0 110.802 177.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -100.48 -47.95 4.72 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.673 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 43.7 p-90 -113.24 -20.9 11.23 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -171.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.402 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 57.2 t80 -75.32 107.39 7.4 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.089 -0.644 . . . . 0.0 109.763 -178.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.78 ' SD ' ' HA ' ' A' ' 104' ' ' ARG . 10.8 tpp -86.71 -10.83 52.81 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.796 -172.171 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 51.3 -112.79 1.91 Allowed Glycine 0 CA--C 1.522 0.51 0 CA-C-N 115.476 -0.784 . . . . 0.0 114.721 175.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.17 70.06 1.29 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.562 2.841 . . . . 0.0 114.037 -173.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.691 HG21 ' HG3' ' A' ' 16' ' ' MET . 60.0 t -130.76 172.26 16.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 176.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.527 ' H ' HG12 ' A' ' 19' ' ' VAL . 89.6 p -145.08 -176.68 5.19 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 -169.185 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 26.7 ttt85 -68.08 -41.57 81.71 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.902 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -65.79 -48.92 70.17 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.4 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.417 ' HB3' HG13 ' A' ' 19' ' ' VAL . 3.0 mp0 -65.65 -48.11 73.28 Favored 'General case' 0 C--O 1.221 -0.399 0 O-C-N 122.423 -0.173 . . . . 0.0 111.357 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.77 -46.94 83.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.7 0.286 . . . . 0.0 111.507 -177.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.549 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 51.5 tp60 -59.2 -42.57 91.24 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.814 178.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.7 m -62.3 -43.24 99.27 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.774 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.534 ' O ' ' HG3' ' A' ' 31' ' ' GLN . 46.2 mtt180 -74.01 -13.83 60.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.796 -174.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.58 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 37.8 mt -124.99 2.23 8.01 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.121 0.486 . . . . 0.0 111.275 -176.189 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.549 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 29.8 tp60 -71.14 96.11 1.32 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.649 -176.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.1 20.83 75.02 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.391 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.534 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 38.5 mm-40 -87.98 -176.14 5.35 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.562 0.22 . . . . 0.0 110.431 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.813 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 50.4 ttp180 -55.79 133.41 51.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.074 177.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -83.66 140.73 31.99 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.904 0.383 . . . . 0.0 110.367 -174.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.58 -10.91 53.65 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.169 -173.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.813 ' SD ' ' HB3' ' A' ' 32' ' ' ARG . 24.8 mtp -79.81 140.07 36.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.475 -0.363 . . . . 0.0 110.436 177.087 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.474 ' HB2' HD11 ' A' ' 50' ' ' LEU . 45.1 p90 -146.58 163.66 35.1 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.124 -176.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.695 ' HB2' ' HB2' ' A' ' 16' ' ' MET . 4.2 pp -152.04 133.63 14.67 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.17 0.51 . . . . 0.0 110.966 175.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 56.1 t -101.84 106.9 20.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 174.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.6 ptt-85 -108.87 179.41 4.19 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.216 -175.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -79.66 138.54 37.41 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 172.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.461 ' HB3' ' O ' ' A' ' 44' ' ' CYS . 46.1 t -60.38 137.05 58.2 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.343 0.592 . . . . 0.0 111.92 -173.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.401 ' OG ' ' HA ' ' A' ' 20' ' ' SER . 10.9 m -87.82 -4.47 58.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.756 -178.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.0 p -112.53 -45.91 3.2 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.901 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.461 ' O ' ' HB3' ' A' ' 41' ' ' SER . 39.2 m -131.17 90.45 38.7 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.493 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 44' ' ' CYS . 10.0 Cg_endo -52.77 133.68 51.49 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.887 2.391 . . . . 0.0 111.804 179.252 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 111.46 -41.66 2.17 Favored Glycine 0 CA--C 1.505 -0.566 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -172.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -79.48 177.16 9.07 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 167.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.561 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 39.2 m-85 -134.66 174.5 10.49 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 118.477 0.581 . . . . 0.0 110.916 -176.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.5 t -144.67 108.09 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.922 0.392 . . . . 0.0 110.706 175.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.474 HD11 ' HB2' ' A' ' 36' ' ' PHE . 48.4 tp -77.54 103.21 7.34 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.881 173.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.5 m -96.42 127.4 42.38 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 175.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.406 HG22 ' HB2' ' A' ' 36' ' ' PHE . 89.2 t -118.85 138.58 49.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.937 0.399 . . . . 0.0 111.085 -175.485 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.58 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 32.3 t -87.67 113.66 23.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.578 -176.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.658 ' HG3' HG22 ' A' ' 95' ' ' THR . 0.0 OUTLIER -149.47 137.29 20.35 Favored 'General case' 0 C--O 1.205 -1.249 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.241 172.921 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.1 m120 56.53 27.13 11.85 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 173.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 49.0 m 57.74 53.06 7.45 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 122.516 1.15 . . . . 0.0 108.189 -175.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.726 HH22 ' HA ' ' A' ' 154' ' ' GLU . 6.0 ttp180 -167.98 64.81 0.07 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 113.133 -1.849 . . . . 0.0 109.246 -153.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 37.3 t -70.25 107.07 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 122.333 1.063 . . . . 0.0 110.142 -167.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 45.5 m -75.71 121.74 22.97 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 113.304 -1.771 . . . . 0.0 110.533 -176.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -99.01 115.32 28.68 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -173.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.553 ' HB3' HD11 ' A' ' 73' ' ' ILE . 44.0 m-85 -112.14 107.88 16.95 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.586 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 65.4 mt -80.77 127.9 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -173.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.561 ' HB ' ' HB2' ' A' ' 48' ' ' TYR . 3.8 mp -102.43 119.32 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 122.947 0.499 . . . . 0.0 111.209 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.555 ' HB2' ' HB3' ' A' ' 72' ' ' LYS . 4.9 m-20 -87.77 134.81 33.6 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.999 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.0 t -83.7 86.1 7.18 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 172.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.565 HD12 ' HB2' ' A' ' 70' ' ' ARG . 83.0 mt -70.21 137.96 86.89 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.778 -176.07 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 66' ' ' LEU . 36.9 Cg_exo -61.85 -16.2 47.7 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.914 2.409 . . . . 0.0 111.394 176.259 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.8 m-20 -81.47 7.98 10.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.222 178.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.807 ' HA ' ' HE ' ' A' ' 69' ' ' ARG . 2.9 mmp_? 64.51 36.59 8.58 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.812 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.565 ' HB2' HD12 ' A' ' 66' ' ' LEU . 82.1 mtm-85 -126.38 179.17 5.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.271 177.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.537 ' HB3' HG23 ' A' ' 63' ' ' ILE . 57.0 m-85 -136.35 116.7 13.63 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.019 0.438 . . . . 0.0 111.156 -176.4 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.597 ' HA ' ' HA ' ' A' ' 77' ' ' GLU . 24.2 ttmm -99.73 116.06 30.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.217 -176.066 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.553 HD11 ' HB3' ' A' ' 61' ' ' TYR . 18.5 tt -93.52 92.37 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 121.995 0.902 . . . . 0.0 111.345 -176.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' A' ' 75' ' ' ASP . . . 77.76 -15.7 7.61 Favored Glycine 0 CA--C 1.517 0.203 0 CA-C-N 115.191 -0.913 . . . . 0.0 113.959 174.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 74' ' ' GLY . 22.3 t70 161.35 -55.24 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.607 0.717 . . . . 0.0 109.167 -171.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -71.27 118.78 14.49 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.63 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.597 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 14.3 pt-20 -105.89 134.44 49.01 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.751 0.786 . . . . 0.0 111.785 -175.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.461 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 88.9 m-85 -112.45 -177.47 3.16 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.848 176.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.405 ' HA ' ' HD2' ' A' ' 70' ' ' ARG . 7.5 p-10 -78.54 -28.67 46.09 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 121.136 -0.226 . . . . 0.0 111.208 -176.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -171.02 174.31 4.76 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 173.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.544 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 13.1 mt -53.9 -56.47 25.25 Favored Pre-proline 0 N--CA 1.471 0.582 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -176.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.544 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 38.9 Cg_exo -61.23 -10.14 14.7 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 122.175 1.917 . . . . 0.0 112.81 -177.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.5 -36.02 15.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.798 -178.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.0 pp -75.44 -34.58 60.97 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.574 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 92.0 mt -64.85 -25.93 68.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.377 177.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -87.27 -34.21 18.99 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.463 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -70.35 -36.87 74.47 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.299 0.571 . . . . 0.0 110.56 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.678 ' CG ' HD23 ' A' ' 93' ' ' LEU . 27.1 m-85 -77.32 -9.41 58.81 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.197 -177.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.629 ' HE2' ' CE1' ' A' ' 6' ' ' PHE . 99.0 mttt -68.1 -12.5 60.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.919 0.39 . . . . 0.0 111.221 177.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 24.2 pt -134.55 18.86 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 121.368 0.604 . . . . 0.0 109.492 -178.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.424 ' O ' ' HB2' ' A' ' 92' ' ' TYR . 4.0 t60 -116.55 -40.66 3.18 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.969 -175.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.424 ' HB2' ' O ' ' A' ' 91' ' ' HIS . 52.6 m-85 68.85 114.21 0.04 OUTLIER 'General case' 0 N--CA 1.461 0.104 0 O-C-N 124.291 0.995 . . . . 0.0 109.115 -169.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.678 HD23 ' CG ' ' A' ' 88' ' ' TYR . 0.8 OUTLIER -109.18 -7.39 15.3 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.055 -0.658 . . . . 0.0 111.099 176.347 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 1.058 ' HA ' ' HB3' ' A' ' 154' ' ' GLU . 0.5 OUTLIER -159.52 81.42 0.74 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.143 0.497 . . . . 0.0 111.166 170.372 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.69 ' OG1' ' HA ' ' A' ' 156' ' ' PRO . 2.3 t 47.67 3.79 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 125.208 1.403 . . . . 0.0 113.858 -176.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.469 ' H ' ' C ' ' A' ' 94' ' ' ASP . 14.6 t -153.76 168.16 27.22 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 32.5 p -101.85 178.46 4.61 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 177.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.1 mt -75.11 96.19 3.21 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 176.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.47 HG23 ' O ' ' A' ' 3' ' ' SER . 37.5 mm -82.15 -63.68 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.707 -173.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.631 ' O ' ' HA ' ' A' ' 35' ' ' MET . 33.3 tt0 -153.33 137.13 10.41 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.16 -178.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -57.33 162.57 9.62 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 123.087 2.524 . . . . 0.0 113.248 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.53 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -78.16 157.98 77.67 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.198 178.066 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.93 107.52 0.23 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.452 2.101 . . . . 0.0 112.089 177.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.78 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 65.0 ttt180 . . . . . 0 C--N 1.326 -0.42 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.705 178.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.71 HD12 HG21 ' A' ' 152' ' ' ILE . 2.6 mm? . . . . . 0 N--CA 1.467 0.408 0 CA-C-O 121.657 0.741 . . . . 0.0 111.351 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.56 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 46.5 tt0 -169.37 -77.12 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.561 -176.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -104.74 107.67 18.75 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 121.611 0.719 . . . . 0.0 110.773 -177.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.75 HG22 ' CG ' ' A' ' 180' ' ' LYS . 65.7 t -123.48 130.67 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 CA-C-N 114.448 -1.251 . . . . 0.0 108.882 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.702 ' HG3' ' HB3' ' A' ' 179' ' ' GLU . 5.2 ptp180 -108.6 149.65 28.6 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 116.831 -1.947 . . . . 0.0 108.196 171.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.532 HG22 HG12 ' A' ' 178' ' ' VAL . 0.8 OUTLIER -106.12 129.56 54.18 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.102 -178.734 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 1.036 HD11 ' HG2' ' A' ' 179' ' ' GLU . 16.8 mt -104.08 -21.17 13.63 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -174.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.429 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 59.2 t80 -77.31 -35.18 55.14 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -172.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.585 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 23.0 t70 70.77 94.72 0.07 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.633 0.73 . . . . 0.0 109.784 -174.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.537 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 37.1 t80 -126.69 86.39 58.66 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.604 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 90.8 Cg_endo -88.89 79.36 1.01 Allowed 'Trans proline' 0 N--CA 1.441 -1.563 0 C-N-CA 121.896 1.731 . . . . 0.0 112.66 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.51 -22.5 75.02 Favored Glycine 0 CA--C 1.51 -0.248 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 175.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.819 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 3.8 m-20 57.43 73.12 0.48 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.09 -1.055 . . . . 0.0 110.997 -175.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.643 ' HB3' ' H ' ' A' ' 141' ' ' ASP . 0.6 OUTLIER -141.26 -173.65 3.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.394 0.616 . . . . 0.0 111.545 -178.588 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -114.99 1.9 14.1 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.674 167.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.562 ' O ' ' HB2' ' A' ' 172' ' ' MET . 40.3 mt-10 -116.35 -41.18 3.15 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.994 175.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.643 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 9.2 m-20 -101.86 114.25 28.17 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 167.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 1.085 HD11 ' HB2' ' A' ' 165' ' ' ASN . 35.2 tp -69.92 127.64 92.31 Favored Pre-proline 0 N--CA 1.465 0.324 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.819 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 6.5 Cg_endo -82.02 90.23 1.14 Allowed 'Trans proline' 0 N--CA 1.443 -1.497 0 C-N-CA 121.956 1.771 . . . . 0.0 110.752 173.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.537 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 9.1 p90 -102.39 155.04 18.51 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.317 -175.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.585 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 99.0 mttt -99.92 -166.65 1.36 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.235 0.54 . . . . 0.0 112.427 -174.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.828 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -83.71 5.29 25.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.288 -169.42 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -179.07 37.59 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.996 176.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.519 ' OE1' ' HA ' ' A' ' 144' ' ' PHE . 1.2 pt-20 -96.59 148.92 22.35 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.751 -174.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.58 128.58 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.723 HD22 HD21 ' A' ' 142' ' ' LEU . 16.6 mt -121.7 156.63 32.67 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 -178.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.564 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 49.2 t -119.51 123.43 71.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 174.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 1.073 HD13 ' HB2' ' A' ' 163' ' ' ALA . 50.4 mm -73.92 94.53 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 -176.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.612 HD12 ' HD3' ' A' ' 164' ' ' ARG . 18.7 tt -79.33 -26.34 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.547 -173.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 1.058 ' HB3' ' HA ' ' A' ' 94' ' ' ASP . 0.0 OUTLIER -141.0 145.56 36.11 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.454 169.123 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -121.86 84.93 44.63 Favored Pre-proline 0 C--N 1.318 -0.784 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 167.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.69 ' HA ' ' OG1' ' A' ' 95' ' ' THR . 13.0 Cg_exo -70.42 -47.73 0.69 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.603 2.202 . . . . 0.0 111.824 177.059 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -118.15 177.29 4.85 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.589 -174.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.428 ' O ' HG21 ' A' ' 175' ' ' VAL . 13.3 pt-20 -92.98 -34.76 13.62 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.556 -176.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.416 ' HG3' ' HG3' ' A' ' 158' ' ' GLU . 36.3 mt-30 -98.74 -10.42 23.15 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.865 0.364 . . . . 0.0 111.66 -176.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.548 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 59.1 m95 -124.36 134.83 53.03 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 172.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' TRP . . . . . 0.786 ' O ' HG13 ' A' ' 173' ' ' ILE . 50.7 m0 -123.99 133.81 53.6 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.144 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.758 ' HB2' ' HG3' ' A' ' 154' ' ' GLU . 50.5 m -93.82 98.47 11.1 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -173.072 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 1.073 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -112.33 146.09 38.88 Favored 'General case' 0 N--CA 1.419 -1.998 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.701 -172.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.735 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 15.1 ptt180 -87.0 120.62 28.46 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 175.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 1.085 ' HB2' HD11 ' A' ' 142' ' ' LEU . 20.7 t30 -52.52 176.85 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 113.455 -1.702 . . . . 0.0 111.753 -173.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 45.5 tptt -58.46 -21.02 49.96 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 169.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -77.38 -28.89 52.97 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.614 175.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 100.17 7.56 52.06 Favored Glycine 0 CA--C 1.519 0.333 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.119 -174.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.735 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.4 OUTLIER -79.9 135.72 36.49 Favored 'General case' 0 C--O 1.22 -0.498 0 C-N-CA 122.819 0.448 . . . . 0.0 111.217 -179.621 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.549 HG22 HG21 ' A' ' 153' ' ' ILE . 47.9 t -81.08 123.34 37.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 C-N-CA 121.119 -0.232 . . . . 0.0 111.252 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -158.06 146.29 13.13 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.865 171.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.57 ' HA ' ' HA ' ' A' ' 162' ' ' SER . 0.0 OUTLIER -68.97 141.06 55.03 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 122.922 0.489 . . . . 0.0 111.219 178.265 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.786 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.7 pp -142.91 143.17 24.23 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.246 -176.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.538 ' HB2' ' CD1' ' A' ' 177' ' ' TYR . 20.5 Cg_exo -68.24 132.26 25.48 Favored 'Trans proline' 0 CA--C 1.528 0.219 0 C-N-CA 122.96 2.44 . . . . 0.0 113.282 -178.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.566 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 67.0 t -60.79 -44.34 94.7 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 178.018 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 20.0 Cg_endo -61.52 -2.05 2.35 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 122.211 1.94 . . . . 0.0 113.217 178.024 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.538 ' CD1' ' HB2' ' A' ' 174' ' ' PRO . 2.8 m-85 -99.83 -12.17 20.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.555 -177.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.649 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 3.7 m -106.36 -172.83 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 -164.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 1.036 ' HG2' HD11 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -157.29 46.44 0.39 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 112.897 -1.956 . . . . 0.0 111.545 -151.755 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.75 ' CG ' HG22 ' A' ' 128' ' ' VAL . 0.8 OUTLIER -71.45 136.55 47.7 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 120.193 -1.567 . . . . 0.0 110.009 -163.369 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 38.8 tp . . . . . 0 CA--C 1.523 -0.067 0 CA-C-N 113.524 -1.671 . . . . 0.0 111.796 -165.47 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo . . . . . 0 N--CA 1.46 -0.447 0 N-CA-C 110.54 -0.6 . . . . 0.0 110.54 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.507 ' HB ' HG13 ' A' ' 266' ' ' VAL . 6.2 t -74.49 127.74 36.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -176.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -98.69 118.2 34.87 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.193 0.52 . . . . 0.0 111.198 -175.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.545 ' HB2' HD12 ' A' ' 293' ' ' ILE . . . -121.78 134.95 54.92 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.067 175.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -94.45 133.62 37.85 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 177.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' ALA . . . . . 0.601 ' O ' ' HA ' ' A' ' 260' ' ' VAL . . . -82.29 105.2 13.17 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.178 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.565 HD13 ' H ' ' A' ' 243' ' ' ILE . 0.2 OUTLIER -88.84 -23.08 6.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.999 0.428 . . . . 0.0 110.727 -178.483 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 12.2 tm0? -130.25 122.61 28.37 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -60.34 138.42 57.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.799 0.809 . . . . 0.0 112.374 -171.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 20.4 tpt180 -116.83 113.99 23.29 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.946 -1.025 . . . . 0.0 108.998 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.416 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 19.9 m -111.65 147.68 37.28 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.774 -178.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.427 ' HA ' ' HB3' ' A' ' 255' ' ' ALA . 11.9 Cg_exo -69.24 105.63 1.43 Allowed 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.68 2.253 . . . . 0.0 111.399 178.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 249' ' ' CYS . . . . . 0.453 ' HB3' ' HB2' ' A' ' 252' ' ' ASP . 34.0 t -76.92 172.34 13.31 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.965 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -55.62 -42.58 75.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.823 0.344 . . . . 0.0 111.131 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -94.23 8.83 40.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.122 0.487 . . . . 0.0 111.172 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 252' ' ' ASP . . . . . 0.453 ' HB2' ' HB3' ' A' ' 249' ' ' CYS . 1.6 m-20 -131.94 51.28 2.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.538 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -67.65 -17.49 64.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.128 0.489 . . . . 0.0 110.106 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 3.7 p -88.23 4.37 46.02 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.55 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 255' ' ' ALA . . . . . 0.427 ' HB3' ' HA ' ' A' ' 248' ' ' PRO . . . -88.39 142.82 27.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.223 0.535 . . . . 0.0 111.299 -178.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.437 HD23 ' N ' ' A' ' 257' ' ' ALA . 1.2 tt -81.68 141.22 33.83 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.11 177.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -88.63 109.53 20.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.139 0.495 . . . . 0.0 110.297 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 72.2 mt -118.42 157.38 27.3 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.96 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -146.01 167.9 22.22 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 177.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.601 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 26.0 t -55.82 120.39 2.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 O-C-N 123.673 0.608 . . . . 0.0 112.55 -171.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 109.76 -21.13 26.07 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.713 -0.676 . . . . 0.0 113.574 172.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -78.79 154.44 29.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 117.033 0.416 . . . . 0.0 110.797 -170.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 43.9 mm -98.12 120.55 47.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.877 -177.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.444 HG21 HG11 ' A' ' 291' ' ' VAL . 21.7 t -95.81 116.67 38.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.532 179.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 43.1 tttm -89.86 99.02 12.11 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.461 177.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.507 HG13 ' HB ' ' A' ' 238' ' ' VAL . 3.6 p -99.52 117.53 44.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.36 0.6 . . . . 0.0 110.174 174.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.42 -13.66 15.04 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.816 -177.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 268' ' ' ARG . . . . . 0.553 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 5.6 ttp180 -130.46 107.3 9.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.174 0.512 . . . . 0.0 110.86 175.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 44.7 mtt -97.92 123.8 42.07 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.684 173.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.433 ' O ' ' HB ' ' A' ' 271' ' ' ILE . 90.8 m-20 -80.74 -93.55 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.976 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.433 ' HB ' ' O ' ' A' ' 270' ' ' ASN . 10.5 tp 177.1 -29.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.153 0.502 . . . . 0.0 109.778 176.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -68.29 -37.5 80.73 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.734 177.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 141.42 -34.36 1.91 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.422 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -76.38 107.72 8.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.875 0.369 . . . . 0.0 110.198 178.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.404 ' HB3' ' CG2' ' A' ' 266' ' ' VAL . 40.6 m0 -98.24 158.1 15.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.176 -178.091 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.553 ' HB2' ' HB3' ' A' ' 268' ' ' ARG . 53.6 mt-10 -95.84 104.27 16.2 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.216 173.155 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 277' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -121.63 141.05 14.26 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 174.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -116.3 112.05 21.0 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.999 0.428 . . . . 0.0 110.43 -177.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 66.3 t -129.4 127.9 65.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.2 -177.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 63.66 21.8 12.86 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.451 177.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 102.44 -14.89 56.52 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.731 177.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 53.4 mtp180 -104.43 132.02 51.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.694 0.247 . . . . 0.0 111.128 -179.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 4.8 ptpp? -111.57 114.83 28.16 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 171.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -133.4 166.38 23.83 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.757 -177.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 74.8 mt -86.98 112.56 21.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.265 0.555 . . . . 0.0 110.443 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -115.56 149.34 42.8 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.859 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -86.11 143.61 7.97 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.471 2.114 . . . . 0.0 111.618 177.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -68.93 4.01 1.72 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -175.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 23.9 p -89.54 -33.67 16.65 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.855 0.359 . . . . 0.0 111.511 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -77.5 -12.32 59.95 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.984 0.421 . . . . 0.0 110.96 -177.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.54 ' HB ' ' HB1' ' A' ' 240' ' ' ALA . 27.8 m -128.38 160.57 38.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.279 179.186 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -133.55 134.92 43.96 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.9 0.381 . . . . 0.0 110.753 174.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.545 HD12 ' HB2' ' A' ' 240' ' ' ALA . 1.2 mp -68.34 138.89 21.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.482 177.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -156.73 158.8 37.57 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 177.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -84.85 114.5 55.97 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 174.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.463 -0.313 0 C-N-CA 122.987 2.458 . . . . 0.0 111.123 178.482 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.528 ' O ' HG23 ' A' ' 99' ' ' ILE . 3.0 p . . . . . 0 N--CA 1.451 -0.391 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -87.86 66.46 8.75 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.772 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -97.91 84.46 3.33 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.816 -173.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -154.37 164.67 38.25 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.506 176.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -89.68 107.29 19.01 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 175.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.577 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 37.8 t -79.09 69.9 5.35 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.306 -178.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.4 t -176.29 -40.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.167 176.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -58.14 108.23 0.58 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.108 0.48 . . . . 0.0 111.469 -174.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 17.8 mmt180 -61.92 -32.22 72.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.853 -174.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 72.4 m -74.47 -5.7 44.11 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.974 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.53 -48.41 6.64 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.429 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.449 ' HB3' ' HB3' ' A' ' 101' ' ' PRO . 22.9 p-90 -114.54 -29.94 6.68 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -170.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -72.27 122.2 20.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.908 0.385 . . . . 0.0 110.618 -175.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.545 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 26.1 mmt -103.06 -5.5 23.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.401 -176.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.475 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 50.97 -114.43 2.79 Favored Glycine 0 CA--C 1.522 0.492 0 CA-C-N 115.614 -0.721 . . . . 0.0 113.498 -177.117 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.475 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 5.3 Cg_exo -77.33 89.18 1.34 Allowed 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 123.091 2.527 . . . . 0.0 113.274 -175.077 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.603 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 97.1 t -139.15 155.51 26.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 177.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.5 m -119.46 174.06 6.61 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -174.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 70.0 mtp85 -55.77 -47.32 77.25 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -62.7 -56.2 19.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.853 0.358 . . . . 0.0 111.113 -178.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.538 ' HB3' HG13 ' A' ' 19' ' ' VAL . 0.5 OUTLIER -57.08 -47.12 81.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.789 -179.156 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.52 -47.4 82.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.204 0.526 . . . . 0.0 111.079 176.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -63.91 -43.19 96.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.495 -178.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.9 t -70.66 -9.16 56.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.651 0.262 . . . . 0.0 111.437 -177.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.487 ' HG3' ' O ' ' A' ' 23' ' ' GLU . 77.5 mtt180 -87.65 -25.84 23.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.987 0.422 . . . . 0.0 110.661 174.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.586 HD22 ' HB2' ' A' ' 53' ' ' SER . 27.3 mt -108.71 -12.49 14.94 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.76 -175.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.0 tp60 -79.7 105.51 11.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.161 0.505 . . . . 0.0 111.297 -177.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.97 -17.84 47.75 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.86 175.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -86.16 175.54 8.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.678 0.275 . . . . 0.0 110.785 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 18.3 ttp180 -62.0 132.09 51.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.732 -177.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.414 ' CD2' ' HA ' ' A' ' 54' ' ' GLU . 33.3 m80 -76.35 158.18 31.71 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.376 -176.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.69 -11.86 46.24 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -174.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.626 ' HB3' ' HB2' ' A' ' 102' ' ' ALA . 66.1 mtt -73.96 150.7 40.62 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 175.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.422 ' CB ' HG22 ' A' ' 52' ' ' VAL . 37.9 p90 -147.8 156.26 42.54 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 175.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.545 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.5 pp -150.45 134.72 17.08 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.058 0.456 . . . . 0.0 110.592 178.084 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.4 t -105.84 107.57 22.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.508 176.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.603 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 24.6 ptt-85 -106.34 -178.85 3.77 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.46 138.82 33.28 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 172.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.593 ' HB3' ' O ' ' A' ' 44' ' ' CYS . 20.8 t -68.05 104.26 1.72 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.39 0.614 . . . . 0.0 110.736 -174.204 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.4 p -69.02 -11.01 60.4 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.839 177.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.0 p -104.97 -22.15 13.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.719 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.593 ' O ' ' HB3' ' A' ' 41' ' ' SER . 57.9 m -136.51 112.68 10.03 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.763 0.316 . . . . 0.0 110.561 -177.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -62.01 114.95 2.53 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.958 2.439 . . . . 0.0 113.098 -175.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.94 -26.53 23.71 Favored Glycine 0 CA--C 1.51 -0.236 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.735 174.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.602 ' OD1' ' HA ' ' A' ' 64' ' ' ASN . 32.0 m-20 -79.95 179.66 7.47 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.544 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 38.3 m-85 -127.48 174.36 9.08 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 176.5 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.403 HG23 ' HA ' ' A' ' 41' ' ' SER . 27.9 t -141.37 111.01 2.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.662 0.267 . . . . 0.0 111.049 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.459 ' HB2' HD11 ' A' ' 63' ' ' ILE . 61.3 tp -78.33 98.76 6.06 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 171.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.8 m -95.62 119.66 34.51 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.266 0.555 . . . . 0.0 109.543 175.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.609 HG21 HD11 ' A' ' 93' ' ' LEU . 48.7 t -112.12 143.32 22.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.903 -173.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.589 ' HA ' ' O ' ' A' ' 57' ' ' ARG . 36.6 t -87.34 111.87 21.52 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.612 -0.144 . . . . 0.0 110.612 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.414 ' HA ' ' CD2' ' A' ' 33' ' ' HIS . 6.8 tp10 -175.92 157.3 1.89 Allowed 'General case' 0 N--CA 1.469 0.523 0 O-C-N 123.486 0.491 . . . . 0.0 111.022 176.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.676 ' HB2' ' NH2' ' A' ' 57' ' ' ARG . 27.0 m-80 61.81 58.26 2.0 Allowed 'General case' 0 CA--C 1.479 -1.752 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -171.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.9 t 70.54 -37.54 0.39 Allowed 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 113.777 -1.556 . . . . 0.0 110.21 -169.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.901 ' NE ' ' H ' ' A' ' 58' ' ' VAL 0.399 0.0 OUTLIER -157.76 -48.06 0.06 Allowed 'General case' 0 C--N 1.364 1.237 1 N-CA-C 125.571 5.397 . . . . 0.0 125.571 -170.116 . . . . . . . . 5 4 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.901 ' H ' ' NE ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -149.43 112.09 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 122.088 2.222 . . . . 0.0 114.573 -168.292 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.548 ' HB2' ' HB ' ' A' ' 52' ' ' VAL . 1.4 m -98.34 114.13 26.34 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 166.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.571 ' O ' HD11 ' A' ' 153' ' ' ILE . 92.0 m-70 -100.68 110.81 22.96 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -170.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.615 ' CZ ' ' HB2' ' A' ' 93' ' ' LEU . 98.7 m-85 -119.03 117.25 28.28 Favored 'General case' 0 C--O 1.218 -0.579 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -178.19 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.516 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 44.8 mm -78.09 127.64 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -177.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.574 HG13 ' HB ' ' A' ' 73' ' ' ILE . 3.8 mp -104.34 114.54 44.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 175.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.602 ' HA ' ' OD1' ' A' ' 47' ' ' ASP . 7.9 m120 -85.89 137.06 33.02 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.577 -173.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.8 t -87.72 95.73 10.18 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 174.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.554 HD11 ' HB2' ' A' ' 72' ' ' LYS . 99.0 mt -82.15 136.19 47.02 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.444 -178.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 66' ' ' LEU . 27.0 Cg_exo -64.82 -2.0 4.87 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.942 2.428 . . . . 0.0 111.311 172.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -79.58 5.22 13.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.614 175.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.536 ' HA ' ' HE ' ' A' ' 69' ' ' ARG . 0.1 OUTLIER 67.91 29.9 6.38 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.227 -176.835 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.423 ' HB3' ' O ' ' A' ' 78' ' ' PHE . 30.7 mtm-85 -140.52 175.23 9.78 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.933 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.467 ' HB3' HG23 ' A' ' 63' ' ' ILE . 68.1 m-85 -125.99 132.22 52.07 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.505 0.193 . . . . 0.0 111.06 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.669 ' HE2' ' HB3' ' A' ' 77' ' ' GLU . 37.1 ttmt -114.32 112.19 22.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.978 -177.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.574 ' HB ' HG13 ' A' ' 63' ' ' ILE . 14.0 tt -105.04 110.72 31.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.344 0.592 . . . . 0.0 111.127 -177.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.58 50.12 45.47 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.63 177.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.9 t0 75.58 -29.24 0.19 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.607 0.763 . . . . 0.0 110.985 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -81.18 121.43 26.13 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.185 0.517 . . . . 0.0 110.716 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.669 ' HB3' ' HE2' ' A' ' 72' ' ' LYS . 7.8 pt-20 -99.6 141.86 31.84 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.437 -176.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.423 ' O ' ' HB3' ' A' ' 70' ' ' ARG . 95.5 m-85 -131.95 -175.56 3.77 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.201 -177.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.401 ' HA ' ' HD2' ' A' ' 70' ' ' ARG . 4.3 m-20 -64.01 -50.88 66.76 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.186 0.517 . . . . 0.0 110.335 175.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.505 ' ND1' ' HD2' ' A' ' 82' ' ' PRO . 4.2 p80 -173.0 -173.8 0.99 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.246 -176.279 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.667 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 19.6 mt -54.3 -58.16 15.1 Favored Pre-proline 0 N--CA 1.467 0.421 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.667 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 52.4 Cg_exo -59.52 -7.7 5.93 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 122.562 2.175 . . . . 0.0 113.765 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -95.46 -36.68 11.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.915 0.388 . . . . 0.0 110.925 -178.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.9 pp -76.59 -30.52 57.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.311 -178.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.452 ' HB2' ' OG ' ' A' ' 8' ' ' SER . 60.0 mt -66.12 -21.91 66.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.322 0.582 . . . . 0.0 110.002 177.12 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -81.66 -39.84 23.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.086 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.637 ' HE1' ' CE1' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -71.64 -21.38 61.83 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.073 0.463 . . . . 0.0 111.079 -179.873 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.697 ' CD1' HD23 ' A' ' 93' ' ' LEU . 32.7 m-85 -89.34 1.91 55.12 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 121.665 -0.647 . . . . 0.0 111.641 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -76.38 -21.47 56.02 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.953 175.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.555 HD13 ' O ' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -125.4 -1.78 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-O 121.558 0.694 . . . . 0.0 110.301 -175.477 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -101.86 -30.71 11.11 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.345 -174.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 67.81 153.56 0.09 Allowed 'General case' 0 C--N 1.332 -0.168 0 O-C-N 124.501 1.125 . . . . 0.0 109.346 -168.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.697 HD23 ' CD1' ' A' ' 88' ' ' TYR . 0.7 OUTLIER -138.24 39.97 2.28 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 164.648 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 1.078 ' HA ' ' HB3' ' A' ' 154' ' ' GLU . 13.8 t0 168.08 -158.47 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 112.058 -2.337 . . . . 0.0 106.01 172.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.748 ' CB ' ' HA ' ' A' ' 156' ' ' PRO . 14.2 t -76.76 11.36 1.73 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.21 0.529 . . . . 0.0 110.564 176.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.2 t -146.43 161.58 40.1 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.752 176.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.8 p -97.7 -176.18 3.4 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 176.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 81.5 mt -77.33 92.91 3.96 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 176.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.528 HG23 ' O ' ' A' ' 3' ' ' SER . 48.1 mm -74.9 -59.08 3.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.985 -176.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.546 ' O ' ' HA ' ' A' ' 35' ' ' MET . 8.8 pt-20 -159.98 154.42 20.36 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.257 178.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.449 ' HB3' ' HB3' ' A' ' 14' ' ' TRP . 38.1 Cg_endo -67.18 142.64 61.75 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.323 2.015 . . . . 0.0 112.003 177.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.626 ' HB2' ' HB3' ' A' ' 35' ' ' MET . . . -69.01 148.0 97.8 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.945 177.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -63.26 129.13 24.57 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.704 1.603 . . . . 0.0 111.102 174.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 . . . . . 0 C--N 1.33 -0.279 0 CA-C-O 121.056 0.455 . . . . 0.0 111.194 178.336 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.929 HD12 HG21 ' A' ' 152' ' ' ILE . 4.6 mm? . . . . . 0 N--CA 1.468 0.465 0 CA-C-O 121.696 0.76 . . . . 0.0 110.516 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.502 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 40.1 tt0 -172.88 -68.72 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.825 -1.08 . . . . 0.0 108.942 -172.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -115.63 108.02 15.86 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 121.061 0.457 . . . . 0.0 110.163 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.724 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 69.4 t -118.1 132.47 67.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.961 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.691 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 5.6 ptp180 -110.38 144.37 39.25 Favored 'General case' 0 N--CA 1.436 -1.167 0 C-N-CA 117.162 -1.815 . . . . 0.0 107.92 169.276 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.605 HG22 HG12 ' A' ' 178' ' ' VAL . 6.0 p -98.19 138.5 35.38 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.064 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.566 HD21 ' HG2' ' A' ' 179' ' ' GLU . 15.6 mt -110.96 -8.14 14.5 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.448 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 22.0 t80 -91.03 -42.46 10.51 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.432 -0.507 . . . . 0.0 112.01 -173.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.583 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 10.0 t70 77.3 98.39 0.07 Allowed 'General case' 0 N--CA 1.475 0.808 0 O-C-N 123.581 0.55 . . . . 0.0 110.459 -176.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.532 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 76.0 t80 -134.12 93.86 19.11 Favored Pre-proline 0 N--CA 1.45 -0.47 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 176.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.69 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 91.9 Cg_endo -84.02 89.53 0.97 Allowed 'Trans proline' 0 N--CA 1.443 -1.476 0 C-N-CA 121.767 1.645 . . . . 0.0 112.64 -178.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -79.74 -36.48 25.66 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.65 176.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.54 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 16.7 m120 67.62 34.21 4.64 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 122.958 0.503 . . . . 0.0 111.648 175.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.543 ' HB3' ' H ' ' A' ' 140' ' ' GLU . 0.1 OUTLIER -117.3 178.22 4.45 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.135 -178.071 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -92.71 -7.31 47.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.926 0.87 . . . . 0.0 108.749 171.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.676 ' O ' ' HB2' ' A' ' 172' ' ' MET . 32.4 mt-10 -118.06 -5.02 10.98 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.712 177.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.483 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 7.9 m-20 -139.53 102.44 4.46 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 174.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 1.098 HD11 ' HB2' ' A' ' 165' ' ' ASN . 31.0 tp -71.74 135.21 83.45 Favored Pre-proline 0 CA--C 1.512 -0.517 0 C-N-CA 120.535 -0.466 . . . . 0.0 109.966 -177.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.69 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 94.4 Cg_endo -88.54 96.85 0.38 Allowed 'Trans proline' 0 N--CA 1.438 -1.767 0 C-N-CA 121.54 1.493 . . . . 0.0 112.193 173.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.532 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 1.8 p90 -94.54 -177.7 4.32 Favored 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.85 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.583 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 29.1 mtmm -125.96 -172.25 2.57 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.676 174.166 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.984 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -78.13 22.74 0.29 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.749 -173.1 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 165.5 35.13 0.02 OUTLIER Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.446 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.491 ' OE1' ' HA ' ' A' ' 144' ' ' PHE . 0.8 OUTLIER -96.79 150.51 20.63 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 119.286 -0.966 . . . . 0.0 110.688 -178.876 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.2 mp -93.5 123.76 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -173.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.781 HD22 HD21 ' A' ' 142' ' ' LEU . 13.2 mt -119.91 156.89 29.88 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -175.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.592 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 99.5 t -117.74 121.42 67.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 176.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 1.007 HD13 ' HB2' ' A' ' 163' ' ' ALA . 47.2 mm -77.21 105.21 5.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.548 0.69 . . . . 0.0 109.181 -175.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.571 HD11 ' O ' ' A' ' 60' ' ' HIS . 19.5 tt -96.33 -29.01 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.954 -174.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 1.078 ' HB3' ' HA ' ' A' ' 94' ' ' ASP . 2.6 mt-10 -123.25 143.15 50.24 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 168.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.625 ' CD ' ' HG ' ' A' ' 125' ' ' LEU . 70.2 tttt -134.86 78.44 54.58 Favored Pre-proline 0 C--N 1.314 -0.952 0 CA-C-O 121.323 0.583 . . . . 0.0 109.512 166.185 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.748 ' HA ' ' CB ' ' A' ' 95' ' ' THR . 26.1 Cg_exo -64.47 -52.41 1.47 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.178 1.919 . . . . 0.0 111.908 172.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.427 ' HG2' ' HB2' ' A' ' 156' ' ' PRO . 17.7 mm-40 -114.73 168.08 10.2 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.194 -169.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -96.19 1.56 52.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.395 0.617 . . . . 0.0 109.466 173.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.401 ' OE1' ' HA ' ' A' ' 159' ' ' GLN . 10.4 mm-40 -104.73 -34.34 8.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.72 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.485 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 35.1 m95 -129.55 142.28 50.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.985 176.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' TRP . . . . . 0.751 ' O ' HG13 ' A' ' 173' ' ' ILE . 52.4 m0 -125.68 137.96 53.87 Favored 'General case' 0 C--O 1.216 -0.695 0 C-N-CA 123.155 0.582 . . . . 0.0 110.143 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.539 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 18.2 m -98.12 107.11 19.51 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -175.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 1.007 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -117.3 152.22 35.32 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 119.899 -0.72 . . . . 0.0 110.742 -176.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.824 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 11.8 ptt180 -87.37 121.91 30.42 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 171.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 1.098 ' HB2' HD11 ' A' ' 142' ' ' LEU . 14.9 t30 -55.92 -179.83 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 113.748 -1.569 . . . . 0.0 111.668 -174.044 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -66.51 -22.15 66.17 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 167.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -68.85 -20.36 64.28 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.709 168.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 165' ' ' ASN . . . 82.73 19.51 63.46 Favored Glycine 0 CA--C 1.527 0.844 0 CA-C-N 115.148 -0.933 . . . . 0.0 113.246 -175.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.824 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 1.5 ttm-85 -94.12 142.53 27.3 Favored 'General case' 0 C--O 1.214 -0.788 0 C-N-CA 122.482 0.313 . . . . 0.0 111.03 -178.048 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 59.4 t -83.96 123.41 38.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 O-C-N 122.191 -0.318 . . . . 0.0 111.29 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -158.53 151.97 23.05 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.723 171.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.676 ' HB2' ' O ' ' A' ' 140' ' ' GLU . 0.2 OUTLIER -73.17 142.91 47.4 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.735 0.302 . . . . 0.0 111.187 178.202 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.751 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.7 pp -143.88 147.96 40.52 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.115 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.505 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 11.2 Cg_exo -72.67 132.37 18.67 Favored 'Trans proline' 0 CA--C 1.528 0.214 0 C-N-CA 122.654 2.236 . . . . 0.0 112.826 -175.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.498 ' O ' HG22 ' A' ' 178' ' ' VAL . 70.1 t -60.41 -44.32 95.5 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.462 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 39.2 Cg_exo -62.59 -5.7 7.56 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 122.213 1.942 . . . . 0.0 112.95 176.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.505 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.2 m-85 -94.67 -12.17 27.82 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.216 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.644 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 2.8 m -107.41 -175.18 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 -166.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.696 ' O ' ' HG3' ' A' ' 179' ' ' GLU . 3.6 tp10 -160.9 46.32 0.2 Allowed 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 112.725 -2.034 . . . . 0.0 111.541 -152.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.777 ' HD2' ' H ' ' A' ' 180' ' ' LYS . 0.0 OUTLIER -73.17 137.86 45.34 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 119.125 -2.235 . . . . 0.0 111.874 -161.328 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 15.3 tp . . . . . 0 N--CA 1.445 -0.69 0 CA-C-N 112.217 -2.265 . . . . 0.0 110.15 -173.401 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo . . . . . 0 N--CA 1.459 -0.516 0 N-CA-C 110.732 -0.526 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.68 HG12 HD11 ' A' ' 293' ' ' ILE . 2.8 t -90.18 145.0 7.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.557 -176.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.477 ' HB2' ' HA ' ' A' ' 295' ' ' ASP . 77.1 m-85 -116.28 124.77 51.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.291 0.567 . . . . 0.0 112.302 -172.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.61 ' HB2' HD12 ' A' ' 293' ' ' ILE . . . -119.48 149.85 41.21 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.919 175.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -106.65 123.72 48.54 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 173.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' ALA . . . . . 0.505 ' O ' ' HA ' ' A' ' 260' ' ' VAL . . . -68.34 97.24 0.72 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.92 0.391 . . . . 0.0 110.304 -178.219 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.471 HD13 ' HB2' ' A' ' 292' ' ' LYS . 27.1 pt -86.29 -24.39 6.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.077 -177.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 5.2 tm0? -126.39 123.85 38.88 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 176.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -53.98 138.63 36.56 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.38 0.609 . . . . 0.0 111.598 -173.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 28.4 tpt180 -123.32 111.63 16.63 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.161 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.442 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 23.6 m -115.95 144.22 32.34 Favored Pre-proline 0 C--N 1.318 -0.802 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.264 177.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 247' ' ' VAL . 4.4 Cg_exo -75.09 121.87 6.81 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.478 2.119 . . . . 0.0 110.953 177.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 18.2 t -75.42 -178.41 4.02 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.105 -177.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -59.23 -23.62 62.48 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.289 0.478 . . . . 0.0 112.289 -176.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -107.0 4.9 27.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.621 -177.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -96.3 112.88 24.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.773 0.32 . . . . 0.0 110.808 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -106.75 -37.82 6.29 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.014 176.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 24.8 p -99.41 19.97 14.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.708 -176.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -93.36 145.09 24.72 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.057 0.456 . . . . 0.0 111.164 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -93.78 135.79 34.73 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.921 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -91.91 122.09 34.11 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.162 177.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 81.4 mt -129.43 135.74 49.05 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -175.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -99.38 161.86 13.37 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 175.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 36.4 t -73.21 109.06 5.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.642 -178.342 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 120.35 -0.77 12.78 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.716 178.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -89.73 160.34 16.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.943 0.372 . . . . 0.0 110.131 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 30.1 mm -103.65 116.75 47.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.184 0.516 . . . . 0.0 110.733 -176.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 13.7 t -97.8 109.66 23.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.476 -178.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 9.4 ptmt -93.35 102.47 14.73 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.274 175.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.443 HG13 ' HB ' ' A' ' 238' ' ' VAL . 2.3 p -93.22 128.54 44.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.333 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.23 -39.33 7.69 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.149 -176.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 268' ' ' ARG . . . . . 0.499 ' HB2' ' CG ' ' A' ' 276' ' ' GLU . 63.2 mtt85 -128.11 127.27 42.75 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.979 0.418 . . . . 0.0 110.498 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 269' ' ' MET . . . . . 0.501 ' HE2' ' CZ3' ' A' ' 275' ' ' TRP . 43.4 mtt -105.36 140.11 38.97 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.342 -176.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.413 ' HB2' ' OD1' ' A' ' 272' ' ' ASN . 34.6 m-80 -106.94 169.08 8.76 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.477 177.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 18.4 pt -98.24 9.36 7.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.156 0.503 . . . . 0.0 111.162 -176.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 272' ' ' ASN . . . . . 0.413 ' OD1' ' HB2' ' A' ' 270' ' ' ASN . 30.1 p-10 -87.69 -20.87 25.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.995 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 114.83 -12.39 20.43 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.386 -178.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.411 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 89.7 mt-30 -116.98 122.5 44.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.085 0.469 . . . . 0.0 110.373 177.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.501 ' CZ3' ' HE2' ' A' ' 269' ' ' MET . 6.6 m0 -99.02 169.22 9.58 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.807 -176.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.499 ' CG ' ' HB2' ' A' ' 268' ' ' ARG . 0.0 OUTLIER -101.36 115.76 31.24 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 121.536 0.684 . . . . 0.0 110.324 174.882 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 277' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -119.57 146.85 18.17 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.167 177.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -109.88 106.58 16.21 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 60.9 t -131.85 125.37 55.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.829 0.347 . . . . 0.0 111.025 -171.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 58.74 27.77 16.41 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.336 175.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 91.02 -4.25 81.28 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.721 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 19.3 mtp-105 -113.55 120.2 40.13 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.467 ' HB2' ' HE3' ' A' ' 283' ' ' LYS . 15.1 ptmt -111.39 138.71 47.53 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.24 0.543 . . . . 0.0 110.611 175.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -173.45 -169.73 36.17 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.435 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 87.4 mt -90.41 134.14 34.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.981 0.419 . . . . 0.0 110.734 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -133.7 137.74 29.41 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.983 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -78.06 130.91 10.6 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 122.647 2.231 . . . . 0.0 112.042 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.499 ' HA ' HG22 ' A' ' 291' ' ' VAL . 35.6 p90 -62.33 -17.91 60.04 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.911 0.386 . . . . 0.0 110.731 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.39 -20.18 65.32 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.888 -0.597 . . . . 0.0 112.099 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -105.66 -5.69 19.82 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.713 0.292 . . . . 0.0 111.601 -176.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.499 HG22 ' HA ' ' A' ' 288' ' ' PHE . 33.7 m -123.43 166.26 18.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 120.987 0.422 . . . . 0.0 110.676 -177.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 292' ' ' LYS . . . . . 0.471 ' HB2' HD13 ' A' ' 243' ' ' ILE . 39.9 tptt -122.4 107.25 11.85 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.68 HD11 HG12 ' A' ' 238' ' ' VAL . 4.2 tp -74.54 135.36 27.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -157.14 -29.33 0.09 Allowed 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.321 -0.552 . . . . 0.0 112.042 -175.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 295' ' ' ASP . . . . . 0.477 ' HA ' ' HB2' ' A' ' 239' ' ' PHE . 32.5 m-20 60.79 97.22 0.04 OUTLIER Pre-proline 0 N--CA 1.464 0.227 0 CA-C-O 121.056 0.455 . . . . 0.0 110.613 -176.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo . . . . . 0 C--N 1.345 0.371 0 C-N-CA 122.841 2.361 . . . . 0.0 112.486 -177.399 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 121.54 0.686 . . . . 0.0 109.767 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.79 93.44 5.6 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.122 175.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -115.27 90.34 3.31 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.597 0.713 . . . . 0.0 111.014 -178.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.482 ' CE1' ' HE2' ' A' ' 89' ' ' LYS . 32.1 p90 -160.66 151.67 18.83 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.446 -1.252 . . . . 0.0 108.482 177.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -80.46 115.46 20.0 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 177.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.3 m -67.29 -9.01 36.55 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -173.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.7 t -106.86 -24.43 12.05 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.308 -176.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -63.39 98.83 0.17 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.028 0.442 . . . . 0.0 110.874 -174.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.457 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 2.9 tpp180 -57.11 -43.41 82.25 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.402 -176.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.0 m -75.74 7.0 4.21 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -177.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -95.75 -46.28 6.65 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.613 0.244 . . . . 0.0 110.749 173.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.469 ' HB3' ' HB3' ' A' ' 101' ' ' PRO . 34.7 p-90 -121.68 -26.66 4.85 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -173.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.457 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 60.8 t80 -75.32 107.98 7.79 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.335 0.588 . . . . 0.0 110.03 -176.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.461 ' SD ' ' HG2' ' A' ' 104' ' ' ARG . 5.4 tpp -91.4 -9.53 44.41 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.993 -174.092 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 39' ' ' ARG . . . 50.5 -112.66 1.66 Allowed Glycine 0 C--N 1.333 0.399 0 O-C-N 123.839 0.712 . . . . 0.0 114.293 175.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -74.16 93.66 0.89 Allowed 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.473 2.115 . . . . 0.0 112.461 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.473 ' O ' ' CB ' ' A' ' 20' ' ' SER . 7.3 t -125.7 -77.02 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.954 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.473 ' CB ' ' O ' ' A' ' 19' ' ' VAL . 32.3 t 125.86 156.39 0.0 OUTLIER 'General case' 0 C--N 1.355 0.84 0 C-N-CA 124.973 1.309 . . . . 0.0 108.311 168.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.52 ' HA ' ' NH2' ' A' ' 39' ' ' ARG . 21.1 tpt180 -52.91 -52.33 58.1 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.746 0.308 . . . . 0.0 111.003 178.12 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -64.77 -33.89 77.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.111 -176.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.636 ' HG2' ' HE ' ' A' ' 27' ' ' ARG . 24.8 tt0 -82.57 -45.99 13.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.929 0.395 . . . . 0.0 110.898 -177.316 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.49 -38.29 68.96 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.132 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 55.0 tp60 -60.9 -47.52 86.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.342 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.6 t -78.27 -22.66 47.95 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 121.056 -0.258 . . . . 0.0 111.166 -175.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.636 ' HE ' ' HG2' ' A' ' 23' ' ' GLU . 63.9 mtt180 -68.59 -21.19 64.53 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.662 0.268 . . . . 0.0 110.565 177.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.575 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 95.3 mt -125.93 6.96 7.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.154 -0.475 . . . . 0.0 112.276 -176.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -82.89 110.91 18.29 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 122.129 -0.357 . . . . 0.0 110.933 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.413 ' H ' ' HA ' ' A' ' 56' ' ' SER . . . 69.77 18.66 74.33 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.841 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.564 ' HG3' ' HA ' ' A' ' 28' ' ' LEU . 12.2 mm100 -83.34 -168.33 2.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.604 0.24 . . . . 0.0 110.607 -178.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.562 ' HB2' ' SD ' ' A' ' 35' ' ' MET . 46.3 mtm180 -58.31 141.98 49.4 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 173.057 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 63.6 m170 -88.33 122.22 31.6 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 120.847 0.356 . . . . 0.0 110.495 -177.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.75 -5.73 14.1 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.91 -175.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.67 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 34.1 mtp -80.3 146.81 31.43 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 122.451 0.3 . . . . 0.0 110.74 177.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -151.81 161.31 42.87 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 121.118 -0.233 . . . . 0.0 110.931 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.53 ' HG ' HD11 ' A' ' 28' ' ' LEU . 4.5 pp -154.75 140.99 18.57 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.057 0.456 . . . . 0.0 111.229 176.277 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 51.8 t -110.99 112.29 39.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.547 176.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.542 ' HD3' ' O ' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -113.99 -179.3 3.6 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 178.345 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.542 ' O ' ' HD3' ' A' ' 39' ' ' ARG . 4.1 m-20 -66.97 137.83 56.81 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 175.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.545 ' HA ' HG23 ' A' ' 49' ' ' VAL . 46.7 t -54.4 141.74 29.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.179 0.514 . . . . 0.0 111.281 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.2 m -85.53 -13.07 50.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.087 -176.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.4 p -125.1 -44.68 1.89 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -174.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.436 ' HA ' ' HD2' ' A' ' 45' ' ' PRO . 3.0 p -114.66 102.36 54.8 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-O 120.858 0.361 . . . . 0.0 111.559 -176.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 44' ' ' CYS . 10.8 Cg_endo -54.59 139.03 76.06 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.881 2.387 . . . . 0.0 111.908 177.179 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.1 -32.38 7.37 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.251 -177.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -87.42 175.18 8.1 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.856 0.36 . . . . 0.0 110.201 177.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.459 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 38.2 m-85 -131.39 174.28 10.23 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.861 178.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.545 HG23 ' HA ' ' A' ' 41' ' ' SER . 65.0 t -142.47 106.67 1.39 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-O 120.969 0.414 . . . . 0.0 110.952 177.18 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.6 tp -78.42 104.75 9.22 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.148 175.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.7 m -96.33 132.8 41.46 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 176.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.643 HG21 HD13 ' A' ' 93' ' ' LEU . 86.9 t -124.49 136.27 61.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.882 0.372 . . . . 0.0 111.158 -175.079 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.575 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 32.2 t -96.38 104.86 16.86 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.207 -172.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.795 ' O ' ' HB3' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -152.8 151.74 30.8 Favored 'General case' 0 C--O 1.204 -1.332 0 C-N-CA 120.287 -0.565 . . . . 0.0 109.704 169.245 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.579 ' HB2' ' HD3' ' A' ' 57' ' ' ARG . 54.9 m-80 56.76 22.76 7.23 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 178.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.413 ' HA ' ' H ' ' A' ' 30' ' ' GLY . 46.8 m 54.06 54.8 9.12 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 122.801 1.286 . . . . 0.0 107.964 -172.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.795 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 0.2 OUTLIER -161.96 65.94 0.25 Allowed 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 112.873 -1.967 . . . . 0.0 109.353 -151.168 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.616 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 18.6 t -72.54 97.11 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 121.865 0.841 . . . . 0.0 109.789 -170.223 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.7 m -68.32 121.12 15.61 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 113.88 -1.509 . . . . 0.0 110.96 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -100.15 107.12 18.91 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.811 0.339 . . . . 0.0 111.491 -176.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.741 ' HE1' HD11 ' A' ' 153' ' ' ILE . 72.8 m-85 -102.34 107.04 17.92 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.128 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.528 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 63.8 mt -80.4 129.37 37.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -174.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.503 HG23 ' HB3' ' A' ' 71' ' ' PHE . 5.0 mp -104.28 114.97 45.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.392 178.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -87.76 139.41 30.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.744 -173.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 31.3 t -81.86 95.05 7.2 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 169.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.566 HD11 ' HB2' ' A' ' 72' ' ' LYS . 91.9 mt -74.63 148.45 85.37 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.996 -176.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.67 -14.85 45.23 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.682 2.255 . . . . 0.0 110.617 171.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.35 -3.01 24.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.847 176.05 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.493 ' NE ' ' HA ' ' A' ' 69' ' ' ARG . 3.7 mmp_? 66.38 26.27 10.21 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.291 0.567 . . . . 0.0 110.049 -173.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 47.7 mtp180 -123.76 -179.64 4.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.599 -177.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.503 ' HB3' HG23 ' A' ' 63' ' ' ILE . 29.2 m-85 -127.87 115.9 19.31 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -173.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 77' ' ' GLU . 38.6 ttmt -102.09 116.47 32.76 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.188 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.619 HD11 ' HB3' ' A' ' 61' ' ' TYR . 11.7 tt -94.7 93.04 3.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.707 0.765 . . . . 0.0 110.773 -178.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.62 69.92 1.16 Allowed Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.438 -0.801 . . . . 0.0 113.075 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.524 ' HA ' ' HD3' ' A' ' 72' ' ' LYS . 31.4 t70 75.47 -38.76 0.37 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.139 0.576 . . . . 0.0 112.354 176.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -80.83 114.22 19.57 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.573 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 9.5 pt-20 -95.07 134.33 37.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.681 0.753 . . . . 0.0 112.177 -174.03 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -119.27 179.03 4.31 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.528 171.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.24 -32.4 22.61 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 -175.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -161.68 167.66 24.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.673 0.273 . . . . 0.0 111.074 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.613 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 14.5 mt -53.94 -56.47 25.3 Favored Pre-proline 0 N--CA 1.467 0.398 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.403 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.613 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 29.7 Cg_exo -65.94 2.17 1.89 Allowed 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.409 2.072 . . . . 0.0 113.204 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -98.7 -34.91 10.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.839 0.352 . . . . 0.0 110.567 176.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.2 pp -76.56 -33.9 58.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.134 0.492 . . . . 0.0 109.78 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.457 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 72.8 mt -67.89 -14.76 63.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.185 176.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -88.94 -40.2 13.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.247 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -71.77 -28.97 63.99 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.784 -178.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.435 ' CG ' HD21 ' A' ' 93' ' ' LEU . 20.7 m-85 -84.58 -2.5 57.49 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -177.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.482 ' HE2' ' CE1' ' A' ' 6' ' ' PHE . 98.8 mttt -73.3 -6.89 48.96 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.099 174.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.6 pt -132.91 -6.45 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.232 0 CA-C-O 120.938 0.399 . . . . 0.0 110.573 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -93.16 -34.19 13.72 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.516 -171.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 70.87 128.36 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.159 0 O-C-N 124.411 1.07 . . . . 0.0 109.956 -169.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.643 HD13 HG21 ' A' ' 52' ' ' VAL . 0.9 OUTLIER -103.75 -14.96 15.88 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.767 0.794 . . . . 0.0 109.783 173.084 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.863 ' HA ' ' HB3' ' A' ' 154' ' ' GLU . 1.5 m-20 -133.22 -100.01 0.27 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.613 -177.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.725 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 14.0 t -134.13 14.76 3.87 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 165.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.537 HG22 ' HG3' ' A' ' 54' ' ' GLU . 3.8 t -140.84 169.88 16.8 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 113.962 -1.472 . . . . 0.0 107.403 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.6 p -104.11 -179.38 3.93 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 176.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 74.2 mt -68.39 88.59 0.33 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 175.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 48.9 mm -78.25 -54.98 11.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.137 -173.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.67 ' O ' ' HA ' ' A' ' 35' ' ' MET . 39.7 tt0 -160.09 136.71 6.53 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.925 -177.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.469 ' HB3' ' HB3' ' A' ' 14' ' ' TRP . 18.2 Cg_endo -59.9 158.95 27.04 Favored 'Trans proline' 0 CA--C 1.531 0.325 0 C-N-CA 122.793 2.329 . . . . 0.0 112.743 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.567 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -75.17 145.4 80.35 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.844 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -55.66 130.93 43.08 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.634 2.223 . . . . 0.0 111.514 174.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.461 ' HG2' ' SD ' ' A' ' 16' ' ' MET . 78.3 mtp180 . . . . . 0 C--N 1.322 -0.598 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.248 -174.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.742 HD12 HG21 ' A' ' 152' ' ' ILE . 4.0 mm? . . . . . 0 N--CA 1.455 -0.194 0 CA-C-O 122.128 0.966 . . . . 0.0 112.686 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -169.6 -60.37 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 113.866 -1.516 . . . . 0.0 107.614 -176.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -123.0 133.48 54.36 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.95 176.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.541 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 23.7 t -133.18 160.86 42.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.757 ' HG2' ' O ' ' A' ' 180' ' ' LYS . 2.0 ptp180 -138.39 138.03 37.86 Favored 'General case' 0 CA--C 1.494 -1.2 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.924 171.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.869 HG22 HG12 ' A' ' 178' ' ' VAL . 30.4 p -92.75 140.44 29.52 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.566 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.5 mt -114.06 -5.08 13.11 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.82 -172.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.491 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 59.7 t80 -107.21 -42.68 4.79 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -171.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.716 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 16.1 t70 79.79 93.5 0.05 Allowed 'General case' 0 N--CA 1.474 0.73 0 O-C-N 123.778 0.673 . . . . 0.0 110.63 -173.25 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.585 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 68.4 t80 -124.07 88.06 52.89 Favored Pre-proline 0 N--CA 1.45 -0.436 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 172.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.573 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 95.4 Cg_endo -84.55 84.82 1.42 Allowed 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 121.488 1.459 . . . . 0.0 112.239 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.54 -25.0 75.26 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 173.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.677 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 19.8 m120 53.68 72.09 0.46 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.214 -0.993 . . . . 0.0 111.17 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -141.88 173.11 11.81 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.483 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -100.33 12.03 38.07 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -127.57 -36.64 2.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.048 -1.433 . . . . 0.0 109.261 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -113.77 128.04 56.26 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 173.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.985 HD11 ' HB2' ' A' ' 165' ' ' ASN . 32.4 tp -83.29 124.72 75.73 Favored Pre-proline 0 C--N 1.325 -0.489 0 C-N-CA 120.178 -0.609 . . . . 0.0 111.457 -176.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.677 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 57.4 Cg_endo -76.31 102.41 1.61 Allowed 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 121.71 1.607 . . . . 0.0 111.673 167.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.585 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 0.5 OUTLIER -92.03 -163.84 1.1 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.938 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.716 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 55.4 mttp -134.8 -176.02 4.09 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.114 175.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.804 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -77.61 39.61 0.28 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.481 0.657 . . . . 0.0 111.382 -174.641 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 130' ' ' THR . . . 136.05 49.16 0.07 OUTLIER Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 -176.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.676 ' OE2' ' HG ' ' A' ' 150' ' ' LEU . 1.2 pp20? -92.28 179.26 5.6 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.514 HD11 ' NH2' ' A' ' 129' ' ' ARG . 1.3 mp -118.48 124.48 73.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 175.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.742 ' CD2' ' HA ' ' A' ' 165' ' ' ASN . 72.5 mt -118.91 156.44 29.52 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.405 0.621 . . . . 0.0 109.691 -172.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.568 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 52.4 t -118.49 122.95 70.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 173.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.949 HD13 ' HB2' ' A' ' 163' ' ' ALA . 46.5 mm -77.54 79.61 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.468 0 CA-C-O 122.519 1.152 . . . . 0.0 108.964 -175.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.741 HD11 ' HE1' ' A' ' 61' ' ' TYR . 21.0 tt -65.87 -27.31 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 CA-C-N 113.107 -1.86 . . . . 0.0 109.852 -176.276 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.863 ' HB3' ' HA ' ' A' ' 94' ' ' ASP . 0.2 OUTLIER -145.83 146.45 31.15 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 121.143 0.497 . . . . 0.0 110.957 171.248 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.57 ' HD2' ' HG ' ' A' ' 125' ' ' LEU . 86.3 tttt -126.14 87.69 55.68 Favored Pre-proline 0 C--N 1.319 -0.758 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 168.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.725 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 5.4 Cg_exo -81.58 -51.55 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.993 2.462 . . . . 0.0 111.721 175.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.683 ' HG2' ' CE ' ' A' ' 172' ' ' MET . 6.1 mm-40 -97.39 160.75 14.14 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.094 0.474 . . . . 0.0 111.049 -175.141 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -85.25 -33.14 22.25 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.914 175.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -92.82 -17.15 24.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.399 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.427 ' HB2' ' HB2' ' A' ' 157' ' ' GLU . 62.7 m95 -127.41 124.17 37.86 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.116 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' TRP . . . . . 0.562 ' O ' HG13 ' A' ' 173' ' ' ILE . 45.9 m0 -110.67 136.27 50.02 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.707 ' OG ' ' HG2' ' A' ' 172' ' ' MET . 38.0 m -97.35 109.09 21.92 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -173.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.949 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -122.85 152.1 41.07 Favored 'General case' 0 N--CA 1.426 -1.657 0 C-N-CA 119.888 -0.725 . . . . 0.0 110.405 -174.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.831 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 9.8 ptt180 -87.69 126.88 35.23 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 171.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.985 ' HB2' HD11 ' A' ' 142' ' ' LEU . 64.2 t30 -60.31 178.09 0.22 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.306 -1.315 . . . . 0.0 111.406 -172.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 19.5 tttp -58.15 -11.99 3.1 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.866 167.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -89.84 -27.65 19.79 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.393 174.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 105.07 -0.81 41.04 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.729 -175.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.831 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 3.3 ttm-85 -76.11 140.02 41.61 Favored 'General case' 0 C--O 1.217 -0.61 0 C-N-CA 123.324 0.65 . . . . 0.0 112.008 -177.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.529 HG22 HD13 ' A' ' 153' ' ' ILE . 48.1 t -87.21 123.52 40.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 111.353 0.131 . . . . 0.0 111.353 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -158.12 151.9 23.05 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.258 172.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.707 ' HG2' ' OG ' ' A' ' 162' ' ' SER . 36.8 mtp -81.37 142.73 32.75 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.885 0.342 . . . . 0.0 110.583 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 1.001 HD13 HG11 ' A' ' 178' ' ' VAL . 2.8 pp -143.24 150.63 52.72 Favored Pre-proline 0 C--O 1.222 -0.349 0 O-C-N 123.442 0.464 . . . . 0.0 111.119 -178.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.503 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 6.7 Cg_exo -72.82 132.1 18.05 Favored 'Trans proline' 0 CA--C 1.529 0.241 0 C-N-CA 122.387 2.058 . . . . 0.0 112.615 -176.151 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.555 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 18.3 t -57.9 -43.1 98.31 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 32.8 Cg_endo -64.84 -2.36 5.33 Favored 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 122.049 1.833 . . . . 0.0 113.116 176.059 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.503 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 4.5 m-85 -98.2 -18.45 18.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.71 177.135 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 1.001 HG11 HD13 ' A' ' 173' ' ' ILE . 2.2 m -130.68 -172.32 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.102 -168.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.879 ' HG3' ' H ' ' A' ' 180' ' ' LYS . 8.7 pt-20 -156.34 -65.67 0.11 Allowed 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 117.404 2.372 . . . . 0.0 117.404 152.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.879 ' H ' ' HG3' ' A' ' 179' ' ' GLU . 4.2 mptt -157.59 -177.54 6.66 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.153 0.888 . . . . 0.0 109.891 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.42 ' HG ' ' NH2' ' A' ' 129' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.319 -0.719 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 153.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 N--CA 1.459 -0.558 0 N-CA-C 111.02 -0.415 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.499 ' CG1' HD12 ' A' ' 293' ' ' ILE . 66.8 t -77.06 123.83 34.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.92 0.391 . . . . 0.0 110.562 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -99.04 115.25 28.55 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.999 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.662 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -119.37 121.16 38.9 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.091 178.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.538 ' HB2' ' CE1' ' A' ' 294' ' ' PHE . 48.2 tttp -86.68 118.85 26.36 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -178.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -72.8 102.59 3.42 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.411 HG12 ' O ' ' A' ' 290' ' ' HIS . 9.6 pt -89.47 4.6 5.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.955 0.407 . . . . 0.0 111.142 -176.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -149.89 149.11 29.96 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 173.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 10.3 ptpp? -75.59 175.88 8.15 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.02 0.438 . . . . 0.0 111.169 -176.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.471 ' CB ' HG21 ' A' ' 289' ' ' THR . 21.4 tpt180 -157.08 127.41 6.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.979 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 28.0 m -121.37 143.57 37.91 Favored Pre-proline 0 C--N 1.32 -0.706 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 171.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.432 ' HD3' ' HB2' ' A' ' 257' ' ' ALA . 38.0 Cg_endo -66.58 104.51 0.79 Allowed 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.179 1.919 . . . . 0.0 111.694 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 249' ' ' CYS . . . . . 0.433 ' H ' ' HB2' ' A' ' 252' ' ' ASP . 1.7 t -72.61 169.7 16.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.862 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.74 -32.43 69.23 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.806 0.336 . . . . 0.0 111.609 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -95.08 -15.42 23.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.948 0.404 . . . . 0.0 110.886 177.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 252' ' ' ASP . . . . . 0.464 ' HB3' ' HB2' ' A' ' 255' ' ' ALA . 60.3 m-20 -100.69 67.93 1.3 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.061 0.458 . . . . 0.0 110.071 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 253' ' ' LYS . . . . . 0.694 ' H ' ' HD2' ' A' ' 253' ' ' LYS . 0.0 OUTLIER -75.24 -33.99 61.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.291 -174.95 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.66 -1.04 57.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.554 -178.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 255' ' ' ALA . . . . . 0.464 ' HB2' ' HB3' ' A' ' 252' ' ' ASP . . . -70.12 126.06 28.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.165 0.507 . . . . 0.0 111.81 -175.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.3 tt -71.77 134.16 46.02 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.315 176.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.432 ' HB2' ' HD3' ' A' ' 248' ' ' PRO . . . -84.92 128.95 34.85 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 89.4 mt -135.43 165.53 25.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.59 -172.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -129.49 -177.25 4.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.08 177.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 39.8 t -80.83 129.88 36.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.865 -178.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 80.37 11.81 83.8 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.654 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -87.14 140.28 29.71 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -176.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 38.5 mm -88.11 110.28 20.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.992 0.425 . . . . 0.0 110.561 -178.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 20.9 t -88.1 102.99 13.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.287 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 5.6 tppp? -79.44 95.1 5.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.232 177.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.483 HG13 ' HB ' ' A' ' 238' ' ' VAL . 4.5 p -99.88 117.42 45.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.384 0.612 . . . . 0.0 110.4 177.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 267' ' ' THR . . . . . 0.524 ' OG1' ' HD2' ' A' ' 268' ' ' ARG . 20.2 p -104.19 -18.9 14.32 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.155 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 268' ' ' ARG . . . . . 0.524 ' HD2' ' OG1' ' A' ' 267' ' ' THR . 0.1 OUTLIER -130.48 91.79 3.15 Favored 'General case' 0 C--O 1.224 -0.281 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 176.847 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 6.5 ptp -98.56 130.51 45.12 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 119.531 -0.868 . . . . 0.0 111.028 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -103.28 150.1 24.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.153 -174.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.421 ' H ' HG13 ' A' ' 271' ' ' ILE . 1.8 pp -71.87 -5.8 6.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.419 0.628 . . . . 0.0 110.941 175.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -70.75 -21.03 62.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.087 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 110.93 -47.67 1.02 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.683 -178.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.493 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 59.1 mt-30 -80.18 121.13 25.2 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 174.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 34.2 m0 -103.36 149.98 24.24 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.454 ' HB3' ' HB2' ' A' ' 268' ' ' ARG . 34.3 tt0 -99.53 116.81 32.51 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.074 0.464 . . . . 0.0 109.929 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -139.94 164.44 26.12 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.934 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.529 ' HG2' ' HB2' ' A' ' 283' ' ' LYS . 37.2 mt-10 -123.42 109.85 14.38 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 25.6 t -123.62 -81.06 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 120.354 -0.539 . . . . 0.0 111.793 -175.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -91.96 77.2 5.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.793 0.33 . . . . 0.0 111.284 -173.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 50.5 34.73 27.75 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.372 -0.831 . . . . 0.0 113.335 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 282' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 282' ' ' ARG . 34.0 ttt-85 -170.71 138.75 1.45 Allowed 'General case' 0 C--O 1.237 0.423 0 CA-C-O 120.895 0.379 . . . . 0.0 111.0 -173.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.529 ' HB2' ' HG2' ' A' ' 278' ' ' GLU . 38.2 ttpt -99.72 137.85 37.63 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.087 173.175 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -158.13 169.98 34.85 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.167 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.493 ' HB3' ' HB3' ' A' ' 274' ' ' GLN . 62.8 mt -97.59 113.3 25.0 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 176.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.736 ' HD2' ' H ' ' A' ' 289' ' ' THR . 49.4 p90 -113.72 125.31 29.68 Favored Pre-proline 0 C--N 1.315 -0.931 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.468 -177.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 287' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 35.0 Cg_exo -64.06 70.93 0.19 Allowed 'Trans proline' 0 N--CA 1.479 0.665 0 C-N-CA 123.709 2.939 . . . . 0.0 112.689 176.25 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.539 ' O ' ' N ' ' A' ' 290' ' ' HIS . 34.5 p90 37.96 40.55 0.3 Allowed 'General case' 0 CA--C 1.49 -1.355 0 O-C-N 124.447 1.092 . . . . 0.0 108.689 -171.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 289' ' ' THR . . . . . 0.736 ' H ' ' HD2' ' A' ' 286' ' ' PHE . 41.9 m -40.81 73.41 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.043 0 O-C-N 126.499 2.374 . . . . 0.0 112.995 -156.175 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 290' ' ' HIS . . . . . 0.539 ' N ' ' O ' ' A' ' 288' ' ' PHE . 16.4 m80 63.87 25.21 13.95 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 112.192 -2.276 . . . . 0.0 109.363 169.236 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.576 ' HB ' ' HB1' ' A' ' 240' ' ' ALA . 33.5 m -88.58 169.71 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 121.41 0.624 . . . . 0.0 111.621 -173.613 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -129.69 114.36 15.91 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.115 178.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.662 HD13 ' HB2' ' A' ' 240' ' ' ALA . 50.2 mm -72.0 124.55 28.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.331 -178.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 294' ' ' PHE . . . . . 0.538 ' CE1' ' HB2' ' A' ' 241' ' ' LYS . 1.8 p90 -154.27 -176.01 5.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.984 -178.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -130.37 116.96 17.64 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 172.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo . . . . . 0 C--O 1.232 0.183 0 C-N-CA 122.789 2.326 . . . . 0.0 112.508 -177.549 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.57 ' O ' HG23 ' A' ' 99' ' ' ILE . 16.1 m . . . . . 0 N--CA 1.451 -0.384 0 CA-C-O 121.128 0.489 . . . . 0.0 109.714 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.515 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . -78.79 105.81 10.36 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.996 176.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 32.6 ttm180 -138.84 97.12 3.25 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.331 0.586 . . . . 0.0 111.113 -176.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -168.45 163.04 12.57 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.726 178.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.503 ' HB2' ' HB2' ' A' ' 10' ' ' ASP . 22.8 m-20 -89.19 117.08 27.91 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 174.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.8 m -66.57 -13.53 61.15 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.092 -0.503 . . . . 0.0 112.086 -172.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.7 t -115.54 -0.16 13.14 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.26 0.552 . . . . 0.0 111.107 -176.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.503 ' HB2' ' HB2' ' A' ' 7' ' ' ASP . 8.1 t0 -79.47 91.68 5.16 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 121.916 -0.49 . . . . 0.0 110.232 -177.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.516 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 5.0 mtm-85 -69.44 -14.25 62.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.513 -178.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.7 t -84.9 0.04 52.48 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 175.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -109.95 -48.79 3.15 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.434 ' HB3' ' HB3' ' A' ' 101' ' ' PRO . 40.2 p-90 -108.86 -20.45 13.05 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -173.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.516 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 19.3 t80 -73.38 108.89 6.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.094 0.473 . . . . 0.0 109.808 -177.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.726 ' HG3' HG21 ' A' ' 19' ' ' VAL . 12.0 tpp -89.01 -8.45 54.02 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.901 -171.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.494 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 50.23 -114.97 2.83 Favored Glycine 0 CA--C 1.522 0.475 0 CA-C-N 115.269 -0.878 . . . . 0.0 114.438 177.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.494 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 8.5 Cg_exo -72.52 82.14 1.45 Allowed 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 123.202 2.601 . . . . 0.0 113.158 -173.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.726 HG21 ' HG3' ' A' ' 16' ' ' MET . 44.0 t -142.02 166.4 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.456 ' N ' HG12 ' A' ' 19' ' ' VAL . 15.6 m -137.79 172.12 13.42 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -170.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 54.8 mtp85 -54.53 -53.79 49.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 118.154 0.434 . . . . 0.0 111.925 -177.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -57.89 -63.13 1.36 Allowed 'General case' 0 C--N 1.327 -0.374 0 O-C-N 123.477 0.486 . . . . 0.0 111.087 -177.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.453 ' O ' ' HB ' ' A' ' 26' ' ' THR . 36.6 tt0 -57.95 -45.45 86.62 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.67 -176.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.479 ' HB2' HG12 ' A' ' 19' ' ' VAL . . . -57.09 -50.8 71.65 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 120.933 0.397 . . . . 0.0 111.375 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.66 ' HG3' ' HB ' ' A' ' 58' ' ' VAL . 18.5 tt0 -64.4 -32.91 74.72 Favored 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.111 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.453 ' HB ' ' O ' ' A' ' 23' ' ' GLU . 7.8 m -59.81 -41.93 92.34 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.607 174.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.492 ' O ' ' HG3' ' A' ' 31' ' ' GLN . 95.4 mtt180 -68.8 -14.44 63.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.893 0.377 . . . . 0.0 110.896 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.596 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 72.3 mt -120.62 -12.6 8.87 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -174.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.2 tp60 -70.03 105.77 2.99 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.833 0.349 . . . . 0.0 111.024 -174.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.405 ' H ' ' HA ' ' A' ' 56' ' ' SER . . . 72.64 5.35 63.77 Favored Glycine 0 C--O 1.226 -0.398 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.241 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.492 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 81.9 mm-40 -80.67 -162.16 0.45 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.845 0.355 . . . . 0.0 111.194 -176.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.445 ' HB2' ' HG3' ' A' ' 35' ' ' MET . 34.7 mtm180 -59.31 119.29 7.15 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.984 0.421 . . . . 0.0 110.098 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 27.4 m170 -76.6 125.93 30.1 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.952 -177.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.42 -6.25 22.96 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 -175.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.571 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 51.3 mtm -82.93 146.64 28.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.762 0.315 . . . . 0.0 110.216 177.006 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -145.94 163.6 34.64 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 176.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.45 ' O ' HD12 ' A' ' 37' ' ' LEU . 4.4 pp -152.61 137.21 16.87 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.058 0.456 . . . . 0.0 111.067 177.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.9 t -107.1 105.38 18.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 173.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.445 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 25.8 ptt-85 -104.13 166.69 10.24 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.731 -175.21 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -76.79 124.23 27.38 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 174.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.516 ' HB2' HG23 ' A' ' 49' ' ' VAL . 25.6 t -99.39 166.19 11.3 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.24 0.543 . . . . 0.0 111.225 -173.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.8 m -118.28 18.16 13.76 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.999 -175.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.2 m -75.02 -43.91 51.02 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 177.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 49.5 t -168.09 112.93 0.59 Allowed Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.696 177.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -34.67 102.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 124.155 3.237 . . . . 0.0 113.433 -175.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 134.1 -25.43 3.5 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.638 -175.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -83.17 151.59 25.63 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 177.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -128.43 174.08 9.65 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -178.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.516 HG23 ' HB2' ' A' ' 41' ' ' SER . 58.5 t -137.74 112.81 9.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.425 0.631 . . . . 0.0 111.541 176.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.495 HD23 HD11 ' A' ' 73' ' ' ILE . 51.5 tp -81.01 98.34 7.91 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.225 -1.352 . . . . 0.0 109.698 174.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.3 m -96.0 128.93 43.33 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 175.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.614 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 94.6 t -122.06 142.4 38.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.117 -174.163 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.596 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 45.0 t -105.89 114.91 29.35 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -175.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.53 155.65 33.77 Favored 'General case' 0 C--O 1.207 -1.18 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 160.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 59.13 20.42 8.38 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 174.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.405 ' HA ' ' H ' ' A' ' 30' ' ' GLY . 22.3 m 56.43 54.34 7.67 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 122.797 1.284 . . . . 0.0 108.082 -172.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.429 HH22 ' C ' ' A' ' 153' ' ' ILE . 0.2 OUTLIER -162.33 64.03 0.22 Allowed 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 112.751 -2.022 . . . . 0.0 109.493 -151.166 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.66 ' HB ' ' HG3' ' A' ' 25' ' ' GLN . 26.1 t -74.65 99.94 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 122.032 0.92 . . . . 0.0 111.03 -168.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.3 m -67.84 120.9 14.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 113.985 -1.461 . . . . 0.0 111.255 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -96.68 109.32 21.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.882 0.372 . . . . 0.0 111.513 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.461 ' HB2' ' HB3' ' A' ' 50' ' ' LEU . 89.4 m-85 -106.0 117.59 34.43 Favored 'General case' 0 C--O 1.216 -0.709 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.537 177.211 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.709 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 53.4 mt -80.36 145.99 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 O-C-N 121.872 -0.517 . . . . 0.0 111.076 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.683 HG13 HG12 ' A' ' 73' ' ' ILE . 4.8 mp -129.53 104.11 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.122 0.487 . . . . 0.0 110.455 177.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.554 ' HB2' ' HB3' ' A' ' 72' ' ' LYS . 31.0 m-80 -90.56 142.75 27.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.485 -172.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 31.6 t -81.82 97.17 7.87 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 172.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.0 mt -73.99 143.44 80.85 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.543 -177.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.5 -23.29 70.16 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 123.078 2.518 . . . . 0.0 112.555 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 36.8 p30 -83.64 12.34 5.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.8 177.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 69' ' ' ARG . 5.2 tpp85 69.79 25.82 4.97 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.465 0.65 . . . . 0.0 111.317 175.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.695 ' HG2' ' HA ' ' A' ' 79' ' ' ASP . 68.1 mtt180 -113.71 -174.81 2.54 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.815 174.363 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.52 ' HB3' HG23 ' A' ' 63' ' ' ILE . 39.1 m-85 -131.09 131.78 44.41 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.019 0.438 . . . . 0.0 111.471 -177.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.554 ' HB3' ' HB2' ' A' ' 64' ' ' ASN . 14.6 tppt? -97.58 100.92 12.33 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.679 177.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.758 HG13 HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -99.1 86.4 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 122.92 1.343 . . . . 0.0 109.017 -177.262 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.16 -110.76 3.74 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.502 -174.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 168' ' ' GLY . 26.4 t0 -108.24 -18.99 13.63 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.575 0.702 . . . . 0.0 109.536 176.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -90.74 136.35 33.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.747 -176.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.467 ' HB3' ' HE2' ' A' ' 72' ' ' LYS . 0.9 OUTLIER -110.41 128.13 55.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.364 0.602 . . . . 0.0 111.025 175.306 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.42 ' O ' ' HB3' ' A' ' 70' ' ' ARG . 8.8 m-85 -122.88 172.24 8.62 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 176.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.695 ' HA ' ' HG2' ' A' ' 70' ' ' ARG . 5.7 m-20 -75.09 -34.84 61.81 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -172.138 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.499 ' ND1' ' HG2' ' A' ' 82' ' ' PRO . 3.3 p80 -156.58 166.66 32.76 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 121.33 -0.148 . . . . 0.0 110.819 -178.184 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.603 HD23 HD21 ' A' ' 84' ' ' LEU . 18.0 mt -54.94 -54.68 47.17 Favored Pre-proline 0 N--CA 1.469 0.487 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -177.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.499 ' HG2' ' ND1' ' A' ' 80' ' ' HIS . 18.0 Cg_endo -61.67 -10.51 17.01 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.172 1.914 . . . . 0.0 113.418 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.402 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -90.62 -36.79 14.2 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.873 0.368 . . . . 0.0 110.554 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.758 HD13 HG13 ' A' ' 73' ' ' ILE . 3.2 pp -76.92 -35.78 57.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.92 0.39 . . . . 0.0 110.022 -178.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.493 ' O ' ' HG2' ' A' ' 89' ' ' LYS . 89.1 mt -64.91 -24.1 67.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.999 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.515 ' HA ' ' CG ' ' A' ' 89' ' ' LYS . 26.9 tt0 -83.09 -22.34 33.45 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.79 -176.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -72.2 -35.67 69.0 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.731 0.777 . . . . 0.0 109.547 175.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.723 ' CG ' HD23 ' A' ' 93' ' ' LEU . 74.5 m-85 -86.63 1.43 51.87 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.43 -176.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.515 ' CG ' ' HA ' ' A' ' 86' ' ' GLU . 9.6 mmmm -71.75 -23.39 61.59 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 171.418 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 30.6 pt -121.2 7.96 6.07 Favored 'Isoleucine or valine' 0 C--N 1.339 0.151 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.112 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.412 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 5.8 t-160 -98.28 -40.37 8.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.08 -176.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.596 ' CD2' HG23 ' A' ' 97' ' ' THR . 60.7 m-85 64.75 77.64 0.31 Allowed 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -170.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.723 HD23 ' CG ' ' A' ' 88' ' ' TYR . 1.4 pp -79.29 18.15 0.72 Allowed 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -172.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.521 ' O ' HG22 ' A' ' 95' ' ' THR . 27.3 t70 -175.22 65.19 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.258 162.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.69 ' CB ' ' HA ' ' A' ' 156' ' ' PRO . 0.6 OUTLIER 62.16 -28.5 0.07 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.048 1.339 . . . . 0.0 112.528 -174.013 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.476 ' H ' ' C ' ' A' ' 94' ' ' ASP . 2.0 t -109.3 157.4 18.89 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 172.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.596 HG23 ' CD2' ' A' ' 92' ' ' TYR . 7.4 p -90.33 -179.99 5.75 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 177.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 89.4 mt -73.16 91.49 1.65 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 171.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.57 HG23 ' O ' ' A' ' 3' ' ' SER . 37.4 mm -74.84 -61.87 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.856 -174.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.571 ' O ' ' HA ' ' A' ' 35' ' ' MET . 10.4 pt-20 -157.19 157.46 30.46 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.183 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.46 ' HD2' ' HB2' ' A' ' 100' ' ' GLU . 55.9 Cg_endo -69.58 152.83 70.31 Favored 'Trans proline' 0 C--O 1.237 0.458 0 C-N-CA 122.502 2.135 . . . . 0.0 112.91 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -77.29 156.78 81.34 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.526 177.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.523 ' HD3' ' SD ' ' A' ' 35' ' ' MET . 23.6 Cg_exo -64.21 132.16 32.98 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.342 2.028 . . . . 0.0 112.186 177.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.433 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 34.2 ptt180 . . . . . 0 C--N 1.326 -0.451 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.855 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.688 ' HG ' ' HD2' ' A' ' 155' ' ' LYS . 3.3 mm? . . . . . 0 CA--C 1.517 -0.297 0 CA-C-O 121.703 0.763 . . . . 0.0 111.66 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -174.5 -38.79 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.566 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.483 ' HB3' ' HB3' ' A' ' 181' ' ' LEU . 79.9 m-85 -127.64 116.02 19.65 Favored 'General case' 0 CA--C 1.504 -0.804 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.487 176.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.662 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 2.1 t -115.47 153.72 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.748 -177.1 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.775 ' NH2' HD13 ' A' ' 181' ' ' LEU . 1.7 ptp180 -137.59 124.59 21.43 Favored 'General case' 0 CA--C 1.496 -1.11 0 C-N-CA 117.281 -1.767 . . . . 0.0 112.891 173.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.69 HG22 HG12 ' A' ' 178' ' ' VAL . 81.7 p -79.49 131.88 36.18 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 114.268 -1.333 . . . . 0.0 111.13 -177.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.477 HD21 ' HG3' ' A' ' 129' ' ' ARG . 2.5 mt -116.59 8.5 13.91 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.624 -175.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -122.82 -36.07 2.94 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -171.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.499 ' HB2' ' HB3' ' A' ' 146' ' ' LYS . 11.0 t70 78.52 110.7 0.07 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.23 0.612 . . . . 0.0 110.873 -178.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.619 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 79.2 t80 -144.55 91.66 6.17 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 177.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.643 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 72.8 Cg_endo -79.53 85.98 1.75 Allowed 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 121.846 1.697 . . . . 0.0 112.404 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.38 -35.38 60.0 Favored Glycine 0 C--N 1.333 0.384 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.445 179.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.804 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 4.5 m-20 68.27 37.66 2.75 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 122.652 0.381 . . . . 0.0 111.548 178.05 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -137.71 170.41 16.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.662 0.267 . . . . 0.0 110.554 -177.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -89.86 -6.19 56.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.74 0.781 . . . . 0.0 109.108 174.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -103.14 -34.14 8.96 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.57 177.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -120.08 109.55 15.6 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.385 176.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 1.057 HD11 ' HB2' ' A' ' 165' ' ' ASN . 36.5 tp -68.15 132.11 91.92 Favored Pre-proline 0 CA--C 1.515 -0.378 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.394 -177.172 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.804 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 7.6 Cg_endo -83.05 104.1 1.22 Allowed 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 121.785 1.657 . . . . 0.0 110.108 169.163 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.677 ' CG ' HG21 ' A' ' 130' ' ' THR . 9.4 p90 -121.39 163.6 18.44 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.254 -176.261 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.533 ' HB2' ' HB3' ' A' ' 148' ' ' GLU . 12.8 mptt -96.51 -169.82 1.97 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.376 0.607 . . . . 0.0 112.494 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.902 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -89.29 5.49 44.69 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.238 -176.456 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -168.7 37.35 0.21 Allowed Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 176.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.583 ' OE1' ' HA ' ' A' ' 144' ' ' PHE . 0.4 OUTLIER -92.95 157.69 16.21 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 120.87 0.367 . . . . 0.0 110.272 -177.713 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -98.38 131.89 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-O 121.774 0.797 . . . . 0.0 109.727 178.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.616 HD22 HD21 ' A' ' 142' ' ' LEU . 14.9 mt -120.31 156.27 31.62 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.086 -1.415 . . . . 0.0 107.646 -174.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.561 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 60.8 t -124.16 122.93 65.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 176.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.935 HD13 ' HB2' ' A' ' 163' ' ' ALA . 26.1 mm -76.16 102.99 3.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.578 0.704 . . . . 0.0 109.458 -174.031 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.527 HG21 HG22 ' A' ' 170' ' ' VAL . 20.3 tt -97.91 -30.0 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-N 114.801 -1.091 . . . . 0.0 109.802 -173.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.621 ' OE2' ' HA ' ' A' ' 93' ' ' LEU . 1.8 mt-10 -131.77 140.84 49.33 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 165.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.688 ' HD2' ' HG ' ' A' ' 125' ' ' LEU . 39.9 tttp -123.02 89.55 50.68 Favored Pre-proline 0 C--N 1.321 -0.657 0 O-C-N 121.231 -0.918 . . . . 0.0 109.868 167.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.69 ' HA ' ' CB ' ' A' ' 95' ' ' THR . 3.0 Cg_exo -77.81 -51.54 0.08 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.592 2.195 . . . . 0.0 112.023 175.433 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.57 ' HG2' ' CE ' ' A' ' 172' ' ' MET . 22.5 mm-40 -102.67 179.44 4.29 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -171.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.415 ' HA ' ' HE1' ' A' ' 161' ' ' TRP . 11.5 pt-20 -107.13 -20.03 13.43 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.56 176.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -109.41 -8.69 15.01 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.803 0.335 . . . . 0.0 110.871 177.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.54 ' O ' ' HB2' ' A' ' 157' ' ' GLU . 83.4 m95 -132.03 131.39 42.44 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 169.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' TRP . . . . . 0.49 ' CE3' HD11 ' A' ' 125' ' ' LEU . 48.1 m0 -122.88 143.47 49.85 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.37 177.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.609 ' HA ' ' HA ' ' A' ' 172' ' ' MET . 21.6 m -89.14 99.67 12.61 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -176.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.935 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -110.09 151.6 27.02 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.027 -175.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.828 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 12.8 ptt180 -87.97 121.18 30.08 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-O 122.109 0.957 . . . . 0.0 108.944 172.067 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 1.057 ' HB2' HD11 ' A' ' 142' ' ' LEU . 11.7 t30 -45.21 167.3 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 112.131 -2.304 . . . . 0.0 112.006 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.419 ' HA ' ' HD2' ' A' ' 166' ' ' LYS . 15.5 tptm -58.32 -14.29 7.1 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.015 173.059 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.518 ' HB2' ' ND2' ' A' ' 165' ' ' ASN . 21.7 m-20 -95.62 -9.19 32.81 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.001 0.429 . . . . 0.0 109.987 174.18 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 75' ' ' ASP . . . 90.2 39.06 6.15 Favored Glycine 0 CA--C 1.522 0.489 0 CA-C-N 115.85 -0.614 . . . . 0.0 113.406 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.828 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 7.8 ttm-85 -111.76 138.71 47.98 Favored 'General case' 0 C--O 1.214 -0.777 0 CA-C-N 116.933 0.367 . . . . 0.0 111.472 -177.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.527 HG22 HG21 ' A' ' 153' ' ' ILE . 21.9 t -78.96 125.61 38.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 C-N-CA 120.839 -0.345 . . . . 0.0 111.552 -179.172 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -164.02 149.72 17.24 Favored Glycine 0 C--N 1.332 0.321 0 N-CA-C 111.59 -0.604 . . . . 0.0 111.59 168.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.609 ' HA ' ' HA ' ' A' ' 162' ' ' SER . 59.5 mtp -77.0 143.32 39.48 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 117.565 0.682 . . . . 0.0 110.751 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.695 HD12 ' O ' ' A' ' 173' ' ' ILE . 1.6 pp -134.88 151.84 76.33 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.444 -177.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.733 ' O ' HG13 ' A' ' 178' ' ' VAL . 1.0 OUTLIER -85.24 123.79 2.72 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.821 2.347 . . . . 0.0 113.241 -174.819 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.574 ' HA ' HG22 ' A' ' 178' ' ' VAL . 94.8 t -53.73 -45.42 98.77 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 178.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.496 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 65.2 Cg_exo -54.91 -23.93 36.69 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 122.112 1.875 . . . . 0.0 112.817 174.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.554 ' CD2' ' HG2' ' A' ' 174' ' ' PRO . 3.4 m-30 -84.82 -39.58 18.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.018 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.733 HG13 ' O ' ' A' ' 174' ' ' PRO . 1.1 m -111.65 -177.77 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.637 -164.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.897 ' HG3' ' H ' ' A' ' 180' ' ' LYS . 11.2 pt-20 -158.13 -71.03 0.09 Allowed 'General case' 0 C--O 1.207 -1.142 0 N-CA-C 118.011 2.597 . . . . 0.0 118.011 144.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.897 ' H ' ' HG3' ' A' ' 179' ' ' GLU . 3.6 mppt? -156.25 179.64 9.05 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 118.855 -2.403 . . . . 0.0 114.593 -169.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.775 HD13 ' NH2' ' A' ' 129' ' ' ARG . 12.0 tp . . . . . 0 C--N 1.327 -0.408 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.929 164.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo . . . . . 0 N--CA 1.459 -0.507 0 N-CA-C 110.87 -0.473 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.453 HG11 HD12 ' A' ' 293' ' ' ILE . 3.5 t -89.82 141.59 14.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.846 -173.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.447 ' HB2' ' HG3' ' A' ' 296' ' ' PRO . 94.0 m-85 -113.26 122.98 49.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.28 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.464 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -119.72 144.26 47.33 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.421 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -90.87 119.83 31.39 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -66.95 102.46 0.98 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.928 0.394 . . . . 0.0 110.024 177.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 24.8 pt -83.31 -35.29 11.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.421 -174.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 10.3 tm0? -132.89 130.89 40.29 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -54.36 140.38 33.75 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.883 -171.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.578 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 27.5 tpt180 -124.03 107.12 10.96 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.896 -178.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 16.5 m -115.87 126.67 27.46 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-O 120.954 0.407 . . . . 0.0 110.477 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.464 ' HB3' ' HB3' ' A' ' 255' ' ' ALA . 39.5 Cg_endo -67.68 127.66 16.68 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.629 2.219 . . . . 0.0 112.596 -178.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 39.2 t -78.58 171.94 14.41 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -53.1 -37.78 62.02 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.734 0.302 . . . . 0.0 111.72 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -97.71 14.25 27.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.898 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -90.89 -75.19 0.47 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 173.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 66.0 mttm 69.87 -58.41 0.53 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.944 178.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 11.2 p -73.32 -13.54 61.13 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.368 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 255' ' ' ALA . . . . . 0.464 ' HB3' ' HB3' ' A' ' 248' ' ' PRO . . . -71.86 123.99 23.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.047 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.2 tt -73.5 133.94 43.75 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.636 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.578 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -81.62 104.93 12.37 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.093 0.473 . . . . 0.0 109.934 176.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 96.0 mt -109.0 134.94 50.98 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.481 -177.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -99.41 155.14 17.7 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.216 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 62.2 t -66.94 122.04 17.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.006 0.431 . . . . 0.0 111.083 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 95.21 11.42 56.15 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.675 -0.693 . . . . 0.0 113.202 175.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -95.14 166.93 11.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.985 0.392 . . . . 0.0 109.971 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 34.3 mm -102.55 118.24 49.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.114 0.483 . . . . 0.0 110.728 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 19.3 t -93.48 104.9 16.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.165 0.507 . . . . 0.0 110.284 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -85.7 87.7 7.44 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.814 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.43 HG21 ' HB3' ' A' ' 275' ' ' TRP . 6.2 p -91.73 126.02 44.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.489 0.661 . . . . 0.0 111.607 -175.434 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 44.7 p -104.69 -39.23 6.42 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.725 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 -105.6 117.44 34.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.124 -177.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 41.5 mtt -114.4 134.86 54.68 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.798 174.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -97.45 160.06 14.55 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.714 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 10.5 tp -75.21 -11.98 14.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.502 0.667 . . . . 0.0 109.972 176.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -75.2 -65.49 0.88 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.938 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 156.47 -23.55 0.5 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.383 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.439 ' HB3' HD22 ' A' ' 285' ' ' LEU . 98.3 mt-30 -87.06 119.75 27.61 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 176.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.48 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 31.4 m0 -101.43 156.23 17.59 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.789 -176.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.495 ' HA ' ' O ' ' A' ' 284' ' ' GLY . 47.9 mt-10 -112.28 114.57 27.41 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.061 175.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 277' ' ' GLY . . . . . 0.704 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -120.71 155.01 16.32 Favored Glycine 0 C--O 1.225 -0.434 0 C-N-CA 120.894 -0.669 . . . . 0.0 111.595 177.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.786 ' HG2' ' HB3' ' A' ' 283' ' ' LYS . 38.0 mt-10 -100.7 109.9 21.97 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.092 0.473 . . . . 0.0 110.849 179.203 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 48.7 t -118.95 130.82 73.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 176.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 44.54 34.77 1.18 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.958 0.903 . . . . 0.0 112.482 -174.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 94.49 -9.1 71.77 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.483 175.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -108.35 124.72 50.79 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 117.014 0.407 . . . . 0.0 111.259 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.786 ' HB3' ' HG2' ' A' ' 278' ' ' GLU . 9.4 ptpp? -96.33 142.17 28.78 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 172.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 284' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 276' ' ' GLU . . . -164.05 172.03 39.78 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.987 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.48 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 17.2 mt -82.44 130.74 35.17 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.158 0.504 . . . . 0.0 111.341 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -136.23 135.49 21.15 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.651 173.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 287' ' ' PRO . . . . . 0.9 ' HB2' HG22 ' A' ' 289' ' ' THR . 59.0 Cg_endo -75.61 138.31 21.45 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.237 1.958 . . . . 0.0 111.444 175.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.467 ' HA ' HG22 ' A' ' 291' ' ' VAL . 49.4 p90 -63.27 -8.47 8.52 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.932 0.396 . . . . 0.0 111.282 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 289' ' ' THR . . . . . 0.9 HG22 ' HB2' ' A' ' 287' ' ' PRO . 15.3 t -79.62 -13.81 59.24 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.012 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 16.8 m80 -101.19 -6.19 24.59 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.695 0.283 . . . . 0.0 110.846 178.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.467 HG22 ' HA ' ' A' ' 288' ' ' PHE . 35.9 m -127.78 178.99 4.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.94 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -140.76 116.01 9.95 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.039 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.464 HD13 ' HB2' ' A' ' 240' ' ' ALA . 34.2 mm -70.41 112.96 5.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 174.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -135.24 -169.87 2.47 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.865 -176.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -115.68 94.67 41.31 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 296' ' ' PRO . . . . . 0.447 ' HG3' ' HB2' ' A' ' 239' ' ' PHE . 36.2 Cg_endo . . . . . 0 C--N 1.345 0.39 0 C-N-CA 122.31 2.006 . . . . 0.0 111.334 178.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.498 ' O ' HG23 ' A' ' 99' ' ' ILE . 9.4 p . . . . . 0 N--CA 1.446 -0.634 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.609 ' HB1' ' HE3' ' A' ' 89' ' ' LYS . . . -83.27 104.56 13.53 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.745 175.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 63.8 mtt180 -109.47 -10.49 14.88 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -167.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.449 ' H ' ' HD1' ' A' ' 6' ' ' PHE . 4.6 p90 -84.31 156.02 22.11 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.594 -170.106 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -66.7 -27.77 67.9 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.587 -177.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.3 t 75.09 -22.73 0.25 Allowed 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.412 0.685 . . . . 0.0 111.137 -178.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.6 t -105.17 -17.39 14.49 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 122.262 -0.273 . . . . 0.0 111.707 -177.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -81.08 107.74 14.15 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 121.718 -0.614 . . . . 0.0 110.625 -177.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.49 -41.59 94.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.948 -176.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.457 ' C ' HH22 ' A' ' 104' ' ' ARG . 24.2 t -68.77 -4.01 14.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.156 -176.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -91.84 -47.27 7.42 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.419 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 43.4 p-90 -117.33 -21.21 8.82 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -171.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -75.05 127.16 32.58 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -177.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.784 ' HG3' ' HB2' ' A' ' 37' ' ' LEU . 26.3 mmt -109.67 -8.35 14.96 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -173.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 50.55 -112.84 1.74 Allowed Glycine 0 CA--C 1.525 0.665 0 C-N-CA 121.376 -0.44 . . . . 0.0 113.2 -176.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -76.01 102.16 1.57 Allowed 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.52 2.147 . . . . 0.0 112.766 -178.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.737 ' HB ' ' HG3' ' A' ' 39' ' ' ARG . 22.2 t -142.07 -76.39 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.397 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.815 ' H ' ' HG3' ' A' ' 39' ' ' ARG . 51.1 m 93.41 171.01 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 168.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.0 mtp85 -62.1 -32.58 73.16 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.861 -172.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -59.65 -54.12 50.08 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 123.842 0.713 . . . . 0.0 110.751 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.485 ' O ' ' HG3' ' A' ' 27' ' ' ARG . 17.4 mt-10 -74.71 -47.22 32.64 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.784 -177.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.35 -51.17 70.46 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -172.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.546 ' HA ' HG11 ' A' ' 58' ' ' VAL . 3.9 tt0 -66.27 -33.79 76.53 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -177.091 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.3 m -63.41 -35.45 80.45 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.344 -0.843 . . . . 0.0 112.113 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.485 ' HG3' ' O ' ' A' ' 23' ' ' GLU . 98.0 mtt180 -81.19 -13.3 58.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.599 0.238 . . . . 0.0 111.256 -177.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.57 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 41.0 mt -121.27 -13.33 8.5 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -172.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.518 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 26.6 tp60 -66.61 104.8 1.36 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.926 0.393 . . . . 0.0 110.32 -176.052 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 64.59 34.17 89.19 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.444 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 73.4 mm-40 -106.5 -160.85 0.76 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 178.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.568 ' HB2' ' HG3' ' A' ' 35' ' ' MET . 43.6 mtm180 -56.17 111.17 0.89 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.896 0.379 . . . . 0.0 110.624 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -67.38 111.06 3.84 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.008 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.472 ' HA2' HG21 ' A' ' 96' ' ' THR . . . 130.86 -14.26 5.5 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.499 -176.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.568 ' HG3' ' HB2' ' A' ' 32' ' ' ARG . 55.3 mtm -77.3 143.6 38.71 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 120.871 0.367 . . . . 0.0 110.426 177.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.471 ' HB2' HG22 ' A' ' 52' ' ' VAL . 34.0 p90 -141.39 166.01 25.94 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.236 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.784 ' HB2' ' HG3' ' A' ' 16' ' ' MET . 4.3 pp -157.13 139.14 14.4 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.234 0.54 . . . . 0.0 110.674 176.411 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.3 t -113.27 108.27 25.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.181 177.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.815 ' HG3' ' H ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -120.77 173.85 6.96 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.26 -178.533 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -61.69 130.32 45.29 Favored 'General case' 0 C--O 1.238 0.459 0 O-C-N 123.854 0.721 . . . . 0.0 110.147 178.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.4 t -80.13 154.98 27.69 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.517 -173.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.9 m -92.83 -5.32 51.3 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.744 177.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.2 m -73.34 -49.54 26.85 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.973 177.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 49.1 t -167.36 136.61 2.2 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.618 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -59.96 105.68 0.29 Allowed 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.503 2.135 . . . . 0.0 111.796 176.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 133.27 -29.41 3.18 Favored Glycine 0 N--CA 1.452 -0.278 0 N-CA-C 110.526 -1.029 . . . . 0.0 110.526 -174.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.409 ' OD1' ' HA ' ' A' ' 64' ' ' ASN . 30.3 t70 -80.58 151.41 29.1 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 173.12 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -127.25 157.93 38.51 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.506 ' HB ' ' CZ ' ' A' ' 39' ' ' ARG . 39.2 t -128.52 110.38 21.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.761 0.791 . . . . 0.0 111.316 176.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.46 ' HB3' ' HB2' ' A' ' 61' ' ' TYR . 47.5 tp -76.29 95.78 3.83 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 113.731 -1.577 . . . . 0.0 110.121 175.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 59' ' ' SER . 65.7 m -96.96 133.79 41.16 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 175.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.681 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 60.1 t -130.92 138.5 53.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.302 -171.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.57 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 40.0 t -89.68 108.22 19.55 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.803 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.682 ' O ' ' HB3' ' A' ' 57' ' ' ARG . 26.8 mt-10 -146.67 131.93 18.46 Favored 'General case' 0 C--O 1.206 -1.206 0 C-N-CA 119.685 -0.806 . . . . 0.0 110.253 176.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 23.9 m120 52.47 28.8 6.27 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 177.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.2 m 59.83 58.68 2.72 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 122.778 1.275 . . . . 0.0 108.67 -175.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.796 HH21 ' HB2' ' A' ' 94' ' ' ASP . 17.0 ttp85 -162.2 66.88 0.24 Allowed 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 112.869 -1.969 . . . . 0.0 109.395 -159.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.681 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 41.1 t -69.08 92.11 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-O 122.58 1.181 . . . . 0.0 109.143 -170.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 51' ' ' SER . 1.8 m -61.17 119.64 8.79 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 112.579 -2.1 . . . . 0.0 110.722 -177.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -99.53 96.49 7.7 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.913 0.387 . . . . 0.0 110.969 -178.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.633 ' CE2' HD22 ' A' ' 93' ' ' LEU . 88.6 m-85 -95.5 116.44 28.82 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.074 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.557 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 55.4 mt -81.53 146.48 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 O-C-N 122.24 -0.287 . . . . 0.0 111.35 -178.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.654 HG13 ' CG1' ' A' ' 73' ' ' ILE . 4.8 mp -134.14 102.04 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 122.571 0.349 . . . . 0.0 110.243 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.409 ' HA ' ' OD1' ' A' ' 47' ' ' ASP . 9.2 m120 -81.14 130.95 35.25 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.237 -177.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.2 t -78.54 100.39 6.9 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 172.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.567 HD11 ' HB2' ' A' ' 72' ' ' LYS . 85.8 mt -80.64 142.78 53.69 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.28 -174.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -63.07 -8.63 14.56 Favored 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 122.766 2.31 . . . . 0.0 111.344 170.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -75.82 2.85 11.21 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.883 172.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 69' ' ' ARG . 4.5 mmp_? 68.01 24.9 7.74 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.489 -178.081 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.417 ' HB3' ' O ' ' A' ' 78' ' ' PHE . 67.2 mtt180 -121.4 176.41 5.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.952 -178.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.415 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 57.2 m-85 -124.46 117.92 25.49 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.112 0.482 . . . . 0.0 110.277 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.656 ' HG3' ' HB3' ' A' ' 77' ' ' GLU . 74.1 tttt -98.12 99.93 11.21 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.826 -173.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.696 ' HB ' HD22 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -90.14 76.45 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 123.0 1.381 . . . . 0.0 110.228 -173.69 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.43 74.71 0.88 Allowed Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 114.578 -1.192 . . . . 0.0 113.262 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.446 ' HA ' ' HE2' ' A' ' 72' ' ' LYS . 38.6 t70 73.94 -40.96 0.47 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 174.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -91.82 119.73 31.88 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.656 ' HB3' ' HG3' ' A' ' 72' ' ' LYS . 13.5 pt-20 -100.14 139.85 35.21 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.328 0.585 . . . . 0.0 111.488 -176.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.435 ' CE1' HG22 ' A' ' 73' ' ' ILE . 26.9 m-85 -117.66 168.13 10.71 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 174.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -69.91 -20.72 63.35 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -171.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.489 ' CE1' ' HB2' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -170.81 172.92 5.46 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 122.553 -0.092 . . . . 0.0 111.183 174.741 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.533 HD23 HD21 ' A' ' 84' ' ' LEU . 13.0 mt -51.8 -54.89 35.23 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.058 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 81' ' ' LEU . 38.3 Cg_endo -64.68 -4.53 8.63 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 122.369 2.046 . . . . 0.0 113.448 -177.13 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.489 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -94.43 -34.17 12.85 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.921 0.391 . . . . 0.0 110.524 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.696 HD22 ' HB ' ' A' ' 73' ' ' ILE . 2.3 pp -75.34 -36.67 60.99 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.534 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 81.4 mt -65.35 -31.24 72.26 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.236 177.174 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.647 ' HA ' ' HD3' ' A' ' 89' ' ' LYS . 3.3 tp10 -70.77 -27.84 64.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.935 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.4 ' CD2' ' HZ ' ' A' ' 78' ' ' PHE . 18.5 t80 -75.66 -32.17 60.08 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.734 0.778 . . . . 0.0 109.593 -177.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.541 ' HA ' ' HB3' ' A' ' 91' ' ' HIS . 64.7 m-85 -89.62 2.05 55.22 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.471 -175.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.647 ' HD3' ' HA ' ' A' ' 86' ' ' GLU . 56.9 mtpt -84.4 -15.29 46.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.884 173.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 34.0 pt -121.03 0.49 7.25 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 CA-C-O 121.291 0.567 . . . . 0.0 110.285 174.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.541 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 3.3 t-160 -88.97 -44.29 10.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.859 -176.253 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.46 ' HB2' ' O ' ' A' ' 91' ' ' HIS . 90.4 m-85 67.33 88.64 0.11 Allowed 'General case' 0 CA--C 1.519 -0.237 0 O-C-N 124.135 0.897 . . . . 0.0 108.946 -165.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.638 ' O ' ' HB3' ' A' ' 154' ' ' GLU . 11.9 mt -44.02 -61.59 1.41 Allowed 'General case' 0 C--O 1.218 -0.576 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 175.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.796 ' HB2' HH21 ' A' ' 57' ' ' ARG . 21.0 t0 -141.62 89.68 2.23 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.688 170.227 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.532 ' HB ' ' O ' ' A' ' 94' ' ' ASP . 1.3 m 69.91 -6.84 1.0 Allowed 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.981 0.896 . . . . 0.0 110.558 175.069 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.472 HG21 ' HA2' ' A' ' 34' ' ' GLY . 76.2 m -135.59 142.91 45.36 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.782 -178.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.42 ' O ' HG22 ' A' ' 96' ' ' THR . 3.1 p -95.4 171.37 8.74 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 174.193 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.448 HD21 HD11 ' A' ' 93' ' ' LEU . 96.8 mt -66.77 91.84 0.2 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 173.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.498 HG23 ' O ' ' A' ' 3' ' ' SER . 47.0 mm -75.41 -66.86 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.298 -174.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.558 ' O ' ' HA ' ' A' ' 35' ' ' MET . 9.7 pt-20 -156.75 154.76 27.39 Favored Pre-proline 0 N--CA 1.447 -0.588 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.743 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.33 155.3 67.74 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.409 2.072 . . . . 0.0 112.982 -177.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.58 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -77.21 166.41 44.67 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.925 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.58 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 43.3 Cg_endo -68.63 132.94 26.38 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.317 2.011 . . . . 0.0 112.566 176.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.457 HH22 ' C ' ' A' ' 12' ' ' SER . 46.3 ttm180 . . . . . 0 C--N 1.324 -0.509 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.859 177.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.802 HD12 HG21 ' A' ' 152' ' ' ILE . 3.9 mm? . . . . . 0 N--CA 1.474 0.739 0 CA-C-O 121.639 0.733 . . . . 0.0 112.881 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 41.5 tt0 -179.7 -75.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.35 -1.295 . . . . 0.0 109.157 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -98.88 108.13 20.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.188 0.518 . . . . 0.0 110.96 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.996 HG22 ' HG3' ' A' ' 180' ' ' LYS . 56.2 t -124.07 135.48 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.667 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.671 ' NH1' ' HB2' ' A' ' 181' ' ' LEU . 0.0 OUTLIER -111.29 148.05 33.75 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 117.51 -1.676 . . . . 0.0 108.538 169.977 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.557 HG22 HG12 ' A' ' 178' ' ' VAL . 0.9 OUTLIER -101.78 131.82 47.87 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.269 -179.903 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.563 HD21 ' HG2' ' A' ' 179' ' ' GLU . 21.8 mt -106.58 -17.5 14.23 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -176.052 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -87.09 -34.16 19.23 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.507 -174.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.527 ' HB2' ' HA ' ' A' ' 145' ' ' LYS . 0.0 OUTLIER 65.06 121.1 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 122.229 1.014 . . . . 0.0 111.317 -173.838 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -146.36 87.42 6.54 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 114.636 -1.166 . . . . 0.0 108.194 177.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.609 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 72.6 Cg_endo -83.0 85.99 1.51 Allowed 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 121.778 1.652 . . . . 0.0 112.578 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -77.18 -13.74 83.31 Favored Glycine 0 C--N 1.332 0.358 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 173.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.628 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 86.1 m-20 52.59 64.74 1.74 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 114.235 -0.982 . . . . 0.0 111.216 178.043 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.608 ' HB3' ' H ' ' A' ' 141' ' ' ASP . 0.4 OUTLIER -130.84 -177.29 4.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.239 0.543 . . . . 0.0 111.335 -175.931 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -110.95 0.8 17.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.675 167.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -116.72 -43.54 2.89 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.1 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.608 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 14.5 m-20 -101.07 123.62 45.52 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 169.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 1.075 HD11 ' HB2' ' A' ' 165' ' ' ASN . 32.2 tp -77.98 120.44 81.26 Favored Pre-proline 0 N--CA 1.468 0.459 0 CA-C-O 120.743 0.306 . . . . 0.0 111.058 -175.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.628 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 36.2 Cg_endo -72.44 95.46 0.78 Allowed 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.444 1.429 . . . . 0.0 111.272 168.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.551 ' CE2' ' HB ' ' A' ' 173' ' ' ILE . 10.4 p90 -106.7 160.55 15.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.391 -177.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.527 ' HA ' ' HB2' ' A' ' 133' ' ' ASP . 0.1 OUTLIER -103.56 -171.77 2.0 Allowed 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.929 -0.308 . . . . 0.0 111.25 -177.344 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.814 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -88.57 5.31 43.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.36 -171.985 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -165.11 36.68 0.28 Allowed Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 175.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.453 ' HB3' ' HB2' ' A' ' 145' ' ' LYS . 0.0 OUTLIER -101.08 150.53 22.82 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.043 0.449 . . . . 0.0 111.368 -175.365 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.56 HD12 ' HB3' ' A' ' 129' ' ' ARG . 0.7 OUTLIER -90.14 132.14 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.567 -177.541 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.761 HD22 HD21 ' A' ' 142' ' ' LEU . 44.7 mt -127.9 157.15 41.31 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -177.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.581 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 58.0 t -122.93 123.8 68.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 174.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.957 HD13 ' HB2' ' A' ' 163' ' ' ALA . 36.8 mm -76.21 79.04 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.727 HG23 ' HG3' ' A' ' 154' ' ' GLU . 11.1 tt -75.62 -28.25 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-N 113.165 -1.834 . . . . 0.0 109.559 -174.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.727 ' HG3' HG23 ' A' ' 153' ' ' ILE . 29.8 mt-10 -134.39 142.15 47.08 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 175.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.424 ' HE3' ' HE1' ' A' ' 161' ' ' TRP . 81.8 tttt -143.62 78.23 14.6 Favored Pre-proline 0 C--N 1.324 -0.505 0 O-C-N 121.547 -0.721 . . . . 0.0 111.264 177.29 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.438 ' HG2' ' HG2' ' A' ' 157' ' ' GLU . 59.2 Cg_endo -73.93 -31.56 8.02 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.113 1.875 . . . . 0.0 111.552 176.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.438 ' HG2' ' HG2' ' A' ' 156' ' ' PRO . 14.2 mm-40 -119.89 164.37 16.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.519 -172.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.566 ' O ' HG21 ' A' ' 175' ' ' VAL . 9.3 tp10 -102.86 -22.24 13.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.587 0.232 . . . . 0.0 110.878 178.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.43 ' OE1' ' HA ' ' A' ' 159' ' ' GLN . 11.5 mm-40 -91.19 -21.14 21.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.094 0.474 . . . . 0.0 110.059 177.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 56.7 m95 -124.75 133.51 53.14 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.119 174.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' TRP . . . . . 0.931 ' HB3' HD12 ' A' ' 152' ' ' ILE . 46.1 m0 -110.94 133.6 53.24 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.258 0.551 . . . . 0.0 110.664 176.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.576 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 67.4 m -93.02 89.05 6.35 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -176.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.957 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -106.27 145.63 31.37 Favored 'General case' 0 N--CA 1.418 -2.033 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 -169.082 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.688 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 13.3 ptt180 -87.07 123.85 32.59 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 175.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 1.075 ' HB2' HD11 ' A' ' 142' ' ' LEU . 24.3 t30 -53.0 171.11 0.07 Allowed 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 113.277 -1.783 . . . . 0.0 110.736 -174.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 61.9 tttt -57.35 -19.99 26.31 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 173.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -70.64 -54.94 10.0 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.273 169.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' A' ' 164' ' ' ARG . . . 134.3 -8.86 4.72 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.947 -171.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.688 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -65.57 130.26 42.67 Favored 'General case' 0 C--O 1.217 -0.624 0 C-N-CA 123.343 0.657 . . . . 0.0 111.734 178.767 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.509 HG22 HG21 ' A' ' 153' ' ' ILE . 27.0 t -83.69 126.99 40.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.128 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -158.07 149.45 19.82 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.428 -0.892 . . . . 0.0 112.243 171.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.544 ' HG2' ' OG ' ' A' ' 162' ' ' SER . 9.3 mtp -74.63 141.14 44.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.843 0.354 . . . . 0.0 110.773 -178.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.721 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.6 pp -142.12 141.72 22.38 Favored Pre-proline 0 N--CA 1.45 -0.474 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.795 -174.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.526 ' HB2' ' CD1' ' A' ' 177' ' ' TYR . 24.5 Cg_exo -64.88 127.47 18.68 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.804 2.336 . . . . 0.0 112.879 -178.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.566 HG21 ' O ' ' A' ' 158' ' ' GLU . 72.9 t -61.33 -40.73 74.86 Favored Pre-proline 0 CA--C 1.545 0.75 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 177.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -61.44 -5.4 5.39 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 121.92 1.747 . . . . 0.0 112.906 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.526 ' CD1' ' HB2' ' A' ' 174' ' ' PRO . 2.8 m-30 -97.53 -10.96 24.31 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.632 -177.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.637 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 4.0 m -105.67 -172.98 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -164.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.653 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 3.8 tp10 -159.98 50.76 0.31 Allowed 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 113.143 -1.844 . . . . 0.0 112.949 -151.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.996 ' HG3' HG22 ' A' ' 128' ' ' VAL . 2.2 mppt? -69.83 137.56 51.87 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 119.451 -2.031 . . . . 0.0 111.061 -161.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.671 ' HB2' ' NH1' ' A' ' 129' ' ' ARG . 12.3 tp . . . . . 0 C--N 1.332 -0.182 0 CA-C-N 112.999 -1.91 . . . . 0.0 111.694 -169.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo . . . . . 0 C--O 1.234 0.284 0 CA-C-O 120.872 0.28 . . . . 0.0 111.937 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.529 ' HB ' HG13 ' A' ' 266' ' ' VAL . 58.6 t -83.91 116.5 27.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.315 0.578 . . . . 0.0 110.908 -176.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -103.91 114.45 28.71 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.566 175.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.624 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -119.54 131.17 55.49 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.06 -178.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.637 ' HE3' ' HA2' ' A' ' 261' ' ' GLY . 48.5 tttp -90.13 126.12 35.68 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 242' ' ' ALA . . . . . 0.461 ' O ' ' HA ' ' A' ' 260' ' ' VAL . . . -74.83 97.08 3.21 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.23 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 48.2 pt -77.35 -21.91 14.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.127 0.489 . . . . 0.0 110.444 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.17 141.11 50.69 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.293 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -67.91 161.4 26.51 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-O 121.175 0.512 . . . . 0.0 111.073 -174.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.451 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 24.7 tpt180 -151.67 101.36 2.78 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.623 179.267 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 29.6 m -97.46 154.24 38.07 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.528 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.457 ' HA ' ' HB3' ' A' ' 255' ' ' ALA . 10.1 Cg_exo -69.63 99.98 0.77 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.202 1.934 . . . . 0.0 111.176 177.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 249' ' ' CYS . . . . . 0.53 ' HB3' ' HB2' ' A' ' 252' ' ' ASP . 42.3 t -70.24 167.96 16.82 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.325 -178.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -53.83 -38.28 64.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.917 0.389 . . . . 0.0 110.977 176.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -103.53 17.27 24.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.006 0.431 . . . . 0.0 111.142 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 252' ' ' ASP . . . . . 0.53 ' HB2' ' HB3' ' A' ' 249' ' ' CYS . 4.0 m-20 -140.18 54.4 1.64 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.539 175.088 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -75.04 -14.85 60.64 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.37 -177.029 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 4.4 p -93.57 6.76 47.18 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.733 176.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 255' ' ' ALA . . . . . 0.457 ' HB3' ' HA ' ' A' ' 248' ' ' PRO . . . -80.8 150.92 29.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.14 0.495 . . . . 0.0 110.984 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.9 tt -90.63 124.43 35.05 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -67.87 100.13 0.91 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.335 0.588 . . . . 0.0 110.427 177.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.521 HD22 HG22 ' A' ' 264' ' ' VAL . 93.4 mt -108.29 147.82 30.9 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.138 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -129.03 163.49 25.28 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.854 178.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 61.6 t -62.13 122.48 12.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.164 0.506 . . . . 0.0 111.4 -176.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 261' ' ' GLY . . . . . 0.637 ' HA2' ' HE3' ' A' ' 241' ' ' LYS . . . 102.71 -9.39 55.41 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.694 177.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -79.52 140.28 37.3 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 -173.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 44.3 mm -88.57 109.22 19.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.394 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.521 HG22 HD22 ' A' ' 258' ' ' LEU . 15.0 t -83.58 100.69 7.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.129 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -83.14 87.33 6.92 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.853 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.529 HG13 ' HB ' ' A' ' 238' ' ' VAL . 4.8 p -97.53 133.4 39.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.071 0.462 . . . . 0.0 110.688 -177.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 20.7 p -103.57 -35.46 8.29 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.849 -175.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 268' ' ' ARG . . . . . 0.419 ' HG3' ' HB3' ' A' ' 276' ' ' GLU . 3.1 ptp180 -118.21 121.53 40.71 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.095 0.474 . . . . 0.0 110.68 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 269' ' ' MET . . . . . 0.49 ' HE1' HG11 ' A' ' 266' ' ' VAL . 45.7 mmm -95.36 99.38 11.31 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.577 -177.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.509 ' HB2' ' O ' ' A' ' 274' ' ' GLN . 84.3 m-20 -75.34 129.94 38.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.542 -178.09 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 11.1 tp -69.25 -15.19 19.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -171.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -71.39 -18.34 62.36 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.756 0.313 . . . . 0.0 111.033 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 115.24 -34.1 4.98 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.993 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.529 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 90.4 mt-30 -83.6 105.04 14.21 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 175.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.426 ' HB3' HG21 ' A' ' 266' ' ' VAL . 40.2 m0 -92.71 156.7 16.87 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -176.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.419 ' HB3' ' HG3' ' A' ' 268' ' ' ARG . 30.4 tt0 -108.01 106.52 16.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.99 0.424 . . . . 0.0 110.379 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 277' ' ' GLY . . . . . 0.483 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -121.06 153.82 16.55 Favored Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 177.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -116.23 111.92 20.87 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 279' ' ' VAL . . . . . 0.438 HG12 ' OD1' ' A' ' 280' ' ' ASN . 16.7 t -122.93 125.76 72.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.515 -177.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 280' ' ' ASN . . . . . 0.438 ' OD1' HG12 ' A' ' 279' ' ' VAL . 1.9 p-10 44.0 41.58 4.11 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.144 0.978 . . . . 0.0 112.981 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 102.6 -20.48 44.08 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.782 -0.723 . . . . 0.0 113.675 173.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 17.2 mtp-105 -109.1 125.18 51.88 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 117.232 0.516 . . . . 0.0 110.908 -177.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 42.1 pttt -114.88 134.73 54.91 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 120.289 -0.564 . . . . 0.0 109.999 172.341 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -155.96 176.41 33.45 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.675 -177.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.529 ' HB3' ' HB3' ' A' ' 274' ' ' GLN . 57.6 mt -91.08 118.29 30.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.983 0.42 . . . . 0.0 110.678 178.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.427 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 45.9 p90 -120.94 138.86 28.29 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.256 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 287' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 6.3 Cg_exo -76.06 139.41 21.6 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.043 2.495 . . . . 0.0 111.469 175.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -69.8 1.38 4.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.997 -177.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 19.8 p -82.7 -15.03 53.5 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.682 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -103.57 -17.27 15.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.794 0.331 . . . . 0.0 111.343 -177.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.517 ' O ' ' HD2' ' A' ' 292' ' ' LYS . 32.7 m -115.29 159.31 15.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.269 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 292' ' ' LYS . . . . . 0.517 ' HD2' ' O ' ' A' ' 291' ' ' VAL . 11.1 mptt -126.9 129.02 47.4 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.923 0.392 . . . . 0.0 110.682 177.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.624 HD13 ' HB2' ' A' ' 240' ' ' ALA . 39.7 mm -73.41 130.84 35.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.42 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 294' ' ' PHE . . . . . 0.445 ' CE1' ' HB2' ' A' ' 241' ' ' LYS . 0.6 OUTLIER -152.56 165.34 35.46 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.451 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -104.8 102.01 32.51 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 175.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo . . . . . 0 C--N 1.341 0.182 0 C-N-CA 122.702 2.268 . . . . 0.0 112.567 -173.854 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.4 t . . . . . 0 N--CA 1.453 -0.32 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -85.39 119.82 26.18 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.617 177.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.508 ' HD3' ' HA ' ' A' ' 5' ' ' ARG . 22.1 mmt180 -131.35 87.7 2.5 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.38 0.609 . . . . 0.0 111.412 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -158.81 168.17 27.53 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 177.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -100.58 131.59 46.41 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.061 175.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.5 m -69.65 -19.76 63.61 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.19 -174.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.8 t -106.24 -24.37 12.32 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -172.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -60.82 95.13 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.961 0.41 . . . . 0.0 111.143 -175.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.8 tpp180 -52.74 -51.23 61.41 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 123.205 0.602 . . . . 0.0 112.15 -174.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.6 m -72.93 4.88 3.71 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -176.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -91.65 -48.7 6.69 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.55 175.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 37.4 p-90 -113.92 -30.39 6.74 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -172.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -70.99 113.52 8.11 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.391 -0.524 . . . . 0.0 109.634 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.799 ' HB3' HG11 ' A' ' 19' ' ' VAL . 27.9 tpp -94.22 1.63 56.0 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 120.911 0.386 . . . . 0.0 110.293 -170.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 50.65 -111.96 1.43 Allowed Glycine 0 C--N 1.334 0.451 0 CA-C-N 115.041 -0.981 . . . . 0.0 113.653 177.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -64.97 90.87 0.2 Allowed 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.846 2.364 . . . . 0.0 112.297 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.947 HG22 ' HD2' ' A' ' 39' ' ' ARG . 2.7 p -162.5 159.43 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.7 m -156.64 -166.63 2.17 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 -160.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.48 ' O ' ' HB2' ' A' ' 25' ' ' GLN . 44.1 mtp85 -69.25 -41.56 76.76 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.663 -175.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 15.5 tp60 -64.24 -54.02 39.89 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 123.458 0.473 . . . . 0.0 111.024 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.401 ' O ' ' HG3' ' A' ' 27' ' ' ARG . 47.9 mm-40 -61.12 -56.43 20.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.835 -176.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.91 -33.66 67.15 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.738 0.304 . . . . 0.0 111.614 -178.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.48 ' HB2' ' O ' ' A' ' 21' ' ' ARG . 26.9 tp60 -61.8 -47.69 83.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.867 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.0 t -79.97 -25.27 40.45 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 120.88 0.372 . . . . 0.0 111.553 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.428 ' NH1' ' HB ' ' A' ' 19' ' ' VAL . 97.5 mtt180 -74.72 -38.16 62.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.987 0.422 . . . . 0.0 110.962 -177.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.925 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 28.7 mt -99.72 6.66 45.5 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.935 -176.199 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.476 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 17.0 tp60 -72.05 95.31 1.6 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.083 0.468 . . . . 0.0 111.725 -172.231 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 66.37 29.04 74.16 Favored Glycine 0 N--CA 1.453 -0.202 0 CA-C-N 115.608 -0.724 . . . . 0.0 113.815 173.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.451 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 0.0 OUTLIER -85.39 -91.91 0.09 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 117.027 0.414 . . . . 0.0 110.082 178.483 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.567 ' HB2' ' SD ' ' A' ' 35' ' ' MET . 86.7 mtm-85 -127.54 135.54 50.48 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 170.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 58.5 m170 -71.06 124.61 24.79 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.06 -13.75 14.03 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.649 -176.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.656 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 93.4 mtp -73.62 126.37 30.13 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 175.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.52 ' CB ' HG22 ' A' ' 52' ' ' VAL . 47.1 p90 -133.6 166.0 23.61 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.901 0.381 . . . . 0.0 111.013 -177.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.528 ' HB2' ' HB2' ' A' ' 16' ' ' MET . 4.0 pp -158.07 138.79 12.96 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.499 176.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.428 ' CG2' HD13 ' A' ' 50' ' ' LEU . 87.7 t -102.1 123.58 55.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.947 ' HD2' HG22 ' A' ' 19' ' ' VAL . 5.0 mtm-85 -106.77 175.01 5.64 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.163 -171.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -86.62 90.96 8.43 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 167.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.711 ' HA ' HG23 ' A' ' 49' ' ' VAL . 7.5 t 24.76 -141.41 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.347 1.459 . . . . 0.0 114.487 -176.096 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.595 ' HB3' HH21 ' A' ' 39' ' ' ARG . 56.0 p 172.26 -29.13 0.0 OUTLIER 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 114.106 -1.406 . . . . 0.0 108.778 174.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 40.3 p -122.88 -13.0 7.95 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.982 -177.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.46 ' HA ' ' HD2' ' A' ' 45' ' ' PRO . 64.0 m -133.47 100.17 13.96 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 110.527 -0.175 . . . . 0.0 110.527 -175.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.46 ' HD2' ' HA ' ' A' ' 44' ' ' CYS . 17.9 Cg_endo -57.42 109.18 0.43 Allowed 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.97 2.447 . . . . 0.0 113.069 -174.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.81 -19.73 18.26 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.695 177.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' A' ' 41' ' ' SER . 74.8 m-20 -90.25 -174.65 4.25 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.34 -0.245 . . . . 0.0 110.34 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.615 ' HA ' ' H ' ' A' ' 41' ' ' SER . 26.9 m-85 -129.55 167.77 17.41 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.711 HG23 ' HA ' ' A' ' 41' ' ' SER . 96.6 t -142.22 98.07 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 121.046 0.451 . . . . 0.0 111.298 177.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.428 HD13 ' CG2' ' A' ' 38' ' ' VAL . 40.8 tp -70.1 103.02 2.19 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.963 175.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.508 ' HB3' ' CG1' ' A' ' 58' ' ' VAL . 21.5 m -96.56 134.4 39.82 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.807 175.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.578 HG21 HD13 ' A' ' 93' ' ' LEU . 96.4 t -123.0 142.8 38.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.329 -178.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.925 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 36.0 t -88.05 116.92 26.57 Favored 'General case' 0 C--N 1.334 -0.081 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.649 176.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.851 ' HB2' ' HB3' ' A' ' 94' ' ' ASP . 4.8 pt-20 -165.64 141.88 5.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.775 -0.193 . . . . 0.0 110.997 -177.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 53.16 32.12 12.65 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 122.933 0.493 . . . . 0.0 111.881 -174.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.1 m 67.34 11.12 8.21 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.62 177.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.583 ' HG3' ' O ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -125.39 165.31 18.63 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.187 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.508 ' CG1' ' HB3' ' A' ' 51' ' ' SER . 84.1 t -106.32 105.47 18.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.035 0.445 . . . . 0.0 110.651 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.7 t -76.51 120.36 21.61 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.765 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -99.76 102.4 13.84 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.61 -174.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.713 ' HE1' HD11 ' A' ' 153' ' ' ILE . 66.9 m-85 -100.53 101.5 12.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.621 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.597 HG12 HG22 ' A' ' 49' ' ' VAL . 25.6 mt -81.05 138.41 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 121.152 0.501 . . . . 0.0 112.311 -174.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.625 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 3.7 mp -116.85 122.24 69.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.603 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -104.01 140.42 37.77 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -175.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.4 t -79.85 104.83 10.7 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.103 0.478 . . . . 0.0 110.444 -177.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.519 HD11 ' HB2' ' A' ' 72' ' ' LYS . 90.6 mt -75.24 132.73 75.87 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.617 178.169 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -57.18 -19.85 35.81 Favored 'Trans proline' 0 N--CA 1.473 0.302 0 C-N-CA 123.425 2.75 . . . . 0.0 113.409 -174.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -90.28 26.85 1.81 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.238 178.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.706 ' HA ' ' HE ' ' A' ' 69' ' ' ARG . 2.2 mmp_? 69.3 26.07 5.44 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.356 173.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.638 ' HG2' ' HA ' ' A' ' 79' ' ' ASP . 69.8 mtt180 -114.47 179.0 4.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.604 176.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.625 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 36.6 m-85 -139.1 120.39 14.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.774 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.519 ' HB2' HD11 ' A' ' 66' ' ' LEU . 19.6 ttmm -106.65 110.21 22.34 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.615 -178.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.679 HD11 ' HB3' ' A' ' 61' ' ' TYR . 3.9 tt -94.06 103.62 14.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.084 0.468 . . . . 0.0 110.869 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 52.69 63.11 5.24 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.658 -0.701 . . . . 0.0 113.111 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.1 t0 78.59 -38.88 0.24 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.002 0.521 . . . . 0.0 111.081 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -69.09 119.12 12.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.002 0.429 . . . . 0.0 110.259 177.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.431 ' HB3' ' NZ ' ' A' ' 72' ' ' LYS . 7.7 pt-20 -99.23 133.67 43.18 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.274 0.559 . . . . 0.0 111.846 -174.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.46 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 79.7 m-85 -136.83 164.1 29.09 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.818 177.077 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.638 ' HA ' ' HG2' ' A' ' 70' ' ' ARG . 6.9 m-20 -73.75 -26.56 60.73 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -176.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.431 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 5.7 p80 -163.11 172.96 14.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.848 -0.16 . . . . 0.0 110.937 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.555 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 19.6 mt -58.34 -52.25 75.93 Favored Pre-proline 0 CA--C 1.535 0.367 0 O-C-N 123.251 0.344 . . . . 0.0 111.656 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.555 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 52.0 Cg_exo -58.11 -9.03 5.56 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 122.419 2.079 . . . . 0.0 113.467 177.038 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.28 -36.35 15.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.953 0.406 . . . . 0.0 110.799 -178.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.496 HD21 HD23 ' A' ' 81' ' ' LEU . 3.7 pp -79.97 -33.89 39.12 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.3 mt -68.08 -14.2 62.79 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.635 0.731 . . . . 0.0 110.115 175.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -85.98 -44.9 11.96 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.667 177.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.454 ' O ' HG12 ' A' ' 90' ' ' ILE . 84.9 t80 -70.15 -37.13 75.17 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.534 -177.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.492 ' HE2' HD13 ' A' ' 73' ' ' ILE . 16.7 m-85 -72.77 5.2 3.33 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -176.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -83.76 -14.98 50.21 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 119.915 -0.714 . . . . 0.0 111.144 171.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.454 HG12 ' O ' ' A' ' 87' ' ' PHE . 5.6 pt -87.89 -28.93 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.227 166.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.451 ' N ' HG13 ' A' ' 90' ' ' ILE . 3.0 m170 -91.14 124.53 35.43 Favored 'General case' 0 CA--C 1.502 -0.865 0 CA-C-O 121.135 0.493 . . . . 0.0 111.181 -177.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -86.81 90.04 8.17 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 175.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.578 HD13 HG21 ' A' ' 52' ' ' VAL . 5.3 mt -46.63 -36.36 6.91 Favored 'General case' 0 C--O 1.218 -0.567 0 O-C-N 124.346 1.029 . . . . 0.0 110.204 -177.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.851 ' HB3' ' HB2' ' A' ' 54' ' ' GLU . 21.6 t70 -158.82 99.35 1.54 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.841 165.051 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.634 ' HA ' ' HA ' ' A' ' 156' ' ' PRO . 5.7 t 44.3 18.16 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.663 1.185 . . . . 0.0 112.498 -177.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.7 t -162.77 154.58 18.15 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.48 ' O ' HG12 ' A' ' 99' ' ' ILE . 52.2 p -104.11 -179.01 3.82 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.4 104.97 0.84 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 173.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 97' ' ' THR . 45.1 mm -99.86 -54.93 6.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.737 -173.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.656 ' O ' ' HA ' ' A' ' 35' ' ' MET . 10.6 pt-20 -151.59 153.02 31.55 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.062 -173.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 100' ' ' GLU . 1.9 Cg_endo -83.84 158.61 13.89 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.948 2.432 . . . . 0.0 112.746 178.13 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -88.18 164.62 32.56 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.054 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -78.28 164.92 26.23 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.99 2.46 . . . . 0.0 112.453 175.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.793 ' HG2' ' SD ' ' A' ' 16' ' ' MET . 19.8 mtm180 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.492 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.443 HD12 HG21 ' A' ' 152' ' ' ILE . 2.6 mm? . . . . . 0 N--CA 1.468 0.473 0 CA-C-O 121.305 0.574 . . . . 0.0 112.328 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 179.84 -48.57 0.01 OUTLIER 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.106 174.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.547 ' CE2' HG22 ' A' ' 151' ' ' VAL . 35.5 m-85 -122.76 131.03 53.59 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.373 177.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.505 ' CG1' ' HB ' ' A' ' 178' ' ' VAL . 5.8 t -134.93 156.8 40.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.087 -174.413 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.591 ' NH2' HD13 ' A' ' 181' ' ' LEU . 1.2 ptp180 -134.17 133.54 41.1 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 172.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' THR . . . . . 1.109 HG22 HG12 ' A' ' 178' ' ' VAL . 23.8 p -88.77 140.57 29.31 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.273 0.559 . . . . 0.0 112.213 -174.356 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.717 HD11 ' HG2' ' A' ' 179' ' ' GLU . 13.6 mt -106.99 -42.23 4.96 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.397 -176.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -83.31 -36.45 24.45 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -168.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.806 ' HB2' ' HA ' ' A' ' 145' ' ' LYS . 0.0 OUTLIER 79.25 133.67 0.06 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.434 0.693 . . . . 0.0 111.021 -174.59 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.587 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 59.1 t80 -156.05 110.38 2.11 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.072 -178.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.432 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 11.1 Cg_endo -89.42 90.91 0.36 Allowed 'Trans proline' 0 N--CA 1.445 -1.348 0 C-N-CA 122.591 2.194 . . . . 0.0 112.586 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLY . . . . . 0.507 ' HA3' ' HB3' ' A' ' 141' ' ' ASP . . . -84.4 -21.14 57.31 Favored Glycine 0 N--CA 1.454 -0.166 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.048 173.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 28.4 m120 46.29 48.67 13.27 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 114.443 -0.878 . . . . 0.0 112.532 178.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.423 ' OD1' ' HG2' ' A' ' 140' ' ' GLU . 5.0 t70 -149.53 179.23 8.14 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.39 -178.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -95.17 -7.5 39.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.336 0.588 . . . . 0.0 110.197 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.574 ' O ' ' HB2' ' A' ' 172' ' ' MET . 10.0 pt-20 -113.28 -3.32 13.86 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.987 173.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.507 ' HB3' ' HA3' ' A' ' 136' ' ' GLY . 4.1 m-20 -140.14 102.03 4.29 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 1.104 HD12 ' HD2' ' A' ' 143' ' ' PRO . 57.8 tp -74.03 126.13 89.56 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.417 0.627 . . . . 0.0 111.639 -172.448 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 1.104 ' HD2' HD12 ' A' ' 142' ' ' LEU . 68.8 Cg_endo -76.73 65.58 7.54 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 124.263 3.308 . . . . 0.0 113.132 177.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.621 ' CG ' HG21 ' A' ' 130' ' ' THR . 36.3 p90 -84.43 162.08 20.09 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.504 -0.479 . . . . 0.0 111.736 -176.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.806 ' HA ' ' HB2' ' A' ' 133' ' ' ASP . 10.9 mtmt -121.98 179.92 4.36 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.178 -176.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.746 ' H ' ' HD3' ' A' ' 146' ' ' LYS . 0.3 OUTLIER -79.47 27.62 0.27 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -167.753 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 175.72 32.91 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 119.721 -1.228 . . . . 0.0 113.594 176.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.575 ' OE2' ' HA ' ' A' ' 144' ' ' PHE . 8.7 pt-20 -106.63 167.15 10.06 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 117.826 0.813 . . . . 0.0 110.916 177.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.436 ' C ' HD23 ' A' ' 150' ' ' LEU . 19.8 mm -101.55 138.38 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -175.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.608 HD22 ' HA ' ' A' ' 165' ' ' ASN . 11.5 mt -122.9 179.64 4.57 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.888 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 47.8 t -145.29 123.46 5.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 178.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.582 HG23 ' HB3' ' A' ' 161' ' ' TRP . 20.4 mm -77.85 77.77 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-O 122.659 1.219 . . . . 0.0 108.55 -178.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.713 HD11 ' HE1' ' A' ' 61' ' ' TYR . 13.5 tt -71.4 -41.45 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-N 112.847 -1.979 . . . . 0.0 109.905 -177.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 1.132 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 73.4 mt-10 -116.79 138.92 51.15 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 172.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.609 ' O ' ' HB ' ' A' ' 95' ' ' THR . 22.1 ttpt -132.94 79.54 62.94 Favored Pre-proline 0 C--N 1.322 -0.593 0 O-C-N 122.043 -0.411 . . . . 0.0 110.015 167.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.634 ' HA ' ' HA ' ' A' ' 95' ' ' THR . 14.6 Cg_exo -66.35 -49.17 1.97 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 121.95 1.767 . . . . 0.0 110.945 177.122 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -119.93 176.44 5.41 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.205 -174.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -95.6 -30.34 13.85 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.619 -176.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -84.25 -22.71 30.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.021 0.438 . . . . 0.0 110.793 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.766 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 60.5 m95 -129.2 126.89 40.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.425 -178.218 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' TRP . . . . . 0.582 ' HB3' HG23 ' A' ' 152' ' ' ILE . 49.5 m0 -119.75 134.26 55.3 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.752 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' SER . . . . . 1.132 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 6.5 m -84.47 98.09 9.9 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 177.19 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.573 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -103.98 157.78 16.87 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.136 -176.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.888 ' HG2' ' HB ' ' A' ' 151' ' ' VAL . 14.2 ptt180 -104.66 129.64 52.8 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 176.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.644 HD22 ' HE ' ' A' ' 169' ' ' ARG . 46.7 p30 -73.03 -166.99 0.35 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.453 0.168 . . . . 0.0 110.971 -178.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.517 ' HE3' ' HB2' ' A' ' 148' ' ' GLU . 93.8 mttt -55.96 -38.06 69.86 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -176.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -86.46 0.96 53.07 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.308 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 92.42 3.06 67.34 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 120.447 -0.882 . . . . 0.0 113.973 174.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.731 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 12.5 ttm-85 -68.1 130.25 42.36 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 122.511 0.324 . . . . 0.0 110.777 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.468 HG22 HG21 ' A' ' 153' ' ' ILE . 39.8 t -95.19 143.02 12.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-O 120.855 0.36 . . . . 0.0 111.008 -177.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -170.92 155.53 24.87 Favored Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 175.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.766 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.4 OUTLIER -70.26 131.66 44.53 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.967 0.384 . . . . 0.0 110.864 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.829 HD13 HG11 ' A' ' 178' ' ' VAL . 2.6 pp -133.52 145.4 56.2 Favored Pre-proline 0 N--CA 1.451 -0.394 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.199 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.484 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 8.2 Cg_exo -71.69 125.43 11.11 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.957 2.438 . . . . 0.0 111.859 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.622 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 24.1 t -68.76 -35.29 6.34 Favored Pre-proline 0 C--N 1.32 -0.682 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -178.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.622 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 19.0 Cg_endo -61.43 -11.22 18.77 Favored 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 121.656 1.571 . . . . 0.0 112.537 172.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.484 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.4 m-85 -92.01 -14.35 29.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.243 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 1.109 HG12 HG22 ' A' ' 130' ' ' THR . 10.3 m -122.01 173.64 7.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -169.072 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.717 ' HG2' HD11 ' A' ' 131' ' ' LEU . 9.3 mm-40 -136.34 169.71 17.23 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.933 177.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.511 ' N ' ' HD3' ' A' ' 180' ' ' LYS . 2.3 mppt? -101.22 136.92 40.27 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.802 0.334 . . . . 0.0 110.563 -175.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.591 HD13 ' NH2' ' A' ' 129' ' ' ARG . 7.8 tp . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.371 -178.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo . . . . . 0 C--O 1.234 0.283 0 CA-C-O 120.973 0.322 . . . . 0.0 111.83 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.63 HG11 HD12 ' A' ' 293' ' ' ILE . 39.6 t -100.68 135.88 34.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.967 -173.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -88.27 121.85 31.14 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.459 173.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.467 ' HB1' ' HB ' ' A' ' 291' ' ' VAL . . . -126.5 123.69 38.36 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.391 176.12 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.408 ' O ' HG23 ' A' ' 243' ' ' ILE . 63.8 tttm -86.07 119.41 26.34 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.131 -177.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 242' ' ' ALA . . . . . 0.619 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -70.81 99.9 1.81 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.31 0.576 . . . . 0.0 110.418 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.408 HG23 ' O ' ' A' ' 241' ' ' LYS . 34.2 pt -88.75 -27.87 5.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.421 -173.281 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -129.89 147.81 51.69 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.368 -0.378 . . . . 0.0 109.996 -178.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -55.53 122.21 10.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.432 0.634 . . . . 0.0 111.296 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.747 ' HB3' ' HB2' ' A' ' 258' ' ' LEU . 20.9 tpt180 -122.73 77.04 1.4 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.382 -0.826 . . . . 0.0 108.856 173.283 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.425 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 7.4 m -111.62 137.46 21.2 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.67 -178.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 247' ' ' VAL . 31.8 Cg_exo -57.76 111.4 0.83 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 123.048 2.499 . . . . 0.0 112.044 -178.012 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 249' ' ' CYS . . . . . 0.428 ' N ' ' HB2' ' A' ' 252' ' ' ASP . 19.3 t -88.6 -169.86 2.71 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.2 -39.15 78.25 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -177.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -91.1 -9.91 43.92 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.381 -176.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 252' ' ' ASP . . . . . 0.428 ' HB2' ' N ' ' A' ' 249' ' ' CYS . 19.4 m-20 -80.89 116.67 20.99 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.364 0.602 . . . . 0.0 111.571 -174.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -120.47 145.97 46.73 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 172.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 25.2 p 61.92 17.73 9.19 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.581 0.752 . . . . 0.0 111.017 -174.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -81.17 130.99 35.27 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.999 0.428 . . . . 0.0 111.426 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.748 HD21 ' HB ' ' A' ' 279' ' ' VAL . 2.0 tt -86.07 131.29 34.29 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 175.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.46 ' N ' HD23 ' A' ' 256' ' ' LEU . . . -79.86 95.95 6.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.211 0.529 . . . . 0.0 111.182 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.895 HD21 HG21 ' A' ' 279' ' ' VAL . 68.8 mt -105.39 105.48 15.54 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.377 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -87.82 150.3 23.62 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.066 -177.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 47.0 t -61.8 121.21 9.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.038 -176.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 101.87 39.73 2.85 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.964 175.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -141.58 174.82 10.2 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.938 0.369 . . . . 0.0 110.138 177.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 263' ' ' ILE . . . . . 0.449 HD12 ' HZ ' ' A' ' 294' ' ' PHE . 49.8 mm -107.38 133.82 50.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.944 0.402 . . . . 0.0 111.203 -175.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.572 HG22 HD22 ' A' ' 258' ' ' LEU . 5.2 t -113.75 115.76 50.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.885 175.209 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -95.94 103.17 15.04 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 173.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.626 HG13 ' HB ' ' A' ' 238' ' ' VAL . 2.1 p -94.65 141.4 15.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.562 -178.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 19.5 p -126.34 -23.74 3.77 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.913 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 268' ' ' ARG . . . . . 0.482 ' HB2' ' HB3' ' A' ' 276' ' ' GLU . 83.4 mtt180 -116.51 119.42 35.53 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.43 177.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 58.6 mtt -117.25 110.36 18.01 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 175.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -84.21 12.12 7.09 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.237 -170.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 48.0 mm 72.05 -39.0 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 175.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -78.8 27.05 0.23 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.444 0.64 . . . . 0.0 111.067 -178.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 81.99 -29.14 3.12 Favored Glycine 0 C--N 1.32 -0.308 0 C-N-CA 121.096 -0.573 . . . . 0.0 113.077 176.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -78.7 105.54 10.08 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.514 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 49.4 m0 -99.82 153.96 18.72 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.274 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.482 ' HB3' ' HB2' ' A' ' 268' ' ' ARG . 38.9 tt0 -120.59 115.6 23.72 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.887 178.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 277' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -138.06 164.3 25.56 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 176.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -106.17 112.33 25.32 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 117.784 0.792 . . . . 0.0 109.669 -177.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 279' ' ' VAL . . . . . 0.895 HG21 HD21 ' A' ' 258' ' ' LEU . 70.8 t -121.15 99.67 7.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.171 -177.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 42.18 63.13 1.44 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.353 -1.294 . . . . 0.0 113.173 173.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 144.68 -51.08 0.63 Allowed Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.025 -1.083 . . . . 0.0 112.585 173.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.46 162.15 16.71 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.222 0.534 . . . . 0.0 111.755 -178.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.572 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 0.0 OUTLIER -88.84 143.06 27.15 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.673 175.976 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -150.56 172.18 30.33 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.539 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.514 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 72.0 mt -90.1 123.65 34.13 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.16 0.505 . . . . 0.0 110.958 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.435 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 36.6 p90 -133.68 136.71 27.22 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.173 177.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 287' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 10.4 Cg_exo -71.78 140.08 34.81 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.501 2.134 . . . . 0.0 111.614 176.012 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -60.07 -20.56 58.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.837 -178.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 1.4 p -73.89 -3.52 29.37 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -177.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -101.19 -7.54 23.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.666 0.27 . . . . 0.0 110.678 177.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.619 HG12 ' HA ' ' A' ' 242' ' ' ALA . 15.4 m -128.74 178.0 5.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.145 0.498 . . . . 0.0 111.302 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 57.8 tttm -140.81 123.28 15.97 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.515 175.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.63 HD12 HG11 ' A' ' 238' ' ' VAL . 35.3 mm -65.07 144.31 14.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.152 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 294' ' ' PHE . . . . . 0.449 ' HZ ' HD12 ' A' ' 263' ' ' ILE . 6.4 p90 -173.39 -179.07 1.81 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.637 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -151.58 144.48 16.97 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 172.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo . . . . . 0 C--N 1.348 0.504 0 C-N-CA 123.563 2.842 . . . . 0.0 114.178 178.435 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.5 p . . . . . 0 N--CA 1.449 -0.523 0 CA-C-O 121.091 0.472 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.561 ' HB3' ' HE2' ' A' ' 253' ' ' LYS . . . -67.07 133.64 50.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.771 178.253 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 5' ' ' ARG . 47.0 ttm180 -150.92 100.09 2.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.773 0.32 . . . . 0.0 110.821 -176.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -166.07 -177.23 4.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.885 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.514 ' HB3' ' CB ' ' A' ' 13' ' ' ALA . 12.9 t70 -103.17 141.46 35.83 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.07 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.471 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 31.7 m -79.36 -0.19 31.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.808 0.337 . . . . 0.0 111.429 -176.023 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.759 ' CA ' ' HE1' ' A' ' 14' ' ' TRP . 8.7 t -149.17 -95.22 0.07 Allowed 'General case' 0 C--O 1.245 0.816 0 CA-C-O 122.2 1.0 . . . . 0.0 111.302 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.476 ' O ' ' N ' ' A' ' 12' ' ' SER . 37.5 t70 -8.16 74.89 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.099 -1.409 . . . . 0.0 112.01 -155.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.401 ' HA ' ' HD3' ' A' ' 11' ' ' ARG . 7.6 mmt180 -2.24 -58.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 126.189 2.18 . . . . 0.0 115.331 -163.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.476 ' N ' ' O ' ' A' ' 10' ' ' ASP . 58.2 m -70.1 18.08 0.05 Allowed 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -177.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.514 ' CB ' ' HB3' ' A' ' 7' ' ' ASP . . . -91.46 -19.1 23.2 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 120.332 -0.547 . . . . 0.0 109.725 170.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.759 ' HE1' ' CA ' ' A' ' 9' ' ' SER . 7.4 p-90 -151.71 -39.84 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.477 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.551 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 34.0 t80 -67.36 119.84 12.88 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 121.126 0.489 . . . . 0.0 110.179 -177.311 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.811 ' SD ' ' HB3' ' A' ' 104' ' ' ARG . 15.0 tpp -110.03 9.22 24.25 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.296 -172.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.56 ' O ' ' HB2' ' A' ' 39' ' ' ARG . . . 50.85 -112.07 1.51 Allowed Glycine 0 C--O 1.222 -0.639 0 CA-C-N 115.805 -0.634 . . . . 0.0 113.713 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.417 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 2.8 Cg_exo -77.03 109.15 2.78 Favored 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 122.462 2.108 . . . . 0.0 112.606 178.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.066 ' HB ' ' HG3' ' A' ' 39' ' ' ARG . 27.5 t -136.29 -71.4 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 119.212 -0.423 . . . . 0.0 111.701 178.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.489 ' HB3' ' O ' ' A' ' 19' ' ' VAL . 37.7 t 79.72 -172.6 0.05 Allowed 'General case' 0 C--N 1.345 0.412 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 171.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 -65.6 -42.95 91.06 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.716 0.293 . . . . 0.0 110.977 -173.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.523 ' HG3' ' H ' ' A' ' 23' ' ' GLU . 10.9 pt20 -61.01 -59.96 4.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.58 -0.737 . . . . 0.0 112.002 -176.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.611 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 64.8 mm-40 -66.61 -45.28 79.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.818 -175.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 28' ' ' LEU . . . -54.72 -36.75 65.07 Favored 'General case' 0 C--O 1.222 -0.371 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.187 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.671 ' HA ' HG21 ' A' ' 58' ' ' VAL . 6.1 tp-100 -73.4 -51.96 15.45 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.994 178.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.478 HG22 ' HA ' ' A' ' 23' ' ' GLU . 6.2 t -63.24 -26.68 68.9 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -171.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.611 ' HG2' ' O ' ' A' ' 23' ' ' GLU . 18.1 ptp180 -101.58 -9.46 20.96 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.565 -178.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.691 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 87.6 mt -119.61 17.2 12.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.75 -0.205 . . . . 0.0 111.542 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -71.56 74.15 0.78 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.377 0.608 . . . . 0.0 110.314 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.23 -69.43 1.34 Allowed Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.122 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.401 ' HB3' ' H ' ' A' ' 32' ' ' ARG . 6.9 tt0 34.12 -93.24 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.947 1.299 . . . . 0.0 113.561 -175.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.401 ' H ' ' HB3' ' A' ' 31' ' ' GLN . 33.2 ttp-105 -115.46 -11.78 11.78 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -172.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 33.6 m170 67.65 157.65 0.13 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.296 0.638 . . . . 0.0 111.948 -178.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.48 3.21 82.38 Favored Glycine 0 C--N 1.334 0.451 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 177.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.519 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 44.2 mtp -90.13 136.6 32.95 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.959 -0.62 . . . . 0.0 109.918 -176.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.49 ' CB ' HG22 ' A' ' 52' ' ' VAL . 34.2 p90 -138.78 165.06 27.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.55 0.214 . . . . 0.0 110.657 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.599 ' O ' ' HA ' ' A' ' 50' ' ' LEU . 4.6 pp -158.3 140.61 14.25 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.835 174.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 15' ' ' TYR . 80.2 t -110.17 120.66 61.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 174.083 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 1.066 ' HG3' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -138.01 175.93 9.15 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.683 -176.61 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.463 ' O ' ' HG2' ' A' ' 39' ' ' ARG . 2.1 m-20 -66.82 137.71 56.81 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.997 0.427 . . . . 0.0 110.337 176.044 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.499 ' HB3' ' O ' ' A' ' 44' ' ' CYS . 22.8 t -76.92 147.95 36.67 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.495 -179.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.8 p -87.03 -29.43 21.96 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.034 -178.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.5 p -82.54 -42.27 18.57 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.035 0.445 . . . . 0.0 110.955 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.499 ' O ' ' HB3' ' A' ' 41' ' ' SER . 56.1 m -127.15 112.25 21.6 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.209 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.93 14.86 0.63 Allowed 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.792 2.328 . . . . 0.0 112.918 -178.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -117.06 -5.72 14.75 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.627 -0.589 . . . . 0.0 111.627 175.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -119.61 175.26 5.94 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -177.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.43 ' O ' HG23 ' A' ' 62' ' ' ILE . 22.1 m-85 -127.49 179.67 5.37 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 122.176 0.19 . . . . 0.0 110.491 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.609 HG22 HG12 ' A' ' 62' ' ' ILE . 54.2 t -148.91 96.82 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-O 120.743 0.306 . . . . 0.0 111.319 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.599 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 50.6 tp -70.8 101.01 2.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.481 171.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.4 m -97.21 130.01 44.49 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.439 177.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.753 HG21 HD13 ' A' ' 93' ' ' LEU . 69.9 t -119.86 140.97 42.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.205 -177.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.691 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 42.1 t -102.82 107.8 18.78 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.687 -177.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.837 ' HG3' HG22 ' A' ' 96' ' ' THR . 0.0 OUTLIER -158.39 157.28 32.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.769 -0.196 . . . . 0.0 110.756 171.31 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 59.41 18.6 6.97 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 123.557 0.536 . . . . 0.0 110.424 -173.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.0 m 68.47 21.85 8.02 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.949 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -125.65 151.67 46.22 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 174.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.671 HG21 ' HA ' ' A' ' 25' ' ' GLN . 44.9 t -97.33 91.55 2.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.931 0.396 . . . . 0.0 110.521 178.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.9 t -68.46 118.12 11.11 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -98.62 106.75 19.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.312 -174.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.735 ' HB3' HD11 ' A' ' 73' ' ' ILE . 53.9 m-85 -101.97 92.05 4.62 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.581 178.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.609 HG12 HG22 ' A' ' 49' ' ' VAL . 38.5 mt -72.15 130.52 35.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -177.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.641 ' HA ' ' HA ' ' A' ' 73' ' ' ILE . 4.9 mp -106.98 119.46 56.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.204 178.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -97.96 134.6 40.86 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -177.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.5 t -84.3 110.85 18.89 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.156 0.503 . . . . 0.0 110.066 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.729 HD12 ' HG3' ' A' ' 70' ' ' ARG . 67.9 mt -83.32 144.65 46.98 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.422 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.34 -19.01 20.48 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.106 2.538 . . . . 0.0 113.095 -178.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 56.0 m-20 -84.83 14.76 4.45 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.632 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.668 ' HA ' ' HE ' ' A' ' 69' ' ' ARG . 3.3 tpm_? 66.29 26.71 10.3 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.299 0.64 . . . . 0.0 111.154 176.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.729 ' HG3' HD12 ' A' ' 66' ' ' LEU . 6.7 ptm180 -119.47 164.49 15.69 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 176.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.635 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 74.1 m-85 -123.05 120.11 32.35 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.821 0.343 . . . . 0.0 111.853 -171.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 77' ' ' GLU . 20.7 ttmm -102.21 110.29 22.2 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 175.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.735 HD11 ' HB3' ' A' ' 61' ' ' TYR . 2.4 tt -87.05 83.58 2.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.614 0.721 . . . . 0.0 111.406 -175.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.25 -53.25 2.25 Favored Glycine 0 C--N 1.336 0.567 0 CA-C-N 114.66 -1.155 . . . . 0.0 113.342 174.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.71 ' OD2' ' HA2' ' A' ' 168' ' ' GLY . 11.6 t70 -135.57 -55.26 0.79 Allowed 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.081 0.467 . . . . 0.0 109.931 -174.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.5 124.74 28.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.896 -177.223 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 10.0 pt-20 -99.08 129.94 45.38 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.185 0.517 . . . . 0.0 110.984 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.525 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 93.9 m-85 -124.92 -169.1 1.92 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.893 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -112.11 -19.93 12.11 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -177.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.574 ' ND1' ' HG2' ' A' ' 82' ' ' PRO . 6.7 p80 -149.11 165.41 31.83 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 122.376 -0.203 . . . . 0.0 110.533 172.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.504 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 4.4 mt -61.34 -52.19 72.41 Favored Pre-proline 0 N--CA 1.467 0.383 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.466 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.574 ' HG2' ' ND1' ' A' ' 80' ' ' HIS . 12.9 Cg_endo -60.31 -5.87 4.63 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 121.982 1.788 . . . . 0.0 113.18 176.099 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.513 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -85.77 -30.47 23.02 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.118 0.485 . . . . 0.0 110.172 -175.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.525 ' HB3' ' CD2' ' A' ' 78' ' ' PHE . 3.4 pp -82.58 -32.93 28.24 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 174.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.0 mt -66.37 -37.15 84.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.676 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.409 ' OE2' ' HA ' ' A' ' 83' ' ' ALA . 13.8 pt-20 -78.65 -19.77 51.83 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.947 178.163 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.532 ' O ' HG12 ' A' ' 90' ' ' ILE . 73.7 t80 -81.76 -33.97 30.66 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.253 0.549 . . . . 0.0 110.06 -178.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.443 ' CG ' HD21 ' A' ' 93' ' ' LEU . 33.9 m-85 -79.18 5.07 13.02 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.713 -178.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.683 ' HE3' HG22 ' A' ' 90' ' ' ILE . 0.1 OUTLIER -68.01 -34.03 75.72 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 168.873 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.683 HG22 ' HE3' ' A' ' 89' ' ' LYS . 11.0 pt -85.77 -30.91 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 174.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.407 ' HB2' ' HD1' ' A' ' 88' ' ' TYR . 8.1 m170 -93.35 125.58 38.03 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.074 0.464 . . . . 0.0 111.168 -176.501 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.446 ' CD2' HG23 ' A' ' 97' ' ' THR . 59.0 m-85 -86.71 82.1 7.98 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.615 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.753 HD13 HG21 ' A' ' 52' ' ' VAL . 24.0 mt -31.79 -52.24 0.24 Allowed 'General case' 0 N--CA 1.473 0.694 0 O-C-N 125.199 1.562 . . . . 0.0 113.962 -172.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.478 ' OD1' ' HB3' ' A' ' 54' ' ' GLU . 7.3 t70 -118.53 -34.05 4.13 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.49 0.662 . . . . 0.0 109.769 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.422 ' HB ' ' O ' ' A' ' 94' ' ' ASP . 5.8 t 176.99 -20.41 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.245 176.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.837 HG22 ' HG3' ' A' ' 54' ' ' GLU . 3.6 t -113.97 171.76 7.4 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.407 170.362 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.446 HG23 ' CD2' ' A' ' 92' ' ' TYR . 69.9 p -99.58 -177.26 3.52 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.447 HD22 ' CG ' ' A' ' 36' ' ' PHE . 89.5 mt -70.52 105.37 3.07 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.483 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 45.8 mm -99.7 -53.71 7.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.701 -174.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.519 ' O ' ' HA ' ' A' ' 35' ' ' MET . 7.4 pt-20 -149.37 157.25 39.42 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 120.819 0.342 . . . . 0.0 111.46 -174.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.52 163.33 29.69 Favored 'Trans proline' 0 C--O 1.233 0.275 0 C-N-CA 122.495 2.13 . . . . 0.0 112.504 176.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.621 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -90.01 161.36 38.33 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.776 177.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -68.46 159.71 52.28 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.444 2.096 . . . . 0.0 111.912 174.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.811 ' HB3' ' SD ' ' A' ' 16' ' ' MET . 13.8 ptm180 . . . . . 0 C--N 1.325 -0.467 0 CA-C-O 121.081 0.467 . . . . 0.0 111.715 -177.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.665 HD12 HG21 ' A' ' 152' ' ' ILE . 4.1 mm? . . . . . 0 N--CA 1.473 0.678 0 CA-C-O 121.045 0.45 . . . . 0.0 112.205 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.488 ' HG3' ' CD1' ' A' ' 127' ' ' TYR . 9.9 tp10 -170.72 -72.97 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.546 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.488 ' CD1' ' HG3' ' A' ' 126' ' ' GLU . 38.4 m-85 -112.97 131.99 55.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.231 0.539 . . . . 0.0 111.123 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.565 ' CG1' ' HB ' ' A' ' 178' ' ' VAL . 8.3 t -131.59 158.26 43.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.361 -176.088 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -138.77 133.43 32.13 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 170.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' THR . . . . . 1.05 HG22 HG12 ' A' ' 178' ' ' VAL . 35.8 p -86.97 141.46 28.68 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.231 -173.265 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.755 HD11 ' CG ' ' A' ' 179' ' ' GLU . 10.9 mt -111.27 -30.93 7.24 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -174.264 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.518 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 55.5 t80 -90.09 -27.38 19.7 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -168.104 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.518 ' HB3' ' O ' ' A' ' 132' ' ' TYR . 19.5 t70 73.83 130.88 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 O-C-N 123.564 0.54 . . . . 0.0 111.06 -172.235 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.452 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 76.4 t80 -161.86 99.48 1.19 Allowed Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.97 -177.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -82.36 81.46 2.49 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.916 2.411 . . . . 0.0 112.731 178.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.56 -17.12 74.44 Favored Glycine 0 C--O 1.227 -0.319 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 172.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 40.53 35.54 0.31 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.944 1.298 . . . . 0.0 113.945 178.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.508 ' HB2' ' HB2' ' A' ' 141' ' ' ASP . 1.6 m-20 -121.12 -173.42 2.61 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 121.981 -0.449 . . . . 0.0 111.5 -178.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -105.13 -6.64 19.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.245 0.545 . . . . 0.0 110.637 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -122.17 -1.26 9.27 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.692 174.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.508 ' HB2' ' HB2' ' A' ' 138' ' ' ASP . 5.4 m-20 -132.32 108.4 9.18 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 174.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.82 HD11 ' HB2' ' A' ' 165' ' ' ASN . 60.5 tp -74.59 119.79 78.35 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 121.215 0.531 . . . . 0.0 111.868 -170.125 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.625 ' HD2' HD12 ' A' ' 142' ' ' LEU . 55.8 Cg_endo -72.8 102.66 1.46 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.579 2.186 . . . . 0.0 111.57 171.201 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.612 ' CG ' HG21 ' A' ' 130' ' ' THR . 12.6 p90 -117.49 163.94 15.64 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.786 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.48 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 12.4 mmtm -108.65 -159.48 0.69 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.001 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.506 ' H ' ' HD3' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -101.46 6.53 42.47 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.986 -0.285 . . . . 0.0 111.768 -173.885 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -155.34 24.28 0.59 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.055 -1.069 . . . . 0.0 112.704 178.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.13 159.47 14.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.636 0.255 . . . . 0.0 110.562 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.429 ' C ' HD23 ' A' ' 150' ' ' LEU . 15.5 mm -101.56 135.88 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -174.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.605 ' HB3' ' HB1' ' A' ' 163' ' ' ALA . 10.4 mt -122.11 175.9 6.11 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 46.6 t -145.5 123.0 4.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.672 HG23 ' HB3' ' A' ' 161' ' ' TRP . 23.9 mm -79.16 78.75 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-O 122.483 1.135 . . . . 0.0 108.657 -176.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.679 HG23 ' HG3' ' A' ' 154' ' ' GLU . 11.5 tt -69.2 -46.21 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 CA-C-N 113.176 -1.829 . . . . 0.0 109.359 -178.254 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 1.016 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 40.5 mt-10 -115.27 140.05 49.44 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -127.66 82.12 68.91 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 167.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.409 ' HG2' ' HE3' ' A' ' 172' ' ' MET . 3.3 Cg_exo -77.32 -50.76 0.09 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.327 2.685 . . . . 0.0 111.242 176.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -108.4 170.33 8.09 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.402 -176.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -88.3 -41.39 12.92 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.742 -176.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -83.18 -24.37 32.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.909 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 57.2 m95 -123.72 119.65 30.4 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.244 -176.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' TRP . . . . . 0.672 ' HB3' HG23 ' A' ' 152' ' ' ILE . 44.8 m0 -106.24 138.29 42.69 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.732 176.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' SER . . . . . 1.016 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 13.8 m -85.83 101.01 12.46 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 177.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.619 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -106.23 157.01 17.89 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.909 -179.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.713 ' HB3' HG22 ' A' ' 170' ' ' VAL . 25.0 ptt-85 -107.67 128.98 55.04 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 175.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.82 ' HB2' HD11 ' A' ' 142' ' ' LEU . 58.5 t30 -69.15 151.91 45.78 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 175.302 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 29.0 ttpp -65.06 -12.0 45.74 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.683 -176.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.422 ' HB3' ' NH2' ' A' ' 169' ' ' ARG . 19.4 t70 -86.41 -26.43 24.75 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -177.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.71 ' HA2' ' OD2' ' A' ' 75' ' ' ASP . . . 123.54 67.42 0.21 Allowed Glycine 0 CA--C 1.528 0.845 0 C-N-CA 118.587 -1.768 . . . . 0.0 115.684 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.54 ' HD2' ' HD2' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -178.66 148.64 0.44 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.656 0.383 . . . . 0.0 110.178 161.568 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.713 HG22 ' HB3' ' A' ' 164' ' ' ARG . 61.2 t -101.06 142.87 15.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.316 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -167.05 157.01 29.26 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.56 ' HA ' ' HA ' ' A' ' 162' ' ' SER . 31.7 mtp -74.21 136.49 42.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.973 0.386 . . . . 0.0 110.135 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.897 HD13 HG11 ' A' ' 178' ' ' VAL . 2.7 pp -134.17 150.19 73.47 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.631 -177.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 173' ' ' ILE . 4.0 Cg_exo -76.97 127.86 9.61 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 123.0 2.467 . . . . 0.0 112.33 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.616 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 26.2 t -64.11 -42.16 66.79 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 9.6 Cg_endo -53.27 -13.6 3.44 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.968 2.445 . . . . 0.0 113.962 171.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -96.58 -14.69 22.04 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 111.607 0.225 . . . . 0.0 111.607 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 1.05 HG12 HG22 ' A' ' 130' ' ' THR . 5.9 m -125.6 161.55 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 121.992 0.901 . . . . 0.0 113.112 -169.106 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.755 ' CG ' HD11 ' A' ' 131' ' ' LEU . 3.5 mm-40 -124.45 160.36 28.42 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.156 177.311 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -98.34 137.18 37.43 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -176.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 10.2 tp . . . . . 0 C--N 1.324 -0.501 0 CA-C-O 121.094 0.473 . . . . 0.0 109.921 -179.451 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo . . . . . 0 N--CA 1.466 -0.144 0 CA-C-O 121.224 0.427 . . . . 0.0 111.691 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.717 ' CG1' HD12 ' A' ' 293' ' ' ILE . 41.4 t -115.49 136.88 50.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.992 -176.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -104.68 117.04 33.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.96 178.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.492 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -120.2 125.12 47.38 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.739 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -85.26 124.15 31.57 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' ALA . . . . . 0.579 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -69.53 112.38 6.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.841 0.353 . . . . 0.0 110.385 -178.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 33.7 pt -84.46 -16.94 10.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.507 -177.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.505 ' HA ' HG22 ' A' ' 260' ' ' VAL . 16.4 pt20 -150.35 153.68 36.48 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.099 173.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.463 ' C ' ' HD2' ' A' ' 245' ' ' LYS . 0.1 OUTLIER -75.75 169.79 17.45 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.449 0.642 . . . . 0.0 112.112 -171.708 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 38.6 ttt85 -170.28 115.94 0.51 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.409 172.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 8.7 p -122.11 141.02 33.4 Favored Pre-proline 0 C--N 1.316 -0.875 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -45.49 111.36 0.31 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.846 2.364 . . . . 0.0 112.873 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' CYS . . . . . 0.431 ' H ' ' HB2' ' A' ' 252' ' ' ASP . 31.7 t -90.16 -173.03 3.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.717 178.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.418 ' N ' ' SG ' ' A' ' 249' ' ' CYS . . . -62.69 -27.92 69.58 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.982 0.42 . . . . 0.0 111.938 -177.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -101.02 1.14 39.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.327 -177.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' ASP . . . . . 0.451 ' HB3' ' CB ' ' A' ' 255' ' ' ALA . 27.2 m-20 -97.7 97.19 8.81 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -173.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 253' ' ' LYS . . . . . 0.835 ' HG3' HG23 ' A' ' 254' ' ' THR . 45.6 tptt -91.25 139.44 30.74 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 171.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 254' ' ' THR . . . . . 0.835 HG23 ' HG3' ' A' ' 253' ' ' LYS . 26.2 p 65.96 14.92 9.85 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.035 0.934 . . . . 0.0 112.27 178.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 255' ' ' ALA . . . . . 0.451 ' CB ' ' HB3' ' A' ' 252' ' ' ASP . . . -79.11 151.88 31.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.655 0.264 . . . . 0.0 110.974 -178.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.576 HD23 ' N ' ' A' ' 257' ' ' ALA . 2.5 tt -102.91 142.99 33.09 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.576 ' N ' HD23 ' A' ' 256' ' ' LEU . . . -87.43 101.75 13.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.147 0.499 . . . . 0.0 110.451 178.066 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.986 HD21 HG21 ' A' ' 279' ' ' VAL . 84.0 mt -116.38 142.75 46.44 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.557 -177.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -124.13 162.57 23.3 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.109 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.505 HG22 ' HA ' ' A' ' 244' ' ' GLN . 43.6 t -66.59 125.46 23.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.38 -174.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 105.53 -11.92 46.88 Favored Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.074 176.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -84.8 175.44 9.15 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.932 0.366 . . . . 0.0 110.204 -174.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 48.4 mm -115.57 117.46 55.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.352 0.596 . . . . 0.0 110.982 -176.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.517 HG22 HD22 ' A' ' 258' ' ' LEU . 2.9 t -97.05 103.06 14.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.713 178.112 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -85.94 90.4 8.07 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.259 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.579 ' HA ' ' HA2' ' A' ' 277' ' ' GLY . 1.8 p -86.82 137.51 20.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.158 0.504 . . . . 0.0 110.582 -175.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 20.5 p -109.67 -35.73 6.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.527 -173.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 268' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 268' ' ' ARG . 1.0 OUTLIER -131.73 126.24 34.0 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.139 0.495 . . . . 0.0 109.683 179.407 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 57.9 mtt -106.3 116.64 32.28 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.935 0.398 . . . . 0.0 111.162 -178.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.531 ' HB2' ' O ' ' A' ' 274' ' ' GLN . 85.6 m-20 -78.68 121.46 24.72 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 175.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 47.2 mm -57.79 -24.96 24.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.173 -174.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -61.77 -32.28 72.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.411 -178.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 146.41 -44.45 0.84 Allowed Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.172 -1.013 . . . . 0.0 113.342 177.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.531 ' O ' ' HB2' ' A' ' 270' ' ' ASN . 0.1 OUTLIER -86.29 120.05 27.23 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.067 0.46 . . . . 0.0 110.608 -178.988 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.424 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 41.7 m0 -94.48 160.83 14.47 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.597 -177.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.494 ' HB3' ' HD2' ' A' ' 283' ' ' LYS . 39.3 mt-10 -106.59 105.84 16.07 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 173.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 277' ' ' GLY . . . . . 0.579 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -108.5 146.7 16.52 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.608 -178.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -102.03 108.54 20.01 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 279' ' ' VAL . . . . . 0.986 HG21 HD21 ' A' ' 258' ' ' LEU . 97.1 t -119.4 117.58 54.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.694 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 62.86 30.82 16.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.549 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 83.38 6.27 87.86 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.772 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 282' ' ' ARG . . . . . 0.412 ' NH1' ' H ' ' A' ' 257' ' ' ALA . 51.1 ttt180 -117.52 126.28 52.32 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.667 0.27 . . . . 0.0 110.759 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.567 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 27.2 ttpp -102.97 133.62 47.78 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.124 0.488 . . . . 0.0 111.035 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -153.98 171.02 32.63 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.625 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.424 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 64.0 mt -83.88 131.33 34.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.977 0.417 . . . . 0.0 111.027 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.402 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 23.9 p90 -142.34 144.37 30.79 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.777 175.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 287' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 1.8 Cg_endo -83.7 138.77 8.46 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.911 2.407 . . . . 0.0 111.661 176.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.4 ' HA ' HG22 ' A' ' 291' ' ' VAL . 41.5 p90 -65.54 -8.39 19.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.592 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 17.2 p -75.85 -9.34 58.52 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.52 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -104.97 -6.25 20.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.799 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.579 HG12 ' HA ' ' A' ' 242' ' ' ALA . 22.4 m -128.34 172.25 15.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.125 0.488 . . . . 0.0 111.173 -177.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -137.47 131.42 31.86 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.032 171.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.717 HD12 ' CG1' ' A' ' 238' ' ' VAL . 47.5 mm -73.39 134.47 29.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.731 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -138.03 151.68 48.11 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 174.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 295' ' ' ASP . . . . . 0.778 ' HB3' ' HD3' ' A' ' 296' ' ' PRO . 12.2 t70 -93.1 -58.48 0.22 Allowed Pre-proline 0 C--N 1.323 -0.586 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.026 -178.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 296' ' ' PRO . . . . . 0.778 ' HD3' ' HB3' ' A' ' 295' ' ' ASP . 9.6 Cg_endo . . . . . 0 C--N 1.357 0.983 0 C-N-CA 122.615 2.21 . . . . 0.0 112.779 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.414 ' O ' HG23 ' A' ' 99' ' ' ILE . 20.4 m . . . . . 0 CA--C 1.529 0.158 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.15 102.66 3.09 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 177.162 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 25.6 mtm105 -122.35 3.35 9.73 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -175.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.45 ' HB3' ' HA ' ' A' ' 100' ' ' GLU . 17.0 p90 -83.13 150.42 26.27 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.917 -178.139 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -52.61 -43.85 65.65 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.479 -176.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.6 t 58.33 47.59 13.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.048 -172.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.7 t -171.97 -36.36 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.617 178.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -70.73 107.19 3.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.472 -175.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -60.43 -37.35 80.63 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.506 -175.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.5 t -72.87 -6.52 45.59 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.463 -177.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.86 -37.39 12.31 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -178.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 38.2 p-90 -122.58 -24.85 4.84 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -174.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -79.41 118.05 20.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.166 0.508 . . . . 0.0 110.687 -176.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.575 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 22.0 mmt -99.42 -10.08 22.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.894 -176.604 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.49 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.22 -113.47 2.27 Favored Glycine 0 CA--C 1.519 0.327 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.282 -178.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.49 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 19.4 Cg_exo -66.62 87.13 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.271 2.648 . . . . 0.0 113.161 -176.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.933 HG12 ' H ' ' A' ' 20' ' ' SER . 93.3 t -136.84 -166.58 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 178.262 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.933 ' H ' HG12 ' A' ' 19' ' ' VAL . 42.1 p -162.25 169.73 20.2 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 119.768 1.167 . . . . 0.0 108.122 -168.03 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 34.8 ttt85 -67.16 -39.37 86.5 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.739 -175.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -65.0 -53.83 39.96 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.88 0.372 . . . . 0.0 110.995 178.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -62.57 -47.22 84.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.356 -177.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.14 -38.58 71.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.117 0.484 . . . . 0.0 110.706 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -62.24 -57.74 10.33 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.655 178.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.8 t -65.73 -15.23 62.62 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -173.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.6 mtp180 -87.33 -13.52 43.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.589 0.233 . . . . 0.0 110.951 179.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.557 HD11 ' HG ' ' A' ' 37' ' ' LEU . 32.6 mt -130.43 -1.88 4.4 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -73.91 96.0 2.55 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.216 0.531 . . . . 0.0 111.109 -174.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.13 14.09 69.97 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.146 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -81.58 -169.03 2.11 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 122.281 0.233 . . . . 0.0 110.752 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.604 ' HB2' ' SD ' ' A' ' 35' ' ' MET . 51.3 mtm180 -60.99 127.03 29.54 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 177.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.484 ' CE1' ' HA ' ' A' ' 55' ' ' ASN . 6.2 m-70 -77.49 116.97 18.5 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.862 -176.178 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 129.33 -17.92 5.55 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -172.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.759 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 50.0 mtp -72.88 160.15 32.59 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 115.432 -0.384 . . . . 0.0 110.335 176.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.456 ' H ' ' HA ' ' A' ' 101' ' ' PRO . 43.3 p90 -163.98 169.23 18.29 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 178.03 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.575 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.6 pp -157.0 140.89 16.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.163 0.506 . . . . 0.0 111.183 175.056 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 50.8 t -108.92 123.0 64.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.261 175.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.44 ' HB2' ' HB ' ' A' ' 19' ' ' VAL . 33.3 ptt-85 -123.04 -177.83 3.79 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.013 -177.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -80.34 138.99 36.78 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 175.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.1 m -77.4 99.06 5.46 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 172.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.9 m -73.93 -9.62 58.83 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.247 178.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.3 p -83.53 -56.69 3.6 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.101 175.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 57.7 m -114.84 96.33 44.17 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.88 176.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.82 132.72 51.0 Favored 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 123.006 2.471 . . . . 0.0 112.618 -178.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.64 -27.14 17.55 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.389 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.59 ' OD1' ' HA ' ' A' ' 64' ' ' ASN . 33.1 m-20 -93.45 178.24 5.77 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -131.42 171.41 13.41 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 178.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.6 t -139.41 112.24 5.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.97 0.414 . . . . 0.0 110.999 175.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.403 ' CB ' HD11 ' A' ' 63' ' ' ILE . 51.0 tp -82.05 103.44 11.69 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.741 174.141 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 37.5 m -96.18 127.66 42.39 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 174.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 98.3 t -111.18 139.89 33.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.02 0.438 . . . . 0.0 111.038 -174.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.556 ' HB2' HD22 ' A' ' 28' ' ' LEU . 28.3 t -87.95 116.12 25.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.282 179.256 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.498 ' O ' ' N ' ' A' ' 56' ' ' SER . 75.8 mt-10 -144.46 178.4 7.97 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-O 118.379 -0.819 . . . . 0.0 108.832 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.624 ' C ' ' HB2' ' A' ' 57' ' ' ARG . 11.2 m-80 -24.11 65.46 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 126.934 2.094 . . . . 0.0 115.833 -176.337 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 54' ' ' GLU . 21.0 m 48.59 57.35 6.39 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -171.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.785 HH22 ' HA ' ' A' ' 154' ' ' GLU . 0.3 OUTLIER -162.05 58.24 0.25 Allowed 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.322 -1.308 . . . . 0.0 112.18 -145.641 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 11.2 t -74.5 97.91 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 122.058 0.933 . . . . 0.0 109.394 -172.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.565 ' HB2' ' CE2' ' A' ' 61' ' ' TYR . 0.1 OUTLIER -79.07 121.02 24.45 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 113.907 -1.497 . . . . 0.0 111.287 -175.456 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -98.05 108.34 21.02 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -173.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.565 ' CE2' ' HB2' ' A' ' 59' ' ' SER . 79.3 m-85 -110.18 107.42 17.22 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.04 178.002 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.578 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 53.3 mt -80.49 137.35 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -175.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.58 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 5.4 mp -116.47 117.69 56.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.728 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.59 ' HA ' ' OD1' ' A' ' 47' ' ' ASP . 87.3 m-20 -87.3 139.73 30.26 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.863 -177.15 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.8 t -86.76 98.51 11.2 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 173.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 1.003 HD11 ' HG3' ' A' ' 72' ' ' LYS . 91.6 mt -80.78 146.66 60.55 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.346 -175.286 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 66' ' ' LEU . 11.9 Cg_exo -71.05 -2.19 10.69 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.743 2.295 . . . . 0.0 110.235 170.039 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -81.92 5.07 20.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.151 177.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.731 ' HA ' ' HE ' ' A' ' 69' ' ' ARG . 3.2 tpm_? 62.98 29.0 16.47 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.306 -173.138 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.452 ' HB2' HD12 ' A' ' 66' ' ' LEU . 88.7 mtt180 -128.63 179.17 5.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.402 -177.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.58 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 31.4 m-85 -134.92 119.76 18.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.19 -178.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 1.003 ' HG3' HD11 ' A' ' 66' ' ' LEU . 38.8 mttm -96.31 101.11 12.7 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -175.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.626 HD13 ' HE2' ' A' ' 88' ' ' TYR . 10.0 tt -83.37 99.11 5.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.405 0.622 . . . . 0.0 109.476 173.073 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.408 ' O ' ' HB3' ' A' ' 75' ' ' ASP . . . 62.8 44.31 97.65 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.428 -174.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.445 ' HA ' ' HD3' ' A' ' 72' ' ' LYS . 25.4 t70 75.61 -25.07 0.21 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.172 0.589 . . . . 0.0 111.915 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.69 107.79 4.1 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 174.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.497 ' HB3' ' CG ' ' A' ' 72' ' ' LYS . 12.7 pt-20 -96.23 137.87 34.66 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.887 0.851 . . . . 0.0 112.404 -171.226 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.595 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 96.6 m-85 -122.33 162.65 21.14 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 114.159 -1.382 . . . . 0.0 107.97 174.036 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.45 ' HA ' ' HG2' ' A' ' 70' ' ' ARG . 3.2 p-10 -69.55 -15.36 63.21 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -172.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.456 ' CE1' ' HB2' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -172.29 171.57 4.75 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.459 174.036 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.512 HD23 HD21 ' A' ' 84' ' ' LEU . 9.7 mt -53.32 -54.22 47.52 Favored Pre-proline 0 N--CA 1.469 0.511 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 81' ' ' LEU . 27.6 Cg_endo -63.21 3.56 0.56 Allowed 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.436 2.09 . . . . 0.0 114.176 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.456 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -98.46 -31.49 11.97 Favored 'General case' 0 C--N 1.331 -0.211 0 O-C-N 122.292 -0.255 . . . . 0.0 110.53 178.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.595 ' HB3' ' CD2' ' A' ' 78' ' ' PHE . 4.0 pp -76.42 -35.7 58.4 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 51.0 mt -68.54 -20.03 64.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.893 176.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -86.53 -28.41 23.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.619 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.711 ' HE1' ' CE1' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -88.41 -19.52 26.46 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.238 0.542 . . . . 0.0 111.167 -177.341 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.711 ' CE1' ' HE1' ' A' ' 87' ' ' PHE . 45.1 m-85 -87.33 2.33 50.6 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 121.19 -0.944 . . . . 0.0 110.659 177.241 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -74.97 -18.32 60.4 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.021 174.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.618 HD13 ' O ' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -127.02 -3.83 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 CA-C-O 121.174 0.512 . . . . 0.0 110.194 -179.306 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.4 ' HB2' ' O ' ' A' ' 87' ' ' PHE . 3.3 t60 -88.92 -32.76 17.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.848 -173.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.518 ' CD2' HG23 ' A' ' 97' ' ' THR . 95.5 m-85 61.86 106.25 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 O-C-N 124.119 0.887 . . . . 0.0 110.108 -171.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 13.0 mt -66.49 -85.51 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 174.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.418 ' OD1' ' ND2' ' A' ' 55' ' ' ASN . 14.5 t70 -79.9 -130.76 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 172.299 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.1 t -87.27 12.25 12.29 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.211 0.529 . . . . 0.0 110.164 177.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.9 t -143.03 160.34 40.55 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.585 -178.116 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.518 HG23 ' CD2' ' A' ' 92' ' ' TYR . 6.6 p -100.27 -179.7 4.2 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.119 175.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.7 mt -75.41 106.89 7.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.187 0.517 . . . . 0.0 109.779 175.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.414 HG23 ' O ' ' A' ' 3' ' ' SER . 46.4 mm -90.23 -65.21 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.503 -175.291 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.759 ' O ' ' HA ' ' A' ' 35' ' ' MET . 10.9 pt-20 -159.18 140.81 9.7 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.206 178.428 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.456 ' HA ' ' H ' ' A' ' 36' ' ' PHE . 38.3 Cg_endo -65.49 170.2 11.4 Favored 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.831 2.354 . . . . 0.0 112.984 -175.335 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.423 ' C ' ' H ' ' A' ' 104' ' ' ARG . . . -68.71 126.5 92.81 Favored Pre-proline 0 N--CA 1.447 -0.597 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 170.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -69.15 28.86 0.16 Allowed 'Trans proline' 0 N--CA 1.478 0.571 0 C-N-CA 123.461 2.774 . . . . 0.0 114.135 -169.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.423 ' H ' ' C ' ' A' ' 102' ' ' ALA . 41.0 ttm180 . . . . . 0 N--CA 1.464 0.255 0 C-N-CA 123.644 0.777 . . . . 0.0 111.056 -177.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.776 HD12 HG21 ' A' ' 152' ' ' ILE . 3.1 mm? . . . . . 0 CA--C 1.516 -0.347 0 CA-C-O 121.665 0.745 . . . . 0.0 109.493 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.526 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 39.9 tt0 -173.69 -60.07 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.303 -172.061 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -118.76 106.79 12.9 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 121.691 0.758 . . . . 0.0 110.524 177.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.876 HG22 ' HB3' ' A' ' 180' ' ' LYS . 20.9 t -115.68 134.97 57.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 114.375 -1.284 . . . . 0.0 108.771 -178.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.68 ' HG3' ' CG ' ' A' ' 179' ' ' GLU . 5.7 ptp180 -110.48 136.12 50.12 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 116.463 -2.095 . . . . 0.0 109.773 167.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.594 HG22 HG12 ' A' ' 178' ' ' VAL . 0.7 OUTLIER -93.57 142.21 27.6 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.711 -175.655 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.654 HD22 ' N ' ' A' ' 131' ' ' LEU . 2.0 mm? -115.04 -26.99 7.5 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.342 -165.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.513 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 37.1 t80 -89.36 -30.79 18.14 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.86 -172.328 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.604 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 8.8 t70 71.63 98.69 0.07 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.391 0.615 . . . . 0.0 109.545 -174.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.455 ' O ' ' HA ' ' A' ' 143' ' ' PRO . 53.7 t80 -123.9 84.07 54.67 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 177.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.622 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 66.7 Cg_endo -82.29 61.29 7.67 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.281 1.988 . . . . 0.0 112.894 -177.001 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -62.38 -29.8 74.35 Favored Glycine 0 C--N 1.331 0.301 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.589 178.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.46 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 10.0 m-80 64.03 65.39 0.69 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 114.861 -0.669 . . . . 0.0 112.143 176.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.479 ' HB3' ' H ' ' A' ' 140' ' ' GLU . 0.8 OUTLIER -145.72 169.49 18.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.908 177.019 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -89.41 -6.64 56.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.765 0.793 . . . . 0.0 109.253 172.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.479 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 11.6 mp0 -104.23 -19.76 14.01 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.575 175.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -135.38 107.69 7.28 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 1.058 HD11 ' HB2' ' A' ' 165' ' ' ASN . 33.1 tp -70.96 127.32 91.83 Favored Pre-proline 0 C--N 1.325 -0.465 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.745 -176.146 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.651 ' HD2' HD12 ' A' ' 142' ' ' LEU . 95.9 Cg_endo -81.7 93.71 0.95 Allowed 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 122.014 1.809 . . . . 0.0 111.367 172.391 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.514 ' CD1' ' HB ' ' A' ' 130' ' ' THR . 10.0 p90 -105.76 159.74 15.76 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.385 -174.213 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.604 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 56.5 mtpt -102.68 -169.0 1.6 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -175.031 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.574 ' HD2' ' N ' ' A' ' 146' ' ' LYS . 9.2 mptt -74.54 -13.49 60.68 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.154 -167.495 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -164.67 25.77 0.18 Allowed Glycine 0 CA--C 1.503 -0.692 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.32 -178.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.531 ' HB3' ' HB2' ' A' ' 145' ' ' LYS . 0.1 OUTLIER -79.54 148.28 31.84 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.001 0.429 . . . . 0.0 111.024 -177.458 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.516 HG13 ' HB3' ' A' ' 129' ' ' ARG . 1.8 mp -94.13 129.77 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.399 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.764 HD22 HD21 ' A' ' 142' ' ' LEU . 9.3 mt -121.47 156.95 31.67 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 -175.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.608 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 57.3 t -111.12 122.82 66.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 174.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 1.054 HD13 ' HB2' ' A' ' 163' ' ' ALA . 49.8 mm -76.78 79.91 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 122.344 1.069 . . . . 0.0 108.49 -177.347 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.529 HG23 ' HG3' ' A' ' 154' ' ' GLU . 18.1 tt -72.6 -25.89 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 113.551 -1.658 . . . . 0.0 110.113 -174.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.785 ' HA ' HH22 ' A' ' 57' ' ' ARG . 0.5 OUTLIER -140.88 153.36 45.68 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 173.85 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.413 ' HG3' ' CD1' ' A' ' 161' ' ' TRP . 79.3 tttt -140.85 91.98 8.94 Favored Pre-proline 0 C--N 1.32 -0.68 0 O-C-N 122.047 -0.408 . . . . 0.0 110.591 177.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.756 ' HG2' ' SD ' ' A' ' 172' ' ' MET . 2.8 Cg_endo -81.62 -39.85 0.17 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.573 2.182 . . . . 0.0 111.999 -174.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.43 ' HB2' ' HB2' ' A' ' 160' ' ' TRP . 46.2 mm-40 -114.66 161.86 17.55 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.38 -179.185 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -85.68 -7.87 58.54 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 173.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.992 ' HG3' ' HD1' ' A' ' 160' ' ' TRP . 21.0 pt20 -111.16 -17.69 13.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.728 178.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.992 ' HD1' ' HG3' ' A' ' 159' ' ' GLN . 47.5 m95 -131.78 131.55 43.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.397 178.559 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' TRP . . . . . 0.731 ' HB3' HD12 ' A' ' 152' ' ' ILE . 48.5 m0 -119.53 140.56 50.32 Favored 'General case' 0 C--O 1.212 -0.911 0 C-N-CA 122.877 0.471 . . . . 0.0 110.643 -176.067 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.591 ' OG ' ' HG2' ' A' ' 172' ' ' MET . 30.4 m -100.2 97.59 8.38 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -176.375 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 1.054 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -108.66 146.44 33.42 Favored 'General case' 0 N--CA 1.416 -2.129 0 C-N-CA 119.951 -0.7 . . . . 0.0 109.154 -173.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.692 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 19.9 ptt-85 -87.48 122.67 31.5 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 175.163 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 1.058 ' HB2' HD11 ' A' ' 142' ' ' LEU . 7.6 t30 -56.74 175.5 0.12 Allowed 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 113.572 -1.649 . . . . 0.0 110.282 -175.362 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -60.3 -13.48 13.06 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.322 0.582 . . . . 0.0 109.78 171.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -81.92 -26.43 34.07 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.005 174.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 100.69 -4.97 56.6 Favored Glycine 0 CA--C 1.521 0.421 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.112 -173.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.692 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.7 OUTLIER -69.05 134.31 49.24 Favored 'General case' 0 C--O 1.216 -0.71 0 C-N-CA 123.108 0.563 . . . . 0.0 110.903 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.499 HG22 HG21 ' A' ' 153' ' ' ILE . 39.3 t -86.75 128.07 39.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 O-C-N 122.049 -0.407 . . . . 0.0 110.969 178.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -154.08 154.72 25.7 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.122 170.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.756 ' SD ' ' HG2' ' A' ' 156' ' ' PRO . 29.5 mtp -81.11 141.05 34.66 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 117.284 0.542 . . . . 0.0 110.889 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.664 ' CG2' ' HB3' ' A' ' 142' ' ' LEU . 2.6 pp -141.4 143.14 29.01 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.558 -174.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.481 ' HB2' ' CD1' ' A' ' 177' ' ' TYR . 15.3 Cg_exo -67.7 135.91 37.31 Favored 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 122.739 2.293 . . . . 0.0 113.164 -178.552 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.54 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 98.1 t -64.54 -45.65 76.86 Favored Pre-proline 0 CA--C 1.539 0.519 0 N-CA-C 112.816 0.672 . . . . 0.0 112.816 178.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 36.1 Cg_endo -66.41 7.9 0.35 Allowed 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 122.022 1.815 . . . . 0.0 112.938 178.161 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.481 ' CD1' ' HB2' ' A' ' 174' ' ' PRO . 3.7 m-85 -101.05 -13.87 18.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.258 177.296 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.598 ' HA ' HD23 ' A' ' 131' ' ' LEU . 1.5 m -116.07 175.49 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 N-CA-C 115.956 1.836 . . . . 0.0 115.956 -166.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.734 ' O ' ' HG3' ' A' ' 179' ' ' GLU 0.273 2.0 pt-20 -149.09 57.69 1.02 Allowed 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 112.294 -2.23 . . . . 0.0 111.044 -165.699 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.876 ' HB3' HG22 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -69.36 141.7 54.13 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 118.748 -2.47 . . . . 0.0 111.768 -165.498 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.453 HD13 ' CZ ' ' A' ' 129' ' ' ARG . 32.7 tp . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 112.161 -2.291 . . . . 0.0 112.362 -162.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo . . . . . 0 N--CA 1.454 -0.809 0 N-CA-C 109.604 -0.96 . . . . 0.0 109.604 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.538 ' CG1' HD12 ' A' ' 293' ' ' ILE . 2.8 t -65.66 139.67 20.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.729 -169.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -106.16 121.56 44.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.994 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.508 ' HB1' ' HB ' ' A' ' 291' ' ' VAL . . . -119.26 136.57 54.16 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.36 179.133 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.425 ' HB2' ' CE1' ' A' ' 294' ' ' PHE . 2.8 tppp? -86.97 122.34 30.69 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 178.399 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 242' ' ' ALA . . . . . 0.532 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -72.43 97.02 1.99 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.154 0.502 . . . . 0.0 110.278 177.36 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 19.1 pt -85.59 -25.68 6.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.712 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.79 138.92 50.14 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.409 ' HE3' ' HB2' ' A' ' 245' ' ' LYS . 34.5 ttmt -67.61 155.81 38.28 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.2 -173.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 15.5 mmm180 -134.91 128.44 32.58 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.473 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.474 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 8.2 m -134.56 130.14 19.78 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.18 176.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.546 ' HD3' ' HB2' ' A' ' 257' ' ' ALA . 3.5 Cg_exo -75.5 145.51 29.87 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 123.059 2.506 . . . . 0.0 112.128 -176.008 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 51.1 t -75.12 169.98 16.95 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -61.68 -19.56 62.48 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -176.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -110.61 4.52 20.32 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -178.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 252' ' ' ASP . . . . . 0.544 ' HB3' ' HB3' ' A' ' 255' ' ' ALA . 61.7 m-20 -91.06 112.96 25.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.51 0.195 . . . . 0.0 111.054 -178.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 253' ' ' LYS . . . . . 0.444 ' N ' ' HD2' ' A' ' 253' ' ' LYS . 10.9 mptt -95.4 -41.3 9.06 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.272 0.558 . . . . 0.0 109.986 175.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 6.8 p -98.93 21.25 11.86 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.188 -174.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 255' ' ' ALA . . . . . 0.544 ' HB3' ' HB3' ' A' ' 252' ' ' ASP . . . -102.61 113.31 26.57 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 121.06 -0.256 . . . . 0.0 110.434 177.397 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.529 HD23 ' H ' ' A' ' 257' ' ' ALA . 0.5 OUTLIER -70.87 144.03 50.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.048 0.452 . . . . 0.0 110.965 -175.705 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.546 ' HB2' ' HD3' ' A' ' 248' ' ' PRO . . . -105.43 136.21 45.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.58 177.163 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 94.9 mt -135.88 152.16 50.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.799 -173.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -118.64 155.57 30.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.267 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 36.6 t -68.19 129.9 33.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.607 -174.223 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 83.32 33.92 21.64 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.316 178.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -119.28 162.67 18.34 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 39.2 mm -102.18 109.81 27.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.01 0.434 . . . . 0.0 110.78 -177.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 16.8 t -89.61 104.82 15.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.381 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 265' ' ' LYS . . . . . 0.424 ' HE2' ' HB3' ' A' ' 278' ' ' GLU . 4.4 ptmt -87.06 102.02 14.02 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.631 177.071 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.504 HG21 ' HB3' ' A' ' 275' ' ' TRP . 3.0 p -92.93 123.99 45.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.182 0.515 . . . . 0.0 110.723 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 16.1 p -94.98 -27.01 15.86 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.383 -177.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 268' ' ' ARG . . . . . 0.577 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 42.2 ttm180 -131.92 103.16 6.16 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.997 0.427 . . . . 0.0 110.394 178.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 269' ' ' MET . . . . . 0.48 ' HG3' ' CD1' ' A' ' 275' ' ' TRP . 29.6 ttm -93.97 109.87 21.58 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.992 0.425 . . . . 0.0 110.734 -179.031 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -87.78 173.93 8.68 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.502 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 31.3 pt -107.6 5.7 9.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.874 0.369 . . . . 0.0 111.523 -176.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -83.3 -26.28 30.78 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.124 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 119.18 -10.29 11.83 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.139 -177.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.558 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 99.1 mt-30 -118.06 111.97 19.6 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 177.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.59 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 19.2 m0 -96.74 159.55 14.86 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.117 -175.25 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.577 ' HB2' ' HB3' ' A' ' 268' ' ' ARG . 48.0 mt-10 -100.81 111.68 23.95 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.255 175.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 277' ' ' GLY . . . . . 0.574 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -129.15 158.58 22.08 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.533 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.424 ' HB3' ' HE2' ' A' ' 265' ' ' LYS . 39.6 tt0 -110.25 109.99 20.66 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.902 0.382 . . . . 0.0 110.155 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 57.3 t -127.18 128.49 70.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.869 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 17.1 m120 63.03 25.59 15.07 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 123.442 0.464 . . . . 0.0 111.238 -177.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 75.52 19.49 79.25 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.059 -177.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 282' ' ' ARG . . . . . 0.403 ' NH1' ' HA ' ' A' ' 256' ' ' LEU . 1.4 tmt_? -129.73 117.36 20.16 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.574 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 25.1 pttm -103.68 142.4 34.39 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.803 -178.173 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -173.18 178.37 45.18 Favored Glycine 0 N--CA 1.439 -1.12 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.707 178.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.59 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 94.8 mt -81.09 130.55 35.07 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.766 0.317 . . . . 0.0 110.314 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -129.2 125.24 22.61 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.424 175.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -58.36 126.42 21.38 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 123.183 2.589 . . . . 0.0 111.787 174.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -64.75 -12.66 49.73 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.305 -174.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.19 -3.77 11.75 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -176.101 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -114.91 -2.65 12.83 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.023 -0.423 . . . . 0.0 111.212 -178.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.532 HG12 ' HA ' ' A' ' 242' ' ' ALA . 35.8 m -128.7 166.51 25.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.737 -0.21 . . . . 0.0 110.606 179.345 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? -131.34 132.49 44.5 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.716 0.293 . . . . 0.0 110.26 172.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.538 HD12 ' CG1' ' A' ' 238' ' ' VAL . 40.8 mm -76.61 125.29 36.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.116 177.066 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 294' ' ' PHE . . . . . 0.425 ' CE1' ' HB2' ' A' ' 241' ' ' LYS . 5.3 p90 -149.67 166.64 28.72 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -103.7 104.81 44.49 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 178.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo . . . . . 0 N--CA 1.459 -0.501 0 C-N-CA 122.883 2.388 . . . . 0.0 112.368 -179.261 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.8 m . . . . . 0 C--O 1.233 0.219 0 CA-C-O 120.865 0.364 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.558 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . 69.39 100.86 0.06 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.161 -176.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.432 HH11 ' HD3' ' A' ' 5' ' ' ARG . 3.4 ptp180 -125.87 81.33 1.98 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.433 0.635 . . . . 0.0 111.32 -177.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -147.98 157.56 43.59 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.74 177.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -85.88 9.51 16.55 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -171.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.0 m 65.54 -15.61 0.11 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 173.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.83 ' CA ' ' HE1' ' A' ' 14' ' ' TRP . 8.2 t -142.4 -71.02 0.33 Allowed 'General case' 0 C--O 1.246 0.919 0 CA-C-O 122.224 1.011 . . . . 0.0 110.82 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' A' ' 12' ' ' SER . 25.0 t0 -25.16 72.29 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 113.908 -1.497 . . . . 0.0 111.484 -148.589 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.68 ' H ' ' HD2' ' A' ' 11' ' ' ARG . 11.4 mmm180 -6.03 -53.37 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 126.437 2.335 . . . . 0.0 115.099 -159.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.5 ' N ' ' O ' ' A' ' 10' ' ' ASP . 6.0 t -65.49 12.84 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 121.548 -0.061 . . . . 0.0 110.912 176.49 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.492 ' O ' ' HG2' ' A' ' 101' ' ' PRO . . . -91.0 -29.71 17.22 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.187 177.534 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.83 ' HE1' ' CA ' ' A' ' 9' ' ' SER . 24.5 p-90 -151.49 -28.03 0.19 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -173.463 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -59.4 123.79 17.91 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -178.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.49 ' SD ' ' HA ' ' A' ' 104' ' ' ARG . 33.1 tpp -110.1 2.66 19.62 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.485 -171.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.53 ' O ' ' HB2' ' A' ' 39' ' ' ARG . . . 51.53 -104.85 0.17 Allowed Glycine 0 CA--C 1.524 0.619 0 O-C-N 123.592 0.557 . . . . 0.0 114.476 177.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.428 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 3.5 Cg_exo -78.25 110.13 2.81 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.783 2.322 . . . . 0.0 112.756 179.08 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.944 ' HB ' ' HG3' ' A' ' 39' ' ' ARG . 23.5 t -138.23 -73.1 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 119.421 -0.323 . . . . 0.0 111.636 177.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.478 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 69.9 m 79.93 -177.35 0.08 Allowed 'General case' 0 C--N 1.342 0.26 0 CA-C-N 117.781 0.264 . . . . 0.0 110.929 174.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -63.81 -49.61 72.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.549 0.214 . . . . 0.0 111.154 -171.072 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -59.89 -53.62 55.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.622 -173.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 57.9 mm-40 -64.07 -48.93 74.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.42 -178.448 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.02 -39.66 75.18 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.811 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.638 ' HA ' HG21 ' A' ' 58' ' ' VAL . 12.4 mm100 -70.06 -53.7 16.31 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -178.499 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.0 t -68.28 -27.14 66.06 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.007 0.432 . . . . 0.0 111.611 -173.056 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -87.46 -33.75 18.93 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.094 0.473 . . . . 0.0 110.87 -175.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.682 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 30.7 mt -106.33 28.17 8.01 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.616 -176.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.11 65.77 2.16 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.073 0.463 . . . . 0.0 111.941 -173.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 59.53 23.53 58.4 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.979 176.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -64.46 -81.67 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.681 0.277 . . . . 0.0 110.367 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.43 HH11 ' HD3' ' A' ' 32' ' ' ARG . 39.9 ttp-105 -107.34 132.57 52.99 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 173.212 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 67.2 m170 -81.74 110.64 17.25 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.026 0.441 . . . . 0.0 110.527 -179.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 137.25 -19.92 3.39 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.382 -175.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.732 ' HB2' ' HB3' ' A' ' 53' ' ' SER . 34.3 mtt -59.82 137.04 58.16 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 122.404 0.282 . . . . 0.0 111.169 176.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.575 ' CB ' HG22 ' A' ' 52' ' ' VAL . 22.0 p90 -146.78 158.27 43.87 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.941 173.216 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.498 ' O ' HD12 ' A' ' 37' ' ' LEU . 4.5 pp -151.66 143.0 23.42 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.574 173.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 84.2 t -114.65 120.58 64.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 176.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.944 ' HG3' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -134.51 169.22 17.6 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.714 -176.728 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.405 ' O ' ' HG2' ' A' ' 39' ' ' ARG . 1.8 m-20 -57.99 127.96 34.73 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 175.313 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.3 t -64.62 157.57 26.71 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.401 0.62 . . . . 0.0 111.895 -173.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.2 p -86.47 -11.01 52.98 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.4 177.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 32.7 p -88.62 -63.6 1.27 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.645 178.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.447 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 57.4 m -136.91 145.4 50.59 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.835 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 44' ' ' CYS . 21.8 Cg_exo -65.51 -28.09 53.74 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.765 2.31 . . . . 0.0 112.51 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -76.73 -6.17 84.63 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.121 -0.561 . . . . 0.0 112.317 178.02 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.49 ' OD1' ' HA ' ' A' ' 64' ' ' ASN . 46.1 m-20 -111.28 159.48 17.9 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 176.196 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -129.54 169.45 14.97 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 177.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.511 HG22 HG12 ' A' ' 62' ' ' ILE . 45.2 t -140.14 98.84 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.184 0.516 . . . . 0.0 111.144 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.8 tp -69.05 99.84 1.15 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.872 172.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.1 m -96.74 126.2 41.73 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 177.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.575 HG22 ' CB ' ' A' ' 36' ' ' PHE . 80.9 t -117.46 146.92 21.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.704 -176.485 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.732 ' HB3' ' HB2' ' A' ' 35' ' ' MET . 26.6 t -100.27 98.88 9.5 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 175.357 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.469 ' HB2' ' OD1' ' A' ' 94' ' ' ASP . 0.0 OUTLIER -144.35 156.39 44.22 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.727 -176.352 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.552 ' OD1' ' HE2' ' A' ' 155' ' ' LYS . 0.7 OUTLIER 66.56 -56.04 0.4 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.243 0.617 . . . . 0.0 112.652 -179.235 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.8 p 169.77 -6.95 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.721 0.809 . . . . 0.0 110.774 -175.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -134.68 -169.11 2.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.512 -175.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.638 HG21 ' HA ' ' A' ' 25' ' ' GLN . 26.2 t -114.55 104.92 17.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.504 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 75.1 m -84.0 119.34 24.82 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.551 0.691 . . . . 0.0 110.133 176.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -94.88 104.22 16.11 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.033 -175.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.81 ' HB3' HD11 ' A' ' 73' ' ' ILE . 57.6 m-85 -98.95 98.43 9.48 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.431 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.511 HG12 HG22 ' A' ' 49' ' ' VAL . 30.3 mt -80.75 130.93 35.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -174.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.617 HG13 ' HB ' ' A' ' 73' ' ' ILE . 4.0 mp -103.81 123.46 57.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.858 178.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.49 ' HA ' ' OD1' ' A' ' 47' ' ' ASP . 17.0 m120 -104.13 131.07 51.79 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -175.509 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.9 t -77.55 111.18 13.01 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 175.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.413 HD12 ' HB2' ' A' ' 70' ' ' ARG . 93.2 mt -77.15 143.69 70.24 Favored Pre-proline 0 C--N 1.318 -0.78 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.183 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 66' ' ' LEU . 52.3 Cg_exo -56.36 -22.33 41.11 Favored 'Trans proline' 0 CA--C 1.528 0.214 0 C-N-CA 122.888 2.392 . . . . 0.0 112.383 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.9 p30 -86.03 16.42 4.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.916 178.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.81 ' HA ' ' HE ' ' A' ' 69' ' ' ARG . 0.2 OUTLIER 66.73 35.38 5.15 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.008 174.172 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.413 ' HB2' HD12 ' A' ' 66' ' ' LEU . 97.6 mtt180 -114.4 171.03 7.87 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.096 173.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.493 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 36.6 m-85 -119.69 120.3 36.2 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.014 0.435 . . . . 0.0 110.753 179.105 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.897 ' HE2' ' HA ' ' A' ' 75' ' ' ASP . 88.0 tttt -114.48 103.74 11.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.867 -176.447 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.81 HD11 ' HB3' ' A' ' 61' ' ' TYR . 5.6 tt -92.71 111.69 24.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.279 0.561 . . . . 0.0 111.531 -175.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 57.25 51.15 59.29 Favored Glycine 0 C--N 1.329 0.183 0 CA-C-N 115.446 -0.797 . . . . 0.0 113.164 177.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.897 ' HA ' ' HE2' ' A' ' 72' ' ' LYS . 29.7 t70 72.04 -15.43 0.46 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.997 0.519 . . . . 0.0 111.872 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 46.3 tp60 -82.85 110.64 18.04 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.446 ' H ' ' HG2' ' A' ' 77' ' ' GLU . 7.1 pt-20 -87.82 127.82 35.33 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.026 -171.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -129.61 -179.86 5.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.066 177.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -76.71 -56.48 4.57 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.172 0.51 . . . . 0.0 110.843 177.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.569 ' ND1' ' HG2' ' A' ' 82' ' ' PRO . 2.4 p80 -147.08 177.8 8.88 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.519 -176.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.568 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 12.5 mt -59.49 -52.36 74.72 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -176.379 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.569 ' HG2' ' ND1' ' A' ' 80' ' ' HIS . 14.6 Cg_endo -60.65 -8.78 9.82 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 121.953 1.769 . . . . 0.0 113.197 177.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.92 -26.35 21.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.787 0.327 . . . . 0.0 110.485 -178.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.1 pp -91.1 -30.72 16.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.925 0.393 . . . . 0.0 110.082 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 95.0 mt -68.58 -33.9 74.86 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.253 178.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -71.83 -27.78 63.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.519 0.676 . . . . 0.0 110.376 175.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.523 ' O ' HG12 ' A' ' 90' ' ' ILE . 82.8 t80 -79.82 -37.02 36.01 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.806 -174.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.504 ' HE2' HD13 ' A' ' 73' ' ' ILE . 27.7 m-85 -74.16 0.59 13.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.795 0.331 . . . . 0.0 111.787 -178.384 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.403 ' HA ' ' HB ' ' A' ' 97' ' ' THR . 62.4 tttm -66.18 -25.35 66.9 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.34 168.398 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.523 HG12 ' O ' ' A' ' 87' ' ' PHE . 6.6 pt -88.21 -28.96 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 174.22 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.472 ' HB2' ' HD1' ' A' ' 88' ' ' TYR . 2.5 m170 -84.58 -24.44 29.21 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -172.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.612 ' HA ' ' HA ' ' A' ' 97' ' ' THR . 29.8 m-85 73.07 -7.61 1.46 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -179.131 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.667 HD22 ' CE2' ' A' ' 61' ' ' TYR . 14.3 mt 53.8 -25.67 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.586 1.554 . . . . 0.0 113.656 -169.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.555 ' H ' ' C ' ' A' ' 92' ' ' TYR . 2.9 p-10 -151.46 -51.92 0.12 Allowed 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 169.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.688 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 14.1 t -177.0 14.53 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.77 0.319 . . . . 0.0 110.745 -178.241 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.417 HG22 ' OD1' ' A' ' 94' ' ' ASP . 13.2 t -128.58 -29.38 2.41 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -173.227 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.612 ' HA ' ' HA ' ' A' ' 92' ' ' TYR . 16.4 p 70.18 166.0 0.28 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.995 1.318 . . . . 0.0 110.56 -171.149 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.49 ' CD2' HD11 ' A' ' 93' ' ' LEU . 21.3 mt -70.1 103.16 2.23 Favored 'General case' 0 C--O 1.221 -0.401 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 178.455 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.558 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 43.4 mm -87.81 -61.09 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.482 -175.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 101' ' ' PRO . 0.9 OUTLIER -148.43 154.82 42.13 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-O 120.994 0.426 . . . . 0.0 110.549 179.262 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.492 ' HG2' ' O ' ' A' ' 13' ' ' ALA . 16.9 Cg_exo -69.36 149.04 68.94 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.792 2.328 . . . . 0.0 112.092 177.056 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.48 153.42 93.77 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.577 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.87 136.4 69.74 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.561 2.174 . . . . 0.0 111.787 175.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.49 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 36.0 mtt180 . . . . . 0 C--N 1.327 -0.408 0 CA-C-O 121.235 0.54 . . . . 0.0 110.474 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.663 HD12 HG21 ' A' ' 152' ' ' ILE . 4.4 mm? . . . . . 0 CA--C 1.519 -0.238 0 CA-C-O 121.85 0.833 . . . . 0.0 112.861 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -173.27 -73.04 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.073 -1.421 . . . . 0.0 107.364 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.455 ' HB3' ' HB3' ' A' ' 181' ' ' LEU . 47.2 m-85 -109.64 139.21 44.94 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.081 -0.647 . . . . 0.0 110.643 177.238 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.489 ' CG1' ' HB ' ' A' ' 178' ' ' VAL . 5.3 t -135.29 161.5 39.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -178.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.491 ' CZ ' HD13 ' A' ' 181' ' ' LEU . 2.1 ptp180 -140.56 136.56 32.95 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 169.166 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' THR . . . . . 1.046 HG22 HG12 ' A' ' 178' ' ' VAL . 20.7 p -87.08 140.03 29.96 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.027 -174.326 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 13.1 mt -112.05 -31.66 6.82 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.245 -175.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -81.7 -31.78 31.98 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.432 -169.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.47 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 9.8 t70 69.02 110.4 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 O-C-N 123.627 0.58 . . . . 0.0 110.373 -173.265 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -141.85 101.5 5.9 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.877 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -94.42 90.69 0.12 Allowed 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 123.153 2.569 . . . . 0.0 112.44 176.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -89.86 -28.82 17.3 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.211 176.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 63.11 83.97 0.15 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 114.695 -0.753 . . . . 0.0 112.232 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.774 ' HB3' ' HB3' ' A' ' 141' ' ' ASP . 31.9 t70 -160.66 178.06 9.86 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 177.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -92.83 -12.19 31.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.082 0.468 . . . . 0.0 110.929 178.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.55 ' O ' ' HB2' ' A' ' 172' ' ' MET . 5.0 mp0 -120.54 6.78 10.56 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 176.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.774 ' HB3' ' HB3' ' A' ' 138' ' ' ASP . 10.7 t70 -132.91 107.21 8.16 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 175.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.633 ' HB3' ' CG2' ' A' ' 173' ' ' ILE . 57.3 tp -82.25 112.92 40.02 Favored Pre-proline 0 C--N 1.323 -0.575 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.681 -173.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.54 ' HD2' ' HD2' ' A' ' 169' ' ' ARG . 28.6 Cg_endo -69.71 100.96 0.85 Allowed 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 121.998 1.799 . . . . 0.0 111.489 175.301 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.593 ' CG ' HG21 ' A' ' 130' ' ' THR . 13.0 p90 -115.61 168.7 9.78 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.047 0.451 . . . . 0.0 111.669 -176.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.554 ' HB2' ' HG2' ' A' ' 148' ' ' GLU . 1.4 mptp? -112.66 -169.93 1.57 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.32 -177.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.897 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -87.56 3.96 45.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.226 0.536 . . . . 0.0 110.355 179.093 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.11 31.61 1.43 Allowed Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.157 -178.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.554 ' HG2' ' HB2' ' A' ' 145' ' ' LYS . 13.0 mm-40 -98.16 143.95 28.15 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.421 -0.215 . . . . 0.0 110.421 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.6 mp -102.6 132.69 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 175.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.636 ' HB3' ' HB1' ' A' ' 163' ' ' ALA . 11.1 mt -119.02 175.78 5.6 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -177.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.586 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 15.3 t -142.25 123.56 12.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.663 HG21 HD12 ' A' ' 125' ' ' LEU . 25.2 mm -78.91 79.79 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-O 122.404 1.097 . . . . 0.0 110.285 -174.103 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.503 HG23 ' HG3' ' A' ' 154' ' ' GLU . 19.4 tt -74.67 -35.76 38.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 113.452 -1.704 . . . . 0.0 110.418 -175.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 1.101 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 53.0 mt-10 -120.18 139.44 52.63 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 171.235 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.552 ' HE2' ' OD1' ' A' ' 55' ' ' ASN . 35.9 ttpt -132.25 81.89 59.8 Favored Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 122.037 -0.414 . . . . 0.0 110.058 170.024 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.688 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 11.7 Cg_exo -72.1 -46.36 0.54 Allowed 'Trans proline' 0 CA--C 1.515 -0.465 0 C-N-CA 122.43 2.086 . . . . 0.0 111.34 177.411 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -122.15 -178.94 4.0 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.265 -174.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -101.73 -22.25 14.45 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.302 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -89.14 -27.6 20.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.21 0.528 . . . . 0.0 110.5 -179.124 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.718 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 42.0 m95 -129.21 130.4 46.26 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.906 -179.406 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' TRP . . . . . 0.629 ' O ' HG13 ' A' ' 173' ' ' ILE . 54.2 m0 -123.12 137.58 54.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.704 178.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' SER . . . . . 1.101 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 16.2 m -84.46 106.37 15.99 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 176.062 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.636 ' HB1' ' HB3' ' A' ' 150' ' ' LEU . . . -116.9 162.27 18.01 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.279 -174.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.749 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 21.8 ptt-85 -109.93 127.78 54.96 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 175.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 0.6 ' HA ' HD22 ' A' ' 150' ' ' LEU . 19.7 p-10 -77.3 -174.06 3.11 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.999 -0.28 . . . . 0.0 111.205 -176.487 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -66.46 -25.8 66.9 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.237 0.541 . . . . 0.0 110.29 -177.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -70.72 -28.62 64.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.46 175.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 107.33 15.39 15.88 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.854 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.749 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 13.3 ttm-85 -92.86 134.3 35.22 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 122.779 0.431 . . . . 0.0 111.051 -176.01 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.557 HG22 ' HB3' ' A' ' 164' ' ' ARG . 60.0 t -99.18 136.89 28.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 120.848 0.356 . . . . 0.0 110.825 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -168.97 161.28 34.96 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 175.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.718 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.0 OUTLIER -69.26 132.56 46.66 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.897 0.348 . . . . 0.0 110.124 179.234 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.852 HD13 HG11 ' A' ' 178' ' ' VAL . 2.6 pp -134.12 144.0 49.58 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.645 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.483 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 5.2 Cg_exo -73.87 127.82 11.85 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.853 2.369 . . . . 0.0 111.688 -178.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.642 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 19.2 t -69.93 -35.33 5.16 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.642 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 11.3 Cg_endo -57.76 -16.83 26.82 Favored 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 121.832 1.688 . . . . 0.0 112.672 170.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.483 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.8 m-30 -87.33 -20.34 26.91 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.392 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 1.046 HG12 HG22 ' A' ' 130' ' ' THR . 4.8 m -118.83 174.66 4.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -168.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -140.62 166.83 23.67 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 173.176 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -94.76 138.68 32.27 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.119 0.485 . . . . 0.0 111.451 -176.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.491 HD13 ' CZ ' ' A' ' 129' ' ' ARG . 57.7 tp . . . . . 0 C--N 1.324 -0.521 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.34 175.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo . . . . . 0 N--CA 1.461 -0.423 0 CA-C-O 120.707 0.211 . . . . 0.0 111.594 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.661 HG11 HD12 ' A' ' 293' ' ' ILE . 41.1 t -91.23 129.39 42.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 120.908 0.385 . . . . 0.0 110.247 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -93.85 114.55 26.81 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.911 177.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.407 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -120.37 126.48 50.59 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.029 178.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -92.05 125.19 36.64 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 242' ' ' ALA . . . . . 0.601 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -71.52 114.77 9.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.038 0.447 . . . . 0.0 110.955 -176.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 23.1 pt -96.46 -20.28 5.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.672 -177.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 19.3 tm0? -140.16 138.09 34.91 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.124 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -55.8 152.89 9.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.491 0.662 . . . . 0.0 112.596 -172.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.693 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -142.4 99.95 3.6 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 177.999 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 17.9 m -123.51 156.1 64.75 Favored Pre-proline 0 C--N 1.321 -0.672 0 C-N-CA 120.804 -0.359 . . . . 0.0 111.9 -174.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -66.0 132.83 31.33 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.116 2.544 . . . . 0.0 112.949 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 25.7 p -151.19 152.2 32.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.991 177.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 60.03 -78.43 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 O-C-N 124.197 0.936 . . . . 0.0 112.963 176.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 251' ' ' TYR . . . . . 0.618 ' HD1' ' H ' ' A' ' 253' ' ' LYS . 6.4 p90 -79.74 -32.63 41.15 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.175 -178.076 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 55.57 25.42 7.96 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.898 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 253' ' ' LYS . . . . . 0.618 ' H ' ' HD1' ' A' ' 251' ' ' TYR . 63.1 tttm -130.88 144.6 51.58 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -178.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 254' ' ' THR . . . . . 0.41 HG23 ' HG2' ' A' ' 253' ' ' LYS . 27.0 p 60.77 15.4 5.86 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.716 0.806 . . . . 0.0 111.1 -175.4 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -102.12 102.43 12.89 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.154 -176.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.568 HD21 ' HB ' ' A' ' 279' ' ' VAL . 1.6 tt -83.95 123.38 29.91 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 176.376 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.693 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -79.43 93.18 5.33 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.185 0.517 . . . . 0.0 110.903 -178.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.815 HD21 HG21 ' A' ' 279' ' ' VAL . 65.7 mt -95.34 128.18 41.99 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.878 -178.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -101.94 148.13 25.71 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.22 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 57.5 t -63.94 127.56 24.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.009 0.433 . . . . 0.0 110.634 -177.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 103.21 -9.18 53.99 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.679 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -88.63 165.72 14.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.885 0.342 . . . . 0.0 110.339 -175.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 43.9 mm -107.5 132.11 55.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.826 -177.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.634 ' HA ' HG22 ' A' ' 279' ' ' VAL . 20.3 t -107.13 111.21 34.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.816 178.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -77.69 87.27 3.97 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.987 174.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.536 HG13 ' HB ' ' A' ' 238' ' ' VAL . 14.9 p -95.04 120.78 44.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.608 179.008 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 9.8 p -113.46 -16.72 12.38 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.891 -178.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 268' ' ' ARG . . . . . 0.567 ' HB2' ' HB3' ' A' ' 276' ' ' GLU . 16.1 mmm180 -121.98 100.28 6.89 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.566 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 55.6 mtt -95.49 116.35 28.7 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.967 0.413 . . . . 0.0 110.347 176.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.416 ' O ' ' HB ' ' A' ' 271' ' ' ILE . 78.8 m-20 -80.38 -6.73 58.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.915 -176.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.416 ' HB ' ' O ' ' A' ' 270' ' ' ASN . 48.1 mm 77.91 -39.52 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 123.537 0.735 . . . . 0.0 112.649 174.394 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 272' ' ' ASN . . . . . 0.745 HD21 ' HG2' ' A' ' 274' ' ' GLN . 22.7 p-10 -55.92 -37.92 69.56 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -177.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 150.82 -34.64 0.94 Allowed Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.622 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.745 ' HG2' HD21 ' A' ' 272' ' ' ASN . 2.4 pt20 -94.2 124.86 38.48 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 176.046 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.55 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 34.0 m0 -108.61 171.15 7.59 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 120.764 0.316 . . . . 0.0 111.243 -175.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.567 ' HB3' ' HB2' ' A' ' 268' ' ' ARG . 6.3 tp10 -112.93 100.24 8.49 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -178.322 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 277' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -119.54 145.69 17.97 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.872 -177.443 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.641 ' HB3' ' HG2' ' A' ' 283' ' ' LYS . 3.5 pt-20 -103.12 109.27 20.78 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.322 0.582 . . . . 0.0 109.765 176.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 279' ' ' VAL . . . . . 0.815 HG21 HD21 ' A' ' 258' ' ' LEU . 95.4 t -122.73 112.61 34.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.456 -173.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 59.14 20.25 8.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.412 172.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 127.63 -30.35 4.02 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.258 -0.972 . . . . 0.0 114.201 176.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 282' ' ' ARG . . . . . 0.402 ' HG2' ' N ' ' A' ' 283' ' ' LYS . 9.1 ttm105 -110.17 139.46 45.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 117.889 0.845 . . . . 0.0 111.578 -177.265 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.641 ' HG2' ' HB3' ' A' ' 278' ' ' GLU . 51.5 mttm -97.98 130.25 44.83 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 170.329 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 284' ' ' GLY . . . . . 0.527 ' HA3' ' HB2' ' A' ' 256' ' ' LEU . . . -152.94 162.47 30.07 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.263 -0.97 . . . . 0.0 112.65 -177.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.55 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 76.5 mt -85.35 115.71 23.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.13 0.49 . . . . 0.0 110.595 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.415 ' CZ ' HG11 ' A' ' 264' ' ' VAL . 16.7 p90 -122.82 129.37 25.03 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.132 178.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 287' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 18.8 Cg_exo -67.47 138.3 45.64 Favored 'Trans proline' 0 C--O 1.236 0.394 0 C-N-CA 122.435 2.09 . . . . 0.0 111.018 173.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -58.38 -22.17 52.82 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.065 -176.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 2.7 p -71.35 -1.49 13.11 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -178.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -100.03 -13.46 19.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.899 0.38 . . . . 0.0 110.396 177.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.601 HG12 ' HA ' ' A' ' 242' ' ' ALA . 30.7 m -128.31 177.78 5.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.634 -177.191 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -132.88 128.87 37.54 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.854 172.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.661 HD12 HG11 ' A' ' 238' ' ' VAL . 37.3 mm -78.63 128.02 38.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.691 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -141.31 151.42 43.6 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.787 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -99.14 129.43 29.47 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 175.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo . . . . . 0 CA--C 1.529 0.268 0 C-N-CA 122.975 2.45 . . . . 0.0 112.994 -178.19 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.545 ' HB2' HD12 ' A' ' 99' ' ' ILE . 8.7 p . . . . . 0 N--CA 1.452 -0.355 0 CA-C-O 120.651 0.262 . . . . 0.0 110.766 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.55 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . -69.74 98.82 1.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.775 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 5' ' ' ARG . 10.4 mmt85 -140.41 93.77 2.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.418 0.627 . . . . 0.0 111.566 -178.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -156.65 150.86 25.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.823 175.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.529 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 35.1 t0 -81.72 115.39 20.94 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 177.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.4 m -70.11 -12.73 61.81 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.743 -175.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.2 t -102.85 -12.32 17.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.239 0.542 . . . . 0.0 110.741 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.529 ' HB2' ' HB3' ' A' ' 7' ' ' ASP . 6.9 t70 -75.42 91.41 2.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.921 0.391 . . . . 0.0 110.05 -178.032 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -57.82 -39.13 76.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.545 -176.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.491 ' HA ' ' NH2' ' A' ' 104' ' ' ARG . 4.8 t -73.43 -1.55 18.76 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.159 -176.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.61 -44.47 8.58 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.356 176.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 29.9 p-90 -120.24 -21.2 7.05 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -171.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -77.58 122.83 25.81 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.102 0.477 . . . . 0.0 110.782 -176.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.542 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 25.0 mmt -104.53 -8.24 19.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.436 -175.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.447 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 50.89 -114.74 2.94 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-N 115.8 -0.636 . . . . 0.0 113.556 -176.272 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.447 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 11.3 Cg_exo -71.64 92.18 0.69 Allowed 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.948 2.432 . . . . 0.0 113.081 -176.405 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.467 HG21 ' HB3' ' A' ' 16' ' ' MET . 69.9 t -142.17 157.69 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 177.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.6 m -120.91 166.48 13.75 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -170.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 41.4 ttt85 -58.68 -48.98 79.26 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 123.04 0.213 . . . . 0.0 111.493 -177.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.469 ' CD ' ' H ' ' A' ' 22' ' ' GLN . 0.5 OUTLIER -60.59 -52.28 65.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.332 0.587 . . . . 0.0 110.767 -178.37 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -65.43 -47.62 75.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.261 -175.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.34 -38.65 71.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.488 0.661 . . . . 0.0 111.076 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.559 ' HA ' HG11 ' A' ' 58' ' ' VAL . 38.3 tt0 -72.66 -37.71 67.87 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.982 -174.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 10.2 t -75.08 -22.53 58.24 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 120.481 -0.487 . . . . 0.0 110.819 -178.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -81.26 -13.44 58.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.233 0.539 . . . . 0.0 110.583 177.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.577 ' O ' HG22 ' A' ' 58' ' ' VAL . 83.1 mt -126.11 16.25 7.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.486 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.35 77.67 3.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.087 0.47 . . . . 0.0 111.099 -174.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.63 16.75 72.25 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.678 -0.692 . . . . 0.0 113.067 177.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -64.41 -77.26 0.06 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.992 0.425 . . . . 0.0 110.39 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.6 mtm180 -124.63 125.69 44.55 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 175.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 53.0 m170 -71.38 119.08 15.01 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.957 0.408 . . . . 0.0 110.478 -178.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 109.36 -8.77 32.92 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.749 -176.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.612 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 37.4 ttp -84.28 129.5 34.88 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -138.11 171.43 14.41 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.711 -172.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.567 ' HG ' HD11 ' A' ' 28' ' ' LEU . 4.6 pp -157.72 139.58 14.08 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.181 173.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.42 HG22 HD13 ' A' ' 50' ' ' LEU . 42.4 t -105.83 123.69 60.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 176.137 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.442 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 24.3 ptt-85 -124.67 -179.47 4.52 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.341 -176.086 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -78.5 135.55 37.37 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 175.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.7 t -78.41 118.37 20.52 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.123 -178.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.8 t -78.46 -15.56 58.49 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.314 172.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 25.5 m -73.69 -45.32 53.09 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.734 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.428 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 50.6 t -138.83 124.47 12.2 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.323 -178.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 44' ' ' CYS . 23.4 Cg_exo -64.63 114.56 2.78 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 123.067 2.511 . . . . 0.0 112.548 -178.256 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.62 -16.05 29.04 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.835 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.571 ' OD2' ' HA ' ' A' ' 64' ' ' ASN . 1.2 m-20 -93.35 177.89 5.89 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.563 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 38.6 m-85 -130.59 174.18 10.16 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 179.023 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.9 t -142.59 110.04 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.611 0.243 . . . . 0.0 110.418 175.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.42 HD13 HG22 ' A' ' 38' ' ' VAL . 36.7 tp -82.23 106.31 14.02 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.951 174.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 53.1 m -96.15 134.04 39.71 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 173.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.661 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 67.2 t -121.96 146.46 27.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.097 -177.414 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.576 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 12.9 t -94.74 106.53 18.52 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 174.375 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.667 ' O ' ' HB3' ' A' ' 57' ' ' ARG . 1.0 OUTLIER -147.06 138.75 24.24 Favored 'General case' 0 C--O 1.207 -1.166 0 C-N-CA 118.564 -1.254 . . . . 0.0 110.989 176.075 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.433 HD21 ' HB2' ' A' ' 94' ' ' ASP . 2.5 p30 37.66 47.48 0.82 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -175.046 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.5 m 58.47 44.33 18.2 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 122.279 1.038 . . . . 0.0 109.907 176.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.71 HH22 ' HA ' ' A' ' 154' ' ' GLU . 8.7 ttp180 -157.84 67.41 0.49 Allowed 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.705 -1.589 . . . . 0.0 110.71 -154.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.661 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 5.0 t -69.98 99.53 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.893 0.854 . . . . 0.0 108.901 -170.465 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.463 ' HB2' ' CE2' ' A' ' 61' ' ' TYR . 7.9 m -84.19 122.58 29.06 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 113.799 -1.546 . . . . 0.0 111.157 -172.294 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 60.0 m-70 -93.39 101.95 14.18 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.968 0.413 . . . . 0.0 111.982 -174.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.8 ' HB3' HD11 ' A' ' 73' ' ' ILE . 65.1 m-85 -99.91 105.42 17.14 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.805 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.82 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 61.6 mt -80.7 129.53 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -173.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.587 HG13 ' HB ' ' A' ' 73' ' ' ILE . 3.8 mp -98.8 119.09 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.129 0.572 . . . . 0.0 110.424 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.616 ' O ' ' HA ' ' A' ' 71' ' ' PHE . 4.3 m120 -89.25 139.44 30.49 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.405 -169.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.1 t -88.34 92.06 9.03 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 171.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.683 HD12 ' HG3' ' A' ' 70' ' ' ARG . 84.8 mt -79.83 138.96 53.77 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.576 -178.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.99 -7.98 16.85 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.949 2.433 . . . . 0.0 112.118 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -90.21 20.22 4.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.758 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.605 ' HA ' ' HE ' ' A' ' 69' ' ' ARG . 0.3 OUTLIER 65.78 30.52 10.09 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.247 0.546 . . . . 0.0 111.089 177.362 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.683 ' HG3' HD12 ' A' ' 66' ' ' LEU . 3.8 ptp180 -138.66 -177.03 4.69 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.444 -178.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.616 ' HA ' ' O ' ' A' ' 64' ' ' ASN . 47.8 m-85 -124.06 157.87 33.51 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.264 -178.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.587 ' HB2' HD11 ' A' ' 66' ' ' LEU . 35.1 ttpt -138.69 100.49 4.09 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 175.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.82 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 3.9 tt -89.28 108.25 18.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.442 0.639 . . . . 0.0 110.666 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.09 37.88 94.69 Favored Glycine 0 C--N 1.321 -0.265 0 CA-C-N 115.175 -0.921 . . . . 0.0 112.366 176.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.407 ' HA ' ' HE3' ' A' ' 72' ' ' LYS . 17.5 t70 77.75 6.2 2.84 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.607 0.763 . . . . 0.0 111.501 178.031 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -102.73 123.39 46.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.867 0.365 . . . . 0.0 110.308 171.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -94.04 134.38 36.52 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.697 0.761 . . . . 0.0 112.102 -175.092 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.57 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 51.0 m-85 -136.43 170.28 16.3 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 172.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -70.68 -54.66 11.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.136 0.493 . . . . 0.0 111.182 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.552 ' ND1' ' HG2' ' A' ' 82' ' ' PRO . 3.0 p80 -144.31 172.65 12.64 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.624 -174.497 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.622 HD23 HD21 ' A' ' 84' ' ' LEU . 16.2 mt -55.18 -52.75 68.71 Favored Pre-proline 0 N--CA 1.469 0.514 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.552 ' HG2' ' ND1' ' A' ' 80' ' ' HIS . 19.5 Cg_endo -60.52 -3.41 2.56 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.316 2.011 . . . . 0.0 113.597 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.37 -36.45 10.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.723 0.297 . . . . 0.0 110.896 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.622 HD21 HD23 ' A' ' 81' ' ' LEU . 4.4 pp -76.51 -34.84 58.59 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.048 0.451 . . . . 0.0 110.154 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 78.0 mt -62.22 -33.31 74.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.122 176.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.632 ' HA ' ' HD3' ' A' ' 89' ' ' LYS . 20.0 tp10 -73.9 -37.4 64.67 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.506 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.436 ' CD2' ' HZ ' ' A' ' 78' ' ' PHE . 23.1 t80 -64.28 -37.61 88.09 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.124 0.487 . . . . 0.0 110.67 177.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.698 ' HE2' HD13 ' A' ' 73' ' ' ILE . 36.1 m-85 -79.16 -6.52 56.74 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.92 0.39 . . . . 0.0 111.759 -178.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.632 ' HD3' ' HA ' ' A' ' 86' ' ' GLU . 53.7 mtpt -83.81 -8.56 59.19 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.384 172.497 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 21.8 pt -128.23 9.42 3.01 Favored 'Isoleucine or valine' 0 C--N 1.342 0.26 0 CA-C-O 121.549 0.69 . . . . 0.0 109.604 174.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.433 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 3.3 t-160 -95.02 -47.2 6.5 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.244 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.447 ' H ' HG22 ' A' ' 97' ' ' THR . 95.3 m-85 62.77 88.33 0.1 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.028 -161.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.612 ' O ' ' HB3' ' A' ' 154' ' ' GLU . 13.7 mt -46.37 -65.14 0.6 Allowed 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 177.179 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.575 ' HB3' ' HG3' ' A' ' 54' ' ' GLU . 13.7 p-10 -98.86 -120.36 0.14 Allowed 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.249 172.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.551 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 4.6 t -94.11 6.15 49.49 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-O 120.963 0.411 . . . . 0.0 109.989 176.057 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.403 HG22 ' OD1' ' A' ' 94' ' ' ASP . 8.3 t -141.26 164.58 29.86 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.085 0.469 . . . . 0.0 110.706 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.447 HG22 ' H ' ' A' ' 92' ' ' TYR . 9.1 p -99.61 174.53 6.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.62 178.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 82.3 mt -68.42 107.06 2.73 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 173.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.55 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 49.2 mm -91.55 -58.73 3.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.792 -174.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.612 ' O ' ' HA ' ' A' ' 35' ' ' MET . 11.9 pt-20 -159.02 153.23 19.97 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.176 -178.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.34 163.31 39.03 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 122.668 2.245 . . . . 0.0 113.364 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.457 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -83.11 158.39 64.41 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.803 178.413 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -66.91 136.39 41.32 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.315 2.01 . . . . 0.0 111.151 173.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.535 ' HG2' ' SD ' ' A' ' 16' ' ' MET . 87.6 mtt180 . . . . . 0 C--N 1.328 -0.353 0 CA-C-O 120.815 0.34 . . . . 0.0 110.787 178.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.681 HD12 HG21 ' A' ' 152' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.278 0 N-CA-C 102.41 -3.182 . . . . 0.0 102.41 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.719 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 4.9 tp10 74.19 -73.23 0.1 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 118.501 0.591 . . . . 0.0 110.759 175.652 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -101.33 107.44 18.8 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 118.848 -1.141 . . . . 0.0 111.494 -176.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 1.054 HG22 ' HG3' ' A' ' 180' ' ' LYS . 97.3 t -124.87 136.37 61.02 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.078 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.298 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.65 ' CZ ' HD13 ' A' ' 181' ' ' LEU . 0.0 OUTLIER -111.18 151.37 28.29 Favored 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 117.376 -1.73 . . . . 0.0 108.33 167.925 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.597 ' OG1' ' HB2' ' A' ' 144' ' ' PHE . 0.9 OUTLIER -107.77 134.26 50.98 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.882 0.849 . . . . 0.0 111.234 179.379 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.57 HD21 ' HG2' ' A' ' 179' ' ' GLU . 10.5 mt -110.21 2.39 19.28 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.61 -176.229 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.523 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 24.2 t80 -105.2 -39.62 6.13 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.103 -0.639 . . . . 0.0 112.614 -174.291 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.588 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 8.6 t70 79.05 98.47 0.06 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.444 0.64 . . . . 0.0 109.973 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 69.4 t80 -126.32 91.65 47.26 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 173.164 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.742 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 70.8 Cg_endo -86.24 83.61 1.22 Allowed 'Trans proline' 0 N--CA 1.442 -1.549 0 C-N-CA 121.675 1.583 . . . . 0.0 112.808 -178.171 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -76.58 -31.19 54.97 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.092 175.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.424 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 20.9 m120 63.46 49.85 3.02 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.247 0.546 . . . . 0.0 111.34 176.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.457 ' HB3' ' H ' ' A' ' 140' ' ' GLU . 1.2 m-20 -135.24 177.44 7.81 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.779 176.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 170' ' ' VAL . . . -91.57 -10.96 38.65 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.674 0.75 . . . . 0.0 109.583 172.232 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.692 ' O ' ' HB2' ' A' ' 172' ' ' MET . 45.3 mt-10 -109.23 -2.83 17.68 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.066 176.098 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.41 ' HB2' ' HB2' ' A' ' 138' ' ' ASP . 29.5 m-20 -143.5 100.96 3.7 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 174.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 1.02 HD11 ' HB2' ' A' ' 165' ' ' ASN . 52.9 tp -70.6 132.1 87.57 Favored Pre-proline 0 CA--C 1.51 -0.581 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.351 -175.582 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.854 ' HD2' HD12 ' A' ' 142' ' ' LEU . 73.2 Cg_endo -83.07 93.53 0.85 Allowed 'Trans proline' 0 N--CA 1.436 -1.885 0 C-N-CA 120.931 1.088 . . . . 0.0 111.761 170.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.597 ' HB2' ' OG1' ' A' ' 130' ' ' THR . 17.2 p90 -102.78 164.18 11.78 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.957 ' H ' ' HG3' ' A' ' 148' ' ' GLU . 2.9 mptp? -114.57 -148.51 0.43 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.119 0.485 . . . . 0.0 111.769 -171.436 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.789 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -109.44 41.29 1.69 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.256 -179.648 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 147.89 28.88 0.07 OUTLIER Glycine 0 CA--C 1.525 0.716 0 C-N-CA 120.723 -0.751 . . . . 0.0 113.435 177.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.957 ' HG3' ' H ' ' A' ' 145' ' ' LYS . 0.0 OUTLIER -80.83 172.78 13.31 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 123.871 0.868 . . . . 0.0 109.732 171.319 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.637 HD12 ' HB3' ' A' ' 129' ' ' ARG . 0.6 OUTLIER -115.92 129.28 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.584 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.746 HD22 HD21 ' A' ' 142' ' ' LEU . 27.0 mt -120.76 157.27 30.07 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -173.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.719 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 70.7 t -130.78 123.15 53.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.577 177.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 1.063 HD13 ' HB2' ' A' ' 163' ' ' ALA . 40.8 mm -75.91 84.36 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 122.109 0.957 . . . . 0.0 109.706 -172.069 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.534 ' C ' HH12 ' A' ' 57' ' ' ARG . 14.0 tt -87.42 -31.89 6.08 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 CA-C-N 114.043 -1.435 . . . . 0.0 111.605 -169.075 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.71 ' HA ' HH22 ' A' ' 57' ' ' ARG . 10.8 mt-10 -122.49 142.27 50.76 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 164.345 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.464 ' NZ ' HD21 ' A' ' 125' ' ' LEU . 74.5 tttt -137.43 87.6 17.73 Favored Pre-proline 0 C--N 1.316 -0.86 0 CA-C-O 121.314 0.578 . . . . 0.0 110.627 176.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.496 ' HG2' ' HE2' ' A' ' 172' ' ' MET . 17.5 Cg_exo -71.24 -54.52 0.16 Allowed 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.683 2.255 . . . . 0.0 111.826 170.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.423 ' HG2' ' HB2' ' A' ' 156' ' ' PRO . 6.5 mm-40 -112.53 -176.58 2.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.815 -169.363 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -109.87 -8.9 14.82 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.231 173.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -96.13 -32.28 12.58 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.513 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.426 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 28.7 m95 -127.19 144.02 51.13 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.082 174.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' TRP . . . . . 0.917 ' HB3' HD12 ' A' ' 152' ' ' ILE . 20.7 m0 -126.71 139.92 52.79 Favored 'General case' 0 C--O 1.213 -0.835 0 CA-C-O 121.032 0.444 . . . . 0.0 111.126 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.577 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 19.6 m -97.51 94.55 7.08 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -175.486 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 1.063 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -109.18 152.25 25.4 Favored 'General case' 0 N--CA 1.428 -1.574 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.135 -173.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.85 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 27.5 ptt-85 -87.42 123.82 32.76 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 172.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 1.02 ' HB2' HD11 ' A' ' 142' ' ' LEU . 66.1 t30 -59.01 -178.2 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.259 -1.337 . . . . 0.0 110.957 -172.277 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.642 ' HB2' ' HB2' ' A' ' 148' ' ' GLU . 37.8 tttp -66.77 -12.15 57.64 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.222 168.357 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -73.59 -21.25 60.39 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.412 167.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 77.47 35.13 37.92 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.005 -168.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.85 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 2.9 ttm-85 -113.47 137.65 51.24 Favored 'General case' 0 C--O 1.213 -0.845 0 C-N-CA 122.779 0.431 . . . . 0.0 110.937 -176.212 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.515 HG22 HG21 ' A' ' 153' ' ' ILE . 38.9 t -78.17 128.98 38.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 118.146 0.43 . . . . 0.0 111.777 -177.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -164.49 155.95 27.61 Favored Glycine 0 C--N 1.339 0.708 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.612 167.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.692 ' HB2' ' O ' ' A' ' 140' ' ' GLU . 0.6 OUTLIER -74.95 142.83 43.9 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 117.144 0.472 . . . . 0.0 111.291 178.817 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.768 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.4 pp -143.67 141.04 18.08 Favored Pre-proline 0 N--CA 1.452 -0.336 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.715 -176.149 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.436 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 18.5 Cg_exo -66.38 127.09 16.7 Favored 'Trans proline' 0 C--N 1.34 0.125 0 C-N-CA 122.468 2.112 . . . . 0.0 112.546 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.629 ' O ' HG22 ' A' ' 178' ' ' VAL . 96.2 t -61.94 -40.99 73.84 Favored Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 11.5 Cg_endo -56.88 -15.81 18.13 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 121.974 1.783 . . . . 0.0 113.221 175.412 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.436 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.2 m-30 -88.71 -8.04 55.23 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -177.223 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.662 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 3.3 m -105.59 -170.89 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 115.896 1.813 . . . . 0.0 115.896 -164.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.58 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 7.7 tp10 -159.89 49.98 0.3 Allowed 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 112.956 -1.929 . . . . 0.0 112.705 -152.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 1.054 ' HG3' HG22 ' A' ' 128' ' ' VAL . 3.5 mppt? -69.89 135.77 49.91 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 119.583 -1.948 . . . . 0.0 111.246 -161.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.65 HD13 ' CZ ' ' A' ' 129' ' ' ARG . 16.5 tp . . . . . 0 N--CA 1.463 0.22 0 CA-C-N 112.956 -1.929 . . . . 0.0 113.582 -163.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo . . . . . 0 N--CA 1.459 -0.533 0 N-CA-C 111.031 -0.411 . . . . 0.0 111.031 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.466 ' HB ' ' CG1' ' A' ' 266' ' ' VAL . 2.5 t -75.9 138.13 21.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.415 -175.194 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -112.57 121.29 44.36 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.784 0.326 . . . . 0.0 110.927 -178.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -120.15 137.8 53.96 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.636 177.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.5 ' HB2' ' CE1' ' A' ' 294' ' ' PHE . 11.6 tppt? -80.94 123.53 28.39 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.656 177.163 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -75.45 102.9 5.36 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 174.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 290' ' ' HIS . 18.6 pt -88.15 -7.17 10.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.245 0.545 . . . . 0.0 110.783 -176.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.573 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 27.2 tt0 -138.66 142.89 39.03 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.231 175.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.479 ' HE3' ' OE2' ' A' ' 259' ' ' GLU . 1.5 ptpp? -68.65 174.16 4.5 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 174.577 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.525 ' HG3' ' NE2' ' A' ' 290' ' ' HIS . 0.0 OUTLIER -166.57 136.43 3.15 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.187 -179.77 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 24.6 m -127.8 150.29 72.9 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.304 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.546 ' HD3' ' HB2' ' A' ' 257' ' ' ALA . 58.0 Cg_endo -72.41 149.08 49.83 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.477 2.118 . . . . 0.0 112.631 -179.002 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 249' ' ' CYS . . . . . 0.56 ' HB3' ' HB2' ' A' ' 252' ' ' ASP . 25.0 t -95.95 165.97 12.01 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 177.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -55.3 -39.77 70.3 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.114 0.483 . . . . 0.0 111.446 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -102.43 15.74 28.34 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.167 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 252' ' ' ASP . . . . . 0.56 ' HB2' ' HB3' ' A' ' 249' ' ' CYS . 1.7 m-20 -124.6 85.59 2.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.039 0.447 . . . . 0.0 110.334 177.264 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -86.56 -22.85 26.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.876 -179.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 4.0 p -89.87 5.01 48.13 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.259 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 255' ' ' ALA . . . . . 0.45 ' HB2' ' HB3' ' A' ' 252' ' ' ASP . . . -82.57 109.43 16.76 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.565 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.427 ' HA ' ' NH1' ' A' ' 282' ' ' ARG . 0.6 OUTLIER -66.0 137.34 57.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.456 -177.524 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.546 ' HB2' ' HD3' ' A' ' 248' ' ' PRO . . . -98.18 129.13 44.96 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.673 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 84.2 mt -136.71 162.51 32.98 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.512 -174.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.479 ' OE2' ' HE3' ' A' ' 245' ' ' LYS . 65.7 mm-40 -127.26 165.79 18.99 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 172.297 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 62.1 t -70.71 123.04 23.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.145 0.498 . . . . 0.0 110.956 -178.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 107.81 0.48 34.23 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.201 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -84.73 142.98 29.46 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.003 0.43 . . . . 0.0 110.713 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 48.6 mm -100.02 110.12 26.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.084 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 33.3 t -86.4 109.45 18.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.689 -177.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 27.8 tttm -84.46 94.67 8.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.923 175.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.466 ' CG1' ' HB ' ' A' ' 238' ' ' VAL . 3.6 p -93.32 117.56 37.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.33 0.586 . . . . 0.0 110.454 -178.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 1.2 p -95.9 -35.21 11.54 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.615 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 268' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 268' ' ' ARG . 13.0 ttp180 -115.89 122.12 44.4 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 177.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 32.4 mtt -106.49 125.08 50.55 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.189 0.519 . . . . 0.0 110.981 178.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 274' ' ' GLN . 87.6 m-20 -89.69 134.04 34.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.767 -179.236 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 2.3 pp -74.45 9.5 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -173.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 272' ' ' ASN . . . . . 0.455 ' OD1' ' HG2' ' A' ' 274' ' ' GLN . 6.0 p30 -97.95 -24.55 15.33 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 122.299 -0.25 . . . . 0.0 111.172 -178.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 135.4 -37.25 1.94 Allowed Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.151 -1.023 . . . . 0.0 113.222 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.475 ' O ' ' HB2' ' A' ' 270' ' ' ASN . 18.9 pt20 -95.6 118.27 31.99 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 177.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.456 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 20.3 m0 -95.2 166.95 11.66 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.293 -173.099 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -99.64 99.09 9.89 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.106 -178.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 277' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -108.74 153.26 16.87 Favored Glycine 0 C--O 1.224 -0.528 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.382 -175.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.672 ' HG2' ' HE2' ' A' ' 283' ' ' LYS . 21.2 mt-10 -119.83 108.46 14.41 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -178.322 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 50.9 t -138.05 132.64 43.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.613 -176.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 64.14 24.07 13.35 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.975 0.417 . . . . 0.0 110.965 176.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 86.47 -2.88 87.44 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.272 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 282' ' ' ARG . . . . . 0.427 ' NH1' ' HA ' ' A' ' 256' ' ' LEU . 0.6 OUTLIER -117.57 131.48 56.68 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.956 0.408 . . . . 0.0 109.937 -176.503 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.672 ' HE2' ' HG2' ' A' ' 278' ' ' GLU . 15.7 ptpt -113.08 142.32 45.88 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.977 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -168.04 -174.24 36.74 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.481 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.456 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 86.0 mt -88.05 136.04 33.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.245 0.545 . . . . 0.0 111.92 -177.169 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -138.94 127.86 14.06 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.979 174.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 287' ' ' PRO . . . . . 0.769 ' HD2' ' HE1' ' A' ' 290' ' ' HIS . 11.6 Cg_exo -73.48 151.35 47.53 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.925 2.417 . . . . 0.0 111.78 175.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -73.08 -1.6 18.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.135 0.493 . . . . 0.0 111.765 -178.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 3.4 m -64.63 -42.21 95.63 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.731 -176.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 290' ' ' HIS . . . . . 0.769 ' HE1' ' HD2' ' A' ' 287' ' ' PRO . 0.0 OUTLIER -110.63 12.31 22.7 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -174.852 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 22.3 m -129.33 149.94 34.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 172.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 292' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' A' ' 292' ' ' LYS . 44.3 mmtm -139.36 136.12 34.43 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.738 0.304 . . . . 0.0 110.559 177.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 1.1 mp -76.85 141.39 15.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.89 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 294' ' ' PHE . . . . . 0.537 ' CE2' ' HA ' ' A' ' 296' ' ' PRO . 7.9 p90 -154.87 176.53 12.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.2 -179.273 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -91.47 104.28 9.63 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 173.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 296' ' ' PRO . . . . . 0.537 ' HA ' ' CE2' ' A' ' 294' ' ' PHE . 26.3 Cg_endo . . . . . 0 C--N 1.344 0.323 0 C-N-CA 122.326 2.017 . . . . 0.0 112.776 -173.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.7 m . . . . . 0 N--CA 1.461 0.112 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -78.98 78.92 5.4 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.258 0.551 . . . . 0.0 110.28 177.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 18.7 tpp180 -99.61 86.79 3.41 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.357 0.598 . . . . 0.0 110.503 -176.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -167.52 143.39 4.08 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.991 -1.004 . . . . 0.0 108.798 175.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -72.48 -9.37 58.46 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -173.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.4 t 73.19 -29.52 0.2 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.267 0.627 . . . . 0.0 112.086 175.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.0 t -102.6 -19.21 14.92 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 122.067 -0.395 . . . . 0.0 111.016 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -67.09 104.05 1.33 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.979 0.419 . . . . 0.0 111.003 -176.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -60.75 -37.67 82.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.872 -175.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.5 m -69.17 -5.47 22.73 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.802 -177.212 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.33 -47.52 6.57 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.895 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.518 ' HB3' ' HB3' ' A' ' 101' ' ' PRO . 41.9 p-90 -119.72 -20.46 7.64 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -169.538 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -72.16 108.43 5.33 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.131 0.491 . . . . 0.0 110.455 -175.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.647 ' SD ' ' HA ' ' A' ' 104' ' ' ARG . 9.2 tpp -90.84 -4.79 56.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.868 -174.223 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 50.02 -114.57 2.53 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-N 115.243 -0.89 . . . . 0.0 114.344 176.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -74.4 83.19 1.73 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.04 2.493 . . . . 0.0 113.368 -174.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.623 HG12 ' H ' ' A' ' 20' ' ' SER . 98.4 t -135.92 177.08 6.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.358 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.623 ' H ' HG12 ' A' ' 19' ' ' VAL . 57.3 p -149.36 177.53 9.59 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -168.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.5 ttt85 -63.69 -39.6 94.71 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.784 178.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 35.5 mm-40 -61.87 -64.02 1.07 Allowed 'General case' 0 C--O 1.235 0.318 0 O-C-N 123.38 0.425 . . . . 0.0 110.754 176.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.471 ' O ' ' HB ' ' A' ' 26' ' ' THR . 8.1 tp10 -56.77 -47.78 79.36 Favored 'General case' 0 C--O 1.217 -0.658 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.467 -176.114 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.437 ' HB2' ' HD3' ' A' ' 39' ' ' ARG . . . -57.69 -42.01 82.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.96 0.41 . . . . 0.0 111.79 -177.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.454 ' NE2' ' HG2' ' A' ' 29' ' ' GLN . 23.1 tm0? -68.11 -32.52 72.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.55 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.471 ' HB ' ' O ' ' A' ' 23' ' ' GLU . 4.2 m -65.23 -43.4 91.55 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.661 176.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.443 ' HG2' ' O ' ' A' ' 23' ' ' GLU . 42.0 mmm-85 -72.85 -20.75 61.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.518 -173.05 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.62 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 88.6 mt -126.83 17.4 7.37 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.059 -171.366 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.454 ' HG2' ' NE2' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -69.49 76.53 0.4 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.476 0.655 . . . . 0.0 109.475 178.916 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.7 -66.72 3.86 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.4 -176.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 27.55 -99.12 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.208 1.003 . . . . 0.0 112.536 -166.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.578 ' HB2' ' SD ' ' A' ' 35' ' ' MET . 47.6 mtm105 -112.76 -6.77 13.84 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -176.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 49.7 m170 67.49 155.12 0.1 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.229 0.538 . . . . 0.0 111.132 -175.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.14 10.87 84.28 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 121.085 -0.578 . . . . 0.0 111.824 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.606 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 41.4 mtp -103.97 145.82 29.59 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -177.407 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.457 ' CG ' HD22 ' A' ' 98' ' ' LEU . 33.5 p90 -146.26 164.32 32.68 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.694 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.542 ' HG ' HD11 ' A' ' 28' ' ' LEU . 4.3 pp -152.72 137.16 16.72 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.847 174.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.4 t -101.95 114.37 41.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 173.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.571 ' HG3' ' O ' ' A' ' 40' ' ' ASP . 24.2 ptt-85 -116.09 176.5 5.07 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.7 -172.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.571 ' O ' ' HG3' ' A' ' 39' ' ' ARG . 10.6 t70 -58.66 132.28 53.37 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 166.218 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.68 ' HA ' HG23 ' A' ' 49' ' ' VAL . 44.5 t -44.37 -48.66 9.77 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 123.674 0.609 . . . . 0.0 112.223 -174.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.1 t 72.73 -1.66 2.93 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.979 0.799 . . . . 0.0 109.81 -175.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.4 m -111.51 -37.09 5.33 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.712 175.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 45.3 t -147.2 122.84 5.37 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.306 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -61.95 122.12 10.49 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.94 2.426 . . . . 0.0 112.857 -178.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.94 -31.81 7.0 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.742 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.416 ' C ' ' HB2' ' A' ' 41' ' ' SER . 4.7 m-20 -87.81 174.96 8.06 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -133.28 169.66 16.59 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 122.284 -0.26 . . . . 0.0 111.049 -177.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.68 HG23 ' HA ' ' A' ' 41' ' ' SER . 90.3 t -143.01 117.28 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 121.29 0.566 . . . . 0.0 110.632 174.066 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.45 ' CB ' HD11 ' A' ' 63' ' ' ILE . 28.3 tp -85.04 108.48 17.65 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.885 178.496 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.7 m -96.39 137.26 35.72 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 174.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.681 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 91.3 t -130.76 134.24 62.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.632 0.253 . . . . 0.0 111.444 -175.516 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.62 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 40.8 t -94.93 114.66 26.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.208 -175.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.666 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 8.6 tp10 -159.45 153.56 23.51 Favored 'General case' 0 C--O 1.21 -0.991 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 164.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.629 ' HB2' ' CG ' ' A' ' 57' ' ' ARG . 28.5 m120 61.4 17.36 8.3 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 179.064 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.2 m 55.22 55.54 7.43 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 122.59 1.186 . . . . 0.0 108.19 -170.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.753 HH21 ' HA ' ' A' ' 154' ' ' GLU 0.282 0.0 OUTLIER -163.24 67.73 0.2 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 113.227 -1.806 . . . . 0.0 109.883 -153.69 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.681 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 5.2 t -73.64 102.57 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.316 -1.311 . . . . 0.0 110.26 -173.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 71.6 m -78.38 122.46 25.8 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.174 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 45.3 m-70 -93.14 102.97 15.28 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.971 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.949 ' HB3' HD11 ' A' ' 73' ' ' ILE . 70.0 m-85 -97.99 105.07 17.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.591 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.609 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 54.8 mt -80.47 127.77 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -174.003 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.578 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 3.5 mp -115.44 112.01 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 120.82 0.343 . . . . 0.0 110.22 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -87.4 148.29 25.07 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.415 -176.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.8 t -87.83 109.19 19.56 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 175.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.3 mt -81.52 143.25 50.99 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -62.14 -11.54 22.46 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.44 2.094 . . . . 0.0 110.915 175.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -76.24 0.51 18.93 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.421 176.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.34 21.78 9.7 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.559 -174.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -115.96 175.0 5.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.82 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.578 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 64.8 m-85 -130.76 132.19 45.16 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.962 0.411 . . . . 0.0 111.21 -176.402 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -121.88 122.41 39.36 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.996 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.949 HD11 ' HB3' ' A' ' 61' ' ' TYR . 7.5 tt -108.42 109.25 27.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.502 0.668 . . . . 0.0 111.218 -174.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.03 -94.37 0.37 Allowed Glycine 0 CA--C 1.519 0.329 0 CA-C-N 115.431 -0.804 . . . . 0.0 113.136 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -121.2 -11.04 8.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.332 0.587 . . . . 0.0 110.323 -176.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -108.86 126.07 52.66 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.382 0.61 . . . . 0.0 110.784 -176.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.35 135.1 37.39 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.64 178.129 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.461 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 93.4 m-85 -126.38 178.43 5.85 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -71.18 -43.06 68.21 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.284 -178.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.422 ' ND1' ' HG2' ' A' ' 82' ' ' PRO . 16.4 p80 -165.97 -179.43 5.21 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.742 -178.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.619 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 10.0 mt -57.33 -62.18 5.76 Favored Pre-proline 0 N--CA 1.471 0.585 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -175.381 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.422 ' HG2' ' ND1' ' A' ' 80' ' ' HIS . 19.8 Cg_endo -63.99 1.24 1.6 Allowed 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 121.702 1.602 . . . . 0.0 113.483 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.97 -36.38 14.13 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.844 0.354 . . . . 0.0 110.323 177.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.1 pp -76.68 -32.69 58.07 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.479 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 80.0 mt -63.45 -28.7 70.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.857 176.168 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.9 tp10 -77.8 -38.72 45.94 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.758 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -64.88 -37.4 87.51 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.421 0.629 . . . . 0.0 110.884 178.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.493 ' HE2' HD13 ' A' ' 73' ' ' ILE . 30.3 m-85 -80.55 -2.75 47.52 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.958 -176.432 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 85' ' ' LEU . 97.5 mttt -69.9 -27.02 64.45 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.889 174.539 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.4 pp -120.1 9.0 6.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.889 179.018 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 -90.6 -39.89 12.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.627 -178.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.5 ' CD2' HG23 ' A' ' 97' ' ' THR . 82.0 m-85 67.51 84.86 0.15 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.173 -169.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.683 ' HA ' ' OE2' ' A' ' 154' ' ' GLU . 5.8 mt -56.39 -20.79 21.1 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 122.241 1.02 . . . . 0.0 111.007 178.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.566 ' OD1' HG22 ' A' ' 96' ' ' THR . 0.1 OUTLIER -134.78 -68.41 0.54 Allowed 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.003 -1.453 . . . . 0.0 109.063 -179.666 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.708 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 8.8 t -177.64 15.93 0.0 OUTLIER 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 114.198 -1.364 . . . . 0.0 108.548 174.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.566 HG22 ' OD1' ' A' ' 94' ' ' ASP . 4.9 t -129.58 -28.48 2.27 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.046 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.5 HG23 ' CD2' ' A' ' 92' ' ' TYR . 12.8 p 78.82 -179.52 0.11 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.964 1.306 . . . . 0.0 110.805 -175.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.457 HD22 ' CG ' ' A' ' 36' ' ' PHE . 89.9 mt -78.77 89.62 4.63 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.804 177.564 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 50.2 mm -75.6 -54.44 13.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.723 -177.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.606 ' O ' ' HA ' ' A' ' 35' ' ' MET . 15.5 pt-20 -157.22 152.72 22.18 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.561 -177.406 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.518 ' HB3' ' HB3' ' A' ' 14' ' ' TRP . 72.8 Cg_endo -76.06 148.58 31.47 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.262 1.975 . . . . 0.0 112.135 176.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.594 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -73.04 146.05 86.9 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.206 178.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.49 124.18 15.25 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.465 2.11 . . . . 0.0 111.232 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.647 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 34.8 ptt180 . . . . . 0 C--N 1.328 -0.329 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -172.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.827 HD12 HG21 ' A' ' 152' ' ' ILE . 4.6 mm? . . . . . 0 N--CA 1.464 0.257 0 CA-C-O 121.779 0.8 . . . . 0.0 112.779 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.761 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 0.6 OUTLIER -178.35 -72.44 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.033 -1.44 . . . . 0.0 107.858 179.59 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.427 ' O ' ' HB3' ' A' ' 180' ' ' LYS . 70.8 m-85 -96.95 107.45 19.98 Favored 'General case' 0 CA--C 1.495 -1.148 0 C-N-CA 119.199 -1.0 . . . . 0.0 110.569 -179.157 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.959 HG22 ' HG3' ' A' ' 180' ' ' LYS . 89.4 t -124.16 126.67 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 CA-C-N 114.55 -1.205 . . . . 0.0 109.301 175.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.686 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 6.5 ptp180 -107.52 142.79 36.85 Favored 'General case' 0 N--CA 1.435 -1.175 0 C-N-CA 117.528 -1.669 . . . . 0.0 108.093 171.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.582 HG22 HG12 ' A' ' 178' ' ' VAL . 0.8 OUTLIER -102.58 127.4 49.68 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.873 -176.941 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.695 HD11 ' HB2' ' A' ' 179' ' ' GLU . 6.3 mt -100.21 -21.73 15.4 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.629 -174.51 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.431 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 30.1 t80 -81.17 -35.88 30.88 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.93 -171.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.597 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 13.6 t70 71.06 101.14 0.06 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.688 0.756 . . . . 0.0 110.562 -175.498 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.468 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 51.5 t80 -129.87 85.6 57.4 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 177.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.678 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 94.8 Cg_endo -82.17 80.43 2.81 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 121.896 1.731 . . . . 0.0 112.773 -178.403 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -75.97 -30.59 57.27 Favored Glycine 0 C--N 1.329 0.173 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.765 178.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 66.04 50.95 1.37 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.096 -0.552 . . . . 0.0 111.234 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -142.14 177.75 8.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.414 177.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.506 ' O ' ' HA2' ' A' ' 171' ' ' GLY . . . -92.71 -11.0 35.12 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.73 0.776 . . . . 0.0 109.136 172.575 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' A' ' 172' ' ' MET . 44.9 mt-10 -91.95 -31.95 15.44 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.001 -0.999 . . . . 0.0 109.537 175.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -127.57 104.82 8.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.317 176.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 1.083 HD11 ' HB2' ' A' ' 165' ' ' ASN . 32.1 tp -65.42 129.52 94.42 Favored Pre-proline 0 C--N 1.327 -0.394 0 C-N-CA 120.562 -0.455 . . . . 0.0 109.977 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.789 ' HD2' HD12 ' A' ' 142' ' ' LEU . 72.6 Cg_endo -78.78 88.57 1.44 Allowed 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 121.541 1.494 . . . . 0.0 111.511 175.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.489 ' CD1' ' HB ' ' A' ' 130' ' ' THR . 10.4 p90 -103.49 156.14 17.99 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.96 -174.305 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.597 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -96.85 -171.63 2.28 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.189 0.441 . . . . 0.0 112.189 -174.858 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.865 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -92.81 33.05 1.17 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.942 -174.029 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 159.51 31.33 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.555 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.556 ' HB3' ' HB2' ' A' ' 145' ' ' LYS . 0.1 OUTLIER -101.01 152.71 20.25 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.663 -176.554 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.7 mp -97.55 127.14 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-O 121.496 0.665 . . . . 0.0 109.802 -176.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.772 HD22 HD21 ' A' ' 142' ' ' LEU . 9.7 mt -121.63 157.71 30.21 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 -176.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.761 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 92.7 t -118.09 124.19 72.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 174.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 1.116 HD13 ' HB2' ' A' ' 163' ' ' ALA . 43.6 mm -75.93 79.66 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 122.024 0.916 . . . . 0.0 108.717 -177.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.519 HG21 HG22 ' A' ' 170' ' ' VAL . 18.4 tt -70.37 -29.7 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-N 114.005 -1.452 . . . . 0.0 109.76 -176.507 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.753 ' HA ' HH21 ' A' ' 57' ' ' ARG . 0.4 OUTLIER -131.44 141.72 49.87 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 172.152 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.589 ' HD2' ' HG ' ' A' ' 125' ' ' LEU . 81.4 tttt -134.77 87.83 29.64 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 172.232 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.708 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 2.3 Cg_endo -82.5 -37.78 0.2 Allowed 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.695 2.264 . . . . 0.0 111.8 176.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.604 ' HG2' ' CE ' ' A' ' 172' ' ' MET . 25.2 mm-40 -109.91 168.13 9.65 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.755 -174.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.513 ' O ' HG21 ' A' ' 175' ' ' VAL . 6.1 pt-20 -101.67 -16.86 16.55 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.462 178.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.406 ' C ' HG23 ' A' ' 175' ' ' VAL . 5.2 tp-100 -107.32 -11.72 15.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.163 0.506 . . . . 0.0 109.873 176.193 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -129.07 121.6 28.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.212 176.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' TRP . . . . . 0.759 ' HB3' HD12 ' A' ' 152' ' ' ILE . 49.2 m0 -115.32 134.87 54.72 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.501 -178.087 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.59 ' HA ' ' HA ' ' A' ' 172' ' ' MET . 13.4 m -93.79 94.22 8.41 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -173.267 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 1.116 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -108.54 147.05 32.33 Favored 'General case' 0 N--CA 1.419 -1.998 0 C-N-CA 119.501 -0.88 . . . . 0.0 109.703 -171.646 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.831 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 15.8 ptt-85 -86.79 119.66 27.25 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 175.477 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 1.083 ' HB2' HD11 ' A' ' 142' ' ' LEU . 18.1 t30 -53.34 177.69 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 113.724 -1.58 . . . . 0.0 110.865 -176.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -63.56 -15.31 57.68 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 168.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.417 ' H ' ' HB3' ' A' ' 165' ' ' ASN . 36.9 m-20 -69.28 -30.38 68.47 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.74 169.154 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 90.28 25.79 25.29 Favored Glycine 0 C--O 1.228 -0.259 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.16 -170.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.887 ' HD2' ' CD1' ' A' ' 142' ' ' LEU . 0.3 OUTLIER -105.06 138.14 41.72 Favored 'General case' 0 C--O 1.217 -0.608 0 C-N-CA 123.437 0.695 . . . . 0.0 111.331 -174.003 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.519 HG22 HG21 ' A' ' 153' ' ' ILE . 24.1 t -86.45 119.75 35.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -175.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' GLY . . . . . 0.506 ' HA2' ' O ' ' A' ' 139' ' ' ALA . . . -152.49 148.94 20.44 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.696 170.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.604 ' CE ' ' HG2' ' A' ' 157' ' ' GLU . 59.6 mtp -78.43 142.48 37.51 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 117.663 0.731 . . . . 0.0 110.703 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.698 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.7 pp -140.54 145.47 40.78 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.9 -173.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.554 ' HB2' ' CD1' ' A' ' 177' ' ' TYR . 17.6 Cg_exo -68.41 129.87 19.93 Favored 'Trans proline' 0 N--CA 1.465 -0.149 0 C-N-CA 122.959 2.439 . . . . 0.0 113.104 -177.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.568 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 58.0 t -62.62 -42.22 77.68 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 29.0 Cg_endo -63.62 -5.16 8.14 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 121.951 1.767 . . . . 0.0 112.682 177.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.554 ' CD1' ' HB2' ' A' ' 174' ' ' PRO . 3.0 m-85 -91.95 -15.8 27.5 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.442 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.606 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 3.2 m -105.95 -174.04 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -163.196 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.695 ' HB2' HD11 ' A' ' 131' ' ' LEU . 3.5 tp10 -159.95 49.22 0.29 Allowed 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 113.071 -1.877 . . . . 0.0 112.454 -150.046 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.959 ' HG3' HG22 ' A' ' 128' ' ' VAL . 0.5 OUTLIER -69.27 170.73 9.68 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 118.937 -2.352 . . . . 0.0 111.308 -160.511 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 15.9 tp . . . . . 0 C--O 1.236 0.355 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.767 -168.131 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo . . . . . 0 N--CA 1.445 -1.336 0 N-CA-C 110.291 -0.696 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.585 ' CG1' HD12 ' A' ' 293' ' ' ILE . 15.2 t -95.3 138.93 19.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.158 0.504 . . . . 0.0 111.393 -171.466 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -109.9 121.68 45.8 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.833 177.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.61 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -118.68 155.02 31.78 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.887 -175.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -99.84 120.47 39.81 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.779 179.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 242' ' ' ALA . . . . . 0.546 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -72.31 106.78 4.6 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 175.282 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 41.2 pt -94.85 -5.83 10.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.159 0.504 . . . . 0.0 110.995 -176.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -137.37 140.76 41.61 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.98 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -63.62 126.29 27.05 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 176.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.551 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 24.5 tpt180 -125.62 101.89 7.1 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.968 0.413 . . . . 0.0 110.562 -178.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 25.7 m -111.94 150.13 41.9 Favored Pre-proline 0 C--N 1.316 -0.88 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 174.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -62.89 102.73 0.31 Allowed 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.245 1.963 . . . . 0.0 111.865 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 249' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 250' ' ' ALA . 45.8 t -73.33 178.17 4.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.58 -177.303 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.405 ' N ' ' SG ' ' A' ' 249' ' ' CYS . . . -63.74 -25.2 68.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.853 -177.065 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -99.11 1.11 44.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.876 0.37 . . . . 0.0 111.314 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -101.32 161.13 13.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.233 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -138.74 -66.12 0.48 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.393 178.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 2.3 m -82.49 10.34 7.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.006 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 255' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 285' ' ' LEU . . . -65.57 119.07 10.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.044 0.449 . . . . 0.0 111.434 -175.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.494 HD23 ' H ' ' A' ' 257' ' ' ALA . 1.2 tt -72.27 140.51 48.65 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.696 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.551 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -86.88 117.53 25.68 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.333 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 84.5 mt -126.86 142.69 51.48 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.557 -177.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -106.56 158.34 17.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.085 177.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 45.0 t -70.23 109.99 3.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.975 0.417 . . . . 0.0 110.088 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 108.54 11.69 22.79 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.852 -0.69 . . . . 0.0 111.948 -177.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -95.3 146.64 24.22 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 39.8 mm -90.28 117.63 33.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.914 0.388 . . . . 0.0 110.651 -179.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.426 HG21 HG11 ' A' ' 291' ' ' VAL . 22.0 t -92.94 109.4 21.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.432 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -91.11 88.18 6.86 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.065 178.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 7.6 p -88.67 125.47 41.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.341 0.591 . . . . 0.0 110.536 -177.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 37.2 p -97.27 -31.1 12.59 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.527 -175.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 268' ' ' ARG . . . . . 0.485 ' HD3' ' OE1' ' A' ' 276' ' ' GLU . 55.8 mtp180 -131.2 113.87 14.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.723 -177.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 31.6 mtt -93.86 113.42 25.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.124 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -83.57 169.98 14.84 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.576 176.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 32.4 mm -94.75 -20.32 6.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.476 -176.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -81.68 3.89 23.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.758 -176.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 99.31 -35.17 4.87 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.55 -0.833 . . . . 0.0 113.129 174.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -84.2 111.32 19.26 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 41.1 m0 -93.53 158.45 15.7 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.297 -177.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.485 ' OE1' ' HD3' ' A' ' 268' ' ' ARG . 58.7 mt-10 -91.66 106.75 18.71 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 172.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 277' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -108.52 146.33 16.49 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.012 -176.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -114.81 106.26 13.98 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 176.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 279' ' ' VAL . . . . . 0.43 HG12 ' OD1' ' A' ' 280' ' ' ASN . 15.1 t -141.48 134.11 29.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -175.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 280' ' ' ASN . . . . . 0.43 ' OD1' HG12 ' A' ' 279' ' ' VAL . 24.4 m120 62.21 23.59 13.96 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.251 -177.201 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 84.5 -4.19 84.78 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.511 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 -104.62 134.07 48.4 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.865 0.364 . . . . 0.0 111.021 -176.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 42.8 tttp -104.78 117.33 33.79 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.176 177.04 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -146.79 175.51 26.16 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 255' ' ' ALA . 89.5 mt -94.61 143.8 26.13 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 177.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.422 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 43.2 p90 -144.7 139.83 15.81 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.301 176.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 287' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 15.4 Cg_exo -69.59 125.11 11.84 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.651 2.234 . . . . 0.0 111.19 173.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -58.71 -19.96 44.53 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.269 -0.423 . . . . 0.0 112.04 -175.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 15.8 p -67.66 -9.26 41.75 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -177.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -99.55 -7.86 25.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.903 0.383 . . . . 0.0 111.053 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.546 HG12 ' HA ' ' A' ' 242' ' ' ALA . 34.0 m -127.56 170.12 17.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.891 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -138.77 134.83 33.98 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.07 0.462 . . . . 0.0 110.83 174.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.61 HD13 ' HB2' ' A' ' 240' ' ' ALA . 46.9 mm -76.78 128.81 37.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.329 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -138.61 -36.04 0.57 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.401 178.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 62.36 103.47 0.03 OUTLIER Pre-proline 0 C--N 1.341 0.197 0 CA-C-O 121.418 0.628 . . . . 0.0 111.354 -178.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo . . . . . 0 C--O 1.235 0.351 0 C-N-CA 123.209 2.606 . . . . 0.0 111.677 -178.824 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.451 -0.402 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.538 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . -75.51 89.92 2.72 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.429 171.014 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -119.09 95.72 4.93 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.607 0.718 . . . . 0.0 111.741 -175.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.411 ' HE1' ' O ' ' A' ' 98' ' ' LEU . 12.2 p90 -159.66 169.84 22.87 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.532 174.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -75.83 -26.83 57.54 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -173.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.0 t 72.61 -39.16 0.44 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.622 0.769 . . . . 0.0 111.382 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.1 m -91.03 -26.11 19.35 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.49 0.186 . . . . 0.0 111.1 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -63.36 105.76 0.8 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.987 0.422 . . . . 0.0 111.291 -172.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -60.62 -39.75 89.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.63 -176.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.1 m -72.99 -3.18 24.43 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.614 -176.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.52 -41.74 10.09 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.654 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 33.1 p-90 -125.09 -21.68 4.6 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -172.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -71.6 109.25 5.41 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.044 -176.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.832 ' SD ' ' HA ' ' A' ' 104' ' ' ARG . 8.3 tpp -91.03 -9.25 46.56 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.649 -174.419 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.455 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 50.6 -112.07 1.46 Allowed Glycine 0 CA--C 1.52 0.358 0 CA-C-N 115.55 -0.75 . . . . 0.0 113.986 177.194 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.455 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 19.3 Cg_exo -66.15 82.18 0.28 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.424 2.749 . . . . 0.0 113.324 -177.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.759 HG12 ' H ' ' A' ' 20' ' ' SER . 59.5 t -139.68 -178.31 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.043 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.759 ' H ' HG12 ' A' ' 19' ' ' VAL . 47.4 t -168.62 178.88 4.52 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 -166.013 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.493 ' O ' ' HG2' ' A' ' 25' ' ' GLN . 0.1 OUTLIER -58.73 -45.16 90.24 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 118.59 0.632 . . . . 0.0 109.391 176.222 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -60.07 -60.2 4.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.799 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.547 ' O ' ' HG3' ' A' ' 27' ' ' ARG . 29.5 mm-40 -56.94 -49.31 76.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.007 -178.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.83 -38.0 72.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.582 -175.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.566 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 16.4 mm100 -61.9 -52.69 63.07 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.889 178.611 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.2 t -70.45 -10.54 59.41 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -172.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.547 ' HG3' ' O ' ' A' ' 23' ' ' GLU . 55.5 mtp180 -100.44 -11.2 20.4 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 121.081 -0.248 . . . . 0.0 111.338 -179.277 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.576 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 62.9 mt -132.2 -13.0 3.15 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -176.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.566 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -68.69 109.0 3.6 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.919 -0.488 . . . . 0.0 109.944 -178.316 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.52 26.1 66.3 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.393 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.428 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 13.3 mm100 -94.07 -170.61 2.34 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 178.367 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.515 ' HB2' ' SD ' ' A' ' 35' ' ' MET . 56.0 mtm180 -61.81 150.83 35.99 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 177.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -92.31 113.92 26.33 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -178.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.505 ' CA ' HG21 ' A' ' 96' ' ' THR . . . 127.75 -4.62 7.02 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.746 -175.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.618 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 62.8 mtp -84.7 143.14 29.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.464 -0.368 . . . . 0.0 110.387 178.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.557 ' CD1' HD22 ' A' ' 98' ' ' LEU . 46.9 p90 -149.6 159.19 44.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.742 -0.208 . . . . 0.0 110.604 -178.447 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.623 ' HB2' ' HB2' ' A' ' 16' ' ' MET . 4.6 pp -150.69 138.52 19.92 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.141 0.496 . . . . 0.0 111.01 177.212 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 85.5 t -105.19 119.89 54.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 174.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.523 ' CB ' ' HB ' ' A' ' 19' ' ' VAL . 28.2 ptt-85 -117.08 161.58 19.18 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.89 -174.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -73.87 124.51 26.26 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 173.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.476 ' HB2' HG23 ' A' ' 49' ' ' VAL . 47.2 t -87.56 143.98 26.93 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.0 0.429 . . . . 0.0 110.902 -176.142 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.4 p -91.9 4.25 53.38 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.234 176.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 26.4 m -76.28 -43.12 43.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.173 175.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 47' ' ' ASP . 11.7 m -143.66 135.27 12.84 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -70.38 72.84 1.72 Allowed 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.453 2.102 . . . . 0.0 111.677 176.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 65' ' ' SER . . . 155.55 -23.51 0.56 Allowed Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -176.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.437 ' HB2' ' HB2' ' A' ' 44' ' ' CYS . 16.0 m-20 -81.79 155.83 25.23 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 176.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -131.79 177.21 7.7 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.532 HG13 HD13 ' A' ' 62' ' ' ILE . 38.7 t -145.4 115.3 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.714 0.292 . . . . 0.0 111.288 177.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.426 HD11 ' HB2' ' A' ' 36' ' ' PHE . 57.5 tp -81.61 103.94 11.67 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.267 175.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.5 m -96.92 127.84 43.28 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 176.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.57 HG21 HD13 ' A' ' 93' ' ' LEU . 59.7 t -121.69 133.27 68.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.025 0.44 . . . . 0.0 111.063 -175.131 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.576 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 26.6 t -91.0 110.31 21.57 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.531 -178.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.653 ' OE2' ' HB ' ' A' ' 96' ' ' THR . 40.8 mt-10 -146.78 136.88 23.47 Favored 'General case' 0 C--O 1.21 -0.984 0 C-N-CA 119.673 -0.811 . . . . 0.0 109.678 175.138 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 52.95 31.09 10.3 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 174.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 44.8 m 58.33 53.31 6.49 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 122.134 0.968 . . . . 0.0 109.367 -178.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.88 HH21 ' HB2' ' A' ' 94' ' ' ASP 0.256 0.2 OUTLIER -168.39 67.94 0.07 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 113.577 -1.647 . . . . 0.0 108.668 -156.915 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 21.7 t -72.49 102.8 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 O-C-N 120.588 -1.32 . . . . 0.0 110.299 -167.702 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.6 m -73.61 118.88 17.08 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 113.133 -1.849 . . . . 0.0 110.737 -176.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -97.93 113.53 25.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.854 0.359 . . . . 0.0 111.43 -178.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.736 ' HB3' HD11 ' A' ' 73' ' ' ILE . 70.2 m-85 -107.24 110.2 22.18 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.964 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.808 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 34.2 mm -77.46 132.75 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -173.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.546 HG23 ' HB3' ' A' ' 71' ' ' PHE . 3.7 mp -115.84 115.91 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 120.947 0.403 . . . . 0.0 111.125 177.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -88.57 142.71 27.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.371 -177.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.457 ' HB2' ' O ' ' A' ' 46' ' ' GLY . 35.9 t -83.38 100.15 10.5 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 169.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 90.3 mt -78.11 140.42 61.69 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -59.05 -15.45 27.95 Favored 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 122.982 2.455 . . . . 0.0 112.446 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -83.45 10.79 8.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.419 176.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? 63.59 27.81 15.02 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.667 -178.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.458 ' NH2' ' HB3' ' A' ' 77' ' ' GLU . 37.0 mtp180 -115.44 -175.21 2.66 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.988 -1.006 . . . . 0.0 109.52 178.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.546 ' HB3' HG23 ' A' ' 63' ' ' ILE . 62.0 m-85 -135.57 143.44 45.67 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.063 0.459 . . . . 0.0 111.735 -175.143 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -123.47 116.46 23.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.992 177.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.808 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 7.9 tt -102.87 94.74 3.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.493 0.663 . . . . 0.0 110.807 -179.174 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.405 ' O ' ' HB3' ' A' ' 75' ' ' ASP . . . 58.78 68.75 1.53 Allowed Glycine 0 C--N 1.331 0.284 0 CA-C-N 115.098 -0.955 . . . . 0.0 112.651 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.405 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 20.4 t0 76.55 -45.01 0.49 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 122.628 0.371 . . . . 0.0 111.333 178.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -75.78 129.18 36.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.146 0.498 . . . . 0.0 110.861 -178.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.458 ' HB3' ' NH2' ' A' ' 70' ' ' ARG . 64.6 mt-10 -101.32 153.3 19.77 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.428 -177.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.47 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 96.8 m-85 -141.01 -173.91 3.85 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.041 173.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -77.68 -48.76 15.97 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.019 0.438 . . . . 0.0 110.729 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.416 ' H ' ' HB3' ' A' ' 83' ' ' ALA . 4.7 p80 -156.89 -179.38 8.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.397 -178.079 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.609 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 14.2 mt -57.77 -57.1 27.93 Favored Pre-proline 0 N--CA 1.469 0.493 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -178.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.605 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 24.4 Cg_exo -64.37 -2.33 4.86 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.13 1.887 . . . . 0.0 112.948 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.416 ' HB3' ' H ' ' A' ' 80' ' ' HIS . . . -89.9 -36.8 14.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.793 0.33 . . . . 0.0 110.348 179.084 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.7 pp -76.78 -31.11 56.8 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.514 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.477 ' HA ' ' CD1' ' A' ' 98' ' ' LEU . 57.2 mt -67.62 -26.72 66.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.653 174.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -79.12 -33.44 44.29 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.788 177.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -76.07 -38.11 57.47 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.028 0.442 . . . . 0.0 111.049 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.486 ' HE2' HD13 ' A' ' 73' ' ' ILE . 33.5 m-85 -76.26 1.55 15.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.962 0.41 . . . . 0.0 111.779 -177.159 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -70.27 -25.99 63.61 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.45 171.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 29.8 pt -117.14 26.57 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 120.585 -0.446 . . . . 0.0 112.067 178.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.423 ' O ' ' HB2' ' A' ' 92' ' ' TYR . 2.8 t-160 -114.46 -42.64 3.27 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -175.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.47 ' CD1' HG23 ' A' ' 97' ' ' THR . 97.8 m-85 70.46 86.62 0.12 Allowed 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.751 0.657 . . . . 0.0 110.278 -171.242 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.685 ' HA ' ' OE2' ' A' ' 154' ' ' GLU . 14.8 mt -59.94 -30.75 69.28 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.51 -178.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.88 ' HB2' HH21 ' A' ' 57' ' ' ARG . 31.6 t0 -160.94 68.55 0.33 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.317 0.58 . . . . 0.0 109.863 170.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.534 HG22 ' O ' ' A' ' 94' ' ' ASP . 0.5 OUTLIER 70.2 -4.49 1.54 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.956 -175.629 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.653 ' HB ' ' OE2' ' A' ' 54' ' ' GLU . 16.2 m -127.73 138.84 52.9 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 121.237 0.542 . . . . 0.0 109.933 178.189 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.472 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.5 p -89.5 168.39 12.22 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 173.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.557 HD22 ' CD1' ' A' ' 36' ' ' PHE . 97.3 mt -63.58 96.36 0.12 Allowed 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.635 -0.426 . . . . 0.0 109.871 178.187 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.538 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 49.0 mm -86.06 -56.72 5.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.645 -174.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.618 ' O ' ' HA ' ' A' ' 35' ' ' MET . 42.5 tt0 -158.85 133.39 5.37 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.912 -176.296 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 100' ' ' GLU . 17.8 Cg_exo -64.91 157.75 55.03 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 122.88 2.386 . . . . 0.0 112.829 -177.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.09 141.13 86.15 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.9 112.44 1.21 Allowed 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.384 2.056 . . . . 0.0 112.116 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.832 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 41.7 ttp180 . . . . . 0 C--O 1.234 0.241 0 CA-C-O 121.374 0.607 . . . . 0.0 109.474 178.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.711 HD12 HG21 ' A' ' 152' ' ' ILE . 3.3 mm? . . . . . 0 CA--C 1.515 -0.399 0 CA-C-O 121.771 0.796 . . . . 0.0 111.803 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.515 ' HG2' ' CD2' ' A' ' 127' ' ' TYR . 28.4 tt0 -171.72 -78.23 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.531 -1.213 . . . . 0.0 109.674 -174.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.515 ' CD2' ' HG2' ' A' ' 126' ' ' GLU . 54.7 m-85 -117.57 107.85 14.76 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.377 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.698 HG22 ' CG ' ' A' ' 180' ' ' LYS . 56.6 t -114.87 131.11 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -178.25 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.709 ' HB3' HD12 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -109.79 144.66 37.91 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 116.892 -1.923 . . . . 0.0 108.989 170.988 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.609 HG22 HG12 ' A' ' 178' ' ' VAL . 1.2 p -100.68 128.91 46.56 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.316 -179.312 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.531 HD21 ' HG2' ' A' ' 179' ' ' GLU . 14.8 mt -105.27 -23.16 12.92 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.934 -176.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.459 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 32.6 t80 -79.9 -33.41 39.89 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.727 -173.021 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.607 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 15.7 t70 71.77 120.14 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.365 0.602 . . . . 0.0 110.842 -174.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.568 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 64.4 t80 -153.85 91.96 3.16 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.615 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 74.2 Cg_endo -90.0 86.77 0.39 Allowed 'Trans proline' 0 N--CA 1.441 -1.605 0 C-N-CA 122.014 1.809 . . . . 0.0 112.573 177.324 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -76.79 -16.11 81.04 Favored Glycine 0 C--N 1.331 0.298 0 N-CA-C 111.056 -0.817 . . . . 0.0 111.056 174.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.697 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 90.5 m-20 52.97 68.31 0.86 Allowed 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.21 -0.995 . . . . 0.0 111.8 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.595 ' HB3' ' H ' ' A' ' 141' ' ' ASP . 1.0 OUTLIER -136.27 -174.87 3.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.229 0.538 . . . . 0.0 110.932 -178.962 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -115.32 3.69 14.27 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 166.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.431 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 32.9 tt0 -112.34 -49.74 2.94 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 113.9 -1.5 . . . . 0.0 108.65 177.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.595 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 4.9 m-20 -96.64 133.28 41.36 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.852 167.281 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 1.123 HD11 ' HB2' ' A' ' 165' ' ' ASN . 34.2 tp -83.62 131.65 51.68 Favored Pre-proline 0 N--CA 1.468 0.44 0 O-C-N 122.075 -0.39 . . . . 0.0 110.135 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.697 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 11.6 Cg_endo -85.63 91.06 0.69 Allowed 'Trans proline' 0 N--CA 1.444 -1.425 0 C-N-CA 122.115 1.877 . . . . 0.0 111.266 172.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.568 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 12.8 p90 -103.71 159.48 15.59 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.234 -176.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.607 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 5.0 mppt? -104.91 -168.28 1.45 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.262 0.554 . . . . 0.0 112.195 -178.494 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.735 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -86.84 9.11 20.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.0 -169.688 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -172.63 36.93 0.14 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.857 175.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.545 ' OE1' ' HA ' ' A' ' 144' ' ' PHE . 0.3 OUTLIER -101.06 149.05 24.35 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.351 -175.648 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.709 HD12 ' HB3' ' A' ' 129' ' ' ARG . 0.3 OUTLIER -89.06 124.57 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.677 -178.116 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.727 HD22 HD21 ' A' ' 142' ' ' LEU . 19.3 mt -119.45 155.35 32.21 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.588 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 67.6 t -117.56 125.53 74.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 174.607 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 1.084 HD13 ' HB2' ' A' ' 163' ' ' ALA . 49.5 mm -76.54 87.18 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 122.423 1.106 . . . . 0.0 108.118 -176.203 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.612 HG21 HG22 ' A' ' 170' ' ' VAL . 17.9 tt -75.66 -25.1 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 CA-C-N 113.292 -1.776 . . . . 0.0 109.875 -174.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.685 ' OE2' ' HA ' ' A' ' 93' ' ' LEU . 0.2 OUTLIER -141.0 141.21 34.39 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 170.458 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 61.0 tttt -128.83 92.75 39.16 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.44 0.638 . . . . 0.0 110.356 170.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.427 ' HG2' ' HE2' ' A' ' 172' ' ' MET . 10.3 Cg_exo -74.3 -44.04 0.46 Allowed 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.338 2.025 . . . . 0.0 112.002 172.718 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -120.2 178.74 4.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.099 -172.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.448 ' HA ' ' HE1' ' A' ' 161' ' ' TRP . 6.7 pt-20 -116.12 4.68 13.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.094 0.473 . . . . 0.0 110.672 174.338 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -102.34 -31.26 10.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.696 172.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.442 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 34.5 m95 -129.11 146.16 51.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.613 173.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' TRP . . . . . 0.741 ' O ' HG13 ' A' ' 173' ' ' ILE . 47.8 m0 -126.79 138.33 53.34 Favored 'General case' 0 C--O 1.215 -0.757 0 C-N-CA 122.788 0.435 . . . . 0.0 110.657 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.566 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 25.6 m -95.4 96.33 9.05 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -175.102 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 1.084 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -108.7 150.29 27.77 Favored 'General case' 0 N--CA 1.422 -1.833 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.505 -172.175 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.779 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 12.7 ptt180 -87.46 122.17 30.85 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 173.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 1.123 ' HB2' HD11 ' A' ' 142' ' ' LEU . 17.5 t30 -54.61 176.79 0.04 OUTLIER 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 113.293 -1.776 . . . . 0.0 110.91 -177.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.541 ' HD2' ' H ' ' A' ' 149' ' ' ILE . 30.9 mtpt -62.95 -17.98 62.61 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.828 169.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -68.94 -36.24 77.72 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.468 0.652 . . . . 0.0 109.46 168.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.432 ' C ' ' HB2' ' A' ' 164' ' ' ARG . . . 105.06 3.96 41.75 Favored Glycine 0 CA--C 1.524 0.598 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.343 -172.401 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.779 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -79.33 137.59 37.39 Favored 'General case' 0 C--O 1.218 -0.574 0 C-N-CA 123.16 0.584 . . . . 0.0 111.77 -178.77 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.612 HG22 HG21 ' A' ' 153' ' ' ILE . 22.1 t -79.87 125.87 39.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 120.417 0.151 . . . . 0.0 111.291 177.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -157.88 148.37 17.67 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 120.209 -0.996 . . . . 0.0 112.665 169.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.472 ' HA ' ' HA ' ' A' ' 162' ' ' SER . 0.4 OUTLIER -69.88 140.65 53.19 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 122.756 0.422 . . . . 0.0 111.378 179.408 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.741 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.6 pp -144.45 144.39 25.1 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.105 -176.478 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.514 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 8.1 Cg_exo -73.38 132.13 17.3 Favored 'Trans proline' 0 C--O 1.23 0.115 0 C-N-CA 122.498 2.132 . . . . 0.0 112.644 -174.296 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.601 ' O ' HG22 ' A' ' 178' ' ' VAL . 82.9 t -60.98 -44.03 93.2 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 19.0 Cg_endo -61.08 -11.2 17.56 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 121.981 1.787 . . . . 0.0 112.873 177.425 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.514 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.1 m-85 -88.22 -15.18 36.63 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.525 -178.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.611 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 4.1 m -106.58 -172.44 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 115.558 1.688 . . . . 0.0 115.558 -164.343 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.663 ' O ' ' HG3' ' A' ' 179' ' ' GLU . 3.9 tp10 -159.9 44.32 0.22 Allowed 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 112.941 -1.936 . . . . 0.0 111.638 -154.559 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.773 ' HD2' ' H ' ' A' ' 180' ' ' LYS . 0.0 OUTLIER -74.13 144.23 44.99 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 119.275 -2.141 . . . . 0.0 111.554 -166.07 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.448 ' HB2' HH12 ' A' ' 129' ' ' ARG . 23.8 tp . . . . . 0 N--CA 1.448 -0.533 0 CA-C-N 111.416 -2.629 . . . . 0.0 114.282 -157.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo . . . . . 0 N--CA 1.46 -0.473 0 N-CA-C 111.283 -0.314 . . . . 0.0 111.283 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.464 ' CG1' HD12 ' A' ' 293' ' ' ILE . 21.7 t -84.71 134.55 26.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.945 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.53 ' HB2' ' CG ' ' A' ' 296' ' ' PRO . 93.8 m-85 -104.46 124.24 48.9 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.141 0.496 . . . . 0.0 110.468 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.585 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -119.24 140.65 49.89 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.26 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -88.2 124.36 33.76 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 242' ' ' ALA . . . . . 0.522 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -75.29 99.52 4.09 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.253 178.388 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 39.4 pt -80.59 -23.26 11.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.276 0.56 . . . . 0.0 110.74 -177.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -135.26 148.52 49.59 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 177.215 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -67.79 169.56 9.47 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.239 0.542 . . . . 0.0 110.607 -178.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.564 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 27.3 tpt180 -154.1 109.78 3.2 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.166 178.236 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 24.0 m -108.77 150.15 40.43 Favored Pre-proline 0 C--N 1.315 -0.923 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.505 ' HA ' ' HB3' ' A' ' 255' ' ' ALA . 12.4 Cg_exo -68.44 110.5 2.29 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.416 2.077 . . . . 0.0 111.518 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 249' ' ' CYS . . . . . 0.535 ' HB3' ' HB2' ' A' ' 252' ' ' ASP . 51.9 t -70.52 164.65 24.32 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.907 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -53.34 -40.05 64.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.6 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -99.86 7.17 45.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.793 0.33 . . . . 0.0 111.493 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 252' ' ' ASP . . . . . 0.535 ' HB2' ' HB3' ' A' ' 249' ' ' CYS . 7.4 m-20 -127.6 69.19 1.31 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.132 0.491 . . . . 0.0 110.131 176.618 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -78.2 -21.58 49.86 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.178 0.513 . . . . 0.0 110.189 -179.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 19.8 p -83.04 -0.35 48.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.847 177.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 255' ' ' ALA . . . . . 0.505 ' HB3' ' HA ' ' A' ' 248' ' ' PRO . . . -77.19 132.59 38.84 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.572 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.62 137.28 40.64 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.026 -178.297 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.564 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -87.26 107.59 18.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.141 0.496 . . . . 0.0 110.095 179.342 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 94.4 mt -116.3 151.11 36.5 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.782 -176.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -119.13 157.0 28.77 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.22 176.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 47.4 t -65.03 122.64 16.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.565 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 96.28 18.45 31.09 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.801 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -99.38 170.5 8.59 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 177.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 25.9 mm -117.76 112.83 40.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.042 0.449 . . . . 0.0 110.307 -178.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 239' ' ' PHE . 30.8 t -88.41 113.0 24.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.65 -178.166 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -92.26 87.59 6.13 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.829 177.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.518 HG21 ' HB3' ' A' ' 275' ' ' TRP . 3.0 p -92.69 120.05 41.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.384 0.611 . . . . 0.0 110.809 -177.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 1.4 p -94.03 -26.95 16.57 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.754 -178.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 268' ' ' ARG . . . . . 0.586 ' HB2' ' HB3' ' A' ' 276' ' ' GLU . 28.6 mmm180 -116.24 104.51 11.58 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.864 0.364 . . . . 0.0 110.938 -178.561 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 36.9 mmm -94.51 131.87 39.78 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 177.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 31.7 p30 -125.44 -179.16 4.49 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.638 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 19.6 pt -103.31 8.21 9.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.172 0.51 . . . . 0.0 110.738 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -81.35 -31.51 33.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.717 -176.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 117.91 -40.2 2.39 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.665 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.543 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 1.9 mp0 -94.76 114.98 26.96 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 174.234 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.518 ' HB3' HG21 ' A' ' 266' ' ' VAL . 21.9 m0 -91.68 157.53 16.9 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -177.041 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.586 ' HB3' ' HB2' ' A' ' 268' ' ' ARG . 8.0 tp10 -90.39 103.08 15.8 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 277' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -115.91 137.96 14.17 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.266 -0.968 . . . . 0.0 113.559 -172.077 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -105.99 108.95 20.72 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 175.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 279' ' ' VAL . . . . . 0.404 HG22 ' HA ' ' A' ' 264' ' ' VAL . 37.9 t -119.47 -87.64 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.056 -0.658 . . . . 0.0 112.108 -173.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -105.08 76.25 1.23 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.936 0.398 . . . . 0.0 111.072 -174.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 66.15 20.73 69.38 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.825 176.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 282' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 282' ' ' ARG . 38.1 ttt-85 -158.87 137.41 10.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.838 0.319 . . . . 0.0 110.64 -175.298 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 38.1 ttpt -110.08 128.45 55.44 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.599 177.135 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -156.67 173.72 34.4 Favored Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 -178.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.543 ' HB3' ' HB3' ' A' ' 274' ' ' GLN . 72.5 mt -89.1 138.01 31.8 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.039 0.447 . . . . 0.0 110.417 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.445 ' O ' ' HA ' ' A' ' 274' ' ' GLN . 35.7 p90 -137.83 133.08 17.53 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.21 178.187 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.67 131.93 23.97 Favored 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 122.547 2.164 . . . . 0.0 111.656 176.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -65.62 -2.39 3.47 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.69 -177.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.89 -0.46 55.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.96 0.41 . . . . 0.0 111.296 -179.295 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -111.65 -12.5 13.89 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.801 0.334 . . . . 0.0 110.892 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.522 HG12 ' HA ' ' A' ' 242' ' ' ALA . 27.9 m -128.29 162.47 34.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.999 -179.037 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -136.43 132.35 35.33 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.944 0.402 . . . . 0.0 111.027 175.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.585 HD13 ' HB2' ' A' ' 240' ' ' ALA . 42.0 mm -72.29 129.81 35.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.454 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 294' ' ' PHE . . . . . 0.641 ' O ' ' HD3' ' A' ' 296' ' ' PRO . 10.2 p90 -135.08 -170.93 2.68 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.595 -179.403 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -98.07 97.08 3.99 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-O 121.357 0.599 . . . . 0.0 110.87 176.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 296' ' ' PRO . . . . . 0.641 ' HD3' ' O ' ' A' ' 294' ' ' PHE . 1.1 Cg_endo . . . . . 0 N--CA 1.458 -0.579 0 C-N-CA 122.921 2.414 . . . . 0.0 112.098 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.584 ' HB3' HD12 ' A' ' 99' ' ' ILE . 64.2 m . . . . . 0 N--CA 1.467 0.403 0 CA-C-O 120.508 0.194 . . . . 0.0 111.485 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.563 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . -72.36 107.22 4.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.689 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.445 ' HD3' ' HA ' ' A' ' 5' ' ' ARG . 19.1 mmt180 -137.55 100.05 4.11 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.112 0.482 . . . . 0.0 111.418 -178.078 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -167.65 159.69 12.16 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.33 -0.85 . . . . 0.0 108.88 177.006 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -83.11 108.42 16.37 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 177.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.636 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 15.4 m -74.89 55.86 0.71 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.319 179.202 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.1 m -161.85 -39.67 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.948 0.404 . . . . 0.0 110.781 -179.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -71.81 110.37 6.29 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.19 0.519 . . . . 0.0 111.386 -171.132 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.401 ' HG2' ' H ' ' A' ' 11' ' ' ARG . 9.3 mmt180 -60.78 -35.65 77.0 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.712 -178.409 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.526 ' HA ' ' NH1' ' A' ' 104' ' ' ARG . 67.0 m -71.18 -3.57 20.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.504 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.73 -46.87 7.36 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.139 177.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 17.3 p-90 -118.57 -21.25 8.04 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -170.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -80.4 121.72 26.07 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 121.86 -0.525 . . . . 0.0 111.18 -173.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.577 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 23.1 mmt -99.81 -5.21 28.95 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.653 -176.363 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.442 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.15 -113.82 2.47 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 116.034 -0.53 . . . . 0.0 113.359 -176.095 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.442 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 9.2 Cg_exo -72.56 91.09 0.79 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.19 2.593 . . . . 0.0 113.511 -176.091 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.5 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 73.7 t -144.99 153.76 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 176.008 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.2 p -121.19 -179.83 4.17 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 118.233 0.469 . . . . 0.0 109.78 -174.203 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.619 ' HD2' HH22 ' A' ' 39' ' ' ARG . 21.2 mmm180 -55.25 -54.59 41.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.649 0.261 . . . . 0.0 110.879 177.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -64.47 -39.59 94.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.868 -175.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.509 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 50.4 mt-10 -69.68 -48.08 60.98 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.404 179.275 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.19 -38.8 71.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.017 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -53.2 -58.56 6.62 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.451 175.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.57 ' HA ' ' HB3' ' A' ' 29' ' ' GLN . 10.4 t -75.99 -2.63 31.48 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -171.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' A' ' 23' ' ' GLU . 52.2 mmm-85 -85.29 -20.93 29.29 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.162 0.506 . . . . 0.0 109.682 175.153 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.576 HD22 ' HB2' ' A' ' 53' ' ' SER . 29.7 mt -123.14 -12.71 7.87 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.737 -177.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.573 ' OE1' ' HB3' ' A' ' 57' ' ' ARG . 36.3 tp60 -67.33 115.64 7.2 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.172 0.589 . . . . 0.0 111.743 -178.243 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 66.62 10.98 56.1 Favored Glycine 0 C--N 1.331 0.292 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.855 176.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.486 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 15.2 mm100 -70.1 -87.02 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -177.305 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -158.07 -4.36 0.09 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.465 ' HA ' ' OG ' ' A' ' 53' ' ' SER . 29.0 m170 71.17 161.37 0.23 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.359 0.599 . . . . 0.0 111.559 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.11 -22.55 8.15 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.07 177.21 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.743 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 57.9 mtm -82.25 147.44 28.94 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 178.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -140.25 164.37 30.26 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.261 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.577 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.3 pp -152.69 134.88 14.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.037 0.446 . . . . 0.0 111.463 178.432 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.6 t -105.81 127.29 60.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 173.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.619 HH22 ' HD2' ' A' ' 21' ' ' ARG . 31.9 ptt-85 -131.15 -178.45 4.84 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.684 -0.235 . . . . 0.0 110.652 -174.389 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -69.93 132.21 45.61 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 171.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.493 ' HA ' HG23 ' A' ' 49' ' ' VAL . 22.6 t -72.87 155.91 39.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.65 0.738 . . . . 0.0 112.246 -175.058 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.4 p -102.14 10.29 39.55 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.383 177.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 36.0 p -95.27 -51.54 4.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.855 178.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 1.7 p -165.91 144.11 4.81 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.127 179.158 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 44' ' ' CYS . 47.4 Cg_exo -57.54 125.37 18.57 Favored 'Trans proline' 0 C--O 1.237 0.471 0 C-N-CA 123.006 2.471 . . . . 0.0 112.268 178.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.65 -31.42 5.56 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -176.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -89.3 167.78 12.78 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 177.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -135.98 176.01 9.08 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.76 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.493 HG23 ' HA ' ' A' ' 41' ' ' SER . 48.4 t -142.93 110.87 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.945 0.402 . . . . 0.0 111.319 177.184 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.3 tp -80.84 105.61 12.2 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.184 174.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.0 m -98.27 131.57 44.48 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 174.132 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.587 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 46.2 t -118.64 143.13 30.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.493 -177.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.576 ' HB2' HD22 ' A' ' 28' ' ' LEU . 40.2 t -88.75 110.32 20.9 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 122.218 -0.301 . . . . 0.0 111.267 -177.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.516 ' HG2' ' O ' ' A' ' 94' ' ' ASP . 6.2 tp10 -177.85 165.93 2.05 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 174.147 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.55 ' HB2' HH21 ' A' ' 57' ' ' ARG . 2.6 m-80 60.3 50.48 6.17 Favored 'General case' 0 CA--C 1.48 -1.742 0 C-N-CA 123.905 0.882 . . . . 0.0 108.657 -168.21 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 55' ' ' ASN . 66.4 m 71.61 -28.7 0.19 Allowed 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 113.516 -1.675 . . . . 0.0 110.95 -171.164 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.753 ' NE ' ' H ' ' A' ' 58' ' ' VAL 0.399 0.0 OUTLIER -153.21 -54.01 0.11 Allowed 'General case' 0 C--N 1.364 1.23 1 N-CA-C 124.965 5.172 . . . . 0.0 124.965 -174.619 . . . . . . . . 5 4 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.753 ' H ' ' NE ' ' A' ' 57' ' ' ARG . 1.7 t -152.29 120.8 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 CA-C-N 122.49 2.405 . . . . 0.0 114.046 -173.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.531 ' HB2' ' HB ' ' A' ' 52' ' ' VAL . 0.9 OUTLIER -97.98 110.83 23.33 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 163.513 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.587 ' CE1' HG11 ' A' ' 58' ' ' VAL . 92.4 m-70 -98.13 118.17 34.16 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 121.546 -0.721 . . . . 0.0 112.555 -173.021 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.716 ' CZ ' HD22 ' A' ' 93' ' ' LEU . 37.2 m-85 -122.36 109.21 14.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.674 179.244 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.573 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 67.9 mt -81.03 135.12 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 O-C-N 121.859 -0.526 . . . . 0.0 111.636 -178.513 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.475 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 5.3 mp -112.96 111.69 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 120.881 0.372 . . . . 0.0 110.905 179.083 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.692 ' HB2' ' CG ' ' A' ' 72' ' ' LYS . 23.4 m120 -88.98 148.13 23.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.495 -174.136 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.6 t -83.82 105.84 15.04 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.136 175.294 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.407 HD21 ' HE2' ' A' ' 72' ' ' LYS . 91.0 mt -82.74 140.68 43.98 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 177.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.52 -9.05 16.68 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.077 2.518 . . . . 0.0 112.978 -177.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -91.82 19.26 6.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.326 177.087 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.481 ' HA ' ' NE ' ' A' ' 69' ' ' ARG . 5.2 mmp_? 58.7 32.32 22.06 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.405 0.621 . . . . 0.0 110.627 -174.284 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.448 HH11 ' HD3' ' A' ' 70' ' ' ARG . 34.1 mtp180 -114.42 -178.84 3.47 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.272 179.164 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.475 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 55.6 m-85 -138.87 142.41 38.59 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.486 0.184 . . . . 0.0 111.148 -178.278 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.692 ' CG ' ' HB2' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -123.26 120.57 33.49 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-O 120.813 0.339 . . . . 0.0 110.874 178.914 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.621 HD11 ' CB ' ' A' ' 61' ' ' TYR . 17.6 tt -93.51 89.53 2.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.917 0.865 . . . . 0.0 110.817 -177.478 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.523 ' O ' ' HB3' ' A' ' 75' ' ' ASP . . . 59.51 77.08 0.19 Allowed Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.305 -178.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.523 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 16.6 t70 78.54 -52.24 0.48 Allowed 'General case' 0 N--CA 1.48 1.051 0 O-C-N 123.749 0.323 . . . . 0.0 111.409 178.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -70.47 134.8 48.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.0 0.429 . . . . 0.0 111.795 -173.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.422 ' OE1' ' HB3' ' A' ' 72' ' ' LYS . 6.0 mm-40 -89.49 143.9 26.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.185 -177.33 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.482 ' HZ ' ' CD2' ' A' ' 87' ' ' PHE . 47.0 m-85 -140.52 -175.42 4.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.293 172.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -75.38 -56.81 4.35 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.17 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.479 ' ND1' ' HD2' ' A' ' 82' ' ' PRO . 2.5 p80 -166.81 -174.0 2.59 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.762 175.059 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.664 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 16.4 mt -53.51 -59.74 8.73 Favored Pre-proline 0 N--CA 1.47 0.547 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -177.413 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.664 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 38.5 Cg_exo -65.11 3.2 1.05 Allowed 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 122.752 2.301 . . . . 0.0 113.56 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.475 ' HB3' ' H ' ' A' ' 80' ' ' HIS . . . -106.07 -35.06 7.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.911 0.386 . . . . 0.0 110.669 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.6 pp -76.14 -30.74 58.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.938 0.399 . . . . 0.0 110.127 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.477 ' N ' HD12 ' A' ' 84' ' ' LEU . 79.2 mt -63.66 -27.88 69.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.042 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.581 ' HA ' ' HD3' ' A' ' 89' ' ' LYS . 19.9 tp10 -80.9 -21.96 40.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.98 -176.284 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.482 ' CD2' ' HZ ' ' A' ' 78' ' ' PHE . 62.4 t80 -83.02 -20.61 34.72 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.898 0.856 . . . . 0.0 109.243 -177.133 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.517 ' CG ' HD21 ' A' ' 93' ' ' LEU . 35.5 m-85 -97.27 1.98 50.24 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.444 -177.221 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.581 ' HD3' ' HA ' ' A' ' 86' ' ' GLU . 53.8 mtpt -86.23 -2.24 58.19 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.967 173.059 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 33.2 pt -131.85 -8.52 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 CA-C-O 121.432 0.634 . . . . 0.0 109.365 177.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.462 ' HB2' ' O ' ' A' ' 87' ' ' PHE . 8.2 t60 -82.82 -32.54 27.56 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.602 -174.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.441 ' H ' HG22 ' A' ' 97' ' ' THR . 95.4 m-85 56.93 78.84 0.2 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.92 -166.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.716 HD22 ' CZ ' ' A' ' 61' ' ' TYR . 12.9 mt -45.77 -83.03 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.21 0 O-C-N 124.091 0.87 . . . . 0.0 110.34 178.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.572 ' HB2' ' HG3' ' A' ' 154' ' ' GLU . 45.5 t0 -109.13 84.17 1.88 Allowed 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.908 -179.115 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' THR . . . . . 1.086 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 4.8 t 49.93 17.68 0.31 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.643 0.777 . . . . 0.0 112.152 -178.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.8 t -163.12 157.58 20.82 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 -178.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.441 HG22 ' H ' ' A' ' 92' ' ' TYR . 7.9 p -98.4 176.33 5.73 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.644 0.259 . . . . 0.0 110.463 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.4 mt -72.02 90.65 1.18 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 174.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.584 HD12 ' HB3' ' A' ' 3' ' ' SER . 50.1 mm -73.74 -54.39 15.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.247 -175.031 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.743 ' O ' ' HA ' ' A' ' 35' ' ' MET . 11.1 pt-20 -158.44 153.74 22.06 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.032 -177.224 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.73 145.95 33.23 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 121.924 1.749 . . . . 0.0 111.531 176.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.433 ' HB2' ' HB3' ' A' ' 35' ' ' MET . . . -72.08 150.7 92.5 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.34 134.35 63.17 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.409 2.073 . . . . 0.0 111.673 175.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.526 ' NH1' ' HA ' ' A' ' 12' ' ' SER . 56.2 mtm180 . . . . . 0 C--N 1.33 -0.263 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -174.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.904 HD12 HG21 ' A' ' 152' ' ' ILE . 3.9 mm? . . . . . 0 N--CA 1.469 0.488 0 CA-C-O 121.695 0.76 . . . . 0.0 111.386 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.46 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 44.7 tt0 -169.39 -72.25 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.161 -178.07 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -117.66 114.64 23.67 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.634 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.868 HG22 ' HG3' ' A' ' 180' ' ' LYS . 57.4 t -126.38 150.15 31.82 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.096 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.105 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.732 ' CZ ' HD13 ' A' ' 181' ' ' LEU . 0.0 OUTLIER -124.73 155.01 39.98 Favored 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 118.014 -1.474 . . . . 0.0 109.031 165.158 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.639 ' OG1' ' HB2' ' A' ' 144' ' ' PHE . 72.9 p -106.02 140.05 39.61 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.216 0.531 . . . . 0.0 111.072 178.129 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.579 HD21 ' HG2' ' A' ' 179' ' ' GLU . 8.8 mt -113.73 -5.9 13.31 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.039 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.443 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 28.6 t80 -93.91 -41.11 9.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.694 -173.257 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.647 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 10.7 t70 74.28 95.53 0.07 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.486 0.66 . . . . 0.0 110.69 -178.188 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.64 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 75.4 t80 -126.01 90.46 50.21 Favored Pre-proline 0 C--N 1.318 -0.765 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 173.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.584 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 95.0 Cg_endo -85.92 81.19 1.7 Allowed 'Trans proline' 0 N--CA 1.44 -1.636 0 C-N-CA 121.712 1.608 . . . . 0.0 112.144 178.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -69.69 -11.96 66.55 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.302 175.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.52 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 89.1 m-20 50.3 65.86 1.32 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 114.297 -0.951 . . . . 0.0 111.629 177.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.563 ' HB3' ' H ' ' A' ' 141' ' ' ASP . 1.0 OUTLIER -130.88 -176.61 4.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.364 0.602 . . . . 0.0 110.898 -178.612 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -111.41 0.63 16.64 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 167.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -117.09 -45.99 2.73 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.691 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.563 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 8.4 m-20 -97.67 128.1 44.12 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 168.424 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 1.098 HD11 ' HB2' ' A' ' 165' ' ' ASN . 28.9 tp -84.61 124.48 73.17 Favored Pre-proline 0 CA--C 1.517 -0.321 0 O-C-N 122.095 -0.378 . . . . 0.0 110.98 -176.121 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.584 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 49.7 Cg_endo -76.11 105.79 2.14 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 121.502 1.468 . . . . 0.0 111.707 166.4 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.64 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -93.42 -161.68 0.87 Allowed 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 175.364 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.647 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 68.6 mttm -138.07 -170.94 2.9 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.801 176.096 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.991 ' H ' ' HD2' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -84.7 25.26 0.93 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.384 0.612 . . . . 0.0 109.913 -179.533 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 158.78 41.6 0.02 OUTLIER Glycine 0 N--CA 1.436 -1.353 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.898 -177.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.684 ' CD ' ' HG ' ' A' ' 150' ' ' LEU . 1.8 pp20? -84.7 170.04 13.68 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 173.299 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.438 HG13 ' CZ ' ' A' ' 129' ' ' ARG . 1.1 mp -111.78 128.54 68.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 118.453 0.569 . . . . 0.0 109.62 170.061 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.773 ' CD2' ' HA ' ' A' ' 165' ' ' ASN . 82.1 mt -119.42 155.95 31.05 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -172.746 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.595 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 62.0 t -123.51 120.22 59.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 172.132 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 1.122 HD13 ' HB2' ' A' ' 163' ' ' ALA . 25.8 mm -79.79 82.34 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.675 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.707 HG12 ' OE2' ' A' ' 154' ' ' GLU . 14.3 tt -72.21 -33.72 47.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-N 114.203 -1.362 . . . . 0.0 108.904 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.707 ' OE2' HG12 ' A' ' 153' ' ' ILE . 3.4 mp0 -125.86 143.61 51.0 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.046 176.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.587 ' HD2' ' HG ' ' A' ' 125' ' ' LEU . 83.1 tttt -136.08 87.82 23.12 Favored Pre-proline 0 C--N 1.316 -0.858 0 CA-C-O 121.108 0.48 . . . . 0.0 109.76 171.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 1.086 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 8.0 Cg_exo -76.35 -50.52 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.787 2.324 . . . . 0.0 112.112 174.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.651 ' HG2' ' CE ' ' A' ' 172' ' ' MET . 5.4 mm-40 -102.21 173.31 6.43 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.113 -173.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.515 ' O ' HG21 ' A' ' 175' ' ' VAL . 8.7 tp10 -104.83 -17.93 14.41 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 175.547 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -99.99 -17.0 17.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.314 174.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.463 ' HB2' ' HE1' ' A' ' 172' ' ' MET . 73.1 m95 -130.26 125.35 34.61 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.735 178.564 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' TRP . . . . . 0.749 ' HB3' HD12 ' A' ' 152' ' ' ILE . 50.0 m0 -112.81 135.81 53.14 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.021 0.438 . . . . 0.0 110.437 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.615 ' OG ' ' HG2' ' A' ' 172' ' ' MET . 70.5 m -93.31 92.93 7.92 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -174.355 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 1.122 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -109.45 146.78 33.96 Favored 'General case' 0 N--CA 1.415 -2.194 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -172.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.784 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 12.3 ptt180 -88.16 127.21 35.43 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 174.152 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 1.098 ' HB2' HD11 ' A' ' 142' ' ' LEU . 63.5 t30 -59.41 179.94 0.1 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.103 -1.408 . . . . 0.0 111.793 -170.134 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.434 ' HD3' ' H ' ' A' ' 149' ' ' ILE . 48.9 tptt -56.74 -20.88 24.37 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.52 167.601 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -79.88 -30.71 40.23 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.843 172.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.521 ' C ' ' HB2' ' A' ' 164' ' ' ARG . . . 101.53 7.95 47.43 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.064 -174.024 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.784 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -77.97 132.11 37.7 Favored 'General case' 0 C--O 1.217 -0.625 0 C-N-CA 122.646 0.378 . . . . 0.0 111.222 177.243 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.461 HG22 HG21 ' A' ' 153' ' ' ILE . 47.9 t -82.43 125.47 39.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.634 -179.067 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -159.17 152.39 23.4 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 121.042 -0.599 . . . . 0.0 111.965 173.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.651 ' CE ' ' HG2' ' A' ' 157' ' ' GLU . 35.9 mtp -77.5 142.96 38.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.893 0.346 . . . . 0.0 110.704 -178.474 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.69 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.7 pp -142.45 144.93 32.67 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.019 -175.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.453 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 22.8 Cg_exo -65.05 129.94 24.41 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 122.834 2.356 . . . . 0.0 113.004 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.643 ' O ' HG22 ' A' ' 178' ' ' VAL . 58.0 t -64.87 -41.6 56.75 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 18.6 Cg_endo -61.29 -6.8 7.23 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 121.858 1.705 . . . . 0.0 112.748 176.204 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.453 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.2 m-30 -95.53 -9.23 32.96 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.814 -178.363 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 175' ' ' VAL . 4.3 m -105.04 -171.98 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 -166.538 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.648 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 6.7 tp10 -159.15 49.6 0.34 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 112.678 -2.056 . . . . 0.0 111.812 -153.286 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.868 ' HG3' HG22 ' A' ' 128' ' ' VAL . 3.2 mppt? -69.66 136.13 50.74 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 119.603 -1.935 . . . . 0.0 111.081 -160.223 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.732 HD13 ' CZ ' ' A' ' 129' ' ' ARG . 14.6 tp . . . . . 0 CA--C 1.523 -0.096 0 CA-C-N 113.207 -1.815 . . . . 0.0 110.655 -168.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo . . . . . 0 N--CA 1.451 -1.02 0 CA-C-O 120.808 0.253 . . . . 0.0 112.029 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 22.9 t -89.63 145.32 7.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.507 ' HB2' ' HG3' ' A' ' 296' ' ' PRO . 84.7 m-85 -108.78 119.72 40.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.077 0.465 . . . . 0.0 111.105 -177.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.579 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -119.66 140.93 49.86 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.691 178.086 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.515 ' HB2' ' CE1' ' A' ' 294' ' ' PHE . 47.5 tttp -95.07 123.44 38.56 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 242' ' ' ALA . . . . . 0.505 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -71.44 102.77 2.74 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.29 -0.414 . . . . 0.0 109.961 -179.457 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 2.3 pp -82.27 -5.56 9.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.923 0.392 . . . . 0.0 111.972 -174.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.445 ' HG2' ' H ' ' A' ' 245' ' ' LYS . 21.5 tt0 -146.95 164.32 33.33 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 176.591 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.445 ' H ' ' HG2' ' A' ' 244' ' ' GLN . 45.1 mttp -61.37 149.66 37.58 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 176.228 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.588 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 24.3 tpt180 -137.62 94.81 2.96 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 169.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 34.4 m -101.2 152.94 38.03 Favored Pre-proline 0 C--N 1.315 -0.919 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.709 -176.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.408 ' HD3' ' HB2' ' A' ' 257' ' ' ALA . 71.8 Cg_endo -74.53 -161.2 0.11 Allowed 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.424 2.083 . . . . 0.0 111.816 177.248 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 34.9 t -151.05 -179.22 7.13 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -175.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -64.37 -34.01 77.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.671 0.272 . . . . 0.0 111.254 -178.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -95.55 11.19 33.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.399 -179.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.33 131.96 47.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.505 0.669 . . . . 0.0 112.638 -175.222 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 253' ' ' LYS . . . . . 0.419 ' HE3' ' HB3' ' A' ' 253' ' ' LYS . 6.3 ptpp? -150.53 0.46 0.43 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.663 167.34 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 1.2 p -144.88 14.85 1.54 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.304 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -101.59 117.86 35.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.137 0.494 . . . . 0.0 110.494 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.423 HD21 ' HB ' ' A' ' 279' ' ' VAL . 0.7 OUTLIER -78.59 134.68 37.18 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.178 -178.228 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.588 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -93.9 121.22 35.14 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.201 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.539 ' HB2' ' HB3' ' A' ' 246' ' ' ARG . 79.9 mt -123.73 152.68 41.86 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.041 -175.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -102.47 177.74 4.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.038 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 59.2 t -90.18 111.83 23.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.195 0.521 . . . . 0.0 110.551 -179.337 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 98.39 9.18 53.85 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.188 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -82.84 166.4 19.0 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -175.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 33.5 mm -104.67 110.82 31.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.255 0.55 . . . . 0.0 110.281 -177.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.489 HG22 HD22 ' A' ' 258' ' ' LEU . 14.0 t -96.44 108.75 21.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.806 -177.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 38.4 tttt -83.3 105.31 14.15 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.728 175.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.437 HG21 ' HB3' ' A' ' 275' ' ' TRP . 4.3 p -99.22 117.17 43.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.496 0.665 . . . . 0.0 110.605 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 12.1 m -94.94 -25.23 16.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.844 -176.519 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 268' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 268' ' ' ARG . 36.6 ttm180 -132.2 108.22 9.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.007 0.432 . . . . 0.0 110.954 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 32.1 mtt -94.75 126.95 40.4 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.657 178.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 274' ' ' GLN . 56.5 m-80 -99.9 153.56 19.06 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 177.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.585 HD12 ' H ' ' A' ' 271' ' ' ILE . 4.3 mp -72.73 -34.48 47.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.147 -172.005 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -62.67 -26.4 68.63 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.742 -176.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 127.92 -26.93 4.7 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.35 -0.929 . . . . 0.0 112.637 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.478 ' O ' ' HB2' ' A' ' 270' ' ' ASN . 45.3 mt-30 -78.92 115.5 18.65 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 177.344 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.517 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 49.9 m0 -96.24 150.9 20.03 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.816 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.44 ' HA ' ' O ' ' A' ' 284' ' ' GLY . 43.6 tt0 -108.93 109.58 20.69 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 175.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 277' ' ' GLY . . . . . 0.555 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -122.16 155.36 16.83 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.841 -178.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.572 ' HG2' ' HB3' ' A' ' 283' ' ' LYS . 23.2 mt-10 -104.58 109.0 20.73 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 279' ' ' VAL . . . . . 0.423 ' HB ' HD21 ' A' ' 256' ' ' LEU . 46.9 t -121.92 114.5 43.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -178.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 32.4 m120 64.77 27.6 13.0 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.896 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 90.01 -10.78 72.83 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.417 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 44.5 ttt-85 -102.35 118.55 37.12 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.572 ' HB3' ' HG2' ' A' ' 278' ' ' GLU . 57.3 pttt -109.82 141.95 41.78 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.094 0.473 . . . . 0.0 111.188 179.21 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 284' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 276' ' ' GLU . . . -167.21 -174.79 36.68 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 -179.077 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.517 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 68.8 mt -90.2 138.66 31.34 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.162 0.506 . . . . 0.0 111.252 -177.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.446 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 46.1 p90 -142.74 131.58 11.69 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.711 173.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 287' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 17.6 Cg_exo -69.06 139.2 42.03 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 122.902 2.401 . . . . 0.0 111.822 177.351 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -65.57 -4.64 6.36 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.663 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 2.4 m -74.42 -22.82 58.96 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.933 0.397 . . . . 0.0 111.088 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 41.0 m-70 -94.12 -11.58 30.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.848 0.356 . . . . 0.0 111.149 -176.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.505 HG12 ' HA ' ' A' ' 242' ' ' ALA . 34.8 m -128.02 167.5 22.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.057 -178.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -140.9 128.47 21.4 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.848 0.356 . . . . 0.0 110.727 175.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.579 HD13 ' HB2' ' A' ' 240' ' ' ALA . 41.0 mm -67.83 126.54 27.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.241 177.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 294' ' ' PHE . . . . . 0.515 ' CE1' ' HB2' ' A' ' 241' ' ' LYS . 1.4 p90 -141.14 -179.59 6.19 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.504 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -101.6 96.09 5.96 Favored Pre-proline 0 C--N 1.322 -0.628 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.039 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 296' ' ' PRO . . . . . 0.507 ' HG3' ' HB2' ' A' ' 239' ' ' PHE . 43.0 Cg_endo . . . . . 0 C--N 1.345 0.363 0 C-N-CA 122.604 2.203 . . . . 0.0 113.112 -173.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.547 ' HB2' HD12 ' A' ' 99' ' ' ILE . 13.7 p . . . . . 0 CA--C 1.529 0.171 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.98 110.76 4.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.378 177.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.548 ' CZ ' ' HA ' ' A' ' 5' ' ' ARG . 3.6 mmp_? -115.25 -5.72 12.38 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -172.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.435 ' H ' ' HD1' ' A' ' 6' ' ' PHE . 6.3 p90 -79.25 155.41 28.58 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.476 -174.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -66.24 -36.29 82.63 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.574 -176.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.1 t 65.39 37.88 6.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.335 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.8 m -152.34 -33.05 0.13 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.278 177.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -77.56 113.93 15.88 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.98 0.419 . . . . 0.0 111.285 -173.072 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -57.72 -45.35 85.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.201 -175.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 51.1 m -71.74 1.67 6.5 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -91.06 -42.07 10.71 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.601 176.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 22.4 p-90 -122.73 -29.07 4.07 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -174.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -77.71 103.2 7.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.808 0.337 . . . . 0.0 111.554 -173.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.468 ' HB3' HG21 ' A' ' 19' ' ' VAL . 23.6 mmt -87.28 -6.53 58.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.288 -176.283 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 49.93 -115.54 3.17 Favored Glycine 0 CA--C 1.52 0.359 0 CA-C-N 115.629 -0.714 . . . . 0.0 113.306 -178.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.58 99.78 1.26 Allowed 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 122.475 2.116 . . . . 0.0 112.535 -176.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.62 HG13 ' HB3' ' A' ' 23' ' ' GLU . 3.5 t -130.11 -70.49 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-O 118.243 -0.884 . . . . 0.0 111.73 -176.162 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 19' ' ' VAL . 22.9 t 108.46 161.32 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.126 1.371 . . . . 0.0 109.219 173.384 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 34.0 ttt85 -64.89 -38.81 92.23 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.801 0.334 . . . . 0.0 110.241 -177.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -64.9 -34.26 77.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.429 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.62 ' HB3' HG13 ' A' ' 19' ' ' VAL . 0.4 OUTLIER -84.21 -53.13 5.72 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.801 -174.565 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.503 ' HB2' ' HD3' ' A' ' 39' ' ' ARG . . . -56.05 -40.95 74.3 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.782 -178.288 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.58 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 55.0 tp60 -62.42 -44.53 96.22 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.569 -178.299 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.485 HG22 ' O ' ' A' ' 23' ' ' GLU . 9.1 t -75.69 -15.49 60.3 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 120.818 0.342 . . . . 0.0 111.055 -177.438 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.53 ' HG2' ' O ' ' A' ' 23' ' ' GLU . 52.2 mmm-85 -76.96 -19.59 57.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.922 0.392 . . . . 0.0 110.357 176.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.635 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 78.1 mt -128.84 -13.1 4.7 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -173.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.58 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -66.21 107.61 2.01 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.844 0.354 . . . . 0.0 110.757 -173.789 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.3 -2.24 67.2 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.822 -0.704 . . . . 0.0 113.331 175.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -78.31 -175.05 4.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.728 0.264 . . . . 0.0 110.587 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.606 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 12.4 ttp180 -52.68 131.02 34.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.334 0.588 . . . . 0.0 110.827 -179.428 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.59 ' HB3' ' OE1' ' A' ' 54' ' ' GLU . 43.6 m170 -82.03 145.1 30.4 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.407 -175.045 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.35 -12.91 48.02 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 111.606 -0.597 . . . . 0.0 111.606 -176.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.606 ' SD ' ' HB3' ' A' ' 32' ' ' ARG . 11.6 mtp -81.55 141.47 33.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.687 0.28 . . . . 0.0 110.737 178.457 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.504 ' HB2' HG22 ' A' ' 52' ' ' VAL . 33.1 p90 -143.24 167.43 22.15 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.691 -178.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.463 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.4 pp -158.08 138.52 12.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.155 0.503 . . . . 0.0 111.453 175.428 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.411 HG22 HD13 ' A' ' 50' ' ' LEU . 48.3 t -102.94 120.8 53.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 174.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.503 ' HD3' ' HB2' ' A' ' 24' ' ' ALA . 23.8 ptt-85 -125.94 -169.45 2.01 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.639 0.257 . . . . 0.0 110.71 -175.083 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -68.9 140.49 55.14 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.829 177.007 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.4 t -86.23 104.66 15.98 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 167.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.9 m -71.65 -11.4 60.82 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.378 -177.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 16.9 p -84.59 -29.74 25.57 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.996 0.427 . . . . 0.0 110.261 176.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 52.4 t -151.34 95.37 3.34 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.017 178.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -58.06 113.9 1.73 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.922 2.415 . . . . 0.0 112.066 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 130.37 -33.04 2.97 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -174.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.595 ' OD2' ' HA ' ' A' ' 64' ' ' ASN . 2.6 m-20 -88.42 175.86 7.43 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 170.082 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.535 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 44.1 m-85 -136.17 175.58 9.47 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.407 -175.371 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.2 t -142.46 106.71 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.926 0.393 . . . . 0.0 110.67 176.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.411 HD13 HG22 ' A' ' 38' ' ' VAL . 46.7 tp -80.97 103.76 11.01 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.389 176.406 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.1 m -96.45 126.66 41.79 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 176.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 95.4 t -121.76 135.89 60.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.754 -175.176 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.635 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 23.4 t -95.88 114.75 26.51 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -175.44 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.602 ' HG3' HD22 ' A' ' 55' ' ' ASN . 9.4 tp10 -151.48 154.7 37.08 Favored 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 119.53 -0.868 . . . . 0.0 108.999 164.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.602 HD22 ' HG3' ' A' ' 54' ' ' GLU . 0.5 OUTLIER 45.4 37.52 3.01 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.537 0.735 . . . . 0.0 112.701 -177.666 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 34.5 m 49.38 56.09 8.35 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 122.403 1.097 . . . . 0.0 109.459 -178.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.523 ' HB2' ' O ' ' A' ' 55' ' ' ASN . 1.5 tmm_? -165.67 64.32 0.11 Allowed 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 113.312 -1.767 . . . . 0.0 109.33 -152.433 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 14.1 t -72.3 106.33 2.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.961 0.886 . . . . 0.0 110.353 -169.209 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.4 m -76.64 122.49 24.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 113.899 -1.5 . . . . 0.0 111.31 -177.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -95.55 102.37 14.17 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.107 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.674 ' OH ' ' HB3' ' A' ' 93' ' ' LEU . 70.8 m-85 -97.35 109.26 22.05 Favored 'General case' 0 C--O 1.221 -0.396 0 C-N-CA 123.079 0.552 . . . . 0.0 110.667 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.559 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 59.2 mt -80.03 128.88 38.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -173.304 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.629 HG23 ' HB3' ' A' ' 71' ' ' PHE . 3.1 mp -99.7 111.08 28.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.707 177.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.595 ' HA ' ' OD2' ' A' ' 47' ' ' ASP . 15.9 m120 -83.94 133.81 34.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.944 178.137 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.2 t -89.16 95.79 10.45 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.555 HD11 ' HB2' ' A' ' 72' ' ' LYS . 83.6 mt -81.07 147.79 62.25 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.247 -176.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -76.77 -9.38 18.3 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.932 2.421 . . . . 0.0 112.877 -179.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 35.2 p30 -81.19 7.85 10.25 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.575 0.702 . . . . 0.0 109.322 171.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.741 ' NE ' ' HA ' ' A' ' 69' ' ' ARG . 3.4 tpm_? 61.64 58.27 2.06 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.125 -1.398 . . . . 0.0 110.981 -176.529 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.873 ' HG2' ' HA ' ' A' ' 79' ' ' ASP . 79.4 mtt180 -135.41 176.73 8.41 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.24 172.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.629 ' HB3' HG23 ' A' ' 63' ' ' ILE . 52.2 m-85 -130.48 113.51 14.38 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.021 0.438 . . . . 0.0 109.83 176.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.593 ' HE2' ' HA ' ' A' ' 75' ' ' ASP . 36.0 tttm -98.19 105.02 17.1 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.981 -173.092 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.687 HD13 ' CE2' ' A' ' 88' ' ' TYR . 16.3 tt -81.0 79.35 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 122.18 0.99 . . . . 0.0 111.0 -176.56 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.78 -10.36 18.97 Favored Glycine 0 CA--C 1.52 0.378 0 CA-C-N 115.004 -0.998 . . . . 0.0 113.87 176.401 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.593 ' HA ' ' HE2' ' A' ' 72' ' ' LYS . 8.7 t70 177.28 -68.71 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 116.944 0.372 . . . . 0.0 110.321 -170.561 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -66.35 123.64 20.52 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.921 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.445 ' O ' ' HG3' ' A' ' 77' ' ' GLU . 13.7 pt-20 -93.62 105.25 17.31 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.734 0.778 . . . . 0.0 110.728 177.46 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.478 ' CZ ' ' CD1' ' A' ' 87' ' ' PHE . 84.1 m-85 -95.03 152.25 18.48 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 174.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.873 ' HA ' ' HG2' ' A' ' 70' ' ' ARG . 8.3 m-20 -67.99 -23.24 65.0 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -171.338 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.624 ' ND1' ' HG2' ' A' ' 82' ' ' PRO . 6.0 p80 -162.36 165.47 26.44 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.736 -0.211 . . . . 0.0 110.438 -178.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.547 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 10.0 mt -55.99 -54.89 47.32 Favored Pre-proline 0 CA--C 1.535 0.377 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -178.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.624 ' HG2' ' ND1' ' A' ' 80' ' ' HIS . 15.4 Cg_endo -61.12 -4.17 3.65 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.183 1.922 . . . . 0.0 113.796 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.412 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -89.87 -34.94 15.91 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.762 0.315 . . . . 0.0 110.769 178.492 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.1 pp -76.94 -30.96 56.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.135 0.493 . . . . 0.0 109.838 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 70.1 mt -68.43 -21.56 64.65 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.491 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.548 ' OE2' ' HD2' ' A' ' 89' ' ' LYS . 18.8 tp10 -85.81 -35.43 20.68 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.183 176.598 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.547 ' HE1' ' CZ ' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -71.56 -19.54 62.14 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.333 0.587 . . . . 0.0 111.436 -179.815 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.687 ' CE2' HD13 ' A' ' 73' ' ' ILE . 38.7 m-85 -94.96 5.47 51.83 Favored 'General case' 0 C--N 1.313 -0.98 0 O-C-N 121.685 -0.634 . . . . 0.0 111.769 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.548 ' HD2' ' OE2' ' A' ' 86' ' ' GLU . 96.2 mttt -77.52 -25.91 50.64 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.685 171.389 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.596 HD13 ' H ' ' A' ' 90' ' ' ILE . 0.3 OUTLIER -106.32 -17.67 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 CA-C-O 121.41 0.624 . . . . 0.0 109.756 174.148 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.489 ' HB2' ' O ' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -93.97 106.41 18.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.78 178.771 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -72.46 104.23 3.74 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.756 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.713 ' O ' ' HB3' ' A' ' 154' ' ' GLU . 16.5 mt -59.43 -31.02 68.9 Favored 'General case' 0 C--O 1.215 -0.757 0 O-C-N 124.356 1.035 . . . . 0.0 111.431 -176.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.483 ' HB3' ' HA ' ' A' ' 154' ' ' GLU . 24.5 p-10 -176.18 85.47 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.883 0.849 . . . . 0.0 110.532 164.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 71.78 -19.18 0.27 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.592 -175.266 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 97' ' ' THR . 18.0 m -132.49 146.03 51.62 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 120.968 0.413 . . . . 0.0 110.625 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.44 ' O ' HG22 ' A' ' 96' ' ' THR . 37.4 p -96.16 -178.17 4.24 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.533 178.199 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.468 HD22 ' CD2' ' A' ' 36' ' ' PHE . 96.1 mt -70.84 106.3 3.55 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 174.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.547 HD12 ' HB2' ' A' ' 3' ' ' SER . 46.4 mm -89.86 -63.07 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.189 0.519 . . . . 0.0 110.422 -177.343 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.585 ' O ' ' HA ' ' A' ' 35' ' ' MET . 11.2 pt-20 -157.69 151.5 19.51 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.426 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.6 155.55 68.55 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.274 1.983 . . . . 0.0 112.362 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.563 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -69.07 146.56 97.25 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.476 179.095 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -57.61 130.92 41.25 Favored 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 122.618 2.212 . . . . 0.0 112.951 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 . . . . . 0 C--N 1.325 -0.485 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 172.823 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.865 HD12 HG21 ' A' ' 152' ' ' ILE . 4.3 mm? . . . . . 0 N--CA 1.468 0.428 0 CA-C-O 121.652 0.739 . . . . 0.0 110.814 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.71 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 4.9 tp10 -165.61 -74.28 0.03 OUTLIER 'General case' 0 C--O 1.218 -0.554 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.028 -169.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -108.17 110.95 22.71 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.036 0.446 . . . . 0.0 110.296 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.821 HG22 ' HG3' ' A' ' 180' ' ' LYS . 86.4 t -125.87 136.65 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.647 176.48 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.683 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 5.6 ptp180 -112.13 147.16 36.71 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 117.41 -1.716 . . . . 0.0 108.474 169.334 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.599 HG22 HG12 ' A' ' 178' ' ' VAL . 7.6 p -99.72 135.56 40.96 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.628 177.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.594 HD21 ' HG2' ' A' ' 179' ' ' GLU . 14.3 mt -108.41 3.0 22.8 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -177.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.449 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 27.0 t80 -99.94 -43.34 6.42 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.494 -0.483 . . . . 0.0 112.112 -174.174 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.669 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 14.5 t70 73.04 96.85 0.07 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.513 0.673 . . . . 0.0 109.888 -171.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.538 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 44.2 t80 -129.14 90.06 46.37 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 174.503 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.59 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 92.7 Cg_endo -90.52 84.35 0.4 Allowed 'Trans proline' 0 N--CA 1.436 -1.862 0 C-N-CA 121.914 1.743 . . . . 0.0 112.358 -178.11 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -78.67 -2.37 85.31 Favored Glycine 0 C--N 1.329 0.191 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.217 176.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.456 ' H ' ' HB3' ' A' ' 143' ' ' PRO . 19.0 m120 36.16 71.04 0.14 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 113.872 -1.164 . . . . 0.0 112.461 -175.533 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.594 ' HB3' ' H ' ' A' ' 141' ' ' ASP . 0.4 OUTLIER -132.7 -176.59 4.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.22 0.533 . . . . 0.0 111.317 -177.394 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -112.17 1.75 16.37 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 167.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -115.41 -44.4 2.98 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.296 175.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.594 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 9.7 m-20 -98.36 127.61 44.37 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 166.226 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 1.038 HD11 ' HB2' ' A' ' 165' ' ' ASN . 24.6 tp -81.88 130.7 59.68 Favored Pre-proline 0 CA--C 1.518 -0.254 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.283 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.619 ' HD2' HD12 ' A' ' 142' ' ' LEU . 72.0 Cg_endo -84.0 92.04 0.82 Allowed 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.121 1.881 . . . . 0.0 112.292 174.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.538 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 1.5 p90 -90.89 179.73 5.69 Favored 'General case' 0 CA--C 1.504 -0.799 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.817 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.669 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 16.3 mtpp -122.05 -176.6 3.38 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.294 172.378 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.757 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -78.65 36.78 0.27 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.798 0.809 . . . . 0.0 110.852 -174.635 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 145' ' ' LYS . . . 151.66 42.75 0.02 OUTLIER Glycine 0 N--CA 1.433 -1.554 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.32 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.84 147.11 27.68 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 119.352 -0.939 . . . . 0.0 109.993 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.6 mp -87.26 125.76 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.868 -177.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.77 HD22 ' CD2' ' A' ' 142' ' ' LEU . 33.8 mt -122.18 158.11 30.1 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -176.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.71 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 61.8 t -120.08 121.49 65.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 175.117 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 1.043 HD13 ' HB2' ' A' ' 163' ' ' ALA . 38.0 mm -77.18 79.31 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 CA-C-O 122.183 0.992 . . . . 0.0 108.682 -177.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.572 HD12 ' HD3' ' A' ' 164' ' ' ARG . 16.7 tt -71.43 -32.87 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 CA-C-N 113.856 -1.52 . . . . 0.0 109.09 -177.081 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.713 ' HB3' ' O ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -123.35 140.27 53.18 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.604 171.909 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -127.73 88.46 53.37 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 167.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.616 ' HG2' ' HE3' ' A' ' 172' ' ' MET . 0.9 OUTLIER -81.74 -46.75 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.224 2.616 . . . . 0.0 111.71 177.678 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.487 ' HB2' ' O ' ' A' ' 160' ' ' TRP . 33.8 mm-40 -102.94 161.67 13.57 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.928 -176.198 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -88.96 -27.41 20.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.452 0.644 . . . . 0.0 109.338 172.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -94.12 -18.76 21.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.249 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.651 ' HB3' ' HE1' ' A' ' 172' ' ' MET . 48.5 m95 -130.24 131.45 45.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.132 -178.02 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' TRP . . . . . 0.72 ' HB3' HD12 ' A' ' 152' ' ' ILE . 50.5 m0 -119.4 135.15 54.87 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -178.198 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.58 ' OG ' ' HG2' ' A' ' 172' ' ' MET . 21.6 m -99.6 95.0 6.68 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -174.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 1.043 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -104.03 147.21 27.65 Favored 'General case' 0 N--CA 1.418 -2.037 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.075 -174.363 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.752 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 24.5 ptt-85 -86.44 123.24 31.44 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 175.243 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 1.038 ' HB2' HD11 ' A' ' 142' ' ' LEU . 6.1 t30 -55.09 172.04 0.13 Allowed 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 113.151 -1.841 . . . . 0.0 110.416 -172.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 36.5 tttp -58.21 -12.68 3.82 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.227 0.537 . . . . 0.0 110.039 174.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -83.5 -45.76 13.22 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.71 172.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 130.24 -9.62 5.93 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.959 -173.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.752 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.1 OUTLIER -62.56 132.47 52.53 Favored 'General case' 0 C--O 1.216 -0.703 0 C-N-CA 123.712 0.805 . . . . 0.0 112.373 179.489 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.442 HG22 HG21 ' A' ' 153' ' ' ILE . 78.8 t -85.81 122.25 38.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 O-C-N 122.462 -0.149 . . . . 0.0 110.906 177.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 162' ' ' SER . . . -153.59 149.37 20.85 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.55 172.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.651 ' HE1' ' HB3' ' A' ' 160' ' ' TRP . 7.0 mtp -77.51 142.42 39.1 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.712 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.8 pp -143.77 144.94 28.94 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.42 -178.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.483 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 21.7 Cg_exo -65.01 133.47 35.9 Favored 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 122.854 2.369 . . . . 0.0 113.181 -178.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.485 ' O ' HG22 ' A' ' 178' ' ' VAL . 60.2 t -63.24 -42.02 72.66 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 177.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.409 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 36.3 Cg_exo -62.3 1.32 0.98 Allowed 'Trans proline' 0 C--N 1.359 1.097 0 C-N-CA 122.164 1.91 . . . . 0.0 113.172 176.224 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.483 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.1 m-85 -103.16 -12.78 17.11 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.506 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.669 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 3.8 m -105.83 -172.82 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 -166.389 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.683 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 7.5 tp10 -160.23 50.97 0.3 Allowed 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 113.004 -1.907 . . . . 0.0 112.271 -152.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.821 ' HG3' HG22 ' A' ' 128' ' ' VAL . 2.2 mppt? -69.2 137.45 53.25 Favored 'General case' 0 N--CA 1.462 0.161 0 O-C-N 119.706 -1.871 . . . . 0.0 111.319 -159.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.434 HD13 ' CZ ' ' A' ' 129' ' ' ARG . 13.0 tp . . . . . 0 N--CA 1.45 -0.464 0 CA-C-N 112.634 -2.076 . . . . 0.0 111.016 -170.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo . . . . . 0 N--CA 1.451 -1.023 0 N-CA-C 110.322 -0.684 . . . . 0.0 110.322 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.545 ' HB ' HG13 ' A' ' 266' ' ' VAL . 19.6 t -89.09 126.35 42.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-O 121.056 0.455 . . . . 0.0 110.425 -175.433 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -115.89 120.38 39.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.72 -177.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.571 ' HB2' HG13 ' A' ' 293' ' ' ILE . . . -120.34 145.05 47.5 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.262 178.402 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -95.1 120.69 35.75 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 175.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 242' ' ' ALA . . . . . 0.553 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -68.62 107.6 3.03 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.381 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.5 HD13 ' HD3' ' A' ' 292' ' ' LYS . 39.1 pt -85.17 -21.28 7.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.049 0.452 . . . . 0.0 110.611 -177.025 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -134.85 147.12 49.81 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.487 -178.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 245' ' ' LYS . . . . . 0.453 ' HG2' ' HA ' ' A' ' 259' ' ' GLU . 10.7 mtmp? -63.32 156.9 24.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.519 0.676 . . . . 0.0 111.32 -176.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.531 ' HG3' ' O ' ' A' ' 256' ' ' LEU . 27.6 tpt180 -140.35 122.21 15.48 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.764 -179.24 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 247' ' ' VAL . . . . . 0.402 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 16.9 m -127.58 153.68 77.58 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-O 120.834 0.35 . . . . 0.0 111.613 -175.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.514 ' HB3' ' CG ' ' A' ' 252' ' ' ASP . 7.4 Cg_exo -72.92 159.35 48.29 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.966 2.444 . . . . 0.0 112.078 178.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 249' ' ' CYS . . . . . 0.477 ' SG ' ' N ' ' A' ' 250' ' ' ALA . 42.3 t -104.59 -175.63 2.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.875 -178.609 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.477 ' N ' ' SG ' ' A' ' 249' ' ' CYS . . . -58.85 -44.6 91.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.154 0.502 . . . . 0.0 110.506 176.226 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -91.43 31.94 1.11 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.809 178.076 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 252' ' ' ASP . . . . . 0.514 ' CG ' ' HB3' ' A' ' 248' ' ' PRO . 2.9 t70 -60.92 112.75 2.18 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.492 178.33 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -139.13 -6.77 1.39 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.385 169.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -151.77 34.81 0.55 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.376 176.506 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -112.54 100.62 8.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.201 0.524 . . . . 0.0 110.759 -179.001 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.531 ' O ' ' HG3' ' A' ' 246' ' ' ARG . 0.5 OUTLIER -67.13 146.76 53.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.977 -175.764 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -107.87 120.22 41.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.055 178.066 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.525 HD21 HG21 ' A' ' 279' ' ' VAL . 51.3 mt -136.39 152.75 50.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.536 -175.025 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 259' ' ' GLU . . . . . 0.453 ' HA ' ' HG2' ' A' ' 245' ' ' LYS . 0.9 OUTLIER -115.07 -176.39 2.9 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 172.657 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 51.1 t -81.29 120.91 33.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.569 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 111.08 2.78 28.17 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.001 -0.619 . . . . 0.0 113.054 177.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -90.88 146.74 23.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.814 0.34 . . . . 0.0 110.79 -178.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 24.3 mm -92.67 109.86 22.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.538 177.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 20.8 t -83.28 108.46 15.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.217 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -80.42 86.48 5.75 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.881 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.545 HG13 ' HB ' ' A' ' 238' ' ' VAL . 2.6 p -98.41 117.69 43.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.671 0.748 . . . . 0.0 110.656 -178.161 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 18.4 p -94.46 -49.66 5.58 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.303 -177.016 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -100.61 114.31 27.88 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 120.955 0.407 . . . . 0.0 111.06 -177.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 269' ' ' MET . . . . . 0.429 ' CE ' HG11 ' A' ' 238' ' ' VAL . 40.7 mtt -106.61 140.19 39.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.145 0.497 . . . . 0.0 110.735 174.382 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -119.78 -170.05 1.88 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.575 -175.335 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.434 HD12 ' N ' ' A' ' 271' ' ' ILE . 4.5 mp -95.81 -30.81 4.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.135 -174.176 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -66.81 -23.39 66.05 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -173.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 115.21 -32.37 5.79 Favored Glycine 0 C--O 1.23 -0.128 0 C-N-CA 120.194 -1.003 . . . . 0.0 113.084 173.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.485 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 48.7 mt-30 -86.23 107.53 17.96 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 176.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.512 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 12.7 m0 -92.22 157.61 16.6 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.106 -173.164 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -100.29 108.35 20.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.256 0.551 . . . . 0.0 109.857 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 277' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -110.0 145.38 17.02 Favored Glycine 0 N--CA 1.44 -1.042 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.573 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -107.66 108.68 20.04 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.33 0.586 . . . . 0.0 110.042 177.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 279' ' ' VAL . . . . . 0.525 HG21 HD21 ' A' ' 258' ' ' LEU . 60.3 t -120.54 127.62 75.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.777 -178.642 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 47.91 33.02 3.05 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.18 0.992 . . . . 0.0 112.203 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 81.37 25.85 53.3 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.773 177.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 282' ' ' ARG . . . . . 0.482 ' NH1' ' HA ' ' A' ' 256' ' ' LEU . 1.0 OUTLIER -137.85 125.72 22.59 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 178.643 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 24.1 pttm -101.36 142.82 32.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.978 -175.351 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -163.53 152.16 22.01 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.208 177.005 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.512 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 90.9 mt -78.39 120.68 23.48 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.116 0.484 . . . . 0.0 110.372 176.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.408 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 43.8 p90 -118.24 146.24 38.95 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.857 178.058 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 287' ' ' PRO . . . . . 0.409 ' HG2' ' CD2' ' A' ' 290' ' ' HIS . 20.9 Cg_endo -87.69 137.08 3.95 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.752 2.302 . . . . 0.0 111.948 -179.012 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -60.17 -14.95 19.97 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -175.172 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.08 -12.28 61.42 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.005 0.431 . . . . 0.0 111.358 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 290' ' ' HIS . . . . . 0.409 ' CD2' ' HG2' ' A' ' 287' ' ' PRO . 10.9 m170 -101.07 -15.91 17.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.362 -176.742 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.56 ' HB ' ' HB1' ' A' ' 240' ' ' ALA . 35.4 m -128.39 152.7 36.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.897 0.38 . . . . 0.0 111.33 -175.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 292' ' ' LYS . . . . . 0.5 ' HD3' HD13 ' A' ' 243' ' ' ILE . 3.2 mptp? -130.88 134.83 47.14 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 170.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.571 HG13 ' HB2' ' A' ' 240' ' ' ALA . 1.0 OUTLIER -88.43 122.58 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 CA-C-O 122.068 0.937 . . . . 0.0 112.029 -177.291 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 294' ' ' PHE . . . . . 0.582 ' O ' ' HD3' ' A' ' 296' ' ' PRO . 5.1 p90 -117.3 140.15 49.92 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 168.354 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -79.95 107.61 7.21 Favored Pre-proline 0 C--N 1.317 -0.833 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.297 178.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 296' ' ' PRO . . . . . 0.582 ' HD3' ' O ' ' A' ' 294' ' ' PHE . 91.0 Cg_endo . . . . . 0 N--CA 1.459 -0.542 0 C-N-CA 122.666 2.244 . . . . 0.0 110.912 -177.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.4 p . . . . . 0 N--CA 1.452 -0.342 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -81.45 102.48 10.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.18 175.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -115.2 77.35 1.07 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.549 0.69 . . . . 0.0 111.572 -177.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -157.61 151.61 24.39 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.171 176.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.425 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 16.9 t70 -85.41 126.91 34.16 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.772 176.396 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.441 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 5.3 t -68.67 -20.12 64.43 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.044 -174.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 t -97.8 -13.62 21.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.766 0.317 . . . . 0.0 110.909 -177.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.425 ' HB2' ' HB3' ' A' ' 7' ' ' ASP . 17.3 t70 -79.09 78.41 5.54 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.514 0.674 . . . . 0.0 109.412 -178.587 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.449 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 3.8 ptp180 -69.8 -14.69 62.89 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.179 -175.288 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.5 t -82.91 14.86 3.01 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.61 0.719 . . . . 0.0 109.333 173.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.25 -42.51 3.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.122 170.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.424 ' CE2' ' HA ' ' A' ' 11' ' ' ARG . 44.9 p-90 -108.45 -22.05 12.47 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -172.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.449 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 25.1 t80 -86.34 120.63 27.9 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.205 0.526 . . . . 0.0 110.108 -177.08 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.575 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 25.1 mmt -100.38 1.36 41.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.796 -172.476 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.441 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.0 -112.46 1.69 Allowed Glycine 0 CA--C 1.525 0.719 0 N-CA-C 114.368 0.507 . . . . 0.0 114.368 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.441 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 11.3 Cg_exo -72.4 55.22 2.5 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 124.191 3.26 . . . . 0.0 114.299 -172.344 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.751 HG12 ' H ' ' A' ' 20' ' ' SER . 59.5 t -104.18 -178.42 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 172.656 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.751 ' H ' HG12 ' A' ' 19' ' ' VAL . 23.4 t -165.38 176.49 8.24 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -165.352 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 21.3 tpt180 -55.09 -55.7 28.12 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.684 0.278 . . . . 0.0 111.393 -174.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -59.11 -60.06 4.47 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.46 -177.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.425 ' HG2' ' HD2' ' A' ' 27' ' ' ARG . 25.6 tt0 -61.5 -46.03 91.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.679 -175.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.437 ' HB2' HG12 ' A' ' 19' ' ' VAL . . . -53.57 -49.23 68.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.962 0.41 . . . . 0.0 111.67 -175.276 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.613 ' HG3' ' HB ' ' A' ' 58' ' ' VAL . 12.5 tt0 -74.25 -37.25 63.81 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 120.117 -0.633 . . . . 0.0 111.183 -174.509 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.402 HG22 ' O ' ' A' ' 23' ' ' GLU . 7.4 t -70.42 -21.5 62.82 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 120.784 -0.367 . . . . 0.0 111.177 -177.379 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.425 ' HD2' ' HG2' ' A' ' 23' ' ' GLU . 56.4 mtp180 -82.79 -20.56 35.57 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.996 0.427 . . . . 0.0 110.736 178.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.638 HD21 ' HB2' ' A' ' 102' ' ' ALA . 13.0 mt -108.14 -15.74 14.43 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.95 179.224 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -84.71 130.24 34.72 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.243 0.544 . . . . 0.0 110.832 -173.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.522 ' C ' ' HG2' ' A' ' 32' ' ' ARG . . . 76.81 -3.38 56.45 Favored Glycine 0 C--N 1.314 -0.668 0 C-N-CA 119.914 -1.136 . . . . 0.0 112.747 178.4 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.5 ' HB2' ' CE ' ' A' ' 35' ' ' MET . 31.8 mt-30 -91.86 -52.17 4.86 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 172.096 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.743 ' CD ' ' HA ' ' A' ' 56' ' ' SER . 3.6 mmp_? 85.08 128.82 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 116.378 1.992 . . . . 0.0 116.378 152.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.541 ' ND1' ' HB3' ' A' ' 32' ' ' ARG . 0.2 OUTLIER 77.24 109.13 0.08 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 112.657 -2.065 . . . . 0.0 113.021 157.678 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.84 -37.83 3.46 Favored Glycine 0 N--CA 1.453 -0.222 0 CA-C-N 114.981 -1.009 . . . . 0.0 112.842 173.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.546 ' HE3' ' HB2' ' A' ' 35' ' ' MET . 33.4 mtm -70.5 141.48 51.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.794 0.331 . . . . 0.0 111.293 -177.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.433 ' CG ' HD22 ' A' ' 98' ' ' LEU . 37.7 p90 -143.93 160.8 40.19 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 172.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.575 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.4 pp -153.91 139.57 17.93 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.172 0.511 . . . . 0.0 111.447 174.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 49.9 t -104.67 130.82 55.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.415 -0.811 . . . . 0.0 108.949 173.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.409 ' CB ' ' HB ' ' A' ' 19' ' ' VAL . 24.9 ptt-85 -127.9 175.97 7.95 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -177.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -80.89 137.6 36.16 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 170.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.3 t -78.95 97.3 5.98 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.196 0.522 . . . . 0.0 110.64 -176.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.22 -8.82 26.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.426 0.631 . . . . 0.0 110.483 174.556 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.5 p -97.95 -8.26 28.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.764 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.47 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 28.4 t -164.4 122.88 1.21 Allowed Pre-proline 0 C--N 1.333 -0.136 0 CA-C-O 120.589 0.233 . . . . 0.0 110.763 -177.605 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 44' ' ' CYS . 10.1 Cg_exo -71.53 119.41 6.23 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 123.048 2.499 . . . . 0.0 112.618 -179.12 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.07 25.34 17.25 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.019 178.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -134.35 163.17 30.26 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.301 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.565 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 25.3 m-85 -124.61 166.07 16.75 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 175.032 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.478 HG13 HD13 ' A' ' 62' ' ' ILE . 21.5 t -137.13 108.16 5.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.239 178.606 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.4 tp -84.18 102.02 12.29 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.864 175.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 51.0 m -95.61 124.39 39.61 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 177.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.684 HG21 HD13 ' A' ' 93' ' ' LEU . 58.0 t -114.67 139.89 38.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.271 0.558 . . . . 0.0 111.421 -173.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.419 ' HA ' HH22 ' A' ' 32' ' ' ARG . 47.0 t -98.46 103.33 15.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.74 -174.177 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.776 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 6.3 tp10 -157.68 163.04 38.6 Favored 'General case' 0 C--O 1.213 -0.831 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.33 171.376 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.758 ' ND2' ' HG3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER 44.62 42.23 5.55 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.724 1.209 . . . . 0.0 112.813 -175.653 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.743 ' HA ' ' CD ' ' A' ' 32' ' ' ARG . 68.2 m 44.23 54.72 5.95 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 121.809 0.814 . . . . 0.0 111.028 -175.295 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.783 HH21 ' HA ' ' A' ' 154' ' ' GLU 0.341 0.0 OUTLIER -169.24 75.59 0.09 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.642 -1.163 . . . . 0.0 113.543 -154.384 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.613 ' HB ' ' HG3' ' A' ' 25' ' ' GLN . 14.9 t -69.14 108.12 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 O-C-N 119.475 -2.016 . . . . 0.0 110.355 -173.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.2 m -84.9 123.9 31.02 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.475 -178.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 36.1 m-70 -96.59 108.97 21.66 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.682 -174.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.607 ' HB3' HD11 ' A' ' 73' ' ' ILE . 79.1 m-85 -98.7 110.57 23.14 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.268 0.627 . . . . 0.0 111.118 178.428 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.664 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 40.3 mm -80.55 123.95 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -174.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.565 ' HB ' ' HB2' ' A' ' 48' ' ' TYR . 5.3 mp -102.68 112.54 36.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 120.797 0.332 . . . . 0.0 110.76 177.56 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.515 ' HB2' ' HB3' ' A' ' 72' ' ' LYS . 15.0 m120 -86.13 140.38 30.26 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.686 -176.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.3 t -86.52 101.15 12.92 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 169.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.885 HD12 ' HG3' ' A' ' 70' ' ' ARG . 91.9 mt -83.56 140.22 41.32 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.515 -178.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.65 -11.44 26.38 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.408 2.072 . . . . 0.0 110.678 172.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.54 ' HB2' ' HG2' ' A' ' 70' ' ' ARG . 2.9 m-20 -72.15 -2.48 18.8 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.114 174.401 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.87 ' HA ' ' HE ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER 67.09 35.02 4.76 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.858 -178.459 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.885 ' HG3' HD12 ' A' ' 66' ' ' LEU . 4.3 ptp180 -133.64 168.22 19.07 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.829 176.417 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.436 ' HB3' HG23 ' A' ' 63' ' ' ILE . 37.5 m-85 -114.0 124.23 51.65 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.977 0.418 . . . . 0.0 110.553 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.642 ' HB2' HD11 ' A' ' 66' ' ' LEU . 28.9 ttpp -108.73 95.88 5.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.287 -173.283 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.664 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 3.8 tt -87.83 118.31 33.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.073 0.463 . . . . 0.0 110.747 -178.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.95 31.54 78.87 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.729 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.526 ' HA ' ' HG2' ' A' ' 72' ' ' LYS . 31.2 t70 74.34 4.65 4.53 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.139 0.576 . . . . 0.0 111.47 -178.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -90.93 119.73 31.36 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 173.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -81.72 121.77 26.81 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.968 0.413 . . . . 0.0 111.487 -176.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.441 ' O ' ' HB2' ' A' ' 70' ' ' ARG . 87.3 m-85 -125.28 165.75 17.77 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 172.153 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -58.28 -49.25 77.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.132 0.491 . . . . 0.0 111.316 -179.033 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.486 ' ND1' ' HG2' ' A' ' 82' ' ' PRO . 4.7 p80 -164.0 -178.5 5.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.063 -177.351 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.522 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 14.2 mt -56.76 -57.05 26.56 Favored Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -176.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.486 ' HG2' ' ND1' ' A' ' 80' ' ' HIS . 24.0 Cg_endo -64.46 3.03 0.94 Allowed 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.237 1.958 . . . . 0.0 113.605 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.35 -36.27 10.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.868 0.366 . . . . 0.0 110.297 178.224 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.1 pp -76.48 -33.89 58.67 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.51 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 68.0 mt -66.74 -19.76 65.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.735 178.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -89.08 -37.9 14.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.444 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -71.32 -30.68 66.49 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.405 0.622 . . . . 0.0 110.382 -178.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.465 ' CG ' HD21 ' A' ' 93' ' ' LEU . 19.8 m-85 -82.57 -3.2 55.67 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.978 -0.556 . . . . 0.0 112.025 -178.467 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.51 ' HG3' ' O ' ' A' ' 85' ' ' LEU . 99.4 mttt -72.33 -13.06 61.39 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.523 174.377 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 16.7 pt -132.68 10.53 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 CA-C-O 121.37 0.605 . . . . 0.0 110.054 -177.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -107.0 -37.48 6.31 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.954 -175.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.496 ' CD2' HG23 ' A' ' 97' ' ' THR . 75.1 m-85 69.06 115.89 0.04 OUTLIER 'General case' 0 C--O 1.224 -0.279 0 O-C-N 124.227 0.954 . . . . 0.0 109.702 -173.417 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.684 HD13 HG21 ' A' ' 52' ' ' VAL . 1.2 mt -91.14 -7.64 50.99 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.516 0.674 . . . . 0.0 110.433 177.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.693 ' HA ' ' HB3' ' A' ' 154' ' ' GLU . 0.2 OUTLIER -144.61 -45.52 0.24 Allowed 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 122.107 0.956 . . . . 0.0 111.032 -172.381 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.571 ' HB ' ' O ' ' A' ' 94' ' ' ASP . 5.6 t 152.45 -15.72 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 104.457 -2.423 . . . . 0.0 104.457 -167.275 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.1 m -117.81 145.83 44.27 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 112.878 -1.965 . . . . 0.0 108.162 177.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.496 HG23 ' CD2' ' A' ' 92' ' ' TYR . 27.4 p -94.94 171.49 8.73 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 174.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.433 HD22 ' CG ' ' A' ' 36' ' ' PHE . 92.7 mt -66.24 93.33 0.21 Allowed 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 177.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 39.9 mm -79.66 -61.05 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.969 -175.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.518 ' O ' ' HA ' ' A' ' 35' ' ' MET . 0.6 OUTLIER -160.58 150.1 14.19 Favored Pre-proline 0 N--CA 1.453 -0.312 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.121 178.452 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.86 163.41 30.93 Favored 'Trans proline' 0 CA--C 1.532 0.384 0 C-N-CA 122.91 2.407 . . . . 0.0 114.414 -172.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.638 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -63.83 155.47 77.17 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.475 176.623 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.418 ' HD3' ' SD ' ' A' ' 35' ' ' MET . 84.1 Cg_exo -51.38 95.83 0.03 OUTLIER 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 123.116 2.544 . . . . 0.0 112.755 174.649 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.446 ' HG3' ' SD ' ' A' ' 16' ' ' MET . 49.5 ttt180 . . . . . 0 C--N 1.331 -0.218 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 177.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.933 HD12 HG21 ' A' ' 152' ' ' ILE . 4.2 mm? . . . . . 0 N--CA 1.467 0.414 0 CA-C-O 121.527 0.68 . . . . 0.0 112.53 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 48.4 tt0 -172.65 -56.46 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.65 178.166 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -117.99 108.64 15.51 Favored 'General case' 0 CA--C 1.51 -0.582 0 C-N-CA 120.071 -0.651 . . . . 0.0 111.134 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.684 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 3.1 t -115.8 142.32 29.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.669 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 0.1 OUTLIER -115.38 145.01 42.94 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 116.623 -2.031 . . . . 0.0 108.688 160.493 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.561 HG22 HG12 ' A' ' 178' ' ' VAL . 0.8 OUTLIER -103.48 128.04 50.75 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.086 -177.601 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.543 HD21 ' HG2' ' A' ' 179' ' ' GLU . 20.3 mt -102.0 -24.0 14.04 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -174.291 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.496 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 46.8 t80 -82.03 -35.3 28.94 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.271 -0.571 . . . . 0.0 112.378 -172.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.665 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 9.7 t70 75.18 104.64 0.07 Allowed 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.423 0.63 . . . . 0.0 110.726 -175.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.474 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 63.9 t80 -129.77 88.85 48.1 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 175.048 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.663 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 60.4 Cg_endo -85.3 71.18 4.95 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.039 1.826 . . . . 0.0 113.099 -176.119 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.72 -30.53 76.41 Favored Glycine 0 C--N 1.331 0.287 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.778 178.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.535 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 13.7 m-80 56.0 71.01 0.58 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 114.862 -0.669 . . . . 0.0 110.718 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.569 ' HB3' ' H ' ' A' ' 141' ' ' ASP . 0.7 OUTLIER -145.6 -169.47 3.23 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.149 -174.442 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -110.73 -5.53 14.97 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 166.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -101.31 -56.88 2.2 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 113.698 -1.592 . . . . 0.0 108.529 177.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ASP . . . . . 0.569 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 3.4 m-20 -96.81 120.86 37.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.489 174.478 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 1.074 HD11 ' HB2' ' A' ' 165' ' ' ASN . 32.9 tp -76.68 130.13 77.34 Favored Pre-proline 0 N--CA 1.467 0.404 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 175.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.663 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 74.1 Cg_endo -82.28 94.04 0.9 Allowed 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 121.67 1.58 . . . . 0.0 111.966 172.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.565 ' HA ' ' OE1' ' A' ' 148' ' ' GLU . 12.2 p90 -106.58 153.7 21.97 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -176.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.665 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 88.9 mttt -103.16 -162.03 0.88 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -173.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.57 ' HD2' ' N ' ' A' ' 146' ' ' LYS . 9.0 mptt -81.98 -7.94 59.64 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.858 -166.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -167.83 27.5 0.15 Allowed Glycine 0 C--N 1.311 -0.825 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.352 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.565 ' OE1' ' HA ' ' A' ' 144' ' ' PHE . 0.1 OUTLIER -78.99 154.39 29.55 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.071 0.462 . . . . 0.0 111.684 -177.157 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.651 HD12 ' HB3' ' A' ' 129' ' ' ARG . 0.5 OUTLIER -95.19 128.72 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.702 -177.961 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.7 HD22 HD21 ' A' ' 142' ' ' LEU . 61.8 mt -122.98 156.19 35.27 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -175.369 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.602 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 85.2 t -119.2 121.07 65.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 174.447 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 1.027 HD13 ' HB2' ' A' ' 163' ' ' ALA . 48.5 mm -76.88 91.75 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 CA-C-O 121.889 0.852 . . . . 0.0 108.711 -176.018 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.555 HG23 ' HG3' ' A' ' 154' ' ' GLU . 17.6 tt -79.95 -26.66 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 CA-C-N 114.237 -1.347 . . . . 0.0 109.696 -174.572 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.783 ' HA ' HH21 ' A' ' 57' ' ' ARG . 0.9 OUTLIER -134.7 144.9 48.04 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 172.461 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.588 ' HD2' ' HG ' ' A' ' 125' ' ' LEU . 77.0 tttt -127.84 85.06 61.61 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-O 121.148 0.499 . . . . 0.0 109.914 164.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.522 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 13.2 Cg_exo -73.45 -41.33 1.22 Allowed 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.62 2.213 . . . . 0.0 112.28 175.057 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -121.7 176.84 5.52 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.931 -173.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -106.65 -0.98 23.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.777 0.798 . . . . 0.0 109.283 174.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -102.82 -36.68 8.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.801 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.545 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 31.1 m95 -127.03 144.71 50.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.932 176.072 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' TRP . . . . . 0.769 ' O ' HG13 ' A' ' 173' ' ' ILE . 49.3 m0 -125.75 138.98 53.89 Favored 'General case' 0 C--O 1.215 -0.756 0 C-N-CA 123.346 0.658 . . . . 0.0 109.776 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.532 ' HA ' ' HA ' ' A' ' 172' ' ' MET . 23.9 m -97.98 104.87 16.94 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -173.524 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 1.027 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -114.94 149.4 37.34 Favored 'General case' 0 N--CA 1.425 -1.687 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.235 -176.443 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.698 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 13.0 ptt180 -87.48 122.33 31.07 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 171.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 1.074 ' HB2' HD11 ' A' ' 142' ' ' LEU . 14.4 t30 -52.8 172.19 0.05 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.577 -1.647 . . . . 0.0 110.648 -175.243 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -63.75 -10.22 18.53 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.282 0.563 . . . . 0.0 109.554 173.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -85.21 -27.02 26.38 Favored 'General case' 0 N--CA 1.46 0.073 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.332 171.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 108.73 -2.28 32.11 Favored Glycine 0 CA--C 1.522 0.49 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.677 -176.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.698 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 3.3 ttm-85 -74.3 132.79 42.39 Favored 'General case' 0 C--O 1.214 -0.815 0 C-N-CA 123.054 0.542 . . . . 0.0 111.798 -177.309 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 64.7 t -84.81 121.88 37.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 O-C-N 122.032 -0.418 . . . . 0.0 111.391 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -158.36 156.35 27.33 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.578 173.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.545 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.0 OUTLIER -75.75 145.22 40.97 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 122.604 0.361 . . . . 0.0 111.479 -179.735 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.769 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.6 pp -144.69 145.62 28.86 Favored Pre-proline 0 C--O 1.221 -0.411 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.444 -177.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.512 ' HB2' ' CD1' ' A' ' 177' ' ' TYR . 10.3 Cg_exo -73.69 132.98 18.0 Favored 'Trans proline' 0 CA--C 1.527 0.126 0 C-N-CA 122.688 2.259 . . . . 0.0 112.889 -175.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.55 ' HB ' ' HD3' ' A' ' 176' ' ' PRO . 47.8 t -61.43 -45.71 94.45 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.55 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 50.8 Cg_exo -57.55 -8.01 3.62 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.383 2.056 . . . . 0.0 113.643 175.42 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.512 ' CD1' ' HB2' ' A' ' 174' ' ' PRO . 3.0 m-85 -95.57 -11.49 27.24 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.622 -178.393 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.673 ' HB ' HG13 ' A' ' 128' ' ' VAL . 3.4 m -106.49 -174.08 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 -165.492 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.673 ' O ' ' HG3' ' A' ' 179' ' ' GLU . 8.2 tp10 -161.02 44.29 0.17 Allowed 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 112.477 -2.147 . . . . 0.0 111.152 -155.354 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.849 ' HD2' ' H ' ' A' ' 180' ' ' LYS . 0.0 OUTLIER -73.71 141.85 46.38 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 119.411 -2.056 . . . . 0.0 111.663 -163.49 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.488 ' HB2' HH22 ' A' ' 129' ' ' ARG . 18.0 tp . . . . . 0 C--O 1.231 0.094 0 CA-C-N 112.608 -2.087 . . . . 0.0 112.259 -161.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo . . . . . 0 N--CA 1.462 -0.346 0 N-CA-C 111.347 -0.29 . . . . 0.0 111.347 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.418 ' CG1' HD12 ' A' ' 293' ' ' ILE . 13.2 t -66.85 136.48 26.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.18 -174.307 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.542 ' HB2' ' HG3' ' A' ' 296' ' ' PRO . 82.8 m-85 -98.63 125.51 43.93 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.971 178.026 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.516 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -118.21 148.53 42.29 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.417 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -92.31 125.29 36.91 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 177.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 242' ' ' ALA . . . . . 0.533 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -71.01 104.95 3.14 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 176.041 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.606 HD13 ' HG2' ' A' ' 292' ' ' LYS . 41.2 pt -88.0 0.82 6.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.936 0.398 . . . . 0.0 111.311 -174.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -155.79 146.47 22.05 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 15.7 pttm -66.41 109.16 2.62 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.57 0.7 . . . . 0.0 110.542 176.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.569 ' HB3' ' HB2' ' A' ' 258' ' ' LEU . 24.9 tpt180 -84.46 93.56 8.33 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.711 178.028 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 27.1 m -105.87 138.17 19.56 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.007 176.031 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.515 ' HB3' ' HB3' ' A' ' 255' ' ' ALA . 90.4 Cg_endo -80.62 148.72 18.19 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.471 2.114 . . . . 0.0 112.282 -179.325 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 249' ' ' CYS . . . . . 0.417 ' SG ' ' N ' ' A' ' 250' ' ' ALA . 41.8 t -92.74 -176.55 4.28 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 175.479 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 250' ' ' ALA . . . . . 0.417 ' N ' ' SG ' ' A' ' 249' ' ' CYS . . . -61.34 -24.0 66.14 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -175.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -102.75 -9.63 19.84 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -177.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -84.35 88.1 7.24 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.109 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -87.21 -16.92 33.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.039 -178.096 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 10.2 p -110.3 7.12 22.94 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.622 -176.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 255' ' ' ALA . . . . . 0.515 ' HB3' ' HB3' ' A' ' 248' ' ' PRO . . . -86.85 132.92 33.69 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.258 0.551 . . . . 0.0 111.328 -176.374 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.478 ' O ' ' HG3' ' A' ' 246' ' ' ARG . 1.0 OUTLIER -81.89 143.39 31.72 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 176.633 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -97.53 110.36 22.93 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.928 0.394 . . . . 0.0 110.329 178.054 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.569 ' HB2' ' HB3' ' A' ' 246' ' ' ARG . 65.5 mt -113.34 139.13 49.12 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.451 -175.188 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -91.67 137.61 32.22 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.726 173.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 2.5 p -67.37 119.21 12.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.163 0.506 . . . . 0.0 110.284 178.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 115.55 -3.26 21.72 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.266 -177.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -99.08 159.58 14.87 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -177.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 20.8 mm -87.38 122.76 39.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.062 0.458 . . . . 0.0 110.45 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.49 HG13 HG21 ' A' ' 279' ' ' VAL . 21.5 t -102.07 99.2 7.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.906 176.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -78.94 101.75 7.91 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.925 176.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 5.5 p -88.27 123.73 40.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.293 0.568 . . . . 0.0 109.983 179.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 2.4 m -93.83 -35.11 12.88 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.47 -175.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 268' ' ' ARG . . . . . 0.494 ' NE ' ' HA ' ' A' ' 268' ' ' ARG . 3.2 mmp_? -132.6 112.74 12.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.923 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 41.3 mtt -87.83 121.52 30.35 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.455 175.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -95.78 155.55 16.7 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 271' ' ' ILE . . . . . 0.809 ' H ' HD13 ' A' ' 271' ' ' ILE . 0.2 OUTLIER -82.53 -8.61 11.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -172.522 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -80.63 -24.0 39.34 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.717 0.294 . . . . 0.0 111.077 -178.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 123.85 -21.86 6.96 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.569 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -94.97 123.2 38.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.056 0.455 . . . . 0.0 109.805 177.204 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 47.4 m0 -98.3 153.29 18.63 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.929 -176.445 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -105.45 105.69 15.84 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.492 176.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 277' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -127.41 153.07 19.0 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.207 -178.335 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -107.46 108.62 20.03 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 279' ' ' VAL . . . . . 0.49 HG21 HG13 ' A' ' 264' ' ' VAL . 89.2 t -133.04 128.67 56.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.544 -175.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 59.83 27.5 16.83 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.262 176.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 92.19 -5.92 78.42 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.337 177.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -115.74 134.48 54.98 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 122.714 -0.286 . . . . 0.0 110.768 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 15.7 ptpt -112.87 131.01 55.9 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.038 0.447 . . . . 0.0 110.018 171.343 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -156.04 -175.79 27.43 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.51 -177.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 79.5 mt -98.63 124.31 43.36 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.422 0.629 . . . . 0.0 111.128 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -129.59 135.05 26.93 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.68 177.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.88 140.08 28.33 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.381 2.054 . . . . 0.0 111.461 178.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -64.22 -8.5 12.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.775 -176.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -71.03 -16.6 62.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.045 0.45 . . . . 0.0 111.209 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -101.89 -8.31 21.7 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.827 -176.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.533 HG12 ' HA ' ' A' ' 242' ' ' ALA . 30.2 m -129.61 166.89 26.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.639 0.257 . . . . 0.0 110.783 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 292' ' ' LYS . . . . . 0.606 ' HG2' HD13 ' A' ' 243' ' ' ILE . 28.8 mmtp -137.48 136.26 37.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.966 0.412 . . . . 0.0 110.903 175.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.516 HD13 ' HB2' ' A' ' 240' ' ' ALA . 38.9 mm -82.17 101.85 7.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 174.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -105.81 -7.72 18.15 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.005 -174.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 59.48 93.03 0.06 OUTLIER Pre-proline 0 N--CA 1.464 0.249 0 O-C-N 123.72 0.637 . . . . 0.0 111.465 -176.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 296' ' ' PRO . . . . . 0.542 ' HG3' ' HB2' ' A' ' 239' ' ' PHE . 60.4 Cg_endo . . . . . 0 C--O 1.233 0.272 0 C-N-CA 122.766 2.311 . . . . 0.0 111.4 175.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.6 t . . . . . 0 N--CA 1.45 -0.433 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.421 ' HB1' ' HE3' ' A' ' 89' ' ' LYS . . . -74.0 105.59 5.31 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.551 173.305 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -121.32 35.92 4.75 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.357 -172.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -117.51 157.45 26.27 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.107 -179.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -84.63 111.18 19.31 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 174.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.6 m -61.33 -15.49 36.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.183 -174.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.4 p -101.11 -20.88 15.15 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -177.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -77.11 93.99 3.98 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.943 -172.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.436 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 13.4 mtm-85 -61.11 -28.68 69.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.464 -178.609 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.459 ' HA ' ' NH1' ' A' ' 104' ' ' ARG . 67.7 m -73.83 4.45 5.22 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.799 0.333 . . . . 0.0 111.504 178.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -106.29 -43.8 4.7 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.521 174.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' TRP . . . . . 0.478 ' HB3' ' HB3' ' A' ' 101' ' ' PRO . 19.9 p-90 -114.91 -20.22 10.64 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -172.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.436 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 70.8 t80 -80.69 125.21 29.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.04 0.447 . . . . 0.0 110.92 -175.407 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.49 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 25.5 mmt -104.63 -6.18 20.72 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.182 -173.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 51.62 -113.36 2.34 Favored Glycine 0 CA--C 1.524 0.606 0 O-C-N 123.419 0.449 . . . . 0.0 113.738 -176.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -69.56 85.51 0.58 Allowed 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 122.924 2.416 . . . . 0.0 113.604 -176.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.468 ' HB ' ' HB2' ' A' ' 39' ' ' ARG . 85.9 t -140.3 156.85 24.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 175.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.583 ' HB3' ' OE1' ' A' ' 23' ' ' GLU . 34.4 t -127.39 -179.32 4.84 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -171.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 45.6 ttt85 -62.05 -53.24 58.28 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -173.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -64.86 -43.13 93.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.729 0.3 . . . . 0.0 110.786 -177.163 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.583 ' OE1' ' HB3' ' A' ' 20' ' ' SER . 13.6 mp0 -60.22 -51.16 70.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.682 179.189 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.25 -40.87 78.54 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.649 0.737 . . . . 0.0 110.795 176.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.451 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 33.4 tp60 -64.28 -44.28 92.18 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.441 -177.509 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 10.6 t -75.67 -31.25 59.69 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 111.655 0.242 . . . . 0.0 111.655 -176.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.484 ' O ' ' HG3' ' A' ' 31' ' ' GLN . 74.9 mtp180 -74.12 -13.21 60.79 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.711 0.291 . . . . 0.0 111.232 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.593 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 79.8 mt -121.48 -6.0 9.27 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.503 -178.629 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 19.2 tp60 -65.24 103.34 0.77 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.783 0.325 . . . . 0.0 111.127 -175.293 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.74 9.04 84.96 Favored Glycine 0 C--N 1.329 0.154 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.494 175.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 81.4 mm-40 -73.96 -164.91 0.26 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.998 0.427 . . . . 0.0 111.213 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.486 ' HB3' ' HE3' ' A' ' 35' ' ' MET . 55.2 ttp180 -58.08 125.88 25.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.989 176.639 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.42 ' HB3' ' CD ' ' A' ' 54' ' ' GLU . 65.0 m170 -72.5 122.14 20.81 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.906 -178.467 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 108.89 -4.73 32.18 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 -173.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.779 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 43.6 ttm -77.27 129.44 35.89 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 176.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.465 ' HB2' HG22 ' A' ' 52' ' ' VAL . 37.9 p90 -138.99 162.18 35.54 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.34 -177.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.527 ' HG ' HD11 ' A' ' 28' ' ' LEU . 4.6 pp -151.48 141.36 21.98 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.108 0.48 . . . . 0.0 110.777 174.455 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.5 t -107.59 118.79 56.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.59 176.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.468 ' HB2' ' HB ' ' A' ' 19' ' ' VAL . 23.4 ptt-85 -116.25 175.91 5.34 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.318 -176.568 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -77.7 127.56 32.64 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 173.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.8 t -71.61 121.55 18.97 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.693 -174.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.9 t -83.54 -18.71 37.45 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 170.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 27.2 m -62.59 -44.61 95.88 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.712 174.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.424 ' HA ' ' HD2' ' A' ' 45' ' ' PRO . 51.1 t -150.84 99.59 3.11 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.056 176.126 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 44' ' ' CYS . 10.3 Cg_endo -52.68 132.27 45.22 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.998 2.465 . . . . 0.0 112.213 -179.067 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.24 -34.68 5.52 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -175.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.621 ' OD2' ' HA ' ' A' ' 64' ' ' ASN . 2.7 m-20 -85.25 -177.49 6.51 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 175.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.416 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 27.9 m-85 -130.87 168.47 17.23 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.568 0.223 . . . . 0.0 110.971 -177.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.2 t -138.87 109.52 4.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.065 0.46 . . . . 0.0 110.82 174.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.429 ' CB ' HD11 ' A' ' 63' ' ' ILE . 40.5 tp -84.74 102.04 12.7 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.051 176.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 53.8 m -96.14 126.18 41.18 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 175.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.743 HG21 HD13 ' A' ' 93' ' ' LEU . 58.8 t -121.7 133.53 67.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.257 -175.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.593 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 41.6 t -87.43 121.45 29.88 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -176.146 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.649 ' HG3' ' HB3' ' A' ' 94' ' ' ASP . 0.6 OUTLIER -150.48 148.59 28.91 Favored 'General case' 0 C--O 1.209 -1.076 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.424 165.863 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 40.05 40.56 0.78 Allowed 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -176.699 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.2 m 57.25 49.86 12.62 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 122.139 0.971 . . . . 0.0 109.267 178.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.488 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 2.6 tmm_? -167.13 64.44 0.09 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 113.906 -1.497 . . . . 0.0 109.711 -151.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.6 t -71.6 113.89 9.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 122.004 0.906 . . . . 0.0 110.612 -166.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.0 m -76.86 120.73 22.41 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 113.915 -1.493 . . . . 0.0 110.807 -177.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -96.35 106.05 18.21 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -176.024 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.722 ' HB3' HD11 ' A' ' 73' ' ' ILE . 88.7 m-85 -105.7 109.26 21.15 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 122.853 0.461 . . . . 0.0 111.691 179.103 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 66.3 mt -81.31 132.68 30.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -177.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.453 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 5.4 mp -110.07 117.8 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 122.779 0.432 . . . . 0.0 110.481 178.608 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.621 ' HA ' ' OD2' ' A' ' 47' ' ' ASP . 6.6 m120 -87.75 133.59 33.83 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.194 -175.161 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.7 t -86.8 96.63 10.25 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 170.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.4 mt -70.54 140.22 87.0 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.634 178.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.61 -21.39 31.14 Favored 'Trans proline' 0 CA--C 1.529 0.25 0 C-N-CA 122.86 2.373 . . . . 0.0 112.413 177.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -78.69 7.55 6.74 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.214 176.113 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.665 ' HA ' ' HE ' ' A' ' 69' ' ' ARG . 7.7 mmp_? 65.39 51.35 1.57 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.738 0.78 . . . . 0.0 110.764 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.44 ' NH2' ' HB3' ' A' ' 77' ' ' GLU . 30.2 mtp180 -137.49 174.01 11.05 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.096 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.561 ' HA ' ' O ' ' A' ' 64' ' ' ASN . 47.2 m-85 -132.09 121.15 23.35 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.15 0.5 . . . . 0.0 111.694 -176.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 1.043 ' HD3' ' HG2' ' A' ' 77' ' ' GLU . 24.5 ttpt -111.91 119.33 38.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.513 176.486 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.722 HD11 ' HB3' ' A' ' 61' ' ' TYR . 2.9 tt -109.3 102.89 14.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.397 0.618 . . . . 0.0 111.068 -176.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.49 61.94 5.52 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.4 177.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 30.6 t70 75.04 -28.63 0.19 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.976 0.51 . . . . 0.0 111.788 175.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -78.23 122.86 26.24 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.698 0.285 . . . . 0.0 110.579 175.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 1.043 ' HG2' ' HD3' ' A' ' 72' ' ' LYS . 30.6 mt-10 -95.53 126.26 40.7 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.792 0.329 . . . . 0.0 110.605 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -121.78 -169.81 1.94 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.388 177.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -82.67 -56.78 3.65 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.07 0.462 . . . . 0.0 110.365 177.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' HIS . . . . . 0.418 ' HA ' ' HD2' ' A' ' 71' ' ' PHE . 1.6 p80 -157.87 179.95 8.72 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.485 -176.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.655 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 19.6 mt -49.96 -59.17 7.42 Favored Pre-proline 0 N--CA 1.469 0.495 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.655 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 15.4 Cg_exo -68.85 -2.49 9.6 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 121.975 1.783 . . . . 0.0 112.743 -175.601 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.32 -36.71 12.4 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.063 176.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.4 pp -76.69 -34.68 58.19 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.12 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.565 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 76.2 mt -62.59 -38.01 88.46 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.834 177.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.583 ' HA ' ' HD3' ' A' ' 89' ' ' LYS . 14.4 tp10 -70.63 -34.13 71.75 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 -177.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -70.56 -37.8 74.05 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.321 0.582 . . . . 0.0 110.594 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.529 ' HE2' HD13 ' A' ' 73' ' ' ILE . 21.3 m-85 -78.32 -19.77 52.85 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.743 -177.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.583 ' HD3' ' HA ' ' A' ' 86' ' ' GLU . 50.0 mtpt -62.34 -20.18 64.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.685 172.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 23.9 pt -121.04 18.58 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 120.58 -0.448 . . . . 0.0 112.105 175.033 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 6.6 t-160 -106.14 -33.23 7.92 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.887 0.375 . . . . 0.0 110.559 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.567 ' N ' HG22 ' A' ' 97' ' ' THR . 52.9 m-85 66.61 91.63 0.08 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.284 -168.305 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.743 HD13 HG21 ' A' ' 52' ' ' VAL . 12.7 mt -60.81 -8.45 3.05 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.989 0.9 . . . . 0.0 110.506 173.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.649 ' HB3' ' HG3' ' A' ' 54' ' ' GLU . 16.1 t70 -161.68 -108.59 0.02 OUTLIER 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 174.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.8 t -117.6 15.56 14.58 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.638 -0.825 . . . . 0.0 111.198 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.462 HG23 ' O ' ' A' ' 97' ' ' THR . 13.3 t -139.71 -19.39 0.93 Allowed 'General case' 0 C--N 1.349 0.544 0 C-N-CA 118.192 -1.403 . . . . 0.0 114.326 -177.075 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.567 HG22 ' N ' ' A' ' 92' ' ' TYR . 6.6 p 74.95 -164.1 0.08 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.845 0.858 . . . . 0.0 109.989 -171.744 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 42.7 mt -89.6 111.29 22.19 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 175.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.412 HD11 ' O ' ' A' ' 96' ' ' THR . 51.3 mm -105.19 -58.07 4.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -173.368 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.779 ' O ' ' HA ' ' A' ' 35' ' ' MET . 4.7 tp10 -153.72 131.27 6.13 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 -174.072 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.478 ' HB3' ' HB3' ' A' ' 14' ' ' TRP . 28.3 Cg_endo -62.8 166.43 13.95 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 122.764 2.309 . . . . 0.0 112.896 -179.253 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.403 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -75.62 148.17 82.42 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.648 176.182 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.33 106.62 0.31 Allowed 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 122.562 2.175 . . . . 0.0 112.628 -177.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ARG . . . . . 0.459 ' NH1' ' HA ' ' A' ' 12' ' ' SER . 24.1 ttp180 . . . . . 0 C--N 1.329 -0.298 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 174.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 0.601 HD12 HG21 ' A' ' 152' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.47 0.553 0 CA-C-O 121.648 0.737 . . . . 0.0 111.36 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.685 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 28.0 tt0 174.92 -52.33 0.01 OUTLIER 'General case' 0 C--O 1.22 -0.488 0 CA-C-N 114.005 -1.452 . . . . 0.0 109.26 179.19 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -110.97 105.93 14.87 Favored 'General case' 0 CA--C 1.511 -0.55 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.416 178.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.698 HG22 ' CG ' ' A' ' 180' ' ' LYS . 41.5 t -120.93 127.71 75.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.982 -178.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.605 ' O ' ' HG2' ' A' ' 179' ' ' GLU . 9.3 ptp180 -109.11 140.05 43.19 Favored 'General case' 0 C--O 1.22 -0.452 0 C-N-CA 117.336 -1.745 . . . . 0.0 110.267 173.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.78 HG22 HG12 ' A' ' 178' ' ' VAL . 1.4 p -98.54 139.91 33.57 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.285 -179.001 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.867 ' CD1' ' HG3' ' A' ' 179' ' ' GLU . 62.9 mt -126.39 1.94 6.99 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -178.272 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.521 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 36.7 t80 -93.46 -33.98 13.6 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.677 178.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.586 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 11.7 t70 74.51 101.3 0.07 Allowed 'General case' 0 N--CA 1.467 0.411 0 O-C-N 123.916 0.76 . . . . 0.0 109.868 -177.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.622 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 70.3 t80 -131.61 87.99 44.35 Favored Pre-proline 0 N--CA 1.446 -0.667 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.738 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 97.1 Cg_endo -79.08 88.3 1.47 Allowed 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 121.729 1.62 . . . . 0.0 112.49 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.72 -31.76 32.0 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.89 177.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.796 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 21.8 m120 66.89 35.68 4.74 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.027 0.531 . . . . 0.0 111.563 177.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.454 ' HB3' ' H ' ' A' ' 140' ' ' GLU . 2.6 m-20 -136.39 172.81 12.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.734 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.637 ' O ' ' HA2' ' A' ' 171' ' ' GLY . . . -86.88 -13.79 43.86 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.642 0.734 . . . . 0.0 109.498 171.305 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.676 ' O ' ' HB2' ' A' ' 172' ' ' MET . 3.4 mp0 -94.83 -18.59 21.06 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.635 176.111 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -139.77 102.29 4.4 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 176.042 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 1.037 HD11 ' HB2' ' A' ' 165' ' ' ASN . 49.9 tp -64.46 129.54 94.23 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -178.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.796 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 27.8 Cg_endo -81.92 88.62 1.3 Allowed 'Trans proline' 0 N--CA 1.439 -1.69 0 C-N-CA 121.239 1.292 . . . . 0.0 111.535 174.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.622 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 20.5 p90 -108.06 165.5 11.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.389 -173.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.586 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 37.0 mttp -109.49 -173.76 2.34 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.253 0.549 . . . . 0.0 111.853 -175.262 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.754 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -89.09 21.29 3.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.322 -174.846 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.453 ' HA2' HD23 ' A' ' 131' ' ' LEU . . . -179.96 35.03 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.121 177.235 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -107.68 150.25 27.16 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.073 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.526 HG13 ' HB3' ' A' ' 129' ' ' ARG . 1.9 mp -98.32 131.22 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -177.1 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.81 HD22 HD21 ' A' ' 142' ' ' LEU . 7.7 mt -122.3 169.51 10.86 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -175.455 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.685 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 74.1 t -128.98 122.4 56.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 110.422 -0.214 . . . . 0.0 110.422 178.047 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 1.086 HD13 ' HB2' ' A' ' 163' ' ' ALA . 45.8 mm -75.84 98.59 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -174.51 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.52 HG21 HG22 ' A' ' 170' ' ' VAL . 19.9 tt -96.07 -32.74 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.581 -173.002 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.573 ' OE2' ' HA ' ' A' ' 93' ' ' LEU . 7.7 mt-10 -115.93 140.05 49.63 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 167.108 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.704 ' HE3' ' HE1' ' A' ' 161' ' ' TRP . 83.7 tttt -127.84 73.66 78.77 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 121.901 -0.499 . . . . 0.0 110.944 170.136 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.512 ' HG2' ' HE2' ' A' ' 172' ' ' MET . 39.9 Cg_exo -61.19 -42.1 38.03 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.439 2.092 . . . . 0.0 112.183 175.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -124.91 -177.91 4.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.4 -175.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.463 ' O ' HG21 ' A' ' 175' ' ' VAL . 0.2 OUTLIER -108.5 -10.92 15.21 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 173.537 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -93.62 -30.95 14.69 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.555 177.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.57 ' CH2' ' HG3' ' A' ' 174' ' ' PRO . 65.0 m95 -124.06 141.71 51.82 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.409 174.715 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' TRP . . . . . 0.835 ' HB3' HD12 ' A' ' 152' ' ' ILE . 43.9 m0 -132.52 137.97 47.35 Favored 'General case' 0 C--O 1.21 -1.021 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.238 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.593 ' HA ' ' HA ' ' A' ' 172' ' ' MET . 19.0 m -93.34 99.34 11.89 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -174.404 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 1.086 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -109.09 143.17 38.79 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -171.627 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.8 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 11.1 ptt180 -86.35 119.46 26.64 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 176.651 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 1.037 ' HB2' HD11 ' A' ' 142' ' ' LEU . 16.4 t30 -50.75 170.12 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 113.117 -1.856 . . . . 0.0 111.543 -174.132 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -66.7 -9.14 33.24 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.49 0.662 . . . . 0.0 109.392 174.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -85.91 -18.7 31.99 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.259 171.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.29 56.87 2.2 Favored Glycine 0 CA--C 1.52 0.397 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.422 -174.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.8 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 4.2 ttm-85 -136.61 135.0 37.97 Favored 'General case' 0 C--O 1.216 -0.669 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.566 ' O ' ' HA ' ' A' ' 139' ' ' ALA . 43.0 t -79.66 124.95 38.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.375 -178.145 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' GLY . . . . . 0.637 ' HA2' ' O ' ' A' ' 139' ' ' ALA . . . -160.86 150.78 20.93 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.856 169.638 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.676 ' HB2' ' O ' ' A' ' 140' ' ' GLU . 1.5 mmt -67.18 138.2 56.82 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 117.515 0.657 . . . . 0.0 111.187 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.799 HD13 HG11 ' A' ' 178' ' ' VAL . 2.8 pp -134.1 140.06 35.01 Favored Pre-proline 0 N--CA 1.443 -0.799 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.271 179.224 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.734 ' HB2' ' HB2' ' A' ' 177' ' ' TYR . 26.3 Cg_exo -67.77 128.81 18.56 Favored 'Trans proline' 0 C--O 1.212 -0.779 0 C-N-CA 123.243 2.629 . . . . 0.0 112.871 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.532 ' C ' ' H ' ' A' ' 177' ' ' TYR . 88.0 t -64.72 -45.09 75.4 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 178.538 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 39.5 Cg_endo -67.63 8.96 0.37 Allowed 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 121.996 1.798 . . . . 0.0 111.933 175.575 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.734 ' HB2' ' HB2' ' A' ' 174' ' ' PRO . 1.5 m-85 -111.79 -5.34 14.42 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.256 -1.338 . . . . 0.0 109.649 -175.448 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.799 HG11 HD13 ' A' ' 173' ' ' ILE . 2.7 m -133.28 171.24 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-O 123.596 1.665 . . . . 0.0 114.717 -167.534 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.867 ' HG3' ' CD1' ' A' ' 131' ' ' LEU . 2.7 mm-40 -140.64 51.88 1.64 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 110.612 -2.995 . . . . 0.0 110.635 -155.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.698 ' CG ' HG22 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -69.69 136.78 51.47 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 120.209 -1.557 . . . . 0.0 109.894 -166.733 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 20.7 tp . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 112.329 -2.214 . . . . 0.0 113.244 -156.851 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo . . . . . 0 N--CA 1.459 -0.51 0 N-CA-C 111.187 -0.351 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.621 ' HB ' ' HE3' ' A' ' 269' ' ' MET . 3.4 t -83.07 146.06 7.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -178.601 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.406 ' CG ' ' HG3' ' A' ' 296' ' ' PRO . 57.0 m-85 -115.0 131.88 56.78 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.45 0.643 . . . . 0.0 112.02 -172.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.76 ' HB2' HD12 ' A' ' 293' ' ' ILE . . . -133.37 146.03 50.9 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.092 176.384 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.407 ' HB3' HD13 ' A' ' 263' ' ' ILE . 18.5 ptmt -111.38 132.34 54.5 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.693 -0.403 . . . . 0.0 109.952 176.255 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -63.36 117.86 7.25 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.945 -175.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 19.2 pt -98.43 -14.02 7.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.082 -177.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 20.7 tm0? -146.17 138.91 25.53 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 47.7 mttp -52.95 140.0 25.99 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.843 0.83 . . . . 0.0 113.159 -172.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.524 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 21.0 tpt180 -130.42 86.15 2.36 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.969 172.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 19.4 m -95.99 140.89 22.48 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.189 -179.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.41 ' HA ' ' HB3' ' A' ' 255' ' ' ALA . 13.4 Cg_exo -66.96 136.87 42.8 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.405 2.07 . . . . 0.0 111.604 -179.096 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 33.0 t -104.03 175.5 5.46 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.652 -178.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -56.3 -42.88 78.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.994 0.425 . . . . 0.0 111.43 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -85.81 -14.79 44.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.06 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -129.58 70.58 1.42 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.946 0.403 . . . . 0.0 110.185 -176.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -83.73 -14.13 52.35 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 174.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 5.2 p -76.82 -5.81 49.8 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.409 174.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 255' ' ' ALA . . . . . 0.41 ' HB3' ' HA ' ' A' ' 248' ' ' PRO . . . -72.88 139.55 46.95 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.745 178.441 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.07 119.75 23.95 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.524 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -70.03 103.65 2.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.653 178.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 258' ' ' LEU . . . . . 0.496 ' HB2' ' HB3' ' A' ' 246' ' ' ARG . 96.1 mt -112.07 128.03 56.08 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.075 -178.204 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.75 157.17 17.04 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 176.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 47.4 t -67.57 124.18 22.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.985 0.422 . . . . 0.0 110.253 -178.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 98.74 5.65 56.55 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.255 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -93.38 135.42 34.63 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 263' ' ' ILE . . . . . 0.407 HD13 ' HB3' ' A' ' 241' ' ' LYS . 24.8 mm -81.52 121.79 35.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.964 0.411 . . . . 0.0 110.184 177.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.494 HG11 ' CZ ' ' A' ' 286' ' ' PHE . 22.0 t -95.15 109.66 22.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.91 -178.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 43.4 tttp -85.76 87.46 7.41 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.59 176.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.432 HG21 ' HB3' ' A' ' 275' ' ' TRP . 4.0 p -89.92 125.8 42.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.156 0.503 . . . . 0.0 110.59 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 16.1 p -95.8 -32.87 12.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.256 -177.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 268' ' ' ARG . . . . . 0.568 ' HD2' ' OE2' ' A' ' 276' ' ' GLU . 41.3 ttm180 -132.39 118.46 19.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.992 0.425 . . . . 0.0 111.786 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 269' ' ' MET . . . . . 0.621 ' HE3' ' HB ' ' A' ' 238' ' ' VAL . 46.8 mtt -90.78 107.25 19.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.137 172.532 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 274' ' ' GLN . 26.4 m120 -78.68 137.82 37.99 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 178.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 10.7 tt -79.9 71.46 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 122.153 0.978 . . . . 0.0 110.969 -178.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 272' ' ' ASN . . . . . 0.419 ' H ' ' H ' ' A' ' 273' ' ' GLY . 4.3 p30 -168.27 -4.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.852 176.62 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 273' ' ' GLY . . . . . 0.419 ' H ' ' H ' ' A' ' 272' ' ' ASN . . . 119.42 -31.24 5.49 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.159 171.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.415 ' H ' ' HG2' ' A' ' 274' ' ' GLN . 12.1 pt20 -95.46 129.48 42.61 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.04 0.447 . . . . 0.0 110.519 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 275' ' ' TRP . . . . . 0.432 ' HB3' HG21 ' A' ' 266' ' ' VAL . 50.7 m0 -105.72 154.01 21.06 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.317 -179.154 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.568 ' OE2' ' HD2' ' A' ' 268' ' ' ARG . 43.0 mt-10 -96.0 111.45 23.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.335 172.25 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 277' ' ' GLY . . . . . 0.555 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -134.26 156.56 22.45 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.493 -0.861 . . . . 0.0 111.625 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.548 ' HG2' ' HB2' ' A' ' 283' ' ' LYS . 41.1 mt-10 -117.32 108.08 15.17 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.091 0.472 . . . . 0.0 109.808 178.259 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 279' ' ' VAL . . . . . 0.566 HG12 ' ND2' ' A' ' 280' ' ' ASN . 15.4 t -138.39 137.68 43.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.574 -177.647 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 280' ' ' ASN . . . . . 0.566 ' ND2' HG12 ' A' ' 279' ' ' VAL . 52.9 m-80 61.64 21.51 12.19 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.604 0.362 . . . . 0.0 111.051 -178.715 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 90.97 -5.87 81.86 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.979 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 32.7 mtp-105 -110.08 132.45 54.15 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 122.663 -0.316 . . . . 0.0 111.258 -178.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.555 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 2.0 ttmp? -97.11 122.28 39.94 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 168.263 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -150.85 168.5 30.59 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.308 -0.949 . . . . 0.0 111.949 -178.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 84.6 mt -91.28 138.72 31.36 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.07 0.462 . . . . 0.0 110.313 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.494 ' CZ ' HG11 ' A' ' 264' ' ' VAL . 34.3 p90 -148.14 144.42 18.82 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.663 178.642 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 287' ' ' PRO . . . . . 0.406 ' HA ' ' O ' ' A' ' 273' ' ' GLY . 84.5 Cg_endo -82.11 144.31 13.25 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.49 2.127 . . . . 0.0 111.542 176.022 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -65.93 -10.52 39.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.869 0.366 . . . . 0.0 111.89 -176.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 3.0 p -71.94 -4.87 30.85 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -178.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 7.4 m80 -111.29 -2.71 15.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.705 0.288 . . . . 0.0 111.155 -177.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.447 ' HB ' ' HB1' ' A' ' 240' ' ' ALA . 31.2 m -127.58 156.3 39.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.082 0.468 . . . . 0.0 111.371 -176.157 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 44.9 tptt -112.71 111.27 21.94 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.406 177.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.76 HD12 ' HB2' ' A' ' 240' ' ' ALA . 4.0 tp -72.11 141.2 16.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -162.54 -174.66 4.1 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.809 0.338 . . . . 0.0 110.694 -178.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -108.82 106.94 59.63 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.707 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 296' ' ' PRO . . . . . 0.406 ' HG3' ' CG ' ' A' ' 239' ' ' PHE . 87.3 Cg_endo . . . . . 0 N--CA 1.462 -0.336 0 C-N-CA 122.786 2.324 . . . . 0.0 112.471 -178.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.3 t . . . . . 0 N--CA 1.451 -0.378 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.57 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . -77.19 101.28 6.11 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 114.535 -1.212 . . . . 0.0 109.775 174.047 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -131.53 106.81 8.44 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.503 0.668 . . . . 0.0 111.269 -177.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.569 ' CE1' ' HE2' ' A' ' 89' ' ' LYS . 34.3 p90 -168.01 139.44 2.88 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.647 -1.161 . . . . 0.0 108.402 175.048 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -74.1 102.34 4.19 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.208 0.528 . . . . 0.0 110.284 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.1 m -57.73 -32.13 67.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.586 -175.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.4 t -81.47 -2.12 48.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.888 -174.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -103.66 105.83 16.17 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 121.585 -0.697 . . . . 0.0 110.901 -177.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.11 -29.09 70.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.899 178.083 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.8 m -74.79 4.04 7.06 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.974 0.416 . . . . 0.0 110.731 178.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -99.05 -30.48 12.3 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.558 175.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 36.6 p-90 -138.2 -20.83 1.08 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -171.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -77.14 115.41 16.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.041 0.448 . . . . 0.0 110.15 -174.562 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' MET . . . . . 0.582 ' HG3' ' HB2' ' A' ' 37' ' ' LEU . 25.1 mmt -97.94 -7.68 29.62 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.991 -175.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.483 ' O ' ' HB2' ' A' ' 39' ' ' ARG . . . 50.78 -111.69 1.34 Allowed Glycine 0 CA--C 1.523 0.577 0 O-C-N 123.694 0.622 . . . . 0.0 113.427 -178.543 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.435 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 4.4 Cg_exo -76.87 103.18 1.71 Allowed 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.845 2.363 . . . . 0.0 112.417 -179.535 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.724 ' HB ' ' HG3' ' A' ' 39' ' ' ARG . 2.9 t -138.13 -69.87 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.758 -178.405 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.527 ' H ' ' HG3' ' A' ' 39' ' ' ARG . 21.4 t 95.85 162.89 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 124.662 1.185 . . . . 0.0 109.083 172.431 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.432 ' O ' ' HG2' ' A' ' 25' ' ' GLN . 69.8 mtp85 -55.78 -44.56 77.83 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 123.04 0.212 . . . . 0.0 110.804 -175.062 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.87 -46.95 74.79 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 123.993 0.808 . . . . 0.0 110.718 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.52 ' HB3' HG13 ' A' ' 19' ' ' VAL . 14.1 tp10 -76.24 -46.91 25.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.298 0.57 . . . . 0.0 110.469 -175.303 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.11 -39.6 75.38 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.99 -176.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' A' ' 21' ' ' ARG . 20.2 pt20 -75.34 -33.15 61.09 Favored 'General case' 0 C--O 1.219 -0.513 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -173.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.1 t -75.48 -32.14 60.46 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.149 -176.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -84.22 -7.07 59.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.947 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.6 HD21 ' HB2' ' A' ' 102' ' ' ALA . 97.0 mt -125.97 13.3 7.87 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.639 175.538 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLN . . . . . 0.407 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 27.3 tp60 -72.36 84.72 1.08 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.634 ' HA2' ' HA ' ' A' ' 56' ' ' SER . . . 85.12 -64.81 4.15 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.518 -178.285 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 39.87 -125.8 0.4 Allowed 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 123.257 0.623 . . . . 0.0 112.222 -176.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 20.1 ptp180 -106.73 -7.24 17.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.242 -0.436 . . . . 0.0 109.876 178.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 37.7 m80 67.91 153.15 0.09 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.254 -173.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.98 -0.79 76.69 Favored Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.881 -177.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.674 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 37.1 mtm -104.7 147.51 27.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.749 0.309 . . . . 0.0 110.566 -178.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.427 ' CB ' HG22 ' A' ' 52' ' ' VAL . 43.2 p90 -143.27 169.42 17.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.49 -178.385 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.582 ' HB2' ' HG3' ' A' ' 16' ' ' MET . 4.5 pp -158.21 143.76 16.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.012 0.434 . . . . 0.0 110.769 173.485 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.5 t -115.44 112.66 40.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 175.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.724 ' HG3' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -121.66 167.75 12.57 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.407 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -62.28 137.93 58.34 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 28.4 t -66.63 126.11 27.9 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.282 0.563 . . . . 0.0 111.298 -173.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.4 p -86.13 6.44 29.2 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.591 174.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.8 -39.73 8.47 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.046 179.329 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.475 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 71.1 m -149.66 137.4 11.61 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.956 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 44' ' ' CYS . 38.2 Cg_exo -61.15 -32.5 91.15 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.283 2.655 . . . . 0.0 113.799 -175.122 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -101.84 33.06 6.81 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.849 -176.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.635 ' OD1' ' HA ' ' A' ' 64' ' ' ASN . 15.6 m-20 -138.71 167.56 21.71 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 110.375 -0.232 . . . . 0.0 110.375 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.427 ' CD2' HD11 ' A' ' 81' ' ' LEU . 16.7 m-85 -126.42 170.62 11.77 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 174.145 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.409 ' HB ' ' NH1' ' A' ' 39' ' ' ARG . 44.8 t -144.16 115.96 2.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-O 121.002 0.43 . . . . 0.0 111.653 176.299 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.5 tp -82.7 106.05 14.23 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.025 174.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.8 m -96.82 129.04 44.31 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 176.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.721 HG12 ' HG2' ' A' ' 54' ' ' GLU . 70.8 t -121.9 134.56 64.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.843 -176.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.573 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 41.0 t -88.04 99.18 11.97 Favored 'General case' 0 CA--C 1.513 -0.442 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.965 -177.062 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.721 ' HG2' HG12 ' A' ' 52' ' ' VAL . 65.5 mm-40 -144.94 142.08 29.55 Favored 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 119.51 -0.876 . . . . 0.0 109.403 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 61.04 15.81 6.51 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.594 0.558 . . . . 0.0 111.927 -178.244 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.634 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 27.4 m 58.89 54.55 5.05 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 122.935 1.35 . . . . 0.0 107.374 -173.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.593 HH22 ' CG ' ' A' ' 94' ' ' ASP . 0.1 OUTLIER -167.01 67.88 0.09 Allowed 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 112.26 -2.245 . . . . 0.0 108.831 -151.638 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 9.9 t -69.63 100.52 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.815 0.816 . . . . 0.0 109.777 -167.541 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 50.9 m -74.76 120.72 20.69 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 114.213 -1.358 . . . . 0.0 110.474 -178.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 -93.29 103.28 15.53 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.003 -177.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.657 ' HB3' HD11 ' A' ' 73' ' ' ILE . 58.5 m-85 -91.35 104.29 16.83 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.159 177.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 59.9 mt -79.46 125.76 38.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.848 0.356 . . . . 0.0 111.758 -175.276 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.457 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 4.6 mp -103.51 109.93 28.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.471 178.277 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.635 ' HA ' ' OD1' ' A' ' 47' ' ' ASP . 15.4 m120 -83.13 160.41 21.87 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.735 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.6 t -99.87 109.7 22.08 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 172.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.552 HD11 ' HB2' ' A' ' 72' ' ' LYS . 85.3 mt -78.68 153.25 78.31 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.327 -176.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -62.9 -14.58 41.95 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.668 2.245 . . . . 0.0 111.655 173.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -81.65 8.63 9.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.618 177.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? 62.9 29.0 16.56 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.587 0.708 . . . . 0.0 110.014 -177.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 27.8 mtp180 -124.34 -174.9 3.12 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.581 -177.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PHE . . . . . 0.457 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 72.9 m-85 -122.12 151.37 41.01 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.551 0.215 . . . . 0.0 111.027 -177.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.581 ' HE3' ' O ' ' A' ' 75' ' ' ASP . 86.5 tttt -138.89 113.81 9.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.767 -175.492 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.657 HD11 ' HB3' ' A' ' 61' ' ' TYR . 20.3 tt -89.87 100.48 10.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.858 0.837 . . . . 0.0 110.916 -174.588 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.45 -65.04 2.45 Favored Glycine 0 CA--C 1.519 0.29 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.95 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.581 ' O ' ' HE3' ' A' ' 72' ' ' LYS . 20.0 t70 -154.15 -29.56 0.12 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.024 0.44 . . . . 0.0 110.221 -176.284 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -85.48 121.7 28.56 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -93.49 145.87 24.19 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.226 0.536 . . . . 0.0 111.288 -175.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.441 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 86.3 m-85 -131.94 -173.73 3.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.815 178.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -74.94 -61.7 1.8 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.555 178.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -146.27 -179.1 6.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.272 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.56 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 7.5 mt -56.27 -56.9 26.48 Favored Pre-proline 0 N--CA 1.467 0.405 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -178.88 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.469 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 50.9 Cg_exo -57.79 -10.52 7.58 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.399 2.066 . . . . 0.0 113.607 178.108 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.04 -32.93 17.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.554 0.216 . . . . 0.0 111.034 -175.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.1 pp -76.6 -33.89 58.4 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.401 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 77.6 mt -65.25 -31.21 72.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.603 178.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -72.85 -39.82 66.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.267 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.43 ' CE2' ' ND1' ' A' ' 91' ' ' HIS . 68.6 t80 -68.03 -30.94 70.29 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.405 -178.61 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.43 ' HE2' HD13 ' A' ' 73' ' ' ILE . 27.8 m-85 -84.08 2.3 40.0 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -176.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.569 ' HE2' ' CE1' ' A' ' 6' ' ' PHE . 96.4 mttt -80.47 -15.82 55.82 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.335 172.419 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.7 pp -126.74 9.39 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.14 0 CA-C-O 121.385 0.612 . . . . 0.0 110.556 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.44 ' O ' ' HB2' ' A' ' 92' ' ' TYR . 9.1 t60 -94.32 -42.43 8.91 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.713 -177.689 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.448 ' H ' HG22 ' A' ' 97' ' ' THR . 75.8 m-85 65.53 95.72 0.05 Allowed 'General case' 0 C--N 1.329 -0.318 0 O-C-N 124.402 1.063 . . . . 0.0 109.054 -163.149 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.625 ' O ' ' HB3' ' A' ' 154' ' ' GLU . 30.8 mt -61.07 -92.8 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 173.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.593 ' CG ' HH22 ' A' ' 57' ' ' ARG . 20.6 t0 -99.83 86.3 3.26 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.104 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.845 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 2.2 t 48.6 15.18 0.08 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.815 -1.084 . . . . 0.0 112.665 -176.259 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -156.75 153.17 27.96 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 120.966 0.412 . . . . 0.0 110.383 -177.065 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.448 HG22 ' H ' ' A' ' 92' ' ' TYR . 7.5 p -98.15 168.28 10.35 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.133 -179.256 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 97.3 mt -70.08 92.67 0.75 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 177.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.57 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 37.4 mm -78.18 -59.29 3.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.34 -174.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.674 ' O ' ' HA ' ' A' ' 35' ' ' MET . 38.4 tt0 -155.8 135.4 8.11 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.14 -176.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -62.12 157.1 46.23 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.791 2.327 . . . . 0.0 113.023 -178.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.6 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -68.91 142.87 93.97 Favored Pre-proline 0 N--CA 1.452 -0.366 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.131 177.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -60.91 124.78 15.63 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.604 2.203 . . . . 0.0 112.362 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.746 176.054 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LEU . . . . . 1.004 HD12 HG21 ' A' ' 152' ' ' ILE . 1.4 mm? . . . . . 0 N--CA 1.468 0.454 0 CA-C-O 120.965 0.412 . . . . 0.0 111.811 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.756 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 0.0 OUTLIER -171.83 -61.59 0.02 OUTLIER 'General case' 0 C--O 1.215 -0.729 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.566 -179.926 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.556 ' N ' ' HG2' ' A' ' 126' ' ' GLU . 50.1 m-85 -115.21 108.44 16.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.394 0.616 . . . . 0.0 111.843 179.296 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.944 HG22 ' HG3' ' A' ' 180' ' ' LYS . 38.8 t -126.88 136.13 61.67 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.287 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.398 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.645 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 5.7 ptp180 -113.39 153.75 28.06 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 117.789 -1.564 . . . . 0.0 108.915 172.089 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.546 HG22 HG12 ' A' ' 178' ' ' VAL . 68.2 p -102.74 140.17 37.36 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.512 0.672 . . . . 0.0 111.757 178.216 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.553 HD21 ' HG2' ' A' ' 179' ' ' GLU . 9.8 mt -113.4 -16.26 12.49 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.89 178.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.442 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 21.7 t80 -82.72 -39.66 21.65 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.313 -174.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ASP . . . . . 0.689 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 13.6 t70 72.82 104.81 0.07 Allowed 'General case' 0 N--CA 1.468 0.443 0 O-C-N 123.695 0.622 . . . . 0.0 110.873 -177.219 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.546 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 67.0 t80 -132.12 94.14 24.7 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 174.525 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.677 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 69.8 Cg_endo -87.05 92.25 0.53 Allowed 'Trans proline' 0 N--CA 1.442 -1.507 0 C-N-CA 121.667 1.578 . . . . 0.0 112.893 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -88.54 -25.51 30.21 Favored Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.672 174.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ASN . . . . . 0.52 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 0.8 OUTLIER 60.13 52.28 5.16 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.385 0.674 . . . . 0.0 111.933 178.685 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ASP . . . . . 0.438 ' HB3' ' H ' ' A' ' 140' ' ' GLU . 0.9 OUTLIER -138.57 172.89 12.21 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.794 177.99 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -89.32 -13.15 38.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.924 0.869 . . . . 0.0 109.084 172.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.666 ' O ' ' HB2' ' A' ' 172' ' ' MET . 5.9 mm-40 -93.02 -35.25 13.36 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.994 176.393 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -125.72 109.69 12.87 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.817 177.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 1.052 HD11 ' HB2' ' A' ' 165' ' ' ASN . 34.2 tp -69.35 130.76 90.65 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.002 -176.252 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' PRO . . . . . 0.677 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 73.7 Cg_endo -82.26 88.69 1.26 Allowed 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 121.867 1.711 . . . . 0.0 112.071 171.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' PHE . . . . . 0.546 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 22.3 p90 -100.25 172.92 6.87 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -176.538 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' LYS . . . . . 0.689 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 14.1 mptt -122.92 -164.59 1.21 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -168.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.56 ' HD2' ' N ' ' A' ' 146' ' ' LYS . 7.6 mptt -85.39 1.29 49.23 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.59 -174.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -177.39 30.86 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.612 -178.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.682 ' OE2' ' HG ' ' A' ' 150' ' ' LEU . 1.6 pp20? -73.06 169.92 15.98 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 175.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.6 mp -117.89 128.46 75.02 Favored 'Isoleucine or valine' 0 C--N 1.35 0.619 0 CA-C-N 118.498 0.59 . . . . 0.0 110.083 173.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.862 ' CD2' ' HA ' ' A' ' 165' ' ' ASN . 86.0 mt -118.38 158.67 24.83 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-O 121.51 0.671 . . . . 0.0 110.493 -173.279 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.756 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 97.2 t -128.08 121.07 55.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.187 174.217 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 1.075 HD13 ' HB2' ' A' ' 163' ' ' ALA . 26.6 mm -78.83 84.0 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 CA-C-O 121.826 0.822 . . . . 0.0 109.134 -176.258 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.785 HG23 ' HG2' ' A' ' 154' ' ' GLU . 20.9 tt -73.94 -32.83 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.535 -176.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' GLU . . . . . 0.785 ' HG2' HG23 ' A' ' 153' ' ' ILE . 0.0 OUTLIER -125.46 144.84 50.35 Favored 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 175.753 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -131.94 76.59 73.51 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-O 121.453 0.644 . . . . 0.0 109.638 168.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.845 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 15.6 Cg_exo -66.88 -47.67 2.43 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.512 2.142 . . . . 0.0 111.581 176.122 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -112.19 -170.97 1.76 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.629 -177.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -124.85 -14.45 6.69 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.24 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -89.96 -21.35 22.47 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 168.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.667 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 80.9 m95 -125.97 139.15 53.67 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.171 177.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' TRP . . . . . 0.752 ' O ' HG13 ' A' ' 173' ' ' ILE . 45.7 m0 -128.37 137.39 51.87 Favored 'General case' 0 C--O 1.206 -1.187 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.25 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.563 ' HA ' ' HA ' ' A' ' 172' ' ' MET . 6.3 m -97.67 102.68 14.5 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -172.22 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 1.075 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -115.53 147.09 41.09 Favored 'General case' 0 N--CA 1.415 -2.2 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.489 -171.256 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.753 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 13.5 ptt-85 -86.64 127.26 34.92 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 175.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ASN . . . . . 1.052 ' HB2' HD11 ' A' ' 142' ' ' LEU . 61.5 t30 -62.41 177.03 0.55 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.875 -169.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.536 ' HB2' ' HB2' ' A' ' 148' ' ' GLU . 40.5 tptt -50.86 -26.42 5.78 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.331 164.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -69.51 -43.04 73.9 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.832 173.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 113.12 -5.02 25.4 Favored Glycine 0 CA--C 1.516 0.146 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.276 -170.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ARG . . . . . 0.753 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.6 OUTLIER -71.29 135.82 47.6 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 123.389 0.675 . . . . 0.0 111.692 -178.819 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 59.6 t -83.48 123.44 38.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 C-N-CA 121.202 -0.199 . . . . 0.0 110.491 177.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -160.76 158.25 29.77 Favored Glycine 0 C--O 1.227 -0.299 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.68 173.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' MET . . . . . 0.667 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.6 OUTLIER -74.89 140.67 43.97 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 117.234 0.517 . . . . 0.0 112.001 -178.19 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.752 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.8 pp -137.09 140.49 31.47 Favored Pre-proline 0 N--CA 1.451 -0.418 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.368 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' PRO . . . . . 0.602 ' O ' HG13 ' A' ' 178' ' ' VAL . 6.3 Cg_exo -76.56 127.04 9.38 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.969 2.446 . . . . 0.0 113.115 -175.467 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.601 ' O ' HG22 ' A' ' 178' ' ' VAL . 59.4 t -53.23 -45.3 98.41 Favored Pre-proline 0 CA--C 1.542 0.635 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 177.05 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 27.7 Cg_endo -63.44 -1.0 2.72 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.044 1.83 . . . . 0.0 113.318 176.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.475 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.1 m-30 -104.26 -10.01 18.17 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.588 0.232 . . . . 0.0 111.351 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.647 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 5.0 m -108.16 -171.96 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 115.786 1.773 . . . . 0.0 115.786 -162.192 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' GLU . . . . . 0.645 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 5.1 tp10 -155.75 50.95 0.55 Allowed 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 113.009 -1.905 . . . . 0.0 113.503 -153.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' LYS . . . . . 0.944 ' HG3' HG22 ' A' ' 128' ' ' VAL . 3.6 mppt? -67.28 136.44 54.91 Favored 'General case' 0 CA--C 1.518 -0.259 0 O-C-N 119.498 -2.001 . . . . 0.0 109.012 -165.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 61.5 tp . . . . . 0 C--N 1.33 -0.283 0 CA-C-N 112.583 -2.099 . . . . 0.0 112.369 -165.461 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo . . . . . 0 C--O 1.232 0.221 0 CA-C-O 120.741 0.226 . . . . 0.0 111.759 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.45 HG11 HD12 ' A' ' 293' ' ' ILE . 20.1 t -94.19 143.84 10.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.079 -178.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 239' ' ' PHE . . . . . 0.518 ' HB2' ' HG3' ' A' ' 296' ' ' PRO . 95.3 m-85 -111.8 124.21 51.87 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.503 -178.131 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 240' ' ' ALA . . . . . 0.412 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -119.7 127.62 53.04 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.076 179.115 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 241' ' ' LYS . . . . . 0.43 ' HB2' ' CE1' ' A' ' 294' ' ' PHE . 50.5 tttp -85.92 119.38 26.17 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -178.084 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 242' ' ' ALA . . . . . 0.479 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -71.03 106.84 3.84 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.542 -178.085 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.749 HG12 ' HG3' ' A' ' 292' ' ' LYS . 2.6 pp -104.56 -14.74 8.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.168 -177.313 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 244' ' ' GLN . . . . . 0.432 ' HB2' HD12 ' A' ' 243' ' ' ILE . 4.5 tm0? -130.76 137.95 49.72 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 175.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -62.3 163.6 8.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.409 0.623 . . . . 0.0 111.944 -173.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 246' ' ' ARG . . . . . 0.615 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -145.78 121.43 10.47 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 177.898 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 16.5 m -122.36 139.18 30.27 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-O 120.795 0.331 . . . . 0.0 110.753 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.475 ' HD3' ' HB2' ' A' ' 257' ' ' ALA . 42.5 Cg_endo -68.98 125.75 12.95 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.645 2.23 . . . . 0.0 112.249 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 249' ' ' CYS . . . . . 0.549 ' HB3' ' HB2' ' A' ' 252' ' ' ASP . 16.5 t -90.64 172.45 8.67 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.676 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -55.71 -47.59 76.59 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.945 0.402 . . . . 0.0 111.283 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -87.68 -6.31 58.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.767 179.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 252' ' ' ASP . . . . . 0.549 ' HB2' ' HB3' ' A' ' 249' ' ' CYS . 2.9 m-20 -114.48 52.11 0.86 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.342 178.574 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -71.02 -13.51 62.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.32 0.581 . . . . 0.0 109.865 177.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 2.7 p -89.25 -8.22 53.91 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.969 176.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -76.71 123.18 25.79 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.687 -178.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 256' ' ' LEU . . . . . 0.417 ' HA ' HH11 ' A' ' 282' ' ' ARG . 0.6 OUTLIER -70.33 139.34 51.99 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.629 -178.295 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 257' ' ' ALA . . . . . 0.615 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -89.15 117.55 28.22 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.094 0.473 . . . . 0.0 109.921 176.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 35.4 mt -129.14 157.76 40.88 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.928 -176.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -136.86 160.29 39.31 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 260' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 21.7 t -66.29 105.32 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.087 -172.071 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 130.6 10.7 2.56 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.689 175.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -118.41 157.57 26.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 117.879 0.839 . . . . 0.0 111.375 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 37.2 mm -94.04 124.07 46.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.753 -178.158 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 32.0 t -95.5 111.02 25.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.957 175.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -95.28 97.26 9.73 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.563 -178.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 266' ' ' VAL . . . . . 0.493 ' HA ' ' HA2' ' A' ' 277' ' ' GLY . 6.6 p -88.41 134.89 26.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.704 -0.399 . . . . 0.0 110.394 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 22.1 p -92.93 -44.1 8.61 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.512 -176.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 29.3 ptt180 -131.21 126.46 35.62 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 121.365 0.602 . . . . 0.0 110.951 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 40.1 mmm -83.08 110.44 18.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.527 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 270' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 274' ' ' GLN . 86.9 m-20 -85.4 126.97 34.2 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.283 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 22.8 mt -70.73 -18.62 21.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.295 -175.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -61.88 -23.89 66.59 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.702 0.287 . . . . 0.0 111.162 -178.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 109.19 21.79 7.17 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.746 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.504 ' HA ' ' CZ ' ' A' ' 288' ' ' PHE . 37.9 mt-30 -151.56 111.35 4.03 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 167.556 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 1.3 m0 -92.08 164.81 13.46 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -176.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 276' ' ' GLU . . . . . 0.668 ' HB3' ' HE2' ' A' ' 283' ' ' LYS . 43.3 mt-10 -104.78 117.98 35.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.128 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 277' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -122.01 142.33 14.97 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.725 -178.197 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -99.38 111.52 23.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.817 0.818 . . . . 0.0 109.922 175.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 95.7 t -124.39 158.03 31.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.74 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -61.8 82.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.732 0.777 . . . . 0.0 110.79 175.57 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 160.85 -35.77 0.42 Allowed Glycine 0 N--CA 1.441 -0.996 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.17 -177.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 282' ' ' ARG . . . . . 0.438 HH11 ' HD2' ' A' ' 282' ' ' ARG . 42.8 ttm105 177.92 159.71 0.49 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 117.054 0.427 . . . . 0.0 110.197 -178.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 283' ' ' LYS . . . . . 0.668 ' HE2' ' HB3' ' A' ' 276' ' ' GLU . 2.5 tmtp? -110.1 101.17 9.99 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 171.728 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -151.96 -168.92 16.84 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.926 -172.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 73.2 mt -90.73 149.15 22.15 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.859 0.361 . . . . 0.0 110.455 -177.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 286' ' ' PHE . . . . . 0.421 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 42.0 p90 -143.91 152.54 55.58 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.402 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 287' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 2.3 Cg_endo -81.37 145.3 14.92 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 123.346 2.697 . . . . 0.0 111.752 177.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 288' ' ' PHE . . . . . 0.504 ' CZ ' ' HA ' ' A' ' 274' ' ' GLN . 3.6 m-85 -91.73 -5.47 53.59 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.116 0.414 . . . . 0.0 112.116 -167.455 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 4.5 m -94.4 -19.73 20.35 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.325 0.583 . . . . 0.0 109.887 175.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -77.23 -22.43 52.24 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.574 177.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 291' ' ' VAL . . . . . 0.479 HG12 ' HA ' ' A' ' 242' ' ' ALA . 28.5 m -117.19 164.49 13.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.235 178.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 292' ' ' LYS . . . . . 0.749 ' HG3' HG12 ' A' ' 243' ' ' ILE . 98.1 mttt -119.39 119.92 35.35 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.609 177.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 293' ' ' ILE . . . . . 0.45 HD12 HG11 ' A' ' 238' ' ' VAL . 18.9 mm -74.63 110.69 9.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 172.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 294' ' ' PHE . . . . . 0.43 ' CE1' ' HB2' ' A' ' 241' ' ' LYS . 2.3 p90 -132.24 -178.62 4.99 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.894 -175.045 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -104.49 101.88 30.37 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 296' ' ' PRO . . . . . 0.518 ' HG3' ' HB2' ' A' ' 239' ' ' PHE . 60.7 Cg_endo . . . . . 0 CA--C 1.529 0.256 0 C-N-CA 122.311 2.007 . . . . 0.0 111.878 177.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptm . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.0 p -91.51 131.77 36.73 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.154 0.502 . . . . 0.0 110.97 178.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.54 ' HB2' HD12 ' A' ' 99' ' ' ILE . 13.0 p -88.39 -38.14 15.32 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 174.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.537 ' HB1' ' HG2' ' A' ' 89' ' ' LYS . . . -93.87 127.91 39.88 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.766 178.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 26.0 mtt180 -142.14 -66.61 0.4 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.443 -176.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.43 ' HB2' ' H ' ' A' ' 7' ' ' ASP . 6.8 p90 11.15 -147.18 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 113.653 -1.612 . . . . 0.0 115.253 -161.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.43 ' H ' ' HB2' ' A' ' 6' ' ' PHE . 6.2 p-10 -101.98 -49.54 3.92 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.986 -174.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.44 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 50.4 m 65.16 35.87 7.58 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.586 -175.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.7 m -161.23 -25.92 0.05 Allowed 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 176.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -85.31 108.71 17.93 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.238 0.542 . . . . 0.0 111.064 -169.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.568 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 9.7 mmt180 -62.06 -25.72 67.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.758 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.9 m -90.11 3.51 53.13 Favored 'General case' 0 C--N 1.32 -0.714 0 O-C-N 122.149 -0.344 . . . . 0.0 110.941 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -99.21 -47.62 5.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.448 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.475 ' HB3' ' HB3' ' A' ' 101' ' ' PRO . 36.2 p-90 -114.2 -24.76 8.79 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -174.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.568 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 21.6 t80 -76.97 116.42 17.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.303 0.573 . . . . 0.0 110.107 -177.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.607 ' HG3' HG21 ' A' ' 19' ' ' VAL . 9.1 tpp -97.26 -9.16 28.19 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.085 -171.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.509 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 49.81 -115.21 2.85 Favored Glycine 0 CA--C 1.523 0.564 0 CA-C-N 115.398 -0.819 . . . . 0.0 114.292 177.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.509 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 4.6 Cg_exo -74.99 101.19 1.44 Allowed 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 123.056 2.504 . . . . 0.0 112.239 -177.082 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.607 HG21 ' HG3' ' A' ' 16' ' ' MET . 5.3 t -138.55 -76.46 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 CA-C-O 118.909 -0.567 . . . . 0.0 111.523 -175.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.761 ' H ' ' HD2' ' A' ' 39' ' ' ARG . 51.4 m 94.8 171.66 0.02 OUTLIER 'General case' 0 C--N 1.35 0.63 0 C-N-CA 124.187 0.995 . . . . 0.0 109.353 170.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.524 ' HD2' ' NH2' ' A' ' 39' ' ' ARG . 19.4 mmm180 -51.65 -53.46 38.52 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 123.388 0.43 . . . . 0.0 112.129 -169.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -62.95 -42.53 99.85 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.506 -175.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.433 ' HB3' HG13 ' A' ' 19' ' ' VAL . 12.7 tp10 -72.63 -46.03 56.08 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.296 0.569 . . . . 0.0 109.521 -174.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.24 -47.62 80.89 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.305 -0.862 . . . . 0.0 111.455 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.502 ' NE2' ' H ' ' A' ' 117' ' ' ASN . 50.6 tp60 -64.05 -41.57 97.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.081 -175.021 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.5 t -79.55 -20.92 45.89 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -175.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -80.69 -13.72 58.76 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 120.944 0.402 . . . . 0.0 110.708 178.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.608 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 80.2 mt -128.96 17.07 6.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.244 -177.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.519 ' HG2' ' O ' ' A' ' 114' ' ' SER . 0.0 OUTLIER -66.5 82.0 0.1 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.047 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.99 -63.94 4.22 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.715 -177.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 45.41 -105.16 0.1 Allowed 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.191 0.596 . . . . 0.0 111.858 -176.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 54.5 mtm180 -126.72 3.0 6.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.579 0.228 . . . . 0.0 110.409 176.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 28.0 m170 66.85 150.62 0.06 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.033 -174.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.33 19.22 79.68 Favored Glycine 0 C--O 1.227 -0.314 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.011 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 76.3 mtp -112.3 141.78 45.6 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.483 ' HB2' HD11 ' A' ' 50' ' ' LEU . 38.4 p90 -137.98 161.62 36.22 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.136 -174.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.489 ' O ' HD12 ' A' ' 37' ' ' LEU . 4.6 pp -150.25 133.83 16.6 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.247 0.546 . . . . 0.0 110.569 172.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.417 HG22 HD13 ' A' ' 50' ' ' LEU . 42.3 t -101.92 107.21 21.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 175.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.761 ' HD2' ' H ' ' A' ' 20' ' ' SER . 28.3 ptt-85 -103.32 177.45 4.84 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 -178.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -75.2 137.43 41.27 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 174.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.518 ' HB3' ' O ' ' A' ' 44' ' ' CYS . 21.1 t -64.56 109.9 2.14 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.378 0.609 . . . . 0.0 111.229 -173.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 57.2 p -77.45 -4.83 47.43 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.602 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.69 -51.34 4.76 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.313 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.518 ' O ' ' HB3' ' A' ' 41' ' ' SER . 34.3 m -135.03 118.95 13.29 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.602 -177.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -59.03 123.86 14.41 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.601 2.201 . . . . 0.0 112.104 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.05 -34.73 4.94 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.947 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.588 ' OD1' ' HA ' ' A' ' 64' ' ' ASN . 44.5 m-20 -86.4 -176.86 6.04 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.49 ' HE2' ' CE1' ' A' ' 71' ' ' PHE . 35.1 m-85 -134.15 172.58 12.65 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 176.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.471 HG23 ' HA ' ' A' ' 41' ' ' SER . 43.1 t -140.7 106.12 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.938 0.399 . . . . 0.0 111.065 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.483 HD11 ' HB2' ' A' ' 36' ' ' PHE . 43.0 tp -78.9 106.26 10.79 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.308 176.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 24.1 m -96.66 132.38 42.37 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 174.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 72.0 t -125.13 133.3 69.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.712 0.291 . . . . 0.0 111.297 -177.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.608 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 30.7 t -87.52 116.49 25.67 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.288 -0.415 . . . . 0.0 112.063 -176.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.54 ' HG2' HG22 ' A' ' 95' ' ' THR . 7.6 tp10 -151.65 147.7 27.05 Favored 'General case' 0 C--O 1.21 -1.009 0 C-N-CA 119.682 -0.807 . . . . 0.0 109.225 164.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.5 ' HB2' ' HG2' ' A' ' 57' ' ' ARG . 67.4 m-80 56.84 24.05 8.79 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.402 ' HB3' HE22 ' A' ' 29' ' ' GLN . 14.4 m 57.47 52.82 8.07 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 122.522 1.153 . . . . 0.0 108.411 -174.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.66 ' HA ' ' HA ' ' A' ' 117' ' ' ASN 0.25 0.0 OUTLIER -167.44 66.49 0.08 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 113.504 -1.68 . . . . 0.0 109.814 -152.188 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 20.2 t -73.32 101.01 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 120.861 -1.15 . . . . 0.0 111.252 -167.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.8 m -69.87 122.15 18.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.807 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -96.26 115.92 28.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.891 -175.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.626 ' OH ' ' HB3' ' A' ' 93' ' ' LEU . 37.0 m-85 -108.84 113.95 27.31 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.63 178.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.652 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 57.3 mt -81.35 133.83 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 O-C-N 122.078 -0.388 . . . . 0.0 111.986 -177.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.523 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 5.3 mp -114.27 119.43 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 122.968 0.507 . . . . 0.0 110.853 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.588 ' HA ' ' OD1' ' A' ' 47' ' ' ASP . 85.7 m-20 -86.97 148.23 25.41 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.356 -174.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.7 t -89.53 94.96 10.06 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 170.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.464 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 81.6 mt -71.6 135.58 83.66 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 66' ' ' LEU . 33.7 Cg_exo -60.66 -22.43 72.83 Favored 'Trans proline' 0 N--CA 1.473 0.312 0 C-N-CA 123.014 2.476 . . . . 0.0 113.072 -174.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -84.28 17.48 2.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.259 0.552 . . . . 0.0 110.37 176.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.627 ' NE ' ' HA ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER 65.33 52.1 1.48 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.142 175.846 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 63.8 mtt180 -135.54 -175.16 3.85 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.462 175.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.523 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 67.8 m-85 -137.27 136.58 38.18 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.633 0.254 . . . . 0.0 111.25 -173.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.533 ' HB3' ' HB2' ' A' ' 64' ' ' ASN . 61.7 tttp -125.76 108.49 11.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.763 -174.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.652 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 7.3 tt -99.52 102.26 13.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.238 0.542 . . . . 0.0 111.494 -175.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 53.3 70.34 0.95 Allowed Glycine 0 CA--C 1.52 0.392 0 CA-C-N 115.437 -0.801 . . . . 0.0 113.728 175.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 34.6 t70 74.89 -30.41 0.2 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.325 0.65 . . . . 0.0 111.568 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -89.55 112.82 24.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.642 0.258 . . . . 0.0 110.809 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 1.3 pm0 -97.41 139.79 32.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.663 0.744 . . . . 0.0 111.484 176.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.515 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 89.9 m-85 -122.34 -172.04 2.38 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.611 175.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -86.11 -29.21 23.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.745 0.307 . . . . 0.0 111.514 -179.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -163.78 168.11 20.05 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.515 0.198 . . . . 0.0 111.417 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.654 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 6.7 mt -54.51 -58.61 13.3 Favored Pre-proline 0 N--CA 1.468 0.462 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.211 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.576 ' HA ' HD12 ' A' ' 85' ' ' LEU . 36.9 Cg_exo -63.9 -3.05 5.19 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.132 1.888 . . . . 0.0 113.263 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.82 -33.79 17.28 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.654 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.1 pp -76.39 -34.09 58.87 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 177.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.576 HD12 ' HA ' ' A' ' 82' ' ' PRO . 60.1 mt -64.66 -29.51 70.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.13 177.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.2 tp10 -79.1 -33.9 43.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.378 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -72.21 -33.44 67.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.402 0.62 . . . . 0.0 110.388 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.413 ' HE2' HD13 ' A' ' 73' ' ' ILE . 38.3 m-85 -82.44 1.86 35.47 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.619 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.537 ' HG2' ' HB1' ' A' ' 4' ' ' ALA . 93.8 mttt -73.76 -16.53 61.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.774 173.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 36.8 pt -129.96 -0.65 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 CA-C-O 121.15 0.5 . . . . 0.0 110.725 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -82.67 -40.83 20.17 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.889 -175.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.413 ' H ' HG22 ' A' ' 97' ' ' THR . 96.1 m-85 64.82 101.05 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.382 0 O-C-N 124.548 1.155 . . . . 0.0 109.209 -164.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.626 ' HB3' ' OH ' ' A' ' 61' ' ' TYR . 26.6 mt -63.66 -99.25 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.763 174.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.648 ' HA ' ' HB3' ' A' ' 154' ' ' GLU . 40.7 t0 -68.35 -59.97 2.79 Favored 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -175.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.656 ' CB ' ' HA ' ' A' ' 156' ' ' PRO . 12.6 t -154.37 14.85 0.45 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.661 0.743 . . . . 0.0 109.594 169.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 12.3 t -145.57 167.07 23.93 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.542 -177.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.413 HG22 ' H ' ' A' ' 92' ' ' TYR . 38.9 p -97.86 176.01 5.95 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.458 HD22 ' CD2' ' A' ' 36' ' ' PHE . 96.2 mt -77.99 89.4 4.15 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.188 0.518 . . . . 0.0 110.088 177.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.54 HD12 ' HB2' ' A' ' 3' ' ' SER . 38.9 mm -61.95 -64.1 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.327 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.465 ' HB2' ' HD2' ' A' ' 101' ' ' PRO . 13.3 pt-20 -159.44 159.53 28.32 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.569 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.475 ' HB3' ' HB3' ' A' ' 14' ' ' TRP . 59.8 Cg_endo -72.63 155.62 54.29 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.268 1.979 . . . . 0.0 112.074 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.03 135.3 70.46 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 176.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.76 138.07 67.9 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.285 1.99 . . . . 0.0 111.262 176.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.592 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 36.6 mtm180 -68.44 -16.41 63.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.082 0.468 . . . . 0.0 110.737 -177.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -120.67 76.47 27.59 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-O 121.617 0.723 . . . . 0.0 109.438 170.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -95.76 40.78 0.14 Allowed 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.431 2.754 . . . . 0.0 112.507 -173.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 9.7 p -51.39 108.67 1.11 Allowed Pre-proline 0 C--N 1.329 -0.321 0 O-C-N 123.82 0.7 . . . . 0.0 111.823 -177.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -94.2 153.89 2.11 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 123.339 2.693 . . . . 0.0 112.22 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -62.49 -68.8 0.04 OUTLIER 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.353 2.035 . . . . 0.0 112.075 176.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 18.7 ptp 179.81 -168.7 0.11 Allowed 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 89.76 -78.27 1.59 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.948 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.45 ' HB3' ' HB3' ' A' ' 29' ' ' GLN . 46.5 m -79.03 93.66 5.16 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.113 0.482 . . . . 0.0 110.727 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.1 m -123.65 126.28 72.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.752 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.519 ' O ' ' HG2' ' A' ' 29' ' ' GLN . 29.6 t 56.86 -97.91 0.08 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.226 -178.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . 51.5 85.06 0.2 Allowed Pre-proline 0 C--O 1.235 0.333 0 C-N-CA 123.148 0.579 . . . . 0.0 111.638 -178.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.02 91.89 0.54 Allowed 'Trans proline' 0 N--CA 1.465 -0.205 0 C-N-CA 122.678 2.252 . . . . 0.0 112.362 -178.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.66 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 9.0 m-20 56.01 83.45 0.09 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.378 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 37.5 tp -124.98 81.95 61.96 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.805 -176.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -90.73 -10.22 3.09 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.547 2.165 . . . . 0.0 112.187 177.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 19.5 m -157.04 -66.88 0.1 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.437 0.637 . . . . 0.0 110.393 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -158.48 -166.96 2.03 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.447 -178.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.426 ' H ' ' CD ' ' A' ' 122' ' ' GLU . 0.9 OUTLIER -91.93 30.02 1.48 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.673 0.273 . . . . 0.0 110.872 -178.8 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.799 ' HB2' ' HA ' ' A' ' 183' ' ' ARG . 21.1 p-10 -123.77 -75.86 0.59 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -175.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -86.93 149.93 24.44 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -165.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.696 HD12 HG21 ' A' ' 152' ' ' ILE . 3.0 mm? 67.73 88.38 0.11 Allowed 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 114.138 -1.392 . . . . 0.0 112.993 177.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 173.29 -51.84 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 113.34 -1.755 . . . . 0.0 107.08 177.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -119.73 110.83 17.26 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.196 0.522 . . . . 0.0 110.681 173.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.96 HG22 ' HG3' ' A' ' 180' ' ' LYS . 61.1 t -128.72 139.39 52.02 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.018 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.572 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 7.5 ptp180 -112.48 155.52 24.12 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 116.834 -1.946 . . . . 0.0 108.952 170.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.603 ' OG1' ' HB2' ' A' ' 144' ' ' PHE . 1.0 OUTLIER -110.32 140.6 44.34 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.477 0.656 . . . . 0.0 110.896 178.981 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.567 HD21 ' HG2' ' A' ' 179' ' ' GLU . 8.1 mt -113.38 -15.14 12.7 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -177.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -94.73 -14.72 24.5 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -171.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.56 ' HB3' ' C ' ' A' ' 145' ' ' LYS . 3.8 p-10 54.99 102.08 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 122.559 1.171 . . . . 0.0 112.637 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -119.39 86.64 34.08 Favored Pre-proline 0 C--N 1.317 -0.84 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 171.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.666 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 65.9 Cg_endo -85.56 72.97 4.09 Favored 'Trans proline' 0 N--CA 1.445 -1.376 0 C-N-CA 121.897 1.731 . . . . 0.0 112.638 -176.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.67 -34.19 66.92 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 174.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.871 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 0.4 OUTLIER 70.98 40.5 0.9 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.471 -0.864 . . . . 0.0 111.589 174.784 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -126.09 175.03 8.04 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.881 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -92.66 -7.66 46.23 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.8 0.81 . . . . 0.0 109.052 171.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.615 ' O ' ' HB2' ' A' ' 172' ' ' MET . 8.8 mm-40 -93.32 -29.87 15.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.752 176.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -136.18 108.88 7.5 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.851 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.996 HD11 ' HB2' ' A' ' 165' ' ' ASN . 58.1 tp -67.26 123.87 87.56 Favored Pre-proline 0 CA--C 1.509 -0.611 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.824 -176.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.871 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 56.3 Cg_endo -71.87 93.6 0.71 Allowed 'Trans proline' 0 N--CA 1.443 -1.472 0 C-N-CA 120.987 1.125 . . . . 0.0 111.348 167.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.603 ' HB2' ' OG1' ' A' ' 130' ' ' THR . 16.7 p90 -103.32 159.61 15.41 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 1.002 ' H ' ' HG3' ' A' ' 148' ' ' GLU . 47.6 mtpt -110.16 -151.81 0.48 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.144 0.497 . . . . 0.0 111.929 -170.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.824 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -104.47 27.94 7.41 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.323 -176.843 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 159.14 36.96 0.02 OUTLIER Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.242 178.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 1.002 ' HG3' ' H ' ' A' ' 145' ' ' LYS . 0.0 OUTLIER -86.11 170.25 12.37 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.895 0.878 . . . . 0.0 109.399 171.966 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.5 mp -114.0 133.04 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 172.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.713 HD22 ' CD2' ' A' ' 142' ' ' LEU . 72.2 mt -118.47 155.79 30.18 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -174.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.603 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 92.2 t -122.22 121.73 64.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 174.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.984 HD13 ' HB2' ' A' ' 163' ' ' ALA . 46.9 mm -78.04 79.09 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 122.125 0.964 . . . . 0.0 108.411 -177.112 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.737 HG23 ' HG2' ' A' ' 154' ' ' GLU . 16.9 tt -69.38 -27.96 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 CA-C-N 113.91 -1.495 . . . . 0.0 109.288 -177.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.737 ' HG2' HG23 ' A' ' 153' ' ' ILE . 0.0 OUTLIER -133.01 141.49 48.31 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 171.778 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.56 ' HD2' ' HG ' ' A' ' 125' ' ' LEU . 82.9 tttt -135.1 82.61 41.74 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 168.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.656 ' HA ' ' CB ' ' A' ' 95' ' ' THR . 8.3 Cg_exo -73.03 -47.72 0.31 Allowed 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.538 2.159 . . . . 0.0 111.87 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -107.57 171.13 7.56 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.032 -173.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.642 ' HG3' ' HG2' ' A' ' 159' ' ' GLN . 8.1 pt-20 -89.7 -26.92 20.43 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.752 178.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.642 ' HG2' ' HG3' ' A' ' 158' ' ' GLU . 82.9 mm-40 -101.8 -18.74 15.63 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.483 -175.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.53 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 63.7 m95 -126.66 135.28 50.96 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 175.018 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' TRP . . . . . 0.779 ' O ' HG13 ' A' ' 173' ' ' ILE . 49.4 m0 -125.33 137.93 54.06 Favored 'General case' 0 C--O 1.214 -0.771 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.525 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 14.7 m -96.87 102.79 14.64 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -174.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.984 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -118.93 151.74 37.6 Favored 'General case' 0 N--CA 1.426 -1.667 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.069 -174.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.792 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 15.3 ptt-85 -88.69 129.39 35.54 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 175.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.996 ' HB2' HD11 ' A' ' 142' ' ' LEU . 65.2 t30 -60.72 178.64 0.21 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.234 -1.348 . . . . 0.0 111.514 -171.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.555 ' HB2' ' HB2' ' A' ' 148' ' ' GLU . 44.0 tptt -50.71 -33.2 21.91 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.103 166.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -64.7 -38.68 91.82 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.709 173.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.498 ' C ' ' HB2' ' A' ' 164' ' ' ARG . . . 107.09 3.81 35.92 Favored Glycine 0 CA--C 1.522 0.471 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.217 -171.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.792 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.4 OUTLIER -77.4 134.61 38.39 Favored 'General case' 0 C--O 1.216 -0.671 0 C-N-CA 123.141 0.576 . . . . 0.0 111.21 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.5 HG22 HG21 ' A' ' 153' ' ' ILE . 60.4 t -85.12 125.55 40.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 117.684 0.22 . . . . 0.0 111.526 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -157.1 157.71 28.27 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.172 172.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.615 ' HB2' ' O ' ' A' ' 140' ' ' GLU . 0.0 OUTLIER -76.94 141.09 40.62 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 117.242 0.521 . . . . 0.0 111.228 179.367 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.779 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.4 pp -142.25 142.9 25.44 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.424 -176.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.522 ' HB2' ' CD1' ' A' ' 177' ' ' TYR . 15.7 Cg_exo -70.36 138.57 36.21 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 123.275 2.65 . . . . 0.0 113.351 -178.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.574 ' O ' HG22 ' A' ' 178' ' ' VAL . 58.9 t -65.1 -45.09 72.57 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 28.0 Cg_endo -63.81 3.09 0.77 Allowed 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.044 1.829 . . . . 0.0 113.2 177.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.522 ' CD1' ' HB2' ' A' ' 174' ' ' PRO . 3.3 m-85 -103.41 -11.85 17.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.237 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.614 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 4.6 m -104.84 -170.8 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 115.691 1.737 . . . . 0.0 115.691 -166.12 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.572 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 4.0 tp10 -159.73 48.21 0.29 Allowed 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 113.164 -1.835 . . . . 0.0 113.226 -153.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.96 ' HG3' HG22 ' A' ' 128' ' ' VAL . 2.9 mppt? -70.73 138.1 50.24 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 119.746 -1.846 . . . . 0.0 110.248 -162.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.401 HD13 ' NH2' ' A' ' 129' ' ' ARG . 39.9 tp -73.22 -91.41 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 113.557 -1.656 . . . . 0.0 112.473 -162.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 3.0 p -87.01 89.77 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-O 121.713 0.768 . . . . 0.0 109.743 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.799 ' HA ' ' HB2' ' A' ' 123' ' ' ASP . 0.0 OUTLIER -145.84 154.18 41.7 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.265 -178.211 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 11.7 m -76.65 -83.44 0.07 Allowed 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.358 178.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 9.8 p 175.26 168.88 0.35 Allowed Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -178.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -64.06 96.54 0.22 Allowed 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.289 1.993 . . . . 0.0 111.78 177.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 1.05 ' HB2' ' HB2' ' A' ' 190' ' ' HIS . 87.1 m-70 -105.02 14.39 29.4 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.545 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 81.22 -79.14 1.84 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.699 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.804 ' H ' ' HD3' ' A' ' 189' ' ' LYS . 0.4 OUTLIER -73.56 -23.62 59.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.206 0.527 . . . . 0.0 110.024 177.112 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 190' ' ' HIS . . . . . 1.05 ' HB2' ' HB2' ' A' ' 187' ' ' HIS . 0.5 OUTLIER -88.24 84.13 6.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.942 172.9 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 175.47 17.86 0.02 OUTLIER Glycine 0 C--O 1.239 0.411 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.171 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 56.6 t30 70.7 -64.47 0.37 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.322 1.049 . . . . 0.0 111.069 -175.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 53.6 ttt-85 59.13 80.06 0.2 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.603 -177.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -54.14 -53.52 52.19 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 173.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 45.8 p -174.01 163.77 4.05 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 113.453 -1.703 . . . . 0.0 106.812 174.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -82.42 70.82 9.45 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 176.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 23.6 t 70.49 124.01 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.986 -177.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -76.45 177.19 7.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.151 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 175.61 124.87 0.84 Allowed Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.841 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.413 HD12 ' N ' ' A' ' 200' ' ' ILE . 4.0 mp -104.12 102.78 34.39 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -88.59 86.65 0.53 Allowed 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.985 2.457 . . . . 0.0 113.144 -175.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -134.69 101.17 11.91 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 171.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -62.5 -11.45 23.22 Favored 'Trans proline' 0 N--CA 1.473 0.273 0 C-N-CA 123.434 2.756 . . . . 0.0 113.073 -175.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -65.99 -19.18 65.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.144 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' HIS . . . . . 0.539 ' HB3' ' HB2' ' A' ' 208' ' ' ALA . 95.9 m-70 -118.31 48.36 1.44 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.613 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -70.65 -40.48 73.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.272 0.558 . . . . 0.0 110.096 177.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -124.22 70.51 1.1 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 173.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' ALA . . . . . 0.539 ' HB2' ' HB3' ' A' ' 205' ' ' HIS . . . -72.37 152.91 41.75 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.988 -1.005 . . . . 0.0 112.301 -171.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -71.64 127.47 90.93 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.708 174.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.1 155.95 17.61 Favored 'Trans proline' 0 C--O 1.237 0.435 0 C-N-CA 122.938 2.425 . . . . 0.0 112.427 178.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -58.58 -40.55 83.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.737 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 20.0 m 72.88 132.88 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.304 172.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 23.6 m -74.54 106.21 6.02 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.639 175.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 33.4 m -149.26 91.3 4.51 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 120.968 0.413 . . . . 0.0 110.558 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -78.75 105.35 1.94 Allowed 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.992 2.462 . . . . 0.0 111.276 177.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.47 ' O ' HD12 ' A' ' 216' ' ' LEU . 3.4 pp -91.57 136.75 26.32 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-O 120.952 0.406 . . . . 0.0 110.936 -177.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -76.8 89.2 1.32 Allowed 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.349 2.033 . . . . 0.0 111.914 178.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -82.25 128.17 33.91 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.974 177.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 7.6 p -59.33 116.59 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.569 0.7 . . . . 0.0 111.188 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 24.6 p -113.9 -165.8 1.04 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.225 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 148.14 -107.28 0.37 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.444 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 8.2 t -131.55 150.93 77.73 Favored Pre-proline 0 C--N 1.32 -0.7 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -177.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -48.98 110.54 0.36 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.119 2.546 . . . . 0.0 112.47 177.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -86.44 80.51 1.76 Allowed Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.112 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -128.65 92.07 3.35 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.885 0.374 . . . . 0.0 110.382 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -80.17 104.7 10.91 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.777 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 33.7 mm -86.79 -8.34 11.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.609 0.719 . . . . 0.0 109.723 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 4.0 p -60.74 146.2 86.72 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.559 177.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.8 10.75 0.77 Allowed 'Trans proline' 0 CA--C 1.533 0.446 0 C-N-CA 122.837 2.358 . . . . 0.0 113.399 -175.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 33.9 tp 64.15 95.85 0.05 OUTLIER Pre-proline 0 C--O 1.235 0.294 0 C-N-CA 123.249 0.62 . . . . 0.0 111.206 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -73.5 -159.07 0.08 OUTLIER 'Trans proline' 0 C--O 1.237 0.454 0 C-N-CA 122.98 2.453 . . . . 0.0 112.538 -178.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 37.2 m -57.63 99.22 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.43 0.633 . . . . 0.0 111.051 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 7.1 p -129.94 -30.66 1.99 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.512 -178.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 95.5 mt-30 64.89 25.11 12.8 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.223 178.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -77.04 156.89 31.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.592 176.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -118.98 -133.3 4.66 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.027 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -72.24 165.31 33.02 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 122.86 2.374 . . . . 0.0 111.802 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.541 ' HB ' HG13 ' A' ' 266' ' ' VAL . 11.7 t -101.91 130.85 50.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.025 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -115.56 134.92 54.6 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.35 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.628 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -131.72 145.1 51.45 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.359 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -98.5 127.94 44.64 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.156 177.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' ALA . . . . . 0.572 ' O ' ' HA ' ' A' ' 260' ' ' VAL . . . -76.82 102.09 6.15 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 176.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 25.3 pt -94.65 -5.02 10.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.585 -173.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.12 147.62 46.13 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -63.57 133.04 53.06 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.112 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.78 95.37 3.12 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.793 0.33 . . . . 0.0 110.582 -177.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 27.2 m -90.26 162.37 34.83 Favored Pre-proline 0 C--N 1.318 -0.773 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 172.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.504 ' HG3' ' HB2' ' A' ' 257' ' ' ALA . 5.1 Cg_exo -75.67 -151.45 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.152 1.901 . . . . 0.0 111.399 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' CYS . . . . . 0.504 ' O ' ' HB3' ' A' ' 252' ' ' ASP . 42.6 t -147.45 171.74 15.04 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 122.123 -0.361 . . . . 0.0 111.342 -173.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -68.08 -31.16 70.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.958 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -102.41 22.59 13.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.285 0.564 . . . . 0.0 110.539 176.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.504 ' HB3' ' O ' ' A' ' 249' ' ' CYS . 0.1 OUTLIER -83.2 129.03 34.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.416 178.205 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -138.68 -0.57 1.92 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.416 167.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 2.1 p -151.45 21.38 0.73 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.924 -177.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -102.93 109.44 21.0 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.034 0.445 . . . . 0.0 110.594 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.519 ' HA ' ' NH1' ' A' ' 282' ' ' ARG . 0.5 OUTLIER -65.93 139.07 58.23 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.874 -176.821 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.504 ' HB2' ' HG3' ' A' ' 248' ' ' PRO . . . -103.03 123.76 47.23 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.032 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.693 HD12 HG21 ' A' ' 289' ' ' THR . 57.1 mt -135.93 176.36 8.76 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.233 -175.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -160.38 177.29 10.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.65 0.262 . . . . 0.0 111.095 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 57.4 t -66.42 126.55 26.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.954 -171.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 96.14 8.65 57.66 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.888 175.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -103.61 147.27 27.41 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 31.4 mm -107.24 116.08 50.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.124 0.488 . . . . 0.0 110.336 -176.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 10.2 t -85.77 120.77 36.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.572 -177.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' LYS . . . . . 0.706 ' HD3' ' HG3' ' A' ' 278' ' ' GLU . 35.8 tttp -86.48 100.41 12.35 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.784 175.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.541 HG13 ' HB ' ' A' ' 238' ' ' VAL . 3.9 p -117.0 117.19 54.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.7 0.762 . . . . 0.0 111.095 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 12.7 p -98.2 -38.51 9.27 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.308 177.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' ARG . . . . . 0.524 ' HB2' ' HB2' ' A' ' 276' ' ' GLU . 42.7 mtt180 -106.81 108.75 20.41 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.141 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 6.2 ptp -114.18 114.51 26.13 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.717 0.77 . . . . 0.0 110.972 173.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -83.89 150.93 25.39 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.514 -176.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 34.4 pt -82.72 11.37 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.042 -177.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -98.58 -6.62 29.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.722 0.296 . . . . 0.0 110.544 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 113.25 -39.13 2.95 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.725 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.518 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 2.4 mp0 -88.3 111.16 21.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.862 0.363 . . . . 0.0 110.366 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.504 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 10.1 m0 -93.86 157.03 16.33 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.524 ' HB2' ' HB2' ' A' ' 268' ' ' ARG . 38.8 mt-10 -100.62 114.05 27.42 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 176.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -138.32 146.53 18.32 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.615 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.706 ' HG3' ' HD3' ' A' ' 265' ' ' LYS . 6.1 pt-20 -114.02 109.95 19.26 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.027 0.441 . . . . 0.0 110.024 177.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 279' ' ' VAL . . . . . 0.441 HG21 HD21 ' A' ' 258' ' ' LEU . 14.5 t -109.27 -109.68 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.013 -175.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -85.98 82.56 8.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.788 0.327 . . . . 0.0 111.615 -174.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 66.02 6.68 32.99 Favored Glycine 0 C--N 1.332 0.337 0 CA-C-N 115.928 -0.578 . . . . 0.0 113.421 174.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' ARG . . . . . 0.519 ' NH1' ' HA ' ' A' ' 256' ' ' LEU . 1.7 tmt_? -146.92 127.98 14.61 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -176.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.454 ' HB3' ' HB3' ' A' ' 278' ' ' GLU . 15.0 ptpt -120.71 142.43 49.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.684 -178.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -173.69 -169.7 36.29 Favored Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 111.564 -0.614 . . . . 0.0 111.564 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.518 ' HB3' ' HB3' ' A' ' 274' ' ' GLN . 94.4 mt -86.78 146.95 26.04 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.167 0.508 . . . . 0.0 110.247 177.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.684 ' HB2' ' OG1' ' A' ' 289' ' ' THR . 26.3 p90 -143.18 123.39 7.88 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.582 176.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 287' ' ' PRO . . . . . 0.638 ' C ' ' H ' ' A' ' 289' ' ' THR . 51.5 Cg_exo -62.98 62.26 0.16 Allowed 'Trans proline' 0 N--CA 1.486 1.061 0 C-N-CA 124.597 3.531 . . . . 0.0 112.565 175.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.668 ' O ' HG22 ' A' ' 291' ' ' VAL . 4.3 m-85 62.54 -14.77 0.06 Allowed 'General case' 0 C--O 1.213 -0.849 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.736 -168.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.693 HG21 HD12 ' A' ' 258' ' ' LEU . 1.4 m 69.68 -12.31 0.46 Allowed 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 123.573 0.749 . . . . 0.0 112.824 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 290' ' ' HIS . . . . . 0.472 ' CB ' ' O ' ' A' ' 289' ' ' THR . 32.2 m170 89.37 25.0 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 O-C-N 124.313 1.008 . . . . 0.0 109.829 -164.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.668 HG22 ' O ' ' A' ' 288' ' ' PHE . 13.1 m -86.99 179.57 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.358 0.599 . . . . 0.0 111.206 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -135.25 129.99 34.49 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.306 173.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.628 HD13 ' HB2' ' A' ' 240' ' ' ALA . 19.0 mm -77.35 126.02 37.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.064 0.459 . . . . 0.0 111.16 -178.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -151.44 -171.56 3.97 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.459 ' HB3' ' ND2' ' A' ' 298' ' ' ASN . 14.7 t70 -133.07 105.88 12.45 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-O 120.889 0.376 . . . . 0.0 110.221 175.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -85.32 11.87 3.23 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.919 2.413 . . . . 0.0 112.678 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -99.37 -32.49 11.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.297 -176.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' ASN . . . . . 0.459 ' ND2' ' HB3' ' A' ' 295' ' ' ASP . 7.8 p30 -91.28 150.43 41.46 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.471 -178.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 299' ' ' PRO . . . . . 0.587 ' HA ' ' HB3' ' A' ' 302' ' ' ASN . 6.1 Cg_exo -80.81 -15.67 10.59 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.994 2.463 . . . . 0.0 112.464 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -62.67 -47.14 84.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.138 -175.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -117.13 42.34 2.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.319 0.581 . . . . 0.0 110.092 175.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 302' ' ' ASN . . . . . 0.587 ' HB3' ' HA ' ' A' ' 299' ' ' PRO . 8.1 p30 -62.97 -25.1 68.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.229 -177.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 . . . . . 0 C--O 1.252 1.206 0 CA-C-O 118.26 -0.876 . . . . 0.0 109.724 -179.489 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ptp . . . . . 0 N--CA 1.483 1.192 0 CA-C-O 120.454 0.169 . . . . 0.0 110.549 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.6 m 70.13 142.0 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.468 0.707 . . . . 0.0 110.916 -175.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.485 ' O ' HG23 ' A' ' 99' ' ' ILE . 19.5 m -72.45 -46.28 55.71 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.42 -178.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -86.7 56.11 3.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.168 0.509 . . . . 0.0 110.707 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 20.7 tpp180 -93.55 96.75 10.06 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.383 -174.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.617 ' CE1' ' HE2' ' A' ' 89' ' ' LYS . 41.3 p90 -167.62 147.93 5.21 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.105 174.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -79.04 102.79 8.57 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.867 -178.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.405 ' O ' ' HB2' ' A' ' 9' ' ' SER . 30.4 m -69.36 76.88 0.39 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.079 175.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 8' ' ' SER . 21.4 t 178.48 -37.33 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.831 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -69.13 106.95 3.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.428 -173.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 -61.58 -31.03 71.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.397 -177.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 61.1 m -80.37 3.41 21.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.352 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -91.71 -47.81 7.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.941 0.4 . . . . 0.0 110.513 175.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 25.9 p-90 -122.62 -24.21 4.96 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -168.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -74.65 118.6 17.79 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.173 0.511 . . . . 0.0 110.913 -174.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.787 ' HG3' ' HB2' ' A' ' 37' ' ' LEU . 25.9 mmt -101.16 -11.71 19.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.062 -174.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.406 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 50.55 -114.21 2.51 Favored Glycine 0 CA--C 1.524 0.602 0 O-C-N 123.653 0.595 . . . . 0.0 113.25 -176.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.406 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 9.0 Cg_exo -72.31 91.33 0.76 Allowed 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 122.994 2.463 . . . . 0.0 113.273 -175.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.722 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 71.1 t -143.88 161.74 15.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 176.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.614 ' HA ' ' OG ' ' A' ' 42' ' ' SER . 16.0 m -128.68 174.06 9.76 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -172.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 63.3 mtp85 -57.32 -54.27 48.71 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.484 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 25.3 pt20 -60.99 -40.95 95.43 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.726 0.298 . . . . 0.0 111.684 -177.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.538 ' O ' ' HG3' ' A' ' 27' ' ' ARG . 0.3 OUTLIER -70.98 -47.04 61.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.138 0.494 . . . . 0.0 110.17 -177.262 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.44 -42.83 83.19 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.157 0.503 . . . . 0.0 110.998 175.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.663 ' HG3' HG21 ' A' ' 58' ' ' VAL . 64.6 tt0 -65.29 -40.84 94.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.232 -177.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.6 t -76.19 -4.58 42.54 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.929 0.395 . . . . 0.0 111.167 -177.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.538 ' HG3' ' O ' ' A' ' 23' ' ' GLU . 90.7 mtt180 -90.03 -25.91 20.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.206 0.527 . . . . 0.0 109.746 172.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.57 HD22 ' HB2' ' A' ' 53' ' ' SER . 25.5 mt -116.7 16.9 15.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.953 -171.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.4 90.57 4.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.036 0.446 . . . . 0.0 110.686 -176.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.449 ' HA2' ' HB2' ' A' ' 117' ' ' ASN . . . 81.97 -4.68 74.34 Favored Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.576 176.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.448 ' HA ' HG11 ' A' ' 113' ' ' VAL . 77.4 mm-40 -65.55 167.99 8.1 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.792 0.329 . . . . 0.0 111.527 -178.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -43.19 125.53 3.72 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.476 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.546 ' HB3' HG21 ' A' ' 96' ' ' THR . 29.8 m170 -69.39 142.22 53.96 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.335 -178.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.562 ' HA3' ' HB ' ' A' ' 99' ' ' ILE . . . 110.64 -20.16 25.24 Favored Glycine 0 N--CA 1.437 -1.241 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 -175.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.664 ' HB3' ' HB2' ' A' ' 102' ' ' ALA . 63.3 mtt -61.75 142.41 57.29 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 173.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.56 ' HB2' HD11 ' A' ' 50' ' ' LEU . 51.6 p90 -153.19 162.74 40.97 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.148 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.787 ' HB2' ' HG3' ' A' ' 16' ' ' MET . 4.4 pp -155.66 132.66 10.68 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.132 0.491 . . . . 0.0 111.432 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.4 t -103.79 109.8 28.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 174.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.722 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 29.5 ptt-85 -113.22 177.82 4.5 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.82 -177.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -73.78 134.35 43.41 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 172.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.524 ' HA ' HG23 ' A' ' 49' ' ' VAL . 39.2 t -57.09 119.13 5.81 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.61 0.719 . . . . 0.0 111.965 -173.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.614 ' OG ' ' HA ' ' A' ' 20' ' ' SER . 1.5 m -77.44 -11.75 59.88 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.426 173.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.0 m -83.58 -41.4 17.92 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.372 177.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.465 ' O ' ' HB3' ' A' ' 41' ' ' SER . 6.5 p -157.36 94.63 2.15 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.107 178.358 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -47.91 127.05 13.96 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.11 2.54 . . . . 0.0 112.087 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.48 -45.58 1.15 Allowed Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -172.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -83.67 -166.06 1.29 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 172.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.6 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 25.4 m-85 -134.8 171.27 14.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 117.902 0.319 . . . . 0.0 110.563 177.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.524 HG23 ' HA ' ' A' ' 41' ' ' SER . 59.9 t -145.37 109.4 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 175.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.56 HD11 ' HB2' ' A' ' 36' ' ' PHE . 56.2 tp -80.33 100.95 8.66 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.636 175.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.3 m -96.69 121.78 38.91 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 174.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.646 HG12 ' HG3' ' A' ' 54' ' ' GLU . 87.0 t -111.82 138.59 39.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.712 -174.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.679 ' HA ' ' O ' ' A' ' 57' ' ' ARG . 48.1 t -82.63 98.48 9.03 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 175.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.646 ' HG3' HG12 ' A' ' 52' ' ' VAL . 24.2 mt-10 -151.36 160.81 43.58 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.97 -175.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 70.43 -65.85 0.31 Allowed 'General case' 0 CA--C 1.49 -1.333 0 CA-C-O 122.742 1.258 . . . . 0.0 110.456 -168.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.674 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 74.8 m -157.9 -22.16 0.08 Allowed 'General case' 0 N--CA 1.419 -1.992 0 CA-C-N 112.56 -2.109 . . . . 0.0 107.626 -175.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.709 ' HG2' HG23 ' A' ' 58' ' ' VAL 0.359 0.0 OUTLIER -166.61 -50.23 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.124 1 N-CA-C 121.877 4.029 . . . . 0.0 121.877 -179.836 . . . . . . . . 5 4 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.709 HG23 ' HG2' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -149.78 99.42 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 CA-C-N 121.729 2.058 . . . . 0.0 112.939 -170.148 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.7 m -94.83 111.06 22.87 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 172.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -97.39 112.67 24.4 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -168.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.718 ' OH ' ' HB3' ' A' ' 93' ' ' LEU . 54.3 m-85 -120.14 105.78 11.32 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.415 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.606 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 63.6 mt -80.52 127.0 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -174.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.6 ' HB ' ' HB2' ' A' ' 48' ' ' TYR . 4.3 mp -101.05 119.72 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 121.17 0.51 . . . . 0.0 111.17 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.551 ' HB2' ' HB3' ' A' ' 72' ' ' LYS . 16.7 m120 -86.04 136.11 33.37 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.798 -178.148 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.1 t -85.58 93.75 8.88 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 171.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.663 HD11 ' HB2' ' A' ' 72' ' ' LYS . 83.6 mt -84.99 145.84 44.36 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.834 -177.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 66' ' ' LEU . 18.5 Cg_exo -67.57 -3.85 10.95 Favored 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 122.92 2.414 . . . . 0.0 111.547 174.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.426 ' HB3' ' HD3' ' A' ' 70' ' ' ARG . 42.2 m-20 -80.66 2.21 26.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.71 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? 63.59 31.89 14.37 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.469 0.652 . . . . 0.0 109.51 -170.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.754 ' HG2' ' HA ' ' A' ' 79' ' ' ASP . 35.5 mtp180 -132.44 162.03 32.19 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.708 -175.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.475 ' HB3' HG23 ' A' ' 63' ' ' ILE . 47.3 m-85 -122.85 117.84 26.55 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.965 0.412 . . . . 0.0 111.142 -174.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.663 ' HB2' HD11 ' A' ' 66' ' ' LEU . 29.5 ttpp -104.09 98.99 8.73 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.462 -173.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.706 HD11 ' CB ' ' A' ' 61' ' ' TYR . 6.7 tt -88.45 119.64 36.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.293 0.568 . . . . 0.0 111.286 -177.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.37 32.16 83.19 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.828 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.497 ' HA ' ' HZ3' ' A' ' 72' ' ' LYS . 35.1 t70 74.62 -11.61 1.01 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.035 0.534 . . . . 0.0 111.835 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -86.66 126.66 34.68 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 171.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 0.7 OUTLIER -100.57 140.79 34.34 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.909 0.861 . . . . 0.0 113.169 -169.134 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.559 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 91.0 m-85 -129.02 172.16 11.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.218 -1.356 . . . . 0.0 108.376 173.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.754 ' HA ' ' HG2' ' A' ' 70' ' ' ARG . 5.9 m-20 -74.88 -30.33 61.28 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.66 0.266 . . . . 0.0 111.693 -175.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.504 ' ND1' ' HG2' ' A' ' 82' ' ' PRO . 4.9 p80 -165.07 168.35 17.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.563 -176.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.668 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 14.3 mt -57.97 -54.63 53.5 Favored Pre-proline 0 N--CA 1.469 0.482 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -177.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.504 ' HG2' ' ND1' ' A' ' 80' ' ' HIS . 20.9 Cg_endo -62.95 -3.02 4.15 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 121.976 1.784 . . . . 0.0 113.637 178.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.421 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -89.01 -36.51 15.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.94 0.4 . . . . 0.0 110.263 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.668 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.0 pp -76.81 -29.86 56.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.064 0.459 . . . . 0.0 109.891 178.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.514 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 79.7 mt -68.46 -21.04 64.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.336 177.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -91.97 -17.45 25.12 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.37 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -91.23 -30.88 16.39 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 121.784 0.802 . . . . 0.0 109.272 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.694 ' HE2' HD13 ' A' ' 73' ' ' ILE . 28.4 m-85 -84.21 1.88 42.48 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.125 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.617 ' HE2' ' CE1' ' A' ' 6' ' ' PHE . 85.8 mttt -77.61 -11.91 59.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.687 169.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 35.7 pt -134.84 8.82 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.204 0 CA-C-O 121.05 0.453 . . . . 0.0 110.302 -176.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.487 ' HB2' ' HA ' ' A' ' 88' ' ' TYR . 16.8 t60 -88.14 -38.87 15.0 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.199 -177.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.499 ' HA ' ' O ' ' A' ' 96' ' ' THR . 92.5 m-85 58.46 86.07 0.09 Allowed 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.344 -1.298 . . . . 0.0 107.797 -161.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.718 ' HB3' ' OH ' ' A' ' 61' ' ' TYR . 76.2 mt -44.23 -65.32 0.53 Allowed 'General case' 0 CA--C 1.517 -0.297 0 O-C-N 124.151 0.907 . . . . 0.0 108.805 178.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.701 ' HB3' ' HB3' ' A' ' 154' ' ' GLU . 1.6 p30 -111.99 -86.53 0.56 Allowed 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.771 163.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . 1.015 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 11.5 t -118.97 14.4 13.22 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.296 0.57 . . . . 0.0 110.994 -174.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.546 HG21 ' HB3' ' A' ' 33' ' ' HIS . 5.8 t -153.72 -179.89 8.23 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 172.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.474 HG22 ' H ' ' A' ' 92' ' ' TYR . 20.2 p -116.56 171.13 8.05 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 122.4 -0.188 . . . . 0.0 110.733 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 92.5 mt -61.62 104.12 0.4 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.018 0.437 . . . . 0.0 110.113 175.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.562 ' HB ' ' HA3' ' A' ' 34' ' ' GLY . 45.8 mm -89.21 -56.91 4.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.807 -176.122 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.658 ' O ' ' HA ' ' A' ' 35' ' ' MET . 10.6 pt-20 -162.98 142.3 6.8 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.956 -177.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.21 149.51 90.14 Favored 'Trans proline' 0 C--O 1.235 0.375 0 C-N-CA 122.411 2.074 . . . . 0.0 112.57 -177.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.664 ' HB2' ' HB3' ' A' ' 35' ' ' MET . . . -73.07 146.24 87.05 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.99 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.67 115.68 3.69 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.234 1.956 . . . . 0.0 111.625 176.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.631 ' HB3' ' SD ' ' A' ' 16' ' ' MET . 37.6 ptt180 -66.22 135.16 54.09 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 178.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 59.64 68.03 1.64 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.859 -172.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -94.53 165.21 1.87 Allowed 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 123.168 2.579 . . . . 0.0 112.237 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 37.2 p -148.69 93.5 4.26 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.669 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -86.2 109.56 0.97 Allowed 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.448 2.099 . . . . 0.0 111.464 176.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -62.98 106.06 0.5 Allowed 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.678 2.252 . . . . 0.0 112.397 -176.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 51.8 ttm 72.87 -52.03 0.71 Allowed 'General case' 0 N--CA 1.47 0.542 0 O-C-N 123.922 0.764 . . . . 0.0 111.826 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 124.52 108.3 1.76 Allowed Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 -178.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 21.6 m -104.84 -3.76 23.07 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.109 0.481 . . . . 0.0 110.838 -177.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.448 HG11 ' HA ' ' A' ' 31' ' ' GLN . 8.7 m -80.96 81.48 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.627 0.727 . . . . 0.0 111.221 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 20.2 m -115.79 1.73 13.49 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.762 177.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.488 ' H ' ' HD2' ' A' ' 116' ' ' PRO . . . -96.59 -48.74 0.24 Allowed Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.551 177.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.488 ' HD2' ' H ' ' A' ' 115' ' ' ALA . 71.9 Cg_endo -81.47 171.59 13.4 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 121.848 1.699 . . . . 0.0 110.669 168.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.674 ' HA ' ' HB3' ' A' ' 56' ' ' SER . 60.3 t30 63.21 88.04 0.1 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.485 0.659 . . . . 0.0 110.316 -176.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.588 ' N ' ' HD2' ' A' ' 119' ' ' PRO . 4.1 mm? -86.81 -44.03 0.55 Allowed Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -174.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' A' ' 118' ' ' LEU . 18.8 Cg_endo -59.23 99.53 0.11 Allowed 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.035 1.824 . . . . 0.0 112.589 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.566 HG23 ' H ' ' A' ' 121' ' ' ALA . 0.6 OUTLIER -89.54 -64.12 1.19 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.934 -179.459 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.566 ' H ' HG23 ' A' ' 120' ' ' THR . . . -151.35 88.59 1.44 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.098 0.475 . . . . 0.0 111.041 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -130.89 -30.95 1.76 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.362 173.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.798 ' O ' ' HA ' ' A' ' 183' ' ' ARG . 24.6 t70 62.5 99.66 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.197 0 O-C-N 124.159 0.912 . . . . 0.0 108.607 -169.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 178.82 168.3 0.91 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.73 -175.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.597 HD21 ' CH2' ' A' ' 161' ' ' TRP . 3.9 mm? 62.47 91.6 0.06 Allowed 'General case' 0 N--CA 1.47 0.555 0 O-C-N 123.913 0.758 . . . . 0.0 111.913 173.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 32.9 tt0 177.73 -60.16 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.302 -177.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -112.69 112.97 24.86 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.286 176.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.985 HG22 ' HG3' ' A' ' 180' ' ' LYS . 10.4 t -115.71 146.34 20.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 177.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.664 ' CZ ' HD13 ' A' ' 181' ' ' LEU . 0.0 OUTLIER -118.71 147.69 43.56 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 117.244 -1.783 . . . . 0.0 109.024 158.903 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.515 HG22 HG12 ' A' ' 178' ' ' VAL . 0.8 OUTLIER -102.69 130.32 49.58 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.839 -1.073 . . . . 0.0 111.3 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.559 HD21 ' HG2' ' A' ' 179' ' ' GLU . 24.6 mt -104.97 -7.47 19.25 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -175.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.51 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 63.6 t80 -95.42 -42.53 8.43 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.233 -0.587 . . . . 0.0 112.543 -174.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.61 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 15.7 t70 77.75 89.71 0.07 Allowed 'General case' 0 N--CA 1.474 0.761 0 O-C-N 123.746 0.654 . . . . 0.0 110.431 -175.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.455 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 63.3 t80 -119.09 85.79 30.46 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 176.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.596 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 87.5 Cg_endo -81.94 83.76 2.02 Favored 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 121.608 1.539 . . . . 0.0 112.556 178.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -76.31 -20.58 76.97 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 175.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.83 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 88.0 m-20 58.41 68.23 0.85 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.643 -0.778 . . . . 0.0 111.679 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.485 ' HB3' ' H ' ' A' ' 140' ' ' GLU . 0.4 OUTLIER -152.3 170.73 19.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.85 179.066 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -94.97 -5.42 44.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.937 0.875 . . . . 0.0 108.975 170.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.485 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 42.7 mm-40 -96.34 -36.91 10.7 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.809 174.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.458 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 13.6 m-20 -123.01 112.73 18.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.273 178.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.993 HD11 ' HB2' ' A' ' 165' ' ' ASN . 30.4 tp -68.61 129.95 92.25 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-O 120.776 0.322 . . . . 0.0 110.534 -177.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.83 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 11.6 Cg_endo -85.64 91.26 0.69 Allowed 'Trans proline' 0 N--CA 1.442 -1.55 0 C-N-CA 122.092 1.861 . . . . 0.0 111.012 172.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.522 ' CE2' ' HB ' ' A' ' 173' ' ' ILE . 14.3 p90 -101.54 164.85 11.55 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.817 -174.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.61 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 1.4 mptp? -100.29 -172.71 2.26 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.203 0.525 . . . . 0.0 111.75 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.742 ' H ' ' HD2' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -91.62 9.03 33.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.972 -175.986 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -167.13 32.95 0.21 Allowed Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.48 175.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.511 ' OE1' ' HA ' ' A' ' 144' ' ' PHE . 0.1 OUTLIER -100.13 157.45 16.56 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.214 -174.92 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.638 HD12 ' HB3' ' A' ' 129' ' ' ARG . 0.6 OUTLIER -97.49 129.38 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-O 121.692 0.758 . . . . 0.0 109.978 -176.682 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.738 HD22 HD21 ' A' ' 142' ' ' LEU . 31.9 mt -123.94 158.77 31.24 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 114.522 -1.217 . . . . 0.0 108.01 -177.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.608 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 97.4 t -122.04 120.43 61.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 175.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 1.044 HD13 ' HB2' ' A' ' 163' ' ' ALA . 42.1 mm -78.21 79.14 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -178.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.665 HG23 ' HG2' ' A' ' 154' ' ' GLU . 7.6 tt -74.57 -34.18 34.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 114.535 -1.212 . . . . 0.0 109.318 -178.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.701 ' HB3' ' HB3' ' A' ' 94' ' ' ASP . 0.0 OUTLIER -123.46 142.92 50.51 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.502 175.577 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.486 ' HE3' ' NE1' ' A' ' 161' ' ' TRP . 83.1 tttt -140.47 81.75 17.13 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-O 120.982 0.42 . . . . 0.0 109.993 172.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 1.015 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 38.4 Cg_endo -73.25 -40.28 1.74 Allowed 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.03 1.82 . . . . 0.0 111.972 175.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -111.05 162.65 14.66 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.407 -171.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -100.17 -11.54 20.36 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 172.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -89.81 -34.1 16.27 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.916 177.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 49.4 m95 -129.45 139.44 51.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.942 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' TRP . . . . . 0.76 ' O ' HG13 ' A' ' 173' ' ' ILE . 47.8 m0 -113.63 137.02 52.18 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 176.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.53 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 16.2 m -96.96 97.59 9.39 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -175.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 1.044 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -110.84 149.54 30.43 Favored 'General case' 0 N--CA 1.425 -1.72 0 C-N-CA 119.859 -0.736 . . . . 0.0 109.956 -174.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.721 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 11.7 ptt180 -87.25 122.16 30.67 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 173.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.993 ' HB2' HD11 ' A' ' 142' ' ' LEU . 12.9 t30 -58.42 -178.07 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 113.755 -1.566 . . . . 0.0 111.381 -173.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.552 ' HD3' ' HB ' ' A' ' 149' ' ' ILE . 10.0 mmmm -66.38 -11.67 52.68 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.414 0.626 . . . . 0.0 109.906 166.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.499 ' H ' ' HB3' ' A' ' 165' ' ' ASN . 22.3 m-20 -82.29 -15.99 50.99 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 170.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 80.28 10.82 84.98 Favored Glycine 0 CA--C 1.52 0.36 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.923 -174.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.721 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.3 OUTLIER -81.94 133.91 35.34 Favored 'General case' 0 C--O 1.217 -0.615 0 C-N-CA 123.106 0.562 . . . . 0.0 110.803 -178.846 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 80.4 t -82.38 123.62 38.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.862 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -157.02 158.11 28.58 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.75 171.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.519 ' HA ' ' HA ' ' A' ' 162' ' ' SER . 10.5 mtp -82.84 144.79 29.87 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 117.482 0.641 . . . . 0.0 111.039 -178.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.76 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.7 pp -142.87 147.96 43.85 Favored Pre-proline 0 C--O 1.223 -0.317 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.43 -175.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.481 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 8.0 Cg_exo -73.55 129.8 14.13 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.547 2.165 . . . . 0.0 112.71 -175.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.579 ' O ' HG22 ' A' ' 178' ' ' VAL . 61.5 t -59.19 -44.51 98.57 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.467 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 36.4 Cg_exo -61.93 -2.54 2.96 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 122.206 1.937 . . . . 0.0 113.136 176.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.481 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.1 m-30 -100.85 -9.23 21.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.641 -178.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.635 ' HB ' HG13 ' A' ' 128' ' ' VAL . 6.1 m -107.87 -173.29 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 -166.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.63 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 5.2 tp10 -159.74 49.18 0.3 Allowed 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 113.221 -1.809 . . . . 0.0 112.559 -151.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.985 ' HG3' HG22 ' A' ' 128' ' ' VAL . 1.2 mppt? -71.47 138.52 49.05 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 120.042 -1.661 . . . . 0.0 111.803 -158.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.664 HD13 ' CZ ' ' A' ' 129' ' ' ARG . 11.8 tp -75.69 -80.08 0.09 Allowed 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 112.84 -1.982 . . . . 0.0 111.387 -170.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 8.3 m -77.63 103.51 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.88 178.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.945 ' HD2' ' HB2' ' A' ' 180' ' ' LYS . 3.6 ptm180 -170.04 154.21 5.0 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.248 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.424 ' O ' ' HB2' ' A' ' 185' ' ' SER . 35.9 t -68.63 -94.37 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 169.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.575 ' HB3' ' NE2' ' A' ' 187' ' ' HIS . 37.1 t 173.12 154.95 0.26 Allowed Pre-proline 0 C--O 1.236 0.369 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.553 ' HG3' HH22 ' A' ' 183' ' ' ARG . 9.3 Cg_exo -69.45 80.69 0.78 Allowed 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.352 2.035 . . . . 0.0 111.655 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.575 ' NE2' ' HB3' ' A' ' 185' ' ' SER . 99.5 m-70 -94.31 -12.86 27.17 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.279 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 67.8 -89.56 0.19 Allowed Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -173.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.948 ' HE2' ' HA ' ' A' ' 195' ' ' SER . 20.6 ttpp -66.33 111.56 3.57 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 168.144 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 64.9 m80 -91.02 90.82 8.03 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -136.18 159.86 24.49 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -105.9 6.13 31.19 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.912 0.356 . . . . 0.0 111.894 -175.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 25.9 ttp180 -117.9 -79.75 0.6 Allowed 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.325 -0.55 . . . . 0.0 111.774 -177.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ASN . . . . . 0.4 ' OD1' ' HB2' ' A' ' 196' ' ' ASN . 29.3 p-10 -158.25 -163.23 1.25 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 -173.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.948 ' HA ' ' HE2' ' A' ' 189' ' ' LYS . 13.4 p -57.98 -69.81 0.16 Allowed 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 173.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ASN . . . . . 0.4 ' HB2' ' OD1' ' A' ' 194' ' ' ASN . 2.9 t-20 71.11 -40.98 0.49 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.66 0.784 . . . . 0.0 112.913 171.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 22.7 t 72.75 86.6 0.11 Allowed 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.391 0.676 . . . . 0.0 109.357 -174.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -83.36 75.49 9.98 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.181 -178.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -93.39 -33.78 7.01 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.364 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 12.2 pt -107.48 104.28 52.07 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-O 121.22 0.533 . . . . 0.0 111.835 -177.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -88.22 0.37 6.78 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.704 2.27 . . . . 0.0 111.587 174.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.441 ' HA ' ' HD3' ' A' ' 203' ' ' PRO . 9.8 pt-20 -140.75 142.77 29.6 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.189 -177.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 202' ' ' GLU . 5.1 Cg_exo -75.3 96.82 1.05 Allowed 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.823 2.349 . . . . 0.0 111.107 174.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -88.91 89.8 8.14 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.854 -176.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -140.61 90.17 2.33 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.178 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . 58.08 25.42 12.36 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.512 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -103.43 -45.44 4.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.503 -175.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -101.24 -34.53 9.62 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.249 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -115.12 105.62 52.52 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.792 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -64.86 -58.13 0.24 Allowed 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.662 2.242 . . . . 0.0 111.732 175.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 63.11 172.55 0.15 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.627 0.727 . . . . 0.0 112.069 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 5.2 m -115.36 40.1 2.78 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 172.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 10.4 m -58.76 -45.85 88.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.712 -177.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 27.8 m -153.43 131.6 6.42 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.275 -176.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.504 ' HB2' ' O ' ' A' ' 218' ' ' ALA . 72.9 Cg_endo -80.17 120.41 4.11 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.424 2.083 . . . . 0.0 111.851 174.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.606 ' HB2' ' HD3' ' A' ' 217' ' ' PRO . 7.2 mp -99.77 -58.53 0.13 Allowed Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -178.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.606 ' HD3' ' HB2' ' A' ' 216' ' ' LEU . 87.9 Cg_endo -85.07 -10.82 7.87 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 121.754 1.636 . . . . 0.0 112.662 -178.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.504 ' O ' ' HB2' ' A' ' 215' ' ' PRO . . . -125.02 91.36 3.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.966 0.413 . . . . 0.0 110.893 -178.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 27.5 m -88.26 165.85 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.359 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 14.4 m -91.91 10.27 29.48 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.008 0.432 . . . . 0.0 110.766 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 80.78 -56.83 4.79 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.19 -0.529 . . . . 0.0 112.006 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.459 ' HA ' ' HD3' ' A' ' 223' ' ' PRO . 28.5 t -131.0 133.43 24.74 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 177.079 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 222' ' ' SER . 16.1 Cg_exo -67.49 161.14 44.69 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.579 2.186 . . . . 0.0 111.677 177.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -84.14 -25.4 44.55 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.589 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -138.45 157.7 45.69 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.721 -0.239 . . . . 0.0 110.373 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . 68.6 35.31 3.22 Favored 'General case' 0 C--O 1.233 0.23 0 O-C-N 123.971 0.795 . . . . 0.0 111.655 176.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.576 HD12 ' H ' ' A' ' 227' ' ' ILE . 4.3 mp -78.11 90.11 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 175.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 20.8 m 60.78 79.11 0.29 Allowed Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.324 -173.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.457 ' HB2' HD23 ' A' ' 230' ' ' LEU . 23.4 Cg_exo -64.79 -69.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.602 2.201 . . . . 0.0 111.774 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.457 HD23 ' HB2' ' A' ' 229' ' ' PRO . 2.6 pt? -162.31 123.25 1.55 Allowed Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.916 177.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 230' ' ' LEU . 7.7 Cg_exo -72.43 -68.09 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.296 1.997 . . . . 0.0 111.374 177.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 3.0 p -161.71 26.83 0.12 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.618 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 2.9 p -82.44 -16.79 47.64 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.207 -173.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 58.36 83.58 0.12 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 121.433 0.635 . . . . 0.0 110.881 -175.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -110.64 99.2 8.2 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.531 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -90.97 163.84 29.57 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.222 174.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -68.81 161.57 44.96 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.533 2.155 . . . . 0.0 111.751 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.505 ' HB ' HG13 ' A' ' 266' ' ' VAL . 18.3 t -89.03 128.95 40.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.516 ' HB2' ' HG3' ' A' ' 296' ' ' PRO . 93.9 m-85 -102.87 117.68 35.16 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.092 0.472 . . . . 0.0 110.959 -177.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -119.95 134.35 55.27 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.104 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -84.59 126.39 33.29 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' ALA . . . . . 0.476 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -72.65 100.71 2.87 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.03 0.443 . . . . 0.0 109.829 177.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.453 ' H ' HG13 ' A' ' 243' ' ' ILE . 2.4 pp -96.05 -9.0 9.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.557 -176.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.28 138.25 36.59 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 176.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -58.23 149.62 23.72 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 120.968 0.414 . . . . 0.0 110.71 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 24.7 tpt180 -143.78 91.52 2.24 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 174.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 29.2 m -100.23 142.6 24.93 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.098 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.486 ' HB3' ' HB3' ' A' ' 255' ' ' ALA . 72.8 Cg_endo -79.11 148.58 21.71 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.404 2.07 . . . . 0.0 112.101 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 48.7 t -79.66 176.58 9.59 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 173.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -59.62 -30.36 68.64 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.659 0.266 . . . . 0.0 111.548 -177.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -96.02 -5.42 41.11 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.467 ' HB3' ' HB3' ' A' ' 255' ' ' ALA . 4.1 m-20 -82.82 107.6 15.56 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.263 0.554 . . . . 0.0 111.467 -176.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 47.2 mttp -104.01 -34.41 8.46 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.308 176.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 3.0 p -86.81 9.4 19.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.589 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.486 ' HB3' ' HB3' ' A' ' 248' ' ' PRO . . . -95.8 131.84 41.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.051 0.453 . . . . 0.0 110.857 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.536 HD21 ' HB ' ' A' ' 279' ' ' VAL . 0.9 OUTLIER -88.24 133.32 34.07 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.188 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -89.3 109.75 20.61 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.861 0.363 . . . . 0.0 110.169 -179.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 94.2 mt -115.11 143.69 44.82 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.012 -175.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -120.4 149.95 41.55 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.503 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 59.8 t -64.17 117.15 4.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.784 0.326 . . . . 0.0 110.874 -178.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 108.93 10.19 24.95 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.587 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -103.19 167.59 9.72 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 37.3 mm -114.35 118.09 57.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.038 0.447 . . . . 0.0 110.814 -176.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 20.0 t -93.69 109.37 21.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.514 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -87.2 87.47 7.45 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.746 177.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.505 HG13 ' HB ' ' A' ' 238' ' ' VAL . 7.2 p -91.19 136.52 24.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.88 -175.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 18.1 p -114.06 -50.61 2.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.19 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 14.2 tpp180 -100.79 101.27 12.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.12 0.486 . . . . 0.0 110.657 -175.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 41.4 mtt -91.54 118.9 31.01 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.007 0.432 . . . . 0.0 110.304 177.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 274' ' ' GLN . 90.6 m-20 -83.11 0.61 44.3 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.472 -176.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 50.6 mm 72.94 -47.85 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 171.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -61.84 -24.75 67.09 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -173.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 155.38 -48.48 0.49 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.252 -0.975 . . . . 0.0 112.694 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.515 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 26.9 mp0 -86.46 116.52 24.66 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.387 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.475 ' HB3' HG21 ' A' ' 266' ' ' VAL . 43.8 m0 -97.17 153.42 18.0 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.613 178.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -106.26 109.47 21.41 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.184 0.516 . . . . 0.0 110.026 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -123.21 164.18 16.33 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.786 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -114.61 115.28 26.91 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -178.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 279' ' ' VAL . . . . . 0.536 ' HB ' HD21 ' A' ' 256' ' ' LEU . 88.1 t -136.15 125.2 38.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.258 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 56.95 38.78 29.58 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.893 176.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 89.34 -15.63 57.99 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.437 175.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' A' ' 282' ' ' ARG . 40.6 mtp-105 -107.96 132.7 53.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 117.164 0.482 . . . . 0.0 110.645 -177.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 0.0 OUTLIER -114.61 130.06 56.74 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 174.507 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -157.96 -175.73 29.22 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.279 -177.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.515 ' HB3' ' HB3' ' A' ' 274' ' ' GLN . 78.6 mt -93.8 129.75 40.06 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.126 0.489 . . . . 0.0 110.804 -178.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.474 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 47.8 p90 -132.72 141.18 40.18 Favored Pre-proline 0 C--N 1.317 -0.804 0 CA-C-N 115.696 -0.683 . . . . 0.0 109.837 176.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 287' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 4.6 Cg_exo -74.89 140.38 25.71 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.735 2.29 . . . . 0.0 111.58 177.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -72.58 7.12 2.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.045 0.45 . . . . 0.0 111.821 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 4.1 p -90.83 -10.68 41.84 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.157 0.503 . . . . 0.0 110.968 177.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -104.89 -10.45 17.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.874 -178.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.476 HG12 ' HA ' ' A' ' 242' ' ' ALA . 35.6 m -128.36 162.74 34.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.455 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -140.69 136.72 32.91 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.32 175.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 1.2 mp -72.56 135.96 26.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 174.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -144.63 -165.81 2.24 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.941 -175.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.95 ' HB3' ' HA ' ' A' ' 298' ' ' ASN . 23.8 m-20 -103.43 95.35 6.98 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.228 175.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 296' ' ' PRO . . . . . 0.516 ' HG3' ' HB2' ' A' ' 239' ' ' PHE . 74.5 Cg_endo -77.13 -30.8 4.08 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.193 1.929 . . . . 0.0 111.665 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -99.32 -20.73 16.39 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.444 175.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 298' ' ' ASN . . . . . 0.95 ' HA ' ' HB3' ' A' ' 295' ' ' ASP . 18.3 m120 72.53 157.63 0.16 Allowed Pre-proline 0 N--CA 1.467 0.391 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.881 175.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -90.29 7.59 3.75 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.897 2.398 . . . . 0.0 111.275 172.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -135.27 136.44 41.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.582 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 65.95 7.24 4.53 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.839 0.712 . . . . 0.0 111.31 -176.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -87.55 92.27 9.03 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 176.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 . . . . . 0 C--O 1.249 1.039 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.562 -172.749 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 ptp . . . . . 0 N--CA 1.484 1.245 0 CA-C-O 121.085 0.469 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.8 t -74.07 131.89 41.78 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.838 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.402 ' O ' HG23 ' A' ' 99' ' ' ILE . 22.7 t -66.84 -18.32 65.32 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 177.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . -75.38 87.19 2.56 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.83 175.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -115.55 88.56 2.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.648 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -161.09 161.29 31.18 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.385 177.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -88.25 91.47 8.8 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.875 0.845 . . . . 0.0 110.11 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.6 p -73.86 77.81 1.62 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.894 -176.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.4 t -176.59 -39.78 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.586 176.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -64.51 113.81 3.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.018 0.437 . . . . 0.0 110.828 -174.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -58.46 -35.81 72.71 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.742 -176.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.2 t -73.51 -6.49 46.8 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.176 -176.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.01 -47.49 7.25 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 121.046 -0.262 . . . . 0.0 111.556 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 30.1 p-90 -116.67 -22.74 8.49 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -171.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -73.27 112.84 9.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.361 0.6 . . . . 0.0 109.747 -177.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.565 ' SD ' ' HA ' ' A' ' 104' ' ' ARG . 15.7 tpp -95.3 5.86 50.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.31 -171.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.486 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 49.65 -113.65 1.92 Allowed Glycine 0 CA--C 1.522 0.493 0 CA-C-N 115.516 -0.765 . . . . 0.0 114.357 176.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.486 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 5.0 Cg_exo -77.13 88.49 1.4 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.454 2.77 . . . . 0.0 113.159 -175.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.582 HG12 ' HD2' ' A' ' 39' ' ' ARG . 71.3 t -145.34 160.44 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.452 ' H ' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -143.27 -168.81 2.9 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -171.354 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 35.6 mtp85 -59.06 -57.82 11.4 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 118.652 0.66 . . . . 0.0 112.182 -176.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -64.68 -44.97 88.64 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 123.29 0.369 . . . . 0.0 110.847 -175.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.638 ' O ' ' HG3' ' A' ' 27' ' ' ARG . 12.5 mp0 -60.68 -49.84 75.9 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.534 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.92 -44.69 82.7 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.427 0.632 . . . . 0.0 110.344 177.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.525 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 6.9 tp60 -60.72 -58.25 9.24 Favored 'General case' 0 C--O 1.214 -0.786 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.563 -178.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.2 t -61.83 -27.53 68.84 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -172.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.638 ' HG3' ' O ' ' A' ' 23' ' ' GLU . 62.5 mtp180 -83.48 -10.44 58.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.717 0.294 . . . . 0.0 111.258 -178.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.64 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 87.7 mt -125.58 -13.39 6.53 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.525 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -70.24 107.09 3.57 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 122.765 0.426 . . . . 0.0 110.434 -174.855 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.53 ' O ' ' HB3' ' A' ' 116' ' ' PRO . . . 70.61 20.24 77.08 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.05 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.483 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 12.2 mm100 -92.89 -161.17 0.81 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.427 ' HG2' ' HB3' ' A' ' 115' ' ' ALA . 47.0 mtm180 -52.64 130.76 33.23 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 175.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.41 ' ND1' ' HB2' ' A' ' 117' ' ' ASN . 63.5 m170 -86.35 126.31 34.25 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.25 11.2 42.92 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -171.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.543 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 50.6 ttp -104.07 134.61 47.04 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -178.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.437 ' CB ' HG22 ' A' ' 52' ' ' VAL . 39.9 p90 -139.29 167.78 21.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.768 0.318 . . . . 0.0 111.777 -174.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.545 ' HG ' HD11 ' A' ' 28' ' ' LEU . 4.6 pp -153.83 140.0 18.45 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.146 0.498 . . . . 0.0 110.825 173.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.6 t -105.71 114.21 44.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 174.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.582 ' HD2' HG12 ' A' ' 19' ' ' VAL . 22.3 ptt-85 -112.33 167.72 10.2 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.953 -173.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -76.44 125.36 29.06 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 170.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.0 t -75.77 152.51 37.36 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.395 0.617 . . . . 0.0 111.531 -172.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.8 t -111.69 14.54 21.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.226 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 46.7 p -92.16 -57.25 2.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.957 176.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.418 ' HB2' ' OD2' ' A' ' 47' ' ' ASP . 56.8 m -134.56 137.9 28.74 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.754 178.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.6 127.18 17.47 Favored 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 122.8 2.333 . . . . 0.0 112.754 -178.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.65 -16.68 43.8 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.339 176.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.418 ' OD2' ' HB2' ' A' ' 44' ' ' CYS . 65.8 m-20 -96.89 166.34 11.67 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 -177.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -128.33 175.22 8.65 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -178.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.7 t -144.66 117.35 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 120.902 0.382 . . . . 0.0 110.93 174.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 33.5 tp -84.83 102.1 12.8 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.442 176.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 55.9 m -96.52 133.65 40.72 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 175.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.798 HG21 HD13 ' A' ' 93' ' ' LEU . 99.2 t -129.53 134.3 63.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.841 0.353 . . . . 0.0 111.825 -173.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.64 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 9.2 t -94.5 117.18 29.73 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -177.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.684 ' O ' ' HB3' ' A' ' 57' ' ' ARG . 9.9 tp10 -158.26 147.94 19.71 Favored 'General case' 0 C--O 1.211 -0.967 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.276 163.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.521 ' ND2' ' HG3' ' A' ' 54' ' ' GLU . 50.7 m-80 62.89 16.59 9.27 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 123.35 0.407 . . . . 0.0 111.59 -176.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 67.2 m 56.22 59.46 3.68 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 122.724 1.25 . . . . 0.0 108.164 -168.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.684 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 19.4 ttp85 -155.59 65.12 0.6 Allowed 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 112.768 -2.015 . . . . 0.0 109.398 -160.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.673 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 21.4 t -71.61 96.79 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 122.346 1.07 . . . . 0.0 109.187 -171.039 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.483 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 1.4 p -75.07 121.37 21.92 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 113.237 -1.801 . . . . 0.0 111.166 -176.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 62.4 m-70 -93.59 108.08 19.84 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.211 -176.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.935 ' HB3' HD11 ' A' ' 73' ' ' ILE . 66.6 m-85 -105.63 103.24 12.71 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.071 177.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.686 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 55.8 mt -78.33 133.47 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -174.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.587 HG13 ' HB ' ' A' ' 73' ' ' ILE . 4.2 mp -118.03 118.67 58.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 122.831 0.452 . . . . 0.0 111.275 -179.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -87.78 151.06 23.17 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.0 t -92.46 100.84 13.32 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 171.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.575 HD21 ' HD2' ' A' ' 72' ' ' LYS . 80.2 mt -78.61 137.16 58.99 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.663 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -63.3 -7.03 11.14 Favored 'Trans proline' 0 CA--C 1.529 0.237 0 C-N-CA 122.889 2.392 . . . . 0.0 112.238 177.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 -78.24 6.74 7.53 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.723 173.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.778 ' HE ' ' HA ' ' A' ' 69' ' ' ARG . 2.6 tpm_? 63.57 32.87 13.8 Favored 'General case' 0 N--CA 1.46 0.065 0 CA-C-O 122.009 0.909 . . . . 0.0 109.106 -173.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.788 ' HG2' ' HA ' ' A' ' 79' ' ' ASP . 69.6 mtt180 -120.78 179.39 4.37 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.692 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.559 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 54.0 m-85 -135.82 119.35 16.98 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.096 0.474 . . . . 0.0 111.379 -176.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.583 ' HG3' ' HG2' ' A' ' 77' ' ' GLU . 46.3 tttm -101.82 101.28 11.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.567 -172.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.935 HD11 ' HB3' ' A' ' 61' ' ' TYR . 7.0 tt -100.77 110.17 27.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.38 0.609 . . . . 0.0 111.444 -176.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.96 -55.39 3.51 Favored Glycine 0 CA--C 1.519 0.326 0 CA-C-N 115.396 -0.82 . . . . 0.0 113.263 177.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -165.4 -40.86 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -176.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -69.27 141.18 54.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.24 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.583 ' HG2' ' HG3' ' A' ' 72' ' ' LYS . 43.5 mt-10 -108.99 104.86 14.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.434 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.54 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 77.6 m-85 -100.26 160.41 14.35 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 176.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.788 ' HA ' ' HG2' ' A' ' 70' ' ' ARG . 6.0 m-20 -74.82 -32.79 62.07 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -174.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.54 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 1.2 p80 -153.22 166.44 32.54 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.473 0.178 . . . . 0.0 110.875 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.668 HD23 HD21 ' A' ' 84' ' ' LEU . 9.0 mt -57.23 -51.22 83.33 Favored Pre-proline 0 N--CA 1.466 0.328 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.865 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.54 ' HD2' ' HB2' ' A' ' 80' ' ' HIS . 23.4 Cg_endo -61.11 -10.69 15.93 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.118 1.879 . . . . 0.0 113.034 177.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.58 -36.3 16.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.672 0.272 . . . . 0.0 110.466 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.668 HD21 HD23 ' A' ' 81' ' ' LEU . 4.1 pp -76.49 -35.38 58.41 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 177.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.559 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 77.3 mt -62.07 -38.5 89.04 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.554 175.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.56 ' HA ' ' HD3' ' A' ' 89' ' ' LYS . 11.0 tp10 -67.55 -38.73 84.6 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.596 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -65.66 -37.99 88.06 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.216 0.531 . . . . 0.0 110.747 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.543 ' HE2' HD13 ' A' ' 73' ' ' ILE . 35.0 m-85 -81.25 -15.59 55.13 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.777 -177.197 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.56 ' HD3' ' HA ' ' A' ' 86' ' ' GLU . 40.8 mtpt -64.72 -26.33 68.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.092 174.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.8 pp -114.48 8.48 7.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.421 -0.512 . . . . 0.0 112.349 174.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.422 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 6.2 t-160 -93.81 -37.95 11.5 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.747 0.308 . . . . 0.0 110.868 -176.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.485 ' N ' HG22 ' A' ' 97' ' ' THR . 58.8 m-85 67.41 84.55 0.15 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.275 -168.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.798 HD13 HG21 ' A' ' 52' ' ' VAL . 14.2 mt -53.98 -25.05 18.93 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 122.208 1.004 . . . . 0.0 110.888 175.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.528 ' CG ' ' HB3' ' A' ' 54' ' ' GLU . 0.4 OUTLIER -132.05 -91.6 0.4 Allowed 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 114.339 -1.3 . . . . 0.0 107.607 175.6 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.541 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 13.8 t -145.67 21.63 1.47 Allowed 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 172.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.8 t -135.41 -21.85 1.54 Allowed 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 119.605 -0.838 . . . . 0.0 112.852 -174.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.485 HG22 ' N ' ' A' ' 92' ' ' TYR . 7.1 p 72.96 -162.2 0.1 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.02 0.928 . . . . 0.0 110.214 -173.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.421 HD22 ' CD2' ' A' ' 36' ' ' PHE . 81.5 mt -95.96 94.45 7.61 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.068 178.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.553 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 43.9 mm -76.52 -61.26 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.958 -176.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.543 ' O ' ' HA ' ' A' ' 35' ' ' MET . 11.3 pt-20 -161.66 151.8 14.32 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.569 178.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.37 159.04 55.25 Favored 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 122.892 2.395 . . . . 0.0 113.512 -177.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.459 ' HA ' ' SD ' ' A' ' 35' ' ' MET . . . -72.31 145.7 88.43 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.91 176.014 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.451 ' HB3' ' HG3' ' A' ' 106' ' ' PRO . 82.1 Cg_exo -50.24 120.91 6.82 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.696 2.264 . . . . 0.0 111.503 175.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.565 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 39.1 ttt180 -58.22 -66.89 0.41 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.776 -0.454 . . . . 0.0 109.776 -175.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -163.34 81.49 1.53 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.769 0.795 . . . . 0.0 110.272 171.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.451 ' HG3' ' HB3' ' A' ' 103' ' ' PRO . 71.0 Cg_endo -83.0 -50.98 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.153 1.902 . . . . 0.0 112.315 179.039 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 47.3 t -169.81 151.45 4.18 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -177.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.405 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 72.9 Cg_exo -51.02 143.98 29.53 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.409 2.073 . . . . 0.0 111.544 173.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 108' ' ' PRO . 58.9 Cg_exo -52.37 105.36 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.127 2.552 . . . . 0.0 112.848 -176.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 52.0 ttm -119.02 -28.94 5.4 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.469 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -150.11 -118.91 0.91 Allowed Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.03 177.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 30.7 m 59.72 27.67 16.98 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.912 0.387 . . . . 0.0 111.378 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.3 m -103.85 1.32 10.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.223 0.535 . . . . 0.0 110.731 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.4 p -88.32 41.77 1.03 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.673 176.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.656 ' H ' ' HD2' ' A' ' 116' ' ' PRO . . . -157.94 -44.65 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.375 -177.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.656 ' HD2' ' H ' ' A' ' 115' ' ' ALA . 90.3 Cg_exo -48.32 121.31 6.03 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 122.195 1.93 . . . . 0.0 112.274 170.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.41 ' HB2' ' ND1' ' A' ' 33' ' ' HIS . 6.2 m-20 -97.14 -178.77 4.3 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.473 178.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.442 ' HA ' ' HD3' ' A' ' 119' ' ' PRO . 3.6 pp -70.76 153.13 95.02 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-O 121.07 0.462 . . . . 0.0 112.092 -172.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 118' ' ' LEU . 2.7 Cg_exo -76.71 163.81 31.08 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.156 2.571 . . . . 0.0 112.308 179.184 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 51.2 m -148.27 -50.21 0.17 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.312 175.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.47 ' HB3' ' HB2' ' A' ' 57' ' ' ARG . . . -95.09 71.12 3.32 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.103 0.478 . . . . 0.0 110.686 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -118.3 117.03 28.01 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.752 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 30.3 t70 72.21 3.91 4.83 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 123.88 0.737 . . . . 0.0 110.386 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.532 ' HB2' ' CD ' ' A' ' 183' ' ' ARG . 6.4 p30 -148.28 169.73 19.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.636 -178.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.702 HD12 HG21 ' A' ' 152' ' ' ILE . 1.9 mm? 61.24 90.34 0.07 Allowed 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.229 0.538 . . . . 0.0 111.547 -177.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 40.2 tt0 179.86 -39.73 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.341 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -124.38 119.82 30.32 Favored 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 119.839 -0.745 . . . . 0.0 110.302 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.773 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 56.0 t -134.63 144.07 35.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.976 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.746 ' NH2' ' HG ' ' A' ' 181' ' ' LEU . 0.0 OUTLIER -118.9 143.54 46.93 Favored 'General case' 0 CA--C 1.501 -0.928 0 C-N-CA 116.755 -1.978 . . . . 0.0 108.741 168.059 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.813 HG22 HG12 ' A' ' 178' ' ' VAL . 1.4 p -103.89 141.08 36.77 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.749 0.785 . . . . 0.0 111.005 -177.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.771 HD11 ' HG2' ' A' ' 179' ' ' GLU . 0.5 OUTLIER -116.43 -20.34 9.73 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.921 -173.652 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.43 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 37.3 t80 -83.85 -26.23 29.66 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.764 -171.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.466 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 12.6 t70 67.94 90.65 0.09 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.748 0.785 . . . . 0.0 110.204 -178.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.565 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 74.4 t80 -120.56 91.1 46.59 Favored Pre-proline 0 C--N 1.314 -0.976 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 176.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.742 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 92.7 Cg_endo -84.14 79.9 2.5 Favored 'Trans proline' 0 N--CA 1.444 -1.421 0 C-N-CA 121.832 1.688 . . . . 0.0 112.71 -176.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.15 -23.25 74.67 Favored Glycine 0 C--N 1.334 0.417 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.687 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.424 ' H ' ' HB3' ' A' ' 143' ' ' PRO . 88.5 m-20 62.77 31.92 16.26 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 122.669 0.387 . . . . 0.0 111.686 176.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.469 ' HB3' ' H ' ' A' ' 141' ' ' ASP . 0.2 OUTLIER -127.17 178.32 6.1 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.054 0.454 . . . . 0.0 111.586 -176.097 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -97.15 -10.49 25.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.634 172.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.666 ' O ' ' HB2' ' A' ' 172' ' ' MET . 46.4 mt-10 -113.14 -7.97 13.59 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.48 176.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.469 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 9.8 m-20 -135.65 104.63 5.86 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 173.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 1.03 HD11 ' HB2' ' A' ' 165' ' ' ASN . 52.5 tp -70.83 129.24 89.95 Favored Pre-proline 0 CA--C 1.509 -0.621 0 CA-C-O 120.837 0.351 . . . . 0.0 110.83 -172.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.82 ' HD2' HD12 ' A' ' 142' ' ' LEU . 47.6 Cg_endo -80.21 96.46 1.02 Allowed 'Trans proline' 0 N--CA 1.436 -1.899 0 C-N-CA 121.01 1.14 . . . . 0.0 111.544 168.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.61 ' HB2' ' OG1' ' A' ' 130' ' ' THR . 9.0 p90 -107.18 159.87 16.01 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.926 ' H ' ' HG3' ' A' ' 148' ' ' GLU . 4.1 mppt? -111.09 -140.34 0.38 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.368 0.604 . . . . 0.0 111.818 -175.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.721 ' HD3' ' N ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -116.58 55.72 0.81 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.276 -177.019 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 135.6 23.86 0.56 Allowed Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.244 -0.889 . . . . 0.0 113.055 174.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.926 ' HG3' ' H ' ' A' ' 145' ' ' LYS . 0.0 OUTLIER -74.73 164.83 26.14 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 169.694 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.682 HD12 ' HB3' ' A' ' 129' ' ' ARG . 0.4 OUTLIER -107.86 132.12 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 173.392 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.726 HD22 HD21 ' A' ' 142' ' ' LEU . 37.9 mt -118.54 154.69 32.15 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -176.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.565 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 98.0 t -121.98 122.83 67.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.992 HD13 ' HB2' ' A' ' 163' ' ' ALA . 44.4 mm -75.0 83.27 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -175.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.604 HD12 ' HD3' ' A' ' 164' ' ' ARG . 16.4 tt -75.3 -27.94 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 CA-C-N 113.398 -1.728 . . . . 0.0 110.134 -171.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.712 ' OE2' ' HA ' ' A' ' 93' ' ' LEU . 1.8 mt-10 -135.66 141.05 44.95 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 170.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.585 ' HD2' ' HG ' ' A' ' 125' ' ' LEU . 58.6 tttp -130.1 91.53 38.97 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 122.047 -0.408 . . . . 0.0 111.202 173.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.541 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 8.4 Cg_exo -77.59 -45.14 0.16 Allowed 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.656 2.237 . . . . 0.0 112.285 171.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -117.83 -178.61 3.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.152 0.501 . . . . 0.0 111.832 -170.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.506 ' O ' HG21 ' A' ' 175' ' ' VAL . 2.6 mm-40 -106.39 -19.1 13.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.485 174.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -95.5 -28.68 14.77 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.735 0.302 . . . . 0.0 111.547 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.493 ' O ' ' HD1' ' A' ' 161' ' ' TRP . 42.6 m95 -124.22 137.91 54.46 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 174.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' TRP . . . . . 0.733 ' HB3' HD12 ' A' ' 152' ' ' ILE . 45.8 m0 -124.37 140.0 53.37 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-O 121.025 0.441 . . . . 0.0 111.007 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.57 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 19.4 m -97.94 97.02 8.58 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -174.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.992 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -110.93 148.68 31.95 Favored 'General case' 0 N--CA 1.425 -1.695 0 C-N-CA 119.846 -0.742 . . . . 0.0 109.903 -174.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.84 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 17.2 ptt-85 -86.86 122.29 30.53 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 173.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 1.03 ' HB2' HD11 ' A' ' 142' ' ' LEU . 63.8 t30 -56.38 177.44 0.07 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.005 -1.452 . . . . 0.0 110.443 -174.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.402 ' HD2' ' H ' ' A' ' 149' ' ' ILE . 46.8 tttt -63.66 -12.76 36.56 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.759 169.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -74.16 -30.38 62.23 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.186 0.517 . . . . 0.0 109.745 168.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 97.26 15.85 36.96 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.462 -171.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.84 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 2.5 ttm-85 -95.43 139.0 32.34 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 122.785 0.434 . . . . 0.0 111.457 -177.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.549 HG22 HD13 ' A' ' 153' ' ' ILE . 39.2 t -78.71 130.98 35.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.202 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -162.93 155.27 26.55 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.501 166.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.666 ' HB2' ' O ' ' A' ' 140' ' ' GLU . 0.2 OUTLIER -76.9 140.56 40.58 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 117.057 0.428 . . . . 0.0 111.042 178.854 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.731 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.4 pp -142.0 146.7 41.51 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.343 -176.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.591 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 5.3 Cg_exo -77.02 130.34 11.21 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.85 2.367 . . . . 0.0 112.746 -176.069 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.553 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 87.0 t -62.02 -42.2 80.48 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 24.6 Cg_endo -63.36 -0.12 2.13 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 121.948 1.766 . . . . 0.0 112.969 175.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.591 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.3 m-85 -97.07 -16.4 20.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.399 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.813 HG12 HG22 ' A' ' 130' ' ' THR . 2.4 m -112.11 -173.52 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 117.712 2.486 . . . . 0.0 117.712 -160.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.771 ' HG2' HD11 ' A' ' 131' ' ' LEU . 2.1 mm-40 -139.96 49.35 1.77 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 111.558 -2.565 . . . . 0.0 115.654 -161.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.773 ' HA ' ' HA ' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -69.51 134.35 48.77 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 124.366 3.257 . . . . 0.0 111.879 -158.69 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.746 ' HG ' ' NH2' ' A' ' 129' ' ' ARG . 0.3 OUTLIER -69.65 -65.41 0.72 Allowed 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 110.755 -2.93 . . . . 0.0 111.997 -170.483 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 29.5 m -93.46 17.44 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.485 0.66 . . . . 0.0 110.839 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.576 ' O ' ' HB2' ' A' ' 180' ' ' LYS . 4.6 tpt180 -142.39 108.93 5.33 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.212 -173.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 20.7 p -81.74 -164.04 0.73 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.778 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.529 ' HB2' ' HD2' ' A' ' 186' ' ' PRO . 2.9 p -65.18 166.3 13.69 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 173.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.529 ' HD2' ' HB2' ' A' ' 185' ' ' SER . 10.0 Cg_endo -51.21 107.48 0.18 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.984 2.456 . . . . 0.0 112.996 -179.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -131.27 -7.34 3.8 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.158 176.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 82.6 -79.4 1.89 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.138 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.44 ' O ' ' HB3' ' A' ' 190' ' ' HIS . 18.3 ptpt -85.08 -5.7 59.34 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.545 0.202 . . . . 0.0 111.545 -176.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' HIS . . . . . 0.44 ' HB3' ' O ' ' A' ' 189' ' ' LYS . 9.1 t-160 71.05 -52.51 0.68 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.975 0.51 . . . . 0.0 110.985 -175.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 145.79 159.97 8.43 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.228 176.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ASN . . . . . 0.41 ' O ' ' HD3' ' A' ' 193' ' ' ARG . 33.0 t30 -72.39 -75.08 0.14 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.887 0.375 . . . . 0.0 110.793 177.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 193' ' ' ARG . 35.3 mmt180 -130.0 81.05 1.99 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.082 0.467 . . . . 0.0 110.311 -178.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -150.71 103.45 3.1 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.456 0.646 . . . . 0.0 110.131 177.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 6.7 m -82.22 -44.48 16.3 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.844 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -92.67 127.31 38.13 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.118 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 23.6 t -85.02 24.5 1.07 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.048 0.451 . . . . 0.0 110.507 -178.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -111.64 12.3 21.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.122 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -85.67 44.96 3.42 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.134 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 50.1 mm -111.14 121.79 39.62 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-O 120.571 0.224 . . . . 0.0 110.454 -177.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -74.41 87.13 1.26 Allowed 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.526 2.15 . . . . 0.0 112.311 177.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.521 ' N ' ' HD2' ' A' ' 203' ' ' PRO . 41.3 mm-40 -82.44 -50.48 0.79 Allowed Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.758 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 202' ' ' GLU . 13.3 Cg_endo -57.1 129.64 35.42 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 122.11 1.873 . . . . 0.0 112.133 177.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -120.71 140.49 51.56 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.029 -176.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 13.3 p-80 -140.88 153.91 45.92 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.484 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -99.59 -45.51 5.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.017 0.437 . . . . 0.0 110.155 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -142.68 110.77 5.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.519 177.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -78.04 129.11 34.85 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 174.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 68.31 93.19 0.06 OUTLIER Pre-proline 0 C--O 1.233 0.235 0 O-C-N 123.847 0.717 . . . . 0.0 110.43 -175.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.63 -43.92 35.48 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.797 2.331 . . . . 0.0 112.734 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -100.66 81.77 2.35 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.06 0.457 . . . . 0.0 110.528 -178.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 12.2 t -99.27 -34.66 10.24 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.837 173.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 75.1 m -159.29 101.96 1.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.676 174.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.419 ' HA ' ' HD3' ' A' ' 215' ' ' PRO . 9.2 t -177.4 140.93 0.45 Allowed Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.494 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 214' ' ' THR . 17.2 Cg_exo -68.03 143.52 60.34 Favored 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 122.435 2.09 . . . . 0.0 110.967 173.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.912 ' HB3' ' HD3' ' A' ' 217' ' ' PRO . 47.1 tp -141.42 -61.47 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.53 0 C-N-CA 121.024 -0.27 . . . . 0.0 111.413 -177.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.912 ' HD3' ' HB3' ' A' ' 216' ' ' LEU . 1.5 Cg_endo -83.92 -46.19 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 121.922 1.748 . . . . 0.0 112.607 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . 66.14 178.22 0.21 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.943 -173.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 43.8 t -115.87 -52.21 4.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.941 0.401 . . . . 0.0 111.098 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 2.6 p -91.85 116.27 28.76 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -171.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 84.35 -51.82 4.62 Favored Glycine 0 C--N 1.33 0.197 0 CA-C-N 116.07 -0.514 . . . . 0.0 114.053 168.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.644 ' HB3' ' HD3' ' A' ' 223' ' ' PRO . 20.9 t -53.58 -55.1 38.54 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -175.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.644 ' HD3' ' HB3' ' A' ' 222' ' ' SER . 4.4 Cg_endo -83.53 37.52 0.66 Allowed 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.117 1.878 . . . . 0.0 112.242 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -149.83 64.71 0.39 Allowed Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.871 -178.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -79.27 105.25 10.46 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.8 0.333 . . . . 0.0 110.176 178.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -70.66 146.63 49.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.613 -176.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 49.2 mm -103.27 121.88 55.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.998 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 5.9 t -81.81 133.55 51.83 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 120.686 0.279 . . . . 0.0 110.758 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -72.05 -176.68 2.23 Favored 'Trans proline' 0 C--O 1.237 0.459 0 C-N-CA 122.556 2.17 . . . . 0.0 111.994 174.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 9.6 mp 66.59 107.78 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.359 0 C-N-CA 123.192 0.597 . . . . 0.0 111.15 -176.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -55.18 -48.24 21.99 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.81 2.34 . . . . 0.0 111.411 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 7.0 t 179.17 152.46 0.38 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.01 175.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 7.6 p -144.15 -102.01 0.11 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.811 0.338 . . . . 0.0 110.761 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 175.25 -68.63 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 53.33 -155.01 0.22 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.478 175.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -139.3 81.15 0.27 Allowed Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.952 177.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -65.14 105.71 0.72 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.39 2.06 . . . . 0.0 110.156 175.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.1 t -66.81 135.6 28.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.24 -170.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -104.05 123.42 47.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.688 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -119.32 124.22 46.1 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 175.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.659 ' HB2' ' CE1' ' A' ' 294' ' ' PHE . 44.8 tttp -88.19 119.92 29.05 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -176.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -67.74 110.82 3.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.013 0.435 . . . . 0.0 110.254 -178.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 21.1 pt -85.16 1.42 4.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.122 0.486 . . . . 0.0 111.207 -174.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -158.13 152.12 24.01 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.866 178.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.92 ' HG3' HG23 ' A' ' 260' ' ' VAL . 54.6 mtmt -78.67 120.72 23.75 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.135 0.493 . . . . 0.0 110.625 177.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.633 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 22.6 ttt85 -113.01 109.67 19.23 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.843 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 29.5 m -102.69 143.05 25.82 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 177.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.557 ' HD3' ' HB2' ' A' ' 257' ' ' ALA . 55.2 Cg_endo -70.46 151.59 65.18 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 122.461 2.107 . . . . 0.0 112.764 -177.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' CYS . . . . . 0.43 ' H ' ' HB2' ' A' ' 252' ' ' ASP . 46.0 t -89.09 168.26 12.47 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 174.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -55.84 -41.03 73.69 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.657 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -95.44 8.23 43.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.91 0.386 . . . . 0.0 111.452 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.43 ' HB2' ' H ' ' A' ' 249' ' ' CYS . 8.5 m-20 -110.82 73.47 0.82 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.851 0.358 . . . . 0.0 111.017 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -72.95 -24.73 60.84 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-O 121.269 0.557 . . . . 0.0 110.146 175.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 1.1 p -86.48 11.0 13.53 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.709 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.415 ' HB2' ' HB3' ' A' ' 252' ' ' ASP . . . -99.92 116.6 32.36 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.847 0.356 . . . . 0.0 110.515 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.404 HD23 ' H ' ' A' ' 257' ' ' ALA . 0.8 OUTLIER -75.55 137.46 40.85 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.085 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.633 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -91.75 128.66 37.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.169 177.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 245' ' ' LYS . 69.4 mt -132.04 149.3 52.45 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.146 -173.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.799 ' HA ' ' HG2' ' A' ' 245' ' ' LYS . 64.5 mm-40 -101.54 167.77 9.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.604 178.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.92 HG23 ' HG3' ' A' ' 245' ' ' LYS . 60.0 t -74.89 115.94 16.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 176.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.543 ' HA2' ' HE3' ' A' ' 241' ' ' LYS . . . 99.71 -2.76 57.27 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.635 -177.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -71.75 151.93 43.15 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -174.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 43.0 mm -103.75 109.05 25.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.107 0.48 . . . . 0.0 110.907 -175.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.453 ' HA ' HG21 ' A' ' 279' ' ' VAL . 39.1 t -82.77 105.27 12.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.103 178.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -91.07 98.95 12.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.583 178.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 4.8 p -92.13 123.12 44.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.414 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 6.6 p -96.54 -33.01 11.98 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.654 -177.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 32.6 mtm180 -131.9 126.03 33.15 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.412 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 38.3 mtt -105.04 121.28 43.45 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.183 0.516 . . . . 0.0 111.127 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' A' ' 274' ' ' GLN . 79.4 m-20 -88.72 120.68 30.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.536 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 32.1 mm -76.35 80.84 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.333 0.587 . . . . 0.0 110.389 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -163.14 -37.55 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.622 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 131.4 28.73 0.62 Allowed Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.179 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.508 ' HA ' ' CZ ' ' A' ' 288' ' ' PHE . 12.8 pt20 -159.79 113.51 2.24 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 168.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 3.6 m0 -93.68 158.21 15.79 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 122.16 -0.337 . . . . 0.0 110.454 -175.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -101.06 108.45 20.15 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -132.44 136.45 8.75 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 177.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 283' ' ' LYS . 29.4 tt0 -114.69 114.62 25.89 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.987 0.423 . . . . 0.0 110.022 -178.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 279' ' ' VAL . . . . . 0.453 HG21 ' HA ' ' A' ' 264' ' ' VAL . 28.4 t -118.94 -78.69 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.195 0.522 . . . . 0.0 111.147 -175.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -86.58 60.7 6.38 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.22 -173.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 71.66 2.05 48.58 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.489 -0.778 . . . . 0.0 113.111 177.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 44.5 mtp180 -139.91 137.91 35.21 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.389 -0.226 . . . . 0.0 110.389 -175.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.459 ' NZ ' ' HB3' ' A' ' 283' ' ' LYS . 0.1 OUTLIER -91.92 125.15 36.51 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 168.391 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -142.52 162.0 27.34 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.241 -0.981 . . . . 0.0 112.07 -176.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 67.3 mt -95.23 131.76 40.93 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.125 0.488 . . . . 0.0 109.917 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -123.47 149.95 59.67 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.34 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 287' ' ' PRO . . . . . 0.558 ' HD3' ' CZ ' ' A' ' 246' ' ' ARG . 76.8 Cg_endo -83.59 16.12 1.97 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.729 2.286 . . . . 0.0 113.496 -171.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.508 ' CZ ' ' HA ' ' A' ' 274' ' ' GLN . 2.8 m-85 66.46 -40.98 0.37 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.041 0.936 . . . . 0.0 113.11 177.012 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 1.7 m -66.63 -16.57 64.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.974 0.416 . . . . 0.0 111.973 -177.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -89.94 -3.82 57.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.861 0.362 . . . . 0.0 110.787 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.421 HG11 HG21 ' A' ' 264' ' ' VAL . 33.6 m -127.12 165.68 25.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -130.7 115.95 17.38 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -84.55 138.65 18.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -177.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 294' ' ' PHE . . . . . 0.659 ' CE1' ' HB2' ' A' ' 241' ' ' LYS . 0.8 OUTLIER -159.57 174.2 14.98 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.729 -171.537 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -92.08 105.06 12.34 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 172.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -78.37 -15.64 14.02 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.085 1.856 . . . . 0.0 111.819 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -124.84 -28.01 3.55 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.902 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 19.2 m120 60.42 92.1 0.07 OUTLIER Pre-proline 0 N--CA 1.465 0.292 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.29 -173.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -76.48 21.3 0.56 Allowed 'Trans proline' 0 CA--C 1.528 0.198 0 C-N-CA 122.943 2.428 . . . . 0.0 113.202 -176.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -72.85 -56.17 5.59 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 176.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -93.45 34.5 1.16 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.55 176.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -53.16 -54.07 41.27 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.889 -174.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.306 -0.854 . . . . 0.0 109.66 -178.577 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 120.677 0.275 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.7 m -88.31 141.21 28.73 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 174.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.47 ' O ' HG23 ' A' ' 99' ' ' ILE . 3.1 t -73.52 -45.81 51.5 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 176.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.402 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . -79.51 106.65 11.69 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.631 175.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.435 HH11 ' HD2' ' A' ' 5' ' ' ARG . 1.6 tpp180 -140.45 91.55 2.45 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.409 0.623 . . . . 0.0 110.904 -177.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.629 ' CE1' ' HE2' ' A' ' 89' ' ' LYS . 29.1 p90 -161.74 154.59 20.44 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.08 -0.963 . . . . 0.0 108.91 178.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -79.87 111.82 16.56 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.1 m -65.13 -13.18 57.47 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.222 -173.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.1 m -103.9 -20.55 13.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.788 0.328 . . . . 0.0 111.729 -178.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -73.91 92.93 2.13 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.323 0.582 . . . . 0.0 111.041 -175.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.402 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 10.8 mtm-85 -64.27 -23.32 67.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.121 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.5 m -70.1 -9.14 54.54 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.778 0.323 . . . . 0.0 110.802 177.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -100.48 -47.95 4.72 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.673 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 43.7 p-90 -113.24 -20.9 11.23 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -171.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.402 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 57.2 t80 -75.32 107.39 7.4 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.089 -0.644 . . . . 0.0 109.763 -178.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.78 ' SD ' ' HA ' ' A' ' 104' ' ' ARG . 10.8 tpp -86.71 -10.83 52.81 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.796 -172.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 51.3 -112.79 1.91 Allowed Glycine 0 CA--C 1.522 0.51 0 CA-C-N 115.476 -0.784 . . . . 0.0 114.721 175.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.17 70.06 1.29 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.562 2.841 . . . . 0.0 114.037 -173.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.691 HG21 ' HG3' ' A' ' 16' ' ' MET . 60.0 t -130.76 172.26 16.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 176.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.527 ' H ' HG12 ' A' ' 19' ' ' VAL . 89.6 p -145.08 -176.68 5.19 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 -169.185 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 26.7 ttt85 -68.08 -41.57 81.71 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.902 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -65.79 -48.92 70.17 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.4 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.417 ' HB3' HG13 ' A' ' 19' ' ' VAL . 3.0 mp0 -65.65 -48.11 73.28 Favored 'General case' 0 C--O 1.221 -0.399 0 O-C-N 122.423 -0.173 . . . . 0.0 111.357 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.77 -46.94 83.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.7 0.286 . . . . 0.0 111.507 -177.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.549 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 51.5 tp60 -59.2 -42.57 91.24 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.814 178.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.7 m -62.3 -43.24 99.27 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.774 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.534 ' O ' ' HG3' ' A' ' 31' ' ' GLN . 46.2 mtt180 -74.01 -13.83 60.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.796 -174.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.58 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 37.8 mt -124.99 2.23 8.01 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.121 0.486 . . . . 0.0 111.275 -176.189 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.549 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 29.8 tp60 -71.14 96.11 1.32 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.649 -176.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.1 20.83 75.02 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.391 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.534 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 38.5 mm-40 -87.98 -176.14 5.35 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.562 0.22 . . . . 0.0 110.431 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.813 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 50.4 ttp180 -55.79 133.41 51.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.074 177.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 14.2 m-70 -83.66 140.73 31.99 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.904 0.383 . . . . 0.0 110.367 -174.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.58 -10.91 53.65 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.169 -173.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.813 ' SD ' ' HB3' ' A' ' 32' ' ' ARG . 24.8 mtp -79.81 140.07 36.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.475 -0.363 . . . . 0.0 110.436 177.087 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.474 ' HB2' HD11 ' A' ' 50' ' ' LEU . 45.1 p90 -146.58 163.66 35.1 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.124 -176.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.695 ' HB2' ' HB2' ' A' ' 16' ' ' MET . 4.2 pp -152.04 133.63 14.67 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.17 0.51 . . . . 0.0 110.966 175.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 56.1 t -101.84 106.9 20.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 174.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.6 ptt-85 -108.87 179.41 4.19 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.216 -175.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -79.66 138.54 37.41 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 172.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.461 ' HB3' ' O ' ' A' ' 44' ' ' CYS . 46.1 t -60.38 137.05 58.2 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.343 0.592 . . . . 0.0 111.92 -173.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.401 ' OG ' ' HA ' ' A' ' 20' ' ' SER . 10.9 m -87.82 -4.47 58.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.756 -178.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.0 p -112.53 -45.91 3.2 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.901 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.461 ' O ' ' HB3' ' A' ' 41' ' ' SER . 39.2 m -131.17 90.45 38.7 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.493 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 44' ' ' CYS . 10.0 Cg_endo -52.77 133.68 51.49 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.887 2.391 . . . . 0.0 111.804 179.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 111.46 -41.66 2.17 Favored Glycine 0 CA--C 1.505 -0.566 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -172.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -79.48 177.16 9.07 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 167.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.561 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 39.2 m-85 -134.66 174.5 10.49 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 118.477 0.581 . . . . 0.0 110.916 -176.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.5 t -144.67 108.09 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.922 0.392 . . . . 0.0 110.706 175.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.474 HD11 ' HB2' ' A' ' 36' ' ' PHE . 48.4 tp -77.54 103.21 7.34 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.881 173.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.5 m -96.42 127.4 42.38 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 175.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.406 HG22 ' HB2' ' A' ' 36' ' ' PHE . 89.2 t -118.85 138.58 49.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.937 0.399 . . . . 0.0 111.085 -175.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.58 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 32.3 t -87.67 113.66 23.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.578 -176.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.658 ' HG3' HG22 ' A' ' 95' ' ' THR . 0.0 OUTLIER -149.47 137.29 20.35 Favored 'General case' 0 C--O 1.205 -1.249 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.241 172.921 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.1 m120 56.53 27.13 11.85 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 173.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.477 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 49.0 m 57.74 53.06 7.45 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 122.516 1.15 . . . . 0.0 108.189 -175.306 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.726 HH22 ' HA ' ' A' ' 154' ' ' GLU . 6.0 ttp180 -167.98 64.81 0.07 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 113.133 -1.849 . . . . 0.0 109.246 -153.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 37.3 t -70.25 107.07 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 122.333 1.063 . . . . 0.0 110.142 -167.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 45.5 m -75.71 121.74 22.97 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 113.304 -1.771 . . . . 0.0 110.533 -176.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -99.01 115.32 28.68 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -173.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.553 ' HB3' HD11 ' A' ' 73' ' ' ILE . 44.0 m-85 -112.14 107.88 16.95 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.586 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 65.4 mt -80.77 127.9 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -173.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.561 ' HB ' ' HB2' ' A' ' 48' ' ' TYR . 3.8 mp -102.43 119.32 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 122.947 0.499 . . . . 0.0 111.209 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.555 ' HB2' ' HB3' ' A' ' 72' ' ' LYS . 4.9 m-20 -87.77 134.81 33.6 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.999 -178.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.0 t -83.7 86.1 7.18 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 172.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.565 HD12 ' HB2' ' A' ' 70' ' ' ARG . 83.0 mt -70.21 137.96 86.89 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.778 -176.07 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 66' ' ' LEU . 36.9 Cg_exo -61.85 -16.2 47.7 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.914 2.409 . . . . 0.0 111.394 176.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.8 m-20 -81.47 7.98 10.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.222 178.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.807 ' HA ' ' HE ' ' A' ' 69' ' ' ARG . 2.9 mmp_? 64.51 36.59 8.58 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.812 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.565 ' HB2' HD12 ' A' ' 66' ' ' LEU . 82.1 mtm-85 -126.38 179.17 5.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.271 177.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.537 ' HB3' HG23 ' A' ' 63' ' ' ILE . 57.0 m-85 -136.35 116.7 13.63 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.019 0.438 . . . . 0.0 111.156 -176.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.597 ' HA ' ' HA ' ' A' ' 77' ' ' GLU . 24.2 ttmm -99.73 116.06 30.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.217 -176.066 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.553 HD11 ' HB3' ' A' ' 61' ' ' TYR . 18.5 tt -93.52 92.37 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 121.995 0.902 . . . . 0.0 111.345 -176.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' A' ' 75' ' ' ASP . . . 77.76 -15.7 7.61 Favored Glycine 0 CA--C 1.517 0.203 0 CA-C-N 115.191 -0.913 . . . . 0.0 113.959 174.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 74' ' ' GLY . 22.3 t70 161.35 -55.24 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.607 0.717 . . . . 0.0 109.167 -171.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -71.27 118.78 14.49 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.63 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.597 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 14.3 pt-20 -105.89 134.44 49.01 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.751 0.786 . . . . 0.0 111.785 -175.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.461 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 88.9 m-85 -112.45 -177.47 3.16 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.848 176.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.405 ' HA ' ' HD2' ' A' ' 70' ' ' ARG . 7.5 p-10 -78.54 -28.67 46.09 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 121.136 -0.226 . . . . 0.0 111.208 -176.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -171.02 174.31 4.76 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 173.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.544 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 13.1 mt -53.9 -56.47 25.25 Favored Pre-proline 0 N--CA 1.471 0.582 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -176.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.544 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 38.9 Cg_exo -61.23 -10.14 14.7 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 122.175 1.917 . . . . 0.0 112.81 -177.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.5 -36.02 15.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.798 -178.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.0 pp -75.44 -34.58 60.97 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.574 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 92.0 mt -64.85 -25.93 68.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.377 177.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -87.27 -34.21 18.99 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.463 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -70.35 -36.87 74.47 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.299 0.571 . . . . 0.0 110.56 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.678 ' CG ' HD23 ' A' ' 93' ' ' LEU . 27.1 m-85 -77.32 -9.41 58.81 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.197 -177.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.629 ' HE2' ' CE1' ' A' ' 6' ' ' PHE . 99.0 mttt -68.1 -12.5 60.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.919 0.39 . . . . 0.0 111.221 177.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 24.2 pt -134.55 18.86 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 121.368 0.604 . . . . 0.0 109.492 -178.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.424 ' O ' ' HB2' ' A' ' 92' ' ' TYR . 4.0 t60 -116.55 -40.66 3.18 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.969 -175.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.424 ' HB2' ' O ' ' A' ' 91' ' ' HIS . 52.6 m-85 68.85 114.21 0.04 OUTLIER 'General case' 0 N--CA 1.461 0.104 0 O-C-N 124.291 0.995 . . . . 0.0 109.115 -169.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.678 HD23 ' CG ' ' A' ' 88' ' ' TYR . 0.8 OUTLIER -109.18 -7.39 15.3 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.055 -0.658 . . . . 0.0 111.099 176.347 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 1.058 ' HA ' ' HB3' ' A' ' 154' ' ' GLU . 0.5 OUTLIER -159.52 81.42 0.74 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.143 0.497 . . . . 0.0 111.166 170.372 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.69 ' OG1' ' HA ' ' A' ' 156' ' ' PRO . 2.3 t 47.67 3.79 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 125.208 1.403 . . . . 0.0 113.858 -176.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.469 ' H ' ' C ' ' A' ' 94' ' ' ASP . 14.6 t -153.76 168.16 27.22 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 32.5 p -101.85 178.46 4.61 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 177.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.1 mt -75.11 96.19 3.21 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 176.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.47 HG23 ' O ' ' A' ' 3' ' ' SER . 37.5 mm -82.15 -63.68 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.707 -173.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.631 ' O ' ' HA ' ' A' ' 35' ' ' MET . 33.3 tt0 -153.33 137.13 10.41 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.16 -178.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -57.33 162.57 9.62 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 123.087 2.524 . . . . 0.0 113.248 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.53 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -78.16 157.98 77.67 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.198 178.066 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.93 107.52 0.23 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.452 2.101 . . . . 0.0 112.089 177.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.78 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 65.0 ttt180 -60.34 -55.18 36.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.705 178.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -101.02 129.34 27.43 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.827 174.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.27 110.86 0.57 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.909 2.406 . . . . 0.0 112.548 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.1 p -96.57 149.2 35.53 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.113 177.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -56.4 128.36 29.79 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.598 2.199 . . . . 0.0 112.188 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.99 -9.98 27.39 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.926 2.417 . . . . 0.0 112.438 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 61.3 mtt -71.5 95.79 1.43 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.427 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 138.19 -66.64 0.53 Allowed Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.602 -178.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 51.0 m -81.51 53.45 2.1 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.294 0.569 . . . . 0.0 110.839 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 22.7 m -81.81 -23.23 9.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.904 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.561 ' HB3' ' HB3' ' A' ' 210' ' ' PRO . 41.2 m -98.03 12.24 34.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.967 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.59 ' HB3' ' HD3' ' A' ' 116' ' ' PRO . . . -79.99 -50.99 1.15 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.424 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.59 ' HD3' ' HB3' ' A' ' 115' ' ' ALA . 11.0 Cg_exo -71.21 86.79 0.77 Allowed 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 122.015 1.81 . . . . 0.0 112.317 178.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -89.97 119.4 30.3 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 174.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -148.03 149.57 33.08 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-O 120.708 0.29 . . . . 0.0 111.17 -176.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -89.79 9.08 3.47 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.408 2.739 . . . . 0.0 111.766 173.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.9 m 67.03 42.73 2.32 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.519 0.676 . . . . 0.0 111.071 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.477 ' HB2' ' HB2' ' A' ' 56' ' ' SER . . . 63.27 -171.51 0.17 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.579 174.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.464 ' HB3' ' H ' ' A' ' 123' ' ' ASP . 38.9 mt-10 -130.2 -160.33 1.03 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.664 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.464 ' H ' ' HB3' ' A' ' 122' ' ' GLU . 7.1 p-10 -86.11 -19.74 29.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.85 -175.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -174.28 -93.11 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 175.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.71 HD12 HG21 ' A' ' 152' ' ' ILE . 2.6 mm? 59.07 93.51 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.657 0.741 . . . . 0.0 111.351 -171.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.56 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 46.5 tt0 -169.37 -77.12 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.561 -176.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -104.74 107.67 18.75 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 121.611 0.719 . . . . 0.0 110.773 -177.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.75 HG22 ' CG ' ' A' ' 180' ' ' LYS . 65.7 t -123.48 130.67 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 CA-C-N 114.448 -1.251 . . . . 0.0 108.882 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.702 ' HG3' ' HB3' ' A' ' 179' ' ' GLU . 5.2 ptp180 -108.6 149.65 28.6 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 116.831 -1.947 . . . . 0.0 108.196 171.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.532 HG22 HG12 ' A' ' 178' ' ' VAL . 0.8 OUTLIER -106.12 129.56 54.18 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.102 -178.734 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 1.036 HD11 ' HG2' ' A' ' 179' ' ' GLU . 16.8 mt -104.08 -21.17 13.63 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -174.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.429 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 59.2 t80 -77.31 -35.18 55.14 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -172.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.585 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 23.0 t70 70.77 94.72 0.07 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.633 0.73 . . . . 0.0 109.784 -174.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.537 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 37.1 t80 -126.69 86.39 58.66 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.604 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 90.8 Cg_endo -88.89 79.36 1.01 Allowed 'Trans proline' 0 N--CA 1.441 -1.563 0 C-N-CA 121.896 1.731 . . . . 0.0 112.66 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.51 -22.5 75.02 Favored Glycine 0 CA--C 1.51 -0.248 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 175.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.819 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 3.8 m-20 57.43 73.12 0.48 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.09 -1.055 . . . . 0.0 110.997 -175.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.643 ' HB3' ' H ' ' A' ' 141' ' ' ASP . 0.6 OUTLIER -141.26 -173.65 3.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.394 0.616 . . . . 0.0 111.545 -178.588 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -114.99 1.9 14.1 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.674 167.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.562 ' O ' ' HB2' ' A' ' 172' ' ' MET . 40.3 mt-10 -116.35 -41.18 3.15 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.994 175.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.643 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 9.2 m-20 -101.86 114.25 28.17 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 167.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 1.085 HD11 ' HB2' ' A' ' 165' ' ' ASN . 35.2 tp -69.92 127.64 92.31 Favored Pre-proline 0 N--CA 1.465 0.324 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.819 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 6.5 Cg_endo -82.02 90.23 1.14 Allowed 'Trans proline' 0 N--CA 1.443 -1.497 0 C-N-CA 121.956 1.771 . . . . 0.0 110.752 173.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.537 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 9.1 p90 -102.39 155.04 18.51 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.317 -175.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.585 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 99.0 mttt -99.92 -166.65 1.36 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.235 0.54 . . . . 0.0 112.427 -174.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.828 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -83.71 5.29 25.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.288 -169.42 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -179.07 37.59 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.996 176.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.519 ' OE1' ' HA ' ' A' ' 144' ' ' PHE . 1.2 pt-20 -96.59 148.92 22.35 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.751 -174.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.58 128.58 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.723 HD22 HD21 ' A' ' 142' ' ' LEU . 16.6 mt -121.7 156.63 32.67 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 -178.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.564 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 49.2 t -119.51 123.43 71.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 174.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 1.073 HD13 ' HB2' ' A' ' 163' ' ' ALA . 50.4 mm -73.92 94.53 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 -176.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.612 HD12 ' HD3' ' A' ' 164' ' ' ARG . 18.7 tt -79.33 -26.34 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.547 -173.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 1.058 ' HB3' ' HA ' ' A' ' 94' ' ' ASP . 0.0 OUTLIER -141.0 145.56 36.11 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.454 169.123 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -121.86 84.93 44.63 Favored Pre-proline 0 C--N 1.318 -0.784 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 167.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.69 ' HA ' ' OG1' ' A' ' 95' ' ' THR . 13.0 Cg_exo -70.42 -47.73 0.69 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.603 2.202 . . . . 0.0 111.824 177.059 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -118.15 177.29 4.85 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.589 -174.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.428 ' O ' HG21 ' A' ' 175' ' ' VAL . 13.3 pt-20 -92.98 -34.76 13.62 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.556 -176.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.416 ' HG3' ' HG3' ' A' ' 158' ' ' GLU . 36.3 mt-30 -98.74 -10.42 23.15 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.865 0.364 . . . . 0.0 111.66 -176.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.548 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 59.1 m95 -124.36 134.83 53.03 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 172.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' TRP . . . . . 0.786 ' O ' HG13 ' A' ' 173' ' ' ILE . 50.7 m0 -123.99 133.81 53.6 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.144 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.758 ' HB2' ' HG3' ' A' ' 154' ' ' GLU . 50.5 m -93.82 98.47 11.1 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -173.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 1.073 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -112.33 146.09 38.88 Favored 'General case' 0 N--CA 1.419 -1.998 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.701 -172.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.735 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 15.1 ptt180 -87.0 120.62 28.46 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 175.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 1.085 ' HB2' HD11 ' A' ' 142' ' ' LEU . 20.7 t30 -52.52 176.85 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 113.455 -1.702 . . . . 0.0 111.753 -173.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 45.5 tptt -58.46 -21.02 49.96 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 169.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -77.38 -28.89 52.97 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.614 175.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 100.17 7.56 52.06 Favored Glycine 0 CA--C 1.519 0.333 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.119 -174.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.735 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.4 OUTLIER -79.9 135.72 36.49 Favored 'General case' 0 C--O 1.22 -0.498 0 C-N-CA 122.819 0.448 . . . . 0.0 111.217 -179.621 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.549 HG22 HG21 ' A' ' 153' ' ' ILE . 47.9 t -81.08 123.34 37.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 C-N-CA 121.119 -0.232 . . . . 0.0 111.252 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -158.06 146.29 13.13 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.865 171.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.57 ' HA ' ' HA ' ' A' ' 162' ' ' SER . 0.0 OUTLIER -68.97 141.06 55.03 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 122.922 0.489 . . . . 0.0 111.219 178.265 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.786 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.7 pp -142.91 143.17 24.23 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.246 -176.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.538 ' HB2' ' CD1' ' A' ' 177' ' ' TYR . 20.5 Cg_exo -68.24 132.26 25.48 Favored 'Trans proline' 0 CA--C 1.528 0.219 0 C-N-CA 122.96 2.44 . . . . 0.0 113.282 -178.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.566 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 67.0 t -60.79 -44.34 94.7 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 178.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 20.0 Cg_endo -61.52 -2.05 2.35 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 122.211 1.94 . . . . 0.0 113.217 178.024 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.538 ' CD1' ' HB2' ' A' ' 174' ' ' PRO . 2.8 m-85 -99.83 -12.17 20.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.555 -177.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.649 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 3.7 m -106.36 -172.83 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 -164.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 1.036 ' HG2' HD11 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -157.29 46.44 0.39 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 112.897 -1.956 . . . . 0.0 111.545 -151.755 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.75 ' CG ' HG22 ' A' ' 128' ' ' VAL . 0.8 OUTLIER -71.45 136.55 47.7 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 120.193 -1.567 . . . . 0.0 110.009 -163.369 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 38.8 tp -79.12 -80.88 0.11 Allowed 'General case' 0 CA--C 1.523 -0.067 0 CA-C-N 113.524 -1.671 . . . . 0.0 111.796 -165.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 4.1 m -70.32 81.58 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 175.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.622 ' HG2' ' HE2' ' A' ' 180' ' ' LYS . 5.5 tpt180 -153.91 135.65 14.46 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -166.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 30.1 p -132.79 62.47 1.65 Allowed 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 164.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.477 ' HB2' ' HD2' ' A' ' 186' ' ' PRO . 5.1 p -66.49 163.82 37.36 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 114.724 -1.126 . . . . 0.0 112.163 -170.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.477 ' HD2' ' HB2' ' A' ' 185' ' ' SER . 55.1 Cg_exo -37.97 110.16 0.08 OUTLIER 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 124.016 3.144 . . . . 0.0 114.086 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 31.5 m80 -128.73 42.77 3.26 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 175.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 93.24 -75.43 1.19 Allowed Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 -172.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.61 5.85 0.46 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 171.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 65.58 -67.45 0.13 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.378 -176.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 132.08 162.99 10.59 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -172.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -104.14 12.82 33.44 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 117.282 0.541 . . . . 0.0 110.49 -178.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -95.19 137.09 34.72 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.332 177.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 68.5 -66.2 0.24 Allowed 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.989 0.806 . . . . 0.0 111.41 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 13.1 m -116.2 116.07 27.15 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -97.43 148.41 23.22 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.018 0.437 . . . . 0.0 110.35 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 33.7 t -131.21 -61.98 0.9 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.224 -179.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 60.22 -90.38 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 O-C-N 123.867 0.729 . . . . 0.0 111.043 -178.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 76.21 -62.77 2.96 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.55 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.513 HG13 ' HD2' ' A' ' 201' ' ' PRO . 16.0 tt -150.51 136.06 10.34 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.513 ' HD2' HG13 ' A' ' 200' ' ' ILE . 9.5 Cg_endo -53.08 -43.2 59.03 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.777 2.318 . . . . 0.0 112.541 -178.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -142.1 121.37 7.91 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -56.3 105.42 0.17 Allowed 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 122.856 2.371 . . . . 0.0 112.275 177.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -98.61 152.21 19.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.678 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 34.0 m170 -116.29 148.28 40.68 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -133.57 157.18 46.36 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.995 0.426 . . . . 0.0 111.687 -175.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -102.76 -10.49 19.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.844 173.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . 57.92 -105.69 0.27 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.492 175.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 60.82 90.88 0.08 OUTLIER Pre-proline 0 C--O 1.233 0.23 0 O-C-N 123.767 0.667 . . . . 0.0 111.049 -174.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 0.561 ' HB3' ' HB3' ' A' ' 114' ' ' SER . 11.9 Cg_exo -70.23 143.56 48.96 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.688 2.259 . . . . 0.0 111.828 178.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -82.91 89.87 6.9 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.203 0.525 . . . . 0.0 110.242 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 6.5 p -74.83 -36.98 62.4 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.137 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 56.9 m -69.98 96.4 1.03 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.494 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 13.5 p -125.19 155.74 70.73 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.29 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -79.6 29.8 0.49 Allowed 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 123.164 2.576 . . . . 0.0 112.308 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.553 ' N ' ' HD2' ' A' ' 217' ' ' PRO . 66.8 tp -71.83 -51.3 8.96 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.825 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 216' ' ' LEU . 19.0 Cg_endo -58.34 108.83 0.43 Allowed 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 122.343 2.028 . . . . 0.0 113.183 -178.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -145.52 102.79 3.74 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.912 176.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.425 HG13 ' N ' ' A' ' 220' ' ' SER . 3.5 p -158.0 -55.98 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.268 -176.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' SER . . . . . 0.425 ' N ' HG13 ' A' ' 219' ' ' VAL . 19.3 m -113.67 145.62 41.04 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.729 0.299 . . . . 0.0 110.379 -178.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -99.22 -139.62 10.96 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.027 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 8.7 t 61.36 84.42 0.19 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.131 0.491 . . . . 0.0 110.129 -178.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -56.65 101.33 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.986 2.457 . . . . 0.0 112.484 -178.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 161.89 57.39 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 71.53 -10.26 0.84 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.545 0.738 . . . . 0.0 112.372 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -84.64 4.38 32.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.662 0.268 . . . . 0.0 111.494 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 59.8 mt -62.65 -37.59 79.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-O 121.48 0.657 . . . . 0.0 110.575 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.435 ' HA ' ' HD2' ' A' ' 229' ' ' PRO . 34.2 m -150.92 100.97 3.04 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.482 177.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 228' ' ' THR . 28.7 Cg_endo -63.69 113.34 2.1 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 122.738 2.292 . . . . 0.0 112.68 -178.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.469 ' HA ' ' HD3' ' A' ' 231' ' ' PRO . 2.5 mm? -81.28 127.31 74.25 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.102 177.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 230' ' ' LEU . 9.1 Cg_exo -71.99 73.05 2.58 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.934 2.423 . . . . 0.0 111.133 175.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 44.6 m 62.47 -83.03 0.02 OUTLIER 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.02 -176.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 7.0 m 64.2 -83.13 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 122.988 0.515 . . . . 0.0 111.08 -178.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -144.47 12.96 1.55 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 176.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -100.62 125.09 46.99 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.921 -177.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -173.07 88.78 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.403 -178.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -66.56 117.25 4.59 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.469 2.113 . . . . 0.0 110.54 173.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.507 ' HB ' HG13 ' A' ' 266' ' ' VAL . 6.2 t -74.49 127.74 36.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -176.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -98.69 118.2 34.87 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.193 0.52 . . . . 0.0 111.198 -175.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.545 ' HB2' HD12 ' A' ' 293' ' ' ILE . . . -121.78 134.95 54.92 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.067 175.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -94.45 133.62 37.85 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 177.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' ALA . . . . . 0.601 ' O ' ' HA ' ' A' ' 260' ' ' VAL . . . -82.29 105.2 13.17 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.178 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.565 HD13 ' H ' ' A' ' 243' ' ' ILE . 0.2 OUTLIER -88.84 -23.08 6.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.999 0.428 . . . . 0.0 110.727 -178.483 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 12.2 tm0? -130.25 122.61 28.37 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -60.34 138.42 57.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.799 0.809 . . . . 0.0 112.374 -171.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 20.4 tpt180 -116.83 113.99 23.29 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.946 -1.025 . . . . 0.0 108.998 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.416 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 19.9 m -111.65 147.68 37.28 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.774 -178.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.427 ' HA ' ' HB3' ' A' ' 255' ' ' ALA . 11.9 Cg_exo -69.24 105.63 1.43 Allowed 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.68 2.253 . . . . 0.0 111.399 178.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 249' ' ' CYS . . . . . 0.453 ' HB3' ' HB2' ' A' ' 252' ' ' ASP . 34.0 t -76.92 172.34 13.31 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.965 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -55.62 -42.58 75.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.823 0.344 . . . . 0.0 111.131 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -94.23 8.83 40.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.122 0.487 . . . . 0.0 111.172 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.453 ' HB2' ' HB3' ' A' ' 249' ' ' CYS . 1.6 m-20 -131.94 51.28 2.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.538 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -67.65 -17.49 64.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.128 0.489 . . . . 0.0 110.106 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 3.7 p -88.23 4.37 46.02 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.55 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.427 ' HB3' ' HA ' ' A' ' 248' ' ' PRO . . . -88.39 142.82 27.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.223 0.535 . . . . 0.0 111.299 -178.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.437 HD23 ' N ' ' A' ' 257' ' ' ALA . 1.2 tt -81.68 141.22 33.83 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.11 177.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -88.63 109.53 20.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.139 0.495 . . . . 0.0 110.297 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 72.2 mt -118.42 157.38 27.3 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.96 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -146.01 167.9 22.22 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 177.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.601 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 26.0 t -55.82 120.39 2.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 O-C-N 123.673 0.608 . . . . 0.0 112.55 -171.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 109.76 -21.13 26.07 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.713 -0.676 . . . . 0.0 113.574 172.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -78.79 154.44 29.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 117.033 0.416 . . . . 0.0 110.797 -170.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 43.9 mm -98.12 120.55 47.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.877 -177.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.444 HG21 HG11 ' A' ' 291' ' ' VAL . 21.7 t -95.81 116.67 38.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.532 179.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 43.1 tttm -89.86 99.02 12.11 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.461 177.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.507 HG13 ' HB ' ' A' ' 238' ' ' VAL . 3.6 p -99.52 117.53 44.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.36 0.6 . . . . 0.0 110.174 174.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.42 -13.66 15.04 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.816 -177.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 268' ' ' ARG . . . . . 0.553 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 5.6 ttp180 -130.46 107.3 9.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.174 0.512 . . . . 0.0 110.86 175.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 44.7 mtt -97.92 123.8 42.07 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.684 173.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.433 ' O ' ' HB ' ' A' ' 271' ' ' ILE . 90.8 m-20 -80.74 -93.55 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.976 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.433 ' HB ' ' O ' ' A' ' 270' ' ' ASN . 10.5 tp 177.1 -29.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.153 0.502 . . . . 0.0 109.778 176.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -68.29 -37.5 80.73 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.734 177.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 141.42 -34.36 1.91 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.422 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -76.38 107.72 8.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.875 0.369 . . . . 0.0 110.198 178.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.404 ' HB3' ' CG2' ' A' ' 266' ' ' VAL . 40.6 m0 -98.24 158.1 15.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.176 -178.091 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.553 ' HB2' ' HB3' ' A' ' 268' ' ' ARG . 53.6 mt-10 -95.84 104.27 16.2 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.216 173.155 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 277' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -121.63 141.05 14.26 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 174.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -116.3 112.05 21.0 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.999 0.428 . . . . 0.0 110.43 -177.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 66.3 t -129.4 127.9 65.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.2 -177.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 63.66 21.8 12.86 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.451 177.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 102.44 -14.89 56.52 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.731 177.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 53.4 mtp180 -104.43 132.02 51.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.694 0.247 . . . . 0.0 111.128 -179.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 4.8 ptpp? -111.57 114.83 28.16 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 171.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -133.4 166.38 23.83 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.757 -177.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 74.8 mt -86.98 112.56 21.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.265 0.555 . . . . 0.0 110.443 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -115.56 149.34 42.8 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.859 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -86.11 143.61 7.97 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.471 2.114 . . . . 0.0 111.618 177.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -68.93 4.01 1.72 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -175.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 23.9 p -89.54 -33.67 16.65 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.855 0.359 . . . . 0.0 111.511 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -77.5 -12.32 59.95 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.984 0.421 . . . . 0.0 110.96 -177.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.54 ' HB ' ' HB1' ' A' ' 240' ' ' ALA . 27.8 m -128.38 160.57 38.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.279 179.186 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -133.55 134.92 43.96 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.9 0.381 . . . . 0.0 110.753 174.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.545 HD12 ' HB2' ' A' ' 240' ' ' ALA . 1.2 mp -68.34 138.89 21.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.482 177.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -156.73 158.8 37.57 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 177.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -84.85 114.5 55.97 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 174.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.9 46.97 1.83 Allowed 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.987 2.458 . . . . 0.0 111.123 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 65.91 14.04 9.36 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.794 -176.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 61.65 96.31 0.05 OUTLIER Pre-proline 0 N--CA 1.467 0.413 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.863 175.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.25 -9.02 15.24 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.631 2.221 . . . . 0.0 111.691 173.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -57.44 -61.95 2.12 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.717 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -89.57 46.79 1.4 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.669 -176.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -102.84 -59.01 1.77 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.204 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 . . . . . 0 C--O 1.247 0.946 0 CA-C-O 118.36 -0.828 . . . . 0.0 111.184 178.493 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.1 mtp . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.1 m -143.04 147.34 34.91 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.327 -178.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.528 ' O ' HG23 ' A' ' 99' ' ' ILE . 3.0 p -75.92 -50.89 13.72 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 175.052 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -87.86 66.46 8.75 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.772 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -97.91 84.46 3.33 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.816 -173.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -154.37 164.67 38.25 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.506 176.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -89.68 107.29 19.01 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 175.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.577 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 37.8 t -79.09 69.9 5.35 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.306 -178.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.4 t -176.29 -40.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.167 176.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -58.14 108.23 0.58 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.108 0.48 . . . . 0.0 111.469 -174.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 17.8 mmt180 -61.92 -32.22 72.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.853 -174.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 72.4 m -74.47 -5.7 44.11 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.974 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.53 -48.41 6.64 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.429 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.449 ' HB3' ' HB3' ' A' ' 101' ' ' PRO . 22.9 p-90 -114.54 -29.94 6.68 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -170.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -72.27 122.2 20.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.908 0.385 . . . . 0.0 110.618 -175.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.545 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 26.1 mmt -103.06 -5.5 23.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.401 -176.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.475 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 50.97 -114.43 2.79 Favored Glycine 0 CA--C 1.522 0.492 0 CA-C-N 115.614 -0.721 . . . . 0.0 113.498 -177.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.475 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 5.3 Cg_exo -77.33 89.18 1.34 Allowed 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 123.091 2.527 . . . . 0.0 113.274 -175.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.603 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 97.1 t -139.15 155.51 26.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 177.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.5 m -119.46 174.06 6.61 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -174.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 70.0 mtp85 -55.77 -47.32 77.25 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -62.7 -56.2 19.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.853 0.358 . . . . 0.0 111.113 -178.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.538 ' HB3' HG13 ' A' ' 19' ' ' VAL . 0.5 OUTLIER -57.08 -47.12 81.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.789 -179.156 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.52 -47.4 82.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.204 0.526 . . . . 0.0 111.079 176.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -63.91 -43.19 96.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.495 -178.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.9 t -70.66 -9.16 56.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.651 0.262 . . . . 0.0 111.437 -177.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.487 ' HG3' ' O ' ' A' ' 23' ' ' GLU . 77.5 mtt180 -87.65 -25.84 23.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.987 0.422 . . . . 0.0 110.661 174.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.586 HD22 ' HB2' ' A' ' 53' ' ' SER . 27.3 mt -108.71 -12.49 14.94 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.76 -175.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.0 tp60 -79.7 105.51 11.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.161 0.505 . . . . 0.0 111.297 -177.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.97 -17.84 47.75 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.86 175.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -86.16 175.54 8.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.678 0.275 . . . . 0.0 110.785 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 18.3 ttp180 -62.0 132.09 51.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.732 -177.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.414 ' CD2' ' HA ' ' A' ' 54' ' ' GLU . 33.3 m80 -76.35 158.18 31.71 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.376 -176.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.69 -11.86 46.24 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -174.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.626 ' HB3' ' HB2' ' A' ' 102' ' ' ALA . 66.1 mtt -73.96 150.7 40.62 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 175.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.422 ' CB ' HG22 ' A' ' 52' ' ' VAL . 37.9 p90 -147.8 156.26 42.54 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 175.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.545 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.5 pp -150.45 134.72 17.08 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.058 0.456 . . . . 0.0 110.592 178.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.4 t -105.84 107.57 22.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.508 176.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.603 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 24.6 ptt-85 -106.34 -178.85 3.77 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.46 138.82 33.28 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 172.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.593 ' HB3' ' O ' ' A' ' 44' ' ' CYS . 20.8 t -68.05 104.26 1.72 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.39 0.614 . . . . 0.0 110.736 -174.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.4 p -69.02 -11.01 60.4 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.839 177.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.0 p -104.97 -22.15 13.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.719 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.593 ' O ' ' HB3' ' A' ' 41' ' ' SER . 57.9 m -136.51 112.68 10.03 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.763 0.316 . . . . 0.0 110.561 -177.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -62.01 114.95 2.53 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.958 2.439 . . . . 0.0 113.098 -175.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.94 -26.53 23.71 Favored Glycine 0 CA--C 1.51 -0.236 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.735 174.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.602 ' OD1' ' HA ' ' A' ' 64' ' ' ASN . 32.0 m-20 -79.95 179.66 7.47 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.544 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 38.3 m-85 -127.48 174.36 9.08 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 176.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.403 HG23 ' HA ' ' A' ' 41' ' ' SER . 27.9 t -141.37 111.01 2.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.662 0.267 . . . . 0.0 111.049 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.459 ' HB2' HD11 ' A' ' 63' ' ' ILE . 61.3 tp -78.33 98.76 6.06 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 171.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.8 m -95.62 119.66 34.51 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.266 0.555 . . . . 0.0 109.543 175.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.609 HG21 HD11 ' A' ' 93' ' ' LEU . 48.7 t -112.12 143.32 22.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.903 -173.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.589 ' HA ' ' O ' ' A' ' 57' ' ' ARG . 36.6 t -87.34 111.87 21.52 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.612 -0.144 . . . . 0.0 110.612 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.414 ' HA ' ' CD2' ' A' ' 33' ' ' HIS . 6.8 tp10 -175.92 157.3 1.89 Allowed 'General case' 0 N--CA 1.469 0.523 0 O-C-N 123.486 0.491 . . . . 0.0 111.022 176.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.676 ' HB2' ' NH2' ' A' ' 57' ' ' ARG . 27.0 m-80 61.81 58.26 2.0 Allowed 'General case' 0 CA--C 1.479 -1.752 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -171.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.9 t 70.54 -37.54 0.39 Allowed 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 113.777 -1.556 . . . . 0.0 110.21 -169.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.901 ' NE ' ' H ' ' A' ' 58' ' ' VAL 0.399 0.0 OUTLIER -157.76 -48.06 0.06 Allowed 'General case' 0 C--N 1.364 1.237 1 N-CA-C 125.571 5.397 . . . . 0.0 125.571 -170.116 . . . . . . . . 5 4 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.901 ' H ' ' NE ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -149.43 112.09 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 122.088 2.222 . . . . 0.0 114.573 -168.292 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.548 ' HB2' ' HB ' ' A' ' 52' ' ' VAL . 1.4 m -98.34 114.13 26.34 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 166.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.571 ' O ' HD11 ' A' ' 153' ' ' ILE . 92.0 m-70 -100.68 110.81 22.96 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -170.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.615 ' CZ ' ' HB2' ' A' ' 93' ' ' LEU . 98.7 m-85 -119.03 117.25 28.28 Favored 'General case' 0 C--O 1.218 -0.579 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -178.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.516 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 44.8 mm -78.09 127.64 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -177.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.574 HG13 ' HB ' ' A' ' 73' ' ' ILE . 3.8 mp -104.34 114.54 44.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 175.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.602 ' HA ' ' OD1' ' A' ' 47' ' ' ASP . 7.9 m120 -85.89 137.06 33.02 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.577 -173.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.8 t -87.72 95.73 10.18 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 174.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.554 HD11 ' HB2' ' A' ' 72' ' ' LYS . 99.0 mt -82.15 136.19 47.02 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.444 -178.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 66' ' ' LEU . 27.0 Cg_exo -64.82 -2.0 4.87 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.942 2.428 . . . . 0.0 111.311 172.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -79.58 5.22 13.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.614 175.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.536 ' HE ' ' HA ' ' A' ' 69' ' ' ARG . 0.1 OUTLIER 67.91 29.9 6.38 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.227 -176.835 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.423 ' HB3' ' O ' ' A' ' 78' ' ' PHE . 30.7 mtm-85 -140.52 175.23 9.78 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.933 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.467 ' HB3' HG23 ' A' ' 63' ' ' ILE . 68.1 m-85 -125.99 132.22 52.07 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.505 0.193 . . . . 0.0 111.06 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.669 ' HE2' ' HB3' ' A' ' 77' ' ' GLU . 37.1 ttmt -114.32 112.19 22.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.978 -177.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.574 ' HB ' HG13 ' A' ' 63' ' ' ILE . 14.0 tt -105.04 110.72 31.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.344 0.592 . . . . 0.0 111.127 -177.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.58 50.12 45.47 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.63 177.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.9 t0 75.58 -29.24 0.19 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.607 0.763 . . . . 0.0 110.985 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -81.18 121.43 26.13 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.185 0.517 . . . . 0.0 110.716 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.669 ' HB3' ' HE2' ' A' ' 72' ' ' LYS . 7.8 pt-20 -99.6 141.86 31.84 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.437 -176.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.423 ' O ' ' HB3' ' A' ' 70' ' ' ARG . 95.5 m-85 -131.95 -175.56 3.77 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.201 -177.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.401 ' HA ' ' HD2' ' A' ' 70' ' ' ARG . 4.3 m-20 -64.01 -50.88 66.76 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.186 0.517 . . . . 0.0 110.335 175.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.505 ' ND1' ' HD2' ' A' ' 82' ' ' PRO . 4.2 p80 -173.0 -173.8 0.99 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.246 -176.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.667 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 19.6 mt -54.3 -58.16 15.1 Favored Pre-proline 0 N--CA 1.467 0.421 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.667 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 52.4 Cg_exo -59.52 -7.7 5.93 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 122.562 2.175 . . . . 0.0 113.765 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -95.46 -36.68 11.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.915 0.388 . . . . 0.0 110.925 -178.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.9 pp -76.59 -30.52 57.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.311 -178.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.452 ' HB2' ' OG ' ' A' ' 8' ' ' SER . 60.0 mt -66.12 -21.91 66.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.322 0.582 . . . . 0.0 110.002 177.12 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -81.66 -39.84 23.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.086 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.637 ' HE1' ' CE1' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -71.64 -21.38 61.83 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.073 0.463 . . . . 0.0 111.079 -179.873 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.697 ' CD1' HD23 ' A' ' 93' ' ' LEU . 32.7 m-85 -89.34 1.91 55.12 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 121.665 -0.647 . . . . 0.0 111.641 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -76.38 -21.47 56.02 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.953 175.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.555 HD13 ' O ' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -125.4 -1.78 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-O 121.558 0.694 . . . . 0.0 110.301 -175.477 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -101.86 -30.71 11.11 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.345 -174.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 67.81 153.56 0.09 Allowed 'General case' 0 C--N 1.332 -0.168 0 O-C-N 124.501 1.125 . . . . 0.0 109.346 -168.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.697 HD23 ' CD1' ' A' ' 88' ' ' TYR . 0.7 OUTLIER -138.24 39.97 2.28 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 164.648 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 1.078 ' HA ' ' HB3' ' A' ' 154' ' ' GLU . 13.8 t0 168.08 -158.47 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 112.058 -2.337 . . . . 0.0 106.01 172.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.748 ' CB ' ' HA ' ' A' ' 156' ' ' PRO . 14.2 t -76.76 11.36 1.73 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.21 0.529 . . . . 0.0 110.564 176.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.2 t -146.43 161.58 40.1 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.752 176.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.8 p -97.7 -176.18 3.4 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 176.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 81.5 mt -77.33 92.91 3.96 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 176.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.528 HG23 ' O ' ' A' ' 3' ' ' SER . 48.1 mm -74.9 -59.08 3.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.985 -176.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.546 ' O ' ' HA ' ' A' ' 35' ' ' MET . 8.8 pt-20 -159.98 154.42 20.36 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.257 178.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.449 ' HB3' ' HB3' ' A' ' 14' ' ' TRP . 38.1 Cg_endo -67.18 142.64 61.75 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.323 2.015 . . . . 0.0 112.003 177.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.626 ' HB2' ' HB3' ' A' ' 35' ' ' MET . . . -69.01 148.0 97.8 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.945 177.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -63.26 129.13 24.57 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.704 1.603 . . . . 0.0 111.102 174.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -71.75 7.3 1.56 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.056 0.455 . . . . 0.0 111.194 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -121.97 103.37 39.84 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 175.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.423 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 27.2 Cg_exo -62.87 146.86 95.09 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.876 2.384 . . . . 0.0 112.303 -178.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 39.2 t -96.06 110.48 52.21 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.688 -178.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.595 ' HB2' ' HD3' ' A' ' 109' ' ' PRO . 47.5 Cg_exo -55.91 -51.54 9.4 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.709 2.273 . . . . 0.0 113.167 175.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.595 ' HD3' ' HB2' ' A' ' 108' ' ' PRO . 76.6 Cg_endo -91.52 176.23 2.11 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 121.965 1.777 . . . . 0.0 111.895 174.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 64.4 mtm -93.18 108.44 20.05 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.294 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -93.23 -106.05 1.75 Allowed Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.027 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 54.7 m -82.6 90.8 6.85 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.133 0.492 . . . . 0.0 111.037 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 48.8 t -82.03 116.3 26.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.847 177.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.2 t -135.74 141.76 44.89 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.778 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -137.5 158.56 71.8 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.338 -176.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.48 ' HG2' ' ND2' ' A' ' 194' ' ' ASN . 14.9 Cg_exo -69.38 163.27 38.62 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.539 2.159 . . . . 0.0 111.883 178.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -74.72 90.83 2.34 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.253 0.549 . . . . 0.0 110.884 -179.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.601 HD21 ' HB2' ' A' ' 121' ' ' ALA . 60.0 tp -159.69 114.1 1.5 Allowed Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.43 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.551 ' HD2' HD12 ' A' ' 118' ' ' LEU . 16.4 Cg_endo -58.34 -54.34 3.15 Favored 'Trans proline' 0 CA--C 1.529 0.246 0 C-N-CA 122.661 2.241 . . . . 0.0 113.066 -177.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 34.8 m -155.85 139.99 16.5 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.664 0.268 . . . . 0.0 111.025 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.601 ' HB2' HD21 ' A' ' 118' ' ' LEU . . . -140.88 129.06 22.19 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 174.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.729 ' HB2' ' HD3' ' A' ' 186' ' ' PRO . 10.8 pt-20 -97.94 -29.47 13.28 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -166.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.739 ' HB3' ' HE ' ' A' ' 183' ' ' ARG . 0.1 OUTLIER -72.18 -178.04 2.31 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -173.254 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.529 ' O ' ' HB2' ' A' ' 125' ' ' LEU . 56.5 t30 -110.74 -58.65 2.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.943 -176.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.929 HD12 HG21 ' A' ' 152' ' ' ILE . 4.6 mm? 72.89 105.96 0.07 Allowed 'General case' 0 N--CA 1.468 0.465 0 O-C-N 123.925 0.766 . . . . 0.0 110.516 -176.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.502 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 40.1 tt0 -172.88 -68.72 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.825 -1.08 . . . . 0.0 108.942 -172.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -115.63 108.02 15.86 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 121.061 0.457 . . . . 0.0 110.163 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.724 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 69.4 t -118.1 132.47 67.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.961 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.691 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 5.6 ptp180 -110.38 144.37 39.25 Favored 'General case' 0 N--CA 1.436 -1.167 0 C-N-CA 117.162 -1.815 . . . . 0.0 107.92 169.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.605 HG22 HG12 ' A' ' 178' ' ' VAL . 6.0 p -98.19 138.5 35.38 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.064 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.566 HD21 ' HG2' ' A' ' 179' ' ' GLU . 15.6 mt -110.96 -8.14 14.5 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.448 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 22.0 t80 -91.03 -42.46 10.51 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.432 -0.507 . . . . 0.0 112.01 -173.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.583 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 10.0 t70 77.3 98.39 0.07 Allowed 'General case' 0 N--CA 1.475 0.808 0 O-C-N 123.581 0.55 . . . . 0.0 110.459 -176.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.532 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 76.0 t80 -134.12 93.86 19.11 Favored Pre-proline 0 N--CA 1.45 -0.47 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 176.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.69 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 91.9 Cg_endo -84.02 89.53 0.97 Allowed 'Trans proline' 0 N--CA 1.443 -1.476 0 C-N-CA 121.767 1.645 . . . . 0.0 112.64 -178.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -79.74 -36.48 25.66 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.65 176.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.54 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 16.7 m120 67.62 34.21 4.64 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 122.958 0.503 . . . . 0.0 111.648 175.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.543 ' HB3' ' H ' ' A' ' 140' ' ' GLU . 0.1 OUTLIER -117.3 178.22 4.45 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.135 -178.071 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -92.71 -7.31 47.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.926 0.87 . . . . 0.0 108.749 171.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.676 ' O ' ' HB2' ' A' ' 172' ' ' MET . 32.4 mt-10 -118.06 -5.02 10.98 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.712 177.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.483 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 7.9 m-20 -139.53 102.44 4.46 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 174.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 1.098 HD11 ' HB2' ' A' ' 165' ' ' ASN . 31.0 tp -71.74 135.21 83.45 Favored Pre-proline 0 CA--C 1.512 -0.517 0 C-N-CA 120.535 -0.466 . . . . 0.0 109.966 -177.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.69 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 94.4 Cg_endo -88.54 96.85 0.38 Allowed 'Trans proline' 0 N--CA 1.438 -1.767 0 C-N-CA 121.54 1.493 . . . . 0.0 112.193 173.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.532 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 1.8 p90 -94.54 -177.7 4.32 Favored 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.85 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.583 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 29.1 mtmm -125.96 -172.25 2.57 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.676 174.166 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.984 ' H ' ' HD2' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -78.13 22.74 0.29 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.749 -173.1 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 165.5 35.13 0.02 OUTLIER Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.446 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.491 ' OE1' ' HA ' ' A' ' 144' ' ' PHE . 0.8 OUTLIER -96.79 150.51 20.63 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 119.286 -0.966 . . . . 0.0 110.688 -178.876 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.2 mp -93.5 123.76 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -173.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.781 HD22 HD21 ' A' ' 142' ' ' LEU . 13.2 mt -119.91 156.89 29.88 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -175.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.592 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 99.5 t -117.74 121.42 67.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 176.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 1.007 HD13 ' HB2' ' A' ' 163' ' ' ALA . 47.2 mm -77.21 105.21 5.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.548 0.69 . . . . 0.0 109.181 -175.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.571 HD11 ' O ' ' A' ' 60' ' ' HIS . 19.5 tt -96.33 -29.01 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.954 -174.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 1.078 ' HB3' ' HA ' ' A' ' 94' ' ' ASP . 2.6 mt-10 -123.25 143.15 50.24 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 168.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.625 ' CD ' ' HG ' ' A' ' 125' ' ' LEU . 70.2 tttt -134.86 78.44 54.58 Favored Pre-proline 0 C--N 1.314 -0.952 0 CA-C-O 121.323 0.583 . . . . 0.0 109.512 166.185 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.748 ' HA ' ' CB ' ' A' ' 95' ' ' THR . 26.1 Cg_exo -64.47 -52.41 1.47 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.178 1.919 . . . . 0.0 111.908 172.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.427 ' HG2' ' HB2' ' A' ' 156' ' ' PRO . 17.7 mm-40 -114.73 168.08 10.2 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.194 -169.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -96.19 1.56 52.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.395 0.617 . . . . 0.0 109.466 173.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.401 ' OE1' ' HA ' ' A' ' 159' ' ' GLN . 10.4 mm-40 -104.73 -34.34 8.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.72 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.485 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 35.1 m95 -129.55 142.28 50.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.985 176.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' TRP . . . . . 0.751 ' O ' HG13 ' A' ' 173' ' ' ILE . 52.4 m0 -125.68 137.96 53.87 Favored 'General case' 0 C--O 1.216 -0.695 0 C-N-CA 123.155 0.582 . . . . 0.0 110.143 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.539 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 18.2 m -98.12 107.11 19.51 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -175.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 1.007 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -117.3 152.22 35.32 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 119.899 -0.72 . . . . 0.0 110.742 -176.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.824 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 11.8 ptt180 -87.37 121.91 30.42 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 171.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 1.098 ' HB2' HD11 ' A' ' 142' ' ' LEU . 14.9 t30 -55.92 -179.83 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 113.748 -1.569 . . . . 0.0 111.668 -174.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -66.51 -22.15 66.17 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 167.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -68.85 -20.36 64.28 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.709 168.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 165' ' ' ASN . . . 82.73 19.51 63.46 Favored Glycine 0 CA--C 1.527 0.844 0 CA-C-N 115.148 -0.933 . . . . 0.0 113.246 -175.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.824 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 1.5 ttm-85 -94.12 142.53 27.3 Favored 'General case' 0 C--O 1.214 -0.788 0 C-N-CA 122.482 0.313 . . . . 0.0 111.03 -178.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 59.4 t -83.96 123.41 38.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 O-C-N 122.191 -0.318 . . . . 0.0 111.29 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -158.53 151.97 23.05 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.723 171.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.676 ' HB2' ' O ' ' A' ' 140' ' ' GLU . 0.2 OUTLIER -73.17 142.91 47.4 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.735 0.302 . . . . 0.0 111.187 178.202 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.751 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.7 pp -143.88 147.96 40.52 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.115 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.505 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 11.2 Cg_exo -72.67 132.37 18.67 Favored 'Trans proline' 0 CA--C 1.528 0.214 0 C-N-CA 122.654 2.236 . . . . 0.0 112.826 -175.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.498 ' O ' HG22 ' A' ' 178' ' ' VAL . 70.1 t -60.41 -44.32 95.5 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.462 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 39.2 Cg_exo -62.59 -5.7 7.56 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 122.213 1.942 . . . . 0.0 112.95 176.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.505 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.2 m-85 -94.67 -12.17 27.82 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.216 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.644 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 2.8 m -107.41 -175.18 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 -166.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.696 ' O ' ' HG3' ' A' ' 179' ' ' GLU . 3.6 tp10 -160.9 46.32 0.2 Allowed 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 112.725 -2.034 . . . . 0.0 111.541 -152.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.777 ' H ' ' HD2' ' A' ' 180' ' ' LYS . 0.0 OUTLIER -73.17 137.86 45.34 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 119.125 -2.235 . . . . 0.0 111.874 -161.328 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 183' ' ' ARG . 15.3 tp -71.64 151.21 43.92 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 112.217 -2.265 . . . . 0.0 110.15 -173.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.684 HG13 ' H ' ' A' ' 183' ' ' ARG . 7.7 p 42.51 -72.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 125.385 1.474 . . . . 0.0 113.862 -174.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.739 ' HE ' ' HB3' ' A' ' 123' ' ' ASP . 66.8 ttt180 71.53 112.13 0.06 Allowed 'General case' 0 C--O 1.231 0.092 0 C-N-CA 123.798 0.839 . . . . 0.0 111.119 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.488 ' HB3' ' CG ' ' A' ' 190' ' ' HIS . 12.8 m -75.54 66.26 1.89 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.456 178.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.55 ' HB3' ' HD2' ' A' ' 186' ' ' PRO . 5.0 m -72.25 177.34 1.81 Allowed Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.107 179.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.729 ' HD3' ' HB2' ' A' ' 122' ' ' GLU . 71.1 Cg_exo -49.4 98.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.804 2.336 . . . . 0.0 113.198 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -130.79 22.73 5.0 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.735 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.97 -78.56 1.26 Allowed Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.818 -177.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 9.7 tmtm? -71.92 -23.92 61.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.402 0.62 . . . . 0.0 109.623 177.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' HIS . . . . . 0.488 ' CG ' ' HB3' ' A' ' 184' ' ' SER . 91.2 m-70 -107.17 144.5 33.82 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.774 175.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 138.34 19.8 0.52 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.052 -175.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -135.7 88.18 2.38 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.436 ' HG3' ' OD1' ' A' ' 123' ' ' ASP . 5.0 tmm_? -70.05 -35.29 74.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.399 -174.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ASN . . . . . 0.48 ' ND2' ' HG2' ' A' ' 116' ' ' PRO . 46.5 t30 -147.41 -51.43 0.19 Allowed 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.83 -177.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 15.6 m -89.91 160.77 16.27 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 175.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -123.29 131.08 53.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.474 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 7.5 t 65.78 -167.79 0.21 Allowed 'General case' 0 CA--C 1.533 0.315 0 O-C-N 123.852 0.72 . . . . 0.0 110.838 176.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -88.67 133.97 34.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.721 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -156.14 117.17 0.76 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.468 177.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.499 HG22 ' HG3' ' A' ' 202' ' ' GLU . 70.9 mt 72.21 107.43 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.332 0 CA-C-O 121.359 0.6 . . . . 0.0 112.366 173.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -85.86 119.34 1.86 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.231 2.621 . . . . 0.0 111.816 174.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.499 ' HG3' HG22 ' A' ' 200' ' ' ILE . 47.0 mt-10 -135.41 154.14 78.32 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.645 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -80.69 15.62 1.76 Allowed 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 123.244 2.629 . . . . 0.0 112.408 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.16 123.15 23.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.992 0.425 . . . . 0.0 110.817 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -119.58 126.88 52.26 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.491 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 207' ' ' TYR . . . -69.79 155.79 40.0 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.361 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' TYR . . . . . 0.447 ' HB2' ' O ' ' A' ' 206' ' ' ALA . 45.0 m-85 73.42 -11.91 0.87 Allowed 'General case' 0 N--CA 1.471 0.597 0 O-C-N 123.847 0.717 . . . . 0.0 111.861 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -91.12 103.52 16.2 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.887 0.375 . . . . 0.0 110.294 178.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -109.38 147.25 35.65 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.61 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -85.97 11.17 3.41 Favored 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 123.032 2.488 . . . . 0.0 112.551 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -129.64 147.42 51.43 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.663 -178.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 14.0 t -99.58 159.63 14.89 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.659 0.266 . . . . 0.0 110.62 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 18.0 m -74.83 124.58 27.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.797 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 17.4 m -88.03 113.36 54.51 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.403 177.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -71.51 119.4 6.22 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.575 2.184 . . . . 0.0 111.393 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.799 ' HB2' ' HD3' ' A' ' 217' ' ' PRO . 6.5 mp -65.61 -56.81 16.57 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.823 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.799 ' HD3' ' HB2' ' A' ' 216' ' ' LEU . 6.3 Cg_exo -78.69 135.35 12.81 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 121.981 1.787 . . . . 0.0 111.352 175.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -67.09 127.38 32.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.337 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 43.2 t -74.02 86.98 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.227 0.537 . . . . 0.0 111.536 -175.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 16.7 t -95.39 -24.93 16.48 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 170.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -170.73 -171.25 35.87 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.229 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 14.4 p -100.97 130.9 24.12 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 117.519 0.66 . . . . 0.0 110.312 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -64.01 146.59 91.32 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.912 2.408 . . . . 0.0 112.304 -178.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 92.35 -87.44 1.26 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.835 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 68.23 -60.05 0.43 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.698 0.799 . . . . 0.0 112.021 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . 68.02 108.01 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.436 0.694 . . . . 0.0 111.161 -177.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 48.5 mm -79.02 115.56 21.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.866 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.505 ' HA ' ' HD3' ' A' ' 229' ' ' PRO . 8.7 t -57.65 130.23 81.6 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.433 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.505 ' HD3' ' HA ' ' A' ' 228' ' ' THR . 16.4 Cg_exo -67.25 96.96 0.41 Allowed 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.906 2.404 . . . . 0.0 112.407 -177.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 98.4 mt -86.02 118.77 71.06 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.157 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.89 -54.7 4.37 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 123.136 2.558 . . . . 0.0 112.297 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 14.2 p -138.57 -72.25 0.41 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.398 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 73.4 p 47.68 43.28 16.46 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.806 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -77.83 96.44 4.96 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.185 -177.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -96.6 20.11 11.28 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.958 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 83.81 139.78 4.09 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.326 -176.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -66.43 113.6 2.75 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.135 1.89 . . . . 0.0 110.732 177.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.68 HG12 HD11 ' A' ' 293' ' ' ILE . 2.8 t -90.18 145.0 7.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.557 -176.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.477 ' HB2' ' HA ' ' A' ' 295' ' ' ASP . 77.1 m-85 -116.28 124.77 51.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.291 0.567 . . . . 0.0 112.302 -172.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.61 ' HB2' HD12 ' A' ' 293' ' ' ILE . . . -119.48 149.85 41.21 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.919 175.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -106.65 123.72 48.54 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 173.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' ALA . . . . . 0.505 ' O ' ' HA ' ' A' ' 260' ' ' VAL . . . -68.34 97.24 0.72 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.92 0.391 . . . . 0.0 110.304 -178.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.471 HD13 ' HB2' ' A' ' 292' ' ' LYS . 27.1 pt -86.29 -24.39 6.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.077 -177.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 5.2 tm0? -126.39 123.85 38.88 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 176.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -53.98 138.63 36.56 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.38 0.609 . . . . 0.0 111.598 -173.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 28.4 tpt180 -123.32 111.63 16.63 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.161 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.442 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 23.6 m -115.95 144.22 32.34 Favored Pre-proline 0 C--N 1.318 -0.802 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.264 177.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 247' ' ' VAL . 4.4 Cg_exo -75.09 121.87 6.81 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.478 2.119 . . . . 0.0 110.953 177.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 18.2 t -75.42 -178.41 4.02 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.105 -177.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -59.23 -23.62 62.48 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.289 0.478 . . . . 0.0 112.289 -176.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -107.0 4.9 27.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.621 -177.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -96.3 112.88 24.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.773 0.32 . . . . 0.0 110.808 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -106.75 -37.82 6.29 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.014 176.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 24.8 p -99.41 19.97 14.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.708 -176.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -93.36 145.09 24.72 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.057 0.456 . . . . 0.0 111.164 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -93.78 135.79 34.73 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.921 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -91.91 122.09 34.11 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.162 177.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 81.4 mt -129.43 135.74 49.05 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -175.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -99.38 161.86 13.37 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 175.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 36.4 t -73.21 109.06 5.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.642 -178.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 120.35 -0.77 12.78 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.716 178.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -89.73 160.34 16.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.943 0.372 . . . . 0.0 110.131 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 30.1 mm -103.65 116.75 47.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.184 0.516 . . . . 0.0 110.733 -176.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 13.7 t -97.8 109.66 23.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.476 -178.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 9.4 ptmt -93.35 102.47 14.73 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.274 175.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.443 HG13 ' HB ' ' A' ' 238' ' ' VAL . 2.3 p -93.22 128.54 44.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.333 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.23 -39.33 7.69 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.149 -176.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 268' ' ' ARG . . . . . 0.499 ' HB2' ' CG ' ' A' ' 276' ' ' GLU . 63.2 mtt85 -128.11 127.27 42.75 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.979 0.418 . . . . 0.0 110.498 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 269' ' ' MET . . . . . 0.501 ' HE2' ' CZ3' ' A' ' 275' ' ' TRP . 43.4 mtt -105.36 140.11 38.97 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.342 -176.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.413 ' HB2' ' OD1' ' A' ' 272' ' ' ASN . 34.6 m-80 -106.94 169.08 8.76 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.477 177.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 18.4 pt -98.24 9.36 7.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.156 0.503 . . . . 0.0 111.162 -176.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 272' ' ' ASN . . . . . 0.413 ' OD1' ' HB2' ' A' ' 270' ' ' ASN . 30.1 p-10 -87.69 -20.87 25.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.995 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 114.83 -12.39 20.43 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.386 -178.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.411 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 89.7 mt-30 -116.98 122.5 44.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.085 0.469 . . . . 0.0 110.373 177.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.501 ' CZ3' ' HE2' ' A' ' 269' ' ' MET . 6.6 m0 -99.02 169.22 9.58 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.807 -176.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.499 ' CG ' ' HB2' ' A' ' 268' ' ' ARG . 0.0 OUTLIER -101.36 115.76 31.24 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 121.536 0.684 . . . . 0.0 110.324 174.882 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 277' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -119.57 146.85 18.17 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.167 177.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -109.88 106.58 16.21 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 60.9 t -131.85 125.37 55.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.829 0.347 . . . . 0.0 111.025 -171.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 58.74 27.77 16.41 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.336 175.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 91.02 -4.25 81.28 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.721 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 19.3 mtp-105 -113.55 120.2 40.13 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.467 ' HE3' ' HB2' ' A' ' 283' ' ' LYS . 15.1 ptmt -111.39 138.71 47.53 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.24 0.543 . . . . 0.0 110.611 175.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -173.45 -169.73 36.17 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.435 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 87.4 mt -90.41 134.14 34.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.981 0.419 . . . . 0.0 110.734 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -133.7 137.74 29.41 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.983 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -78.06 130.91 10.6 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 122.647 2.231 . . . . 0.0 112.042 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.499 ' HA ' HG22 ' A' ' 291' ' ' VAL . 35.6 p90 -62.33 -17.91 60.04 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.911 0.386 . . . . 0.0 110.731 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.39 -20.18 65.32 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.888 -0.597 . . . . 0.0 112.099 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -105.66 -5.69 19.82 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.713 0.292 . . . . 0.0 111.601 -176.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.499 HG22 ' HA ' ' A' ' 288' ' ' PHE . 33.7 m -123.43 166.26 18.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 120.987 0.422 . . . . 0.0 110.676 -177.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 292' ' ' LYS . . . . . 0.471 ' HB2' HD13 ' A' ' 243' ' ' ILE . 39.9 tptt -122.4 107.25 11.85 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.68 HD11 HG12 ' A' ' 238' ' ' VAL . 4.2 tp -74.54 135.36 27.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -157.14 -29.33 0.09 Allowed 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.321 -0.552 . . . . 0.0 112.042 -175.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.477 ' HA ' ' HB2' ' A' ' 239' ' ' PHE . 32.5 m-20 60.79 97.22 0.04 OUTLIER Pre-proline 0 N--CA 1.464 0.227 0 CA-C-O 121.056 0.455 . . . . 0.0 110.613 -176.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.57 50.05 2.27 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.841 2.361 . . . . 0.0 112.486 -177.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 60.45 50.76 5.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.721 0.772 . . . . 0.0 109.292 -177.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 298' ' ' ASN . . . . . 0.478 ' HA ' ' HD3' ' A' ' 299' ' ' PRO . 0.3 OUTLIER -53.28 138.38 48.21 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 114.21 -1.359 . . . . 0.0 111.713 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 299' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 298' ' ' ASN . 5.9 Cg_endo -88.39 6.65 4.74 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.335 2.69 . . . . 0.0 112.892 -176.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -68.02 119.25 12.34 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.52 178.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 40.23 48.65 2.33 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 124.487 1.117 . . . . 0.0 112.148 -176.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -79.73 3.07 20.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.773 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.327 -0.844 . . . . 0.0 110.468 -178.746 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.5 ttm . . . . . 0 N--CA 1.48 1.048 0 CA-C-O 120.636 0.255 . . . . 0.0 110.43 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.8 m -119.46 116.31 25.86 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.358 177.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.3 p -70.98 -25.94 62.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.54 0.686 . . . . 0.0 109.767 174.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.79 93.44 5.6 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.122 175.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -115.27 90.34 3.31 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.597 0.713 . . . . 0.0 111.014 -178.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.482 ' CE1' ' HE2' ' A' ' 89' ' ' LYS . 32.1 p90 -160.66 151.67 18.83 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.446 -1.252 . . . . 0.0 108.482 177.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -80.46 115.46 20.0 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 177.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.3 m -67.29 -9.01 36.55 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -173.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.7 t -106.86 -24.43 12.05 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.308 -176.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -63.39 98.83 0.17 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.028 0.442 . . . . 0.0 110.874 -174.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.457 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 2.9 tpp180 -57.11 -43.41 82.25 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.402 -176.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.0 m -75.74 7.0 4.21 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -177.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -95.75 -46.28 6.65 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.613 0.244 . . . . 0.0 110.749 173.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.469 ' HB3' ' HB3' ' A' ' 101' ' ' PRO . 34.7 p-90 -121.68 -26.66 4.85 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -173.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.457 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 60.8 t80 -75.32 107.98 7.79 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.335 0.588 . . . . 0.0 110.03 -176.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.461 ' SD ' ' HG2' ' A' ' 104' ' ' ARG . 5.4 tpp -91.4 -9.53 44.41 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.993 -174.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 39' ' ' ARG . . . 50.5 -112.66 1.66 Allowed Glycine 0 C--N 1.333 0.399 0 O-C-N 123.839 0.712 . . . . 0.0 114.293 175.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -74.16 93.66 0.89 Allowed 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.473 2.115 . . . . 0.0 112.461 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.473 ' O ' ' CB ' ' A' ' 20' ' ' SER . 7.3 t -125.7 -77.02 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.954 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.473 ' CB ' ' O ' ' A' ' 19' ' ' VAL . 32.3 t 125.86 156.39 0.0 OUTLIER 'General case' 0 C--N 1.355 0.84 0 C-N-CA 124.973 1.309 . . . . 0.0 108.311 168.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.52 ' HA ' ' NH2' ' A' ' 39' ' ' ARG . 21.1 tpt180 -52.91 -52.33 58.1 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.746 0.308 . . . . 0.0 111.003 178.12 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -64.77 -33.89 77.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.111 -176.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.636 ' HG2' ' HE ' ' A' ' 27' ' ' ARG . 24.8 tt0 -82.57 -45.99 13.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.929 0.395 . . . . 0.0 110.898 -177.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.49 -38.29 68.96 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.132 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 55.0 tp60 -60.9 -47.52 86.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.342 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.6 t -78.27 -22.66 47.95 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 121.056 -0.258 . . . . 0.0 111.166 -175.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.636 ' HE ' ' HG2' ' A' ' 23' ' ' GLU . 63.9 mtt180 -68.59 -21.19 64.53 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.662 0.268 . . . . 0.0 110.565 177.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.575 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 95.3 mt -125.93 6.96 7.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.154 -0.475 . . . . 0.0 112.276 -176.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -82.89 110.91 18.29 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 122.129 -0.357 . . . . 0.0 110.933 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.413 ' H ' ' HA ' ' A' ' 56' ' ' SER . . . 69.77 18.66 74.33 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.841 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.564 ' HG3' ' HA ' ' A' ' 28' ' ' LEU . 12.2 mm100 -83.34 -168.33 2.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.604 0.24 . . . . 0.0 110.607 -178.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.562 ' HB2' ' SD ' ' A' ' 35' ' ' MET . 46.3 mtm180 -58.31 141.98 49.4 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 173.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 63.6 m170 -88.33 122.22 31.6 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 120.847 0.356 . . . . 0.0 110.495 -177.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.75 -5.73 14.1 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.91 -175.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.67 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 34.1 mtp -80.3 146.81 31.43 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 122.451 0.3 . . . . 0.0 110.74 177.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -151.81 161.31 42.87 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 121.118 -0.233 . . . . 0.0 110.931 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.53 ' HG ' HD11 ' A' ' 28' ' ' LEU . 4.5 pp -154.75 140.99 18.57 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.057 0.456 . . . . 0.0 111.229 176.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 51.8 t -110.99 112.29 39.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.547 176.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.542 ' HD3' ' O ' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -113.99 -179.3 3.6 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 178.345 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.542 ' O ' ' HD3' ' A' ' 39' ' ' ARG . 4.1 m-20 -66.97 137.83 56.81 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 175.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.545 ' HA ' HG23 ' A' ' 49' ' ' VAL . 46.7 t -54.4 141.74 29.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.179 0.514 . . . . 0.0 111.281 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.2 m -85.53 -13.07 50.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.087 -176.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.46 HG21 ' HB2' ' A' ' 196' ' ' ASN . 22.4 p -125.1 -44.68 1.89 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -174.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.436 ' HA ' ' HD2' ' A' ' 45' ' ' PRO . 3.0 p -114.66 102.36 54.8 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-O 120.858 0.361 . . . . 0.0 111.559 -176.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 44' ' ' CYS . 10.8 Cg_endo -54.59 139.03 76.06 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.881 2.387 . . . . 0.0 111.908 177.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.1 -32.38 7.37 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.251 -177.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -87.42 175.18 8.1 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.856 0.36 . . . . 0.0 110.201 177.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.459 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 38.2 m-85 -131.39 174.28 10.23 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.861 178.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.545 HG23 ' HA ' ' A' ' 41' ' ' SER . 65.0 t -142.47 106.67 1.39 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-O 120.969 0.414 . . . . 0.0 110.952 177.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.6 tp -78.42 104.75 9.22 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.148 175.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.7 m -96.33 132.8 41.46 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 176.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.643 HG21 HD13 ' A' ' 93' ' ' LEU . 86.9 t -124.49 136.27 61.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.882 0.372 . . . . 0.0 111.158 -175.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.575 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 32.2 t -96.38 104.86 16.86 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.207 -172.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.795 ' O ' ' HB3' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -152.8 151.74 30.8 Favored 'General case' 0 C--O 1.204 -1.332 0 C-N-CA 120.287 -0.565 . . . . 0.0 109.704 169.245 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.579 ' HB2' ' HD3' ' A' ' 57' ' ' ARG . 54.9 m-80 56.76 22.76 7.23 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 178.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.413 ' HA ' ' H ' ' A' ' 30' ' ' GLY . 46.8 m 54.06 54.8 9.12 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 122.801 1.286 . . . . 0.0 107.964 -172.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.795 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 0.2 OUTLIER -161.96 65.94 0.25 Allowed 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 112.873 -1.967 . . . . 0.0 109.353 -151.168 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.616 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 18.6 t -72.54 97.11 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 121.865 0.841 . . . . 0.0 109.789 -170.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.7 m -68.32 121.12 15.61 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 113.88 -1.509 . . . . 0.0 110.96 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -100.15 107.12 18.91 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.811 0.339 . . . . 0.0 111.491 -176.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.741 ' HE1' HD11 ' A' ' 153' ' ' ILE . 72.8 m-85 -102.34 107.04 17.92 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.128 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.528 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 63.8 mt -80.4 129.37 37.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -174.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.503 HG23 ' HB3' ' A' ' 71' ' ' PHE . 5.0 mp -104.28 114.97 45.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.392 178.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -87.76 139.41 30.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.744 -173.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 31.3 t -81.86 95.05 7.2 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 169.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.566 HD11 ' HB2' ' A' ' 72' ' ' LYS . 91.9 mt -74.63 148.45 85.37 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.996 -176.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.67 -14.85 45.23 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.682 2.255 . . . . 0.0 110.617 171.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.35 -3.01 24.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.847 176.05 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.493 ' HA ' ' NE ' ' A' ' 69' ' ' ARG . 3.7 mmp_? 66.38 26.27 10.21 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.291 0.567 . . . . 0.0 110.049 -173.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 47.7 mtp180 -123.76 -179.64 4.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.599 -177.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.503 ' HB3' HG23 ' A' ' 63' ' ' ILE . 29.2 m-85 -127.87 115.9 19.31 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -173.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 77' ' ' GLU . 38.6 ttmt -102.09 116.47 32.76 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.188 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.619 HD11 ' HB3' ' A' ' 61' ' ' TYR . 11.7 tt -94.7 93.04 3.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.707 0.765 . . . . 0.0 110.773 -178.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.62 69.92 1.16 Allowed Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.438 -0.801 . . . . 0.0 113.075 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.524 ' HA ' ' HD3' ' A' ' 72' ' ' LYS . 31.4 t70 75.47 -38.76 0.37 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.139 0.576 . . . . 0.0 112.354 176.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -80.83 114.22 19.57 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.573 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 9.5 pt-20 -95.07 134.33 37.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.681 0.753 . . . . 0.0 112.177 -174.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -119.27 179.03 4.31 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.528 171.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.24 -32.4 22.61 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 -175.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -161.68 167.66 24.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.673 0.273 . . . . 0.0 111.074 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.613 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 14.5 mt -53.94 -56.47 25.3 Favored Pre-proline 0 N--CA 1.467 0.398 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.403 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.613 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 29.7 Cg_exo -65.94 2.17 1.89 Allowed 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.409 2.072 . . . . 0.0 113.204 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -98.7 -34.91 10.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.839 0.352 . . . . 0.0 110.567 176.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.2 pp -76.56 -33.9 58.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.134 0.492 . . . . 0.0 109.78 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.457 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 72.8 mt -67.89 -14.76 63.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.185 176.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -88.94 -40.2 13.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.247 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -71.77 -28.97 63.99 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.784 -178.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.435 ' CG ' HD21 ' A' ' 93' ' ' LEU . 20.7 m-85 -84.58 -2.5 57.49 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -177.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.482 ' HE2' ' CE1' ' A' ' 6' ' ' PHE . 98.8 mttt -73.3 -6.89 48.96 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.099 174.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.6 pt -132.91 -6.45 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.232 0 CA-C-O 120.938 0.399 . . . . 0.0 110.573 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -93.16 -34.19 13.72 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.516 -171.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 70.87 128.36 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.159 0 O-C-N 124.411 1.07 . . . . 0.0 109.956 -169.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.643 HD13 HG21 ' A' ' 52' ' ' VAL . 0.9 OUTLIER -103.75 -14.96 15.88 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.767 0.794 . . . . 0.0 109.783 173.084 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.863 ' HA ' ' HB3' ' A' ' 154' ' ' GLU . 1.5 m-20 -133.22 -100.01 0.27 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.613 -177.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.725 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 14.0 t -134.13 14.76 3.87 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 165.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.537 HG22 ' HG3' ' A' ' 54' ' ' GLU . 3.8 t -140.84 169.88 16.8 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 113.962 -1.472 . . . . 0.0 107.403 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.6 p -104.11 -179.38 3.93 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 176.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 74.2 mt -68.39 88.59 0.33 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 175.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 48.9 mm -78.25 -54.98 11.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.137 -173.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.67 ' O ' ' HA ' ' A' ' 35' ' ' MET . 39.7 tt0 -160.09 136.71 6.53 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.925 -177.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.469 ' HB3' ' HB3' ' A' ' 14' ' ' TRP . 18.2 Cg_endo -59.9 158.95 27.04 Favored 'Trans proline' 0 CA--C 1.531 0.325 0 C-N-CA 122.793 2.329 . . . . 0.0 112.743 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.567 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -75.17 145.4 80.35 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.844 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -55.66 130.93 43.08 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.634 2.223 . . . . 0.0 111.514 174.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.461 ' HG2' ' SD ' ' A' ' 16' ' ' MET . 78.3 mtp180 -76.56 -40.58 49.31 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.248 -174.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -140.75 100.43 6.66 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -73.3 70.93 3.82 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 123.284 2.656 . . . . 0.0 113.004 -176.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.893 ' HB3' ' HD3' ' A' ' 108' ' ' PRO . 47.2 t -93.23 -61.48 0.19 Allowed Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 173.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.893 ' HD3' ' HB3' ' A' ' 107' ' ' SER . 24.2 Cg_exo -65.59 -55.78 0.4 Allowed 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 121.851 1.701 . . . . 0.0 112.951 171.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.556 ' HD3' ' HB2' ' A' ' 108' ' ' PRO . 8.4 Cg_exo -72.01 107.01 2.13 Favored 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 121.662 1.575 . . . . 0.0 111.389 177.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 25.9 ttt -145.44 158.6 43.81 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -178.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 100.58 -81.74 0.49 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.145 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 55.0 p -80.41 39.59 0.47 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.927 0.394 . . . . 0.0 111.047 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.406 HG13 ' N ' ' A' ' 114' ' ' SER . 3.3 p -65.47 -54.47 28.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.286 -176.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.406 ' N ' HG13 ' A' ' 113' ' ' VAL . 0.9 OUTLIER -97.63 36.66 1.47 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.183 0.516 . . . . 0.0 111.23 -178.773 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.46 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . . . -97.86 107.59 41.21 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.915 176.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 115' ' ' ALA . 7.1 Cg_endo -86.43 -177.47 2.39 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 123.195 2.596 . . . . 0.0 112.56 -175.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' A' ' 118' ' ' LEU . 2.1 m-20 -104.79 102.99 12.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.816 179.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.409 ' HB2' ' O ' ' A' ' 117' ' ' ASN . 10.5 mp 70.57 165.05 0.14 Allowed Pre-proline 0 CA--C 1.535 0.389 0 O-C-N 123.597 0.56 . . . . 0.0 111.492 176.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -73.37 17.5 0.43 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.311 2.674 . . . . 0.0 113.217 178.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 6.8 m -76.18 83.29 3.0 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 178.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -172.98 175.57 3.23 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.49 -177.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.458 ' HB3' ' H ' ' A' ' 123' ' ' ASP . 42.1 mt-10 61.57 -149.48 0.4 Allowed 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.056 -0.975 . . . . 0.0 113.627 169.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.458 ' H ' ' HB3' ' A' ' 122' ' ' GLU . 9.3 t70 78.18 -61.76 0.37 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.646 -173.013 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.635 ' CG ' ' H ' ' A' ' 125' ' ' LEU . 4.0 p30 -176.12 -101.53 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 172.176 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.742 HD12 HG21 ' A' ' 152' ' ' ILE . 4.0 mm? 64.35 96.61 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 122.128 0.966 . . . . 0.0 112.686 168.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -169.6 -60.37 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 113.866 -1.516 . . . . 0.0 107.614 -176.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.437 ' HD2' ' CG1' ' A' ' 182' ' ' VAL . 43.1 m-85 -123.0 133.48 54.36 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.95 176.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.541 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 23.7 t -133.18 160.86 42.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.757 ' HG2' ' O ' ' A' ' 180' ' ' LYS . 2.0 ptp180 -138.39 138.03 37.86 Favored 'General case' 0 CA--C 1.494 -1.2 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.924 171.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.869 HG22 HG12 ' A' ' 178' ' ' VAL . 30.4 p -92.75 140.44 29.52 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.566 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.5 mt -114.06 -5.08 13.11 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.82 -172.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.491 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 59.7 t80 -107.21 -42.68 4.79 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -171.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.716 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 16.1 t70 79.79 93.5 0.05 Allowed 'General case' 0 N--CA 1.474 0.73 0 O-C-N 123.778 0.673 . . . . 0.0 110.63 -173.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.585 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 68.4 t80 -124.07 88.06 52.89 Favored Pre-proline 0 N--CA 1.45 -0.436 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 172.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.573 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 95.4 Cg_endo -84.55 84.82 1.42 Allowed 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 121.488 1.459 . . . . 0.0 112.239 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.54 -25.0 75.26 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 173.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.677 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 19.8 m120 53.68 72.09 0.46 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.214 -0.993 . . . . 0.0 111.17 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -141.88 173.11 11.81 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.483 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -100.33 12.03 38.07 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -127.57 -36.64 2.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.048 -1.433 . . . . 0.0 109.261 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -113.77 128.04 56.26 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 173.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.985 HD11 ' HB2' ' A' ' 165' ' ' ASN . 32.4 tp -83.29 124.72 75.73 Favored Pre-proline 0 C--N 1.325 -0.489 0 C-N-CA 120.178 -0.609 . . . . 0.0 111.457 -176.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.677 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 57.4 Cg_endo -76.31 102.41 1.61 Allowed 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 121.71 1.607 . . . . 0.0 111.673 167.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.585 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 0.5 OUTLIER -92.03 -163.84 1.1 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.938 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.716 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 55.4 mttp -134.8 -176.02 4.09 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.114 175.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.804 ' H ' ' HD2' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -77.61 39.61 0.28 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.481 0.657 . . . . 0.0 111.382 -174.641 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 130' ' ' THR . . . 136.05 49.16 0.07 OUTLIER Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 -176.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.676 ' OE2' ' HG ' ' A' ' 150' ' ' LEU . 1.2 pp20? -92.28 179.26 5.6 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.514 HD11 ' NH2' ' A' ' 129' ' ' ARG . 1.3 mp -118.48 124.48 73.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 175.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.742 ' CD2' ' HA ' ' A' ' 165' ' ' ASN . 72.5 mt -118.91 156.44 29.52 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.405 0.621 . . . . 0.0 109.691 -172.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.568 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 52.4 t -118.49 122.95 70.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 173.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.949 HD13 ' HB2' ' A' ' 163' ' ' ALA . 46.5 mm -77.54 79.61 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.468 0 CA-C-O 122.519 1.152 . . . . 0.0 108.964 -175.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.741 HD11 ' HE1' ' A' ' 61' ' ' TYR . 21.0 tt -65.87 -27.31 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 CA-C-N 113.107 -1.86 . . . . 0.0 109.852 -176.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.863 ' HB3' ' HA ' ' A' ' 94' ' ' ASP . 0.2 OUTLIER -145.83 146.45 31.15 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 121.143 0.497 . . . . 0.0 110.957 171.248 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.57 ' HD2' ' HG ' ' A' ' 125' ' ' LEU . 86.3 tttt -126.14 87.69 55.68 Favored Pre-proline 0 C--N 1.319 -0.758 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 168.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.725 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 5.4 Cg_exo -81.58 -51.55 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.993 2.462 . . . . 0.0 111.721 175.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.683 ' HG2' ' CE ' ' A' ' 172' ' ' MET . 6.1 mm-40 -97.39 160.75 14.14 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.094 0.474 . . . . 0.0 111.049 -175.141 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -85.25 -33.14 22.25 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.914 175.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 85.1 mm-40 -92.82 -17.15 24.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.399 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.427 ' HB2' ' HB2' ' A' ' 157' ' ' GLU . 62.7 m95 -127.41 124.17 37.86 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.116 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' TRP . . . . . 0.562 ' O ' HG13 ' A' ' 173' ' ' ILE . 45.9 m0 -110.67 136.27 50.02 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.707 ' OG ' ' HG2' ' A' ' 172' ' ' MET . 38.0 m -97.35 109.09 21.92 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -173.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.949 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -122.85 152.1 41.07 Favored 'General case' 0 N--CA 1.426 -1.657 0 C-N-CA 119.888 -0.725 . . . . 0.0 110.405 -174.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.831 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 9.8 ptt180 -87.69 126.88 35.23 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 171.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.985 ' HB2' HD11 ' A' ' 142' ' ' LEU . 64.2 t30 -60.31 178.09 0.22 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.306 -1.315 . . . . 0.0 111.406 -172.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 19.5 tttp -58.15 -11.99 3.1 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.866 167.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -89.84 -27.65 19.79 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.393 174.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 105.07 -0.81 41.04 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.729 -175.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.831 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 3.3 ttm-85 -76.11 140.02 41.61 Favored 'General case' 0 C--O 1.217 -0.61 0 C-N-CA 123.324 0.65 . . . . 0.0 112.008 -177.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.529 HG22 HD13 ' A' ' 153' ' ' ILE . 48.1 t -87.21 123.52 40.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 111.353 0.131 . . . . 0.0 111.353 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -158.12 151.9 23.05 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.258 172.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.707 ' HG2' ' OG ' ' A' ' 162' ' ' SER . 36.8 mtp -81.37 142.73 32.75 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.885 0.342 . . . . 0.0 110.583 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 1.001 HD13 HG11 ' A' ' 178' ' ' VAL . 2.8 pp -143.24 150.63 52.72 Favored Pre-proline 0 C--O 1.222 -0.349 0 O-C-N 123.442 0.464 . . . . 0.0 111.119 -178.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.503 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 6.7 Cg_exo -72.82 132.1 18.05 Favored 'Trans proline' 0 CA--C 1.529 0.241 0 C-N-CA 122.387 2.058 . . . . 0.0 112.615 -176.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.555 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 18.3 t -57.9 -43.1 98.31 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 32.8 Cg_endo -64.84 -2.36 5.33 Favored 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 122.049 1.833 . . . . 0.0 113.116 176.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.503 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 4.5 m-85 -98.2 -18.45 18.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.71 177.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 1.001 HG11 HD13 ' A' ' 173' ' ' ILE . 2.2 m -130.68 -172.32 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.102 -168.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.879 ' HG3' ' H ' ' A' ' 180' ' ' LYS . 8.7 pt-20 -156.34 -65.67 0.11 Allowed 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 117.404 2.372 . . . . 0.0 117.404 152.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.879 ' H ' ' HG3' ' A' ' 179' ' ' GLU . 4.2 mptt -157.59 -177.54 6.66 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.153 0.888 . . . . 0.0 109.891 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.42 ' HG ' ' NH2' ' A' ' 129' ' ' ARG . 0.1 OUTLIER -128.71 -68.67 0.74 Allowed 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 153.421 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.437 ' CG1' ' HD2' ' A' ' 127' ' ' TYR . 4.1 p -108.74 99.78 9.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.494 0.664 . . . . 0.0 109.296 171.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.656 ' HB2' ' HG2' ' A' ' 180' ' ' LYS . 68.5 ttt180 -86.94 99.81 12.14 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.458 -176.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 18.6 m -84.14 95.33 8.59 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.87 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.413 ' HB2' ' HD2' ' A' ' 186' ' ' PRO . 3.3 p -74.8 167.6 34.94 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.258 177.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.413 ' HD2' ' HB2' ' A' ' 185' ' ' SER . 74.0 Cg_exo -49.11 105.6 0.1 OUTLIER 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.971 2.448 . . . . 0.0 113.294 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -131.55 -27.69 1.92 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.758 175.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 124.04 -70.42 0.45 Allowed Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 110.191 -1.163 . . . . 0.0 110.191 -176.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 16.2 pttm -135.87 133.75 38.07 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 171.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -86.92 -49.45 7.37 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.078 0.466 . . . . 0.0 110.112 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 132.22 111.69 1.35 Allowed Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 -175.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -87.96 99.25 12.01 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -177.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 193' ' ' ARG . 12.4 ttt180 -66.39 -55.39 16.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.345 -177.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 65.59 123.69 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 O-C-N 123.732 0.645 . . . . 0.0 109.962 -172.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 46.6 m -138.11 24.42 2.77 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.127 0.489 . . . . 0.0 111.639 -175.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ASN . . . . . 0.46 ' HB2' HG21 ' A' ' 43' ' ' THR . 15.5 m120 -86.51 157.13 19.84 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.567 175.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 11.6 t -168.94 -165.85 0.59 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -176.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 65.9 -171.12 0.19 Allowed 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.764 0.665 . . . . 0.0 110.688 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 84.32 80.33 1.07 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.42 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.459 ' N ' HD13 ' A' ' 200' ' ' ILE . 0.1 OUTLIER -123.72 96.8 42.62 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-O 121.226 0.536 . . . . 0.0 110.7 178.88 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -76.21 -15.5 18.12 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.506 2.138 . . . . 0.0 112.473 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 65.17 101.99 0.04 OUTLIER Pre-proline 0 N--CA 1.463 0.204 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.194 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.75 118.02 4.91 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 122.595 2.197 . . . . 0.0 111.321 176.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -138.53 -67.81 0.46 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.462 -176.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -79.31 87.61 4.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.188 0.518 . . . . 0.0 110.703 -177.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -118.24 -5.97 10.86 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.778 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -115.82 114.65 25.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.185 0.517 . . . . 0.0 111.337 -178.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -150.47 123.99 9.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.829 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.451 ' HA ' ' HD3' ' A' ' 210' ' ' PRO . 62.2 tt0 -94.98 115.83 65.76 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.348 -179.087 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 209' ' ' GLN . 7.7 Cg_exo -72.65 100.32 1.15 Allowed 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.749 2.3 . . . . 0.0 112.105 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -108.14 3.13 23.47 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.282 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.578 HG23 HD11 ' A' ' 216' ' ' LEU . 16.8 m -77.13 79.42 3.66 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.215 0.531 . . . . 0.0 110.922 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 10.4 p -91.27 -72.32 0.59 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.546 172.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.724 ' N ' ' HD3' ' A' ' 215' ' ' PRO . 12.1 t -161.77 27.37 0.03 OUTLIER Pre-proline 0 CA--C 1.552 1.03 0 N-CA-C 112.781 0.659 . . . . 0.0 112.781 173.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.724 ' HD3' ' N ' ' A' ' 214' ' ' THR . 94.6 Cg_endo -96.48 11.37 1.26 Allowed 'Trans proline' 0 C--N 1.362 1.28 0 C-N-CA 121.896 1.73 . . . . 0.0 112.293 -175.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.602 ' HB2' ' HD2' ' A' ' 217' ' ' PRO . 2.5 pp -157.17 165.98 17.63 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.758 -176.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.602 ' HD2' ' HB2' ' A' ' 216' ' ' LEU . 9.6 Cg_endo -51.87 -37.39 66.23 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.35 2.7 . . . . 0.0 113.377 -177.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . 67.84 13.27 9.15 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 122.875 0.47 . . . . 0.0 111.697 178.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 9.5 p -69.8 -26.86 31.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.342 0.591 . . . . 0.0 110.075 176.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 13.5 t -139.02 155.07 48.25 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -70.99 -42.18 59.98 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.365 -177.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 13.8 p -96.52 112.92 61.57 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-O 120.47 0.176 . . . . 0.0 110.958 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -66.44 113.08 2.55 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.684 2.256 . . . . 0.0 111.64 177.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -162.59 44.39 0.35 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 121.115 -0.564 . . . . 0.0 111.727 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -107.35 -23.59 12.16 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.103 0.477 . . . . 0.0 110.241 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -83.0 61.57 6.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.351 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 62.5 mt -66.25 -36.71 78.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 176.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 19.1 m 68.11 95.93 0.05 OUTLIER Pre-proline 0 C--O 1.235 0.296 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.762 176.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -56.47 133.42 57.93 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.719 2.279 . . . . 0.0 111.608 177.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.632 ' H ' HD23 ' A' ' 230' ' ' LEU . 2.4 pt? -67.85 148.45 98.46 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.92 -177.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 230' ' ' LEU . 21.7 Cg_exo -66.07 176.81 3.5 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.878 2.385 . . . . 0.0 111.998 175.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 25.1 m -95.61 51.01 1.25 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.012 0.434 . . . . 0.0 110.993 -176.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 2.8 p -74.89 104.06 5.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.019 0.438 . . . . 0.0 110.311 177.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -76.39 98.93 4.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.028 0.442 . . . . 0.0 111.48 -175.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -157.63 7.81 0.16 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.767 174.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 80.98 -175.92 54.73 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.108 -177.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.09 148.11 30.81 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.718 2.279 . . . . 0.0 111.02 174.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.499 ' CG1' HD12 ' A' ' 293' ' ' ILE . 66.8 t -77.06 123.83 34.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.92 0.391 . . . . 0.0 110.562 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -99.04 115.25 28.55 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.999 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.662 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -119.37 121.16 38.9 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.091 178.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.538 ' HB2' ' CE1' ' A' ' 294' ' ' PHE . 48.2 tttp -86.68 118.85 26.36 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -178.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -72.8 102.59 3.42 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.411 HG12 ' O ' ' A' ' 290' ' ' HIS . 9.6 pt -89.47 4.6 5.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.955 0.407 . . . . 0.0 111.142 -176.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -149.89 149.11 29.96 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 173.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 10.3 ptpp? -75.59 175.88 8.15 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.02 0.438 . . . . 0.0 111.169 -176.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.471 ' CB ' HG21 ' A' ' 289' ' ' THR . 21.4 tpt180 -157.08 127.41 6.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.979 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 28.0 m -121.37 143.57 37.91 Favored Pre-proline 0 C--N 1.32 -0.706 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 171.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.432 ' HD3' ' HB2' ' A' ' 257' ' ' ALA . 38.0 Cg_endo -66.58 104.51 0.79 Allowed 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.179 1.919 . . . . 0.0 111.694 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 249' ' ' CYS . . . . . 0.433 ' H ' ' HB2' ' A' ' 252' ' ' ASP . 1.7 t -72.61 169.7 16.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.862 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.74 -32.43 69.23 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.806 0.336 . . . . 0.0 111.609 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -95.08 -15.42 23.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.948 0.404 . . . . 0.0 110.886 177.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.464 ' HB3' ' HB2' ' A' ' 255' ' ' ALA . 60.3 m-20 -100.69 67.93 1.3 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.061 0.458 . . . . 0.0 110.071 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 253' ' ' LYS . . . . . 0.694 ' H ' ' HD2' ' A' ' 253' ' ' LYS . 0.0 OUTLIER -75.24 -33.99 61.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.291 -174.95 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.66 -1.04 57.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.554 -178.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.464 ' HB2' ' HB3' ' A' ' 252' ' ' ASP . . . -70.12 126.06 28.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.165 0.507 . . . . 0.0 111.81 -175.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.3 tt -71.77 134.16 46.02 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.315 176.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.432 ' HB2' ' HD3' ' A' ' 248' ' ' PRO . . . -84.92 128.95 34.85 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 89.4 mt -135.43 165.53 25.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.59 -172.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -129.49 -177.25 4.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.08 177.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 39.8 t -80.83 129.88 36.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.865 -178.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 80.37 11.81 83.8 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.654 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -87.14 140.28 29.71 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -176.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 38.5 mm -88.11 110.28 20.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.992 0.425 . . . . 0.0 110.561 -178.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 20.9 t -88.1 102.99 13.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.287 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 5.6 tppp? -79.44 95.1 5.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.232 177.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.483 HG13 ' HB ' ' A' ' 238' ' ' VAL . 4.5 p -99.88 117.42 45.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.384 0.612 . . . . 0.0 110.4 177.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 267' ' ' THR . . . . . 0.524 ' OG1' ' HD2' ' A' ' 268' ' ' ARG . 20.2 p -104.19 -18.9 14.32 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.155 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 268' ' ' ARG . . . . . 0.524 ' HD2' ' OG1' ' A' ' 267' ' ' THR . 0.1 OUTLIER -130.48 91.79 3.15 Favored 'General case' 0 C--O 1.224 -0.281 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 176.847 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 6.5 ptp -98.56 130.51 45.12 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 119.531 -0.868 . . . . 0.0 111.028 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -103.28 150.1 24.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.153 -174.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.421 ' H ' HG13 ' A' ' 271' ' ' ILE . 1.8 pp -71.87 -5.8 6.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.419 0.628 . . . . 0.0 110.941 175.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -70.75 -21.03 62.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.087 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 110.93 -47.67 1.02 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.683 -178.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.493 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 59.1 mt-30 -80.18 121.13 25.2 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 174.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 34.2 m0 -103.36 149.98 24.24 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.454 ' HB3' ' HB2' ' A' ' 268' ' ' ARG . 34.3 tt0 -99.53 116.81 32.51 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.074 0.464 . . . . 0.0 109.929 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -139.94 164.44 26.12 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.934 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.529 ' HG2' ' HB2' ' A' ' 283' ' ' LYS . 37.2 mt-10 -123.42 109.85 14.38 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 25.6 t -123.62 -81.06 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 120.354 -0.539 . . . . 0.0 111.793 -175.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -91.96 77.2 5.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.793 0.33 . . . . 0.0 111.284 -173.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 50.5 34.73 27.75 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.372 -0.831 . . . . 0.0 113.335 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 282' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 282' ' ' ARG . 34.0 ttt-85 -170.71 138.75 1.45 Allowed 'General case' 0 C--O 1.237 0.423 0 CA-C-O 120.895 0.379 . . . . 0.0 111.0 -173.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.529 ' HB2' ' HG2' ' A' ' 278' ' ' GLU . 38.2 ttpt -99.72 137.85 37.63 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.087 173.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -158.13 169.98 34.85 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.167 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.493 ' HB3' ' HB3' ' A' ' 274' ' ' GLN . 62.8 mt -97.59 113.3 25.0 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 176.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.736 ' HD2' ' H ' ' A' ' 289' ' ' THR . 49.4 p90 -113.72 125.31 29.68 Favored Pre-proline 0 C--N 1.315 -0.931 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.468 -177.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 287' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 35.0 Cg_exo -64.06 70.93 0.19 Allowed 'Trans proline' 0 N--CA 1.479 0.665 0 C-N-CA 123.709 2.939 . . . . 0.0 112.689 176.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.539 ' O ' ' N ' ' A' ' 290' ' ' HIS . 34.5 p90 37.96 40.55 0.3 Allowed 'General case' 0 CA--C 1.49 -1.355 0 O-C-N 124.447 1.092 . . . . 0.0 108.689 -171.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.736 ' H ' ' HD2' ' A' ' 286' ' ' PHE . 41.9 m -40.81 73.41 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.043 0 O-C-N 126.499 2.374 . . . . 0.0 112.995 -156.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 290' ' ' HIS . . . . . 0.539 ' N ' ' O ' ' A' ' 288' ' ' PHE . 16.4 m80 63.87 25.21 13.95 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 112.192 -2.276 . . . . 0.0 109.363 169.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.576 ' HB ' ' HB1' ' A' ' 240' ' ' ALA . 33.5 m -88.58 169.71 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 121.41 0.624 . . . . 0.0 111.621 -173.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -129.69 114.36 15.91 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.115 178.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.662 HD13 ' HB2' ' A' ' 240' ' ' ALA . 50.2 mm -72.0 124.55 28.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.331 -178.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 294' ' ' PHE . . . . . 0.538 ' CE1' ' HB2' ' A' ' 241' ' ' LYS . 1.8 p90 -154.27 -176.01 5.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.984 -178.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.586 ' OD2' ' HB2' ' A' ' 297' ' ' GLN . 21.1 t70 -130.37 116.96 17.64 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 172.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.62 -13.31 34.84 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.789 2.326 . . . . 0.0 112.508 -177.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 297' ' ' GLN . . . . . 0.586 ' HB2' ' OD2' ' A' ' 295' ' ' ASP . 89.8 mt-30 -72.27 -46.86 54.09 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.67 178.286 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 298' ' ' ASN . . . . . 0.408 ' HA ' ' HD3' ' A' ' 299' ' ' PRO . 0.3 OUTLIER -110.47 96.44 27.32 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-O 121.712 0.768 . . . . 0.0 110.723 171.8 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 299' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 298' ' ' ASN . 2.9 Cg_exo -76.57 35.96 0.49 Allowed 'Trans proline' 0 CA--C 1.528 0.211 0 C-N-CA 123.306 2.671 . . . . 0.0 113.272 -173.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -79.51 -65.64 0.97 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.696 0.284 . . . . 0.0 110.349 177.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -90.45 85.54 6.19 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.973 0.416 . . . . 0.0 110.738 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -178.57 141.24 0.21 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.356 174.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 . . . . . 0 C--O 1.246 0.895 0 CA-C-O 118.295 -0.859 . . . . 0.0 110.55 177.625 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.4 tpp . . . . . 0 N--CA 1.481 1.119 0 CA-C-O 120.924 0.392 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m -83.71 118.5 23.92 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.16 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.57 ' O ' HG23 ' A' ' 99' ' ' ILE . 16.1 m -61.58 -56.13 23.22 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.128 0.489 . . . . 0.0 109.714 173.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.515 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . -78.79 105.81 10.36 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.996 176.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 32.6 ttm180 -138.84 97.12 3.25 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.331 0.586 . . . . 0.0 111.113 -176.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -168.45 163.04 12.57 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.726 178.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.503 ' HB2' ' HB2' ' A' ' 10' ' ' ASP . 22.8 m-20 -89.19 117.08 27.91 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 174.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.8 m -66.57 -13.53 61.15 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.092 -0.503 . . . . 0.0 112.086 -172.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.7 t -115.54 -0.16 13.14 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.26 0.552 . . . . 0.0 111.107 -176.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.503 ' HB2' ' HB2' ' A' ' 7' ' ' ASP . 8.1 t0 -79.47 91.68 5.16 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 121.916 -0.49 . . . . 0.0 110.232 -177.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.516 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 5.0 mtm-85 -69.44 -14.25 62.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.513 -178.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.7 t -84.9 0.04 52.48 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 175.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -109.95 -48.79 3.15 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.434 ' HB3' ' HB3' ' A' ' 101' ' ' PRO . 40.2 p-90 -108.86 -20.45 13.05 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -173.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.516 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 19.3 t80 -73.38 108.89 6.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.094 0.473 . . . . 0.0 109.808 -177.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.726 ' HG3' HG21 ' A' ' 19' ' ' VAL . 12.0 tpp -89.01 -8.45 54.02 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.901 -171.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.494 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 50.23 -114.97 2.83 Favored Glycine 0 CA--C 1.522 0.475 0 CA-C-N 115.269 -0.878 . . . . 0.0 114.438 177.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.494 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 8.5 Cg_exo -72.52 82.14 1.45 Allowed 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 123.202 2.601 . . . . 0.0 113.158 -173.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.726 HG21 ' HG3' ' A' ' 16' ' ' MET . 44.0 t -142.02 166.4 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.456 ' N ' HG12 ' A' ' 19' ' ' VAL . 15.6 m -137.79 172.12 13.42 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -170.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 54.8 mtp85 -54.53 -53.79 49.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 118.154 0.434 . . . . 0.0 111.925 -177.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -57.89 -63.13 1.36 Allowed 'General case' 0 C--N 1.327 -0.374 0 O-C-N 123.477 0.486 . . . . 0.0 111.087 -177.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.453 ' O ' ' HB ' ' A' ' 26' ' ' THR . 36.6 tt0 -57.95 -45.45 86.62 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.67 -176.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.479 ' HB2' HG12 ' A' ' 19' ' ' VAL . . . -57.09 -50.8 71.65 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 120.933 0.397 . . . . 0.0 111.375 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.66 ' HG3' ' HB ' ' A' ' 58' ' ' VAL . 18.5 tt0 -64.4 -32.91 74.72 Favored 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.453 ' HB ' ' O ' ' A' ' 23' ' ' GLU . 7.8 m -59.81 -41.93 92.34 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.607 174.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.492 ' O ' ' HG3' ' A' ' 31' ' ' GLN . 95.4 mtt180 -68.8 -14.44 63.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.893 0.377 . . . . 0.0 110.896 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.596 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 72.3 mt -120.62 -12.6 8.87 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -174.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.2 tp60 -70.03 105.77 2.99 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.833 0.349 . . . . 0.0 111.024 -174.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 117' ' ' ASN . . . 72.64 5.35 63.77 Favored Glycine 0 C--O 1.226 -0.398 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.241 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.492 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 81.9 mm-40 -80.67 -162.16 0.45 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.845 0.355 . . . . 0.0 111.194 -176.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.46 ' HA ' ' CB ' ' A' ' 116' ' ' PRO . 34.7 mtm180 -59.31 119.29 7.15 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.984 0.421 . . . . 0.0 110.098 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.59 ' H ' ' HB3' ' A' ' 116' ' ' PRO . 27.4 m170 -76.6 125.93 30.1 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.952 -177.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.42 -6.25 22.96 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 -175.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.571 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 51.3 mtm -82.93 146.64 28.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.762 0.315 . . . . 0.0 110.216 177.006 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -145.94 163.6 34.64 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 176.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.45 ' O ' HD12 ' A' ' 37' ' ' LEU . 4.4 pp -152.61 137.21 16.87 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.058 0.456 . . . . 0.0 111.067 177.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.9 t -107.1 105.38 18.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 173.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.445 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 25.8 ptt-85 -104.13 166.69 10.24 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.731 -175.21 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -76.79 124.23 27.38 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 174.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.516 ' HB2' HG23 ' A' ' 49' ' ' VAL . 25.6 t -99.39 166.19 11.3 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.24 0.543 . . . . 0.0 111.225 -173.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.8 m -118.28 18.16 13.76 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.999 -175.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.2 m -75.02 -43.91 51.02 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 177.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 49.5 t -168.09 112.93 0.59 Allowed Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.696 177.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -34.67 102.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 124.155 3.237 . . . . 0.0 113.433 -175.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 134.1 -25.43 3.5 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.638 -175.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -83.17 151.59 25.63 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 177.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -128.43 174.08 9.65 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -178.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.516 HG23 ' HB2' ' A' ' 41' ' ' SER . 58.5 t -137.74 112.81 9.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.425 0.631 . . . . 0.0 111.541 176.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.495 HD23 HD11 ' A' ' 73' ' ' ILE . 51.5 tp -81.01 98.34 7.91 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.225 -1.352 . . . . 0.0 109.698 174.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.3 m -96.0 128.93 43.33 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 175.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.614 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 94.6 t -122.06 142.4 38.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.117 -174.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.596 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 45.0 t -105.89 114.91 29.35 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -175.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.53 155.65 33.77 Favored 'General case' 0 C--O 1.207 -1.18 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 160.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 59.13 20.42 8.38 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 174.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.564 ' OG ' ' HA ' ' A' ' 119' ' ' PRO . 22.3 m 56.43 54.34 7.67 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 122.797 1.284 . . . . 0.0 108.082 -172.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.429 HH22 ' C ' ' A' ' 153' ' ' ILE . 0.2 OUTLIER -162.33 64.03 0.22 Allowed 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 112.751 -2.022 . . . . 0.0 109.493 -151.166 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.66 ' HB ' ' HG3' ' A' ' 25' ' ' GLN . 26.1 t -74.65 99.94 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 122.032 0.92 . . . . 0.0 111.03 -168.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.3 m -67.84 120.9 14.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 113.985 -1.461 . . . . 0.0 111.255 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -96.68 109.32 21.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.882 0.372 . . . . 0.0 111.513 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.461 ' HB2' ' HB3' ' A' ' 50' ' ' LEU . 89.4 m-85 -106.0 117.59 34.43 Favored 'General case' 0 C--O 1.216 -0.709 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.537 177.211 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.709 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 53.4 mt -80.36 145.99 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 O-C-N 121.872 -0.517 . . . . 0.0 111.076 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.683 HG13 HG12 ' A' ' 73' ' ' ILE . 4.8 mp -129.53 104.11 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.122 0.487 . . . . 0.0 110.455 177.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.554 ' HB2' ' HB3' ' A' ' 72' ' ' LYS . 31.0 m-80 -90.56 142.75 27.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.485 -172.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 31.6 t -81.82 97.17 7.87 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 172.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.0 mt -73.99 143.44 80.85 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.543 -177.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.5 -23.29 70.16 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 123.078 2.518 . . . . 0.0 112.555 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 36.8 p30 -83.64 12.34 5.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.8 177.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 69' ' ' ARG . 5.2 tpp85 69.79 25.82 4.97 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.465 0.65 . . . . 0.0 111.317 175.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.695 ' HG2' ' HA ' ' A' ' 79' ' ' ASP . 68.1 mtt180 -113.71 -174.81 2.54 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.815 174.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.52 ' HB3' HG23 ' A' ' 63' ' ' ILE . 39.1 m-85 -131.09 131.78 44.41 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.019 0.438 . . . . 0.0 111.471 -177.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.554 ' HB3' ' HB2' ' A' ' 64' ' ' ASN . 14.6 tppt? -97.58 100.92 12.33 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.679 177.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.758 HG13 HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -99.1 86.4 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 122.92 1.343 . . . . 0.0 109.017 -177.262 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.16 -110.76 3.74 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.502 -174.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 168' ' ' GLY . 26.4 t0 -108.24 -18.99 13.63 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.575 0.702 . . . . 0.0 109.536 176.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -90.74 136.35 33.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.747 -176.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.467 ' HB3' ' HE2' ' A' ' 72' ' ' LYS . 0.9 OUTLIER -110.41 128.13 55.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.364 0.602 . . . . 0.0 111.025 175.306 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.42 ' O ' ' HB3' ' A' ' 70' ' ' ARG . 8.8 m-85 -122.88 172.24 8.62 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 176.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.695 ' HA ' ' HG2' ' A' ' 70' ' ' ARG . 5.7 m-20 -75.09 -34.84 61.81 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -172.138 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.499 ' ND1' ' HG2' ' A' ' 82' ' ' PRO . 3.3 p80 -156.58 166.66 32.76 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 121.33 -0.148 . . . . 0.0 110.819 -178.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.603 HD23 HD21 ' A' ' 84' ' ' LEU . 18.0 mt -54.94 -54.68 47.17 Favored Pre-proline 0 N--CA 1.469 0.487 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -177.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.499 ' HG2' ' ND1' ' A' ' 80' ' ' HIS . 18.0 Cg_endo -61.67 -10.51 17.01 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.172 1.914 . . . . 0.0 113.418 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.402 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -90.62 -36.79 14.2 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.873 0.368 . . . . 0.0 110.554 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.758 HD13 HG13 ' A' ' 73' ' ' ILE . 3.2 pp -76.92 -35.78 57.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.92 0.39 . . . . 0.0 110.022 -178.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.493 ' O ' ' HG2' ' A' ' 89' ' ' LYS . 89.1 mt -64.91 -24.1 67.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.999 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.515 ' HA ' ' CG ' ' A' ' 89' ' ' LYS . 26.9 tt0 -83.09 -22.34 33.45 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.79 -176.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -72.2 -35.67 69.0 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.731 0.777 . . . . 0.0 109.547 175.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.723 ' CG ' HD23 ' A' ' 93' ' ' LEU . 74.5 m-85 -86.63 1.43 51.87 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.43 -176.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.515 ' CG ' ' HA ' ' A' ' 86' ' ' GLU . 9.6 mmmm -71.75 -23.39 61.59 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 171.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 30.6 pt -121.2 7.96 6.07 Favored 'Isoleucine or valine' 0 C--N 1.339 0.151 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.112 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.412 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 5.8 t-160 -98.28 -40.37 8.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.08 -176.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.596 ' CD2' HG23 ' A' ' 97' ' ' THR . 60.7 m-85 64.75 77.64 0.31 Allowed 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -170.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.723 HD23 ' CG ' ' A' ' 88' ' ' TYR . 1.4 pp -79.29 18.15 0.72 Allowed 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -172.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.521 ' O ' HG22 ' A' ' 95' ' ' THR . 27.3 t70 -175.22 65.19 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.258 162.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.69 ' CB ' ' HA ' ' A' ' 156' ' ' PRO . 0.6 OUTLIER 62.16 -28.5 0.07 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.048 1.339 . . . . 0.0 112.528 -174.013 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.476 ' H ' ' C ' ' A' ' 94' ' ' ASP . 2.0 t -109.3 157.4 18.89 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 172.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.596 HG23 ' CD2' ' A' ' 92' ' ' TYR . 7.4 p -90.33 -179.99 5.75 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 177.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 89.4 mt -73.16 91.49 1.65 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 171.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.57 HG23 ' O ' ' A' ' 3' ' ' SER . 37.4 mm -74.84 -61.87 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.856 -174.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.571 ' O ' ' HA ' ' A' ' 35' ' ' MET . 10.4 pt-20 -157.19 157.46 30.46 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.183 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.46 ' HD2' ' HB2' ' A' ' 100' ' ' GLU . 55.9 Cg_endo -69.58 152.83 70.31 Favored 'Trans proline' 0 C--O 1.237 0.458 0 C-N-CA 122.502 2.135 . . . . 0.0 112.91 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -77.29 156.78 81.34 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.526 177.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.523 ' HD3' ' SD ' ' A' ' 35' ' ' MET . 23.6 Cg_exo -64.21 132.16 32.98 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.342 2.028 . . . . 0.0 112.186 177.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.433 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 34.2 ptt180 -86.33 27.85 0.89 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.855 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.41 ' HA ' ' HD2' ' A' ' 106' ' ' PRO . 89.9 m-85 -95.45 116.49 66.33 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.341 178.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 105' ' ' TYR . 31.6 Cg_endo -65.46 124.22 12.55 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.186 1.924 . . . . 0.0 110.673 174.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.9 m 65.77 96.98 0.04 OUTLIER Pre-proline 0 C--O 1.233 0.188 0 O-C-N 123.688 0.618 . . . . 0.0 109.659 -170.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.504 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 22.4 Cg_endo -60.91 146.33 97.78 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 123.088 2.525 . . . . 0.0 113.071 -173.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.504 ' HD3' ' HA ' ' A' ' 108' ' ' PRO . 38.1 Cg_exo -61.55 150.76 83.97 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 123.123 2.548 . . . . 0.0 112.01 178.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 38.2 tpp -85.8 107.95 17.88 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.724 -174.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 134.56 -158.04 23.25 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.96 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.1 m 65.77 25.19 11.39 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.129 0.49 . . . . 0.0 111.21 177.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 39.3 t -77.1 98.88 2.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.121 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.54 ' HB3' ' HD2' ' A' ' 116' ' ' PRO . 20.0 t -105.22 -148.57 0.41 Allowed 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.428 ' HB3' ' HD3' ' A' ' 116' ' ' PRO . . . -58.84 -41.55 89.29 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 175.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.59 ' HB3' ' H ' ' A' ' 33' ' ' HIS . 22.1 Cg_exo -68.11 -167.36 0.17 Allowed 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 122.034 1.823 . . . . 0.0 112.192 171.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.412 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 4.9 m-20 67.19 19.9 10.27 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.947 0.403 . . . . 0.0 111.245 -177.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 73.5 mt -99.93 113.11 65.01 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.262 177.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.564 ' HA ' ' OG ' ' A' ' 56' ' ' SER . 32.5 Cg_exo -59.31 -64.24 0.11 Allowed 'Trans proline' 0 N--CA 1.464 -0.247 0 C-N-CA 122.872 2.382 . . . . 0.0 112.115 177.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 69.4 p 61.41 -36.96 0.11 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.049 1.34 . . . . 0.0 113.637 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.405 ' H ' ' C ' ' A' ' 119' ' ' PRO . . . -134.51 172.66 12.61 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 177.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -132.01 -106.74 0.26 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.299 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -88.12 93.32 9.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.136 0.494 . . . . 0.0 110.442 177.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -163.82 146.06 9.39 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.688 ' HG ' ' HD2' ' A' ' 155' ' ' LYS . 3.3 mm? 67.82 96.73 0.06 Allowed 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.703 0.763 . . . . 0.0 111.66 -177.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -174.5 -38.79 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.566 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.483 ' HB3' ' HB3' ' A' ' 181' ' ' LEU . 79.9 m-85 -127.64 116.02 19.65 Favored 'General case' 0 CA--C 1.504 -0.804 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.487 176.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.662 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 2.1 t -115.47 153.72 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.748 -177.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.775 ' NH2' HD13 ' A' ' 181' ' ' LEU . 1.7 ptp180 -137.59 124.59 21.43 Favored 'General case' 0 CA--C 1.496 -1.11 0 C-N-CA 117.281 -1.767 . . . . 0.0 112.891 173.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.69 HG22 HG12 ' A' ' 178' ' ' VAL . 81.7 p -79.49 131.88 36.18 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 114.268 -1.333 . . . . 0.0 111.13 -177.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.477 HD21 ' HG3' ' A' ' 129' ' ' ARG . 2.5 mt -116.59 8.5 13.91 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.624 -175.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -122.82 -36.07 2.94 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -171.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.499 ' HB2' ' HB3' ' A' ' 146' ' ' LYS . 11.0 t70 78.52 110.7 0.07 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.23 0.612 . . . . 0.0 110.873 -178.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.619 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 79.2 t80 -144.55 91.66 6.17 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 177.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.643 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 72.8 Cg_endo -79.53 85.98 1.75 Allowed 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 121.846 1.697 . . . . 0.0 112.404 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.38 -35.38 60.0 Favored Glycine 0 C--N 1.333 0.384 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.445 179.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.804 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 4.5 m-20 68.27 37.66 2.75 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 122.652 0.381 . . . . 0.0 111.548 178.05 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -137.71 170.41 16.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.662 0.267 . . . . 0.0 110.554 -177.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -89.86 -6.19 56.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.74 0.781 . . . . 0.0 109.108 174.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -103.14 -34.14 8.96 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.57 177.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -120.08 109.55 15.6 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.385 176.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 1.057 HD11 ' HB2' ' A' ' 165' ' ' ASN . 36.5 tp -68.15 132.11 91.92 Favored Pre-proline 0 CA--C 1.515 -0.378 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.394 -177.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.804 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 7.6 Cg_endo -83.05 104.1 1.22 Allowed 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 121.785 1.657 . . . . 0.0 110.108 169.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.677 ' CG ' HG21 ' A' ' 130' ' ' THR . 9.4 p90 -121.39 163.6 18.44 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.254 -176.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.533 ' HB2' ' HB3' ' A' ' 148' ' ' GLU . 12.8 mptt -96.51 -169.82 1.97 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.376 0.607 . . . . 0.0 112.494 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.902 ' H ' ' HD2' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -89.29 5.49 44.69 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.238 -176.456 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -168.7 37.35 0.21 Allowed Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 176.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.583 ' OE1' ' HA ' ' A' ' 144' ' ' PHE . 0.4 OUTLIER -92.95 157.69 16.21 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 120.87 0.367 . . . . 0.0 110.272 -177.713 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -98.38 131.89 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-O 121.774 0.797 . . . . 0.0 109.727 178.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.616 HD22 HD21 ' A' ' 142' ' ' LEU . 14.9 mt -120.31 156.27 31.62 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.086 -1.415 . . . . 0.0 107.646 -174.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.561 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 60.8 t -124.16 122.93 65.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 176.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.935 HD13 ' HB2' ' A' ' 163' ' ' ALA . 26.1 mm -76.16 102.99 3.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.578 0.704 . . . . 0.0 109.458 -174.031 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.527 HG21 HG22 ' A' ' 170' ' ' VAL . 20.3 tt -97.91 -30.0 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-N 114.801 -1.091 . . . . 0.0 109.802 -173.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.621 ' OE2' ' HA ' ' A' ' 93' ' ' LEU . 1.8 mt-10 -131.77 140.84 49.33 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 165.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.688 ' HD2' ' HG ' ' A' ' 125' ' ' LEU . 39.9 tttp -123.02 89.55 50.68 Favored Pre-proline 0 C--N 1.321 -0.657 0 O-C-N 121.231 -0.918 . . . . 0.0 109.868 167.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.69 ' HA ' ' CB ' ' A' ' 95' ' ' THR . 3.0 Cg_exo -77.81 -51.54 0.08 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.592 2.195 . . . . 0.0 112.023 175.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.57 ' HG2' ' CE ' ' A' ' 172' ' ' MET . 22.5 mm-40 -102.67 179.44 4.29 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -171.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.415 ' HA ' ' HE1' ' A' ' 161' ' ' TRP . 11.5 pt-20 -107.13 -20.03 13.43 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.56 176.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -109.41 -8.69 15.01 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.803 0.335 . . . . 0.0 110.871 177.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.54 ' O ' ' HB2' ' A' ' 157' ' ' GLU . 83.4 m95 -132.03 131.39 42.44 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 169.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' TRP . . . . . 0.49 ' CE3' HD11 ' A' ' 125' ' ' LEU . 48.1 m0 -122.88 143.47 49.85 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.37 177.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.609 ' HA ' ' HA ' ' A' ' 172' ' ' MET . 21.6 m -89.14 99.67 12.61 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -176.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.935 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -110.09 151.6 27.02 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.027 -175.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.828 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 12.8 ptt180 -87.97 121.18 30.08 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-O 122.109 0.957 . . . . 0.0 108.944 172.067 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 1.057 ' HB2' HD11 ' A' ' 142' ' ' LEU . 11.7 t30 -45.21 167.3 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 112.131 -2.304 . . . . 0.0 112.006 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.419 ' HD2' ' HA ' ' A' ' 166' ' ' LYS . 15.5 tptm -58.32 -14.29 7.1 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.015 173.059 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.518 ' HB2' ' ND2' ' A' ' 165' ' ' ASN . 21.7 m-20 -95.62 -9.19 32.81 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.001 0.429 . . . . 0.0 109.987 174.18 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 75' ' ' ASP . . . 90.2 39.06 6.15 Favored Glycine 0 CA--C 1.522 0.489 0 CA-C-N 115.85 -0.614 . . . . 0.0 113.406 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.828 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 7.8 ttm-85 -111.76 138.71 47.98 Favored 'General case' 0 C--O 1.214 -0.777 0 CA-C-N 116.933 0.367 . . . . 0.0 111.472 -177.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.527 HG22 HG21 ' A' ' 153' ' ' ILE . 21.9 t -78.96 125.61 38.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 C-N-CA 120.839 -0.345 . . . . 0.0 111.552 -179.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -164.02 149.72 17.24 Favored Glycine 0 C--N 1.332 0.321 0 N-CA-C 111.59 -0.604 . . . . 0.0 111.59 168.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.609 ' HA ' ' HA ' ' A' ' 162' ' ' SER . 59.5 mtp -77.0 143.32 39.48 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 117.565 0.682 . . . . 0.0 110.751 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.695 ' O ' HD12 ' A' ' 173' ' ' ILE . 1.6 pp -134.88 151.84 76.33 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.444 -177.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.733 ' O ' HG13 ' A' ' 178' ' ' VAL . 1.0 OUTLIER -85.24 123.79 2.72 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.821 2.347 . . . . 0.0 113.241 -174.819 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.574 ' HA ' HG22 ' A' ' 178' ' ' VAL . 94.8 t -53.73 -45.42 98.77 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 178.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.496 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 65.2 Cg_exo -54.91 -23.93 36.69 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 122.112 1.875 . . . . 0.0 112.817 174.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.554 ' CD2' ' HG2' ' A' ' 174' ' ' PRO . 3.4 m-30 -84.82 -39.58 18.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.018 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.733 HG13 ' O ' ' A' ' 174' ' ' PRO . 1.1 m -111.65 -177.77 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.637 -164.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.897 ' HG3' ' H ' ' A' ' 180' ' ' LYS . 11.2 pt-20 -158.13 -71.03 0.09 Allowed 'General case' 0 C--O 1.207 -1.142 0 N-CA-C 118.011 2.597 . . . . 0.0 118.011 144.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.897 ' H ' ' HG3' ' A' ' 179' ' ' GLU . 3.6 mppt? -156.25 179.64 9.05 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 118.855 -2.403 . . . . 0.0 114.593 -169.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.775 HD13 ' NH2' ' A' ' 129' ' ' ARG . 12.0 tp -125.15 -60.49 1.34 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.929 164.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.842 HG13 ' H ' ' A' ' 183' ' ' ARG . 2.4 p -90.65 -89.81 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 119.447 -0.311 . . . . 0.0 110.717 177.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.842 ' H ' HG13 ' A' ' 182' ' ' VAL . 0.2 OUTLIER 68.82 141.84 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.612 0.765 . . . . 0.0 112.979 172.235 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.445 ' N ' ' HD3' ' A' ' 183' ' ' ARG . 10.5 p -85.47 -100.72 0.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.771 171.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 60.5 p 170.46 166.11 0.2 Allowed Pre-proline 0 C--O 1.237 0.4 0 C-N-CA 123.273 0.629 . . . . 0.0 109.814 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -61.32 123.67 13.26 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.46 2.107 . . . . 0.0 111.099 173.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.44 ' HB2' ' HB2' ' A' ' 190' ' ' HIS . 31.6 m80 -122.92 15.73 10.05 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.228 -175.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 77.25 -63.6 3.26 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.754 -177.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 64.0 mmtt -76.15 -11.3 59.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.587 0.708 . . . . 0.0 109.299 176.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' HIS . . . . . 0.44 ' HB2' ' HB2' ' A' ' 187' ' ' HIS . 18.4 m-70 -119.38 88.75 2.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.055 173.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 142.49 -148.66 20.43 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.014 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 66.59 142.62 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.773 0.797 . . . . 0.0 112.328 -178.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.464 ' HA ' ' NE ' ' A' ' 193' ' ' ARG . 4.6 mmp_? -125.49 113.57 17.65 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.053 176.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -102.8 140.28 37.28 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.957 0.408 . . . . 0.0 110.259 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 29.0 m -128.06 107.94 10.24 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -114.79 -43.75 3.11 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.29 -175.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 12.6 t 61.64 -176.48 0.13 Allowed 'General case' 0 CA--C 1.535 0.389 0 O-C-N 123.296 0.373 . . . . 0.0 110.685 178.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -132.69 -16.54 2.61 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.878 0.371 . . . . 0.0 110.026 175.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 78.82 -57.62 4.26 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.755 -178.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.471 HD12 ' HD2' ' A' ' 201' ' ' PRO . 6.6 tp -114.03 122.02 35.52 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-O 120.895 0.378 . . . . 0.0 110.467 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.481 ' O ' ' HD3' ' A' ' 203' ' ' PRO . 9.6 Cg_exo -72.65 163.8 37.44 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.715 2.276 . . . . 0.0 111.208 174.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -83.39 103.37 2.62 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 201' ' ' PRO . 93.0 Cg_endo -93.61 -5.75 2.68 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.878 2.385 . . . . 0.0 113.889 -171.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -113.1 -63.86 1.39 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.876 0.37 . . . . 0.0 111.3 -177.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -83.22 67.06 9.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.437 0.637 . . . . 0.0 111.576 -174.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -140.03 -3.18 1.43 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.033 174.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 55.18 72.76 0.46 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.478 -176.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -80.4 92.12 5.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.254 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -115.46 150.0 43.85 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.193 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.83 120.32 8.06 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.835 2.357 . . . . 0.0 112.666 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.409 ' HB3' ' H ' ' A' ' 212' ' ' THR . 26.4 mt-30 -139.16 -162.63 1.35 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.18 179.115 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.409 ' H ' ' HB3' ' A' ' 211' ' ' GLN . 12.7 p -71.94 -61.72 1.69 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.985 0.421 . . . . 0.0 111.547 -177.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.69 95.99 9.91 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.724 178.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.566 HG22 ' HG ' ' A' ' 216' ' ' LEU . 8.8 m -82.04 115.05 55.14 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.043 -178.047 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 214' ' ' THR . 1.2 Cg_endo -82.94 82.54 2.15 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.912 2.408 . . . . 0.0 112.251 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.958 ' HB2' ' HD3' ' A' ' 217' ' ' PRO . 97.2 mt -111.01 -62.91 0.04 OUTLIER Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.421 174.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.958 ' HD3' ' HB2' ' A' ' 216' ' ' LEU . 4.4 Cg_exo -80.58 -57.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 121.704 1.602 . . . . 0.0 110.91 175.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -166.15 142.56 5.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.305 176.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 40.1 t -63.99 -34.94 71.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.049 0.452 . . . . 0.0 110.781 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 5.5 m -74.58 -13.36 60.65 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.157 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 94.06 103.15 1.72 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.51 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.416 ' HA ' ' HD3' ' A' ' 223' ' ' PRO . 14.1 m -74.29 125.05 90.29 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 110.435 -0.209 . . . . 0.0 110.435 178.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 222' ' ' SER . 46.9 Cg_exo -56.07 121.52 10.14 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.878 2.386 . . . . 0.0 112.058 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.568 ' H ' HG23 ' A' ' 227' ' ' ILE . . . 102.7 -48.09 1.07 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.327 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -87.44 -37.12 17.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.832 0.348 . . . . 0.0 111.535 -177.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -115.12 27.28 9.5 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.599 -175.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.568 HG23 ' H ' ' A' ' 224' ' ' GLY . 2.7 pp -85.83 161.71 2.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.468 176.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 5.0 t -102.94 118.69 57.58 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-O 121.211 0.529 . . . . 0.0 111.148 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -84.63 -177.13 2.77 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.661 2.241 . . . . 0.0 111.705 174.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.819 ' H ' HD23 ' A' ' 230' ' ' LEU . 2.0 pt? -91.0 125.69 57.93 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.859 0.361 . . . . 0.0 110.679 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.517 ' HD3' ' HA ' ' A' ' 230' ' ' LEU . 1.2 Cg_endo -84.94 93.85 0.68 Allowed 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.265 2.644 . . . . 0.0 112.692 -178.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 22.1 t 67.05 -79.32 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.569 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 70.6 p 55.69 -84.0 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.324 1.05 . . . . 0.0 112.377 -177.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -175.14 -35.92 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 -178.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -103.23 17.04 25.01 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.418 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -64.29 -56.18 19.28 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.802 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -74.4 108.89 2.78 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.139 1.893 . . . . 0.0 110.87 172.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.453 HG11 HD12 ' A' ' 293' ' ' ILE . 3.5 t -89.82 141.59 14.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.846 -173.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.447 ' HB2' ' HG3' ' A' ' 296' ' ' PRO . 94.0 m-85 -113.26 122.98 49.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.28 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.464 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -119.72 144.26 47.33 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.421 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -90.87 119.83 31.39 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -66.95 102.46 0.98 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.928 0.394 . . . . 0.0 110.024 177.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 24.8 pt -83.31 -35.29 11.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.421 -174.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 10.3 tm0? -132.89 130.89 40.29 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -54.36 140.38 33.75 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.883 -171.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.578 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 27.5 tpt180 -124.03 107.12 10.96 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.896 -178.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 16.5 m -115.87 126.67 27.46 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-O 120.954 0.407 . . . . 0.0 110.477 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.464 ' HB3' ' HB3' ' A' ' 255' ' ' ALA . 39.5 Cg_endo -67.68 127.66 16.68 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.629 2.219 . . . . 0.0 112.596 -178.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 39.2 t -78.58 171.94 14.41 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -53.1 -37.78 62.02 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.734 0.302 . . . . 0.0 111.72 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -97.71 14.25 27.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.898 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -90.89 -75.19 0.47 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 173.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 66.0 mttm 69.87 -58.41 0.53 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.944 178.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 11.2 p -73.32 -13.54 61.13 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.368 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.464 ' HB3' ' HB3' ' A' ' 248' ' ' PRO . . . -71.86 123.99 23.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.047 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.2 tt -73.5 133.94 43.75 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.636 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.578 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -81.62 104.93 12.37 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.093 0.473 . . . . 0.0 109.934 176.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 96.0 mt -109.0 134.94 50.98 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.481 -177.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -99.41 155.14 17.7 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.216 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 62.2 t -66.94 122.04 17.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.006 0.431 . . . . 0.0 111.083 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 95.21 11.42 56.15 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.675 -0.693 . . . . 0.0 113.202 175.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -95.14 166.93 11.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.985 0.392 . . . . 0.0 109.971 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 34.3 mm -102.55 118.24 49.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.114 0.483 . . . . 0.0 110.728 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 19.3 t -93.48 104.9 16.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.165 0.507 . . . . 0.0 110.284 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -85.7 87.7 7.44 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.814 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.43 HG21 ' HB3' ' A' ' 275' ' ' TRP . 6.2 p -91.73 126.02 44.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.489 0.661 . . . . 0.0 111.607 -175.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 44.7 p -104.69 -39.23 6.42 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.725 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 -105.6 117.44 34.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.124 -177.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 41.5 mtt -114.4 134.86 54.68 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.798 174.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -97.45 160.06 14.55 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.714 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 10.5 tp -75.21 -11.98 14.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.502 0.667 . . . . 0.0 109.972 176.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -75.2 -65.49 0.88 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.938 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 156.47 -23.55 0.5 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.383 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.439 ' HB3' HD22 ' A' ' 285' ' ' LEU . 98.3 mt-30 -87.06 119.75 27.61 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 176.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.48 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 31.4 m0 -101.43 156.23 17.59 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.789 -176.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.495 ' HA ' ' O ' ' A' ' 284' ' ' GLY . 47.9 mt-10 -112.28 114.57 27.41 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.061 175.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 277' ' ' GLY . . . . . 0.704 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -120.71 155.01 16.32 Favored Glycine 0 C--O 1.225 -0.434 0 C-N-CA 120.894 -0.669 . . . . 0.0 111.595 177.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.786 ' HG2' ' HB3' ' A' ' 283' ' ' LYS . 38.0 mt-10 -100.7 109.9 21.97 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.092 0.473 . . . . 0.0 110.849 179.203 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 48.7 t -118.95 130.82 73.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 176.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 44.54 34.77 1.18 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.958 0.903 . . . . 0.0 112.482 -174.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 94.49 -9.1 71.77 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.483 175.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -108.35 124.72 50.79 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 117.014 0.407 . . . . 0.0 111.259 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.786 ' HB3' ' HG2' ' A' ' 278' ' ' GLU . 9.4 ptpp? -96.33 142.17 28.78 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 172.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 284' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 276' ' ' GLU . . . -164.05 172.03 39.78 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.987 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.48 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 17.2 mt -82.44 130.74 35.17 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.158 0.504 . . . . 0.0 111.341 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -136.23 135.49 21.15 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.651 173.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 287' ' ' PRO . . . . . 0.9 ' HB2' HG22 ' A' ' 289' ' ' THR . 59.0 Cg_endo -75.61 138.31 21.45 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.237 1.958 . . . . 0.0 111.444 175.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.467 ' HA ' HG22 ' A' ' 291' ' ' VAL . 49.4 p90 -63.27 -8.47 8.52 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.932 0.396 . . . . 0.0 111.282 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 289' ' ' THR . . . . . 0.9 HG22 ' HB2' ' A' ' 287' ' ' PRO . 15.3 t -79.62 -13.81 59.24 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.012 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 16.8 m80 -101.19 -6.19 24.59 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.695 0.283 . . . . 0.0 110.846 178.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.467 HG22 ' HA ' ' A' ' 288' ' ' PHE . 35.9 m -127.78 178.99 4.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.94 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -140.76 116.01 9.95 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.039 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.464 HD13 ' HB2' ' A' ' 240' ' ' ALA . 34.2 mm -70.41 112.96 5.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 174.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -135.24 -169.87 2.47 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.865 -176.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -115.68 94.67 41.31 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 296' ' ' PRO . . . . . 0.447 ' HG3' ' HB2' ' A' ' 239' ' ' PHE . 36.2 Cg_endo -67.13 -48.06 2.01 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.31 2.006 . . . . 0.0 111.334 178.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -108.07 82.44 1.64 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.708 175.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 298' ' ' ASN . . . . . 0.423 ' HA ' ' HD2' ' A' ' 299' ' ' PRO . 14.0 m120 -58.51 118.32 27.28 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.604 176.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 299' ' ' PRO . . . . . 0.446 ' HA ' ' HB2' ' A' ' 302' ' ' ASN . 9.9 Cg_endo -52.97 -31.35 52.64 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.087 2.524 . . . . 0.0 112.784 -176.15 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -58.83 -40.54 84.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.051 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -119.49 37.49 4.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.364 0.602 . . . . 0.0 110.477 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 302' ' ' ASN . . . . . 0.446 ' HB2' ' HA ' ' A' ' 299' ' ' PRO . 13.0 t30 -76.27 -3.54 37.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.787 175.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 . . . . . 0 C--O 1.252 1.191 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.662 177.386 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.0 mtt . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 120.879 0.371 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.2 m -84.74 141.34 30.61 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.139 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.498 ' O ' HG23 ' A' ' 99' ' ' ILE . 9.4 p -83.75 -47.73 10.86 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 174.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.609 ' HB1' ' HE3' ' A' ' 89' ' ' LYS . . . -83.27 104.56 13.53 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.745 175.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 63.8 mtt180 -109.47 -10.49 14.88 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -167.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.449 ' H ' ' HD1' ' A' ' 6' ' ' PHE . 4.6 p90 -84.31 156.02 22.11 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.594 -170.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -66.7 -27.77 67.9 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.587 -177.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.3 t 75.09 -22.73 0.25 Allowed 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.412 0.685 . . . . 0.0 111.137 -178.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.6 t -105.17 -17.39 14.49 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 122.262 -0.273 . . . . 0.0 111.707 -177.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -81.08 107.74 14.15 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 121.718 -0.614 . . . . 0.0 110.625 -177.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.49 -41.59 94.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.948 -176.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.457 ' C ' HH22 ' A' ' 104' ' ' ARG . 24.2 t -68.77 -4.01 14.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.156 -176.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -91.84 -47.27 7.42 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.419 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 43.4 p-90 -117.33 -21.21 8.82 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -171.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -75.05 127.16 32.58 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -177.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.784 ' HG3' ' HB2' ' A' ' 37' ' ' LEU . 26.3 mmt -109.67 -8.35 14.96 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -173.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 50.55 -112.84 1.74 Allowed Glycine 0 CA--C 1.525 0.665 0 C-N-CA 121.376 -0.44 . . . . 0.0 113.2 -176.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -76.01 102.16 1.57 Allowed 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.52 2.147 . . . . 0.0 112.766 -178.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.737 ' HB ' ' HG3' ' A' ' 39' ' ' ARG . 22.2 t -142.07 -76.39 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.397 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.815 ' H ' ' HG3' ' A' ' 39' ' ' ARG . 51.1 m 93.41 171.01 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 168.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.511 ' HD3' ' HA ' ' A' ' 116' ' ' PRO . 74.0 mtp85 -62.1 -32.58 73.16 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.861 -172.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.407 ' HA ' ' HB ' ' A' ' 113' ' ' VAL . 33.5 mt-30 -59.65 -54.12 50.08 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 123.842 0.713 . . . . 0.0 110.751 178.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.485 ' O ' ' HG3' ' A' ' 27' ' ' ARG . 17.4 mt-10 -74.71 -47.22 32.64 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.784 -177.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.35 -51.17 70.46 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -172.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.546 ' HA ' HG11 ' A' ' 58' ' ' VAL . 3.9 tt0 -66.27 -33.79 76.53 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -177.091 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.401 ' HA ' ' HB2' ' A' ' 112' ' ' SER . 2.3 m -63.41 -35.45 80.45 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.344 -0.843 . . . . 0.0 112.113 178.068 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.485 ' HG3' ' O ' ' A' ' 23' ' ' GLU . 98.0 mtt180 -81.19 -13.3 58.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.599 0.238 . . . . 0.0 111.256 -177.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.57 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 41.0 mt -121.27 -13.33 8.5 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -172.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.518 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 26.6 tp60 -66.61 104.8 1.36 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.926 0.393 . . . . 0.0 110.32 -176.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 64.59 34.17 89.19 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.444 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 73.4 mm-40 -106.5 -160.85 0.76 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 178.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.568 ' HB2' ' HG3' ' A' ' 35' ' ' MET . 43.6 mtm180 -56.17 111.17 0.89 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.896 0.379 . . . . 0.0 110.624 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -67.38 111.06 3.84 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.008 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.472 ' HA2' HG21 ' A' ' 96' ' ' THR . . . 130.86 -14.26 5.5 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.499 -176.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.568 ' HG3' ' HB2' ' A' ' 32' ' ' ARG . 55.3 mtm -77.3 143.6 38.71 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 120.871 0.367 . . . . 0.0 110.426 177.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.471 ' HB2' HG22 ' A' ' 52' ' ' VAL . 34.0 p90 -141.39 166.01 25.94 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.236 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.784 ' HB2' ' HG3' ' A' ' 16' ' ' MET . 4.3 pp -157.13 139.14 14.4 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.234 0.54 . . . . 0.0 110.674 176.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.3 t -113.27 108.27 25.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.181 177.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.815 ' HG3' ' H ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -120.77 173.85 6.96 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.26 -178.533 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -61.69 130.32 45.29 Favored 'General case' 0 C--O 1.238 0.459 0 O-C-N 123.854 0.721 . . . . 0.0 110.147 178.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.4 t -80.13 154.98 27.69 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.517 -173.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.9 m -92.83 -5.32 51.3 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.744 177.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.2 m -73.34 -49.54 26.85 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.973 177.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 49.1 t -167.36 136.61 2.2 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.618 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -59.96 105.68 0.29 Allowed 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.503 2.135 . . . . 0.0 111.796 176.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 133.27 -29.41 3.18 Favored Glycine 0 N--CA 1.452 -0.278 0 N-CA-C 110.526 -1.029 . . . . 0.0 110.526 -174.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.409 ' OD1' ' HA ' ' A' ' 64' ' ' ASN . 30.3 t70 -80.58 151.41 29.1 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 173.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -127.25 157.93 38.51 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.506 ' HB ' ' CZ ' ' A' ' 39' ' ' ARG . 39.2 t -128.52 110.38 21.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.761 0.791 . . . . 0.0 111.316 176.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.46 ' HB3' ' HB2' ' A' ' 61' ' ' TYR . 47.5 tp -76.29 95.78 3.83 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 113.731 -1.577 . . . . 0.0 110.121 175.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 59' ' ' SER . 65.7 m -96.96 133.79 41.16 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 175.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.681 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 60.1 t -130.92 138.5 53.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.302 -171.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.57 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 40.0 t -89.68 108.22 19.55 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.803 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.682 ' O ' ' HB3' ' A' ' 57' ' ' ARG . 26.8 mt-10 -146.67 131.93 18.46 Favored 'General case' 0 C--O 1.206 -1.206 0 C-N-CA 119.685 -0.806 . . . . 0.0 110.253 176.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 23.9 m120 52.47 28.8 6.27 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 177.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.2 m 59.83 58.68 2.72 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 122.778 1.275 . . . . 0.0 108.67 -175.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.796 HH21 ' HB2' ' A' ' 94' ' ' ASP . 17.0 ttp85 -162.2 66.88 0.24 Allowed 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 112.869 -1.969 . . . . 0.0 109.395 -159.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.681 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 41.1 t -69.08 92.11 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-O 122.58 1.181 . . . . 0.0 109.143 -170.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 51' ' ' SER . 1.8 m -61.17 119.64 8.79 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 112.579 -2.1 . . . . 0.0 110.722 -177.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -99.53 96.49 7.7 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.913 0.387 . . . . 0.0 110.969 -178.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.633 ' CE2' HD22 ' A' ' 93' ' ' LEU . 88.6 m-85 -95.5 116.44 28.82 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.074 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.557 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 55.4 mt -81.53 146.48 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 O-C-N 122.24 -0.287 . . . . 0.0 111.35 -178.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.654 HG13 ' CG1' ' A' ' 73' ' ' ILE . 4.8 mp -134.14 102.04 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 122.571 0.349 . . . . 0.0 110.243 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.409 ' HA ' ' OD1' ' A' ' 47' ' ' ASP . 9.2 m120 -81.14 130.95 35.25 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.237 -177.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.2 t -78.54 100.39 6.9 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 172.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.567 HD11 ' HB2' ' A' ' 72' ' ' LYS . 85.8 mt -80.64 142.78 53.69 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.28 -174.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -63.07 -8.63 14.56 Favored 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 122.766 2.31 . . . . 0.0 111.344 170.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -75.82 2.85 11.21 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.883 172.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 69' ' ' ARG . 4.5 mmp_? 68.01 24.9 7.74 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.489 -178.081 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.417 ' HB3' ' O ' ' A' ' 78' ' ' PHE . 67.2 mtt180 -121.4 176.41 5.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.952 -178.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.415 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 57.2 m-85 -124.46 117.92 25.49 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.112 0.482 . . . . 0.0 110.277 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.656 ' HG3' ' HB3' ' A' ' 77' ' ' GLU . 74.1 tttt -98.12 99.93 11.21 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.826 -173.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.696 ' HB ' HD22 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -90.14 76.45 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 123.0 1.381 . . . . 0.0 110.228 -173.69 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.43 74.71 0.88 Allowed Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 114.578 -1.192 . . . . 0.0 113.262 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.446 ' HA ' ' HE2' ' A' ' 72' ' ' LYS . 38.6 t70 73.94 -40.96 0.47 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 174.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -91.82 119.73 31.88 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.656 ' HB3' ' HG3' ' A' ' 72' ' ' LYS . 13.5 pt-20 -100.14 139.85 35.21 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.328 0.585 . . . . 0.0 111.488 -176.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.435 ' CE1' HG22 ' A' ' 73' ' ' ILE . 26.9 m-85 -117.66 168.13 10.71 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 174.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -69.91 -20.72 63.35 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -171.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.489 ' CE1' ' HB2' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -170.81 172.92 5.46 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 122.553 -0.092 . . . . 0.0 111.183 174.741 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.533 HD23 HD21 ' A' ' 84' ' ' LEU . 13.0 mt -51.8 -54.89 35.23 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.058 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 81' ' ' LEU . 38.3 Cg_endo -64.68 -4.53 8.63 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 122.369 2.046 . . . . 0.0 113.448 -177.13 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.489 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -94.43 -34.17 12.85 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.921 0.391 . . . . 0.0 110.524 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.696 HD22 ' HB ' ' A' ' 73' ' ' ILE . 2.3 pp -75.34 -36.67 60.99 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.534 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 81.4 mt -65.35 -31.24 72.26 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.236 177.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.647 ' HA ' ' HD3' ' A' ' 89' ' ' LYS . 3.3 tp10 -70.77 -27.84 64.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.935 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.4 ' CD2' ' HZ ' ' A' ' 78' ' ' PHE . 18.5 t80 -75.66 -32.17 60.08 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.734 0.778 . . . . 0.0 109.593 -177.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.541 ' HA ' ' HB3' ' A' ' 91' ' ' HIS . 64.7 m-85 -89.62 2.05 55.22 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.471 -175.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.647 ' HD3' ' HA ' ' A' ' 86' ' ' GLU . 56.9 mtpt -84.4 -15.29 46.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.884 173.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 34.0 pt -121.03 0.49 7.25 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 CA-C-O 121.291 0.567 . . . . 0.0 110.285 174.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.541 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 3.3 t-160 -88.97 -44.29 10.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.859 -176.253 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.46 ' HB2' ' O ' ' A' ' 91' ' ' HIS . 90.4 m-85 67.33 88.64 0.11 Allowed 'General case' 0 CA--C 1.519 -0.237 0 O-C-N 124.135 0.897 . . . . 0.0 108.946 -165.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.638 ' O ' ' HB3' ' A' ' 154' ' ' GLU . 11.9 mt -44.02 -61.59 1.41 Allowed 'General case' 0 C--O 1.218 -0.576 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 175.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.796 ' HB2' HH21 ' A' ' 57' ' ' ARG . 21.0 t0 -141.62 89.68 2.23 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.688 170.227 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.532 ' HB ' ' O ' ' A' ' 94' ' ' ASP . 1.3 m 69.91 -6.84 1.0 Allowed 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.981 0.896 . . . . 0.0 110.558 175.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.472 HG21 ' HA2' ' A' ' 34' ' ' GLY . 76.2 m -135.59 142.91 45.36 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.782 -178.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.42 ' O ' HG22 ' A' ' 96' ' ' THR . 3.1 p -95.4 171.37 8.74 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 174.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.448 HD21 HD11 ' A' ' 93' ' ' LEU . 96.8 mt -66.77 91.84 0.2 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 173.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.498 HG23 ' O ' ' A' ' 3' ' ' SER . 47.0 mm -75.41 -66.86 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.298 -174.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.558 ' O ' ' HA ' ' A' ' 35' ' ' MET . 9.7 pt-20 -156.75 154.76 27.39 Favored Pre-proline 0 N--CA 1.447 -0.588 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.743 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.33 155.3 67.74 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.409 2.072 . . . . 0.0 112.982 -177.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.58 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -77.21 166.41 44.67 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.925 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.58 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 43.3 Cg_endo -68.63 132.94 26.38 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.317 2.011 . . . . 0.0 112.566 176.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.457 HH22 ' C ' ' A' ' 12' ' ' SER . 46.3 ttm180 -86.84 90.58 8.36 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.859 177.036 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.446 ' HA ' ' HD2' ' A' ' 106' ' ' PRO . 32.1 t80 -145.18 117.33 5.26 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.46 -177.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.525 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 10.4 Cg_endo -53.38 117.6 3.97 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.954 2.436 . . . . 0.0 111.452 178.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 18.7 m -90.73 109.73 36.57 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.511 -172.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.525 ' HD3' ' O ' ' A' ' 106' ' ' PRO . 39.2 Cg_exo -60.12 -55.27 1.67 Allowed 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 123.082 2.521 . . . . 0.0 113.894 178.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.426 ' HD3' ' HB2' ' A' ' 108' ' ' PRO . 60.7 Cg_endo -72.98 118.18 5.45 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 121.455 1.437 . . . . 0.0 112.84 -177.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 25.7 ttt -83.11 103.83 12.84 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.531 175.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -120.68 -64.73 0.26 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.151 -1.023 . . . . 0.0 113.076 -176.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.401 ' HB2' ' HA ' ' A' ' 26' ' ' THR . 13.4 m -94.56 125.54 39.28 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.873 0.368 . . . . 0.0 111.222 -173.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.407 ' HB ' ' HA ' ' A' ' 22' ' ' GLN . 10.5 p -175.64 144.0 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.817 -178.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 21.8 t -159.68 109.8 1.9 Allowed 'General case' 0 C--O 1.239 0.545 0 CA-C-O 120.484 0.183 . . . . 0.0 110.662 -178.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 118' ' ' LEU . . . 63.11 168.95 0.09 OUTLIER Pre-proline 0 N--CA 1.469 0.516 0 O-C-N 124.133 0.896 . . . . 0.0 112.36 174.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.511 ' HA ' ' HD3' ' A' ' 21' ' ' ARG . 9.9 Cg_endo -92.34 -10.15 2.28 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 123.422 2.748 . . . . 0.0 113.028 175.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 26.4 t30 -154.53 105.71 2.66 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -175.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.649 ' HG ' ' HD2' ' A' ' 119' ' ' PRO . 15.8 tp 71.55 151.76 0.14 Allowed Pre-proline 0 N--CA 1.466 0.359 0 O-C-N 124.32 1.012 . . . . 0.0 108.503 -174.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.649 ' HD2' ' HG ' ' A' ' 118' ' ' LEU . 42.2 Cg_endo -69.2 -147.07 0.02 OUTLIER 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 121.544 1.496 . . . . 0.0 111.808 174.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.452 ' H ' ' HB2' ' A' ' 119' ' ' PRO . 41.1 m -145.4 119.2 9.24 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 174.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.766 ' HB2' ' HB3' ' A' ' 126' ' ' GLU . . . -67.56 73.91 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.449 0.642 . . . . 0.0 111.502 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -84.05 -21.89 31.42 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.355 177.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -108.59 -69.1 0.87 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.537 171.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.413 ' N ' HD22 ' A' ' 124' ' ' ASN . 0.1 OUTLIER -172.47 161.92 5.18 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 118.66 0.663 . . . . 0.0 112.76 177.789 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.802 HD12 HG21 ' A' ' 152' ' ' ILE . 3.9 mm? 72.25 98.59 0.07 Allowed 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.881 174.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.766 ' HB3' ' HB2' ' A' ' 121' ' ' ALA . 41.5 tt0 -179.7 -75.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.35 -1.295 . . . . 0.0 109.157 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -98.88 108.13 20.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.188 0.518 . . . . 0.0 110.96 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.996 HG22 ' HG3' ' A' ' 180' ' ' LYS . 56.2 t -124.07 135.48 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.667 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.671 ' NH1' ' HB2' ' A' ' 181' ' ' LEU . 0.0 OUTLIER -111.29 148.05 33.75 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 117.51 -1.676 . . . . 0.0 108.538 169.977 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.557 HG22 HG12 ' A' ' 178' ' ' VAL . 0.9 OUTLIER -101.78 131.82 47.87 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.269 -179.903 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.563 HD21 ' HG2' ' A' ' 179' ' ' GLU . 21.8 mt -106.58 -17.5 14.23 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -176.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -87.09 -34.16 19.23 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.507 -174.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.527 ' HB2' ' HA ' ' A' ' 145' ' ' LYS . 0.0 OUTLIER 65.06 121.1 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 122.229 1.014 . . . . 0.0 111.317 -173.838 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -146.36 87.42 6.54 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 114.636 -1.166 . . . . 0.0 108.194 177.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.609 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 72.6 Cg_endo -83.0 85.99 1.51 Allowed 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 121.778 1.652 . . . . 0.0 112.578 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -77.18 -13.74 83.31 Favored Glycine 0 C--N 1.332 0.358 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 173.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.628 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 86.1 m-20 52.59 64.74 1.74 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 114.235 -0.982 . . . . 0.0 111.216 178.043 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.608 ' HB3' ' H ' ' A' ' 141' ' ' ASP . 0.4 OUTLIER -130.84 -177.29 4.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.239 0.543 . . . . 0.0 111.335 -175.931 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -110.95 0.8 17.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.675 167.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -116.72 -43.54 2.89 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.1 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.608 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 14.5 m-20 -101.07 123.62 45.52 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 169.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 1.075 HD11 ' HB2' ' A' ' 165' ' ' ASN . 32.2 tp -77.98 120.44 81.26 Favored Pre-proline 0 N--CA 1.468 0.459 0 CA-C-O 120.743 0.306 . . . . 0.0 111.058 -175.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.628 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 36.2 Cg_endo -72.44 95.46 0.78 Allowed 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.444 1.429 . . . . 0.0 111.272 168.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.551 ' CE2' ' HB ' ' A' ' 173' ' ' ILE . 10.4 p90 -106.7 160.55 15.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.391 -177.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.527 ' HA ' ' HB2' ' A' ' 133' ' ' ASP . 0.1 OUTLIER -103.56 -171.77 2.0 Allowed 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.929 -0.308 . . . . 0.0 111.25 -177.344 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.814 ' H ' ' HD2' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -88.57 5.31 43.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.36 -171.985 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -165.11 36.68 0.28 Allowed Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 175.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.453 ' HB3' ' HB2' ' A' ' 145' ' ' LYS . 0.0 OUTLIER -101.08 150.53 22.82 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.043 0.449 . . . . 0.0 111.368 -175.365 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.56 HD12 ' HB3' ' A' ' 129' ' ' ARG . 0.7 OUTLIER -90.14 132.14 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.567 -177.541 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.761 HD22 HD21 ' A' ' 142' ' ' LEU . 44.7 mt -127.9 157.15 41.31 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -177.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.581 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 58.0 t -122.93 123.8 68.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 174.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.957 HD13 ' HB2' ' A' ' 163' ' ' ALA . 36.8 mm -76.21 79.04 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.727 HG23 ' HG3' ' A' ' 154' ' ' GLU . 11.1 tt -75.62 -28.25 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-N 113.165 -1.834 . . . . 0.0 109.559 -174.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.727 ' HG3' HG23 ' A' ' 153' ' ' ILE . 29.8 mt-10 -134.39 142.15 47.08 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 175.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.424 ' HE3' ' HE1' ' A' ' 161' ' ' TRP . 81.8 tttt -143.62 78.23 14.6 Favored Pre-proline 0 C--N 1.324 -0.505 0 O-C-N 121.547 -0.721 . . . . 0.0 111.264 177.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.438 ' HG2' ' HG2' ' A' ' 157' ' ' GLU . 59.2 Cg_endo -73.93 -31.56 8.02 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.113 1.875 . . . . 0.0 111.552 176.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.438 ' HG2' ' HG2' ' A' ' 156' ' ' PRO . 14.2 mm-40 -119.89 164.37 16.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.519 -172.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.566 ' O ' HG21 ' A' ' 175' ' ' VAL . 9.3 tp10 -102.86 -22.24 13.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.587 0.232 . . . . 0.0 110.878 178.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.43 ' HA ' ' OE1' ' A' ' 159' ' ' GLN . 11.5 mm-40 -91.19 -21.14 21.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.094 0.474 . . . . 0.0 110.059 177.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 56.7 m95 -124.75 133.51 53.14 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.119 174.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' TRP . . . . . 0.931 ' HB3' HD12 ' A' ' 152' ' ' ILE . 46.1 m0 -110.94 133.6 53.24 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.258 0.551 . . . . 0.0 110.664 176.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.576 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 67.4 m -93.02 89.05 6.35 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -176.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.957 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -106.27 145.63 31.37 Favored 'General case' 0 N--CA 1.418 -2.033 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 -169.082 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.688 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 13.3 ptt180 -87.07 123.85 32.59 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 175.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 1.075 ' HB2' HD11 ' A' ' 142' ' ' LEU . 24.3 t30 -53.0 171.11 0.07 Allowed 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 113.277 -1.783 . . . . 0.0 110.736 -174.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 61.9 tttt -57.35 -19.99 26.31 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 173.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -70.64 -54.94 10.0 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.273 169.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' A' ' 164' ' ' ARG . . . 134.3 -8.86 4.72 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.947 -171.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.688 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -65.57 130.26 42.67 Favored 'General case' 0 C--O 1.217 -0.624 0 C-N-CA 123.343 0.657 . . . . 0.0 111.734 178.767 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.509 HG22 HG21 ' A' ' 153' ' ' ILE . 27.0 t -83.69 126.99 40.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.128 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -158.07 149.45 19.82 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.428 -0.892 . . . . 0.0 112.243 171.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.544 ' HG2' ' OG ' ' A' ' 162' ' ' SER . 9.3 mtp -74.63 141.14 44.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.843 0.354 . . . . 0.0 110.773 -178.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.721 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.6 pp -142.12 141.72 22.38 Favored Pre-proline 0 N--CA 1.45 -0.474 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.795 -174.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.526 ' HB2' ' CD1' ' A' ' 177' ' ' TYR . 24.5 Cg_exo -64.88 127.47 18.68 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.804 2.336 . . . . 0.0 112.879 -178.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.566 HG21 ' O ' ' A' ' 158' ' ' GLU . 72.9 t -61.33 -40.73 74.86 Favored Pre-proline 0 CA--C 1.545 0.75 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 177.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -61.44 -5.4 5.39 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 121.92 1.747 . . . . 0.0 112.906 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.526 ' CD1' ' HB2' ' A' ' 174' ' ' PRO . 2.8 m-30 -97.53 -10.96 24.31 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.632 -177.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.637 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 4.0 m -105.67 -172.98 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -164.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.653 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 3.8 tp10 -159.98 50.76 0.31 Allowed 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 113.143 -1.844 . . . . 0.0 112.949 -151.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.996 ' HG3' HG22 ' A' ' 128' ' ' VAL . 2.2 mppt? -69.83 137.56 51.87 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 119.451 -2.031 . . . . 0.0 111.061 -161.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.671 ' HB2' ' NH1' ' A' ' 129' ' ' ARG . 12.3 tp -71.98 -92.31 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 112.999 -1.91 . . . . 0.0 111.694 -169.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.455 ' H ' ' HB3' ' A' ' 181' ' ' LEU . 6.9 p -86.27 122.34 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 176.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.431 ' NH1' ' HE3' ' A' ' 180' ' ' LYS . 24.3 ttt180 -173.63 141.3 0.84 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.149 -173.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 27.7 t -82.43 143.53 31.11 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 172.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.687 ' HB2' ' HD2' ' A' ' 186' ' ' PRO . 5.0 p -65.88 168.46 8.86 Favored Pre-proline 0 C--N 1.324 -0.534 0 N-CA-C 110.49 -0.189 . . . . 0.0 110.49 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.687 ' HD2' ' HB2' ' A' ' 185' ' ' SER . 18.3 Cg_endo -58.96 82.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.005 2.47 . . . . 0.0 113.266 -175.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -102.09 -43.96 5.6 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.34 174.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 81.95 -53.86 4.78 Favored Glycine 0 N--CA 1.451 -0.315 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -176.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.417 ' HE2' ' HB3' ' A' ' 189' ' ' LYS . 35.1 ttpt -79.32 76.28 5.89 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.258 0.551 . . . . 0.0 110.323 175.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -114.91 90.36 3.32 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 174.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 84.24 -151.09 26.66 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 -171.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -117.77 108.78 15.79 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 117.476 0.638 . . . . 0.0 109.739 176.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -136.01 24.16 3.3 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -128.44 86.42 2.45 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.593 -176.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 14.1 t -176.6 178.17 1.31 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 13.1 m120 64.89 100.82 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.74 0.65 . . . . 0.0 112.493 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 20.4 m -93.94 103.9 15.98 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 174.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -92.59 111.52 23.14 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -174.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -79.12 152.26 36.17 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 165.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.47 ' HA ' ' HD3' ' A' ' 201' ' ' PRO . 45.9 mm -48.1 110.54 1.44 Allowed Pre-proline 0 C--O 1.236 0.37 0 CA-C-N 117.44 0.62 . . . . 0.0 111.467 -175.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 200' ' ' ILE . 16.8 Cg_exo -67.44 144.59 67.98 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 123.208 2.605 . . . . 0.0 112.446 -175.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -83.01 130.03 59.05 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.652 -176.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -77.79 106.49 2.19 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.367 2.045 . . . . 0.0 110.948 172.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.65 141.54 56.68 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.328 -176.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -107.08 -22.22 12.72 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 177.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -112.98 121.01 43.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.486 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' TYR . . . . . 0.461 ' O ' ' HD2' ' A' ' 210' ' ' PRO . 76.7 m-85 -115.16 159.54 20.79 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.995 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -78.65 -20.22 50.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.786 -177.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.683 ' HB2' ' HD3' ' A' ' 210' ' ' PRO . 15.7 mm100 -60.12 -53.79 61.62 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -178.122 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 0.683 ' HD3' ' HB2' ' A' ' 209' ' ' GLN . 38.4 Cg_exo -62.17 -16.66 52.11 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.252 1.968 . . . . 0.0 113.563 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -109.18 -7.87 15.22 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.615 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.438 HG22 ' HA ' ' A' ' 209' ' ' GLN . 6.9 t -95.07 -11.44 28.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.16 0.505 . . . . 0.0 109.843 177.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' THR . . . . . 0.426 ' O ' ' HD3' ' A' ' 215' ' ' PRO . 50.9 m -126.42 109.52 12.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.973 176.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 33.4 p -109.66 94.31 16.39 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.302 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 213' ' ' THR . 74.1 Cg_endo -89.64 133.18 2.15 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.799 2.332 . . . . 0.0 113.27 -175.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.402 ' HA ' ' HD3' ' A' ' 217' ' ' PRO . 3.5 mm? -97.74 105.13 24.73 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 173.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 216' ' ' LEU . 17.0 Cg_exo -66.55 -75.84 0.01 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.194 0 C-N-CA 122.845 2.363 . . . . 0.0 112.55 -175.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -138.32 103.14 4.83 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.914 0.387 . . . . 0.0 110.603 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 27.6 m -106.23 -16.4 8.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.325 177.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 3.5 p -79.4 161.34 26.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.868 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 157.08 -6.51 0.2 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.412 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 16.7 t -98.87 105.9 34.17 Favored Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -68.31 -44.64 3.31 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.772 2.315 . . . . 0.0 113.009 -176.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 62.05 91.24 0.02 OUTLIER Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.874 -175.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -87.68 86.09 7.15 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 122.533 -0.392 . . . . 0.0 110.788 -177.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . 70.16 -64.7 0.35 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.654 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 45.1 mm -121.57 123.41 69.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.409 ' CG2' ' HB2' ' A' ' 301' ' ' GLU . 44.7 m -70.42 126.13 92.2 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.932 176.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.16 -177.89 2.92 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.497 2.131 . . . . 0.0 112.444 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 60.3 mt 68.73 92.19 0.06 OUTLIER Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.465 177.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -67.15 -66.91 0.04 OUTLIER 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.716 2.277 . . . . 0.0 112.147 177.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 14.0 m -141.57 13.38 2.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.006 0.431 . . . . 0.0 110.78 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 2.2 p -113.11 122.8 48.63 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.951 0.405 . . . . 0.0 111.872 -177.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 234' ' ' GLN . 5.1 pm0 -77.14 98.09 4.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.636 0.731 . . . . 0.0 109.386 173.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -95.53 104.89 16.82 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.101 -175.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' GLY . . . . . 0.438 ' HA2' ' HD3' ' A' ' 237' ' ' PRO . . . 174.14 145.76 5.35 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.648 177.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.438 ' HD3' ' HA2' ' A' ' 236' ' ' GLY . 39.6 Cg_exo -63.11 169.71 8.77 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.964 2.443 . . . . 0.0 111.937 174.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.529 ' HB ' HG13 ' A' ' 266' ' ' VAL . 58.6 t -83.91 116.5 27.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.315 0.578 . . . . 0.0 110.908 -176.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -103.91 114.45 28.71 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.566 175.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.624 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -119.54 131.17 55.49 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.06 -178.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.637 ' HE3' ' HA2' ' A' ' 261' ' ' GLY . 48.5 tttp -90.13 126.12 35.68 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' ALA . . . . . 0.461 ' O ' ' HA ' ' A' ' 260' ' ' VAL . . . -74.83 97.08 3.21 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.23 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 48.2 pt -77.35 -21.91 14.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.127 0.489 . . . . 0.0 110.444 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.17 141.11 50.69 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.293 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -67.91 161.4 26.51 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-O 121.175 0.512 . . . . 0.0 111.073 -174.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.451 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 24.7 tpt180 -151.67 101.36 2.78 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.623 179.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 29.6 m -97.46 154.24 38.07 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.528 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.457 ' HA ' ' HB3' ' A' ' 255' ' ' ALA . 10.1 Cg_exo -69.63 99.98 0.77 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.202 1.934 . . . . 0.0 111.176 177.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 249' ' ' CYS . . . . . 0.53 ' HB3' ' HB2' ' A' ' 252' ' ' ASP . 42.3 t -70.24 167.96 16.82 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.325 -178.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -53.83 -38.28 64.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.917 0.389 . . . . 0.0 110.977 176.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -103.53 17.27 24.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.006 0.431 . . . . 0.0 111.142 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.53 ' HB2' ' HB3' ' A' ' 249' ' ' CYS . 4.0 m-20 -140.18 54.4 1.64 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.539 175.088 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -75.04 -14.85 60.64 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.37 -177.029 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 4.4 p -93.57 6.76 47.18 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.733 176.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.457 ' HB3' ' HA ' ' A' ' 248' ' ' PRO . . . -80.8 150.92 29.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.14 0.495 . . . . 0.0 110.984 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.9 tt -90.63 124.43 35.05 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -67.87 100.13 0.91 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.335 0.588 . . . . 0.0 110.427 177.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.521 HD22 HG22 ' A' ' 264' ' ' VAL . 93.4 mt -108.29 147.82 30.9 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.138 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -129.03 163.49 25.28 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.854 178.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 61.6 t -62.13 122.48 12.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.164 0.506 . . . . 0.0 111.4 -176.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.637 ' HA2' ' HE3' ' A' ' 241' ' ' LYS . . . 102.71 -9.39 55.41 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.694 177.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -79.52 140.28 37.3 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 -173.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 44.3 mm -88.57 109.22 19.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.394 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.521 HG22 HD22 ' A' ' 258' ' ' LEU . 15.0 t -83.58 100.69 7.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.129 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -83.14 87.33 6.92 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.853 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.529 HG13 ' HB ' ' A' ' 238' ' ' VAL . 4.8 p -97.53 133.4 39.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.071 0.462 . . . . 0.0 110.688 -177.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 20.7 p -103.57 -35.46 8.29 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.849 -175.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' ARG . . . . . 0.419 ' HG3' ' HB3' ' A' ' 276' ' ' GLU . 3.1 ptp180 -118.21 121.53 40.71 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.095 0.474 . . . . 0.0 110.68 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 269' ' ' MET . . . . . 0.49 ' HE1' HG11 ' A' ' 266' ' ' VAL . 45.7 mmm -95.36 99.38 11.31 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.577 -177.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.509 ' HB2' ' O ' ' A' ' 274' ' ' GLN . 84.3 m-20 -75.34 129.94 38.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.542 -178.09 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 11.1 tp -69.25 -15.19 19.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -171.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -71.39 -18.34 62.36 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.756 0.313 . . . . 0.0 111.033 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 115.24 -34.1 4.98 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.993 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.529 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 90.4 mt-30 -83.6 105.04 14.21 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 175.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.426 ' HB3' HG21 ' A' ' 266' ' ' VAL . 40.2 m0 -92.71 156.7 16.87 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -176.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.419 ' HB3' ' HG3' ' A' ' 268' ' ' ARG . 30.4 tt0 -108.01 106.52 16.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.99 0.424 . . . . 0.0 110.379 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 277' ' ' GLY . . . . . 0.483 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -121.06 153.82 16.55 Favored Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 177.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -116.23 111.92 20.87 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 279' ' ' VAL . . . . . 0.438 HG12 ' OD1' ' A' ' 280' ' ' ASN . 16.7 t -122.93 125.76 72.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.515 -177.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 280' ' ' ASN . . . . . 0.438 ' OD1' HG12 ' A' ' 279' ' ' VAL . 1.9 p-10 44.0 41.58 4.11 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.144 0.978 . . . . 0.0 112.981 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 102.6 -20.48 44.08 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.782 -0.723 . . . . 0.0 113.675 173.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 17.2 mtp-105 -109.1 125.18 51.88 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 117.232 0.516 . . . . 0.0 110.908 -177.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 42.1 pttt -114.88 134.73 54.91 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 120.289 -0.564 . . . . 0.0 109.999 172.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -155.96 176.41 33.45 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.675 -177.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.529 ' HB3' ' HB3' ' A' ' 274' ' ' GLN . 57.6 mt -91.08 118.29 30.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.983 0.42 . . . . 0.0 110.678 178.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.427 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 45.9 p90 -120.94 138.86 28.29 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.256 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 287' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 6.3 Cg_exo -76.06 139.41 21.6 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.043 2.495 . . . . 0.0 111.469 175.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -69.8 1.38 4.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.997 -177.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 19.8 p -82.7 -15.03 53.5 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.682 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -103.57 -17.27 15.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.794 0.331 . . . . 0.0 111.343 -177.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.517 ' O ' ' HD2' ' A' ' 292' ' ' LYS . 32.7 m -115.29 159.31 15.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.269 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 292' ' ' LYS . . . . . 0.517 ' HD2' ' O ' ' A' ' 291' ' ' VAL . 11.1 mptt -126.9 129.02 47.4 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.923 0.392 . . . . 0.0 110.682 177.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.624 HD13 ' HB2' ' A' ' 240' ' ' ALA . 39.7 mm -73.41 130.84 35.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.42 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 294' ' ' PHE . . . . . 0.445 ' CE1' ' HB2' ' A' ' 241' ' ' LYS . 0.6 OUTLIER -152.56 165.34 35.46 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.451 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.486 ' HB3' ' HA ' ' A' ' 298' ' ' ASN . 17.2 m-20 -104.8 102.01 32.51 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 175.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -66.41 -33.03 39.22 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.702 2.268 . . . . 0.0 112.567 -173.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -120.83 -6.92 9.59 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.82 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 298' ' ' ASN . . . . . 0.486 ' HA ' ' HB3' ' A' ' 295' ' ' ASP . 16.8 m120 59.61 100.12 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.474 0 O-C-N 123.63 0.581 . . . . 0.0 111.09 -173.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 299' ' ' PRO . . . . . 0.416 ' HD3' ' HB3' ' A' ' 295' ' ' ASP . 6.9 Cg_exo -73.76 36.87 0.4 Allowed 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 123.236 2.624 . . . . 0.0 112.334 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -73.69 -48.09 34.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.221 0.534 . . . . 0.0 109.755 178.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 301' ' ' GLU . . . . . 0.409 ' HB2' ' CG2' ' A' ' 228' ' ' THR . 11.2 pt-20 -130.64 6.68 4.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.324 173.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -100.64 119.84 39.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.52 -174.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 . . . . . 0 C--O 1.252 1.215 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.146 176.336 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 pmm? . . . . . 0 N--CA 1.483 1.22 0 CA-C-O 120.267 0.079 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.4 t 72.06 137.82 0.05 OUTLIER 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 121.388 0.613 . . . . 0.0 110.974 -178.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.4 t -152.35 -60.39 0.15 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -85.39 119.82 26.18 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.617 177.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.508 ' HD3' ' HA ' ' A' ' 5' ' ' ARG . 22.1 mmt180 -131.35 87.7 2.5 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.38 0.609 . . . . 0.0 111.412 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -158.81 168.17 27.53 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 177.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -100.58 131.59 46.41 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.061 175.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.5 m -69.65 -19.76 63.61 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.19 -174.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.8 t -106.24 -24.37 12.32 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -172.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -60.82 95.13 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.961 0.41 . . . . 0.0 111.143 -175.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.8 tpp180 -52.74 -51.23 61.41 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 123.205 0.602 . . . . 0.0 112.15 -174.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.6 m -72.93 4.88 3.71 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -176.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -91.65 -48.7 6.69 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.55 175.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 37.4 p-90 -113.92 -30.39 6.74 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -172.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -70.99 113.52 8.11 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.391 -0.524 . . . . 0.0 109.634 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.799 ' HB3' HG11 ' A' ' 19' ' ' VAL . 27.9 tpp -94.22 1.63 56.0 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 120.911 0.386 . . . . 0.0 110.293 -170.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 50.65 -111.96 1.43 Allowed Glycine 0 C--N 1.334 0.451 0 CA-C-N 115.041 -0.981 . . . . 0.0 113.653 177.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -64.97 90.87 0.2 Allowed 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.846 2.364 . . . . 0.0 112.297 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.947 HG22 ' HD2' ' A' ' 39' ' ' ARG . 2.7 p -162.5 159.43 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.7 m -156.64 -166.63 2.17 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 -160.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.48 ' O ' ' HB2' ' A' ' 25' ' ' GLN . 44.1 mtp85 -69.25 -41.56 76.76 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.663 -175.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 15.5 tp60 -64.24 -54.02 39.89 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 123.458 0.473 . . . . 0.0 111.024 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.696 ' OE1' ' HA ' ' A' ' 106' ' ' PRO . 47.9 mm-40 -61.12 -56.43 20.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.835 -176.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.91 -33.66 67.15 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.738 0.304 . . . . 0.0 111.614 -178.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.48 ' HB2' ' O ' ' A' ' 21' ' ' ARG . 26.9 tp60 -61.8 -47.69 83.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.867 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.0 t -79.97 -25.27 40.45 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 120.88 0.372 . . . . 0.0 111.553 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.428 ' NH1' ' HB ' ' A' ' 19' ' ' VAL . 97.5 mtt180 -74.72 -38.16 62.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.987 0.422 . . . . 0.0 110.962 -177.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.925 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 28.7 mt -99.72 6.66 45.5 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.935 -176.199 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.476 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 17.0 tp60 -72.05 95.31 1.6 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.083 0.468 . . . . 0.0 111.725 -172.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 66.37 29.04 74.16 Favored Glycine 0 N--CA 1.453 -0.202 0 CA-C-N 115.608 -0.724 . . . . 0.0 113.815 173.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.451 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 0.0 OUTLIER -85.39 -91.91 0.09 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 117.027 0.414 . . . . 0.0 110.082 178.483 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.567 ' HB2' ' SD ' ' A' ' 35' ' ' MET . 86.7 mtm-85 -127.54 135.54 50.48 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 170.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 58.5 m170 -71.06 124.61 24.79 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.06 -13.75 14.03 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.649 -176.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.656 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 93.4 mtp -73.62 126.37 30.13 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 175.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.52 ' CB ' HG22 ' A' ' 52' ' ' VAL . 47.1 p90 -133.6 166.0 23.61 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.901 0.381 . . . . 0.0 111.013 -177.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.528 ' HB2' ' HB2' ' A' ' 16' ' ' MET . 4.0 pp -158.07 138.79 12.96 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.499 176.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.428 ' CG2' HD13 ' A' ' 50' ' ' LEU . 87.7 t -102.1 123.58 55.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.947 ' HD2' HG22 ' A' ' 19' ' ' VAL . 5.0 mtm-85 -106.77 175.01 5.64 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.163 -171.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -86.62 90.96 8.43 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 167.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.711 ' HA ' HG23 ' A' ' 49' ' ' VAL . 7.5 t 24.76 -141.41 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.347 1.459 . . . . 0.0 114.487 -176.096 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.595 ' HB3' HH21 ' A' ' 39' ' ' ARG . 56.0 p 172.26 -29.13 0.0 OUTLIER 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 114.106 -1.406 . . . . 0.0 108.778 174.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 40.3 p -122.88 -13.0 7.95 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.982 -177.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.46 ' HA ' ' HD2' ' A' ' 45' ' ' PRO . 64.0 m -133.47 100.17 13.96 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 110.527 -0.175 . . . . 0.0 110.527 -175.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.46 ' HD2' ' HA ' ' A' ' 44' ' ' CYS . 17.9 Cg_endo -57.42 109.18 0.43 Allowed 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.97 2.447 . . . . 0.0 113.069 -174.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.81 -19.73 18.26 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.695 177.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' A' ' 41' ' ' SER . 74.8 m-20 -90.25 -174.65 4.25 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.34 -0.245 . . . . 0.0 110.34 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.615 ' HA ' ' H ' ' A' ' 41' ' ' SER . 26.9 m-85 -129.55 167.77 17.41 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.711 HG23 ' HA ' ' A' ' 41' ' ' SER . 96.6 t -142.22 98.07 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 121.046 0.451 . . . . 0.0 111.298 177.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.428 HD13 ' CG2' ' A' ' 38' ' ' VAL . 40.8 tp -70.1 103.02 2.19 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.963 175.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.508 ' HB3' ' CG1' ' A' ' 58' ' ' VAL . 21.5 m -96.56 134.4 39.82 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.807 175.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.578 HG21 HD13 ' A' ' 93' ' ' LEU . 96.4 t -123.0 142.8 38.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.329 -178.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.925 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 36.0 t -88.05 116.92 26.57 Favored 'General case' 0 C--N 1.334 -0.081 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.649 176.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.851 ' HB2' ' HB3' ' A' ' 94' ' ' ASP . 4.8 pt-20 -165.64 141.88 5.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.775 -0.193 . . . . 0.0 110.997 -177.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 53.16 32.12 12.65 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 122.933 0.493 . . . . 0.0 111.881 -174.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.1 m 67.34 11.12 8.21 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.62 177.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.583 ' HG3' ' O ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -125.39 165.31 18.63 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.187 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.508 ' CG1' ' HB3' ' A' ' 51' ' ' SER . 84.1 t -106.32 105.47 18.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.035 0.445 . . . . 0.0 110.651 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.7 t -76.51 120.36 21.61 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.765 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -99.76 102.4 13.84 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.61 -174.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.713 ' HE1' HD11 ' A' ' 153' ' ' ILE . 66.9 m-85 -100.53 101.5 12.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.621 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.597 HG12 HG22 ' A' ' 49' ' ' VAL . 25.6 mt -81.05 138.41 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 121.152 0.501 . . . . 0.0 112.311 -174.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.625 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 3.7 mp -116.85 122.24 69.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.603 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -104.01 140.42 37.77 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -175.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.4 t -79.85 104.83 10.7 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.103 0.478 . . . . 0.0 110.444 -177.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.519 HD11 ' HB2' ' A' ' 72' ' ' LYS . 90.6 mt -75.24 132.73 75.87 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.617 178.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -57.18 -19.85 35.81 Favored 'Trans proline' 0 N--CA 1.473 0.302 0 C-N-CA 123.425 2.75 . . . . 0.0 113.409 -174.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -90.28 26.85 1.81 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.238 178.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.706 ' HA ' ' HE ' ' A' ' 69' ' ' ARG . 2.2 mmp_? 69.3 26.07 5.44 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.356 173.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.638 ' HG2' ' HA ' ' A' ' 79' ' ' ASP . 69.8 mtt180 -114.47 179.0 4.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.604 176.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.625 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 36.6 m-85 -139.1 120.39 14.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.774 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.519 ' HB2' HD11 ' A' ' 66' ' ' LEU . 19.6 ttmm -106.65 110.21 22.34 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.615 -178.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.679 HD11 ' HB3' ' A' ' 61' ' ' TYR . 3.9 tt -94.06 103.62 14.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.084 0.468 . . . . 0.0 110.869 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 52.69 63.11 5.24 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.658 -0.701 . . . . 0.0 113.111 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.1 t0 78.59 -38.88 0.24 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.002 0.521 . . . . 0.0 111.081 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -69.09 119.12 12.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.002 0.429 . . . . 0.0 110.259 177.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.431 ' HB3' ' NZ ' ' A' ' 72' ' ' LYS . 7.7 pt-20 -99.23 133.67 43.18 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.274 0.559 . . . . 0.0 111.846 -174.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.46 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 79.7 m-85 -136.83 164.1 29.09 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.818 177.077 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.638 ' HA ' ' HG2' ' A' ' 70' ' ' ARG . 6.9 m-20 -73.75 -26.56 60.73 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -176.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.431 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 5.7 p80 -163.11 172.96 14.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.848 -0.16 . . . . 0.0 110.937 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.555 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 19.6 mt -58.34 -52.25 75.93 Favored Pre-proline 0 CA--C 1.535 0.367 0 O-C-N 123.251 0.344 . . . . 0.0 111.656 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.555 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 52.0 Cg_exo -58.11 -9.03 5.56 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 122.419 2.079 . . . . 0.0 113.467 177.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.28 -36.35 15.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.953 0.406 . . . . 0.0 110.799 -178.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.496 HD21 HD23 ' A' ' 81' ' ' LEU . 3.7 pp -79.97 -33.89 39.12 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.3 mt -68.08 -14.2 62.79 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.635 0.731 . . . . 0.0 110.115 175.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -85.98 -44.9 11.96 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.667 177.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.454 ' O ' HG12 ' A' ' 90' ' ' ILE . 84.9 t80 -70.15 -37.13 75.17 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.534 -177.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.492 ' HE2' HD13 ' A' ' 73' ' ' ILE . 16.7 m-85 -72.77 5.2 3.33 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -176.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -83.76 -14.98 50.21 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 119.915 -0.714 . . . . 0.0 111.144 171.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.454 HG12 ' O ' ' A' ' 87' ' ' PHE . 5.6 pt -87.89 -28.93 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.227 166.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.451 ' N ' HG13 ' A' ' 90' ' ' ILE . 3.0 m170 -91.14 124.53 35.43 Favored 'General case' 0 CA--C 1.502 -0.865 0 CA-C-O 121.135 0.493 . . . . 0.0 111.181 -177.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -86.81 90.04 8.17 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 175.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.578 HD13 HG21 ' A' ' 52' ' ' VAL . 5.3 mt -46.63 -36.36 6.91 Favored 'General case' 0 C--O 1.218 -0.567 0 O-C-N 124.346 1.029 . . . . 0.0 110.204 -177.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.851 ' HB3' ' HB2' ' A' ' 54' ' ' GLU . 21.6 t70 -158.82 99.35 1.54 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.841 165.051 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.634 ' HA ' ' HA ' ' A' ' 156' ' ' PRO . 5.7 t 44.3 18.16 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.663 1.185 . . . . 0.0 112.498 -177.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.7 t -162.77 154.58 18.15 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.48 ' O ' HG12 ' A' ' 99' ' ' ILE . 52.2 p -104.11 -179.01 3.82 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.4 104.97 0.84 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 173.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 97' ' ' THR . 45.1 mm -99.86 -54.93 6.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.737 -173.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.656 ' O ' ' HA ' ' A' ' 35' ' ' MET . 10.6 pt-20 -151.59 153.02 31.55 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.062 -173.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 100' ' ' GLU . 1.9 Cg_endo -83.84 158.61 13.89 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.948 2.432 . . . . 0.0 112.746 178.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -88.18 164.62 32.56 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.054 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -78.28 164.92 26.23 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.99 2.46 . . . . 0.0 112.453 175.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.793 ' HG2' ' SD ' ' A' ' 16' ' ' MET . 19.8 mtm180 -99.78 111.99 24.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.492 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.428 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 1.6 t80 -170.48 117.71 0.49 Allowed Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 120.511 0.196 . . . . 0.0 111.099 178.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.696 ' HA ' ' OE1' ' A' ' 23' ' ' GLU . 2.6 Cg_endo -82.29 159.37 17.51 Favored 'Trans proline' 0 C--O 1.238 0.487 0 C-N-CA 123.449 2.766 . . . . 0.0 111.945 176.066 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.855 ' HB2' ' HD3' ' A' ' 108' ' ' PRO . 41.0 m -150.26 -68.39 0.02 OUTLIER Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.855 ' HD3' ' HB2' ' A' ' 107' ' ' SER . 3.0 Cg_endo -85.87 164.62 10.32 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.84 2.36 . . . . 0.0 113.048 -173.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -71.75 -79.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.818 2.346 . . . . 0.0 112.186 177.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -168.61 140.85 2.78 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.121 0.486 . . . . 0.0 110.703 177.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 151.63 74.24 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.6 -178.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 12.1 p -74.87 172.22 12.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.757 0.313 . . . . 0.0 110.826 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.9 t -82.29 46.24 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 120.74 0.305 . . . . 0.0 111.236 -175.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 25.4 t 67.41 179.35 0.23 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.111 176.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.456 ' HA ' ' HD2' ' A' ' 116' ' ' PRO . . . 60.07 102.49 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.368 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 173.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.456 ' HD2' ' HA ' ' A' ' 115' ' ' ALA . 26.2 Cg_endo -63.9 -26.61 66.97 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.761 2.307 . . . . 0.0 112.267 177.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.586 ' O ' ' HB2' ' A' ' 118' ' ' LEU . 24.0 t-20 -116.16 59.69 0.73 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.645 0.259 . . . . 0.0 110.363 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.586 ' HB2' ' O ' ' A' ' 117' ' ' ASN . 10.2 mp 90.35 118.18 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.899 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.247 172.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -93.98 121.28 0.37 Allowed 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 123.63 2.887 . . . . 0.0 113.633 -175.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.598 HG23 ' HB3' ' A' ' 126' ' ' GLU . 7.0 m -75.08 -13.04 60.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.177 0.513 . . . . 0.0 110.352 174.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.447 ' O ' ' HG2' ' A' ' 122' ' ' GLU . . . 66.24 -79.39 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.058 -172.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.524 ' O ' ' HB2' ' A' ' 184' ' ' SER . 36.8 mm-40 -162.5 -35.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 O-C-N 123.438 0.461 . . . . 0.0 111.165 -178.142 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.468 ' O ' ' HD3' ' A' ' 183' ' ' ARG . 1.5 t70 -74.45 -92.36 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -164.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.455 ' OD1' HD23 ' A' ' 125' ' ' LEU . 8.4 p30 -161.85 172.99 15.18 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.775 -172.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.455 HD23 ' OD1' ' A' ' 124' ' ' ASN . 2.6 mm? 57.47 87.37 0.06 Allowed 'General case' 0 N--CA 1.468 0.473 0 O-C-N 124.014 0.821 . . . . 0.0 112.328 -178.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.598 ' HB3' HG23 ' A' ' 120' ' ' THR . 10.0 tp10 179.84 -48.57 0.01 OUTLIER 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.106 174.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.547 ' CE2' HG22 ' A' ' 151' ' ' VAL . 35.5 m-85 -122.76 131.03 53.59 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.373 177.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.505 ' CG1' ' HB ' ' A' ' 178' ' ' VAL . 5.8 t -134.93 156.8 40.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.087 -174.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.591 ' NH2' HD13 ' A' ' 181' ' ' LEU . 1.2 ptp180 -134.17 133.54 41.1 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 172.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' THR . . . . . 1.109 HG22 HG12 ' A' ' 178' ' ' VAL . 23.8 p -88.77 140.57 29.31 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.273 0.559 . . . . 0.0 112.213 -174.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.717 HD11 ' HG2' ' A' ' 179' ' ' GLU . 13.6 mt -106.99 -42.23 4.96 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.397 -176.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -83.31 -36.45 24.45 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -168.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.806 ' HB2' ' HA ' ' A' ' 145' ' ' LYS . 0.0 OUTLIER 79.25 133.67 0.06 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.434 0.693 . . . . 0.0 111.021 -174.59 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.587 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 59.1 t80 -156.05 110.38 2.11 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.072 -178.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.432 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 11.1 Cg_endo -89.42 90.91 0.36 Allowed 'Trans proline' 0 N--CA 1.445 -1.348 0 C-N-CA 122.591 2.194 . . . . 0.0 112.586 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.507 ' HA3' ' HB3' ' A' ' 141' ' ' ASP . . . -84.4 -21.14 57.31 Favored Glycine 0 N--CA 1.454 -0.166 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.048 173.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 28.4 m120 46.29 48.67 13.27 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 114.443 -0.878 . . . . 0.0 112.532 178.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.423 ' OD1' ' HG2' ' A' ' 140' ' ' GLU . 5.0 t70 -149.53 179.23 8.14 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.39 -178.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -95.17 -7.5 39.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.336 0.588 . . . . 0.0 110.197 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.574 ' O ' ' HB2' ' A' ' 172' ' ' MET . 10.0 pt-20 -113.28 -3.32 13.86 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.987 173.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.507 ' HB3' ' HA3' ' A' ' 136' ' ' GLY . 4.1 m-20 -140.14 102.03 4.29 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 1.104 HD12 ' HD2' ' A' ' 143' ' ' PRO . 57.8 tp -74.03 126.13 89.56 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.417 0.627 . . . . 0.0 111.639 -172.448 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 1.104 ' HD2' HD12 ' A' ' 142' ' ' LEU . 68.8 Cg_endo -76.73 65.58 7.54 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 124.263 3.308 . . . . 0.0 113.132 177.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.621 ' CG ' HG21 ' A' ' 130' ' ' THR . 36.3 p90 -84.43 162.08 20.09 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.504 -0.479 . . . . 0.0 111.736 -176.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.806 ' HA ' ' HB2' ' A' ' 133' ' ' ASP . 10.9 mtmt -121.98 179.92 4.36 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.178 -176.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.746 ' H ' ' HD3' ' A' ' 146' ' ' LYS . 0.3 OUTLIER -79.47 27.62 0.27 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -167.753 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 175.72 32.91 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 119.721 -1.228 . . . . 0.0 113.594 176.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.575 ' OE2' ' HA ' ' A' ' 144' ' ' PHE . 8.7 pt-20 -106.63 167.15 10.06 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 117.826 0.813 . . . . 0.0 110.916 177.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.436 ' C ' HD23 ' A' ' 150' ' ' LEU . 19.8 mm -101.55 138.38 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -175.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.608 HD22 ' HA ' ' A' ' 165' ' ' ASN . 11.5 mt -122.9 179.64 4.57 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.888 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 47.8 t -145.29 123.46 5.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 178.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.582 HG23 ' HB3' ' A' ' 161' ' ' TRP . 20.4 mm -77.85 77.77 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-O 122.659 1.219 . . . . 0.0 108.55 -178.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.713 HD11 ' HE1' ' A' ' 61' ' ' TYR . 13.5 tt -71.4 -41.45 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-N 112.847 -1.979 . . . . 0.0 109.905 -177.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 1.132 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 73.4 mt-10 -116.79 138.92 51.15 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 172.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.609 ' O ' ' HB ' ' A' ' 95' ' ' THR . 22.1 ttpt -132.94 79.54 62.94 Favored Pre-proline 0 C--N 1.322 -0.593 0 O-C-N 122.043 -0.411 . . . . 0.0 110.015 167.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.634 ' HA ' ' HA ' ' A' ' 95' ' ' THR . 14.6 Cg_exo -66.35 -49.17 1.97 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 121.95 1.767 . . . . 0.0 110.945 177.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -119.93 176.44 5.41 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.205 -174.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -95.6 -30.34 13.85 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.619 -176.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -84.25 -22.71 30.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.021 0.438 . . . . 0.0 110.793 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.766 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 60.5 m95 -129.2 126.89 40.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.425 -178.218 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' TRP . . . . . 0.582 ' HB3' HG23 ' A' ' 152' ' ' ILE . 49.5 m0 -119.75 134.26 55.3 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.752 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' SER . . . . . 1.132 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 6.5 m -84.47 98.09 9.9 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 177.19 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.573 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -103.98 157.78 16.87 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.136 -176.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.888 ' HG2' ' HB ' ' A' ' 151' ' ' VAL . 14.2 ptt180 -104.66 129.64 52.8 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 176.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.644 HD22 ' HE ' ' A' ' 169' ' ' ARG . 46.7 p30 -73.03 -166.99 0.35 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.453 0.168 . . . . 0.0 110.971 -178.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.517 ' HE3' ' HB2' ' A' ' 148' ' ' GLU . 93.8 mttt -55.96 -38.06 69.86 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -176.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -86.46 0.96 53.07 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.308 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 92.42 3.06 67.34 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 120.447 -0.882 . . . . 0.0 113.973 174.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.731 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 12.5 ttm-85 -68.1 130.25 42.36 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 122.511 0.324 . . . . 0.0 110.777 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.468 HG22 HG21 ' A' ' 153' ' ' ILE . 39.8 t -95.19 143.02 12.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-O 120.855 0.36 . . . . 0.0 111.008 -177.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -170.92 155.53 24.87 Favored Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 175.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.766 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.4 OUTLIER -70.26 131.66 44.53 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.967 0.384 . . . . 0.0 110.864 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.829 HD13 HG11 ' A' ' 178' ' ' VAL . 2.6 pp -133.52 145.4 56.2 Favored Pre-proline 0 N--CA 1.451 -0.394 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.199 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.484 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 8.2 Cg_exo -71.69 125.43 11.11 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.957 2.438 . . . . 0.0 111.859 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.622 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 24.1 t -68.76 -35.29 6.34 Favored Pre-proline 0 C--N 1.32 -0.682 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -178.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.622 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 19.0 Cg_endo -61.43 -11.22 18.77 Favored 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 121.656 1.571 . . . . 0.0 112.537 172.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.484 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.4 m-85 -92.01 -14.35 29.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.243 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 1.109 HG12 HG22 ' A' ' 130' ' ' THR . 10.3 m -122.01 173.64 7.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -169.072 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.717 ' HG2' HD11 ' A' ' 131' ' ' LEU . 9.3 mm-40 -136.34 169.71 17.23 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.933 177.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.511 ' N ' ' HD3' ' A' ' 180' ' ' LYS . 2.3 mppt? -101.22 136.92 40.27 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.802 0.334 . . . . 0.0 110.563 -175.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.591 HD13 ' NH2' ' A' ' 129' ' ' ARG . 7.8 tp -84.18 -86.17 0.12 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.371 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.497 HG13 ' HG ' ' A' ' 181' ' ' LEU . 1.6 m -82.26 38.55 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.125 -174.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.468 ' HD3' ' O ' ' A' ' 123' ' ' ASP . 1.4 tpp180 -70.68 115.82 10.28 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 168.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.524 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 0.9 OUTLIER -72.97 76.28 1.18 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.523 0.678 . . . . 0.0 110.119 179.956 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.592 ' HB2' ' HD2' ' A' ' 186' ' ' PRO . 28.1 p -85.19 168.57 19.77 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.889 178.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.592 ' HD2' ' HB2' ' A' ' 185' ' ' SER . 6.0 Cg_endo -48.84 -55.77 3.81 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.115 2.543 . . . . 0.0 112.883 177.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.46 ' HB2' ' O ' ' A' ' 186' ' ' PRO . 48.7 m80 72.5 -43.08 0.55 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.396 0.678 . . . . 0.0 111.996 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 108.72 95.83 2.41 Favored Glycine 0 N--CA 1.439 -1.129 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -168.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm 68.93 11.28 8.29 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.109 0.564 . . . . 0.0 110.771 -173.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 1.3 t60 62.18 21.64 12.58 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.529 176.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -91.03 173.47 37.9 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.327 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -83.26 -75.49 0.32 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.851 0.357 . . . . 0.0 111.195 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 31.8 mmm180 -127.73 125.83 40.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.744 -175.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -73.65 137.94 44.47 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.686 174.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 17.4 m -65.36 97.07 0.26 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.064 0.459 . . . . 0.0 110.85 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -84.95 96.1 9.26 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.376 -178.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 15.7 m -95.24 117.93 31.12 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.598 176.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -72.88 130.32 40.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.193 0.521 . . . . 0.0 111.502 -175.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -107.02 54.32 0.57 Allowed Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 175.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 40.7 mm -129.58 131.56 23.66 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.878 -0.161 . . . . 0.0 110.604 -174.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -66.88 120.33 7.41 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.573 2.182 . . . . 0.0 111.322 174.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -74.59 127.21 87.73 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.9 -175.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -77.3 131.01 11.41 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.434 2.089 . . . . 0.0 111.404 174.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.03 -77.94 0.08 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.358 -177.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -119.98 -9.5 9.63 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.087 0.47 . . . . 0.0 110.644 -178.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -84.55 100.74 11.59 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.632 177.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -133.16 173.34 11.54 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.308 178.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -85.29 137.38 33.0 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.71 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -79.21 145.63 65.16 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.013 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -81.6 92.39 1.02 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.359 2.039 . . . . 0.0 113.431 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -143.99 13.25 1.65 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.289 0.566 . . . . 0.0 109.729 171.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 4.5 m -89.28 15.17 9.46 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.269 -176.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 27.9 m 77.45 135.95 0.06 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.418 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 56.5 p 54.66 93.66 0.05 OUTLIER Pre-proline 0 N--CA 1.468 0.439 0 C-N-CA 123.866 0.866 . . . . 0.0 112.041 -178.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -66.81 -14.28 43.18 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.857 2.371 . . . . 0.0 112.04 178.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 217' ' ' PRO . 6.8 mp -92.95 132.7 30.35 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.737 177.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.462 ' HB2' HG12 ' A' ' 219' ' ' VAL . 42.1 Cg_exo -58.94 -28.87 88.85 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.879 2.386 . . . . 0.0 112.438 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . 58.87 24.99 13.07 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.191 176.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.462 HG12 ' HB2' ' A' ' 217' ' ' PRO . 3.7 p -96.8 110.23 24.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.438 0.637 . . . . 0.0 110.628 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 50.6 m -152.97 -3.12 0.22 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.755 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 125.22 178.85 15.48 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.937 -177.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 23.6 t 61.38 93.43 0.06 OUTLIER Pre-proline 0 CA--C 1.532 0.284 0 C-N-CA 123.061 0.544 . . . . 0.0 111.707 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -84.48 13.91 2.6 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 123.175 2.583 . . . . 0.0 112.311 177.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 140.93 107.7 0.69 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.092 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -85.06 -53.93 4.96 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.853 0.359 . . . . 0.0 111.102 -178.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -134.74 36.17 3.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.976 0.417 . . . . 0.0 110.7 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 6.0 tp -78.49 117.43 23.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.336 178.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 20.3 p 48.49 81.99 0.25 Allowed Pre-proline 0 N--CA 1.468 0.425 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.259 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -70.67 134.61 26.44 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.823 2.349 . . . . 0.0 112.289 -177.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.418 HD13 ' HA ' ' A' ' 230' ' ' LEU . 3.6 mm? -93.06 126.72 50.05 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 176.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 230' ' ' LEU . 6.4 Cg_exo -75.77 47.73 2.0 Favored 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 123.081 2.52 . . . . 0.0 112.454 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 50.4 m 61.05 26.72 16.63 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.279 0.562 . . . . 0.0 110.557 -176.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 12.3 p -81.49 124.92 29.87 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.743 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.507 ' CD ' ' H ' ' A' ' 234' ' ' GLN . 0.0 OUTLIER -83.99 77.09 9.98 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.658 0.742 . . . . 0.0 111.343 -179.326 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -164.43 -178.65 5.55 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.68 177.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' GLY . . . . . 0.443 ' HA2' ' HD3' ' A' ' 237' ' ' PRO . . . -154.11 139.32 6.72 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.198 -0.525 . . . . 0.0 111.994 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.443 ' HD3' ' HA2' ' A' ' 236' ' ' GLY . 12.2 Cg_exo -71.19 124.32 10.38 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 123.084 2.523 . . . . 0.0 111.83 178.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.63 HG11 HD12 ' A' ' 293' ' ' ILE . 39.6 t -100.68 135.88 34.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.967 -173.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -88.27 121.85 31.14 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.459 173.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.467 ' HB1' ' HB ' ' A' ' 291' ' ' VAL . . . -126.5 123.69 38.36 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.391 176.12 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.408 ' O ' HG23 ' A' ' 243' ' ' ILE . 63.8 tttm -86.07 119.41 26.34 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.131 -177.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' ALA . . . . . 0.619 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -70.81 99.9 1.81 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.31 0.576 . . . . 0.0 110.418 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.408 HG23 ' O ' ' A' ' 241' ' ' LYS . 34.2 pt -88.75 -27.87 5.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.421 -173.281 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -129.89 147.81 51.69 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.368 -0.378 . . . . 0.0 109.996 -178.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -55.53 122.21 10.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.432 0.634 . . . . 0.0 111.296 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.747 ' HB3' ' HB2' ' A' ' 258' ' ' LEU . 20.9 tpt180 -122.73 77.04 1.4 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.382 -0.826 . . . . 0.0 108.856 173.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.425 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 7.4 m -111.62 137.46 21.2 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.67 -178.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 247' ' ' VAL . 31.8 Cg_exo -57.76 111.4 0.83 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 123.048 2.499 . . . . 0.0 112.044 -178.012 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' CYS . . . . . 0.428 ' N ' ' HB2' ' A' ' 252' ' ' ASP . 19.3 t -88.6 -169.86 2.71 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.2 -39.15 78.25 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -177.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -91.1 -9.91 43.92 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.381 -176.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.428 ' HB2' ' N ' ' A' ' 249' ' ' CYS . 19.4 m-20 -80.89 116.67 20.99 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.364 0.602 . . . . 0.0 111.571 -174.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -120.47 145.97 46.73 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 172.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 25.2 p 61.92 17.73 9.19 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.581 0.752 . . . . 0.0 111.017 -174.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -81.17 130.99 35.27 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.999 0.428 . . . . 0.0 111.426 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.748 HD21 ' HB ' ' A' ' 279' ' ' VAL . 2.0 tt -86.07 131.29 34.29 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 175.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.46 ' N ' HD23 ' A' ' 256' ' ' LEU . . . -79.86 95.95 6.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.211 0.529 . . . . 0.0 111.182 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.895 HD21 HG21 ' A' ' 279' ' ' VAL . 68.8 mt -105.39 105.48 15.54 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.377 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -87.82 150.3 23.62 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.066 -177.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 47.0 t -61.8 121.21 9.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.038 -176.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 101.87 39.73 2.85 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.964 175.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -141.58 174.82 10.2 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.938 0.369 . . . . 0.0 110.138 177.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 263' ' ' ILE . . . . . 0.449 HD12 ' HZ ' ' A' ' 294' ' ' PHE . 49.8 mm -107.38 133.82 50.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.944 0.402 . . . . 0.0 111.203 -175.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.572 HG22 HD22 ' A' ' 258' ' ' LEU . 5.2 t -113.75 115.76 50.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.885 175.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -95.94 103.17 15.04 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 173.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.626 HG13 ' HB ' ' A' ' 238' ' ' VAL . 2.1 p -94.65 141.4 15.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.562 -178.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 19.5 p -126.34 -23.74 3.77 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.913 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' ARG . . . . . 0.482 ' HB2' ' HB3' ' A' ' 276' ' ' GLU . 83.4 mtt180 -116.51 119.42 35.53 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.43 177.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 58.6 mtt -117.25 110.36 18.01 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 175.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -84.21 12.12 7.09 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.237 -170.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 48.0 mm 72.05 -39.0 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 175.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -78.8 27.05 0.23 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.444 0.64 . . . . 0.0 111.067 -178.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 81.99 -29.14 3.12 Favored Glycine 0 C--N 1.32 -0.308 0 C-N-CA 121.096 -0.573 . . . . 0.0 113.077 176.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -78.7 105.54 10.08 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.514 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 49.4 m0 -99.82 153.96 18.72 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.274 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.482 ' HB3' ' HB2' ' A' ' 268' ' ' ARG . 38.9 tt0 -120.59 115.6 23.72 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.887 178.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 277' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -138.06 164.3 25.56 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 176.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -106.17 112.33 25.32 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 117.784 0.792 . . . . 0.0 109.669 -177.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 279' ' ' VAL . . . . . 0.895 HG21 HD21 ' A' ' 258' ' ' LEU . 70.8 t -121.15 99.67 7.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.171 -177.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 42.18 63.13 1.44 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.353 -1.294 . . . . 0.0 113.173 173.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 144.68 -51.08 0.63 Allowed Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.025 -1.083 . . . . 0.0 112.585 173.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.46 162.15 16.71 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.222 0.534 . . . . 0.0 111.755 -178.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.572 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 0.0 OUTLIER -88.84 143.06 27.15 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.673 175.976 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -150.56 172.18 30.33 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.539 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.514 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 72.0 mt -90.1 123.65 34.13 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.16 0.505 . . . . 0.0 110.958 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.435 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 36.6 p90 -133.68 136.71 27.22 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.173 177.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 287' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 10.4 Cg_exo -71.78 140.08 34.81 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.501 2.134 . . . . 0.0 111.614 176.012 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -60.07 -20.56 58.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.837 -178.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 1.4 p -73.89 -3.52 29.37 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -177.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -101.19 -7.54 23.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.666 0.27 . . . . 0.0 110.678 177.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.619 HG12 ' HA ' ' A' ' 242' ' ' ALA . 15.4 m -128.74 178.0 5.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.145 0.498 . . . . 0.0 111.302 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 57.8 tttm -140.81 123.28 15.97 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.515 175.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.63 HD12 HG11 ' A' ' 238' ' ' VAL . 35.3 mm -65.07 144.31 14.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.152 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 294' ' ' PHE . . . . . 0.449 ' HZ ' HD12 ' A' ' 263' ' ' ILE . 6.4 p90 -173.39 -179.07 1.81 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.637 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -151.58 144.48 16.97 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 172.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -45.73 -28.47 4.65 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.563 2.842 . . . . 0.0 114.178 178.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -141.83 -51.03 0.41 Allowed 'General case' 0 C--O 1.234 0.268 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -143.24 104.24 5.12 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.699 0.285 . . . . 0.0 111.12 -173.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.17 73.49 5.75 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.483 2.122 . . . . 0.0 112.586 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -98.22 150.28 21.67 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 175.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -70.1 -29.51 66.49 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.421 -175.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -124.89 -24.32 4.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.235 -177.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 . . . . . 0 C--O 1.247 0.932 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.545 -178.782 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 N--CA 1.482 1.17 0 CA-C-O 120.807 0.336 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.2 t -116.35 92.89 4.02 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.361 0.6 . . . . 0.0 111.084 -175.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.5 p -80.45 -71.55 0.46 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.221 173.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.561 ' HB3' ' HE2' ' A' ' 253' ' ' LYS . . . -67.07 133.64 50.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.771 178.253 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 5' ' ' ARG . 47.0 ttm180 -150.92 100.09 2.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.773 0.32 . . . . 0.0 110.821 -176.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -166.07 -177.23 4.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.885 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.514 ' HB3' ' CB ' ' A' ' 13' ' ' ALA . 12.9 t70 -103.17 141.46 35.83 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.07 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.471 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 31.7 m -79.36 -0.19 31.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.808 0.337 . . . . 0.0 111.429 -176.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.759 ' CA ' ' HE1' ' A' ' 14' ' ' TRP . 8.7 t -149.17 -95.22 0.07 Allowed 'General case' 0 C--O 1.245 0.816 0 CA-C-O 122.2 1.0 . . . . 0.0 111.302 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.476 ' O ' ' N ' ' A' ' 12' ' ' SER . 37.5 t70 -8.16 74.89 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.099 -1.409 . . . . 0.0 112.01 -155.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.401 ' HA ' ' HD3' ' A' ' 11' ' ' ARG . 7.6 mmt180 -2.24 -58.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 126.189 2.18 . . . . 0.0 115.331 -163.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.476 ' N ' ' O ' ' A' ' 10' ' ' ASP . 58.2 m -70.1 18.08 0.05 Allowed 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -177.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.514 ' CB ' ' HB3' ' A' ' 7' ' ' ASP . . . -91.46 -19.1 23.2 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 120.332 -0.547 . . . . 0.0 109.725 170.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.759 ' HE1' ' CA ' ' A' ' 9' ' ' SER . 7.4 p-90 -151.71 -39.84 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.477 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.551 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 34.0 t80 -67.36 119.84 12.88 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 121.126 0.489 . . . . 0.0 110.179 -177.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.811 ' SD ' ' HB3' ' A' ' 104' ' ' ARG . 15.0 tpp -110.03 9.22 24.25 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.296 -172.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.56 ' O ' ' HB2' ' A' ' 39' ' ' ARG . . . 50.85 -112.07 1.51 Allowed Glycine 0 C--O 1.222 -0.639 0 CA-C-N 115.805 -0.634 . . . . 0.0 113.713 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.417 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 2.8 Cg_exo -77.03 109.15 2.78 Favored 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 122.462 2.108 . . . . 0.0 112.606 178.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.066 ' HB ' ' HG3' ' A' ' 39' ' ' ARG . 27.5 t -136.29 -71.4 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 119.212 -0.423 . . . . 0.0 111.701 178.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.489 ' HB3' ' O ' ' A' ' 19' ' ' VAL . 37.7 t 79.72 -172.6 0.05 Allowed 'General case' 0 C--N 1.345 0.412 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 171.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 -65.6 -42.95 91.06 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.716 0.293 . . . . 0.0 110.977 -173.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.523 ' HG3' ' H ' ' A' ' 23' ' ' GLU . 10.9 pt20 -61.01 -59.96 4.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.58 -0.737 . . . . 0.0 112.002 -176.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.611 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 64.8 mm-40 -66.61 -45.28 79.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.818 -175.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 28' ' ' LEU . . . -54.72 -36.75 65.07 Favored 'General case' 0 C--O 1.222 -0.371 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.187 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.671 ' HA ' HG21 ' A' ' 58' ' ' VAL . 6.1 tp-100 -73.4 -51.96 15.45 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.994 178.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.607 ' HA ' ' SD ' ' A' ' 110' ' ' MET . 6.2 t -63.24 -26.68 68.9 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -171.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.611 ' HG2' ' O ' ' A' ' 23' ' ' GLU . 18.1 ptp180 -101.58 -9.46 20.96 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.565 -178.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.691 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 87.6 mt -119.61 17.2 12.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.75 -0.205 . . . . 0.0 111.542 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -71.56 74.15 0.78 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.377 0.608 . . . . 0.0 110.314 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.23 -69.43 1.34 Allowed Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.122 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.401 ' HB3' ' H ' ' A' ' 32' ' ' ARG . 6.9 tt0 34.12 -93.24 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.947 1.299 . . . . 0.0 113.561 -175.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.401 ' H ' ' HB3' ' A' ' 31' ' ' GLN . 33.2 ttp-105 -115.46 -11.78 11.78 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -172.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 33.6 m170 67.65 157.65 0.13 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.296 0.638 . . . . 0.0 111.948 -178.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.48 3.21 82.38 Favored Glycine 0 C--N 1.334 0.451 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 177.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.519 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 44.2 mtp -90.13 136.6 32.95 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.959 -0.62 . . . . 0.0 109.918 -176.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.49 ' CB ' HG22 ' A' ' 52' ' ' VAL . 34.2 p90 -138.78 165.06 27.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.55 0.214 . . . . 0.0 110.657 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.599 ' O ' ' HA ' ' A' ' 50' ' ' LEU . 4.6 pp -158.3 140.61 14.25 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.835 174.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 15' ' ' TYR . 80.2 t -110.17 120.66 61.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 174.083 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 1.066 ' HG3' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -138.01 175.93 9.15 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.683 -176.61 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.463 ' O ' ' HG2' ' A' ' 39' ' ' ARG . 2.1 m-20 -66.82 137.71 56.81 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.997 0.427 . . . . 0.0 110.337 176.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.499 ' HB3' ' O ' ' A' ' 44' ' ' CYS . 22.8 t -76.92 147.95 36.67 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.495 -179.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.8 p -87.03 -29.43 21.96 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.034 -178.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.483 HG21 ' HB3' ' A' ' 116' ' ' PRO . 20.5 p -82.54 -42.27 18.57 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.035 0.445 . . . . 0.0 110.955 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.499 ' O ' ' HB3' ' A' ' 41' ' ' SER . 56.1 m -127.15 112.25 21.6 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.209 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.93 14.86 0.63 Allowed 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.792 2.328 . . . . 0.0 112.918 -178.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -117.06 -5.72 14.75 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.627 -0.589 . . . . 0.0 111.627 175.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -119.61 175.26 5.94 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -177.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.43 ' O ' HG23 ' A' ' 62' ' ' ILE . 22.1 m-85 -127.49 179.67 5.37 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 122.176 0.19 . . . . 0.0 110.491 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.609 HG22 HG12 ' A' ' 62' ' ' ILE . 54.2 t -148.91 96.82 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-O 120.743 0.306 . . . . 0.0 111.319 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.599 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 50.6 tp -70.8 101.01 2.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.481 171.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.4 m -97.21 130.01 44.49 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.439 177.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.753 HG21 HD13 ' A' ' 93' ' ' LEU . 69.9 t -119.86 140.97 42.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.205 -177.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.691 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 42.1 t -102.82 107.8 18.78 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.687 -177.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.837 ' HG3' HG22 ' A' ' 96' ' ' THR . 0.0 OUTLIER -158.39 157.28 32.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.769 -0.196 . . . . 0.0 110.756 171.31 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 59.41 18.6 6.97 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 123.557 0.536 . . . . 0.0 110.424 -173.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.0 m 68.47 21.85 8.02 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.949 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -125.65 151.67 46.22 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 174.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.671 HG21 ' HA ' ' A' ' 25' ' ' GLN . 44.9 t -97.33 91.55 2.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.931 0.396 . . . . 0.0 110.521 178.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.555 ' HA ' ' HB3' ' A' ' 119' ' ' PRO . 5.9 t -68.46 118.12 11.11 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -98.62 106.75 19.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.312 -174.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.735 ' HB3' HD11 ' A' ' 73' ' ' ILE . 53.9 m-85 -101.97 92.05 4.62 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.581 178.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.609 HG12 HG22 ' A' ' 49' ' ' VAL . 38.5 mt -72.15 130.52 35.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -177.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.641 ' HA ' ' HA ' ' A' ' 73' ' ' ILE . 4.9 mp -106.98 119.46 56.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.204 178.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -97.96 134.6 40.86 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -177.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.5 t -84.3 110.85 18.89 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.156 0.503 . . . . 0.0 110.066 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.729 HD12 ' HG3' ' A' ' 70' ' ' ARG . 67.9 mt -83.32 144.65 46.98 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.422 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.34 -19.01 20.48 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.106 2.538 . . . . 0.0 113.095 -178.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 56.0 m-20 -84.83 14.76 4.45 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.632 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.668 ' HA ' ' HE ' ' A' ' 69' ' ' ARG . 3.3 tpm_? 66.29 26.71 10.3 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.299 0.64 . . . . 0.0 111.154 176.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.729 ' HG3' HD12 ' A' ' 66' ' ' LEU . 6.7 ptm180 -119.47 164.49 15.69 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 176.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.635 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 74.1 m-85 -123.05 120.11 32.35 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.821 0.343 . . . . 0.0 111.853 -171.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 77' ' ' GLU . 20.7 ttmm -102.21 110.29 22.2 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 175.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.735 HD11 ' HB3' ' A' ' 61' ' ' TYR . 2.4 tt -87.05 83.58 2.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.614 0.721 . . . . 0.0 111.406 -175.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.25 -53.25 2.25 Favored Glycine 0 C--N 1.336 0.567 0 CA-C-N 114.66 -1.155 . . . . 0.0 113.342 174.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.71 ' OD2' ' HA2' ' A' ' 168' ' ' GLY . 11.6 t70 -135.57 -55.26 0.79 Allowed 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.081 0.467 . . . . 0.0 109.931 -174.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.5 124.74 28.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.896 -177.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 10.0 pt-20 -99.08 129.94 45.38 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.185 0.517 . . . . 0.0 110.984 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.525 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 93.9 m-85 -124.92 -169.1 1.92 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.893 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -112.11 -19.93 12.11 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -177.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.574 ' ND1' ' HG2' ' A' ' 82' ' ' PRO . 6.7 p80 -149.11 165.41 31.83 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 122.376 -0.203 . . . . 0.0 110.533 172.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.504 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 4.4 mt -61.34 -52.19 72.41 Favored Pre-proline 0 N--CA 1.467 0.383 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.466 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.574 ' HG2' ' ND1' ' A' ' 80' ' ' HIS . 12.9 Cg_endo -60.31 -5.87 4.63 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 121.982 1.788 . . . . 0.0 113.18 176.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.513 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -85.77 -30.47 23.02 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.118 0.485 . . . . 0.0 110.172 -175.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.525 ' HB3' ' CD2' ' A' ' 78' ' ' PHE . 3.4 pp -82.58 -32.93 28.24 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 174.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.0 mt -66.37 -37.15 84.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.676 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.409 ' OE2' ' HA ' ' A' ' 83' ' ' ALA . 13.8 pt-20 -78.65 -19.77 51.83 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.947 178.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.532 ' O ' HG12 ' A' ' 90' ' ' ILE . 73.7 t80 -81.76 -33.97 30.66 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.253 0.549 . . . . 0.0 110.06 -178.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.443 ' CG ' HD21 ' A' ' 93' ' ' LEU . 33.9 m-85 -79.18 5.07 13.02 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.713 -178.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.683 ' HE3' HG22 ' A' ' 90' ' ' ILE . 0.1 OUTLIER -68.01 -34.03 75.72 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 168.873 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.683 HG22 ' HE3' ' A' ' 89' ' ' LYS . 11.0 pt -85.77 -30.91 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 174.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.407 ' HB2' ' HD1' ' A' ' 88' ' ' TYR . 8.1 m170 -93.35 125.58 38.03 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.074 0.464 . . . . 0.0 111.168 -176.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.446 ' CD2' HG23 ' A' ' 97' ' ' THR . 59.0 m-85 -86.71 82.1 7.98 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.615 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.753 HD13 HG21 ' A' ' 52' ' ' VAL . 24.0 mt -31.79 -52.24 0.24 Allowed 'General case' 0 N--CA 1.473 0.694 0 O-C-N 125.199 1.562 . . . . 0.0 113.962 -172.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.478 ' OD1' ' HB3' ' A' ' 54' ' ' GLU . 7.3 t70 -118.53 -34.05 4.13 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.49 0.662 . . . . 0.0 109.769 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.422 ' HB ' ' O ' ' A' ' 94' ' ' ASP . 5.8 t 176.99 -20.41 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.245 176.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.837 HG22 ' HG3' ' A' ' 54' ' ' GLU . 3.6 t -113.97 171.76 7.4 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.407 170.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.446 HG23 ' CD2' ' A' ' 92' ' ' TYR . 69.9 p -99.58 -177.26 3.52 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.447 HD22 ' CG ' ' A' ' 36' ' ' PHE . 89.5 mt -70.52 105.37 3.07 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.483 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 45.8 mm -99.7 -53.71 7.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.701 -174.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.519 ' O ' ' HA ' ' A' ' 35' ' ' MET . 7.4 pt-20 -149.37 157.25 39.42 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 120.819 0.342 . . . . 0.0 111.46 -174.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.52 163.33 29.69 Favored 'Trans proline' 0 C--O 1.233 0.275 0 C-N-CA 122.495 2.13 . . . . 0.0 112.504 176.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.621 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -90.01 161.36 38.33 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.776 177.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -68.46 159.71 52.28 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.444 2.096 . . . . 0.0 111.912 174.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.811 ' HB3' ' SD ' ' A' ' 16' ' ' MET . 13.8 ptm180 -126.25 88.18 2.8 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.081 0.467 . . . . 0.0 111.715 -177.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.433 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 45.4 t80 -169.63 116.22 0.53 Allowed Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.009 177.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 105' ' ' TYR . 8.8 Cg_exo -72.29 142.4 37.38 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.74 2.294 . . . . 0.0 111.222 176.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.747 ' HB3' ' HD3' ' A' ' 108' ' ' PRO . 41.7 t -171.76 -57.87 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.09 -177.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.747 ' HD3' ' HB3' ' A' ' 107' ' ' SER . 5.5 Cg_exo -77.61 124.31 6.9 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.136 1.891 . . . . 0.0 112.187 -178.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 108' ' ' PRO . 4.9 Cg_endo -87.53 113.73 0.93 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.297 2.665 . . . . 0.0 112.208 178.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.607 ' SD ' ' HA ' ' A' ' 26' ' ' THR . 62.8 mtt -119.76 168.25 11.26 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.887 178.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.477 ' O ' ' HB3' ' A' ' 112' ' ' SER . . . -69.67 -25.21 75.78 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.411 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.477 ' HB3' ' O ' ' A' ' 111' ' ' GLY . 30.6 t 73.96 154.55 0.15 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.29 0.567 . . . . 0.0 111.737 177.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 39.7 t -62.79 113.35 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.721 173.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 13.5 m -83.35 30.9 0.46 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.944 0.402 . . . . 0.0 111.716 -174.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.419 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . . . -143.0 143.91 26.9 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.015 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.483 ' HB3' HG21 ' A' ' 43' ' ' THR . 20.7 Cg_exo -66.97 -36.36 22.83 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.131 2.554 . . . . 0.0 111.819 177.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -107.45 -163.36 0.89 Allowed 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 173.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 9.1 mp 66.99 135.45 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.311 0 CA-C-O 121.52 0.676 . . . . 0.0 111.622 -178.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.555 ' HB3' ' HA ' ' A' ' 59' ' ' SER . 44.6 Cg_exo -61.02 -58.39 0.46 Allowed 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.979 2.453 . . . . 0.0 112.949 176.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 85.1 m -154.36 -66.24 0.14 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.846 0.355 . . . . 0.0 111.01 -178.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -154.75 175.17 14.05 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.439 ' OE1' ' HA ' ' A' ' 186' ' ' PRO . 0.0 OUTLIER -94.07 -90.92 0.2 Allowed 'General case' 0 C--N 1.321 -0.659 0 O-C-N 123.18 0.3 . . . . 0.0 111.209 -178.941 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.564 ' OD2' ' HD3' ' A' ' 186' ' ' PRO . 13.1 t70 64.39 -73.04 0.06 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.057 0.543 . . . . 0.0 110.879 -175.14 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.438 ' O ' ' HB2' ' A' ' 125' ' ' LEU . 74.1 m-20 -146.9 125.55 12.54 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.416 0.686 . . . . 0.0 109.961 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.665 HD12 HG21 ' A' ' 152' ' ' ILE . 4.1 mm? 71.81 96.27 0.07 Allowed 'General case' 0 N--CA 1.473 0.678 0 O-C-N 123.522 0.513 . . . . 0.0 112.205 174.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.488 ' HG3' ' CD1' ' A' ' 127' ' ' TYR . 9.9 tp10 -170.72 -72.97 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.546 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.488 ' CD1' ' HG3' ' A' ' 126' ' ' GLU . 38.4 m-85 -112.97 131.99 55.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.231 0.539 . . . . 0.0 111.123 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.565 ' CG1' ' HB ' ' A' ' 178' ' ' VAL . 8.3 t -131.59 158.26 43.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.361 -176.088 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -138.77 133.43 32.13 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 170.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' THR . . . . . 1.05 HG22 HG12 ' A' ' 178' ' ' VAL . 35.8 p -86.97 141.46 28.68 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.231 -173.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.755 HD11 ' CG ' ' A' ' 179' ' ' GLU . 10.9 mt -111.27 -30.93 7.24 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -174.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.518 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 55.5 t80 -90.09 -27.38 19.7 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -168.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.518 ' HB3' ' O ' ' A' ' 132' ' ' TYR . 19.5 t70 73.83 130.88 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 O-C-N 123.564 0.54 . . . . 0.0 111.06 -172.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.452 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 76.4 t80 -161.86 99.48 1.19 Allowed Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.97 -177.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -82.36 81.46 2.49 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.916 2.411 . . . . 0.0 112.731 178.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.56 -17.12 74.44 Favored Glycine 0 C--O 1.227 -0.319 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 172.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 40.53 35.54 0.31 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.944 1.298 . . . . 0.0 113.945 178.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.508 ' HB2' ' HB2' ' A' ' 141' ' ' ASP . 1.6 m-20 -121.12 -173.42 2.61 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 121.981 -0.449 . . . . 0.0 111.5 -178.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -105.13 -6.64 19.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.245 0.545 . . . . 0.0 110.637 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -122.17 -1.26 9.27 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.692 174.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.508 ' HB2' ' HB2' ' A' ' 138' ' ' ASP . 5.4 m-20 -132.32 108.4 9.18 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 174.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.82 HD11 ' HB2' ' A' ' 165' ' ' ASN . 60.5 tp -74.59 119.79 78.35 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 121.215 0.531 . . . . 0.0 111.868 -170.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.625 ' HD2' HD12 ' A' ' 142' ' ' LEU . 55.8 Cg_endo -72.8 102.66 1.46 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.579 2.186 . . . . 0.0 111.57 171.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.612 ' CG ' HG21 ' A' ' 130' ' ' THR . 12.6 p90 -117.49 163.94 15.64 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.786 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.48 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 12.4 mmtm -108.65 -159.48 0.69 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.001 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.506 ' H ' ' HD3' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -101.46 6.53 42.47 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.986 -0.285 . . . . 0.0 111.768 -173.885 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -155.34 24.28 0.59 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.055 -1.069 . . . . 0.0 112.704 178.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.13 159.47 14.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.636 0.255 . . . . 0.0 110.562 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.429 ' C ' HD23 ' A' ' 150' ' ' LEU . 15.5 mm -101.56 135.88 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -174.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.605 ' HB3' ' HB1' ' A' ' 163' ' ' ALA . 10.4 mt -122.11 175.9 6.11 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 46.6 t -145.5 123.0 4.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.672 HG23 ' HB3' ' A' ' 161' ' ' TRP . 23.9 mm -79.16 78.75 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-O 122.483 1.135 . . . . 0.0 108.657 -176.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.679 HG23 ' HG3' ' A' ' 154' ' ' GLU . 11.5 tt -69.2 -46.21 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 CA-C-N 113.176 -1.829 . . . . 0.0 109.359 -178.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 1.016 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 40.5 mt-10 -115.27 140.05 49.44 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -127.66 82.12 68.91 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 167.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.409 ' HG2' ' HE3' ' A' ' 172' ' ' MET . 3.3 Cg_exo -77.32 -50.76 0.09 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.327 2.685 . . . . 0.0 111.242 176.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -108.4 170.33 8.09 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.402 -176.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -88.3 -41.39 12.92 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.742 -176.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -83.18 -24.37 32.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.909 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 57.2 m95 -123.72 119.65 30.4 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.244 -176.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' TRP . . . . . 0.672 ' HB3' HG23 ' A' ' 152' ' ' ILE . 44.8 m0 -106.24 138.29 42.69 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.732 176.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' SER . . . . . 1.016 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 13.8 m -85.83 101.01 12.46 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 177.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.619 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -106.23 157.01 17.89 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.909 -179.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.713 ' HB3' HG22 ' A' ' 170' ' ' VAL . 25.0 ptt-85 -107.67 128.98 55.04 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 175.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.82 ' HB2' HD11 ' A' ' 142' ' ' LEU . 58.5 t30 -69.15 151.91 45.78 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 175.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 29.0 ttpp -65.06 -12.0 45.74 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.683 -176.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.422 ' HB3' ' NH2' ' A' ' 169' ' ' ARG . 19.4 t70 -86.41 -26.43 24.75 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -177.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.71 ' HA2' ' OD2' ' A' ' 75' ' ' ASP . . . 123.54 67.42 0.21 Allowed Glycine 0 CA--C 1.528 0.845 0 C-N-CA 118.587 -1.768 . . . . 0.0 115.684 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.54 ' HD2' ' HD2' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -178.66 148.64 0.44 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.656 0.383 . . . . 0.0 110.178 161.568 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.713 HG22 ' HB3' ' A' ' 164' ' ' ARG . 61.2 t -101.06 142.87 15.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.316 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -167.05 157.01 29.26 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.56 ' HA ' ' HA ' ' A' ' 162' ' ' SER . 31.7 mtp -74.21 136.49 42.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.973 0.386 . . . . 0.0 110.135 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.897 HD13 HG11 ' A' ' 178' ' ' VAL . 2.7 pp -134.17 150.19 73.47 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.631 -177.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 173' ' ' ILE . 4.0 Cg_exo -76.97 127.86 9.61 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 123.0 2.467 . . . . 0.0 112.33 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.616 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 26.2 t -64.11 -42.16 66.79 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 9.6 Cg_endo -53.27 -13.6 3.44 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.968 2.445 . . . . 0.0 113.962 171.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -96.58 -14.69 22.04 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 111.607 0.225 . . . . 0.0 111.607 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 1.05 HG12 HG22 ' A' ' 130' ' ' THR . 5.9 m -125.6 161.55 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 121.992 0.901 . . . . 0.0 113.112 -169.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.755 ' CG ' HD11 ' A' ' 131' ' ' LEU . 3.5 mm-40 -124.45 160.36 28.42 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.156 177.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.682 ' HG2' ' HD2' ' A' ' 183' ' ' ARG . 1.4 mppt? -98.34 137.18 37.43 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -176.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 10.2 tp -66.72 -83.23 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.094 0.473 . . . . 0.0 109.921 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.491 HG12 ' HA3' ' A' ' 191' ' ' GLY . 10.9 m -102.04 113.75 39.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-O 121.296 0.569 . . . . 0.0 109.734 172.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.682 ' HD2' ' HG2' ' A' ' 180' ' ' LYS . 31.6 ttt180 -153.29 122.38 6.55 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.956 -178.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 16.3 p 179.58 -64.87 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.481 ' HB2' ' CE1' ' A' ' 187' ' ' HIS . 7.8 m -160.97 168.28 11.97 Favored Pre-proline 0 C--N 1.316 -0.859 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 167.273 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.564 ' HD3' ' OD2' ' A' ' 123' ' ' ASP . 23.3 Cg_exo -63.85 102.5 0.36 Allowed 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 121.33 1.353 . . . . 0.0 111.049 177.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.49 ' HA ' ' CD ' ' A' ' 202' ' ' GLU . 38.4 m80 -125.9 155.5 41.17 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.207 -174.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -68.42 97.8 0.48 Allowed Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.806 -0.633 . . . . 0.0 112.203 174.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 64.4 pttt 45.56 32.0 1.05 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.515 1.126 . . . . 0.0 113.415 177.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -98.69 91.34 5.07 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 177.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.491 ' HA3' HG12 ' A' ' 182' ' ' VAL . . . -128.36 -88.7 0.59 Allowed Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.92 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -135.99 95.96 3.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.087 0.47 . . . . 0.0 110.44 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.686 ' HA ' ' HE ' ' A' ' 193' ' ' ARG . 1.2 tpm_? -157.58 -88.98 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.185 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -150.08 130.98 14.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.896 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 69.4 m -152.8 85.92 1.25 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.104 0.478 . . . . 0.0 111.134 177.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -107.42 -45.39 4.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.696 174.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 69.6 m -86.88 63.64 8.06 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 171.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -96.42 164.52 12.6 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.844 -176.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 149.0 49.24 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 11.7 pt -121.82 86.11 45.44 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-O 121.171 0.51 . . . . 0.0 111.758 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -87.97 116.11 1.0 Allowed 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 123.174 2.583 . . . . 0.0 110.956 171.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.49 ' CD ' ' HA ' ' A' ' 187' ' ' HIS . 6.9 pt-20 -122.21 120.32 28.27 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-O 121.015 0.436 . . . . 0.0 110.287 -178.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 202' ' ' GLU . 22.9 Cg_exo -64.12 125.95 16.21 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 123.269 2.646 . . . . 0.0 113.03 -175.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -95.76 8.09 44.48 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.956 177.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -123.83 109.0 13.08 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.748 178.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -124.55 173.71 8.3 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.618 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 18.9 m-30 63.15 -163.36 0.27 Allowed 'General case' 0 N--CA 1.465 0.31 0 O-C-N 123.796 0.685 . . . . 0.0 110.552 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -143.72 -71.63 0.29 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.737 0.304 . . . . 0.0 111.107 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -166.68 157.72 10.91 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.983 -176.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -66.73 104.08 0.77 Allowed 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.072 1.848 . . . . 0.0 110.21 170.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -70.9 -40.42 72.18 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.146 -172.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 13.9 m -123.98 97.15 5.22 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.95 0.405 . . . . 0.0 110.277 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 47.6 m -78.41 -39.36 39.18 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.457 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 21.7 m 69.57 94.59 0.05 OUTLIER Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.316 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -71.57 141.15 37.56 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.714 2.276 . . . . 0.0 111.737 178.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.457 ' HA ' ' HD3' ' A' ' 217' ' ' PRO . 3.4 mm? -88.92 131.96 39.69 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.053 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 216' ' ' LEU . 31.3 Cg_exo -62.46 -46.49 11.83 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.64 2.226 . . . . 0.0 112.041 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -150.11 115.76 5.54 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.02 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 61.9 t -88.03 105.36 15.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 171.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 4.8 p -85.42 162.76 18.86 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.371 -175.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -88.7 161.42 30.86 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.915 177.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 5.7 p -80.74 117.73 69.23 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-O 120.566 0.222 . . . . 0.0 110.555 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -57.36 129.46 34.15 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.906 2.404 . . . . 0.0 112.522 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -125.45 119.79 3.66 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.065 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -95.63 -5.05 43.31 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.092 0.472 . . . . 0.0 110.684 177.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -100.39 88.17 3.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.255 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 20.3 pt -93.71 120.2 42.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.992 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 6.2 t -172.87 126.27 0.49 Allowed Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.548 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -82.06 -170.67 1.0 Allowed 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.582 2.188 . . . . 0.0 111.423 174.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.408 ' HA ' ' HD3' ' A' ' 231' ' ' PRO . 4.0 mm? -95.65 112.55 59.46 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 177.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 230' ' ' LEU . 5.8 Cg_exo -79.49 -168.74 0.67 Allowed 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.18 2.586 . . . . 0.0 112.026 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 50.3 m -73.89 102.84 4.21 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.052 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 13.6 p -73.53 -31.63 63.78 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 173.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 7.6 tp60 60.3 76.23 0.37 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.023 174.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' ASN . . . . . 0.491 ' HB2' ' O ' ' A' ' 267' ' ' THR . 5.1 m-20 -85.53 -36.05 20.74 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.745 176.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 157.14 94.31 0.1 Allowed Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.605 178.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -65.45 100.98 0.41 Allowed 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.606 2.204 . . . . 0.0 111.691 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.717 ' CG1' HD12 ' A' ' 293' ' ' ILE . 41.4 t -115.49 136.88 50.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.992 -176.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -104.68 117.04 33.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.96 178.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.492 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -120.2 125.12 47.38 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.739 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -85.26 124.15 31.57 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' ALA . . . . . 0.579 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -69.53 112.38 6.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.841 0.353 . . . . 0.0 110.385 -178.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 33.7 pt -84.46 -16.94 10.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.507 -177.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.505 ' HA ' HG22 ' A' ' 260' ' ' VAL . 16.4 pt20 -150.35 153.68 36.48 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.099 173.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.463 ' C ' ' HD2' ' A' ' 245' ' ' LYS . 0.1 OUTLIER -75.75 169.79 17.45 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.449 0.642 . . . . 0.0 112.112 -171.708 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 38.6 ttt85 -170.28 115.94 0.51 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.409 172.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 8.7 p -122.11 141.02 33.4 Favored Pre-proline 0 C--N 1.316 -0.875 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -45.49 111.36 0.31 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.846 2.364 . . . . 0.0 112.873 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' CYS . . . . . 0.431 ' H ' ' HB2' ' A' ' 252' ' ' ASP . 31.7 t -90.16 -173.03 3.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.717 178.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.418 ' N ' ' SG ' ' A' ' 249' ' ' CYS . . . -62.69 -27.92 69.58 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.982 0.42 . . . . 0.0 111.938 -177.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -101.02 1.14 39.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.327 -177.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.451 ' HB3' ' CB ' ' A' ' 255' ' ' ALA . 27.2 m-20 -97.7 97.19 8.81 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -173.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 253' ' ' LYS . . . . . 0.835 ' HG3' HG23 ' A' ' 254' ' ' THR . 45.6 tptt -91.25 139.44 30.74 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 171.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 254' ' ' THR . . . . . 0.835 HG23 ' HG3' ' A' ' 253' ' ' LYS . 26.2 p 65.96 14.92 9.85 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.035 0.934 . . . . 0.0 112.27 178.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.451 ' CB ' ' HB3' ' A' ' 252' ' ' ASP . . . -79.11 151.88 31.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.655 0.264 . . . . 0.0 110.974 -178.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.576 HD23 ' N ' ' A' ' 257' ' ' ALA . 2.5 tt -102.91 142.99 33.09 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.576 ' N ' HD23 ' A' ' 256' ' ' LEU . . . -87.43 101.75 13.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.147 0.499 . . . . 0.0 110.451 178.066 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.986 HD21 HG21 ' A' ' 279' ' ' VAL . 84.0 mt -116.38 142.75 46.44 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.557 -177.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -124.13 162.57 23.3 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.109 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.505 HG22 ' HA ' ' A' ' 244' ' ' GLN . 43.6 t -66.59 125.46 23.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.38 -174.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 105.53 -11.92 46.88 Favored Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.074 176.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -84.8 175.44 9.15 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.932 0.366 . . . . 0.0 110.204 -174.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 48.4 mm -115.57 117.46 55.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.352 0.596 . . . . 0.0 110.982 -176.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.517 HG22 HD22 ' A' ' 258' ' ' LEU . 2.9 t -97.05 103.06 14.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.713 178.112 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -85.94 90.4 8.07 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.259 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.579 ' HA ' ' HA2' ' A' ' 277' ' ' GLY . 1.8 p -86.82 137.51 20.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.158 0.504 . . . . 0.0 110.582 -175.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 267' ' ' THR . . . . . 0.491 ' O ' ' HB2' ' A' ' 235' ' ' ASN . 20.5 p -109.67 -35.73 6.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.527 -173.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 268' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 268' ' ' ARG . 1.0 OUTLIER -131.73 126.24 34.0 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.139 0.495 . . . . 0.0 109.683 179.407 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 57.9 mtt -106.3 116.64 32.28 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.935 0.398 . . . . 0.0 111.162 -178.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.531 ' HB2' ' O ' ' A' ' 274' ' ' GLN . 85.6 m-20 -78.68 121.46 24.72 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 175.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 47.2 mm -57.79 -24.96 24.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.173 -174.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -61.77 -32.28 72.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.411 -178.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 146.41 -44.45 0.84 Allowed Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.172 -1.013 . . . . 0.0 113.342 177.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.531 ' O ' ' HB2' ' A' ' 270' ' ' ASN . 0.1 OUTLIER -86.29 120.05 27.23 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.067 0.46 . . . . 0.0 110.608 -178.988 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.424 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 41.7 m0 -94.48 160.83 14.47 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.597 -177.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.494 ' HB3' ' HD2' ' A' ' 283' ' ' LYS . 39.3 mt-10 -106.59 105.84 16.07 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 173.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 277' ' ' GLY . . . . . 0.579 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -108.5 146.7 16.52 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.608 -178.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -102.03 108.54 20.01 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 279' ' ' VAL . . . . . 0.986 HG21 HD21 ' A' ' 258' ' ' LEU . 97.1 t -119.4 117.58 54.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.694 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 62.86 30.82 16.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.549 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 83.38 6.27 87.86 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.772 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 282' ' ' ARG . . . . . 0.412 ' NH1' ' H ' ' A' ' 257' ' ' ALA . 51.1 ttt180 -117.52 126.28 52.32 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.667 0.27 . . . . 0.0 110.759 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.567 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 27.2 ttpp -102.97 133.62 47.78 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.124 0.488 . . . . 0.0 111.035 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -153.98 171.02 32.63 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.625 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.424 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 64.0 mt -83.88 131.33 34.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.977 0.417 . . . . 0.0 111.027 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.402 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 23.9 p90 -142.34 144.37 30.79 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.777 175.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 287' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 1.8 Cg_endo -83.7 138.77 8.46 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.911 2.407 . . . . 0.0 111.661 176.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.4 ' HA ' HG22 ' A' ' 291' ' ' VAL . 41.5 p90 -65.54 -8.39 19.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.592 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 17.2 p -75.85 -9.34 58.52 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.52 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -104.97 -6.25 20.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.799 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.579 HG12 ' HA ' ' A' ' 242' ' ' ALA . 22.4 m -128.34 172.25 15.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.125 0.488 . . . . 0.0 111.173 -177.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -137.47 131.42 31.86 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.032 171.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.717 HD12 ' CG1' ' A' ' 238' ' ' VAL . 47.5 mm -73.39 134.47 29.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.731 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -138.03 151.68 48.11 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 174.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.778 ' HB3' ' HD3' ' A' ' 296' ' ' PRO . 12.2 t70 -93.1 -58.48 0.22 Allowed Pre-proline 0 C--N 1.323 -0.586 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.026 -178.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 296' ' ' PRO . . . . . 0.778 ' HD3' ' HB3' ' A' ' 295' ' ' ASP . 9.6 Cg_endo -91.16 -78.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 122.615 2.21 . . . . 0.0 112.779 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 79.5 mm-40 -142.76 -160.12 1.06 Allowed 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.883 -177.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 298' ' ' ASN . . . . . 0.581 ' H ' ' CD ' ' A' ' 299' ' ' PRO . 9.5 t30 -149.48 -48.41 0.02 OUTLIER Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.844 -178.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 299' ' ' PRO . . . . . 0.581 ' CD ' ' H ' ' A' ' 298' ' ' ASN . 12.1 Cg_exo -71.21 18.01 0.26 Allowed 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 122.522 2.148 . . . . 0.0 113.815 -176.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -69.19 -36.33 77.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.063 0.459 . . . . 0.0 110.156 175.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -78.75 -71.69 0.42 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.175 177.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 302' ' ' ASN . . . . . 0.457 ' O ' ' HA ' ' A' ' 299' ' ' PRO . 21.8 m120 -141.89 174.44 10.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.746 176.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.372 -0.823 . . . . 0.0 109.462 178.893 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 N--CA 1.48 1.057 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.3 m -115.91 -18.18 10.79 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.796 -177.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.414 ' O ' HG23 ' A' ' 99' ' ' ILE . 20.4 m 68.51 -71.45 0.11 Allowed 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.307 -175.175 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.15 102.66 3.09 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 177.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 25.6 mtm105 -122.35 3.35 9.73 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -175.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.45 ' HB3' ' HA ' ' A' ' 100' ' ' GLU . 17.0 p90 -83.13 150.42 26.27 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.917 -178.139 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -52.61 -43.85 65.65 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.479 -176.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.6 t 58.33 47.59 13.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.048 -172.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.7 t -171.97 -36.36 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.617 178.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -70.73 107.19 3.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.472 -175.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -60.43 -37.35 80.63 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.506 -175.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.5 t -72.87 -6.52 45.59 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.463 -177.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.86 -37.39 12.31 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -178.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 38.2 p-90 -122.58 -24.85 4.84 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -174.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -79.41 118.05 20.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.166 0.508 . . . . 0.0 110.687 -176.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.575 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 22.0 mmt -99.42 -10.08 22.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.894 -176.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.49 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.22 -113.47 2.27 Favored Glycine 0 CA--C 1.519 0.327 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.282 -178.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.49 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 19.4 Cg_exo -66.62 87.13 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.271 2.648 . . . . 0.0 113.161 -176.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.933 HG12 ' H ' ' A' ' 20' ' ' SER . 93.3 t -136.84 -166.58 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 178.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.933 ' H ' HG12 ' A' ' 19' ' ' VAL . 42.1 p -162.25 169.73 20.2 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 119.768 1.167 . . . . 0.0 108.122 -168.03 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 34.8 ttt85 -67.16 -39.37 86.5 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.739 -175.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -65.0 -53.83 39.96 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.88 0.372 . . . . 0.0 110.995 178.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -62.57 -47.22 84.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.356 -177.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.14 -38.58 71.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.117 0.484 . . . . 0.0 110.706 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -62.24 -57.74 10.33 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.655 178.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.8 t -65.73 -15.23 62.62 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -173.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.6 mtp180 -87.33 -13.52 43.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.589 0.233 . . . . 0.0 110.951 179.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.557 HD11 ' HG ' ' A' ' 37' ' ' LEU . 32.6 mt -130.43 -1.88 4.4 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -73.91 96.0 2.55 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.216 0.531 . . . . 0.0 111.109 -174.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.13 14.09 69.97 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.146 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -81.58 -169.03 2.11 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 122.281 0.233 . . . . 0.0 110.752 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.604 ' HB2' ' SD ' ' A' ' 35' ' ' MET . 51.3 mtm180 -60.99 127.03 29.54 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 177.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.484 ' CE1' ' HA ' ' A' ' 55' ' ' ASN . 6.2 m-70 -77.49 116.97 18.5 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.862 -176.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 129.33 -17.92 5.55 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -172.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.759 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 50.0 mtp -72.88 160.15 32.59 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 115.432 -0.384 . . . . 0.0 110.335 176.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.456 ' H ' ' HA ' ' A' ' 101' ' ' PRO . 43.3 p90 -163.98 169.23 18.29 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 178.03 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.575 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.6 pp -157.0 140.89 16.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.163 0.506 . . . . 0.0 111.183 175.056 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 50.8 t -108.92 123.0 64.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.261 175.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.44 ' HB2' ' HB ' ' A' ' 19' ' ' VAL . 33.3 ptt-85 -123.04 -177.83 3.79 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.013 -177.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -80.34 138.99 36.78 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 175.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.1 m -77.4 99.06 5.46 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 172.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.9 m -73.93 -9.62 58.83 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.247 178.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.3 p -83.53 -56.69 3.6 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.101 175.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 57.7 m -114.84 96.33 44.17 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.88 176.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.82 132.72 51.0 Favored 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 123.006 2.471 . . . . 0.0 112.618 -178.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.64 -27.14 17.55 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.389 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.59 ' OD1' ' HA ' ' A' ' 64' ' ' ASN . 33.1 m-20 -93.45 178.24 5.77 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -131.42 171.41 13.41 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 178.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.6 t -139.41 112.24 5.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.97 0.414 . . . . 0.0 110.999 175.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.403 ' CB ' HD11 ' A' ' 63' ' ' ILE . 51.0 tp -82.05 103.44 11.69 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.741 174.141 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 37.5 m -96.18 127.66 42.39 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 174.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 98.3 t -111.18 139.89 33.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.02 0.438 . . . . 0.0 111.038 -174.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.556 ' HB2' HD22 ' A' ' 28' ' ' LEU . 28.3 t -87.95 116.12 25.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.282 179.256 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.498 ' O ' ' N ' ' A' ' 56' ' ' SER . 75.8 mt-10 -144.46 178.4 7.97 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-O 118.379 -0.819 . . . . 0.0 108.832 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.624 ' C ' ' HB2' ' A' ' 57' ' ' ARG . 11.2 m-80 -24.11 65.46 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 126.934 2.094 . . . . 0.0 115.833 -176.337 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 54' ' ' GLU . 21.0 m 48.59 57.35 6.39 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -171.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.785 HH22 ' HA ' ' A' ' 154' ' ' GLU . 0.3 OUTLIER -162.05 58.24 0.25 Allowed 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.322 -1.308 . . . . 0.0 112.18 -145.641 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 11.2 t -74.5 97.91 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 122.058 0.933 . . . . 0.0 109.394 -172.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.565 ' HB2' ' CE2' ' A' ' 61' ' ' TYR . 0.1 OUTLIER -79.07 121.02 24.45 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 113.907 -1.497 . . . . 0.0 111.287 -175.456 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -98.05 108.34 21.02 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -173.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.565 ' CE2' ' HB2' ' A' ' 59' ' ' SER . 79.3 m-85 -110.18 107.42 17.22 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.04 178.002 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.578 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 53.3 mt -80.49 137.35 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -175.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.58 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 5.4 mp -116.47 117.69 56.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.728 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.59 ' HA ' ' OD1' ' A' ' 47' ' ' ASP . 87.3 m-20 -87.3 139.73 30.26 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.863 -177.15 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.8 t -86.76 98.51 11.2 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 173.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 1.003 HD11 ' HG3' ' A' ' 72' ' ' LYS . 91.6 mt -80.78 146.66 60.55 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.346 -175.286 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 66' ' ' LEU . 11.9 Cg_exo -71.05 -2.19 10.69 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.743 2.295 . . . . 0.0 110.235 170.039 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -81.92 5.07 20.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.151 177.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.731 ' HA ' ' HE ' ' A' ' 69' ' ' ARG . 3.2 tpm_? 62.98 29.0 16.47 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.306 -173.138 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.452 ' HB2' HD12 ' A' ' 66' ' ' LEU . 88.7 mtt180 -128.63 179.17 5.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.402 -177.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.58 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 31.4 m-85 -134.92 119.76 18.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.19 -178.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 1.003 ' HG3' HD11 ' A' ' 66' ' ' LEU . 38.8 mttm -96.31 101.11 12.7 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -175.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.626 HD13 ' HE2' ' A' ' 88' ' ' TYR . 10.0 tt -83.37 99.11 5.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.405 0.622 . . . . 0.0 109.476 173.073 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.408 ' O ' ' HB3' ' A' ' 75' ' ' ASP . . . 62.8 44.31 97.65 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.428 -174.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.445 ' HA ' ' HD3' ' A' ' 72' ' ' LYS . 25.4 t70 75.61 -25.07 0.21 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.172 0.589 . . . . 0.0 111.915 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.69 107.79 4.1 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 174.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.497 ' HB3' ' CG ' ' A' ' 72' ' ' LYS . 12.7 pt-20 -96.23 137.87 34.66 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.887 0.851 . . . . 0.0 112.404 -171.226 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.595 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 96.6 m-85 -122.33 162.65 21.14 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 114.159 -1.382 . . . . 0.0 107.97 174.036 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.45 ' HA ' ' HG2' ' A' ' 70' ' ' ARG . 3.2 p-10 -69.55 -15.36 63.21 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -172.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.456 ' CE1' ' HB2' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -172.29 171.57 4.75 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.459 174.036 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.512 HD23 HD21 ' A' ' 84' ' ' LEU . 9.7 mt -53.32 -54.22 47.52 Favored Pre-proline 0 N--CA 1.469 0.511 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 81' ' ' LEU . 27.6 Cg_endo -63.21 3.56 0.56 Allowed 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.436 2.09 . . . . 0.0 114.176 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.456 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -98.46 -31.49 11.97 Favored 'General case' 0 C--N 1.331 -0.211 0 O-C-N 122.292 -0.255 . . . . 0.0 110.53 178.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.595 ' HB3' ' CD2' ' A' ' 78' ' ' PHE . 4.0 pp -76.42 -35.7 58.4 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 51.0 mt -68.54 -20.03 64.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.893 176.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -86.53 -28.41 23.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.619 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.711 ' HE1' ' CE1' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -88.41 -19.52 26.46 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.238 0.542 . . . . 0.0 111.167 -177.341 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.711 ' CE1' ' HE1' ' A' ' 87' ' ' PHE . 45.1 m-85 -87.33 2.33 50.6 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 121.19 -0.944 . . . . 0.0 110.659 177.241 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -74.97 -18.32 60.4 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.021 174.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.618 HD13 ' O ' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -127.02 -3.83 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 CA-C-O 121.174 0.512 . . . . 0.0 110.194 -179.306 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.4 ' HB2' ' O ' ' A' ' 87' ' ' PHE . 3.3 t60 -88.92 -32.76 17.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.848 -173.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.518 ' CD2' HG23 ' A' ' 97' ' ' THR . 95.5 m-85 61.86 106.25 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 O-C-N 124.119 0.887 . . . . 0.0 110.108 -171.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 13.0 mt -66.49 -85.51 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 174.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.418 ' OD1' ' ND2' ' A' ' 55' ' ' ASN . 14.5 t70 -79.9 -130.76 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 172.299 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.1 t -87.27 12.25 12.29 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.211 0.529 . . . . 0.0 110.164 177.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.9 t -143.03 160.34 40.55 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.585 -178.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.518 HG23 ' CD2' ' A' ' 92' ' ' TYR . 6.6 p -100.27 -179.7 4.2 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.119 175.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.7 mt -75.41 106.89 7.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.187 0.517 . . . . 0.0 109.779 175.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.414 HG23 ' O ' ' A' ' 3' ' ' SER . 46.4 mm -90.23 -65.21 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.503 -175.291 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.759 ' O ' ' HA ' ' A' ' 35' ' ' MET . 10.9 pt-20 -159.18 140.81 9.7 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.206 178.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.456 ' HA ' ' H ' ' A' ' 36' ' ' PHE . 38.3 Cg_endo -65.49 170.2 11.4 Favored 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.831 2.354 . . . . 0.0 112.984 -175.335 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.423 ' C ' ' H ' ' A' ' 104' ' ' ARG . . . -68.71 126.5 92.81 Favored Pre-proline 0 N--CA 1.447 -0.597 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 170.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -69.15 28.86 0.16 Allowed 'Trans proline' 0 N--CA 1.478 0.571 0 C-N-CA 123.461 2.774 . . . . 0.0 114.135 -169.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.423 ' H ' ' C ' ' A' ' 102' ' ' ALA . 41.0 ttm180 66.46 -60.44 0.33 Allowed 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.644 0.777 . . . . 0.0 111.056 -177.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -89.34 134.82 32.08 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 178.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -61.47 -25.67 80.07 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.948 2.432 . . . . 0.0 112.51 178.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.3 t 72.03 142.75 0.09 OUTLIER Pre-proline 0 CA--C 1.533 0.298 0 O-C-N 123.799 0.687 . . . . 0.0 110.993 178.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.72 153.0 79.49 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.344 2.029 . . . . 0.0 111.433 175.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -65.47 98.26 0.33 Allowed 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.346 2.031 . . . . 0.0 112.041 178.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 86.2 mmm -105.74 -175.16 2.71 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.794 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -80.22 69.5 3.11 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.169 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 33.7 t -112.07 135.41 52.76 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.042 0.449 . . . . 0.0 110.609 -178.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.3 p -141.42 15.11 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.766 0.793 . . . . 0.0 109.555 177.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.7 p -77.91 8.13 5.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.928 -175.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.451 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . . . -129.22 125.0 22.51 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.262 177.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 115' ' ' ALA . 33.3 Cg_exo -62.17 -52.46 2.71 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 122.716 2.277 . . . . 0.0 112.128 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.476 ' C ' HD12 ' A' ' 118' ' ' LEU . 6.4 m-20 67.14 152.64 0.08 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 121.589 0.709 . . . . 0.0 112.002 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.48 ' HA ' ' HD3' ' A' ' 119' ' ' PRO . 9.2 mp -131.05 115.58 16.57 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.036 -178.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 118' ' ' LEU . 4.4 Cg_exo -81.14 19.31 1.18 Allowed 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 123.398 2.732 . . . . 0.0 112.207 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 27.1 m -68.6 117.11 9.92 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.596 -177.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -100.78 90.22 4.15 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 172.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -112.37 155.31 24.36 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.188 0.518 . . . . 0.0 110.913 -173.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -102.66 170.23 8.15 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.137 -178.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 7.2 p30 50.28 -147.77 0.35 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.385 1.074 . . . . 0.0 113.127 173.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.776 HD12 HG21 ' A' ' 152' ' ' ILE . 3.1 mm? 64.11 80.3 0.23 Allowed 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.665 0.745 . . . . 0.0 109.493 -166.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.526 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 39.9 tt0 -173.69 -60.07 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.303 -172.061 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -118.76 106.79 12.9 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 121.691 0.758 . . . . 0.0 110.524 177.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.876 HG22 ' HB3' ' A' ' 180' ' ' LYS . 20.9 t -115.68 134.97 57.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 114.375 -1.284 . . . . 0.0 108.771 -178.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.68 ' HG3' ' CG ' ' A' ' 179' ' ' GLU . 5.7 ptp180 -110.48 136.12 50.12 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 116.463 -2.095 . . . . 0.0 109.773 167.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.594 HG22 HG12 ' A' ' 178' ' ' VAL . 0.7 OUTLIER -93.57 142.21 27.6 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.711 -175.655 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.654 HD22 ' N ' ' A' ' 131' ' ' LEU . 2.0 mm? -115.04 -26.99 7.5 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.342 -165.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.513 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 37.1 t80 -89.36 -30.79 18.14 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.86 -172.328 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.604 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 8.8 t70 71.63 98.69 0.07 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.391 0.615 . . . . 0.0 109.545 -174.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.455 ' O ' ' HA ' ' A' ' 143' ' ' PRO . 53.7 t80 -123.9 84.07 54.67 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 177.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.622 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 66.7 Cg_endo -82.29 61.29 7.67 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.281 1.988 . . . . 0.0 112.894 -177.001 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -62.38 -29.8 74.35 Favored Glycine 0 C--N 1.331 0.301 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.589 178.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.46 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 10.0 m-80 64.03 65.39 0.69 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 114.861 -0.669 . . . . 0.0 112.143 176.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.479 ' HB3' ' H ' ' A' ' 140' ' ' GLU . 0.8 OUTLIER -145.72 169.49 18.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.908 177.019 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -89.41 -6.64 56.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.765 0.793 . . . . 0.0 109.253 172.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.479 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 11.6 mp0 -104.23 -19.76 14.01 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.575 175.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -135.38 107.69 7.28 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 1.058 HD11 ' HB2' ' A' ' 165' ' ' ASN . 33.1 tp -70.96 127.32 91.83 Favored Pre-proline 0 C--N 1.325 -0.465 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.745 -176.146 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.651 ' HD2' HD12 ' A' ' 142' ' ' LEU . 95.9 Cg_endo -81.7 93.71 0.95 Allowed 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 122.014 1.809 . . . . 0.0 111.367 172.391 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.514 ' CD1' ' HB ' ' A' ' 130' ' ' THR . 10.0 p90 -105.76 159.74 15.76 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.385 -174.213 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.604 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 56.5 mtpt -102.68 -169.0 1.6 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -175.031 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.574 ' HD2' ' N ' ' A' ' 146' ' ' LYS . 9.2 mptt -74.54 -13.49 60.68 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.154 -167.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -164.67 25.77 0.18 Allowed Glycine 0 CA--C 1.503 -0.692 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.32 -178.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.531 ' HB3' ' HB2' ' A' ' 145' ' ' LYS . 0.1 OUTLIER -79.54 148.28 31.84 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.001 0.429 . . . . 0.0 111.024 -177.458 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.516 HG13 ' HB3' ' A' ' 129' ' ' ARG . 1.8 mp -94.13 129.77 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.399 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.764 HD22 HD21 ' A' ' 142' ' ' LEU . 9.3 mt -121.47 156.95 31.67 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 -175.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.608 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 57.3 t -111.12 122.82 66.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 174.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 1.054 HD13 ' HB2' ' A' ' 163' ' ' ALA . 49.8 mm -76.78 79.91 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 122.344 1.069 . . . . 0.0 108.49 -177.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.529 HG23 ' HG3' ' A' ' 154' ' ' GLU . 18.1 tt -72.6 -25.89 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 113.551 -1.658 . . . . 0.0 110.113 -174.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.785 ' HA ' HH22 ' A' ' 57' ' ' ARG . 0.5 OUTLIER -140.88 153.36 45.68 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 173.85 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.413 ' HG3' ' CD1' ' A' ' 161' ' ' TRP . 79.3 tttt -140.85 91.98 8.94 Favored Pre-proline 0 C--N 1.32 -0.68 0 O-C-N 122.047 -0.408 . . . . 0.0 110.591 177.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.756 ' HG2' ' SD ' ' A' ' 172' ' ' MET . 2.8 Cg_endo -81.62 -39.85 0.17 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.573 2.182 . . . . 0.0 111.999 -174.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.43 ' HB2' ' HB2' ' A' ' 160' ' ' TRP . 46.2 mm-40 -114.66 161.86 17.55 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.38 -179.185 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -85.68 -7.87 58.54 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 173.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.992 ' HG3' ' HD1' ' A' ' 160' ' ' TRP . 21.0 pt20 -111.16 -17.69 13.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.728 178.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.992 ' HD1' ' HG3' ' A' ' 159' ' ' GLN . 47.5 m95 -131.78 131.55 43.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.397 178.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' TRP . . . . . 0.731 ' HB3' HD12 ' A' ' 152' ' ' ILE . 48.5 m0 -119.53 140.56 50.32 Favored 'General case' 0 C--O 1.212 -0.911 0 C-N-CA 122.877 0.471 . . . . 0.0 110.643 -176.067 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.591 ' OG ' ' HG2' ' A' ' 172' ' ' MET . 30.4 m -100.2 97.59 8.38 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -176.375 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 1.054 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -108.66 146.44 33.42 Favored 'General case' 0 N--CA 1.416 -2.129 0 C-N-CA 119.951 -0.7 . . . . 0.0 109.154 -173.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.692 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 19.9 ptt-85 -87.48 122.67 31.5 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 175.163 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 1.058 ' HB2' HD11 ' A' ' 142' ' ' LEU . 7.6 t30 -56.74 175.5 0.12 Allowed 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 113.572 -1.649 . . . . 0.0 110.282 -175.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -60.3 -13.48 13.06 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.322 0.582 . . . . 0.0 109.78 171.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -81.92 -26.43 34.07 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.005 174.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 100.69 -4.97 56.6 Favored Glycine 0 CA--C 1.521 0.421 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.112 -173.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.692 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.7 OUTLIER -69.05 134.31 49.24 Favored 'General case' 0 C--O 1.216 -0.71 0 C-N-CA 123.108 0.563 . . . . 0.0 110.903 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.499 HG22 HG21 ' A' ' 153' ' ' ILE . 39.3 t -86.75 128.07 39.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 O-C-N 122.049 -0.407 . . . . 0.0 110.969 178.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -154.08 154.72 25.7 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.122 170.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.756 ' SD ' ' HG2' ' A' ' 156' ' ' PRO . 29.5 mtp -81.11 141.05 34.66 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 117.284 0.542 . . . . 0.0 110.889 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.664 ' CG2' ' HB3' ' A' ' 142' ' ' LEU . 2.6 pp -141.4 143.14 29.01 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.558 -174.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.481 ' HB2' ' CD1' ' A' ' 177' ' ' TYR . 15.3 Cg_exo -67.7 135.91 37.31 Favored 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 122.739 2.293 . . . . 0.0 113.164 -178.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.54 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 98.1 t -64.54 -45.65 76.86 Favored Pre-proline 0 CA--C 1.539 0.519 0 N-CA-C 112.816 0.672 . . . . 0.0 112.816 178.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 36.1 Cg_endo -66.41 7.9 0.35 Allowed 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 122.022 1.815 . . . . 0.0 112.938 178.161 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.481 ' CD1' ' HB2' ' A' ' 174' ' ' PRO . 3.7 m-85 -101.05 -13.87 18.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.258 177.296 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.598 ' HA ' HD23 ' A' ' 131' ' ' LEU . 1.5 m -116.07 175.49 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 N-CA-C 115.956 1.836 . . . . 0.0 115.956 -166.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.734 ' O ' ' HG3' ' A' ' 179' ' ' GLU 0.273 2.0 pt-20 -149.09 57.69 1.02 Allowed 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 112.294 -2.23 . . . . 0.0 111.044 -165.699 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.876 ' HB3' HG22 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -69.36 141.7 54.13 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 118.748 -2.47 . . . . 0.0 111.768 -165.498 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.453 HD13 ' CZ ' ' A' ' 129' ' ' ARG . 32.7 tp -78.39 -66.72 0.82 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 112.161 -2.291 . . . . 0.0 112.362 -162.119 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 11.3 p -77.64 55.76 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 122.242 1.02 . . . . 0.0 111.051 -173.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.601 ' CD ' ' HB2' ' A' ' 185' ' ' SER . 0.0 OUTLIER -142.74 -6.65 0.87 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.323 178.712 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 8.6 t 61.92 23.53 13.86 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.095 178.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.637 ' HB3' ' HD3' ' A' ' 186' ' ' PRO . 9.3 t -37.01 -49.73 2.1 Favored Pre-proline 0 N--CA 1.471 0.618 0 C-N-CA 124.805 1.242 . . . . 0.0 113.773 -176.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.637 ' HD3' ' HB3' ' A' ' 185' ' ' SER . 16.8 Cg_exo -68.52 92.18 0.41 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 121.11 1.207 . . . . 0.0 110.292 169.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.425 ' CE1' ' HA ' ' A' ' 185' ' ' SER . 6.6 m-70 -88.0 80.98 7.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.959 0.409 . . . . 0.0 110.11 -174.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -107.74 -27.19 5.29 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 177.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -106.79 -29.24 9.66 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 175.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -82.75 91.87 7.11 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.218 0.532 . . . . 0.0 110.656 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 169.3 49.53 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -73.93 -29.62 62.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.993 0.425 . . . . 0.0 111.037 -172.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 70.7 mtp180 -84.79 -12.7 53.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.98 177.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 68.82 -62.39 0.39 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.627 0.771 . . . . 0.0 111.419 -176.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 13.6 p -160.96 155.06 22.8 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.254 -178.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -91.14 -167.22 1.75 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 175.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 47.0 m 72.29 -58.97 0.57 Allowed 'General case' 0 N--CA 1.466 0.371 0 O-C-N 123.679 0.612 . . . . 0.0 110.695 -177.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -85.9 145.22 27.26 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 173.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 82.16 -54.78 4.9 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.328 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 6.5 tp -159.48 108.6 1.5 Allowed Pre-proline 0 N--CA 1.448 -0.544 0 CA-C-O 121.08 0.467 . . . . 0.0 110.036 176.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -63.64 -30.4 70.17 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.544 2.163 . . . . 0.0 111.096 175.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.436 ' N ' ' HD3' ' A' ' 203' ' ' PRO . 37.8 tt0 58.88 66.37 2.44 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.501 177.207 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.436 ' HD3' ' N ' ' A' ' 202' ' ' GLU . 3.3 Cg_endo -86.4 124.46 2.38 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.068 2.512 . . . . 0.0 111.063 175.062 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -61.79 -41.04 97.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.931 0.396 . . . . 0.0 111.165 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -115.16 -85.15 0.61 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.168 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -144.99 -70.71 0.28 Allowed 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 121.121 -0.231 . . . . 0.0 111.331 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -102.88 -21.18 14.04 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.447 -175.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . 67.67 -169.0 0.19 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.849 178.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.87 ' H ' ' HD2' ' A' ' 210' ' ' PRO . 76.4 mm-40 -138.02 -50.58 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.95 -177.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 0.87 ' HD2' ' H ' ' A' ' 209' ' ' GLN . 37.8 Cg_endo -66.23 85.91 0.26 Allowed 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 121.984 1.79 . . . . 0.0 112.88 -179.33 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -104.44 3.7 32.47 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.105 177.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 8.1 p -78.62 -30.73 46.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.593 -176.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -78.95 105.83 10.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.909 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.481 ' HA ' ' HD3' ' A' ' 215' ' ' PRO . 10.2 t -151.92 136.1 10.0 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.524 -178.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 214' ' ' THR . 4.4 Cg_endo -86.17 148.14 9.1 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 123.385 2.724 . . . . 0.0 112.118 177.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 48.0 tp -139.19 94.69 9.64 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 120.858 0.361 . . . . 0.0 110.745 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.21 73.98 4.26 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 123.125 2.55 . . . . 0.0 111.972 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -143.62 -70.42 0.31 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.941 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 26.1 m -93.64 -27.2 4.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.182 175.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 9.4 t -93.58 97.09 10.27 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.434 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -138.01 117.06 1.4 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.044 -178.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 3.1 t -123.61 143.42 41.62 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -179.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.26 119.5 6.78 Favored 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 122.789 2.326 . . . . 0.0 112.162 176.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -81.55 -28.37 43.7 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.918 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -154.77 143.75 20.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.655 0.264 . . . . 0.0 110.42 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -74.86 94.16 2.75 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.024 0.44 . . . . 0.0 110.656 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 8.0 tp -163.27 137.63 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.068 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.875 ' HB ' ' HD3' ' A' ' 229' ' ' PRO . 25.2 m -152.75 -59.8 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.727 177.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.875 ' HD3' ' HB ' ' A' ' 228' ' ' THR . 5.9 Cg_exo -79.9 112.93 2.94 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.151 1.901 . . . . 0.0 111.927 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 79.5 mt -73.23 154.23 90.34 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.458 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.38 124.43 15.14 Favored 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 122.288 1.992 . . . . 0.0 110.707 172.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 27.8 m -74.75 74.02 2.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.619 0.723 . . . . 0.0 110.811 -176.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 11.0 p -78.13 -37.66 45.57 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.052 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 62.5 tp60 55.62 84.49 0.08 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.448 0.642 . . . . 0.0 111.108 -177.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 24.7 p-10 -168.35 142.03 3.2 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.732 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' GLY . . . . . 0.491 ' N ' ' HD3' ' A' ' 237' ' ' PRO . . . 75.15 57.97 4.15 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 115.924 -0.58 . . . . 0.0 113.853 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.491 ' HD3' ' N ' ' A' ' 236' ' ' GLY . 1.1 Cg_endo -82.61 95.31 0.85 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.144 1.896 . . . . 0.0 109.604 170.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.538 ' CG1' HD12 ' A' ' 293' ' ' ILE . 2.8 t -65.66 139.67 20.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.729 -169.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -106.16 121.56 44.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.994 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.508 ' HB1' ' HB ' ' A' ' 291' ' ' VAL . . . -119.26 136.57 54.16 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.36 179.133 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.425 ' HB2' ' CE1' ' A' ' 294' ' ' PHE . 2.8 tppp? -86.97 122.34 30.69 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 178.399 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 242' ' ' ALA . . . . . 0.532 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -72.43 97.02 1.99 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.154 0.502 . . . . 0.0 110.278 177.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 19.1 pt -85.59 -25.68 6.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.712 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.79 138.92 50.14 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.409 ' HE3' ' HB2' ' A' ' 245' ' ' LYS . 34.5 ttmt -67.61 155.81 38.28 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.2 -173.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 15.5 mmm180 -134.91 128.44 32.58 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.473 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.474 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 8.2 m -134.56 130.14 19.78 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.18 176.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.546 ' HD3' ' HB2' ' A' ' 257' ' ' ALA . 3.5 Cg_exo -75.5 145.51 29.87 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 123.059 2.506 . . . . 0.0 112.128 -176.008 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 51.1 t -75.12 169.98 16.95 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -61.68 -19.56 62.48 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -176.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -110.61 4.52 20.32 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -178.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.544 ' HB3' ' HB3' ' A' ' 255' ' ' ALA . 61.7 m-20 -91.06 112.96 25.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.51 0.195 . . . . 0.0 111.054 -178.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 253' ' ' LYS . . . . . 0.444 ' N ' ' HD2' ' A' ' 253' ' ' LYS . 10.9 mptt -95.4 -41.3 9.06 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.272 0.558 . . . . 0.0 109.986 175.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 6.8 p -98.93 21.25 11.86 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.188 -174.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.544 ' HB3' ' HB3' ' A' ' 252' ' ' ASP . . . -102.61 113.31 26.57 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 121.06 -0.256 . . . . 0.0 110.434 177.397 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.529 HD23 ' H ' ' A' ' 257' ' ' ALA . 0.5 OUTLIER -70.87 144.03 50.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.048 0.452 . . . . 0.0 110.965 -175.705 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.546 ' HB2' ' HD3' ' A' ' 248' ' ' PRO . . . -105.43 136.21 45.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.58 177.163 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 94.9 mt -135.88 152.16 50.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.799 -173.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -118.64 155.57 30.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.267 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 36.6 t -68.19 129.9 33.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.607 -174.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 83.32 33.92 21.64 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.316 178.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -119.28 162.67 18.34 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 39.2 mm -102.18 109.81 27.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.01 0.434 . . . . 0.0 110.78 -177.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 16.8 t -89.61 104.82 15.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.381 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 265' ' ' LYS . . . . . 0.424 ' HE2' ' HB3' ' A' ' 278' ' ' GLU . 4.4 ptmt -87.06 102.02 14.02 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.631 177.071 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.504 HG21 ' HB3' ' A' ' 275' ' ' TRP . 3.0 p -92.93 123.99 45.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.182 0.515 . . . . 0.0 110.723 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 16.1 p -94.98 -27.01 15.86 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.383 -177.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 268' ' ' ARG . . . . . 0.577 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 42.2 ttm180 -131.92 103.16 6.16 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.997 0.427 . . . . 0.0 110.394 178.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 269' ' ' MET . . . . . 0.48 ' HG3' ' CD1' ' A' ' 275' ' ' TRP . 29.6 ttm -93.97 109.87 21.58 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.992 0.425 . . . . 0.0 110.734 -179.031 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -87.78 173.93 8.68 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.502 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 31.3 pt -107.6 5.7 9.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.874 0.369 . . . . 0.0 111.523 -176.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -83.3 -26.28 30.78 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.124 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 119.18 -10.29 11.83 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.139 -177.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.558 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 99.1 mt-30 -118.06 111.97 19.6 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 177.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.59 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 19.2 m0 -96.74 159.55 14.86 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.117 -175.25 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.577 ' HB2' ' HB3' ' A' ' 268' ' ' ARG . 48.0 mt-10 -100.81 111.68 23.95 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.255 175.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 277' ' ' GLY . . . . . 0.574 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -129.15 158.58 22.08 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.533 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.424 ' HB3' ' HE2' ' A' ' 265' ' ' LYS . 39.6 tt0 -110.25 109.99 20.66 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.902 0.382 . . . . 0.0 110.155 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 57.3 t -127.18 128.49 70.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.869 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 17.1 m120 63.03 25.59 15.07 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 123.442 0.464 . . . . 0.0 111.238 -177.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 75.52 19.49 79.25 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.059 -177.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 282' ' ' ARG . . . . . 0.403 ' NH1' ' HA ' ' A' ' 256' ' ' LEU . 1.4 tmt_? -129.73 117.36 20.16 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.574 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 25.1 pttm -103.68 142.4 34.39 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.803 -178.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -173.18 178.37 45.18 Favored Glycine 0 N--CA 1.439 -1.12 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.707 178.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.59 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 94.8 mt -81.09 130.55 35.07 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.766 0.317 . . . . 0.0 110.314 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -129.2 125.24 22.61 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.424 175.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -58.36 126.42 21.38 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 123.183 2.589 . . . . 0.0 111.787 174.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -64.75 -12.66 49.73 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.305 -174.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.19 -3.77 11.75 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -176.101 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -114.91 -2.65 12.83 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.023 -0.423 . . . . 0.0 111.212 -178.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.532 HG12 ' HA ' ' A' ' 242' ' ' ALA . 35.8 m -128.7 166.51 25.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.737 -0.21 . . . . 0.0 110.606 179.345 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? -131.34 132.49 44.5 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.716 0.293 . . . . 0.0 110.26 172.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.538 HD12 ' CG1' ' A' ' 238' ' ' VAL . 40.8 mm -76.61 125.29 36.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.116 177.066 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 294' ' ' PHE . . . . . 0.425 ' CE1' ' HB2' ' A' ' 241' ' ' LYS . 5.3 p90 -149.67 166.64 28.72 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -103.7 104.81 44.49 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 178.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -87.42 10.03 3.67 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.883 2.388 . . . . 0.0 112.368 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -90.51 -47.0 7.98 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.246 -177.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 298' ' ' ASN . . . . . 0.462 ' OD1' ' HB3' ' A' ' 300' ' ' ASP . 4.8 p30 -98.07 135.45 21.39 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.299 -179.006 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -87.53 5.62 5.48 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.717 2.278 . . . . 0.0 112.004 177.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.462 ' HB3' ' OD1' ' A' ' 298' ' ' ASN . 14.3 t70 -70.76 -45.86 63.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.993 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -120.86 10.69 10.94 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.53 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -79.4 110.61 14.86 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.154 178.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 . . . . . 0 C--O 1.246 0.89 0 CA-C-O 118.575 -0.726 . . . . 0.0 109.531 178.346 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.286 0 CA-C-O 120.724 0.297 . . . . 0.0 110.419 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.7 m -115.25 168.19 10.17 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.8 m 60.82 86.59 0.1 Allowed 'General case' 0 C--O 1.233 0.219 0 O-C-N 123.661 0.601 . . . . 0.0 110.279 -175.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.558 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . 69.39 100.86 0.06 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.161 -176.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.432 HH11 ' HD3' ' A' ' 5' ' ' ARG . 3.4 ptp180 -125.87 81.33 1.98 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.433 0.635 . . . . 0.0 111.32 -177.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -147.98 157.56 43.59 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.74 177.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -85.88 9.51 16.55 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -171.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.0 m 65.54 -15.61 0.11 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 173.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.83 ' CA ' ' HE1' ' A' ' 14' ' ' TRP . 8.2 t -142.4 -71.02 0.33 Allowed 'General case' 0 C--O 1.246 0.919 0 CA-C-O 122.224 1.011 . . . . 0.0 110.82 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' A' ' 12' ' ' SER . 25.0 t0 -25.16 72.29 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 113.908 -1.497 . . . . 0.0 111.484 -148.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.68 ' H ' ' HD2' ' A' ' 11' ' ' ARG . 11.4 mmm180 -6.03 -53.37 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 126.437 2.335 . . . . 0.0 115.099 -159.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.5 ' N ' ' O ' ' A' ' 10' ' ' ASP . 6.0 t -65.49 12.84 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 121.548 -0.061 . . . . 0.0 110.912 176.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.492 ' O ' ' HG2' ' A' ' 101' ' ' PRO . . . -91.0 -29.71 17.22 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.187 177.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.83 ' HE1' ' CA ' ' A' ' 9' ' ' SER . 24.5 p-90 -151.49 -28.03 0.19 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -173.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -59.4 123.79 17.91 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -178.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.49 ' SD ' ' HA ' ' A' ' 104' ' ' ARG . 33.1 tpp -110.1 2.66 19.62 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.485 -171.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.53 ' O ' ' HB2' ' A' ' 39' ' ' ARG . . . 51.53 -104.85 0.17 Allowed Glycine 0 CA--C 1.524 0.619 0 O-C-N 123.592 0.557 . . . . 0.0 114.476 177.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.428 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 3.5 Cg_exo -78.25 110.13 2.81 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.783 2.322 . . . . 0.0 112.756 179.08 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.944 ' HB ' ' HG3' ' A' ' 39' ' ' ARG . 23.5 t -138.23 -73.1 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 119.421 -0.323 . . . . 0.0 111.636 177.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.478 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 69.9 m 79.93 -177.35 0.08 Allowed 'General case' 0 C--N 1.342 0.26 0 CA-C-N 117.781 0.264 . . . . 0.0 110.929 174.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -63.81 -49.61 72.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.549 0.214 . . . . 0.0 111.154 -171.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -59.89 -53.62 55.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.622 -173.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 57.9 mm-40 -64.07 -48.93 74.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.42 -178.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.02 -39.66 75.18 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.811 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.638 ' HA ' HG21 ' A' ' 58' ' ' VAL . 12.4 mm100 -70.06 -53.7 16.31 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -178.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.0 t -68.28 -27.14 66.06 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.007 0.432 . . . . 0.0 111.611 -173.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -87.46 -33.75 18.93 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.094 0.473 . . . . 0.0 110.87 -175.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.682 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 30.7 mt -106.33 28.17 8.01 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.616 -176.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.11 65.77 2.16 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.073 0.463 . . . . 0.0 111.941 -173.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 59.53 23.53 58.4 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.979 176.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.476 ' O ' ' HB2' ' A' ' 117' ' ' ASN . 8.4 tt0 -64.46 -81.67 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.681 0.277 . . . . 0.0 110.367 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.433 ' HA ' ' HA ' ' A' ' 117' ' ' ASN . 39.9 ttp-105 -107.34 132.57 52.99 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 173.212 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 67.2 m170 -81.74 110.64 17.25 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.026 0.441 . . . . 0.0 110.527 -179.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 137.25 -19.92 3.39 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.382 -175.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.732 ' HB2' ' HB3' ' A' ' 53' ' ' SER . 34.3 mtt -59.82 137.04 58.16 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 122.404 0.282 . . . . 0.0 111.169 176.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.575 ' CB ' HG22 ' A' ' 52' ' ' VAL . 22.0 p90 -146.78 158.27 43.87 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.941 173.216 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.498 ' O ' HD12 ' A' ' 37' ' ' LEU . 4.5 pp -151.66 143.0 23.42 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.574 173.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 84.2 t -114.65 120.58 64.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 176.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.944 ' HG3' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -134.51 169.22 17.6 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.714 -176.728 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.405 ' O ' ' HG2' ' A' ' 39' ' ' ARG . 1.8 m-20 -57.99 127.96 34.73 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 175.313 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.3 t -64.62 157.57 26.71 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.401 0.62 . . . . 0.0 111.895 -173.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.2 p -86.47 -11.01 52.98 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.4 177.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 32.7 p -88.62 -63.6 1.27 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.645 178.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.447 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 57.4 m -136.91 145.4 50.59 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.835 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 44' ' ' CYS . 21.8 Cg_exo -65.51 -28.09 53.74 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.765 2.31 . . . . 0.0 112.51 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -76.73 -6.17 84.63 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.121 -0.561 . . . . 0.0 112.317 178.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.49 ' OD1' ' HA ' ' A' ' 64' ' ' ASN . 46.1 m-20 -111.28 159.48 17.9 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 176.196 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -129.54 169.45 14.97 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 177.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.511 HG22 HG12 ' A' ' 62' ' ' ILE . 45.2 t -140.14 98.84 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.184 0.516 . . . . 0.0 111.144 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.8 tp -69.05 99.84 1.15 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.872 172.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.1 m -96.74 126.2 41.73 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 177.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.575 HG22 ' CB ' ' A' ' 36' ' ' PHE . 80.9 t -117.46 146.92 21.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.704 -176.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.732 ' HB3' ' HB2' ' A' ' 35' ' ' MET . 26.6 t -100.27 98.88 9.5 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 175.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.469 ' HB2' ' OD1' ' A' ' 94' ' ' ASP . 0.0 OUTLIER -144.35 156.39 44.22 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.727 -176.352 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.552 ' OD1' ' HE2' ' A' ' 155' ' ' LYS . 0.7 OUTLIER 66.56 -56.04 0.4 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.243 0.617 . . . . 0.0 112.652 -179.235 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.8 p 169.77 -6.95 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.721 0.809 . . . . 0.0 110.774 -175.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -134.68 -169.11 2.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.512 -175.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.638 HG21 ' HA ' ' A' ' 25' ' ' GLN . 26.2 t -114.55 104.92 17.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.504 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 75.1 m -84.0 119.34 24.82 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.551 0.691 . . . . 0.0 110.133 176.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -94.88 104.22 16.11 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.033 -175.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.81 ' HB3' HD11 ' A' ' 73' ' ' ILE . 57.6 m-85 -98.95 98.43 9.48 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.431 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.511 HG12 HG22 ' A' ' 49' ' ' VAL . 30.3 mt -80.75 130.93 35.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -174.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.617 HG13 ' HB ' ' A' ' 73' ' ' ILE . 4.0 mp -103.81 123.46 57.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.858 178.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.49 ' HA ' ' OD1' ' A' ' 47' ' ' ASP . 17.0 m120 -104.13 131.07 51.79 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -175.509 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.9 t -77.55 111.18 13.01 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 175.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.413 HD12 ' HB2' ' A' ' 70' ' ' ARG . 93.2 mt -77.15 143.69 70.24 Favored Pre-proline 0 C--N 1.318 -0.78 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.183 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 66' ' ' LEU . 52.3 Cg_exo -56.36 -22.33 41.11 Favored 'Trans proline' 0 CA--C 1.528 0.214 0 C-N-CA 122.888 2.392 . . . . 0.0 112.383 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.9 p30 -86.03 16.42 4.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.916 178.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.81 ' HA ' ' HE ' ' A' ' 69' ' ' ARG . 0.2 OUTLIER 66.73 35.38 5.15 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.008 174.172 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.413 ' HB2' HD12 ' A' ' 66' ' ' LEU . 97.6 mtt180 -114.4 171.03 7.87 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.096 173.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.493 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 36.6 m-85 -119.69 120.3 36.2 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.014 0.435 . . . . 0.0 110.753 179.105 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.897 ' HE2' ' HA ' ' A' ' 75' ' ' ASP . 88.0 tttt -114.48 103.74 11.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.867 -176.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.81 HD11 ' HB3' ' A' ' 61' ' ' TYR . 5.6 tt -92.71 111.69 24.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.279 0.561 . . . . 0.0 111.531 -175.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 57.25 51.15 59.29 Favored Glycine 0 C--N 1.329 0.183 0 CA-C-N 115.446 -0.797 . . . . 0.0 113.164 177.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.897 ' HA ' ' HE2' ' A' ' 72' ' ' LYS . 29.7 t70 72.04 -15.43 0.46 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.997 0.519 . . . . 0.0 111.872 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 46.3 tp60 -82.85 110.64 18.04 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.446 ' H ' ' HG2' ' A' ' 77' ' ' GLU . 7.1 pt-20 -87.82 127.82 35.33 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.026 -171.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -129.61 -179.86 5.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.066 177.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -76.71 -56.48 4.57 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.172 0.51 . . . . 0.0 110.843 177.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.569 ' ND1' ' HG2' ' A' ' 82' ' ' PRO . 2.4 p80 -147.08 177.8 8.88 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.519 -176.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.568 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 12.5 mt -59.49 -52.36 74.72 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -176.379 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.569 ' HG2' ' ND1' ' A' ' 80' ' ' HIS . 14.6 Cg_endo -60.65 -8.78 9.82 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 121.953 1.769 . . . . 0.0 113.197 177.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.92 -26.35 21.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.787 0.327 . . . . 0.0 110.485 -178.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.1 pp -91.1 -30.72 16.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.925 0.393 . . . . 0.0 110.082 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 95.0 mt -68.58 -33.9 74.86 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.253 178.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -71.83 -27.78 63.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.519 0.676 . . . . 0.0 110.376 175.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.523 ' O ' HG12 ' A' ' 90' ' ' ILE . 82.8 t80 -79.82 -37.02 36.01 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.806 -174.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.504 ' HE2' HD13 ' A' ' 73' ' ' ILE . 27.7 m-85 -74.16 0.59 13.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.795 0.331 . . . . 0.0 111.787 -178.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.403 ' HA ' ' HB ' ' A' ' 97' ' ' THR . 62.4 tttm -66.18 -25.35 66.9 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.34 168.398 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.523 HG12 ' O ' ' A' ' 87' ' ' PHE . 6.6 pt -88.21 -28.96 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 174.22 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.472 ' HB2' ' HD1' ' A' ' 88' ' ' TYR . 2.5 m170 -84.58 -24.44 29.21 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -172.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.612 ' HA ' ' HA ' ' A' ' 97' ' ' THR . 29.8 m-85 73.07 -7.61 1.46 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -179.131 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.667 HD22 ' CE2' ' A' ' 61' ' ' TYR . 14.3 mt 53.8 -25.67 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.586 1.554 . . . . 0.0 113.656 -169.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.555 ' H ' ' C ' ' A' ' 92' ' ' TYR . 2.9 p-10 -151.46 -51.92 0.12 Allowed 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 169.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.688 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 14.1 t -177.0 14.53 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.77 0.319 . . . . 0.0 110.745 -178.241 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.417 HG22 ' OD1' ' A' ' 94' ' ' ASP . 13.2 t -128.58 -29.38 2.41 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -173.227 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.612 ' HA ' ' HA ' ' A' ' 92' ' ' TYR . 16.4 p 70.18 166.0 0.28 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.995 1.318 . . . . 0.0 110.56 -171.149 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.49 ' CD2' HD11 ' A' ' 93' ' ' LEU . 21.3 mt -70.1 103.16 2.23 Favored 'General case' 0 C--O 1.221 -0.401 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 178.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.558 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 43.4 mm -87.81 -61.09 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.482 -175.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 101' ' ' PRO . 0.9 OUTLIER -148.43 154.82 42.13 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-O 120.994 0.426 . . . . 0.0 110.549 179.262 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.492 ' HG2' ' O ' ' A' ' 13' ' ' ALA . 16.9 Cg_exo -69.36 149.04 68.94 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.792 2.328 . . . . 0.0 112.092 177.056 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.48 153.42 93.77 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.577 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.87 136.4 69.74 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.561 2.174 . . . . 0.0 111.787 175.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.49 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 36.0 mtt180 -67.53 -30.76 70.49 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.235 0.54 . . . . 0.0 110.474 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -153.49 164.64 19.84 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.25 104.75 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.418 2.079 . . . . 0.0 111.752 175.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.5 m -106.8 141.57 23.13 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.165 -173.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.454 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 57.7 Cg_endo -70.83 156.97 59.57 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.944 2.429 . . . . 0.0 112.06 177.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 108' ' ' PRO . 15.7 Cg_exo -68.2 96.34 0.46 Allowed 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.675 2.25 . . . . 0.0 112.419 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -72.95 -22.0 60.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.427 0.632 . . . . 0.0 109.859 174.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -159.57 -163.72 13.75 Favored Glycine 0 N--CA 1.441 -0.971 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 178.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.2 t -103.92 138.85 39.89 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.3 m -119.97 94.59 3.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.527 0.68 . . . . 0.0 111.098 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 52.7 m -92.79 30.26 1.61 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.77 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.422 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . . . -81.42 137.4 48.49 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.216 177.339 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 115' ' ' ALA . 22.5 Cg_exo -64.53 94.63 0.21 Allowed 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.803 2.335 . . . . 0.0 112.591 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 31' ' ' GLN . 4.8 p30 -74.4 -64.3 1.05 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.604 175.17 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 44.8 tp 60.27 83.66 0.21 Allowed Pre-proline 0 C--O 1.236 0.367 0 O-C-N 123.755 0.659 . . . . 0.0 111.587 178.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -73.11 73.76 3.11 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 123.054 2.502 . . . . 0.0 110.942 176.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.5 m -68.34 125.37 26.23 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.295 -176.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -93.77 90.11 6.43 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 172.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -95.87 150.93 19.88 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.766 -174.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -113.85 161.31 17.75 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.103 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 59.82 -148.09 0.46 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -177.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.663 HD12 HG21 ' A' ' 152' ' ' ILE . 4.4 mm? 57.03 89.86 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.85 0.833 . . . . 0.0 112.861 171.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -173.27 -73.04 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.073 -1.421 . . . . 0.0 107.364 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.455 ' HB3' ' HB3' ' A' ' 181' ' ' LEU . 47.2 m-85 -109.64 139.21 44.94 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.081 -0.647 . . . . 0.0 110.643 177.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.489 ' CG1' ' HB ' ' A' ' 178' ' ' VAL . 5.3 t -135.29 161.5 39.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -178.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.491 ' CZ ' HD13 ' A' ' 181' ' ' LEU . 2.1 ptp180 -140.56 136.56 32.95 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 169.166 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' THR . . . . . 1.046 HG22 HG12 ' A' ' 178' ' ' VAL . 20.7 p -87.08 140.03 29.96 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.027 -174.326 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 13.1 mt -112.05 -31.66 6.82 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.245 -175.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -81.7 -31.78 31.98 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.432 -169.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.47 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 9.8 t70 69.02 110.4 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 O-C-N 123.627 0.58 . . . . 0.0 110.373 -173.265 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -141.85 101.5 5.9 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.877 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -94.42 90.69 0.12 Allowed 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 123.153 2.569 . . . . 0.0 112.44 176.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -89.86 -28.82 17.3 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.211 176.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 63.11 83.97 0.15 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 114.695 -0.753 . . . . 0.0 112.232 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.774 ' HB3' ' HB3' ' A' ' 141' ' ' ASP . 31.9 t70 -160.66 178.06 9.86 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 177.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -92.83 -12.19 31.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.082 0.468 . . . . 0.0 110.929 178.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.55 ' O ' ' HB2' ' A' ' 172' ' ' MET . 5.0 mp0 -120.54 6.78 10.56 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 176.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.774 ' HB3' ' HB3' ' A' ' 138' ' ' ASP . 10.7 t70 -132.91 107.21 8.16 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 175.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.633 ' HB3' ' CG2' ' A' ' 173' ' ' ILE . 57.3 tp -82.25 112.92 40.02 Favored Pre-proline 0 C--N 1.323 -0.575 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.681 -173.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.54 ' HD2' ' HD2' ' A' ' 169' ' ' ARG . 28.6 Cg_endo -69.71 100.96 0.85 Allowed 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 121.998 1.799 . . . . 0.0 111.489 175.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.593 ' CG ' HG21 ' A' ' 130' ' ' THR . 13.0 p90 -115.61 168.7 9.78 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.047 0.451 . . . . 0.0 111.669 -176.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.554 ' HB2' ' HG2' ' A' ' 148' ' ' GLU . 1.4 mptp? -112.66 -169.93 1.57 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.32 -177.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.897 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -87.56 3.96 45.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.226 0.536 . . . . 0.0 110.355 179.093 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.11 31.61 1.43 Allowed Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.157 -178.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.554 ' HG2' ' HB2' ' A' ' 145' ' ' LYS . 13.0 mm-40 -98.16 143.95 28.15 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.421 -0.215 . . . . 0.0 110.421 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.6 mp -102.6 132.69 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 175.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.636 ' HB3' ' HB1' ' A' ' 163' ' ' ALA . 11.1 mt -119.02 175.78 5.6 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -177.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.586 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 15.3 t -142.25 123.56 12.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.663 HG21 HD12 ' A' ' 125' ' ' LEU . 25.2 mm -78.91 79.79 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-O 122.404 1.097 . . . . 0.0 110.285 -174.103 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.503 HG23 ' HG3' ' A' ' 154' ' ' GLU . 19.4 tt -74.67 -35.76 38.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 113.452 -1.704 . . . . 0.0 110.418 -175.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 1.101 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 53.0 mt-10 -120.18 139.44 52.63 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 171.235 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.552 ' HE2' ' OD1' ' A' ' 55' ' ' ASN . 35.9 ttpt -132.25 81.89 59.8 Favored Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 122.037 -0.414 . . . . 0.0 110.058 170.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.688 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 11.7 Cg_exo -72.1 -46.36 0.54 Allowed 'Trans proline' 0 CA--C 1.515 -0.465 0 C-N-CA 122.43 2.086 . . . . 0.0 111.34 177.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -122.15 -178.94 4.0 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.265 -174.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -101.73 -22.25 14.45 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.302 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -89.14 -27.6 20.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.21 0.528 . . . . 0.0 110.5 -179.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.718 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 42.0 m95 -129.21 130.4 46.26 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.906 -179.406 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' TRP . . . . . 0.629 ' O ' HG13 ' A' ' 173' ' ' ILE . 54.2 m0 -123.12 137.58 54.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.704 178.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' SER . . . . . 1.101 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 16.2 m -84.46 106.37 15.99 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 176.062 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.636 ' HB1' ' HB3' ' A' ' 150' ' ' LEU . . . -116.9 162.27 18.01 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.279 -174.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.749 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 21.8 ptt-85 -109.93 127.78 54.96 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 175.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 0.6 ' HA ' HD22 ' A' ' 150' ' ' LEU . 19.7 p-10 -77.3 -174.06 3.11 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.999 -0.28 . . . . 0.0 111.205 -176.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -66.46 -25.8 66.9 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.237 0.541 . . . . 0.0 110.29 -177.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -70.72 -28.62 64.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.46 175.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 107.33 15.39 15.88 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.854 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.749 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 13.3 ttm-85 -92.86 134.3 35.22 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 122.779 0.431 . . . . 0.0 111.051 -176.01 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.557 HG22 ' HB3' ' A' ' 164' ' ' ARG . 60.0 t -99.18 136.89 28.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 120.848 0.356 . . . . 0.0 110.825 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -168.97 161.28 34.96 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 175.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.718 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.0 OUTLIER -69.26 132.56 46.66 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.897 0.348 . . . . 0.0 110.124 179.234 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.852 HD13 HG11 ' A' ' 178' ' ' VAL . 2.6 pp -134.12 144.0 49.58 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.645 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.483 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 5.2 Cg_exo -73.87 127.82 11.85 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.853 2.369 . . . . 0.0 111.688 -178.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.642 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 19.2 t -69.93 -35.33 5.16 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.642 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 11.3 Cg_endo -57.76 -16.83 26.82 Favored 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 121.832 1.688 . . . . 0.0 112.672 170.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.483 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.8 m-30 -87.33 -20.34 26.91 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.392 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 1.046 HG12 HG22 ' A' ' 130' ' ' THR . 4.8 m -118.83 174.66 4.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -168.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -140.62 166.83 23.67 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 173.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.462 ' HB2' ' HD2' ' A' ' 183' ' ' ARG . 3.2 mppt? -94.76 138.68 32.27 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.119 0.485 . . . . 0.0 111.451 -176.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.491 HD13 ' CZ ' ' A' ' 129' ' ' ARG . 57.7 tp -93.68 157.74 16.02 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.34 175.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 18.3 m 38.6 39.36 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.959 0.904 . . . . 0.0 111.71 -176.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.462 ' HD2' ' HB2' ' A' ' 180' ' ' LYS . 53.5 ttt180 -75.39 12.2 1.03 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.434 -174.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.417 ' O ' ' ND1' ' A' ' 187' ' ' HIS . 32.5 t -74.32 73.68 1.84 Allowed 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.025 174.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.598 ' HA ' ' CE1' ' A' ' 187' ' ' HIS . 37.7 m -34.8 -45.31 0.72 Allowed Pre-proline 0 N--CA 1.472 0.655 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 -173.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 185' ' ' SER . 9.6 Cg_endo -57.63 92.91 0.06 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 121.28 1.32 . . . . 0.0 111.79 169.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.598 ' CE1' ' HA ' ' A' ' 185' ' ' SER . 2.0 p-80 -160.69 133.93 6.62 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.826 0.822 . . . . 0.0 112.998 -178.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -123.9 -33.08 0.82 Allowed Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 114.071 -1.422 . . . . 0.0 110.088 170.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -122.64 80.76 1.78 Allowed 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.175 0.512 . . . . 0.0 110.566 178.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -135.57 32.0 3.07 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.506 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -91.28 59.95 3.02 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.258 -175.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -94.05 153.26 18.25 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.3 177.52 5.53 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.336 178.089 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -136.8 116.99 13.46 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.264 0.554 . . . . 0.0 111.327 -171.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 24.4 p -87.44 -160.68 0.63 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.249 -177.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 45.5 95.51 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.434 1.093 . . . . 0.0 113.644 174.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 16.5 m -126.47 121.62 32.89 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.114 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 65.61 111.25 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.898 0.749 . . . . 0.0 112.108 175.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -142.53 108.37 0.52 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.04 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.753 HG22 ' HG3' ' A' ' 202' ' ' GLU . 4.3 mp -125.8 109.75 25.23 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -65.52 -58.46 0.19 Allowed 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.963 2.442 . . . . 0.0 113.073 -176.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.753 ' HG3' HG22 ' A' ' 200' ' ' ILE . 47.6 mt-10 62.54 90.08 0.1 OUTLIER Pre-proline 0 N--CA 1.467 0.423 0 C-N-CA 123.105 0.562 . . . . 0.0 111.503 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -78.4 128.67 8.97 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.609 2.206 . . . . 0.0 112.097 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.56 140.71 57.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.544 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 18.8 p-80 -147.65 93.2 2.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.374 0.606 . . . . 0.0 111.141 -177.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -86.61 112.21 21.38 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.753 175.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -113.13 107.72 16.32 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.975 0.417 . . . . 0.0 110.742 -175.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -111.17 140.49 45.68 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.124 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -107.72 115.08 59.62 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.415 178.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.41 170.96 19.18 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.842 2.361 . . . . 0.0 112.711 -177.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -93.79 165.29 12.76 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.418 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 4.3 m -93.55 -26.41 17.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.432 -173.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 11.7 p 53.86 -167.23 0.07 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.698 0.799 . . . . 0.0 111.997 -176.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 5.6 t -95.78 121.83 60.23 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 121.122 0.487 . . . . 0.0 111.234 -176.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -78.03 157.48 30.56 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.544 2.163 . . . . 0.0 110.807 173.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 7.8 mp 58.19 93.54 0.05 OUTLIER Pre-proline 0 N--CA 1.465 0.306 0 O-C-N 123.631 0.582 . . . . 0.0 110.951 -177.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -79.69 3.73 7.29 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.587 2.191 . . . . 0.0 112.852 -176.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . 68.25 111.74 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 O-C-N 123.91 0.756 . . . . 0.0 110.902 -177.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 27.8 m -79.39 157.43 4.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.956 -177.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 12.6 t -104.09 -28.98 11.17 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.763 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -95.72 48.69 1.83 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.417 -177.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 56.5 m -154.09 99.47 2.53 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 120.711 0.291 . . . . 0.0 110.586 177.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.4 -20.3 14.31 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.316 2.011 . . . . 0.0 110.989 173.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.72 -147.4 24.0 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.918 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -146.5 87.09 1.7 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.989 0.423 . . . . 0.0 110.131 178.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -153.45 173.91 15.07 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.309 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 7.4 tt -96.41 110.58 24.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.102 0.477 . . . . 0.0 110.072 177.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 23.5 m -61.34 121.26 62.11 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.343 -178.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -63.16 141.38 82.59 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 122.845 2.363 . . . . 0.0 112.071 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.28 121.02 67.03 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.688 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.66 62.14 7.7 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 122.704 2.269 . . . . 0.0 112.446 -178.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 48.8 m 66.45 93.48 0.07 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.163 -178.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 24.4 p -111.26 156.61 21.23 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.765 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 40.4 mt-30 -96.26 91.33 5.83 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.491 -176.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -114.35 -39.08 3.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.034 0.445 . . . . 0.0 110.088 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -123.67 98.8 0.6 Allowed Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.131 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -72.1 135.57 25.37 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.392 2.061 . . . . 0.0 111.594 176.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.661 HG11 HD12 ' A' ' 293' ' ' ILE . 41.1 t -91.23 129.39 42.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 120.908 0.385 . . . . 0.0 110.247 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -93.85 114.55 26.81 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.911 177.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.407 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -120.37 126.48 50.59 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.029 178.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -92.05 125.19 36.64 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' ALA . . . . . 0.601 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -71.52 114.77 9.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.038 0.447 . . . . 0.0 110.955 -176.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 23.1 pt -96.46 -20.28 5.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.672 -177.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 19.3 tm0? -140.16 138.09 34.91 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -55.8 152.89 9.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.491 0.662 . . . . 0.0 112.596 -172.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.693 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -142.4 99.95 3.6 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 177.999 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 17.9 m -123.51 156.1 64.75 Favored Pre-proline 0 C--N 1.321 -0.672 0 C-N-CA 120.804 -0.359 . . . . 0.0 111.9 -174.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -66.0 132.83 31.33 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.116 2.544 . . . . 0.0 112.949 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 25.7 p -151.19 152.2 32.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.991 177.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 60.03 -78.43 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 O-C-N 124.197 0.936 . . . . 0.0 112.963 176.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' TYR . . . . . 0.618 ' HD1' ' H ' ' A' ' 253' ' ' LYS . 6.4 p90 -79.74 -32.63 41.15 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.175 -178.076 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 55.57 25.42 7.96 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.898 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' LYS . . . . . 0.618 ' H ' ' HD1' ' A' ' 251' ' ' TYR . 63.1 tttm -130.88 144.6 51.58 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -178.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 254' ' ' THR . . . . . 0.41 HG23 ' HG2' ' A' ' 253' ' ' LYS . 27.0 p 60.77 15.4 5.86 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.716 0.806 . . . . 0.0 111.1 -175.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -102.12 102.43 12.89 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.154 -176.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.568 HD21 ' HB ' ' A' ' 279' ' ' VAL . 1.6 tt -83.95 123.38 29.91 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 176.376 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.693 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -79.43 93.18 5.33 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.185 0.517 . . . . 0.0 110.903 -178.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.815 HD21 HG21 ' A' ' 279' ' ' VAL . 65.7 mt -95.34 128.18 41.99 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.878 -178.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -101.94 148.13 25.71 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.22 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 57.5 t -63.94 127.56 24.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.009 0.433 . . . . 0.0 110.634 -177.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 103.21 -9.18 53.99 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.679 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -88.63 165.72 14.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.885 0.342 . . . . 0.0 110.339 -175.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 43.9 mm -107.5 132.11 55.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.826 -177.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.634 ' HA ' HG22 ' A' ' 279' ' ' VAL . 20.3 t -107.13 111.21 34.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.816 178.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -77.69 87.27 3.97 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.987 174.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.536 HG13 ' HB ' ' A' ' 238' ' ' VAL . 14.9 p -95.04 120.78 44.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.608 179.008 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 9.8 p -113.46 -16.72 12.38 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.891 -178.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 268' ' ' ARG . . . . . 0.567 ' HB2' ' HB3' ' A' ' 276' ' ' GLU . 16.1 mmm180 -121.98 100.28 6.89 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.566 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 55.6 mtt -95.49 116.35 28.7 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.967 0.413 . . . . 0.0 110.347 176.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.416 ' O ' ' HB ' ' A' ' 271' ' ' ILE . 78.8 m-20 -80.38 -6.73 58.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.915 -176.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.416 ' HB ' ' O ' ' A' ' 270' ' ' ASN . 48.1 mm 77.91 -39.52 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 123.537 0.735 . . . . 0.0 112.649 174.394 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 272' ' ' ASN . . . . . 0.745 HD21 ' HG2' ' A' ' 274' ' ' GLN . 22.7 p-10 -55.92 -37.92 69.56 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -177.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 150.82 -34.64 0.94 Allowed Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.622 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.745 ' HG2' HD21 ' A' ' 272' ' ' ASN . 2.4 pt20 -94.2 124.86 38.48 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 176.046 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.55 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 34.0 m0 -108.61 171.15 7.59 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 120.764 0.316 . . . . 0.0 111.243 -175.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.567 ' HB3' ' HB2' ' A' ' 268' ' ' ARG . 6.3 tp10 -112.93 100.24 8.49 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -178.322 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 277' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -119.54 145.69 17.97 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.872 -177.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.641 ' HB3' ' HG2' ' A' ' 283' ' ' LYS . 3.5 pt-20 -103.12 109.27 20.78 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.322 0.582 . . . . 0.0 109.765 176.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 279' ' ' VAL . . . . . 0.815 HG21 HD21 ' A' ' 258' ' ' LEU . 95.4 t -122.73 112.61 34.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.456 -173.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 59.14 20.25 8.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.412 172.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 127.63 -30.35 4.02 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.258 -0.972 . . . . 0.0 114.201 176.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 282' ' ' ARG . . . . . 0.402 ' HG2' ' N ' ' A' ' 283' ' ' LYS . 9.1 ttm105 -110.17 139.46 45.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 117.889 0.845 . . . . 0.0 111.578 -177.265 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.641 ' HG2' ' HB3' ' A' ' 278' ' ' GLU . 51.5 mttm -97.98 130.25 44.83 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 170.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 284' ' ' GLY . . . . . 0.527 ' HA3' ' HB2' ' A' ' 256' ' ' LEU . . . -152.94 162.47 30.07 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.263 -0.97 . . . . 0.0 112.65 -177.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.55 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 76.5 mt -85.35 115.71 23.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.13 0.49 . . . . 0.0 110.595 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.415 ' CZ ' HG11 ' A' ' 264' ' ' VAL . 16.7 p90 -122.82 129.37 25.03 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.132 178.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 287' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 18.8 Cg_exo -67.47 138.3 45.64 Favored 'Trans proline' 0 C--O 1.236 0.394 0 C-N-CA 122.435 2.09 . . . . 0.0 111.018 173.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -58.38 -22.17 52.82 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.065 -176.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 2.7 p -71.35 -1.49 13.11 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -178.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -100.03 -13.46 19.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.899 0.38 . . . . 0.0 110.396 177.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.601 HG12 ' HA ' ' A' ' 242' ' ' ALA . 30.7 m -128.31 177.78 5.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.634 -177.191 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -132.88 128.87 37.54 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.854 172.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.661 HD12 HG11 ' A' ' 238' ' ' VAL . 37.3 mm -78.63 128.02 38.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.691 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -141.31 151.42 43.6 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.787 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -99.14 129.43 29.47 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 175.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -58.34 -24.15 66.68 Favored 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 122.975 2.45 . . . . 0.0 112.994 -178.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -134.31 -160.03 1.01 Allowed 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -177.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 298' ' ' ASN . . . . . 0.402 ' HA ' ' HD3' ' A' ' 299' ' ' PRO . 8.1 t30 -110.79 111.86 56.41 Favored Pre-proline 0 C--N 1.316 -0.859 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.111 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 299' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 298' ' ' ASN . 14.7 Cg_exo -68.83 -16.68 41.73 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.899 2.399 . . . . 0.0 112.406 -177.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 64.18 -167.68 0.21 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.271 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -125.49 -28.8 3.27 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.067 -178.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -131.96 170.02 15.49 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -177.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 . . . . . 0 C--O 1.252 1.221 0 CA-C-O 118.372 -0.823 . . . . 0.0 111.166 -178.481 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 pmm? . . . . . 0 N--CA 1.48 1.072 0 CA-C-O 120.516 0.198 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.423 ' HB2' ' HE ' ' A' ' 5' ' ' ARG . 5.8 m -105.59 136.14 45.72 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.545 ' HB2' HD12 ' A' ' 99' ' ' ILE . 8.7 p -70.39 -54.66 11.53 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.651 0.262 . . . . 0.0 110.766 178.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.55 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . -69.74 98.82 1.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.775 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.423 ' HE ' ' HB2' ' A' ' 2' ' ' SER . 10.4 mmt85 -140.41 93.77 2.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.418 0.627 . . . . 0.0 111.566 -178.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -156.65 150.86 25.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.823 175.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.529 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 35.1 t0 -81.72 115.39 20.94 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 177.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.4 m -70.11 -12.73 61.81 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.743 -175.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.2 t -102.85 -12.32 17.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.239 0.542 . . . . 0.0 110.741 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.529 ' HB2' ' HB3' ' A' ' 7' ' ' ASP . 6.9 t70 -75.42 91.41 2.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.921 0.391 . . . . 0.0 110.05 -178.032 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -57.82 -39.13 76.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.545 -176.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.491 ' HA ' ' NH2' ' A' ' 104' ' ' ARG . 4.8 t -73.43 -1.55 18.76 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.159 -176.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.61 -44.47 8.58 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.356 176.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 29.9 p-90 -120.24 -21.2 7.05 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -171.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -77.58 122.83 25.81 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.102 0.477 . . . . 0.0 110.782 -176.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.542 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 25.0 mmt -104.53 -8.24 19.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.436 -175.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.447 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 50.89 -114.74 2.94 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-N 115.8 -0.636 . . . . 0.0 113.556 -176.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.447 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 11.3 Cg_exo -71.64 92.18 0.69 Allowed 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.948 2.432 . . . . 0.0 113.081 -176.405 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.467 HG21 ' HB3' ' A' ' 16' ' ' MET . 69.9 t -142.17 157.69 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 177.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.6 m -120.91 166.48 13.75 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -170.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 41.4 ttt85 -58.68 -48.98 79.26 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 123.04 0.213 . . . . 0.0 111.493 -177.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.469 ' CD ' ' H ' ' A' ' 22' ' ' GLN . 0.5 OUTLIER -60.59 -52.28 65.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.332 0.587 . . . . 0.0 110.767 -178.37 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -65.43 -47.62 75.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.261 -175.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.34 -38.65 71.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.488 0.661 . . . . 0.0 111.076 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.559 ' HA ' HG11 ' A' ' 58' ' ' VAL . 38.3 tt0 -72.66 -37.71 67.87 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.982 -174.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 10.2 t -75.08 -22.53 58.24 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 120.481 -0.487 . . . . 0.0 110.819 -178.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -81.26 -13.44 58.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.233 0.539 . . . . 0.0 110.583 177.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.577 ' O ' HG22 ' A' ' 58' ' ' VAL . 83.1 mt -126.11 16.25 7.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.486 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.35 77.67 3.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.087 0.47 . . . . 0.0 111.099 -174.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.63 16.75 72.25 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.678 -0.692 . . . . 0.0 113.067 177.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.579 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 44.1 tt0 -64.41 -77.26 0.06 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.992 0.425 . . . . 0.0 110.39 -178.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.6 mtm180 -124.63 125.69 44.55 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 175.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.471 ' HB2' HD21 ' A' ' 117' ' ' ASN . 53.0 m170 -71.38 119.08 15.01 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.957 0.408 . . . . 0.0 110.478 -178.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 109.36 -8.77 32.92 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.749 -176.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.612 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 37.4 ttp -84.28 129.5 34.88 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -138.11 171.43 14.41 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.711 -172.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.567 ' HG ' HD11 ' A' ' 28' ' ' LEU . 4.6 pp -157.72 139.58 14.08 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.181 173.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.42 HG22 HD13 ' A' ' 50' ' ' LEU . 42.4 t -105.83 123.69 60.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 176.137 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.442 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 24.3 ptt-85 -124.67 -179.47 4.52 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.341 -176.086 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -78.5 135.55 37.37 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 175.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.7 t -78.41 118.37 20.52 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.123 -178.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.8 t -78.46 -15.56 58.49 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.314 172.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 25.5 m -73.69 -45.32 53.09 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.734 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.428 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 50.6 t -138.83 124.47 12.2 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.323 -178.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 44' ' ' CYS . 23.4 Cg_exo -64.63 114.56 2.78 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 123.067 2.511 . . . . 0.0 112.548 -178.256 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.62 -16.05 29.04 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.835 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.571 ' OD2' ' HA ' ' A' ' 64' ' ' ASN . 1.2 m-20 -93.35 177.89 5.89 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.563 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 38.6 m-85 -130.59 174.18 10.16 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 179.023 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.9 t -142.59 110.04 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.611 0.243 . . . . 0.0 110.418 175.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.42 HD13 HG22 ' A' ' 38' ' ' VAL . 36.7 tp -82.23 106.31 14.02 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.951 174.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 53.1 m -96.15 134.04 39.71 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 173.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.661 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 67.2 t -121.96 146.46 27.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.097 -177.414 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.576 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 12.9 t -94.74 106.53 18.52 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 174.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.667 ' O ' ' HB3' ' A' ' 57' ' ' ARG . 1.0 OUTLIER -147.06 138.75 24.24 Favored 'General case' 0 C--O 1.207 -1.166 0 C-N-CA 118.564 -1.254 . . . . 0.0 110.989 176.075 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.433 HD21 ' HB2' ' A' ' 94' ' ' ASP . 2.5 p30 37.66 47.48 0.82 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -175.046 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.5 m 58.47 44.33 18.2 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 122.279 1.038 . . . . 0.0 109.907 176.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.71 HH22 ' HA ' ' A' ' 154' ' ' GLU . 8.7 ttp180 -157.84 67.41 0.49 Allowed 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.705 -1.589 . . . . 0.0 110.71 -154.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.661 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 5.0 t -69.98 99.53 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.893 0.854 . . . . 0.0 108.901 -170.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.463 ' HB2' ' CE2' ' A' ' 61' ' ' TYR . 7.9 m -84.19 122.58 29.06 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 113.799 -1.546 . . . . 0.0 111.157 -172.294 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 60.0 m-70 -93.39 101.95 14.18 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.968 0.413 . . . . 0.0 111.982 -174.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.8 ' HB3' HD11 ' A' ' 73' ' ' ILE . 65.1 m-85 -99.91 105.42 17.14 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.805 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.82 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 61.6 mt -80.7 129.53 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -173.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.587 HG13 ' HB ' ' A' ' 73' ' ' ILE . 3.8 mp -98.8 119.09 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.129 0.572 . . . . 0.0 110.424 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.616 ' O ' ' HA ' ' A' ' 71' ' ' PHE . 4.3 m120 -89.25 139.44 30.49 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.405 -169.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.1 t -88.34 92.06 9.03 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 171.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.683 HD12 ' HG3' ' A' ' 70' ' ' ARG . 84.8 mt -79.83 138.96 53.77 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.576 -178.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.99 -7.98 16.85 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.949 2.433 . . . . 0.0 112.118 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -90.21 20.22 4.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.758 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.605 ' HE ' ' HA ' ' A' ' 69' ' ' ARG . 0.3 OUTLIER 65.78 30.52 10.09 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.247 0.546 . . . . 0.0 111.089 177.362 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.683 ' HG3' HD12 ' A' ' 66' ' ' LEU . 3.8 ptp180 -138.66 -177.03 4.69 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.444 -178.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.616 ' HA ' ' O ' ' A' ' 64' ' ' ASN . 47.8 m-85 -124.06 157.87 33.51 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.264 -178.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.587 ' HB2' HD11 ' A' ' 66' ' ' LEU . 35.1 ttpt -138.69 100.49 4.09 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 175.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.82 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 3.9 tt -89.28 108.25 18.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.442 0.639 . . . . 0.0 110.666 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.09 37.88 94.69 Favored Glycine 0 C--N 1.321 -0.265 0 CA-C-N 115.175 -0.921 . . . . 0.0 112.366 176.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.407 ' HA ' ' HE3' ' A' ' 72' ' ' LYS . 17.5 t70 77.75 6.2 2.84 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.607 0.763 . . . . 0.0 111.501 178.031 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -102.73 123.39 46.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.867 0.365 . . . . 0.0 110.308 171.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -94.04 134.38 36.52 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.697 0.761 . . . . 0.0 112.102 -175.092 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.57 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 51.0 m-85 -136.43 170.28 16.3 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 172.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -70.68 -54.66 11.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.136 0.493 . . . . 0.0 111.182 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.552 ' ND1' ' HG2' ' A' ' 82' ' ' PRO . 3.0 p80 -144.31 172.65 12.64 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.624 -174.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.622 HD23 HD21 ' A' ' 84' ' ' LEU . 16.2 mt -55.18 -52.75 68.71 Favored Pre-proline 0 N--CA 1.469 0.514 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.552 ' HG2' ' ND1' ' A' ' 80' ' ' HIS . 19.5 Cg_endo -60.52 -3.41 2.56 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.316 2.011 . . . . 0.0 113.597 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.37 -36.45 10.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.723 0.297 . . . . 0.0 110.896 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.622 HD21 HD23 ' A' ' 81' ' ' LEU . 4.4 pp -76.51 -34.84 58.59 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.048 0.451 . . . . 0.0 110.154 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 78.0 mt -62.22 -33.31 74.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.122 176.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.632 ' HA ' ' HD3' ' A' ' 89' ' ' LYS . 20.0 tp10 -73.9 -37.4 64.67 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.506 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.436 ' CD2' ' HZ ' ' A' ' 78' ' ' PHE . 23.1 t80 -64.28 -37.61 88.09 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.124 0.487 . . . . 0.0 110.67 177.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.698 ' HE2' HD13 ' A' ' 73' ' ' ILE . 36.1 m-85 -79.16 -6.52 56.74 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.92 0.39 . . . . 0.0 111.759 -178.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.632 ' HD3' ' HA ' ' A' ' 86' ' ' GLU . 53.7 mtpt -83.81 -8.56 59.19 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.384 172.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 21.8 pt -128.23 9.42 3.01 Favored 'Isoleucine or valine' 0 C--N 1.342 0.26 0 CA-C-O 121.549 0.69 . . . . 0.0 109.604 174.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.433 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 3.3 t-160 -95.02 -47.2 6.5 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.244 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.447 ' H ' HG22 ' A' ' 97' ' ' THR . 95.3 m-85 62.77 88.33 0.1 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.028 -161.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.612 ' O ' ' HB3' ' A' ' 154' ' ' GLU . 13.7 mt -46.37 -65.14 0.6 Allowed 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 177.179 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.575 ' HB3' ' HG3' ' A' ' 54' ' ' GLU . 13.7 p-10 -98.86 -120.36 0.14 Allowed 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.249 172.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.551 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 4.6 t -94.11 6.15 49.49 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-O 120.963 0.411 . . . . 0.0 109.989 176.057 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.403 HG22 ' OD1' ' A' ' 94' ' ' ASP . 8.3 t -141.26 164.58 29.86 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.085 0.469 . . . . 0.0 110.706 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.447 HG22 ' H ' ' A' ' 92' ' ' TYR . 9.1 p -99.61 174.53 6.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.62 178.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 82.3 mt -68.42 107.06 2.73 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 173.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.55 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 49.2 mm -91.55 -58.73 3.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.792 -174.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.612 ' O ' ' HA ' ' A' ' 35' ' ' MET . 11.9 pt-20 -159.02 153.23 19.97 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.176 -178.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.34 163.31 39.03 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 122.668 2.245 . . . . 0.0 113.364 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.457 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -83.11 158.39 64.41 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.803 178.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -66.91 136.39 41.32 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.315 2.01 . . . . 0.0 111.151 173.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.535 ' HG2' ' SD ' ' A' ' 16' ' ' MET . 87.6 mtt180 -64.97 -38.69 91.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.815 0.34 . . . . 0.0 110.787 178.452 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.537 ' HB2' ' HD2' ' A' ' 106' ' ' PRO . 41.1 p90 -170.26 164.59 5.84 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.308 178.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.537 ' HD2' ' HB2' ' A' ' 105' ' ' TYR . 29.6 Cg_endo -64.88 79.37 0.19 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.414 2.076 . . . . 0.0 111.73 175.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.756 ' HB3' ' HD3' ' A' ' 108' ' ' PRO . 35.0 t -78.13 -57.47 0.93 Allowed Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.964 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.756 ' HD3' ' HB3' ' A' ' 107' ' ' SER . 10.3 Cg_exo -71.47 125.16 10.97 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 121.746 1.631 . . . . 0.0 111.916 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 108' ' ' PRO . 33.9 Cg_endo -66.63 -30.01 42.94 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.288 1.992 . . . . 0.0 111.056 175.161 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 25.3 ptm -141.5 145.89 35.75 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.754 177.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 97.0 11.8 51.79 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.079 178.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.3 m -82.85 101.19 10.82 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.026 0.441 . . . . 0.0 109.993 177.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 43.3 t -66.2 100.45 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.777 178.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 17.7 m -109.34 77.15 1.04 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.659 178.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -112.77 102.06 53.95 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.822 -178.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.579 ' HA ' ' O ' ' A' ' 31' ' ' GLN . 80.6 Cg_endo -85.2 126.06 3.14 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.74 2.293 . . . . 0.0 111.751 176.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.471 HD21 ' HB2' ' A' ' 33' ' ' HIS . 25.3 p-10 -89.35 72.7 8.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.974 0.892 . . . . 0.0 111.095 -177.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 60.13 89.75 0.1 Allowed Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 113.672 -1.604 . . . . 0.0 112.017 176.04 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -89.58 134.57 2.37 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.327 2.685 . . . . 0.0 111.987 174.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 45.4 m -155.14 97.09 1.89 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 176.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 122' ' ' GLU . . . -112.83 -162.9 0.82 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.1 -176.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' ' 121' ' ' ALA . 42.1 mt-10 72.51 29.24 2.11 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.829 0.705 . . . . 0.0 110.677 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -91.54 -173.43 3.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.294 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.52 ' HB3' ' HG3' ' A' ' 183' ' ' ARG . 10.5 m120 -123.32 140.5 52.95 Favored 'General case' 0 C--O 1.211 -0.948 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.87 178.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.681 HD12 HG21 ' A' ' 152' ' ' ILE . 0.3 OUTLIER 158.19 -162.08 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 102.41 -3.182 . . . . 0.0 102.41 -151.511 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.719 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 4.9 tp10 74.19 -73.23 0.1 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 118.501 0.591 . . . . 0.0 110.759 175.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -101.33 107.44 18.8 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 118.848 -1.141 . . . . 0.0 111.494 -176.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 1.054 HG22 ' HG3' ' A' ' 180' ' ' LYS . 97.3 t -124.87 136.37 61.02 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.078 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.298 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.65 ' CZ ' HD13 ' A' ' 181' ' ' LEU . 0.0 OUTLIER -111.18 151.37 28.29 Favored 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 117.376 -1.73 . . . . 0.0 108.33 167.925 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.597 ' OG1' ' HB2' ' A' ' 144' ' ' PHE . 0.9 OUTLIER -107.77 134.26 50.98 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.882 0.849 . . . . 0.0 111.234 179.379 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.57 HD21 ' HG2' ' A' ' 179' ' ' GLU . 10.5 mt -110.21 2.39 19.28 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.61 -176.229 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.523 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 24.2 t80 -105.2 -39.62 6.13 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.103 -0.639 . . . . 0.0 112.614 -174.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.588 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 8.6 t70 79.05 98.47 0.06 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.444 0.64 . . . . 0.0 109.973 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 69.4 t80 -126.32 91.65 47.26 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 173.164 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.742 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 70.8 Cg_endo -86.24 83.61 1.22 Allowed 'Trans proline' 0 N--CA 1.442 -1.549 0 C-N-CA 121.675 1.583 . . . . 0.0 112.808 -178.171 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -76.58 -31.19 54.97 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.092 175.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.424 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 20.9 m120 63.46 49.85 3.02 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.247 0.546 . . . . 0.0 111.34 176.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.457 ' HB3' ' H ' ' A' ' 140' ' ' GLU . 1.2 m-20 -135.24 177.44 7.81 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.779 176.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 170' ' ' VAL . . . -91.57 -10.96 38.65 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.674 0.75 . . . . 0.0 109.583 172.232 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.692 ' O ' ' HB2' ' A' ' 172' ' ' MET . 45.3 mt-10 -109.23 -2.83 17.68 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.066 176.098 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.41 ' HB2' ' HB2' ' A' ' 138' ' ' ASP . 29.5 m-20 -143.5 100.96 3.7 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 174.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 1.02 HD11 ' HB2' ' A' ' 165' ' ' ASN . 52.9 tp -70.6 132.1 87.57 Favored Pre-proline 0 CA--C 1.51 -0.581 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.351 -175.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.854 ' HD2' HD12 ' A' ' 142' ' ' LEU . 73.2 Cg_endo -83.07 93.53 0.85 Allowed 'Trans proline' 0 N--CA 1.436 -1.885 0 C-N-CA 120.931 1.088 . . . . 0.0 111.761 170.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.597 ' HB2' ' OG1' ' A' ' 130' ' ' THR . 17.2 p90 -102.78 164.18 11.78 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.957 ' H ' ' HG3' ' A' ' 148' ' ' GLU . 2.9 mptp? -114.57 -148.51 0.43 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.119 0.485 . . . . 0.0 111.769 -171.436 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.789 ' H ' ' HD2' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -109.44 41.29 1.69 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.256 -179.648 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 147.89 28.88 0.07 OUTLIER Glycine 0 CA--C 1.525 0.716 0 C-N-CA 120.723 -0.751 . . . . 0.0 113.435 177.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.957 ' HG3' ' H ' ' A' ' 145' ' ' LYS . 0.0 OUTLIER -80.83 172.78 13.31 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 123.871 0.868 . . . . 0.0 109.732 171.319 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.637 HD12 ' HB3' ' A' ' 129' ' ' ARG . 0.6 OUTLIER -115.92 129.28 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.584 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.746 HD22 HD21 ' A' ' 142' ' ' LEU . 27.0 mt -120.76 157.27 30.07 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -173.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.719 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 70.7 t -130.78 123.15 53.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.577 177.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 1.063 HD13 ' HB2' ' A' ' 163' ' ' ALA . 40.8 mm -75.91 84.36 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 122.109 0.957 . . . . 0.0 109.706 -172.069 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.534 ' C ' HH12 ' A' ' 57' ' ' ARG . 14.0 tt -87.42 -31.89 6.08 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 CA-C-N 114.043 -1.435 . . . . 0.0 111.605 -169.075 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.71 ' HA ' HH22 ' A' ' 57' ' ' ARG . 10.8 mt-10 -122.49 142.27 50.76 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 164.345 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.464 ' NZ ' HD21 ' A' ' 125' ' ' LEU . 74.5 tttt -137.43 87.6 17.73 Favored Pre-proline 0 C--N 1.316 -0.86 0 CA-C-O 121.314 0.578 . . . . 0.0 110.627 176.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.496 ' HG2' ' HE2' ' A' ' 172' ' ' MET . 17.5 Cg_exo -71.24 -54.52 0.16 Allowed 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.683 2.255 . . . . 0.0 111.826 170.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.423 ' HG2' ' HB2' ' A' ' 156' ' ' PRO . 6.5 mm-40 -112.53 -176.58 2.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.815 -169.363 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -109.87 -8.9 14.82 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.231 173.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -96.13 -32.28 12.58 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.513 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.426 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 28.7 m95 -127.19 144.02 51.13 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.082 174.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' TRP . . . . . 0.917 ' HB3' HD12 ' A' ' 152' ' ' ILE . 20.7 m0 -126.71 139.92 52.79 Favored 'General case' 0 C--O 1.213 -0.835 0 CA-C-O 121.032 0.444 . . . . 0.0 111.126 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.577 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 19.6 m -97.51 94.55 7.08 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -175.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 1.063 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -109.18 152.25 25.4 Favored 'General case' 0 N--CA 1.428 -1.574 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.135 -173.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.85 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 27.5 ptt-85 -87.42 123.82 32.76 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 172.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 1.02 ' HB2' HD11 ' A' ' 142' ' ' LEU . 66.1 t30 -59.01 -178.2 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.259 -1.337 . . . . 0.0 110.957 -172.277 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.642 ' HB2' ' HB2' ' A' ' 148' ' ' GLU . 37.8 tttp -66.77 -12.15 57.64 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.222 168.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -73.59 -21.25 60.39 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.412 167.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 77.47 35.13 37.92 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.005 -168.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.85 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 2.9 ttm-85 -113.47 137.65 51.24 Favored 'General case' 0 C--O 1.213 -0.845 0 C-N-CA 122.779 0.431 . . . . 0.0 110.937 -176.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.515 HG22 HG21 ' A' ' 153' ' ' ILE . 38.9 t -78.17 128.98 38.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 118.146 0.43 . . . . 0.0 111.777 -177.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -164.49 155.95 27.61 Favored Glycine 0 C--N 1.339 0.708 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.612 167.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.692 ' HB2' ' O ' ' A' ' 140' ' ' GLU . 0.6 OUTLIER -74.95 142.83 43.9 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 117.144 0.472 . . . . 0.0 111.291 178.817 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.768 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.4 pp -143.67 141.04 18.08 Favored Pre-proline 0 N--CA 1.452 -0.336 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.715 -176.149 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.436 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 18.5 Cg_exo -66.38 127.09 16.7 Favored 'Trans proline' 0 C--N 1.34 0.125 0 C-N-CA 122.468 2.112 . . . . 0.0 112.546 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.629 ' O ' HG22 ' A' ' 178' ' ' VAL . 96.2 t -61.94 -40.99 73.84 Favored Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 11.5 Cg_endo -56.88 -15.81 18.13 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 121.974 1.783 . . . . 0.0 113.221 175.412 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.436 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.2 m-30 -88.71 -8.04 55.23 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -177.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.662 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 3.3 m -105.59 -170.89 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 115.896 1.813 . . . . 0.0 115.896 -164.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.58 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 7.7 tp10 -159.89 49.98 0.3 Allowed 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 112.956 -1.929 . . . . 0.0 112.705 -152.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 1.054 ' HG3' HG22 ' A' ' 128' ' ' VAL . 3.5 mppt? -69.89 135.77 49.91 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 119.583 -1.948 . . . . 0.0 111.246 -161.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.65 HD13 ' CZ ' ' A' ' 129' ' ' ARG . 16.5 tp -67.1 -97.74 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 112.956 -1.929 . . . . 0.0 113.582 -163.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 22.2 m -79.67 37.29 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.54 0.686 . . . . 0.0 110.743 -175.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.74 HH12 ' HH2' ' A' ' 161' ' ' TRP . 50.0 ttt180 -93.76 135.01 35.5 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.724 -175.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 43.1 m -113.74 175.76 5.32 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.377 174.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.416 ' HA ' ' HD3' ' A' ' 186' ' ' PRO . 39.3 t -100.7 139.93 20.97 Favored Pre-proline 0 C--N 1.317 -0.823 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.229 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 185' ' ' SER . 23.0 Cg_exo -63.97 88.14 0.15 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 123.003 2.469 . . . . 0.0 112.543 -178.06 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 51.2 m80 -91.7 -19.44 22.63 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.819 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 117.98 -74.68 0.29 Allowed Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -177.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -100.28 68.59 1.43 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.167 0.508 . . . . 0.0 110.669 177.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -130.28 75.99 1.69 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 173.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -162.81 70.66 0.21 Allowed Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.005 -177.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -92.29 -43.27 9.37 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 68.4 mtt85 63.99 179.54 0.17 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.009 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -130.94 -33.7 1.54 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.363 -178.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 17.5 m -117.82 136.11 53.63 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.789 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -64.39 133.17 52.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.053 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 36.4 m -75.35 84.33 2.48 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.178 0.513 . . . . 0.0 110.177 175.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -107.45 -19.18 13.65 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.204 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 148.46 -104.29 0.28 Allowed Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 -178.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.48 ' HA ' ' HD3' ' A' ' 201' ' ' PRO . 19.0 pt -105.98 112.82 64.18 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-O 121.13 0.49 . . . . 0.0 110.314 175.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 200' ' ' ILE . 12.2 Cg_exo -71.22 -50.04 0.34 Allowed 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.75 2.3 . . . . 0.0 112.976 -177.068 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.44 ' HB2' ' O ' ' A' ' 201' ' ' PRO . 18.0 mm-40 68.71 114.87 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.305 0 O-C-N 123.893 0.746 . . . . 0.0 110.62 -172.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -62.61 124.52 14.3 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.528 2.152 . . . . 0.0 111.472 179.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . 60.06 52.65 5.01 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.882 -177.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -75.42 -16.35 60.36 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.442 0.639 . . . . 0.0 109.466 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -141.48 112.71 7.45 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.153 174.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -90.0 14.88 11.13 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.376 -176.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . 71.56 121.45 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 O-C-N 124.039 0.837 . . . . 0.0 112.965 171.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 87.7 mm-40 -110.18 156.0 40.88 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.611 174.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.88 -61.73 0.47 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.887 2.392 . . . . 0.0 112.876 -177.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' GLN . . . . . 0.407 ' O ' ' HG3' ' A' ' 211' ' ' GLN . 61.5 tp60 61.38 26.67 16.43 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.877 0.846 . . . . 0.0 109.548 -177.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 16.8 p -97.22 102.8 14.65 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.595 -176.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 28.0 m -115.76 91.84 3.72 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.743 177.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.825 ' HB ' ' HD3' ' A' ' 215' ' ' PRO . 85.1 m -79.1 -57.05 0.78 Allowed Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.701 -177.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.825 ' HD3' ' HB ' ' A' ' 214' ' ' THR . 6.5 Cg_exo -73.15 94.82 0.82 Allowed 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 121.843 1.695 . . . . 0.0 111.35 176.12 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 217' ' ' PRO . 9.5 tt -105.93 107.41 59.53 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.148 -178.012 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 216' ' ' LEU . 1.6 Cg_endo -84.09 104.92 1.09 Allowed 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.089 2.526 . . . . 0.0 111.785 177.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -112.33 -31.02 6.97 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.157 0.503 . . . . 0.0 110.146 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 24.3 m -96.06 137.27 24.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.532 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 16.0 p -129.33 80.86 1.99 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.408 0.623 . . . . 0.0 110.827 177.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -112.2 179.59 19.52 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.504 178.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.621 ' HB2' ' HD3' ' A' ' 223' ' ' PRO . 68.3 m -157.06 -53.78 0.02 OUTLIER Pre-proline 0 C--N 1.323 -0.553 0 CA-C-O 119.483 -0.294 . . . . 0.0 111.523 -179.161 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.621 ' HD3' ' HB2' ' A' ' 222' ' ' SER . 76.8 Cg_exo -52.2 -53.08 7.54 Favored 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 122.411 2.074 . . . . 0.0 113.251 -177.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 76.01 -67.67 2.37 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.783 -177.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -97.08 140.71 31.18 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 176.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -93.35 154.83 17.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.51 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 11.6 pt -59.67 100.79 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.313 0.577 . . . . 0.0 110.543 177.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.652 ' HB ' ' HD3' ' A' ' 229' ' ' PRO . 5.3 m -91.41 -55.19 0.26 Allowed Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.448 -173.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.652 ' HD3' ' HB ' ' A' ' 228' ' ' THR . 13.2 Cg_exo -70.23 91.2 0.56 Allowed 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 122.399 2.066 . . . . 0.0 112.992 -176.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 95.4 mt -106.56 124.15 36.52 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 173.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -57.5 -67.75 0.06 OUTLIER 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.84 2.36 . . . . 0.0 112.578 -176.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 35.9 m -151.04 67.41 0.92 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.032 0.444 . . . . 0.0 110.726 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.433 ' HB ' ' ND2' ' A' ' 235' ' ' ASN . 39.7 p -143.5 116.6 8.91 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.47 177.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -90.15 31.56 0.98 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 177.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' ASN . . . . . 0.433 ' ND2' ' HB ' ' A' ' 233' ' ' THR . 30.5 p30 -114.88 164.06 14.66 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.275 -171.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 165.37 -170.33 40.24 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.227 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -70.69 105.32 1.61 Allowed 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.409 2.073 . . . . 0.0 111.031 177.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.466 ' HB ' ' CG1' ' A' ' 266' ' ' VAL . 2.5 t -75.9 138.13 21.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.415 -175.194 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -112.57 121.29 44.36 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.784 0.326 . . . . 0.0 110.927 -178.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -120.15 137.8 53.96 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.636 177.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.5 ' HB2' ' CE1' ' A' ' 294' ' ' PHE . 11.6 tppt? -80.94 123.53 28.39 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.656 177.163 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -75.45 102.9 5.36 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 174.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 290' ' ' HIS . 18.6 pt -88.15 -7.17 10.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.245 0.545 . . . . 0.0 110.783 -176.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.573 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 27.2 tt0 -138.66 142.89 39.03 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.231 175.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.479 ' HE3' ' OE2' ' A' ' 259' ' ' GLU . 1.5 ptpp? -68.65 174.16 4.5 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 174.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.525 ' HG3' ' NE2' ' A' ' 290' ' ' HIS . 0.0 OUTLIER -166.57 136.43 3.15 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.187 -179.77 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 24.6 m -127.8 150.29 72.9 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.304 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.546 ' HD3' ' HB2' ' A' ' 257' ' ' ALA . 58.0 Cg_endo -72.41 149.08 49.83 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.477 2.118 . . . . 0.0 112.631 -179.002 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 249' ' ' CYS . . . . . 0.56 ' HB3' ' HB2' ' A' ' 252' ' ' ASP . 25.0 t -95.95 165.97 12.01 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 177.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -55.3 -39.77 70.3 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.114 0.483 . . . . 0.0 111.446 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -102.43 15.74 28.34 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.167 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.56 ' HB2' ' HB3' ' A' ' 249' ' ' CYS . 1.7 m-20 -124.6 85.59 2.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.039 0.447 . . . . 0.0 110.334 177.264 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -86.56 -22.85 26.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.876 -179.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 4.0 p -89.87 5.01 48.13 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.259 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.45 ' HB2' ' HB3' ' A' ' 252' ' ' ASP . . . -82.57 109.43 16.76 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.565 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.427 ' HA ' ' NH1' ' A' ' 282' ' ' ARG . 0.6 OUTLIER -66.0 137.34 57.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.456 -177.524 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.546 ' HB2' ' HD3' ' A' ' 248' ' ' PRO . . . -98.18 129.13 44.96 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.673 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 84.2 mt -136.71 162.51 32.98 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.512 -174.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.479 ' OE2' ' HE3' ' A' ' 245' ' ' LYS . 65.7 mm-40 -127.26 165.79 18.99 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 172.297 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 62.1 t -70.71 123.04 23.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.145 0.498 . . . . 0.0 110.956 -178.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 107.81 0.48 34.23 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.201 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -84.73 142.98 29.46 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.003 0.43 . . . . 0.0 110.713 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 48.6 mm -100.02 110.12 26.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.084 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 33.3 t -86.4 109.45 18.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.689 -177.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 27.8 tttm -84.46 94.67 8.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.923 175.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.466 ' CG1' ' HB ' ' A' ' 238' ' ' VAL . 3.6 p -93.32 117.56 37.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.33 0.586 . . . . 0.0 110.454 -178.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 1.2 p -95.9 -35.21 11.54 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.615 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 268' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 268' ' ' ARG . 13.0 ttp180 -115.89 122.12 44.4 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 177.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 32.4 mtt -106.49 125.08 50.55 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.189 0.519 . . . . 0.0 110.981 178.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 274' ' ' GLN . 87.6 m-20 -89.69 134.04 34.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.767 -179.236 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 2.3 pp -74.45 9.5 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -173.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 272' ' ' ASN . . . . . 0.455 ' OD1' ' HG2' ' A' ' 274' ' ' GLN . 6.0 p30 -97.95 -24.55 15.33 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 122.299 -0.25 . . . . 0.0 111.172 -178.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 135.4 -37.25 1.94 Allowed Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.151 -1.023 . . . . 0.0 113.222 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.475 ' O ' ' HB2' ' A' ' 270' ' ' ASN . 18.9 pt20 -95.6 118.27 31.99 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 177.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.456 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 20.3 m0 -95.2 166.95 11.66 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.293 -173.099 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -99.64 99.09 9.89 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.106 -178.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 277' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -108.74 153.26 16.87 Favored Glycine 0 C--O 1.224 -0.528 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.382 -175.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.672 ' HG2' ' HE2' ' A' ' 283' ' ' LYS . 21.2 mt-10 -119.83 108.46 14.41 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -178.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 50.9 t -138.05 132.64 43.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.613 -176.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 64.14 24.07 13.35 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.975 0.417 . . . . 0.0 110.965 176.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 86.47 -2.88 87.44 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.272 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 282' ' ' ARG . . . . . 0.427 ' NH1' ' HA ' ' A' ' 256' ' ' LEU . 0.6 OUTLIER -117.57 131.48 56.68 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.956 0.408 . . . . 0.0 109.937 -176.503 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.672 ' HE2' ' HG2' ' A' ' 278' ' ' GLU . 15.7 ptpt -113.08 142.32 45.88 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.977 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -168.04 -174.24 36.74 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.481 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.456 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 86.0 mt -88.05 136.04 33.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.245 0.545 . . . . 0.0 111.92 -177.169 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -138.94 127.86 14.06 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.979 174.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 287' ' ' PRO . . . . . 0.769 ' HD2' ' HE1' ' A' ' 290' ' ' HIS . 11.6 Cg_exo -73.48 151.35 47.53 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.925 2.417 . . . . 0.0 111.78 175.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -73.08 -1.6 18.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.135 0.493 . . . . 0.0 111.765 -178.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 3.4 m -64.63 -42.21 95.63 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.731 -176.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 290' ' ' HIS . . . . . 0.769 ' HE1' ' HD2' ' A' ' 287' ' ' PRO . 0.0 OUTLIER -110.63 12.31 22.7 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -174.852 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 22.3 m -129.33 149.94 34.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 172.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 292' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' A' ' 292' ' ' LYS . 44.3 mmtm -139.36 136.12 34.43 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.738 0.304 . . . . 0.0 110.559 177.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 1.1 mp -76.85 141.39 15.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.89 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 294' ' ' PHE . . . . . 0.537 ' CE2' ' HA ' ' A' ' 296' ' ' PRO . 7.9 p90 -154.87 176.53 12.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.2 -179.273 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -91.47 104.28 9.63 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 173.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 296' ' ' PRO . . . . . 0.537 ' HA ' ' CE2' ' A' ' 294' ' ' PHE . 26.3 Cg_endo -63.29 -42.69 21.28 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.326 2.017 . . . . 0.0 112.776 -173.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -103.38 79.73 1.74 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.143 0.497 . . . . 0.0 110.162 176.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -63.97 136.47 96.75 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.538 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.03 -30.69 94.03 Favored 'Trans proline' 0 N--CA 1.466 -0.145 0 C-N-CA 122.378 2.052 . . . . 0.0 110.884 174.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -65.05 -26.49 68.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.549 177.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -99.01 -20.64 16.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.819 -175.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -86.14 -13.19 47.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.318 -177.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.492 -0.765 . . . . 0.0 110.185 177.8 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.8 mtm . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.4 m -107.68 -20.2 13.3 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.745 177.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.7 m 65.32 -71.3 0.08 Allowed 'General case' 0 N--CA 1.461 0.112 0 O-C-N 123.828 0.705 . . . . 0.0 109.807 -170.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -78.98 78.92 5.4 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.258 0.551 . . . . 0.0 110.28 177.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 18.7 tpp180 -99.61 86.79 3.41 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.357 0.598 . . . . 0.0 110.503 -176.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -167.52 143.39 4.08 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.991 -1.004 . . . . 0.0 108.798 175.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -72.48 -9.37 58.46 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -173.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.4 t 73.19 -29.52 0.2 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.267 0.627 . . . . 0.0 112.086 175.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.0 t -102.6 -19.21 14.92 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 122.067 -0.395 . . . . 0.0 111.016 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -67.09 104.05 1.33 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.979 0.419 . . . . 0.0 111.003 -176.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -60.75 -37.67 82.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.872 -175.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.5 m -69.17 -5.47 22.73 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.802 -177.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.33 -47.52 6.57 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.895 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.518 ' HB3' ' HB3' ' A' ' 101' ' ' PRO . 41.9 p-90 -119.72 -20.46 7.64 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -169.538 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -72.16 108.43 5.33 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.131 0.491 . . . . 0.0 110.455 -175.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.647 ' SD ' ' HA ' ' A' ' 104' ' ' ARG . 9.2 tpp -90.84 -4.79 56.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.868 -174.223 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 50.02 -114.57 2.53 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-N 115.243 -0.89 . . . . 0.0 114.344 176.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -74.4 83.19 1.73 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.04 2.493 . . . . 0.0 113.368 -174.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.623 HG12 ' H ' ' A' ' 20' ' ' SER . 98.4 t -135.92 177.08 6.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.358 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.623 ' H ' HG12 ' A' ' 19' ' ' VAL . 57.3 p -149.36 177.53 9.59 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -168.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.5 ttt85 -63.69 -39.6 94.71 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.784 178.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 35.5 mm-40 -61.87 -64.02 1.07 Allowed 'General case' 0 C--O 1.235 0.318 0 O-C-N 123.38 0.425 . . . . 0.0 110.754 176.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.471 ' O ' ' HB ' ' A' ' 26' ' ' THR . 8.1 tp10 -56.77 -47.78 79.36 Favored 'General case' 0 C--O 1.217 -0.658 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.467 -176.114 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.437 ' HB2' ' HD3' ' A' ' 39' ' ' ARG . . . -57.69 -42.01 82.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.96 0.41 . . . . 0.0 111.79 -177.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.454 ' NE2' ' HG2' ' A' ' 29' ' ' GLN . 23.1 tm0? -68.11 -32.52 72.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.55 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.471 ' HB ' ' O ' ' A' ' 23' ' ' GLU . 4.2 m -65.23 -43.4 91.55 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.661 176.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.443 ' HG2' ' O ' ' A' ' 23' ' ' GLU . 42.0 mmm-85 -72.85 -20.75 61.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.518 -173.05 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.62 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 88.6 mt -126.83 17.4 7.37 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.059 -171.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.454 ' HG2' ' NE2' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -69.49 76.53 0.4 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.476 0.655 . . . . 0.0 109.475 178.916 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.7 -66.72 3.86 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.4 -176.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 27.55 -99.12 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.208 1.003 . . . . 0.0 112.536 -166.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.578 ' HB2' ' SD ' ' A' ' 35' ' ' MET . 47.6 mtm105 -112.76 -6.77 13.84 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -176.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 49.7 m170 67.49 155.12 0.1 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.229 0.538 . . . . 0.0 111.132 -175.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.14 10.87 84.28 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 121.085 -0.578 . . . . 0.0 111.824 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.606 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 41.4 mtp -103.97 145.82 29.59 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -177.407 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.457 ' CG ' HD22 ' A' ' 98' ' ' LEU . 33.5 p90 -146.26 164.32 32.68 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.694 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.542 ' HG ' HD11 ' A' ' 28' ' ' LEU . 4.3 pp -152.72 137.16 16.72 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.847 174.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.4 t -101.95 114.37 41.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 173.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.571 ' HG3' ' O ' ' A' ' 40' ' ' ASP . 24.2 ptt-85 -116.09 176.5 5.07 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.7 -172.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.571 ' O ' ' HG3' ' A' ' 39' ' ' ARG . 10.6 t70 -58.66 132.28 53.37 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 166.218 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.68 ' HA ' HG23 ' A' ' 49' ' ' VAL . 44.5 t -44.37 -48.66 9.77 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 123.674 0.609 . . . . 0.0 112.223 -174.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.1 t 72.73 -1.66 2.93 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.979 0.799 . . . . 0.0 109.81 -175.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.4 m -111.51 -37.09 5.33 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.712 175.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 45.3 t -147.2 122.84 5.37 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.306 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -61.95 122.12 10.49 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.94 2.426 . . . . 0.0 112.857 -178.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.94 -31.81 7.0 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.742 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.416 ' C ' ' HB2' ' A' ' 41' ' ' SER . 4.7 m-20 -87.81 174.96 8.06 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -133.28 169.66 16.59 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 122.284 -0.26 . . . . 0.0 111.049 -177.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.68 HG23 ' HA ' ' A' ' 41' ' ' SER . 90.3 t -143.01 117.28 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 121.29 0.566 . . . . 0.0 110.632 174.066 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.45 ' CB ' HD11 ' A' ' 63' ' ' ILE . 28.3 tp -85.04 108.48 17.65 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.885 178.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.7 m -96.39 137.26 35.72 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 174.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.681 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 91.3 t -130.76 134.24 62.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.632 0.253 . . . . 0.0 111.444 -175.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.62 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 40.8 t -94.93 114.66 26.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.208 -175.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.666 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 8.6 tp10 -159.45 153.56 23.51 Favored 'General case' 0 C--O 1.21 -0.991 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 164.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.629 ' HB2' ' CG ' ' A' ' 57' ' ' ARG . 28.5 m120 61.4 17.36 8.3 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 179.064 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.2 m 55.22 55.54 7.43 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 122.59 1.186 . . . . 0.0 108.19 -170.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.753 HH21 ' HA ' ' A' ' 154' ' ' GLU 0.282 0.0 OUTLIER -163.24 67.73 0.2 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 113.227 -1.806 . . . . 0.0 109.883 -153.69 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.681 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 5.2 t -73.64 102.57 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.316 -1.311 . . . . 0.0 110.26 -173.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 71.6 m -78.38 122.46 25.8 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.174 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 45.3 m-70 -93.14 102.97 15.28 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.971 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.949 ' HB3' HD11 ' A' ' 73' ' ' ILE . 70.0 m-85 -97.99 105.07 17.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.591 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.609 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 54.8 mt -80.47 127.77 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -174.003 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.578 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 3.5 mp -115.44 112.01 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 120.82 0.343 . . . . 0.0 110.22 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -87.4 148.29 25.07 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.415 -176.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.8 t -87.83 109.19 19.56 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 175.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.3 mt -81.52 143.25 50.99 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -62.14 -11.54 22.46 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.44 2.094 . . . . 0.0 110.915 175.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -76.24 0.51 18.93 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.421 176.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.34 21.78 9.7 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.559 -174.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -115.96 175.0 5.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.82 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.578 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 64.8 m-85 -130.76 132.19 45.16 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.962 0.411 . . . . 0.0 111.21 -176.402 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -121.88 122.41 39.36 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.996 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.949 HD11 ' HB3' ' A' ' 61' ' ' TYR . 7.5 tt -108.42 109.25 27.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.502 0.668 . . . . 0.0 111.218 -174.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.03 -94.37 0.37 Allowed Glycine 0 CA--C 1.519 0.329 0 CA-C-N 115.431 -0.804 . . . . 0.0 113.136 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -121.2 -11.04 8.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.332 0.587 . . . . 0.0 110.323 -176.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -108.86 126.07 52.66 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.382 0.61 . . . . 0.0 110.784 -176.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.35 135.1 37.39 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.64 178.129 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.461 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 93.4 m-85 -126.38 178.43 5.85 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -71.18 -43.06 68.21 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.284 -178.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.422 ' ND1' ' HG2' ' A' ' 82' ' ' PRO . 16.4 p80 -165.97 -179.43 5.21 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.742 -178.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.619 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 10.0 mt -57.33 -62.18 5.76 Favored Pre-proline 0 N--CA 1.471 0.585 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -175.381 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.422 ' HG2' ' ND1' ' A' ' 80' ' ' HIS . 19.8 Cg_endo -63.99 1.24 1.6 Allowed 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 121.702 1.602 . . . . 0.0 113.483 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.97 -36.38 14.13 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.844 0.354 . . . . 0.0 110.323 177.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.1 pp -76.68 -32.69 58.07 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.479 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 80.0 mt -63.45 -28.7 70.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.857 176.168 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.9 tp10 -77.8 -38.72 45.94 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.758 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -64.88 -37.4 87.51 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.421 0.629 . . . . 0.0 110.884 178.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.493 ' HE2' HD13 ' A' ' 73' ' ' ILE . 30.3 m-85 -80.55 -2.75 47.52 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.958 -176.432 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 85' ' ' LEU . 97.5 mttt -69.9 -27.02 64.45 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.889 174.539 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.4 pp -120.1 9.0 6.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.889 179.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 -90.6 -39.89 12.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.627 -178.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.5 ' CD2' HG23 ' A' ' 97' ' ' THR . 82.0 m-85 67.51 84.86 0.15 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.173 -169.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.683 ' HA ' ' OE2' ' A' ' 154' ' ' GLU . 5.8 mt -56.39 -20.79 21.1 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 122.241 1.02 . . . . 0.0 111.007 178.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.566 ' OD1' HG22 ' A' ' 96' ' ' THR . 0.1 OUTLIER -134.78 -68.41 0.54 Allowed 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.003 -1.453 . . . . 0.0 109.063 -179.666 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.708 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 8.8 t -177.64 15.93 0.0 OUTLIER 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 114.198 -1.364 . . . . 0.0 108.548 174.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.566 HG22 ' OD1' ' A' ' 94' ' ' ASP . 4.9 t -129.58 -28.48 2.27 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.046 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.5 HG23 ' CD2' ' A' ' 92' ' ' TYR . 12.8 p 78.82 -179.52 0.11 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.964 1.306 . . . . 0.0 110.805 -175.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.457 HD22 ' CG ' ' A' ' 36' ' ' PHE . 89.9 mt -78.77 89.62 4.63 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.804 177.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 50.2 mm -75.6 -54.44 13.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.723 -177.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.606 ' O ' ' HA ' ' A' ' 35' ' ' MET . 15.5 pt-20 -157.22 152.72 22.18 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.561 -177.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.518 ' HB3' ' HB3' ' A' ' 14' ' ' TRP . 72.8 Cg_endo -76.06 148.58 31.47 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.262 1.975 . . . . 0.0 112.135 176.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.594 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -73.04 146.05 86.9 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.206 178.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.49 124.18 15.25 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.465 2.11 . . . . 0.0 111.232 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.647 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 34.8 ptt180 -79.36 22.34 0.44 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -172.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.438 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 85.6 t80 -105.52 108.62 61.87 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 171.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.466 ' C ' ' HD3' ' A' ' 108' ' ' PRO . 3.9 Cg_exo -80.23 119.99 3.99 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.934 2.422 . . . . 0.0 112.475 -178.052 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 40.0 p -126.66 64.74 58.71 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 172.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.466 ' HD3' ' C ' ' A' ' 106' ' ' PRO . 77.8 Cg_endo -98.49 146.26 0.6 Allowed 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 123.145 2.563 . . . . 0.0 113.769 -171.145 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -83.83 -9.46 9.85 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.422 2.081 . . . . 0.0 110.637 168.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 51.3 ttp 58.84 91.8 0.04 OUTLIER 'General case' 0 C--O 1.232 0.14 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.775 -175.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 166.83 133.59 1.55 Allowed Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.294 -177.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 21.6 t -92.53 122.87 35.38 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.674 0.274 . . . . 0.0 110.645 -177.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.4 t -75.42 -53.19 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.064 0.459 . . . . 0.0 109.858 175.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 17.4 t -142.74 153.05 42.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.303 174.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.436 ' O ' ' HB3' ' A' ' 121' ' ' ALA . . . -158.62 98.47 1.72 Allowed Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.161 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.445 ' HG2' ' HB2' ' A' ' 57' ' ' ARG . 31.6 Cg_exo -59.12 -39.37 80.01 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.547 2.165 . . . . 0.0 112.618 -178.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.73 ' HA ' ' HG3' ' A' ' 126' ' ' GLU . 28.9 p-10 -63.75 162.38 13.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.12 -175.447 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.617 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 91.1 mt 80.67 156.99 0.13 Allowed Pre-proline 0 N--CA 1.469 0.508 0 O-C-N 124.08 0.862 . . . . 0.0 111.458 176.019 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.617 ' HD2' ' HB3' ' A' ' 118' ' ' LEU . 37.7 Cg_exo -29.19 -64.11 0.08 OUTLIER 'Trans proline' 0 C--N 1.361 1.218 0 C-N-CA 125.23 3.953 . . . . 0.0 115.173 -172.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 22.5 m -154.1 97.44 2.05 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.874 0.369 . . . . 0.0 110.368 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 115' ' ' ALA . . . -128.61 19.1 6.23 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.818 176.063 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.542 ' HB3' ' O ' ' A' ' 188' ' ' GLY . 15.6 mm-40 75.28 -171.15 0.1 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.708 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.1 t0 68.79 171.15 0.29 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.535 -177.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -101.23 160.71 14.17 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -169.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.827 HD12 HG21 ' A' ' 152' ' ' ILE . 4.6 mm? 67.2 103.05 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.779 171.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.761 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 0.6 OUTLIER -178.35 -72.44 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.033 -1.44 . . . . 0.0 107.858 179.59 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.55 ' H ' ' HD3' ' A' ' 193' ' ' ARG . 70.8 m-85 -96.95 107.45 19.98 Favored 'General case' 0 CA--C 1.495 -1.148 0 C-N-CA 119.199 -1.0 . . . . 0.0 110.569 -179.157 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.959 HG22 ' HG3' ' A' ' 180' ' ' LYS . 89.4 t -124.16 126.67 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 CA-C-N 114.55 -1.205 . . . . 0.0 109.301 175.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.686 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 6.5 ptp180 -107.52 142.79 36.85 Favored 'General case' 0 N--CA 1.435 -1.175 0 C-N-CA 117.528 -1.669 . . . . 0.0 108.093 171.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.582 HG22 HG12 ' A' ' 178' ' ' VAL . 0.8 OUTLIER -102.58 127.4 49.68 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.873 -176.941 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.695 HD11 ' HB2' ' A' ' 179' ' ' GLU . 6.3 mt -100.21 -21.73 15.4 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.629 -174.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.431 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 30.1 t80 -81.17 -35.88 30.88 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.93 -171.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.597 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 13.6 t70 71.06 101.14 0.06 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.688 0.756 . . . . 0.0 110.562 -175.498 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.468 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 51.5 t80 -129.87 85.6 57.4 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 177.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.678 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 94.8 Cg_endo -82.17 80.43 2.81 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 121.896 1.731 . . . . 0.0 112.773 -178.403 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -75.97 -30.59 57.27 Favored Glycine 0 C--N 1.329 0.173 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.765 178.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 66.04 50.95 1.37 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.096 -0.552 . . . . 0.0 111.234 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -142.14 177.75 8.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.414 177.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.506 ' O ' ' HA2' ' A' ' 171' ' ' GLY . . . -92.71 -11.0 35.12 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.73 0.776 . . . . 0.0 109.136 172.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' A' ' 172' ' ' MET . 44.9 mt-10 -91.95 -31.95 15.44 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.001 -0.999 . . . . 0.0 109.537 175.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -127.57 104.82 8.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.317 176.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 1.083 HD11 ' HB2' ' A' ' 165' ' ' ASN . 32.1 tp -65.42 129.52 94.42 Favored Pre-proline 0 C--N 1.327 -0.394 0 C-N-CA 120.562 -0.455 . . . . 0.0 109.977 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.789 ' HD2' HD12 ' A' ' 142' ' ' LEU . 72.6 Cg_endo -78.78 88.57 1.44 Allowed 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 121.541 1.494 . . . . 0.0 111.511 175.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.489 ' CD1' ' HB ' ' A' ' 130' ' ' THR . 10.4 p90 -103.49 156.14 17.99 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.96 -174.305 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.597 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -96.85 -171.63 2.28 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.189 0.441 . . . . 0.0 112.189 -174.858 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.865 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -92.81 33.05 1.17 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.942 -174.029 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 159.51 31.33 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.555 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.556 ' HB3' ' HB2' ' A' ' 145' ' ' LYS . 0.1 OUTLIER -101.01 152.71 20.25 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.663 -176.554 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.7 mp -97.55 127.14 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-O 121.496 0.665 . . . . 0.0 109.802 -176.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.772 HD22 HD21 ' A' ' 142' ' ' LEU . 9.7 mt -121.63 157.71 30.21 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 -176.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.761 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 92.7 t -118.09 124.19 72.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 174.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 1.116 HD13 ' HB2' ' A' ' 163' ' ' ALA . 43.6 mm -75.93 79.66 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 122.024 0.916 . . . . 0.0 108.717 -177.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.519 HG21 HG22 ' A' ' 170' ' ' VAL . 18.4 tt -70.37 -29.7 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-N 114.005 -1.452 . . . . 0.0 109.76 -176.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.753 ' HA ' HH21 ' A' ' 57' ' ' ARG . 0.4 OUTLIER -131.44 141.72 49.87 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 172.152 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.589 ' HD2' ' HG ' ' A' ' 125' ' ' LEU . 81.4 tttt -134.77 87.83 29.64 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 172.232 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.708 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 2.3 Cg_endo -82.5 -37.78 0.2 Allowed 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.695 2.264 . . . . 0.0 111.8 176.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.604 ' HG2' ' CE ' ' A' ' 172' ' ' MET . 25.2 mm-40 -109.91 168.13 9.65 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.755 -174.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.513 ' O ' HG21 ' A' ' 175' ' ' VAL . 6.1 pt-20 -101.67 -16.86 16.55 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.462 178.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.406 ' C ' HG23 ' A' ' 175' ' ' VAL . 5.2 tp-100 -107.32 -11.72 15.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.163 0.506 . . . . 0.0 109.873 176.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -129.07 121.6 28.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.212 176.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' TRP . . . . . 0.759 ' HB3' HD12 ' A' ' 152' ' ' ILE . 49.2 m0 -115.32 134.87 54.72 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.501 -178.087 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.59 ' HA ' ' HA ' ' A' ' 172' ' ' MET . 13.4 m -93.79 94.22 8.41 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -173.267 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 1.116 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -108.54 147.05 32.33 Favored 'General case' 0 N--CA 1.419 -1.998 0 C-N-CA 119.501 -0.88 . . . . 0.0 109.703 -171.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.831 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 15.8 ptt-85 -86.79 119.66 27.25 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 175.477 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 1.083 ' HB2' HD11 ' A' ' 142' ' ' LEU . 18.1 t30 -53.34 177.69 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 113.724 -1.58 . . . . 0.0 110.865 -176.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -63.56 -15.31 57.68 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 168.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.417 ' H ' ' HB3' ' A' ' 165' ' ' ASN . 36.9 m-20 -69.28 -30.38 68.47 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.74 169.154 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 90.28 25.79 25.29 Favored Glycine 0 C--O 1.228 -0.259 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.16 -170.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.887 ' HD2' ' CD1' ' A' ' 142' ' ' LEU . 0.3 OUTLIER -105.06 138.14 41.72 Favored 'General case' 0 C--O 1.217 -0.608 0 C-N-CA 123.437 0.695 . . . . 0.0 111.331 -174.003 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.519 HG22 HG21 ' A' ' 153' ' ' ILE . 24.1 t -86.45 119.75 35.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -175.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.506 ' HA2' ' O ' ' A' ' 139' ' ' ALA . . . -152.49 148.94 20.44 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.696 170.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.604 ' CE ' ' HG2' ' A' ' 157' ' ' GLU . 59.6 mtp -78.43 142.48 37.51 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 117.663 0.731 . . . . 0.0 110.703 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.698 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.7 pp -140.54 145.47 40.78 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.9 -173.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.554 ' HB2' ' CD1' ' A' ' 177' ' ' TYR . 17.6 Cg_exo -68.41 129.87 19.93 Favored 'Trans proline' 0 N--CA 1.465 -0.149 0 C-N-CA 122.959 2.439 . . . . 0.0 113.104 -177.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.568 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 58.0 t -62.62 -42.22 77.68 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 29.0 Cg_endo -63.62 -5.16 8.14 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 121.951 1.767 . . . . 0.0 112.682 177.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.554 ' CD1' ' HB2' ' A' ' 174' ' ' PRO . 3.0 m-85 -91.95 -15.8 27.5 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.442 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.606 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 3.2 m -105.95 -174.04 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -163.196 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.695 ' HB2' HD11 ' A' ' 131' ' ' LEU . 3.5 tp10 -159.95 49.22 0.29 Allowed 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 113.071 -1.877 . . . . 0.0 112.454 -150.046 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.959 ' HG3' HG22 ' A' ' 128' ' ' VAL . 0.5 OUTLIER -69.27 170.73 9.68 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 118.937 -2.352 . . . . 0.0 111.308 -160.511 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 15.9 tp -100.28 114.71 28.39 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.767 -168.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 13.4 p 51.92 104.3 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 126.455 1.902 . . . . 0.0 114.158 -178.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.802 ' HB3' ' N ' ' A' ' 194' ' ' ASN . 0.2 OUTLIER -178.96 109.52 0.05 OUTLIER 'General case' 0 C--N 1.343 0.297 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.678 178.937 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -31.2 69.57 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.058 0.456 . . . . 0.0 111.469 176.349 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.816 ' HB2' ' HD2' ' A' ' 186' ' ' PRO . 21.2 p -176.03 -177.84 0.3 Allowed Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -174.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.816 ' HD2' ' HB2' ' A' ' 185' ' ' SER . 98.5 Cg_exo -43.73 -69.42 0.08 OUTLIER 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.377 2.052 . . . . 0.0 113.261 176.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 2.4 p80 33.5 -89.3 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.303 1.041 . . . . 0.0 113.771 -175.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.542 ' O ' ' HB3' ' A' ' 122' ' ' GLU . . . 119.61 -54.16 0.65 Allowed Glycine 0 C--O 1.225 -0.464 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 -178.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 16.2 pttp -101.67 34.93 2.46 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.303 0.573 . . . . 0.0 110.731 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 60.0 t60 -162.94 38.15 0.1 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.132 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 135.95 160.67 8.93 Favored Glycine 0 CA--C 1.505 -0.564 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 -176.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ASN . . . . . 0.651 ' HB3' ' CZ ' ' A' ' 193' ' ' ARG . 2.8 m-20 -101.97 -89.17 0.37 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.917 0.389 . . . . 0.0 111.532 -171.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.802 ' HG2' ' HB3' ' A' ' 180' ' ' LYS . 0.0 OUTLIER -149.28 134.73 18.46 Favored 'General case' 0 C--O 1.208 -1.098 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -177.633 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ASN . . . . . 0.901 ' HA ' ' HB2' ' A' ' 180' ' ' LYS . 34.6 t30 -171.74 156.71 4.37 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 118.315 0.507 . . . . 0.0 111.298 -175.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 16.4 m -103.28 -145.19 0.36 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 9.0 p30 41.13 40.03 1.02 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.693 0.797 . . . . 0.0 112.409 174.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 6.6 m -70.87 -13.75 62.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.56 -175.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -93.71 -9.87 36.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.163 0.506 . . . . 0.0 109.912 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 83.47 -124.31 6.52 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -171.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.673 HD11 ' HA ' ' A' ' 203' ' ' PRO . 10.2 tt -126.67 94.51 39.96 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-O 121.607 0.718 . . . . 0.0 110.017 172.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.66 -35.22 22.84 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.98 2.453 . . . . 0.0 112.456 -176.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -132.96 106.79 12.56 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.371 -177.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.673 ' HA ' HD11 ' A' ' 200' ' ' ILE . 34.1 Cg_exo -60.82 -60.49 0.24 Allowed 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 123.044 2.496 . . . . 0.0 112.648 -178.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -154.13 120.83 5.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.801 0.334 . . . . 0.0 110.562 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -97.78 105.25 17.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.045 -178.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . 71.27 -54.79 0.66 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.55 0.74 . . . . 0.0 111.943 179.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -80.38 106.1 12.13 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.107 0.48 . . . . 0.0 110.579 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -129.37 -39.64 1.49 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.358 178.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -148.0 112.52 3.87 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.001 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -80.07 -172.63 1.58 Allowed 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.734 2.289 . . . . 0.0 112.006 178.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -91.74 88.43 6.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.058 0.456 . . . . 0.0 109.776 177.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 1.1 m -84.77 93.61 8.5 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.225 0.536 . . . . 0.0 110.875 -177.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' THR . . . . . 0.559 ' H ' ' HD2' ' A' ' 215' ' ' PRO . 13.7 p -113.3 -68.65 0.91 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.849 175.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.468 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 0.7 OUTLIER -87.55 -31.92 0.41 Allowed Pre-proline 0 CA--C 1.544 0.748 0 CA-C-N 115.442 -0.799 . . . . 0.0 113.006 173.374 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.559 ' HD2' ' H ' ' A' ' 213' ' ' THR . 83.7 Cg_exo -52.64 -16.87 6.1 Favored 'Trans proline' 0 C--N 1.368 1.583 0 C-N-CA 122.458 2.105 . . . . 0.0 114.219 174.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.498 ' O ' HD12 ' A' ' 216' ' ' LEU . 4.7 pp -99.39 135.49 20.67 Favored Pre-proline 0 C--N 1.329 -0.291 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.229 175.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 216' ' ' LEU . 6.3 Cg_exo -79.86 124.21 5.52 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.802 2.334 . . . . 0.0 111.048 173.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -77.9 -47.52 18.53 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.298 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 21.7 t 54.03 71.05 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.246 -178.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 49.2 m -95.04 104.53 16.41 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.664 -177.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' GLY . . . . . 0.568 ' O ' ' HD3' ' A' ' 223' ' ' PRO . . . -127.4 1.22 7.04 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.152 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 7.8 m -97.8 102.94 14.72 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 120.518 0.199 . . . . 0.0 110.528 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.568 ' HD3' ' O ' ' A' ' 221' ' ' GLY . 9.6 Cg_exo -72.31 130.29 16.09 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.568 2.179 . . . . 0.0 111.311 176.174 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -81.59 56.04 4.89 Favored Glycine 0 N--CA 1.454 -0.14 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.183 -178.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -162.39 166.87 24.55 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 122.446 0.298 . . . . 0.0 110.295 -177.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -93.85 104.63 16.7 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.854 177.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 10.9 tp -79.27 -15.47 13.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.381 -177.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 20.7 m 71.86 107.97 0.03 OUTLIER Pre-proline 0 C--O 1.232 0.176 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.157 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.461 ' C ' HD22 ' A' ' 230' ' ' LEU . 16.7 Cg_exo -66.99 -73.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.249 1.966 . . . . 0.0 110.767 174.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.461 HD22 ' C ' ' A' ' 229' ' ' PRO . 3.2 mm? -133.11 145.95 59.05 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 174.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.18 -56.93 1.94 Allowed 'Trans proline' 0 CA--C 1.53 0.278 0 C-N-CA 123.166 2.577 . . . . 0.0 113.334 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 21.9 t -140.01 79.31 1.7 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.046 0.45 . . . . 0.0 111.263 -176.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.402 ' OG1' ' HB2' ' A' ' 230' ' ' LEU . 26.0 p -132.97 4.14 3.78 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.493 174.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 234' ' ' GLN . . . . . 0.694 ' HB3' ' HG3' ' A' ' 237' ' ' PRO . 96.4 mt-30 70.19 -55.54 0.61 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.302 -177.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 71.14 -56.63 0.62 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 173.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' GLY . . . . . 0.426 ' N ' ' HD3' ' A' ' 237' ' ' PRO . . . -134.17 61.77 0.64 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 119.867 -1.159 . . . . 0.0 113.926 -176.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.694 ' HG3' ' HB3' ' A' ' 234' ' ' GLN . 45.7 Cg_endo -93.95 95.37 0.13 Allowed 'Trans proline' 0 N--CA 1.445 -1.336 0 C-N-CA 122.728 2.285 . . . . 0.0 110.291 170.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.585 ' CG1' HD12 ' A' ' 293' ' ' ILE . 15.2 t -95.3 138.93 19.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.158 0.504 . . . . 0.0 111.393 -171.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -109.9 121.68 45.8 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.833 177.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.61 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -118.68 155.02 31.78 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.887 -175.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -99.84 120.47 39.81 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.779 179.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 242' ' ' ALA . . . . . 0.546 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -72.31 106.78 4.6 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 175.282 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 41.2 pt -94.85 -5.83 10.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.159 0.504 . . . . 0.0 110.995 -176.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -137.37 140.76 41.61 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.98 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -63.62 126.29 27.05 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 176.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.551 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 24.5 tpt180 -125.62 101.89 7.1 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.968 0.413 . . . . 0.0 110.562 -178.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 25.7 m -111.94 150.13 41.9 Favored Pre-proline 0 C--N 1.316 -0.88 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 174.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -62.89 102.73 0.31 Allowed 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.245 1.963 . . . . 0.0 111.865 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 250' ' ' ALA . 45.8 t -73.33 178.17 4.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.58 -177.303 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.405 ' N ' ' SG ' ' A' ' 249' ' ' CYS . . . -63.74 -25.2 68.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.853 -177.065 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -99.11 1.11 44.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.876 0.37 . . . . 0.0 111.314 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -101.32 161.13 13.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.233 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -138.74 -66.12 0.48 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.393 178.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 2.3 m -82.49 10.34 7.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.006 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 285' ' ' LEU . . . -65.57 119.07 10.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.044 0.449 . . . . 0.0 111.434 -175.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.494 HD23 ' H ' ' A' ' 257' ' ' ALA . 1.2 tt -72.27 140.51 48.65 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.696 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.551 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -86.88 117.53 25.68 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.333 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 84.5 mt -126.86 142.69 51.48 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.557 -177.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -106.56 158.34 17.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.085 177.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 45.0 t -70.23 109.99 3.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.975 0.417 . . . . 0.0 110.088 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 108.54 11.69 22.79 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.852 -0.69 . . . . 0.0 111.948 -177.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -95.3 146.64 24.22 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 39.8 mm -90.28 117.63 33.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.914 0.388 . . . . 0.0 110.651 -179.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.426 HG21 HG11 ' A' ' 291' ' ' VAL . 22.0 t -92.94 109.4 21.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.432 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -91.11 88.18 6.86 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.065 178.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 7.6 p -88.67 125.47 41.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.341 0.591 . . . . 0.0 110.536 -177.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 37.2 p -97.27 -31.1 12.59 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.527 -175.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 268' ' ' ARG . . . . . 0.485 ' HD3' ' OE1' ' A' ' 276' ' ' GLU . 55.8 mtp180 -131.2 113.87 14.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.723 -177.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 31.6 mtt -93.86 113.42 25.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.124 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -83.57 169.98 14.84 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.576 176.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 32.4 mm -94.75 -20.32 6.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.476 -176.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -81.68 3.89 23.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.758 -176.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 99.31 -35.17 4.87 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.55 -0.833 . . . . 0.0 113.129 174.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -84.2 111.32 19.26 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 41.1 m0 -93.53 158.45 15.7 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.297 -177.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.485 ' OE1' ' HD3' ' A' ' 268' ' ' ARG . 58.7 mt-10 -91.66 106.75 18.71 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 172.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 277' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -108.52 146.33 16.49 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.012 -176.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -114.81 106.26 13.98 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 176.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 279' ' ' VAL . . . . . 0.43 HG12 ' OD1' ' A' ' 280' ' ' ASN . 15.1 t -141.48 134.11 29.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -175.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 280' ' ' ASN . . . . . 0.43 ' OD1' HG12 ' A' ' 279' ' ' VAL . 24.4 m120 62.21 23.59 13.96 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.251 -177.201 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 84.5 -4.19 84.78 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.511 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 -104.62 134.07 48.4 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.865 0.364 . . . . 0.0 111.021 -176.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 42.8 tttp -104.78 117.33 33.79 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.176 177.04 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -146.79 175.51 26.16 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 255' ' ' ALA . 89.5 mt -94.61 143.8 26.13 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 177.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.422 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 43.2 p90 -144.7 139.83 15.81 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.301 176.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 287' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 15.4 Cg_exo -69.59 125.11 11.84 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.651 2.234 . . . . 0.0 111.19 173.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -58.71 -19.96 44.53 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.269 -0.423 . . . . 0.0 112.04 -175.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 15.8 p -67.66 -9.26 41.75 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -177.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -99.55 -7.86 25.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.903 0.383 . . . . 0.0 111.053 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.546 HG12 ' HA ' ' A' ' 242' ' ' ALA . 34.0 m -127.56 170.12 17.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.891 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -138.77 134.83 33.98 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.07 0.462 . . . . 0.0 110.83 174.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.61 HD13 ' HB2' ' A' ' 240' ' ' ALA . 46.9 mm -76.78 128.81 37.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.329 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -138.61 -36.04 0.57 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.401 178.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 62.36 103.47 0.03 OUTLIER Pre-proline 0 C--N 1.341 0.197 0 CA-C-O 121.418 0.628 . . . . 0.0 111.354 -178.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 296' ' ' PRO . . . . . 0.487 ' O ' ' HB2' ' A' ' 297' ' ' GLN . 92.9 Cg_endo -79.43 50.45 3.51 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 123.209 2.606 . . . . 0.0 111.677 -178.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 297' ' ' GLN . . . . . 0.487 ' HB2' ' O ' ' A' ' 296' ' ' PRO . 2.0 mp0 77.84 -33.81 0.18 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.238 1.015 . . . . 0.0 111.309 -177.065 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 298' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 297' ' ' GLN . 35.0 m-80 72.88 132.55 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.28 0 O-C-N 123.747 0.654 . . . . 0.0 111.383 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.93 -17.26 43.24 Favored 'Trans proline' 0 CA--C 1.527 0.162 0 C-N-CA 122.702 2.268 . . . . 0.0 111.675 176.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -64.52 -28.21 69.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.604 176.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -90.47 -6.65 54.59 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.066 178.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -104.82 13.96 30.39 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.173 0.511 . . . . 0.0 111.051 -173.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.556 -0.735 . . . . 0.0 110.17 178.048 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 mmt . . . . . 0 N--CA 1.48 1.029 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.0 m -84.43 99.09 10.45 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.513 177.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.9 p -65.75 -39.09 90.72 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 173.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.538 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . -75.51 89.92 2.72 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.429 171.014 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -119.09 95.72 4.93 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.607 0.718 . . . . 0.0 111.741 -175.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.411 ' HE1' ' O ' ' A' ' 98' ' ' LEU . 12.2 p90 -159.66 169.84 22.87 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.532 174.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -75.83 -26.83 57.54 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -173.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.0 t 72.61 -39.16 0.44 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.622 0.769 . . . . 0.0 111.382 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.1 m -91.03 -26.11 19.35 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.49 0.186 . . . . 0.0 111.1 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -63.36 105.76 0.8 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.987 0.422 . . . . 0.0 111.291 -172.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -60.62 -39.75 89.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.63 -176.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.1 m -72.99 -3.18 24.43 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.614 -176.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.52 -41.74 10.09 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.654 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 33.1 p-90 -125.09 -21.68 4.6 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -172.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -71.6 109.25 5.41 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.044 -176.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.832 ' SD ' ' HA ' ' A' ' 104' ' ' ARG . 8.3 tpp -91.03 -9.25 46.56 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.649 -174.419 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.455 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 50.6 -112.07 1.46 Allowed Glycine 0 CA--C 1.52 0.358 0 CA-C-N 115.55 -0.75 . . . . 0.0 113.986 177.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.455 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 19.3 Cg_exo -66.15 82.18 0.28 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.424 2.749 . . . . 0.0 113.324 -177.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.759 HG12 ' H ' ' A' ' 20' ' ' SER . 59.5 t -139.68 -178.31 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.043 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.759 ' H ' HG12 ' A' ' 19' ' ' VAL . 47.4 t -168.62 178.88 4.52 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 -166.013 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.493 ' O ' ' HG2' ' A' ' 25' ' ' GLN . 0.1 OUTLIER -58.73 -45.16 90.24 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 118.59 0.632 . . . . 0.0 109.391 176.222 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -60.07 -60.2 4.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.799 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.547 ' O ' ' HG3' ' A' ' 27' ' ' ARG . 29.5 mm-40 -56.94 -49.31 76.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.007 -178.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.83 -38.0 72.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.582 -175.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.566 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 16.4 mm100 -61.9 -52.69 63.07 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.889 178.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.2 t -70.45 -10.54 59.41 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -172.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.547 ' HG3' ' O ' ' A' ' 23' ' ' GLU . 55.5 mtp180 -100.44 -11.2 20.4 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 121.081 -0.248 . . . . 0.0 111.338 -179.277 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.576 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 62.9 mt -132.2 -13.0 3.15 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -176.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.566 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -68.69 109.0 3.6 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.919 -0.488 . . . . 0.0 109.944 -178.316 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.52 26.1 66.3 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.393 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.428 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 17.4 mm-40 -94.07 -170.61 2.34 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 178.367 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.515 ' HB2' ' SD ' ' A' ' 35' ' ' MET . 56.0 mtm180 -61.81 150.83 35.99 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 177.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -92.31 113.92 26.33 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -178.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.505 ' CA ' HG21 ' A' ' 96' ' ' THR . . . 127.75 -4.62 7.02 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.746 -175.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.618 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 62.8 mtp -84.7 143.14 29.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.464 -0.368 . . . . 0.0 110.387 178.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.557 ' CD1' HD22 ' A' ' 98' ' ' LEU . 46.9 p90 -149.6 159.19 44.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.742 -0.208 . . . . 0.0 110.604 -178.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.623 ' HB2' ' HB2' ' A' ' 16' ' ' MET . 4.6 pp -150.69 138.52 19.92 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.141 0.496 . . . . 0.0 111.01 177.212 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 85.5 t -105.19 119.89 54.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 174.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.523 ' CB ' ' HB ' ' A' ' 19' ' ' VAL . 28.2 ptt-85 -117.08 161.58 19.18 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.89 -174.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -73.87 124.51 26.26 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 173.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.476 ' HB2' HG23 ' A' ' 49' ' ' VAL . 47.2 t -87.56 143.98 26.93 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.0 0.429 . . . . 0.0 110.902 -176.142 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.4 p -91.9 4.25 53.38 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.234 176.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 26.4 m -76.28 -43.12 43.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.173 175.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 47' ' ' ASP . 11.7 m -143.66 135.27 12.84 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -70.38 72.84 1.72 Allowed 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.453 2.102 . . . . 0.0 111.677 176.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 65' ' ' SER . . . 155.55 -23.51 0.56 Allowed Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -176.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.437 ' HB2' ' HB2' ' A' ' 44' ' ' CYS . 16.0 m-20 -81.79 155.83 25.23 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 176.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -131.79 177.21 7.7 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.532 HG13 HD13 ' A' ' 62' ' ' ILE . 38.7 t -145.4 115.3 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.714 0.292 . . . . 0.0 111.288 177.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.426 HD11 ' HB2' ' A' ' 36' ' ' PHE . 57.5 tp -81.61 103.94 11.67 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.267 175.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.5 m -96.92 127.84 43.28 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 176.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.57 HG21 HD13 ' A' ' 93' ' ' LEU . 59.7 t -121.69 133.27 68.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.025 0.44 . . . . 0.0 111.063 -175.131 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.576 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 26.6 t -91.0 110.31 21.57 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.531 -178.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.653 ' OE2' ' HB ' ' A' ' 96' ' ' THR . 40.8 mt-10 -146.78 136.88 23.47 Favored 'General case' 0 C--O 1.21 -0.984 0 C-N-CA 119.673 -0.811 . . . . 0.0 109.678 175.138 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 52.95 31.09 10.3 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 174.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 44.8 m 58.33 53.31 6.49 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 122.134 0.968 . . . . 0.0 109.367 -178.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.88 HH21 ' HB2' ' A' ' 94' ' ' ASP 0.256 0.2 OUTLIER -168.39 67.94 0.07 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 113.577 -1.647 . . . . 0.0 108.668 -156.915 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 21.7 t -72.49 102.8 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 O-C-N 120.588 -1.32 . . . . 0.0 110.299 -167.702 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.6 m -73.61 118.88 17.08 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 113.133 -1.849 . . . . 0.0 110.737 -176.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -97.93 113.53 25.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.854 0.359 . . . . 0.0 111.43 -178.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.736 ' HB3' HD11 ' A' ' 73' ' ' ILE . 70.2 m-85 -107.24 110.2 22.18 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.964 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.808 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 34.2 mm -77.46 132.75 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -173.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.546 HG23 ' HB3' ' A' ' 71' ' ' PHE . 3.7 mp -115.84 115.91 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 120.947 0.403 . . . . 0.0 111.125 177.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -88.57 142.71 27.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.371 -177.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.457 ' HB2' ' O ' ' A' ' 46' ' ' GLY . 35.9 t -83.38 100.15 10.5 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 169.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 90.3 mt -78.11 140.42 61.69 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -59.05 -15.45 27.95 Favored 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 122.982 2.455 . . . . 0.0 112.446 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -83.45 10.79 8.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.419 176.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? 63.59 27.81 15.02 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.667 -178.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.458 ' NH2' ' HB3' ' A' ' 77' ' ' GLU . 37.0 mtp180 -115.44 -175.21 2.66 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.988 -1.006 . . . . 0.0 109.52 178.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.546 ' HB3' HG23 ' A' ' 63' ' ' ILE . 62.0 m-85 -135.57 143.44 45.67 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.063 0.459 . . . . 0.0 111.735 -175.143 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -123.47 116.46 23.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.992 177.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.808 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 7.9 tt -102.87 94.74 3.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.493 0.663 . . . . 0.0 110.807 -179.174 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.405 ' O ' ' HB3' ' A' ' 75' ' ' ASP . . . 58.78 68.75 1.53 Allowed Glycine 0 C--N 1.331 0.284 0 CA-C-N 115.098 -0.955 . . . . 0.0 112.651 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.405 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 20.4 t0 76.55 -45.01 0.49 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 122.628 0.371 . . . . 0.0 111.333 178.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -75.78 129.18 36.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.146 0.498 . . . . 0.0 110.861 -178.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.458 ' HB3' ' NH2' ' A' ' 70' ' ' ARG . 64.6 mt-10 -101.32 153.3 19.77 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.428 -177.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.47 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 96.8 m-85 -141.01 -173.91 3.85 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.041 173.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -77.68 -48.76 15.97 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.019 0.438 . . . . 0.0 110.729 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.416 ' H ' ' HB3' ' A' ' 83' ' ' ALA . 4.7 p80 -156.89 -179.38 8.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.397 -178.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.609 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 14.2 mt -57.77 -57.1 27.93 Favored Pre-proline 0 N--CA 1.469 0.493 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -178.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.605 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 24.4 Cg_exo -64.37 -2.33 4.86 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.13 1.887 . . . . 0.0 112.948 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.416 ' HB3' ' H ' ' A' ' 80' ' ' HIS . . . -89.9 -36.8 14.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.793 0.33 . . . . 0.0 110.348 179.084 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.7 pp -76.78 -31.11 56.8 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.477 ' HA ' ' CD1' ' A' ' 98' ' ' LEU . 57.2 mt -67.62 -26.72 66.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.653 174.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -79.12 -33.44 44.29 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.788 177.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -76.07 -38.11 57.47 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.028 0.442 . . . . 0.0 111.049 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.486 ' HE2' HD13 ' A' ' 73' ' ' ILE . 33.5 m-85 -76.26 1.55 15.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.962 0.41 . . . . 0.0 111.779 -177.159 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -70.27 -25.99 63.61 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.45 171.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 29.8 pt -117.14 26.57 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 120.585 -0.446 . . . . 0.0 112.067 178.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.423 ' O ' ' HB2' ' A' ' 92' ' ' TYR . 2.8 t-160 -114.46 -42.64 3.27 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -175.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.47 ' CD1' HG23 ' A' ' 97' ' ' THR . 97.8 m-85 70.46 86.62 0.12 Allowed 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.751 0.657 . . . . 0.0 110.278 -171.242 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.685 ' HA ' ' OE2' ' A' ' 154' ' ' GLU . 14.8 mt -59.94 -30.75 69.28 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.51 -178.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.88 ' HB2' HH21 ' A' ' 57' ' ' ARG . 31.6 t0 -160.94 68.55 0.33 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.317 0.58 . . . . 0.0 109.863 170.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.534 HG22 ' O ' ' A' ' 94' ' ' ASP . 0.5 OUTLIER 70.2 -4.49 1.54 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.956 -175.629 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.653 ' HB ' ' OE2' ' A' ' 54' ' ' GLU . 16.2 m -127.73 138.84 52.9 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 121.237 0.542 . . . . 0.0 109.933 178.189 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.472 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.5 p -89.5 168.39 12.22 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 173.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.557 HD22 ' CD1' ' A' ' 36' ' ' PHE . 97.3 mt -63.58 96.36 0.12 Allowed 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.635 -0.426 . . . . 0.0 109.871 178.187 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.538 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 49.0 mm -86.06 -56.72 5.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.645 -174.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.618 ' O ' ' HA ' ' A' ' 35' ' ' MET . 42.5 tt0 -158.85 133.39 5.37 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.912 -176.296 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 100' ' ' GLU . 17.8 Cg_exo -64.91 157.75 55.03 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 122.88 2.386 . . . . 0.0 112.829 -177.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.09 141.13 86.15 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.9 112.44 1.21 Allowed 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.384 2.056 . . . . 0.0 112.116 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.832 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 41.7 ttp180 -59.09 -40.03 84.02 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.374 0.607 . . . . 0.0 109.474 178.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.448 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 59.7 m-85 -124.87 124.91 25.47 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.531 171.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 105' ' ' TYR . 16.3 Cg_exo -70.63 45.35 0.54 Allowed 'Trans proline' 0 N--CA 1.475 0.401 0 C-N-CA 123.544 2.83 . . . . 0.0 113.376 -177.215 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.654 ' HB3' ' HD3' ' A' ' 108' ' ' PRO . 22.8 t -80.11 -48.04 1.34 Allowed Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.43 175.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.654 ' HD3' ' HB3' ' A' ' 107' ' ' SER . 19.7 Cg_exo -67.66 129.2 19.44 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 121.957 1.771 . . . . 0.0 111.586 172.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' A' ' 108' ' ' PRO . 15.6 Cg_exo -68.47 121.71 8.66 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.856 2.37 . . . . 0.0 112.028 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 79.2 mtp -80.46 -10.31 59.75 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.367 177.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 120.5 -11.41 10.43 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.585 177.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 26.7 m 60.42 30.56 19.89 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 121.325 0.583 . . . . 0.0 110.518 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.4 m -104.39 -43.0 7.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.494 -176.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 32.0 t 52.28 34.52 14.89 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.151 0.5 . . . . 0.0 110.648 -177.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -131.17 104.67 15.02 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.943 -174.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -91.61 -178.81 1.21 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.209 2.606 . . . . 0.0 111.459 172.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -87.82 31.83 0.76 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.261 0.553 . . . . 0.0 111.082 -177.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.4 tt -173.96 82.6 0.37 Allowed Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.52 -54.28 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.108 2.539 . . . . 0.0 111.99 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 6.3 m -87.76 105.25 17.26 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.539 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -122.93 14.67 9.95 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.463 -177.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.436 ' CG ' ' H ' ' A' ' 123' ' ' ASP . 6.1 pt-20 38.53 -115.78 0.16 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.462 0.705 . . . . 0.0 112.674 -179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.436 ' H ' ' CG ' ' A' ' 122' ' ' GLU . 15.6 m-20 -131.23 29.2 4.66 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -178.592 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.855 ' HA ' ' HG3' ' A' ' 183' ' ' ARG . 13.7 p-10 -77.44 138.41 39.25 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -171.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.911 ' H ' ' HD2' ' A' ' 183' ' ' ARG . 3.3 mm? 72.53 108.06 0.07 Allowed 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.803 173.165 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.515 ' HG2' ' CD2' ' A' ' 127' ' ' TYR . 28.4 tt0 -171.72 -78.23 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.531 -1.213 . . . . 0.0 109.674 -174.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.515 ' CD2' ' HG2' ' A' ' 126' ' ' GLU . 54.7 m-85 -117.57 107.85 14.76 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.377 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.698 HG22 ' CG ' ' A' ' 180' ' ' LYS . 56.6 t -114.87 131.11 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -178.25 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.709 ' HB3' HD12 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -109.79 144.66 37.91 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 116.892 -1.923 . . . . 0.0 108.989 170.988 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.609 HG22 HG12 ' A' ' 178' ' ' VAL . 1.2 p -100.68 128.91 46.56 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.316 -179.312 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.531 HD21 ' HG2' ' A' ' 179' ' ' GLU . 14.8 mt -105.27 -23.16 12.92 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.934 -176.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.459 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 32.6 t80 -79.9 -33.41 39.89 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.727 -173.021 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.607 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 15.7 t70 71.77 120.14 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.365 0.602 . . . . 0.0 110.842 -174.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.568 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 64.4 t80 -153.85 91.96 3.16 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.615 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 74.2 Cg_endo -90.0 86.77 0.39 Allowed 'Trans proline' 0 N--CA 1.441 -1.605 0 C-N-CA 122.014 1.809 . . . . 0.0 112.573 177.324 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -76.79 -16.11 81.04 Favored Glycine 0 C--N 1.331 0.298 0 N-CA-C 111.056 -0.817 . . . . 0.0 111.056 174.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.697 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 90.5 m-20 52.97 68.31 0.86 Allowed 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.21 -0.995 . . . . 0.0 111.8 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.595 ' HB3' ' H ' ' A' ' 141' ' ' ASP . 1.0 OUTLIER -136.27 -174.87 3.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.229 0.538 . . . . 0.0 110.932 -178.962 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -115.32 3.69 14.27 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 166.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.431 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 32.9 tt0 -112.34 -49.74 2.94 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 113.9 -1.5 . . . . 0.0 108.65 177.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.595 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 4.9 m-20 -96.64 133.28 41.36 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.852 167.281 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 1.123 HD11 ' HB2' ' A' ' 165' ' ' ASN . 34.2 tp -83.62 131.65 51.68 Favored Pre-proline 0 N--CA 1.468 0.44 0 O-C-N 122.075 -0.39 . . . . 0.0 110.135 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.697 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 11.6 Cg_endo -85.63 91.06 0.69 Allowed 'Trans proline' 0 N--CA 1.444 -1.425 0 C-N-CA 122.115 1.877 . . . . 0.0 111.266 172.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.568 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 12.8 p90 -103.71 159.48 15.59 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.234 -176.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.607 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 5.0 mppt? -104.91 -168.28 1.45 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.262 0.554 . . . . 0.0 112.195 -178.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.735 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -86.84 9.11 20.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.0 -169.688 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -172.63 36.93 0.14 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.857 175.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.545 ' OE1' ' HA ' ' A' ' 144' ' ' PHE . 0.3 OUTLIER -101.06 149.05 24.35 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.351 -175.648 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.709 HD12 ' HB3' ' A' ' 129' ' ' ARG . 0.3 OUTLIER -89.06 124.57 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.677 -178.116 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.727 HD22 HD21 ' A' ' 142' ' ' LEU . 19.3 mt -119.45 155.35 32.21 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.588 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 67.6 t -117.56 125.53 74.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 174.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 1.084 HD13 ' HB2' ' A' ' 163' ' ' ALA . 49.5 mm -76.54 87.18 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 122.423 1.106 . . . . 0.0 108.118 -176.203 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.612 HG21 HG22 ' A' ' 170' ' ' VAL . 17.9 tt -75.66 -25.1 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 CA-C-N 113.292 -1.776 . . . . 0.0 109.875 -174.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.685 ' OE2' ' HA ' ' A' ' 93' ' ' LEU . 0.2 OUTLIER -141.0 141.21 34.39 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 170.458 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 61.0 tttt -128.83 92.75 39.16 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.44 0.638 . . . . 0.0 110.356 170.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.427 ' HG2' ' HE2' ' A' ' 172' ' ' MET . 10.3 Cg_exo -74.3 -44.04 0.46 Allowed 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.338 2.025 . . . . 0.0 112.002 172.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -120.2 178.74 4.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.099 -172.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.448 ' HA ' ' HE1' ' A' ' 161' ' ' TRP . 6.7 pt-20 -116.12 4.68 13.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.094 0.473 . . . . 0.0 110.672 174.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -102.34 -31.26 10.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.696 172.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.442 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 34.5 m95 -129.11 146.16 51.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.613 173.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' TRP . . . . . 0.741 ' O ' HG13 ' A' ' 173' ' ' ILE . 47.8 m0 -126.79 138.33 53.34 Favored 'General case' 0 C--O 1.215 -0.757 0 C-N-CA 122.788 0.435 . . . . 0.0 110.657 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.566 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 25.6 m -95.4 96.33 9.05 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -175.102 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 1.084 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -108.7 150.29 27.77 Favored 'General case' 0 N--CA 1.422 -1.833 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.505 -172.175 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.779 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 12.7 ptt180 -87.46 122.17 30.85 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 173.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 1.123 ' HB2' HD11 ' A' ' 142' ' ' LEU . 17.5 t30 -54.61 176.79 0.04 OUTLIER 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 113.293 -1.776 . . . . 0.0 110.91 -177.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.541 ' HD2' ' H ' ' A' ' 149' ' ' ILE . 30.9 mtpt -62.95 -17.98 62.61 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.828 169.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -68.94 -36.24 77.72 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.468 0.652 . . . . 0.0 109.46 168.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.432 ' C ' ' HB2' ' A' ' 164' ' ' ARG . . . 105.06 3.96 41.75 Favored Glycine 0 CA--C 1.524 0.598 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.343 -172.401 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.779 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -79.33 137.59 37.39 Favored 'General case' 0 C--O 1.218 -0.574 0 C-N-CA 123.16 0.584 . . . . 0.0 111.77 -178.77 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.612 HG22 HG21 ' A' ' 153' ' ' ILE . 22.1 t -79.87 125.87 39.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 120.417 0.151 . . . . 0.0 111.291 177.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -157.88 148.37 17.67 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 120.209 -0.996 . . . . 0.0 112.665 169.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.472 ' HA ' ' HA ' ' A' ' 162' ' ' SER . 0.4 OUTLIER -69.88 140.65 53.19 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 122.756 0.422 . . . . 0.0 111.378 179.408 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.741 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.6 pp -144.45 144.39 25.1 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.105 -176.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.514 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 8.1 Cg_exo -73.38 132.13 17.3 Favored 'Trans proline' 0 C--O 1.23 0.115 0 C-N-CA 122.498 2.132 . . . . 0.0 112.644 -174.296 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.601 ' O ' HG22 ' A' ' 178' ' ' VAL . 82.9 t -60.98 -44.03 93.2 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 19.0 Cg_endo -61.08 -11.2 17.56 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 121.981 1.787 . . . . 0.0 112.873 177.425 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.514 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.1 m-85 -88.22 -15.18 36.63 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.525 -178.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.611 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 4.1 m -106.58 -172.44 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 115.558 1.688 . . . . 0.0 115.558 -164.343 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.663 ' O ' ' HG3' ' A' ' 179' ' ' GLU . 3.9 tp10 -159.9 44.32 0.22 Allowed 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 112.941 -1.936 . . . . 0.0 111.638 -154.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.773 ' HD2' ' H ' ' A' ' 180' ' ' LYS . 0.0 OUTLIER -74.13 144.23 44.99 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 119.275 -2.141 . . . . 0.0 111.554 -166.07 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.448 ' HB2' HH12 ' A' ' 129' ' ' ARG . 23.8 tp -64.81 -85.07 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 111.416 -2.629 . . . . 0.0 114.282 -157.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 21.3 t -89.62 -14.69 9.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.666 0.746 . . . . 0.0 110.546 -173.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.911 ' HD2' ' H ' ' A' ' 125' ' ' LEU . 28.2 ttt-85 -75.33 107.15 7.25 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.606 -177.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 50.6 m -65.16 152.85 42.57 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 170.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.549 ' CB ' HH12 ' A' ' 183' ' ' ARG . 41.3 t -113.76 148.43 39.82 Favored Pre-proline 0 C--N 1.315 -0.904 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.29 -173.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.5 ' HD2' HH22 ' A' ' 183' ' ' ARG . 19.2 Cg_endo -58.81 104.54 0.19 Allowed 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.031 2.487 . . . . 0.0 111.314 174.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.452 ' HB3' ' CD ' ' A' ' 193' ' ' ARG . 37.5 m80 -108.51 25.83 11.22 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.659 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 89.89 -65.55 2.93 Favored Glycine 0 CA--C 1.505 -0.538 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -173.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -132.84 136.38 46.2 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 168.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 64.3 m80 -79.03 115.1 18.5 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.483 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 109.16 -121.66 6.24 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 -176.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -68.07 115.29 7.39 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 176.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.452 ' CD ' ' HB3' ' A' ' 187' ' ' HIS . 16.7 ptt180 -145.61 150.69 36.82 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.182 0.515 . . . . 0.0 111.605 -173.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -117.61 87.12 2.65 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.443 172.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 1.5 p -76.37 138.38 40.39 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.356 -177.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -97.45 109.27 22.06 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.727 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 2.6 p -90.3 7.06 40.32 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.102 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -124.87 117.32 23.83 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.547 -178.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 107.7 172.41 22.03 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.341 176.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.525 HD13 ' H ' ' A' ' 200' ' ' ILE . 0.2 OUTLIER -133.98 144.39 51.41 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-O 120.632 0.253 . . . . 0.0 110.46 178.904 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 200' ' ' ILE . 3.0 Cg_exo -75.74 78.67 3.03 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.923 2.416 . . . . 0.0 111.566 176.171 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 66.19 123.33 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.382 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.062 -178.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -68.03 157.76 60.39 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.306 2.004 . . . . 0.0 111.531 176.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -95.51 142.23 28.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.731 0.301 . . . . 0.0 110.611 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 -86.33 -41.67 14.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.19 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -149.03 157.83 43.72 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.537 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -85.87 103.27 14.46 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.045 177.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . 64.67 -172.14 0.18 Allowed 'General case' 0 N--CA 1.465 0.314 0 O-C-N 123.848 0.718 . . . . 0.0 111.008 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -89.64 134.48 32.27 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-O 120.649 0.261 . . . . 0.0 110.714 176.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -62.05 140.23 83.1 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.776 2.317 . . . . 0.0 112.272 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -91.47 123.36 34.83 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.006 -176.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 7.7 m 61.67 49.17 5.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.723 0.773 . . . . 0.0 111.664 175.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.0 104.34 16.89 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.452 173.056 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.731 ' HB ' ' HD3' ' A' ' 215' ' ' PRO . 49.3 m -152.65 -56.47 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.668 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.731 ' HD3' ' HB ' ' A' ' 214' ' ' THR . 89.1 Cg_endo -85.03 171.62 9.13 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 121.873 1.715 . . . . 0.0 112.213 176.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 95.8 mt -111.93 117.68 47.79 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.018 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -69.45 -75.44 0.01 OUTLIER 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 122.976 2.451 . . . . 0.0 112.605 -178.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -145.34 149.11 34.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.374 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 61.1 t -84.12 100.49 7.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.964 -177.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 74.8 m 56.62 29.4 15.6 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.249 175.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 68.99 21.12 75.25 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.749 178.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.451 ' HA ' ' HD3' ' A' ' 223' ' ' PRO . 27.4 m -109.77 127.24 27.47 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-O 120.559 0.218 . . . . 0.0 110.522 178.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 222' ' ' SER . 17.4 Cg_exo -67.43 -17.63 49.14 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.852 2.368 . . . . 0.0 112.138 178.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 133.29 -79.28 0.34 Allowed Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -88.82 95.62 10.36 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 177.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . 61.67 -167.62 0.2 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.65 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 50.4 mm -109.2 -39.4 4.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.812 177.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.68 ' HB ' ' HD2' ' A' ' 229' ' ' PRO . 77.4 p -132.66 170.69 10.73 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.54 178.001 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.68 ' HD2' ' HB ' ' A' ' 228' ' ' THR . 53.6 Cg_endo -70.3 168.23 22.87 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 122.207 1.938 . . . . 0.0 111.616 172.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -100.75 115.16 65.67 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 120.672 0.272 . . . . 0.0 110.925 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.94 178.11 7.67 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 122.866 2.377 . . . . 0.0 111.938 177.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 61.3 m -81.44 56.22 2.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.976 0.417 . . . . 0.0 111.366 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 1.4 p -78.1 75.21 4.63 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.308 0.575 . . . . 0.0 110.116 175.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 77.1 mm-40 -85.27 98.29 10.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.505 -176.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -125.02 -35.98 2.6 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.41 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' GLY . . . . . 0.424 ' HA3' ' HD3' ' A' ' 237' ' ' PRO . . . 97.72 -100.61 2.41 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -174.189 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 237' ' ' PRO . . . . . 0.424 ' HD3' ' HA3' ' A' ' 236' ' ' GLY . 12.9 Cg_exo -69.9 114.82 3.85 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.563 2.175 . . . . 0.0 111.283 173.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.464 ' CG1' HD12 ' A' ' 293' ' ' ILE . 21.7 t -84.71 134.55 26.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.945 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.53 ' HB2' ' CG ' ' A' ' 296' ' ' PRO . 93.8 m-85 -104.46 124.24 48.9 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.141 0.496 . . . . 0.0 110.468 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.585 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -119.24 140.65 49.89 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.26 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -88.2 124.36 33.76 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' ALA . . . . . 0.522 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -75.29 99.52 4.09 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.253 178.388 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 39.4 pt -80.59 -23.26 11.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.276 0.56 . . . . 0.0 110.74 -177.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -135.26 148.52 49.59 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 177.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -67.79 169.56 9.47 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.239 0.542 . . . . 0.0 110.607 -178.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.564 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 27.3 tpt180 -154.1 109.78 3.2 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.166 178.236 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 24.0 m -108.77 150.15 40.43 Favored Pre-proline 0 C--N 1.315 -0.923 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.505 ' HA ' ' HB3' ' A' ' 255' ' ' ALA . 12.4 Cg_exo -68.44 110.5 2.29 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.416 2.077 . . . . 0.0 111.518 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 249' ' ' CYS . . . . . 0.535 ' HB3' ' HB2' ' A' ' 252' ' ' ASP . 51.9 t -70.52 164.65 24.32 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.907 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -53.34 -40.05 64.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.6 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -99.86 7.17 45.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.793 0.33 . . . . 0.0 111.493 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.535 ' HB2' ' HB3' ' A' ' 249' ' ' CYS . 7.4 m-20 -127.6 69.19 1.31 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.132 0.491 . . . . 0.0 110.131 176.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -78.2 -21.58 49.86 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.178 0.513 . . . . 0.0 110.189 -179.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 19.8 p -83.04 -0.35 48.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.847 177.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.505 ' HB3' ' HA ' ' A' ' 248' ' ' PRO . . . -77.19 132.59 38.84 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.572 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.62 137.28 40.64 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.026 -178.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.564 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -87.26 107.59 18.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.141 0.496 . . . . 0.0 110.095 179.342 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 94.4 mt -116.3 151.11 36.5 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.782 -176.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -119.13 157.0 28.77 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.22 176.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 47.4 t -65.03 122.64 16.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.565 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 96.28 18.45 31.09 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.801 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -99.38 170.5 8.59 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 177.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 25.9 mm -117.76 112.83 40.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.042 0.449 . . . . 0.0 110.307 -178.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 239' ' ' PHE . 30.8 t -88.41 113.0 24.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.65 -178.166 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -92.26 87.59 6.13 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.829 177.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.518 HG21 ' HB3' ' A' ' 275' ' ' TRP . 3.0 p -92.69 120.05 41.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.384 0.611 . . . . 0.0 110.809 -177.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 1.4 p -94.03 -26.95 16.57 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.754 -178.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 268' ' ' ARG . . . . . 0.586 ' HB2' ' HB3' ' A' ' 276' ' ' GLU . 28.6 mmm180 -116.24 104.51 11.58 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.864 0.364 . . . . 0.0 110.938 -178.561 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 36.9 mmm -94.51 131.87 39.78 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 177.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 31.7 p30 -125.44 -179.16 4.49 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.638 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 19.6 pt -103.31 8.21 9.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.172 0.51 . . . . 0.0 110.738 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -81.35 -31.51 33.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.717 -176.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 117.91 -40.2 2.39 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.665 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.543 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 1.9 mp0 -94.76 114.98 26.96 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 174.234 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.518 ' HB3' HG21 ' A' ' 266' ' ' VAL . 21.9 m0 -91.68 157.53 16.9 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -177.041 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.586 ' HB3' ' HB2' ' A' ' 268' ' ' ARG . 8.0 tp10 -90.39 103.08 15.8 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 277' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -115.91 137.96 14.17 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.266 -0.968 . . . . 0.0 113.559 -172.077 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -105.99 108.95 20.72 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 175.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 279' ' ' VAL . . . . . 0.404 HG22 ' HA ' ' A' ' 264' ' ' VAL . 37.9 t -119.47 -87.64 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.056 -0.658 . . . . 0.0 112.108 -173.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -105.08 76.25 1.23 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.936 0.398 . . . . 0.0 111.072 -174.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 66.15 20.73 69.38 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.825 176.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 282' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 282' ' ' ARG . 38.1 ttt-85 -158.87 137.41 10.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.838 0.319 . . . . 0.0 110.64 -175.298 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 38.1 ttpt -110.08 128.45 55.44 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.599 177.135 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -156.67 173.72 34.4 Favored Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 -178.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.543 ' HB3' ' HB3' ' A' ' 274' ' ' GLN . 72.5 mt -89.1 138.01 31.8 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.039 0.447 . . . . 0.0 110.417 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.445 ' O ' ' HA ' ' A' ' 274' ' ' GLN . 35.7 p90 -137.83 133.08 17.53 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.21 178.187 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.67 131.93 23.97 Favored 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 122.547 2.164 . . . . 0.0 111.656 176.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -65.62 -2.39 3.47 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.69 -177.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.89 -0.46 55.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.96 0.41 . . . . 0.0 111.296 -179.295 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -111.65 -12.5 13.89 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.801 0.334 . . . . 0.0 110.892 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.522 HG12 ' HA ' ' A' ' 242' ' ' ALA . 27.9 m -128.29 162.47 34.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.999 -179.037 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -136.43 132.35 35.33 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.944 0.402 . . . . 0.0 111.027 175.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.585 HD13 ' HB2' ' A' ' 240' ' ' ALA . 42.0 mm -72.29 129.81 35.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.454 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 294' ' ' PHE . . . . . 0.641 ' O ' ' HD3' ' A' ' 296' ' ' PRO . 10.2 p90 -135.08 -170.93 2.68 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.595 -179.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 295' ' ' ASP . . . . . 0.551 ' HB2' ' O ' ' A' ' 298' ' ' ASN . 6.1 p-10 -98.07 97.08 3.99 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-O 121.357 0.599 . . . . 0.0 110.87 176.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 296' ' ' PRO . . . . . 0.641 ' HD3' ' O ' ' A' ' 294' ' ' PHE . 1.1 Cg_endo -83.53 -53.27 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.921 2.414 . . . . 0.0 112.098 -178.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -124.49 -10.57 7.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.232 0.539 . . . . 0.0 110.554 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 298' ' ' ASN . . . . . 0.551 ' O ' ' HB2' ' A' ' 295' ' ' ASP . 2.7 p-10 -100.98 114.5 65.82 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.595 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 299' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 298' ' ' ASN . 13.6 Cg_exo -71.72 -11.21 27.62 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.755 2.303 . . . . 0.0 111.836 178.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -65.14 153.47 40.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.131 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 73.12 -32.58 0.25 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.772 0.829 . . . . 0.0 111.999 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 302' ' ' ASN . . . . . 0.478 HD22 ' CG ' ' A' ' 295' ' ' ASP . 44.0 t-20 -80.84 116.85 21.03 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 175.063 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 . . . . . 0 C--O 1.246 0.87 0 CA-C-O 118.542 -0.742 . . . . 0.0 110.046 -177.932 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 N--CA 1.48 1.056 0 CA-C-O 120.596 0.236 . . . . 0.0 110.96 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.4 m -90.45 -10.86 42.18 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.732 -0.213 . . . . 0.0 110.866 -178.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.584 ' HB3' HD12 ' A' ' 99' ' ' ILE . 64.2 m 69.55 -55.9 0.57 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.331 0.652 . . . . 0.0 111.485 -176.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.563 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . -72.36 107.22 4.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.689 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.445 ' HD3' ' HA ' ' A' ' 5' ' ' ARG . 19.1 mmt180 -137.55 100.05 4.11 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.112 0.482 . . . . 0.0 111.418 -178.078 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -167.65 159.69 12.16 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.33 -0.85 . . . . 0.0 108.88 177.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -83.11 108.42 16.37 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 177.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.636 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 15.4 m -74.89 55.86 0.71 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.319 179.202 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.1 m -161.85 -39.67 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.948 0.404 . . . . 0.0 110.781 -179.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -71.81 110.37 6.29 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.19 0.519 . . . . 0.0 111.386 -171.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.401 ' HG2' ' H ' ' A' ' 11' ' ' ARG . 9.3 mmt180 -60.78 -35.65 77.0 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.712 -178.409 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.526 ' HA ' ' NH1' ' A' ' 104' ' ' ARG . 67.0 m -71.18 -3.57 20.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.504 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.73 -46.87 7.36 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.139 177.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 17.3 p-90 -118.57 -21.25 8.04 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -170.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -80.4 121.72 26.07 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 121.86 -0.525 . . . . 0.0 111.18 -173.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.577 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 23.1 mmt -99.81 -5.21 28.95 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.653 -176.363 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.442 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.15 -113.82 2.47 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 116.034 -0.53 . . . . 0.0 113.359 -176.095 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.442 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 9.2 Cg_exo -72.56 91.09 0.79 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.19 2.593 . . . . 0.0 113.511 -176.091 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.5 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 73.7 t -144.99 153.76 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 176.008 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.2 p -121.19 -179.83 4.17 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 118.233 0.469 . . . . 0.0 109.78 -174.203 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.751 HH21 ' HA ' ' A' ' 117' ' ' ASN . 21.2 mmm180 -55.25 -54.59 41.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.649 0.261 . . . . 0.0 110.879 177.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.492 ' HB2' ' HB3' ' A' ' 114' ' ' SER . 11.3 pt20 -64.47 -39.59 94.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.868 -175.105 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.509 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 50.4 mt-10 -69.68 -48.08 60.98 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.404 179.275 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.19 -38.8 71.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.017 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.916 ' HG2' ' H ' ' A' ' 115' ' ' ALA . 3.6 tp-100 -53.2 -58.56 6.62 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.451 175.075 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.57 ' HA ' ' HB3' ' A' ' 29' ' ' GLN . 10.4 t -75.99 -2.63 31.48 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -171.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' A' ' 23' ' ' GLU . 52.2 mmm-85 -85.29 -20.93 29.29 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.162 0.506 . . . . 0.0 109.682 175.153 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.576 HD22 ' HB2' ' A' ' 53' ' ' SER . 29.7 mt -123.14 -12.71 7.87 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.737 -177.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.573 ' OE1' ' HB3' ' A' ' 57' ' ' ARG . 36.3 tp60 -67.33 115.64 7.2 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.172 0.589 . . . . 0.0 111.743 -178.243 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 66.62 10.98 56.1 Favored Glycine 0 C--N 1.331 0.292 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.855 176.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.486 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 15.2 mm100 -70.1 -87.02 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -177.305 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -158.07 -4.36 0.09 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.465 ' HA ' ' OG ' ' A' ' 53' ' ' SER . 29.0 m170 71.17 161.37 0.23 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.359 0.599 . . . . 0.0 111.559 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.11 -22.55 8.15 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.07 177.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.743 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 57.9 mtm -82.25 147.44 28.94 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 178.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -140.25 164.37 30.26 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.261 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.577 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.3 pp -152.69 134.88 14.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.037 0.446 . . . . 0.0 111.463 178.432 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.6 t -105.81 127.29 60.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 173.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.619 HH22 ' HD2' ' A' ' 21' ' ' ARG . 31.9 ptt-85 -131.15 -178.45 4.84 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.684 -0.235 . . . . 0.0 110.652 -174.389 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -69.93 132.21 45.61 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 171.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.493 ' HA ' HG23 ' A' ' 49' ' ' VAL . 22.6 t -72.87 155.91 39.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.65 0.738 . . . . 0.0 112.246 -175.058 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.4 p -102.14 10.29 39.55 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.383 177.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 36.0 p -95.27 -51.54 4.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.855 178.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 1.7 p -165.91 144.11 4.81 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.127 179.158 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 44' ' ' CYS . 47.4 Cg_exo -57.54 125.37 18.57 Favored 'Trans proline' 0 C--O 1.237 0.471 0 C-N-CA 123.006 2.471 . . . . 0.0 112.268 178.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.65 -31.42 5.56 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -176.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -89.3 167.78 12.78 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 177.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -135.98 176.01 9.08 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.76 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.493 HG23 ' HA ' ' A' ' 41' ' ' SER . 48.4 t -142.93 110.87 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.945 0.402 . . . . 0.0 111.319 177.184 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.3 tp -80.84 105.61 12.2 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.184 174.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.0 m -98.27 131.57 44.48 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 174.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.587 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 46.2 t -118.64 143.13 30.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.493 -177.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.576 ' HB2' HD22 ' A' ' 28' ' ' LEU . 40.2 t -88.75 110.32 20.9 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 122.218 -0.301 . . . . 0.0 111.267 -177.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.516 ' HG2' ' O ' ' A' ' 94' ' ' ASP . 6.2 tp10 -177.85 165.93 2.05 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 174.147 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.55 ' HB2' HH21 ' A' ' 57' ' ' ARG . 2.6 m-80 60.3 50.48 6.17 Favored 'General case' 0 CA--C 1.48 -1.742 0 C-N-CA 123.905 0.882 . . . . 0.0 108.657 -168.21 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 55' ' ' ASN . 66.4 m 71.61 -28.7 0.19 Allowed 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 113.516 -1.675 . . . . 0.0 110.95 -171.164 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.753 ' NE ' ' H ' ' A' ' 58' ' ' VAL 0.399 0.0 OUTLIER -153.21 -54.01 0.11 Allowed 'General case' 0 C--N 1.364 1.23 1 N-CA-C 124.965 5.172 . . . . 0.0 124.965 -174.619 . . . . . . . . 5 4 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.753 ' H ' ' NE ' ' A' ' 57' ' ' ARG . 1.7 t -152.29 120.8 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 CA-C-N 122.49 2.405 . . . . 0.0 114.046 -173.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.531 ' HB2' ' HB ' ' A' ' 52' ' ' VAL . 0.9 OUTLIER -97.98 110.83 23.33 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 163.513 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.475 ' CE1' HG11 ' A' ' 58' ' ' VAL . 60.6 m80 -98.13 118.17 34.16 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 121.546 -0.721 . . . . 0.0 112.555 -173.021 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.716 ' CZ ' HD22 ' A' ' 93' ' ' LEU . 37.2 m-85 -122.36 109.21 14.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.674 179.244 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.573 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 67.9 mt -81.03 135.12 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 O-C-N 121.859 -0.526 . . . . 0.0 111.636 -178.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.475 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 5.3 mp -112.96 111.69 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 120.881 0.372 . . . . 0.0 110.905 179.083 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.692 ' HB2' ' CG ' ' A' ' 72' ' ' LYS . 23.4 m120 -88.98 148.13 23.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.495 -174.136 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.6 t -83.82 105.84 15.04 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.136 175.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.407 HD21 ' HE2' ' A' ' 72' ' ' LYS . 91.0 mt -82.74 140.68 43.98 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 177.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.52 -9.05 16.68 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.077 2.518 . . . . 0.0 112.978 -177.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -91.82 19.26 6.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.326 177.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.481 ' HA ' ' NE ' ' A' ' 69' ' ' ARG . 5.2 mmp_? 58.7 32.32 22.06 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.405 0.621 . . . . 0.0 110.627 -174.284 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.448 HH11 ' HD3' ' A' ' 70' ' ' ARG . 34.1 mtp180 -114.42 -178.84 3.47 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.272 179.164 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.475 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 55.6 m-85 -138.87 142.41 38.59 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.486 0.184 . . . . 0.0 111.148 -178.278 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.692 ' CG ' ' HB2' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -123.26 120.57 33.49 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-O 120.813 0.339 . . . . 0.0 110.874 178.914 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.621 HD11 ' CB ' ' A' ' 61' ' ' TYR . 17.6 tt -93.51 89.53 2.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.917 0.865 . . . . 0.0 110.817 -177.478 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.523 ' O ' ' HB3' ' A' ' 75' ' ' ASP . . . 59.51 77.08 0.19 Allowed Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.305 -178.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.523 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 16.6 t70 78.54 -52.24 0.48 Allowed 'General case' 0 N--CA 1.48 1.051 0 O-C-N 123.749 0.323 . . . . 0.0 111.409 178.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -70.47 134.8 48.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.0 0.429 . . . . 0.0 111.795 -173.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.422 ' OE1' ' HB3' ' A' ' 72' ' ' LYS . 6.0 mm-40 -89.49 143.9 26.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.185 -177.33 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.482 ' HZ ' ' CD2' ' A' ' 87' ' ' PHE . 47.0 m-85 -140.52 -175.42 4.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.293 172.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -75.38 -56.81 4.35 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.17 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.479 ' ND1' ' HD2' ' A' ' 82' ' ' PRO . 2.5 p80 -166.81 -174.0 2.59 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.762 175.059 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.664 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 16.4 mt -53.51 -59.74 8.73 Favored Pre-proline 0 N--CA 1.47 0.547 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -177.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.664 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 38.5 Cg_exo -65.11 3.2 1.05 Allowed 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 122.752 2.301 . . . . 0.0 113.56 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.475 ' HB3' ' H ' ' A' ' 80' ' ' HIS . . . -106.07 -35.06 7.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.911 0.386 . . . . 0.0 110.669 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.6 pp -76.14 -30.74 58.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.938 0.399 . . . . 0.0 110.127 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.477 ' N ' HD12 ' A' ' 84' ' ' LEU . 79.2 mt -63.66 -27.88 69.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.042 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.581 ' HA ' ' HD3' ' A' ' 89' ' ' LYS . 19.9 tp10 -80.9 -21.96 40.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.98 -176.284 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.482 ' CD2' ' HZ ' ' A' ' 78' ' ' PHE . 62.4 t80 -83.02 -20.61 34.72 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.898 0.856 . . . . 0.0 109.243 -177.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.517 ' CG ' HD21 ' A' ' 93' ' ' LEU . 35.5 m-85 -97.27 1.98 50.24 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.444 -177.221 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.581 ' HD3' ' HA ' ' A' ' 86' ' ' GLU . 53.8 mtpt -86.23 -2.24 58.19 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.967 173.059 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 33.2 pt -131.85 -8.52 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 CA-C-O 121.432 0.634 . . . . 0.0 109.365 177.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.462 ' HB2' ' O ' ' A' ' 87' ' ' PHE . 8.2 t60 -82.82 -32.54 27.56 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.602 -174.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.441 ' H ' HG22 ' A' ' 97' ' ' THR . 95.4 m-85 56.93 78.84 0.2 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.92 -166.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.716 HD22 ' CZ ' ' A' ' 61' ' ' TYR . 12.9 mt -45.77 -83.03 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.21 0 O-C-N 124.091 0.87 . . . . 0.0 110.34 178.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.572 ' HB2' ' HG3' ' A' ' 154' ' ' GLU . 45.5 t0 -109.13 84.17 1.88 Allowed 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.908 -179.115 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' THR . . . . . 1.086 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 4.8 t 49.93 17.68 0.31 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.643 0.777 . . . . 0.0 112.152 -178.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.8 t -163.12 157.58 20.82 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 -178.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.441 HG22 ' H ' ' A' ' 92' ' ' TYR . 7.9 p -98.4 176.33 5.73 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.644 0.259 . . . . 0.0 110.463 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.4 mt -72.02 90.65 1.18 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 174.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.584 HD12 ' HB3' ' A' ' 3' ' ' SER . 50.1 mm -73.74 -54.39 15.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.247 -175.031 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.743 ' O ' ' HA ' ' A' ' 35' ' ' MET . 11.1 pt-20 -158.44 153.74 22.06 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.032 -177.224 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.73 145.95 33.23 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 121.924 1.749 . . . . 0.0 111.531 176.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.433 ' HB2' ' HB3' ' A' ' 35' ' ' MET . . . -72.08 150.7 92.5 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.34 134.35 63.17 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.409 2.073 . . . . 0.0 111.673 175.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.526 ' NH1' ' HA ' ' A' ' 12' ' ' SER . 56.2 mtm180 -80.83 -14.29 58.18 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -174.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -69.14 150.01 97.5 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -68.86 100.36 0.71 Allowed 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.229 1.952 . . . . 0.0 111.389 174.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.42 ' HB2' ' HA ' ' A' ' 110' ' ' MET . 19.0 m -57.91 119.74 36.61 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.045 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.548 ' HB2' ' HD3' ' A' ' 109' ' ' PRO . 51.0 Cg_exo -53.27 -51.25 11.41 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.041 2.494 . . . . 0.0 113.672 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.548 ' HD3' ' HB2' ' A' ' 108' ' ' PRO . 78.0 Cg_endo -84.23 -1.88 9.91 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 121.648 1.565 . . . . 0.0 111.775 175.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' MET . . . . . 0.42 ' HA ' ' HB2' ' A' ' 107' ' ' SER . 64.1 mtt 64.37 -83.44 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.094 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.789 -175.066 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -173.54 -61.45 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -178.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' SER . . . . . 0.549 ' HB2' ' HG3' ' A' ' 29' ' ' GLN . 48.7 m -154.9 -81.62 0.08 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 172.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.3 m -140.82 162.84 22.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.742 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.492 ' HB3' ' HB2' ' A' ' 22' ' ' GLN . 14.9 m -90.24 91.75 8.64 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.87 0.367 . . . . 0.0 110.328 177.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.916 ' H ' ' HG2' ' A' ' 25' ' ' GLN . . . -92.63 147.19 33.74 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.433 178.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 115' ' ' ALA . 1.0 OUTLIER -84.32 136.49 6.66 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.908 2.405 . . . . 0.0 112.81 -178.597 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.751 ' HA ' HH21 ' A' ' 21' ' ' ARG . 63.7 t30 70.37 -140.08 0.06 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.632 173.08 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.826 ' HB2' ' HD3' ' A' ' 119' ' ' PRO . 83.4 mt -75.82 -66.62 0.38 Allowed Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -169.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.826 ' HD3' ' HB2' ' A' ' 118' ' ' LEU . 72.8 Cg_endo -87.58 -168.77 0.42 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.258 1.972 . . . . 0.0 113.323 -171.023 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.3 m -91.88 32.44 1.13 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.682 -177.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 73.16 -51.69 0.71 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.669 0.788 . . . . 0.0 112.272 178.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -137.44 85.34 2.11 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.387 0.613 . . . . 0.0 110.294 176.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -138.26 -74.45 0.4 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.539 176.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.451 ' O ' ' HB2' ' A' ' 125' ' ' LEU . 0.4 OUTLIER 173.85 147.05 0.06 Allowed 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 123.199 0.6 . . . . 0.0 109.453 179.424 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.904 HD12 HG21 ' A' ' 152' ' ' ILE . 3.9 mm? 72.04 109.12 0.07 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.695 0.76 . . . . 0.0 111.386 177.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.46 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 44.7 tt0 -169.39 -72.25 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.161 -178.07 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -117.66 114.64 23.67 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.634 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.868 HG22 ' HG3' ' A' ' 180' ' ' LYS . 57.4 t -126.38 150.15 31.82 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.096 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.105 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.732 ' CZ ' HD13 ' A' ' 181' ' ' LEU . 0.0 OUTLIER -124.73 155.01 39.98 Favored 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 118.014 -1.474 . . . . 0.0 109.031 165.158 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.639 ' OG1' ' HB2' ' A' ' 144' ' ' PHE . 72.9 p -106.02 140.05 39.61 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.216 0.531 . . . . 0.0 111.072 178.129 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.579 HD21 ' HG2' ' A' ' 179' ' ' GLU . 8.8 mt -113.73 -5.9 13.31 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.039 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.443 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 28.6 t80 -93.91 -41.11 9.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.694 -173.257 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.647 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 10.7 t70 74.28 95.53 0.07 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.486 0.66 . . . . 0.0 110.69 -178.188 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.64 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 75.4 t80 -126.01 90.46 50.21 Favored Pre-proline 0 C--N 1.318 -0.765 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 173.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.584 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 95.0 Cg_endo -85.92 81.19 1.7 Allowed 'Trans proline' 0 N--CA 1.44 -1.636 0 C-N-CA 121.712 1.608 . . . . 0.0 112.144 178.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -69.69 -11.96 66.55 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.302 175.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.52 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 89.1 m-20 50.3 65.86 1.32 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 114.297 -0.951 . . . . 0.0 111.629 177.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.563 ' HB3' ' H ' ' A' ' 141' ' ' ASP . 1.0 OUTLIER -130.88 -176.61 4.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.364 0.602 . . . . 0.0 110.898 -178.612 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -111.41 0.63 16.64 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 167.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -117.09 -45.99 2.73 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.691 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.563 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 8.4 m-20 -97.67 128.1 44.12 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 168.424 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 1.098 HD11 ' HB2' ' A' ' 165' ' ' ASN . 28.9 tp -84.61 124.48 73.17 Favored Pre-proline 0 CA--C 1.517 -0.321 0 O-C-N 122.095 -0.378 . . . . 0.0 110.98 -176.121 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.584 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 49.7 Cg_endo -76.11 105.79 2.14 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 121.502 1.468 . . . . 0.0 111.707 166.4 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.64 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -93.42 -161.68 0.87 Allowed 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 175.364 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.647 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 68.6 mttm -138.07 -170.94 2.9 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.801 176.096 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.991 ' H ' ' HD2' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -84.7 25.26 0.93 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.384 0.612 . . . . 0.0 109.913 -179.533 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 158.78 41.6 0.02 OUTLIER Glycine 0 N--CA 1.436 -1.353 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.898 -177.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.684 ' CD ' ' HG ' ' A' ' 150' ' ' LEU . 1.8 pp20? -84.7 170.04 13.68 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 173.299 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.438 HG13 ' CZ ' ' A' ' 129' ' ' ARG . 1.1 mp -111.78 128.54 68.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 118.453 0.569 . . . . 0.0 109.62 170.061 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.773 ' CD2' ' HA ' ' A' ' 165' ' ' ASN . 82.1 mt -119.42 155.95 31.05 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -172.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.595 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 62.0 t -123.51 120.22 59.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 172.132 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 1.122 HD13 ' HB2' ' A' ' 163' ' ' ALA . 25.8 mm -79.79 82.34 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.675 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.825 ' HA ' HD13 ' A' ' 118' ' ' LEU . 14.3 tt -72.21 -33.72 47.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-N 114.203 -1.362 . . . . 0.0 108.904 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.707 ' OE2' HG12 ' A' ' 153' ' ' ILE . 3.4 mp0 -125.86 143.61 51.0 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.046 176.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.587 ' HD2' ' HG ' ' A' ' 125' ' ' LEU . 83.1 tttt -136.08 87.82 23.12 Favored Pre-proline 0 C--N 1.316 -0.858 0 CA-C-O 121.108 0.48 . . . . 0.0 109.76 171.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 1.086 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 8.0 Cg_exo -76.35 -50.52 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.787 2.324 . . . . 0.0 112.112 174.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.651 ' HG2' ' CE ' ' A' ' 172' ' ' MET . 5.4 mm-40 -102.21 173.31 6.43 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.113 -173.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.515 ' O ' HG21 ' A' ' 175' ' ' VAL . 8.7 tp10 -104.83 -17.93 14.41 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 175.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -99.99 -17.0 17.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.314 174.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.463 ' HB2' ' HE1' ' A' ' 172' ' ' MET . 73.1 m95 -130.26 125.35 34.61 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.735 178.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' TRP . . . . . 0.749 ' HB3' HD12 ' A' ' 152' ' ' ILE . 50.0 m0 -112.81 135.81 53.14 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.021 0.438 . . . . 0.0 110.437 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.615 ' OG ' ' HG2' ' A' ' 172' ' ' MET . 70.5 m -93.31 92.93 7.92 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -174.355 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 1.122 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -109.45 146.78 33.96 Favored 'General case' 0 N--CA 1.415 -2.194 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -172.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.784 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 12.3 ptt180 -88.16 127.21 35.43 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 174.152 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 1.098 ' HB2' HD11 ' A' ' 142' ' ' LEU . 63.5 t30 -59.41 179.94 0.1 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.103 -1.408 . . . . 0.0 111.793 -170.134 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.434 ' HD3' ' H ' ' A' ' 149' ' ' ILE . 48.9 tptt -56.74 -20.88 24.37 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.52 167.601 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -79.88 -30.71 40.23 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.843 172.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.521 ' C ' ' HB2' ' A' ' 164' ' ' ARG . . . 101.53 7.95 47.43 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.064 -174.024 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.784 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -77.97 132.11 37.7 Favored 'General case' 0 C--O 1.217 -0.625 0 C-N-CA 122.646 0.378 . . . . 0.0 111.222 177.243 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.461 HG22 HG21 ' A' ' 153' ' ' ILE . 47.9 t -82.43 125.47 39.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.634 -179.067 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -159.17 152.39 23.4 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 121.042 -0.599 . . . . 0.0 111.965 173.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.651 ' CE ' ' HG2' ' A' ' 157' ' ' GLU . 35.9 mtp -77.5 142.96 38.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.893 0.346 . . . . 0.0 110.704 -178.474 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.69 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.7 pp -142.45 144.93 32.67 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.019 -175.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.453 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 22.8 Cg_exo -65.05 129.94 24.41 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 122.834 2.356 . . . . 0.0 113.004 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.643 ' O ' HG22 ' A' ' 178' ' ' VAL . 58.0 t -64.87 -41.6 56.75 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 18.6 Cg_endo -61.29 -6.8 7.23 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 121.858 1.705 . . . . 0.0 112.748 176.204 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.453 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.2 m-30 -95.53 -9.23 32.96 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.814 -178.363 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 175' ' ' VAL . 4.3 m -105.04 -171.98 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 -166.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.648 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 6.7 tp10 -159.15 49.6 0.34 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 112.678 -2.056 . . . . 0.0 111.812 -153.286 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.868 ' HG3' HG22 ' A' ' 128' ' ' VAL . 3.2 mppt? -69.66 136.13 50.74 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 119.603 -1.935 . . . . 0.0 111.081 -160.223 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.732 HD13 ' CZ ' ' A' ' 129' ' ' ARG . 14.6 tp -72.21 -76.67 0.11 Allowed 'General case' 0 CA--C 1.523 -0.096 0 CA-C-N 113.207 -1.815 . . . . 0.0 110.655 -168.235 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 5.7 m -101.08 105.24 17.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.179 -0.918 . . . . 0.0 109.263 175.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -164.36 -49.06 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.269 -175.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 41.7 m 59.56 91.18 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.567 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.714 ' HB3' ' HD2' ' A' ' 186' ' ' PRO . 1.0 OUTLIER -65.11 176.74 0.74 Allowed Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.749 -174.504 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.714 ' HD2' ' HB3' ' A' ' 185' ' ' SER . 2.3 Cg_endo -46.29 119.85 3.35 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.932 2.421 . . . . 0.0 112.409 173.495 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -137.71 -174.33 3.74 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -73.86 65.52 1.83 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.975 175.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 97.3 mttt 61.94 98.09 0.03 OUTLIER 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.57 0.7 . . . . 0.0 111.067 -176.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -103.29 162.43 13.0 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.757 -176.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -171.03 108.84 0.3 Allowed Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.267 178.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -64.29 -60.4 3.23 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 175.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 72.9 mtt180 -129.66 -7.58 4.58 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.333 -0.848 . . . . 0.0 108.8 168.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 66.9 t30 56.11 70.06 0.68 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.033 -166.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 13.0 m -72.86 -33.97 66.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.68 -172.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -161.32 -177.23 5.87 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -174.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' SER . . . . . 0.425 ' HA ' ' CG2' ' A' ' 200' ' ' ILE . 22.9 t 80.0 29.23 0.27 Allowed 'General case' 0 CA--C 1.531 0.233 0 O-C-N 123.91 0.756 . . . . 0.0 111.199 176.332 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -84.83 -40.66 16.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.323 177.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -137.6 36.15 1.98 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.909 -177.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.425 ' CG2' ' HA ' ' A' ' 197' ' ' SER . 6.2 tp -128.03 97.72 28.74 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 121.334 0.588 . . . . 0.0 111.007 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -73.62 -59.33 0.05 OUTLIER 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 123.344 2.696 . . . . 0.0 112.794 178.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -68.95 120.85 79.05 Favored Pre-proline 0 N--CA 1.463 0.215 0 CA-C-O 120.574 0.226 . . . . 0.0 110.98 -177.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -83.85 178.43 5.44 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.684 2.256 . . . . 0.0 112.129 177.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -77.95 84.26 4.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.102 0.477 . . . . 0.0 110.51 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 69.8 t60 -121.21 141.23 51.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.037 -177.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -72.12 106.66 4.43 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 177.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -74.5 159.89 31.64 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.094 -175.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -156.14 130.92 9.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.719 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -100.33 145.51 30.39 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.305 -0.407 . . . . 0.0 109.966 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.09 105.37 0.68 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.737 2.291 . . . . 0.0 111.395 174.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -83.62 -34.58 25.07 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.299 -173.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 2.7 m -134.25 112.8 11.36 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.26 -175.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 28.6 m -112.97 -80.17 0.59 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 175.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 7.6 p -144.8 94.37 5.46 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-O 120.976 0.417 . . . . 0.0 111.544 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -71.98 -39.37 3.26 Favored 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 122.279 1.986 . . . . 0.0 112.128 174.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 50.0 tp 58.95 90.06 0.1 OUTLIER Pre-proline 0 N--CA 1.464 0.238 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.798 -177.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.34 -67.95 0.05 OUTLIER 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 122.711 2.274 . . . . 0.0 112.434 -178.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -161.26 159.74 29.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.576 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 4.9 m -98.94 96.05 4.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.545 0.688 . . . . 0.0 110.684 178.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 16.0 m -94.82 99.96 11.93 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.642 -178.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 130.7 -167.46 22.14 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 -178.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.417 ' HA ' ' HD2' ' A' ' 223' ' ' PRO . 68.9 p 51.52 94.55 0.05 OUTLIER Pre-proline 0 N--CA 1.467 0.404 0 C-N-CA 123.753 0.821 . . . . 0.0 111.597 -178.429 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 222' ' ' SER . 11.1 Cg_endo -54.38 106.92 0.19 Allowed 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.182 2.588 . . . . 0.0 112.78 -176.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -106.84 49.59 0.86 Allowed Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 178.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -149.85 175.45 11.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.54 -0.33 . . . . 0.0 110.338 -176.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -78.72 89.98 4.61 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.16 0.505 . . . . 0.0 110.345 177.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.768 ' H ' HD13 ' A' ' 227' ' ' ILE . 0.2 OUTLIER -96.48 4.37 9.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.586 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.458 ' HA ' ' HD3' ' A' ' 229' ' ' PRO . 4.6 p -84.28 142.56 40.92 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.369 -178.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 228' ' ' THR . 13.1 Cg_exo -71.02 176.76 7.27 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.872 2.381 . . . . 0.0 112.025 177.179 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.526 HD12 ' HD2' ' A' ' 231' ' ' PRO . 24.4 tp -147.77 141.99 16.2 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.622 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.526 ' HD2' HD12 ' A' ' 230' ' ' LEU . 87.1 Cg_exo -47.98 144.31 12.21 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.529 2.153 . . . . 0.0 111.235 171.116 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.3 89.49 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.552 0.692 . . . . 0.0 112.786 -171.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 8.7 p -141.76 86.83 2.02 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.608 174.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -82.25 25.32 0.61 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.61 -169.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -83.4 -16.72 44.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.509 0.671 . . . . 0.0 109.266 171.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -97.64 -79.34 1.46 Allowed Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.556 176.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -92.1 116.41 0.4 Allowed 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 122.976 2.45 . . . . 0.0 112.029 175.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 22.9 t -89.63 145.32 7.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.507 ' HB2' ' HG3' ' A' ' 296' ' ' PRO . 84.7 m-85 -108.78 119.72 40.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.077 0.465 . . . . 0.0 111.105 -177.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.579 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -119.66 140.93 49.86 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.691 178.086 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.515 ' HB2' ' CE1' ' A' ' 294' ' ' PHE . 47.5 tttp -95.07 123.44 38.56 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 242' ' ' ALA . . . . . 0.505 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -71.44 102.77 2.74 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.29 -0.414 . . . . 0.0 109.961 -179.457 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 2.3 pp -82.27 -5.56 9.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.923 0.392 . . . . 0.0 111.972 -174.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.445 ' HG2' ' H ' ' A' ' 245' ' ' LYS . 21.5 tt0 -146.95 164.32 33.33 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 176.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.445 ' H ' ' HG2' ' A' ' 244' ' ' GLN . 45.1 mttp -61.37 149.66 37.58 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 176.228 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.588 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 24.3 tpt180 -137.62 94.81 2.96 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 169.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 34.4 m -101.2 152.94 38.03 Favored Pre-proline 0 C--N 1.315 -0.919 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.709 -176.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.408 ' HD3' ' HB2' ' A' ' 257' ' ' ALA . 71.8 Cg_endo -74.53 -161.2 0.11 Allowed 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.424 2.083 . . . . 0.0 111.816 177.248 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 34.9 t -151.05 -179.22 7.13 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -175.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -64.37 -34.01 77.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.671 0.272 . . . . 0.0 111.254 -178.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -95.55 11.19 33.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.399 -179.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.33 131.96 47.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.505 0.669 . . . . 0.0 112.638 -175.222 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 253' ' ' LYS . . . . . 0.419 ' HE3' ' HB3' ' A' ' 253' ' ' LYS . 6.3 ptpp? -150.53 0.46 0.43 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.663 167.34 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 1.2 p -144.88 14.85 1.54 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.304 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -101.59 117.86 35.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.137 0.494 . . . . 0.0 110.494 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.423 HD21 ' HB ' ' A' ' 279' ' ' VAL . 0.7 OUTLIER -78.59 134.68 37.18 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.178 -178.228 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.588 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -93.9 121.22 35.14 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.201 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.539 ' HB2' ' HB3' ' A' ' 246' ' ' ARG . 79.9 mt -123.73 152.68 41.86 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.041 -175.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -102.47 177.74 4.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.038 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 59.2 t -90.18 111.83 23.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.195 0.521 . . . . 0.0 110.551 -179.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 98.39 9.18 53.85 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.188 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -82.84 166.4 19.0 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -175.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 33.5 mm -104.67 110.82 31.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.255 0.55 . . . . 0.0 110.281 -177.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.489 HG22 HD22 ' A' ' 258' ' ' LEU . 14.0 t -96.44 108.75 21.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.806 -177.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 38.4 tttt -83.3 105.31 14.15 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.728 175.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.437 HG21 ' HB3' ' A' ' 275' ' ' TRP . 4.3 p -99.22 117.17 43.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.496 0.665 . . . . 0.0 110.605 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 12.1 m -94.94 -25.23 16.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.844 -176.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 268' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 268' ' ' ARG . 36.6 ttm180 -132.2 108.22 9.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.007 0.432 . . . . 0.0 110.954 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 32.1 mtt -94.75 126.95 40.4 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.657 178.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 274' ' ' GLN . 56.5 m-80 -99.9 153.56 19.06 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 177.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.585 HD12 ' H ' ' A' ' 271' ' ' ILE . 4.3 mp -72.73 -34.48 47.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.147 -172.005 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -62.67 -26.4 68.63 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.742 -176.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 127.92 -26.93 4.7 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.35 -0.929 . . . . 0.0 112.637 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.478 ' O ' ' HB2' ' A' ' 270' ' ' ASN . 45.3 mt-30 -78.92 115.5 18.65 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 177.344 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.517 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 49.9 m0 -96.24 150.9 20.03 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.816 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.44 ' HA ' ' O ' ' A' ' 284' ' ' GLY . 43.6 tt0 -108.93 109.58 20.69 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 175.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 277' ' ' GLY . . . . . 0.555 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -122.16 155.36 16.83 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.841 -178.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.572 ' HG2' ' HB3' ' A' ' 283' ' ' LYS . 23.2 mt-10 -104.58 109.0 20.73 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 279' ' ' VAL . . . . . 0.423 ' HB ' HD21 ' A' ' 256' ' ' LEU . 46.9 t -121.92 114.5 43.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -178.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 32.4 m120 64.77 27.6 13.0 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.896 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 90.01 -10.78 72.83 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.417 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 44.5 ttt-85 -102.35 118.55 37.12 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.572 ' HB3' ' HG2' ' A' ' 278' ' ' GLU . 57.3 pttt -109.82 141.95 41.78 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.094 0.473 . . . . 0.0 111.188 179.21 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 284' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 276' ' ' GLU . . . -167.21 -174.79 36.68 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 -179.077 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.517 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 68.8 mt -90.2 138.66 31.34 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.162 0.506 . . . . 0.0 111.252 -177.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.446 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 46.1 p90 -142.74 131.58 11.69 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.711 173.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 287' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 17.6 Cg_exo -69.06 139.2 42.03 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 122.902 2.401 . . . . 0.0 111.822 177.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -65.57 -4.64 6.36 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.663 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 2.4 m -74.42 -22.82 58.96 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.933 0.397 . . . . 0.0 111.088 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 41.0 m-70 -94.12 -11.58 30.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.848 0.356 . . . . 0.0 111.149 -176.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.505 HG12 ' HA ' ' A' ' 242' ' ' ALA . 34.8 m -128.02 167.5 22.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.057 -178.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -140.9 128.47 21.4 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.848 0.356 . . . . 0.0 110.727 175.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.579 HD13 ' HB2' ' A' ' 240' ' ' ALA . 41.0 mm -67.83 126.54 27.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.241 177.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 294' ' ' PHE . . . . . 0.515 ' CE1' ' HB2' ' A' ' 241' ' ' LYS . 1.4 p90 -141.14 -179.59 6.19 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.504 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -101.6 96.09 5.96 Favored Pre-proline 0 C--N 1.322 -0.628 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 296' ' ' PRO . . . . . 0.507 ' HG3' ' HB2' ' A' ' 239' ' ' PHE . 43.0 Cg_endo -69.24 -46.26 1.52 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.604 2.203 . . . . 0.0 113.112 -173.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 297' ' ' GLN . . . . . 0.477 ' OE1' ' HA ' ' A' ' 297' ' ' GLN . 6.3 tp60 -90.76 89.5 7.52 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.29 0.567 . . . . 0.0 109.924 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -121.43 113.84 32.0 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.406 176.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 299' ' ' PRO . . . . . 0.556 ' HA ' ' HB3' ' A' ' 302' ' ' ASN . 43.8 Cg_exo -57.56 -17.98 30.47 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 123.256 2.638 . . . . 0.0 112.104 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -54.81 -37.59 66.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.117 177.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -105.88 11.41 31.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.885 0.374 . . . . 0.0 110.832 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 302' ' ' ASN . . . . . 0.556 ' HB3' ' HA ' ' A' ' 299' ' ' PRO . 18.7 t-20 -113.27 -26.62 8.3 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.869 -176.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 . . . . . 0 C--O 1.245 0.836 0 CA-C-O 118.723 -0.656 . . . . 0.0 109.731 176.44 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.0 mtt . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.7 p -103.58 127.63 50.97 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 174.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.547 ' HB2' HD12 ' A' ' 99' ' ' ILE . 13.7 p -55.53 -44.63 76.87 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.985 -175.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.98 110.76 4.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.378 177.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.548 ' CZ ' ' HA ' ' A' ' 5' ' ' ARG . 3.6 mmp_? -115.25 -5.72 12.38 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -172.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.435 ' H ' ' HD1' ' A' ' 6' ' ' PHE . 6.3 p90 -79.25 155.41 28.58 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.476 -174.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -66.24 -36.29 82.63 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.574 -176.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.1 t 65.39 37.88 6.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.335 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.8 m -152.34 -33.05 0.13 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.278 177.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -77.56 113.93 15.88 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.98 0.419 . . . . 0.0 111.285 -173.072 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -57.72 -45.35 85.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.201 -175.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 51.1 m -71.74 1.67 6.5 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -91.06 -42.07 10.71 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.601 176.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 22.4 p-90 -122.73 -29.07 4.07 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -174.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -77.71 103.2 7.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.808 0.337 . . . . 0.0 111.554 -173.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.468 ' HB3' HG21 ' A' ' 19' ' ' VAL . 23.6 mmt -87.28 -6.53 58.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.288 -176.283 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 49.93 -115.54 3.17 Favored Glycine 0 CA--C 1.52 0.359 0 CA-C-N 115.629 -0.714 . . . . 0.0 113.306 -178.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.58 99.78 1.26 Allowed 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 122.475 2.116 . . . . 0.0 112.535 -176.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.62 HG13 ' HB3' ' A' ' 23' ' ' GLU . 3.5 t -130.11 -70.49 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-O 118.243 -0.884 . . . . 0.0 111.73 -176.162 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 19' ' ' VAL . 22.9 t 108.46 161.32 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.126 1.371 . . . . 0.0 109.219 173.384 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 34.0 ttt85 -64.89 -38.81 92.23 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.801 0.334 . . . . 0.0 110.241 -177.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -64.9 -34.26 77.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.429 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.62 ' HB3' HG13 ' A' ' 19' ' ' VAL . 0.4 OUTLIER -84.21 -53.13 5.72 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.801 -174.565 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.503 ' HB2' ' HD3' ' A' ' 39' ' ' ARG . . . -56.05 -40.95 74.3 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.782 -178.288 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.58 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 55.0 tp60 -62.42 -44.53 96.22 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.569 -178.299 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.485 HG22 ' O ' ' A' ' 23' ' ' GLU . 9.1 t -75.69 -15.49 60.3 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 120.818 0.342 . . . . 0.0 111.055 -177.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.53 ' HG2' ' O ' ' A' ' 23' ' ' GLU . 52.2 mmm-85 -76.96 -19.59 57.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.922 0.392 . . . . 0.0 110.357 176.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.635 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 78.1 mt -128.84 -13.1 4.7 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -173.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.58 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -66.21 107.61 2.01 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.844 0.354 . . . . 0.0 110.757 -173.789 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.3 -2.24 67.2 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.822 -0.704 . . . . 0.0 113.331 175.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -78.31 -175.05 4.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.728 0.264 . . . . 0.0 110.587 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.606 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 12.4 ttp180 -52.68 131.02 34.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.334 0.588 . . . . 0.0 110.827 -179.428 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.59 ' HB3' ' OE1' ' A' ' 54' ' ' GLU . 43.6 m170 -82.03 145.1 30.4 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.407 -175.045 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.35 -12.91 48.02 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 111.606 -0.597 . . . . 0.0 111.606 -176.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.606 ' SD ' ' HB3' ' A' ' 32' ' ' ARG . 11.6 mtp -81.55 141.47 33.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.687 0.28 . . . . 0.0 110.737 178.457 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.504 ' HB2' HG22 ' A' ' 52' ' ' VAL . 33.1 p90 -143.24 167.43 22.15 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.691 -178.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.463 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.4 pp -158.08 138.52 12.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.155 0.503 . . . . 0.0 111.453 175.428 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.411 HG22 HD13 ' A' ' 50' ' ' LEU . 48.3 t -102.94 120.8 53.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 174.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.503 ' HD3' ' HB2' ' A' ' 24' ' ' ALA . 23.8 ptt-85 -125.94 -169.45 2.01 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.639 0.257 . . . . 0.0 110.71 -175.083 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -68.9 140.49 55.14 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.829 177.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.4 t -86.23 104.66 15.98 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 167.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.9 m -71.65 -11.4 60.82 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.378 -177.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 16.9 p -84.59 -29.74 25.57 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.996 0.427 . . . . 0.0 110.261 176.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 52.4 t -151.34 95.37 3.34 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.017 178.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -58.06 113.9 1.73 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.922 2.415 . . . . 0.0 112.066 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 130.37 -33.04 2.97 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -174.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.595 ' OD2' ' HA ' ' A' ' 64' ' ' ASN . 2.6 m-20 -88.42 175.86 7.43 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 170.082 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.535 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 44.1 m-85 -136.17 175.58 9.47 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.407 -175.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.2 t -142.46 106.71 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.926 0.393 . . . . 0.0 110.67 176.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.411 HD13 HG22 ' A' ' 38' ' ' VAL . 46.7 tp -80.97 103.76 11.01 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.389 176.406 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.1 m -96.45 126.66 41.79 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 176.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 95.4 t -121.76 135.89 60.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.754 -175.176 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.635 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 23.4 t -95.88 114.75 26.51 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -175.44 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.602 ' HG3' HD22 ' A' ' 55' ' ' ASN . 9.4 tp10 -151.48 154.7 37.08 Favored 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 119.53 -0.868 . . . . 0.0 108.999 164.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.602 HD22 ' HG3' ' A' ' 54' ' ' GLU . 0.5 OUTLIER 45.4 37.52 3.01 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.537 0.735 . . . . 0.0 112.701 -177.666 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 34.5 m 49.38 56.09 8.35 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 122.403 1.097 . . . . 0.0 109.459 -178.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.523 ' HB2' ' O ' ' A' ' 55' ' ' ASN . 1.5 tmm_? -165.67 64.32 0.11 Allowed 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 113.312 -1.767 . . . . 0.0 109.33 -152.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 14.1 t -72.3 106.33 2.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.961 0.886 . . . . 0.0 110.353 -169.209 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.4 m -76.64 122.49 24.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 113.899 -1.5 . . . . 0.0 111.31 -177.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -95.55 102.37 14.17 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.107 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.674 ' OH ' ' HB3' ' A' ' 93' ' ' LEU . 70.8 m-85 -97.35 109.26 22.05 Favored 'General case' 0 C--O 1.221 -0.396 0 C-N-CA 123.079 0.552 . . . . 0.0 110.667 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.559 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 59.2 mt -80.03 128.88 38.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -173.304 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.629 HG23 ' HB3' ' A' ' 71' ' ' PHE . 3.1 mp -99.7 111.08 28.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.707 177.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.595 ' HA ' ' OD2' ' A' ' 47' ' ' ASP . 15.9 m120 -83.94 133.81 34.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.944 178.137 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.2 t -89.16 95.79 10.45 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.555 HD11 ' HB2' ' A' ' 72' ' ' LYS . 83.6 mt -81.07 147.79 62.25 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.247 -176.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -76.77 -9.38 18.3 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.932 2.421 . . . . 0.0 112.877 -179.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 35.2 p30 -81.19 7.85 10.25 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.575 0.702 . . . . 0.0 109.322 171.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.741 ' NE ' ' HA ' ' A' ' 69' ' ' ARG . 3.4 tpm_? 61.64 58.27 2.06 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.125 -1.398 . . . . 0.0 110.981 -176.529 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.873 ' HG2' ' HA ' ' A' ' 79' ' ' ASP . 79.4 mtt180 -135.41 176.73 8.41 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.24 172.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.629 ' HB3' HG23 ' A' ' 63' ' ' ILE . 52.2 m-85 -130.48 113.51 14.38 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.021 0.438 . . . . 0.0 109.83 176.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.593 ' HE2' ' HA ' ' A' ' 75' ' ' ASP . 36.0 tttm -98.19 105.02 17.1 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.981 -173.092 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.687 HD13 ' CE2' ' A' ' 88' ' ' TYR . 16.3 tt -81.0 79.35 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 122.18 0.99 . . . . 0.0 111.0 -176.56 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.78 -10.36 18.97 Favored Glycine 0 CA--C 1.52 0.378 0 CA-C-N 115.004 -0.998 . . . . 0.0 113.87 176.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.593 ' HA ' ' HE2' ' A' ' 72' ' ' LYS . 8.7 t70 177.28 -68.71 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 116.944 0.372 . . . . 0.0 110.321 -170.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -66.35 123.64 20.52 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.921 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.445 ' O ' ' HG3' ' A' ' 77' ' ' GLU . 13.7 pt-20 -93.62 105.25 17.31 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.734 0.778 . . . . 0.0 110.728 177.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.478 ' CZ ' ' CD1' ' A' ' 87' ' ' PHE . 84.1 m-85 -95.03 152.25 18.48 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 174.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.873 ' HA ' ' HG2' ' A' ' 70' ' ' ARG . 8.3 m-20 -67.99 -23.24 65.0 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -171.338 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.624 ' ND1' ' HG2' ' A' ' 82' ' ' PRO . 6.0 p80 -162.36 165.47 26.44 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.736 -0.211 . . . . 0.0 110.438 -178.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.547 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 10.0 mt -55.99 -54.89 47.32 Favored Pre-proline 0 CA--C 1.535 0.377 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -178.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.624 ' HG2' ' ND1' ' A' ' 80' ' ' HIS . 15.4 Cg_endo -61.12 -4.17 3.65 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.183 1.922 . . . . 0.0 113.796 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.412 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -89.87 -34.94 15.91 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.762 0.315 . . . . 0.0 110.769 178.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.1 pp -76.94 -30.96 56.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.135 0.493 . . . . 0.0 109.838 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 70.1 mt -68.43 -21.56 64.65 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.491 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.548 ' OE2' ' HD2' ' A' ' 89' ' ' LYS . 18.8 tp10 -85.81 -35.43 20.68 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.183 176.598 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.547 ' HE1' ' CZ ' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -71.56 -19.54 62.14 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.333 0.587 . . . . 0.0 111.436 -179.815 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.687 ' CE2' HD13 ' A' ' 73' ' ' ILE . 38.7 m-85 -94.96 5.47 51.83 Favored 'General case' 0 C--N 1.313 -0.98 0 O-C-N 121.685 -0.634 . . . . 0.0 111.769 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.548 ' HD2' ' OE2' ' A' ' 86' ' ' GLU . 96.2 mttt -77.52 -25.91 50.64 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.685 171.389 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.596 HD13 ' H ' ' A' ' 90' ' ' ILE . 0.3 OUTLIER -106.32 -17.67 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 CA-C-O 121.41 0.624 . . . . 0.0 109.756 174.148 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.489 ' HB2' ' O ' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -93.97 106.41 18.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.78 178.771 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -72.46 104.23 3.74 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.756 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.713 ' O ' ' HB3' ' A' ' 154' ' ' GLU . 16.5 mt -59.43 -31.02 68.9 Favored 'General case' 0 C--O 1.215 -0.757 0 O-C-N 124.356 1.035 . . . . 0.0 111.431 -176.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.483 ' HB3' ' HA ' ' A' ' 154' ' ' GLU . 24.5 p-10 -176.18 85.47 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.883 0.849 . . . . 0.0 110.532 164.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 71.78 -19.18 0.27 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.592 -175.266 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 97' ' ' THR . 18.0 m -132.49 146.03 51.62 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 120.968 0.413 . . . . 0.0 110.625 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.44 ' O ' HG22 ' A' ' 96' ' ' THR . 37.4 p -96.16 -178.17 4.24 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.533 178.199 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.468 HD22 ' CD2' ' A' ' 36' ' ' PHE . 96.1 mt -70.84 106.3 3.55 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 174.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.547 HD12 ' HB2' ' A' ' 3' ' ' SER . 46.4 mm -89.86 -63.07 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.189 0.519 . . . . 0.0 110.422 -177.343 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.585 ' O ' ' HA ' ' A' ' 35' ' ' MET . 11.2 pt-20 -157.69 151.5 19.51 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.426 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.6 155.55 68.55 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.274 1.983 . . . . 0.0 112.362 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.563 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -69.07 146.56 97.25 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.476 179.095 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -57.61 130.92 41.25 Favored 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 122.618 2.212 . . . . 0.0 112.951 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -87.28 -31.76 20.07 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 172.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -115.35 147.41 38.59 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.04 175.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.55 -8.71 15.79 Favored 'Trans proline' 0 CA--C 1.529 0.256 0 C-N-CA 122.853 2.368 . . . . 0.0 112.88 -177.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 35.6 m 54.8 67.44 3.26 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.639 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.415 ' HB2' ' HD3' ' A' ' 109' ' ' PRO . 51.3 Cg_exo -53.3 -44.62 47.45 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 123.002 2.468 . . . . 0.0 114.147 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.415 ' HD3' ' HB2' ' A' ' 108' ' ' PRO . 32.1 Cg_exo -61.57 -22.55 74.74 Favored 'Trans proline' 0 C--N 1.362 1.263 0 C-N-CA 121.956 1.771 . . . . 0.0 112.56 176.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 54.2 ttm -89.91 68.2 7.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.43 0.633 . . . . 0.0 109.869 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -82.37 94.59 1.71 Allowed Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.502 178.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.1 p -149.25 168.7 22.57 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.584 0.23 . . . . 0.0 110.81 -176.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.3 p -113.62 107.51 23.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.493 0.663 . . . . 0.0 109.809 176.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.445 ' OG ' ' HD3' ' A' ' 32' ' ' ARG . 21.0 t -91.93 113.8 26.16 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.145 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -109.89 103.72 53.97 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.446 178.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -70.4 135.11 28.17 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.288 1.992 . . . . 0.0 111.852 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -70.22 143.45 52.18 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.225 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.7 mp 58.83 78.06 0.37 Allowed Pre-proline 0 N--CA 1.462 0.168 0 O-C-N 123.925 0.766 . . . . 0.0 110.82 -178.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -59.9 -74.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.119 1.879 . . . . 0.0 110.847 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.596 HG22 ' HB2' ' A' ' 122' ' ' GLU . 19.7 m 52.34 77.15 0.16 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 171.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -81.1 74.91 8.09 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 170.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.596 ' HB2' HG22 ' A' ' 120' ' ' THR . 7.4 tp10 -89.86 -32.56 16.83 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.293 -168.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.8 t70 61.02 -152.78 0.38 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -171.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 64.87 -170.62 0.19 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 118.278 0.49 . . . . 0.0 111.228 176.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.865 HD12 HG21 ' A' ' 152' ' ' ILE . 4.3 mm? 60.45 95.83 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.652 0.739 . . . . 0.0 110.814 178.376 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.71 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 4.9 tp10 -165.61 -74.28 0.03 OUTLIER 'General case' 0 C--O 1.218 -0.554 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.028 -169.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -108.17 110.95 22.71 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.036 0.446 . . . . 0.0 110.296 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.821 HG22 ' HG3' ' A' ' 180' ' ' LYS . 86.4 t -125.87 136.65 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.647 176.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.683 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 5.6 ptp180 -112.13 147.16 36.71 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 117.41 -1.716 . . . . 0.0 108.474 169.334 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.599 HG22 HG12 ' A' ' 178' ' ' VAL . 7.6 p -99.72 135.56 40.96 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.628 177.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.594 HD21 ' HG2' ' A' ' 179' ' ' GLU . 14.3 mt -108.41 3.0 22.8 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -177.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.449 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 27.0 t80 -99.94 -43.34 6.42 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.494 -0.483 . . . . 0.0 112.112 -174.174 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.669 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 14.5 t70 73.04 96.85 0.07 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.513 0.673 . . . . 0.0 109.888 -171.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.538 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 44.2 t80 -129.14 90.06 46.37 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 174.503 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.59 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 92.7 Cg_endo -90.52 84.35 0.4 Allowed 'Trans proline' 0 N--CA 1.436 -1.862 0 C-N-CA 121.914 1.743 . . . . 0.0 112.358 -178.11 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -78.67 -2.37 85.31 Favored Glycine 0 C--N 1.329 0.191 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.217 176.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.456 ' H ' ' HB3' ' A' ' 143' ' ' PRO . 19.0 m120 36.16 71.04 0.14 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 113.872 -1.164 . . . . 0.0 112.461 -175.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.594 ' HB3' ' H ' ' A' ' 141' ' ' ASP . 0.4 OUTLIER -132.7 -176.59 4.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.22 0.533 . . . . 0.0 111.317 -177.394 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -112.17 1.75 16.37 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 167.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -115.41 -44.4 2.98 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.296 175.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.594 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 9.7 m-20 -98.36 127.61 44.37 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 166.226 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 1.038 HD11 ' HB2' ' A' ' 165' ' ' ASN . 24.6 tp -81.88 130.7 59.68 Favored Pre-proline 0 CA--C 1.518 -0.254 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.283 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.619 ' HD2' HD12 ' A' ' 142' ' ' LEU . 72.0 Cg_endo -84.0 92.04 0.82 Allowed 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.121 1.881 . . . . 0.0 112.292 174.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.538 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 1.5 p90 -90.89 179.73 5.69 Favored 'General case' 0 CA--C 1.504 -0.799 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.817 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.669 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 16.3 mtpp -122.05 -176.6 3.38 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.294 172.378 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.757 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -78.65 36.78 0.27 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.798 0.809 . . . . 0.0 110.852 -174.635 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 145' ' ' LYS . . . 151.66 42.75 0.02 OUTLIER Glycine 0 N--CA 1.433 -1.554 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.32 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.84 147.11 27.68 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 119.352 -0.939 . . . . 0.0 109.993 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.6 mp -87.26 125.76 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.868 -177.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.77 HD22 ' CD2' ' A' ' 142' ' ' LEU . 33.8 mt -122.18 158.11 30.1 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -176.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.71 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 61.8 t -120.08 121.49 65.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 175.117 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 1.043 HD13 ' HB2' ' A' ' 163' ' ' ALA . 38.0 mm -77.18 79.31 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 CA-C-O 122.183 0.992 . . . . 0.0 108.682 -177.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.572 HD12 ' HD3' ' A' ' 164' ' ' ARG . 16.7 tt -71.43 -32.87 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 CA-C-N 113.856 -1.52 . . . . 0.0 109.09 -177.081 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.713 ' HB3' ' O ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -123.35 140.27 53.18 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.604 171.909 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -127.73 88.46 53.37 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 167.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.616 ' HG2' ' HE3' ' A' ' 172' ' ' MET . 0.9 OUTLIER -81.74 -46.75 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.224 2.616 . . . . 0.0 111.71 177.678 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.487 ' HB2' ' O ' ' A' ' 160' ' ' TRP . 33.8 mm-40 -102.94 161.67 13.57 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.928 -176.198 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -88.96 -27.41 20.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.452 0.644 . . . . 0.0 109.338 172.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -94.12 -18.76 21.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.249 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.651 ' HB3' ' HE1' ' A' ' 172' ' ' MET . 48.5 m95 -130.24 131.45 45.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.132 -178.02 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' TRP . . . . . 0.72 ' HB3' HD12 ' A' ' 152' ' ' ILE . 50.5 m0 -119.4 135.15 54.87 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -178.198 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.58 ' OG ' ' HG2' ' A' ' 172' ' ' MET . 21.6 m -99.6 95.0 6.68 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -174.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 1.043 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -104.03 147.21 27.65 Favored 'General case' 0 N--CA 1.418 -2.037 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.075 -174.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.752 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 24.5 ptt-85 -86.44 123.24 31.44 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 175.243 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 1.038 ' HB2' HD11 ' A' ' 142' ' ' LEU . 6.1 t30 -55.09 172.04 0.13 Allowed 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 113.151 -1.841 . . . . 0.0 110.416 -172.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 36.5 tttp -58.21 -12.68 3.82 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.227 0.537 . . . . 0.0 110.039 174.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -83.5 -45.76 13.22 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.71 172.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 130.24 -9.62 5.93 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.959 -173.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.752 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.1 OUTLIER -62.56 132.47 52.53 Favored 'General case' 0 C--O 1.216 -0.703 0 C-N-CA 123.712 0.805 . . . . 0.0 112.373 179.489 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.442 HG22 HG21 ' A' ' 153' ' ' ILE . 78.8 t -85.81 122.25 38.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 O-C-N 122.462 -0.149 . . . . 0.0 110.906 177.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 162' ' ' SER . . . -153.59 149.37 20.85 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.55 172.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.651 ' HE1' ' HB3' ' A' ' 160' ' ' TRP . 7.0 mtp -77.51 142.42 39.1 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.712 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.8 pp -143.77 144.94 28.94 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.42 -178.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.483 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 21.7 Cg_exo -65.01 133.47 35.9 Favored 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 122.854 2.369 . . . . 0.0 113.181 -178.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.485 ' O ' HG22 ' A' ' 178' ' ' VAL . 60.2 t -63.24 -42.02 72.66 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 177.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.409 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 36.3 Cg_exo -62.3 1.32 0.98 Allowed 'Trans proline' 0 C--N 1.359 1.097 0 C-N-CA 122.164 1.91 . . . . 0.0 113.172 176.224 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.483 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.1 m-85 -103.16 -12.78 17.11 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.506 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.669 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 3.8 m -105.83 -172.82 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 -166.389 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.683 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 7.5 tp10 -160.23 50.97 0.3 Allowed 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 113.004 -1.907 . . . . 0.0 112.271 -152.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.821 ' HG3' HG22 ' A' ' 128' ' ' VAL . 2.2 mppt? -69.2 137.45 53.25 Favored 'General case' 0 N--CA 1.462 0.161 0 O-C-N 119.706 -1.871 . . . . 0.0 111.319 -159.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.697 ' HG ' HG23 ' A' ' 182' ' ' VAL . 13.0 tp -96.14 121.0 37.43 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 112.634 -2.076 . . . . 0.0 111.016 -170.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' VAL . . . . . 0.697 HG23 ' HG ' ' A' ' 181' ' ' LEU . 4.7 t 44.36 64.94 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 O-C-N 124.009 0.818 . . . . 0.0 111.649 175.26 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 3.9 ttp180 -87.37 146.88 25.7 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.925 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.499 ' HB3' ' HB2' ' A' ' 190' ' ' HIS . 0.3 OUTLIER -80.16 48.1 0.97 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.968 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 185' ' ' SER . . . . . 1.089 ' HB2' ' HD3' ' A' ' 186' ' ' PRO . 2.8 m -46.45 -74.35 0.07 OUTLIER Pre-proline 0 CA--C 1.545 0.76 0 O-C-N 123.997 0.811 . . . . 0.0 112.35 -166.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 1.089 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 71.9 Cg_endo -103.82 26.88 0.1 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.133 1.889 . . . . 0.0 111.978 170.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.676 ' CD2' ' HD2' ' A' ' 186' ' ' PRO . 7.7 m170 -95.72 -44.32 7.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.822 0.344 . . . . 0.0 110.705 -173.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 80.87 116.99 0.37 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.6 -178.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 19.6 tptm 60.89 87.42 0.09 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.532 0.682 . . . . 0.0 111.099 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' HIS . . . . . 0.499 ' HB2' ' HB3' ' A' ' 184' ' ' SER . 53.8 t-80 -75.26 -43.51 51.04 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.473 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 80.98 -168.48 50.93 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 -172.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -166.69 166.03 16.15 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 62.1 mtp180 -100.05 -99.65 0.24 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 177.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 176.15 179.96 0.17 Allowed 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 42.5 t -157.91 -89.14 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 20.3 p-10 -171.75 142.16 1.51 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 176.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 8.7 t -115.33 92.24 3.86 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 176.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -115.29 -141.96 0.38 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.208 -176.134 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 78.35 47.66 8.01 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.406 -0.902 . . . . 0.0 110.857 -175.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 43.1 mm -98.48 127.93 34.56 Favored Pre-proline 0 C--N 1.323 -0.572 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -176.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -65.56 101.56 0.45 Allowed 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.597 2.198 . . . . 0.0 111.846 176.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -75.43 135.49 72.36 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.727 -179.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -70.62 165.22 32.67 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 122.64 2.227 . . . . 0.0 111.97 177.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -101.0 143.32 31.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.553 177.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' HIS . . . . . 0.421 ' HB3' ' O ' ' A' ' 208' ' ' ALA . 74.4 m80 -102.83 -45.97 4.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.393 178.378 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . 60.8 81.84 0.18 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.105 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 73.32 -32.95 0.25 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.375 177.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' ALA . . . . . 0.421 ' O ' ' HB3' ' A' ' 205' ' ' HIS . . . -81.53 74.63 8.52 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.109 0.48 . . . . 0.0 110.497 177.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.906 ' HB2' ' HD3' ' A' ' 210' ' ' PRO . 19.7 mm-40 -91.52 -58.93 0.23 Allowed Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.967 -178.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 0.906 ' HD3' ' HB2' ' A' ' 209' ' ' GLN . 89.8 Cg_endo -98.49 178.23 0.37 Allowed 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.499 2.133 . . . . 0.0 112.371 178.187 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -147.06 -33.8 0.28 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.193 174.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 4.4 m 63.82 41.27 6.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.059 -178.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 8.9 m -56.45 -43.07 79.16 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.629 177.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 16.9 m -117.13 104.49 50.46 Favored Pre-proline 0 N--CA 1.447 -0.58 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.873 174.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.34 -43.87 31.71 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.541 2.16 . . . . 0.0 111.715 178.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 216' ' ' LEU . 1.2 tm? -152.32 115.38 2.91 Favored Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -61.88 95.77 0.14 Allowed 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.834 2.356 . . . . 0.0 112.273 -177.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -172.44 158.4 4.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.858 -176.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.747 HG13 ' H ' ' A' ' 220' ' ' SER . 2.6 p -136.05 -72.01 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 121.069 -0.252 . . . . 0.0 111.406 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 220' ' ' SER . . . . . 0.747 ' H ' HG13 ' A' ' 219' ' ' VAL . 14.6 t -177.08 -176.22 0.64 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -178.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 175.2 173.32 40.88 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 121.104 -0.57 . . . . 0.0 111.866 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 20.7 t 64.69 92.45 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.213 0.53 . . . . 0.0 111.518 177.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.48 -178.27 4.34 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 123.068 2.512 . . . . 0.0 111.329 174.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 172.83 -165.64 38.05 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.17 -1.014 . . . . 0.0 112.493 178.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -83.59 84.9 7.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.89 0.376 . . . . 0.0 110.697 -179.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -85.36 -48.63 8.85 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.312 0.577 . . . . 0.0 109.545 175.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 64.4 mt -94.67 105.23 16.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.845 176.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 3.5 t -140.04 90.04 10.87 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-O 121.706 0.765 . . . . 0.0 110.866 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -81.33 -16.34 9.59 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.997 2.464 . . . . 0.0 112.388 178.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.741 ' H ' ' HD2' ' A' ' 231' ' ' PRO . 0.5 OUTLIER -154.45 -55.9 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.63 0 CA-C-O 119.162 -0.446 . . . . 0.0 111.792 -175.294 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.741 ' HD2' ' H ' ' A' ' 230' ' ' LEU . 0.9 OUTLIER -42.96 -66.48 0.15 Allowed 'Trans proline' 0 C--N 1.362 1.284 0 C-N-CA 123.357 2.705 . . . . 0.0 114.158 -174.228 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 20.4 t -91.16 90.33 7.75 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.068 0.461 . . . . 0.0 110.099 -177.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 17.2 p -142.87 157.21 44.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.645 177.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -100.87 -36.38 9.08 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 176.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 66.99 -168.2 0.2 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.78 174.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 108.35 -135.96 13.18 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -177.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -81.3 132.85 8.34 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.478 2.119 . . . . 0.0 110.322 172.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.545 ' HB ' HG13 ' A' ' 266' ' ' VAL . 19.6 t -89.09 126.35 42.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-O 121.056 0.455 . . . . 0.0 110.425 -175.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -115.89 120.38 39.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.72 -177.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.571 ' HB2' HG13 ' A' ' 293' ' ' ILE . . . -120.34 145.05 47.5 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.262 178.402 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -95.1 120.69 35.75 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 175.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 242' ' ' ALA . . . . . 0.553 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -68.62 107.6 3.03 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.381 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.5 HD13 ' HD3' ' A' ' 292' ' ' LYS . 39.1 pt -85.17 -21.28 7.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.049 0.452 . . . . 0.0 110.611 -177.025 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -134.85 147.12 49.81 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.487 -178.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' LYS . . . . . 0.453 ' HG2' ' HA ' ' A' ' 259' ' ' GLU . 10.7 mtmp? -63.32 156.9 24.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.519 0.676 . . . . 0.0 111.32 -176.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.531 ' HG3' ' O ' ' A' ' 256' ' ' LEU . 27.6 tpt180 -140.35 122.21 15.48 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.764 -179.24 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 247' ' ' VAL . . . . . 0.402 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 16.9 m -127.58 153.68 77.58 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-O 120.834 0.35 . . . . 0.0 111.613 -175.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.514 ' HB3' ' CG ' ' A' ' 252' ' ' ASP . 7.4 Cg_exo -72.92 159.35 48.29 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.966 2.444 . . . . 0.0 112.078 178.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 249' ' ' CYS . . . . . 0.477 ' SG ' ' N ' ' A' ' 250' ' ' ALA . 42.3 t -104.59 -175.63 2.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.875 -178.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.477 ' N ' ' SG ' ' A' ' 249' ' ' CYS . . . -58.85 -44.6 91.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.154 0.502 . . . . 0.0 110.506 176.226 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -91.43 31.94 1.11 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.809 178.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.514 ' CG ' ' HB3' ' A' ' 248' ' ' PRO . 2.9 t70 -60.92 112.75 2.18 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.492 178.33 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -139.13 -6.77 1.39 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.385 169.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -151.77 34.81 0.55 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.376 176.506 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -112.54 100.62 8.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.201 0.524 . . . . 0.0 110.759 -179.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.531 ' O ' ' HG3' ' A' ' 246' ' ' ARG . 0.5 OUTLIER -67.13 146.76 53.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.977 -175.764 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -107.87 120.22 41.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.055 178.066 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.525 HD21 HG21 ' A' ' 279' ' ' VAL . 51.3 mt -136.39 152.75 50.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.536 -175.025 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 259' ' ' GLU . . . . . 0.453 ' HA ' ' HG2' ' A' ' 245' ' ' LYS . 0.9 OUTLIER -115.07 -176.39 2.9 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 172.657 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 51.1 t -81.29 120.91 33.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.569 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 111.08 2.78 28.17 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.001 -0.619 . . . . 0.0 113.054 177.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -90.88 146.74 23.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.814 0.34 . . . . 0.0 110.79 -178.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 24.3 mm -92.67 109.86 22.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.538 177.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 20.8 t -83.28 108.46 15.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.217 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -80.42 86.48 5.75 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.881 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.545 HG13 ' HB ' ' A' ' 238' ' ' VAL . 2.6 p -98.41 117.69 43.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.671 0.748 . . . . 0.0 110.656 -178.161 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 18.4 p -94.46 -49.66 5.58 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.303 -177.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -100.61 114.31 27.88 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 120.955 0.407 . . . . 0.0 111.06 -177.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 269' ' ' MET . . . . . 0.429 ' CE ' HG11 ' A' ' 238' ' ' VAL . 40.7 mtt -106.61 140.19 39.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.145 0.497 . . . . 0.0 110.735 174.382 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -119.78 -170.05 1.88 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.575 -175.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.434 HD12 ' N ' ' A' ' 271' ' ' ILE . 4.5 mp -95.81 -30.81 4.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.135 -174.176 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -66.81 -23.39 66.05 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -173.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 115.21 -32.37 5.79 Favored Glycine 0 C--O 1.23 -0.128 0 C-N-CA 120.194 -1.003 . . . . 0.0 113.084 173.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.485 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 48.7 mt-30 -86.23 107.53 17.96 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 176.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.512 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 12.7 m0 -92.22 157.61 16.6 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.106 -173.164 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -100.29 108.35 20.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.256 0.551 . . . . 0.0 109.857 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 277' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -110.0 145.38 17.02 Favored Glycine 0 N--CA 1.44 -1.042 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.573 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -107.66 108.68 20.04 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.33 0.586 . . . . 0.0 110.042 177.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 279' ' ' VAL . . . . . 0.525 HG21 HD21 ' A' ' 258' ' ' LEU . 60.3 t -120.54 127.62 75.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.777 -178.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 47.91 33.02 3.05 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.18 0.992 . . . . 0.0 112.203 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 81.37 25.85 53.3 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.773 177.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 282' ' ' ARG . . . . . 0.482 ' NH1' ' HA ' ' A' ' 256' ' ' LEU . 1.0 OUTLIER -137.85 125.72 22.59 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 178.643 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 24.1 pttm -101.36 142.82 32.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.978 -175.351 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -163.53 152.16 22.01 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.208 177.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.512 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 90.9 mt -78.39 120.68 23.48 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.116 0.484 . . . . 0.0 110.372 176.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.408 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 43.8 p90 -118.24 146.24 38.95 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.857 178.058 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 287' ' ' PRO . . . . . 0.409 ' HG2' ' CD2' ' A' ' 290' ' ' HIS . 20.9 Cg_endo -87.69 137.08 3.95 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.752 2.302 . . . . 0.0 111.948 -179.012 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -60.17 -14.95 19.97 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -175.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.08 -12.28 61.42 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.005 0.431 . . . . 0.0 111.358 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 290' ' ' HIS . . . . . 0.409 ' CD2' ' HG2' ' A' ' 287' ' ' PRO . 10.9 m170 -101.07 -15.91 17.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.362 -176.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.56 ' HB ' ' HB1' ' A' ' 240' ' ' ALA . 35.4 m -128.39 152.7 36.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.897 0.38 . . . . 0.0 111.33 -175.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 292' ' ' LYS . . . . . 0.5 ' HD3' HD13 ' A' ' 243' ' ' ILE . 3.2 mptp? -130.88 134.83 47.14 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 170.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.571 HG13 ' HB2' ' A' ' 240' ' ' ALA . 1.0 OUTLIER -88.43 122.58 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 CA-C-O 122.068 0.937 . . . . 0.0 112.029 -177.291 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 294' ' ' PHE . . . . . 0.582 ' O ' ' HD3' ' A' ' 296' ' ' PRO . 5.1 p90 -117.3 140.15 49.92 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 168.354 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -79.95 107.61 7.21 Favored Pre-proline 0 C--N 1.317 -0.833 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.297 178.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 296' ' ' PRO . . . . . 0.582 ' HD3' ' O ' ' A' ' 294' ' ' PHE . 91.0 Cg_endo -81.36 -2.69 11.73 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.666 2.244 . . . . 0.0 110.912 -177.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 297' ' ' GLN . . . . . 0.401 ' H ' ' HG2' ' A' ' 297' ' ' GLN . 21.2 pt20 -87.92 16.12 6.33 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.959 -178.446 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -146.09 131.48 9.22 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.593 171.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -88.3 27.12 0.55 Allowed 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.831 2.354 . . . . 0.0 112.159 177.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -81.57 -9.99 59.55 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.636 0.732 . . . . 0.0 110.121 -178.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -110.69 14.79 22.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.191 176.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -155.38 126.74 7.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.941 0.401 . . . . 0.0 111.584 -175.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 . . . . . 0 C--O 1.246 0.912 0 CA-C-O 118.239 -0.886 . . . . 0.0 109.501 174.738 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.3 ptp . . . . . 0 N--CA 1.483 1.19 0 CA-C-O 120.822 0.344 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.5 p -141.61 94.83 2.73 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 120.994 0.426 . . . . 0.0 111.29 -178.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.4 p -70.85 -33.08 70.28 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 169.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -81.45 102.48 10.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.18 175.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -115.2 77.35 1.07 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.549 0.69 . . . . 0.0 111.572 -177.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -157.61 151.61 24.39 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.171 176.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.425 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 16.9 t70 -85.41 126.91 34.16 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.772 176.396 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.441 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 5.3 t -68.67 -20.12 64.43 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.044 -174.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 t -97.8 -13.62 21.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.766 0.317 . . . . 0.0 110.909 -177.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.425 ' HB2' ' HB3' ' A' ' 7' ' ' ASP . 17.3 t70 -79.09 78.41 5.54 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.514 0.674 . . . . 0.0 109.412 -178.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.449 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 3.8 ptp180 -69.8 -14.69 62.89 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.179 -175.288 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.5 t -82.91 14.86 3.01 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.61 0.719 . . . . 0.0 109.333 173.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.25 -42.51 3.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.122 170.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.424 ' CE2' ' HA ' ' A' ' 11' ' ' ARG . 44.9 p-90 -108.45 -22.05 12.47 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -172.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.449 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 25.1 t80 -86.34 120.63 27.9 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.205 0.526 . . . . 0.0 110.108 -177.08 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.575 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 25.1 mmt -100.38 1.36 41.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.796 -172.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.441 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.0 -112.46 1.69 Allowed Glycine 0 CA--C 1.525 0.719 0 N-CA-C 114.368 0.507 . . . . 0.0 114.368 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.441 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 11.3 Cg_exo -72.4 55.22 2.5 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 124.191 3.26 . . . . 0.0 114.299 -172.344 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.751 HG12 ' H ' ' A' ' 20' ' ' SER . 59.5 t -104.18 -178.42 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 172.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.751 ' H ' HG12 ' A' ' 19' ' ' VAL . 23.4 t -165.38 176.49 8.24 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -165.352 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 21.3 tpt180 -55.09 -55.7 28.12 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.684 0.278 . . . . 0.0 111.393 -174.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -59.11 -60.06 4.47 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.46 -177.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.425 ' HG2' ' HD2' ' A' ' 27' ' ' ARG . 25.6 tt0 -61.5 -46.03 91.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.679 -175.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.437 ' HB2' HG12 ' A' ' 19' ' ' VAL . . . -53.57 -49.23 68.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.962 0.41 . . . . 0.0 111.67 -175.276 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.613 ' HG3' ' HB ' ' A' ' 58' ' ' VAL . 12.5 tt0 -74.25 -37.25 63.81 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 120.117 -0.633 . . . . 0.0 111.183 -174.509 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.402 HG22 ' O ' ' A' ' 23' ' ' GLU . 7.4 t -70.42 -21.5 62.82 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 120.784 -0.367 . . . . 0.0 111.177 -177.379 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.425 ' HD2' ' HG2' ' A' ' 23' ' ' GLU . 56.4 mtp180 -82.79 -20.56 35.57 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.996 0.427 . . . . 0.0 110.736 178.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.638 HD21 ' HB2' ' A' ' 102' ' ' ALA . 13.0 mt -108.14 -15.74 14.43 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.95 179.224 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -84.71 130.24 34.72 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.243 0.544 . . . . 0.0 110.832 -173.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.522 ' C ' ' HG2' ' A' ' 32' ' ' ARG . . . 76.81 -3.38 56.45 Favored Glycine 0 C--N 1.314 -0.668 0 C-N-CA 119.914 -1.136 . . . . 0.0 112.747 178.4 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.5 ' HB2' ' CE ' ' A' ' 35' ' ' MET . 31.8 mt-30 -91.86 -52.17 4.86 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 172.096 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.743 ' CD ' ' HA ' ' A' ' 56' ' ' SER . 3.6 mmp_? 85.08 128.82 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 116.378 1.992 . . . . 0.0 116.378 152.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.731 ' CD2' ' HB3' ' A' ' 32' ' ' ARG . 9.0 m170 77.24 109.13 0.08 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 112.657 -2.065 . . . . 0.0 113.021 157.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.84 -37.83 3.46 Favored Glycine 0 N--CA 1.453 -0.222 0 CA-C-N 114.981 -1.009 . . . . 0.0 112.842 173.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.546 ' HE3' ' HB2' ' A' ' 35' ' ' MET . 33.4 mtm -70.5 141.48 51.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.794 0.331 . . . . 0.0 111.293 -177.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.433 ' CG ' HD22 ' A' ' 98' ' ' LEU . 37.7 p90 -143.93 160.8 40.19 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 172.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.575 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.4 pp -153.91 139.57 17.93 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.172 0.511 . . . . 0.0 111.447 174.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 49.9 t -104.67 130.82 55.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.415 -0.811 . . . . 0.0 108.949 173.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.409 ' CB ' ' HB ' ' A' ' 19' ' ' VAL . 24.9 ptt-85 -127.9 175.97 7.95 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -177.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -80.89 137.6 36.16 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 170.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.3 t -78.95 97.3 5.98 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.196 0.522 . . . . 0.0 110.64 -176.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.22 -8.82 26.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.426 0.631 . . . . 0.0 110.483 174.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.5 p -97.95 -8.26 28.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.764 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.47 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 28.4 t -164.4 122.88 1.21 Allowed Pre-proline 0 C--N 1.333 -0.136 0 CA-C-O 120.589 0.233 . . . . 0.0 110.763 -177.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 44' ' ' CYS . 10.1 Cg_exo -71.53 119.41 6.23 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 123.048 2.499 . . . . 0.0 112.618 -179.12 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.07 25.34 17.25 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.019 178.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -134.35 163.17 30.26 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.565 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 25.3 m-85 -124.61 166.07 16.75 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 175.032 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.478 HG13 HD13 ' A' ' 62' ' ' ILE . 21.5 t -137.13 108.16 5.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.239 178.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.4 tp -84.18 102.02 12.29 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.864 175.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 51.0 m -95.61 124.39 39.61 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 177.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.684 HG21 HD13 ' A' ' 93' ' ' LEU . 58.0 t -114.67 139.89 38.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.271 0.558 . . . . 0.0 111.421 -173.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.419 ' HA ' HH22 ' A' ' 32' ' ' ARG . 47.0 t -98.46 103.33 15.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.74 -174.177 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.776 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 6.3 tp10 -157.68 163.04 38.6 Favored 'General case' 0 C--O 1.213 -0.831 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.33 171.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.758 ' ND2' ' HG3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER 44.62 42.23 5.55 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.724 1.209 . . . . 0.0 112.813 -175.653 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.743 ' HA ' ' CD ' ' A' ' 32' ' ' ARG . 68.2 m 44.23 54.72 5.95 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 121.809 0.814 . . . . 0.0 111.028 -175.295 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.783 HH21 ' HA ' ' A' ' 154' ' ' GLU 0.341 0.0 OUTLIER -169.24 75.59 0.09 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.642 -1.163 . . . . 0.0 113.543 -154.384 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.613 ' HB ' ' HG3' ' A' ' 25' ' ' GLN . 14.9 t -69.14 108.12 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 O-C-N 119.475 -2.016 . . . . 0.0 110.355 -173.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.2 m -84.9 123.9 31.02 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.475 -178.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 36.1 m-70 -96.59 108.97 21.66 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.682 -174.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.607 ' HB3' HD11 ' A' ' 73' ' ' ILE . 79.1 m-85 -98.7 110.57 23.14 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.268 0.627 . . . . 0.0 111.118 178.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.664 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 40.3 mm -80.55 123.95 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -174.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.565 ' HB ' ' HB2' ' A' ' 48' ' ' TYR . 5.3 mp -102.68 112.54 36.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 120.797 0.332 . . . . 0.0 110.76 177.56 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.515 ' HB2' ' HB3' ' A' ' 72' ' ' LYS . 15.0 m120 -86.13 140.38 30.26 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.686 -176.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.3 t -86.52 101.15 12.92 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 169.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.885 HD12 ' HG3' ' A' ' 70' ' ' ARG . 91.9 mt -83.56 140.22 41.32 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.515 -178.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.65 -11.44 26.38 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.408 2.072 . . . . 0.0 110.678 172.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.54 ' HB2' ' HG2' ' A' ' 70' ' ' ARG . 2.9 m-20 -72.15 -2.48 18.8 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.114 174.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.87 ' HE ' ' HA ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER 67.09 35.02 4.76 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.858 -178.459 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.885 ' HG3' HD12 ' A' ' 66' ' ' LEU . 4.3 ptp180 -133.64 168.22 19.07 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.829 176.417 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.436 ' HB3' HG23 ' A' ' 63' ' ' ILE . 37.5 m-85 -114.0 124.23 51.65 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.977 0.418 . . . . 0.0 110.553 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.642 ' HB2' HD11 ' A' ' 66' ' ' LEU . 28.9 ttpp -108.73 95.88 5.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.287 -173.283 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.664 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 3.8 tt -87.83 118.31 33.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.073 0.463 . . . . 0.0 110.747 -178.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.95 31.54 78.87 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.729 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.526 ' HA ' ' HG2' ' A' ' 72' ' ' LYS . 31.2 t70 74.34 4.65 4.53 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.139 0.576 . . . . 0.0 111.47 -178.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -90.93 119.73 31.36 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 173.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -81.72 121.77 26.81 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.968 0.413 . . . . 0.0 111.487 -176.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.441 ' O ' ' HB2' ' A' ' 70' ' ' ARG . 87.3 m-85 -125.28 165.75 17.77 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 172.153 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -58.28 -49.25 77.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.132 0.491 . . . . 0.0 111.316 -179.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.486 ' ND1' ' HG2' ' A' ' 82' ' ' PRO . 4.7 p80 -164.0 -178.5 5.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.063 -177.351 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.522 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 14.2 mt -56.76 -57.05 26.56 Favored Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -176.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.486 ' HG2' ' ND1' ' A' ' 80' ' ' HIS . 24.0 Cg_endo -64.46 3.03 0.94 Allowed 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.237 1.958 . . . . 0.0 113.605 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.35 -36.27 10.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.868 0.366 . . . . 0.0 110.297 178.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.1 pp -76.48 -33.89 58.67 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.51 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 68.0 mt -66.74 -19.76 65.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.735 178.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -89.08 -37.9 14.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.444 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -71.32 -30.68 66.49 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.405 0.622 . . . . 0.0 110.382 -178.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.465 ' CG ' HD21 ' A' ' 93' ' ' LEU . 19.8 m-85 -82.57 -3.2 55.67 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.978 -0.556 . . . . 0.0 112.025 -178.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.51 ' HG3' ' O ' ' A' ' 85' ' ' LEU . 99.4 mttt -72.33 -13.06 61.39 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.523 174.377 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 16.7 pt -132.68 10.53 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 CA-C-O 121.37 0.605 . . . . 0.0 110.054 -177.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -107.0 -37.48 6.31 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.954 -175.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.496 ' CD2' HG23 ' A' ' 97' ' ' THR . 75.1 m-85 69.06 115.89 0.04 OUTLIER 'General case' 0 C--O 1.224 -0.279 0 O-C-N 124.227 0.954 . . . . 0.0 109.702 -173.417 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.684 HD13 HG21 ' A' ' 52' ' ' VAL . 1.2 mt -91.14 -7.64 50.99 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.516 0.674 . . . . 0.0 110.433 177.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.693 ' HA ' ' HB3' ' A' ' 154' ' ' GLU . 0.2 OUTLIER -144.61 -45.52 0.24 Allowed 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 122.107 0.956 . . . . 0.0 111.032 -172.381 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.571 ' HB ' ' O ' ' A' ' 94' ' ' ASP . 5.6 t 152.45 -15.72 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 104.457 -2.423 . . . . 0.0 104.457 -167.275 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.1 m -117.81 145.83 44.27 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 112.878 -1.965 . . . . 0.0 108.162 177.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.496 HG23 ' CD2' ' A' ' 92' ' ' TYR . 27.4 p -94.94 171.49 8.73 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 174.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.433 HD22 ' CG ' ' A' ' 36' ' ' PHE . 92.7 mt -66.24 93.33 0.21 Allowed 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 177.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 39.9 mm -79.66 -61.05 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.969 -175.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.518 ' O ' ' HA ' ' A' ' 35' ' ' MET . 0.6 OUTLIER -160.58 150.1 14.19 Favored Pre-proline 0 N--CA 1.453 -0.312 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.121 178.452 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.86 163.41 30.93 Favored 'Trans proline' 0 CA--C 1.532 0.384 0 C-N-CA 122.91 2.407 . . . . 0.0 114.414 -172.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.638 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -63.83 155.47 77.17 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.475 176.623 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.418 ' HD3' ' SD ' ' A' ' 35' ' ' MET . 84.1 Cg_exo -51.38 95.83 0.03 OUTLIER 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 123.116 2.544 . . . . 0.0 112.755 174.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.446 ' HG3' ' SD ' ' A' ' 16' ' ' MET . 49.5 ttt180 -71.08 -35.88 72.03 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 177.323 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -89.6 125.07 62.51 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.046 175.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.7 106.77 1.15 Allowed 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.47 2.113 . . . . 0.0 112.285 179.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.484 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 27.2 m -98.61 134.28 21.85 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.482 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.494 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 16.8 Cg_exo -67.93 122.38 9.49 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.961 2.441 . . . . 0.0 112.139 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 108' ' ' PRO . 2.8 Cg_exo -75.51 72.7 4.86 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.999 2.466 . . . . 0.0 111.629 178.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 52.3 ttp -73.44 -29.99 62.92 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.48 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -178.39 -168.32 37.57 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 9.3 p -67.3 110.32 3.49 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.978 0.418 . . . . 0.0 110.238 176.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 57.0 t -94.72 -61.45 2.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.007 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 31.7 p -131.9 -88.59 0.45 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.611 -177.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.572 ' HB1' ' HD3' ' A' ' 119' ' ' PRO . . . 49.12 64.24 9.0 Favored Pre-proline 0 N--CA 1.465 0.277 0 CA-C-O 121.141 0.496 . . . . 0.0 110.003 -171.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.96 -24.27 72.26 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.306 2.671 . . . . 0.0 114.123 -166.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -113.68 5.22 16.37 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.901 -174.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 50.4 tp 59.88 111.36 0.02 OUTLIER Pre-proline 0 N--CA 1.469 0.501 0 CA-C-O 121.059 0.457 . . . . 0.0 111.713 -175.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.572 ' HD3' ' HB1' ' A' ' 115' ' ' ALA . 38.5 Cg_exo -61.08 98.44 0.14 Allowed 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 122.724 2.282 . . . . 0.0 112.48 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.8 p -146.65 153.37 40.22 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.494 -177.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.572 ' HB3' ' HB2' ' A' ' 56' ' ' SER . . . 174.15 164.63 0.2 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.262 1.025 . . . . 0.0 108.811 174.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 123' ' ' ASP . 7.9 pt-20 -147.13 177.79 8.89 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -176.193 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.412 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 1.8 m-20 74.15 -104.62 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.093 -0.958 . . . . 0.0 112.801 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.491 ' HB3' ' HG3' ' A' ' 183' ' ' ARG . 28.0 t-20 -169.96 -87.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 110.52 -0.178 . . . . 0.0 110.52 -173.116 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.933 HD12 HG21 ' A' ' 152' ' ' ILE . 4.2 mm? 68.35 102.29 0.05 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.527 0.68 . . . . 0.0 112.53 177.063 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 48.4 tt0 -172.65 -56.46 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.65 178.166 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -117.99 108.64 15.51 Favored 'General case' 0 CA--C 1.51 -0.582 0 C-N-CA 120.071 -0.651 . . . . 0.0 111.134 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.684 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 3.1 t -115.8 142.32 29.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.669 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 0.1 OUTLIER -115.38 145.01 42.94 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 116.623 -2.031 . . . . 0.0 108.688 160.493 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.561 HG22 HG12 ' A' ' 178' ' ' VAL . 0.8 OUTLIER -103.48 128.04 50.75 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.086 -177.601 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.543 HD21 ' HG2' ' A' ' 179' ' ' GLU . 20.3 mt -102.0 -24.0 14.04 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -174.291 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.496 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 46.8 t80 -82.03 -35.3 28.94 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.271 -0.571 . . . . 0.0 112.378 -172.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.665 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 9.7 t70 75.18 104.64 0.07 Allowed 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.423 0.63 . . . . 0.0 110.726 -175.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.474 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 63.9 t80 -129.77 88.85 48.1 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 175.048 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.663 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 60.4 Cg_endo -85.3 71.18 4.95 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.039 1.826 . . . . 0.0 113.099 -176.119 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.72 -30.53 76.41 Favored Glycine 0 C--N 1.331 0.287 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.778 178.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.535 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 13.7 m-80 56.0 71.01 0.58 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 114.862 -0.669 . . . . 0.0 110.718 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.569 ' HB3' ' H ' ' A' ' 141' ' ' ASP . 0.7 OUTLIER -145.6 -169.47 3.23 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.149 -174.442 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -110.73 -5.53 14.97 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 166.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -101.31 -56.88 2.2 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 113.698 -1.592 . . . . 0.0 108.529 177.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.569 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 3.4 m-20 -96.81 120.86 37.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.489 174.478 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 1.074 HD11 ' HB2' ' A' ' 165' ' ' ASN . 32.9 tp -76.68 130.13 77.34 Favored Pre-proline 0 N--CA 1.467 0.404 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 175.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.663 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 74.1 Cg_endo -82.28 94.04 0.9 Allowed 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 121.67 1.58 . . . . 0.0 111.966 172.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.565 ' HA ' ' OE1' ' A' ' 148' ' ' GLU . 12.2 p90 -106.58 153.7 21.97 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -176.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.665 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 88.9 mttt -103.16 -162.03 0.88 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -173.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.57 ' N ' ' HD2' ' A' ' 146' ' ' LYS . 9.0 mptt -81.98 -7.94 59.64 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.858 -166.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -167.83 27.5 0.15 Allowed Glycine 0 C--N 1.311 -0.825 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.352 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.565 ' OE1' ' HA ' ' A' ' 144' ' ' PHE . 0.1 OUTLIER -78.99 154.39 29.55 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.071 0.462 . . . . 0.0 111.684 -177.157 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.651 HD12 ' HB3' ' A' ' 129' ' ' ARG . 0.5 OUTLIER -95.19 128.72 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.702 -177.961 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.7 HD22 HD21 ' A' ' 142' ' ' LEU . 61.8 mt -122.98 156.19 35.27 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -175.369 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.602 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 85.2 t -119.2 121.07 65.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 174.447 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 1.027 HD13 ' HB2' ' A' ' 163' ' ' ALA . 48.5 mm -76.88 91.75 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 CA-C-O 121.889 0.852 . . . . 0.0 108.711 -176.018 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.555 HG23 ' HG3' ' A' ' 154' ' ' GLU . 17.6 tt -79.95 -26.66 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 CA-C-N 114.237 -1.347 . . . . 0.0 109.696 -174.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.783 ' HA ' HH21 ' A' ' 57' ' ' ARG . 0.9 OUTLIER -134.7 144.9 48.04 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 172.461 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.588 ' HD2' ' HG ' ' A' ' 125' ' ' LEU . 77.0 tttt -127.84 85.06 61.61 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-O 121.148 0.499 . . . . 0.0 109.914 164.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.522 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 13.2 Cg_exo -73.45 -41.33 1.22 Allowed 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.62 2.213 . . . . 0.0 112.28 175.057 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -121.7 176.84 5.52 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.931 -173.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -106.65 -0.98 23.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.777 0.798 . . . . 0.0 109.283 174.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -102.82 -36.68 8.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.801 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.545 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 31.1 m95 -127.03 144.71 50.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.932 176.072 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' TRP . . . . . 0.769 ' O ' HG13 ' A' ' 173' ' ' ILE . 49.3 m0 -125.75 138.98 53.89 Favored 'General case' 0 C--O 1.215 -0.756 0 C-N-CA 123.346 0.658 . . . . 0.0 109.776 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.532 ' HA ' ' HA ' ' A' ' 172' ' ' MET . 23.9 m -97.98 104.87 16.94 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -173.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 1.027 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -114.94 149.4 37.34 Favored 'General case' 0 N--CA 1.425 -1.687 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.235 -176.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.698 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 13.0 ptt180 -87.48 122.33 31.07 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 171.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 1.074 ' HB2' HD11 ' A' ' 142' ' ' LEU . 14.4 t30 -52.8 172.19 0.05 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.577 -1.647 . . . . 0.0 110.648 -175.243 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -63.75 -10.22 18.53 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.282 0.563 . . . . 0.0 109.554 173.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -85.21 -27.02 26.38 Favored 'General case' 0 N--CA 1.46 0.073 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.332 171.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 108.73 -2.28 32.11 Favored Glycine 0 CA--C 1.522 0.49 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.677 -176.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.698 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 3.3 ttm-85 -74.3 132.79 42.39 Favored 'General case' 0 C--O 1.214 -0.815 0 C-N-CA 123.054 0.542 . . . . 0.0 111.798 -177.309 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 64.7 t -84.81 121.88 37.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 O-C-N 122.032 -0.418 . . . . 0.0 111.391 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -158.36 156.35 27.33 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.578 173.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.545 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.0 OUTLIER -75.75 145.22 40.97 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 122.604 0.361 . . . . 0.0 111.479 -179.735 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.769 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.6 pp -144.69 145.62 28.86 Favored Pre-proline 0 C--O 1.221 -0.411 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.444 -177.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.512 ' HB2' ' CD1' ' A' ' 177' ' ' TYR . 10.3 Cg_exo -73.69 132.98 18.0 Favored 'Trans proline' 0 CA--C 1.527 0.126 0 C-N-CA 122.688 2.259 . . . . 0.0 112.889 -175.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.55 ' HB ' ' HD3' ' A' ' 176' ' ' PRO . 47.8 t -61.43 -45.71 94.45 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.55 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 50.8 Cg_exo -57.55 -8.01 3.62 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.383 2.056 . . . . 0.0 113.643 175.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.512 ' CD1' ' HB2' ' A' ' 174' ' ' PRO . 3.0 m-85 -95.57 -11.49 27.24 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.622 -178.393 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.673 ' HB ' HG13 ' A' ' 128' ' ' VAL . 3.4 m -106.49 -174.08 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 -165.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.673 ' O ' ' HG3' ' A' ' 179' ' ' GLU . 8.2 tp10 -161.02 44.29 0.17 Allowed 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 112.477 -2.147 . . . . 0.0 111.152 -155.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.849 ' H ' ' HD2' ' A' ' 180' ' ' LYS . 0.0 OUTLIER -73.71 141.85 46.38 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 119.411 -2.056 . . . . 0.0 111.663 -163.49 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.488 ' HB2' HH22 ' A' ' 129' ' ' ARG . 18.0 tp -69.13 -84.72 0.03 OUTLIER 'General case' 0 C--O 1.231 0.094 0 CA-C-N 112.608 -2.087 . . . . 0.0 112.259 -161.405 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 26.5 m -89.02 137.86 20.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.401 178.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.528 ' NH1' ' HE3' ' A' ' 180' ' ' LYS . 37.2 ttt85 -167.73 162.07 13.71 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.222 0.534 . . . . 0.0 111.235 -176.1 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 47.0 p -141.67 115.07 8.89 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.366 173.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' SER . . . . . 0.429 ' HA ' ' HD3' ' A' ' 186' ' ' PRO . 5.6 p -68.18 150.32 97.78 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 178.472 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 185' ' ' SER . 24.7 Cg_exo -63.57 87.08 0.13 Allowed 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.695 2.263 . . . . 0.0 112.547 -178.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 46.9 m80 -87.18 -4.34 59.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.989 176.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 104.84 -56.76 0.53 Allowed Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 -177.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -121.46 116.42 24.69 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 177.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -104.41 128.58 52.3 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.553 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.418 ' O ' ' HG3' ' A' ' 193' ' ' ARG . . . -95.67 -122.88 4.06 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 174.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 17.7 m120 59.33 27.72 16.87 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 122.641 0.377 . . . . 0.0 111.294 177.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' A' ' 191' ' ' GLY . 66.1 mtp180 -121.73 -30.72 4.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.724 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 66.53 98.47 0.05 OUTLIER 'General case' 0 C--O 1.234 0.271 0 O-C-N 123.891 0.744 . . . . 0.0 110.35 -172.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 8.8 t -91.32 -176.87 4.69 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.186 -176.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 63.5 t30 62.37 38.34 13.09 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.925 0.869 . . . . 0.0 109.397 -177.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 10.5 t -122.01 110.83 16.29 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.212 -0.903 . . . . 0.0 110.067 -177.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 60.74 -161.98 0.28 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.864 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 98.55 -42.13 2.11 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.51 177.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.573 HG22 ' HG3' ' A' ' 202' ' ' GLU . 47.9 mm -96.0 110.41 51.75 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 120.723 0.297 . . . . 0.0 110.236 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 200' ' ' ILE . 10.2 Cg_endo -90.11 97.24 0.28 Allowed 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.142 2.562 . . . . 0.0 112.37 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.573 ' HG3' HG22 ' A' ' 200' ' ' ILE . 43.0 mt-10 -124.94 99.99 34.16 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.471 176.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -74.81 -80.71 0.01 OUTLIER 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 122.403 2.069 . . . . 0.0 111.974 177.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -164.98 136.81 4.27 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 177.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 -134.24 96.67 3.66 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.931 0.396 . . . . 0.0 110.581 -178.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -100.77 -65.4 0.97 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.848 177.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -129.72 -61.17 1.01 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.843 176.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . 55.0 -96.6 0.06 Allowed 'General case' 0 C--O 1.231 0.101 0 O-C-N 123.748 0.655 . . . . 0.0 110.096 -171.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.445 ' HA ' ' HD2' ' A' ' 210' ' ' PRO . 89.7 mt-30 -143.77 104.69 4.92 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 172.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 209' ' ' GLN . 20.0 Cg_endo -61.69 -59.86 0.26 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.732 2.288 . . . . 0.0 112.357 -178.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -137.26 126.01 23.94 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 14.7 p -109.89 5.59 22.6 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -175.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 11.8 t -104.99 12.58 32.15 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 121.024 -0.27 . . . . 0.0 111.687 -175.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.539 ' H ' ' CD ' ' A' ' 215' ' ' PRO . 2.4 p -132.19 -45.02 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -178.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.539 ' CD ' ' H ' ' A' ' 214' ' ' THR . 18.2 Cg_exo -68.24 -43.37 4.6 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 121.863 1.709 . . . . 0.0 112.841 -177.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.83 ' HB2' ' HD3' ' A' ' 217' ' ' PRO . 5.8 mp -84.38 -58.8 0.36 Allowed Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.748 -179.008 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.83 ' HD3' ' HB2' ' A' ' 216' ' ' LEU . 57.8 Cg_endo -97.35 114.87 0.11 Allowed 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.581 2.187 . . . . 0.0 112.523 176.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -81.15 102.98 10.64 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 176.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 29.8 m -110.56 144.5 18.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.58 -176.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 15.5 p -148.21 127.43 12.96 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.746 176.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -155.56 61.37 0.36 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.468 -0.873 . . . . 0.0 112.68 -176.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 47.8 m -115.55 109.43 45.87 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-O 120.704 0.288 . . . . 0.0 110.296 178.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -73.58 -11.47 24.31 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 123.126 2.551 . . . . 0.0 112.206 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -76.87 61.66 3.32 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.356 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -123.61 13.18 9.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.961 0.41 . . . . 0.0 110.326 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -136.57 165.83 24.94 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.344 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 40.3 pt -70.01 -28.33 35.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.836 0.35 . . . . 0.0 110.747 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 31.7 m -135.91 88.69 22.27 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.84 177.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -83.0 164.0 15.49 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.549 2.166 . . . . 0.0 111.477 174.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 230' ' ' LEU . 1.0 OUTLIER -103.29 103.83 37.35 Favored Pre-proline 0 C--N 1.32 -0.682 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.905 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.427 ' HG2' HG23 ' A' ' 233' ' ' THR . 88.4 Cg_endo -79.23 -169.98 0.91 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.771 2.314 . . . . 0.0 111.759 -178.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 18.4 m -76.15 71.45 2.89 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.432 0.634 . . . . 0.0 110.57 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' THR . . . . . 0.427 HG23 ' HG2' ' A' ' 231' ' ' PRO . 15.1 p -84.46 -60.73 1.99 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.064 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 72.89 -33.77 0.28 Allowed 'General case' 0 N--CA 1.468 0.467 0 O-C-N 124.053 0.846 . . . . 0.0 111.544 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 235' ' ' ASN . . . . . 0.426 ' H ' ' C ' ' A' ' 233' ' ' THR . 45.9 m-80 71.18 102.39 0.06 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.505 0.722 . . . . 0.0 111.084 175.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 102.28 114.37 3.86 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.869 -178.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -62.36 113.98 2.15 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.582 2.188 . . . . 0.0 111.347 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.418 ' CG1' HD12 ' A' ' 293' ' ' ILE . 13.2 t -66.85 136.48 26.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.18 -174.307 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.542 ' HB2' ' HG3' ' A' ' 296' ' ' PRO . 82.8 m-85 -98.63 125.51 43.93 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.971 178.026 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.516 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -118.21 148.53 42.29 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.417 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -92.31 125.29 36.91 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 177.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 242' ' ' ALA . . . . . 0.533 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -71.01 104.95 3.14 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 176.041 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.606 HD13 ' HG2' ' A' ' 292' ' ' LYS . 41.2 pt -88.0 0.82 6.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.936 0.398 . . . . 0.0 111.311 -174.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -155.79 146.47 22.05 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 15.7 pttm -66.41 109.16 2.62 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.57 0.7 . . . . 0.0 110.542 176.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.569 ' HB3' ' HB2' ' A' ' 258' ' ' LEU . 24.9 tpt180 -84.46 93.56 8.33 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.711 178.028 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 27.1 m -105.87 138.17 19.56 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.007 176.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.515 ' HB3' ' HB3' ' A' ' 255' ' ' ALA . 90.4 Cg_endo -80.62 148.72 18.19 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.471 2.114 . . . . 0.0 112.282 -179.325 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 249' ' ' CYS . . . . . 0.417 ' SG ' ' N ' ' A' ' 250' ' ' ALA . 41.8 t -92.74 -176.55 4.28 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 175.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 250' ' ' ALA . . . . . 0.417 ' N ' ' SG ' ' A' ' 249' ' ' CYS . . . -61.34 -24.0 66.14 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -175.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -102.75 -9.63 19.84 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -177.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -84.35 88.1 7.24 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.109 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -87.21 -16.92 33.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.039 -178.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 10.2 p -110.3 7.12 22.94 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.622 -176.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.515 ' HB3' ' HB3' ' A' ' 248' ' ' PRO . . . -86.85 132.92 33.69 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.258 0.551 . . . . 0.0 111.328 -176.374 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.478 ' O ' ' HG3' ' A' ' 246' ' ' ARG . 1.0 OUTLIER -81.89 143.39 31.72 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 176.633 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -97.53 110.36 22.93 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.928 0.394 . . . . 0.0 110.329 178.054 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.569 ' HB2' ' HB3' ' A' ' 246' ' ' ARG . 65.5 mt -113.34 139.13 49.12 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.451 -175.188 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -91.67 137.61 32.22 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.726 173.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 2.5 p -67.37 119.21 12.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.163 0.506 . . . . 0.0 110.284 178.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 115.55 -3.26 21.72 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.266 -177.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -99.08 159.58 14.87 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -177.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 20.8 mm -87.38 122.76 39.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.062 0.458 . . . . 0.0 110.45 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.49 HG13 HG21 ' A' ' 279' ' ' VAL . 21.5 t -102.07 99.2 7.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.906 176.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -78.94 101.75 7.91 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.925 176.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 5.5 p -88.27 123.73 40.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.293 0.568 . . . . 0.0 109.983 179.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 2.4 m -93.83 -35.11 12.88 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.47 -175.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 268' ' ' ARG . . . . . 0.494 ' HA ' ' NE ' ' A' ' 268' ' ' ARG . 3.2 mmp_? -132.6 112.74 12.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.923 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 41.3 mtt -87.83 121.52 30.35 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.455 175.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -95.78 155.55 16.7 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 271' ' ' ILE . . . . . 0.809 ' H ' HD13 ' A' ' 271' ' ' ILE . 0.2 OUTLIER -82.53 -8.61 11.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -172.522 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -80.63 -24.0 39.34 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.717 0.294 . . . . 0.0 111.077 -178.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 123.85 -21.86 6.96 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.569 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -94.97 123.2 38.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.056 0.455 . . . . 0.0 109.805 177.204 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 47.4 m0 -98.3 153.29 18.63 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.929 -176.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -105.45 105.69 15.84 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.492 176.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 277' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -127.41 153.07 19.0 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.207 -178.335 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -107.46 108.62 20.03 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 279' ' ' VAL . . . . . 0.49 HG21 HG13 ' A' ' 264' ' ' VAL . 89.2 t -133.04 128.67 56.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.544 -175.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 59.83 27.5 16.83 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.262 176.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 92.19 -5.92 78.42 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.337 177.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -115.74 134.48 54.98 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 122.714 -0.286 . . . . 0.0 110.768 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 15.7 ptpt -112.87 131.01 55.9 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.038 0.447 . . . . 0.0 110.018 171.343 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -156.04 -175.79 27.43 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.51 -177.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 79.5 mt -98.63 124.31 43.36 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.422 0.629 . . . . 0.0 111.128 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -129.59 135.05 26.93 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.68 177.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.88 140.08 28.33 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.381 2.054 . . . . 0.0 111.461 178.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -64.22 -8.5 12.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.775 -176.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -71.03 -16.6 62.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.045 0.45 . . . . 0.0 111.209 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -101.89 -8.31 21.7 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.827 -176.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.533 HG12 ' HA ' ' A' ' 242' ' ' ALA . 30.2 m -129.61 166.89 26.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.639 0.257 . . . . 0.0 110.783 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 292' ' ' LYS . . . . . 0.606 ' HG2' HD13 ' A' ' 243' ' ' ILE . 28.8 mmtp -137.48 136.26 37.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.966 0.412 . . . . 0.0 110.903 175.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.516 HD13 ' HB2' ' A' ' 240' ' ' ALA . 38.9 mm -82.17 101.85 7.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 174.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -105.81 -7.72 18.15 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.005 -174.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 59.48 93.03 0.06 OUTLIER Pre-proline 0 N--CA 1.464 0.249 0 O-C-N 123.72 0.637 . . . . 0.0 111.465 -176.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 296' ' ' PRO . . . . . 0.542 ' HG3' ' HB2' ' A' ' 239' ' ' PHE . 60.4 Cg_endo -73.95 59.9 4.45 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 122.766 2.311 . . . . 0.0 111.4 175.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 297' ' ' GLN . . . . . 0.428 ' HB3' ' O ' ' A' ' 296' ' ' PRO . 59.3 tt0 78.22 -64.66 0.27 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.05 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 298' ' ' ASN . . . . . 0.41 ' HA ' ' HD2' ' A' ' 299' ' ' PRO . 88.5 m-20 62.36 95.76 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.254 0 O-C-N 123.845 0.716 . . . . 0.0 111.447 178.162 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 299' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 298' ' ' ASN . 33.2 Cg_endo -64.8 -21.92 64.14 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.618 2.212 . . . . 0.0 111.888 177.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 300' ' ' ASP . . . . . 0.485 ' O ' ' HB2' ' A' ' 301' ' ' GLU . 9.5 m-20 -70.62 89.35 0.72 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.923 -178.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 301' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 300' ' ' ASP . 33.4 tt0 165.3 -31.46 0.0 OUTLIER 'General case' 0 C--O 1.233 0.229 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.525 -177.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -78.34 73.19 4.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.166 -175.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 . . . . . 0 C--O 1.248 0.981 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 176.998 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 120.575 0.226 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 p -161.4 120.08 2.43 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 120.959 0.409 . . . . 0.0 111.197 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.6 t -76.13 -32.26 59.03 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 172.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.421 ' HB1' ' HE3' ' A' ' 89' ' ' LYS . . . -74.0 105.59 5.31 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.551 173.305 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -121.32 35.92 4.75 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.357 -172.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -117.51 157.45 26.27 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.107 -179.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -84.63 111.18 19.31 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 174.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.6 m -61.33 -15.49 36.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.183 -174.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.4 p -101.11 -20.88 15.15 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -177.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -77.11 93.99 3.98 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.943 -172.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.436 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 13.4 mtm-85 -61.11 -28.68 69.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.464 -178.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.459 ' HA ' ' NH1' ' A' ' 104' ' ' ARG . 67.7 m -73.83 4.45 5.22 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.799 0.333 . . . . 0.0 111.504 178.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -106.29 -43.8 4.7 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.521 174.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' TRP . . . . . 0.478 ' HB3' ' HB3' ' A' ' 101' ' ' PRO . 19.9 p-90 -114.91 -20.22 10.64 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -172.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.436 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 70.8 t80 -80.69 125.21 29.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.04 0.447 . . . . 0.0 110.92 -175.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.49 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 25.5 mmt -104.63 -6.18 20.72 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.182 -173.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 51.62 -113.36 2.34 Favored Glycine 0 CA--C 1.524 0.606 0 O-C-N 123.419 0.449 . . . . 0.0 113.738 -176.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -69.56 85.51 0.58 Allowed 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 122.924 2.416 . . . . 0.0 113.604 -176.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.468 ' HB ' ' HB2' ' A' ' 39' ' ' ARG . 85.9 t -140.3 156.85 24.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 175.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.583 ' HB3' ' OE1' ' A' ' 23' ' ' GLU . 34.4 t -127.39 -179.32 4.84 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -171.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 45.6 ttt85 -62.05 -53.24 58.28 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -173.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -64.86 -43.13 93.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.729 0.3 . . . . 0.0 110.786 -177.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.583 ' OE1' ' HB3' ' A' ' 20' ' ' SER . 13.6 mp0 -60.22 -51.16 70.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.682 179.189 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.25 -40.87 78.54 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.649 0.737 . . . . 0.0 110.795 176.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.451 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 33.4 tp60 -64.28 -44.28 92.18 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.441 -177.509 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 10.6 t -75.67 -31.25 59.69 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 111.655 0.242 . . . . 0.0 111.655 -176.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.484 ' O ' ' HG3' ' A' ' 31' ' ' GLN . 74.9 mtp180 -74.12 -13.21 60.79 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.711 0.291 . . . . 0.0 111.232 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.593 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 79.8 mt -121.48 -6.0 9.27 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.503 -178.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 19.2 tp60 -65.24 103.34 0.77 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.783 0.325 . . . . 0.0 111.127 -175.293 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.655 ' HA3' ' HB3' ' A' ' 119' ' ' PRO . . . 75.74 9.04 84.96 Favored Glycine 0 C--N 1.329 0.154 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.494 175.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 81.4 mm-40 -73.96 -164.91 0.26 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.998 0.427 . . . . 0.0 111.213 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.486 ' HB3' ' HE3' ' A' ' 35' ' ' MET . 55.2 ttp180 -58.08 125.88 25.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.989 176.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.42 ' HB3' ' CD ' ' A' ' 54' ' ' GLU . 65.0 m170 -72.5 122.14 20.81 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.906 -178.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 108.89 -4.73 32.18 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 -173.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.779 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 43.6 ttm -77.27 129.44 35.89 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 176.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.465 ' HB2' HG22 ' A' ' 52' ' ' VAL . 37.9 p90 -138.99 162.18 35.54 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.34 -177.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.527 ' HG ' HD11 ' A' ' 28' ' ' LEU . 4.6 pp -151.48 141.36 21.98 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.108 0.48 . . . . 0.0 110.777 174.455 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.5 t -107.59 118.79 56.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.59 176.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.468 ' HB2' ' HB ' ' A' ' 19' ' ' VAL . 23.4 ptt-85 -116.25 175.91 5.34 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.318 -176.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -77.7 127.56 32.64 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 173.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.8 t -71.61 121.55 18.97 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.693 -174.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.9 t -83.54 -18.71 37.45 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 170.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 27.2 m -62.59 -44.61 95.88 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.712 174.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.424 ' HA ' ' HD2' ' A' ' 45' ' ' PRO . 51.1 t -150.84 99.59 3.11 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.056 176.126 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 44' ' ' CYS . 10.3 Cg_endo -52.68 132.27 45.22 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.998 2.465 . . . . 0.0 112.213 -179.067 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.24 -34.68 5.52 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -175.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.621 ' OD2' ' HA ' ' A' ' 64' ' ' ASN . 2.7 m-20 -85.25 -177.49 6.51 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 175.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.416 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 27.9 m-85 -130.87 168.47 17.23 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.568 0.223 . . . . 0.0 110.971 -177.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.2 t -138.87 109.52 4.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.065 0.46 . . . . 0.0 110.82 174.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.429 ' CB ' HD11 ' A' ' 63' ' ' ILE . 40.5 tp -84.74 102.04 12.7 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.051 176.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 53.8 m -96.14 126.18 41.18 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 175.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.743 HG21 HD13 ' A' ' 93' ' ' LEU . 58.8 t -121.7 133.53 67.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.257 -175.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.593 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 41.6 t -87.43 121.45 29.88 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -176.146 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.649 ' HG3' ' HB3' ' A' ' 94' ' ' ASP . 0.6 OUTLIER -150.48 148.59 28.91 Favored 'General case' 0 C--O 1.209 -1.076 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.424 165.863 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 40.05 40.56 0.78 Allowed 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -176.699 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.678 ' OG ' ' HA ' ' A' ' 119' ' ' PRO . 7.2 m 57.25 49.86 12.62 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 122.139 0.971 . . . . 0.0 109.267 178.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.488 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 2.6 tmm_? -167.13 64.44 0.09 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 113.906 -1.497 . . . . 0.0 109.711 -151.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.6 t -71.6 113.89 9.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 122.004 0.906 . . . . 0.0 110.612 -166.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.0 m -76.86 120.73 22.41 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 113.915 -1.493 . . . . 0.0 110.807 -177.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -96.35 106.05 18.21 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -176.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.722 ' HB3' HD11 ' A' ' 73' ' ' ILE . 88.7 m-85 -105.7 109.26 21.15 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 122.853 0.461 . . . . 0.0 111.691 179.103 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 66.3 mt -81.31 132.68 30.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -177.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.453 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 5.4 mp -110.07 117.8 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 122.779 0.432 . . . . 0.0 110.481 178.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.621 ' HA ' ' OD2' ' A' ' 47' ' ' ASP . 6.6 m120 -87.75 133.59 33.83 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.194 -175.161 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.7 t -86.8 96.63 10.25 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 170.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.4 mt -70.54 140.22 87.0 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.634 178.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.61 -21.39 31.14 Favored 'Trans proline' 0 CA--C 1.529 0.25 0 C-N-CA 122.86 2.373 . . . . 0.0 112.413 177.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -78.69 7.55 6.74 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.214 176.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.665 ' HE ' ' HA ' ' A' ' 69' ' ' ARG . 7.7 mmp_? 65.39 51.35 1.57 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.738 0.78 . . . . 0.0 110.764 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.44 ' NH2' ' HB3' ' A' ' 77' ' ' GLU . 30.2 mtp180 -137.49 174.01 11.05 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.096 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.561 ' HA ' ' O ' ' A' ' 64' ' ' ASN . 47.2 m-85 -132.09 121.15 23.35 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.15 0.5 . . . . 0.0 111.694 -176.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 1.043 ' HD3' ' HG2' ' A' ' 77' ' ' GLU . 24.5 ttpt -111.91 119.33 38.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.513 176.486 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.722 HD11 ' HB3' ' A' ' 61' ' ' TYR . 2.9 tt -109.3 102.89 14.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.397 0.618 . . . . 0.0 111.068 -176.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.49 61.94 5.52 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.4 177.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 30.6 t70 75.04 -28.63 0.19 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.976 0.51 . . . . 0.0 111.788 175.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -78.23 122.86 26.24 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.698 0.285 . . . . 0.0 110.579 175.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 1.043 ' HG2' ' HD3' ' A' ' 72' ' ' LYS . 30.6 mt-10 -95.53 126.26 40.7 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.792 0.329 . . . . 0.0 110.605 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -121.78 -169.81 1.94 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.388 177.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -82.67 -56.78 3.65 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.07 0.462 . . . . 0.0 110.365 177.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.418 ' HA ' ' HD2' ' A' ' 71' ' ' PHE . 1.6 p80 -157.87 179.95 8.72 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.485 -176.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.655 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 19.6 mt -49.96 -59.17 7.42 Favored Pre-proline 0 N--CA 1.469 0.495 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.655 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 15.4 Cg_exo -68.85 -2.49 9.6 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 121.975 1.783 . . . . 0.0 112.743 -175.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.32 -36.71 12.4 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.063 176.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.4 pp -76.69 -34.68 58.19 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.12 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.565 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 76.2 mt -62.59 -38.01 88.46 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.834 177.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.583 ' HA ' ' HD3' ' A' ' 89' ' ' LYS . 14.4 tp10 -70.63 -34.13 71.75 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 -177.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -70.56 -37.8 74.05 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.321 0.582 . . . . 0.0 110.594 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.529 ' HE2' HD13 ' A' ' 73' ' ' ILE . 21.3 m-85 -78.32 -19.77 52.85 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.743 -177.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.583 ' HD3' ' HA ' ' A' ' 86' ' ' GLU . 50.0 mtpt -62.34 -20.18 64.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.685 172.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 23.9 pt -121.04 18.58 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 120.58 -0.448 . . . . 0.0 112.105 175.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 6.6 t-160 -106.14 -33.23 7.92 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.887 0.375 . . . . 0.0 110.559 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.567 ' N ' HG22 ' A' ' 97' ' ' THR . 52.9 m-85 66.61 91.63 0.08 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.284 -168.305 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.743 HD13 HG21 ' A' ' 52' ' ' VAL . 12.7 mt -60.81 -8.45 3.05 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.989 0.9 . . . . 0.0 110.506 173.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.649 ' HB3' ' HG3' ' A' ' 54' ' ' GLU . 16.1 t70 -161.68 -108.59 0.02 OUTLIER 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 174.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.8 t -117.6 15.56 14.58 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.638 -0.825 . . . . 0.0 111.198 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.462 HG23 ' O ' ' A' ' 97' ' ' THR . 13.3 t -139.71 -19.39 0.93 Allowed 'General case' 0 C--N 1.349 0.544 0 C-N-CA 118.192 -1.403 . . . . 0.0 114.326 -177.075 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.567 HG22 ' N ' ' A' ' 92' ' ' TYR . 6.6 p 74.95 -164.1 0.08 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.845 0.858 . . . . 0.0 109.989 -171.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 42.7 mt -89.6 111.29 22.19 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 175.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.412 HD11 ' O ' ' A' ' 96' ' ' THR . 51.3 mm -105.19 -58.07 4.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -173.368 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.779 ' O ' ' HA ' ' A' ' 35' ' ' MET . 4.7 tp10 -153.72 131.27 6.13 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 -174.072 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.478 ' HB3' ' HB3' ' A' ' 14' ' ' TRP . 28.3 Cg_endo -62.8 166.43 13.95 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 122.764 2.309 . . . . 0.0 112.896 -179.253 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.403 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -75.62 148.17 82.42 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.648 176.182 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.33 106.62 0.31 Allowed 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 122.562 2.175 . . . . 0.0 112.628 -177.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ARG . . . . . 0.459 ' NH1' ' HA ' ' A' ' 12' ' ' SER . 24.1 ttp180 -90.07 -9.97 46.49 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 174.006 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -117.27 114.85 38.39 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.643 177.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.8 129.31 20.65 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 122.693 2.262 . . . . 0.0 112.555 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.737 ' HB3' ' HD3' ' A' ' 108' ' ' PRO . 40.7 t -139.88 -56.86 0.02 OUTLIER Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.394 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.737 ' HD3' ' HB3' ' A' ' 107' ' ' SER . 91.7 Cg_endo -87.2 161.79 8.51 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 121.888 1.725 . . . . 0.0 112.012 177.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 108' ' ' PRO . 10.3 Cg_endo -91.06 -163.86 0.13 Allowed 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 123.015 2.477 . . . . 0.0 111.758 176.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -69.08 -23.0 63.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.679 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -78.44 58.86 4.09 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.545 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 57.8 m -114.39 105.15 12.79 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 176.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.8 p -118.24 -26.48 2.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.172 0.511 . . . . 0.0 110.854 -177.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 32.8 t -87.04 -21.32 26.17 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.797 -177.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.492 ' HB3' ' HD3' ' A' ' 116' ' ' PRO . . . -74.2 -53.3 3.83 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.111 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.492 ' HD3' ' HB3' ' A' ' 115' ' ' ALA . 81.1 Cg_endo -78.58 167.19 23.0 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 121.736 1.624 . . . . 0.0 112.294 178.124 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -92.23 1.39 57.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.458 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 88.8 mt 76.03 131.69 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.368 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.943 173.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.678 ' HA ' ' OG ' ' A' ' 56' ' ' SER . 74.5 Cg_endo -76.97 136.94 17.01 Favored 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 122.886 2.39 . . . . 0.0 113.236 -178.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.777 HG23 ' H ' ' A' ' 121' ' ' ALA . 2.1 t -158.42 -74.08 0.08 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.993 175.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.777 ' H ' HG23 ' A' ' 120' ' ' THR . . . 56.15 -157.54 0.25 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 175.335 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -132.28 -178.6 4.98 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 175.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -87.4 33.15 0.69 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.132 0.491 . . . . 0.0 111.902 -170.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.541 ' O ' ' HB2' ' A' ' 125' ' ' LEU . 4.7 p30 -167.57 -155.59 0.18 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 122.03 -0.419 . . . . 0.0 110.599 -177.667 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 0.601 HD12 HG21 ' A' ' 152' ' ' ILE . 1.0 OUTLIER 80.67 88.07 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.797 0.839 . . . . 0.0 111.36 -174.705 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.685 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 28.0 tt0 174.92 -52.33 0.01 OUTLIER 'General case' 0 C--O 1.22 -0.488 0 CA-C-N 114.005 -1.452 . . . . 0.0 109.26 179.19 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -110.97 105.93 14.87 Favored 'General case' 0 CA--C 1.511 -0.55 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.416 178.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.698 HG22 ' CG ' ' A' ' 180' ' ' LYS . 41.5 t -120.93 127.71 75.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.982 -178.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.605 ' O ' ' HG2' ' A' ' 179' ' ' GLU . 9.3 ptp180 -109.11 140.05 43.19 Favored 'General case' 0 C--O 1.22 -0.452 0 C-N-CA 117.336 -1.745 . . . . 0.0 110.267 173.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.78 HG22 HG12 ' A' ' 178' ' ' VAL . 1.4 p -98.54 139.91 33.57 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.285 -179.001 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.867 ' CD1' ' HG3' ' A' ' 179' ' ' GLU . 62.9 mt -126.39 1.94 6.99 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -178.272 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.521 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 36.7 t80 -93.46 -33.98 13.6 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.677 178.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.586 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 11.7 t70 74.51 101.3 0.07 Allowed 'General case' 0 N--CA 1.467 0.411 0 O-C-N 123.916 0.76 . . . . 0.0 109.868 -177.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.622 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 70.3 t80 -131.61 87.99 44.35 Favored Pre-proline 0 N--CA 1.446 -0.667 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.738 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 97.1 Cg_endo -79.08 88.3 1.47 Allowed 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 121.729 1.62 . . . . 0.0 112.49 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.72 -31.76 32.0 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.89 177.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.796 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 21.8 m120 66.89 35.68 4.74 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.027 0.531 . . . . 0.0 111.563 177.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.454 ' HB3' ' H ' ' A' ' 140' ' ' GLU . 2.6 m-20 -136.39 172.81 12.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.734 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.637 ' O ' ' HA2' ' A' ' 171' ' ' GLY . . . -86.88 -13.79 43.86 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.642 0.734 . . . . 0.0 109.498 171.305 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.676 ' O ' ' HB2' ' A' ' 172' ' ' MET . 3.4 mp0 -94.83 -18.59 21.06 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.635 176.111 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -139.77 102.29 4.4 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 176.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 1.037 HD11 ' HB2' ' A' ' 165' ' ' ASN . 49.9 tp -64.46 129.54 94.23 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -178.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.796 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 27.8 Cg_endo -81.92 88.62 1.3 Allowed 'Trans proline' 0 N--CA 1.439 -1.69 0 C-N-CA 121.239 1.292 . . . . 0.0 111.535 174.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.622 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 20.5 p90 -108.06 165.5 11.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.389 -173.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.586 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 37.0 mttp -109.49 -173.76 2.34 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.253 0.549 . . . . 0.0 111.853 -175.262 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.754 ' H ' ' HD2' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -89.09 21.29 3.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.322 -174.846 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.453 ' HA2' HD23 ' A' ' 131' ' ' LEU . . . -179.96 35.03 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.121 177.235 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -107.68 150.25 27.16 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.073 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.526 HG13 ' HB3' ' A' ' 129' ' ' ARG . 1.9 mp -98.32 131.22 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -177.1 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.81 HD22 HD21 ' A' ' 142' ' ' LEU . 7.7 mt -122.3 169.51 10.86 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -175.455 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.685 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 74.1 t -128.98 122.4 56.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 110.422 -0.214 . . . . 0.0 110.422 178.047 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 1.086 HD13 ' HB2' ' A' ' 163' ' ' ALA . 45.8 mm -75.84 98.59 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -174.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.52 HG21 HG22 ' A' ' 170' ' ' VAL . 19.9 tt -96.07 -32.74 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.581 -173.002 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.573 ' OE2' ' HA ' ' A' ' 93' ' ' LEU . 7.7 mt-10 -115.93 140.05 49.63 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 167.108 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.704 ' HE3' ' HE1' ' A' ' 161' ' ' TRP . 83.7 tttt -127.84 73.66 78.77 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 121.901 -0.499 . . . . 0.0 110.944 170.136 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.512 ' HG2' ' HE2' ' A' ' 172' ' ' MET . 39.9 Cg_exo -61.19 -42.1 38.03 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.439 2.092 . . . . 0.0 112.183 175.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -124.91 -177.91 4.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.4 -175.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.463 ' O ' HG21 ' A' ' 175' ' ' VAL . 0.2 OUTLIER -108.5 -10.92 15.21 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 173.537 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -93.62 -30.95 14.69 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.555 177.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.57 ' CH2' ' HG3' ' A' ' 174' ' ' PRO . 65.0 m95 -124.06 141.71 51.82 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.409 174.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' TRP . . . . . 0.835 ' HB3' HD12 ' A' ' 152' ' ' ILE . 43.9 m0 -132.52 137.97 47.35 Favored 'General case' 0 C--O 1.21 -1.021 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.238 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.593 ' HA ' ' HA ' ' A' ' 172' ' ' MET . 19.0 m -93.34 99.34 11.89 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -174.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 1.086 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -109.09 143.17 38.79 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -171.627 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.8 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 11.1 ptt180 -86.35 119.46 26.64 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 176.651 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 1.037 ' HB2' HD11 ' A' ' 142' ' ' LEU . 16.4 t30 -50.75 170.12 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 113.117 -1.856 . . . . 0.0 111.543 -174.132 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -66.7 -9.14 33.24 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.49 0.662 . . . . 0.0 109.392 174.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -85.91 -18.7 31.99 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.259 171.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.29 56.87 2.2 Favored Glycine 0 CA--C 1.52 0.397 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.422 -174.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.8 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 4.2 ttm-85 -136.61 135.0 37.97 Favored 'General case' 0 C--O 1.216 -0.669 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.566 ' O ' ' HA ' ' A' ' 139' ' ' ALA . 43.0 t -79.66 124.95 38.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.375 -178.145 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.637 ' HA2' ' O ' ' A' ' 139' ' ' ALA . . . -160.86 150.78 20.93 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.856 169.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.676 ' HB2' ' O ' ' A' ' 140' ' ' GLU . 1.5 mmt -67.18 138.2 56.82 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 117.515 0.657 . . . . 0.0 111.187 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.799 HD13 HG11 ' A' ' 178' ' ' VAL . 2.8 pp -134.1 140.06 35.01 Favored Pre-proline 0 N--CA 1.443 -0.799 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.271 179.224 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.734 ' HB2' ' HB2' ' A' ' 177' ' ' TYR . 26.3 Cg_exo -67.77 128.81 18.56 Favored 'Trans proline' 0 C--O 1.212 -0.779 0 C-N-CA 123.243 2.629 . . . . 0.0 112.871 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.532 ' C ' ' H ' ' A' ' 177' ' ' TYR . 88.0 t -64.72 -45.09 75.4 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 178.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 39.5 Cg_endo -67.63 8.96 0.37 Allowed 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 121.996 1.798 . . . . 0.0 111.933 175.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.734 ' HB2' ' HB2' ' A' ' 174' ' ' PRO . 1.5 m-85 -111.79 -5.34 14.42 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.256 -1.338 . . . . 0.0 109.649 -175.448 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.799 HG11 HD13 ' A' ' 173' ' ' ILE . 2.7 m -133.28 171.24 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-O 123.596 1.665 . . . . 0.0 114.717 -167.534 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.867 ' HG3' ' CD1' ' A' ' 131' ' ' LEU . 2.7 mm-40 -140.64 51.88 1.64 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 110.612 -2.995 . . . . 0.0 110.635 -155.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.698 ' CG ' HG22 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -69.69 136.78 51.47 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 120.209 -1.557 . . . . 0.0 109.894 -166.733 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 20.7 tp -63.16 -79.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 112.329 -2.214 . . . . 0.0 113.244 -156.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 40.5 t -78.53 88.09 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.858 0.361 . . . . 0.0 110.349 -176.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ARG . . . . . 0.509 ' HE ' ' ND2' ' A' ' 124' ' ' ASN . 24.3 ttt180 -146.51 -100.29 0.09 Allowed 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.491 177.221 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.447 ' H ' ' HB3' ' A' ' 183' ' ' ARG . 33.9 t 55.91 93.88 0.02 OUTLIER 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -167.063 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 4.4 p -52.67 156.98 2.84 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.076 -177.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -48.79 99.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.877 2.385 . . . . 0.0 113.074 -177.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -119.31 -51.99 2.29 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.66 -0.866 . . . . 0.0 108.66 174.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 115.27 -71.31 0.25 Allowed Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.573 -178.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -109.97 104.44 13.35 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 174.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 74.8 t60 -136.97 -40.55 0.6 Allowed 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.056 -176.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 91.32 -129.87 10.01 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.787 -0.721 . . . . 0.0 113.122 178.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 12.3 m120 68.22 168.77 0.27 Allowed 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 123.566 0.747 . . . . 0.0 111.812 -176.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 20.9 ttm180 70.06 1.4 3.49 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.631 -177.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -100.47 84.63 2.81 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 176.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.822 ' HA ' ' CD1' ' A' ' 198' ' ' TYR . 23.3 t -159.87 118.0 2.69 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.01 0.434 . . . . 0.0 111.1 -178.315 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -135.6 -59.51 0.76 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.537 172.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 24.6 m -92.98 -4.37 52.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.685 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.822 ' CD1' ' HA ' ' A' ' 195' ' ' SER . 71.1 m-85 -69.33 -56.9 6.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.263 0.554 . . . . 0.0 109.515 176.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -73.56 135.83 21.24 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 115.351 -0.841 . . . . 0.0 112.13 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.437 ' HA ' ' HD3' ' A' ' 201' ' ' PRO . 10.6 pt -104.08 132.1 21.32 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-O 120.803 0.335 . . . . 0.0 110.436 178.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 201' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 200' ' ' ILE . 3.9 Cg_exo -75.69 77.59 3.31 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.957 2.438 . . . . 0.0 112.15 -178.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.19 80.13 3.47 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -93.91 -18.32 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.068 2.512 . . . . 0.0 113.5 -177.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -157.69 155.25 29.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.846 0.355 . . . . 0.0 110.295 -176.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 49.7 m80 -107.47 -177.44 3.35 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.546 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -146.66 147.37 30.95 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.999 177.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -88.63 145.31 25.75 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.432 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -133.82 177.07 8.01 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.824 -176.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -111.67 105.39 56.66 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 177.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -56.82 -64.29 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.871 2.381 . . . . 0.0 112.097 -178.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -109.62 109.33 20.06 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.418 178.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 10.8 t -115.63 8.22 14.99 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.632 0.73 . . . . 0.0 109.475 176.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 4.4 m -68.74 102.11 1.46 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.498 178.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.69 ' HB ' ' HD3' ' A' ' 215' ' ' PRO . 25.7 m -88.41 -55.6 0.32 Allowed Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.79 179.49 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.69 ' HD3' ' HB ' ' A' ' 214' ' ' THR . 72.6 Cg_endo -82.37 104.1 1.32 Allowed 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 121.804 1.669 . . . . 0.0 112.804 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 9.6 mp -97.92 116.18 65.7 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.618 177.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -87.75 31.71 0.43 Allowed 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.081 2.521 . . . . 0.0 112.172 178.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -86.68 27.43 0.98 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.7 -174.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.438 HG23 HD11 ' A' ' 285' ' ' LEU . 3.6 p -79.39 86.05 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.867 0.841 . . . . 0.0 110.815 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 35.2 t -86.39 109.5 19.06 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.864 177.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -86.99 80.76 1.72 Allowed Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.769 -176.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.462 ' HA ' ' HD3' ' A' ' 223' ' ' PRO . 14.6 p -82.0 111.85 30.41 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-O 120.701 0.286 . . . . 0.0 110.476 176.446 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.702 ' HA ' ' HB2' ' A' ' 272' ' ' ASN . 5.4 Cg_exo -77.29 101.36 1.49 Allowed 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 123.316 2.677 . . . . 0.0 112.393 -177.155 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -128.15 75.88 0.41 Allowed Glycine 0 N--CA 1.443 -0.87 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 176.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 57.21 -155.61 0.32 Allowed 'General case' 0 C--O 1.235 0.317 0 O-C-N 123.939 0.435 . . . . 0.0 110.25 -175.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.73 ' HB1' ' HE1' ' A' ' 288' ' ' PHE . . . 61.51 31.28 18.97 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.83 0.347 . . . . 0.0 111.85 174.524 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.49 ' O ' ' HD3' ' A' ' 229' ' ' PRO . 38.4 pt -65.67 146.96 12.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.248 179.012 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 8.6 m -110.28 95.84 23.73 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.088 -178.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 227' ' ' ILE . 37.7 Cg_endo -96.77 105.27 0.09 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 123.569 2.846 . . . . 0.0 112.231 177.388 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.478 ' HA ' ' HD3' ' A' ' 231' ' ' PRO . 3.4 pp -82.95 138.83 42.84 Favored Pre-proline 0 C--N 1.323 -0.554 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.271 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 230' ' ' LEU . 5.9 Cg_exo -74.76 71.85 4.68 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 123.173 2.582 . . . . 0.0 113.268 -175.067 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 67.6 p 51.13 27.65 3.53 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.782 0.833 . . . . 0.0 112.966 173.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 46.2 p -77.34 -56.16 4.79 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.973 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 39.22 42.98 0.83 Allowed 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 122.076 0.941 . . . . 0.0 111.207 -177.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -92.61 26.09 2.81 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.539 -1.209 . . . . 0.0 110.853 -175.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 94.27 -148.86 19.17 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.147 177.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -65.85 118.79 5.79 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.549 2.166 . . . . 0.0 111.187 176.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.621 ' HB ' ' HE3' ' A' ' 269' ' ' MET . 3.4 t -83.07 146.06 7.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -178.601 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.406 ' CG ' ' HG3' ' A' ' 296' ' ' PRO . 57.0 m-85 -115.0 131.88 56.78 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.45 0.643 . . . . 0.0 112.02 -172.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.76 ' HB2' HD12 ' A' ' 293' ' ' ILE . . . -133.37 146.03 50.9 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.092 176.384 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.407 ' HB3' HD13 ' A' ' 263' ' ' ILE . 18.5 ptmt -111.38 132.34 54.5 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.693 -0.403 . . . . 0.0 109.952 176.255 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -63.36 117.86 7.25 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.945 -175.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 19.2 pt -98.43 -14.02 7.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.082 -177.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 20.7 tm0? -146.17 138.91 25.53 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 47.7 mttp -52.95 140.0 25.99 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.843 0.83 . . . . 0.0 113.159 -172.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.524 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 21.0 tpt180 -130.42 86.15 2.36 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.969 172.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 19.4 m -95.99 140.89 22.48 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.189 -179.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.41 ' HA ' ' HB3' ' A' ' 255' ' ' ALA . 13.4 Cg_exo -66.96 136.87 42.8 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.405 2.07 . . . . 0.0 111.604 -179.096 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 33.0 t -104.03 175.5 5.46 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.652 -178.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -56.3 -42.88 78.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.994 0.425 . . . . 0.0 111.43 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -85.81 -14.79 44.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.06 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -129.58 70.58 1.42 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.946 0.403 . . . . 0.0 110.185 -176.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -83.73 -14.13 52.35 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 174.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 5.2 p -76.82 -5.81 49.8 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.409 174.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 255' ' ' ALA . . . . . 0.41 ' HB3' ' HA ' ' A' ' 248' ' ' PRO . . . -72.88 139.55 46.95 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.745 178.441 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.07 119.75 23.95 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.524 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -70.03 103.65 2.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.653 178.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 258' ' ' LEU . . . . . 0.496 ' HB2' ' HB3' ' A' ' 246' ' ' ARG . 96.1 mt -112.07 128.03 56.08 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.075 -178.204 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.75 157.17 17.04 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 176.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 47.4 t -67.57 124.18 22.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.985 0.422 . . . . 0.0 110.253 -178.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 98.74 5.65 56.55 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.255 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -93.38 135.42 34.63 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 263' ' ' ILE . . . . . 0.407 HD13 ' HB3' ' A' ' 241' ' ' LYS . 24.8 mm -81.52 121.79 35.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.964 0.411 . . . . 0.0 110.184 177.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.494 HG11 ' CZ ' ' A' ' 286' ' ' PHE . 22.0 t -95.15 109.66 22.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.91 -178.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 43.4 tttp -85.76 87.46 7.41 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.59 176.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.432 HG21 ' HB3' ' A' ' 275' ' ' TRP . 4.0 p -89.92 125.8 42.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.156 0.503 . . . . 0.0 110.59 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 16.1 p -95.8 -32.87 12.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.256 -177.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 268' ' ' ARG . . . . . 0.568 ' HD2' ' OE2' ' A' ' 276' ' ' GLU . 41.3 ttm180 -132.39 118.46 19.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.992 0.425 . . . . 0.0 111.786 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 269' ' ' MET . . . . . 0.621 ' HE3' ' HB ' ' A' ' 238' ' ' VAL . 46.8 mtt -90.78 107.25 19.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.137 172.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 274' ' ' GLN . 26.4 m120 -78.68 137.82 37.99 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 178.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 10.7 tt -79.9 71.46 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 122.153 0.978 . . . . 0.0 110.969 -178.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 272' ' ' ASN . . . . . 0.702 ' HB2' ' HA ' ' A' ' 223' ' ' PRO . 4.3 p30 -168.27 -4.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.852 176.62 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 273' ' ' GLY . . . . . 0.419 ' H ' ' H ' ' A' ' 272' ' ' ASN . . . 119.42 -31.24 5.49 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.159 171.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.415 ' H ' ' HG2' ' A' ' 274' ' ' GLN . 12.1 pt20 -95.46 129.48 42.61 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.04 0.447 . . . . 0.0 110.519 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.432 ' HB3' HG21 ' A' ' 266' ' ' VAL . 50.7 m0 -105.72 154.01 21.06 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.317 -179.154 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.568 ' OE2' ' HD2' ' A' ' 268' ' ' ARG . 43.0 mt-10 -96.0 111.45 23.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.335 172.25 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 277' ' ' GLY . . . . . 0.555 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -134.26 156.56 22.45 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.493 -0.861 . . . . 0.0 111.625 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.548 ' HG2' ' HB2' ' A' ' 283' ' ' LYS . 41.1 mt-10 -117.32 108.08 15.17 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.091 0.472 . . . . 0.0 109.808 178.259 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 279' ' ' VAL . . . . . 0.566 HG12 ' ND2' ' A' ' 280' ' ' ASN . 15.4 t -138.39 137.68 43.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.574 -177.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 280' ' ' ASN . . . . . 0.566 ' ND2' HG12 ' A' ' 279' ' ' VAL . 52.9 m-80 61.64 21.51 12.19 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.604 0.362 . . . . 0.0 111.051 -178.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 90.97 -5.87 81.86 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.979 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 32.7 mtp-105 -110.08 132.45 54.15 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 122.663 -0.316 . . . . 0.0 111.258 -178.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.555 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 2.0 ttmp? -97.11 122.28 39.94 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 168.263 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -150.85 168.5 30.59 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.308 -0.949 . . . . 0.0 111.949 -178.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.438 HD11 HG23 ' A' ' 219' ' ' VAL . 84.6 mt -91.28 138.72 31.36 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.07 0.462 . . . . 0.0 110.313 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.494 ' CZ ' HG11 ' A' ' 264' ' ' VAL . 34.3 p90 -148.14 144.42 18.82 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.663 178.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 287' ' ' PRO . . . . . 0.406 ' HA ' ' O ' ' A' ' 273' ' ' GLY . 84.5 Cg_endo -82.11 144.31 13.25 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.49 2.127 . . . . 0.0 111.542 176.022 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.73 ' HE1' ' HB1' ' A' ' 226' ' ' ALA . 44.3 p90 -65.93 -10.52 39.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.869 0.366 . . . . 0.0 111.89 -176.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 3.0 p -71.94 -4.87 30.85 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -178.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 7.4 m80 -111.29 -2.71 15.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.705 0.288 . . . . 0.0 111.155 -177.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.447 ' HB ' ' HB1' ' A' ' 240' ' ' ALA . 31.2 m -127.58 156.3 39.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.082 0.468 . . . . 0.0 111.371 -176.157 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 44.9 tptt -112.71 111.27 21.94 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.406 177.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.76 HD12 ' HB2' ' A' ' 240' ' ' ALA . 4.0 tp -72.11 141.2 16.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -162.54 -174.66 4.1 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.809 0.338 . . . . 0.0 110.694 -178.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -108.82 106.94 59.63 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.707 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 296' ' ' PRO . . . . . 0.406 ' HG3' ' CG ' ' A' ' 239' ' ' PHE . 87.3 Cg_endo -83.55 2.62 8.23 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.786 2.324 . . . . 0.0 112.471 -178.397 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -95.02 -13.42 25.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.225 -178.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 298' ' ' ASN . . . . . 0.501 ' HA ' ' HD3' ' A' ' 299' ' ' PRO . 94.9 m-20 -63.6 120.96 67.4 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.995 173.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 299' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 298' ' ' ASN . 6.0 Cg_exo -79.46 31.33 0.47 Allowed 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 123.165 2.577 . . . . 0.0 112.497 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 32.0 p-10 -88.18 -63.7 1.26 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.901 0.381 . . . . 0.0 110.616 -179.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -82.21 -37.75 25.57 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 174.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 63.6 t30 53.75 -85.46 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 114.575 -1.193 . . . . 0.0 113.231 175.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.938 -0.554 . . . . 0.0 110.417 -173.973 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ttt . . . . . 0 N--CA 1.479 0.979 0 CA-C-O 120.545 0.212 . . . . 0.0 110.743 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.4 m -95.48 120.52 35.87 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.812 0.339 . . . . 0.0 111.113 -176.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.3 t -76.11 -44.98 36.05 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 169.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.57 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . -77.19 101.28 6.11 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 114.535 -1.212 . . . . 0.0 109.775 174.047 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -131.53 106.81 8.44 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.503 0.668 . . . . 0.0 111.269 -177.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.569 ' CE1' ' HE2' ' A' ' 89' ' ' LYS . 34.3 p90 -168.01 139.44 2.88 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.647 -1.161 . . . . 0.0 108.402 175.048 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -74.1 102.34 4.19 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.208 0.528 . . . . 0.0 110.284 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.1 m -57.73 -32.13 67.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.586 -175.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.4 t -81.47 -2.12 48.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.888 -174.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -103.66 105.83 16.17 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 121.585 -0.697 . . . . 0.0 110.901 -177.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.11 -29.09 70.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.899 178.083 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.8 m -74.79 4.04 7.06 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.974 0.416 . . . . 0.0 110.731 178.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -99.05 -30.48 12.3 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.558 175.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 36.6 p-90 -138.2 -20.83 1.08 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -171.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -77.14 115.41 16.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.041 0.448 . . . . 0.0 110.15 -174.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' MET . . . . . 0.582 ' HG3' ' HB2' ' A' ' 37' ' ' LEU . 25.1 mmt -97.94 -7.68 29.62 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.991 -175.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.483 ' O ' ' HB2' ' A' ' 39' ' ' ARG . . . 50.78 -111.69 1.34 Allowed Glycine 0 CA--C 1.523 0.577 0 O-C-N 123.694 0.622 . . . . 0.0 113.427 -178.543 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.435 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 4.4 Cg_exo -76.87 103.18 1.71 Allowed 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.845 2.363 . . . . 0.0 112.417 -179.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.724 ' HB ' ' HG3' ' A' ' 39' ' ' ARG . 2.9 t -138.13 -69.87 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.758 -178.405 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.527 ' H ' ' HG3' ' A' ' 39' ' ' ARG . 21.4 t 95.85 162.89 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 124.662 1.185 . . . . 0.0 109.083 172.431 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.432 ' O ' ' HG2' ' A' ' 25' ' ' GLN . 69.8 mtp85 -55.78 -44.56 77.83 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 123.04 0.212 . . . . 0.0 110.804 -175.062 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.87 -46.95 74.79 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 123.993 0.808 . . . . 0.0 110.718 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.52 ' HB3' HG13 ' A' ' 19' ' ' VAL . 14.1 tp10 -76.24 -46.91 25.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.298 0.57 . . . . 0.0 110.469 -175.303 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.11 -39.6 75.38 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.99 -176.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' A' ' 21' ' ' ARG . 20.2 pt20 -75.34 -33.15 61.09 Favored 'General case' 0 C--O 1.219 -0.513 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -173.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.1 t -75.48 -32.14 60.46 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.149 -176.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -84.22 -7.07 59.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.947 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.6 HD21 ' HB2' ' A' ' 102' ' ' ALA . 97.0 mt -125.97 13.3 7.87 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.639 175.538 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.407 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 27.3 tp60 -72.36 84.72 1.08 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.634 ' HA2' ' HA ' ' A' ' 56' ' ' SER . . . 85.12 -64.81 4.15 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.518 -178.285 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 39.87 -125.8 0.4 Allowed 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 123.257 0.623 . . . . 0.0 112.222 -176.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.451 ' HA ' ' HB3' ' A' ' 116' ' ' PRO . 20.1 ptp180 -106.73 -7.24 17.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.242 -0.436 . . . . 0.0 109.876 178.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 37.7 m80 67.91 153.15 0.09 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.254 -173.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.98 -0.79 76.69 Favored Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.881 -177.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.674 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 37.1 mtm -104.7 147.51 27.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.749 0.309 . . . . 0.0 110.566 -178.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.427 ' CB ' HG22 ' A' ' 52' ' ' VAL . 43.2 p90 -143.27 169.42 17.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.49 -178.385 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.582 ' HB2' ' HG3' ' A' ' 16' ' ' MET . 4.5 pp -158.21 143.76 16.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.012 0.434 . . . . 0.0 110.769 173.485 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.5 t -115.44 112.66 40.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 175.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.724 ' HG3' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -121.66 167.75 12.57 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.407 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -62.28 137.93 58.34 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 28.4 t -66.63 126.11 27.9 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.282 0.563 . . . . 0.0 111.298 -173.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.4 p -86.13 6.44 29.2 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.591 174.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.8 -39.73 8.47 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.046 179.329 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.475 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 71.1 m -149.66 137.4 11.61 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.956 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 44' ' ' CYS . 38.2 Cg_exo -61.15 -32.5 91.15 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.283 2.655 . . . . 0.0 113.799 -175.122 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -101.84 33.06 6.81 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.849 -176.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.635 ' OD1' ' HA ' ' A' ' 64' ' ' ASN . 15.6 m-20 -138.71 167.56 21.71 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 110.375 -0.232 . . . . 0.0 110.375 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.427 ' CD2' HD11 ' A' ' 81' ' ' LEU . 16.7 m-85 -126.42 170.62 11.77 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 174.145 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.409 ' HB ' ' NH1' ' A' ' 39' ' ' ARG . 44.8 t -144.16 115.96 2.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-O 121.002 0.43 . . . . 0.0 111.653 176.299 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.5 tp -82.7 106.05 14.23 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.025 174.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.8 m -96.82 129.04 44.31 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 176.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.721 HG12 ' HG2' ' A' ' 54' ' ' GLU . 70.8 t -121.9 134.56 64.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.843 -176.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.573 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 41.0 t -88.04 99.18 11.97 Favored 'General case' 0 CA--C 1.513 -0.442 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.965 -177.062 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.721 ' HG2' HG12 ' A' ' 52' ' ' VAL . 65.5 mm-40 -144.94 142.08 29.55 Favored 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 119.51 -0.876 . . . . 0.0 109.403 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 61.04 15.81 6.51 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.594 0.558 . . . . 0.0 111.927 -178.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.634 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 27.4 m 58.89 54.55 5.05 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 122.935 1.35 . . . . 0.0 107.374 -173.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.593 HH22 ' CG ' ' A' ' 94' ' ' ASP . 0.1 OUTLIER -167.01 67.88 0.09 Allowed 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 112.26 -2.245 . . . . 0.0 108.831 -151.638 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 9.9 t -69.63 100.52 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.815 0.816 . . . . 0.0 109.777 -167.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 50.9 m -74.76 120.72 20.69 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 114.213 -1.358 . . . . 0.0 110.474 -178.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 -93.29 103.28 15.53 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.003 -177.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.657 ' HB3' HD11 ' A' ' 73' ' ' ILE . 58.5 m-85 -91.35 104.29 16.83 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.159 177.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 59.9 mt -79.46 125.76 38.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.848 0.356 . . . . 0.0 111.758 -175.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.457 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 4.6 mp -103.51 109.93 28.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.471 178.277 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.635 ' HA ' ' OD1' ' A' ' 47' ' ' ASP . 15.4 m120 -83.13 160.41 21.87 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.735 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.6 t -99.87 109.7 22.08 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 172.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.552 HD11 ' HB2' ' A' ' 72' ' ' LYS . 85.3 mt -78.68 153.25 78.31 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.327 -176.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -62.9 -14.58 41.95 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.668 2.245 . . . . 0.0 111.655 173.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -81.65 8.63 9.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.618 177.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? 62.9 29.0 16.56 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.587 0.708 . . . . 0.0 110.014 -177.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 27.8 mtp180 -124.34 -174.9 3.12 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.581 -177.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PHE . . . . . 0.457 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 72.9 m-85 -122.12 151.37 41.01 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.551 0.215 . . . . 0.0 111.027 -177.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.581 ' HE3' ' O ' ' A' ' 75' ' ' ASP . 86.5 tttt -138.89 113.81 9.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.767 -175.492 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.657 HD11 ' HB3' ' A' ' 61' ' ' TYR . 20.3 tt -89.87 100.48 10.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.858 0.837 . . . . 0.0 110.916 -174.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.45 -65.04 2.45 Favored Glycine 0 CA--C 1.519 0.29 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.95 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.581 ' O ' ' HE3' ' A' ' 72' ' ' LYS . 20.0 t70 -154.15 -29.56 0.12 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.024 0.44 . . . . 0.0 110.221 -176.284 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -85.48 121.7 28.56 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -93.49 145.87 24.19 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.226 0.536 . . . . 0.0 111.288 -175.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.441 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 86.3 m-85 -131.94 -173.73 3.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.815 178.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -74.94 -61.7 1.8 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.555 178.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -146.27 -179.1 6.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.272 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.56 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 7.5 mt -56.27 -56.9 26.48 Favored Pre-proline 0 N--CA 1.467 0.405 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -178.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.469 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 50.9 Cg_exo -57.79 -10.52 7.58 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.399 2.066 . . . . 0.0 113.607 178.108 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.04 -32.93 17.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.554 0.216 . . . . 0.0 111.034 -175.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.1 pp -76.6 -33.89 58.4 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.401 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 77.6 mt -65.25 -31.21 72.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.603 178.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -72.85 -39.82 66.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.267 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.43 ' CE2' ' ND1' ' A' ' 91' ' ' HIS . 68.6 t80 -68.03 -30.94 70.29 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.405 -178.61 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.43 ' HE2' HD13 ' A' ' 73' ' ' ILE . 27.8 m-85 -84.08 2.3 40.0 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -176.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.569 ' HE2' ' CE1' ' A' ' 6' ' ' PHE . 96.4 mttt -80.47 -15.82 55.82 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.335 172.419 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.7 pp -126.74 9.39 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.14 0 CA-C-O 121.385 0.612 . . . . 0.0 110.556 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.44 ' O ' ' HB2' ' A' ' 92' ' ' TYR . 9.1 t60 -94.32 -42.43 8.91 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.713 -177.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.448 ' H ' HG22 ' A' ' 97' ' ' THR . 75.8 m-85 65.53 95.72 0.05 Allowed 'General case' 0 C--N 1.329 -0.318 0 O-C-N 124.402 1.063 . . . . 0.0 109.054 -163.149 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.625 ' O ' ' HB3' ' A' ' 154' ' ' GLU . 30.8 mt -61.07 -92.8 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 173.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.593 ' CG ' HH22 ' A' ' 57' ' ' ARG . 20.6 t0 -99.83 86.3 3.26 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.104 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.845 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 2.2 t 48.6 15.18 0.08 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.815 -1.084 . . . . 0.0 112.665 -176.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -156.75 153.17 27.96 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 120.966 0.412 . . . . 0.0 110.383 -177.065 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.448 HG22 ' H ' ' A' ' 92' ' ' TYR . 7.5 p -98.15 168.28 10.35 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.133 -179.256 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 97.3 mt -70.08 92.67 0.75 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 177.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.57 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 37.4 mm -78.18 -59.29 3.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.34 -174.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.674 ' O ' ' HA ' ' A' ' 35' ' ' MET . 38.4 tt0 -155.8 135.4 8.11 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.14 -176.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -62.12 157.1 46.23 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.791 2.327 . . . . 0.0 113.023 -178.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.6 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -68.91 142.87 93.97 Favored Pre-proline 0 N--CA 1.452 -0.366 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.131 177.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -60.91 124.78 15.63 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.604 2.203 . . . . 0.0 112.362 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -100.82 3.55 42.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.746 176.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.576 ' HB3' ' HD3' ' A' ' 106' ' ' PRO . 80.1 t80 -153.6 -58.8 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.433 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.576 ' HD3' ' HB3' ' A' ' 105' ' ' TYR . 60.2 Cg_endo -73.55 109.85 2.94 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 121.912 1.741 . . . . 0.0 112.191 -178.265 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 50.5 m -152.66 107.4 2.72 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-O 120.8 0.333 . . . . 0.0 111.211 -178.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.45 ' HA ' ' HD2' ' A' ' 109' ' ' PRO . 17.5 Cg_endo -88.93 119.47 1.01 Allowed 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.283 2.656 . . . . 0.0 111.606 176.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.45 ' HD2' ' HA ' ' A' ' 108' ' ' PRO . 19.4 Cg_endo -59.76 -35.59 93.97 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.78 2.32 . . . . 0.0 112.792 -177.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 18.8 ptp -88.74 22.97 2.45 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.955 0.407 . . . . 0.0 110.957 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -77.2 83.05 1.1 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.827 -0.701 . . . . 0.0 111.549 176.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.9 p -75.39 101.53 4.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.071 0.462 . . . . 0.0 111.253 -178.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.7 p -80.67 110.71 16.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.348 0.594 . . . . 0.0 110.442 178.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 13.5 p -90.37 -35.46 15.19 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.936 -178.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -142.59 108.55 5.6 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.448 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.451 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 2.1 Cg_endo -81.08 -177.47 3.73 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.968 2.445 . . . . 0.0 111.753 178.073 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 14.1 t30 -67.51 -63.15 1.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.501 HD12 ' OE1' ' A' ' 54' ' ' GLU . 74.0 mt -96.57 156.88 36.2 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.708 169.37 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -88.09 -154.86 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.231 2.62 . . . . 0.0 110.376 165.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 26.5 m -122.25 105.47 10.25 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 174.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -72.97 -72.27 0.26 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.697 -174.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.49 ' OE1' HD21 ' A' ' 125' ' ' LEU . 43.3 tt0 -134.95 113.34 11.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.378 -175.135 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -75.11 73.3 2.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.386 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.701 ' HA ' ' HD3' ' A' ' 186' ' ' PRO . 22.1 m120 -160.44 -147.38 0.15 Allowed 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -176.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LEU . . . . . 1.004 HD12 HG21 ' A' ' 152' ' ' ILE . 1.4 mm? 76.06 105.24 0.07 Allowed 'General case' 0 C--N 1.351 0.667 0 O-C-N 123.55 0.531 . . . . 0.0 111.811 166.352 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.756 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 0.0 OUTLIER -171.83 -61.59 0.02 OUTLIER 'General case' 0 C--O 1.215 -0.729 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.566 -179.926 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.556 ' N ' ' HG2' ' A' ' 126' ' ' GLU . 50.1 m-85 -115.21 108.44 16.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.394 0.616 . . . . 0.0 111.843 179.296 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.944 HG22 ' HG3' ' A' ' 180' ' ' LYS . 38.8 t -126.88 136.13 61.67 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.287 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.398 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.645 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 5.7 ptp180 -113.39 153.75 28.06 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 117.789 -1.564 . . . . 0.0 108.915 172.089 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.546 HG22 HG12 ' A' ' 178' ' ' VAL . 68.2 p -102.74 140.17 37.36 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.512 0.672 . . . . 0.0 111.757 178.216 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.553 HD21 ' HG2' ' A' ' 179' ' ' GLU . 9.8 mt -113.4 -16.26 12.49 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.89 178.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.442 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 21.7 t80 -82.72 -39.66 21.65 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.313 -174.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ASP . . . . . 0.689 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 13.6 t70 72.82 104.81 0.07 Allowed 'General case' 0 N--CA 1.468 0.443 0 O-C-N 123.695 0.622 . . . . 0.0 110.873 -177.219 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.546 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 67.0 t80 -132.12 94.14 24.7 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 174.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.677 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 69.8 Cg_endo -87.05 92.25 0.53 Allowed 'Trans proline' 0 N--CA 1.442 -1.507 0 C-N-CA 121.667 1.578 . . . . 0.0 112.893 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -88.54 -25.51 30.21 Favored Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.672 174.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ASN . . . . . 0.52 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 0.8 OUTLIER 60.13 52.28 5.16 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.385 0.674 . . . . 0.0 111.933 178.685 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ASP . . . . . 0.438 ' HB3' ' H ' ' A' ' 140' ' ' GLU . 0.9 OUTLIER -138.57 172.89 12.21 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.794 177.99 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -89.32 -13.15 38.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.924 0.869 . . . . 0.0 109.084 172.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.666 ' O ' ' HB2' ' A' ' 172' ' ' MET . 5.9 mm-40 -93.02 -35.25 13.36 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.994 176.393 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -125.72 109.69 12.87 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.817 177.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 1.052 HD11 ' HB2' ' A' ' 165' ' ' ASN . 34.2 tp -69.35 130.76 90.65 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.002 -176.252 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' PRO . . . . . 0.677 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 73.7 Cg_endo -82.26 88.69 1.26 Allowed 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 121.867 1.711 . . . . 0.0 112.071 171.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.546 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 22.3 p90 -100.25 172.92 6.87 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -176.538 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.689 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 14.1 mptt -122.92 -164.59 1.21 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -168.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.56 ' HD2' ' N ' ' A' ' 146' ' ' LYS . 7.6 mptt -85.39 1.29 49.23 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.59 -174.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -177.39 30.86 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.612 -178.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.682 ' OE2' ' HG ' ' A' ' 150' ' ' LEU . 1.6 pp20? -73.06 169.92 15.98 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 175.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.6 mp -117.89 128.46 75.02 Favored 'Isoleucine or valine' 0 C--N 1.35 0.619 0 CA-C-N 118.498 0.59 . . . . 0.0 110.083 173.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.862 ' CD2' ' HA ' ' A' ' 165' ' ' ASN . 86.0 mt -118.38 158.67 24.83 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-O 121.51 0.671 . . . . 0.0 110.493 -173.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.756 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 97.2 t -128.08 121.07 55.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.187 174.217 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 1.075 HD13 ' HB2' ' A' ' 163' ' ' ALA . 26.6 mm -78.83 84.0 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 CA-C-O 121.826 0.822 . . . . 0.0 109.134 -176.258 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.785 HG23 ' HG2' ' A' ' 154' ' ' GLU . 20.9 tt -73.94 -32.83 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.535 -176.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLU . . . . . 0.785 ' HG2' HG23 ' A' ' 153' ' ' ILE . 0.0 OUTLIER -125.46 144.84 50.35 Favored 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 175.753 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -131.94 76.59 73.51 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-O 121.453 0.644 . . . . 0.0 109.638 168.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.845 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 15.6 Cg_exo -66.88 -47.67 2.43 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.512 2.142 . . . . 0.0 111.581 176.122 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -112.19 -170.97 1.76 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.629 -177.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -124.85 -14.45 6.69 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.24 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -89.96 -21.35 22.47 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 168.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.667 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 80.9 m95 -125.97 139.15 53.67 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.171 177.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' TRP . . . . . 0.752 ' O ' HG13 ' A' ' 173' ' ' ILE . 45.7 m0 -128.37 137.39 51.87 Favored 'General case' 0 C--O 1.206 -1.187 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.25 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.563 ' HA ' ' HA ' ' A' ' 172' ' ' MET . 6.3 m -97.67 102.68 14.5 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -172.22 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 1.075 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -115.53 147.09 41.09 Favored 'General case' 0 N--CA 1.415 -2.2 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.489 -171.256 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.753 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 13.5 ptt-85 -86.64 127.26 34.92 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 175.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ASN . . . . . 1.052 ' HB2' HD11 ' A' ' 142' ' ' LEU . 61.5 t30 -62.41 177.03 0.55 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.875 -169.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.536 ' HB2' ' HB2' ' A' ' 148' ' ' GLU . 40.5 tptt -50.86 -26.42 5.78 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.331 164.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -69.51 -43.04 73.9 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.832 173.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 113.12 -5.02 25.4 Favored Glycine 0 CA--C 1.516 0.146 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.276 -170.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ARG . . . . . 0.753 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.6 OUTLIER -71.29 135.82 47.6 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 123.389 0.675 . . . . 0.0 111.692 -178.819 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 59.6 t -83.48 123.44 38.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 C-N-CA 121.202 -0.199 . . . . 0.0 110.491 177.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -160.76 158.25 29.77 Favored Glycine 0 C--O 1.227 -0.299 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.68 173.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' MET . . . . . 0.667 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.6 OUTLIER -74.89 140.67 43.97 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 117.234 0.517 . . . . 0.0 112.001 -178.19 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.752 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.8 pp -137.09 140.49 31.47 Favored Pre-proline 0 N--CA 1.451 -0.418 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.368 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' PRO . . . . . 0.602 ' O ' HG13 ' A' ' 178' ' ' VAL . 6.3 Cg_exo -76.56 127.04 9.38 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.969 2.446 . . . . 0.0 113.115 -175.467 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.601 ' O ' HG22 ' A' ' 178' ' ' VAL . 59.4 t -53.23 -45.3 98.41 Favored Pre-proline 0 CA--C 1.542 0.635 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 177.05 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 27.7 Cg_endo -63.44 -1.0 2.72 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.044 1.83 . . . . 0.0 113.318 176.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.475 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.1 m-30 -104.26 -10.01 18.17 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.588 0.232 . . . . 0.0 111.351 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.647 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 5.0 m -108.16 -171.96 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 115.786 1.773 . . . . 0.0 115.786 -162.192 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' GLU . . . . . 0.645 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 5.1 tp10 -155.75 50.95 0.55 Allowed 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 113.009 -1.905 . . . . 0.0 113.503 -153.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' LYS . . . . . 0.944 ' HG3' HG22 ' A' ' 128' ' ' VAL . 3.6 mppt? -67.28 136.44 54.91 Favored 'General case' 0 CA--C 1.518 -0.259 0 O-C-N 119.498 -2.001 . . . . 0.0 109.012 -165.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 61.5 tp -54.2 -90.97 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 112.583 -2.099 . . . . 0.0 112.369 -165.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 17.1 m -118.86 -34.87 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 172.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 11.0 ttp180 60.09 -82.34 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 114.274 -1.33 . . . . 0.0 111.543 175.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 25.6 m 66.45 -67.9 0.15 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.222 0.609 . . . . 0.0 110.106 -173.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 17.8 p 170.09 160.61 0.2 Allowed Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 175.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' PRO . . . . . 0.701 ' HD3' ' HA ' ' A' ' 124' ' ' ASN . 96.4 Cg_exo -43.04 -61.37 0.57 Allowed 'Trans proline' 0 C--O 1.237 0.446 0 C-N-CA 122.85 2.366 . . . . 0.0 113.132 -176.537 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 28.2 m80 68.27 -47.6 0.54 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.483 0.713 . . . . 0.0 111.966 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 105.95 -22.61 31.24 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 111.629 -0.588 . . . . 0.0 111.629 -178.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -137.07 25.07 3.01 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -175.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -77.37 84.9 3.79 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 121.783 0.801 . . . . 0.0 110.669 179.141 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 100.72 133.53 8.17 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.597 -176.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -77.71 70.27 4.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.22 0.534 . . . . 0.0 109.664 178.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 68.69 -70.54 0.13 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.588 -176.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 19.5 m120 50.74 28.35 3.55 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.206 0.603 . . . . 0.0 111.953 178.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 20.2 m -108.46 114.57 28.51 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.461 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -126.64 141.53 51.83 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.941 -176.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 16.0 m -68.8 -28.15 66.51 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.155 0.502 . . . . 0.0 110.455 176.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -88.78 -171.25 3.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.345 -176.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 134.8 -31.33 2.74 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 -174.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 49.7 mm 71.86 103.97 0.03 OUTLIER Pre-proline 0 C--O 1.235 0.308 0 C-N-CA 123.483 0.713 . . . . 0.0 111.855 175.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -66.44 147.21 82.25 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.706 2.271 . . . . 0.0 111.441 174.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.618 ' HB2' ' HD3' ' A' ' 203' ' ' PRO . 2.2 mp0 -58.53 -55.83 41.83 Favored Pre-proline 0 CA--C 1.538 0.5 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.945 -177.32 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 203' ' ' PRO . . . . . 0.618 ' HD3' ' HB2' ' A' ' 202' ' ' GLU . 19.3 Cg_endo -92.05 30.36 0.32 Allowed 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.456 2.104 . . . . 0.0 112.746 -177.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -75.96 -40.15 54.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.864 0.364 . . . . 0.0 110.871 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -107.29 121.78 45.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.953 0.406 . . . . 0.0 110.963 178.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -111.27 113.92 26.75 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.718 177.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -65.53 125.43 25.15 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.293 -175.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -72.38 141.91 48.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.184 -178.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' GLN . . . . . 0.468 ' HA ' ' HD3' ' A' ' 210' ' ' PRO . 72.9 mt-30 -69.48 133.85 88.91 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.794 178.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 209' ' ' GLN . 8.0 Cg_exo -74.06 152.33 45.64 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.936 2.424 . . . . 0.0 111.162 173.41 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -127.46 145.99 50.64 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.123 0.487 . . . . 0.0 111.162 -178.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 87.3 m -155.31 117.0 4.05 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.516 177.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 26.4 m -79.62 91.07 5.18 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.295 0.569 . . . . 0.0 110.602 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.434 ' OG1' ' HD3' ' A' ' 215' ' ' PRO . 0.0 OUTLIER -83.71 -49.53 0.69 Allowed Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.385 178.185 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.434 ' HD3' ' OG1' ' A' ' 214' ' ' THR . 11.3 Cg_exo -70.74 88.59 0.65 Allowed 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 122.122 1.881 . . . . 0.0 112.387 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.744 ' HB2' ' HD3' ' A' ' 217' ' ' PRO . 95.3 mt -93.6 -53.25 0.25 Allowed Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.466 176.178 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.744 ' HD3' ' HB2' ' A' ' 216' ' ' LEU . 22.0 Cg_exo -67.33 -28.18 39.8 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 121.944 1.763 . . . . 0.0 111.764 174.333 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . 64.79 -170.37 0.19 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.853 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 33.9 m -113.08 -4.21 11.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.038 0.446 . . . . 0.0 110.877 178.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 28.5 m -79.59 113.84 18.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.194 178.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -174.13 95.18 0.1 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.669 -178.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 8.2 t -115.18 97.23 47.64 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -179.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -80.07 131.64 8.99 Favored 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.79 2.327 . . . . 0.0 112.318 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -99.01 121.15 7.11 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.437 -178.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -87.65 87.42 7.38 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.103 0.478 . . . . 0.0 110.765 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' ALA . . . . . 0.813 ' HA ' HD12 ' A' ' 230' ' ' LEU . . . -81.12 74.65 8.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.538 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 227' ' ' ILE . . . . . 0.663 HG13 ' H ' ' A' ' 228' ' ' THR . 8.7 pt -132.91 -69.65 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -176.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.663 ' H ' HG13 ' A' ' 227' ' ' ILE . 2.5 m -106.67 -59.32 0.05 OUTLIER Pre-proline 0 CA--C 1.541 0.609 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -168.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.603 ' HD3' ' HB ' ' A' ' 228' ' ' THR . 84.7 Cg_endo -80.54 10.92 3.09 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.218 1.945 . . . . 0.0 114.335 -169.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.813 HD12 ' HA ' ' A' ' 226' ' ' ALA . 68.7 mt -104.34 111.75 65.26 Favored Pre-proline 0 C--N 1.321 -0.632 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.173 -178.251 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -80.83 112.6 2.67 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.31 2.673 . . . . 0.0 111.632 178.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 32.9 t 63.52 -81.5 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 123.148 0.579 . . . . 0.0 110.392 -174.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 29.6 p 48.84 -165.69 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.723 0.809 . . . . 0.0 112.86 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -97.71 83.62 3.23 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.505 178.306 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -101.76 5.65 41.36 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.006 0.431 . . . . 0.0 110.429 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 175.98 96.02 0.1 Allowed Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.794 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -66.28 124.71 12.89 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.596 2.198 . . . . 0.0 111.759 178.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.45 HG11 HD12 ' A' ' 293' ' ' ILE . 20.1 t -94.19 143.84 10.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.079 -178.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 239' ' ' PHE . . . . . 0.518 ' HB2' ' HG3' ' A' ' 296' ' ' PRO . 95.3 m-85 -111.8 124.21 51.87 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.503 -178.131 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 240' ' ' ALA . . . . . 0.412 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -119.7 127.62 53.04 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.076 179.115 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 241' ' ' LYS . . . . . 0.43 ' HB2' ' CE1' ' A' ' 294' ' ' PHE . 50.5 tttp -85.92 119.38 26.17 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -178.084 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 242' ' ' ALA . . . . . 0.479 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -71.03 106.84 3.84 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.542 -178.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.749 HG12 ' HG3' ' A' ' 292' ' ' LYS . 2.6 pp -104.56 -14.74 8.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.168 -177.313 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 244' ' ' GLN . . . . . 0.432 ' HB2' HD12 ' A' ' 243' ' ' ILE . 4.5 tm0? -130.76 137.95 49.72 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 175.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -62.3 163.6 8.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.409 0.623 . . . . 0.0 111.944 -173.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' ARG . . . . . 0.615 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -145.78 121.43 10.47 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 177.898 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 16.5 m -122.36 139.18 30.27 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-O 120.795 0.331 . . . . 0.0 110.753 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.475 ' HD3' ' HB2' ' A' ' 257' ' ' ALA . 42.5 Cg_endo -68.98 125.75 12.95 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.645 2.23 . . . . 0.0 112.249 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 249' ' ' CYS . . . . . 0.549 ' HB3' ' HB2' ' A' ' 252' ' ' ASP . 16.5 t -90.64 172.45 8.67 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -55.71 -47.59 76.59 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.945 0.402 . . . . 0.0 111.283 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -87.68 -6.31 58.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.767 179.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.549 ' HB2' ' HB3' ' A' ' 249' ' ' CYS . 2.9 m-20 -114.48 52.11 0.86 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.342 178.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -71.02 -13.51 62.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.32 0.581 . . . . 0.0 109.865 177.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 2.7 p -89.25 -8.22 53.91 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.969 176.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -76.71 123.18 25.79 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.687 -178.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 256' ' ' LEU . . . . . 0.417 ' HA ' HH11 ' A' ' 282' ' ' ARG . 0.6 OUTLIER -70.33 139.34 51.99 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.629 -178.295 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 257' ' ' ALA . . . . . 0.615 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -89.15 117.55 28.22 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.094 0.473 . . . . 0.0 109.921 176.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 35.4 mt -129.14 157.76 40.88 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.928 -176.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -136.86 160.29 39.31 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 260' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 21.7 t -66.29 105.32 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.087 -172.071 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 130.6 10.7 2.56 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.689 175.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -118.41 157.57 26.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 117.879 0.839 . . . . 0.0 111.375 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 37.2 mm -94.04 124.07 46.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.753 -178.158 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 32.0 t -95.5 111.02 25.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.957 175.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -95.28 97.26 9.73 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.563 -178.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 266' ' ' VAL . . . . . 0.493 ' HA ' ' HA2' ' A' ' 277' ' ' GLY . 6.6 p -88.41 134.89 26.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.704 -0.399 . . . . 0.0 110.394 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 22.1 p -92.93 -44.1 8.61 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.512 -176.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 29.3 ptt180 -131.21 126.46 35.62 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 121.365 0.602 . . . . 0.0 110.951 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 40.1 mmm -83.08 110.44 18.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.527 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 270' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 274' ' ' GLN . 86.9 m-20 -85.4 126.97 34.2 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.283 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 22.8 mt -70.73 -18.62 21.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.295 -175.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -61.88 -23.89 66.59 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.702 0.287 . . . . 0.0 111.162 -178.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 109.19 21.79 7.17 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.746 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.504 ' HA ' ' CZ ' ' A' ' 288' ' ' PHE . 37.9 mt-30 -151.56 111.35 4.03 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 167.556 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 1.3 m0 -92.08 164.81 13.46 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -176.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 276' ' ' GLU . . . . . 0.668 ' HB3' ' HE2' ' A' ' 283' ' ' LYS . 43.3 mt-10 -104.78 117.98 35.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.128 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 277' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -122.01 142.33 14.97 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.725 -178.197 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -99.38 111.52 23.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.817 0.818 . . . . 0.0 109.922 175.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 95.7 t -124.39 158.03 31.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.74 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -61.8 82.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.732 0.777 . . . . 0.0 110.79 175.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 160.85 -35.77 0.42 Allowed Glycine 0 N--CA 1.441 -0.996 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.17 -177.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 282' ' ' ARG . . . . . 0.438 HH11 ' HD2' ' A' ' 282' ' ' ARG . 42.8 ttm105 177.92 159.71 0.49 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 117.054 0.427 . . . . 0.0 110.197 -178.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.668 ' HE2' ' HB3' ' A' ' 276' ' ' GLU . 2.5 tmtp? -110.1 101.17 9.99 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 171.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -151.96 -168.92 16.84 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.926 -172.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 73.2 mt -90.73 149.15 22.15 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.859 0.361 . . . . 0.0 110.455 -177.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 286' ' ' PHE . . . . . 0.421 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 42.0 p90 -143.91 152.54 55.58 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.402 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 287' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 2.3 Cg_endo -81.37 145.3 14.92 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 123.346 2.697 . . . . 0.0 111.752 177.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 288' ' ' PHE . . . . . 0.504 ' CZ ' ' HA ' ' A' ' 274' ' ' GLN . 3.6 m-85 -91.73 -5.47 53.59 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.116 0.414 . . . . 0.0 112.116 -167.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 4.5 m -94.4 -19.73 20.35 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.325 0.583 . . . . 0.0 109.887 175.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -77.23 -22.43 52.24 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.574 177.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 291' ' ' VAL . . . . . 0.479 HG12 ' HA ' ' A' ' 242' ' ' ALA . 28.5 m -117.19 164.49 13.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.235 178.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 292' ' ' LYS . . . . . 0.749 ' HG3' HG12 ' A' ' 243' ' ' ILE . 98.1 mttt -119.39 119.92 35.35 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.609 177.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 293' ' ' ILE . . . . . 0.45 HD12 HG11 ' A' ' 238' ' ' VAL . 18.9 mm -74.63 110.69 9.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 172.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 294' ' ' PHE . . . . . 0.43 ' CE1' ' HB2' ' A' ' 241' ' ' LYS . 2.3 p90 -132.24 -178.62 4.99 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.894 -175.045 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -104.49 101.88 30.37 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 296' ' ' PRO . . . . . 0.518 ' HG3' ' HB2' ' A' ' 239' ' ' PHE . 60.7 Cg_endo -75.43 -42.63 0.44 Allowed 'Trans proline' 0 CA--C 1.529 0.256 0 C-N-CA 122.311 2.007 . . . . 0.0 111.878 177.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -94.66 83.91 4.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.566 0.698 . . . . 0.0 109.907 176.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 298' ' ' ASN . . . . . 0.434 ' HA ' ' HD3' ' A' ' 299' ' ' PRO . 17.3 m120 -79.95 127.18 78.09 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.288 -175.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 299' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 298' ' ' ASN . 6.3 Cg_exo -74.81 7.18 2.9 Favored 'Trans proline' 0 CA--C 1.529 0.229 0 C-N-CA 123.126 2.55 . . . . 0.0 111.211 172.567 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -53.39 -47.05 69.84 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.568 -179.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -111.42 -23.02 11.0 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.729 177.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 70.81 -58.1 0.57 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.443 178.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.414 -0.803 . . . . 0.0 110.047 177.86 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.54 ' HB2' HD12 ' A' ' 99' ' ' ILE . 13.0 p . . . . . 0 N--CA 1.443 -0.782 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.537 ' HB1' ' HG2' ' A' ' 89' ' ' LYS . . . -93.87 127.91 39.88 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.766 178.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 26.0 mtt180 -142.14 -66.61 0.4 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.443 -176.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.43 ' HB2' ' H ' ' A' ' 7' ' ' ASP . 6.8 p90 11.15 -147.18 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 113.653 -1.612 . . . . 0.0 115.253 -161.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.43 ' H ' ' HB2' ' A' ' 6' ' ' PHE . 6.2 p-10 -101.98 -49.54 3.92 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.986 -174.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.44 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 50.4 m 65.16 35.87 7.58 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.586 -175.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.7 m -161.23 -25.92 0.05 Allowed 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 176.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -85.31 108.71 17.93 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.238 0.542 . . . . 0.0 111.064 -169.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.568 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 9.7 mmt180 -62.06 -25.72 67.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.758 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.9 m -90.11 3.51 53.13 Favored 'General case' 0 C--N 1.32 -0.714 0 O-C-N 122.149 -0.344 . . . . 0.0 110.941 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -99.21 -47.62 5.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.448 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.475 ' HB3' ' HB3' ' A' ' 101' ' ' PRO . 36.2 p-90 -114.2 -24.76 8.79 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -174.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.568 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 21.6 t80 -76.97 116.42 17.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.303 0.573 . . . . 0.0 110.107 -177.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.607 ' HG3' HG21 ' A' ' 19' ' ' VAL . 9.1 tpp -97.26 -9.16 28.19 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.085 -171.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.509 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 49.81 -115.21 2.85 Favored Glycine 0 CA--C 1.523 0.564 0 CA-C-N 115.398 -0.819 . . . . 0.0 114.292 177.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.509 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 4.6 Cg_exo -74.99 101.19 1.44 Allowed 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 123.056 2.504 . . . . 0.0 112.239 -177.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.607 HG21 ' HG3' ' A' ' 16' ' ' MET . 5.3 t -138.55 -76.46 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 CA-C-O 118.909 -0.567 . . . . 0.0 111.523 -175.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.761 ' H ' ' HD2' ' A' ' 39' ' ' ARG . 51.4 m 94.8 171.66 0.02 OUTLIER 'General case' 0 C--N 1.35 0.63 0 C-N-CA 124.187 0.995 . . . . 0.0 109.353 170.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.524 ' HD2' ' NH2' ' A' ' 39' ' ' ARG . 19.4 mmm180 -51.65 -53.46 38.52 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 123.388 0.43 . . . . 0.0 112.129 -169.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -62.95 -42.53 99.85 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.506 -175.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.433 ' HB3' HG13 ' A' ' 19' ' ' VAL . 12.7 tp10 -72.63 -46.03 56.08 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.296 0.569 . . . . 0.0 109.521 -174.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.24 -47.62 80.89 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.305 -0.862 . . . . 0.0 111.455 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 50.6 tp60 -64.05 -41.57 97.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.081 -175.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.5 t -79.55 -20.92 45.89 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -175.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -80.69 -13.72 58.76 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 120.944 0.402 . . . . 0.0 110.708 178.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.608 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 80.2 mt -128.96 17.07 6.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.244 -177.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.402 HE22 ' HB3' ' A' ' 56' ' ' SER . 0.0 OUTLIER -66.5 82.0 0.1 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.047 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.99 -63.94 4.22 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.715 -177.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 45.41 -105.16 0.1 Allowed 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.191 0.596 . . . . 0.0 111.858 -176.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 54.5 mtm180 -126.72 3.0 6.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.579 0.228 . . . . 0.0 110.409 176.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 28.0 m170 66.85 150.62 0.06 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.033 -174.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.33 19.22 79.68 Favored Glycine 0 C--O 1.227 -0.314 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.011 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 76.3 mtp -112.3 141.78 45.6 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.483 ' HB2' HD11 ' A' ' 50' ' ' LEU . 38.4 p90 -137.98 161.62 36.22 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.136 -174.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.489 ' O ' HD12 ' A' ' 37' ' ' LEU . 4.6 pp -150.25 133.83 16.6 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.247 0.546 . . . . 0.0 110.569 172.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.417 HG22 HD13 ' A' ' 50' ' ' LEU . 42.3 t -101.92 107.21 21.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 175.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.761 ' HD2' ' H ' ' A' ' 20' ' ' SER . 28.3 ptt-85 -103.32 177.45 4.84 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 -178.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -75.2 137.43 41.27 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 174.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.518 ' HB3' ' O ' ' A' ' 44' ' ' CYS . 21.1 t -64.56 109.9 2.14 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.378 0.609 . . . . 0.0 111.229 -173.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 57.2 p -77.45 -4.83 47.43 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.602 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.69 -51.34 4.76 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.313 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.518 ' O ' ' HB3' ' A' ' 41' ' ' SER . 34.3 m -135.03 118.95 13.29 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.602 -177.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -59.03 123.86 14.41 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.601 2.201 . . . . 0.0 112.104 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.05 -34.73 4.94 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.947 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.588 ' OD1' ' HA ' ' A' ' 64' ' ' ASN . 44.5 m-20 -86.4 -176.86 6.04 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.49 ' HE2' ' CE1' ' A' ' 71' ' ' PHE . 35.1 m-85 -134.15 172.58 12.65 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 176.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.471 HG23 ' HA ' ' A' ' 41' ' ' SER . 43.1 t -140.7 106.12 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.938 0.399 . . . . 0.0 111.065 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.483 HD11 ' HB2' ' A' ' 36' ' ' PHE . 43.0 tp -78.9 106.26 10.79 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.308 176.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 24.1 m -96.66 132.38 42.37 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 174.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 72.0 t -125.13 133.3 69.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.712 0.291 . . . . 0.0 111.297 -177.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.608 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 30.7 t -87.52 116.49 25.67 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.288 -0.415 . . . . 0.0 112.063 -176.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.54 ' HG2' HG22 ' A' ' 95' ' ' THR . 7.6 tp10 -151.65 147.7 27.05 Favored 'General case' 0 C--O 1.21 -1.009 0 C-N-CA 119.682 -0.807 . . . . 0.0 109.225 164.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.5 ' HB2' ' HG2' ' A' ' 57' ' ' ARG . 67.4 m-80 56.84 24.05 8.79 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.402 ' HB3' HE22 ' A' ' 29' ' ' GLN . 14.4 m 57.47 52.82 8.07 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 122.522 1.153 . . . . 0.0 108.411 -174.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.5 ' HG2' ' HB2' ' A' ' 55' ' ' ASN 0.25 0.0 OUTLIER -167.44 66.49 0.08 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 113.504 -1.68 . . . . 0.0 109.814 -152.188 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 20.2 t -73.32 101.01 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 120.861 -1.15 . . . . 0.0 111.252 -167.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.8 m -69.87 122.15 18.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.807 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -96.26 115.92 28.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.891 -175.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.626 ' OH ' ' HB3' ' A' ' 93' ' ' LEU . 37.0 m-85 -108.84 113.95 27.31 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.63 178.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.652 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 57.3 mt -81.35 133.83 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 O-C-N 122.078 -0.388 . . . . 0.0 111.986 -177.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.523 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 5.3 mp -114.27 119.43 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 122.968 0.507 . . . . 0.0 110.853 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.588 ' HA ' ' OD1' ' A' ' 47' ' ' ASP . 11.0 m120 -86.97 148.23 25.41 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.356 -174.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.7 t -89.53 94.96 10.06 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 170.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.464 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 81.6 mt -71.6 135.58 83.66 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 66' ' ' LEU . 33.7 Cg_exo -60.66 -22.43 72.83 Favored 'Trans proline' 0 N--CA 1.473 0.312 0 C-N-CA 123.014 2.476 . . . . 0.0 113.072 -174.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -84.28 17.48 2.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.259 0.552 . . . . 0.0 110.37 176.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.627 ' HA ' ' NE ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER 65.33 52.1 1.48 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.142 175.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 63.8 mtt180 -135.54 -175.16 3.85 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.462 175.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.523 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 67.8 m-85 -137.27 136.58 38.18 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.633 0.254 . . . . 0.0 111.25 -173.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.533 ' HB3' ' HB2' ' A' ' 64' ' ' ASN . 61.7 tttp -125.76 108.49 11.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.763 -174.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.652 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 7.3 tt -99.52 102.26 13.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.238 0.542 . . . . 0.0 111.494 -175.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 53.3 70.34 0.95 Allowed Glycine 0 CA--C 1.52 0.392 0 CA-C-N 115.437 -0.801 . . . . 0.0 113.728 175.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 34.6 t70 74.89 -30.41 0.2 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.325 0.65 . . . . 0.0 111.568 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -89.55 112.82 24.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.642 0.258 . . . . 0.0 110.809 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 1.3 pm0 -97.41 139.79 32.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.663 0.744 . . . . 0.0 111.484 176.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.515 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 89.9 m-85 -122.34 -172.04 2.38 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.611 175.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -86.11 -29.21 23.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.745 0.307 . . . . 0.0 111.514 -179.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -163.78 168.11 20.05 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.515 0.198 . . . . 0.0 111.417 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.654 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 6.7 mt -54.51 -58.61 13.3 Favored Pre-proline 0 N--CA 1.468 0.462 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.211 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.576 ' HA ' HD12 ' A' ' 85' ' ' LEU . 36.9 Cg_exo -63.9 -3.05 5.19 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.132 1.888 . . . . 0.0 113.263 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.82 -33.79 17.28 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.654 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.1 pp -76.39 -34.09 58.87 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 177.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.576 HD12 ' HA ' ' A' ' 82' ' ' PRO . 60.1 mt -64.66 -29.51 70.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.13 177.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.2 tp10 -79.1 -33.9 43.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.378 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -72.21 -33.44 67.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.402 0.62 . . . . 0.0 110.388 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.413 ' HE2' HD13 ' A' ' 73' ' ' ILE . 38.3 m-85 -82.44 1.86 35.47 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.619 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.537 ' HG2' ' HB1' ' A' ' 4' ' ' ALA . 93.8 mttt -73.76 -16.53 61.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.774 173.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 36.8 pt -129.96 -0.65 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 CA-C-O 121.15 0.5 . . . . 0.0 110.725 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -82.67 -40.83 20.17 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.889 -175.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.413 ' H ' HG22 ' A' ' 97' ' ' THR . 96.1 m-85 64.82 101.05 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.382 0 O-C-N 124.548 1.155 . . . . 0.0 109.209 -164.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.626 ' HB3' ' OH ' ' A' ' 61' ' ' TYR . 26.6 mt -63.66 -99.25 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.763 174.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.648 ' HA ' ' HB3' ' A' ' 154' ' ' GLU . 40.7 t0 -68.35 -59.97 2.79 Favored 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -175.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.656 ' CB ' ' HA ' ' A' ' 156' ' ' PRO . 12.6 t -154.37 14.85 0.45 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.661 0.743 . . . . 0.0 109.594 169.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 12.3 t -145.57 167.07 23.93 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.542 -177.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.413 HG22 ' H ' ' A' ' 92' ' ' TYR . 38.9 p -97.86 176.01 5.95 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.458 HD22 ' CD2' ' A' ' 36' ' ' PHE . 96.2 mt -77.99 89.4 4.15 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.188 0.518 . . . . 0.0 110.088 177.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.54 HD12 ' HB2' ' A' ' 3' ' ' SER . 38.9 mm -61.95 -64.1 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.327 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.465 ' HB2' ' HD2' ' A' ' 101' ' ' PRO . 13.3 pt-20 -159.44 159.53 28.32 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.569 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.475 ' HB3' ' HB3' ' A' ' 14' ' ' TRP . 59.8 Cg_endo -72.63 155.62 54.29 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.268 1.979 . . . . 0.0 112.074 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.03 135.3 70.46 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 176.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.76 138.07 67.9 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.285 1.99 . . . . 0.0 111.262 176.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.592 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 36.6 mtm180 . . . . . 0 C--N 1.327 -0.403 0 CA-C-O 121.082 0.468 . . . . 0.0 110.737 -177.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.696 HD12 HG21 ' A' ' 152' ' ' ILE . 3.0 mm? . . . . . 0 CA--C 1.516 -0.363 0 CA-C-O 121.862 0.839 . . . . 0.0 112.993 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 173.29 -51.84 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 113.34 -1.755 . . . . 0.0 107.08 177.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -119.73 110.83 17.26 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.196 0.522 . . . . 0.0 110.681 173.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.96 HG22 ' HG3' ' A' ' 180' ' ' LYS . 61.1 t -128.72 139.39 52.02 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.018 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.572 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 7.5 ptp180 -112.48 155.52 24.12 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 116.834 -1.946 . . . . 0.0 108.952 170.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.603 ' OG1' ' HB2' ' A' ' 144' ' ' PHE . 1.0 OUTLIER -110.32 140.6 44.34 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.477 0.656 . . . . 0.0 110.896 178.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.567 HD21 ' HG2' ' A' ' 179' ' ' GLU . 8.1 mt -113.38 -15.14 12.7 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -177.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -94.73 -14.72 24.5 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -171.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.56 ' HB3' ' C ' ' A' ' 145' ' ' LYS . 3.8 p-10 54.99 102.08 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 122.559 1.171 . . . . 0.0 112.637 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -119.39 86.64 34.08 Favored Pre-proline 0 C--N 1.317 -0.84 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 171.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.666 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 65.9 Cg_endo -85.56 72.97 4.09 Favored 'Trans proline' 0 N--CA 1.445 -1.376 0 C-N-CA 121.897 1.731 . . . . 0.0 112.638 -176.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.67 -34.19 66.92 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 174.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.871 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 0.4 OUTLIER 70.98 40.5 0.9 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.471 -0.864 . . . . 0.0 111.589 174.784 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -126.09 175.03 8.04 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.881 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -92.66 -7.66 46.23 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.8 0.81 . . . . 0.0 109.052 171.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.615 ' O ' ' HB2' ' A' ' 172' ' ' MET . 8.8 mm-40 -93.32 -29.87 15.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.752 176.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -136.18 108.88 7.5 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.851 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.996 HD11 ' HB2' ' A' ' 165' ' ' ASN . 58.1 tp -67.26 123.87 87.56 Favored Pre-proline 0 CA--C 1.509 -0.611 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.824 -176.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.871 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 56.3 Cg_endo -71.87 93.6 0.71 Allowed 'Trans proline' 0 N--CA 1.443 -1.472 0 C-N-CA 120.987 1.125 . . . . 0.0 111.348 167.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.603 ' HB2' ' OG1' ' A' ' 130' ' ' THR . 16.7 p90 -103.32 159.61 15.41 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 1.002 ' H ' ' HG3' ' A' ' 148' ' ' GLU . 47.6 mtpt -110.16 -151.81 0.48 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.144 0.497 . . . . 0.0 111.929 -170.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.824 ' H ' ' HD2' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -104.47 27.94 7.41 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.323 -176.843 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 159.14 36.96 0.02 OUTLIER Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.242 178.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 1.002 ' HG3' ' H ' ' A' ' 145' ' ' LYS . 0.0 OUTLIER -86.11 170.25 12.37 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.895 0.878 . . . . 0.0 109.399 171.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.5 mp -114.0 133.04 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 172.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.713 HD22 ' CD2' ' A' ' 142' ' ' LEU . 72.2 mt -118.47 155.79 30.18 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -174.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.603 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 92.2 t -122.22 121.73 64.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 174.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.984 HD13 ' HB2' ' A' ' 163' ' ' ALA . 46.9 mm -78.04 79.09 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 122.125 0.964 . . . . 0.0 108.411 -177.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.737 HG23 ' HG2' ' A' ' 154' ' ' GLU . 16.9 tt -69.38 -27.96 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 CA-C-N 113.91 -1.495 . . . . 0.0 109.288 -177.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.737 ' HG2' HG23 ' A' ' 153' ' ' ILE . 0.0 OUTLIER -133.01 141.49 48.31 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 171.778 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.56 ' HD2' ' HG ' ' A' ' 125' ' ' LEU . 82.9 tttt -135.1 82.61 41.74 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 168.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.656 ' HA ' ' CB ' ' A' ' 95' ' ' THR . 8.3 Cg_exo -73.03 -47.72 0.31 Allowed 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.538 2.159 . . . . 0.0 111.87 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -107.57 171.13 7.56 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.032 -173.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.642 ' HG3' ' HG2' ' A' ' 159' ' ' GLN . 8.1 pt-20 -89.7 -26.92 20.43 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.752 178.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.642 ' HG2' ' HG3' ' A' ' 158' ' ' GLU . 82.9 mm-40 -101.8 -18.74 15.63 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.483 -175.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.53 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 63.7 m95 -126.66 135.28 50.96 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 175.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . 0.779 ' O ' HG13 ' A' ' 173' ' ' ILE . 49.4 m0 -125.33 137.93 54.06 Favored 'General case' 0 C--O 1.214 -0.771 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.525 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 14.7 m -96.87 102.79 14.64 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -174.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.984 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -118.93 151.74 37.6 Favored 'General case' 0 N--CA 1.426 -1.667 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.069 -174.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.792 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 15.3 ptt-85 -88.69 129.39 35.54 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 175.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.996 ' HB2' HD11 ' A' ' 142' ' ' LEU . 65.2 t30 -60.72 178.64 0.21 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.234 -1.348 . . . . 0.0 111.514 -171.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.555 ' HB2' ' HB2' ' A' ' 148' ' ' GLU . 44.0 tptt -50.71 -33.2 21.91 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.103 166.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -64.7 -38.68 91.82 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.709 173.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.498 ' C ' ' HB2' ' A' ' 164' ' ' ARG . . . 107.09 3.81 35.92 Favored Glycine 0 CA--C 1.522 0.471 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.217 -171.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.792 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.4 OUTLIER -77.4 134.61 38.39 Favored 'General case' 0 C--O 1.216 -0.671 0 C-N-CA 123.141 0.576 . . . . 0.0 111.21 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.5 HG22 HG21 ' A' ' 153' ' ' ILE . 60.4 t -85.12 125.55 40.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 117.684 0.22 . . . . 0.0 111.526 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -157.1 157.71 28.27 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.172 172.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.615 ' HB2' ' O ' ' A' ' 140' ' ' GLU . 0.0 OUTLIER -76.94 141.09 40.62 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 117.242 0.521 . . . . 0.0 111.228 179.367 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.779 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.4 pp -142.25 142.9 25.44 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.424 -176.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.522 ' HB2' ' CD1' ' A' ' 177' ' ' TYR . 15.7 Cg_exo -70.36 138.57 36.21 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 123.275 2.65 . . . . 0.0 113.351 -178.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.574 ' O ' HG22 ' A' ' 178' ' ' VAL . 58.9 t -65.1 -45.09 72.57 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 28.0 Cg_endo -63.81 3.09 0.77 Allowed 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.044 1.829 . . . . 0.0 113.2 177.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.522 ' CD1' ' HB2' ' A' ' 174' ' ' PRO . 3.3 m-85 -103.41 -11.85 17.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.237 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.614 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 4.6 m -104.84 -170.8 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 115.691 1.737 . . . . 0.0 115.691 -166.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.572 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 4.0 tp10 -159.73 48.21 0.29 Allowed 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 113.164 -1.835 . . . . 0.0 113.226 -153.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.96 ' HG3' HG22 ' A' ' 128' ' ' VAL . 2.9 mppt? -70.73 138.1 50.24 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 119.746 -1.846 . . . . 0.0 110.248 -162.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.401 HD13 ' NH2' ' A' ' 129' ' ' ARG . 39.9 tp . . . . . 0 C--N 1.332 -0.188 0 CA-C-N 113.557 -1.656 . . . . 0.0 112.473 -162.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo . . . . . 0 C--O 1.236 0.378 0 CA-C-O 120.782 0.242 . . . . 0.0 111.802 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.541 ' HB ' HG13 ' A' ' 266' ' ' VAL . 11.7 t -101.91 130.85 50.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.025 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -115.56 134.92 54.6 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.35 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.628 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -131.72 145.1 51.45 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.359 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -98.5 127.94 44.64 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.156 177.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . 0.572 ' O ' ' HA ' ' A' ' 260' ' ' VAL . . . -76.82 102.09 6.15 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 176.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 25.3 pt -94.65 -5.02 10.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.585 -173.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.12 147.62 46.13 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -63.57 133.04 53.06 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.112 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.78 95.37 3.12 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.793 0.33 . . . . 0.0 110.582 -177.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 27.2 m -90.26 162.37 34.83 Favored Pre-proline 0 C--N 1.318 -0.773 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 172.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.504 ' HG3' ' HB2' ' A' ' 257' ' ' ALA . 5.1 Cg_exo -75.67 -151.45 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.152 1.901 . . . . 0.0 111.399 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' CYS . . . . . 0.504 ' O ' ' HB3' ' A' ' 252' ' ' ASP . 42.6 t -147.45 171.74 15.04 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 122.123 -0.361 . . . . 0.0 111.342 -173.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -68.08 -31.16 70.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.958 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -102.41 22.59 13.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.285 0.564 . . . . 0.0 110.539 176.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . 0.504 ' HB3' ' O ' ' A' ' 249' ' ' CYS . 0.1 OUTLIER -83.2 129.03 34.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.416 178.205 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -138.68 -0.57 1.92 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.416 167.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 2.1 p -151.45 21.38 0.73 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.924 -177.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -102.93 109.44 21.0 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.034 0.445 . . . . 0.0 110.594 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.519 ' HA ' ' NH1' ' A' ' 282' ' ' ARG . 0.5 OUTLIER -65.93 139.07 58.23 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.874 -176.821 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.504 ' HB2' ' HG3' ' A' ' 248' ' ' PRO . . . -103.03 123.76 47.23 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.032 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.693 HD12 HG21 ' A' ' 289' ' ' THR . 57.1 mt -135.93 176.36 8.76 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.233 -175.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -160.38 177.29 10.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.65 0.262 . . . . 0.0 111.095 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 57.4 t -66.42 126.55 26.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.954 -171.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 96.14 8.65 57.66 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.888 175.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -103.61 147.27 27.41 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 31.4 mm -107.24 116.08 50.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.124 0.488 . . . . 0.0 110.336 -176.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 10.2 t -85.77 120.77 36.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.572 -177.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . 0.706 ' HD3' ' HG3' ' A' ' 278' ' ' GLU . 35.8 tttp -86.48 100.41 12.35 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.784 175.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.541 HG13 ' HB ' ' A' ' 238' ' ' VAL . 3.9 p -117.0 117.19 54.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.7 0.762 . . . . 0.0 111.095 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 12.7 p -98.2 -38.51 9.27 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.308 177.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . 0.524 ' HB2' ' HB2' ' A' ' 276' ' ' GLU . 42.7 mtt180 -106.81 108.75 20.41 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.141 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 6.2 ptp -114.18 114.51 26.13 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.717 0.77 . . . . 0.0 110.972 173.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -83.89 150.93 25.39 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.514 -176.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 34.4 pt -82.72 11.37 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.042 -177.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -98.58 -6.62 29.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.722 0.296 . . . . 0.0 110.544 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 113.25 -39.13 2.95 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.725 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.518 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 2.4 mp0 -88.3 111.16 21.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.862 0.363 . . . . 0.0 110.366 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.504 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 10.1 m0 -93.86 157.03 16.33 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.524 ' HB2' ' HB2' ' A' ' 268' ' ' ARG . 38.8 mt-10 -100.62 114.05 27.42 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 176.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -138.32 146.53 18.32 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.615 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.706 ' HG3' ' HD3' ' A' ' 265' ' ' LYS . 6.1 pt-20 -114.02 109.95 19.26 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.027 0.441 . . . . 0.0 110.024 177.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . 0.441 HG21 HD21 ' A' ' 258' ' ' LEU . 14.5 t -109.27 -109.68 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.013 -175.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -85.98 82.56 8.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.788 0.327 . . . . 0.0 111.615 -174.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 66.02 6.68 32.99 Favored Glycine 0 C--N 1.332 0.337 0 CA-C-N 115.928 -0.578 . . . . 0.0 113.421 174.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . 0.519 ' NH1' ' HA ' ' A' ' 256' ' ' LEU . 1.7 tmt_? -146.92 127.98 14.61 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -176.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.454 ' HB3' ' HB3' ' A' ' 278' ' ' GLU . 15.0 ptpt -120.71 142.43 49.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.684 -178.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -173.69 -169.7 36.29 Favored Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 111.564 -0.614 . . . . 0.0 111.564 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.518 ' HB3' ' HB3' ' A' ' 274' ' ' GLN . 94.4 mt -86.78 146.95 26.04 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.167 0.508 . . . . 0.0 110.247 177.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.684 ' HB2' ' OG1' ' A' ' 289' ' ' THR . 26.3 p90 -143.18 123.39 7.88 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.582 176.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . 0.638 ' C ' ' H ' ' A' ' 289' ' ' THR . 51.5 Cg_exo -62.98 62.26 0.16 Allowed 'Trans proline' 0 N--CA 1.486 1.061 0 C-N-CA 124.597 3.531 . . . . 0.0 112.565 175.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.668 ' O ' HG22 ' A' ' 291' ' ' VAL . 4.3 m-85 62.54 -14.77 0.06 Allowed 'General case' 0 C--O 1.213 -0.849 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.736 -168.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . 0.693 HG21 HD12 ' A' ' 258' ' ' LEU . 1.4 m 69.68 -12.31 0.46 Allowed 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 123.573 0.749 . . . . 0.0 112.824 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . 0.472 ' CB ' ' O ' ' A' ' 289' ' ' THR . 32.2 m170 89.37 25.0 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 O-C-N 124.313 1.008 . . . . 0.0 109.829 -164.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.668 HG22 ' O ' ' A' ' 288' ' ' PHE . 13.1 m -86.99 179.57 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.358 0.599 . . . . 0.0 111.206 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -135.25 129.99 34.49 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.306 173.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.628 HD13 ' HB2' ' A' ' 240' ' ' ALA . 19.0 mm -77.35 126.02 37.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.064 0.459 . . . . 0.0 111.16 -178.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -151.44 -171.56 3.97 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -133.07 105.88 12.45 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-O 120.889 0.376 . . . . 0.0 110.221 175.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo . . . . . 0 C--O 1.234 0.294 0 C-N-CA 122.919 2.413 . . . . 0.0 112.678 -179.176 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.485 ' O ' HG23 ' A' ' 99' ' ' ILE . 19.5 m . . . . . 0 N--CA 1.449 -0.477 0 CA-C-O 120.762 0.315 . . . . 0.0 110.42 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -86.7 56.11 3.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.168 0.509 . . . . 0.0 110.707 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 20.7 tpp180 -93.55 96.75 10.06 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.383 -174.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.617 ' CE1' ' HE2' ' A' ' 89' ' ' LYS . 41.3 p90 -167.62 147.93 5.21 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.105 174.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -79.04 102.79 8.57 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.867 -178.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.405 ' O ' ' HB2' ' A' ' 9' ' ' SER . 30.4 m -69.36 76.88 0.39 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.079 175.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 8' ' ' SER . 21.4 t 178.48 -37.33 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.831 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -69.13 106.95 3.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.428 -173.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 -61.58 -31.03 71.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.397 -177.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 61.1 m -80.37 3.41 21.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.352 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -91.71 -47.81 7.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.941 0.4 . . . . 0.0 110.513 175.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 25.9 p-90 -122.62 -24.21 4.96 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -168.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -74.65 118.6 17.79 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.173 0.511 . . . . 0.0 110.913 -174.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.787 ' HG3' ' HB2' ' A' ' 37' ' ' LEU . 25.9 mmt -101.16 -11.71 19.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.062 -174.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.406 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 50.55 -114.21 2.51 Favored Glycine 0 CA--C 1.524 0.602 0 O-C-N 123.653 0.595 . . . . 0.0 113.25 -176.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.406 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 9.0 Cg_exo -72.31 91.33 0.76 Allowed 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 122.994 2.463 . . . . 0.0 113.273 -175.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.722 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 71.1 t -143.88 161.74 15.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 176.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.614 ' HA ' ' OG ' ' A' ' 42' ' ' SER . 16.0 m -128.68 174.06 9.76 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -172.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 63.3 mtp85 -57.32 -54.27 48.71 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.484 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -60.99 -40.95 95.43 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.726 0.298 . . . . 0.0 111.684 -177.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.538 ' O ' ' HG3' ' A' ' 27' ' ' ARG . 0.3 OUTLIER -70.98 -47.04 61.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.138 0.494 . . . . 0.0 110.17 -177.262 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.44 -42.83 83.19 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.157 0.503 . . . . 0.0 110.998 175.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.663 ' HG3' HG21 ' A' ' 58' ' ' VAL . 64.6 tt0 -65.29 -40.84 94.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.232 -177.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.6 t -76.19 -4.58 42.54 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.929 0.395 . . . . 0.0 111.167 -177.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.538 ' HG3' ' O ' ' A' ' 23' ' ' GLU . 90.7 mtt180 -90.03 -25.91 20.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.206 0.527 . . . . 0.0 109.746 172.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.57 HD22 ' HB2' ' A' ' 53' ' ' SER . 25.5 mt -116.7 16.9 15.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.953 -171.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.4 90.57 4.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.036 0.446 . . . . 0.0 110.686 -176.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.97 -4.68 74.34 Favored Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.576 176.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -65.55 167.99 8.1 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.792 0.329 . . . . 0.0 111.527 -178.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -43.19 125.53 3.72 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.476 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.546 ' HB3' HG21 ' A' ' 96' ' ' THR . 29.8 m170 -69.39 142.22 53.96 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.335 -178.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.562 ' HA3' ' HB ' ' A' ' 99' ' ' ILE . . . 110.64 -20.16 25.24 Favored Glycine 0 N--CA 1.437 -1.241 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 -175.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.664 ' HB3' ' HB2' ' A' ' 102' ' ' ALA . 63.3 mtt -61.75 142.41 57.29 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 173.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.56 ' HB2' HD11 ' A' ' 50' ' ' LEU . 51.6 p90 -153.19 162.74 40.97 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.787 ' HB2' ' HG3' ' A' ' 16' ' ' MET . 4.4 pp -155.66 132.66 10.68 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.132 0.491 . . . . 0.0 111.432 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.4 t -103.79 109.8 28.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 174.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.722 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 29.5 ptt-85 -113.22 177.82 4.5 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.82 -177.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -73.78 134.35 43.41 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 172.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.524 ' HA ' HG23 ' A' ' 49' ' ' VAL . 39.2 t -57.09 119.13 5.81 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.61 0.719 . . . . 0.0 111.965 -173.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.614 ' OG ' ' HA ' ' A' ' 20' ' ' SER . 1.5 m -77.44 -11.75 59.88 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.426 173.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.0 m -83.58 -41.4 17.92 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.372 177.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.465 ' O ' ' HB3' ' A' ' 41' ' ' SER . 6.5 p -157.36 94.63 2.15 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.107 178.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -47.91 127.05 13.96 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.11 2.54 . . . . 0.0 112.087 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.48 -45.58 1.15 Allowed Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -172.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -83.67 -166.06 1.29 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 172.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.6 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 25.4 m-85 -134.8 171.27 14.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 117.902 0.319 . . . . 0.0 110.563 177.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.524 HG23 ' HA ' ' A' ' 41' ' ' SER . 59.9 t -145.37 109.4 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 175.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.56 HD11 ' HB2' ' A' ' 36' ' ' PHE . 56.2 tp -80.33 100.95 8.66 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.636 175.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.3 m -96.69 121.78 38.91 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 174.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.646 HG12 ' HG3' ' A' ' 54' ' ' GLU . 87.0 t -111.82 138.59 39.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.712 -174.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.679 ' HA ' ' O ' ' A' ' 57' ' ' ARG . 48.1 t -82.63 98.48 9.03 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 175.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.646 ' HG3' HG12 ' A' ' 52' ' ' VAL . 24.2 mt-10 -151.36 160.81 43.58 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.97 -175.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.624 ' ND2' ' H ' ' A' ' 155' ' ' LYS . 0.5 OUTLIER 70.43 -65.85 0.31 Allowed 'General case' 0 CA--C 1.49 -1.333 0 CA-C-O 122.742 1.258 . . . . 0.0 110.456 -168.417 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.438 ' HB2' ' HD3' ' A' ' 57' ' ' ARG . 74.8 m -157.9 -22.16 0.08 Allowed 'General case' 0 N--CA 1.419 -1.992 0 CA-C-N 112.56 -2.109 . . . . 0.0 107.626 -175.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.709 ' HG2' HG23 ' A' ' 58' ' ' VAL 0.359 0.0 OUTLIER -166.61 -50.23 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.124 1 N-CA-C 121.877 4.029 . . . . 0.0 121.877 -179.836 . . . . . . . . 5 4 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.709 HG23 ' HG2' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -149.78 99.42 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 CA-C-N 121.729 2.058 . . . . 0.0 112.939 -170.148 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.7 m -94.83 111.06 22.87 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 172.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -97.39 112.67 24.4 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -168.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.718 ' OH ' ' HB3' ' A' ' 93' ' ' LEU . 54.3 m-85 -120.14 105.78 11.32 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.415 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.606 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 63.6 mt -80.52 127.0 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -174.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.6 ' HB ' ' HB2' ' A' ' 48' ' ' TYR . 4.3 mp -101.05 119.72 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 121.17 0.51 . . . . 0.0 111.17 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.551 ' HB2' ' HB3' ' A' ' 72' ' ' LYS . 16.7 m120 -86.04 136.11 33.37 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.798 -178.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.1 t -85.58 93.75 8.88 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 171.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.663 HD11 ' HB2' ' A' ' 72' ' ' LYS . 83.6 mt -84.99 145.84 44.36 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.834 -177.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 66' ' ' LEU . 18.5 Cg_exo -67.57 -3.85 10.95 Favored 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 122.92 2.414 . . . . 0.0 111.547 174.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.426 ' HB3' ' HD3' ' A' ' 70' ' ' ARG . 42.2 m-20 -80.66 2.21 26.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.71 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? 63.59 31.89 14.37 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.469 0.652 . . . . 0.0 109.51 -170.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.754 ' HG2' ' HA ' ' A' ' 79' ' ' ASP . 35.5 mtp180 -132.44 162.03 32.19 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.708 -175.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.475 ' HB3' HG23 ' A' ' 63' ' ' ILE . 47.3 m-85 -122.85 117.84 26.55 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.965 0.412 . . . . 0.0 111.142 -174.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.663 ' HB2' HD11 ' A' ' 66' ' ' LEU . 29.5 ttpp -104.09 98.99 8.73 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.462 -173.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.706 HD11 ' CB ' ' A' ' 61' ' ' TYR . 6.7 tt -88.45 119.64 36.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.293 0.568 . . . . 0.0 111.286 -177.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.37 32.16 83.19 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.828 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.497 ' HA ' ' HZ3' ' A' ' 72' ' ' LYS . 35.1 t70 74.62 -11.61 1.01 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.035 0.534 . . . . 0.0 111.835 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -86.66 126.66 34.68 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 171.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 0.7 OUTLIER -100.57 140.79 34.34 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.909 0.861 . . . . 0.0 113.169 -169.134 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.559 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 91.0 m-85 -129.02 172.16 11.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.218 -1.356 . . . . 0.0 108.376 173.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.754 ' HA ' ' HG2' ' A' ' 70' ' ' ARG . 5.9 m-20 -74.88 -30.33 61.28 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.66 0.266 . . . . 0.0 111.693 -175.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.504 ' ND1' ' HG2' ' A' ' 82' ' ' PRO . 4.9 p80 -165.07 168.35 17.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.563 -176.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.668 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 14.3 mt -57.97 -54.63 53.5 Favored Pre-proline 0 N--CA 1.469 0.482 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -177.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.504 ' HG2' ' ND1' ' A' ' 80' ' ' HIS . 20.9 Cg_endo -62.95 -3.02 4.15 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 121.976 1.784 . . . . 0.0 113.637 178.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.421 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -89.01 -36.51 15.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.94 0.4 . . . . 0.0 110.263 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.668 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.0 pp -76.81 -29.86 56.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.064 0.459 . . . . 0.0 109.891 178.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.514 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 79.7 mt -68.46 -21.04 64.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.336 177.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -91.97 -17.45 25.12 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.37 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -91.23 -30.88 16.39 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 121.784 0.802 . . . . 0.0 109.272 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.694 ' HE2' HD13 ' A' ' 73' ' ' ILE . 28.4 m-85 -84.21 1.88 42.48 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.125 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.617 ' HE2' ' CE1' ' A' ' 6' ' ' PHE . 85.8 mttt -77.61 -11.91 59.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.687 169.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 35.7 pt -134.84 8.82 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.204 0 CA-C-O 121.05 0.453 . . . . 0.0 110.302 -176.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.487 ' HB2' ' HA ' ' A' ' 88' ' ' TYR . 16.8 t60 -88.14 -38.87 15.0 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.199 -177.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.499 ' HA ' ' O ' ' A' ' 96' ' ' THR . 92.5 m-85 58.46 86.07 0.09 Allowed 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.344 -1.298 . . . . 0.0 107.797 -161.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.718 ' HB3' ' OH ' ' A' ' 61' ' ' TYR . 76.2 mt -44.23 -65.32 0.53 Allowed 'General case' 0 CA--C 1.517 -0.297 0 O-C-N 124.151 0.907 . . . . 0.0 108.805 178.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.701 ' HB3' ' HB3' ' A' ' 154' ' ' GLU . 1.6 p30 -111.99 -86.53 0.56 Allowed 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.771 163.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 1.015 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 11.5 t -118.97 14.4 13.22 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.296 0.57 . . . . 0.0 110.994 -174.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.546 HG21 ' HB3' ' A' ' 33' ' ' HIS . 5.8 t -153.72 -179.89 8.23 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 172.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.474 HG22 ' H ' ' A' ' 92' ' ' TYR . 20.2 p -116.56 171.13 8.05 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 122.4 -0.188 . . . . 0.0 110.733 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 92.5 mt -61.62 104.12 0.4 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.018 0.437 . . . . 0.0 110.113 175.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.562 ' HB ' ' HA3' ' A' ' 34' ' ' GLY . 45.8 mm -89.21 -56.91 4.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.807 -176.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.658 ' O ' ' HA ' ' A' ' 35' ' ' MET . 10.6 pt-20 -162.98 142.3 6.8 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.956 -177.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.21 149.51 90.14 Favored 'Trans proline' 0 C--O 1.235 0.375 0 C-N-CA 122.411 2.074 . . . . 0.0 112.57 -177.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.664 ' HB2' ' HB3' ' A' ' 35' ' ' MET . . . -73.07 146.24 87.05 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.99 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.67 115.68 3.69 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.234 1.956 . . . . 0.0 111.625 176.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.631 ' HB3' ' SD ' ' A' ' 16' ' ' MET . 37.6 ptt180 . . . . . 0 C--N 1.328 -0.368 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 178.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.597 HD21 ' CH2' ' A' ' 161' ' ' TRP . 3.9 mm? . . . . . 0 N--CA 1.47 0.555 0 CA-C-O 121.521 0.677 . . . . 0.0 111.913 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 32.9 tt0 177.73 -60.16 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.302 -177.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -112.69 112.97 24.86 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.286 176.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.985 HG22 ' HG3' ' A' ' 180' ' ' LYS . 10.4 t -115.71 146.34 20.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 177.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.664 ' CZ ' HD13 ' A' ' 181' ' ' LEU . 0.0 OUTLIER -118.71 147.69 43.56 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 117.244 -1.783 . . . . 0.0 109.024 158.903 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.515 HG22 HG12 ' A' ' 178' ' ' VAL . 0.8 OUTLIER -102.69 130.32 49.58 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.839 -1.073 . . . . 0.0 111.3 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.559 HD21 ' HG2' ' A' ' 179' ' ' GLU . 24.6 mt -104.97 -7.47 19.25 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -175.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.51 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 63.6 t80 -95.42 -42.53 8.43 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.233 -0.587 . . . . 0.0 112.543 -174.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.61 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 15.7 t70 77.75 89.71 0.07 Allowed 'General case' 0 N--CA 1.474 0.761 0 O-C-N 123.746 0.654 . . . . 0.0 110.431 -175.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.455 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 63.3 t80 -119.09 85.79 30.46 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 176.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.596 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 87.5 Cg_endo -81.94 83.76 2.02 Favored 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 121.608 1.539 . . . . 0.0 112.556 178.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -76.31 -20.58 76.97 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 175.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.83 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 12.3 m120 58.41 68.23 0.85 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.643 -0.778 . . . . 0.0 111.679 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.485 ' HB3' ' H ' ' A' ' 140' ' ' GLU . 0.4 OUTLIER -152.3 170.73 19.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.85 179.066 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -94.97 -5.42 44.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.937 0.875 . . . . 0.0 108.975 170.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.485 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 42.7 mm-40 -96.34 -36.91 10.7 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.809 174.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.458 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 13.6 m-20 -123.01 112.73 18.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.273 178.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.993 HD11 ' HB2' ' A' ' 165' ' ' ASN . 30.4 tp -68.61 129.95 92.25 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-O 120.776 0.322 . . . . 0.0 110.534 -177.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.83 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 11.6 Cg_endo -85.64 91.26 0.69 Allowed 'Trans proline' 0 N--CA 1.442 -1.55 0 C-N-CA 122.092 1.861 . . . . 0.0 111.012 172.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.522 ' CE2' ' HB ' ' A' ' 173' ' ' ILE . 14.3 p90 -101.54 164.85 11.55 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.817 -174.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.61 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 1.4 mptp? -100.29 -172.71 2.26 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.203 0.525 . . . . 0.0 111.75 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.742 ' H ' ' HD2' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -91.62 9.03 33.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.972 -175.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -167.13 32.95 0.21 Allowed Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.48 175.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.511 ' OE1' ' HA ' ' A' ' 144' ' ' PHE . 0.1 OUTLIER -100.13 157.45 16.56 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.214 -174.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.638 HD12 ' HB3' ' A' ' 129' ' ' ARG . 0.6 OUTLIER -97.49 129.38 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-O 121.692 0.758 . . . . 0.0 109.978 -176.682 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.738 HD22 HD21 ' A' ' 142' ' ' LEU . 31.9 mt -123.94 158.77 31.24 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 114.522 -1.217 . . . . 0.0 108.01 -177.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.608 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 97.4 t -122.04 120.43 61.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 175.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 1.044 HD13 ' HB2' ' A' ' 163' ' ' ALA . 42.1 mm -78.21 79.14 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -178.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.665 HG23 ' HG2' ' A' ' 154' ' ' GLU . 7.6 tt -74.57 -34.18 34.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 114.535 -1.212 . . . . 0.0 109.318 -178.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.701 ' HB3' ' HB3' ' A' ' 94' ' ' ASP . 0.0 OUTLIER -123.46 142.92 50.51 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.502 175.577 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.624 ' H ' ' ND2' ' A' ' 55' ' ' ASN . 83.1 tttt -140.47 81.75 17.13 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-O 120.982 0.42 . . . . 0.0 109.993 172.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 1.015 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 38.4 Cg_endo -73.25 -40.28 1.74 Allowed 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.03 1.82 . . . . 0.0 111.972 175.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -111.05 162.65 14.66 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.407 -171.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -100.17 -11.54 20.36 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 172.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -89.81 -34.1 16.27 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.916 177.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 49.4 m95 -129.45 139.44 51.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.942 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . 0.76 ' O ' HG13 ' A' ' 173' ' ' ILE . 47.8 m0 -113.63 137.02 52.18 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 176.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.53 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 16.2 m -96.96 97.59 9.39 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -175.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 1.044 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -110.84 149.54 30.43 Favored 'General case' 0 N--CA 1.425 -1.72 0 C-N-CA 119.859 -0.736 . . . . 0.0 109.956 -174.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.721 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 11.7 ptt180 -87.25 122.16 30.67 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 173.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.993 ' HB2' HD11 ' A' ' 142' ' ' LEU . 12.9 t30 -58.42 -178.07 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 113.755 -1.566 . . . . 0.0 111.381 -173.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.552 ' HD3' ' HB ' ' A' ' 149' ' ' ILE . 10.0 mmmm -66.38 -11.67 52.68 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.414 0.626 . . . . 0.0 109.906 166.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.499 ' H ' ' HB3' ' A' ' 165' ' ' ASN . 22.3 m-20 -82.29 -15.99 50.99 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 170.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 80.28 10.82 84.98 Favored Glycine 0 CA--C 1.52 0.36 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.923 -174.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.721 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.3 OUTLIER -81.94 133.91 35.34 Favored 'General case' 0 C--O 1.217 -0.615 0 C-N-CA 123.106 0.562 . . . . 0.0 110.803 -178.846 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 80.4 t -82.38 123.62 38.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.862 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -157.02 158.11 28.58 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.75 171.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.519 ' HA ' ' HA ' ' A' ' 162' ' ' SER . 10.5 mtp -82.84 144.79 29.87 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 117.482 0.641 . . . . 0.0 111.039 -178.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.76 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.7 pp -142.87 147.96 43.85 Favored Pre-proline 0 C--O 1.223 -0.317 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.43 -175.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.481 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 8.0 Cg_exo -73.55 129.8 14.13 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.547 2.165 . . . . 0.0 112.71 -175.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.579 ' O ' HG22 ' A' ' 178' ' ' VAL . 61.5 t -59.19 -44.51 98.57 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.467 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 36.4 Cg_exo -61.93 -2.54 2.96 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 122.206 1.937 . . . . 0.0 113.136 176.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.481 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.1 m-30 -100.85 -9.23 21.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.641 -178.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.635 ' HB ' HG13 ' A' ' 128' ' ' VAL . 6.1 m -107.87 -173.29 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 -166.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.63 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 5.2 tp10 -159.74 49.18 0.3 Allowed 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 113.221 -1.809 . . . . 0.0 112.559 -151.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.985 ' HG3' HG22 ' A' ' 128' ' ' VAL . 1.2 mppt? -71.47 138.52 49.05 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 120.042 -1.661 . . . . 0.0 111.803 -158.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.664 HD13 ' CZ ' ' A' ' 129' ' ' ARG . 11.8 tp . . . . . 0 N--CA 1.455 -0.191 0 CA-C-N 112.84 -1.982 . . . . 0.0 111.387 -170.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo . . . . . 0 N--CA 1.461 -0.384 0 CA-C-O 120.673 0.197 . . . . 0.0 111.751 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.505 ' HB ' HG13 ' A' ' 266' ' ' VAL . 18.3 t -89.03 128.95 40.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.516 ' HB2' ' HG3' ' A' ' 296' ' ' PRO . 93.9 m-85 -102.87 117.68 35.16 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.092 0.472 . . . . 0.0 110.959 -177.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -119.95 134.35 55.27 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.104 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -84.59 126.39 33.29 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . 0.476 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -72.65 100.71 2.87 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.03 0.443 . . . . 0.0 109.829 177.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.453 ' H ' HG13 ' A' ' 243' ' ' ILE . 2.4 pp -96.05 -9.0 9.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.557 -176.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.28 138.25 36.59 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 176.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -58.23 149.62 23.72 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 120.968 0.414 . . . . 0.0 110.71 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 24.7 tpt180 -143.78 91.52 2.24 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 174.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 29.2 m -100.23 142.6 24.93 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.098 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.486 ' HB3' ' HB3' ' A' ' 255' ' ' ALA . 72.8 Cg_endo -79.11 148.58 21.71 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.404 2.07 . . . . 0.0 112.101 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 48.7 t -79.66 176.58 9.59 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 173.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -59.62 -30.36 68.64 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.659 0.266 . . . . 0.0 111.548 -177.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -96.02 -5.42 41.11 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . 0.467 ' HB3' ' HB3' ' A' ' 255' ' ' ALA . 4.1 m-20 -82.82 107.6 15.56 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.263 0.554 . . . . 0.0 111.467 -176.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 47.2 mttp -104.01 -34.41 8.46 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.308 176.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 3.0 p -86.81 9.4 19.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.589 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . 0.486 ' HB3' ' HB3' ' A' ' 248' ' ' PRO . . . -95.8 131.84 41.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.051 0.453 . . . . 0.0 110.857 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.536 HD21 ' HB ' ' A' ' 279' ' ' VAL . 0.9 OUTLIER -88.24 133.32 34.07 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.188 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -89.3 109.75 20.61 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.861 0.363 . . . . 0.0 110.169 -179.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 94.2 mt -115.11 143.69 44.82 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.012 -175.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -120.4 149.95 41.55 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.503 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 59.8 t -64.17 117.15 4.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.784 0.326 . . . . 0.0 110.874 -178.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 108.93 10.19 24.95 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.587 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -103.19 167.59 9.72 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 37.3 mm -114.35 118.09 57.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.038 0.447 . . . . 0.0 110.814 -176.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 20.0 t -93.69 109.37 21.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.514 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -87.2 87.47 7.45 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.746 177.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.505 HG13 ' HB ' ' A' ' 238' ' ' VAL . 7.2 p -91.19 136.52 24.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.88 -175.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 18.1 p -114.06 -50.61 2.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.19 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 14.2 tpp180 -100.79 101.27 12.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.12 0.486 . . . . 0.0 110.657 -175.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 41.4 mtt -91.54 118.9 31.01 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.007 0.432 . . . . 0.0 110.304 177.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 274' ' ' GLN . 90.6 m-20 -83.11 0.61 44.3 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.472 -176.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 50.6 mm 72.94 -47.85 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 171.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -61.84 -24.75 67.09 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -173.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 155.38 -48.48 0.49 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.252 -0.975 . . . . 0.0 112.694 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.515 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 1.8 mp0 -86.46 116.52 24.66 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.387 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.475 ' HB3' HG21 ' A' ' 266' ' ' VAL . 43.8 m0 -97.17 153.42 18.0 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.613 178.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -106.26 109.47 21.41 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.184 0.516 . . . . 0.0 110.026 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -123.21 164.18 16.33 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.786 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -114.61 115.28 26.91 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -178.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . 0.536 ' HB ' HD21 ' A' ' 256' ' ' LEU . 88.1 t -136.15 125.2 38.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.258 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 56.95 38.78 29.58 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.893 176.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 89.34 -15.63 57.99 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.437 175.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' A' ' 282' ' ' ARG . 40.6 mtp-105 -107.96 132.7 53.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 117.164 0.482 . . . . 0.0 110.645 -177.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 0.0 OUTLIER -114.61 130.06 56.74 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 174.507 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -157.96 -175.73 29.22 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.279 -177.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.515 ' HB3' ' HB3' ' A' ' 274' ' ' GLN . 78.6 mt -93.8 129.75 40.06 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.126 0.489 . . . . 0.0 110.804 -178.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.474 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 47.8 p90 -132.72 141.18 40.18 Favored Pre-proline 0 C--N 1.317 -0.804 0 CA-C-N 115.696 -0.683 . . . . 0.0 109.837 176.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 4.6 Cg_exo -74.89 140.38 25.71 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.735 2.29 . . . . 0.0 111.58 177.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -72.58 7.12 2.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.045 0.45 . . . . 0.0 111.821 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 4.1 p -90.83 -10.68 41.84 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.157 0.503 . . . . 0.0 110.968 177.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -104.89 -10.45 17.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.874 -178.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.476 HG12 ' HA ' ' A' ' 242' ' ' ALA . 35.6 m -128.36 162.74 34.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.455 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -140.69 136.72 32.91 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.32 175.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 1.2 mp -72.56 135.96 26.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 174.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -144.63 -165.81 2.24 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.941 -175.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -103.43 95.35 6.98 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.228 175.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . 0.516 ' HG3' ' HB2' ' A' ' 239' ' ' PHE . 74.5 Cg_endo . . . . . 0 N--CA 1.461 -0.396 0 C-N-CA 122.193 1.929 . . . . 0.0 111.665 179.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.402 ' O ' HG23 ' A' ' 99' ' ' ILE . 22.7 t . . . . . 0 N--CA 1.453 -0.277 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . -75.38 87.19 2.56 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.83 175.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -115.55 88.56 2.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.648 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -161.09 161.29 31.18 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.385 177.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -88.25 91.47 8.8 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.875 0.845 . . . . 0.0 110.11 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.6 p -73.86 77.81 1.62 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.894 -176.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.4 t -176.59 -39.78 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.586 176.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -64.51 113.81 3.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.018 0.437 . . . . 0.0 110.828 -174.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -58.46 -35.81 72.71 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.742 -176.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.2 t -73.51 -6.49 46.8 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.176 -176.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.01 -47.49 7.25 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 121.046 -0.262 . . . . 0.0 111.556 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 30.1 p-90 -116.67 -22.74 8.49 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -171.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -73.27 112.84 9.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.361 0.6 . . . . 0.0 109.747 -177.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.565 ' SD ' ' HA ' ' A' ' 104' ' ' ARG . 15.7 tpp -95.3 5.86 50.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.31 -171.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.486 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 49.65 -113.65 1.92 Allowed Glycine 0 CA--C 1.522 0.493 0 CA-C-N 115.516 -0.765 . . . . 0.0 114.357 176.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.486 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 5.0 Cg_exo -77.13 88.49 1.4 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.454 2.77 . . . . 0.0 113.159 -175.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.582 HG12 ' HD2' ' A' ' 39' ' ' ARG . 71.3 t -145.34 160.44 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.452 ' H ' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -143.27 -168.81 2.9 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -171.354 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 35.6 mtp85 -59.06 -57.82 11.4 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 118.652 0.66 . . . . 0.0 112.182 -176.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -64.68 -44.97 88.64 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 123.29 0.369 . . . . 0.0 110.847 -175.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.638 ' O ' ' HG3' ' A' ' 27' ' ' ARG . 12.5 mp0 -60.68 -49.84 75.9 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.534 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.92 -44.69 82.7 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.427 0.632 . . . . 0.0 110.344 177.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.525 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 6.9 tp60 -60.72 -58.25 9.24 Favored 'General case' 0 C--O 1.214 -0.786 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.563 -178.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.2 t -61.83 -27.53 68.84 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -172.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.638 ' HG3' ' O ' ' A' ' 23' ' ' GLU . 62.5 mtp180 -83.48 -10.44 58.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.717 0.294 . . . . 0.0 111.258 -178.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.64 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 87.7 mt -125.58 -13.39 6.53 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.525 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -70.24 107.09 3.57 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 122.765 0.426 . . . . 0.0 110.434 -174.855 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 70.61 20.24 77.08 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.05 -179.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.483 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 12.2 mm100 -92.89 -161.17 0.81 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 47.0 mtm180 -52.64 130.76 33.23 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 175.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 63.5 m170 -86.35 126.31 34.25 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.25 11.2 42.92 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -171.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.543 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 50.6 ttp -104.07 134.61 47.04 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -178.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.437 ' CB ' HG22 ' A' ' 52' ' ' VAL . 39.9 p90 -139.29 167.78 21.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.768 0.318 . . . . 0.0 111.777 -174.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.545 ' HG ' HD11 ' A' ' 28' ' ' LEU . 4.6 pp -153.83 140.0 18.45 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.146 0.498 . . . . 0.0 110.825 173.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.6 t -105.71 114.21 44.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 174.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.582 ' HD2' HG12 ' A' ' 19' ' ' VAL . 22.3 ptt-85 -112.33 167.72 10.2 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.953 -173.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -76.44 125.36 29.06 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 170.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.0 t -75.77 152.51 37.36 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.395 0.617 . . . . 0.0 111.531 -172.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.8 t -111.69 14.54 21.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.226 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 46.7 p -92.16 -57.25 2.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.957 176.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.418 ' HB2' ' OD2' ' A' ' 47' ' ' ASP . 56.8 m -134.56 137.9 28.74 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.754 178.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.6 127.18 17.47 Favored 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 122.8 2.333 . . . . 0.0 112.754 -178.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.65 -16.68 43.8 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.339 176.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.418 ' OD2' ' HB2' ' A' ' 44' ' ' CYS . 65.8 m-20 -96.89 166.34 11.67 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 -177.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -128.33 175.22 8.65 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -178.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.7 t -144.66 117.35 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 120.902 0.382 . . . . 0.0 110.93 174.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 33.5 tp -84.83 102.1 12.8 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.442 176.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 55.9 m -96.52 133.65 40.72 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 175.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.798 HG21 HD13 ' A' ' 93' ' ' LEU . 99.2 t -129.53 134.3 63.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.841 0.353 . . . . 0.0 111.825 -173.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.64 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 9.2 t -94.5 117.18 29.73 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -177.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.684 ' O ' ' HB3' ' A' ' 57' ' ' ARG . 9.9 tp10 -158.26 147.94 19.71 Favored 'General case' 0 C--O 1.211 -0.967 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.276 163.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.521 ' ND2' ' HG3' ' A' ' 54' ' ' GLU . 50.7 m-80 62.89 16.59 9.27 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 123.35 0.407 . . . . 0.0 111.59 -176.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 67.2 m 56.22 59.46 3.68 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 122.724 1.25 . . . . 0.0 108.164 -168.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.684 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 19.4 ttp85 -155.59 65.12 0.6 Allowed 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 112.768 -2.015 . . . . 0.0 109.398 -160.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.673 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 21.4 t -71.61 96.79 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 122.346 1.07 . . . . 0.0 109.187 -171.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.483 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 1.4 p -75.07 121.37 21.92 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 113.237 -1.801 . . . . 0.0 111.166 -176.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 62.4 m-70 -93.59 108.08 19.84 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.211 -176.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.935 ' HB3' HD11 ' A' ' 73' ' ' ILE . 66.6 m-85 -105.63 103.24 12.71 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.071 177.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.686 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 55.8 mt -78.33 133.47 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -174.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.587 HG13 ' HB ' ' A' ' 73' ' ' ILE . 4.2 mp -118.03 118.67 58.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 122.831 0.452 . . . . 0.0 111.275 -179.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -87.78 151.06 23.17 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.0 t -92.46 100.84 13.32 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 171.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.575 HD21 ' HD2' ' A' ' 72' ' ' LYS . 80.2 mt -78.61 137.16 58.99 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.663 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -63.3 -7.03 11.14 Favored 'Trans proline' 0 CA--C 1.529 0.237 0 C-N-CA 122.889 2.392 . . . . 0.0 112.238 177.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 -78.24 6.74 7.53 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.723 173.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.778 ' HE ' ' HA ' ' A' ' 69' ' ' ARG . 2.6 tpm_? 63.57 32.87 13.8 Favored 'General case' 0 N--CA 1.46 0.065 0 CA-C-O 122.009 0.909 . . . . 0.0 109.106 -173.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.788 ' HG2' ' HA ' ' A' ' 79' ' ' ASP . 69.6 mtt180 -120.78 179.39 4.37 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.692 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.559 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 54.0 m-85 -135.82 119.35 16.98 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.096 0.474 . . . . 0.0 111.379 -176.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.583 ' HG3' ' HG2' ' A' ' 77' ' ' GLU . 46.3 tttm -101.82 101.28 11.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.567 -172.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.935 HD11 ' HB3' ' A' ' 61' ' ' TYR . 7.0 tt -100.77 110.17 27.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.38 0.609 . . . . 0.0 111.444 -176.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.96 -55.39 3.51 Favored Glycine 0 CA--C 1.519 0.326 0 CA-C-N 115.396 -0.82 . . . . 0.0 113.263 177.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -165.4 -40.86 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -176.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.454 HE21 ' HB2' ' A' ' 76' ' ' GLN . 6.4 mt-30 -69.27 141.18 54.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.24 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.583 ' HG2' ' HG3' ' A' ' 72' ' ' LYS . 43.5 mt-10 -108.99 104.86 14.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.434 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.54 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 77.6 m-85 -100.26 160.41 14.35 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 176.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.788 ' HA ' ' HG2' ' A' ' 70' ' ' ARG . 6.0 m-20 -74.82 -32.79 62.07 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -174.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.54 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 1.2 p80 -153.22 166.44 32.54 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.473 0.178 . . . . 0.0 110.875 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.668 HD23 HD21 ' A' ' 84' ' ' LEU . 9.0 mt -57.23 -51.22 83.33 Favored Pre-proline 0 N--CA 1.466 0.328 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.865 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.54 ' HD2' ' HB2' ' A' ' 80' ' ' HIS . 23.4 Cg_endo -61.11 -10.69 15.93 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.118 1.879 . . . . 0.0 113.034 177.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.58 -36.3 16.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.672 0.272 . . . . 0.0 110.466 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.668 HD21 HD23 ' A' ' 81' ' ' LEU . 4.1 pp -76.49 -35.38 58.41 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 177.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.559 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 77.3 mt -62.07 -38.5 89.04 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.554 175.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.56 ' HA ' ' HD3' ' A' ' 89' ' ' LYS . 11.0 tp10 -67.55 -38.73 84.6 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.596 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -65.66 -37.99 88.06 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.216 0.531 . . . . 0.0 110.747 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.543 ' HE2' HD13 ' A' ' 73' ' ' ILE . 35.0 m-85 -81.25 -15.59 55.13 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.777 -177.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.56 ' HD3' ' HA ' ' A' ' 86' ' ' GLU . 40.8 mtpt -64.72 -26.33 68.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.092 174.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.8 pp -114.48 8.48 7.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.421 -0.512 . . . . 0.0 112.349 174.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.422 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 6.2 t-160 -93.81 -37.95 11.5 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.747 0.308 . . . . 0.0 110.868 -176.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.485 ' N ' HG22 ' A' ' 97' ' ' THR . 58.8 m-85 67.41 84.55 0.15 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.275 -168.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.798 HD13 HG21 ' A' ' 52' ' ' VAL . 14.2 mt -53.98 -25.05 18.93 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 122.208 1.004 . . . . 0.0 110.888 175.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.528 ' CG ' ' HB3' ' A' ' 54' ' ' GLU . 0.4 OUTLIER -132.05 -91.6 0.4 Allowed 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 114.339 -1.3 . . . . 0.0 107.607 175.6 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.541 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 13.8 t -145.67 21.63 1.47 Allowed 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 172.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.8 t -135.41 -21.85 1.54 Allowed 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 119.605 -0.838 . . . . 0.0 112.852 -174.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.485 HG22 ' N ' ' A' ' 92' ' ' TYR . 7.1 p 72.96 -162.2 0.1 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.02 0.928 . . . . 0.0 110.214 -173.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.421 HD22 ' CD2' ' A' ' 36' ' ' PHE . 81.5 mt -95.96 94.45 7.61 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.068 178.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.553 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 43.9 mm -76.52 -61.26 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.958 -176.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.543 ' O ' ' HA ' ' A' ' 35' ' ' MET . 11.3 pt-20 -161.66 151.8 14.32 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.569 178.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.37 159.04 55.25 Favored 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 122.892 2.395 . . . . 0.0 113.512 -177.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.459 ' HA ' ' SD ' ' A' ' 35' ' ' MET . . . -72.31 145.7 88.43 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.91 176.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -50.24 120.91 6.82 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.696 2.264 . . . . 0.0 111.503 175.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.565 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 39.1 ttt180 . . . . . 0 C--N 1.328 -0.356 0 N-CA-C 109.776 -0.454 . . . . 0.0 109.776 -175.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.702 HD12 HG21 ' A' ' 152' ' ' ILE . 1.9 mm? . . . . . 0 N--CA 1.474 0.746 0 CA-C-O 121.229 0.538 . . . . 0.0 111.547 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 40.2 tt0 179.86 -39.73 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.341 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -124.38 119.82 30.32 Favored 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 119.839 -0.745 . . . . 0.0 110.302 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.773 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 56.0 t -134.63 144.07 35.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.976 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.746 ' NH2' ' HG ' ' A' ' 181' ' ' LEU . 0.0 OUTLIER -118.9 143.54 46.93 Favored 'General case' 0 CA--C 1.501 -0.928 0 C-N-CA 116.755 -1.978 . . . . 0.0 108.741 168.059 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.813 HG22 HG12 ' A' ' 178' ' ' VAL . 1.4 p -103.89 141.08 36.77 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.749 0.785 . . . . 0.0 111.005 -177.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.771 HD11 ' HG2' ' A' ' 179' ' ' GLU . 0.5 OUTLIER -116.43 -20.34 9.73 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.921 -173.652 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.43 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 37.3 t80 -83.85 -26.23 29.66 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.764 -171.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.466 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 12.6 t70 67.94 90.65 0.09 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.748 0.785 . . . . 0.0 110.204 -178.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.565 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 74.4 t80 -120.56 91.1 46.59 Favored Pre-proline 0 C--N 1.314 -0.976 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 176.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.742 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 92.7 Cg_endo -84.14 79.9 2.5 Favored 'Trans proline' 0 N--CA 1.444 -1.421 0 C-N-CA 121.832 1.688 . . . . 0.0 112.71 -176.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.15 -23.25 74.67 Favored Glycine 0 C--N 1.334 0.417 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.687 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.424 ' H ' ' HB3' ' A' ' 143' ' ' PRO . 18.9 m120 62.77 31.92 16.26 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 122.669 0.387 . . . . 0.0 111.686 176.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.469 ' HB3' ' H ' ' A' ' 141' ' ' ASP . 0.2 OUTLIER -127.17 178.32 6.1 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.054 0.454 . . . . 0.0 111.586 -176.097 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -97.15 -10.49 25.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.634 172.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.666 ' O ' ' HB2' ' A' ' 172' ' ' MET . 46.4 mt-10 -113.14 -7.97 13.59 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.48 176.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.469 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 9.8 m-20 -135.65 104.63 5.86 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 173.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 1.03 HD11 ' HB2' ' A' ' 165' ' ' ASN . 52.5 tp -70.83 129.24 89.95 Favored Pre-proline 0 CA--C 1.509 -0.621 0 CA-C-O 120.837 0.351 . . . . 0.0 110.83 -172.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.82 ' HD2' HD12 ' A' ' 142' ' ' LEU . 47.6 Cg_endo -80.21 96.46 1.02 Allowed 'Trans proline' 0 N--CA 1.436 -1.899 0 C-N-CA 121.01 1.14 . . . . 0.0 111.544 168.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.61 ' HB2' ' OG1' ' A' ' 130' ' ' THR . 9.0 p90 -107.18 159.87 16.01 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.926 ' H ' ' HG3' ' A' ' 148' ' ' GLU . 4.1 mppt? -111.09 -140.34 0.38 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.368 0.604 . . . . 0.0 111.818 -175.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.721 ' HD3' ' N ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -116.58 55.72 0.81 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.276 -177.019 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 135.6 23.86 0.56 Allowed Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.244 -0.889 . . . . 0.0 113.055 174.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.926 ' HG3' ' H ' ' A' ' 145' ' ' LYS . 0.0 OUTLIER -74.73 164.83 26.14 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 169.694 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.682 HD12 ' HB3' ' A' ' 129' ' ' ARG . 0.4 OUTLIER -107.86 132.12 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 173.392 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.726 HD22 HD21 ' A' ' 142' ' ' LEU . 37.9 mt -118.54 154.69 32.15 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -176.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.565 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 98.0 t -121.98 122.83 67.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.992 HD13 ' HB2' ' A' ' 163' ' ' ALA . 44.4 mm -75.0 83.27 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -175.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.604 HD12 ' HD3' ' A' ' 164' ' ' ARG . 16.4 tt -75.3 -27.94 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 CA-C-N 113.398 -1.728 . . . . 0.0 110.134 -171.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.712 ' OE2' ' HA ' ' A' ' 93' ' ' LEU . 1.8 mt-10 -135.66 141.05 44.95 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 170.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.585 ' HD2' ' HG ' ' A' ' 125' ' ' LEU . 58.6 tttp -130.1 91.53 38.97 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 122.047 -0.408 . . . . 0.0 111.202 173.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.541 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 8.4 Cg_exo -77.59 -45.14 0.16 Allowed 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.656 2.237 . . . . 0.0 112.285 171.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -117.83 -178.61 3.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.152 0.501 . . . . 0.0 111.832 -170.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.506 ' O ' HG21 ' A' ' 175' ' ' VAL . 2.6 mm-40 -106.39 -19.1 13.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.485 174.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -95.5 -28.68 14.77 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.735 0.302 . . . . 0.0 111.547 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.493 ' O ' ' HD1' ' A' ' 161' ' ' TRP . 42.6 m95 -124.22 137.91 54.46 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 174.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . 0.733 ' HB3' HD12 ' A' ' 152' ' ' ILE . 45.8 m0 -124.37 140.0 53.37 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-O 121.025 0.441 . . . . 0.0 111.007 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.57 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 19.4 m -97.94 97.02 8.58 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -174.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.992 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -110.93 148.68 31.95 Favored 'General case' 0 N--CA 1.425 -1.695 0 C-N-CA 119.846 -0.742 . . . . 0.0 109.903 -174.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.84 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 17.2 ptt-85 -86.86 122.29 30.53 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 173.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 1.03 ' HB2' HD11 ' A' ' 142' ' ' LEU . 63.8 t30 -56.38 177.44 0.07 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.005 -1.452 . . . . 0.0 110.443 -174.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.402 ' HD2' ' H ' ' A' ' 149' ' ' ILE . 46.8 tttt -63.66 -12.76 36.56 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.759 169.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -74.16 -30.38 62.23 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.186 0.517 . . . . 0.0 109.745 168.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 97.26 15.85 36.96 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.462 -171.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.84 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 2.5 ttm-85 -95.43 139.0 32.34 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 122.785 0.434 . . . . 0.0 111.457 -177.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.549 HG22 HD13 ' A' ' 153' ' ' ILE . 39.2 t -78.71 130.98 35.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.202 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -162.93 155.27 26.55 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.501 166.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.666 ' HB2' ' O ' ' A' ' 140' ' ' GLU . 0.2 OUTLIER -76.9 140.56 40.58 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 117.057 0.428 . . . . 0.0 111.042 178.854 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.731 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.4 pp -142.0 146.7 41.51 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.343 -176.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.591 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 5.3 Cg_exo -77.02 130.34 11.21 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.85 2.367 . . . . 0.0 112.746 -176.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.553 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 87.0 t -62.02 -42.2 80.48 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 24.6 Cg_endo -63.36 -0.12 2.13 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 121.948 1.766 . . . . 0.0 112.969 175.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.591 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.3 m-85 -97.07 -16.4 20.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.399 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.813 HG12 HG22 ' A' ' 130' ' ' THR . 2.4 m -112.11 -173.52 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 117.712 2.486 . . . . 0.0 117.712 -160.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.771 ' HG2' HD11 ' A' ' 131' ' ' LEU . 2.1 mm-40 -139.96 49.35 1.77 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 111.558 -2.565 . . . . 0.0 115.654 -161.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.773 ' HA ' ' HA ' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -69.51 134.35 48.77 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 124.366 3.257 . . . . 0.0 111.879 -158.69 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.746 ' HG ' ' NH2' ' A' ' 129' ' ' ARG . 0.3 OUTLIER . . . . . 0 N--CA 1.446 -0.641 0 CA-C-N 110.755 -2.93 . . . . 0.0 111.997 -170.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo . . . . . 0 N--CA 1.463 -0.286 0 N-CA-C 110.156 -0.748 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.1 t -66.81 135.6 28.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.24 -170.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -104.05 123.42 47.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.688 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -119.32 124.22 46.1 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 175.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.659 ' HB2' ' CE1' ' A' ' 294' ' ' PHE . 44.8 tttp -88.19 119.92 29.05 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -176.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -67.74 110.82 3.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.013 0.435 . . . . 0.0 110.254 -178.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 21.1 pt -85.16 1.42 4.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.122 0.486 . . . . 0.0 111.207 -174.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -158.13 152.12 24.01 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.866 178.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.92 ' HG3' HG23 ' A' ' 260' ' ' VAL . 54.6 mtmt -78.67 120.72 23.75 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.135 0.493 . . . . 0.0 110.625 177.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.633 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 22.6 ttt85 -113.01 109.67 19.23 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.843 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 29.5 m -102.69 143.05 25.82 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 177.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.557 ' HD3' ' HB2' ' A' ' 257' ' ' ALA . 55.2 Cg_endo -70.46 151.59 65.18 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 122.461 2.107 . . . . 0.0 112.764 -177.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' CYS . . . . . 0.43 ' H ' ' HB2' ' A' ' 252' ' ' ASP . 46.0 t -89.09 168.26 12.47 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 174.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -55.84 -41.03 73.69 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.657 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -95.44 8.23 43.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.91 0.386 . . . . 0.0 111.452 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . 0.43 ' HB2' ' H ' ' A' ' 249' ' ' CYS . 8.5 m-20 -110.82 73.47 0.82 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.851 0.358 . . . . 0.0 111.017 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -72.95 -24.73 60.84 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-O 121.269 0.557 . . . . 0.0 110.146 175.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 1.1 p -86.48 11.0 13.53 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.709 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . 0.415 ' HB2' ' HB3' ' A' ' 252' ' ' ASP . . . -99.92 116.6 32.36 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.847 0.356 . . . . 0.0 110.515 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.404 HD23 ' H ' ' A' ' 257' ' ' ALA . 0.8 OUTLIER -75.55 137.46 40.85 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.085 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.633 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -91.75 128.66 37.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.169 177.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 245' ' ' LYS . 69.4 mt -132.04 149.3 52.45 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.146 -173.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.799 ' HA ' ' HG2' ' A' ' 245' ' ' LYS . 64.5 mm-40 -101.54 167.77 9.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.604 178.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.92 HG23 ' HG3' ' A' ' 245' ' ' LYS . 60.0 t -74.89 115.94 16.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 176.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . 0.543 ' HA2' ' HE3' ' A' ' 241' ' ' LYS . . . 99.71 -2.76 57.27 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.635 -177.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -71.75 151.93 43.15 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -174.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 43.0 mm -103.75 109.05 25.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.107 0.48 . . . . 0.0 110.907 -175.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.453 ' HA ' HG21 ' A' ' 279' ' ' VAL . 39.1 t -82.77 105.27 12.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.103 178.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -91.07 98.95 12.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.583 178.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 4.8 p -92.13 123.12 44.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.414 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 6.6 p -96.54 -33.01 11.98 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.654 -177.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 32.6 mtm180 -131.9 126.03 33.15 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.412 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 38.3 mtt -105.04 121.28 43.45 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.183 0.516 . . . . 0.0 111.127 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' A' ' 274' ' ' GLN . 79.4 m-20 -88.72 120.68 30.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.536 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 32.1 mm -76.35 80.84 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.333 0.587 . . . . 0.0 110.389 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . 0.784 HD21 ' HG2' ' A' ' 274' ' ' GLN . 3.3 p-10 -163.14 -37.55 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.622 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 131.4 28.73 0.62 Allowed Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.179 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.784 ' HG2' HD21 ' A' ' 272' ' ' ASN . 2.4 pt20 -159.79 113.51 2.24 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 168.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 3.6 m0 -93.68 158.21 15.79 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 122.16 -0.337 . . . . 0.0 110.454 -175.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -101.06 108.45 20.15 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -132.44 136.45 8.75 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 177.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 283' ' ' LYS . 29.4 tt0 -114.69 114.62 25.89 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.987 0.423 . . . . 0.0 110.022 -178.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . 0.453 HG21 ' HA ' ' A' ' 264' ' ' VAL . 28.4 t -118.94 -78.69 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.195 0.522 . . . . 0.0 111.147 -175.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -86.58 60.7 6.38 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.22 -173.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 71.66 2.05 48.58 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.489 -0.778 . . . . 0.0 113.111 177.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 44.5 mtp180 -139.91 137.91 35.21 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.389 -0.226 . . . . 0.0 110.389 -175.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.459 ' HB3' ' NZ ' ' A' ' 283' ' ' LYS . 0.1 OUTLIER -91.92 125.15 36.51 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 168.391 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -142.52 162.0 27.34 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.241 -0.981 . . . . 0.0 112.07 -176.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 67.3 mt -95.23 131.76 40.93 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.125 0.488 . . . . 0.0 109.917 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -123.47 149.95 59.67 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.34 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . 0.558 ' HD3' ' CZ ' ' A' ' 246' ' ' ARG . 76.8 Cg_endo -83.59 16.12 1.97 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.729 2.286 . . . . 0.0 113.496 -171.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.508 ' CZ ' ' HA ' ' A' ' 274' ' ' GLN . 2.8 m-85 66.46 -40.98 0.37 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.041 0.936 . . . . 0.0 113.11 177.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 1.7 m -66.63 -16.57 64.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.974 0.416 . . . . 0.0 111.973 -177.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -89.94 -3.82 57.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.861 0.362 . . . . 0.0 110.787 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.421 HG11 HG21 ' A' ' 264' ' ' VAL . 33.6 m -127.12 165.68 25.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -130.7 115.95 17.38 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -84.55 138.65 18.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -177.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' PHE . . . . . 0.659 ' CE1' ' HB2' ' A' ' 241' ' ' LYS . 0.8 OUTLIER -159.57 174.2 14.98 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.729 -171.537 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -92.08 105.06 12.34 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 172.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo . . . . . 0 N--CA 1.463 -0.283 0 C-N-CA 122.085 1.856 . . . . 0.0 111.819 -179.971 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.47 ' O ' HG23 ' A' ' 99' ' ' ILE . 3.1 t . . . . . 0 N--CA 1.451 -0.404 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.402 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . -79.51 106.65 11.69 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.631 175.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.435 HH11 ' HD2' ' A' ' 5' ' ' ARG . 1.6 tpp180 -140.45 91.55 2.45 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.409 0.623 . . . . 0.0 110.904 -177.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.629 ' CE1' ' HE2' ' A' ' 89' ' ' LYS . 29.1 p90 -161.74 154.59 20.44 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.08 -0.963 . . . . 0.0 108.91 178.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -79.87 111.82 16.56 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.1 m -65.13 -13.18 57.47 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.222 -173.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.1 m -103.9 -20.55 13.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.788 0.328 . . . . 0.0 111.729 -178.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -73.91 92.93 2.13 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.323 0.582 . . . . 0.0 111.041 -175.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.402 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 10.8 mtm-85 -64.27 -23.32 67.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.121 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.5 m -70.1 -9.14 54.54 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.778 0.323 . . . . 0.0 110.802 177.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -100.48 -47.95 4.72 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.673 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 43.7 p-90 -113.24 -20.9 11.23 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -171.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.402 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 57.2 t80 -75.32 107.39 7.4 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.089 -0.644 . . . . 0.0 109.763 -178.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.78 ' SD ' ' HA ' ' A' ' 104' ' ' ARG . 10.8 tpp -86.71 -10.83 52.81 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.796 -172.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 51.3 -112.79 1.91 Allowed Glycine 0 CA--C 1.522 0.51 0 CA-C-N 115.476 -0.784 . . . . 0.0 114.721 175.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.17 70.06 1.29 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.562 2.841 . . . . 0.0 114.037 -173.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.691 HG21 ' HG3' ' A' ' 16' ' ' MET . 60.0 t -130.76 172.26 16.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 176.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.527 ' H ' HG12 ' A' ' 19' ' ' VAL . 89.6 p -145.08 -176.68 5.19 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 -169.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 26.7 ttt85 -68.08 -41.57 81.71 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.902 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -65.79 -48.92 70.17 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.4 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.417 ' HB3' HG13 ' A' ' 19' ' ' VAL . 3.0 mp0 -65.65 -48.11 73.28 Favored 'General case' 0 C--O 1.221 -0.399 0 O-C-N 122.423 -0.173 . . . . 0.0 111.357 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.77 -46.94 83.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.7 0.286 . . . . 0.0 111.507 -177.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.549 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 51.5 tp60 -59.2 -42.57 91.24 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.814 178.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.7 m -62.3 -43.24 99.27 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.774 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.534 ' O ' ' HG3' ' A' ' 31' ' ' GLN . 46.2 mtt180 -74.01 -13.83 60.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.796 -174.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.58 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 37.8 mt -124.99 2.23 8.01 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.121 0.486 . . . . 0.0 111.275 -176.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.549 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 29.8 tp60 -71.14 96.11 1.32 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.649 -176.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.1 20.83 75.02 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.391 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.534 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 4.6 mm100 -87.98 -176.14 5.35 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.562 0.22 . . . . 0.0 110.431 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.813 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 50.4 ttp180 -55.79 133.41 51.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.074 177.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -83.66 140.73 31.99 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.904 0.383 . . . . 0.0 110.367 -174.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.58 -10.91 53.65 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.169 -173.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.813 ' SD ' ' HB3' ' A' ' 32' ' ' ARG . 24.8 mtp -79.81 140.07 36.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.475 -0.363 . . . . 0.0 110.436 177.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.474 ' HB2' HD11 ' A' ' 50' ' ' LEU . 45.1 p90 -146.58 163.66 35.1 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.124 -176.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.695 ' HB2' ' HB2' ' A' ' 16' ' ' MET . 4.2 pp -152.04 133.63 14.67 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.17 0.51 . . . . 0.0 110.966 175.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 56.1 t -101.84 106.9 20.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 174.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.6 ptt-85 -108.87 179.41 4.19 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.216 -175.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -79.66 138.54 37.41 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 172.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.461 ' HB3' ' O ' ' A' ' 44' ' ' CYS . 46.1 t -60.38 137.05 58.2 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.343 0.592 . . . . 0.0 111.92 -173.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.401 ' OG ' ' HA ' ' A' ' 20' ' ' SER . 10.9 m -87.82 -4.47 58.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.756 -178.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.0 p -112.53 -45.91 3.2 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.901 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.461 ' O ' ' HB3' ' A' ' 41' ' ' SER . 39.2 m -131.17 90.45 38.7 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.493 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 44' ' ' CYS . 10.0 Cg_endo -52.77 133.68 51.49 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.887 2.391 . . . . 0.0 111.804 179.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 111.46 -41.66 2.17 Favored Glycine 0 CA--C 1.505 -0.566 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -172.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -79.48 177.16 9.07 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 167.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.561 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 39.2 m-85 -134.66 174.5 10.49 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 118.477 0.581 . . . . 0.0 110.916 -176.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.5 t -144.67 108.09 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.922 0.392 . . . . 0.0 110.706 175.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.474 HD11 ' HB2' ' A' ' 36' ' ' PHE . 48.4 tp -77.54 103.21 7.34 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.881 173.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.5 m -96.42 127.4 42.38 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 175.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.406 HG22 ' HB2' ' A' ' 36' ' ' PHE . 89.2 t -118.85 138.58 49.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.937 0.399 . . . . 0.0 111.085 -175.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.58 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 32.3 t -87.67 113.66 23.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.578 -176.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.658 ' HG3' HG22 ' A' ' 95' ' ' THR . 0.0 OUTLIER -149.47 137.29 20.35 Favored 'General case' 0 C--O 1.205 -1.249 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.241 172.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 56.53 27.13 11.85 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 173.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 49.0 m 57.74 53.06 7.45 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 122.516 1.15 . . . . 0.0 108.189 -175.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.726 HH22 ' HA ' ' A' ' 154' ' ' GLU . 6.0 ttp180 -167.98 64.81 0.07 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 113.133 -1.849 . . . . 0.0 109.246 -153.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 37.3 t -70.25 107.07 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 122.333 1.063 . . . . 0.0 110.142 -167.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 45.5 m -75.71 121.74 22.97 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 113.304 -1.771 . . . . 0.0 110.533 -176.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -99.01 115.32 28.68 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -173.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.553 ' HB3' HD11 ' A' ' 73' ' ' ILE . 44.0 m-85 -112.14 107.88 16.95 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.586 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 65.4 mt -80.77 127.9 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -173.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.561 ' HB ' ' HB2' ' A' ' 48' ' ' TYR . 3.8 mp -102.43 119.32 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 122.947 0.499 . . . . 0.0 111.209 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.555 ' HB2' ' HB3' ' A' ' 72' ' ' LYS . 0.8 OUTLIER -87.77 134.81 33.6 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.999 -178.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.0 t -83.7 86.1 7.18 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 172.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.565 HD12 ' HB2' ' A' ' 70' ' ' ARG . 83.0 mt -70.21 137.96 86.89 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.778 -176.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 66' ' ' LEU . 36.9 Cg_exo -61.85 -16.2 47.7 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.914 2.409 . . . . 0.0 111.394 176.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.8 m-20 -81.47 7.98 10.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.222 178.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.807 ' HE ' ' HA ' ' A' ' 69' ' ' ARG . 2.9 mmp_? 64.51 36.59 8.58 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.812 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.565 ' HB2' HD12 ' A' ' 66' ' ' LEU . 82.1 mtm-85 -126.38 179.17 5.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.271 177.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.537 ' HB3' HG23 ' A' ' 63' ' ' ILE . 57.0 m-85 -136.35 116.7 13.63 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.019 0.438 . . . . 0.0 111.156 -176.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.597 ' HA ' ' HA ' ' A' ' 77' ' ' GLU . 24.2 ttmm -99.73 116.06 30.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.217 -176.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.553 HD11 ' HB3' ' A' ' 61' ' ' TYR . 18.5 tt -93.52 92.37 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 121.995 0.902 . . . . 0.0 111.345 -176.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' A' ' 75' ' ' ASP . . . 77.76 -15.7 7.61 Favored Glycine 0 CA--C 1.517 0.203 0 CA-C-N 115.191 -0.913 . . . . 0.0 113.959 174.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 74' ' ' GLY . 22.3 t70 161.35 -55.24 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.607 0.717 . . . . 0.0 109.167 -171.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -71.27 118.78 14.49 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.63 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.597 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 14.3 pt-20 -105.89 134.44 49.01 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.751 0.786 . . . . 0.0 111.785 -175.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.461 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 88.9 m-85 -112.45 -177.47 3.16 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.848 176.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.405 ' HA ' ' HD2' ' A' ' 70' ' ' ARG . 7.5 p-10 -78.54 -28.67 46.09 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 121.136 -0.226 . . . . 0.0 111.208 -176.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -171.02 174.31 4.76 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 173.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.544 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 13.1 mt -53.9 -56.47 25.25 Favored Pre-proline 0 N--CA 1.471 0.582 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -176.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.544 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 38.9 Cg_exo -61.23 -10.14 14.7 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 122.175 1.917 . . . . 0.0 112.81 -177.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.5 -36.02 15.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.798 -178.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.0 pp -75.44 -34.58 60.97 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.574 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 92.0 mt -64.85 -25.93 68.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.377 177.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -87.27 -34.21 18.99 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.463 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -70.35 -36.87 74.47 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.299 0.571 . . . . 0.0 110.56 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.678 ' CG ' HD23 ' A' ' 93' ' ' LEU . 27.1 m-85 -77.32 -9.41 58.81 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.197 -177.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.629 ' HE2' ' CE1' ' A' ' 6' ' ' PHE . 99.0 mttt -68.1 -12.5 60.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.919 0.39 . . . . 0.0 111.221 177.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 24.2 pt -134.55 18.86 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 121.368 0.604 . . . . 0.0 109.492 -178.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.424 ' O ' ' HB2' ' A' ' 92' ' ' TYR . 4.0 t60 -116.55 -40.66 3.18 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.969 -175.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.424 ' HB2' ' O ' ' A' ' 91' ' ' HIS . 52.6 m-85 68.85 114.21 0.04 OUTLIER 'General case' 0 N--CA 1.461 0.104 0 O-C-N 124.291 0.995 . . . . 0.0 109.115 -169.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.678 HD23 ' CG ' ' A' ' 88' ' ' TYR . 0.8 OUTLIER -109.18 -7.39 15.3 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.055 -0.658 . . . . 0.0 111.099 176.347 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 1.058 ' HA ' ' HB3' ' A' ' 154' ' ' GLU . 0.5 OUTLIER -159.52 81.42 0.74 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.143 0.497 . . . . 0.0 111.166 170.372 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.69 ' OG1' ' HA ' ' A' ' 156' ' ' PRO . 2.3 t 47.67 3.79 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 125.208 1.403 . . . . 0.0 113.858 -176.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.469 ' H ' ' C ' ' A' ' 94' ' ' ASP . 14.6 t -153.76 168.16 27.22 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 32.5 p -101.85 178.46 4.61 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 177.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.1 mt -75.11 96.19 3.21 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 176.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.47 HG23 ' O ' ' A' ' 3' ' ' SER . 37.5 mm -82.15 -63.68 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.707 -173.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.631 ' O ' ' HA ' ' A' ' 35' ' ' MET . 33.3 tt0 -153.33 137.13 10.41 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.16 -178.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -57.33 162.57 9.62 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 123.087 2.524 . . . . 0.0 113.248 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.53 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -78.16 157.98 77.67 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.198 178.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.93 107.52 0.23 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.452 2.101 . . . . 0.0 112.089 177.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.78 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 65.0 ttt180 . . . . . 0 C--N 1.326 -0.42 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.705 178.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.71 HD12 HG21 ' A' ' 152' ' ' ILE . 2.6 mm? . . . . . 0 N--CA 1.467 0.408 0 CA-C-O 121.657 0.741 . . . . 0.0 111.351 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.56 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 46.5 tt0 -169.37 -77.12 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.561 -176.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -104.74 107.67 18.75 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 121.611 0.719 . . . . 0.0 110.773 -177.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.75 HG22 ' CG ' ' A' ' 180' ' ' LYS . 65.7 t -123.48 130.67 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 CA-C-N 114.448 -1.251 . . . . 0.0 108.882 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.702 ' HG3' ' HB3' ' A' ' 179' ' ' GLU . 5.2 ptp180 -108.6 149.65 28.6 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 116.831 -1.947 . . . . 0.0 108.196 171.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.532 HG22 HG12 ' A' ' 178' ' ' VAL . 0.8 OUTLIER -106.12 129.56 54.18 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.102 -178.734 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 1.036 HD11 ' HG2' ' A' ' 179' ' ' GLU . 16.8 mt -104.08 -21.17 13.63 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -174.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.429 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 59.2 t80 -77.31 -35.18 55.14 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -172.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.585 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 23.0 t70 70.77 94.72 0.07 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.633 0.73 . . . . 0.0 109.784 -174.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.537 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 37.1 t80 -126.69 86.39 58.66 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.604 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 90.8 Cg_endo -88.89 79.36 1.01 Allowed 'Trans proline' 0 N--CA 1.441 -1.563 0 C-N-CA 121.896 1.731 . . . . 0.0 112.66 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.51 -22.5 75.02 Favored Glycine 0 CA--C 1.51 -0.248 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 175.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.819 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 1.0 OUTLIER 57.43 73.12 0.48 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.09 -1.055 . . . . 0.0 110.997 -175.704 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.643 ' HB3' ' H ' ' A' ' 141' ' ' ASP . 0.6 OUTLIER -141.26 -173.65 3.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.394 0.616 . . . . 0.0 111.545 -178.588 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -114.99 1.9 14.1 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.674 167.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.562 ' O ' ' HB2' ' A' ' 172' ' ' MET . 40.3 mt-10 -116.35 -41.18 3.15 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.994 175.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.643 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 9.2 m-20 -101.86 114.25 28.17 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 167.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 1.085 HD11 ' HB2' ' A' ' 165' ' ' ASN . 35.2 tp -69.92 127.64 92.31 Favored Pre-proline 0 N--CA 1.465 0.324 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.819 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 6.5 Cg_endo -82.02 90.23 1.14 Allowed 'Trans proline' 0 N--CA 1.443 -1.497 0 C-N-CA 121.956 1.771 . . . . 0.0 110.752 173.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.537 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 9.1 p90 -102.39 155.04 18.51 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.317 -175.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.585 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 99.0 mttt -99.92 -166.65 1.36 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.235 0.54 . . . . 0.0 112.427 -174.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.828 ' H ' ' HD2' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -83.71 5.29 25.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.288 -169.42 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -179.07 37.59 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.996 176.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.519 ' OE1' ' HA ' ' A' ' 144' ' ' PHE . 1.2 pt-20 -96.59 148.92 22.35 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.751 -174.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.58 128.58 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.723 HD22 HD21 ' A' ' 142' ' ' LEU . 16.6 mt -121.7 156.63 32.67 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 -178.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.564 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 49.2 t -119.51 123.43 71.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 174.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 1.073 HD13 ' HB2' ' A' ' 163' ' ' ALA . 50.4 mm -73.92 94.53 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 -176.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.612 HD12 ' HD3' ' A' ' 164' ' ' ARG . 18.7 tt -79.33 -26.34 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.547 -173.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 1.058 ' HB3' ' HA ' ' A' ' 94' ' ' ASP . 0.0 OUTLIER -141.0 145.56 36.11 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.454 169.123 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -121.86 84.93 44.63 Favored Pre-proline 0 C--N 1.318 -0.784 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 167.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.69 ' HA ' ' OG1' ' A' ' 95' ' ' THR . 13.0 Cg_exo -70.42 -47.73 0.69 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.603 2.202 . . . . 0.0 111.824 177.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -118.15 177.29 4.85 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.589 -174.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.428 ' O ' HG21 ' A' ' 175' ' ' VAL . 13.3 pt-20 -92.98 -34.76 13.62 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.556 -176.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.416 ' HG3' ' HG3' ' A' ' 158' ' ' GLU . 36.3 mt-30 -98.74 -10.42 23.15 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.865 0.364 . . . . 0.0 111.66 -176.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.548 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 59.1 m95 -124.36 134.83 53.03 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 172.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . 0.786 ' O ' HG13 ' A' ' 173' ' ' ILE . 50.7 m0 -123.99 133.81 53.6 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.144 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.758 ' HB2' ' HG3' ' A' ' 154' ' ' GLU . 50.5 m -93.82 98.47 11.1 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -173.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 1.073 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -112.33 146.09 38.88 Favored 'General case' 0 N--CA 1.419 -1.998 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.701 -172.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.735 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 15.1 ptt180 -87.0 120.62 28.46 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 175.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 1.085 ' HB2' HD11 ' A' ' 142' ' ' LEU . 20.7 t30 -52.52 176.85 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 113.455 -1.702 . . . . 0.0 111.753 -173.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 45.5 tptt -58.46 -21.02 49.96 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 169.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -77.38 -28.89 52.97 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.614 175.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 100.17 7.56 52.06 Favored Glycine 0 CA--C 1.519 0.333 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.119 -174.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.735 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.4 OUTLIER -79.9 135.72 36.49 Favored 'General case' 0 C--O 1.22 -0.498 0 C-N-CA 122.819 0.448 . . . . 0.0 111.217 -179.621 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.549 HG22 HG21 ' A' ' 153' ' ' ILE . 47.9 t -81.08 123.34 37.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 C-N-CA 121.119 -0.232 . . . . 0.0 111.252 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -158.06 146.29 13.13 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.865 171.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.57 ' HA ' ' HA ' ' A' ' 162' ' ' SER . 0.0 OUTLIER -68.97 141.06 55.03 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 122.922 0.489 . . . . 0.0 111.219 178.265 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.786 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.7 pp -142.91 143.17 24.23 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.246 -176.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.538 ' HB2' ' CD1' ' A' ' 177' ' ' TYR . 20.5 Cg_exo -68.24 132.26 25.48 Favored 'Trans proline' 0 CA--C 1.528 0.219 0 C-N-CA 122.96 2.44 . . . . 0.0 113.282 -178.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.566 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 67.0 t -60.79 -44.34 94.7 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 178.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 20.0 Cg_endo -61.52 -2.05 2.35 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 122.211 1.94 . . . . 0.0 113.217 178.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.538 ' CD1' ' HB2' ' A' ' 174' ' ' PRO . 2.8 m-85 -99.83 -12.17 20.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.555 -177.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.649 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 3.7 m -106.36 -172.83 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 -164.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 1.036 ' HG2' HD11 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -157.29 46.44 0.39 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 112.897 -1.956 . . . . 0.0 111.545 -151.755 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.75 ' CG ' HG22 ' A' ' 128' ' ' VAL . 0.8 OUTLIER -71.45 136.55 47.7 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 120.193 -1.567 . . . . 0.0 110.009 -163.369 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 38.8 tp . . . . . 0 CA--C 1.523 -0.067 0 CA-C-N 113.524 -1.671 . . . . 0.0 111.796 -165.47 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo . . . . . 0 N--CA 1.46 -0.447 0 N-CA-C 110.54 -0.6 . . . . 0.0 110.54 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.507 ' HB ' HG13 ' A' ' 266' ' ' VAL . 6.2 t -74.49 127.74 36.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -176.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -98.69 118.2 34.87 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.193 0.52 . . . . 0.0 111.198 -175.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.545 ' HB2' HD12 ' A' ' 293' ' ' ILE . . . -121.78 134.95 54.92 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.067 175.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -94.45 133.62 37.85 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 177.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . 0.601 ' O ' ' HA ' ' A' ' 260' ' ' VAL . . . -82.29 105.2 13.17 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.178 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.565 HD13 ' H ' ' A' ' 243' ' ' ILE . 0.2 OUTLIER -88.84 -23.08 6.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.999 0.428 . . . . 0.0 110.727 -178.483 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -130.25 122.61 28.37 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 178.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -60.34 138.42 57.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.799 0.809 . . . . 0.0 112.374 -171.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 20.4 tpt180 -116.83 113.99 23.29 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.946 -1.025 . . . . 0.0 108.998 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.416 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 19.9 m -111.65 147.68 37.28 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.774 -178.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.427 ' HA ' ' HB3' ' A' ' 255' ' ' ALA . 11.9 Cg_exo -69.24 105.63 1.43 Allowed 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.68 2.253 . . . . 0.0 111.399 178.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' CYS . . . . . 0.453 ' HB3' ' HB2' ' A' ' 252' ' ' ASP . 34.0 t -76.92 172.34 13.31 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.965 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -55.62 -42.58 75.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.823 0.344 . . . . 0.0 111.131 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -94.23 8.83 40.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.122 0.487 . . . . 0.0 111.172 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . 0.453 ' HB2' ' HB3' ' A' ' 249' ' ' CYS . 1.6 m-20 -131.94 51.28 2.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.538 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -67.65 -17.49 64.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.128 0.489 . . . . 0.0 110.106 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 3.7 p -88.23 4.37 46.02 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.55 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . 0.427 ' HB3' ' HA ' ' A' ' 248' ' ' PRO . . . -88.39 142.82 27.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.223 0.535 . . . . 0.0 111.299 -178.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.437 HD23 ' N ' ' A' ' 257' ' ' ALA . 1.2 tt -81.68 141.22 33.83 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.11 177.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -88.63 109.53 20.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.139 0.495 . . . . 0.0 110.297 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 72.2 mt -118.42 157.38 27.3 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.96 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -146.01 167.9 22.22 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 177.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.601 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 26.0 t -55.82 120.39 2.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 O-C-N 123.673 0.608 . . . . 0.0 112.55 -171.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 109.76 -21.13 26.07 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.713 -0.676 . . . . 0.0 113.574 172.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -78.79 154.44 29.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 117.033 0.416 . . . . 0.0 110.797 -170.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 43.9 mm -98.12 120.55 47.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.877 -177.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.444 HG21 HG11 ' A' ' 291' ' ' VAL . 21.7 t -95.81 116.67 38.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.532 179.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 43.1 tttm -89.86 99.02 12.11 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.461 177.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.507 HG13 ' HB ' ' A' ' 238' ' ' VAL . 3.6 p -99.52 117.53 44.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.36 0.6 . . . . 0.0 110.174 174.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.42 -13.66 15.04 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.816 -177.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . 0.553 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 5.6 ttp180 -130.46 107.3 9.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.174 0.512 . . . . 0.0 110.86 175.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 44.7 mtt -97.92 123.8 42.07 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.684 173.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.433 ' O ' ' HB ' ' A' ' 271' ' ' ILE . 90.8 m-20 -80.74 -93.55 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.976 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.433 ' HB ' ' O ' ' A' ' 270' ' ' ASN . 10.5 tp 177.1 -29.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.153 0.502 . . . . 0.0 109.778 176.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -68.29 -37.5 80.73 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.734 177.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 141.42 -34.36 1.91 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.422 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.439 ' NE2' HD13 ' A' ' 285' ' ' LEU . 26.8 mt-30 -76.38 107.72 8.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.875 0.369 . . . . 0.0 110.198 178.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.404 ' HB3' ' CG2' ' A' ' 266' ' ' VAL . 40.6 m0 -98.24 158.1 15.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.176 -178.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.553 ' HB2' ' HB3' ' A' ' 268' ' ' ARG . 53.6 mt-10 -95.84 104.27 16.2 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.216 173.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -121.63 141.05 14.26 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 174.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -116.3 112.05 21.0 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.999 0.428 . . . . 0.0 110.43 -177.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 66.3 t -129.4 127.9 65.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.2 -177.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 63.66 21.8 12.86 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.451 177.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 102.44 -14.89 56.52 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.731 177.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 53.4 mtp180 -104.43 132.02 51.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.694 0.247 . . . . 0.0 111.128 -179.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 4.8 ptpp? -111.57 114.83 28.16 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 171.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -133.4 166.38 23.83 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.757 -177.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.439 HD13 ' NE2' ' A' ' 274' ' ' GLN . 74.8 mt -86.98 112.56 21.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.265 0.555 . . . . 0.0 110.443 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -115.56 149.34 42.8 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.859 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -86.11 143.61 7.97 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.471 2.114 . . . . 0.0 111.618 177.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -68.93 4.01 1.72 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -175.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 23.9 p -89.54 -33.67 16.65 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.855 0.359 . . . . 0.0 111.511 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -77.5 -12.32 59.95 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.984 0.421 . . . . 0.0 110.96 -177.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.54 ' HB ' ' HB1' ' A' ' 240' ' ' ALA . 27.8 m -128.38 160.57 38.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.279 179.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -133.55 134.92 43.96 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.9 0.381 . . . . 0.0 110.753 174.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.545 HD12 ' HB2' ' A' ' 240' ' ' ALA . 1.2 mp -68.34 138.89 21.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.482 177.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -156.73 158.8 37.57 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 177.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -84.85 114.5 55.97 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 174.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 N--CA 1.463 -0.313 0 C-N-CA 122.987 2.458 . . . . 0.0 111.123 178.482 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.528 ' O ' HG23 ' A' ' 99' ' ' ILE . 3.0 p . . . . . 0 N--CA 1.451 -0.391 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -87.86 66.46 8.75 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.772 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -97.91 84.46 3.33 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.816 -173.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -154.37 164.67 38.25 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.506 176.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -89.68 107.29 19.01 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 175.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.577 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 37.8 t -79.09 69.9 5.35 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.306 -178.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.4 t -176.29 -40.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.167 176.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -58.14 108.23 0.58 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.108 0.48 . . . . 0.0 111.469 -174.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 17.8 mmt180 -61.92 -32.22 72.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.853 -174.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 72.4 m -74.47 -5.7 44.11 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.974 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.53 -48.41 6.64 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.429 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.449 ' HB3' ' HB3' ' A' ' 101' ' ' PRO . 22.9 p-90 -114.54 -29.94 6.68 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -170.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -72.27 122.2 20.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.908 0.385 . . . . 0.0 110.618 -175.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.545 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 26.1 mmt -103.06 -5.5 23.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.401 -176.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.475 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 50.97 -114.43 2.79 Favored Glycine 0 CA--C 1.522 0.492 0 CA-C-N 115.614 -0.721 . . . . 0.0 113.498 -177.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.475 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 5.3 Cg_exo -77.33 89.18 1.34 Allowed 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 123.091 2.527 . . . . 0.0 113.274 -175.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.603 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 97.1 t -139.15 155.51 26.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 177.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.5 m -119.46 174.06 6.61 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -174.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 70.0 mtp85 -55.77 -47.32 77.25 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -62.7 -56.2 19.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.853 0.358 . . . . 0.0 111.113 -178.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.538 ' HB3' HG13 ' A' ' 19' ' ' VAL . 0.5 OUTLIER -57.08 -47.12 81.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.789 -179.156 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.52 -47.4 82.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.204 0.526 . . . . 0.0 111.079 176.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -63.91 -43.19 96.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.495 -178.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.9 t -70.66 -9.16 56.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.651 0.262 . . . . 0.0 111.437 -177.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.487 ' HG3' ' O ' ' A' ' 23' ' ' GLU . 77.5 mtt180 -87.65 -25.84 23.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.987 0.422 . . . . 0.0 110.661 174.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.586 HD22 ' HB2' ' A' ' 53' ' ' SER . 27.3 mt -108.71 -12.49 14.94 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.76 -175.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.0 tp60 -79.7 105.51 11.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.161 0.505 . . . . 0.0 111.297 -177.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.97 -17.84 47.75 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.86 175.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -86.16 175.54 8.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.678 0.275 . . . . 0.0 110.785 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 18.3 ttp180 -62.0 132.09 51.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.732 -177.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.414 ' CD2' ' HA ' ' A' ' 54' ' ' GLU . 33.3 m80 -76.35 158.18 31.71 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.376 -176.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.69 -11.86 46.24 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -174.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.626 ' HB3' ' HB2' ' A' ' 102' ' ' ALA . 66.1 mtt -73.96 150.7 40.62 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 175.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.422 ' CB ' HG22 ' A' ' 52' ' ' VAL . 37.9 p90 -147.8 156.26 42.54 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 175.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.545 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.5 pp -150.45 134.72 17.08 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.058 0.456 . . . . 0.0 110.592 178.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.4 t -105.84 107.57 22.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.508 176.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.603 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 24.6 ptt-85 -106.34 -178.85 3.77 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.46 138.82 33.28 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 172.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.593 ' HB3' ' O ' ' A' ' 44' ' ' CYS . 20.8 t -68.05 104.26 1.72 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.39 0.614 . . . . 0.0 110.736 -174.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.4 p -69.02 -11.01 60.4 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.839 177.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.0 p -104.97 -22.15 13.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.719 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.593 ' O ' ' HB3' ' A' ' 41' ' ' SER . 57.9 m -136.51 112.68 10.03 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.763 0.316 . . . . 0.0 110.561 -177.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -62.01 114.95 2.53 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.958 2.439 . . . . 0.0 113.098 -175.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.94 -26.53 23.71 Favored Glycine 0 CA--C 1.51 -0.236 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.735 174.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.602 ' OD1' ' HA ' ' A' ' 64' ' ' ASN . 32.0 m-20 -79.95 179.66 7.47 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.544 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 38.3 m-85 -127.48 174.36 9.08 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 176.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.403 HG23 ' HA ' ' A' ' 41' ' ' SER . 27.9 t -141.37 111.01 2.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.662 0.267 . . . . 0.0 111.049 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.459 ' HB2' HD11 ' A' ' 63' ' ' ILE . 61.3 tp -78.33 98.76 6.06 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 171.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.8 m -95.62 119.66 34.51 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.266 0.555 . . . . 0.0 109.543 175.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.609 HG21 HD11 ' A' ' 93' ' ' LEU . 48.7 t -112.12 143.32 22.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.903 -173.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.589 ' HA ' ' O ' ' A' ' 57' ' ' ARG . 36.6 t -87.34 111.87 21.52 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.612 -0.144 . . . . 0.0 110.612 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.414 ' HA ' ' CD2' ' A' ' 33' ' ' HIS . 6.8 tp10 -175.92 157.3 1.89 Allowed 'General case' 0 N--CA 1.469 0.523 0 O-C-N 123.486 0.491 . . . . 0.0 111.022 176.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.676 ' HB2' ' NH2' ' A' ' 57' ' ' ARG . 27.0 m-80 61.81 58.26 2.0 Allowed 'General case' 0 CA--C 1.479 -1.752 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -171.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.9 t 70.54 -37.54 0.39 Allowed 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 113.777 -1.556 . . . . 0.0 110.21 -169.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.901 ' NE ' ' H ' ' A' ' 58' ' ' VAL 0.399 0.0 OUTLIER -157.76 -48.06 0.06 Allowed 'General case' 0 C--N 1.364 1.237 1 N-CA-C 125.571 5.397 . . . . 0.0 125.571 -170.116 . . . . . . . . 5 4 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.901 ' H ' ' NE ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -149.43 112.09 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 122.088 2.222 . . . . 0.0 114.573 -168.292 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.548 ' HB2' ' HB ' ' A' ' 52' ' ' VAL . 1.4 m -98.34 114.13 26.34 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 166.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.571 ' O ' HD11 ' A' ' 153' ' ' ILE . 92.0 m-70 -100.68 110.81 22.96 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -170.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.615 ' CZ ' ' HB2' ' A' ' 93' ' ' LEU . 98.7 m-85 -119.03 117.25 28.28 Favored 'General case' 0 C--O 1.218 -0.579 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -178.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.516 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 44.8 mm -78.09 127.64 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -177.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.574 HG13 ' HB ' ' A' ' 73' ' ' ILE . 3.8 mp -104.34 114.54 44.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 175.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.602 ' HA ' ' OD1' ' A' ' 47' ' ' ASP . 7.9 m120 -85.89 137.06 33.02 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.577 -173.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.8 t -87.72 95.73 10.18 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 174.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.554 HD11 ' HB2' ' A' ' 72' ' ' LYS . 99.0 mt -82.15 136.19 47.02 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.444 -178.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 66' ' ' LEU . 27.0 Cg_exo -64.82 -2.0 4.87 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.942 2.428 . . . . 0.0 111.311 172.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -79.58 5.22 13.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.614 175.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.536 ' HE ' ' HA ' ' A' ' 69' ' ' ARG . 0.1 OUTLIER 67.91 29.9 6.38 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.227 -176.835 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.423 ' HB3' ' O ' ' A' ' 78' ' ' PHE . 30.7 mtm-85 -140.52 175.23 9.78 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.933 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.467 ' HB3' HG23 ' A' ' 63' ' ' ILE . 68.1 m-85 -125.99 132.22 52.07 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.505 0.193 . . . . 0.0 111.06 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.669 ' HE2' ' HB3' ' A' ' 77' ' ' GLU . 37.1 ttmt -114.32 112.19 22.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.978 -177.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.574 ' HB ' HG13 ' A' ' 63' ' ' ILE . 14.0 tt -105.04 110.72 31.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.344 0.592 . . . . 0.0 111.127 -177.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.58 50.12 45.47 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.63 177.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.9 t0 75.58 -29.24 0.19 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.607 0.763 . . . . 0.0 110.985 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -81.18 121.43 26.13 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.185 0.517 . . . . 0.0 110.716 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.669 ' HB3' ' HE2' ' A' ' 72' ' ' LYS . 7.8 pt-20 -99.6 141.86 31.84 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.437 -176.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.423 ' O ' ' HB3' ' A' ' 70' ' ' ARG . 95.5 m-85 -131.95 -175.56 3.77 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.201 -177.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.401 ' HA ' ' HD2' ' A' ' 70' ' ' ARG . 4.3 m-20 -64.01 -50.88 66.76 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.186 0.517 . . . . 0.0 110.335 175.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.505 ' ND1' ' HD2' ' A' ' 82' ' ' PRO . 4.2 p80 -173.0 -173.8 0.99 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.246 -176.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.667 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 19.6 mt -54.3 -58.16 15.1 Favored Pre-proline 0 N--CA 1.467 0.421 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.667 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 52.4 Cg_exo -59.52 -7.7 5.93 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 122.562 2.175 . . . . 0.0 113.765 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -95.46 -36.68 11.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.915 0.388 . . . . 0.0 110.925 -178.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.9 pp -76.59 -30.52 57.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.311 -178.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.452 ' HB2' ' OG ' ' A' ' 8' ' ' SER . 60.0 mt -66.12 -21.91 66.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.322 0.582 . . . . 0.0 110.002 177.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -81.66 -39.84 23.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.086 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.637 ' HE1' ' CE1' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -71.64 -21.38 61.83 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.073 0.463 . . . . 0.0 111.079 -179.873 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.697 ' CD1' HD23 ' A' ' 93' ' ' LEU . 32.7 m-85 -89.34 1.91 55.12 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 121.665 -0.647 . . . . 0.0 111.641 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -76.38 -21.47 56.02 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.953 175.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.555 HD13 ' O ' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -125.4 -1.78 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-O 121.558 0.694 . . . . 0.0 110.301 -175.477 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -101.86 -30.71 11.11 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.345 -174.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 67.81 153.56 0.09 Allowed 'General case' 0 C--N 1.332 -0.168 0 O-C-N 124.501 1.125 . . . . 0.0 109.346 -168.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.697 HD23 ' CD1' ' A' ' 88' ' ' TYR . 0.7 OUTLIER -138.24 39.97 2.28 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 164.648 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 1.078 ' HA ' ' HB3' ' A' ' 154' ' ' GLU . 13.8 t0 168.08 -158.47 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 112.058 -2.337 . . . . 0.0 106.01 172.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.748 ' CB ' ' HA ' ' A' ' 156' ' ' PRO . 14.2 t -76.76 11.36 1.73 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.21 0.529 . . . . 0.0 110.564 176.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.2 t -146.43 161.58 40.1 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.752 176.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.8 p -97.7 -176.18 3.4 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 176.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 81.5 mt -77.33 92.91 3.96 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 176.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.528 HG23 ' O ' ' A' ' 3' ' ' SER . 48.1 mm -74.9 -59.08 3.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.985 -176.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.546 ' O ' ' HA ' ' A' ' 35' ' ' MET . 8.8 pt-20 -159.98 154.42 20.36 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.257 178.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.449 ' HB3' ' HB3' ' A' ' 14' ' ' TRP . 38.1 Cg_endo -67.18 142.64 61.75 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.323 2.015 . . . . 0.0 112.003 177.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.626 ' HB2' ' HB3' ' A' ' 35' ' ' MET . . . -69.01 148.0 97.8 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.945 177.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -63.26 129.13 24.57 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.704 1.603 . . . . 0.0 111.102 174.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 . . . . . 0 C--N 1.33 -0.279 0 CA-C-O 121.056 0.455 . . . . 0.0 111.194 178.336 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.929 HD12 HG21 ' A' ' 152' ' ' ILE . 4.6 mm? . . . . . 0 N--CA 1.468 0.465 0 CA-C-O 121.696 0.76 . . . . 0.0 110.516 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.502 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 40.1 tt0 -172.88 -68.72 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.825 -1.08 . . . . 0.0 108.942 -172.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -115.63 108.02 15.86 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 121.061 0.457 . . . . 0.0 110.163 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.724 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 69.4 t -118.1 132.47 67.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.961 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.691 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 5.6 ptp180 -110.38 144.37 39.25 Favored 'General case' 0 N--CA 1.436 -1.167 0 C-N-CA 117.162 -1.815 . . . . 0.0 107.92 169.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.605 HG22 HG12 ' A' ' 178' ' ' VAL . 6.0 p -98.19 138.5 35.38 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.064 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.566 HD21 ' HG2' ' A' ' 179' ' ' GLU . 15.6 mt -110.96 -8.14 14.5 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.448 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 22.0 t80 -91.03 -42.46 10.51 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.432 -0.507 . . . . 0.0 112.01 -173.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.583 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 10.0 t70 77.3 98.39 0.07 Allowed 'General case' 0 N--CA 1.475 0.808 0 O-C-N 123.581 0.55 . . . . 0.0 110.459 -176.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.532 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 76.0 t80 -134.12 93.86 19.11 Favored Pre-proline 0 N--CA 1.45 -0.47 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 176.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.69 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 91.9 Cg_endo -84.02 89.53 0.97 Allowed 'Trans proline' 0 N--CA 1.443 -1.476 0 C-N-CA 121.767 1.645 . . . . 0.0 112.64 -178.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -79.74 -36.48 25.66 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.65 176.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.54 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 16.7 m120 67.62 34.21 4.64 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 122.958 0.503 . . . . 0.0 111.648 175.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.543 ' HB3' ' H ' ' A' ' 140' ' ' GLU . 0.1 OUTLIER -117.3 178.22 4.45 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.135 -178.071 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -92.71 -7.31 47.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.926 0.87 . . . . 0.0 108.749 171.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.676 ' O ' ' HB2' ' A' ' 172' ' ' MET . 32.4 mt-10 -118.06 -5.02 10.98 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.712 177.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.483 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 7.9 m-20 -139.53 102.44 4.46 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 174.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 1.098 HD11 ' HB2' ' A' ' 165' ' ' ASN . 31.0 tp -71.74 135.21 83.45 Favored Pre-proline 0 CA--C 1.512 -0.517 0 C-N-CA 120.535 -0.466 . . . . 0.0 109.966 -177.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.69 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 94.4 Cg_endo -88.54 96.85 0.38 Allowed 'Trans proline' 0 N--CA 1.438 -1.767 0 C-N-CA 121.54 1.493 . . . . 0.0 112.193 173.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.532 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 1.8 p90 -94.54 -177.7 4.32 Favored 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.85 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.583 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 29.1 mtmm -125.96 -172.25 2.57 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.676 174.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.984 ' H ' ' HD2' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -78.13 22.74 0.29 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.749 -173.1 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 165.5 35.13 0.02 OUTLIER Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.446 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.491 ' OE1' ' HA ' ' A' ' 144' ' ' PHE . 0.8 OUTLIER -96.79 150.51 20.63 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 119.286 -0.966 . . . . 0.0 110.688 -178.876 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.2 mp -93.5 123.76 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -173.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.781 HD22 HD21 ' A' ' 142' ' ' LEU . 13.2 mt -119.91 156.89 29.88 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -175.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.592 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 99.5 t -117.74 121.42 67.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 176.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 1.007 HD13 ' HB2' ' A' ' 163' ' ' ALA . 47.2 mm -77.21 105.21 5.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.548 0.69 . . . . 0.0 109.181 -175.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.571 HD11 ' O ' ' A' ' 60' ' ' HIS . 19.5 tt -96.33 -29.01 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.954 -174.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 1.078 ' HB3' ' HA ' ' A' ' 94' ' ' ASP . 2.6 mt-10 -123.25 143.15 50.24 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 168.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.625 ' CD ' ' HG ' ' A' ' 125' ' ' LEU . 70.2 tttt -134.86 78.44 54.58 Favored Pre-proline 0 C--N 1.314 -0.952 0 CA-C-O 121.323 0.583 . . . . 0.0 109.512 166.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.748 ' HA ' ' CB ' ' A' ' 95' ' ' THR . 26.1 Cg_exo -64.47 -52.41 1.47 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.178 1.919 . . . . 0.0 111.908 172.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.427 ' HG2' ' HB2' ' A' ' 156' ' ' PRO . 17.7 mm-40 -114.73 168.08 10.2 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.194 -169.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -96.19 1.56 52.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.395 0.617 . . . . 0.0 109.466 173.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.937 HE21 ' HA ' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -104.73 -34.34 8.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.72 179.651 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.485 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 35.1 m95 -129.55 142.28 50.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.985 176.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . 0.751 ' O ' HG13 ' A' ' 173' ' ' ILE . 52.4 m0 -125.68 137.96 53.87 Favored 'General case' 0 C--O 1.216 -0.695 0 C-N-CA 123.155 0.582 . . . . 0.0 110.143 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.539 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 18.2 m -98.12 107.11 19.51 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -175.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 1.007 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -117.3 152.22 35.32 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 119.899 -0.72 . . . . 0.0 110.742 -176.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.824 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 11.8 ptt180 -87.37 121.91 30.42 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 171.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 1.098 ' HB2' HD11 ' A' ' 142' ' ' LEU . 14.9 t30 -55.92 -179.83 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 113.748 -1.569 . . . . 0.0 111.668 -174.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -66.51 -22.15 66.17 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 167.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -68.85 -20.36 64.28 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.709 168.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 165' ' ' ASN . . . 82.73 19.51 63.46 Favored Glycine 0 CA--C 1.527 0.844 0 CA-C-N 115.148 -0.933 . . . . 0.0 113.246 -175.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.824 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 1.5 ttm-85 -94.12 142.53 27.3 Favored 'General case' 0 C--O 1.214 -0.788 0 C-N-CA 122.482 0.313 . . . . 0.0 111.03 -178.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 59.4 t -83.96 123.41 38.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 O-C-N 122.191 -0.318 . . . . 0.0 111.29 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -158.53 151.97 23.05 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.723 171.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.676 ' HB2' ' O ' ' A' ' 140' ' ' GLU . 0.2 OUTLIER -73.17 142.91 47.4 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.735 0.302 . . . . 0.0 111.187 178.202 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.751 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.7 pp -143.88 147.96 40.52 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.115 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.505 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 11.2 Cg_exo -72.67 132.37 18.67 Favored 'Trans proline' 0 CA--C 1.528 0.214 0 C-N-CA 122.654 2.236 . . . . 0.0 112.826 -175.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.498 ' O ' HG22 ' A' ' 178' ' ' VAL . 70.1 t -60.41 -44.32 95.5 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.462 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 39.2 Cg_exo -62.59 -5.7 7.56 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 122.213 1.942 . . . . 0.0 112.95 176.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.505 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.2 m-85 -94.67 -12.17 27.82 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.216 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.644 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 2.8 m -107.41 -175.18 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 -166.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.696 ' O ' ' HG3' ' A' ' 179' ' ' GLU . 3.6 tp10 -160.9 46.32 0.2 Allowed 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 112.725 -2.034 . . . . 0.0 111.541 -152.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.777 ' HD2' ' H ' ' A' ' 180' ' ' LYS . 0.0 OUTLIER -73.17 137.86 45.34 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 119.125 -2.235 . . . . 0.0 111.874 -161.328 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 15.3 tp . . . . . 0 N--CA 1.445 -0.69 0 CA-C-N 112.217 -2.265 . . . . 0.0 110.15 -173.401 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo . . . . . 0 N--CA 1.459 -0.516 0 N-CA-C 110.732 -0.526 . . . . 0.0 110.732 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.68 HG12 HD11 ' A' ' 293' ' ' ILE . 2.8 t -90.18 145.0 7.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.557 -176.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.477 ' HB2' ' HA ' ' A' ' 295' ' ' ASP . 77.1 m-85 -116.28 124.77 51.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.291 0.567 . . . . 0.0 112.302 -172.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.61 ' HB2' HD12 ' A' ' 293' ' ' ILE . . . -119.48 149.85 41.21 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.919 175.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -106.65 123.72 48.54 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 173.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . 0.505 ' O ' ' HA ' ' A' ' 260' ' ' VAL . . . -68.34 97.24 0.72 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.92 0.391 . . . . 0.0 110.304 -178.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.471 HD13 ' HB2' ' A' ' 292' ' ' LYS . 27.1 pt -86.29 -24.39 6.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.077 -177.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.39 123.85 38.88 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 176.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -53.98 138.63 36.56 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.38 0.609 . . . . 0.0 111.598 -173.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 28.4 tpt180 -123.32 111.63 16.63 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.161 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.442 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 23.6 m -115.95 144.22 32.34 Favored Pre-proline 0 C--N 1.318 -0.802 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.264 177.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 247' ' ' VAL . 4.4 Cg_exo -75.09 121.87 6.81 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.478 2.119 . . . . 0.0 110.953 177.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 18.2 t -75.42 -178.41 4.02 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.105 -177.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -59.23 -23.62 62.48 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.289 0.478 . . . . 0.0 112.289 -176.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -107.0 4.9 27.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.621 -177.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -96.3 112.88 24.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.773 0.32 . . . . 0.0 110.808 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -106.75 -37.82 6.29 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.014 176.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 24.8 p -99.41 19.97 14.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.708 -176.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -93.36 145.09 24.72 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.057 0.456 . . . . 0.0 111.164 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -93.78 135.79 34.73 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.921 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -91.91 122.09 34.11 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.162 177.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 81.4 mt -129.43 135.74 49.05 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -175.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -99.38 161.86 13.37 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 175.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 36.4 t -73.21 109.06 5.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.642 -178.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 120.35 -0.77 12.78 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.716 178.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -89.73 160.34 16.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.943 0.372 . . . . 0.0 110.131 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 30.1 mm -103.65 116.75 47.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.184 0.516 . . . . 0.0 110.733 -176.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 13.7 t -97.8 109.66 23.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.476 -178.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 9.4 ptmt -93.35 102.47 14.73 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.274 175.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.443 HG13 ' HB ' ' A' ' 238' ' ' VAL . 2.3 p -93.22 128.54 44.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.333 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.23 -39.33 7.69 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.149 -176.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . 0.499 ' HB2' ' CG ' ' A' ' 276' ' ' GLU . 63.2 mtt85 -128.11 127.27 42.75 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.979 0.418 . . . . 0.0 110.498 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' MET . . . . . 0.501 ' HE2' ' CZ3' ' A' ' 275' ' ' TRP . 43.4 mtt -105.36 140.11 38.97 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.342 -176.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.413 ' HB2' ' OD1' ' A' ' 272' ' ' ASN . 34.6 m-80 -106.94 169.08 8.76 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.477 177.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 18.4 pt -98.24 9.36 7.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.156 0.503 . . . . 0.0 111.162 -176.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . 0.413 ' OD1' ' HB2' ' A' ' 270' ' ' ASN . 30.1 p-10 -87.69 -20.87 25.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.995 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 114.83 -12.39 20.43 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.386 -178.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.411 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 26.0 mt-30 -116.98 122.5 44.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.085 0.469 . . . . 0.0 110.373 177.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.501 ' CZ3' ' HE2' ' A' ' 269' ' ' MET . 6.6 m0 -99.02 169.22 9.58 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.807 -176.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.499 ' CG ' ' HB2' ' A' ' 268' ' ' ARG . 0.0 OUTLIER -101.36 115.76 31.24 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 121.536 0.684 . . . . 0.0 110.324 174.882 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -119.57 146.85 18.17 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.167 177.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -109.88 106.58 16.21 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 60.9 t -131.85 125.37 55.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.829 0.347 . . . . 0.0 111.025 -171.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 58.74 27.77 16.41 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.336 175.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 91.02 -4.25 81.28 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.721 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 19.3 mtp-105 -113.55 120.2 40.13 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.467 ' HE3' ' HB2' ' A' ' 283' ' ' LYS . 15.1 ptmt -111.39 138.71 47.53 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.24 0.543 . . . . 0.0 110.611 175.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -173.45 -169.73 36.17 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.435 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 87.4 mt -90.41 134.14 34.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.981 0.419 . . . . 0.0 110.734 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -133.7 137.74 29.41 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.983 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -78.06 130.91 10.6 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 122.647 2.231 . . . . 0.0 112.042 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.499 ' HA ' HG22 ' A' ' 291' ' ' VAL . 35.6 p90 -62.33 -17.91 60.04 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.911 0.386 . . . . 0.0 110.731 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.39 -20.18 65.32 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.888 -0.597 . . . . 0.0 112.099 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -105.66 -5.69 19.82 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.713 0.292 . . . . 0.0 111.601 -176.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.499 HG22 ' HA ' ' A' ' 288' ' ' PHE . 33.7 m -123.43 166.26 18.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 120.987 0.422 . . . . 0.0 110.676 -177.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . 0.471 ' HB2' HD13 ' A' ' 243' ' ' ILE . 39.9 tptt -122.4 107.25 11.85 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.68 HD11 HG12 ' A' ' 238' ' ' VAL . 4.2 tp -74.54 135.36 27.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -157.14 -29.33 0.09 Allowed 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.321 -0.552 . . . . 0.0 112.042 -175.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . 0.477 ' HA ' ' HB2' ' A' ' 239' ' ' PHE . 32.5 m-20 60.79 97.22 0.04 OUTLIER Pre-proline 0 N--CA 1.464 0.227 0 CA-C-O 121.056 0.455 . . . . 0.0 110.613 -176.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo . . . . . 0 C--N 1.345 0.371 0 C-N-CA 122.841 2.361 . . . . 0.0 112.486 -177.399 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.3 p . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 121.54 0.686 . . . . 0.0 109.767 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.79 93.44 5.6 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.122 175.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -115.27 90.34 3.31 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.597 0.713 . . . . 0.0 111.014 -178.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.482 ' CE1' ' HE2' ' A' ' 89' ' ' LYS . 32.1 p90 -160.66 151.67 18.83 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.446 -1.252 . . . . 0.0 108.482 177.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -80.46 115.46 20.0 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 177.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.3 m -67.29 -9.01 36.55 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -173.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.7 t -106.86 -24.43 12.05 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.308 -176.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -63.39 98.83 0.17 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.028 0.442 . . . . 0.0 110.874 -174.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.457 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 2.9 tpp180 -57.11 -43.41 82.25 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.402 -176.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.0 m -75.74 7.0 4.21 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -177.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -95.75 -46.28 6.65 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.613 0.244 . . . . 0.0 110.749 173.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.469 ' HB3' ' HB3' ' A' ' 101' ' ' PRO . 34.7 p-90 -121.68 -26.66 4.85 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -173.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.457 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 60.8 t80 -75.32 107.98 7.79 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.335 0.588 . . . . 0.0 110.03 -176.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.461 ' SD ' ' HG2' ' A' ' 104' ' ' ARG . 5.4 tpp -91.4 -9.53 44.41 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.993 -174.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 39' ' ' ARG . . . 50.5 -112.66 1.66 Allowed Glycine 0 C--N 1.333 0.399 0 O-C-N 123.839 0.712 . . . . 0.0 114.293 175.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -74.16 93.66 0.89 Allowed 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.473 2.115 . . . . 0.0 112.461 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.473 ' O ' ' CB ' ' A' ' 20' ' ' SER . 7.3 t -125.7 -77.02 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.954 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.473 ' CB ' ' O ' ' A' ' 19' ' ' VAL . 32.3 t 125.86 156.39 0.0 OUTLIER 'General case' 0 C--N 1.355 0.84 0 C-N-CA 124.973 1.309 . . . . 0.0 108.311 168.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.52 ' HA ' ' NH2' ' A' ' 39' ' ' ARG . 21.1 tpt180 -52.91 -52.33 58.1 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.746 0.308 . . . . 0.0 111.003 178.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -64.77 -33.89 77.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.111 -176.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.636 ' HG2' ' HE ' ' A' ' 27' ' ' ARG . 24.8 tt0 -82.57 -45.99 13.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.929 0.395 . . . . 0.0 110.898 -177.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.49 -38.29 68.96 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.132 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 55.0 tp60 -60.9 -47.52 86.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.342 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.6 t -78.27 -22.66 47.95 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 121.056 -0.258 . . . . 0.0 111.166 -175.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.636 ' HE ' ' HG2' ' A' ' 23' ' ' GLU . 63.9 mtt180 -68.59 -21.19 64.53 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.662 0.268 . . . . 0.0 110.565 177.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.575 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 95.3 mt -125.93 6.96 7.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.154 -0.475 . . . . 0.0 112.276 -176.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -82.89 110.91 18.29 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 122.129 -0.357 . . . . 0.0 110.933 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.413 ' H ' ' HA ' ' A' ' 56' ' ' SER . . . 69.77 18.66 74.33 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.841 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.564 ' HG3' ' HA ' ' A' ' 28' ' ' LEU . 12.2 mm100 -83.34 -168.33 2.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.604 0.24 . . . . 0.0 110.607 -178.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.562 ' HB2' ' SD ' ' A' ' 35' ' ' MET . 46.3 mtm180 -58.31 141.98 49.4 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 173.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 63.6 m170 -88.33 122.22 31.6 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 120.847 0.356 . . . . 0.0 110.495 -177.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.75 -5.73 14.1 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.91 -175.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.67 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 34.1 mtp -80.3 146.81 31.43 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 122.451 0.3 . . . . 0.0 110.74 177.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -151.81 161.31 42.87 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 121.118 -0.233 . . . . 0.0 110.931 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.53 ' HG ' HD11 ' A' ' 28' ' ' LEU . 4.5 pp -154.75 140.99 18.57 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.057 0.456 . . . . 0.0 111.229 176.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 51.8 t -110.99 112.29 39.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.547 176.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.542 ' HD3' ' O ' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -113.99 -179.3 3.6 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 178.345 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.542 ' O ' ' HD3' ' A' ' 39' ' ' ARG . 4.1 m-20 -66.97 137.83 56.81 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 175.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.545 ' HA ' HG23 ' A' ' 49' ' ' VAL . 46.7 t -54.4 141.74 29.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.179 0.514 . . . . 0.0 111.281 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.2 m -85.53 -13.07 50.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.087 -176.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 22.4 p -125.1 -44.68 1.89 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -174.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.436 ' HA ' ' HD2' ' A' ' 45' ' ' PRO . 3.0 p -114.66 102.36 54.8 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-O 120.858 0.361 . . . . 0.0 111.559 -176.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 44' ' ' CYS . 10.8 Cg_endo -54.59 139.03 76.06 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.881 2.387 . . . . 0.0 111.908 177.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.1 -32.38 7.37 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.251 -177.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -87.42 175.18 8.1 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.856 0.36 . . . . 0.0 110.201 177.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.459 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 38.2 m-85 -131.39 174.28 10.23 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.861 178.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.545 HG23 ' HA ' ' A' ' 41' ' ' SER . 65.0 t -142.47 106.67 1.39 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-O 120.969 0.414 . . . . 0.0 110.952 177.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.6 tp -78.42 104.75 9.22 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.148 175.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.7 m -96.33 132.8 41.46 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 176.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.643 HG21 HD13 ' A' ' 93' ' ' LEU . 86.9 t -124.49 136.27 61.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.882 0.372 . . . . 0.0 111.158 -175.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.575 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 32.2 t -96.38 104.86 16.86 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.207 -172.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.795 ' O ' ' HB3' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -152.8 151.74 30.8 Favored 'General case' 0 C--O 1.204 -1.332 0 C-N-CA 120.287 -0.565 . . . . 0.0 109.704 169.245 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.579 ' HB2' ' HD3' ' A' ' 57' ' ' ARG . 54.9 m-80 56.76 22.76 7.23 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 178.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.413 ' HA ' ' H ' ' A' ' 30' ' ' GLY . 46.8 m 54.06 54.8 9.12 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 122.801 1.286 . . . . 0.0 107.964 -172.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.795 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 0.2 OUTLIER -161.96 65.94 0.25 Allowed 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 112.873 -1.967 . . . . 0.0 109.353 -151.168 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.616 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 18.6 t -72.54 97.11 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 121.865 0.841 . . . . 0.0 109.789 -170.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.7 m -68.32 121.12 15.61 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 113.88 -1.509 . . . . 0.0 110.96 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -100.15 107.12 18.91 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.811 0.339 . . . . 0.0 111.491 -176.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.741 ' HE1' HD11 ' A' ' 153' ' ' ILE . 72.8 m-85 -102.34 107.04 17.92 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.128 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.528 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 63.8 mt -80.4 129.37 37.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -174.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.503 HG23 ' HB3' ' A' ' 71' ' ' PHE . 5.0 mp -104.28 114.97 45.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.392 178.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -87.76 139.41 30.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.744 -173.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 31.3 t -81.86 95.05 7.2 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 169.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.566 HD11 ' HB2' ' A' ' 72' ' ' LYS . 91.9 mt -74.63 148.45 85.37 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.996 -176.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.67 -14.85 45.23 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.682 2.255 . . . . 0.0 110.617 171.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.35 -3.01 24.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.847 176.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.493 ' HA ' ' NE ' ' A' ' 69' ' ' ARG . 3.7 mmp_? 66.38 26.27 10.21 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.291 0.567 . . . . 0.0 110.049 -173.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 47.7 mtp180 -123.76 -179.64 4.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.599 -177.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.503 ' HB3' HG23 ' A' ' 63' ' ' ILE . 29.2 m-85 -127.87 115.9 19.31 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -173.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 77' ' ' GLU . 38.6 ttmt -102.09 116.47 32.76 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.188 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.619 HD11 ' HB3' ' A' ' 61' ' ' TYR . 11.7 tt -94.7 93.04 3.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.707 0.765 . . . . 0.0 110.773 -178.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.62 69.92 1.16 Allowed Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.438 -0.801 . . . . 0.0 113.075 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.524 ' HA ' ' HD3' ' A' ' 72' ' ' LYS . 31.4 t70 75.47 -38.76 0.37 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.139 0.576 . . . . 0.0 112.354 176.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -80.83 114.22 19.57 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.573 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 9.5 pt-20 -95.07 134.33 37.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.681 0.753 . . . . 0.0 112.177 -174.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -119.27 179.03 4.31 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.528 171.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.24 -32.4 22.61 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 -175.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -161.68 167.66 24.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.673 0.273 . . . . 0.0 111.074 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.613 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 14.5 mt -53.94 -56.47 25.3 Favored Pre-proline 0 N--CA 1.467 0.398 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.403 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.613 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 29.7 Cg_exo -65.94 2.17 1.89 Allowed 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.409 2.072 . . . . 0.0 113.204 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -98.7 -34.91 10.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.839 0.352 . . . . 0.0 110.567 176.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.2 pp -76.56 -33.9 58.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.134 0.492 . . . . 0.0 109.78 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.457 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 72.8 mt -67.89 -14.76 63.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.185 176.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -88.94 -40.2 13.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.247 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -71.77 -28.97 63.99 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.784 -178.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.435 ' CG ' HD21 ' A' ' 93' ' ' LEU . 20.7 m-85 -84.58 -2.5 57.49 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -177.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.482 ' HE2' ' CE1' ' A' ' 6' ' ' PHE . 98.8 mttt -73.3 -6.89 48.96 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.099 174.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.6 pt -132.91 -6.45 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.232 0 CA-C-O 120.938 0.399 . . . . 0.0 110.573 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -93.16 -34.19 13.72 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.516 -171.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 70.87 128.36 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.159 0 O-C-N 124.411 1.07 . . . . 0.0 109.956 -169.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.643 HD13 HG21 ' A' ' 52' ' ' VAL . 0.9 OUTLIER -103.75 -14.96 15.88 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.767 0.794 . . . . 0.0 109.783 173.084 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.863 ' HA ' ' HB3' ' A' ' 154' ' ' GLU . 1.5 m-20 -133.22 -100.01 0.27 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.613 -177.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.725 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 14.0 t -134.13 14.76 3.87 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 165.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.537 HG22 ' HG3' ' A' ' 54' ' ' GLU . 3.8 t -140.84 169.88 16.8 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 113.962 -1.472 . . . . 0.0 107.403 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.6 p -104.11 -179.38 3.93 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 176.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 74.2 mt -68.39 88.59 0.33 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 175.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 48.9 mm -78.25 -54.98 11.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.137 -173.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.67 ' O ' ' HA ' ' A' ' 35' ' ' MET . 39.7 tt0 -160.09 136.71 6.53 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.925 -177.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.469 ' HB3' ' HB3' ' A' ' 14' ' ' TRP . 18.2 Cg_endo -59.9 158.95 27.04 Favored 'Trans proline' 0 CA--C 1.531 0.325 0 C-N-CA 122.793 2.329 . . . . 0.0 112.743 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.567 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -75.17 145.4 80.35 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.844 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -55.66 130.93 43.08 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.634 2.223 . . . . 0.0 111.514 174.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.461 ' HG2' ' SD ' ' A' ' 16' ' ' MET . 78.3 mtp180 . . . . . 0 C--N 1.322 -0.598 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.248 -174.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.742 HD12 HG21 ' A' ' 152' ' ' ILE . 4.0 mm? . . . . . 0 N--CA 1.455 -0.194 0 CA-C-O 122.128 0.966 . . . . 0.0 112.686 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -169.6 -60.37 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 113.866 -1.516 . . . . 0.0 107.614 -176.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -123.0 133.48 54.36 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.95 176.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.541 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 23.7 t -133.18 160.86 42.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.757 ' HG2' ' O ' ' A' ' 180' ' ' LYS . 2.0 ptp180 -138.39 138.03 37.86 Favored 'General case' 0 CA--C 1.494 -1.2 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.924 171.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.869 HG22 HG12 ' A' ' 178' ' ' VAL . 30.4 p -92.75 140.44 29.52 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.566 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.5 mt -114.06 -5.08 13.11 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.82 -172.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.491 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 59.7 t80 -107.21 -42.68 4.79 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -171.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.716 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 16.1 t70 79.79 93.5 0.05 Allowed 'General case' 0 N--CA 1.474 0.73 0 O-C-N 123.778 0.673 . . . . 0.0 110.63 -173.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.585 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 68.4 t80 -124.07 88.06 52.89 Favored Pre-proline 0 N--CA 1.45 -0.436 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 172.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.573 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 95.4 Cg_endo -84.55 84.82 1.42 Allowed 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 121.488 1.459 . . . . 0.0 112.239 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.54 -25.0 75.26 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 173.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.677 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 19.8 m120 53.68 72.09 0.46 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.214 -0.993 . . . . 0.0 111.17 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -141.88 173.11 11.81 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.483 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -100.33 12.03 38.07 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -127.57 -36.64 2.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.048 -1.433 . . . . 0.0 109.261 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -113.77 128.04 56.26 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 173.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.985 HD11 ' HB2' ' A' ' 165' ' ' ASN . 32.4 tp -83.29 124.72 75.73 Favored Pre-proline 0 C--N 1.325 -0.489 0 C-N-CA 120.178 -0.609 . . . . 0.0 111.457 -176.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.677 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 57.4 Cg_endo -76.31 102.41 1.61 Allowed 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 121.71 1.607 . . . . 0.0 111.673 167.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.585 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 0.5 OUTLIER -92.03 -163.84 1.1 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.716 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 55.4 mttp -134.8 -176.02 4.09 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.114 175.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.804 ' H ' ' HD2' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -77.61 39.61 0.28 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.481 0.657 . . . . 0.0 111.382 -174.641 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 130' ' ' THR . . . 136.05 49.16 0.07 OUTLIER Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 -176.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.676 ' OE2' ' HG ' ' A' ' 150' ' ' LEU . 1.2 pp20? -92.28 179.26 5.6 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.514 HD11 ' NH2' ' A' ' 129' ' ' ARG . 1.3 mp -118.48 124.48 73.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 175.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.742 ' CD2' ' HA ' ' A' ' 165' ' ' ASN . 72.5 mt -118.91 156.44 29.52 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.405 0.621 . . . . 0.0 109.691 -172.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.568 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 52.4 t -118.49 122.95 70.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 173.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.949 HD13 ' HB2' ' A' ' 163' ' ' ALA . 46.5 mm -77.54 79.61 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.468 0 CA-C-O 122.519 1.152 . . . . 0.0 108.964 -175.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.741 HD11 ' HE1' ' A' ' 61' ' ' TYR . 21.0 tt -65.87 -27.31 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 CA-C-N 113.107 -1.86 . . . . 0.0 109.852 -176.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.863 ' HB3' ' HA ' ' A' ' 94' ' ' ASP . 0.2 OUTLIER -145.83 146.45 31.15 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 121.143 0.497 . . . . 0.0 110.957 171.248 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.57 ' HD2' ' HG ' ' A' ' 125' ' ' LEU . 86.3 tttt -126.14 87.69 55.68 Favored Pre-proline 0 C--N 1.319 -0.758 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 168.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.725 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 5.4 Cg_exo -81.58 -51.55 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.993 2.462 . . . . 0.0 111.721 175.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.683 ' HG2' ' CE ' ' A' ' 172' ' ' MET . 6.1 mm-40 -97.39 160.75 14.14 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.094 0.474 . . . . 0.0 111.049 -175.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -85.25 -33.14 22.25 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.914 175.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -92.82 -17.15 24.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.399 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.427 ' HB2' ' HB2' ' A' ' 157' ' ' GLU . 62.7 m95 -127.41 124.17 37.86 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.116 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . 0.562 ' O ' HG13 ' A' ' 173' ' ' ILE . 45.9 m0 -110.67 136.27 50.02 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.707 ' OG ' ' HG2' ' A' ' 172' ' ' MET . 38.0 m -97.35 109.09 21.92 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -173.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.949 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -122.85 152.1 41.07 Favored 'General case' 0 N--CA 1.426 -1.657 0 C-N-CA 119.888 -0.725 . . . . 0.0 110.405 -174.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.831 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 9.8 ptt180 -87.69 126.88 35.23 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 171.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.985 ' HB2' HD11 ' A' ' 142' ' ' LEU . 64.2 t30 -60.31 178.09 0.22 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.306 -1.315 . . . . 0.0 111.406 -172.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 19.5 tttp -58.15 -11.99 3.1 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.866 167.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -89.84 -27.65 19.79 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.393 174.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 105.07 -0.81 41.04 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.729 -175.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.831 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 3.3 ttm-85 -76.11 140.02 41.61 Favored 'General case' 0 C--O 1.217 -0.61 0 C-N-CA 123.324 0.65 . . . . 0.0 112.008 -177.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.529 HG22 HD13 ' A' ' 153' ' ' ILE . 48.1 t -87.21 123.52 40.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 111.353 0.131 . . . . 0.0 111.353 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -158.12 151.9 23.05 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.258 172.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.707 ' HG2' ' OG ' ' A' ' 162' ' ' SER . 36.8 mtp -81.37 142.73 32.75 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.885 0.342 . . . . 0.0 110.583 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 1.001 HD13 HG11 ' A' ' 178' ' ' VAL . 2.8 pp -143.24 150.63 52.72 Favored Pre-proline 0 C--O 1.222 -0.349 0 O-C-N 123.442 0.464 . . . . 0.0 111.119 -178.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.503 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 6.7 Cg_exo -72.82 132.1 18.05 Favored 'Trans proline' 0 CA--C 1.529 0.241 0 C-N-CA 122.387 2.058 . . . . 0.0 112.615 -176.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.555 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 18.3 t -57.9 -43.1 98.31 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 32.8 Cg_endo -64.84 -2.36 5.33 Favored 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 122.049 1.833 . . . . 0.0 113.116 176.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.503 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 4.5 m-85 -98.2 -18.45 18.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.71 177.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 1.001 HG11 HD13 ' A' ' 173' ' ' ILE . 2.2 m -130.68 -172.32 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.102 -168.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.879 ' HG3' ' H ' ' A' ' 180' ' ' LYS . 8.7 pt-20 -156.34 -65.67 0.11 Allowed 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 117.404 2.372 . . . . 0.0 117.404 152.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.879 ' H ' ' HG3' ' A' ' 179' ' ' GLU . 4.2 mptt -157.59 -177.54 6.66 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.153 0.888 . . . . 0.0 109.891 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.42 ' HG ' ' NH2' ' A' ' 129' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.319 -0.719 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 153.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 N--CA 1.459 -0.558 0 N-CA-C 111.02 -0.415 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.499 ' CG1' HD12 ' A' ' 293' ' ' ILE . 66.8 t -77.06 123.83 34.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.92 0.391 . . . . 0.0 110.562 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -99.04 115.25 28.55 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.999 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.662 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -119.37 121.16 38.9 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.091 178.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.538 ' HB2' ' CE1' ' A' ' 294' ' ' PHE . 48.2 tttp -86.68 118.85 26.36 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -178.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -72.8 102.59 3.42 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.411 HG12 ' O ' ' A' ' 290' ' ' HIS . 9.6 pt -89.47 4.6 5.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.955 0.407 . . . . 0.0 111.142 -176.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -149.89 149.11 29.96 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 173.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 10.3 ptpp? -75.59 175.88 8.15 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.02 0.438 . . . . 0.0 111.169 -176.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.471 ' CB ' HG21 ' A' ' 289' ' ' THR . 21.4 tpt180 -157.08 127.41 6.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.979 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 28.0 m -121.37 143.57 37.91 Favored Pre-proline 0 C--N 1.32 -0.706 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 171.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.432 ' HD3' ' HB2' ' A' ' 257' ' ' ALA . 38.0 Cg_endo -66.58 104.51 0.79 Allowed 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.179 1.919 . . . . 0.0 111.694 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' CYS . . . . . 0.433 ' H ' ' HB2' ' A' ' 252' ' ' ASP . 1.7 t -72.61 169.7 16.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.862 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.74 -32.43 69.23 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.806 0.336 . . . . 0.0 111.609 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -95.08 -15.42 23.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.948 0.404 . . . . 0.0 110.886 177.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . 0.464 ' HB3' ' HB2' ' A' ' 255' ' ' ALA . 60.3 m-20 -100.69 67.93 1.3 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.061 0.458 . . . . 0.0 110.071 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . 0.694 ' H ' ' HD2' ' A' ' 253' ' ' LYS . 0.0 OUTLIER -75.24 -33.99 61.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.291 -174.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.66 -1.04 57.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.554 -178.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . 0.464 ' HB2' ' HB3' ' A' ' 252' ' ' ASP . . . -70.12 126.06 28.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.165 0.507 . . . . 0.0 111.81 -175.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.3 tt -71.77 134.16 46.02 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.315 176.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.432 ' HB2' ' HD3' ' A' ' 248' ' ' PRO . . . -84.92 128.95 34.85 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 89.4 mt -135.43 165.53 25.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.59 -172.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -129.49 -177.25 4.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.08 177.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 39.8 t -80.83 129.88 36.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.865 -178.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 80.37 11.81 83.8 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.654 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -87.14 140.28 29.71 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -176.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 38.5 mm -88.11 110.28 20.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.992 0.425 . . . . 0.0 110.561 -178.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 20.9 t -88.1 102.99 13.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.287 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 5.6 tppp? -79.44 95.1 5.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.232 177.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.483 HG13 ' HB ' ' A' ' 238' ' ' VAL . 4.5 p -99.88 117.42 45.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.384 0.612 . . . . 0.0 110.4 177.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . 0.524 ' OG1' ' HD2' ' A' ' 268' ' ' ARG . 20.2 p -104.19 -18.9 14.32 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.155 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . 0.524 ' HD2' ' OG1' ' A' ' 267' ' ' THR . 0.1 OUTLIER -130.48 91.79 3.15 Favored 'General case' 0 C--O 1.224 -0.281 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 176.847 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 6.5 ptp -98.56 130.51 45.12 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 119.531 -0.868 . . . . 0.0 111.028 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -103.28 150.1 24.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.153 -174.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.421 ' H ' HG13 ' A' ' 271' ' ' ILE . 1.8 pp -71.87 -5.8 6.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.419 0.628 . . . . 0.0 110.941 175.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -70.75 -21.03 62.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.087 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 110.93 -47.67 1.02 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.683 -178.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.493 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 59.1 mt-30 -80.18 121.13 25.2 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 174.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 34.2 m0 -103.36 149.98 24.24 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.454 ' HB3' ' HB2' ' A' ' 268' ' ' ARG . 34.3 tt0 -99.53 116.81 32.51 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.074 0.464 . . . . 0.0 109.929 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -139.94 164.44 26.12 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.934 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.529 ' HG2' ' HB2' ' A' ' 283' ' ' LYS . 37.2 mt-10 -123.42 109.85 14.38 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 25.6 t -123.62 -81.06 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 120.354 -0.539 . . . . 0.0 111.793 -175.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -91.96 77.2 5.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.793 0.33 . . . . 0.0 111.284 -173.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 50.5 34.73 27.75 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.372 -0.831 . . . . 0.0 113.335 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 282' ' ' ARG . 34.0 ttt-85 -170.71 138.75 1.45 Allowed 'General case' 0 C--O 1.237 0.423 0 CA-C-O 120.895 0.379 . . . . 0.0 111.0 -173.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.529 ' HB2' ' HG2' ' A' ' 278' ' ' GLU . 38.2 ttpt -99.72 137.85 37.63 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.087 173.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -158.13 169.98 34.85 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.167 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.493 ' HB3' ' HB3' ' A' ' 274' ' ' GLN . 62.8 mt -97.59 113.3 25.0 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 176.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.736 ' HD2' ' H ' ' A' ' 289' ' ' THR . 49.4 p90 -113.72 125.31 29.68 Favored Pre-proline 0 C--N 1.315 -0.931 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.468 -177.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 35.0 Cg_exo -64.06 70.93 0.19 Allowed 'Trans proline' 0 N--CA 1.479 0.665 0 C-N-CA 123.709 2.939 . . . . 0.0 112.689 176.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.539 ' O ' ' N ' ' A' ' 290' ' ' HIS . 34.5 p90 37.96 40.55 0.3 Allowed 'General case' 0 CA--C 1.49 -1.355 0 O-C-N 124.447 1.092 . . . . 0.0 108.689 -171.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . 0.736 ' H ' ' HD2' ' A' ' 286' ' ' PHE . 41.9 m -40.81 73.41 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.043 0 O-C-N 126.499 2.374 . . . . 0.0 112.995 -156.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . 0.539 ' N ' ' O ' ' A' ' 288' ' ' PHE . 16.4 m80 63.87 25.21 13.95 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 112.192 -2.276 . . . . 0.0 109.363 169.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.576 ' HB ' ' HB1' ' A' ' 240' ' ' ALA . 33.5 m -88.58 169.71 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 121.41 0.624 . . . . 0.0 111.621 -173.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -129.69 114.36 15.91 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.115 178.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.662 HD13 ' HB2' ' A' ' 240' ' ' ALA . 50.2 mm -72.0 124.55 28.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.331 -178.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' PHE . . . . . 0.538 ' CE1' ' HB2' ' A' ' 241' ' ' LYS . 1.8 p90 -154.27 -176.01 5.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.984 -178.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -130.37 116.96 17.64 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 172.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo . . . . . 0 C--O 1.232 0.183 0 C-N-CA 122.789 2.326 . . . . 0.0 112.508 -177.549 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.57 ' O ' HG23 ' A' ' 99' ' ' ILE . 16.1 m . . . . . 0 N--CA 1.451 -0.384 0 CA-C-O 121.128 0.489 . . . . 0.0 109.714 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.515 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . -78.79 105.81 10.36 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.996 176.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 32.6 ttm180 -138.84 97.12 3.25 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.331 0.586 . . . . 0.0 111.113 -176.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -168.45 163.04 12.57 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.726 178.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.503 ' HB2' ' HB2' ' A' ' 10' ' ' ASP . 22.8 m-20 -89.19 117.08 27.91 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 174.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.8 m -66.57 -13.53 61.15 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.092 -0.503 . . . . 0.0 112.086 -172.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.7 t -115.54 -0.16 13.14 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.26 0.552 . . . . 0.0 111.107 -176.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.503 ' HB2' ' HB2' ' A' ' 7' ' ' ASP . 8.1 t0 -79.47 91.68 5.16 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 121.916 -0.49 . . . . 0.0 110.232 -177.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.516 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 5.0 mtm-85 -69.44 -14.25 62.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.513 -178.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.7 t -84.9 0.04 52.48 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 175.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -109.95 -48.79 3.15 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.434 ' HB3' ' HB3' ' A' ' 101' ' ' PRO . 40.2 p-90 -108.86 -20.45 13.05 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -173.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.516 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 19.3 t80 -73.38 108.89 6.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.094 0.473 . . . . 0.0 109.808 -177.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.726 ' HG3' HG21 ' A' ' 19' ' ' VAL . 12.0 tpp -89.01 -8.45 54.02 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.901 -171.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.494 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 50.23 -114.97 2.83 Favored Glycine 0 CA--C 1.522 0.475 0 CA-C-N 115.269 -0.878 . . . . 0.0 114.438 177.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.494 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 8.5 Cg_exo -72.52 82.14 1.45 Allowed 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 123.202 2.601 . . . . 0.0 113.158 -173.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.726 HG21 ' HG3' ' A' ' 16' ' ' MET . 44.0 t -142.02 166.4 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.456 ' N ' HG12 ' A' ' 19' ' ' VAL . 15.6 m -137.79 172.12 13.42 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -170.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 54.8 mtp85 -54.53 -53.79 49.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 118.154 0.434 . . . . 0.0 111.925 -177.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -57.89 -63.13 1.36 Allowed 'General case' 0 C--N 1.327 -0.374 0 O-C-N 123.477 0.486 . . . . 0.0 111.087 -177.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.453 ' O ' ' HB ' ' A' ' 26' ' ' THR . 36.6 tt0 -57.95 -45.45 86.62 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.67 -176.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.479 ' HB2' HG12 ' A' ' 19' ' ' VAL . . . -57.09 -50.8 71.65 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 120.933 0.397 . . . . 0.0 111.375 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.66 ' HG3' ' HB ' ' A' ' 58' ' ' VAL . 18.5 tt0 -64.4 -32.91 74.72 Favored 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.453 ' HB ' ' O ' ' A' ' 23' ' ' GLU . 7.8 m -59.81 -41.93 92.34 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.607 174.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.492 ' O ' ' HG3' ' A' ' 31' ' ' GLN . 95.4 mtt180 -68.8 -14.44 63.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.893 0.377 . . . . 0.0 110.896 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.596 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 72.3 mt -120.62 -12.6 8.87 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -174.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.792 HE21 ' HA ' ' A' ' 29' ' ' GLN . 0.0 OUTLIER -70.03 105.77 2.99 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.833 0.349 . . . . 0.0 111.024 -174.328 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.405 ' H ' ' HA ' ' A' ' 56' ' ' SER . . . 72.64 5.35 63.77 Favored Glycine 0 C--O 1.226 -0.398 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.241 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.492 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 12.9 mm100 -80.67 -162.16 0.45 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.845 0.355 . . . . 0.0 111.194 -176.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.445 ' HB2' ' HG3' ' A' ' 35' ' ' MET . 34.7 mtm180 -59.31 119.29 7.15 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.984 0.421 . . . . 0.0 110.098 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 27.4 m170 -76.6 125.93 30.1 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.952 -177.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.42 -6.25 22.96 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 -175.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.571 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 51.3 mtm -82.93 146.64 28.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.762 0.315 . . . . 0.0 110.216 177.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -145.94 163.6 34.64 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 176.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.45 ' O ' HD12 ' A' ' 37' ' ' LEU . 4.4 pp -152.61 137.21 16.87 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.058 0.456 . . . . 0.0 111.067 177.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.9 t -107.1 105.38 18.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 173.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.445 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 25.8 ptt-85 -104.13 166.69 10.24 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.731 -175.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -76.79 124.23 27.38 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 174.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.516 ' HB2' HG23 ' A' ' 49' ' ' VAL . 25.6 t -99.39 166.19 11.3 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.24 0.543 . . . . 0.0 111.225 -173.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.8 m -118.28 18.16 13.76 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.999 -175.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.2 m -75.02 -43.91 51.02 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 177.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 49.5 t -168.09 112.93 0.59 Allowed Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.696 177.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -34.67 102.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 124.155 3.237 . . . . 0.0 113.433 -175.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 134.1 -25.43 3.5 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.638 -175.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -83.17 151.59 25.63 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 177.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -128.43 174.08 9.65 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -178.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.516 HG23 ' HB2' ' A' ' 41' ' ' SER . 58.5 t -137.74 112.81 9.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.425 0.631 . . . . 0.0 111.541 176.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.495 HD23 HD11 ' A' ' 73' ' ' ILE . 51.5 tp -81.01 98.34 7.91 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.225 -1.352 . . . . 0.0 109.698 174.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.3 m -96.0 128.93 43.33 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 175.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.614 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 94.6 t -122.06 142.4 38.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.117 -174.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.596 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 45.0 t -105.89 114.91 29.35 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -175.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.53 155.65 33.77 Favored 'General case' 0 C--O 1.207 -1.18 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 160.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 59.13 20.42 8.38 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 174.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.405 ' HA ' ' H ' ' A' ' 30' ' ' GLY . 22.3 m 56.43 54.34 7.67 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 122.797 1.284 . . . . 0.0 108.082 -172.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.429 HH22 ' C ' ' A' ' 153' ' ' ILE . 0.2 OUTLIER -162.33 64.03 0.22 Allowed 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 112.751 -2.022 . . . . 0.0 109.493 -151.166 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.66 ' HB ' ' HG3' ' A' ' 25' ' ' GLN . 26.1 t -74.65 99.94 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 122.032 0.92 . . . . 0.0 111.03 -168.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.3 m -67.84 120.9 14.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 113.985 -1.461 . . . . 0.0 111.255 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -96.68 109.32 21.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.882 0.372 . . . . 0.0 111.513 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.461 ' HB2' ' HB3' ' A' ' 50' ' ' LEU . 89.4 m-85 -106.0 117.59 34.43 Favored 'General case' 0 C--O 1.216 -0.709 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.537 177.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.709 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 53.4 mt -80.36 145.99 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 O-C-N 121.872 -0.517 . . . . 0.0 111.076 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.683 HG13 HG12 ' A' ' 73' ' ' ILE . 4.8 mp -129.53 104.11 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.122 0.487 . . . . 0.0 110.455 177.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.554 ' HB2' ' HB3' ' A' ' 72' ' ' LYS . 31.0 m-80 -90.56 142.75 27.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.485 -172.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 31.6 t -81.82 97.17 7.87 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 172.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.0 mt -73.99 143.44 80.85 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.543 -177.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.5 -23.29 70.16 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 123.078 2.518 . . . . 0.0 112.555 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 36.8 p30 -83.64 12.34 5.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.8 177.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 69' ' ' ARG . 5.2 tpp85 69.79 25.82 4.97 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.465 0.65 . . . . 0.0 111.317 175.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.695 ' HG2' ' HA ' ' A' ' 79' ' ' ASP . 68.1 mtt180 -113.71 -174.81 2.54 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.815 174.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.52 ' HB3' HG23 ' A' ' 63' ' ' ILE . 39.1 m-85 -131.09 131.78 44.41 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.019 0.438 . . . . 0.0 111.471 -177.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.554 ' HB3' ' HB2' ' A' ' 64' ' ' ASN . 14.6 tppt? -97.58 100.92 12.33 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.679 177.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.758 HG13 HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -99.1 86.4 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 122.92 1.343 . . . . 0.0 109.017 -177.262 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.16 -110.76 3.74 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.502 -174.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 168' ' ' GLY . 26.4 t0 -108.24 -18.99 13.63 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.575 0.702 . . . . 0.0 109.536 176.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -90.74 136.35 33.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.747 -176.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.467 ' HB3' ' HE2' ' A' ' 72' ' ' LYS . 0.9 OUTLIER -110.41 128.13 55.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.364 0.602 . . . . 0.0 111.025 175.306 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.42 ' O ' ' HB3' ' A' ' 70' ' ' ARG . 8.8 m-85 -122.88 172.24 8.62 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 176.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.695 ' HA ' ' HG2' ' A' ' 70' ' ' ARG . 5.7 m-20 -75.09 -34.84 61.81 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -172.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.499 ' ND1' ' HG2' ' A' ' 82' ' ' PRO . 3.3 p80 -156.58 166.66 32.76 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 121.33 -0.148 . . . . 0.0 110.819 -178.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.603 HD23 HD21 ' A' ' 84' ' ' LEU . 18.0 mt -54.94 -54.68 47.17 Favored Pre-proline 0 N--CA 1.469 0.487 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -177.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.499 ' HG2' ' ND1' ' A' ' 80' ' ' HIS . 18.0 Cg_endo -61.67 -10.51 17.01 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.172 1.914 . . . . 0.0 113.418 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.402 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -90.62 -36.79 14.2 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.873 0.368 . . . . 0.0 110.554 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.758 HD13 HG13 ' A' ' 73' ' ' ILE . 3.2 pp -76.92 -35.78 57.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.92 0.39 . . . . 0.0 110.022 -178.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.493 ' O ' ' HG2' ' A' ' 89' ' ' LYS . 89.1 mt -64.91 -24.1 67.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.999 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.515 ' HA ' ' CG ' ' A' ' 89' ' ' LYS . 26.9 tt0 -83.09 -22.34 33.45 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.79 -176.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -72.2 -35.67 69.0 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.731 0.777 . . . . 0.0 109.547 175.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.723 ' CG ' HD23 ' A' ' 93' ' ' LEU . 74.5 m-85 -86.63 1.43 51.87 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.43 -176.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.515 ' CG ' ' HA ' ' A' ' 86' ' ' GLU . 9.6 mmmm -71.75 -23.39 61.59 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 171.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 30.6 pt -121.2 7.96 6.07 Favored 'Isoleucine or valine' 0 C--N 1.339 0.151 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.112 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.412 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 5.8 t-160 -98.28 -40.37 8.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.08 -176.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.596 ' CD2' HG23 ' A' ' 97' ' ' THR . 60.7 m-85 64.75 77.64 0.31 Allowed 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -170.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.723 HD23 ' CG ' ' A' ' 88' ' ' TYR . 1.4 pp -79.29 18.15 0.72 Allowed 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -172.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.521 ' O ' HG22 ' A' ' 95' ' ' THR . 27.3 t70 -175.22 65.19 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.258 162.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.69 ' CB ' ' HA ' ' A' ' 156' ' ' PRO . 0.6 OUTLIER 62.16 -28.5 0.07 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.048 1.339 . . . . 0.0 112.528 -174.013 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.476 ' H ' ' C ' ' A' ' 94' ' ' ASP . 2.0 t -109.3 157.4 18.89 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 172.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.596 HG23 ' CD2' ' A' ' 92' ' ' TYR . 7.4 p -90.33 -179.99 5.75 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 177.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 89.4 mt -73.16 91.49 1.65 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 171.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.57 HG23 ' O ' ' A' ' 3' ' ' SER . 37.4 mm -74.84 -61.87 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.856 -174.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.571 ' O ' ' HA ' ' A' ' 35' ' ' MET . 10.4 pt-20 -157.19 157.46 30.46 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.183 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.46 ' HD2' ' HB2' ' A' ' 100' ' ' GLU . 55.9 Cg_endo -69.58 152.83 70.31 Favored 'Trans proline' 0 C--O 1.237 0.458 0 C-N-CA 122.502 2.135 . . . . 0.0 112.91 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -77.29 156.78 81.34 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.526 177.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.523 ' HD3' ' SD ' ' A' ' 35' ' ' MET . 23.6 Cg_exo -64.21 132.16 32.98 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.342 2.028 . . . . 0.0 112.186 177.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.433 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 34.2 ptt180 . . . . . 0 C--N 1.326 -0.451 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.855 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.688 ' HG ' ' HD2' ' A' ' 155' ' ' LYS . 3.3 mm? . . . . . 0 CA--C 1.517 -0.297 0 CA-C-O 121.703 0.763 . . . . 0.0 111.66 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -174.5 -38.79 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.566 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.483 ' HB3' ' HB3' ' A' ' 181' ' ' LEU . 79.9 m-85 -127.64 116.02 19.65 Favored 'General case' 0 CA--C 1.504 -0.804 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.487 176.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.662 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 2.1 t -115.47 153.72 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.748 -177.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.775 ' NH2' HD13 ' A' ' 181' ' ' LEU . 1.7 ptp180 -137.59 124.59 21.43 Favored 'General case' 0 CA--C 1.496 -1.11 0 C-N-CA 117.281 -1.767 . . . . 0.0 112.891 173.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.69 HG22 HG12 ' A' ' 178' ' ' VAL . 81.7 p -79.49 131.88 36.18 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 114.268 -1.333 . . . . 0.0 111.13 -177.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.477 HD21 ' HG3' ' A' ' 129' ' ' ARG . 2.5 mt -116.59 8.5 13.91 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.624 -175.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -122.82 -36.07 2.94 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -171.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.499 ' HB2' ' HB3' ' A' ' 146' ' ' LYS . 11.0 t70 78.52 110.7 0.07 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.23 0.612 . . . . 0.0 110.873 -178.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.619 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 79.2 t80 -144.55 91.66 6.17 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 177.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.643 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 72.8 Cg_endo -79.53 85.98 1.75 Allowed 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 121.846 1.697 . . . . 0.0 112.404 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.38 -35.38 60.0 Favored Glycine 0 C--N 1.333 0.384 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.445 179.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.804 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 0.9 OUTLIER 68.27 37.66 2.75 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 122.652 0.381 . . . . 0.0 111.548 178.05 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -137.71 170.41 16.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.662 0.267 . . . . 0.0 110.554 -177.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -89.86 -6.19 56.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.74 0.781 . . . . 0.0 109.108 174.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -103.14 -34.14 8.96 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.57 177.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -120.08 109.55 15.6 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.385 176.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 1.057 HD11 ' HB2' ' A' ' 165' ' ' ASN . 36.5 tp -68.15 132.11 91.92 Favored Pre-proline 0 CA--C 1.515 -0.378 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.394 -177.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.804 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 7.6 Cg_endo -83.05 104.1 1.22 Allowed 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 121.785 1.657 . . . . 0.0 110.108 169.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.677 ' CG ' HG21 ' A' ' 130' ' ' THR . 9.4 p90 -121.39 163.6 18.44 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.254 -176.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.533 ' HB2' ' HB3' ' A' ' 148' ' ' GLU . 12.8 mptt -96.51 -169.82 1.97 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.376 0.607 . . . . 0.0 112.494 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.902 ' H ' ' HD2' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -89.29 5.49 44.69 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.238 -176.456 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -168.7 37.35 0.21 Allowed Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 176.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.583 ' OE1' ' HA ' ' A' ' 144' ' ' PHE . 0.4 OUTLIER -92.95 157.69 16.21 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 120.87 0.367 . . . . 0.0 110.272 -177.713 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -98.38 131.89 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-O 121.774 0.797 . . . . 0.0 109.727 178.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.616 HD22 HD21 ' A' ' 142' ' ' LEU . 14.9 mt -120.31 156.27 31.62 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.086 -1.415 . . . . 0.0 107.646 -174.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.561 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 60.8 t -124.16 122.93 65.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 176.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.935 HD13 ' HB2' ' A' ' 163' ' ' ALA . 26.1 mm -76.16 102.99 3.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.578 0.704 . . . . 0.0 109.458 -174.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.527 HG21 HG22 ' A' ' 170' ' ' VAL . 20.3 tt -97.91 -30.0 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-N 114.801 -1.091 . . . . 0.0 109.802 -173.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.621 ' OE2' ' HA ' ' A' ' 93' ' ' LEU . 1.8 mt-10 -131.77 140.84 49.33 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 165.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.688 ' HD2' ' HG ' ' A' ' 125' ' ' LEU . 39.9 tttp -123.02 89.55 50.68 Favored Pre-proline 0 C--N 1.321 -0.657 0 O-C-N 121.231 -0.918 . . . . 0.0 109.868 167.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.69 ' HA ' ' CB ' ' A' ' 95' ' ' THR . 3.0 Cg_exo -77.81 -51.54 0.08 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.592 2.195 . . . . 0.0 112.023 175.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.57 ' HG2' ' CE ' ' A' ' 172' ' ' MET . 22.5 mm-40 -102.67 179.44 4.29 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -171.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.415 ' HA ' ' HE1' ' A' ' 161' ' ' TRP . 11.5 pt-20 -107.13 -20.03 13.43 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.56 176.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -109.41 -8.69 15.01 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.803 0.335 . . . . 0.0 110.871 177.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.54 ' O ' ' HB2' ' A' ' 157' ' ' GLU . 83.4 m95 -132.03 131.39 42.44 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 169.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . 0.49 ' CE3' HD11 ' A' ' 125' ' ' LEU . 48.1 m0 -122.88 143.47 49.85 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.37 177.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.609 ' HA ' ' HA ' ' A' ' 172' ' ' MET . 21.6 m -89.14 99.67 12.61 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -176.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.935 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -110.09 151.6 27.02 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.027 -175.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.828 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 12.8 ptt180 -87.97 121.18 30.08 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-O 122.109 0.957 . . . . 0.0 108.944 172.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 1.057 ' HB2' HD11 ' A' ' 142' ' ' LEU . 11.7 t30 -45.21 167.3 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 112.131 -2.304 . . . . 0.0 112.006 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.419 ' HA ' ' HD2' ' A' ' 166' ' ' LYS . 15.5 tptm -58.32 -14.29 7.1 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.015 173.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.518 ' HB2' ' ND2' ' A' ' 165' ' ' ASN . 21.7 m-20 -95.62 -9.19 32.81 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.001 0.429 . . . . 0.0 109.987 174.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 75' ' ' ASP . . . 90.2 39.06 6.15 Favored Glycine 0 CA--C 1.522 0.489 0 CA-C-N 115.85 -0.614 . . . . 0.0 113.406 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.828 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 7.8 ttm-85 -111.76 138.71 47.98 Favored 'General case' 0 C--O 1.214 -0.777 0 CA-C-N 116.933 0.367 . . . . 0.0 111.472 -177.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.527 HG22 HG21 ' A' ' 153' ' ' ILE . 21.9 t -78.96 125.61 38.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 C-N-CA 120.839 -0.345 . . . . 0.0 111.552 -179.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -164.02 149.72 17.24 Favored Glycine 0 C--N 1.332 0.321 0 N-CA-C 111.59 -0.604 . . . . 0.0 111.59 168.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.609 ' HA ' ' HA ' ' A' ' 162' ' ' SER . 59.5 mtp -77.0 143.32 39.48 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 117.565 0.682 . . . . 0.0 110.751 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.695 ' O ' HD12 ' A' ' 173' ' ' ILE . 1.6 pp -134.88 151.84 76.33 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.444 -177.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.733 ' O ' HG13 ' A' ' 178' ' ' VAL . 1.0 OUTLIER -85.24 123.79 2.72 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.821 2.347 . . . . 0.0 113.241 -174.819 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.574 ' HA ' HG22 ' A' ' 178' ' ' VAL . 94.8 t -53.73 -45.42 98.77 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 178.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.496 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 65.2 Cg_exo -54.91 -23.93 36.69 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 122.112 1.875 . . . . 0.0 112.817 174.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.554 ' CD2' ' HG2' ' A' ' 174' ' ' PRO . 3.4 m-30 -84.82 -39.58 18.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.018 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.733 HG13 ' O ' ' A' ' 174' ' ' PRO . 1.1 m -111.65 -177.77 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.637 -164.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.897 ' HG3' ' H ' ' A' ' 180' ' ' LYS . 11.2 pt-20 -158.13 -71.03 0.09 Allowed 'General case' 0 C--O 1.207 -1.142 0 N-CA-C 118.011 2.597 . . . . 0.0 118.011 144.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.897 ' H ' ' HG3' ' A' ' 179' ' ' GLU . 3.6 mppt? -156.25 179.64 9.05 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 118.855 -2.403 . . . . 0.0 114.593 -169.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.775 HD13 ' NH2' ' A' ' 129' ' ' ARG . 12.0 tp . . . . . 0 C--N 1.327 -0.408 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.929 164.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo . . . . . 0 N--CA 1.459 -0.507 0 N-CA-C 110.87 -0.473 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.453 HG11 HD12 ' A' ' 293' ' ' ILE . 3.5 t -89.82 141.59 14.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.846 -173.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.447 ' HB2' ' HG3' ' A' ' 296' ' ' PRO . 94.0 m-85 -113.26 122.98 49.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.28 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.464 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -119.72 144.26 47.33 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.421 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -90.87 119.83 31.39 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -66.95 102.46 0.98 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.928 0.394 . . . . 0.0 110.024 177.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 24.8 pt -83.31 -35.29 11.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.421 -174.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -132.89 130.89 40.29 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -54.36 140.38 33.75 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.883 -171.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.578 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 27.5 tpt180 -124.03 107.12 10.96 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.896 -178.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 16.5 m -115.87 126.67 27.46 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-O 120.954 0.407 . . . . 0.0 110.477 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.464 ' HB3' ' HB3' ' A' ' 255' ' ' ALA . 39.5 Cg_endo -67.68 127.66 16.68 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.629 2.219 . . . . 0.0 112.596 -178.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 39.2 t -78.58 171.94 14.41 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -53.1 -37.78 62.02 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.734 0.302 . . . . 0.0 111.72 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -97.71 14.25 27.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.898 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -90.89 -75.19 0.47 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 173.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 66.0 mttm 69.87 -58.41 0.53 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.944 178.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 11.2 p -73.32 -13.54 61.13 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.368 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . 0.464 ' HB3' ' HB3' ' A' ' 248' ' ' PRO . . . -71.86 123.99 23.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.047 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.2 tt -73.5 133.94 43.75 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.636 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.578 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -81.62 104.93 12.37 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.093 0.473 . . . . 0.0 109.934 176.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 96.0 mt -109.0 134.94 50.98 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.481 -177.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -99.41 155.14 17.7 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.216 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 62.2 t -66.94 122.04 17.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.006 0.431 . . . . 0.0 111.083 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 95.21 11.42 56.15 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.675 -0.693 . . . . 0.0 113.202 175.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -95.14 166.93 11.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.985 0.392 . . . . 0.0 109.971 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 34.3 mm -102.55 118.24 49.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.114 0.483 . . . . 0.0 110.728 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 19.3 t -93.48 104.9 16.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.165 0.507 . . . . 0.0 110.284 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -85.7 87.7 7.44 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.814 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.43 HG21 ' HB3' ' A' ' 275' ' ' TRP . 6.2 p -91.73 126.02 44.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.489 0.661 . . . . 0.0 111.607 -175.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 44.7 p -104.69 -39.23 6.42 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.725 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 -105.6 117.44 34.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.124 -177.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 41.5 mtt -114.4 134.86 54.68 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.798 174.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -97.45 160.06 14.55 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.714 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 10.5 tp -75.21 -11.98 14.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.502 0.667 . . . . 0.0 109.972 176.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -75.2 -65.49 0.88 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.938 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 156.47 -23.55 0.5 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.383 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.439 ' HB3' HD22 ' A' ' 285' ' ' LEU . 23.2 mt-30 -87.06 119.75 27.61 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 176.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.48 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 31.4 m0 -101.43 156.23 17.59 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.789 -176.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.495 ' HA ' ' O ' ' A' ' 284' ' ' GLY . 47.9 mt-10 -112.28 114.57 27.41 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.061 175.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . 0.704 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -120.71 155.01 16.32 Favored Glycine 0 C--O 1.225 -0.434 0 C-N-CA 120.894 -0.669 . . . . 0.0 111.595 177.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.786 ' HG2' ' HB3' ' A' ' 283' ' ' LYS . 38.0 mt-10 -100.7 109.9 21.97 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.092 0.473 . . . . 0.0 110.849 179.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . 0.415 HG12 HD22 ' A' ' 280' ' ' ASN . 48.7 t -118.95 130.82 73.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 176.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . 0.415 HD22 HG12 ' A' ' 279' ' ' VAL . 10.1 p30 44.54 34.77 1.18 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.958 0.903 . . . . 0.0 112.482 -174.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 94.49 -9.1 71.77 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.483 175.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -108.35 124.72 50.79 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 117.014 0.407 . . . . 0.0 111.259 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.786 ' HB3' ' HG2' ' A' ' 278' ' ' GLU . 9.4 ptpp? -96.33 142.17 28.78 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 172.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 276' ' ' GLU . . . -164.05 172.03 39.78 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.987 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.48 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 17.2 mt -82.44 130.74 35.17 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.158 0.504 . . . . 0.0 111.341 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -136.23 135.49 21.15 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.651 173.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . 0.9 ' HB2' HG22 ' A' ' 289' ' ' THR . 59.0 Cg_endo -75.61 138.31 21.45 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.237 1.958 . . . . 0.0 111.444 175.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.467 ' HA ' HG22 ' A' ' 291' ' ' VAL . 49.4 p90 -63.27 -8.47 8.52 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.932 0.396 . . . . 0.0 111.282 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . 0.9 HG22 ' HB2' ' A' ' 287' ' ' PRO . 15.3 t -79.62 -13.81 59.24 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.012 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . 0.506 ' HD2' HG23 ' A' ' 289' ' ' THR . 6.8 m-70 -101.19 -6.19 24.59 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.695 0.283 . . . . 0.0 110.846 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.467 HG22 ' HA ' ' A' ' 288' ' ' PHE . 35.9 m -127.78 178.99 4.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.94 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -140.76 116.01 9.95 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.039 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.464 HD13 ' HB2' ' A' ' 240' ' ' ALA . 34.2 mm -70.41 112.96 5.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 174.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -135.24 -169.87 2.47 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.865 -176.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -115.68 94.67 41.31 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . 0.447 ' HG3' ' HB2' ' A' ' 239' ' ' PHE . 36.2 Cg_endo . . . . . 0 C--N 1.345 0.39 0 C-N-CA 122.31 2.006 . . . . 0.0 111.334 178.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.498 ' O ' HG23 ' A' ' 99' ' ' ILE . 9.4 p . . . . . 0 N--CA 1.446 -0.634 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.609 ' HB1' ' HE3' ' A' ' 89' ' ' LYS . . . -83.27 104.56 13.53 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.745 175.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 63.8 mtt180 -109.47 -10.49 14.88 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -167.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.449 ' HD1' ' H ' ' A' ' 6' ' ' PHE . 4.6 p90 -84.31 156.02 22.11 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.594 -170.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -66.7 -27.77 67.9 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.587 -177.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.3 t 75.09 -22.73 0.25 Allowed 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.412 0.685 . . . . 0.0 111.137 -178.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.6 t -105.17 -17.39 14.49 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 122.262 -0.273 . . . . 0.0 111.707 -177.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -81.08 107.74 14.15 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 121.718 -0.614 . . . . 0.0 110.625 -177.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.49 -41.59 94.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.948 -176.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.457 ' C ' HH22 ' A' ' 104' ' ' ARG . 24.2 t -68.77 -4.01 14.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.156 -176.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -91.84 -47.27 7.42 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.419 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 43.4 p-90 -117.33 -21.21 8.82 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -171.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -75.05 127.16 32.58 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -177.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.784 ' HG3' ' HB2' ' A' ' 37' ' ' LEU . 26.3 mmt -109.67 -8.35 14.96 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -173.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 50.55 -112.84 1.74 Allowed Glycine 0 CA--C 1.525 0.665 0 C-N-CA 121.376 -0.44 . . . . 0.0 113.2 -176.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -76.01 102.16 1.57 Allowed 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.52 2.147 . . . . 0.0 112.766 -178.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.737 ' HB ' ' HG3' ' A' ' 39' ' ' ARG . 22.2 t -142.07 -76.39 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.397 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.815 ' H ' ' HG3' ' A' ' 39' ' ' ARG . 51.1 m 93.41 171.01 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 168.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 74.0 mtp85 -62.1 -32.58 73.16 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.861 -172.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -59.65 -54.12 50.08 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 123.842 0.713 . . . . 0.0 110.751 178.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.485 ' O ' ' HG3' ' A' ' 27' ' ' ARG . 17.4 mt-10 -74.71 -47.22 32.64 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.784 -177.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.35 -51.17 70.46 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -172.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.546 ' HA ' HG11 ' A' ' 58' ' ' VAL . 3.9 tt0 -66.27 -33.79 76.53 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -177.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.3 m -63.41 -35.45 80.45 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.344 -0.843 . . . . 0.0 112.113 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.485 ' HG3' ' O ' ' A' ' 23' ' ' GLU . 98.0 mtt180 -81.19 -13.3 58.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.599 0.238 . . . . 0.0 111.256 -177.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.57 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 41.0 mt -121.27 -13.33 8.5 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -172.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.518 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 26.6 tp60 -66.61 104.8 1.36 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.926 0.393 . . . . 0.0 110.32 -176.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 64.59 34.17 89.19 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.444 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 12.0 mm100 -106.5 -160.85 0.76 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 178.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.568 ' HB2' ' HG3' ' A' ' 35' ' ' MET . 43.6 mtm180 -56.17 111.17 0.89 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.896 0.379 . . . . 0.0 110.624 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -67.38 111.06 3.84 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.008 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.472 ' HA2' HG21 ' A' ' 96' ' ' THR . . . 130.86 -14.26 5.5 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.499 -176.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.568 ' HG3' ' HB2' ' A' ' 32' ' ' ARG . 55.3 mtm -77.3 143.6 38.71 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 120.871 0.367 . . . . 0.0 110.426 177.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.471 ' HB2' HG22 ' A' ' 52' ' ' VAL . 34.0 p90 -141.39 166.01 25.94 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.236 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.784 ' HB2' ' HG3' ' A' ' 16' ' ' MET . 4.3 pp -157.13 139.14 14.4 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.234 0.54 . . . . 0.0 110.674 176.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.3 t -113.27 108.27 25.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.181 177.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.815 ' HG3' ' H ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -120.77 173.85 6.96 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.26 -178.533 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -61.69 130.32 45.29 Favored 'General case' 0 C--O 1.238 0.459 0 O-C-N 123.854 0.721 . . . . 0.0 110.147 178.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.4 t -80.13 154.98 27.69 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.517 -173.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.9 m -92.83 -5.32 51.3 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.744 177.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.2 m -73.34 -49.54 26.85 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.973 177.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 49.1 t -167.36 136.61 2.2 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.618 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -59.96 105.68 0.29 Allowed 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.503 2.135 . . . . 0.0 111.796 176.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 133.27 -29.41 3.18 Favored Glycine 0 N--CA 1.452 -0.278 0 N-CA-C 110.526 -1.029 . . . . 0.0 110.526 -174.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.409 ' OD1' ' HA ' ' A' ' 64' ' ' ASN . 30.3 t70 -80.58 151.41 29.1 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 173.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -127.25 157.93 38.51 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.506 ' HB ' ' CZ ' ' A' ' 39' ' ' ARG . 39.2 t -128.52 110.38 21.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.761 0.791 . . . . 0.0 111.316 176.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.46 ' HB3' ' HB2' ' A' ' 61' ' ' TYR . 47.5 tp -76.29 95.78 3.83 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 113.731 -1.577 . . . . 0.0 110.121 175.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 59' ' ' SER . 65.7 m -96.96 133.79 41.16 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 175.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.681 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 60.1 t -130.92 138.5 53.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.302 -171.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.57 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 40.0 t -89.68 108.22 19.55 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.803 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.682 ' O ' ' HB3' ' A' ' 57' ' ' ARG . 26.8 mt-10 -146.67 131.93 18.46 Favored 'General case' 0 C--O 1.206 -1.206 0 C-N-CA 119.685 -0.806 . . . . 0.0 110.253 176.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.453 HD21 ' HB ' ' A' ' 95' ' ' THR . 43.0 m-80 52.47 28.8 6.27 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 177.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.2 m 59.83 58.68 2.72 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 122.778 1.275 . . . . 0.0 108.67 -175.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.796 HH21 ' HB2' ' A' ' 94' ' ' ASP . 17.0 ttp85 -162.2 66.88 0.24 Allowed 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 112.869 -1.969 . . . . 0.0 109.395 -159.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.681 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 41.1 t -69.08 92.11 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-O 122.58 1.181 . . . . 0.0 109.143 -170.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 51' ' ' SER . 1.8 m -61.17 119.64 8.79 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 112.579 -2.1 . . . . 0.0 110.722 -177.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -99.53 96.49 7.7 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.913 0.387 . . . . 0.0 110.969 -178.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.633 ' CE2' HD22 ' A' ' 93' ' ' LEU . 88.6 m-85 -95.5 116.44 28.82 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.074 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.557 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 55.4 mt -81.53 146.48 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 O-C-N 122.24 -0.287 . . . . 0.0 111.35 -178.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.654 HG13 ' CG1' ' A' ' 73' ' ' ILE . 4.8 mp -134.14 102.04 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 122.571 0.349 . . . . 0.0 110.243 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.409 ' HA ' ' OD1' ' A' ' 47' ' ' ASP . 9.2 m120 -81.14 130.95 35.25 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.237 -177.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.2 t -78.54 100.39 6.9 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 172.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.567 HD11 ' HB2' ' A' ' 72' ' ' LYS . 85.8 mt -80.64 142.78 53.69 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.28 -174.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -63.07 -8.63 14.56 Favored 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 122.766 2.31 . . . . 0.0 111.344 170.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -75.82 2.85 11.21 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.883 172.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 69' ' ' ARG . 4.5 mmp_? 68.01 24.9 7.74 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.489 -178.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.417 ' HB3' ' O ' ' A' ' 78' ' ' PHE . 67.2 mtt180 -121.4 176.41 5.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.952 -178.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.415 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 57.2 m-85 -124.46 117.92 25.49 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.112 0.482 . . . . 0.0 110.277 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.656 ' HG3' ' HB3' ' A' ' 77' ' ' GLU . 74.1 tttt -98.12 99.93 11.21 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.826 -173.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.696 ' HB ' HD22 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -90.14 76.45 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 123.0 1.381 . . . . 0.0 110.228 -173.69 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.43 74.71 0.88 Allowed Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 114.578 -1.192 . . . . 0.0 113.262 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.446 ' HA ' ' HE2' ' A' ' 72' ' ' LYS . 38.6 t70 73.94 -40.96 0.47 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 174.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -91.82 119.73 31.88 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.656 ' HB3' ' HG3' ' A' ' 72' ' ' LYS . 13.5 pt-20 -100.14 139.85 35.21 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.328 0.585 . . . . 0.0 111.488 -176.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.435 ' CE1' HG22 ' A' ' 73' ' ' ILE . 26.9 m-85 -117.66 168.13 10.71 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 174.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -69.91 -20.72 63.35 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -171.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.489 ' CE1' ' HB2' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -170.81 172.92 5.46 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 122.553 -0.092 . . . . 0.0 111.183 174.741 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.533 HD23 HD21 ' A' ' 84' ' ' LEU . 13.0 mt -51.8 -54.89 35.23 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 81' ' ' LEU . 38.3 Cg_endo -64.68 -4.53 8.63 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 122.369 2.046 . . . . 0.0 113.448 -177.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.489 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -94.43 -34.17 12.85 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.921 0.391 . . . . 0.0 110.524 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.696 HD22 ' HB ' ' A' ' 73' ' ' ILE . 2.3 pp -75.34 -36.67 60.99 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.534 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 81.4 mt -65.35 -31.24 72.26 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.236 177.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.647 ' HA ' ' HD3' ' A' ' 89' ' ' LYS . 3.3 tp10 -70.77 -27.84 64.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.935 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.4 ' CD2' ' HZ ' ' A' ' 78' ' ' PHE . 18.5 t80 -75.66 -32.17 60.08 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.734 0.778 . . . . 0.0 109.593 -177.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.541 ' HA ' ' HB3' ' A' ' 91' ' ' HIS . 64.7 m-85 -89.62 2.05 55.22 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.471 -175.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.647 ' HD3' ' HA ' ' A' ' 86' ' ' GLU . 56.9 mtpt -84.4 -15.29 46.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.884 173.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 34.0 pt -121.03 0.49 7.25 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 CA-C-O 121.291 0.567 . . . . 0.0 110.285 174.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.541 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 3.3 t-160 -88.97 -44.29 10.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.859 -176.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.46 ' HB2' ' O ' ' A' ' 91' ' ' HIS . 90.4 m-85 67.33 88.64 0.11 Allowed 'General case' 0 CA--C 1.519 -0.237 0 O-C-N 124.135 0.897 . . . . 0.0 108.946 -165.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.638 ' O ' ' HB3' ' A' ' 154' ' ' GLU . 11.9 mt -44.02 -61.59 1.41 Allowed 'General case' 0 C--O 1.218 -0.576 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 175.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.796 ' HB2' HH21 ' A' ' 57' ' ' ARG . 21.0 t0 -141.62 89.68 2.23 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.688 170.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.532 ' HB ' ' O ' ' A' ' 94' ' ' ASP . 1.3 m 69.91 -6.84 1.0 Allowed 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.981 0.896 . . . . 0.0 110.558 175.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.472 HG21 ' HA2' ' A' ' 34' ' ' GLY . 76.2 m -135.59 142.91 45.36 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.782 -178.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.42 ' O ' HG22 ' A' ' 96' ' ' THR . 3.1 p -95.4 171.37 8.74 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 174.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.448 HD21 HD11 ' A' ' 93' ' ' LEU . 96.8 mt -66.77 91.84 0.2 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 173.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.498 HG23 ' O ' ' A' ' 3' ' ' SER . 47.0 mm -75.41 -66.86 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.298 -174.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.558 ' O ' ' HA ' ' A' ' 35' ' ' MET . 9.7 pt-20 -156.75 154.76 27.39 Favored Pre-proline 0 N--CA 1.447 -0.588 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.743 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.33 155.3 67.74 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.409 2.072 . . . . 0.0 112.982 -177.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.58 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -77.21 166.41 44.67 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.925 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.58 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 43.3 Cg_endo -68.63 132.94 26.38 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.317 2.011 . . . . 0.0 112.566 176.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.457 HH22 ' C ' ' A' ' 12' ' ' SER . 46.3 ttm180 . . . . . 0 C--N 1.324 -0.509 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.859 177.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.802 HD12 HG21 ' A' ' 152' ' ' ILE . 3.9 mm? . . . . . 0 N--CA 1.474 0.739 0 CA-C-O 121.639 0.733 . . . . 0.0 112.881 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 41.5 tt0 -179.7 -75.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.35 -1.295 . . . . 0.0 109.157 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -98.88 108.13 20.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.188 0.518 . . . . 0.0 110.96 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.996 HG22 ' HG3' ' A' ' 180' ' ' LYS . 56.2 t -124.07 135.48 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.667 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.671 ' NH1' ' HB2' ' A' ' 181' ' ' LEU . 0.0 OUTLIER -111.29 148.05 33.75 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 117.51 -1.676 . . . . 0.0 108.538 169.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.557 HG22 HG12 ' A' ' 178' ' ' VAL . 0.9 OUTLIER -101.78 131.82 47.87 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.269 -179.903 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.563 HD21 ' HG2' ' A' ' 179' ' ' GLU . 21.8 mt -106.58 -17.5 14.23 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -176.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -87.09 -34.16 19.23 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.507 -174.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.527 ' HB2' ' HA ' ' A' ' 145' ' ' LYS . 0.0 OUTLIER 65.06 121.1 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 122.229 1.014 . . . . 0.0 111.317 -173.838 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -146.36 87.42 6.54 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 114.636 -1.166 . . . . 0.0 108.194 177.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.609 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 72.6 Cg_endo -83.0 85.99 1.51 Allowed 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 121.778 1.652 . . . . 0.0 112.578 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -77.18 -13.74 83.31 Favored Glycine 0 C--N 1.332 0.358 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 173.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.628 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 17.4 m120 52.59 64.74 1.74 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 114.235 -0.982 . . . . 0.0 111.216 178.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.608 ' HB3' ' H ' ' A' ' 141' ' ' ASP . 0.4 OUTLIER -130.84 -177.29 4.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.239 0.543 . . . . 0.0 111.335 -175.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -110.95 0.8 17.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.675 167.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -116.72 -43.54 2.89 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.1 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.608 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 14.5 m-20 -101.07 123.62 45.52 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 169.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 1.075 HD11 ' HB2' ' A' ' 165' ' ' ASN . 32.2 tp -77.98 120.44 81.26 Favored Pre-proline 0 N--CA 1.468 0.459 0 CA-C-O 120.743 0.306 . . . . 0.0 111.058 -175.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.628 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 36.2 Cg_endo -72.44 95.46 0.78 Allowed 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.444 1.429 . . . . 0.0 111.272 168.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.551 ' CE2' ' HB ' ' A' ' 173' ' ' ILE . 10.4 p90 -106.7 160.55 15.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.391 -177.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.527 ' HA ' ' HB2' ' A' ' 133' ' ' ASP . 0.1 OUTLIER -103.56 -171.77 2.0 Allowed 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.929 -0.308 . . . . 0.0 111.25 -177.344 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.814 ' H ' ' HD2' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -88.57 5.31 43.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.36 -171.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -165.11 36.68 0.28 Allowed Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 175.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.453 ' HB3' ' HB2' ' A' ' 145' ' ' LYS . 0.0 OUTLIER -101.08 150.53 22.82 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.043 0.449 . . . . 0.0 111.368 -175.365 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.56 HD12 ' HB3' ' A' ' 129' ' ' ARG . 0.7 OUTLIER -90.14 132.14 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.567 -177.541 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.761 HD22 HD21 ' A' ' 142' ' ' LEU . 44.7 mt -127.9 157.15 41.31 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -177.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.581 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 58.0 t -122.93 123.8 68.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 174.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.957 HD13 ' HB2' ' A' ' 163' ' ' ALA . 36.8 mm -76.21 79.04 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.727 HG23 ' HG3' ' A' ' 154' ' ' GLU . 11.1 tt -75.62 -28.25 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-N 113.165 -1.834 . . . . 0.0 109.559 -174.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.727 ' HG3' HG23 ' A' ' 153' ' ' ILE . 29.8 mt-10 -134.39 142.15 47.08 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 175.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.424 ' HE3' ' HE1' ' A' ' 161' ' ' TRP . 81.8 tttt -143.62 78.23 14.6 Favored Pre-proline 0 C--N 1.324 -0.505 0 O-C-N 121.547 -0.721 . . . . 0.0 111.264 177.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.438 ' HG2' ' HG2' ' A' ' 157' ' ' GLU . 59.2 Cg_endo -73.93 -31.56 8.02 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.113 1.875 . . . . 0.0 111.552 176.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.438 ' HG2' ' HG2' ' A' ' 156' ' ' PRO . 14.2 mm-40 -119.89 164.37 16.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.519 -172.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.566 ' O ' HG21 ' A' ' 175' ' ' VAL . 9.3 tp10 -102.86 -22.24 13.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.587 0.232 . . . . 0.0 110.878 178.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.958 HE21 ' HA ' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -91.19 -21.14 21.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.094 0.474 . . . . 0.0 110.059 177.463 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 56.7 m95 -124.75 133.51 53.14 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.119 174.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . 0.931 ' HB3' HD12 ' A' ' 152' ' ' ILE . 46.1 m0 -110.94 133.6 53.24 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.258 0.551 . . . . 0.0 110.664 176.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.576 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 67.4 m -93.02 89.05 6.35 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -176.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.957 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -106.27 145.63 31.37 Favored 'General case' 0 N--CA 1.418 -2.033 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 -169.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.688 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 13.3 ptt180 -87.07 123.85 32.59 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 175.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 1.075 ' HB2' HD11 ' A' ' 142' ' ' LEU . 24.3 t30 -53.0 171.11 0.07 Allowed 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 113.277 -1.783 . . . . 0.0 110.736 -174.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 61.9 tttt -57.35 -19.99 26.31 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 173.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -70.64 -54.94 10.0 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.273 169.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' A' ' 164' ' ' ARG . . . 134.3 -8.86 4.72 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.947 -171.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.688 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -65.57 130.26 42.67 Favored 'General case' 0 C--O 1.217 -0.624 0 C-N-CA 123.343 0.657 . . . . 0.0 111.734 178.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.509 HG22 HG21 ' A' ' 153' ' ' ILE . 27.0 t -83.69 126.99 40.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.128 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -158.07 149.45 19.82 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.428 -0.892 . . . . 0.0 112.243 171.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.544 ' HG2' ' OG ' ' A' ' 162' ' ' SER . 9.3 mtp -74.63 141.14 44.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.843 0.354 . . . . 0.0 110.773 -178.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.721 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.6 pp -142.12 141.72 22.38 Favored Pre-proline 0 N--CA 1.45 -0.474 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.795 -174.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.526 ' HB2' ' CD1' ' A' ' 177' ' ' TYR . 24.5 Cg_exo -64.88 127.47 18.68 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.804 2.336 . . . . 0.0 112.879 -178.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.566 HG21 ' O ' ' A' ' 158' ' ' GLU . 72.9 t -61.33 -40.73 74.86 Favored Pre-proline 0 CA--C 1.545 0.75 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 177.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -61.44 -5.4 5.39 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 121.92 1.747 . . . . 0.0 112.906 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.526 ' CD1' ' HB2' ' A' ' 174' ' ' PRO . 2.8 m-30 -97.53 -10.96 24.31 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.632 -177.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.637 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 4.0 m -105.67 -172.98 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -164.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.653 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 3.8 tp10 -159.98 50.76 0.31 Allowed 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 113.143 -1.844 . . . . 0.0 112.949 -151.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.996 ' HG3' HG22 ' A' ' 128' ' ' VAL . 2.2 mppt? -69.83 137.56 51.87 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 119.451 -2.031 . . . . 0.0 111.061 -161.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.671 ' HB2' ' NH1' ' A' ' 129' ' ' ARG . 12.3 tp . . . . . 0 C--N 1.332 -0.182 0 CA-C-N 112.999 -1.91 . . . . 0.0 111.694 -169.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo . . . . . 0 C--O 1.234 0.284 0 CA-C-O 120.872 0.28 . . . . 0.0 111.937 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.529 ' HB ' HG13 ' A' ' 266' ' ' VAL . 58.6 t -83.91 116.5 27.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.315 0.578 . . . . 0.0 110.908 -176.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -103.91 114.45 28.71 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.566 175.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.624 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -119.54 131.17 55.49 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.06 -178.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.637 ' HE3' ' HA2' ' A' ' 261' ' ' GLY . 48.5 tttp -90.13 126.12 35.68 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . 0.461 ' O ' ' HA ' ' A' ' 260' ' ' VAL . . . -74.83 97.08 3.21 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.23 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 48.2 pt -77.35 -21.91 14.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.127 0.489 . . . . 0.0 110.444 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.17 141.11 50.69 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -67.91 161.4 26.51 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-O 121.175 0.512 . . . . 0.0 111.073 -174.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.451 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 24.7 tpt180 -151.67 101.36 2.78 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.623 179.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 29.6 m -97.46 154.24 38.07 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.528 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.457 ' HA ' ' HB3' ' A' ' 255' ' ' ALA . 10.1 Cg_exo -69.63 99.98 0.77 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.202 1.934 . . . . 0.0 111.176 177.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' CYS . . . . . 0.53 ' HB3' ' HB2' ' A' ' 252' ' ' ASP . 42.3 t -70.24 167.96 16.82 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.325 -178.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -53.83 -38.28 64.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.917 0.389 . . . . 0.0 110.977 176.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -103.53 17.27 24.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.006 0.431 . . . . 0.0 111.142 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . 0.53 ' HB2' ' HB3' ' A' ' 249' ' ' CYS . 4.0 m-20 -140.18 54.4 1.64 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.539 175.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -75.04 -14.85 60.64 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.37 -177.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 4.4 p -93.57 6.76 47.18 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.733 176.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . 0.457 ' HB3' ' HA ' ' A' ' 248' ' ' PRO . . . -80.8 150.92 29.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.14 0.495 . . . . 0.0 110.984 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.9 tt -90.63 124.43 35.05 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -67.87 100.13 0.91 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.335 0.588 . . . . 0.0 110.427 177.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.521 HD22 HG22 ' A' ' 264' ' ' VAL . 93.4 mt -108.29 147.82 30.9 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.138 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -129.03 163.49 25.28 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.854 178.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 61.6 t -62.13 122.48 12.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.164 0.506 . . . . 0.0 111.4 -176.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . 0.637 ' HA2' ' HE3' ' A' ' 241' ' ' LYS . . . 102.71 -9.39 55.41 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.694 177.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -79.52 140.28 37.3 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 -173.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 44.3 mm -88.57 109.22 19.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.394 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.521 HG22 HD22 ' A' ' 258' ' ' LEU . 15.0 t -83.58 100.69 7.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.129 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -83.14 87.33 6.92 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.853 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.529 HG13 ' HB ' ' A' ' 238' ' ' VAL . 4.8 p -97.53 133.4 39.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.071 0.462 . . . . 0.0 110.688 -177.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 20.7 p -103.57 -35.46 8.29 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.849 -175.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . 0.419 ' HG3' ' HB3' ' A' ' 276' ' ' GLU . 3.1 ptp180 -118.21 121.53 40.71 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.095 0.474 . . . . 0.0 110.68 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' MET . . . . . 0.49 ' HE1' HG11 ' A' ' 266' ' ' VAL . 45.7 mmm -95.36 99.38 11.31 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.577 -177.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.509 ' HB2' ' O ' ' A' ' 274' ' ' GLN . 84.3 m-20 -75.34 129.94 38.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.542 -178.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 11.1 tp -69.25 -15.19 19.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -171.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -71.39 -18.34 62.36 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.756 0.313 . . . . 0.0 111.033 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 115.24 -34.1 4.98 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.993 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.529 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 17.2 mt-30 -83.6 105.04 14.21 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 175.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.426 ' HB3' HG21 ' A' ' 266' ' ' VAL . 40.2 m0 -92.71 156.7 16.87 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -176.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.419 ' HB3' ' HG3' ' A' ' 268' ' ' ARG . 30.4 tt0 -108.01 106.52 16.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.99 0.424 . . . . 0.0 110.379 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . 0.483 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -121.06 153.82 16.55 Favored Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 177.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -116.23 111.92 20.87 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . 0.627 HG12 HD22 ' A' ' 280' ' ' ASN . 16.7 t -122.93 125.76 72.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.515 -177.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . 0.627 HD22 HG12 ' A' ' 279' ' ' VAL . 9.6 p30 44.0 41.58 4.11 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.144 0.978 . . . . 0.0 112.981 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 102.6 -20.48 44.08 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.782 -0.723 . . . . 0.0 113.675 173.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 17.2 mtp-105 -109.1 125.18 51.88 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 117.232 0.516 . . . . 0.0 110.908 -177.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 42.1 pttt -114.88 134.73 54.91 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 120.289 -0.564 . . . . 0.0 109.999 172.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -155.96 176.41 33.45 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.675 -177.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.529 ' HB3' ' HB3' ' A' ' 274' ' ' GLN . 57.6 mt -91.08 118.29 30.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.983 0.42 . . . . 0.0 110.678 178.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.427 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 45.9 p90 -120.94 138.86 28.29 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.256 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 6.3 Cg_exo -76.06 139.41 21.6 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.043 2.495 . . . . 0.0 111.469 175.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -69.8 1.38 4.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.997 -177.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 19.8 p -82.7 -15.03 53.5 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.682 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -103.57 -17.27 15.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.794 0.331 . . . . 0.0 111.343 -177.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.517 ' O ' ' HD2' ' A' ' 292' ' ' LYS . 32.7 m -115.29 159.31 15.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.269 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . 0.517 ' HD2' ' O ' ' A' ' 291' ' ' VAL . 11.1 mptt -126.9 129.02 47.4 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.923 0.392 . . . . 0.0 110.682 177.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.624 HD13 ' HB2' ' A' ' 240' ' ' ALA . 39.7 mm -73.41 130.84 35.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.42 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' PHE . . . . . 0.445 ' CE1' ' HB2' ' A' ' 241' ' ' LYS . 0.6 OUTLIER -152.56 165.34 35.46 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.451 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -104.8 102.01 32.51 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 175.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo . . . . . 0 C--N 1.341 0.182 0 C-N-CA 122.702 2.268 . . . . 0.0 112.567 -173.854 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.4 t . . . . . 0 N--CA 1.453 -0.32 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -85.39 119.82 26.18 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.617 177.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.508 ' HD3' ' HA ' ' A' ' 5' ' ' ARG . 22.1 mmt180 -131.35 87.7 2.5 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.38 0.609 . . . . 0.0 111.412 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -158.81 168.17 27.53 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 177.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -100.58 131.59 46.41 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.061 175.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.5 m -69.65 -19.76 63.61 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.19 -174.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.8 t -106.24 -24.37 12.32 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -172.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -60.82 95.13 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.961 0.41 . . . . 0.0 111.143 -175.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.8 tpp180 -52.74 -51.23 61.41 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 123.205 0.602 . . . . 0.0 112.15 -174.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.6 m -72.93 4.88 3.71 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -176.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -91.65 -48.7 6.69 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.55 175.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 37.4 p-90 -113.92 -30.39 6.74 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -172.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -70.99 113.52 8.11 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.391 -0.524 . . . . 0.0 109.634 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.799 ' HB3' HG11 ' A' ' 19' ' ' VAL . 27.9 tpp -94.22 1.63 56.0 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 120.911 0.386 . . . . 0.0 110.293 -170.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 50.65 -111.96 1.43 Allowed Glycine 0 C--N 1.334 0.451 0 CA-C-N 115.041 -0.981 . . . . 0.0 113.653 177.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -64.97 90.87 0.2 Allowed 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.846 2.364 . . . . 0.0 112.297 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.947 HG22 ' HD2' ' A' ' 39' ' ' ARG . 2.7 p -162.5 159.43 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.7 m -156.64 -166.63 2.17 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 -160.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.48 ' O ' ' HB2' ' A' ' 25' ' ' GLN . 44.1 mtp85 -69.25 -41.56 76.76 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.663 -175.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 15.5 tp60 -64.24 -54.02 39.89 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 123.458 0.473 . . . . 0.0 111.024 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.401 ' O ' ' HG3' ' A' ' 27' ' ' ARG . 47.9 mm-40 -61.12 -56.43 20.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.835 -176.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.91 -33.66 67.15 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.738 0.304 . . . . 0.0 111.614 -178.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.48 ' HB2' ' O ' ' A' ' 21' ' ' ARG . 26.9 tp60 -61.8 -47.69 83.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.867 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.0 t -79.97 -25.27 40.45 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 120.88 0.372 . . . . 0.0 111.553 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.428 ' NH1' ' HB ' ' A' ' 19' ' ' VAL . 97.5 mtt180 -74.72 -38.16 62.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.987 0.422 . . . . 0.0 110.962 -177.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.925 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 28.7 mt -99.72 6.66 45.5 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.935 -176.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.476 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 17.0 tp60 -72.05 95.31 1.6 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.083 0.468 . . . . 0.0 111.725 -172.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 66.37 29.04 74.16 Favored Glycine 0 N--CA 1.453 -0.202 0 CA-C-N 115.608 -0.724 . . . . 0.0 113.815 173.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.451 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 0.0 OUTLIER -85.39 -91.91 0.09 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 117.027 0.414 . . . . 0.0 110.082 178.483 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.567 ' HB2' ' SD ' ' A' ' 35' ' ' MET . 86.7 mtm-85 -127.54 135.54 50.48 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 170.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 58.5 m170 -71.06 124.61 24.79 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.06 -13.75 14.03 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.649 -176.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.656 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 93.4 mtp -73.62 126.37 30.13 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 175.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.52 ' CB ' HG22 ' A' ' 52' ' ' VAL . 47.1 p90 -133.6 166.0 23.61 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.901 0.381 . . . . 0.0 111.013 -177.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.528 ' HB2' ' HB2' ' A' ' 16' ' ' MET . 4.0 pp -158.07 138.79 12.96 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.499 176.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.428 ' CG2' HD13 ' A' ' 50' ' ' LEU . 87.7 t -102.1 123.58 55.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.947 ' HD2' HG22 ' A' ' 19' ' ' VAL . 5.0 mtm-85 -106.77 175.01 5.64 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.163 -171.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -86.62 90.96 8.43 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 167.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.711 ' HA ' HG23 ' A' ' 49' ' ' VAL . 7.5 t 24.76 -141.41 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.347 1.459 . . . . 0.0 114.487 -176.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.595 ' HB3' HH21 ' A' ' 39' ' ' ARG . 56.0 p 172.26 -29.13 0.0 OUTLIER 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 114.106 -1.406 . . . . 0.0 108.778 174.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 40.3 p -122.88 -13.0 7.95 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.982 -177.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.46 ' HA ' ' HD2' ' A' ' 45' ' ' PRO . 64.0 m -133.47 100.17 13.96 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 110.527 -0.175 . . . . 0.0 110.527 -175.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.46 ' HD2' ' HA ' ' A' ' 44' ' ' CYS . 17.9 Cg_endo -57.42 109.18 0.43 Allowed 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.97 2.447 . . . . 0.0 113.069 -174.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.81 -19.73 18.26 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.695 177.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' A' ' 41' ' ' SER . 74.8 m-20 -90.25 -174.65 4.25 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.34 -0.245 . . . . 0.0 110.34 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.615 ' HA ' ' H ' ' A' ' 41' ' ' SER . 26.9 m-85 -129.55 167.77 17.41 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.711 HG23 ' HA ' ' A' ' 41' ' ' SER . 96.6 t -142.22 98.07 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 121.046 0.451 . . . . 0.0 111.298 177.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.428 HD13 ' CG2' ' A' ' 38' ' ' VAL . 40.8 tp -70.1 103.02 2.19 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.963 175.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.508 ' HB3' ' CG1' ' A' ' 58' ' ' VAL . 21.5 m -96.56 134.4 39.82 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.807 175.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.578 HG21 HD13 ' A' ' 93' ' ' LEU . 96.4 t -123.0 142.8 38.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.329 -178.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.925 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 36.0 t -88.05 116.92 26.57 Favored 'General case' 0 C--N 1.334 -0.081 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.649 176.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.851 ' HB2' ' HB3' ' A' ' 94' ' ' ASP . 4.8 pt-20 -165.64 141.88 5.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.775 -0.193 . . . . 0.0 110.997 -177.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.62 HD21 ' HE2' ' A' ' 155' ' ' LYS . 0.5 OUTLIER 53.16 32.12 12.65 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 122.933 0.493 . . . . 0.0 111.881 -174.385 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.1 m 67.34 11.12 8.21 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.62 177.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.583 ' HG3' ' O ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -125.39 165.31 18.63 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.187 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.508 ' CG1' ' HB3' ' A' ' 51' ' ' SER . 84.1 t -106.32 105.47 18.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.035 0.445 . . . . 0.0 110.651 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.7 t -76.51 120.36 21.61 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.765 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -99.76 102.4 13.84 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.61 -174.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.713 ' HE1' HD11 ' A' ' 153' ' ' ILE . 66.9 m-85 -100.53 101.5 12.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.621 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.597 HG12 HG22 ' A' ' 49' ' ' VAL . 25.6 mt -81.05 138.41 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 121.152 0.501 . . . . 0.0 112.311 -174.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.625 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 3.7 mp -116.85 122.24 69.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.603 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -104.01 140.42 37.77 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -175.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.4 t -79.85 104.83 10.7 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.103 0.478 . . . . 0.0 110.444 -177.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.519 HD11 ' HB2' ' A' ' 72' ' ' LYS . 90.6 mt -75.24 132.73 75.87 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.617 178.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -57.18 -19.85 35.81 Favored 'Trans proline' 0 N--CA 1.473 0.302 0 C-N-CA 123.425 2.75 . . . . 0.0 113.409 -174.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -90.28 26.85 1.81 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.238 178.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.706 ' HE ' ' HA ' ' A' ' 69' ' ' ARG . 2.2 mmp_? 69.3 26.07 5.44 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.356 173.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.638 ' HG2' ' HA ' ' A' ' 79' ' ' ASP . 69.8 mtt180 -114.47 179.0 4.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.604 176.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.625 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 36.6 m-85 -139.1 120.39 14.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.774 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.519 ' HB2' HD11 ' A' ' 66' ' ' LEU . 19.6 ttmm -106.65 110.21 22.34 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.615 -178.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.679 HD11 ' HB3' ' A' ' 61' ' ' TYR . 3.9 tt -94.06 103.62 14.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.084 0.468 . . . . 0.0 110.869 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 52.69 63.11 5.24 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.658 -0.701 . . . . 0.0 113.111 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.1 t0 78.59 -38.88 0.24 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.002 0.521 . . . . 0.0 111.081 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -69.09 119.12 12.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.002 0.429 . . . . 0.0 110.259 177.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.431 ' HB3' ' NZ ' ' A' ' 72' ' ' LYS . 7.7 pt-20 -99.23 133.67 43.18 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.274 0.559 . . . . 0.0 111.846 -174.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.46 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 79.7 m-85 -136.83 164.1 29.09 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.818 177.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.638 ' HA ' ' HG2' ' A' ' 70' ' ' ARG . 6.9 m-20 -73.75 -26.56 60.73 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -176.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.431 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 5.7 p80 -163.11 172.96 14.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.848 -0.16 . . . . 0.0 110.937 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.555 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 19.6 mt -58.34 -52.25 75.93 Favored Pre-proline 0 CA--C 1.535 0.367 0 O-C-N 123.251 0.344 . . . . 0.0 111.656 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.555 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 52.0 Cg_exo -58.11 -9.03 5.56 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 122.419 2.079 . . . . 0.0 113.467 177.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.28 -36.35 15.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.953 0.406 . . . . 0.0 110.799 -178.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.496 HD21 HD23 ' A' ' 81' ' ' LEU . 3.7 pp -79.97 -33.89 39.12 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.3 mt -68.08 -14.2 62.79 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.635 0.731 . . . . 0.0 110.115 175.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -85.98 -44.9 11.96 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.667 177.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.454 ' O ' HG12 ' A' ' 90' ' ' ILE . 84.9 t80 -70.15 -37.13 75.17 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.534 -177.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.492 ' HE2' HD13 ' A' ' 73' ' ' ILE . 16.7 m-85 -72.77 5.2 3.33 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -176.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -83.76 -14.98 50.21 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 119.915 -0.714 . . . . 0.0 111.144 171.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.454 HG12 ' O ' ' A' ' 87' ' ' PHE . 5.6 pt -87.89 -28.93 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.227 166.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.451 ' N ' HG13 ' A' ' 90' ' ' ILE . 3.0 m170 -91.14 124.53 35.43 Favored 'General case' 0 CA--C 1.502 -0.865 0 CA-C-O 121.135 0.493 . . . . 0.0 111.181 -177.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -86.81 90.04 8.17 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 175.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.578 HD13 HG21 ' A' ' 52' ' ' VAL . 5.3 mt -46.63 -36.36 6.91 Favored 'General case' 0 C--O 1.218 -0.567 0 O-C-N 124.346 1.029 . . . . 0.0 110.204 -177.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.851 ' HB3' ' HB2' ' A' ' 54' ' ' GLU . 21.6 t70 -158.82 99.35 1.54 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.841 165.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.634 ' HA ' ' HA ' ' A' ' 156' ' ' PRO . 5.7 t 44.3 18.16 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.663 1.185 . . . . 0.0 112.498 -177.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.7 t -162.77 154.58 18.15 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.48 ' O ' HG12 ' A' ' 99' ' ' ILE . 52.2 p -104.11 -179.01 3.82 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.4 104.97 0.84 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 173.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 97' ' ' THR . 45.1 mm -99.86 -54.93 6.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.737 -173.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.656 ' O ' ' HA ' ' A' ' 35' ' ' MET . 10.6 pt-20 -151.59 153.02 31.55 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.062 -173.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 100' ' ' GLU . 1.9 Cg_endo -83.84 158.61 13.89 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.948 2.432 . . . . 0.0 112.746 178.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -88.18 164.62 32.56 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.054 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -78.28 164.92 26.23 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.99 2.46 . . . . 0.0 112.453 175.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.793 ' HG2' ' SD ' ' A' ' 16' ' ' MET . 19.8 mtm180 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.492 -179.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.443 HD12 HG21 ' A' ' 152' ' ' ILE . 2.6 mm? . . . . . 0 N--CA 1.468 0.473 0 CA-C-O 121.305 0.574 . . . . 0.0 112.328 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 179.84 -48.57 0.01 OUTLIER 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.106 174.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.547 ' CE2' HG22 ' A' ' 151' ' ' VAL . 35.5 m-85 -122.76 131.03 53.59 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.373 177.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.505 ' CG1' ' HB ' ' A' ' 178' ' ' VAL . 5.8 t -134.93 156.8 40.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.087 -174.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.591 ' NH2' HD13 ' A' ' 181' ' ' LEU . 1.2 ptp180 -134.17 133.54 41.1 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 172.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 1.109 HG22 HG12 ' A' ' 178' ' ' VAL . 23.8 p -88.77 140.57 29.31 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.273 0.559 . . . . 0.0 112.213 -174.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.717 HD11 ' HG2' ' A' ' 179' ' ' GLU . 13.6 mt -106.99 -42.23 4.96 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.397 -176.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -83.31 -36.45 24.45 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -168.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.806 ' HB2' ' HA ' ' A' ' 145' ' ' LYS . 0.0 OUTLIER 79.25 133.67 0.06 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.434 0.693 . . . . 0.0 111.021 -174.59 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.587 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 59.1 t80 -156.05 110.38 2.11 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.072 -178.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.432 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 11.1 Cg_endo -89.42 90.91 0.36 Allowed 'Trans proline' 0 N--CA 1.445 -1.348 0 C-N-CA 122.591 2.194 . . . . 0.0 112.586 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . 0.507 ' HA3' ' HB3' ' A' ' 141' ' ' ASP . . . -84.4 -21.14 57.31 Favored Glycine 0 N--CA 1.454 -0.166 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.048 173.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 28.4 m120 46.29 48.67 13.27 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 114.443 -0.878 . . . . 0.0 112.532 178.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.423 ' OD1' ' HG2' ' A' ' 140' ' ' GLU . 5.0 t70 -149.53 179.23 8.14 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.39 -178.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -95.17 -7.5 39.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.336 0.588 . . . . 0.0 110.197 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.574 ' O ' ' HB2' ' A' ' 172' ' ' MET . 10.0 pt-20 -113.28 -3.32 13.86 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.987 173.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.507 ' HB3' ' HA3' ' A' ' 136' ' ' GLY . 4.1 m-20 -140.14 102.03 4.29 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 1.104 HD12 ' HD2' ' A' ' 143' ' ' PRO . 57.8 tp -74.03 126.13 89.56 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.417 0.627 . . . . 0.0 111.639 -172.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 1.104 ' HD2' HD12 ' A' ' 142' ' ' LEU . 68.8 Cg_endo -76.73 65.58 7.54 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 124.263 3.308 . . . . 0.0 113.132 177.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.621 ' CG ' HG21 ' A' ' 130' ' ' THR . 36.3 p90 -84.43 162.08 20.09 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.504 -0.479 . . . . 0.0 111.736 -176.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.806 ' HA ' ' HB2' ' A' ' 133' ' ' ASP . 10.9 mtmt -121.98 179.92 4.36 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.178 -176.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.746 ' HD3' ' H ' ' A' ' 146' ' ' LYS . 0.3 OUTLIER -79.47 27.62 0.27 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -167.753 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 175.72 32.91 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 119.721 -1.228 . . . . 0.0 113.594 176.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.575 ' OE2' ' HA ' ' A' ' 144' ' ' PHE . 8.7 pt-20 -106.63 167.15 10.06 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 117.826 0.813 . . . . 0.0 110.916 177.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.436 ' C ' HD23 ' A' ' 150' ' ' LEU . 19.8 mm -101.55 138.38 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -175.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.608 HD22 ' HA ' ' A' ' 165' ' ' ASN . 11.5 mt -122.9 179.64 4.57 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.888 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 47.8 t -145.29 123.46 5.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 178.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.582 HG23 ' HB3' ' A' ' 161' ' ' TRP . 20.4 mm -77.85 77.77 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-O 122.659 1.219 . . . . 0.0 108.55 -178.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.713 HD11 ' HE1' ' A' ' 61' ' ' TYR . 13.5 tt -71.4 -41.45 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-N 112.847 -1.979 . . . . 0.0 109.905 -177.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 1.132 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 73.4 mt-10 -116.79 138.92 51.15 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 172.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.62 ' HE2' HD21 ' A' ' 55' ' ' ASN . 22.1 ttpt -132.94 79.54 62.94 Favored Pre-proline 0 C--N 1.322 -0.593 0 O-C-N 122.043 -0.411 . . . . 0.0 110.015 167.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.634 ' HA ' ' HA ' ' A' ' 95' ' ' THR . 14.6 Cg_exo -66.35 -49.17 1.97 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 121.95 1.767 . . . . 0.0 110.945 177.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -119.93 176.44 5.41 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.205 -174.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -95.6 -30.34 13.85 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.619 -176.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -84.25 -22.71 30.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.021 0.438 . . . . 0.0 110.793 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.766 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 60.5 m95 -129.2 126.89 40.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.425 -178.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . 0.582 ' HB3' HG23 ' A' ' 152' ' ' ILE . 49.5 m0 -119.75 134.26 55.3 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.752 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 1.132 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 6.5 m -84.47 98.09 9.9 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 177.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.573 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -103.98 157.78 16.87 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.136 -176.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.888 ' HG2' ' HB ' ' A' ' 151' ' ' VAL . 14.2 ptt180 -104.66 129.64 52.8 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 176.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.608 ' HA ' HD22 ' A' ' 150' ' ' LEU . 0.2 OUTLIER -73.03 -166.99 0.35 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.453 0.168 . . . . 0.0 110.971 -178.225 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.517 ' HE3' ' HB2' ' A' ' 148' ' ' GLU . 93.8 mttt -55.96 -38.06 69.86 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -176.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.424 ' CG ' HD21 ' A' ' 165' ' ' ASN . 3.3 p30 -86.46 0.96 53.07 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.308 -178.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 92.42 3.06 67.34 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 120.447 -0.882 . . . . 0.0 113.973 174.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.731 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 12.5 ttm-85 -68.1 130.25 42.36 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 122.511 0.324 . . . . 0.0 110.777 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.468 HG22 HG21 ' A' ' 153' ' ' ILE . 39.8 t -95.19 143.02 12.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-O 120.855 0.36 . . . . 0.0 111.008 -177.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -170.92 155.53 24.87 Favored Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 175.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.766 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.4 OUTLIER -70.26 131.66 44.53 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.967 0.384 . . . . 0.0 110.864 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.829 HD13 HG11 ' A' ' 178' ' ' VAL . 2.6 pp -133.52 145.4 56.2 Favored Pre-proline 0 N--CA 1.451 -0.394 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.199 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.484 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 8.2 Cg_exo -71.69 125.43 11.11 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.957 2.438 . . . . 0.0 111.859 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.622 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 24.1 t -68.76 -35.29 6.34 Favored Pre-proline 0 C--N 1.32 -0.682 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -178.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.622 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 19.0 Cg_endo -61.43 -11.22 18.77 Favored 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 121.656 1.571 . . . . 0.0 112.537 172.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.484 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.4 m-85 -92.01 -14.35 29.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.243 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 1.109 HG12 HG22 ' A' ' 130' ' ' THR . 10.3 m -122.01 173.64 7.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -169.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.717 ' HG2' HD11 ' A' ' 131' ' ' LEU . 9.3 mm-40 -136.34 169.71 17.23 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.933 177.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.511 ' HD3' ' N ' ' A' ' 180' ' ' LYS . 2.3 mppt? -101.22 136.92 40.27 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.802 0.334 . . . . 0.0 110.563 -175.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.591 HD13 ' NH2' ' A' ' 129' ' ' ARG . 7.8 tp . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.371 -178.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo . . . . . 0 C--O 1.234 0.283 0 CA-C-O 120.973 0.322 . . . . 0.0 111.83 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.63 HG11 HD12 ' A' ' 293' ' ' ILE . 39.6 t -100.68 135.88 34.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.967 -173.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -88.27 121.85 31.14 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.459 173.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.467 ' HB1' ' HB ' ' A' ' 291' ' ' VAL . . . -126.5 123.69 38.36 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.391 176.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.408 ' O ' HG23 ' A' ' 243' ' ' ILE . 63.8 tttm -86.07 119.41 26.34 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.131 -177.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . 0.619 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -70.81 99.9 1.81 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.31 0.576 . . . . 0.0 110.418 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.408 HG23 ' O ' ' A' ' 241' ' ' LYS . 34.2 pt -88.75 -27.87 5.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.421 -173.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -129.89 147.81 51.69 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.368 -0.378 . . . . 0.0 109.996 -178.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -55.53 122.21 10.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.432 0.634 . . . . 0.0 111.296 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.747 ' HB3' ' HB2' ' A' ' 258' ' ' LEU . 20.9 tpt180 -122.73 77.04 1.4 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.382 -0.826 . . . . 0.0 108.856 173.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.425 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 7.4 m -111.62 137.46 21.2 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.67 -178.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 247' ' ' VAL . 31.8 Cg_exo -57.76 111.4 0.83 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 123.048 2.499 . . . . 0.0 112.044 -178.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' CYS . . . . . 0.428 ' N ' ' HB2' ' A' ' 252' ' ' ASP . 19.3 t -88.6 -169.86 2.71 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.2 -39.15 78.25 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -177.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -91.1 -9.91 43.92 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.381 -176.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . 0.428 ' HB2' ' N ' ' A' ' 249' ' ' CYS . 19.4 m-20 -80.89 116.67 20.99 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.364 0.602 . . . . 0.0 111.571 -174.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -120.47 145.97 46.73 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 172.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 25.2 p 61.92 17.73 9.19 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.581 0.752 . . . . 0.0 111.017 -174.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -81.17 130.99 35.27 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.999 0.428 . . . . 0.0 111.426 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.748 HD21 ' HB ' ' A' ' 279' ' ' VAL . 2.0 tt -86.07 131.29 34.29 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 175.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.46 ' N ' HD23 ' A' ' 256' ' ' LEU . . . -79.86 95.95 6.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.211 0.529 . . . . 0.0 111.182 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.895 HD21 HG21 ' A' ' 279' ' ' VAL . 68.8 mt -105.39 105.48 15.54 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.377 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -87.82 150.3 23.62 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.066 -177.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 47.0 t -61.8 121.21 9.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.038 -176.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 101.87 39.73 2.85 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.964 175.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -141.58 174.82 10.2 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.938 0.369 . . . . 0.0 110.138 177.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . 0.449 HD12 ' HZ ' ' A' ' 294' ' ' PHE . 49.8 mm -107.38 133.82 50.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.944 0.402 . . . . 0.0 111.203 -175.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.572 HG22 HD22 ' A' ' 258' ' ' LEU . 5.2 t -113.75 115.76 50.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.885 175.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -95.94 103.17 15.04 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 173.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.626 HG13 ' HB ' ' A' ' 238' ' ' VAL . 2.1 p -94.65 141.4 15.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.562 -178.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 19.5 p -126.34 -23.74 3.77 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.913 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . 0.482 ' HB2' ' HB3' ' A' ' 276' ' ' GLU . 83.4 mtt180 -116.51 119.42 35.53 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.43 177.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 58.6 mtt -117.25 110.36 18.01 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 175.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -84.21 12.12 7.09 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.237 -170.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 48.0 mm 72.05 -39.0 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 175.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -78.8 27.05 0.23 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.444 0.64 . . . . 0.0 111.067 -178.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 81.99 -29.14 3.12 Favored Glycine 0 C--N 1.32 -0.308 0 C-N-CA 121.096 -0.573 . . . . 0.0 113.077 176.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -78.7 105.54 10.08 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.514 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 49.4 m0 -99.82 153.96 18.72 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.274 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.482 ' HB3' ' HB2' ' A' ' 268' ' ' ARG . 38.9 tt0 -120.59 115.6 23.72 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.887 178.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -138.06 164.3 25.56 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 176.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -106.17 112.33 25.32 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 117.784 0.792 . . . . 0.0 109.669 -177.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . 0.895 HG21 HD21 ' A' ' 258' ' ' LEU . 70.8 t -121.15 99.67 7.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.171 -177.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 42.18 63.13 1.44 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.353 -1.294 . . . . 0.0 113.173 173.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 144.68 -51.08 0.63 Allowed Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.025 -1.083 . . . . 0.0 112.585 173.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.46 162.15 16.71 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.222 0.534 . . . . 0.0 111.755 -178.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.572 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 0.0 OUTLIER -88.84 143.06 27.15 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.673 175.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -150.56 172.18 30.33 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.539 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.514 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 72.0 mt -90.1 123.65 34.13 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.16 0.505 . . . . 0.0 110.958 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.435 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 36.6 p90 -133.68 136.71 27.22 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.173 177.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 10.4 Cg_exo -71.78 140.08 34.81 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.501 2.134 . . . . 0.0 111.614 176.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -60.07 -20.56 58.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.837 -178.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 1.4 p -73.89 -3.52 29.37 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -177.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -101.19 -7.54 23.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.666 0.27 . . . . 0.0 110.678 177.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.619 HG12 ' HA ' ' A' ' 242' ' ' ALA . 15.4 m -128.74 178.0 5.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.145 0.498 . . . . 0.0 111.302 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 57.8 tttm -140.81 123.28 15.97 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.515 175.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.63 HD12 HG11 ' A' ' 238' ' ' VAL . 35.3 mm -65.07 144.31 14.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.152 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' PHE . . . . . 0.449 ' HZ ' HD12 ' A' ' 263' ' ' ILE . 6.4 p90 -173.39 -179.07 1.81 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.637 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -151.58 144.48 16.97 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 172.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo . . . . . 0 C--N 1.348 0.504 0 C-N-CA 123.563 2.842 . . . . 0.0 114.178 178.435 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.5 p . . . . . 0 N--CA 1.449 -0.523 0 CA-C-O 121.091 0.472 . . . . 0.0 110.221 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.561 ' HB3' ' HE2' ' A' ' 253' ' ' LYS . . . -67.07 133.64 50.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.771 178.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 5' ' ' ARG . 47.0 ttm180 -150.92 100.09 2.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.773 0.32 . . . . 0.0 110.821 -176.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -166.07 -177.23 4.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.885 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.514 ' HB3' ' CB ' ' A' ' 13' ' ' ALA . 12.9 t70 -103.17 141.46 35.83 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.471 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 31.7 m -79.36 -0.19 31.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.808 0.337 . . . . 0.0 111.429 -176.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.759 ' CA ' ' HE1' ' A' ' 14' ' ' TRP . 8.7 t -149.17 -95.22 0.07 Allowed 'General case' 0 C--O 1.245 0.816 0 CA-C-O 122.2 1.0 . . . . 0.0 111.302 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.476 ' O ' ' N ' ' A' ' 12' ' ' SER . 37.5 t70 -8.16 74.89 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.099 -1.409 . . . . 0.0 112.01 -155.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.401 ' HA ' ' HD3' ' A' ' 11' ' ' ARG . 7.6 mmt180 -2.24 -58.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 126.189 2.18 . . . . 0.0 115.331 -163.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.476 ' N ' ' O ' ' A' ' 10' ' ' ASP . 58.2 m -70.1 18.08 0.05 Allowed 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -177.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.514 ' CB ' ' HB3' ' A' ' 7' ' ' ASP . . . -91.46 -19.1 23.2 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 120.332 -0.547 . . . . 0.0 109.725 170.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.759 ' HE1' ' CA ' ' A' ' 9' ' ' SER . 7.4 p-90 -151.71 -39.84 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.477 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.551 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 34.0 t80 -67.36 119.84 12.88 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 121.126 0.489 . . . . 0.0 110.179 -177.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.811 ' SD ' ' HB3' ' A' ' 104' ' ' ARG . 15.0 tpp -110.03 9.22 24.25 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.296 -172.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.56 ' O ' ' HB2' ' A' ' 39' ' ' ARG . . . 50.85 -112.07 1.51 Allowed Glycine 0 C--O 1.222 -0.639 0 CA-C-N 115.805 -0.634 . . . . 0.0 113.713 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.417 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 2.8 Cg_exo -77.03 109.15 2.78 Favored 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 122.462 2.108 . . . . 0.0 112.606 178.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.066 ' HB ' ' HG3' ' A' ' 39' ' ' ARG . 27.5 t -136.29 -71.4 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 119.212 -0.423 . . . . 0.0 111.701 178.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.489 ' HB3' ' O ' ' A' ' 19' ' ' VAL . 37.7 t 79.72 -172.6 0.05 Allowed 'General case' 0 C--N 1.345 0.412 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 171.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 -65.6 -42.95 91.06 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.716 0.293 . . . . 0.0 110.977 -173.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.523 ' HG3' ' H ' ' A' ' 23' ' ' GLU . 2.2 pt20 -61.01 -59.96 4.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.58 -0.737 . . . . 0.0 112.002 -176.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.611 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 64.8 mm-40 -66.61 -45.28 79.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.818 -175.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 28' ' ' LEU . . . -54.72 -36.75 65.07 Favored 'General case' 0 C--O 1.222 -0.371 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.187 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.671 ' HA ' HG21 ' A' ' 58' ' ' VAL . 6.1 tp-100 -73.4 -51.96 15.45 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.994 178.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.478 HG22 ' HA ' ' A' ' 23' ' ' GLU . 6.2 t -63.24 -26.68 68.9 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -171.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.611 ' HG2' ' O ' ' A' ' 23' ' ' GLU . 18.1 ptp180 -101.58 -9.46 20.96 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.565 -178.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.691 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 87.6 mt -119.61 17.2 12.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.75 -0.205 . . . . 0.0 111.542 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -71.56 74.15 0.78 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.377 0.608 . . . . 0.0 110.314 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.23 -69.43 1.34 Allowed Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.122 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.401 ' HB3' ' H ' ' A' ' 32' ' ' ARG . 6.9 tt0 34.12 -93.24 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.947 1.299 . . . . 0.0 113.561 -175.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.401 ' H ' ' HB3' ' A' ' 31' ' ' GLN . 33.2 ttp-105 -115.46 -11.78 11.78 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -172.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 33.6 m170 67.65 157.65 0.13 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.296 0.638 . . . . 0.0 111.948 -178.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.48 3.21 82.38 Favored Glycine 0 C--N 1.334 0.451 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 177.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.519 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 44.2 mtp -90.13 136.6 32.95 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.959 -0.62 . . . . 0.0 109.918 -176.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.49 ' CB ' HG22 ' A' ' 52' ' ' VAL . 34.2 p90 -138.78 165.06 27.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.55 0.214 . . . . 0.0 110.657 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.599 ' O ' ' HA ' ' A' ' 50' ' ' LEU . 4.6 pp -158.3 140.61 14.25 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.835 174.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 15' ' ' TYR . 80.2 t -110.17 120.66 61.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 174.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 1.066 ' HG3' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -138.01 175.93 9.15 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.683 -176.61 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.463 ' O ' ' HG2' ' A' ' 39' ' ' ARG . 2.1 m-20 -66.82 137.71 56.81 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.997 0.427 . . . . 0.0 110.337 176.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.499 ' HB3' ' O ' ' A' ' 44' ' ' CYS . 22.8 t -76.92 147.95 36.67 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.495 -179.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.8 p -87.03 -29.43 21.96 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.034 -178.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 20.5 p -82.54 -42.27 18.57 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.035 0.445 . . . . 0.0 110.955 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.499 ' O ' ' HB3' ' A' ' 41' ' ' SER . 56.1 m -127.15 112.25 21.6 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.209 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.93 14.86 0.63 Allowed 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.792 2.328 . . . . 0.0 112.918 -178.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -117.06 -5.72 14.75 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.627 -0.589 . . . . 0.0 111.627 175.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -119.61 175.26 5.94 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -177.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.43 ' O ' HG23 ' A' ' 62' ' ' ILE . 22.1 m-85 -127.49 179.67 5.37 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 122.176 0.19 . . . . 0.0 110.491 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.609 HG22 HG12 ' A' ' 62' ' ' ILE . 54.2 t -148.91 96.82 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-O 120.743 0.306 . . . . 0.0 111.319 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.599 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 50.6 tp -70.8 101.01 2.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.481 171.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.4 m -97.21 130.01 44.49 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.439 177.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.753 HG21 HD13 ' A' ' 93' ' ' LEU . 69.9 t -119.86 140.97 42.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.205 -177.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.691 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 42.1 t -102.82 107.8 18.78 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.687 -177.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.837 ' HG3' HG22 ' A' ' 96' ' ' THR . 0.0 OUTLIER -158.39 157.28 32.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.769 -0.196 . . . . 0.0 110.756 171.31 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 59.41 18.6 6.97 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 123.557 0.536 . . . . 0.0 110.424 -173.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.0 m 68.47 21.85 8.02 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.949 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -125.65 151.67 46.22 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 174.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.671 HG21 ' HA ' ' A' ' 25' ' ' GLN . 44.9 t -97.33 91.55 2.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.931 0.396 . . . . 0.0 110.521 178.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.9 t -68.46 118.12 11.11 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -98.62 106.75 19.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.312 -174.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.735 ' HB3' HD11 ' A' ' 73' ' ' ILE . 53.9 m-85 -101.97 92.05 4.62 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.581 178.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.609 HG12 HG22 ' A' ' 49' ' ' VAL . 38.5 mt -72.15 130.52 35.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -177.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.641 ' HA ' ' HA ' ' A' ' 73' ' ' ILE . 4.9 mp -106.98 119.46 56.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.204 178.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -97.96 134.6 40.86 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -177.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.5 t -84.3 110.85 18.89 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.156 0.503 . . . . 0.0 110.066 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.729 HD12 ' HG3' ' A' ' 70' ' ' ARG . 67.9 mt -83.32 144.65 46.98 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.422 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.34 -19.01 20.48 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.106 2.538 . . . . 0.0 113.095 -178.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 56.0 m-20 -84.83 14.76 4.45 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.632 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.668 ' HE ' ' HA ' ' A' ' 69' ' ' ARG . 3.3 tpm_? 66.29 26.71 10.3 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.299 0.64 . . . . 0.0 111.154 176.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.729 ' HG3' HD12 ' A' ' 66' ' ' LEU . 6.7 ptm180 -119.47 164.49 15.69 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 176.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.635 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 74.1 m-85 -123.05 120.11 32.35 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.821 0.343 . . . . 0.0 111.853 -171.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 77' ' ' GLU . 20.7 ttmm -102.21 110.29 22.2 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 175.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.735 HD11 ' HB3' ' A' ' 61' ' ' TYR . 2.4 tt -87.05 83.58 2.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.614 0.721 . . . . 0.0 111.406 -175.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.25 -53.25 2.25 Favored Glycine 0 C--N 1.336 0.567 0 CA-C-N 114.66 -1.155 . . . . 0.0 113.342 174.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.71 ' OD2' ' HA2' ' A' ' 168' ' ' GLY . 11.6 t70 -135.57 -55.26 0.79 Allowed 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.081 0.467 . . . . 0.0 109.931 -174.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.5 124.74 28.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.896 -177.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 10.0 pt-20 -99.08 129.94 45.38 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.185 0.517 . . . . 0.0 110.984 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.525 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 93.9 m-85 -124.92 -169.1 1.92 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.893 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -112.11 -19.93 12.11 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -177.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.574 ' ND1' ' HG2' ' A' ' 82' ' ' PRO . 6.7 p80 -149.11 165.41 31.83 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 122.376 -0.203 . . . . 0.0 110.533 172.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.504 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 4.4 mt -61.34 -52.19 72.41 Favored Pre-proline 0 N--CA 1.467 0.383 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.466 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.574 ' HG2' ' ND1' ' A' ' 80' ' ' HIS . 12.9 Cg_endo -60.31 -5.87 4.63 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 121.982 1.788 . . . . 0.0 113.18 176.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.513 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -85.77 -30.47 23.02 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.118 0.485 . . . . 0.0 110.172 -175.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.525 ' HB3' ' CD2' ' A' ' 78' ' ' PHE . 3.4 pp -82.58 -32.93 28.24 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 174.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.0 mt -66.37 -37.15 84.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.676 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.409 ' OE2' ' HA ' ' A' ' 83' ' ' ALA . 13.8 pt-20 -78.65 -19.77 51.83 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.947 178.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.532 ' O ' HG12 ' A' ' 90' ' ' ILE . 73.7 t80 -81.76 -33.97 30.66 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.253 0.549 . . . . 0.0 110.06 -178.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.443 ' CG ' HD21 ' A' ' 93' ' ' LEU . 33.9 m-85 -79.18 5.07 13.02 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.713 -178.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.683 ' HE3' HG22 ' A' ' 90' ' ' ILE . 0.1 OUTLIER -68.01 -34.03 75.72 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 168.873 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.683 HG22 ' HE3' ' A' ' 89' ' ' LYS . 11.0 pt -85.77 -30.91 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 174.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.407 ' HB2' ' HD1' ' A' ' 88' ' ' TYR . 8.1 m170 -93.35 125.58 38.03 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.074 0.464 . . . . 0.0 111.168 -176.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.446 ' CD2' HG23 ' A' ' 97' ' ' THR . 59.0 m-85 -86.71 82.1 7.98 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.615 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.753 HD13 HG21 ' A' ' 52' ' ' VAL . 24.0 mt -31.79 -52.24 0.24 Allowed 'General case' 0 N--CA 1.473 0.694 0 O-C-N 125.199 1.562 . . . . 0.0 113.962 -172.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.478 ' OD1' ' HB3' ' A' ' 54' ' ' GLU . 7.3 t70 -118.53 -34.05 4.13 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.49 0.662 . . . . 0.0 109.769 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.422 ' HB ' ' O ' ' A' ' 94' ' ' ASP . 5.8 t 176.99 -20.41 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.245 176.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.837 HG22 ' HG3' ' A' ' 54' ' ' GLU . 3.6 t -113.97 171.76 7.4 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.407 170.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.446 HG23 ' CD2' ' A' ' 92' ' ' TYR . 69.9 p -99.58 -177.26 3.52 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.447 HD22 ' CG ' ' A' ' 36' ' ' PHE . 89.5 mt -70.52 105.37 3.07 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.483 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 45.8 mm -99.7 -53.71 7.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.701 -174.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.519 ' O ' ' HA ' ' A' ' 35' ' ' MET . 7.4 pt-20 -149.37 157.25 39.42 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 120.819 0.342 . . . . 0.0 111.46 -174.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.52 163.33 29.69 Favored 'Trans proline' 0 C--O 1.233 0.275 0 C-N-CA 122.495 2.13 . . . . 0.0 112.504 176.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.621 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -90.01 161.36 38.33 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.776 177.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -68.46 159.71 52.28 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.444 2.096 . . . . 0.0 111.912 174.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.811 ' HB3' ' SD ' ' A' ' 16' ' ' MET . 13.8 ptm180 . . . . . 0 C--N 1.325 -0.467 0 CA-C-O 121.081 0.467 . . . . 0.0 111.715 -177.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.665 HD12 HG21 ' A' ' 152' ' ' ILE . 4.1 mm? . . . . . 0 N--CA 1.473 0.678 0 CA-C-O 121.045 0.45 . . . . 0.0 112.205 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.488 ' HG3' ' CD1' ' A' ' 127' ' ' TYR . 9.9 tp10 -170.72 -72.97 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.546 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.488 ' CD1' ' HG3' ' A' ' 126' ' ' GLU . 38.4 m-85 -112.97 131.99 55.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.231 0.539 . . . . 0.0 111.123 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.565 ' CG1' ' HB ' ' A' ' 178' ' ' VAL . 8.3 t -131.59 158.26 43.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.361 -176.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -138.77 133.43 32.13 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 170.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 1.05 HG22 HG12 ' A' ' 178' ' ' VAL . 35.8 p -86.97 141.46 28.68 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.231 -173.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.755 HD11 ' CG ' ' A' ' 179' ' ' GLU . 10.9 mt -111.27 -30.93 7.24 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -174.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.518 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 55.5 t80 -90.09 -27.38 19.7 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -168.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.518 ' HB3' ' O ' ' A' ' 132' ' ' TYR . 19.5 t70 73.83 130.88 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 O-C-N 123.564 0.54 . . . . 0.0 111.06 -172.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.452 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 76.4 t80 -161.86 99.48 1.19 Allowed Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.97 -177.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -82.36 81.46 2.49 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.916 2.411 . . . . 0.0 112.731 178.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.56 -17.12 74.44 Favored Glycine 0 C--O 1.227 -0.319 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 172.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 40.53 35.54 0.31 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.944 1.298 . . . . 0.0 113.945 178.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.508 ' HB2' ' HB2' ' A' ' 141' ' ' ASP . 1.6 m-20 -121.12 -173.42 2.61 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 121.981 -0.449 . . . . 0.0 111.5 -178.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -105.13 -6.64 19.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.245 0.545 . . . . 0.0 110.637 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -122.17 -1.26 9.27 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.692 174.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.508 ' HB2' ' HB2' ' A' ' 138' ' ' ASP . 5.4 m-20 -132.32 108.4 9.18 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 174.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.82 HD11 ' HB2' ' A' ' 165' ' ' ASN . 60.5 tp -74.59 119.79 78.35 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 121.215 0.531 . . . . 0.0 111.868 -170.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.625 ' HD2' HD12 ' A' ' 142' ' ' LEU . 55.8 Cg_endo -72.8 102.66 1.46 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.579 2.186 . . . . 0.0 111.57 171.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.612 ' CG ' HG21 ' A' ' 130' ' ' THR . 12.6 p90 -117.49 163.94 15.64 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.786 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.48 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 12.4 mmtm -108.65 -159.48 0.69 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.001 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.506 ' HD3' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -101.46 6.53 42.47 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.986 -0.285 . . . . 0.0 111.768 -173.885 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -155.34 24.28 0.59 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.055 -1.069 . . . . 0.0 112.704 178.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.13 159.47 14.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.636 0.255 . . . . 0.0 110.562 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.429 ' C ' HD23 ' A' ' 150' ' ' LEU . 15.5 mm -101.56 135.88 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -174.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.605 ' HB3' ' HB1' ' A' ' 163' ' ' ALA . 10.4 mt -122.11 175.9 6.11 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 46.6 t -145.5 123.0 4.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.672 HG23 ' HB3' ' A' ' 161' ' ' TRP . 23.9 mm -79.16 78.75 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-O 122.483 1.135 . . . . 0.0 108.657 -176.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.679 HG23 ' HG3' ' A' ' 154' ' ' GLU . 11.5 tt -69.2 -46.21 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 CA-C-N 113.176 -1.829 . . . . 0.0 109.359 -178.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 1.016 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 40.5 mt-10 -115.27 140.05 49.44 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -127.66 82.12 68.91 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 167.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.409 ' HG2' ' HE3' ' A' ' 172' ' ' MET . 3.3 Cg_exo -77.32 -50.76 0.09 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.327 2.685 . . . . 0.0 111.242 176.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -108.4 170.33 8.09 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.402 -176.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -88.3 -41.39 12.92 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.742 -176.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -83.18 -24.37 32.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.909 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 57.2 m95 -123.72 119.65 30.4 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.244 -176.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . 0.672 ' HB3' HG23 ' A' ' 152' ' ' ILE . 44.8 m0 -106.24 138.29 42.69 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.732 176.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 1.016 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 13.8 m -85.83 101.01 12.46 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 177.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.619 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -106.23 157.01 17.89 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.909 -179.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.713 ' HB3' HG22 ' A' ' 170' ' ' VAL . 25.0 ptt-85 -107.67 128.98 55.04 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 175.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.82 ' HB2' HD11 ' A' ' 142' ' ' LEU . 58.5 t30 -69.15 151.91 45.78 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 175.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 29.0 ttpp -65.06 -12.0 45.74 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.683 -176.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.422 ' HB3' ' NH2' ' A' ' 169' ' ' ARG . 19.4 t70 -86.41 -26.43 24.75 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -177.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.71 ' HA2' ' OD2' ' A' ' 75' ' ' ASP . . . 123.54 67.42 0.21 Allowed Glycine 0 CA--C 1.528 0.845 0 C-N-CA 118.587 -1.768 . . . . 0.0 115.684 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.54 ' HD2' ' HD2' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -178.66 148.64 0.44 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.656 0.383 . . . . 0.0 110.178 161.568 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.713 HG22 ' HB3' ' A' ' 164' ' ' ARG . 61.2 t -101.06 142.87 15.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.316 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -167.05 157.01 29.26 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.56 ' HA ' ' HA ' ' A' ' 162' ' ' SER . 31.7 mtp -74.21 136.49 42.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.973 0.386 . . . . 0.0 110.135 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.897 HD13 HG11 ' A' ' 178' ' ' VAL . 2.7 pp -134.17 150.19 73.47 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.631 -177.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 173' ' ' ILE . 4.0 Cg_exo -76.97 127.86 9.61 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 123.0 2.467 . . . . 0.0 112.33 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.616 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 26.2 t -64.11 -42.16 66.79 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 9.6 Cg_endo -53.27 -13.6 3.44 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.968 2.445 . . . . 0.0 113.962 171.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -96.58 -14.69 22.04 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 111.607 0.225 . . . . 0.0 111.607 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 1.05 HG12 HG22 ' A' ' 130' ' ' THR . 5.9 m -125.6 161.55 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 121.992 0.901 . . . . 0.0 113.112 -169.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.755 ' CG ' HD11 ' A' ' 131' ' ' LEU . 3.5 mm-40 -124.45 160.36 28.42 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.156 177.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -98.34 137.18 37.43 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -176.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 10.2 tp . . . . . 0 C--N 1.324 -0.501 0 CA-C-O 121.094 0.473 . . . . 0.0 109.921 -179.451 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo . . . . . 0 N--CA 1.466 -0.144 0 CA-C-O 121.224 0.427 . . . . 0.0 111.691 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.717 ' CG1' HD12 ' A' ' 293' ' ' ILE . 41.4 t -115.49 136.88 50.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.992 -176.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -104.68 117.04 33.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.96 178.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.492 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -120.2 125.12 47.38 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.739 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -85.26 124.15 31.57 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . 0.579 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -69.53 112.38 6.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.841 0.353 . . . . 0.0 110.385 -178.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 33.7 pt -84.46 -16.94 10.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.507 -177.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.505 ' HA ' HG22 ' A' ' 260' ' ' VAL . 16.4 pt20 -150.35 153.68 36.48 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.099 173.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.463 ' C ' ' HD2' ' A' ' 245' ' ' LYS . 0.1 OUTLIER -75.75 169.79 17.45 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.449 0.642 . . . . 0.0 112.112 -171.708 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 38.6 ttt85 -170.28 115.94 0.51 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.409 172.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 8.7 p -122.11 141.02 33.4 Favored Pre-proline 0 C--N 1.316 -0.875 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -45.49 111.36 0.31 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.846 2.364 . . . . 0.0 112.873 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' CYS . . . . . 0.431 ' H ' ' HB2' ' A' ' 252' ' ' ASP . 31.7 t -90.16 -173.03 3.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.717 178.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.418 ' N ' ' SG ' ' A' ' 249' ' ' CYS . . . -62.69 -27.92 69.58 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.982 0.42 . . . . 0.0 111.938 -177.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -101.02 1.14 39.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.327 -177.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . 0.451 ' HB3' ' CB ' ' A' ' 255' ' ' ALA . 27.2 m-20 -97.7 97.19 8.81 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -173.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . 0.835 ' HG3' HG23 ' A' ' 254' ' ' THR . 45.6 tptt -91.25 139.44 30.74 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 171.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . 0.835 HG23 ' HG3' ' A' ' 253' ' ' LYS . 26.2 p 65.96 14.92 9.85 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.035 0.934 . . . . 0.0 112.27 178.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . 0.451 ' CB ' ' HB3' ' A' ' 252' ' ' ASP . . . -79.11 151.88 31.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.655 0.264 . . . . 0.0 110.974 -178.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.576 HD23 ' N ' ' A' ' 257' ' ' ALA . 2.5 tt -102.91 142.99 33.09 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.576 ' N ' HD23 ' A' ' 256' ' ' LEU . . . -87.43 101.75 13.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.147 0.499 . . . . 0.0 110.451 178.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.986 HD21 HG21 ' A' ' 279' ' ' VAL . 84.0 mt -116.38 142.75 46.44 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.557 -177.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -124.13 162.57 23.3 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.109 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.505 HG22 ' HA ' ' A' ' 244' ' ' GLN . 43.6 t -66.59 125.46 23.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.38 -174.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 105.53 -11.92 46.88 Favored Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.074 176.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -84.8 175.44 9.15 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.932 0.366 . . . . 0.0 110.204 -174.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 48.4 mm -115.57 117.46 55.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.352 0.596 . . . . 0.0 110.982 -176.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.517 HG22 HD22 ' A' ' 258' ' ' LEU . 2.9 t -97.05 103.06 14.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.713 178.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -85.94 90.4 8.07 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.259 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.579 ' HA ' ' HA2' ' A' ' 277' ' ' GLY . 1.8 p -86.82 137.51 20.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.158 0.504 . . . . 0.0 110.582 -175.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 20.5 p -109.67 -35.73 6.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.527 -173.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 268' ' ' ARG . 1.0 OUTLIER -131.73 126.24 34.0 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.139 0.495 . . . . 0.0 109.683 179.407 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 57.9 mtt -106.3 116.64 32.28 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.935 0.398 . . . . 0.0 111.162 -178.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.531 ' HB2' ' O ' ' A' ' 274' ' ' GLN . 85.6 m-20 -78.68 121.46 24.72 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 175.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 47.2 mm -57.79 -24.96 24.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.173 -174.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -61.77 -32.28 72.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.411 -178.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 146.41 -44.45 0.84 Allowed Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.172 -1.013 . . . . 0.0 113.342 177.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.531 ' O ' ' HB2' ' A' ' 270' ' ' ASN . 0.1 OUTLIER -86.29 120.05 27.23 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.067 0.46 . . . . 0.0 110.608 -178.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.424 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 41.7 m0 -94.48 160.83 14.47 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.597 -177.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.494 ' HB3' ' HD2' ' A' ' 283' ' ' LYS . 39.3 mt-10 -106.59 105.84 16.07 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 173.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . 0.579 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -108.5 146.7 16.52 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.608 -178.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -102.03 108.54 20.01 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . 0.986 HG21 HD21 ' A' ' 258' ' ' LEU . 97.1 t -119.4 117.58 54.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.694 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . 0.453 HD22 ' N ' ' A' ' 280' ' ' ASN . 0.9 OUTLIER 62.86 30.82 16.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.549 -179.387 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 83.38 6.27 87.86 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.772 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . 0.412 ' NH1' ' H ' ' A' ' 257' ' ' ALA . 51.1 ttt180 -117.52 126.28 52.32 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.667 0.27 . . . . 0.0 110.759 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.567 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 27.2 ttpp -102.97 133.62 47.78 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.124 0.488 . . . . 0.0 111.035 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -153.98 171.02 32.63 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.625 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.424 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 64.0 mt -83.88 131.33 34.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.977 0.417 . . . . 0.0 111.027 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.402 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 23.9 p90 -142.34 144.37 30.79 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.777 175.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 1.8 Cg_endo -83.7 138.77 8.46 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.911 2.407 . . . . 0.0 111.661 176.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.4 ' HA ' HG22 ' A' ' 291' ' ' VAL . 41.5 p90 -65.54 -8.39 19.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.592 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 17.2 p -75.85 -9.34 58.52 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.52 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -104.97 -6.25 20.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.799 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.579 HG12 ' HA ' ' A' ' 242' ' ' ALA . 22.4 m -128.34 172.25 15.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.125 0.488 . . . . 0.0 111.173 -177.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -137.47 131.42 31.86 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.032 171.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.717 HD12 ' CG1' ' A' ' 238' ' ' VAL . 47.5 mm -73.39 134.47 29.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.731 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -138.03 151.68 48.11 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 174.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . 0.778 ' HB3' ' HD3' ' A' ' 296' ' ' PRO . 12.2 t70 -93.1 -58.48 0.22 Allowed Pre-proline 0 C--N 1.323 -0.586 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.026 -178.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . 0.778 ' HD3' ' HB3' ' A' ' 295' ' ' ASP . 9.6 Cg_endo . . . . . 0 C--N 1.357 0.983 0 C-N-CA 122.615 2.21 . . . . 0.0 112.779 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.414 ' O ' HG23 ' A' ' 99' ' ' ILE . 20.4 m . . . . . 0 CA--C 1.529 0.158 0 N-CA-C 110.307 -0.257 . . . . 0.0 110.307 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.15 102.66 3.09 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 177.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 25.6 mtm105 -122.35 3.35 9.73 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -175.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.45 ' HB3' ' HA ' ' A' ' 100' ' ' GLU . 17.0 p90 -83.13 150.42 26.27 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.917 -178.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -52.61 -43.85 65.65 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.479 -176.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.6 t 58.33 47.59 13.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.048 -172.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.7 t -171.97 -36.36 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.617 178.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -70.73 107.19 3.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.472 -175.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -60.43 -37.35 80.63 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.506 -175.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.5 t -72.87 -6.52 45.59 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.463 -177.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.86 -37.39 12.31 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -178.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 38.2 p-90 -122.58 -24.85 4.84 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -174.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -79.41 118.05 20.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.166 0.508 . . . . 0.0 110.687 -176.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.575 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 22.0 mmt -99.42 -10.08 22.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.894 -176.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.49 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.22 -113.47 2.27 Favored Glycine 0 CA--C 1.519 0.327 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.282 -178.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.49 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 19.4 Cg_exo -66.62 87.13 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.271 2.648 . . . . 0.0 113.161 -176.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.933 HG12 ' H ' ' A' ' 20' ' ' SER . 93.3 t -136.84 -166.58 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 178.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.933 ' H ' HG12 ' A' ' 19' ' ' VAL . 42.1 p -162.25 169.73 20.2 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 119.768 1.167 . . . . 0.0 108.122 -168.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 34.8 ttt85 -67.16 -39.37 86.5 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.739 -175.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -65.0 -53.83 39.96 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.88 0.372 . . . . 0.0 110.995 178.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -62.57 -47.22 84.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.356 -177.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.14 -38.58 71.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.117 0.484 . . . . 0.0 110.706 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -62.24 -57.74 10.33 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.655 178.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.8 t -65.73 -15.23 62.62 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -173.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.6 mtp180 -87.33 -13.52 43.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.589 0.233 . . . . 0.0 110.951 179.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.557 HD11 ' HG ' ' A' ' 37' ' ' LEU . 32.6 mt -130.43 -1.88 4.4 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 30.6 tp60 -73.91 96.0 2.55 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.216 0.531 . . . . 0.0 111.109 -174.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.13 14.09 69.97 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.146 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -81.58 -169.03 2.11 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 122.281 0.233 . . . . 0.0 110.752 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.604 ' HB2' ' SD ' ' A' ' 35' ' ' MET . 51.3 mtm180 -60.99 127.03 29.54 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 177.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.536 ' CE1' ' HA ' ' A' ' 55' ' ' ASN . 41.0 m170 -77.49 116.97 18.5 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.862 -176.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 129.33 -17.92 5.55 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -172.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.759 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 50.0 mtp -72.88 160.15 32.59 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 115.432 -0.384 . . . . 0.0 110.335 176.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.456 ' H ' ' HA ' ' A' ' 101' ' ' PRO . 43.3 p90 -163.98 169.23 18.29 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 178.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.575 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.6 pp -157.0 140.89 16.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.163 0.506 . . . . 0.0 111.183 175.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 50.8 t -108.92 123.0 64.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.261 175.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.44 ' HB2' ' HB ' ' A' ' 19' ' ' VAL . 33.3 ptt-85 -123.04 -177.83 3.79 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.013 -177.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -80.34 138.99 36.78 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 175.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.1 m -77.4 99.06 5.46 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 172.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.9 m -73.93 -9.62 58.83 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.247 178.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.3 p -83.53 -56.69 3.6 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.101 175.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 57.7 m -114.84 96.33 44.17 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.88 176.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.82 132.72 51.0 Favored 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 123.006 2.471 . . . . 0.0 112.618 -178.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.64 -27.14 17.55 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.389 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.59 ' OD1' ' HA ' ' A' ' 64' ' ' ASN . 33.1 m-20 -93.45 178.24 5.77 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -131.42 171.41 13.41 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 178.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.6 t -139.41 112.24 5.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.97 0.414 . . . . 0.0 110.999 175.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.403 ' CB ' HD11 ' A' ' 63' ' ' ILE . 51.0 tp -82.05 103.44 11.69 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.741 174.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 37.5 m -96.18 127.66 42.39 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 174.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 98.3 t -111.18 139.89 33.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.02 0.438 . . . . 0.0 111.038 -174.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.556 ' HB2' HD22 ' A' ' 28' ' ' LEU . 28.3 t -87.95 116.12 25.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.282 179.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.498 ' O ' ' N ' ' A' ' 56' ' ' SER . 75.8 mt-10 -144.46 178.4 7.97 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-O 118.379 -0.819 . . . . 0.0 108.832 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.624 ' C ' ' HB2' ' A' ' 57' ' ' ARG . 11.2 m-80 -24.11 65.46 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 126.934 2.094 . . . . 0.0 115.833 -176.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 54' ' ' GLU . 21.0 m 48.59 57.35 6.39 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -171.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.785 HH22 ' HA ' ' A' ' 154' ' ' GLU . 0.3 OUTLIER -162.05 58.24 0.25 Allowed 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.322 -1.308 . . . . 0.0 112.18 -145.641 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 11.2 t -74.5 97.91 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 122.058 0.933 . . . . 0.0 109.394 -172.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.565 ' HB2' ' CE2' ' A' ' 61' ' ' TYR . 0.1 OUTLIER -79.07 121.02 24.45 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 113.907 -1.497 . . . . 0.0 111.287 -175.456 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -98.05 108.34 21.02 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -173.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.565 ' CE2' ' HB2' ' A' ' 59' ' ' SER . 79.3 m-85 -110.18 107.42 17.22 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.04 178.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.578 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 53.3 mt -80.49 137.35 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -175.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.58 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 5.4 mp -116.47 117.69 56.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.728 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.59 ' HA ' ' OD1' ' A' ' 47' ' ' ASP . 13.7 m120 -87.3 139.73 30.26 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.863 -177.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.8 t -86.76 98.51 11.2 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 173.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 1.003 HD11 ' HG3' ' A' ' 72' ' ' LYS . 91.6 mt -80.78 146.66 60.55 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.346 -175.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 66' ' ' LEU . 11.9 Cg_exo -71.05 -2.19 10.69 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.743 2.295 . . . . 0.0 110.235 170.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -81.92 5.07 20.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.151 177.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.731 ' HE ' ' HA ' ' A' ' 69' ' ' ARG . 3.2 tpm_? 62.98 29.0 16.47 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.306 -173.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.452 ' HB2' HD12 ' A' ' 66' ' ' LEU . 88.7 mtt180 -128.63 179.17 5.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.402 -177.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.58 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 31.4 m-85 -134.92 119.76 18.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.19 -178.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 1.003 ' HG3' HD11 ' A' ' 66' ' ' LEU . 38.8 mttm -96.31 101.11 12.7 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -175.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.626 HD13 ' HE2' ' A' ' 88' ' ' TYR . 10.0 tt -83.37 99.11 5.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.405 0.622 . . . . 0.0 109.476 173.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.408 ' O ' ' HB3' ' A' ' 75' ' ' ASP . . . 62.8 44.31 97.65 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.428 -174.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.445 ' HA ' ' HD3' ' A' ' 72' ' ' LYS . 25.4 t70 75.61 -25.07 0.21 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.172 0.589 . . . . 0.0 111.915 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.69 107.79 4.1 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 174.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.497 ' HB3' ' CG ' ' A' ' 72' ' ' LYS . 12.7 pt-20 -96.23 137.87 34.66 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.887 0.851 . . . . 0.0 112.404 -171.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.595 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 96.6 m-85 -122.33 162.65 21.14 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 114.159 -1.382 . . . . 0.0 107.97 174.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.45 ' HA ' ' HG2' ' A' ' 70' ' ' ARG . 3.2 p-10 -69.55 -15.36 63.21 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -172.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.456 ' CE1' ' HB2' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -172.29 171.57 4.75 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.459 174.036 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.512 HD23 HD21 ' A' ' 84' ' ' LEU . 9.7 mt -53.32 -54.22 47.52 Favored Pre-proline 0 N--CA 1.469 0.511 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 81' ' ' LEU . 27.6 Cg_endo -63.21 3.56 0.56 Allowed 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.436 2.09 . . . . 0.0 114.176 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.456 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -98.46 -31.49 11.97 Favored 'General case' 0 C--N 1.331 -0.211 0 O-C-N 122.292 -0.255 . . . . 0.0 110.53 178.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.595 ' HB3' ' CD2' ' A' ' 78' ' ' PHE . 4.0 pp -76.42 -35.7 58.4 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 51.0 mt -68.54 -20.03 64.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.893 176.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -86.53 -28.41 23.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.619 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.711 ' HE1' ' CE1' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -88.41 -19.52 26.46 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.238 0.542 . . . . 0.0 111.167 -177.341 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.711 ' CE1' ' HE1' ' A' ' 87' ' ' PHE . 45.1 m-85 -87.33 2.33 50.6 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 121.19 -0.944 . . . . 0.0 110.659 177.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -74.97 -18.32 60.4 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.021 174.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.618 HD13 ' O ' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -127.02 -3.83 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 CA-C-O 121.174 0.512 . . . . 0.0 110.194 -179.306 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.4 ' HB2' ' O ' ' A' ' 87' ' ' PHE . 3.3 t60 -88.92 -32.76 17.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.848 -173.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.518 ' CD2' HG23 ' A' ' 97' ' ' THR . 95.5 m-85 61.86 106.25 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 O-C-N 124.119 0.887 . . . . 0.0 110.108 -171.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 13.0 mt -66.49 -85.51 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 174.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.418 ' OD1' ' ND2' ' A' ' 55' ' ' ASN . 14.5 t70 -79.9 -130.76 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 172.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.1 t -87.27 12.25 12.29 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.211 0.529 . . . . 0.0 110.164 177.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.9 t -143.03 160.34 40.55 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.585 -178.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.518 HG23 ' CD2' ' A' ' 92' ' ' TYR . 6.6 p -100.27 -179.7 4.2 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.119 175.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.7 mt -75.41 106.89 7.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.187 0.517 . . . . 0.0 109.779 175.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.414 HG23 ' O ' ' A' ' 3' ' ' SER . 46.4 mm -90.23 -65.21 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.503 -175.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.759 ' O ' ' HA ' ' A' ' 35' ' ' MET . 10.9 pt-20 -159.18 140.81 9.7 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.206 178.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.456 ' HA ' ' H ' ' A' ' 36' ' ' PHE . 38.3 Cg_endo -65.49 170.2 11.4 Favored 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.831 2.354 . . . . 0.0 112.984 -175.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.423 ' C ' ' H ' ' A' ' 104' ' ' ARG . . . -68.71 126.5 92.81 Favored Pre-proline 0 N--CA 1.447 -0.597 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 170.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -69.15 28.86 0.16 Allowed 'Trans proline' 0 N--CA 1.478 0.571 0 C-N-CA 123.461 2.774 . . . . 0.0 114.135 -169.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.423 ' H ' ' C ' ' A' ' 102' ' ' ALA . 41.0 ttm180 . . . . . 0 N--CA 1.464 0.255 0 C-N-CA 123.644 0.777 . . . . 0.0 111.056 -177.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.776 HD12 HG21 ' A' ' 152' ' ' ILE . 3.1 mm? . . . . . 0 CA--C 1.516 -0.347 0 CA-C-O 121.665 0.745 . . . . 0.0 109.493 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.526 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 39.9 tt0 -173.69 -60.07 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.303 -172.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -118.76 106.79 12.9 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 121.691 0.758 . . . . 0.0 110.524 177.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.876 HG22 ' HB3' ' A' ' 180' ' ' LYS . 20.9 t -115.68 134.97 57.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 114.375 -1.284 . . . . 0.0 108.771 -178.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.68 ' HG3' ' CG ' ' A' ' 179' ' ' GLU . 5.7 ptp180 -110.48 136.12 50.12 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 116.463 -2.095 . . . . 0.0 109.773 167.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.594 HG22 HG12 ' A' ' 178' ' ' VAL . 0.7 OUTLIER -93.57 142.21 27.6 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.711 -175.655 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.654 ' N ' HD22 ' A' ' 131' ' ' LEU . 2.0 mm? -115.04 -26.99 7.5 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.342 -165.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.513 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 37.1 t80 -89.36 -30.79 18.14 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.86 -172.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.604 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 8.8 t70 71.63 98.69 0.07 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.391 0.615 . . . . 0.0 109.545 -174.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.455 ' O ' ' HA ' ' A' ' 143' ' ' PRO . 53.7 t80 -123.9 84.07 54.67 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 177.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.622 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 66.7 Cg_endo -82.29 61.29 7.67 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.281 1.988 . . . . 0.0 112.894 -177.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -62.38 -29.8 74.35 Favored Glycine 0 C--N 1.331 0.301 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.589 178.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.46 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 10.0 m-80 64.03 65.39 0.69 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 114.861 -0.669 . . . . 0.0 112.143 176.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.479 ' HB3' ' H ' ' A' ' 140' ' ' GLU . 0.8 OUTLIER -145.72 169.49 18.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.908 177.019 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -89.41 -6.64 56.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.765 0.793 . . . . 0.0 109.253 172.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.479 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 11.6 mp0 -104.23 -19.76 14.01 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.575 175.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -135.38 107.69 7.28 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 1.058 HD11 ' HB2' ' A' ' 165' ' ' ASN . 33.1 tp -70.96 127.32 91.83 Favored Pre-proline 0 C--N 1.325 -0.465 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.745 -176.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.651 ' HD2' HD12 ' A' ' 142' ' ' LEU . 95.9 Cg_endo -81.7 93.71 0.95 Allowed 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 122.014 1.809 . . . . 0.0 111.367 172.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.514 ' CD1' ' HB ' ' A' ' 130' ' ' THR . 10.0 p90 -105.76 159.74 15.76 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.385 -174.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.604 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 56.5 mtpt -102.68 -169.0 1.6 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -175.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.574 ' HD2' ' N ' ' A' ' 146' ' ' LYS . 9.2 mptt -74.54 -13.49 60.68 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.154 -167.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -164.67 25.77 0.18 Allowed Glycine 0 CA--C 1.503 -0.692 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.32 -178.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.531 ' HB3' ' HB2' ' A' ' 145' ' ' LYS . 0.1 OUTLIER -79.54 148.28 31.84 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.001 0.429 . . . . 0.0 111.024 -177.458 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.516 HG13 ' HB3' ' A' ' 129' ' ' ARG . 1.8 mp -94.13 129.77 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.399 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.764 HD22 HD21 ' A' ' 142' ' ' LEU . 9.3 mt -121.47 156.95 31.67 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 -175.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.608 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 57.3 t -111.12 122.82 66.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 174.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 1.054 HD13 ' HB2' ' A' ' 163' ' ' ALA . 49.8 mm -76.78 79.91 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 122.344 1.069 . . . . 0.0 108.49 -177.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.529 HG23 ' HG3' ' A' ' 154' ' ' GLU . 18.1 tt -72.6 -25.89 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 113.551 -1.658 . . . . 0.0 110.113 -174.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.785 ' HA ' HH22 ' A' ' 57' ' ' ARG . 0.5 OUTLIER -140.88 153.36 45.68 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 173.85 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.413 ' HG3' ' CD1' ' A' ' 161' ' ' TRP . 79.3 tttt -140.85 91.98 8.94 Favored Pre-proline 0 C--N 1.32 -0.68 0 O-C-N 122.047 -0.408 . . . . 0.0 110.591 177.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.756 ' HG2' ' SD ' ' A' ' 172' ' ' MET . 2.8 Cg_endo -81.62 -39.85 0.17 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.573 2.182 . . . . 0.0 111.999 -174.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.43 ' HB2' ' HB2' ' A' ' 160' ' ' TRP . 46.2 mm-40 -114.66 161.86 17.55 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.38 -179.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -85.68 -7.87 58.54 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 173.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.992 ' HG3' ' HD1' ' A' ' 160' ' ' TRP . 21.0 pt20 -111.16 -17.69 13.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.728 178.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.992 ' HD1' ' HG3' ' A' ' 159' ' ' GLN . 47.5 m95 -131.78 131.55 43.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.397 178.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . 0.731 ' HB3' HD12 ' A' ' 152' ' ' ILE . 48.5 m0 -119.53 140.56 50.32 Favored 'General case' 0 C--O 1.212 -0.911 0 C-N-CA 122.877 0.471 . . . . 0.0 110.643 -176.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.591 ' OG ' ' HG2' ' A' ' 172' ' ' MET . 30.4 m -100.2 97.59 8.38 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -176.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 1.054 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -108.66 146.44 33.42 Favored 'General case' 0 N--CA 1.416 -2.129 0 C-N-CA 119.951 -0.7 . . . . 0.0 109.154 -173.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.692 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 19.9 ptt-85 -87.48 122.67 31.5 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 175.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 1.058 ' HB2' HD11 ' A' ' 142' ' ' LEU . 7.6 t30 -56.74 175.5 0.12 Allowed 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 113.572 -1.649 . . . . 0.0 110.282 -175.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -60.3 -13.48 13.06 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.322 0.582 . . . . 0.0 109.78 171.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -81.92 -26.43 34.07 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.005 174.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 100.69 -4.97 56.6 Favored Glycine 0 CA--C 1.521 0.421 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.112 -173.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.692 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.7 OUTLIER -69.05 134.31 49.24 Favored 'General case' 0 C--O 1.216 -0.71 0 C-N-CA 123.108 0.563 . . . . 0.0 110.903 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.499 HG22 HG21 ' A' ' 153' ' ' ILE . 39.3 t -86.75 128.07 39.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 O-C-N 122.049 -0.407 . . . . 0.0 110.969 178.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -154.08 154.72 25.7 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.122 170.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.756 ' SD ' ' HG2' ' A' ' 156' ' ' PRO . 29.5 mtp -81.11 141.05 34.66 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 117.284 0.542 . . . . 0.0 110.889 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.664 ' CG2' ' HB3' ' A' ' 142' ' ' LEU . 2.6 pp -141.4 143.14 29.01 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.558 -174.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.481 ' HB2' ' CD1' ' A' ' 177' ' ' TYR . 15.3 Cg_exo -67.7 135.91 37.31 Favored 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 122.739 2.293 . . . . 0.0 113.164 -178.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.54 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 98.1 t -64.54 -45.65 76.86 Favored Pre-proline 0 CA--C 1.539 0.519 0 N-CA-C 112.816 0.672 . . . . 0.0 112.816 178.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 36.1 Cg_endo -66.41 7.9 0.35 Allowed 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 122.022 1.815 . . . . 0.0 112.938 178.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.481 ' CD1' ' HB2' ' A' ' 174' ' ' PRO . 3.7 m-85 -101.05 -13.87 18.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.258 177.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.598 ' HA ' HD23 ' A' ' 131' ' ' LEU . 1.5 m -116.07 175.49 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 N-CA-C 115.956 1.836 . . . . 0.0 115.956 -166.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.734 ' O ' ' HG3' ' A' ' 179' ' ' GLU 0.273 2.0 pt-20 -149.09 57.69 1.02 Allowed 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 112.294 -2.23 . . . . 0.0 111.044 -165.699 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.876 ' HB3' HG22 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -69.36 141.7 54.13 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 118.748 -2.47 . . . . 0.0 111.768 -165.498 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.453 HD13 ' CZ ' ' A' ' 129' ' ' ARG . 32.7 tp . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 112.161 -2.291 . . . . 0.0 112.362 -162.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo . . . . . 0 N--CA 1.454 -0.809 0 N-CA-C 109.604 -0.96 . . . . 0.0 109.604 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.538 ' CG1' HD12 ' A' ' 293' ' ' ILE . 2.8 t -65.66 139.67 20.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.729 -169.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -106.16 121.56 44.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.994 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.508 ' HB1' ' HB ' ' A' ' 291' ' ' VAL . . . -119.26 136.57 54.16 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.36 179.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.425 ' HB2' ' CE1' ' A' ' 294' ' ' PHE . 2.8 tppp? -86.97 122.34 30.69 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 178.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . 0.532 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -72.43 97.02 1.99 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.154 0.502 . . . . 0.0 110.278 177.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 19.1 pt -85.59 -25.68 6.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.712 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.79 138.92 50.14 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.409 ' HE3' ' HB2' ' A' ' 245' ' ' LYS . 34.5 ttmt -67.61 155.81 38.28 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.2 -173.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 15.5 mmm180 -134.91 128.44 32.58 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.473 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.474 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 8.2 m -134.56 130.14 19.78 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.18 176.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.546 ' HD3' ' HB2' ' A' ' 257' ' ' ALA . 3.5 Cg_exo -75.5 145.51 29.87 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 123.059 2.506 . . . . 0.0 112.128 -176.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 51.1 t -75.12 169.98 16.95 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -61.68 -19.56 62.48 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -176.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -110.61 4.52 20.32 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -178.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . 0.544 ' HB3' ' HB3' ' A' ' 255' ' ' ALA . 61.7 m-20 -91.06 112.96 25.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.51 0.195 . . . . 0.0 111.054 -178.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . 0.444 ' N ' ' HD2' ' A' ' 253' ' ' LYS . 10.9 mptt -95.4 -41.3 9.06 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.272 0.558 . . . . 0.0 109.986 175.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 6.8 p -98.93 21.25 11.86 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.188 -174.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . 0.544 ' HB3' ' HB3' ' A' ' 252' ' ' ASP . . . -102.61 113.31 26.57 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 121.06 -0.256 . . . . 0.0 110.434 177.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.529 HD23 ' H ' ' A' ' 257' ' ' ALA . 0.5 OUTLIER -70.87 144.03 50.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.048 0.452 . . . . 0.0 110.965 -175.705 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.546 ' HB2' ' HD3' ' A' ' 248' ' ' PRO . . . -105.43 136.21 45.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.58 177.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 94.9 mt -135.88 152.16 50.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.799 -173.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -118.64 155.57 30.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.267 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 36.6 t -68.19 129.9 33.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.607 -174.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 83.32 33.92 21.64 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.316 178.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -119.28 162.67 18.34 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 39.2 mm -102.18 109.81 27.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.01 0.434 . . . . 0.0 110.78 -177.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 16.8 t -89.61 104.82 15.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.381 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . 0.424 ' HE2' ' HB3' ' A' ' 278' ' ' GLU . 4.4 ptmt -87.06 102.02 14.02 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.631 177.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.504 HG21 ' HB3' ' A' ' 275' ' ' TRP . 3.0 p -92.93 123.99 45.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.182 0.515 . . . . 0.0 110.723 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 16.1 p -94.98 -27.01 15.86 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.383 -177.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . 0.577 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 42.2 ttm180 -131.92 103.16 6.16 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.997 0.427 . . . . 0.0 110.394 178.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' MET . . . . . 0.48 ' HG3' ' CD1' ' A' ' 275' ' ' TRP . 29.6 ttm -93.97 109.87 21.58 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.992 0.425 . . . . 0.0 110.734 -179.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -87.78 173.93 8.68 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.502 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 31.3 pt -107.6 5.7 9.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.874 0.369 . . . . 0.0 111.523 -176.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -83.3 -26.28 30.78 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.124 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 119.18 -10.29 11.83 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.139 -177.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.558 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 27.1 mt-30 -118.06 111.97 19.6 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 177.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.59 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 19.2 m0 -96.74 159.55 14.86 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.117 -175.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.577 ' HB2' ' HB3' ' A' ' 268' ' ' ARG . 48.0 mt-10 -100.81 111.68 23.95 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.255 175.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . 0.574 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -129.15 158.58 22.08 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.533 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.424 ' HB3' ' HE2' ' A' ' 265' ' ' LYS . 39.6 tt0 -110.25 109.99 20.66 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.902 0.382 . . . . 0.0 110.155 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . 0.727 HG12 HD22 ' A' ' 280' ' ' ASN . 57.3 t -127.18 128.49 70.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.869 179.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . 0.727 HD22 HG12 ' A' ' 279' ' ' VAL . 46.2 m-80 63.03 25.59 15.07 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 123.442 0.464 . . . . 0.0 111.238 -177.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 75.52 19.49 79.25 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.059 -177.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . 0.403 ' NH1' ' HA ' ' A' ' 256' ' ' LEU . 1.4 tmt_? -129.73 117.36 20.16 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.574 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 25.1 pttm -103.68 142.4 34.39 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.803 -178.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -173.18 178.37 45.18 Favored Glycine 0 N--CA 1.439 -1.12 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.707 178.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.59 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 94.8 mt -81.09 130.55 35.07 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.766 0.317 . . . . 0.0 110.314 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -129.2 125.24 22.61 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.424 175.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -58.36 126.42 21.38 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 123.183 2.589 . . . . 0.0 111.787 174.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -64.75 -12.66 49.73 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.305 -174.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.19 -3.77 11.75 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -176.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -114.91 -2.65 12.83 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.023 -0.423 . . . . 0.0 111.212 -178.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.532 HG12 ' HA ' ' A' ' 242' ' ' ALA . 35.8 m -128.7 166.51 25.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.737 -0.21 . . . . 0.0 110.606 179.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? -131.34 132.49 44.5 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.716 0.293 . . . . 0.0 110.26 172.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.538 HD12 ' CG1' ' A' ' 238' ' ' VAL . 40.8 mm -76.61 125.29 36.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.116 177.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' PHE . . . . . 0.425 ' CE1' ' HB2' ' A' ' 241' ' ' LYS . 5.3 p90 -149.67 166.64 28.72 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -103.7 104.81 44.49 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 178.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo . . . . . 0 N--CA 1.459 -0.501 0 C-N-CA 122.883 2.388 . . . . 0.0 112.368 -179.261 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.8 m . . . . . 0 C--O 1.233 0.219 0 CA-C-O 120.865 0.364 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.558 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . 69.39 100.86 0.06 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.161 -176.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.432 HH11 ' HD3' ' A' ' 5' ' ' ARG . 3.4 ptp180 -125.87 81.33 1.98 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.433 0.635 . . . . 0.0 111.32 -177.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -147.98 157.56 43.59 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.74 177.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -85.88 9.51 16.55 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -171.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.0 m 65.54 -15.61 0.11 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 173.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.83 ' CA ' ' HE1' ' A' ' 14' ' ' TRP . 8.2 t -142.4 -71.02 0.33 Allowed 'General case' 0 C--O 1.246 0.919 0 CA-C-O 122.224 1.011 . . . . 0.0 110.82 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' A' ' 12' ' ' SER . 25.0 t0 -25.16 72.29 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 113.908 -1.497 . . . . 0.0 111.484 -148.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.68 ' H ' ' HD2' ' A' ' 11' ' ' ARG . 11.4 mmm180 -6.03 -53.37 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 126.437 2.335 . . . . 0.0 115.099 -159.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.5 ' N ' ' O ' ' A' ' 10' ' ' ASP . 6.0 t -65.49 12.84 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 121.548 -0.061 . . . . 0.0 110.912 176.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.492 ' O ' ' HG2' ' A' ' 101' ' ' PRO . . . -91.0 -29.71 17.22 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.187 177.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.83 ' HE1' ' CA ' ' A' ' 9' ' ' SER . 24.5 p-90 -151.49 -28.03 0.19 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -173.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -59.4 123.79 17.91 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -178.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.49 ' SD ' ' HA ' ' A' ' 104' ' ' ARG . 33.1 tpp -110.1 2.66 19.62 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.485 -171.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.53 ' O ' ' HB2' ' A' ' 39' ' ' ARG . . . 51.53 -104.85 0.17 Allowed Glycine 0 CA--C 1.524 0.619 0 O-C-N 123.592 0.557 . . . . 0.0 114.476 177.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.428 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 3.5 Cg_exo -78.25 110.13 2.81 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.783 2.322 . . . . 0.0 112.756 179.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.944 ' HB ' ' HG3' ' A' ' 39' ' ' ARG . 23.5 t -138.23 -73.1 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 119.421 -0.323 . . . . 0.0 111.636 177.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.478 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 69.9 m 79.93 -177.35 0.08 Allowed 'General case' 0 C--N 1.342 0.26 0 CA-C-N 117.781 0.264 . . . . 0.0 110.929 174.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -63.81 -49.61 72.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.549 0.214 . . . . 0.0 111.154 -171.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -59.89 -53.62 55.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.622 -173.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 57.9 mm-40 -64.07 -48.93 74.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.42 -178.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.02 -39.66 75.18 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.811 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.638 ' HA ' HG21 ' A' ' 58' ' ' VAL . 12.4 mm100 -70.06 -53.7 16.31 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -178.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.0 t -68.28 -27.14 66.06 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.007 0.432 . . . . 0.0 111.611 -173.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -87.46 -33.75 18.93 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.094 0.473 . . . . 0.0 110.87 -175.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.682 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 30.7 mt -106.33 28.17 8.01 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.616 -176.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.11 65.77 2.16 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.073 0.463 . . . . 0.0 111.941 -173.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 59.53 23.53 58.4 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.979 176.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -64.46 -81.67 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.681 0.277 . . . . 0.0 110.367 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.43 HH11 ' HD3' ' A' ' 32' ' ' ARG . 39.9 ttp-105 -107.34 132.57 52.99 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 173.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 67.2 m170 -81.74 110.64 17.25 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.026 0.441 . . . . 0.0 110.527 -179.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 137.25 -19.92 3.39 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.382 -175.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.732 ' HB2' ' HB3' ' A' ' 53' ' ' SER . 34.3 mtt -59.82 137.04 58.16 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 122.404 0.282 . . . . 0.0 111.169 176.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.575 ' CB ' HG22 ' A' ' 52' ' ' VAL . 22.0 p90 -146.78 158.27 43.87 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.941 173.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.498 ' O ' HD12 ' A' ' 37' ' ' LEU . 4.5 pp -151.66 143.0 23.42 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.574 173.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 84.2 t -114.65 120.58 64.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 176.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.944 ' HG3' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -134.51 169.22 17.6 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.714 -176.728 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.405 ' O ' ' HG2' ' A' ' 39' ' ' ARG . 1.8 m-20 -57.99 127.96 34.73 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 175.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.3 t -64.62 157.57 26.71 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.401 0.62 . . . . 0.0 111.895 -173.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.2 p -86.47 -11.01 52.98 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.4 177.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 32.7 p -88.62 -63.6 1.27 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.645 178.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.447 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 57.4 m -136.91 145.4 50.59 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.835 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 44' ' ' CYS . 21.8 Cg_exo -65.51 -28.09 53.74 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.765 2.31 . . . . 0.0 112.51 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -76.73 -6.17 84.63 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.121 -0.561 . . . . 0.0 112.317 178.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.49 ' OD1' ' HA ' ' A' ' 64' ' ' ASN . 46.1 m-20 -111.28 159.48 17.9 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 176.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -129.54 169.45 14.97 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 177.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.511 HG22 HG12 ' A' ' 62' ' ' ILE . 45.2 t -140.14 98.84 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.184 0.516 . . . . 0.0 111.144 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.8 tp -69.05 99.84 1.15 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.872 172.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.1 m -96.74 126.2 41.73 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 177.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.575 HG22 ' CB ' ' A' ' 36' ' ' PHE . 80.9 t -117.46 146.92 21.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.704 -176.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.732 ' HB3' ' HB2' ' A' ' 35' ' ' MET . 26.6 t -100.27 98.88 9.5 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 175.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.469 ' HB2' ' OD1' ' A' ' 94' ' ' ASP . 0.0 OUTLIER -144.35 156.39 44.22 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.727 -176.352 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.552 ' OD1' ' HE2' ' A' ' 155' ' ' LYS . 0.7 OUTLIER 66.56 -56.04 0.4 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.243 0.617 . . . . 0.0 112.652 -179.235 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.8 p 169.77 -6.95 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.721 0.809 . . . . 0.0 110.774 -175.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -134.68 -169.11 2.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.512 -175.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.638 HG21 ' HA ' ' A' ' 25' ' ' GLN . 26.2 t -114.55 104.92 17.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.504 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 75.1 m -84.0 119.34 24.82 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.551 0.691 . . . . 0.0 110.133 176.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -94.88 104.22 16.11 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.033 -175.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.81 ' HB3' HD11 ' A' ' 73' ' ' ILE . 57.6 m-85 -98.95 98.43 9.48 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.431 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.511 HG12 HG22 ' A' ' 49' ' ' VAL . 30.3 mt -80.75 130.93 35.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -174.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.617 HG13 ' HB ' ' A' ' 73' ' ' ILE . 4.0 mp -103.81 123.46 57.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.858 178.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.49 ' HA ' ' OD1' ' A' ' 47' ' ' ASP . 17.0 m120 -104.13 131.07 51.79 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -175.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.9 t -77.55 111.18 13.01 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 175.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.413 HD12 ' HB2' ' A' ' 70' ' ' ARG . 93.2 mt -77.15 143.69 70.24 Favored Pre-proline 0 C--N 1.318 -0.78 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 66' ' ' LEU . 52.3 Cg_exo -56.36 -22.33 41.11 Favored 'Trans proline' 0 CA--C 1.528 0.214 0 C-N-CA 122.888 2.392 . . . . 0.0 112.383 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.9 p30 -86.03 16.42 4.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.916 178.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.81 ' HE ' ' HA ' ' A' ' 69' ' ' ARG . 0.2 OUTLIER 66.73 35.38 5.15 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.008 174.172 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.413 ' HB2' HD12 ' A' ' 66' ' ' LEU . 97.6 mtt180 -114.4 171.03 7.87 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.096 173.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.493 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 36.6 m-85 -119.69 120.3 36.2 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.014 0.435 . . . . 0.0 110.753 179.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.897 ' HE2' ' HA ' ' A' ' 75' ' ' ASP . 88.0 tttt -114.48 103.74 11.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.867 -176.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.81 HD11 ' HB3' ' A' ' 61' ' ' TYR . 5.6 tt -92.71 111.69 24.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.279 0.561 . . . . 0.0 111.531 -175.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 57.25 51.15 59.29 Favored Glycine 0 C--N 1.329 0.183 0 CA-C-N 115.446 -0.797 . . . . 0.0 113.164 177.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.897 ' HA ' ' HE2' ' A' ' 72' ' ' LYS . 29.7 t70 72.04 -15.43 0.46 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.997 0.519 . . . . 0.0 111.872 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 46.3 tp60 -82.85 110.64 18.04 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.446 ' H ' ' HG2' ' A' ' 77' ' ' GLU . 7.1 pt-20 -87.82 127.82 35.33 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.026 -171.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -129.61 -179.86 5.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.066 177.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -76.71 -56.48 4.57 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.172 0.51 . . . . 0.0 110.843 177.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.569 ' ND1' ' HG2' ' A' ' 82' ' ' PRO . 2.4 p80 -147.08 177.8 8.88 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.519 -176.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.568 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 12.5 mt -59.49 -52.36 74.72 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -176.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.569 ' HG2' ' ND1' ' A' ' 80' ' ' HIS . 14.6 Cg_endo -60.65 -8.78 9.82 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 121.953 1.769 . . . . 0.0 113.197 177.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.92 -26.35 21.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.787 0.327 . . . . 0.0 110.485 -178.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.1 pp -91.1 -30.72 16.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.925 0.393 . . . . 0.0 110.082 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 95.0 mt -68.58 -33.9 74.86 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.253 178.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -71.83 -27.78 63.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.519 0.676 . . . . 0.0 110.376 175.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.523 ' O ' HG12 ' A' ' 90' ' ' ILE . 82.8 t80 -79.82 -37.02 36.01 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.806 -174.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.504 ' HE2' HD13 ' A' ' 73' ' ' ILE . 27.7 m-85 -74.16 0.59 13.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.795 0.331 . . . . 0.0 111.787 -178.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.403 ' HA ' ' HB ' ' A' ' 97' ' ' THR . 62.4 tttm -66.18 -25.35 66.9 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.34 168.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.523 HG12 ' O ' ' A' ' 87' ' ' PHE . 6.6 pt -88.21 -28.96 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 174.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.472 ' HB2' ' HD1' ' A' ' 88' ' ' TYR . 2.5 m170 -84.58 -24.44 29.21 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -172.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.612 ' HA ' ' HA ' ' A' ' 97' ' ' THR . 29.8 m-85 73.07 -7.61 1.46 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -179.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.667 HD22 ' CE2' ' A' ' 61' ' ' TYR . 14.3 mt 53.8 -25.67 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.586 1.554 . . . . 0.0 113.656 -169.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.555 ' H ' ' C ' ' A' ' 92' ' ' TYR . 2.9 p-10 -151.46 -51.92 0.12 Allowed 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 169.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.688 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 14.1 t -177.0 14.53 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.77 0.319 . . . . 0.0 110.745 -178.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.417 HG22 ' OD1' ' A' ' 94' ' ' ASP . 13.2 t -128.58 -29.38 2.41 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -173.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.612 ' HA ' ' HA ' ' A' ' 92' ' ' TYR . 16.4 p 70.18 166.0 0.28 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.995 1.318 . . . . 0.0 110.56 -171.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.49 ' CD2' HD11 ' A' ' 93' ' ' LEU . 21.3 mt -70.1 103.16 2.23 Favored 'General case' 0 C--O 1.221 -0.401 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 178.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.558 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 43.4 mm -87.81 -61.09 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.482 -175.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 101' ' ' PRO . 0.9 OUTLIER -148.43 154.82 42.13 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-O 120.994 0.426 . . . . 0.0 110.549 179.262 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.492 ' HG2' ' O ' ' A' ' 13' ' ' ALA . 16.9 Cg_exo -69.36 149.04 68.94 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.792 2.328 . . . . 0.0 112.092 177.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.48 153.42 93.77 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.577 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.87 136.4 69.74 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.561 2.174 . . . . 0.0 111.787 175.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.49 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 36.0 mtt180 . . . . . 0 C--N 1.327 -0.408 0 CA-C-O 121.235 0.54 . . . . 0.0 110.474 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.663 HD12 HG21 ' A' ' 152' ' ' ILE . 4.4 mm? . . . . . 0 CA--C 1.519 -0.238 0 CA-C-O 121.85 0.833 . . . . 0.0 112.861 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -173.27 -73.04 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.073 -1.421 . . . . 0.0 107.364 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.455 ' HB3' ' HB3' ' A' ' 181' ' ' LEU . 47.2 m-85 -109.64 139.21 44.94 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.081 -0.647 . . . . 0.0 110.643 177.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.489 ' CG1' ' HB ' ' A' ' 178' ' ' VAL . 5.3 t -135.29 161.5 39.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -178.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.491 ' CZ ' HD13 ' A' ' 181' ' ' LEU . 2.1 ptp180 -140.56 136.56 32.95 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 169.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 1.046 HG22 HG12 ' A' ' 178' ' ' VAL . 20.7 p -87.08 140.03 29.96 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.027 -174.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 13.1 mt -112.05 -31.66 6.82 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.245 -175.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -81.7 -31.78 31.98 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.432 -169.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.47 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 9.8 t70 69.02 110.4 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 O-C-N 123.627 0.58 . . . . 0.0 110.373 -173.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -141.85 101.5 5.9 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.877 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -94.42 90.69 0.12 Allowed 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 123.153 2.569 . . . . 0.0 112.44 176.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -89.86 -28.82 17.3 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.211 176.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 18.2 m120 63.11 83.97 0.15 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 114.695 -0.753 . . . . 0.0 112.232 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.774 ' HB3' ' HB3' ' A' ' 141' ' ' ASP . 31.9 t70 -160.66 178.06 9.86 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 177.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -92.83 -12.19 31.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.082 0.468 . . . . 0.0 110.929 178.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.55 ' O ' ' HB2' ' A' ' 172' ' ' MET . 5.0 mp0 -120.54 6.78 10.56 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 176.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.774 ' HB3' ' HB3' ' A' ' 138' ' ' ASP . 10.7 t70 -132.91 107.21 8.16 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 175.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.633 ' HB3' ' CG2' ' A' ' 173' ' ' ILE . 57.3 tp -82.25 112.92 40.02 Favored Pre-proline 0 C--N 1.323 -0.575 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.681 -173.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.54 ' HD2' ' HD2' ' A' ' 169' ' ' ARG . 28.6 Cg_endo -69.71 100.96 0.85 Allowed 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 121.998 1.799 . . . . 0.0 111.489 175.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.593 ' CG ' HG21 ' A' ' 130' ' ' THR . 13.0 p90 -115.61 168.7 9.78 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.047 0.451 . . . . 0.0 111.669 -176.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.554 ' HB2' ' HG2' ' A' ' 148' ' ' GLU . 1.4 mptp? -112.66 -169.93 1.57 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.32 -177.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.897 ' H ' ' HD2' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -87.56 3.96 45.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.226 0.536 . . . . 0.0 110.355 179.093 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.11 31.61 1.43 Allowed Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.157 -178.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.554 ' HG2' ' HB2' ' A' ' 145' ' ' LYS . 13.0 mm-40 -98.16 143.95 28.15 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.421 -0.215 . . . . 0.0 110.421 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.6 mp -102.6 132.69 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 175.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.636 ' HB3' ' HB1' ' A' ' 163' ' ' ALA . 11.1 mt -119.02 175.78 5.6 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -177.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.586 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 15.3 t -142.25 123.56 12.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.663 HG21 HD12 ' A' ' 125' ' ' LEU . 25.2 mm -78.91 79.79 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-O 122.404 1.097 . . . . 0.0 110.285 -174.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.503 HG23 ' HG3' ' A' ' 154' ' ' GLU . 19.4 tt -74.67 -35.76 38.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 113.452 -1.704 . . . . 0.0 110.418 -175.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 1.101 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 53.0 mt-10 -120.18 139.44 52.63 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 171.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.552 ' HE2' ' OD1' ' A' ' 55' ' ' ASN . 35.9 ttpt -132.25 81.89 59.8 Favored Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 122.037 -0.414 . . . . 0.0 110.058 170.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.688 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 11.7 Cg_exo -72.1 -46.36 0.54 Allowed 'Trans proline' 0 CA--C 1.515 -0.465 0 C-N-CA 122.43 2.086 . . . . 0.0 111.34 177.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -122.15 -178.94 4.0 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.265 -174.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -101.73 -22.25 14.45 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.302 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -89.14 -27.6 20.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.21 0.528 . . . . 0.0 110.5 -179.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.718 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 42.0 m95 -129.21 130.4 46.26 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.906 -179.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . 0.629 ' O ' HG13 ' A' ' 173' ' ' ILE . 54.2 m0 -123.12 137.58 54.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.704 178.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 1.101 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 16.2 m -84.46 106.37 15.99 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 176.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.636 ' HB1' ' HB3' ' A' ' 150' ' ' LEU . . . -116.9 162.27 18.01 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.279 -174.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.749 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 21.8 ptt-85 -109.93 127.78 54.96 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 175.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 0.6 ' HA ' HD22 ' A' ' 150' ' ' LEU . 19.7 p-10 -77.3 -174.06 3.11 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.999 -0.28 . . . . 0.0 111.205 -176.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -66.46 -25.8 66.9 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.237 0.541 . . . . 0.0 110.29 -177.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -70.72 -28.62 64.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.46 175.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 107.33 15.39 15.88 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.854 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.749 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 13.3 ttm-85 -92.86 134.3 35.22 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 122.779 0.431 . . . . 0.0 111.051 -176.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.557 HG22 ' HB3' ' A' ' 164' ' ' ARG . 60.0 t -99.18 136.89 28.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 120.848 0.356 . . . . 0.0 110.825 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -168.97 161.28 34.96 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 175.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.718 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.0 OUTLIER -69.26 132.56 46.66 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.897 0.348 . . . . 0.0 110.124 179.234 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.852 HD13 HG11 ' A' ' 178' ' ' VAL . 2.6 pp -134.12 144.0 49.58 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.645 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.483 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 5.2 Cg_exo -73.87 127.82 11.85 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.853 2.369 . . . . 0.0 111.688 -178.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.642 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 19.2 t -69.93 -35.33 5.16 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.642 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 11.3 Cg_endo -57.76 -16.83 26.82 Favored 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 121.832 1.688 . . . . 0.0 112.672 170.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.483 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.8 m-30 -87.33 -20.34 26.91 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.392 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 1.046 HG12 HG22 ' A' ' 130' ' ' THR . 4.8 m -118.83 174.66 4.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -168.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -140.62 166.83 23.67 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 173.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . . . . . . . . . 3.2 mppt? -94.76 138.68 32.27 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.119 0.485 . . . . 0.0 111.451 -176.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.491 HD13 ' CZ ' ' A' ' 129' ' ' ARG . 57.7 tp . . . . . 0 C--N 1.324 -0.521 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.34 175.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo . . . . . 0 N--CA 1.461 -0.423 0 CA-C-O 120.707 0.211 . . . . 0.0 111.594 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.661 HG11 HD12 ' A' ' 293' ' ' ILE . 41.1 t -91.23 129.39 42.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 120.908 0.385 . . . . 0.0 110.247 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -93.85 114.55 26.81 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.911 177.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.407 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -120.37 126.48 50.59 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.029 178.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -92.05 125.19 36.64 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . 0.601 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -71.52 114.77 9.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.038 0.447 . . . . 0.0 110.955 -176.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 23.1 pt -96.46 -20.28 5.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.672 -177.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -140.16 138.09 34.91 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -55.8 152.89 9.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.491 0.662 . . . . 0.0 112.596 -172.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.693 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -142.4 99.95 3.6 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 177.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 17.9 m -123.51 156.1 64.75 Favored Pre-proline 0 C--N 1.321 -0.672 0 C-N-CA 120.804 -0.359 . . . . 0.0 111.9 -174.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -66.0 132.83 31.33 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.116 2.544 . . . . 0.0 112.949 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 25.7 p -151.19 152.2 32.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.991 177.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 60.03 -78.43 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 O-C-N 124.197 0.936 . . . . 0.0 112.963 176.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . 0.618 ' HD1' ' H ' ' A' ' 253' ' ' LYS . 6.4 p90 -79.74 -32.63 41.15 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.175 -178.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 55.57 25.42 7.96 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.898 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . 0.618 ' H ' ' HD1' ' A' ' 251' ' ' TYR . 63.1 tttm -130.88 144.6 51.58 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -178.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . 0.41 HG23 ' HG2' ' A' ' 253' ' ' LYS . 27.0 p 60.77 15.4 5.86 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.716 0.806 . . . . 0.0 111.1 -175.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -102.12 102.43 12.89 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.154 -176.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.568 HD21 ' HB ' ' A' ' 279' ' ' VAL . 1.6 tt -83.95 123.38 29.91 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 176.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.693 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -79.43 93.18 5.33 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.185 0.517 . . . . 0.0 110.903 -178.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.815 HD21 HG21 ' A' ' 279' ' ' VAL . 65.7 mt -95.34 128.18 41.99 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.878 -178.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -101.94 148.13 25.71 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.22 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 57.5 t -63.94 127.56 24.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.009 0.433 . . . . 0.0 110.634 -177.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 103.21 -9.18 53.99 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.679 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -88.63 165.72 14.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.885 0.342 . . . . 0.0 110.339 -175.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 43.9 mm -107.5 132.11 55.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.826 -177.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.634 ' HA ' HG22 ' A' ' 279' ' ' VAL . 20.3 t -107.13 111.21 34.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.816 178.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -77.69 87.27 3.97 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.987 174.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.536 HG13 ' HB ' ' A' ' 238' ' ' VAL . 14.9 p -95.04 120.78 44.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.608 179.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 9.8 p -113.46 -16.72 12.38 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.891 -178.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . 0.567 ' HB2' ' HB3' ' A' ' 276' ' ' GLU . 16.1 mmm180 -121.98 100.28 6.89 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.566 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 55.6 mtt -95.49 116.35 28.7 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.967 0.413 . . . . 0.0 110.347 176.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.416 ' O ' ' HB ' ' A' ' 271' ' ' ILE . 78.8 m-20 -80.38 -6.73 58.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.915 -176.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.416 ' HB ' ' O ' ' A' ' 270' ' ' ASN . 48.1 mm 77.91 -39.52 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 123.537 0.735 . . . . 0.0 112.649 174.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . 0.745 HD21 ' HG2' ' A' ' 274' ' ' GLN . 22.7 p-10 -55.92 -37.92 69.56 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -177.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 150.82 -34.64 0.94 Allowed Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.622 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.745 ' HG2' HD21 ' A' ' 272' ' ' ASN . 2.4 pt20 -94.2 124.86 38.48 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 176.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.55 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 34.0 m0 -108.61 171.15 7.59 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 120.764 0.316 . . . . 0.0 111.243 -175.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.567 ' HB3' ' HB2' ' A' ' 268' ' ' ARG . 6.3 tp10 -112.93 100.24 8.49 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -178.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -119.54 145.69 17.97 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.872 -177.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.641 ' HB3' ' HG2' ' A' ' 283' ' ' LYS . 3.5 pt-20 -103.12 109.27 20.78 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.322 0.582 . . . . 0.0 109.765 176.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . 0.815 HG21 HD21 ' A' ' 258' ' ' LEU . 95.4 t -122.73 112.61 34.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.456 -173.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 59.14 20.25 8.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.412 172.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 127.63 -30.35 4.02 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.258 -0.972 . . . . 0.0 114.201 176.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . 0.402 ' HG2' ' N ' ' A' ' 283' ' ' LYS . 9.1 ttm105 -110.17 139.46 45.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 117.889 0.845 . . . . 0.0 111.578 -177.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.641 ' HG2' ' HB3' ' A' ' 278' ' ' GLU . 51.5 mttm -97.98 130.25 44.83 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 170.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . 0.527 ' HA3' ' HB2' ' A' ' 256' ' ' LEU . . . -152.94 162.47 30.07 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.263 -0.97 . . . . 0.0 112.65 -177.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.55 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 76.5 mt -85.35 115.71 23.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.13 0.49 . . . . 0.0 110.595 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.415 ' CZ ' HG11 ' A' ' 264' ' ' VAL . 16.7 p90 -122.82 129.37 25.03 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.132 178.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 18.8 Cg_exo -67.47 138.3 45.64 Favored 'Trans proline' 0 C--O 1.236 0.394 0 C-N-CA 122.435 2.09 . . . . 0.0 111.018 173.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -58.38 -22.17 52.82 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.065 -176.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 2.7 p -71.35 -1.49 13.11 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -178.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -100.03 -13.46 19.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.899 0.38 . . . . 0.0 110.396 177.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.601 HG12 ' HA ' ' A' ' 242' ' ' ALA . 30.7 m -128.31 177.78 5.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.634 -177.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -132.88 128.87 37.54 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.854 172.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.661 HD12 HG11 ' A' ' 238' ' ' VAL . 37.3 mm -78.63 128.02 38.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.691 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -141.31 151.42 43.6 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.787 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -99.14 129.43 29.47 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 175.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo . . . . . 0 CA--C 1.529 0.268 0 C-N-CA 122.975 2.45 . . . . 0.0 112.994 -178.19 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.545 ' HB2' HD12 ' A' ' 99' ' ' ILE . 8.7 p . . . . . 0 N--CA 1.452 -0.355 0 CA-C-O 120.651 0.262 . . . . 0.0 110.766 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.55 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . -69.74 98.82 1.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.775 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 5' ' ' ARG . 10.4 mmt85 -140.41 93.77 2.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.418 0.627 . . . . 0.0 111.566 -178.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -156.65 150.86 25.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.823 175.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.529 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 35.1 t0 -81.72 115.39 20.94 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 177.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.4 m -70.11 -12.73 61.81 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.743 -175.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.2 t -102.85 -12.32 17.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.239 0.542 . . . . 0.0 110.741 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.529 ' HB2' ' HB3' ' A' ' 7' ' ' ASP . 6.9 t70 -75.42 91.41 2.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.921 0.391 . . . . 0.0 110.05 -178.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -57.82 -39.13 76.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.545 -176.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.491 ' HA ' ' NH2' ' A' ' 104' ' ' ARG . 4.8 t -73.43 -1.55 18.76 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.159 -176.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.61 -44.47 8.58 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.356 176.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 29.9 p-90 -120.24 -21.2 7.05 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -171.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -77.58 122.83 25.81 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.102 0.477 . . . . 0.0 110.782 -176.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.542 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 25.0 mmt -104.53 -8.24 19.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.436 -175.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.447 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 50.89 -114.74 2.94 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-N 115.8 -0.636 . . . . 0.0 113.556 -176.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.447 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 11.3 Cg_exo -71.64 92.18 0.69 Allowed 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.948 2.432 . . . . 0.0 113.081 -176.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.467 HG21 ' HB3' ' A' ' 16' ' ' MET . 69.9 t -142.17 157.69 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 177.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.6 m -120.91 166.48 13.75 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -170.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 41.4 ttt85 -58.68 -48.98 79.26 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 123.04 0.213 . . . . 0.0 111.493 -177.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.469 ' H ' ' CD ' ' A' ' 22' ' ' GLN . 0.5 OUTLIER -60.59 -52.28 65.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.332 0.587 . . . . 0.0 110.767 -178.37 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -65.43 -47.62 75.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.261 -175.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.34 -38.65 71.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.488 0.661 . . . . 0.0 111.076 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.559 ' HA ' HG11 ' A' ' 58' ' ' VAL . 38.3 tt0 -72.66 -37.71 67.87 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.982 -174.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 10.2 t -75.08 -22.53 58.24 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 120.481 -0.487 . . . . 0.0 110.819 -178.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -81.26 -13.44 58.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.233 0.539 . . . . 0.0 110.583 177.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.577 ' O ' HG22 ' A' ' 58' ' ' VAL . 83.1 mt -126.11 16.25 7.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.486 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.35 77.67 3.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.087 0.47 . . . . 0.0 111.099 -174.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.63 16.75 72.25 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.678 -0.692 . . . . 0.0 113.067 177.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -64.41 -77.26 0.06 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.992 0.425 . . . . 0.0 110.39 -178.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.6 mtm180 -124.63 125.69 44.55 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 175.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 53.0 m170 -71.38 119.08 15.01 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.957 0.408 . . . . 0.0 110.478 -178.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 109.36 -8.77 32.92 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.749 -176.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.612 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 37.4 ttp -84.28 129.5 34.88 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -138.11 171.43 14.41 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.711 -172.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.567 ' HG ' HD11 ' A' ' 28' ' ' LEU . 4.6 pp -157.72 139.58 14.08 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.181 173.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.42 HG22 HD13 ' A' ' 50' ' ' LEU . 42.4 t -105.83 123.69 60.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 176.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.442 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 24.3 ptt-85 -124.67 -179.47 4.52 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.341 -176.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -78.5 135.55 37.37 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 175.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.7 t -78.41 118.37 20.52 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.123 -178.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.8 t -78.46 -15.56 58.49 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.314 172.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 25.5 m -73.69 -45.32 53.09 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.734 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.428 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 50.6 t -138.83 124.47 12.2 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.323 -178.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 44' ' ' CYS . 23.4 Cg_exo -64.63 114.56 2.78 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 123.067 2.511 . . . . 0.0 112.548 -178.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.62 -16.05 29.04 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.835 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.571 ' OD2' ' HA ' ' A' ' 64' ' ' ASN . 1.2 m-20 -93.35 177.89 5.89 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.563 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 38.6 m-85 -130.59 174.18 10.16 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 179.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.9 t -142.59 110.04 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.611 0.243 . . . . 0.0 110.418 175.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.42 HD13 HG22 ' A' ' 38' ' ' VAL . 36.7 tp -82.23 106.31 14.02 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.951 174.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 53.1 m -96.15 134.04 39.71 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 173.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.661 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 67.2 t -121.96 146.46 27.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.097 -177.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.576 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 12.9 t -94.74 106.53 18.52 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 174.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.667 ' O ' ' HB3' ' A' ' 57' ' ' ARG . 1.0 OUTLIER -147.06 138.75 24.24 Favored 'General case' 0 C--O 1.207 -1.166 0 C-N-CA 118.564 -1.254 . . . . 0.0 110.989 176.075 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.433 HD21 ' HB2' ' A' ' 94' ' ' ASP . 2.5 p30 37.66 47.48 0.82 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -175.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.5 m 58.47 44.33 18.2 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 122.279 1.038 . . . . 0.0 109.907 176.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.71 HH22 ' HA ' ' A' ' 154' ' ' GLU . 8.7 ttp180 -157.84 67.41 0.49 Allowed 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.705 -1.589 . . . . 0.0 110.71 -154.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.661 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 5.0 t -69.98 99.53 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.893 0.854 . . . . 0.0 108.901 -170.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.463 ' HB2' ' CE2' ' A' ' 61' ' ' TYR . 7.9 m -84.19 122.58 29.06 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 113.799 -1.546 . . . . 0.0 111.157 -172.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 60.0 m-70 -93.39 101.95 14.18 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.968 0.413 . . . . 0.0 111.982 -174.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.8 ' HB3' HD11 ' A' ' 73' ' ' ILE . 65.1 m-85 -99.91 105.42 17.14 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.805 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.82 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 61.6 mt -80.7 129.53 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -173.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.587 HG13 ' HB ' ' A' ' 73' ' ' ILE . 3.8 mp -98.8 119.09 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.129 0.572 . . . . 0.0 110.424 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.616 ' O ' ' HA ' ' A' ' 71' ' ' PHE . 4.3 m120 -89.25 139.44 30.49 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.405 -169.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.1 t -88.34 92.06 9.03 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 171.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.683 HD12 ' HG3' ' A' ' 70' ' ' ARG . 84.8 mt -79.83 138.96 53.77 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.576 -178.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.99 -7.98 16.85 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.949 2.433 . . . . 0.0 112.118 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -90.21 20.22 4.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.758 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.605 ' HE ' ' HA ' ' A' ' 69' ' ' ARG . 0.3 OUTLIER 65.78 30.52 10.09 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.247 0.546 . . . . 0.0 111.089 177.362 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.683 ' HG3' HD12 ' A' ' 66' ' ' LEU . 3.8 ptp180 -138.66 -177.03 4.69 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.444 -178.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.616 ' HA ' ' O ' ' A' ' 64' ' ' ASN . 47.8 m-85 -124.06 157.87 33.51 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.264 -178.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.587 ' HB2' HD11 ' A' ' 66' ' ' LEU . 35.1 ttpt -138.69 100.49 4.09 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 175.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.82 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 3.9 tt -89.28 108.25 18.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.442 0.639 . . . . 0.0 110.666 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.09 37.88 94.69 Favored Glycine 0 C--N 1.321 -0.265 0 CA-C-N 115.175 -0.921 . . . . 0.0 112.366 176.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.407 ' HA ' ' HE3' ' A' ' 72' ' ' LYS . 17.5 t70 77.75 6.2 2.84 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.607 0.763 . . . . 0.0 111.501 178.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -102.73 123.39 46.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.867 0.365 . . . . 0.0 110.308 171.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -94.04 134.38 36.52 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.697 0.761 . . . . 0.0 112.102 -175.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.57 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 51.0 m-85 -136.43 170.28 16.3 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 172.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -70.68 -54.66 11.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.136 0.493 . . . . 0.0 111.182 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.552 ' ND1' ' HG2' ' A' ' 82' ' ' PRO . 3.0 p80 -144.31 172.65 12.64 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.624 -174.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.622 HD23 HD21 ' A' ' 84' ' ' LEU . 16.2 mt -55.18 -52.75 68.71 Favored Pre-proline 0 N--CA 1.469 0.514 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.552 ' HG2' ' ND1' ' A' ' 80' ' ' HIS . 19.5 Cg_endo -60.52 -3.41 2.56 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.316 2.011 . . . . 0.0 113.597 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.37 -36.45 10.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.723 0.297 . . . . 0.0 110.896 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.622 HD21 HD23 ' A' ' 81' ' ' LEU . 4.4 pp -76.51 -34.84 58.59 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.048 0.451 . . . . 0.0 110.154 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 78.0 mt -62.22 -33.31 74.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.122 176.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.632 ' HA ' ' HD3' ' A' ' 89' ' ' LYS . 20.0 tp10 -73.9 -37.4 64.67 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.506 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.436 ' CD2' ' HZ ' ' A' ' 78' ' ' PHE . 23.1 t80 -64.28 -37.61 88.09 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.124 0.487 . . . . 0.0 110.67 177.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.698 ' HE2' HD13 ' A' ' 73' ' ' ILE . 36.1 m-85 -79.16 -6.52 56.74 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.92 0.39 . . . . 0.0 111.759 -178.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.632 ' HD3' ' HA ' ' A' ' 86' ' ' GLU . 53.7 mtpt -83.81 -8.56 59.19 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.384 172.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 21.8 pt -128.23 9.42 3.01 Favored 'Isoleucine or valine' 0 C--N 1.342 0.26 0 CA-C-O 121.549 0.69 . . . . 0.0 109.604 174.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.433 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 3.3 t-160 -95.02 -47.2 6.5 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.244 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.447 ' H ' HG22 ' A' ' 97' ' ' THR . 95.3 m-85 62.77 88.33 0.1 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.028 -161.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.612 ' O ' ' HB3' ' A' ' 154' ' ' GLU . 13.7 mt -46.37 -65.14 0.6 Allowed 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 177.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.575 ' HB3' ' HG3' ' A' ' 54' ' ' GLU . 13.7 p-10 -98.86 -120.36 0.14 Allowed 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.249 172.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.551 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 4.6 t -94.11 6.15 49.49 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-O 120.963 0.411 . . . . 0.0 109.989 176.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.403 HG22 ' OD1' ' A' ' 94' ' ' ASP . 8.3 t -141.26 164.58 29.86 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.085 0.469 . . . . 0.0 110.706 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.447 HG22 ' H ' ' A' ' 92' ' ' TYR . 9.1 p -99.61 174.53 6.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.62 178.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 82.3 mt -68.42 107.06 2.73 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 173.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.55 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 49.2 mm -91.55 -58.73 3.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.792 -174.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.612 ' O ' ' HA ' ' A' ' 35' ' ' MET . 11.9 pt-20 -159.02 153.23 19.97 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.176 -178.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.34 163.31 39.03 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 122.668 2.245 . . . . 0.0 113.364 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.457 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -83.11 158.39 64.41 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.803 178.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -66.91 136.39 41.32 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.315 2.01 . . . . 0.0 111.151 173.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.535 ' HG2' ' SD ' ' A' ' 16' ' ' MET . 87.6 mtt180 . . . . . 0 C--N 1.328 -0.353 0 CA-C-O 120.815 0.34 . . . . 0.0 110.787 178.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.681 HD12 HG21 ' A' ' 152' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.485 1.278 0 N-CA-C 102.41 -3.182 . . . . 0.0 102.41 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.719 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 4.9 tp10 74.19 -73.23 0.1 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 118.501 0.591 . . . . 0.0 110.759 175.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -101.33 107.44 18.8 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 118.848 -1.141 . . . . 0.0 111.494 -176.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 1.054 HG22 ' HG3' ' A' ' 180' ' ' LYS . 97.3 t -124.87 136.37 61.02 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.078 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.298 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.65 ' CZ ' HD13 ' A' ' 181' ' ' LEU . 0.0 OUTLIER -111.18 151.37 28.29 Favored 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 117.376 -1.73 . . . . 0.0 108.33 167.925 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.597 ' OG1' ' HB2' ' A' ' 144' ' ' PHE . 0.9 OUTLIER -107.77 134.26 50.98 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.882 0.849 . . . . 0.0 111.234 179.379 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.57 HD21 ' HG2' ' A' ' 179' ' ' GLU . 10.5 mt -110.21 2.39 19.28 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.61 -176.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.523 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 24.2 t80 -105.2 -39.62 6.13 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.103 -0.639 . . . . 0.0 112.614 -174.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.588 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 8.6 t70 79.05 98.47 0.06 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.444 0.64 . . . . 0.0 109.973 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 69.4 t80 -126.32 91.65 47.26 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 173.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.742 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 70.8 Cg_endo -86.24 83.61 1.22 Allowed 'Trans proline' 0 N--CA 1.442 -1.549 0 C-N-CA 121.675 1.583 . . . . 0.0 112.808 -178.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -76.58 -31.19 54.97 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.092 175.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.424 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 20.9 m120 63.46 49.85 3.02 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.247 0.546 . . . . 0.0 111.34 176.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.457 ' HB3' ' H ' ' A' ' 140' ' ' GLU . 1.2 m-20 -135.24 177.44 7.81 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.779 176.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 170' ' ' VAL . . . -91.57 -10.96 38.65 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.674 0.75 . . . . 0.0 109.583 172.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.692 ' O ' ' HB2' ' A' ' 172' ' ' MET . 45.3 mt-10 -109.23 -2.83 17.68 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.066 176.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.41 ' HB2' ' HB2' ' A' ' 138' ' ' ASP . 29.5 m-20 -143.5 100.96 3.7 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 174.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 1.02 HD11 ' HB2' ' A' ' 165' ' ' ASN . 52.9 tp -70.6 132.1 87.57 Favored Pre-proline 0 CA--C 1.51 -0.581 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.351 -175.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.854 ' HD2' HD12 ' A' ' 142' ' ' LEU . 73.2 Cg_endo -83.07 93.53 0.85 Allowed 'Trans proline' 0 N--CA 1.436 -1.885 0 C-N-CA 120.931 1.088 . . . . 0.0 111.761 170.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.597 ' HB2' ' OG1' ' A' ' 130' ' ' THR . 17.2 p90 -102.78 164.18 11.78 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.957 ' H ' ' HG3' ' A' ' 148' ' ' GLU . 2.9 mptp? -114.57 -148.51 0.43 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.119 0.485 . . . . 0.0 111.769 -171.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.789 ' H ' ' HD2' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -109.44 41.29 1.69 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.256 -179.648 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 147.89 28.88 0.07 OUTLIER Glycine 0 CA--C 1.525 0.716 0 C-N-CA 120.723 -0.751 . . . . 0.0 113.435 177.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.957 ' HG3' ' H ' ' A' ' 145' ' ' LYS . 0.0 OUTLIER -80.83 172.78 13.31 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 123.871 0.868 . . . . 0.0 109.732 171.319 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.637 HD12 ' HB3' ' A' ' 129' ' ' ARG . 0.6 OUTLIER -115.92 129.28 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.584 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.746 HD22 HD21 ' A' ' 142' ' ' LEU . 27.0 mt -120.76 157.27 30.07 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -173.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.719 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 70.7 t -130.78 123.15 53.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.577 177.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 1.063 HD13 ' HB2' ' A' ' 163' ' ' ALA . 40.8 mm -75.91 84.36 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 122.109 0.957 . . . . 0.0 109.706 -172.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.534 ' C ' HH12 ' A' ' 57' ' ' ARG . 14.0 tt -87.42 -31.89 6.08 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 CA-C-N 114.043 -1.435 . . . . 0.0 111.605 -169.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.71 ' HA ' HH22 ' A' ' 57' ' ' ARG . 10.8 mt-10 -122.49 142.27 50.76 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 164.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.464 ' NZ ' HD21 ' A' ' 125' ' ' LEU . 74.5 tttt -137.43 87.6 17.73 Favored Pre-proline 0 C--N 1.316 -0.86 0 CA-C-O 121.314 0.578 . . . . 0.0 110.627 176.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.496 ' HG2' ' HE2' ' A' ' 172' ' ' MET . 17.5 Cg_exo -71.24 -54.52 0.16 Allowed 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.683 2.255 . . . . 0.0 111.826 170.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.423 ' HG2' ' HB2' ' A' ' 156' ' ' PRO . 6.5 mm-40 -112.53 -176.58 2.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.815 -169.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -109.87 -8.9 14.82 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.231 173.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -96.13 -32.28 12.58 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.513 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.426 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 28.7 m95 -127.19 144.02 51.13 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.082 174.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . 0.917 ' HB3' HD12 ' A' ' 152' ' ' ILE . 20.7 m0 -126.71 139.92 52.79 Favored 'General case' 0 C--O 1.213 -0.835 0 CA-C-O 121.032 0.444 . . . . 0.0 111.126 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.577 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 19.6 m -97.51 94.55 7.08 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -175.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 1.063 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -109.18 152.25 25.4 Favored 'General case' 0 N--CA 1.428 -1.574 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.135 -173.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.85 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 27.5 ptt-85 -87.42 123.82 32.76 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 172.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 1.02 ' HB2' HD11 ' A' ' 142' ' ' LEU . 66.1 t30 -59.01 -178.2 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.259 -1.337 . . . . 0.0 110.957 -172.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.642 ' HB2' ' HB2' ' A' ' 148' ' ' GLU . 37.8 tttp -66.77 -12.15 57.64 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.222 168.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -73.59 -21.25 60.39 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.412 167.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 77.47 35.13 37.92 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.005 -168.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.85 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 2.9 ttm-85 -113.47 137.65 51.24 Favored 'General case' 0 C--O 1.213 -0.845 0 C-N-CA 122.779 0.431 . . . . 0.0 110.937 -176.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.515 HG22 HG21 ' A' ' 153' ' ' ILE . 38.9 t -78.17 128.98 38.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 118.146 0.43 . . . . 0.0 111.777 -177.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -164.49 155.95 27.61 Favored Glycine 0 C--N 1.339 0.708 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.612 167.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.692 ' HB2' ' O ' ' A' ' 140' ' ' GLU . 0.6 OUTLIER -74.95 142.83 43.9 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 117.144 0.472 . . . . 0.0 111.291 178.817 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.768 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.4 pp -143.67 141.04 18.08 Favored Pre-proline 0 N--CA 1.452 -0.336 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.715 -176.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.436 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 18.5 Cg_exo -66.38 127.09 16.7 Favored 'Trans proline' 0 C--N 1.34 0.125 0 C-N-CA 122.468 2.112 . . . . 0.0 112.546 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.629 ' O ' HG22 ' A' ' 178' ' ' VAL . 96.2 t -61.94 -40.99 73.84 Favored Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 11.5 Cg_endo -56.88 -15.81 18.13 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 121.974 1.783 . . . . 0.0 113.221 175.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.436 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.2 m-30 -88.71 -8.04 55.23 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -177.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.662 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 3.3 m -105.59 -170.89 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 115.896 1.813 . . . . 0.0 115.896 -164.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.58 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 7.7 tp10 -159.89 49.98 0.3 Allowed 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 112.956 -1.929 . . . . 0.0 112.705 -152.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 1.054 ' HG3' HG22 ' A' ' 128' ' ' VAL . 3.5 mppt? -69.89 135.77 49.91 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 119.583 -1.948 . . . . 0.0 111.246 -161.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.65 HD13 ' CZ ' ' A' ' 129' ' ' ARG . 16.5 tp . . . . . 0 N--CA 1.463 0.22 0 CA-C-N 112.956 -1.929 . . . . 0.0 113.582 -163.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo . . . . . 0 N--CA 1.459 -0.533 0 N-CA-C 111.031 -0.411 . . . . 0.0 111.031 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.466 ' HB ' ' CG1' ' A' ' 266' ' ' VAL . 2.5 t -75.9 138.13 21.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.415 -175.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -112.57 121.29 44.36 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.784 0.326 . . . . 0.0 110.927 -178.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -120.15 137.8 53.96 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.636 177.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.5 ' HB2' ' CE1' ' A' ' 294' ' ' PHE . 11.6 tppt? -80.94 123.53 28.39 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.656 177.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -75.45 102.9 5.36 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 174.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 290' ' ' HIS . 18.6 pt -88.15 -7.17 10.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.245 0.545 . . . . 0.0 110.783 -176.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.573 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 2.3 tt0 -138.66 142.89 39.03 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.231 175.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.479 ' HE3' ' OE2' ' A' ' 259' ' ' GLU . 1.5 ptpp? -68.65 174.16 4.5 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 174.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.833 ' HG3' ' HE1' ' A' ' 290' ' ' HIS . 0.0 OUTLIER -166.57 136.43 3.15 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.187 -179.77 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 24.6 m -127.8 150.29 72.9 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.304 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.546 ' HD3' ' HB2' ' A' ' 257' ' ' ALA . 58.0 Cg_endo -72.41 149.08 49.83 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.477 2.118 . . . . 0.0 112.631 -179.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' CYS . . . . . 0.56 ' HB3' ' HB2' ' A' ' 252' ' ' ASP . 25.0 t -95.95 165.97 12.01 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 177.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -55.3 -39.77 70.3 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.114 0.483 . . . . 0.0 111.446 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -102.43 15.74 28.34 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.167 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . 0.56 ' HB2' ' HB3' ' A' ' 249' ' ' CYS . 1.7 m-20 -124.6 85.59 2.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.039 0.447 . . . . 0.0 110.334 177.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -86.56 -22.85 26.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.876 -179.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 4.0 p -89.87 5.01 48.13 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.259 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . 0.45 ' HB2' ' HB3' ' A' ' 252' ' ' ASP . . . -82.57 109.43 16.76 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.565 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.427 ' HA ' ' NH1' ' A' ' 282' ' ' ARG . 0.6 OUTLIER -66.0 137.34 57.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.456 -177.524 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.546 ' HB2' ' HD3' ' A' ' 248' ' ' PRO . . . -98.18 129.13 44.96 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.673 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 84.2 mt -136.71 162.51 32.98 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.512 -174.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.479 ' OE2' ' HE3' ' A' ' 245' ' ' LYS . 65.7 mm-40 -127.26 165.79 18.99 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 172.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 62.1 t -70.71 123.04 23.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.145 0.498 . . . . 0.0 110.956 -178.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 107.81 0.48 34.23 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.201 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -84.73 142.98 29.46 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.003 0.43 . . . . 0.0 110.713 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 48.6 mm -100.02 110.12 26.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.084 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 33.3 t -86.4 109.45 18.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.689 -177.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 27.8 tttm -84.46 94.67 8.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.923 175.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.466 ' CG1' ' HB ' ' A' ' 238' ' ' VAL . 3.6 p -93.32 117.56 37.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.33 0.586 . . . . 0.0 110.454 -178.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 1.2 p -95.9 -35.21 11.54 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.615 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 268' ' ' ARG . 13.0 ttp180 -115.89 122.12 44.4 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 177.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 32.4 mtt -106.49 125.08 50.55 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.189 0.519 . . . . 0.0 110.981 178.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 274' ' ' GLN . 87.6 m-20 -89.69 134.04 34.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.767 -179.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 2.3 pp -74.45 9.5 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -173.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . 0.971 HD21 ' HG2' ' A' ' 274' ' ' GLN . 1.7 p-10 -97.95 -24.55 15.33 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 122.299 -0.25 . . . . 0.0 111.172 -178.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 135.4 -37.25 1.94 Allowed Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.151 -1.023 . . . . 0.0 113.222 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.971 ' HG2' HD21 ' A' ' 272' ' ' ASN . 18.9 pt20 -95.6 118.27 31.99 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 177.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.456 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 20.3 m0 -95.2 166.95 11.66 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.293 -173.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -99.64 99.09 9.89 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.106 -178.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -108.74 153.26 16.87 Favored Glycine 0 C--O 1.224 -0.528 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.382 -175.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.672 ' HG2' ' HE2' ' A' ' 283' ' ' LYS . 21.2 mt-10 -119.83 108.46 14.41 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -178.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 50.9 t -138.05 132.64 43.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.613 -176.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 64.14 24.07 13.35 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.975 0.417 . . . . 0.0 110.965 176.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 86.47 -2.88 87.44 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.272 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . 0.427 ' NH1' ' HA ' ' A' ' 256' ' ' LEU . 0.6 OUTLIER -117.57 131.48 56.68 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.956 0.408 . . . . 0.0 109.937 -176.503 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.672 ' HE2' ' HG2' ' A' ' 278' ' ' GLU . 15.7 ptpt -113.08 142.32 45.88 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.977 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -168.04 -174.24 36.74 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.481 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.456 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 86.0 mt -88.05 136.04 33.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.245 0.545 . . . . 0.0 111.92 -177.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -138.94 127.86 14.06 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.979 174.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . 0.505 ' HD2' ' NE2' ' A' ' 290' ' ' HIS . 11.6 Cg_exo -73.48 151.35 47.53 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.925 2.417 . . . . 0.0 111.78 175.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -73.08 -1.6 18.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.135 0.493 . . . . 0.0 111.765 -178.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 3.4 m -64.63 -42.21 95.63 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.731 -176.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . 0.833 ' HE1' ' HG3' ' A' ' 246' ' ' ARG . 0.3 OUTLIER -110.63 12.31 22.7 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -174.852 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 22.3 m -129.33 149.94 34.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 172.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' A' ' 292' ' ' LYS . 44.3 mmtm -139.36 136.12 34.43 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.738 0.304 . . . . 0.0 110.559 177.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 1.1 mp -76.85 141.39 15.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.89 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 294' ' ' PHE . . . . . 0.537 ' CE2' ' HA ' ' A' ' 296' ' ' PRO . 7.9 p90 -154.87 176.53 12.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.2 -179.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -91.47 104.28 9.63 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 173.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . 0.537 ' HA ' ' CE2' ' A' ' 294' ' ' PHE . 26.3 Cg_endo . . . . . 0 C--N 1.344 0.323 0 C-N-CA 122.326 2.017 . . . . 0.0 112.776 -173.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.7 m . . . . . 0 N--CA 1.461 0.112 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -78.98 78.92 5.4 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.258 0.551 . . . . 0.0 110.28 177.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 18.7 tpp180 -99.61 86.79 3.41 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.357 0.598 . . . . 0.0 110.503 -176.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -167.52 143.39 4.08 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.991 -1.004 . . . . 0.0 108.798 175.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -72.48 -9.37 58.46 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -173.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.4 t 73.19 -29.52 0.2 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.267 0.627 . . . . 0.0 112.086 175.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.0 t -102.6 -19.21 14.92 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 122.067 -0.395 . . . . 0.0 111.016 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -67.09 104.05 1.33 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.979 0.419 . . . . 0.0 111.003 -176.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -60.75 -37.67 82.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.872 -175.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.5 m -69.17 -5.47 22.73 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.802 -177.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.33 -47.52 6.57 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.895 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.518 ' HB3' ' HB3' ' A' ' 101' ' ' PRO . 41.9 p-90 -119.72 -20.46 7.64 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -169.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -72.16 108.43 5.33 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.131 0.491 . . . . 0.0 110.455 -175.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.647 ' SD ' ' HA ' ' A' ' 104' ' ' ARG . 9.2 tpp -90.84 -4.79 56.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.868 -174.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 50.02 -114.57 2.53 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-N 115.243 -0.89 . . . . 0.0 114.344 176.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -74.4 83.19 1.73 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.04 2.493 . . . . 0.0 113.368 -174.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.623 HG12 ' H ' ' A' ' 20' ' ' SER . 98.4 t -135.92 177.08 6.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.623 ' H ' HG12 ' A' ' 19' ' ' VAL . 57.3 p -149.36 177.53 9.59 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -168.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.5 ttt85 -63.69 -39.6 94.71 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.784 178.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 35.5 mm-40 -61.87 -64.02 1.07 Allowed 'General case' 0 C--O 1.235 0.318 0 O-C-N 123.38 0.425 . . . . 0.0 110.754 176.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.471 ' O ' ' HB ' ' A' ' 26' ' ' THR . 8.1 tp10 -56.77 -47.78 79.36 Favored 'General case' 0 C--O 1.217 -0.658 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.467 -176.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.437 ' HB2' ' HD3' ' A' ' 39' ' ' ARG . . . -57.69 -42.01 82.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.96 0.41 . . . . 0.0 111.79 -177.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.454 ' NE2' ' HG2' ' A' ' 29' ' ' GLN . 23.1 tm0? -68.11 -32.52 72.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.55 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.471 ' HB ' ' O ' ' A' ' 23' ' ' GLU . 4.2 m -65.23 -43.4 91.55 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.661 176.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.443 ' HG2' ' O ' ' A' ' 23' ' ' GLU . 42.0 mmm-85 -72.85 -20.75 61.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.518 -173.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.62 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 88.6 mt -126.83 17.4 7.37 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.059 -171.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.454 ' HG2' ' NE2' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -69.49 76.53 0.4 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.476 0.655 . . . . 0.0 109.475 178.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.7 -66.72 3.86 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.4 -176.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 27.55 -99.12 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.208 1.003 . . . . 0.0 112.536 -166.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.578 ' HB2' ' SD ' ' A' ' 35' ' ' MET . 47.6 mtm105 -112.76 -6.77 13.84 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -176.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 49.7 m170 67.49 155.12 0.1 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.229 0.538 . . . . 0.0 111.132 -175.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.14 10.87 84.28 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 121.085 -0.578 . . . . 0.0 111.824 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.606 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 41.4 mtp -103.97 145.82 29.59 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -177.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.457 ' CG ' HD22 ' A' ' 98' ' ' LEU . 33.5 p90 -146.26 164.32 32.68 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.694 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.542 ' HG ' HD11 ' A' ' 28' ' ' LEU . 4.3 pp -152.72 137.16 16.72 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.847 174.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.4 t -101.95 114.37 41.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 173.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.571 ' HG3' ' O ' ' A' ' 40' ' ' ASP . 24.2 ptt-85 -116.09 176.5 5.07 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.7 -172.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.571 ' O ' ' HG3' ' A' ' 39' ' ' ARG . 10.6 t70 -58.66 132.28 53.37 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 166.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.68 ' HA ' HG23 ' A' ' 49' ' ' VAL . 44.5 t -44.37 -48.66 9.77 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 123.674 0.609 . . . . 0.0 112.223 -174.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.1 t 72.73 -1.66 2.93 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.979 0.799 . . . . 0.0 109.81 -175.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.4 m -111.51 -37.09 5.33 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.712 175.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 45.3 t -147.2 122.84 5.37 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.306 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -61.95 122.12 10.49 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.94 2.426 . . . . 0.0 112.857 -178.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.94 -31.81 7.0 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.742 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.416 ' C ' ' HB2' ' A' ' 41' ' ' SER . 4.7 m-20 -87.81 174.96 8.06 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -133.28 169.66 16.59 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 122.284 -0.26 . . . . 0.0 111.049 -177.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.68 HG23 ' HA ' ' A' ' 41' ' ' SER . 90.3 t -143.01 117.28 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 121.29 0.566 . . . . 0.0 110.632 174.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.45 ' CB ' HD11 ' A' ' 63' ' ' ILE . 28.3 tp -85.04 108.48 17.65 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.885 178.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.7 m -96.39 137.26 35.72 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 174.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.681 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 91.3 t -130.76 134.24 62.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.632 0.253 . . . . 0.0 111.444 -175.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.62 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 40.8 t -94.93 114.66 26.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.208 -175.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.666 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 8.6 tp10 -159.45 153.56 23.51 Favored 'General case' 0 C--O 1.21 -0.991 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 164.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.629 ' HB2' ' CG ' ' A' ' 57' ' ' ARG . 63.2 m-80 61.4 17.36 8.3 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 179.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.2 m 55.22 55.54 7.43 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 122.59 1.186 . . . . 0.0 108.19 -170.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.753 HH21 ' HA ' ' A' ' 154' ' ' GLU 0.282 0.0 OUTLIER -163.24 67.73 0.2 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 113.227 -1.806 . . . . 0.0 109.883 -153.69 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.681 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 5.2 t -73.64 102.57 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.316 -1.311 . . . . 0.0 110.26 -173.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 71.6 m -78.38 122.46 25.8 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.174 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 45.3 m-70 -93.14 102.97 15.28 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.971 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.949 ' HB3' HD11 ' A' ' 73' ' ' ILE . 70.0 m-85 -97.99 105.07 17.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.591 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.609 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 54.8 mt -80.47 127.77 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -174.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.578 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 3.5 mp -115.44 112.01 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 120.82 0.343 . . . . 0.0 110.22 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -87.4 148.29 25.07 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.415 -176.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.8 t -87.83 109.19 19.56 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 175.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.3 mt -81.52 143.25 50.99 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -62.14 -11.54 22.46 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.44 2.094 . . . . 0.0 110.915 175.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -76.24 0.51 18.93 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.421 176.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.34 21.78 9.7 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.559 -174.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -115.96 175.0 5.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.82 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.578 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 64.8 m-85 -130.76 132.19 45.16 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.962 0.411 . . . . 0.0 111.21 -176.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -121.88 122.41 39.36 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.996 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.949 HD11 ' HB3' ' A' ' 61' ' ' TYR . 7.5 tt -108.42 109.25 27.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.502 0.668 . . . . 0.0 111.218 -174.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.03 -94.37 0.37 Allowed Glycine 0 CA--C 1.519 0.329 0 CA-C-N 115.431 -0.804 . . . . 0.0 113.136 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -121.2 -11.04 8.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.332 0.587 . . . . 0.0 110.323 -176.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -108.86 126.07 52.66 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.382 0.61 . . . . 0.0 110.784 -176.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.35 135.1 37.39 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.64 178.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.461 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 93.4 m-85 -126.38 178.43 5.85 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -71.18 -43.06 68.21 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.284 -178.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.422 ' ND1' ' HG2' ' A' ' 82' ' ' PRO . 16.4 p80 -165.97 -179.43 5.21 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.742 -178.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.619 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 10.0 mt -57.33 -62.18 5.76 Favored Pre-proline 0 N--CA 1.471 0.585 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -175.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.422 ' HG2' ' ND1' ' A' ' 80' ' ' HIS . 19.8 Cg_endo -63.99 1.24 1.6 Allowed 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 121.702 1.602 . . . . 0.0 113.483 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.97 -36.38 14.13 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.844 0.354 . . . . 0.0 110.323 177.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.1 pp -76.68 -32.69 58.07 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.479 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 80.0 mt -63.45 -28.7 70.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.857 176.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.9 tp10 -77.8 -38.72 45.94 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.758 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -64.88 -37.4 87.51 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.421 0.629 . . . . 0.0 110.884 178.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.493 ' HE2' HD13 ' A' ' 73' ' ' ILE . 30.3 m-85 -80.55 -2.75 47.52 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.958 -176.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 85' ' ' LEU . 97.5 mttt -69.9 -27.02 64.45 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.889 174.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.4 pp -120.1 9.0 6.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.889 179.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 -90.6 -39.89 12.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.627 -178.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.5 ' CD2' HG23 ' A' ' 97' ' ' THR . 82.0 m-85 67.51 84.86 0.15 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.173 -169.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.683 ' HA ' ' OE2' ' A' ' 154' ' ' GLU . 5.8 mt -56.39 -20.79 21.1 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 122.241 1.02 . . . . 0.0 111.007 178.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.566 ' OD1' HG22 ' A' ' 96' ' ' THR . 0.1 OUTLIER -134.78 -68.41 0.54 Allowed 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.003 -1.453 . . . . 0.0 109.063 -179.666 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.708 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 8.8 t -177.64 15.93 0.0 OUTLIER 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 114.198 -1.364 . . . . 0.0 108.548 174.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.566 HG22 ' OD1' ' A' ' 94' ' ' ASP . 4.9 t -129.58 -28.48 2.27 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.5 HG23 ' CD2' ' A' ' 92' ' ' TYR . 12.8 p 78.82 -179.52 0.11 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.964 1.306 . . . . 0.0 110.805 -175.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.457 HD22 ' CG ' ' A' ' 36' ' ' PHE . 89.9 mt -78.77 89.62 4.63 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.804 177.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 50.2 mm -75.6 -54.44 13.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.723 -177.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.606 ' O ' ' HA ' ' A' ' 35' ' ' MET . 15.5 pt-20 -157.22 152.72 22.18 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.561 -177.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.518 ' HB3' ' HB3' ' A' ' 14' ' ' TRP . 72.8 Cg_endo -76.06 148.58 31.47 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.262 1.975 . . . . 0.0 112.135 176.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.594 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -73.04 146.05 86.9 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.206 178.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.49 124.18 15.25 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.465 2.11 . . . . 0.0 111.232 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.647 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 34.8 ptt180 . . . . . 0 C--N 1.328 -0.329 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -172.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.827 HD12 HG21 ' A' ' 152' ' ' ILE . 4.6 mm? . . . . . 0 N--CA 1.464 0.257 0 CA-C-O 121.779 0.8 . . . . 0.0 112.779 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.761 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 0.6 OUTLIER -178.35 -72.44 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.033 -1.44 . . . . 0.0 107.858 179.59 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.427 ' O ' ' HB3' ' A' ' 180' ' ' LYS . 70.8 m-85 -96.95 107.45 19.98 Favored 'General case' 0 CA--C 1.495 -1.148 0 C-N-CA 119.199 -1.0 . . . . 0.0 110.569 -179.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.959 HG22 ' HG3' ' A' ' 180' ' ' LYS . 89.4 t -124.16 126.67 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 CA-C-N 114.55 -1.205 . . . . 0.0 109.301 175.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.686 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 6.5 ptp180 -107.52 142.79 36.85 Favored 'General case' 0 N--CA 1.435 -1.175 0 C-N-CA 117.528 -1.669 . . . . 0.0 108.093 171.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.582 HG22 HG12 ' A' ' 178' ' ' VAL . 0.8 OUTLIER -102.58 127.4 49.68 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.873 -176.941 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.695 HD11 ' HB2' ' A' ' 179' ' ' GLU . 6.3 mt -100.21 -21.73 15.4 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.629 -174.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.431 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 30.1 t80 -81.17 -35.88 30.88 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.93 -171.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.597 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 13.6 t70 71.06 101.14 0.06 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.688 0.756 . . . . 0.0 110.562 -175.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.468 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 51.5 t80 -129.87 85.6 57.4 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 177.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.678 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 94.8 Cg_endo -82.17 80.43 2.81 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 121.896 1.731 . . . . 0.0 112.773 -178.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -75.97 -30.59 57.27 Favored Glycine 0 C--N 1.329 0.173 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.765 178.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.435 HD22 ' HB3' ' A' ' 143' ' ' PRO . 1.0 OUTLIER 66.04 50.95 1.37 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.096 -0.552 . . . . 0.0 111.234 179.281 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -142.14 177.75 8.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.414 177.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.506 ' O ' ' HA2' ' A' ' 171' ' ' GLY . . . -92.71 -11.0 35.12 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.73 0.776 . . . . 0.0 109.136 172.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' A' ' 172' ' ' MET . 44.9 mt-10 -91.95 -31.95 15.44 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.001 -0.999 . . . . 0.0 109.537 175.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -127.57 104.82 8.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.317 176.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 1.083 HD11 ' HB2' ' A' ' 165' ' ' ASN . 32.1 tp -65.42 129.52 94.42 Favored Pre-proline 0 C--N 1.327 -0.394 0 C-N-CA 120.562 -0.455 . . . . 0.0 109.977 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.789 ' HD2' HD12 ' A' ' 142' ' ' LEU . 72.6 Cg_endo -78.78 88.57 1.44 Allowed 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 121.541 1.494 . . . . 0.0 111.511 175.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.489 ' CD1' ' HB ' ' A' ' 130' ' ' THR . 10.4 p90 -103.49 156.14 17.99 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.96 -174.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.597 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -96.85 -171.63 2.28 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.189 0.441 . . . . 0.0 112.189 -174.858 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.865 ' H ' ' HD2' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -92.81 33.05 1.17 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.942 -174.029 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 159.51 31.33 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.555 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.556 ' HB3' ' HB2' ' A' ' 145' ' ' LYS . 0.1 OUTLIER -101.01 152.71 20.25 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.663 -176.554 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.7 mp -97.55 127.14 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-O 121.496 0.665 . . . . 0.0 109.802 -176.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.772 HD22 HD21 ' A' ' 142' ' ' LEU . 9.7 mt -121.63 157.71 30.21 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 -176.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.761 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 92.7 t -118.09 124.19 72.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 174.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 1.116 HD13 ' HB2' ' A' ' 163' ' ' ALA . 43.6 mm -75.93 79.66 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 122.024 0.916 . . . . 0.0 108.717 -177.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.519 HG21 HG22 ' A' ' 170' ' ' VAL . 18.4 tt -70.37 -29.7 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-N 114.005 -1.452 . . . . 0.0 109.76 -176.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.753 ' HA ' HH21 ' A' ' 57' ' ' ARG . 0.4 OUTLIER -131.44 141.72 49.87 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 172.152 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.589 ' HD2' ' HG ' ' A' ' 125' ' ' LEU . 81.4 tttt -134.77 87.83 29.64 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 172.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.708 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 2.3 Cg_endo -82.5 -37.78 0.2 Allowed 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.695 2.264 . . . . 0.0 111.8 176.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.604 ' HG2' ' CE ' ' A' ' 172' ' ' MET . 25.2 mm-40 -109.91 168.13 9.65 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.755 -174.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.513 ' O ' HG21 ' A' ' 175' ' ' VAL . 6.1 pt-20 -101.67 -16.86 16.55 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.462 178.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.406 ' C ' HG23 ' A' ' 175' ' ' VAL . 5.2 tp-100 -107.32 -11.72 15.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.163 0.506 . . . . 0.0 109.873 176.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -129.07 121.6 28.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.212 176.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . 0.759 ' HB3' HD12 ' A' ' 152' ' ' ILE . 49.2 m0 -115.32 134.87 54.72 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.501 -178.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.59 ' HA ' ' HA ' ' A' ' 172' ' ' MET . 13.4 m -93.79 94.22 8.41 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -173.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 1.116 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -108.54 147.05 32.33 Favored 'General case' 0 N--CA 1.419 -1.998 0 C-N-CA 119.501 -0.88 . . . . 0.0 109.703 -171.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.831 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 15.8 ptt-85 -86.79 119.66 27.25 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 175.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 1.083 ' HB2' HD11 ' A' ' 142' ' ' LEU . 18.1 t30 -53.34 177.69 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 113.724 -1.58 . . . . 0.0 110.865 -176.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -63.56 -15.31 57.68 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 168.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.417 ' H ' ' HB3' ' A' ' 165' ' ' ASN . 36.9 m-20 -69.28 -30.38 68.47 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.74 169.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 90.28 25.79 25.29 Favored Glycine 0 C--O 1.228 -0.259 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.16 -170.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.887 ' HD2' ' CD1' ' A' ' 142' ' ' LEU . 0.3 OUTLIER -105.06 138.14 41.72 Favored 'General case' 0 C--O 1.217 -0.608 0 C-N-CA 123.437 0.695 . . . . 0.0 111.331 -174.003 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.519 HG22 HG21 ' A' ' 153' ' ' ILE . 24.1 t -86.45 119.75 35.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -175.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.506 ' HA2' ' O ' ' A' ' 139' ' ' ALA . . . -152.49 148.94 20.44 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.696 170.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.604 ' CE ' ' HG2' ' A' ' 157' ' ' GLU . 59.6 mtp -78.43 142.48 37.51 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 117.663 0.731 . . . . 0.0 110.703 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.698 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.7 pp -140.54 145.47 40.78 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.9 -173.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.554 ' HB2' ' CD1' ' A' ' 177' ' ' TYR . 17.6 Cg_exo -68.41 129.87 19.93 Favored 'Trans proline' 0 N--CA 1.465 -0.149 0 C-N-CA 122.959 2.439 . . . . 0.0 113.104 -177.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.568 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 58.0 t -62.62 -42.22 77.68 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 29.0 Cg_endo -63.62 -5.16 8.14 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 121.951 1.767 . . . . 0.0 112.682 177.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.554 ' CD1' ' HB2' ' A' ' 174' ' ' PRO . 3.0 m-85 -91.95 -15.8 27.5 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.442 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.606 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 3.2 m -105.95 -174.04 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -163.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.695 ' HB2' HD11 ' A' ' 131' ' ' LEU . 3.5 tp10 -159.95 49.22 0.29 Allowed 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 113.071 -1.877 . . . . 0.0 112.454 -150.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.959 ' HG3' HG22 ' A' ' 128' ' ' VAL . 0.5 OUTLIER -69.27 170.73 9.68 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 118.937 -2.352 . . . . 0.0 111.308 -160.511 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 15.9 tp . . . . . 0 C--O 1.236 0.355 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.767 -168.131 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo . . . . . 0 N--CA 1.445 -1.336 0 N-CA-C 110.291 -0.696 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.585 ' CG1' HD12 ' A' ' 293' ' ' ILE . 15.2 t -95.3 138.93 19.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.158 0.504 . . . . 0.0 111.393 -171.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -109.9 121.68 45.8 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.833 177.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.61 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -118.68 155.02 31.78 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.887 -175.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -99.84 120.47 39.81 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.779 179.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . 0.546 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -72.31 106.78 4.6 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 175.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 41.2 pt -94.85 -5.83 10.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.159 0.504 . . . . 0.0 110.995 -176.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -137.37 140.76 41.61 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.98 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -63.62 126.29 27.05 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 176.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.551 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 24.5 tpt180 -125.62 101.89 7.1 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.968 0.413 . . . . 0.0 110.562 -178.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 25.7 m -111.94 150.13 41.9 Favored Pre-proline 0 C--N 1.316 -0.88 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 174.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -62.89 102.73 0.31 Allowed 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.245 1.963 . . . . 0.0 111.865 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 250' ' ' ALA . 45.8 t -73.33 178.17 4.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.58 -177.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.405 ' N ' ' SG ' ' A' ' 249' ' ' CYS . . . -63.74 -25.2 68.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.853 -177.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -99.11 1.11 44.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.876 0.37 . . . . 0.0 111.314 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -101.32 161.13 13.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.233 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -138.74 -66.12 0.48 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.393 178.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 2.3 m -82.49 10.34 7.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.006 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 285' ' ' LEU . . . -65.57 119.07 10.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.044 0.449 . . . . 0.0 111.434 -175.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.494 HD23 ' H ' ' A' ' 257' ' ' ALA . 1.2 tt -72.27 140.51 48.65 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.696 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.551 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -86.88 117.53 25.68 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.333 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 84.5 mt -126.86 142.69 51.48 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.557 -177.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -106.56 158.34 17.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.085 177.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 45.0 t -70.23 109.99 3.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.975 0.417 . . . . 0.0 110.088 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 108.54 11.69 22.79 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.852 -0.69 . . . . 0.0 111.948 -177.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -95.3 146.64 24.22 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 39.8 mm -90.28 117.63 33.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.914 0.388 . . . . 0.0 110.651 -179.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.426 HG21 HG11 ' A' ' 291' ' ' VAL . 22.0 t -92.94 109.4 21.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.432 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -91.11 88.18 6.86 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.065 178.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 7.6 p -88.67 125.47 41.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.341 0.591 . . . . 0.0 110.536 -177.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 37.2 p -97.27 -31.1 12.59 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.527 -175.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . 0.485 ' HD3' ' OE1' ' A' ' 276' ' ' GLU . 55.8 mtp180 -131.2 113.87 14.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.723 -177.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 31.6 mtt -93.86 113.42 25.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.124 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -83.57 169.98 14.84 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.576 176.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 32.4 mm -94.75 -20.32 6.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.476 -176.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -81.68 3.89 23.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.758 -176.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 99.31 -35.17 4.87 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.55 -0.833 . . . . 0.0 113.129 174.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -84.2 111.32 19.26 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 41.1 m0 -93.53 158.45 15.7 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.297 -177.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.485 ' OE1' ' HD3' ' A' ' 268' ' ' ARG . 58.7 mt-10 -91.66 106.75 18.71 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 172.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -108.52 146.33 16.49 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.012 -176.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -114.81 106.26 13.98 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 176.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . 0.58 HG12 ' ND2' ' A' ' 280' ' ' ASN . 15.1 t -141.48 134.11 29.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -175.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . 0.58 ' ND2' HG12 ' A' ' 279' ' ' VAL . 52.1 m-80 62.21 23.59 13.96 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.251 -177.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 84.5 -4.19 84.78 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.511 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 -104.62 134.07 48.4 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.865 0.364 . . . . 0.0 111.021 -176.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 42.8 tttp -104.78 117.33 33.79 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.176 177.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -146.79 175.51 26.16 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 255' ' ' ALA . 89.5 mt -94.61 143.8 26.13 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 177.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.422 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 43.2 p90 -144.7 139.83 15.81 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.301 176.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 15.4 Cg_exo -69.59 125.11 11.84 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.651 2.234 . . . . 0.0 111.19 173.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -58.71 -19.96 44.53 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.269 -0.423 . . . . 0.0 112.04 -175.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 15.8 p -67.66 -9.26 41.75 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -177.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -99.55 -7.86 25.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.903 0.383 . . . . 0.0 111.053 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.546 HG12 ' HA ' ' A' ' 242' ' ' ALA . 34.0 m -127.56 170.12 17.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.891 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -138.77 134.83 33.98 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.07 0.462 . . . . 0.0 110.83 174.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.61 HD13 ' HB2' ' A' ' 240' ' ' ALA . 46.9 mm -76.78 128.81 37.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.329 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -138.61 -36.04 0.57 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.401 178.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 62.36 103.47 0.03 OUTLIER Pre-proline 0 C--N 1.341 0.197 0 CA-C-O 121.418 0.628 . . . . 0.0 111.354 -178.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo . . . . . 0 C--O 1.235 0.351 0 C-N-CA 123.209 2.606 . . . . 0.0 111.677 -178.824 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.451 -0.402 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.538 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . -75.51 89.92 2.72 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.429 171.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -119.09 95.72 4.93 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.607 0.718 . . . . 0.0 111.741 -175.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.411 ' HE1' ' O ' ' A' ' 98' ' ' LEU . 12.2 p90 -159.66 169.84 22.87 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.532 174.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -75.83 -26.83 57.54 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -173.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.0 t 72.61 -39.16 0.44 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.622 0.769 . . . . 0.0 111.382 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.1 m -91.03 -26.11 19.35 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.49 0.186 . . . . 0.0 111.1 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -63.36 105.76 0.8 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.987 0.422 . . . . 0.0 111.291 -172.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -60.62 -39.75 89.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.63 -176.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.1 m -72.99 -3.18 24.43 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.614 -176.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.52 -41.74 10.09 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.654 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 33.1 p-90 -125.09 -21.68 4.6 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -172.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -71.6 109.25 5.41 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.044 -176.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.832 ' SD ' ' HA ' ' A' ' 104' ' ' ARG . 8.3 tpp -91.03 -9.25 46.56 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.649 -174.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.455 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 50.6 -112.07 1.46 Allowed Glycine 0 CA--C 1.52 0.358 0 CA-C-N 115.55 -0.75 . . . . 0.0 113.986 177.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.455 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 19.3 Cg_exo -66.15 82.18 0.28 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.424 2.749 . . . . 0.0 113.324 -177.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.759 HG12 ' H ' ' A' ' 20' ' ' SER . 59.5 t -139.68 -178.31 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.759 ' H ' HG12 ' A' ' 19' ' ' VAL . 47.4 t -168.62 178.88 4.52 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 -166.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.493 ' O ' ' HG2' ' A' ' 25' ' ' GLN . 0.1 OUTLIER -58.73 -45.16 90.24 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 118.59 0.632 . . . . 0.0 109.391 176.222 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -60.07 -60.2 4.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.799 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.547 ' O ' ' HG3' ' A' ' 27' ' ' ARG . 29.5 mm-40 -56.94 -49.31 76.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.007 -178.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.83 -38.0 72.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.582 -175.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.566 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 16.4 mm100 -61.9 -52.69 63.07 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.889 178.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.2 t -70.45 -10.54 59.41 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -172.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.547 ' HG3' ' O ' ' A' ' 23' ' ' GLU . 55.5 mtp180 -100.44 -11.2 20.4 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 121.081 -0.248 . . . . 0.0 111.338 -179.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.576 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 62.9 mt -132.2 -13.0 3.15 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -176.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.566 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -68.69 109.0 3.6 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.919 -0.488 . . . . 0.0 109.944 -178.316 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.52 26.1 66.3 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.393 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.428 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 13.3 mm100 -94.07 -170.61 2.34 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 178.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.515 ' HB2' ' SD ' ' A' ' 35' ' ' MET . 56.0 mtm180 -61.81 150.83 35.99 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 177.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.433 ' CE1' ' HA ' ' A' ' 55' ' ' ASN . 55.9 m170 -92.31 113.92 26.33 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -178.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.505 ' CA ' HG21 ' A' ' 96' ' ' THR . . . 127.75 -4.62 7.02 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.746 -175.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.618 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 62.8 mtp -84.7 143.14 29.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.464 -0.368 . . . . 0.0 110.387 178.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.557 ' CD1' HD22 ' A' ' 98' ' ' LEU . 46.9 p90 -149.6 159.19 44.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.742 -0.208 . . . . 0.0 110.604 -178.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.623 ' HB2' ' HB2' ' A' ' 16' ' ' MET . 4.6 pp -150.69 138.52 19.92 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.141 0.496 . . . . 0.0 111.01 177.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 85.5 t -105.19 119.89 54.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 174.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.523 ' CB ' ' HB ' ' A' ' 19' ' ' VAL . 28.2 ptt-85 -117.08 161.58 19.18 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.89 -174.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -73.87 124.51 26.26 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 173.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.476 ' HB2' HG23 ' A' ' 49' ' ' VAL . 47.2 t -87.56 143.98 26.93 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.0 0.429 . . . . 0.0 110.902 -176.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.4 p -91.9 4.25 53.38 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.234 176.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 26.4 m -76.28 -43.12 43.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.173 175.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 47' ' ' ASP . 11.7 m -143.66 135.27 12.84 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -70.38 72.84 1.72 Allowed 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.453 2.102 . . . . 0.0 111.677 176.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 65' ' ' SER . . . 155.55 -23.51 0.56 Allowed Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -176.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.437 ' HB2' ' HB2' ' A' ' 44' ' ' CYS . 16.0 m-20 -81.79 155.83 25.23 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 176.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -131.79 177.21 7.7 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.532 HG13 HD13 ' A' ' 62' ' ' ILE . 38.7 t -145.4 115.3 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.714 0.292 . . . . 0.0 111.288 177.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.426 HD11 ' HB2' ' A' ' 36' ' ' PHE . 57.5 tp -81.61 103.94 11.67 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.267 175.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.5 m -96.92 127.84 43.28 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 176.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.57 HG21 HD13 ' A' ' 93' ' ' LEU . 59.7 t -121.69 133.27 68.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.025 0.44 . . . . 0.0 111.063 -175.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.576 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 26.6 t -91.0 110.31 21.57 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.531 -178.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.653 ' OE2' ' HB ' ' A' ' 96' ' ' THR . 40.8 mt-10 -146.78 136.88 23.47 Favored 'General case' 0 C--O 1.21 -0.984 0 C-N-CA 119.673 -0.811 . . . . 0.0 109.678 175.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.433 ' HA ' ' CE1' ' A' ' 33' ' ' HIS . 80.2 m-20 52.95 31.09 10.3 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 174.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 44.8 m 58.33 53.31 6.49 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 122.134 0.968 . . . . 0.0 109.367 -178.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.88 HH21 ' HB2' ' A' ' 94' ' ' ASP 0.256 0.2 OUTLIER -168.39 67.94 0.07 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 113.577 -1.647 . . . . 0.0 108.668 -156.915 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 21.7 t -72.49 102.8 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 O-C-N 120.588 -1.32 . . . . 0.0 110.299 -167.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.6 m -73.61 118.88 17.08 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 113.133 -1.849 . . . . 0.0 110.737 -176.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -97.93 113.53 25.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.854 0.359 . . . . 0.0 111.43 -178.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.736 ' HB3' HD11 ' A' ' 73' ' ' ILE . 70.2 m-85 -107.24 110.2 22.18 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.964 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.808 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 34.2 mm -77.46 132.75 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -173.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.546 HG23 ' HB3' ' A' ' 71' ' ' PHE . 3.7 mp -115.84 115.91 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 120.947 0.403 . . . . 0.0 111.125 177.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -88.57 142.71 27.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.371 -177.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.457 ' HB2' ' O ' ' A' ' 46' ' ' GLY . 35.9 t -83.38 100.15 10.5 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 169.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 90.3 mt -78.11 140.42 61.69 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -59.05 -15.45 27.95 Favored 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 122.982 2.455 . . . . 0.0 112.446 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -83.45 10.79 8.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.419 176.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? 63.59 27.81 15.02 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.667 -178.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.458 ' NH2' ' HB3' ' A' ' 77' ' ' GLU . 37.0 mtp180 -115.44 -175.21 2.66 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.988 -1.006 . . . . 0.0 109.52 178.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.546 ' HB3' HG23 ' A' ' 63' ' ' ILE . 62.0 m-85 -135.57 143.44 45.67 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.063 0.459 . . . . 0.0 111.735 -175.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -123.47 116.46 23.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.992 177.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.808 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 7.9 tt -102.87 94.74 3.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.493 0.663 . . . . 0.0 110.807 -179.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.405 ' O ' ' HB3' ' A' ' 75' ' ' ASP . . . 58.78 68.75 1.53 Allowed Glycine 0 C--N 1.331 0.284 0 CA-C-N 115.098 -0.955 . . . . 0.0 112.651 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.405 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 20.4 t0 76.55 -45.01 0.49 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 122.628 0.371 . . . . 0.0 111.333 178.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -75.78 129.18 36.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.146 0.498 . . . . 0.0 110.861 -178.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.458 ' HB3' ' NH2' ' A' ' 70' ' ' ARG . 64.6 mt-10 -101.32 153.3 19.77 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.428 -177.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.47 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 96.8 m-85 -141.01 -173.91 3.85 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.041 173.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -77.68 -48.76 15.97 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.019 0.438 . . . . 0.0 110.729 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.416 ' H ' ' HB3' ' A' ' 83' ' ' ALA . 4.7 p80 -156.89 -179.38 8.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.397 -178.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.609 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 14.2 mt -57.77 -57.1 27.93 Favored Pre-proline 0 N--CA 1.469 0.493 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -178.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.605 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 24.4 Cg_exo -64.37 -2.33 4.86 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.13 1.887 . . . . 0.0 112.948 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.416 ' HB3' ' H ' ' A' ' 80' ' ' HIS . . . -89.9 -36.8 14.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.793 0.33 . . . . 0.0 110.348 179.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.7 pp -76.78 -31.11 56.8 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.477 ' HA ' ' CD1' ' A' ' 98' ' ' LEU . 57.2 mt -67.62 -26.72 66.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.653 174.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -79.12 -33.44 44.29 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.788 177.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -76.07 -38.11 57.47 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.028 0.442 . . . . 0.0 111.049 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.486 ' HE2' HD13 ' A' ' 73' ' ' ILE . 33.5 m-85 -76.26 1.55 15.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.962 0.41 . . . . 0.0 111.779 -177.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -70.27 -25.99 63.61 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.45 171.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 29.8 pt -117.14 26.57 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 120.585 -0.446 . . . . 0.0 112.067 178.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.423 ' O ' ' HB2' ' A' ' 92' ' ' TYR . 2.8 t-160 -114.46 -42.64 3.27 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -175.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.47 ' CD1' HG23 ' A' ' 97' ' ' THR . 97.8 m-85 70.46 86.62 0.12 Allowed 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.751 0.657 . . . . 0.0 110.278 -171.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.685 ' HA ' ' OE2' ' A' ' 154' ' ' GLU . 14.8 mt -59.94 -30.75 69.28 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.51 -178.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.88 ' HB2' HH21 ' A' ' 57' ' ' ARG . 31.6 t0 -160.94 68.55 0.33 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.317 0.58 . . . . 0.0 109.863 170.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.534 HG22 ' O ' ' A' ' 94' ' ' ASP . 0.5 OUTLIER 70.2 -4.49 1.54 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.956 -175.629 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.653 ' HB ' ' OE2' ' A' ' 54' ' ' GLU . 16.2 m -127.73 138.84 52.9 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 121.237 0.542 . . . . 0.0 109.933 178.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.472 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.5 p -89.5 168.39 12.22 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 173.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.557 HD22 ' CD1' ' A' ' 36' ' ' PHE . 97.3 mt -63.58 96.36 0.12 Allowed 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.635 -0.426 . . . . 0.0 109.871 178.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.538 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 49.0 mm -86.06 -56.72 5.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.645 -174.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.618 ' O ' ' HA ' ' A' ' 35' ' ' MET . 42.5 tt0 -158.85 133.39 5.37 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.912 -176.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 100' ' ' GLU . 17.8 Cg_exo -64.91 157.75 55.03 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 122.88 2.386 . . . . 0.0 112.829 -177.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.09 141.13 86.15 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.9 112.44 1.21 Allowed 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.384 2.056 . . . . 0.0 112.116 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.832 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 41.7 ttp180 . . . . . 0 C--O 1.234 0.241 0 CA-C-O 121.374 0.607 . . . . 0.0 109.474 178.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.711 HD12 HG21 ' A' ' 152' ' ' ILE . 3.3 mm? . . . . . 0 CA--C 1.515 -0.399 0 CA-C-O 121.771 0.796 . . . . 0.0 111.803 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.515 ' HG2' ' CD2' ' A' ' 127' ' ' TYR . 28.4 tt0 -171.72 -78.23 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.531 -1.213 . . . . 0.0 109.674 -174.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.515 ' CD2' ' HG2' ' A' ' 126' ' ' GLU . 54.7 m-85 -117.57 107.85 14.76 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.377 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.698 HG22 ' CG ' ' A' ' 180' ' ' LYS . 56.6 t -114.87 131.11 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -178.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.709 ' HB3' HD12 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -109.79 144.66 37.91 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 116.892 -1.923 . . . . 0.0 108.989 170.988 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.609 HG22 HG12 ' A' ' 178' ' ' VAL . 1.2 p -100.68 128.91 46.56 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.316 -179.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.531 HD21 ' HG2' ' A' ' 179' ' ' GLU . 14.8 mt -105.27 -23.16 12.92 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.934 -176.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.459 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 32.6 t80 -79.9 -33.41 39.89 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.727 -173.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.607 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 15.7 t70 71.77 120.14 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.365 0.602 . . . . 0.0 110.842 -174.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.568 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 64.4 t80 -153.85 91.96 3.16 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.615 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 74.2 Cg_endo -90.0 86.77 0.39 Allowed 'Trans proline' 0 N--CA 1.441 -1.605 0 C-N-CA 122.014 1.809 . . . . 0.0 112.573 177.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -76.79 -16.11 81.04 Favored Glycine 0 C--N 1.331 0.298 0 N-CA-C 111.056 -0.817 . . . . 0.0 111.056 174.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.697 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 18.1 m120 52.97 68.31 0.86 Allowed 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.21 -0.995 . . . . 0.0 111.8 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.595 ' HB3' ' H ' ' A' ' 141' ' ' ASP . 1.0 OUTLIER -136.27 -174.87 3.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.229 0.538 . . . . 0.0 110.932 -178.962 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -115.32 3.69 14.27 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 166.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.431 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 32.9 tt0 -112.34 -49.74 2.94 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 113.9 -1.5 . . . . 0.0 108.65 177.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.595 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 4.9 m-20 -96.64 133.28 41.36 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.852 167.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 1.123 HD11 ' HB2' ' A' ' 165' ' ' ASN . 34.2 tp -83.62 131.65 51.68 Favored Pre-proline 0 N--CA 1.468 0.44 0 O-C-N 122.075 -0.39 . . . . 0.0 110.135 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.697 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 11.6 Cg_endo -85.63 91.06 0.69 Allowed 'Trans proline' 0 N--CA 1.444 -1.425 0 C-N-CA 122.115 1.877 . . . . 0.0 111.266 172.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.568 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 12.8 p90 -103.71 159.48 15.59 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.234 -176.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.607 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 5.0 mppt? -104.91 -168.28 1.45 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.262 0.554 . . . . 0.0 112.195 -178.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.735 ' H ' ' HD2' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -86.84 9.11 20.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.0 -169.688 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -172.63 36.93 0.14 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.857 175.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.545 ' OE1' ' HA ' ' A' ' 144' ' ' PHE . 0.3 OUTLIER -101.06 149.05 24.35 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.351 -175.648 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.709 HD12 ' HB3' ' A' ' 129' ' ' ARG . 0.3 OUTLIER -89.06 124.57 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.677 -178.116 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.727 HD22 HD21 ' A' ' 142' ' ' LEU . 19.3 mt -119.45 155.35 32.21 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.588 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 67.6 t -117.56 125.53 74.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 174.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 1.084 HD13 ' HB2' ' A' ' 163' ' ' ALA . 49.5 mm -76.54 87.18 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 122.423 1.106 . . . . 0.0 108.118 -176.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.612 HG21 HG22 ' A' ' 170' ' ' VAL . 17.9 tt -75.66 -25.1 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 CA-C-N 113.292 -1.776 . . . . 0.0 109.875 -174.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.685 ' OE2' ' HA ' ' A' ' 93' ' ' LEU . 0.2 OUTLIER -141.0 141.21 34.39 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 170.458 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 61.0 tttt -128.83 92.75 39.16 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.44 0.638 . . . . 0.0 110.356 170.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.427 ' HG2' ' HE2' ' A' ' 172' ' ' MET . 10.3 Cg_exo -74.3 -44.04 0.46 Allowed 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.338 2.025 . . . . 0.0 112.002 172.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -120.2 178.74 4.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.099 -172.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.448 ' HA ' ' HE1' ' A' ' 161' ' ' TRP . 6.7 pt-20 -116.12 4.68 13.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.094 0.473 . . . . 0.0 110.672 174.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -102.34 -31.26 10.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.696 172.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.442 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 34.5 m95 -129.11 146.16 51.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.613 173.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . 0.741 ' O ' HG13 ' A' ' 173' ' ' ILE . 47.8 m0 -126.79 138.33 53.34 Favored 'General case' 0 C--O 1.215 -0.757 0 C-N-CA 122.788 0.435 . . . . 0.0 110.657 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.566 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 25.6 m -95.4 96.33 9.05 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -175.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 1.084 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -108.7 150.29 27.77 Favored 'General case' 0 N--CA 1.422 -1.833 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.505 -172.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.779 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 12.7 ptt180 -87.46 122.17 30.85 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 173.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 1.123 ' HB2' HD11 ' A' ' 142' ' ' LEU . 17.5 t30 -54.61 176.79 0.04 OUTLIER 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 113.293 -1.776 . . . . 0.0 110.91 -177.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.541 ' HD2' ' H ' ' A' ' 149' ' ' ILE . 30.9 mtpt -62.95 -17.98 62.61 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.828 169.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -68.94 -36.24 77.72 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.468 0.652 . . . . 0.0 109.46 168.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.432 ' C ' ' HB2' ' A' ' 164' ' ' ARG . . . 105.06 3.96 41.75 Favored Glycine 0 CA--C 1.524 0.598 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.343 -172.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.779 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -79.33 137.59 37.39 Favored 'General case' 0 C--O 1.218 -0.574 0 C-N-CA 123.16 0.584 . . . . 0.0 111.77 -178.77 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.612 HG22 HG21 ' A' ' 153' ' ' ILE . 22.1 t -79.87 125.87 39.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 120.417 0.151 . . . . 0.0 111.291 177.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -157.88 148.37 17.67 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 120.209 -0.996 . . . . 0.0 112.665 169.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.472 ' HA ' ' HA ' ' A' ' 162' ' ' SER . 0.4 OUTLIER -69.88 140.65 53.19 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 122.756 0.422 . . . . 0.0 111.378 179.408 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.741 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.6 pp -144.45 144.39 25.1 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.105 -176.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.514 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 8.1 Cg_exo -73.38 132.13 17.3 Favored 'Trans proline' 0 C--O 1.23 0.115 0 C-N-CA 122.498 2.132 . . . . 0.0 112.644 -174.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.601 ' O ' HG22 ' A' ' 178' ' ' VAL . 82.9 t -60.98 -44.03 93.2 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 19.0 Cg_endo -61.08 -11.2 17.56 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 121.981 1.787 . . . . 0.0 112.873 177.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.514 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.1 m-85 -88.22 -15.18 36.63 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.525 -178.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.611 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 4.1 m -106.58 -172.44 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 115.558 1.688 . . . . 0.0 115.558 -164.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.663 ' O ' ' HG3' ' A' ' 179' ' ' GLU . 3.9 tp10 -159.9 44.32 0.22 Allowed 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 112.941 -1.936 . . . . 0.0 111.638 -154.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.773 ' HD2' ' H ' ' A' ' 180' ' ' LYS . 0.0 OUTLIER -74.13 144.23 44.99 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 119.275 -2.141 . . . . 0.0 111.554 -166.07 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.448 ' HB2' HH12 ' A' ' 129' ' ' ARG . 23.8 tp . . . . . 0 N--CA 1.448 -0.533 0 CA-C-N 111.416 -2.629 . . . . 0.0 114.282 -157.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo . . . . . 0 N--CA 1.46 -0.473 0 N-CA-C 111.283 -0.314 . . . . 0.0 111.283 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.464 ' CG1' HD12 ' A' ' 293' ' ' ILE . 21.7 t -84.71 134.55 26.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.945 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.53 ' HB2' ' CG ' ' A' ' 296' ' ' PRO . 93.8 m-85 -104.46 124.24 48.9 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.141 0.496 . . . . 0.0 110.468 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.585 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -119.24 140.65 49.89 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.26 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -88.2 124.36 33.76 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . 0.522 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -75.29 99.52 4.09 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.253 178.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 39.4 pt -80.59 -23.26 11.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.276 0.56 . . . . 0.0 110.74 -177.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -135.26 148.52 49.59 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 177.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -67.79 169.56 9.47 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.239 0.542 . . . . 0.0 110.607 -178.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.564 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 27.3 tpt180 -154.1 109.78 3.2 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.166 178.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 24.0 m -108.77 150.15 40.43 Favored Pre-proline 0 C--N 1.315 -0.923 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.505 ' HA ' ' HB3' ' A' ' 255' ' ' ALA . 12.4 Cg_exo -68.44 110.5 2.29 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.416 2.077 . . . . 0.0 111.518 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' CYS . . . . . 0.535 ' HB3' ' HB2' ' A' ' 252' ' ' ASP . 51.9 t -70.52 164.65 24.32 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.907 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -53.34 -40.05 64.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.6 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -99.86 7.17 45.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.793 0.33 . . . . 0.0 111.493 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . 0.535 ' HB2' ' HB3' ' A' ' 249' ' ' CYS . 7.4 m-20 -127.6 69.19 1.31 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.132 0.491 . . . . 0.0 110.131 176.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -78.2 -21.58 49.86 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.178 0.513 . . . . 0.0 110.189 -179.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 19.8 p -83.04 -0.35 48.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.847 177.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . 0.505 ' HB3' ' HA ' ' A' ' 248' ' ' PRO . . . -77.19 132.59 38.84 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.572 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.62 137.28 40.64 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.026 -178.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.564 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -87.26 107.59 18.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.141 0.496 . . . . 0.0 110.095 179.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 94.4 mt -116.3 151.11 36.5 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.782 -176.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -119.13 157.0 28.77 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.22 176.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 47.4 t -65.03 122.64 16.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.565 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 96.28 18.45 31.09 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.801 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -99.38 170.5 8.59 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 177.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 25.9 mm -117.76 112.83 40.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.042 0.449 . . . . 0.0 110.307 -178.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 239' ' ' PHE . 30.8 t -88.41 113.0 24.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.65 -178.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -92.26 87.59 6.13 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.829 177.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.518 HG21 ' HB3' ' A' ' 275' ' ' TRP . 3.0 p -92.69 120.05 41.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.384 0.611 . . . . 0.0 110.809 -177.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 1.4 p -94.03 -26.95 16.57 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.754 -178.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . 0.586 ' HB2' ' HB3' ' A' ' 276' ' ' GLU . 28.6 mmm180 -116.24 104.51 11.58 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.864 0.364 . . . . 0.0 110.938 -178.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 36.9 mmm -94.51 131.87 39.78 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 177.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 31.7 p30 -125.44 -179.16 4.49 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.638 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 19.6 pt -103.31 8.21 9.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.172 0.51 . . . . 0.0 110.738 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -81.35 -31.51 33.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.717 -176.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 117.91 -40.2 2.39 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.665 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.543 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 1.9 mp0 -94.76 114.98 26.96 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 174.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.518 ' HB3' HG21 ' A' ' 266' ' ' VAL . 21.9 m0 -91.68 157.53 16.9 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -177.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.586 ' HB3' ' HB2' ' A' ' 268' ' ' ARG . 8.0 tp10 -90.39 103.08 15.8 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -115.91 137.96 14.17 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.266 -0.968 . . . . 0.0 113.559 -172.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -105.99 108.95 20.72 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 175.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . 0.404 HG22 ' HA ' ' A' ' 264' ' ' VAL . 37.9 t -119.47 -87.64 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.056 -0.658 . . . . 0.0 112.108 -173.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -105.08 76.25 1.23 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.936 0.398 . . . . 0.0 111.072 -174.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 66.15 20.73 69.38 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.825 176.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 282' ' ' ARG . 38.1 ttt-85 -158.87 137.41 10.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.838 0.319 . . . . 0.0 110.64 -175.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 38.1 ttpt -110.08 128.45 55.44 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.599 177.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -156.67 173.72 34.4 Favored Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 -178.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.543 ' HB3' ' HB3' ' A' ' 274' ' ' GLN . 72.5 mt -89.1 138.01 31.8 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.039 0.447 . . . . 0.0 110.417 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.445 ' O ' ' HA ' ' A' ' 274' ' ' GLN . 35.7 p90 -137.83 133.08 17.53 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.21 178.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.67 131.93 23.97 Favored 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 122.547 2.164 . . . . 0.0 111.656 176.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -65.62 -2.39 3.47 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.69 -177.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.89 -0.46 55.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.96 0.41 . . . . 0.0 111.296 -179.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -111.65 -12.5 13.89 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.801 0.334 . . . . 0.0 110.892 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.522 HG12 ' HA ' ' A' ' 242' ' ' ALA . 27.9 m -128.29 162.47 34.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.999 -179.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -136.43 132.35 35.33 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.944 0.402 . . . . 0.0 111.027 175.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.585 HD13 ' HB2' ' A' ' 240' ' ' ALA . 42.0 mm -72.29 129.81 35.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.454 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 294' ' ' PHE . . . . . 0.641 ' O ' ' HD3' ' A' ' 296' ' ' PRO . 10.2 p90 -135.08 -170.93 2.68 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.595 -179.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -98.07 97.08 3.99 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-O 121.357 0.599 . . . . 0.0 110.87 176.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . 0.641 ' HD3' ' O ' ' A' ' 294' ' ' PHE . 1.1 Cg_endo . . . . . 0 N--CA 1.458 -0.579 0 C-N-CA 122.921 2.414 . . . . 0.0 112.098 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.584 ' HB3' HD12 ' A' ' 99' ' ' ILE . 64.2 m . . . . . 0 N--CA 1.467 0.403 0 CA-C-O 120.508 0.194 . . . . 0.0 111.485 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.563 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . -72.36 107.22 4.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.689 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.445 ' HD3' ' HA ' ' A' ' 5' ' ' ARG . 19.1 mmt180 -137.55 100.05 4.11 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.112 0.482 . . . . 0.0 111.418 -178.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -167.65 159.69 12.16 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.33 -0.85 . . . . 0.0 108.88 177.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -83.11 108.42 16.37 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 177.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.636 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 15.4 m -74.89 55.86 0.71 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.319 179.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.1 m -161.85 -39.67 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.948 0.404 . . . . 0.0 110.781 -179.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -71.81 110.37 6.29 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.19 0.519 . . . . 0.0 111.386 -171.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.401 ' HG2' ' H ' ' A' ' 11' ' ' ARG . 9.3 mmt180 -60.78 -35.65 77.0 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.712 -178.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.526 ' HA ' ' NH1' ' A' ' 104' ' ' ARG . 67.0 m -71.18 -3.57 20.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.504 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.73 -46.87 7.36 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.139 177.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 17.3 p-90 -118.57 -21.25 8.04 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -170.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -80.4 121.72 26.07 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 121.86 -0.525 . . . . 0.0 111.18 -173.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.577 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 23.1 mmt -99.81 -5.21 28.95 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.653 -176.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.442 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.15 -113.82 2.47 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 116.034 -0.53 . . . . 0.0 113.359 -176.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.442 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 9.2 Cg_exo -72.56 91.09 0.79 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.19 2.593 . . . . 0.0 113.511 -176.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.5 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 73.7 t -144.99 153.76 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 176.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.2 p -121.19 -179.83 4.17 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 118.233 0.469 . . . . 0.0 109.78 -174.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.619 ' HD2' HH22 ' A' ' 39' ' ' ARG . 21.2 mmm180 -55.25 -54.59 41.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.649 0.261 . . . . 0.0 110.879 177.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -64.47 -39.59 94.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.868 -175.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.509 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 50.4 mt-10 -69.68 -48.08 60.98 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.404 179.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.19 -38.8 71.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.017 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.6 tp-100 -53.2 -58.56 6.62 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.451 175.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.57 ' HA ' ' HB3' ' A' ' 29' ' ' GLN . 10.4 t -75.99 -2.63 31.48 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -171.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' A' ' 23' ' ' GLU . 52.2 mmm-85 -85.29 -20.93 29.29 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.162 0.506 . . . . 0.0 109.682 175.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.576 HD22 ' HB2' ' A' ' 53' ' ' SER . 29.7 mt -123.14 -12.71 7.87 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.737 -177.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.729 ' NE2' ' HB3' ' A' ' 57' ' ' ARG . 3.9 tp-100 -67.33 115.64 7.2 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.172 0.589 . . . . 0.0 111.743 -178.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 66.62 10.98 56.1 Favored Glycine 0 C--N 1.331 0.292 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.855 176.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.486 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 15.2 mm100 -70.1 -87.02 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -177.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -158.07 -4.36 0.09 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.465 ' HA ' ' OG ' ' A' ' 53' ' ' SER . 29.0 m170 71.17 161.37 0.23 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.359 0.599 . . . . 0.0 111.559 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.11 -22.55 8.15 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.07 177.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.743 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 57.9 mtm -82.25 147.44 28.94 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 178.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -140.25 164.37 30.26 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.261 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.577 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.3 pp -152.69 134.88 14.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.037 0.446 . . . . 0.0 111.463 178.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.6 t -105.81 127.29 60.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 173.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.619 HH22 ' HD2' ' A' ' 21' ' ' ARG . 31.9 ptt-85 -131.15 -178.45 4.84 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.684 -0.235 . . . . 0.0 110.652 -174.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -69.93 132.21 45.61 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 171.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.493 ' HA ' HG23 ' A' ' 49' ' ' VAL . 22.6 t -72.87 155.91 39.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.65 0.738 . . . . 0.0 112.246 -175.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.4 p -102.14 10.29 39.55 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.383 177.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 36.0 p -95.27 -51.54 4.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.855 178.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 1.7 p -165.91 144.11 4.81 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.127 179.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 44' ' ' CYS . 47.4 Cg_exo -57.54 125.37 18.57 Favored 'Trans proline' 0 C--O 1.237 0.471 0 C-N-CA 123.006 2.471 . . . . 0.0 112.268 178.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.65 -31.42 5.56 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -176.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -89.3 167.78 12.78 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 177.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -135.98 176.01 9.08 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.76 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.493 HG23 ' HA ' ' A' ' 41' ' ' SER . 48.4 t -142.93 110.87 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.945 0.402 . . . . 0.0 111.319 177.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.3 tp -80.84 105.61 12.2 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.184 174.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.0 m -98.27 131.57 44.48 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 174.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.587 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 46.2 t -118.64 143.13 30.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.493 -177.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.576 ' HB2' HD22 ' A' ' 28' ' ' LEU . 40.2 t -88.75 110.32 20.9 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 122.218 -0.301 . . . . 0.0 111.267 -177.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.516 ' HG2' ' O ' ' A' ' 94' ' ' ASP . 6.2 tp10 -177.85 165.93 2.05 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 174.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.55 ' HB2' HH21 ' A' ' 57' ' ' ARG . 2.6 m-80 60.3 50.48 6.17 Favored 'General case' 0 CA--C 1.48 -1.742 0 C-N-CA 123.905 0.882 . . . . 0.0 108.657 -168.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 55' ' ' ASN . 66.4 m 71.61 -28.7 0.19 Allowed 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 113.516 -1.675 . . . . 0.0 110.95 -171.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.753 ' NE ' ' H ' ' A' ' 58' ' ' VAL 0.399 0.0 OUTLIER -153.21 -54.01 0.11 Allowed 'General case' 0 C--N 1.364 1.23 1 N-CA-C 124.965 5.172 . . . . 0.0 124.965 -174.619 . . . . . . . . 5 4 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.753 ' H ' ' NE ' ' A' ' 57' ' ' ARG . 1.7 t -152.29 120.8 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 CA-C-N 122.49 2.405 . . . . 0.0 114.046 -173.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.531 ' HB2' ' HB ' ' A' ' 52' ' ' VAL . 0.9 OUTLIER -97.98 110.83 23.33 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 163.513 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.587 ' CE1' HG11 ' A' ' 58' ' ' VAL . 92.4 m-70 -98.13 118.17 34.16 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 121.546 -0.721 . . . . 0.0 112.555 -173.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.716 ' CZ ' HD22 ' A' ' 93' ' ' LEU . 37.2 m-85 -122.36 109.21 14.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.674 179.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.573 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 67.9 mt -81.03 135.12 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 O-C-N 121.859 -0.526 . . . . 0.0 111.636 -178.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.475 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 5.3 mp -112.96 111.69 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 120.881 0.372 . . . . 0.0 110.905 179.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.692 ' HB2' ' CG ' ' A' ' 72' ' ' LYS . 23.4 m120 -88.98 148.13 23.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.495 -174.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.6 t -83.82 105.84 15.04 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.136 175.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.407 HD21 ' HE2' ' A' ' 72' ' ' LYS . 91.0 mt -82.74 140.68 43.98 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 177.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.52 -9.05 16.68 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.077 2.518 . . . . 0.0 112.978 -177.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -91.82 19.26 6.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.326 177.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.481 ' HA ' ' NE ' ' A' ' 69' ' ' ARG . 5.2 mmp_? 58.7 32.32 22.06 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.405 0.621 . . . . 0.0 110.627 -174.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.448 HH11 ' HD3' ' A' ' 70' ' ' ARG . 34.1 mtp180 -114.42 -178.84 3.47 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.272 179.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.475 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 55.6 m-85 -138.87 142.41 38.59 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.486 0.184 . . . . 0.0 111.148 -178.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.692 ' CG ' ' HB2' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -123.26 120.57 33.49 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-O 120.813 0.339 . . . . 0.0 110.874 178.914 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.621 HD11 ' CB ' ' A' ' 61' ' ' TYR . 17.6 tt -93.51 89.53 2.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.917 0.865 . . . . 0.0 110.817 -177.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.523 ' O ' ' HB3' ' A' ' 75' ' ' ASP . . . 59.51 77.08 0.19 Allowed Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.305 -178.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.523 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 16.6 t70 78.54 -52.24 0.48 Allowed 'General case' 0 N--CA 1.48 1.051 0 O-C-N 123.749 0.323 . . . . 0.0 111.409 178.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -70.47 134.8 48.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.0 0.429 . . . . 0.0 111.795 -173.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.422 ' OE1' ' HB3' ' A' ' 72' ' ' LYS . 6.0 mm-40 -89.49 143.9 26.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.185 -177.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.482 ' HZ ' ' CD2' ' A' ' 87' ' ' PHE . 47.0 m-85 -140.52 -175.42 4.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.293 172.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -75.38 -56.81 4.35 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.17 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.479 ' ND1' ' HD2' ' A' ' 82' ' ' PRO . 2.5 p80 -166.81 -174.0 2.59 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.762 175.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.664 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 16.4 mt -53.51 -59.74 8.73 Favored Pre-proline 0 N--CA 1.47 0.547 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -177.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.664 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 38.5 Cg_exo -65.11 3.2 1.05 Allowed 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 122.752 2.301 . . . . 0.0 113.56 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.475 ' HB3' ' H ' ' A' ' 80' ' ' HIS . . . -106.07 -35.06 7.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.911 0.386 . . . . 0.0 110.669 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.6 pp -76.14 -30.74 58.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.938 0.399 . . . . 0.0 110.127 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.477 ' N ' HD12 ' A' ' 84' ' ' LEU . 79.2 mt -63.66 -27.88 69.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.042 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.581 ' HA ' ' HD3' ' A' ' 89' ' ' LYS . 19.9 tp10 -80.9 -21.96 40.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.98 -176.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.482 ' CD2' ' HZ ' ' A' ' 78' ' ' PHE . 62.4 t80 -83.02 -20.61 34.72 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.898 0.856 . . . . 0.0 109.243 -177.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.517 ' CG ' HD21 ' A' ' 93' ' ' LEU . 35.5 m-85 -97.27 1.98 50.24 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.444 -177.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.581 ' HD3' ' HA ' ' A' ' 86' ' ' GLU . 53.8 mtpt -86.23 -2.24 58.19 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.967 173.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 33.2 pt -131.85 -8.52 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 CA-C-O 121.432 0.634 . . . . 0.0 109.365 177.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.462 ' HB2' ' O ' ' A' ' 87' ' ' PHE . 8.2 t60 -82.82 -32.54 27.56 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.602 -174.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.441 ' H ' HG22 ' A' ' 97' ' ' THR . 95.4 m-85 56.93 78.84 0.2 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.92 -166.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.716 HD22 ' CZ ' ' A' ' 61' ' ' TYR . 12.9 mt -45.77 -83.03 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.21 0 O-C-N 124.091 0.87 . . . . 0.0 110.34 178.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.572 ' HB2' ' HG3' ' A' ' 154' ' ' GLU . 45.5 t0 -109.13 84.17 1.88 Allowed 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.908 -179.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 1.086 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 4.8 t 49.93 17.68 0.31 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.643 0.777 . . . . 0.0 112.152 -178.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.8 t -163.12 157.58 20.82 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 -178.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.441 HG22 ' H ' ' A' ' 92' ' ' TYR . 7.9 p -98.4 176.33 5.73 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.644 0.259 . . . . 0.0 110.463 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.4 mt -72.02 90.65 1.18 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 174.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.584 HD12 ' HB3' ' A' ' 3' ' ' SER . 50.1 mm -73.74 -54.39 15.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.247 -175.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.743 ' O ' ' HA ' ' A' ' 35' ' ' MET . 11.1 pt-20 -158.44 153.74 22.06 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.032 -177.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.73 145.95 33.23 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 121.924 1.749 . . . . 0.0 111.531 176.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.433 ' HB2' ' HB3' ' A' ' 35' ' ' MET . . . -72.08 150.7 92.5 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.34 134.35 63.17 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.409 2.073 . . . . 0.0 111.673 175.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.526 ' NH1' ' HA ' ' A' ' 12' ' ' SER . 56.2 mtm180 . . . . . 0 C--N 1.33 -0.263 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -174.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.904 HD12 HG21 ' A' ' 152' ' ' ILE . 3.9 mm? . . . . . 0 N--CA 1.469 0.488 0 CA-C-O 121.695 0.76 . . . . 0.0 111.386 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.46 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 44.7 tt0 -169.39 -72.25 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.161 -178.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -117.66 114.64 23.67 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.634 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.868 HG22 ' HG3' ' A' ' 180' ' ' LYS . 57.4 t -126.38 150.15 31.82 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.096 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.732 ' CZ ' HD13 ' A' ' 181' ' ' LEU . 0.0 OUTLIER -124.73 155.01 39.98 Favored 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 118.014 -1.474 . . . . 0.0 109.031 165.158 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.639 ' OG1' ' HB2' ' A' ' 144' ' ' PHE . 72.9 p -106.02 140.05 39.61 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.216 0.531 . . . . 0.0 111.072 178.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.579 HD21 ' HG2' ' A' ' 179' ' ' GLU . 8.8 mt -113.73 -5.9 13.31 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.039 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.443 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 28.6 t80 -93.91 -41.11 9.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.694 -173.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.647 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 10.7 t70 74.28 95.53 0.07 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.486 0.66 . . . . 0.0 110.69 -178.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.64 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 75.4 t80 -126.01 90.46 50.21 Favored Pre-proline 0 C--N 1.318 -0.765 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 173.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.584 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 95.0 Cg_endo -85.92 81.19 1.7 Allowed 'Trans proline' 0 N--CA 1.44 -1.636 0 C-N-CA 121.712 1.608 . . . . 0.0 112.144 178.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -69.69 -11.96 66.55 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.302 175.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.52 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 19.5 m120 50.3 65.86 1.32 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 114.297 -0.951 . . . . 0.0 111.629 177.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.563 ' HB3' ' H ' ' A' ' 141' ' ' ASP . 1.0 OUTLIER -130.88 -176.61 4.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.364 0.602 . . . . 0.0 110.898 -178.612 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -111.41 0.63 16.64 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 167.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -117.09 -45.99 2.73 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.691 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.563 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 8.4 m-20 -97.67 128.1 44.12 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 168.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 1.098 HD11 ' HB2' ' A' ' 165' ' ' ASN . 28.9 tp -84.61 124.48 73.17 Favored Pre-proline 0 CA--C 1.517 -0.321 0 O-C-N 122.095 -0.378 . . . . 0.0 110.98 -176.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.584 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 49.7 Cg_endo -76.11 105.79 2.14 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 121.502 1.468 . . . . 0.0 111.707 166.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.64 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -93.42 -161.68 0.87 Allowed 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 175.364 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.647 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 68.6 mttm -138.07 -170.94 2.9 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.801 176.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.991 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -84.7 25.26 0.93 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.384 0.612 . . . . 0.0 109.913 -179.533 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 158.78 41.6 0.02 OUTLIER Glycine 0 N--CA 1.436 -1.353 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.898 -177.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.684 ' CD ' ' HG ' ' A' ' 150' ' ' LEU . 1.8 pp20? -84.7 170.04 13.68 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 173.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.438 HG13 ' CZ ' ' A' ' 129' ' ' ARG . 1.1 mp -111.78 128.54 68.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 118.453 0.569 . . . . 0.0 109.62 170.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.773 ' CD2' ' HA ' ' A' ' 165' ' ' ASN . 82.1 mt -119.42 155.95 31.05 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -172.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.595 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 62.0 t -123.51 120.22 59.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 172.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 1.122 HD13 ' HB2' ' A' ' 163' ' ' ALA . 25.8 mm -79.79 82.34 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.675 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.707 HG12 ' OE2' ' A' ' 154' ' ' GLU . 14.3 tt -72.21 -33.72 47.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-N 114.203 -1.362 . . . . 0.0 108.904 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.707 ' OE2' HG12 ' A' ' 153' ' ' ILE . 3.4 mp0 -125.86 143.61 51.0 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.046 176.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.587 ' HD2' ' HG ' ' A' ' 125' ' ' LEU . 83.1 tttt -136.08 87.82 23.12 Favored Pre-proline 0 C--N 1.316 -0.858 0 CA-C-O 121.108 0.48 . . . . 0.0 109.76 171.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 1.086 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 8.0 Cg_exo -76.35 -50.52 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.787 2.324 . . . . 0.0 112.112 174.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.651 ' HG2' ' CE ' ' A' ' 172' ' ' MET . 5.4 mm-40 -102.21 173.31 6.43 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.113 -173.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.515 ' O ' HG21 ' A' ' 175' ' ' VAL . 8.7 tp10 -104.83 -17.93 14.41 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 175.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -99.99 -17.0 17.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.314 174.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.463 ' HB2' ' HE1' ' A' ' 172' ' ' MET . 73.1 m95 -130.26 125.35 34.61 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.735 178.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . 0.749 ' HB3' HD12 ' A' ' 152' ' ' ILE . 50.0 m0 -112.81 135.81 53.14 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.021 0.438 . . . . 0.0 110.437 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.615 ' OG ' ' HG2' ' A' ' 172' ' ' MET . 70.5 m -93.31 92.93 7.92 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -174.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 1.122 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -109.45 146.78 33.96 Favored 'General case' 0 N--CA 1.415 -2.194 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -172.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.784 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 12.3 ptt180 -88.16 127.21 35.43 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 174.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 1.098 ' HB2' HD11 ' A' ' 142' ' ' LEU . 63.5 t30 -59.41 179.94 0.1 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.103 -1.408 . . . . 0.0 111.793 -170.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.434 ' HD3' ' H ' ' A' ' 149' ' ' ILE . 48.9 tptt -56.74 -20.88 24.37 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.52 167.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -79.88 -30.71 40.23 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.843 172.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.521 ' C ' ' HB2' ' A' ' 164' ' ' ARG . . . 101.53 7.95 47.43 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.064 -174.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.784 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -77.97 132.11 37.7 Favored 'General case' 0 C--O 1.217 -0.625 0 C-N-CA 122.646 0.378 . . . . 0.0 111.222 177.243 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.461 HG22 HG21 ' A' ' 153' ' ' ILE . 47.9 t -82.43 125.47 39.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.634 -179.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -159.17 152.39 23.4 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 121.042 -0.599 . . . . 0.0 111.965 173.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.651 ' CE ' ' HG2' ' A' ' 157' ' ' GLU . 35.9 mtp -77.5 142.96 38.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.893 0.346 . . . . 0.0 110.704 -178.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.69 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.7 pp -142.45 144.93 32.67 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.019 -175.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.453 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 22.8 Cg_exo -65.05 129.94 24.41 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 122.834 2.356 . . . . 0.0 113.004 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.643 ' O ' HG22 ' A' ' 178' ' ' VAL . 58.0 t -64.87 -41.6 56.75 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 18.6 Cg_endo -61.29 -6.8 7.23 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 121.858 1.705 . . . . 0.0 112.748 176.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.453 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.2 m-30 -95.53 -9.23 32.96 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.814 -178.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 175' ' ' VAL . 4.3 m -105.04 -171.98 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 -166.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.648 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 6.7 tp10 -159.15 49.6 0.34 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 112.678 -2.056 . . . . 0.0 111.812 -153.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.868 ' HG3' HG22 ' A' ' 128' ' ' VAL . 3.2 mppt? -69.66 136.13 50.74 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 119.603 -1.935 . . . . 0.0 111.081 -160.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.732 HD13 ' CZ ' ' A' ' 129' ' ' ARG . 14.6 tp . . . . . 0 CA--C 1.523 -0.096 0 CA-C-N 113.207 -1.815 . . . . 0.0 110.655 -168.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo . . . . . 0 N--CA 1.451 -1.02 0 CA-C-O 120.808 0.253 . . . . 0.0 112.029 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 22.9 t -89.63 145.32 7.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.507 ' HB2' ' HG3' ' A' ' 296' ' ' PRO . 84.7 m-85 -108.78 119.72 40.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.077 0.465 . . . . 0.0 111.105 -177.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.579 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -119.66 140.93 49.86 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.691 178.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.515 ' HB2' ' CE1' ' A' ' 294' ' ' PHE . 47.5 tttp -95.07 123.44 38.56 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . 0.505 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -71.44 102.77 2.74 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.29 -0.414 . . . . 0.0 109.961 -179.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 2.3 pp -82.27 -5.56 9.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.923 0.392 . . . . 0.0 111.972 -174.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.445 ' HG2' ' H ' ' A' ' 245' ' ' LYS . 2.2 tt0 -146.95 164.32 33.33 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 176.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.445 ' H ' ' HG2' ' A' ' 244' ' ' GLN . 45.1 mttp -61.37 149.66 37.58 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 176.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.588 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 24.3 tpt180 -137.62 94.81 2.96 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 169.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 34.4 m -101.2 152.94 38.03 Favored Pre-proline 0 C--N 1.315 -0.919 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.709 -176.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.408 ' HD3' ' HB2' ' A' ' 257' ' ' ALA . 71.8 Cg_endo -74.53 -161.2 0.11 Allowed 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.424 2.083 . . . . 0.0 111.816 177.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 34.9 t -151.05 -179.22 7.13 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -175.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -64.37 -34.01 77.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.671 0.272 . . . . 0.0 111.254 -178.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -95.55 11.19 33.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.399 -179.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.33 131.96 47.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.505 0.669 . . . . 0.0 112.638 -175.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . 0.419 ' HE3' ' HB3' ' A' ' 253' ' ' LYS . 6.3 ptpp? -150.53 0.46 0.43 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.663 167.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 1.2 p -144.88 14.85 1.54 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.304 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -101.59 117.86 35.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.137 0.494 . . . . 0.0 110.494 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.423 HD21 ' HB ' ' A' ' 279' ' ' VAL . 0.7 OUTLIER -78.59 134.68 37.18 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.178 -178.228 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.588 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -93.9 121.22 35.14 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.201 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.539 ' HB2' ' HB3' ' A' ' 246' ' ' ARG . 79.9 mt -123.73 152.68 41.86 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.041 -175.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -102.47 177.74 4.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.038 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 59.2 t -90.18 111.83 23.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.195 0.521 . . . . 0.0 110.551 -179.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 98.39 9.18 53.85 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.188 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -82.84 166.4 19.0 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -175.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 33.5 mm -104.67 110.82 31.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.255 0.55 . . . . 0.0 110.281 -177.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.489 HG22 HD22 ' A' ' 258' ' ' LEU . 14.0 t -96.44 108.75 21.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.806 -177.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 38.4 tttt -83.3 105.31 14.15 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.728 175.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.437 HG21 ' HB3' ' A' ' 275' ' ' TRP . 4.3 p -99.22 117.17 43.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.496 0.665 . . . . 0.0 110.605 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 12.1 m -94.94 -25.23 16.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.844 -176.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 268' ' ' ARG . 36.6 ttm180 -132.2 108.22 9.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.007 0.432 . . . . 0.0 110.954 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 32.1 mtt -94.75 126.95 40.4 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.657 178.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 274' ' ' GLN . 56.5 m-80 -99.9 153.56 19.06 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 177.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.585 ' H ' HD12 ' A' ' 271' ' ' ILE . 4.3 mp -72.73 -34.48 47.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.147 -172.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -62.67 -26.4 68.63 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.742 -176.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 127.92 -26.93 4.7 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.35 -0.929 . . . . 0.0 112.637 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.478 ' O ' ' HB2' ' A' ' 270' ' ' ASN . 45.3 mt-30 -78.92 115.5 18.65 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 177.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.517 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 49.9 m0 -96.24 150.9 20.03 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.816 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.44 ' HA ' ' O ' ' A' ' 284' ' ' GLY . 43.6 tt0 -108.93 109.58 20.69 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 175.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . 0.555 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -122.16 155.36 16.83 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.841 -178.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.572 ' HG2' ' HB3' ' A' ' 283' ' ' LYS . 23.2 mt-10 -104.58 109.0 20.73 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . 0.556 HG12 HD22 ' A' ' 280' ' ' ASN . 46.9 t -121.92 114.5 43.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -178.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . 0.556 HD22 HG12 ' A' ' 279' ' ' VAL . 67.2 m-80 64.77 27.6 13.0 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.896 -178.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 90.01 -10.78 72.83 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.417 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 44.5 ttt-85 -102.35 118.55 37.12 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.572 ' HB3' ' HG2' ' A' ' 278' ' ' GLU . 57.3 pttt -109.82 141.95 41.78 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.094 0.473 . . . . 0.0 111.188 179.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 276' ' ' GLU . . . -167.21 -174.79 36.68 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 -179.077 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.517 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 68.8 mt -90.2 138.66 31.34 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.162 0.506 . . . . 0.0 111.252 -177.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.446 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 46.1 p90 -142.74 131.58 11.69 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.711 173.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 17.6 Cg_exo -69.06 139.2 42.03 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 122.902 2.401 . . . . 0.0 111.822 177.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -65.57 -4.64 6.36 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.663 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 2.4 m -74.42 -22.82 58.96 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.933 0.397 . . . . 0.0 111.088 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 41.0 m-70 -94.12 -11.58 30.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.848 0.356 . . . . 0.0 111.149 -176.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.505 HG12 ' HA ' ' A' ' 242' ' ' ALA . 34.8 m -128.02 167.5 22.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.057 -178.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -140.9 128.47 21.4 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.848 0.356 . . . . 0.0 110.727 175.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.579 HD13 ' HB2' ' A' ' 240' ' ' ALA . 41.0 mm -67.83 126.54 27.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.241 177.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 294' ' ' PHE . . . . . 0.515 ' CE1' ' HB2' ' A' ' 241' ' ' LYS . 1.4 p90 -141.14 -179.59 6.19 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.504 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -101.6 96.09 5.96 Favored Pre-proline 0 C--N 1.322 -0.628 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . 0.507 ' HG3' ' HB2' ' A' ' 239' ' ' PHE . 43.0 Cg_endo . . . . . 0 C--N 1.345 0.363 0 C-N-CA 122.604 2.203 . . . . 0.0 113.112 -173.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.547 ' HB2' HD12 ' A' ' 99' ' ' ILE . 13.7 p . . . . . 0 CA--C 1.529 0.171 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.98 110.76 4.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.378 177.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.548 ' HA ' ' CZ ' ' A' ' 5' ' ' ARG . 3.6 mmp_? -115.25 -5.72 12.38 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -172.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.435 ' HD1' ' H ' ' A' ' 6' ' ' PHE . 6.3 p90 -79.25 155.41 28.58 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.476 -174.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -66.24 -36.29 82.63 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.574 -176.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.1 t 65.39 37.88 6.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.335 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.8 m -152.34 -33.05 0.13 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.278 177.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -77.56 113.93 15.88 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.98 0.419 . . . . 0.0 111.285 -173.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -57.72 -45.35 85.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.201 -175.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 51.1 m -71.74 1.67 6.5 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -91.06 -42.07 10.71 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.601 176.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 22.4 p-90 -122.73 -29.07 4.07 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -174.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -77.71 103.2 7.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.808 0.337 . . . . 0.0 111.554 -173.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.468 ' HB3' HG21 ' A' ' 19' ' ' VAL . 23.6 mmt -87.28 -6.53 58.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.288 -176.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 49.93 -115.54 3.17 Favored Glycine 0 CA--C 1.52 0.359 0 CA-C-N 115.629 -0.714 . . . . 0.0 113.306 -178.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.58 99.78 1.26 Allowed 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 122.475 2.116 . . . . 0.0 112.535 -176.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.62 HG13 ' HB3' ' A' ' 23' ' ' GLU . 3.5 t -130.11 -70.49 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-O 118.243 -0.884 . . . . 0.0 111.73 -176.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 19' ' ' VAL . 22.9 t 108.46 161.32 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.126 1.371 . . . . 0.0 109.219 173.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 34.0 ttt85 -64.89 -38.81 92.23 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.801 0.334 . . . . 0.0 110.241 -177.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -64.9 -34.26 77.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.429 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.62 ' HB3' HG13 ' A' ' 19' ' ' VAL . 0.4 OUTLIER -84.21 -53.13 5.72 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.801 -174.565 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.503 ' HB2' ' HD3' ' A' ' 39' ' ' ARG . . . -56.05 -40.95 74.3 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.782 -178.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.58 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 55.0 tp60 -62.42 -44.53 96.22 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.569 -178.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.485 HG22 ' O ' ' A' ' 23' ' ' GLU . 9.1 t -75.69 -15.49 60.3 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 120.818 0.342 . . . . 0.0 111.055 -177.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.53 ' HG2' ' O ' ' A' ' 23' ' ' GLU . 52.2 mmm-85 -76.96 -19.59 57.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.922 0.392 . . . . 0.0 110.357 176.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.635 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 78.1 mt -128.84 -13.1 4.7 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -173.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.58 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -66.21 107.61 2.01 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.844 0.354 . . . . 0.0 110.757 -173.789 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.3 -2.24 67.2 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.822 -0.704 . . . . 0.0 113.331 175.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -78.31 -175.05 4.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.728 0.264 . . . . 0.0 110.587 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.606 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 12.4 ttp180 -52.68 131.02 34.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.334 0.588 . . . . 0.0 110.827 -179.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.59 ' HB3' ' OE1' ' A' ' 54' ' ' GLU . 43.6 m170 -82.03 145.1 30.4 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.407 -175.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.35 -12.91 48.02 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 111.606 -0.597 . . . . 0.0 111.606 -176.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.606 ' SD ' ' HB3' ' A' ' 32' ' ' ARG . 11.6 mtp -81.55 141.47 33.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.687 0.28 . . . . 0.0 110.737 178.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.504 ' HB2' HG22 ' A' ' 52' ' ' VAL . 33.1 p90 -143.24 167.43 22.15 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.691 -178.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.463 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.4 pp -158.08 138.52 12.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.155 0.503 . . . . 0.0 111.453 175.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.411 HG22 HD13 ' A' ' 50' ' ' LEU . 48.3 t -102.94 120.8 53.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 174.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.503 ' HD3' ' HB2' ' A' ' 24' ' ' ALA . 23.8 ptt-85 -125.94 -169.45 2.01 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.639 0.257 . . . . 0.0 110.71 -175.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -68.9 140.49 55.14 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.829 177.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.4 t -86.23 104.66 15.98 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 167.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.9 m -71.65 -11.4 60.82 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.378 -177.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 16.9 p -84.59 -29.74 25.57 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.996 0.427 . . . . 0.0 110.261 176.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 52.4 t -151.34 95.37 3.34 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.017 178.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -58.06 113.9 1.73 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.922 2.415 . . . . 0.0 112.066 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 130.37 -33.04 2.97 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -174.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.595 ' OD2' ' HA ' ' A' ' 64' ' ' ASN . 2.6 m-20 -88.42 175.86 7.43 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 170.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.535 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 44.1 m-85 -136.17 175.58 9.47 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.407 -175.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.2 t -142.46 106.71 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.926 0.393 . . . . 0.0 110.67 176.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.411 HD13 HG22 ' A' ' 38' ' ' VAL . 46.7 tp -80.97 103.76 11.01 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.389 176.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.1 m -96.45 126.66 41.79 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 176.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 95.4 t -121.76 135.89 60.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.754 -175.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.635 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 23.4 t -95.88 114.75 26.51 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -175.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.602 ' HG3' HD22 ' A' ' 55' ' ' ASN . 9.4 tp10 -151.48 154.7 37.08 Favored 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 119.53 -0.868 . . . . 0.0 108.999 164.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.602 HD22 ' HG3' ' A' ' 54' ' ' GLU . 0.5 OUTLIER 45.4 37.52 3.01 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.537 0.735 . . . . 0.0 112.701 -177.666 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 34.5 m 49.38 56.09 8.35 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 122.403 1.097 . . . . 0.0 109.459 -178.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.523 ' HB2' ' O ' ' A' ' 55' ' ' ASN . 1.5 tmm_? -165.67 64.32 0.11 Allowed 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 113.312 -1.767 . . . . 0.0 109.33 -152.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 14.1 t -72.3 106.33 2.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.961 0.886 . . . . 0.0 110.353 -169.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.4 m -76.64 122.49 24.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 113.899 -1.5 . . . . 0.0 111.31 -177.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -95.55 102.37 14.17 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.107 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.674 ' OH ' ' HB3' ' A' ' 93' ' ' LEU . 70.8 m-85 -97.35 109.26 22.05 Favored 'General case' 0 C--O 1.221 -0.396 0 C-N-CA 123.079 0.552 . . . . 0.0 110.667 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.559 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 59.2 mt -80.03 128.88 38.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -173.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.629 HG23 ' HB3' ' A' ' 71' ' ' PHE . 3.1 mp -99.7 111.08 28.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.707 177.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.595 ' HA ' ' OD2' ' A' ' 47' ' ' ASP . 15.9 m120 -83.94 133.81 34.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.944 178.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.2 t -89.16 95.79 10.45 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.555 HD11 ' HB2' ' A' ' 72' ' ' LYS . 83.6 mt -81.07 147.79 62.25 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.247 -176.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -76.77 -9.38 18.3 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.932 2.421 . . . . 0.0 112.877 -179.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 35.2 p30 -81.19 7.85 10.25 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.575 0.702 . . . . 0.0 109.322 171.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.741 ' HA ' ' NE ' ' A' ' 69' ' ' ARG . 3.4 tpm_? 61.64 58.27 2.06 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.125 -1.398 . . . . 0.0 110.981 -176.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.873 ' HG2' ' HA ' ' A' ' 79' ' ' ASP . 79.4 mtt180 -135.41 176.73 8.41 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.24 172.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.629 ' HB3' HG23 ' A' ' 63' ' ' ILE . 52.2 m-85 -130.48 113.51 14.38 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.021 0.438 . . . . 0.0 109.83 176.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.593 ' HE2' ' HA ' ' A' ' 75' ' ' ASP . 36.0 tttm -98.19 105.02 17.1 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.981 -173.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.687 HD13 ' CE2' ' A' ' 88' ' ' TYR . 16.3 tt -81.0 79.35 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 122.18 0.99 . . . . 0.0 111.0 -176.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.78 -10.36 18.97 Favored Glycine 0 CA--C 1.52 0.378 0 CA-C-N 115.004 -0.998 . . . . 0.0 113.87 176.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.593 ' HA ' ' HE2' ' A' ' 72' ' ' LYS . 8.7 t70 177.28 -68.71 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 116.944 0.372 . . . . 0.0 110.321 -170.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -66.35 123.64 20.52 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.921 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.445 ' O ' ' HG3' ' A' ' 77' ' ' GLU . 13.7 pt-20 -93.62 105.25 17.31 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.734 0.778 . . . . 0.0 110.728 177.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.478 ' CZ ' ' CD1' ' A' ' 87' ' ' PHE . 84.1 m-85 -95.03 152.25 18.48 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 174.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.873 ' HA ' ' HG2' ' A' ' 70' ' ' ARG . 8.3 m-20 -67.99 -23.24 65.0 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -171.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.624 ' ND1' ' HG2' ' A' ' 82' ' ' PRO . 6.0 p80 -162.36 165.47 26.44 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.736 -0.211 . . . . 0.0 110.438 -178.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.547 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 10.0 mt -55.99 -54.89 47.32 Favored Pre-proline 0 CA--C 1.535 0.377 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -178.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.624 ' HG2' ' ND1' ' A' ' 80' ' ' HIS . 15.4 Cg_endo -61.12 -4.17 3.65 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.183 1.922 . . . . 0.0 113.796 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.412 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -89.87 -34.94 15.91 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.762 0.315 . . . . 0.0 110.769 178.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.1 pp -76.94 -30.96 56.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.135 0.493 . . . . 0.0 109.838 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 70.1 mt -68.43 -21.56 64.65 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.491 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.548 ' OE2' ' HD2' ' A' ' 89' ' ' LYS . 18.8 tp10 -85.81 -35.43 20.68 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.183 176.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.547 ' HE1' ' CZ ' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -71.56 -19.54 62.14 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.333 0.587 . . . . 0.0 111.436 -179.815 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.687 ' CE2' HD13 ' A' ' 73' ' ' ILE . 38.7 m-85 -94.96 5.47 51.83 Favored 'General case' 0 C--N 1.313 -0.98 0 O-C-N 121.685 -0.634 . . . . 0.0 111.769 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.548 ' HD2' ' OE2' ' A' ' 86' ' ' GLU . 96.2 mttt -77.52 -25.91 50.64 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.685 171.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.596 ' H ' HD13 ' A' ' 90' ' ' ILE . 0.3 OUTLIER -106.32 -17.67 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 CA-C-O 121.41 0.624 . . . . 0.0 109.756 174.148 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.489 ' HB2' ' O ' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -93.97 106.41 18.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.78 178.771 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -72.46 104.23 3.74 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.756 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.713 ' O ' ' HB3' ' A' ' 154' ' ' GLU . 16.5 mt -59.43 -31.02 68.9 Favored 'General case' 0 C--O 1.215 -0.757 0 O-C-N 124.356 1.035 . . . . 0.0 111.431 -176.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.483 ' HB3' ' HA ' ' A' ' 154' ' ' GLU . 24.5 p-10 -176.18 85.47 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.883 0.849 . . . . 0.0 110.532 164.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 71.78 -19.18 0.27 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.592 -175.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 97' ' ' THR . 18.0 m -132.49 146.03 51.62 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 120.968 0.413 . . . . 0.0 110.625 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.44 ' O ' HG22 ' A' ' 96' ' ' THR . 37.4 p -96.16 -178.17 4.24 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.533 178.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.468 HD22 ' CD2' ' A' ' 36' ' ' PHE . 96.1 mt -70.84 106.3 3.55 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 174.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.547 HD12 ' HB2' ' A' ' 3' ' ' SER . 46.4 mm -89.86 -63.07 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.189 0.519 . . . . 0.0 110.422 -177.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.585 ' O ' ' HA ' ' A' ' 35' ' ' MET . 11.2 pt-20 -157.69 151.5 19.51 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.426 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.6 155.55 68.55 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.274 1.983 . . . . 0.0 112.362 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.563 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -69.07 146.56 97.25 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.476 179.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -57.61 130.92 41.25 Favored 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 122.618 2.212 . . . . 0.0 112.951 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 . . . . . 0 C--N 1.325 -0.485 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 172.823 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.865 HD12 HG21 ' A' ' 152' ' ' ILE . 4.3 mm? . . . . . 0 N--CA 1.468 0.428 0 CA-C-O 121.652 0.739 . . . . 0.0 110.814 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.71 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 4.9 tp10 -165.61 -74.28 0.03 OUTLIER 'General case' 0 C--O 1.218 -0.554 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.028 -169.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -108.17 110.95 22.71 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.036 0.446 . . . . 0.0 110.296 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.821 HG22 ' HG3' ' A' ' 180' ' ' LYS . 86.4 t -125.87 136.65 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.647 176.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.683 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 5.6 ptp180 -112.13 147.16 36.71 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 117.41 -1.716 . . . . 0.0 108.474 169.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.599 HG22 HG12 ' A' ' 178' ' ' VAL . 7.6 p -99.72 135.56 40.96 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.628 177.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.594 HD21 ' HG2' ' A' ' 179' ' ' GLU . 14.3 mt -108.41 3.0 22.8 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -177.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.449 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 27.0 t80 -99.94 -43.34 6.42 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.494 -0.483 . . . . 0.0 112.112 -174.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.669 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 14.5 t70 73.04 96.85 0.07 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.513 0.673 . . . . 0.0 109.888 -171.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.538 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 44.2 t80 -129.14 90.06 46.37 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 174.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.59 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 92.7 Cg_endo -90.52 84.35 0.4 Allowed 'Trans proline' 0 N--CA 1.436 -1.862 0 C-N-CA 121.914 1.743 . . . . 0.0 112.358 -178.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -78.67 -2.37 85.31 Favored Glycine 0 C--N 1.329 0.191 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.217 176.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.456 ' H ' ' HB3' ' A' ' 143' ' ' PRO . 19.0 m120 36.16 71.04 0.14 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 113.872 -1.164 . . . . 0.0 112.461 -175.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.594 ' HB3' ' H ' ' A' ' 141' ' ' ASP . 0.4 OUTLIER -132.7 -176.59 4.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.22 0.533 . . . . 0.0 111.317 -177.394 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -112.17 1.75 16.37 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 167.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -115.41 -44.4 2.98 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.296 175.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.594 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 9.7 m-20 -98.36 127.61 44.37 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 166.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 1.038 HD11 ' HB2' ' A' ' 165' ' ' ASN . 24.6 tp -81.88 130.7 59.68 Favored Pre-proline 0 CA--C 1.518 -0.254 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.283 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.619 ' HD2' HD12 ' A' ' 142' ' ' LEU . 72.0 Cg_endo -84.0 92.04 0.82 Allowed 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.121 1.881 . . . . 0.0 112.292 174.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.538 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 1.5 p90 -90.89 179.73 5.69 Favored 'General case' 0 CA--C 1.504 -0.799 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.817 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.669 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 16.3 mtpp -122.05 -176.6 3.38 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.294 172.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.757 ' H ' ' HD2' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -78.65 36.78 0.27 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.798 0.809 . . . . 0.0 110.852 -174.635 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 145' ' ' LYS . . . 151.66 42.75 0.02 OUTLIER Glycine 0 N--CA 1.433 -1.554 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.32 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.84 147.11 27.68 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 119.352 -0.939 . . . . 0.0 109.993 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.6 mp -87.26 125.76 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.868 -177.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.77 HD22 ' CD2' ' A' ' 142' ' ' LEU . 33.8 mt -122.18 158.11 30.1 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -176.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.71 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 61.8 t -120.08 121.49 65.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 175.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 1.043 HD13 ' HB2' ' A' ' 163' ' ' ALA . 38.0 mm -77.18 79.31 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 CA-C-O 122.183 0.992 . . . . 0.0 108.682 -177.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.572 HD12 ' HD3' ' A' ' 164' ' ' ARG . 16.7 tt -71.43 -32.87 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 CA-C-N 113.856 -1.52 . . . . 0.0 109.09 -177.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.713 ' HB3' ' O ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -123.35 140.27 53.18 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.604 171.909 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -127.73 88.46 53.37 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 167.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.616 ' HG2' ' HE3' ' A' ' 172' ' ' MET . 0.9 OUTLIER -81.74 -46.75 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.224 2.616 . . . . 0.0 111.71 177.678 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.487 ' HB2' ' O ' ' A' ' 160' ' ' TRP . 33.8 mm-40 -102.94 161.67 13.57 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.928 -176.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -88.96 -27.41 20.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.452 0.644 . . . . 0.0 109.338 172.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -94.12 -18.76 21.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.249 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.651 ' HB3' ' HE1' ' A' ' 172' ' ' MET . 48.5 m95 -130.24 131.45 45.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.132 -178.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . 0.72 ' HB3' HD12 ' A' ' 152' ' ' ILE . 50.5 m0 -119.4 135.15 54.87 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -178.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.58 ' OG ' ' HG2' ' A' ' 172' ' ' MET . 21.6 m -99.6 95.0 6.68 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -174.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 1.043 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -104.03 147.21 27.65 Favored 'General case' 0 N--CA 1.418 -2.037 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.075 -174.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.752 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 24.5 ptt-85 -86.44 123.24 31.44 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 175.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 1.038 ' HB2' HD11 ' A' ' 142' ' ' LEU . 6.1 t30 -55.09 172.04 0.13 Allowed 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 113.151 -1.841 . . . . 0.0 110.416 -172.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 36.5 tttp -58.21 -12.68 3.82 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.227 0.537 . . . . 0.0 110.039 174.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -83.5 -45.76 13.22 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.71 172.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 130.24 -9.62 5.93 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.959 -173.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.752 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.1 OUTLIER -62.56 132.47 52.53 Favored 'General case' 0 C--O 1.216 -0.703 0 C-N-CA 123.712 0.805 . . . . 0.0 112.373 179.489 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.442 HG22 HG21 ' A' ' 153' ' ' ILE . 78.8 t -85.81 122.25 38.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 O-C-N 122.462 -0.149 . . . . 0.0 110.906 177.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 162' ' ' SER . . . -153.59 149.37 20.85 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.55 172.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.651 ' HE1' ' HB3' ' A' ' 160' ' ' TRP . 7.0 mtp -77.51 142.42 39.1 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.712 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.8 pp -143.77 144.94 28.94 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.42 -178.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.483 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 21.7 Cg_exo -65.01 133.47 35.9 Favored 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 122.854 2.369 . . . . 0.0 113.181 -178.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.485 ' O ' HG22 ' A' ' 178' ' ' VAL . 60.2 t -63.24 -42.02 72.66 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 177.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.409 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 36.3 Cg_exo -62.3 1.32 0.98 Allowed 'Trans proline' 0 C--N 1.359 1.097 0 C-N-CA 122.164 1.91 . . . . 0.0 113.172 176.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.483 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.1 m-85 -103.16 -12.78 17.11 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.506 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.669 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 3.8 m -105.83 -172.82 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 -166.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.683 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 7.5 tp10 -160.23 50.97 0.3 Allowed 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 113.004 -1.907 . . . . 0.0 112.271 -152.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.821 ' HG3' HG22 ' A' ' 128' ' ' VAL . 2.2 mppt? -69.2 137.45 53.25 Favored 'General case' 0 N--CA 1.462 0.161 0 O-C-N 119.706 -1.871 . . . . 0.0 111.319 -159.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.434 HD13 ' CZ ' ' A' ' 129' ' ' ARG . 13.0 tp . . . . . 0 N--CA 1.45 -0.464 0 CA-C-N 112.634 -2.076 . . . . 0.0 111.016 -170.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo . . . . . 0 N--CA 1.451 -1.023 0 N-CA-C 110.322 -0.684 . . . . 0.0 110.322 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.545 ' HB ' HG13 ' A' ' 266' ' ' VAL . 19.6 t -89.09 126.35 42.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-O 121.056 0.455 . . . . 0.0 110.425 -175.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -115.89 120.38 39.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.72 -177.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.571 ' HB2' HG13 ' A' ' 293' ' ' ILE . . . -120.34 145.05 47.5 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.262 178.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -95.1 120.69 35.75 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 175.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . 0.553 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -68.62 107.6 3.03 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.381 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.5 HD13 ' HD3' ' A' ' 292' ' ' LYS . 39.1 pt -85.17 -21.28 7.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.049 0.452 . . . . 0.0 110.611 -177.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -134.85 147.12 49.81 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.487 -178.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . 0.453 ' HG2' ' HA ' ' A' ' 259' ' ' GLU . 10.7 mtmp? -63.32 156.9 24.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.519 0.676 . . . . 0.0 111.32 -176.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.531 ' HG3' ' O ' ' A' ' 256' ' ' LEU . 27.6 tpt180 -140.35 122.21 15.48 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.764 -179.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . 0.402 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 16.9 m -127.58 153.68 77.58 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-O 120.834 0.35 . . . . 0.0 111.613 -175.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.514 ' HB3' ' CG ' ' A' ' 252' ' ' ASP . 7.4 Cg_exo -72.92 159.35 48.29 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.966 2.444 . . . . 0.0 112.078 178.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' CYS . . . . . 0.477 ' SG ' ' N ' ' A' ' 250' ' ' ALA . 42.3 t -104.59 -175.63 2.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.875 -178.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.477 ' N ' ' SG ' ' A' ' 249' ' ' CYS . . . -58.85 -44.6 91.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.154 0.502 . . . . 0.0 110.506 176.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -91.43 31.94 1.11 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.809 178.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . 0.514 ' CG ' ' HB3' ' A' ' 248' ' ' PRO . 2.9 t70 -60.92 112.75 2.18 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.492 178.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -139.13 -6.77 1.39 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.385 169.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -151.77 34.81 0.55 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.376 176.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -112.54 100.62 8.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.201 0.524 . . . . 0.0 110.759 -179.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.531 ' O ' ' HG3' ' A' ' 246' ' ' ARG . 0.5 OUTLIER -67.13 146.76 53.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.977 -175.764 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -107.87 120.22 41.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.055 178.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.525 HD21 HG21 ' A' ' 279' ' ' VAL . 51.3 mt -136.39 152.75 50.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.536 -175.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . 0.453 ' HA ' ' HG2' ' A' ' 245' ' ' LYS . 0.9 OUTLIER -115.07 -176.39 2.9 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 172.657 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 51.1 t -81.29 120.91 33.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.569 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 111.08 2.78 28.17 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.001 -0.619 . . . . 0.0 113.054 177.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -90.88 146.74 23.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.814 0.34 . . . . 0.0 110.79 -178.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 24.3 mm -92.67 109.86 22.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.538 177.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 20.8 t -83.28 108.46 15.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.217 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -80.42 86.48 5.75 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.881 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.545 HG13 ' HB ' ' A' ' 238' ' ' VAL . 2.6 p -98.41 117.69 43.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.671 0.748 . . . . 0.0 110.656 -178.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 18.4 p -94.46 -49.66 5.58 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.303 -177.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -100.61 114.31 27.88 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 120.955 0.407 . . . . 0.0 111.06 -177.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' MET . . . . . 0.429 ' CE ' HG11 ' A' ' 238' ' ' VAL . 40.7 mtt -106.61 140.19 39.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.145 0.497 . . . . 0.0 110.735 174.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -119.78 -170.05 1.88 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.575 -175.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.434 ' N ' HD12 ' A' ' 271' ' ' ILE . 4.5 mp -95.81 -30.81 4.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.135 -174.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . 0.423 ' ND2' ' H ' ' A' ' 274' ' ' GLN . 3.5 p-10 -66.81 -23.39 66.05 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -173.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 115.21 -32.37 5.79 Favored Glycine 0 C--O 1.23 -0.128 0 C-N-CA 120.194 -1.003 . . . . 0.0 113.084 173.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.485 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 48.7 mt-30 -86.23 107.53 17.96 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 176.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.512 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 12.7 m0 -92.22 157.61 16.6 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.106 -173.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -100.29 108.35 20.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.256 0.551 . . . . 0.0 109.857 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -110.0 145.38 17.02 Favored Glycine 0 N--CA 1.44 -1.042 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.573 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -107.66 108.68 20.04 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.33 0.586 . . . . 0.0 110.042 177.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . 0.621 HG12 HD22 ' A' ' 280' ' ' ASN . 60.3 t -120.54 127.62 75.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.777 -178.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . 0.621 HD22 HG12 ' A' ' 279' ' ' VAL . 10.7 p30 47.91 33.02 3.05 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.18 0.992 . . . . 0.0 112.203 -178.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 81.37 25.85 53.3 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.773 177.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . 0.482 ' NH1' ' HA ' ' A' ' 256' ' ' LEU . 1.0 OUTLIER -137.85 125.72 22.59 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 178.643 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 24.1 pttm -101.36 142.82 32.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.978 -175.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -163.53 152.16 22.01 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.208 177.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.512 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 90.9 mt -78.39 120.68 23.48 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.116 0.484 . . . . 0.0 110.372 176.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.408 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 43.8 p90 -118.24 146.24 38.95 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.857 178.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . 0.409 ' HG2' ' CD2' ' A' ' 290' ' ' HIS . 20.9 Cg_endo -87.69 137.08 3.95 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.752 2.302 . . . . 0.0 111.948 -179.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -60.17 -14.95 19.97 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -175.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.08 -12.28 61.42 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.005 0.431 . . . . 0.0 111.358 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . 0.409 ' CD2' ' HG2' ' A' ' 287' ' ' PRO . 10.9 m170 -101.07 -15.91 17.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.362 -176.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.56 ' HB ' ' HB1' ' A' ' 240' ' ' ALA . 35.4 m -128.39 152.7 36.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.897 0.38 . . . . 0.0 111.33 -175.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . 0.5 ' HD3' HD13 ' A' ' 243' ' ' ILE . 3.2 mptp? -130.88 134.83 47.14 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 170.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.571 HG13 ' HB2' ' A' ' 240' ' ' ALA . 1.0 OUTLIER -88.43 122.58 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 CA-C-O 122.068 0.937 . . . . 0.0 112.029 -177.291 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 294' ' ' PHE . . . . . 0.582 ' O ' ' HD3' ' A' ' 296' ' ' PRO . 5.1 p90 -117.3 140.15 49.92 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 168.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -79.95 107.61 7.21 Favored Pre-proline 0 C--N 1.317 -0.833 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.297 178.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . 0.582 ' HD3' ' O ' ' A' ' 294' ' ' PHE . 91.0 Cg_endo . . . . . 0 N--CA 1.459 -0.542 0 C-N-CA 122.666 2.244 . . . . 0.0 110.912 -177.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.4 p . . . . . 0 N--CA 1.452 -0.342 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -81.45 102.48 10.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.18 175.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -115.2 77.35 1.07 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.549 0.69 . . . . 0.0 111.572 -177.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -157.61 151.61 24.39 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.171 176.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.425 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 16.9 t70 -85.41 126.91 34.16 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.772 176.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.441 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 5.3 t -68.67 -20.12 64.43 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.044 -174.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 t -97.8 -13.62 21.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.766 0.317 . . . . 0.0 110.909 -177.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.425 ' HB2' ' HB3' ' A' ' 7' ' ' ASP . 17.3 t70 -79.09 78.41 5.54 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.514 0.674 . . . . 0.0 109.412 -178.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.449 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 3.8 ptp180 -69.8 -14.69 62.89 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.179 -175.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.5 t -82.91 14.86 3.01 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.61 0.719 . . . . 0.0 109.333 173.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.25 -42.51 3.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.122 170.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.424 ' CE2' ' HA ' ' A' ' 11' ' ' ARG . 44.9 p-90 -108.45 -22.05 12.47 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -172.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.449 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 25.1 t80 -86.34 120.63 27.9 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.205 0.526 . . . . 0.0 110.108 -177.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.575 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 25.1 mmt -100.38 1.36 41.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.796 -172.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.441 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.0 -112.46 1.69 Allowed Glycine 0 CA--C 1.525 0.719 0 N-CA-C 114.368 0.507 . . . . 0.0 114.368 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.441 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 11.3 Cg_exo -72.4 55.22 2.5 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 124.191 3.26 . . . . 0.0 114.299 -172.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.751 HG12 ' H ' ' A' ' 20' ' ' SER . 59.5 t -104.18 -178.42 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 172.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.751 ' H ' HG12 ' A' ' 19' ' ' VAL . 23.4 t -165.38 176.49 8.24 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -165.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 21.3 tpt180 -55.09 -55.7 28.12 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.684 0.278 . . . . 0.0 111.393 -174.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -59.11 -60.06 4.47 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.46 -177.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.425 ' HG2' ' HD2' ' A' ' 27' ' ' ARG . 25.6 tt0 -61.5 -46.03 91.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.679 -175.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.437 ' HB2' HG12 ' A' ' 19' ' ' VAL . . . -53.57 -49.23 68.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.962 0.41 . . . . 0.0 111.67 -175.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.613 ' HG3' ' HB ' ' A' ' 58' ' ' VAL . 12.5 tt0 -74.25 -37.25 63.81 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 120.117 -0.633 . . . . 0.0 111.183 -174.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.402 HG22 ' O ' ' A' ' 23' ' ' GLU . 7.4 t -70.42 -21.5 62.82 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 120.784 -0.367 . . . . 0.0 111.177 -177.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.425 ' HD2' ' HG2' ' A' ' 23' ' ' GLU . 56.4 mtp180 -82.79 -20.56 35.57 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.996 0.427 . . . . 0.0 110.736 178.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.638 HD21 ' HB2' ' A' ' 102' ' ' ALA . 13.0 mt -108.14 -15.74 14.43 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.95 179.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -84.71 130.24 34.72 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.243 0.544 . . . . 0.0 110.832 -173.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.522 ' C ' ' HG2' ' A' ' 32' ' ' ARG . . . 76.81 -3.38 56.45 Favored Glycine 0 C--N 1.314 -0.668 0 C-N-CA 119.914 -1.136 . . . . 0.0 112.747 178.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.5 ' HB2' ' CE ' ' A' ' 35' ' ' MET . 10.8 mt-30 -91.86 -52.17 4.86 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 172.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.743 ' CD ' ' HA ' ' A' ' 56' ' ' SER . 3.6 mmp_? 85.08 128.82 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 116.378 1.992 . . . . 0.0 116.378 152.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.731 ' CD2' ' HB3' ' A' ' 32' ' ' ARG . 9.0 m170 77.24 109.13 0.08 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 112.657 -2.065 . . . . 0.0 113.021 157.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.84 -37.83 3.46 Favored Glycine 0 N--CA 1.453 -0.222 0 CA-C-N 114.981 -1.009 . . . . 0.0 112.842 173.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.518 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 33.4 mtm -70.5 141.48 51.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.794 0.331 . . . . 0.0 111.293 -177.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.433 ' CG ' HD22 ' A' ' 98' ' ' LEU . 37.7 p90 -143.93 160.8 40.19 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 172.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.575 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.4 pp -153.91 139.57 17.93 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.172 0.511 . . . . 0.0 111.447 174.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 49.9 t -104.67 130.82 55.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.415 -0.811 . . . . 0.0 108.949 173.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.409 ' CB ' ' HB ' ' A' ' 19' ' ' VAL . 24.9 ptt-85 -127.9 175.97 7.95 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -177.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -80.89 137.6 36.16 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 170.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.3 t -78.95 97.3 5.98 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.196 0.522 . . . . 0.0 110.64 -176.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.22 -8.82 26.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.426 0.631 . . . . 0.0 110.483 174.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.5 p -97.95 -8.26 28.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.764 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.47 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 28.4 t -164.4 122.88 1.21 Allowed Pre-proline 0 C--N 1.333 -0.136 0 CA-C-O 120.589 0.233 . . . . 0.0 110.763 -177.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 44' ' ' CYS . 10.1 Cg_exo -71.53 119.41 6.23 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 123.048 2.499 . . . . 0.0 112.618 -179.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.07 25.34 17.25 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.019 178.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -134.35 163.17 30.26 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.565 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 25.3 m-85 -124.61 166.07 16.75 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 175.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.478 HG13 HD13 ' A' ' 62' ' ' ILE . 21.5 t -137.13 108.16 5.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.239 178.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.4 tp -84.18 102.02 12.29 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.864 175.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 51.0 m -95.61 124.39 39.61 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 177.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.684 HG21 HD13 ' A' ' 93' ' ' LEU . 58.0 t -114.67 139.89 38.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.271 0.558 . . . . 0.0 111.421 -173.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.419 ' HA ' HH22 ' A' ' 32' ' ' ARG . 47.0 t -98.46 103.33 15.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.74 -174.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.776 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 6.3 tp10 -157.68 163.04 38.6 Favored 'General case' 0 C--O 1.213 -0.831 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.33 171.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.758 ' ND2' ' HG3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER 44.62 42.23 5.55 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.724 1.209 . . . . 0.0 112.813 -175.653 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.743 ' HA ' ' CD ' ' A' ' 32' ' ' ARG . 68.2 m 44.23 54.72 5.95 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 121.809 0.814 . . . . 0.0 111.028 -175.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.783 HH21 ' HA ' ' A' ' 154' ' ' GLU 0.341 0.0 OUTLIER -169.24 75.59 0.09 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.642 -1.163 . . . . 0.0 113.543 -154.384 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.613 ' HB ' ' HG3' ' A' ' 25' ' ' GLN . 14.9 t -69.14 108.12 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 O-C-N 119.475 -2.016 . . . . 0.0 110.355 -173.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.2 m -84.9 123.9 31.02 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.475 -178.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 36.1 m-70 -96.59 108.97 21.66 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.682 -174.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.607 ' HB3' HD11 ' A' ' 73' ' ' ILE . 79.1 m-85 -98.7 110.57 23.14 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.268 0.627 . . . . 0.0 111.118 178.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.664 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 40.3 mm -80.55 123.95 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -174.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.565 ' HB ' ' HB2' ' A' ' 48' ' ' TYR . 5.3 mp -102.68 112.54 36.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 120.797 0.332 . . . . 0.0 110.76 177.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.515 ' HB2' ' HB3' ' A' ' 72' ' ' LYS . 15.0 m120 -86.13 140.38 30.26 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.686 -176.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.3 t -86.52 101.15 12.92 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 169.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.885 HD12 ' HG3' ' A' ' 70' ' ' ARG . 91.9 mt -83.56 140.22 41.32 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.515 -178.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.65 -11.44 26.38 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.408 2.072 . . . . 0.0 110.678 172.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.54 ' HB2' ' HG2' ' A' ' 70' ' ' ARG . 2.9 m-20 -72.15 -2.48 18.8 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.114 174.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.87 ' HE ' ' HA ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER 67.09 35.02 4.76 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.858 -178.459 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.885 ' HG3' HD12 ' A' ' 66' ' ' LEU . 4.3 ptp180 -133.64 168.22 19.07 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.829 176.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.436 ' HB3' HG23 ' A' ' 63' ' ' ILE . 37.5 m-85 -114.0 124.23 51.65 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.977 0.418 . . . . 0.0 110.553 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.642 ' HB2' HD11 ' A' ' 66' ' ' LEU . 28.9 ttpp -108.73 95.88 5.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.287 -173.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.664 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 3.8 tt -87.83 118.31 33.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.073 0.463 . . . . 0.0 110.747 -178.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.95 31.54 78.87 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.729 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.526 ' HA ' ' HG2' ' A' ' 72' ' ' LYS . 31.2 t70 74.34 4.65 4.53 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.139 0.576 . . . . 0.0 111.47 -178.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -90.93 119.73 31.36 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 173.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -81.72 121.77 26.81 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.968 0.413 . . . . 0.0 111.487 -176.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.441 ' O ' ' HB2' ' A' ' 70' ' ' ARG . 87.3 m-85 -125.28 165.75 17.77 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 172.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -58.28 -49.25 77.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.132 0.491 . . . . 0.0 111.316 -179.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.486 ' ND1' ' HG2' ' A' ' 82' ' ' PRO . 4.7 p80 -164.0 -178.5 5.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.063 -177.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.522 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 14.2 mt -56.76 -57.05 26.56 Favored Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -176.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.486 ' HG2' ' ND1' ' A' ' 80' ' ' HIS . 24.0 Cg_endo -64.46 3.03 0.94 Allowed 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.237 1.958 . . . . 0.0 113.605 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.35 -36.27 10.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.868 0.366 . . . . 0.0 110.297 178.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.1 pp -76.48 -33.89 58.67 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.51 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 68.0 mt -66.74 -19.76 65.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.735 178.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -89.08 -37.9 14.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.444 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -71.32 -30.68 66.49 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.405 0.622 . . . . 0.0 110.382 -178.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.465 ' CG ' HD21 ' A' ' 93' ' ' LEU . 19.8 m-85 -82.57 -3.2 55.67 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.978 -0.556 . . . . 0.0 112.025 -178.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.51 ' HG3' ' O ' ' A' ' 85' ' ' LEU . 99.4 mttt -72.33 -13.06 61.39 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.523 174.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 16.7 pt -132.68 10.53 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 CA-C-O 121.37 0.605 . . . . 0.0 110.054 -177.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -107.0 -37.48 6.31 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.954 -175.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.496 ' CD2' HG23 ' A' ' 97' ' ' THR . 75.1 m-85 69.06 115.89 0.04 OUTLIER 'General case' 0 C--O 1.224 -0.279 0 O-C-N 124.227 0.954 . . . . 0.0 109.702 -173.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.684 HD13 HG21 ' A' ' 52' ' ' VAL . 1.2 mt -91.14 -7.64 50.99 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.516 0.674 . . . . 0.0 110.433 177.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.693 ' HA ' ' HB3' ' A' ' 154' ' ' GLU . 0.2 OUTLIER -144.61 -45.52 0.24 Allowed 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 122.107 0.956 . . . . 0.0 111.032 -172.381 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.571 ' HB ' ' O ' ' A' ' 94' ' ' ASP . 5.6 t 152.45 -15.72 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 104.457 -2.423 . . . . 0.0 104.457 -167.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.1 m -117.81 145.83 44.27 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 112.878 -1.965 . . . . 0.0 108.162 177.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.496 HG23 ' CD2' ' A' ' 92' ' ' TYR . 27.4 p -94.94 171.49 8.73 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 174.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.433 HD22 ' CG ' ' A' ' 36' ' ' PHE . 92.7 mt -66.24 93.33 0.21 Allowed 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 177.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 39.9 mm -79.66 -61.05 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.969 -175.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.518 ' O ' ' HA ' ' A' ' 35' ' ' MET . 0.6 OUTLIER -160.58 150.1 14.19 Favored Pre-proline 0 N--CA 1.453 -0.312 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.121 178.452 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.86 163.41 30.93 Favored 'Trans proline' 0 CA--C 1.532 0.384 0 C-N-CA 122.91 2.407 . . . . 0.0 114.414 -172.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.638 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -63.83 155.47 77.17 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.475 176.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.419 ' HG2' HE22 ' A' ' 31' ' ' GLN . 84.1 Cg_exo -51.38 95.83 0.03 OUTLIER 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 123.116 2.544 . . . . 0.0 112.755 174.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.446 ' HG3' ' SD ' ' A' ' 16' ' ' MET . 49.5 ttt180 . . . . . 0 C--N 1.331 -0.218 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 177.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.933 HD12 HG21 ' A' ' 152' ' ' ILE . 4.2 mm? . . . . . 0 N--CA 1.467 0.414 0 CA-C-O 121.527 0.68 . . . . 0.0 112.53 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 48.4 tt0 -172.65 -56.46 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.65 178.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -117.99 108.64 15.51 Favored 'General case' 0 CA--C 1.51 -0.582 0 C-N-CA 120.071 -0.651 . . . . 0.0 111.134 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.684 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 3.1 t -115.8 142.32 29.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.669 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 0.1 OUTLIER -115.38 145.01 42.94 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 116.623 -2.031 . . . . 0.0 108.688 160.493 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.561 HG22 HG12 ' A' ' 178' ' ' VAL . 0.8 OUTLIER -103.48 128.04 50.75 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.086 -177.601 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.543 HD21 ' HG2' ' A' ' 179' ' ' GLU . 20.3 mt -102.0 -24.0 14.04 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -174.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.496 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 46.8 t80 -82.03 -35.3 28.94 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.271 -0.571 . . . . 0.0 112.378 -172.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.665 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 9.7 t70 75.18 104.64 0.07 Allowed 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.423 0.63 . . . . 0.0 110.726 -175.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.474 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 63.9 t80 -129.77 88.85 48.1 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 175.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.663 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 60.4 Cg_endo -85.3 71.18 4.95 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.039 1.826 . . . . 0.0 113.099 -176.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.72 -30.53 76.41 Favored Glycine 0 C--N 1.331 0.287 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.778 178.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.535 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 13.7 m-80 56.0 71.01 0.58 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 114.862 -0.669 . . . . 0.0 110.718 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.569 ' HB3' ' H ' ' A' ' 141' ' ' ASP . 0.7 OUTLIER -145.6 -169.47 3.23 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.149 -174.442 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -110.73 -5.53 14.97 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 166.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -101.31 -56.88 2.2 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 113.698 -1.592 . . . . 0.0 108.529 177.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . 0.569 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 3.4 m-20 -96.81 120.86 37.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.489 174.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 1.074 HD11 ' HB2' ' A' ' 165' ' ' ASN . 32.9 tp -76.68 130.13 77.34 Favored Pre-proline 0 N--CA 1.467 0.404 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 175.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.663 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 74.1 Cg_endo -82.28 94.04 0.9 Allowed 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 121.67 1.58 . . . . 0.0 111.966 172.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.565 ' HA ' ' OE1' ' A' ' 148' ' ' GLU . 12.2 p90 -106.58 153.7 21.97 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -176.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.665 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 88.9 mttt -103.16 -162.03 0.88 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -173.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.57 ' HD2' ' N ' ' A' ' 146' ' ' LYS . 9.0 mptt -81.98 -7.94 59.64 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.858 -166.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -167.83 27.5 0.15 Allowed Glycine 0 C--N 1.311 -0.825 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.352 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.565 ' OE1' ' HA ' ' A' ' 144' ' ' PHE . 0.1 OUTLIER -78.99 154.39 29.55 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.071 0.462 . . . . 0.0 111.684 -177.157 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.651 HD12 ' HB3' ' A' ' 129' ' ' ARG . 0.5 OUTLIER -95.19 128.72 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.702 -177.961 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.7 HD22 HD21 ' A' ' 142' ' ' LEU . 61.8 mt -122.98 156.19 35.27 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -175.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.602 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 85.2 t -119.2 121.07 65.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 174.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 1.027 HD13 ' HB2' ' A' ' 163' ' ' ALA . 48.5 mm -76.88 91.75 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 CA-C-O 121.889 0.852 . . . . 0.0 108.711 -176.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.555 HG23 ' HG3' ' A' ' 154' ' ' GLU . 17.6 tt -79.95 -26.66 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 CA-C-N 114.237 -1.347 . . . . 0.0 109.696 -174.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.783 ' HA ' HH21 ' A' ' 57' ' ' ARG . 0.9 OUTLIER -134.7 144.9 48.04 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 172.461 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.588 ' HD2' ' HG ' ' A' ' 125' ' ' LEU . 77.0 tttt -127.84 85.06 61.61 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-O 121.148 0.499 . . . . 0.0 109.914 164.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.522 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 13.2 Cg_exo -73.45 -41.33 1.22 Allowed 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.62 2.213 . . . . 0.0 112.28 175.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -121.7 176.84 5.52 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.931 -173.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -106.65 -0.98 23.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.777 0.798 . . . . 0.0 109.283 174.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -102.82 -36.68 8.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.801 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.545 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 31.1 m95 -127.03 144.71 50.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.932 176.072 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . 0.769 ' O ' HG13 ' A' ' 173' ' ' ILE . 49.3 m0 -125.75 138.98 53.89 Favored 'General case' 0 C--O 1.215 -0.756 0 C-N-CA 123.346 0.658 . . . . 0.0 109.776 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.532 ' HA ' ' HA ' ' A' ' 172' ' ' MET . 23.9 m -97.98 104.87 16.94 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -173.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 1.027 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -114.94 149.4 37.34 Favored 'General case' 0 N--CA 1.425 -1.687 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.235 -176.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.698 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 13.0 ptt180 -87.48 122.33 31.07 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 171.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 1.074 ' HB2' HD11 ' A' ' 142' ' ' LEU . 14.4 t30 -52.8 172.19 0.05 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.577 -1.647 . . . . 0.0 110.648 -175.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -63.75 -10.22 18.53 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.282 0.563 . . . . 0.0 109.554 173.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -85.21 -27.02 26.38 Favored 'General case' 0 N--CA 1.46 0.073 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.332 171.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 108.73 -2.28 32.11 Favored Glycine 0 CA--C 1.522 0.49 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.677 -176.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.698 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 3.3 ttm-85 -74.3 132.79 42.39 Favored 'General case' 0 C--O 1.214 -0.815 0 C-N-CA 123.054 0.542 . . . . 0.0 111.798 -177.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 64.7 t -84.81 121.88 37.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 O-C-N 122.032 -0.418 . . . . 0.0 111.391 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -158.36 156.35 27.33 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.578 173.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.545 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.0 OUTLIER -75.75 145.22 40.97 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 122.604 0.361 . . . . 0.0 111.479 -179.735 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.769 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.6 pp -144.69 145.62 28.86 Favored Pre-proline 0 C--O 1.221 -0.411 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.444 -177.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.512 ' HB2' ' CD1' ' A' ' 177' ' ' TYR . 10.3 Cg_exo -73.69 132.98 18.0 Favored 'Trans proline' 0 CA--C 1.527 0.126 0 C-N-CA 122.688 2.259 . . . . 0.0 112.889 -175.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.55 ' HB ' ' HD3' ' A' ' 176' ' ' PRO . 47.8 t -61.43 -45.71 94.45 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.55 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 50.8 Cg_exo -57.55 -8.01 3.62 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.383 2.056 . . . . 0.0 113.643 175.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.512 ' CD1' ' HB2' ' A' ' 174' ' ' PRO . 3.0 m-85 -95.57 -11.49 27.24 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.622 -178.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.673 ' HB ' HG13 ' A' ' 128' ' ' VAL . 3.4 m -106.49 -174.08 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 -165.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.673 ' O ' ' HG3' ' A' ' 179' ' ' GLU . 8.2 tp10 -161.02 44.29 0.17 Allowed 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 112.477 -2.147 . . . . 0.0 111.152 -155.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.849 ' HD2' ' H ' ' A' ' 180' ' ' LYS . 0.0 OUTLIER -73.71 141.85 46.38 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 119.411 -2.056 . . . . 0.0 111.663 -163.49 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.488 ' HB2' HH22 ' A' ' 129' ' ' ARG . 18.0 tp . . . . . 0 C--O 1.231 0.094 0 CA-C-N 112.608 -2.087 . . . . 0.0 112.259 -161.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo . . . . . 0 N--CA 1.462 -0.346 0 N-CA-C 111.347 -0.29 . . . . 0.0 111.347 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.418 ' CG1' HD12 ' A' ' 293' ' ' ILE . 13.2 t -66.85 136.48 26.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.18 -174.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.542 ' HB2' ' HG3' ' A' ' 296' ' ' PRO . 82.8 m-85 -98.63 125.51 43.93 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.971 178.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.516 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -118.21 148.53 42.29 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.417 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -92.31 125.29 36.91 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 177.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . 0.533 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -71.01 104.95 3.14 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 176.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.606 HD13 ' HG2' ' A' ' 292' ' ' LYS . 41.2 pt -88.0 0.82 6.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.936 0.398 . . . . 0.0 111.311 -174.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -155.79 146.47 22.05 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 15.7 pttm -66.41 109.16 2.62 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.57 0.7 . . . . 0.0 110.542 176.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.569 ' HB3' ' HB2' ' A' ' 258' ' ' LEU . 24.9 tpt180 -84.46 93.56 8.33 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.711 178.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 27.1 m -105.87 138.17 19.56 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.007 176.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.515 ' HB3' ' HB3' ' A' ' 255' ' ' ALA . 90.4 Cg_endo -80.62 148.72 18.19 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.471 2.114 . . . . 0.0 112.282 -179.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' CYS . . . . . 0.417 ' SG ' ' N ' ' A' ' 250' ' ' ALA . 41.8 t -92.74 -176.55 4.28 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 175.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . 0.417 ' N ' ' SG ' ' A' ' 249' ' ' CYS . . . -61.34 -24.0 66.14 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -175.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -102.75 -9.63 19.84 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -177.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -84.35 88.1 7.24 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.109 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -87.21 -16.92 33.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.039 -178.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 10.2 p -110.3 7.12 22.94 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.622 -176.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . 0.515 ' HB3' ' HB3' ' A' ' 248' ' ' PRO . . . -86.85 132.92 33.69 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.258 0.551 . . . . 0.0 111.328 -176.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.478 ' O ' ' HG3' ' A' ' 246' ' ' ARG . 1.0 OUTLIER -81.89 143.39 31.72 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 176.633 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -97.53 110.36 22.93 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.928 0.394 . . . . 0.0 110.329 178.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.569 ' HB2' ' HB3' ' A' ' 246' ' ' ARG . 65.5 mt -113.34 139.13 49.12 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.451 -175.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -91.67 137.61 32.22 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.726 173.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 2.5 p -67.37 119.21 12.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.163 0.506 . . . . 0.0 110.284 178.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 115.55 -3.26 21.72 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.266 -177.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -99.08 159.58 14.87 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -177.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 20.8 mm -87.38 122.76 39.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.062 0.458 . . . . 0.0 110.45 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.49 HG13 HG21 ' A' ' 279' ' ' VAL . 21.5 t -102.07 99.2 7.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.906 176.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -78.94 101.75 7.91 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.925 176.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 5.5 p -88.27 123.73 40.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.293 0.568 . . . . 0.0 109.983 179.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 2.4 m -93.83 -35.11 12.88 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.47 -175.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . 0.494 ' NE ' ' HA ' ' A' ' 268' ' ' ARG . 3.2 mmp_? -132.6 112.74 12.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.923 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 41.3 mtt -87.83 121.52 30.35 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.455 175.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -95.78 155.55 16.7 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . 0.809 ' H ' HD13 ' A' ' 271' ' ' ILE . 0.2 OUTLIER -82.53 -8.61 11.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -172.522 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -80.63 -24.0 39.34 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.717 0.294 . . . . 0.0 111.077 -178.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 123.85 -21.86 6.96 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.569 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -94.97 123.2 38.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.056 0.455 . . . . 0.0 109.805 177.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 47.4 m0 -98.3 153.29 18.63 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.929 -176.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -105.45 105.69 15.84 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.492 176.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -127.41 153.07 19.0 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.207 -178.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -107.46 108.62 20.03 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . 0.49 HG21 HG13 ' A' ' 264' ' ' VAL . 89.2 t -133.04 128.67 56.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.544 -175.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 59.83 27.5 16.83 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.262 176.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 92.19 -5.92 78.42 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.337 177.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -115.74 134.48 54.98 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 122.714 -0.286 . . . . 0.0 110.768 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 15.7 ptpt -112.87 131.01 55.9 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.038 0.447 . . . . 0.0 110.018 171.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -156.04 -175.79 27.43 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.51 -177.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 79.5 mt -98.63 124.31 43.36 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.422 0.629 . . . . 0.0 111.128 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -129.59 135.05 26.93 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.68 177.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.88 140.08 28.33 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.381 2.054 . . . . 0.0 111.461 178.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -64.22 -8.5 12.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.775 -176.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -71.03 -16.6 62.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.045 0.45 . . . . 0.0 111.209 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -101.89 -8.31 21.7 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.827 -176.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.533 HG12 ' HA ' ' A' ' 242' ' ' ALA . 30.2 m -129.61 166.89 26.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.639 0.257 . . . . 0.0 110.783 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . 0.606 ' HG2' HD13 ' A' ' 243' ' ' ILE . 28.8 mmtp -137.48 136.26 37.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.966 0.412 . . . . 0.0 110.903 175.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.516 HD13 ' HB2' ' A' ' 240' ' ' ALA . 38.9 mm -82.17 101.85 7.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 174.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -105.81 -7.72 18.15 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.005 -174.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 59.48 93.03 0.06 OUTLIER Pre-proline 0 N--CA 1.464 0.249 0 O-C-N 123.72 0.637 . . . . 0.0 111.465 -176.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . 0.542 ' HG3' ' HB2' ' A' ' 239' ' ' PHE . 60.4 Cg_endo . . . . . 0 C--O 1.233 0.272 0 C-N-CA 122.766 2.311 . . . . 0.0 111.4 175.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.6 t . . . . . 0 N--CA 1.45 -0.433 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.421 ' HB1' ' HE3' ' A' ' 89' ' ' LYS . . . -74.0 105.59 5.31 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.551 173.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -121.32 35.92 4.75 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.357 -172.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -117.51 157.45 26.27 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.107 -179.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -84.63 111.18 19.31 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 174.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.6 m -61.33 -15.49 36.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.183 -174.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.4 p -101.11 -20.88 15.15 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -177.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -77.11 93.99 3.98 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.943 -172.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.436 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 13.4 mtm-85 -61.11 -28.68 69.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.464 -178.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.459 ' HA ' ' NH1' ' A' ' 104' ' ' ARG . 67.7 m -73.83 4.45 5.22 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.799 0.333 . . . . 0.0 111.504 178.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -106.29 -43.8 4.7 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.521 174.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . 0.478 ' HB3' ' HB3' ' A' ' 101' ' ' PRO . 19.9 p-90 -114.91 -20.22 10.64 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -172.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.436 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 70.8 t80 -80.69 125.21 29.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.04 0.447 . . . . 0.0 110.92 -175.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.49 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 25.5 mmt -104.63 -6.18 20.72 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.182 -173.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 51.62 -113.36 2.34 Favored Glycine 0 CA--C 1.524 0.606 0 O-C-N 123.419 0.449 . . . . 0.0 113.738 -176.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -69.56 85.51 0.58 Allowed 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 122.924 2.416 . . . . 0.0 113.604 -176.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.468 ' HB ' ' HB2' ' A' ' 39' ' ' ARG . 85.9 t -140.3 156.85 24.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 175.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.583 ' HB3' ' OE1' ' A' ' 23' ' ' GLU . 34.4 t -127.39 -179.32 4.84 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -171.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 45.6 ttt85 -62.05 -53.24 58.28 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -173.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.86 -43.13 93.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.729 0.3 . . . . 0.0 110.786 -177.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.583 ' OE1' ' HB3' ' A' ' 20' ' ' SER . 13.6 mp0 -60.22 -51.16 70.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.682 179.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.25 -40.87 78.54 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.649 0.737 . . . . 0.0 110.795 176.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.451 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 33.4 tp60 -64.28 -44.28 92.18 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.441 -177.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 10.6 t -75.67 -31.25 59.69 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 111.655 0.242 . . . . 0.0 111.655 -176.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.484 ' O ' ' HG3' ' A' ' 31' ' ' GLN . 74.9 mtp180 -74.12 -13.21 60.79 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.711 0.291 . . . . 0.0 111.232 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.593 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 79.8 mt -121.48 -6.0 9.27 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.503 -178.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 19.2 tp60 -65.24 103.34 0.77 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.783 0.325 . . . . 0.0 111.127 -175.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.74 9.04 84.96 Favored Glycine 0 C--N 1.329 0.154 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.494 175.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 13.4 mm100 -73.96 -164.91 0.26 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.998 0.427 . . . . 0.0 111.213 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.433 ' H ' ' HE3' ' A' ' 35' ' ' MET . 55.2 ttp180 -58.08 125.88 25.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.989 176.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.42 ' HB3' ' CD ' ' A' ' 54' ' ' GLU . 65.0 m170 -72.5 122.14 20.81 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.906 -178.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 108.89 -4.73 32.18 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 -173.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.779 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 43.6 ttm -77.27 129.44 35.89 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 176.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.465 ' HB2' HG22 ' A' ' 52' ' ' VAL . 37.9 p90 -138.99 162.18 35.54 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.34 -177.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.527 ' HG ' HD11 ' A' ' 28' ' ' LEU . 4.6 pp -151.48 141.36 21.98 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.108 0.48 . . . . 0.0 110.777 174.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.5 t -107.59 118.79 56.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.59 176.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.468 ' HB2' ' HB ' ' A' ' 19' ' ' VAL . 23.4 ptt-85 -116.25 175.91 5.34 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.318 -176.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -77.7 127.56 32.64 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 173.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.8 t -71.61 121.55 18.97 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.693 -174.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.9 t -83.54 -18.71 37.45 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 170.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 27.2 m -62.59 -44.61 95.88 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.712 174.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.424 ' HA ' ' HD2' ' A' ' 45' ' ' PRO . 51.1 t -150.84 99.59 3.11 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.056 176.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 44' ' ' CYS . 10.3 Cg_endo -52.68 132.27 45.22 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.998 2.465 . . . . 0.0 112.213 -179.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.24 -34.68 5.52 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -175.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.621 ' OD2' ' HA ' ' A' ' 64' ' ' ASN . 2.7 m-20 -85.25 -177.49 6.51 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 175.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.416 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 27.9 m-85 -130.87 168.47 17.23 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.568 0.223 . . . . 0.0 110.971 -177.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.2 t -138.87 109.52 4.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.065 0.46 . . . . 0.0 110.82 174.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.429 ' CB ' HD11 ' A' ' 63' ' ' ILE . 40.5 tp -84.74 102.04 12.7 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.051 176.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 53.8 m -96.14 126.18 41.18 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 175.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.743 HG21 HD13 ' A' ' 93' ' ' LEU . 58.8 t -121.7 133.53 67.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.257 -175.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.593 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 41.6 t -87.43 121.45 29.88 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -176.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.649 ' HG3' ' HB3' ' A' ' 94' ' ' ASP . 0.6 OUTLIER -150.48 148.59 28.91 Favored 'General case' 0 C--O 1.209 -1.076 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.424 165.863 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 40.05 40.56 0.78 Allowed 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -176.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 7.2 m 57.25 49.86 12.62 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 122.139 0.971 . . . . 0.0 109.267 178.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.488 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 2.6 tmm_? -167.13 64.44 0.09 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 113.906 -1.497 . . . . 0.0 109.711 -151.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.6 t -71.6 113.89 9.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 122.004 0.906 . . . . 0.0 110.612 -166.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.0 m -76.86 120.73 22.41 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 113.915 -1.493 . . . . 0.0 110.807 -177.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -96.35 106.05 18.21 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -176.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.722 ' HB3' HD11 ' A' ' 73' ' ' ILE . 88.7 m-85 -105.7 109.26 21.15 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 122.853 0.461 . . . . 0.0 111.691 179.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 66.3 mt -81.31 132.68 30.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -177.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.453 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 5.4 mp -110.07 117.8 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 122.779 0.432 . . . . 0.0 110.481 178.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.621 ' HA ' ' OD2' ' A' ' 47' ' ' ASP . 6.6 m120 -87.75 133.59 33.83 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.194 -175.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.7 t -86.8 96.63 10.25 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 170.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.4 mt -70.54 140.22 87.0 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.634 178.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.61 -21.39 31.14 Favored 'Trans proline' 0 CA--C 1.529 0.25 0 C-N-CA 122.86 2.373 . . . . 0.0 112.413 177.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -78.69 7.55 6.74 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.214 176.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.665 ' HE ' ' HA ' ' A' ' 69' ' ' ARG . 7.7 mmp_? 65.39 51.35 1.57 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.738 0.78 . . . . 0.0 110.764 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.44 ' NH2' ' HB3' ' A' ' 77' ' ' GLU . 30.2 mtp180 -137.49 174.01 11.05 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.096 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.561 ' HA ' ' O ' ' A' ' 64' ' ' ASN . 47.2 m-85 -132.09 121.15 23.35 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.15 0.5 . . . . 0.0 111.694 -176.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 1.043 ' HD3' ' HG2' ' A' ' 77' ' ' GLU . 24.5 ttpt -111.91 119.33 38.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.513 176.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.722 HD11 ' HB3' ' A' ' 61' ' ' TYR . 2.9 tt -109.3 102.89 14.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.397 0.618 . . . . 0.0 111.068 -176.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.49 61.94 5.52 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.4 177.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 30.6 t70 75.04 -28.63 0.19 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.976 0.51 . . . . 0.0 111.788 175.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -78.23 122.86 26.24 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.698 0.285 . . . . 0.0 110.579 175.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 1.043 ' HG2' ' HD3' ' A' ' 72' ' ' LYS . 30.6 mt-10 -95.53 126.26 40.7 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.792 0.329 . . . . 0.0 110.605 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -121.78 -169.81 1.94 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.388 177.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -82.67 -56.78 3.65 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.07 0.462 . . . . 0.0 110.365 177.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . 0.418 ' HA ' ' HD2' ' A' ' 71' ' ' PHE . 1.6 p80 -157.87 179.95 8.72 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.485 -176.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.655 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 19.6 mt -49.96 -59.17 7.42 Favored Pre-proline 0 N--CA 1.469 0.495 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.655 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 15.4 Cg_exo -68.85 -2.49 9.6 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 121.975 1.783 . . . . 0.0 112.743 -175.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.32 -36.71 12.4 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.063 176.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.4 pp -76.69 -34.68 58.19 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.12 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.565 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 76.2 mt -62.59 -38.01 88.46 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.834 177.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.583 ' HA ' ' HD3' ' A' ' 89' ' ' LYS . 14.4 tp10 -70.63 -34.13 71.75 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 -177.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -70.56 -37.8 74.05 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.321 0.582 . . . . 0.0 110.594 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.529 ' HE2' HD13 ' A' ' 73' ' ' ILE . 21.3 m-85 -78.32 -19.77 52.85 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.743 -177.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.583 ' HD3' ' HA ' ' A' ' 86' ' ' GLU . 50.0 mtpt -62.34 -20.18 64.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.685 172.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 23.9 pt -121.04 18.58 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 120.58 -0.448 . . . . 0.0 112.105 175.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 6.6 t-160 -106.14 -33.23 7.92 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.887 0.375 . . . . 0.0 110.559 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.567 ' N ' HG22 ' A' ' 97' ' ' THR . 52.9 m-85 66.61 91.63 0.08 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.284 -168.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.743 HD13 HG21 ' A' ' 52' ' ' VAL . 12.7 mt -60.81 -8.45 3.05 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.989 0.9 . . . . 0.0 110.506 173.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.649 ' HB3' ' HG3' ' A' ' 54' ' ' GLU . 16.1 t70 -161.68 -108.59 0.02 OUTLIER 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 174.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.8 t -117.6 15.56 14.58 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.638 -0.825 . . . . 0.0 111.198 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.462 HG23 ' O ' ' A' ' 97' ' ' THR . 13.3 t -139.71 -19.39 0.93 Allowed 'General case' 0 C--N 1.349 0.544 0 C-N-CA 118.192 -1.403 . . . . 0.0 114.326 -177.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.567 HG22 ' N ' ' A' ' 92' ' ' TYR . 6.6 p 74.95 -164.1 0.08 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.845 0.858 . . . . 0.0 109.989 -171.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 42.7 mt -89.6 111.29 22.19 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 175.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.412 HD11 ' O ' ' A' ' 96' ' ' THR . 51.3 mm -105.19 -58.07 4.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -173.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.779 ' O ' ' HA ' ' A' ' 35' ' ' MET . 4.7 tp10 -153.72 131.27 6.13 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 -174.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.478 ' HB3' ' HB3' ' A' ' 14' ' ' TRP . 28.3 Cg_endo -62.8 166.43 13.95 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 122.764 2.309 . . . . 0.0 112.896 -179.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.403 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -75.62 148.17 82.42 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.648 176.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.33 106.62 0.31 Allowed 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 122.562 2.175 . . . . 0.0 112.628 -177.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . 0.459 ' NH1' ' HA ' ' A' ' 12' ' ' SER . 24.1 ttp180 . . . . . 0 C--N 1.329 -0.298 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 174.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 0.601 HD12 HG21 ' A' ' 152' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.47 0.553 0 CA-C-O 121.648 0.737 . . . . 0.0 111.36 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.685 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 28.0 tt0 174.92 -52.33 0.01 OUTLIER 'General case' 0 C--O 1.22 -0.488 0 CA-C-N 114.005 -1.452 . . . . 0.0 109.26 179.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -110.97 105.93 14.87 Favored 'General case' 0 CA--C 1.511 -0.55 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.416 178.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.698 HG22 ' CG ' ' A' ' 180' ' ' LYS . 41.5 t -120.93 127.71 75.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.982 -178.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.605 ' O ' ' HG2' ' A' ' 179' ' ' GLU . 9.3 ptp180 -109.11 140.05 43.19 Favored 'General case' 0 C--O 1.22 -0.452 0 C-N-CA 117.336 -1.745 . . . . 0.0 110.267 173.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.78 HG22 HG12 ' A' ' 178' ' ' VAL . 1.4 p -98.54 139.91 33.57 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.285 -179.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.867 ' CD1' ' HG3' ' A' ' 179' ' ' GLU . 62.9 mt -126.39 1.94 6.99 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -178.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.521 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 36.7 t80 -93.46 -33.98 13.6 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.677 178.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.586 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 11.7 t70 74.51 101.3 0.07 Allowed 'General case' 0 N--CA 1.467 0.411 0 O-C-N 123.916 0.76 . . . . 0.0 109.868 -177.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.622 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 70.3 t80 -131.61 87.99 44.35 Favored Pre-proline 0 N--CA 1.446 -0.667 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.738 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 97.1 Cg_endo -79.08 88.3 1.47 Allowed 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 121.729 1.62 . . . . 0.0 112.49 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.72 -31.76 32.0 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.89 177.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.796 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 21.8 m120 66.89 35.68 4.74 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.027 0.531 . . . . 0.0 111.563 177.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.454 ' HB3' ' H ' ' A' ' 140' ' ' GLU . 2.6 m-20 -136.39 172.81 12.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.734 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.637 ' O ' ' HA2' ' A' ' 171' ' ' GLY . . . -86.88 -13.79 43.86 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.642 0.734 . . . . 0.0 109.498 171.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.676 ' O ' ' HB2' ' A' ' 172' ' ' MET . 3.4 mp0 -94.83 -18.59 21.06 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.635 176.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -139.77 102.29 4.4 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 176.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 1.037 HD11 ' HB2' ' A' ' 165' ' ' ASN . 49.9 tp -64.46 129.54 94.23 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -178.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.796 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 27.8 Cg_endo -81.92 88.62 1.3 Allowed 'Trans proline' 0 N--CA 1.439 -1.69 0 C-N-CA 121.239 1.292 . . . . 0.0 111.535 174.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.622 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 20.5 p90 -108.06 165.5 11.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.389 -173.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.586 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 37.0 mttp -109.49 -173.76 2.34 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.253 0.549 . . . . 0.0 111.853 -175.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.754 ' H ' ' HD2' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -89.09 21.29 3.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.322 -174.846 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.453 ' HA2' HD23 ' A' ' 131' ' ' LEU . . . -179.96 35.03 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.121 177.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -107.68 150.25 27.16 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.073 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.526 HG13 ' HB3' ' A' ' 129' ' ' ARG . 1.9 mp -98.32 131.22 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -177.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.81 HD22 HD21 ' A' ' 142' ' ' LEU . 7.7 mt -122.3 169.51 10.86 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -175.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.685 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 74.1 t -128.98 122.4 56.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 110.422 -0.214 . . . . 0.0 110.422 178.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 1.086 HD13 ' HB2' ' A' ' 163' ' ' ALA . 45.8 mm -75.84 98.59 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -174.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.52 HG21 HG22 ' A' ' 170' ' ' VAL . 19.9 tt -96.07 -32.74 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.581 -173.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.573 ' OE2' ' HA ' ' A' ' 93' ' ' LEU . 7.7 mt-10 -115.93 140.05 49.63 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 167.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.704 ' HE3' ' HE1' ' A' ' 161' ' ' TRP . 83.7 tttt -127.84 73.66 78.77 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 121.901 -0.499 . . . . 0.0 110.944 170.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.512 ' HG2' ' HE2' ' A' ' 172' ' ' MET . 39.9 Cg_exo -61.19 -42.1 38.03 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.439 2.092 . . . . 0.0 112.183 175.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -124.91 -177.91 4.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.4 -175.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.463 ' O ' HG21 ' A' ' 175' ' ' VAL . 0.2 OUTLIER -108.5 -10.92 15.21 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 173.537 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -93.62 -30.95 14.69 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.555 177.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.57 ' CH2' ' HG3' ' A' ' 174' ' ' PRO . 65.0 m95 -124.06 141.71 51.82 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.409 174.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . 0.835 ' HB3' HD12 ' A' ' 152' ' ' ILE . 43.9 m0 -132.52 137.97 47.35 Favored 'General case' 0 C--O 1.21 -1.021 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.238 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.593 ' HA ' ' HA ' ' A' ' 172' ' ' MET . 19.0 m -93.34 99.34 11.89 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -174.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 1.086 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -109.09 143.17 38.79 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -171.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.8 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 11.1 ptt180 -86.35 119.46 26.64 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 176.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 1.037 ' HB2' HD11 ' A' ' 142' ' ' LEU . 16.4 t30 -50.75 170.12 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 113.117 -1.856 . . . . 0.0 111.543 -174.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -66.7 -9.14 33.24 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.49 0.662 . . . . 0.0 109.392 174.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -85.91 -18.7 31.99 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.259 171.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.29 56.87 2.2 Favored Glycine 0 CA--C 1.52 0.397 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.422 -174.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.8 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 4.2 ttm-85 -136.61 135.0 37.97 Favored 'General case' 0 C--O 1.216 -0.669 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.566 ' O ' ' HA ' ' A' ' 139' ' ' ALA . 43.0 t -79.66 124.95 38.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.375 -178.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . 0.637 ' HA2' ' O ' ' A' ' 139' ' ' ALA . . . -160.86 150.78 20.93 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.856 169.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.676 ' HB2' ' O ' ' A' ' 140' ' ' GLU . 1.5 mmt -67.18 138.2 56.82 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 117.515 0.657 . . . . 0.0 111.187 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.799 HD13 HG11 ' A' ' 178' ' ' VAL . 2.8 pp -134.1 140.06 35.01 Favored Pre-proline 0 N--CA 1.443 -0.799 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.271 179.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.734 ' HB2' ' HB2' ' A' ' 177' ' ' TYR . 26.3 Cg_exo -67.77 128.81 18.56 Favored 'Trans proline' 0 C--O 1.212 -0.779 0 C-N-CA 123.243 2.629 . . . . 0.0 112.871 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.532 ' C ' ' H ' ' A' ' 177' ' ' TYR . 88.0 t -64.72 -45.09 75.4 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 178.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 39.5 Cg_endo -67.63 8.96 0.37 Allowed 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 121.996 1.798 . . . . 0.0 111.933 175.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.734 ' HB2' ' HB2' ' A' ' 174' ' ' PRO . 1.5 m-85 -111.79 -5.34 14.42 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.256 -1.338 . . . . 0.0 109.649 -175.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.799 HG11 HD13 ' A' ' 173' ' ' ILE . 2.7 m -133.28 171.24 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-O 123.596 1.665 . . . . 0.0 114.717 -167.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.867 ' HG3' ' CD1' ' A' ' 131' ' ' LEU . 2.7 mm-40 -140.64 51.88 1.64 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 110.612 -2.995 . . . . 0.0 110.635 -155.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.698 ' CG ' HG22 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -69.69 136.78 51.47 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 120.209 -1.557 . . . . 0.0 109.894 -166.733 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 20.7 tp . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 112.329 -2.214 . . . . 0.0 113.244 -156.851 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo . . . . . 0 N--CA 1.459 -0.51 0 N-CA-C 111.187 -0.351 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.621 ' HB ' ' HE3' ' A' ' 269' ' ' MET . 3.4 t -83.07 146.06 7.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -178.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.406 ' CG ' ' HG3' ' A' ' 296' ' ' PRO . 57.0 m-85 -115.0 131.88 56.78 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.45 0.643 . . . . 0.0 112.02 -172.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.76 ' HB2' HD12 ' A' ' 293' ' ' ILE . . . -133.37 146.03 50.9 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.092 176.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.407 ' HB3' HD13 ' A' ' 263' ' ' ILE . 18.5 ptmt -111.38 132.34 54.5 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.693 -0.403 . . . . 0.0 109.952 176.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -63.36 117.86 7.25 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.945 -175.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 19.2 pt -98.43 -14.02 7.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.082 -177.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -146.17 138.91 25.53 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 47.7 mttp -52.95 140.0 25.99 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.843 0.83 . . . . 0.0 113.159 -172.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.524 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 21.0 tpt180 -130.42 86.15 2.36 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.969 172.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 19.4 m -95.99 140.89 22.48 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.189 -179.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.41 ' HA ' ' HB3' ' A' ' 255' ' ' ALA . 13.4 Cg_exo -66.96 136.87 42.8 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.405 2.07 . . . . 0.0 111.604 -179.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 33.0 t -104.03 175.5 5.46 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.652 -178.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -56.3 -42.88 78.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.994 0.425 . . . . 0.0 111.43 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -85.81 -14.79 44.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.06 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -129.58 70.58 1.42 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.946 0.403 . . . . 0.0 110.185 -176.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -83.73 -14.13 52.35 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 174.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 5.2 p -76.82 -5.81 49.8 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.409 174.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . 0.41 ' HB3' ' HA ' ' A' ' 248' ' ' PRO . . . -72.88 139.55 46.95 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.745 178.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.07 119.75 23.95 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.524 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -70.03 103.65 2.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.653 178.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . 0.496 ' HB2' ' HB3' ' A' ' 246' ' ' ARG . 96.1 mt -112.07 128.03 56.08 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.075 -178.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.75 157.17 17.04 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 176.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 47.4 t -67.57 124.18 22.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.985 0.422 . . . . 0.0 110.253 -178.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 98.74 5.65 56.55 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.255 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -93.38 135.42 34.63 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . 0.407 HD13 ' HB3' ' A' ' 241' ' ' LYS . 24.8 mm -81.52 121.79 35.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.964 0.411 . . . . 0.0 110.184 177.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.494 HG11 ' CZ ' ' A' ' 286' ' ' PHE . 22.0 t -95.15 109.66 22.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.91 -178.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 43.4 tttp -85.76 87.46 7.41 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.59 176.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.432 HG21 ' HB3' ' A' ' 275' ' ' TRP . 4.0 p -89.92 125.8 42.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.156 0.503 . . . . 0.0 110.59 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 16.1 p -95.8 -32.87 12.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.256 -177.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . 0.568 ' HD2' ' OE2' ' A' ' 276' ' ' GLU . 41.3 ttm180 -132.39 118.46 19.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.992 0.425 . . . . 0.0 111.786 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' MET . . . . . 0.621 ' HE3' ' HB ' ' A' ' 238' ' ' VAL . 46.8 mtt -90.78 107.25 19.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.137 172.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.729 HD21 ' HG3' ' A' ' 276' ' ' GLU . 44.1 m-80 -78.68 137.82 37.99 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 178.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 10.7 tt -79.9 71.46 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 122.153 0.978 . . . . 0.0 110.969 -178.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . 0.58 HD21 ' HG2' ' A' ' 274' ' ' GLN . 2.8 p-10 -168.27 -4.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.852 176.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . 0.419 ' H ' ' H ' ' A' ' 272' ' ' ASN . . . 119.42 -31.24 5.49 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.159 171.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.58 ' HG2' HD21 ' A' ' 272' ' ' ASN . 12.1 pt20 -95.46 129.48 42.61 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.04 0.447 . . . . 0.0 110.519 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . 0.432 ' HB3' HG21 ' A' ' 266' ' ' VAL . 50.7 m0 -105.72 154.01 21.06 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.317 -179.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.729 ' HG3' HD21 ' A' ' 270' ' ' ASN . 43.0 mt-10 -96.0 111.45 23.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.335 172.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . 0.555 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -134.26 156.56 22.45 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.493 -0.861 . . . . 0.0 111.625 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.548 ' HG2' ' HB2' ' A' ' 283' ' ' LYS . 41.1 mt-10 -117.32 108.08 15.17 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.091 0.472 . . . . 0.0 109.808 178.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . 0.566 HG12 ' ND2' ' A' ' 280' ' ' ASN . 15.4 t -138.39 137.68 43.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.574 -177.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . 0.566 ' ND2' HG12 ' A' ' 279' ' ' VAL . 52.9 m-80 61.64 21.51 12.19 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.604 0.362 . . . . 0.0 111.051 -178.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 90.97 -5.87 81.86 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.979 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 32.7 mtp-105 -110.08 132.45 54.15 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 122.663 -0.316 . . . . 0.0 111.258 -178.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.555 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 2.0 ttmp? -97.11 122.28 39.94 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 168.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -150.85 168.5 30.59 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.308 -0.949 . . . . 0.0 111.949 -178.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 84.6 mt -91.28 138.72 31.36 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.07 0.462 . . . . 0.0 110.313 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.494 ' CZ ' HG11 ' A' ' 264' ' ' VAL . 34.3 p90 -148.14 144.42 18.82 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.663 178.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . 0.505 ' HG2' ' CD2' ' A' ' 290' ' ' HIS . 84.5 Cg_endo -82.11 144.31 13.25 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.49 2.127 . . . . 0.0 111.542 176.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -65.93 -10.52 39.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.869 0.366 . . . . 0.0 111.89 -176.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 3.0 p -71.94 -4.87 30.85 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -178.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . 0.505 ' CD2' ' HG2' ' A' ' 287' ' ' PRO . 14.2 m-70 -111.29 -2.71 15.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.705 0.288 . . . . 0.0 111.155 -177.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.447 ' HB ' ' HB1' ' A' ' 240' ' ' ALA . 31.2 m -127.58 156.3 39.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.082 0.468 . . . . 0.0 111.371 -176.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 44.9 tptt -112.71 111.27 21.94 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.406 177.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.76 HD12 ' HB2' ' A' ' 240' ' ' ALA . 4.0 tp -72.11 141.2 16.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -162.54 -174.66 4.1 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.809 0.338 . . . . 0.0 110.694 -178.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -108.82 106.94 59.63 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.707 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . 0.406 ' HG3' ' CG ' ' A' ' 239' ' ' PHE . 87.3 Cg_endo . . . . . 0 N--CA 1.462 -0.336 0 C-N-CA 122.786 2.324 . . . . 0.0 112.471 -178.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.3 t . . . . . 0 N--CA 1.451 -0.378 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.57 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . -77.19 101.28 6.11 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 114.535 -1.212 . . . . 0.0 109.775 174.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -131.53 106.81 8.44 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.503 0.668 . . . . 0.0 111.269 -177.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.569 ' CE1' ' HE2' ' A' ' 89' ' ' LYS . 34.3 p90 -168.01 139.44 2.88 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.647 -1.161 . . . . 0.0 108.402 175.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -74.1 102.34 4.19 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.208 0.528 . . . . 0.0 110.284 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.1 m -57.73 -32.13 67.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.586 -175.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.4 t -81.47 -2.12 48.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.888 -174.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -103.66 105.83 16.17 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 121.585 -0.697 . . . . 0.0 110.901 -177.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.11 -29.09 70.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.899 178.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.8 m -74.79 4.04 7.06 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.974 0.416 . . . . 0.0 110.731 178.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -99.05 -30.48 12.3 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.558 175.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 36.6 p-90 -138.2 -20.83 1.08 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -171.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -77.14 115.41 16.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.041 0.448 . . . . 0.0 110.15 -174.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' MET . . . . . 0.582 ' HG3' ' HB2' ' A' ' 37' ' ' LEU . 25.1 mmt -97.94 -7.68 29.62 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.991 -175.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.483 ' O ' ' HB2' ' A' ' 39' ' ' ARG . . . 50.78 -111.69 1.34 Allowed Glycine 0 CA--C 1.523 0.577 0 O-C-N 123.694 0.622 . . . . 0.0 113.427 -178.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.435 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 4.4 Cg_exo -76.87 103.18 1.71 Allowed 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.845 2.363 . . . . 0.0 112.417 -179.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.724 ' HB ' ' HG3' ' A' ' 39' ' ' ARG . 2.9 t -138.13 -69.87 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.758 -178.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.527 ' H ' ' HG3' ' A' ' 39' ' ' ARG . 21.4 t 95.85 162.89 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 124.662 1.185 . . . . 0.0 109.083 172.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.432 ' O ' ' HG2' ' A' ' 25' ' ' GLN . 69.8 mtp85 -55.78 -44.56 77.83 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 123.04 0.212 . . . . 0.0 110.804 -175.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.87 -46.95 74.79 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 123.993 0.808 . . . . 0.0 110.718 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.52 ' HB3' HG13 ' A' ' 19' ' ' VAL . 14.1 tp10 -76.24 -46.91 25.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.298 0.57 . . . . 0.0 110.469 -175.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.11 -39.6 75.38 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.99 -176.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' A' ' 21' ' ' ARG . 2.1 pt20 -75.34 -33.15 61.09 Favored 'General case' 0 C--O 1.219 -0.513 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -173.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.1 t -75.48 -32.14 60.46 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.149 -176.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -84.22 -7.07 59.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.947 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.6 HD21 ' HB2' ' A' ' 102' ' ' ALA . 97.0 mt -125.97 13.3 7.87 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.639 175.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . 0.407 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 27.3 tp60 -72.36 84.72 1.08 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.634 ' HA2' ' HA ' ' A' ' 56' ' ' SER . . . 85.12 -64.81 4.15 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.518 -178.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 39.87 -125.8 0.4 Allowed 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 123.257 0.623 . . . . 0.0 112.222 -176.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 20.1 ptp180 -106.73 -7.24 17.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.242 -0.436 . . . . 0.0 109.876 178.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 37.7 m80 67.91 153.15 0.09 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.254 -173.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.98 -0.79 76.69 Favored Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.881 -177.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.674 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 37.1 mtm -104.7 147.51 27.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.749 0.309 . . . . 0.0 110.566 -178.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.427 ' CB ' HG22 ' A' ' 52' ' ' VAL . 43.2 p90 -143.27 169.42 17.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.49 -178.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.582 ' HB2' ' HG3' ' A' ' 16' ' ' MET . 4.5 pp -158.21 143.76 16.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.012 0.434 . . . . 0.0 110.769 173.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.5 t -115.44 112.66 40.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 175.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.724 ' HG3' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -121.66 167.75 12.57 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.407 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -62.28 137.93 58.34 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 28.4 t -66.63 126.11 27.9 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.282 0.563 . . . . 0.0 111.298 -173.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.4 p -86.13 6.44 29.2 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.591 174.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.8 -39.73 8.47 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.046 179.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.475 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 71.1 m -149.66 137.4 11.61 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.956 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 44' ' ' CYS . 38.2 Cg_exo -61.15 -32.5 91.15 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.283 2.655 . . . . 0.0 113.799 -175.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -101.84 33.06 6.81 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.849 -176.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.635 ' OD1' ' HA ' ' A' ' 64' ' ' ASN . 15.6 m-20 -138.71 167.56 21.71 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 110.375 -0.232 . . . . 0.0 110.375 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.427 ' CD2' HD11 ' A' ' 81' ' ' LEU . 16.7 m-85 -126.42 170.62 11.77 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 174.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.409 ' HB ' ' NH1' ' A' ' 39' ' ' ARG . 44.8 t -144.16 115.96 2.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-O 121.002 0.43 . . . . 0.0 111.653 176.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.5 tp -82.7 106.05 14.23 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.025 174.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.8 m -96.82 129.04 44.31 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 176.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.721 HG12 ' HG2' ' A' ' 54' ' ' GLU . 70.8 t -121.9 134.56 64.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.843 -176.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.573 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 41.0 t -88.04 99.18 11.97 Favored 'General case' 0 CA--C 1.513 -0.442 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.965 -177.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.721 ' HG2' HG12 ' A' ' 52' ' ' VAL . 65.5 mm-40 -144.94 142.08 29.55 Favored 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 119.51 -0.876 . . . . 0.0 109.403 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 61.04 15.81 6.51 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.594 0.558 . . . . 0.0 111.927 -178.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.634 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 27.4 m 58.89 54.55 5.05 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 122.935 1.35 . . . . 0.0 107.374 -173.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.593 HH22 ' CG ' ' A' ' 94' ' ' ASP . 0.1 OUTLIER -167.01 67.88 0.09 Allowed 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 112.26 -2.245 . . . . 0.0 108.831 -151.638 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 9.9 t -69.63 100.52 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.815 0.816 . . . . 0.0 109.777 -167.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 50.9 m -74.76 120.72 20.69 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 114.213 -1.358 . . . . 0.0 110.474 -178.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 -93.29 103.28 15.53 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.003 -177.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.657 ' HB3' HD11 ' A' ' 73' ' ' ILE . 58.5 m-85 -91.35 104.29 16.83 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.159 177.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 59.9 mt -79.46 125.76 38.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.848 0.356 . . . . 0.0 111.758 -175.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.457 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 4.6 mp -103.51 109.93 28.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.471 178.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.635 ' HA ' ' OD1' ' A' ' 47' ' ' ASP . 15.4 m120 -83.13 160.41 21.87 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.735 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.6 t -99.87 109.7 22.08 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 172.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.552 HD11 ' HB2' ' A' ' 72' ' ' LYS . 85.3 mt -78.68 153.25 78.31 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.327 -176.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -62.9 -14.58 41.95 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.668 2.245 . . . . 0.0 111.655 173.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -81.65 8.63 9.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.618 177.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? 62.9 29.0 16.56 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.587 0.708 . . . . 0.0 110.014 -177.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 27.8 mtp180 -124.34 -174.9 3.12 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.581 -177.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . 0.457 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 72.9 m-85 -122.12 151.37 41.01 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.551 0.215 . . . . 0.0 111.027 -177.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.581 ' HE3' ' O ' ' A' ' 75' ' ' ASP . 86.5 tttt -138.89 113.81 9.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.767 -175.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.657 HD11 ' HB3' ' A' ' 61' ' ' TYR . 20.3 tt -89.87 100.48 10.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.858 0.837 . . . . 0.0 110.916 -174.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.45 -65.04 2.45 Favored Glycine 0 CA--C 1.519 0.29 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.95 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.581 ' O ' ' HE3' ' A' ' 72' ' ' LYS . 20.0 t70 -154.15 -29.56 0.12 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.024 0.44 . . . . 0.0 110.221 -176.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -85.48 121.7 28.56 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -93.49 145.87 24.19 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.226 0.536 . . . . 0.0 111.288 -175.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.441 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 86.3 m-85 -131.94 -173.73 3.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.815 178.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -74.94 -61.7 1.8 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.555 178.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -146.27 -179.1 6.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.272 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.56 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 7.5 mt -56.27 -56.9 26.48 Favored Pre-proline 0 N--CA 1.467 0.405 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -178.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.469 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 50.9 Cg_exo -57.79 -10.52 7.58 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.399 2.066 . . . . 0.0 113.607 178.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.04 -32.93 17.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.554 0.216 . . . . 0.0 111.034 -175.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.1 pp -76.6 -33.89 58.4 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.401 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 77.6 mt -65.25 -31.21 72.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.603 178.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -72.85 -39.82 66.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.267 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.43 ' CE2' ' ND1' ' A' ' 91' ' ' HIS . 68.6 t80 -68.03 -30.94 70.29 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.405 -178.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.43 ' HE2' HD13 ' A' ' 73' ' ' ILE . 27.8 m-85 -84.08 2.3 40.0 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -176.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.569 ' HE2' ' CE1' ' A' ' 6' ' ' PHE . 96.4 mttt -80.47 -15.82 55.82 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.335 172.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.7 pp -126.74 9.39 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.14 0 CA-C-O 121.385 0.612 . . . . 0.0 110.556 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.44 ' O ' ' HB2' ' A' ' 92' ' ' TYR . 9.1 t60 -94.32 -42.43 8.91 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.713 -177.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.448 ' H ' HG22 ' A' ' 97' ' ' THR . 75.8 m-85 65.53 95.72 0.05 Allowed 'General case' 0 C--N 1.329 -0.318 0 O-C-N 124.402 1.063 . . . . 0.0 109.054 -163.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.625 ' O ' ' HB3' ' A' ' 154' ' ' GLU . 30.8 mt -61.07 -92.8 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 173.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.593 ' CG ' HH22 ' A' ' 57' ' ' ARG . 20.6 t0 -99.83 86.3 3.26 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.104 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.845 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 2.2 t 48.6 15.18 0.08 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.815 -1.084 . . . . 0.0 112.665 -176.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -156.75 153.17 27.96 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 120.966 0.412 . . . . 0.0 110.383 -177.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.448 HG22 ' H ' ' A' ' 92' ' ' TYR . 7.5 p -98.15 168.28 10.35 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.133 -179.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 97.3 mt -70.08 92.67 0.75 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 177.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.57 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 37.4 mm -78.18 -59.29 3.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.34 -174.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.674 ' O ' ' HA ' ' A' ' 35' ' ' MET . 38.4 tt0 -155.8 135.4 8.11 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.14 -176.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -62.12 157.1 46.23 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.791 2.327 . . . . 0.0 113.023 -178.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.6 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -68.91 142.87 93.97 Favored Pre-proline 0 N--CA 1.452 -0.366 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.131 177.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -60.91 124.78 15.63 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.604 2.203 . . . . 0.0 112.362 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.746 176.054 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . 1.004 HD12 HG21 ' A' ' 152' ' ' ILE . 1.4 mm? . . . . . 0 N--CA 1.468 0.454 0 CA-C-O 120.965 0.412 . . . . 0.0 111.811 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.756 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 0.0 OUTLIER -171.83 -61.59 0.02 OUTLIER 'General case' 0 C--O 1.215 -0.729 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.566 -179.926 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.556 ' N ' ' HG2' ' A' ' 126' ' ' GLU . 50.1 m-85 -115.21 108.44 16.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.394 0.616 . . . . 0.0 111.843 179.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.944 HG22 ' HG3' ' A' ' 180' ' ' LYS . 38.8 t -126.88 136.13 61.67 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.287 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.645 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 5.7 ptp180 -113.39 153.75 28.06 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 117.789 -1.564 . . . . 0.0 108.915 172.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.546 HG22 HG12 ' A' ' 178' ' ' VAL . 68.2 p -102.74 140.17 37.36 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.512 0.672 . . . . 0.0 111.757 178.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.553 HD21 ' HG2' ' A' ' 179' ' ' GLU . 9.8 mt -113.4 -16.26 12.49 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.89 178.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.442 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 21.7 t80 -82.72 -39.66 21.65 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.313 -174.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ASP . . . . . 0.689 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 13.6 t70 72.82 104.81 0.07 Allowed 'General case' 0 N--CA 1.468 0.443 0 O-C-N 123.695 0.622 . . . . 0.0 110.873 -177.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.546 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 67.0 t80 -132.12 94.14 24.7 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 174.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.677 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 69.8 Cg_endo -87.05 92.25 0.53 Allowed 'Trans proline' 0 N--CA 1.442 -1.507 0 C-N-CA 121.667 1.578 . . . . 0.0 112.893 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -88.54 -25.51 30.21 Favored Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.672 174.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ASN . . . . . 0.52 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 0.8 OUTLIER 60.13 52.28 5.16 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.385 0.674 . . . . 0.0 111.933 178.685 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ASP . . . . . 0.438 ' HB3' ' H ' ' A' ' 140' ' ' GLU . 0.9 OUTLIER -138.57 172.89 12.21 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.794 177.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -89.32 -13.15 38.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.924 0.869 . . . . 0.0 109.084 172.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.666 ' O ' ' HB2' ' A' ' 172' ' ' MET . 5.9 mm-40 -93.02 -35.25 13.36 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.994 176.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -125.72 109.69 12.87 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.817 177.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 1.052 HD11 ' HB2' ' A' ' 165' ' ' ASN . 34.2 tp -69.35 130.76 90.65 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.002 -176.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . 0.677 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 73.7 Cg_endo -82.26 88.69 1.26 Allowed 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 121.867 1.711 . . . . 0.0 112.071 171.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . 0.546 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 22.3 p90 -100.25 172.92 6.87 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -176.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' LYS . . . . . 0.689 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 14.1 mptt -122.92 -164.59 1.21 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -168.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.56 ' HD2' ' N ' ' A' ' 146' ' ' LYS . 7.6 mptt -85.39 1.29 49.23 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.59 -174.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -177.39 30.86 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.612 -178.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.682 ' OE2' ' HG ' ' A' ' 150' ' ' LEU . 1.6 pp20? -73.06 169.92 15.98 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 175.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.6 mp -117.89 128.46 75.02 Favored 'Isoleucine or valine' 0 C--N 1.35 0.619 0 CA-C-N 118.498 0.59 . . . . 0.0 110.083 173.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.862 ' CD2' ' HA ' ' A' ' 165' ' ' ASN . 86.0 mt -118.38 158.67 24.83 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-O 121.51 0.671 . . . . 0.0 110.493 -173.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.756 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 97.2 t -128.08 121.07 55.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.187 174.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 1.075 HD13 ' HB2' ' A' ' 163' ' ' ALA . 26.6 mm -78.83 84.0 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 CA-C-O 121.826 0.822 . . . . 0.0 109.134 -176.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.785 HG23 ' HG2' ' A' ' 154' ' ' GLU . 20.9 tt -73.94 -32.83 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.535 -176.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' GLU . . . . . 0.785 ' HG2' HG23 ' A' ' 153' ' ' ILE . 0.0 OUTLIER -125.46 144.84 50.35 Favored 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 175.753 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -131.94 76.59 73.51 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-O 121.453 0.644 . . . . 0.0 109.638 168.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.845 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 15.6 Cg_exo -66.88 -47.67 2.43 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.512 2.142 . . . . 0.0 111.581 176.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -112.19 -170.97 1.76 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.629 -177.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -124.85 -14.45 6.69 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.24 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -89.96 -21.35 22.47 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 168.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.667 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 80.9 m95 -125.97 139.15 53.67 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.171 177.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' TRP . . . . . 0.752 ' O ' HG13 ' A' ' 173' ' ' ILE . 45.7 m0 -128.37 137.39 51.87 Favored 'General case' 0 C--O 1.206 -1.187 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.25 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.563 ' HA ' ' HA ' ' A' ' 172' ' ' MET . 6.3 m -97.67 102.68 14.5 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -172.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 1.075 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -115.53 147.09 41.09 Favored 'General case' 0 N--CA 1.415 -2.2 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.489 -171.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.753 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 13.5 ptt-85 -86.64 127.26 34.92 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 175.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ASN . . . . . 1.052 ' HB2' HD11 ' A' ' 142' ' ' LEU . 61.5 t30 -62.41 177.03 0.55 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.875 -169.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.536 ' HB2' ' HB2' ' A' ' 148' ' ' GLU . 40.5 tptt -50.86 -26.42 5.78 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.331 164.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -69.51 -43.04 73.9 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.832 173.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 113.12 -5.02 25.4 Favored Glycine 0 CA--C 1.516 0.146 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.276 -170.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ARG . . . . . 0.753 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.6 OUTLIER -71.29 135.82 47.6 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 123.389 0.675 . . . . 0.0 111.692 -178.819 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 59.6 t -83.48 123.44 38.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 C-N-CA 121.202 -0.199 . . . . 0.0 110.491 177.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -160.76 158.25 29.77 Favored Glycine 0 C--O 1.227 -0.299 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.68 173.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' MET . . . . . 0.667 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.6 OUTLIER -74.89 140.67 43.97 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 117.234 0.517 . . . . 0.0 112.001 -178.19 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.752 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.8 pp -137.09 140.49 31.47 Favored Pre-proline 0 N--CA 1.451 -0.418 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.368 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' PRO . . . . . 0.602 ' O ' HG13 ' A' ' 178' ' ' VAL . 6.3 Cg_exo -76.56 127.04 9.38 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.969 2.446 . . . . 0.0 113.115 -175.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.601 ' O ' HG22 ' A' ' 178' ' ' VAL . 59.4 t -53.23 -45.3 98.41 Favored Pre-proline 0 CA--C 1.542 0.635 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 177.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 27.7 Cg_endo -63.44 -1.0 2.72 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.044 1.83 . . . . 0.0 113.318 176.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.475 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.1 m-30 -104.26 -10.01 18.17 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.588 0.232 . . . . 0.0 111.351 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.647 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 5.0 m -108.16 -171.96 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 115.786 1.773 . . . . 0.0 115.786 -162.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' GLU . . . . . 0.645 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 5.1 tp10 -155.75 50.95 0.55 Allowed 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 113.009 -1.905 . . . . 0.0 113.503 -153.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' LYS . . . . . 0.944 ' HG3' HG22 ' A' ' 128' ' ' VAL . 3.6 mppt? -67.28 136.44 54.91 Favored 'General case' 0 CA--C 1.518 -0.259 0 O-C-N 119.498 -2.001 . . . . 0.0 109.012 -165.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 61.5 tp . . . . . 0 C--N 1.33 -0.283 0 CA-C-N 112.583 -2.099 . . . . 0.0 112.369 -165.461 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo . . . . . 0 C--O 1.232 0.221 0 CA-C-O 120.741 0.226 . . . . 0.0 111.759 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.45 HG11 HD12 ' A' ' 293' ' ' ILE . 20.1 t -94.19 143.84 10.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.079 -178.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' PHE . . . . . 0.518 ' HB2' ' HG3' ' A' ' 296' ' ' PRO . 95.3 m-85 -111.8 124.21 51.87 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.503 -178.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' ALA . . . . . 0.412 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -119.7 127.62 53.04 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.076 179.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . 0.43 ' HB2' ' CE1' ' A' ' 294' ' ' PHE . 50.5 tttp -85.92 119.38 26.17 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -178.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' ALA . . . . . 0.479 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -71.03 106.84 3.84 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.542 -178.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.749 HG12 ' HG3' ' A' ' 292' ' ' LYS . 2.6 pp -104.56 -14.74 8.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.168 -177.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . 0.432 ' HB2' HD12 ' A' ' 243' ' ' ILE . 0.0 OUTLIER -130.76 137.95 49.72 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 175.622 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -62.3 163.6 8.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.409 0.623 . . . . 0.0 111.944 -173.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' ARG . . . . . 0.615 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -145.78 121.43 10.47 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 177.898 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 16.5 m -122.36 139.18 30.27 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-O 120.795 0.331 . . . . 0.0 110.753 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.475 ' HD3' ' HB2' ' A' ' 257' ' ' ALA . 42.5 Cg_endo -68.98 125.75 12.95 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.645 2.23 . . . . 0.0 112.249 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' CYS . . . . . 0.549 ' HB3' ' HB2' ' A' ' 252' ' ' ASP . 16.5 t -90.64 172.45 8.67 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -55.71 -47.59 76.59 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.945 0.402 . . . . 0.0 111.283 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -87.68 -6.31 58.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.767 179.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . 0.549 ' HB2' ' HB3' ' A' ' 249' ' ' CYS . 2.9 m-20 -114.48 52.11 0.86 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.342 178.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -71.02 -13.51 62.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.32 0.581 . . . . 0.0 109.865 177.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 2.7 p -89.25 -8.22 53.91 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.969 176.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -76.71 123.18 25.79 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.687 -178.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' LEU . . . . . 0.417 ' HA ' HH11 ' A' ' 282' ' ' ARG . 0.6 OUTLIER -70.33 139.34 51.99 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.629 -178.295 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' ALA . . . . . 0.615 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -89.15 117.55 28.22 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.094 0.473 . . . . 0.0 109.921 176.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 35.4 mt -129.14 157.76 40.88 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.928 -176.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -136.86 160.29 39.31 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 21.7 t -66.29 105.32 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.087 -172.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 130.6 10.7 2.56 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.689 175.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -118.41 157.57 26.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 117.879 0.839 . . . . 0.0 111.375 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 37.2 mm -94.04 124.07 46.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.753 -178.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 32.0 t -95.5 111.02 25.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.957 175.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -95.28 97.26 9.73 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.563 -178.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' VAL . . . . . 0.493 ' HA ' ' HA2' ' A' ' 277' ' ' GLY . 6.6 p -88.41 134.89 26.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.704 -0.399 . . . . 0.0 110.394 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 22.1 p -92.93 -44.1 8.61 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.512 -176.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 29.3 ptt180 -131.21 126.46 35.62 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 121.365 0.602 . . . . 0.0 110.951 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 40.1 mmm -83.08 110.44 18.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.527 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 274' ' ' GLN . 86.9 m-20 -85.4 126.97 34.2 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.283 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 22.8 mt -70.73 -18.62 21.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.295 -175.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -61.88 -23.89 66.59 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.702 0.287 . . . . 0.0 111.162 -178.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 109.19 21.79 7.17 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.746 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.504 ' HA ' ' CZ ' ' A' ' 288' ' ' PHE . 37.9 mt-30 -151.56 111.35 4.03 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 167.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 1.3 m0 -92.08 164.81 13.46 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -176.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 276' ' ' GLU . . . . . 0.668 ' HB3' ' HE2' ' A' ' 283' ' ' LYS . 43.3 mt-10 -104.78 117.98 35.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.128 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -122.01 142.33 14.97 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.725 -178.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -99.38 111.52 23.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.817 0.818 . . . . 0.0 109.922 175.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 95.7 t -124.39 158.03 31.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.74 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -61.8 82.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.732 0.777 . . . . 0.0 110.79 175.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 160.85 -35.77 0.42 Allowed Glycine 0 N--CA 1.441 -0.996 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.17 -177.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' ARG . . . . . 0.438 HH11 ' HD2' ' A' ' 282' ' ' ARG . 42.8 ttm105 177.92 159.71 0.49 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 117.054 0.427 . . . . 0.0 110.197 -178.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . 0.668 ' HE2' ' HB3' ' A' ' 276' ' ' GLU . 2.5 tmtp? -110.1 101.17 9.99 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 171.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -151.96 -168.92 16.84 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.926 -172.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 73.2 mt -90.73 149.15 22.15 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.859 0.361 . . . . 0.0 110.455 -177.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 286' ' ' PHE . . . . . 0.421 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 42.0 p90 -143.91 152.54 55.58 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.402 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 287' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 2.3 Cg_endo -81.37 145.3 14.92 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 123.346 2.697 . . . . 0.0 111.752 177.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 288' ' ' PHE . . . . . 0.504 ' CZ ' ' HA ' ' A' ' 274' ' ' GLN . 3.6 m-85 -91.73 -5.47 53.59 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.116 0.414 . . . . 0.0 112.116 -167.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 4.5 m -94.4 -19.73 20.35 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.325 0.583 . . . . 0.0 109.887 175.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -77.23 -22.43 52.24 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.574 177.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 291' ' ' VAL . . . . . 0.479 HG12 ' HA ' ' A' ' 242' ' ' ALA . 28.5 m -117.19 164.49 13.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.235 178.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . 0.749 ' HG3' HG12 ' A' ' 243' ' ' ILE . 98.1 mttt -119.39 119.92 35.35 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.609 177.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 293' ' ' ILE . . . . . 0.45 HD12 HG11 ' A' ' 238' ' ' VAL . 18.9 mm -74.63 110.69 9.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 172.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 294' ' ' PHE . . . . . 0.43 ' CE1' ' HB2' ' A' ' 241' ' ' LYS . 2.3 p90 -132.24 -178.62 4.99 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.894 -175.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -104.49 101.88 30.37 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . 0.518 ' HG3' ' HB2' ' A' ' 239' ' ' PHE . 60.7 Cg_endo . . . . . 0 CA--C 1.529 0.256 0 C-N-CA 122.311 2.007 . . . . 0.0 111.878 177.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.6 ptm . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.0 p -91.51 131.77 36.73 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.154 0.502 . . . . 0.0 110.97 178.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.54 ' HB2' HD12 ' A' ' 99' ' ' ILE . 13.0 p -88.39 -38.14 15.32 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 174.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.537 ' HB1' ' HG2' ' A' ' 89' ' ' LYS . . . -93.87 127.91 39.88 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.766 178.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 26.0 mtt180 -142.14 -66.61 0.4 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.443 -176.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.43 ' HB2' ' H ' ' A' ' 7' ' ' ASP . 6.8 p90 11.15 -147.18 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 113.653 -1.612 . . . . 0.0 115.253 -161.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.43 ' H ' ' HB2' ' A' ' 6' ' ' PHE . 6.2 p-10 -101.98 -49.54 3.92 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.986 -174.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.44 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 50.4 m 65.16 35.87 7.58 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.586 -175.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.7 m -161.23 -25.92 0.05 Allowed 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 176.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -85.31 108.71 17.93 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.238 0.542 . . . . 0.0 111.064 -169.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.568 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 9.7 mmt180 -62.06 -25.72 67.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.758 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.9 m -90.11 3.51 53.13 Favored 'General case' 0 C--N 1.32 -0.714 0 O-C-N 122.149 -0.344 . . . . 0.0 110.941 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -99.21 -47.62 5.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.448 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.475 ' HB3' ' HB3' ' A' ' 101' ' ' PRO . 36.2 p-90 -114.2 -24.76 8.79 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -174.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.568 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 21.6 t80 -76.97 116.42 17.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.303 0.573 . . . . 0.0 110.107 -177.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.607 ' HG3' HG21 ' A' ' 19' ' ' VAL . 9.1 tpp -97.26 -9.16 28.19 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.085 -171.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.509 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 49.81 -115.21 2.85 Favored Glycine 0 CA--C 1.523 0.564 0 CA-C-N 115.398 -0.819 . . . . 0.0 114.292 177.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.509 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 4.6 Cg_exo -74.99 101.19 1.44 Allowed 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 123.056 2.504 . . . . 0.0 112.239 -177.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.607 HG21 ' HG3' ' A' ' 16' ' ' MET . 5.3 t -138.55 -76.46 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 CA-C-O 118.909 -0.567 . . . . 0.0 111.523 -175.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.761 ' H ' ' HD2' ' A' ' 39' ' ' ARG . 51.4 m 94.8 171.66 0.02 OUTLIER 'General case' 0 C--N 1.35 0.63 0 C-N-CA 124.187 0.995 . . . . 0.0 109.353 170.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.524 ' HD2' ' NH2' ' A' ' 39' ' ' ARG . 19.4 mmm180 -51.65 -53.46 38.52 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 123.388 0.43 . . . . 0.0 112.129 -169.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -62.95 -42.53 99.85 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.506 -175.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.433 ' HB3' HG13 ' A' ' 19' ' ' VAL . 12.7 tp10 -72.63 -46.03 56.08 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.296 0.569 . . . . 0.0 109.521 -174.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.24 -47.62 80.89 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.305 -0.862 . . . . 0.0 111.455 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.502 ' NE2' ' H ' ' A' ' 117' ' ' ASN . 50.6 tp60 -64.05 -41.57 97.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.081 -175.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.5 t -79.55 -20.92 45.89 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.775 0.287 . . . . 0.0 111.775 -175.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -80.69 -13.72 58.76 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 120.944 0.402 . . . . 0.0 110.708 178.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.608 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 80.2 mt -128.96 17.07 6.22 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.244 -177.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.519 ' HG2' ' O ' ' A' ' 114' ' ' SER . 0.0 OUTLIER -66.5 82.0 0.1 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 178.047 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.99 -63.94 4.22 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.715 -177.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 45.41 -105.16 0.1 Allowed 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.191 0.596 . . . . 0.0 111.858 -176.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 54.5 mtm180 -126.72 3.0 6.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.579 0.228 . . . . 0.0 110.409 176.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 28.0 m170 66.85 150.62 0.06 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.033 -174.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.33 19.22 79.68 Favored Glycine 0 C--O 1.227 -0.314 0 C-N-CA 120.577 -0.821 . . . . 0.0 112.011 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 76.3 mtp -112.3 141.78 45.6 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.483 ' HB2' HD11 ' A' ' 50' ' ' LEU . 38.4 p90 -137.98 161.62 36.22 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.99 -0.284 . . . . 0.0 111.136 -174.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.489 ' O ' HD12 ' A' ' 37' ' ' LEU . 4.6 pp -150.25 133.83 16.6 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.247 0.546 . . . . 0.0 110.569 172.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.417 HG22 HD13 ' A' ' 50' ' ' LEU . 42.3 t -101.92 107.21 21.16 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 175.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.761 ' HD2' ' H ' ' A' ' 20' ' ' SER . 28.3 ptt-85 -103.32 177.45 4.84 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 -178.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -75.2 137.43 41.27 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 174.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.518 ' HB3' ' O ' ' A' ' 44' ' ' CYS . 21.1 t -64.56 109.9 2.14 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.378 0.609 . . . . 0.0 111.229 -173.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 57.2 p -77.45 -4.83 47.43 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.602 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.69 -51.34 4.76 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.155 -0.929 . . . . 0.0 111.313 178.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.518 ' O ' ' HB3' ' A' ' 41' ' ' SER . 34.3 m -135.03 118.95 13.29 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.602 -177.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -59.03 123.86 14.41 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.601 2.201 . . . . 0.0 112.104 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.05 -34.73 4.94 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.947 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.588 ' OD1' ' HA ' ' A' ' 64' ' ' ASN . 44.5 m-20 -86.4 -176.86 6.04 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.49 ' HE2' ' CE1' ' A' ' 71' ' ' PHE . 35.1 m-85 -134.15 172.58 12.65 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 176.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.471 HG23 ' HA ' ' A' ' 41' ' ' SER . 43.1 t -140.7 106.12 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 120.938 0.399 . . . . 0.0 111.065 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.483 HD11 ' HB2' ' A' ' 36' ' ' PHE . 43.0 tp -78.9 106.26 10.79 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.308 176.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 24.1 m -96.66 132.38 42.37 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 174.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.567 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 72.0 t -125.13 133.3 69.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.712 0.291 . . . . 0.0 111.297 -177.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.608 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 30.7 t -87.52 116.49 25.67 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.288 -0.415 . . . . 0.0 112.063 -176.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.54 ' HG2' HG22 ' A' ' 95' ' ' THR . 7.6 tp10 -151.65 147.7 27.05 Favored 'General case' 0 C--O 1.21 -1.009 0 C-N-CA 119.682 -0.807 . . . . 0.0 109.225 164.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.5 ' HB2' ' HG2' ' A' ' 57' ' ' ARG . 67.4 m-80 56.84 24.05 8.79 Favored 'General case' 0 N--CA 1.468 0.431 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.402 ' HB3' HE22 ' A' ' 29' ' ' GLN . 14.4 m 57.47 52.82 8.07 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 122.522 1.153 . . . . 0.0 108.411 -174.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.66 ' HA ' ' HA ' ' A' ' 117' ' ' ASN 0.25 0.0 OUTLIER -167.44 66.49 0.08 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 113.504 -1.68 . . . . 0.0 109.814 -152.188 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 20.2 t -73.32 101.01 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 O-C-N 120.861 -1.15 . . . . 0.0 111.252 -167.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.8 m -69.87 122.15 18.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.807 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -96.26 115.92 28.2 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.891 -175.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.626 ' OH ' ' HB3' ' A' ' 93' ' ' LEU . 37.0 m-85 -108.84 113.95 27.31 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.63 178.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.652 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 57.3 mt -81.35 133.83 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 O-C-N 122.078 -0.388 . . . . 0.0 111.986 -177.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.523 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 5.3 mp -114.27 119.43 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 122.968 0.507 . . . . 0.0 110.853 179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.588 ' HA ' ' OD1' ' A' ' 47' ' ' ASP . 11.0 m120 -86.97 148.23 25.41 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.356 -174.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.7 t -89.53 94.96 10.06 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 170.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.464 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . 81.6 mt -71.6 135.58 83.66 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 66' ' ' LEU . 33.7 Cg_exo -60.66 -22.43 72.83 Favored 'Trans proline' 0 N--CA 1.473 0.312 0 C-N-CA 123.014 2.476 . . . . 0.0 113.072 -174.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -84.28 17.48 2.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.259 0.552 . . . . 0.0 110.37 176.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.627 ' HA ' ' NE ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER 65.33 52.1 1.48 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.142 175.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 63.8 mtt180 -135.54 -175.16 3.85 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.462 175.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.523 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 67.8 m-85 -137.27 136.58 38.18 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.633 0.254 . . . . 0.0 111.25 -173.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.533 ' HB3' ' HB2' ' A' ' 64' ' ' ASN . 61.7 tttp -125.76 108.49 11.55 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.763 -174.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.652 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 7.3 tt -99.52 102.26 13.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.238 0.542 . . . . 0.0 111.494 -175.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 53.3 70.34 0.95 Allowed Glycine 0 CA--C 1.52 0.392 0 CA-C-N 115.437 -0.801 . . . . 0.0 113.728 175.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 34.6 t70 74.89 -30.41 0.2 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.325 0.65 . . . . 0.0 111.568 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -89.55 112.82 24.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.642 0.258 . . . . 0.0 110.809 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 1.3 pm0 -97.41 139.79 32.83 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.663 0.744 . . . . 0.0 111.484 176.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.515 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 89.9 m-85 -122.34 -172.04 2.38 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.528 -1.215 . . . . 0.0 108.611 175.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -86.11 -29.21 23.5 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.745 0.307 . . . . 0.0 111.514 -179.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -163.78 168.11 20.05 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.515 0.198 . . . . 0.0 111.417 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.654 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 6.7 mt -54.51 -58.61 13.3 Favored Pre-proline 0 N--CA 1.468 0.462 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.211 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.576 ' HA ' HD12 ' A' ' 85' ' ' LEU . 36.9 Cg_exo -63.9 -3.05 5.19 Favored 'Trans proline' 0 C--N 1.351 0.708 0 C-N-CA 122.132 1.888 . . . . 0.0 113.263 -179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.82 -33.79 17.28 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 110.322 -0.251 . . . . 0.0 110.322 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.654 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.1 pp -76.39 -34.09 58.87 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 177.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.576 HD12 ' HA ' ' A' ' 82' ' ' PRO . 60.1 mt -64.66 -29.51 70.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.13 177.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.2 tp10 -79.1 -33.9 43.98 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.378 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -72.21 -33.44 67.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.402 0.62 . . . . 0.0 110.388 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.413 ' HE2' HD13 ' A' ' 73' ' ' ILE . 38.3 m-85 -82.44 1.86 35.47 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.619 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.537 ' HG2' ' HB1' ' A' ' 4' ' ' ALA . 93.8 mttt -73.76 -16.53 61.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.774 173.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 36.8 pt -129.96 -0.65 2.58 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.149 0 CA-C-O 121.15 0.5 . . . . 0.0 110.725 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -82.67 -40.83 20.17 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.889 -175.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.413 ' H ' HG22 ' A' ' 97' ' ' THR . 96.1 m-85 64.82 101.05 0.04 OUTLIER 'General case' 0 CA--C 1.515 -0.382 0 O-C-N 124.548 1.155 . . . . 0.0 109.209 -164.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.626 ' HB3' ' OH ' ' A' ' 61' ' ' TYR . 26.6 mt -63.66 -99.25 0.0 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.763 174.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.648 ' HA ' ' HB3' ' A' ' 154' ' ' GLU . 40.7 t0 -68.35 -59.97 2.79 Favored 'General case' 0 C--O 1.218 -0.578 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -175.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.656 ' CB ' ' HA ' ' A' ' 156' ' ' PRO . 12.6 t -154.37 14.85 0.45 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.661 0.743 . . . . 0.0 109.594 169.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 12.3 t -145.57 167.07 23.93 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.139 -0.937 . . . . 0.0 109.542 -177.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.413 HG22 ' H ' ' A' ' 92' ' ' TYR . 38.9 p -97.86 176.01 5.95 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 178.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.458 HD22 ' CD2' ' A' ' 36' ' ' PHE . 96.2 mt -77.99 89.4 4.15 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.188 0.518 . . . . 0.0 110.088 177.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.54 HD12 ' HB2' ' A' ' 3' ' ' SER . 38.9 mm -61.95 -64.1 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.327 -179.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.465 ' HB2' ' HD2' ' A' ' 101' ' ' PRO . 13.3 pt-20 -159.44 159.53 28.32 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.254 -0.884 . . . . 0.0 109.569 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.475 ' HB3' ' HB3' ' A' ' 14' ' ' TRP . 59.8 Cg_endo -72.63 155.62 54.29 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.268 1.979 . . . . 0.0 112.074 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.03 135.3 70.46 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 176.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.76 138.07 67.9 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.285 1.99 . . . . 0.0 111.262 176.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.592 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 36.6 mtm180 -68.44 -16.41 63.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.082 0.468 . . . . 0.0 110.737 -177.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -120.67 76.47 27.59 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-O 121.617 0.723 . . . . 0.0 109.438 170.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -95.76 40.78 0.14 Allowed 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.431 2.754 . . . . 0.0 112.507 -173.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 9.7 p -51.39 108.67 1.11 Allowed Pre-proline 0 C--N 1.329 -0.321 0 O-C-N 123.82 0.7 . . . . 0.0 111.823 -177.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -94.2 153.89 2.11 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 123.339 2.693 . . . . 0.0 112.22 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -62.49 -68.8 0.04 OUTLIER 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.353 2.035 . . . . 0.0 112.075 176.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 18.7 ptp 179.81 -168.7 0.11 Allowed 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 89.76 -78.27 1.59 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.948 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.45 ' HB3' ' HB3' ' A' ' 29' ' ' GLN . 46.5 m -79.03 93.66 5.16 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.113 0.482 . . . . 0.0 110.727 178.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.1 m -123.65 126.28 72.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.752 179.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.519 ' O ' ' HG2' ' A' ' 29' ' ' GLN . 29.6 t 56.86 -97.91 0.08 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.226 -178.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . 51.5 85.06 0.2 Allowed Pre-proline 0 C--O 1.235 0.333 0 C-N-CA 123.148 0.579 . . . . 0.0 111.638 -178.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.02 91.89 0.54 Allowed 'Trans proline' 0 N--CA 1.465 -0.205 0 C-N-CA 122.678 2.252 . . . . 0.0 112.362 -178.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.66 ' HA ' ' HA ' ' A' ' 57' ' ' ARG . 9.0 m-20 56.01 83.45 0.09 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.378 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 37.5 tp -124.98 81.95 61.96 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.805 -176.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -90.73 -10.22 3.09 Favored 'Trans proline' 0 N--CA 1.455 -0.779 0 C-N-CA 122.547 2.165 . . . . 0.0 112.187 177.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 19.5 m -157.04 -66.88 0.1 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.437 0.637 . . . . 0.0 110.393 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -158.48 -166.96 2.03 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.447 -178.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.426 ' H ' ' CD ' ' A' ' 122' ' ' GLU . 0.9 OUTLIER -91.93 30.02 1.48 Allowed 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.673 0.273 . . . . 0.0 110.872 -178.8 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.799 ' HB2' ' HA ' ' A' ' 183' ' ' ARG . 21.1 p-10 -123.77 -75.86 0.59 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -175.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -86.93 149.93 24.44 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -165.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.696 HD12 HG21 ' A' ' 152' ' ' ILE . 3.0 mm? 67.73 88.38 0.11 Allowed 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 114.138 -1.392 . . . . 0.0 112.993 177.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 173.29 -51.84 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 113.34 -1.755 . . . . 0.0 107.08 177.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -119.73 110.83 17.26 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.196 0.522 . . . . 0.0 110.681 173.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.96 HG22 ' HG3' ' A' ' 180' ' ' LYS . 61.1 t -128.72 139.39 52.02 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.018 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.572 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 7.5 ptp180 -112.48 155.52 24.12 Favored 'General case' 0 N--CA 1.434 -1.231 0 C-N-CA 116.834 -1.946 . . . . 0.0 108.952 170.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.603 ' OG1' ' HB2' ' A' ' 144' ' ' PHE . 1.0 OUTLIER -110.32 140.6 44.34 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.477 0.656 . . . . 0.0 110.896 178.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.567 HD21 ' HG2' ' A' ' 179' ' ' GLU . 8.1 mt -113.38 -15.14 12.7 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -177.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -94.73 -14.72 24.5 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -171.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.56 ' HB3' ' C ' ' A' ' 145' ' ' LYS . 3.8 p-10 54.99 102.08 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.856 0 CA-C-O 122.559 1.171 . . . . 0.0 112.637 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -119.39 86.64 34.08 Favored Pre-proline 0 C--N 1.317 -0.84 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 171.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.666 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 65.9 Cg_endo -85.56 72.97 4.09 Favored 'Trans proline' 0 N--CA 1.445 -1.376 0 C-N-CA 121.897 1.731 . . . . 0.0 112.638 -176.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.67 -34.19 66.92 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 110.755 -0.938 . . . . 0.0 110.755 174.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.871 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 0.4 OUTLIER 70.98 40.5 0.9 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 114.471 -0.864 . . . . 0.0 111.589 174.784 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -126.09 175.03 8.04 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.881 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -92.66 -7.66 46.23 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.8 0.81 . . . . 0.0 109.052 171.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.615 ' O ' ' HB2' ' A' ' 172' ' ' MET . 8.8 mm-40 -93.32 -29.87 15.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.653 -1.158 . . . . 0.0 108.752 176.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -136.18 108.88 7.5 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.851 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.996 HD11 ' HB2' ' A' ' 165' ' ' ASN . 58.1 tp -67.26 123.87 87.56 Favored Pre-proline 0 CA--C 1.509 -0.611 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.824 -176.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.871 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 56.3 Cg_endo -71.87 93.6 0.71 Allowed 'Trans proline' 0 N--CA 1.443 -1.472 0 C-N-CA 120.987 1.125 . . . . 0.0 111.348 167.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.603 ' HB2' ' OG1' ' A' ' 130' ' ' THR . 16.7 p90 -103.32 159.61 15.41 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 1.002 ' H ' ' HG3' ' A' ' 148' ' ' GLU . 47.6 mtpt -110.16 -151.81 0.48 Allowed 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.144 0.497 . . . . 0.0 111.929 -170.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.824 ' H ' ' HD2' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -104.47 27.94 7.41 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.323 -176.843 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 159.14 36.96 0.02 OUTLIER Glycine 0 CA--C 1.527 0.837 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.242 178.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 1.002 ' HG3' ' H ' ' A' ' 145' ' ' LYS . 0.0 OUTLIER -86.11 170.25 12.37 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.895 0.878 . . . . 0.0 109.399 171.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.5 mp -114.0 133.04 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 172.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.713 HD22 ' CD2' ' A' ' 142' ' ' LEU . 72.2 mt -118.47 155.79 30.18 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 -174.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.603 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 92.2 t -122.22 121.73 64.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 174.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.984 HD13 ' HB2' ' A' ' 163' ' ' ALA . 46.9 mm -78.04 79.09 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 122.125 0.964 . . . . 0.0 108.411 -177.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.737 HG23 ' HG2' ' A' ' 154' ' ' GLU . 16.9 tt -69.38 -27.96 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 CA-C-N 113.91 -1.495 . . . . 0.0 109.288 -177.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.737 ' HG2' HG23 ' A' ' 153' ' ' ILE . 0.0 OUTLIER -133.01 141.49 48.31 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 171.778 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.56 ' HD2' ' HG ' ' A' ' 125' ' ' LEU . 82.9 tttt -135.1 82.61 41.74 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 168.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.656 ' HA ' ' CB ' ' A' ' 95' ' ' THR . 8.3 Cg_exo -73.03 -47.72 0.31 Allowed 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.538 2.159 . . . . 0.0 111.87 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -107.57 171.13 7.56 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.032 -173.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.642 ' HG3' ' HG2' ' A' ' 159' ' ' GLN . 8.1 pt-20 -89.7 -26.92 20.43 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.752 178.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.642 ' HG2' ' HG3' ' A' ' 158' ' ' GLU . 82.9 mm-40 -101.8 -18.74 15.63 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.483 -175.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.53 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 63.7 m95 -126.66 135.28 50.96 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 175.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . 0.779 ' O ' HG13 ' A' ' 173' ' ' ILE . 49.4 m0 -125.33 137.93 54.06 Favored 'General case' 0 C--O 1.214 -0.771 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.525 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 14.7 m -96.87 102.79 14.64 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -174.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.984 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -118.93 151.74 37.6 Favored 'General case' 0 N--CA 1.426 -1.667 0 C-N-CA 119.751 -0.78 . . . . 0.0 110.069 -174.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.792 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 15.3 ptt-85 -88.69 129.39 35.54 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 175.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.996 ' HB2' HD11 ' A' ' 142' ' ' LEU . 65.2 t30 -60.72 178.64 0.21 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.234 -1.348 . . . . 0.0 111.514 -171.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.555 ' HB2' ' HB2' ' A' ' 148' ' ' GLU . 44.0 tptt -50.71 -33.2 21.91 Favored 'General case' 0 C--N 1.312 -1.028 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.103 166.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 57.0 m-20 -64.7 -38.68 91.82 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.709 173.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.498 ' C ' ' HB2' ' A' ' 164' ' ' ARG . . . 107.09 3.81 35.92 Favored Glycine 0 CA--C 1.522 0.471 0 CA-C-N 115.637 -0.71 . . . . 0.0 112.217 -171.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.792 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.4 OUTLIER -77.4 134.61 38.39 Favored 'General case' 0 C--O 1.216 -0.671 0 C-N-CA 123.141 0.576 . . . . 0.0 111.21 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.5 HG22 HG21 ' A' ' 153' ' ' ILE . 60.4 t -85.12 125.55 40.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 117.684 0.22 . . . . 0.0 111.526 -179.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -157.1 157.71 28.27 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 120.831 -0.7 . . . . 0.0 112.172 172.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.615 ' HB2' ' O ' ' A' ' 140' ' ' GLU . 0.0 OUTLIER -76.94 141.09 40.62 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 117.242 0.521 . . . . 0.0 111.228 179.367 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.779 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.4 pp -142.25 142.9 25.44 Favored Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 115.837 -0.619 . . . . 0.0 111.424 -176.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.522 ' HB2' ' CD1' ' A' ' 177' ' ' TYR . 15.7 Cg_exo -70.36 138.57 36.21 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 123.275 2.65 . . . . 0.0 113.351 -178.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.574 ' O ' HG22 ' A' ' 178' ' ' VAL . 58.9 t -65.1 -45.09 72.57 Favored Pre-proline 0 CA--C 1.536 0.432 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 28.0 Cg_endo -63.81 3.09 0.77 Allowed 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.044 1.829 . . . . 0.0 113.2 177.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.522 ' CD1' ' HB2' ' A' ' 174' ' ' PRO . 3.3 m-85 -103.41 -11.85 17.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.237 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.614 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 4.6 m -104.84 -170.8 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 N-CA-C 115.691 1.737 . . . . 0.0 115.691 -166.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.572 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 4.0 tp10 -159.73 48.21 0.29 Allowed 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 113.164 -1.835 . . . . 0.0 113.226 -153.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.96 ' HG3' HG22 ' A' ' 128' ' ' VAL . 2.9 mppt? -70.73 138.1 50.24 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 119.746 -1.846 . . . . 0.0 110.248 -162.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.401 HD13 ' NH2' ' A' ' 129' ' ' ARG . 39.9 tp -73.22 -91.41 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 113.557 -1.656 . . . . 0.0 112.473 -162.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 3.0 p -87.01 89.77 3.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-O 121.713 0.768 . . . . 0.0 109.743 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.799 ' HA ' ' HB2' ' A' ' 123' ' ' ASP . 0.0 OUTLIER -145.84 154.18 41.7 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.265 -178.211 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 11.7 m -76.65 -83.44 0.07 Allowed 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 121.001 -0.28 . . . . 0.0 110.358 178.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 9.8 p 175.26 168.88 0.35 Allowed Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -178.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -64.06 96.54 0.22 Allowed 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.289 1.993 . . . . 0.0 111.78 177.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 1.05 ' HB2' ' HB2' ' A' ' 190' ' ' HIS . 35.0 m80 -105.02 14.39 29.4 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.545 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 81.22 -79.14 1.84 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.699 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.804 ' HD3' ' H ' ' A' ' 189' ' ' LYS . 0.4 OUTLIER -73.56 -23.62 59.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.206 0.527 . . . . 0.0 110.024 177.112 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . 1.05 ' HB2' ' HB2' ' A' ' 187' ' ' HIS . 0.5 OUTLIER -88.24 84.13 6.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.942 172.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 175.47 17.86 0.02 OUTLIER Glycine 0 C--O 1.239 0.411 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.171 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 56.6 t30 70.7 -64.47 0.37 Allowed 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 124.322 1.049 . . . . 0.0 111.069 -175.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 53.6 ttt-85 59.13 80.06 0.2 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.603 -177.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -54.14 -53.52 52.19 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 173.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 45.8 p -174.01 163.77 4.05 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 113.453 -1.703 . . . . 0.0 106.812 174.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -82.42 70.82 9.45 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 176.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 23.6 t 70.49 124.01 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.986 -177.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -76.45 177.19 7.58 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.151 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 175.61 124.87 0.84 Allowed Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.841 178.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.413 ' N ' HD12 ' A' ' 200' ' ' ILE . 4.0 mp -104.12 102.78 34.39 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -88.59 86.65 0.53 Allowed 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.985 2.457 . . . . 0.0 113.144 -175.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -134.69 101.17 11.91 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 171.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -62.5 -11.45 23.22 Favored 'Trans proline' 0 N--CA 1.473 0.273 0 C-N-CA 123.434 2.756 . . . . 0.0 113.073 -175.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -65.99 -19.18 65.77 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.144 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . 0.539 ' HB3' ' HB2' ' A' ' 208' ' ' ALA . 95.9 m-70 -118.31 48.36 1.44 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.613 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -70.65 -40.48 73.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.272 0.558 . . . . 0.0 110.096 177.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -124.22 70.51 1.1 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 173.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . 0.539 ' HB2' ' HB3' ' A' ' 205' ' ' HIS . . . -72.37 152.91 41.75 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.988 -1.005 . . . . 0.0 112.301 -171.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -71.64 127.47 90.93 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.708 174.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.1 155.95 17.61 Favored 'Trans proline' 0 C--O 1.237 0.435 0 C-N-CA 122.938 2.425 . . . . 0.0 112.427 178.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -58.58 -40.55 83.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.737 -179.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 20.0 m 72.88 132.88 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.304 172.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 23.6 m -74.54 106.21 6.02 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.639 175.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 33.4 m -149.26 91.3 4.51 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 120.968 0.413 . . . . 0.0 110.558 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -78.75 105.35 1.94 Allowed 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.992 2.462 . . . . 0.0 111.276 177.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.47 HD12 ' O ' ' A' ' 216' ' ' LEU . 3.4 pp -91.57 136.75 26.32 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-O 120.952 0.406 . . . . 0.0 110.936 -177.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -76.8 89.2 1.32 Allowed 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.349 2.033 . . . . 0.0 111.914 178.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -82.25 128.17 33.91 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.974 177.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 7.6 p -59.33 116.59 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.569 0.7 . . . . 0.0 111.188 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 24.6 p -113.9 -165.8 1.04 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.225 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 148.14 -107.28 0.37 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.444 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 8.2 t -131.55 150.93 77.73 Favored Pre-proline 0 C--N 1.32 -0.7 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -177.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -48.98 110.54 0.36 Allowed 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 123.119 2.546 . . . . 0.0 112.47 177.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -86.44 80.51 1.76 Allowed Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.112 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -128.65 92.07 3.35 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.885 0.374 . . . . 0.0 110.382 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -80.17 104.7 10.91 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.777 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 33.7 mm -86.79 -8.34 11.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.609 0.719 . . . . 0.0 109.723 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 4.0 p -60.74 146.2 86.72 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.259 -0.882 . . . . 0.0 110.559 177.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.8 10.75 0.77 Allowed 'Trans proline' 0 CA--C 1.533 0.446 0 C-N-CA 122.837 2.358 . . . . 0.0 113.399 -175.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 33.9 tp 64.15 95.85 0.05 OUTLIER Pre-proline 0 C--O 1.235 0.294 0 C-N-CA 123.249 0.62 . . . . 0.0 111.206 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -73.5 -159.07 0.08 OUTLIER 'Trans proline' 0 C--O 1.237 0.454 0 C-N-CA 122.98 2.453 . . . . 0.0 112.538 -178.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 37.2 m -57.63 99.22 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.43 0.633 . . . . 0.0 111.051 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 7.1 p -129.94 -30.66 1.99 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.512 -178.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 64.89 25.11 12.8 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.223 178.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -77.04 156.89 31.47 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.592 176.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -118.98 -133.3 4.66 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.027 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -72.24 165.31 33.02 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 122.86 2.374 . . . . 0.0 111.802 178.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.541 ' HB ' HG13 ' A' ' 266' ' ' VAL . 11.7 t -101.91 130.85 50.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.025 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -115.56 134.92 54.6 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.35 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.628 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -131.72 145.1 51.45 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.359 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 37.2 ttmt -98.5 127.94 44.64 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.156 177.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . 0.572 ' O ' ' HA ' ' A' ' 260' ' ' VAL . . . -76.82 102.09 6.15 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 176.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 25.3 pt -94.65 -5.02 10.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.585 -173.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.12 147.62 46.13 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -63.57 133.04 53.06 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.112 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.78 95.37 3.12 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.793 0.33 . . . . 0.0 110.582 -177.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 27.2 m -90.26 162.37 34.83 Favored Pre-proline 0 C--N 1.318 -0.773 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 172.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.504 ' HG3' ' HB2' ' A' ' 257' ' ' ALA . 5.1 Cg_exo -75.67 -151.45 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.152 1.901 . . . . 0.0 111.399 178.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' CYS . . . . . 0.504 ' O ' ' HB3' ' A' ' 252' ' ' ASP . 42.6 t -147.45 171.74 15.04 Favored 'General case' 0 C--N 1.321 -0.66 0 O-C-N 122.123 -0.361 . . . . 0.0 111.342 -173.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -68.08 -31.16 70.59 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.958 178.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -102.41 22.59 13.17 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.285 0.564 . . . . 0.0 110.539 176.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.504 ' HB3' ' O ' ' A' ' 249' ' ' CYS . 0.1 OUTLIER -83.2 129.03 34.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.416 178.205 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 40.1 mmtm -138.68 -0.57 1.92 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.416 167.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 2.1 p -151.45 21.38 0.73 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.924 -177.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -102.93 109.44 21.0 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.034 0.445 . . . . 0.0 110.594 -179.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.519 ' HA ' ' NH1' ' A' ' 282' ' ' ARG . 0.5 OUTLIER -65.93 139.07 58.23 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.874 -176.821 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.504 ' HB2' ' HG3' ' A' ' 248' ' ' PRO . . . -103.03 123.76 47.23 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.032 179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.693 HD12 HG21 ' A' ' 289' ' ' THR . 57.1 mt -135.93 176.36 8.76 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.233 -175.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -160.38 177.29 10.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.65 0.262 . . . . 0.0 111.095 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 57.4 t -66.42 126.55 26.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.954 -171.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 96.14 8.65 57.66 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.888 175.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -103.61 147.27 27.41 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 110.043 -0.355 . . . . 0.0 110.043 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 31.4 mm -107.24 116.08 50.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.124 0.488 . . . . 0.0 110.336 -176.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 10.2 t -85.77 120.77 36.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.572 -177.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . 0.706 ' HD3' ' HG3' ' A' ' 278' ' ' GLU . 35.8 tttp -86.48 100.41 12.35 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.784 175.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.541 HG13 ' HB ' ' A' ' 238' ' ' VAL . 3.9 p -117.0 117.19 54.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.7 0.762 . . . . 0.0 111.095 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 12.7 p -98.2 -38.51 9.27 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.308 177.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . 0.524 ' HB2' ' HB2' ' A' ' 276' ' ' GLU . 42.7 mtt180 -106.81 108.75 20.41 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.141 178.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 6.2 ptp -114.18 114.51 26.13 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.717 0.77 . . . . 0.0 110.972 173.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -83.89 150.93 25.39 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.566 -1.197 . . . . 0.0 110.514 -176.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 34.4 pt -82.72 11.37 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.042 -177.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -98.58 -6.62 29.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.722 0.296 . . . . 0.0 110.544 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 113.25 -39.13 2.95 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.725 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.518 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 2.4 mp0 -88.3 111.16 21.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.862 0.363 . . . . 0.0 110.366 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.504 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 10.1 m0 -93.86 157.03 16.33 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.524 ' HB2' ' HB2' ' A' ' 268' ' ' ARG . 38.8 mt-10 -100.62 114.05 27.42 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 176.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -138.32 146.53 18.32 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.615 -178.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.706 ' HG3' ' HD3' ' A' ' 265' ' ' LYS . 6.1 pt-20 -114.02 109.95 19.26 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.027 0.441 . . . . 0.0 110.024 177.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . 0.441 HG21 HD21 ' A' ' 258' ' ' LEU . 14.5 t -109.27 -109.68 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.013 -175.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -85.98 82.56 8.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.788 0.327 . . . . 0.0 111.615 -174.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 66.02 6.68 32.99 Favored Glycine 0 C--N 1.332 0.337 0 CA-C-N 115.928 -0.578 . . . . 0.0 113.421 174.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . 0.519 ' NH1' ' HA ' ' A' ' 256' ' ' LEU . 1.7 tmt_? -146.92 127.98 14.61 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -176.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.454 ' HB3' ' HB3' ' A' ' 278' ' ' GLU . 15.0 ptpt -120.71 142.43 49.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.684 -178.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -173.69 -169.7 36.29 Favored Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 111.564 -0.614 . . . . 0.0 111.564 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.518 ' HB3' ' HB3' ' A' ' 274' ' ' GLN . 94.4 mt -86.78 146.95 26.04 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.167 0.508 . . . . 0.0 110.247 177.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.684 ' HB2' ' OG1' ' A' ' 289' ' ' THR . 26.3 p90 -143.18 123.39 7.88 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.582 176.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . 0.638 ' C ' ' H ' ' A' ' 289' ' ' THR . 51.5 Cg_exo -62.98 62.26 0.16 Allowed 'Trans proline' 0 N--CA 1.486 1.061 0 C-N-CA 124.597 3.531 . . . . 0.0 112.565 175.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.668 ' O ' HG22 ' A' ' 291' ' ' VAL . 4.3 m-85 62.54 -14.77 0.06 Allowed 'General case' 0 C--O 1.213 -0.849 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.736 -168.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.693 HG21 HD12 ' A' ' 258' ' ' LEU . 1.4 m 69.68 -12.31 0.46 Allowed 'General case' 0 CA--C 1.517 -0.298 0 C-N-CA 123.573 0.749 . . . . 0.0 112.824 -179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . 0.472 ' CB ' ' O ' ' A' ' 289' ' ' THR . 32.2 m170 89.37 25.0 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.79 0 O-C-N 124.313 1.008 . . . . 0.0 109.829 -164.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.668 HG22 ' O ' ' A' ' 288' ' ' PHE . 13.1 m -86.99 179.57 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.445 0 CA-C-O 121.358 0.599 . . . . 0.0 111.206 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -135.25 129.99 34.49 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.306 173.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.628 HD13 ' HB2' ' A' ' 240' ' ' ALA . 19.0 mm -77.35 126.02 37.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.064 0.459 . . . . 0.0 111.16 -178.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -151.44 -171.56 3.97 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.459 ' HB3' ' ND2' ' A' ' 298' ' ' ASN . 14.7 t70 -133.07 105.88 12.45 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-O 120.889 0.376 . . . . 0.0 110.221 175.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -85.32 11.87 3.23 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.919 2.413 . . . . 0.0 112.678 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 19.6 mt-30 -99.37 -32.49 11.14 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.297 -176.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . 0.459 ' ND2' ' HB3' ' A' ' 295' ' ' ASP . 7.8 p30 -91.28 150.43 41.46 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.471 -178.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' PRO . . . . . 0.587 ' HA ' ' HB3' ' A' ' 302' ' ' ASN . 6.1 Cg_exo -80.81 -15.67 10.59 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.994 2.463 . . . . 0.0 112.464 179.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -62.67 -47.14 84.98 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.138 -175.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -117.13 42.34 2.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.319 0.581 . . . . 0.0 110.092 175.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . 0.587 ' HB3' ' HA ' ' A' ' 299' ' ' PRO . 8.1 p30 -62.97 -25.1 68.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.229 -177.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 . . . . . 0 C--O 1.252 1.206 0 CA-C-O 118.26 -0.876 . . . . 0.0 109.724 -179.489 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ptp . . . . . 0 N--CA 1.483 1.192 0 CA-C-O 120.454 0.169 . . . . 0.0 110.549 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.6 m 70.13 142.0 0.05 OUTLIER 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.468 0.707 . . . . 0.0 110.916 -175.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.485 ' O ' HG23 ' A' ' 99' ' ' ILE . 19.5 m -72.45 -46.28 55.71 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.42 -178.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -86.7 56.11 3.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.168 0.509 . . . . 0.0 110.707 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 20.7 tpp180 -93.55 96.75 10.06 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.383 -174.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.617 ' CE1' ' HE2' ' A' ' 89' ' ' LYS . 41.3 p90 -167.62 147.93 5.21 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.105 174.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -79.04 102.79 8.57 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.867 -178.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.405 ' O ' ' HB2' ' A' ' 9' ' ' SER . 30.4 m -69.36 76.88 0.39 Allowed 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.079 175.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 8' ' ' SER . 21.4 t 178.48 -37.33 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.831 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -69.13 106.95 3.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.428 -173.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 22.0 mmt180 -61.58 -31.03 71.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.397 -177.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 61.1 m -80.37 3.41 21.3 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.352 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -91.71 -47.81 7.16 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.941 0.4 . . . . 0.0 110.513 175.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 25.9 p-90 -122.62 -24.21 4.96 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.369 0.877 . . . . 0.0 113.369 -168.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -74.65 118.6 17.79 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.173 0.511 . . . . 0.0 110.913 -174.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.787 ' HG3' ' HB2' ' A' ' 37' ' ' LEU . 25.9 mmt -101.16 -11.71 19.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.062 -174.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.406 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 50.55 -114.21 2.51 Favored Glycine 0 CA--C 1.524 0.602 0 O-C-N 123.653 0.595 . . . . 0.0 113.25 -176.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.406 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 9.0 Cg_exo -72.31 91.33 0.76 Allowed 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 122.994 2.463 . . . . 0.0 113.273 -175.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.722 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 71.1 t -143.88 161.74 15.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 176.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.614 ' HA ' ' OG ' ' A' ' 42' ' ' SER . 16.0 m -128.68 174.06 9.76 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -172.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 63.3 mtp85 -57.32 -54.27 48.71 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.484 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -60.99 -40.95 95.43 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.726 0.298 . . . . 0.0 111.684 -177.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.538 ' O ' ' HG3' ' A' ' 27' ' ' ARG . 0.3 OUTLIER -70.98 -47.04 61.14 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.138 0.494 . . . . 0.0 110.17 -177.262 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.44 -42.83 83.19 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.157 0.503 . . . . 0.0 110.998 175.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.663 ' HG3' HG21 ' A' ' 58' ' ' VAL . 64.6 tt0 -65.29 -40.84 94.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.232 -177.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.6 t -76.19 -4.58 42.54 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 120.929 0.395 . . . . 0.0 111.167 -177.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.538 ' HG3' ' O ' ' A' ' 23' ' ' GLU . 90.7 mtt180 -90.03 -25.91 20.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.206 0.527 . . . . 0.0 109.746 172.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.57 HD22 ' HB2' ' A' ' 53' ' ' SER . 25.5 mt -116.7 16.9 15.36 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.953 -171.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.436 HE22 ' ND2' ' A' ' 117' ' ' ASN . 0.0 OUTLIER -78.4 90.57 4.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.036 0.446 . . . . 0.0 110.686 -176.125 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.449 ' HA2' ' HB2' ' A' ' 117' ' ' ASN . . . 81.97 -4.68 74.34 Favored Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.576 176.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.448 ' HA ' HG11 ' A' ' 113' ' ' VAL . 12.9 mm100 -65.55 167.99 8.1 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.792 0.329 . . . . 0.0 111.527 -178.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 46.7 mtm180 -43.19 125.53 3.72 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.476 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.546 ' HB3' HG21 ' A' ' 96' ' ' THR . 29.8 m170 -69.39 142.22 53.96 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.335 -178.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.562 ' HA3' ' HB ' ' A' ' 99' ' ' ILE . . . 110.64 -20.16 25.24 Favored Glycine 0 N--CA 1.437 -1.241 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 -175.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.664 ' HB3' ' HB2' ' A' ' 102' ' ' ALA . 63.3 mtt -61.75 142.41 57.29 Favored 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 173.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.56 ' HB2' HD11 ' A' ' 50' ' ' LEU . 51.6 p90 -153.19 162.74 40.97 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 177.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.787 ' HB2' ' HG3' ' A' ' 16' ' ' MET . 4.4 pp -155.66 132.66 10.68 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 121.132 0.491 . . . . 0.0 111.432 179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.4 t -103.79 109.8 28.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 174.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.722 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 29.5 ptt-85 -113.22 177.82 4.5 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.079 -0.51 . . . . 0.0 109.82 -177.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -73.78 134.35 43.41 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 172.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.524 ' HA ' HG23 ' A' ' 49' ' ' VAL . 39.2 t -57.09 119.13 5.81 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.61 0.719 . . . . 0.0 111.965 -173.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.614 ' OG ' ' HA ' ' A' ' 20' ' ' SER . 1.5 m -77.44 -11.75 59.88 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.426 173.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.0 m -83.58 -41.4 17.92 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.372 177.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.465 ' O ' ' HB3' ' A' ' 41' ' ' SER . 6.5 p -157.36 94.63 2.15 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.107 178.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -47.91 127.05 13.96 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.11 2.54 . . . . 0.0 112.087 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.48 -45.58 1.15 Allowed Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -172.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -83.67 -166.06 1.29 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 172.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.6 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 25.4 m-85 -134.8 171.27 14.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 117.902 0.319 . . . . 0.0 110.563 177.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.524 HG23 ' HA ' ' A' ' 41' ' ' SER . 59.9 t -145.37 109.4 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 175.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.56 HD11 ' HB2' ' A' ' 36' ' ' PHE . 56.2 tp -80.33 100.95 8.66 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.636 175.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 48.3 m -96.69 121.78 38.91 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 174.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.646 HG12 ' HG3' ' A' ' 54' ' ' GLU . 87.0 t -111.82 138.59 39.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.712 -174.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.679 ' HA ' ' O ' ' A' ' 57' ' ' ARG . 48.1 t -82.63 98.48 9.03 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 175.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.646 ' HG3' HG12 ' A' ' 52' ' ' VAL . 24.2 mt-10 -151.36 160.81 43.58 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.97 -175.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.624 ' ND2' ' H ' ' A' ' 155' ' ' LYS . 0.5 OUTLIER 70.43 -65.85 0.31 Allowed 'General case' 0 CA--C 1.49 -1.333 0 CA-C-O 122.742 1.258 . . . . 0.0 110.456 -168.417 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.674 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 74.8 m -157.9 -22.16 0.08 Allowed 'General case' 0 N--CA 1.419 -1.992 0 CA-C-N 112.56 -2.109 . . . . 0.0 107.626 -175.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.709 ' HG2' HG23 ' A' ' 58' ' ' VAL 0.359 0.0 OUTLIER -166.61 -50.23 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.124 1 N-CA-C 121.877 4.029 . . . . 0.0 121.877 -179.836 . . . . . . . . 5 4 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.709 HG23 ' HG2' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -149.78 99.42 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 CA-C-N 121.729 2.058 . . . . 0.0 112.939 -170.148 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.7 m -94.83 111.06 22.87 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 172.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -97.39 112.67 24.4 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -168.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.718 ' OH ' ' HB3' ' A' ' 93' ' ' LEU . 54.3 m-85 -120.14 105.78 11.32 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.415 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.606 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 63.6 mt -80.52 127.0 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -174.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.6 ' HB ' ' HB2' ' A' ' 48' ' ' TYR . 4.3 mp -101.05 119.72 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 121.17 0.51 . . . . 0.0 111.17 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.551 ' HB2' ' HB3' ' A' ' 72' ' ' LYS . 16.7 m120 -86.04 136.11 33.37 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.798 -178.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.1 t -85.58 93.75 8.88 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 171.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.663 HD11 ' HB2' ' A' ' 72' ' ' LYS . 83.6 mt -84.99 145.84 44.36 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.834 -177.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 66' ' ' LEU . 18.5 Cg_exo -67.57 -3.85 10.95 Favored 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 122.92 2.414 . . . . 0.0 111.547 174.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.426 ' HB3' ' HD3' ' A' ' 70' ' ' ARG . 42.2 m-20 -80.66 2.21 26.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.71 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? 63.59 31.89 14.37 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-O 121.469 0.652 . . . . 0.0 109.51 -170.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.754 ' HG2' ' HA ' ' A' ' 79' ' ' ASP . 35.5 mtp180 -132.44 162.03 32.19 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.708 -175.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.475 ' HB3' HG23 ' A' ' 63' ' ' ILE . 47.3 m-85 -122.85 117.84 26.55 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.965 0.412 . . . . 0.0 111.142 -174.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.663 ' HB2' HD11 ' A' ' 66' ' ' LEU . 29.5 ttpp -104.09 98.99 8.73 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.462 -173.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.706 HD11 ' CB ' ' A' ' 61' ' ' TYR . 6.7 tt -88.45 119.64 36.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.293 0.568 . . . . 0.0 111.286 -177.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 63.37 32.16 83.19 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.828 179.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.497 ' HA ' ' HZ3' ' A' ' 72' ' ' LYS . 35.1 t70 74.62 -11.61 1.01 Allowed 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.035 0.534 . . . . 0.0 111.835 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -86.66 126.66 34.68 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 171.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 0.7 OUTLIER -100.57 140.79 34.34 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.909 0.861 . . . . 0.0 113.169 -169.134 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.559 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 91.0 m-85 -129.02 172.16 11.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.218 -1.356 . . . . 0.0 108.376 173.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.754 ' HA ' ' HG2' ' A' ' 70' ' ' ARG . 5.9 m-20 -74.88 -30.33 61.28 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.66 0.266 . . . . 0.0 111.693 -175.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.504 ' ND1' ' HG2' ' A' ' 82' ' ' PRO . 4.9 p80 -165.07 168.35 17.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.563 -176.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.668 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 14.3 mt -57.97 -54.63 53.5 Favored Pre-proline 0 N--CA 1.469 0.482 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -177.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.504 ' HG2' ' ND1' ' A' ' 80' ' ' HIS . 20.9 Cg_endo -62.95 -3.02 4.15 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 121.976 1.784 . . . . 0.0 113.637 178.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.421 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -89.01 -36.51 15.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.94 0.4 . . . . 0.0 110.263 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.668 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.0 pp -76.81 -29.86 56.14 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.064 0.459 . . . . 0.0 109.891 178.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.514 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 79.7 mt -68.46 -21.04 64.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.336 177.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -91.97 -17.45 25.12 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.37 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -91.23 -30.88 16.39 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 121.784 0.802 . . . . 0.0 109.272 -178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.694 ' HE2' HD13 ' A' ' 73' ' ' ILE . 28.4 m-85 -84.21 1.88 42.48 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.125 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.617 ' HE2' ' CE1' ' A' ' 6' ' ' PHE . 85.8 mttt -77.61 -11.91 59.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.687 169.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 35.7 pt -134.84 8.82 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.204 0 CA-C-O 121.05 0.453 . . . . 0.0 110.302 -176.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.487 ' HB2' ' HA ' ' A' ' 88' ' ' TYR . 16.8 t60 -88.14 -38.87 15.0 Favored 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.199 -177.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.499 ' HA ' ' O ' ' A' ' 96' ' ' THR . 92.5 m-85 58.46 86.07 0.09 Allowed 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.344 -1.298 . . . . 0.0 107.797 -161.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.718 ' HB3' ' OH ' ' A' ' 61' ' ' TYR . 76.2 mt -44.23 -65.32 0.53 Allowed 'General case' 0 CA--C 1.517 -0.297 0 O-C-N 124.151 0.907 . . . . 0.0 108.805 178.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.701 ' HB3' ' HB3' ' A' ' 154' ' ' GLU . 1.6 p30 -111.99 -86.53 0.56 Allowed 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.771 163.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 1.015 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 11.5 t -118.97 14.4 13.22 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.296 0.57 . . . . 0.0 110.994 -174.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.546 HG21 ' HB3' ' A' ' 33' ' ' HIS . 5.8 t -153.72 -179.89 8.23 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 172.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.474 HG22 ' H ' ' A' ' 92' ' ' TYR . 20.2 p -116.56 171.13 8.05 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 122.4 -0.188 . . . . 0.0 110.733 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 92.5 mt -61.62 104.12 0.4 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.018 0.437 . . . . 0.0 110.113 175.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.562 ' HB ' ' HA3' ' A' ' 34' ' ' GLY . 45.8 mm -89.21 -56.91 4.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.807 -176.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.658 ' O ' ' HA ' ' A' ' 35' ' ' MET . 10.6 pt-20 -162.98 142.3 6.8 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.956 -177.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.21 149.51 90.14 Favored 'Trans proline' 0 C--O 1.235 0.375 0 C-N-CA 122.411 2.074 . . . . 0.0 112.57 -177.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.664 ' HB2' ' HB3' ' A' ' 35' ' ' MET . . . -73.07 146.24 87.05 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.99 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.67 115.68 3.69 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.234 1.956 . . . . 0.0 111.625 176.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.631 ' HB3' ' SD ' ' A' ' 16' ' ' MET . 37.6 ptt180 -66.22 135.16 54.09 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 178.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 59.64 68.03 1.64 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.859 -172.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -94.53 165.21 1.87 Allowed 'Trans proline' 0 N--CA 1.452 -0.945 0 C-N-CA 123.168 2.579 . . . . 0.0 112.237 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 37.2 p -148.69 93.5 4.26 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.669 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -86.2 109.56 0.97 Allowed 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.448 2.099 . . . . 0.0 111.464 176.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -62.98 106.06 0.5 Allowed 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.678 2.252 . . . . 0.0 112.397 -176.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 51.8 ttm 72.87 -52.03 0.71 Allowed 'General case' 0 N--CA 1.47 0.542 0 O-C-N 123.922 0.764 . . . . 0.0 111.826 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 124.52 108.3 1.76 Allowed Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 -178.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 21.6 m -104.84 -3.76 23.07 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.109 0.481 . . . . 0.0 110.838 -177.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.448 HG11 ' HA ' ' A' ' 31' ' ' GLN . 8.7 m -80.96 81.48 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.627 0.727 . . . . 0.0 111.221 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 20.2 m -115.79 1.73 13.49 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.762 177.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.488 ' H ' ' HD2' ' A' ' 116' ' ' PRO . . . -96.59 -48.74 0.24 Allowed Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.551 177.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.488 ' HD2' ' H ' ' A' ' 115' ' ' ALA . 71.9 Cg_endo -81.47 171.59 13.4 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 121.848 1.699 . . . . 0.0 110.669 168.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.674 ' HA ' ' HB3' ' A' ' 56' ' ' SER . 60.3 t30 63.21 88.04 0.1 Allowed 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.485 0.659 . . . . 0.0 110.316 -176.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.588 ' N ' ' HD2' ' A' ' 119' ' ' PRO . 4.1 mm? -86.81 -44.03 0.55 Allowed Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -174.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.588 ' HD2' ' N ' ' A' ' 118' ' ' LEU . 18.8 Cg_endo -59.23 99.53 0.11 Allowed 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.035 1.824 . . . . 0.0 112.589 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.566 HG23 ' H ' ' A' ' 121' ' ' ALA . 0.6 OUTLIER -89.54 -64.12 1.19 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.934 -179.459 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.566 ' H ' HG23 ' A' ' 120' ' ' THR . . . -151.35 88.59 1.44 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.098 0.475 . . . . 0.0 111.041 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -130.89 -30.95 1.76 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.362 173.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.798 ' O ' ' HA ' ' A' ' 183' ' ' ARG . 24.6 t70 62.5 99.66 0.03 OUTLIER 'General case' 0 CA--C 1.52 -0.197 0 O-C-N 124.159 0.912 . . . . 0.0 108.607 -169.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 178.82 168.3 0.91 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.572 -0.285 . . . . 0.0 110.73 -175.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.597 HD21 ' CH2' ' A' ' 161' ' ' TRP . 3.9 mm? 62.47 91.6 0.06 Allowed 'General case' 0 N--CA 1.47 0.555 0 O-C-N 123.913 0.758 . . . . 0.0 111.913 173.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 32.9 tt0 177.73 -60.16 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.302 -177.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -112.69 112.97 24.86 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.286 176.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.985 HG22 ' HG3' ' A' ' 180' ' ' LYS . 10.4 t -115.71 146.34 20.27 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 177.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.664 ' CZ ' HD13 ' A' ' 181' ' ' LEU . 0.0 OUTLIER -118.71 147.69 43.56 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 117.244 -1.783 . . . . 0.0 109.024 158.903 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.515 HG22 HG12 ' A' ' 178' ' ' VAL . 0.8 OUTLIER -102.69 130.32 49.58 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.839 -1.073 . . . . 0.0 111.3 -179.951 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.559 HD21 ' HG2' ' A' ' 179' ' ' GLU . 24.6 mt -104.97 -7.47 19.25 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -175.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.51 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 63.6 t80 -95.42 -42.53 8.43 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.233 -0.587 . . . . 0.0 112.543 -174.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.61 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 15.7 t70 77.75 89.71 0.07 Allowed 'General case' 0 N--CA 1.474 0.761 0 O-C-N 123.746 0.654 . . . . 0.0 110.431 -175.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.455 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 63.3 t80 -119.09 85.79 30.46 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 176.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.596 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 87.5 Cg_endo -81.94 83.76 2.02 Favored 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 121.608 1.539 . . . . 0.0 112.556 178.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -76.31 -20.58 76.97 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 175.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.83 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 12.3 m120 58.41 68.23 0.85 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.643 -0.778 . . . . 0.0 111.679 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.485 ' HB3' ' H ' ' A' ' 140' ' ' GLU . 0.4 OUTLIER -152.3 170.73 19.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.85 179.066 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -94.97 -5.42 44.71 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.937 0.875 . . . . 0.0 108.975 170.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.485 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 42.7 mm-40 -96.34 -36.91 10.7 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.548 -1.205 . . . . 0.0 108.809 174.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.458 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 13.6 m-20 -123.01 112.73 18.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.273 178.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.993 HD11 ' HB2' ' A' ' 165' ' ' ASN . 30.4 tp -68.61 129.95 92.25 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-O 120.776 0.322 . . . . 0.0 110.534 -177.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.83 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 11.6 Cg_endo -85.64 91.26 0.69 Allowed 'Trans proline' 0 N--CA 1.442 -1.55 0 C-N-CA 122.092 1.861 . . . . 0.0 111.012 172.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.522 ' CE2' ' HB ' ' A' ' 173' ' ' ILE . 14.3 p90 -101.54 164.85 11.55 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.817 -174.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.61 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 1.4 mptp? -100.29 -172.71 2.26 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.203 0.525 . . . . 0.0 111.75 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.742 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -91.62 9.03 33.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.972 -175.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -167.13 32.95 0.21 Allowed Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.48 175.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.511 ' OE1' ' HA ' ' A' ' 144' ' ' PHE . 0.1 OUTLIER -100.13 157.45 16.56 Favored 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.214 -174.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.638 HD12 ' HB3' ' A' ' 129' ' ' ARG . 0.6 OUTLIER -97.49 129.38 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-O 121.692 0.758 . . . . 0.0 109.978 -176.682 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.738 HD22 HD21 ' A' ' 142' ' ' LEU . 31.9 mt -123.94 158.77 31.24 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 114.522 -1.217 . . . . 0.0 108.01 -177.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.608 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 97.4 t -122.04 120.43 61.36 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 175.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 1.044 HD13 ' HB2' ' A' ' 163' ' ' ALA . 42.1 mm -78.21 79.14 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -178.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.665 HG23 ' HG2' ' A' ' 154' ' ' GLU . 7.6 tt -74.57 -34.18 34.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-N 114.535 -1.212 . . . . 0.0 109.318 -178.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.701 ' HB3' ' HB3' ' A' ' 94' ' ' ASP . 0.0 OUTLIER -123.46 142.92 50.51 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.502 175.577 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.624 ' H ' ' ND2' ' A' ' 55' ' ' ASN . 83.1 tttt -140.47 81.75 17.13 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-O 120.982 0.42 . . . . 0.0 109.993 172.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 1.015 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 38.4 Cg_endo -73.25 -40.28 1.74 Allowed 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 122.03 1.82 . . . . 0.0 111.972 175.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -111.05 162.65 14.66 Favored 'General case' 0 N--CA 1.445 -0.711 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.407 -171.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -100.17 -11.54 20.36 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 172.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -89.81 -34.1 16.27 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.922 -1.035 . . . . 0.0 109.916 177.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 49.4 m95 -129.45 139.44 51.61 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.942 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . 0.76 ' O ' HG13 ' A' ' 173' ' ' ILE . 47.8 m0 -113.63 137.02 52.18 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 176.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.53 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 16.2 m -96.96 97.59 9.39 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -175.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 1.044 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -110.84 149.54 30.43 Favored 'General case' 0 N--CA 1.425 -1.72 0 C-N-CA 119.859 -0.736 . . . . 0.0 109.956 -174.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.721 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 11.7 ptt180 -87.25 122.16 30.67 Favored 'General case' 0 N--CA 1.433 -1.305 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 173.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.993 ' HB2' HD11 ' A' ' 142' ' ' LEU . 12.9 t30 -58.42 -178.07 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 113.755 -1.566 . . . . 0.0 111.381 -173.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.552 ' HD3' ' HB ' ' A' ' 149' ' ' ILE . 10.0 mmmm -66.38 -11.67 52.68 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.414 0.626 . . . . 0.0 109.906 166.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.499 ' H ' ' HB3' ' A' ' 165' ' ' ASN . 22.3 m-20 -82.29 -15.99 50.99 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 170.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 80.28 10.82 84.98 Favored Glycine 0 CA--C 1.52 0.36 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.923 -174.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.721 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.3 OUTLIER -81.94 133.91 35.34 Favored 'General case' 0 C--O 1.217 -0.615 0 C-N-CA 123.106 0.562 . . . . 0.0 110.803 -178.846 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 80.4 t -82.38 123.62 38.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.862 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -157.02 158.11 28.58 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.75 171.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.519 ' HA ' ' HA ' ' A' ' 162' ' ' SER . 10.5 mtp -82.84 144.79 29.87 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 117.482 0.641 . . . . 0.0 111.039 -178.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.76 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.7 pp -142.87 147.96 43.85 Favored Pre-proline 0 C--O 1.223 -0.317 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.43 -175.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.481 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 8.0 Cg_exo -73.55 129.8 14.13 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.547 2.165 . . . . 0.0 112.71 -175.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.579 ' O ' HG22 ' A' ' 178' ' ' VAL . 61.5 t -59.19 -44.51 98.57 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 113.087 0.773 . . . . 0.0 113.087 178.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.467 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 36.4 Cg_exo -61.93 -2.54 2.96 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 122.206 1.937 . . . . 0.0 113.136 176.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.481 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.1 m-30 -100.85 -9.23 21.84 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.641 -178.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.635 ' HB ' HG13 ' A' ' 128' ' ' VAL . 6.1 m -107.87 -173.29 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 -166.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.63 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 5.2 tp10 -159.74 49.18 0.3 Allowed 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 113.221 -1.809 . . . . 0.0 112.559 -151.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.985 ' HG3' HG22 ' A' ' 128' ' ' VAL . 1.2 mppt? -71.47 138.52 49.05 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 120.042 -1.661 . . . . 0.0 111.803 -158.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.664 HD13 ' CZ ' ' A' ' 129' ' ' ARG . 11.8 tp -75.69 -80.08 0.09 Allowed 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 112.84 -1.982 . . . . 0.0 111.387 -170.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 8.3 m -77.63 103.51 4.81 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.88 178.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.945 ' HD2' ' HB2' ' A' ' 180' ' ' LYS . 3.6 ptm180 -170.04 154.21 5.0 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.248 -179.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.424 ' O ' ' HB2' ' A' ' 185' ' ' SER . 35.9 t -68.63 -94.37 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 169.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.775 ' HB3' ' CE1' ' A' ' 187' ' ' HIS . 37.1 t 173.12 154.95 0.26 Allowed Pre-proline 0 C--O 1.236 0.369 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.553 ' HG3' HH22 ' A' ' 183' ' ' ARG . 9.3 Cg_exo -69.45 80.69 0.78 Allowed 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.352 2.035 . . . . 0.0 111.655 178.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.775 ' CE1' ' HB3' ' A' ' 185' ' ' SER . 52.8 m80 -94.31 -12.86 27.17 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.279 -178.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 67.8 -89.56 0.19 Allowed Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -173.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.948 ' HE2' ' HA ' ' A' ' 195' ' ' SER . 20.6 ttpp -66.33 111.56 3.57 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 168.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 64.9 m80 -91.02 90.82 8.03 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -136.18 159.86 24.49 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 111.075 -0.81 . . . . 0.0 111.075 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 18.7 m120 -105.9 6.13 31.19 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.912 0.356 . . . . 0.0 111.894 -175.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 25.9 ttp180 -117.9 -79.75 0.6 Allowed 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.325 -0.55 . . . . 0.0 111.774 -177.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.4 ' OD1' ' HB2' ' A' ' 196' ' ' ASN . 29.3 p-10 -158.25 -163.23 1.25 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 -173.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.948 ' HA ' ' HE2' ' A' ' 189' ' ' LYS . 13.4 p -57.98 -69.81 0.16 Allowed 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 173.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . 0.4 ' HB2' ' OD1' ' A' ' 194' ' ' ASN . 2.9 t-20 71.11 -40.98 0.49 Allowed 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.66 0.784 . . . . 0.0 112.913 171.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 22.7 t 72.75 86.6 0.11 Allowed 'General case' 0 C--O 1.233 0.194 0 C-N-CA 123.391 0.676 . . . . 0.0 109.357 -174.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -83.36 75.49 9.98 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.181 -178.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -93.39 -33.78 7.01 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.364 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 12.2 pt -107.48 104.28 52.07 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-O 121.22 0.533 . . . . 0.0 111.835 -177.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -88.22 0.37 6.78 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.704 2.27 . . . . 0.0 111.587 174.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.441 ' HA ' ' HD3' ' A' ' 203' ' ' PRO . 9.8 pt-20 -140.75 142.77 29.6 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.189 -177.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 202' ' ' GLU . 5.1 Cg_exo -75.3 96.82 1.05 Allowed 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.823 2.349 . . . . 0.0 111.107 174.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -88.91 89.8 8.14 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.854 -176.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 54.1 t-80 -140.61 90.17 2.33 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.178 179.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . 58.08 25.42 12.36 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.512 178.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -103.43 -45.44 4.86 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.503 -175.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -101.24 -34.53 9.62 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.249 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -115.12 105.62 52.52 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.792 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -64.86 -58.13 0.24 Allowed 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.662 2.242 . . . . 0.0 111.732 175.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 63.11 172.55 0.15 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.627 0.727 . . . . 0.0 112.069 178.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 5.2 m -115.36 40.1 2.78 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 172.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 10.4 m -58.76 -45.85 88.8 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.224 -0.898 . . . . 0.0 111.712 -177.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 27.8 m -153.43 131.6 6.42 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.275 -176.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.504 ' HB2' ' O ' ' A' ' 218' ' ' ALA . 72.9 Cg_endo -80.17 120.41 4.11 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.424 2.083 . . . . 0.0 111.851 174.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.606 ' HB2' ' HD3' ' A' ' 217' ' ' PRO . 7.2 mp -99.77 -58.53 0.13 Allowed Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -178.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.606 ' HD3' ' HB2' ' A' ' 216' ' ' LEU . 87.9 Cg_endo -85.07 -10.82 7.87 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 121.754 1.636 . . . . 0.0 112.662 -178.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.504 ' O ' ' HB2' ' A' ' 215' ' ' PRO . . . -125.02 91.36 3.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.966 0.413 . . . . 0.0 110.893 -178.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 27.5 m -88.26 165.85 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.359 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 14.4 m -91.91 10.27 29.48 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.008 0.432 . . . . 0.0 110.766 -179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 80.78 -56.83 4.79 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 121.19 -0.529 . . . . 0.0 112.006 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.459 ' HA ' ' HD3' ' A' ' 223' ' ' PRO . 28.5 t -131.0 133.43 24.74 Favored Pre-proline 0 C--N 1.32 -0.694 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 177.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 222' ' ' SER . 16.1 Cg_exo -67.49 161.14 44.69 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.579 2.186 . . . . 0.0 111.677 177.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -84.14 -25.4 44.55 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.589 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -138.45 157.7 45.69 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.721 -0.239 . . . . 0.0 110.373 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . 68.6 35.31 3.22 Favored 'General case' 0 C--O 1.233 0.23 0 O-C-N 123.971 0.795 . . . . 0.0 111.655 176.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.576 ' H ' HD12 ' A' ' 227' ' ' ILE . 4.3 mp -78.11 90.11 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 175.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 20.8 m 60.78 79.11 0.29 Allowed Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.324 -173.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.457 ' HB2' HD23 ' A' ' 230' ' ' LEU . 23.4 Cg_exo -64.79 -69.21 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.602 2.201 . . . . 0.0 111.774 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.457 HD23 ' HB2' ' A' ' 229' ' ' PRO . 2.6 pt? -162.31 123.25 1.55 Allowed Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.916 177.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 230' ' ' LEU . 7.7 Cg_exo -72.43 -68.09 0.02 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.296 1.997 . . . . 0.0 111.374 177.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 3.0 p -161.71 26.83 0.12 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.618 179.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 2.9 p -82.44 -16.79 47.64 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.055 -0.975 . . . . 0.0 112.207 -173.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 58.36 83.58 0.12 Allowed 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 121.433 0.635 . . . . 0.0 110.881 -175.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -110.64 99.2 8.2 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.531 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -90.97 163.84 29.57 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.222 174.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -68.81 161.57 44.96 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.533 2.155 . . . . 0.0 111.751 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.505 ' HB ' HG13 ' A' ' 266' ' ' VAL . 18.3 t -89.03 128.95 40.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.516 ' HB2' ' HG3' ' A' ' 296' ' ' PRO . 93.9 m-85 -102.87 117.68 35.16 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.092 0.472 . . . . 0.0 110.959 -177.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -119.95 134.35 55.27 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.104 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -84.59 126.39 33.29 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . 0.476 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -72.65 100.71 2.87 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.03 0.443 . . . . 0.0 109.829 177.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.453 ' H ' HG13 ' A' ' 243' ' ' ILE . 2.4 pp -96.05 -9.0 9.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.557 -176.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.28 138.25 36.59 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 176.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -58.23 149.62 23.72 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 120.968 0.414 . . . . 0.0 110.71 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 24.7 tpt180 -143.78 91.52 2.24 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 174.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 29.2 m -100.23 142.6 24.93 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.098 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.486 ' HB3' ' HB3' ' A' ' 255' ' ' ALA . 72.8 Cg_endo -79.11 148.58 21.71 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.404 2.07 . . . . 0.0 112.101 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 48.7 t -79.66 176.58 9.59 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 173.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -59.62 -30.36 68.64 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.659 0.266 . . . . 0.0 111.548 -177.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -96.02 -5.42 41.11 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -178.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.467 ' HB3' ' HB3' ' A' ' 255' ' ' ALA . 4.1 m-20 -82.82 107.6 15.56 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.263 0.554 . . . . 0.0 111.467 -176.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 47.2 mttp -104.01 -34.41 8.46 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.308 176.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 3.0 p -86.81 9.4 19.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.589 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.486 ' HB3' ' HB3' ' A' ' 248' ' ' PRO . . . -95.8 131.84 41.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.051 0.453 . . . . 0.0 110.857 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.536 HD21 ' HB ' ' A' ' 279' ' ' VAL . 0.9 OUTLIER -88.24 133.32 34.07 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.188 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -89.3 109.75 20.61 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 120.861 0.363 . . . . 0.0 110.169 -179.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 94.2 mt -115.11 143.69 44.82 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.012 -175.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -120.4 149.95 41.55 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.503 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 59.8 t -64.17 117.15 4.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.784 0.326 . . . . 0.0 110.874 -178.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 108.93 10.19 24.95 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.587 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -103.19 167.59 9.72 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 37.3 mm -114.35 118.09 57.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.038 0.447 . . . . 0.0 110.814 -176.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 20.0 t -93.69 109.37 21.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.514 -179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -87.2 87.47 7.45 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.746 177.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.505 HG13 ' HB ' ' A' ' 238' ' ' VAL . 7.2 p -91.19 136.52 24.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.88 -175.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 18.1 p -114.06 -50.61 2.81 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.19 179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 14.2 tpp180 -100.79 101.27 12.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.12 0.486 . . . . 0.0 110.657 -175.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 41.4 mtt -91.54 118.9 31.01 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.007 0.432 . . . . 0.0 110.304 177.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 274' ' ' GLN . 90.6 m-20 -83.11 0.61 44.3 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.472 -176.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 50.6 mm 72.94 -47.85 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 171.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -61.84 -24.75 67.09 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -173.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 155.38 -48.48 0.49 Allowed Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.252 -0.975 . . . . 0.0 112.694 178.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.515 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 1.8 mp0 -86.46 116.52 24.66 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.387 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.475 ' HB3' HG21 ' A' ' 266' ' ' VAL . 43.8 m0 -97.17 153.42 18.0 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.613 178.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -106.26 109.47 21.41 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.184 0.516 . . . . 0.0 110.026 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -123.21 164.18 16.33 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.786 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -114.61 115.28 26.91 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 -178.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . 0.536 ' HB ' HD21 ' A' ' 256' ' ' LEU . 88.1 t -136.15 125.2 38.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.258 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 56.95 38.78 29.58 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.893 176.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 89.34 -15.63 57.99 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.437 175.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' A' ' 282' ' ' ARG . 40.6 mtp-105 -107.96 132.7 53.23 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 117.164 0.482 . . . . 0.0 110.645 -177.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 0.0 OUTLIER -114.61 130.06 56.74 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 174.507 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -157.96 -175.73 29.22 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.53 -0.843 . . . . 0.0 112.279 -177.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.515 ' HB3' ' HB3' ' A' ' 274' ' ' GLN . 78.6 mt -93.8 129.75 40.06 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.126 0.489 . . . . 0.0 110.804 -178.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.474 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 47.8 p90 -132.72 141.18 40.18 Favored Pre-proline 0 C--N 1.317 -0.804 0 CA-C-N 115.696 -0.683 . . . . 0.0 109.837 176.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . 0.474 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 4.6 Cg_exo -74.89 140.38 25.71 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.735 2.29 . . . . 0.0 111.58 177.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -72.58 7.12 2.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.045 0.45 . . . . 0.0 111.821 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 4.1 p -90.83 -10.68 41.84 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.157 0.503 . . . . 0.0 110.968 177.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -104.89 -10.45 17.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.874 -178.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.476 HG12 ' HA ' ' A' ' 242' ' ' ALA . 35.6 m -128.36 162.74 34.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.455 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -140.69 136.72 32.91 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.32 175.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 1.2 mp -72.56 135.96 26.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 174.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -144.63 -165.81 2.24 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.941 -175.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.95 ' HB3' ' HA ' ' A' ' 298' ' ' ASN . 23.8 m-20 -103.43 95.35 6.98 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.228 175.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . 0.516 ' HG3' ' HB2' ' A' ' 239' ' ' PHE . 74.5 Cg_endo -77.13 -30.8 4.08 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.193 1.929 . . . . 0.0 111.665 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -99.32 -20.73 16.39 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.444 175.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . 0.95 ' HA ' ' HB3' ' A' ' 295' ' ' ASP . 18.3 m120 72.53 157.63 0.16 Allowed Pre-proline 0 N--CA 1.467 0.391 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.881 175.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -90.29 7.59 3.75 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.897 2.398 . . . . 0.0 111.275 172.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 36.5 t0 -135.27 136.44 41.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.582 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 65.95 7.24 4.53 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.839 0.712 . . . . 0.0 111.31 -176.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -87.55 92.27 9.03 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 176.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 . . . . . 0 C--O 1.249 1.039 0 CA-C-N 115.703 -0.681 . . . . 0.0 109.562 -172.749 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 ptp . . . . . 0 N--CA 1.484 1.245 0 CA-C-O 121.085 0.469 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.8 t -74.07 131.89 41.78 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.838 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.402 ' O ' HG23 ' A' ' 99' ' ' ILE . 22.7 t -66.84 -18.32 65.32 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 177.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . -75.38 87.19 2.56 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.83 175.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? -115.55 88.56 2.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.648 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -161.09 161.29 31.18 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.385 177.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -88.25 91.47 8.8 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.875 0.845 . . . . 0.0 110.11 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.6 p -73.86 77.81 1.62 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.894 -176.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.4 t -176.59 -39.78 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.586 176.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -64.51 113.81 3.93 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.018 0.437 . . . . 0.0 110.828 -174.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 13.1 mmt180 -58.46 -35.81 72.71 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.742 -176.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.2 t -73.51 -6.49 46.8 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.176 -176.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.01 -47.49 7.25 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 121.046 -0.262 . . . . 0.0 111.556 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 30.1 p-90 -116.67 -22.74 8.49 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -171.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -73.27 112.84 9.7 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.361 0.6 . . . . 0.0 109.747 -177.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.565 ' SD ' ' HA ' ' A' ' 104' ' ' ARG . 15.7 tpp -95.3 5.86 50.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.31 -171.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.486 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 49.65 -113.65 1.92 Allowed Glycine 0 CA--C 1.522 0.493 0 CA-C-N 115.516 -0.765 . . . . 0.0 114.357 176.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.486 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 5.0 Cg_exo -77.13 88.49 1.4 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.454 2.77 . . . . 0.0 113.159 -175.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.582 HG12 ' HD2' ' A' ' 39' ' ' ARG . 71.3 t -145.34 160.44 12.97 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.452 ' H ' ' HB2' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -143.27 -168.81 2.9 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -171.354 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 35.6 mtp85 -59.06 -57.82 11.4 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 118.652 0.66 . . . . 0.0 112.182 -176.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -64.68 -44.97 88.64 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 123.29 0.369 . . . . 0.0 110.847 -175.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.638 ' O ' ' HG3' ' A' ' 27' ' ' ARG . 12.5 mp0 -60.68 -49.84 75.9 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.534 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.92 -44.69 82.7 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.427 0.632 . . . . 0.0 110.344 177.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.525 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 6.9 tp60 -60.72 -58.25 9.24 Favored 'General case' 0 C--O 1.214 -0.786 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.563 -178.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.2 t -61.83 -27.53 68.84 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -172.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.638 ' HG3' ' O ' ' A' ' 23' ' ' GLU . 62.5 mtp180 -83.48 -10.44 58.35 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.717 0.294 . . . . 0.0 111.258 -178.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.64 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 87.7 mt -125.58 -13.39 6.53 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.525 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -70.24 107.09 3.57 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 122.765 0.426 . . . . 0.0 110.434 -174.855 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.53 ' O ' ' HB3' ' A' ' 116' ' ' PRO . . . 70.61 20.24 77.08 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.501 -0.857 . . . . 0.0 112.05 -179.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.483 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 12.2 mm100 -92.89 -161.17 0.81 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.427 ' HG2' ' HB3' ' A' ' 115' ' ' ALA . 47.0 mtm180 -52.64 130.76 33.23 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 175.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.41 ' ND1' ' HB2' ' A' ' 117' ' ' ASN . 63.5 m170 -86.35 126.31 34.25 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 100.25 11.2 42.92 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -171.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.543 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 50.6 ttp -104.07 134.61 47.04 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -178.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.437 ' CB ' HG22 ' A' ' 52' ' ' VAL . 39.9 p90 -139.29 167.78 21.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.768 0.318 . . . . 0.0 111.777 -174.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.545 ' HG ' HD11 ' A' ' 28' ' ' LEU . 4.6 pp -153.83 140.0 18.45 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.146 0.498 . . . . 0.0 110.825 173.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.6 t -105.71 114.21 44.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 174.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.582 ' HD2' HG12 ' A' ' 19' ' ' VAL . 22.3 ptt-85 -112.33 167.72 10.2 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.953 -173.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -76.44 125.36 29.06 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 170.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.0 t -75.77 152.51 37.36 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.395 0.617 . . . . 0.0 111.531 -172.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 6.8 t -111.69 14.54 21.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.226 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 46.7 p -92.16 -57.25 2.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.957 176.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.418 ' HB2' ' OD2' ' A' ' 47' ' ' ASP . 56.8 m -134.56 137.9 28.74 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.754 178.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.6 127.18 17.47 Favored 'Trans proline' 0 CA--C 1.529 0.254 0 C-N-CA 122.8 2.333 . . . . 0.0 112.754 -178.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.65 -16.68 43.8 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.339 176.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.418 ' OD2' ' HB2' ' A' ' 44' ' ' CYS . 65.8 m-20 -96.89 166.34 11.67 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 -177.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -128.33 175.22 8.65 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -178.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.7 t -144.66 117.35 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-O 120.902 0.382 . . . . 0.0 110.93 174.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 33.5 tp -84.83 102.1 12.8 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.442 176.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 55.9 m -96.52 133.65 40.72 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 175.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.798 HG21 HD13 ' A' ' 93' ' ' LEU . 99.2 t -129.53 134.3 63.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.841 0.353 . . . . 0.0 111.825 -173.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.64 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 9.2 t -94.5 117.18 29.73 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -177.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.684 ' O ' ' HB3' ' A' ' 57' ' ' ARG . 9.9 tp10 -158.26 147.94 19.71 Favored 'General case' 0 C--O 1.211 -0.967 0 C-N-CA 120.053 -0.659 . . . . 0.0 109.276 163.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.521 ' ND2' ' HG3' ' A' ' 54' ' ' GLU . 50.7 m-80 62.89 16.59 9.27 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 123.35 0.407 . . . . 0.0 111.59 -176.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 67.2 m 56.22 59.46 3.68 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 122.724 1.25 . . . . 0.0 108.164 -168.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.684 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 19.4 ttp85 -155.59 65.12 0.6 Allowed 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 112.768 -2.015 . . . . 0.0 109.398 -160.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.673 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 21.4 t -71.61 96.79 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 122.346 1.07 . . . . 0.0 109.187 -171.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.483 ' HB2' ' CZ ' ' A' ' 61' ' ' TYR . 1.4 p -75.07 121.37 21.92 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 113.237 -1.801 . . . . 0.0 111.166 -176.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 62.4 m-70 -93.59 108.08 19.84 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.211 -176.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.935 ' HB3' HD11 ' A' ' 73' ' ' ILE . 66.6 m-85 -105.63 103.24 12.71 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.071 177.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.686 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 55.8 mt -78.33 133.47 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -174.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.587 HG13 ' HB ' ' A' ' 73' ' ' ILE . 4.2 mp -118.03 118.67 58.99 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 122.831 0.452 . . . . 0.0 111.275 -179.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -87.78 151.06 23.17 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.0 t -92.46 100.84 13.32 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 171.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.575 HD21 ' HD2' ' A' ' 72' ' ' LYS . 80.2 mt -78.61 137.16 58.99 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.663 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -63.3 -7.03 11.14 Favored 'Trans proline' 0 CA--C 1.529 0.237 0 C-N-CA 122.889 2.392 . . . . 0.0 112.238 177.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 54.1 m-20 -78.24 6.74 7.53 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.723 173.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.778 ' HA ' ' HE ' ' A' ' 69' ' ' ARG . 2.6 tpm_? 63.57 32.87 13.8 Favored 'General case' 0 N--CA 1.46 0.065 0 CA-C-O 122.009 0.909 . . . . 0.0 109.106 -173.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.788 ' HG2' ' HA ' ' A' ' 79' ' ' ASP . 69.6 mtt180 -120.78 179.39 4.37 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.88 -1.055 . . . . 0.0 109.692 -179.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.559 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 54.0 m-85 -135.82 119.35 16.98 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.096 0.474 . . . . 0.0 111.379 -176.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.583 ' HG3' ' HG2' ' A' ' 77' ' ' GLU . 46.3 tttm -101.82 101.28 11.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.567 -172.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.935 HD11 ' HB3' ' A' ' 61' ' ' TYR . 7.0 tt -100.77 110.17 27.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.38 0.609 . . . . 0.0 111.444 -176.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.96 -55.39 3.51 Favored Glycine 0 CA--C 1.519 0.326 0 CA-C-N 115.396 -0.82 . . . . 0.0 113.263 177.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -165.4 -40.86 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -176.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.454 HE21 ' HB2' ' A' ' 76' ' ' GLN . 6.4 mt-30 -69.27 141.18 54.42 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.24 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.583 ' HG2' ' HG3' ' A' ' 72' ' ' LYS . 43.5 mt-10 -108.99 104.86 14.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.434 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.54 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 77.6 m-85 -100.26 160.41 14.35 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 176.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.788 ' HA ' ' HG2' ' A' ' 70' ' ' ARG . 6.0 m-20 -74.82 -32.79 62.07 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -174.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.54 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 1.2 p80 -153.22 166.44 32.54 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.473 0.178 . . . . 0.0 110.875 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.668 HD23 HD21 ' A' ' 84' ' ' LEU . 9.0 mt -57.23 -51.22 83.33 Favored Pre-proline 0 N--CA 1.466 0.328 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.865 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.54 ' HD2' ' HB2' ' A' ' 80' ' ' HIS . 23.4 Cg_endo -61.11 -10.69 15.93 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 122.118 1.879 . . . . 0.0 113.034 177.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.58 -36.3 16.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.672 0.272 . . . . 0.0 110.466 -178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.668 HD21 HD23 ' A' ' 81' ' ' LEU . 4.1 pp -76.49 -35.38 58.41 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 177.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.559 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 77.3 mt -62.07 -38.5 89.04 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.554 175.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.56 ' HA ' ' HD3' ' A' ' 89' ' ' LYS . 11.0 tp10 -67.55 -38.73 84.6 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.596 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -65.66 -37.99 88.06 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.216 0.531 . . . . 0.0 110.747 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.543 ' HE2' HD13 ' A' ' 73' ' ' ILE . 35.0 m-85 -81.25 -15.59 55.13 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.777 -177.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.56 ' HD3' ' HA ' ' A' ' 86' ' ' GLU . 40.8 mtpt -64.72 -26.33 68.32 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.092 174.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.8 pp -114.48 8.48 7.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 C-N-CA 120.421 -0.512 . . . . 0.0 112.349 174.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.422 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 6.2 t-160 -93.81 -37.95 11.5 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.747 0.308 . . . . 0.0 110.868 -176.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.485 ' N ' HG22 ' A' ' 97' ' ' THR . 58.8 m-85 67.41 84.55 0.15 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.275 -168.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.798 HD13 HG21 ' A' ' 52' ' ' VAL . 14.2 mt -53.98 -25.05 18.93 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 122.208 1.004 . . . . 0.0 110.888 175.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.528 ' CG ' ' HB3' ' A' ' 54' ' ' GLU . 0.4 OUTLIER -132.05 -91.6 0.4 Allowed 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 114.339 -1.3 . . . . 0.0 107.607 175.6 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.541 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 13.8 t -145.67 21.63 1.47 Allowed 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 172.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.8 t -135.41 -21.85 1.54 Allowed 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 119.605 -0.838 . . . . 0.0 112.852 -174.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.485 HG22 ' N ' ' A' ' 92' ' ' TYR . 7.1 p 72.96 -162.2 0.1 Allowed 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.02 0.928 . . . . 0.0 110.214 -173.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.421 HD22 ' CD2' ' A' ' 36' ' ' PHE . 81.5 mt -95.96 94.45 7.61 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.068 178.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.553 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 43.9 mm -76.52 -61.26 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.958 -176.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.543 ' O ' ' HA ' ' A' ' 35' ' ' MET . 11.3 pt-20 -161.66 151.8 14.32 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.569 178.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.37 159.04 55.25 Favored 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 122.892 2.395 . . . . 0.0 113.512 -177.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.459 ' HA ' ' SD ' ' A' ' 35' ' ' MET . . . -72.31 145.7 88.43 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.91 176.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.451 ' HB3' ' HG3' ' A' ' 106' ' ' PRO . 82.1 Cg_exo -50.24 120.91 6.82 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.696 2.264 . . . . 0.0 111.503 175.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.565 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 39.1 ttt180 -58.22 -66.89 0.41 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.776 -0.454 . . . . 0.0 109.776 -175.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -163.34 81.49 1.53 Allowed Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.769 0.795 . . . . 0.0 110.272 171.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.451 ' HG3' ' HB3' ' A' ' 103' ' ' PRO . 71.0 Cg_endo -83.0 -50.98 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.153 1.902 . . . . 0.0 112.315 179.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 47.3 t -169.81 151.45 4.18 Favored Pre-proline 0 C--N 1.325 -0.457 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -177.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.405 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 72.9 Cg_exo -51.02 143.98 29.53 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.409 2.073 . . . . 0.0 111.544 173.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 108' ' ' PRO . 58.9 Cg_exo -52.37 105.36 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 123.127 2.552 . . . . 0.0 112.848 -176.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 52.0 ttm -119.02 -28.94 5.4 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.469 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -150.11 -118.91 0.91 Allowed Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.03 177.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 30.7 m 59.72 27.67 16.98 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 120.912 0.387 . . . . 0.0 111.378 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 28.3 m -103.85 1.32 10.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.223 0.535 . . . . 0.0 110.731 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.4 p -88.32 41.77 1.03 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.673 176.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.656 ' H ' ' HD2' ' A' ' 116' ' ' PRO . . . -157.94 -44.65 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.395 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.375 -177.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.656 ' HD2' ' H ' ' A' ' 115' ' ' ALA . 90.3 Cg_exo -48.32 121.31 6.03 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 122.195 1.93 . . . . 0.0 112.274 170.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.41 ' HB2' ' ND1' ' A' ' 33' ' ' HIS . 0.9 OUTLIER -97.14 -178.77 4.3 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.473 178.285 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.442 ' HA ' ' HD3' ' A' ' 119' ' ' PRO . 3.6 pp -70.76 153.13 95.02 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-O 121.07 0.462 . . . . 0.0 112.092 -172.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 118' ' ' LEU . 2.7 Cg_exo -76.71 163.81 31.08 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.156 2.571 . . . . 0.0 112.308 179.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 51.2 m -148.27 -50.21 0.17 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.312 175.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.47 ' HB3' ' HB2' ' A' ' 57' ' ' ARG . . . -95.09 71.12 3.32 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.103 0.478 . . . . 0.0 110.686 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -118.3 117.03 28.01 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.752 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 30.3 t70 72.21 3.91 4.83 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 123.88 0.737 . . . . 0.0 110.386 179.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.532 ' HB2' ' CD ' ' A' ' 183' ' ' ARG . 6.4 p30 -148.28 169.73 19.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.636 -178.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.702 HD12 HG21 ' A' ' 152' ' ' ILE . 1.9 mm? 61.24 90.34 0.07 Allowed 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.229 0.538 . . . . 0.0 111.547 -177.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 40.2 tt0 179.86 -39.73 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.341 -179.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -124.38 119.82 30.32 Favored 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 119.839 -0.745 . . . . 0.0 110.302 178.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.773 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 56.0 t -134.63 144.07 35.94 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.976 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.746 ' NH2' ' HG ' ' A' ' 181' ' ' LEU . 0.0 OUTLIER -118.9 143.54 46.93 Favored 'General case' 0 CA--C 1.501 -0.928 0 C-N-CA 116.755 -1.978 . . . . 0.0 108.741 168.059 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.813 HG22 HG12 ' A' ' 178' ' ' VAL . 1.4 p -103.89 141.08 36.77 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.749 0.785 . . . . 0.0 111.005 -177.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.771 HD11 ' HG2' ' A' ' 179' ' ' GLU . 0.5 OUTLIER -116.43 -20.34 9.73 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.921 -173.652 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.43 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 37.3 t80 -83.85 -26.23 29.66 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.764 -171.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.466 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 12.6 t70 67.94 90.65 0.09 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.748 0.785 . . . . 0.0 110.204 -178.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.565 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 74.4 t80 -120.56 91.1 46.59 Favored Pre-proline 0 C--N 1.314 -0.976 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 176.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.742 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 92.7 Cg_endo -84.14 79.9 2.5 Favored 'Trans proline' 0 N--CA 1.444 -1.421 0 C-N-CA 121.832 1.688 . . . . 0.0 112.71 -176.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.15 -23.25 74.67 Favored Glycine 0 C--N 1.334 0.417 0 CA-C-N 115.44 -0.8 . . . . 0.0 112.687 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.424 ' H ' ' HB3' ' A' ' 143' ' ' PRO . 18.9 m120 62.77 31.92 16.26 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 122.669 0.387 . . . . 0.0 111.686 176.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.469 ' HB3' ' H ' ' A' ' 141' ' ' ASP . 0.2 OUTLIER -127.17 178.32 6.1 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.054 0.454 . . . . 0.0 111.586 -176.097 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -97.15 -10.49 25.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.634 172.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.666 ' O ' ' HB2' ' A' ' 172' ' ' MET . 46.4 mt-10 -113.14 -7.97 13.59 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.276 -0.875 . . . . 0.0 110.48 176.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.469 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 9.8 m-20 -135.65 104.63 5.86 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 173.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 1.03 HD11 ' HB2' ' A' ' 165' ' ' ASN . 52.5 tp -70.83 129.24 89.95 Favored Pre-proline 0 CA--C 1.509 -0.621 0 CA-C-O 120.837 0.351 . . . . 0.0 110.83 -172.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.82 ' HD2' HD12 ' A' ' 142' ' ' LEU . 47.6 Cg_endo -80.21 96.46 1.02 Allowed 'Trans proline' 0 N--CA 1.436 -1.899 0 C-N-CA 121.01 1.14 . . . . 0.0 111.544 168.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.61 ' HB2' ' OG1' ' A' ' 130' ' ' THR . 9.0 p90 -107.18 159.87 16.01 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.926 ' H ' ' HG3' ' A' ' 148' ' ' GLU . 4.1 mppt? -111.09 -140.34 0.38 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.368 0.604 . . . . 0.0 111.818 -175.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.721 ' N ' ' HD3' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -116.58 55.72 0.81 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.276 -177.019 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 135.6 23.86 0.56 Allowed Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.244 -0.889 . . . . 0.0 113.055 174.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.926 ' HG3' ' H ' ' A' ' 145' ' ' LYS . 0.0 OUTLIER -74.73 164.83 26.14 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 169.694 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.682 HD12 ' HB3' ' A' ' 129' ' ' ARG . 0.4 OUTLIER -107.86 132.12 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.046 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 173.392 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.726 HD22 HD21 ' A' ' 142' ' ' LEU . 37.9 mt -118.54 154.69 32.15 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -176.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.565 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 98.0 t -121.98 122.83 67.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 177.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.992 HD13 ' HB2' ' A' ' 163' ' ' ALA . 44.4 mm -75.0 83.27 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -175.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.604 HD12 ' HD3' ' A' ' 164' ' ' ARG . 16.4 tt -75.3 -27.94 19.91 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.881 0 CA-C-N 113.398 -1.728 . . . . 0.0 110.134 -171.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.712 ' OE2' ' HA ' ' A' ' 93' ' ' LEU . 1.8 mt-10 -135.66 141.05 44.95 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 170.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.585 ' HD2' ' HG ' ' A' ' 125' ' ' LEU . 58.6 tttp -130.1 91.53 38.97 Favored Pre-proline 0 C--N 1.325 -0.473 0 O-C-N 122.047 -0.408 . . . . 0.0 111.202 173.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.541 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 8.4 Cg_exo -77.59 -45.14 0.16 Allowed 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.656 2.237 . . . . 0.0 112.285 171.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -117.83 -178.61 3.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.152 0.501 . . . . 0.0 111.832 -170.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.506 ' O ' HG21 ' A' ' 175' ' ' VAL . 2.6 mm-40 -106.39 -19.1 13.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.485 174.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -95.5 -28.68 14.77 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.735 0.302 . . . . 0.0 111.547 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.493 ' O ' ' HD1' ' A' ' 161' ' ' TRP . 42.6 m95 -124.22 137.91 54.46 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 174.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . 0.733 ' HB3' HD12 ' A' ' 152' ' ' ILE . 45.8 m0 -124.37 140.0 53.37 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-O 121.025 0.441 . . . . 0.0 111.007 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.57 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 19.4 m -97.94 97.02 8.58 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 -174.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.992 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -110.93 148.68 31.95 Favored 'General case' 0 N--CA 1.425 -1.695 0 C-N-CA 119.846 -0.742 . . . . 0.0 109.903 -174.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.84 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 17.2 ptt-85 -86.86 122.29 30.53 Favored 'General case' 0 N--CA 1.431 -1.418 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 173.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 1.03 ' HB2' HD11 ' A' ' 142' ' ' LEU . 63.8 t30 -56.38 177.44 0.07 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.005 -1.452 . . . . 0.0 110.443 -174.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.402 ' HD2' ' H ' ' A' ' 149' ' ' ILE . 46.8 tttt -63.66 -12.76 36.56 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.759 169.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -74.16 -30.38 62.23 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.186 0.517 . . . . 0.0 109.745 168.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 97.26 15.85 36.96 Favored Glycine 0 CA--C 1.524 0.614 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.462 -171.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.84 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 2.5 ttm-85 -95.43 139.0 32.34 Favored 'General case' 0 C--O 1.214 -0.776 0 C-N-CA 122.785 0.434 . . . . 0.0 111.457 -177.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.549 HG22 HD13 ' A' ' 153' ' ' ILE . 39.2 t -78.71 130.98 35.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 C-N-CA 121.125 -0.23 . . . . 0.0 111.202 178.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -162.93 155.27 26.55 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.501 166.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.666 ' HB2' ' O ' ' A' ' 140' ' ' GLU . 0.2 OUTLIER -76.9 140.56 40.58 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 117.057 0.428 . . . . 0.0 111.042 178.854 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.731 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.4 pp -142.0 146.7 41.51 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.343 -176.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.591 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 5.3 Cg_exo -77.02 130.34 11.21 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.85 2.367 . . . . 0.0 112.746 -176.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.553 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 87.0 t -62.02 -42.2 80.48 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 24.6 Cg_endo -63.36 -0.12 2.13 Favored 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 121.948 1.766 . . . . 0.0 112.969 175.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.591 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.3 m-85 -97.07 -16.4 20.55 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.399 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.813 HG12 HG22 ' A' ' 130' ' ' THR . 2.4 m -112.11 -173.52 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 117.712 2.486 . . . . 0.0 117.712 -160.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.771 ' HG2' HD11 ' A' ' 131' ' ' LEU . 2.1 mm-40 -139.96 49.35 1.77 Allowed 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 111.558 -2.565 . . . . 0.0 115.654 -161.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.773 ' HA ' ' HA ' ' A' ' 128' ' ' VAL . 0.0 OUTLIER -69.51 134.35 48.77 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 124.366 3.257 . . . . 0.0 111.879 -158.69 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.746 ' HG ' ' NH2' ' A' ' 129' ' ' ARG . 0.3 OUTLIER -69.65 -65.41 0.72 Allowed 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 110.755 -2.93 . . . . 0.0 111.997 -170.483 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 29.5 m -93.46 17.44 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.485 0.66 . . . . 0.0 110.839 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.576 ' O ' ' HB2' ' A' ' 180' ' ' LYS . 4.6 tpt180 -142.39 108.93 5.33 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.212 -173.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 20.7 p -81.74 -164.04 0.73 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.778 -179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.529 ' HB2' ' HD2' ' A' ' 186' ' ' PRO . 2.9 p -65.18 166.3 13.69 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 173.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.529 ' HD2' ' HB2' ' A' ' 185' ' ' SER . 10.0 Cg_endo -51.21 107.48 0.18 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.984 2.456 . . . . 0.0 112.996 -179.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -131.27 -7.34 3.8 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.158 176.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 82.6 -79.4 1.89 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.138 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.44 ' O ' ' HB3' ' A' ' 190' ' ' HIS . 18.3 ptpt -85.08 -5.7 59.34 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 111.545 0.202 . . . . 0.0 111.545 -176.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . 0.44 ' HB3' ' O ' ' A' ' 189' ' ' LYS . 9.1 t-160 71.05 -52.51 0.68 Allowed 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 122.975 0.51 . . . . 0.0 110.985 -175.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.665 ' HA3' HD21 ' A' ' 194' ' ' ASN . . . 145.79 159.97 8.43 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.228 176.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . 0.41 ' O ' ' HD3' ' A' ' 193' ' ' ARG . 33.0 t30 -72.39 -75.08 0.14 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.887 0.375 . . . . 0.0 110.793 177.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 193' ' ' ARG . 35.3 mmt180 -130.0 81.05 1.99 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.082 0.467 . . . . 0.0 110.311 -178.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.665 HD21 ' HA3' ' A' ' 191' ' ' GLY . 5.2 p30 -150.71 103.45 3.1 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.456 0.646 . . . . 0.0 110.131 177.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 6.7 m -82.22 -44.48 16.3 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.844 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -92.67 127.31 38.13 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.118 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 23.6 t -85.02 24.5 1.07 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.048 0.451 . . . . 0.0 110.507 -178.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -111.64 12.3 21.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.122 -178.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -85.67 44.96 3.42 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.134 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 50.1 mm -111.14 121.79 39.62 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-O 120.571 0.224 . . . . 0.0 110.454 -177.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -74.41 87.13 1.26 Allowed 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.526 2.15 . . . . 0.0 112.311 177.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.521 ' N ' ' HD2' ' A' ' 203' ' ' PRO . 41.3 mm-40 -82.44 -50.48 0.79 Allowed Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.758 176.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 202' ' ' GLU . 13.3 Cg_endo -57.1 129.64 35.42 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 122.11 1.873 . . . . 0.0 112.133 177.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -120.71 140.49 51.56 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.029 -176.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 13.3 p-80 -140.88 153.91 45.92 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.484 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -99.59 -45.51 5.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.017 0.437 . . . . 0.0 110.155 178.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -142.68 110.77 5.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.519 177.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -78.04 129.11 34.85 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 174.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 56.0 tt0 68.31 93.19 0.06 OUTLIER Pre-proline 0 C--O 1.233 0.235 0 O-C-N 123.847 0.717 . . . . 0.0 110.43 -175.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.63 -43.92 35.48 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.797 2.331 . . . . 0.0 112.734 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -100.66 81.77 2.35 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.06 0.457 . . . . 0.0 110.528 -178.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 12.2 t -99.27 -34.66 10.24 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.837 173.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 75.1 m -159.29 101.96 1.57 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.676 174.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.419 ' HA ' ' HD3' ' A' ' 215' ' ' PRO . 9.2 t -177.4 140.93 0.45 Allowed Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.494 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 214' ' ' THR . 17.2 Cg_exo -68.03 143.52 60.34 Favored 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 122.435 2.09 . . . . 0.0 110.967 173.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.912 ' HB3' ' HD3' ' A' ' 217' ' ' PRO . 47.1 tp -141.42 -61.47 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.53 0 C-N-CA 121.024 -0.27 . . . . 0.0 111.413 -177.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.912 ' HD3' ' HB3' ' A' ' 216' ' ' LEU . 1.5 Cg_endo -83.92 -46.19 0.05 OUTLIER 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 121.922 1.748 . . . . 0.0 112.607 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . 66.14 178.22 0.21 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.943 -173.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 43.8 t -115.87 -52.21 4.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 120.941 0.401 . . . . 0.0 111.098 -178.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 2.6 p -91.85 116.27 28.76 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -171.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 84.35 -51.82 4.62 Favored Glycine 0 C--N 1.33 0.197 0 CA-C-N 116.07 -0.514 . . . . 0.0 114.053 168.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.644 ' HB3' ' HD3' ' A' ' 223' ' ' PRO . 20.9 t -53.58 -55.1 38.54 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 112.264 0.468 . . . . 0.0 112.264 -175.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.644 ' HD3' ' HB3' ' A' ' 222' ' ' SER . 4.4 Cg_endo -83.53 37.52 0.66 Allowed 'Trans proline' 0 C--N 1.353 0.804 0 C-N-CA 122.117 1.878 . . . . 0.0 112.242 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -149.83 64.71 0.39 Allowed Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.871 -178.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -79.27 105.25 10.46 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.8 0.333 . . . . 0.0 110.176 178.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -70.66 146.63 49.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.613 -176.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 49.2 mm -103.27 121.88 55.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.998 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 5.9 t -81.81 133.55 51.83 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 120.686 0.279 . . . . 0.0 110.758 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -72.05 -176.68 2.23 Favored 'Trans proline' 0 C--O 1.237 0.459 0 C-N-CA 122.556 2.17 . . . . 0.0 111.994 174.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 9.6 mp 66.59 107.78 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.359 0 C-N-CA 123.192 0.597 . . . . 0.0 111.15 -176.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -55.18 -48.24 21.99 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.81 2.34 . . . . 0.0 111.411 178.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 7.0 t 179.17 152.46 0.38 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.01 175.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 7.6 p -144.15 -102.01 0.11 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.811 0.338 . . . . 0.0 110.761 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 175.25 -68.63 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 53.33 -155.01 0.22 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.078 -0.964 . . . . 0.0 111.478 175.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -139.3 81.15 0.27 Allowed Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.952 177.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -65.14 105.71 0.72 Allowed 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.39 2.06 . . . . 0.0 110.156 175.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 2.1 t -66.81 135.6 28.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.24 -170.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -104.05 123.42 47.2 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.688 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -119.32 124.22 46.1 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 175.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.659 ' HB2' ' CE1' ' A' ' 294' ' ' PHE . 44.8 tttp -88.19 119.92 29.05 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 -176.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -67.74 110.82 3.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.013 0.435 . . . . 0.0 110.254 -178.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 21.1 pt -85.16 1.42 4.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.122 0.486 . . . . 0.0 111.207 -174.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -158.13 152.12 24.01 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.866 178.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.92 ' HG3' HG23 ' A' ' 260' ' ' VAL . 54.6 mtmt -78.67 120.72 23.75 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.135 0.493 . . . . 0.0 110.625 177.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.633 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 22.6 ttt85 -113.01 109.67 19.23 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.843 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 29.5 m -102.69 143.05 25.82 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 177.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.557 ' HD3' ' HB2' ' A' ' 257' ' ' ALA . 55.2 Cg_endo -70.46 151.59 65.18 Favored 'Trans proline' 0 C--O 1.235 0.349 0 C-N-CA 122.461 2.107 . . . . 0.0 112.764 -177.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' CYS . . . . . 0.43 ' H ' ' HB2' ' A' ' 252' ' ' ASP . 46.0 t -89.09 168.26 12.47 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 174.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -55.84 -41.03 73.69 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.657 -178.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -95.44 8.23 43.87 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.91 0.386 . . . . 0.0 111.452 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.43 ' HB2' ' H ' ' A' ' 249' ' ' CYS . 8.5 m-20 -110.82 73.47 0.82 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.851 0.358 . . . . 0.0 111.017 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -72.95 -24.73 60.84 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-O 121.269 0.557 . . . . 0.0 110.146 175.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 1.1 p -86.48 11.0 13.53 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.709 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.415 ' HB2' ' HB3' ' A' ' 252' ' ' ASP . . . -99.92 116.6 32.36 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.847 0.356 . . . . 0.0 110.515 178.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.404 HD23 ' H ' ' A' ' 257' ' ' ALA . 0.8 OUTLIER -75.55 137.46 40.85 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.085 179.935 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.633 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -91.75 128.66 37.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.169 177.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 245' ' ' LYS . 69.4 mt -132.04 149.3 52.45 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.146 -173.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.799 ' HA ' ' HG2' ' A' ' 245' ' ' LYS . 64.5 mm-40 -101.54 167.77 9.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.604 178.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.92 HG23 ' HG3' ' A' ' 245' ' ' LYS . 60.0 t -74.89 115.94 16.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 176.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.543 ' HA2' ' HE3' ' A' ' 241' ' ' LYS . . . 99.71 -2.76 57.27 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.635 -177.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -71.75 151.93 43.15 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -174.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 43.0 mm -103.75 109.05 25.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.107 0.48 . . . . 0.0 110.907 -175.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.453 ' HA ' HG21 ' A' ' 279' ' ' VAL . 39.1 t -82.77 105.27 12.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.103 178.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -91.07 98.95 12.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.583 178.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 4.8 p -92.13 123.12 44.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.414 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 6.6 p -96.54 -33.01 11.98 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.654 -177.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 32.6 mtm180 -131.9 126.03 33.15 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.412 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 38.3 mtt -105.04 121.28 43.45 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.183 0.516 . . . . 0.0 111.127 179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' A' ' 274' ' ' GLN . 79.4 m-20 -88.72 120.68 30.34 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.536 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 32.1 mm -76.35 80.84 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.333 0.587 . . . . 0.0 110.389 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . 0.784 HD21 ' HG2' ' A' ' 274' ' ' GLN . 3.3 p-10 -163.14 -37.55 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.622 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 131.4 28.73 0.62 Allowed Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.633 -0.794 . . . . 0.0 113.179 -178.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.784 ' HG2' HD21 ' A' ' 272' ' ' ASN . 2.4 pt20 -159.79 113.51 2.24 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 168.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 3.6 m0 -93.68 158.21 15.79 Favored 'General case' 0 N--CA 1.465 0.324 0 O-C-N 122.16 -0.337 . . . . 0.0 110.454 -175.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 8.3 tm-20 -101.06 108.45 20.15 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -132.44 136.45 8.75 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 111.406 -0.677 . . . . 0.0 111.406 177.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 283' ' ' LYS . 29.4 tt0 -114.69 114.62 25.89 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.987 0.423 . . . . 0.0 110.022 -178.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . 0.453 HG21 ' HA ' ' A' ' 264' ' ' VAL . 28.4 t -118.94 -78.69 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.195 0.522 . . . . 0.0 111.147 -175.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -86.58 60.7 6.38 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.22 -173.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 71.66 2.05 48.58 Favored Glycine 0 C--N 1.333 0.406 0 CA-C-N 115.489 -0.778 . . . . 0.0 113.111 177.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 44.5 mtp180 -139.91 137.91 35.21 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.389 -0.226 . . . . 0.0 110.389 -175.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.459 ' NZ ' ' HB3' ' A' ' 283' ' ' LYS . 0.1 OUTLIER -91.92 125.15 36.51 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 168.391 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -142.52 162.0 27.34 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.241 -0.981 . . . . 0.0 112.07 -176.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 67.3 mt -95.23 131.76 40.93 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.125 0.488 . . . . 0.0 109.917 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -123.47 149.95 59.67 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.34 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . 0.558 ' HD3' ' CZ ' ' A' ' 246' ' ' ARG . 76.8 Cg_endo -83.59 16.12 1.97 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.729 2.286 . . . . 0.0 113.496 -171.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.508 ' CZ ' ' HA ' ' A' ' 274' ' ' GLN . 2.8 m-85 66.46 -40.98 0.37 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.041 0.936 . . . . 0.0 113.11 177.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 1.7 m -66.63 -16.57 64.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.974 0.416 . . . . 0.0 111.973 -177.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -89.94 -3.82 57.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.861 0.362 . . . . 0.0 110.787 -179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.421 HG11 HG21 ' A' ' 264' ' ' VAL . 33.6 m -127.12 165.68 25.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -130.7 115.95 17.38 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -84.55 138.65 18.77 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -177.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' PHE . . . . . 0.659 ' CE1' ' HB2' ' A' ' 241' ' ' LYS . 0.8 OUTLIER -159.57 174.2 14.98 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.729 -171.537 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -92.08 105.06 12.34 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 172.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -78.37 -15.64 14.02 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.085 1.856 . . . . 0.0 111.819 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -124.84 -28.01 3.55 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.902 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 19.2 m120 60.42 92.1 0.07 OUTLIER Pre-proline 0 N--CA 1.465 0.292 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.29 -173.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -76.48 21.3 0.56 Allowed 'Trans proline' 0 CA--C 1.528 0.198 0 C-N-CA 122.943 2.428 . . . . 0.0 113.202 -176.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -72.85 -56.17 5.59 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 176.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -93.45 34.5 1.16 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.55 176.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -53.16 -54.07 41.27 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.889 -174.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.306 -0.854 . . . . 0.0 109.66 -178.577 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 120.677 0.275 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.7 m -88.31 141.21 28.73 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 174.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.47 ' O ' HG23 ' A' ' 99' ' ' ILE . 3.1 t -73.52 -45.81 51.5 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 176.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.402 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . -79.51 106.65 11.69 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.631 175.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.435 HH11 ' HD2' ' A' ' 5' ' ' ARG . 1.6 tpp180 -140.45 91.55 2.45 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.409 0.623 . . . . 0.0 110.904 -177.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.629 ' CE1' ' HE2' ' A' ' 89' ' ' LYS . 29.1 p90 -161.74 154.59 20.44 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.08 -0.963 . . . . 0.0 108.91 178.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -79.87 111.82 16.56 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.1 m -65.13 -13.18 57.47 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.222 -173.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.1 m -103.9 -20.55 13.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.788 0.328 . . . . 0.0 111.729 -178.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -73.91 92.93 2.13 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.323 0.582 . . . . 0.0 111.041 -175.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.402 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 10.8 mtm-85 -64.27 -23.32 67.26 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.121 179.287 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.5 m -70.1 -9.14 54.54 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.778 0.323 . . . . 0.0 110.802 177.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -100.48 -47.95 4.72 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.673 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 43.7 p-90 -113.24 -20.9 11.23 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -171.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.402 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 57.2 t80 -75.32 107.39 7.4 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.089 -0.644 . . . . 0.0 109.763 -178.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.78 ' SD ' ' HA ' ' A' ' 104' ' ' ARG . 10.8 tpp -86.71 -10.83 52.81 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.796 -172.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 51.3 -112.79 1.91 Allowed Glycine 0 CA--C 1.522 0.51 0 CA-C-N 115.476 -0.784 . . . . 0.0 114.721 175.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.17 70.06 1.29 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.562 2.841 . . . . 0.0 114.037 -173.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.691 HG21 ' HG3' ' A' ' 16' ' ' MET . 60.0 t -130.76 172.26 16.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 176.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.527 ' H ' HG12 ' A' ' 19' ' ' VAL . 89.6 p -145.08 -176.68 5.19 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 -169.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 26.7 ttt85 -68.08 -41.57 81.71 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.902 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -65.79 -48.92 70.17 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.4 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.417 ' HB3' HG13 ' A' ' 19' ' ' VAL . 3.0 mp0 -65.65 -48.11 73.28 Favored 'General case' 0 C--O 1.221 -0.399 0 O-C-N 122.423 -0.173 . . . . 0.0 111.357 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.77 -46.94 83.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.7 0.286 . . . . 0.0 111.507 -177.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.549 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 51.5 tp60 -59.2 -42.57 91.24 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.814 178.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.7 m -62.3 -43.24 99.27 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.383 -0.826 . . . . 0.0 112.774 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.534 ' O ' ' HG3' ' A' ' 31' ' ' GLN . 46.2 mtt180 -74.01 -13.83 60.92 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.796 -174.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.58 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 37.8 mt -124.99 2.23 8.01 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.121 0.486 . . . . 0.0 111.275 -176.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.549 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 29.8 tp60 -71.14 96.11 1.32 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.649 -176.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.1 20.83 75.02 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.391 178.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.534 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 4.6 mm100 -87.98 -176.14 5.35 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.562 0.22 . . . . 0.0 110.431 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.813 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 50.4 ttp180 -55.79 133.41 51.04 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.074 177.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -83.66 140.73 31.99 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.904 0.383 . . . . 0.0 110.367 -174.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 103.58 -10.91 53.65 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.639 -0.791 . . . . 0.0 111.169 -173.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.813 ' SD ' ' HB3' ' A' ' 32' ' ' ARG . 24.8 mtp -79.81 140.07 36.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.475 -0.363 . . . . 0.0 110.436 177.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.474 ' HB2' HD11 ' A' ' 50' ' ' LEU . 45.1 p90 -146.58 163.66 35.1 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.124 -176.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.695 ' HB2' ' HB2' ' A' ' 16' ' ' MET . 4.2 pp -152.04 133.63 14.67 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.17 0.51 . . . . 0.0 110.966 175.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 56.1 t -101.84 106.9 20.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 174.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 17.6 ptt-85 -108.87 179.41 4.19 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.216 -175.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -79.66 138.54 37.41 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 172.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.461 ' HB3' ' O ' ' A' ' 44' ' ' CYS . 46.1 t -60.38 137.05 58.2 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.343 0.592 . . . . 0.0 111.92 -173.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.401 ' OG ' ' HA ' ' A' ' 20' ' ' SER . 10.9 m -87.82 -4.47 58.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.756 -178.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 7.0 p -112.53 -45.91 3.2 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.901 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.461 ' O ' ' HB3' ' A' ' 41' ' ' SER . 39.2 m -131.17 90.45 38.7 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.493 179.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 44' ' ' CYS . 10.0 Cg_endo -52.77 133.68 51.49 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.887 2.391 . . . . 0.0 111.804 179.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 111.46 -41.66 2.17 Favored Glycine 0 CA--C 1.505 -0.566 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -172.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -79.48 177.16 9.07 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 167.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.561 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 39.2 m-85 -134.66 174.5 10.49 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 118.477 0.581 . . . . 0.0 110.916 -176.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.5 t -144.67 108.09 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.922 0.392 . . . . 0.0 110.706 175.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.474 HD11 ' HB2' ' A' ' 36' ' ' PHE . 48.4 tp -77.54 103.21 7.34 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.881 173.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.5 m -96.42 127.4 42.38 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 175.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.406 HG22 ' HB2' ' A' ' 36' ' ' PHE . 89.2 t -118.85 138.58 49.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 120.937 0.399 . . . . 0.0 111.085 -175.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.58 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 32.3 t -87.67 113.66 23.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.578 -176.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.658 ' HG3' HG22 ' A' ' 95' ' ' THR . 0.0 OUTLIER -149.47 137.29 20.35 Favored 'General case' 0 C--O 1.205 -1.249 0 C-N-CA 119.756 -0.778 . . . . 0.0 110.241 172.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 56.53 27.13 11.85 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 173.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.477 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 49.0 m 57.74 53.06 7.45 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 122.516 1.15 . . . . 0.0 108.189 -175.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.726 HH22 ' HA ' ' A' ' 154' ' ' GLU . 6.0 ttp180 -167.98 64.81 0.07 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 113.133 -1.849 . . . . 0.0 109.246 -153.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.402 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 37.3 t -70.25 107.07 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-O 122.333 1.063 . . . . 0.0 110.142 -167.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 45.5 m -75.71 121.74 22.97 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 113.304 -1.771 . . . . 0.0 110.533 -176.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -99.01 115.32 28.68 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -173.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.553 ' HB3' HD11 ' A' ' 73' ' ' ILE . 44.0 m-85 -112.14 107.88 16.95 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.586 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 65.4 mt -80.77 127.9 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 112.7 0.63 . . . . 0.0 112.7 -173.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.561 ' HB ' ' HB2' ' A' ' 48' ' ' TYR . 3.8 mp -102.43 119.32 50.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 C-N-CA 122.947 0.499 . . . . 0.0 111.209 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.555 ' HB2' ' HB3' ' A' ' 72' ' ' LYS . 0.8 OUTLIER -87.77 134.81 33.6 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.015 -0.538 . . . . 0.0 109.999 -178.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.0 t -83.7 86.1 7.18 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 172.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.565 HD12 ' HB2' ' A' ' 70' ' ' ARG . 83.0 mt -70.21 137.96 86.89 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.778 -176.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 66' ' ' LEU . 36.9 Cg_exo -61.85 -16.2 47.7 Favored 'Trans proline' 0 C--N 1.343 0.252 0 C-N-CA 122.914 2.409 . . . . 0.0 111.394 176.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 51.8 m-20 -81.47 7.98 10.58 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.222 178.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.807 ' HE ' ' HA ' ' A' ' 69' ' ' ARG . 2.9 mmp_? 64.51 36.59 8.58 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.812 -179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.565 ' HB2' HD12 ' A' ' 66' ' ' LEU . 82.1 mtm-85 -126.38 179.17 5.42 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.271 177.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.537 ' HB3' HG23 ' A' ' 63' ' ' ILE . 57.0 m-85 -136.35 116.7 13.63 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.019 0.438 . . . . 0.0 111.156 -176.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.597 ' HA ' ' HA ' ' A' ' 77' ' ' GLU . 24.2 ttmm -99.73 116.06 30.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.217 -176.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.553 HD11 ' HB3' ' A' ' 61' ' ' TYR . 18.5 tt -93.52 92.37 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 121.995 0.902 . . . . 0.0 111.345 -176.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' A' ' 75' ' ' ASP . . . 77.76 -15.7 7.61 Favored Glycine 0 CA--C 1.517 0.203 0 CA-C-N 115.191 -0.913 . . . . 0.0 113.959 174.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 74' ' ' GLY . 22.3 t70 161.35 -55.24 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 121.607 0.717 . . . . 0.0 109.167 -171.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -71.27 118.78 14.49 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.63 -179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.597 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 14.3 pt-20 -105.89 134.44 49.01 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.751 0.786 . . . . 0.0 111.785 -175.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.461 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 88.9 m-85 -112.45 -177.47 3.16 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.848 176.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.405 ' HA ' ' HD2' ' A' ' 70' ' ' ARG . 7.5 p-10 -78.54 -28.67 46.09 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 121.136 -0.226 . . . . 0.0 111.208 -176.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -171.02 174.31 4.76 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 173.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.544 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 13.1 mt -53.9 -56.47 25.25 Favored Pre-proline 0 N--CA 1.471 0.582 0 N-CA-C 112.721 0.638 . . . . 0.0 112.721 -176.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.544 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 38.9 Cg_exo -61.23 -10.14 14.7 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 122.175 1.917 . . . . 0.0 112.81 -177.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.5 -36.02 15.63 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.798 -178.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.0 pp -75.44 -34.58 60.97 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.574 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 92.0 mt -64.85 -25.93 68.11 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.377 177.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -87.27 -34.21 18.99 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.463 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -70.35 -36.87 74.47 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.299 0.571 . . . . 0.0 110.56 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.678 ' CG ' HD23 ' A' ' 93' ' ' LEU . 27.1 m-85 -77.32 -9.41 58.81 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.197 -177.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.629 ' HE2' ' CE1' ' A' ' 6' ' ' PHE . 99.0 mttt -68.1 -12.5 60.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.919 0.39 . . . . 0.0 111.221 177.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 24.2 pt -134.55 18.86 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.307 0 CA-C-O 121.368 0.604 . . . . 0.0 109.492 -178.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.424 ' O ' ' HB2' ' A' ' 92' ' ' TYR . 4.0 t60 -116.55 -40.66 3.18 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.969 -175.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.424 ' HB2' ' O ' ' A' ' 91' ' ' HIS . 52.6 m-85 68.85 114.21 0.04 OUTLIER 'General case' 0 N--CA 1.461 0.104 0 O-C-N 124.291 0.995 . . . . 0.0 109.115 -169.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.678 HD23 ' CG ' ' A' ' 88' ' ' TYR . 0.8 OUTLIER -109.18 -7.39 15.3 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.055 -0.658 . . . . 0.0 111.099 176.347 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 1.058 ' HA ' ' HB3' ' A' ' 154' ' ' GLU . 0.5 OUTLIER -159.52 81.42 0.74 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.143 0.497 . . . . 0.0 111.166 170.372 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.69 ' OG1' ' HA ' ' A' ' 156' ' ' PRO . 2.3 t 47.67 3.79 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 125.208 1.403 . . . . 0.0 113.858 -176.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.469 ' H ' ' C ' ' A' ' 94' ' ' ASP . 14.6 t -153.76 168.16 27.22 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 32.5 p -101.85 178.46 4.61 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 177.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.1 mt -75.11 96.19 3.21 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 176.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.47 HG23 ' O ' ' A' ' 3' ' ' SER . 37.5 mm -82.15 -63.68 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.707 -173.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.631 ' O ' ' HA ' ' A' ' 35' ' ' MET . 33.3 tt0 -153.33 137.13 10.41 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.16 -178.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -57.33 162.57 9.62 Favored 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 123.087 2.524 . . . . 0.0 113.248 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.53 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -78.16 157.98 77.67 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.198 178.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.93 107.52 0.23 Allowed 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.452 2.101 . . . . 0.0 112.089 177.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.78 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 65.0 ttt180 -60.34 -55.18 36.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.705 178.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -101.02 129.34 27.43 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.827 174.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -54.27 110.86 0.57 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.909 2.406 . . . . 0.0 112.548 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 11.1 p -96.57 149.2 35.53 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.113 177.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -56.4 128.36 29.79 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.598 2.199 . . . . 0.0 112.188 178.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.99 -9.98 27.39 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.926 2.417 . . . . 0.0 112.438 -179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 61.3 mtt -71.5 95.79 1.43 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.427 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 138.19 -66.64 0.53 Allowed Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.602 -178.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 51.0 m -81.51 53.45 2.1 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.294 0.569 . . . . 0.0 110.839 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 22.7 m -81.81 -23.23 9.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.904 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.561 ' HB3' ' HB3' ' A' ' 210' ' ' PRO . 41.2 m -98.03 12.24 34.93 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.967 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.59 ' HB3' ' HD3' ' A' ' 116' ' ' PRO . . . -79.99 -50.99 1.15 Allowed Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.424 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.59 ' HD3' ' HB3' ' A' ' 115' ' ' ALA . 11.0 Cg_exo -71.21 86.79 0.77 Allowed 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 122.015 1.81 . . . . 0.0 112.317 178.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -89.97 119.4 30.3 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 174.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -148.03 149.57 33.08 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-O 120.708 0.29 . . . . 0.0 111.17 -176.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -89.79 9.08 3.47 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.408 2.739 . . . . 0.0 111.766 173.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 8.9 m 67.03 42.73 2.32 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.519 0.676 . . . . 0.0 111.071 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.477 ' HB2' ' HB2' ' A' ' 56' ' ' SER . . . 63.27 -171.51 0.17 Allowed 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.178 -0.919 . . . . 0.0 112.579 174.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.464 ' HB3' ' H ' ' A' ' 123' ' ' ASP . 38.9 mt-10 -130.2 -160.33 1.03 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.664 179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.464 ' H ' ' HB3' ' A' ' 122' ' ' GLU . 7.1 p-10 -86.11 -19.74 29.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.85 -175.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 29.5 t-20 -174.28 -93.11 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 111.862 0.319 . . . . 0.0 111.862 175.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.71 HD12 HG21 ' A' ' 152' ' ' ILE . 2.6 mm? 59.07 93.51 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.657 0.741 . . . . 0.0 111.351 -171.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.56 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 46.5 tt0 -169.37 -77.12 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.561 -176.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -104.74 107.67 18.75 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-O 121.611 0.719 . . . . 0.0 110.773 -177.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.75 HG22 ' CG ' ' A' ' 180' ' ' LYS . 65.7 t -123.48 130.67 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.361 0 CA-C-N 114.448 -1.251 . . . . 0.0 108.882 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.702 ' HG3' ' HB3' ' A' ' 179' ' ' GLU . 5.2 ptp180 -108.6 149.65 28.6 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 116.831 -1.947 . . . . 0.0 108.196 171.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.532 HG22 HG12 ' A' ' 178' ' ' VAL . 0.8 OUTLIER -106.12 129.56 54.18 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.102 -178.734 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 1.036 HD11 ' HG2' ' A' ' 179' ' ' GLU . 16.8 mt -104.08 -21.17 13.63 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -174.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.429 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 59.2 t80 -77.31 -35.18 55.14 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -172.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.585 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 23.0 t70 70.77 94.72 0.07 Allowed 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.633 0.73 . . . . 0.0 109.784 -174.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.537 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 37.1 t80 -126.69 86.39 58.66 Favored Pre-proline 0 C--N 1.32 -0.677 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.604 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 90.8 Cg_endo -88.89 79.36 1.01 Allowed 'Trans proline' 0 N--CA 1.441 -1.563 0 C-N-CA 121.896 1.731 . . . . 0.0 112.66 -179.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -68.51 -22.5 75.02 Favored Glycine 0 CA--C 1.51 -0.248 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 175.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.819 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 1.0 OUTLIER 57.43 73.12 0.48 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.09 -1.055 . . . . 0.0 110.997 -175.704 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.643 ' HB3' ' H ' ' A' ' 141' ' ' ASP . 0.6 OUTLIER -141.26 -173.65 3.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.394 0.616 . . . . 0.0 111.545 -178.588 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -114.99 1.9 14.1 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.585 -1.189 . . . . 0.0 108.674 167.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.562 ' O ' ' HB2' ' A' ' 172' ' ' MET . 40.3 mt-10 -116.35 -41.18 3.15 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 114.563 -1.199 . . . . 0.0 109.994 175.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.643 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 9.2 m-20 -101.86 114.25 28.17 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 167.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 1.085 HD11 ' HB2' ' A' ' 165' ' ' ASN . 35.2 tp -69.92 127.64 92.31 Favored Pre-proline 0 N--CA 1.465 0.324 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.819 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 6.5 Cg_endo -82.02 90.23 1.14 Allowed 'Trans proline' 0 N--CA 1.443 -1.497 0 C-N-CA 121.956 1.771 . . . . 0.0 110.752 173.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.537 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 9.1 p90 -102.39 155.04 18.51 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.317 -175.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.585 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 99.0 mttt -99.92 -166.65 1.36 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.235 0.54 . . . . 0.0 112.427 -174.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.828 ' H ' ' HD2' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -83.71 5.29 25.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.288 -169.42 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -179.07 37.59 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.996 176.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.519 ' OE1' ' HA ' ' A' ' 144' ' ' PHE . 1.2 pt-20 -96.59 148.92 22.35 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 120.589 -0.444 . . . . 0.0 110.751 -174.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.58 128.58 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.723 HD22 HD21 ' A' ' 142' ' ' LEU . 16.6 mt -121.7 156.63 32.67 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 -178.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.564 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 49.2 t -119.51 123.43 71.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 174.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 1.073 HD13 ' HB2' ' A' ' 163' ' ' ALA . 50.4 mm -73.92 94.53 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 -176.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.612 HD12 ' HD3' ' A' ' 164' ' ' ARG . 18.7 tt -79.33 -26.34 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.876 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.547 -173.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 1.058 ' HB3' ' HA ' ' A' ' 94' ' ' ASP . 0.0 OUTLIER -141.0 145.56 36.11 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.454 169.123 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -121.86 84.93 44.63 Favored Pre-proline 0 C--N 1.318 -0.784 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 167.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.69 ' HA ' ' OG1' ' A' ' 95' ' ' THR . 13.0 Cg_exo -70.42 -47.73 0.69 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.603 2.202 . . . . 0.0 111.824 177.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -118.15 177.29 4.85 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.589 -174.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.428 ' O ' HG21 ' A' ' 175' ' ' VAL . 13.3 pt-20 -92.98 -34.76 13.62 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.556 -176.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.416 ' HG3' ' HG3' ' A' ' 158' ' ' GLU . 36.3 mt-30 -98.74 -10.42 23.15 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.865 0.364 . . . . 0.0 111.66 -176.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.548 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 59.1 m95 -124.36 134.83 53.03 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 172.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . 0.786 ' O ' HG13 ' A' ' 173' ' ' ILE . 50.7 m0 -123.99 133.81 53.6 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.144 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.758 ' HB2' ' HG3' ' A' ' 154' ' ' GLU . 50.5 m -93.82 98.47 11.1 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -173.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 1.073 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -112.33 146.09 38.88 Favored 'General case' 0 N--CA 1.419 -1.998 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.701 -172.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.735 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 15.1 ptt180 -87.0 120.62 28.46 Favored 'General case' 0 N--CA 1.431 -1.396 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 175.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 1.085 ' HB2' HD11 ' A' ' 142' ' ' LEU . 20.7 t30 -52.52 176.85 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 113.455 -1.702 . . . . 0.0 111.753 -173.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 45.5 tptt -58.46 -21.02 49.96 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 169.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -77.38 -28.89 52.97 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.614 175.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 100.17 7.56 52.06 Favored Glycine 0 CA--C 1.519 0.333 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.119 -174.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.735 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.4 OUTLIER -79.9 135.72 36.49 Favored 'General case' 0 C--O 1.22 -0.498 0 C-N-CA 122.819 0.448 . . . . 0.0 111.217 -179.621 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.549 HG22 HG21 ' A' ' 153' ' ' ILE . 47.9 t -81.08 123.34 37.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 C-N-CA 121.119 -0.232 . . . . 0.0 111.252 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -158.06 146.29 13.13 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.865 171.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.57 ' HA ' ' HA ' ' A' ' 162' ' ' SER . 0.0 OUTLIER -68.97 141.06 55.03 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 122.922 0.489 . . . . 0.0 111.219 178.265 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.786 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.7 pp -142.91 143.17 24.23 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.246 -176.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.538 ' HB2' ' CD1' ' A' ' 177' ' ' TYR . 20.5 Cg_exo -68.24 132.26 25.48 Favored 'Trans proline' 0 CA--C 1.528 0.219 0 C-N-CA 122.96 2.44 . . . . 0.0 113.282 -178.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.566 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 67.0 t -60.79 -44.34 94.7 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 178.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 20.0 Cg_endo -61.52 -2.05 2.35 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 122.211 1.94 . . . . 0.0 113.217 178.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.538 ' CD1' ' HB2' ' A' ' 174' ' ' PRO . 2.8 m-85 -99.83 -12.17 20.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.555 -177.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.649 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 3.7 m -106.36 -172.83 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 -164.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 1.036 ' HG2' HD11 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -157.29 46.44 0.39 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 112.897 -1.956 . . . . 0.0 111.545 -151.755 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.75 ' CG ' HG22 ' A' ' 128' ' ' VAL . 0.8 OUTLIER -71.45 136.55 47.7 Favored 'General case' 0 C--N 1.331 -0.233 0 O-C-N 120.193 -1.567 . . . . 0.0 110.009 -163.369 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 38.8 tp -79.12 -80.88 0.11 Allowed 'General case' 0 CA--C 1.523 -0.067 0 CA-C-N 113.524 -1.671 . . . . 0.0 111.796 -165.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 4.1 m -70.32 81.58 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 175.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.622 ' HG2' ' HE2' ' A' ' 180' ' ' LYS . 5.5 tpt180 -153.91 135.65 14.46 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 113.283 0.845 . . . . 0.0 113.283 -166.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 30.1 p -132.79 62.47 1.65 Allowed 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 164.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.477 ' HB2' ' HD2' ' A' ' 186' ' ' PRO . 5.1 p -66.49 163.82 37.36 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 114.724 -1.126 . . . . 0.0 112.163 -170.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.477 ' HD2' ' HB2' ' A' ' 185' ' ' SER . 55.1 Cg_exo -37.97 110.16 0.08 OUTLIER 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 124.016 3.144 . . . . 0.0 114.086 179.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 31.5 m80 -128.73 42.77 3.26 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 175.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 93.24 -75.43 1.19 Allowed Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 110.331 -1.108 . . . . 0.0 110.331 -172.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.61 5.85 0.46 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 171.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 65.58 -67.45 0.13 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.378 -176.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 132.08 162.99 10.59 Favored Glycine 0 N--CA 1.442 -0.96 0 N-CA-C 110.303 -1.119 . . . . 0.0 110.303 -172.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -104.14 12.82 33.44 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 117.282 0.541 . . . . 0.0 110.49 -178.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 83.1 mtp180 -95.19 137.09 34.72 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.332 177.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 68.5 -66.2 0.24 Allowed 'General case' 0 N--CA 1.468 0.455 0 O-C-N 123.989 0.806 . . . . 0.0 111.41 -178.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 13.1 m -116.2 116.07 27.15 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -97.43 148.41 23.22 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.018 0.437 . . . . 0.0 110.35 -179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 33.7 t -131.21 -61.98 0.9 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.224 -179.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 60.22 -90.38 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 O-C-N 123.867 0.729 . . . . 0.0 111.043 -178.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 76.21 -62.77 2.96 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 121.185 -0.531 . . . . 0.0 112.55 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.513 HG13 ' HD2' ' A' ' 201' ' ' PRO . 16.0 tt -150.51 136.06 10.34 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.513 ' HD2' HG13 ' A' ' 200' ' ' ILE . 9.5 Cg_endo -53.08 -43.2 59.03 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.777 2.318 . . . . 0.0 112.541 -178.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -142.1 121.37 7.91 Favored Pre-proline 0 C--N 1.324 -0.509 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -178.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -56.3 105.42 0.17 Allowed 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 122.856 2.371 . . . . 0.0 112.275 177.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -98.61 152.21 19.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.678 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 34.0 m170 -116.29 148.28 40.68 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -133.57 157.18 46.36 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.995 0.426 . . . . 0.0 111.687 -175.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -102.76 -10.49 19.1 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.009 -0.542 . . . . 0.0 109.844 173.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . 57.92 -105.69 0.27 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.492 175.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 60.82 90.88 0.08 OUTLIER Pre-proline 0 C--O 1.233 0.23 0 O-C-N 123.767 0.667 . . . . 0.0 111.049 -174.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 0.561 ' HB3' ' HB3' ' A' ' 114' ' ' SER . 11.9 Cg_exo -70.23 143.56 48.96 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.688 2.259 . . . . 0.0 111.828 178.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -82.91 89.87 6.9 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.203 0.525 . . . . 0.0 110.242 179.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 6.5 p -74.83 -36.98 62.4 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.137 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 56.9 m -69.98 96.4 1.03 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.494 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 13.5 p -125.19 155.74 70.73 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.29 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -79.6 29.8 0.49 Allowed 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 123.164 2.576 . . . . 0.0 112.308 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.553 ' N ' ' HD2' ' A' ' 217' ' ' PRO . 66.8 tp -71.83 -51.3 8.96 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.825 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 216' ' ' LEU . 19.0 Cg_endo -58.34 108.83 0.43 Allowed 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 122.343 2.028 . . . . 0.0 113.183 -178.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -145.52 102.79 3.74 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.912 176.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.425 HG13 ' N ' ' A' ' 220' ' ' SER . 3.5 p -158.0 -55.98 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.268 -176.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . 0.425 ' N ' HG13 ' A' ' 219' ' ' VAL . 19.3 m -113.67 145.62 41.04 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.729 0.299 . . . . 0.0 110.379 -178.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -99.22 -139.62 10.96 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.027 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 8.7 t 61.36 84.42 0.19 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.131 0.491 . . . . 0.0 110.129 -178.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -56.65 101.33 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.986 2.457 . . . . 0.0 112.484 -178.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 161.89 57.39 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 111.336 -0.706 . . . . 0.0 111.336 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 71.53 -10.26 0.84 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.545 0.738 . . . . 0.0 112.372 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -84.64 4.38 32.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.662 0.268 . . . . 0.0 111.494 -178.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 59.8 mt -62.65 -37.59 79.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-O 121.48 0.657 . . . . 0.0 110.575 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.435 ' HA ' ' HD2' ' A' ' 229' ' ' PRO . 34.2 m -150.92 100.97 3.04 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.482 177.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 228' ' ' THR . 28.7 Cg_endo -63.69 113.34 2.1 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 122.738 2.292 . . . . 0.0 112.68 -178.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.469 ' HA ' ' HD3' ' A' ' 231' ' ' PRO . 2.5 mm? -81.28 127.31 74.25 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.102 177.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 230' ' ' LEU . 9.1 Cg_exo -71.99 73.05 2.58 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.934 2.423 . . . . 0.0 111.133 175.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 44.6 m 62.47 -83.03 0.02 OUTLIER 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.02 -176.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 7.0 m 64.2 -83.13 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 122.988 0.515 . . . . 0.0 111.08 -178.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -144.47 12.96 1.55 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 176.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -100.62 125.09 46.99 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.921 -177.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -173.07 88.78 0.08 OUTLIER Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.403 -178.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -66.56 117.25 4.59 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.469 2.113 . . . . 0.0 110.54 173.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.507 ' HB ' HG13 ' A' ' 266' ' ' VAL . 6.2 t -74.49 127.74 36.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -176.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -98.69 118.2 34.87 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.193 0.52 . . . . 0.0 111.198 -175.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.545 ' HB2' HD12 ' A' ' 293' ' ' ILE . . . -121.78 134.95 54.92 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.067 175.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -94.45 133.62 37.85 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 177.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . 0.601 ' O ' ' HA ' ' A' ' 260' ' ' VAL . . . -82.29 105.2 13.17 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.178 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.565 HD13 ' H ' ' A' ' 243' ' ' ILE . 0.2 OUTLIER -88.84 -23.08 6.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.999 0.428 . . . . 0.0 110.727 -178.483 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -130.25 122.61 28.37 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 178.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -60.34 138.42 57.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.799 0.809 . . . . 0.0 112.374 -171.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.504 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 20.4 tpt180 -116.83 113.99 23.29 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.946 -1.025 . . . . 0.0 108.998 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.416 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 19.9 m -111.65 147.68 37.28 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.774 -178.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.427 ' HA ' ' HB3' ' A' ' 255' ' ' ALA . 11.9 Cg_exo -69.24 105.63 1.43 Allowed 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.68 2.253 . . . . 0.0 111.399 178.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' CYS . . . . . 0.453 ' HB3' ' HB2' ' A' ' 252' ' ' ASP . 34.0 t -76.92 172.34 13.31 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.965 -179.398 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -55.62 -42.58 75.14 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.823 0.344 . . . . 0.0 111.131 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -94.23 8.83 40.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.122 0.487 . . . . 0.0 111.172 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.453 ' HB2' ' HB3' ' A' ' 249' ' ' CYS . 1.6 m-20 -131.94 51.28 2.16 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.538 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -67.65 -17.49 64.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.128 0.489 . . . . 0.0 110.106 178.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 3.7 p -88.23 4.37 46.02 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.368 -0.833 . . . . 0.0 111.55 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.427 ' HB3' ' HA ' ' A' ' 248' ' ' PRO . . . -88.39 142.82 27.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.223 0.535 . . . . 0.0 111.299 -178.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.437 HD23 ' N ' ' A' ' 257' ' ' ALA . 1.2 tt -81.68 141.22 33.83 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.375 -0.829 . . . . 0.0 109.11 177.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -88.63 109.53 20.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.139 0.495 . . . . 0.0 110.297 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 72.2 mt -118.42 157.38 27.3 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.96 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -146.01 167.9 22.22 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 177.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.601 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 26.0 t -55.82 120.39 2.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 O-C-N 123.673 0.608 . . . . 0.0 112.55 -171.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 109.76 -21.13 26.07 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.713 -0.676 . . . . 0.0 113.574 172.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -78.79 154.44 29.92 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 117.033 0.416 . . . . 0.0 110.797 -170.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 43.9 mm -98.12 120.55 47.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.877 -177.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.444 HG21 HG11 ' A' ' 291' ' ' VAL . 21.7 t -95.81 116.67 38.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.532 179.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 43.1 tttm -89.86 99.02 12.11 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.461 177.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.507 HG13 ' HB ' ' A' ' 238' ' ' VAL . 3.6 p -99.52 117.53 44.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.36 0.6 . . . . 0.0 110.174 174.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.42 -13.66 15.04 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.816 -177.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . 0.553 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 5.6 ttp180 -130.46 107.3 9.13 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.174 0.512 . . . . 0.0 110.86 175.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 44.7 mtt -97.92 123.8 42.07 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.684 173.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.433 ' O ' ' HB ' ' A' ' 271' ' ' ILE . 90.8 m-20 -80.74 -93.55 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.976 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.433 ' HB ' ' O ' ' A' ' 270' ' ' ASN . 10.5 tp 177.1 -29.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.153 0.502 . . . . 0.0 109.778 176.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -68.29 -37.5 80.73 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.734 177.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 141.42 -34.36 1.91 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.399 -0.905 . . . . 0.0 112.422 179.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.439 ' NE2' HD13 ' A' ' 285' ' ' LEU . 26.8 mt-30 -76.38 107.72 8.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.875 0.369 . . . . 0.0 110.198 178.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.404 ' HB3' ' CG2' ' A' ' 266' ' ' VAL . 40.6 m0 -98.24 158.1 15.77 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.176 -178.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.553 ' HB2' ' HB3' ' A' ' 268' ' ' ARG . 53.6 mt-10 -95.84 104.27 16.2 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.216 173.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -121.63 141.05 14.26 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 174.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -116.3 112.05 21.0 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.999 0.428 . . . . 0.0 110.43 -177.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 66.3 t -129.4 127.9 65.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.518 -0.764 . . . . 0.0 110.2 -177.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 63.66 21.8 12.86 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.451 177.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 102.44 -14.89 56.52 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.731 177.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 53.4 mtp180 -104.43 132.02 51.15 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.694 0.247 . . . . 0.0 111.128 -179.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 4.8 ptpp? -111.57 114.83 28.16 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 171.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -133.4 166.38 23.83 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.757 -177.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.439 HD13 ' NE2' ' A' ' 274' ' ' GLN . 74.8 mt -86.98 112.56 21.94 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.265 0.555 . . . . 0.0 110.443 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -115.56 149.34 42.8 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.859 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -86.11 143.61 7.97 Favored 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 122.471 2.114 . . . . 0.0 111.618 177.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -68.93 4.01 1.72 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -175.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 23.9 p -89.54 -33.67 16.65 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.855 0.359 . . . . 0.0 111.511 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 14.7 m-70 -77.5 -12.32 59.95 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.984 0.421 . . . . 0.0 110.96 -177.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.54 ' HB ' ' HB1' ' A' ' 240' ' ' ALA . 27.8 m -128.38 160.57 38.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.279 179.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -133.55 134.92 43.96 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.9 0.381 . . . . 0.0 110.753 174.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.545 HD12 ' HB2' ' A' ' 240' ' ' ALA . 1.2 mp -68.34 138.89 21.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.482 177.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -156.73 158.8 37.57 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 177.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.479 ' HB3' ' ND2' ' A' ' 298' ' ' ASN . 20.1 m-20 -84.85 114.5 55.97 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 174.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.9 46.97 1.83 Allowed 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.987 2.458 . . . . 0.0 111.123 178.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 65.91 14.04 9.36 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.794 -176.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . 0.479 ' ND2' ' HB3' ' A' ' 295' ' ' ASP . 1.0 OUTLIER 61.65 96.31 0.05 OUTLIER Pre-proline 0 N--CA 1.467 0.413 0 CA-C-N 115.127 -0.942 . . . . 0.0 112.863 175.042 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.25 -9.02 15.24 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 122.631 2.221 . . . . 0.0 111.691 173.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -57.44 -61.95 2.12 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.717 179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -89.57 46.79 1.4 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.669 -176.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -102.84 -59.01 1.77 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.204 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 . . . . . 0 C--O 1.247 0.946 0 CA-C-O 118.36 -0.828 . . . . 0.0 111.184 178.493 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.1 mtp . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 110.202 -0.296 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.1 m -143.04 147.34 34.91 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.327 -178.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.528 ' O ' HG23 ' A' ' 99' ' ' ILE . 3.0 p -75.92 -50.89 13.72 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 175.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -87.86 66.46 8.75 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.772 177.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -97.91 84.46 3.33 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.816 -173.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -154.37 164.67 38.25 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.506 176.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -89.68 107.29 19.01 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 175.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.577 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 37.8 t -79.09 69.9 5.35 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.306 -178.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.4 t -176.29 -40.74 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.167 176.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -58.14 108.23 0.58 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.108 0.48 . . . . 0.0 111.469 -174.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 17.8 mmt180 -61.92 -32.22 72.6 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.853 -174.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 72.4 m -74.47 -5.7 44.11 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.974 -178.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.53 -48.41 6.64 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.429 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.449 ' HB3' ' HB3' ' A' ' 101' ' ' PRO . 22.9 p-90 -114.54 -29.94 6.68 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -170.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 31.6 t80 -72.27 122.2 20.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.908 0.385 . . . . 0.0 110.618 -175.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.545 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 26.1 mmt -103.06 -5.5 23.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.401 -176.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.475 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 50.97 -114.43 2.79 Favored Glycine 0 CA--C 1.522 0.492 0 CA-C-N 115.614 -0.721 . . . . 0.0 113.498 -177.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.475 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 5.3 Cg_exo -77.33 89.18 1.34 Allowed 'Trans proline' 0 C--O 1.236 0.422 0 C-N-CA 123.091 2.527 . . . . 0.0 113.274 -175.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.603 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 97.1 t -139.15 155.51 26.6 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 177.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 13.5 m -119.46 174.06 6.61 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -174.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 70.0 mtp85 -55.77 -47.32 77.25 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -62.7 -56.2 19.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.853 0.358 . . . . 0.0 111.113 -178.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.538 ' HB3' HG13 ' A' ' 19' ' ' VAL . 0.5 OUTLIER -57.08 -47.12 81.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.789 -179.156 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.52 -47.4 82.08 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.204 0.526 . . . . 0.0 111.079 176.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -63.91 -43.19 96.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.495 -178.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 11.9 t -70.66 -9.16 56.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.651 0.262 . . . . 0.0 111.437 -177.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.487 ' HG3' ' O ' ' A' ' 23' ' ' GLU . 77.5 mtt180 -87.65 -25.84 23.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.987 0.422 . . . . 0.0 110.661 174.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.586 HD22 ' HB2' ' A' ' 53' ' ' SER . 27.3 mt -108.71 -12.49 14.94 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.76 -175.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 26.0 tp60 -79.7 105.51 11.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.161 0.505 . . . . 0.0 111.297 -177.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.97 -17.84 47.75 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.86 175.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -86.16 175.54 8.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.678 0.275 . . . . 0.0 110.785 179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 18.3 ttp180 -62.0 132.09 51.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.732 -177.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.414 ' CD2' ' HA ' ' A' ' 54' ' ' GLU . 33.3 m80 -76.35 158.18 31.71 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.376 -176.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.69 -11.86 46.24 Favored Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 110.969 -0.852 . . . . 0.0 110.969 -174.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.626 ' HB3' ' HB2' ' A' ' 102' ' ' ALA . 66.1 mtt -73.96 150.7 40.62 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 175.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.422 ' CB ' HG22 ' A' ' 52' ' ' VAL . 37.9 p90 -147.8 156.26 42.54 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 175.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.545 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.5 pp -150.45 134.72 17.08 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.058 0.456 . . . . 0.0 110.592 178.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.4 t -105.84 107.57 22.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.508 176.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.603 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 24.6 ptt-85 -106.34 -178.85 3.77 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -83.46 138.82 33.28 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 172.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.593 ' HB3' ' O ' ' A' ' 44' ' ' CYS . 20.8 t -68.05 104.26 1.72 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.39 0.614 . . . . 0.0 110.736 -174.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.4 p -69.02 -11.01 60.4 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.21 -0.905 . . . . 0.0 110.839 177.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 6.0 p -104.97 -22.15 13.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.719 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.593 ' O ' ' HB3' ' A' ' 41' ' ' SER . 57.9 m -136.51 112.68 10.03 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.763 0.316 . . . . 0.0 110.561 -177.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -62.01 114.95 2.53 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.958 2.439 . . . . 0.0 113.098 -175.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.94 -26.53 23.71 Favored Glycine 0 CA--C 1.51 -0.236 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.735 174.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.602 ' OD1' ' HA ' ' A' ' 64' ' ' ASN . 32.0 m-20 -79.95 179.66 7.47 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.544 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 38.3 m-85 -127.48 174.36 9.08 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 176.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.403 HG23 ' HA ' ' A' ' 41' ' ' SER . 27.9 t -141.37 111.01 2.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.662 0.267 . . . . 0.0 111.049 178.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.459 ' HB2' HD11 ' A' ' 63' ' ' ILE . 61.3 tp -78.33 98.76 6.06 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 171.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 69.8 m -95.62 119.66 34.51 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.266 0.555 . . . . 0.0 109.543 175.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.609 HG21 HD11 ' A' ' 93' ' ' LEU . 48.7 t -112.12 143.32 22.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.903 -173.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.589 ' HA ' ' O ' ' A' ' 57' ' ' ARG . 36.6 t -87.34 111.87 21.52 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.612 -0.144 . . . . 0.0 110.612 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.414 ' HA ' ' CD2' ' A' ' 33' ' ' HIS . 6.8 tp10 -175.92 157.3 1.89 Allowed 'General case' 0 N--CA 1.469 0.523 0 O-C-N 123.486 0.491 . . . . 0.0 111.022 176.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.676 ' HB2' ' NH2' ' A' ' 57' ' ' ARG . 27.0 m-80 61.81 58.26 2.0 Allowed 'General case' 0 CA--C 1.479 -1.752 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -171.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.9 t 70.54 -37.54 0.39 Allowed 'General case' 0 N--CA 1.426 -1.665 0 CA-C-N 113.777 -1.556 . . . . 0.0 110.21 -169.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.901 ' NE ' ' H ' ' A' ' 58' ' ' VAL 0.399 0.0 OUTLIER -157.76 -48.06 0.06 Allowed 'General case' 0 C--N 1.364 1.237 1 N-CA-C 125.571 5.397 . . . . 0.0 125.571 -170.116 . . . . . . . . 5 4 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.901 ' H ' ' NE ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -149.43 112.09 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 CA-C-N 122.088 2.222 . . . . 0.0 114.573 -168.292 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.548 ' HB2' ' HB ' ' A' ' 52' ' ' VAL . 1.4 m -98.34 114.13 26.34 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 166.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.571 ' O ' HD11 ' A' ' 153' ' ' ILE . 92.0 m-70 -100.68 110.81 22.96 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -170.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.615 ' CZ ' ' HB2' ' A' ' 93' ' ' LEU . 98.7 m-85 -119.03 117.25 28.28 Favored 'General case' 0 C--O 1.218 -0.579 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -178.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.516 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 44.8 mm -78.09 127.64 38.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -177.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.574 HG13 ' HB ' ' A' ' 73' ' ' ILE . 3.8 mp -104.34 114.54 44.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 109.643 -0.502 . . . . 0.0 109.643 175.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.602 ' HA ' ' OD1' ' A' ' 47' ' ' ASP . 7.9 m120 -85.89 137.06 33.02 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.577 -173.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.8 t -87.72 95.73 10.18 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 174.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.554 HD11 ' HB2' ' A' ' 72' ' ' LYS . 99.0 mt -82.15 136.19 47.02 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.444 -178.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 66' ' ' LEU . 27.0 Cg_exo -64.82 -2.0 4.87 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.942 2.428 . . . . 0.0 111.311 172.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -79.58 5.22 13.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.614 175.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.536 ' HA ' ' HE ' ' A' ' 69' ' ' ARG . 0.1 OUTLIER 67.91 29.9 6.38 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.227 -176.835 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.423 ' HB3' ' O ' ' A' ' 78' ' ' PHE . 30.7 mtm-85 -140.52 175.23 9.78 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.933 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.467 ' HB3' HG23 ' A' ' 63' ' ' ILE . 68.1 m-85 -125.99 132.22 52.07 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.505 0.193 . . . . 0.0 111.06 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.669 ' HE2' ' HB3' ' A' ' 77' ' ' GLU . 37.1 ttmt -114.32 112.19 22.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.978 -177.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.574 ' HB ' HG13 ' A' ' 63' ' ' ILE . 14.0 tt -105.04 110.72 31.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.344 0.592 . . . . 0.0 111.127 -177.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.58 50.12 45.47 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.63 177.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.9 t0 75.58 -29.24 0.19 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.607 0.763 . . . . 0.0 110.985 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -81.18 121.43 26.13 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.185 0.517 . . . . 0.0 110.716 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.669 ' HB3' ' HE2' ' A' ' 72' ' ' LYS . 7.8 pt-20 -99.6 141.86 31.84 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.437 -176.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.423 ' O ' ' HB3' ' A' ' 70' ' ' ARG . 95.5 m-85 -131.95 -175.56 3.77 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.201 -177.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.401 ' HA ' ' HD2' ' A' ' 70' ' ' ARG . 4.3 m-20 -64.01 -50.88 66.76 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.186 0.517 . . . . 0.0 110.335 175.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.505 ' ND1' ' HD2' ' A' ' 82' ' ' PRO . 4.2 p80 -173.0 -173.8 0.99 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.246 -176.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.667 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 19.6 mt -54.3 -58.16 15.1 Favored Pre-proline 0 N--CA 1.467 0.421 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -178.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.667 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 52.4 Cg_exo -59.52 -7.7 5.93 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 122.562 2.175 . . . . 0.0 113.765 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -95.46 -36.68 11.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.915 0.388 . . . . 0.0 110.925 -178.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.9 pp -76.59 -30.52 57.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.311 -178.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.452 ' HB2' ' OG ' ' A' ' 8' ' ' SER . 60.0 mt -66.12 -21.91 66.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.322 0.582 . . . . 0.0 110.002 177.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -81.66 -39.84 23.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.086 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.637 ' HE1' ' CE1' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -71.64 -21.38 61.83 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 121.073 0.463 . . . . 0.0 111.079 -179.873 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.697 ' CD1' HD23 ' A' ' 93' ' ' LEU . 32.7 m-85 -89.34 1.91 55.12 Favored 'General case' 0 C--N 1.321 -0.667 0 O-C-N 121.665 -0.647 . . . . 0.0 111.641 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -76.38 -21.47 56.02 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.953 175.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.555 HD13 ' O ' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -125.4 -1.78 5.3 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 CA-C-O 121.558 0.694 . . . . 0.0 110.301 -175.477 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -101.86 -30.71 11.11 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.179 -0.918 . . . . 0.0 110.345 -174.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 38.5 m-85 67.81 153.56 0.09 Allowed 'General case' 0 C--N 1.332 -0.168 0 O-C-N 124.501 1.125 . . . . 0.0 109.346 -168.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.697 HD23 ' CD1' ' A' ' 88' ' ' TYR . 0.7 OUTLIER -138.24 39.97 2.28 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 164.648 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 1.078 ' HA ' ' HB3' ' A' ' 154' ' ' GLU . 13.8 t0 168.08 -158.47 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 112.058 -2.337 . . . . 0.0 106.01 172.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.748 ' CB ' ' HA ' ' A' ' 156' ' ' PRO . 14.2 t -76.76 11.36 1.73 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.21 0.529 . . . . 0.0 110.564 176.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.2 t -146.43 161.58 40.1 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.752 176.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.8 p -97.7 -176.18 3.4 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 176.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 81.5 mt -77.33 92.91 3.96 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 176.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.528 HG23 ' O ' ' A' ' 3' ' ' SER . 48.1 mm -74.9 -59.08 3.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.985 -176.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.546 ' O ' ' HA ' ' A' ' 35' ' ' MET . 8.8 pt-20 -159.98 154.42 20.36 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.257 178.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.449 ' HB3' ' HB3' ' A' ' 14' ' ' TRP . 38.1 Cg_endo -67.18 142.64 61.75 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.323 2.015 . . . . 0.0 112.003 177.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.626 ' HB2' ' HB3' ' A' ' 35' ' ' MET . . . -69.01 148.0 97.8 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.945 177.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -63.26 129.13 24.57 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.704 1.603 . . . . 0.0 111.102 174.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -71.75 7.3 1.56 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.056 0.455 . . . . 0.0 111.194 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -121.97 103.37 39.84 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 175.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.423 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 27.2 Cg_exo -62.87 146.86 95.09 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.876 2.384 . . . . 0.0 112.303 -178.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 39.2 t -96.06 110.48 52.21 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.688 -178.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.595 ' HB2' ' HD3' ' A' ' 109' ' ' PRO . 47.5 Cg_exo -55.91 -51.54 9.4 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.709 2.273 . . . . 0.0 113.167 175.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.595 ' HD3' ' HB2' ' A' ' 108' ' ' PRO . 76.6 Cg_endo -91.52 176.23 2.11 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 121.965 1.777 . . . . 0.0 111.895 174.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 64.4 mtm -93.18 108.44 20.05 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.294 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -93.23 -106.05 1.75 Allowed Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.027 -178.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 54.7 m -82.6 90.8 6.85 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.133 0.492 . . . . 0.0 111.037 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 48.8 t -82.03 116.3 26.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.847 177.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.2 t -135.74 141.76 44.89 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.778 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -137.5 158.56 71.8 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.338 -176.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.48 ' HG2' ' ND2' ' A' ' 194' ' ' ASN . 14.9 Cg_exo -69.38 163.27 38.62 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.539 2.159 . . . . 0.0 111.883 178.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -74.72 90.83 2.34 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.253 0.549 . . . . 0.0 110.884 -179.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.601 HD21 ' HB2' ' A' ' 121' ' ' ALA . 60.0 tp -159.69 114.1 1.5 Allowed Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.43 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.551 ' HD2' HD12 ' A' ' 118' ' ' LEU . 16.4 Cg_endo -58.34 -54.34 3.15 Favored 'Trans proline' 0 CA--C 1.529 0.246 0 C-N-CA 122.661 2.241 . . . . 0.0 113.066 -177.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 34.8 m -155.85 139.99 16.5 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.664 0.268 . . . . 0.0 111.025 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.601 ' HB2' HD21 ' A' ' 118' ' ' LEU . . . -140.88 129.06 22.19 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 174.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.729 ' HB2' ' HD3' ' A' ' 186' ' ' PRO . 10.8 pt-20 -97.94 -29.47 13.28 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 -166.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.739 ' HB3' ' HE ' ' A' ' 183' ' ' ARG . 0.1 OUTLIER -72.18 -178.04 2.31 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -173.254 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.529 ' O ' ' HB2' ' A' ' 125' ' ' LEU . 56.5 t30 -110.74 -58.65 2.06 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.943 -176.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.929 HD12 HG21 ' A' ' 152' ' ' ILE . 4.6 mm? 72.89 105.96 0.07 Allowed 'General case' 0 N--CA 1.468 0.465 0 O-C-N 123.925 0.766 . . . . 0.0 110.516 -176.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.502 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 40.1 tt0 -172.88 -68.72 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.825 -1.08 . . . . 0.0 108.942 -172.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -115.63 108.02 15.86 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 121.061 0.457 . . . . 0.0 110.163 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.724 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 69.4 t -118.1 132.47 67.86 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.961 178.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.691 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 5.6 ptp180 -110.38 144.37 39.25 Favored 'General case' 0 N--CA 1.436 -1.167 0 C-N-CA 117.162 -1.815 . . . . 0.0 107.92 169.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.605 HG22 HG12 ' A' ' 178' ' ' VAL . 6.0 p -98.19 138.5 35.38 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.064 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.566 HD21 ' HG2' ' A' ' 179' ' ' GLU . 15.6 mt -110.96 -8.14 14.5 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.448 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 22.0 t80 -91.03 -42.46 10.51 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.432 -0.507 . . . . 0.0 112.01 -173.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.583 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 10.0 t70 77.3 98.39 0.07 Allowed 'General case' 0 N--CA 1.475 0.808 0 O-C-N 123.581 0.55 . . . . 0.0 110.459 -176.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.532 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 76.0 t80 -134.12 93.86 19.11 Favored Pre-proline 0 N--CA 1.45 -0.47 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 176.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.69 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 91.9 Cg_endo -84.02 89.53 0.97 Allowed 'Trans proline' 0 N--CA 1.443 -1.476 0 C-N-CA 121.767 1.645 . . . . 0.0 112.64 -178.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -79.74 -36.48 25.66 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.65 176.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.54 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 16.7 m120 67.62 34.21 4.64 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 122.958 0.503 . . . . 0.0 111.648 175.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.543 ' HB3' ' H ' ' A' ' 140' ' ' GLU . 0.1 OUTLIER -117.3 178.22 4.45 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.135 -178.071 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -92.71 -7.31 47.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.926 0.87 . . . . 0.0 108.749 171.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.676 ' O ' ' HB2' ' A' ' 172' ' ' MET . 32.4 mt-10 -118.06 -5.02 10.98 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.507 -1.224 . . . . 0.0 110.712 177.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.483 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 7.9 m-20 -139.53 102.44 4.46 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 174.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 1.098 HD11 ' HB2' ' A' ' 165' ' ' ASN . 31.0 tp -71.74 135.21 83.45 Favored Pre-proline 0 CA--C 1.512 -0.517 0 C-N-CA 120.535 -0.466 . . . . 0.0 109.966 -177.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.69 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 94.4 Cg_endo -88.54 96.85 0.38 Allowed 'Trans proline' 0 N--CA 1.438 -1.767 0 C-N-CA 121.54 1.493 . . . . 0.0 112.193 173.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.532 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 1.8 p90 -94.54 -177.7 4.32 Favored 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 119.967 -0.693 . . . . 0.0 109.85 178.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.583 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 29.1 mtmm -125.96 -172.25 2.57 Favored 'General case' 0 N--CA 1.43 -1.464 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.676 174.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.984 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -78.13 22.74 0.29 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.749 -173.1 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 165.5 35.13 0.02 OUTLIER Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.446 179.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.491 ' OE1' ' HA ' ' A' ' 144' ' ' PHE . 0.8 OUTLIER -96.79 150.51 20.63 Favored 'General case' 0 N--CA 1.444 -0.729 0 C-N-CA 119.286 -0.966 . . . . 0.0 110.688 -178.876 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.2 mp -93.5 123.76 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 -173.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.781 HD22 HD21 ' A' ' 142' ' ' LEU . 13.2 mt -119.91 156.89 29.88 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -175.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.592 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 99.5 t -117.74 121.42 67.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 176.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 1.007 HD13 ' HB2' ' A' ' 163' ' ' ALA . 47.2 mm -77.21 105.21 5.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 121.548 0.69 . . . . 0.0 109.181 -175.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.571 HD11 ' O ' ' A' ' 60' ' ' HIS . 19.5 tt -96.33 -29.01 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.954 -174.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 1.078 ' HB3' ' HA ' ' A' ' 94' ' ' ASP . 2.6 mt-10 -123.25 143.15 50.24 Favored 'General case' 0 CA--C 1.517 -0.307 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 168.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.625 ' CD ' ' HG ' ' A' ' 125' ' ' LEU . 70.2 tttt -134.86 78.44 54.58 Favored Pre-proline 0 C--N 1.314 -0.952 0 CA-C-O 121.323 0.583 . . . . 0.0 109.512 166.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.748 ' HA ' ' CB ' ' A' ' 95' ' ' THR . 26.1 Cg_exo -64.47 -52.41 1.47 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.178 1.919 . . . . 0.0 111.908 172.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.427 ' HG2' ' HB2' ' A' ' 156' ' ' PRO . 17.7 mm-40 -114.73 168.08 10.2 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.194 -169.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -96.19 1.56 52.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.395 0.617 . . . . 0.0 109.466 173.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.937 HE21 ' HA ' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -104.73 -34.34 8.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.72 179.651 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.485 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 35.1 m95 -129.55 142.28 50.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.985 176.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . 0.751 ' O ' HG13 ' A' ' 173' ' ' ILE . 52.4 m0 -125.68 137.96 53.87 Favored 'General case' 0 C--O 1.216 -0.695 0 C-N-CA 123.155 0.582 . . . . 0.0 110.143 179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.539 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 18.2 m -98.12 107.11 19.51 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -175.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 1.007 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -117.3 152.22 35.32 Favored 'General case' 0 N--CA 1.432 -1.328 0 C-N-CA 119.899 -0.72 . . . . 0.0 110.742 -176.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.824 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 11.8 ptt180 -87.37 121.91 30.42 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 171.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 1.098 ' HB2' HD11 ' A' ' 142' ' ' LEU . 14.9 t30 -55.92 -179.83 0.03 OUTLIER 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 113.748 -1.569 . . . . 0.0 111.668 -174.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -66.51 -22.15 66.17 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 167.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -68.85 -20.36 64.28 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.709 168.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 165' ' ' ASN . . . 82.73 19.51 63.46 Favored Glycine 0 CA--C 1.527 0.844 0 CA-C-N 115.148 -0.933 . . . . 0.0 113.246 -175.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.824 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 1.5 ttm-85 -94.12 142.53 27.3 Favored 'General case' 0 C--O 1.214 -0.788 0 C-N-CA 122.482 0.313 . . . . 0.0 111.03 -178.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 59.4 t -83.96 123.41 38.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 O-C-N 122.191 -0.318 . . . . 0.0 111.29 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -158.53 151.97 23.05 Favored Glycine 0 C--N 1.337 0.598 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.723 171.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.676 ' HB2' ' O ' ' A' ' 140' ' ' GLU . 0.2 OUTLIER -73.17 142.91 47.4 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.735 0.302 . . . . 0.0 111.187 178.202 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.751 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.7 pp -143.88 147.96 40.52 Favored Pre-proline 0 C--N 1.326 -0.424 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.115 -179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.505 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 11.2 Cg_exo -72.67 132.37 18.67 Favored 'Trans proline' 0 CA--C 1.528 0.214 0 C-N-CA 122.654 2.236 . . . . 0.0 112.826 -175.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.498 ' O ' HG22 ' A' ' 178' ' ' VAL . 70.1 t -60.41 -44.32 95.5 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.462 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 39.2 Cg_exo -62.59 -5.7 7.56 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 122.213 1.942 . . . . 0.0 112.95 176.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.505 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.2 m-85 -94.67 -12.17 27.82 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.216 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.644 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 2.8 m -107.41 -175.18 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 116.008 1.855 . . . . 0.0 116.008 -166.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.696 ' O ' ' HG3' ' A' ' 179' ' ' GLU . 3.6 tp10 -160.9 46.32 0.2 Allowed 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 112.725 -2.034 . . . . 0.0 111.541 -152.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.777 ' HD2' ' H ' ' A' ' 180' ' ' LYS . 0.0 OUTLIER -73.17 137.86 45.34 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 119.125 -2.235 . . . . 0.0 111.874 -161.328 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.441 ' O ' ' N ' ' A' ' 183' ' ' ARG . 15.3 tp -71.64 151.21 43.92 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 112.217 -2.265 . . . . 0.0 110.15 -173.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.684 HG13 ' H ' ' A' ' 183' ' ' ARG . 7.7 p 42.51 -72.8 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 125.385 1.474 . . . . 0.0 113.862 -174.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.739 ' HE ' ' HB3' ' A' ' 123' ' ' ASP . 66.8 ttt180 71.53 112.13 0.06 Allowed 'General case' 0 C--O 1.231 0.092 0 C-N-CA 123.798 0.839 . . . . 0.0 111.119 179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.488 ' HB3' ' CG ' ' A' ' 190' ' ' HIS . 12.8 m -75.54 66.26 1.89 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.456 178.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.55 ' HB3' ' HD2' ' A' ' 186' ' ' PRO . 5.0 m -72.25 177.34 1.81 Allowed Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.107 179.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.729 ' HD3' ' HB2' ' A' ' 122' ' ' GLU . 71.1 Cg_exo -49.4 98.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.804 2.336 . . . . 0.0 113.198 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 32.3 m170 -130.79 22.73 5.0 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.735 -179.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.97 -78.56 1.26 Allowed Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.818 -177.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 9.7 tmtm? -71.92 -23.92 61.55 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.402 0.62 . . . . 0.0 109.623 177.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . 0.488 ' CG ' ' HB3' ' A' ' 184' ' ' SER . 91.2 m-70 -107.17 144.5 33.82 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.774 175.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 138.34 19.8 0.52 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.052 -175.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -135.7 88.18 2.38 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.436 ' HG3' ' OD1' ' A' ' 123' ' ' ASP . 5.0 tmm_? -70.05 -35.29 74.16 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.399 -174.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.48 ' ND2' ' HG2' ' A' ' 116' ' ' PRO . 46.5 t30 -147.41 -51.43 0.19 Allowed 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.83 -177.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 15.6 m -89.91 160.77 16.27 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 175.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -123.29 131.08 53.54 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.474 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 7.5 t 65.78 -167.79 0.21 Allowed 'General case' 0 CA--C 1.533 0.315 0 O-C-N 123.852 0.72 . . . . 0.0 110.838 176.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -88.67 133.97 34.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.721 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -156.14 117.17 0.76 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.468 177.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.499 HG22 ' HG3' ' A' ' 202' ' ' GLU . 70.9 mt 72.21 107.43 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.332 0 CA-C-O 121.359 0.6 . . . . 0.0 112.366 173.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -85.86 119.34 1.86 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.231 2.621 . . . . 0.0 111.816 174.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.499 ' HG3' HG22 ' A' ' 200' ' ' ILE . 47.0 mt-10 -135.41 154.14 78.32 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.645 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -80.69 15.62 1.76 Allowed 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 123.244 2.629 . . . . 0.0 112.408 179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -73.16 123.15 23.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.992 0.425 . . . . 0.0 110.817 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -119.58 126.88 52.26 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.491 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 207' ' ' TYR . . . -69.79 155.79 40.0 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.361 179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' TYR . . . . . 0.447 ' HB2' ' O ' ' A' ' 206' ' ' ALA . 45.0 m-85 73.42 -11.91 0.87 Allowed 'General case' 0 N--CA 1.471 0.597 0 O-C-N 123.847 0.717 . . . . 0.0 111.861 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -91.12 103.52 16.2 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.887 0.375 . . . . 0.0 110.294 178.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -109.38 147.25 35.65 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.61 -179.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 79.5 Cg_endo -85.97 11.17 3.41 Favored 'Trans proline' 0 N--CA 1.464 -0.245 0 C-N-CA 123.032 2.488 . . . . 0.0 112.551 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -129.64 147.42 51.43 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.101 -0.5 . . . . 0.0 109.663 -178.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 14.0 t -99.58 159.63 14.89 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.659 0.266 . . . . 0.0 110.62 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 18.0 m -74.83 124.58 27.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.797 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 17.4 m -88.03 113.36 54.51 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.403 177.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -71.51 119.4 6.22 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.575 2.184 . . . . 0.0 111.393 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.799 ' HB2' ' HD3' ' A' ' 217' ' ' PRO . 6.5 mp -65.61 -56.81 16.57 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.823 179.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.799 ' HD3' ' HB2' ' A' ' 216' ' ' LEU . 6.3 Cg_exo -78.69 135.35 12.81 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 121.981 1.787 . . . . 0.0 111.352 175.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -67.09 127.38 32.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.337 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 43.2 t -74.02 86.98 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.227 0.537 . . . . 0.0 111.536 -175.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 16.7 t -95.39 -24.93 16.48 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 170.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -170.73 -171.25 35.87 Favored Glycine 0 N--CA 1.445 -0.737 0 CA-C-N 114.593 -1.185 . . . . 0.0 110.229 178.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 14.4 p -100.97 130.9 24.12 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 117.519 0.66 . . . . 0.0 110.312 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -64.01 146.59 91.32 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.912 2.408 . . . . 0.0 112.304 -178.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 92.35 -87.44 1.26 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.835 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 68.23 -60.05 0.43 Allowed 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.698 0.799 . . . . 0.0 112.021 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . 68.02 108.01 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 123.436 0.694 . . . . 0.0 111.161 -177.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 48.5 mm -79.02 115.56 21.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.866 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.505 ' HA ' ' HD3' ' A' ' 229' ' ' PRO . 8.7 t -57.65 130.23 81.6 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.433 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.505 ' HD3' ' HA ' ' A' ' 228' ' ' THR . 16.4 Cg_exo -67.25 96.96 0.41 Allowed 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.906 2.404 . . . . 0.0 112.407 -177.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 98.4 mt -86.02 118.77 71.06 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.157 178.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.89 -54.7 4.37 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 123.136 2.558 . . . . 0.0 112.297 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 14.2 p -138.57 -72.25 0.41 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.398 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 73.4 p 47.68 43.28 16.46 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.806 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -77.83 96.44 4.96 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.185 -177.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 34.7 m-80 -96.6 20.11 11.28 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.958 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 83.81 139.78 4.09 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.326 -176.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -66.43 113.6 2.75 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.135 1.89 . . . . 0.0 110.732 177.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.68 HG12 HD11 ' A' ' 293' ' ' ILE . 2.8 t -90.18 145.0 7.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.557 -176.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.504 ' HD1' HD22 ' A' ' 298' ' ' ASN . 77.1 m-85 -116.28 124.77 51.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.291 0.567 . . . . 0.0 112.302 -172.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.61 ' HB2' HD12 ' A' ' 293' ' ' ILE . . . -119.48 149.85 41.21 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.919 175.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -106.65 123.72 48.54 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 173.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . 0.505 ' O ' ' HA ' ' A' ' 260' ' ' VAL . . . -68.34 97.24 0.72 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.92 0.391 . . . . 0.0 110.304 -178.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.471 HD13 ' HB2' ' A' ' 292' ' ' LYS . 27.1 pt -86.29 -24.39 6.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.077 -177.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.39 123.85 38.88 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 176.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -53.98 138.63 36.56 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.38 0.609 . . . . 0.0 111.598 -173.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 28.4 tpt180 -123.32 111.63 16.63 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.161 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.442 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 23.6 m -115.95 144.22 32.34 Favored Pre-proline 0 C--N 1.318 -0.802 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.264 177.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 247' ' ' VAL . 4.4 Cg_exo -75.09 121.87 6.81 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.478 2.119 . . . . 0.0 110.953 177.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 18.2 t -75.42 -178.41 4.02 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.105 -177.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -59.23 -23.62 62.48 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.289 0.478 . . . . 0.0 112.289 -176.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 9.9 p90 -107.0 4.9 27.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.621 -177.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -96.3 112.88 24.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.773 0.32 . . . . 0.0 110.808 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -106.75 -37.82 6.29 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.014 176.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 24.8 p -99.41 19.97 14.6 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.708 -176.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -93.36 145.09 24.72 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.057 0.456 . . . . 0.0 111.164 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -93.78 135.79 34.73 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.921 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . . . . . . . . . . . -91.91 122.09 34.11 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.162 177.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 81.4 mt -129.43 135.74 49.05 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 -175.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -99.38 161.86 13.37 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 175.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 36.4 t -73.21 109.06 5.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.642 -178.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 120.35 -0.77 12.78 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.716 178.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -89.73 160.34 16.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.943 0.372 . . . . 0.0 110.131 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 30.1 mm -103.65 116.75 47.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.184 0.516 . . . . 0.0 110.733 -176.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 13.7 t -97.8 109.66 23.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.476 -178.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 9.4 ptmt -93.35 102.47 14.73 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.274 175.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.443 HG13 ' HB ' ' A' ' 238' ' ' VAL . 2.3 p -93.22 128.54 44.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.333 178.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.23 -39.33 7.69 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.149 -176.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . 0.499 ' HB2' ' CG ' ' A' ' 276' ' ' GLU . 63.2 mtt85 -128.11 127.27 42.75 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 120.979 0.418 . . . . 0.0 110.498 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' MET . . . . . 0.501 ' HE2' ' CZ3' ' A' ' 275' ' ' TRP . 43.4 mtt -105.36 140.11 38.97 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.342 -176.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.413 ' HB2' ' OD1' ' A' ' 272' ' ' ASN . 34.6 m-80 -106.94 169.08 8.76 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.477 177.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 18.4 pt -98.24 9.36 7.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.156 0.503 . . . . 0.0 111.162 -176.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . 0.413 ' OD1' ' HB2' ' A' ' 270' ' ' ASN . 30.1 p-10 -87.69 -20.87 25.67 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.995 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 114.83 -12.39 20.43 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.386 -178.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.411 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 26.0 mt-30 -116.98 122.5 44.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.085 0.469 . . . . 0.0 110.373 177.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.501 ' CZ3' ' HE2' ' A' ' 269' ' ' MET . 6.6 m0 -99.02 169.22 9.58 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.943 -0.572 . . . . 0.0 109.807 -176.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.499 ' CG ' ' HB2' ' A' ' 268' ' ' ARG . 0.0 OUTLIER -101.36 115.76 31.24 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 121.536 0.684 . . . . 0.0 110.324 174.882 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -119.57 146.85 18.17 Favored Glycine 0 N--CA 1.44 -1.094 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.167 177.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -109.88 106.58 16.21 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 60.9 t -131.85 125.37 55.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.829 0.347 . . . . 0.0 111.025 -171.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 58.74 27.77 16.41 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.336 175.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 91.02 -4.25 81.28 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.721 177.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 19.3 mtp-105 -113.55 120.2 40.13 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.467 ' HE3' ' HB2' ' A' ' 283' ' ' LYS . 15.1 ptmt -111.39 138.71 47.53 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.24 0.543 . . . . 0.0 110.611 175.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -173.45 -169.73 36.17 Favored Glycine 0 N--CA 1.444 -0.777 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.435 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 87.4 mt -90.41 134.14 34.54 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.981 0.419 . . . . 0.0 110.734 -178.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -133.7 137.74 29.41 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.983 176.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -78.06 130.91 10.6 Favored 'Trans proline' 0 C--O 1.237 0.467 0 C-N-CA 122.647 2.231 . . . . 0.0 112.042 178.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.499 ' HA ' HG22 ' A' ' 291' ' ' VAL . 35.6 p90 -62.33 -17.91 60.04 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.911 0.386 . . . . 0.0 110.731 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.39 -20.18 65.32 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.888 -0.597 . . . . 0.0 112.099 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -105.66 -5.69 19.82 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 120.713 0.292 . . . . 0.0 111.601 -176.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.499 HG22 ' HA ' ' A' ' 288' ' ' PHE . 33.7 m -123.43 166.26 18.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 120.987 0.422 . . . . 0.0 110.676 -177.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . 0.471 ' HB2' HD13 ' A' ' 243' ' ' ILE . 39.9 tptt -122.4 107.25 11.85 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 177.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.68 HD11 HG12 ' A' ' 238' ' ' VAL . 4.2 tp -74.54 135.36 27.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -157.14 -29.33 0.09 Allowed 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.321 -0.552 . . . . 0.0 112.042 -175.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.477 ' HA ' ' HB2' ' A' ' 239' ' ' PHE . 32.5 m-20 60.79 97.22 0.04 OUTLIER Pre-proline 0 N--CA 1.464 0.227 0 CA-C-O 121.056 0.455 . . . . 0.0 110.613 -176.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.57 50.05 2.27 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.841 2.361 . . . . 0.0 112.486 -177.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 60.45 50.76 5.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.721 0.772 . . . . 0.0 109.292 -177.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . 0.504 HD22 ' HD1' ' A' ' 239' ' ' PHE . 17.5 p30 -53.28 138.38 48.21 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 114.21 -1.359 . . . . 0.0 111.713 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 298' ' ' ASN . 5.9 Cg_endo -88.39 6.65 4.74 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 123.335 2.69 . . . . 0.0 112.892 -176.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -68.02 119.25 12.34 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.52 178.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 40.23 48.65 2.33 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 124.487 1.117 . . . . 0.0 112.148 -176.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 23.3 p-10 -79.73 3.07 20.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.773 178.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.327 -0.844 . . . . 0.0 110.468 -178.746 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.5 ttm . . . . . 0 N--CA 1.48 1.048 0 CA-C-O 120.636 0.255 . . . . 0.0 110.43 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.8 m -119.46 116.31 25.86 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.358 177.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.3 p -70.98 -25.94 62.92 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.54 0.686 . . . . 0.0 109.767 174.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -79.79 93.44 5.6 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.122 175.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -115.27 90.34 3.31 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.597 0.713 . . . . 0.0 111.014 -178.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.482 ' CE1' ' HE2' ' A' ' 89' ' ' LYS . 32.1 p90 -160.66 151.67 18.83 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.446 -1.252 . . . . 0.0 108.482 177.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -80.46 115.46 20.0 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 177.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 22.3 m -67.29 -9.01 36.55 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -173.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 8.7 t -106.86 -24.43 12.05 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.308 -176.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -63.39 98.83 0.17 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.028 0.442 . . . . 0.0 110.874 -174.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.457 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 2.9 tpp180 -57.11 -43.41 82.25 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.402 -176.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 66.0 m -75.74 7.0 4.21 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -177.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -95.75 -46.28 6.65 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.613 0.244 . . . . 0.0 110.749 173.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.469 ' HB3' ' HB3' ' A' ' 101' ' ' PRO . 34.7 p-90 -121.68 -26.66 4.85 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -173.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.457 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 60.8 t80 -75.32 107.98 7.79 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.335 0.588 . . . . 0.0 110.03 -176.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.461 ' SD ' ' HG2' ' A' ' 104' ' ' ARG . 5.4 tpp -91.4 -9.53 44.41 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.993 -174.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 39' ' ' ARG . . . 50.5 -112.66 1.66 Allowed Glycine 0 C--N 1.333 0.399 0 O-C-N 123.839 0.712 . . . . 0.0 114.293 175.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -74.16 93.66 0.89 Allowed 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.473 2.115 . . . . 0.0 112.461 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.473 ' O ' ' CB ' ' A' ' 20' ' ' SER . 7.3 t -125.7 -77.02 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-O 118.138 -0.934 . . . . 0.0 110.954 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.473 ' CB ' ' O ' ' A' ' 19' ' ' VAL . 32.3 t 125.86 156.39 0.0 OUTLIER 'General case' 0 C--N 1.355 0.84 0 C-N-CA 124.973 1.309 . . . . 0.0 108.311 168.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.52 ' HA ' ' NH2' ' A' ' 39' ' ' ARG . 21.1 tpt180 -52.91 -52.33 58.1 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.746 0.308 . . . . 0.0 111.003 178.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -64.77 -33.89 77.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.111 -176.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.636 ' HG2' ' HE ' ' A' ' 27' ' ' ARG . 24.8 tt0 -82.57 -45.99 13.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.929 0.395 . . . . 0.0 110.898 -177.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -55.49 -38.29 68.96 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.132 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 55.0 tp60 -60.9 -47.52 86.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.342 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.6 t -78.27 -22.66 47.95 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 121.056 -0.258 . . . . 0.0 111.166 -175.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.636 ' HE ' ' HG2' ' A' ' 23' ' ' GLU . 63.9 mtt180 -68.59 -21.19 64.53 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 120.662 0.268 . . . . 0.0 110.565 177.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.575 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 95.3 mt -125.93 6.96 7.32 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.154 -0.475 . . . . 0.0 112.276 -176.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -82.89 110.91 18.29 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 122.129 -0.357 . . . . 0.0 110.933 -178.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.413 ' H ' ' HA ' ' A' ' 56' ' ' SER . . . 69.77 18.66 74.33 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.841 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.564 ' HG3' ' HA ' ' A' ' 28' ' ' LEU . 12.2 mm100 -83.34 -168.33 2.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.604 0.24 . . . . 0.0 110.607 -178.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.562 ' HB2' ' SD ' ' A' ' 35' ' ' MET . 46.3 mtm180 -58.31 141.98 49.4 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 173.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 63.6 m170 -88.33 122.22 31.6 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 120.847 0.356 . . . . 0.0 110.495 -177.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 118.75 -5.73 14.1 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.738 -0.664 . . . . 0.0 111.91 -175.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.67 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 34.1 mtp -80.3 146.81 31.43 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 122.451 0.3 . . . . 0.0 110.74 177.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -151.81 161.31 42.87 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 121.118 -0.233 . . . . 0.0 110.931 178.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.53 ' HG ' HD11 ' A' ' 28' ' ' LEU . 4.5 pp -154.75 140.99 18.57 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.057 0.456 . . . . 0.0 111.229 176.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 51.8 t -110.99 112.29 39.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.547 176.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.542 ' HD3' ' O ' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -113.99 -179.3 3.6 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 178.345 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.542 ' O ' ' HD3' ' A' ' 39' ' ' ARG . 4.1 m-20 -66.97 137.83 56.81 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 175.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.545 ' HA ' HG23 ' A' ' 49' ' ' VAL . 46.7 t -54.4 141.74 29.44 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.179 0.514 . . . . 0.0 111.281 -178.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.2 m -85.53 -13.07 50.12 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.087 -176.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.46 HG21 ' HB2' ' A' ' 196' ' ' ASN . 22.4 p -125.1 -44.68 1.89 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -174.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.436 ' HA ' ' HD2' ' A' ' 45' ' ' PRO . 3.0 p -114.66 102.36 54.8 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-O 120.858 0.361 . . . . 0.0 111.559 -176.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.436 ' HD2' ' HA ' ' A' ' 44' ' ' CYS . 10.8 Cg_endo -54.59 139.03 76.06 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.881 2.387 . . . . 0.0 111.908 177.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.1 -32.38 7.37 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.251 -177.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -87.42 175.18 8.1 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.856 0.36 . . . . 0.0 110.201 177.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.459 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 38.2 m-85 -131.39 174.28 10.23 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.861 178.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.545 HG23 ' HA ' ' A' ' 41' ' ' SER . 65.0 t -142.47 106.67 1.39 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-O 120.969 0.414 . . . . 0.0 110.952 177.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 36.6 tp -78.42 104.75 9.22 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.148 175.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 16.7 m -96.33 132.8 41.46 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 176.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.643 HG21 HD13 ' A' ' 93' ' ' LEU . 86.9 t -124.49 136.27 61.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.882 0.372 . . . . 0.0 111.158 -175.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.575 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 32.2 t -96.38 104.86 16.86 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.982 -0.554 . . . . 0.0 112.207 -172.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.795 ' O ' ' HB3' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -152.8 151.74 30.8 Favored 'General case' 0 C--O 1.204 -1.332 0 C-N-CA 120.287 -0.565 . . . . 0.0 109.704 169.245 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.579 ' HB2' ' HD3' ' A' ' 57' ' ' ARG . 54.9 m-80 56.76 22.76 7.23 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 178.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.413 ' HA ' ' H ' ' A' ' 30' ' ' GLY . 46.8 m 54.06 54.8 9.12 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 122.801 1.286 . . . . 0.0 107.964 -172.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.795 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 0.2 OUTLIER -161.96 65.94 0.25 Allowed 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 112.873 -1.967 . . . . 0.0 109.353 -151.168 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.616 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 18.6 t -72.54 97.11 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 CA-C-O 121.865 0.841 . . . . 0.0 109.789 -170.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.7 m -68.32 121.12 15.61 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 113.88 -1.509 . . . . 0.0 110.96 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 94.2 m-70 -100.15 107.12 18.91 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.811 0.339 . . . . 0.0 111.491 -176.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.741 ' HE1' HD11 ' A' ' 153' ' ' ILE . 72.8 m-85 -102.34 107.04 17.92 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.128 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.528 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 63.8 mt -80.4 129.37 37.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -174.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.503 HG23 ' HB3' ' A' ' 71' ' ' PHE . 5.0 mp -104.28 114.97 45.31 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.392 178.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -87.76 139.41 30.56 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.744 -173.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 31.3 t -81.86 95.05 7.2 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 169.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.566 HD11 ' HB2' ' A' ' 72' ' ' LYS . 91.9 mt -74.63 148.45 85.37 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.996 -176.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.67 -14.85 45.23 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.682 2.255 . . . . 0.0 110.617 171.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -73.35 -3.01 24.55 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.831 -1.077 . . . . 0.0 109.847 176.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.493 ' HA ' ' NE ' ' A' ' 69' ' ' ARG . 3.7 mmp_? 66.38 26.27 10.21 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.291 0.567 . . . . 0.0 110.049 -173.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 47.7 mtp180 -123.76 -179.64 4.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.599 -177.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.503 ' HB3' HG23 ' A' ' 63' ' ' ILE . 29.2 m-85 -127.87 115.9 19.31 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.874 0.324 . . . . 0.0 111.874 -173.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 77' ' ' GLU . 38.6 ttmt -102.09 116.47 32.76 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.188 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.619 HD11 ' HB3' ' A' ' 61' ' ' TYR . 11.7 tt -94.7 93.04 3.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.707 0.765 . . . . 0.0 110.773 -178.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 60.62 69.92 1.16 Allowed Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 115.438 -0.801 . . . . 0.0 113.075 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.524 ' HA ' ' HD3' ' A' ' 72' ' ' LYS . 31.4 t70 75.47 -38.76 0.37 Allowed 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.139 0.576 . . . . 0.0 112.354 176.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -80.83 114.22 19.57 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 177.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.573 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 9.5 pt-20 -95.07 134.33 37.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.681 0.753 . . . . 0.0 112.177 -174.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -119.27 179.03 4.31 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.528 171.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.24 -32.4 22.61 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 -175.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -161.68 167.66 24.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.673 0.273 . . . . 0.0 111.074 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.613 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 14.5 mt -53.94 -56.47 25.3 Favored Pre-proline 0 N--CA 1.467 0.398 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.403 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.613 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 29.7 Cg_exo -65.94 2.17 1.89 Allowed 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.409 2.072 . . . . 0.0 113.204 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -98.7 -34.91 10.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.839 0.352 . . . . 0.0 110.567 176.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.2 pp -76.56 -33.9 58.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.134 0.492 . . . . 0.0 109.78 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.457 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 72.8 mt -67.89 -14.76 63.22 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.185 176.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -88.94 -40.2 13.22 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.247 -178.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -71.77 -28.97 63.99 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.784 -178.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.435 ' CG ' HD21 ' A' ' 93' ' ' LEU . 20.7 m-85 -84.58 -2.5 57.49 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -177.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.482 ' HE2' ' CE1' ' A' ' 6' ' ' PHE . 98.8 mttt -73.3 -6.89 48.96 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.664 -0.244 . . . . 0.0 111.099 174.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.6 pt -132.91 -6.45 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.232 0 CA-C-O 120.938 0.399 . . . . 0.0 110.573 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -93.16 -34.19 13.72 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.516 -171.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 70.87 128.36 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.159 0 O-C-N 124.411 1.07 . . . . 0.0 109.956 -169.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.643 HD13 HG21 ' A' ' 52' ' ' VAL . 0.9 OUTLIER -103.75 -14.96 15.88 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.767 0.794 . . . . 0.0 109.783 173.084 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.863 ' HA ' ' HB3' ' A' ' 154' ' ' GLU . 1.5 m-20 -133.22 -100.01 0.27 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.613 -177.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.725 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 14.0 t -134.13 14.76 3.87 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 106.492 -1.67 . . . . 0.0 106.492 165.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.537 HG22 ' HG3' ' A' ' 54' ' ' GLU . 3.8 t -140.84 169.88 16.8 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 113.962 -1.472 . . . . 0.0 107.403 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 17.6 p -104.11 -179.38 3.93 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 176.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 74.2 mt -68.39 88.59 0.33 Allowed 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 175.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 48.9 mm -78.25 -54.98 11.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.137 -173.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.67 ' O ' ' HA ' ' A' ' 35' ' ' MET . 39.7 tt0 -160.09 136.71 6.53 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.925 -177.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.469 ' HB3' ' HB3' ' A' ' 14' ' ' TRP . 18.2 Cg_endo -59.9 158.95 27.04 Favored 'Trans proline' 0 CA--C 1.531 0.325 0 C-N-CA 122.793 2.329 . . . . 0.0 112.743 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.567 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -75.17 145.4 80.35 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.844 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -55.66 130.93 43.08 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.634 2.223 . . . . 0.0 111.514 174.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.461 ' HG2' ' SD ' ' A' ' 16' ' ' MET . 78.3 mtp180 -76.56 -40.58 49.31 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.248 -174.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -140.75 100.43 6.66 Favored Pre-proline 0 C--N 1.325 -0.476 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -73.3 70.93 3.82 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 123.284 2.656 . . . . 0.0 113.004 -176.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.893 ' HB3' ' HD3' ' A' ' 108' ' ' PRO . 47.2 t -93.23 -61.48 0.19 Allowed Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 173.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.893 ' HD3' ' HB3' ' A' ' 107' ' ' SER . 24.2 Cg_exo -65.59 -55.78 0.4 Allowed 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 121.851 1.701 . . . . 0.0 112.951 171.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.556 ' HD3' ' HB2' ' A' ' 108' ' ' PRO . 8.4 Cg_exo -72.01 107.01 2.13 Favored 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 121.662 1.575 . . . . 0.0 111.389 177.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 25.9 ttt -145.44 158.6 43.81 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -178.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 100.58 -81.74 0.49 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.477 -0.868 . . . . 0.0 112.145 -179.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 55.0 p -80.41 39.59 0.47 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.927 0.394 . . . . 0.0 111.047 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.406 HG13 ' N ' ' A' ' 114' ' ' SER . 3.3 p -65.47 -54.47 28.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.286 -176.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.406 ' N ' HG13 ' A' ' 113' ' ' VAL . 0.9 OUTLIER -97.63 36.66 1.47 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.183 0.516 . . . . 0.0 111.23 -178.773 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.46 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . . . -97.86 107.59 41.21 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.915 176.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 115' ' ' ALA . 7.1 Cg_endo -86.43 -177.47 2.39 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 123.195 2.596 . . . . 0.0 112.56 -175.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' A' ' 118' ' ' LEU . 2.1 m-20 -104.79 102.99 12.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.816 179.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.409 ' HB2' ' O ' ' A' ' 117' ' ' ASN . 10.5 mp 70.57 165.05 0.14 Allowed Pre-proline 0 CA--C 1.535 0.389 0 O-C-N 123.597 0.56 . . . . 0.0 111.492 176.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -73.37 17.5 0.43 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.311 2.674 . . . . 0.0 113.217 178.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 6.8 m -76.18 83.29 3.0 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 178.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -172.98 175.57 3.23 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.49 -177.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.458 ' HB3' ' H ' ' A' ' 123' ' ' ASP . 42.1 mt-10 61.57 -149.48 0.4 Allowed 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.056 -0.975 . . . . 0.0 113.627 169.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.458 ' H ' ' HB3' ' A' ' 122' ' ' GLU . 9.3 t70 78.18 -61.76 0.37 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.646 -173.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.635 ' CG ' ' H ' ' A' ' 125' ' ' LEU . 4.0 p30 -176.12 -101.53 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 172.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.742 HD12 HG21 ' A' ' 152' ' ' ILE . 4.0 mm? 64.35 96.61 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 122.128 0.966 . . . . 0.0 112.686 168.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -169.6 -60.37 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 113.866 -1.516 . . . . 0.0 107.614 -176.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.437 ' HD2' ' CG1' ' A' ' 182' ' ' VAL . 43.1 m-85 -123.0 133.48 54.36 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.95 176.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.541 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 23.7 t -133.18 160.86 42.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.757 ' HG2' ' O ' ' A' ' 180' ' ' LYS . 2.0 ptp180 -138.39 138.03 37.86 Favored 'General case' 0 CA--C 1.494 -1.2 0 C-N-CA 120.286 -0.566 . . . . 0.0 109.924 171.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.869 HG22 HG12 ' A' ' 178' ' ' VAL . 30.4 p -92.75 140.44 29.52 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.566 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.5 mt -114.06 -5.08 13.11 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.82 -172.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.491 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 59.7 t80 -107.21 -42.68 4.79 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -171.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.716 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 16.1 t70 79.79 93.5 0.05 Allowed 'General case' 0 N--CA 1.474 0.73 0 O-C-N 123.778 0.673 . . . . 0.0 110.63 -173.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.585 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 68.4 t80 -124.07 88.06 52.89 Favored Pre-proline 0 N--CA 1.45 -0.436 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 172.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.573 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 95.4 Cg_endo -84.55 84.82 1.42 Allowed 'Trans proline' 0 N--CA 1.442 -1.551 0 C-N-CA 121.488 1.459 . . . . 0.0 112.239 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.54 -25.0 75.26 Favored Glycine 0 N--CA 1.45 -0.412 0 N-CA-C 110.379 -1.088 . . . . 0.0 110.379 173.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.677 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 19.8 m120 53.68 72.09 0.46 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.214 -0.993 . . . . 0.0 111.17 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -141.88 173.11 11.81 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.483 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -100.33 12.03 38.07 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 175.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -127.57 -36.64 2.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 114.048 -1.433 . . . . 0.0 109.261 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -113.77 128.04 56.26 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 173.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.985 HD11 ' HB2' ' A' ' 165' ' ' ASN . 32.4 tp -83.29 124.72 75.73 Favored Pre-proline 0 C--N 1.325 -0.489 0 C-N-CA 120.178 -0.609 . . . . 0.0 111.457 -176.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.677 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 57.4 Cg_endo -76.31 102.41 1.61 Allowed 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 121.71 1.607 . . . . 0.0 111.673 167.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.585 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 0.5 OUTLIER -92.03 -163.84 1.1 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.938 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.716 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 55.4 mttp -134.8 -176.02 4.09 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.114 175.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.804 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -77.61 39.61 0.28 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.481 0.657 . . . . 0.0 111.382 -174.641 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 130' ' ' THR . . . 136.05 49.16 0.07 OUTLIER Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 -176.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.676 ' OE2' ' HG ' ' A' ' 150' ' ' LEU . 1.2 pp20? -92.28 179.26 5.6 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.514 HD11 ' NH2' ' A' ' 129' ' ' ARG . 1.3 mp -118.48 124.48 73.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 175.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.742 ' CD2' ' HA ' ' A' ' 165' ' ' ASN . 72.5 mt -118.91 156.44 29.52 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.405 0.621 . . . . 0.0 109.691 -172.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.568 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 52.4 t -118.49 122.95 70.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.166 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 173.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.949 HD13 ' HB2' ' A' ' 163' ' ' ALA . 46.5 mm -77.54 79.61 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.468 0 CA-C-O 122.519 1.152 . . . . 0.0 108.964 -175.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.741 HD11 ' HE1' ' A' ' 61' ' ' TYR . 21.0 tt -65.87 -27.31 40.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 CA-C-N 113.107 -1.86 . . . . 0.0 109.852 -176.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.863 ' HB3' ' HA ' ' A' ' 94' ' ' ASP . 0.2 OUTLIER -145.83 146.45 31.15 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-O 121.143 0.497 . . . . 0.0 110.957 171.248 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.57 ' HD2' ' HG ' ' A' ' 125' ' ' LEU . 86.3 tttt -126.14 87.69 55.68 Favored Pre-proline 0 C--N 1.319 -0.758 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 168.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.725 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 5.4 Cg_exo -81.58 -51.55 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.993 2.462 . . . . 0.0 111.721 175.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.683 ' HG2' ' CE ' ' A' ' 172' ' ' MET . 6.1 mm-40 -97.39 160.75 14.14 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.094 0.474 . . . . 0.0 111.049 -175.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -85.25 -33.14 22.25 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.914 175.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -92.82 -17.15 24.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.399 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.427 ' HB2' ' HB2' ' A' ' 157' ' ' GLU . 62.7 m95 -127.41 124.17 37.86 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.116 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . 0.562 ' O ' HG13 ' A' ' 173' ' ' ILE . 45.9 m0 -110.67 136.27 50.02 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.707 ' OG ' ' HG2' ' A' ' 172' ' ' MET . 38.0 m -97.35 109.09 21.92 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -173.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.949 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -122.85 152.1 41.07 Favored 'General case' 0 N--CA 1.426 -1.657 0 C-N-CA 119.888 -0.725 . . . . 0.0 110.405 -174.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.831 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 9.8 ptt180 -87.69 126.88 35.23 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 171.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.985 ' HB2' HD11 ' A' ' 142' ' ' LEU . 64.2 t30 -60.31 178.09 0.22 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.306 -1.315 . . . . 0.0 111.406 -172.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 19.5 tttp -58.15 -11.99 3.1 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.866 167.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -89.84 -27.65 19.79 Favored 'General case' 0 CA--C 1.529 0.162 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.393 174.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 105.07 -0.81 41.04 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.729 -175.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.831 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 3.3 ttm-85 -76.11 140.02 41.61 Favored 'General case' 0 C--O 1.217 -0.61 0 C-N-CA 123.324 0.65 . . . . 0.0 112.008 -177.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.529 HG22 HD13 ' A' ' 153' ' ' ILE . 48.1 t -87.21 123.52 40.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 111.353 0.131 . . . . 0.0 111.353 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -158.12 151.9 23.05 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.258 172.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.707 ' HG2' ' OG ' ' A' ' 162' ' ' SER . 36.8 mtp -81.37 142.73 32.75 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 116.885 0.342 . . . . 0.0 110.583 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 1.001 HD13 HG11 ' A' ' 178' ' ' VAL . 2.8 pp -143.24 150.63 52.72 Favored Pre-proline 0 C--O 1.222 -0.349 0 O-C-N 123.442 0.464 . . . . 0.0 111.119 -178.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.503 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 6.7 Cg_exo -72.82 132.1 18.05 Favored 'Trans proline' 0 CA--C 1.529 0.241 0 C-N-CA 122.387 2.058 . . . . 0.0 112.615 -176.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.555 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 18.3 t -57.9 -43.1 98.31 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 178.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 32.8 Cg_endo -64.84 -2.36 5.33 Favored 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 122.049 1.833 . . . . 0.0 113.116 176.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.503 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 4.5 m-85 -98.2 -18.45 18.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.71 177.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 1.001 HG11 HD13 ' A' ' 173' ' ' ILE . 2.2 m -130.68 -172.32 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.102 -168.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.879 ' HG3' ' H ' ' A' ' 180' ' ' LYS . 8.7 pt-20 -156.34 -65.67 0.11 Allowed 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 117.404 2.372 . . . . 0.0 117.404 152.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.879 ' H ' ' HG3' ' A' ' 179' ' ' GLU . 4.2 mptt -157.59 -177.54 6.66 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 119.153 0.888 . . . . 0.0 109.891 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.42 ' HG ' ' NH2' ' A' ' 129' ' ' ARG . 0.1 OUTLIER -128.71 -68.67 0.74 Allowed 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 153.421 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.437 ' CG1' ' HD2' ' A' ' 127' ' ' TYR . 4.1 p -108.74 99.78 9.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.494 0.664 . . . . 0.0 109.296 171.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.656 ' HB2' ' HG2' ' A' ' 180' ' ' LYS . 68.5 ttt180 -86.94 99.81 12.14 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.44 -0.504 . . . . 0.0 110.458 -176.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 18.6 m -84.14 95.33 8.59 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.87 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.413 ' HB2' ' HD2' ' A' ' 186' ' ' PRO . 3.3 p -74.8 167.6 34.94 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.258 177.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.413 ' HD2' ' HB2' ' A' ' 185' ' ' SER . 74.0 Cg_exo -49.11 105.6 0.1 OUTLIER 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.971 2.448 . . . . 0.0 113.294 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -131.55 -27.69 1.92 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.758 175.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 124.04 -70.42 0.45 Allowed Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 110.191 -1.163 . . . . 0.0 110.191 -176.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 16.2 pttm -135.87 133.75 38.07 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 171.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -86.92 -49.45 7.37 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.078 0.466 . . . . 0.0 110.112 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 132.22 111.69 1.35 Allowed Glycine 0 N--CA 1.443 -0.893 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 -175.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -87.96 99.25 12.01 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -177.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 193' ' ' ARG . 12.4 ttt180 -66.39 -55.39 16.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.345 -177.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 65.59 123.69 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.552 0 O-C-N 123.732 0.645 . . . . 0.0 109.962 -172.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 46.6 m -138.11 24.42 2.77 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.127 0.489 . . . . 0.0 111.639 -175.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . 0.46 ' HB2' HG21 ' A' ' 43' ' ' THR . 15.5 m120 -86.51 157.13 19.84 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.567 175.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 11.6 t -168.94 -165.85 0.59 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -176.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 65.9 -171.12 0.19 Allowed 'General case' 0 N--CA 1.466 0.365 0 O-C-N 123.764 0.665 . . . . 0.0 110.688 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 84.32 80.33 1.07 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.42 179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.459 ' N ' HD13 ' A' ' 200' ' ' ILE . 0.1 OUTLIER -123.72 96.8 42.62 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-O 121.226 0.536 . . . . 0.0 110.7 178.88 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -76.21 -15.5 18.12 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.506 2.138 . . . . 0.0 112.473 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 65.17 101.99 0.04 OUTLIER Pre-proline 0 N--CA 1.463 0.204 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.194 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.75 118.02 4.91 Favored 'Trans proline' 0 C--O 1.236 0.415 0 C-N-CA 122.595 2.197 . . . . 0.0 111.321 176.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -138.53 -67.81 0.46 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.462 -176.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 -79.31 87.61 4.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.188 0.518 . . . . 0.0 110.703 -177.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -118.24 -5.97 10.86 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.778 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -115.82 114.65 25.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.185 0.517 . . . . 0.0 111.337 -178.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -150.47 123.99 9.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.829 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.451 ' HA ' ' HD3' ' A' ' 210' ' ' PRO . 9.6 tt0 -94.98 115.83 65.76 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 116.548 -0.296 . . . . 0.0 110.348 -179.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 209' ' ' GLN . 7.7 Cg_exo -72.65 100.32 1.15 Allowed 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.749 2.3 . . . . 0.0 112.105 -179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -108.14 3.13 23.47 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.282 178.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.578 HG23 HD11 ' A' ' 216' ' ' LEU . 16.8 m -77.13 79.42 3.66 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-O 121.215 0.531 . . . . 0.0 110.922 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 10.4 p -91.27 -72.32 0.59 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.546 172.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.724 ' N ' ' HD3' ' A' ' 215' ' ' PRO . 12.1 t -161.77 27.37 0.03 OUTLIER Pre-proline 0 CA--C 1.552 1.03 0 N-CA-C 112.781 0.659 . . . . 0.0 112.781 173.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.724 ' HD3' ' N ' ' A' ' 214' ' ' THR . 94.6 Cg_endo -96.48 11.37 1.26 Allowed 'Trans proline' 0 C--N 1.362 1.28 0 C-N-CA 121.896 1.73 . . . . 0.0 112.293 -175.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.602 ' HB2' ' HD2' ' A' ' 217' ' ' PRO . 2.5 pp -157.17 165.98 17.63 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.758 -176.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.602 ' HD2' ' HB2' ' A' ' 216' ' ' LEU . 9.6 Cg_endo -51.87 -37.39 66.23 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.35 2.7 . . . . 0.0 113.377 -177.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . 67.84 13.27 9.15 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 122.875 0.47 . . . . 0.0 111.697 178.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 9.5 p -69.8 -26.86 31.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.342 0.591 . . . . 0.0 110.075 176.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 13.5 t -139.02 155.07 48.25 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -70.99 -42.18 59.98 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.365 -177.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 13.8 p -96.52 112.92 61.57 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-O 120.47 0.176 . . . . 0.0 110.958 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -66.44 113.08 2.55 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.684 2.256 . . . . 0.0 111.64 177.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -162.59 44.39 0.35 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 121.115 -0.564 . . . . 0.0 111.727 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -107.35 -23.59 12.16 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.103 0.477 . . . . 0.0 110.241 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -83.0 61.57 6.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.351 -179.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 62.5 mt -66.25 -36.71 78.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 176.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 19.1 m 68.11 95.93 0.05 OUTLIER Pre-proline 0 C--O 1.235 0.296 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.762 176.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -56.47 133.42 57.93 Favored 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.719 2.279 . . . . 0.0 111.608 177.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.632 HD23 ' H ' ' A' ' 230' ' ' LEU . 2.4 pt? -67.85 148.45 98.46 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.92 -177.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 230' ' ' LEU . 21.7 Cg_exo -66.07 176.81 3.5 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.878 2.385 . . . . 0.0 111.998 175.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 25.1 m -95.61 51.01 1.25 Allowed 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.012 0.434 . . . . 0.0 110.993 -176.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 2.8 p -74.89 104.06 5.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.019 0.438 . . . . 0.0 110.311 177.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -76.39 98.93 4.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.028 0.442 . . . . 0.0 111.48 -175.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -157.63 7.81 0.16 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.767 174.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 80.98 -175.92 54.73 Favored Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.108 -177.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.09 148.11 30.81 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.718 2.279 . . . . 0.0 111.02 174.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.499 ' CG1' HD12 ' A' ' 293' ' ' ILE . 66.8 t -77.06 123.83 34.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.92 0.391 . . . . 0.0 110.562 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -99.04 115.25 28.55 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.999 177.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.662 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -119.37 121.16 38.9 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.091 178.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.538 ' HB2' ' CE1' ' A' ' 294' ' ' PHE . 48.2 tttp -86.68 118.85 26.36 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -178.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -72.8 102.59 3.42 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.04 -0.356 . . . . 0.0 110.04 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.411 HG12 ' O ' ' A' ' 290' ' ' HIS . 9.6 pt -89.47 4.6 5.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 120.955 0.407 . . . . 0.0 111.142 -176.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -149.89 149.11 29.96 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 173.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 10.3 ptpp? -75.59 175.88 8.15 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.02 0.438 . . . . 0.0 111.169 -176.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.471 ' CB ' HG21 ' A' ' 289' ' ' THR . 21.4 tpt180 -157.08 127.41 6.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.979 -178.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 28.0 m -121.37 143.57 37.91 Favored Pre-proline 0 C--N 1.32 -0.706 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 171.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.432 ' HD3' ' HB2' ' A' ' 257' ' ' ALA . 38.0 Cg_endo -66.58 104.51 0.79 Allowed 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.179 1.919 . . . . 0.0 111.694 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' CYS . . . . . 0.433 ' H ' ' HB2' ' A' ' 252' ' ' ASP . 1.7 t -72.61 169.7 16.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.862 -178.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.74 -32.43 69.23 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.806 0.336 . . . . 0.0 111.609 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -95.08 -15.42 23.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.948 0.404 . . . . 0.0 110.886 177.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.464 ' HB3' ' HB2' ' A' ' 255' ' ' ALA . 60.3 m-20 -100.69 67.93 1.3 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.061 0.458 . . . . 0.0 110.071 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . 0.694 ' HD2' ' H ' ' A' ' 253' ' ' LYS . 0.0 OUTLIER -75.24 -33.99 61.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.291 -174.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.66 -1.04 57.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.554 -178.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.464 ' HB2' ' HB3' ' A' ' 252' ' ' ASP . . . -70.12 126.06 28.58 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.165 0.507 . . . . 0.0 111.81 -175.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.3 tt -71.77 134.16 46.02 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.315 176.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.432 ' HB2' ' HD3' ' A' ' 248' ' ' PRO . . . -84.92 128.95 34.85 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 89.4 mt -135.43 165.53 25.27 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.59 -172.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -129.49 -177.25 4.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.08 177.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 39.8 t -80.83 129.88 36.81 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.865 -178.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 80.37 11.81 83.8 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.654 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 28.8 t0 -87.14 140.28 29.71 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -176.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 38.5 mm -88.11 110.28 20.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.992 0.425 . . . . 0.0 110.561 -178.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 20.9 t -88.1 102.99 13.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.287 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 5.6 tppp? -79.44 95.1 5.69 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.232 177.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.483 HG13 ' HB ' ' A' ' 238' ' ' VAL . 4.5 p -99.88 117.42 45.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 121.384 0.612 . . . . 0.0 110.4 177.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . 0.524 ' OG1' ' HD2' ' A' ' 268' ' ' ARG . 20.2 p -104.19 -18.9 14.32 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.155 -179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . 0.524 ' HD2' ' OG1' ' A' ' 267' ' ' THR . 0.1 OUTLIER -130.48 91.79 3.15 Favored 'General case' 0 C--O 1.224 -0.281 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 176.847 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 6.5 ptp -98.56 130.51 45.12 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 119.531 -0.868 . . . . 0.0 111.028 177.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -103.28 150.1 24.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.011 -0.995 . . . . 0.0 111.153 -174.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.421 ' H ' HG13 ' A' ' 271' ' ' ILE . 1.8 pp -71.87 -5.8 6.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.419 0.628 . . . . 0.0 110.941 175.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -70.75 -21.03 62.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.087 178.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 110.93 -47.67 1.02 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.683 -178.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.493 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 59.1 mt-30 -80.18 121.13 25.2 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 174.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 34.2 m0 -103.36 149.98 24.24 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.454 ' HB3' ' HB2' ' A' ' 268' ' ' ARG . 34.3 tt0 -99.53 116.81 32.51 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.074 0.464 . . . . 0.0 109.929 179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . -139.94 164.44 26.12 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.829 -0.701 . . . . 0.0 111.934 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.529 ' HG2' ' HB2' ' A' ' 283' ' ' LYS . 37.2 mt-10 -123.42 109.85 14.38 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 25.6 t -123.62 -81.06 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 C-N-CA 120.354 -0.539 . . . . 0.0 111.793 -175.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -91.96 77.2 5.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.793 0.33 . . . . 0.0 111.284 -173.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 50.5 34.73 27.75 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 115.372 -0.831 . . . . 0.0 113.335 178.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 282' ' ' ARG . 34.0 ttt-85 -170.71 138.75 1.45 Allowed 'General case' 0 C--O 1.237 0.423 0 CA-C-O 120.895 0.379 . . . . 0.0 111.0 -173.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.529 ' HB2' ' HG2' ' A' ' 278' ' ' GLU . 38.2 ttpt -99.72 137.85 37.63 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.087 173.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -158.13 169.98 34.85 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.167 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.493 ' HB3' ' HB3' ' A' ' 274' ' ' GLN . 62.8 mt -97.59 113.3 25.0 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 176.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.736 ' HD2' ' H ' ' A' ' 289' ' ' THR . 49.4 p90 -113.72 125.31 29.68 Favored Pre-proline 0 C--N 1.315 -0.931 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.468 -177.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 35.0 Cg_exo -64.06 70.93 0.19 Allowed 'Trans proline' 0 N--CA 1.479 0.665 0 C-N-CA 123.709 2.939 . . . . 0.0 112.689 176.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.539 ' O ' ' N ' ' A' ' 290' ' ' HIS . 34.5 p90 37.96 40.55 0.3 Allowed 'General case' 0 CA--C 1.49 -1.355 0 O-C-N 124.447 1.092 . . . . 0.0 108.689 -171.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.736 ' H ' ' HD2' ' A' ' 286' ' ' PHE . 41.9 m -40.81 73.41 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.043 0 O-C-N 126.499 2.374 . . . . 0.0 112.995 -156.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . 0.539 ' N ' ' O ' ' A' ' 288' ' ' PHE . 16.4 m80 63.87 25.21 13.95 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 112.192 -2.276 . . . . 0.0 109.363 169.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.576 ' HB ' ' HB1' ' A' ' 240' ' ' ALA . 33.5 m -88.58 169.71 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.258 0 CA-C-O 121.41 0.624 . . . . 0.0 111.621 -173.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 21.4 tptm -129.69 114.36 15.91 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.115 178.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.662 HD13 ' HB2' ' A' ' 240' ' ' ALA . 50.2 mm -72.0 124.55 28.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.331 -178.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' PHE . . . . . 0.538 ' CE1' ' HB2' ' A' ' 241' ' ' LYS . 1.8 p90 -154.27 -176.01 5.67 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.178 -0.465 . . . . 0.0 109.984 -178.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.586 ' OD2' ' HB2' ' A' ' 297' ' ' GLN . 21.1 t70 -130.37 116.96 17.64 Favored Pre-proline 0 C--N 1.321 -0.665 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 172.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.62 -13.31 34.84 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.789 2.326 . . . . 0.0 112.508 -177.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . 0.586 ' HB2' ' OD2' ' A' ' 295' ' ' ASP . 18.1 mt-30 -72.27 -46.86 54.09 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.67 178.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . 0.408 ' HA ' ' HD3' ' A' ' 299' ' ' PRO . 0.3 OUTLIER -110.47 96.44 27.32 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-O 121.712 0.768 . . . . 0.0 110.723 171.8 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 298' ' ' ASN . 2.9 Cg_exo -76.57 35.96 0.49 Allowed 'Trans proline' 0 CA--C 1.528 0.211 0 C-N-CA 123.306 2.671 . . . . 0.0 113.272 -173.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -79.51 -65.64 0.97 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.696 0.284 . . . . 0.0 110.349 177.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -90.45 85.54 6.19 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.973 0.416 . . . . 0.0 110.738 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -178.57 141.24 0.21 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.356 174.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 . . . . . 0 C--O 1.246 0.895 0 CA-C-O 118.295 -0.859 . . . . 0.0 110.55 177.625 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.4 tpp . . . . . 0 N--CA 1.481 1.119 0 CA-C-O 120.924 0.392 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m -83.71 118.5 23.92 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.16 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.57 ' O ' HG23 ' A' ' 99' ' ' ILE . 16.1 m -61.58 -56.13 23.22 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.128 0.489 . . . . 0.0 109.714 173.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.515 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . -78.79 105.81 10.36 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.996 176.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 32.6 ttm180 -138.84 97.12 3.25 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.331 0.586 . . . . 0.0 111.113 -176.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 24.4 p90 -168.45 163.04 12.57 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.726 178.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.503 ' HB2' ' HB2' ' A' ' 10' ' ' ASP . 22.8 m-20 -89.19 117.08 27.91 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 174.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.8 m -66.57 -13.53 61.15 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.092 -0.503 . . . . 0.0 112.086 -172.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.7 t -115.54 -0.16 13.14 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.26 0.552 . . . . 0.0 111.107 -176.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.503 ' HB2' ' HB2' ' A' ' 7' ' ' ASP . 8.1 t0 -79.47 91.68 5.16 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 121.916 -0.49 . . . . 0.0 110.232 -177.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.516 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 5.0 mtm-85 -69.44 -14.25 62.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.513 -178.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.7 t -84.9 0.04 52.48 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 175.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -109.95 -48.79 3.15 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 112.119 0.415 . . . . 0.0 112.119 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.434 ' HB3' ' HB3' ' A' ' 101' ' ' PRO . 40.2 p-90 -108.86 -20.45 13.05 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -173.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.516 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 19.3 t80 -73.38 108.89 6.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.094 0.473 . . . . 0.0 109.808 -177.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.726 ' HG3' HG21 ' A' ' 19' ' ' VAL . 12.0 tpp -89.01 -8.45 54.02 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.901 -171.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.494 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 50.23 -114.97 2.83 Favored Glycine 0 CA--C 1.522 0.475 0 CA-C-N 115.269 -0.878 . . . . 0.0 114.438 177.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.494 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 8.5 Cg_exo -72.52 82.14 1.45 Allowed 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 123.202 2.601 . . . . 0.0 113.158 -173.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.726 HG21 ' HG3' ' A' ' 16' ' ' MET . 44.0 t -142.02 166.4 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.456 ' N ' HG12 ' A' ' 19' ' ' VAL . 15.6 m -137.79 172.12 13.42 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -170.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 54.8 mtp85 -54.53 -53.79 49.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 118.154 0.434 . . . . 0.0 111.925 -177.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -57.89 -63.13 1.36 Allowed 'General case' 0 C--N 1.327 -0.374 0 O-C-N 123.477 0.486 . . . . 0.0 111.087 -177.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.453 ' O ' ' HB ' ' A' ' 26' ' ' THR . 36.6 tt0 -57.95 -45.45 86.62 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.67 -176.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.479 ' HB2' HG12 ' A' ' 19' ' ' VAL . . . -57.09 -50.8 71.65 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 120.933 0.397 . . . . 0.0 111.375 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.66 ' HG3' ' HB ' ' A' ' 58' ' ' VAL . 18.5 tt0 -64.4 -32.91 74.72 Favored 'General case' 0 C--O 1.219 -0.508 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -179.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.453 ' HB ' ' O ' ' A' ' 23' ' ' GLU . 7.8 m -59.81 -41.93 92.34 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.607 174.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.492 ' O ' ' HG3' ' A' ' 31' ' ' GLN . 95.4 mtt180 -68.8 -14.44 63.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.893 0.377 . . . . 0.0 110.896 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.596 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 72.3 mt -120.62 -12.6 8.87 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -174.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.792 ' HA ' HE21 ' A' ' 29' ' ' GLN . 0.0 OUTLIER -70.03 105.77 2.99 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.833 0.349 . . . . 0.0 111.024 -174.328 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 117' ' ' ASN . . . 72.64 5.35 63.77 Favored Glycine 0 C--O 1.226 -0.398 0 C-N-CA 120.953 -0.642 . . . . 0.0 112.241 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.492 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 12.9 mm100 -80.67 -162.16 0.45 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.845 0.355 . . . . 0.0 111.194 -176.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.46 ' HA ' ' CB ' ' A' ' 116' ' ' PRO . 34.7 mtm180 -59.31 119.29 7.15 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.984 0.421 . . . . 0.0 110.098 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.59 ' H ' ' HB3' ' A' ' 116' ' ' PRO . 27.4 m170 -76.6 125.93 30.1 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.952 -177.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 114.42 -6.25 22.96 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 -175.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.571 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 51.3 mtm -82.93 146.64 28.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.762 0.315 . . . . 0.0 110.216 177.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -145.94 163.6 34.64 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 176.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.45 ' O ' HD12 ' A' ' 37' ' ' LEU . 4.4 pp -152.61 137.21 16.87 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.058 0.456 . . . . 0.0 111.067 177.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.9 t -107.1 105.38 18.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 173.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.445 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 25.8 ptt-85 -104.13 166.69 10.24 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.731 -175.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -76.79 124.23 27.38 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 174.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.516 ' HB2' HG23 ' A' ' 49' ' ' VAL . 25.6 t -99.39 166.19 11.3 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.24 0.543 . . . . 0.0 111.225 -173.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.8 m -118.28 18.16 13.76 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.999 -175.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.2 m -75.02 -43.91 51.02 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 177.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 49.5 t -168.09 112.93 0.59 Allowed Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.696 177.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_exo -34.67 102.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 124.155 3.237 . . . . 0.0 113.433 -175.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 134.1 -25.43 3.5 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.638 -175.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -83.17 151.59 25.63 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 177.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -128.43 174.08 9.65 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -178.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.516 HG23 ' HB2' ' A' ' 41' ' ' SER . 58.5 t -137.74 112.81 9.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.425 0.631 . . . . 0.0 111.541 176.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.495 HD23 HD11 ' A' ' 73' ' ' ILE . 51.5 tp -81.01 98.34 7.91 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.225 -1.352 . . . . 0.0 109.698 174.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.3 m -96.0 128.93 43.33 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 175.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.614 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 94.6 t -122.06 142.4 38.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.117 -174.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.596 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 45.0 t -105.89 114.91 29.35 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -175.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.53 155.65 33.77 Favored 'General case' 0 C--O 1.207 -1.18 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 160.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 46.8 m-80 59.13 20.42 8.38 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 174.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.564 ' OG ' ' HA ' ' A' ' 119' ' ' PRO . 22.3 m 56.43 54.34 7.67 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 122.797 1.284 . . . . 0.0 108.082 -172.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.429 HH22 ' C ' ' A' ' 153' ' ' ILE . 0.2 OUTLIER -162.33 64.03 0.22 Allowed 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 112.751 -2.022 . . . . 0.0 109.493 -151.166 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.66 ' HB ' ' HG3' ' A' ' 25' ' ' GLN . 26.1 t -74.65 99.94 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 122.032 0.92 . . . . 0.0 111.03 -168.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.3 m -67.84 120.9 14.91 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 113.985 -1.461 . . . . 0.0 111.255 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -96.68 109.32 21.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.882 0.372 . . . . 0.0 111.513 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.461 ' HB2' ' HB3' ' A' ' 50' ' ' LEU . 89.4 m-85 -106.0 117.59 34.43 Favored 'General case' 0 C--O 1.216 -0.709 0 CA-C-N 115.641 -0.708 . . . . 0.0 111.537 177.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.709 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 53.4 mt -80.36 145.99 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 O-C-N 121.872 -0.517 . . . . 0.0 111.076 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.683 HG13 HG12 ' A' ' 73' ' ' ILE . 4.8 mp -129.53 104.11 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.122 0.487 . . . . 0.0 110.455 177.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.554 ' HB2' ' HB3' ' A' ' 72' ' ' LYS . 31.0 m-80 -90.56 142.75 27.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.485 -172.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 31.6 t -81.82 97.17 7.87 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 172.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 95.0 mt -73.99 143.44 80.85 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.543 -177.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.5 -23.29 70.16 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 123.078 2.518 . . . . 0.0 112.555 178.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 36.8 p30 -83.64 12.34 5.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.8 177.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 69' ' ' ARG . 5.2 tpp85 69.79 25.82 4.97 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.465 0.65 . . . . 0.0 111.317 175.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.695 ' HG2' ' HA ' ' A' ' 79' ' ' ASP . 68.1 mtt180 -113.71 -174.81 2.54 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.815 174.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.52 ' HB3' HG23 ' A' ' 63' ' ' ILE . 39.1 m-85 -131.09 131.78 44.41 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.019 0.438 . . . . 0.0 111.471 -177.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.554 ' HB3' ' HB2' ' A' ' 64' ' ' ASN . 14.6 tppt? -97.58 100.92 12.33 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.679 177.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.758 HG13 HD13 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -99.1 86.4 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 122.92 1.343 . . . . 0.0 109.017 -177.262 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 89.16 -110.76 3.74 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 114.532 -1.213 . . . . 0.0 111.502 -174.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 168' ' ' GLY . 26.4 t0 -108.24 -18.99 13.63 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.575 0.702 . . . . 0.0 109.536 176.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -90.74 136.35 33.12 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.747 -176.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.467 ' HB3' ' HE2' ' A' ' 72' ' ' LYS . 0.9 OUTLIER -110.41 128.13 55.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.364 0.602 . . . . 0.0 111.025 175.306 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.42 ' O ' ' HB3' ' A' ' 70' ' ' ARG . 8.8 m-85 -122.88 172.24 8.62 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 176.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.695 ' HA ' ' HG2' ' A' ' 70' ' ' ARG . 5.7 m-20 -75.09 -34.84 61.81 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -172.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.499 ' ND1' ' HG2' ' A' ' 82' ' ' PRO . 3.3 p80 -156.58 166.66 32.76 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 121.33 -0.148 . . . . 0.0 110.819 -178.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.603 HD23 HD21 ' A' ' 84' ' ' LEU . 18.0 mt -54.94 -54.68 47.17 Favored Pre-proline 0 N--CA 1.469 0.487 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -177.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.499 ' HG2' ' ND1' ' A' ' 80' ' ' HIS . 18.0 Cg_endo -61.67 -10.51 17.01 Favored 'Trans proline' 0 C--N 1.354 0.865 0 C-N-CA 122.172 1.914 . . . . 0.0 113.418 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.402 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -90.62 -36.79 14.2 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.873 0.368 . . . . 0.0 110.554 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.758 HD13 HG13 ' A' ' 73' ' ' ILE . 3.2 pp -76.92 -35.78 57.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.92 0.39 . . . . 0.0 110.022 -178.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.493 ' O ' ' HG2' ' A' ' 89' ' ' LYS . 89.1 mt -64.91 -24.1 67.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.999 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.515 ' HA ' ' CG ' ' A' ' 89' ' ' LYS . 26.9 tt0 -83.09 -22.34 33.45 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.79 -176.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -72.2 -35.67 69.0 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 121.731 0.777 . . . . 0.0 109.547 175.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.723 ' CG ' HD23 ' A' ' 93' ' ' LEU . 74.5 m-85 -86.63 1.43 51.87 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.459 -0.791 . . . . 0.0 111.43 -176.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.515 ' CG ' ' HA ' ' A' ' 86' ' ' GLU . 9.6 mmmm -71.75 -23.39 61.59 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 171.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 30.6 pt -121.2 7.96 6.07 Favored 'Isoleucine or valine' 0 C--N 1.339 0.151 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.112 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.412 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 5.8 t-160 -98.28 -40.37 8.38 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.08 -176.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.596 ' CD2' HG23 ' A' ' 97' ' ' THR . 60.7 m-85 64.75 77.64 0.31 Allowed 'General case' 0 C--N 1.333 -0.134 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -170.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.723 HD23 ' CG ' ' A' ' 88' ' ' TYR . 1.4 pp -79.29 18.15 0.72 Allowed 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -172.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.521 ' O ' HG22 ' A' ' 95' ' ' THR . 27.3 t70 -175.22 65.19 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.258 162.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.69 ' CB ' ' HA ' ' A' ' 156' ' ' PRO . 0.6 OUTLIER 62.16 -28.5 0.07 Allowed 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 125.048 1.339 . . . . 0.0 112.528 -174.013 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.476 ' H ' ' C ' ' A' ' 94' ' ' ASP . 2.0 t -109.3 157.4 18.89 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 172.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.596 HG23 ' CD2' ' A' ' 92' ' ' TYR . 7.4 p -90.33 -179.99 5.75 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 177.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 89.4 mt -73.16 91.49 1.65 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 171.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.57 HG23 ' O ' ' A' ' 3' ' ' SER . 37.4 mm -74.84 -61.87 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.856 -174.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.571 ' O ' ' HA ' ' A' ' 35' ' ' MET . 10.4 pt-20 -157.19 157.46 30.46 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.183 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.46 ' HD2' ' HB2' ' A' ' 100' ' ' GLU . 55.9 Cg_endo -69.58 152.83 70.31 Favored 'Trans proline' 0 C--O 1.237 0.458 0 C-N-CA 122.502 2.135 . . . . 0.0 112.91 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -77.29 156.78 81.34 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.526 177.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.523 ' HD3' ' SD ' ' A' ' 35' ' ' MET . 23.6 Cg_exo -64.21 132.16 32.98 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.342 2.028 . . . . 0.0 112.186 177.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.433 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 34.2 ptt180 -86.33 27.85 0.89 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.855 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.41 ' HA ' ' HD2' ' A' ' 106' ' ' PRO . 89.9 m-85 -95.45 116.49 66.33 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.341 178.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 105' ' ' TYR . 31.6 Cg_endo -65.46 124.22 12.55 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.186 1.924 . . . . 0.0 110.673 174.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 19.9 m 65.77 96.98 0.04 OUTLIER Pre-proline 0 C--O 1.233 0.188 0 O-C-N 123.688 0.618 . . . . 0.0 109.659 -170.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.504 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 22.4 Cg_endo -60.91 146.33 97.78 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 123.088 2.525 . . . . 0.0 113.071 -173.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.504 ' HD3' ' HA ' ' A' ' 108' ' ' PRO . 38.1 Cg_exo -61.55 150.76 83.97 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 123.123 2.548 . . . . 0.0 112.01 178.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 38.2 tpp -85.8 107.95 17.88 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.724 -174.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 134.56 -158.04 23.25 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.96 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 20.1 m 65.77 25.19 11.39 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 121.129 0.49 . . . . 0.0 111.21 177.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 39.3 t -77.1 98.88 2.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.121 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.54 ' HB3' ' HD2' ' A' ' 116' ' ' PRO . 20.0 t -105.22 -148.57 0.41 Allowed 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.428 ' HB3' ' HD3' ' A' ' 116' ' ' PRO . . . -58.84 -41.55 89.29 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 175.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.59 ' HB3' ' H ' ' A' ' 33' ' ' HIS . 22.1 Cg_exo -68.11 -167.36 0.17 Allowed 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 122.034 1.823 . . . . 0.0 112.192 171.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.412 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 4.9 m-20 67.19 19.9 10.27 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.947 0.403 . . . . 0.0 111.245 -177.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 73.5 mt -99.93 113.11 65.01 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.262 177.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.564 ' HA ' ' OG ' ' A' ' 56' ' ' SER . 32.5 Cg_exo -59.31 -64.24 0.11 Allowed 'Trans proline' 0 N--CA 1.464 -0.247 0 C-N-CA 122.872 2.382 . . . . 0.0 112.115 177.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 69.4 p 61.41 -36.96 0.11 Allowed 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.049 1.34 . . . . 0.0 113.637 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.405 ' H ' ' C ' ' A' ' 119' ' ' PRO . . . -134.51 172.66 12.61 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 177.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -132.01 -106.74 0.26 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.299 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -88.12 93.32 9.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.136 0.494 . . . . 0.0 110.442 177.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -163.82 146.06 9.39 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.688 ' HG ' ' HD2' ' A' ' 155' ' ' LYS . 3.3 mm? 67.82 96.73 0.06 Allowed 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.703 0.763 . . . . 0.0 111.66 -177.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -174.5 -38.79 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.566 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.483 ' HB3' ' HB3' ' A' ' 181' ' ' LEU . 79.9 m-85 -127.64 116.02 19.65 Favored 'General case' 0 CA--C 1.504 -0.804 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.487 176.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.662 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 2.1 t -115.47 153.72 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 CA-C-N 115.171 -0.922 . . . . 0.0 108.748 -177.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.775 ' NH2' HD13 ' A' ' 181' ' ' LEU . 1.7 ptp180 -137.59 124.59 21.43 Favored 'General case' 0 CA--C 1.496 -1.11 0 C-N-CA 117.281 -1.767 . . . . 0.0 112.891 173.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.69 HG22 HG12 ' A' ' 178' ' ' VAL . 81.7 p -79.49 131.88 36.18 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 114.268 -1.333 . . . . 0.0 111.13 -177.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.477 HD21 ' HG3' ' A' ' 129' ' ' ARG . 2.5 mt -116.59 8.5 13.91 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.624 -175.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -122.82 -36.07 2.94 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.276 0.473 . . . . 0.0 112.276 -171.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.499 ' HB2' ' HB3' ' A' ' 146' ' ' LYS . 11.0 t70 78.52 110.7 0.07 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.23 0.612 . . . . 0.0 110.873 -178.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.619 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 79.2 t80 -144.55 91.66 6.17 Favored Pre-proline 0 C--N 1.325 -0.47 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 177.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.643 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 72.8 Cg_endo -79.53 85.98 1.75 Allowed 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 121.846 1.697 . . . . 0.0 112.404 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.38 -35.38 60.0 Favored Glycine 0 C--N 1.333 0.384 0 CA-C-N 115.452 -0.794 . . . . 0.0 112.445 179.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.804 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 0.9 OUTLIER 68.27 37.66 2.75 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 122.652 0.381 . . . . 0.0 111.548 178.05 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -137.71 170.41 16.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.662 0.267 . . . . 0.0 110.554 -177.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -89.86 -6.19 56.08 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.74 0.781 . . . . 0.0 109.108 174.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -103.14 -34.14 8.96 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.815 -1.084 . . . . 0.0 109.57 177.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -120.08 109.55 15.6 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.385 176.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 1.057 HD11 ' HB2' ' A' ' 165' ' ' ASN . 36.5 tp -68.15 132.11 91.92 Favored Pre-proline 0 CA--C 1.515 -0.378 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.394 -177.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.804 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 7.6 Cg_endo -83.05 104.1 1.22 Allowed 'Trans proline' 0 N--CA 1.438 -1.778 0 C-N-CA 121.785 1.657 . . . . 0.0 110.108 169.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.677 ' CG ' HG21 ' A' ' 130' ' ' THR . 9.4 p90 -121.39 163.6 18.44 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.254 -176.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.533 ' HB2' ' HB3' ' A' ' 148' ' ' GLU . 12.8 mptt -96.51 -169.82 1.97 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.376 0.607 . . . . 0.0 112.494 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.902 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -89.29 5.49 44.69 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.238 -176.456 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -168.7 37.35 0.21 Allowed Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 176.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.583 ' OE1' ' HA ' ' A' ' 144' ' ' PHE . 0.4 OUTLIER -92.95 157.69 16.21 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 120.87 0.367 . . . . 0.0 110.272 -177.713 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -98.38 131.89 44.57 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-O 121.774 0.797 . . . . 0.0 109.727 178.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.616 HD22 HD21 ' A' ' 142' ' ' LEU . 14.9 mt -120.31 156.27 31.62 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 114.086 -1.415 . . . . 0.0 107.646 -174.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.561 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 60.8 t -124.16 122.93 65.46 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 176.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.935 HD13 ' HB2' ' A' ' 163' ' ' ALA . 26.1 mm -76.16 102.99 3.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-O 121.578 0.704 . . . . 0.0 109.458 -174.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.527 HG21 HG22 ' A' ' 170' ' ' VAL . 20.3 tt -97.91 -30.0 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.661 0 CA-C-N 114.801 -1.091 . . . . 0.0 109.802 -173.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.621 ' OE2' ' HA ' ' A' ' 93' ' ' LEU . 1.8 mt-10 -131.77 140.84 49.33 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 165.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.688 ' HD2' ' HG ' ' A' ' 125' ' ' LEU . 39.9 tttp -123.02 89.55 50.68 Favored Pre-proline 0 C--N 1.321 -0.657 0 O-C-N 121.231 -0.918 . . . . 0.0 109.868 167.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.69 ' HA ' ' CB ' ' A' ' 95' ' ' THR . 3.0 Cg_exo -77.81 -51.54 0.08 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.592 2.195 . . . . 0.0 112.023 175.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.57 ' HG2' ' CE ' ' A' ' 172' ' ' MET . 22.5 mm-40 -102.67 179.44 4.29 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -171.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.415 ' HA ' ' HE1' ' A' ' 161' ' ' TRP . 11.5 pt-20 -107.13 -20.03 13.43 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.56 176.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -109.41 -8.69 15.01 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.803 0.335 . . . . 0.0 110.871 177.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.54 ' O ' ' HB2' ' A' ' 157' ' ' GLU . 83.4 m95 -132.03 131.39 42.44 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 169.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . 0.49 ' CE3' HD11 ' A' ' 125' ' ' LEU . 48.1 m0 -122.88 143.47 49.85 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.948 -0.701 . . . . 0.0 110.37 177.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.609 ' HA ' ' HA ' ' A' ' 172' ' ' MET . 21.6 m -89.14 99.67 12.61 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 -176.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.935 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -110.09 151.6 27.02 Favored 'General case' 0 N--CA 1.43 -1.447 0 C-N-CA 120.012 -0.675 . . . . 0.0 110.027 -175.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.828 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 12.8 ptt180 -87.97 121.18 30.08 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-O 122.109 0.957 . . . . 0.0 108.944 172.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 1.057 ' HB2' HD11 ' A' ' 142' ' ' LEU . 11.7 t30 -45.21 167.3 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 112.131 -2.304 . . . . 0.0 112.006 178.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.419 ' HD2' ' HA ' ' A' ' 166' ' ' LYS . 15.5 tptm -58.32 -14.29 7.1 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.015 173.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.518 ' HB2' ' ND2' ' A' ' 165' ' ' ASN . 21.7 m-20 -95.62 -9.19 32.81 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.001 0.429 . . . . 0.0 109.987 174.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 75' ' ' ASP . . . 90.2 39.06 6.15 Favored Glycine 0 CA--C 1.522 0.489 0 CA-C-N 115.85 -0.614 . . . . 0.0 113.406 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.828 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 7.8 ttm-85 -111.76 138.71 47.98 Favored 'General case' 0 C--O 1.214 -0.777 0 CA-C-N 116.933 0.367 . . . . 0.0 111.472 -177.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.527 HG22 HG21 ' A' ' 153' ' ' ILE . 21.9 t -78.96 125.61 38.45 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 C-N-CA 120.839 -0.345 . . . . 0.0 111.552 -179.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -164.02 149.72 17.24 Favored Glycine 0 C--N 1.332 0.321 0 N-CA-C 111.59 -0.604 . . . . 0.0 111.59 168.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.609 ' HA ' ' HA ' ' A' ' 162' ' ' SER . 59.5 mtp -77.0 143.32 39.48 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 117.565 0.682 . . . . 0.0 110.751 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.695 ' O ' HD12 ' A' ' 173' ' ' ILE . 1.6 pp -134.88 151.84 76.33 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 115.369 -0.832 . . . . 0.0 110.444 -177.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.733 ' O ' HG13 ' A' ' 178' ' ' VAL . 1.0 OUTLIER -85.24 123.79 2.72 Favored 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.821 2.347 . . . . 0.0 113.241 -174.819 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.574 ' HA ' HG22 ' A' ' 178' ' ' VAL . 94.8 t -53.73 -45.42 98.77 Favored Pre-proline 0 CA--C 1.539 0.557 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 178.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.496 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 65.2 Cg_exo -54.91 -23.93 36.69 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 122.112 1.875 . . . . 0.0 112.817 174.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.554 ' CD2' ' HG2' ' A' ' 174' ' ' PRO . 3.4 m-30 -84.82 -39.58 18.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.018 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.733 HG13 ' O ' ' A' ' 174' ' ' PRO . 1.1 m -111.65 -177.77 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.637 -164.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.897 ' HG3' ' H ' ' A' ' 180' ' ' LYS . 11.2 pt-20 -158.13 -71.03 0.09 Allowed 'General case' 0 C--O 1.207 -1.142 0 N-CA-C 118.011 2.597 . . . . 0.0 118.011 144.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.897 ' H ' ' HG3' ' A' ' 179' ' ' GLU . 3.6 mppt? -156.25 179.64 9.05 Favored 'General case' 0 N--CA 1.481 1.119 0 O-C-N 118.855 -2.403 . . . . 0.0 114.593 -169.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.775 HD13 ' NH2' ' A' ' 129' ' ' ARG . 12.0 tp -125.15 -60.49 1.34 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.929 164.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.842 HG13 ' H ' ' A' ' 183' ' ' ARG . 2.4 p -90.65 -89.81 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-O 119.447 -0.311 . . . . 0.0 110.717 177.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.842 ' H ' HG13 ' A' ' 182' ' ' VAL . 0.2 OUTLIER 68.82 141.84 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.612 0.765 . . . . 0.0 112.979 172.235 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.445 ' N ' ' HD3' ' A' ' 183' ' ' ARG . 10.5 p -85.47 -100.72 0.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.771 171.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 60.5 p 170.46 166.11 0.2 Allowed Pre-proline 0 C--O 1.237 0.4 0 C-N-CA 123.273 0.629 . . . . 0.0 109.814 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -61.32 123.67 13.26 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.46 2.107 . . . . 0.0 111.099 173.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.44 ' HB2' ' HB2' ' A' ' 190' ' ' HIS . 31.6 m80 -122.92 15.73 10.05 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.228 -175.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 77.25 -63.6 3.26 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.566 -0.826 . . . . 0.0 111.754 -177.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 64.0 mmtt -76.15 -11.3 59.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.587 0.708 . . . . 0.0 109.299 176.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . 0.44 ' HB2' ' HB2' ' A' ' 187' ' ' HIS . 18.4 m-70 -119.38 88.75 2.99 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.055 173.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 142.49 -148.66 20.43 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.014 -179.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 66.59 142.62 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.773 0.797 . . . . 0.0 112.328 -178.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.464 ' HA ' ' NE ' ' A' ' 193' ' ' ARG . 4.6 mmp_? -125.49 113.57 17.65 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.053 176.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -102.8 140.28 37.28 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.957 0.408 . . . . 0.0 110.259 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 29.0 m -128.06 107.94 10.24 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -114.79 -43.75 3.11 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.29 -175.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 12.6 t 61.64 -176.48 0.13 Allowed 'General case' 0 CA--C 1.535 0.389 0 O-C-N 123.296 0.373 . . . . 0.0 110.685 178.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -132.69 -16.54 2.61 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.878 0.371 . . . . 0.0 110.026 175.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 78.82 -57.62 4.26 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.755 -178.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.471 HD12 ' HD2' ' A' ' 201' ' ' PRO . 6.6 tp -114.03 122.02 35.52 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-O 120.895 0.378 . . . . 0.0 110.467 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.481 ' O ' ' HD3' ' A' ' 203' ' ' PRO . 9.6 Cg_exo -72.65 163.8 37.44 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.715 2.276 . . . . 0.0 111.208 174.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -83.39 103.37 2.62 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 201' ' ' PRO . 93.0 Cg_endo -93.61 -5.75 2.68 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 122.878 2.385 . . . . 0.0 113.889 -171.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -113.1 -63.86 1.39 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.876 0.37 . . . . 0.0 111.3 -177.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -83.22 67.06 9.05 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.437 0.637 . . . . 0.0 111.576 -174.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -140.03 -3.18 1.43 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.033 174.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 55.18 72.76 0.46 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.051 -0.977 . . . . 0.0 111.478 -176.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -80.4 92.12 5.79 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.254 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -115.46 150.0 43.85 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.193 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.83 120.32 8.06 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.835 2.357 . . . . 0.0 112.666 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.409 ' HB3' ' H ' ' A' ' 212' ' ' THR . 72.7 mt-30 -139.16 -162.63 1.35 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.18 179.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.409 ' H ' ' HB3' ' A' ' 211' ' ' GLN . 12.7 p -71.94 -61.72 1.69 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.985 0.421 . . . . 0.0 111.547 -177.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.69 95.99 9.91 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.724 178.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.566 HG22 ' HG ' ' A' ' 216' ' ' LEU . 8.8 m -82.04 115.05 55.14 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.043 -178.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 214' ' ' THR . 1.2 Cg_endo -82.94 82.54 2.15 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.912 2.408 . . . . 0.0 112.251 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.958 ' HB2' ' HD3' ' A' ' 217' ' ' PRO . 97.2 mt -111.01 -62.91 0.04 OUTLIER Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.421 174.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.958 ' HD3' ' HB2' ' A' ' 216' ' ' LEU . 4.4 Cg_exo -80.58 -57.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 121.704 1.602 . . . . 0.0 110.91 175.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -166.15 142.56 5.03 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.305 176.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 40.1 t -63.99 -34.94 71.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.049 0.452 . . . . 0.0 110.781 -178.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 5.5 m -74.58 -13.36 60.65 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.157 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 94.06 103.15 1.72 Allowed Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.51 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.416 ' HA ' ' HD3' ' A' ' 223' ' ' PRO . 14.1 m -74.29 125.05 90.29 Favored Pre-proline 0 C--N 1.327 -0.385 0 N-CA-C 110.435 -0.209 . . . . 0.0 110.435 178.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 222' ' ' SER . 46.9 Cg_exo -56.07 121.52 10.14 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.878 2.386 . . . . 0.0 112.058 -179.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.568 ' H ' HG23 ' A' ' 227' ' ' ILE . . . 102.7 -48.09 1.07 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.327 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -87.44 -37.12 17.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.832 0.348 . . . . 0.0 111.535 -177.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -115.12 27.28 9.5 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.599 -175.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.568 HG23 ' H ' ' A' ' 224' ' ' GLY . 2.7 pp -85.83 161.71 2.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 C-N-CA 120.95 -0.3 . . . . 0.0 110.468 176.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 5.0 t -102.94 118.69 57.58 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-O 121.211 0.529 . . . . 0.0 111.148 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -84.63 -177.13 2.77 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.661 2.241 . . . . 0.0 111.705 174.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.819 HD23 ' H ' ' A' ' 230' ' ' LEU . 2.0 pt? -91.0 125.69 57.93 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-O 120.859 0.361 . . . . 0.0 110.679 -179.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.517 ' HD3' ' HA ' ' A' ' 230' ' ' LEU . 1.2 Cg_endo -84.94 93.85 0.68 Allowed 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.265 2.644 . . . . 0.0 112.692 -178.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 22.1 t 67.05 -79.32 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.569 176.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 70.6 p 55.69 -84.0 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.324 1.05 . . . . 0.0 112.377 -177.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 7.2 tp60 -175.14 -35.92 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 -178.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -103.23 17.04 25.01 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.418 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -64.29 -56.18 19.28 Favored Glycine 0 C--N 1.334 0.453 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.802 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -74.4 108.89 2.78 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.139 1.893 . . . . 0.0 110.87 172.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.453 HG11 HD12 ' A' ' 293' ' ' ILE . 3.5 t -89.82 141.59 14.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.846 -173.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.447 ' HB2' ' HG3' ' A' ' 296' ' ' PRO . 94.0 m-85 -113.26 122.98 49.07 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.28 178.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.464 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -119.72 144.26 47.33 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.421 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -90.87 119.83 31.39 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 177.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -66.95 102.46 0.98 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.928 0.394 . . . . 0.0 110.024 177.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 24.8 pt -83.31 -35.29 11.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.421 -174.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -132.89 130.89 40.29 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -54.36 140.38 33.75 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.883 -171.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.578 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 27.5 tpt180 -124.03 107.12 10.96 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.896 -178.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 16.5 m -115.87 126.67 27.46 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-O 120.954 0.407 . . . . 0.0 110.477 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.464 ' HB3' ' HB3' ' A' ' 255' ' ' ALA . 39.5 Cg_endo -67.68 127.66 16.68 Favored 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.629 2.219 . . . . 0.0 112.596 -178.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 39.2 t -78.58 171.94 14.41 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 175.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -53.1 -37.78 62.02 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.734 0.302 . . . . 0.0 111.72 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -97.71 14.25 27.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.898 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -90.89 -75.19 0.47 Allowed 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 173.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 66.0 mttm 69.87 -58.41 0.53 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.944 178.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 11.2 p -73.32 -13.54 61.13 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.368 -179.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.464 ' HB3' ' HB3' ' A' ' 248' ' ' PRO . . . -71.86 123.99 23.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.047 -179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.2 tt -73.5 133.94 43.75 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.636 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.578 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -81.62 104.93 12.37 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.093 0.473 . . . . 0.0 109.934 176.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 96.0 mt -109.0 134.94 50.98 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.481 -177.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -99.41 155.14 17.7 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.216 179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 62.2 t -66.94 122.04 17.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.006 0.431 . . . . 0.0 111.083 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 95.21 11.42 56.15 Favored Glycine 0 N--CA 1.449 -0.47 0 CA-C-N 115.675 -0.693 . . . . 0.0 113.202 175.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -95.14 166.93 11.67 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.985 0.392 . . . . 0.0 109.971 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 34.3 mm -102.55 118.24 49.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.114 0.483 . . . . 0.0 110.728 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 19.3 t -93.48 104.9 16.22 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.165 0.507 . . . . 0.0 110.284 179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -85.7 87.7 7.44 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.814 178.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.43 HG21 ' HB3' ' A' ' 275' ' ' TRP . 6.2 p -91.73 126.02 44.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 121.489 0.661 . . . . 0.0 111.607 -175.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 44.7 p -104.69 -39.23 6.42 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.725 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 20.1 tpp180 -105.6 117.44 34.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.124 -177.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 41.5 mtt -114.4 134.86 54.68 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.798 174.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -97.45 160.06 14.55 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.714 -178.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 10.5 tp -75.21 -11.98 14.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.502 0.667 . . . . 0.0 109.972 176.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -75.2 -65.49 0.88 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.938 179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 156.47 -23.55 0.5 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.383 -178.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.439 ' HB3' HD22 ' A' ' 285' ' ' LEU . 23.2 mt-30 -87.06 119.75 27.61 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 176.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.48 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 31.4 m0 -101.43 156.23 17.59 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.789 -176.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.495 ' HA ' ' O ' ' A' ' 284' ' ' GLY . 47.9 mt-10 -112.28 114.57 27.41 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.061 175.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . 0.704 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -120.71 155.01 16.32 Favored Glycine 0 C--O 1.225 -0.434 0 C-N-CA 120.894 -0.669 . . . . 0.0 111.595 177.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.786 ' HG2' ' HB3' ' A' ' 283' ' ' LYS . 38.0 mt-10 -100.7 109.9 21.97 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.092 0.473 . . . . 0.0 110.849 179.203 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . 0.415 HG12 HD22 ' A' ' 280' ' ' ASN . 48.7 t -118.95 130.82 73.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 176.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . 0.415 HD22 HG12 ' A' ' 279' ' ' VAL . 10.1 p30 44.54 34.77 1.18 Allowed 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.958 0.903 . . . . 0.0 112.482 -174.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 94.49 -9.1 71.77 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 121.01 -0.614 . . . . 0.0 113.483 175.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 48.8 ttt180 -108.35 124.72 50.79 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 117.014 0.407 . . . . 0.0 111.259 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.786 ' HB3' ' HG2' ' A' ' 278' ' ' GLU . 9.4 ptpp? -96.33 142.17 28.78 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 172.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 276' ' ' GLU . . . -164.05 172.03 39.78 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.987 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.48 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 17.2 mt -82.44 130.74 35.17 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.158 0.504 . . . . 0.0 111.341 -179.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -136.23 135.49 21.15 Favored Pre-proline 0 C--N 1.318 -0.803 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.651 173.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . 0.9 ' HB2' HG22 ' A' ' 289' ' ' THR . 59.0 Cg_endo -75.61 138.31 21.45 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.237 1.958 . . . . 0.0 111.444 175.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.467 ' HA ' HG22 ' A' ' 291' ' ' VAL . 49.4 p90 -63.27 -8.47 8.52 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.932 0.396 . . . . 0.0 111.282 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . 0.9 HG22 ' HB2' ' A' ' 287' ' ' PRO . 15.3 t -79.62 -13.81 59.24 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.012 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . 0.506 ' HD2' HG23 ' A' ' 289' ' ' THR . 6.8 m-70 -101.19 -6.19 24.59 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.695 0.283 . . . . 0.0 110.846 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.467 HG22 ' HA ' ' A' ' 288' ' ' PHE . 35.9 m -127.78 178.99 4.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.94 -178.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -140.76 116.01 9.95 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.039 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.464 HD13 ' HB2' ' A' ' 240' ' ' ALA . 34.2 mm -70.41 112.96 5.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 174.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -135.24 -169.87 2.47 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.865 -176.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -115.68 94.67 41.31 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . 0.447 ' HG3' ' HB2' ' A' ' 239' ' ' PHE . 36.2 Cg_endo -67.13 -48.06 2.01 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.31 2.006 . . . . 0.0 111.334 178.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -108.07 82.44 1.64 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.708 175.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . 0.423 ' HA ' ' HD2' ' A' ' 299' ' ' PRO . 14.0 m120 -58.51 118.32 27.28 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.604 176.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' PRO . . . . . 0.446 ' HA ' ' HB2' ' A' ' 302' ' ' ASN . 9.9 Cg_endo -52.97 -31.35 52.64 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.087 2.524 . . . . 0.0 112.784 -176.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -58.83 -40.54 84.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.051 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -119.49 37.49 4.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.364 0.602 . . . . 0.0 110.477 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . 0.446 ' HB2' ' HA ' ' A' ' 299' ' ' PRO . 13.0 t30 -76.27 -3.54 37.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.787 175.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 . . . . . 0 C--O 1.252 1.191 0 CA-C-N 114.765 -1.107 . . . . 0.0 110.662 177.386 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.0 mtt . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 120.879 0.371 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.2 m -84.74 141.34 30.61 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.139 179.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.498 ' O ' HG23 ' A' ' 99' ' ' ILE . 9.4 p -83.75 -47.73 10.86 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 174.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.609 ' HB1' ' HE3' ' A' ' 89' ' ' LYS . . . -83.27 104.56 13.53 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.745 175.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 63.8 mtt180 -109.47 -10.49 14.88 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 -167.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.449 ' H ' ' HD1' ' A' ' 6' ' ' PHE . 4.6 p90 -84.31 156.02 22.11 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.594 -170.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -66.7 -27.77 67.9 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.587 -177.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.3 t 75.09 -22.73 0.25 Allowed 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.412 0.685 . . . . 0.0 111.137 -178.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.6 t -105.17 -17.39 14.49 Favored 'General case' 0 C--N 1.329 -0.303 0 O-C-N 122.262 -0.273 . . . . 0.0 111.707 -177.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -81.08 107.74 14.15 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 121.718 -0.614 . . . . 0.0 110.625 -177.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.49 -41.59 94.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.948 -176.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.457 ' C ' HH22 ' A' ' 104' ' ' ARG . 24.2 t -68.77 -4.01 14.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.156 -176.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -91.84 -47.27 7.42 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.419 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 43.4 p-90 -117.33 -21.21 8.82 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -171.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -75.05 127.16 32.58 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 -177.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.784 ' HG3' ' HB2' ' A' ' 37' ' ' LEU . 26.3 mmt -109.67 -8.35 14.96 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -173.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 50.55 -112.84 1.74 Allowed Glycine 0 CA--C 1.525 0.665 0 C-N-CA 121.376 -0.44 . . . . 0.0 113.2 -176.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -76.01 102.16 1.57 Allowed 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.52 2.147 . . . . 0.0 112.766 -178.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.737 ' HB ' ' HG3' ' A' ' 39' ' ' ARG . 22.2 t -142.07 -76.39 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.397 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.815 ' H ' ' HG3' ' A' ' 39' ' ' ARG . 51.1 m 93.41 171.01 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.738 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 168.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.511 ' HD3' ' HA ' ' A' ' 116' ' ' PRO . 74.0 mtp85 -62.1 -32.58 73.16 Favored 'General case' 0 C--N 1.313 -0.979 0 C-N-CA 120.686 -0.405 . . . . 0.0 110.861 -172.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.407 ' HA ' ' HB ' ' A' ' 113' ' ' VAL . 33.5 mt-30 -59.65 -54.12 50.08 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 123.842 0.713 . . . . 0.0 110.751 178.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.485 ' O ' ' HG3' ' A' ' 27' ' ' ARG . 17.4 mt-10 -74.71 -47.22 32.64 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.784 -177.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.35 -51.17 70.46 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.688 0.625 . . . . 0.0 112.688 -172.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.546 ' HA ' HG11 ' A' ' 58' ' ' VAL . 3.9 tt0 -66.27 -33.79 76.53 Favored 'General case' 0 C--O 1.221 -0.441 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -177.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.401 ' HA ' ' HB2' ' A' ' 112' ' ' SER . 2.3 m -63.41 -35.45 80.45 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.344 -0.843 . . . . 0.0 112.113 178.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.485 ' HG3' ' O ' ' A' ' 23' ' ' GLU . 98.0 mtt180 -81.19 -13.3 58.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.599 0.238 . . . . 0.0 111.256 -177.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.57 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 41.0 mt -121.27 -13.33 8.5 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -172.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.518 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 26.6 tp60 -66.61 104.8 1.36 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.926 0.393 . . . . 0.0 110.32 -176.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 64.59 34.17 89.19 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.444 -178.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 12.0 mm100 -106.5 -160.85 0.76 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 178.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.568 ' HB2' ' HG3' ' A' ' 35' ' ' MET . 43.6 mtm180 -56.17 111.17 0.89 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.896 0.379 . . . . 0.0 110.624 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -67.38 111.06 3.84 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.008 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.472 ' HA2' HG21 ' A' ' 96' ' ' THR . . . 130.86 -14.26 5.5 Favored Glycine 0 N--CA 1.441 -0.969 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.499 -176.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.568 ' HG3' ' HB2' ' A' ' 32' ' ' ARG . 55.3 mtm -77.3 143.6 38.71 Favored 'General case' 0 CA--C 1.513 -0.449 0 CA-C-O 120.871 0.367 . . . . 0.0 110.426 177.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.471 ' HB2' HG22 ' A' ' 52' ' ' VAL . 34.0 p90 -141.39 166.01 25.94 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.236 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.784 ' HB2' ' HG3' ' A' ' 16' ' ' MET . 4.3 pp -157.13 139.14 14.4 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.234 0.54 . . . . 0.0 110.674 176.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.3 t -113.27 108.27 25.08 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.181 177.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.815 ' HG3' ' H ' ' A' ' 20' ' ' SER . 0.0 OUTLIER -120.77 173.85 6.96 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 120.616 -0.433 . . . . 0.0 110.26 -178.533 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -61.69 130.32 45.29 Favored 'General case' 0 C--O 1.238 0.459 0 O-C-N 123.854 0.721 . . . . 0.0 110.147 178.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.4 t -80.13 154.98 27.69 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.517 -173.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 16.9 m -92.83 -5.32 51.3 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.41 -0.814 . . . . 0.0 109.744 177.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 8.2 m -73.34 -49.54 26.85 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.973 177.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 49.1 t -167.36 136.61 2.2 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.618 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -59.96 105.68 0.29 Allowed 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 122.503 2.135 . . . . 0.0 111.796 176.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 133.27 -29.41 3.18 Favored Glycine 0 N--CA 1.452 -0.278 0 N-CA-C 110.526 -1.029 . . . . 0.0 110.526 -174.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.409 ' OD1' ' HA ' ' A' ' 64' ' ' ASN . 30.3 t70 -80.58 151.41 29.1 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 173.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -127.25 157.93 38.51 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.506 ' HB ' ' CZ ' ' A' ' 39' ' ' ARG . 39.2 t -128.52 110.38 21.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 121.761 0.791 . . . . 0.0 111.316 176.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.46 ' HB3' ' HB2' ' A' ' 61' ' ' TYR . 47.5 tp -76.29 95.78 3.83 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 113.731 -1.577 . . . . 0.0 110.121 175.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 59' ' ' SER . 65.7 m -96.96 133.79 41.16 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 175.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.681 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 60.1 t -130.92 138.5 53.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.302 -171.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.57 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 40.0 t -89.68 108.22 19.55 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.803 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.682 ' O ' ' HB3' ' A' ' 57' ' ' ARG . 26.8 mt-10 -146.67 131.93 18.46 Favored 'General case' 0 C--O 1.206 -1.206 0 C-N-CA 119.685 -0.806 . . . . 0.0 110.253 176.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.453 HD21 ' HB ' ' A' ' 95' ' ' THR . 43.0 m-80 52.47 28.8 6.27 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 177.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 33.2 m 59.83 58.68 2.72 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 122.778 1.275 . . . . 0.0 108.67 -175.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.796 HH21 ' HB2' ' A' ' 94' ' ' ASP . 17.0 ttp85 -162.2 66.88 0.24 Allowed 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 112.869 -1.969 . . . . 0.0 109.395 -159.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.681 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 41.1 t -69.08 92.11 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-O 122.58 1.181 . . . . 0.0 109.143 -170.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 51' ' ' SER . 1.8 m -61.17 119.64 8.79 Favored 'General case' 0 N--CA 1.442 -0.852 0 CA-C-N 112.579 -2.1 . . . . 0.0 110.722 -177.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -99.53 96.49 7.7 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.913 0.387 . . . . 0.0 110.969 -178.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.633 ' CE2' HD22 ' A' ' 93' ' ' LEU . 88.6 m-85 -95.5 116.44 28.82 Favored 'General case' 0 C--O 1.216 -0.67 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.074 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.557 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 55.4 mt -81.53 146.48 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 O-C-N 122.24 -0.287 . . . . 0.0 111.35 -178.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.654 HG13 ' CG1' ' A' ' 73' ' ' ILE . 4.8 mp -134.14 102.04 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 C-N-CA 122.571 0.349 . . . . 0.0 110.243 179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.409 ' HA ' ' OD1' ' A' ' 47' ' ' ASP . 9.2 m120 -81.14 130.95 35.25 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.237 -177.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.2 t -78.54 100.39 6.9 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 172.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.567 HD11 ' HB2' ' A' ' 72' ' ' LYS . 85.8 mt -80.64 142.78 53.69 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.28 -174.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -63.07 -8.63 14.56 Favored 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 122.766 2.31 . . . . 0.0 111.344 170.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -75.82 2.85 11.21 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.883 172.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 69' ' ' ARG . 4.5 mmp_? 68.01 24.9 7.74 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.489 -178.081 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.417 ' HB3' ' O ' ' A' ' 78' ' ' PHE . 67.2 mtt180 -121.4 176.41 5.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.952 -178.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.415 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 57.2 m-85 -124.46 117.92 25.49 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.112 0.482 . . . . 0.0 110.277 178.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.656 ' HG3' ' HB3' ' A' ' 77' ' ' GLU . 74.1 tttt -98.12 99.93 11.21 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.826 -173.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.696 ' HB ' HD22 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -90.14 76.45 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-O 123.0 1.381 . . . . 0.0 110.228 -173.69 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.43 74.71 0.88 Allowed Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 114.578 -1.192 . . . . 0.0 113.262 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.446 ' HA ' ' HE2' ' A' ' 72' ' ' LYS . 38.6 t70 73.94 -40.96 0.47 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 174.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -91.82 119.73 31.88 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 177.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.656 ' HB3' ' HG3' ' A' ' 72' ' ' LYS . 13.5 pt-20 -100.14 139.85 35.21 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.328 0.585 . . . . 0.0 111.488 -176.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.435 ' CE1' HG22 ' A' ' 73' ' ' ILE . 26.9 m-85 -117.66 168.13 10.71 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 174.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -69.91 -20.72 63.35 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -171.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.489 ' CE1' ' HB2' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -170.81 172.92 5.46 Favored 'General case' 0 N--CA 1.464 0.275 0 O-C-N 122.553 -0.092 . . . . 0.0 111.183 174.741 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.533 HD23 HD21 ' A' ' 84' ' ' LEU . 13.0 mt -51.8 -54.89 35.23 Favored Pre-proline 0 CA--C 1.539 0.555 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 81' ' ' LEU . 38.3 Cg_endo -64.68 -4.53 8.63 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 122.369 2.046 . . . . 0.0 113.448 -177.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.489 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -94.43 -34.17 12.85 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.921 0.391 . . . . 0.0 110.524 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.696 HD22 ' HB ' ' A' ' 73' ' ' ILE . 2.3 pp -75.34 -36.67 60.99 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.534 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 81.4 mt -65.35 -31.24 72.26 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.236 177.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.647 ' HA ' ' HD3' ' A' ' 89' ' ' LYS . 3.3 tp10 -70.77 -27.84 64.22 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.935 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.4 ' CD2' ' HZ ' ' A' ' 78' ' ' PHE . 18.5 t80 -75.66 -32.17 60.08 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-O 121.734 0.778 . . . . 0.0 109.593 -177.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.541 ' HA ' ' HB3' ' A' ' 91' ' ' HIS . 64.7 m-85 -89.62 2.05 55.22 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.177 -0.919 . . . . 0.0 111.471 -175.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.647 ' HD3' ' HA ' ' A' ' 86' ' ' GLU . 56.9 mtpt -84.4 -15.29 46.8 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.884 173.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 34.0 pt -121.03 0.49 7.25 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 CA-C-O 121.291 0.567 . . . . 0.0 110.285 174.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.541 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 3.3 t-160 -88.97 -44.29 10.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.859 -176.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.46 ' HB2' ' O ' ' A' ' 91' ' ' HIS . 90.4 m-85 67.33 88.64 0.11 Allowed 'General case' 0 CA--C 1.519 -0.237 0 O-C-N 124.135 0.897 . . . . 0.0 108.946 -165.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.638 ' O ' ' HB3' ' A' ' 154' ' ' GLU . 11.9 mt -44.02 -61.59 1.41 Allowed 'General case' 0 C--O 1.218 -0.576 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 175.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.796 ' HB2' HH21 ' A' ' 57' ' ' ARG . 21.0 t0 -141.62 89.68 2.23 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 119.828 -0.749 . . . . 0.0 110.688 170.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.532 ' HB ' ' O ' ' A' ' 94' ' ' ASP . 1.3 m 69.91 -6.84 1.0 Allowed 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 121.981 0.896 . . . . 0.0 110.558 175.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.472 HG21 ' HA2' ' A' ' 34' ' ' GLY . 76.2 m -135.59 142.91 45.36 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.782 -178.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.42 ' O ' HG22 ' A' ' 96' ' ' THR . 3.1 p -95.4 171.37 8.74 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 174.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.448 HD21 HD11 ' A' ' 93' ' ' LEU . 96.8 mt -66.77 91.84 0.2 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 173.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.498 HG23 ' O ' ' A' ' 3' ' ' SER . 47.0 mm -75.41 -66.86 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.298 -174.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.558 ' O ' ' HA ' ' A' ' 35' ' ' MET . 9.7 pt-20 -156.75 154.76 27.39 Favored Pre-proline 0 N--CA 1.447 -0.588 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.743 -178.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.33 155.3 67.74 Favored 'Trans proline' 0 C--O 1.236 0.389 0 C-N-CA 122.409 2.072 . . . . 0.0 112.982 -177.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.58 ' HB1' ' HD2' ' A' ' 103' ' ' PRO . . . -77.21 166.41 44.67 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.925 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.58 ' HD2' ' HB1' ' A' ' 102' ' ' ALA . 43.3 Cg_endo -68.63 132.94 26.38 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.317 2.011 . . . . 0.0 112.566 176.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.457 HH22 ' C ' ' A' ' 12' ' ' SER . 46.3 ttm180 -86.84 90.58 8.36 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.859 177.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.446 ' HA ' ' HD2' ' A' ' 106' ' ' PRO . 32.1 t80 -145.18 117.33 5.26 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.46 -177.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.525 ' O ' ' HD3' ' A' ' 108' ' ' PRO . 10.4 Cg_endo -53.38 117.6 3.97 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.954 2.436 . . . . 0.0 111.452 178.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 18.7 m -90.73 109.73 36.57 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.511 -172.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.525 ' HD3' ' O ' ' A' ' 106' ' ' PRO . 39.2 Cg_exo -60.12 -55.27 1.67 Allowed 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 123.082 2.521 . . . . 0.0 113.894 178.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.426 ' HD3' ' HB2' ' A' ' 108' ' ' PRO . 60.7 Cg_endo -72.98 118.18 5.45 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 121.455 1.437 . . . . 0.0 112.84 -177.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 25.7 ttt -83.11 103.83 12.84 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.531 175.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -120.68 -64.73 0.26 Allowed Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.151 -1.023 . . . . 0.0 113.076 -176.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.401 ' HB2' ' HA ' ' A' ' 26' ' ' THR . 13.4 m -94.56 125.54 39.28 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.873 0.368 . . . . 0.0 111.222 -173.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.407 ' HB ' ' HA ' ' A' ' 22' ' ' GLN . 10.5 p -175.64 144.0 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.817 -178.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 21.8 t -159.68 109.8 1.9 Allowed 'General case' 0 C--O 1.239 0.545 0 CA-C-O 120.484 0.183 . . . . 0.0 110.662 -178.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 118' ' ' LEU . . . 63.11 168.95 0.09 OUTLIER Pre-proline 0 N--CA 1.469 0.516 0 O-C-N 124.133 0.896 . . . . 0.0 112.36 174.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.511 ' HA ' ' HD3' ' A' ' 21' ' ' ARG . 9.9 Cg_endo -92.34 -10.15 2.28 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 123.422 2.748 . . . . 0.0 113.028 175.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 26.4 t30 -154.53 105.71 2.66 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 -175.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.649 ' HG ' ' HD2' ' A' ' 119' ' ' PRO . 15.8 tp 71.55 151.76 0.14 Allowed Pre-proline 0 N--CA 1.466 0.359 0 O-C-N 124.32 1.012 . . . . 0.0 108.503 -174.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.649 ' HD2' ' HG ' ' A' ' 118' ' ' LEU . 42.2 Cg_endo -69.2 -147.07 0.02 OUTLIER 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 121.544 1.496 . . . . 0.0 111.808 174.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.452 ' H ' ' HB2' ' A' ' 119' ' ' PRO . 41.1 m -145.4 119.2 9.24 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 174.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.766 ' HB2' ' HB3' ' A' ' 126' ' ' GLU . . . -67.56 73.91 0.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.449 0.642 . . . . 0.0 111.502 179.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -84.05 -21.89 31.42 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.355 177.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -108.59 -69.1 0.87 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.537 171.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.413 HD22 ' N ' ' A' ' 124' ' ' ASN . 0.1 OUTLIER -172.47 161.92 5.18 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 118.66 0.663 . . . . 0.0 112.76 177.789 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.802 HD12 HG21 ' A' ' 152' ' ' ILE . 3.9 mm? 72.25 98.59 0.07 Allowed 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.881 174.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.766 ' HB3' ' HB2' ' A' ' 121' ' ' ALA . 41.5 tt0 -179.7 -75.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.35 -1.295 . . . . 0.0 109.157 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 21.0 m-85 -98.88 108.13 20.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.188 0.518 . . . . 0.0 110.96 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.996 HG22 ' HG3' ' A' ' 180' ' ' LYS . 56.2 t -124.07 135.48 63.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.667 -179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.671 ' NH1' ' HB2' ' A' ' 181' ' ' LEU . 0.0 OUTLIER -111.29 148.05 33.75 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 117.51 -1.676 . . . . 0.0 108.538 169.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.557 HG22 HG12 ' A' ' 178' ' ' VAL . 0.9 OUTLIER -101.78 131.82 47.87 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.269 -179.903 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.563 HD21 ' HG2' ' A' ' 179' ' ' GLU . 21.8 mt -106.58 -17.5 14.23 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -176.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -87.09 -34.16 19.23 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.852 -0.339 . . . . 0.0 111.507 -174.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.527 ' HB2' ' HA ' ' A' ' 145' ' ' LYS . 0.0 OUTLIER 65.06 121.1 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 122.229 1.014 . . . . 0.0 111.317 -173.838 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -146.36 87.42 6.54 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 114.636 -1.166 . . . . 0.0 108.194 177.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.609 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 72.6 Cg_endo -83.0 85.99 1.51 Allowed 'Trans proline' 0 N--CA 1.445 -1.333 0 C-N-CA 121.778 1.652 . . . . 0.0 112.578 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -77.18 -13.74 83.31 Favored Glycine 0 C--N 1.332 0.358 0 N-CA-C 110.861 -0.895 . . . . 0.0 110.861 173.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.628 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 17.4 m120 52.59 64.74 1.74 Allowed 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 114.235 -0.982 . . . . 0.0 111.216 178.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.608 ' HB3' ' H ' ' A' ' 141' ' ' ASP . 0.4 OUTLIER -130.84 -177.29 4.3 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.239 0.543 . . . . 0.0 111.335 -175.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -110.95 0.8 17.18 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.675 167.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -116.72 -43.54 2.89 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.1 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.608 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 14.5 m-20 -101.07 123.62 45.52 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 169.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 1.075 HD11 ' HB2' ' A' ' 165' ' ' ASN . 32.2 tp -77.98 120.44 81.26 Favored Pre-proline 0 N--CA 1.468 0.459 0 CA-C-O 120.743 0.306 . . . . 0.0 111.058 -175.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.628 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 36.2 Cg_endo -72.44 95.46 0.78 Allowed 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 121.444 1.429 . . . . 0.0 111.272 168.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.551 ' CE2' ' HB ' ' A' ' 173' ' ' ILE . 10.4 p90 -106.7 160.55 15.38 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.391 -177.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.527 ' HA ' ' HB2' ' A' ' 133' ' ' ASP . 0.1 OUTLIER -103.56 -171.77 2.0 Allowed 'General case' 0 C--N 1.321 -0.633 0 C-N-CA 120.929 -0.308 . . . . 0.0 111.25 -177.344 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.814 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -88.57 5.31 43.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.36 -171.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -165.11 36.68 0.28 Allowed Glycine 0 N--CA 1.443 -0.873 0 N-CA-C 111.199 -0.76 . . . . 0.0 111.199 175.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.453 ' HB3' ' HB2' ' A' ' 145' ' ' LYS . 0.0 OUTLIER -101.08 150.53 22.82 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.043 0.449 . . . . 0.0 111.368 -175.365 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.56 HD12 ' HB3' ' A' ' 129' ' ' ARG . 0.7 OUTLIER -90.14 132.14 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.798 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.567 -177.541 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.761 HD22 HD21 ' A' ' 142' ' ' LEU . 44.7 mt -127.9 157.15 41.31 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -177.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.581 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 58.0 t -122.93 123.8 68.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 174.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.957 HD13 ' HB2' ' A' ' 163' ' ' ALA . 36.8 mm -76.21 79.04 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.727 HG23 ' HG3' ' A' ' 154' ' ' GLU . 11.1 tt -75.62 -28.25 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-N 113.165 -1.834 . . . . 0.0 109.559 -174.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.727 ' HG3' HG23 ' A' ' 153' ' ' ILE . 29.8 mt-10 -134.39 142.15 47.08 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 175.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.424 ' HE3' ' HE1' ' A' ' 161' ' ' TRP . 81.8 tttt -143.62 78.23 14.6 Favored Pre-proline 0 C--N 1.324 -0.505 0 O-C-N 121.547 -0.721 . . . . 0.0 111.264 177.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.438 ' HG2' ' HG2' ' A' ' 157' ' ' GLU . 59.2 Cg_endo -73.93 -31.56 8.02 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.113 1.875 . . . . 0.0 111.552 176.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.438 ' HG2' ' HG2' ' A' ' 156' ' ' PRO . 14.2 mm-40 -119.89 164.37 16.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.519 -172.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.566 ' O ' HG21 ' A' ' 175' ' ' VAL . 9.3 tp10 -102.86 -22.24 13.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.587 0.232 . . . . 0.0 110.878 178.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.958 HE21 ' HA ' ' A' ' 159' ' ' GLN . 0.0 OUTLIER -91.19 -21.14 21.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.094 0.474 . . . . 0.0 110.059 177.463 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 56.7 m95 -124.75 133.51 53.14 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.119 174.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . 0.931 ' HB3' HD12 ' A' ' 152' ' ' ILE . 46.1 m0 -110.94 133.6 53.24 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.258 0.551 . . . . 0.0 110.664 176.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.576 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 67.4 m -93.02 89.05 6.35 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -176.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.957 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -106.27 145.63 31.37 Favored 'General case' 0 N--CA 1.418 -2.033 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 -169.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.688 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 13.3 ptt180 -87.07 123.85 32.59 Favored 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 175.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 1.075 ' HB2' HD11 ' A' ' 142' ' ' LEU . 24.3 t30 -53.0 171.11 0.07 Allowed 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 113.277 -1.783 . . . . 0.0 110.736 -174.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 61.9 tttt -57.35 -19.99 26.31 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 173.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -70.64 -54.94 10.0 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 115.41 -0.813 . . . . 0.0 110.273 169.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' A' ' 164' ' ' ARG . . . 134.3 -8.86 4.72 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.947 -171.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.688 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -65.57 130.26 42.67 Favored 'General case' 0 C--O 1.217 -0.624 0 C-N-CA 123.343 0.657 . . . . 0.0 111.734 178.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.509 HG22 HG21 ' A' ' 153' ' ' ILE . 27.0 t -83.69 126.99 40.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.128 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -158.07 149.45 19.82 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.428 -0.892 . . . . 0.0 112.243 171.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.544 ' HG2' ' OG ' ' A' ' 162' ' ' SER . 9.3 mtp -74.63 141.14 44.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.843 0.354 . . . . 0.0 110.773 -178.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.721 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.6 pp -142.12 141.72 22.38 Favored Pre-proline 0 N--CA 1.45 -0.474 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.795 -174.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.526 ' HB2' ' CD1' ' A' ' 177' ' ' TYR . 24.5 Cg_exo -64.88 127.47 18.68 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.804 2.336 . . . . 0.0 112.879 -178.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.566 HG21 ' O ' ' A' ' 158' ' ' GLU . 72.9 t -61.33 -40.73 74.86 Favored Pre-proline 0 CA--C 1.545 0.75 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 177.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -61.44 -5.4 5.39 Favored 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 121.92 1.747 . . . . 0.0 112.906 176.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.526 ' CD1' ' HB2' ' A' ' 174' ' ' PRO . 2.8 m-30 -97.53 -10.96 24.31 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.632 -177.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.637 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 4.0 m -105.67 -172.98 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -164.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.653 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 3.8 tp10 -159.98 50.76 0.31 Allowed 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 113.143 -1.844 . . . . 0.0 112.949 -151.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.996 ' HG3' HG22 ' A' ' 128' ' ' VAL . 2.2 mppt? -69.83 137.56 51.87 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 119.451 -2.031 . . . . 0.0 111.061 -161.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.671 ' HB2' ' NH1' ' A' ' 129' ' ' ARG . 12.3 tp -71.98 -92.31 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 112.999 -1.91 . . . . 0.0 111.694 -169.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.455 ' H ' ' HB3' ' A' ' 181' ' ' LEU . 6.9 p -86.27 122.34 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 176.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.431 ' NH1' ' HE3' ' A' ' 180' ' ' LYS . 24.3 ttt180 -173.63 141.3 0.84 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.149 -173.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 27.7 t -82.43 143.53 31.11 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 172.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.687 ' HB2' ' HD2' ' A' ' 186' ' ' PRO . 5.0 p -65.88 168.46 8.86 Favored Pre-proline 0 C--N 1.324 -0.534 0 N-CA-C 110.49 -0.189 . . . . 0.0 110.49 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.687 ' HD2' ' HB2' ' A' ' 185' ' ' SER . 18.3 Cg_endo -58.96 82.97 0.05 OUTLIER 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.005 2.47 . . . . 0.0 113.266 -175.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -102.09 -43.96 5.6 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.34 174.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 81.95 -53.86 4.78 Favored Glycine 0 N--CA 1.451 -0.315 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -176.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.417 ' HE2' ' HB3' ' A' ' 189' ' ' LYS . 35.1 ttpt -79.32 76.28 5.89 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.258 0.551 . . . . 0.0 110.323 175.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -114.91 90.36 3.32 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 174.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 84.24 -151.09 26.66 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 -171.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -117.77 108.78 15.79 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 117.476 0.638 . . . . 0.0 109.739 176.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -136.01 24.16 3.3 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -128.44 86.42 2.45 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.593 -176.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 14.1 t -176.6 178.17 1.31 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 13.1 m120 64.89 100.82 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.74 0.65 . . . . 0.0 112.493 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 20.4 m -93.94 103.9 15.98 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 174.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -92.59 111.52 23.14 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.325 0.491 . . . . 0.0 112.325 -174.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -79.12 152.26 36.17 Favored Glycine 0 N--CA 1.443 -0.847 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 165.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.47 ' HA ' ' HD3' ' A' ' 201' ' ' PRO . 45.9 mm -48.1 110.54 1.44 Allowed Pre-proline 0 C--O 1.236 0.37 0 CA-C-N 117.44 0.62 . . . . 0.0 111.467 -175.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 200' ' ' ILE . 16.8 Cg_exo -67.44 144.59 67.98 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 123.208 2.605 . . . . 0.0 112.446 -175.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -83.01 130.03 59.05 Favored Pre-proline 0 C--N 1.319 -0.721 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.652 -176.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -77.79 106.49 2.19 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.367 2.045 . . . . 0.0 110.948 172.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -67.65 141.54 56.68 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.328 -176.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -107.08 -22.22 12.72 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 177.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -112.98 121.01 43.37 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.486 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' TYR . . . . . 0.461 ' O ' ' HD2' ' A' ' 210' ' ' PRO . 76.7 m-85 -115.16 159.54 20.79 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.995 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -78.65 -20.22 50.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.786 -177.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.683 ' HB2' ' HD3' ' A' ' 210' ' ' PRO . 15.7 mm100 -60.12 -53.79 61.62 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -178.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 0.683 ' HD3' ' HB2' ' A' ' 209' ' ' GLN . 38.4 Cg_exo -62.17 -16.66 52.11 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.252 1.968 . . . . 0.0 113.563 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -109.18 -7.87 15.22 Favored 'General case' 0 C--N 1.331 -0.221 0 C-N-CA 120.909 -0.316 . . . . 0.0 111.615 -178.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.438 HG22 ' HA ' ' A' ' 209' ' ' GLN . 6.9 t -95.07 -11.44 28.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.16 0.505 . . . . 0.0 109.843 177.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . 0.426 ' O ' ' HD3' ' A' ' 215' ' ' PRO . 50.9 m -126.42 109.52 12.31 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.973 176.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 33.4 p -109.66 94.31 16.39 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.302 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 213' ' ' THR . 74.1 Cg_endo -89.64 133.18 2.15 Favored 'Trans proline' 0 N--CA 1.453 -0.897 0 C-N-CA 122.799 2.332 . . . . 0.0 113.27 -175.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.402 ' HA ' ' HD3' ' A' ' 217' ' ' PRO . 3.5 mm? -97.74 105.13 24.73 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 173.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 216' ' ' LEU . 17.0 Cg_exo -66.55 -75.84 0.01 OUTLIER 'Trans proline' 0 N--CA 1.465 -0.194 0 C-N-CA 122.845 2.363 . . . . 0.0 112.55 -175.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -138.32 103.14 4.83 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.914 0.387 . . . . 0.0 110.603 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 27.6 m -106.23 -16.4 8.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.325 177.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 3.5 p -79.4 161.34 26.22 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.868 -179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 157.08 -6.51 0.2 Allowed Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.412 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 16.7 t -98.87 105.9 34.17 Favored Pre-proline 0 C--N 1.328 -0.327 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -68.31 -44.64 3.31 Favored 'Trans proline' 0 C--O 1.235 0.347 0 C-N-CA 122.772 2.315 . . . . 0.0 113.009 -176.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 62.05 91.24 0.02 OUTLIER Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.996 -0.621 . . . . 0.0 111.874 -175.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -87.68 86.09 7.15 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 122.533 -0.392 . . . . 0.0 110.788 -177.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . 70.16 -64.7 0.35 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.654 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 45.1 mm -121.57 123.41 69.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.409 ' CG2' ' HB2' ' A' ' 301' ' ' GLU . 44.7 m -70.42 126.13 92.2 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.252 -0.431 . . . . 0.0 109.932 176.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -72.16 -177.89 2.92 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.497 2.131 . . . . 0.0 112.444 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.518 HD22 HD22 ' A' ' 235' ' ' ASN . 60.3 mt 68.73 92.19 0.06 OUTLIER Pre-proline 0 N--CA 1.463 0.213 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.465 177.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -67.15 -66.91 0.04 OUTLIER 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.716 2.277 . . . . 0.0 112.147 177.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 14.0 m -141.57 13.38 2.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.006 0.431 . . . . 0.0 110.78 179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 2.2 p -113.11 122.8 48.63 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.951 0.405 . . . . 0.0 111.872 -177.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 234' ' ' GLN . 5.1 pm0 -77.14 98.09 4.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.636 0.731 . . . . 0.0 109.386 173.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . 0.518 HD22 HD22 ' A' ' 230' ' ' LEU . 36.6 m-80 -95.53 104.89 16.82 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.101 -175.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . 0.438 ' HA2' ' HD3' ' A' ' 237' ' ' PRO . . . 174.14 145.76 5.35 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.648 177.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.438 ' HD3' ' HA2' ' A' ' 236' ' ' GLY . 39.6 Cg_exo -63.11 169.71 8.77 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.964 2.443 . . . . 0.0 111.937 174.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.529 ' HB ' HG13 ' A' ' 266' ' ' VAL . 58.6 t -83.91 116.5 27.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-O 121.315 0.578 . . . . 0.0 110.908 -176.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -103.91 114.45 28.71 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.566 175.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.624 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -119.54 131.17 55.49 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.06 -178.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.637 ' HE3' ' HA2' ' A' ' 261' ' ' GLY . 48.5 tttp -90.13 126.12 35.68 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . 0.461 ' O ' ' HA ' ' A' ' 260' ' ' VAL . . . -74.83 97.08 3.21 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.23 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 48.2 pt -77.35 -21.91 14.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.127 0.489 . . . . 0.0 110.444 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.17 141.11 50.69 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 177.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -67.91 161.4 26.51 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-O 121.175 0.512 . . . . 0.0 111.073 -174.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.451 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 24.7 tpt180 -151.67 101.36 2.78 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.623 179.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 29.6 m -97.46 154.24 38.07 Favored Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.528 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.457 ' HA ' ' HB3' ' A' ' 255' ' ' ALA . 10.1 Cg_exo -69.63 99.98 0.77 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 122.202 1.934 . . . . 0.0 111.176 177.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' CYS . . . . . 0.53 ' HB3' ' HB2' ' A' ' 252' ' ' ASP . 42.3 t -70.24 167.96 16.82 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.325 -178.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -53.83 -38.28 64.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.917 0.389 . . . . 0.0 110.977 176.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -103.53 17.27 24.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.006 0.431 . . . . 0.0 111.142 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.53 ' HB2' ' HB3' ' A' ' 249' ' ' CYS . 4.0 m-20 -140.18 54.4 1.64 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.539 175.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 35.7 mtmm -75.04 -14.85 60.64 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.37 -177.029 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 4.4 p -93.57 6.76 47.18 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.733 176.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.457 ' HB3' ' HA ' ' A' ' 248' ' ' PRO . . . -80.8 150.92 29.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.14 0.495 . . . . 0.0 110.984 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.9 tt -90.63 124.43 35.05 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -67.87 100.13 0.91 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.335 0.588 . . . . 0.0 110.427 177.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.521 HD22 HG22 ' A' ' 264' ' ' VAL . 93.4 mt -108.29 147.82 30.9 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.138 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -129.03 163.49 25.28 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.854 178.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 61.6 t -62.13 122.48 12.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.164 0.506 . . . . 0.0 111.4 -176.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.637 ' HA2' ' HE3' ' A' ' 241' ' ' LYS . . . 102.71 -9.39 55.41 Favored Glycine 0 N--CA 1.446 -0.694 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.694 177.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -79.52 140.28 37.3 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 -173.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 44.3 mm -88.57 109.22 19.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.394 -179.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.521 HG22 HD22 ' A' ' 258' ' ' LEU . 15.0 t -83.58 100.69 7.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.129 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 58.9 tttm -83.14 87.33 6.92 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.853 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.529 HG13 ' HB ' ' A' ' 238' ' ' VAL . 4.8 p -97.53 133.4 39.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.071 0.462 . . . . 0.0 110.688 -177.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 20.7 p -103.57 -35.46 8.29 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.849 -175.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . 0.419 ' HG3' ' HB3' ' A' ' 276' ' ' GLU . 3.1 ptp180 -118.21 121.53 40.71 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.095 0.474 . . . . 0.0 110.68 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' MET . . . . . 0.49 ' HE1' HG11 ' A' ' 266' ' ' VAL . 45.7 mmm -95.36 99.38 11.31 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.577 -177.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.509 ' HB2' ' O ' ' A' ' 274' ' ' GLN . 84.3 m-20 -75.34 129.94 38.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.542 -178.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 11.1 tp -69.25 -15.19 19.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -171.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -71.39 -18.34 62.36 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 120.756 0.313 . . . . 0.0 111.033 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 115.24 -34.1 4.98 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.993 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.529 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 17.2 mt-30 -83.6 105.04 14.21 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 175.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.426 ' HB3' HG21 ' A' ' 266' ' ' VAL . 40.2 m0 -92.71 156.7 16.87 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -176.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.419 ' HB3' ' HG3' ' A' ' 268' ' ' ARG . 30.4 tt0 -108.01 106.52 16.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.99 0.424 . . . . 0.0 110.379 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . 0.483 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -121.06 153.82 16.55 Favored Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 177.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -116.23 111.92 20.87 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . 0.627 HG12 HD22 ' A' ' 280' ' ' ASN . 16.7 t -122.93 125.76 72.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.515 -177.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . 0.627 HD22 HG12 ' A' ' 279' ' ' VAL . 9.6 p30 44.0 41.58 4.11 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.144 0.978 . . . . 0.0 112.981 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 102.6 -20.48 44.08 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.782 -0.723 . . . . 0.0 113.675 173.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 17.2 mtp-105 -109.1 125.18 51.88 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 117.232 0.516 . . . . 0.0 110.908 -177.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 42.1 pttt -114.88 134.73 54.91 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 120.289 -0.564 . . . . 0.0 109.999 172.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -155.96 176.41 33.45 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.675 -177.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.529 ' HB3' ' HB3' ' A' ' 274' ' ' GLN . 57.6 mt -91.08 118.29 30.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.983 0.42 . . . . 0.0 110.678 178.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.427 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 45.9 p90 -120.94 138.86 28.29 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.256 179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 6.3 Cg_exo -76.06 139.41 21.6 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.043 2.495 . . . . 0.0 111.469 175.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -69.8 1.38 4.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.997 -177.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 19.8 p -82.7 -15.03 53.5 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.682 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 13.9 m-70 -103.57 -17.27 15.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.794 0.331 . . . . 0.0 111.343 -177.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.517 ' O ' ' HD2' ' A' ' 292' ' ' LYS . 32.7 m -115.29 159.31 15.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.269 -178.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . 0.517 ' HD2' ' O ' ' A' ' 291' ' ' VAL . 11.1 mptt -126.9 129.02 47.4 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.923 0.392 . . . . 0.0 110.682 177.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.624 HD13 ' HB2' ' A' ' 240' ' ' ALA . 39.7 mm -73.41 130.84 35.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.42 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' PHE . . . . . 0.445 ' CE1' ' HB2' ' A' ' 241' ' ' LYS . 0.6 OUTLIER -152.56 165.34 35.46 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.451 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.486 ' HB3' ' HA ' ' A' ' 298' ' ' ASN . 17.2 m-20 -104.8 102.01 32.51 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 175.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -66.41 -33.03 39.22 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.702 2.268 . . . . 0.0 112.567 -173.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -120.83 -6.92 9.59 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.82 179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . 0.486 ' HA ' ' HB3' ' A' ' 295' ' ' ASP . 16.8 m120 59.61 100.12 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.474 0 O-C-N 123.63 0.581 . . . . 0.0 111.09 -173.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' PRO . . . . . 0.416 ' HD3' ' HB3' ' A' ' 295' ' ' ASP . 6.9 Cg_exo -73.76 36.87 0.4 Allowed 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 123.236 2.624 . . . . 0.0 112.334 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -73.69 -48.09 34.76 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.221 0.534 . . . . 0.0 109.755 178.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . 0.409 ' HB2' ' CG2' ' A' ' 228' ' ' THR . 11.2 pt-20 -130.64 6.68 4.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.324 173.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -100.64 119.84 39.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.52 -174.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 . . . . . 0 C--O 1.252 1.215 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.146 176.336 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 pmm? . . . . . 0 N--CA 1.483 1.22 0 CA-C-O 120.267 0.079 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.4 t 72.06 137.82 0.05 OUTLIER 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 121.388 0.613 . . . . 0.0 110.974 -178.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.4 t -152.35 -60.39 0.15 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -85.39 119.82 26.18 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.617 177.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.508 ' HD3' ' HA ' ' A' ' 5' ' ' ARG . 22.1 mmt180 -131.35 87.7 2.5 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.38 0.609 . . . . 0.0 111.412 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -158.81 168.17 27.53 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 177.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -100.58 131.59 46.41 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.061 175.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.5 m -69.65 -19.76 63.61 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.19 -174.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.8 t -106.24 -24.37 12.32 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.913 0.338 . . . . 0.0 111.913 -172.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -60.82 95.13 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.961 0.41 . . . . 0.0 111.143 -175.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 7.8 tpp180 -52.74 -51.23 61.41 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 123.205 0.602 . . . . 0.0 112.15 -174.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 29.6 m -72.93 4.88 3.71 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.968 0.359 . . . . 0.0 111.968 -176.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -91.65 -48.7 6.69 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 120.488 -0.485 . . . . 0.0 110.55 175.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 37.4 p-90 -113.92 -30.39 6.74 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -172.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -70.99 113.52 8.11 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.391 -0.524 . . . . 0.0 109.634 -179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.799 ' HB3' HG11 ' A' ' 19' ' ' VAL . 27.9 tpp -94.22 1.63 56.0 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-O 120.911 0.386 . . . . 0.0 110.293 -170.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 50.65 -111.96 1.43 Allowed Glycine 0 C--N 1.334 0.451 0 CA-C-N 115.041 -0.981 . . . . 0.0 113.653 177.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -64.97 90.87 0.2 Allowed 'Trans proline' 0 C--O 1.233 0.273 0 C-N-CA 122.846 2.364 . . . . 0.0 112.297 178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.947 HG22 ' HD2' ' A' ' 39' ' ' ARG . 2.7 p -162.5 159.43 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 25.7 m -156.64 -166.63 2.17 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 -160.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.48 ' O ' ' HB2' ' A' ' 25' ' ' GLN . 44.1 mtp85 -69.25 -41.56 76.76 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.663 -175.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 15.5 tp60 -64.24 -54.02 39.89 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 123.458 0.473 . . . . 0.0 111.024 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.696 ' OE1' ' HA ' ' A' ' 106' ' ' PRO . 47.9 mm-40 -61.12 -56.43 20.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.835 -176.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.91 -33.66 67.15 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.738 0.304 . . . . 0.0 111.614 -178.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.48 ' HB2' ' O ' ' A' ' 21' ' ' ARG . 26.9 tp60 -61.8 -47.69 83.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.867 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 5.0 t -79.97 -25.27 40.45 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 120.88 0.372 . . . . 0.0 111.553 -175.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.428 ' NH1' ' HB ' ' A' ' 19' ' ' VAL . 97.5 mtt180 -74.72 -38.16 62.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.987 0.422 . . . . 0.0 110.962 -177.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.925 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 28.7 mt -99.72 6.66 45.5 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.935 -176.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.476 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 17.0 tp60 -72.05 95.31 1.6 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.083 0.468 . . . . 0.0 111.725 -172.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 66.37 29.04 74.16 Favored Glycine 0 N--CA 1.453 -0.202 0 CA-C-N 115.608 -0.724 . . . . 0.0 113.815 173.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.451 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 0.0 OUTLIER -85.39 -91.91 0.09 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 117.027 0.414 . . . . 0.0 110.082 178.483 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.567 ' HB2' ' SD ' ' A' ' 35' ' ' MET . 86.7 mtm-85 -127.54 135.54 50.48 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.013 -0.366 . . . . 0.0 110.013 170.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 58.5 m170 -71.06 124.61 24.79 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 176.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 117.06 -13.75 14.03 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.649 -176.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.656 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 93.4 mtp -73.62 126.37 30.13 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 175.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.52 ' CB ' HG22 ' A' ' 52' ' ' VAL . 47.1 p90 -133.6 166.0 23.61 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.901 0.381 . . . . 0.0 111.013 -177.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.528 ' HB2' ' HB2' ' A' ' 16' ' ' MET . 4.0 pp -158.07 138.79 12.96 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.499 176.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.428 ' CG2' HD13 ' A' ' 50' ' ' LEU . 87.7 t -102.1 123.58 55.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 176.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.947 ' HD2' HG22 ' A' ' 19' ' ' VAL . 5.0 mtm-85 -106.77 175.01 5.64 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.163 -171.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -86.62 90.96 8.43 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 167.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.711 ' HA ' HG23 ' A' ' 49' ' ' VAL . 7.5 t 24.76 -141.41 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.347 1.459 . . . . 0.0 114.487 -176.096 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.595 ' HB3' HH21 ' A' ' 39' ' ' ARG . 56.0 p 172.26 -29.13 0.0 OUTLIER 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 114.106 -1.406 . . . . 0.0 108.778 174.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 40.3 p -122.88 -13.0 7.95 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.982 -177.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.46 ' HA ' ' HD2' ' A' ' 45' ' ' PRO . 64.0 m -133.47 100.17 13.96 Favored Pre-proline 0 C--N 1.326 -0.431 0 N-CA-C 110.527 -0.175 . . . . 0.0 110.527 -175.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.46 ' HD2' ' HA ' ' A' ' 44' ' ' CYS . 17.9 Cg_endo -57.42 109.18 0.43 Allowed 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.97 2.447 . . . . 0.0 113.069 -174.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 113.81 -19.73 18.26 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.695 177.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' A' ' 41' ' ' SER . 74.8 m-20 -90.25 -174.65 4.25 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.34 -0.245 . . . . 0.0 110.34 179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.615 ' HA ' ' H ' ' A' ' 41' ' ' SER . 26.9 m-85 -129.55 167.77 17.41 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.711 HG23 ' HA ' ' A' ' 41' ' ' SER . 96.6 t -142.22 98.07 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-O 121.046 0.451 . . . . 0.0 111.298 177.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.428 HD13 ' CG2' ' A' ' 38' ' ' VAL . 40.8 tp -70.1 103.02 2.19 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.963 175.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.508 ' HB3' ' CG1' ' A' ' 58' ' ' VAL . 21.5 m -96.56 134.4 39.82 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.807 175.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.578 HG21 HD13 ' A' ' 93' ' ' LEU . 96.4 t -123.0 142.8 38.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.329 -178.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.925 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 36.0 t -88.05 116.92 26.57 Favored 'General case' 0 C--N 1.334 -0.081 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.649 176.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.851 ' HB2' ' HB3' ' A' ' 94' ' ' ASP . 4.8 pt-20 -165.64 141.88 5.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.775 -0.193 . . . . 0.0 110.997 -177.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.62 HD21 ' HE2' ' A' ' 155' ' ' LYS . 0.5 OUTLIER 53.16 32.12 12.65 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 122.933 0.493 . . . . 0.0 111.881 -174.385 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 8.1 m 67.34 11.12 8.21 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.62 177.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.583 ' HG3' ' O ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -125.39 165.31 18.63 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.187 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.508 ' CG1' ' HB3' ' A' ' 51' ' ' SER . 84.1 t -106.32 105.47 18.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 121.035 0.445 . . . . 0.0 110.651 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.7 t -76.51 120.36 21.61 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.765 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -99.76 102.4 13.84 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.61 -174.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.713 ' HE1' HD11 ' A' ' 153' ' ' ILE . 66.9 m-85 -100.53 101.5 12.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.621 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.597 HG12 HG22 ' A' ' 49' ' ' VAL . 25.6 mt -81.05 138.41 19.7 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 121.152 0.501 . . . . 0.0 112.311 -174.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.625 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 3.7 mp -116.85 122.24 69.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.603 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -104.01 140.42 37.77 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -175.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.4 t -79.85 104.83 10.7 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.103 0.478 . . . . 0.0 110.444 -177.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.519 HD11 ' HB2' ' A' ' 72' ' ' LYS . 90.6 mt -75.24 132.73 75.87 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.617 178.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -57.18 -19.85 35.81 Favored 'Trans proline' 0 N--CA 1.473 0.302 0 C-N-CA 123.425 2.75 . . . . 0.0 113.409 -174.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -90.28 26.85 1.81 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.238 178.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.706 ' HE ' ' HA ' ' A' ' 69' ' ' ARG . 2.2 mmp_? 69.3 26.07 5.44 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.356 173.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.638 ' HG2' ' HA ' ' A' ' 79' ' ' ASP . 69.8 mtt180 -114.47 179.0 4.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.604 176.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.625 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 36.6 m-85 -139.1 120.39 14.82 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.774 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.519 ' HB2' HD11 ' A' ' 66' ' ' LEU . 19.6 ttmm -106.65 110.21 22.34 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.615 -178.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.679 HD11 ' HB3' ' A' ' 61' ' ' TYR . 3.9 tt -94.06 103.62 14.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.084 0.468 . . . . 0.0 110.869 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 52.69 63.11 5.24 Favored Glycine 0 N--CA 1.452 -0.28 0 CA-C-N 115.658 -0.701 . . . . 0.0 113.111 178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.1 t0 78.59 -38.88 0.24 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.002 0.521 . . . . 0.0 111.081 177.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -69.09 119.12 12.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.002 0.429 . . . . 0.0 110.259 177.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.431 ' HB3' ' NZ ' ' A' ' 72' ' ' LYS . 7.7 pt-20 -99.23 133.67 43.18 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.274 0.559 . . . . 0.0 111.846 -174.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.46 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 79.7 m-85 -136.83 164.1 29.09 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.818 177.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.638 ' HA ' ' HG2' ' A' ' 70' ' ' ARG . 6.9 m-20 -73.75 -26.56 60.73 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -176.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.431 ' HB2' ' HD2' ' A' ' 82' ' ' PRO . 5.7 p80 -163.11 172.96 14.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.848 -0.16 . . . . 0.0 110.937 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.555 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 19.6 mt -58.34 -52.25 75.93 Favored Pre-proline 0 CA--C 1.535 0.367 0 O-C-N 123.251 0.344 . . . . 0.0 111.656 179.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.555 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 52.0 Cg_exo -58.11 -9.03 5.56 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 122.419 2.079 . . . . 0.0 113.467 177.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.28 -36.35 15.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.953 0.406 . . . . 0.0 110.799 -178.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.496 HD21 HD23 ' A' ' 81' ' ' LEU . 3.7 pp -79.97 -33.89 39.12 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 90.3 mt -68.08 -14.2 62.79 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.635 0.731 . . . . 0.0 110.115 175.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -85.98 -44.9 11.96 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.667 177.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.454 ' O ' HG12 ' A' ' 90' ' ' ILE . 84.9 t80 -70.15 -37.13 75.17 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.534 -177.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.492 ' HE2' HD13 ' A' ' 73' ' ' ILE . 16.7 m-85 -72.77 5.2 3.33 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -176.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -83.76 -14.98 50.21 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 119.915 -0.714 . . . . 0.0 111.144 171.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.454 HG12 ' O ' ' A' ' 87' ' ' PHE . 5.6 pt -87.89 -28.93 5.47 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.227 166.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.451 ' N ' HG13 ' A' ' 90' ' ' ILE . 3.0 m170 -91.14 124.53 35.43 Favored 'General case' 0 CA--C 1.502 -0.865 0 CA-C-O 121.135 0.493 . . . . 0.0 111.181 -177.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -86.81 90.04 8.17 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 175.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.578 HD13 HG21 ' A' ' 52' ' ' VAL . 5.3 mt -46.63 -36.36 6.91 Favored 'General case' 0 C--O 1.218 -0.567 0 O-C-N 124.346 1.029 . . . . 0.0 110.204 -177.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.851 ' HB3' ' HB2' ' A' ' 54' ' ' GLU . 21.6 t70 -158.82 99.35 1.54 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.841 165.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.634 ' HA ' ' HA ' ' A' ' 156' ' ' PRO . 5.7 t 44.3 18.16 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.663 1.185 . . . . 0.0 112.498 -177.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 4.7 t -162.77 154.58 18.15 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.48 ' O ' HG12 ' A' ' 99' ' ' ILE . 52.2 p -104.11 -179.01 3.82 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.4 104.97 0.84 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 173.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 97' ' ' THR . 45.1 mm -99.86 -54.93 6.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.737 -173.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.656 ' O ' ' HA ' ' A' ' 35' ' ' MET . 10.6 pt-20 -151.59 153.02 31.55 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.062 -173.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 100' ' ' GLU . 1.9 Cg_endo -83.84 158.61 13.89 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.948 2.432 . . . . 0.0 112.746 178.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -88.18 164.62 32.56 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.054 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -78.28 164.92 26.23 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.99 2.46 . . . . 0.0 112.453 175.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.793 ' HG2' ' SD ' ' A' ' 16' ' ' MET . 19.8 mtm180 -99.78 111.99 24.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.492 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.428 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 1.6 t80 -170.48 117.71 0.49 Allowed Pre-proline 0 C--N 1.331 -0.216 0 CA-C-O 120.511 0.196 . . . . 0.0 111.099 178.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.696 ' HA ' ' OE1' ' A' ' 23' ' ' GLU . 2.6 Cg_endo -82.29 159.37 17.51 Favored 'Trans proline' 0 C--O 1.238 0.487 0 C-N-CA 123.449 2.766 . . . . 0.0 111.945 176.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.855 ' HB2' ' HD3' ' A' ' 108' ' ' PRO . 41.0 m -150.26 -68.39 0.02 OUTLIER Pre-proline 0 CA--C 1.546 0.799 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.855 ' HD3' ' HB2' ' A' ' 107' ' ' SER . 3.0 Cg_endo -85.87 164.62 10.32 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 122.84 2.36 . . . . 0.0 113.048 -173.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -71.75 -79.99 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.818 2.346 . . . . 0.0 112.186 177.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -168.61 140.85 2.78 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 121.121 0.486 . . . . 0.0 110.703 177.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 151.63 74.24 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.6 -178.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 12.1 p -74.87 172.22 12.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.757 0.313 . . . . 0.0 110.826 -179.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 2.9 t -82.29 46.24 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 120.74 0.305 . . . . 0.0 111.236 -175.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 25.4 t 67.41 179.35 0.23 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.111 176.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.456 ' HA ' ' HD2' ' A' ' 116' ' ' PRO . . . 60.07 102.49 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.368 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 173.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.456 ' HD2' ' HA ' ' A' ' 115' ' ' ALA . 26.2 Cg_endo -63.9 -26.61 66.97 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.761 2.307 . . . . 0.0 112.267 177.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.586 ' O ' ' HB2' ' A' ' 118' ' ' LEU . 24.0 t-20 -116.16 59.69 0.73 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.645 0.259 . . . . 0.0 110.363 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.586 ' HB2' ' O ' ' A' ' 117' ' ' ASN . 10.2 mp 90.35 118.18 0.03 OUTLIER Pre-proline 0 N--CA 1.477 0.899 0 CA-C-N 115.198 -0.91 . . . . 0.0 111.247 172.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -93.98 121.28 0.37 Allowed 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 123.63 2.887 . . . . 0.0 113.633 -175.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.598 HG23 ' HB3' ' A' ' 126' ' ' GLU . 7.0 m -75.08 -13.04 60.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.177 0.513 . . . . 0.0 110.352 174.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.447 ' O ' ' HG2' ' A' ' 122' ' ' GLU . . . 66.24 -79.39 0.03 OUTLIER 'General case' 0 N--CA 1.456 -0.134 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.058 -172.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.524 ' O ' ' HB2' ' A' ' 184' ' ' SER . 36.8 mm-40 -162.5 -35.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 O-C-N 123.438 0.461 . . . . 0.0 111.165 -178.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.468 ' O ' ' HD3' ' A' ' 183' ' ' ARG . 1.5 t70 -74.45 -92.36 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 113.218 0.821 . . . . 0.0 113.218 -164.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.455 ' OD1' HD23 ' A' ' 125' ' ' LEU . 8.4 p30 -161.85 172.99 15.18 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.775 -172.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.455 HD23 ' OD1' ' A' ' 124' ' ' ASN . 2.6 mm? 57.47 87.37 0.06 Allowed 'General case' 0 N--CA 1.468 0.473 0 O-C-N 124.014 0.821 . . . . 0.0 112.328 -178.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.598 ' HB3' HG23 ' A' ' 120' ' ' THR . 10.0 tp10 179.84 -48.57 0.01 OUTLIER 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 114.695 -1.139 . . . . 0.0 109.106 174.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.547 ' CE2' HG22 ' A' ' 151' ' ' VAL . 35.5 m-85 -122.76 131.03 53.59 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.373 177.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.505 ' CG1' ' HB ' ' A' ' 178' ' ' VAL . 5.8 t -134.93 156.8 40.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.087 -174.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.591 ' NH2' HD13 ' A' ' 181' ' ' LEU . 1.2 ptp180 -134.17 133.54 41.1 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 172.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 1.109 HG22 HG12 ' A' ' 178' ' ' VAL . 23.8 p -88.77 140.57 29.31 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.273 0.559 . . . . 0.0 112.213 -174.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.717 HD11 ' HG2' ' A' ' 179' ' ' GLU . 13.6 mt -106.99 -42.23 4.96 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.397 -176.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -83.31 -36.45 24.45 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -168.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.806 ' HB2' ' HA ' ' A' ' 145' ' ' LYS . 0.0 OUTLIER 79.25 133.67 0.06 Allowed 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.434 0.693 . . . . 0.0 111.021 -174.59 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.587 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 59.1 t80 -156.05 110.38 2.11 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.072 -178.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.432 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 11.1 Cg_endo -89.42 90.91 0.36 Allowed 'Trans proline' 0 N--CA 1.445 -1.348 0 C-N-CA 122.591 2.194 . . . . 0.0 112.586 -179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.507 ' HA3' ' HB3' ' A' ' 141' ' ' ASP . . . -84.4 -21.14 57.31 Favored Glycine 0 N--CA 1.454 -0.166 0 C-N-CA 120.528 -0.844 . . . . 0.0 111.048 173.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 28.4 m120 46.29 48.67 13.27 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 114.443 -0.878 . . . . 0.0 112.532 178.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.423 ' OD1' ' HG2' ' A' ' 140' ' ' GLU . 5.0 t70 -149.53 179.23 8.14 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.39 -178.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -95.17 -7.5 39.01 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.336 0.588 . . . . 0.0 110.197 178.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.574 ' O ' ' HB2' ' A' ' 172' ' ' MET . 10.0 pt-20 -113.28 -3.32 13.86 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.987 173.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.507 ' HB3' ' HA3' ' A' ' 136' ' ' GLY . 4.1 m-20 -140.14 102.03 4.29 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 1.104 HD12 ' HD2' ' A' ' 143' ' ' PRO . 57.8 tp -74.03 126.13 89.56 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.417 0.627 . . . . 0.0 111.639 -172.448 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 1.104 ' HD2' HD12 ' A' ' 142' ' ' LEU . 68.8 Cg_endo -76.73 65.58 7.54 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 124.263 3.308 . . . . 0.0 113.132 177.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.621 ' CG ' HG21 ' A' ' 130' ' ' THR . 36.3 p90 -84.43 162.08 20.09 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.504 -0.479 . . . . 0.0 111.736 -176.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.806 ' HA ' ' HB2' ' A' ' 133' ' ' ASP . 10.9 mtmt -121.98 179.92 4.36 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.178 -176.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.746 ' HD3' ' H ' ' A' ' 146' ' ' LYS . 0.3 OUTLIER -79.47 27.62 0.27 Allowed 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -167.753 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 175.72 32.91 0.04 OUTLIER Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 119.721 -1.228 . . . . 0.0 113.594 176.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.575 ' OE2' ' HA ' ' A' ' 144' ' ' PHE . 8.7 pt-20 -106.63 167.15 10.06 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 117.826 0.813 . . . . 0.0 110.916 177.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.436 ' C ' HD23 ' A' ' 150' ' ' LEU . 19.8 mm -101.55 138.38 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -175.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.608 HD22 ' HA ' ' A' ' 165' ' ' ASN . 11.5 mt -122.9 179.64 4.57 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.888 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 47.8 t -145.29 123.46 5.07 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 178.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.582 HG23 ' HB3' ' A' ' 161' ' ' TRP . 20.4 mm -77.85 77.77 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-O 122.659 1.219 . . . . 0.0 108.55 -178.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.713 HD11 ' HE1' ' A' ' 61' ' ' TYR . 13.5 tt -71.4 -41.45 73.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-N 112.847 -1.979 . . . . 0.0 109.905 -177.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 1.132 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 73.4 mt-10 -116.79 138.92 51.15 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 172.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.62 ' HE2' HD21 ' A' ' 55' ' ' ASN . 22.1 ttpt -132.94 79.54 62.94 Favored Pre-proline 0 C--N 1.322 -0.593 0 O-C-N 122.043 -0.411 . . . . 0.0 110.015 167.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.634 ' HA ' ' HA ' ' A' ' 95' ' ' THR . 14.6 Cg_exo -66.35 -49.17 1.97 Allowed 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 121.95 1.767 . . . . 0.0 110.945 177.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 32.5 mm-40 -119.93 176.44 5.41 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.205 -174.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 56.4 mm-40 -95.6 -30.34 13.85 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.619 -176.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -84.25 -22.71 30.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.021 0.438 . . . . 0.0 110.793 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.766 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 60.5 m95 -129.2 126.89 40.18 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.425 -178.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . 0.582 ' HB3' HG23 ' A' ' 152' ' ' ILE . 49.5 m0 -119.75 134.26 55.3 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.752 178.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 1.132 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 6.5 m -84.47 98.09 9.9 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 177.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.573 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -103.98 157.78 16.87 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.136 -176.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.888 ' HG2' ' HB ' ' A' ' 151' ' ' VAL . 14.2 ptt180 -104.66 129.64 52.8 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 176.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.608 ' HA ' HD22 ' A' ' 150' ' ' LEU . 0.2 OUTLIER -73.03 -166.99 0.35 Allowed 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.453 0.168 . . . . 0.0 110.971 -178.225 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.517 ' HE3' ' HB2' ' A' ' 148' ' ' GLU . 93.8 mttt -55.96 -38.06 69.86 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.269 0.47 . . . . 0.0 112.269 -176.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.424 ' CG ' HD21 ' A' ' 165' ' ' ASN . 3.3 p30 -86.46 0.96 53.07 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.308 -178.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 92.42 3.06 67.34 Favored Glycine 0 CA--C 1.522 0.489 0 C-N-CA 120.447 -0.882 . . . . 0.0 113.973 174.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.731 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 12.5 ttm-85 -68.1 130.25 42.36 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 122.511 0.324 . . . . 0.0 110.777 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.468 HG22 HG21 ' A' ' 153' ' ' ILE . 39.8 t -95.19 143.02 12.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-O 120.855 0.36 . . . . 0.0 111.008 -177.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -170.92 155.53 24.87 Favored Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 175.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.766 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.4 OUTLIER -70.26 131.66 44.53 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.967 0.384 . . . . 0.0 110.864 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.829 HD13 HG11 ' A' ' 178' ' ' VAL . 2.6 pp -133.52 145.4 56.2 Favored Pre-proline 0 N--CA 1.451 -0.394 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.199 -179.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.484 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 8.2 Cg_exo -71.69 125.43 11.11 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.957 2.438 . . . . 0.0 111.859 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.622 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 24.1 t -68.76 -35.29 6.34 Favored Pre-proline 0 C--N 1.32 -0.682 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -178.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.622 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 19.0 Cg_endo -61.43 -11.22 18.77 Favored 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 121.656 1.571 . . . . 0.0 112.537 172.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.484 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.4 m-85 -92.01 -14.35 29.55 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.243 179.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 1.109 HG12 HG22 ' A' ' 130' ' ' THR . 10.3 m -122.01 173.64 7.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -169.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.717 ' HG2' HD11 ' A' ' 131' ' ' LEU . 9.3 mm-40 -136.34 169.71 17.23 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.933 177.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.511 ' HD3' ' N ' ' A' ' 180' ' ' LYS . 2.3 mppt? -101.22 136.92 40.27 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.802 0.334 . . . . 0.0 110.563 -175.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.591 HD13 ' NH2' ' A' ' 129' ' ' ARG . 7.8 tp -84.18 -86.17 0.12 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.371 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.497 HG13 ' HG ' ' A' ' 181' ' ' LEU . 1.6 m -82.26 38.55 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.125 -174.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.468 ' HD3' ' O ' ' A' ' 123' ' ' ASP . 1.4 tpp180 -70.68 115.82 10.28 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 168.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.524 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 0.9 OUTLIER -72.97 76.28 1.18 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.523 0.678 . . . . 0.0 110.119 179.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.592 ' HB2' ' HD2' ' A' ' 186' ' ' PRO . 28.1 p -85.19 168.57 19.77 Favored Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.889 178.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.592 ' HD2' ' HB2' ' A' ' 185' ' ' SER . 6.0 Cg_endo -48.84 -55.77 3.81 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 123.115 2.543 . . . . 0.0 112.883 177.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.46 ' HB2' ' O ' ' A' ' 186' ' ' PRO . 48.7 m80 72.5 -43.08 0.55 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.396 0.678 . . . . 0.0 111.996 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 108.72 95.83 2.41 Favored Glycine 0 N--CA 1.439 -1.129 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -168.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 14.6 mmmm 68.93 11.28 8.29 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.109 0.564 . . . . 0.0 110.771 -173.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 1.3 t60 62.18 21.64 12.58 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.529 176.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -91.03 173.47 37.9 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.327 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 10.1 m120 -83.26 -75.49 0.32 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.851 0.357 . . . . 0.0 111.195 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 31.8 mmm180 -127.73 125.83 40.69 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.744 -175.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -73.65 137.94 44.47 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.686 174.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 17.4 m -65.36 97.07 0.26 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.064 0.459 . . . . 0.0 110.85 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -84.95 96.1 9.26 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.376 -178.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 15.7 m -95.24 117.93 31.12 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.598 176.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -72.88 130.32 40.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.193 0.521 . . . . 0.0 111.502 -175.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -107.02 54.32 0.57 Allowed Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 175.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 40.7 mm -129.58 131.56 23.66 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.878 -0.161 . . . . 0.0 110.604 -174.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -66.88 120.33 7.41 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.573 2.182 . . . . 0.0 111.322 174.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -74.59 127.21 87.73 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.9 -175.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -77.3 131.01 11.41 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.434 2.089 . . . . 0.0 111.404 174.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -70.03 -77.94 0.08 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.358 -177.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -119.98 -9.5 9.63 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.087 0.47 . . . . 0.0 110.644 -178.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -84.55 100.74 11.59 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.632 177.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -133.16 173.34 11.54 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.308 178.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -85.29 137.38 33.0 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.71 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -79.21 145.63 65.16 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.013 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -81.6 92.39 1.02 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.359 2.039 . . . . 0.0 113.431 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -143.99 13.25 1.65 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.289 0.566 . . . . 0.0 109.729 171.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 4.5 m -89.28 15.17 9.46 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.269 -176.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 27.9 m 77.45 135.95 0.06 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.418 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 56.5 p 54.66 93.66 0.05 OUTLIER Pre-proline 0 N--CA 1.468 0.439 0 C-N-CA 123.866 0.866 . . . . 0.0 112.041 -178.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -66.81 -14.28 43.18 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.857 2.371 . . . . 0.0 112.04 178.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 217' ' ' PRO . 6.8 mp -92.95 132.7 30.35 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.737 177.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.462 ' HB2' HG12 ' A' ' 219' ' ' VAL . 42.1 Cg_exo -58.94 -28.87 88.85 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.879 2.386 . . . . 0.0 112.438 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . 58.87 24.99 13.07 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.191 176.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.462 HG12 ' HB2' ' A' ' 217' ' ' PRO . 3.7 p -96.8 110.23 24.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.438 0.637 . . . . 0.0 110.628 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 50.6 m -152.97 -3.12 0.22 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.755 179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 125.22 178.85 15.48 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.937 -177.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 23.6 t 61.38 93.43 0.06 OUTLIER Pre-proline 0 CA--C 1.532 0.284 0 C-N-CA 123.061 0.544 . . . . 0.0 111.707 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -84.48 13.91 2.6 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 123.175 2.583 . . . . 0.0 112.311 177.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 140.93 107.7 0.69 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.092 -178.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -85.06 -53.93 4.96 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.853 0.359 . . . . 0.0 111.102 -178.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -134.74 36.17 3.11 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.976 0.417 . . . . 0.0 110.7 -178.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 6.0 tp -78.49 117.43 23.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.336 178.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 20.3 p 48.49 81.99 0.25 Allowed Pre-proline 0 N--CA 1.468 0.425 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.259 -178.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -70.67 134.61 26.44 Favored 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.823 2.349 . . . . 0.0 112.289 -177.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.418 HD13 ' HA ' ' A' ' 230' ' ' LEU . 3.6 mm? -93.06 126.72 50.05 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 176.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 230' ' ' LEU . 6.4 Cg_exo -75.77 47.73 2.0 Favored 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 123.081 2.52 . . . . 0.0 112.454 179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 50.4 m 61.05 26.72 16.63 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.279 0.562 . . . . 0.0 110.557 -176.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.517 ' HB ' ' ND2' ' A' ' 235' ' ' ASN . 12.3 p -81.49 124.92 29.87 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.743 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.698 ' NE2' ' H ' ' A' ' 234' ' ' GLN . 0.8 OUTLIER -83.99 77.09 9.98 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.658 0.742 . . . . 0.0 111.343 -179.326 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . 0.517 ' ND2' ' HB ' ' A' ' 233' ' ' THR . 11.1 p30 -164.43 -178.65 5.55 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.68 177.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . 0.443 ' HA2' ' HD3' ' A' ' 237' ' ' PRO . . . -154.11 139.32 6.72 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.198 -0.525 . . . . 0.0 111.994 179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.443 ' HD3' ' HA2' ' A' ' 236' ' ' GLY . 12.2 Cg_exo -71.19 124.32 10.38 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 123.084 2.523 . . . . 0.0 111.83 178.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.63 HG11 HD12 ' A' ' 293' ' ' ILE . 39.6 t -100.68 135.88 34.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.967 -173.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 30.2 m-85 -88.27 121.85 31.14 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.459 173.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.467 ' HB1' ' HB ' ' A' ' 291' ' ' VAL . . . -126.5 123.69 38.36 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.391 176.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.408 ' O ' HG23 ' A' ' 243' ' ' ILE . 63.8 tttm -86.07 119.41 26.34 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.131 -177.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . 0.619 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -70.81 99.9 1.81 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.31 0.576 . . . . 0.0 110.418 -179.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.408 HG23 ' O ' ' A' ' 241' ' ' LYS . 34.2 pt -88.75 -27.87 5.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.421 -173.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -129.89 147.81 51.69 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.368 -0.378 . . . . 0.0 109.996 -178.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -55.53 122.21 10.77 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.432 0.634 . . . . 0.0 111.296 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.747 ' HB3' ' HB2' ' A' ' 258' ' ' LEU . 20.9 tpt180 -122.73 77.04 1.4 Allowed 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.382 -0.826 . . . . 0.0 108.856 173.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.425 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 7.4 m -111.62 137.46 21.2 Favored Pre-proline 0 C--N 1.316 -0.851 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.67 -178.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 247' ' ' VAL . 31.8 Cg_exo -57.76 111.4 0.83 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 123.048 2.499 . . . . 0.0 112.044 -178.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' CYS . . . . . 0.428 ' N ' ' HB2' ' A' ' 252' ' ' ASP . 19.3 t -88.6 -169.86 2.71 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -58.2 -39.15 78.25 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -177.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 14.9 p90 -91.1 -9.91 43.92 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.381 -176.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.428 ' HB2' ' N ' ' A' ' 249' ' ' CYS . 19.4 m-20 -80.89 116.67 20.99 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 121.364 0.602 . . . . 0.0 111.571 -174.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -120.47 145.97 46.73 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 172.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 25.2 p 61.92 17.73 9.19 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.581 0.752 . . . . 0.0 111.017 -174.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -81.17 130.99 35.27 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.999 0.428 . . . . 0.0 111.426 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.748 HD21 ' HB ' ' A' ' 279' ' ' VAL . 2.0 tt -86.07 131.29 34.29 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 175.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.46 ' N ' HD23 ' A' ' 256' ' ' LEU . . . -79.86 95.95 6.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.211 0.529 . . . . 0.0 111.182 179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.895 HD21 HG21 ' A' ' 279' ' ' VAL . 68.8 mt -105.39 105.48 15.54 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.377 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -87.82 150.3 23.62 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.066 -177.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 47.0 t -61.8 121.21 9.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.038 -176.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 101.87 39.73 2.85 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.964 175.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -141.58 174.82 10.2 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.938 0.369 . . . . 0.0 110.138 177.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . 0.449 HD12 ' HZ ' ' A' ' 294' ' ' PHE . 49.8 mm -107.38 133.82 50.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.944 0.402 . . . . 0.0 111.203 -175.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.572 HG22 HD22 ' A' ' 258' ' ' LEU . 5.2 t -113.75 115.76 50.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.885 175.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -95.94 103.17 15.04 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 173.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.626 HG13 ' HB ' ' A' ' 238' ' ' VAL . 2.1 p -94.65 141.4 15.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.562 -178.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 19.5 p -126.34 -23.74 3.77 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.913 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . 0.482 ' HB2' ' HB3' ' A' ' 276' ' ' GLU . 83.4 mtt180 -116.51 119.42 35.53 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.43 177.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 58.6 mtt -117.25 110.36 18.01 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 175.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -84.21 12.12 7.09 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.052 -0.522 . . . . 0.0 112.237 -170.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 48.0 mm 72.05 -39.0 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 175.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -78.8 27.05 0.23 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.444 0.64 . . . . 0.0 111.067 -178.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 81.99 -29.14 3.12 Favored Glycine 0 C--N 1.32 -0.308 0 C-N-CA 121.096 -0.573 . . . . 0.0 113.077 176.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -78.7 105.54 10.08 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.514 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 49.4 m0 -99.82 153.96 18.72 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.274 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.482 ' HB3' ' HB2' ' A' ' 268' ' ' ARG . 38.9 tt0 -120.59 115.6 23.72 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.887 178.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . 0.572 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -138.06 164.3 25.56 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 176.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -106.17 112.33 25.32 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 117.784 0.792 . . . . 0.0 109.669 -177.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . 0.895 HG21 HD21 ' A' ' 258' ' ' LEU . 70.8 t -121.15 99.67 7.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.171 -177.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 42.18 63.13 1.44 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.353 -1.294 . . . . 0.0 113.173 173.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 144.68 -51.08 0.63 Allowed Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.025 -1.083 . . . . 0.0 112.585 173.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.46 162.15 16.71 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.222 0.534 . . . . 0.0 111.755 -178.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.572 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 0.0 OUTLIER -88.84 143.06 27.15 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.673 175.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -150.56 172.18 30.33 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.539 179.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.514 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 72.0 mt -90.1 123.65 34.13 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.16 0.505 . . . . 0.0 110.958 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.435 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 36.6 p90 -133.68 136.71 27.22 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.173 177.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 10.4 Cg_exo -71.78 140.08 34.81 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.501 2.134 . . . . 0.0 111.614 176.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -60.07 -20.56 58.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.837 -178.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 1.4 p -73.89 -3.52 29.37 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -177.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 27.0 m-70 -101.19 -7.54 23.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.666 0.27 . . . . 0.0 110.678 177.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.619 HG12 ' HA ' ' A' ' 242' ' ' ALA . 15.4 m -128.74 178.0 5.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.145 0.498 . . . . 0.0 111.302 -179.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 57.8 tttm -140.81 123.28 15.97 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.515 175.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.63 HD12 HG11 ' A' ' 238' ' ' VAL . 35.3 mm -65.07 144.31 14.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.152 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' PHE . . . . . 0.449 ' HZ ' HD12 ' A' ' 263' ' ' ILE . 6.4 p90 -173.39 -179.07 1.81 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.637 179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -151.58 144.48 16.97 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 172.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_exo -45.73 -28.47 4.65 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.563 2.842 . . . . 0.0 114.178 178.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -141.83 -51.03 0.41 Allowed 'General case' 0 C--O 1.234 0.268 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -143.24 104.24 5.12 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 120.699 0.285 . . . . 0.0 111.12 -173.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.17 73.49 5.75 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.483 2.122 . . . . 0.0 112.586 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -98.22 150.28 21.67 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 175.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -70.1 -29.51 66.49 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.421 -175.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -124.89 -24.32 4.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.671 -0.24 . . . . 0.0 111.235 -177.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 . . . . . 0 C--O 1.247 0.932 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.545 -178.782 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 N--CA 1.482 1.17 0 CA-C-O 120.807 0.336 . . . . 0.0 111.152 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.2 t -116.35 92.89 4.02 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.361 0.6 . . . . 0.0 111.084 -175.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.5 p -80.45 -71.55 0.46 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.221 173.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.561 ' HB3' ' HE2' ' A' ' 253' ' ' LYS . . . -67.07 133.64 50.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.771 178.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 5' ' ' ARG . 47.0 ttm180 -150.92 100.09 2.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.773 0.32 . . . . 0.0 110.821 -176.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -166.07 -177.23 4.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.885 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.514 ' HB3' ' CB ' ' A' ' 13' ' ' ALA . 12.9 t70 -103.17 141.46 35.83 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.471 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 31.7 m -79.36 -0.19 31.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.808 0.337 . . . . 0.0 111.429 -176.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.759 ' CA ' ' HE1' ' A' ' 14' ' ' TRP . 8.7 t -149.17 -95.22 0.07 Allowed 'General case' 0 C--O 1.245 0.816 0 CA-C-O 122.2 1.0 . . . . 0.0 111.302 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.476 ' O ' ' N ' ' A' ' 12' ' ' SER . 37.5 t70 -8.16 74.89 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.099 -1.409 . . . . 0.0 112.01 -155.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.401 ' HA ' ' HD3' ' A' ' 11' ' ' ARG . 7.6 mmt180 -2.24 -58.01 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 126.189 2.18 . . . . 0.0 115.331 -163.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.476 ' N ' ' O ' ' A' ' 10' ' ' ASP . 58.2 m -70.1 18.08 0.05 Allowed 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 112.331 0.493 . . . . 0.0 112.331 -177.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.514 ' CB ' ' HB3' ' A' ' 7' ' ' ASP . . . -91.46 -19.1 23.2 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 120.332 -0.547 . . . . 0.0 109.725 170.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.759 ' HE1' ' CA ' ' A' ' 9' ' ' SER . 7.4 p-90 -151.71 -39.84 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.477 -179.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.551 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 34.0 t80 -67.36 119.84 12.88 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 121.126 0.489 . . . . 0.0 110.179 -177.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.811 ' SD ' ' HB3' ' A' ' 104' ' ' ARG . 15.0 tpp -110.03 9.22 24.25 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.296 -172.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.56 ' O ' ' HB2' ' A' ' 39' ' ' ARG . . . 50.85 -112.07 1.51 Allowed Glycine 0 C--O 1.222 -0.639 0 CA-C-N 115.805 -0.634 . . . . 0.0 113.713 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.417 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 2.8 Cg_exo -77.03 109.15 2.78 Favored 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 122.462 2.108 . . . . 0.0 112.606 178.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.066 ' HB ' ' HG3' ' A' ' 39' ' ' ARG . 27.5 t -136.29 -71.4 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 CA-C-O 119.212 -0.423 . . . . 0.0 111.701 178.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.489 ' HB3' ' O ' ' A' ' 19' ' ' VAL . 37.7 t 79.72 -172.6 0.05 Allowed 'General case' 0 C--N 1.345 0.412 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 171.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 -65.6 -42.95 91.06 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.716 0.293 . . . . 0.0 110.977 -173.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.523 ' HG3' ' H ' ' A' ' 23' ' ' GLU . 2.2 pt20 -61.01 -59.96 4.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.58 -0.737 . . . . 0.0 112.002 -176.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.611 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 64.8 mm-40 -66.61 -45.28 79.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.818 -175.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 28' ' ' LEU . . . -54.72 -36.75 65.07 Favored 'General case' 0 C--O 1.222 -0.371 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.187 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.671 ' HA ' HG21 ' A' ' 58' ' ' VAL . 6.1 tp-100 -73.4 -51.96 15.45 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.994 178.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.607 ' HA ' ' SD ' ' A' ' 110' ' ' MET . 6.2 t -63.24 -26.68 68.9 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -171.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.611 ' HG2' ' O ' ' A' ' 23' ' ' GLU . 18.1 ptp180 -101.58 -9.46 20.96 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.565 -178.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.691 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 87.6 mt -119.61 17.2 12.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.75 -0.205 . . . . 0.0 111.542 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 24.5 tp60 -71.56 74.15 0.78 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.377 0.608 . . . . 0.0 110.314 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.23 -69.43 1.34 Allowed Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 115.401 -0.818 . . . . 0.0 112.122 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.401 ' HB3' ' H ' ' A' ' 32' ' ' ARG . 6.9 tt0 34.12 -93.24 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.947 1.299 . . . . 0.0 113.561 -175.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.401 ' H ' ' HB3' ' A' ' 31' ' ' GLN . 33.2 ttp-105 -115.46 -11.78 11.78 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -172.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 33.6 m170 67.65 157.65 0.13 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.296 0.638 . . . . 0.0 111.948 -178.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.48 3.21 82.38 Favored Glycine 0 C--N 1.334 0.451 0 N-CA-C 111.255 -0.738 . . . . 0.0 111.255 177.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.519 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 44.2 mtp -90.13 136.6 32.95 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.959 -0.62 . . . . 0.0 109.918 -176.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.49 ' CB ' HG22 ' A' ' 52' ' ' VAL . 34.2 p90 -138.78 165.06 27.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.55 0.214 . . . . 0.0 110.657 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.599 ' O ' ' HA ' ' A' ' 50' ' ' LEU . 4.6 pp -158.3 140.61 14.25 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.835 174.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 15' ' ' TYR . 80.2 t -110.17 120.66 61.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 174.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 1.066 ' HG3' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -138.01 175.93 9.15 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.047 -0.661 . . . . 0.0 110.683 -176.61 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.463 ' O ' ' HG2' ' A' ' 39' ' ' ARG . 2.1 m-20 -66.82 137.71 56.81 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 120.997 0.427 . . . . 0.0 110.337 176.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.499 ' HB3' ' O ' ' A' ' 44' ' ' CYS . 22.8 t -76.92 147.95 36.67 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.495 -179.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.8 p -87.03 -29.43 21.96 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.034 -178.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.483 HG21 ' HB3' ' A' ' 116' ' ' PRO . 20.5 p -82.54 -42.27 18.57 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.035 0.445 . . . . 0.0 110.955 -179.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.499 ' O ' ' HB3' ' A' ' 41' ' ' SER . 56.1 m -127.15 112.25 21.6 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.209 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -73.93 14.86 0.63 Allowed 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.792 2.328 . . . . 0.0 112.918 -178.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -117.06 -5.72 14.75 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.627 -0.589 . . . . 0.0 111.627 175.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -119.61 175.26 5.94 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -177.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.43 ' O ' HG23 ' A' ' 62' ' ' ILE . 22.1 m-85 -127.49 179.67 5.37 Favored 'General case' 0 C--O 1.221 -0.403 0 C-N-CA 122.176 0.19 . . . . 0.0 110.491 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.609 HG22 HG12 ' A' ' 62' ' ' ILE . 54.2 t -148.91 96.82 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-O 120.743 0.306 . . . . 0.0 111.319 179.183 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.599 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 50.6 tp -70.8 101.01 2.01 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.481 171.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.4 m -97.21 130.01 44.49 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.439 177.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.753 HG21 HD13 ' A' ' 93' ' ' LEU . 69.9 t -119.86 140.97 42.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.205 -177.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.691 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 42.1 t -102.82 107.8 18.78 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.687 -177.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.837 ' HG3' HG22 ' A' ' 96' ' ' THR . 0.0 OUTLIER -158.39 157.28 32.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.769 -0.196 . . . . 0.0 110.756 171.31 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 59.41 18.6 6.97 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 123.557 0.536 . . . . 0.0 110.424 -173.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 58.0 m 68.47 21.85 8.02 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.311 -0.858 . . . . 0.0 111.949 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -125.65 151.67 46.22 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 174.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.671 HG21 ' HA ' ' A' ' 25' ' ' GLN . 44.9 t -97.33 91.55 2.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.931 0.396 . . . . 0.0 110.521 178.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.555 ' HA ' ' HB3' ' A' ' 119' ' ' PRO . 5.9 t -68.46 118.12 11.11 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -98.62 106.75 19.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.312 -174.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.735 ' HB3' HD11 ' A' ' 73' ' ' ILE . 53.9 m-85 -101.97 92.05 4.62 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.581 178.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.609 HG12 HG22 ' A' ' 49' ' ' VAL . 38.5 mt -72.15 130.52 35.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -177.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.641 ' HA ' ' HA ' ' A' ' 73' ' ' ILE . 4.9 mp -106.98 119.46 56.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.204 178.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -97.96 134.6 40.86 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 -177.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 42.5 t -84.3 110.85 18.89 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.156 0.503 . . . . 0.0 110.066 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.729 HD12 ' HG3' ' A' ' 70' ' ' ARG . 67.9 mt -83.32 144.65 46.98 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.422 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -55.34 -19.01 20.48 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 123.106 2.538 . . . . 0.0 113.095 -178.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 56.0 m-20 -84.83 14.76 4.45 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.632 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.668 ' HE ' ' HA ' ' A' ' 69' ' ' ARG . 3.3 tpm_? 66.29 26.71 10.3 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.299 0.64 . . . . 0.0 111.154 176.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.729 ' HG3' HD12 ' A' ' 66' ' ' LEU . 6.7 ptm180 -119.47 164.49 15.69 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 176.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.635 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 74.1 m-85 -123.05 120.11 32.35 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.821 0.343 . . . . 0.0 111.853 -171.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 77' ' ' GLU . 20.7 ttmm -102.21 110.29 22.2 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 175.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.735 HD11 ' HB3' ' A' ' 61' ' ' TYR . 2.4 tt -87.05 83.58 2.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.614 0.721 . . . . 0.0 111.406 -175.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.25 -53.25 2.25 Favored Glycine 0 C--N 1.336 0.567 0 CA-C-N 114.66 -1.155 . . . . 0.0 113.342 174.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.71 ' OD2' ' HA2' ' A' ' 168' ' ' GLY . 11.6 t70 -135.57 -55.26 0.79 Allowed 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.081 0.467 . . . . 0.0 109.931 -174.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.5 124.74 28.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.896 -177.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 10.0 pt-20 -99.08 129.94 45.38 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.185 0.517 . . . . 0.0 110.984 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.525 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 93.9 m-85 -124.92 -169.1 1.92 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.893 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -112.11 -19.93 12.11 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -177.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.574 ' ND1' ' HG2' ' A' ' 82' ' ' PRO . 6.7 p80 -149.11 165.41 31.83 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 122.376 -0.203 . . . . 0.0 110.533 172.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.504 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 4.4 mt -61.34 -52.19 72.41 Favored Pre-proline 0 N--CA 1.467 0.383 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.466 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.574 ' HG2' ' ND1' ' A' ' 80' ' ' HIS . 12.9 Cg_endo -60.31 -5.87 4.63 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 121.982 1.788 . . . . 0.0 113.18 176.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.513 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -85.77 -30.47 23.02 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.118 0.485 . . . . 0.0 110.172 -175.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.525 ' HB3' ' CD2' ' A' ' 78' ' ' PHE . 3.4 pp -82.58 -32.93 28.24 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 174.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 96.0 mt -66.37 -37.15 84.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.676 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.409 ' OE2' ' HA ' ' A' ' 83' ' ' ALA . 13.8 pt-20 -78.65 -19.77 51.83 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.595 -0.275 . . . . 0.0 110.947 178.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.532 ' O ' HG12 ' A' ' 90' ' ' ILE . 73.7 t80 -81.76 -33.97 30.66 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 121.253 0.549 . . . . 0.0 110.06 -178.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.443 ' CG ' HD21 ' A' ' 93' ' ' LEU . 33.9 m-85 -79.18 5.07 13.02 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.713 -178.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.683 ' HE3' HG22 ' A' ' 90' ' ' ILE . 0.1 OUTLIER -68.01 -34.03 75.72 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 168.873 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.683 HG22 ' HE3' ' A' ' 89' ' ' LYS . 11.0 pt -85.77 -30.91 6.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 174.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.407 ' HB2' ' HD1' ' A' ' 88' ' ' TYR . 8.1 m170 -93.35 125.58 38.03 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.074 0.464 . . . . 0.0 111.168 -176.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.446 ' CD2' HG23 ' A' ' 97' ' ' THR . 59.0 m-85 -86.71 82.1 7.98 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.615 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.753 HD13 HG21 ' A' ' 52' ' ' VAL . 24.0 mt -31.79 -52.24 0.24 Allowed 'General case' 0 N--CA 1.473 0.694 0 O-C-N 125.199 1.562 . . . . 0.0 113.962 -172.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.478 ' OD1' ' HB3' ' A' ' 54' ' ' GLU . 7.3 t70 -118.53 -34.05 4.13 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.49 0.662 . . . . 0.0 109.769 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.422 ' HB ' ' O ' ' A' ' 94' ' ' ASP . 5.8 t 176.99 -20.41 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.245 176.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.837 HG22 ' HG3' ' A' ' 54' ' ' GLU . 3.6 t -113.97 171.76 7.4 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 115.081 -0.963 . . . . 0.0 108.407 170.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.446 HG23 ' CD2' ' A' ' 92' ' ' TYR . 69.9 p -99.58 -177.26 3.52 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.447 HD22 ' CG ' ' A' ' 36' ' ' PHE . 89.5 mt -70.52 105.37 3.07 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.483 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 45.8 mm -99.7 -53.71 7.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.574 -0.284 . . . . 0.0 111.701 -174.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.519 ' O ' ' HA ' ' A' ' 35' ' ' MET . 7.4 pt-20 -149.37 157.25 39.42 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 120.819 0.342 . . . . 0.0 111.46 -174.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.52 163.33 29.69 Favored 'Trans proline' 0 C--O 1.233 0.275 0 C-N-CA 122.495 2.13 . . . . 0.0 112.504 176.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.621 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -90.01 161.36 38.33 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.776 177.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -68.46 159.71 52.28 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.444 2.096 . . . . 0.0 111.912 174.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.811 ' HB3' ' SD ' ' A' ' 16' ' ' MET . 13.8 ptm180 -126.25 88.18 2.8 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.081 0.467 . . . . 0.0 111.715 -177.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.433 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 45.4 t80 -169.63 116.22 0.53 Allowed Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.009 177.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 105' ' ' TYR . 8.8 Cg_exo -72.29 142.4 37.38 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.74 2.294 . . . . 0.0 111.222 176.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.747 ' HB3' ' HD3' ' A' ' 108' ' ' PRO . 41.7 t -171.76 -57.87 0.0 OUTLIER Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.09 -177.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.747 ' HD3' ' HB3' ' A' ' 107' ' ' SER . 5.5 Cg_exo -77.61 124.31 6.9 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 122.136 1.891 . . . . 0.0 112.187 -178.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 108' ' ' PRO . 4.9 Cg_endo -87.53 113.73 0.93 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.297 2.665 . . . . 0.0 112.208 178.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.607 ' SD ' ' HA ' ' A' ' 26' ' ' THR . 62.8 mtt -119.76 168.25 11.26 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.887 178.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.477 ' O ' ' HB3' ' A' ' 112' ' ' SER . . . -69.67 -25.21 75.78 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.762 -0.654 . . . . 0.0 112.411 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.477 ' HB3' ' O ' ' A' ' 111' ' ' GLY . 30.6 t 73.96 154.55 0.15 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.29 0.567 . . . . 0.0 111.737 177.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 39.7 t -62.79 113.35 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.721 173.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 13.5 m -83.35 30.9 0.46 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.944 0.402 . . . . 0.0 111.716 -174.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.419 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . . . -143.0 143.91 26.9 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.015 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.483 ' HB3' HG21 ' A' ' 43' ' ' THR . 20.7 Cg_exo -66.97 -36.36 22.83 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.131 2.554 . . . . 0.0 111.819 177.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -107.45 -163.36 0.89 Allowed 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 173.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 9.1 mp 66.99 135.45 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.311 0 CA-C-O 121.52 0.676 . . . . 0.0 111.622 -178.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.555 ' HB3' ' HA ' ' A' ' 59' ' ' SER . 44.6 Cg_exo -61.02 -58.39 0.46 Allowed 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.979 2.453 . . . . 0.0 112.949 176.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 85.1 m -154.36 -66.24 0.14 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.846 0.355 . . . . 0.0 111.01 -178.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -154.75 175.17 14.05 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.439 ' OE1' ' HA ' ' A' ' 186' ' ' PRO . 0.0 OUTLIER -94.07 -90.92 0.2 Allowed 'General case' 0 C--N 1.321 -0.659 0 O-C-N 123.18 0.3 . . . . 0.0 111.209 -178.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.564 ' OD2' ' HD3' ' A' ' 186' ' ' PRO . 13.1 t70 64.39 -73.04 0.06 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.057 0.543 . . . . 0.0 110.879 -175.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.438 ' O ' ' HB2' ' A' ' 125' ' ' LEU . 74.1 m-20 -146.9 125.55 12.54 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.416 0.686 . . . . 0.0 109.961 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.665 HD12 HG21 ' A' ' 152' ' ' ILE . 4.1 mm? 71.81 96.27 0.07 Allowed 'General case' 0 N--CA 1.473 0.678 0 O-C-N 123.522 0.513 . . . . 0.0 112.205 174.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.488 ' HG3' ' CD1' ' A' ' 127' ' ' TYR . 9.9 tp10 -170.72 -72.97 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.546 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.488 ' CD1' ' HG3' ' A' ' 126' ' ' GLU . 38.4 m-85 -112.97 131.99 55.53 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.231 0.539 . . . . 0.0 111.123 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.565 ' CG1' ' HB ' ' A' ' 178' ' ' VAL . 8.3 t -131.59 158.26 43.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.361 -176.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 10.7 ptp180 -138.77 133.43 32.13 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 170.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 1.05 HG22 HG12 ' A' ' 178' ' ' VAL . 35.8 p -86.97 141.46 28.68 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.231 -173.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.755 HD11 ' CG ' ' A' ' 179' ' ' GLU . 10.9 mt -111.27 -30.93 7.24 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -174.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.518 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 55.5 t80 -90.09 -27.38 19.7 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -168.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.518 ' HB3' ' O ' ' A' ' 132' ' ' TYR . 19.5 t70 73.83 130.88 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.811 0 O-C-N 123.564 0.54 . . . . 0.0 111.06 -172.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.452 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 76.4 t80 -161.86 99.48 1.19 Allowed Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.97 -177.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -82.36 81.46 2.49 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.916 2.411 . . . . 0.0 112.731 178.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -70.56 -17.12 74.44 Favored Glycine 0 C--O 1.227 -0.319 0 N-CA-C 110.595 -1.002 . . . . 0.0 110.595 172.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 40.53 35.54 0.31 Allowed 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.944 1.298 . . . . 0.0 113.945 178.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.508 ' HB2' ' HB2' ' A' ' 141' ' ' ASP . 1.6 m-20 -121.12 -173.42 2.61 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 121.981 -0.449 . . . . 0.0 111.5 -178.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -105.13 -6.64 19.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.245 0.545 . . . . 0.0 110.637 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -122.17 -1.26 9.27 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.692 174.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.508 ' HB2' ' HB2' ' A' ' 138' ' ' ASP . 5.4 m-20 -132.32 108.4 9.18 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 174.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.82 HD11 ' HB2' ' A' ' 165' ' ' ASN . 60.5 tp -74.59 119.79 78.35 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-O 121.215 0.531 . . . . 0.0 111.868 -170.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.625 ' HD2' HD12 ' A' ' 142' ' ' LEU . 55.8 Cg_endo -72.8 102.66 1.46 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.579 2.186 . . . . 0.0 111.57 171.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.612 ' CG ' HG21 ' A' ' 130' ' ' THR . 12.6 p90 -117.49 163.94 15.64 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.786 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.48 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 12.4 mmtm -108.65 -159.48 0.69 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.001 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.506 ' HD3' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -101.46 6.53 42.47 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.986 -0.285 . . . . 0.0 111.768 -173.885 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -155.34 24.28 0.59 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.055 -1.069 . . . . 0.0 112.704 178.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.13 159.47 14.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.636 0.255 . . . . 0.0 110.562 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.429 ' C ' HD23 ' A' ' 150' ' ' LEU . 15.5 mm -101.56 135.88 36.06 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.939 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 -174.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.605 ' HB3' ' HB1' ' A' ' 163' ' ' ALA . 10.4 mt -122.11 175.9 6.11 Favored 'General case' 0 N--CA 1.437 -1.107 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 163' ' ' ALA . 46.6 t -145.5 123.0 4.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.672 HG23 ' HB3' ' A' ' 161' ' ' TRP . 23.9 mm -79.16 78.75 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-O 122.483 1.135 . . . . 0.0 108.657 -176.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.679 HG23 ' HG3' ' A' ' 154' ' ' GLU . 11.5 tt -69.2 -46.21 78.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.972 0 CA-C-N 113.176 -1.829 . . . . 0.0 109.359 -178.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 1.016 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 40.5 mt-10 -115.27 140.05 49.44 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -127.66 82.12 68.91 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 167.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.409 ' HG2' ' HE3' ' A' ' 172' ' ' MET . 3.3 Cg_exo -77.32 -50.76 0.09 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 123.327 2.685 . . . . 0.0 111.242 176.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -108.4 170.33 8.09 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.402 -176.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -88.3 -41.39 12.92 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.742 -176.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -83.18 -24.37 32.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.909 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 57.2 m95 -123.72 119.65 30.4 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.244 -176.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . 0.672 ' HB3' HG23 ' A' ' 152' ' ' ILE . 44.8 m0 -106.24 138.29 42.69 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.732 176.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 1.016 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 13.8 m -85.83 101.01 12.46 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 177.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.619 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -106.23 157.01 17.89 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.909 -179.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.713 ' HB3' HG22 ' A' ' 170' ' ' VAL . 25.0 ptt-85 -107.67 128.98 55.04 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 175.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.82 ' HB2' HD11 ' A' ' 142' ' ' LEU . 58.5 t30 -69.15 151.91 45.78 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 175.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 29.0 ttpp -65.06 -12.0 45.74 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.683 -176.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.422 ' HB3' ' NH2' ' A' ' 169' ' ' ARG . 19.4 t70 -86.41 -26.43 24.75 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -177.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.71 ' HA2' ' OD2' ' A' ' 75' ' ' ASP . . . 123.54 67.42 0.21 Allowed Glycine 0 CA--C 1.528 0.845 0 C-N-CA 118.587 -1.768 . . . . 0.0 115.684 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.54 ' HD2' ' HD2' ' A' ' 143' ' ' PRO . 0.0 OUTLIER -178.66 148.64 0.44 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.656 0.383 . . . . 0.0 110.178 161.568 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.713 HG22 ' HB3' ' A' ' 164' ' ' ARG . 61.2 t -101.06 142.87 15.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.316 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -167.05 157.01 29.26 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.56 ' HA ' ' HA ' ' A' ' 162' ' ' SER . 31.7 mtp -74.21 136.49 42.78 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.973 0.386 . . . . 0.0 110.135 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.897 HD13 HG11 ' A' ' 178' ' ' VAL . 2.7 pp -134.17 150.19 73.47 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.631 -177.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 173' ' ' ILE . 4.0 Cg_exo -76.97 127.86 9.61 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 123.0 2.467 . . . . 0.0 112.33 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.616 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 26.2 t -64.11 -42.16 66.79 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 9.6 Cg_endo -53.27 -13.6 3.44 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.968 2.445 . . . . 0.0 113.962 171.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -96.58 -14.69 22.04 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 111.607 0.225 . . . . 0.0 111.607 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 1.05 HG12 HG22 ' A' ' 130' ' ' THR . 5.9 m -125.6 161.55 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-O 121.992 0.901 . . . . 0.0 113.112 -169.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.755 ' CG ' HD11 ' A' ' 131' ' ' LEU . 3.5 mm-40 -124.45 160.36 28.42 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.156 177.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.682 ' HG2' ' HD2' ' A' ' 183' ' ' ARG . 1.4 mppt? -98.34 137.18 37.43 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -176.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 10.2 tp -66.72 -83.23 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.094 0.473 . . . . 0.0 109.921 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.491 HG12 ' HA3' ' A' ' 191' ' ' GLY . 10.9 m -102.04 113.75 39.37 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-O 121.296 0.569 . . . . 0.0 109.734 172.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.682 ' HD2' ' HG2' ' A' ' 180' ' ' LYS . 31.6 ttt180 -153.29 122.38 6.55 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.956 -178.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 16.3 p 179.58 -64.87 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 177.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.481 ' HB2' ' CE1' ' A' ' 187' ' ' HIS . 7.8 m -160.97 168.28 11.97 Favored Pre-proline 0 C--N 1.316 -0.859 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 167.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.564 ' HD3' ' OD2' ' A' ' 123' ' ' ASP . 23.3 Cg_exo -63.85 102.5 0.36 Allowed 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 121.33 1.353 . . . . 0.0 111.049 177.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.49 ' HA ' ' CD ' ' A' ' 202' ' ' GLU . 38.4 m80 -125.9 155.5 41.17 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.207 -174.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -68.42 97.8 0.48 Allowed Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.806 -0.633 . . . . 0.0 112.203 174.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 64.4 pttt 45.56 32.0 1.05 Allowed 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.515 1.126 . . . . 0.0 113.415 177.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -98.69 91.34 5.07 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 177.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.491 ' HA3' HG12 ' A' ' 182' ' ' VAL . . . -128.36 -88.7 0.59 Allowed Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.92 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -135.99 95.96 3.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.087 0.47 . . . . 0.0 110.44 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.686 ' HA ' ' HE ' ' A' ' 193' ' ' ARG . 1.2 tpm_? -157.58 -88.98 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.185 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -150.08 130.98 14.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.896 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 69.4 m -152.8 85.92 1.25 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.104 0.478 . . . . 0.0 111.134 177.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 22.7 p-10 -107.42 -45.39 4.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.696 174.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 69.6 m -86.88 63.64 8.06 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 171.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -96.42 164.52 12.6 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.844 -176.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 149.0 49.24 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 11.7 pt -121.82 86.11 45.44 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-O 121.171 0.51 . . . . 0.0 111.758 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_endo -87.97 116.11 1.0 Allowed 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 123.174 2.583 . . . . 0.0 110.956 171.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.49 ' CD ' ' HA ' ' A' ' 187' ' ' HIS . 6.9 pt-20 -122.21 120.32 28.27 Favored Pre-proline 0 C--N 1.319 -0.74 0 CA-C-O 121.015 0.436 . . . . 0.0 110.287 -178.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 202' ' ' GLU . 22.9 Cg_exo -64.12 125.95 16.21 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 123.269 2.646 . . . . 0.0 113.03 -175.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -95.76 8.09 44.48 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.956 177.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 29.7 m80 -123.83 109.0 13.08 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.748 178.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -124.55 173.71 8.3 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.618 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 18.9 m-30 63.15 -163.36 0.27 Allowed 'General case' 0 N--CA 1.465 0.31 0 O-C-N 123.796 0.685 . . . . 0.0 110.552 -179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -143.72 -71.63 0.29 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.737 0.304 . . . . 0.0 111.107 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -166.68 157.72 10.91 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.983 -176.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_exo -66.73 104.08 0.77 Allowed 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.072 1.848 . . . . 0.0 110.21 170.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -70.9 -40.42 72.18 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.146 -172.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 13.9 m -123.98 97.15 5.22 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.95 0.405 . . . . 0.0 110.277 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 47.6 m -78.41 -39.36 39.18 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.457 -179.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 21.7 m 69.57 94.59 0.05 OUTLIER Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.316 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -71.57 141.15 37.56 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.714 2.276 . . . . 0.0 111.737 178.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.457 ' HA ' ' HD3' ' A' ' 217' ' ' PRO . 3.4 mm? -88.92 131.96 39.69 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.053 179.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 216' ' ' LEU . 31.3 Cg_exo -62.46 -46.49 11.83 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.64 2.226 . . . . 0.0 112.041 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -150.11 115.76 5.54 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.02 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 61.9 t -88.03 105.36 15.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 171.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 4.8 p -85.42 162.76 18.86 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.371 -175.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -88.7 161.42 30.86 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.915 177.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 5.7 p -80.74 117.73 69.23 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-O 120.566 0.222 . . . . 0.0 110.555 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -57.36 129.46 34.15 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.906 2.404 . . . . 0.0 112.522 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -125.45 119.79 3.66 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.065 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -95.63 -5.05 43.31 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.092 0.472 . . . . 0.0 110.684 177.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -100.39 88.17 3.6 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.255 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 20.3 pt -93.71 120.2 42.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.992 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 6.2 t -172.87 126.27 0.49 Allowed Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.548 179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -82.06 -170.67 1.0 Allowed 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.582 2.188 . . . . 0.0 111.423 174.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.408 ' HA ' ' HD3' ' A' ' 231' ' ' PRO . 4.0 mm? -95.65 112.55 59.46 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 177.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 230' ' ' LEU . 5.8 Cg_exo -79.49 -168.74 0.67 Allowed 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 123.18 2.586 . . . . 0.0 112.026 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 50.3 m -73.89 102.84 4.21 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.052 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 13.6 p -73.53 -31.63 63.78 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 173.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.712 ' HA ' HE21 ' A' ' 234' ' ' GLN . 0.1 OUTLIER 60.3 76.23 0.37 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.023 174.535 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . 0.491 ' HB2' ' O ' ' A' ' 267' ' ' THR . 0.9 OUTLIER -85.53 -36.05 20.74 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.745 176.876 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 157.14 94.31 0.1 Allowed Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.605 178.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -65.45 100.98 0.41 Allowed 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.606 2.204 . . . . 0.0 111.691 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.717 ' CG1' HD12 ' A' ' 293' ' ' ILE . 41.4 t -115.49 136.88 50.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.992 -176.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -104.68 117.04 33.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.96 178.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.492 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -120.2 125.12 47.38 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.739 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -85.26 124.15 31.57 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . 0.579 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -69.53 112.38 6.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.841 0.353 . . . . 0.0 110.385 -178.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 33.7 pt -84.46 -16.94 10.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.507 -177.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.505 ' HA ' HG22 ' A' ' 260' ' ' VAL . 16.4 pt20 -150.35 153.68 36.48 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.099 173.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.463 ' C ' ' HD2' ' A' ' 245' ' ' LYS . 0.1 OUTLIER -75.75 169.79 17.45 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.449 0.642 . . . . 0.0 112.112 -171.708 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 38.6 ttt85 -170.28 115.94 0.51 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.409 172.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 8.7 p -122.11 141.02 33.4 Favored Pre-proline 0 C--N 1.316 -0.875 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -45.49 111.36 0.31 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.846 2.364 . . . . 0.0 112.873 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' CYS . . . . . 0.431 ' H ' ' HB2' ' A' ' 252' ' ' ASP . 31.7 t -90.16 -173.03 3.69 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.717 178.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.418 ' N ' ' SG ' ' A' ' 249' ' ' CYS . . . -62.69 -27.92 69.58 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.982 0.42 . . . . 0.0 111.938 -177.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -101.02 1.14 39.26 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.327 -177.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.451 ' HB3' ' CB ' ' A' ' 255' ' ' ALA . 27.2 m-20 -97.7 97.19 8.81 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -173.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . 0.835 ' HG3' HG23 ' A' ' 254' ' ' THR . 45.6 tptt -91.25 139.44 30.74 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 171.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . 0.835 HG23 ' HG3' ' A' ' 253' ' ' LYS . 26.2 p 65.96 14.92 9.85 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.035 0.934 . . . . 0.0 112.27 178.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.451 ' CB ' ' HB3' ' A' ' 252' ' ' ASP . . . -79.11 151.88 31.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.655 0.264 . . . . 0.0 110.974 -178.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.576 HD23 ' N ' ' A' ' 257' ' ' ALA . 2.5 tt -102.91 142.99 33.09 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.576 ' N ' HD23 ' A' ' 256' ' ' LEU . . . -87.43 101.75 13.88 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.147 0.499 . . . . 0.0 110.451 178.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.986 HD21 HG21 ' A' ' 279' ' ' VAL . 84.0 mt -116.38 142.75 46.44 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.557 -177.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -124.13 162.57 23.3 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.109 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.505 HG22 ' HA ' ' A' ' 244' ' ' GLN . 43.6 t -66.59 125.46 23.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.38 -174.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 105.53 -11.92 46.88 Favored Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 120.742 -0.742 . . . . 0.0 113.074 176.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -84.8 175.44 9.15 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.932 0.366 . . . . 0.0 110.204 -174.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 48.4 mm -115.57 117.46 55.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.352 0.596 . . . . 0.0 110.982 -176.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.517 HG22 HD22 ' A' ' 258' ' ' LEU . 2.9 t -97.05 103.06 14.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.713 178.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 30.2 ttpt -85.94 90.4 8.07 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.259 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.579 ' HA ' ' HA2' ' A' ' 277' ' ' GLY . 1.8 p -86.82 137.51 20.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-O 121.158 0.504 . . . . 0.0 110.582 -175.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . 0.491 ' O ' ' HB2' ' A' ' 235' ' ' ASN . 20.5 p -109.67 -35.73 6.12 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.527 -173.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 268' ' ' ARG . 1.0 OUTLIER -131.73 126.24 34.0 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.139 0.495 . . . . 0.0 109.683 179.407 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 57.9 mtt -106.3 116.64 32.28 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.935 0.398 . . . . 0.0 111.162 -178.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.531 ' HB2' ' O ' ' A' ' 274' ' ' GLN . 85.6 m-20 -78.68 121.46 24.72 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 175.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 47.2 mm -57.79 -24.96 24.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.173 -174.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -61.77 -32.28 72.53 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.411 -178.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 146.41 -44.45 0.84 Allowed Glycine 0 C--N 1.33 0.215 0 C-N-CA 120.172 -1.013 . . . . 0.0 113.342 177.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.531 ' O ' ' HB2' ' A' ' 270' ' ' ASN . 0.1 OUTLIER -86.29 120.05 27.23 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.067 0.46 . . . . 0.0 110.608 -178.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.424 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 41.7 m0 -94.48 160.83 14.47 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.597 -177.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.494 ' HB3' ' HD2' ' A' ' 283' ' ' LYS . 39.3 mt-10 -106.59 105.84 16.07 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 173.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . 0.579 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -108.5 146.7 16.52 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.608 -178.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -102.03 108.54 20.01 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . 0.986 HG21 HD21 ' A' ' 258' ' ' LEU . 97.1 t -119.4 117.58 54.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.563 -0.744 . . . . 0.0 109.694 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . 0.453 HD22 ' N ' ' A' ' 280' ' ' ASN . 0.9 OUTLIER 62.86 30.82 16.58 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.549 -179.387 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 83.38 6.27 87.86 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.772 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . 0.412 ' NH1' ' H ' ' A' ' 257' ' ' ALA . 51.1 ttt180 -117.52 126.28 52.32 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.667 0.27 . . . . 0.0 110.759 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.567 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 27.2 ttpp -102.97 133.62 47.78 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.124 0.488 . . . . 0.0 111.035 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -153.98 171.02 32.63 Favored Glycine 0 N--CA 1.444 -0.788 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.625 177.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.424 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 64.0 mt -83.88 131.33 34.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.977 0.417 . . . . 0.0 111.027 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.402 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 23.9 p90 -142.34 144.37 30.79 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.777 175.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 1.8 Cg_endo -83.7 138.77 8.46 Favored 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 122.911 2.407 . . . . 0.0 111.661 176.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.4 ' HA ' HG22 ' A' ' 291' ' ' VAL . 41.5 p90 -65.54 -8.39 19.47 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.592 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 17.2 p -75.85 -9.34 58.52 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.52 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -104.97 -6.25 20.25 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.799 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.579 HG12 ' HA ' ' A' ' 242' ' ' ALA . 22.4 m -128.34 172.25 15.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.125 0.488 . . . . 0.0 111.173 -177.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 32.9 ttmt -137.47 131.42 31.86 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.032 171.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.717 HD12 ' CG1' ' A' ' 238' ' ' VAL . 47.5 mm -73.39 134.47 29.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.731 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -138.03 151.68 48.11 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 174.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.778 ' HB3' ' HD3' ' A' ' 296' ' ' PRO . 12.2 t70 -93.1 -58.48 0.22 Allowed Pre-proline 0 C--N 1.323 -0.586 0 C-N-CA 120.968 -0.293 . . . . 0.0 111.026 -178.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . 0.778 ' HD3' ' HB3' ' A' ' 295' ' ' ASP . 9.6 Cg_endo -91.16 -78.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 122.615 2.21 . . . . 0.0 112.779 179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 79.5 mm-40 -142.76 -160.12 1.06 Allowed 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.883 -177.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . 0.581 ' H ' ' CD ' ' A' ' 299' ' ' PRO . 9.5 t30 -149.48 -48.41 0.02 OUTLIER Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.844 -178.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' PRO . . . . . 0.581 ' CD ' ' H ' ' A' ' 298' ' ' ASN . 12.1 Cg_exo -71.21 18.01 0.26 Allowed 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 122.522 2.148 . . . . 0.0 113.815 -176.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -69.19 -36.33 77.19 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.063 0.459 . . . . 0.0 110.156 175.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -78.75 -71.69 0.42 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.175 177.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . 0.457 ' O ' ' HA ' ' A' ' 299' ' ' PRO . 21.8 m120 -141.89 174.44 10.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.746 176.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.372 -0.823 . . . . 0.0 109.462 178.893 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 N--CA 1.48 1.057 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.3 m -115.91 -18.18 10.79 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.796 -177.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.414 ' O ' HG23 ' A' ' 99' ' ' ILE . 20.4 m 68.51 -71.45 0.11 Allowed 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.307 -175.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -72.15 102.66 3.09 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 177.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 25.6 mtm105 -122.35 3.35 9.73 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -175.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.45 ' HB3' ' HA ' ' A' ' 100' ' ' GLU . 17.0 p90 -83.13 150.42 26.27 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 120.426 -0.509 . . . . 0.0 110.917 -178.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -52.61 -43.85 65.65 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.479 -176.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 14.6 t 58.33 47.59 13.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.048 -172.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.7 t -171.97 -36.36 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.617 178.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -70.73 107.19 3.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.472 -175.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -60.43 -37.35 80.63 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.506 -175.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 34.5 t -72.87 -6.52 45.59 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.463 -177.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.86 -37.39 12.31 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -178.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 38.2 p-90 -122.58 -24.85 4.84 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -174.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -79.41 118.05 20.95 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.166 0.508 . . . . 0.0 110.687 -176.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.575 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 22.0 mmt -99.42 -10.08 22.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.894 -176.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.49 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.22 -113.47 2.27 Favored Glycine 0 CA--C 1.519 0.327 0 CA-C-N 115.486 -0.779 . . . . 0.0 113.282 -178.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.49 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 19.4 Cg_exo -66.62 87.13 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.271 2.648 . . . . 0.0 113.161 -176.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.933 HG12 ' H ' ' A' ' 20' ' ' SER . 93.3 t -136.84 -166.58 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 178.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.933 ' H ' HG12 ' A' ' 19' ' ' VAL . 42.1 p -162.25 169.73 20.2 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 119.768 1.167 . . . . 0.0 108.122 -168.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 34.8 ttt85 -67.16 -39.37 86.5 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.739 -175.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -65.0 -53.83 39.96 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.88 0.372 . . . . 0.0 110.995 178.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -62.57 -47.22 84.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.356 -177.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.14 -38.58 71.03 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.117 0.484 . . . . 0.0 110.706 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -62.24 -57.74 10.33 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.655 178.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.8 t -65.73 -15.23 62.62 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 111.938 0.347 . . . . 0.0 111.938 -173.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 26.6 mtp180 -87.33 -13.52 43.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.589 0.233 . . . . 0.0 110.951 179.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.557 HD11 ' HG ' ' A' ' 37' ' ' LEU . 32.6 mt -130.43 -1.88 4.4 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 30.6 tp60 -73.91 96.0 2.55 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.216 0.531 . . . . 0.0 111.109 -174.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.13 14.09 69.97 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.146 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -81.58 -169.03 2.11 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 122.281 0.233 . . . . 0.0 110.752 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.604 ' HB2' ' SD ' ' A' ' 35' ' ' MET . 51.3 mtm180 -60.99 127.03 29.54 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 177.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.536 ' CE1' ' HA ' ' A' ' 55' ' ' ASN . 41.0 m170 -77.49 116.97 18.5 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.862 -176.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 129.33 -17.92 5.55 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 -172.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.759 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 50.0 mtp -72.88 160.15 32.59 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-N 115.432 -0.384 . . . . 0.0 110.335 176.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.456 ' H ' ' HA ' ' A' ' 101' ' ' PRO . 43.3 p90 -163.98 169.23 18.29 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 178.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.575 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.6 pp -157.0 140.89 16.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.163 0.506 . . . . 0.0 111.183 175.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 50.8 t -108.92 123.0 64.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.261 175.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.44 ' HB2' ' HB ' ' A' ' 19' ' ' VAL . 33.3 ptt-85 -123.04 -177.83 3.79 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.013 -177.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -80.34 138.99 36.78 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 175.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 73.1 m -77.4 99.06 5.46 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 172.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.9 m -73.93 -9.62 58.83 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.247 178.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 15.3 p -83.53 -56.69 3.6 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.101 175.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 57.7 m -114.84 96.33 44.17 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.88 176.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -53.82 132.72 51.0 Favored 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 123.006 2.471 . . . . 0.0 112.618 -178.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.64 -27.14 17.55 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.389 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.59 ' OD1' ' HA ' ' A' ' 64' ' ' ASN . 33.1 m-20 -93.45 178.24 5.77 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.1 m-85 -131.42 171.41 13.41 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 178.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 57.6 t -139.41 112.24 5.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 120.97 0.414 . . . . 0.0 110.999 175.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.403 ' CB ' HD11 ' A' ' 63' ' ' ILE . 51.0 tp -82.05 103.44 11.69 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.741 174.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 37.5 m -96.18 127.66 42.39 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 174.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 98.3 t -111.18 139.89 33.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 121.02 0.438 . . . . 0.0 111.038 -174.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.556 ' HB2' HD22 ' A' ' 28' ' ' LEU . 28.3 t -87.95 116.12 25.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.282 179.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.498 ' O ' ' N ' ' A' ' 56' ' ' SER . 75.8 mt-10 -144.46 178.4 7.97 Favored 'General case' 0 C--O 1.215 -0.759 0 CA-C-O 118.379 -0.819 . . . . 0.0 108.832 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.624 ' C ' ' HB2' ' A' ' 57' ' ' ARG . 11.2 m-80 -24.11 65.46 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 126.934 2.094 . . . . 0.0 115.833 -176.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.498 ' N ' ' O ' ' A' ' 54' ' ' GLU . 21.0 m 48.59 57.35 6.39 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -171.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.785 HH22 ' HA ' ' A' ' 154' ' ' GLU . 0.3 OUTLIER -162.05 58.24 0.25 Allowed 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 114.322 -1.308 . . . . 0.0 112.18 -145.641 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 11.2 t -74.5 97.91 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 122.058 0.933 . . . . 0.0 109.394 -172.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.565 ' HB2' ' CE2' ' A' ' 61' ' ' TYR . 0.1 OUTLIER -79.07 121.02 24.45 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 113.907 -1.497 . . . . 0.0 111.287 -175.456 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -98.05 108.34 21.02 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -173.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.565 ' CE2' ' HB2' ' A' ' 59' ' ' SER . 79.3 m-85 -110.18 107.42 17.22 Favored 'General case' 0 C--O 1.219 -0.547 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.04 178.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.578 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 53.3 mt -80.49 137.35 21.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -175.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.58 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 5.4 mp -116.47 117.69 56.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.728 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.59 ' HA ' ' OD1' ' A' ' 47' ' ' ASP . 13.7 m120 -87.3 139.73 30.26 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.863 -177.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.8 t -86.76 98.51 11.2 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 173.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 1.003 HD11 ' HG3' ' A' ' 72' ' ' LYS . 91.6 mt -80.78 146.66 60.55 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.346 -175.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 66' ' ' LEU . 11.9 Cg_exo -71.05 -2.19 10.69 Favored 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 122.743 2.295 . . . . 0.0 110.235 170.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -81.92 5.07 20.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.151 177.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.731 ' HE ' ' HA ' ' A' ' 69' ' ' ARG . 3.2 tpm_? 62.98 29.0 16.47 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.306 -173.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.452 ' HB2' HD12 ' A' ' 66' ' ' LEU . 88.7 mtt180 -128.63 179.17 5.83 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.402 -177.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.58 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 31.4 m-85 -134.92 119.76 18.42 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.19 -178.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 1.003 ' HG3' HD11 ' A' ' 66' ' ' LEU . 38.8 mttm -96.31 101.11 12.7 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 -175.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.626 HD13 ' HE2' ' A' ' 88' ' ' TYR . 10.0 tt -83.37 99.11 5.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.405 0.622 . . . . 0.0 109.476 173.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.408 ' O ' ' HB3' ' A' ' 75' ' ' ASP . . . 62.8 44.31 97.65 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.428 -174.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.445 ' HA ' ' HD3' ' A' ' 72' ' ' LYS . 25.4 t70 75.61 -25.07 0.21 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.172 0.589 . . . . 0.0 111.915 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.69 107.79 4.1 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 174.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.497 ' HB3' ' CG ' ' A' ' 72' ' ' LYS . 12.7 pt-20 -96.23 137.87 34.66 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.887 0.851 . . . . 0.0 112.404 -171.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.595 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 96.6 m-85 -122.33 162.65 21.14 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 114.159 -1.382 . . . . 0.0 107.97 174.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.45 ' HA ' ' HG2' ' A' ' 70' ' ' ARG . 3.2 p-10 -69.55 -15.36 63.21 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -172.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.456 ' CE1' ' HB2' ' A' ' 83' ' ' ALA . 0.2 OUTLIER -172.29 171.57 4.75 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.459 174.036 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.512 HD23 HD21 ' A' ' 84' ' ' LEU . 9.7 mt -53.32 -54.22 47.52 Favored Pre-proline 0 N--CA 1.469 0.511 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 81' ' ' LEU . 27.6 Cg_endo -63.21 3.56 0.56 Allowed 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.436 2.09 . . . . 0.0 114.176 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.456 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -98.46 -31.49 11.97 Favored 'General case' 0 C--N 1.331 -0.211 0 O-C-N 122.292 -0.255 . . . . 0.0 110.53 178.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.595 ' HB3' ' CD2' ' A' ' 78' ' ' PHE . 4.0 pp -76.42 -35.7 58.4 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 51.0 mt -68.54 -20.03 64.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.893 176.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -86.53 -28.41 23.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.267 -0.878 . . . . 0.0 110.619 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.711 ' HE1' ' CE1' ' A' ' 88' ' ' TYR . 0.0 OUTLIER -88.41 -19.52 26.46 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.238 0.542 . . . . 0.0 111.167 -177.341 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.711 ' CE1' ' HE1' ' A' ' 87' ' ' PHE . 45.1 m-85 -87.33 2.33 50.6 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 121.19 -0.944 . . . . 0.0 110.659 177.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -74.97 -18.32 60.4 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.021 174.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.618 HD13 ' O ' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -127.02 -3.83 4.46 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 CA-C-O 121.174 0.512 . . . . 0.0 110.194 -179.306 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.4 ' HB2' ' O ' ' A' ' 87' ' ' PHE . 3.3 t60 -88.92 -32.76 17.56 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.848 -173.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.518 ' CD2' HG23 ' A' ' 97' ' ' THR . 95.5 m-85 61.86 106.25 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 O-C-N 124.119 0.887 . . . . 0.0 110.108 -171.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 13.0 mt -66.49 -85.51 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 174.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.418 ' OD1' ' ND2' ' A' ' 55' ' ' ASN . 14.5 t70 -79.9 -130.76 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 172.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 5.1 t -87.27 12.25 12.29 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 121.211 0.529 . . . . 0.0 110.164 177.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.9 t -143.03 160.34 40.55 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.585 -178.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.518 HG23 ' CD2' ' A' ' 92' ' ' TYR . 6.6 p -100.27 -179.7 4.2 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.119 175.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 95.7 mt -75.41 106.89 7.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.187 0.517 . . . . 0.0 109.779 175.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.414 HG23 ' O ' ' A' ' 3' ' ' SER . 46.4 mm -90.23 -65.21 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.503 -175.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.759 ' O ' ' HA ' ' A' ' 35' ' ' MET . 10.9 pt-20 -159.18 140.81 9.7 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.206 178.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.456 ' HA ' ' H ' ' A' ' 36' ' ' PHE . 38.3 Cg_endo -65.49 170.2 11.4 Favored 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 122.831 2.354 . . . . 0.0 112.984 -175.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.423 ' C ' ' H ' ' A' ' 104' ' ' ARG . . . -68.71 126.5 92.81 Favored Pre-proline 0 N--CA 1.447 -0.597 0 N-CA-C 107.262 -1.385 . . . . 0.0 107.262 170.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -69.15 28.86 0.16 Allowed 'Trans proline' 0 N--CA 1.478 0.571 0 C-N-CA 123.461 2.774 . . . . 0.0 114.135 -169.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.423 ' H ' ' C ' ' A' ' 102' ' ' ALA . 41.0 ttm180 66.46 -60.44 0.33 Allowed 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.644 0.777 . . . . 0.0 111.056 -177.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -89.34 134.82 32.08 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 178.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -61.47 -25.67 80.07 Favored 'Trans proline' 0 C--O 1.236 0.406 0 C-N-CA 122.948 2.432 . . . . 0.0 112.51 178.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.3 t 72.03 142.75 0.09 OUTLIER Pre-proline 0 CA--C 1.533 0.298 0 O-C-N 123.799 0.687 . . . . 0.0 110.993 178.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.72 153.0 79.49 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.344 2.029 . . . . 0.0 111.433 175.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -65.47 98.26 0.33 Allowed 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.346 2.031 . . . . 0.0 112.041 178.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 86.2 mmm -105.74 -175.16 2.71 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.794 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -80.22 69.5 3.11 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.169 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 33.7 t -112.07 135.41 52.76 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.042 0.449 . . . . 0.0 110.609 -178.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 7.3 p -141.42 15.11 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.766 0.793 . . . . 0.0 109.555 177.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.7 p -77.91 8.13 5.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.928 -175.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.451 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . . . -129.22 125.0 22.51 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.262 177.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 115' ' ' ALA . 33.3 Cg_exo -62.17 -52.46 2.71 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 122.716 2.277 . . . . 0.0 112.128 179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.476 ' C ' HD12 ' A' ' 118' ' ' LEU . 6.4 m-20 67.14 152.64 0.08 Allowed 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 121.589 0.709 . . . . 0.0 112.002 -179.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.48 ' HA ' ' HD3' ' A' ' 119' ' ' PRO . 9.2 mp -131.05 115.58 16.57 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.036 -178.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 118' ' ' LEU . 4.4 Cg_exo -81.14 19.31 1.18 Allowed 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 123.398 2.732 . . . . 0.0 112.207 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 27.1 m -68.6 117.11 9.92 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.596 -177.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -100.78 90.22 4.15 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 172.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -112.37 155.31 24.36 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.188 0.518 . . . . 0.0 110.913 -173.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -102.66 170.23 8.15 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.137 -178.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 7.2 p30 50.28 -147.77 0.35 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.385 1.074 . . . . 0.0 113.127 173.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.776 HD12 HG21 ' A' ' 152' ' ' ILE . 3.1 mm? 64.11 80.3 0.23 Allowed 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.665 0.745 . . . . 0.0 109.493 -166.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.526 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 39.9 tt0 -173.69 -60.07 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.656 -1.156 . . . . 0.0 109.303 -172.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -118.76 106.79 12.9 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 121.691 0.758 . . . . 0.0 110.524 177.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.876 HG22 ' HB3' ' A' ' 180' ' ' LYS . 20.9 t -115.68 134.97 57.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 114.375 -1.284 . . . . 0.0 108.771 -178.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.68 ' HG3' ' CG ' ' A' ' 179' ' ' GLU . 5.7 ptp180 -110.48 136.12 50.12 Favored 'General case' 0 CA--C 1.514 -0.415 0 C-N-CA 116.463 -2.095 . . . . 0.0 109.773 167.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.594 HG22 HG12 ' A' ' 178' ' ' VAL . 0.7 OUTLIER -93.57 142.21 27.6 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.711 -175.655 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.654 ' N ' HD22 ' A' ' 131' ' ' LEU . 2.0 mm? -115.04 -26.99 7.5 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.342 -165.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.513 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 37.1 t80 -89.36 -30.79 18.14 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 120.642 -0.423 . . . . 0.0 111.86 -172.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.604 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 8.8 t70 71.63 98.69 0.07 Allowed 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.391 0.615 . . . . 0.0 109.545 -174.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.455 ' O ' ' HA ' ' A' ' 143' ' ' PRO . 53.7 t80 -123.9 84.07 54.67 Favored Pre-proline 0 C--N 1.32 -0.704 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 177.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.622 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 66.7 Cg_endo -82.29 61.29 7.67 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.281 1.988 . . . . 0.0 112.894 -177.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -62.38 -29.8 74.35 Favored Glycine 0 C--N 1.331 0.301 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.589 178.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.46 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 10.0 m-80 64.03 65.39 0.69 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 114.861 -0.669 . . . . 0.0 112.143 176.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.479 ' HB3' ' H ' ' A' ' 140' ' ' GLU . 0.8 OUTLIER -145.72 169.49 18.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.908 177.019 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -89.41 -6.64 56.39 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.765 0.793 . . . . 0.0 109.253 172.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.479 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 11.6 mp0 -104.23 -19.76 14.01 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.575 175.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -135.38 107.69 7.28 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 1.058 HD11 ' HB2' ' A' ' 165' ' ' ASN . 33.1 tp -70.96 127.32 91.83 Favored Pre-proline 0 C--N 1.325 -0.465 0 C-N-CA 120.822 -0.351 . . . . 0.0 110.745 -176.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.651 ' HD2' HD12 ' A' ' 142' ' ' LEU . 95.9 Cg_endo -81.7 93.71 0.95 Allowed 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 122.014 1.809 . . . . 0.0 111.367 172.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.514 ' CD1' ' HB ' ' A' ' 130' ' ' THR . 10.0 p90 -105.76 159.74 15.76 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.385 -174.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.604 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 56.5 mtpt -102.68 -169.0 1.6 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -175.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.574 ' HD2' ' N ' ' A' ' 146' ' ' LYS . 9.2 mptt -74.54 -13.49 60.68 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.154 -167.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -164.67 25.77 0.18 Allowed Glycine 0 CA--C 1.503 -0.692 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.32 -178.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.531 ' HB3' ' HB2' ' A' ' 145' ' ' LYS . 0.1 OUTLIER -79.54 148.28 31.84 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.001 0.429 . . . . 0.0 111.024 -177.458 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.516 HG13 ' HB3' ' A' ' 129' ' ' ARG . 1.8 mp -94.13 129.77 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.399 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.764 HD22 HD21 ' A' ' 142' ' ' LEU . 9.3 mt -121.47 156.95 31.67 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 -175.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.608 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 57.3 t -111.12 122.82 66.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 174.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 1.054 HD13 ' HB2' ' A' ' 163' ' ' ALA . 49.8 mm -76.78 79.91 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-O 122.344 1.069 . . . . 0.0 108.49 -177.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.529 HG23 ' HG3' ' A' ' 154' ' ' GLU . 18.1 tt -72.6 -25.89 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 113.551 -1.658 . . . . 0.0 110.113 -174.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.785 ' HA ' HH22 ' A' ' 57' ' ' ARG . 0.5 OUTLIER -140.88 153.36 45.68 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 173.85 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.413 ' HG3' ' CD1' ' A' ' 161' ' ' TRP . 79.3 tttt -140.85 91.98 8.94 Favored Pre-proline 0 C--N 1.32 -0.68 0 O-C-N 122.047 -0.408 . . . . 0.0 110.591 177.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.756 ' HG2' ' SD ' ' A' ' 172' ' ' MET . 2.8 Cg_endo -81.62 -39.85 0.17 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.573 2.182 . . . . 0.0 111.999 -174.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.43 ' HB2' ' HB2' ' A' ' 160' ' ' TRP . 46.2 mm-40 -114.66 161.86 17.55 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.38 -179.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -85.68 -7.87 58.54 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 173.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.992 ' HG3' ' HD1' ' A' ' 160' ' ' TRP . 21.0 pt20 -111.16 -17.69 13.16 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.728 178.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.992 ' HD1' ' HG3' ' A' ' 159' ' ' GLN . 47.5 m95 -131.78 131.55 43.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.397 178.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . 0.731 ' HB3' HD12 ' A' ' 152' ' ' ILE . 48.5 m0 -119.53 140.56 50.32 Favored 'General case' 0 C--O 1.212 -0.911 0 C-N-CA 122.877 0.471 . . . . 0.0 110.643 -176.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.591 ' OG ' ' HG2' ' A' ' 172' ' ' MET . 30.4 m -100.2 97.59 8.38 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -176.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 1.054 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -108.66 146.44 33.42 Favored 'General case' 0 N--CA 1.416 -2.129 0 C-N-CA 119.951 -0.7 . . . . 0.0 109.154 -173.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.692 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 19.9 ptt-85 -87.48 122.67 31.5 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 175.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 1.058 ' HB2' HD11 ' A' ' 142' ' ' LEU . 7.6 t30 -56.74 175.5 0.12 Allowed 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 113.572 -1.649 . . . . 0.0 110.282 -175.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 35.4 ttmt -60.3 -13.48 13.06 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.322 0.582 . . . . 0.0 109.78 171.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -81.92 -26.43 34.07 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.005 174.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 100.69 -4.97 56.6 Favored Glycine 0 CA--C 1.521 0.421 0 CA-C-N 115.358 -0.837 . . . . 0.0 112.112 -173.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.692 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.7 OUTLIER -69.05 134.31 49.24 Favored 'General case' 0 C--O 1.216 -0.71 0 C-N-CA 123.108 0.563 . . . . 0.0 110.903 179.927 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.499 HG22 HG21 ' A' ' 153' ' ' ILE . 39.3 t -86.75 128.07 39.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 O-C-N 122.049 -0.407 . . . . 0.0 110.969 178.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -154.08 154.72 25.7 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.122 170.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.756 ' SD ' ' HG2' ' A' ' 156' ' ' PRO . 29.5 mtp -81.11 141.05 34.66 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 117.284 0.542 . . . . 0.0 110.889 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.664 ' CG2' ' HB3' ' A' ' 142' ' ' LEU . 2.6 pp -141.4 143.14 29.01 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.558 -174.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.481 ' HB2' ' CD1' ' A' ' 177' ' ' TYR . 15.3 Cg_exo -67.7 135.91 37.31 Favored 'Trans proline' 0 CA--C 1.532 0.389 0 C-N-CA 122.739 2.293 . . . . 0.0 113.164 -178.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.54 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 98.1 t -64.54 -45.65 76.86 Favored Pre-proline 0 CA--C 1.539 0.519 0 N-CA-C 112.816 0.672 . . . . 0.0 112.816 178.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 36.1 Cg_endo -66.41 7.9 0.35 Allowed 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 122.022 1.815 . . . . 0.0 112.938 178.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.481 ' CD1' ' HB2' ' A' ' 174' ' ' PRO . 3.7 m-85 -101.05 -13.87 18.04 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.258 177.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.598 ' HA ' HD23 ' A' ' 131' ' ' LEU . 1.5 m -116.07 175.49 2.84 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 N-CA-C 115.956 1.836 . . . . 0.0 115.956 -166.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.734 ' O ' ' HG3' ' A' ' 179' ' ' GLU 0.273 2.0 pt-20 -149.09 57.69 1.02 Allowed 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 112.294 -2.23 . . . . 0.0 111.044 -165.699 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.876 ' HB3' HG22 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -69.36 141.7 54.13 Favored 'General case' 0 C--N 1.33 -0.273 0 O-C-N 118.748 -2.47 . . . . 0.0 111.768 -165.498 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.453 HD13 ' CZ ' ' A' ' 129' ' ' ARG . 32.7 tp -78.39 -66.72 0.82 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 112.161 -2.291 . . . . 0.0 112.362 -162.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 11.3 p -77.64 55.76 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 122.242 1.02 . . . . 0.0 111.051 -173.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.601 ' CD ' ' HB2' ' A' ' 185' ' ' SER . 0.0 OUTLIER -142.74 -6.65 0.87 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.323 178.712 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 8.6 t 61.92 23.53 13.86 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.095 178.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.637 ' HB3' ' HD3' ' A' ' 186' ' ' PRO . 9.3 t -37.01 -49.73 2.1 Favored Pre-proline 0 N--CA 1.471 0.618 0 C-N-CA 124.805 1.242 . . . . 0.0 113.773 -176.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.637 ' HD3' ' HB3' ' A' ' 185' ' ' SER . 16.8 Cg_exo -68.52 92.18 0.41 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 121.11 1.207 . . . . 0.0 110.292 169.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.425 ' CE1' ' HA ' ' A' ' 185' ' ' SER . 6.6 m-70 -88.0 80.98 7.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.959 0.409 . . . . 0.0 110.11 -174.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -107.74 -27.19 5.29 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 177.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -106.79 -29.24 9.66 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 175.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 69.0 t60 -82.75 91.87 7.11 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.218 0.532 . . . . 0.0 110.656 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 169.3 49.53 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.613 0 N-CA-C 110.869 -0.893 . . . . 0.0 110.869 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -73.93 -29.62 62.12 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.993 0.425 . . . . 0.0 111.037 -172.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 70.7 mtp180 -84.79 -12.7 53.12 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.98 177.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 63.4 m-80 68.82 -62.39 0.39 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.627 0.771 . . . . 0.0 111.419 -176.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 13.6 p -160.96 155.06 22.8 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.254 -178.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -91.14 -167.22 1.75 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 175.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 47.0 m 72.29 -58.97 0.57 Allowed 'General case' 0 N--CA 1.466 0.371 0 O-C-N 123.679 0.612 . . . . 0.0 110.695 -177.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -85.9 145.22 27.26 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 173.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 82.16 -54.78 4.9 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.328 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 6.5 tp -159.48 108.6 1.5 Allowed Pre-proline 0 N--CA 1.448 -0.544 0 CA-C-O 121.08 0.467 . . . . 0.0 110.036 176.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -63.64 -30.4 70.17 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.544 2.163 . . . . 0.0 111.096 175.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.436 ' N ' ' HD3' ' A' ' 203' ' ' PRO . 37.8 tt0 58.88 66.37 2.44 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 114.687 -1.142 . . . . 0.0 111.501 177.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.436 ' HD3' ' N ' ' A' ' 202' ' ' GLU . 3.3 Cg_endo -86.4 124.46 2.38 Favored 'Trans proline' 0 N--CA 1.452 -0.919 0 C-N-CA 123.068 2.512 . . . . 0.0 111.063 175.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -61.79 -41.04 97.22 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.931 0.396 . . . . 0.0 111.165 -179.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -115.16 -85.15 0.61 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.168 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -144.99 -70.71 0.28 Allowed 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 121.121 -0.231 . . . . 0.0 111.331 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -102.88 -21.18 14.04 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.447 -175.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . 67.67 -169.0 0.19 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.849 178.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.87 ' H ' ' HD2' ' A' ' 210' ' ' PRO . 76.4 mm-40 -138.02 -50.58 0.02 OUTLIER Pre-proline 0 CA--C 1.534 0.356 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.95 -177.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 0.87 ' HD2' ' H ' ' A' ' 209' ' ' GLN . 37.8 Cg_endo -66.23 85.91 0.26 Allowed 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 121.984 1.79 . . . . 0.0 112.88 -179.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 -104.44 3.7 32.47 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.105 177.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 8.1 p -78.62 -30.73 46.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.593 -176.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -78.95 105.83 10.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.909 179.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.481 ' HA ' ' HD3' ' A' ' 215' ' ' PRO . 10.2 t -151.92 136.1 10.0 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.524 -178.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 214' ' ' THR . 4.4 Cg_endo -86.17 148.14 9.1 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 123.385 2.724 . . . . 0.0 112.118 177.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 48.0 tp -139.19 94.69 9.64 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 120.858 0.361 . . . . 0.0 110.745 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -75.21 73.98 4.26 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 123.125 2.55 . . . . 0.0 111.972 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -143.62 -70.42 0.31 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.941 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 26.1 m -93.64 -27.2 4.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.182 175.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 9.4 t -93.58 97.09 10.27 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.434 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -138.01 117.06 1.4 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.044 -178.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 3.1 t -123.61 143.42 41.62 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 -179.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.26 119.5 6.78 Favored 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 122.789 2.326 . . . . 0.0 112.162 176.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -81.55 -28.37 43.7 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.807 -0.711 . . . . 0.0 111.918 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -154.77 143.75 20.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.655 0.264 . . . . 0.0 110.42 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -74.86 94.16 2.75 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.024 0.44 . . . . 0.0 110.656 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 8.0 tp -163.27 137.63 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.068 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.875 ' HB ' ' HD3' ' A' ' 229' ' ' PRO . 25.2 m -152.75 -59.8 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.727 177.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.875 ' HD3' ' HB ' ' A' ' 228' ' ' THR . 5.9 Cg_exo -79.9 112.93 2.94 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.151 1.901 . . . . 0.0 111.927 179.244 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 79.5 mt -73.23 154.23 90.34 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.458 177.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.38 124.43 15.14 Favored 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 122.288 1.992 . . . . 0.0 110.707 172.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 27.8 m -74.75 74.02 2.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.619 0.723 . . . . 0.0 110.811 -176.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 11.0 p -78.13 -37.66 45.57 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.089 -0.96 . . . . 0.0 111.052 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 55.62 84.49 0.08 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.448 0.642 . . . . 0.0 111.108 -177.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . 0.504 HD22 ' N ' ' A' ' 235' ' ' ASN . 0.1 OUTLIER -168.35 142.03 3.2 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.732 179.118 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . 0.491 ' N ' ' HD3' ' A' ' 237' ' ' PRO . . . 75.15 57.97 4.15 Favored Glycine 0 CA--C 1.524 0.648 0 CA-C-N 115.924 -0.58 . . . . 0.0 113.853 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.491 ' HD3' ' N ' ' A' ' 236' ' ' GLY . 1.1 Cg_endo -82.61 95.31 0.85 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.144 1.896 . . . . 0.0 109.604 170.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.538 ' CG1' HD12 ' A' ' 293' ' ' ILE . 2.8 t -65.66 139.67 20.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.729 -169.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -106.16 121.56 44.41 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.994 178.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.508 ' HB1' ' HB ' ' A' ' 291' ' ' VAL . . . -119.26 136.57 54.16 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.36 179.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.425 ' HB2' ' CE1' ' A' ' 294' ' ' PHE . 2.8 tppp? -86.97 122.34 30.69 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 178.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . 0.532 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -72.43 97.02 1.99 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.154 0.502 . . . . 0.0 110.278 177.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 19.1 pt -85.59 -25.68 6.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.712 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.79 138.92 50.14 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.409 ' HE3' ' HB2' ' A' ' 245' ' ' LYS . 34.5 ttmt -67.61 155.81 38.28 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.2 -173.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 15.5 mmm180 -134.91 128.44 32.58 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.473 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.474 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 8.2 m -134.56 130.14 19.78 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.18 176.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.546 ' HD3' ' HB2' ' A' ' 257' ' ' ALA . 3.5 Cg_exo -75.5 145.51 29.87 Favored 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 123.059 2.506 . . . . 0.0 112.128 -176.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 51.1 t -75.12 169.98 16.95 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -61.68 -19.56 62.48 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -176.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -110.61 4.52 20.32 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.975 0.361 . . . . 0.0 111.975 -178.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.544 ' HB3' ' HB3' ' A' ' 255' ' ' ALA . 61.7 m-20 -91.06 112.96 25.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.51 0.195 . . . . 0.0 111.054 -178.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . 0.444 ' N ' ' HD2' ' A' ' 253' ' ' LYS . 10.9 mptt -95.4 -41.3 9.06 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.272 0.558 . . . . 0.0 109.986 175.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 6.8 p -98.93 21.25 11.86 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.639 -0.709 . . . . 0.0 112.188 -174.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.544 ' HB3' ' HB3' ' A' ' 252' ' ' ASP . . . -102.61 113.31 26.57 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 121.06 -0.256 . . . . 0.0 110.434 177.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.529 HD23 ' H ' ' A' ' 257' ' ' ALA . 0.5 OUTLIER -70.87 144.03 50.83 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.048 0.452 . . . . 0.0 110.965 -175.705 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.546 ' HB2' ' HD3' ' A' ' 248' ' ' PRO . . . -105.43 136.21 45.41 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.58 177.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 94.9 mt -135.88 152.16 50.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.799 -173.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -118.64 155.57 30.76 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.267 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 36.6 t -68.19 129.9 33.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.607 -174.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 83.32 33.92 21.64 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.316 178.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -119.28 162.67 18.34 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.141 -0.318 . . . . 0.0 110.141 179.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 39.2 mm -102.18 109.81 27.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.01 0.434 . . . . 0.0 110.78 -177.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 16.8 t -89.61 104.82 15.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.381 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . 0.424 ' HE2' ' HB3' ' A' ' 278' ' ' GLU . 4.4 ptmt -87.06 102.02 14.02 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.631 177.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.504 HG21 ' HB3' ' A' ' 275' ' ' TRP . 3.0 p -92.93 123.99 45.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.182 0.515 . . . . 0.0 110.723 -179.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 16.1 p -94.98 -27.01 15.86 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.383 -177.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . 0.577 ' HB3' ' HB2' ' A' ' 276' ' ' GLU . 42.2 ttm180 -131.92 103.16 6.16 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.997 0.427 . . . . 0.0 110.394 178.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' MET . . . . . 0.48 ' HG3' ' CD1' ' A' ' 275' ' ' TRP . 29.6 ttm -93.97 109.87 21.58 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.992 0.425 . . . . 0.0 110.734 -179.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -87.78 173.93 8.68 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.502 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 31.3 pt -107.6 5.7 9.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.874 0.369 . . . . 0.0 111.523 -176.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 29.6 p-10 -83.3 -26.28 30.78 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.124 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 119.18 -10.29 11.83 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.139 -177.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.558 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 27.1 mt-30 -118.06 111.97 19.6 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.765 -0.458 . . . . 0.0 109.765 177.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.59 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 19.2 m0 -96.74 159.55 14.86 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.117 -175.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.577 ' HB2' ' HB3' ' A' ' 268' ' ' ARG . 48.0 mt-10 -100.81 111.68 23.95 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.255 175.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . 0.574 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -129.15 158.58 22.08 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.533 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.424 ' HB3' ' HE2' ' A' ' 265' ' ' LYS . 39.6 tt0 -110.25 109.99 20.66 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.902 0.382 . . . . 0.0 110.155 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . 0.727 HG12 HD22 ' A' ' 280' ' ' ASN . 57.3 t -127.18 128.49 70.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.869 179.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . 0.727 HD22 HG12 ' A' ' 279' ' ' VAL . 46.2 m-80 63.03 25.59 15.07 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 123.442 0.464 . . . . 0.0 111.238 -177.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 75.52 19.49 79.25 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.059 -177.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . 0.403 ' NH1' ' HA ' ' A' ' 256' ' ' LEU . 1.4 tmt_? -129.73 117.36 20.16 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 179.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.574 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 25.1 pttm -103.68 142.4 34.39 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.803 -178.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -173.18 178.37 45.18 Favored Glycine 0 N--CA 1.439 -1.12 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.707 178.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.59 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 94.8 mt -81.09 130.55 35.07 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.766 0.317 . . . . 0.0 110.314 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -129.2 125.24 22.61 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.424 175.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -58.36 126.42 21.38 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 123.183 2.589 . . . . 0.0 111.787 174.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -64.75 -12.66 49.73 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.305 -174.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.19 -3.77 11.75 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -176.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -114.91 -2.65 12.83 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.023 -0.423 . . . . 0.0 111.212 -178.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.532 HG12 ' HA ' ' A' ' 242' ' ' ALA . 35.8 m -128.7 166.51 25.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.737 -0.21 . . . . 0.0 110.606 179.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? -131.34 132.49 44.5 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.716 0.293 . . . . 0.0 110.26 172.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.538 HD12 ' CG1' ' A' ' 238' ' ' VAL . 40.8 mm -76.61 125.29 36.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.116 177.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' PHE . . . . . 0.425 ' CE1' ' HB2' ' A' ' 241' ' ' LYS . 5.3 p90 -149.67 166.64 28.72 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -103.7 104.81 44.49 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 178.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -87.42 10.03 3.67 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.883 2.388 . . . . 0.0 112.368 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -90.51 -47.0 7.98 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.246 -177.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . 0.462 ' OD1' ' HB3' ' A' ' 300' ' ' ASP . 4.8 p30 -98.07 135.45 21.39 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.299 -179.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -87.53 5.62 5.48 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.717 2.278 . . . . 0.0 112.004 177.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.462 ' HB3' ' OD1' ' A' ' 298' ' ' ASN . 14.3 t70 -70.76 -45.86 63.99 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.993 -179.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -120.86 10.69 10.94 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.53 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -79.4 110.61 14.86 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.154 178.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 . . . . . 0 C--O 1.246 0.89 0 CA-C-O 118.575 -0.726 . . . . 0.0 109.531 178.346 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.286 0 CA-C-O 120.724 0.297 . . . . 0.0 110.419 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.7 m -115.25 168.19 10.17 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.8 m 60.82 86.59 0.1 Allowed 'General case' 0 C--O 1.233 0.219 0 O-C-N 123.661 0.601 . . . . 0.0 110.279 -175.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.558 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . 69.39 100.86 0.06 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.161 -176.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.432 HH11 ' HD3' ' A' ' 5' ' ' ARG . 3.4 ptp180 -125.87 81.33 1.98 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.433 0.635 . . . . 0.0 111.32 -177.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.5 p90 -147.98 157.56 43.59 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.74 177.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -85.88 9.51 16.55 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -171.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.0 m 65.54 -15.61 0.11 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 173.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.83 ' CA ' ' HE1' ' A' ' 14' ' ' TRP . 8.2 t -142.4 -71.02 0.33 Allowed 'General case' 0 C--O 1.246 0.919 0 CA-C-O 122.224 1.011 . . . . 0.0 110.82 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' A' ' 12' ' ' SER . 25.0 t0 -25.16 72.29 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 113.908 -1.497 . . . . 0.0 111.484 -148.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.68 ' H ' ' HD2' ' A' ' 11' ' ' ARG . 11.4 mmm180 -6.03 -53.37 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 126.437 2.335 . . . . 0.0 115.099 -159.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.5 ' N ' ' O ' ' A' ' 10' ' ' ASP . 6.0 t -65.49 12.84 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 121.548 -0.061 . . . . 0.0 110.912 176.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.492 ' O ' ' HG2' ' A' ' 101' ' ' PRO . . . -91.0 -29.71 17.22 Favored 'General case' 0 N--CA 1.441 -0.91 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.187 177.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.83 ' HE1' ' CA ' ' A' ' 9' ' ' SER . 24.5 p-90 -151.49 -28.03 0.19 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -173.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -59.4 123.79 17.91 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -178.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.49 ' SD ' ' HA ' ' A' ' 104' ' ' ARG . 33.1 tpp -110.1 2.66 19.62 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.71 -0.223 . . . . 0.0 111.485 -171.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.53 ' O ' ' HB2' ' A' ' 39' ' ' ARG . . . 51.53 -104.85 0.17 Allowed Glycine 0 CA--C 1.524 0.619 0 O-C-N 123.592 0.557 . . . . 0.0 114.476 177.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.428 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 3.5 Cg_exo -78.25 110.13 2.81 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.783 2.322 . . . . 0.0 112.756 179.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.944 ' HB ' ' HG3' ' A' ' 39' ' ' ARG . 23.5 t -138.23 -73.1 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 119.421 -0.323 . . . . 0.0 111.636 177.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.478 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 69.9 m 79.93 -177.35 0.08 Allowed 'General case' 0 C--N 1.342 0.26 0 CA-C-N 117.781 0.264 . . . . 0.0 110.929 174.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.4 mmm180 -63.81 -49.61 72.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.549 0.214 . . . . 0.0 111.154 -171.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -59.89 -53.62 55.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.622 -173.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 19' ' ' VAL . 57.9 mm-40 -64.07 -48.93 74.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.42 -178.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.02 -39.66 75.18 Favored 'General case' 0 C--O 1.224 -0.27 0 C-N-CA 120.918 -0.313 . . . . 0.0 111.811 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.638 ' HA ' HG21 ' A' ' 58' ' ' VAL . 12.4 mm100 -70.06 -53.7 16.31 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -178.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 7.0 t -68.28 -27.14 66.06 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 121.007 0.432 . . . . 0.0 111.611 -173.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -87.46 -33.75 18.93 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.094 0.473 . . . . 0.0 110.87 -175.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.682 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 30.7 mt -106.33 28.17 8.01 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.616 -176.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.11 65.77 2.16 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.073 0.463 . . . . 0.0 111.941 -173.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 59.53 23.53 58.4 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.507 -0.769 . . . . 0.0 112.979 176.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.476 ' O ' ' HB2' ' A' ' 117' ' ' ASN . 4.6 tt0 -64.46 -81.67 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.681 0.277 . . . . 0.0 110.367 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.433 ' HA ' ' HA ' ' A' ' 117' ' ' ASN . 39.9 ttp-105 -107.34 132.57 52.99 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 173.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 67.2 m170 -81.74 110.64 17.25 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.026 0.441 . . . . 0.0 110.527 -179.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 137.25 -19.92 3.39 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.382 -175.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.732 ' HB2' ' HB3' ' A' ' 53' ' ' SER . 34.3 mtt -59.82 137.04 58.16 Favored 'General case' 0 CA--C 1.519 -0.242 0 C-N-CA 122.404 0.282 . . . . 0.0 111.169 176.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.575 ' CB ' HG22 ' A' ' 52' ' ' VAL . 22.0 p90 -146.78 158.27 43.87 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 120.742 -0.383 . . . . 0.0 110.941 173.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.498 ' O ' HD12 ' A' ' 37' ' ' LEU . 4.5 pp -151.66 143.0 23.42 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.574 173.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 84.2 t -114.65 120.58 64.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 176.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.944 ' HG3' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -134.51 169.22 17.6 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.671 -0.411 . . . . 0.0 110.714 -176.728 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.405 ' O ' ' HG2' ' A' ' 39' ' ' ARG . 1.8 m-20 -57.99 127.96 34.73 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 175.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.3 t -64.62 157.57 26.71 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.401 0.62 . . . . 0.0 111.895 -173.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.2 p -86.47 -11.01 52.98 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.4 177.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 32.7 p -88.62 -63.6 1.27 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.645 178.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.447 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 57.4 m -136.91 145.4 50.59 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.835 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 44' ' ' CYS . 21.8 Cg_exo -65.51 -28.09 53.74 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.765 2.31 . . . . 0.0 112.51 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -76.73 -6.17 84.63 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 121.121 -0.561 . . . . 0.0 112.317 178.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.49 ' OD1' ' HA ' ' A' ' 64' ' ' ASN . 46.1 m-20 -111.28 159.48 17.9 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 176.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -129.54 169.45 14.97 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 177.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.511 HG22 HG12 ' A' ' 62' ' ' ILE . 45.2 t -140.14 98.84 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.184 0.516 . . . . 0.0 111.144 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 35.8 tp -69.05 99.84 1.15 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.872 172.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.1 m -96.74 126.2 41.73 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 177.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.575 HG22 ' CB ' ' A' ' 36' ' ' PHE . 80.9 t -117.46 146.92 21.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.704 -176.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.732 ' HB3' ' HB2' ' A' ' 35' ' ' MET . 26.6 t -100.27 98.88 9.5 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 175.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.469 ' HB2' ' OD1' ' A' ' 94' ' ' ASP . 0.0 OUTLIER -144.35 156.39 44.22 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.727 -176.352 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.552 ' OD1' ' HE2' ' A' ' 155' ' ' LYS . 0.7 OUTLIER 66.56 -56.04 0.4 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.243 0.617 . . . . 0.0 112.652 -179.235 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 2.8 p 169.77 -6.95 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.721 0.809 . . . . 0.0 110.774 -175.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -134.68 -169.11 2.28 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.512 -175.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.638 HG21 ' HA ' ' A' ' 25' ' ' GLN . 26.2 t -114.55 104.92 17.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.504 -179.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 75.1 m -84.0 119.34 24.82 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.551 0.691 . . . . 0.0 110.133 176.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -94.88 104.22 16.11 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.033 -175.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.81 ' HB3' HD11 ' A' ' 73' ' ' ILE . 57.6 m-85 -98.95 98.43 9.48 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.431 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.511 HG12 HG22 ' A' ' 49' ' ' VAL . 30.3 mt -80.75 130.93 35.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -174.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.617 HG13 ' HB ' ' A' ' 73' ' ' ILE . 4.0 mp -103.81 123.46 57.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.858 178.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.49 ' HA ' ' OD1' ' A' ' 47' ' ' ASP . 17.0 m120 -104.13 131.07 51.79 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 -175.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 45.9 t -77.55 111.18 13.01 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 175.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.413 HD12 ' HB2' ' A' ' 70' ' ' ARG . 93.2 mt -77.15 143.69 70.24 Favored Pre-proline 0 C--N 1.318 -0.78 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 177.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 66' ' ' LEU . 52.3 Cg_exo -56.36 -22.33 41.11 Favored 'Trans proline' 0 CA--C 1.528 0.214 0 C-N-CA 122.888 2.392 . . . . 0.0 112.383 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.9 p30 -86.03 16.42 4.24 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.916 178.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.81 ' HE ' ' HA ' ' A' ' 69' ' ' ARG . 0.2 OUTLIER 66.73 35.38 5.15 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.008 174.172 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.413 ' HB2' HD12 ' A' ' 66' ' ' LEU . 97.6 mtt180 -114.4 171.03 7.87 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.096 173.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.493 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 36.6 m-85 -119.69 120.3 36.2 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.014 0.435 . . . . 0.0 110.753 179.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.897 ' HE2' ' HA ' ' A' ' 75' ' ' ASP . 88.0 tttt -114.48 103.74 11.34 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.867 -176.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.81 HD11 ' HB3' ' A' ' 61' ' ' TYR . 5.6 tt -92.71 111.69 24.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.279 0.561 . . . . 0.0 111.531 -175.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 57.25 51.15 59.29 Favored Glycine 0 C--N 1.329 0.183 0 CA-C-N 115.446 -0.797 . . . . 0.0 113.164 177.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.897 ' HA ' ' HE2' ' A' ' 72' ' ' LYS . 29.7 t70 72.04 -15.43 0.46 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 122.997 0.519 . . . . 0.0 111.872 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 46.3 tp60 -82.85 110.64 18.04 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 175.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.446 ' H ' ' HG2' ' A' ' 77' ' ' GLU . 7.1 pt-20 -87.82 127.82 35.33 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.026 -171.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -129.61 -179.86 5.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.066 177.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -76.71 -56.48 4.57 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.172 0.51 . . . . 0.0 110.843 177.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.569 ' ND1' ' HG2' ' A' ' 82' ' ' PRO . 2.4 p80 -147.08 177.8 8.88 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.519 -176.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.568 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 12.5 mt -59.49 -52.36 74.72 Favored Pre-proline 0 CA--C 1.537 0.45 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -176.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.569 ' HG2' ' ND1' ' A' ' 80' ' ' HIS . 14.6 Cg_endo -60.65 -8.78 9.82 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 121.953 1.769 . . . . 0.0 113.197 177.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -88.92 -26.35 21.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.787 0.327 . . . . 0.0 110.485 -178.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.1 pp -91.1 -30.72 16.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.925 0.393 . . . . 0.0 110.082 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 95.0 mt -68.58 -33.9 74.86 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.253 178.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -71.83 -27.78 63.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.519 0.676 . . . . 0.0 110.376 175.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.523 ' O ' HG12 ' A' ' 90' ' ' ILE . 82.8 t80 -79.82 -37.02 36.01 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.806 -174.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.504 ' HE2' HD13 ' A' ' 73' ' ' ILE . 27.7 m-85 -74.16 0.59 13.49 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.795 0.331 . . . . 0.0 111.787 -178.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.403 ' HA ' ' HB ' ' A' ' 97' ' ' THR . 62.4 tttm -66.18 -25.35 66.9 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.34 168.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.523 HG12 ' O ' ' A' ' 87' ' ' PHE . 6.6 pt -88.21 -28.96 5.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 113.42 0.896 . . . . 0.0 113.42 174.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.472 ' HB2' ' HD1' ' A' ' 88' ' ' TYR . 2.5 m170 -84.58 -24.44 29.21 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -172.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.612 ' HA ' ' HA ' ' A' ' 97' ' ' THR . 29.8 m-85 73.07 -7.61 1.46 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -179.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.667 HD22 ' CE2' ' A' ' 61' ' ' TYR . 14.3 mt 53.8 -25.67 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.586 1.554 . . . . 0.0 113.656 -169.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.555 ' H ' ' C ' ' A' ' 92' ' ' TYR . 2.9 p-10 -151.46 -51.92 0.12 Allowed 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 169.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.688 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 14.1 t -177.0 14.53 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.77 0.319 . . . . 0.0 110.745 -178.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.417 HG22 ' OD1' ' A' ' 94' ' ' ASP . 13.2 t -128.58 -29.38 2.41 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -173.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.612 ' HA ' ' HA ' ' A' ' 92' ' ' TYR . 16.4 p 70.18 166.0 0.28 Allowed 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.995 1.318 . . . . 0.0 110.56 -171.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.49 ' CD2' HD11 ' A' ' 93' ' ' LEU . 21.3 mt -70.1 103.16 2.23 Favored 'General case' 0 C--O 1.221 -0.401 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 178.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.558 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 43.4 mm -87.81 -61.09 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.482 -175.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 101' ' ' PRO . 0.9 OUTLIER -148.43 154.82 42.13 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-O 120.994 0.426 . . . . 0.0 110.549 179.262 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.492 ' HG2' ' O ' ' A' ' 13' ' ' ALA . 16.9 Cg_exo -69.36 149.04 68.94 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.792 2.328 . . . . 0.0 112.092 177.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.48 153.42 93.77 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.577 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.87 136.4 69.74 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.561 2.174 . . . . 0.0 111.787 175.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.49 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 36.0 mtt180 -67.53 -30.76 70.49 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.235 0.54 . . . . 0.0 110.474 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -153.49 164.64 19.84 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.25 104.75 0.12 Allowed 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.418 2.079 . . . . 0.0 111.752 175.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 15.5 m -106.8 141.57 23.13 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.165 -173.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.454 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 57.7 Cg_endo -70.83 156.97 59.57 Favored 'Trans proline' 0 CA--C 1.531 0.332 0 C-N-CA 122.944 2.429 . . . . 0.0 112.06 177.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 108' ' ' PRO . 15.7 Cg_exo -68.2 96.34 0.46 Allowed 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.675 2.25 . . . . 0.0 112.419 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -72.95 -22.0 60.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.427 0.632 . . . . 0.0 109.859 174.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -159.57 -163.72 13.75 Favored Glycine 0 N--CA 1.441 -0.971 0 N-CA-C 110.308 -1.117 . . . . 0.0 110.308 178.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 8.2 t -103.92 138.85 39.89 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.3 m -119.97 94.59 3.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 121.527 0.68 . . . . 0.0 111.098 179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 52.7 m -92.79 30.26 1.61 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.77 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.422 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . . . -81.42 137.4 48.49 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.216 177.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 115' ' ' ALA . 22.5 Cg_exo -64.53 94.63 0.21 Allowed 'Trans proline' 0 C--O 1.233 0.259 0 C-N-CA 122.803 2.335 . . . . 0.0 112.591 -179.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 31' ' ' GLN . 4.8 p30 -74.4 -64.3 1.05 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.604 175.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 44.8 tp 60.27 83.66 0.21 Allowed Pre-proline 0 C--O 1.236 0.367 0 O-C-N 123.755 0.659 . . . . 0.0 111.587 178.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -73.11 73.76 3.11 Favored 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 123.054 2.502 . . . . 0.0 110.942 176.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.5 m -68.34 125.37 26.23 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.295 -176.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -93.77 90.11 6.43 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 172.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -95.87 150.93 19.88 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.766 -174.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -113.85 161.31 17.75 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.103 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 25.7 m-80 59.82 -148.09 0.46 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -177.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.663 HD12 HG21 ' A' ' 152' ' ' ILE . 4.4 mm? 57.03 89.86 0.04 OUTLIER 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.85 0.833 . . . . 0.0 112.861 171.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -173.27 -73.04 0.01 OUTLIER 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.073 -1.421 . . . . 0.0 107.364 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.455 ' HB3' ' HB3' ' A' ' 181' ' ' LEU . 47.2 m-85 -109.64 139.21 44.94 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.081 -0.647 . . . . 0.0 110.643 177.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.489 ' CG1' ' HB ' ' A' ' 178' ' ' VAL . 5.3 t -135.29 161.5 39.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 -178.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.491 ' CZ ' HD13 ' A' ' 181' ' ' LEU . 2.1 ptp180 -140.56 136.56 32.95 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 169.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 1.046 HG22 HG12 ' A' ' 178' ' ' VAL . 20.7 p -87.08 140.03 29.96 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.784 -0.644 . . . . 0.0 112.027 -174.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 13.1 mt -112.05 -31.66 6.82 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.245 -175.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -81.7 -31.78 31.98 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.432 -169.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.47 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 9.8 t70 69.02 110.4 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 O-C-N 123.627 0.58 . . . . 0.0 110.373 -173.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -141.85 101.5 5.9 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.877 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -94.42 90.69 0.12 Allowed 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 123.153 2.569 . . . . 0.0 112.44 176.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -89.86 -28.82 17.3 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.211 176.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . . . . . . . . . 18.2 m120 63.11 83.97 0.15 Allowed 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 114.695 -0.753 . . . . 0.0 112.232 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.774 ' HB3' ' HB3' ' A' ' 141' ' ' ASP . 31.9 t70 -160.66 178.06 9.86 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 177.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -92.83 -12.19 31.74 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.082 0.468 . . . . 0.0 110.929 178.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.55 ' O ' ' HB2' ' A' ' 172' ' ' MET . 5.0 mp0 -120.54 6.78 10.56 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 176.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.774 ' HB3' ' HB3' ' A' ' 138' ' ' ASP . 10.7 t70 -132.91 107.21 8.16 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 175.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.633 ' HB3' ' CG2' ' A' ' 173' ' ' ILE . 57.3 tp -82.25 112.92 40.02 Favored Pre-proline 0 C--N 1.323 -0.575 0 C-N-CA 120.657 -0.417 . . . . 0.0 110.681 -173.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.54 ' HD2' ' HD2' ' A' ' 169' ' ' ARG . 28.6 Cg_endo -69.71 100.96 0.85 Allowed 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 121.998 1.799 . . . . 0.0 111.489 175.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.593 ' CG ' HG21 ' A' ' 130' ' ' THR . 13.0 p90 -115.61 168.7 9.78 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.047 0.451 . . . . 0.0 111.669 -176.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.554 ' HB2' ' HG2' ' A' ' 148' ' ' GLU . 1.4 mptp? -112.66 -169.93 1.57 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.32 -177.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.897 ' H ' ' HD2' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -87.56 3.96 45.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.226 0.536 . . . . 0.0 110.355 179.093 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -147.11 31.61 1.43 Allowed Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.157 -178.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.554 ' HG2' ' HB2' ' A' ' 145' ' ' LYS . 13.0 mm-40 -98.16 143.95 28.15 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 110.421 -0.215 . . . . 0.0 110.421 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.6 mp -102.6 132.69 48.17 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.921 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 175.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.636 ' HB3' ' HB1' ' A' ' 163' ' ' ALA . 11.1 mt -119.02 175.78 5.6 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -177.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.586 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 15.3 t -142.25 123.56 12.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.3 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.663 HG21 HD12 ' A' ' 125' ' ' LEU . 25.2 mm -78.91 79.79 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-O 122.404 1.097 . . . . 0.0 110.285 -174.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.503 HG23 ' HG3' ' A' ' 154' ' ' GLU . 19.4 tt -74.67 -35.76 38.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 113.452 -1.704 . . . . 0.0 110.418 -175.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 1.101 ' HB2' ' HB2' ' A' ' 162' ' ' SER . 53.0 mt-10 -120.18 139.44 52.63 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 171.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.552 ' HE2' ' OD1' ' A' ' 55' ' ' ASN . 35.9 ttpt -132.25 81.89 59.8 Favored Pre-proline 0 C--N 1.326 -0.447 0 O-C-N 122.037 -0.414 . . . . 0.0 110.058 170.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.688 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 11.7 Cg_exo -72.1 -46.36 0.54 Allowed 'Trans proline' 0 CA--C 1.515 -0.465 0 C-N-CA 122.43 2.086 . . . . 0.0 111.34 177.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -122.15 -178.94 4.0 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.265 -174.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -101.73 -22.25 14.45 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.302 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -89.14 -27.6 20.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.21 0.528 . . . . 0.0 110.5 -179.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.718 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 42.0 m95 -129.21 130.4 46.26 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.906 -179.406 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . 0.629 ' O ' HG13 ' A' ' 173' ' ' ILE . 54.2 m0 -123.12 137.58 54.88 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.704 178.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 1.101 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 16.2 m -84.46 106.37 15.99 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 176.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.636 ' HB1' ' HB3' ' A' ' 150' ' ' LEU . . . -116.9 162.27 18.01 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.279 -174.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.749 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 21.8 ptt-85 -109.93 127.78 54.96 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 175.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 0.6 ' HA ' HD22 ' A' ' 150' ' ' LEU . 19.7 p-10 -77.3 -174.06 3.11 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.999 -0.28 . . . . 0.0 111.205 -176.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -66.46 -25.8 66.9 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 121.237 0.541 . . . . 0.0 110.29 -177.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -70.72 -28.62 64.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.46 175.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 107.33 15.39 15.88 Favored Glycine 0 CA--C 1.521 0.419 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.854 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.749 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 13.3 ttm-85 -92.86 134.3 35.22 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 122.779 0.431 . . . . 0.0 111.051 -176.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.557 HG22 ' HB3' ' A' ' 164' ' ' ARG . 60.0 t -99.18 136.89 28.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 120.848 0.356 . . . . 0.0 110.825 178.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -168.97 161.28 34.96 Favored Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 175.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.718 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.0 OUTLIER -69.26 132.56 46.66 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.897 0.348 . . . . 0.0 110.124 179.234 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.852 HD13 HG11 ' A' ' 178' ' ' VAL . 2.6 pp -134.12 144.0 49.58 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.645 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.483 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 5.2 Cg_exo -73.87 127.82 11.85 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.853 2.369 . . . . 0.0 111.688 -178.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.642 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 19.2 t -69.93 -35.33 5.16 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 112.946 0.721 . . . . 0.0 112.946 -178.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.642 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 11.3 Cg_endo -57.76 -16.83 26.82 Favored 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 121.832 1.688 . . . . 0.0 112.672 170.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.483 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.8 m-30 -87.33 -20.34 26.91 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.392 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 1.046 HG12 HG22 ' A' ' 130' ' ' THR . 4.8 m -118.83 174.66 4.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 112.743 0.645 . . . . 0.0 112.743 -168.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -140.62 166.83 23.67 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 173.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.462 ' HB2' ' HD2' ' A' ' 183' ' ' ARG . 3.2 mppt? -94.76 138.68 32.27 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.119 0.485 . . . . 0.0 111.451 -176.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.491 HD13 ' CZ ' ' A' ' 129' ' ' ARG . 57.7 tp -93.68 157.74 16.02 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.34 175.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 18.3 m 38.6 39.36 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.959 0.904 . . . . 0.0 111.71 -176.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.462 ' HD2' ' HB2' ' A' ' 180' ' ' LYS . 53.5 ttt180 -75.39 12.2 1.03 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.835 -1.075 . . . . 0.0 111.434 -174.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.417 ' O ' ' ND1' ' A' ' 187' ' ' HIS . 32.5 t -74.32 73.68 1.84 Allowed 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.025 174.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.598 ' HA ' ' CE1' ' A' ' 187' ' ' HIS . 37.7 m -34.8 -45.31 0.72 Allowed Pre-proline 0 N--CA 1.472 0.655 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 -173.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 185' ' ' SER . 9.6 Cg_endo -57.63 92.91 0.06 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 121.28 1.32 . . . . 0.0 111.79 169.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.598 ' CE1' ' HA ' ' A' ' 185' ' ' SER . 2.0 p-80 -160.69 133.93 6.62 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-O 121.826 0.822 . . . . 0.0 112.998 -178.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -123.9 -33.08 0.82 Allowed Glycine 0 N--CA 1.44 -1.044 0 CA-C-N 114.071 -1.422 . . . . 0.0 110.088 170.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -122.64 80.76 1.78 Allowed 'General case' 0 N--CA 1.453 -0.303 0 CA-C-O 121.175 0.512 . . . . 0.0 110.566 178.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -135.57 32.0 3.07 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.506 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -91.28 59.95 3.02 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.258 -175.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -94.05 153.26 18.25 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.3 177.52 5.53 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.949 -0.301 . . . . 0.0 110.336 178.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -136.8 116.99 13.46 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.264 0.554 . . . . 0.0 111.327 -171.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 24.4 p -87.44 -160.68 0.63 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.469 -0.787 . . . . 0.0 111.249 -177.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 45.5 95.51 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.434 1.093 . . . . 0.0 113.644 174.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 16.5 m -126.47 121.62 32.89 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.114 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 65.61 111.25 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.898 0.749 . . . . 0.0 112.108 175.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -142.53 108.37 0.52 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.04 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.753 HG22 ' HG3' ' A' ' 202' ' ' GLU . 4.3 mp -125.8 109.75 25.23 Favored Pre-proline 0 C--N 1.329 -0.311 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -65.52 -58.46 0.19 Allowed 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.963 2.442 . . . . 0.0 113.073 -176.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.753 ' HG3' HG22 ' A' ' 200' ' ' ILE . 47.6 mt-10 62.54 90.08 0.1 OUTLIER Pre-proline 0 N--CA 1.467 0.423 0 C-N-CA 123.105 0.562 . . . . 0.0 111.503 -178.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -78.4 128.67 8.97 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.609 2.206 . . . . 0.0 112.097 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -60.56 140.71 57.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.544 178.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 18.8 p-80 -147.65 93.2 2.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.374 0.606 . . . . 0.0 111.141 -177.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -86.61 112.21 21.38 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.753 175.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -113.13 107.72 16.32 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.975 0.417 . . . . 0.0 110.742 -175.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -111.17 140.49 45.68 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.124 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -107.72 115.08 59.62 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.415 178.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.41 170.96 19.18 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.842 2.361 . . . . 0.0 112.711 -177.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -93.79 165.29 12.76 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.418 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 4.3 m -93.55 -26.41 17.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.432 -173.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 11.7 p 53.86 -167.23 0.07 Allowed 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.698 0.799 . . . . 0.0 111.997 -176.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 5.6 t -95.78 121.83 60.23 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-O 121.122 0.487 . . . . 0.0 111.234 -176.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -78.03 157.48 30.56 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.544 2.163 . . . . 0.0 110.807 173.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 7.8 mp 58.19 93.54 0.05 OUTLIER Pre-proline 0 N--CA 1.465 0.306 0 O-C-N 123.631 0.582 . . . . 0.0 110.951 -177.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -79.69 3.73 7.29 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.587 2.191 . . . . 0.0 112.852 -176.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . 68.25 111.74 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.227 0 O-C-N 123.91 0.756 . . . . 0.0 110.902 -177.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 27.8 m -79.39 157.43 4.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.956 -177.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 12.6 t -104.09 -28.98 11.17 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.763 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -95.72 48.69 1.83 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.417 -177.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 56.5 m -154.09 99.47 2.53 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 120.711 0.291 . . . . 0.0 110.586 177.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.4 -20.3 14.31 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.316 2.011 . . . . 0.0 110.989 173.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 83.72 -147.4 24.0 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.918 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -146.5 87.09 1.7 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.989 0.423 . . . . 0.0 110.131 178.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -153.45 173.91 15.07 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.309 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 7.4 tt -96.41 110.58 24.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.102 0.477 . . . . 0.0 110.072 177.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 23.5 m -61.34 121.26 62.11 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.343 -178.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -63.16 141.38 82.59 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 122.845 2.363 . . . . 0.0 112.071 178.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -63.28 121.02 67.03 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.688 -178.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -77.66 62.14 7.7 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 122.704 2.269 . . . . 0.0 112.446 -178.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 48.8 m 66.45 93.48 0.07 Allowed 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.163 -178.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 24.4 p -111.26 156.61 21.23 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.765 -179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.462 HE21 ' CB ' ' A' ' 267' ' ' THR . 43.8 mt-30 -96.26 91.33 5.83 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.491 -176.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 -114.35 -39.08 3.92 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.034 0.445 . . . . 0.0 110.088 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -123.67 98.8 0.6 Allowed Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.131 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -72.1 135.57 25.37 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.392 2.061 . . . . 0.0 111.594 176.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.661 HG11 HD12 ' A' ' 293' ' ' ILE . 41.1 t -91.23 129.39 42.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 120.908 0.385 . . . . 0.0 110.247 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -93.85 114.55 26.81 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.911 177.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.407 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -120.37 126.48 50.59 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.029 178.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -92.05 125.19 36.64 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -178.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . 0.601 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -71.52 114.77 9.95 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.038 0.447 . . . . 0.0 110.955 -176.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 23.1 pt -96.46 -20.28 5.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.672 -177.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -140.16 138.09 34.91 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.124 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -55.8 152.89 9.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.491 0.662 . . . . 0.0 112.596 -172.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.693 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -142.4 99.95 3.6 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 177.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 17.9 m -123.51 156.1 64.75 Favored Pre-proline 0 C--N 1.321 -0.672 0 C-N-CA 120.804 -0.359 . . . . 0.0 111.9 -174.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -66.0 132.83 31.33 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.116 2.544 . . . . 0.0 112.949 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 25.7 p -151.19 152.2 32.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.991 177.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . 60.03 -78.43 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.42 0 O-C-N 124.197 0.936 . . . . 0.0 112.963 176.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . 0.618 ' HD1' ' H ' ' A' ' 253' ' ' LYS . 6.4 p90 -79.74 -32.63 41.15 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.175 -178.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 55.57 25.42 7.96 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.898 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . 0.618 ' H ' ' HD1' ' A' ' 251' ' ' TYR . 63.1 tttm -130.88 144.6 51.58 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 -178.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . 0.41 HG23 ' HG2' ' A' ' 253' ' ' LYS . 27.0 p 60.77 15.4 5.86 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.716 0.806 . . . . 0.0 111.1 -175.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -102.12 102.43 12.89 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.154 -176.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.568 HD21 ' HB ' ' A' ' 279' ' ' VAL . 1.6 tt -83.95 123.38 29.91 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 176.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.693 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -79.43 93.18 5.33 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.185 0.517 . . . . 0.0 110.903 -178.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.815 HD21 HG21 ' A' ' 279' ' ' VAL . 65.7 mt -95.34 128.18 41.99 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.878 -178.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -101.94 148.13 25.71 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.22 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 57.5 t -63.94 127.56 24.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.009 0.433 . . . . 0.0 110.634 -177.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 103.21 -9.18 53.99 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.679 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -88.63 165.72 14.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.885 0.342 . . . . 0.0 110.339 -175.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 43.9 mm -107.5 132.11 55.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.826 -177.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.634 ' HA ' HG22 ' A' ' 279' ' ' VAL . 20.3 t -107.13 111.21 34.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.816 178.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -77.69 87.27 3.97 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.987 174.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.536 HG13 ' HB ' ' A' ' 238' ' ' VAL . 14.9 p -95.04 120.78 44.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.608 179.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . 0.462 ' CB ' HE21 ' A' ' 234' ' ' GLN . 9.8 p -113.46 -16.72 12.38 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.891 -178.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . 0.567 ' HB2' ' HB3' ' A' ' 276' ' ' GLU . 16.1 mmm180 -121.98 100.28 6.89 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.566 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 55.6 mtt -95.49 116.35 28.7 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 120.967 0.413 . . . . 0.0 110.347 176.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.416 ' O ' ' HB ' ' A' ' 271' ' ' ILE . 78.8 m-20 -80.38 -6.73 58.5 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.915 -176.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.416 ' HB ' ' O ' ' A' ' 270' ' ' ASN . 48.1 mm 77.91 -39.52 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 C-N-CA 123.537 0.735 . . . . 0.0 112.649 174.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . 0.745 HD21 ' HG2' ' A' ' 274' ' ' GLN . 22.7 p-10 -55.92 -37.92 69.56 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -177.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 150.82 -34.64 0.94 Allowed Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.622 -179.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.745 ' HG2' HD21 ' A' ' 272' ' ' ASN . 2.4 pt20 -94.2 124.86 38.48 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 176.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.55 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 34.0 m0 -108.61 171.15 7.59 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 120.764 0.316 . . . . 0.0 111.243 -175.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.567 ' HB3' ' HB2' ' A' ' 268' ' ' ARG . 6.3 tp10 -112.93 100.24 8.49 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -178.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -119.54 145.69 17.97 Favored Glycine 0 N--CA 1.442 -0.909 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.872 -177.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.641 ' HB3' ' HG2' ' A' ' 283' ' ' LYS . 3.5 pt-20 -103.12 109.27 20.78 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.322 0.582 . . . . 0.0 109.765 176.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . 0.815 HG21 HD21 ' A' ' 258' ' ' LEU . 95.4 t -122.73 112.61 34.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.456 -173.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 59.14 20.25 8.22 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.412 172.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 127.63 -30.35 4.02 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.258 -0.972 . . . . 0.0 114.201 176.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . 0.402 ' HG2' ' N ' ' A' ' 283' ' ' LYS . 9.1 ttm105 -110.17 139.46 45.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 117.889 0.845 . . . . 0.0 111.578 -177.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.641 ' HG2' ' HB3' ' A' ' 278' ' ' GLU . 51.5 mttm -97.98 130.25 44.83 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 170.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . 0.527 ' HA3' ' HB2' ' A' ' 256' ' ' LEU . . . -152.94 162.47 30.07 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.263 -0.97 . . . . 0.0 112.65 -177.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.55 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 76.5 mt -85.35 115.71 23.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.13 0.49 . . . . 0.0 110.595 -179.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.415 ' CZ ' HG11 ' A' ' 264' ' ' VAL . 16.7 p90 -122.82 129.37 25.03 Favored Pre-proline 0 C--N 1.316 -0.857 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.132 178.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 18.8 Cg_exo -67.47 138.3 45.64 Favored 'Trans proline' 0 C--O 1.236 0.394 0 C-N-CA 122.435 2.09 . . . . 0.0 111.018 173.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -58.38 -22.17 52.82 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.065 -176.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 2.7 p -71.35 -1.49 13.11 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -178.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 28.2 m-70 -100.03 -13.46 19.04 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.899 0.38 . . . . 0.0 110.396 177.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.601 HG12 ' HA ' ' A' ' 242' ' ' ALA . 30.7 m -128.31 177.78 5.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.634 -177.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -132.88 128.87 37.54 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.854 172.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.661 HD12 HG11 ' A' ' 238' ' ' VAL . 37.3 mm -78.63 128.02 38.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.691 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 54.3 p90 -141.31 151.42 43.6 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.787 178.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -99.14 129.43 29.47 Favored Pre-proline 0 C--N 1.318 -0.796 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 175.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -58.34 -24.15 66.68 Favored 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 122.975 2.45 . . . . 0.0 112.994 -178.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -134.31 -160.03 1.01 Allowed 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -177.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . 0.402 ' HA ' ' HD3' ' A' ' 299' ' ' PRO . 8.1 t30 -110.79 111.86 56.41 Favored Pre-proline 0 C--N 1.316 -0.859 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 177.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 298' ' ' ASN . 14.7 Cg_exo -68.83 -16.68 41.73 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.899 2.399 . . . . 0.0 112.406 -177.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 64.18 -167.68 0.21 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.271 -179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -125.49 -28.8 3.27 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.067 -178.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -131.96 170.02 15.49 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 -177.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 . . . . . 0 C--O 1.252 1.221 0 CA-C-O 118.372 -0.823 . . . . 0.0 111.166 -178.481 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 pmm? . . . . . 0 N--CA 1.48 1.072 0 CA-C-O 120.516 0.198 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.423 ' HB2' ' HE ' ' A' ' 5' ' ' ARG . 5.8 m -105.59 136.14 45.72 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.545 ' HB2' HD12 ' A' ' 99' ' ' ILE . 8.7 p -70.39 -54.66 11.53 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.651 0.262 . . . . 0.0 110.766 178.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.55 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . -69.74 98.82 1.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.775 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.423 ' HE ' ' HB2' ' A' ' 2' ' ' SER . 10.4 mmt85 -140.41 93.77 2.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.418 0.627 . . . . 0.0 111.566 -178.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -156.65 150.86 25.21 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.257 -0.883 . . . . 0.0 108.823 175.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.529 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 35.1 t0 -81.72 115.39 20.94 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 177.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.4 m -70.11 -12.73 61.81 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.743 -175.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 34.2 t -102.85 -12.32 17.65 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.239 0.542 . . . . 0.0 110.741 -178.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.529 ' HB2' ' HB3' ' A' ' 7' ' ' ASP . 6.9 t70 -75.42 91.41 2.74 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.921 0.391 . . . . 0.0 110.05 -178.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 16.1 mmt180 -57.82 -39.13 76.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.545 -176.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.491 ' HA ' ' NH2' ' A' ' 104' ' ' ARG . 4.8 t -73.43 -1.55 18.76 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.159 -176.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.61 -44.47 8.58 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.919 -0.312 . . . . 0.0 111.356 176.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 29.9 p-90 -120.24 -21.2 7.05 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -171.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -77.58 122.83 25.81 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.102 0.477 . . . . 0.0 110.782 -176.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.542 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 25.0 mmt -104.53 -8.24 19.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.436 -175.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.447 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 50.89 -114.74 2.94 Favored Glycine 0 CA--C 1.523 0.579 0 CA-C-N 115.8 -0.636 . . . . 0.0 113.556 -176.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.447 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 11.3 Cg_exo -71.64 92.18 0.69 Allowed 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.948 2.432 . . . . 0.0 113.081 -176.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.467 HG21 ' HB3' ' A' ' 16' ' ' MET . 69.9 t -142.17 157.69 19.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 177.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.6 m -120.91 166.48 13.75 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -170.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 41.4 ttt85 -58.68 -48.98 79.26 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 123.04 0.213 . . . . 0.0 111.493 -177.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.469 ' H ' ' CD ' ' A' ' 22' ' ' GLN . 0.5 OUTLIER -60.59 -52.28 65.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.332 0.587 . . . . 0.0 110.767 -178.37 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -65.43 -47.62 75.57 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.261 -175.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.34 -38.65 71.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.488 0.661 . . . . 0.0 111.076 178.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.559 ' HA ' HG11 ' A' ' 58' ' ' VAL . 38.3 tt0 -72.66 -37.71 67.87 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.982 -174.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 10.2 t -75.08 -22.53 58.24 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 120.481 -0.487 . . . . 0.0 110.819 -178.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -81.26 -13.44 58.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.233 0.539 . . . . 0.0 110.583 177.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.577 ' O ' HG22 ' A' ' 58' ' ' VAL . 83.1 mt -126.11 16.25 7.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.486 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.35 77.67 3.1 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.087 0.47 . . . . 0.0 111.099 -174.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.63 16.75 72.25 Favored Glycine 0 N--CA 1.449 -0.458 0 CA-C-N 115.678 -0.692 . . . . 0.0 113.067 177.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.579 ' O ' ' HA ' ' A' ' 116' ' ' PRO . 44.1 tt0 -64.41 -77.26 0.06 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.992 0.425 . . . . 0.0 110.39 -178.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.6 mtm180 -124.63 125.69 44.55 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 175.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.471 ' HB2' HD21 ' A' ' 117' ' ' ASN . 53.0 m170 -71.38 119.08 15.01 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.957 0.408 . . . . 0.0 110.478 -178.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 109.36 -8.77 32.92 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.749 -176.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.612 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 37.4 ttp -84.28 129.5 34.88 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 46.8 p90 -138.11 171.43 14.41 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.957 -0.297 . . . . 0.0 111.711 -172.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.567 ' HG ' HD11 ' A' ' 28' ' ' LEU . 4.6 pp -157.72 139.58 14.08 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.181 173.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.42 HG22 HD13 ' A' ' 50' ' ' LEU . 42.4 t -105.83 123.69 60.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 176.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.442 ' HD2' ' HB ' ' A' ' 19' ' ' VAL . 24.3 ptt-85 -124.67 -179.47 4.52 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.341 -176.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -78.5 135.55 37.37 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 175.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.7 t -78.41 118.37 20.52 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.123 -178.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.8 t -78.46 -15.56 58.49 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.314 172.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 25.5 m -73.69 -45.32 53.09 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.734 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.428 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 50.6 t -138.83 124.47 12.2 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.323 -178.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 44' ' ' CYS . 23.4 Cg_exo -64.63 114.56 2.78 Favored 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 123.067 2.511 . . . . 0.0 112.548 -178.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.62 -16.05 29.04 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.835 178.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.571 ' OD2' ' HA ' ' A' ' 64' ' ' ASN . 1.2 m-20 -93.35 177.89 5.89 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.541 -0.541 . . . . 0.0 109.541 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.563 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 38.6 m-85 -130.59 174.18 10.16 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.105 -0.332 . . . . 0.0 110.105 179.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 59.9 t -142.59 110.04 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.611 0.243 . . . . 0.0 110.418 175.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.42 HD13 HG22 ' A' ' 38' ' ' VAL . 36.7 tp -82.23 106.31 14.02 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.998 -0.547 . . . . 0.0 109.951 174.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 53.1 m -96.15 134.04 39.71 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 173.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.661 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 67.2 t -121.96 146.46 27.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.097 -177.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.576 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 12.9 t -94.74 106.53 18.52 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 174.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.667 ' O ' ' HB3' ' A' ' 57' ' ' ARG . 1.0 OUTLIER -147.06 138.75 24.24 Favored 'General case' 0 C--O 1.207 -1.166 0 C-N-CA 118.564 -1.254 . . . . 0.0 110.989 176.075 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.433 HD21 ' HB2' ' A' ' 94' ' ' ASP . 2.5 p30 37.66 47.48 0.82 Allowed 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -175.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 3.5 m 58.47 44.33 18.2 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 122.279 1.038 . . . . 0.0 109.907 176.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.71 HH22 ' HA ' ' A' ' 154' ' ' GLU . 8.7 ttp180 -157.84 67.41 0.49 Allowed 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 113.705 -1.589 . . . . 0.0 110.71 -154.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.661 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 5.0 t -69.98 99.53 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.893 0.854 . . . . 0.0 108.901 -170.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.463 ' HB2' ' CE2' ' A' ' 61' ' ' TYR . 7.9 m -84.19 122.58 29.06 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 113.799 -1.546 . . . . 0.0 111.157 -172.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 60.0 m-70 -93.39 101.95 14.18 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.968 0.413 . . . . 0.0 111.982 -174.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.8 ' HB3' HD11 ' A' ' 73' ' ' ILE . 65.1 m-85 -99.91 105.42 17.14 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.805 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.82 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 61.6 mt -80.7 129.53 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -173.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.587 HG13 ' HB ' ' A' ' 73' ' ' ILE . 3.8 mp -98.8 119.09 46.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 123.129 0.572 . . . . 0.0 110.424 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.616 ' O ' ' HA ' ' A' ' 71' ' ' PHE . 4.3 m120 -89.25 139.44 30.49 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.405 -169.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.1 t -88.34 92.06 9.03 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 171.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.683 HD12 ' HG3' ' A' ' 70' ' ' ARG . 84.8 mt -79.83 138.96 53.77 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.576 -178.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.99 -7.98 16.85 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.949 2.433 . . . . 0.0 112.118 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 -90.21 20.22 4.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.758 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.605 ' HA ' ' HE ' ' A' ' 69' ' ' ARG . 0.3 OUTLIER 65.78 30.52 10.09 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.247 0.546 . . . . 0.0 111.089 177.362 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.683 ' HG3' HD12 ' A' ' 66' ' ' LEU . 3.8 ptp180 -138.66 -177.03 4.69 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.444 -178.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.616 ' HA ' ' O ' ' A' ' 64' ' ' ASN . 47.8 m-85 -124.06 157.87 33.51 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.264 -178.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.587 ' HB2' HD11 ' A' ' 66' ' ' LEU . 35.1 ttpt -138.69 100.49 4.09 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 175.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.82 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 3.9 tt -89.28 108.25 18.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.442 0.639 . . . . 0.0 110.666 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 65.09 37.88 94.69 Favored Glycine 0 C--N 1.321 -0.265 0 CA-C-N 115.175 -0.921 . . . . 0.0 112.366 176.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.407 ' HA ' ' HE3' ' A' ' 72' ' ' LYS . 17.5 t70 77.75 6.2 2.84 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.607 0.763 . . . . 0.0 111.501 178.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -102.73 123.39 46.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.867 0.365 . . . . 0.0 110.308 171.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -94.04 134.38 36.52 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.697 0.761 . . . . 0.0 112.102 -175.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.57 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 51.0 m-85 -136.43 170.28 16.3 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 172.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -70.68 -54.66 11.03 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.136 0.493 . . . . 0.0 111.182 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.552 ' ND1' ' HG2' ' A' ' 82' ' ' PRO . 3.0 p80 -144.31 172.65 12.64 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.624 -174.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.622 HD23 HD21 ' A' ' 84' ' ' LEU . 16.2 mt -55.18 -52.75 68.71 Favored Pre-proline 0 N--CA 1.469 0.514 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -178.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.552 ' HG2' ' ND1' ' A' ' 80' ' ' HIS . 19.5 Cg_endo -60.52 -3.41 2.56 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.316 2.011 . . . . 0.0 113.597 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.37 -36.45 10.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.723 0.297 . . . . 0.0 110.896 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.622 HD21 HD23 ' A' ' 81' ' ' LEU . 4.4 pp -76.51 -34.84 58.59 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.048 0.451 . . . . 0.0 110.154 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 78.0 mt -62.22 -33.31 74.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.122 176.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.632 ' HA ' ' HD3' ' A' ' 89' ' ' LYS . 20.0 tp10 -73.9 -37.4 64.67 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.506 179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.436 ' CD2' ' HZ ' ' A' ' 78' ' ' PHE . 23.1 t80 -64.28 -37.61 88.09 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.124 0.487 . . . . 0.0 110.67 177.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.698 ' HE2' HD13 ' A' ' 73' ' ' ILE . 36.1 m-85 -79.16 -6.52 56.74 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.92 0.39 . . . . 0.0 111.759 -178.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.632 ' HD3' ' HA ' ' A' ' 86' ' ' GLU . 53.7 mtpt -83.81 -8.56 59.19 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.384 172.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 21.8 pt -128.23 9.42 3.01 Favored 'Isoleucine or valine' 0 C--N 1.342 0.26 0 CA-C-O 121.549 0.69 . . . . 0.0 109.604 174.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.433 ' HB3' ' HA ' ' A' ' 88' ' ' TYR . 3.3 t-160 -95.02 -47.2 6.5 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.244 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.447 ' H ' HG22 ' A' ' 97' ' ' THR . 95.3 m-85 62.77 88.33 0.1 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 114.764 -1.107 . . . . 0.0 108.028 -161.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.612 ' O ' ' HB3' ' A' ' 154' ' ' GLU . 13.7 mt -46.37 -65.14 0.6 Allowed 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 177.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.575 ' HB3' ' HG3' ' A' ' 54' ' ' GLU . 13.7 p-10 -98.86 -120.36 0.14 Allowed 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.525 -1.216 . . . . 0.0 109.249 172.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.551 ' H ' ' CG ' ' A' ' 94' ' ' ASP . 4.6 t -94.11 6.15 49.49 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-O 120.963 0.411 . . . . 0.0 109.989 176.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.403 HG22 ' OD1' ' A' ' 94' ' ' ASP . 8.3 t -141.26 164.58 29.86 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.085 0.469 . . . . 0.0 110.706 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.447 HG22 ' H ' ' A' ' 92' ' ' TYR . 9.1 p -99.61 174.53 6.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.62 178.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 82.3 mt -68.42 107.06 2.73 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 173.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.55 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 49.2 mm -91.55 -58.73 3.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.792 -174.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.612 ' O ' ' HA ' ' A' ' 35' ' ' MET . 11.9 pt-20 -159.02 153.23 19.97 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.176 -178.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.34 163.31 39.03 Favored 'Trans proline' 0 CA--C 1.532 0.38 0 C-N-CA 122.668 2.245 . . . . 0.0 113.364 -178.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.457 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -83.11 158.39 64.41 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.803 178.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -66.91 136.39 41.32 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.315 2.01 . . . . 0.0 111.151 173.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.535 ' HG2' ' SD ' ' A' ' 16' ' ' MET . 87.6 mtt180 -64.97 -38.69 91.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.815 0.34 . . . . 0.0 110.787 178.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.537 ' HB2' ' HD2' ' A' ' 106' ' ' PRO . 41.1 p90 -170.26 164.59 5.84 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.308 178.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.537 ' HD2' ' HB2' ' A' ' 105' ' ' TYR . 29.6 Cg_endo -64.88 79.37 0.19 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.414 2.076 . . . . 0.0 111.73 175.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.756 ' HB3' ' HD3' ' A' ' 108' ' ' PRO . 35.0 t -78.13 -57.47 0.93 Allowed Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.964 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.756 ' HD3' ' HB3' ' A' ' 107' ' ' SER . 10.3 Cg_exo -71.47 125.16 10.97 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 121.746 1.631 . . . . 0.0 111.916 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.431 ' HD2' ' HA ' ' A' ' 108' ' ' PRO . 33.9 Cg_endo -66.63 -30.01 42.94 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.288 1.992 . . . . 0.0 111.056 175.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 25.3 ptm -141.5 145.89 35.75 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.754 177.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 97.0 11.8 51.79 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.079 178.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 49.3 m -82.85 101.19 10.82 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.026 0.441 . . . . 0.0 109.993 177.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 43.3 t -66.2 100.45 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.777 178.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 17.7 m -109.34 77.15 1.04 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.659 178.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -112.77 102.06 53.95 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.822 -178.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.579 ' HA ' ' O ' ' A' ' 31' ' ' GLN . 80.6 Cg_endo -85.2 126.06 3.14 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.74 2.293 . . . . 0.0 111.751 176.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.471 HD21 ' HB2' ' A' ' 33' ' ' HIS . 25.3 p-10 -89.35 72.7 8.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.974 0.892 . . . . 0.0 111.095 -177.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 60.13 89.75 0.1 Allowed Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 113.672 -1.604 . . . . 0.0 112.017 176.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -89.58 134.57 2.37 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.327 2.685 . . . . 0.0 111.987 174.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 45.4 m -155.14 97.09 1.89 Allowed 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 176.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 122' ' ' GLU . . . -112.83 -162.9 0.82 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.1 -176.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' ' 121' ' ' ALA . 42.1 mt-10 72.51 29.24 2.11 Favored 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.829 0.705 . . . . 0.0 110.677 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -91.54 -173.43 3.56 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.294 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.52 ' HB3' ' HG3' ' A' ' 183' ' ' ARG . 10.5 m120 -123.32 140.5 52.95 Favored 'General case' 0 C--O 1.211 -0.948 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.87 178.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.681 HD12 HG21 ' A' ' 152' ' ' ILE . 0.3 OUTLIER 158.19 -162.08 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 102.41 -3.182 . . . . 0.0 102.41 -151.511 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.719 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 4.9 tp10 74.19 -73.23 0.1 Allowed 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 118.501 0.591 . . . . 0.0 110.759 175.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -101.33 107.44 18.8 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 118.848 -1.141 . . . . 0.0 111.494 -176.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 1.054 HG22 ' HG3' ' A' ' 180' ' ' LYS . 97.3 t -124.87 136.37 61.02 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.078 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.298 179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.65 ' CZ ' HD13 ' A' ' 181' ' ' LEU . 0.0 OUTLIER -111.18 151.37 28.29 Favored 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 117.376 -1.73 . . . . 0.0 108.33 167.925 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.597 ' OG1' ' HB2' ' A' ' 144' ' ' PHE . 0.9 OUTLIER -107.77 134.26 50.98 Favored 'General case' 0 C--N 1.309 -1.191 0 CA-C-O 121.882 0.849 . . . . 0.0 111.234 179.379 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.57 HD21 ' HG2' ' A' ' 179' ' ' GLU . 10.5 mt -110.21 2.39 19.28 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.61 -176.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.523 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 24.2 t80 -105.2 -39.62 6.13 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.103 -0.639 . . . . 0.0 112.614 -174.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.588 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 8.6 t70 79.05 98.47 0.06 Allowed 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.444 0.64 . . . . 0.0 109.973 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 69.4 t80 -126.32 91.65 47.26 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 173.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.742 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 70.8 Cg_endo -86.24 83.61 1.22 Allowed 'Trans proline' 0 N--CA 1.442 -1.549 0 C-N-CA 121.675 1.583 . . . . 0.0 112.808 -178.171 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -76.58 -31.19 54.97 Favored Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.092 175.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.424 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 20.9 m120 63.46 49.85 3.02 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.247 0.546 . . . . 0.0 111.34 176.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.457 ' HB3' ' H ' ' A' ' 140' ' ' GLU . 1.2 m-20 -135.24 177.44 7.81 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.779 176.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 170' ' ' VAL . . . -91.57 -10.96 38.65 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.674 0.75 . . . . 0.0 109.583 172.232 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.692 ' O ' ' HB2' ' A' ' 172' ' ' MET . 45.3 mt-10 -109.23 -2.83 17.68 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.066 176.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.41 ' HB2' ' HB2' ' A' ' 138' ' ' ASP . 29.5 m-20 -143.5 100.96 3.7 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 174.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 1.02 HD11 ' HB2' ' A' ' 165' ' ' ASN . 52.9 tp -70.6 132.1 87.57 Favored Pre-proline 0 CA--C 1.51 -0.581 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.351 -175.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.854 ' HD2' HD12 ' A' ' 142' ' ' LEU . 73.2 Cg_endo -83.07 93.53 0.85 Allowed 'Trans proline' 0 N--CA 1.436 -1.885 0 C-N-CA 120.931 1.088 . . . . 0.0 111.761 170.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.597 ' HB2' ' OG1' ' A' ' 130' ' ' THR . 17.2 p90 -102.78 164.18 11.78 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.957 ' H ' ' HG3' ' A' ' 148' ' ' GLU . 2.9 mptp? -114.57 -148.51 0.43 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.119 0.485 . . . . 0.0 111.769 -171.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.789 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -109.44 41.29 1.69 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.256 -179.648 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 147.89 28.88 0.07 OUTLIER Glycine 0 CA--C 1.525 0.716 0 C-N-CA 120.723 -0.751 . . . . 0.0 113.435 177.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.957 ' HG3' ' H ' ' A' ' 145' ' ' LYS . 0.0 OUTLIER -80.83 172.78 13.31 Favored 'General case' 0 C--N 1.317 -0.829 0 C-N-CA 123.871 0.868 . . . . 0.0 109.732 171.319 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.637 HD12 ' HB3' ' A' ' 129' ' ' ARG . 0.6 OUTLIER -115.92 129.28 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.2 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.584 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.746 HD22 HD21 ' A' ' 142' ' ' LEU . 27.0 mt -120.76 157.27 30.07 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -173.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.719 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 70.7 t -130.78 123.15 53.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.577 177.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 1.063 HD13 ' HB2' ' A' ' 163' ' ' ALA . 40.8 mm -75.91 84.36 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 122.109 0.957 . . . . 0.0 109.706 -172.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.534 ' C ' HH12 ' A' ' 57' ' ' ARG . 14.0 tt -87.42 -31.89 6.08 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.258 0 CA-C-N 114.043 -1.435 . . . . 0.0 111.605 -169.075 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.71 ' HA ' HH22 ' A' ' 57' ' ' ARG . 10.8 mt-10 -122.49 142.27 50.76 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 164.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.464 ' NZ ' HD21 ' A' ' 125' ' ' LEU . 74.5 tttt -137.43 87.6 17.73 Favored Pre-proline 0 C--N 1.316 -0.86 0 CA-C-O 121.314 0.578 . . . . 0.0 110.627 176.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.496 ' HG2' ' HE2' ' A' ' 172' ' ' MET . 17.5 Cg_exo -71.24 -54.52 0.16 Allowed 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.683 2.255 . . . . 0.0 111.826 170.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.423 ' HG2' ' HB2' ' A' ' 156' ' ' PRO . 6.5 mm-40 -112.53 -176.58 2.95 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.815 -169.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -109.87 -8.9 14.82 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.231 173.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -96.13 -32.28 12.58 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.513 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.426 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 28.7 m95 -127.19 144.02 51.13 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.082 174.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . 0.917 ' HB3' HD12 ' A' ' 152' ' ' ILE . 20.7 m0 -126.71 139.92 52.79 Favored 'General case' 0 C--O 1.213 -0.835 0 CA-C-O 121.032 0.444 . . . . 0.0 111.126 179.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.577 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 19.6 m -97.51 94.55 7.08 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -175.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 1.063 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -109.18 152.25 25.4 Favored 'General case' 0 N--CA 1.428 -1.574 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.135 -173.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.85 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 27.5 ptt-85 -87.42 123.82 32.76 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 172.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 1.02 ' HB2' HD11 ' A' ' 142' ' ' LEU . 66.1 t30 -59.01 -178.2 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 114.259 -1.337 . . . . 0.0 110.957 -172.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.642 ' HB2' ' HB2' ' A' ' 148' ' ' GLU . 37.8 tttp -66.77 -12.15 57.64 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.222 168.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 58.6 m-20 -73.59 -21.25 60.39 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.412 167.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 77.47 35.13 37.92 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 115.277 -0.874 . . . . 0.0 112.005 -168.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.85 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 2.9 ttm-85 -113.47 137.65 51.24 Favored 'General case' 0 C--O 1.213 -0.845 0 C-N-CA 122.779 0.431 . . . . 0.0 110.937 -176.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.515 HG22 HG21 ' A' ' 153' ' ' ILE . 38.9 t -78.17 128.98 38.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 118.146 0.43 . . . . 0.0 111.777 -177.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -164.49 155.95 27.61 Favored Glycine 0 C--N 1.339 0.708 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.612 167.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.692 ' HB2' ' O ' ' A' ' 140' ' ' GLU . 0.6 OUTLIER -74.95 142.83 43.9 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 117.144 0.472 . . . . 0.0 111.291 178.817 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.768 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.4 pp -143.67 141.04 18.08 Favored Pre-proline 0 N--CA 1.452 -0.336 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.715 -176.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.436 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 18.5 Cg_exo -66.38 127.09 16.7 Favored 'Trans proline' 0 C--N 1.34 0.125 0 C-N-CA 122.468 2.112 . . . . 0.0 112.546 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.629 ' O ' HG22 ' A' ' 178' ' ' VAL . 96.2 t -61.94 -40.99 73.84 Favored Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 11.5 Cg_endo -56.88 -15.81 18.13 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 121.974 1.783 . . . . 0.0 113.221 175.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.436 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.2 m-30 -88.71 -8.04 55.23 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -177.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.662 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 3.3 m -105.59 -170.89 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 115.896 1.813 . . . . 0.0 115.896 -164.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.58 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 7.7 tp10 -159.89 49.98 0.3 Allowed 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 112.956 -1.929 . . . . 0.0 112.705 -152.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 1.054 ' HG3' HG22 ' A' ' 128' ' ' VAL . 3.5 mppt? -69.89 135.77 49.91 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 119.583 -1.948 . . . . 0.0 111.246 -161.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.65 HD13 ' CZ ' ' A' ' 129' ' ' ARG . 16.5 tp -67.1 -97.74 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 112.956 -1.929 . . . . 0.0 113.582 -163.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 22.2 m -79.67 37.29 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.54 0.686 . . . . 0.0 110.743 -175.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.74 HH12 ' HH2' ' A' ' 161' ' ' TRP . 50.0 ttt180 -93.76 135.01 35.5 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.724 -175.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 43.1 m -113.74 175.76 5.32 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.377 174.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.416 ' HA ' ' HD3' ' A' ' 186' ' ' PRO . 39.3 t -100.7 139.93 20.97 Favored Pre-proline 0 C--N 1.317 -0.823 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 178.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 185' ' ' SER . 23.0 Cg_exo -63.97 88.14 0.15 Allowed 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 123.003 2.469 . . . . 0.0 112.543 -178.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 51.2 m80 -91.7 -19.44 22.63 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.819 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 117.98 -74.68 0.29 Allowed Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -177.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -100.28 68.59 1.43 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.167 0.508 . . . . 0.0 110.669 177.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 51.6 t-80 -130.28 75.99 1.69 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 173.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -162.81 70.66 0.21 Allowed Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.005 -177.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -92.29 -43.27 9.37 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 68.4 mtt85 63.99 179.54 0.17 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.237 -0.892 . . . . 0.0 111.009 -179.047 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -130.94 -33.7 1.54 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.363 -178.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 17.5 m -117.82 136.11 53.63 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.789 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -64.39 133.17 52.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.053 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 36.4 m -75.35 84.33 2.48 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.178 0.513 . . . . 0.0 110.177 175.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -107.45 -19.18 13.65 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.204 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 148.46 -104.29 0.28 Allowed Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 -178.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.48 ' HA ' ' HD3' ' A' ' 201' ' ' PRO . 19.0 pt -105.98 112.82 64.18 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-O 121.13 0.49 . . . . 0.0 110.314 175.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 200' ' ' ILE . 12.2 Cg_exo -71.22 -50.04 0.34 Allowed 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.75 2.3 . . . . 0.0 112.976 -177.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.44 ' HB2' ' O ' ' A' ' 201' ' ' PRO . 18.0 mm-40 68.71 114.87 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.305 0 O-C-N 123.893 0.746 . . . . 0.0 110.62 -172.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -62.61 124.52 14.3 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 122.528 2.152 . . . . 0.0 111.472 179.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . 60.06 52.65 5.01 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.882 -177.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -75.42 -16.35 60.36 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 121.442 0.639 . . . . 0.0 109.466 178.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -141.48 112.71 7.45 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.153 174.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -90.0 14.88 11.13 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.376 -176.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . 71.56 121.45 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 O-C-N 124.039 0.837 . . . . 0.0 112.965 171.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 87.7 mm-40 -110.18 156.0 40.88 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.611 174.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.88 -61.73 0.47 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.887 2.392 . . . . 0.0 112.876 -177.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 211' ' ' GLN . 9.0 tp-100 61.38 26.67 16.43 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.877 0.846 . . . . 0.0 109.548 -177.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 16.8 p -97.22 102.8 14.65 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.595 -176.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 28.0 m -115.76 91.84 3.72 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.743 177.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.825 ' HB ' ' HD3' ' A' ' 215' ' ' PRO . 85.1 m -79.1 -57.05 0.78 Allowed Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.701 -177.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.825 ' HD3' ' HB ' ' A' ' 214' ' ' THR . 6.5 Cg_exo -73.15 94.82 0.82 Allowed 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 121.843 1.695 . . . . 0.0 111.35 176.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 217' ' ' PRO . 9.5 tt -105.93 107.41 59.53 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.148 -178.012 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 216' ' ' LEU . 1.6 Cg_endo -84.09 104.92 1.09 Allowed 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 123.089 2.526 . . . . 0.0 111.785 177.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -112.33 -31.02 6.97 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.157 0.503 . . . . 0.0 110.146 177.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 24.3 m -96.06 137.27 24.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.532 178.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 16.0 p -129.33 80.86 1.99 Allowed 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 121.408 0.623 . . . . 0.0 110.827 177.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -112.2 179.59 19.52 Favored Glycine 0 N--CA 1.444 -0.784 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.504 178.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.621 ' HB2' ' HD3' ' A' ' 223' ' ' PRO . 68.3 m -157.06 -53.78 0.02 OUTLIER Pre-proline 0 C--N 1.323 -0.553 0 CA-C-O 119.483 -0.294 . . . . 0.0 111.523 -179.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.621 ' HD3' ' HB2' ' A' ' 222' ' ' SER . 76.8 Cg_exo -52.2 -53.08 7.54 Favored 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 122.411 2.074 . . . . 0.0 113.251 -177.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 76.01 -67.67 2.37 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.84 -0.695 . . . . 0.0 111.783 -177.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -97.08 140.71 31.18 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 176.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -93.35 154.83 17.75 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.51 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 11.6 pt -59.67 100.79 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.313 0.577 . . . . 0.0 110.543 177.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.652 ' HB ' ' HD3' ' A' ' 229' ' ' PRO . 5.3 m -91.41 -55.19 0.26 Allowed Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.448 -173.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.652 ' HD3' ' HB ' ' A' ' 228' ' ' THR . 13.2 Cg_exo -70.23 91.2 0.56 Allowed 'Trans proline' 0 C--N 1.355 0.911 0 C-N-CA 122.399 2.066 . . . . 0.0 112.992 -176.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 95.4 mt -106.56 124.15 36.52 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 173.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -57.5 -67.75 0.06 OUTLIER 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.84 2.36 . . . . 0.0 112.578 -176.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 35.9 m -151.04 67.41 0.92 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.032 0.444 . . . . 0.0 110.726 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.433 ' HB ' ' ND2' ' A' ' 235' ' ' ASN . 39.7 p -143.5 116.6 8.91 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.47 177.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -90.15 31.56 0.98 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 177.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . 0.433 ' ND2' ' HB ' ' A' ' 233' ' ' THR . 30.5 p30 -114.88 164.06 14.66 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.275 -171.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 165.37 -170.33 40.24 Favored Glycine 0 N--CA 1.447 -0.583 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.227 178.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -70.69 105.32 1.61 Allowed 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.409 2.073 . . . . 0.0 111.031 177.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.466 ' HB ' ' CG1' ' A' ' 266' ' ' VAL . 2.5 t -75.9 138.13 21.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.415 -175.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -112.57 121.29 44.36 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.784 0.326 . . . . 0.0 110.927 -178.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -120.15 137.8 53.96 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.636 177.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.5 ' HB2' ' CE1' ' A' ' 294' ' ' PHE . 11.6 tppt? -80.94 123.53 28.39 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.656 177.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -75.45 102.9 5.36 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 174.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 290' ' ' HIS . 18.6 pt -88.15 -7.17 10.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.245 0.545 . . . . 0.0 110.783 -176.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.573 ' HB3' ' HB2' ' A' ' 290' ' ' HIS . 2.3 tt0 -138.66 142.89 39.03 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.231 175.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.479 ' HE3' ' OE2' ' A' ' 259' ' ' GLU . 1.5 ptpp? -68.65 174.16 4.5 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 174.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.833 ' HG3' ' HE1' ' A' ' 290' ' ' HIS . 0.0 OUTLIER -166.57 136.43 3.15 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.187 -179.77 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 24.6 m -127.8 150.29 72.9 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.304 179.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.546 ' HD3' ' HB2' ' A' ' 257' ' ' ALA . 58.0 Cg_endo -72.41 149.08 49.83 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.477 2.118 . . . . 0.0 112.631 -179.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' CYS . . . . . 0.56 ' HB3' ' HB2' ' A' ' 252' ' ' ASP . 25.0 t -95.95 165.97 12.01 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 177.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -55.3 -39.77 70.3 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.114 0.483 . . . . 0.0 111.446 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 22.8 p90 -102.43 15.74 28.34 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.167 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.56 ' HB2' ' HB3' ' A' ' 249' ' ' CYS . 1.7 m-20 -124.6 85.59 2.44 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.039 0.447 . . . . 0.0 110.334 177.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -86.56 -22.85 26.07 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.876 -179.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 4.0 p -89.87 5.01 48.13 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.259 179.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.45 ' HB2' ' HB3' ' A' ' 252' ' ' ASP . . . -82.57 109.43 16.76 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.565 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.427 ' HA ' ' NH1' ' A' ' 282' ' ' ARG . 0.6 OUTLIER -66.0 137.34 57.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.456 -177.524 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.546 ' HB2' ' HD3' ' A' ' 248' ' ' PRO . . . -98.18 129.13 44.96 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.673 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 84.2 mt -136.71 162.51 32.98 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.512 -174.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.479 ' OE2' ' HE3' ' A' ' 245' ' ' LYS . 65.7 mm-40 -127.26 165.79 18.99 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 172.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 62.1 t -70.71 123.04 23.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 121.145 0.498 . . . . 0.0 110.956 -178.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 107.81 0.48 34.23 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.201 179.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -84.73 142.98 29.46 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.003 0.43 . . . . 0.0 110.713 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 48.6 mm -100.02 110.12 26.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.084 179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 33.3 t -86.4 109.45 18.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.689 -177.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 27.8 tttm -84.46 94.67 8.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.923 175.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.466 ' CG1' ' HB ' ' A' ' 238' ' ' VAL . 3.6 p -93.32 117.56 37.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.33 0.586 . . . . 0.0 110.454 -178.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 1.2 p -95.9 -35.21 11.54 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.615 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 268' ' ' ARG . 13.0 ttp180 -115.89 122.12 44.4 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 177.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 32.4 mtt -106.49 125.08 50.55 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.189 0.519 . . . . 0.0 110.981 178.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 274' ' ' GLN . 87.6 m-20 -89.69 134.04 34.36 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.767 -179.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 2.3 pp -74.45 9.5 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -173.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . 0.971 HD21 ' HG2' ' A' ' 274' ' ' GLN . 1.7 p-10 -97.95 -24.55 15.33 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 122.299 -0.25 . . . . 0.0 111.172 -178.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 135.4 -37.25 1.94 Allowed Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.151 -1.023 . . . . 0.0 113.222 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.971 ' HG2' HD21 ' A' ' 272' ' ' ASN . 18.9 pt20 -95.6 118.27 31.99 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 177.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.456 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 20.3 m0 -95.2 166.95 11.66 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.293 -173.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -99.64 99.09 9.89 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.106 -178.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -108.74 153.26 16.87 Favored Glycine 0 C--O 1.224 -0.528 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.382 -175.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.672 ' HG2' ' HE2' ' A' ' 283' ' ' LYS . 21.2 mt-10 -119.83 108.46 14.41 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 -178.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 50.9 t -138.05 132.64 43.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.613 -176.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 64.14 24.07 13.35 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.975 0.417 . . . . 0.0 110.965 176.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 86.47 -2.88 87.44 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.272 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . 0.427 ' NH1' ' HA ' ' A' ' 256' ' ' LEU . 0.6 OUTLIER -117.57 131.48 56.68 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.956 0.408 . . . . 0.0 109.937 -176.503 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.672 ' HE2' ' HG2' ' A' ' 278' ' ' GLU . 15.7 ptpt -113.08 142.32 45.88 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.977 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -168.04 -174.24 36.74 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.481 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.456 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 86.0 mt -88.05 136.04 33.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.245 0.545 . . . . 0.0 111.92 -177.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -138.94 127.86 14.06 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.979 174.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . 0.505 ' HD2' ' NE2' ' A' ' 290' ' ' HIS . 11.6 Cg_exo -73.48 151.35 47.53 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.925 2.417 . . . . 0.0 111.78 175.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -73.08 -1.6 18.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.135 0.493 . . . . 0.0 111.765 -178.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 3.4 m -64.63 -42.21 95.63 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.731 -176.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . 0.833 ' HE1' ' HG3' ' A' ' 246' ' ' ARG . 0.3 OUTLIER -110.63 12.31 22.7 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -174.852 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . . . . . . . . . 22.3 m -129.33 149.94 34.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 172.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' A' ' 292' ' ' LYS . 44.3 mmtm -139.36 136.12 34.43 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.738 0.304 . . . . 0.0 110.559 177.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . . . . . . . . . 1.1 mp -76.85 141.39 15.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.89 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' PHE . . . . . 0.537 ' CE2' ' HA ' ' A' ' 296' ' ' PRO . 7.9 p90 -154.87 176.53 12.38 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.2 -179.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -91.47 104.28 9.63 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 173.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . 0.537 ' HA ' ' CE2' ' A' ' 294' ' ' PHE . 26.3 Cg_endo -63.29 -42.69 21.28 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.326 2.017 . . . . 0.0 112.776 -173.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . 0.495 ' HB3' HD21 ' A' ' 302' ' ' ASN . 27.6 mp0 -103.38 79.73 1.74 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.143 0.497 . . . . 0.0 110.162 176.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -63.97 136.47 96.75 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.538 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.03 -30.69 94.03 Favored 'Trans proline' 0 N--CA 1.466 -0.145 0 C-N-CA 122.378 2.052 . . . . 0.0 110.884 174.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -65.05 -26.49 68.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.549 177.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -99.01 -20.64 16.64 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.819 -175.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . 0.495 HD21 ' HB3' ' A' ' 297' ' ' GLN . 94.8 m-20 -86.14 -13.19 47.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.318 -177.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 67.9 mm-40 . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.492 -0.765 . . . . 0.0 110.185 177.8 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.8 mtm . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.4 m -107.68 -20.2 13.3 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.745 177.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.7 m 65.32 -71.3 0.08 Allowed 'General case' 0 N--CA 1.461 0.112 0 O-C-N 123.828 0.705 . . . . 0.0 109.807 -170.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -78.98 78.92 5.4 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.258 0.551 . . . . 0.0 110.28 177.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 18.7 tpp180 -99.61 86.79 3.41 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.357 0.598 . . . . 0.0 110.503 -176.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -167.52 143.39 4.08 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.991 -1.004 . . . . 0.0 108.798 175.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -72.48 -9.37 58.46 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -173.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 17.4 t 73.19 -29.52 0.2 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.267 0.627 . . . . 0.0 112.086 175.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.0 t -102.6 -19.21 14.92 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 122.067 -0.395 . . . . 0.0 111.016 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -67.09 104.05 1.33 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.979 0.419 . . . . 0.0 111.003 -176.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 28.4 mmt180 -60.75 -37.67 82.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.872 -175.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 32.5 m -69.17 -5.47 22.73 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.802 -177.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -94.33 -47.52 6.57 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.742 -0.383 . . . . 0.0 111.895 -179.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.518 ' HB3' ' HB3' ' A' ' 101' ' ' PRO . 41.9 p-90 -119.72 -20.46 7.64 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -169.538 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -72.16 108.43 5.33 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.131 0.491 . . . . 0.0 110.455 -175.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.647 ' SD ' ' HA ' ' A' ' 104' ' ' ARG . 9.2 tpp -90.84 -4.79 56.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.868 -174.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 50.02 -114.57 2.53 Favored Glycine 0 CA--C 1.523 0.536 0 CA-C-N 115.243 -0.89 . . . . 0.0 114.344 176.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -74.4 83.19 1.73 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 123.04 2.493 . . . . 0.0 113.368 -174.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.623 HG12 ' H ' ' A' ' 20' ' ' SER . 98.4 t -135.92 177.08 6.95 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.623 ' H ' HG12 ' A' ' 19' ' ' VAL . 57.3 p -149.36 177.53 9.59 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -168.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 32.5 ttt85 -63.69 -39.6 94.71 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.784 178.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 35.5 mm-40 -61.87 -64.02 1.07 Allowed 'General case' 0 C--O 1.235 0.318 0 O-C-N 123.38 0.425 . . . . 0.0 110.754 176.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.471 ' O ' ' HB ' ' A' ' 26' ' ' THR . 8.1 tp10 -56.77 -47.78 79.36 Favored 'General case' 0 C--O 1.217 -0.658 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.467 -176.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.437 ' HB2' ' HD3' ' A' ' 39' ' ' ARG . . . -57.69 -42.01 82.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.96 0.41 . . . . 0.0 111.79 -177.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.454 ' NE2' ' HG2' ' A' ' 29' ' ' GLN . 23.1 tm0? -68.11 -32.52 72.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.55 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.471 ' HB ' ' O ' ' A' ' 23' ' ' GLU . 4.2 m -65.23 -43.4 91.55 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.661 176.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.443 ' HG2' ' O ' ' A' ' 23' ' ' GLU . 42.0 mmm-85 -72.85 -20.75 61.06 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.518 -173.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.62 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 88.6 mt -126.83 17.4 7.37 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.059 -171.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.454 ' HG2' ' NE2' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -69.49 76.53 0.4 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.476 0.655 . . . . 0.0 109.475 178.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.7 -66.72 3.86 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.4 -176.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 27.55 -99.12 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.208 1.003 . . . . 0.0 112.536 -166.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.578 ' HB2' ' SD ' ' A' ' 35' ' ' MET . 47.6 mtm105 -112.76 -6.77 13.84 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -176.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 49.7 m170 67.49 155.12 0.1 Allowed 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.229 0.538 . . . . 0.0 111.132 -175.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 75.14 10.87 84.28 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 121.085 -0.578 . . . . 0.0 111.824 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.606 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 41.4 mtp -103.97 145.82 29.59 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -177.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.457 ' CG ' HD22 ' A' ' 98' ' ' LEU . 33.5 p90 -146.26 164.32 32.68 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.694 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.542 ' HG ' HD11 ' A' ' 28' ' ' LEU . 4.3 pp -152.72 137.16 16.72 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.847 174.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.4 t -101.95 114.37 41.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 173.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.571 ' HG3' ' O ' ' A' ' 40' ' ' ASP . 24.2 ptt-85 -116.09 176.5 5.07 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.7 -172.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.571 ' O ' ' HG3' ' A' ' 39' ' ' ARG . 10.6 t70 -58.66 132.28 53.37 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 166.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.68 ' HA ' HG23 ' A' ' 49' ' ' VAL . 44.5 t -44.37 -48.66 9.77 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 123.674 0.609 . . . . 0.0 112.223 -174.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.1 t 72.73 -1.66 2.93 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.979 0.799 . . . . 0.0 109.81 -175.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 23.4 m -111.51 -37.09 5.33 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.712 175.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 45.3 t -147.2 122.84 5.37 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.306 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -61.95 122.12 10.49 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.94 2.426 . . . . 0.0 112.857 -178.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 110.94 -31.81 7.0 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.742 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.416 ' C ' ' HB2' ' A' ' 41' ' ' SER . 4.7 m-20 -87.81 174.96 8.06 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -133.28 169.66 16.59 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 122.284 -0.26 . . . . 0.0 111.049 -177.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.68 HG23 ' HA ' ' A' ' 41' ' ' SER . 90.3 t -143.01 117.28 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 121.29 0.566 . . . . 0.0 110.632 174.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.45 ' CB ' HD11 ' A' ' 63' ' ' ILE . 28.3 tp -85.04 108.48 17.65 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.885 178.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.7 m -96.39 137.26 35.72 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 174.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.681 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 91.3 t -130.76 134.24 62.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.632 0.253 . . . . 0.0 111.444 -175.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.62 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 40.8 t -94.93 114.66 26.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.208 -175.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.666 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 8.6 tp10 -159.45 153.56 23.51 Favored 'General case' 0 C--O 1.21 -0.991 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 164.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.629 ' HB2' ' CG ' ' A' ' 57' ' ' ARG . 63.2 m-80 61.4 17.36 8.3 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 179.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.2 m 55.22 55.54 7.43 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 122.59 1.186 . . . . 0.0 108.19 -170.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.753 HH21 ' HA ' ' A' ' 154' ' ' GLU 0.282 0.0 OUTLIER -163.24 67.73 0.2 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 113.227 -1.806 . . . . 0.0 109.883 -153.69 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.681 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 5.2 t -73.64 102.57 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.316 -1.311 . . . . 0.0 110.26 -173.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 71.6 m -78.38 122.46 25.8 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.619 -1.173 . . . . 0.0 111.174 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 45.3 m-70 -93.14 102.97 15.28 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.971 -177.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.949 ' HB3' HD11 ' A' ' 73' ' ' ILE . 70.0 m-85 -97.99 105.07 17.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.591 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.609 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 54.8 mt -80.47 127.77 39.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -174.003 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.578 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 3.5 mp -115.44 112.01 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 120.82 0.343 . . . . 0.0 110.22 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -87.4 148.29 25.07 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.415 -176.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.8 t -87.83 109.19 19.56 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 175.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.3 mt -81.52 143.25 50.99 Favored Pre-proline 0 C--N 1.321 -0.634 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -62.14 -11.54 22.46 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.44 2.094 . . . . 0.0 110.915 175.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -76.24 0.51 18.93 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.421 176.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.34 21.78 9.7 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.559 -174.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 70.1 mtt180 -115.96 175.0 5.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.82 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.578 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 64.8 m-85 -130.76 132.19 45.16 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.962 0.411 . . . . 0.0 111.21 -176.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -121.88 122.41 39.36 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.996 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.949 HD11 ' HB3' ' A' ' 61' ' ' TYR . 7.5 tt -108.42 109.25 27.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.502 0.668 . . . . 0.0 111.218 -174.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 69.03 -94.37 0.37 Allowed Glycine 0 CA--C 1.519 0.329 0 CA-C-N 115.431 -0.804 . . . . 0.0 113.136 178.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -121.2 -11.04 8.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.332 0.587 . . . . 0.0 110.323 -176.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -108.86 126.07 52.66 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.382 0.61 . . . . 0.0 110.784 -176.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -95.35 135.1 37.39 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.64 178.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.461 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 93.4 m-85 -126.38 178.43 5.85 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 178.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -71.18 -43.06 68.21 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.284 -178.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.422 ' ND1' ' HG2' ' A' ' 82' ' ' PRO . 16.4 p80 -165.97 -179.43 5.21 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.742 -178.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.619 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 10.0 mt -57.33 -62.18 5.76 Favored Pre-proline 0 N--CA 1.471 0.585 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -175.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.422 ' HG2' ' ND1' ' A' ' 80' ' ' HIS . 19.8 Cg_endo -63.99 1.24 1.6 Allowed 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 121.702 1.602 . . . . 0.0 113.483 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.97 -36.38 14.13 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.844 0.354 . . . . 0.0 110.323 177.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.1 pp -76.68 -32.69 58.07 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.479 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 80.0 mt -63.45 -28.7 70.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.857 176.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.9 tp10 -77.8 -38.72 45.94 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.758 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -64.88 -37.4 87.51 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.421 0.629 . . . . 0.0 110.884 178.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.493 ' HE2' HD13 ' A' ' 73' ' ' ILE . 30.3 m-85 -80.55 -2.75 47.52 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.958 -176.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 85' ' ' LEU . 97.5 mttt -69.9 -27.02 64.45 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.889 174.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.4 pp -120.1 9.0 6.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.889 179.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 -90.6 -39.89 12.25 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.627 -178.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.5 ' CD2' HG23 ' A' ' 97' ' ' THR . 82.0 m-85 67.51 84.86 0.15 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.173 -169.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.683 ' HA ' ' OE2' ' A' ' 154' ' ' GLU . 5.8 mt -56.39 -20.79 21.1 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 122.241 1.02 . . . . 0.0 111.007 178.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.566 ' OD1' HG22 ' A' ' 96' ' ' THR . 0.1 OUTLIER -134.78 -68.41 0.54 Allowed 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.003 -1.453 . . . . 0.0 109.063 -179.666 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.708 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 8.8 t -177.64 15.93 0.0 OUTLIER 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 114.198 -1.364 . . . . 0.0 108.548 174.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.566 HG22 ' OD1' ' A' ' 94' ' ' ASP . 4.9 t -129.58 -28.48 2.27 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.5 HG23 ' CD2' ' A' ' 92' ' ' TYR . 12.8 p 78.82 -179.52 0.11 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.964 1.306 . . . . 0.0 110.805 -175.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.457 HD22 ' CG ' ' A' ' 36' ' ' PHE . 89.9 mt -78.77 89.62 4.63 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.804 177.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 50.2 mm -75.6 -54.44 13.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.723 -177.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.606 ' O ' ' HA ' ' A' ' 35' ' ' MET . 15.5 pt-20 -157.22 152.72 22.18 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.561 -177.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.518 ' HB3' ' HB3' ' A' ' 14' ' ' TRP . 72.8 Cg_endo -76.06 148.58 31.47 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 122.262 1.975 . . . . 0.0 112.135 176.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.594 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -73.04 146.05 86.9 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.206 178.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.49 124.18 15.25 Favored 'Trans proline' 0 C--O 1.235 0.332 0 C-N-CA 122.465 2.11 . . . . 0.0 111.232 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.647 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 34.8 ptt180 -79.36 22.34 0.44 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.154 0.428 . . . . 0.0 112.154 -172.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.438 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 85.6 t80 -105.52 108.62 61.87 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 171.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.466 ' C ' ' HD3' ' A' ' 108' ' ' PRO . 3.9 Cg_exo -80.23 119.99 3.99 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 122.934 2.422 . . . . 0.0 112.475 -178.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 40.0 p -126.66 64.74 58.71 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 172.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.466 ' HD3' ' C ' ' A' ' 106' ' ' PRO . 77.8 Cg_endo -98.49 146.26 0.6 Allowed 'Trans proline' 0 N--CA 1.449 -1.09 0 C-N-CA 123.145 2.563 . . . . 0.0 113.769 -171.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -83.83 -9.46 9.85 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 122.422 2.081 . . . . 0.0 110.637 168.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 51.3 ttp 58.84 91.8 0.04 OUTLIER 'General case' 0 C--O 1.232 0.14 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.775 -175.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 166.83 133.59 1.55 Allowed Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.294 -177.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 21.6 t -92.53 122.87 35.38 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.674 0.274 . . . . 0.0 110.645 -177.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 59.4 t -75.42 -53.19 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 121.064 0.459 . . . . 0.0 109.858 175.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 17.4 t -142.74 153.05 42.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.303 174.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.436 ' O ' ' HB3' ' A' ' 121' ' ' ALA . . . -158.62 98.47 1.72 Allowed Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.161 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.445 ' HG2' ' HB2' ' A' ' 57' ' ' ARG . 31.6 Cg_exo -59.12 -39.37 80.01 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.547 2.165 . . . . 0.0 112.618 -178.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.73 ' HA ' ' HG3' ' A' ' 126' ' ' GLU . 0.1 OUTLIER -63.75 162.38 13.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.616 -0.72 . . . . 0.0 112.12 -175.447 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.617 ' HB3' ' HD2' ' A' ' 119' ' ' PRO . 91.1 mt 80.67 156.99 0.13 Allowed Pre-proline 0 N--CA 1.469 0.508 0 O-C-N 124.08 0.862 . . . . 0.0 111.458 176.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.617 ' HD2' ' HB3' ' A' ' 118' ' ' LEU . 37.7 Cg_exo -29.19 -64.11 0.08 OUTLIER 'Trans proline' 0 C--N 1.361 1.218 0 C-N-CA 125.23 3.953 . . . . 0.0 115.173 -172.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 22.5 m -154.1 97.44 2.05 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.874 0.369 . . . . 0.0 110.368 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 115' ' ' ALA . . . -128.61 19.1 6.23 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.818 176.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.542 ' HB3' ' O ' ' A' ' 188' ' ' GLY . 15.6 mm-40 75.28 -171.15 0.1 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.708 178.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.1 t0 68.79 171.15 0.29 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.535 -177.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -101.23 160.71 14.17 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -169.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.827 HD12 HG21 ' A' ' 152' ' ' ILE . 4.6 mm? 67.2 103.05 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.779 171.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.761 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 0.6 OUTLIER -178.35 -72.44 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 114.033 -1.44 . . . . 0.0 107.858 179.59 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.55 ' H ' ' HD3' ' A' ' 193' ' ' ARG . 70.8 m-85 -96.95 107.45 19.98 Favored 'General case' 0 CA--C 1.495 -1.148 0 C-N-CA 119.199 -1.0 . . . . 0.0 110.569 -179.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.959 HG22 ' HG3' ' A' ' 180' ' ' LYS . 89.4 t -124.16 126.67 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.424 0 CA-C-N 114.55 -1.205 . . . . 0.0 109.301 175.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.686 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 6.5 ptp180 -107.52 142.79 36.85 Favored 'General case' 0 N--CA 1.435 -1.175 0 C-N-CA 117.528 -1.669 . . . . 0.0 108.093 171.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.582 HG22 HG12 ' A' ' 178' ' ' VAL . 0.8 OUTLIER -102.58 127.4 49.68 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.873 -176.941 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.695 HD11 ' HB2' ' A' ' 179' ' ' GLU . 6.3 mt -100.21 -21.73 15.4 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.629 -174.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.431 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 30.1 t80 -81.17 -35.88 30.88 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.93 -171.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.597 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 13.6 t70 71.06 101.14 0.06 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.688 0.756 . . . . 0.0 110.562 -175.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.468 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 51.5 t80 -129.87 85.6 57.4 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 177.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.678 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 94.8 Cg_endo -82.17 80.43 2.81 Favored 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 121.896 1.731 . . . . 0.0 112.773 -178.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -75.97 -30.59 57.27 Favored Glycine 0 C--N 1.329 0.173 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.765 178.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.435 HD22 ' HB3' ' A' ' 143' ' ' PRO . 1.0 OUTLIER 66.04 50.95 1.37 Allowed 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.096 -0.552 . . . . 0.0 111.234 179.281 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -142.14 177.75 8.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.414 177.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.506 ' O ' ' HA2' ' A' ' 171' ' ' GLY . . . -92.71 -11.0 35.12 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.73 0.776 . . . . 0.0 109.136 172.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' A' ' 172' ' ' MET . 44.9 mt-10 -91.95 -31.95 15.44 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.001 -0.999 . . . . 0.0 109.537 175.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -127.57 104.82 8.09 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.317 176.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 1.083 HD11 ' HB2' ' A' ' 165' ' ' ASN . 32.1 tp -65.42 129.52 94.42 Favored Pre-proline 0 C--N 1.327 -0.394 0 C-N-CA 120.562 -0.455 . . . . 0.0 109.977 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.789 ' HD2' HD12 ' A' ' 142' ' ' LEU . 72.6 Cg_endo -78.78 88.57 1.44 Allowed 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 121.541 1.494 . . . . 0.0 111.511 175.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.489 ' CD1' ' HB ' ' A' ' 130' ' ' THR . 10.4 p90 -103.49 156.14 17.99 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.96 -174.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.597 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 0.0 OUTLIER -96.85 -171.63 2.28 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.189 0.441 . . . . 0.0 112.189 -174.858 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.865 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -92.81 33.05 1.17 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.942 -174.029 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 159.51 31.33 0.02 OUTLIER Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.555 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.556 ' HB3' ' HB2' ' A' ' 145' ' ' LYS . 0.1 OUTLIER -101.01 152.71 20.25 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.663 -176.554 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.7 mp -97.55 127.14 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-O 121.496 0.665 . . . . 0.0 109.802 -176.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.772 HD22 HD21 ' A' ' 142' ' ' LEU . 9.7 mt -121.63 157.71 30.21 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 -176.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.761 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 92.7 t -118.09 124.19 72.74 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 174.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 1.116 HD13 ' HB2' ' A' ' 163' ' ' ALA . 43.6 mm -75.93 79.66 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-O 122.024 0.916 . . . . 0.0 108.717 -177.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.519 HG21 HG22 ' A' ' 170' ' ' VAL . 18.4 tt -70.37 -29.7 40.08 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 CA-C-N 114.005 -1.452 . . . . 0.0 109.76 -176.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.753 ' HA ' HH21 ' A' ' 57' ' ' ARG . 0.4 OUTLIER -131.44 141.72 49.87 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 172.152 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.589 ' HD2' ' HG ' ' A' ' 125' ' ' LEU . 81.4 tttt -134.77 87.83 29.64 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 172.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.708 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 2.3 Cg_endo -82.5 -37.78 0.2 Allowed 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.695 2.264 . . . . 0.0 111.8 176.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.604 ' HG2' ' CE ' ' A' ' 172' ' ' MET . 25.2 mm-40 -109.91 168.13 9.65 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.755 -174.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.513 ' O ' HG21 ' A' ' 175' ' ' VAL . 6.1 pt-20 -101.67 -16.86 16.55 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.462 178.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.406 ' C ' HG23 ' A' ' 175' ' ' VAL . 5.2 tp-100 -107.32 -11.72 15.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.163 0.506 . . . . 0.0 109.873 176.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -129.07 121.6 28.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.212 176.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . 0.759 ' HB3' HD12 ' A' ' 152' ' ' ILE . 49.2 m0 -115.32 134.87 54.72 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.501 -178.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.59 ' HA ' ' HA ' ' A' ' 172' ' ' MET . 13.4 m -93.79 94.22 8.41 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -173.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 1.116 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -108.54 147.05 32.33 Favored 'General case' 0 N--CA 1.419 -1.998 0 C-N-CA 119.501 -0.88 . . . . 0.0 109.703 -171.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.831 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 15.8 ptt-85 -86.79 119.66 27.25 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 175.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 1.083 ' HB2' HD11 ' A' ' 142' ' ' LEU . 18.1 t30 -53.34 177.69 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 113.724 -1.58 . . . . 0.0 110.865 -176.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 35.6 ttmt -63.56 -15.31 57.68 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 168.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.417 ' H ' ' HB3' ' A' ' 165' ' ' ASN . 36.9 m-20 -69.28 -30.38 68.47 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.74 169.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 90.28 25.79 25.29 Favored Glycine 0 C--O 1.228 -0.259 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.16 -170.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.887 ' HD2' ' CD1' ' A' ' 142' ' ' LEU . 0.3 OUTLIER -105.06 138.14 41.72 Favored 'General case' 0 C--O 1.217 -0.608 0 C-N-CA 123.437 0.695 . . . . 0.0 111.331 -174.003 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.519 HG22 HG21 ' A' ' 153' ' ' ILE . 24.1 t -86.45 119.75 35.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -175.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.506 ' HA2' ' O ' ' A' ' 139' ' ' ALA . . . -152.49 148.94 20.44 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.696 170.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.604 ' CE ' ' HG2' ' A' ' 157' ' ' GLU . 59.6 mtp -78.43 142.48 37.51 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 117.663 0.731 . . . . 0.0 110.703 -179.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.698 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.7 pp -140.54 145.47 40.78 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.9 -173.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.554 ' HB2' ' CD1' ' A' ' 177' ' ' TYR . 17.6 Cg_exo -68.41 129.87 19.93 Favored 'Trans proline' 0 N--CA 1.465 -0.149 0 C-N-CA 122.959 2.439 . . . . 0.0 113.104 -177.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.568 ' N ' ' HD2' ' A' ' 176' ' ' PRO . 58.0 t -62.62 -42.22 77.68 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 29.0 Cg_endo -63.62 -5.16 8.14 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 121.951 1.767 . . . . 0.0 112.682 177.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.554 ' CD1' ' HB2' ' A' ' 174' ' ' PRO . 3.0 m-85 -91.95 -15.8 27.5 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.442 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.606 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 3.2 m -105.95 -174.04 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 -163.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.695 ' HB2' HD11 ' A' ' 131' ' ' LEU . 3.5 tp10 -159.95 49.22 0.29 Allowed 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 113.071 -1.877 . . . . 0.0 112.454 -150.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.959 ' HG3' HG22 ' A' ' 128' ' ' VAL . 0.5 OUTLIER -69.27 170.73 9.68 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 118.937 -2.352 . . . . 0.0 111.308 -160.511 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 15.9 tp -100.28 114.71 28.39 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.767 -168.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 13.4 p 51.92 104.3 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 126.455 1.902 . . . . 0.0 114.158 -178.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.802 ' HB3' ' N ' ' A' ' 194' ' ' ASN . 0.2 OUTLIER -178.96 109.52 0.05 OUTLIER 'General case' 0 C--N 1.343 0.297 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.678 178.937 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.422 ' OG ' ' HE1' ' A' ' 187' ' ' HIS . 0.0 OUTLIER -69.26 -31.2 69.57 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.058 0.456 . . . . 0.0 111.469 176.349 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.816 ' HB2' ' HD2' ' A' ' 186' ' ' PRO . 21.2 p -176.03 -177.84 0.3 Allowed Pre-proline 0 C--N 1.329 -0.304 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -174.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.816 ' HD2' ' HB2' ' A' ' 185' ' ' SER . 98.5 Cg_exo -43.73 -69.42 0.08 OUTLIER 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 122.377 2.052 . . . . 0.0 113.261 176.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.647 ' CD2' ' H ' ' A' ' 188' ' ' GLY . 1.0 OUTLIER 33.5 -89.3 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.303 1.041 . . . . 0.0 113.771 -175.487 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.647 ' H ' ' CD2' ' A' ' 187' ' ' HIS . . . 119.61 -54.16 0.65 Allowed Glycine 0 C--O 1.225 -0.464 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 -178.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 16.2 pttp -101.67 34.93 2.46 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.303 0.573 . . . . 0.0 110.731 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 60.0 t60 -162.94 38.15 0.1 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.132 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 135.95 160.67 8.93 Favored Glycine 0 CA--C 1.505 -0.564 0 N-CA-C 111.299 -0.72 . . . . 0.0 111.299 -176.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . 0.651 ' HB3' ' CZ ' ' A' ' 193' ' ' ARG . 0.8 OUTLIER -101.97 -89.17 0.37 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.917 0.389 . . . . 0.0 111.532 -171.631 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.802 ' HG2' ' HB3' ' A' ' 180' ' ' LYS . 0.0 OUTLIER -149.28 134.73 18.46 Favored 'General case' 0 C--O 1.208 -1.098 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -177.633 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.901 ' HA ' ' HB2' ' A' ' 180' ' ' LYS . 34.6 t30 -171.74 156.71 4.37 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 118.315 0.507 . . . . 0.0 111.298 -175.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 16.4 m -103.28 -145.19 0.36 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 176.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 9.0 p30 41.13 40.03 1.02 Allowed 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.693 0.797 . . . . 0.0 112.409 174.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 6.6 m -70.87 -13.75 62.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.813 -0.631 . . . . 0.0 111.56 -175.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -93.71 -9.87 36.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.163 0.506 . . . . 0.0 109.912 178.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 83.47 -124.31 6.52 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -171.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.673 HD11 ' HA ' ' A' ' 203' ' ' PRO . 10.2 tt -126.67 94.51 39.96 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-O 121.607 0.718 . . . . 0.0 110.017 172.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.66 -35.22 22.84 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.98 2.453 . . . . 0.0 112.456 -176.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -132.96 106.79 12.56 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.371 -177.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.673 ' HA ' HD11 ' A' ' 200' ' ' ILE . 34.1 Cg_exo -60.82 -60.49 0.24 Allowed 'Trans proline' 0 C--O 1.235 0.362 0 C-N-CA 123.044 2.496 . . . . 0.0 112.648 -178.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -154.13 120.83 5.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.801 0.334 . . . . 0.0 110.562 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -97.78 105.25 17.37 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.045 -178.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . 71.27 -54.79 0.66 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.55 0.74 . . . . 0.0 111.943 179.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -80.38 106.1 12.13 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.107 0.48 . . . . 0.0 110.579 179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -129.37 -39.64 1.49 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.358 178.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -148.0 112.52 3.87 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.001 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -80.07 -172.63 1.58 Allowed 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.734 2.289 . . . . 0.0 112.006 178.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -91.74 88.43 6.68 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.058 0.456 . . . . 0.0 109.776 177.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 1.1 m -84.77 93.61 8.5 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.225 0.536 . . . . 0.0 110.875 -177.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . 0.559 ' H ' ' HD2' ' A' ' 215' ' ' PRO . 13.7 p -113.3 -68.65 0.91 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.849 175.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.468 ' N ' ' CD ' ' A' ' 215' ' ' PRO . 0.7 OUTLIER -87.55 -31.92 0.41 Allowed Pre-proline 0 CA--C 1.544 0.748 0 CA-C-N 115.442 -0.799 . . . . 0.0 113.006 173.374 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.559 ' HD2' ' H ' ' A' ' 213' ' ' THR . 83.7 Cg_exo -52.64 -16.87 6.1 Favored 'Trans proline' 0 C--N 1.368 1.583 0 C-N-CA 122.458 2.105 . . . . 0.0 114.219 174.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.498 ' O ' HD12 ' A' ' 216' ' ' LEU . 4.7 pp -99.39 135.49 20.67 Favored Pre-proline 0 C--N 1.329 -0.291 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.229 175.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 216' ' ' LEU . 6.3 Cg_exo -79.86 124.21 5.52 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.802 2.334 . . . . 0.0 111.048 173.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -77.9 -47.52 18.53 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.298 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 21.7 t 54.03 71.05 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.246 -178.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 49.2 m -95.04 104.53 16.41 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.664 -177.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . 0.568 ' O ' ' HD3' ' A' ' 223' ' ' PRO . . . -127.4 1.22 7.04 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.152 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 7.8 m -97.8 102.94 14.72 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 120.518 0.199 . . . . 0.0 110.528 178.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.568 ' HD3' ' O ' ' A' ' 221' ' ' GLY . 9.6 Cg_exo -72.31 130.29 16.09 Favored 'Trans proline' 0 N--CA 1.46 -0.475 0 C-N-CA 122.568 2.179 . . . . 0.0 111.311 176.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -81.59 56.04 4.89 Favored Glycine 0 N--CA 1.454 -0.14 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.183 -178.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -162.39 166.87 24.55 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 122.446 0.298 . . . . 0.0 110.295 -177.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -93.85 104.63 16.7 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.854 177.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 10.9 tp -79.27 -15.47 13.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.381 -177.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 20.7 m 71.86 107.97 0.03 OUTLIER Pre-proline 0 C--O 1.232 0.176 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.157 -179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.461 ' C ' HD22 ' A' ' 230' ' ' LEU . 16.7 Cg_exo -66.99 -73.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.249 1.966 . . . . 0.0 110.767 174.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.461 HD22 ' C ' ' A' ' 229' ' ' PRO . 3.2 mm? -133.11 145.95 59.05 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 174.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -55.18 -56.93 1.94 Allowed 'Trans proline' 0 CA--C 1.53 0.278 0 C-N-CA 123.166 2.577 . . . . 0.0 113.334 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 21.9 t -140.01 79.31 1.7 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.046 0.45 . . . . 0.0 111.263 -176.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.402 ' OG1' ' HB2' ' A' ' 230' ' ' LEU . 26.0 p -132.97 4.14 3.78 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.493 174.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . 0.694 ' HB3' ' HG3' ' A' ' 237' ' ' PRO . 25.9 mt-30 70.19 -55.54 0.61 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.302 -177.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . 0.452 HD22 ' HA ' ' A' ' 235' ' ' ASN . 6.3 m120 71.14 -56.63 0.62 Allowed 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 173.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . 0.426 ' N ' ' HD3' ' A' ' 237' ' ' PRO . . . -134.17 61.77 0.64 Allowed Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 119.867 -1.159 . . . . 0.0 113.926 -176.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.694 ' HG3' ' HB3' ' A' ' 234' ' ' GLN . 45.7 Cg_endo -93.95 95.37 0.13 Allowed 'Trans proline' 0 N--CA 1.445 -1.336 0 C-N-CA 122.728 2.285 . . . . 0.0 110.291 170.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.585 ' CG1' HD12 ' A' ' 293' ' ' ILE . 15.2 t -95.3 138.93 19.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 121.158 0.504 . . . . 0.0 111.393 -171.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -109.9 121.68 45.8 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.833 177.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.61 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -118.68 155.02 31.78 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.887 -175.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -99.84 120.47 39.81 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.779 179.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . 0.546 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -72.31 106.78 4.6 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 175.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 41.2 pt -94.85 -5.83 10.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.159 0.504 . . . . 0.0 110.995 -176.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 39.8 tt0 -137.37 140.76 41.61 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.98 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -63.62 126.29 27.05 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 176.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.551 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 24.5 tpt180 -125.62 101.89 7.1 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.968 0.413 . . . . 0.0 110.562 -178.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 25.7 m -111.94 150.13 41.9 Favored Pre-proline 0 C--N 1.316 -0.88 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 174.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -62.89 102.73 0.31 Allowed 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.245 1.963 . . . . 0.0 111.865 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 250' ' ' ALA . 45.8 t -73.33 178.17 4.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.58 -177.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.405 ' N ' ' SG ' ' A' ' 249' ' ' CYS . . . -63.74 -25.2 68.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.853 -177.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -99.11 1.11 44.81 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.876 0.37 . . . . 0.0 111.314 179.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 46.7 m-20 -101.32 161.13 13.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.233 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 43.4 mmtm -138.74 -66.12 0.48 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.393 178.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 2.3 m -82.49 10.34 7.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.006 -179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 285' ' ' LEU . . . -65.57 119.07 10.44 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.044 0.449 . . . . 0.0 111.434 -175.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.494 HD23 ' H ' ' A' ' 257' ' ' ALA . 1.2 tt -72.27 140.51 48.65 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.696 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.551 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -86.88 117.53 25.68 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.333 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 84.5 mt -126.86 142.69 51.48 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.557 -177.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 32.4 mm-40 -106.56 158.34 17.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.085 177.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 45.0 t -70.23 109.99 3.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.975 0.417 . . . . 0.0 110.088 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 108.54 11.69 22.79 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 120.852 -0.69 . . . . 0.0 111.948 -177.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 21.3 t0 -95.3 146.64 24.22 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 39.8 mm -90.28 117.63 33.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.914 0.388 . . . . 0.0 110.651 -179.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.426 HG21 HG11 ' A' ' 291' ' ' VAL . 22.0 t -92.94 109.4 21.61 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.432 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 50.6 tttm -91.11 88.18 6.86 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.065 178.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 7.6 p -88.67 125.47 41.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.341 0.591 . . . . 0.0 110.536 -177.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 37.2 p -97.27 -31.1 12.59 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.527 -175.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . 0.485 ' HD3' ' OE1' ' A' ' 276' ' ' GLU . 55.8 mtp180 -131.2 113.87 14.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.723 -177.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 31.6 mtt -93.86 113.42 25.44 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.124 178.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -83.57 169.98 14.84 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.576 176.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 32.4 mm -94.75 -20.32 6.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.476 -176.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 -81.68 3.89 23.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.758 -176.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 99.31 -35.17 4.87 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.55 -0.833 . . . . 0.0 113.129 174.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -84.2 111.32 19.26 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 41.1 m0 -93.53 158.45 15.7 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.297 -177.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.485 ' OE1' ' HD3' ' A' ' 268' ' ' ARG . 58.7 mt-10 -91.66 106.75 18.71 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 172.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -108.52 146.33 16.49 Favored Glycine 0 N--CA 1.44 -1.082 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.012 -176.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -114.81 106.26 13.98 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 176.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . 0.58 HG12 ' ND2' ' A' ' 280' ' ' ASN . 15.1 t -141.48 134.11 29.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -175.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . 0.58 ' ND2' HG12 ' A' ' 279' ' ' VAL . 52.1 m-80 62.21 23.59 13.96 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.251 -177.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 84.5 -4.19 84.78 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.036 -0.602 . . . . 0.0 112.511 -179.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 -104.62 134.07 48.4 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.865 0.364 . . . . 0.0 111.021 -176.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 42.8 tttp -104.78 117.33 33.79 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.176 177.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -146.79 175.51 26.16 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 255' ' ' ALA . 89.5 mt -94.61 143.8 26.13 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 110.194 -0.298 . . . . 0.0 110.194 177.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.422 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 43.2 p90 -144.7 139.83 15.81 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.301 176.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 15.4 Cg_exo -69.59 125.11 11.84 Favored 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.651 2.234 . . . . 0.0 111.19 173.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -58.71 -19.96 44.53 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.269 -0.423 . . . . 0.0 112.04 -175.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 15.8 p -67.66 -9.26 41.75 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -177.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -99.55 -7.86 25.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.903 0.383 . . . . 0.0 111.053 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.546 HG12 ' HA ' ' A' ' 242' ' ' ALA . 34.0 m -127.56 170.12 17.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.891 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -138.77 134.83 33.98 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.07 0.462 . . . . 0.0 110.83 174.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.61 HD13 ' HB2' ' A' ' 240' ' ' ALA . 46.9 mm -76.78 128.81 37.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.329 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 6.1 p90 -138.61 -36.04 0.57 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.401 178.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 62.36 103.47 0.03 OUTLIER Pre-proline 0 C--N 1.341 0.197 0 CA-C-O 121.418 0.628 . . . . 0.0 111.354 -178.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . 0.487 ' O ' ' HB2' ' A' ' 297' ' ' GLN . 92.9 Cg_endo -79.43 50.45 3.51 Favored 'Trans proline' 0 C--O 1.235 0.351 0 C-N-CA 123.209 2.606 . . . . 0.0 111.677 -178.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . 0.487 ' HB2' ' O ' ' A' ' 296' ' ' PRO . 2.0 mp0 77.84 -33.81 0.18 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.238 1.015 . . . . 0.0 111.309 -177.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 297' ' ' GLN . 35.0 m-80 72.88 132.55 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.28 0 O-C-N 123.747 0.654 . . . . 0.0 111.383 -179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.93 -17.26 43.24 Favored 'Trans proline' 0 CA--C 1.527 0.162 0 C-N-CA 122.702 2.268 . . . . 0.0 111.675 176.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -64.52 -28.21 69.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.604 176.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -90.47 -6.65 54.59 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.066 178.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -104.82 13.96 30.39 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.173 0.511 . . . . 0.0 111.051 -173.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.556 -0.735 . . . . 0.0 110.17 178.048 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.3 mmt . . . . . 0 N--CA 1.48 1.029 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.0 m -84.43 99.09 10.45 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.513 177.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.9 p -65.75 -39.09 90.72 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 173.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.538 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . -75.51 89.92 2.72 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.429 171.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -119.09 95.72 4.93 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.607 0.718 . . . . 0.0 111.741 -175.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.411 ' HE1' ' O ' ' A' ' 98' ' ' LEU . 12.2 p90 -159.66 169.84 22.87 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.532 174.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -75.83 -26.83 57.54 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -173.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.0 t 72.61 -39.16 0.44 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 123.622 0.769 . . . . 0.0 111.382 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 13.1 m -91.03 -26.11 19.35 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.49 0.186 . . . . 0.0 111.1 178.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -63.36 105.76 0.8 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.987 0.422 . . . . 0.0 111.291 -172.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 22.8 mmt180 -60.62 -39.75 89.34 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.63 -176.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.1 m -72.99 -3.18 24.43 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.614 -176.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.52 -41.74 10.09 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.654 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 33.1 p-90 -125.09 -21.68 4.6 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -172.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -71.6 109.25 5.41 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.493 -0.483 . . . . 0.0 110.044 -176.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.832 ' SD ' ' HA ' ' A' ' 104' ' ' ARG . 8.3 tpp -91.03 -9.25 46.56 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.649 -174.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.455 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 50.6 -112.07 1.46 Allowed Glycine 0 CA--C 1.52 0.358 0 CA-C-N 115.55 -0.75 . . . . 0.0 113.986 177.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.455 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 19.3 Cg_exo -66.15 82.18 0.28 Allowed 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.424 2.749 . . . . 0.0 113.324 -177.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.759 HG12 ' H ' ' A' ' 20' ' ' SER . 59.5 t -139.68 -178.31 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.759 ' H ' HG12 ' A' ' 19' ' ' VAL . 47.4 t -168.62 178.88 4.52 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 -166.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.493 ' O ' ' HG2' ' A' ' 25' ' ' GLN . 0.1 OUTLIER -58.73 -45.16 90.24 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 118.59 0.632 . . . . 0.0 109.391 176.222 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -60.07 -60.2 4.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.799 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.547 ' O ' ' HG3' ' A' ' 27' ' ' ARG . 29.5 mm-40 -56.94 -49.31 76.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.007 -178.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.83 -38.0 72.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.582 -175.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.566 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 16.4 mm100 -61.9 -52.69 63.07 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.889 178.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.2 t -70.45 -10.54 59.41 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -172.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.547 ' HG3' ' O ' ' A' ' 23' ' ' GLU . 55.5 mtp180 -100.44 -11.2 20.4 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 121.081 -0.248 . . . . 0.0 111.338 -179.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.576 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 62.9 mt -132.2 -13.0 3.15 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -176.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.566 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -68.69 109.0 3.6 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 121.919 -0.488 . . . . 0.0 109.944 -178.316 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.52 26.1 66.3 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.393 178.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.428 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 13.3 mm100 -94.07 -170.61 2.34 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 110.311 -0.255 . . . . 0.0 110.311 178.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.515 ' HB2' ' SD ' ' A' ' 35' ' ' MET . 56.0 mtm180 -61.81 150.83 35.99 Favored 'General case' 0 C--O 1.232 0.165 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 177.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.433 ' CE1' ' HA ' ' A' ' 55' ' ' ASN . 55.9 m170 -92.31 113.92 26.33 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -178.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.505 ' CA ' HG21 ' A' ' 96' ' ' THR . . . 127.75 -4.62 7.02 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.746 -175.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.618 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 62.8 mtp -84.7 143.14 29.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.464 -0.368 . . . . 0.0 110.387 178.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.557 ' CD1' HD22 ' A' ' 98' ' ' LEU . 46.9 p90 -149.6 159.19 44.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.742 -0.208 . . . . 0.0 110.604 -178.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.623 ' HB2' ' HB2' ' A' ' 16' ' ' MET . 4.6 pp -150.69 138.52 19.92 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.141 0.496 . . . . 0.0 111.01 177.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 85.5 t -105.19 119.89 54.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 174.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.523 ' CB ' ' HB ' ' A' ' 19' ' ' VAL . 28.2 ptt-85 -117.08 161.58 19.18 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.89 -174.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -73.87 124.51 26.26 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 173.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.476 ' HB2' HG23 ' A' ' 49' ' ' VAL . 47.2 t -87.56 143.98 26.93 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.0 0.429 . . . . 0.0 110.902 -176.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.4 p -91.9 4.25 53.38 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.234 176.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 26.4 m -76.28 -43.12 43.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.173 175.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 47' ' ' ASP . 11.7 m -143.66 135.27 12.84 Favored Pre-proline 0 C--N 1.329 -0.317 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -70.38 72.84 1.72 Allowed 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.453 2.102 . . . . 0.0 111.677 176.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 65' ' ' SER . . . 155.55 -23.51 0.56 Allowed Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 -176.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.437 ' HB2' ' HB2' ' A' ' 44' ' ' CYS . 16.0 m-20 -81.79 155.83 25.23 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 176.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.9 m-85 -131.79 177.21 7.7 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.532 HG13 HD13 ' A' ' 62' ' ' ILE . 38.7 t -145.4 115.3 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.714 0.292 . . . . 0.0 111.288 177.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.426 HD11 ' HB2' ' A' ' 36' ' ' PHE . 57.5 tp -81.61 103.94 11.67 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.267 175.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.5 m -96.92 127.84 43.28 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 176.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.57 HG21 HD13 ' A' ' 93' ' ' LEU . 59.7 t -121.69 133.27 68.65 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.025 0.44 . . . . 0.0 111.063 -175.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.576 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 26.6 t -91.0 110.31 21.57 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.531 -178.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.653 ' OE2' ' HB ' ' A' ' 96' ' ' THR . 40.8 mt-10 -146.78 136.88 23.47 Favored 'General case' 0 C--O 1.21 -0.984 0 C-N-CA 119.673 -0.811 . . . . 0.0 109.678 175.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.433 ' HA ' ' CE1' ' A' ' 33' ' ' HIS . 80.2 m-20 52.95 31.09 10.3 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 174.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 44.8 m 58.33 53.31 6.49 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 122.134 0.968 . . . . 0.0 109.367 -178.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.88 HH21 ' HB2' ' A' ' 94' ' ' ASP 0.256 0.2 OUTLIER -168.39 67.94 0.07 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 113.577 -1.647 . . . . 0.0 108.668 -156.915 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 21.7 t -72.49 102.8 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 O-C-N 120.588 -1.32 . . . . 0.0 110.299 -167.702 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.6 m -73.61 118.88 17.08 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 113.133 -1.849 . . . . 0.0 110.737 -176.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -97.93 113.53 25.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.854 0.359 . . . . 0.0 111.43 -178.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.736 ' HB3' HD11 ' A' ' 73' ' ' ILE . 70.2 m-85 -107.24 110.2 22.18 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.964 179.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.808 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 34.2 mm -77.46 132.75 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -173.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.546 HG23 ' HB3' ' A' ' 71' ' ' PHE . 3.7 mp -115.84 115.91 50.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-O 120.947 0.403 . . . . 0.0 111.125 177.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -88.57 142.71 27.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.371 -177.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.457 ' HB2' ' O ' ' A' ' 46' ' ' GLY . 35.9 t -83.38 100.15 10.5 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 169.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 90.3 mt -78.11 140.42 61.69 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -59.05 -15.45 27.95 Favored 'Trans proline' 0 CA--C 1.53 0.279 0 C-N-CA 122.982 2.455 . . . . 0.0 112.446 179.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -83.45 10.79 8.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.419 176.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? 63.59 27.81 15.02 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.667 -178.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.458 ' NH2' ' HB3' ' A' ' 77' ' ' GLU . 37.0 mtp180 -115.44 -175.21 2.66 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.988 -1.006 . . . . 0.0 109.52 178.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.546 ' HB3' HG23 ' A' ' 63' ' ' ILE . 62.0 m-85 -135.57 143.44 45.67 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.063 0.459 . . . . 0.0 111.735 -175.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -123.47 116.46 23.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.992 177.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.808 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 7.9 tt -102.87 94.74 3.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.493 0.663 . . . . 0.0 110.807 -179.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.405 ' O ' ' HB3' ' A' ' 75' ' ' ASP . . . 58.78 68.75 1.53 Allowed Glycine 0 C--N 1.331 0.284 0 CA-C-N 115.098 -0.955 . . . . 0.0 112.651 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.405 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 20.4 t0 76.55 -45.01 0.49 Allowed 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 122.628 0.371 . . . . 0.0 111.333 178.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -75.78 129.18 36.64 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.146 0.498 . . . . 0.0 110.861 -178.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.458 ' HB3' ' NH2' ' A' ' 70' ' ' ARG . 64.6 mt-10 -101.32 153.3 19.77 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.428 -177.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.47 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 96.8 m-85 -141.01 -173.91 3.85 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.041 173.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -77.68 -48.76 15.97 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.019 0.438 . . . . 0.0 110.729 -178.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.416 ' H ' ' HB3' ' A' ' 83' ' ' ALA . 4.7 p80 -156.89 -179.38 8.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.397 -178.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.609 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 14.2 mt -57.77 -57.1 27.93 Favored Pre-proline 0 N--CA 1.469 0.493 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -178.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.605 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 24.4 Cg_exo -64.37 -2.33 4.86 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 122.13 1.887 . . . . 0.0 112.948 179.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.416 ' HB3' ' H ' ' A' ' 80' ' ' HIS . . . -89.9 -36.8 14.83 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.793 0.33 . . . . 0.0 110.348 179.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 3.7 pp -76.78 -31.11 56.8 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 177.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.477 ' HA ' ' CD1' ' A' ' 98' ' ' LEU . 57.2 mt -67.62 -26.72 66.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.653 174.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -79.12 -33.44 44.29 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.788 177.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -76.07 -38.11 57.47 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.028 0.442 . . . . 0.0 111.049 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.486 ' HE2' HD13 ' A' ' 73' ' ' ILE . 33.5 m-85 -76.26 1.55 15.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.962 0.41 . . . . 0.0 111.779 -177.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -70.27 -25.99 63.61 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.45 171.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 29.8 pt -117.14 26.57 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 C-N-CA 120.585 -0.446 . . . . 0.0 112.067 178.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.423 ' O ' ' HB2' ' A' ' 92' ' ' TYR . 2.8 t-160 -114.46 -42.64 3.27 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -175.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.47 ' CD1' HG23 ' A' ' 97' ' ' THR . 97.8 m-85 70.46 86.62 0.12 Allowed 'General case' 0 N--CA 1.467 0.376 0 O-C-N 123.751 0.657 . . . . 0.0 110.278 -171.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.685 ' HA ' ' OE2' ' A' ' 154' ' ' GLU . 14.8 mt -59.94 -30.75 69.28 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.51 -178.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.88 ' HB2' HH21 ' A' ' 57' ' ' ARG . 31.6 t0 -160.94 68.55 0.33 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.317 0.58 . . . . 0.0 109.863 170.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.534 HG22 ' O ' ' A' ' 94' ' ' ASP . 0.5 OUTLIER 70.2 -4.49 1.54 Allowed 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.956 -175.629 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.653 ' HB ' ' OE2' ' A' ' 54' ' ' GLU . 16.2 m -127.73 138.84 52.9 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 121.237 0.542 . . . . 0.0 109.933 178.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.472 ' O ' HG12 ' A' ' 99' ' ' ILE . 27.5 p -89.5 168.39 12.22 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 173.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.557 HD22 ' CD1' ' A' ' 36' ' ' PHE . 97.3 mt -63.58 96.36 0.12 Allowed 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 120.635 -0.426 . . . . 0.0 109.871 178.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.538 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 49.0 mm -86.06 -56.72 5.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.645 -174.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.618 ' O ' ' HA ' ' A' ' 35' ' ' MET . 42.5 tt0 -158.85 133.39 5.37 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.912 -176.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 100' ' ' GLU . 17.8 Cg_exo -64.91 157.75 55.03 Favored 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 122.88 2.386 . . . . 0.0 112.829 -177.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.09 141.13 86.15 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.9 112.44 1.21 Allowed 'Trans proline' 0 C--O 1.236 0.376 0 C-N-CA 122.384 2.056 . . . . 0.0 112.116 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.832 ' HA ' ' SD ' ' A' ' 16' ' ' MET . 41.7 ttp180 -59.09 -40.03 84.02 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-O 121.374 0.607 . . . . 0.0 109.474 178.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.448 ' HA ' ' HD3' ' A' ' 106' ' ' PRO . 59.7 m-85 -124.87 124.91 25.47 Favored Pre-proline 0 C--N 1.32 -0.697 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.531 171.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 105' ' ' TYR . 16.3 Cg_exo -70.63 45.35 0.54 Allowed 'Trans proline' 0 N--CA 1.475 0.401 0 C-N-CA 123.544 2.83 . . . . 0.0 113.376 -177.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.654 ' HB3' ' HD3' ' A' ' 108' ' ' PRO . 22.8 t -80.11 -48.04 1.34 Allowed Pre-proline 0 C--N 1.324 -0.519 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.43 175.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.654 ' HD3' ' HB3' ' A' ' 107' ' ' SER . 19.7 Cg_exo -67.66 129.2 19.44 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 121.957 1.771 . . . . 0.0 111.586 172.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' A' ' 108' ' ' PRO . 15.6 Cg_exo -68.47 121.71 8.66 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.856 2.37 . . . . 0.0 112.028 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 79.2 mtp -80.46 -10.31 59.75 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.367 177.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 120.5 -11.41 10.43 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.585 177.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 26.7 m 60.42 30.56 19.89 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 121.325 0.583 . . . . 0.0 110.518 -177.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 17.4 m -104.39 -43.0 7.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.494 -176.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 32.0 t 52.28 34.52 14.89 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.151 0.5 . . . . 0.0 110.648 -177.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -131.17 104.67 15.02 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.943 -174.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -91.61 -178.81 1.21 Allowed 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 123.209 2.606 . . . . 0.0 111.459 172.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -87.82 31.83 0.76 Allowed 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.261 0.553 . . . . 0.0 111.082 -177.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 1.4 tt -173.96 82.6 0.37 Allowed Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 178.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.52 -54.28 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.108 2.539 . . . . 0.0 111.99 179.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 6.3 m -87.76 105.25 17.26 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.539 -178.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -122.93 14.67 9.95 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.463 -177.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.436 ' CG ' ' H ' ' A' ' 123' ' ' ASP . 6.1 pt-20 38.53 -115.78 0.16 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.462 0.705 . . . . 0.0 112.674 -179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.436 ' H ' ' CG ' ' A' ' 122' ' ' GLU . 15.6 m-20 -131.23 29.2 4.66 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -178.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.855 ' HA ' ' HG3' ' A' ' 183' ' ' ARG . 0.1 OUTLIER -77.44 138.41 39.25 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -171.918 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.911 ' H ' ' HD2' ' A' ' 183' ' ' ARG . 3.3 mm? 72.53 108.06 0.07 Allowed 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.803 173.165 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.515 ' HG2' ' CD2' ' A' ' 127' ' ' TYR . 28.4 tt0 -171.72 -78.23 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.531 -1.213 . . . . 0.0 109.674 -174.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.515 ' CD2' ' HG2' ' A' ' 126' ' ' GLU . 54.7 m-85 -117.57 107.85 14.76 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.377 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.698 HG22 ' CG ' ' A' ' 180' ' ' LYS . 56.6 t -114.87 131.11 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -178.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.709 ' HB3' HD12 ' A' ' 149' ' ' ILE . 0.2 OUTLIER -109.79 144.66 37.91 Favored 'General case' 0 N--CA 1.434 -1.24 0 C-N-CA 116.892 -1.923 . . . . 0.0 108.989 170.988 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.609 HG22 HG12 ' A' ' 178' ' ' VAL . 1.2 p -100.68 128.91 46.56 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.316 -179.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.531 HD21 ' HG2' ' A' ' 179' ' ' GLU . 14.8 mt -105.27 -23.16 12.92 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.934 -176.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.459 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 32.6 t80 -79.9 -33.41 39.89 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.727 -173.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.607 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 15.7 t70 71.77 120.14 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 121.365 0.602 . . . . 0.0 110.842 -174.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.568 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 64.4 t80 -153.85 91.96 3.16 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.615 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 74.2 Cg_endo -90.0 86.77 0.39 Allowed 'Trans proline' 0 N--CA 1.441 -1.605 0 C-N-CA 122.014 1.809 . . . . 0.0 112.573 177.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -76.79 -16.11 81.04 Favored Glycine 0 C--N 1.331 0.298 0 N-CA-C 111.056 -0.817 . . . . 0.0 111.056 174.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.697 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 18.1 m120 52.97 68.31 0.86 Allowed 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.21 -0.995 . . . . 0.0 111.8 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.595 ' HB3' ' H ' ' A' ' 141' ' ' ASP . 1.0 OUTLIER -136.27 -174.87 3.81 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.229 0.538 . . . . 0.0 110.932 -178.962 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -115.32 3.69 14.27 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 166.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.431 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 32.9 tt0 -112.34 -49.74 2.94 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 113.9 -1.5 . . . . 0.0 108.65 177.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.595 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 4.9 m-20 -96.64 133.28 41.36 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 109.852 167.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 1.123 HD11 ' HB2' ' A' ' 165' ' ' ASN . 34.2 tp -83.62 131.65 51.68 Favored Pre-proline 0 N--CA 1.468 0.44 0 O-C-N 122.075 -0.39 . . . . 0.0 110.135 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.697 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 11.6 Cg_endo -85.63 91.06 0.69 Allowed 'Trans proline' 0 N--CA 1.444 -1.425 0 C-N-CA 122.115 1.877 . . . . 0.0 111.266 172.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.568 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 12.8 p90 -103.71 159.48 15.59 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.234 -176.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.607 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 5.0 mppt? -104.91 -168.28 1.45 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.262 0.554 . . . . 0.0 112.195 -178.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.735 ' H ' ' HD2' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -86.84 9.11 20.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.0 -169.688 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -172.63 36.93 0.14 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.714 -0.755 . . . . 0.0 111.857 175.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.545 ' OE1' ' HA ' ' A' ' 144' ' ' PHE . 0.3 OUTLIER -101.06 149.05 24.35 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 120.425 -0.51 . . . . 0.0 111.351 -175.648 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.709 HD12 ' HB3' ' A' ' 129' ' ' ARG . 0.3 OUTLIER -89.06 124.57 41.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.677 -178.116 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.727 HD22 HD21 ' A' ' 142' ' ' LEU . 19.3 mt -119.45 155.35 32.21 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.588 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 67.6 t -117.56 125.53 74.12 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 174.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 1.084 HD13 ' HB2' ' A' ' 163' ' ' ALA . 49.5 mm -76.54 87.18 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 122.423 1.106 . . . . 0.0 108.118 -176.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.612 HG21 HG22 ' A' ' 170' ' ' VAL . 17.9 tt -75.66 -25.1 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 CA-C-N 113.292 -1.776 . . . . 0.0 109.875 -174.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.685 ' OE2' ' HA ' ' A' ' 93' ' ' LEU . 0.2 OUTLIER -141.0 141.21 34.39 Favored 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 170.458 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 61.0 tttt -128.83 92.75 39.16 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-O 121.44 0.638 . . . . 0.0 110.356 170.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.427 ' HG2' ' HE2' ' A' ' 172' ' ' MET . 10.3 Cg_exo -74.3 -44.04 0.46 Allowed 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.338 2.025 . . . . 0.0 112.002 172.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -120.2 178.74 4.52 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.099 -172.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.448 ' HA ' ' HE1' ' A' ' 161' ' ' TRP . 6.7 pt-20 -116.12 4.68 13.67 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.094 0.473 . . . . 0.0 110.672 174.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -102.34 -31.26 10.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.696 172.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.442 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 34.5 m95 -129.11 146.16 51.12 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.613 173.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . 0.741 ' O ' HG13 ' A' ' 173' ' ' ILE . 47.8 m0 -126.79 138.33 53.34 Favored 'General case' 0 C--O 1.215 -0.757 0 C-N-CA 122.788 0.435 . . . . 0.0 110.657 179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.566 ' HB2' ' HB2' ' A' ' 154' ' ' GLU . 25.6 m -95.4 96.33 9.05 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -175.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 1.084 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -108.7 150.29 27.77 Favored 'General case' 0 N--CA 1.422 -1.833 0 C-N-CA 119.86 -0.736 . . . . 0.0 109.505 -172.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.779 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 12.7 ptt180 -87.46 122.17 30.85 Favored 'General case' 0 N--CA 1.428 -1.556 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 173.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 1.123 ' HB2' HD11 ' A' ' 142' ' ' LEU . 17.5 t30 -54.61 176.79 0.04 OUTLIER 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 113.293 -1.776 . . . . 0.0 110.91 -177.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.541 ' HD2' ' H ' ' A' ' 149' ' ' ILE . 30.9 mtpt -62.95 -17.98 62.61 Favored 'General case' 0 C--N 1.312 -1.062 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.828 169.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -68.94 -36.24 77.72 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.468 0.652 . . . . 0.0 109.46 168.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.432 ' C ' ' HB2' ' A' ' 164' ' ' ARG . . . 105.06 3.96 41.75 Favored Glycine 0 CA--C 1.524 0.598 0 CA-C-N 115.13 -0.941 . . . . 0.0 112.343 -172.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.779 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -79.33 137.59 37.39 Favored 'General case' 0 C--O 1.218 -0.574 0 C-N-CA 123.16 0.584 . . . . 0.0 111.77 -178.77 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.612 HG22 HG21 ' A' ' 153' ' ' ILE . 22.1 t -79.87 125.87 39.04 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-O 120.417 0.151 . . . . 0.0 111.291 177.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -157.88 148.37 17.67 Favored Glycine 0 CA--C 1.522 0.483 0 C-N-CA 120.209 -0.996 . . . . 0.0 112.665 169.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.472 ' HA ' ' HA ' ' A' ' 162' ' ' SER . 0.4 OUTLIER -69.88 140.65 53.19 Favored 'General case' 0 CA--C 1.515 -0.377 0 C-N-CA 122.756 0.422 . . . . 0.0 111.378 179.408 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.741 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.6 pp -144.45 144.39 25.1 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.105 -176.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.514 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 8.1 Cg_exo -73.38 132.13 17.3 Favored 'Trans proline' 0 C--O 1.23 0.115 0 C-N-CA 122.498 2.132 . . . . 0.0 112.644 -174.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.601 ' O ' HG22 ' A' ' 178' ' ' VAL . 82.9 t -60.98 -44.03 93.2 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 19.0 Cg_endo -61.08 -11.2 17.56 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 121.981 1.787 . . . . 0.0 112.873 177.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.514 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.1 m-85 -88.22 -15.18 36.63 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.525 -178.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.611 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 4.1 m -106.58 -172.44 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 115.558 1.688 . . . . 0.0 115.558 -164.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.663 ' O ' ' HG3' ' A' ' 179' ' ' GLU . 3.9 tp10 -159.9 44.32 0.22 Allowed 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 112.941 -1.936 . . . . 0.0 111.638 -154.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.773 ' HD2' ' H ' ' A' ' 180' ' ' LYS . 0.0 OUTLIER -74.13 144.23 44.99 Favored 'General case' 0 C--N 1.329 -0.324 0 O-C-N 119.275 -2.141 . . . . 0.0 111.554 -166.07 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.448 ' HB2' HH12 ' A' ' 129' ' ' ARG . 23.8 tp -64.81 -85.07 0.02 OUTLIER 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 111.416 -2.629 . . . . 0.0 114.282 -157.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 21.3 t -89.62 -14.69 9.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.666 0.746 . . . . 0.0 110.546 -173.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.911 ' HD2' ' H ' ' A' ' 125' ' ' LEU . 28.2 ttt-85 -75.33 107.15 7.25 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.606 -177.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 50.6 m -65.16 152.85 42.57 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 170.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.549 ' CB ' HH12 ' A' ' 183' ' ' ARG . 41.3 t -113.76 148.43 39.82 Favored Pre-proline 0 C--N 1.315 -0.904 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.29 -173.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.5 ' HD2' HH22 ' A' ' 183' ' ' ARG . 19.2 Cg_endo -58.81 104.54 0.19 Allowed 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.031 2.487 . . . . 0.0 111.314 174.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.452 ' HB3' ' CD ' ' A' ' 193' ' ' ARG . 37.5 m80 -108.51 25.83 11.22 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.659 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 89.89 -65.55 2.93 Favored Glycine 0 CA--C 1.505 -0.538 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -173.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -132.84 136.38 46.2 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 168.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 64.3 m80 -79.03 115.1 18.5 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.132 -0.627 . . . . 0.0 109.483 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 109.16 -121.66 6.24 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 -176.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -68.07 115.29 7.39 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 176.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.452 ' CD ' ' HB3' ' A' ' 187' ' ' HIS . 16.7 ptt180 -145.61 150.69 36.82 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.182 0.515 . . . . 0.0 111.605 -173.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -117.61 87.12 2.65 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.443 172.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 1.5 p -76.37 138.38 40.39 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.356 -177.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -97.45 109.27 22.06 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.727 -178.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 2.6 p -90.3 7.06 40.32 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.615 -0.721 . . . . 0.0 111.102 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -124.87 117.32 23.83 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.547 -178.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 107.7 172.41 22.03 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.341 176.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.525 HD13 ' H ' ' A' ' 200' ' ' ILE . 0.2 OUTLIER -133.98 144.39 51.41 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-O 120.632 0.253 . . . . 0.0 110.46 178.904 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 200' ' ' ILE . 3.0 Cg_exo -75.74 78.67 3.03 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.923 2.416 . . . . 0.0 111.566 176.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 59.0 mm-40 66.19 123.33 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.382 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.062 -178.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -68.03 157.76 60.39 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.306 2.004 . . . . 0.0 111.531 176.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -95.51 142.23 28.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.731 0.301 . . . . 0.0 110.611 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 -86.33 -41.67 14.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.19 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -149.03 157.83 43.72 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.537 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -85.87 103.27 14.46 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.045 177.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . 64.67 -172.14 0.18 Allowed 'General case' 0 N--CA 1.465 0.314 0 O-C-N 123.848 0.718 . . . . 0.0 111.008 -179.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -89.64 134.48 32.27 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-O 120.649 0.261 . . . . 0.0 110.714 176.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -62.05 140.23 83.1 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.776 2.317 . . . . 0.0 112.272 179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -91.47 123.36 34.83 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.006 -176.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 7.7 m 61.67 49.17 5.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.723 0.773 . . . . 0.0 111.664 175.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.0 104.34 16.89 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.452 173.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.731 ' HB ' ' HD3' ' A' ' 215' ' ' PRO . 49.3 m -152.65 -56.47 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.668 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.731 ' HD3' ' HB ' ' A' ' 214' ' ' THR . 89.1 Cg_endo -85.03 171.62 9.13 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 121.873 1.715 . . . . 0.0 112.213 176.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 95.8 mt -111.93 117.68 47.79 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.018 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -69.45 -75.44 0.01 OUTLIER 'Trans proline' 0 C--O 1.233 0.235 0 C-N-CA 122.976 2.451 . . . . 0.0 112.605 -178.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -145.34 149.11 34.2 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.374 -179.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 61.1 t -84.12 100.49 7.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.964 -177.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 74.8 m 56.62 29.4 15.6 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.249 175.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 68.99 21.12 75.25 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 121.012 -0.613 . . . . 0.0 112.749 178.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.451 ' HA ' ' HD3' ' A' ' 223' ' ' PRO . 27.4 m -109.77 127.24 27.47 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-O 120.559 0.218 . . . . 0.0 110.522 178.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 222' ' ' SER . 17.4 Cg_exo -67.43 -17.63 49.14 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.852 2.368 . . . . 0.0 112.138 178.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 133.29 -79.28 0.34 Allowed Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.594 -0.602 . . . . 0.0 111.594 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -88.82 95.62 10.36 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 177.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . 61.67 -167.62 0.2 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.65 179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 50.4 mm -109.2 -39.4 4.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.812 177.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.68 ' HB ' ' HD2' ' A' ' 229' ' ' PRO . 77.4 p -132.66 170.69 10.73 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.54 178.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.68 ' HD2' ' HB ' ' A' ' 228' ' ' THR . 53.6 Cg_endo -70.3 168.23 22.87 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 122.207 1.938 . . . . 0.0 111.616 172.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -100.75 115.16 65.67 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 120.672 0.272 . . . . 0.0 110.925 179.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.94 178.11 7.67 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 122.866 2.377 . . . . 0.0 111.938 177.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 61.3 m -81.44 56.22 2.86 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.976 0.417 . . . . 0.0 111.366 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 1.4 p -78.1 75.21 4.63 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.308 0.575 . . . . 0.0 110.116 175.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -85.27 98.29 10.43 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.505 -176.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -125.02 -35.98 2.6 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.41 -178.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . 0.424 ' HA3' ' HD3' ' A' ' 237' ' ' PRO . . . 97.72 -100.61 2.41 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -174.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . 0.424 ' HD3' ' HA3' ' A' ' 236' ' ' GLY . 12.9 Cg_exo -69.9 114.82 3.85 Favored 'Trans proline' 0 N--CA 1.46 -0.473 0 C-N-CA 122.563 2.175 . . . . 0.0 111.283 173.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.464 ' CG1' HD12 ' A' ' 293' ' ' ILE . 21.7 t -84.71 134.55 26.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.945 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.53 ' HB2' ' CG ' ' A' ' 296' ' ' PRO . 93.8 m-85 -104.46 124.24 48.9 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.141 0.496 . . . . 0.0 110.468 -179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.585 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -119.24 140.65 49.89 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.26 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -88.2 124.36 33.76 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . 0.522 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -75.29 99.52 4.09 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.253 178.388 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 39.4 pt -80.59 -23.26 11.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.276 0.56 . . . . 0.0 110.74 -177.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -135.26 148.52 49.59 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 177.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -67.79 169.56 9.47 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.239 0.542 . . . . 0.0 110.607 -178.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.564 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 27.3 tpt180 -154.1 109.78 3.2 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.166 178.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 24.0 m -108.77 150.15 40.43 Favored Pre-proline 0 C--N 1.315 -0.923 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.505 ' HA ' ' HB3' ' A' ' 255' ' ' ALA . 12.4 Cg_exo -68.44 110.5 2.29 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.416 2.077 . . . . 0.0 111.518 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' CYS . . . . . 0.535 ' HB3' ' HB2' ' A' ' 252' ' ' ASP . 51.9 t -70.52 164.65 24.32 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.907 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -53.34 -40.05 64.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.6 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -99.86 7.17 45.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.793 0.33 . . . . 0.0 111.493 179.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.535 ' HB2' ' HB3' ' A' ' 249' ' ' CYS . 7.4 m-20 -127.6 69.19 1.31 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.132 0.491 . . . . 0.0 110.131 176.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -78.2 -21.58 49.86 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.178 0.513 . . . . 0.0 110.189 -179.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 19.8 p -83.04 -0.35 48.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.847 177.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.505 ' HB3' ' HA ' ' A' ' 248' ' ' PRO . . . -77.19 132.59 38.84 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.572 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.62 137.28 40.64 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.026 -178.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.564 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -87.26 107.59 18.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.141 0.496 . . . . 0.0 110.095 179.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 94.4 mt -116.3 151.11 36.5 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.782 -176.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -119.13 157.0 28.77 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.22 176.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 47.4 t -65.03 122.64 16.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.565 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 96.28 18.45 31.09 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.801 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -99.38 170.5 8.59 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 177.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 25.9 mm -117.76 112.83 40.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.042 0.449 . . . . 0.0 110.307 -178.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 239' ' ' PHE . 30.8 t -88.41 113.0 24.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.65 -178.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -92.26 87.59 6.13 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.829 177.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.518 HG21 ' HB3' ' A' ' 275' ' ' TRP . 3.0 p -92.69 120.05 41.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.384 0.611 . . . . 0.0 110.809 -177.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 1.4 p -94.03 -26.95 16.57 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.754 -178.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . 0.586 ' HB2' ' HB3' ' A' ' 276' ' ' GLU . 28.6 mmm180 -116.24 104.51 11.58 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.864 0.364 . . . . 0.0 110.938 -178.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 36.9 mmm -94.51 131.87 39.78 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 177.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 31.7 p30 -125.44 -179.16 4.49 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.638 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 19.6 pt -103.31 8.21 9.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.172 0.51 . . . . 0.0 110.738 -179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -81.35 -31.51 33.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.717 -176.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 117.91 -40.2 2.39 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.665 179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.543 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 1.9 mp0 -94.76 114.98 26.96 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 174.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.518 ' HB3' HG21 ' A' ' 266' ' ' VAL . 21.9 m0 -91.68 157.53 16.9 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -177.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.586 ' HB3' ' HB2' ' A' ' 268' ' ' ARG . 8.0 tp10 -90.39 103.08 15.8 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 177.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -115.91 137.96 14.17 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.266 -0.968 . . . . 0.0 113.559 -172.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -105.99 108.95 20.72 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 175.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . 0.404 HG22 ' HA ' ' A' ' 264' ' ' VAL . 37.9 t -119.47 -87.64 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.056 -0.658 . . . . 0.0 112.108 -173.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -105.08 76.25 1.23 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.936 0.398 . . . . 0.0 111.072 -174.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 66.15 20.73 69.38 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.825 176.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 282' ' ' ARG . 38.1 ttt-85 -158.87 137.41 10.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.838 0.319 . . . . 0.0 110.64 -175.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 38.1 ttpt -110.08 128.45 55.44 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.599 177.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -156.67 173.72 34.4 Favored Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 -178.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.543 ' HB3' ' HB3' ' A' ' 274' ' ' GLN . 72.5 mt -89.1 138.01 31.8 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.039 0.447 . . . . 0.0 110.417 -179.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.445 ' O ' ' HA ' ' A' ' 274' ' ' GLN . 35.7 p90 -137.83 133.08 17.53 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.21 178.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.67 131.93 23.97 Favored 'Trans proline' 0 C--O 1.237 0.451 0 C-N-CA 122.547 2.164 . . . . 0.0 111.656 176.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -65.62 -2.39 3.47 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.69 -177.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.89 -0.46 55.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.96 0.41 . . . . 0.0 111.296 -179.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 13.0 m-70 -111.65 -12.5 13.89 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.801 0.334 . . . . 0.0 110.892 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.522 HG12 ' HA ' ' A' ' 242' ' ' ALA . 27.9 m -128.29 162.47 34.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.211 -0.45 . . . . 0.0 109.999 -179.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -136.43 132.35 35.33 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.944 0.402 . . . . 0.0 111.027 175.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.585 HD13 ' HB2' ' A' ' 240' ' ' ALA . 42.0 mm -72.29 129.81 35.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.454 179.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' PHE . . . . . 0.641 ' O ' ' HD3' ' A' ' 296' ' ' PRO . 10.2 p90 -135.08 -170.93 2.68 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.595 -179.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . 0.551 ' HB2' ' O ' ' A' ' 298' ' ' ASN . 6.1 p-10 -98.07 97.08 3.99 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-O 121.357 0.599 . . . . 0.0 110.87 176.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . 0.641 ' HD3' ' O ' ' A' ' 294' ' ' PHE . 1.1 Cg_endo -83.53 -53.27 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.921 2.414 . . . . 0.0 112.098 -178.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -124.49 -10.57 7.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.232 0.539 . . . . 0.0 110.554 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . 0.551 ' O ' ' HB2' ' A' ' 295' ' ' ASP . 2.7 p-10 -100.98 114.5 65.82 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.595 -179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 298' ' ' ASN . 13.6 Cg_exo -71.72 -11.21 27.62 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.755 2.303 . . . . 0.0 111.836 178.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -65.14 153.47 40.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.131 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 73.12 -32.58 0.25 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.772 0.829 . . . . 0.0 111.999 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . 0.478 HD22 ' CG ' ' A' ' 295' ' ' ASP . 44.0 t-20 -80.84 116.85 21.03 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 175.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 . . . . . 0 C--O 1.246 0.87 0 CA-C-O 118.542 -0.742 . . . . 0.0 110.046 -177.932 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 N--CA 1.48 1.056 0 CA-C-O 120.596 0.236 . . . . 0.0 110.96 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.4 m -90.45 -10.86 42.18 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.732 -0.213 . . . . 0.0 110.866 -178.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.584 ' HB3' HD12 ' A' ' 99' ' ' ILE . 64.2 m 69.55 -55.9 0.57 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.331 0.652 . . . . 0.0 111.485 -176.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.563 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . -72.36 107.22 4.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.689 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.445 ' HD3' ' HA ' ' A' ' 5' ' ' ARG . 19.1 mmt180 -137.55 100.05 4.11 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.112 0.482 . . . . 0.0 111.418 -178.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -167.65 159.69 12.16 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.33 -0.85 . . . . 0.0 108.88 177.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -83.11 108.42 16.37 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 177.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.636 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 15.4 m -74.89 55.86 0.71 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.319 179.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 67.1 m -161.85 -39.67 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.948 0.404 . . . . 0.0 110.781 -179.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -71.81 110.37 6.29 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.19 0.519 . . . . 0.0 111.386 -171.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.401 ' HG2' ' H ' ' A' ' 11' ' ' ARG . 9.3 mmt180 -60.78 -35.65 77.0 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.712 -178.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.526 ' HA ' ' NH1' ' A' ' 104' ' ' ARG . 67.0 m -71.18 -3.57 20.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.504 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -92.73 -46.87 7.36 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.963 -0.295 . . . . 0.0 111.139 177.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 17.3 p-90 -118.57 -21.25 8.04 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -170.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 25.9 t80 -80.4 121.72 26.07 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 121.86 -0.525 . . . . 0.0 111.18 -173.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.577 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 23.1 mmt -99.81 -5.21 28.95 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.653 -176.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.442 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.15 -113.82 2.47 Favored Glycine 0 CA--C 1.523 0.591 0 CA-C-N 116.034 -0.53 . . . . 0.0 113.359 -176.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.442 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 9.2 Cg_exo -72.56 91.09 0.79 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.19 2.593 . . . . 0.0 113.511 -176.091 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.5 ' HB ' ' HD2' ' A' ' 39' ' ' ARG . 73.7 t -144.99 153.76 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 176.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.2 p -121.19 -179.83 4.17 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 118.233 0.469 . . . . 0.0 109.78 -174.203 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.751 HH21 ' HA ' ' A' ' 117' ' ' ASN . 21.2 mmm180 -55.25 -54.59 41.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.649 0.261 . . . . 0.0 110.879 177.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.492 ' HB2' ' HB3' ' A' ' 114' ' ' SER . 11.3 pt20 -64.47 -39.59 94.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.868 -175.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.509 ' O ' ' HG2' ' A' ' 27' ' ' ARG . 50.4 mt-10 -69.68 -48.08 60.98 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.404 179.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -56.19 -38.8 71.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.017 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.916 ' HG2' ' H ' ' A' ' 115' ' ' ALA . 3.6 tp-100 -53.2 -58.56 6.62 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.451 175.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.57 ' HA ' ' HB3' ' A' ' 29' ' ' GLN . 10.4 t -75.99 -2.63 31.48 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 111.808 0.299 . . . . 0.0 111.808 -171.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.509 ' HG2' ' O ' ' A' ' 23' ' ' GLU . 52.2 mmm-85 -85.29 -20.93 29.29 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.162 0.506 . . . . 0.0 109.682 175.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.576 HD22 ' HB2' ' A' ' 53' ' ' SER . 29.7 mt -123.14 -12.71 7.87 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.737 -177.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.729 ' NE2' ' HB3' ' A' ' 57' ' ' ARG . 3.9 tp-100 -67.33 115.64 7.2 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.172 0.589 . . . . 0.0 111.743 -178.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 66.62 10.98 56.1 Favored Glycine 0 C--N 1.331 0.292 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.855 176.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.486 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 15.2 mm100 -70.1 -87.02 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -177.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -158.07 -4.36 0.09 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.465 ' HA ' ' OG ' ' A' ' 53' ' ' SER . 29.0 m170 71.17 161.37 0.23 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.359 0.599 . . . . 0.0 111.559 179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.11 -22.55 8.15 Favored Glycine 0 N--CA 1.451 -0.344 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.07 177.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.743 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 57.9 mtm -82.25 147.44 28.94 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 178.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -140.25 164.37 30.26 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.261 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.577 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.3 pp -152.69 134.88 14.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.037 0.446 . . . . 0.0 111.463 178.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 59.6 t -105.81 127.29 60.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 173.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.619 HH22 ' HD2' ' A' ' 21' ' ' ARG . 31.9 ptt-85 -131.15 -178.45 4.84 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.684 -0.235 . . . . 0.0 110.652 -174.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -69.93 132.21 45.61 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 171.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.493 ' HA ' HG23 ' A' ' 49' ' ' VAL . 22.6 t -72.87 155.91 39.41 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.65 0.738 . . . . 0.0 112.246 -175.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.4 p -102.14 10.29 39.55 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.383 177.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 36.0 p -95.27 -51.54 4.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.855 178.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 1.7 p -165.91 144.11 4.81 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.127 179.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 44' ' ' CYS . 47.4 Cg_exo -57.54 125.37 18.57 Favored 'Trans proline' 0 C--O 1.237 0.471 0 C-N-CA 123.006 2.471 . . . . 0.0 112.268 178.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.65 -31.42 5.56 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -176.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -89.3 167.78 12.78 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 177.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -135.98 176.01 9.08 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.76 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.493 HG23 ' HA ' ' A' ' 41' ' ' SER . 48.4 t -142.93 110.87 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 120.945 0.402 . . . . 0.0 111.319 177.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.3 tp -80.84 105.61 12.2 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.184 174.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 21.0 m -98.27 131.57 44.48 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 174.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.587 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 46.2 t -118.64 143.13 30.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.493 -177.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.576 ' HB2' HD22 ' A' ' 28' ' ' LEU . 40.2 t -88.75 110.32 20.9 Favored 'General case' 0 C--N 1.329 -0.321 0 O-C-N 122.218 -0.301 . . . . 0.0 111.267 -177.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.516 ' HG2' ' O ' ' A' ' 94' ' ' ASP . 6.2 tp10 -177.85 165.93 2.05 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 112.003 0.372 . . . . 0.0 112.003 174.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.55 ' HB2' HH21 ' A' ' 57' ' ' ARG . 2.6 m-80 60.3 50.48 6.17 Favored 'General case' 0 CA--C 1.48 -1.742 0 C-N-CA 123.905 0.882 . . . . 0.0 108.657 -168.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' A' ' 55' ' ' ASN . 66.4 m 71.61 -28.7 0.19 Allowed 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 113.516 -1.675 . . . . 0.0 110.95 -171.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.753 ' NE ' ' H ' ' A' ' 58' ' ' VAL 0.399 0.0 OUTLIER -153.21 -54.01 0.11 Allowed 'General case' 0 C--N 1.364 1.23 1 N-CA-C 124.965 5.172 . . . . 0.0 124.965 -174.619 . . . . . . . . 5 4 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.753 ' H ' ' NE ' ' A' ' 57' ' ' ARG . 1.7 t -152.29 120.8 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.564 0 CA-C-N 122.49 2.405 . . . . 0.0 114.046 -173.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.531 ' HB2' ' HB ' ' A' ' 52' ' ' VAL . 0.9 OUTLIER -97.98 110.83 23.33 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 163.513 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.653 ' HD2' HD23 ' A' ' 118' ' ' LEU . 92.4 m-70 -98.13 118.17 34.16 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 121.546 -0.721 . . . . 0.0 112.555 -173.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.716 ' CZ ' HD22 ' A' ' 93' ' ' LEU . 37.2 m-85 -122.36 109.21 14.13 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.674 179.244 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.573 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 67.9 mt -81.03 135.12 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 O-C-N 121.859 -0.526 . . . . 0.0 111.636 -178.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.475 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 5.3 mp -112.96 111.69 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 120.881 0.372 . . . . 0.0 110.905 179.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.692 ' HB2' ' CG ' ' A' ' 72' ' ' LYS . 23.4 m120 -88.98 148.13 23.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.495 -174.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.6 t -83.82 105.84 15.04 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.136 175.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.407 HD21 ' HE2' ' A' ' 72' ' ' LYS . 91.0 mt -82.74 140.68 43.98 Favored Pre-proline 0 C--N 1.325 -0.484 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 177.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -63.52 -9.05 16.68 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.077 2.518 . . . . 0.0 112.978 -177.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -91.82 19.26 6.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.326 177.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.481 ' HA ' ' NE ' ' A' ' 69' ' ' ARG . 5.2 mmp_? 58.7 32.32 22.06 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.405 0.621 . . . . 0.0 110.627 -174.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.448 HH11 ' HD3' ' A' ' 70' ' ' ARG . 34.1 mtp180 -114.42 -178.84 3.47 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.272 179.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.475 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 55.6 m-85 -138.87 142.41 38.59 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.486 0.184 . . . . 0.0 111.148 -178.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.692 ' CG ' ' HB2' ' A' ' 64' ' ' ASN . 0.0 OUTLIER -123.26 120.57 33.49 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-O 120.813 0.339 . . . . 0.0 110.874 178.914 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.621 HD11 ' CB ' ' A' ' 61' ' ' TYR . 17.6 tt -93.51 89.53 2.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.917 0.865 . . . . 0.0 110.817 -177.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.523 ' O ' ' HB3' ' A' ' 75' ' ' ASP . . . 59.51 77.08 0.19 Allowed Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.305 -178.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.523 ' HB3' ' O ' ' A' ' 74' ' ' GLY . 16.6 t70 78.54 -52.24 0.48 Allowed 'General case' 0 N--CA 1.48 1.051 0 O-C-N 123.749 0.323 . . . . 0.0 111.409 178.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -70.47 134.8 48.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.0 0.429 . . . . 0.0 111.795 -173.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.422 ' OE1' ' HB3' ' A' ' 72' ' ' LYS . 6.0 mm-40 -89.49 143.9 26.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.185 -177.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.482 ' HZ ' ' CD2' ' A' ' 87' ' ' PHE . 47.0 m-85 -140.52 -175.42 4.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.293 172.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -75.38 -56.81 4.35 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.17 179.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.479 ' ND1' ' HD2' ' A' ' 82' ' ' PRO . 2.5 p80 -166.81 -174.0 2.59 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.762 175.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.664 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 16.4 mt -53.51 -59.74 8.73 Favored Pre-proline 0 N--CA 1.47 0.547 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -177.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.664 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 38.5 Cg_exo -65.11 3.2 1.05 Allowed 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 122.752 2.301 . . . . 0.0 113.56 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.475 ' HB3' ' H ' ' A' ' 80' ' ' HIS . . . -106.07 -35.06 7.36 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.911 0.386 . . . . 0.0 110.669 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.6 pp -76.14 -30.74 58.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.938 0.399 . . . . 0.0 110.127 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.477 ' N ' HD12 ' A' ' 84' ' ' LEU . 79.2 mt -63.66 -27.88 69.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.042 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.581 ' HA ' ' HD3' ' A' ' 89' ' ' LYS . 19.9 tp10 -80.9 -21.96 40.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.98 -176.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.482 ' CD2' ' HZ ' ' A' ' 78' ' ' PHE . 62.4 t80 -83.02 -20.61 34.72 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.898 0.856 . . . . 0.0 109.243 -177.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.517 ' CG ' HD21 ' A' ' 93' ' ' LEU . 35.5 m-85 -97.27 1.98 50.24 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.444 -177.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.581 ' HD3' ' HA ' ' A' ' 86' ' ' GLU . 53.8 mtpt -86.23 -2.24 58.19 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.967 173.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 33.2 pt -131.85 -8.52 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 CA-C-O 121.432 0.634 . . . . 0.0 109.365 177.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.462 ' HB2' ' O ' ' A' ' 87' ' ' PHE . 8.2 t60 -82.82 -32.54 27.56 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.602 -174.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.441 ' H ' HG22 ' A' ' 97' ' ' THR . 95.4 m-85 56.93 78.84 0.2 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.048 -0.978 . . . . 0.0 108.92 -166.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.716 HD22 ' CZ ' ' A' ' 61' ' ' TYR . 12.9 mt -45.77 -83.03 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.21 0 O-C-N 124.091 0.87 . . . . 0.0 110.34 178.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.572 ' HB2' ' HG3' ' A' ' 154' ' ' GLU . 45.5 t0 -109.13 84.17 1.88 Allowed 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.908 -179.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 1.086 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 4.8 t 49.93 17.68 0.31 Allowed 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.643 0.777 . . . . 0.0 112.152 -178.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.8 t -163.12 157.58 20.82 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 -178.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.441 HG22 ' H ' ' A' ' 92' ' ' TYR . 7.9 p -98.4 176.33 5.73 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.644 0.259 . . . . 0.0 110.463 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 96.4 mt -72.02 90.65 1.18 Allowed 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 174.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.584 HD12 ' HB3' ' A' ' 3' ' ' SER . 50.1 mm -73.74 -54.39 15.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.247 -175.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.743 ' O ' ' HA ' ' A' ' 35' ' ' MET . 11.1 pt-20 -158.44 153.74 22.06 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.032 -177.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.73 145.95 33.23 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 121.924 1.749 . . . . 0.0 111.531 176.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.433 ' HB2' ' HB3' ' A' ' 35' ' ' MET . . . -72.08 150.7 92.5 Favored Pre-proline 0 C--N 1.324 -0.504 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 178.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.34 134.35 63.17 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.409 2.073 . . . . 0.0 111.673 175.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.526 ' NH1' ' HA ' ' A' ' 12' ' ' SER . 56.2 mtm180 -80.83 -14.29 58.18 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 -174.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -69.14 150.01 97.5 Favored Pre-proline 0 C--N 1.326 -0.418 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -68.86 100.36 0.71 Allowed 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.229 1.952 . . . . 0.0 111.389 174.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.42 ' HB2' ' HA ' ' A' ' 110' ' ' MET . 19.0 m -57.91 119.74 36.61 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.045 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.548 ' HB2' ' HD3' ' A' ' 109' ' ' PRO . 51.0 Cg_exo -53.27 -51.25 11.41 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.041 2.494 . . . . 0.0 113.672 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.548 ' HD3' ' HB2' ' A' ' 108' ' ' PRO . 78.0 Cg_endo -84.23 -1.88 9.91 Favored 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 121.648 1.565 . . . . 0.0 111.775 175.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . 0.42 ' HA ' ' HB2' ' A' ' 107' ' ' SER . 64.1 mtt 64.37 -83.44 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.094 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.789 -175.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -173.54 -61.45 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 -178.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . 0.549 ' HB2' ' HG3' ' A' ' 29' ' ' GLN . 48.7 m -154.9 -81.62 0.08 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 172.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 21.3 m -140.82 162.84 22.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.742 -179.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.492 ' HB3' ' HB2' ' A' ' 22' ' ' GLN . 14.9 m -90.24 91.75 8.64 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.87 0.367 . . . . 0.0 110.328 177.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.916 ' H ' ' HG2' ' A' ' 25' ' ' GLN . . . -92.63 147.19 33.74 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.433 178.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 115' ' ' ALA . 1.0 OUTLIER -84.32 136.49 6.66 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.908 2.405 . . . . 0.0 112.81 -178.597 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.751 ' HA ' HH21 ' A' ' 21' ' ' ARG . 63.7 t30 70.37 -140.08 0.06 Allowed 'General case' 0 C--O 1.234 0.288 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.632 173.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.826 ' HB2' ' HD3' ' A' ' 119' ' ' PRO . 83.4 mt -75.82 -66.62 0.38 Allowed Pre-proline 0 C--N 1.324 -0.503 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -169.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.826 ' HD3' ' HB2' ' A' ' 118' ' ' LEU . 72.8 Cg_endo -87.58 -168.77 0.42 Allowed 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.258 1.972 . . . . 0.0 113.323 -171.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.3 m -91.88 32.44 1.13 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.682 -177.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 73.16 -51.69 0.71 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.669 0.788 . . . . 0.0 112.272 178.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -137.44 85.34 2.11 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.387 0.613 . . . . 0.0 110.294 176.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.5 p30 -138.26 -74.45 0.4 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.539 176.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.451 ' O ' ' HB2' ' A' ' 125' ' ' LEU . 0.4 OUTLIER 173.85 147.05 0.06 Allowed 'General case' 0 C--N 1.332 -0.195 0 C-N-CA 123.199 0.6 . . . . 0.0 109.453 179.424 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.904 HD12 HG21 ' A' ' 152' ' ' ILE . 3.9 mm? 72.04 109.12 0.07 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.695 0.76 . . . . 0.0 111.386 177.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.46 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 44.7 tt0 -169.39 -72.25 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.068 -0.969 . . . . 0.0 109.161 -178.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -117.66 114.64 23.67 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.634 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.868 HG22 ' HG3' ' A' ' 180' ' ' LYS . 57.4 t -126.38 150.15 31.82 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.096 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.732 ' CZ ' HD13 ' A' ' 181' ' ' LEU . 0.0 OUTLIER -124.73 155.01 39.98 Favored 'General case' 0 N--CA 1.437 -1.075 0 C-N-CA 118.014 -1.474 . . . . 0.0 109.031 165.158 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.639 ' OG1' ' HB2' ' A' ' 144' ' ' PHE . 72.9 p -106.02 140.05 39.61 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.216 0.531 . . . . 0.0 111.072 178.129 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.579 HD21 ' HG2' ' A' ' 179' ' ' GLU . 8.8 mt -113.73 -5.9 13.31 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.039 -179.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.443 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 28.6 t80 -93.91 -41.11 9.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.694 -173.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.647 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 10.7 t70 74.28 95.53 0.07 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.486 0.66 . . . . 0.0 110.69 -178.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.64 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 75.4 t80 -126.01 90.46 50.21 Favored Pre-proline 0 C--N 1.318 -0.765 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 173.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.584 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 95.0 Cg_endo -85.92 81.19 1.7 Allowed 'Trans proline' 0 N--CA 1.44 -1.636 0 C-N-CA 121.712 1.608 . . . . 0.0 112.144 178.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -69.69 -11.96 66.55 Favored Glycine 0 C--N 1.335 0.513 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.302 175.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.52 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 19.5 m120 50.3 65.86 1.32 Allowed 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 114.297 -0.951 . . . . 0.0 111.629 177.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.563 ' HB3' ' H ' ' A' ' 141' ' ' ASP . 1.0 OUTLIER -130.88 -176.61 4.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.364 0.602 . . . . 0.0 110.898 -178.612 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -111.41 0.63 16.64 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 167.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -117.09 -45.99 2.73 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.691 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.563 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 8.4 m-20 -97.67 128.1 44.12 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 168.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 1.098 HD11 ' HB2' ' A' ' 165' ' ' ASN . 28.9 tp -84.61 124.48 73.17 Favored Pre-proline 0 CA--C 1.517 -0.321 0 O-C-N 122.095 -0.378 . . . . 0.0 110.98 -176.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.584 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 49.7 Cg_endo -76.11 105.79 2.14 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 121.502 1.468 . . . . 0.0 111.707 166.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.64 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 0.2 OUTLIER -93.42 -161.68 0.87 Allowed 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 175.364 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.647 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 68.6 mttm -138.07 -170.94 2.9 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.801 176.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.991 ' H ' ' HD2' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -84.7 25.26 0.93 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.384 0.612 . . . . 0.0 109.913 -179.533 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 158.78 41.6 0.02 OUTLIER Glycine 0 N--CA 1.436 -1.353 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.898 -177.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.684 ' CD ' ' HG ' ' A' ' 150' ' ' LEU . 1.8 pp20? -84.7 170.04 13.68 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 173.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.438 HG13 ' CZ ' ' A' ' 129' ' ' ARG . 1.1 mp -111.78 128.54 68.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 118.453 0.569 . . . . 0.0 109.62 170.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.773 ' CD2' ' HA ' ' A' ' 165' ' ' ASN . 82.1 mt -119.42 155.95 31.05 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -172.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.595 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 62.0 t -123.51 120.22 59.44 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 172.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 1.122 HD13 ' HB2' ' A' ' 163' ' ' ALA . 25.8 mm -79.79 82.34 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.507 -0.675 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -179.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.825 ' HA ' HD13 ' A' ' 118' ' ' LEU . 14.3 tt -72.21 -33.72 47.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-N 114.203 -1.362 . . . . 0.0 108.904 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.707 ' OE2' HG12 ' A' ' 153' ' ' ILE . 3.4 mp0 -125.86 143.61 51.0 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.046 176.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.587 ' HD2' ' HG ' ' A' ' 125' ' ' LEU . 83.1 tttt -136.08 87.82 23.12 Favored Pre-proline 0 C--N 1.316 -0.858 0 CA-C-O 121.108 0.48 . . . . 0.0 109.76 171.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 1.086 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 8.0 Cg_exo -76.35 -50.52 0.11 Allowed 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.787 2.324 . . . . 0.0 112.112 174.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.651 ' HG2' ' CE ' ' A' ' 172' ' ' MET . 5.4 mm-40 -102.21 173.31 6.43 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.113 -173.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.515 ' O ' HG21 ' A' ' 175' ' ' VAL . 8.7 tp10 -104.83 -17.93 14.41 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 175.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -99.99 -17.0 17.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.314 174.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.463 ' HB2' ' HE1' ' A' ' 172' ' ' MET . 73.1 m95 -130.26 125.35 34.61 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.735 178.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . 0.749 ' HB3' HD12 ' A' ' 152' ' ' ILE . 50.0 m0 -112.81 135.81 53.14 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.021 0.438 . . . . 0.0 110.437 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.615 ' OG ' ' HG2' ' A' ' 172' ' ' MET . 70.5 m -93.31 92.93 7.92 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 -174.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 1.122 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -109.45 146.78 33.96 Favored 'General case' 0 N--CA 1.415 -2.194 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -172.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.784 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 12.3 ptt180 -88.16 127.21 35.43 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 174.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 1.098 ' HB2' HD11 ' A' ' 142' ' ' LEU . 63.5 t30 -59.41 179.94 0.1 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.103 -1.408 . . . . 0.0 111.793 -170.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.434 ' HD3' ' H ' ' A' ' 149' ' ' ILE . 48.9 tptt -56.74 -20.88 24.37 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.52 167.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -79.88 -30.71 40.23 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.843 172.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.521 ' C ' ' HB2' ' A' ' 164' ' ' ARG . . . 101.53 7.95 47.43 Favored Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.515 -0.85 . . . . 0.0 113.064 -174.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.784 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -77.97 132.11 37.7 Favored 'General case' 0 C--O 1.217 -0.625 0 C-N-CA 122.646 0.378 . . . . 0.0 111.222 177.243 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.461 HG22 HG21 ' A' ' 153' ' ' ILE . 47.9 t -82.43 125.47 39.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.634 -179.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -159.17 152.39 23.4 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 121.042 -0.599 . . . . 0.0 111.965 173.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.651 ' CE ' ' HG2' ' A' ' 157' ' ' GLU . 35.9 mtp -77.5 142.96 38.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.893 0.346 . . . . 0.0 110.704 -178.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.69 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.7 pp -142.45 144.93 32.67 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.019 -175.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.453 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 22.8 Cg_exo -65.05 129.94 24.41 Favored 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 122.834 2.356 . . . . 0.0 113.004 -179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.643 ' O ' HG22 ' A' ' 178' ' ' VAL . 58.0 t -64.87 -41.6 56.75 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 18.6 Cg_endo -61.29 -6.8 7.23 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 121.858 1.705 . . . . 0.0 112.748 176.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.453 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.2 m-30 -95.53 -9.23 32.96 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.814 -178.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 175' ' ' VAL . 4.3 m -105.04 -171.98 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 -166.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.648 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 6.7 tp10 -159.15 49.6 0.34 Allowed 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 112.678 -2.056 . . . . 0.0 111.812 -153.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.868 ' HG3' HG22 ' A' ' 128' ' ' VAL . 3.2 mppt? -69.66 136.13 50.74 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 119.603 -1.935 . . . . 0.0 111.081 -160.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.732 HD13 ' CZ ' ' A' ' 129' ' ' ARG . 14.6 tp -72.21 -76.67 0.11 Allowed 'General case' 0 CA--C 1.523 -0.096 0 CA-C-N 113.207 -1.815 . . . . 0.0 110.655 -168.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 5.7 m -101.08 105.24 17.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.179 -0.918 . . . . 0.0 109.263 175.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 2.2 tmt_? -164.36 -49.06 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.269 -175.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 41.7 m 59.56 91.18 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.567 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.714 ' HB3' ' HD2' ' A' ' 186' ' ' PRO . 1.0 OUTLIER -65.11 176.74 0.74 Allowed Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.749 -174.504 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.714 ' HD2' ' HB3' ' A' ' 185' ' ' SER . 2.3 Cg_endo -46.29 119.85 3.35 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.932 2.421 . . . . 0.0 112.409 173.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 40.1 m80 -137.71 -174.33 3.74 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -73.86 65.52 1.83 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.882 -0.675 . . . . 0.0 111.975 175.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 97.3 mttt 61.94 98.09 0.03 OUTLIER 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.57 0.7 . . . . 0.0 111.067 -176.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -103.29 162.43 13.0 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.757 -176.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -171.03 108.84 0.3 Allowed Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.267 178.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -64.29 -60.4 3.23 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 175.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 72.9 mtt180 -129.66 -7.58 4.58 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.333 -0.848 . . . . 0.0 108.8 168.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 66.9 t30 56.11 70.06 0.68 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.034 -0.984 . . . . 0.0 109.033 -166.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 13.0 m -72.86 -33.97 66.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.68 -172.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -161.32 -177.23 5.87 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -174.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . 0.425 ' HA ' ' CG2' ' A' ' 200' ' ' ILE . 22.9 t 80.0 29.23 0.27 Allowed 'General case' 0 CA--C 1.531 0.233 0 O-C-N 123.91 0.756 . . . . 0.0 111.199 176.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 84.1 t80 -84.83 -40.66 16.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.323 177.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -137.6 36.15 1.98 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.909 -177.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.425 ' CG2' ' HA ' ' A' ' 197' ' ' SER . 6.2 tp -128.03 97.72 28.74 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-O 121.334 0.588 . . . . 0.0 111.007 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_exo -73.62 -59.33 0.05 OUTLIER 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 123.344 2.696 . . . . 0.0 112.794 178.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -68.95 120.85 79.05 Favored Pre-proline 0 N--CA 1.463 0.215 0 CA-C-O 120.574 0.226 . . . . 0.0 110.98 -177.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -83.85 178.43 5.44 Favored 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.684 2.256 . . . . 0.0 112.129 177.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -77.95 84.26 4.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.102 0.477 . . . . 0.0 110.51 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 69.8 t60 -121.21 141.23 51.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.037 -177.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -72.12 106.66 4.43 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 177.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 38.5 p90 -74.5 159.89 31.64 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.094 -175.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -156.14 130.92 9.06 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.719 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -100.33 145.51 30.39 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.305 -0.407 . . . . 0.0 109.966 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.09 105.37 0.68 Allowed 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.737 2.291 . . . . 0.0 111.395 174.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 -83.62 -34.58 25.07 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.299 -173.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 2.7 m -134.25 112.8 11.36 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.26 -175.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 28.6 m -112.97 -80.17 0.59 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 175.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 7.6 p -144.8 94.37 5.46 Favored Pre-proline 0 CA--C 1.531 0.246 0 CA-C-O 120.976 0.417 . . . . 0.0 111.544 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -71.98 -39.37 3.26 Favored 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 122.279 1.986 . . . . 0.0 112.128 174.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 50.0 tp 58.95 90.06 0.1 OUTLIER Pre-proline 0 N--CA 1.464 0.238 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.798 -177.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -60.34 -67.95 0.05 OUTLIER 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 122.711 2.274 . . . . 0.0 112.434 -178.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -161.26 159.74 29.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.576 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 4.9 m -98.94 96.05 4.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.545 0.688 . . . . 0.0 110.684 178.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 16.0 m -94.82 99.96 11.93 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.642 -178.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 130.7 -167.46 22.14 Favored Glycine 0 N--CA 1.446 -0.642 0 N-CA-C 111.462 -0.655 . . . . 0.0 111.462 -178.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.417 ' HA ' ' HD2' ' A' ' 223' ' ' PRO . 68.9 p 51.52 94.55 0.05 OUTLIER Pre-proline 0 N--CA 1.467 0.404 0 C-N-CA 123.753 0.821 . . . . 0.0 111.597 -178.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.417 ' HD2' ' HA ' ' A' ' 222' ' ' SER . 11.1 Cg_endo -54.38 106.92 0.19 Allowed 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.182 2.588 . . . . 0.0 112.78 -176.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -106.84 49.59 0.86 Allowed Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 111.249 -0.74 . . . . 0.0 111.249 178.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -149.85 175.45 11.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.54 -0.33 . . . . 0.0 110.338 -176.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -78.72 89.98 4.61 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.16 0.505 . . . . 0.0 110.345 177.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.768 ' H ' HD13 ' A' ' 227' ' ' ILE . 0.2 OUTLIER -96.48 4.37 9.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.586 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.458 ' HA ' ' HD3' ' A' ' 229' ' ' PRO . 4.6 p -84.28 142.56 40.92 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.369 -178.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 228' ' ' THR . 13.1 Cg_exo -71.02 176.76 7.27 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.872 2.381 . . . . 0.0 112.025 177.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.526 HD12 ' HD2' ' A' ' 231' ' ' PRO . 24.4 tp -147.77 141.99 16.2 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.622 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.526 ' HD2' HD12 ' A' ' 230' ' ' LEU . 87.1 Cg_exo -47.98 144.31 12.21 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.529 2.153 . . . . 0.0 111.235 171.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.3 89.49 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.552 0.692 . . . . 0.0 112.786 -171.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.472 ' HB ' ' ND2' ' A' ' 235' ' ' ASN . 8.7 p -141.76 86.83 2.02 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.774 -1.103 . . . . 0.0 108.608 174.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -82.25 25.32 0.61 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.61 -169.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . 0.472 ' ND2' ' HB ' ' A' ' 233' ' ' THR . 9.3 p30 -83.4 -16.72 44.83 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.509 0.671 . . . . 0.0 109.266 171.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . -97.64 -79.34 1.46 Allowed Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 115.056 -0.975 . . . . 0.0 111.556 176.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -92.1 116.41 0.4 Allowed 'Trans proline' 0 N--CA 1.451 -1.02 0 C-N-CA 122.976 2.45 . . . . 0.0 112.029 175.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 22.9 t -89.63 145.32 7.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 177.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.507 ' HB2' ' HG3' ' A' ' 296' ' ' PRO . 84.7 m-85 -108.78 119.72 40.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.077 0.465 . . . . 0.0 111.105 -177.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.579 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -119.66 140.93 49.86 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.691 178.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.515 ' HB2' ' CE1' ' A' ' 294' ' ' PHE . 47.5 tttp -95.07 123.44 38.56 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . 0.505 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -71.44 102.77 2.74 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.29 -0.414 . . . . 0.0 109.961 -179.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 2.3 pp -82.27 -5.56 9.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.923 0.392 . . . . 0.0 111.972 -174.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.445 ' HG2' ' H ' ' A' ' 245' ' ' LYS . 2.2 tt0 -146.95 164.32 33.33 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 176.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.445 ' H ' ' HG2' ' A' ' 244' ' ' GLN . 45.1 mttp -61.37 149.66 37.58 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 176.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.588 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 24.3 tpt180 -137.62 94.81 2.96 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 169.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 34.4 m -101.2 152.94 38.03 Favored Pre-proline 0 C--N 1.315 -0.919 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.709 -176.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.408 ' HD3' ' HB2' ' A' ' 257' ' ' ALA . 71.8 Cg_endo -74.53 -161.2 0.11 Allowed 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.424 2.083 . . . . 0.0 111.816 177.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 34.9 t -151.05 -179.22 7.13 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -175.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -64.37 -34.01 77.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.671 0.272 . . . . 0.0 111.254 -178.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -95.55 11.19 33.95 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.399 -179.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.33 131.96 47.29 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.505 0.669 . . . . 0.0 112.638 -175.222 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . 0.419 ' HE3' ' HB3' ' A' ' 253' ' ' LYS . 6.3 ptpp? -150.53 0.46 0.43 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.663 167.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 1.2 p -144.88 14.85 1.54 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.304 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -101.59 117.86 35.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.137 0.494 . . . . 0.0 110.494 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.423 HD21 ' HB ' ' A' ' 279' ' ' VAL . 0.7 OUTLIER -78.59 134.68 37.18 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.178 -178.228 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.588 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -93.9 121.22 35.14 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.201 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.539 ' HB2' ' HB3' ' A' ' 246' ' ' ARG . 79.9 mt -123.73 152.68 41.86 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.041 -175.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -102.47 177.74 4.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.038 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 59.2 t -90.18 111.83 23.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.195 0.521 . . . . 0.0 110.551 -179.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 98.39 9.18 53.85 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.188 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -82.84 166.4 19.0 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 -175.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 33.5 mm -104.67 110.82 31.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.255 0.55 . . . . 0.0 110.281 -177.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.489 HG22 HD22 ' A' ' 258' ' ' LEU . 14.0 t -96.44 108.75 21.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.806 -177.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 38.4 tttt -83.3 105.31 14.15 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.728 175.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.437 HG21 ' HB3' ' A' ' 275' ' ' TRP . 4.3 p -99.22 117.17 43.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.496 0.665 . . . . 0.0 110.605 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 12.1 m -94.94 -25.23 16.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.844 -176.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 268' ' ' ARG . 36.6 ttm180 -132.2 108.22 9.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.007 0.432 . . . . 0.0 110.954 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 32.1 mtt -94.75 126.95 40.4 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.657 178.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 274' ' ' GLN . 56.5 m-80 -99.9 153.56 19.06 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 177.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.585 ' H ' HD12 ' A' ' 271' ' ' ILE . 4.3 mp -72.73 -34.48 47.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.147 -172.005 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -62.67 -26.4 68.63 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.742 -176.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 127.92 -26.93 4.7 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.35 -0.929 . . . . 0.0 112.637 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.478 ' O ' ' HB2' ' A' ' 270' ' ' ASN . 45.3 mt-30 -78.92 115.5 18.65 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 177.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.517 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 49.9 m0 -96.24 150.9 20.03 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.816 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.44 ' HA ' ' O ' ' A' ' 284' ' ' GLY . 43.6 tt0 -108.93 109.58 20.69 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 175.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . 0.555 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -122.16 155.36 16.83 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.841 -178.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.572 ' HG2' ' HB3' ' A' ' 283' ' ' LYS . 23.2 mt-10 -104.58 109.0 20.73 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . 0.556 HG12 HD22 ' A' ' 280' ' ' ASN . 46.9 t -121.92 114.5 43.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -178.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . 0.556 HD22 HG12 ' A' ' 279' ' ' VAL . 67.2 m-80 64.77 27.6 13.0 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.896 -178.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 90.01 -10.78 72.83 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.417 179.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 44.5 ttt-85 -102.35 118.55 37.12 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.572 ' HB3' ' HG2' ' A' ' 278' ' ' GLU . 57.3 pttt -109.82 141.95 41.78 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.094 0.473 . . . . 0.0 111.188 179.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 276' ' ' GLU . . . -167.21 -174.79 36.68 Favored Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 -179.077 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.517 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 68.8 mt -90.2 138.66 31.34 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.162 0.506 . . . . 0.0 111.252 -177.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.446 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 46.1 p90 -142.74 131.58 11.69 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.711 173.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 17.6 Cg_exo -69.06 139.2 42.03 Favored 'Trans proline' 0 C--O 1.237 0.433 0 C-N-CA 122.902 2.401 . . . . 0.0 111.822 177.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -65.57 -4.64 6.36 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.663 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 2.4 m -74.42 -22.82 58.96 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.933 0.397 . . . . 0.0 111.088 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 41.0 m-70 -94.12 -11.58 30.22 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.848 0.356 . . . . 0.0 111.149 -176.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.505 HG12 ' HA ' ' A' ' 242' ' ' ALA . 34.8 m -128.02 167.5 22.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.057 -178.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -140.9 128.47 21.4 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.848 0.356 . . . . 0.0 110.727 175.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.579 HD13 ' HB2' ' A' ' 240' ' ' ALA . 41.0 mm -67.83 126.54 27.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.241 177.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' PHE . . . . . 0.515 ' CE1' ' HB2' ' A' ' 241' ' ' LYS . 1.4 p90 -141.14 -179.59 6.19 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.504 -178.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -101.6 96.09 5.96 Favored Pre-proline 0 C--N 1.322 -0.628 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 177.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . 0.507 ' HG3' ' HB2' ' A' ' 239' ' ' PHE . 43.0 Cg_endo -69.24 -46.26 1.52 Allowed 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.604 2.203 . . . . 0.0 113.112 -173.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . 0.477 ' HA ' ' OE1' ' A' ' 297' ' ' GLN . 6.3 tp60 -90.76 89.5 7.52 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.29 0.567 . . . . 0.0 109.924 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -121.43 113.84 32.0 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.406 176.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' PRO . . . . . 0.556 ' HA ' ' HB3' ' A' ' 302' ' ' ASN . 43.8 Cg_exo -57.56 -17.98 30.47 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 123.256 2.638 . . . . 0.0 112.104 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -54.81 -37.59 66.28 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.117 177.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -105.88 11.41 31.83 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.885 0.374 . . . . 0.0 110.832 179.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . 0.556 ' HB3' ' HA ' ' A' ' 299' ' ' PRO . 18.7 t-20 -113.27 -26.62 8.3 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.869 -176.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 67.5 mt-10 . . . . . 0 C--O 1.245 0.836 0 CA-C-O 118.723 -0.656 . . . . 0.0 109.731 176.44 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.0 mtt . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.7 p -103.58 127.63 50.97 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 174.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.547 ' HB2' HD12 ' A' ' 99' ' ' ILE . 13.7 p -55.53 -44.63 76.87 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.985 -175.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.98 110.76 4.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.378 177.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.548 ' CZ ' ' HA ' ' A' ' 5' ' ' ARG . 3.6 mmp_? -115.25 -5.72 12.38 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -172.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.435 ' H ' ' HD1' ' A' ' 6' ' ' PHE . 6.3 p90 -79.25 155.41 28.58 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.572 -0.451 . . . . 0.0 111.476 -174.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -66.24 -36.29 82.63 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.574 -176.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.1 t 65.39 37.88 6.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.335 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.8 m -152.34 -33.05 0.13 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.278 177.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -77.56 113.93 15.88 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.98 0.419 . . . . 0.0 111.285 -173.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -57.72 -45.35 85.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.201 -175.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 51.1 m -71.74 1.67 6.5 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -91.06 -42.07 10.71 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.601 176.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 22.4 p-90 -122.73 -29.07 4.07 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 -174.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -77.71 103.2 7.51 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.808 0.337 . . . . 0.0 111.554 -173.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.468 ' HB3' HG21 ' A' ' 19' ' ' VAL . 23.6 mmt -87.28 -6.53 58.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.288 -176.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 49.93 -115.54 3.17 Favored Glycine 0 CA--C 1.52 0.359 0 CA-C-N 115.629 -0.714 . . . . 0.0 113.306 -178.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -74.58 99.78 1.26 Allowed 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 122.475 2.116 . . . . 0.0 112.535 -176.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.62 HG13 ' HB3' ' A' ' 23' ' ' GLU . 3.5 t -130.11 -70.49 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.742 0 CA-C-O 118.243 -0.884 . . . . 0.0 111.73 -176.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 19' ' ' VAL . 22.9 t 108.46 161.32 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 125.126 1.371 . . . . 0.0 109.219 173.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 34.0 ttt85 -64.89 -38.81 92.23 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.801 0.334 . . . . 0.0 110.241 -177.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -64.9 -34.26 77.97 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.429 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.62 ' HB3' HG13 ' A' ' 19' ' ' VAL . 0.4 OUTLIER -84.21 -53.13 5.72 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.801 -174.565 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.503 ' HB2' ' HD3' ' A' ' 39' ' ' ARG . . . -56.05 -40.95 74.3 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.782 -178.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.58 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 55.0 tp60 -62.42 -44.53 96.22 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.569 -178.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.485 HG22 ' O ' ' A' ' 23' ' ' GLU . 9.1 t -75.69 -15.49 60.3 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 120.818 0.342 . . . . 0.0 111.055 -177.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.53 ' HG2' ' O ' ' A' ' 23' ' ' GLU . 52.2 mmm-85 -76.96 -19.59 57.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.922 0.392 . . . . 0.0 110.357 176.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.635 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 78.1 mt -128.84 -13.1 4.7 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 113.188 0.81 . . . . 0.0 113.188 -173.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.58 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -66.21 107.61 2.01 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.844 0.354 . . . . 0.0 110.757 -173.789 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.3 -2.24 67.2 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.822 -0.704 . . . . 0.0 113.331 175.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -78.31 -175.05 4.01 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.728 0.264 . . . . 0.0 110.587 179.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.606 ' HB3' ' SD ' ' A' ' 35' ' ' MET . 12.4 ttp180 -52.68 131.02 34.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.334 0.588 . . . . 0.0 110.827 -179.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.59 ' HB3' ' OE1' ' A' ' 54' ' ' GLU . 43.6 m170 -82.03 145.1 30.4 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.407 -175.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 105.35 -12.91 48.02 Favored Glycine 0 N--CA 1.451 -0.318 0 N-CA-C 111.606 -0.597 . . . . 0.0 111.606 -176.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.606 ' SD ' ' HB3' ' A' ' 32' ' ' ARG . 11.6 mtp -81.55 141.47 33.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.687 0.28 . . . . 0.0 110.737 178.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.504 ' HB2' HG22 ' A' ' 52' ' ' VAL . 33.1 p90 -143.24 167.43 22.15 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.691 -178.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.463 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.4 pp -158.08 138.52 12.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.155 0.503 . . . . 0.0 111.453 175.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.411 HG22 HD13 ' A' ' 50' ' ' LEU . 48.3 t -102.94 120.8 53.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 174.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.503 ' HD3' ' HB2' ' A' ' 24' ' ' ALA . 23.8 ptt-85 -125.94 -169.45 2.01 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.639 0.257 . . . . 0.0 110.71 -175.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -68.9 140.49 55.14 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.829 177.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 32.4 t -86.23 104.66 15.98 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 167.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 18.9 m -71.65 -11.4 60.82 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.378 -177.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 16.9 p -84.59 -29.74 25.57 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.996 0.427 . . . . 0.0 110.261 176.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 52.4 t -151.34 95.37 3.34 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.017 178.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -58.06 113.9 1.73 Allowed 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.922 2.415 . . . . 0.0 112.066 179.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 130.37 -33.04 2.97 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -174.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.595 ' OD2' ' HA ' ' A' ' 64' ' ' ASN . 2.6 m-20 -88.42 175.86 7.43 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 170.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.535 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 44.1 m-85 -136.17 175.58 9.47 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.857 -0.337 . . . . 0.0 111.407 -175.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 58.2 t -142.46 106.71 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.926 0.393 . . . . 0.0 110.67 176.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.411 HD13 HG22 ' A' ' 38' ' ' VAL . 46.7 tp -80.97 103.76 11.01 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.389 176.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 50.1 m -96.45 126.66 41.79 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 176.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 58' ' ' VAL . 95.4 t -121.76 135.89 60.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.754 -175.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.635 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 23.4 t -95.88 114.75 26.51 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 111.984 0.364 . . . . 0.0 111.984 -175.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.602 ' HG3' HD22 ' A' ' 55' ' ' ASN . 9.4 tp10 -151.48 154.7 37.08 Favored 'General case' 0 C--O 1.217 -0.617 0 C-N-CA 119.53 -0.868 . . . . 0.0 108.999 164.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.602 HD22 ' HG3' ' A' ' 54' ' ' GLU . 0.5 OUTLIER 45.4 37.52 3.01 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.537 0.735 . . . . 0.0 112.701 -177.666 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 34.5 m 49.38 56.09 8.35 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 122.403 1.097 . . . . 0.0 109.459 -178.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.523 ' HB2' ' O ' ' A' ' 55' ' ' ASN . 1.5 tmm_? -165.67 64.32 0.11 Allowed 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 113.312 -1.767 . . . . 0.0 109.33 -152.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 14.1 t -72.3 106.33 2.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.961 0.886 . . . . 0.0 110.353 -169.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 8.4 m -76.64 122.49 24.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 113.899 -1.5 . . . . 0.0 111.31 -177.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 60.2 m-70 -95.55 102.37 14.17 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.107 -177.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.674 ' OH ' ' HB3' ' A' ' 93' ' ' LEU . 70.8 m-85 -97.35 109.26 22.05 Favored 'General case' 0 C--O 1.221 -0.396 0 C-N-CA 123.079 0.552 . . . . 0.0 110.667 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.559 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 59.2 mt -80.03 128.88 38.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 112.162 0.43 . . . . 0.0 112.162 -173.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.629 HG23 ' HB3' ' A' ' 71' ' ' PHE . 3.1 mp -99.7 111.08 28.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.707 177.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.595 ' HA ' ' OD2' ' A' ' 47' ' ' ASP . 15.9 m120 -83.94 133.81 34.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.944 178.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 26.2 t -89.16 95.79 10.45 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.555 HD11 ' HB2' ' A' ' 72' ' ' LYS . 83.6 mt -81.07 147.79 62.25 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.247 -176.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -76.77 -9.38 18.3 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 122.932 2.421 . . . . 0.0 112.877 -179.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 35.2 p30 -81.19 7.85 10.25 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.575 0.702 . . . . 0.0 109.322 171.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.741 ' HA ' ' NE ' ' A' ' 69' ' ' ARG . 3.4 tpm_? 61.64 58.27 2.06 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 114.125 -1.398 . . . . 0.0 110.981 -176.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.873 ' HG2' ' HA ' ' A' ' 79' ' ' ASP . 79.4 mtt180 -135.41 176.73 8.41 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.24 172.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.629 ' HB3' HG23 ' A' ' 63' ' ' ILE . 52.2 m-85 -130.48 113.51 14.38 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.021 0.438 . . . . 0.0 109.83 176.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.593 ' HE2' ' HA ' ' A' ' 75' ' ' ASP . 36.0 tttm -98.19 105.02 17.1 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.981 -173.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.687 HD13 ' CE2' ' A' ' 88' ' ' TYR . 16.3 tt -81.0 79.35 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 122.18 0.99 . . . . 0.0 111.0 -176.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 76.78 -10.36 18.97 Favored Glycine 0 CA--C 1.52 0.378 0 CA-C-N 115.004 -0.998 . . . . 0.0 113.87 176.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.593 ' HA ' ' HE2' ' A' ' 72' ' ' LYS . 8.7 t70 177.28 -68.71 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 116.944 0.372 . . . . 0.0 110.321 -170.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -66.35 123.64 20.52 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.921 -179.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 77' ' ' GLU . 13.7 pt-20 -93.62 105.25 17.31 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.734 0.778 . . . . 0.0 110.728 177.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.478 ' CZ ' ' CD1' ' A' ' 87' ' ' PHE . 84.1 m-85 -95.03 152.25 18.48 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 174.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.873 ' HA ' ' HG2' ' A' ' 70' ' ' ARG . 8.3 m-20 -67.99 -23.24 65.0 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -171.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.624 ' ND1' ' HG2' ' A' ' 82' ' ' PRO . 6.0 p80 -162.36 165.47 26.44 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.736 -0.211 . . . . 0.0 110.438 -178.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.547 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 10.0 mt -55.99 -54.89 47.32 Favored Pre-proline 0 CA--C 1.535 0.377 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -178.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.624 ' HG2' ' ND1' ' A' ' 80' ' ' HIS . 15.4 Cg_endo -61.12 -4.17 3.65 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.183 1.922 . . . . 0.0 113.796 178.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.412 ' HB2' ' CE1' ' A' ' 80' ' ' HIS . . . -89.87 -34.94 15.91 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.762 0.315 . . . . 0.0 110.769 178.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.1 pp -76.94 -30.96 56.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.135 0.493 . . . . 0.0 109.838 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 70.1 mt -68.43 -21.56 64.65 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.491 179.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.548 ' OE2' ' HD2' ' A' ' 89' ' ' LYS . 18.8 tp10 -85.81 -35.43 20.68 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.183 176.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.547 ' HE1' ' CZ ' ' A' ' 88' ' ' TYR . 0.4 OUTLIER -71.56 -19.54 62.14 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 121.333 0.587 . . . . 0.0 111.436 -179.815 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.687 ' CE2' HD13 ' A' ' 73' ' ' ILE . 38.7 m-85 -94.96 5.47 51.83 Favored 'General case' 0 C--N 1.313 -0.98 0 O-C-N 121.685 -0.634 . . . . 0.0 111.769 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.548 ' HD2' ' OE2' ' A' ' 86' ' ' GLU . 96.2 mttt -77.52 -25.91 50.64 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.685 171.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.596 ' H ' HD13 ' A' ' 90' ' ' ILE . 0.3 OUTLIER -106.32 -17.67 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.112 0 CA-C-O 121.41 0.624 . . . . 0.0 109.756 174.148 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.489 ' HB2' ' O ' ' A' ' 87' ' ' PHE . 0.1 OUTLIER -93.97 106.41 18.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.78 178.771 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -72.46 104.23 3.74 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.756 -179.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.713 ' O ' ' HB3' ' A' ' 154' ' ' GLU . 16.5 mt -59.43 -31.02 68.9 Favored 'General case' 0 C--O 1.215 -0.757 0 O-C-N 124.356 1.035 . . . . 0.0 111.431 -176.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.483 ' HB3' ' HA ' ' A' ' 154' ' ' GLU . 24.5 p-10 -176.18 85.47 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 121.883 0.849 . . . . 0.0 110.532 164.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 71.78 -19.18 0.27 Allowed 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.592 -175.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 97' ' ' THR . 18.0 m -132.49 146.03 51.62 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-O 120.968 0.413 . . . . 0.0 110.625 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.44 ' O ' HG22 ' A' ' 96' ' ' THR . 37.4 p -96.16 -178.17 4.24 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.533 178.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.468 HD22 ' CD2' ' A' ' 36' ' ' PHE . 96.1 mt -70.84 106.3 3.55 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 174.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.547 HD12 ' HB2' ' A' ' 3' ' ' SER . 46.4 mm -89.86 -63.07 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.189 0.519 . . . . 0.0 110.422 -177.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.585 ' O ' ' HA ' ' A' ' 35' ' ' MET . 11.2 pt-20 -157.69 151.5 19.51 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.426 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.6 155.55 68.55 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.274 1.983 . . . . 0.0 112.362 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.563 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -69.07 146.56 97.25 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.476 179.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -57.61 130.92 41.25 Favored 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 122.618 2.212 . . . . 0.0 112.951 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -87.28 -31.76 20.07 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 172.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 57.2 m-85 -115.35 147.41 38.59 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.04 175.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.55 -8.71 15.79 Favored 'Trans proline' 0 CA--C 1.529 0.256 0 C-N-CA 122.853 2.368 . . . . 0.0 112.88 -177.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 35.6 m 54.8 67.44 3.26 Favored Pre-proline 0 CA--C 1.531 0.235 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.639 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.415 ' HB2' ' HD3' ' A' ' 109' ' ' PRO . 51.3 Cg_exo -53.3 -44.62 47.45 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 123.002 2.468 . . . . 0.0 114.147 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.415 ' HD3' ' HB2' ' A' ' 108' ' ' PRO . 32.1 Cg_exo -61.57 -22.55 74.74 Favored 'Trans proline' 0 C--N 1.362 1.263 0 C-N-CA 121.956 1.771 . . . . 0.0 112.56 176.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 54.2 ttm -89.91 68.2 7.31 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.43 0.633 . . . . 0.0 109.869 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -82.37 94.59 1.71 Allowed Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.502 178.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.1 p -149.25 168.7 22.57 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.584 0.23 . . . . 0.0 110.81 -176.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 4.3 p -113.62 107.51 23.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.493 0.663 . . . . 0.0 109.809 176.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.445 ' OG ' ' HD3' ' A' ' 32' ' ' ARG . 21.0 t -91.93 113.8 26.16 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.145 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -109.89 103.72 53.97 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.446 178.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -70.4 135.11 28.17 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.288 1.992 . . . . 0.0 111.852 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 47.9 m-80 -70.22 143.45 52.18 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.225 179.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 6.7 mp 58.83 78.06 0.37 Allowed Pre-proline 0 N--CA 1.462 0.168 0 O-C-N 123.925 0.766 . . . . 0.0 110.82 -178.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_exo -59.9 -74.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.119 1.879 . . . . 0.0 110.847 178.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.596 HG22 ' HB2' ' A' ' 122' ' ' GLU . 19.7 m 52.34 77.15 0.16 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 171.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -81.1 74.91 8.09 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 170.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.596 ' HB2' HG22 ' A' ' 120' ' ' THR . 7.4 tp10 -89.86 -32.56 16.83 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.293 -168.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.8 t70 61.02 -152.78 0.38 Allowed 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -171.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 64.87 -170.62 0.19 Allowed 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 118.278 0.49 . . . . 0.0 111.228 176.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.865 HD12 HG21 ' A' ' 152' ' ' ILE . 4.3 mm? 60.45 95.83 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 121.652 0.739 . . . . 0.0 110.814 178.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.71 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 4.9 tp10 -165.61 -74.28 0.03 OUTLIER 'General case' 0 C--O 1.218 -0.554 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.028 -169.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -108.17 110.95 22.71 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.036 0.446 . . . . 0.0 110.296 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.821 HG22 ' HG3' ' A' ' 180' ' ' LYS . 86.4 t -125.87 136.65 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.647 176.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.683 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 5.6 ptp180 -112.13 147.16 36.71 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 117.41 -1.716 . . . . 0.0 108.474 169.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.599 HG22 HG12 ' A' ' 178' ' ' VAL . 7.6 p -99.72 135.56 40.96 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.628 177.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.594 HD21 ' HG2' ' A' ' 179' ' ' GLU . 14.3 mt -108.41 3.0 22.8 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -177.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.449 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 27.0 t80 -99.94 -43.34 6.42 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.494 -0.483 . . . . 0.0 112.112 -174.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.669 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 14.5 t70 73.04 96.85 0.07 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.513 0.673 . . . . 0.0 109.888 -171.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.538 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 44.2 t80 -129.14 90.06 46.37 Favored Pre-proline 0 C--N 1.319 -0.722 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 174.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.59 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 92.7 Cg_endo -90.52 84.35 0.4 Allowed 'Trans proline' 0 N--CA 1.436 -1.862 0 C-N-CA 121.914 1.743 . . . . 0.0 112.358 -178.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -78.67 -2.37 85.31 Favored Glycine 0 C--N 1.329 0.191 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.217 176.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.456 ' H ' ' HB3' ' A' ' 143' ' ' PRO . 19.0 m120 36.16 71.04 0.14 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 113.872 -1.164 . . . . 0.0 112.461 -175.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.594 ' HB3' ' H ' ' A' ' 141' ' ' ASP . 0.4 OUTLIER -132.7 -176.59 4.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.22 0.533 . . . . 0.0 111.317 -177.394 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -112.17 1.75 16.37 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 167.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -115.41 -44.4 2.98 Favored 'General case' 0 C--O 1.221 -0.444 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.296 175.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.594 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 9.7 m-20 -98.36 127.61 44.37 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 166.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 1.038 HD11 ' HB2' ' A' ' 165' ' ' ASN . 24.6 tp -81.88 130.7 59.68 Favored Pre-proline 0 CA--C 1.518 -0.254 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.283 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.619 ' HD2' HD12 ' A' ' 142' ' ' LEU . 72.0 Cg_endo -84.0 92.04 0.82 Allowed 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 122.121 1.881 . . . . 0.0 112.292 174.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.538 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 1.5 p90 -90.89 179.73 5.69 Favored 'General case' 0 CA--C 1.504 -0.799 0 C-N-CA 120.217 -0.593 . . . . 0.0 109.817 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.669 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 16.3 mtpp -122.05 -176.6 3.38 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.294 172.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.757 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -78.65 36.78 0.27 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.798 0.809 . . . . 0.0 110.852 -174.635 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 145' ' ' LYS . . . 151.66 42.75 0.02 OUTLIER Glycine 0 N--CA 1.433 -1.554 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.32 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -103.84 147.11 27.68 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 119.352 -0.939 . . . . 0.0 109.993 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.6 mp -87.26 125.76 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.868 -177.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.77 HD22 ' CD2' ' A' ' 142' ' ' LEU . 33.8 mt -122.18 158.11 30.1 Favored 'General case' 0 N--CA 1.436 -1.132 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 -176.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.71 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 61.8 t -120.08 121.49 65.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 175.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 1.043 HD13 ' HB2' ' A' ' 163' ' ' ALA . 38.0 mm -77.18 79.31 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 CA-C-O 122.183 0.992 . . . . 0.0 108.682 -177.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.572 HD12 ' HD3' ' A' ' 164' ' ' ARG . 16.7 tt -71.43 -32.87 47.9 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 CA-C-N 113.856 -1.52 . . . . 0.0 109.09 -177.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.713 ' HB3' ' O ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -123.35 140.27 53.18 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.604 171.909 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -127.73 88.46 53.37 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 167.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.616 ' HG2' ' HE3' ' A' ' 172' ' ' MET . 0.9 OUTLIER -81.74 -46.75 0.07 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.224 2.616 . . . . 0.0 111.71 177.678 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.487 ' HB2' ' O ' ' A' ' 160' ' ' TRP . 33.8 mm-40 -102.94 161.67 13.57 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.928 -176.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -88.96 -27.41 20.93 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.452 0.644 . . . . 0.0 109.338 172.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -94.12 -18.76 21.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.249 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.651 ' HB3' ' HE1' ' A' ' 172' ' ' MET . 48.5 m95 -130.24 131.45 45.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.132 -178.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . 0.72 ' HB3' HD12 ' A' ' 152' ' ' ILE . 50.5 m0 -119.4 135.15 54.87 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -178.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.58 ' OG ' ' HG2' ' A' ' 172' ' ' MET . 21.6 m -99.6 95.0 6.68 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -174.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 1.043 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -104.03 147.21 27.65 Favored 'General case' 0 N--CA 1.418 -2.037 0 C-N-CA 119.815 -0.754 . . . . 0.0 109.075 -174.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.752 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 24.5 ptt-85 -86.44 123.24 31.44 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 175.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 1.038 ' HB2' HD11 ' A' ' 142' ' ' LEU . 6.1 t30 -55.09 172.04 0.13 Allowed 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 113.151 -1.841 . . . . 0.0 110.416 -172.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 36.5 tttp -58.21 -12.68 3.82 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.227 0.537 . . . . 0.0 110.039 174.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -83.5 -45.76 13.22 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.71 172.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 130.24 -9.62 5.93 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.959 -173.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.752 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.1 OUTLIER -62.56 132.47 52.53 Favored 'General case' 0 C--O 1.216 -0.703 0 C-N-CA 123.712 0.805 . . . . 0.0 112.373 179.489 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.442 HG22 HG21 ' A' ' 153' ' ' ILE . 78.8 t -85.81 122.25 38.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 O-C-N 122.462 -0.149 . . . . 0.0 110.906 177.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 162' ' ' SER . . . -153.59 149.37 20.85 Favored Glycine 0 CA--C 1.522 0.504 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.55 172.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.651 ' HE1' ' HB3' ' A' ' 160' ' ' TRP . 7.0 mtp -77.51 142.42 39.1 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.712 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.8 pp -143.77 144.94 28.94 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.42 -178.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.483 ' O ' ' HB2' ' A' ' 177' ' ' TYR . 21.7 Cg_exo -65.01 133.47 35.9 Favored 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 122.854 2.369 . . . . 0.0 113.181 -178.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.485 ' O ' HG22 ' A' ' 178' ' ' VAL . 60.2 t -63.24 -42.02 72.66 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 177.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.409 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 36.3 Cg_exo -62.3 1.32 0.98 Allowed 'Trans proline' 0 C--N 1.359 1.097 0 C-N-CA 122.164 1.91 . . . . 0.0 113.172 176.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.483 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.1 m-85 -103.16 -12.78 17.11 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.506 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.669 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 3.8 m -105.83 -172.82 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 -166.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.683 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 7.5 tp10 -160.23 50.97 0.3 Allowed 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 113.004 -1.907 . . . . 0.0 112.271 -152.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.821 ' HG3' HG22 ' A' ' 128' ' ' VAL . 2.2 mppt? -69.2 137.45 53.25 Favored 'General case' 0 N--CA 1.462 0.161 0 O-C-N 119.706 -1.871 . . . . 0.0 111.319 -159.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.697 ' HG ' HG23 ' A' ' 182' ' ' VAL . 13.0 tp -96.14 121.0 37.43 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 112.634 -2.076 . . . . 0.0 111.016 -170.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . 0.697 HG23 ' HG ' ' A' ' 181' ' ' LEU . 4.7 t 44.36 64.94 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 O-C-N 124.009 0.818 . . . . 0.0 111.649 175.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 3.9 ttp180 -87.37 146.88 25.7 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.925 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.499 ' HB3' ' HB2' ' A' ' 190' ' ' HIS . 0.3 OUTLIER -80.16 48.1 0.97 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.968 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 1.089 ' HB2' ' HD3' ' A' ' 186' ' ' PRO . 2.8 m -46.45 -74.35 0.07 OUTLIER Pre-proline 0 CA--C 1.545 0.76 0 O-C-N 123.997 0.811 . . . . 0.0 112.35 -166.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 1.089 ' HD3' ' HB2' ' A' ' 185' ' ' SER . 71.9 Cg_endo -103.82 26.88 0.1 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.133 1.889 . . . . 0.0 111.978 170.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.676 ' CD2' ' HD2' ' A' ' 186' ' ' PRO . 7.7 m170 -95.72 -44.32 7.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.822 0.344 . . . . 0.0 110.705 -173.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 80.87 116.99 0.37 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.6 -178.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 19.6 tptm 60.89 87.42 0.09 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.532 0.682 . . . . 0.0 111.099 178.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . 0.499 ' HB2' ' HB3' ' A' ' 184' ' ' SER . 53.8 t-80 -75.26 -43.51 51.04 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.473 179.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 80.98 -168.48 50.93 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 -172.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -166.69 166.03 16.15 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 62.1 mtp180 -100.05 -99.65 0.24 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 177.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 176.15 179.96 0.17 Allowed 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 42.5 t -157.91 -89.14 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . 0.435 HD22 ' N ' ' A' ' 196' ' ' ASN . 0.0 OUTLIER -171.75 142.16 1.51 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 176.132 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 8.7 t -115.33 92.24 3.86 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 176.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -115.29 -141.96 0.38 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.208 -176.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 78.35 47.66 8.01 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.406 -0.902 . . . . 0.0 110.857 -175.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 43.1 mm -98.48 127.93 34.56 Favored Pre-proline 0 C--N 1.323 -0.572 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -176.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -65.56 101.56 0.45 Allowed 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.597 2.198 . . . . 0.0 111.846 176.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -75.43 135.49 72.36 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.727 -179.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -70.62 165.22 32.67 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 122.64 2.227 . . . . 0.0 111.97 177.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -101.0 143.32 31.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.553 177.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . 0.421 ' HB3' ' O ' ' A' ' 208' ' ' ALA . 74.4 m80 -102.83 -45.97 4.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.393 178.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . 60.8 81.84 0.18 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.105 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 73.32 -32.95 0.25 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.375 177.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . 0.421 ' O ' ' HB3' ' A' ' 205' ' ' HIS . . . -81.53 74.63 8.52 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.109 0.48 . . . . 0.0 110.497 177.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.906 ' HB2' ' HD3' ' A' ' 210' ' ' PRO . 19.7 mm-40 -91.52 -58.93 0.23 Allowed Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.967 -178.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 0.906 ' HD3' ' HB2' ' A' ' 209' ' ' GLN . 89.8 Cg_endo -98.49 178.23 0.37 Allowed 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.499 2.133 . . . . 0.0 112.371 178.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -147.06 -33.8 0.28 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.193 174.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 4.4 m 63.82 41.27 6.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.059 -178.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 8.9 m -56.45 -43.07 79.16 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.629 177.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 16.9 m -117.13 104.49 50.46 Favored Pre-proline 0 N--CA 1.447 -0.58 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.873 174.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -60.34 -43.87 31.71 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.541 2.16 . . . . 0.0 111.715 178.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 216' ' ' LEU . 1.2 tm? -152.32 115.38 2.91 Favored Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_exo -61.88 95.77 0.14 Allowed 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.834 2.356 . . . . 0.0 112.273 -177.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -172.44 158.4 4.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.858 -176.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.747 HG13 ' H ' ' A' ' 220' ' ' SER . 2.6 p -136.05 -72.01 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 C-N-CA 121.069 -0.252 . . . . 0.0 111.406 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . 0.747 ' H ' HG13 ' A' ' 219' ' ' VAL . 14.6 t -177.08 -176.22 0.64 Allowed 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -178.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 175.2 173.32 40.88 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 121.104 -0.57 . . . . 0.0 111.866 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 20.7 t 64.69 92.45 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.213 0.53 . . . . 0.0 111.518 177.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.48 -178.27 4.34 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 123.068 2.512 . . . . 0.0 111.329 174.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 172.83 -165.64 38.05 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.17 -1.014 . . . . 0.0 112.493 178.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -83.59 84.9 7.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.89 0.376 . . . . 0.0 110.697 -179.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -85.36 -48.63 8.85 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.312 0.577 . . . . 0.0 109.545 175.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 64.4 mt -94.67 105.23 16.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.845 176.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 3.5 t -140.04 90.04 10.87 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-O 121.706 0.765 . . . . 0.0 110.866 179.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -81.33 -16.34 9.59 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.997 2.464 . . . . 0.0 112.388 178.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.741 ' H ' ' HD2' ' A' ' 231' ' ' PRO . 0.5 OUTLIER -154.45 -55.9 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.63 0 CA-C-O 119.162 -0.446 . . . . 0.0 111.792 -175.294 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.741 ' HD2' ' H ' ' A' ' 230' ' ' LEU . 0.9 OUTLIER -42.96 -66.48 0.15 Allowed 'Trans proline' 0 C--N 1.362 1.284 0 C-N-CA 123.357 2.705 . . . . 0.0 114.158 -174.228 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 20.4 t -91.16 90.33 7.75 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.068 0.461 . . . . 0.0 110.099 -177.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 17.2 p -142.87 157.21 44.82 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.645 177.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -100.87 -36.38 9.08 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 176.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 66.99 -168.2 0.2 Allowed 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.78 174.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 108.35 -135.96 13.18 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -177.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -81.3 132.85 8.34 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.478 2.119 . . . . 0.0 110.322 172.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.545 ' HB ' HG13 ' A' ' 266' ' ' VAL . 19.6 t -89.09 126.35 42.1 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-O 121.056 0.455 . . . . 0.0 110.425 -175.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -115.89 120.38 39.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.72 -177.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.571 ' HB2' HG13 ' A' ' 293' ' ' ILE . . . -120.34 145.05 47.5 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.262 178.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -95.1 120.69 35.75 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 175.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . 0.553 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -68.62 107.6 3.03 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.381 -179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.5 HD13 ' HD3' ' A' ' 292' ' ' LYS . 39.1 pt -85.17 -21.28 7.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.049 0.452 . . . . 0.0 110.611 -177.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 14.9 tt0 -134.85 147.12 49.81 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.487 -178.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . 0.453 ' HG2' ' HA ' ' A' ' 259' ' ' GLU . 10.7 mtmp? -63.32 156.9 24.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.519 0.676 . . . . 0.0 111.32 -176.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.531 ' HG3' ' O ' ' A' ' 256' ' ' LEU . 27.6 tpt180 -140.35 122.21 15.48 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.212 -0.904 . . . . 0.0 108.764 -179.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . 0.402 ' HA ' ' HD3' ' A' ' 248' ' ' PRO . 16.9 m -127.58 153.68 77.58 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-O 120.834 0.35 . . . . 0.0 111.613 -175.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.514 ' HB3' ' CG ' ' A' ' 252' ' ' ASP . 7.4 Cg_exo -72.92 159.35 48.29 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.966 2.444 . . . . 0.0 112.078 178.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' CYS . . . . . 0.477 ' SG ' ' N ' ' A' ' 250' ' ' ALA . 42.3 t -104.59 -175.63 2.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.875 -178.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.477 ' N ' ' SG ' ' A' ' 249' ' ' CYS . . . -58.85 -44.6 91.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.154 0.502 . . . . 0.0 110.506 176.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -91.43 31.94 1.11 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.809 178.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.514 ' CG ' ' HB3' ' A' ' 248' ' ' PRO . 2.9 t70 -60.92 112.75 2.18 Favored 'General case' 0 CA--C 1.51 -0.591 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.492 178.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -139.13 -6.77 1.39 Allowed 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.385 169.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -151.77 34.81 0.55 Allowed 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.376 176.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -112.54 100.62 8.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.201 0.524 . . . . 0.0 110.759 -179.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.531 ' O ' ' HG3' ' A' ' 246' ' ' ARG . 0.5 OUTLIER -67.13 146.76 53.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.977 -175.764 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -107.87 120.22 41.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.055 178.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.525 HD21 HG21 ' A' ' 279' ' ' VAL . 51.3 mt -136.39 152.75 50.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.536 -175.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . 0.453 ' HA ' ' HG2' ' A' ' 245' ' ' LYS . 0.9 OUTLIER -115.07 -176.39 2.9 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 172.657 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 51.1 t -81.29 120.91 33.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.569 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 111.08 2.78 28.17 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.001 -0.619 . . . . 0.0 113.054 177.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -90.88 146.74 23.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.814 0.34 . . . . 0.0 110.79 -178.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 24.3 mm -92.67 109.86 22.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.538 177.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 20.8 t -83.28 108.46 15.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.217 -179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -80.42 86.48 5.75 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.881 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.545 HG13 ' HB ' ' A' ' 238' ' ' VAL . 2.6 p -98.41 117.69 43.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.671 0.748 . . . . 0.0 110.656 -178.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 18.4 p -94.46 -49.66 5.58 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.303 -177.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 58.0 ttt180 -100.61 114.31 27.88 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 120.955 0.407 . . . . 0.0 111.06 -177.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' MET . . . . . 0.429 ' CE ' HG11 ' A' ' 238' ' ' VAL . 40.7 mtt -106.61 140.19 39.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.145 0.497 . . . . 0.0 110.735 174.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 22.4 p30 -119.78 -170.05 1.88 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.575 -175.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.434 ' N ' HD12 ' A' ' 271' ' ' ILE . 4.5 mp -95.81 -30.81 4.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.135 -174.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . 0.423 ' ND2' ' H ' ' A' ' 274' ' ' GLN . 3.5 p-10 -66.81 -23.39 66.05 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -173.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 115.21 -32.37 5.79 Favored Glycine 0 C--O 1.23 -0.128 0 C-N-CA 120.194 -1.003 . . . . 0.0 113.084 173.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.485 ' HB3' ' HB3' ' A' ' 285' ' ' LEU . 48.7 mt-30 -86.23 107.53 17.96 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 176.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.512 ' O ' ' HA ' ' A' ' 285' ' ' LEU . 12.7 m0 -92.22 157.61 16.6 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.106 -173.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -100.29 108.35 20.38 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.256 0.551 . . . . 0.0 109.857 179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -110.0 145.38 17.02 Favored Glycine 0 N--CA 1.44 -1.042 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.573 179.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -107.66 108.68 20.04 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.33 0.586 . . . . 0.0 110.042 177.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . 0.621 HG12 HD22 ' A' ' 280' ' ' ASN . 60.3 t -120.54 127.62 75.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.777 -178.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . 0.621 HD22 HG12 ' A' ' 279' ' ' VAL . 10.7 p30 47.91 33.02 3.05 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.18 0.992 . . . . 0.0 112.203 -178.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 81.37 25.85 53.3 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.773 177.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . 0.482 ' NH1' ' HA ' ' A' ' 256' ' ' LEU . 1.0 OUTLIER -137.85 125.72 22.59 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 178.643 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 24.1 pttm -101.36 142.82 32.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.978 -175.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -163.53 152.16 22.01 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.208 177.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.512 ' HA ' ' O ' ' A' ' 275' ' ' TRP . 90.9 mt -78.39 120.68 23.48 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.116 0.484 . . . . 0.0 110.372 176.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.408 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 43.8 p90 -118.24 146.24 38.95 Favored Pre-proline 0 C--N 1.32 -0.71 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.857 178.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . 0.409 ' HG2' ' CD2' ' A' ' 290' ' ' HIS . 20.9 Cg_endo -87.69 137.08 3.95 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.752 2.302 . . . . 0.0 111.948 -179.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -60.17 -14.95 19.97 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -175.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.08 -12.28 61.42 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.005 0.431 . . . . 0.0 111.358 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . 0.409 ' CD2' ' HG2' ' A' ' 287' ' ' PRO . 10.9 m170 -101.07 -15.91 17.27 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.362 -176.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.56 ' HB ' ' HB1' ' A' ' 240' ' ' ALA . 35.4 m -128.39 152.7 36.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.897 0.38 . . . . 0.0 111.33 -175.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . 0.5 ' HD3' HD13 ' A' ' 243' ' ' ILE . 3.2 mptp? -130.88 134.83 47.14 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 170.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.571 HG13 ' HB2' ' A' ' 240' ' ' ALA . 1.0 OUTLIER -88.43 122.58 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 CA-C-O 122.068 0.937 . . . . 0.0 112.029 -177.291 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' PHE . . . . . 0.582 ' O ' ' HD3' ' A' ' 296' ' ' PRO . 5.1 p90 -117.3 140.15 49.92 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 168.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -79.95 107.61 7.21 Favored Pre-proline 0 C--N 1.317 -0.833 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.297 178.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . 0.582 ' HD3' ' O ' ' A' ' 294' ' ' PHE . 91.0 Cg_endo -81.36 -2.69 11.73 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.666 2.244 . . . . 0.0 110.912 -177.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . 0.401 ' H ' ' HG2' ' A' ' 297' ' ' GLN . 21.2 pt20 -87.92 16.12 6.33 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.983 -1.008 . . . . 0.0 110.959 -178.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -146.09 131.48 9.22 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.593 171.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -88.3 27.12 0.55 Allowed 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.831 2.354 . . . . 0.0 112.159 177.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -81.57 -9.99 59.55 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.636 0.732 . . . . 0.0 110.121 -178.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -110.69 14.79 22.25 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.422 -0.808 . . . . 0.0 111.191 176.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -155.38 126.74 7.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.941 0.401 . . . . 0.0 111.584 -175.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 . . . . . 0 C--O 1.246 0.912 0 CA-C-O 118.239 -0.886 . . . . 0.0 109.501 174.738 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.3 ptp . . . . . 0 N--CA 1.483 1.19 0 CA-C-O 120.822 0.344 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.5 p -141.61 94.83 2.73 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 120.994 0.426 . . . . 0.0 111.29 -178.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.4 p -70.85 -33.08 70.28 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 169.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -81.45 102.48 10.56 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.18 175.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -115.2 77.35 1.07 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.549 0.69 . . . . 0.0 111.572 -177.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -157.61 151.61 24.39 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.843 -1.071 . . . . 0.0 108.171 176.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.425 ' HB3' ' HB2' ' A' ' 10' ' ' ASP . 16.9 t70 -85.41 126.91 34.16 Favored 'General case' 0 C--N 1.319 -0.732 0 C-N-CA 119.731 -0.788 . . . . 0.0 109.772 176.396 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.441 ' O ' ' HB3' ' A' ' 82' ' ' PRO . 5.3 t -68.67 -20.12 64.43 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.044 -174.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.9 t -97.8 -13.62 21.25 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.766 0.317 . . . . 0.0 110.909 -177.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.425 ' HB2' ' HB3' ' A' ' 7' ' ' ASP . 17.3 t70 -79.09 78.41 5.54 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.514 0.674 . . . . 0.0 109.412 -178.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.449 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 3.8 ptp180 -69.8 -14.69 62.89 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.179 -175.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.5 t -82.91 14.86 3.01 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.61 0.719 . . . . 0.0 109.333 173.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -115.25 -42.51 3.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.122 170.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.424 ' CE2' ' HA ' ' A' ' 11' ' ' ARG . 44.9 p-90 -108.45 -22.05 12.47 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -172.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.449 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 25.1 t80 -86.34 120.63 27.9 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.205 0.526 . . . . 0.0 110.108 -177.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.575 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 25.1 mmt -100.38 1.36 41.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.796 -172.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.441 ' HA3' ' HD3' ' A' ' 18' ' ' PRO . . . 51.0 -112.46 1.69 Allowed Glycine 0 CA--C 1.525 0.719 0 N-CA-C 114.368 0.507 . . . . 0.0 114.368 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.441 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 11.3 Cg_exo -72.4 55.22 2.5 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 124.191 3.26 . . . . 0.0 114.299 -172.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.751 HG12 ' H ' ' A' ' 20' ' ' SER . 59.5 t -104.18 -178.42 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 172.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.751 ' H ' HG12 ' A' ' 19' ' ' VAL . 23.4 t -165.38 176.49 8.24 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 -165.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 21.3 tpt180 -55.09 -55.7 28.12 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 120.684 0.278 . . . . 0.0 111.393 -174.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -59.11 -60.06 4.47 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.46 -177.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.425 ' HG2' ' HD2' ' A' ' 27' ' ' ARG . 25.6 tt0 -61.5 -46.03 91.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.679 -175.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.437 ' HB2' HG12 ' A' ' 19' ' ' VAL . . . -53.57 -49.23 68.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.962 0.41 . . . . 0.0 111.67 -175.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.613 ' HG3' ' HB ' ' A' ' 58' ' ' VAL . 12.5 tt0 -74.25 -37.25 63.81 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 120.117 -0.633 . . . . 0.0 111.183 -174.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.402 HG22 ' O ' ' A' ' 23' ' ' GLU . 7.4 t -70.42 -21.5 62.82 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 120.784 -0.367 . . . . 0.0 111.177 -177.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.425 ' HD2' ' HG2' ' A' ' 23' ' ' GLU . 56.4 mtp180 -82.79 -20.56 35.57 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.996 0.427 . . . . 0.0 110.736 178.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.638 HD21 ' HB2' ' A' ' 102' ' ' ALA . 13.0 mt -108.14 -15.74 14.43 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.95 179.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -84.71 130.24 34.72 Favored 'General case' 0 CA--C 1.504 -0.794 0 CA-C-O 121.243 0.544 . . . . 0.0 110.832 -173.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.522 ' C ' ' HG2' ' A' ' 32' ' ' ARG . . . 76.81 -3.38 56.45 Favored Glycine 0 C--N 1.314 -0.668 0 C-N-CA 119.914 -1.136 . . . . 0.0 112.747 178.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.5 ' HB2' ' CE ' ' A' ' 35' ' ' MET . 10.8 mt-30 -91.86 -52.17 4.86 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 172.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.743 ' CD ' ' HA ' ' A' ' 56' ' ' SER . 3.6 mmp_? 85.08 128.82 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 116.378 1.992 . . . . 0.0 116.378 152.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.731 ' CD2' ' HB3' ' A' ' 32' ' ' ARG . 9.0 m170 77.24 109.13 0.08 Allowed 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 112.657 -2.065 . . . . 0.0 113.021 157.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 101.84 -37.83 3.46 Favored Glycine 0 N--CA 1.453 -0.222 0 CA-C-N 114.981 -1.009 . . . . 0.0 112.842 173.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.518 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 33.4 mtm -70.5 141.48 51.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.794 0.331 . . . . 0.0 111.293 -177.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.433 ' CG ' HD22 ' A' ' 98' ' ' LEU . 37.7 p90 -143.93 160.8 40.19 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 172.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.575 ' HB2' ' CG ' ' A' ' 16' ' ' MET . 4.4 pp -153.91 139.57 17.93 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.172 0.511 . . . . 0.0 111.447 174.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 49.9 t -104.67 130.82 55.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.415 -0.811 . . . . 0.0 108.949 173.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.409 ' CB ' ' HB ' ' A' ' 19' ' ' VAL . 24.9 ptt-85 -127.9 175.97 7.95 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -177.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -80.89 137.6 36.16 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 170.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 23.3 t -78.95 97.3 5.98 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.196 0.522 . . . . 0.0 110.64 -176.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.22 -8.82 26.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.426 0.631 . . . . 0.0 110.483 174.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 2.5 p -97.95 -8.26 28.43 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.764 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.47 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 28.4 t -164.4 122.88 1.21 Allowed Pre-proline 0 C--N 1.333 -0.136 0 CA-C-O 120.589 0.233 . . . . 0.0 110.763 -177.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 44' ' ' CYS . 10.1 Cg_exo -71.53 119.41 6.23 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 123.048 2.499 . . . . 0.0 112.618 -179.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.07 25.34 17.25 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.019 178.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -134.35 163.17 30.26 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 177.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.565 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 25.3 m-85 -124.61 166.07 16.75 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 175.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.478 HG13 HD13 ' A' ' 62' ' ' ILE . 21.5 t -137.13 108.16 5.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.239 178.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 47.4 tp -84.18 102.02 12.29 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.373 -0.831 . . . . 0.0 109.864 175.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 51.0 m -95.61 124.39 39.61 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 177.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.684 HG21 HD13 ' A' ' 93' ' ' LEU . 58.0 t -114.67 139.89 38.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.271 0.558 . . . . 0.0 111.421 -173.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.419 ' HA ' HH22 ' A' ' 32' ' ' ARG . 47.0 t -98.46 103.33 15.27 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.74 -174.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.776 ' O ' ' HG3' ' A' ' 57' ' ' ARG . 6.3 tp10 -157.68 163.04 38.6 Favored 'General case' 0 C--O 1.213 -0.831 0 C-N-CA 119.223 -0.991 . . . . 0.0 110.33 171.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.758 ' ND2' ' HG3' ' A' ' 54' ' ' GLU . 0.0 OUTLIER 44.62 42.23 5.55 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.724 1.209 . . . . 0.0 112.813 -175.653 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.743 ' HA ' ' CD ' ' A' ' 32' ' ' ARG . 68.2 m 44.23 54.72 5.95 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 121.809 0.814 . . . . 0.0 111.028 -175.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.783 HH21 ' HA ' ' A' ' 154' ' ' GLU 0.341 0.0 OUTLIER -169.24 75.59 0.09 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 114.642 -1.163 . . . . 0.0 113.543 -154.384 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.613 ' HB ' ' HG3' ' A' ' 25' ' ' GLN . 14.9 t -69.14 108.12 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 O-C-N 119.475 -2.016 . . . . 0.0 110.355 -173.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.2 m -84.9 123.9 31.02 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.475 -178.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 36.1 m-70 -96.59 108.97 21.66 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.682 -174.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.607 ' HB3' HD11 ' A' ' 73' ' ' ILE . 79.1 m-85 -98.7 110.57 23.14 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 123.268 0.627 . . . . 0.0 111.118 178.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.664 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 40.3 mm -80.55 123.95 37.85 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -174.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.565 ' HB ' ' HB2' ' A' ' 48' ' ' TYR . 5.3 mp -102.68 112.54 36.39 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-O 120.797 0.332 . . . . 0.0 110.76 177.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.515 ' HB2' ' HB3' ' A' ' 72' ' ' LYS . 15.0 m120 -86.13 140.38 30.26 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.686 -176.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.3 t -86.52 101.15 12.92 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 169.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.885 HD12 ' HG3' ' A' ' 70' ' ' ARG . 91.9 mt -83.56 140.22 41.32 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.515 -178.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -63.65 -11.44 26.38 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.408 2.072 . . . . 0.0 110.678 172.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.54 ' HB2' ' HG2' ' A' ' 70' ' ' ARG . 2.9 m-20 -72.15 -2.48 18.8 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 114.913 -1.04 . . . . 0.0 110.114 174.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.87 ' HA ' ' HE ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER 67.09 35.02 4.76 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.858 -178.459 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.885 ' HG3' HD12 ' A' ' 66' ' ' LEU . 4.3 ptp180 -133.64 168.22 19.07 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.829 176.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.436 ' HB3' HG23 ' A' ' 63' ' ' ILE . 37.5 m-85 -114.0 124.23 51.65 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.977 0.418 . . . . 0.0 110.553 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.642 ' HB2' HD11 ' A' ' 66' ' ' LEU . 28.9 ttpp -108.73 95.88 5.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.287 -173.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.664 ' HA ' ' O ' ' A' ' 62' ' ' ILE . 3.8 tt -87.83 118.31 33.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.073 0.463 . . . . 0.0 110.747 -178.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 61.95 31.54 78.87 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.729 -179.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.526 ' HA ' ' HG2' ' A' ' 72' ' ' LYS . 31.2 t70 74.34 4.65 4.53 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.139 0.576 . . . . 0.0 111.47 -178.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -90.93 119.73 31.36 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 173.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -81.72 121.77 26.81 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.968 0.413 . . . . 0.0 111.487 -176.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.441 ' O ' ' HB2' ' A' ' 70' ' ' ARG . 87.3 m-85 -125.28 165.75 17.77 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 172.153 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -58.28 -49.25 77.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.132 0.491 . . . . 0.0 111.316 -179.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.486 ' ND1' ' HG2' ' A' ' 82' ' ' PRO . 4.7 p80 -164.0 -178.5 5.66 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.063 -177.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.522 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 14.2 mt -56.76 -57.05 26.56 Favored Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -176.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.486 ' HG2' ' ND1' ' A' ' 80' ' ' HIS . 24.0 Cg_endo -64.46 3.03 0.94 Allowed 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.237 1.958 . . . . 0.0 113.605 179.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -96.35 -36.27 10.91 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.868 0.366 . . . . 0.0 110.297 178.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.1 pp -76.48 -33.89 58.67 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.51 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 68.0 mt -66.74 -19.76 65.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.735 178.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -89.08 -37.9 14.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.444 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -71.32 -30.68 66.49 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.405 0.622 . . . . 0.0 110.382 -178.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.465 ' CG ' HD21 ' A' ' 93' ' ' LEU . 19.8 m-85 -82.57 -3.2 55.67 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.978 -0.556 . . . . 0.0 112.025 -178.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.51 ' HG3' ' O ' ' A' ' 85' ' ' LEU . 99.4 mttt -72.33 -13.06 61.39 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.523 174.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 16.7 pt -132.68 10.53 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.386 0 CA-C-O 121.37 0.605 . . . . 0.0 110.054 -177.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 3.2 t60 -107.0 -37.48 6.31 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.954 -175.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.496 ' CD2' HG23 ' A' ' 97' ' ' THR . 75.1 m-85 69.06 115.89 0.04 OUTLIER 'General case' 0 C--O 1.224 -0.279 0 O-C-N 124.227 0.954 . . . . 0.0 109.702 -173.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.684 HD13 HG21 ' A' ' 52' ' ' VAL . 1.2 mt -91.14 -7.64 50.99 Favored 'General case' 0 CA--C 1.514 -0.408 0 CA-C-O 121.516 0.674 . . . . 0.0 110.433 177.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.693 ' HA ' ' HB3' ' A' ' 154' ' ' GLU . 0.2 OUTLIER -144.61 -45.52 0.24 Allowed 'General case' 0 C--N 1.312 -1.05 0 CA-C-O 122.107 0.956 . . . . 0.0 111.032 -172.381 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.571 ' HB ' ' O ' ' A' ' 94' ' ' ASP . 5.6 t 152.45 -15.72 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 104.457 -2.423 . . . . 0.0 104.457 -167.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.1 m -117.81 145.83 44.27 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 112.878 -1.965 . . . . 0.0 108.162 177.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.496 HG23 ' CD2' ' A' ' 92' ' ' TYR . 27.4 p -94.94 171.49 8.73 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 174.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.433 HD22 ' CG ' ' A' ' 36' ' ' PHE . 92.7 mt -66.24 93.33 0.21 Allowed 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 177.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 39.9 mm -79.66 -61.05 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.969 -175.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.518 ' O ' ' HA ' ' A' ' 35' ' ' MET . 0.6 OUTLIER -160.58 150.1 14.19 Favored Pre-proline 0 N--CA 1.453 -0.312 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.121 178.452 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -65.86 163.41 30.93 Favored 'Trans proline' 0 CA--C 1.532 0.384 0 C-N-CA 122.91 2.407 . . . . 0.0 114.414 -172.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.638 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -63.83 155.47 77.17 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.475 176.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.419 ' HG2' HE22 ' A' ' 31' ' ' GLN . 84.1 Cg_exo -51.38 95.83 0.03 OUTLIER 'Trans proline' 0 CA--C 1.534 0.512 0 C-N-CA 123.116 2.544 . . . . 0.0 112.755 174.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.446 ' HG3' ' SD ' ' A' ' 16' ' ' MET . 49.5 ttt180 -71.08 -35.88 72.03 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 177.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -89.6 125.07 62.51 Favored Pre-proline 0 C--N 1.326 -0.449 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.046 175.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.7 106.77 1.15 Allowed 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.47 2.113 . . . . 0.0 112.285 179.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.484 ' HA ' ' HD3' ' A' ' 108' ' ' PRO . 27.2 m -98.61 134.28 21.85 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.482 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.494 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 16.8 Cg_exo -67.93 122.38 9.49 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.961 2.441 . . . . 0.0 112.139 179.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.494 ' HD3' ' HA ' ' A' ' 108' ' ' PRO . 2.8 Cg_exo -75.51 72.7 4.86 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 122.999 2.466 . . . . 0.0 111.629 178.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 52.3 ttp -73.44 -29.99 62.92 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.48 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -178.39 -168.32 37.57 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 9.3 p -67.3 110.32 3.49 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.978 0.418 . . . . 0.0 110.238 176.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 57.0 t -94.72 -61.45 2.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.007 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 31.7 p -131.9 -88.59 0.45 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.611 -177.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.572 ' HB1' ' HD3' ' A' ' 119' ' ' PRO . . . 49.12 64.24 9.0 Favored Pre-proline 0 N--CA 1.465 0.277 0 CA-C-O 121.141 0.496 . . . . 0.0 110.003 -171.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -58.96 -24.27 72.26 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.306 2.671 . . . . 0.0 114.123 -166.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -113.68 5.22 16.37 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.901 -174.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 50.4 tp 59.88 111.36 0.02 OUTLIER Pre-proline 0 N--CA 1.469 0.501 0 CA-C-O 121.059 0.457 . . . . 0.0 111.713 -175.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.572 ' HD3' ' HB1' ' A' ' 115' ' ' ALA . 38.5 Cg_exo -61.08 98.44 0.14 Allowed 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 122.724 2.282 . . . . 0.0 112.48 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.8 p -146.65 153.37 40.22 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.494 -177.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.572 ' HB3' ' HB2' ' A' ' 56' ' ' SER . . . 174.15 164.63 0.2 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.262 1.025 . . . . 0.0 108.811 174.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 123' ' ' ASP . 7.9 pt-20 -147.13 177.79 8.89 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -176.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.412 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 1.8 m-20 74.15 -104.62 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.093 -0.958 . . . . 0.0 112.801 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.491 ' HB3' ' HG3' ' A' ' 183' ' ' ARG . 28.0 t-20 -169.96 -87.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 110.52 -0.178 . . . . 0.0 110.52 -173.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.933 HD12 HG21 ' A' ' 152' ' ' ILE . 4.2 mm? 68.35 102.29 0.05 Allowed 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.527 0.68 . . . . 0.0 112.53 177.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 48.4 tt0 -172.65 -56.46 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 114.828 -1.078 . . . . 0.0 109.65 178.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -117.99 108.64 15.51 Favored 'General case' 0 CA--C 1.51 -0.582 0 C-N-CA 120.071 -0.651 . . . . 0.0 111.134 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.684 ' HA ' ' HA ' ' A' ' 180' ' ' LYS . 3.1 t -115.8 142.32 29.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.669 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 0.1 OUTLIER -115.38 145.01 42.94 Favored 'General case' 0 N--CA 1.431 -1.422 0 C-N-CA 116.623 -2.031 . . . . 0.0 108.688 160.493 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.561 HG22 HG12 ' A' ' 178' ' ' VAL . 0.8 OUTLIER -103.48 128.04 50.75 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 114.896 -1.047 . . . . 0.0 111.086 -177.601 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.543 HD21 ' HG2' ' A' ' 179' ' ' GLU . 20.3 mt -102.0 -24.0 14.04 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -174.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.496 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 46.8 t80 -82.03 -35.3 28.94 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.271 -0.571 . . . . 0.0 112.378 -172.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.665 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 9.7 t70 75.18 104.64 0.07 Allowed 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 121.423 0.63 . . . . 0.0 110.726 -175.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.474 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 63.9 t80 -129.77 88.85 48.1 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 175.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.663 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 60.4 Cg_endo -85.3 71.18 4.95 Favored 'Trans proline' 0 N--CA 1.451 -1.003 0 C-N-CA 122.039 1.826 . . . . 0.0 113.099 -176.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -66.72 -30.53 76.41 Favored Glycine 0 C--N 1.331 0.287 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.778 178.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.535 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 13.7 m-80 56.0 71.01 0.58 Allowed 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 114.862 -0.669 . . . . 0.0 110.718 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.569 ' HB3' ' H ' ' A' ' 141' ' ' ASP . 0.7 OUTLIER -145.6 -169.47 3.23 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.149 -174.442 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -110.73 -5.53 14.97 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 166.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -101.31 -56.88 2.2 Favored 'General case' 0 C--O 1.219 -0.52 0 CA-C-N 113.698 -1.592 . . . . 0.0 108.529 177.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.569 ' H ' ' HB3' ' A' ' 138' ' ' ASP . 3.4 m-20 -96.81 120.86 37.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.489 174.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 1.074 HD11 ' HB2' ' A' ' 165' ' ' ASN . 32.9 tp -76.68 130.13 77.34 Favored Pre-proline 0 N--CA 1.467 0.404 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 175.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.663 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 74.1 Cg_endo -82.28 94.04 0.9 Allowed 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 121.67 1.58 . . . . 0.0 111.966 172.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.565 ' HA ' ' OE1' ' A' ' 148' ' ' GLU . 12.2 p90 -106.58 153.7 21.97 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -176.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.665 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 88.9 mttt -103.16 -162.03 0.88 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -173.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.57 ' HD2' ' N ' ' A' ' 146' ' ' LYS . 9.0 mptt -81.98 -7.94 59.64 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.858 -166.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -167.83 27.5 0.15 Allowed Glycine 0 C--N 1.311 -0.825 0 C-N-CA 120.652 -0.785 . . . . 0.0 111.352 179.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.565 ' OE1' ' HA ' ' A' ' 144' ' ' PHE . 0.1 OUTLIER -78.99 154.39 29.55 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.071 0.462 . . . . 0.0 111.684 -177.157 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.651 HD12 ' HB3' ' A' ' 129' ' ' ARG . 0.5 OUTLIER -95.19 128.72 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.702 -177.961 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.7 HD22 HD21 ' A' ' 142' ' ' LEU . 61.8 mt -122.98 156.19 35.27 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -175.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.602 ' HB ' ' HG2' ' A' ' 164' ' ' ARG . 85.2 t -119.2 121.07 65.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 174.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 1.027 HD13 ' HB2' ' A' ' 163' ' ' ALA . 48.5 mm -76.88 91.75 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 CA-C-O 121.889 0.852 . . . . 0.0 108.711 -176.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.555 HG23 ' HG3' ' A' ' 154' ' ' GLU . 17.6 tt -79.95 -26.66 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.333 0 CA-C-N 114.237 -1.347 . . . . 0.0 109.696 -174.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.783 ' HA ' HH21 ' A' ' 57' ' ' ARG . 0.9 OUTLIER -134.7 144.9 48.04 Favored 'General case' 0 CA--C 1.519 -0.218 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 172.461 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.588 ' HD2' ' HG ' ' A' ' 125' ' ' LEU . 77.0 tttt -127.84 85.06 61.61 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-O 121.148 0.499 . . . . 0.0 109.914 164.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.522 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 13.2 Cg_exo -73.45 -41.33 1.22 Allowed 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.62 2.213 . . . . 0.0 112.28 175.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -121.7 176.84 5.52 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.931 -173.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -106.65 -0.98 23.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.777 0.798 . . . . 0.0 109.283 174.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -102.82 -36.68 8.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.801 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.545 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 31.1 m95 -127.03 144.71 50.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.932 176.072 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . 0.769 ' O ' HG13 ' A' ' 173' ' ' ILE . 49.3 m0 -125.75 138.98 53.89 Favored 'General case' 0 C--O 1.215 -0.756 0 C-N-CA 123.346 0.658 . . . . 0.0 109.776 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.532 ' HA ' ' HA ' ' A' ' 172' ' ' MET . 23.9 m -97.98 104.87 16.94 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -173.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 1.027 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -114.94 149.4 37.34 Favored 'General case' 0 N--CA 1.425 -1.687 0 C-N-CA 119.917 -0.713 . . . . 0.0 110.235 -176.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.698 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 13.0 ptt180 -87.48 122.33 31.07 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 171.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 1.074 ' HB2' HD11 ' A' ' 142' ' ' LEU . 14.4 t30 -52.8 172.19 0.05 Allowed 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 113.577 -1.647 . . . . 0.0 110.648 -175.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 48.1 tttp -63.75 -10.22 18.53 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.282 0.563 . . . . 0.0 109.554 173.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 36.3 m-20 -85.21 -27.02 26.38 Favored 'General case' 0 N--CA 1.46 0.073 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.332 171.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 108.73 -2.28 32.11 Favored Glycine 0 CA--C 1.522 0.49 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.677 -176.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.698 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 3.3 ttm-85 -74.3 132.79 42.39 Favored 'General case' 0 C--O 1.214 -0.815 0 C-N-CA 123.054 0.542 . . . . 0.0 111.798 -177.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 64.7 t -84.81 121.88 37.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 O-C-N 122.032 -0.418 . . . . 0.0 111.391 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -158.36 156.35 27.33 Favored Glycine 0 CA--C 1.526 0.759 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.578 173.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.545 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.0 OUTLIER -75.75 145.22 40.97 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 122.604 0.361 . . . . 0.0 111.479 -179.735 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.769 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.6 pp -144.69 145.62 28.86 Favored Pre-proline 0 C--O 1.221 -0.411 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.444 -177.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.512 ' HB2' ' CD1' ' A' ' 177' ' ' TYR . 10.3 Cg_exo -73.69 132.98 18.0 Favored 'Trans proline' 0 CA--C 1.527 0.126 0 C-N-CA 122.688 2.259 . . . . 0.0 112.889 -175.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.55 ' HB ' ' HD3' ' A' ' 176' ' ' PRO . 47.8 t -61.43 -45.71 94.45 Favored Pre-proline 0 CA--C 1.537 0.455 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.55 ' HD3' ' HB ' ' A' ' 175' ' ' VAL . 50.8 Cg_exo -57.55 -8.01 3.62 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.383 2.056 . . . . 0.0 113.643 175.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.512 ' CD1' ' HB2' ' A' ' 174' ' ' PRO . 3.0 m-85 -95.57 -11.49 27.24 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.622 -178.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.673 ' HB ' HG13 ' A' ' 128' ' ' VAL . 3.4 m -106.49 -174.08 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 -165.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.673 ' O ' ' HG3' ' A' ' 179' ' ' GLU . 8.2 tp10 -161.02 44.29 0.17 Allowed 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 112.477 -2.147 . . . . 0.0 111.152 -155.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.849 ' HD2' ' H ' ' A' ' 180' ' ' LYS . 0.0 OUTLIER -73.71 141.85 46.38 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 119.411 -2.056 . . . . 0.0 111.663 -163.49 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.488 ' HB2' HH22 ' A' ' 129' ' ' ARG . 18.0 tp -69.13 -84.72 0.03 OUTLIER 'General case' 0 C--O 1.231 0.094 0 CA-C-N 112.608 -2.087 . . . . 0.0 112.259 -161.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 26.5 m -89.02 137.86 20.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.401 178.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.528 ' NH1' ' HE3' ' A' ' 180' ' ' LYS . 37.2 ttt85 -167.73 162.07 13.71 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.222 0.534 . . . . 0.0 111.235 -176.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 47.0 p -141.67 115.07 8.89 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.366 173.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . 0.429 ' HA ' ' HD3' ' A' ' 186' ' ' PRO . 5.6 p -68.18 150.32 97.78 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 178.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 185' ' ' SER . 24.7 Cg_exo -63.57 87.08 0.13 Allowed 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.695 2.263 . . . . 0.0 112.547 -178.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 46.9 m80 -87.18 -4.34 59.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.989 176.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 104.84 -56.76 0.53 Allowed Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 -177.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -121.46 116.42 24.69 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 177.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -104.41 128.58 52.3 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.553 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.418 ' O ' ' HG3' ' A' ' 193' ' ' ARG . . . -95.67 -122.88 4.06 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 174.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 17.7 m120 59.33 27.72 16.87 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 122.641 0.377 . . . . 0.0 111.294 177.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' A' ' 191' ' ' GLY . 66.1 mtp180 -121.73 -30.72 4.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.724 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 66.53 98.47 0.05 OUTLIER 'General case' 0 C--O 1.234 0.271 0 O-C-N 123.891 0.744 . . . . 0.0 110.35 -172.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 8.8 t -91.32 -176.87 4.69 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.186 -176.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 62.37 38.34 13.09 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.925 0.869 . . . . 0.0 109.397 -177.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 10.5 t -122.01 110.83 16.29 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.212 -0.903 . . . . 0.0 110.067 -177.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 60.74 -161.98 0.28 Allowed 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.864 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 98.55 -42.13 2.11 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.51 177.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.573 HG22 ' HG3' ' A' ' 202' ' ' GLU . 47.9 mm -96.0 110.41 51.75 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 120.723 0.297 . . . . 0.0 110.236 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 200' ' ' ILE . 10.2 Cg_endo -90.11 97.24 0.28 Allowed 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 123.142 2.562 . . . . 0.0 112.37 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.573 ' HG3' HG22 ' A' ' 200' ' ' ILE . 43.0 mt-10 -124.94 99.99 34.16 Favored Pre-proline 0 C--N 1.326 -0.431 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.471 176.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -74.81 -80.71 0.01 OUTLIER 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 122.403 2.069 . . . . 0.0 111.974 177.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -164.98 136.81 4.27 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 177.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 -134.24 96.67 3.66 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.931 0.396 . . . . 0.0 110.581 -178.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -100.77 -65.4 0.97 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.848 177.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -129.72 -61.17 1.01 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.843 176.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . 55.0 -96.6 0.06 Allowed 'General case' 0 C--O 1.231 0.101 0 O-C-N 123.748 0.655 . . . . 0.0 110.096 -171.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.445 ' HA ' ' HD2' ' A' ' 210' ' ' PRO . 89.7 mt-30 -143.77 104.69 4.92 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 172.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 0.445 ' HD2' ' HA ' ' A' ' 209' ' ' GLN . 20.0 Cg_endo -61.69 -59.86 0.26 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.732 2.288 . . . . 0.0 112.357 -178.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -137.26 126.01 23.94 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 14.7 p -109.89 5.59 22.6 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -175.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 11.8 t -104.99 12.58 32.15 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 121.024 -0.27 . . . . 0.0 111.687 -175.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.539 ' H ' ' CD ' ' A' ' 215' ' ' PRO . 2.4 p -132.19 -45.02 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -178.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.539 ' CD ' ' H ' ' A' ' 214' ' ' THR . 18.2 Cg_exo -68.24 -43.37 4.6 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 121.863 1.709 . . . . 0.0 112.841 -177.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.83 ' HB2' ' HD3' ' A' ' 217' ' ' PRO . 5.8 mp -84.38 -58.8 0.36 Allowed Pre-proline 0 CA--C 1.536 0.427 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.748 -179.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.83 ' HD3' ' HB2' ' A' ' 216' ' ' LEU . 57.8 Cg_endo -97.35 114.87 0.11 Allowed 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.581 2.187 . . . . 0.0 112.523 176.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -81.15 102.98 10.64 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 176.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 29.8 m -110.56 144.5 18.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.58 -176.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 15.5 p -148.21 127.43 12.96 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.746 176.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -155.56 61.37 0.36 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.468 -0.873 . . . . 0.0 112.68 -176.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 47.8 m -115.55 109.43 45.87 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-O 120.704 0.288 . . . . 0.0 110.296 178.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -73.58 -11.47 24.31 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 123.126 2.551 . . . . 0.0 112.206 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -76.87 61.66 3.32 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.356 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -123.61 13.18 9.34 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.961 0.41 . . . . 0.0 110.326 178.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . . . . . . . . . . . -136.57 165.83 24.94 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.344 -178.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . . . . . . . . . 40.3 pt -70.01 -28.33 35.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.836 0.35 . . . . 0.0 110.747 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 31.7 m -135.91 88.69 22.27 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.84 177.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -83.0 164.0 15.49 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.549 2.166 . . . . 0.0 111.477 174.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.409 HD22 ' HA ' ' A' ' 230' ' ' LEU . 1.0 OUTLIER -103.29 103.83 37.35 Favored Pre-proline 0 C--N 1.32 -0.682 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 177.905 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.427 ' HG2' HG23 ' A' ' 233' ' ' THR . 88.4 Cg_endo -79.23 -169.98 0.91 Allowed 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.771 2.314 . . . . 0.0 111.759 -178.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 18.4 m -76.15 71.45 2.89 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.432 0.634 . . . . 0.0 110.57 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . 0.427 HG23 ' HG2' ' A' ' 231' ' ' PRO . 15.1 p -84.46 -60.73 1.99 Allowed 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.064 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 72.89 -33.77 0.28 Allowed 'General case' 0 N--CA 1.468 0.467 0 O-C-N 124.053 0.846 . . . . 0.0 111.544 179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . 0.426 ' H ' ' C ' ' A' ' 233' ' ' THR . 45.9 m-80 71.18 102.39 0.06 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.505 0.722 . . . . 0.0 111.084 175.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 102.28 114.37 3.86 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.869 -178.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -62.36 113.98 2.15 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.582 2.188 . . . . 0.0 111.347 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.418 ' CG1' HD12 ' A' ' 293' ' ' ILE . 13.2 t -66.85 136.48 26.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.18 -174.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.542 ' HB2' ' HG3' ' A' ' 296' ' ' PRO . 82.8 m-85 -98.63 125.51 43.93 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.971 178.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.516 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -118.21 148.53 42.29 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.417 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -92.31 125.29 36.91 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 177.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . 0.533 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -71.01 104.95 3.14 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 176.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.606 HD13 ' HG2' ' A' ' 292' ' ' LYS . 41.2 pt -88.0 0.82 6.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.936 0.398 . . . . 0.0 111.311 -174.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -155.79 146.47 22.05 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 177.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 15.7 pttm -66.41 109.16 2.62 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.57 0.7 . . . . 0.0 110.542 176.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.569 ' HB3' ' HB2' ' A' ' 258' ' ' LEU . 24.9 tpt180 -84.46 93.56 8.33 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.711 178.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 27.1 m -105.87 138.17 19.56 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.007 176.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.515 ' HB3' ' HB3' ' A' ' 255' ' ' ALA . 90.4 Cg_endo -80.62 148.72 18.19 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.471 2.114 . . . . 0.0 112.282 -179.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' CYS . . . . . 0.417 ' SG ' ' N ' ' A' ' 250' ' ' ALA . 41.8 t -92.74 -176.55 4.28 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 175.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . 0.417 ' N ' ' SG ' ' A' ' 249' ' ' CYS . . . -61.34 -24.0 66.14 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -175.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -102.75 -9.63 19.84 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.326 0.491 . . . . 0.0 112.326 -177.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -84.35 88.1 7.24 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.109 -178.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -87.21 -16.92 33.88 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.039 -178.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 10.2 p -110.3 7.12 22.94 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.622 -176.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.515 ' HB3' ' HB3' ' A' ' 248' ' ' PRO . . . -86.85 132.92 33.69 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.258 0.551 . . . . 0.0 111.328 -176.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.478 ' O ' ' HG3' ' A' ' 246' ' ' ARG . 1.0 OUTLIER -81.89 143.39 31.72 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 176.633 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -97.53 110.36 22.93 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.928 0.394 . . . . 0.0 110.329 178.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.569 ' HB2' ' HB3' ' A' ' 246' ' ' ARG . 65.5 mt -113.34 139.13 49.12 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.451 -175.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -91.67 137.61 32.22 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.726 173.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 2.5 p -67.37 119.21 12.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.163 0.506 . . . . 0.0 110.284 178.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 115.55 -3.26 21.72 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.266 -177.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -99.08 159.58 14.87 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -177.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 20.8 mm -87.38 122.76 39.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.062 0.458 . . . . 0.0 110.45 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.49 HG13 HG21 ' A' ' 279' ' ' VAL . 21.5 t -102.07 99.2 7.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.906 176.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -78.94 101.75 7.91 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.925 176.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . . . . . . . . . 5.5 p -88.27 123.73 40.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.293 0.568 . . . . 0.0 109.983 179.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 2.4 m -93.83 -35.11 12.88 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.47 -175.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . 0.494 ' HA ' ' NE ' ' A' ' 268' ' ' ARG . 3.2 mmp_? -132.6 112.74 12.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.923 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 41.3 mtt -87.83 121.52 30.35 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.455 175.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -95.78 155.55 16.7 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 178.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . 0.809 ' H ' HD13 ' A' ' 271' ' ' ILE . 0.2 OUTLIER -82.53 -8.61 11.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -172.522 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -80.63 -24.0 39.34 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.717 0.294 . . . . 0.0 111.077 -178.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 123.85 -21.86 6.96 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.569 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -94.97 123.2 38.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.056 0.455 . . . . 0.0 109.805 177.204 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 47.4 m0 -98.3 153.29 18.63 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.929 -176.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -105.45 105.69 15.84 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.492 176.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . 0.489 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -127.41 153.07 19.0 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.207 -178.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -107.46 108.62 20.03 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . 0.49 HG21 HG13 ' A' ' 264' ' ' VAL . 89.2 t -133.04 128.67 56.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.544 -175.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 84.1 m-20 59.83 27.5 16.83 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.262 176.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 92.19 -5.92 78.42 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.337 177.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 48.6 mtp180 -115.74 134.48 54.98 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 122.714 -0.286 . . . . 0.0 110.768 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 15.7 ptpt -112.87 131.01 55.9 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.038 0.447 . . . . 0.0 110.018 171.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -156.04 -175.79 27.43 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.51 -177.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 79.5 mt -98.63 124.31 43.36 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.422 0.629 . . . . 0.0 111.128 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . . . . . . . . . 42.2 p90 -129.59 135.05 26.93 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.68 177.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.88 140.08 28.33 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.381 2.054 . . . . 0.0 111.461 178.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -64.22 -8.5 12.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.775 -176.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -71.03 -16.6 62.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.045 0.45 . . . . 0.0 111.209 179.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -101.89 -8.31 21.7 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.827 -176.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.533 HG12 ' HA ' ' A' ' 242' ' ' ALA . 30.2 m -129.61 166.89 26.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.639 0.257 . . . . 0.0 110.783 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . 0.606 ' HG2' HD13 ' A' ' 243' ' ' ILE . 28.8 mmtp -137.48 136.26 37.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.966 0.412 . . . . 0.0 110.903 175.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.516 HD13 ' HB2' ' A' ' 240' ' ' ALA . 38.9 mm -82.17 101.85 7.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 174.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 11.3 p90 -105.81 -7.72 18.15 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.005 -174.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 59.48 93.03 0.06 OUTLIER Pre-proline 0 N--CA 1.464 0.249 0 O-C-N 123.72 0.637 . . . . 0.0 111.465 -176.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . 0.542 ' HG3' ' HB2' ' A' ' 239' ' ' PHE . 60.4 Cg_endo -73.95 59.9 4.45 Favored 'Trans proline' 0 C--O 1.233 0.272 0 C-N-CA 122.766 2.311 . . . . 0.0 111.4 175.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . 0.428 ' HB3' ' O ' ' A' ' 296' ' ' PRO . 8.4 tt0 78.22 -64.66 0.27 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.05 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . 0.41 ' HA ' ' HD2' ' A' ' 299' ' ' PRO . 88.5 m-20 62.36 95.76 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.254 0 O-C-N 123.845 0.716 . . . . 0.0 111.447 178.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 298' ' ' ASN . 33.2 Cg_endo -64.8 -21.92 64.14 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.618 2.212 . . . . 0.0 111.888 177.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . 0.485 ' O ' ' HB2' ' A' ' 301' ' ' GLU . 9.5 m-20 -70.62 89.35 0.72 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.923 -178.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 300' ' ' ASP . 33.4 tt0 165.3 -31.46 0.0 OUTLIER 'General case' 0 C--O 1.233 0.229 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.525 -177.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -78.34 73.19 4.9 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.166 -175.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 . . . . . 0 C--O 1.248 0.981 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 176.998 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 120.575 0.226 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 p -161.4 120.08 2.43 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-O 120.959 0.409 . . . . 0.0 111.197 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.6 t -76.13 -32.26 59.03 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 172.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.421 ' HB1' ' HE3' ' A' ' 89' ' ' LYS . . . -74.0 105.59 5.31 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.551 173.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -121.32 35.92 4.75 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.357 -172.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -117.51 157.45 26.27 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.107 -179.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -84.63 111.18 19.31 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 174.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.6 m -61.33 -15.49 36.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.911 -0.586 . . . . 0.0 112.183 -174.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 12.4 p -101.11 -20.88 15.15 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -177.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -77.11 93.99 3.98 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.943 -172.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.436 ' O ' ' HB3' ' A' ' 15' ' ' TYR . 13.4 mtm-85 -61.11 -28.68 69.27 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.464 -178.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.459 ' HA ' ' NH1' ' A' ' 104' ' ' ARG . 67.7 m -73.83 4.45 5.22 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 120.799 0.333 . . . . 0.0 111.504 178.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -106.29 -43.8 4.7 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 116.627 -0.261 . . . . 0.0 111.521 174.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . 0.478 ' HB3' ' HB3' ' A' ' 101' ' ' PRO . 19.9 p-90 -114.91 -20.22 10.64 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -172.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.436 ' HB3' ' O ' ' A' ' 11' ' ' ARG . 70.8 t80 -80.69 125.21 29.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.04 0.447 . . . . 0.0 110.92 -175.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.49 ' CG ' ' HB2' ' A' ' 37' ' ' LEU . 25.5 mmt -104.63 -6.18 20.72 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.182 -173.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 51.62 -113.36 2.34 Favored Glycine 0 CA--C 1.524 0.606 0 O-C-N 123.419 0.449 . . . . 0.0 113.738 -176.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -69.56 85.51 0.58 Allowed 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 122.924 2.416 . . . . 0.0 113.604 -176.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.468 ' HB ' ' HB2' ' A' ' 39' ' ' ARG . 85.9 t -140.3 156.85 24.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 175.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.583 ' HB3' ' OE1' ' A' ' 23' ' ' GLU . 34.4 t -127.39 -179.32 4.84 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 -171.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 45.6 ttt85 -62.05 -53.24 58.28 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 111.664 0.246 . . . . 0.0 111.664 -173.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.86 -43.13 93.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.729 0.3 . . . . 0.0 110.786 -177.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.583 ' OE1' ' HB3' ' A' ' 20' ' ' SER . 13.6 mp0 -60.22 -51.16 70.74 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.682 179.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.25 -40.87 78.54 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.649 0.737 . . . . 0.0 110.795 176.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.451 ' O ' ' HB2' ' A' ' 29' ' ' GLN . 33.4 tp60 -64.28 -44.28 92.18 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.979 -1.009 . . . . 0.0 111.441 -177.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 10.6 t -75.67 -31.25 59.69 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 111.655 0.242 . . . . 0.0 111.655 -176.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.484 ' O ' ' HG3' ' A' ' 31' ' ' GLN . 74.9 mtp180 -74.12 -13.21 60.79 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.711 0.291 . . . . 0.0 111.232 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.593 ' HB3' ' HB2' ' A' ' 53' ' ' SER . 79.8 mt -121.48 -6.0 9.27 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.503 -178.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 19.2 tp60 -65.24 103.34 0.77 Allowed 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.783 0.325 . . . . 0.0 111.127 -175.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.655 ' HA3' ' HB3' ' A' ' 119' ' ' PRO . . . 75.74 9.04 84.96 Favored Glycine 0 C--N 1.329 0.154 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.494 175.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.484 ' HG3' ' O ' ' A' ' 27' ' ' ARG . 13.4 mm100 -73.96 -164.91 0.26 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.998 0.427 . . . . 0.0 111.213 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.433 ' H ' ' HE3' ' A' ' 35' ' ' MET . 55.2 ttp180 -58.08 125.88 25.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.989 176.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.42 ' HB3' ' CD ' ' A' ' 54' ' ' GLU . 65.0 m170 -72.5 122.14 20.81 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.906 -178.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 108.89 -4.73 32.18 Favored Glycine 0 N--CA 1.445 -0.71 0 N-CA-C 110.986 -0.846 . . . . 0.0 110.986 -173.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.779 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 43.6 ttm -77.27 129.44 35.89 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 176.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.465 ' HB2' HG22 ' A' ' 52' ' ' VAL . 37.9 p90 -138.99 162.18 35.54 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.34 -177.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.527 ' HG ' HD11 ' A' ' 28' ' ' LEU . 4.6 pp -151.48 141.36 21.98 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.108 0.48 . . . . 0.0 110.777 174.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.5 t -107.59 118.79 56.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.59 176.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.468 ' HB2' ' HB ' ' A' ' 19' ' ' VAL . 23.4 ptt-85 -116.25 175.91 5.34 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.318 -176.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -77.7 127.56 32.64 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 173.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 33.8 t -71.61 121.55 18.97 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.693 -174.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.9 t -83.54 -18.71 37.45 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 170.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 27.2 m -62.59 -44.61 95.88 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.712 174.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.424 ' HA ' ' HD2' ' A' ' 45' ' ' PRO . 51.1 t -150.84 99.59 3.11 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.056 176.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 44' ' ' CYS . 10.3 Cg_endo -52.68 132.27 45.22 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.998 2.465 . . . . 0.0 112.213 -179.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 107.24 -34.68 5.52 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -175.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.621 ' OD2' ' HA ' ' A' ' 64' ' ' ASN . 2.7 m-20 -85.25 -177.49 6.51 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 175.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.416 ' HB2' ' HB ' ' A' ' 63' ' ' ILE . 27.9 m-85 -130.87 168.47 17.23 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.568 0.223 . . . . 0.0 110.971 -177.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 46.2 t -138.87 109.52 4.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.065 0.46 . . . . 0.0 110.82 174.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.429 ' CB ' HD11 ' A' ' 63' ' ' ILE . 40.5 tp -84.74 102.04 12.7 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.051 176.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 53.8 m -96.14 126.18 41.18 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 175.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.743 HG21 HD13 ' A' ' 93' ' ' LEU . 58.8 t -121.7 133.53 67.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.257 -175.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.593 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 41.6 t -87.43 121.45 29.88 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -176.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.649 ' HG3' ' HB3' ' A' ' 94' ' ' ASP . 0.6 OUTLIER -150.48 148.59 28.91 Favored 'General case' 0 C--O 1.209 -1.076 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.424 165.863 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 40.05 40.56 0.78 Allowed 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 114.173 1.175 . . . . 0.0 114.173 -176.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.678 ' OG ' ' HA ' ' A' ' 119' ' ' PRO . 7.2 m 57.25 49.86 12.62 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 122.139 0.971 . . . . 0.0 109.267 178.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.488 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 2.6 tmm_? -167.13 64.44 0.09 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 113.906 -1.497 . . . . 0.0 109.711 -151.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 46.6 t -71.6 113.89 9.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-O 122.004 0.906 . . . . 0.0 110.612 -166.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 2.0 m -76.86 120.73 22.41 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 113.915 -1.493 . . . . 0.0 110.807 -177.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -96.35 106.05 18.21 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -176.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.722 ' HB3' HD11 ' A' ' 73' ' ' ILE . 88.7 m-85 -105.7 109.26 21.15 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 122.853 0.461 . . . . 0.0 111.691 179.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 73' ' ' ILE . 66.3 mt -81.31 132.68 30.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -177.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.453 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 5.4 mp -110.07 117.8 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 122.779 0.432 . . . . 0.0 110.481 178.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.621 ' HA ' ' OD2' ' A' ' 47' ' ' ASP . 6.6 m120 -87.75 133.59 33.83 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.194 -175.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.7 t -86.8 96.63 10.25 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 170.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.4 mt -70.54 140.22 87.0 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.634 178.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.61 -21.39 31.14 Favored 'Trans proline' 0 CA--C 1.529 0.25 0 C-N-CA 122.86 2.373 . . . . 0.0 112.413 177.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -78.69 7.55 6.74 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.214 176.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.665 ' HA ' ' HE ' ' A' ' 69' ' ' ARG . 7.7 mmp_? 65.39 51.35 1.57 Allowed 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 121.738 0.78 . . . . 0.0 110.764 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.44 ' NH2' ' HB3' ' A' ' 77' ' ' GLU . 30.2 mtp180 -137.49 174.01 11.05 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.096 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.561 ' HA ' ' O ' ' A' ' 64' ' ' ASN . 47.2 m-85 -132.09 121.15 23.35 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.15 0.5 . . . . 0.0 111.694 -176.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 1.043 ' HD3' ' HG2' ' A' ' 77' ' ' GLU . 24.5 ttpt -111.91 119.33 38.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.513 176.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.722 HD11 ' HB3' ' A' ' 61' ' ' TYR . 2.9 tt -109.3 102.89 14.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-O 121.397 0.618 . . . . 0.0 111.068 -176.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 64.49 61.94 5.52 Favored Glycine 0 CA--C 1.519 0.314 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.4 177.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 30.6 t70 75.04 -28.63 0.19 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 122.976 0.51 . . . . 0.0 111.788 175.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -78.23 122.86 26.24 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.698 0.285 . . . . 0.0 110.579 175.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 1.043 ' HG2' ' HD3' ' A' ' 72' ' ' LYS . 30.6 mt-10 -95.53 126.26 40.7 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.792 0.329 . . . . 0.0 110.605 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -121.78 -169.81 1.94 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.747 -0.66 . . . . 0.0 109.388 177.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 -82.67 -56.78 3.65 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.07 0.462 . . . . 0.0 110.365 177.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.418 ' HA ' ' HD2' ' A' ' 71' ' ' PHE . 1.6 p80 -157.87 179.95 8.72 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.485 -176.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.655 ' HB2' ' HD3' ' A' ' 82' ' ' PRO . 19.6 mt -49.96 -59.17 7.42 Favored Pre-proline 0 N--CA 1.469 0.495 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.655 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 15.4 Cg_exo -68.85 -2.49 9.6 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 121.975 1.783 . . . . 0.0 112.743 -175.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -93.32 -36.71 12.4 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.063 176.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.4 pp -76.69 -34.68 58.19 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.12 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.565 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 76.2 mt -62.59 -38.01 88.46 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.834 177.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.583 ' HA ' ' HD3' ' A' ' 89' ' ' LYS . 14.4 tp10 -70.63 -34.13 71.75 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.912 -177.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 42.2 t80 -70.56 -37.8 74.05 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.321 0.582 . . . . 0.0 110.594 176.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.529 ' HE2' HD13 ' A' ' 73' ' ' ILE . 21.3 m-85 -78.32 -19.77 52.85 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.743 -177.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.583 ' HD3' ' HA ' ' A' ' 86' ' ' GLU . 50.0 mtpt -62.34 -20.18 64.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.685 172.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 23.9 pt -121.04 18.58 5.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 120.58 -0.448 . . . . 0.0 112.105 175.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 6.6 t-160 -106.14 -33.23 7.92 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.887 0.375 . . . . 0.0 110.559 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.567 ' N ' HG22 ' A' ' 97' ' ' THR . 52.9 m-85 66.61 91.63 0.08 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.284 -168.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.743 HD13 HG21 ' A' ' 52' ' ' VAL . 12.7 mt -60.81 -8.45 3.05 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.989 0.9 . . . . 0.0 110.506 173.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.649 ' HB3' ' HG3' ' A' ' 54' ' ' GLU . 16.1 t70 -161.68 -108.59 0.02 OUTLIER 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 174.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 1.8 t -117.6 15.56 14.58 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.638 -0.825 . . . . 0.0 111.198 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.462 HG23 ' O ' ' A' ' 97' ' ' THR . 13.3 t -139.71 -19.39 0.93 Allowed 'General case' 0 C--N 1.349 0.544 0 C-N-CA 118.192 -1.403 . . . . 0.0 114.326 -177.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.567 HG22 ' N ' ' A' ' 92' ' ' TYR . 6.6 p 74.95 -164.1 0.08 Allowed 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.845 0.858 . . . . 0.0 109.989 -171.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 42.7 mt -89.6 111.29 22.19 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 175.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.412 HD11 ' O ' ' A' ' 96' ' ' THR . 51.3 mm -105.19 -58.07 4.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -173.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.779 ' O ' ' HA ' ' A' ' 35' ' ' MET . 4.7 tp10 -153.72 131.27 6.13 Favored Pre-proline 0 C--N 1.323 -0.557 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 -174.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.478 ' HB3' ' HB3' ' A' ' 14' ' ' TRP . 28.3 Cg_endo -62.8 166.43 13.95 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 122.764 2.309 . . . . 0.0 112.896 -179.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.403 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -75.62 148.17 82.42 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.648 176.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.33 106.62 0.31 Allowed 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 122.562 2.175 . . . . 0.0 112.628 -177.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . 0.459 ' NH1' ' HA ' ' A' ' 12' ' ' SER . 24.1 ttp180 -90.07 -9.97 46.49 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 174.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -117.27 114.85 38.39 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.643 177.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.8 129.31 20.65 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 122.693 2.262 . . . . 0.0 112.555 -179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.737 ' HB3' ' HD3' ' A' ' 108' ' ' PRO . 40.7 t -139.88 -56.86 0.02 OUTLIER Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.394 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.737 ' HD3' ' HB3' ' A' ' 107' ' ' SER . 91.7 Cg_endo -87.2 161.79 8.51 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 121.888 1.725 . . . . 0.0 112.012 177.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 108' ' ' PRO . 10.3 Cg_endo -91.06 -163.86 0.13 Allowed 'Trans proline' 0 N--CA 1.448 -1.157 0 C-N-CA 123.015 2.477 . . . . 0.0 111.758 176.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 3.8 mpp? -69.08 -23.0 63.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.679 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -78.44 58.86 4.09 Favored Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 116.05 -0.523 . . . . 0.0 112.545 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 57.8 m -114.39 105.15 12.79 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 176.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.8 p -118.24 -26.48 2.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.172 0.511 . . . . 0.0 110.854 -177.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 32.8 t -87.04 -21.32 26.17 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.797 -177.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.492 ' HB3' ' HD3' ' A' ' 116' ' ' PRO . . . -74.2 -53.3 3.83 Favored Pre-proline 0 CA--C 1.536 0.432 0 CA-C-N 116.209 -0.45 . . . . 0.0 112.111 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.492 ' HD3' ' HB3' ' A' ' 115' ' ' ALA . 81.1 Cg_endo -78.58 167.19 23.0 Favored 'Trans proline' 0 C--N 1.356 0.931 0 C-N-CA 121.736 1.624 . . . . 0.0 112.294 178.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -92.23 1.39 57.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.458 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 88.8 mt 76.03 131.69 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.368 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.943 173.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.678 ' HA ' ' OG ' ' A' ' 56' ' ' SER . 74.5 Cg_endo -76.97 136.94 17.01 Favored 'Trans proline' 0 CA--C 1.533 0.432 0 C-N-CA 122.886 2.39 . . . . 0.0 113.236 -178.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.777 HG23 ' H ' ' A' ' 121' ' ' ALA . 2.1 t -158.42 -74.08 0.08 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.993 175.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.777 ' H ' HG23 ' A' ' 120' ' ' THR . . . 56.15 -157.54 0.25 Allowed 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 175.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -132.28 -178.6 4.98 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 175.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -87.4 33.15 0.69 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.132 0.491 . . . . 0.0 111.902 -170.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.541 ' O ' ' HB2' ' A' ' 125' ' ' LEU . 4.7 p30 -167.57 -155.59 0.18 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 122.03 -0.419 . . . . 0.0 110.599 -177.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 0.601 HD12 HG21 ' A' ' 152' ' ' ILE . 1.0 OUTLIER 80.67 88.07 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.797 0.839 . . . . 0.0 111.36 -174.705 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.685 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 28.0 tt0 174.92 -52.33 0.01 OUTLIER 'General case' 0 C--O 1.22 -0.488 0 CA-C-N 114.005 -1.452 . . . . 0.0 109.26 179.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -110.97 105.93 14.87 Favored 'General case' 0 CA--C 1.511 -0.55 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.416 178.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.698 HG22 ' CG ' ' A' ' 180' ' ' LYS . 41.5 t -120.93 127.71 75.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.982 -178.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.605 ' O ' ' HG2' ' A' ' 179' ' ' GLU . 9.3 ptp180 -109.11 140.05 43.19 Favored 'General case' 0 C--O 1.22 -0.452 0 C-N-CA 117.336 -1.745 . . . . 0.0 110.267 173.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.78 HG22 HG12 ' A' ' 178' ' ' VAL . 1.4 p -98.54 139.91 33.57 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.285 -179.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.867 ' CD1' ' HG3' ' A' ' 179' ' ' GLU . 62.9 mt -126.39 1.94 6.99 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -178.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.521 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 36.7 t80 -93.46 -33.98 13.6 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.677 178.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.586 ' OD1' ' HA ' ' A' ' 145' ' ' LYS . 11.7 t70 74.51 101.3 0.07 Allowed 'General case' 0 N--CA 1.467 0.411 0 O-C-N 123.916 0.76 . . . . 0.0 109.868 -177.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.622 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 70.3 t80 -131.61 87.99 44.35 Favored Pre-proline 0 N--CA 1.446 -0.667 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.738 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 97.1 Cg_endo -79.08 88.3 1.47 Allowed 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 121.729 1.62 . . . . 0.0 112.49 179.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -81.72 -31.76 32.0 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.89 177.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.796 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 21.8 m120 66.89 35.68 4.74 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.027 0.531 . . . . 0.0 111.563 177.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.454 ' HB3' ' H ' ' A' ' 140' ' ' GLU . 2.6 m-20 -136.39 172.81 12.46 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.734 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.637 ' O ' ' HA2' ' A' ' 171' ' ' GLY . . . -86.88 -13.79 43.86 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.642 0.734 . . . . 0.0 109.498 171.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.676 ' O ' ' HB2' ' A' ' 172' ' ' MET . 3.4 mp0 -94.83 -18.59 21.06 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.635 176.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -139.77 102.29 4.4 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 176.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 1.037 HD11 ' HB2' ' A' ' 165' ' ' ASN . 49.9 tp -64.46 129.54 94.23 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -178.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.796 ' HG3' ' HA ' ' A' ' 137' ' ' ASN . 27.8 Cg_endo -81.92 88.62 1.3 Allowed 'Trans proline' 0 N--CA 1.439 -1.69 0 C-N-CA 121.239 1.292 . . . . 0.0 111.535 174.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.622 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 20.5 p90 -108.06 165.5 11.42 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.389 -173.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.586 ' HA ' ' OD1' ' A' ' 133' ' ' ASP . 37.0 mttp -109.49 -173.76 2.34 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.253 0.549 . . . . 0.0 111.853 -175.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.754 ' HD2' ' H ' ' A' ' 146' ' ' LYS . 0.0 OUTLIER -89.09 21.29 3.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.322 -174.846 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.453 ' HA2' HD23 ' A' ' 131' ' ' LEU . . . -179.96 35.03 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.121 177.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -107.68 150.25 27.16 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.58 -0.448 . . . . 0.0 111.073 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.526 HG13 ' HB3' ' A' ' 129' ' ' ARG . 1.9 mp -98.32 131.22 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -177.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.81 HD22 HD21 ' A' ' 142' ' ' LEU . 7.7 mt -122.3 169.51 10.86 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -175.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.685 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 74.1 t -128.98 122.4 56.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 110.422 -0.214 . . . . 0.0 110.422 178.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 1.086 HD13 ' HB2' ' A' ' 163' ' ' ALA . 45.8 mm -75.84 98.59 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -174.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.52 HG21 HG22 ' A' ' 170' ' ' VAL . 19.9 tt -96.07 -32.74 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.581 -173.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.573 ' OE2' ' HA ' ' A' ' 93' ' ' LEU . 7.7 mt-10 -115.93 140.05 49.63 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 167.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.704 ' HE3' ' HE1' ' A' ' 161' ' ' TRP . 83.7 tttt -127.84 73.66 78.77 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 121.901 -0.499 . . . . 0.0 110.944 170.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.512 ' HG2' ' HE2' ' A' ' 172' ' ' MET . 39.9 Cg_exo -61.19 -42.1 38.03 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.439 2.092 . . . . 0.0 112.183 175.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -124.91 -177.91 4.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.4 -175.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.463 ' O ' HG21 ' A' ' 175' ' ' VAL . 0.2 OUTLIER -108.5 -10.92 15.21 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 173.537 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -93.62 -30.95 14.69 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.555 177.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.57 ' CH2' ' HG3' ' A' ' 174' ' ' PRO . 65.0 m95 -124.06 141.71 51.82 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.409 174.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . 0.835 ' HB3' HD12 ' A' ' 152' ' ' ILE . 43.9 m0 -132.52 137.97 47.35 Favored 'General case' 0 C--O 1.21 -1.021 0 CA-C-N 115.628 -0.715 . . . . 0.0 110.238 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.593 ' HA ' ' HA ' ' A' ' 172' ' ' MET . 19.0 m -93.34 99.34 11.89 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -174.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 1.086 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -109.09 143.17 38.79 Favored 'General case' 0 N--CA 1.419 -1.996 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -171.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.8 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 11.1 ptt180 -86.35 119.46 26.64 Favored 'General case' 0 N--CA 1.434 -1.273 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 176.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 1.037 ' HB2' HD11 ' A' ' 142' ' ' LEU . 16.4 t30 -50.75 170.12 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 113.117 -1.856 . . . . 0.0 111.543 -174.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -66.7 -9.14 33.24 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.49 0.662 . . . . 0.0 109.392 174.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -85.91 -18.7 31.99 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.259 171.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 86.29 56.87 2.2 Favored Glycine 0 CA--C 1.52 0.397 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.422 -174.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.8 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 4.2 ttm-85 -136.61 135.0 37.97 Favored 'General case' 0 C--O 1.216 -0.669 0 N-CA-C 110.305 -0.258 . . . . 0.0 110.305 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.566 ' O ' ' HA ' ' A' ' 139' ' ' ALA . 43.0 t -79.66 124.95 38.48 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 C-N-CA 121.055 -0.258 . . . . 0.0 111.375 -178.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.637 ' HA2' ' O ' ' A' ' 139' ' ' ALA . . . -160.86 150.78 20.93 Favored Glycine 0 C--N 1.334 0.432 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.856 169.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.676 ' HB2' ' O ' ' A' ' 140' ' ' GLU . 1.5 mmt -67.18 138.2 56.82 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 117.515 0.657 . . . . 0.0 111.187 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.799 HD13 HG11 ' A' ' 178' ' ' VAL . 2.8 pp -134.1 140.06 35.01 Favored Pre-proline 0 N--CA 1.443 -0.799 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.271 179.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.734 ' HB2' ' HB2' ' A' ' 177' ' ' TYR . 26.3 Cg_exo -67.77 128.81 18.56 Favored 'Trans proline' 0 C--O 1.212 -0.779 0 C-N-CA 123.243 2.629 . . . . 0.0 112.871 -179.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.532 ' C ' ' H ' ' A' ' 177' ' ' TYR . 88.0 t -64.72 -45.09 75.4 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 178.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 39.5 Cg_endo -67.63 8.96 0.37 Allowed 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 121.996 1.798 . . . . 0.0 111.933 175.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.734 ' HB2' ' HB2' ' A' ' 174' ' ' PRO . 1.5 m-85 -111.79 -5.34 14.42 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.256 -1.338 . . . . 0.0 109.649 -175.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.799 HG11 HD13 ' A' ' 173' ' ' ILE . 2.7 m -133.28 171.24 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-O 123.596 1.665 . . . . 0.0 114.717 -167.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.867 ' HG3' ' CD1' ' A' ' 131' ' ' LEU . 2.7 mm-40 -140.64 51.88 1.64 Allowed 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 110.612 -2.995 . . . . 0.0 110.635 -155.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.698 ' CG ' HG22 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -69.69 136.78 51.47 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 120.209 -1.557 . . . . 0.0 109.894 -166.733 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 20.7 tp -63.16 -79.85 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 112.329 -2.214 . . . . 0.0 113.244 -156.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 40.5 t -78.53 88.09 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.858 0.361 . . . . 0.0 110.349 -176.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . 0.509 ' HE ' ' ND2' ' A' ' 124' ' ' ASN . 24.3 ttt180 -146.51 -100.29 0.09 Allowed 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.491 177.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.447 ' H ' ' HB3' ' A' ' 183' ' ' ARG . 33.9 t 55.91 93.88 0.02 OUTLIER 'General case' 0 C--O 1.233 0.225 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -167.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 4.4 p -52.67 156.98 2.84 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.076 -177.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -48.79 99.96 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.877 2.385 . . . . 0.0 113.074 -177.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -119.31 -51.99 2.29 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.66 -0.866 . . . . 0.0 108.66 174.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 115.27 -71.31 0.25 Allowed Glycine 0 N--CA 1.446 -0.662 0 CA-C-N 114.911 -1.041 . . . . 0.0 110.573 -178.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -109.97 104.44 13.35 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 174.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 74.8 t60 -136.97 -40.55 0.6 Allowed 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 121.004 -0.278 . . . . 0.0 111.056 -176.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 91.32 -129.87 10.01 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.787 -0.721 . . . . 0.0 113.122 178.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 12.3 m120 68.22 168.77 0.27 Allowed 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 123.566 0.747 . . . . 0.0 111.812 -176.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 20.9 ttm180 70.06 1.4 3.49 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.631 -177.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -100.47 84.63 2.81 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 176.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.822 ' HA ' ' CD1' ' A' ' 198' ' ' TYR . 23.3 t -159.87 118.0 2.69 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.01 0.434 . . . . 0.0 111.1 -178.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -135.6 -59.51 0.76 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.989 -0.551 . . . . 0.0 109.537 172.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 24.6 m -92.98 -4.37 52.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.685 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.822 ' CD1' ' HA ' ' A' ' 195' ' ' SER . 71.1 m-85 -69.33 -56.9 6.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.263 0.554 . . . . 0.0 109.515 176.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -73.56 135.83 21.24 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 115.351 -0.841 . . . . 0.0 112.13 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.437 ' HA ' ' HD3' ' A' ' 201' ' ' PRO . 10.6 pt -104.08 132.1 21.32 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-O 120.803 0.335 . . . . 0.0 110.436 178.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 200' ' ' ILE . 3.9 Cg_exo -75.69 77.59 3.31 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.957 2.438 . . . . 0.0 112.15 -178.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.19 80.13 3.47 Favored Pre-proline 0 C--N 1.326 -0.454 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 177.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -93.91 -18.32 0.51 Allowed 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.068 2.512 . . . . 0.0 113.5 -177.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -157.69 155.25 29.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.846 0.355 . . . . 0.0 110.295 -176.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 49.7 m80 -107.47 -177.44 3.35 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.546 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -146.66 147.37 30.95 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.192 -0.458 . . . . 0.0 109.999 177.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -88.63 145.31 25.75 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.432 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -133.82 177.07 8.01 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.824 -176.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -111.67 105.39 56.66 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 177.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -56.82 -64.29 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.871 2.381 . . . . 0.0 112.097 -178.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -109.62 109.33 20.06 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.418 178.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 10.8 t -115.63 8.22 14.99 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.632 0.73 . . . . 0.0 109.475 176.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 4.4 m -68.74 102.11 1.46 Allowed 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.498 178.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.69 ' HB ' ' HD3' ' A' ' 215' ' ' PRO . 25.7 m -88.41 -55.6 0.32 Allowed Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.79 179.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.69 ' HD3' ' HB ' ' A' ' 214' ' ' THR . 72.6 Cg_endo -82.37 104.1 1.32 Allowed 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 121.804 1.669 . . . . 0.0 112.804 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 9.6 mp -97.92 116.18 65.7 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.618 177.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -87.75 31.71 0.43 Allowed 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.081 2.521 . . . . 0.0 112.172 178.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -86.68 27.43 0.98 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.7 -174.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.438 HG23 HD11 ' A' ' 285' ' ' LEU . 3.6 p -79.39 86.05 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.867 0.841 . . . . 0.0 110.815 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 35.2 t -86.39 109.5 19.06 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.864 177.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -86.99 80.76 1.72 Allowed Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.769 -176.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.462 ' HA ' ' HD3' ' A' ' 223' ' ' PRO . 14.6 p -82.0 111.85 30.41 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-O 120.701 0.286 . . . . 0.0 110.476 176.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.702 ' HA ' ' HB2' ' A' ' 272' ' ' ASN . 5.4 Cg_exo -77.29 101.36 1.49 Allowed 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 123.316 2.677 . . . . 0.0 112.393 -177.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -128.15 75.88 0.41 Allowed Glycine 0 N--CA 1.443 -0.87 0 N-CA-C 110.927 -0.869 . . . . 0.0 110.927 176.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . 57.21 -155.61 0.32 Allowed 'General case' 0 C--O 1.235 0.317 0 O-C-N 123.939 0.435 . . . . 0.0 110.25 -175.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.73 ' HB1' ' HE1' ' A' ' 288' ' ' PHE . . . 61.51 31.28 18.97 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.83 0.347 . . . . 0.0 111.85 174.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.49 ' O ' ' HD3' ' A' ' 229' ' ' PRO . 38.4 pt -65.67 146.96 12.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.248 179.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 8.6 m -110.28 95.84 23.73 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.088 -178.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 227' ' ' ILE . 37.7 Cg_endo -96.77 105.27 0.09 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 123.569 2.846 . . . . 0.0 112.231 177.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.478 ' HA ' ' HD3' ' A' ' 231' ' ' PRO . 3.4 pp -82.95 138.83 42.84 Favored Pre-proline 0 C--N 1.323 -0.554 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.271 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 230' ' ' LEU . 5.9 Cg_exo -74.76 71.85 4.68 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 123.173 2.582 . . . . 0.0 113.268 -175.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 67.6 p 51.13 27.65 3.53 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.782 0.833 . . . . 0.0 112.966 173.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 46.2 p -77.34 -56.16 4.79 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.973 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 39.22 42.98 0.83 Allowed 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 122.076 0.941 . . . . 0.0 111.207 -177.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -92.61 26.09 2.81 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 114.539 -1.209 . . . . 0.0 110.853 -175.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 94.27 -148.86 19.17 Favored Glycine 0 N--CA 1.445 -0.719 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.147 177.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -65.85 118.79 5.79 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.549 2.166 . . . . 0.0 111.187 176.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.621 ' HB ' ' HE3' ' A' ' 269' ' ' MET . 3.4 t -83.07 146.06 7.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -178.601 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.406 ' CG ' ' HG3' ' A' ' 296' ' ' PRO . 57.0 m-85 -115.0 131.88 56.78 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.45 0.643 . . . . 0.0 112.02 -172.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.76 ' HB2' HD12 ' A' ' 293' ' ' ILE . . . -133.37 146.03 50.9 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.092 176.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.407 ' HB3' HD13 ' A' ' 263' ' ' ILE . 18.5 ptmt -111.38 132.34 54.5 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 120.693 -0.403 . . . . 0.0 109.952 176.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . . . . . . . . . . . -63.36 117.86 7.25 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.945 -175.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 19.2 pt -98.43 -14.02 7.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.082 -177.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -146.17 138.91 25.53 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 47.7 mttp -52.95 140.0 25.99 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.843 0.83 . . . . 0.0 113.159 -172.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.524 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 21.0 tpt180 -130.42 86.15 2.36 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.778 -1.101 . . . . 0.0 108.969 172.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 19.4 m -95.99 140.89 22.48 Favored Pre-proline 0 C--N 1.32 -0.683 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.189 -179.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.41 ' HA ' ' HB3' ' A' ' 255' ' ' ALA . 13.4 Cg_exo -66.96 136.87 42.8 Favored 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 122.405 2.07 . . . . 0.0 111.604 -179.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' CYS . . . . . . . . . . . . . 33.0 t -104.03 175.5 5.46 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.652 -178.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -56.3 -42.88 78.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.994 0.425 . . . . 0.0 111.43 -179.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -85.81 -14.79 44.0 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.06 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -129.58 70.58 1.42 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.946 0.403 . . . . 0.0 110.185 -176.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 10.1 ptpp? -83.73 -14.13 52.35 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 174.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 5.2 p -76.82 -5.81 49.8 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 114.162 -1.381 . . . . 0.0 110.409 174.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . 0.41 ' HB3' ' HA ' ' A' ' 248' ' ' PRO . . . -72.88 139.55 46.95 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.745 178.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.07 119.75 23.95 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.524 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -70.03 103.65 2.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.653 178.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . 0.496 ' HB2' ' HB3' ' A' ' 246' ' ' ARG . 96.1 mt -112.07 128.03 56.08 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.075 -178.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.75 157.17 17.04 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 176.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . . . . . . . . . 47.4 t -67.57 124.18 22.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 120.985 0.422 . . . . 0.0 110.253 -178.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 98.74 5.65 56.55 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.255 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -93.38 135.42 34.63 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 -179.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . 0.407 HD13 ' HB3' ' A' ' 241' ' ' LYS . 24.8 mm -81.52 121.79 35.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.964 0.411 . . . . 0.0 110.184 177.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.494 HG11 ' CZ ' ' A' ' 286' ' ' PHE . 22.0 t -95.15 109.66 22.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.91 -178.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 43.4 tttp -85.76 87.46 7.41 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.59 176.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.432 HG21 ' HB3' ' A' ' 275' ' ' TRP . 4.0 p -89.92 125.8 42.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.156 0.503 . . . . 0.0 110.59 -179.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 16.1 p -95.8 -32.87 12.48 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.256 -177.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . 0.568 ' HD2' ' OE2' ' A' ' 276' ' ' GLU . 41.3 ttm180 -132.39 118.46 19.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.992 0.425 . . . . 0.0 111.786 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' MET . . . . . 0.621 ' HE3' ' HB ' ' A' ' 238' ' ' VAL . 46.8 mtt -90.78 107.25 19.06 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.137 172.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.729 HD21 ' HG3' ' A' ' 276' ' ' GLU . 44.1 m-80 -78.68 137.82 37.99 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 178.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 10.7 tt -79.9 71.46 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-O 122.153 0.978 . . . . 0.0 110.969 -178.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . 0.702 ' HB2' ' HA ' ' A' ' 223' ' ' PRO . 2.8 p-10 -168.27 -4.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.852 176.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . 0.419 ' H ' ' H ' ' A' ' 272' ' ' ASN . . . 119.42 -31.24 5.49 Favored Glycine 0 C--N 1.336 0.547 0 C-N-CA 120.738 -0.744 . . . . 0.0 113.159 171.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.58 ' HG2' HD21 ' A' ' 272' ' ' ASN . 12.1 pt20 -95.46 129.48 42.61 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.04 0.447 . . . . 0.0 110.519 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.432 ' HB3' HG21 ' A' ' 266' ' ' VAL . 50.7 m0 -105.72 154.01 21.06 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.317 -179.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.729 ' HG3' HD21 ' A' ' 270' ' ' ASN . 43.0 mt-10 -96.0 111.45 23.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.335 172.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . 0.555 ' O ' ' HA ' ' A' ' 283' ' ' LYS . . . -134.26 156.56 22.45 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.493 -0.861 . . . . 0.0 111.625 179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.548 ' HG2' ' HB2' ' A' ' 283' ' ' LYS . 41.1 mt-10 -117.32 108.08 15.17 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.091 0.472 . . . . 0.0 109.808 178.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . 0.566 HG12 ' ND2' ' A' ' 280' ' ' ASN . 15.4 t -138.39 137.68 43.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.574 -177.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . 0.566 ' ND2' HG12 ' A' ' 279' ' ' VAL . 52.9 m-80 61.64 21.51 12.19 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 122.604 0.362 . . . . 0.0 111.051 -178.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 90.97 -5.87 81.86 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.979 178.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 32.7 mtp-105 -110.08 132.45 54.15 Favored 'General case' 0 C--N 1.327 -0.402 0 O-C-N 122.663 -0.316 . . . . 0.0 111.258 -178.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.555 ' HA ' ' O ' ' A' ' 277' ' ' GLY . 2.0 ttmp? -97.11 122.28 39.94 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 168.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -150.85 168.5 30.59 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 120.308 -0.949 . . . . 0.0 111.949 -178.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.438 HD11 HG23 ' A' ' 219' ' ' VAL . 84.6 mt -91.28 138.72 31.36 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.07 0.462 . . . . 0.0 110.313 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.494 ' CZ ' HG11 ' A' ' 264' ' ' VAL . 34.3 p90 -148.14 144.42 18.82 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.663 178.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . 0.505 ' HG2' ' CD2' ' A' ' 290' ' ' HIS . 84.5 Cg_endo -82.11 144.31 13.25 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.49 2.127 . . . . 0.0 111.542 176.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.73 ' HE1' ' HB1' ' A' ' 226' ' ' ALA . 44.3 p90 -65.93 -10.52 39.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.869 0.366 . . . . 0.0 111.89 -176.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 3.0 p -71.94 -4.87 30.85 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -178.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . 0.505 ' CD2' ' HG2' ' A' ' 287' ' ' PRO . 14.2 m-70 -111.29 -2.71 15.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.705 0.288 . . . . 0.0 111.155 -177.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.447 ' HB ' ' HB1' ' A' ' 240' ' ' ALA . 31.2 m -127.58 156.3 39.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.082 0.468 . . . . 0.0 111.371 -176.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 44.9 tptt -112.71 111.27 21.94 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.406 177.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.76 HD12 ' HB2' ' A' ' 240' ' ' ALA . 4.0 tp -72.11 141.2 16.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' PHE . . . . . . . . . . . . . 7.2 p90 -162.54 -174.66 4.1 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.809 0.338 . . . . 0.0 110.694 -178.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -108.82 106.94 59.63 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.707 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . 0.406 ' HG3' ' CG ' ' A' ' 239' ' ' PHE . 87.3 Cg_endo -83.55 2.62 8.23 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.786 2.324 . . . . 0.0 112.471 -178.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -95.02 -13.42 25.24 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.225 -178.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . 0.501 ' HA ' ' HD3' ' A' ' 299' ' ' PRO . 94.9 m-20 -63.6 120.96 67.4 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.995 173.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 299' ' ' PRO . . . . . 0.501 ' HD3' ' HA ' ' A' ' 298' ' ' ASN . 6.0 Cg_exo -79.46 31.33 0.47 Allowed 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 123.165 2.577 . . . . 0.0 112.497 -179.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 32.0 p-10 -88.18 -63.7 1.26 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.901 0.381 . . . . 0.0 110.616 -179.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -82.21 -37.75 25.57 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 174.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 63.6 t30 53.75 -85.46 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 114.575 -1.193 . . . . 0.0 113.231 175.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.938 -0.554 . . . . 0.0 110.417 -173.973 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ttt . . . . . 0 N--CA 1.479 0.979 0 CA-C-O 120.545 0.212 . . . . 0.0 110.743 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.4 m -95.48 120.52 35.87 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.812 0.339 . . . . 0.0 111.113 -176.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.3 t -76.11 -44.98 36.05 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 169.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.57 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . . . -77.19 101.28 6.11 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 114.535 -1.212 . . . . 0.0 109.775 174.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 25.3 ttm180 -131.53 106.81 8.44 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.503 0.668 . . . . 0.0 111.269 -177.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.569 ' CE1' ' HE2' ' A' ' 89' ' ' LYS . 34.3 p90 -168.01 139.44 2.88 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 114.647 -1.161 . . . . 0.0 108.402 175.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -74.1 102.34 4.19 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.208 0.528 . . . . 0.0 110.284 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.1 m -57.73 -32.13 67.13 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.586 -175.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.4 t -81.47 -2.12 48.46 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.888 -174.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -103.66 105.83 16.17 Favored 'General case' 0 C--N 1.32 -0.684 0 O-C-N 121.585 -0.697 . . . . 0.0 110.901 -177.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.11 -29.09 70.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.899 178.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.8 m -74.79 4.04 7.06 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.974 0.416 . . . . 0.0 110.731 178.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -99.05 -30.48 12.3 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.558 175.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' TRP . . . . . . . . . . . . . 36.6 p-90 -138.2 -20.83 1.08 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -171.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -77.14 115.41 16.91 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.041 0.448 . . . . 0.0 110.15 -174.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . 0.582 ' HG3' ' HB2' ' A' ' 37' ' ' LEU . 25.1 mmt -97.94 -7.68 29.62 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.991 -175.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.483 ' O ' ' HB2' ' A' ' 39' ' ' ARG . . . 50.78 -111.69 1.34 Allowed Glycine 0 CA--C 1.523 0.577 0 O-C-N 123.694 0.622 . . . . 0.0 113.427 -178.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.435 ' HD3' ' HA3' ' A' ' 17' ' ' GLY . 4.4 Cg_exo -76.87 103.18 1.71 Allowed 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.845 2.363 . . . . 0.0 112.417 -179.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.724 ' HB ' ' HG3' ' A' ' 39' ' ' ARG . 2.9 t -138.13 -69.87 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.758 -178.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.527 ' H ' ' HG3' ' A' ' 39' ' ' ARG . 21.4 t 95.85 162.89 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 124.662 1.185 . . . . 0.0 109.083 172.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.432 ' O ' ' HG2' ' A' ' 25' ' ' GLN . 69.8 mtp85 -55.78 -44.56 77.83 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 123.04 0.212 . . . . 0.0 110.804 -175.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.87 -46.95 74.79 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 123.993 0.808 . . . . 0.0 110.718 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.52 ' HB3' HG13 ' A' ' 19' ' ' VAL . 14.1 tp10 -76.24 -46.91 25.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.298 0.57 . . . . 0.0 110.469 -175.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -57.11 -39.6 75.38 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.99 -176.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' A' ' 21' ' ' ARG . 2.1 pt20 -75.34 -33.15 61.09 Favored 'General case' 0 C--O 1.219 -0.513 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -173.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.1 t -75.48 -32.14 60.46 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.37 -0.532 . . . . 0.0 111.149 -176.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -84.22 -7.07 59.46 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.947 179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.6 HD21 ' HB2' ' A' ' 102' ' ' ALA . 97.0 mt -125.97 13.3 7.87 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.639 175.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.407 ' HB2' ' O ' ' A' ' 25' ' ' GLN . 27.3 tp60 -72.36 84.72 1.08 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.634 ' HA2' ' HA ' ' A' ' 56' ' ' SER . . . 85.12 -64.81 4.15 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.518 -178.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 39.87 -125.8 0.4 Allowed 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 123.257 0.623 . . . . 0.0 112.222 -176.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.451 ' HA ' ' HB3' ' A' ' 116' ' ' PRO . 20.1 ptp180 -106.73 -7.24 17.34 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.242 -0.436 . . . . 0.0 109.876 178.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 37.7 m80 67.91 153.15 0.09 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.254 -173.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.98 -0.79 76.69 Favored Glycine 0 N--CA 1.453 -0.171 0 C-N-CA 120.827 -0.702 . . . . 0.0 111.881 -177.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.674 ' HA ' ' O ' ' A' ' 100' ' ' GLU . 37.1 mtm -104.7 147.51 27.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.749 0.309 . . . . 0.0 110.566 -178.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.427 ' CB ' HG22 ' A' ' 52' ' ' VAL . 43.2 p90 -143.27 169.42 17.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.49 -178.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.582 ' HB2' ' HG3' ' A' ' 16' ' ' MET . 4.5 pp -158.21 143.76 16.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.012 0.434 . . . . 0.0 110.769 173.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.5 t -115.44 112.66 40.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 175.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.724 ' HG3' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -121.66 167.75 12.57 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 177.407 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -62.28 137.93 58.34 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 28.4 t -66.63 126.11 27.9 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.282 0.563 . . . . 0.0 111.298 -173.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.4 p -86.13 6.44 29.2 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.472 -0.785 . . . . 0.0 109.591 174.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.8 -39.73 8.47 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.046 179.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.475 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 71.1 m -149.66 137.4 11.61 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 115.861 -0.608 . . . . 0.0 109.956 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 44' ' ' CYS . 38.2 Cg_exo -61.15 -32.5 91.15 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.283 2.655 . . . . 0.0 113.799 -175.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -101.84 33.06 6.81 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.849 -176.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.635 ' OD1' ' HA ' ' A' ' 64' ' ' ASN . 15.6 m-20 -138.71 167.56 21.71 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 110.375 -0.232 . . . . 0.0 110.375 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.427 ' CD2' HD11 ' A' ' 81' ' ' LEU . 16.7 m-85 -126.42 170.62 11.77 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 174.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.409 ' HB ' ' NH1' ' A' ' 39' ' ' ARG . 44.8 t -144.16 115.96 2.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-O 121.002 0.43 . . . . 0.0 111.653 176.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 32.5 tp -82.7 106.05 14.23 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.025 174.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.8 m -96.82 129.04 44.31 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 176.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.721 HG12 ' HG2' ' A' ' 54' ' ' GLU . 70.8 t -121.9 134.56 64.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.843 -176.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.573 ' HB2' ' HB3' ' A' ' 28' ' ' LEU . 41.0 t -88.04 99.18 11.97 Favored 'General case' 0 CA--C 1.513 -0.442 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.965 -177.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.721 ' HG2' HG12 ' A' ' 52' ' ' VAL . 65.5 mm-40 -144.94 142.08 29.55 Favored 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 119.51 -0.876 . . . . 0.0 109.403 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 25.4 m-20 61.04 15.81 6.51 Favored 'General case' 0 N--CA 1.467 0.423 0 O-C-N 123.594 0.558 . . . . 0.0 111.927 -178.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.634 ' HA ' ' HA2' ' A' ' 30' ' ' GLY . 27.4 m 58.89 54.55 5.05 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-O 122.935 1.35 . . . . 0.0 107.374 -173.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.593 HH22 ' CG ' ' A' ' 94' ' ' ASP . 0.1 OUTLIER -167.01 67.88 0.09 Allowed 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 112.26 -2.245 . . . . 0.0 108.831 -151.638 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 9.9 t -69.63 100.52 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.815 0.816 . . . . 0.0 109.777 -167.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 50.9 m -74.76 120.72 20.69 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 114.213 -1.358 . . . . 0.0 110.474 -178.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 -93.29 103.28 15.53 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.003 -177.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.657 ' HB3' HD11 ' A' ' 73' ' ' ILE . 58.5 m-85 -91.35 104.29 16.83 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.159 177.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 59.9 mt -79.46 125.76 38.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 120.848 0.356 . . . . 0.0 111.758 -175.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.457 ' CG2' ' HB3' ' A' ' 71' ' ' PHE . 4.6 mp -103.51 109.93 28.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.471 178.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.635 ' HA ' ' OD1' ' A' ' 47' ' ' ASP . 15.4 m120 -83.13 160.41 21.87 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.735 -179.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.6 t -99.87 109.7 22.08 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 172.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.552 HD11 ' HB2' ' A' ' 72' ' ' LYS . 85.3 mt -78.68 153.25 78.31 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.327 -176.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -62.9 -14.58 41.95 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.668 2.245 . . . . 0.0 111.655 173.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -81.65 8.63 9.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.618 177.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? 62.9 29.0 16.56 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.587 0.708 . . . . 0.0 110.014 -177.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 27.8 mtp180 -124.34 -174.9 3.12 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.581 -177.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . 0.457 ' HB3' ' CG2' ' A' ' 63' ' ' ILE . 72.9 m-85 -122.12 151.37 41.01 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.551 0.215 . . . . 0.0 111.027 -177.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.581 ' HE3' ' O ' ' A' ' 75' ' ' ASP . 86.5 tttt -138.89 113.81 9.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.767 -175.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.657 HD11 ' HB3' ' A' ' 61' ' ' TYR . 20.3 tt -89.87 100.48 10.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.858 0.837 . . . . 0.0 110.916 -174.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.45 -65.04 2.45 Favored Glycine 0 CA--C 1.519 0.29 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.95 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.581 ' O ' ' HE3' ' A' ' 72' ' ' LYS . 20.0 t70 -154.15 -29.56 0.12 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.024 0.44 . . . . 0.0 110.221 -176.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 -85.48 121.7 28.56 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -93.49 145.87 24.19 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.226 0.536 . . . . 0.0 111.288 -175.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.441 ' CD2' ' HB3' ' A' ' 84' ' ' LEU . 86.3 m-85 -131.94 -173.73 3.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.815 178.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -74.94 -61.7 1.8 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.555 178.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.6 p80 -146.27 -179.1 6.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.272 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.56 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 7.5 mt -56.27 -56.9 26.48 Favored Pre-proline 0 N--CA 1.467 0.405 0 N-CA-C 111.872 0.323 . . . . 0.0 111.872 -178.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.469 ' HD3' ' HB2' ' A' ' 81' ' ' LEU . 50.9 Cg_exo -57.79 -10.52 7.58 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.399 2.066 . . . . 0.0 113.607 178.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -89.04 -32.93 17.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.554 0.216 . . . . 0.0 111.034 -175.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' A' ' 81' ' ' LEU . 4.1 pp -76.6 -33.89 58.4 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.401 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 77.6 mt -65.25 -31.21 72.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.603 178.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -72.85 -39.82 66.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.267 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.43 ' CE2' ' ND1' ' A' ' 91' ' ' HIS . 68.6 t80 -68.03 -30.94 70.29 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.405 -178.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.43 ' HE2' HD13 ' A' ' 73' ' ' ILE . 27.8 m-85 -84.08 2.3 40.0 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -176.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.569 ' HE2' ' CE1' ' A' ' 6' ' ' PHE . 96.4 mttt -80.47 -15.82 55.82 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.335 172.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 2.7 pp -126.74 9.39 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.14 0 CA-C-O 121.385 0.612 . . . . 0.0 110.556 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.44 ' O ' ' HB2' ' A' ' 92' ' ' TYR . 9.1 t60 -94.32 -42.43 8.91 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.713 -177.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.448 ' H ' HG22 ' A' ' 97' ' ' THR . 75.8 m-85 65.53 95.72 0.05 Allowed 'General case' 0 C--N 1.329 -0.318 0 O-C-N 124.402 1.063 . . . . 0.0 109.054 -163.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.625 ' O ' ' HB3' ' A' ' 154' ' ' GLU . 30.8 mt -61.07 -92.8 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 173.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.593 ' CG ' HH22 ' A' ' 57' ' ' ARG . 20.6 t0 -99.83 86.3 3.26 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.104 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.845 ' HB ' ' HA ' ' A' ' 156' ' ' PRO . 2.2 t 48.6 15.18 0.08 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.815 -1.084 . . . . 0.0 112.665 -176.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -156.75 153.17 27.96 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 120.966 0.412 . . . . 0.0 110.383 -177.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.448 HG22 ' H ' ' A' ' 92' ' ' TYR . 7.5 p -98.15 168.28 10.35 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.133 -179.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 97.3 mt -70.08 92.67 0.75 Allowed 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 177.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.57 ' HA ' ' HA ' ' A' ' 4' ' ' ALA . 37.4 mm -78.18 -59.29 3.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.34 -174.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.674 ' O ' ' HA ' ' A' ' 35' ' ' MET . 38.4 tt0 -155.8 135.4 8.11 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.14 -176.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -62.12 157.1 46.23 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.791 2.327 . . . . 0.0 113.023 -178.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.6 ' HB2' HD21 ' A' ' 28' ' ' LEU . . . -68.91 142.87 93.97 Favored Pre-proline 0 N--CA 1.452 -0.366 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.131 177.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -60.91 124.78 15.63 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.604 2.203 . . . . 0.0 112.362 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ARG . . . . . . . . . . . . . 27.4 ptt180 -100.82 3.55 42.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.746 176.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.576 ' HB3' ' HD3' ' A' ' 106' ' ' PRO . 80.1 t80 -153.6 -58.8 0.02 OUTLIER Pre-proline 0 CA--C 1.536 0.433 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.576 ' HD3' ' HB3' ' A' ' 105' ' ' TYR . 60.2 Cg_endo -73.55 109.85 2.94 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 121.912 1.741 . . . . 0.0 112.191 -178.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 50.5 m -152.66 107.4 2.72 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-O 120.8 0.333 . . . . 0.0 111.211 -178.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.45 ' HA ' ' HD2' ' A' ' 109' ' ' PRO . 17.5 Cg_endo -88.93 119.47 1.01 Allowed 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 123.283 2.656 . . . . 0.0 111.606 176.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.45 ' HD2' ' HA ' ' A' ' 108' ' ' PRO . 19.4 Cg_endo -59.76 -35.59 93.97 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.78 2.32 . . . . 0.0 112.792 -177.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' MET . . . . . . . . . . . . . 18.8 ptp -88.74 22.97 2.45 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.955 0.407 . . . . 0.0 110.957 -179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -77.2 83.05 1.1 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.827 -0.701 . . . . 0.0 111.549 176.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 5.9 p -75.39 101.53 4.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.071 0.462 . . . . 0.0 111.253 -178.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 3.7 p -80.67 110.71 16.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.348 0.594 . . . . 0.0 110.442 178.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 13.5 p -90.37 -35.46 15.19 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.936 -178.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -142.59 108.55 5.6 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.448 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.451 ' HB3' ' HA ' ' A' ' 32' ' ' ARG . 2.1 Cg_endo -81.08 -177.47 3.73 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.968 2.445 . . . . 0.0 111.753 178.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 14.1 t30 -67.51 -63.15 1.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 177.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.501 HD12 ' OE1' ' A' ' 54' ' ' GLU . 74.0 mt -96.57 156.88 36.2 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.708 169.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -88.09 -154.86 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.231 2.62 . . . . 0.0 110.376 165.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 26.5 m -122.25 105.47 10.25 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 174.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -72.97 -72.27 0.26 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.697 -174.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.49 ' OE1' HD21 ' A' ' 125' ' ' LEU . 43.3 tt0 -134.95 113.34 11.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.378 -175.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -75.11 73.3 2.26 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.386 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.701 ' HA ' ' HD3' ' A' ' 186' ' ' PRO . 22.1 m120 -160.44 -147.38 0.15 Allowed 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -176.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . 1.004 HD12 HG21 ' A' ' 152' ' ' ILE . 1.4 mm? 76.06 105.24 0.07 Allowed 'General case' 0 C--N 1.351 0.667 0 O-C-N 123.55 0.531 . . . . 0.0 111.811 166.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.756 ' O ' ' HA ' ' A' ' 151' ' ' VAL . 0.0 OUTLIER -171.83 -61.59 0.02 OUTLIER 'General case' 0 C--O 1.215 -0.729 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.566 -179.926 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.556 ' N ' ' HG2' ' A' ' 126' ' ' GLU . 50.1 m-85 -115.21 108.44 16.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.394 0.616 . . . . 0.0 111.843 179.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.944 HG22 ' HG3' ' A' ' 180' ' ' LYS . 38.8 t -126.88 136.13 61.67 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.287 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.645 ' O ' ' HB3' ' A' ' 179' ' ' GLU . 5.7 ptp180 -113.39 153.75 28.06 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 117.789 -1.564 . . . . 0.0 108.915 172.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.546 HG22 HG12 ' A' ' 178' ' ' VAL . 68.2 p -102.74 140.17 37.36 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.512 0.672 . . . . 0.0 111.757 178.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.553 HD21 ' HG2' ' A' ' 179' ' ' GLU . 9.8 mt -113.4 -16.26 12.49 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.89 178.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.442 ' O ' ' HB3' ' A' ' 133' ' ' ASP . 21.7 t80 -82.72 -39.66 21.65 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.313 -174.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ASP . . . . . 0.689 ' OD2' ' HA ' ' A' ' 145' ' ' LYS . 13.6 t70 72.82 104.81 0.07 Allowed 'General case' 0 N--CA 1.468 0.443 0 O-C-N 123.695 0.622 . . . . 0.0 110.873 -177.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.546 ' HB3' ' CZ ' ' A' ' 144' ' ' PHE . 67.0 t80 -132.12 94.14 24.7 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 174.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.677 ' HA ' ' HA ' ' A' ' 143' ' ' PRO . 69.8 Cg_endo -87.05 92.25 0.53 Allowed 'Trans proline' 0 N--CA 1.442 -1.507 0 C-N-CA 121.667 1.578 . . . . 0.0 112.893 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -88.54 -25.51 30.21 Favored Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.672 174.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ASN . . . . . 0.52 ' HA ' ' HG3' ' A' ' 143' ' ' PRO . 0.8 OUTLIER 60.13 52.28 5.16 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.385 0.674 . . . . 0.0 111.933 178.685 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ASP . . . . . 0.438 ' HB3' ' H ' ' A' ' 140' ' ' GLU . 0.9 OUTLIER -138.57 172.89 12.21 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.794 177.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -89.32 -13.15 38.59 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.924 0.869 . . . . 0.0 109.084 172.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.666 ' O ' ' HB2' ' A' ' 172' ' ' MET . 5.9 mm-40 -93.02 -35.25 13.36 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.994 176.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -125.72 109.69 12.87 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.817 177.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 1.052 HD11 ' HB2' ' A' ' 165' ' ' ASN . 34.2 tp -69.35 130.76 90.65 Favored Pre-proline 0 C--N 1.319 -0.732 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.002 -176.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . 0.677 ' HA ' ' HA ' ' A' ' 135' ' ' PRO . 73.7 Cg_endo -82.26 88.69 1.26 Allowed 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 121.867 1.711 . . . . 0.0 112.071 171.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.546 ' CZ ' ' HB3' ' A' ' 134' ' ' PHE . 22.3 p90 -100.25 172.92 6.87 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -176.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.689 ' HA ' ' OD2' ' A' ' 133' ' ' ASP . 14.1 mptt -122.92 -164.59 1.21 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -168.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.56 ' HD2' ' N ' ' A' ' 146' ' ' LYS . 7.6 mptt -85.39 1.29 49.23 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.59 -174.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -177.39 30.86 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.516 -0.766 . . . . 0.0 111.612 -178.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.682 ' OE2' ' HG ' ' A' ' 150' ' ' LEU . 1.6 pp20? -73.06 169.92 15.98 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 175.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 1.6 mp -117.89 128.46 75.02 Favored 'Isoleucine or valine' 0 C--N 1.35 0.619 0 CA-C-N 118.498 0.59 . . . . 0.0 110.083 173.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.862 ' CD2' ' HA ' ' A' ' 165' ' ' ASN . 86.0 mt -118.38 158.67 24.83 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-O 121.51 0.671 . . . . 0.0 110.493 -173.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.756 ' HA ' ' O ' ' A' ' 126' ' ' GLU . 97.2 t -128.08 121.07 55.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.187 174.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 1.075 HD13 ' HB2' ' A' ' 163' ' ' ALA . 26.6 mm -78.83 84.0 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.582 0 CA-C-O 121.826 0.822 . . . . 0.0 109.134 -176.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.785 HG23 ' HG2' ' A' ' 154' ' ' GLU . 20.9 tt -73.94 -32.83 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 CA-C-N 114.217 -1.356 . . . . 0.0 109.535 -176.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLU . . . . . 0.785 ' HG2' HG23 ' A' ' 153' ' ' ILE . 0.0 OUTLIER -125.46 144.84 50.35 Favored 'General case' 0 CA--C 1.521 -0.151 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 175.753 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -131.94 76.59 73.51 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-O 121.453 0.644 . . . . 0.0 109.638 168.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.845 ' HA ' ' HB ' ' A' ' 95' ' ' THR . 15.6 Cg_exo -66.88 -47.67 2.43 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.512 2.142 . . . . 0.0 111.581 176.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 37.2 mm-40 -112.19 -170.97 1.76 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.629 -177.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -124.85 -14.45 6.69 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.697 -0.401 . . . . 0.0 111.24 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 16.8 mm100 -89.96 -21.35 22.47 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 168.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.667 ' HB3' ' SD ' ' A' ' 172' ' ' MET . 80.9 m95 -125.97 139.15 53.67 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.171 177.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' TRP . . . . . 0.752 ' O ' HG13 ' A' ' 173' ' ' ILE . 45.7 m0 -128.37 137.39 51.87 Favored 'General case' 0 C--O 1.206 -1.187 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.25 179.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.563 ' HA ' ' HA ' ' A' ' 172' ' ' MET . 6.3 m -97.67 102.68 14.5 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 -172.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 1.075 ' HB2' HD13 ' A' ' 152' ' ' ILE . . . -115.53 147.09 41.09 Favored 'General case' 0 N--CA 1.415 -2.2 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.489 -171.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.753 ' HA ' ' O ' ' A' ' 169' ' ' ARG . 13.5 ptt-85 -86.64 127.26 34.92 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 175.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ASN . . . . . 1.052 ' HB2' HD11 ' A' ' 142' ' ' LEU . 61.5 t30 -62.41 177.03 0.55 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.875 -169.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.536 ' HB2' ' HB2' ' A' ' 148' ' ' GLU . 40.5 tptt -50.86 -26.42 5.78 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.062 -0.972 . . . . 0.0 109.331 164.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -69.51 -43.04 73.9 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.832 173.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 113.12 -5.02 25.4 Favored Glycine 0 CA--C 1.516 0.146 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.276 -170.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ARG . . . . . 0.753 ' O ' ' HA ' ' A' ' 164' ' ' ARG . 0.6 OUTLIER -71.29 135.82 47.6 Favored 'General case' 0 C--O 1.217 -0.627 0 C-N-CA 123.389 0.675 . . . . 0.0 111.692 -178.819 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 59.6 t -83.48 123.44 38.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 C-N-CA 121.202 -0.199 . . . . 0.0 110.491 177.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -160.76 158.25 29.77 Favored Glycine 0 C--O 1.227 -0.299 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.68 173.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' MET . . . . . 0.667 ' SD ' ' HB3' ' A' ' 160' ' ' TRP . 0.6 OUTLIER -74.89 140.67 43.97 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 117.234 0.517 . . . . 0.0 112.001 -178.19 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.752 HG13 ' O ' ' A' ' 161' ' ' TRP . 2.8 pp -137.09 140.49 31.47 Favored Pre-proline 0 N--CA 1.451 -0.418 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.368 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . 0.602 ' O ' HG13 ' A' ' 178' ' ' VAL . 6.3 Cg_exo -76.56 127.04 9.38 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.969 2.446 . . . . 0.0 113.115 -175.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.601 ' O ' HG22 ' A' ' 178' ' ' VAL . 59.4 t -53.23 -45.3 98.41 Favored Pre-proline 0 CA--C 1.542 0.635 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 177.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 175' ' ' VAL . 27.7 Cg_endo -63.44 -1.0 2.72 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.044 1.83 . . . . 0.0 113.318 176.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.475 ' HB2' ' O ' ' A' ' 174' ' ' PRO . 3.1 m-30 -104.26 -10.01 18.17 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.588 0.232 . . . . 0.0 111.351 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.647 ' HB ' ' CG1' ' A' ' 128' ' ' VAL . 5.0 m -108.16 -171.96 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 115.786 1.773 . . . . 0.0 115.786 -162.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . 0.645 ' HB3' ' O ' ' A' ' 129' ' ' ARG . 5.1 tp10 -155.75 50.95 0.55 Allowed 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 113.009 -1.905 . . . . 0.0 113.503 -153.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' LYS . . . . . 0.944 ' HG3' HG22 ' A' ' 128' ' ' VAL . 3.6 mppt? -67.28 136.44 54.91 Favored 'General case' 0 CA--C 1.518 -0.259 0 O-C-N 119.498 -2.001 . . . . 0.0 109.012 -165.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 61.5 tp -54.2 -90.97 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 112.583 -2.099 . . . . 0.0 112.369 -165.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' VAL . . . . . . . . . . . . . 17.1 m -118.86 -34.87 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 172.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 11.0 ttp180 60.09 -82.34 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 114.274 -1.33 . . . . 0.0 111.543 175.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 25.6 m 66.45 -67.9 0.15 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.222 0.609 . . . . 0.0 110.106 -173.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' SER . . . . . . . . . . . . . 17.8 p 170.09 160.61 0.2 Allowed Pre-proline 0 C--N 1.326 -0.415 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 175.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' PRO . . . . . 0.701 ' HD3' ' HA ' ' A' ' 124' ' ' ASN . 96.4 Cg_exo -43.04 -61.37 0.57 Allowed 'Trans proline' 0 C--O 1.237 0.446 0 C-N-CA 122.85 2.366 . . . . 0.0 113.132 -176.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . . . . . . . . . 28.2 m80 68.27 -47.6 0.54 Allowed 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.483 0.713 . . . . 0.0 111.966 -179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 105.95 -22.61 31.24 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 111.629 -0.588 . . . . 0.0 111.629 -178.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -137.07 25.07 3.01 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -175.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -77.37 84.9 3.79 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 121.783 0.801 . . . . 0.0 110.669 179.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 100.72 133.53 8.17 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.597 -176.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -77.71 70.27 4.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.22 0.534 . . . . 0.0 109.664 178.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' ARG . . . . . . . . . . . . . 69.6 ttt180 68.69 -70.54 0.13 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.588 -176.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 19.5 m120 50.74 28.35 3.55 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.206 0.603 . . . . 0.0 111.953 178.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 20.2 m -108.46 114.57 28.51 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.461 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 33.4 t-20 -126.64 141.53 51.83 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.941 -176.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' SER . . . . . . . . . . . . . 16.0 m -68.8 -28.15 66.51 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.155 0.502 . . . . 0.0 110.455 176.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -88.78 -171.25 3.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.345 -176.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 134.8 -31.33 2.74 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 -174.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 49.7 mm 71.86 103.97 0.03 OUTLIER Pre-proline 0 C--O 1.235 0.308 0 C-N-CA 123.483 0.713 . . . . 0.0 111.855 175.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -66.44 147.21 82.25 Favored 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.706 2.271 . . . . 0.0 111.441 174.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.618 ' HB2' ' HD3' ' A' ' 203' ' ' PRO . 2.2 mp0 -58.53 -55.83 41.83 Favored Pre-proline 0 CA--C 1.538 0.5 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.945 -177.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . 0.618 ' HD3' ' HB2' ' A' ' 202' ' ' GLU . 19.3 Cg_endo -92.05 30.36 0.32 Allowed 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 122.456 2.104 . . . . 0.0 112.746 -177.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . . . . . . . . . . . -75.96 -40.15 54.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.864 0.364 . . . . 0.0 110.871 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 27.3 m170 -107.29 121.78 45.25 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.953 0.406 . . . . 0.0 110.963 178.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -111.27 113.92 26.75 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.718 177.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -65.53 125.43 25.15 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.293 -175.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -72.38 141.91 48.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.184 -178.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' GLN . . . . . 0.468 ' HA ' ' HD3' ' A' ' 210' ' ' PRO . 25.9 mt-30 -69.48 133.85 88.91 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.794 178.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 209' ' ' GLN . 8.0 Cg_exo -74.06 152.33 45.64 Favored 'Trans proline' 0 C--O 1.234 0.304 0 C-N-CA 122.936 2.424 . . . . 0.0 111.162 173.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -127.46 145.99 50.64 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.123 0.487 . . . . 0.0 111.162 -178.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 87.3 m -155.31 117.0 4.05 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.516 177.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' THR . . . . . . . . . . . . . 26.4 m -79.62 91.07 5.18 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.295 0.569 . . . . 0.0 110.602 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.434 ' OG1' ' HD3' ' A' ' 215' ' ' PRO . 0.0 OUTLIER -83.71 -49.53 0.69 Allowed Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.385 178.185 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.434 ' HD3' ' OG1' ' A' ' 214' ' ' THR . 11.3 Cg_exo -70.74 88.59 0.65 Allowed 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 122.122 1.881 . . . . 0.0 112.387 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.744 ' HB2' ' HD3' ' A' ' 217' ' ' PRO . 95.3 mt -93.6 -53.25 0.25 Allowed Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.466 176.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.744 ' HD3' ' HB2' ' A' ' 216' ' ' LEU . 22.0 Cg_exo -67.33 -28.18 39.8 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 121.944 1.763 . . . . 0.0 111.764 174.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . 64.79 -170.37 0.19 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.853 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . . . . . . . . . 33.9 m -113.08 -4.21 11.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.038 0.446 . . . . 0.0 110.877 178.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 28.5 m -79.59 113.84 18.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.194 178.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -174.13 95.18 0.1 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.669 -178.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 8.2 t -115.18 97.23 47.64 Favored Pre-proline 0 C--N 1.322 -0.619 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -179.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -80.07 131.64 8.99 Favored 'Trans proline' 0 C--O 1.236 0.398 0 C-N-CA 122.79 2.327 . . . . 0.0 112.318 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -99.01 121.15 7.11 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.437 -178.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -87.65 87.42 7.38 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.103 0.478 . . . . 0.0 110.765 178.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' ALA . . . . . 0.813 ' HA ' HD12 ' A' ' 230' ' ' LEU . . . -81.12 74.65 8.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.538 179.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' ILE . . . . . 0.663 HG13 ' H ' ' A' ' 228' ' ' THR . 8.7 pt -132.91 -69.65 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -176.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.663 ' H ' HG13 ' A' ' 227' ' ' ILE . 2.5 m -106.67 -59.32 0.05 OUTLIER Pre-proline 0 CA--C 1.541 0.609 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -168.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.603 ' HD3' ' HB ' ' A' ' 228' ' ' THR . 84.7 Cg_endo -80.54 10.92 3.09 Favored 'Trans proline' 0 C--N 1.352 0.754 0 C-N-CA 122.218 1.945 . . . . 0.0 114.335 -169.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.813 HD12 ' HA ' ' A' ' 226' ' ' ALA . 68.7 mt -104.34 111.75 65.26 Favored Pre-proline 0 C--N 1.321 -0.632 0 C-N-CA 120.886 -0.326 . . . . 0.0 111.173 -178.251 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -80.83 112.6 2.67 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.31 2.673 . . . . 0.0 111.632 178.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' SER . . . . . . . . . . . . . 32.9 t 63.52 -81.5 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 123.148 0.579 . . . . 0.0 110.392 -174.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' THR . . . . . . . . . . . . . 29.6 p 48.84 -165.69 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.723 0.809 . . . . 0.0 112.86 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -97.71 83.62 3.23 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.927 -0.579 . . . . 0.0 109.505 178.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -101.76 5.65 41.36 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.006 0.431 . . . . 0.0 110.429 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' GLY . . . . . . . . . . . . . . . 175.98 96.02 0.1 Allowed Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.794 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -66.28 124.71 12.89 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.596 2.198 . . . . 0.0 111.759 178.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.45 HG11 HD12 ' A' ' 293' ' ' ILE . 20.1 t -94.19 143.84 10.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.079 -178.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' PHE . . . . . 0.518 ' HB2' ' HG3' ' A' ' 296' ' ' PRO . 95.3 m-85 -111.8 124.21 51.87 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.503 -178.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . 0.412 ' HB2' HD13 ' A' ' 293' ' ' ILE . . . -119.7 127.62 53.04 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.076 179.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . 0.43 ' HB2' ' CE1' ' A' ' 294' ' ' PHE . 50.5 tttp -85.92 119.38 26.17 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -178.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' ALA . . . . . 0.479 ' HA ' HG12 ' A' ' 291' ' ' VAL . . . -71.03 106.84 3.84 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.542 -178.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.749 HG12 ' HG3' ' A' ' 292' ' ' LYS . 2.6 pp -104.56 -14.74 8.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.168 -177.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . 0.432 ' HB2' HD12 ' A' ' 243' ' ' ILE . 0.0 OUTLIER -130.76 137.95 49.72 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 175.622 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -62.3 163.6 8.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.409 0.623 . . . . 0.0 111.944 -173.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . 0.615 ' O ' ' HA ' ' A' ' 257' ' ' ALA . 0.0 OUTLIER -145.78 121.43 10.47 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 177.898 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' VAL . . . . . . . . . . . . . 16.5 m -122.36 139.18 30.27 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-O 120.795 0.331 . . . . 0.0 110.753 178.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.475 ' HD3' ' HB2' ' A' ' 257' ' ' ALA . 42.5 Cg_endo -68.98 125.75 12.95 Favored 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.645 2.23 . . . . 0.0 112.249 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' CYS . . . . . 0.549 ' HB3' ' HB2' ' A' ' 252' ' ' ASP . 16.5 t -90.64 172.45 8.67 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' ALA . . . . . . . . . . . . . . . -55.71 -47.59 76.59 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.945 0.402 . . . . 0.0 111.283 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -87.68 -6.31 58.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.767 179.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.549 ' HB2' ' HB3' ' A' ' 249' ' ' CYS . 2.9 m-20 -114.48 52.11 0.86 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.342 178.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -71.02 -13.51 62.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.32 0.581 . . . . 0.0 109.865 177.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 2.7 p -89.25 -8.22 53.91 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.969 176.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' ALA . . . . . . . . . . . . . . . -76.71 123.18 25.79 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.687 -178.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' LEU . . . . . 0.417 ' HA ' HH11 ' A' ' 282' ' ' ARG . 0.6 OUTLIER -70.33 139.34 51.99 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.629 -178.295 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' ALA . . . . . 0.615 ' HA ' ' O ' ' A' ' 246' ' ' ARG . . . -89.15 117.55 28.22 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.094 0.473 . . . . 0.0 109.921 176.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' LEU . . . . . . . . . . . . . 35.4 mt -129.14 157.76 40.88 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.928 -176.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -136.86 160.29 39.31 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' VAL . . . . . 0.462 ' HA ' ' O ' ' A' ' 242' ' ' ALA . 21.7 t -66.29 105.32 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.087 -172.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . . . . . . . . . . . 130.6 10.7 2.56 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.689 175.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -118.41 157.57 26.92 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 117.879 0.839 . . . . 0.0 111.375 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 37.2 mm -94.04 124.07 46.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.753 -178.158 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 32.0 t -95.5 111.02 25.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.957 175.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -95.28 97.26 9.73 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.563 -178.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' VAL . . . . . 0.493 ' HA ' ' HA2' ' A' ' 277' ' ' GLY . 6.6 p -88.41 134.89 26.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.704 -0.399 . . . . 0.0 110.394 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' THR . . . . . . . . . . . . . 22.1 p -92.93 -44.1 8.61 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.512 -176.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' ARG . . . . . . . . . . . . . 29.3 ptt180 -131.21 126.46 35.62 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 121.365 0.602 . . . . 0.0 110.951 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' MET . . . . . . . . . . . . . 40.1 mmm -83.08 110.44 18.0 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.527 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 274' ' ' GLN . 86.9 m-20 -85.4 126.97 34.2 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.283 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' ILE . . . . . . . . . . . . . 22.8 mt -70.73 -18.62 21.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.295 -175.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -61.88 -23.89 66.59 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.702 0.287 . . . . 0.0 111.162 -178.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . 109.19 21.79 7.17 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.746 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.504 ' HA ' ' CZ ' ' A' ' 288' ' ' PHE . 37.9 mt-30 -151.56 111.35 4.03 Favored 'General case' 0 N--CA 1.464 0.239 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 167.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . . . . . . . . . 1.3 m0 -92.08 164.81 13.46 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -176.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' GLU . . . . . 0.668 ' HB3' ' HE2' ' A' ' 283' ' ' LYS . 43.3 mt-10 -104.78 117.98 35.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.128 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' A' ' 266' ' ' VAL . . . -122.01 142.33 14.97 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.725 -178.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -99.38 111.52 23.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.817 0.818 . . . . 0.0 109.922 175.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 95.7 t -124.39 158.03 31.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.74 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -61.8 82.96 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.732 0.777 . . . . 0.0 110.79 175.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . 160.85 -35.77 0.42 Allowed Glycine 0 N--CA 1.441 -0.996 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.17 -177.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . 0.438 HH11 ' HD2' ' A' ' 282' ' ' ARG . 42.8 ttm105 177.92 159.71 0.49 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 117.054 0.427 . . . . 0.0 110.197 -178.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.668 ' HE2' ' HB3' ' A' ' 276' ' ' GLU . 2.5 tmtp? -110.1 101.17 9.99 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 171.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -151.96 -168.92 16.84 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.45 -0.881 . . . . 0.0 112.926 -172.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 73.2 mt -90.73 149.15 22.15 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.859 0.361 . . . . 0.0 110.455 -177.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' PHE . . . . . 0.421 ' HA ' ' HD3' ' A' ' 287' ' ' PRO . 42.0 p90 -143.91 152.54 55.58 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.402 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 286' ' ' PHE . 2.3 Cg_endo -81.37 145.3 14.92 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 123.346 2.697 . . . . 0.0 111.752 177.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' PHE . . . . . 0.504 ' CZ ' ' HA ' ' A' ' 274' ' ' GLN . 3.6 m-85 -91.73 -5.47 53.59 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.116 0.414 . . . . 0.0 112.116 -167.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' THR . . . . . . . . . . . . . 4.5 m -94.4 -19.73 20.35 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.325 0.583 . . . . 0.0 109.887 175.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -77.23 -22.43 52.24 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.574 177.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' VAL . . . . . 0.479 HG12 ' HA ' ' A' ' 242' ' ' ALA . 28.5 m -117.19 164.49 13.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.235 178.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . 0.749 ' HG3' HG12 ' A' ' 243' ' ' ILE . 98.1 mttt -119.39 119.92 35.35 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.609 177.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' ILE . . . . . 0.45 HD12 HG11 ' A' ' 238' ' ' VAL . 18.9 mm -74.63 110.69 9.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 172.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' PHE . . . . . 0.43 ' CE1' ' HB2' ' A' ' 241' ' ' LYS . 2.3 p90 -132.24 -178.62 4.99 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.894 -175.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -104.49 101.88 30.37 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . 0.518 ' HG3' ' HB2' ' A' ' 239' ' ' PHE . 60.7 Cg_endo -75.43 -42.63 0.44 Allowed 'Trans proline' 0 CA--C 1.529 0.256 0 C-N-CA 122.311 2.007 . . . . 0.0 111.878 177.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -94.66 83.91 4.16 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.566 0.698 . . . . 0.0 109.907 176.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 298' ' ' ASN . . . . . 0.434 ' HA ' ' HD3' ' A' ' 299' ' ' PRO . 17.3 m120 -79.95 127.18 78.09 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 115.395 -0.821 . . . . 0.0 111.288 -175.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 299' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 298' ' ' ASN . 6.3 Cg_exo -74.81 7.18 2.9 Favored 'Trans proline' 0 CA--C 1.529 0.229 0 C-N-CA 123.126 2.55 . . . . 0.0 111.211 172.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -53.39 -47.05 69.84 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.568 -179.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -111.42 -23.02 11.0 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.729 177.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 70.81 -58.1 0.57 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.443 178.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.414 -0.803 . . . . 0.0 110.047 177.86 . . . . . . . . 0 0 . 1 stop_ save_